PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zhang, JC; Qu, PX; Zhou, C; Liu, X; Ma, XN; Wang, MY; Wang, YS; Su, JM; Liu, J; Zhang, Y				Zhang, Jingcheng; Qu, Pengxiang; Zhou, Chuan; Liu, Xin; Ma, Xiaonan; Wang, Mengyun; Wang, Yongsheng; Su, Jianmin; Liu, Jun; Zhang, Yong			MicroRNA-125b is a key epigenetic regulatory factor that promotes nuclear transfer reprogramming	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLURIPOTENT STEM-CELLS; EMBRYONIC-DEVELOPMENT; CLONED EMBRYOS; BOVINE EMBRYOS; HETEROCHROMATIN; METHYLATION; IMPROVES; SUV39H1; DIFFERENTIATION; TRANSCRIPTION	Somatic cell nuclear transfer (SCNT)-mediated reprogramming is a rapid, efficient, and sophisticated process that reprograms differentiated somatic cells to a pluripotent state. However, many factors in this elaborate reprogramming process remain largely unknown. Here, we report that the microRNA (miR) miR-125b is an important component of SCNT-mediated reprogramming. Luciferase reporter assay, quantitative PCR, and Western blotting demonstrated that miR-125b directly binds the 3'-untranslated region of SUV39H1, encoding the histone- lysine N-methyltransferase SUV39H1, to down-regulate histone H3 lysine-9 tri-methylation (H3K9me3) in SCNT embryos. Furthermore, the miR-125b/SUV39H1 interaction induced loss of SUV39H1-mediated H3K9me3, caused heterochromatin relaxation, and promoted the development of SCNT embryos. Transcriptome analyses of SCNT blastomeres indicated that HNF1 homeobox B (HNF1B), a gene encoding a transcription factor downstream of and controlled by the miR-125b/SUV39H1 axis, is important for conferring developmental competence on preimplantation embryos. We conclude that miR-125b promotes SCNT-mediated nuclear reprogramming by targeting SUV39H1 to decrease the deposition of repressive H3K9me3 modifications.	[Zhang, Jingcheng; Qu, Pengxiang; Zhou, Chuan; Liu, Xin; Ma, Xiaonan; Wang, Mengyun; Wang, Yongsheng; Su, Jianmin; Liu, Jun; Zhang, Yong] Northwest A&F Univ, Key Lab Anim Biotechnol, Minist Agr, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Wang, YS; Zhang, Y (corresponding author), Northwest A&F Univ, Key Lab Anim Biotechnol, Taicheng Rd, Yangling 712100, Shaanxi, Peoples R China.	Wangyongsheng01@nwsuaf.edu.cn; zhy1956@263.net			National High Technology Research and Development Program of China (863 Program) [2011AA100303]; National Natural Science Foundation of China [31472094, 31772603]; National Major Project for Production of Transgenic Breeding [2016ZX08007003]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Project for Production of Transgenic Breeding	This work was supported by the National High Technology Research and Development Program of China (863 Program) (2011AA100303), a grant from the National Natural Science Foundation of China (31472094 and 31772603), and the National Major Project for Production of Transgenic Breeding (2016ZX08007003). The authors declare that they have no conflicts of interest with the contents of this article.	Antony J, 2013, MOL CELL BIOL, V33, P974, DOI 10.1128/MCB.01014-12; Barbacci E, 1999, DEVELOPMENT, V126, P4795; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brero A, 2009, CLONING STEM CELLS, V11, P319, DOI 10.1089/clo.2008.0083; Chang CC, 2010, CELL REPROGRAM, V12, P43, DOI 10.1089/cell.2009.0043; Chung YG, 2015, CELL STEM CELL, V17, P758, DOI 10.1016/j.stem.2015.10.001; Coffinier C, 1999, DEVELOPMENT, V126, P4785; Denicol AC, 2013, SCI REP-UK, V3, DOI 10.1038/srep01266; Djeghloul D, 2016, STEM CELL REP, V6, P970, DOI 10.1016/j.stemcr.2016.05.007; Fields SD, 2011, THERIOGENOLOGY, V75, P1466, DOI 10.1016/j.theriogenology.2010.12.007; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Hashem N., 2017, REPROD FERT DEVELOP, V29, P179; Hisada K, 2012, MOL CELL BIOL, V32, P1139, DOI 10.1128/MCB.06441-11; Kallingappa PK, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.115.137109; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim KH, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160181; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li H, 2017, CHRONOBIOL INT, V20, P1; Li ZH, 2011, EMBO J, V30, P823, DOI 10.1038/emboj.2011.2; Liao BJ, 2011, J BIOL CHEM, V286, P17359, DOI 10.1074/jbc.C111.235960; Liu WM, 2012, P NATL ACAD SCI USA, V109, P490, DOI 10.1073/pnas.1110368109; Liu WQ, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.10; Loi P, 2016, TRENDS BIOTECHNOL, V34, P791, DOI 10.1016/j.tibtech.2016.03.008; Matoba S, 2014, CELL, V159, P884, DOI 10.1016/j.cell.2014.09.055; Mondou E, 2012, MOL HUM REPROD, V18, P425, DOI 10.1093/molehr/gas015; Neira JA, 2010, THERIOGENOLOGY, V73, P595, DOI 10.1016/j.theriogenology.2009.10.015; Ono T, 2010, BIOL REPROD, V83, P929, DOI 10.1095/biolreprod.110.085282; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Poleshko A, 2014, NUCLEUS-PHILA, V5, P32, DOI 10.4161/nucl.28167; Takahashi K, 2015, DEVELOPMENT, V142, P3274, DOI 10.1242/dev.114249; Teperek M, 2016, GENOME RES, V26, P1034, DOI 10.1101/gr.201541.115; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Wang DL, 2013, P NATL ACAD SCI USA, V110, P5516, DOI 10.1073/pnas.1216596110; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Wang YS, 2011, REPROD DOMEST ANIM, V46, P404, DOI 10.1111/j.1439-0531.2010.01679.x; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Xie BT, 2016, REPRODUCTION, V151, P9, DOI 10.1530/REP-15-0338; Xiong XR, 2014, ZYGOTE, V22, P1, DOI 10.1017/S0967199412000184; Yang QY, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501482; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973	42	29	30	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15916	15926		10.1074/jbc.M117.796771	http://dx.doi.org/10.1074/jbc.M117.796771			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28794155	Green Published, hybrid			2022-12-26	WOS:000411512200028
J	Wiechmann, S; Gartner, A; Kniss, A; Stengl, A; Behrends, C; Rogov, VV; Rodriguez, MS; Dotsch, V; Muller, S; Ernst, A				Wiechmann, Svenja; Gaertner, Anne; Kniss, Andreas; Stengl, Andreas; Behrends, Christian; Rogov, Vladimir V.; Rodriguez, Manuel S.; Doetsch, Volker; Mueller, Stefan; Ernst, Andreas			Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 LIGASE; STRUCTURAL BASIS; PML DEGRADATION; CONJUGATION; BINDING; SYSTEM; RNF4; IDENTIFICATION; PROTEINS; REVEALS	Posttranslational modifications by small ubiquitin-like modifiers (SUMOs) regulate many cellular processes, including genome integrity, gene expression, and ribosome biogenesis. The E2-conjugating enzyme Ubc9 catalyzes the conjugation of SUMOs to epsilon-amino groups of lysine residues in target proteins. Attachment of SUMO moieties to internal lysines in Ubc9 itself can further lead to the formation of polymeric SUMO chains. Mono-and poly-SUMOylations of target proteins provide docking sites for distinct adapter and effector proteins important for regulating discrete SUMO-regulated pathways. However, molecular tools to dissect pathways depending on either mono-or poly-SUMOylation are largely missing. Using a protein-engineering approach, we generated high-affinity SUMO2 variants by phage display that bind the back side binding site of Ubc9 and function as SUMO-based Ubc9 inhibitors (SUBINs). Importantly, we found that distinct SUBINs primarily inhibit poly-SUMO chain formation, whereas mono-SUMOylation was not impaired. Proof-of-principle experiments demonstrated that in a cellular context, SUBINs largely prevent heat shock-triggered polySUMOylation. Moreover, SUBINs abrogated arsenic-induced degradation of promyelocytic leukemia protein. We propose that the availability of the new chain-selective SUMO inhibitors reported here will enable a thorough investigation of poly-SUMO-mediated cellular processes, such as DNA damage responses and cell cycle progression.	[Wiechmann, Svenja; Gaertner, Anne; Stengl, Andreas; Behrends, Christian; Mueller, Stefan; Ernst, Andreas] Goethe Univ, Sch Med, Inst Biochem 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany; [Kniss, Andreas; Rogov, Vladimir V.; Doetsch, Volker] Goethe Univ, Inst Biophys Chem, Max von Laue Str 9, D-60438 Frankfurt, Germany; [Kniss, Andreas; Rogov, Vladimir V.; Doetsch, Volker] Goethe Univ, Ctr Biomol Magnet Resonance, Max von Laue Str 9, D-60438 Frankfurt, Germany; [Ernst, Andreas] Fraunhofer Inst Mol Biol & Appl Ecol IME, Project Grp Translat Med & Pharmacol TMP, Theodor Stern Kai 7, D-60590 Frankfurt, Germany; [Rodriguez, Manuel S.] Inst Technol Avancees Sci Vivant UPS, 1 Pl Pierre Potier Oncopole Entree B,BP 50624, F-31106 Toulouse 1, France; [Rodriguez, Manuel S.] IPBS CNRS, 1 Pl Pierre Potier Oncopole Entree B,BP 50624, F-31106 Toulouse 1, France; [Stengl, Andreas] Ludwig Maximilian Univ Munich, Dept Biol 2, Grosshaderner Str 2, D-82152 Martinsried, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Fraunhofer Gesellschaft; Centre National de la Recherche Scientifique (CNRS); University of Munich	Muller, S; Ernst, A (corresponding author), Goethe Univ, Sch Med, Inst Biochem 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.; Ernst, A (corresponding author), Fraunhofer Inst Mol Biol & Appl Ecol IME, Project Grp Translat Med & Pharmacol TMP, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	ste.mueller@em.uni-frankfurt.de; a.ernst@em.uni-frankfurt.de	Stengl, Andreas/ABD-2251-2021; Ernst, Andreas/M-3013-2019; RODRIGUEZ, Manuel S./D-5439-2018; Behrends, Christian/AAX-4201-2021	Stengl, Andreas/0000-0002-8802-3260; Behrends, Christian/0000-0002-9184-7607; Muller, Stefan/0000-0002-8792-7700	LOEWE Ub-Net; Cluster of Excellence "Macromolecular Complexes" [DFG EXC115]; Collaborative Research Center [SFB 1177]	LOEWE Ub-Net; Cluster of Excellence "Macromolecular Complexes"; Collaborative Research Center	This work was supported by LOEWE Ub-Net, Cluster of Excellence "Macromolecular Complexes" (DFG EXC115), and the Collaborative Research Center SFB 1177. The authors declare that they have no conflicts of interest with the contents of this article.	Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Brown NG, 2016, CELL, V165, P1440, DOI 10.1016/j.cell.2016.05.037; Capili AD, 2007, J MOL BIOL, V369, P608, DOI 10.1016/j.jmb.2007.04.006; Cappadocia L, 2015, NAT STRUCT MOL BIOL, V22, P968, DOI 10.1038/nsmb.3116; Da Silva-Ferrada E, 2013, SCI REP-UK, V3, DOI 10.1038/srep01690; Eisenhardt N, 2015, NAT STRUCT MOL BIOL, V22, P959, DOI 10.1038/nsmb.3114; Erker Y, 2013, MOL CELL BIOL, V33, P2163, DOI 10.1128/MCB.01019-12; Ernst A, 2013, SCIENCE, V339, P590, DOI 10.1126/science.1230161; Fellouse FAS, 2007, MAKING USING ANTIBOD, P157; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P743; Gorelik M, 2016, P NATL ACAD SCI USA, V113, P3527, DOI 10.1073/pnas.1519389113; Grana-Montes R, 2014, BIOMACROMOLECULES, V15, P1194, DOI 10.1021/bm401776z; Hendriks IA, 2016, NAT REV MOL CELL BIO, V17, P581, DOI 10.1038/nrm.2016.81; Kamitani T, 1998, J BIOL CHEM, V273, P26675, DOI 10.1074/jbc.273.41.26675; Kay Brian K., 2009, V498, P185, DOI 10.1007/978-1-59745-196-3_13; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Leung I, 2016, P NATL ACAD SCI USA, V113, P8705, DOI 10.1073/pnas.1524648113; Liu Q, 1999, J BIOMOL NMR, V13, P89, DOI 10.1023/A:1008364314328; Long XM, 2000, J BIOL CHEM, V275, P40765, DOI 10.1074/jbc.M003949200; Manczyk N, 2017, PROTEIN SCI, V26, P1060, DOI 10.1002/pro.3155; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Nie MH, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010014; Raman N, 2013, CHROMOSOMA, V122, P475, DOI 10.1007/s00412-013-0429-6; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Rogov VV, 2012, CHEMBIOCHEM, V13, P959, DOI 10.1002/cbic.201200045; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Sambrook D. W. R., 2001, MOL CLONING LAB MANU, P1366; Shen LN, 2006, BIOCHEM J, V397, P279, DOI 10.1042/BJ20052030; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Sriramachandran AM, 2014, BBA-MOL CELL RES, V1843, P75, DOI 10.1016/j.bbamcr.2013.08.022; Streich FC, 2014, ANNU REV BIOPHYS, V43, P357, DOI 10.1146/annurev-biophys-051013-022958; Sun HY, 2012, J BIOL CHEM, V287, P42071, DOI 10.1074/jbc.M112.410985; Sun MGF, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600692; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Velazquez-Campoy A, 2006, NAT PROTOC, V1, P186, DOI 10.1038/nprot.2006.28; Wang J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015805; Yamaguchi M, 2016, MOL CELL, V63, P593, DOI 10.1016/j.molcel.2016.07.003; Yin YL, 2012, GENE DEV, V26, P1196, DOI 10.1101/gad.189274.112; Yu B, 2015, P NATL ACAD SCI USA, V112, pE1724, DOI 10.1073/pnas.1415569112; Zhang W, 2016, MOL CELL, V62, P121, DOI 10.1016/j.molcel.2016.02.005; Zhu S, 2010, ONCOGENE, V29, P1763, DOI 10.1038/onc.2009.459	49	19	20	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15340	15351		10.1074/jbc.M117.794255	http://dx.doi.org/10.1074/jbc.M117.794255			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28784659	hybrid, Green Published			2022-12-26	WOS:000410809800016
J	Leontovyc, I; Habart, D; Loukotova, S; Kosinova, L; Kriz, J; Saudek, F; Koblas, T				Leontovyc, Ivan; Habart, David; Loukotova, Sarka; Kosinova, Lucie; Kriz, Jan; Saudek, Frantisek; Koblas, Tomas			Synthetic mRNA is a more reliable tool for the delivery of DNA-targeting proteins into the cell nucleus than fusion with a protein transduction domain	PLOS ONE			English	Article							LINE; FIBROBLASTS; ORIGIN	Cell reprogramming requires efficient delivery of reprogramming transcription factors into the cell nucleus. Here, we compared the robustness and workload of two protein delivery methods that avoid the risk of genomic integration. The first method is based on fusion of the protein of interest to a protein transduction domain (PTD) for delivery across the membranes of target cells. The second method relies on de novo synthesis of the protein of interest inside the target cells utilizing synthetic mRNA (syn-mRNA) as a template. We established a Cre/lox reporter system in three different cell types derived from human (PANC-1, HEK293) and rat (BRIN-BD11) tissues and used Cre recombinase to model a protein of interest. The system allowed constitutive expression of red fluorescence protein (RFP), while green fluorescence protein (GFP) was expressed only after the genomic action of Cre recombinase. The efficiency of protein delivery into cell nuclei was quantified as the frequency of GFP(+) cells in the total cell number. The PTD method showed good efficiency only in BRIN-BD11 cells (68%), whereas it failed in PANC-1 and HEK293 cells. By contrast, the syn-mRNA method was highly effective in all three cell types (29-71%). We conclude that using synthetic mRNA is a more robust and less labor-intensive approach than using the PTD-fusion alternative.	[Leontovyc, Ivan; Loukotova, Sarka; Kosinova, Lucie; Koblas, Tomas] Inst Clin & Expt Med, Dept Expt Med, Prague, Czech Republic; [Habart, David; Kriz, Jan; Saudek, Frantisek] Inst Clin & Expt Med, Dept Diabet, Prague, Czech Republic	Institute for Clinical & Experimental Medicine (IKEM); Institute for Clinical & Experimental Medicine (IKEM)	Leontovyc, I (corresponding author), Inst Clin & Expt Med, Dept Expt Med, Prague, Czech Republic.	ivan.leontovyc@ikem.cz	Saudek, František/E-1975-2018; Kosinová, Lucie/AAW-8533-2021; Habart, David/B-4291-2009; Kriz, Jan/G-1067-2019	Saudek, František/0000-0002-0448-4351; Kosinova, Lucie/0000-0001-5837-5508; Kriz, Jan/0000-0001-7695-3885	Ministry of Health of the Czech Republic [15-25924A]; Grant Agency of the Czech Republic [14-03305S]; Grant Agency of Charles University [34216, SW 260 377/2017]; Specific University Research [260257]; Charles University [14-03305S, 34216, SVV 260 377/2017]	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Grant Agency of Charles University; Specific University Research; Charles University	This work was supported by 15-25924A, http://www.mzcr.cz/en/, Ministry of Health of the Czech Republic, all rights reserved. Koblas T; 14-03305S, https://gacr.cz/en/,Grant Agency of the Czech Republic, Kriz J; GAUK no. 34216 and SW 260 377/2017, http://www.cuni.cz/UK-33.html, Grant Agency of Charles University, Loukotova S; 260257, http://www.cuni.cz/UK-3362.html, Specific University Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Ministry of Health of the Czech Republic, grant nr. 15-25924A. All rights reserved, GA CR no. 14-03305S and grants GAUK no. 34216 and SVV 260 377/2017 from Charles University. The authors have no potential conflicts of interest relevant to this article.	Bach H, 2001, J MOL BIOL, V312, P79, DOI 10.1006/jmbi.2001.4914; Barber GN, 2001, CELL DEATH DIFFER, V8, P113, DOI 10.1038/sj.cdd.4400823; Casademunt E, 2012, EUR J HAEMATOL, V89, P165, DOI 10.1111/j.1600-0609.2012.01804.x; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Heathman TRJ, 2015, REGEN MED, V10, P49, DOI [10.2217/RME.14.73, 10.2217/rme.14.73]; Ho A, 2001, CANCER RES, V61, P474; Horak CE, 2002, P NATL ACAD SCI USA, V99, P2924, DOI 10.1073/pnas.052706999; Kaczmarczyk SJ, 2001, NUCLEIC ACIDS RES, V29, P1; Kaczmarczyk SJ, 2011, P NATL ACAD SCI USA, V108, P16998, DOI 10.1073/pnas.1101874108; Kariko K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr695; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Koblas T, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.33; Kormann MSD, 2011, NAT BIOTECHNOL, V29, P154, DOI 10.1038/nbt.1733; LIEBER M, 1975, INT J CANCER, V15, P741, DOI 10.1002/ijc.2910150505; McClenaghan NH, 1996, DIABETES, V45, P1132, DOI 10.2337/diabetes.45.8.1132; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Raran-Kurussi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049589; Sahin U, 2014, NATURE REW DRUG DISC, V19, P1; Schlaeger TM, 2015, NAT BIOTECHNOL, V33, P58, DOI 10.1038/nbt.3070; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Shaw PA, 2008, BIOCHEMISTRY-US, V47, P1157, DOI 10.1021/bi701542p; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Stephen SL, 2010, J VIROL, V84, P9987, DOI 10.1128/JVI.00751-10; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Waddell J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023020; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wadia JS, 2002, CURR OPIN BIOTECH, V13, P52, DOI 10.1016/S0958-1669(02)00284-7; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wiehe JM, 2007, J CELL MOL MED, V11, P521, DOI 10.1111/j.1582-4934.2007.00038.x; Will E, 2002, NUCLEIC ACIDS RES, V30, P472; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Zhang T, 2010, ENDOCRINOLOGY, V151, P2030, DOI 10.1210/en.2009-1224	33	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2017	12	8							e0182497	10.1371/journal.pone.0182497	http://dx.doi.org/10.1371/journal.pone.0182497			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD5CP	28806415	Green Published, Green Submitted, gold			2022-12-26	WOS:000407548800023
J	Castro-Sanchez, S; Alvarez-Satta, M; Tohamy, MA; Beltran, S; Derdak, S; Valverde, D				Castro-Sanchez, Sheila; Alvarez-Satta, Maria; Tohamy, Mohamed A.; Beltran, Sergi; Derdak, Sophia; Valverde, Diana			Whole exome sequencing as a diagnostic tool for patients with ciliopathy-like phenotypes	PLOS ONE			English	Article							BARDET-BIEDL-SYNDROME; GENE PRIORITIZATION; HUMAN INTERACTOME; MESSENGER-RNA; BBS GENES; MUTATIONS; IDENTIFICATION; CANDIDATE; DISEASE; PROTEIN	Ciliopathies are a group of rare disorders characterized by a high genetic and phenotypic variability, which complicates their molecular diagnosis. Hence the need to use the latest powerful approaches to faster identify the genetic defect in these patients. We applied whole exome sequencing to six consanguineous families clinically diagnosed with ciliopathy- like disease, and for which mutations in predominant Bardet-Biedl syndrome (BBS) genes had previously been excluded. Our strategy, based on first applying several filters to ciliary variants and using many of the bioinformatics tools available, allowed us to identify causal mutations in BBS2, ALMS1 and CRB1 genes in four families, thus confirming the molecular diagnosis of ciliopathy. In the remaining two families, after first rejecting the presence of pathogenic variants in common cilia-related genes, we adopted a new filtering strategy combined with prioritisation tools to rank the final candidate genes for each case. Thus, we propose CORO2B, LMO7 and ZNF17 as novel candidate ciliary genes, but further functional studies will be needed to confirm their role. Our data show the usefulness of this strategy to diagnose patients with unclear phenotypes, and therefore the success of applying such technologies to achieve a rapid and reliable molecular diagnosis, improving genetic counselling for these patients. In addition, the described pipeline also highlights the common pitfalls associated to the large volume of data we have to face and the difficulty of assigning a functional role to these changes, hence the importance of designing the most appropriate strategy according to each case.	[Castro-Sanchez, Sheila; Alvarez-Satta, Maria; Tohamy, Mohamed A.; Valverde, Diana] Univ Vigo, Fac Biol, Dept Bioquim Genet & Inmunol, Vigo, Spain; [Castro-Sanchez, Sheila; Alvarez-Satta, Maria; Valverde, Diana] Hosp Alvaro Cunqueiro, SERGAS UVIGO, IISGS, Res Grp Rare Dis & Pediat Med, Vigo, Spain; [Castro-Sanchez, Sheila; Alvarez-Satta, Maria; Valverde, Diana] Univ Vigo, Ctr Invest Biomed CINBIO, Ctr Singular Invest Galicia, Vigo, Spain; [Beltran, Sergi; Derdak, Sophia] Barcelona Inst Sci & Technol, Ctr Genom Regulat CRG, CNAG CR, Barcelona, Spain; [Beltran, Sergi; Derdak, Sophia] UPF, Barcelona, Spain; [Tohamy, Mohamed A.] Beni Suef Univ, Dept Biochem, Fac Pharm, Bani Suwayf, Egypt	Universidade de Vigo; Universidade de Vigo; CINBIO; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Egyptian Knowledge Bank (EKB); Beni Suef University	Valverde, D (corresponding author), Univ Vigo, Fac Biol, Dept Bioquim Genet & Inmunol, Vigo, Spain.; Valverde, D (corresponding author), Hosp Alvaro Cunqueiro, SERGAS UVIGO, IISGS, Res Grp Rare Dis & Pediat Med, Vigo, Spain.; Valverde, D (corresponding author), Univ Vigo, Ctr Invest Biomed CINBIO, Ctr Singular Invest Galicia, Vigo, Spain.	dianaval@uvigo.es	Valverde, Diana/Y-1101-2019; Beltran, Sergi/I-3408-2015; Diana, Valverde/I-2409-2012; Castro-Sánchez, Sheila/C-3134-2018; Tohamy, Mohamed/AAT-7431-2020	Valverde, Diana/0000-0002-7024-1657; Beltran, Sergi/0000-0002-2810-3445; Diana, Valverde/0000-0002-7024-1657; Castro-Sánchez, Sheila/0000-0001-6614-2608; Alvarez Satta, Maria/0000-0003-2938-5357; Tohamy, Mohamed/0000-0002-5232-4766	Spanish Ministry of Economy, Industry and Competitiveness-Instituto de Salud Carlos III [PI12/01853]; Centro Nacional de Analisis Genomico (CNAG); Spanish Ministry of Education, Culture and Sports [FPU13/01835, FPU12/01442]; Spanish Ministry of Science and Innovation (MICINN) [PTQ-12-05391]	Spanish Ministry of Economy, Industry and Competitiveness-Instituto de Salud Carlos III; Centro Nacional de Analisis Genomico (CNAG); Spanish Ministry of Education, Culture and Sports(Spanish Government); Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the Spanish Ministry of Economy, Industry and Competitiveness-Instituto de Salud Carlos III (http://www.isciii.es/) grant PI12/01853, and the Centro Nacional de Analisis Genomico (CNAG) for the "2013 CNAG-call: 300 exomes to elucidate rare diseases" (code:SENDIS; http//www.cnag.crg.eu/). SC-S and MA-S are recipients of Formacion de Profesorado Universitario (FPU) fellowships (FPU13/01835 and FPU12/01442, respectively) from the Spanish Ministry of Education, Culture and Sports (http://www.mecd.gob.es/portadamecd/). SD was supported by the Torres Quevedo subprogram from the Spanish Ministry of Science and Innovation (MICINN, http://www.idi.mineco.gob.es/portal/site/MICINN/) under the grant agreement PTQ-12-05391. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Abu-Safieh L, 2013, GENOME RES, V23, P236, DOI 10.1101/gr.144105.112; Adly N, 2014, HUM MUTAT, V35, P36, DOI 10.1002/humu.22477; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Alkuraya FS, 2013, HUM GENET, V132, P1197, DOI 10.1007/s00439-013-1344-x; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Alvarez-Satta M, 2014, CLIN GENET, V86, P601, DOI 10.1111/cge.12334; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Arnaiz O, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap022; Bachmann-Gagescu R, 2014, M S-MED SCI, V30, P1011, DOI 10.1051/medsci/20143011016; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Beales PL, 1999, J MED GENET, V36, P437; Beck BB, 2014, HUM MUTAT, V35, P1153, DOI 10.1002/humu.22618; Berger W, 2010, PROG RETIN EYE RES, V29, P335, DOI 10.1016/j.preteyeres.2010.03.004; Bond J, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.026617; Castro-Sanchez S, 2015, MED CLIN-BARCELONA, V145, P147, DOI 10.1016/j.medcli.2014.05.037; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chevrier V, 2016, HUM MOL GENET, V25, P497, DOI 10.1093/hmg/ddv488; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cingolani Pablo, 2012, Frontiers in Genetics, V3, P35, DOI 10.3389/fgene.2012.00035; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; David A, 1999, J MED GENET, V36, P599; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Endsley JK, 1997, KIDNEY INT, V51, P1893, DOI 10.1038/ki.1997.258; Erlich Y, 2011, GENOME RES, V21, P658, DOI 10.1101/gr.117143.110; Girisha KM, 2016, CLIN GENET, V90, P536, DOI 10.1111/cge.12762; Harnevik L, 2001, HUM MUTAT, V18, P516, DOI 10.1002/humu.1228; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Hengl T, 2010, P NATL ACAD SCI USA, V107, P6052, DOI 10.1073/pnas.0909032107; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hostelley TL, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2679-1; Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366; Kancheva D, 2016, GENET MED, V18, P600, DOI 10.1038/gim.2015.139; Kim MK, 2015, DIABETES METAB J, V39, P439, DOI 10.4093/dmj.2015.39.5.439; Knopp C, 2015, MOL CELL PROBE, V29, P299, DOI 10.1016/j.mcp.2015.05.008; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li MX, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1257; Li Q, 2005, HUM MOL GENET, V14, P1587, DOI 10.1093/hmg/ddi167; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Lodh S, 2016, HUM MOL GENET, V25, P57, DOI 10.1093/hmg/ddv447; Lotery AJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P415, DOI 10.1001/archopht.119.3.415; M'hamdi O, 2014, MOL SYNDROMOL, V5, P51, DOI 10.1159/000357054; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mezzavilla M, 2015, HUM HERED, V79, P14, DOI 10.1159/000371387; Mucaki EJ, 2013, HUM MUTAT, V34, P557, DOI 10.1002/humu.22277; Nakamura T, 1999, J BIOL CHEM, V274, P13322, DOI 10.1074/jbc.274.19.13322; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Pearson CG, 2009, J CELL BIOL, V187, P904, DOI 10.1083/jcb.200908019; Pereiro I, 2011, EUR J HUM GENET, V19, P485, DOI 10.1038/ejhg.2010.207; Pereiro I, 2010, MOL VIS, V16, P137; Perez-Carro R, 2016, SCI REP-UK, V6, DOI 10.1038/srep19531; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rabbani B, 2012, J HUM GENET, V57, P621, DOI 10.1038/jhg.2012.91; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Roosing S, 2016, J MED GENET, V53, P608, DOI 10.1136/jmedgenet-2016-103832; Schaefer E, 2011, EUR J MED GENET, V54, P157, DOI 10.1016/j.ejmg.2010.10.004; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Shaheen R, 2013, EUR J HUM GENET, V21, P762, DOI 10.1038/ejhg.2012.254; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Smaoui N, 2006, INVEST OPHTH VIS SCI, V47, P3487, DOI 10.1167/iovs.05-1334; Smith Temple F., 2008, V48, P20, DOI 10.1007/978-0-387-09595-0_3; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; van Dam Teunis Jp, 2013, Cilia, V2, P7, DOI 10.1186/2046-2530-2-7; van Reeuwijk J, 2011, HUM MOL GENET, V20, pR149, DOI 10.1093/hmg/ddr354; Vinayagam A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001699; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Zaki MS, 2016, HUM MUTAT, V37, P170, DOI 10.1002/humu.22934	72	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0183081	10.1371/journal.pone.0183081	http://dx.doi.org/10.1371/journal.pone.0183081			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800606	Green Submitted, Green Published, gold			2022-12-26	WOS:000407431800050
J	Lee, Y; Choo, J; Kim, SJ; Heo, G; Pothoulakis, C; Kim, YH; Im, E				Lee, Yunna; Choo, Jieun; Kim, Su Jin; Heo, Gwangbeom; Pothoulakis, Charalabos; Kim, Yong-Hak; Im, Eunok			Analysis of endogenous lipids during intestinal wound healing	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; SEVERE ULCERATIVE-COLITIS; TRIGGERED RESOLVIN D1; DOCOSAHEXAENOIC ACID; IMPROVED OUTCOMES; EPITHELIAL-CELLS; RESOLUTION; MICE; MEDIATORS; MECHANISMS	Intestinal wound healing is a new therapeutic goal for inflammatory bowel disease (IBD) as complete healing of the mucosa is the key element of clinical remission in IBD. Previous studies showed that termination of inflammation can be achieved by adding pro-resolving lipids like DHA and EPA exogenously. However, the roles of these lipids in mucosal healing have not been investigated. To recapitulate intestinal healing process, mice were received dextran sodium sulfate (DSS) for 7 days in the drinking water followed by regular tap water for 5 additional days. DSS-induced intestinal inflammation featuring body weight loss, histological tissue damage, increased cytokine production and infiltration of inflammatory cells was gradually reduced upon switching to water. To investigate whether endogenous lipids play a role in mucosal healing, the lipidomics analysis of mouse serum was performed. Reduced levels of arachidonic acid, the biosynthetic precursor of prostaglandin F (PGF)(2 alpha), 19H-PGF(1 alpha), the metabolite of prostacyclin, and 20H-PGF(2 alpha), the metabolite of PGF(2 alpha), suggest subsiding inflammation. In contrast, increased levels of an active metabolite of resolvin D1 along with decreased levels of its precursor DHA as well as decreased levels of the precursor of resolvin E, 18-hydroxy-eicosapentaenoic acid, suggest inauguration of mucosal healing by endogenous lipids. Furthermore, exogenously supplied fish oil enhanced the process even further. These results suggest the presence of mucosal healing regulated by endogenous pro-healing lipids and also indicate that the remission state of IBD could be prolonged by enhancing the levels of these lipids.	[Lee, Yunna; Choo, Jieun; Kim, Su Jin; Heo, Gwangbeom; Im, Eunok] Pusan Natl Univ, Coll Pharm, Busan, South Korea; [Pothoulakis, Charalabos] Univ Calif Los Angeles, David Geffen Sch Med, Sect Inflammatory Bowel Dis, Los Angeles, CA 90095 USA; [Pothoulakis, Charalabos] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Inflammatory Bowel Dis, Div Digest Dis, Los Angeles, CA 90095 USA; [Kim, Yong-Hak] Catholic Univ Daegu, Sch Med, Dept Microbiol, Daegu, South Korea	Pusan National University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Catholic University of Daegu	Im, E (corresponding author), Pusan Natl Univ, Coll Pharm, Busan, South Korea.	eoim@pusan.ac.kr			MSIP through National Research Foundation of Korea (NRF) [2009-0083538]; NRF - Ministry of Education [2016R1D1A1B03932222, 2016R1A2B2014493]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301] Funding Source: NIH RePORTER	MSIP through National Research Foundation of Korea (NRF); NRF - Ministry of Education; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by MSIP (2009-0083538) through the National Research Foundation of Korea (NRF) and by Basic Science Research Program through NRF funded by the Ministry of Education (2016R1D1A1B03932222 to E.I. and 2016R1A2B2014493 to Y.H.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandri AL, 2013, PHARMACOL THERAPEUT, V139, P189, DOI 10.1016/j.pharmthera.2013.04.006; Arita M, 2005, P NATL ACAD SCI USA, V102, P7671, DOI 10.1073/pnas.0409271102; Arita M, 2006, J BIOL CHEM, V281, P22847, DOI 10.1074/jbc.M603766200; Arnardottir HH, 2014, J IMMUNOL, V193, P4235, DOI 10.4049/jimmunol.1401313; Artis D, 2002, J IMMUNOL, V169, P4481, DOI 10.4049/jimmunol.169.8.4481; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Basu S, 2010, MOL CELLS, V30, P383, DOI 10.1007/s10059-010-0157-1; Bento AF, 2011, J IMMUNOL, V187, P1957, DOI 10.4049/jimmunol.1101305; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Chen KD, 2013, J CLIN INVEST, V123, P1694, DOI 10.1172/JCI65569; Choi JS, 2015, MUCOSAL IMMUNOL, V8, P1285, DOI 10.1038/mi.2015.19; Crandall WV, 2012, PEDIATRICS, V129, pE1030, DOI 10.1542/peds.2011-1700; Dabritz J, 2013, AM J GASTROENTEROL, V108, P1901, DOI 10.1038/ajg.2013.360; Davidson LA, 2012, BBA-MOL BASIS DIS, V1822, P1600, DOI 10.1016/j.bbadis.2012.06.011; DIGNASS AU, 1993, GASTROENTEROLOGY, V105, P1323, DOI 10.1016/0016-5085(93)90136-Z; Dulai PS, 2014, CLIN GASTROENTEROL H, V12, P1443, DOI 10.1016/j.cgh.2014.01.021; Forster K, 2012, GASTROENTEROLOGY, V143, P1298, DOI 10.1053/j.gastro.2012.07.019; Gao JL, 1999, J EXP MED, V189, P657, DOI 10.1084/jem.189.4.657; Gilbert S, 2012, EMBO MOL MED, V4, P109, DOI 10.1002/emmm.201100192; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Ho SB, 2006, GASTROENTEROLOGY, V131, P1501, DOI 10.1053/j.gastro.2006.09.006; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Hong S, 2008, J IMMUNOL, V180, P3512, DOI 10.4049/jimmunol.180.5.3512; Huebener P, 2013, BBA-MOL BASIS DIS, V1832, P1005, DOI 10.1016/j.bbadis.2012.11.017; Im E, 2014, GASTROENTEROLOGY, V147, P667, DOI 10.1053/j.gastro.2014.05.034; Im E, 2009, AM J PHYSIOL-GASTR L, V297, pG999, DOI 10.1152/ajpgi.00204.2009; Lehtola E, 2016, SCAND J GASTROENTERO, V51, P1476, DOI 10.1080/00365521.2016.1218539; LEUSCHEN MP, 1991, J THORAC CARDIOV SUR, V101, P148; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Moyer RA, 2007, LAB INVEST, V87, P807, DOI 10.1038/labinvest.3700595; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Neurath MF, 2014, MUCOSAL IMMUNOL, V7, P6, DOI 10.1038/mi.2013.73; Otte JM, 2008, J CELL BIOCHEM, V104, P2286, DOI 10.1002/jcb.21787; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Qiu Y, 2017, J GASTROENTEROL, V52, P535, DOI 10.1007/s00535-017-1324-3; Rhee SH, 2005, P NATL ACAD SCI USA, V102, P13610, DOI 10.1073/pnas.0502174102; Rhee SH, 2003, J BIOL CHEM, V278, P22506, DOI 10.1074/jbc.M208633200; Rogerio AP, 2012, J IMMUNOL, V189, P1983, DOI 10.4049/jimmunol.1101665; Rogler G, 2013, WORLD J GASTROENTERO, V19, P7552, DOI 10.3748/wjg.v19.i43.7552; Russel, 2000, Eur J Intern Med, V11, P191, DOI 10.1016/S0953-6205(00)00090-X; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Samson CM, 2012, J PEDIATR GASTR NUTR, V55, P679, DOI 10.1097/MPG.0b013e318262de16; Sandborn WJ, 2014, GASTROENTEROLOGY, V146, P85, DOI 10.1053/j.gastro.2013.05.048; Sandborn WJ, 2012, GASTROENTEROLOGY, V142, P257, DOI 10.1053/j.gastro.2011.10.032; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Serhan CN, 1999, CLIN CHEM LAB MED, V37, P299, DOI 10.1515/CCLM.1999.052; Thai A, 2010, J CROHNS COLITIS, V4, P511, DOI 10.1016/j.crohns.2010.05.006; Varnalidis I, 2011, REV ESP ENFERM DIG, V103, P511, DOI 10.4321/s1130-01082011001000003; Wentworth CC, 2010, AM J PATHOL, V177, P2782, DOI 10.2353/ajpath.2010.100529; Yarur Andres J, 2011, Gastroenterol Hepatol (N Y), V7, P652; Yoon SM, 2017, INFLAMM BOWEL DIS	56	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0183028	10.1371/journal.pone.0183028	http://dx.doi.org/10.1371/journal.pone.0183028			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800645	Green Published, Green Submitted, gold			2022-12-26	WOS:000407431800046
J	Mussawy, H; Viezens, L; Hauenherm, G; Schroeder, M; Schaefer, C				Mussawy, Haider; Viezens, Lennart; Hauenherm, Gerrit; Schroeder, Malte; Schaefer, Christian			In vivo functional and morphological characterization of bone and striated muscle microcirculation in NSG mice	PLOS ONE			English	Article							SCID IL2R-GAMMA(NULL) MICE; DORSAL SKINFOLD CHAMBER; MICROVASCULAR PERMEABILITY; INTRAVITAL MICROSCOPY; TUMOR-GROWTH; STEM-CELLS; MODEL; WINDOW; RECONSTITUTION; SUSCEPTIBILITY	Organ-specific microcirculation plays a central role in tumor growth, tumor cell homing, tissue engineering, and wound healing. Mouse models are widely used to study these processes; however, these mouse strains often possess unique microhemodynamic parameters, making it difficult to directly compare experiments. The full functional characterization of bone and striated muscle microcirculatory parameters in non-obese diabetic-severe combined immunodeficiency/y-chain; NOD-Prkds IL2rg (NSG) mice has not yet been reported. Here, we established either a dorsal skinfold chamber or femur window in NSG mice (n = 23), allowing direct analysis of microcirculatory parameters in vivo by intravital fluorescence microscopy at 7, 14, 21, and 28 days after chamber preparation. Organ-specific differences were observed. Bone had a significantly lower vessel density but a higher vessel diameter than striated muscle. Bone also showed higher effective vascular permeability than striated muscle. The centerline velocity values were similar in the femur window and dorsal skinfold chamber, with a higher volumetric blood flow in bone. Interestingly, bone and striated muscle showed similar tissue perfusion rates. Knowledge of physiological microhemodynamic values of bone and striated muscle in NSG mice makes it possible to analyze pathophysiological processes at these anatomic sites, such as tumor growth, tumor metastasis, and tumor microcirculation, as well as the response to therapeutic agents.	[Mussawy, Haider; Viezens, Lennart; Hauenherm, Gerrit; Schroeder, Malte; Schaefer, Christian] Univ Med Ctr Hamburg Eppendorf, Dept Orthopaed Surg, Hamburg, Germany; [Viezens, Lennart] Univ Med Ctr Hamburg Eppendorf, Dept Trauma Hand & Reconstruct Surg, Hamburg, Germany; [Schroeder, Malte; Schaefer, Christian] Klinikum Bad Bramstedt, Dept Spine Surg, Bad Bramstedt, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Mussawy, H (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Orthopaed Surg, Hamburg, Germany.	h.mussawy@uke.de			Hamburg foundation [1314/100]	Hamburg foundation	There was no additional external funding received for this study except for those indicated in the online submission process: "Hamburg foundation for sponsorship of cancer treatment; Award Number: 1314/100. All funders or sources of support had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agliano A, 2008, INT J CANCER, V123, P2222, DOI 10.1002/ijc.23772; Algenstaedt P, 2003, DIABETES, V52, P542, DOI 10.2337/diabetes.52.2.542; Andre MC, 2010, J IMMUNOL, V185, P2710, DOI 10.4049/jimmunol.1000583; Jimenez-Diaz MB, 2009, ANTIMICROB AGENTS CH, V53, P4533, DOI 10.1128/AAC.00519-09; BRIZEL DM, 1993, INT J RADIAT ONCOL, V25, P269, DOI 10.1016/0360-3016(93)90348-Y; Chen DC, 2006, J SURG RES, V134, P52, DOI 10.1016/j.jss.2006.03.029; Diamanti P, 2012, LEUKEMIA, V26, P376, DOI 10.1038/leu.2011.212; Fuhrhop I, 2010, J ORTHOP RES, V28, P27, DOI 10.1002/jor.20968; Hansen-Algenstaedt N, 2005, J ORTHOP RES, V23, P1073, DOI 10.1016/j.orthres.2005.02.013; Hansen-Algenstaedt N, 2005, EUR J CANCER, V41, P1073, DOI 10.1016/j.ejca.2004.12.034; Harui A, 2011, J NEUROIMMUNE PHARM, V6, P148, DOI 10.1007/s11481-010-9223-x; Hickey RD, 2013, STEM CELL RES, V11, P503, DOI 10.1016/j.scr.2013.02.005; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Ishizawa K, 2010, CELL STEM CELL, V7, P279, DOI 10.1016/j.stem.2010.08.009; Kanaji N, 2014, CANCER MANAG RES, V6, P431, DOI 10.2147/CMAR.S71185; King M, 2008, CLIN IMMUNOL, V126, P303, DOI 10.1016/j.clim.2007.11.001; Ledran MH, 2008, CELL STEM CELL, V3, P85, DOI 10.1016/j.stem.2008.06.001; LEHR HA, 1993, AM J PATHOL, V143, P1055; MENGER MD, 1993, IMMUNOL TODAY, V14, P519, DOI 10.1016/0167-5699(93)90179-O; Menger MD, 2002, EUR SURG RES, V34, P83, DOI 10.1159/000048893; Pazzaglia UE, 2009, CLIN ORTHOP RELAT R, V467, P2446, DOI 10.1007/s11999-009-0806-x; Roth MD, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0056-2; Schaefer C, 2011, J ORTHOP RES, V29, P1251, DOI 10.1002/jor.21402; Schaefer C, 2010, ACTA DIABETOL, V47, pS19, DOI 10.1007/s00592-009-0114-7; Schaefer C, 2010, J ORTHOP RES, V28, P1515, DOI 10.1002/jor.21166; Schroeder M, 2016, J SURG ONCOL, V113, P515, DOI 10.1002/jso.24185; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Simpson-Abelson MR, 2008, J IMMUNOL, V180, P7009, DOI 10.4049/jimmunol.180.10.7009; Stoddart CA, 2011, VIROLOGY, V417, P154, DOI 10.1016/j.virol.2011.05.013; Weigert R, 2013, J CELL BIOL, V201, P969, DOI 10.1083/jcb.201212130; WEILAND AJ, 1982, CLIN ORTHOP RELAT R, P265; Wunderlich M, 2010, LEUKEMIA, V24, P1785, DOI 10.1038/leu.2010.158; YUAN F, 1994, CANCER RES, V54, P3352; YUAN F, 1993, MICROVASC RES, V45, P269, DOI 10.1006/mvre.1993.1024	35	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0183186	10.1371/journal.pone.0183186	http://dx.doi.org/10.1371/journal.pone.0183186			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800593	Green Published, gold, Green Submitted			2022-12-26	WOS:000407431800063
J	Herrera-Ibata, DM; Martinez-Lopez, B; Quijada, D; Burton, K; Mur, L				Herrera-Ibata, Diana Maria; Martinez-Lopez, Beatriz; Quijada, Darla; Burton, Kenneth; Mur, Lina			Quantitative approach for the risk assessment of African swine fever and Classical swine fever introduction into the United States through legal imports of pigs and swine products	PLOS ONE			English	Article							VIRUS; EPIDEMIOLOGY; TRANSMISSION; CONTACT; DISEASE; SPREAD	The US livestock safety strongly depends on its capacity to prevent the introduction of Transboundary Animal Diseases (TADs). Therefore, accurate and updated information on the location and origin of those potential TADs risks is essential, so preventive measures as market restrictions can be put on place. The objective of the present study was to evaluate the current risk of African swine fever (ASF) and Classical swine fever (CSF) introduction into the US through the legal importations of live pigs and swine products using a quantitative approach that could be later applied to other risks. Four quantitative stochastic risk assessment models were developed to estimate the monthly probabilities of ASF and CSF release into the US, and the exposure of susceptible populations (domestic and feral swine) to these introductions at state level. The results suggest a low annual probability of either ASF or CSF introduction into the US, by any of the analyzed pathways (5.5*10(-3)). Being the probability of introduction through legal imports of live pigs (1.8*10(-3) for ASF, and 2.5*10(-3) for CSF) higher than the risk of legally imported swine products (8.90*10(-4) for ASF, and 1.56*10(-3) for CSF). This could be caused due to the low probability of exposure associated with this type of commodity (products). The risk of feral pigs accessing to swine products discarded in landfills was slightly higher than the potential exposure of domestic pigs through swill feeding. The identification of the months at highest risk, the origin of the higher risk imports, and the location of the US states most vulnerable to those introductions (Iowa, Minnesota and Wisconsin for live swine and California, Florida and Texas for swine products), is valuable information that would help to design prevention, risk-mitigation and early-detection strategies that would help to minimize the catastrophic consequences of potential ASF/CSF introductions into the US.	[Herrera-Ibata, Diana Maria; Mur, Lina] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA; [Martinez-Lopez, Beatriz] Univ Calif Davis, CADMS, Davis, CA 95616 USA; [Quijada, Darla; Burton, Kenneth] Kansas State Univ, Natl Agr Biosecur Ctr, Manhattan, KS 66506 USA	Kansas State University; University of California System; University of California Davis; Kansas State University	Mur, L (corresponding author), Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA.	lmur@vet.k-state.edu	Mur, Lina/AAC-8860-2022; Lopez, Beatriz Martinez/AAE-6692-2021		Kansas Bioscience Authority under the Federal Matching Program Grant Agreement through the Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD); National Bio and Agro-defense Facility (NBAF) Transition Fund; State of Kansas	Kansas Bioscience Authority under the Federal Matching Program Grant Agreement through the Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD); National Bio and Agro-defense Facility (NBAF) Transition Fund; State of Kansas	This material is based upon work supported by Kansas Bioscience Authority under the Federal Matching Program Grant Agreement through the Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD) and by the State of Kansas, National Bio and Agro-defense Facility (NBAF) Transition Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This material is based upon work supported by Kansas Bioscience Authority under the Federal Matching Program Grant Agreement through the Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD) and by the State of Kansas, National Bio and Agro-defense Facility (NBAF) Transition Fund.	[Anonymous], 2016, USDA GLOB AGR TRAD S; [Anonymous], 2021, LANG ENV STAT COMP; Broad Leib E., 2016, LEFTOVERS LIVESTOCK; BSR, 2014, AN US FOOD WAST FOOD; Butts C. T., SNA TOOLS SOCIAL NET; Buzby J. C., 2009, EC INFORM B; Buzby J. C., 2014, EC INFORM B, VEIB-121; Buzby J. C., 2016, UPDATED SUPERMARKET; Costard S, 2013, VIRUS RES, V173, P191, DOI 10.1016/j.virusres.2012.10.030; Costard S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061104; Costard S, 2009, PHILOS T R SOC B, V364, P2683, DOI 10.1098/rstb.2009.0098; Csardi G., 2006, INT J COMPLEX SYST, P1695; Davis C. G, 2005, FACTORS AFFECTING US; Environmental Systems Research Institute (ESRI), 2010, ARCGIS REL 10 0; Eurostat, PIG FARM SECT STAT P; FAO, 2011, SAV FOOD IN FOOD LOS; FAO, 2016, SAV FOOD GLOB IN FOO; Ferreira HCD, 2013, VET MICROBIOL, V165, P296, DOI 10.1016/j.vetmic.2013.03.026; Gogin A, 2013, VIRUS RES, V173, P198, DOI 10.1016/j.virusres.2012.12.007; Hernandez-Jover M, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00085; Luo YZ, 2014, VET MICROBIOL, V172, P1, DOI 10.1016/j.vetmic.2014.04.004; Madera R, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0823-4; Moennig V, 2003, VET J, V165, P11, DOI 10.1016/S1090-0233(02)00112-0; Montgomery RE, 1921, J COMP PATHOL, V34, P59, DOI DOI 10.1016/S0368-1742(21)80031-4; Mur L, 2012, TRANSBOUND EMERG DIS, V59, P134, DOI 10.1111/j.1865-1682.2011.01253.x; Mur L, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-145; Murray AC, 1998, CAN J ANIM SCI, V78, P543, DOI 10.4141/A97-122; National Agricultural Biosecurity Center, PATHW AN CLASS SWIN; [Office of Resource Conservation and Recovery U. S. EPA], 2014, MUN SOL WAST GEN REC; Office USEEPAR, 2011, SUMM AN MASS COMM I; OIE, WORLD ORG AN HLTH 20; OIE WAHIS, OIE WAHIS INT 2016; OIE World Organisation for Animal Health, 2004, HDB IMP RISK AN AN A; OIE World Organisation for Animal Health, 2010, HDB IMP RISK AN AN A; PLOWRIGHT W, 1969, NATURE, V221, P1071, DOI 10.1038/2211071a0; Romero L, COMMUNICATION; ROSSI S, 2015, FRONT MICROBIOL, V6, pNIL_0001, DOI DOI 10.3389/fmicb.2015.01141; Rowlands RJ, 2008, EMERG INFECT DIS, V14, P1870, DOI 10.3201/eid1412.080591; Saatkamp HW, 2000, VET MICROBIOL, V73, P221, DOI 10.1016/S0378-1135(00)00147-4; Sanchez-Vizcaino F, 2010, RISK ANAL, V30, P798, DOI 10.1111/j.1539-6924.2009.01351.x; Sanchez-Vizcaino J, AFRICAN SWINE FEVER; Sanchez-Vizcaino JM, 2015, J COMP PATHOL, V152, P9, DOI 10.1016/j.jcpa.2014.09.003; Sanchez-Vizcaino M., 2012, DIS SWINE, P396; Spickler AR, 2006, PESTE PORCINA AFRICA; Stegeman JA, 2002, EPIDEMIOL INFECT, V128, P285, DOI 10.1017/S0950268801006483; United States Environmental Protection Agency, 2015, POSTC FOOD DIV DON A; United States Environmental Protection Agency, 2016, LMOP DAT 2016; United States Environmental Protection Agency, 2014, FOOD WAST SCOP AN; USDA, 2015, FER SWIN POP 2015 CO; USDA. Agricultural Research Service, 2000, 1994 96 CONT SURV FO; USDA APHIS NAHMS, 2012, SWIN 20112 1; USDA APHIS NAHMS, 2007, REF MAN PRACT SMALL; USDA Economic Research Service, 2016, HOGS PORK 2016; USDA Economic Research Service, 2016, ARMS FARM FIN CROP P; USDA USDoA, HOGS PORK TRAD 2017; USEEP, 2016, FOOD WAST MAN US 201; Welte V., 2016, RISK ANAL OIE 2016; Wyckoff AC, 2009, J WILDLIFE DIS, V45, P422, DOI 10.7589/0090-3558-45.2.422	58	26	27	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182850	10.1371/journal.pone.0182850	http://dx.doi.org/10.1371/journal.pone.0182850			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797058	Green Published, Green Submitted, gold			2022-12-26	WOS:000407396200108
J	Nap, JP; Sanchez-Perez, GF; van Dijik, ADJ				Nap, Jan-Peter; Sanchez-Perez, Gabino F.; van Dijik, Aalt D. J.			Similarities between plant traits based on their connection to underlying gene functions	PLOS ONE			English	Article							FUNCTION PREDICTION; NETWORK; QTL; ASSOCIATIONS; INTEGRATION; METABOLISM; PROTEINS; FEATURES; GROWTH; TOOL	Understanding of phenotypes and their genetic basis is a major focus in current plant biology. Large amounts of phenotype data are being generated, both for macroscopic phenotypes such as size or yield, and for molecular phenotypes such as expression levels and metabolite levels. More insight in the underlying genetic and molecular mechanisms that influence phenotypes will enable a better understanding of how various phenotypes are related to each other. This will be a major step forward in understanding plant biology, with immediate value for plant breeding and academic plant research. Currently the genetic basis of most phenotypes remains however to be discovered, and the relatedness of different traits is unclear. We here present a novel approach to connect phenotypes to underlying biological processes and molecular functions. These connections define similarities between different types of phenotypes. The approach starts by using Quantitative Trait Locus (QTL) data, which are abundantly available for many phenotypes of interest. Overrepresentation analysis of gene functions based on Gene Ontology term enrichment across multiple QTL regions for a given phenotype, be it macroscopic or molecular, results in a small set of biological processes and molecular functions for each phenotype. Subsequently, similarity between different phenotypes can be defined in terms of these gene functions. Using publicly available rice data as example, a close relationship with defined molecular phenotypes is demonstrated for many macroscopic phenotypes. This includes for example a link between 'leaf senescence' and 'aspartic acid', as well as between 'days to maturity' and 'choline'. Relationships between macroscopic and molecular phenotypes may result in more efficient marker-assisted breeding and are likely to direct future research aimed at a better understanding of plant phenotypes.	[Nap, Jan-Peter; Sanchez-Perez, Gabino F.; van Dijik, Aalt D. J.] Wageningen Univ & Res, Appl Bioinformat, Droevendaalsesteeg 1, Pb Wageningen, Netherlands; [Sanchez-Perez, Gabino F.; van Dijik, Aalt D. J.] Wageningen Univ & Res, Lab Bioinformat, Droevendaalsesteeg 1, Pb Wageningen, Netherlands; [van Dijik, Aalt D. J.] Wageningen Univ & Res, Biometris, Droevendaalsesteeg 1, Pb Wageningen, Netherlands; [Sanchez-Perez, Gabino F.] Genetwister Technol BV, Genetwister Technol, Nieuwe Kanaal 7b, Pa Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	van Dijik, ADJ (corresponding author), Wageningen Univ & Res, Appl Bioinformat, Droevendaalsesteeg 1, Pb Wageningen, Netherlands.; van Dijik, ADJ (corresponding author), Wageningen Univ & Res, Lab Bioinformat, Droevendaalsesteeg 1, Pb Wageningen, Netherlands.; van Dijik, ADJ (corresponding author), Wageningen Univ & Res, Biometris, Droevendaalsesteeg 1, Pb Wageningen, Netherlands.	aaltjan.vandijk@wur.nl		van Dijk, Aalt-Jan/0000-0002-8872-5123	FP7 "Infrastructures" project transPLANT [283496]	FP7 "Infrastructures" project transPLANT	This work was supported by the FP7 "Infrastructures" project transPLANT Award 283496. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo WL, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00552; Arends D, 2012, BIOINFORMATICS, V28, P1042, DOI 10.1093/bioinformatics/bts049; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bargsten JW, 2014, CURR PLANT BIOL, V1, P73, DOI 10.1016/j.cpb.2014.07.001; Bargsten JW, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0330-3; Caniza H, 2014, BIOINFORMATICS, V30, P2235, DOI 10.1093/bioinformatics/btu144; Chen HD, 2013, CURR OPIN PLANT BIOL, V16, P247, DOI 10.1016/j.pbi.2013.04.002; Chen HJ, 2015, J PLANT PHYSIOL, V180, P1, DOI 10.1016/j.jplph.2015.03.009; Cobb JN, 2013, THEOR APPL GENET, V126, P867, DOI 10.1007/s00122-013-2066-0; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; Fahlgren N, 2015, CURR OPIN PLANT BIOL, V24, P93, DOI 10.1016/j.pbi.2015.02.006; Falda M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S14; Gong L, 2013, P NATL ACAD SCI USA, V110, P20320, DOI 10.1073/pnas.1319681110; Goud PB, 2012, PLANT SIGNAL BEHAV, V7, P1258, DOI 10.4161/psb.21584; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; He X, 2013, AM J HUM GENET, V92, P667, DOI 10.1016/j.ajhg.2013.03.022; Hu CY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05067; Kourmpetis YAI, 2011, PLANT PHYSIOL, V155, P271, DOI 10.1104/pp.110.162164; Kourmpetis YAI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009293; Krajewski P, 2015, J EXP BOT, V66, P5417, DOI 10.1093/jxb/erv271; Lin D, 1998, P INT C MACH LEARN; Lisec J, 2008, PLANT J, V53, P960, DOI 10.1111/j.1365-313X.2007.03383.x; Maloney GS, 2014, PLANT PHYSIOL, V166, P614, DOI 10.1104/pp.114.240507; Matamoros MA, 2010, J EXP BOT, V61, P87, DOI 10.1093/jxb/erp285; Matsuda F, 2012, PLANT J, V70, P624, DOI 10.1111/j.1365-313X.2012.04903.x; Mazandu GK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113859; MELARAGNO JE, 1993, PLANT CELL, V5, P1661, DOI 10.1105/tpc.5.11.1661; Ni JJ, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap005; Patra B, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25901; Patra B, 2013, PLANT J, V74, P435, DOI 10.1111/tpj.12132; Peleman JD, 2003, TRENDS PLANT SCI, V8, P330, DOI 10.1016/S1360-1385(03)00134-1; Riedelsheimer C, 2012, NAT GENET, V44, P217, DOI 10.1038/ng.1033; Salehin M, 2015, PLANT CELL, V27, P9, DOI 10.1105/tpc.114.133744; Slotboom DJ, 1999, MICROBIOL MOL BIOL R, V63, P293, DOI 10.1128/MMBR.63.2.293-307.1999; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Soltis NE, 2015, PLANT PHYSIOL, V169, P1456, DOI 10.1104/pp.15.01108; Sulpice R, 2009, P NATL ACAD SCI USA, V106, P10348, DOI 10.1073/pnas.0903478106; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; team R. d. c., 2011, R LANG ENV STAT COMP; Wang J, 2014, J EXP BOT, V65, P1069, DOI 10.1093/jxb/ert464; Wen WW, 2015, PLANT CELL, V27, P1839, DOI 10.1105/tpc.15.00208; Wen WW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4438; Wentzell AM, 2007, PLOS GENET, V3, P1687, DOI 10.1371/journal.pgen.0030162; Xiao S, 2011, PROG LIPID RES, V50, P141, DOI 10.1016/j.plipres.2010.11.002; Yin YH, 2002, P NATL ACAD SCI USA, V99, P10191, DOI 10.1073/pnas.152337599; Youens-Clark K, 2011, NUCLEIC ACIDS RES, V39, pD1085, DOI 10.1093/nar/gkq1148; Zhang X, 2011, GENOME RES, V21, P725, DOI 10.1101/gr.115337.110	48	1	1	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182097	10.1371/journal.pone.0182097	http://dx.doi.org/10.1371/journal.pone.0182097			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797052	gold, Green Submitted, Green Published			2022-12-26	WOS:000407396200028
J	Figueiredo, MAP; Di Santi, SM; Manrique, WG; Andre, MR; Machado, RZ				Pereira Figueiredo, Mayra Araguaia; Di Santi, Silvia Maria; Manrique, Wilson Gomez; Andre, Marcos Rogerio; Machado, Rosangela Zacarias			Identification of Plasmodium spp. in Neotropical primates of Maranhense Amazon in Northeast Brazil	PLOS ONE			English	Article							REAL-TIME PCR; HUMAN MALARIA PARASITE; RIBOSOMAL-RNA GENE; SIMIAN MALARIA; NATURAL INFECTION; NESTED PCR; MONKEYS; TRANSMISSION; SENSITIVITY; RESERVOIRS	In the Brazilian Amazon region, malaria caused by Plasmodium malariae is considered to be a zoonosis because of cross-transfer of the parasite between humans and Neotropical primates. To contribute information on this issue, we investigated occurrences of natural infection with Plasmodium sp. among Neotropical primates in the Maranhense Amazon (Amazon region of the state of Maranhao), in the northeastern region of Brazil. Blood samples were collected from 161 Neotropical primates of six species that were caught in an environmental reserve (Sitio Aguahy) and from captive primates (CETAS-Wildlife Screening Center, municipality of Sao Luis), in Maranhao. Plasmodium sp. was diagnosed based on light microscopy, PCR, qPCR and LAMP for amplification of the 18S rRNA gene. Serum samples were also assayed by means of indirect immunofluorescence for IgG antibodies against P. malariae/P. brasilianum, P. falciparum and P. berghei. Parasites were detected through light microscopy on five slides from captive primates (four Sapajus spp. and one Callithrix jacchus). In the molecular tests, 34.16% (55/161) and 29.81% (48/161) of the animals sampled were positive in the qPCR and PCR assays, respectively. In the PCR, 47/48 animals were positive for P. malariae/P. brasilianum; of these, eight were free-living primates and 39 from CETAS, Sao Luis. One sample showed a band in the genus-specific reaction, but not in the second PCR reaction. Anti-P. malariae/P. brasilianum IgG antibodies were detected in four serum samples from Sapajus spp. in captivity. In this study, circulation of P. malariae/P. brasilianum in Neotropical primates was confirmed, with low levels of parasitemia and low levels of antibodies. The importance of these animals as reservoirs of human malaria in the region studied is still unknown. This scenario has an impact on control and elimination of malaria in this region.	[Pereira Figueiredo, Mayra Araguaia; Andre, Marcos Rogerio; Machado, Rosangela Zacarias] Univ Estadual Paulista, Sch Agr & Vet Sci FCAV, Lab Immunoparasitol, Jaboticabal Campus, Sao Paulo, Brazil; [Di Santi, Silvia Maria] Univ Sao Paulo, Inst Trop Med Sao Paulo IMTSP, Dept Hlth State Sao Paulo, Ctr Malaria Studies,Superintendency Endem Dis Con, Sao Paulo, SP, Brazil; [Manrique, Wilson Gomez] Brazil Univ, Lab Vet Pathol, Descalvado Campus, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade de Sao Paulo	Figueiredo, MAP; Machado, RZ (corresponding author), Univ Estadual Paulista, Sch Agr & Vet Sci FCAV, Lab Immunoparasitol, Jaboticabal Campus, Sao Paulo, Brazil.	mayraaraguaia@hotmail.com; zacrias@fcav.unesp.br	Di Santi, Silvia/D-8973-2012; MANRIQUE, WILSON GOMEZ/D-9477-2012; André, Marcos Rogério/C-4395-2012	Di Santi, Silvia/0000-0001-8049-2014; MANRIQUE, WILSON GOMEZ/0000-0003-3097-3770; André, Marcos Rogério/0000-0002-1713-5222	Sao Paulo Research Foundation (FAPESP) [12/03961-9, 10/12820-4]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	MAPF acknowledges Sao Paulo Research Foundation (FAPESP) for the doctoral scholarship (grant no.12/03961-9) and http://www.bv.fapesp.br/pt/boisast/34158/identificacao-de-plasmodium-spp-em-primatas-neotropicais-e-ein-anofelinos-em-municipios-da-ilha-de-s/. RZM acknowledges Sao Paulo Research Foundation (FAPESP) for the research grant (no. 10/12820-4) and http://bv.tapesp.br/pt/auxilios/30449/caracterizacao-soroepdemiologica-e-molecular-da-infeccao-malarica-emprimatas-neotropicais-no-estad/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the staff of Sao Paulo Research Foundation (FAPESP) for the doctoral scholarship (grant no. 12/03961-9) and the research grant (no. 10/12820-4). They specially thank the staff of Sitio Aguahy (Joao and Maria) and CETAS of Sao Luis by supporting the work during the collection of samples. We would like to extend our gratitude to Dr. Roberto Rodrigues Veloso Junior (CETAS/MA/IBAMA/MM) for his support at all times. We also thank the State University of Maranhao for the support.	Abdul-Ghani R, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-016-0227-5; Alfaro JWL, 2012, AM J PRIMATOL, V74, P273, DOI 10.1002/ajp.22007; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarenga DAM, 2015, MALARIA J, V14, P2; Alvarenga DAM, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1724-0; Araujo MS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-180; Ayala F, MALARIA PARASITE BIO, P285; BOULOS M, 1984, REV I MED TROP, V26, P60, DOI 10.1590/S0036-46651984000100009; Brasil, 2015, SIV SIST INF VIG EP; Brasil. MS/SVS, 2015, B EPIDEMIOLOGICO SEC, V46; Brasil. Sivep (Sistema de Informacao de Vigilancia Epidemiologica), 2013, SIV SIST INF VIG EP; Brasil. Sivep (Sistema de Informacao de Vigilancia Epidemiologica), 2014, SIV SIST INF VIG EP; Brasil. Sivep-Malaria, 2016, SISTEMA INFORM VIGIL; Bueno MG, 2013, ECOHEALTH, V10, P48, DOI 10.1007/s10393-012-0809-z; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chinchilla Misael, 2006, Parasitologia Latinoamericana, V61, P192; Coatney GR, 1971, PRIMATES MALARIAS; Collins WE, 2007, CLIN MICROBIOL REV, V20, P579, DOI 10.1128/CMR.00027-07; Costa DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131339; da FONSECA FLAVIO, 1951, MEM INST OSWALDO CRUZ, V49, P543, DOI 10.1590/S0074-02761951000100008; de Duarte AMR, 2006, J MED PRIMATOL, V35, P87, DOI 10.1111/j.1600-0684.2006.00148.x; de Pina-Costa A, 2014, MEM I OSWALDO CRUZ, V109, P618, DOI 10.1590/0074-0276140228; Deane L. M., 1969, Revista Latinoamericana de Microbiologia y Parasitologia, P69; DEANE LM, 1966, B WORLD HEALTH ORGAN, V35, P805; DEANE LM, 1992, MEM I OSWALDO CRUZ, V87, P1, DOI 10.1590/S0074-02761992000700001; DEANE LM, 1964, B WORLD HEALTH ORGAN, V31, P752; DEARRUDA M, 1989, AM J TROP MED HYG, V41, P379, DOI 10.4269/ajtmh.1989.41.379; dos Santos LC, 2009, VET PARASITOL, V163, P148, DOI 10.1016/j.vetpar.2009.03.042; ESCALANTE AA, 1995, MOL BIOL EVOL, V12, P616; Escalante AA, 1998, P NATL ACAD SCI USA, V95, P8124, DOI 10.1073/pnas.95.14.8124; Fandeur T, 2000, PARASITOLOGY, V120, P11, DOI 10.1017/S0031182099005168; Faust C, 2015, ONE HEALTH-AMSTERDAM, V1, P66, DOI 10.1016/j.onehlt.2015.10.001; Figueiredo M. A. P., 2015, Brazilian Journal of Veterinary Parasitology, V24, P122; Fuentes-Ramirez A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170704; Gama BE, 2007, EXP PARASITOL, V116, P427, DOI 10.1016/j.exppara.2007.02.011; GIGLIOLI G, 1963, B WORLD HEALTH ORGAN, V29, P131; Han ET, 2007, J CLIN MICROBIOL, V45, P2521, DOI 10.1128/JCM.02117-06; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hong YJ, 2012, ANN LAB MED, V32, P229, DOI 10.3343/alm.2012.32.3.229; Hristov AD, 2014, MEM I OSWALDO CRUZ, V109, P1014, DOI 10.1590/0074-0276140229; Lalremruata A, 2015, EBIOMEDICINE, V2, P1186, DOI 10.1016/j.ebiom.2015.07.033; Lee KS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002015; Lima GFMC, 2011, MEM I OSWALDO CRUZ, V106, P691, DOI 10.1590/S0074-02762011000600008; Liu Q, 1998, J CLIN MICROBIOL, V36, P3378, DOI 10.1128/JCM.36.11.3378-3381.1998; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; Lima GFMD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150391; Mu JB, 2005, MOL BIOL EVOL, V22, P1686, DOI 10.1093/molbev/msi160; NETO J A F, 1970, Revista do Instituto de Medicina Tropical de Sao Paulo, V12, P169; Patel JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054986; Figueiredo MAP, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2133-5; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Qari SH, 1996, MOL PHYLOGENET EVOL, V6, P157, DOI 10.1006/mpev.1996.0068; Ramasamy R, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00123; Duarte AMRD, 2008, ACTA TROP, V107, P179, DOI 10.1016/j.actatropica.2008.05.020; Roman DN, 2017, PARASITOL INT; Rubio JM, 1999, J CLIN MICROBIOL, V37, P3260, DOI 10.1128/JCM.37.10.3260-3264.1999; Scopel KKG, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-8; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Ta TH, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-68; Tazi L, 2011, INFECT GENET EVOL, V11, P209, DOI 10.1016/j.meegid.2010.08.007; Volney B, 2002, ACTA TROP, V82, P11, DOI 10.1016/S0001-706X(02)00036-0; WHO, CAT IN PUBL CIP DAT; World Health Organization - WHO, 2005, BAS MAL MICR; Yamasaki T, 2011, J MED PRIMATOL, V40, P392, DOI 10.1111/j.1600-0684.2011.00498.x	65	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182905	10.1371/journal.pone.0182905	http://dx.doi.org/10.1371/journal.pone.0182905			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796820	Green Published, gold, Green Submitted			2022-12-26	WOS:000407396200117
J	Martrus, G; Kautz, T; Lunemann, S; Richert, L; Glau, L; Salzberger, W; Goebels, H; Langeneckert, A; Hess, L; Poch, T; Schramm, C; Oldhafer, KJ; Koch, M; Tolosa, E; Nashan, B; Altfeld, M				Martrus, Gloria; Kautz, Tobias; Lunemann, Sebastian; Richert, Laura; Glau, Laura; Salzberger, Wilhelm; Goebels, Hanna; Langeneckert, Annika; Hess, Leonard; Poch, Tobias; Schramm, Christoph; Oldhafer, Karl J.; Koch, Martina; Tolosa, Eva; Nashan, Bjoern; Altfeld, Marcus			Proliferative capacity exhibited by human liver-resident CD49a+CD25+NK cells	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; CHRONIC HEPATITIS-C; LAMININ COLLAGEN RECEPTOR; NATURAL-KILLER-CELLS; NK CELLS; DIFFERENTIAL EXPRESSION; EXTRACELLULAR-MATRIX; ADAPTIVE IMMUNITY; TISSUE-RESIDENT; T-CELLS	The recruitment and retention of Natural Killer (NK) cells in the liver are thought to play an important role during hepatotropic infections and liver cirrhosis. The aims of this study were to determine differences between liver-derived and peripheral blood-derived NK cells in the context of liver inflammation and cirrhosis. We conducted a prospective dual-center cross-sectional study in patients undergoing liver transplantation or tumor-free liver resections, in which both liver tissue and peripheral blood samples were obtained from each consenting study participants. Intrahepatic lymphocytes and PBMCs were stained, fixed and analyzed by flow cytometry. Our results showed that, within cirrhotic liver samples, intrahepatic NK cells were particularly enriched for CD49a+ NK cells when compared to tumor-free liver resection samples. CD49a+ liver-derived NK cells included populations of cells expressing CD25, CD34 and CXCR3. Moreover, CD49a+ CD25+ liver-derived NK cells exhibited high proliferative capacity in vitro in response to low doses of IL-2. Our study identified a specific subset of CD49a+ CD25+ NK cells in cirrhotic livers bearing functional features of proliferation.	[Martrus, Gloria; Kautz, Tobias; Lunemann, Sebastian; Richert, Laura; Salzberger, Wilhelm; Goebels, Hanna; Langeneckert, Annika; Hess, Leonard; Altfeld, Marcus] Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany; [Richert, Laura] Univ Bordeaux, INSERM, Bordeaux Populat Hlth Res Ctr, Team SISTM,UMR1219, Bordeaux, France; [Richert, Laura] INRIA, Bordeaux, France; [Glau, Laura; Tolosa, Eva] Univ Med Ctr Hamburg Eppendorf, Dept Immunol, Hamburg, Germany; [Poch, Tobias; Schramm, Christoph] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Hamburg, Germany; [Oldhafer, Karl J.] Semmelweis Univ Med, Asklepios Hosp Barmbek, Dept Gen & Abdominal Surg, Asklepios Campus, Hamburg, Germany; [Koch, Martina; Nashan, Bjoern] Univ Med Ctr Hamburg Eppendorf, Dept Hepatobiliary & Transplant Surg, Hamburg, Germany	Heinrich Pette Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Inria; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Semmelweis University; University of Hamburg; University Medical Center Hamburg-Eppendorf	Altfeld, M (corresponding author), Leibniz Inst Expt Virol, Heinrich Pette Inst, Hamburg, Germany.	marcus.altfeld@leibniz-hpi.de	Altfeld, Marcus/AAE-7306-2019; Richert, Laura/T-5801-2019; Nashan, Björn/H-9087-2019; Koch, Martina/AAJ-6611-2020; Tolosa, Eva/S-3454-2016	Altfeld, Marcus/0000-0001-5972-2997; Nashan, Björn/0000-0001-7587-9935; Martrus, Gloria/0000-0003-2879-3201; Richert, Laura/0000-0002-7682-2225; Poch, Tobias/0000-0001-8178-9522	Deutsche Forschungsgemeinschaft [SFB841]; Helmut and Hannelore Greve Foundation; YAEL Foundation; Graduiertenkolleg (GRK) from University Medical Center Ham burg-Eppendorf (UKE); LTX cohort at the University Medical Center Hamburg-Eppendorf (UKE) in Hamburg; AKB cohort at the Askeplios Hospital Barmbek in Hamburg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmut and Hannelore Greve Foundation; YAEL Foundation; Graduiertenkolleg (GRK) from University Medical Center Ham burg-Eppendorf (UKE); LTX cohort at the University Medical Center Hamburg-Eppendorf (UKE) in Hamburg; AKB cohort at the Askeplios Hospital Barmbek in Hamburg	MA received founding support from the Deutsche Forschungsgemeinschaft (SFB841). CS and TP received founding support from the: Helmut and Hannelore Greve Foundation, http://www.awhamburg.de/en/academy/portrait/funding.html; YAEL Foundation (https://yael-stiftung.de/en/home); TK, HG and LH were financially supported by the Graduiertenkolleg (GRK) from the University Medical Center Ham burg-Eppendorf (UKE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank all the donors from the LTX cohort at the University Medical Center Hamburg-Eppendorf (UKE) in Hamburg and from the AKB cohort at the Askeplios Hospital Barmbek in Hamburg for their contribution to our study. The authors are very grateful to the team of nurses and surgeons from the Department of Hepatobiliary and Transplant Surgery (UKE) and from the Department of General & Abdominal Surgery (Asklepios Hospital Barmbek) for their involvement.	Alter G, 2006, AIDS, V20, P1549, DOI 10.1097/01.aids.0000237371.31315.48; [Anonymous], 2015, RTSNE T DISTRIBUTED; Arai K, 2002, CELL IMMUNOL, V219, P48, DOI 10.1016/S0008-8749(02)00584-1; Benjamini Y, 2001, ANN STAT, V29, P1165; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Cortez VS, 2014, J IMMUNOL, V192, P4487, DOI 10.4049/jimmunol.1303469; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; Crosbie OM, 1999, HEPATOLOGY, V29, P1193, DOI 10.1002/hep.510290402; Eisenhardt M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038846; Ellis B, 2016, FLOWCORE FLOWCORE BA; Freud AG, 2006, J EXP MED, V203, P1033, DOI 10.1084/jem.20052507; Freud AG, 2014, SEMIN IMMUNOL, V26, P132, DOI 10.1016/j.smim.2014.02.008; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gao B, 2008, HEPATOLOGY, V47, P729, DOI 10.1002/hep.22034; Goddard S, 2001, TRANSPLANTATION, V72, P1957, DOI 10.1097/00007890-200112270-00016; Golden-Mason L, 2000, HEPATOLOGY, V31, P1251, DOI 10.1053/jhep.2000.7713; Golden-Mason L, 2002, IMMUNOL CELL BIOL, V80, P45, DOI 10.1046/j.1440-1711.2002.01066.x; Gonzalez VD, 2009, J IMMUNOL, V183, P6612, DOI 10.4049/jimmunol.0901437; Granucci F, 2001, NAT IMMUNOL, V2, P882, DOI 10.1038/ni0901-882; Harmon C, 2016, EUR J IMMUNOL, V46, P2111, DOI 10.1002/eji.201646559; Harvey CE, 2003, J LEUKOCYTE BIOL, V74, P360, DOI 10.1189/jlb.0303093; Helbig KJ, 2004, HEPATOLOGY, V39, P1220, DOI 10.1002/hep.20167; Hershko AY, 2011, IMMUNITY, V35, P562, DOI 10.1016/j.immuni.2011.07.013; Hudspeth K, 2016, J AUTOIMMUN, V66, P40, DOI 10.1016/j.jaut.2015.08.011; Jenne CN, 2013, NAT IMMUNOL, V14, P996, DOI 10.1038/ni.2691; Kasprzak A, 2006, FOLIA HISTOCHEM CYTO, V44, P103; Leong JW, 2014, BIOL BLOOD MARROW TR, V20, P463, DOI 10.1016/j.bbmt.2014.01.006; Li ZP, 2003, CURR OPIN GASTROEN, V19, P565, DOI 10.1097/00001574-200311000-00009; Lisignoli G, 1996, EUR J IMMUNOL, V26, P17, DOI 10.1002/eji.1830260104; MACDONALD TT, 1990, J CLIN PATHOL, V43, P313, DOI 10.1136/jcp.43.4.313; MAHER JJ, 1988, J CLIN INVEST, V82, P450, DOI 10.1172/JCI113618; MAHER JJ, 1990, J CLIN INVEST, V86, P1641, DOI 10.1172/JCI114886; Malek TR, 2008, J CLIN IMMUNOL, V28, P635, DOI 10.1007/s10875-008-9235-y; Marquardt N, 2015, J IMMUNOL, V194, P2467, DOI 10.4049/jimmunol.1402756; Mavilio D, 2005, P NATL ACAD SCI USA, V102, P2886, DOI 10.1073/pnas.0409872102; Melsen JE, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00262; Montaldo E, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00646; Moroso V, 2011, EUR J IMMUNOL, V41, P3340, DOI 10.1002/eji.201141760; Nabekura T, 2014, IMMUNITY, V40, P225, DOI 10.1016/j.immuni.2013.12.011; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Parks DR, 2006, CYTOM PART A, V69A, P541, DOI 10.1002/cyto.a.20258; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Peng H, 2016, CELL MOL IMMUNOL, V13, P328, DOI 10.1038/cmi.2015.96; Peng H, 2013, J IMMUNOL, V190, P4255, DOI 10.4049/jimmunol.1202395; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Petrovic D, 2011, HEPATOLOGY, V53, P1846, DOI 10.1002/hep.24327; Racanelli V, 2006, HEPATOLOGY, V43, pS54, DOI 10.1002/hep.21060; Romee R, 2012, BLOOD, V120, P4751, DOI 10.1182/blood-2012-04-419283; Schlums H, 2015, IMMUNITY, V42, P443, DOI 10.1016/j.immuni.2015.02.008; Seidler S, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-38; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Sheth K, 2001, Curr Opin Crit Care, V7, P99, DOI 10.1097/00075198-200104000-00008; Shields PL, 1999, J IMMUNOL, V163, P6236; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Stegmann KA, 2016, SCI REP-UK, V6, DOI 10.1038/srep26157; Taniguchi H, 1996, NAT MED, V2, P198, DOI 10.1038/nm0296-198; Tao Y, 2015, CELL MOL IMMUNOL, V12, DOI 10.1038/cmi.2014.26; TAWIL NJ, 1990, BIOCHEMISTRY-US, V29, P6540, DOI 10.1021/bi00479a028; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wells RG, 2008, CLIN LIVER DIS, V12, P759, DOI 10.1016/j.cld.2008.07.008; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yeang HXA, 2017, J IMMUNOL, V198, P1417, DOI 10.4049/jimmunol.1601818; Yu JH, 2013, TRENDS IMMUNOL, V34, P573, DOI 10.1016/j.it.2013.07.005	64	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182532	10.1371/journal.pone.0182532	http://dx.doi.org/10.1371/journal.pone.0182532			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28792982	Green Published, Green Submitted, gold			2022-12-26	WOS:000407196700051
J	Muhammad, FF; Yahya, MY; Hameed, SS; Aziz, F; Sulaiman, K; Rasheed, MA; Ahmad, Z				Muhammad, Fahmi F.; Yahya, Mohd Y.; Hameed, Shilan S.; Aziz, Fakhra; Sulaiman, Khaulah; Rasheed, Mariwan A.; Ahmad, Zubair			Employment of single-diode model to elucidate the variations in photovoltaic parameters under different electrical and thermal conditions	PLOS ONE			English	Article							OPEN-CIRCUIT VOLTAGE; ORGANIC SOLAR-CELLS; FILL FACTOR; TEMPERATURE; BULK; PERFORMANCE; ENERGY; EFFICIENCY; THICKNESS; RESISTANCE	In this research work, numerical simulations are performed to correlate the photovoltaic parameters with various internal and external factors influencing the performance of solar cells. Single-diode modeling approach is utilized for this purpose and theoretical investigations are compared with the reported experimental evidences for organic and inorganic solar cells at various electrical and thermal conditions. Electrical parameters include parasitic resistances (R-s and R-p) and ideality factor (n), while thermal parameters can be defined by the cells temperature (T). A comprehensive analysis concerning broad spectral variations in the short circuit current (I-sc), open circuit voltage (V-oc), fill factor (FF) and efficiency (eta) is presented and discussed. It was generally concluded that there exists a good agreement between the simulated results and experimental findings. Nevertheless, the controversial consequence of temperature impact on the performance of organic solar cells necessitates the development of a complementary model which is capable of well simulating the temperature impact on these devices performance.	[Muhammad, Fahmi F.] Koya Univ, Dept Phys, Fac Sci & Hlth, Soft Mat & Devices Lab, Koya, Kurdistan Regio, Iraq; [Yahya, Mohd Y.] Univ Teknol Malaysia, Fac Mech Engn, Inst Vehicle Syst & Engn, Ctr Composites, Johor Baharu, Malaysia; [Hameed, Shilan S.] Univ Teknol Malaysia, Dept Comp Sci, Fac Comp, Johor Baharu, Malaysia; [Hameed, Shilan S.] Univ Salahaddin, Coll Engn, Dept Software & Informat, Erbil, Kurdistan Regio, Iraq; [Aziz, Fakhra] Univ Peshawar, Fac Phys & Numer Sci, Dept Elect, Peshawar, Pakistan; [Sulaiman, Khaulah] Univ Malaya, Dept Phys, Low Dimens Mat Res Ctr, Fac Sci, Kuala Lumpur, Malaysia; [Rasheed, Mariwan A.] Univ Human Dev, DCRT, Sulaimani, Kurdistan Regio, Iraq; [Ahmad, Zubair] Qatar Univ, Dept Elect Engn, Coll Engn, Doha, Qatar	Koya University; Universiti Teknologi Malaysia; Universiti Teknologi Malaysia; Salahaddin University; University of Peshawar; Universiti Malaya; Qatar University	Muhammad, FF (corresponding author), Koya Univ, Dept Phys, Fac Sci & Hlth, Soft Mat & Devices Lab, Koya, Kurdistan Regio, Iraq.; Yahya, MY (corresponding author), Univ Teknol Malaysia, Fac Mech Engn, Inst Vehicle Syst & Engn, Ctr Composites, Johor Baharu, Malaysia.	fahmi982@gmail.com; yazidyahya@utm.my	Muhammadsharif, Fahmi F./B-3802-2010; Hameed, Shilan S./AAQ-9823-2020; sulaiman, khaulah/B-2783-2010	Muhammadsharif, Fahmi F./0000-0002-4563-9671; Hameed, Shilan S./0000-0002-8596-644X; sulaiman, khaulah/0000-0003-3473-0493	Research University Grant (RUG), UTM Malaysia [Q.J130000.21A2.03E00]; University of Human Development	Research University Grant (RUG), UTM Malaysia; University of Human Development	This work was financially supported in part by Research University Grant (RUG), UTM Malaysia (Vot:Q.J130000.21A2.03E00), and in part by the University of Human Development. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r Authors acknowledge the financial support in part by Research University Grant (RUG), UTM Malaysia (Vot: Q.J130000.21A2.03E00), and in part by the University of Human Development.	Aernouts T, 2002, THIN SOLID FILMS, V403, P297, DOI 10.1016/S0040-6090(01)01584-X; Ahmad Z, 2017, APPL PHYS A-MATER, V123, DOI 10.1007/s00339-017-1098-8; Bellia H., 2014, NRIAG J ASTRON GEOPH, V3, P53, DOI [10.1016/j.nrjag.2014.04.001, DOI 10.1016/J.NRJAG.2014.04.001]; Buchele P, 2015, ORG ELECTRON, V22, P29, DOI 10.1016/j.orgel.2015.03.027; Chin VJ, 2015, APPL ENERG, V154, P500, DOI 10.1016/j.apenergy.2015.05.035; Cuce E, 2013, APPL ENERG, V111, P374, DOI 10.1016/j.apenergy.2013.05.025; Du ZK, 2014, J MATER CHEM A, V2, P15904, DOI 10.1039/c4ta03314k; Dualeh A, 2014, ADV FUNCT MATER, V24, P3250, DOI 10.1002/adfm.201304022; Dubey S, 2013, ENRGY PROCED, V33, P311, DOI 10.1016/j.egypro.2013.05.072; Glavin ME, 2007, 2007 42 INT U POW EN; Gupta D, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2841062; Hu XS, 2016, ENERGY, V111, P971, DOI 10.1016/j.energy.2016.06.037; Hu XS, 2015, IEEE T IND ELECTRON, V62, P7847, DOI 10.1109/TIE.2015.2463770; Huang J, 2009, J APPL PHYS, V105, DOI 10.1063/1.3103328; Hurnada AM, 2016, RENEW SUST ENERG REV, V56, P494, DOI 10.1016/j.rser.2015.11.051; Kim Y, 2009, ORG ELECTRON, V10, P205, DOI 10.1016/j.orgel.2008.10.003; Lenes M, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2211189; Leong WL, 2011, ADV ENERGY MATER, V1, P517, DOI 10.1002/aenm.201100196; Li Zheng, 2013, INT SYMP OBJECT COMP; Li ZS, 2007, ENERG POLICY, V35, P4121, DOI 10.1016/j.enpol.2007.02.006; Lineykin S, 2014, RENEW SUST ENERG REV, V30, P282, DOI 10.1016/j.rser.2013.10.015; Lungenschmied C, 2007, SOL ENERG MAT SOL C, V91, P379, DOI 10.1016/j.solmat.2006.10.013; Ma W, 2013, ADV ENERGY MATER, V3, P864, DOI 10.1002/aenm.201200912; Maghami M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135118; Meneses-Rodriguez D, 2005, SOL ENERGY, V78, P243, DOI 10.1016/j.solener.2004.05.016; Messenger RA., 2017, PHOTOVOLTAIC SYSTEMS; Muhammad F.F., 2014, J TECHNOL INNOV RENE, V3, P1; Muhammad FF, 2011, THIN SOLID FILMS, V519, P5230, DOI 10.1016/j.tsf.2011.01.165; Muhammad FF, J MAT SCI MAT ELECT, P1; Nahlik J, 2015, MEASUREMENT, V74, P178, DOI 10.1016/j.measurement.2015.07.025; Barbosa LDNS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173820; Otte K., 2006, THIN SOLID FILMS, V613, P511; Qi BY, 2013, PHYS CHEM CHEM PHYS, V15, P8972, DOI 10.1039/c3cp51383a; Radziemska E, 2003, RENEW ENERG, V28, P1, DOI 10.1016/S0960-1481(02)00015-0; Sapkota SB, 2014, SOL ENERG MAT SOL C, V130, P144, DOI 10.1016/j.solmat.2014.07.004; Servaites JD, 2010, ADV FUNCT MATER, V20, P97, DOI 10.1002/adfm.200901107; Siddiqui MU, 2013, SOL ENERGY, V90, P29, DOI 10.1016/j.solener.2012.12.021; Street RA, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.205307; Street RA, 2013, J AM CHEM SOC, V135, P986, DOI 10.1021/ja3112143; Sun C, 2016, J POWER SOURCES, V325, P723, DOI 10.1016/j.jpowsour.2016.06.076; Um HA, 2016, SYNTHETIC MET, V220, P362, DOI 10.1016/j.synthmet.2016.07.009; van Dyk EE, 2004, RENEW ENERG, V29, P333, DOI 10.1016/S0960-1481(03)00250-7; Vandewal K, 2009, NAT MATER, V8, P904, DOI [10.1038/NMAT2548, 10.1038/nmat2548]; VARSHNI YP, 1967, PHYSICA, V34, P149, DOI 10.1016/0031-8914(67)90062-6; Villalva MG, 2009, IEEE T POWER ELECTR, V24, P1198, DOI 10.1109/TPEL.2009.2013862; Wang GS, 2014, IEEE T SUSTAIN ENERG, V5, P834, DOI 10.1109/TSTE.2014.2305433; Wang HY, 2015, INT J PHOTOENERGY, V2015, DOI 10.1155/2015/982064; Wang YP, 2016, IEEE T IND ELECTRON, V63, P235, DOI 10.1109/TIE.2015.2465897; Wetzelaer GAH, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3651752; Wilken K, 2015, ENRGY PROCED, V84, P17, DOI 10.1016/j.egypro.2015.12.290; Wu XH, 2016, J POWER SOURCES, V333, P203, DOI 10.1016/j.jpowsour.2016.09.157; WYSOCKI JJ, 1960, J APPL PHYS, V31, P571, DOI 10.1063/1.1735630; Yakuphanoglu F, 2005, OPT MATER, V27, P1369, DOI 10.1016/j.optmat.2004.07.015; Yamanari T, 2009, SOL ENERG MAT SOL C, V93, P759, DOI 10.1016/j.solmat.2008.09.022; Yi Z, 2014, J MATER CHEM C, V2, P7247, DOI 10.1039/c4tc00994k; Zhang L, 2018, RENEW SUST ENERG REV, V81, P1868, DOI 10.1016/j.rser.2017.05.283; Zhang L, 2016, J POWER SOURCES, V314, P28, DOI 10.1016/j.jpowsour.2016.01.066; Zhang Y, 2011, ADV ENERGY MATER, V1, P610, DOI 10.1002/aenm.201100040	58	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182925	10.1371/journal.pone.0182925	http://dx.doi.org/10.1371/journal.pone.0182925			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28793325	Green Published, gold, Green Submitted			2022-12-26	WOS:000407196700079
J	Paustian, AMS; Paez-Cortez, J; Bryant, S; Westmoreland, S; Waegell, W; Kingsbury, G				Paustian, Amanda M. Schmidt; Paez-Cortez, Jesus; Bryant, Shaughn; Westmoreland, Susan; Waegell, Wendy; Kingsbury, Gillian			Continuous IL-23 stimulation drives ILC3 depletion in the upper GI tract and, in combination with TNF alpha, induces robust activation and a phenotypic switch of ILC3	PLOS ONE			English	Article							INNATE LYMPHOID-CELLS; INFLAMMATION; MECHANISMS; EXPRESSION; BIOLOGY; MUCOSA; DNA	Mutations in the Interleukin (IL)-23/IL-23 receptor loci are associated with increased inflammatory bowel disease (IBD) susceptibility, and IL-23 neutralization has shown efficacy in early clinical trials. To better understand how an excess of IL-23 affects the gastrointestinal tract, we investigated chronic systemic IL-23 exposure in healthy wildtype mice. As expected, IL-23 exposure resulted in early activation of intestinal type 3 innate lymphoid cells (ILC3), followed by infiltration of activated ROR gamma t+ T helper cells. Surprisingly, however, sustained IL-23 stimulus also dramatically reduced classical ILC3 populations within the proximal small intestine, and a phenotypically distinct T-bet expressing ILC3 population emerged. TNF alpha neutralization, a widely used IBD therapy, reduced several aspects of the IL-23 driven ILC3 response, suggesting a synergy between IL-23 and TNFa in ILC3 activation. In vitro studies supported these findings, revealing previously unappreciated effects of IL-23 and TNFa within the intestine.	[Paustian, Amanda M. Schmidt; Paez-Cortez, Jesus; Bryant, Shaughn; Westmoreland, Susan; Waegell, Wendy; Kingsbury, Gillian] AbbVie Biores Ctr, Worcester, MA 01605 USA; [Paustian, Amanda M. Schmidt] AbbVie Inc, N Chicago, IL 60064 USA; [Kingsbury, Gillian] Agios Pharmaceut, Cambridge, MA USA	AbbVie; AbbVie; Agios Pharmaceuticals	Paustian, AMS (corresponding author), AbbVie Biores Ctr, Worcester, MA 01605 USA.; Paustian, AMS (corresponding author), AbbVie Inc, N Chicago, IL 60064 USA.	amanda.paustian@abbvie.com		Bryant, Shaughn/0000-0001-9006-9922	AbbVie, Inc.	AbbVie, Inc.(Abbott LaboratoriesAbbVie)	This study was supported by funding from AbbVie, Inc. The funder provided support in the form of salaries for all authors and contributed to the study design, participated in the collection, analysis and interpretation of the data, and in the writing, reviewing, and approval of this publication.	Adamopoulos IE, 2011, J IMMUNOL, V187, P951, DOI 10.4049/jimmunol.1003986; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Chan IH, 2014, MUCOSAL IMMUNOL, V7, P842, DOI 10.1038/mi.2013.101; Chen ZY, 2003, MOL THER, V8, P495, DOI 10.1016/S1525-0016(03)00168-0; Chognard G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089092; Eyerich S, 2010, TRENDS IMMUNOL, V31, P354, DOI 10.1016/j.it.2010.06.004; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Goodyear AW, 2014, J IMMUNOL METHODS, V405, P97, DOI 10.1016/j.jim.2014.01.014; Kalliolias GD, 2016, NAT REV RHEUMATOL, V12, P49, DOI 10.1038/nrrheum.2015.169; Kang J, 2012, SEMIN IMMUNOL, V24, P190, DOI 10.1016/j.smim.2012.02.003; Kim CJ, 2012, MUCOSAL IMMUNOL, V5, P670, DOI 10.1038/mi.2012.72; Klatt NR, 2012, MUCOSAL IMMUNOL, V5, P646, DOI 10.1038/mi.2012.38; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Li HY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004551; Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Qiu J, 2013, IMMUNITY, V39, P386, DOI 10.1016/j.immuni.2013.08.002; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Sonnenberg GF, 2015, NAT MED, V21, P698, DOI 10.1038/nm.3892; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Takayama T, 2010, GASTROENTEROLOGY, V139, P882, DOI 10.1053/j.gastro.2010.05.040; Teng MWL, 2015, NAT MED, V21, P719, DOI 10.1038/nm.3895; Viant C, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf2176; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017	26	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2017	12	8							e0182841	10.1371/journal.pone.0182841	http://dx.doi.org/10.1371/journal.pone.0182841			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9EU	28792532	Green Submitted, gold, Green Published			2022-12-26	WOS:000407144700042
J	Qiu, M; Shentu, YP; Zeng, J; Wang, XC; Yan, X; Zhou, XW; Jing, XP; Wang, Q; Man, HY; Wang, JZ; Liu, R				Qiu, Mei; Shentu, Yang-ping; Zeng, Ji; Wang, Xiao-chuan; Yan, Xiong; Zhou, Xin-wen; Jing, Xiao-peng; Wang, Qun; Man, Heng-ye; Wang, Jian-zhi; Liu, Rong			Zinc mediates the neuronal activity-dependent anti-apoptotic effect	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; HIPPOCAMPAL SLICES; ALZHEIMERS-DISEASE; SYNAPTIC ACTIVITY; RELEASED ZINC; BRAIN; ZN2+; INHIBITION; INDUCTION; PATHOLOGY	Synaptic activity increases the resistance of neurons to diverse apoptotic insults; however, the underlying mechanisms remain less well understood. Zinc promotes cell survival under varied conditions, but the role of synaptically released zinc in the activity-dependent antiapoptotic effect is unknown. Using cultured hippocampal slices and primary neurons we show that a typical apoptosis inducer-staurosporine (STP) was able to cause concentration-dependent apoptotic cell death in brain slices; Enhanced synaptic activity by bicuculline (Bic)/4-Aminopyridine (AP) treatment effectively prevented neurons from STP-induced cell apoptosis, as indicated by increased cell survival and suppressed caspase-3 activity. Application of Ca-EDTA, a cell membrane-impermeable zinc chelator which can efficiently capture the synaptically released zinc, completely blocked the neuronal activity-dependent antiapoptotic effect. Same results were also observed in cultured primary hippocampal neurons. Therefore, our results indicate that synaptic activity improves neuronal resistance to apoptosis via synaptically released zinc.	[Qiu, Mei; Shentu, Yang-ping; Wang, Xiao-chuan; Yan, Xiong; Zhou, Xin-wen; Wang, Qun; Wang, Jian-zhi; Liu, Rong] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Dept Pathophysiol,Key Lab,Minist Educ Neurol Diso, Wuhan, Hubei, Peoples R China; [Qiu, Mei] Hubei Univ TCM, Clin Coll, Wuhan, Hubei, Peoples R China; [Zeng, Ji; Jing, Xiao-peng] Huazhong Univ Sci & Technol, Tongji Med Coll, Pu Ai Hosp, Dept Clin Lab, Wuhan, Hubei, Peoples R China; [Man, Heng-ye] Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Boston University	Liu, R (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Dept Pathophysiol,Key Lab,Minist Educ Neurol Diso, Wuhan, Hubei, Peoples R China.	rong.liu@hust.edu.cn			National Natural Science Foundation of China [81471304, 81271403, 91132305]; Natural Science Foundation of Hubei Province, China [2015CKC897]; Hubei Health and Family Planning Commission [WJ2015MB152]; Integrated Innovative Team for Major Human Diseases Program of Tongji Medical College, HUST	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province, China(Natural Science Foundation of Hubei Province); Hubei Health and Family Planning Commission; Integrated Innovative Team for Major Human Diseases Program of Tongji Medical College, HUST	This work was supported by the National Natural Science Foundation of China (No: 81471304, 81271403, 91132305), Natural Science Foundation of Hubei Province, China (No: 2015CKC897), and the foundations from Hubei Health and Family Planning Commission (No: WJ2015MB152) and Integrated Innovative Team for Major Human Diseases Program of Tongji Medical College, HUST.	ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Coleman PD, 2003, NEUROBIOL AGING, V24, P1023, DOI 10.1016/j.neurobiolaging.2003.09.001; Deng XM, 1998, J BIOL CHEM, V273, P34157, DOI 10.1074/jbc.273.51.34157; Frederickson CJ, 2005, NATURE, V268, P148; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Ho LH, 2000, BIOCHEM BIOPH RES CO, V6, P449; HOWELL GA, 1984, NATURE, V308, P736, DOI 10.1038/308736a0; Inoue K, 2015, CURR MED CHEM, V22, P1248, DOI 10.2174/0929867322666150209153750; Jankowski-Hennig MA, 2000, BIOCHEM BIOPH RES CO, V271, P250, DOI 10.1006/bbrc.2000.2608; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Komatsu K, 2005, J AM CHEM SOC, V127, P10197, DOI 10.1021/ja050301e; Konishi Y, 2003, J NEUROSCI, V23, P1649; Kontargiris E, 2012, BIOL TRACE ELEM RES, V150, P460, DOI 10.1007/s12011-012-9492-8; Lee JM, 2015, BIOCHEM BIOPH RES CO, V459, P220, DOI 10.1016/j.bbrc.2015.02.068; Leveille F, 2008, FASEB J, V22, P4258, DOI 10.1096/fj.08-107268; Leveille F, 2010, J NEUROSCI, V30, P2623, DOI 10.1523/JNEUROSCI.5115-09.2010; Lovell MA, 2009, J ALZHEIMERS DIS, V16, P471, DOI 10.3233/JAD-2009-0992; Lu YM, 2000, SYNAPSE, V38, P187, DOI 10.1002/1098-2396(200011)38:2<187::AID-SYN10>3.0.CO;2-R; Mocchegiani E, 2007, J ALZHEIMERS DIS, V12, P101; Nijhawan D, 2000, ANNU REV NEUROSCI, V23, P73, DOI 10.1146/annurev.neuro.23.1.73; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Qian J, 2005, J PHYSIOL-LONDON, V566, P747, DOI 10.1113/jphysiol.2005.089276; Romero-Hernandez A, 2016, NEURON, V92, P1324, DOI 10.1016/j.neuron.2016.11.006; Sandstead HH, 2000, J NUTR, V130, p496S, DOI 10.1093/jn/130.2.496S; Sensi SL, 2011, J NEUROSCI, V31, P16076, DOI 10.1523/JNEUROSCI.3454-11.2011; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Sun XY, 2012, J BIOL CHEM, V287, P11174, DOI 10.1074/jbc.M111.309070; Takeda A, 2013, METALLOMICS, V5, P417, DOI 10.1039/c3mt20269k; Takeda A, 2012, NEUROCHEM INT, V60, P394, DOI 10.1016/j.neuint.2012.01.021; VAN HC, 2003, BIOCHIM BIOPHYS ACTA, V1640, P97; Vogt K, 2000, NEURON, V26, P187, DOI 10.1016/S0896-6273(00)81149-6; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604	35	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182150	10.1371/journal.pone.0182150	http://dx.doi.org/10.1371/journal.pone.0182150			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28787459	gold, Green Submitted, Green Published			2022-12-26	WOS:000406998800017
J	Ding, SB; Jiang, JJ; Yu, PX; Zhang, GF; Zhang, GH; Liu, XT				Ding, Shibin; Jiang, Jinjin; Yu, Pengxin; Zhang, Guofu; Zhang, Guanghui; Liu, Xiaoting			Green tea polyphenol treatment attenuates atherosclerosis in high-fat diet-fed apolipoprotein E-knockout mice via alleviating dyslipidemia and up-regulating autophagy	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; THERAPEUTIC TARGET; LIPID-ACCUMULATION; ENDOTHELIAL-CELLS; INDUCED OBESITY; METABOLISM; DISEASE; LIVER; METAANALYSIS; CHOLESTEROL	Background: Green tea polyphenol (GTP) is a polyphenol source from green tea that has drawn wide attention owing to epidemiological evidence of its beneficial effects in the prevention of cardiovascular disease; the underlying molecular mechanisms of these effects are not well understood. This study aimed to investigate the effects of GTP treatment on autophagy regulation in the vessel wall and lipid metabolism of HFD-fed male ApoE-knockout mice. Methods: Adult male ApoE-knockout mice (n = 30) fed with a high-fat diet (HFD) were treated with either vehicle or GTP (3.2 or 6.4 g/L) administered via drinking water for 15 weeks, and C57BL/6J mice fed with standard chow diet (STD) were used as the control group. Metabolic parameters, expression of key mRNAs and proteins of hepatic lipid metabolism and autophagy in the vessel wall of mice were determined after the 15-week treatment. Results: A HFD induced atherosclerosis formation and lipid metabolism disorders as well as reduced autophagy expression in the vessel wall of ApoE-knockout mice, but GTP treatment alleviated the lipid metabolism disorders, decreased the oxLDL levels in serum, and increased the mRNA and protein expressions of hepatic PPAR alpha and autophagy markers (LC3, Beclin1 and p62) in the vessel wall of ApoE-knockout mice. Conclusions: Our findings suggest that GTP supplementation showed marked suppression of atherogenesis through improved lipid metabolism as well as through a direct impact on oxLDL and autophagy flux in the vessel wall.	[Ding, Shibin; Yu, Pengxin; Zhang, Guofu; Zhang, Guanghui; Liu, Xiaoting] Xinxiang Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Xinxiang, Henan, Peoples R China; [Ding, Shibin] Xinxiang Med Univ, Henan Collaborat Innovat Ctr Mol Diag, Xinxiang, Henan, Peoples R China; [Ding, Shibin] Xinxiang Med Univ, Lab Med, Xinxiang, Henan, Peoples R China; [Jiang, Jinjin] Capital Med Univ, Sch Publ Hlth, Beijing, Peoples R China	Xinxiang Medical University; Xinxiang Medical University; Xinxiang Medical University; Capital Medical University	Ding, SB (corresponding author), Xinxiang Med Univ, Sch Publ Hlth, Dept Nutr & Food Hyg, Xinxiang, Henan, Peoples R China.; Ding, SB (corresponding author), Xinxiang Med Univ, Henan Collaborat Innovat Ctr Mol Diag, Xinxiang, Henan, Peoples R China.	dingshibin@163.com			Key Scientific Research Project of Universities in Henan Province [16A330002, 16A330005]	Key Scientific Research Project of Universities in Henan Province	This study was supported by the Key Scientific Research Project of Universities in Henan Province, grant numbers 16A330002 and 16A330005, http://www.haedu.gov.cn/2015/12/28/1451286482287.html.	Cai Y, 2013, PATHOG DIS, V67, P76, DOI 10.1111/2049-632X.12001; Chyu KY, 2004, CIRCULATION, V109, P2448, DOI 10.1161/01.CIR.0000128034.70732.C2; Ding SB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155352; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Ivanova D, 2013, ARCH PHYSIOL BIOCHEM, V119, P32, DOI 10.3109/13813455.2012.729844; Kavantzas N, 2006, VASC PHARMACOL, V44, P461, DOI 10.1016/j.vph.2006.03.008; Kersten S, 2014, MOL METAB, V3, P354, DOI 10.1016/j.molmet.2014.02.002; Kim HS, 2013, J BIOL CHEM, V288, P22693, DOI 10.1074/jbc.M113.477505; Lee LS, 2015, MOL NUTR FOOD RES, V59, P784, DOI 10.1002/mnfr.201400470; Lee SJ, 2015, CURR OPIN LIPIDOL, V26, P3, DOI 10.1097/MOL.0000000000000145; Li JH, 2016, MOL NUTR FOOD RES, V60, P858, DOI 10.1002/mnfr.201500814; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Luo Y, 2016, J CARDIOVASC PHARM, V67, P266, DOI 10.1097/FJC.0000000000000342; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Martinez N, 2011, BRIT J NUTR, V105, P721, DOI 10.1017/S0007114510004289; Millar JS, 2013, CURR OPIN LIPIDOL, V24, P233, DOI 10.1097/MOL.0b013e3283613a7d; Minatti J, 2012, NUTR RES, V32, P684, DOI 10.1016/j.nutres.2012.08.003; Onakpoya I, 2014, NUTR METAB CARDIOVAS, V24, P823, DOI 10.1016/j.numecd.2014.01.016; Pang J, 2016, INT J CARDIOL, V202, P967, DOI 10.1016/j.ijcard.2014.12.176; Peng N, 2014, SCI REP-UK, V4, DOI 10.1038/srep05519; Rioufol G, 2002, CIRCULATION, V106, P804, DOI 10.1161/01.CIR.0000025609.13806.31; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Santamarina AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141227; Santamarina AB, 2015, J NUTR BIOCHEM, V26, P1348, DOI 10.1016/j.jnutbio.2015.07.002; Sato R, 2010, ARCH BIOCHEM BIOPHYS, V501, P177, DOI 10.1016/j.abb.2010.06.004; Sima AV, 2009, CELL TISSUE RES, V335, P191, DOI 10.1007/s00441-008-0678-5; Sridhar S, 2012, J PATHOL, V226, P255, DOI 10.1002/path.3025; Tian C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053796; Vindis C, 2015, BRIT J PHARMACOL, V172, P2167, DOI 10.1111/bph.13052; Wang ZM, 2011, AM J CLIN NUTR, V93, P506, DOI 10.3945/ajcn.110.005363; Wolfram S, 2007, J AM COLL NUTR, V26, p373S, DOI 10.1080/07315724.2007.10719626; Yamagata K, 2015, PHYTOMEDICINE, V22, P431, DOI 10.1016/j.phymed.2015.01.011; Yang TTC, 2000, ATHEROSCLEROSIS, V148, P67, DOI 10.1016/S0021-9150(99)00239-7; Ying CJ, 2003, HYPERTENS RES, V26, P823, DOI 10.1291/hypres.26.823; Zabirnyk O, 2010, CARCINOGENESIS, V31, P446, DOI 10.1093/carcin/bgp299	36	25	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0181666	10.1371/journal.pone.0181666	http://dx.doi.org/10.1371/journal.pone.0181666			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28777810	Green Published, gold, Green Submitted			2022-12-26	WOS:000406944300009
J	Ilmjarv, T; Naanuri, E; Kivisaar, M				Ilmjarv, Tanel; Naanuri, Eve; Kivisaar, Maia			Contribution of increased mutagenesis to the evolution of pollutants-degrading indigenous bacteria	PLOS ONE			English	Article							STATIONARY-PHASE MUTAGENESIS; POLYMORPHIC MUTATION FREQUENCIES; CONFER UV HYPERSENSITIVITY; STRESS-INDUCED MUTAGENESIS; SOS-INDUCED MUTAGENESIS; ESCHERICHIA-COLI K-12; DNA-POLYMERASE-V; PSEUDOMONAS-PUTIDA; CYSTIC-FIBROSIS; BALTIC SEA	Bacteria can rapidly evolve mechanisms allowing them to use toxic environmental pollutants as a carbon source. In the current study we examined whether the survival and evolution of indigenous bacteria with the capacity to degrade organic pollutants could be connected with increased mutation frequency. The presence of constitutive and transient mutators was monitored among 53 pollutants-degrading indigenous bacterial strains. Only two strains expressed a moderate mutator phenotype and six were hypomutators, which implies that constitutively increased mutability has not been prevalent in the evolution of pollutants degrading bacteria. At the same time, a large proportion of the studied indigenous strains exhibited UV-irradiation-induced mutagenesis, indicating that these strains possess error-prone DNA polymerases which could elevate mutation frequency transiently under the conditions of DNA damage. A closer inspection of two Pseudomonas fluorescens strains PC20 and PC24 revealed that they harbour genes for ImuC (DnaE2) and more than one copy of genes for Pol V. Our results also revealed that availability of other nutrients in addition to aromatic pollutants in the growth environment of bacteria affects mutagenic effects of aromatic compounds. These results also implied that mutagenicity might be affected by a factor of how long bacteria have evolved to use a particular pollutant as a carbon source.	[Ilmjarv, Tanel; Naanuri, Eve; Kivisaar, Maia] Univ Tartu, Inst Mol & Cell Biol, Dept Genet, Tartu, Estonia	University of Tartu	Kivisaar, M (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Dept Genet, Tartu, Estonia.	maia.kivisaar@ut.ee		Ilmjarv, Tanel/0000-0002-2524-498X	Eesti Teadusagentuur (Estonian Research Council) [IUT20-19]	Eesti Teadusagentuur (Estonian Research Council)	This work was supported by Institutional Research Funding IUT20-19 from Eesti Teadusagentuur (Estonian Research Council) to MK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella M, 2004, MOL MICROBIOL, V54, P212, DOI 10.1111/j.1365-2958.2004.04260.x; Baquero MR, 2004, J BACTERIOL, V186, P5538, DOI 10.1128/JB.186.16.5538-5542.2004; BAYLEY SA, 1977, MOL GEN GENET, V154, P203, DOI 10.1007/BF00330838; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bjelland S, 2003, MUTAT RES-FUND MOL M, V531, P37, DOI 10.1016/j.mrfmmm.2003.07.002; Boshoff HIM, 2003, CELL, V113, P183, DOI 10.1016/S0092-8674(03)00270-8; Boudsocq F, 2002, DNA REPAIR, V1, P343, DOI 10.1016/S1568-7864(02)00019-8; BOYCE RP, 1964, P NATL ACAD SCI USA, V51, P293, DOI 10.1073/pnas.51.2.293; Brown EW, 2001, J BACTERIOL, V183, P1631, DOI 10.1128/JB.183.5.1631-1644.2001; Turrientes MC, 2010, APPL ENVIRON MICROB, V76, P1746, DOI 10.1128/AEM.02817-09; Cases I, 2005, NAT REV MICROBIOL, V3, P105, DOI 10.1038/nrmicro1084; Couce A, 2009, FEMS MICROBIOL REV, V33, P531, DOI 10.1111/j.1574-6976.2009.00165.x; Courcelle J, 2001, GENETICS, V158, P41; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; Denamur E, 2000, CELL, V103, P711, DOI 10.1016/S0092-8674(00)00175-6; Dominguez-Cuevas P, 2006, J BIOL CHEM, V281, P11981, DOI 10.1074/jbc.M509848200; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Erill I, 2006, NUCLEIC ACIDS RES, V34, P66, DOI 10.1093/nar/gkj412; Fernandez de Henestrosa AR, 2000, MOL MICROBIOL, V35, P1560, DOI 10.1046/j.1365-2958.2000.01826.x; Foster PL, 2007, CRIT REV BIOCHEM MOL, V42, P373, DOI 10.1080/10409230701648494; Funchain P, 2000, GENETICS, V154, P959; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Galhardo RS, 2005, NUCLEIC ACIDS RES, V33, P2603, DOI 10.1093/nar/gki551; Garibyan L, 2003, DNA REPAIR, V2, P593, DOI 10.1016/S1568-7864(03)00024-7; Giraud A, 2001, SCIENCE, V291, P2606, DOI 10.1126/science.1056421; Good BH, 2016, GENETICS, V204, P1249, DOI 10.1534/genetics.116.193565; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; Hall LMC, 2006, MICROBIOL-SGM, V152, P2505, DOI 10.1099/mic.0.29079-0; Hawver LA, 2011, J BACTERIOL, V193, P5400, DOI 10.1128/JB.05301-11; Heinaru E, 2005, FEMS MICROBIOL ECOL, V51, P363, DOI 10.1016/j.femsec.2004.09.009; Heinaru E, 2000, FEMS MICROBIOL ECOL, V31, P195, DOI 10.1111/j.1574-6941.2000.tb00684.x; Heinaru E, 2016, GENE, V589, P90, DOI 10.1016/j.gene.2016.05.022; Heinaru E, 2009, FEMS MICROBIOL ECOL, V70, P563, DOI 10.1111/j.1574-6941.2009.00763.x; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Ippoliti Paul J, 2012, Cells, V1, P799, DOI 10.3390/cells1040799; Jatsenko T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170719; Jatsenko T, 2010, MUTAT RES-FUND MOL M, V683, P106, DOI 10.1016/j.mrfmmm.2009.10.015; Juhanson J, 2009, FEMS MICROBIOL ECOL, V70, P446, DOI 10.1111/j.1574-6941.2009.00754.x; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Jutkina J, 2011, GENES-BASEL, V2, P853, DOI 10.3390/genes2040853; Juurik T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048511; KATO T, 1977, MOL GEN GENET, V156, P121, DOI 10.1007/BF00283484; Kenna DT, 2007, MICROBIOL-SGM, V153, P1852, DOI 10.1099/mic.0.2006/005082-0; Kim DR, 1997, J BACTERIOL, V179, P6721, DOI 10.1128/jb.179.21.6721-6728.1997; KITAGAWA Y, 1985, P NATL ACAD SCI USA, V82, P4336, DOI 10.1073/pnas.82.13.4336; Kivisaar M, 2003, ENVIRON MICROBIOL, V5, P814, DOI 10.1046/j.1462-2920.2003.00488.x; Kivisaar M, 2009, MOL MICROBIOL, V74, P777, DOI 10.1111/j.1365-2958.2009.06905.x; KOCH WH, 1992, MOL GEN GENET, V233, P443, DOI 10.1007/BF00265442; Koorits L, 2007, DNA REPAIR, V6, P863, DOI 10.1016/j.dnarep.2007.01.010; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LeClerc JE, 1996, SCIENCE, V274, P1208, DOI 10.1126/science.274.5290.1208; Lynch M, 2016, NAT REV GENET, V17, P704, DOI 10.1038/nrg.2016.104; Lynch M, 2011, GENOME BIOL EVOL, V3, P1107, DOI 10.1093/gbe/evr066; MacLean RC, 2013, NAT REV GENET, V14, P221, DOI 10.1038/nrg3415; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Matic I, 1997, SCIENCE, V277, P1833, DOI 10.1126/science.277.5333.1833; McBeth DL, 1996, APPL ENVIRON MICROB, V62, P3538, DOI 10.1128/AEM.62.9.3538-3540.1996; McHenry CS, 2011, EMBO REP, V12, P408, DOI 10.1038/embor.2011.51; Merimaa M, 2006, ARCH MICROBIOL, V186, P287, DOI 10.1007/s00203-006-0143-3; MICHAELS ML, 1992, P NATL ACAD SCI USA, V89, P7022, DOI 10.1073/pnas.89.15.7022; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Miller JH, 1996, ANNU REV MICROBIOL, V50, P625, DOI 10.1146/annurev.micro.50.1.625; NOHMI T, 1988, P NATL ACAD SCI USA, V85, P1816, DOI 10.1073/pnas.85.6.1816; Nohmi T, 2006, ANNU REV MICROBIOL, V60, P231, DOI 10.1146/annurev.micro.60.080805.142238; Nojiri H, 2004, APPL MICROBIOL BIOT, V64, P154, DOI 10.1007/s00253-003-1509-y; Norman A, 2009, PHILOS T R SOC B, V364, P2275, DOI 10.1098/rstb.2009.0037; Notley-McRobb L, 2002, GENETICS, V162, P1055; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Oliver A, 2010, CLIN MICROBIOL INFEC, V16, P798, DOI 10.1111/j.1469-0691.2010.03250.x; Oliver A, 2002, MOL MICROBIOL, V43, P1641, DOI 10.1046/j.1365-2958.2002.02855.x; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Patel M, 2010, CRIT REV BIOCHEM MOL, V45, P171, DOI 10.3109/10409238.2010.480968; Perez-Pantoja D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003764; Permina EA, 2002, GENE, V293, P133, DOI 10.1016/S0378-1119(02)00701-1; Peters M, 1997, APPL ENVIRON MICROB, V63, P4899, DOI 10.1128/AEM.63.12.4899-4906.1997; Ramos JL, 2009, CURR OPIN MICROBIOL, V12, P215, DOI 10.1016/j.mib.2009.02.001; REASONER DJ, 1985, APPL ENVIRON MICROB, V49, P1; Regenhardt D, 2002, ENVIRON MICROBIOL, V4, P912, DOI 10.1046/j.1462-2920.2002.00368.x; Robleto EA, 2007, CRIT REV BIOCHEM MOL, V42, P327, DOI 10.1080/10409230701597717; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Santos PM, 2004, PROTEOMICS, V4, P2640, DOI 10.1002/pmic.200300793; Shurtleff BW, 2009, J BACTERIOL, V191, P4815, DOI 10.1128/JB.01742-08; Sidorenko J, 2011, MUTAT RES-FUND MOL M, V714, P63, DOI 10.1016/j.mrfmmm.2011.06.013; SIKKEMA J, 1995, MICROBIOL REV, V59, P201, DOI 10.1128/MMBR.59.2.201-222.1995; Sniegowski PD, 2000, BIOESSAYS, V22, P1057, DOI 10.1002/1521-1878(200012)22:12&lt;1057::AID-BIES3&gt;3.0.CO;2-W; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; STEINBORN G, 1978, MOL GEN GENET, V165, P87, DOI 10.1007/BF00270380; Sundin GW, 2007, FEMS MICROBIOL LETT, V277, P11, DOI 10.1111/j.1574-6968.2007.00901.x; Sundin GW, 1999, ENVIRON MICROBIOL, V1, P75, DOI 10.1046/j.1462-2920.1999.00008.x; Sundin GW, 1996, GENE, V177, P77, DOI 10.1016/0378-1119(96)00273-9; Sutton MD, 2001, J BACTERIOL, V183, P1215, DOI 10.1128/JB.183.4.1215-1224.2001; Sutton MD, 2000, ANNU REV GENET, V34, P479, DOI 10.1146/annurev.genet.34.1.479; Taddei F, 1997, NATURE, V387, P700, DOI 10.1038/42696; Tang MJ, 1998, P NATL ACAD SCI USA, V95, P9755, DOI 10.1073/pnas.95.17.9755; Tark M, 2005, J BACTERIOL, V187, P5203, DOI 10.1128/JB.187.15.5203-5213.2005; Taverna P, 1996, J BACTERIOL, V178, P5105, DOI 10.1128/jb.178.17.5105-5111.1996; Tegova R, 2004, J BACTERIOL, V186, P2735, DOI 10.1128/JB.186.9.2735-2744.2004; Timinskas K, 2014, NUCLEIC ACIDS RES, V42, P1393, DOI 10.1093/nar/gkt900; Truglio JJ, 2006, CHEM REV, V106, P233, DOI 10.1021/cr040471u; Tsai HH, 2012, NUCLEIC ACIDS RES, V40, P1118, DOI 10.1093/nar/gkr856; Turrientes MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072963; Vaisman A, 2012, NUCLEIC ACIDS RES, V40, P6144, DOI 10.1093/nar/gks233; van der Meer JR, 2003, CURR OPIN BIOTECH, V14, P248, DOI 10.1016/S0958-1669(03)00058-2; Vedler E, 2013, SYST APPL MICROBIOL, V36, P525, DOI 10.1016/j.syapm.2013.07.004; Vidigal PG, 2014, INT J MED MICROBIOL, V304, P613, DOI 10.1016/j.ijmm.2014.04.002; Viggor S, 2013, MICROBIOL RES, V168, P415, DOI 10.1016/j.micres.2013.02.006; WALKER GC, 1984, MICROBIOL REV, V48, P60, DOI 10.1128/MMBR.48.1.60-93.1984; WERTMAN KF, 1985, J BACTERIOL, V163, P376, DOI 10.1128/JB.163.1.376-384.1985; WILLIAMS PA, 1974, J BACTERIOL, V120, P416, DOI 10.1128/JB.120.1.416-423.1974; WOODGATE R, 1994, J BACTERIOL, V176, P5011, DOI 10.1128/jb.176.16.5011-5021.1994; WOODGATE R, 1992, MOL MICROBIOL, V6, P2213, DOI 10.1111/j.1365-2958.1992.tb01397.x	112	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0182484	10.1371/journal.pone.0182484	http://dx.doi.org/10.1371/journal.pone.0182484			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28777807	Green Submitted, Green Published, gold			2022-12-26	WOS:000406944300037
J	D'Abundo, L; Callegari, E; Bresin, A; Chillemi, A; Elamin, BK; Guerriero, P; Huang, X; Saccenti, E; Hussein, EMAA; Casciano, F; Secchiero, P; Zauli, G; Calin, GA; Russo, G; Lee, LJ; Croce, CM; Marcucci, G; Sabbioni, S; Malavasi, F; Negrini, M				D'Abundo, L.; Callegari, E.; Bresin, A.; Chillemi, A.; Elamin, B. K.; Guerriero, P.; Huang, X.; Saccenti, E.; Hussein, E. M. A. A.; Casciano, F.; Secchiero, P.; Zauli, G.; Calin, G. A.; Russo, G.; Lee, L. J.; Croce, C. M.; Marcucci, G.; Sabbioni, S.; Malavasi, F.; Negrini, M.			Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model	ONCOGENE			English	Article							INHIBITS CELL-PROLIFERATION; IN-VIVO; MONOCLONAL-ANTIBODIES; CD38 EXPRESSION; CANCER; DELIVERY; PATHOGENESIS; MIR-130A; SURVIVAL; DISEASE	Dysregulation of microRNAs (miRNAs) plays an important role in the pathogenesis of chronic lymphocytic leukemia (CLL). The E mu-TCL1 transgenic mouse develops a form of leukemia that is similar to the aggressive type of human B-CLL, and this valuable model has been widely used for testing novel therapeutic approaches. Here, we adopted this model to investigate the potential effects of miR-26a, miR-130an and antimiR-155 in CLL therapy. Improved delivery of miRNA molecules into CLL cells was obtained by developing a novel system based on lipid nanoparticles conjugated with an anti-CD38 monoclonal antibody. This methodology has proven to be highly effective in delivering miRNA molecules into leukemic cells. Short-and long-term experiments showed that miR-26a, miR-130a and anti-miR-155 increased apoptosis after in vitro and in vivo treatment. Of this miRNA panel, miR-26a was the most effective in reducing leukemic cell expansion. Following long-term treatment, apoptosis was readily detectable by analyzing cleavage of PARP and caspase-7. These effects could be directly attributed to miR-26a, as confirmed by significant downregulation of its proven targets, namely cyclin-dependent kinase 6 and Mcl1. The results of this study are relevant to two distinct areas. The first is related to the design of a technical strategy and to the selection of CD38 as a molecular target on CLL cells, both consenting efficient and specific intracellular transfer of miRNA. The original scientific finding inferred from the above approach is that miR-26a can elicit in vivo anti-leukemic activities mediated by increased apoptosis.	[D'Abundo, L.; Callegari, E.; Bresin, A.; Guerriero, P.; Hussein, E. M. A. A.; Negrini, M.] Univ Ferrara, Dept Morphol Surg & Expt Med, Via Luigi Borsari 46, I-44121 Ferrara, Italy; [Bresin, A.; Russo, G.] IRCCS, IDI, Lab Oncol Mol, Rome, Italy; [Chillemi, A.; Malavasi, F.] Univ Turin, Dept Med Sci, Lab Immunogenet, Turin, Italy; [Chillemi, A.; Malavasi, F.] Lab Immunol Trapianti Citta Salute & Sci, Turin, Italy; [Elamin, B. K.] Univ Khartoum, Fac Med Lab Sci, Microbiol Dept, Khartoum, Sudan; [Elamin, B. K.] Univ Bisha, Coll Med, Microbiol Dept, Bisha, Saudi Arabia; [Huang, X.; Lee, L. J.] Ohio State Univ, Nanoscale Sci & Engn Ctr Affordable Nanoengn Poly, Columbus, OH 43210 USA; [Huang, X.; Lee, L. J.] Ohio State Univ, Dept Chem & Biomol Engn, Columbus, OH 43210 USA; [Huang, X.; Croce, C. M.] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA; [Saccenti, E.] Univ Ferrara, Univ Hosp Arcispedale S Anna, Dept Med Sci, Hematol Sect, Ferrara, Italy; [Hussein, E. M. A. A.] Univ Khartoum, Fac Med Lab Sci, Hematol & Immunohematol Dept, Khartoum, Sudan; [Casciano, F.; Secchiero, P.; Zauli, G.] Univ Ferrara, Surg Expt Med & LTTA Ctr, Dept Morphol, Ferrara, Italy; [Calin, G. A.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Div Canc Med, Houston, TX 77030 USA; [Marcucci, G.] City Hope Natl Med Ctr, Gehr Family Ctr Leukemia Res Hematol Malignancies, Duarte, CA USA; [Sabbioni, S.] Univ Ferrara, Dept Life Sci & Biotechnol, Ferrara, Italy	University of Ferrara; IRCCS Istituto Dermopatico dell'Immacolata (IDI); University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; University of Khartoum; University of Bisha; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Ferrara; Arcispedale Sant'Anna; University of Khartoum; University of Ferrara; University of Texas System; UTMD Anderson Cancer Center; City of Hope; University of Ferrara	D'Abundo, L; Negrini, M (corresponding author), Univ Ferrara, Dept Morphol Surg & Expt Med, Via Luigi Borsari 46, I-44121 Ferrara, Italy.	dbnlll@unife.it; ngm@unife.it	Zauli, Giorgio/ABE-8001-2020; Casciano, Fabio FC/H-3219-2015; bresin, antonella/AAG-7189-2020; D'ABUNDO, LUCILLA/AAB-9816-2019; Callegari, Elisa/Q-6135-2019; Calin, George/E-9390-2011; Negrini, Matteo/C-8906-2014; Young, Richard A/F-6495-2012; Russo, Giandomenico/K-9566-2016; NEGRINI, Massimo/J-2377-2016	Casciano, Fabio FC/0000-0002-6431-3335; Callegari, Elisa/0000-0002-4969-5400; Negrini, Matteo/0000-0003-0101-6963; Young, Richard A/0000-0001-8855-8647; Russo, Giandomenico/0000-0002-7718-9687; D'Abundo, Lucilla/0000-0003-4196-0203; Elamin, Bahaeldin K./0000-0002-1136-4980; Calin, George/0000-0002-7427-0578; Calin, George/0000-0001-6704-5615; BRESIN, antonella/0000-0003-3954-5481; NEGRINI, Massimo/0000-0002-0007-1920; GUERRIERO, Paola/0000-0003-3724-7472	Italian Association for Cancer Research (AIRC) [9980]; University of Ferrara; US National Cancer Institute [CA19-7706]; FIRB Programme of the Ministry of University and Research (Rome, Italy); Fondazione Cassa di Risparmio di Torino; Fondazione Ricerca Molinette Torino	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); University of Ferrara; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FIRB Programme of the Ministry of University and Research (Rome, Italy); Fondazione Cassa di Risparmio di Torino(Fondazione CRT); Fondazione Ricerca Molinette Torino	This work was supported by funds from the Italian Association for Cancer Research (AIRC Special program 5xmille n.9980) and the University of Ferrara to MN, from the US National Cancer Institute grant CA19-7706 to CMC, from FIRB Programme of the Ministry of University and Research (Rome, Italy), Fondazione Cassa di Risparmio di Torino and Fondazione Ricerca Molinette Torino to FM.	Acunzo M, 2012, ONCOGENE, V31, P634, DOI 10.1038/onc.2011.260; Amendola M, 2009, MOL THER, V17, P1039, DOI 10.1038/mt.2009.48; Ansari MQ, 1996, AM J CLIN PATHOL, V105, P221; Bende RJ, 2003, AM J PATHOL, V162, P105, DOI 10.1016/S0002-9440(10)63802-3; Bichi R, 2002, P NATL ACAD SCI USA, V99, P6955, DOI 10.1073/pnas.102181599; BINET JL, 1981, CANCER-AM CANCER SOC, V48, P198, DOI 10.1002/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V; Boll K, 2013, ONCOGENE, V32, P277, DOI 10.1038/onc.2012.55; Bresin A, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.419; Bresin A, 2015, ONCOTARGET, V6, P19807, DOI 10.18632/oncotarget.4415; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2007, BEST PRACT RES CL HA, V20, P425, DOI 10.1016/j.beha.2007.02.003; Callegari E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073964; Chen JS, 2016, ONCOL REP, V35, P3285, DOI 10.3892/or.2016.4719; Chen YC, 2015, ADV DRUG DELIVER REV, V81, P128, DOI 10.1016/j.addr.2014.05.009; Chillemi A, 2013, MOL MED, V19, P99, DOI 10.2119/molmed.2013.00009; Chiorazzi N, 2005, ANN NY ACAD SCI, V1062, P1, DOI 10.1196/annals.1358.002; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Colomo L, 2004, AM J SURG PATHOL, V28, P736, DOI 10.1097/01.pas.0000126781.87158.e3; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; Cui B, 2014, BLOOD, V124, P546, DOI 10.1182/blood-2014-03-559690; Cuneo A, 2014, CANCER MED-US, V3, P555, DOI 10.1002/cam4.226; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Di Martino MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090005; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Dorrance AM, 2015, LEUKEMIA, V29, P2143, DOI 10.1038/leu.2015.139; Efanov A, 2010, LEUKEMIA, V24, P970, DOI 10.1038/leu.2010.46; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Fabbri M, 2011, JAMA-J AM MED ASSOC, V305, P59, DOI 10.1001/jama.2010.1919; Fujita Y, 2015, PROSTATE, V75, P1568, DOI 10.1002/pros.23031; Gao J, 2013, J CHEM-NY, V2013, DOI 10.1155/2013/719179; Garzon R, 2008, CURR OPIN HEMATOL, V15, P352, DOI 10.1097/MOH.0b013e328303e15d; Ghosh R, 2013, BIOMATERIALS, V34, P807, DOI 10.1016/j.biomaterials.2012.10.023; Grever MR, 2007, J CLIN ONCOL, V25, P799, DOI 10.1200/JCO.2006.08.3089; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Horenstein Alberto L., 2005, V308, P191; Huang XM, 2013, CLIN CANCER RES, V19, P2355, DOI 10.1158/1078-0432.CCR-12-3191; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Ibrahim S, 2001, BLOOD, V98, P181, DOI 10.1182/blood.V98.1.181; Ji JF, 2009, NEW ENGL J MED, V361, P1437, DOI 10.1056/NEJMoa0901282; Jia XQ, 2012, CELL BIOCHEM BIOPHYS, V62, P237, DOI 10.1007/s12013-011-9263-8; Jiang H, 2015, ONCOL REP, V34, P1153, DOI 10.3892/or.2015.4099; Johnson AJ, 2006, BLOOD, V108, P1334, DOI 10.1182/blood-2005-12-011213; Kim H, 2010, P NATL ACAD SCI USA, V107, P2183, DOI 10.1073/pnas.0909896107; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Kovaleva V, 2012, CANCER RES, V72, P1763, DOI 10.1158/0008-5472.CAN-11-3671; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Landau DA, 2015, NATURE, V526, P525, DOI 10.1038/nature15395; Lee SH, 2015, ONCOTARGET, V6, P33269, DOI 10.18632/oncotarget.5037; Li BK, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0230-2; Li YH, 2015, ONCOTARGET, V6, P1101, DOI 10.18632/oncotarget.2728; Li ZH, 2014, NAT REV DRUG DISCOV, V13, P622, DOI 10.1038/nrd4359; Liu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055532; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Malavasi F, 2011, BLOOD, V118, P3470, DOI 10.1182/blood-2011-06-275610; Masotti A, 2016, NANOMED-NANOTECHNOL, V12, P1511, DOI 10.1016/j.nano.2016.02.017; Mattiske S, 2012, CANCER EPIDEM BIOMAR, V21, P1236, DOI 10.1158/1055-9965.EPI-12-0173; Miotto E, 2014, CANCER EPIDEM BIOMAR, V23, P2638, DOI 10.1158/1055-9965.EPI-14-0503; Negrini M, 2007, J CELL SCI, V120, P1833, DOI 10.1242/jcs.03450; Negrini M, 2014, CLIN CANCER RES, V20, P4141, DOI 10.1158/1078-0432.CCR-13-2497; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; Pan YQ, 2015, INT J CLIN EXP PATHO, V8, P384; Perez-Galan P, 2011, BLOOD, V117, P26, DOI 10.1182/blood-2010-04-189977; Roberts AW, 2016, NEW ENGL J MED, V374, P311, DOI 10.1056/NEJMoa1513257; Rossi D, 2011, BLOOD, V118, P6904, DOI 10.1182/blood-2011-08-373159; Rossi S, 2010, BLOOD, V116, P945, DOI 10.1182/blood-2010-01-263889; Sander S, 2008, BLOOD, V112, P4202, DOI 10.1182/blood-2008-03-147645; Scognamiglio I, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/217365; Shen SY, 2015, CELL RES, V25, P997, DOI 10.1038/cr.2015.98; Simonetti G, 2014, BLOOD, V124, P1010, DOI 10.1182/blood-2014-05-577122; Taccioli C, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv220; Tagawa H, 2013, CANCER SCI, V104, P801, DOI 10.1111/cas.12160; Vaisitti T, 2015, LEUKEMIA, V29, P356, DOI 10.1038/leu.2014.207; van de Donk NWCJ, 2016, BLOOD, V127, P681, DOI 10.1182/blood-2015-10-646810; Vargova K, 2011, BLOOD, V117, P3816, DOI 10.1182/blood-2010-05-285064; Visone R, 2011, BLOOD, V118, P3072, DOI 10.1182/blood-2011-01-333484; Visone R, 2009, BLOOD, V114, P3872, DOI 10.1182/blood-2009-06-229211; Wiestner A, 2003, BLOOD, V101, P4944, DOI 10.1182/blood-2002-10-3306; Yan XJ, 2006, P NATL ACAD SCI USA, V103, P11713, DOI 10.1073/pnas.0604564103; Yang X, 2013, HEPATOLOGY, V58, P158, DOI 10.1002/hep.26305; Zanesi Nicola, 2010, J Nucleic Acids Investig, V1, P36; Zenz T, 2010, NAT REV CANCER, V10, P37, DOI 10.1038/nrc2764; Zhang Y, 2012, BLOOD, V120, P1678, DOI 10.1182/blood-2012-02-410647; Zhang Y, 2013, J CONTROL RELEASE, V172, P962, DOI 10.1016/j.jconrel.2013.09.015; Zhu X, 2015, CANCER GENE THER, V22, P573, DOI 10.1038/cgt.2015.50; Zhu Y, 2012, NUCLEIC ACIDS RES, V40, P4615, DOI 10.1093/nar/gkr1278	88	16	16	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 23	2017	36	47					6617	6626		10.1038/onc.2017.269	http://dx.doi.org/10.1038/onc.2017.269			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FN5LN	28783166	Green Submitted			2022-12-26	WOS:000416049200010
J	Glover, K; Li, Y; Mukhopadhyay, S; Leuthner, Z; Chakravarthy, S; Colbert, CL; Sinha, SC				Glover, Karen; Li, Yue; Mukhopadhyay, Shreya; Leuthner, Zoe; Chakravarthy, Srinivas; Colbert, Christopher L.; Sinha, Sangita C.			Structural transitions in conserved, ordered Beclin 1 domains essential to regulating autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM SPECTRA; RAY SOLUTION SCATTERING; SMALL-ANGLE SCATTERING; PHOSPHATIDYLINOSITOL 3-KINASE COMPLEXES; PROTEIN SECONDARY STRUCTURE; 1-DEPENDENT AUTOPHAGY; TERMINAL DOMAIN; COILED-COIL; ATG14; GENE	Beclin 1 (BECN1) is a key regulator of autophagy, a critical catabolic homeostasis pathway that involves sequestration of selected cytoplasmic components by multilayered vesicles called autophagosomes, followed by lysosomal fusion and degradation. BECN1 is a core component of class III phosphatidy-linositol-3-kinase complexes responsible for autophagosome nucleation. Without heterologous binding partners, BECN1 forms an antiparallel homodimer via its coiled-coil domain (CCD). However, the last 16 CCD residues, composing an "overlap helix" (OH), have been crystallized in two mutually exclusive states: either as part of the CCD or packed against the C-terminal beta-alpha repeated, autophagy-specific domain (BARAD). Here, using CD spectroscopy, isothermal titration calorimetry, and small-angle X-ray scattering, we show that in the homodimeric state, the OH transitions between these two different packing states, with the predominant state comprising the OH packed against the BARAD, contrary to expectations based on known BECN1 interactions with heterologous partners. We confirmed this observation by comparing the impact of mutating four residues that mediate packing of the OH against both the CCD and BARAD on structure and stability of the CCD, the OH+ BARAD, and the two-domain CCD-BARAD. Last, we used cellular assays to demonstrate that mutation of these OH-interface residues abrogates starvation-induced up-regulation of autophagy but does not affect basal autophagy. In summary, we have identified a BECN1 helical region that transitions between packing as part of either one of two conserved domains (i.e. the CCD or the BARAD). Our findings have important implications for the relative stability of autophagy-inactive and autophagy-active BECN1 complexes.	[Glover, Karen; Li, Yue; Mukhopadhyay, Shreya; Leuthner, Zoe; Colbert, Christopher L.; Sinha, Sangita C.] North Dakota State Univ, Dept Chem & Biochem, Fargo, ND 58108 USA; [Chakravarthy, Srinivas] BioCAT, Adv Photon Source, Sect 18ID, Argonne, IL 60439 USA	North Dakota State University Fargo; United States Department of Energy (DOE); Argonne National Laboratory	Sinha, SC (corresponding author), North Dakota State Univ, Dept Chem & Biochem, Fargo, ND 58108 USA.	sangita.sinha@ndsu.edu		Mukhopadhyay, Shreya/0000-0002-2419-1409; Sinha, Sangita/0000-0003-0953-4263; Colbert, Christopher/0000-0001-9577-9544; Leuthner, Zoe/0000-0001-6502-1126	NIH NIGMS Grant [9P41 GM103622, S10 OD018090]; NIGMS, National Institutes of Health (NIH) [1S10OD018090-01]; Department of Energy Office of Science [DE-AC02-06CH11357]; NIH [P30 GM103332-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103622, R15GM113227, P30GM103332, R15GM122035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS090939] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018090] Funding Source: NIH RePORTER	NIH NIGMS Grant; NIGMS, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy Office of Science(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Work performed at Bio-CAT was supported by NIH NIGMS Grant 9P41 GM103622 and and S10 OD018090. The use of the Pilatus 3 1M detector was supported by NIGMS, National Institutes of Health (NIH), Grant 1S10OD018090-01. This research used resources of the Advanced Photon Source, a United States Department of Energy Office of Science User Facility operated for the Department of Energy Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. We acknowledge the North Dakota State University (NDSU) Core Biology Facility (funded by NIH Grant P30 GM103332-01) for access to tissue culture facilities and the NDSU Advanced Imaging and Microscopy Core Laboratory for access to microscopy and imaging equipment. We also thank Dr. Pawel Borowicz for assistance with imaging and puncta quantification method development.	Adi-Harel S, 2010, J CELL BIOCHEM, V110, P1262, DOI 10.1002/jcb.22642; BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; Baskaran S, 2014, ELIFE, V3, DOI 10.7554/eLife.05115; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; DeLano W. L., 2015, PYMOL MOL GRAPH SYST; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; Huang WJ, 2012, CELL RES, V22, P473, DOI 10.1038/cr.2012.24; Itakura E, 2009, AUTOPHAGY, V5, P534, DOI 10.4161/auto.5.4.8062; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Klionsky DJ, 2010, DEV CELL, V19, P11, DOI 10.1016/j.devcel.2010.07.005; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Koneri K, 2007, ANTICANCER RES, V27, P1453; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAWRENCE BP, 1992, J CELL SCI, V102, P515; Lee EF, 2016, AUTOPHAGY, V12, P460, DOI 10.1080/15548627.2016.1140292; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li XH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1648; Li ZD, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-98; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liang XH, 2001, CANCER RES, V61, P3443; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mei Y, 2016, PROTEIN SCI, V25, P1767, DOI 10.1002/pro.2984; Mei Y, 2016, BIOCHEMISTRY-US, V55, P4239, DOI 10.1021/acs.biochem.6b00246; Mei Y, 2016, BIOCHEMISTRY-US, V55, P1945, DOI 10.1021/acs.biochem.5b01264; Mei Y, 2014, PROTEINS, V82, P565, DOI 10.1002/prot.24424; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Miracco C, 2007, INT J ONCOL, V30, P429; Noda NN, 2012, J BIOL CHEM, V287, P16256, DOI 10.1074/jbc.M112.348250; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Receveur-Brechot V, 2012, CURR PROTEIN PEPT SC, V13, P55, DOI 10.2174/138920312799277901; Rostislavleva K, 2015, SCIENCE, V350, P140, DOI 10.1126/science.aac7365; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; Sinha S, 2008, AUTOPHAGY, V4, P989, DOI 10.4161/auto.6803; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 2001, ANAL BIOCHEM, V299, P271, DOI 10.1006/abio.2001.5420; Su MF, 2017, PROTEIN SCI, V26, P972, DOI 10.1002/pro.3140; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Zhang Kun, 2014, P 14THWORKSHOP DOMAI, P1, DOI DOI 10.1038/KI.2014.274	54	7	11	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16235	16248		10.1074/jbc.M117.804195	http://dx.doi.org/10.1074/jbc.M117.804195			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28798234	hybrid, Green Published			2022-12-26	WOS:000412109400022
J	Sawai, M; Uchida, Y; Ohno, Y; Miyamoto, M; Nishioka, C; Itohara, S; Sassa, T; Kihara, A				Sawai, Megumi; Uchida, Yukiko; Ohno, Yusuke; Miyamoto, Masatoshi; Nishioka, Chieko; Itohara, Shigeyoshi; Sassa, Takayuki; Kihara, Akio			The 3-hydroxyacyl-CoA dehydratases HACD1 and HACD2 exhibit functional redundancy and are active in a wide range of fatty acid elongation pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-2-ENOYL-COA REDUCTASE TER; PERMEABILITY BARRIER; METABOLIC PATHWAY; GENE; IDENTIFICATION; RESIDUES; MUTATION; PROTEIN; GENOME; CELLS	Differences among fatty acids (FAs) in chain length and number of double bonds create lipid diversity. FA elongation proceeds via a four-step reaction cycle, in which the 3-hydroxyacyl-CoA dehydratases (HACDs) HACD1-4 catalyze the third step. However, the contribution of each HACD to 3-hydroxyacyl-CoA dehydratase activity in certain tissues or in different FA elongation pathways remains unclear. HACD1 is specifically expressed in muscles and is a myopathy-causative gene. Here, we generated Hacd1 KO mice and observed that these mice had reduced body and skeletal muscle weights. In skeletal muscle, HACD1 mRNA expression was by far the highest among the HACDs. However, we observed only an similar to 40% reduction in HACD activity and no changes in membrane lipid composition in Hacd1-KO skeletal muscle, suggesting that some HACD activities are redundant. Moreover, when expressed in yeast, both HACD1 and HACD2 participated in saturated and monounsaturated FA elongation pathways. Disruption of HACD2 in the haploid human cell line HAP1 significantly reduced FA elongation activities toward both saturated and unsaturated FAs, and HACD1 HACD2 double disruption resulted in a further reduction. Overexpressed HACD3 exhibited weak activity in saturated and monounsaturated FA elongation pathways, and no activity was detected for HACD4. We therefore conclude that HACD1 and HACD2 exhibit redundant activities in a wide range of FA elongation pathways, including those for saturated to polyunsaturated FAs, with HACD2 being the major 3-hydroxyacyl-CoA dehydratase. Our findings are important for furthering the understanding of the molecular mechanisms in FA elongation and diversity.	[Sawai, Megumi; Uchida, Yukiko; Ohno, Yusuke; Miyamoto, Masatoshi; Sassa, Takayuki; Kihara, Akio] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan; [Nishioka, Chieko; Itohara, Shigeyoshi] RIKEN, Brain Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan	Hokkaido University; RIKEN	Kihara, A (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Kita 12 Jo,Nishi 6 Chome, Sapporo, Hokkaido 0600812, Japan.	kihara@pharm.hokudai.ac.jp	Ohno, Yusuke/B-5621-2014; Ohno, Yusuke/Q-3285-2019; KIHARA, AKIO/A-3802-2012; Itohara, Shigeyoshi/I-8769-2012; SASSA, Takayuki/B-2519-2012	Ohno, Yusuke/0000-0003-3702-1043; Ohno, Yusuke/0000-0003-3702-1043; KIHARA, AKIO/0000-0001-5889-0788; Itohara, Shigeyoshi/0000-0002-2410-9989; SASSA, Takayuki/0000-0003-3145-9829; Sawai-Ogawa, Megumi/0000-0002-7406-802X; Miyamoto, Masatoshi/0000-0002-7785-7438	Advanced Research and Development Programs for Medical Innovation (AMED-CREST) of the Japan Agency for Medical Research and Development (AMED); Japan Society for the Promotion of Science [26251010, 15H05589]; Grants-in-Aid for Scientific Research [16K08220, 26251010] Funding Source: KAKEN	Advanced Research and Development Programs for Medical Innovation (AMED-CREST) of the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Advanced Research and Development Programs for Medical Innovation (AMED-CREST) (to A. K.) of the Japan Agency for Medical Research and Development (AMED), by Grant-in-aid for Scientific Research (A) 26251010 (to A. K.) from the Japan Society for the Promotion of Science, and by Grant-in-aid for Young Scientists (A) 15H05589 (to Y. O.) from Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	Abe K, 2013, J BIOL CHEM, V288, P36741, DOI 10.1074/jbc.M113.493221; Adams DJ, 2005, GENOMICS, V86, P753, DOI 10.1016/j.ygeno.2005.08.003; Aldahmesh MA, 2011, AM J HUM GENET, V89, P745, DOI 10.1016/j.ajhg.2011.10.011; Ben-David O, 2011, J BIOL CHEM, V286, P30022, DOI 10.1074/jbc.M111.261206; Blondelle J, 2015, J MOL CELL BIOL, V7, P429, DOI 10.1093/jmcb/mjv049; Brachmann CB, 1998, YEAST, V14, P115; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; David D, 1998, J CELL BIOL, V143, P1167, DOI 10.1083/jcb.143.5.1167; Denic V, 2007, CELL, V130, P663, DOI 10.1016/j.cell.2007.06.031; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Han GS, 2002, J BIOL CHEM, V277, P35440, DOI 10.1074/jbc.M205620200; Harkewicz R, 2012, J BIOL CHEM, V287, P11469, DOI 10.1074/jbc.M111.256073; Ikeda M, 2008, FEBS LETT, V582, P2435, DOI 10.1016/j.febslet.2008.06.007; Imgrund S, 2009, J BIOL CHEM, V284, P33549, DOI 10.1074/jbc.M109.031971; Iwabuchi Kazuhisa, 2008, Glycoconj J, V25, P357, DOI 10.1007/s10719-007-9084-6; Kastaniotis AJ, 2004, MOL MICROBIOL, V53, P1407, DOI 10.1111/j.1365-2958.2004.04191.x; Kihara A, 2006, J BIOL CHEM, V281, P4532, DOI 10.1074/jbc.M510308200; Kihara A, 2008, J BIOL CHEM, V283, P11199, DOI 10.1074/jbc.M708993200; Kihara A, 2016, PROG LIPID RES, V63, P50, DOI 10.1016/j.plipres.2016.04.001; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; Kitamura T, 2017, P NATL ACAD SCI USA, V114, pE2616, DOI 10.1073/pnas.1700138114; Kitamura T, 2015, BIOCHEM J, V465, P79, DOI 10.1042/BJ20140624; Kohlwein SD, 2001, MOL CELL BIOL, V21, P109, DOI 10.1128/MCB.21.1.109-125.2001; Kondo N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6338; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Li DX, 2000, GENE, V256, P237, DOI 10.1016/S0378-1119(00)00347-4; Liu L, 2015, NAT PROTOC, V10, P1612, DOI 10.1038/nprot.2015.110; Moon YA, 2003, J BIOL CHEM, V278, P7335, DOI 10.1074/jbc.M211684200; Muhammad E, 2013, HUM MOL GENET, V22, P5229, DOI 10.1093/hmg/ddt380; Naganuma T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101823; Naganuma T, 2011, FEBS LETT, V585, P3337, DOI 10.1016/j.febslet.2011.09.024; NUGTEREN DH, 1965, BIOCHIM BIOPHYS ACTA, V106, P280, DOI 10.1016/0005-2760(65)90036-6; Obara K, 2013, J LIPID RES, V54, P831, DOI 10.1194/jlr.M034678; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Ohno Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14610; Ohno Y, 2015, P NATL ACAD SCI USA, V112, P7707, DOI 10.1073/pnas.1503491112; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P18439, DOI 10.1073/pnas.1005572107; Pele M, 2005, HUM MOL GENET, V14, P1417, DOI 10.1093/hmg/ddi151; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10911, DOI 10.1074/jbc.M109.077610; Rabionet M, 2015, HUM MOL GENET, V24, P4792, DOI 10.1093/hmg/ddv204; Rantakari P, 2010, ENDOCRINOLOGY, V151, P1893, DOI 10.1210/en.2009-0929; REVARDEL E, 1995, BBA-GENE STRUCT EXPR, V1263, P261, DOI 10.1016/0167-4781(95)00124-Y; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Sassa T, 2014, BIOMOL THER, V22, P83, DOI 10.4062/biomolther.2014.017; Sassa T, 2013, MOL CELL BIOL, V33, P2787, DOI 10.1128/MCB.00192-13; Schneiter R, 1996, MOL CELL BIOL, V16, P7161; Steimle A, 2016, INT J MED MICROBIOL, V306, P290, DOI 10.1016/j.ijmm.2016.03.001; Wakashima T, 2014, J BIOL CHEM, V289, P24736, DOI 10.1074/jbc.M114.571869; Wang B, 2004, MOL CELL BIOL, V24, P2767, DOI 10.1128/MCB.24.7.2767-2778.2004; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yazawa T, 2013, FEBS LETT, V587, P804, DOI 10.1016/j.febslet.2013.02.006	51	20	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 15	2017	292	37					15538	15551		10.1074/jbc.M117.803171	http://dx.doi.org/10.1074/jbc.M117.803171			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH0DP	28784662	hybrid, Green Published			2022-12-26	WOS:000410809800032
J	Abizari, AR; Azupogo, F; Nagasu, M; Creemers, N; Brouwer, ID				Abizari, Abdul-Razak; Azupogo, Fusta; Nagasu, Miwako; Creemers, Noortje; Brouwer, Inge D.			Seasonality affects dietary diversity of school-age children in northern Ghana	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; NUTRITIONAL-STATUS; MICRONUTRIENT ADEQUACY; CONSUMPTION PATTERNS; YOUNG-CHILDREN; RURAL-AREAS; QUALITY; URBAN; INDICATOR; VARIETY	Background and objectives Dietary diversity score (DDS) is relatively easy to measure and is shown to be a very useful indicator of the probability of adequate micronutrient intake. Dietary diversity, however, is usually assessed during a single period and little is known about the effect of seasonality on it. This study investigates whether dietary diversity is influenced by seasonality. Methods Two cross-sectional surveys were conducted in two different seasons-dry season (October 2010) and rainy season (May 2011) among the same school-age children (SAC) in two rural schools in northern Ghana. The study population consisted of 228 school-age children. A qualitative 24-hour dietary recall was conducted in both seasons. Based on 13 food groups, a score of 1 was given if a child consumed a food item belonging to a particular food group, else 0. Individual scores were aggregated into DDS for each child. Differences in mean DDS between seasons were compared using linear mixed model analysis. Results The dietary pattern of the SAC was commonly plant foods with poor consumption of animal source foods. The mean DDS was significantly higher (P < 0.001) in the rainy season (6.95 +/- 0.55) compared to the dry season (6.44 +/- 0.55) after adjusting for potential confounders such as age, sex, occupation (household head and mother) and education of household head. The difference in mean DDS between dry and rainy seasons was mainly due to the difference in the consumption of Vitamin A-rich fruits and vegetables between the seasons. While vitamin A-rich fruits (64.0% vs. 0.9%; P < 0.0001) and vitamin A rich dark green leafy vegetables (52.6% vs. 23.3%, P < .0001) were consumed more during the rainy season than the dry season, more children consumed vitamin A-rich deep yellow, orange and red vegetables during the dry season than during the rainy season (73.7% vs. 36.4%, P < 0.001). Conclusion Seasonality has an effect on DDS and may affect the quality of dietary intake of SAC; in such a context, it would be useful to measure DDS in different seasons. Since DDS is a proxy indicator of micronutrient intake, the difference in DDS may reflect in seasonal differences in dietary adequacy and further studies are needed to establish this.	[Abizari, Abdul-Razak] Univ Dev Studies, Sch Allied Hlth Sci, Dept Community Nutr, Tamale, Ghana; [Azupogo, Fusta] Univ Dev Studies, Fac Agr, Dept Family & Consumer Sci, Tamale, Ghana; [Nagasu, Miwako; Creemers, Noortje; Brouwer, Inge D.] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands	University for Development Studies; University for Development Studies; Wageningen University & Research	Abizari, AR (corresponding author), Univ Dev Studies, Sch Allied Hlth Sci, Dept Community Nutr, Tamale, Ghana.	abizaria@yahoo.com	Brouwer, Inge D/K-8455-2013	Brouwer, Inge/0000-0002-2554-7227; Azupogo, Fusta/0000-0003-0467-0856	Nestle Foundation for Nutrition Research [FN4042]	Nestle Foundation for Nutrition Research(Nestle SA)	Funding for this research was received from Nestle Foundation for Nutrition Research with Grant number FN4042. The grant was received by Abdul-Razak Abizari. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizari AR, 2014, BRIT J NUTR, V112, P1019, DOI 10.1017/S0007114514001585; Abizari AR, 2012, J NUTR, V142, P1836, DOI 10.3945/jn.112.165753; Ade-Omowaye BIO, 2015, INT FOOD RES J, V22, P798; [Anonymous], 2006, SAS MIXED MODELS; Arimond M, 2004, J NUTR, V134, P2579, DOI 10.1093/jn/134.10.2579; Arimond M., 2011, DIETARY DIVERSITY ME; Arimond M, 2010, J NUTR, V140, p2059S, DOI 10.3945/jn.110.123414; Arsenault JE, 2014, J NUTR SCI, V3, DOI 10.1017/jns.2014.53; Azupogo F., 2015, DEV FOOD BASED RECOM; Barikmo I, 2004, TABLE COMPOSITION AL; Barreau NZ, 1992, FOOD COMPOSITION TAB; Becquey E, 2012, BRIT J NUTR, V107, P1860, DOI 10.1017/S0007114511005071; Cleghorn G, 2007, NUTR DIET, V64, pS143, DOI 10.1111/j.1747-0080.2007.00203.x; Colecraft E, 2006, ECOL FOOD NUTR, V45, P351, DOI 10.1080/03670240600985464; Daniels MC, 2009, EUR J CLIN NUTR, V63, P199, DOI 10.1038/sj.ejcn.1602927; Drewnowski A, 1997, J AM DIET ASSOC, V97, P266, DOI 10.1016/S0002-8223(97)00070-9; Faber M., 2009, International Journal of Food Safety, Nutrition and Public Health, V2, P1, DOI 10.1504/IJFSNPH.2009.026915; FAO, 2011, GUID MEAS HOUS IND D; FERGUSON EL, 1993, ECOL FOOD NUTR, V29, P219, DOI 10.1080/03670244.1993.9991307; FERGUSON EL, 1994, EUR J CLIN NUTR, V48, P241; Gewa C a, 2014, PUBLIC HEALTH NUTR, V17, P1; Gewa CA, 2007, J NUTR, V137, P2154, DOI 10.1093/jn/137.9.2154; Ghana districts, 2006, REPOSITORY ALL DISTR; Gibson R, 2005, PRINCIPLES NUTR ASSE; Gibson RS, 2006, P NUTR SOC, V65, P160, DOI 10.1079/PNS2006489; Gibson RS, 2015, FOOD NUTR BULL, V31, P134; Hambraeus L, 1999, P NUTR SOC, V58, P235, DOI 10.1017/S0029665199000324; Harris-Fry H, 2015, J HEALTH POPUL NUTR, V33, DOI 10.1186/s41043-015-0022-0; Hatloy A, 1998, EUR J CLIN NUTR, V52, P891, DOI 10.1038/sj.ejcn.1600662; Hatloy A, 2000, PUBLIC HEALTH NUTR, V3, P57, DOI 10.1017/S1368980000000628; Hillbruner C, 2008, FOOD NUTR BULL, V29, P221, DOI 10.1177/156482650802900308; Hudelson P, 1999, ECOL FOOD NUTR, V38, P183, DOI 10.1080/03670244.1999.9991577; Iqbal A, 2006, FOOD CHEM, V97, P331, DOI 10.1016/j.foodchem.2005.05.011; Kant AK, 1996, J AM DIET ASSOC, V96, P785, DOI 10.1016/S0002-8223(96)00217-9; Kant AK, 1997, NUTR RES, V17, P1443, DOI 10.1016/S0271-5317(97)00135-8; Kennedy GL, 2007, J NUTR, V137, P472, DOI 10.1093/jn/137.2.472; Livingstone MBE, 2000, P NUTR SOC, V59, P279, DOI 10.1017/S0029665100000318; Lowik MRH, 1999, BRIT J NUTR, V81, pS143, DOI 10.1017/S0007114599001002; Martin-Prevel Y, 2010, J NUTR, V140, p2086S, DOI 10.3945/jn.110.123380; McPherson RS, 2000, PREV MED, V31, pS11, DOI 10.1006/pmed.2000.0631; Mitchikpe CES, 2009, PUBLIC HEALTH NUTR, V12, P414, DOI 10.1017/S1368980008002929; MKaibi FK, 2015, BMC PUBLIC HEALTH, V15, P1; Moursi MM, 2008, J NUTR, V138, P2448, DOI 10.3945/jn.108.093971; Moursi MM, 2008, AM J CLIN NUTR, V87, P1472, DOI 10.1093/ajcn/87.5.1472; Neumann CG, 2003, J NUTR, V133, p3941S, DOI 10.1093/jn/133.11.3941S; Nupo SS, 2013, NUTR FOOD SCI, V43, P60, DOI 10.1108/00346651311295923; Obayelu A. E., 2012, Food Economics, V9, P241; Odusina O. A., 2014, Discourse Journal of Agriculture and Food Sciences, V2, P53; Ogle BM, 2001, ASIA PAC J CLIN NUTR, V10, P21, DOI 10.1046/j.1440-6047.2001.00206.x; Pelto GH, 2013, MATERN CHILD NUTR, V9, P35, DOI 10.1111/j.1740-8709.2012.00451.x; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Ruel MT, 2003, FOOD NUTR B; Savy M, 2007, PUBLIC HEALTH NUTR, V10, P71, DOI 10.1017/S1368980007219627; Savy M, 2005, EUR J CLIN NUTR, V59, P703, DOI 10.1038/sj.ejcn.1602135; Savy M, 2006, J NUTR, V136, P2625, DOI 10.1093/jn/136.10.2625; Stevens B, 2017, PUBLIC HEALTH NUTR, V20, P121, DOI [10.1017/S136898001600183X, 10.1017/s136898001600183x]; Steyn NP, 2014, NUTRITION, V30, P55, DOI 10.1016/j.nut.2013.06.002; Swindale A., 2006, FHI 360FANTA; TANNER M, 1987, ACTA TROP, V44, P229; Tarasuk VS, 1999, J NUTR, V129, P672, DOI 10.1093/jn/129.3.672; Tatala S., 2004, SAJCN - South African Journal of Clinical Nutrition, V17, P94; Tetens I, 2003, AM J CLIN NUTR, V78, P406, DOI 10.1093/ajcn/78.3.406; Tidemann-Andersen I, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-81; Torheim LE, 2003, EUR J CLIN NUTR, V57, P1283, DOI 10.1038/sj.ejcn.1601686; Van Liere M. J., 1995, Food and Nutrition Bulletin, V16, P147; Van Liere MJ, 1995, FOOD NUTR B; WHO, 2006, WHO CHILD GROWTH STA; Willet W., 2012, MONOGRAPHS EPIDEMIOL	68	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2017	12	8							e0183206	10.1371/journal.pone.0183206	http://dx.doi.org/10.1371/journal.pone.0183206			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD5CP	28806418	gold, Green Published, Green Submitted			2022-12-26	WOS:000407548800065
J	Castellano, I; Metovic, J; Balmativola, D; Annaratone, L; Rangel, N; Vissio, E; Arisio, R; Macri, L; Pecchioni, C; Sarotto, I; Montarolo, F; Muscara, F; Marchio, C; Cassoni, P; Kulka, J; Sapino, A				Castellano, Isabella; Metovic, Jasna; Balmativola, Davide; Annaratone, Laura; Rangel, Nelson; Vissio, Elena; Arisio, Riccardo; Macri, Luigia; Pecchioni, Carla; Sarotto, Ivana; Montarolo, Francesca; Muscara, Francesca; Marchio, Caterina; Cassoni, Paola; Kulka, Janina; Sapino, Anna			The impact of malignant nipple discharge cytology (NDc) in surgical management of breast cancer patients	PLOS ONE			English	Article							AREOLA COMPLEX INVOLVEMENT; DIAGNOSTIC-VALUE; PAGETS-DISEASE; SPARING MASTECTOMY; DUCTAL CARCINOMA; RISK; PRESERVATION; PREDICTORS; EXPRESSION; MAMMARY	Background The role of nipple discharge cytology (NDc) in the surgical management of breast cancer patients is unclear. We aimed: (i) to evaluate the effect of malignant NDc on the surgical approach to the nipple-areola complex, and (ii) to verify the association between malignant NDc and nipple malignancy. Methods We retrospectively analyzed a case series of 139 patients with NDc who underwent breast surgery. The clinical and histological findings, types of surgery with emphasis on nipple-areola complex amputation, immunohistochemical phenotypes of the carcinomas and measurements of the tumor-nipple distance were recorded. Additionally, in patients who showed HER2-positive lesions on definitive surgery, we evaluated the HER2 immunocytochemistry of the NDc smears. Results Thirty-two malignant and 107 benign/borderline NDc diagnoses were identified. All 32 malignant- NDc cases were histologically confirmed as malignant. Thirty borderline/benign-NDc cases were histologically diagnosed as malignant (sensitivity 58%). The majority of the patients with malignant NDc were treated with nipple-areola complex amputations in both the mastectomy and conservative surgery groups (P< 0.001, chi(2)51.77). Nipple involvement was strongly associated with HER2-positive ductal carcinoma in-situ (P< 0.001, chi(2) 11.98). HER2 immunocytochemistry on the NDc revealed a 100% correlation with the immunocytochemistry performed on the surgical tissues. Conclusions Malignant NDc influenced surgical management. The association of malignant NDc with nipple involvement is highly related to ductal carcinoma in-situ with HER2 overexpression. In case of HER2 positive NDc, nipple-areola complex involvement is more likely than in HER2 negative cases.	[Castellano, Isabella; Metovic, Jasna; Annaratone, Laura; Rangel, Nelson; Vissio, Elena; Macri, Luigia; Pecchioni, Carla; Montarolo, Francesca; Marchio, Caterina; Cassoni, Paola; Sapino, Anna] Univ Turin, Dept Med Sci, Turin, Italy; [Balmativola, Davide; Sarotto, Ivana; Sapino, Anna] FPO, Candiolo Canc Inst IRCCs, Candiolo, Italy; [Rangel, Nelson] Univ Rosario, Nat & Math Sci Fac, Bogota, Colombia; [Arisio, Riccardo] AOU Citta Salute & Sci Turin, Dept Surg Pathol, Turin, Italy; [Muscara, Francesca] Royal Marsden Hosp Fdn Trust, Dept Breast Surg, London, England; [Kulka, Janina] Semmelweis Univ, Dept Pathol 2, Budapest, Hungary	University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia; Universidad del Rosario; A.O.U. Citta della Salute e della Scienza di Torino; Royal Marsden NHS Foundation Trust; Semmelweis University	Castellano, I (corresponding author), Univ Turin, Dept Med Sci, Turin, Italy.	isabella.castellano@unito.it; paola.cassoni@unito.it	Annaratone, Laura/J-9261-2016; Arisio, Riccardo/GZK-6395-2022; Cassoni, Paola/I-8544-2018; Balmativola, Davide/AAB-7662-2019; Kulka, Janina/K-5703-2017; Marchio, Caterina/J-9152-2016; sarotto, ivana/AAB-7797-2020; Metovic, Jasna/AAJ-6045-2020; Castellano, Isabella/K-1888-2018; Sapino, Anna/AGY-9901-2022	Annaratone, Laura/0000-0001-5750-1445; Balmativola, Davide/0000-0002-3583-1846; Kulka, Janina/0000-0003-1530-6646; Marchio, Caterina/0000-0003-2024-6131; Metovic, Jasna/0000-0002-9146-1747; Sapino, Anna/0000-0003-3542-9571; Vissio, Elena/0000-0002-3948-0641; Castellano, isabella/0000-0002-9072-1615	Fondazione Cassa di Risparmio di Torino (CRT); Ricerca sanitaria Finalizzata [RF-2010-2310674]; Lega Italiana per la Lotta ai Tumori (LILT); Sections of Turin and Novara, Health Care; Ricerca Locale; Colciencias [617. Colombia]	Fondazione Cassa di Risparmio di Torino (CRT)(Fondazione CRT); Ricerca sanitaria Finalizzata(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF)); Lega Italiana per la Lotta ai Tumori (LILT); Sections of Turin and Novara, Health Care; Ricerca Locale; Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This work was supported by Fondazione Cassa di Risparmio di Torino (CRT) 2013, Ricerca sanitaria Finalizzata (RF-2010-2310674), Lega Italiana per la Lotta ai Tumori (LILT), Sections of Turin and Novara, Health Care 2014 (cinque per mille 2012), Ricerca Locale (ex60%) 2014. NR was supported by Colciencias (Grant No 617. Colombia).	Bauer RL, 1998, ANN SURG ONCOL, V5, P452, DOI 10.1007/BF02303865; Brachtel EF, 2009, J CLIN ONCOL, V27, P4948, DOI 10.1200/JCO.2008.20.8785; Cabioglu N, 2004, CANCER, V101, P508, DOI 10.1002/cncr.20394; Carvalho MJ, 2009, EUR J GYNAECOL ONCOL, V30, P543; Castellano I, 2010, MODERN PATHOL, V23, P260, DOI 10.1038/modpathol.2009.169; Cataliotti L., 2010, ATTUALITA SENOLOGIA, V59, P11; Chang RYK, 2017, WORLD J SURG, V41, P176, DOI 10.1007/s00268-016-3679-7; Chen L, 2012, BREAST CANCER RES TR, V132, P9, DOI 10.1007/s10549-011-1787-5; D'Alonzo M, 2012, EUR J CANCER, V48, P2311, DOI 10.1016/j.ejca.2012.04.017; DEPOTTER CR, 1994, HISTOPATHOLOGY, V24, P349, DOI 10.1111/j.1365-2559.1994.tb00536.x; Dolan RT, 2010, SURG-J R COLL SURG E, V8, P252, DOI 10.1016/j.surge.2010.03.005; El-Daly H, 2010, ACTA CYTOL, V54, P560, DOI 10.1159/000325177; Gray RJ, 2007, AM J SURG, V194, P850, DOI 10.1016/j.amjsurg.2007.08.027; GULAY H, 1994, J AM COLL SURGEONS, V178, P471; Kooistra BW, 2009, EJSO-EUR J SURG ONC, V35, P573, DOI 10.1016/j.ejso.2008.09.009; LAMMIE GA, 1989, HISTOPATHOLOGY, V15, P505, DOI 10.1111/j.1365-2559.1989.tb01610.x; Lee WY, 2003, CYTOPATHOLOGY, V14, P19, DOI 10.1046/j.1365-2303.2003.00419.x; LEIS HP, 1989, WORLD J SURG, V13, P736, DOI 10.1007/BF01658424; Li WD, 2011, INT J SURG PATHOL, V19, P328, DOI 10.1177/1066896911399279; Louie LD, 2006, AM J SURG, V192, P530, DOI 10.1016/j.amjsurg.2006.06.004; MEISSNER K, 1990, AM J PATHOL, V137, P1305; Piato JRM, 2015, EJSO-EUR J SURG ONC, V41, P986, DOI 10.1016/j.ejso.2015.04.019; Morrogh M, 2010, AM J SURG, V200, P73, DOI 10.1016/j.amjsurg.2009.06.021; Niemeyer M, 2010, BREAST CARE, V5, P252, DOI 10.1159/000318186; Ponzone R, 2015, EUR J CANCER, V51, P1882, DOI 10.1016/j.ejca.2015.07.001; Pritt B, 2004, CANCER CYTOPATHOL, V102, P233, DOI 10.1002/cncr.20379; Rusby JE, 2008, BRIT J SURG, V95, P1356, DOI 10.1002/bjs.6349; Sacchini V, 2006, J AM COLL SURGEONS, V203, P704, DOI 10.1016/j.jamcollsurg.2006.07.015; Schecter AK, 2006, ANN PLAS SURG, V56, P498, DOI 10.1097/01.sap.0000216946.83252.e4; Simmons RM, 2002, ANN SURG ONCOL, V9, P165; Tomasovic-Loncaric C, 2010, COLLEGIUM ANTROPOL, V34, P431; Vlajcic Z, 2005, ANN PLAS SURG, V55, P240, DOI 10.1097/01.sap.0000171680.49971.85; Wang JL, 2012, ANN SURG ONCOL, V19, P1174, DOI 10.1245/s10434-011-2107-3; Wang Sheng-ying, 2008, Zhonghua Zhongliu Zazhi, V30, P203; WOLBER RA, 1991, AM J CLIN PATHOL, V96, P243, DOI 10.1093/ajcp/96.2.243; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Zervoudis S, 2010, WOMENS HEALTH, V6, P135, DOI [10.2217/whe.09.81, 10.2217/WHE.09.81]	37	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2017	12	8							e0182073	10.1371/journal.pone.0182073	http://dx.doi.org/10.1371/journal.pone.0182073			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD5CP	28806416	Green Published, Green Submitted, gold			2022-12-26	WOS:000407548800013
J	Dewar, ML; Arnould, JPY; Allnutt, TR; Crowley, T; Krause, L; Reynolds, J; Dann, P; Smith, SC				Dewar, Meagan L.; Arnould, John P. Y.; Allnutt, Theo R.; Crowley, Tamsyn; Krause, Lutz; Reynolds, John; Dann, Peter; Smith, Stuart C.			Microbiota of little penguins and short-tailed shearwaters during development	PLOS ONE			English	Article							GUT MICROBIOTA; GASTROINTESTINAL-TRACT; BACTERIAL COMMUNITY; ANAEROBIC-BACTERIA; INTESTINAL FLORA; BROILER-CHICKENS; EUDYPTULA-MINOR; ECOLOGY; OBESITY; GROWTH	The establishment and early colonisation of the gastrointestinal (GI) tract has been recognised as a crucial stage in chick development, with pioneering microbial species responsible for influencing the development of the GI tract and influencing host health, fitness and disease status throughout life. Development of the microbiota in long lived seabirds is poorly understood. This study characterised the microbial composition of little penguin and short-tailed shearwater chicks throughout development, using Quantitative Real Time PCR (qPCR) and 16S rRNA sequencing. The results indicated that microbial development differed between the two seabird species with the short-tailed shearwater microbiota being relatively stable throughout development whilst significant fluctuations in the microbial composition and an upward trend in the abundance of Firmicutes and Bacteroidetes were observed in the little penguin. When the microbial composition of adults and chicks was compared, both species showed low similarity in microbial composition, indicating that the adult microbiota may have a negligible influence over the chick's microbiota.	[Dewar, Meagan L.; Smith, Stuart C.] Deakin Univ, Sch Exercise & Nutr Sci, Burwood, Australia; [Dewar, Meagan L.; Arnould, John P. Y.] Deakin Univ, Sch Life & Environm Sci, Burwood, Australia; [Allnutt, Theo R.; Crowley, Tamsyn] Deakin Univ, Fac Hlth, Bioinformat Core Res Grp, Waurn Ponds, Australia; [Krause, Lutz] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Krause, Lutz] Univ Queensland, Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia; [Reynolds, John] Deakin Univ, Fac Hlth, Deakin Biostat Unit, Burwood, Australia; [Reynolds, John] Monash Univ, Fac Med Nursing & Hlth Sci, Biostat, Melbourne, Vic, Australia; [Dann, Peter] Phillip Isl Nat Parks, Res Dept, Phillip Island, Australia	Deakin University; Deakin University; Deakin University; QIMR Berghofer Medical Research Institute; University of Queensland; Deakin University; Monash University	Dewar, ML (corresponding author), Deakin Univ, Sch Exercise & Nutr Sci, Burwood, Australia.; Dewar, ML (corresponding author), Deakin Univ, Sch Life & Environm Sci, Burwood, Australia.	meagandewar@hotmail.com	Dewar, Meagan/AAI-3969-2021; Reynolds, John/D-2591-2013; Krause, Lutz/G-6283-2013	Reynolds, John/0000-0002-8825-8625; Krause, Lutz/0000-0003-3806-0845; Crowley, Tamsyn/0000-0002-3698-8917; Dewar, Meagan/0000-0003-0581-2422	Holsworth Wildlife Research Endowment; Centre for Molecular and Medical Research (Deakin University); Life and Environmental Sciences (Deakin University); Phillip Island Nature Parks	Holsworth Wildlife Research Endowment; Centre for Molecular and Medical Research (Deakin University); Life and Environmental Sciences (Deakin University); Phillip Island Nature Parks	This work was supported by funding from Holsworth Wildlife Research Endowment, Centre for Molecular and Medical Research (Deakin University), Life and Environmental Sciences (Deakin University) and Phillip Island Nature Parks. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit-Romach E, 2004, POULTRY SCI, V83, P1093, DOI 10.1093/ps/83.7.1093; Apajalahti J., 2005, AVIAN FUNCTION HLTH, V28, P124; Banks JC, 2009, ENVIRON MICROBIOL, V11, P577, DOI 10.1111/j.1462-2920.2008.01816.x; BARNES EM, 1972, AM J CLIN NUTR, V25, P1475; BARNES EM, 1972, BRIT POULTRY SCI, V13, P311, DOI 10.1080/00071667208415953; Bercik P, 2011, GASTROENTEROLOGY, V141, P599, DOI 10.1053/j.gastro.2011.04.052; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carey M., 2011, EFFECTS INVESTIGATOR; Chapman EW, 2010, DEEP-SEA RES PT II, V57, P543, DOI 10.1016/j.dsr2.2009.10.005; Chiaradia A, 2006, ARDEA, V94, P257; Chiaradia Andre F., 1999, Marine Ornithology, V27, P13; Cimino MA, 2014, MAR ECOL PROG SER, V513, P253, DOI 10.3354/meps10928; COLOE PJ, 1984, J HYG-CAMBRIDGE, V92, P79, DOI 10.1017/S0022172400064056; Dewar ML, 2013, MICROBIOLOGYOPEN, V2, P195, DOI 10.1002/mbo3.66; Dicksved J., 2008, EXPLORING HUMAN INTE; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; EXCOFFIER L, 1992, GENETICS, V131, P479; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; FULLER R, 1984, P NUTR SOC, V43, P55, DOI 10.1079/PNS19840027; Gabriel I, 2006, WORLD POULTRY SCI J, V62, P499, DOI 10.1017/S0043933906001115; Gomes M Soledad Castillo, 2006, DEV GUT MICROBIOTA P; GROH H, 1993, J BASIC MICROB, V33, P59, DOI 10.1002/jobm.3620330115; Jost T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044595; Kelly D, 2007, MUTAT RES-FUND MOL M, V622, P58, DOI 10.1016/j.mrfmmm.2007.03.011; Keszthelyi D, 2009, NEUROGASTROENT MOTIL, V21, P1239, DOI 10.1111/j.1365-2982.2009.01370.x; Klomp NI, 2000, MAR ECOL PROG SER, V194, P307, DOI 10.3354/meps194307; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lu JR, 2003, APPL ENVIRON MICROB, V69, P6816, DOI 10.1128/AEM.69.11.6816-6824.2003; Lucas FS, 2005, J AVIAN BIOL, V36, P510, DOI 10.1111/j.0908-8857.2005.03479.x; Lumpkins BS, 2010, POULTRY SCI, V89, P1614, DOI 10.3382/ps.2010-00747; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; Mackie RI, 2002, INTEGR COMP BIOL, V42, P319, DOI 10.1093/icb/42.2.319; Merchant S., 1990, HDB AUSTR NZ ANTARCT; MONTAGUE TL, 1986, EMU, V86, P207, DOI 10.1071/MU9860207; Naef-Daenzer B, 2001, J ANIM ECOL, V70, P730, DOI 10.1046/j.0021-8790.2001.00533.x; OKA N, 1989, Journal of the Yamashina Institute for Ornithology, V21, P193; Oka N, 2011, ORNITHOL SCI, V10, P39; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Panda AK, 2009, ASIAN AUSTRAL J ANIM, V22, P1026, DOI 10.5713/ajas.2009.80298; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Penders J, 2007, GUT, V56, P661, DOI 10.1136/gut.2006.100164; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; PERRINS CM, 1973, IBIS, V115, P535, DOI 10.1111/j.1474-919X.1973.tb01991.x; Potrykus J, 2008, PROTEOMICS, V8, P2691, DOI 10.1002/pmic.200700437; Potti J, 2002, ECOL LETT, V5, P709, DOI 10.1046/j.1461-0248.2002.00375.x; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rehman HU, 2007, ARCH ANIM NUTR, V61, P319, DOI 10.1080/17450390701556817; Reilly P., 1994, PENGUINS WORLD; REILLY PN, 1981, EMU, V81, P1, DOI 10.1071/MU9810001; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Saraux C, 2011, ECOLOGY, V92, P1909, DOI 10.1890/11-0407.1; Saraux C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020407; Schumann N., 2012, TROPHIC RELATIONSHIP; Serino M, 2012, GUT, V61, P543, DOI 10.1136/gutjnl-2011-301012; Seventry DL, 1971, HDB AUSTR SEABIRDS; Smith SC, 2013, FEMS MICROBIOL ECOL, V86, P246, DOI 10.1111/1574-6941.12157; Snedecor G., 1991, STAT METHODS; Stahel C, 1991, LITTLE PENGUIN FAIRY; STARK PL, 1982, J MED MICROBIOL, V15, P189, DOI 10.1099/00222615-15-2-189; Stevens CE, 1998, PHYSIOL REV, V78, P393, DOI 10.1152/physrev.1998.78.2.393; Sun YZ, 2011, AQUACULT NUTR, V17, pE733, DOI 10.1111/j.1365-2095.2010.00837.x; Swann JR, 2011, P NATL ACAD SCI USA, V108, P4523, DOI 10.1073/pnas.1006734107; Torok VA, 2007, AUSTR POULTR SCI S, P149; Tremaroli V, 2010, GUT; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vaishampayan PA, 2010, GENOME BIOL EVOL, V2, P53, DOI 10.1093/gbe/evp057; van Dongen WFD, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-11; Warham J., 1990, PETREL THEIR ECOLOGY; Weimerskirch H, 1998, MAR ECOL PROG SER, V167, P261, DOI 10.3354/meps167261; Yin YS, 2010, ISME J, V4, P367, DOI 10.1038/ismej.2009.128; YOKOYAMA MT, 1979, AM J CLIN NUTR, V32, P173	78	13	14	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2017	12	8							e0183117	10.1371/journal.pone.0183117	http://dx.doi.org/10.1371/journal.pone.0183117			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD5CP	28806408	Green Published, Green Submitted, gold			2022-12-26	WOS:000407548800053
J	Gillespie, A; Hald, J				Gillespie, Alex; Hald, Julie			The paradox of helping: Contradictory effects of scaffolding people with aphasia to communicate	PLOS ONE			English	Article							INTELLECTUAL DISABILITIES; SIGNIFICANT OTHERS; CONVERSATION; PERSPECTIVE; STRATEGIES; DISCOURSE; ADULTS; QUESTIONS; THERAPY; POWER	When interacting with people with aphasia, communication partners use a range of subtle strategies to scaffold, or facilitate, expression and comprehension. The present article analyses the unintended effects of these ostensibly helpful acts. Twenty people with aphasia and their main communication partners (n = 40) living in the UK were video recorded engaging in a joint task. Three analyses reveal that: (1) scaffolding is widespread and mostly effective, (2) the conversations are dominated by communication partners, and (3) people with aphasia both request and resist help. We propose that scaffolding is inherently paradoxical because it has contradictory effects. While helping facilitates performing an action, and is thus enabling, it simultaneously implies an inability to perform the action independently, and thus it can simultaneously mark the recipient as disabled. Data are in British English.	[Gillespie, Alex; Hald, Julie] London Sch Econ & Polit Sci, Dept Psychol & Behav Sci, London, England	University of London; London School Economics & Political Science	Gillespie, A (corresponding author), London Sch Econ & Polit Sci, Dept Psychol & Behav Sci, London, England.	a.t.gillespie@lse.ac.uk			Economic and Social Research Council, UK [RES-000-22-2473]; Economic and Social Research Council [ES/F024274/1] Funding Source: researchfish; ESRC [ES/F024274/1] Funding Source: UKRI	Economic and Social Research Council, UK(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The research was funded by the Economic and Social Research Council, UK (RES-000-22-2473). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the assistance of Morag Place and Joan Murphy with collecting the data and the support of a research grant from the Economic and Social Research Council, UK (RES-000-22-2473).	Antaki C, 2012, J PRAGMATICS, V44, P876, DOI 10.1016/j.pragma.2012.03.014; Antaki Charles, 2014, IDENTITIES INTERACTI, P181; Avent J, 2009, APHASIOLOGY, V23, P110, DOI 10.1080/02687030802240211; Barnes S, 2015, APHASIOLOGY, V29, P315, DOI 10.1080/02687038.2013.874547; Barnes SE, 2013, INT J LANG COMM DIS, V48, P102, DOI 10.1111/j.1460-6984.2012.00186.x; Barnes SE, 2012, J INTERACT RES COM D, V3, P27, DOI 10.1558/jircd.v3i1.27; Barney LJ, 2006, AUST NZ J PSYCHIAT, V40, P51, DOI 10.1080/j.1440-1614.2006.01741.x; Beeke S, 2015, APHASIOLOGY, V29, P355, DOI 10.1080/02687038.2014.881459; Beeke S, 2014, RES LANG SOC INTERAC, V47, P292, DOI 10.1080/08351813.2014.925667; Beeke S, 2013, CLIN LINGUIST PHONET, V27, P784, DOI 10.3109/02699206.2013.808267; Best W, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2076.00562; Bolden GB, 2006, J COMMUN, V56, P661, DOI 10.1111/j.1460-2466.2006.00314.x; Booth S, 1999, INT J LANG COMM DIS, V34, P291, DOI 10.1080/136828299247423; Brabham EG, 2002, J EDUC PSYCHOL, V94, P465, DOI 10.1037//0022-0663.94.3.465; Brookshire RH, 1975, HUMAN COMMUNICATION, V3, P63; Brown Roger, 1960, STYLE LANGUAGE, P253, DOI [10.1017/CBO9780511813085, DOI 10.1017/CBO9780511813085]; Bute JJ, 2007, HEALTH COMMUN, V21, P235, DOI 10.1080/10410230701307675; Cazden CB, 1983, SOCIOGENESIS LANGUAG, P33; Cicourel AV, 2013, SOCIOLOGY, V47, P51, DOI 10.1177/0038038512456779; Clare L., 2004, DEMENTIA, V3, P211, DOI DOI 10.1177/1471301204042338; Cole AD, 2006, READ TEACH, V59, P450, DOI 10.1598/RT.59.5.4; Collins S, 1997, CLIN LINGUIST PHONET, V11, P467, DOI 10.3109/02699209708985208; CROSSLEY R, 1992, TOP LANG DISORD, V12, P46, DOI 10.1097/00011363-199208000-00005; Croteau C, 2006, APHASIOLOGY, V20, P327, DOI 10.1080/02687030500475051; Davidson B, 2003, APHASIOLOGY, V17, P243, DOI 10.1080/729255457; Drew P., 1992, TALK WORK, P3; Drew Paul., 1991, ASYMMETRIES DIALOGUE, P29; Eriksson K, 2016, INT J LANG COMM DIS, V51, P402, DOI 10.1111/1460-6984.12216; Finlay WML, 2012, J INTELL DISABIL RES, V56, P361, DOI 10.1111/j.1365-2788.2011.01478.x; Foppa K, 1995, MUTUALITIES DIALOGUE, P149; Gillespie A, 2014, INTEGR PSYCHOL BEHAV, V48, P435, DOI 10.1007/s12124-014-9265-3; Gillespie A, 2010, CULT DYN SOC REPRESE, P23; Gillespie A, 2010, APHASIOLOGY, V24, P1559, DOI 10.1080/02687038.2010.500810; GOLDBERG JA, 1990, J PRAGMATICS, V14, P883, DOI 10.1016/0378-2166(90)90045-F; Goodwin C, 2003, POINTING: WHERE LANGAUAGE, CULTURE, AND COGNITON MEET, P217; GOODWIN C, 1995, RES LANG SOC INTERAC, V28, P233, DOI 10.1207/s15327973rlsi2803_4; Goodwin C., 2000, LANGUAGE GESTURE, P84, DOI DOI 10.1017/CBO9780511620850.006; Heritage J., 1984, STRUCTURES SOCIAL AC, P299; Heritage J, 2007, LANG CULT COGN, P255; HOLMES J, 1988, J PRAGMATICS, V12, P445, DOI 10.1016/0378-2166(88)90005-7; Hutchby Ian., 1996, C TALK ARGUMENTS ASY; Ichheiser G., 1949, AM J SOCIOL, V55, P1; Jahoda A, 2009, BRIT J CLIN PSYCHOL, V48, P63, DOI 10.1348/014466508X360746; Jefferson G., 2004, CONVERSATION ANAL ST, P13, DOI DOI 10.1075/PBNS.125.02JEF; Jefferson G., 1987, TALK SOCIAL ORG, P152; Kagan A, 2001, J SPEECH LANG HEAR R, V44, P624, DOI 10.1044/1092-4388(2001/051); Kendrick KH, 2016, RES LANG SOC INTERAC, V49, P1, DOI 10.1080/08351813.2016.1126436; Laakso M, 2015, APHASIOLOGY, V29, P269, DOI 10.1080/02687038.2013.878450; Latour B., 1986, LAB LIFE CONSTRUCTIO; LeDorze G, 1996, DISABIL REHABIL, V18, P550; Lee F, 1997, ORGAN BEHAV HUM DEC, V72, P336, DOI 10.1006/obhd.1997.2746; LINELL P, 1988, LINGUISTICS, V26, P415, DOI 10.1515/ling.1988.26.3.415; Linell P, 2009, ADV CULT PSYCHOL CON, pXXI; Markova A I, 2016, THE DIALOGICAL MIND; Markova I., 1992, ASYMMETRIES DIALOGUE, P221; Mauss M, 1966, GIFT FORM FUNCTIONS; Mead G. H., 1932, PHILOS PRESENT; MILROY L, 1992, CLIN LINGUIST PHONET, V6, P27, DOI 10.3109/02699209208985517; MISHLER EG, 1975, J PSYCHOLINGUIST RES, V4, P99, DOI 10.1007/BF01077031; MURRAY SO, 1985, LANG SOC, V14, P31, DOI 10.1017/S0047404500010927; NEWMAN RS, 1990, J EDUC PSYCHOL, V82, P92, DOI 10.1037/0022-0663.82.1.92; Newsom JT, 1998, HEALTH PSYCHOL, V17, P172, DOI 10.1037/0278-6133.17.2.172; O'Neill B, 2010, NEUROPSYCHOL REHABIL, V20, P509, DOI 10.1080/09602010903519652; Oelschlaeger ML, 1998, APHASIOLOGY, V12, P971, DOI 10.1080/02687039808249464; Parrot J. M, 1863, CONVERSATION BRAIN D, V38, P372; Pea RD, 2004, J LEARN SCI, V13, P423, DOI 10.1207/s15327809jls1303_6; Peirce Charles Sanders, 1991, PEIRCE SIGNS WRITING; Peirce CS, 1933, COLLECTED PAPERS CS, V3; Pomerantz AM, 1995, TALK CLIN EXPLORATIO, P151; Potter J., 1996, HDB QUALITATIVE RES; Potter J, 2010, J PRAGMATICS, V42, P1543, DOI 10.1016/j.pragma.2009.10.003; Proot I M, 2000, Clin Nurs Res, V9, P460, DOI 10.1177/10547730022158690; Rommetveit R., 1974, MESSAGE STRUCTURE FR; Russell B, 1908, AM J MATH, V30, P222, DOI 10.2307/2369948; SACKS H, 1974, LANGUAGE, V50, P696, DOI 10.2307/412243; SCHEGLOFF EA, 1992, AM J SOCIOL, V97, P1295, DOI 10.1086/229903; Schegloff EA, 2009, RES LANG SOC INTERAC, V42, P91, DOI 10.1080/08351810902864511; Schulz R, 2008, AM J NURS, V108, P23, DOI 10.1097/01.NAJ.0000336406.45248.4c; SCHWARTZ B, 1967, AM J SOCIOL, V73, P1, DOI 10.1086/224432; Shelton C, 2007, BRAIN INJURY, V21, P1259, DOI 10.1080/02699050701716935; Simmons-Mackie N, 2003, APHASIOLOGY, V17, P751, DOI 10.1080/02687030344000229; Simmons-Mackie N, 2016, ARCH PHYS MED REHAB, V97, P2202, DOI 10.1016/j.apmr.2016.03.023; Simmons-Mackie N, 2011, INT J LANG COMM DIS, V46, P312, DOI 10.3109/13682822.2010.507616; Simmons-Mackie N, 2010, ARCH PHYS MED REHAB, V91, P1814, DOI 10.1016/j.apmr.2010.08.026; SimmonsMackie NN, 1997, APHASIOLOGY, V11, P761, DOI 10.1080/02687039708250455; Small JA, 2003, J SPEECH LANG HEAR R, V46, P353, DOI 10.1044/1092-4388(2003/028); Steensig J, 2008, DISCOURSE STUD, V10, P5, DOI 10.1177/1461445607085581; Stone CA, 1998, J LEARN DISABIL-US, V31, P344, DOI 10.1177/002221949803100404; Thompson MH, 1949, J PHILOS, V46, P513; Thornborrow Joanna, 2002, POWER TALK LANGUAGE; Turner S, 2006, APHASIOLOGY, V20, P483, DOI 10.1080/02687030600589991; Turner S, 2006, APHASIOLOGY, V20, P616, DOI 10.1080/02687030600687860; Valsiner J, 2007, CAMBRIDGE HANDBOOK OF SOCIOCULTURAL PSYCHOLOGY, P1, DOI 10.1017/CBO9780511611162; Vygotsky L. S., 1978, MIND SOC DEV HIGH PS; WOOD D, 1976, J CHILD PSYCHOL PSYC, V17, P89, DOI 10.1111/j.1469-7610.1976.tb00381.x; WOOD D, 1975, BRIT J PSYCHOL, V66, P181, DOI 10.1111/j.2044-8295.1975.tb01454.x; Zydney JM, 2010, COMPUT EDUC, V54, P360, DOI 10.1016/j.compedu.2009.08.017	98	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2017	12	8							e0180708	10.1371/journal.pone.0180708	http://dx.doi.org/10.1371/journal.pone.0180708			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD5CP	28806409	Green Published, gold, Green Submitted			2022-12-26	WOS:000407548800003
J	Antipov, SS; Tutukina, MN; Preobrazhenskaya, EV; Kondrashov, FA; Patrushev, MV; Toshchakov, SV; Dominova, I; Shvyreva, US; Vrublevskaya, VV; Morenkov, OS; Sukharicheva, NA; Panyukov, VV; Ozoline, ON				Antipov, S. S.; Tutukina, M. N.; Preobrazhenskaya, E. V.; Kondrashov, F. A.; Patrushev, M. V.; Toshchakov, S. V.; Dominova, I.; Shvyreva, U. S.; Vrublevskaya, V. V.; Morenkov, O. S.; Sukharicheva, N. A.; Panyukov, V. V.; Ozoline, O. N.			The nucleoid protein Dps binds genomic DNA of Escherichia coli in a non-random manner	PLOS ONE			English	Article							H-NS; GENE-EXPRESSION; OXIDATIVE STRESS; STARVED CELLS; FERRITIN; PROMOTER; IRON; FIS; PROTECTION; GROWTH	Dps is a multifunctional homododecameric protein that oxidizes Fe2+ ions accumulating them in the form of Fe2O3 within its protein cavity, interacts with DNA tightly condensing bacterial nucleoid upon starvation and performs some other functions. During the last two decades from discovery of this protein, its ferroxidase activity became rather well studied, but the mechanism of Dps interaction with DNA still remains enigmatic. The crucial role of lysine residues in the unstructured N-terminal tails led to the conventional point of view that Dps binds DNA without sequence or structural specificity. However, deletion of dps changed the profile of proteins in starved cells, SELEX screen revealed genomic regions preferentially bound in vitro and certain affinity of Dps for artificial branched molecules was detected by atomic force microscopy. Here we report a non-random distribution of Dps binding sites across the bacterial chromosome in exponentially growing cells and show their enrichment with inverted repeats prone to form secondary structures. We found that the Dps-bound regions overlap with sites occupied by other nucleoid proteins, and contain overrepresented motifs typical for their consensus sequences. Of the two types of genomic domains with extensive protein occupancy, which can be highly expressed or transcriptionally silent only those that are enriched with RNA polymerase molecules were preferentially occupied by Dps. In the dps-null mutant we, therefore, observed a differentially altered expression of several targeted genes and found suppressed transcription from the dps promoter. In most cases this can be explained by the relieved interference with Dps for nucleoid proteins exploiting sequence-specific modes of DNA binding. Thus, protecting bacterial cells from different stresses during exponential growth, Dps can modulate transcriptional integrity of the bacterial chromosome hampering RNA biosynthesis from some genes via competition with RNA polymerase or, vice versa, competing with inhibitors to activate transcription.	[Antipov, S. S.; Tutukina, M. N.; Preobrazhenskaya, E. V.; Shvyreva, U. S.; Sukharicheva, N. A.; Ozoline, O. N.] Russian Acad Sci, Inst Cell Biophys, Dept Funct Genom & Cellular Stress, Moscow, Russia; [Antipov, S. S.; Ozoline, O. N.] Pushchino State Inst Nat Sci, Dept Cell Biol, Moscow, Russia; [Antipov, S. S.] Voronezh State Univ, Dept Biophys & Biotechnol, Voronezh, Russia; [Antipov, S. S.; Patrushev, M. V.; Toshchakov, S. V.; Dominova, I.] Immanuel Kant Balt Fed Univ, Dept Genom Microorg, Kaliningrad, Russia; [Tutukina, M. N.; Kondrashov, F. A.] Ctr Genom Regulat, Bioinformat & Genom Programme, Barcelona, Spain; [Tutukina, M. N.; Kondrashov, F. A.] Univ Pompeu Fabra, Dept Evolutionary Gen, Barcelona, Spain; [Tutukina, M. N.; Panyukov, V. V.; Ozoline, O. N.] Russian Acad Sci, Dept Struct, Moscow, Russia; [Tutukina, M. N.; Panyukov, V. V.; Ozoline, O. N.] Russian Acad Sci, Funct Gen Pushchino Res Ctr, Moscow, Russia; [Kondrashov, F. A.] 23 Pg Llurs Companys, ICREA, Barcelona, Spain; [Vrublevskaya, V. V.; Morenkov, O. S.] Russian Acad Sci, Inst Cell Biophys, Dept Cell Culture & Cell Engn, Moscow, Russia; [Panyukov, V. V.] Russian Acad Sci, Keldysh Inst Appl Math, Inst Math Problems Biol Branch, Dept Bioinformat, Moscow, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Cell Biophysics RAS; Voronezh State University; Immanuel Kant Baltic Federal University; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Russian Academy of Sciences; Russian Academy of Sciences; ICREA; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Cell Biophysics RAS; Russian Academy of Sciences; Keldysh Institute of Applied Mathematics	Ozoline, ON (corresponding author), Russian Acad Sci, Inst Cell Biophys, Dept Funct Genom & Cellular Stress, Moscow, Russia.; Ozoline, ON (corresponding author), Pushchino State Inst Nat Sci, Dept Cell Biol, Moscow, Russia.; Ozoline, ON (corresponding author), Russian Acad Sci, Dept Struct, Moscow, Russia.; Ozoline, ON (corresponding author), Russian Acad Sci, Funct Gen Pushchino Res Ctr, Moscow, Russia.	Ozoline@rambler.ru	Antipov, Sergei/AAD-6556-2019; Dominova, Irina N/O-2540-2013; Vrublevskaya, Veronika/C-7436-2015; Antipov, Sergei S/U-1798-2017; Toshchakov, Stepan/E-5648-2014	Antipov, Sergei/0000-0003-3244-1428; Dominova, Irina N/0000-0001-5570-058X; Vrublevskaya, Veronika/0000-0002-0993-7356; Antipov, Sergei S/0000-0003-3244-1428; Toshchakov, Stepan/0000-0001-7549-3450; Tutukina, Maria/0000-0001-8876-4707	Russian Scientific Foundation [14-14-00985]; Russian Foundation for basic research [16-34-01044, 16-04-01570]; HHMI [55007424]; European Research Council [335980_EinME]; Russian Science Foundation [14-14-00985] Funding Source: Russian Science Foundation	Russian Scientific Foundation(Russian Science Foundation (RSF)); Russian Foundation for basic research(Russian Foundation for Basic Research (RFBR)); HHMI(Howard Hughes Medical Institute); European Research Council(European Research Council (ERC)European Commission); Russian Science Foundation(Russian Science Foundation (RSF))	This work was funded by: 1. Russian Scientific Foundation (grant 14-14-00985, http://rsct.ru/node/8, PI: ONO, team members: SSA, MNT, USS (sample preparation, MiSeq sequencing, data analysis and evaluation)); 2. Russian Foundation for basic research (grant 16-34-01044, http://www.rfbr.ruirfli/eng, PI: USS, reporter assays); 3. HHMI International Early Career Scientist Program (55007424, FAK) (http://www.hhmi.org/, FAK, HiSeq Illumina sequencing); 4. European Research Council grant agreement (335980_EinME, https://erc.europleu/, FAK, HiSeq Illumina sequencing); 5. Russian Foundation for Basic Research 16-04-01570 (httn://www.rfbr.ru/rffi/eng) (PI ONO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Aleksic J, 2014, BIORXIV PREPRINT FIR; Algu K., 2007, J EXP MICROBIOL IMMU, V11, P60; ALMIRON M, 1992, GENE DEV, V6, P2646, DOI 10.1101/gad.6.12b.2646; ALTUVIA S, 1994, MOL MICROBIOL, V13, P265, DOI 10.1111/j.1365-2958.1994.tb00421.x; Azam TA, 2000, GENES CELLS, V5, P613, DOI 10.1046/j.1365-2443.2000.00350.x; Azam TA, 1999, J BIOL CHEM, V274, P33105, DOI 10.1074/jbc.274.46.33105; Azam TA, 1999, J BACTERIOL, V181, P6361, DOI 10.1128/JB.181.20.6361-6370.1999; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bessonova T. A., 2016, Biophysics, V61, P825, DOI 10.1134/S0006350916060075; Bozzi M, 1997, J BIOL CHEM, V272, P3259, DOI 10.1074/jbc.272.6.3259; Calhoun LN, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-249; Ceci P, 2004, NUCLEIC ACIDS RES, V32, P5935, DOI 10.1093/nar/gkh915; Ceci P, 2007, NUCLEIC ACIDS RES, V35, P2247, DOI 10.1093/nar/gkm077; Chang DE, 2002, MOL MICROBIOL, V45, P289, DOI 10.1046/j.1365-2958.2002.03001.x; Chodavarapu S, 2008, MOL MICROBIOL, V67, P1331, DOI 10.1111/j.1365-2958.2008.06127.x; Chowdhury RP, 2010, IUBMB LIFE, V62, P67, DOI 10.1002/iub.285; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dorman CJ, 2007, NAT REV MICROBIOL, V5, P157, DOI 10.1038/nrmicro1598; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Frenkiel-Krispin D, 2004, MOL MICROBIOL, V51, P395, DOI 10.1046/j.1365-2958.2003.03855.x; Frenkiel-Krispin D, 2001, EMBO J, V20, P1184, DOI 10.1093/emboj/20.5.1184; Gama-Castro S, 2011, NUCLEIC ACIDS RES, V39, pD98, DOI 10.1093/nar/gkq1110; Ghatak P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016019; Glazunova OA, 2015, MAT BIOLOG BIOINFORM, V10, pt29, DOI 10.17537/2015.10.t29; Golosova O, 2014, PEERJ, V2, DOI 10.7717/peerj.644; Grainger DC, 2008, MOL MICROBIOL, V68, P1366, DOI 10.1111/j.1365-2958.2008.06253.x; Grainger DC, 2007, NUCLEIC ACIDS RES, V35, P269, DOI 10.1093/nar/gkl1023; Grainger DC, 2006, NUCLEIC ACIDS RES, V34, P4642, DOI 10.1093/nar/gkl542; Grant RA, 1998, NAT STRUCT BIOL, V5, P294, DOI 10.1038/nsb0498-294; Gundlacht J, 2014, MICROBIOL-SGM, V160, P1690, DOI 10.1099/mic.0.074815-0; Gupta S, 2003, J BIOL CHEM, V278, P5235, DOI 10.1074/jbc.M208825200; IGARASHI K, 1991, CELL, V65, P1015, DOI 10.1016/0092-8674(91)90553-B; Ilari A, 2000, NAT STRUCT BIOL, V7, P38; Ishihama A, 2016, NUCLEIC ACIDS RES, V44, P2058, DOI 10.1093/nar/gkw051; Ishihama A, 2014, J BACTERIOL, V196, P2718, DOI 10.1128/JB.01579-14; Ivanova D, 2015, NUCLEIC ACIDS RES, V43, P7865, DOI 10.1093/nar/gkv704; Jeong KC, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-181; Kahramanoglou C, 2011, NUCLEIC ACIDS RES, V39, P2073, DOI 10.1093/nar/gkq934; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Karas VO, 2015, J BACTERIOL, V197, P3206, DOI 10.1128/JB.00475-15; Kim J, 2004, NUCLEIC ACIDS RES, V32, P1982, DOI 10.1093/nar/gkh512; Lacqua A, 2006, APPL ENVIRON MICROB, V72, P956, DOI 10.1128/AEM.72.1.956-959.2006; Lucchini S, 2006, PLOS PATHOG, V2, P746, DOI 10.1371/journal.ppat.0020081; Ma Q, 2014, NUCLEIC ACIDS RES, V42, pW12, DOI 10.1093/nar/gku315; Machanick P, 2011, BIOINFORMATICS, V27, P1696, DOI 10.1093/bioinformatics/btr189; Martinez A, 1997, J BACTERIOL, V179, P5188, DOI 10.1128/jb.179.16.5188-5194.1997; Masulis IS, 2015, SCI REP-UK, V5, DOI 10.1038/srep11449; Melekhov VV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126504; Morikawa K, 2006, GENES CELLS, V11, P409, DOI 10.1111/j.1365-2443.2006.00949.x; Munch R, 2005, BIOINFORMATICS, V21, P4187, DOI 10.1093/bioinformatics/bti635; Myers KS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003565; Nair S, 2004, J BACTERIOL, V186, P4192, DOI 10.1128/JB.186.13.4192-4198.2004; NINNEMANN O, 1992, EMBO J, V11, P1075, DOI 10.1002/j.1460-2075.1992.tb05146.x; Ohniwa RL, 2006, EMBO J, V25, P5591, DOI 10.1038/sj.emboj.7601414; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Oppermann M., 1992, MONOCLONAL ANTIBODIE, P271; Oshima T, 2006, DNA RES, V13, P141, DOI 10.1093/dnares/dsl009; Panyukov VV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062601; Panyukov VV, 2013, MATH BIOL BIOINFORM, V8, pt12; Papinutto E, 2002, J BIOL CHEM, V277, P15093, DOI 10.1074/jbc.M112378200; Pratt TS, 1997, J BACTERIOL, V179, P6367, DOI 10.1128/jb.179.20.6367-6377.1997; Prieto AI, 2012, NUCLEIC ACIDS RES, V40, P3524, DOI 10.1093/nar/gkr1236; Purtov YA, 2014, J BIOINF COMPUT BIOL, V12, DOI 10.1142/S0219720014410066; Roy S, 2008, J MOL BIOL, V375, P948, DOI 10.1016/j.jmb.2007.10.023; Saraswathi R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008017; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shavkunov KS, 2009, NUCLEIC ACIDS RES, V37, P4919, DOI 10.1093/nar/gkp490; Shvyreva U. S., 2011, Biophysics, V56, P795, DOI 10.1134/S0006350911050204; Singh SS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003589; STERN MJ, 1984, CELL, V37, P1015, DOI 10.1016/0092-8674(84)90436-7; Stillman TJ, 2005, MOL MICROBIOL, V57, P1101, DOI 10.1111/j.1365-2958.2005.04757.x; Talukder AA, 2014, ADV MICROBIOL, V4, P1095, DOI [10.4236/aim.2014.415120, DOI 10.4236/AIM.2014.415120]; Theoret JR, 2012, CLIN VACCINE IMMUNOL, V19, P1426, DOI 10.1128/CVI.00151-12; Thomason L. C., 2007, CURRENT PROTOCOLS MO, V79, P1, DOI [DOI 10.1002/0471142727.mb0117s79, 10.1002/0471142727.mb0117s79, DOI 10.1002/0471142727.MB0117S79]; Vora T, 2009, MOL CELL, V35, P247, DOI 10.1016/j.molcel.2009.06.035; Wang WQ, 2011, SCIENCE, V333, P1445, DOI 10.1126/science.1204697; Wolf SG, 1999, NATURE, V400, P83, DOI 10.1038/21918; Yamamoto K, 2011, J BACTERIOL, V193, P1477, DOI 10.1128/JB.01230-10; Zeth K, 2012, BIOCHEM J, V445, P297, DOI 10.1042/BJ20120514; Zhao GH, 2002, J BIOL CHEM, V277, P27689, DOI 10.1074/jbc.M202094200	81	27	30	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0182800	10.1371/journal.pone.0182800	http://dx.doi.org/10.1371/journal.pone.0182800			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800583	gold, Green Published, Green Submitted			2022-12-26	WOS:000407431800028
J	Manning, P; Beynon, SA; Lewis, OT				Manning, Paul; Beynon, Sarah A.; Lewis, Owen T.			Quantifying immediate and delayed effects of anthelmintic exposure on ecosystem functioning supported by a common dung beetle species	PLOS ONE			English	Article							CATTLE DUNG; IVERMECTIN; COLEOPTERA; RESIDUES; SCARABAEIDAE; SURVIVAL; GROWTH; LETHAL; TIME	Dung beetles (Coleoptera: Scarabaeoidea) support numerous ecosystem functions in live-stock-grazed pastures. Exposure to veterinary anthelmintic residues in livestock dung can have lethal and sublethal effects on dung beetles, and can reduce rates of dung removal, but the immediate and longer-term consequences for other dung beetle mediated functions have rarely been studied. We investigated the consequences of anthelmintic exposure on survival of the dung beetle Aphodius fossor and its delivery of four ecosystems functions that underpin pasture production: dung removal, soil fauna feeding activity, primary productivity, and reduction of soil compaction. We tested whether anthelmintic exposure had immediate or delayed effects on these functions individually and simultaneously (i.e., ecosystem multifunctionality). We found no evidence that ivermectin residues had a lethal effect on adult beetles. For dung removal, we found a significant interaction between the timing of exposure and functioning: while dung removal was impaired by concurrent exposure to high levels of ivermectin, functioning was unaffected when beetles that had been exposed previously to the same concentration of anthelmintic later interacted with untreated dung. Other ecosystem functions were not affected significantly by anthelmintic exposure, and there was no evidence to suggest any persistent impact of anthelmintic exposure on ecosystem multifunctionality. While anthelmintic residues remain a significant threat to dung beetle populations, for adult beetles, we found no evidence that residues have detrimental consequences for ecosystem functioning beyond the immediate point of exposure.	[Manning, Paul] Dalhousie Univ, Fac Agr, Dept Plant Food & Environm Sci, Truro, NS, Canada; [Manning, Paul; Beynon, Sarah A.; Lewis, Owen T.] Univ Oxford, Dept Zool, Oxford, England; [Manning, Paul; Beynon, Sarah A.] Dr Beynons Bug Farm, Lower Harglodd Farm, St Davids, Pembrokeshire, Wales	Dalhousie University; University of Oxford	Manning, P (corresponding author), Dalhousie Univ, Fac Agr, Dept Plant Food & Environm Sci, Truro, NS, Canada.; Manning, P (corresponding author), Univ Oxford, Dept Zool, Oxford, England.; Manning, P (corresponding author), Dr Beynons Bug Farm, Lower Harglodd Farm, St Davids, Pembrokeshire, Wales.	paul.manning@dal.ca	Lewis, Owen T/B-9531-2011		Natural Sciences and Engineering Research Council, Canada; Rhodes Scholarship; Graduate Student scholarship; Natural Sciences and Engineering Research Council	Natural Sciences and Engineering Research Council, Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Rhodes Scholarship; Graduate Student scholarship; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was made possible by a Natural Sciences and Engineering Research Council, Canada, Graduate Student scholarship, and a Rhodes Scholarship to PM.; The authors wish to thank Phil Smith and Jo Copping for helping with field work logistics. We also thank Sarah Fanning, Chris Terry, and Olalekan Faniran for assistance in the field. We thank Charlie Gee at Manor Meadows Farm and Jo Copping at the Farm Animal Initiative (Wytham Farm) for allowing us to collect beetles. Hefin Jones and Martin Speight provided invaluable suggestions that improved an earlier version of this manuscript. This work was funded by a Rhodes Scholarship, and a Natural Sciences and Engineering Research Council - Post Graduate Scholarship (M) to PM.	[Anonymous], 2021, LANG ENV STAT COMP; Bang HS, 2005, APPL SOIL ECOL, V29, P165, DOI 10.1016/j.apsoil.2004.11.001; Beynon SA, 2012, FACTORS AFFECTING EC; Beynon SA, 2015, ECOL ENTOMOL, V40, P124, DOI 10.1111/een.12240; Beynon SA, 2012, J APPL ECOL, V49, P1365, DOI 10.1111/j.1365-2664.2012.02210.x; Blanckenhorn WU, 2013, ECOTOX ENVIRON SAFE, V89, P15, DOI 10.1016/j.ecoenv.2012.10.030; Boddey RM, 2004, AGR ECOSYST ENVIRON, V103, P389, DOI 10.1016/j.agee.2003.12.010; Coleman HM, 2013, ENVIRON POLLUT, V174, P265, DOI 10.1016/j.envpol.2012.11.018; Dadour IR, 2000, ENVIRON ENTOMOL, V29, P1116, DOI 10.1603/0046-225X-29.6.1116; Drewry JJ, 2008, AUST J SOIL RES, V46, P237, DOI 10.1071/SR07125; Errouissi F, 2001, VET RES, V32, P421, DOI 10.1051/vetres:2001134; Floate KD, 2005, ANNU REV ENTOMOL, V50, P153, DOI 10.1146/annurev.ento.50.071803.130341; Floate KD, 1998, B ENTOMOL RES, V88, P25, DOI 10.1017/S0007485300041523; Hanski I., 1991, P5; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; HOLTER P, 1982, OIKOS, V39, P213, DOI 10.2307/3544488; Holter P, 2016, ECOL ENTOMOL, V41, P367, DOI 10.1111/een.12316; Huiting H.F., 2006, APPL PLANT RES, P1; Hutton SA, 2003, J APPL ECOL, V40, P994, DOI 10.1111/j.1365-2664.2003.00863.x; Martinez MI, 2017, CAN ENTOMOL, V149, P461, DOI 10.4039/tce.2017.11; Kaartinen R, 2013, ECOLOGY, V94, P2645, DOI 10.1890/12-1165.1; Kratz W, 1998, ENVIRON SCI POLLUT R, V5, P94, DOI 10.1007/BF02986394; LUMARET JP, 1993, J APPL ECOL, V30, P428, DOI 10.2307/2404183; MADSEN M, 1990, J APPL ECOL, V27, P1, DOI 10.2307/2403564; Manning P, 2017, ECOL ENTOMOL; Manning P, 2016, OPEN SCI FRAMEWORK; Manning P, 2016, ECOL ENTOMOL, V41, P500, DOI 10.1111/een.12319; Manning P, 2016, AGR ECOSYST ENVIRON, V218, P87, DOI 10.1016/j.agee.2015.11.007; Mantyla E, 2011, OECOLOGIA, V165, P143, DOI 10.1007/s00442-010-1774-2; Nervo B, 2017, ECOLOGY, V98, P433, DOI 10.1002/ecy.1653; O'Hea NM, 2010, OIKOS, V119, P1081, DOI 10.1111/j.1600-0706.2009.18116.x; Perez-Cogollo LC, 2015, ENVIRON ENTOMOL, V44, P1634, DOI 10.1093/ee/nvv139; Rombke J, 2009, ENVIRON TOXICOL CHEM, V28, P2117, DOI 10.1897/08-599.1; Rosenlew H, 2008, OIKOS, V117, P1659, DOI 10.1111/j.1600-0706.2008.16904.x; Roslin T, 2000, OIKOS, V91, P323, DOI 10.1034/j.1600-0706.2000.910213.x; Sands B, 2016, J APPL ECOL; Sissay MM, 2006, VET PARASITOL, V135, P337, DOI 10.1016/j.vetpar.2005.09.005; SKIDMORE P, 1991, INSECTS BRIT COW DUN; Slade EM, 2016, OIKOS, V125, P1607, DOI 10.1111/oik.03207; SOMMER C, 1992, B ENTOMOL RES, V82, P257, DOI 10.1017/S0007485300051804; SOMMER C, 1993, VET PARASITOL, V48, P67, DOI 10.1016/0304-4017(93)90145-D; SOWIG P, 1995, ECOGRAPHY, V18, P147, DOI 10.1111/j.1600-0587.1995.tb00335.x; Steinfeld H., 2006, LIVESTOCKS LONG SHAD, DOI [10.1890/1540-9295(2007)5[4:D]2.0.CO;2, DOI 10.1890/1540-9295(2007)5[4:D]2.0.CO;2]; STEVENSON B G, 1985, Coleopterists Bulletin, V39, P215; Sutherland IA, 2011, TRENDS PARASITOL, V27, P176, DOI 10.1016/j.pt.2010.11.008; Tixier T, 2015, ACTA OECOL, V69, P31, DOI 10.1016/j.actao.2015.08.003; Tolls B, 2003, AM CHEM SOC, V37, P286; Verdu JR, 2015, SCI REP-UK, V5, DOI 10.1038/srep13912; WALL R, 1987, NATURE, V327, P418, DOI 10.1038/327418a0; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wolstenholme AJ, 2012, J BIOL CHEM, V287, P40232, DOI 10.1074/jbc.R112.406280; Zhao C, 2013, J ANIM ECOL, V82, P749, DOI 10.1111/1365-2656.12058	52	9	9	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0182730	10.1371/journal.pone.0182730	http://dx.doi.org/10.1371/journal.pone.0182730			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800623	Green Published, gold, Green Submitted			2022-12-26	WOS:000407431800027
J	Nolting, S; Rentsch, J; Freitag, H; Detjen, K; Briest, F; Mobs, M; Weissmann, V; Siegmund, B; Auernhammer, CJ; Prada, ETA; Lauseker, M; Grossman, A; Exner, S; Fischer, C; Grotzinger, C; Schrader, J; Grabowski, P				Noelting, Svenja; Rentsch, Jakob; Freitag, Helma; Detjen, Katharina; Briest, Franziska; Moebs, Markus; Weissmann, Victoria; Siegmund, Britta; Auernhammer, Christoph J.; Prada, Elke Tatjana Aristizabal; Lauseker, Michael; Grossman, Ashley; Exner, Samantha; Fischer, Christian; Groetzinger, Carsten; Schrader, Joerg; Grabowski, Patricia		GERMAN NET-Z Study Grp	The selective PI3K alpha inhibitor BYL719 as a novel therapeutic option for neuroendocrine tumors: Results from multiple cell line models	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; SIGNALING PATHWAYS; IN-VIVO; P110-ALPHA ISOFORM; PANCREATIC-CANCER; MAMMALIAN TARGET; CARCINOMA-CELLS; CHROMOGRANIN-A; GROWTH; MTOR	Background/Aims The therapeutic options for metastatic neuroendocrine tumors (NETs) are limited. As PI3K signaling is often activated in NETs, we have assessed the effects of selective PI3Kp110 alpha inhibition by the novel agent BYL719 on cell viability, colony formation, apoptosis, cell cycle, signaling pathways, differentiation and secretion in pancreatic (BON-1, QGP-1) and pulmonary (H727) NET cell lines. Methods Cell viability was investigated by WST-1 assay, colony formation by clonogenic assay, apoptosis by caspase3/7 assay, the cell cycle by FACS, cell signaling by Western blot analysis, expression of chromogranin A and somatostatin receptors 1/2/5 by RT-qPCR, and chromogranin A secretion by ELISA. Results BYL719 dose-dependently decreased cell viability and colony formation with the highest sensitivity in BON-1, followed by H727, and lowest sensitivity in QGP-1 cells. BYL719 induced apoptosis and G0/G1 cell cycle arrest associated with increased p27 expression. Western blots showed inhibition of PI3K downstream targets to a varying degree in the different cell lines, but IGF1R activation. The most sensitive BON-1 cells displayed a significant, and H727 cells a non-significant, GSK3 inhibition after BYL719 treatment, but these effects do not appear to be mediated through the IGF1R. In contrast, the most resistant QGP-1 cells showed no GSK3 inhibition, but a modest activation, which would partially counteract the other anti-proliferative effects. Accordingly, BYL719 enhanced neuroendocrine differentiation with the strongest effect in BON-1, followed by H727 cells indicated by induction of chromogranin A and somatostatin receptor 1/2 mRNA-synthesis, but not in QGP-1 cells. In BON-1 and QGP-1 cells, the BYL719/everolimus combination was synergistic through simultaneous AKT/mTORC1 inhibition, and significantly increased somatostatin receptor 2 transcription compared to each drug separately. Conclusion Our results suggest that the agent BYL719 could be a novel therapeutic approach to the treatment of NETs that may sensitize NET cells to somatostatin analogs, and that if there is resistance to its action this may be overcome by combination with everolimus.	[Noelting, Svenja; Auernhammer, Christoph J.; Prada, Elke Tatjana Aristizabal] Ludwig Maximilians Univ Munchen, KUM, Dept Internal Med 2, Munich, Bavaria, Germany; [Noelting, Svenja; Auernhammer, Christoph J.] Ludwig Maximilians Univ Munchen, KUM, Dept Internal Med 4, Munich, Bavaria, Germany; [Rentsch, Jakob; Freitag, Helma; Detjen, Katharina; Briest, Franziska; Siegmund, Britta; Exner, Samantha; Fischer, Christian; Groetzinger, Carsten; Grabowski, Patricia] Charite, Dept Gastroenterol, CC13, CBF, Berlin, Germany; [Rentsch, Jakob; Freitag, Helma; Detjen, Katharina; Briest, Franziska; Siegmund, Britta; Exner, Samantha; Fischer, Christian; Groetzinger, Carsten; Grabowski, Patricia] Charite, CVK, Berlin, Germany; [Briest, Franziska; Grabowski, Patricia] Zent Klin Bad Berka GmbH, Dept Gastroenterol & Endocrinol, Bad Berka, Germany; [Briest, Franziska] Freie Univ FU Berlin, Dept Chem & Biochem, Berlin, Germany; [Moebs, Markus] Charite, Inst Pathol, Berlin, Germany; [Weissmann, Victoria; Schrader, Joerg] Univ Med Ctr Hamburg Eppendorf, Dept Gen Visceral & Thorac Surg, Hamburg, Germany; [Lauseker, Michael] Ludwig Maximilians Univ Munchen, Inst Med Informat Sci Biometry & Epidemiol, Munich, Bavaria, Germany; [Grossman, Ashley] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Grossman, Ashley] Royal Free Hosp, Neuroendocrine Tumour Ctr, London, England; [Schrader, Joerg] Univ Med Ctr Hamburg Eppendorf, Med Dept 1, Hamburg, Germany	University of Munich; University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Zentralklinik Bad Berka; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; University of Oxford; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Hamburg; University Medical Center Hamburg-Eppendorf	Grabowski, P (corresponding author), Charite, Dept Gastroenterol, CC13, CBF, Berlin, Germany.; Grabowski, P (corresponding author), Charite, CVK, Berlin, Germany.; Grabowski, P (corresponding author), Zent Klin Bad Berka GmbH, Dept Gastroenterol & Endocrinol, Bad Berka, Germany.	patricia.grabowski@charite.de	Siegmund, Britta/E-6929-2018; Briest, Franziska/AAW-9494-2021; Rentsch, Jakob/AAP-1780-2020; Grötzinger, Carsten/B-6938-2008	Siegmund, Britta/0000-0002-0055-958X; Briest, Franziska/0000-0001-5969-9467; Grötzinger, Carsten/0000-0001-9872-3087; Freitag, Helma/0000-0001-5950-0489; Mobs, Markus/0000-0002-1502-3032; Nolting, Svenja/0000-0002-7064-590X; Rentsch, Jakob/0000-0002-5728-7255; Lauseker, Michael/0000-0002-6662-7127	NOVARTIS; Roggenbruck Foundation (Hamburg, Germany); Zentralklinik Bad Berka GmbH, Germany	NOVARTIS(Novartis); Roggenbruck Foundation (Hamburg, Germany); Zentralklinik Bad Berka GmbH, Germany	This work has been supported by a grant from NOVARTIS (YING Investigator program) to JS and from the Roggenbruck Foundation (Hamburg, Germany) to JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. "Zentralklinik Bad Berka GmbH, Germany" is a communal hospital of the Rhon-Klinikum AG and provided support in the form of salaries for authors [FB,PG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.; This work has been supported by a grant from NOVARTIS (YING Investigator program) to JS and PG from the Roggenbruck Foundation (Hamburg, Germany) to JS. We thank Julian Maurer and Gerald Spottl, Klinikum der Universitat Munchen (KUM), and Martina Fahl, Universitatsklinikum Hamburg-Eppendorf (UKE), for technical support.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Almond JB, 2002, LEUKEMIA, V16, P433, DOI 10.1038/sj.leu.2402417; Aoyagi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047381; Atkins RJ, 2013, J CLIN NEUROSCI, V20, P1185, DOI 10.1016/j.jocn.2013.02.003; Bago-Horvath Z, 2012, NEUROENDOCRINOLOGY, V96, P228, DOI 10.1159/000337257; Banck MS, 2013, J CLIN INVEST, V123, P2502, DOI 10.1172/JCI67963; Bilim V, 2009, BRIT J CANCER, V101, P2005, DOI 10.1038/sj.bjc.6605437; Briest F, 2014, THERANOSTICS, V4, P336, DOI 10.7150/thno.7851; Brown JR, 2016, SEMIN ONCOL, V43, P260, DOI 10.1053/j.seminoncol.2016.02.004; Brunner P, 2017, EUR J NUCL MED MOL I, V44, P468, DOI 10.1007/s00259-016-3486-2; Bryant C, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-570; Bu QG, 2017, BIOMED PHARMACOTHER, V88, P443, DOI 10.1016/j.biopha.2016.11.090; Cakir M, 2011, EXPERT OPIN THER TAR, V15, P457, DOI 10.1517/14728222.2011.555403; Cakir M, 2010, J CELL MOL MED, V14, P2585, DOI 10.1111/j.1582-4934.2010.01125_1.x; Capozzi M, 2015, INT J SURG, V21, pS89, DOI 10.1016/j.ijsu.2015.06.064; Capurso G, 2013, INT J MOL SCI, V14, P30, DOI 10.3390/ijms14010030; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Carter YM, 2014, CANCER BIOL THER, V15, P510, DOI 10.4161/cbt.28015; Couderc C, 2011, AM J PATHOL, V178, P336, DOI 10.1016/j.ajpath.2010.11.023; CROSS DAE, 1994, BIOCHEM J, V303, P21, DOI 10.1042/bj3030021; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; De Santi M, 2016, CELL ONCOL, V39, P149, DOI 10.1007/s13402-015-0263-3; Dent P, 2014, CANCER BIOL THER, V15, P481, DOI 10.4161/cbt.28465; Desai SS, 2014, J BIOL CHEM, V289, P5386, DOI 10.1074/jbc.M113.533612; Dickey A, 2011, J NEURO-ONCOL, V104, P145, DOI 10.1007/s11060-010-0491-3; Djukom C, 2014, PANCREAS, V43, P88, DOI 10.1097/MPA.0b013e3182a44ab4; Elkabets M, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005747; EVERS BM, 1991, GASTROENTEROLOGY, V101, P303, DOI 10.1016/0016-5085(91)90004-5; Fazio N, 2015, WORLD J CLIN ONCOL, V6, P194, DOI 10.5306/wjco.v6.i6.194; Francois RA, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv123; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Freitag H, 2016, NEUROENDOCRINOLOGY; Fritsch C, 2014, MOL CANCER THER, V13, P1117, DOI 10.1158/1535-7163.MCT-13-0865; Furet P, 2013, BIOORG MED CHEM LETT, V23, P3741, DOI 10.1016/j.bmcl.2013.05.007; Gagliano T, 2013, ENDOCR-RELAT CANCER, V20, P463, DOI 10.1530/ERC-13-0042; Gao L, 2016, HUM CELL; Geis C, 2015, J SURG RES, V194, P388, DOI 10.1016/j.jss.2014.10.052; Giubellino A, 2013, ENDOCRINOLOGY, V154, P646, DOI 10.1210/en.2012-1854; Grabowski P, 2008, CLIN CANCER RES, V14, P7378, DOI 10.1158/1078-0432.CCR-08-0698; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; Greenblatt DY, 2010, AM J TRANSL RES, V2, P248; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Hsieh HY, 2016, CANCER LETT, V370, P56, DOI 10.1016/j.canlet.2015.09.018; Janicke RU, 2007, CELL CYCLE, V6, P407; Jang S, 2015, CANCER GENE THER, V22, P410, DOI 10.1038/cgt.2015.37; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; KAKU M, 1980, GANN, V71, P596; Kasajima A, 2011, ENDOCR-RELAT CANCER, V18, P181, DOI 10.1677/ERC-10-0126; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Konukiewitz B, 2017, MOD PATHOL; Korse CM, 2012, EUR J CANCER, V48, P662, DOI 10.1016/j.ejca.2011.08.012; Kunnimalaiyaan M, 2007, MOL CANCER THER, V6, P1151, DOI 10.1158/1535-7163.MCT-06-0665; Li J, 2012, MOL ENDOCRINOL, V26, P1380, DOI 10.1210/me.2012-1024; Lida S, 2012, MOL CELL ENDOCRINOL, V350, P99, DOI 10.1016/j.mce.2011.11.024; Ma Y, 2016, ONCOL REP, V35, P3068, DOI 10.3892/or.2016.4641; Madhunapantula SV, 2013, PIGM CELL MELANOMA R, V26, P886, DOI DOI 10.1111/PCMR.12156; Marchand B, 2012, CARCINOGENESIS, V33, P529, DOI 10.1093/carcin/bgr309; Massey AJ, 2015, ONCOTARGET, V6, P35797, DOI 10.18632/oncotarget.5929; Maurer U, 2014, J CELL SCI, V127, P1369, DOI 10.1242/jcs.138057; McCubrey JA, 2016, BBA-MOL CELL RES, V1863, P2942, DOI 10.1016/j.bbamcr.2016.09.004; Mirlashari MR, 2012, LEUKEMIA RES, V36, P499, DOI 10.1016/j.leukres.2011.11.013; Missiaglia E, 2010, J CLIN ONCOL, V28, P245, DOI 10.1200/JCO.2008.21.5988; Nolting S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143830; Nolting S, 2012, J MOL ENDOCRINOL, V49, P79, DOI 10.1530/JME-12-0028; Nurwidya F, 2016, MALAYS J MED SCI, V23, P9; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Ougolkov AV, 2006, CLIN CANCER RES, V12, P5074, DOI 10.1158/1078-0432.CCR-06-0196; Papaxoinis G, 2016, DISCOV MED, V21, P391; Passacantilli I, 2014, ONCOTARGET, V5, P5381, DOI 10.18632/oncotarget.2111; Pavel ME, 2011, LANCET, V378, P2005, DOI 10.1016/S0140-6736(11)61742-X; Pitt SC, 2009, AM J TRANSL RES, V1, P291; Plath T, 2000, J CELL BIOL, V150, P1467, DOI 10.1083/jcb.150.6.1467; Qian ZR, 2016, PANCREAS, V45, P1386, DOI 10.1097/MPA.0000000000000700; Qian ZR, 2013, J CLIN ONCOL, V31, P3418, DOI 10.1200/JCO.2012.46.6946; Raymond E, 2011, NEW ENGL J MED, V364, P501, DOI 10.1056/NEJMoa1003825; Reuther C, 2016, NEUROENDOCRINE TUMOR; Rodriguez R, 2006, MOL BIOL CELL, V17, P402, DOI 10.1091/mbc.E05-07-0594; Schrader J, 2015, EXP CLIN ENDOCR DIAB, V123, P118, DOI 10.1055/s-0034-1390461; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shakoori A, 2007, CANCER SCI, V98, P1388, DOI 10.1111/j.1349-7006.2007.00545.x; Soler A, 2016, CLIN CANCER RES, V22, P5805, DOI 10.1158/1078-0432.CCR-15-3051; Sopasakis VR, 2010, CELL METAB, V11, P220, DOI 10.1016/j.cmet.2010.02.002; Svalina MN, 2016, SCI REP-UK, V6, DOI 10.1038/srep27012; Svejda B, 2011, CANCER-AM CANCER SOC, V117, P4141, DOI 10.1002/cncr.26011; Takahashi-Yanaga F, 2008, CELL SIGNAL, V20, P581, DOI 10.1016/j.cellsig.2007.10.018; Takahashi-Yanaga F, 2013, BIOCHEM PHARMACOL, V86, P191, DOI 10.1016/j.bcp.2013.04.022; Tan HL, 2014, CLIN CANCER RES, V20, P890, DOI 10.1158/1078-0432.CCR-13-1982; Tanthaisong P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168059; Tijeras-Raballand A, 2012, TARGET ONCOL, V7, P173, DOI 10.1007/s11523-012-0229-6; Ungefroren H, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-18; Urbanska K, 2007, ONCOGENE, V26, P2308, DOI 10.1038/sj.onc.1210018; Valentino JD, 2014, CLIN CANCER RES, V20, P1212, DOI 10.1158/1078-0432.CCR-13-1897; Veenstra MJ, 2016, ONCOTARGET; von Wichert G, 2000, CANCER RES, V60, P4573; Wang Z, 2008, NATURE, V455, P1205, DOI 10.1038/nature07284; Wolin EM, 2013, CANCER LETT, V335, P1, DOI 10.1016/j.canlet.2013.02.016; Xu YX, 2014, TRENDS BIOCHEM SCI, V39, P268, DOI 10.1016/j.tibs.2014.04.004; Yao JC, 2016, LANCET, V387, P968, DOI 10.1016/S0140-6736(15)00817-X; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290; Yoshino Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep13249; Zeng J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091231; Zhou CF, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1366-y; Zhou W, 2012, CANCER LETT, V316, P178, DOI 10.1016/j.canlet.2011.10.033; Zhu Q, 2011, PROSTATE, V71, P835, DOI 10.1002/pros.21300; Zitzmann K, 2010, CANCER LETT, V295, P100, DOI 10.1016/j.canlet.2010.02.018	107	19	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0182852	10.1371/journal.pone.0182852	http://dx.doi.org/10.1371/journal.pone.0182852			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800359	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000407431800031
J	Kuryk, L; Vassilev, L; Ranki, T; Hemminki, A; Karioja-Kallio, A; Levalampi, O; Vuolanto, A; Cerullo, V; Pesonen, S				Kuryk, Lukasz; Vassilev, Lotta; Ranki, Tuuli; Hemminki, Akseli; Karioja-Kallio, Aila; Levalampi, Onerva; Vuolanto, Antti; Cerullo, Vincenzo; Pesonen, Sari			Toxicological and bio-distribution profile of a GM-CSF-expressing, double-targeted, chimeric oncolytic adenovirus ONCOS-102-Support for clinical studies on advanced cancer treatment	PLOS ONE			English	Article							REPLICATION-SELECTIVE ADENOVIRUS; GENE DELIVERY; THERAPY; TUMORS; CHEMOTHERAPY; VIROTHERAPY; INFUSION; ONYX-015; VIRUS	The purpose of this work was to carry out preclinical toxicity and bio-distribution studies required for regulatory approval of a clinical trial application for Phase I clinical studies of ONCOS-102 (Ad5/3-D24-GM-CSF) for therapy of advanced cancers (NCT01598129). The study design, route of administration and dosage differs from the clinical protocol and in more detail, investigate bio-distribution and toxicological profile of ONCOS-102 treatment in animal model. The study was carried out in 300 hamsters divided into nine test groups-three bio-distribution groups and six groups for analysis of toxicity. Hamsters received ONCOS-102 by intracardial, intraperitoneal or subcutaneous injections. Additionally, one group was administered twice a week with intraperitoneal injections of Cyclophosphamide. The control animals were administered with NaCl solution without ONCOS-102 in the same volume and the same way. No adverse effects of repeated administration of ONCOS-102 including body weight, food consumption, hematology and clinical chemistry parameters, histopathology and bio-accumulation were observed in the course of 6-month administration and following 3-month recovery period. All obtained findings indicate the treatment clinically safe.	[Kuryk, Lukasz; Vassilev, Lotta; Ranki, Tuuli; Vuolanto, Antti; Pesonen, Sari] Targovax Oy, Helsinki, Finland; [Kuryk, Lukasz; Cerullo, Vincenzo] Univ Helsinki, Fac Pharm, ImmunoViroTherapy Lab, Div Pharmaceut Biosci, Helsinki, Finland; [Kuryk, Lukasz; Cerullo, Vincenzo] Univ Helsinki, Fac Pharm, Ctr Drug Res, Helsinki, Finland; [Kuryk, Lukasz] Natl Inst Hyg, Natl Inst Publ Hlth, Dept Virol, Warsaw, Poland; [Hemminki, Akseli] Univ Helsinki, Dept Pathol, Canc Gene Therapy Grp, Fac Med, Helsinki, Finland; [Hemminki, Akseli] HUCH, Dept Oncol, Helsinki, Finland; [Hemminki, Akseli] TILT Biotherapeut Ltd, Helsinki, Finland; [Karioja-Kallio, Aila; Levalampi, Onerva] Univ Helsinki, Fac Med, Helsinki, Finland	University of Helsinki; University of Helsinki; National Institute of Hygiene (NIH); National Institute of Public Health (NIPH); University of Helsinki; University of Helsinki	Kuryk, L (corresponding author), Targovax Oy, Helsinki, Finland.; Kuryk, L (corresponding author), Univ Helsinki, Fac Pharm, ImmunoViroTherapy Lab, Div Pharmaceut Biosci, Helsinki, Finland.; Kuryk, L (corresponding author), Univ Helsinki, Fac Pharm, Ctr Drug Res, Helsinki, Finland.; Kuryk, L (corresponding author), Natl Inst Hyg, Natl Inst Publ Hlth, Dept Virol, Warsaw, Poland.	lukasz.kuryk@targovax.com	Kuryk, Lukasz/D-9596-2018; Cerullo, Vincenzo/B-9075-2015	Kuryk, Lukasz/0000-0003-1887-6361; Cerullo, Vincenzo/0000-0003-4901-3796	Marie Curie Innovative Training Network (ITN) grant [FP7-290002]	Marie Curie Innovative Training Network (ITN) grant	Marie Curie Innovative Training Network (ITN) grant, ADVance (FP7-290002) provided support in the form of salary for author LK. Targovax Oy provided support in the form of salaries for authors LK, TR, AV, SP, LV. Targovax Oy had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript by supervising, monitoring, funding the study and manuscript preparation. The specific roles of these authors are articulated in the 'author contributions' section.	Diaconu I, 2012, CANCER RES, V72, P2327, DOI 10.1158/0008-5472.CAN-11-2975; Dranoff G, 2002, IMMUNOL REV, V188, P147, DOI 10.1034/j.1600-065X.2002.18813.x; Freytag SO, 2007, MOL THER, V15, P1042, DOI 10.1038/sj.mt.6300162; Gilboa E, 1999, CANCER IMMUNOL IMMUN, V48, P382, DOI 10.1007/s002620050590; Kicielinski KP, 2014, MOL THER, V22, P1056, DOI 10.1038/mt.2014.21; Kirn D, 2001, GENE THER, V8, P89, DOI 10.1038/sj.gt.3301377; Koski A, 2010, MOL THER, V18, P1874, DOI 10.1038/mt.2010.161; Koski A, 2009, J GENE MED, V11, P966, DOI 10.1002/jgm.1373; Liikanen I, 2013, MOL THER, V21, P1212, DOI 10.1038/mt.2013.51; Lubaroff DM, 2009, CLIN CANCER RES, V15, P7375, DOI 10.1158/1078-0432.CCR-09-1910; Nemunaitis J, 2001, GENE THER, V8, P746, DOI 10.1038/sj.gt.3301424; Nguyen A, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00145; Pesonen S, 2010, GENE THER, V17, P892, DOI 10.1038/gt.2010.17; Pesonen S, 2011, MOL PHARMACEUT, V8, P12, DOI 10.1021/mp100219n; Ranki T, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/21624011.2014.958937; Sarkioja M, 2008, GENE THER, V15, P921, DOI 10.1038/gt.2008.56; Siurala M, 2015, INT J CANCER, V136, P945, DOI 10.1002/ijc.29048; Thomas MA, 2006, CANCER RES, V66, P1270, DOI 10.1158/0008-5472.CAN-05-3497; Touchefeu Y, 2011, RADIOTHER ONCOL, V99, P262, DOI 10.1016/j.radonc.2011.05.078; Turnbull S, 2015, VIRUSES-BASEL, V7, P6291, DOI 10.3390/v7122938; van de Laar L, 2012, BLOOD, V119, P3383, DOI 10.1182/blood-2011-11-370130; Vassilev L, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1017702; Vile RG, 2014, MOL THER, V22, P1881, DOI 10.1038/mt.2014.188; Woller N, 2015, Z GASTROENTEROLOGIE, V53; Wollmann G, 2012, CANCER J, V18, P69, DOI 10.1097/PPO.0b013e31824671c9; Yamamoto M, 2010, MOL THER, V18, P243, DOI 10.1038/mt.2009.266	26	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182715	10.1371/journal.pone.0182715	http://dx.doi.org/10.1371/journal.pone.0182715			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796812	Green Published, Green Submitted, gold			2022-12-26	WOS:000407396200087
J	Lemoine, S; Pillot, B; Augeul, L; Rabeyrin, M; Varennes, A; Normand, G; Baetz, D; Ovize, M; Juillard, L				Lemoine, Sandrine; Pillot, Bruno; Augeul, Lionel; Rabeyrin, Maud; Varennes, Annie; Normand, Gabrielle; Baetz, Delphine; Ovize, Michel; Juillard, Laurent			Dose and timing of injections for effective cyclosporine A pretreatment before renal ischemia reperfusion in mice	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; MITOCHONDRIAL PERMEABILITY TRANSITION; ISCHEMIA/REPERFUSION INJURY; RAT KIDNEYS; CYCLOPHILIN-D; METAANALYSIS; APOPTOSIS; PROTECTS; DISEASE; STROKE	Background There is experimental evidence that lethal ischemia-reperfusion injury (IRI) is largely due to mitochondrial permeability transition pore (mPTP) opening, which can be prevented by cyclosporine A (CsA). The aim of our study is to show that a higher dose of CsA (10 mg/kg) injected just before ischemia or a lower dose of CsA (3 mg/kg) injected further in advance of ischemia (1 h) protects the kidneys and improves mitochondrial function. Methods All mice underwent a right unilateral nephrectomy followed by 30 min clamping of the left renal artery. Mice in the control group did not receive any pharmacological treatment. Mice in the three groups treated by CsA were injected at different times and with different doses, namely 3 mg/kg 1 h or 10 min before ischemia or 10 mg/kg 10 min before ischemia. After 24 h of reperfusion, the plasma creatinine level were measured, the histological score was assessed and mitochondria were isolated to calculate the calcium retention capacity (CRC) and level of oxidative phosphorylation. Results Mortality and renal function was significantly higher in the CsA 10 mg/kg-10 min and CsA 3mg/kg-1 h groups than in the CsA 3mg/kg-10 min group. Likewise, the CRC was significantly higher in the former two groups than in the latter, suggesting that the improved renal function was due to a longer delay in the opening of the mPTP. Oxidative phosphorylation levels were also higher 24 h after reperfusion in the protected groups. Conclusions Our results suggest that the protection afforded by CsA is likely limited by its availability. The dose and timing of the injections are therefore crucial to ensure that the treatment is effective, but these findings may prove challenging to apply in practice.	[Lemoine, Sandrine; Pillot, Bruno; Augeul, Lionel; Normand, Gabrielle; Baetz, Delphine; Ovize, Michel; Juillard, Laurent] Univ Lyon1, Inserm 1060CarMeN, Lyon, France; [Lemoine, Sandrine] Hosp Civils Lyon, Edouard Herriot Hosp, Renal Funct Unit, Lyon, France; [Lemoine, Sandrine; Normand, Gabrielle; Juillard, Laurent] Hosp Civils Lyon, Edouard Herriot Hosp, Dept Nephrol, Lyon, France; [Rabeyrin, Maud] Hosp Civils Lyon, Edouard Herriot Hosp, Anatomopathol, Lyon, France; [Varennes, Annie] Hosp Civils Lyon, Edouard Herriot Hosp, Dept Biol, Lyon, France; [Ovize, Michel] Louis Pradel Hosp, Hosp Civils Lyon, Cardiovasc Explorat, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; CHU Lyon; CHU Lyon; CHU Lyon; CHU Lyon	Lemoine, S (corresponding author), Univ Lyon1, Inserm 1060CarMeN, Lyon, France.; Lemoine, S (corresponding author), Hosp Civils Lyon, Edouard Herriot Hosp, Renal Funct Unit, Lyon, France.; Lemoine, S (corresponding author), Hosp Civils Lyon, Edouard Herriot Hosp, Dept Nephrol, Lyon, France.	sandrine.lemoine01@chu-lyon.fr	Ovize, michel/AAL-9247-2020; Pillot, Bruno/D-5448-2015; Lemoine, Sandrine/AAL-4365-2021; Carmen, Team3/Y-7384-2019	Pillot, Bruno/0000-0002-1499-3299; Carmen, Team3/0000-0002-3614-0924; Baetz, Delphine/0000-0001-7678-062X	Bibliotheque Scientifique de l'Internat de Lyon; Hospices Civils de Lyon	Bibliotheque Scientifique de l'Internat de Lyon; Hospices Civils de Lyon	The proofreading of this article was supported by the Bibliotheque Scientifique de l'Internat de Lyon and the Hospices Civils de Lyon.	ABRAHAM JS, 1991, TRANSPLANT P, V23, P356; Argaud Laurent, 2005, J Mol Cell Cardiol, V38, P367, DOI 10.1016/j.yjmcc.2004.12.001; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; BARROS E J G, 1987, Nephrology Dialysis Transplantation, V2, P261; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Bonventre JV, 2004, KIDNEY INT, V66, P480, DOI 10.1111/j.1523-1755.2004.761_2.x; Chen HW, 2002, BRIT J PHARMACOL, V137, P771, DOI 10.1038/sj.bjp.0704908; Coca SG, 2012, KIDNEY INT, V81, P442, DOI 10.1038/ki.2011.379; Delbridge MS, 2007, TRANSPL P, V39, P2992, DOI 10.1016/j.transproceed.2007.04.027; Hu JC, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1272-y; ICHAS F, 1994, FEBS LETT, V348, P211, DOI 10.1016/0014-5793(94)00615-6; Inman SR, 2003, UROLOGY, V62, P750, DOI 10.1016/S0090-4295(03)00475-8; Jonker SJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150863; Kaddourah A, 2016, N ENGL J MED; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Leger PL, 2011, EXP NEUROL, V230, P58, DOI 10.1016/j.expneurol.2010.06.009; Lemoine S, 2015, TRANSPLANTATION, V99, P717, DOI 10.1097/TP.0000000000000530; Martinez-Palli G, 2011, NEPHROL DIAL TRANSPL, V26, P1813, DOI 10.1093/ndt/gfq646; O'Neill S, 2014, NEPHRON EXP NEPHROL, V126, P167, DOI 10.1159/000363323; Palant CE, 2017, CURR OPIN ANESTHESIO, V30, P100, DOI 10.1097/ACO.0000000000000428; Singh D, 2005, TOXICOLOGY, V207, P339, DOI 10.1016/j.tox.2004.09.018; Soriano ME, 2004, J BIOL CHEM, V279, P36803, DOI 10.1074/jbc.M405297200; Wen XY, 2012, NEPHROL DIAL TRANSPL, V27, P3100, DOI 10.1093/ndt/gfr766; Wever KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032296; Yang CW, 2003, TRANSPLANTATION, V75, P20, DOI 10.1097/01.TP.0000040002.12912.65; Yang CW, 2001, TRANSPLANTATION, V72, P1753; Yu GL, 2004, BRAIN RES, V1018, P32, DOI 10.1016/j.brainres.2004.05.056; Zhu T, 2002, CLIN EXP PHARMACOL P, V29, P852, DOI 10.1046/j.1440-1681.2002.03736.x	28	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182358	10.1371/journal.pone.0182358	http://dx.doi.org/10.1371/journal.pone.0182358			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796779	gold, Green Submitted, Green Published			2022-12-26	WOS:000407396200046
J	Shehata, HR; Li, JP; Chen, S; Redda, H; Cheng, SM; Tabujara, N; Li, HH; Warriner, K; Hanner, R				Shehata, Hanan R.; Li, Jiping; Chen, Shu; Redda, Helen; Cheng, Shumei; Tabujara, Nicole; Li, Honghong; Warriner, Keith; Hanner, Robert			Droplet digital polymerase chain reaction (ddPCR) assays integrated with an internal control for quantification of bovine, porcine, chicken and turkey species in food and feed	PLOS ONE			English	Article							TIME QUANTITATIVE PCR; DNA COPY NUMBER; MEAT-PRODUCTS; MITOCHONDRIAL-DNA; IDENTIFICATION; BEEF; RUMINANT; FEEDSTUFFS; AUTHENTICATION; ADULTERATION	Food adulteration and feed contamination are significant issues in the food/feed industry, especially for meat products. Reliable techniques are needed to monitor these issues. Droplet Digital PCR (ddPCR) assays were developed and evaluated for detection and quantification of bovine, porcine, chicken and turkey DNA in food and feed samples. The ddPCR methods were designed based on mitochondrial DNA sequences and integrated with an artificial recombinant plasmid DNA to control variabilities in PCR procedures. The specificity of the ddPCR assays was confirmed by testing both target species and additional 18 nontarget species. Linear regression established a detection range between 79 and 33200 copies of the target molecule from 0.26 to 176 pg of fresh animal tissue DNA with a coefficient of determination (R-2) of 0.997-0.999. The quantification ranges of the methods for testing fortified heat-processed food and feed samples were 0.05-3.0% (wt/wt) for the bovine and turkey targets, and 0.01-1.0% (wt/wt) for pork and chicken targets. Our methods demonstrated acceptable repeatability and reproducibility for the analytical process for food and feed samples. Internal validation of the PCR process was monitored using a control chart for 74 consecutive ddPCR runs for quantifying bovine DNA. A matrix effect was observed while establishing calibration curves with the matrix type under testing, and the inclusion of an internal control in DNA extraction provides a useful means to overcome this effect. DNA degradation caused by heating, sonication or Taq I restriction enzyme digestion was found to reduce ddPCR readings by as much as 4.5 fold. The results illustrated the applicability of the methods to quantify meat species in food and feed samples without the need for a standard curve, and to potentially support enforcement activities for food authentication and feed control. Standard reference materials matching typical manufacturing processes are needed for future validation of ddPCR assays for absolute quantification of meat species.	[Shehata, Hanan R.; Hanner, Robert] Univ Guelph, Dept Integrat Biol, Guelph, ON, Canada; [Shehata, Hanan R.; Hanner, Robert] Univ Guelph, Biodivers Inst Ontario, Guelph, ON, Canada; [Shehata, Hanan R.] Mansoura Univ, Dept Microbiol, Mansoura, Egypt; [Li, Jiping; Chen, Shu; Redda, Helen; Tabujara, Nicole; Li, Honghong] Univ Guelph, Lab Serv Div, Guelph, ON, Canada; [Redda, Helen; Cheng, Shumei; Warriner, Keith] Univ Guelph, Dept Food Sci, Guelph, ON, Canada; [Cheng, Shumei] Agr Univ Hebei, Coll Food Sci & Technol, Baoding, Hebei, Peoples R China	University of Guelph; University of Guelph; Egyptian Knowledge Bank (EKB); Mansoura University; University of Guelph; University of Guelph; Hebei Agricultural University	Chen, S (corresponding author), Univ Guelph, Lab Serv Div, Guelph, ON, Canada.	schen@uoguelph.ca			Canadian Food Inspection Agency (CFIA) (Federal Assistance Program)	Canadian Food Inspection Agency (CFIA) (Federal Assistance Program)	The authors gratefully acknowledge the financial support (for preparation of the manuscript) provided by the Canadian Food Inspection Agency (CFIA) (via the Federal Assistance Program) to RHH for HS, and in-kind contributions from Laboratory Services Division, University of Guelph, for the development and validation of the methods.	Abuzinadah OHA, 2015, MITOCHONDR DNA, V26, P337, DOI 10.3109/19401736.2013.840593; Ali ME, 2012, FOOD ANAL METHOD, V5, P935, DOI 10.1007/s12161-011-9357-3; Ali ME, 2014, FOOD ANAL METHOD, V7, P1933, DOI 10.1007/s12161-014-9844-4; Sentandreu MA, 2014, FOOD RES INT, V60, P19, DOI 10.1016/j.foodres.2014.03.030; [Anonymous], 2008, AOAC98318, V950, p46B; Ansfield M, 2000, FOOD AGR IMMUNOL, V12, P273, DOI 10.1080/09540100020008146; ANSI, 2015, DNA BARCODES; AOAC, 1983, 98318 AOAC; AOAC, 2006, MEAT MEAT PROD PREP; Baker M, 2012, NAT METHODS, V9, P541, DOI 10.1038/nmeth.2027; Ballin NZ, 2009, MEAT SCI, V83, P165, DOI 10.1016/j.meatsci.2009.06.003; Bottaro M, 2014, ALBANIAN J AGR SCI, P455; Cai YC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/810209; Calvo JH, 2002, J AGR FOOD CHEM, V50, P5262, DOI 10.1021/jf020051a; Chuah LO, 2016, FOOD CONTROL, V62, P157, DOI 10.1016/j.foodcont.2015.10.030; Di Pinto A, 2015, J FOOD SCI TECH MYS, V52, P2479, DOI 10.1007/s13197-014-1552-y; Diez-Valcarce M, 2011, FOOD ANAL METHOD, V4, P614, DOI 10.1007/s12161-011-9262-9; Dingle TC, 2013, CLIN CHEM, V59, P1670, DOI 10.1373/clinchem.2013.211045; Ekins J, 2012, J FOOD PROTECT, V75, P1107, DOI 10.4315/0362-028X.JFP-11-415; Floren C, 2015, FOOD CHEM, V173, P1054, DOI 10.1016/j.foodchem.2014.10.138; Frezza D, 2003, J FOOD PROTECT, V66, P103, DOI 10.4315/0362-028X-66.1.103; Haider N, 2012, MEAT SCI, V90, P490, DOI 10.1016/j.meatsci.2011.09.013; Henrich TJ, 2012, J VIROL METHODS, V186, P68, DOI 10.1016/j.jviromet.2012.08.019; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Huggett JF, 2013, CLIN CHEM, V59, P892, DOI 10.1373/clinchem.2013.206375; Kelley K, 2013, J CLIN MICROBIOL, V51, P2033, DOI 10.1128/JCM.00196-13; Krcmar P, 2003, J AGR FOOD CHEM, V51, P7655, DOI 10.1021/jf034167y; Krcmar P, 2001, J FOOD PROTECT, V64, P117; Kumar A, 2015, CRIT REV FOOD SCI, V55, P1340, DOI 10.1080/10408398.2012.693978; Mafra I, 2008, EUR FOOD RES TECHNOL, V227, P649, DOI 10.1007/s00217-007-0782-x; Morisset D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062583; Nadauld LD, 2012, TRANSL MED SUNNYVALE, V2, P1, DOI DOI 10.4172/21611025.1000107; O'Mahony PJ, 2013, QJM-INT J MED, V106, P595, DOI 10.1093/qjmed/hct087; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Prado M, 2007, J AGR FOOD CHEM, V55, P7495, DOI 10.1021/jf0707583; Rodriguez MA, 2004, J FOOD PROTECT, V67, P172, DOI 10.4315/0362-028X-67.1.172; Rodriguez MA, 2003, J AGR FOOD CHEM, V51, P1524, DOI 10.1021/jf025784+; Rothrock M. J., 2013, ADV MICROBIOL-IRVINE, V3, P403, DOI [10.4236/aim.2013.35055, DOI 10.4236/AIM.2013.35055]; Spink J, 2011, J FOOD SCI, V76, pR157, DOI 10.1111/j.1750-3841.2011.02417.x; Strain MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055943; Tanabe S, 2007, BIOSCI BIOTECH BIOCH, V71, P3131, DOI 10.1271/bbb.70683; Tartaglia M, 1998, J FOOD PROTECT, V61, P513, DOI 10.4315/0362-028X-61.5.513; Udomsil N, 2016, FOOD MICROBIOL, V57, P54, DOI 10.1016/j.fm.2016.01.004; Zacharisen Michael C, 2006, WMJ, V105, P50; Zhang CL, 2007, FOOD CONTROL, V18, P1149, DOI 10.1016/j.foodcont.2006.07.018	45	43	45	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182872	10.1371/journal.pone.0182872	http://dx.doi.org/10.1371/journal.pone.0182872			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796824	Green Submitted, Green Published, gold			2022-12-26	WOS:000407396200110
J	Dreschers, S; Gille, C; Haas, M; Seubert, F; Platen, C; Orlikowsky, TW				Dreschers, Stephan; Gille, Christian; Haas, Martin; Seubert, Florence; Platen, Christopher; Orlikowsky, Thorsten W.			Reduced internalization of TNF-alpha/TNFR1 down-regulates caspase dependent phagocytosis induced cell death (PICD) in neonatal monocytes	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; INDUCED APOPTOSIS; ESCHERICHIA-COLI; CORD BLOOD; HUMAN NEWBORN; INFLAMMATION; INFECTION; CHORIOAMNIONITIS; DISTINCT; DISEASE	Phagocytosis-induced cell death (PICD) is diminished in cord blood monocytes (CBMO) as compared to cells from adults (PBMO) due to differences in the CD95-pathway. This may support a prolonged pro-inflammatory response with sequels of sustained inflammation as seen in neonatal sepsis. Here we hypothesized that TNF-alpha mediated induction of apoptosis is impaired in CBMO due to differences in the TNFR1-dependent internalization. Monocytes were infected with Escherichia coli-GFP (E. coli-GFP). Monocyte phenotype, phagocytic activity, induction of apoptosis, and TNF-alpha/TNF-receptor (TNFR) -expression were analysed. In the course of infection TNF-alpha-secretion of CBMO was reduced to 40% as compared to PBMO (p< 0.05). Neutralization of TNF-alpha by an aTNF-alpha antibody reduced apoptotic PICD in PBMO four-fold (p < 0.05 vs. infection with E. coli). PICD in CBMO was reduced 5-fold compared to PBMO and showed less responsiveness to aTNF-alpha antibody. CBMO expressed less pro-apoptotic TNFR1, which, after administration of TNF-alpha or infection with E. coli was internalized to a lesser extent. With similar phagocytic capacity, reduced TNFR1 internalization in CBMO was accompanied by lower activation of caspase-8 (p < 0.05 vs. PBMO). Stronger caspase-8 activation in PBMO caused more activation of effector caspase-3 and apoptosis (all p < 0.05 vs. PBMO). Our results demonstrate that TNFR1 internalization is critical in mediating PICD in monocytes after infection with E. coli and is reduced in CBMO.	[Dreschers, Stephan; Haas, Martin; Seubert, Florence; Platen, Christopher; Orlikowsky, Thorsten W.] Univ Childrens Hosp, Dept Neonatol, Aachen, Germany; [Gille, Christian] Univ Childrens Hosp, Dept Neonatol, Tubingen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Hamburg; University Medical Center Hamburg-Eppendorf	Orlikowsky, TW (corresponding author), Univ Childrens Hosp, Dept Neonatol, Aachen, Germany.	torlikowsky@ukaachen.de	Gille, Christian/AAC-1883-2020					Angelone DF, 2006, PEDIATR RES, V60, P205, DOI 10.1203/01.pdr.0000228319.10481.ea; Baran J, 2001, INFECT IMMUN, V69, P1287, DOI 10.1128/IAI.69.3.1287-1297.2001; Behnia M, 2000, CHEST, V117, P1771, DOI 10.1378/chest.117.6.1771; Bracci R, 2003, BIOL NEONATE, V83, P85, DOI 10.1159/000067956; Dreschers S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053589; Gantert M, 2010, J PERINATOL, V30, pS21, DOI 10.1038/jp.2010.96; Gille C, 2009, CYTOM PART B-CLIN CY, V76B, P271, DOI 10.1002/cyto.b.20474; Gille C, 2008, PEDIATR RES, V63, P33, DOI 10.1203/PDR.0b013e31815b8e9f; Gille C, 2006, PEDIATR RES, V60, P152, DOI 10.1203/01.pdr.0000228345.58509.7b; Gille C, 2013, PEDIATR RES, V73, P402, DOI 10.1038/pr.2012.196; Giogha C, 2014, CYTOKINE GROWTH F R, V25, P235, DOI 10.1016/j.cytogfr.2013.12.012; Hauspurg AK, 2011, NEONATOLOGY, V99, P104, DOI 10.1159/000308454; Hentschel J, 2005, EUR J PEDIATR, V164, P292, DOI 10.1007/s00431-005-1623-1; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; Jin ZY, 2006, MOL CELL BIOL, V26, P8136, DOI 10.1128/MCB.00257-06; Kaufmann T, 2012, CELL DEATH DIFFER, V19, P42, DOI 10.1038/cdd.2011.121; Kohelet D, 2006, J CHILD NEUROL, V21, P965, DOI 10.1177/08830738060210111301; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; Leiber A, 2014, PEDIATR RES, V76, P142, DOI 10.1038/pr.2014.74; Levy O, 2006, J IMMUNOL, V177, P1956, DOI 10.4049/jimmunol.177.3.1956; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Liu CA, 2005, PEDIATR RES, V58, P132, DOI 10.1203/01.PDR.0000163396.89508.5C; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Pedraza-Sanchez S, 2013, CLIN VACCINE IMMUNOL, V20, P962, DOI 10.1128/CVI.00609-12; Richter C, 2012, MOL CELL BIOL, V32, P2515, DOI 10.1128/MCB.06458-11; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017; Schutze S, 2009, RESULTS PROBL CELL D, V49, P63, DOI 10.1007/400_2008_23; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Tchikov V, 2011, EUR J CELL BIOL, V90, P467, DOI 10.1016/j.ejcb.2010.11.002; Wersto RP, 2001, CYTOMETRY, V46, P296, DOI 10.1002/cyto.1171; Zauli G, 2013, CYTOKINE, V64, P51, DOI 10.1016/j.cyto.2013.05.005	33	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182415	10.1371/journal.pone.0182415	http://dx.doi.org/10.1371/journal.pone.0182415			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28793310	gold, Green Published, Green Submitted			2022-12-26	WOS:000407196700041
J	Liu, XF; Zhu, TH; Manojlovich, M; Cohen, HW; Tsilimingras, D				Liu, Xuefeng; Zhu, Tinghui; Manojlovich, Milisa; Cohen, Hillel W.; Tsilimingras, Dennis			Racial/ethnic disparity in the associations of smoking status with uncontrolled hypertension subtypes among hypertensive subjects	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; BLOOD-PRESSURE CONTROL; NATIONAL-HEALTH; CIGARETTE-SMOKING; AMERICANS; SMOKERS; ADULTS; RISK; PREVALENCE; STATEMENT	Background Racial/ethnic differences in the associations of smoking with uncontrolled blood pressure (BP) and its subtypes (isolated uncontrolled systolic BP (SBP), uncontrolled systolic-diastolic BP, and isolated uncontrolled diastolic BP (DBP)) have not been investigated among diagnosed hypertensive subjects. Methods A sample of 7,586 hypertensive patients aged >= 18 years were selected from the National Health and Nutrition Examination Survey 1999-2010. Race/ethnicity was classified into Hispanic, nonHispanic white, and non-Hispanic black. Smoking was categorized as never smoking, ex-smoking, and current smoking. Uncontrolled BP was determined as SBP >= 140 or DBP >= 90 mmHg. Isolated uncontrolled SBP was defined as SBP >= 140 and DBP< 90 mmHg, uncontrolled SDBP as SBP >= 140 and DBP >= 90 mmHg, and isolated uncontrolled DBP as SBP<140 and DBP >= 90 mmHg. Adjusted odds ratios (ORs) with 95% confidence intervals (CIs) of uncontrolled BP and its subtypes were calculated using weighted logistic regression models. Results The interaction effect of race and smoking was significant after adjustment for the full potential confounding covariates (Adjusted p = 0.0412). Compared to never smokers, current smokers were 29% less likely to have uncontrolled BP in non-Hispanic whites (OR = 0.71, 95% CI = 0.56-0.90), although the likelihood for uncontrolled BP is the same for smokers and never smokers in Hispanics and non-Hispanic blacks. Current smokers were 26% less likely than never smokers to have isolated uncontrolled SBP in non-Hispanic whites (OR = 0.74, 95% CI = 0.58-0.95). However, current smoking is associated with an increased likelihood of uncontrolled systolic-diastolic BP in non-Hispanic blacks, and current smokers in this group were 70% more likely to have uncontrolled systolic-diastolic BP than never smokers (OR = 1.70, 95% CI = 1.10-2.65). Conclusion The associations between current smoking and uncontrolled BP differed over race/ethnicity. Health practitioners may need to be especially vigilant with non-Hispanic black smokers with diagnosed hypertension.	[Liu, Xuefeng; Zhu, Tinghui; Manojlovich, Milisa] Univ Michigan, Sch Nursing, Dept Syst Populat & Leadership, Ann Arbor, MI 48109 USA; [Liu, Xuefeng] Univ Michigan, Sch Med, Frankel Cardiovasc Ctr, Ann Arbor, MI 48109 USA; [Cohen, Hillel W.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Tsilimingras, Dennis] Wayne State Univ, Dept Family Med & Publ Hlth Sci, Sch Med, Detroit, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Yeshiva University; Albert Einstein College of Medicine; Wayne State University	Liu, XF (corresponding author), Univ Michigan, Sch Nursing, Dept Syst Populat & Leadership, Ann Arbor, MI 48109 USA.; Liu, XF (corresponding author), Univ Michigan, Sch Med, Frankel Cardiovasc Ctr, Ann Arbor, MI 48109 USA.	liuxf@med.umich.edu						American Heart Association, HIGH BLOOD PRESSURE; Caraballo RS, 1998, JAMA-J AM MED ASSOC, V280, P135, DOI 10.1001/jama.280.2.135; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Douglas JG, 2003, ARCH INTERN MED, V163, P525, DOI 10.1001/archinte.163.5.525; Egan BM, 2013, CIRCULATION, V128, P29, DOI 10.1161/CIRCULATIONAHA.112.000500; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Eknoyan G, 2003, AM J KIDNEY DIS, V42, P617, DOI 10.1016/S0272-6386(03)00826-6; Gerhard GT, 1999, AM J CLIN NUTR, V70, P252; GREEN MS, 1986, AM HEART J, V111, P932, DOI 10.1016/0002-8703(86)90645-9; Hicks LeRoi S, 2005, BMC Cardiovasc Disord, V5, P16, DOI 10.1186/1471-2261-5-16; Hicks LS, 2004, HYPERTENSION, V44, P429, DOI 10.1161/01.HYP.0000141439.34834.84; Holford TR, 2014, JAMA-J AM MED ASSOC, V311, P164, DOI 10.1001/jama.2013.285112; Hyman DJ, 2003, CURR ATHEROSCLER REP, V5, P132; Iyer AS, 2010, J AM SOC HYPERTENS, V4, P22, DOI 10.1016/j.jash.2010.02.002; Johnson CL, 2013, VITAL HLTH STAT, V2, P1; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Klungel OH, 2000, STROKE, V31, P420, DOI 10.1161/01.STR.31.2.420; LAUSTIOLA KE, 1988, CLIN PHARMACOL THER, V44, P426, DOI 10.1038/clpt.1988.175; Lee DH, 2001, HYPERTENSION, V37, P194, DOI 10.1161/01.HYP.37.2.194; Liu XF, 2017, AM J HYPERTENS, V30, P602, DOI 10.1093/ajh/hpx014; Liu XF, 2015, J AM SOC HYPERTENS, V9, P197, DOI 10.1016/j.jash.2015.01.002; Liu XF, 2013, AM J HYPERTENS, V26, P1328, DOI 10.1093/ajh/hpt109; Lloyd-Jones DM, 2005, JAMA-J AM MED ASSOC, V294, P466, DOI 10.1001/jama.294.4.466; McNagny SE, 1997, AM J MED, V103, P121, DOI 10.1016/S0002-9343(97)00131-9; Mikkelsen KL, 1997, AM J HYPERTENS, V10, P483, DOI 10.1016/S0895-7061(96)00487-6; National Health and Nutrition Examination Survey, 2007, PHYS EX PROC MAN; National Lung Heart Blood Institute, EFF HIGH BLOOD PRESS; Ong KL, 2008, HYPERTENSION, V51, P1142, DOI 10.1161/HYPERTENSIONAHA.107.105205; Ong KL, 2008, ANN EPIDEMIOL, V18, P222, DOI 10.1016/j.annepidem.2007.10.007; Perez-Stable EJ, 1998, JAMA-J AM MED ASSOC, V280, P152, DOI 10.1001/jama.280.2.152; Perez-Stable EJ, 2011, AM J HEALTH PROMOT, V25, pS8, DOI 10.4278/ajhp.25.5.c2; Sung KC, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003245; US Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE; Valderrama Amy L., 2012, Morbidity and Mortality Weekly Report, V61, P703	35	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182807	10.1371/journal.pone.0182807	http://dx.doi.org/10.1371/journal.pone.0182807			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28793323	gold, Green Published, Green Submitted			2022-12-26	WOS:000407196700068
J	Chang, CH; Wu, FZ; Yang, WQ; Xu, ZF; Cao, R; He, W; Tan, B; Justine, MF				Chang, Chenhui; Wu, Fuzhong; Yang, Wanqin; Xu, Zhenfeng; Cao, Rui; He, Wei; Tan, Bo; Justine, Meta Francis			The microbial community in decaying fallen logs varies with critical period in an alpine forest	PLOS ONE			English	Article							COARSE WOODY DEBRIS; FOLIAR LITTER; DECOMPOSITION RATES; PINUS-SYLVESTRIS; GROWING-SEASON; BEECH LOGS; FIR FOREST; SOIL; DYNAMICS; RESPIRATION	Little information has been available on the shifts in the microbial community in decaying fallen logs during critical periods in cold forests. Minjiang fir (Abies faxoniana) fallen logs in decay classes I-V were in situ incubated on the forest floor of an alpine forest in the eastern Tibet Plateau. The microbial community was investigated during the seasonal snow cover period (SP), snow thawing period (TP), early growing season (EG) and late growing season (LG) using Phosphorous Lipid Fatty Acid (PLFA) analysis. Total microbial biomass and microbial diversity in fallen logs were much more affected by critical period than decay class, whereas decay class had a stronger effect on microbial diversity than on microbial biomass. Abundant microbial biomass and microbial diversity in logs even without the cover of snow were observed in winter, which could not be linked to thermal insulation by snow cover. The freshly decayed logs functioned as an excellent buffer of environmental variation for microbial organisms during the sharp fluctuations in temperature in winter. We also found distinct decay patterns along with seasonality for heartwood, sapwood and bark, which requires further detailed research. Gram(-) bacteria mainly dominated the shifts in microbial community composition from SP to EG, while fungi and Gram(+) bacteria mainly dominated it from SP to TP. Based on previous work and the present study, we conclude that fallen logs on the forest floor alter ecological processes by influencing microbial communities on woody debris and beneath the soil and litter. Our study also emphasizes the need to maintain a number of fallen logs, especially fresh ones, on the forest floor.	[Chang, Chenhui; Wu, Fuzhong; Yang, Wanqin; Xu, Zhenfeng; Cao, Rui; He, Wei; Tan, Bo; Justine, Meta Francis] Sichuan Agr Univ, Inst Ecol & Forestry, Long Term Res Stn Alpine Forest Ecosyst, Chengdu, Sichuan, Peoples R China; [Wu, Fuzhong; Yang, Wanqin; Xu, Zhenfeng; Tan, Bo] Collaborat Innovat Ctr Ecol Secur Upper Reaches Y, Chengdu 8, Sichuan, Peoples R China	Sichuan Agricultural University	Yang, WQ (corresponding author), Sichuan Agr Univ, Inst Ecol & Forestry, Long Term Res Stn Alpine Forest Ecosyst, Chengdu, Sichuan, Peoples R China.; Yang, WQ (corresponding author), Collaborat Innovat Ctr Ecol Secur Upper Reaches Y, Chengdu 8, Sichuan, Peoples R China.	scyangwq@163.com	常晨晖, Chenhui Chang -/ABC-6906-2020	常晨晖, Chenhui Chang -/0000-0002-4107-2065; yang, wanqin/0000-0002-4399-2914; Francis Justine, Meta/0000-0001-7895-4961	National Natural Science Foundation of China; National Natural Science Foundation of China [31270498, 31570445, 31570601]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by three funds, all of which were from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/). The grant numbers are 31270498(FZ Wu), 31570445 (WQ Yang), 31570601(ZF Xu). All made a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. And the Funding 31570445 made a dominating role.; This study was supported by National Natural Science Foundation of China (31570445, 31570601, 31270498).	Arnstadt T, 2016, FOREST ECOL MANAG, V382, P129, DOI 10.1016/j.foreco.2016.10.004; BEARE MH, 1990, SOIL BIOL BIOCHEM, V22, P585, DOI 10.1016/0038-0717(90)90002-H; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bo Tan, 2010, Acta Ecologica Sinica, V30, P93; Bokhorst S, 2013, SOIL BIOL BIOCHEM, V62, P157, DOI 10.1016/j.soilbio.2013.03.016; Brant JB, 2006, SOIL BIOL BIOCHEM, V38, P2219, DOI 10.1016/j.soilbio.2006.01.022; Campbell LJ, 2007, FOREST ECOL MANAG, V238, P293, DOI 10.1016/j.foreco.2006.10.027; Chang Chen-Hui, 2015, Chinese Journal of Plant Ecology, V39, P14, DOI 10.17521/cjpe.2015.0002; Colwell RK, 2013, ESTIMATES STAT ESTIM; de Boer W, 2005, FEMS MICROBIOL REV, V29, P795, DOI 10.1016/j.femsre.2004.11.005; Forrester JA, 2012, FOREST ECOL MANAG, V265, P124, DOI 10.1016/j.foreco.2011.10.038; Freschet GT, 2012, J ECOL, V100, P161, DOI 10.1111/j.1365-2745.2011.01896.x; Fukami T, 2010, ECOL LETT, V13, P675, DOI 10.1111/j.1461-0248.2010.01465.x; Fukasawa Y, 2014, ECOL RES, V29, P257, DOI 10.1007/s11284-013-1120-3; Fukasawa Y, 2009, CAN J FOREST RES, V39, P1606, DOI 10.1139/X09-080; Gonzalez-Polo M, 2013, ECOSYSTEMS, V16, P1025, DOI 10.1007/s10021-013-9665-0; Harmon ME, 2013, FOREST ECOL MANAG, V291, P259, DOI 10.1016/j.foreco.2012.11.046; HARMON ME, 1986, ADV ECOL RES, V15, P133, DOI 10.1016/S0065-2504(08)60121-X; Harmon ME, 2000, CAN J FOREST RES, V30, P76, DOI 10.1139/cjfr-30-1-76; He W, 2016, ECOSYSTEMS, V19, P115, DOI 10.1007/s10021-015-9921-6; He W, 2015, PLANT SOIL, V393, P109, DOI 10.1007/s11104-015-2479-4; Heilmann-Clausen J, 2001, MYCOL RES, V105, P575, DOI 10.1017/S0953756201003665; Herve V, 2014, ENVIRON MICROBIOL, V16, P2238, DOI 10.1111/1462-2920.12347; Hillebrand H, 2009, ECOL LETT, V12, P1405, DOI 10.1111/j.1461-0248.2009.01388.x; Hoppe B, 2015, SCI REP-UK, V5, DOI 10.1038/srep09456; Jomura M, 2007, TELLUS B, V59, P211, DOI 10.1111/j.1600-0889.2006.00234.x; Jonsson Bengt Gunnar, 2005, SILVA FENNICA, V2, P289; Jousset A, 2011, ECOL LETT, V14, P537, DOI 10.1111/j.1461-0248.2011.01613.x; Juhl H. B., 2012, P 11 ICOM CC C WAT O, P343; Knoblauch C, 2008, SOIL BIOL BIOCHEM, V40, P3004, DOI 10.1016/j.soilbio.2008.08.020; Kubartova A, 2012, MOL ECOL, V21, P4514, DOI 10.1111/j.1365-294X.2012.05723.x; Kubartova A, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv032; Marra JL, 1996, CAN J FOREST RES, V26, P1337, DOI 10.1139/x26-149; Moore-Kucera J, 2008, MICROB ECOL, V55, P500, DOI 10.1007/s00248-007-9295-1; Ni XY, 2015, GEODERMA, V241, P136, DOI 10.1016/j.geoderma.2014.11.018; Norros V, 2015, ECOL EVOL, V5, P3312, DOI 10.1002/ece3.1589; Orwin KH, 2016, FUNCT ECOL, V30, P1430, DOI 10.1111/1365-2435.12610; PARAMESWARAN N, 1976, European Journal of Forest Pathology, V6, P274; Potthoff M, 2005, SOIL BIOL BIOCHEM, V37, P1259, DOI 10.1016/j.soilbio.2004.11.022; Prewitt L, 2014, MICROB ECOL, V68, P212, DOI 10.1007/s00248-014-0396-3; Rouvinen S, 2002, CAN J FOREST RES, V32, P2184, DOI 10.1139/X02-144; RYAN MG, 1995, OECOLOGIA, V101, P133, DOI 10.1007/BF00317276; Schadt CW, 2003, SCIENCE, V301, P1359, DOI 10.1126/science.1086940; Schimel JP, 1996, SOIL BIOL BIOCHEM, V28, P1061, DOI 10.1016/0038-0717(96)00083-1; Shorohova E, 2014, FOREST ECOL MANAG, V315, P185, DOI 10.1016/j.foreco.2013.12.016; Shorohova E, 2014, FOREST ECOL MANAG, V315, P173, DOI 10.1016/j.foreco.2013.12.025; Shortle WC, 2012, 97 NRS; Strukelj M, 2013, CAN J FOREST RES, V43, P785, DOI 10.1139/cjfr-2013-0086; SWIFT MJ, 1979, DECOMPOSITION TERRES, DOI DOI 10.1007/S00442-002-0987-4; TAYLOR BR, 1989, ECOLOGY, V70, P97, DOI 10.2307/1938416; Toljander YK, 2006, OECOLOGIA, V148, P625, DOI 10.1007/s00442-006-0406-3; Wang B, 2016, HYDROL PROCESS, V30, P692, DOI 10.1002/hyp.10613; Wang CK, 2002, OECOLOGIA, V132, P374, DOI 10.1007/s00442-002-0987-4; Wardle DA, 2015, OIKOS, V124, P285, DOI 10.1111/oik.01584; Wei H, 2014, SOIL BIOL BIOCHEM, V71, P1, DOI 10.1016/j.soilbio.2014.01.003; Wilkinson SC, 2002, SOIL BIOL BIOCHEM, V34, P189, DOI 10.1016/S0038-0717(01)00168-7; Wu FZ, 2011, AFR J MICROBIOL RES, V5, P5575, DOI 10.5897/AJMR11.288; Xiao S, 2016, ACTA ECOLOGICA SINIC, V5, P1; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Yang WQ, 2005, PEDOSPHERE, V15, P653; YONEDA T, 1975, Japanese Journal of Ecology, V25, P40	62	8	11	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182576	10.1371/journal.pone.0182576	http://dx.doi.org/10.1371/journal.pone.0182576			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28787465	Green Published, gold, Green Submitted			2022-12-26	WOS:000406998800045
J	Glimcher, PW; Tymula, A				Glimcher, Paul W.; Tymula, Agnieszka			Let the sunshine in? The effects of luminance on economic preferences, choice consistency and dominance violations	PLOS ONE			English	Article							SEASONAL AFFECTIVE-DISORDER; POSITIVE AFFECT; RISK-AVERSION; CIRCADIAN CLOCKS; SUBJECTIVE VALUE; DECISION-MAKING; MOOD DISORDERS; CLIMATE-CHANGE; LIGHT THERAPY; DEPRESSION	Weather, in particular the intensity and duration of sunshine (luminance), has been shown to significantly affect financial markets. Yet, because of the complexity of market interactions we do not know how human behavior is affected by luminance in a way that could inform theoretical choice models. In this paper, we use data from a field study using an incentive-compatible, decision task conducted daily over a period of two years and from the US Earth System Research Laboratory luminance sensor to investigate the impact of luminance on risk preferences, ambiguity preferences, choice consistency and dominance violations. We find that luminance levels affect all of these. Age and gender influence the strength of some of these effects.	[Glimcher, Paul W.; Tymula, Agnieszka] NYU, Inst Study Decis Making, 550 1St Ave, New York, NY 10003 USA; [Tymula, Agnieszka] Univ Sydney, Sch Econ, Sydney, NSW, Australia	New York University; University of Sydney	Tymula, A (corresponding author), NYU, Inst Study Decis Making, 550 1St Ave, New York, NY 10003 USA.; Tymula, A (corresponding author), Univ Sydney, Sch Econ, Sydney, NSW, Australia.	agnieszka.tymula@sydney.edu.au		Tymula, Agnieszka/0000-0002-0521-8477; Glimcher, Paul/0000-0001-7872-3856	National Institutes of Health [1RC1LM010491-01]; NATIONAL EYE INSTITUTE [P30EY013079] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [RC1LM010491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This research was funded through a grant from the National Institutes of Health awarded to the Marian Koshland Science Museum of the National Academy of Sciences (grant number 1RC1LM010491-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Marian Koshland Science Museum of the U. S. National Academy of Sciences, and in particular Monique McIlwain and Erika Shugart, who supported us in data collection for this project. This work was supported by a grant from the National Institutes of Health awarded to the Marian Koshland Science Museum of the National Academy of Sciences (grant number 1RC1LM010491-01).	Baillon A, 2014, SADDER BUT WISER EFF; Bartra O, 2013, NEUROIMAGE, V76, P412, DOI 10.1016/j.neuroimage.2013.02.063; Bassi A, 2013, REV FINANC STUD, V26, P1824, DOI 10.1093/rfs/hht004; BLESS H, 1992, J PERS SOC PSYCHOL, V63, P585, DOI 10.1037/0022-3514.63.4.585; Borghans L, 2009, J EUR ECON ASSOC, V7, P649, DOI 10.1162/JEEA.2009.7.2-3.649; Bradshaw WE, 2010, ANNU REV PHYSIOL, V72, P147, DOI 10.1146/annurev-physiol-021909-135837; Burnett S, 2010, COGNITIVE DEV, V25, P183, DOI 10.1016/j.cogdev.2009.11.003; CAMERER C, 1992, J RISK UNCERTAINTY, V5, P325, DOI 10.1007/BF00122575; Castillo M, 2014, SLEEPINESS CHOICE CO; DEYKIN EY, 1987, AM J PUBLIC HEALTH, V77, P178, DOI 10.2105/AJPH.77.2.178; ELLSBERG D, 1961, Q J ECON, V75, P643, DOI 10.2307/1884324; Ferrara M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120029; Fonken LK, 2010, P NATL ACAD SCI USA, V107, P18664, DOI 10.1073/pnas.1008734107; Forgas JP, 2009, J EXP SOC PSYCHOL, V45, P254, DOI 10.1016/j.jesp.2008.08.014; Gamble JL, 2013, ENVIRON HEALTH PERSP, V121, P15, DOI [10.1289/ehp.1205223, 10.1289/ehp.121-a15]; GILBOA I, 1989, J MATH ECON, V18, P141, DOI 10.1016/0304-4068(89)90018-9; Golden RN, 2005, AM J PSYCHIAT, V162, P656, DOI 10.1176/appi.ajp.162.4.656; GREENE TR, 1988, PSYCHOL REP, V63, P895, DOI 10.2466/pr0.1988.63.3.895; Harrison G.W, 2008, 0612 U CENTR FLOR DE; Harvey AG, 2011, ANNU REV CLIN PSYCHO, V7, P297, DOI 10.1146/annurev-clinpsy-032210-104550; Hicks BB, 1996, B AM METEOROL SOC, V77, P2857, DOI 10.1175/1520-0477(1996)077<2857:TNISIS>2.0.CO;2; Hirshleifer D, 2003, J FINANC, V58, P1009, DOI 10.1111/1540-6261.00556; Hirt ER, 1996, J PERS SOC PSYCHOL, V71, P245, DOI 10.1037/0022-3514.71.2.245; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; ISEN AM, 1988, J PERS SOC PSYCHOL, V55, P710, DOI 10.1037/0022-3514.55.5.710; ISEN AM, 1983, ORGAN BEHAV HUM PERF, V31, P194, DOI 10.1016/0030-5073(83)90120-4; ISEN AM, 1987, ORGAN BEHAV HUM DEC, V39, P145, DOI 10.1016/0749-5978(87)90034-3; ISEN AM, 1992, MOTIV EMOTION, V16, P65, DOI 10.1007/BF00996487; JOHNSON EJ, 1983, J PERS SOC PSYCHOL, V45, P20, DOI 10.1037/0022-3514.45.1.20; Kamstra M, 2016, J FINANC QUANT ANAL; Kamstra MJ, 2014, REV ASSET PRICING ST, V4, P39, DOI 10.1093/rapstu/rau002; Kamstra MJ, 2003, AM ECON REV, V93, P324, DOI 10.1257/000282803321455322; Khan MR, 2009, ARCH PEDIAT ADOL MED, V163, P644, DOI 10.1001/archpediatrics.2009.95; Knight, 1933, RISK UNCERTAINTY PRO; Kocifaj M, 2010, LIGHTING RES TECHNOL, V42, P149, DOI 10.1177/1477153509355507; Kramer LA, 2012, SOC PSYCHOL PERS SCI, V3, P193, DOI 10.1177/1948550611415694; Lambert GW, 2002, LANCET, V360, P1840, DOI 10.1016/S0140-6736(02)11737-5; Levi F, 2007, ANNU REV PHARMACOL, V47, P593, DOI 10.1146/annurev.pharmtox.47.120505.105208; Levy DJ, 2011, J NEUROSCI, V31, P14693, DOI 10.1523/JNEUROSCI.2218-11.2011; Levy DJ, 2013, PLOS ONE, P8; Levy I, 2010, J NEUROPHYSIOL, V103, P1036, DOI 10.1152/jn.00853.2009; LEWY AJ, 1987, SCIENCE, V235, P352, DOI 10.1126/science.3798117; Li R, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01519; Li Z, 2002, NATURE, V376, P486; Lo K, 2008, SSRN ELIBRARY; MACKIE DM, 1989, J PERS SOC PSYCHOL, V57, P27, DOI 10.1037/0022-3514.57.1.27; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Molin J, 1996, J AFFECT DISORDERS, V37, P151, DOI 10.1016/0165-0327(95)00090-9; Pham MT, 2007, REV GEN PSYCHOL, V11, P155, DOI 10.1037/1089-2680.11.2.155; Roecklein Kathryn A, 2005, Psychiatry (Edgmont), V2, P20; SAUNDERS EM, 1993, AM ECON REV, V83, P1337; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Symmonds M, 2010, PLOS ONE, P5; TERMAN M, 1989, NEUROPSYCHOPHARMACOL, V2, P1, DOI 10.1016/0893-133X(89)90002-X; Tymula A, 2013, P NATL ACAD SCI USA, V110, P17143, DOI 10.1073/pnas.1309909110; Tymula A, 2012, P NATL ACAD SCI USA, V109, P17135, DOI 10.1073/pnas.1207144109; Vandewalle G, 2007, PLOS ONE, P2; Vandewalle G, 2009, TRENDS COGN SCI, V13, P429, DOI 10.1016/j.tics.2009.07.004; von Gaudecker HM, 2011, AM ECON REV, V101, P664, DOI 10.1257/aer.101.2.664; Watson E, 2012, INT J MANAG FINANC, V8, P238, DOI 10.1108/17439131211238888; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Wilson K, 2010, CAN J PSYCHIAT, V55, P577, DOI 10.1177/070674371005500906; Xu AJ, 2015, P NATL ACAD SCI US; Yamada H, 2013, P NATL ACAD SCI USA, P110	64	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0181112	10.1371/journal.pone.0181112	http://dx.doi.org/10.1371/journal.pone.0181112			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC6IS	28783734	Green Published, Green Submitted, gold			2022-12-26	WOS:000406944300006
J	Zhang, ZH; Xie, DD; Xu, S; Xia, MZ; Zhang, ZQ; Geng, H; Chen, L; Wang, DM; Wei, W; Yu, DX; Xu, DX				Zhang, Zhi-Hui; Xie, Dong-Dong; Xu, Shen; Xia, Mi-Zhen; Zhang, Zhi-Qiang; Geng, Hao; Chen, Lei; Wang, Da-Ming; Wei, Wei; Yu, De-Xin; Xu, De-Xiang			Total glucosides of paeony inhibits lipopolysaccharide-induced proliferation, migration and invasion in androgen insensitive prostate cancer cells	PLOS ONE			English	Article							KAPPA-B PATHWAY; SIGNALING PATHWAY; INTERLEUKIN-8 EXPRESSION; INDEPENDENT GROWTH; ADJUVANT ARTHRITIS; SUPPRESSES GROWTH; TUMOR-GROWTH; TNF-ALPHA; IN-VIVO; PROGRESSION	Previous studies demonstrated that inflammatory microenvironment promoted prostate cancer progression. This study investigated whether total glucosides of paeony (TGP), the active constituents extracted from the root of Paeonia Lactiflora Pall, suppressed lipopolysaccharide (LPS)-stimulated proliferation, migration and invasion in androgen insensitive prostate cancer cells. PC-3 cells were incubated with LPS (2.0 mu g/mL) in the absence or presence of TGP (312.5 mu g/mL). As expected, cells at S phase and nuclear CyclinD1, the markers of cell proliferation, were increased in LPS-stimulated PC-3 cells. Migration activity, as determined by wound-healing assay and transwell migration assay, and invasion activity, as determined by transwell invasion assay, were elevated in LPS-stimulated PC-3 cells. Interestingly, TGP suppressed LPS-stimulated PC-3 cells proliferation. Moreover, TGP inhibited LPS-stimulated migration and invasion of PC-3 cells. Additional experiment showed that TGP inhibited activation of nuclear factor kappa B (NF-kappa B) and mitogen-activated protein kinase (MAPK)/p38 in LPS-stimulated PC-3 cells. Correspondingly, TGP attenuated upregulation of interleukin (IL)-6 and IL-8 in LPS-stimulated PC-3 cells. In addition, TGP inhibited nuclear translocation of signal transducer and activator of transcription 3 (STAT3) in LPS-stimulated PC-3 cells. These results suggest that TGP inhibits inflammation-associated STAT3 activation and proliferation, migration and invasion in androgen insensitive prostate cancer cells.	[Zhang, Zhi-Hui; Xu, De-Xiang] Anhui Med Univ, Sch Publ Hlth, Dept Toxicol, Hefei, Anhui, Peoples R China; [Xie, Dong-Dong; Xu, Shen; Zhang, Zhi-Qiang; Geng, Hao; Chen, Lei; Wang, Da-Ming; Yu, De-Xin] Anhui Med Univ, Affiliated Hosp 2, Dept Urol, Hefei, Anhui, Peoples R China; [Xia, Mi-Zhen] Anhui Med Univ, Sch Biol Sci, Hefei, Anhui, Peoples R China; [Wei, Wei] Anhui Med Univ, Inst Clin Pharmacol, Key Lab Antiinflammatory & Immunopharmacol, Educ Minist, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University; Anhui Medical University	Xu, DX (corresponding author), Anhui Med Univ, Sch Publ Hlth, Dept Toxicol, Hefei, Anhui, Peoples R China.; Yu, DX (corresponding author), Anhui Med Univ, Affiliated Hosp 2, Dept Urol, Hefei, Anhui, Peoples R China.	yudx_urology@126.com; xudex@126.com	yu, dexin/AAZ-7955-2021; wei, wei/HHR-8613-2022; zhang, zh/GWV-4677-2022		Health and Family Planning Commission Foundation of Anhui Province [2014zy31]	Health and Family Planning Commission Foundation of Anhui Province	This project was supported by Health and Family Planning Commission Foundation of Anhui Province (2014zy31), http://ahtcm.ahwjw.gov.on.	Al-Asmari AK, 2016, INDIAN J PHARMACOL, V48, P537, DOI 10.4103/0253-7613.190742; Araki S, 2007, CANCER RES, V67, P6854, DOI 10.1158/0008-5472.CAN-07-1162; Barton BE, 2004, MOL CANCER THER, V3, P11; Burger M, 2005, ONCOGENE, V24, P2067, DOI 10.1038/SJ.ONC.1208442; Canesin G, 2016, EUR UROL, V69, P400, DOI 10.1016/j.eururo.2015.06.016; Caruso DJ, 2008, CLIN CANCER RES, V14, P4111, DOI 10.1158/1078-0432.CCR-08-0738; Fallowfield L, 2016, NAT REV CLIN ONCOL, V13, P643, DOI 10.1038/nrclinonc.2016.100; Ferraldeschi R, 2015, ONCOGENE, V34, P1745, DOI 10.1038/onc.2014.115; Gao LF, 2005, CLIN CANCER RES, V11, P6333, DOI 10.1158/1078-0432.CCR-05-0148; Gu L, 2014, MOL CANCER THER, V13, P1246, DOI 10.1158/1535-7163.MCT-13-0605; Guo YQ, 2012, CANCER TREAT REV, V38, P904, DOI 10.1016/j.ctrv.2012.04.007; Hayes JH, 2014, JAMA-J AM MED ASSOC, V311, P1143, DOI 10.1001/jama.2014.2085; Hu MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124668; Hu SY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-30; Huang HF, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-2; Huang SY, 2001, ONCOGENE, V20, P4188, DOI 10.1038/sj.onc.1204535; Inoue K, 2000, CLIN CANCER RES, V6, P2104; Ito Y, 2015, PROSTATE, V75, P1009, DOI 10.1002/pros.22972; Izumi K, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26853; Jayatilaka H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15584; Jin RJ, 2008, CANCER RES, V68, P6762, DOI 10.1158/0008-5472.CAN-08-0107; Jin RJ, 2014, CANCER RES, V74, P2763, DOI 10.1158/0008-5472.CAN-13-2543; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Khan Asima, 2012, Postepy Biochem, V58, P492; Lee SO, 2003, CLIN CANCER RES, V9, P370; Lin DL, 2001, CLIN CANCER RES, V7, P1773; Maxwell PJ, 2014, ONCOTARGET, V5, P4895, DOI 10.18632/oncotarget.2052; Maxwell PJ, 2013, EUR UROL, V64, P177, DOI 10.1016/j.eururo.2012.08.032; McCall P, 2012, BRIT J CANCER, V107, P1554, DOI 10.1038/bjc.2012.372; Michalaki V, 2004, BRIT J CANCER, V90, P2312, DOI 10.1038/sj.bjc.6601814; Mistry T, 2007, EUR UROL, V52, P46, DOI 10.1016/j.eururo.2007.03.054; Murphy C, 2005, CLIN CANCER RES, V11, P4117, DOI 10.1158/1078-0432.CCR-04-1518; Nabbi Arash, 2015, Cold Spring Harb Protoc, V2015, P769, DOI 10.1101/pdb.prot083733; Ni Z, 2000, CANCER RES, V60, P1225; Pin E, 2016, MOL ONCOL, V10, P1585, DOI 10.1016/j.molonc.2016.09.007; Sharma J, 2014, PROSTATE, V74, P820, DOI 10.1002/pros.22788; Smith PC, 2001, CYTOKINE GROWTH F R, V12, P33, DOI 10.1016/S1359-6101(00)00021-6; Stark JR, 2009, INT J CANCER, V124, P2683, DOI 10.1002/ijc.24241; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; Thapa D, 2015, BIOCHEM PHARMACOL, V94, P53, DOI 10.1016/j.bcp.2014.12.023; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wallner L, 2006, CANCER RES, V66, P3087, DOI 10.1158/0008-5472.CAN-05-3447; Wang M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11503; Wang YN, 2016, INT IMMUNOPHARMACOL, V36, P67, DOI 10.1016/j.intimp.2016.04.010; Xia MZ, 2012, J PINEAL RES, V53, P325, DOI 10.1111/j.1600-079X.2012.01002.x; Xu HM, 2007, J ETHNOPHARMACOL, V109, P442, DOI 10.1016/j.jep.2006.08.019; Xu XX, 2014, PHYTOMEDICINE, V21, P815, DOI 10.1016/j.phymed.2013.12.003; Zhang JW, 2016, ANTIOXID REDOX SIGN, V24, P575, DOI 10.1089/ars.2015.6418; Zhang L, 2008, CLIN CANCER RES, V14, P559, DOI 10.1158/1078-0432.CCR-07-1176; Zhang YM, 2014, CANCER-AM CANCER SOC, V120, P3208, DOI 10.1002/cncr.28796; Zheng YQ, 2005, INT IMMUNOPHARMACOL, V5, P1560, DOI 10.1016/j.intimp.2005.03.010; Zhou Z, 2012, INT IMMUNOPHARMACOL, V14, P275, DOI 10.1016/j.intimp.2012.07.012; Zhu QJ, 2016, INT UROL NEPHROL, V48, P1873, DOI 10.1007/s11255-016-1345-5	53	18	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0182584	10.1371/journal.pone.0182584	http://dx.doi.org/10.1371/journal.pone.0182584			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28783760	Green Published, gold, Green Submitted			2022-12-26	WOS:000406944300043
J	Plissonnier, ML; Lahlali, T; Raab, M; Michelet, M; Romero-Lopez, C; Rivoire, M; Strebhardt, K; Durantel, D; Levrero, M; Mehlen, P; Zoulim, F; Parent, R				Plissonnier, M-L; Lahlali, T.; Raab, M.; Michelet, M.; Romero-Lopez, C.; Rivoire, M.; Strebhardt, K.; Durantel, D.; Levrero, M.; Mehlen, P.; Zoulim, F.; Parent, R.			Reciprocal antagonism between the netrin-1 receptor uncoordinated-phenotype-5A (UNC5A) and the hepatitis C virus	ONCOGENE			English	Article							HEPATOCELLULAR-CARCINOMA; DAP-KINASE; ENDOPLASMIC-RETICULUM; TUMOR SUPPRESSORS; GENE-EXPRESSION; AUTOPHAGY; REPLICATION; DEPENDENCE; PARTICLES; APOPTOSIS	Hepatitis C virus (HCV) infection is a leading cause of hepatocellular carcinoma (HCC), mainly through cirrhosis induction, spurring research for a deeper understanding of HCV versus host interactions in cirrhosis. The present study investigated crosstalks between HCV infection and UNC5A, a netrin-1 dependence receptor that is inactivated in cancer. UNC5A and HCV parameters were monitored in patients samples (n = 550) as well as in in vitro. In patients, UNC5A mRNA expression is significantly decreased in clinical HCV(+) specimens irrespective of the viral genotype, but not in (HBV)(+) liver biopsies, as compared to uninfected samples. UNC5A mRNA is downregulated in F2 (3-fold; P = 0.009), in F3 (10-fold, P = 0.0004) and more dramatically so in F4/cirrhosis (44-fold; P < 0.0001) histological stages of HCV(+) hepatic lesions compared to histologically matched HCV(-) tissues. UNC5A transcript was found strongly downregulated in HCC samples (33-fold; P < 0.0001) as compared with non-HCC samples. In vivo, association of UNC5A transcripts with polyribosomes is decreased by 50% in HCV(+) livers. Consistent results were obtained in vitro showing HCV-dependent depletion of UNC5A in HCV-infected hepatocyte-like cells and in primary human hepatocytes. Using luciferase reporter constructs, HCV cumulatively decreased UNC5A transcription from the UNC5 promoter and translation in a UNC5A 5'UTR-dependent manner. Proximity ligation assays, kinase assays, as well as knockdown and forced expression experiments identified UNC5A as capable of impeding autophagy and promoting HCV restriction through specific impact on virion infectivity, in a cell death-independent and DAPK-related manner. In conclusion, while the UNC5A dependence receptor counteracts HCV persistence through regulation of autophagy in a DAPK-dependent manner, it is dramatically decreased in all instances in HCC samples, and specifically by HCV in cirrhosis. Such data argue for the evaluation of the implication of UNC5A in liver carcinogenesis.	[Plissonnier, M-L; Lahlali, T.; Michelet, M.; Durantel, D.; Zoulim, F.; Parent, R.] Ctr Rech Cancerol Lyon, Pathogenesis Hepatitis B&C Equipe Labellisee LabE, INSERM U1052, 151 Cours Albert Thomas, F-69424 Lyon, France; [Plissonnier, M-L; Lahlali, T.; Michelet, M.; Durantel, D.; Levrero, M.; Mehlen, P.; Zoulim, F.; Parent, R.] Univ Lyon, Lyon, France; [Plissonnier, M-L; Lahlali, T.; Michelet, M.; Durantel, D.; Levrero, M.; Mehlen, P.; Zoulim, F.; Parent, R.] Univ Lyon 1, ISPB, Lyon, France; [Plissonnier, M-L; Lahlali, T.; Michelet, M.; Durantel, D.; Levrero, M.; Zoulim, F.; Parent, R.] Ctr Rech Cancerol Lyon, CNRS UMR5286, Lyon, France; [Raab, M.; Strebhardt, K.] Goethe Univ, D-60590 Frankfurt, Germany; [Raab, M.; Strebhardt, K.] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany; [Romero-Lopez, C.] Inst Parasitol & Biomed Lopez Neyra, Ave Conocimiento S-N, Armilla, Spain; [Rivoire, M.; Mehlen, P.] Ctr Leon Berard, Lyon, France; [Levrero, M.] Epigenet & Epigenom Hepatocellular Carcinoma, Lyon, France; [Levrero, M.; Zoulim, F.] Hosp Civils Lyon, Serv Hepatogastroenterol, Lyon, France; [Levrero, M.; Mehlen, P.] Ctr Rech Cancerol Lyon, INSERM U1052, Lyon, France; [Mehlen, P.] LabEx DEVweCAN, Apoptosis Canc & Dev Lab Equipe Labellisee La Lig, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UNICANCER; Centre Leon Berard; Goethe University Frankfurt; Helmholtz Association; German Cancer Research Center (DKFZ); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); UNICANCER; Centre Leon Berard; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard	Parent, R (corresponding author), Ctr Rech Cancerol Lyon, Pathogenesis Hepatitis B&C Equipe Labellisee LabE, INSERM U1052, 151 Cours Albert Thomas, F-69424 Lyon, France.	romain.parent@inserm.fr	Durantel, David/I-4639-2018; Zoulim, Fabien/ABD-5594-2021; Strebhardt, Klaus/E-8765-2011; Romero-López, Cristina/G-8282-2015; Parent, Romain/N-7115-2017; Plissonnier, Marie-Laure/Y-9491-2019; Levrero, Massimo/G-5680-2016	Durantel, David/0000-0002-9226-3419; Zoulim, Fabien/0000-0002-2245-0083; Romero-López, Cristina/0000-0001-9818-0529; Parent, Romain/0000-0002-3645-7008; Plissonnier, Marie-Laure/0000-0003-4879-4586; Levrero, Massimo/0000-0002-4978-0875; Strebhardt, Klaus/0000-0003-2173-9763	European Union [248364]; LYric Grant [INCa-DGOS-4664]; French National Agency for AIDS and Viral Hepatitis Research (ANRS) [2011-379]; French Ligue Contre Le Cancer; DevWeCan French Laboratories of Excellence Network (Labex) [ANR-10-LABX-61]	European Union(European Commission); LYric Grant; French National Agency for AIDS and Viral Hepatitis Research (ANRS)(ANRSFrench National Research Agency (ANR)); French Ligue Contre Le Cancer(Ligue nationale contre le cancer); DevWeCan French Laboratories of Excellence Network (Labex)	This study was supported by the European Union (Marie Curie International Reintegration Grant #248364), The LYric Grant (INCa-DGOS-4664), The French National Agency for AIDS and Viral Hepatitis Research (ANRS, Grant #2011-379), The French Ligue Contre Le Cancer and The DevWeCan French Laboratories of Excellence Network (Labex, Grant #ANR-10-LABX-61). We thank T. Wakita (National Institute of Infectious Diseases, Japan), CM Rice (The Rockefeller University, NY, USA) and F Helle (Inserm, France) for Huh7.5 cells and HCV strains.	ANRS Collaborative Study Grp, 2016, J HEPATOL, V65, P734, DOI 10.1016/j.jhep.2016.05.045; Bartoe JL, 2006, J NEUROSCI, V26, P3192, DOI 10.1523/JNEUROSCI.3469-05.2006; Bialik S, 2010, CURR OPIN CELL BIOL, V22, P199, DOI 10.1016/j.ceb.2009.11.004; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Bredesen DE, 2005, CELL DEATH DIFFER, V12, P1031, DOI 10.1038/sj.cdd.4401680; Buehler E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051942; Chang TH, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S4; Conti F, 2016, J HEPATOL, V65, P727, DOI 10.1016/j.jhep.2016.06.015; Dash S, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8050150; Delgrange D, 2007, J GEN VIROL, V88, P2495, DOI 10.1099/vir.0.82872-0; Dreux M, 2009, AUTOPHAGY, V5, P1224, DOI 10.4161/auto.5.8.10219; Dreux M, 2009, P NATL ACAD SCI USA, V106, P14046, DOI 10.1073/pnas.0907344106; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Forcet C, 2002, NATURE, V417, P443, DOI 10.1038/nature748; Grolleau A, 2002, J BIOL CHEM, V277, P22175, DOI 10.1074/jbc.M202014200; Guenebeaud C, 2010, MOL CELL, V40, P863, DOI 10.1016/j.molcel.2010.11.021; Helle F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070809; Hibi K, 2012, HEPATO-GASTROENTEROL, V59, P2573, DOI 10.5754/hge10616; Huang H, 2013, AUTOPHAGY, V9, P175, DOI 10.4161/auto.22791; Kohli A, 2014, JAMA-J AM MED ASSOC, V312, P631, DOI 10.1001/jama.2014.7085; Levin-Salomon V, 2014, APOPTOSIS, V19, P346, DOI 10.1007/s10495-013-0918-3; Li MMH, 2015, TRENDS CELL BIOL, V25, P320, DOI 10.1016/j.tcb.2015.02.001; Lindenbach Brett D., 2009, V510, P329, DOI 10.1007/978-1-59745-394-3_24; Llambi F, 2005, EMBO J, V24, P1192, DOI 10.1038/sj.emboj.7600584; Llambi F, 2001, EMBO J, V20, P2715, DOI 10.1093/emboj/20.11.2715; Llovet JM, 2016, NAT REV GASTRO HEPAT, V13, P561, DOI 10.1038/nrgastro.2016.140; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Mehlen P, 2011, NAT REV CANCER, V11, P188, DOI 10.1038/nrc3005; Mehlen P, 2010, CURR OPIN ONCOL, V22, P46, DOI 10.1097/CCO.0b013e328333dcd1; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Mohl BP, 2016, J GEN VIROL, V97, P680, DOI 10.1099/jgv.0.000387; Paradisi A, 2008, GASTROENTEROLOGY, V135, P1248, DOI 10.1053/j.gastro.2008.06.080; Parent R, 2007, CANCER RES, V67, P4337, DOI 10.1158/0008-5472.CAN-06-3640; Parent R, 2009, HEPATOLOGY, V49, P1798, DOI 10.1002/hep.22852; Parent R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r19; Picard M, 2009, CELL SIGNAL, V21, P1961, DOI 10.1016/j.cellsig.2009.09.004; Plissonnier ML, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002421; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Romanowski T, 2008, MED SCI MONITOR, V14, pBR147; ROSENFELD MG, 1982, J CELL BIOL, V93, P135, DOI 10.1083/jcb.93.1.135; Sainz B, 2006, J VIROL, V80, P10253, DOI 10.1128/JVI.01059-06; Shrivastava S, 2012, J VIROL, V86, P8705, DOI 10.1128/JVI.00616-12; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Stephens SB, 2007, METHOD ENZYMOL, V431, P47, DOI 10.1016/S0076-6879(07)31004-5; Stevens C, 2009, J BIOL CHEM, V284, P334, DOI 10.1074/jbc.M805165200; Stohr S, 2016, GUT, V65, P2017, DOI 10.1136/gutjnl-2014-308971; Tanida I, 2009, AUTOPHAGY, V5, P937, DOI 10.4161/auto.5.7.9243; Thiebault K, 2003, P NATL ACAD SCI USA, V100, P4173, DOI 10.1073/pnas.0738063100; Thomas DL, 2013, NAT MED, V19, P850, DOI 10.1038/nm.3184; Tian Y, 2015, CELL DEATH DIFFER, V22, P1025, DOI 10.1038/cdd.2014.201; Trinchet JC, 2015, HEPATOLOGY, V62, P737, DOI 10.1002/hep.27743; van der Meer AJ, 2017, J HEPATOL, V66, P485, DOI 10.1016/j.jhep.2016.10.017; Weil D, 2000, RNA, V6, P962, DOI 10.1017/S1355838200000479; Yanagi M, 1997, P NATL ACAD SCI USA, V94, P8738, DOI 10.1073/pnas.94.16.8738	55	7	7	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 30	2017	36	48					6712	6724		10.1038/onc.2017.271	http://dx.doi.org/10.1038/onc.2017.271			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FO4AJ	28783179				2022-12-26	WOS:000416780800006
J	Ikezoe, K; Handa, T; Tanizawa, K; Chen-Yoshikawa, TF; Kubo, T; Aoyama, A; Motoyama, H; Hijiya, K; Tokuda, S; Nakatsuka, Y; Yamamoto, Y; Oshima, A; Harashima, S; Nagai, S; Hirai, T; Date, H; Chin, K				Ikezoe, Kohei; Handa, Tomohiro; Tanizawa, Kiminobu; Chen-Yoshikawa, Toyofumi F.; Kubo, Takeshi; Aoyama, Akihiro; Motoyama, Hideki; Hijiya, Kyoko; Tokuda, Shinsaku; Nakatsuka, Yoshinari; Yamamoto, Yuko; Oshima, Ayako; Harashima, Shin-ichi; Nagai, Sonoko; Hirai, Toyohiro; Date, Hiroshi; Chin, Kazuo			Prognostic factors and outcomes in Japanese lung transplant candidates with interstitial lung disease	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; 6-MINUTE WALK TEST; HYPERSENSITIVITY PNEUMONITIS; INTERNATIONAL-SOCIETY; SURVIVAL; GUIDELINES; MORTALITY; STATEMENT; UPDATE; DIAGNOSIS	Objective Young patients with advanced interstitial lung disease (ILD) are potential candidates for cadaveric lung transplantation. This study aimed to examine clinical features, outcomes, and prognostic factors in Japanese ILD patients awaiting lung transplantation. Methods We investigated the clinical features and outcomes of 77 consecutive candidates with ILD who were referred to Kyoto University Hospital and subsequently actively listed for lung transplant in the Japan Organ Transplant Network between 2010 and 2014. Results Of the 77 candidates, 33 had idiopathic pulmonary fibrosis (IPF) and 15 had unclassifiable ILD. During the observational period, 23 patients (30%) received lung transplantations and 49 patients (64%) died before transplantation. Of the 33 patients with IPF, 13 (39%) had a family history of ILD and 13 (39%) had an inconsistent with usual interstitial pneumonia pattern on high-resolution computed tomography (HRCT). The median survival time from registration was 16.7 months, and mortality was similar among patients with IPF, unclassifiable ILD, and other ILDs. Using a multivariate stepwise Cox proportional hazards model, 6-min walking distance was shown to be an independent prognostic factor in candidates with ILD (per 10 m, hazard ratio (HR): 0.97; 95% confidence interval (CI): 0.95-0.99, p < 0.01), while lower body mass index (HR: 0.83; 95% CI: 0.72-0.95, p < 0.01) independently contributed to mortality in patients with IPF. Conclusions Japanese patients with ILD awaiting transplantation had very poor outcomes regardless of their specific diagnosis. A substantial percentage of IPF patients had an atypical HRCT pattern. 6-min walking distance in ILD patients and body mass index in IPF patients were independent predictors of mortality.	[Ikezoe, Kohei; Handa, Tomohiro; Tokuda, Shinsaku; Nakatsuka, Yoshinari; Yamamoto, Yuko; Hirai, Toyohiro] Kyoto Univ, Dept Resp Med, Grad Sch Med, Kyoto, Japan; [Tanizawa, Kiminobu; Chin, Kazuo] Kyoto Univ, Dept Resp Care & Sleep Control Med, Grad Sch Med, Kyoto, Japan; [Chen-Yoshikawa, Toyofumi F.; Aoyama, Akihiro; Motoyama, Hideki; Hijiya, Kyoko; Date, Hiroshi] Kyoto Univ, Dept Thorac Surg, Grad Sch Med, Kyoto, Japan; [Kubo, Takeshi] Kyoto Univ, Dept Diagnost Imaging & Nucl Med, Grad Sch Med, Kyoto, Japan; [Oshima, Ayako] Kyoto Univ Hosp, Dept Metab & Clin Nutr, Kyoto, Japan; [Harashima, Shin-ichi] Kyoto Univ, Dept Diabet Endocrinol & Nutr, Grad Sch Med, Kyoto, Japan; [Nagai, Sonoko] Kyoto Cent Clin, Clin Res Ctr, Kyoto, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University	Handa, T (corresponding author), Kyoto Univ, Dept Resp Med, Grad Sch Med, Kyoto, Japan.	hanta@kuhp.kyoto-u.ac.jp	Tanizawa, Kiminobu/GPC-4728-2022	Ikezoe, Kohei/0000-0003-1097-2084; Handa, Tomohiro/0000-0002-3378-6412; Tanizawa, Kiminobu/0000-0002-5719-0744	Scientific Research/Research on intractable diseases; Japan Agency for Medical Research and Development, AMED [15ek0109079h0001]; Japan Society for the Promotion of Science [17K09612]; Grants-in-Aid for Scientific Research [16K09534] Funding Source: KAKEN	Scientific Research/Research on intractable diseases; Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Scientific Research/Research on intractable diseases, the Practical Research Project for Rare Intractable Diseases from Japan Agency for Medical Research and Development, AMED no. 15ek0109079h0001 (to Tomohiro Handa), and the Japan Society for the Promotion of Science no. 17K09612 (to Tomohiro Handa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alakhras M, 2007, CHEST, V131, P1448, DOI 10.1378/chest.06-2784; Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Date H, 2016, J THORAC DIS, V8, pS631, DOI 10.21037/jtd.2016.06.38; du Bois RM, 2014, EUR RESPIR J, V43, P1421, DOI 10.1183/09031936.00131813; Eaton T, 2005, AM J RESP CRIT CARE, V171, P1150, DOI 10.1164/rccm.200405-578OC; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fischer A, 2012, LANCET, V380, P689, DOI 10.1016/S0140-6736(12)61079-4; Hamada K, 2007, CHEST, V131, P650, DOI 10.1378/chest.06-1466; Kawut SM, 2005, RESP MED, V99, P1431, DOI 10.1016/j.rmed.2005.03.007; Kim JH, 2012, TUBERC RESPIR DIS, V73, P162, DOI 10.4046/trd.2012.73.3.162; Lederer DJ, 2006, AM J RESP CRIT CARE, V174, P659, DOI 10.1164/rccm.200604-520OC; Leslie KO, 2012, ARCH PATHOL LAB MED, V136, P1366, DOI 10.5858/arpa.2011-0627-OAI; Ley B, 2012, ANN INTERN MED, V156, P684, DOI 10.7326/0003-4819-156-10-201205150-00004; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Nadrous HF, 2005, MAYO CLIN PROC, V80, P37; Nunes H, 2015, EUR RESPIR J, V45, P746, DOI 10.1183/09031936.00148613; Orens JB, 2006, J HEART LUNG TRANSPL, V25, P745, DOI 10.1016/j.healun.2006.03.011; Perez ERF, 2013, CHEST, V144, P1644, DOI 10.1378/chest.12-2685; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rasekaba T, 2009, INTERN MED J, V39, P495, DOI 10.1111/j.1445-5994.2008.01880.x; Reddy TL, 2012, EUR RESPIR J, V40, P377, DOI 10.1183/09031936.00165111; Ryerson CJ, 2013, EUR RESPIR J, V42, P750, DOI 10.1183/09031936.00131912; Sato M, 2014, GEN THORAC CARDIOVAS, V62, P594, DOI 10.1007/s11748-014-0418-6; Schuyler M, 1997, CHEST, V111, P534, DOI 10.1378/chest.111.3.534; Shin KM, 2008, RADIOLOGY, V249, P328, DOI 10.1148/radiol.2483071378; Singh SJ, 2014, EUR RESPIR J, V44, P1447, DOI 10.1183/09031936.00150414; Skolnik K, 2016, RESPIROLOGY, V21, P51, DOI 10.1111/resp.12568; Song JW, 2013, SARCOIDOSIS VASC DIF, V30, P103; Timmer SJ, 2002, CHEST, V122, P779, DOI 10.1378/chest.122.3.779; Travis WD, 2008, AM J RESP CRIT CARE, V177, P1338, DOI 10.1164/rccm.200611-1685OC; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Weill D, 2015, J HEART LUNG TRANSPL, V34, P1, DOI 10.1016/j.healun.2014.06.014; Winstone TA, 2014, CHEST, V146, P422, DOI 10.1378/chest.13-2626	34	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0183171	10.1371/journal.pone.0183171	http://dx.doi.org/10.1371/journal.pone.0183171			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800589	gold, Green Submitted, Green Published			2022-12-26	WOS:000407431800060
J	Cheng, SM; Mao, QQ; Dong, YB; Ren, J; Su, LN; Liu, JL; Liu, QM; Zhou, J; Ye, XL; Zheng, SD; Zhu, NW				Cheng, Shimeng; Mao, Qiqi; Dong, Yabing; Ren, Jie; Su, Lina; Liu, Jianlan; Liu, Qingmei; Zhou, Jing; Ye, Xiaolu; Zheng, Shudan; Zhu, Ningwen			GNB2L1 and its O-GIcNAcylation regulates metastasis via modulating epithelial-mesenchymal transition in the chemoresistance of gastric cancer	PLOS ONE			English	Article							N-ACETYLGLUCOSAMINE TRANSFERASE; SCAFFOLD PROTEIN; RESISTANCE; CARCINOMA; PROMOTES; GLCNACYLATION; PROGRESSION; PROGNOSIS; APOPTOSIS	GNB2L1 and its O-GIcNAcylation has been reported to play roles in gastric cancer metastasis. However, the roles of GNB2L1 in chemoresistance of gastric cancer has never been determined. In the present study, we found that GNB2L1 was downregulated in chemoresistant patients of gastric cancer, and observed the decrease of GNB2L1 in protein levels instead of mRNA levels in different chemoresistant gastric cancer cell lines. Further we proved that this downregulation of GNB2L1 was resulted from its elevated O-GIcNAcylation catalyzed by OGT in both cell lines and patients. Next, we investigate the function of GNB2L1 and its O-GIcNAcylation on gastric cancer metastasis during chemoresistance, and confirmed Ser124 as the major O-GIcNAcylation site on GNB2L1 that regulated its function on metastasis. Furthermore, our data demonstrated that GNB2L1 modulated EMT via regulating the translation of EMT-related proteins in the process of chemoresistance. In summary, this study indicated that GNB2L1 and its O-GIcNAcylation regulated metastasis via modulating the translation of EMT-related proteins in the chemoresistance of gastric cancer.	[Cheng, Shimeng; Mao, Qiqi; Dong, Yabing; Ren, Jie; Su, Lina; Liu, Jianlan; Liu, Qingmei; Zhou, Jing; Ye, Xiaolu; Zhu, Ningwen] Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai, Peoples R China; [Zheng, Shudan] Hainan Med Coll, Dept Physiol, Haikou, Hainan, Peoples R China	Fudan University; Hainan Medical University	Zhu, NW (corresponding author), Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai, Peoples R China.	zhuningwen@fudan.edu.cn			National Basic Research Program of China 863 Program [2014AA020705]	National Basic Research Program of China 863 Program(National Basic Research Program of ChinaNational High Technology Research and Development Program of China)	This work was supported by grants from the National Basic Research Program of China 863 Program (2014AA020705). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DR, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-22; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Chen L, 2015, CANCER RES, V75, P3832, DOI 10.1158/0008-5472.CAN-14-3690; Cheng SM, 2016, BIOCHEM BIOPH RES CO, V478, P1497, DOI 10.1016/j.bbrc.2016.08.074; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Deng JY, 2014, WORLD J GASTROENTERO, V20, P3967, DOI 10.3748/wjg.v20.i14.3967; Deng YZ, 2012, GASTROENTEROLOGY, V142, P812, DOI 10.1053/j.gastro.2011.12.046; Fang Q, 2016, MED SCI MONITOR, V22, DOI 10.12659/MSM.900688; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; Huang DS, 2016, SCI REP-UK, V6, DOI 10.1038/srep20502; Jang TJ, 2016, PATHOL RES PRACT, V212, P622, DOI 10.1016/j.prp.2016.04.002; Lv QL, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13101021; Lynch TP, 2012, J BIOL CHEM, V287, P11070, DOI 10.1074/jbc.M111.302547; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; Park SY, 2010, EMBO J, V29, P3787, DOI 10.1038/emboj.2010.254; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Ruan YY, 2012, J CLIN INVEST, V122, P2554, DOI 10.1172/JCI58488; Shibue  T., 2017, NATURE REV CLIN ONCO; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Wang NN, 2015, CANCER BIOL THER, V16, P528, DOI 10.1080/15384047.2015.1016687; Wen T, 2015, ONCOL REP, V34, P3140, DOI 10.3892/or.2015.4276; Xu JH, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-016-0487-8; Yang ZY, 2015, ONCOTARGET, V6, P5072, DOI 10.18632/oncotarget.3241; Zeng YJ, 2015, WORLD J GASTROENTERO, V21, P1628, DOI 10.3748/wjg.v21.i5.1628; Zhang B, 2015, CANCER LETT, V356, P704, DOI 10.1016/j.canlet.2014.10.016; Zhang N, 2015, BIOTECHNOLOGY APPL B; Zheng G, 1997, Zhonghua Wai Ke Za Zhi, V35, P262; Zhu QQ, 2012, MED ONCOL, V29, P985, DOI 10.1007/s12032-011-9912-1	29	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182696	10.1371/journal.pone.0182696	http://dx.doi.org/10.1371/journal.pone.0182696			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797110	Green Published, gold, Green Submitted			2022-12-26	WOS:000407396200083
J	Farizatto, KLG; Ikonne, US; Almeida, MF; Ferrari, MFR; Bahr, B				Farizatto, Karen L. G.; Ikonne, Uzoma S.; Almeida, Michael F.; Ferrari, Merari F. R.; Bahr, Ben A.			A beta(42)-mediated proteasome inhibition and associated tau pathology in hippocampus are governed by a lysosomal response involving cathepsin B: Evidence for protective crosstalk between protein clearance pathways	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; PHE-ALA-DIAZOMETHYLKETONE; IMPROVES MEMORY DEFICITS; ALZHEIMERS-DISEASE; A-BETA; ACCUMULATION DISEASES; MOUSE MODEL; WILD-TYPE; AUTOPHAGY; SYSTEM	Impaired protein clearance likely increases the risk of protein accumulation disorders including Alzheimer's disease (AD). Protein degradation through the proteasome pathway decreases with age and in AD brains, and the A beta peptide has been shown to impair proteasome function in cultured cells and in a cell-free model. Here, A beta(42) was studied in brain tissue to measure changes in protein clearance pathways and related secondary pathology. Oligomerized A beta(42) (0.5-1.5 mu M) reduced proteasome activity by 62% in hippocampal slice cultures over a 4-6-day period, corresponding with increased tau phosphorylation and reduced synaptophysin levels. Interestingly, the decrease in proteasome activity was associated with a delayed inverse effect, >2-fold increase, regarding lysosomal cathepsin B (CatB) activity. The CatB enhancement did not correspond with the A beta(42)-mediated phospho-tau alterations since the latter occurred prior to the CatB response. Hippocampal slices treated with the proteasome inhibitor lactacystin also exhibited an inverse effect on CatB activity with respect to diminished proteasome function. Lactacystin caused earlier CatB enhancement than A beta(42), and no correspondence was evident between up-regulated CatB levels and the delayed synaptic pathology indicated by the loss of pre-and postsynaptic markers. Contrasting the inverse effects on the proteasomal and lysosomal pathways by A beta(42) and lactacystin, such were not found when CatB activity was up-regulated two-fold with Z-Phe-Ala-diazomethylketone (PADK). Instead of an inverse decline, proteasome function was increased marginally in PADK-treated hippocampal slices. Unexpectedly, the proteasomal augmentation was significantly pronounced in A beta(42)-compromised slices, while absent in lactacystin-treated tissue, resulting in >2-fold improvement for nearly complete recovery of proteasome function by the CatB-enhancing compound. The PADK treatment also reduced A beta(42)-mediated tau phosphorylation and synaptic marker declines, corresponding with the positive modulation of both proteasome activity and the lysosomal CatB enzyme. These findings indicate that proteasomal stress contributes to AD-type pathogenesis and that governing such pathology occurs through crosstalk between the two protein clearance pathways.	[Farizatto, Karen L. G.; Ikonne, Uzoma S.; Almeida, Michael F.; Bahr, Ben A.] Univ North Carolina Pembroke, William C Friday Lab, Biotechnol Res & Training Ctr, Pembroke, NC 28372 USA; [Farizatto, Karen L. G.; Ferrari, Merari F. R.] Univ Sao Paulo, Inst Biosci, Dept Genet & Evolutionary Biol, Sao Paulo, SP, Brazil; [Ikonne, Uzoma S.] AT Still Univ, Sch Osteopath Med, Mesa, AZ USA	University of North Carolina; Universidade de Sao Paulo; A.T. Still University of Health Sciences	Bahr, B (corresponding author), Univ North Carolina Pembroke, William C Friday Lab, Biotechnol Res & Training Ctr, Pembroke, NC 28372 USA.	bahr@uncp.edu	Ferrari, Merari F.R./D-9159-2012; Ferrari, Merari F. R./N-1210-2019; Farizatto, Karen/ABG-8051-2020	Ferrari, Merari F.R./0000-0001-7396-2196; Ferrari, Merari F. R./0000-0001-7396-2196; Almeida, Michael F/0000-0002-0188-2717	Coins for Alzheimer's Research Trust (BAB); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2012/15495-2]; NIH RISE grant [5R25GM077634-04];  [472042/2008-4];  [471779/2010-5]	Coins for Alzheimer's Research Trust (BAB); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NIH RISE grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; 	This work was supported by the Coins for Alzheimer's Research Trust (BAB), as well as by grants 472042/2008-4 (MFRF), 471779/2010-5 (MFRF), and a graduate scholarship (KLGF) from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, and by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo grant 2012/15495-2 (MFRF). Helpful student researchers were supported by NIH RISE grant 5R25GM077634-04 to University of North Carolina - Pembroke. The funding agencies had no role in study design, data collection and analysis, or decision to publish.	Bahr BA, 1998, J COMP NEUROL, V397, P139; BAHR BA, 1995, J NEUROSCI RES, V42, P294, DOI 10.1002/jnr.490420303; Bahr BA, 2002, J NEUROCHEM, V83, P481, DOI 10.1046/j.1471-4159.2002.01192.x; Bahr BA, 2012, REJUV RES, V15, P189, DOI 10.1089/rej.2011.1282; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Bendiske J, 2003, J NEUROPATH EXP NEUR, V62, P451, DOI 10.1093/jnen/62.5.451; Bendiske J, 2002, J NEUROPATH EXP NEUR, V61, P640, DOI 10.1093/jnen/61.7.640; Bentea E, 2017, EXP NEUROL, V290, P15, DOI 10.1016/j.expneurol.2016.12.009; Bordi M, 2016, AUTOPHAGY, V12, P2467, DOI 10.1080/15548627.2016.1239003; Butler D, 2006, ANTIOXID REDOX SIGN, V8, P185, DOI 10.1089/ars.2006.8.185; Butler D, 2005, REJUV RES, V8, P227, DOI 10.1089/rej.2005.8.227; Butler D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020501; Carrard G, 2002, INT J BIOCHEM CELL B, V34, P1461, DOI 10.1016/S1357-2725(02)00085-7; Cataldo AM, 1996, J NEUROSCI, V16, P186; Cecarini V, 2007, FREE RADICAL RES, V41, P673, DOI 10.1080/10715760701286159; Cecarini V, 2014, BBA-MOL BASIS DIS, V1842, P127, DOI 10.1016/j.bbadis.2013.11.002; Cecarini V, 2012, BBA-MOL BASIS DIS, V1822, P1741, DOI 10.1016/j.bbadis.2012.07.015; Coers J, 2004, J BIOL CHEM, V279, P36397, DOI 10.1074/jbc.M401386200; Cohen-Kaplan V, 2016, INT J BIOCHEM CELL B, V79, P403, DOI 10.1016/j.biocel.2016.07.019; Di Domenico F, 2013, BBA-MOL BASIS DIS, V1832, P1249, DOI 10.1016/j.bbadis.2013.04.013; Ding QX, 2003, J NEUROCHEM, V86, P489, DOI 10.1046/j.1471-4159.2003.01885.x; Embury CM, 2017, J NEUROIMMUNE PHARM, V12, P340, DOI 10.1007/s11481-016-9721-6; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Fortun J, 2003, J NEUROSCI, V23, P10672; Gavilan E, 2015, NEUROBIOL AGING, V36, P1953, DOI 10.1016/j.neurobiolaging.2015.02.025; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hegde AN, 2017, NEUROBIOL LEARN MEM, V138, P98, DOI 10.1016/j.nlm.2016.09.003; Hook G, 2011, J ALZHEIMERS DIS, V26, P387, DOI 10.3233/JAD-2011-110101; Hook GR, 2014, J NEUROTRAUM, V31, P515, DOI [10.1089/NEU.2013.2944, 10.1089/neu.2013.2944]; Intlekofer KA, 2013, NEUROBIOL DIS, V57, P47, DOI 10.1016/j.nbd.2012.06.011; INUBUSHI T, 1994, J BIOCHEM-TOKYO, V116, P282, DOI 10.1093/oxfordjournals.jbchem.a124520; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Jeon KH, 2016, EUR J MED CHEM, V121, P433, DOI 10.1016/j.ejmech.2016.06.008; Keck S, 2003, J NEUROCHEM, V85, P115, DOI 10.1046/j.1471-4159.2003.01642.x; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; Keller JN, 2002, AGEING RES REV, V1, P279, DOI 10.1016/S1568-1637(01)00006-X; Kindy MS, 2012, J ALZHEIMERS DIS, V29, P827, DOI 10.3233/JAD-2012-111604; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; LaFerla FM, 2010, BIOCHEM SOC T, V38, P993, DOI 10.1042/BST0380993; Li XJ, 2011, NEUROBIOL DIS, V43, P4, DOI 10.1016/j.nbd.2010.11.018; Liebl MP, 2016, AM J PHYSIOL-CELL PH, V311, pC166, DOI 10.1152/ajpcell.00074.2016; Mackay EA, 1997, EUR J BIOCHEM, V244, P414, DOI 10.1111/j.1432-1033.1997.00414.x; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Menzies FM, 2017, NEURON, V93, P1015, DOI 10.1016/j.neuron.2017.01.022; Moon HY, 2016, CELL METAB, V24, P332, DOI 10.1016/j.cmet.2016.05.025; Morel E, 2017, ANNU REV PHARMACOL, V57, P375, DOI 10.1146/annurev-pharmtox-010716-104936; Mueller-Steiner S, 2006, NEURON, V51, P703, DOI 10.1016/j.neuron.2006.07.027; Myeku N, 2016, NAT MED, V22, P46, DOI 10.1038/nm.4011; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Nixon RA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008839; Oddo S, 2006, J BIOL CHEM, V281, P1599, DOI 10.1074/jbc.M507892200; Pan TH, 2008, BRAIN, V131, P1969, DOI 10.1093/brain/awm318; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Park SY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160620; Ryzhikov S, 2008, J MOL NEUROSCI, V34, P131, DOI 10.1007/s12031-007-9009-7; Sun BG, 2008, NEURON, V60, P247, DOI 10.1016/j.neuron.2008.10.001; Sun YN, 2015, J ALZHEIMERS DIS, V45, P269, DOI 10.3233/JAD-142805; Sundelof J, 2010, J ALZHEIMERS DIS, V22, P1223, DOI 10.3233/JAD-2010-101023; Tiribuzi R, 2017, J NEUROL SCI, V372, P408, DOI 10.1016/j.jns.2016.11.004; Tseng BP, 2008, NEUROBIOL AGING, V29, P1607, DOI 10.1016/j.neurobiolaging.2007.04.014; Tsubokawa T, 2006, STROKE, V37, P1888, DOI 10.1161/01.STR.0000227259.15506.24; Viswanathan K, 2012, ACS MED CHEM LETT, V3, P920, DOI 10.1021/ml300197h; Wang C, 2017, CURRENT OPI IN PRESS; Wang C, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.371641; Wisniewski ML, 2011, BBA-MOL BASIS DIS, V1812, P1664, DOI 10.1016/j.bbadis.2011.09.011; Wu JC, 2012, ACTA PHARMACOL SIN, V33, P743, DOI 10.1038/aps.2012.14; Yang DS, 2011, BRAIN, V134, P258, DOI 10.1093/brain/awq341; Zhu K, 2010, ONCOGENE, V29, P451, DOI 10.1038/onc.2009.343	70	14	14	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182895	10.1371/journal.pone.0182895	http://dx.doi.org/10.1371/journal.pone.0182895			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797057	Green Published, gold, Green Submitted			2022-12-26	WOS:000407396200113
J	Smit, B; Smulders, YM; de Waard, MC; Oudemans-van Straaten, HM; Girbes, ARJ; Eringa, EC; Spoelstra-de Man, AME				Smit, B.; Smulders, Y. M.; de Waard, M. C.; Oudemans-van Straaten, H. M.; Girbes, A. R. J.; Eringa, E. C.; Spoelstra-de Man, A. M. E.			Hyperoxia does not directly affect vascular tone in isolated arteries from mice	PLOS ONE			English	Article							CYTOCHROME-P-450 OMEGA-HYDROXYLASE; MECHANICALLY VENTILATED PATIENTS; PERIVASCULAR ADIPOSE-TISSUE; MUSCLE RESISTANCE ARTERIES; PORCINE CORONARY-ARTERIES; MOUSE CREMASTER MUSCLE; CHEEK POUCH ARTERIOLES; OXYGEN-TENSION; SKELETAL-MUSCLE; NITRIC-OXIDE	Hospitalized patients often receive oxygen supplementation, which can lead to a supraphysiological oxygen tension (hyperoxia). Hyperoxia can have hemodynamic effects, including an increase in systemic vascular resistance. This increase suggests hyperoxia-induced vasoconstriction, yet reported direct effects of hyperoxia on vessel tone have been inconsistent. Furthermore, hyperoxia-induced changes in vessel diameter have not been studied in mice, currently the most used mammal model of disease. In this study we set out to develop a pressure-myograph model using isolated vessels from mice for investigation of pathways involved in hyperoxic vasoconstriction. Isolated conduit and resistance arteries (femoral artery and gracilis arteriole, respectively) from C57BL/6 mice were exposed to normoxia (PO2 of 80 mmHg) and three levels of hyperoxia (PO2 of 215, 375 and 665 mmHg) in a no-flow pressure myograph setup. Under the different PO2 levels, dose-response agonist induced endothelium-dependent vasodilation (acetylcholine, arachidonic acid), endothelium- independent vasodilation (s-nitroprusside), as well as vasoconstriction (norepinephrine, prostaglandin F2 alpha) were examined. The investigated arteries did not respond to oxygen by a change in vascular tone. In the dose-response studies, maximal responses and EC50 values to any of the aforementioned agonists were not affected by hyperoxia either. We conclude that arteries and arterioles from healthy mice are not intrinsically sensitive to hyperoxic conditions. The present ex-vivo model is therefore not suitable for further research into mechanisms of hyperoxic vasoconstriction.	[Smit, B.; de Waard, M. C.; Oudemans-van Straaten, H. M.; Girbes, A. R. J.; Spoelstra-de Man, A. M. E.] Vrije Univ Amsterdam, Med Ctr, Dept Intens Care, Amsterdam, Netherlands; [Smulders, Y. M.] Vrije Univ Amsterdam, Med Ctr, Dept Internal Med, Amsterdam, Netherlands; [Eringa, E. C.] Vrije Univ Amsterdam, Med Ctr, Dept Physiol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Smit, B (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Intens Care, Amsterdam, Netherlands.	b.smit@vumc.nl	Eringa, Ed/ABA-3194-2021; Smulders, YM/AAG-7506-2021	de Man, Angelique/0000-0001-8738-8295; Eringa, Etto/0000-0002-9814-5149; Smit, Bob/0000-0003-0862-8014	European Society of Intensive Care Medicine NEXT Start-Up; Netherlands Organisation for Health Research and Development - Meer Kennis met Minder Dieren (MKMD) [114024107]	European Society of Intensive Care Medicine NEXT Start-Up; Netherlands Organisation for Health Research and Development - Meer Kennis met Minder Dieren (MKMD)	This study was supported by European Society of Intensive Care Medicine NEXT Start-Up grant 2014, http://www.esicm.org/NEXT/grant, receiver: AS; and The Netherlands Organisation for Health Research and Development - Meer Kennis met Minder Dieren (MKMD), project number 114024107, http://www.zonmtiw.nl/en/research-and-results/fundamental-research/programmas/programme-detail/more-knowledge-with-fewer-animals/,receiver: AS.	Anderson KJ, 2005, EUR J ANAESTH, V22, P420, DOI 10.1017/S0265021505000712; Anh Thuc Ngo, 2013, BMC Physiology, V13, P8, DOI 10.1186/1472-6793-13-8; Bak Z, 2007, ACTA PHYSIOL, V191, P15, DOI 10.1111/j.1748-1716.2007.01710.x; Bakker W, 2008, DIABETES, V57, P706, DOI 10.2337/db07-0792; Cabrales P, 2006, J APPL PHYSIOL, V100, P1181, DOI 10.1152/japplphysiol.01105.2005; Cornet AD, 2013, CRIT CARE, V17, DOI 10.1186/cc12554; de Jonge E, 2008, CRIT CARE, V12, DOI 10.1186/cc7150; Dietrich HH, 2000, AM J PHYSIOL-HEART C, V278, pH1294, DOI 10.1152/ajpheart.2000.278.4.H1294; Durand MJ, 2013, MICROCIRCULATION, V20, P239, DOI 10.1111/micc.12040; EGGERS GWN, 1962, J APPL PHYSIOL, V17, P75, DOI 10.1152/jappl.1962.17.1.75; ESKINDER H, 1990, CIRC RES, V66, P1427, DOI 10.1161/01.RES.66.5.1427; Frisbee JC, 1999, MICROVASC RES, V58, P99, DOI 10.1006/mvre.1999.2169; Frisbee JC, 2001, MICROVASC RES, V62, P271, DOI 10.1006/mvre.2001.2341; Girardis M, 2016, JAMA-J AM MED ASSOC, V316, P1583, DOI 10.1001/jama.2016.11993; Harder DR, 1996, CIRC RES, V79, P54, DOI 10.1161/01.RES.79.1.54; Hedegaard Elise R., 2011, BMC Physiology, V11, P8, DOI 10.1186/1472-6793-11-8; Hungerford JE, 2000, FASEB J, V14, P197, DOI 10.1096/fasebj.14.1.197; JACKSON WF, 1983, CIRC RES, V53, P515, DOI 10.1161/01.RES.53.4.515; JACKSON WF, 1991, MICROCIRC ENDOTH LYM, V7, P199; JACKSON WF, 1989, AM J PHYSIOL, V257, pH1565, DOI 10.1152/ajpheart.1989.257.5.H1565; JACKSON WF, 1988, AM J PHYSIOL, V255, pH711, DOI 10.1152/ajpheart.1988.255.4.H711; JACKSON WF, 1993, AM J PHYSIOL, V265, pH599, DOI 10.1152/ajpheart.1993.265.2.H599; JACKSON WF, 1986, AM J PHYSIOL, V250, P1102, DOI 10.1152/ajpheart.1986.250.6.H1102; JACKSON WF, 1987, AM J PHYSIOL, V253, pH1120, DOI 10.1152/ajpheart.1987.253.5.H1120; Jackson WF, 2016, J PHYSIOL-LONDON, V594, P5055, DOI 10.1113/JP270192; Jadeja RN, 2015, JOVE-J VIS EXP, DOI 10.3791/50997; JAMIESON D, 1986, ANNU REV PHYSIOL, V48, P703, DOI 10.1146/annurev.ph.48.030186.003415; Janz DR, 2012, CRIT CARE MED, V40, P3135, DOI 10.1097/CCM.0b013e3182656976; Jimenez AH, 1996, MICROVASC RES, V51, P365, DOI 10.1006/mvre.1996.0033; KALSNER S, 1976, BLOOD VESSELS, V13, P155; Kerkhof CJM, 1999, AM J PHYSIOL-HEART C, V277, pH1546, DOI 10.1152/ajpheart.1999.277.4.H1546; Kilgannon JH, 2010, JAMA-J AM MED ASSOC, V303, P2165, DOI 10.1001/jama.2010.707; Komori M, 2001, IN VIVO, V15, P303; Kunert MP, 2001, AM J PHYSIOL-HEART C, V280, pH1840, DOI 10.1152/ajpheart.2001.280.4.H1840; KWAN YW, 1989, BRIT J PHARMACOL, V96, P849, DOI 10.1111/j.1476-5381.1989.tb11894.x; LANG DJ, 1988, AM J PHYSIOL, V255, pH131, DOI 10.1152/ajpheart.1988.255.1.H131; Lombard JH, 1999, AM J PHYSIOL-HEART C, V276, pH503, DOI 10.1152/ajpheart.1999.276.2.H503; MESSINA EJ, 1994, MICROVASC RES, V48, P151, DOI 10.1006/mvre.1994.1046; MYERS PR, 1991, CARDIOVASC RES, V25, P885, DOI 10.1093/cvr/25.11.885; Ngo AT, 2010, PFLUG ARCH EUR J PHY, V460, P41, DOI 10.1007/s00424-010-0837-x; Panwar R, 2016, AM J RESP CRIT CARE, V193, P43, DOI 10.1164/rccm.201505-1019OC; Pasgaard T, 2007, ACTA PHYSIOL, V191, P285, DOI 10.1111/j.1748-1716.2007.01745.x; PITTMAN RN, 1973, MICROVASC RES, V6, P202, DOI 10.1016/0026-2862(73)90020-4; PRIES AR, 1995, MICROVASC RES, V49, P289, DOI 10.1006/mvre.1995.1025; Riemann M, 2011, J VASC RES, V48, P79, DOI 10.1159/000318777; Rincon F, 2014, J NEUROL NEUROSUR PS, V85, P799, DOI 10.1136/jnnp-2013-305505; Rossi P, 2007, CLIN PHYSIOL FUNCT I, V27, P180, DOI 10.1111/j.1475-097X.2007.00732.x; RUBANYI G, 1985, CIRC RES, V56, P1; RUBANYI GM, 1986, AM J PHYSIOL, V250, pH822, DOI 10.1152/ajpheart.1986.250.5.H822; Sauls BA, 2000, AM J PHYSIOL-HEART C, V279, pH484, DOI 10.1152/ajpheart.2000.279.2.H484; SIEGEL G, 1989, Z KARDIOL, V78, P124; SIEGEL G, 1992, J CARDIOVASC PHARM, V20, pS217, DOI 10.1097/00005344-199204002-00062; Sjoberg F, 2013, J INTERN MED, V274, P505, DOI 10.1111/joim.12139; SMITH DJ, 1966, J PHYSIOL-LONDON, V186, P284, DOI 10.1113/jphysiol.1966.sp008034; SULLIVAN SM, 1981, AM J PHYSIOL, V241, pH542, DOI 10.1152/ajpheart.1981.241.4.H547; Suzuki S, 2013, J CRIT CARE, V28, P647, DOI 10.1016/j.jcrc.2013.03.010; Szasz T, 2013, VASC HEALTH RISK MAN, V9, P105, DOI 10.2147/VHRM.S33760; TATEISHI J, 1995, AM J PHYSIOL-HEART C, V268, pH2068, DOI 10.1152/ajpheart.1995.268.5.H2068; Tsai AG, 2003, AM J PHYSIOL-HEART C, V285, pH1537, DOI 10.1152/ajpheart.00176.2003; VALLET B, 1994, J CARDIOVASC PHARM, V24, P595, DOI 10.1097/00005344-199410000-00010; VANDENBOS GC, 1991, INT J MICROCIRC, V10, P303; Wang CH, 2014, RESUSCITATION, V85, P1142, DOI 10.1016/j.resuscitation.2014.05.021; Welsh DG, 1998, AM J PHYSIOL-HEART C, V274, pH2018, DOI 10.1152/ajpheart.1998.274.6.H2018; Withers SB, 2014, CARDIOVASC RES, V101, P130, DOI 10.1093/cvr/cvt229; Wong PS, 2015, PHARMACOL RES, V91, P29, DOI 10.1016/j.phrs.2014.11.001	65	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182637	10.1371/journal.pone.0182637	http://dx.doi.org/10.1371/journal.pone.0182637			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796814	Green Published, Green Submitted, gold			2022-12-26	WOS:000407396200072
J	Zhang, Y; Wei, QS; Ding, WB; Zhang, LL; Wang, HC; Zhu, YJ; He, W; Chai, YN; Liu, YW				Zhang, Ying; Wei, Qiu-Shi; Ding, Wei-Bin; Zhang, Lei-Lei; Wang, Hui-Chao; Zhu, Ying-Jie; He, Wei; Chai, Yu-Na; Liu, You-Wen			Increased microRNA-93-5p inhibits osteogenic differentiation by targeting bone morphogenetic protein-2	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; CLINICAL-SIGNIFICANCE; ADIPOSE-TISSUE; UMBILICAL-CORD; STROMAL CELLS; EXPRESSION; MARROW; BMP2; PROLIFERATION; CANCER	Background and purpose Trauma-induced osteonecrosis of the femoral head (TIONFH) is a major complication of femoral neck fractures. Degeneration and necrosis of subchondral bone can cause collapse, which results in hip joint dysfunction in patients. The destruction of bone metabolism homeostasis is an important factor for osteonecrosis. MicroRNAs (miRNAs) have an important role in regulating osteogenic differentiation, but the mechanisms underlying abnormal bone metabolism of TIONFH are poorly understood. In this study, we screened specific miRNAs in TIONFH by microarray and further explored the mechanism of osteogenic differentiation. Design Blood samples from patients with TIONFH and patients without necrosis after trauma were compared by microarray, and bone collapse of necrotic bone tissue was evaluated by micro-CT and immunohistochemistry. To confirm the relationship between miRNA and osteogenic differentiation, we conducted cell culture experiments. We found that many miRNAs were significantly different, including miR-93-5p; the increase in this miRNA was verified by Q-PCR. Comparison of the tissue samples showed that miR-93-5p expression increased, and alkaline phosphatase (ALP) and osteopontin (OPN) levels decreased, suggesting miR-93-5p may be involved in osteogenic differentiation. Further bioinformatics analysis indicated that miR-93-5p can target bone morphogenetic protein 2 (BMP-2). A luciferase gene reporter assay was performed to confirm these findings. By simulating and/or inhibiting miR-93-5p expression in human bone marrow mesenchymal stem cells, we confirmed that osteogenic differentiation-related indictors, including BMP-2, Osterix, Runt-related transcription factor, ALP and OPN, were decreased by miR-93-5p. Conclusion Our study showed that increased miR-93-5p in TIONFH patients inhibited osteogenic differentiation, which may be associated with BMP-2 reduction. Therefore, miR-93-5p may be a potential target for prevention of TIONFH.	[Zhang, Ying; Zhang, Lei-Lei; Wang, Hui-Chao; Zhu, Ying-Jie; Liu, You-Wen] Orthopaed Hosp Henan Prov, Luoyang Orthopaed Traumatol Hosp, Med Ctr Hip, Luoyang, Peoples R China; [Wei, Qiu-Shi; He, Wei] Guangzhou Univ Chinese Med, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Ding, Wei-Bin] Guangzhou Ginkgo Biotechnol Co LTD, Guangzhou, Guangdong, Peoples R China; [Chai, Yu-Na] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China	Guangzhou University of Chinese Medicine; Zhengzhou University	Liu, YW (corresponding author), Orthopaed Hosp Henan Prov, Luoyang Orthopaed Traumatol Hosp, Med Ctr Hip, Luoyang, Peoples R China.; Chai, YN (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Henan, Peoples R China.	yuna999@126.com; liuyouwenzhenggu@sina.com			National Natural Science Foundation of China [81473704]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (81473704) (https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list). The funders had no role in study design, data collection and analysis, or preparation of the manuscript, but provided support of experimental material expense to this study. The commercial company Guangzhou Ginkgo Biotechnology Co., LTD did not provide funding to this study, only its employee Wei-Bin Ding contributed to analyzing the data.	Armstrong DA, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0466-2; Baksh D, 2007, STEM CELLS, V25, P1384, DOI 10.1634/stemcells.2006-0709; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Brett JO, 2011, AGING-US, V3, P108, DOI 10.18632/aging.100285; Brocher J, 2013, STEM CELL RES, V11, P1393, DOI 10.1016/j.scr.2013.07.008; Dai J, 2013, INT J BIOL SCI, V9, P1089, DOI 10.7150/ijbs.7367; Dickinson BA, 2013, EUR J HEART FAIL, V15, P650, DOI 10.1093/eurjhf/hft018; Duttenhoefer F, 2014, BIORESEARCH OPEN ACC, V3, P75, DOI 10.1089/biores.2014.0003; Fang L, 2011, ONCOGENE, V30, P806, DOI 10.1038/onc.2010.465; Fritz DT, 2006, MOL ENDOCRINOL, V20, P1574, DOI 10.1210/me.2005-0469; Hazarika S, 2013, CIRCULATION, V127, P1818, DOI 10.1161/CIRCULATIONAHA.112.000860; Heo JS, 2016, INT J MOL MED, V37, P115, DOI 10.3892/ijmm.2015.2413; Huang J, 2010, STEM CELLS, V28, P357, DOI 10.1002/stem.288; Hwang S, 2014, FEBS LETT, V588, P2957, DOI 10.1016/j.febslet.2014.05.048; Jang H, 2014, BONE, V61, P10, DOI 10.1016/j.bone.2013.12.028; Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200; Kamath MS, 2014, INT J NANOMED, V9, P183, DOI 10.2147/IJN.S49460; Kawano M, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0192-z; Larsen KH, 2010, J BONE MINER RES, V25, P796, DOI 10.1359/jbmr.091018; Li N, 2011, MECH AGEING DEV, V132, P75, DOI 10.1016/j.mad.2010.12.004; Liu H, 2015, J HUAZHONG U SCI-MED, V35, P766, DOI 10.1007/s11596-015-1505-3; Liu S, 2013, FEBS LETT, V587, P2247, DOI 10.1016/j.febslet.2013.05.054; Maes OC, 2008, MECH AGEING DEV, V129, P534, DOI 10.1016/j.mad.2008.05.004; Mahomed NN, 2001, J ARTHROPLASTY, V16, P575, DOI 10.1054/arth.2001.23716; MANTHA S, 1993, ANESTH ANALG, V77, P1041; Maruyama Z, 2007, DEV DYNAM, V236, P1876, DOI 10.1002/dvdy.21187; Ming LG, 2011, CHINESE J OSTEOPOROS, P275; Noda Masaki, 2003, Clin Calcium, V13, P464; Rogers MB, 2015, J CELL BIOCHEM, V116, P2127, DOI 10.1002/jcb.25164; Shichinohe H, 2011, TRANSL STROKE RES, V2, P307, DOI 10.1007/s12975-011-0088-y; Shu B, 2011, J CELL SCI, V124, P3428, DOI 10.1242/jcs.083659; Tang QC, 2015, TUMOR BIOL, V36, P1701, DOI 10.1007/s13277-014-2771-6; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Wang L, 2013, INT J ONCOL, V43, P1095, DOI 10.3892/ijo.2013.2030; Xiao ZG, 2013, EUR J GASTROEN HEPAT, V25, P296, DOI 10.1097/MEG.0b013e32835c077a; Xu JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114627; Zhao DW, 2012, CHINESE J JOINT SURG, P479; Zhu HY, 2010, CELLS TISSUES ORGANS, V192, P211, DOI 10.1159/000313417	38	33	39	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182678	10.1371/journal.pone.0182678	http://dx.doi.org/10.1371/journal.pone.0182678			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797104	Green Submitted, Green Published, gold			2022-12-26	WOS:000407396200079
J	Hernandez-Mora, G; Bonilla-Montoya, R; Barrantes-Granados, O; Esquivel-Suarez, A; Montero-Caballero, D; Gonzalez-Barrientos, R; Fallas-Monge, Z; Palacios-Alfaro, JD; Baldi, M; Campos, E; Chanto, G; Barquero-Calvo, E; Chacon-Diaz, C; Chaves-Olarte, E; Verri, CG; Romero-Zuniga, JJ; Moreno, E				Hernandez-Mora, Gabriela; Bonilla-Montoya, Roberto; Barrantes-Granados, Osvaldo; Esquivel-Suarez, Andrea; Montero-Caballero, Danilo; Gonzalez-Barrientos, Rocio; Fallas-Monge, Zeanne; David Palacios-Alfaro, Jose; Baldi, Mario; Campos, Elena; Chanto, Grettel; Barquero-Calvo, Elias; Chacon-Diaz, Carlos; Chaves-Olarte, Esteban; Guzman Verri, Caterina; Romero-Zuniga, Juan-Jose; Moreno, Edgardo			Brucellosis in mammals of Costa Rica: An epidemiological survey	PLOS ONE			English	Article							MULTIPLEX PCR ASSAY; SEROLOGICAL TESTS; IDENTIFICATION; PERFORMANCE; INFECTION; DIAGNOSIS; ABORTUS; CETI	Brucellosis has been an endemic disease of cattle and humans in Costa Rica since the beginning of XX century. However, brucellosis in sheep, goats, pigs, water buffaloes, horses and cetaceans, has not been reported in the country. We have performed a brucellosis survey in these host mammal species, from 1999-2016. In addition, we have documented the number of human brucellosis reported cases, from 2003-2016. The brucellosis seroprevalence in goat and sheep herds was 0.98% and 0.7% respectively, with no Brucella isolation. Antibodies against Brucella were not detected in feral or domestic pigs. Likewise, brucellosis seroprevalence in horse and water buffalo farms was estimated in 6.5% and 21.7%, respectively, with no Brucella isolation. Six cetacean species showed positive reactions against Brucella antigens, and B. ceti was isolated in 70% (n = 29) of striped dolphins (Stenella coeruleoalba). A steady increase in the diagnosis of human brucellosis cases was observed. Taking into account the prevalence of brucellosis in the various host mammals of Costa Rica, different measures are recommended.	[Hernandez-Mora, Gabriela; Bonilla-Montoya, Roberto; Barrantes-Granados, Osvaldo; Esquivel-Suarez, Andrea; Gonzalez-Barrientos, Rocio; Fallas-Monge, Zeanne] Minist Agr & Ganaderia, Serv Nacl Salud Anim SENASA, Heredia, Costa Rica; [Montero-Caballero, Danilo] Inst Nacl Aprendizaje, San Jose, Costa Rica; [David Palacios-Alfaro, Jose] Fdn Keto, San Jose, Costa Rica; [Baldi, Mario; Barquero-Calvo, Elias; Guzman Verri, Caterina; Moreno, Edgardo] Univ Nacl, Escuela Med Vet, PIET, Heredia, Costa Rica; [Campos, Elena; Chanto, Grettel] Ctr Nacl Referencia Bacteriol, Inst Costarricense Invest & Ensenanza Nutr & Salu, Cartago, Costa Rica; [Chacon-Diaz, Carlos; Chaves-Olarte, Esteban] Univ Costa Rica, CIET, Fac Microbiol, San Jose, Costa Rica; [Romero-Zuniga, Juan-Jose] Univ Nacl, Escuela Med Vet, Programa Invest Med Poblac, Heredia, Costa Rica; [Moreno, Edgardo] Univ Costa Rica, Inst Clodomiro Picado, San Jose, Costa Rica	Universidad Nacional Costa Rica; Universidad Costa Rica; Universidad Nacional Costa Rica; Universidad Costa Rica	Moreno, E (corresponding author), Univ Nacl, Escuela Med Vet, PIET, Heredia, Costa Rica.; Moreno, E (corresponding author), Univ Costa Rica, Inst Clodomiro Picado, San Jose, Costa Rica.	edgardo.moreno.robles@una.cr	BARQUERO-CALVO, ELIAS/GLU-1867-2022; Guzman-Verri, Caterina/AAP-3074-2020; Hernandez-Mora, Gabriela/AAW-5911-2020	BARQUERO-CALVO, ELIAS/0000-0003-4428-3340; Guzman-Verri, Caterina/0000-0003-1036-920X; Baldi, Mario/0000-0001-6109-4993	Fondos del Sistema del Consejo Nacional de Rectores [FEES-CONAREFSI001]; Ministerio de Ciencia, Tecnologoiay Telecomunicaciones (MICITT-PINN) [PND-033-15-2]	Fondos del Sistema del Consejo Nacional de Rectores; Ministerio de Ciencia, Tecnologoiay Telecomunicaciones (MICITT-PINN)	Fondos del Sistema del Consejo Nacional de Rectores (FEES-CONAREFSI001). Scholarship: Ministerio de Ciencia, Tecnologoiay Telecomunicaciones (MICITT-PINN) PND-033-15-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borriello G, 2006, INFECT IMMUN, V74, P2115, DOI 10.1128/IAI.74.4.2115-2120.2006; Cannon R.M., 1982, LIVESTOCK DIS SURVEY; CATIE-Centro Agronomico Tropical para la Investigacion y Ensenanza, 1987, SIT CAPR COST RIC SI, V114, P120; Chacon-Diaz C, 2015, INFECT IMMUN, V83, P4861, DOI 10.1128/IAI.00995-15; Chanto G, 2007, REV BIOL TROP, V55, P385; De Miguel MJ, 2011, J CLIN MICROBIOL, V49, P1458, DOI 10.1128/JCM.02301-10; Denny H R, 1973, Equine Vet J, V5, P121, DOI 10.1111/j.2042-3306.1973.tb03208.x; Ducrotoy MJ, 2016, VET IMMUNOL IMMUNOP, V171, P81, DOI 10.1016/j.vetimm.2016.02.002; FAOSTAT-Organizacion de las Naciones Unidas para la Alimentacion y la Agricultura, 2016, DIR EST; Fosgate GT, 2011, TROP ANIM HEALTH PRO, V43, P1479, DOI 10.1007/s11250-011-9846-9; Garcia-Yoldi D, 2006, CLIN CHEM, V52, P779, DOI 10.1373/clinchem.2005.062596; Gonzalez-Barrientos R, 2010, J COMP PATHOL, V142, P347, DOI 10.1016/j.jcpa.2009.10.017; Guzman-Verri C, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00003; Hernandez-Mora G, 2017, PLOS ONE UNPUB; Hernandez-Mora G, 2008, EMERG INFECT DIS, V14, P1430, DOI 10.3201/eid1409.071056; Hernandez-Mora G, 2009, CLIN VACCINE IMMUNOL, V16, P906, DOI 10.1128/CVI.00413-08; Instituto Nacional de Estadisticas-INEC, 2014, 6 CENS NAC AGR, P72; Isidoro-Ayza M, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0206-7; Le Fleche P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-9; Lopez-Goni I, 2011, VET MICROBIOL, V154, P152, DOI 10.1016/j.vetmic.2011.06.035; Marin CM, 1999, CLIN DIAGN LAB IMMUN, V6, P269; May-Collado Laura, 2009, V86, P479, DOI 10.1007/978-1-4020-8278-8_45; Moreno E, 2002, VET MICROBIOL, V90, P31, DOI 10.1016/S0378-1135(02)00242-0; Moreno E., 1998, INT ATOMIC ENERGY, P153; Moreno E, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00213; Munoz PM, 2012, VET IMMUNOL IMMUNOP, V146, P150, DOI 10.1016/j.vetimm.2012.02.012; OIE, 2009, BOV BRUC MAN DIAGN T; OIE-World Organization for Animal Health. Caprine and ovine brucellosis, 2009, CAPR OV BRUC MAN DIA; Oliveira JB, 2011, VET PARASITOL, V182, P319, DOI 10.1016/j.vetpar.2011.05.014; Quiros D, 1915, GACETA MED COSTA RIC, V11, P241; Rosales RR, 2007, REV AGRONOMIA COSTAR, V31, P65; Rosales-Rodriguez R, 2011, TECNOLOGIA MARCHA CO, V24, P19; Rosales-Rodriguez R, 2016, REPROD BUFALAS, P251; Scott JC, 2007, APPL ENVIRON MICROB, V73, P7331, DOI 10.1128/AEM.00976-07; SEQUEIRA A, 1984, TURRIALBA, V34, P525; Suarez-Esquivel M, 2017, GENOME BIOL IN PRESS; Suarez-Esquivel M, 2017, EMERG INFECT DIS, V23, P997, DOI 10.3201/eid2306.162018; Thrusfield M, 2001, VET REC, V148, P567, DOI 10.1136/vr.148.18.567; Vargas-Ulate T, 2004, GEOGRAFIA COSTA RICA, P124; Verger JM, 1988, TECHNIQUES BRUCELLOS; Whatmore AM, 2008, EMERG INFECT DIS, V14, P517, DOI 10.3201/eid1403.070829; Zeledon-Alvarado J, 1940, REV MED, V72, P153	42	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182644	10.1371/journal.pone.0182644	http://dx.doi.org/10.1371/journal.pone.0182644			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28793352	Green Submitted, Green Published, gold			2022-12-26	WOS:000407196700056
J	Cheng, CC; Chang, JS; Huang, SCC; Lin, HC; Ho, AS; Lim, KH; Chang, CC; Huang, L; Chang, YC; Chang, YF; Wu, CW				Cheng, Chun-Chia; Chang, Jungshan; Huang, Stanley Ching-Cheng; Lin, Huan-Chau; Ho, Ai-Sheng; Lim, Ken-Hong; Chang, Chun-Chao; Huang, Ling; Chang, Yu-Cheng; Chang, Yi-Fang; Wu, Cheng-Wen			YM155 as an inhibitor of cancer stemness simultaneously inhibits autophosphorylation of epidermal growth factor receptor and G9a-mediated stemness in lung cancer cells	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE; ACQUIRED-RESISTANCE; DRUG-RESISTANCE; G9A; EGFR; AFATINIB; METASTASIS; GEFITINIB; METHYLATION; SUPPRESSION	Cancer stem cell survival is the leading factor for tumor recurrence after tumor-suppressive treatments. Therefore, specific and efficient inhibitors of cancer stemness must be discovered for reducing tumor recurrence. YM155 has been indicated to significantly reduce stemness-derived tumorsphere formation. However, the pharmaceutical mechanism of YM155 against cancer stemness is unclear. This study investigated the potential mechanism of YM155 against cancer stemness in lung cancer. Tumorspheres derived from epidermal growth factor receptor (EGFR)-mutant HCC827 and EGFR wild-type A549 cells expressing higher cancer stemness markers (CD133, Oct4, and Nanog) were used as cancer stemness models. We observed that EGFR autophosphorylation (Y1068) was higher in HCC827- and A549-derived tumorspheres than in parental cells; this autophosphorylation induced tumorsphere formation by activating G9a-mediated stemness. Notably, YM155 inhibited tumorsphere formation by blocking the autophosphorylation of EGFR and the EGFR-G9a-mediated stemness pathway. The chemical and genetic inhibition of EGFR and G9a revealed the significant role of the EGFR-G9a pathway in maintaining the cancer stemness property. In conclusion, this study not only revealed that EGFR could trigger tumorsphere formation by elevating G9a-mediated stemness but also demonstrated that YM155 could inhibit this formation by simultaneously blocking EGFR autophosphorylation and G9a activity, thus acting as a potent agent against lung cancer stemness.	[Cheng, Chun-Chia; Lin, Huan-Chau; Lim, Ken-Hong; Huang, Ling; Chang, Yu-Cheng; Chang, Yi-Fang] MacKay Mem Hosp, Dept Internal Med, Div Hematol & Oncol, Taipei, Taiwan; [Cheng, Chun-Chia; Lin, Huan-Chau; Lim, Ken-Hong; Huang, Ling; Chang, Yu-Cheng; Chang, Yi-Fang] MacKay Mem Hosp, Dept Med Res, Lab Good Clin Res Ctr, New Taipei, Taiwan; [Cheng, Chun-Chia; Wu, Cheng-Wen] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Chang, Jungshan] Taipei Med Univ, Coll Med, Sch Med, Grad Inst Med Sci, Taipei, Taiwan; [Huang, Stanley Ching-Cheng] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Ho, Ai-Sheng] Cheng Hsin Gen Hosp, Div Gastroenterol, Taipei, Taiwan; [Chang, Chun-Chao] Taipei Med Univ Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Taipei, Taiwan; [Chang, Chun-Chao] Taipei Med Univ, Coll Med, Sch Med, Div Gastroenterol & Hepatol,Dept Internal Med, Taipei, Taiwan	Mackay Memorial Hospital; Mackay Memorial Hospital; National Yang Ming Chiao Tung University; Taipei Medical University; Washington University (WUSTL); Cheng Hsin General Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University	Chang, YF (corresponding author), MacKay Mem Hosp, Dept Internal Med, Div Hematol & Oncol, Taipei, Taiwan.; Chang, YF (corresponding author), MacKay Mem Hosp, Dept Med Res, Lab Good Clin Res Ctr, New Taipei, Taiwan.; Wu, CW (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan.	changyifang@gmail.com; ken@ibms.sinica.edu.tw	Huang, Stanley Ching-Cheng/AAE-7866-2019	Huang, Stanley Ching-Cheng/0000-0002-6557-3737; Cheng, Chun-Chia/0000-0002-6455-1798; Lim, Ken-Hong/0000-0003-2282-0416	Ministry of Science and Technology of Taiwan [MOST 105-2811-B-010-001]; Cheng Hsin General Hospital [104-03]; Mackay Memorial Hospital [MMH-CT-10501]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Cheng Hsin General Hospital; Mackay Memorial Hospital	This study was supported by grants from the Ministry of Science and Technology of Taiwan (MOST 105-2811-B-010-001), Cheng Hsin General Hospital (104-03), and Mackay Memorial Hospital (MMH-CT-10501).; We thank Vicky Cheng for helping with EGFR knockdown experiments. This study was supported by grants from the Ministry of Science and Technology of Taiwan (MOST 105-2811-B-010-001), Cheng Hsin General Hospital (104-03), and Mackay Memorial Hospital (MMH-CT-10501). We also acknowledge Wallace Academic Editing (www.editing.tw) for editing this manuscript.	Arteaga CL, 2014, CANCER CELL, V25, P282, DOI 10.1016/j.ccr.2014.02.025; Bittencourt D, 2012, P NATL ACAD SCI USA, V109, P19673, DOI 10.1073/pnas.1211803109; Chen MW, 2010, CANCER RES, V70, P7830, DOI 10.1158/0008-5472.CAN-10-0833; Cheng XJ, 2016, ONCOTARGET, V7, P7096, DOI 10.18632/oncotarget.6898; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Hirsh V, 2011, FUTURE ONCOL, V7, P817, DOI [10.2217/fon.11.62, 10.2217/FON.11.62]; Hsiao SM, 2015, ANN SURG ONCOL, V22, pS1556, DOI 10.1245/s10434-015-4379-5; Huang J, 2010, J BIOL CHEM, V285, P9636, DOI 10.1074/jbc.M109.062588; Kellner S, 2010, HISTOL HISTOPATHOL, V25, P405, DOI 10.14670/HH-25.405; Kim Y, 2012, MOL CANCER THER, V11, P784, DOI 10.1158/1535-7163.MCT-11-0750; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Li L, 2014, GASTROENTEROLOGY, V146, P1108, DOI 10.1053/j.gastro.2013.12.035; Li YZ, 2015, P NATL ACAD SCI USA, V112, P1839, DOI 10.1073/pnas.1424171112; Liao HW, 2015, J CLIN INVEST, V125, P4529, DOI 10.1172/JCI82826; Liu F, 2013, J MED CHEM, V56, P8931, DOI 10.1021/jm401480r; Liu SL, 2015, ONCOTARGET, V6, P6887, DOI 10.18632/oncotarget.3159; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Na YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038625; Nakahara T, 2007, CANCER RES, V67, P8014, DOI 10.1158/0008-5472.CAN-07-1343; Nakamura N, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013243; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Ninomiya T, 2013, MOL CANCER THER, V12, P589, DOI 10.1158/1535-7163.MCT-12-0885; Perona R, 2011, CLIN TRANSL ONCOL, V13, P289, DOI 10.1007/s12094-011-0656-3; Purcell DJ, 2012, J CELL BIOCHEM, V113, P2406, DOI 10.1002/jcb.24114; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Rada M, 2016, ONCOGENE; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Shankar SR, 2013, EPIGENETICS-US, V8, P16, DOI 10.4161/epi.23331; Shostak K, 2015, TRENDS MOL MED, V21, P385, DOI 10.1016/j.molmed.2015.04.001; Sun FF, 2015, INT J CLIN EXP PATHO, V8, P6287; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Takezawa K, 2012, CANCER DISCOV, V2, P922, DOI 10.1158/2159-8290.CD-12-0108; Taus A, 2011, ARCH BRONCONEUMOL, V47, P103, DOI 10.1016/j.arbres.2010.06.013; Vlashi E, 2009, JNCI-J NATL CANCER I, V101, P350, DOI 10.1093/jnci/djn509; Wang F, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-65; Wang M, 2014, CANCER RES, V74, P2825, DOI 10.1158/0008-5472.CAN-13-3157; Wang XK, 2014, CANCER RES, V74, P4431, DOI 10.1158/0008-5472.CAN-13-3553; Wu SG, 2016, ONCOTARGET, V7, P12404, DOI 10.18632/oncotarget.7189; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Yu HA, 2013, NAT REV CLIN ONCOL, V10, P551, DOI 10.1038/nrclinonc.2013.154; Zhang YM, 2016, CANCER MED-US, V5, P1251, DOI 10.1002/cam4.675; Zhao MC, 2015, LUNG CANCER, V87, P98, DOI 10.1016/j.lungcan.2014.11.017	44	26	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182149	10.1371/journal.pone.0182149	http://dx.doi.org/10.1371/journal.pone.0182149			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28787001	Green Published, Green Submitted, gold			2022-12-26	WOS:000406998800016
J	De Melo, J; Kim, SS; Lourenco, C; Penn, LZ				De Melo, J.; Kim, S. S.; Lourenco, C.; Penn, L. Z.			Lysine-52 stabilizes the MYC oncoprotein through an SCFFbxw7-independent mechanism	ONCOGENE			English	Article							C-MYC; TUMOR-SUPPRESSOR; PROTEIN; DEGRADATION; PHOSPHORYLATION; DOMAIN; FBW7; UBIQUITYLATION; TUMORIGENESIS; TRANSCRIPTION	The oncogenic transcription factor c-MYC (MYC) is deregulated and often overexpressed in more than 50% of cancers. MYC deregulation is associated with poor prognosis and aggressive disease, suggesting that the development of therapeutic inhibitors targeting MYC would markedly impact patient outcome. MYC is highly regulated, with a protein and mRNA half-life of similar to 30 min. The most extensively studied pathway regulating MYC protein stability involves ubiquitylation and proteasomal degradation mediated by the E3-ligase, SCFFbxw7. Here we provide evidence for an SCFFbxw7-independent regulatory mechanism centred on the highly conserved lysine-52 (K52) within MYC Box I. This residue has been shown to be post-translationally modified by both ubiquitylation and SUMOylation, hinting at the interplay of post-translational modifications at this site and the importance of this residue. We demonstrate that mutation of K52 to arginine (R) renders the MYC protein more labile. Mechanistically, we show that the degradation pathway regulated by K52 is independent of the Cullin-RING ligase family of E3-ligases, which includes not only the canonical SCFFbxw7 but also other known MYC-targeting E3-ligases, such as SCFSkp2, SCF beta TCRP, SCFFbxo28 and DCXTRUSS. Taken together, our data identify a novel regulatory pathway centred on K52 that may be exploited for the development of anti-MYC therapeutics.	[De Melo, J.; Kim, S. S.; Lourenco, C.; Penn, L. Z.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Lourenco, C.; Penn, L. Z.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Penn, LZ (corresponding author), Univ Hlth Network, Princess Margaret Canc Res Tower,101 Coll St, Toronto, ON M5G 1L7, Canada.	lpenn@uhnresearch.ca		Penn, Linda/0000-0001-8133-5459; De Melo, Jason/0000-0001-6519-4879	Canadian Institutes of Health Research [MOP275788]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank Dr Bert Vogelstein for the HCT116 cells (wt/Fbxw7<SUP>-/-</SUP>) and all members of the Penn lab and especially the technical support of Aaliya Tamachi and Natasha Vitkin. LZP holds the Tier 1 Canada Research Chair in Molecular Oncology. This work was also supported by the Canadian Institutes of Health Research (MOP275788).	Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Cepeda D, 2013, EMBO MOL MED, V5, P1067, DOI 10.1002/emmm.201202341; Chakraborty AA, 2014, ONCOGENE, V34, P1; Choi SH, 2010, GENE DEV, V24, P1236, DOI 10.1101/gad.1920310; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Diefenbacher ME, 2015, CANCER RES, V75, P1181, DOI 10.1158/0008-5472.CAN-14-1726; Fletcher S, 2015, BBA-GENE REGUL MECH, V1849, P525, DOI 10.1016/j.bbagrm.2014.03.005; Gonzalez-Prieto R, 2015, CELL CYCLE, V14, P1859, DOI 10.1080/15384101.2015.1040965; Grim JE, 2008, J CELL BIOL, V181, P913, DOI 10.1083/jcb.200802076; Gustafson WC, 2010, ONCOGENE, V29, P1249, DOI 10.1038/onc.2009.512; Hakem A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002360; Helander S, 2015, STRUCTURE, V23, P2267, DOI 10.1016/j.str.2015.10.010; Herbst A, 2005, EMBO REP, V6, P177, DOI 10.1038/sj.embor.7400333; Inoue S, 2013, GENE DEV, V27, P1101, DOI 10.1101/gad.214577.113; Kalkat M, 2017, GENES-BASEL, V8, DOI 10.3390/genes8060151; Kalkat M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115337; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kress TR, 2015, NAT REV CANCER, V15, P593, DOI 10.1038/nrc3984; LI LH, 1994, EMBO J, V13, P4070, DOI 10.1002/j.1460-2075.1994.tb06724.x; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; McKeown MR, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014266; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Oster SK, 2003, ONCOGENE, V22, P1998, DOI 10.1038/sj.onc.1206228; Paul I, 2013, ONCOGENE, V32, P1284, DOI 10.1038/onc.2012.144; Popov N, 2010, NAT CELL BIOL, V12, P973, DOI 10.1038/ncb2104; Prochownik Edward V, 2010, Genes Cancer, V1, P650; PULVERER BJ, 1994, ONCOGENE, V9, P59; Rabellino A, 2016, CELL REP, V15, P2266, DOI 10.1016/j.celrep.2016.05.015; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Shu SK, 2016, NATURE, V529, P413, DOI 10.1038/nature16508; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Tang Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163324; Topham C, 2015, CANCER CELL, V28, P129, DOI 10.1016/j.ccell.2015.06.001; Tu W.B., 2014, BIOCHIM BIOPHYS ACTA, V1849, P469; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Wasylishen AR, 2014, ONCOGENE, V33, P1066, DOI 10.1038/onc.2013.36; Wasylishen AR, 2011, ONCOGENE, V30, P3727, DOI 10.1038/onc.2011.88; Wasylishen AR, 2013, CANCER RES, V73, P6504, DOI 10.1158/0008-5472.CAN-12-4063; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Wolf E, 2015, TRENDS CELL BIOL, V25, P241, DOI 10.1016/j.tcb.2014.10.006; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Zhang Q, 2013, P NATL ACAD SCI USA, V110, P978, DOI 10.1073/pnas.1208334110; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	53	4	4	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 7	2017	36	49					6815	6822		10.1038/onc.2017.268	http://dx.doi.org/10.1038/onc.2017.268			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FP0IK	28806398				2022-12-26	WOS:000417282500007
J	Cubasch, H; Joffe, M; Ruff, P; Dietz, D; Rosenbaum, E; Murugan, N; Chih, MT; Ayeni, O; Dickens, C; Crew, K; Jacobson, JS; Neugut, A				Cubasch, Herbert; Joffe, Maureen; Ruff, Paul; Dietz, Donald; Rosenbaum, Evan; Murugan, Nivashni; Chih, Ming Tsai; Ayeni, Oluwatosin; Dickens, Caroline; Crew, Katherine; Jacobson, Judith S.; Neugut, Alfred			Breast conservation surgery versus total mastectomy among women with localized breast cancer in Soweto, South Africa	PLOS ONE			English	Article							COMPARING TOTAL MASTECTOMY; 20-YEAR FOLLOW-UP; CONSERVING SURGERY; RADICAL-MASTECTOMY; STAGE; IRRADIATION; RADIATION; MARGINS; RATES	Purpose Breast conserving surgery (BCS) has become the preferred surgical option for the management of patients with nonmetastatic breast cancer in high-income countries. However, little is known about the distribution and determinants of BCS in low-and middle-income countries, especially those with high HIV prevalence. Methods We compared demographic and clinical characteristics of female patients who received BCS and those who received total mastectomy (TM) for nonmetastatic invasive carcinoma of the breast in Soweto, South Africa, 2009-2011. We also developed a multivariable logistic regression model of predictors of type of surgery. Results Of 445 patients, 354 (80%) underwent TM and 91 (20%) BCS. Of 373 patients screened for HIV, 59 (15.8%) tested positive. Eighty-two of 294 patients with stage I/II disease (28%), but just 9 of 151 (6%) with stage III disease had BCS (p<0.001). All women who received BCS (except for seven who received completion mastectomy within 6 weeks of BCS) and 235 (66.4%) women who received TM were referred for radiation therapy (RT). In our multivariable analysis, age group 50-59 years (OR = 2.28, 95% CI = 1.1-4.8) and >= 70 years (OR =9.55, 95% CI = 2.9-31.2) vs. age group < 40 years, stage at diagnosis (stage II (OR = 3.79, 95% CI = 1.6-8.2) and stage III (OR = 27.8, 95% CI = 9.0-78.8) vs. stage 1, HIV (HIV positive (OR = 3.19, 95% CI = 1.3-7.9) vs. HIV negative) and HER2-enriched subtype (OR = 3.50, 95% CI = 1.2-10.1) vs. triple negative were independently associated with TM. Conclusion TM was more common than BCS among patients with nonmetastatic breast cancer in Soweto, not only among patients with locally advanced disease at diagnosis, but also among women with stage I and II disease.	[Cubasch, Herbert; Murugan, Nivashni; Chih, Ming Tsai] Univ Witwatersrand, Fac Hlth Sci, Dept Surg, Johannesburg, South Africa; [Cubasch, Herbert; Joffe, Maureen; Murugan, Nivashni; Chih, Ming Tsai; Ayeni, Oluwatosin] Chris Hani Baragwanath Acad Hosp, Batho Pele Breast Unit, Johannesburg, South Africa; [Cubasch, Herbert; Joffe, Maureen; Ruff, Paul; Ayeni, Oluwatosin] Wits Hlth Consortium, Johannesburg, South Africa; [Joffe, Maureen] Univ Witwatersrand, Fac Hlth Sci, Dept Paediat, Johannesburg, South Africa; [Ruff, Paul] Univ Witwatersrand, Fac Hlth Sci, Dept Internal Med, Div Med Oncol, Johannesburg, South Africa; [Ruff, Paul; Dickens, Caroline] Univ Witwatersrand, Fac Hlth Sci, Dept Internal Med, Johannesburg, South Africa; [Dietz, Donald; Rosenbaum, Evan; Crew, Katherine; Neugut, Alfred] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10027 USA; [Crew, Katherine; Jacobson, Judith S.; Neugut, Alfred] Columbia Univ, Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, New York, NY 10027 USA; [Crew, Katherine; Jacobson, Judith S.; Neugut, Alfred] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA	University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; Columbia University; Columbia University; Columbia University	Neugut, A (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10027 USA.; Neugut, A (corresponding author), Columbia Univ, Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, New York, NY 10027 USA.; Neugut, A (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA.	ain1@columbia.edu		Joffe, Maureen/0000-0001-8616-9672	U.S. National Cancer Institute [1R01 CA192627]; South Africa Medical Research Council/Wits Common Epithelial Cancer Research Centre (CECRC); Herbert Irving Comprehensive Cancer Center of Columbia University (U.S. National Cancer Institute) [P30 CA13696]; NATIONAL CANCER INSTITUTE [R01CA192627] Funding Source: NIH RePORTER	U.S. National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); South Africa Medical Research Council/Wits Common Epithelial Cancer Research Centre (CECRC); Herbert Irving Comprehensive Cancer Center of Columbia University (U.S. National Cancer Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The research described in this report was supported by U.S. National Cancer Institute 1R01 CA192627 to JSJ, MJ, AIN, and PR; the South Africa Medical Research Council/Wits Common Epithelial Cancer Research Centre (CECRC) led by PR; and the Herbert Irving Comprehensive Cancer Center of Columbia University (U.S. National Cancer Institute (P30 CA13696) to AIN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkisson CD, 2012, ANN SURG ONCOL, V19, P1129, DOI 10.1245/s10434-011-2080-x; Ajekigbe A T, 1991, Clin Oncol (R Coll Radiol), V3, P78, DOI 10.1016/S0936-6555(05)81167-7; [Anonymous], 2013, CANC INCIDENCE MORTA; Audretsch W., 1998, PERSPECT PLAST SURG, V11, p71 , DOI DOI 10.1055/s-2008-1080243; Brinton LA, 2014, BREAST CANCER RES TR, V144, P467, DOI 10.1007/s10549-014-2868-z; Churilla TM, 2016, BREAST J; Clough KB, 2010, ANN SURG ONCOL, V17, P1375, DOI 10.1245/s10434-009-0792-y; Crowther NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048883; Cruz-Korchin N, 2003, PLAST RECONSTR SURG, V112, P1573, DOI 10.1097/01.PRS.0000086736.61832.33; Cubasch H, 2013, BREAST CANCER RES TR, V140, P177, DOI 10.1007/s10549-013-2606-y; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Dickens C, 2014, INT J CANCER, V135, P2173, DOI 10.1002/ijc.28861; Dragun AE, 2012, BREAST J, V18, P318, DOI 10.1111/j.1524-4741.2012.01245.x; Emiroglu M, 2016, WSPOLCZESNA ONKOL, V20, P256, DOI 10.5114/wo.2015.55272; FISHER B, 1985, NEW ENGL J MED, V312, P665, DOI 10.1056/NEJM198503143121101; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Galimberti V, 2016, TUMORI, V102, P284, DOI 10.5301/tj.5000500; Jagsi R, 2010, J CLIN ONCOL, V28, P2396, DOI 10.1200/JCO.2009.26.8433; Johnson LF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001418; Kantelhardt EJ, 2015, CURR OPIN OBSTET GYN, V27, P108, DOI 10.1097/GCO.0000000000000139; Kummerow KL, 2015, JAMA SURG, V150, P9, DOI 10.1001/jamasurg.2014.2895; McCormack VA, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3478; Moran MS, 2014, ANN SURG ONCOL, V21, P704, DOI 10.1245/s10434-014-3481-4; Nijenhuis MV, 2013, BREAST, V22, pS110, DOI 10.1016/j.breast.2013.07.021; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; South Africa, 2011, FULL REP; South Africa, 2000, FULL REP NAT CANC RE; Steinert JI, 2016, GLOB PUBLIC HEALTH, P1; Ukwenya AY, 2008, S AFR J SURG, V46, P106; Verkooijen HM, 2005, ANN SURG, V242, P276, DOI 10.1097/01.sla.0000171305.31703.84; VERONESI U, 1981, NEW ENGL J MED, V305, P6, DOI 10.1056/NEJM198107023050102; Veronesi U, 2002, NEW ENGL J MED, V347, P1227, DOI 10.1056/NEJMoa020989; World Development Indicators, 2012, HLTH RISK FACT FUT C	33	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182125	10.1371/journal.pone.0182125	http://dx.doi.org/10.1371/journal.pone.0182125			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797046	gold, Green Published, Green Submitted			2022-12-26	WOS:000407396200032
J	Dos Santos, C; Hamadat, S; Le Saux, K; Newton, C; Mazouni, M; Zargarian, L; Miro-Padovani, M; Zadigue, P; Delbe, J; Hamma-Kourbali, Y; Amiche, M				Dos Santos, Celia; Hamadat, Sabah; Le Saux, Karen; Newton, Clara; Mazouni, Meriem; Zargarian, Loussine; Miro-Padovani, Mickael; Zadigue, Patricia; Delbe, Jean; Hamma-Kourbali, Yamina; Amiche, Mohamed			Studies of the antitumor mechanism of action of dermaseptin B2, a multifunctional cationic antimicrobial peptide, reveal a partial implication of cell surface glycosaminoglycans	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; HOST-DEFENSE PEPTIDES; FROG-SKIN; CANCER; INTERNALIZATION; ADENOREGULIN; ANTIBIOTICS; SECRETIONS; RESISTANCE; RECEPTOR	Dermaseptin-B2 (DRS-B2) is a multifunctional cationic antimicrobial peptide (CAP) isolated from frog skin secretion. We previously reported that DRS-B2 possesses anticancer and antiangiogenic activities in vitro and in vivo. In the present study, we evaluated the antiproliferative activity of DRS-B2 on numerous tumor cell lines, its cell internalization and studies of its molecular partners as well as their influences on its structure. Confocal microscopy using ([Alexa594]-(Cys(0))-DRS-B2) shows that in sensitive human tumor cells (PC3), DRS-B2 seems to accumulate rapidly at the cytoplasmic membranes and enters the cytoplasm and the nucleus, while in less sensitive tumor cells (U87MG), DRS-B2 is found packed in vesicles at the cell membrane. Furthermore FACS analysis shows that PC3 cells viability decreases after DRS-B2 treatment while U87 MG seems to be unaffected. However, "pull down" experiments performed with total protein pools from PC3 or U87MG cells and the comparison between the antiproliferative effect of DRS-B2 and its synthetic analog containing all Damino acids suggest the absence of a stereo-selective protein receptor. Pretreatment of PC3 cells with sodium chlorate, decreases the antiproliferative activity of DRS-B2. This activity is partially restored after addition of exogenous chondroitin sulfate C (CS-C). Moreover, we demonstrate that at nanomolar concentrations CS-C potentiates the antiproliferative effect of DRS-B2. These results highlight the partial implication of glycosaminoglycans in the mechanism of antiproliferative action of DRS-B2. Structural analysis of DRS-B2 by circular dichroism in the presence of increasing concentration of CS-C shows that DRS-B2 adopts an a-helical structure. Finally, structure-activity-relationship studies suggest a key role of the Wresidue in position 3 of the DRS-B2 sequence for its antiproliferative activity.	[Dos Santos, Celia; Hamadat, Sabah; Newton, Clara; Mazouni, Meriem] Univ Paris Est Creteil, CNRS, Lab CRRET, EAC 7149, Creteil, France; [Hamadat, Sabah; Le Saux, Karen; Newton, Clara; Mazouni, Meriem] Univ Paris Est Creteil, Creteil, France; [Le Saux, Karen; Miro-Padovani, Mickael; Zadigue, Patricia; Delbe, Jean; Hamma-Kourbali, Yamina; Amiche, Mohamed] Univ Paris Est Creteil, Sch Med, Mondor Inst Biomed Res, INSERM,U955,Team 7, Creteil, France; [Zargarian, Loussine] Ecole Normale Super, BPA, CNRS, UMR 8113, Batiment IDA, Cachan, France; [Dos Santos, Celia] Mariano R Castex Natl Acad Med, Hematol Res Inst, Hemostasis & Thrombosis Dept, Div Chem, Buenos Aires, DF, Argentina	Centre National de la Recherche Scientifique (CNRS); Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay	Amiche, M (corresponding author), Univ Paris Est Creteil, Sch Med, Mondor Inst Biomed Res, INSERM,U955,Team 7, Creteil, France.	mohamed.amiche@u-pec.fr	Hamma-Kourbali, Yamina/R-3692-2018; Delbe, Jean/R-3680-2018; AMICHE, Mohamed/R-3684-2018	Hamma-Kourbali, Yamina/0000-0002-2754-8928; Mickael, Miro-Padovani/0000-0003-3581-3469; Dos Santos, Celia/0000-0002-0431-1004	 [ANR-10-BIOT-0014]		This work was supported by a grant from program ANR-10-BIOT-0014. "Agence Nationale de la Recherche".	Abbassi F, 2008, BIOCHEMISTRY-US, V47, P10513, DOI 10.1021/bi8006884; AMICHE M, 1994, J BIOL CHEM, V269, P17847; Auvynet C, 2006, EUR J CELL BIOL, V85, P25, DOI 10.1016/j.ejcb.2005.09.022; Bechara C, 2013, FASEB J, V27, P738, DOI 10.1096/fj.12-216176; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Charpentier S, 1998, J BIOL CHEM, V273, P14690, DOI 10.1074/jbc.273.24.14690; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; DALY JW, 1992, P NATL ACAD SCI USA, V89, P10960, DOI 10.1073/pnas.89.22.10960; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Fadnes B, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-183; Galanth C, 2009, BIOCHEMISTRY-US, V48, P313, DOI 10.1021/bi802025a; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; Ishihara M, 2001, TRENDS GLYCOSCI GLYC, V13, P433, DOI 10.4052/tigg.13.433; Kleeff J, 1998, J CLIN INVEST, V102, P1662, DOI 10.1172/JCI4105; LYLE S, 1994, BIOCHEM J, V301, P349, DOI 10.1042/bj3010349; Mader JS, 2006, EXPERT OPIN INV DRUG, V15, P933, DOI 10.1517/13543784.15.8.933; MOR A, 1994, BIOCHEMISTRY-US, V33, P6642, DOI 10.1021/bi00187a034; Nicolas P, 2006, HANDBOOK OF BIOLOGICALLY ACTIVE PEPTIDES, P295, DOI 10.1016/B978-012369442-3/50048-9; Papo N, 2005, CELL MOL LIFE SCI, V62, P784, DOI 10.1007/s00018-005-4560-2; Riedl S, 2011, CHEM PHYS LIPIDS, V164, P766, DOI 10.1016/j.chemphyslip.2011.09.004; Schweizer F, 2009, EUR J PHARMACOL, V625, P190, DOI 10.1016/j.ejphar.2009.08.043; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; UTSUGI T, 1991, CANCER RES, V51, P3062; van Zoggel H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044351; van Zoggel H, 2012, AMINO ACIDS, V42, P385, DOI 10.1007/s00726-010-0815-9; WADE D, 1990, P NATL ACAD SCI USA, V87, P4761, DOI 10.1073/pnas.87.12.4761; Watson PA, 2015, NAT REV CANCER, V15, P701, DOI 10.1038/nrc4016; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x; ZHONG LX, 1992, P NATL ACAD SCI USA, V89, P4462, DOI 10.1073/pnas.89.10.4462	30	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182926	10.1371/journal.pone.0182926	http://dx.doi.org/10.1371/journal.pone.0182926			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797092	Green Published, gold, Green Submitted			2022-12-26	WOS:000407396200125
J	Mohammad, H; Younis, W; Ezzat, HG; Peters, CE; AbdelKhalek, A; Cooper, B; Pogliano, K; Pogliano, J; Mayhoub, AS; Seleem, MN				Mohammad, Haroon; Younis, Waleed; Ezzat, Hany G.; Peters, Christine E.; AbdelKhalek, Ahmed; Cooper, Bruce; Pogliano, Kit; Pogliano, Joe; Mayhoub, Abdelrahman S.; Seleem, Mohamed N.			Bacteriological profiling of diphenylureas as a novel class of antibiotics against methicillin-resistant Staphylococcus aureus	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; COMMUNITY-ASSOCIATED MRSA; CELL-WALL SYNTHESIS; IN-VITRO; PSEUDOMONAS-AERUGINOSA; BACILLUS-SUBTILIS; ANTIBACTERIAL; VANCOMYCIN; INFECTIONS; BINDING	Bacterial resistance to antibiotics remains an imposing global public health challenge. Of the most serious pathogens, methicillin-resistant Staphylococcus aureus (MRSA) is problematic given strains have emerged that exhibit resistance to several antibiotic classes including beta-lactams and agents of last resort such as vancomycin. New antibacterial agents composed of unique chemical scaffolds are needed to counter this public health challenge. The present study examines two synthetic diphenylurea compounds 1 and 2 that inhibit growth of clinically-relevant isolates of MRSA at concentrations as low as 4 mu g/mL and are non-toxic to human colorectal cells at concentrations up to 128 mu g/mL. Both compounds exhibit rapid bactericidal activity, completely eliminating a high inoculum of MRSA within four hours. MRSA mutants exhibiting resistance to 1 and 2 could not be isolated, indicating a low likelihood of rapid resistance emerging to these compounds. Bacterial cytological profiling revealed the diphenylureas exert their antibacterial activity by targeting bacterial cell wall synthesis. Both compounds demonstrate the ability to resensitize vancomycin-resistant Staphylococcus aureus to the effect of vancomycin. The present study lays the foundation for further investigation and development of diphenylurea compounds as a new class of antibacterial agents.	[Mohammad, Haroon; Younis, Waleed; AbdelKhalek, Ahmed; Seleem, Mohamed N.] Purdue Univ, Coll Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Younis, Waleed] South Valley Univ, Fac Vet Med, Dept Microbiol, Qena, Egypt; [Ezzat, Hany G.; Mayhoub, Abdelrahman S.] Al Azhar Univ, Coll Pharm, Dept Organ Chem, Cairo, Egypt; [Peters, Christine E.; Pogliano, Kit; Pogliano, Joe] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Cooper, Bruce] Purdue Univ, Bindley Biosci Ctr, W Lafayette, IN 47907 USA; [Mayhoub, Abdelrahman S.] Univ Sci & Technol, Biomed Sci, Zewail City Sci & Technol, Giza, Egypt; [Seleem, Mohamed N.] Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Egyptian Knowledge Bank (EKB); South Valley University Egypt; Egyptian Knowledge Bank (EKB); Al Azhar University; University of California System; University of California San Diego; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Egyptian Knowledge Bank (EKB); Misr University for Science & Technology; Zewail City of Science & Technology	Seleem, MN (corresponding author), Purdue Univ, Coll Vet Med, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA.; Mayhoub, AS (corresponding author), Al Azhar Univ, Coll Pharm, Dept Organ Chem, Cairo, Egypt.; Mayhoub, AS (corresponding author), Univ Sci & Technol, Biomed Sci, Zewail City Sci & Technol, Giza, Egypt.; Seleem, MN (corresponding author), Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA.	amayhoub@azhar.edu.eg; mseleem@purdue.edu	Seleem, Mohamed/H-2774-2018; Younis, Wlaeed/AAA-1743-2022	Seleem, Mohamed/0000-0003-0939-0458; Younis, Wlaeed/0000-0001-5572-0142; Mohammad, Haroon/0000-0002-8843-8933	US-Egypt Joint Grant from National Academy of Sciences (NAS), Washington, USA [USC17:241]; US-Egypt Joint Grant from the Science & Technology Development Funds (STDF), Egypt [USC17:241]; NIH [5R01AI113295-04]; Purdue University Institute for Drug Discovery	US-Egypt Joint Grant from National Academy of Sciences (NAS), Washington, USA; US-Egypt Joint Grant from the Science & Technology Development Funds (STDF), Egypt(Science and Technology Development Fund (STDF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Purdue University Institute for Drug Discovery	This work was supported by US-Egypt Joint Grant, Grant ID# USC17:241 from both National Academy of Sciences (NAS), Washington, USA, and the Science & Technology Development Funds (STDF), Egypt to A.S.M and M.N.S. This work was also supported by NIH grant 5R01AI113295-04 to K.P. and J.P.H.M. is supported with a fellowship from the Purdue University Institute for Drug Discovery. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bocchini CE, 2006, PEDIATRICS, V117, P433, DOI 10.1542/peds.2005-0566; Carrel M, 2015, EMERG INFECT DIS, V21, P1973, DOI 10.3201/eid2111.150452; Centers for Disease Control and Prevention, 2013, ANTIBIOTIC RESISTANC, P1; Chambers HF, 2005, NEW ENGL J MED, V352, P1485, DOI 10.1056/NEJMe058023; Chang HY, 2014, J BIOL CHEM, V289, P18719, DOI 10.1074/jbc.M114.575076; Chung BC, 2013, SCIENCE, V341, P1012, DOI 10.1126/science.1236501; Clark C, 2009, ANTIMICROB AGENTS CH, V53, P3118, DOI 10.1128/AAC.00183-09; Clinical and Laboratory Standards Institute, 2012, M07A9 CLIN LAB STAND; Cooper MA, 2011, NATURE, V472, P32, DOI 10.1038/472032a; D'Lima L, 2012, ANTIMICROB AGENTS CH, V56, P2753, DOI 10.1128/AAC.05985-11; Deresinski S, 2009, CLIN INFECT DIS, V49, P1072, DOI 10.1086/605572; Eissa IH, 2017, EUR J MED CHEM, V130, P73, DOI 10.1016/j.ejmech.2017.02.044; El Zoeiby A, 2003, MOL MICROBIOL, V47, P1, DOI 10.1046/j.1365-2958.2003.03289.x; Farrell DJ, 2011, ANTIMICROB AGENTS CH, V55, P1177, DOI 10.1128/AAC.01285-10; Frazee BW, 2005, ANN EMERG MED, V45, P311, DOI 10.1016/j.annemergmed.2004.10.011; French GL, 2006, J ANTIMICROB CHEMOTH, V58, P1107, DOI 10.1093/jac/dkl393; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Furlani RE, 2013, EUR J MED CHEM, V62, P59, DOI 10.1016/j.ejmech.2012.12.005; Gilbert DN, 2001, ANTIMICROB AGENTS CH, V45, P883, DOI 10.1128/AAC.45.3.883-892.2001; Gillet Y, 2002, LANCET, V359, P753, DOI 10.1016/S0140-6736(02)07877-7; Golding GR, 2011, EMERG INFECT DIS, V17, P722, DOI 10.3201/eid1704.100482; Graber CJ, 2007, EMERG INFECT DIS, V13, P491, DOI 10.3201/eid1303.060960; Guo RT, 2005, J BIOL CHEM, V280, P20762, DOI 10.1074/jbc.M502121200; Han LL, 2007, J CLIN MICROBIOL, V45, P1350, DOI 10.1128/JCM.02274-06; Hersh AL, 2012, CLIN INFECT DIS, V54, P1677, DOI 10.1093/cid/cis275; HOOPER DC, 1987, AM J MED, V82, P12; Hoque J, 2015, CHEM COMMUN, V51, P13670, DOI 10.1039/c5cc05159b; Kerns EH, 2008, DRUG-LIKE PROPERTIES: CONCEPTS, STRUCTURE DESIGN AND METHODS, P1; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Lamsa A, 2016, ACS CHEM BIOL, V11, P2222, DOI 10.1021/acschembio.5b01050; Lamsa A, 2012, MOL MICROBIOL, V84, P486, DOI 10.1111/j.1365-2958.2012.08038.x; LEE BL, 1991, ANTIMICROB AGENTS CH, V35, P2505, DOI 10.1128/AAC.35.12.2505; Lee SH, 2011, CHEM BIOL, V18, P1379, DOI 10.1016/j.chembiol.2011.08.015; Lipp R, 2013, AM PHARM REV; Liu Y, 2016, ANTIBIOTICS-BASEL, V5, DOI 10.3390/antibiotics5030028; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; May M, 2014, NATURE, V509, pS4, DOI 10.1038/509S4a; McKay GA, 2009, ANTIMICROB AGENTS CH, V53, P2687, DOI 10.1128/AAC.00197-09; Mohammad H, 2017, J MED CHEM, V60, P2425, DOI 10.1021/acs.jmedchem.6b01780; Mohammad H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130385; Mohammad H, 2015, J ANTIBIOT, V68, P259, DOI 10.1038/ja.2014.142; Mohammad H, 2015, EUR J MED CHEM, V94, P306, DOI 10.1016/j.ejmech.2015.03.015; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Mulvey MR, 2005, EMERG INFECT DIS, V11, P844, DOI 10.3201/eid1106.041146; Nonejuie P, 2013, P NATL ACAD SCI USA, V110, P16169, DOI 10.1073/pnas.1311066110; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Odell CA, 2010, CURR OPIN PEDIATR, V22, P273, DOI 10.1097/MOP.0b013e328339421b; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Rybak MJ, 2008, J CLIN MICROBIOL, V46, P2950, DOI 10.1128/JCM.00582-08; Schmitt P, 2010, J BIOL CHEM, V285, P29208, DOI 10.1074/jbc.M110.143388; Seleem MA, 2016, J MED CHEM, V59, P4900, DOI 10.1021/acs.jmedchem.6b00233; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; Simor AE, 2007, ANTIMICROB AGENTS CH, V51, P3880, DOI 10.1128/AAC.00846-07; Singh MP, 2003, ANTIMICROB AGENTS CH, V47, P62, DOI 10.1128/AAC.47.1.62-69.2003; Stryjewski ME, 2008, CLIN INFECT DIS, V46, pS368, DOI 10.1086/533593; The Pew Charitable Trusts IDSoA, 2011, PHARM RES MAN AM; Wang H, 2013, CHEM BIOL, V20, P272, DOI 10.1016/j.chembiol.2012.11.013; Wang R, 2011, J CLIN INVEST, V121, P238, DOI 10.1172/JCI42520; Wilson P, 2003, J ANTIMICROB CHEMOTH, V51, P186, DOI 10.1093/jac/dkg104	59	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182821	10.1371/journal.pone.0182821	http://dx.doi.org/10.1371/journal.pone.0182821			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797064	Green Submitted, Green Published, gold			2022-12-26	WOS:000407396200101
J	Oshota, O; Conway, M; Fookes, M; Schreiber, F; Chaudhuri, RR; Yu, L; Morgan, FJE; Clare, S; Choudhary, J; Thomson, NR; Lio, P; Maskell, DJ; Mastroeni, P; Grant, AJ				Oshota, Olusegun; Conway, Max; Fookes, Maria; Schreiber, Fernanda; Chaudhuri, Roy R.; Yu, Lu; Morgan, Fiona J. E.; Clare, Simon; Choudhary, Jyoti; Thomson, Nicholas R.; Lio, Pietro; Maskell, Duncan J.; Mastroeni, Pietro; Grant, Andrew J.			Transcriptome and proteome analysis of Salmonella enterica serovar Typhimurium systemic infection of wild type and immune-deficient mice	PLOS ONE			English	Article							RESISTANCE; SUSCEPTIBILITY; ENTEROBACTIN; VIRULENCE; PEPTIDES	Salmonella enterica are a threat to public health. Current vaccines are not fully effective. The ability to grow in infected tissues within phagocytes is required for S. enterica virulence in systemic disease. As the infection progresses the bacteria are exposed to a complex host immune response. Consequently, in order to continue growing in the tissues, S. enterica requires the coordinated regulation of fitness genes. Bacterial gene regulation has so far been investigated largely using exposure to artificial environmental conditions or to in vitro cultured cells, and little information is available on how S. enterica adapts in vivo to sustain cell division and survival. We have studied the transcriptome, proteome and metabolic flux of Salmonella, and the transcriptome of the host during infection of wild type C57BL/6 and immune-deficient gp91(-/-) phox mice. Our analyses advance the understanding of how S. enterica and the host behaves during infection to a more sophisticated level than has previously been reported.	[Oshota, Olusegun; Chaudhuri, Roy R.; Morgan, Fiona J. E.; Maskell, Duncan J.; Mastroeni, Pietro; Grant, Andrew J.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Conway, Max; Lio, Pietro] Univ Cambridge, Comp Lab, JJ Thomson Ave, Cambridge, England; [Fookes, Maria; Schreiber, Fernanda; Yu, Lu; Clare, Simon; Choudhary, Jyoti; Thomson, Nicholas R.] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England; [Thomson, Nicholas R.] London Sch Hyg & Trop Med, London, England; [Oshota, Olusegun] Discuva Ltd, Merrifield Ctr, Rosemary Lane, Cambridge, England; [Chaudhuri, Roy R.] Univ Sheffield, Dept Mol Biol & Biotechnol, Firth Court, Western Bank, Sheffield, S Yorkshire, England; [Morgan, Fiona J. E.] Univ Cambridge, Dept Phys, JJ Thomson Ave, Cambridge, England	University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; University of London; London School of Hygiene & Tropical Medicine; University of Sheffield; University of Cambridge	Grant, AJ (corresponding author), Univ Cambridge, Dept Vet Med, Cambridge, England.	ajg60@cam.ac.uk	Chaudhuri, Roy/E-3774-2014; P. Lió, Pietro Lio/AAV-3358-2021; Choudhary, Jyoti/S-1232-2017; Thomson, Nicholas R/P-5988-2014	Chaudhuri, Roy/0000-0001-5037-2695; P. Lió, Pietro Lio/0000-0002-0540-5053; Choudhary, Jyoti/0000-0003-0881-5477; Thomson, Nicholas R/0000-0002-4432-8505; Mastroeni, Pietro/0000-0003-3838-4962; Conway, Max/0000-0001-8913-0909; Morgan, Fiona/0000-0003-0583-7996	Medical Research Council (MRC) [G0801161]; Newton Trust; Engineering and Physical Sciences Research Council (EPSRC) doctoral training studentship; MRC [G1100102, G0801161] Funding Source: UKRI; Engineering and Physical Sciences Research Council [1510469] Funding Source: researchfish; Medical Research Council [G0801161, G1100102] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Newton Trust; Engineering and Physical Sciences Research Council (EPSRC) doctoral training studentship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Medical Research Council (MRC) grant G0801161 awarded to AJG, PM and DJM. OO was supported by a Newton Trust grant awarded to AJG. MC was supported by an Engineering and Physical Sciences Research Council (EPSRC) doctoral training studentship. OO is currently employed by Discuva Ltd, though he was employed by the University of Cambridge at the time that work was conducted. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Angione C, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0912-1; Ao TT, 2015, EMERG INFECT DIS, V21, P941, DOI 10.3201/eid2106.140999; Bailey AM, 2010, J BACTERIOL, V192, P1607, DOI 10.1128/JB.01517-09; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown DP, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-56; CHEN P, 1994, J BACTERIOL, V176, P5474, DOI 10.1128/JB.176.17.5474-5482.1994; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Crump JA, 2015, CLIN MICROBIOL REV, V28, P901, DOI 10.1128/CMR.00002-15; Crump JA, 2014, T ROY SOC TROP MED H, V108, P673, DOI 10.1093/trstmh/tru152; Dybowski R, 2015, J R SOC INTERFACE, V6, P113; Gilchrist JJ, 2015, NAT REV IMMUNOL, V15, P452, DOI 10.1038/nri3858; Grant AJ, 2008, PLOS BIOL, V6, P757, DOI 10.1371/journal.pbio.0060074; Grant AJ, 2016, INFECT IMMUN, V84, P989, DOI 10.1128/IAI.01423-15; Grant AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003070; GROISMAN EA, 1992, P NATL ACAD SCI USA, V89, P11939, DOI 10.1073/pnas.89.24.11939; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Kariuki S, 2015, VACCINE, V33, pS21, DOI 10.1016/j.vaccine.2015.03.102; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Mastroeni P, 2003, REV MED MICROBIOL, V14, P53; Mastroeni P, 2011, INFECT IMMUN, V79, P636, DOI 10.1128/IAI.00954-10; Nagy TA, 2013, INFECT IMMUN, V81, P4063, DOI 10.1128/IAI.00412-13; Paiva JB, 2009, BRAZ J MICROBIOL, V40, P994, DOI 10.1590/S1517-838220090004000035; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; Raghunathan A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-38; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; Saliba AE, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.206; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Srikumar S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005262; Thompson A, 2006, CURR OPIN MICROBIOL, V9, P109, DOI 10.1016/j.mib.2005.12.010	32	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0181365	10.1371/journal.pone.0181365	http://dx.doi.org/10.1371/journal.pone.0181365			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796780	Green Published, Green Accepted, gold			2022-12-26	WOS:000407396200014
J	Park, J; Mori, H; Okuyama, Y; Asada, M				Park, Jihoon; Mori, Hiroki; Okuyama, Yuji; Asada, Minoru			Chaotic itinerancy within the coupled dynamics between a physical body and neural oscillator networks	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; RICH-CLUB ORGANIZATION; SMALL-WORLD; RESTING-STATE; BRAIN; MODEL; PATTERNS; SYNCHRONIZATION; VARIABILITY; EMERGENCE	Chaotic itinerancy is a phenomenon in which the state of a nonlinear dynamical system spontaneously explores and attracts certain states in a state space. From this perspective, the diverse behavior of animals and its spontaneous transitions lead to a complex coupled dynamical system, including a physical body and a brain. Herein, a series of simulations using different types of non-linear oscillator networks (i.e., regular, small-world, scale-free, random) with a musculoskeletal model (i.e., a snake-like robot) as a physical body are conducted to understand how the chaotic itinerancy of bodily behavior emerges from the coupled dynamics between the body and the brain. A behavior analysis (behavior clustering) and network analysis for the classified behavior are then applied. The former consists of feature vector extraction from the motions and classification of the movement patterns that emerged from the coupled dynamics. The network structures behind the classified movement patterns are revealed by estimating the "information networks" different from the given non-linear oscillator networks based on the transfer entropy which finds the information flow among neurons. The experimental results show that: (1) the number of movement patterns and their duration depend on the sensor ratio to control the balance of strength between the body and the brain dynamics and on the type of the given non-linear oscillator networks; and (2) two kinds of information networks are found behind two kinds movement patterns with different durations by utilizing the complex network measures, clustering coefficient and the shortest path length with a negative and a positive relationship with the duration periods of movement patterns. The current results seem promising for a future extension of the method to a more complicated body and environment. Several requirements are also discussed.	[Park, Jihoon; Okuyama, Yuji; Asada, Minoru] Osaka Univ, Grad Sch Engn, Dept Adapt Machine Syst, Suita, Osaka, Japan; [Mori, Hiroki] Waseda Univ, Sch Fundamental Sci & Engn, Dept Intermedia Art & Sci, Tokyo, Japan; [Asada, Minoru] Osaka Univ, Open Res Initiat, Syst Intelligence Div, Suita, Osaka, Japan; [Asada, Minoru] Osaka Univ, Transdisciplinary Res Initiat, Syst Intelligence Div, Suita, Osaka, Japan	Osaka University; Waseda University; Osaka University; Osaka University	Park, J (corresponding author), Osaka Univ, Grad Sch Engn, Dept Adapt Machine Syst, Suita, Osaka, Japan.	jihoon.park@ams.eng.osaka-u.ac.jp		Park, Jihoon/0000-0003-3582-204X	Japan Society for the Promotion of Science (JP) [24000012]	Japan Society for the Promotion of Science (JP)	This work was supported by Japan Society for the Promotion of Science (JP) "Constructive Developmental Science Based on Understanding the Process from Neuro-Dynamics to Social Interaction" (No. 24000012) (https://www.jsps.go.jp/english/index.html). Jihoon Park, Hiroki Mori, and Minoru Asada received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; AMARI SI, 1977, BIOL CYBERN, V27, P77, DOI 10.1007/BF00337259; Anderson ML, 2013, NEUROIMAGE, V73, P50, DOI 10.1016/j.neuroimage.2013.01.071; [Anonymous], 1997, DYNAMIC PATTERNS SEL; Asai Y, 2000, BIOSYSTEMS, V58, P239, DOI 10.1016/S0303-2647(00)00128-3; Ball G, 2014, P NATL ACAD SCI USA, V111, P7456, DOI 10.1073/pnas.1324118111; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; BEER RD, 1995, ARTIF INTELL, V72, P173, DOI 10.1016/0004-3702(94)00005-L; Beer RD, 2000, TRENDS COGN SCI, V4, P91, DOI 10.1016/S1364-6613(99)01440-0; Belkin M, 2003, NEURAL COMPUT, V15, P1373, DOI 10.1162/089976603321780317; Breakspear M, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00190; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Buzsaki Gyorgy, 2012, Dialogues Clin Neurosci, V14, P345; Byrge L, 2014, TRENDS COGN SCI, V18, P395, DOI 10.1016/j.tics.2014.04.010; Cole MW, 2014, NEURON, V83, P238, DOI 10.1016/j.neuron.2014.05.014; Cole MW, 2013, NAT NEUROSCI, V16, P1348, DOI 10.1038/nn.3470; Cumin D, 2007, PHYSICA D, V226, P181, DOI 10.1016/j.physd.2006.12.004; Dumas G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036414; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Ester M., 1996, P 2 INT C KNOWLEDGE, P226; Fagiolo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026107; Fornito A, 2012, NEUROIMAGE, V62, P2296, DOI 10.1016/j.neuroimage.2011.12.090; Freeman WJ, 2003, CHAOS, V13, P1067, DOI 10.1063/1.1596553; FREEMAN WJ, 1987, BIOL CYBERN, V56, P139, DOI 10.1007/BF00317988; Galan RF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002148; Gao ZK, 2017, INT J NEURAL SYST, V27, DOI 10.1142/S0129065717500058; Gao ZK, 2016, EPL-EUROPHYS LETT, V116, DOI 10.1209/0295-5075/116/50001; Gao ZK, 2016, SCI REP-UK, V6, DOI 10.1038/srep35622; Gao ZK, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/30005; Gao ZK, 2015, EXP THERM FLUID SCI, V60, P157, DOI 10.1016/j.expthermflusci.2014.09.008; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Haar S, 2017, BIORXIV; Hadders-Algra M, 2007, NEUROSCI BIOBEHAV R, V31, P1181, DOI 10.1016/j.neubiorev.2007.04.009; Hadders-Algra M, 2010, PHYS THER, V90, P1823, DOI 10.2522/ptj.20100006; He JP, 2001, IEEE CONTR SYST MAG, V21, P55, DOI 10.1109/37.939944; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Hermundstad AM, 2013, P NATL ACAD SCI USA, V110, P6169, DOI 10.1073/pnas.1219562110; Herzfeld DJ, 2014, NAT NEUROSCI, V17, P149, DOI 10.1038/nn.3633; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Izhikevich EM, 2008, P NATL ACAD SCI USA, V105, P3593, DOI 10.1073/pnas.0712231105; KANEKO K, 1990, PHYSICA D, V41, P137, DOI 10.1016/0167-2789(90)90119-A; Kaneko K., 2011, COMPLEX SYSTEMS CHAO; Kemp Charles, 2006, AAAI, DOI DOI 10.1145/1837026.1837061; Kinney R, 2005, EUR PHYS J B, V46, P101, DOI 10.1140/epjb/e2005-00237-9; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Kuniyoshi Y., 2004, IEEE RSJ INT C INT R, V2, P2042; Kuniyoshi Y, 2006, BIOL CYBERN, V95, P589, DOI 10.1007/s00422-006-0127-z; KURAMOTO Y, 1984, SUP PROG THEOR PHYS, P223; Lizier JT, 2014, FRONT ROBOT AI, DOI 10.3389/frobt.2014.00011; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; Menon V, 2013, TRENDS COGN SCI, V17, P627, DOI 10.1016/j.tics.2013.09.015; Mori Hiroki, 2010, 2010 IEEE 9th International Conference on Development and Learning (ICDL 2010), P82, DOI 10.1109/DEVLRN.2010.5578860; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Nomi JS, 2015, NEUROIMAGE-CLIN, V7, P732, DOI 10.1016/j.nicl.2015.02.024; Oku M, 2011, IEICE NONLINEAR THEO, V2, P508, DOI 10.1587/nolta.2.508; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Peyton C, 2016, EARLY HUM DEV, V95, P23, DOI 10.1016/j.earlhumdev.2016.01.017; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017; Rabinovich MI, 2015, TRENDS COGN SCI, V19, P453, DOI 10.1016/j.tics.2015.06.005; Smith LB, 1999, PSYCHOL REV, V106, P235, DOI 10.1037/0033-295X.106.2.235; Smith LB, 2003, TRENDS COGN SCI, V7, P343, DOI 10.1016/S1364-6613(03)00156-6; Smith Russell, 2005, OPEN DYNAMICS ENGINE; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stam CJ, 2004, NEUROSCI LETT, V355, P25, DOI 10.1016/j.neulet.2003.10.063; Strogatz SH, 2000, PHYSICA D, V143, P1, DOI 10.1016/S0167-2789(00)00094-4; Taga G., 1999, IEEE SMC'99 Conference Proceedings. 1999 IEEE International Conference on Systems, Man, and Cybernetics (Cat. No.99CH37028), P678, DOI 10.1109/ICSMC.1999.815633; Tani J., 2016, EXPLORING ROBOTIC MI; Teo JTH, 2011, CEREB CORTEX, V21, P1627, DOI 10.1093/cercor/bhq231; Thelen E, 2001, BEHAV BRAIN SCI, V24, P1, DOI 10.1017/S0140525X01003910; Thelen Esther, 1996, DYNAMIC SYSTEMS APPR; Tomasi D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096176; TSUDA I, 1987, PROG THEOR PHYS, V78, P51, DOI 10.1143/PTP.78.51; Tsuda I, 2001, BEHAV BRAIN SCI, V24, P793, DOI 10.1017/S0140525X01000097; Tsuda Ichiro, 2007, Journal of Integrative Neuroscience, V6, P309, DOI 10.1142/S0219635207001507; Tsuda Ichiro, 2004, Journal of Integrative Neuroscience, V3, P159, DOI 10.1142/S021963520400049X; Tsuda I, 2009, CHAOS, V19, DOI 10.1063/1.3076393; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WILLEBOORDSE FH, 1995, PHYSICA D, V86, P428, DOI 10.1016/0167-2789(95)00044-5; Yamada Y, SCI REPORTS, V6, P27893; Yamanishi T, 2013, GSTF J COMPUTING JOC, V3, P8	91	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182518	10.1371/journal.pone.0182518	http://dx.doi.org/10.1371/journal.pone.0182518			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796797	gold, Green Published, Green Submitted			2022-12-26	WOS:000407396200056
J	Touraine, S; Bouhadoun, H; Engelke, K; Laredo, JD; Chappard, C				Touraine, Sebastien; Bouhadoun, Hamid; Engelke, Klaus; Laredo, Jean Denis; Chappard, Christine			Influence of meniscus on cartilage and subchondral bone features of knees from older individuals: A cadaver study	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; MEDIAL MENISCUS; CANCELLOUS BONE; TRABECULAR BONE; QUANTITATIVE MORPHOLOGY; OSTEOARTHRITIS; QUANTIFICATION; MENISCECTOMY; THICKNESS; MICROARCHITECTURE	Objective Cartilage and subchondral bone form a functional unit. Here, we aimed to examine the effect of meniscus coverage on the characteristics of this unit in knees of older individuals. Methods We assessed the hyaline cartilage, subchondral cortical plate (SCP), and subchondral trabecular bone in areas covered or uncovered by the meniscus from normal cadaver knees (without degeneration). Bone cores harvested from the medial tibial plateau at locations uncovered (central), partially covered (posterior), and completely covered (peripheral) by the meniscus were imaged by micro-CT. The following were measured on images: cartilage volume (Cart.Vol, mm(3)) and thickness (Cart.Th, mm); SCP thickness (SCP.Th, mu m) and porosity (SCP.Por, %); bone volume to total volume fraction (BV/TV, %); trabecular thickness (Tb.Th, mu m), spacing (Tb.Sp, mu m), and number (Tb.N, 1/mm); structure model index (SMI); trabecular pattern factor (Tb.Pf); and degree of anisotropy (DA). Results Among the 28 specimens studied (18 females) from individuals with mean age 82.8 +/- 10.2 years, cartilage and SCP were thicker at the central site uncovered by the meniscus than the posterior and peripheral sites, and Cart.Vol was greater. SCP.Por was highest in posterior samples. In the upper 1-5 mm of subchondral bone, central samples were characterized by higher values for BV/TV, Tb.N, Tb.Th, and connectivity (Tb.Pf), a more plate-like trabecular structure and lower anisotropy than with other samples. Deeper down, at 6-10 mm, the differences were slightly higher for Tb.Th centrally, DA peripherally and SMI posteriorly. Conclusions The coverage or not by meniscus in the knee of older individuals is significantly associated with Cart.Th, SCP.Th, SCP.Por and trabecular microarchitectural parameters in the most superficial 5 mm and to a lesser extent the deepest area of subchondral trabecular bone. These results suggest an effect of differences in local loading conditions. In subchondral bone uncovered by the meniscus, the trabecular architecture resembles that of highly loaded areas.	[Touraine, Sebastien; Bouhadoun, Hamid; Laredo, Jean Denis; Chappard, Christine] Univ Paris Diderot, CNRS, UMR 7052, B2OA, Paris, France; [Touraine, Sebastien; Laredo, Jean Denis] Hop Lariboisiere, Serv Radiol Osteoarticulaire, Paris, France; [Engelke, Klaus] Univ Erlangen Nurnberg, Inst Med Phys, Erlangen, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Erlangen Nuremberg	Chappard, C (corresponding author), Univ Paris Diderot, CNRS, UMR 7052, B2OA, Paris, France.	christine.chappard@inserm.fr	Chappard, Christine/AAB-2613-2022		Agence Nationale de la Recherche [ANR-09-TECS-018, ANR-12-TECS-018]	Agence Nationale de la Recherche(French National Research Agency (ANR))	The only financial support was from the Agence Nationale de la Recherche in 2 programs: ANR MODOS No ANR-09-TECS-018 for specimens and ANR VOXELO No ANR-12-TECS-018 for H Bouhadoun financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaire R, 2008, J BONE JOINT SURG AM, V90A, P1922, DOI 10.2106/JBJS.G.00748; Arkill KP, 2008, OSTEOARTHR CARTILAGE, V16, P708, DOI 10.1016/j.joca.2007.10.001; Bae JY, 2012, MED BIOL ENG COMPUT, V50, P53, DOI 10.1007/s11517-011-0840-1; Bedi A, 2010, J BONE JOINT SURG AM, V92A, P1398, DOI 10.2106/JBJS.I.00539; Biswal S, 2002, ARTHRITIS RHEUM-US, V46, P2884, DOI 10.1002/art.10573; Chappard C, 2006, OSTEOARTHR CARTILAGE, V14, P215, DOI 10.1016/j.joca.2005.09.008; Chen Y, 2015, OSTEOARTHR CARTILAGE, V23, P2174, DOI 10.1016/j.joca.2015.07.012; Delecourt C, 2016, OSTEOARTHR CARTILAGE, V24, P567, DOI 10.1016/j.joca.2015.10.009; Ding M, 2000, BONE, V26, P291, DOI 10.1016/S8756-3282(99)00281-1; Fages J, 1998, J SUPERCRIT FLUID, V13, P351, DOI 10.1016/S0896-8446(98)00071-0; Felson DT, 2006, NEW ENGL J MED, V354, P841, DOI 10.1056/NEJMcp051726; Fox AJS, 2015, CLIN ANAT, V28, P269, DOI 10.1002/ca.22456; Fukuda Y, 2000, CLIN BIOMECH, V15, P516, DOI 10.1016/S0268-0033(00)00013-9; Gale DR, 1999, OSTEOARTHR CARTILAGE, V7, P526, DOI 10.1053/joca.1999.0256; HAHN M, 1992, BONE, V13, P327, DOI 10.1016/8756-3282(92)90078-B; Harada Y, 1988, J Arthroplasty, V3, P167, DOI 10.1016/S0883-5403(88)80082-2; HARRIGAN TP, 1988, J BIOMECH, V21, P269, DOI 10.1016/0021-9290(88)90257-6; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; HSU RWW, 1990, CLIN ORTHOP RELAT R, P215; Hunter DJ, 2006, ARTHRITIS RHEUM-US, V54, P795, DOI 10.1002/art.21724; Iijima H, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-101; Issever A. S., 2003, Journal of Musculoskeletal & Neuronal Interactions, V3, P176; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; LANE LB, 1977, J BONE JOINT SURG BR, V59, P272, DOI 10.1302/0301-620X.59B3.893504; Li GY, 2015, BONE, V77, P91, DOI 10.1016/j.bone.2015.04.019; MEACHIM G, 1975, J PATHOL, V115, P231, DOI 10.1002/path.1711150408; MILZ S, 1994, J ANAT, V185, P103; Muller-Gerbl M., 1998, ADV ANAT EMBRYOL CEL, V141, P1; ODGAARD A, 1989, J ORTHOP RES, V7, P744, DOI 10.1002/jor.1100070517; Odgaard A, 1997, BONE, V20, P315, DOI 10.1016/S8756-3282(97)00007-0; Patel V, 2003, J ORTHOP RES, V21, P6, DOI 10.1016/S0736-0266(02)00093-1; Pauli C, 2011, OSTEOARTHR CARTILAGE, V19, P1132, DOI 10.1016/j.joca.2011.05.008; RADIN EL, 1984, CLIN ORTHOP RELAT R, P290; Shepherd DET, 1999, ANN RHEUM DIS, V58, P27, DOI 10.1136/ard.58.1.27; Thambyah A, 2006, OSTEOARTHR CARTILAGE, V14, P580, DOI 10.1016/j.joca.2006.01.015; Uhl M, 1998, BRIT J RADIOL, V71, P291, DOI 10.1259/bjr.71.843.9616238; Ulrich D, 1999, BONE, V25, P55, DOI 10.1016/S8756-3282(99)00098-8; Walker PS, 2015, J BIOMECH, V48, P1383, DOI 10.1016/j.jbiomech.2015.02.055; WHITEHOUSE WJ, 1974, J MICROSC-OXFORD, V101, P153, DOI 10.1111/j.1365-2818.1974.tb03878.x	40	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0181956	10.1371/journal.pone.0181956	http://dx.doi.org/10.1371/journal.pone.0181956			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797093	Green Published, Green Submitted, gold			2022-12-26	WOS:000407396200022
J	Xu, LL; Zhao, Y; Xu, MS; Yao, Y; Nie, XL; Du, HY; Tu, YG				Xu, Lilan; Zhao, Yan; Xu, Mingsheng; Yao, Yao; Nie, Xuliang; Du, Huaying; Tu, Yong-gang			Effects of salting treatment on the physicochemical properties, textural properties, and microstructures of duck eggs	PLOS ONE			English	Article							HISTOLOGICAL STRUCTURES; CHEMICAL-COMPOSITION; PHYSICAL-PROPERTIES; MASS-TRANSFER; YOLK; PH; GELS	In order to illuminate the forming process of salted egg, the effects of the brine solution with different salt concentrations on the physicochemical properties, textural properties, and microstructures of duck eggs were evaluated using conventional physicochemical property determination methods. The results showed that the moisture contents of both the raw and cooked egg whites and egg yolks, the springiness of the raw egg yolks and cooked egg whites exhibited a decreasing trend with the increase in the salting time and salt concentration. The salt content, oil exudation and the hardness of the raw egg yolks showed a constantly increasing trend. Viscosity of the raw egg whites showed an overall trend in which it first deceased and then increased and decreased again, which was similar to the trend of the hardness of the cooked egg whites and egg yolks. As the salting proceeded, the pH value of the raw and cooked egg whites declined remarkably and then declined slowly, whereas the pH of the raw and cooked egg yolks did not show any noticeable changes. The effect of salting on the pH value varied significantly with the salt concentration in the brine solution. Scanning electron microscopy (SEM) revealed that salted yolks consist of spherical granules and embedded flattened porosities. It was concluded that the treatment of salt induces solidification of yolk, accompanied with higher oil exudation and the development of a gritty texture. Different salt concentrations show certain differences.	[Xu, Lilan; Xu, Mingsheng; Yao, Yao; Nie, Xuliang; Du, Huaying; Tu, Yong-gang] Jiangxi Agr Univ, Jiangxi Key Lab Nat Prod & Funct Food, Nanchang, Jiangxi, Peoples R China; [Zhao, Yan] Nanchang Univ, Minist Educ, Engn Res Ctr Biomass Convers, Nanchang, Jiangxi, Peoples R China; [Zhao, Yan] Nanchang Univ, State Key Lab Food Sci & Technol, Nanchang, Jiangxi, Peoples R China	Jiangxi Agricultural University; Nanchang University; Nanchang University	Tu, YG (corresponding author), Jiangxi Agr Univ, Jiangxi Key Lab Nat Prod & Funct Food, Nanchang, Jiangxi, Peoples R China.	tygzy1212@aliyun.com	Tu, Yonggang/HHT-0746-2022		Young Scientist Training Objects Program of Jiangxi Province, China [20153BCB23028]; Jiangxi Province Outstanding Youth Talent Funded Projects [20162BCB23031]	Young Scientist Training Objects Program of Jiangxi Province, China; Jiangxi Province Outstanding Youth Talent Funded Projects	We gratefully acknowledge the financial support provided by the Young Scientist Training Objects Program of Jiangxi Province, China (grant no. 20153BCB23028) and Jiangxi Province Outstanding Youth Talent Funded Projects (20162BCB23031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Nour N, 2011, FOOD BIOPROCESS TECH, V4, P731, DOI 10.1007/s11947-009-0265-0; [Anonymous], 2010, 5009 GBT MIN HLTH PE; [Anonymous], 5009472003 GBT I FOO; [Anonymous], 124572008 GBT STAND; BELLAIRS R, 1961, J BIOPHYS BIOCHEM CY, V11, P207, DOI 10.1083/jcb.11.1.207; CAUSERET D, 1992, J FOOD SCI, V57, P1323, DOI 10.1111/j.1365-2621.1992.tb06847.x; CAUSERET D, 1991, J FOOD SCI, V56, P1532, DOI 10.1111/j.1365-2621.1991.tb08634.x; Chi SP, 1998, J FOOD SCI, V63, P27, DOI 10.1111/j.1365-2621.1998.tb15668.x; Croguennec T, 2002, J FOOD SCI, V67, P608, DOI 10.1111/j.1365-2621.2002.tb10646.x; FEENEY RE, 1956, POULTRY SCI, V35, P1061, DOI 10.3382/ps.0351061; FLETCHER DL, 1984, POULTRY SCI, V63, P1759, DOI 10.3382/ps.0631759; Gosal WS, 2000, CURR OPIN COLLOID IN, V5, P188, DOI 10.1016/S1359-0294(00)00057-1; Hsu KC, 2009, J AGR FOOD CHEM, V57, P4218, DOI 10.1021/jf900495n; Huang JJ, 1999, J FOOD BIOCHEM, V23, P607, DOI 10.1111/j.1745-4514.1999.tb00589.x; Kaewmanee T, 2009, J SCI FOOD AGR, V89, P625, DOI 10.1002/jsfa.3492; Kaewmanee T, 2009, FOOD CHEM, V112, P560, DOI 10.1016/j.foodchem.2008.06.011; Kaewmanee T, 2011, J FOOD SCI, V76, pS139, DOI 10.1111/j.1750-3841.2010.01975.x; Kaewmanee T, 2012, FOOD BIOPROCESS TECH, V5, P1502, DOI 10.1007/s11947-011-0510-1; Kaewmanee T, 2011, FOOD CHEM, V125, P706, DOI 10.1016/j.foodchem.2010.09.072; Khoa Luu Mai Dang, 2014, Kasetsart Journal, Natural Science, V48, P942; Kiosseoglou V, 2003, CURR OPIN COLLOID IN, V8, P365, DOI 10.1016/S1359-0294(03)00094-3; Lai KM, 2010, POULTRY SCI, V89, P738, DOI 10.3382/ps.2009-00334; Lai KM, 1999, J AGR FOOD CHEM, V47, P733, DOI 10.1021/jf980486r; Long Men, 2015, Transactions of the Chinese Society of Agricultural Engineering, V31, P281, DOI 10.11975/j.issn.1002-6819.2015.18.038; Makki F, 1996, FOOD RES INT, V29, P635, DOI 10.1016/S0963-9969(96)00074-9; McCullagh CM, 1996, INT J BIOL MACROMOL, V18, P247, DOI 10.1016/0141-8130(95)01086-6; Omana DA, 2010, TRENDS FOOD SCI TECH, V21, P455, DOI 10.1016/j.tifs.2010.07.001; Paraskevopoulou A, 1997, J FOOD SCI, V62, P208, DOI 10.1111/j.1365-2621.1997.tb04401.x; [荣建华 Rong Jianhua], 2006, [华中农业大学学报, Journal of Huazhong Agricultural University], V25, P676; Sousa RDS, 2007, LWT-FOOD SCI TECHNOL, V40, P1253, DOI 10.1016/j.lwt.2006.08.001; Stadelman W.J., 1973, EGG SCI TECHNOLOGY; TOMIMATSU Y, 1972, J AGR FOOD CHEM, V20, P1067, DOI 10.1021/jf60183a038; Wang G, 2015, J EXP BIOL, V218, P3468, DOI 10.1242/jeb.129486; Wang M., 2015, THESIS; Wang XT, 2013, J FOOD ENG, V117, P141, DOI 10.1016/j.jfoodeng.2013.02.013; Wang Y, 2015, FOOD SCI TECHNOLOGY, P33; [卫惠萍 Wei Huiping], 2011, [中国农学通报, Chinese Agricultural Science Bulletin], V27, P74; WOODWARD SA, 1988, POULTRY SCI, V67, P1264, DOI 10.3382/ps.0671264; Zuo SM, 2013, THESIS	39	39	39	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182912	10.1371/journal.pone.0182912	http://dx.doi.org/10.1371/journal.pone.0182912			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797071	Green Published, gold, Green Submitted			2022-12-26	WOS:000407396200120
J	Zappes, IA; Fabiani, A; Sbordoni, V; Rakaj, A; Palozzi, R; Allegrucci, G				Zappes, Ighor Antunes; Fabiani, Anna; Sbordoni, Valerio; Rakaj, Arnold; Palozzi, Roberto; Allegrucci, Giuliana			New data on Weddell seal (Leptonychotes weddellii) colonies: A genetic analysis of a top predator from the Ross Sea, Antarctica	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; SOUTHERN ELEPHANT SEALS; NUCLEOTIDE DIVERSITY; DIVING BEHAVIOR; UNDERWATER VOCALIZATIONS; SITE FIDELITY; MCMURDO-SOUND; EVOLUTION; DYNAMICS; SRY	In this paper, we studied the genetic variability in Weddell seal from colonies in Terra Nova Bay and Wood Bay, both sites located in the Ross Sea area, Antarctica. Two mitochondrial genes and one nuclear gene, with different mutation rates, were sequenced to investigate the haplotype diversity of the colonies and to test for a possible recent expansion. Fifteen microsatellites were used to analyze their genetic structure. Sequenced genes and microsatellites were also used to estimate the effective population size of the studied colonies and the Ross Sea seal population. The Ross Sea has a high density population of Weddel seals, with an estimated effective number of 50,000 females, and 1,341 individuals for the sampling area, possibly due to its high primary production. The colonies showed high diversity (Hd > 0.90) and many exclusive haplotypes (> 75%), likely a consequence of the surprisingly high site fidelity of Weddell seals, despite the proximity of the colonies. Nevertheless, there was low microsatellite differentiation between colonies, suggesting that they are part of a single larger population. Their expansion seemed to have started during the last glacial cycle (around 58,000 years ago), indicating that the Ross Sea seal populations have been present in the area for long time, probably due to the lack of hunting by humans and terrestrial predation. As a top predator, the role of Weddell seals in the Ross Sea ecology is crucial, and its demographic dynamics should be monitored to follow the future changes of such an important ecosystem.	[Zappes, Ighor Antunes; Fabiani, Anna; Sbordoni, Valerio; Rakaj, Arnold; Palozzi, Roberto; Allegrucci, Giuliana] Univ Roma Tor Vergata, Dept Biol, Rome, Lazio, Italy	University of Rome Tor Vergata	Zappes, IA (corresponding author), Univ Roma Tor Vergata, Dept Biol, Rome, Lazio, Italy.	ighorzappes@gmail.com	Allegrucci, Giuliana/AAZ-2217-2021; Sbordoni, Valerio/L-8889-2013	Sbordoni, Valerio/0000-0002-9510-1925; Rakaj, Arnold/0000-0003-2213-7131	Ministero dell'Istruzione, dell'Universita e della Ricerca [PdR 2013/AZ1.01]	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was supported by Ministero dell'Istruzione, dell'Universita e della Ricerca (http://www.pnra.it/it), Grant number: PdR 2013/AZ1.01. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abgrall Patrick, 2003, Aquatic Mammals, V29, P268, DOI 10.1578/016754203101024202; Ainley D.G., 2002, ADELIE PENGUIN BELLW; Ainley D.G., 1983, BREEDING BIOL ADELIE; Andersen LW, 2011, BIOL J LINN SOC, V102, P420, DOI 10.1111/j.1095-8312.2010.01577.x; [Anonymous], THESIS; Arrigo KR, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004551; Artico LO, 2010, BRAZ J MED BIOL RES, V43, P816, DOI 10.1590/S0100-879X2010007500074; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BARONI C, 1994, ANTARCT SCI, V6, P497, DOI 10.1017/S0954102094000751; Beerli P, 2012, MIGRATE DOCUMENTATIO; Belkhir K, 2004, GENETIX 4 05 LOGICIE; Bengtson JA., 2002, ENCY MARINE MAMMALS, P302; Boness D.J., 1993, Symposia of the Zoological Society of London, V66, P61; Boness D.J., 1991, P1; Burns JM, 1999, POLAR BIOL, V21, P23, DOI 10.1007/s003000050329; Cameron MF, 2007, ANTARCT SCI, V19, P149, DOI 10.1017/S0954102007000223; Chambert T, 2015, ECOLOGY, V96, P479, DOI 10.1890/14-0911.1; CROXALL JP, 1983, J APPL ECOL, V20, P19, DOI 10.2307/2403373; Curtis C, 2009, MOL ECOL, V18, P2112, DOI 10.1111/j.1365-294X.2009.04166.x; Davis CS, 2008, MOL ECOL, V17, P3078, DOI 10.1111/j.1365-294X.2008.03819.x; Davis Corey S., 2000, P56; Davis CS, 2002, MOL ECOL NOTES, V2, P203, DOI 10.1046/j.1471-8286.2002.00187.x; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Erickson A.W., 1990, P253; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fabiani A, 2004, BEHAV ECOL, V15, P961, DOI 10.1093/beheco/arh112; FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455; Fu YX, 1997, GENETICS, V147, P915; Galimberti F, 1999, MAR MAMMAL SCI, V15, P159, DOI 10.1111/j.1748-7692.1999.tb00787.x; Gelatt T., 2000, P63; Gelatt T, 2001, THESIS; Geraldes A, 2005, ANIM GENET, V36, P349, DOI 10.1111/j.1365-2052.2005.01300.x; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hadley GL, 2006, J ANIM ECOL, V75, P1058, DOI 10.1111/j.1365-2656.2006.01118.x; Hall BL, 2006, P NATL ACAD SCI USA, V103, P10213, DOI 10.1073/pnas.0604002103; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hartl Daniel L., 1997; Hedrick PW, 2011, GENETICS POPULATION, V4, P214; Hellborg L, 2004, MOL BIOL EVOL, V21, P158, DOI 10.1093/molbev/msh008; Hoelzel AR, 1999, BEHAV ECOL SOCIOBIOL, V46, P298; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; HUDSON RR, 1989, THEOR POPUL BIOL, V36, P23, DOI 10.1016/0040-5809(89)90021-X; KAUFMAN G W, 1975, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V169, P228; King V, 2007, GENETICS, V175, P1855, DOI 10.1534/genetics.106.066779; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kooyman G.L., 1981, P1, DOI 10.1017/CBO9780511735653.004; Kooyman GL, 2004, MAR ECOL PROG SER, V267, P281, DOI 10.3354/meps267281; KOVACS KM, 1990, CAN J ZOOL, V68, P2499, DOI 10.1139/z90-349; Krafft BA, 2007, MAR ECOL PROG SER, V335, P199, DOI 10.3354/meps335199; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Lake SE, 1997, POLAR BIOL, V18, P319, DOI 10.1007/s003000050194; LAWS RM, 1977, PHILOS T ROY SOC B, V279, P81, DOI 10.1098/rstb.1977.0073; LI WH, 1977, GENETICS, V85, P331; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Marshall TC, 2013, CERVUS IS COMPUTER P; Meadows JRS, 2004, ANIM GENET, V35, P379, DOI 10.1111/j.1365-2052.2004.01180.x; Nabholz B, 2008, MOL BIOL EVOL, V25, P120, DOI 10.1093/molbev/msm248; Nagai K, 2001, GENE, V270, P161, DOI 10.1016/S0378-1119(01)00479-6; Nakagome S, 2008, MOL BIOL EVOL, V25, P1344, DOI 10.1093/molbev/msn086; Peel D, 2014, NEESTIMATOR SOFTWARE; Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Pritchard JK, 2010, PROGRAM STRUCTURE IS; Raymond M, 2016, GENEPOP VERSION 4 0; Sato K, 2002, POLAR BIOL, V25, P696, DOI 10.1007/s00300-002-0406-7; Schlotterer C, 2004, NAT REV GENET, V5, P63, DOI 10.1038/nrg1249; SINIFF D, 1971, ANTARCT J US, V6, P97; SINIFF DB, 1979, CAN J ZOOL, V57, P2243, DOI 10.1139/z79-292; SINIFF DB, 1977, ECOL MONOGR, V47, P319, DOI 10.2307/1942520; Slade RW, 1998, GENETICS, V149, P1945; SLADE RW, 1994, MOL BIOL EVOL, V11, P341; Smith WO, 2012, OCEANOGRAPHY, V25, P90, DOI 10.5670/oceanog.2012.80; Stirling I., 1983, Special Publication American Society of Mammalogists, P489; STIRLING I, 1969, ECOLOGY, V50, P573, DOI 10.2307/1936247; Sunnucks P, 2000, MOL ECOL, V9, P1699, DOI 10.1046/j.1365-294x.2000.01084.x; Tajima F, 1996, J GENET, V75, P27, DOI 10.1007/BF02931749; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TEDMAN RA, 1979, AUST WILDLIFE RES, V6, P19; TESTA JW, 1994, CAN J ZOOL, V72, P1700, DOI 10.1139/z94-229; TESTA JW, 1989, MAR MAMMAL SCI, V5, P399, DOI 10.1111/j.1748-7692.1989.tb00354.x; THOMAS JA, 1983, CAN J ZOOL, V61, P2203, DOI 10.1139/z83-291; THOMAS JA, 1988, HYDROBIOLOGIA, V165, P279, DOI 10.1007/BF00025597; THOMAS JA, 1983, CAN J ZOOL, V61, P2084, DOI 10.1139/z83-273; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Van Parijs Sofie M., 2003, Aquatic Mammals, V29, P214, DOI 10.1578/016754203101024167; Verma SK, 2003, MOL ECOL NOTES, V3, P28, DOI 10.1046/j.1471-8286.2003.00340.x; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Wright S, 1931, GENETICS, V16, P0097	90	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182922	10.1371/journal.pone.0182922	http://dx.doi.org/10.1371/journal.pone.0182922			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796829	Green Published, gold, Green Submitted			2022-12-26	WOS:000407396200123
J	Gahlaut, V; Jaiswal, V; Tyagi, BS; Singh, G; Sareen, S; Balyan, HS; Gupta, PK				Gahlaut, Vijay; Jaiswal, Vandana; Tyagi, Bhudeva S.; Singh, Gyanendra; Sareen, Sindhu; Balyan, Harindra S.; Gupta, Pushpendra Kumar			QTL mapping for nine drought-responsive agronomic traits in bread wheat under irrigated and rain-fed environments	PLOS ONE			English	Article							YIELD-RELATED TRAITS; TRITICUM-AESTIVUM L.; GRAIN-YIELD; GENETIC ARCHITECTURE; STRESS-ADAPTATION; COMPLEX TRAITS; GENOMIC TOOLS; POPULATION; LOCI; TOLERANCE	In bread wheat, QTL interval mapping was conducted for nine important drought responsive agronomic traits. For this purpose, a doubled haploid (DH) mapping population derived from Kukri/Excalibur was grown over three years at four separate locations in India, both under irrigated and rain-fed environments. Single locus analysis using composite interval mapping (CIM) allowed detection of 98 QTL, which included 66 QTL for nine individual agronomic traits and 32 QTL, which affected drought sensitivity index (DSI) for the same nine traits. Two-locus analysis allowed detection of 19 main effect QTL (M-QTL) for four traits (days to anthesis, days to maturity, grain filling duration and thousand grain weight) and 19 pairs of epistatic QTL (E-QTL) for two traits (days to anthesis and thousand grain weight). Eight QTL were common in single locus analysis and two locus analysis. These QTL (identified both in single-and two-locus analysis) were distributed on 20 different chromosomes (except 4D). Important genomic regions on chromosomes 5A and 7A were also identified (5A carried QTL for seven traits and 7A carried QTL for six traits). Marker-assisted recurrent selection (MARS) involving pyramiding of important QTL reported in the present study, together with important QTL reported earlier, may be used for improvement of drought tolerance in wheat. In future, more closely linked markers for the QTL reported here may be developed through fine mapping, and the candidate genes may be identified and used for developing a better understanding of the genetic basis of drought tolerance in wheat.	[Gahlaut, Vijay; Jaiswal, Vandana; Balyan, Harindra S.; Gupta, Pushpendra Kumar] Ch Charan Singh Univ, Dept Genet & Plant Breeding, Meerut, Uttar Pradesh, India; [Tyagi, Bhudeva S.; Singh, Gyanendra; Sareen, Sindhu] ICAR Indian Inst Wheat & Barley Res, Karnal, India; [Gahlaut, Vijay] Univ Delhi, Dept Plant Mol Biol, South Campus, Delhi, India; [Jaiswal, Vandana] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi, India	Chaudhary Charan Singh University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Wheat & Barley Research; University of Delhi; Jawaharlal Nehru University, New Delhi	Gupta, PK (corresponding author), Ch Charan Singh Univ, Dept Genet & Plant Breeding, Meerut, Uttar Pradesh, India.	pkgupta36@gmail.com	Balyan, H./AAI-9077-2020; Gahlaut, Vijay/K-4904-2012; Tyagi, Bhudeva/AAR-8225-2021; Sareen, Sindhu/A-8465-2012	Gahlaut, Vijay/0000-0003-4381-3573; Sareen, Sindhu/0000-0003-2944-0395; Jaiswal, Vandana/0000-0001-8620-7595	National Academy of Sciences India (NASI); Junior Research Fellowship; Senior Research Fellowship/Research Associate position under a DBT; UGC, Government of India; CSIR	National Academy of Sciences India (NASI)(Department of Science & Technology (India)); Junior Research Fellowship; Senior Research Fellowship/Research Associate position under a DBT; UGC, Government of India(University Grants Commission, India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	PKG was also awarded a National Academy of Sciences India (NASI) Senior Scientist Platinum Jubilee Fellowship during the tenure of this research work and VG was awarded a Junior Research Fellowship under the same program, and was later awarded the position of Senior Research Fellowship/Research Associate position under a DBT project. VG also thanks the UGC, Government of India for awarding Dr. D. S. Kothari Post Doctoral Fellowship. VJ was awarded with CSIR-Nehru Science Post-Doc Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors like to thank The Head, Department of Genetics and Plant Breeding, CCS University (Meerut, India) for providing facilities. PKG and HSB were each awarded the position of INSA Senior Scientist. PKG was also awarded a National Academy of Sciences India (NASI) Senior Scientist Platinum Jubilee Fellowship during the tenure of this research work and VG was awarded a Junior Research Fellowship under the same program, and was later awarded the position of Senior Research Fellowship/Research Associate position under a DBT project. VG also thanks the UGC, Government of India for awarding Dr. D. S. Kothari Post-Doctoral Fellowship. VJ was awarded with CSIR-Nehru Science Post-Doc Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Help from James Edwards and Peter Langridge, Australian Centre for Plant Functional Genomics, Waite Campus, University of Adelaide, Australia in procuring genotyping data of the mapping population is gratefully acknowledged.	Acuna-Galindo MA, 2015, CROP SCI, V55, P477, DOI 10.2135/cropsci2013.11.0793; Ain QU, 2015, FRONT PLANT SCI, V6, DOI [10.3389/fpls.7015.00743, 10.3389/fpls.2015.00743]; Alexander LM, 2012, CROP SCI, V52, P253, DOI 10.2135/cropsci2011.05.0267; Araki E, 1999, THEOR APPL GENET, V98, P977, DOI 10.1007/s001220051158; Araus JL, 2008, CRIT REV PLANT SCI, V27, P377, DOI 10.1080/07352680802467736; Bennett D, 2012, THEOR APPL GENET, V125, P255, DOI 10.1007/s00122-012-1831-9; Bennett D, 2012, THEOR APPL GENET, V124, P697, DOI 10.1007/s00122-011-1740-3; Blum A., 1988, Plant breeding for stress environments.; Borner A, 2002, THEOR APPL GENET, V105, P921, DOI 10.1007/s00122-002-0994-1; Charmet G, 2005, THEOR APPL GENET, V111, P540, DOI 10.1007/s00122-005-2045-1; Edae EA, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2013.04.0010; Edwards J, 2012, GENETIC ANAL DROUGHT; Mason RE, 2010, EUPHYTICA, V174, P423, DOI 10.1007/s10681-010-0151-x; Evans LT, 1999, CROP SCI, V39, P1544, DOI 10.2135/cropsci1999.3961544x; Farooq M, 2014, CRIT REV PLANT SCI, V33, P331, DOI 10.1080/07352689.2014.875291; FISCHER RA, 1978, AUST J AGR RES, V29, P897, DOI 10.1071/AR9780897; Fleury D, 2010, J EXP BOT, V61, P3211, DOI 10.1093/jxb/erq152; Gao FM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01099; Goldringer I, 1997, HEREDITY, V79, P60, DOI 10.1038/hdy.1997.123; Groos C, 2003, THEOR APPL GENET, V106, P1032, DOI 10.1007/s00122-002-1111-1; Gupta P. K., 2012, Plant Breeding Reviews, V36, P85; Gupta PK, 2017, AGRONOMY-BASEL, V7, DOI 10.3390/agronomy7010005; Hadiarto T, 2011, PLANT CELL REP, V30, P297, DOI 10.1007/s00299-010-0956-z; Heidari B, 2011, GENOME, V54, P517, DOI [10.1139/g11-017, 10.1139/G11-017]; Hill CB, 2013, PLANT PHYSIOL, V162, P1266, DOI 10.1104/pp.113.217851; Huang XQ, 2004, THEOR APPL GENET, V109, P933, DOI 10.1007/s00122-004-1708-7; JIANG G. L., 2013, PLANT BREEDING LAB F, P45, DOI DOI 10.5772/52583; Jogaiah S, 2013, CRIT REV BIOTECHNOL, V33, P23, DOI 10.3109/07388551.2012.659174; Kadam S, 2012, FUNCT INTEGR GENOMIC, V12, P447, DOI 10.1007/s10142-012-0276-1; Kamaluddin, 2007, J PLANT BIOL, V50, P504, DOI 10.1007/BF03030690; Kato K, 2000, THEOR APPL GENET, V101, P1114, DOI 10.1007/s001220051587; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Kuchel H, 2007, THEOR APPL GENET, V115, P1029, DOI 10.1007/s00122-007-0629-7; Kumar N, 2007, MOL BREEDING, V19, P163, DOI 10.1007/s11032-006-9056-8; Kumar N, 2006, EUPHYTICA, V151, P135, DOI 10.1007/s10681-006-9133-4; Laido G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095211; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Langridge P, 2015, CURR OPIN BIOTECH, V32, P130, DOI 10.1016/j.copbio.2014.11.027; Lopes MS, 2013, THEOR APPL GENET, V126, P971, DOI 10.1007/s00122-012-2030-4; Maccaferri M, 2008, GENETICS, V178, P489, DOI 10.1534/genetics.107.077297; Marza F, 2006, THEOR APPL GENET, V112, P688, DOI 10.1007/s00122-005-0172-3; Mathews KL, 2008, THEOR APPL GENET, V117, P1077, DOI 10.1007/s00122-008-0846-8; McIntosh RA, 2013, P 12 INT WHEAT GEN S; McIntyre CL, 2010, THEOR APPL GENET, V120, P527, DOI 10.1007/s00122-009-1173-4; Merk HL, 2012, J AM SOC HORTIC SCI, V137, P427, DOI 10.21273/JASHS.137.6.427; Mwadzingeni L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171692; Parry MAJ, 2011, J EXP BOT, V62, P453, DOI 10.1093/jxb/erq304; Passioura JB, 2012, FUNCT PLANT BIOL, V39, P851, DOI 10.1071/FP12079; Portmann FT, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2008GB003435; Quarrie SA, 2006, J EXP BOT, V57, P2627, DOI 10.1093/jxb/erl026; Quarrie SA, 2005, THEOR APPL GENET, V110, P865, DOI 10.1007/s00122-004-1902-7; Ray DK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2296; Reynolds M, 2008, CURR OPIN PLANT BIOL, V11, P171, DOI 10.1016/j.pbi.2008.02.005; Reynolds M, 2011, J EXP BOT, V62, P439, DOI 10.1093/jxb/erq311; Shiferaw B, 2013, FOOD SECUR, V5, P291, DOI 10.1007/s12571-013-0263-y; Shukla S, 2015, EUPHYTICA, V203, P449, DOI 10.1007/s10681-014-1314-y; Pinto RS, 2010, THEOR APPL GENET, V121, P1001, DOI 10.1007/s00122-010-1351-4; Turner NC, 2014, FUNCT PLANT BIOL, V41, P1199, DOI 10.1071/FP14057; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang RX, 2009, THEOR APPL GENET, V118, P313, DOI 10.1007/s00122-008-0901-5; Wang S, 2012, WINDOWS QTL CARTOGRA; Wu XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031249; Yang J, 2008, BIOINFORMATICS, V24, P721, DOI 10.1093/bioinformatics/btm494; Yang J, 2007, BIOINFORMATICS, V23, P1527, DOI 10.1093/bioinformatics/btm143; Zhang LY, 2010, J INTEGR PLANT BIOL, V52, P996, DOI 10.1111/j.1744-7909.2010.00967.x; Zheng J, 2014, J EXP BOT, V65, P5351, DOI 10.1093/jxb/eru306	66	39	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182857	10.1371/journal.pone.0182857	http://dx.doi.org/10.1371/journal.pone.0182857			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28793327	Green Published, Green Submitted, gold			2022-12-26	WOS:000407196700072
J	Jung, M				Jung, Minsoo			Effects of implementing the act of prohibition on sex trafficking on female sex workers' sexually transmitted infections	PLOS ONE			English	Article							SELF-RATED HEALTH; HARD-TO-REACH; POPULATIONS; MORTALITY; CHINA; HIV	This study investigated the effect of implementing the act of prohibition on sex trafficking (PST) on sexually transmitted disease (STD) infections among South Korean female sex workers (FSWs) working at prostitution blocks. Research data were collected twice through the Korean government-sanctioned survey for female sex workers (1st wave = 1,083; 2nd wave = 926). We examined the associations among health behavior, working conditions, and the effect of PST act via hierarchical logistic regression analyses using propensity score matching. After adjusted covariates, the risk probability was 0.288 times lower among FSWs who had remained in prostitute blocks after the PST act enforcement compared to FSWs who had worked before the PST. Similarly, the risk probability for a gonorrhea infection was 0.219 times lower among FSWs who had remained in prostitute blocks after the PST act compared to FSWs who had worked before the PST. Therefore, this study showed that, besides already known factors, the implementation and establishment of the PST Act was a strong factor that suppressed STD infections among FSWs.	[Jung, Minsoo] Dongduk Womens Univ, Dept Hlth Sci, Seoul, South Korea	Dongduk Women's University	Jung, M (corresponding author), Dongduk Womens Univ, Dept Hlth Sci, Seoul, South Korea.	mj748@dongduk.ac.kr		Jung, Minsoo/0000-0003-3317-6507				Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; FHI/Impact Behavioural Surveillance Surveys (BSS), 2000, GUID REP BEH SURV PO; Gender Policy Research Institute, 2008, DESCR CURR STAT KOR; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Institute for Gender Research, 2011, CURR STAT PROS MARK; Jung M, 2013, SEX DISABIL, V31, P275, DOI 10.1007/s11195-013-9305-9; Jung M, 2012, SEX DISABIL, V30, P421, DOI 10.1007/s11195-012-9261-9; Kim Ae-Ryung, 2008, [Economy and Society, 경제와 사회], V79, P254; Ko-Jung KH, 2009, EC SOC, V81, P112; Korea Centers for Disease Control and Prevention (KCDC), 2009, GUID TREATM SEX TRAN; Lee JH, 2010, HLTH SOC WELFARE REV, V30, P220; Lee Ju Yul, 2008, [Health and Social Science, 보건과 사회과학], V23, P83; Li Q, 2010, SEX TRANSM DIS, V37, P700, DOI 10.1097/OLQ.0b013e3181e1a2b2; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Muhib FB, 2001, PUBLIC HEALTH REP, V116, P216, DOI 10.1093/phr/116.S1.216; Park Hyejin, 2007, [Journal of Criminal Law, 형사법연구], V19, P373; Semaan Salaam, 2002, AIDS Reviews, V4, P213; van den Hoek A, 2001, AIDS, V15, P753, DOI 10.1097/00002030-200104130-00011; Vandepitte J, 2006, SEX TRANSM INFECT, V82, pIII18, DOI 10.1136/sti.2006.020081; World Health Organization, 2007, GLOB STRAT PREV CONT	21	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182465	10.1371/journal.pone.0182465	http://dx.doi.org/10.1371/journal.pone.0182465			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC9YJ	28793341	Green Submitted, Green Published, gold			2022-12-26	WOS:000407196700046
J	Adewumi, AO; Chetty, S				Adewumi, Aderemi Oluyinka; Chetty, Sivashan			Investigating the enhanced Best Performance Algorithm for Annual Crop Planning problem based on economic factors	PLOS ONE			English	Article							DIFFERENTIAL EVOLUTION; IRRIGATION; OPTIMIZATION; ALLOCATION; RESERVOIR	The Annual Crop Planning (ACP) problem was a recently introduced problem in the literature. This study further expounds on this problem by presenting a new mathematical formulation, which is based on market economic factors. To determine solutions, a new local search metaheuristic algorithm is investigated which is called the enhanced Best Performance Algorithm (eBPA). eBPA's results are compared against two well-known local search metaheuristic algorithms; these include Tabu Search and Simulated Annealing. The results show the potential of the eBPA for continuous optimization problems.	[Adewumi, Aderemi Oluyinka; Chetty, Sivashan] Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Durban, South Africa	University of Kwazulu Natal	Adewumi, AO (corresponding author), Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Durban, South Africa.	adewumia@ukzn.ac.za			National Research Foundation (DAAD-NRF)	National Research Foundation (DAAD-NRF)	The financial assistance of the National Research Foundation (DAAD-NRF) towards this research is hereby acknowledged. Opinions expressed and conclusions arrived at are those of the authors and are not necessarily to be attributed to the DAAD-NRF.	Adewumi AO, 2010, MATH COMPUT MODEL, V51, P109, DOI 10.1016/j.mcm.2009.09.004; Adeyemo J., 2010, INT J SUST DEV WORLD, V1, P39; Adeyemo J, 2010, INT J PHYS SCI, V5, P1592; [Anonymous], 2008, SIMULATED ANNEALING; Bai R, 2005, THESIS; Chetty S, 2014, J EXPT THEORETICAL A, V27, P159; Chetty S, 2015, STUDY ENHANCED BEST; Chetty S, 2014, IEEE T EVOLUT COMPUT, V18, P258, DOI 10.1109/TEVC.2013.2256427; Chetty S, 2013, S AFR J IND ENG, V24, P205; Chetty S, 2013, J APPL MATH, DOI 10.1155/2013/158538; FARIS JE, 1961, J FARM ECON, V43, P1219, DOI 10.2307/1235579; Georgiou PE, 2008, IRRIGATION SCI, V26, P487, DOI 10.1007/s00271-008-0110-7; GLOVER F, 1986, COMPUT OPER RES, V13, P533, DOI 10.1016/0305-0548(86)90048-1; Glover F., 1989, ORSA Journal on Computing, V1, P190, DOI [10.1287/ijoc.2.1.4, 10.1287/ijoc.1.3.190]; Glover F., 1990, ORSA J COMPUTING, V2, P4, DOI [10.1287/ijoc.2.1.4, DOI 10.1287/IJOC.2.1.4]; Grove B, 2008, THESIS; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; KRUGMAN P, 1980, AM ECON REV, V70, P950; Maisela RJ, 2007, THESIS; Mohamad NH, 2011, AFR J AGR RES, V6, P191; Nyonyi Y., 2010, MODELING HOSTEL SPAC; Oelofse S, 2010, CSIR PERSPECTIVE WAT; Pant M., 2010, WORLD J MODEL SIMUL, V6, P97; Pant M, 2008, LECT NOTES ARTIF INT, V5271, P289, DOI 10.1007/978-3-540-87656-4_36; Raju KS, 2004, WATER RESOUR MANAG, V18, P163, DOI 10.1023/B:WARM.0000024738.72486.b2; Reddy MJ, 2007, HYDROLOG SCI J, V52, P686, DOI 10.1623/hysj.52.4.686; Sarker R, 2009, COMPUT ELECTRON AGR, V68, P191, DOI 10.1016/j.compag.2009.06.002; Schmitz GH, 2007, INT HYDROLOGICAL PRO, P5; Silva JDL, 2003, THESIS; Sunantara JD, 1997, J WATER RES PL-ASCE, V123, P39, DOI 10.1061/(ASCE)0733-9496(1997)123:1(39); Tsai CY, 2010, P WORLD C ENG 2010 L, P3; Wardlaw R, 2004, IRRIG DRAIN, V53, P397, DOI 10.1002/ird.121; Whelan J, 1996, EC SUPPLY DEMAND	33	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2017	12	8							e0180813	10.1371/journal.pone.0180813	http://dx.doi.org/10.1371/journal.pone.0180813			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9EU	28792495	Green Published, gold, Green Submitted			2022-12-26	WOS:000407144700002
J	Covell, DG				Covell, David G.			A data mining approach for identifying pathway-gene biomarkers for predicting clinical outcome: A case study of erlotinib and sorafenib	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASES; MESENCHYMAL TRANSITION; CANCER; GROWTH; ACTIVATION; CELLS; INHIBITION; APOPTOSIS; SURVIVAL; CANALIZATION	A novel data mining procedure is proposed for identifying potential pathway-gene biomarkers from preclinical drug sensitivity data for predicting clinical responses to erlotinib or sorafenib. The analysis applies linear ridge regression modeling to generate a small (N similar to 1000) set of baseline gene expressions that jointly yield quality predictions of preclinical drug sensitivity data and clinical responses. Standard clustering of the pathway-gene combinations from gene set enrichment analysis of this initial gene set, according to their shared appearance in molecular function pathways, yields a reduced (N similar to 300) set of potential pathwaygene biomarkers. A modified method for quantifying pathway fitness is used to determine smaller numbers of over and under expressed genes that correspond with favorable and unfavorable clinical responses. Detailed literature-based evidence is provided in support of the roles of these under and over expressed genes in compound efficacy. RandomForest analysis of potential pathway-gene biomarkers finds average treatment prediction errors of 10% and 22%, respectively, for patients receiving erlotinib or sorafenib that had a favorable clinical response. Higher errors were found for both compounds when predicting an unfavorable clinical response. Collectively these results suggest complementary roles for biomarker genes and biomarker pathways when predicting clinical responses from preclinical data.	[Covell, David G.] NCI, Informat Technol Branch, Dev Therapeut Program, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Covell, DG (corresponding author), NCI, Informat Technol Branch, Dev Therapeut Program, Frederick, MD 21701 USA.	covelld@mail.nih.gov						[Anonymous], 2016, MKCFJWASWAAWACKAAEAT; Arora A, 2005, J PHARMACOL EXP THER, V315, P971, DOI 10.1124/jpet.105.084145; Asghar U, 2015, NAT REV DRUG DISCOV, V14, P130, DOI 10.1038/nrd4504; Aydin OZ, 2014, NUCLEIC ACIDS RES, V42, P8473, DOI 10.1093/nar/gku565; Bauer H, 2001, DEVELOPMENT, V128, P849; Beljanski V, 2011, INVEST NEW DRUG, V29, P1132, DOI 10.1007/s10637-010-9452-0; Bovelstad HM, 2007, BIOINFORMATICS, V23, P2080, DOI 10.1093/bioinformatics/btm305; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brunham LR, 2012, SCIENCE, V336, P1112, DOI 10.1126/science.1220967; Chin L, 2011, NAT MED, V17, P297, DOI 10.1038/nm.2323; Conradt L, 2011, NEOPLASIA, V13, P1026, DOI 10.1593/neo.111016; Cule E, 2012, ANN APPL STAT; Daneshmanesh AH, 2012, LEUKEMIA, V26, P1348, DOI 10.1038/leu.2011.362; Daneshmanesh AH, 2013, LEUKEMIA LYMPHOMA, V54, P843, DOI 10.3109/10428194.2012.731599; De S, 2014, P NATL ACAD SCI USA, V111, P11721, DOI 10.1073/pnas.1412390111; El Jamali A, 2008, FREE RADICAL BIO MED, V44, P868, DOI 10.1016/j.freeradbiomed.2007.11.020; Erler JT, 2012, CELL, V149, P731, DOI 10.1016/j.cell.2012.04.014; Erler JT, 2010, J PATHOL, V220, P290, DOI 10.1002/path.2646; Esseltine Jessica L, 2013, Small GTPases, V4, P132, DOI 10.4161/sgtp.24304; Feng SM, 2009, MOL CELL BIOL, V29, P892, DOI 10.1128/MCB.00595-08; Fernando J, 2012, J CELL PHYSIOL, V227, P1319, DOI 10.1002/jcp.22843; Ferrin G, 2015, HEPATIC MED-EVID RES, V7, P1, DOI 10.2147/HMER.S50161; Firestein R, 2001, J CELL SCI, V114, P2921; Garg R, 2014, ONCOGENE, V33, P5225, DOI 10.1038/onc.2013.524; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Geeleher P, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r47; Gupta S, 2010, CANCER RES, V70, P6735, DOI 10.1158/0008-5472.CAN-10-0244; Halatsch ME, 2009, J NEUROSURG, V111, P211, DOI 10.3171/2008.9.JNS08551; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hancock MK, 2010, MOL BIOSYST, V6, P1834, DOI 10.1039/c003669b; Heinrich C, 2010, ONCOGENE, V29, P1598, DOI 10.1038/onc.2009.456; Hofree M, 2013, NAT METHODS, V10, P1108, DOI [10.1038/NMETH.2651, 10.1038/nmeth.2651]; Hu SY, 2009, CLIN CANCER RES, V15, P6062, DOI 10.1158/1078-0432.CCR-09-0048; Huang R, 2005, PHARMACOGENOMICS J, V5, P381, DOI 10.1038/sj.tpj.6500331; Hubaux R, 2015, INT J CANCER, V137, P2072, DOI 10.1002/ijc.29577; Hui RCY, 2008, MOL CELL BIOL, V28, P5886, DOI 10.1128/MCB.01265-07; Huo LF, 2010, P NATL ACAD SCI USA, V107, P16125, DOI 10.1073/pnas.1000743107; Isono K, 2006, MOL CELL BIOL, V26, P2758, DOI 10.1128/MCB.26.7.2758-2771.2006; Jeon WI, 2012, ANTICANCER RES, V32, P5279; Johnston RA, 2014, DRUG METAB DISPOS, V42, P1851, DOI 10.1124/dmd.114.059097; Joshi AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044372; Kapitonov D, 2009, CANCER RES, V69, P6915, DOI 10.1158/0008-5472.CAN-09-0664; Keating GM, 2009, DRUGS, V69, P223, DOI 10.2165/00003495-200969020-00006; Kelkar A, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-11; Kidger AM, 2016, SEMIN CELL DEV BIOL, V50, P125, DOI 10.1016/j.semcdb.2016.01.009; Kim ES, 2011, CANCER DISCOV, V1, P44, DOI 10.1158/2159-8274.CD-10-0010; Lee MJ, 2012, CELL, V149, P780, DOI 10.1016/j.cell.2012.03.031; LI B, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0130700; Li Qing, 2014, Mol Cell Ther, V2, P15, DOI 10.1186/2052-8426-2-15; Liang WS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043192; Lind JSW, 2010, CLIN CANCER RES, V16, P3078, DOI 10.1158/1078-0432.CCR-09-3033; Liu F, 2015, ONCOL LETT, V10, P778, DOI 10.3892/ol.2015.3315; Marx V, 2014, NAT METHODS, V11, P375, DOI 10.1038/nmeth.2891; Melixetian M, 2009, NAT CELL BIOL, V11, P1247, DOI 10.1038/ncb1969; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Murakami S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082894; Paul Indranil, 2013, Genes Cancer, V4, P427, DOI 10.1177/1947601913503341; Prasad V, 2016, NATURE, V537, pS63, DOI 10.1038/537S63a; Raspe E, 2012, SEMIN CANCER BIOL, V22, P250, DOI 10.1016/j.semcancer.2012.02.011; Reker D, 2015, DRUG DISCOV TODAY, V20, P458, DOI 10.1016/j.drudis.2014.12.004; Reungwetwattana Thanyanan, 2013, J Carcinog, V12, P22, DOI 10.4103/1477-3163.123972; Roll JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031733; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siegal ML, 2002, P NATL ACAD SCI USA, V99, P10528, DOI 10.1073/pnas.102303999; Song IS, 2005, J BIOL CHEM, V280, P28230, DOI 10.1074/jbc.M413103200; Sorensen CS, 2010, CELL CYCLE, V9, P450, DOI 10.4161/cc.9.3.10513; Soubeyrand S, 2013, BBA-MOL CELL RES, V1833, P3405, DOI 10.1016/j.bbamcr.2013.10.001; Stewart S, 2005, CANCER RES, V65, P8730, DOI 10.1158/0008-5472.CAN-05-1500; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takeuchi K, 2011, BIOL PHARM BULL, V34, P1774, DOI 10.1248/bpb.34.1774; Takeuchi K, 2009, FEBS J, V276, P1255, DOI 10.1111/j.1742-4658.2008.06861.x; Tan TZ, 2014, EMBO MOL MED, V6, P1279, DOI 10.15252/emmm.201404208; Van Allen EM, 2015, JAMA ONCOL, V1, P238, DOI 10.1001/jamaoncol.2015.34; van Wieringen WN, 2009, COMPUT STAT DATA AN, V53, P1590, DOI 10.1016/j.csda.2008.05.021; Vincent MD, 2012, CURR ONCOL, V19, pS33, DOI 10.3747/co.19.1149; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; WADDINGTON CH, 1959, NATURE, V183, P1654, DOI 10.1038/1831654a0; Whang YM, 2016, ONCOGENE, V35, P856, DOI 10.1038/onc.2015.140; Williams S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074589; Wu JN, 2013, CANCER DISCOV, V3, P35, DOI 10.1158/2159-8290.CD-12-0361; Xie DY, 2016, AM J CANCER RES, V6, P577; YAFFE MB, 2013, SCI SIGNAL, V6; Yamashita T, 2008, J BIOL CHEM, V283, P18926, DOI 10.1074/jbc.M709133200; Yang SQ, 2016, ONCOTARGET, V7, P5461, DOI 10.18632/oncotarget.6684; Zhai B, 2013, WORLD J HEPATOL, V5, P345, DOI 10.4254/wjh.v5.i7.345; Zhang KZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep31742; Zhang LF, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0361-x	89	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2017	12	8							e0181991	10.1371/journal.pone.0181991	http://dx.doi.org/10.1371/journal.pone.0181991			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9EU	28792525	Green Published, Green Submitted, gold			2022-12-26	WOS:000407144700011
J	Liu, XY; Yang, LP; Tang, L; Chen, L; Liu, XL; Fan, DS				Liu, Xiangyi; Yang, Lipeng; Tang, Lu; Chen, Lu; Liu, Xiaolu; Fan, Dongsheng			DCTN1 gene analysis in Chinese patients with sporadic amyotrophic lateral sclerosis	PLOS ONE			English	Article							DYNACTIN COMPLEX; MUTATIONS; VARIANTS; ALS	Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder. Missense mutations of DCTN1 have been identified as a possible genetic risk factor for ALS. Here, we tested the DCTN1 protein-coding exons in 510 sporadic ALS patients in whom SOD1, TARDBP, FUS, and C9orf72 genes were screened before. Polymerase chain reaction and Sanger sequencing were used for mutation discovery. The results revealed two rare heterozygous missense variants, c.1867C>T (p.R623W) and c. 2798C>T (p.A933V). These two patients exhibited spinal disease onset without cognitive impairment, and their onset age and diagnosis delay was within the average range of Chinese ALS patients. Our results suggested that variants in DCTN1 are not common risk factors for Chinese sporadic ALS and that the frequency of variants of unknown significance in the cohort study was 0.39%.	[Liu, Xiangyi; Yang, Lipeng; Tang, Lu; Chen, Lu; Liu, Xiaolu; Fan, Dongsheng] Peking Univ Third Hosp, Dept Neurol, Beijing, Peoples R China	Peking University	Fan, DS (corresponding author), Peking Univ Third Hosp, Dept Neurol, Beijing, Peoples R China.	dsfan2010@aliyun.com	liu, xiaolu/AAC-6908-2020					Ajroud-Driss S, 2015, BBA-MOL BASIS DIS, V1852, P679, DOI 10.1016/j.bbadis.2014.08.010; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Cady J, 2015, ANN NEUROL, V77, P100, DOI 10.1002/ana.24306; Chen L, 2015, J NEUROL NEUROSUR PS, V86, P1075, DOI 10.1136/jnnp-2015-310471; Couthouis J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004704; Farrer MJ, 2009, NAT GENET, V41, P163, DOI 10.1038/ng.293; He J, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2015.06.002; Holleran EA, 1998, INT REV CYTOL, V182, P69, DOI 10.1016/S0074-7696(08)62168-3; Ikenaka K, 2012, INT J MOL SCI, V13, P1225, DOI 10.3390/ijms13011225; Kenna KP, 2013, J MED GENET, V50, P776, DOI 10.1136/jmedgenet-2013-101795; Lazarus JE, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001611; Li CY, 2015, AMYOTROPH LAT SCL FR, V16, P485, DOI 10.3109/21678421.2015.1089909; Liu ZJ, 2014, NEUROBIOL AGING, V35; Marangi G, 2015, BRAIN RES, V1607, P75, DOI 10.1016/j.brainres.2014.10.009; Munch C, 2005, ANN NEUROL, V58, P777, DOI 10.1002/ana.20631; Munch C, 2004, NEUROLOGY, V63, P724, DOI 10.1212/01.WNL.0000134608.83927.B1; Nakamura R, 2016, NEUROBIOL AGING, V39, DOI 10.1016/j.neurobiolaging.2015.11.030; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; SCHAFER DA, 1994, J CELL BIOL, V126, P403, DOI 10.1083/jcb.126.2.403; Steele JC, 2015, ANN NEUROL, V77, P458, DOI 10.1002/ana.24346; Stockmann M, 2013, J NEURAL TRANSM, V120, P785, DOI 10.1007/s00702-012-0910-z; Takahashi Y, 2008, ARCH NEUROL-CHICAGO, V65, P1326, DOI 10.1001/archneur.65.10.1326; Tokito MK, 1996, MOL BIOL CELL, V7, P1167, DOI 10.1091/mbc.7.8.1167; Yang Y, 2015, AMYOTROPH LAT SCL FR, V16, P378, DOI 10.3109/21678421.2015.1009466	26	40	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2017	12	8							e0182572	10.1371/journal.pone.0182572	http://dx.doi.org/10.1371/journal.pone.0182572			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9EU	28792508	Green Published, Green Submitted, gold			2022-12-26	WOS:000407144700024
J	Yang, YJ; Bang, CS; Shin, SP; Baik, GH				Yang, Young Joo; Bang, Chang Seok; Shin, Suk Pyo; Baik, Gwang Ho			Clinical impact of non-alcoholic fatty liver disease on the occurrence of colorectal neoplasm: Propensity score matching analysis	PLOS ONE			English	Article							COLONOSCOPY SURVEILLANCE; CRYPTOGENIC CIRRHOSIS; ADENOMATOUS POLYPS; METABOLIC SYNDROME; NATURAL-HISTORY; COLON-CANCER; RISK; POLYPECTOMY; METAANALYSIS; ENDOSCOPY	The effect of non-alcoholic fatty liver disease (NAFLD) on the occurrences of colorectal neoplasm (CRN) at surveillance colonoscopy is rarely evaluated. We retrospectively reviewed medical records of 1,023 patients who had both index and surveillance colonoscopy at a single institution. The cumulative occurrence rates of overall and advanced CRN at the time of surveillance colonoscopy were compared between patients with and without NAFLD using propensity score matching analysis. In an analysis of matched cohort of 441 patients, the cumulative rates of overall CRN occurrence at 3 and 5 years after index colonoscopy were higher in subjects with NAFLD than in those without NAFLD (9.1% vs. 5.0% & 35.2% vs. 25.3%, P= 0.01). Cox regression analysis showed that NAFLD independently increased the risk of overall CRN occurrence with marginal significance (adjusted hazard ratio [aHR]: 1.31 95% CI: 1.01-1.71, P= 0.05). Additionally, NAFLD was associated with the development of 3 or more adenomas at the time of surveillance colonoscopy (aHR: 2.49, 95% CI: 1.205.20, P= 0.02). In subgroup analysis based on index colonoscopy risk categories, the effect of NAFLD on the overall CRN occurrence at the time of surveillance colonoscopy was confined to the normal group (aHR: 1.47, 95% CI: 1.05-2.06, P= 0.02). Regarding advanced CRN occurrences at the time of surveillance colonoscopy, age was the only significant risk factor (aHR: 1.06, 95% CI: 1.02-1.10, P= 0.001). NAFLD was associated with overall CRN occurrence, especially in patients with no adenoma at the index colonoscopy. NAFLD may be considered for the determination of the time-interval for surveillance colonoscopy, especially the patients with negative index colonoscopy findings.	[Yang, Young Joo; Bang, Chang Seok; Shin, Suk Pyo; Baik, Gwang Ho] Hallym Univ, Coll Med, Dept Internal Med, Chunchon, South Korea; [Bang, Chang Seok] Hallym Univ, Coll Med, Inst New Frontier Res, Chunchon, South Korea	Hallym University; Hallym University	Bang, CS (corresponding author), Hallym Univ, Coll Med, Dept Internal Med, Chunchon, South Korea.; Bang, CS (corresponding author), Hallym Univ, Coll Med, Inst New Frontier Res, Chunchon, South Korea.	csbang@hallym.ac.kr	Bang, Chang SEOK/I-9689-2019	Bang, Chang seok/0000-0003-4908-5431; YANG, YOUNGJOO/0000-0001-6325-1104	National Research Foundation of Korea [NRF-2017M3A93E8033253]	National Research Foundation of Korea(National Research Foundation of Korea)	This research was funded by NRF-2017M3A93E8033253 (National Research Foundation of Korea). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2007, AM J EPIDEMIOL, V166, P36, DOI 10.1093/aje/kwm049; ATKIN WS, 1992, NEW ENGL J MED, V326, P658, DOI 10.1056/NEJM199203053261002; Ballestri S, 2016, ADV THER, V33, P291, DOI 10.1007/s12325-016-0306-9; Bugianesi E, 2002, GASTROENTEROLOGY, V123, P134, DOI 10.1053/gast.2002.34168; Chiu HM, 2015, CLIN GASTROENTEROL H, V13, P1134, DOI 10.1016/j.cgh.2014.10.022; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Ding WJ, 2015, INT J CLIN EXP MED, V8, P322; Giovannucci E, 2007, AM J CLIN NUTR, V86, p836S, DOI 10.1093/ajcn/86.3.836S; Hassan C, 2013, ENDOSCOPY, V45, P842, DOI 10.1055/s-0033-1344548; Huang KW, 2013, COLORECTAL DIS, V15, P830, DOI 10.1111/codi.12172; Hwang ST, 2010, J GASTROEN HEPATOL, V25, P562, DOI 10.1111/j.1440-1746.2009.06117.x; Lewis JR, 2010, DIGEST DIS SCI, V55, P560, DOI 10.1007/s10620-009-1081-0; Lieberman DA, 2012, GASTROENTEROLOGY, V143, P844, DOI 10.1053/j.gastro.2012.06.001; Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969; Rinaldi L, 2017, WORLD J GASTROENTERO, V23, P1458, DOI 10.3748/wjg.v23.i8.1458; Schoen RE, 2010, GASTROENTEROLOGY, V138, P73, DOI 10.1053/j.gastro.2009.09.062; Shen HF, 2014, J GASTROINTEST ONCOL, V5, P440, DOI 10.3978/j.issn.2078-6891.2014.061; Shen ZL, 2010, AM J SURG, V200, P59, DOI 10.1016/j.amjsurg.2009.05.005; So H, 2016, J GASTROEN HEPATOL, V31, P1273, DOI 10.1111/jgh.13286; Stadlmayr A, 2011, J INTERN MED, V270, P41, DOI 10.1111/j.1365-2796.2011.02377.x; Sterling RK, 2003, GASTROENTEROLOGY, V124, pA705, DOI 10.1016/S0016-5085(03)83563-1; Targher G, 2016, J HEPATOL, V65, P589, DOI 10.1016/j.jhep.2016.05.013; Touzin Nadege T, 2011, Therap Adv Gastroenterol, V4, P169, DOI 10.1177/1756283X11402118; Watson AJM, 2011, DIGEST DIS, V29, P222, DOI 10.1159/000323926; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; WINAWER SJ, 1993, NEW ENGL J MED, V328, P901, DOI 10.1056/NEJM199304013281301; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370	28	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0182014	10.1371/journal.pone.0182014	http://dx.doi.org/10.1371/journal.pone.0182014			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28777831	Green Published, Green Submitted, gold			2022-12-26	WOS:000406944300019
J	Giono, LE; Resnick-Silverman, L; Carvajal, LA; St Clair, S; Manfredi, JJ				Giono, L. E.; Resnick-Silverman, L.; Carvajal, L. A.; St Clair, S.; Manfredi, J. J.			Mdm2 promotes Cdc25C protein degradation and delays cell cycle progression through the G2/M phase	ONCOGENE			English	Article							INDEPENDENT PROTEASOMAL DEGRADATION; DUAL-SPECIFICITY PHOSPHATASE; UBIQUITIN-DEPENDENT DEGRADATION; INDUCED DOWN-REGULATION; TUMOR-SUPPRESSOR P53; DNA-DAMAGE; ONCOPROTEIN MDM2; S-PHASE; TRANSCRIPTIONAL REPRESSION; EMBRYONIC LETHALITY	Upon different types of stress, the gene encoding the mitosis-promoting phosphatase Cdc25C is transcriptionally repressed by p53, contributing to p53's enforcement of a G2 cell cycle arrest. In addition, Cdc25C protein stability is also decreased following DNA damage. Mdm2, another p53 target gene, encodes a ubiquitin ligase that negatively regulates p53 levels by ubiquitination. Ablation of Mdm2 by siRNA led to an increase in p53 protein and repression of Cdc25C gene expression. However, Cdc25C protein levels were actually increased following Mdm2 depletion. Mdm2 is shown to negatively regulate Cdc25C protein levels by reducing its half-life independently of the presence of p53. Further, Mdm2 physically interacts with Cdc25C and promotes its degradation through the proteasome in a ubiquitin-independent manner. Either Mdm2 overexpression or Cdc25C downregulation delays cell cycle progression through the G2/M phase. Thus, the repression of the Cdc25C promoter by p53, together with p53-dependent induction of Mdm2 and subsequent degradation of Cdc25C, could provide a dual mechanism by which p53 can enforce and maintain a G2/M cell cycle arrest.	Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10021 USA; Icahn Sch Med Mt Sinai, Grad Sch Biol Sci, New York, NY 10021 USA; [Giono, L. E.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular, Buenos Aires, DF, Argentina; [Giono, L. E.] Univ Buenos Aires, CONICET, Inst Fisiol Biol Mol & Neurociencias IFIBYNE, Buenos Aires, DF, Argentina; [Carvajal, L. A.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Yeshiva University; Albert Einstein College of Medicine	Manfredi, JJ (corresponding author), Icahn Sch Med Mt Sinai, Oncol Sci, One Gustave L Levy Pl,Box 1130, New York, NY 10021 USA.	james.manfredi@mssm.edu			National Cancer Institute [F31CA150539, R03CA216466];  [P30CA196521]; NATIONAL CANCER INSTITUTE [R03CA216466, P30CA196521, F31CA150539] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Matthew O'Connell and Zhen-Qiang Pan for their technical advice, helpful discussions and sharing reagents. Present and past members of the Manfredi laboratory: Dana Lukin, Anthony Mastropietro, Wendy Liu, Sejal Patel, Shohreh Varmeh-Ziaie, Pierre-Jacques Hamard and Kester Haye are thanked for their help and support. Quantitative PCR was performed at the Mount Sinai shared research facility. These studies were supported by grants from the National Cancer Institute F31CA150539 to LAC, R03CA216466 to JJM, and developmental support from P30CA196521. Grant support: National Cancer Institute F31CA150539 to LAC, R03CA216466 to JJM, and developmental support from P30CA196521.	Asher G, 2002, P NATL ACAD SCI USA, V99, P13125, DOI 10.1073/pnas.202480499; Badie C, 2000, MOL CELL BIOL, V20, P2358, DOI 10.1128/MCB.20.7.2358-2366.2000; Bendjennat M, 2003, CELL, V114, P599, DOI 10.1016/j.cell.2003.08.001; Boyd MT, 2000, J BIOL CHEM, V275, P31883, DOI 10.1074/jbc.M004252200; Brown DR, 1998, EMBO J, V17, P2513, DOI 10.1093/emboj/17.9.2513; Burri N, 2001, LAB INVEST, V81, P217, DOI 10.1038/labinvest.3780230; Calabro V, 2002, J BIOL CHEM, V277, P2674, DOI 10.1074/jbc.M107173200; Chen F, 2002, P NATL ACAD SCI USA, V99, P1990, DOI 10.1073/pnas.032428899; Chen XY, 2004, MOL CELL, V16, P839, DOI 10.1016/j.molcel.2004.11.011; Chin L, 1998, TRENDS BIOCHEM SCI, V23, P291, DOI 10.1016/S0968-0004(98)01236-5; CHOWDARY DR, 1994, MOL CELL BIOL, V14, P1997, DOI 10.1128/MCB.14.3.1997; Ciznadija D, 2011, CELL CYCLE, V10, P2714, DOI 10.4161/cc.10.16.16725; Clair SS, 2006, CELL CYCLE, V5, P709, DOI 10.4161/cc.5.7.2628; Coutts AS, 2007, EMBO REP, V8, P84, DOI 10.1038/sj.embor.7400855; Dang JJ, 2002, CANCER RES, V62, P1222; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Donzelli M, 2003, EMBO REP, V4, P671, DOI 10.1038/sj.embor.embor887; Evans SC, 2001, ONCOGENE, V20, P4041, DOI 10.1038/sj.onc.1204533; Eymin B, 2006, CELL CYCLE, V5, P759, DOI 10.4161/cc.5.7.2625; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Folberg-Blum A, 2002, ONCOGENE, V21, P2413, DOI 10.1038/sj.onc.1205305; Garcia P, 1996, ONCOGENE, V13, P695; Giono LE, 2007, MOL CELL BIOL, V27, P4166, DOI 10.1128/MCB.01967-06; Girnita L, 2003, P NATL ACAD SCI USA, V100, P8247, DOI 10.1073/pnas.1431613100; Graves PR, 2000, J BIOL CHEM, V275, P5600, DOI 10.1074/jbc.275.8.5600; Graves PR, 2001, ONCOGENE, V20, P1839, DOI 10.1038/sj.onc.1204259; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Innocente SA, 1999, P NATL ACAD SCI USA, V96, P2147, DOI 10.1073/pnas.96.5.2147; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kadakia M, 2001, DNA CELL BIOL, V20, P321, DOI 10.1089/10445490152122433; Kawai H, 2003, J BIOL CHEM, V278, P45946, DOI 10.1074/jbc.M308295200; Kong XG, 2006, MOL CELL BIOL, V26, P2019, DOI 10.1128/MCB.26.6.2019-2028.2006; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Le Gac G, 2006, J BIOL CHEM, V281, P24161, DOI 10.1074/jbc.M603724200; Little NA, 2001, ONCOGENE, V20, P4576, DOI 10.1038/sj.onc.1204615; Liu TT, 2012, J BIOL INORG CHEM, V17, P311, DOI 10.1007/s00775-011-0852-1; Lohr K, 2003, J BIOL CHEM, V278, P32507, DOI 10.1074/jbc.M212517200; Loughran O, 2000, MOL CELL BIOL, V20, P2186, DOI 10.1128/MCB.20.6.2186-2197.2000; LUNA RMD, 1995, NATURE, V378, P203; Lundgren K, 1997, GENE DEV, V11, P714, DOI 10.1101/gad.11.6.714; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Manfredi JJ, 2010, GENE DEV, V24, P1580, DOI 10.1101/gad.1941710; Manni I, 2001, J BIOL CHEM, V276, P5570, DOI 10.1074/jbc.M006052200; Migliorini D, 2002, MOL CELL BIOL, V22, P5527, DOI 10.1128/MCB.22.15.5527-5538.2002; Obeyesekere MN, 2004, CELL CYCLE, V3, P655; Ohkubo S, 2006, J BIOL CHEM, V281, P16943, DOI 10.1074/jbc.M601388200; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Ongkeko WM, 1999, CURR BIOL, V9, P829, DOI 10.1016/S0960-9822(99)80367-4; Pan Y, 2003, MOL CELL BIOL, V23, P5113, DOI 10.1128/MCB.23.15.5113-5121.2003; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Perry ME, 2000, J BIOL CHEM, V275, P5733, DOI 10.1074/jbc.275.8.5733; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; Piwnica-Worms H, 1999, NATURE, V401, P535, DOI 10.1038/44029; Raj K, 2001, NATURE, V412, P914, DOI 10.1038/35091082; Rinaldo C, 2007, MOL CELL, V25, P739, DOI 10.1016/j.molcel.2007.02.008; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Shabbeer S, 2013, ONCOGENE, V32, P5005, DOI 10.1038/onc.2012.522; Shmueli A, 2007, MOL CELL, V25, P794, DOI 10.1016/j.molcel.2007.03.006; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Singh SV, 2004, J BIOL CHEM, V279, P25813, DOI 10.1074/jbc.M313538200; St Clair S, 2004, MOL CELL, V16, P725; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Sudo T, 2001, EMBO J, V20, P6499, DOI 10.1093/emboj/20.22.6499; Thanasoula M, 2012, EMBO J, V31, P3398, DOI 10.1038/emboj.2012.191; Turowski P, 2003, MOL BIOL CELL, V14, P2984, DOI 10.1091/mbc.E02-08-0515; Uchida CH, 2005, EMBO J, V24, P160, DOI 10.1038/sj.emboj.7600486; Varmeh-Ziaie S, 2007, J BIOL CHEM, V282, P24633, DOI 10.1074/jbc.M703105200; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vecchione A, 2007, CANCER CELL, V11, P275, DOI 10.1016/j.ccr.2007.01.014; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang B, 2010, MOL CELL BIOL, V30, P1508, DOI 10.1128/MCB.01335-09; Wang XF, 2000, MOL CELL BIOL, V20, P4543, DOI 10.1128/MCB.20.13.4543-4552.2000; Xiao D, 2004, MOL CANCER THER, V3, P567; Xu HX, 2010, J BIOL CHEM, V285, P18407, DOI 10.1074/jbc.M109.059568; Yan Y, 2005, ONCOGENE, V24, P3285, DOI 10.1038/sj.onc.1208492; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhang Z, 2004, J BIOL CHEM, V279, P16000, DOI 10.1074/jbc.M312264200; Zhou RZ, 2005, CANCER RES, V65, P1839, DOI 10.1158/0008-5472.CAN-03-3755	82	33	34	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 7	2017	36	49					6762	6773		10.1038/onc.2017.254	http://dx.doi.org/10.1038/onc.2017.254			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FP0IK	28806397	Green Accepted, Green Published			2022-12-26	WOS:000417282500002
J	Li, J; Hu, SB; Wang, LY; Zhang, X; Zhou, X; Yang, B; Li, JH; Xiong, J; Liu, N; Li, Y; Wu, YZ; Zheng, QC				Li, J.; Hu, S. B.; Wang, L. Y.; Zhang, X.; Zhou, X.; Yang, B.; Li, J. H.; Xiong, J.; Liu, N.; Li, Y.; Wu, Y. Z.; Zheng, Q. C.			Autophagy-dependent generation of Axin2+cancer stem-like cells promotes hepatocarcinogenesis in liver cirrhosis	ONCOGENE			English	Article							HEPATOCELLULAR-CARCINOMA CELLS; SIGNALING PATHWAY; LUNG-CANCER; AXIN2; IDENTIFICATION; PHENOTYPE; TRAITS; EPCAM	Autophagy is a pathophysiological phenomenon in liver cirrhosis that can further progress into hepatocarcinoma. Liver cancer stem cells (CSCs) are believed to initiate hepatocarcinogenesis. To investigate the precise mechanism related to the origin of CSCs in liver cirrhosis and hepatocarcinogenesis, we labeled Axin2+ hepatic cells with EGFP in Axin2Cre;Rosa26EGFP transgenic rats, and then stratified clinical and rat liver cirrhosis samples by autophagy flux. Clinical follow-up and lineage tracing in transgenic rat liver cirrhosis revealed that while Axin2/EGFP+ hepatic cells were present in normal livers and cirrhotic livers without aberrant autophagy, hepatic Axin2/EGFP+CD90+ cells were generated exclusively in cirrhotic livers with aberrant autophagy and promoted hepatocarcinogenesis. Aberrant autophagy in liver cirrhosis resulted in hepatocyte growth factor (HGF) expression, leading to activation of Met/JNK and Met/STAT3 signaling in sorted hepatic Axin2/EGFP+ cells and their transition into Axin2/EGFP+ CD90+ cells that possess CSC properties. In a transgenic rat liver cirrhosis model, induction or inhibition of autophagy in cirrhotic livers by systemic administration of rapamycin or chloroquine or transfection with Atg3- and Atg7-shRNAs significantly induced or suppressed HGF expression, which in turn increased or reduced generation of EGFP+CD90+ hepatic cells by activating or inactivating Met/JNK and Met/STAT3 signaling, thereby promoting or preventing hepatocarcinogenesis. Systemic treatment with HGF-shRNA, SP600125 or stattic also reduced generation of EGFP(Axin2)+ hepatic cell-originated CD90+ CSCs in aberrant autophagic cirrhotic livers by inactivating HGF/Met/JNK or HGF/Met/STAT3 signaling, further preventing hepatocarcinogenesis. These data suggest that activation of Met/JNK and Met/STAT3 signaling in Axin2+ hepatic cells via autophagy-dependent HGF expression and the resultant generation of Axin2+CD90+ CSCs is a major mechanism of hepatocarcinogenesis in cirrhotic livers.	[Li, J.; Liu, N.; Li, Y.] Chongqing Canc Inst & Hosp & Canc Ctr, Dept Urol Oncol Surg, HanYu Rd 181, Chongqing 400030, Peoples R China; [Hu, S. B.; Wang, L. Y.; Zhou, X.; Xiong, J.; Zheng, Q. C.] Huazhong Univ Sci & Technol, Union Hosp, Dept Hepatobiliary Surg, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Zhang, X.] Third Mil Med Univ, Inst Hepatobiliary Surg, Southwest Hosp, Chongqing, Peoples R China; [Yang, B.] Southern Med Univ, Zhujiang Hosp, Dept Hepatobiliary Surg 2, Coinnovat Ctr Organ Failure Res,State Key Lab Org, Guangzhou, Guangdong, Peoples R China; [Li, J. H.] Huazhong Univ Sci & Technol, Union Hosp, Dept Gastroenterol, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Wu, Y. Z.] Chongqing Canc Inst & Hosp & Canc Ctr, Dept Radiotherapy, Chongqing, Peoples R China	Huazhong University of Science & Technology; Army Medical University; Southern Medical University - China; Huazhong University of Science & Technology	Li, J (corresponding author), Chongqing Canc Inst & Hosp & Canc Ctr, Dept Urol Oncol Surg, HanYu Rd 181, Chongqing 400030, Peoples R China.	herrleej@foxmail.com			National Natural Science Foundation of China [81400674]; China Scholarship Council [201508500057]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	This work was supported by the National Natural Science Foundation of China under Grant (No. 81400674) and China Scholarship Council under Grant (No. 201508500057) to JL.	Bourdeau V, 2016, AUTOPHAGY, V12, P1965, DOI 10.1080/15548627.2016.1214779; Bowman AN, 2013, P NATL ACAD SCI USA, V110, P7324, DOI 10.1073/pnas.1305411110; Cao L, 2015, ONCOTARGET, V6, P6627, DOI 10.18632/oncotarget.3113; Capone F, 2014, WORLD J GASTROENTERO, V20, P9261, DOI 10.3748/wjg.v20.i28.9261; Cecchi F, 2010, EUR J CANCER, V46, P1260, DOI 10.1016/j.ejca.2010.02.028; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Chai S, 2016, HEPATOLOGY, V64, P2062, DOI 10.1002/hep.28821; Fang LS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9640; Gong LY, 2016, J PATHOL, V240, P184, DOI 10.1002/path.4767; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kitanaka Chifumi, 2013, Genes Cancer, V4, P388, DOI 10.1177/1947601912474892; Kowalik MA, 2016, ONCOTARGET, V7, P5788, DOI 10.18632/oncotarget.6810; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lim XH, 2016, P NATL ACAD SCI USA, V113, pE1498, DOI 10.1073/pnas.1601599113; Liu D, 2016, ONCOTARGET, V7, P40704, DOI 10.18632/oncotarget.9930; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Martins-Neves SR, 2016, J CELL PHYSIOL, V231, P876, DOI 10.1002/jcp.25179; Oikawa T, 2016, HEPATOLOGY, V64, P645, DOI 10.1002/hep.28485; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Sakai K, 2015, ONCOL LETT, V9, P405, DOI 10.3892/ol.2014.2702; Song WQ, 2014, CANCER RES, V74, P2444, DOI 10.1158/0008-5472.CAN-13-2136; Song YJ, 2013, CANCER LETT, V339, P70, DOI 10.1016/j.canlet.2013.07.021; Terris B, 2010, J HEPATOL, V52, P280, DOI 10.1016/j.jhep.2009.10.026; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; Wang B, 2015, NATURE, V524, P180, DOI 10.1038/nature14863; Wang X, 2016, J HEPATOL, V64, P1283, DOI 10.1016/j.jhep.2016.01.019; Wang YY, 2015, CELL STEM CELL, V16, P413, DOI 10.1016/j.stem.2015.03.003; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wiegand J, 2013, DTSCH ARZTEBL INT, V110, P85, DOI 10.3238/arztebl.2013.0085; Wu GY, 2015, ONCOTARGET, V6, P28882, DOI 10.18632/oncotarget.4921; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yang ZF, 2008, HEPATOLOGY, V47, P919, DOI 10.1002/hep.22082; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Zhang XZ, 2016, PROCEEDINGS 2016 IEEE INTERNATIONAL CONFERENCE ON INDUSTRIAL TECHNOLOGY (ICIT), P2016, DOI 10.1109/ICIT.2016.7475077; Zhang YW, 2002, ONCOGENE, V21, P217, DOI 10.1038/sj/onc/1205004	36	21	21	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 30	2017	36	48					6725	6737		10.1038/onc.2017.272	http://dx.doi.org/10.1038/onc.2017.272			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FO4AJ	28783177	Green Published, hybrid			2022-12-26	WOS:000416780800007
J	Yu, XJ; Niks, D; Mulchandani, A; Hille, R				Yu, Xuejun; Niks, Dimitri; Mulchandani, Ashok; Hille, Russ			Efficient reduction of CO2 by the molybdenum-containing formate dehydrogenase from Cupriavidus necator (Ralstonia eutropha)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biofuel; carbon dioxide; enzyme catalysis; molybdenum; multifunctional enzyme	CARBON-DIOXIDE; CONVERSION; METHANOL	The ability of the FdsABG formate dehydrogenase from Cupriavidus necator (formerly known as Ralstonia eutropha) to catalyze the reverse of the physiological reaction, the reduction of CO2 to formate utilizing NADH as electron donor, has been investigated. Contrary to previous studies of this enzyme, we demonstrate that it is in fact effective in catalyzing the reverse reaction with a k(cat) of 11 +/- 0.4 s(-1). We also quantify the stoichiometric accumulation of formic acid as the product of the reaction and demonstrate that the observed kinetic parameters for catalysis in the forward and reverse reactions are thermodynamically consistent, complying with the expected Haldane relationships. Finally, we demonstrate the reaction conditions necessary for gauging the ability of a given formate dehydrogenase or other CO2-utilizing enzyme to catalyze the reverse direction to avoid false negative results. In conjunction with our earlier studies on the reaction mechanism of this enzyme and on the basis of the present work, we conclude that all molybdenum- and tungsten-containing formate dehydrogenases and related enzymes likely operate via a simple hydride transfer mechanism and are effective in catalyzing the reversible interconversion of CO2 and formate under the appropriate experimental conditions.	[Yu, Xuejun; Mulchandani, Ashok] Univ Calif Riverside, Dept Chem & Environm Engn, Riverside, CA 92521 USA; [Niks, Dimitri; Hille, Russ] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Yu, Xuejun] Univ Calif Riverside, Dept Bioengn Engn, Riverside, CA 92521 USA; [Mulchandani, Ashok] Univ Calif Riverside, Mat Sci & Engn Program, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside	Mulchandani, A (corresponding author), Univ Calif Riverside, Dept Chem & Environm Engn, Riverside, CA 92521 USA.; Hille, R (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.; Mulchandani, A (corresponding author), Univ Calif Riverside, Mat Sci & Engn Program, Riverside, CA 92521 USA.	adani@engr.ucr.edu; russ.hille@ucr.edu	Mulchandani, Ashok/R-6130-2019		National Science Foundation [NSF-CBET 1265044]; United States Department of Energy [DE-SC0010666]; University of California, Riverside; Directorate For Engineering [1265044] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); United States Department of Energy(United States Department of Energy (DOE)); University of California, Riverside(University of California System); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by National Science Foundation Grant NSF-CBET 1265044 (to A. M.) and United States Department of Energy Grant DE-SC0010666 (to R. H.) as well as a seed grant from the University of California, Riverside. The authors declare that they have no conflicts of interest with the contents of this article.	Appel AM, 2013, CHEM REV, V113, P6621, DOI 10.1021/cr300463y; Boyington JC, 1997, SCIENCE, V275, P1305, DOI 10.1126/science.275.5304.1305; Butler JN, 1991, CARBON DIOXIDE EQUIL; FRIEDEBOLD J, 1993, J BACTERIOL, V175, P4719, DOI 10.1128/JB.175.15.4719-4728.1993; Gottlieb HE, 1997, J ORG CHEM, V62, P7512, DOI 10.1021/jo971176v; Hille R, 2014, CHEM REV, V114, P3963, DOI 10.1021/cr400443z; Maia LB, 2017, INORG CHIM ACTA, V455, P350, DOI 10.1016/j.ica.2016.07.010; Maia LB, 2016, J AM CHEM SOC, V138, P8834, DOI 10.1021/jacs.6b03941; Maia LB, 2015, J BIOL INORG CHEM, V20, P287, DOI 10.1007/s00775-014-1218-2; Mondal B, 2015, CURR OPIN CHEM BIOL, V25, P103, DOI 10.1016/j.cbpa.2014.12.022; Niks D, 2016, J BIOL CHEM, V291, P1162, DOI 10.1074/jbc.M115.688457; Oh JI, 1998, J BIOL CHEM, V273, P26349, DOI 10.1074/jbc.273.41.26349; Olah GA, 2005, ANGEW CHEM INT EDIT, V44, P2636, DOI 10.1002/anie.200462121; Pohlmann A, 2006, NAT BIOTECHNOL, V24, P1257, DOI 10.1038/nbt1244; Qiao JL, 2014, CHEM SOC REV, V43, P631, DOI 10.1039/c3cs60323g; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Schuchmann K, 2013, SCIENCE, V342, P1382, DOI 10.1126/science.1244758; Schuchmann K, 2014, NAT REV MICROBIOL, V12, P809, DOI 10.1038/nrmicro3365; Segel I. H., 1993, ENZYME KINETICS BEHA; Shi JF, 2015, CHEM SOC REV, V44, P5981, DOI 10.1039/c5cs00182j; Sun QY, 2009, IND ENG CHEM RES, V48, P4210, DOI 10.1021/ie801931j; Wagner T, 2016, SCIENCE, V354, P114, DOI 10.1126/science.aaf9284	22	49	50	3	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					16872	16879		10.1074/jbc.M117.785576	http://dx.doi.org/10.1074/jbc.M117.785576			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28784661	Green Published, hybrid			2022-12-26	WOS:000413140600009
J	Ivankov, DN				Ivankov, Dmitry N.			Exact correspondence between walk in nucleotide and protein sequence spaces	PLOS ONE			English	Article							LANDSCAPES; EVOLUTION	In the course of evolution, genes traverse the nucleotide sequence space, which translates to a trajectory of changes in the protein sequence in protein sequence space. The correspondence between regions of the nucleotide and protein sequence spaces is understood in general but not in detail. One of the unexplored questions is how many sequences a protein can reach with a certain number of nucleotide substitutions in its gene sequence. Here I propose an algorithm to calculate the volume of protein sequence space accessible to a given protein sequence as a function of the number of nucleotide substitutions made in the protein-coding sequence. The algorithm utilizes the power of the dynamic programming approach, and makes all calculations within a couple of seconds on a desktop computer. I apply the algorithm to green fluorescence protein, and get the number of sequences four times higher than estimated before. However, taking into account the astronomically huge size of the protein sequence space, the previous estimate can be considered as acceptable as an order of magnitude estimation. The proposed algorithm has practical applications in the study of evolutionary trajectories in sequence space.	[Ivankov, Dmitry N.] Ctr Genom Regulat CRG, Bioinformat & Genom Programme, Lab Evolutionary Genom, Barcelona, Spain; [Ivankov, Dmitry N.] Univ Pompeu Fabra, Barcelona, Spain; [Ivankov, Dmitry N.] Russian Acad Sci, Inst Prot Res, Lab Prot Phys, Pushchino, Moscow Region, Russia	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Russian Academy of Sciences	Ivankov, DN (corresponding author), Ctr Genom Regulat CRG, Bioinformat & Genom Programme, Lab Evolutionary Genom, Barcelona, Spain.; Ivankov, DN (corresponding author), Univ Pompeu Fabra, Barcelona, Spain.; Ivankov, DN (corresponding author), Russian Acad Sci, Inst Prot Res, Lab Prot Phys, Pushchino, Moscow Region, Russia.	ivankov13@gmail.com	Ivankov, Dmitry/AAD-8104-2019	Ivankov, Dmitry/0000-0002-8224-4118	HHMI International Early Career Scientist Program [55007424]; MINECO [BFU2015-68723-P]; Spanish Ministry of Economy and Competitiveness Centro de Excelencia Severo Ochoa [SEV-2012-0208]; Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat's AGAUR program [2014 SGR 0974]; European Research Council under European Union's Seventh Framework Programme (ERC) [335980_EinME]	HHMI International Early Career Scientist Program; MINECO(Spanish Government); Spanish Ministry of Economy and Competitiveness Centro de Excelencia Severo Ochoa(Spanish Government); Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat's AGAUR program; European Research Council under European Union's Seventh Framework Programme (ERC)(European Research Council (ERC))	This work was supported by HHMI International Early Career Scientist Program (55007424), The MINECO (BFU2015-68723-P), Spanish Ministry of Economy and Competitiveness Centro de Excelencia Severo Ochoa 2013-2017 grant (SEV-2012-0208), Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat's AGAUR program (2014 SGR 0974), and European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013, ERC grant agreement 335980_EinME). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cormen T., 2009, INTRO ALGORITHMS; FINKELSTEIN AV, 1993, BIOSYSTEMS, V30, P1, DOI 10.1016/0303-2647(93)90058-K; Finkelstein AV, 2014, FRONTIERS PROTEIN PE, P91; Gavrilets S, 1997, TRENDS ECOL EVOL, V12, P307, DOI 10.1016/S0169-5347(97)01098-7; Guo JX, 2011, J COMPUT CHEM, V32, P1612, DOI 10.1002/jcc.21740; KAUFFMAN S, 1987, J THEOR BIOL, V128, P11, DOI 10.1016/S0022-5193(87)80029-2; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Sarkisyan KS, 2016, NATURE, V533, P397, DOI 10.1038/nature17995; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Usmanova DR, 2015, MOL BIOL EVOL, V32, P542, DOI 10.1093/molbev/msu318	12	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0182525	10.1371/journal.pone.0182525	http://dx.doi.org/10.1371/journal.pone.0182525			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800638	gold, Green Published, Green Submitted			2022-12-26	WOS:000407431800020
J	Aftab, H; Miftahussurur, M; Subsomwong, P; Ahmed, F; Khan, AKA; Matsumoto, T; Suzuki, R; Yamaoka, Y				Aftab, Hafeza; Miftahussurur, Muhammad; Subsomwong, Phawinee; Ahmed, Faruque; Khan, A. K. Azad; Matsumoto, Takashi; Suzuki, Rumiko; Yamaoka, Yoshio			Two populations of less-virulent Helicobacter pylori genotypes in Bangladesh	PLOS ONE			English	Article							GASTRIC-CANCER; INTERMEDIATE REGION; CAGA PROTEIN; INDIA; PREVALENCE; MECHANISMS; INFECTION; DISEASE; RISK; RECOMBINATION	Bangladesh has a population with a low gastric cancer risk but high prevalence of Helicobacter pylori infection. Several studies have examined virulence genes in H. pylori from Bangladesh. We analyzed cagA and vacA subtypes and their association with severe histology phenotypes, and analyzed population types among Bangladeshi strains. We included patients who underwent endoscopy in Dhaka. Sequences of virulence genes and seven housekeeping genes were obtained by next generation sequencing and confirmed by Sanger sequencing. We isolated 56 H. pylori strains from 133 patients, of which 73.2% carried cagA, and all were considered Western-type. Patients infected with cagA-positive strains had more severe histological scores than patients infected with cagA-negative strains. Among vacA s1 and m1 genotypes, the s1a (97.8%, 43/44) and m1c (28/30, 93.3%) genotypes were predominant. All strains containing s1 and m1 (30/56, 53.6%) also had i1, d1, and c1. In contrast, all strains containing the less-virulent genotypes s2 and m2 (12/56, 21.4%) also possessed i2, d2, and c2. Multivariate analysis indicated that subjects infected with vacA m1-genotype strains only had a significantly higher risk of antrum atrophy than patients infected with m2-genotype strains. Of the two main H. pylori populations in this study, hpAsia2 strains were associated with higher activity and inflammation in the antrum compared to hpEurope strains; however, only vacA s1m1i1d1c1 strains, independent of population type, were significantly associated with inflammation in the antrum, unlike the s2m2i2d2c2 genotype. In conclusion, Bangladeshi strains were divided into two main populations of different genotypes. The low incidence of gastric cancer in Bangladesh might be attributable to the high proportion of less-virulent genotypes, which may be a better predictor of gastric cancer risk than the ancestral origin of the H. pylori strains. Finally, the vacA m region may be a better virulence marker than other regions.	[Aftab, Hafeza; Miftahussurur, Muhammad; Subsomwong, Phawinee; Matsumoto, Takashi; Suzuki, Rumiko; Yamaoka, Yoshio] Oita Univ, Fac Med, Dept Environm & Prevent Med, Yufu, Japan; [Aftab, Hafeza; Ahmed, Faruque] Dhaka Med Coll & Hosp, Dept Gastroenterol, Dhaka, Bangladesh; [Miftahussurur, Muhammad] Airlangga Univ, Inst Trop Dis, Dr Soetomo Teaching Hosp, Gastroenterohepatol Div,Dept Internal Med,Fac Med, Surabaya, Indonesia; [Miftahussurur, Muhammad; Yamaoka, Yoshio] Baylor Coll Med, Dept Med, Gastroenterol & Hepatol Sect, Houston, TX 77030 USA; [Khan, A. K. Azad] Bangladesh Inst Res & Rehabil Diabet Endocrine &, Dept Gastroenterol, Dhaka, Bangladesh	Oita University; Dhaka Medical College; Airlangga University; Baylor College of Medicine	Yamaoka, Y (corresponding author), Oita Univ, Fac Med, Dept Environm & Prevent Med, Yufu, Japan.; Yamaoka, Y (corresponding author), Baylor Coll Med, Dept Med, Gastroenterol & Hepatol Sect, Houston, TX 77030 USA.	yyamaoka@oita-u.ac.jp	Miftahussurur, Muhammad/AAB-6151-2021	Yamaoka, Yoshio/0000-0002-1222-5819; Miftahussurur, Muhammad/0000-0003-1415-6033; Subsomwong, Phawinee/0000-0002-9961-9350	National Institutes of Health [DK62813]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [25293104, 26640114, 16H05191]; Okinawa Prefectural Government; Japan Society for the Promotion of Science (JSPS) Institutional Program for Young Researcher Overseas Visits; Strategic Funds for the Promotion of Science and Technology from the Japan Science and Technology Agency (JST); JSPS RONPAKU program; Japanese government (MEXT) scholarship program	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Okinawa Prefectural Government; Japan Society for the Promotion of Science (JSPS) Institutional Program for Young Researcher Overseas Visits(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Strategic Funds for the Promotion of Science and Technology from the Japan Science and Technology Agency (JST); JSPS RONPAKU program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese government (MEXT) scholarship program	This work was supported in part by grants from the National Institutes of Health (DK62813) and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (25293104, 26640114 and 16H05191) (YY). This work was also supported by the Okinawa Prefectural Government. It was also supported by the Japan Society for the Promotion of Science (JSPS) Institutional Program for Young Researcher Overseas Visits (YY) and the Strategic Funds for the Promotion of Science and Technology from the Japan Science and Technology Agency (JST) (YY). HA was a dissertation PhD student supported by the JSPS RONPAKU program in 2013. MM was a PhD student and PS is a PhD student supported by the Japanese government (MEXT) scholarship program in 2012 and 2013, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backert S, 2001, MOL MICROBIOL, V42, P631, DOI 10.1046/j.1365-2958.2001.02649.x; Backert S, 2010, HELICOBACTER, V15, P163, DOI 10.1111/j.1523-5378.2010.00759.x; Bakhti SZ, 2015, HELICOBACTER; Basiri Z, 2014, ASIAN PAC J CANCER P, V15, P1575, DOI 10.7314/APJCP.2014.15.4.1575; Basso D, 2008, GASTROENTEROLOGY, V135, P91, DOI 10.1053/j.gastro.2008.03.041; Basu A, 2003, GENOME RES, V13, P2277, DOI 10.1101/gr.1413403; Breurec S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022058; COVACCI A, 1993, P NATL ACAD SCI USA, V90, P5791, DOI 10.1073/pnas.90.12.5791; Datta S, 2005, J GASTROEN HEPATOL, V20, P1253, DOI 10.1111/j.1440-1746.2005.03811.x; de Sablet T, 2011, GUT, V60, P1189, DOI 10.1136/gut.2010.234468; Devi SM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-184; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Fujiya K, 2014, DIGEST DIS SCI, V59, P631, DOI 10.1007/s10620-013-2961-x; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Kibria KMK, 2015, HELICOBACTER, V20, P397, DOI 10.1111/hel.12213; Kodaman N, 2014, P NATL ACAD SCI USA, V111, P1455, DOI 10.1073/pnas.1318093111; Kraft C, 2005, INT J MED MICROBIOL, V295, P299, DOI 10.1016/j.ijmm.2005.06.002; Kumar S, 2011, INFECT GENET EVOL, V11, P242, DOI 10.1016/j.meegid.2010.09.001; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Lin HJ, 2004, WORLD J GASTROENTERO, V10, P2493, DOI 10.3748/wjg.v10.i17.2493; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Lopez-Vidal Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003849; Maixner F, 2016, SCIENCE, V351, P162, DOI 10.1126/science.aad2545; Matsuhisa T, 2012, HELICOBACTER, V17, P398, DOI 10.1111/j.1523-5378.2012.00967.x; Matsunari O, 2016, SCI REP-UK, V6, DOI 10.1038/srep22584; Matsunari O, 2012, J CLIN MICROBIOL, V50, P876, DOI 10.1128/JCM.05562-11; Miftahussurur M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134216; Moodley Y, 2009, SCIENCE, V323, P527, DOI 10.1126/science.1166083; Mukhopadhyay AK, 2000, J BACTERIOL, V182, P3219, DOI 10.1128/JB.182.11.3219-3227.2000; Ogiwara H, 2009, J CLIN MICROBIOL, V47, P3493, DOI 10.1128/JCM.00887-09; Rahman M, 2003, J CLIN MICROBIOL, V41, P2008, DOI 10.1128/JCM.41.5.2008-2014.2003; Rasheed F, 2014, HELICOBACTER, V19, P387, DOI 10.1111/hel.12142; Rhead JL, 2007, GASTROENTEROLOGY, V133, P926, DOI 10.1053/j.gastro.2007.06.056; Rugge M, 2007, GUT, V56, P631, DOI 10.1136/gut.2006.106666; Shiota S, 2012, GUT, V61, P469, DOI 10.1136/gutjnl-2011-300317; Sodhi JS, 2013, J GASTROEN HEPATOL, V28, P808, DOI 10.1111/jgh.12178; Suerbaum S, 1999, TRENDS MICROBIOL, V7, P182, DOI 10.1016/S0966-842X(99)01505-X; Suzuki R, 2012, INFECT GENET EVOL, V12, P203, DOI 10.1016/j.meegid.2011.12.002; Tangmankongworakoon Nathaya, 2003, Journal of the Medical Association of Thailand, V86, pS439; Uchida T, 2007, CANCER SCI, V98, P521, DOI 10.1111/j.1349-7006.2007.00415.x; Uchida T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-175; Vilaichone RK, 2013, WORLD J GASTROENTERO, V19, P2806, DOI 10.3748/wjg.v19.i18.2806; Wirth T, 2004, P NATL ACAD SCI USA, V101, P4746, DOI 10.1073/pnas.0306629101; Xia YL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007736; Yamaoka Y, 2014, FUTURE ONCOL, V10, P1487, DOI [10.2217/fon.14.29, 10.2217/FON.14.29]; Yamaoka Y, 2010, NAT REV GASTRO HEPAT, V7, P629, DOI 10.1038/nrgastro.2010.154; Yordanov D, 2012, DIAGN MICR INFEC DIS, V74, P253, DOI 10.1016/j.diagmicrobio.2012.07.008	48	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182947	10.1371/journal.pone.0182947	http://dx.doi.org/10.1371/journal.pone.0182947			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797101	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000407396200131
J	Sandhu, D; Ghosh, J; Johnson, C; Baumbach, J; Baumert, E; Cina, T; Grant, D; Palmer, RG; Bhattacharyya, MK				Sandhu, Devinder; Ghosh, Jayadri; Johnson, Callie; Baumbach, Jordan; Baumert, Eric; Cina, Tyler; Grant, David; Palmer, Reid G.; Bhattacharyya, Madan K.			The endogenous transposable element Tgm9 is suitable for generating knockout mutants for functional analyses of soybean genes and genetic improvement in soybean	PLOS ONE			English	Article							MAX L. MERR.; GLYCINE-MAX; ANTHOCYANIN PIGMENTATION; CHROMOSOMAL REGION; UNSTABLE MUTATION; MALE-STERILE; ARABIDOPSIS; MAIZE; RNA; INSERTION	In soybean, variegated flowers can be caused by somatic excision of the CACTA-type transposable element Tgm9 from Intron 2 of the DFR2 gene encoding dihydroflavonol-4-reductase of the anthocyanin pigment biosynthetic pathway. DFR2 was mapped to the W4 locus, where the allele containing Tgm9 was termed w4-m. In this study we have demonstrated that previously identified morphological mutants (three chlorophyll deficient mutants, one male sterile-female fertile mutant, and three partial female sterile mutants) were caused by insertion of Tgm9 following its excision from DFR2. Analyses of Tgm9 insertion sites among 105 independent mutants demonstrated that Tgm9 hops to all 20 soybean chromosomes from its original location on Chromosome 17. Some genomic regions are prone to increased Tgm9-insertions. Tgm9 transposed over 25% of the time into exon or intron sequences. Tgm9 is therefore suitable for generating an indexed insertional mutant collection for functional analyses of most soybean genes. Furthermore, desirable Tgm9-induced stable knockout mutants can be utilized in generating improved traits for commercial soybean cultivars.	[Sandhu, Devinder] USDA ARS, US Salin Lab, 4500 Glenwood Dr, Riverside, CA 92501 USA; [Ghosh, Jayadri; Baumbach, Jordan; Grant, David; Palmer, Reid G.; Bhattacharyya, Madan K.] Iowa State Univ, Dept Agron, Ames, IA 50011 USA; [Johnson, Callie; Baumert, Eric; Cina, Tyler] Univ Wisconsin, Dept Biol, Stevens Point, WI 54481 USA; [Grant, David; Palmer, Reid G.] USDA ARS, Corn Insects & Crop Genom Res Unit, Ames, IA USA	United States Department of Agriculture (USDA); Iowa State University; University of Wisconsin System; University of Wisconsin Stevens Point; United States Department of Agriculture (USDA)	Sandhu, D (corresponding author), USDA ARS, US Salin Lab, 4500 Glenwood Dr, Riverside, CA 92501 USA.; Bhattacharyya, MK (corresponding author), Iowa State Univ, Dept Agron, Ames, IA 50011 USA.	devinder.sandhu@ars.usda.gov; mbhattac@iastate.edu	Grant, David/HGU-0154-2022	Sandhu, Devinder/0000-0003-4193-3408	United Soybean Board; Undergraduate Research, Scholarship and Creative Activity; UWSP	United Soybean Board; Undergraduate Research, Scholarship and Creative Activity; UWSP	A grant from United Soybean Board and a grant from Undergraduate Research, Scholarship and Creative Activity grant, UWSP supported this investigation. Granting agencies did play any role in designing the experiments.r This project was supported by a grant from United Soybean Board and a grant from Undergraduate Research, Scholarship and Creative Activity grant, UWSP.	Baumbach J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150482; Bolon YT, 2011, PLANT PHYSIOL, V156, P240, DOI 10.1104/pp.110.170811; Brutnell TP, 2002, FUNCT INTEGR GENOMIC, V2, P4, DOI 10.1007/s10142-001-0044-0; Cervantes-Martinez I, 2007, CROP SCI, V47, P374, DOI 10.2135/cropsci2006.03.0143; Chen XF, 1999, J HERED, V90, P399, DOI 10.1093/jhered/90.3.399; Chuang CF, 2000, P NATL ACAD SCI USA, V97, P4985, DOI 10.1073/pnas.060034297; Cooper JL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-9; Cui YY, 2013, PLANT PHYSIOL, V161, P36, DOI 10.1104/pp.112.205369; DOONER HK, 1989, GENETICS, V122, P447; FEDOROFF NV, 1984, P NATL ACAD SCI-BIOL, V81, P3825, DOI 10.1073/pnas.81.12.3825; Grant D, 2010, NUCLEIC ACIDS RES, V38, pD843, DOI 10.1093/nar/gkp798; GROOSE RW, 1990, THEOR APPL GENET, V79, P161, DOI 10.1007/BF00225946; GROOSE RW, 1988, J HERED, V79, P263, DOI 10.1093/oxfordjournals.jhered.a110507; Hancock CN, 2011, PLANT PHYSIOL, V157, P552, DOI 10.1104/pp.111.181206; HEDGES BR, 1992, BIOCHEM GENET, V30, P491, DOI 10.1007/BF01037587; HOFGEN R, 1994, P NATL ACAD SCI USA, V91, P1726, DOI 10.1073/pnas.91.5.1726; JAMES DW, 1995, PLANT CELL, V7, P309, DOI 10.2307/3869853; JONES DA, 1994, SCIENCE, V266, P789, DOI 10.1126/science.7973631; Kato KK, 2004, THEOR APPL GENET, V108, P577, DOI 10.1007/s00122-003-1482-y; Levin HL, 2011, NAT REV GENET, V12, P615, DOI 10.1038/nrg3030; Mabuchi A, 2016, J PLANT PHYSIOL, V191, P29, DOI 10.1016/j.jplph.2015.11.011; Mathieu M, 2009, PLANTA, V229, P279, DOI 10.1007/s00425-008-0827-9; MCKINNEY EC, 1995, PLANT J, V8, P613, DOI 10.1046/j.1365-313X.1995.8040613.x; O'Malley RC, 2007, NAT PROTOC, V2, P2910, DOI 10.1038/nprot.2007.425; O'Malley RC, 2010, PLANT J, V61, P928, DOI 10.1111/j.1365-313X.2010.04119.x; Palmer RG, 2008, THEOR APPL GENET, V117, P711, DOI 10.1007/s00122-008-0812-5; Palmer R. G., 1992, Soybean Genetics Newsletter, V19, P112; Palmer RG, 2008, GENOME, V51, P243, DOI 10.1139/G08-001; PALMER RG, 1990, CROP SCI, V30, P1376, DOI 10.2135/cropsci1990.0011183X003000060078x; PALMER RG, 1989, DEV GENET, V10, P542, DOI 10.1002/dvg.1020100613; Palmer RG, 2000, CROP SCI, V40, P78, DOI 10.2135/cropsci2000.40178x; Palmer RG., 2004, SOYBEANS IMPROVEMENT, P137, DOI DOI 10.2134/AGRONMONOGR16.3ED.C5; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Raval J, 2013, FUNCT INTEGR GENOMIC, V13, P67, DOI 10.1007/s10142-012-0304-1; RHODES PR, 1988, GENETICS, V120, P597; Sandhu D, 2004, GENETICS, V168, P2157, DOI 10.1534/genetics.104.032037; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Svitashev S, 2015, PLANT PHYSIOL, V169, P931, DOI 10.1104/pp.15.00793; Xu M, 2005, THEOR APPL GENET, V111, P1457, DOI 10.1007/s00122-005-0027-y; Xu M, 2010, GENETICS, V184, P53, DOI 10.1534/genetics.109.107904; Zabala G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111959; Zabala G, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-124	43	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0180732	10.1371/journal.pone.0180732	http://dx.doi.org/10.1371/journal.pone.0180732			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797084	gold, Green Submitted, Green Published			2022-12-26	WOS:000407396200006
J	Vitale, S; Strisciuglio, C; Pisapia, L; Miele, E; Barba, P; Vitale, A; Cenni, S; Bassi, V; Maglio, M; Del Pozzo, G; Troncone, R; Staiano, A; Gianfrani, C				Vitale, Serena; Strisciuglio, Caterina; Pisapia, Laura; Miele, Erasmo; Barba, Pasquale; Vitale, Alessandra; Cenni, Sabrina; Bassi, Virginia; Maglio, Mariantonia; Del Pozzo, Giovanna; Troncone, Riccardo; Staiano, Annamaria; Gianfrani, Carmen			Cytokine production profile in intestinal mucosa of paediatric inflammatory bowel disease	PLOS ONE			English	Article							ACTIVE ULCERATIVE-COLITIS; BLOOD MONONUCLEAR-CELLS; NECROSIS-FACTOR-ALPHA; CELIAC-DISEASE; T-CELLS; EPITHELIAL-CELLS; DENDRITIC CELLS; CROHNS-DISEASE; INTERLEUKIN 15; EXPRESSION	In the recent years, the incidence of inflammatory bowel disease (IBD) has dramatically increased in young subjects, however, the pathogenesis of paediatric IBD is poorly investigated. In this study we aimed to evaluate the cytokine pattern and the phenotype of cytokine producing cells in the intestinal mucosa of paediatric patients affected by Crohn's disease (CD) or ulcerative colitis (UC) and of non-IBD healthy controls (HC). Cytokine (IL-15, TNF-alpha, INF-gamma) production was analyzed at basal condition and after mitogen stimulation either intracellularly by flow cytometry or in intestinal cell culture supernatants by enzyme-linked immunosorbent assay (ELISA). A higher frequency of enterocytes (EpCam+cells) was observed in UC patients compared to CD or HC. An expansion of enterocytes producing IL-15 and TNF-alpha were found in IBD patients compared to HC. A marked expression of IL-15 in the intestinal epithelium of IBD patients was further confirmed by immunohistochemistry. Myeloid dendritic (CD11c+) cells producing TNF-alpha and INF-gamma were increased in IBD biopsies. Unexpectedly, only after a strong mitogen stimulus, as phytohaemagglutinin, the frequency of CD3+ cells producing IFN-gamma was increased in IBD compared to control intestinal mucosa. Interestingly, functional studies performed on organ cultures of intestinal biopsies with neutralizing anti-IL-15 monoclonal antibody showed a marked reduction of mononuclear cell activation, proliferation of crypt enterocytes, as well as a reduction of TNF-alpha release in organ culture supernatants. In conclusion, we found that in the gut mucosa of IBD children both enterocytes and dendritic cells produce proinflammatory cytokines. The over-expression of IL-15 by enterocytes in IBD intestine and the reduced IBD inflammation by IL-15 blockage suggests that this cytokine could be a therapeutic target in IBD.	[Vitale, Serena; Gianfrani, Carmen] CNR, Inst Prot Biochem, Naples, Italy; [Strisciuglio, Caterina; Vitale, Alessandra] Univ Naples 2, Dept Woman Child & Gen & Specialized Surg, Naples, Italy; [Strisciuglio, Caterina; Miele, Erasmo; Cenni, Sabrina; Bassi, Virginia; Maglio, Mariantonia; Troncone, Riccardo; Staiano, Annamaria; Gianfrani, Carmen] Univ Federico II, Dept Translat Med Sci, Paediat Sect, Naples, Italy; [Strisciuglio, Caterina; Miele, Erasmo; Cenni, Sabrina; Bassi, Virginia; Maglio, Mariantonia; Troncone, Riccardo; Staiano, Annamaria; Gianfrani, Carmen] Univ Federico II, European Lab Invest Food Induced Dis, Naples, Italy; [Pisapia, Laura; Barba, Pasquale; Del Pozzo, Giovanna] CNR, Inst Genet & Biophys Adriano Buzzati Traverso, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Universita della Campania Vanvitelli; University of Naples Federico II; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR)	Gianfrani, C (corresponding author), CNR, Inst Prot Biochem, Naples, Italy.; Gianfrani, C (corresponding author), Univ Federico II, Dept Translat Med Sci, Paediat Sect, Naples, Italy.; Gianfrani, C (corresponding author), Univ Federico II, European Lab Invest Food Induced Dis, Naples, Italy.	c.gianfrani@ibp.cnr.it	Del Pozzo, Giovanna/AAW-9209-2020; Cenni, Sabrina/AAC-5184-2022; Strisciuglio, Caterina/ABD-2466-2020; Staiano, Annamaria/H-3026-2011	Del Pozzo, Giovanna/0000-0001-8937-9018; Vitale, Serena/0000-0003-3310-1054; Staiano, Annamaria/0000-0003-0586-1339	project "New insights in the pathogenesis and in the identification of new therapeutic targets of inflammatory bowel disease" [MIUR PRIN 2009-2011; 2010K34C45_006]	project "New insights in the pathogenesis and in the identification of new therapeutic targets of inflammatory bowel disease"	This work has been supported by funding from the project "New insights in the pathogenesis and in the identification of new therapeutic targets of inflammatory bowel disease" (MIUR PRIN 2009-2011; 2010K34C45_006).	Abadie V, 2014, IMMUNOL REV, V260, P221, DOI 10.1111/imr.12191; Agace WW, 2008, TRENDS IMMUNOL, V29, P514, DOI 10.1016/j.it.2008.08.003; ANDERSON DM, 1995, J BIOL CHEM, V270, P29862; Bamias G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072594; Baran J, 2001, CLIN DIAGN LAB IMMUN, V8, P303, DOI 10.1128/CDLI.8.2.303-313.2001; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Benahmed M, 2007, GASTROENTEROLOGY, V132, P994, DOI 10.1053/j.gastro.2006.12.025; Bernardo D, 2013, REV ESP ENFERM DIG, V105, P279, DOI 10.4321/s1130-01082013000500006; Biancheri P, 2014, EUR J IMMUNOL, V44, P370, DOI 10.1002/eji.201343524; Budagian V, 2006, CYTOKINE GROWTH F R, V17, P259, DOI 10.1016/j.cytogfr.2006.05.001; Burman S, 2016, DIGEST DIS, V34, P64, DOI 10.1159/000443759; Carrasco A, 2016, J CROHNS COLITIS, V10, P1042, DOI 10.1093/ecco-jcc/jjw066; Carson WE, 1997, J CLIN INVEST, V99, P937, DOI 10.1172/JCI119258; Castillo EF, 2012, CYTOKINE, V59, P479, DOI 10.1016/j.cyto.2012.06.017; Coskun M, 2014, FRONT MED, V1, DOI 10.3389/fmed.2014.00024; D'Ambrosio A, 2016, J CROHNS COLITIS, V10, P346, DOI 10.1093/ecco-jcc/jjv216; Dahan S, 2008, GASTROENTEROLOGY, V134, P192, DOI 10.1053/j.gastro.2007.10.022; Danese S, 2008, TRENDS IMMUNOL, V29, P555, DOI 10.1016/j.it.2008.07.009; Di Sabatino A, 2006, GUT, V55, P469, DOI 10.1136/gut.2005.068684; Eppinga H, 2016, J CROHNS COLITIS, V10, P1067, DOI 10.1093/ecco-jcc/jjw070; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Fischer A, 2013, AM J PHYSIOL-GASTR L, V304, pG970, DOI 10.1152/ajpgi.00183.2012; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Garcia-Lora A, 2003, J CELL PHYSIOL, V195, P346, DOI 10.1002/jcp.10290; Geremia A, 2014, AUTOIMMUN REV, V13, P3, DOI 10.1016/j.autrev.2013.06.004; Gianfrani C, 2007, GASTROENTEROLOGY, V133, P780, DOI 10.1053/j.gastro.2007.06.023; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; Gologan S, 2013, J CROHNS COLITIS, V7, P622, DOI 10.1016/j.crohns.2012.08.015; Hasan AN, 2016, CLIN EXP IMMUNOL, V186, P249, DOI 10.1111/cei.12816; Hassan C, 2007, DIGEST LIVER DIS, V39, P811, DOI 10.1016/j.dld.2007.06.003; Imamura M, 2014, BLOOD, V124, P1081, DOI 10.1182/blood-2014-02-556837; Leon AJ, 2006, MED CLIN-BARCELONA, V127, P145, DOI 10.1157/13090382; Kelsall Brian L, 2004, Nat Immunol, V5, P1091, DOI 10.1038/ni1104-1091; Kirman I, 1996, AM J GASTROENTEROL, V91, P1789; Leon AJ, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/580450; Levine A, 2014, J PEDIATR GASTR NUTR, V58, P795, DOI 10.1097/MPG.0000000000000239; Liu ZJ, 2000, J IMMUNOL, V164, P3608, DOI 10.4049/jimmunol.164.7.3608; Ma LJ, 2009, J IMMUNOL, V183, P1044, DOI 10.4049/jimmunol.0900420; Maglio M, 2011, SCAND J GASTROENTERO, V46, P1194, DOI 10.3109/00365521.2011.603159; Maiuri L, 2000, GASTROENTEROLOGY, V119, P996, DOI 10.1053/gast.2000.18149; Maiuri L, 2001, AM J GASTROENTEROL, V96, P150; Malamut G, 2010, J CLIN INVEST, V120, P2131, DOI 10.1172/JCI41344; Maukonen J, 2015, J CROHNS COLITIS, V9, P1088, DOI 10.1093/ecco-jcc/jjv147; Mention JJ, 2003, GASTROENTEROLOGY, V125, P730, DOI 10.1016/S0016-5085(03)01047-3; Miron N, 2012, CLIN EXP IMMUNOL, V167, P405, DOI 10.1111/j.1365-2249.2011.04523.x; Mortier E, 2009, IMMUNITY, V31, P811, DOI 10.1016/j.immuni.2009.09.017; Neurath MF, 2002, NAT MED, V8, P567, DOI 10.1038/nm0602-567; Niess JH, 2008, WORLD J GASTROENTERO, V14, P5138, DOI 10.3748/wjg.14.5138; Nishiwaki T, 2005, J GASTROENTEROL, V40, P128, DOI 10.1007/s00535-004-1510-y; Olsen I, 2013, SCAND J GASTROENTERO, V48, P1278, DOI 10.3109/00365521.2013.837952; Olsen I, 2013, J IMMUNOL METHODS, V390, P106, DOI 10.1016/j.jim.2013.01.015; Pagliari D, 2013, CYTOKINE GROWTH F R, V24, P455, DOI 10.1016/j.cytogfr.2013.05.004; Paparo F, 2005, AM J GASTROENTEROL, V100, P2294, DOI 10.1111/j.1572-0241.2005.41134.x; Raki M, 2006, GASTROENTEROLOGY, V131, P428, DOI 10.1053/j.gastro.2006.06.002; Reimund JM, 1996, GUT, V39, P684, DOI 10.1136/gut.39.5.684; Reinecker HC, 1996, GASTROENTEROLOGY, V111, P1706, DOI 10.1016/S0016-5085(96)70036-7; Rescigno M, 2009, J CLIN INVEST, V119, P2441, DOI 10.1172/JCI39134; Rostaing L, 1999, CYTOMETRY, V35, P318, DOI 10.1002/(SICI)1097-0320(19990401)35:4<318::AID-CYTO4>3.0.CO;2-4; Ruemmele FM, 2010, CURR OPIN GASTROEN, V26, P332, DOI 10.1097/MOG.0b013e328339ec2d; Sollid LM, 2011, J INTERN MED, V269, P604, DOI 10.1111/j.1365-2796.2011.02376.x; Strisciuglio C, 2015, INFLAMM BOWEL DIS, V21, P1491, DOI 10.1097/MIB.0000000000000389; Su LP, 2013, GASTROENTEROLOGY, V145, P407, DOI 10.1053/j.gastro.2013.04.011; Tanahashi T, 2000, INFECT IMMUN, V68, P664, DOI 10.1128/IAI.68.2.664-671.2000; Troncone R, 1998, DIGEST DIS SCI, V43, P156, DOI 10.1023/A:1018896625699; Vainer B, 2000, CYTOKINE, V12, P1531, DOI 10.1006/cyto.2000.0744; Van Limbergent J, 2008, GASTROENTEROLOGY, V135, P1114, DOI 10.1053/j.gastro.2008.06.081; Verdier J, 2012, INFLAMM BOWEL DIS, V18, P1260, DOI 10.1002/ibd.21905; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Weidlich S, 2014, J PEDIATR GASTR NUTR, V59, pE18, DOI 10.1097/MPG.0000000000000387; Zeng JQ, 2015, WORLD J GASTROENTERO, V21, P187, DOI 10.3748/wjg.v21.i1.187	70	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182313	10.1371/journal.pone.0182313	http://dx.doi.org/10.1371/journal.pone.0182313			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797042	Green Published, Green Submitted, gold			2022-12-26	WOS:000407396200042
J	Converse, PE; Kuchta, SR; Hauswaldt, JS; Roosenburg, WM				Converse, Paul E.; Kuchta, Shawn R.; Hauswaldt, J. Susanne; Roosenburg, Willem M.			Turtle soup, Prohibition, and the population genetic structure of Diamondback Terrapins (Malaclemys terrapin)	PLOS ONE			English	Article							ALLELE FREQUENCY DATA; MIGRATION RATES; EVOLUTIONARY PROCESSES; HABITAT FRAGMENTATION; BIODIVERSITY LOSS; CLIMATE-CHANGE; BIGHORN SHEEP; DIVERSITY; PROGRAM; FLOW	Diamondback terrapins (Malaclemys terrapin) were a popular food item in early twentieth century America, and were consumed in soup with sherry. Intense market demand for terrapin meat resulted in population declines, notably along the Atlantic seaboard. Efforts to supply terrapins to markets resulted in translocation events, as individuals were moved about to stock terrapin farms. However, in 1920 the market for turtle soup buckled with the enactment of the eighteenth amendment to the United States' Constitution-which initiated the prohibition of alcoholic drinks-and many terrapin fisheries dumped their stocks into local waters. We used microsatellite data to show that patterns of genetic diversity along the terrapin's coastal range are consistent with historical accounts of translocation and cultivation activities. We identified possible instances of human-mediated dispersal by estimating gene flow over historical and contemporary timescales, Bayesian model testing, and bottleneck tests. We recovered six genotypic clusters along the Gulf and Atlantic coasts with varying degrees of admixture, including increased contemporary gene flow from Texas to South Carolina, from North Carolina to Maryland, and from North Carolina to New York. In addition, Bayesian models incorporating translocation events outperformed stepping-stone models. Finally, we were unable to detect population bottlenecks, possibly due to translocation reintroducing genetic diversity into bottlenecked populations. Our data suggest that current patterns of genetic diversity in the terrapin were altered by the demand for turtle soup followed by the enactment of alcohol prohibition. In addition, our study shows that population genetic tools can elucidate metapopulation dynamics in taxa with complex genetic histories impacted by anthropogenic activities.	[Converse, Paul E.; Kuchta, Shawn R.; Roosenburg, Willem M.] Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA; [Kuchta, Shawn R.; Roosenburg, Willem M.] Ohio Univ, Ohio Ctr Ecol & Evolutionary Studies, Athens, OH 45701 USA; [Hauswaldt, J. Susanne] Univ South Carolina, Dept Biol Sci, Columbia, SC USA	University System of Ohio; Ohio University; University System of Ohio; Ohio University; University of South Carolina System; University of South Carolina Columbia	Converse, PE (corresponding author), Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA.	paulconverse@icloud.com		Roosenburg, Willem/0000-0002-3683-1637	Ohio University; Ohio Center for Ecology and Evolutionary Studies	Ohio University; Ohio Center for Ecology and Evolutionary Studies	Ohio University Student Enhancement award, Ohio Center for Ecology and Evolutionary Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, TRACER V1 6; Assis J, 2016, MAR ENVIRON RES, V113, P174, DOI 10.1016/j.marenvres.2015.11.005; AVISE JC, 1992, MOL BIOL EVOL, V9, P457; Banks SC, 2013, TRENDS ECOL EVOL, V28, P670, DOI 10.1016/j.tree.2013.08.005; Barr KR, 2015, MOL ECOL, V24, P2349, DOI 10.1111/mec.13176; Beerli Peter, 2009, V17, P42; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; BERT TM, 1986, MAR BIOL, V93, P157, DOI 10.1007/BF00508253; Calsbeek R, 2012, ADAPTIVE LANDSCAPE IN EVOLUTIONARY BIOLOGY, P89; Chiucchi JE, 2010, MOL ECOL, V19, P5345, DOI 10.1111/j.1365-294X.2010.04860.x; Coker R, 1920, SCI MONTHLY, V11, P171; Converse PE, 2015, MOL ECOL, V24, P5864, DOI 10.1111/mec.13440; Converse PE, 2017, ECOLOGY CONSERVATION; Cook B., 1989, Underwater Naturalist, V18, P25; Cornuet JM, 1996, GENETICS, V144, P2001; Doody JS, 2009, ANIM CONSERV, V12, P46, DOI 10.1111/j.1469-1795.2008.00219.x; Drabeck DH, 2014, J HERPETOL, V48, P125, DOI 10.1670/12-186; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Epps CW, 2015, MOL ECOL, V24, P6021, DOI 10.1111/mec.13454; Epps CW, 2005, ECOL LETT, V8, P1029, DOI 10.1111/j.1461-0248.2005.00804.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Faubet P, 2007, MOL ECOL, V16, P1149, DOI 10.1111/j.1365-294X.2007.03218.x; Frankham D, 2010, CONSERVATION GENETIC; Handazzo AF, 1997, GEOLOGY FLORIDA; Hart KM, 2014, CONSERV GENET, V15, P593, DOI 10.1007/s10592-014-0563-6; Hauswaldt JS, 2005, MOL ECOL, V14, P723, DOI 10.1111/j.1365-294X.2005.02451.x; Hauswaldt JS, 2003, MOL ECOL NOTES, V3, P174, DOI 10.1046/j.1471-8286.2003.00388.x; Hauswaldt JS, 2004, THESIS; Hay WP., 1917, B US BUR FISH, V24, P1; HILDEBRAND SAMUEL F., 1929, BULL BUR FISHERIES, V45, P25; Hildebrand SF, 1933, J HERED, V24, P231, DOI 10.1093/oxfordjournals.jhered.a103783; Hildebrand SF, 1926, NC US BUREAU FISHERI, V60, P1; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kennedy V., 2017, ECOLOGY CONSERVATION; Laikre L, 2010, TRENDS ECOL EVOL, V25, P520, DOI 10.1016/j.tree.2010.06.013; LAMB T, 1992, J HERED, V83, P262, DOI 10.1093/oxfordjournals.jhered.a111211; Lee T, 2003, ZOOL J LINN SOC-LOND, V137, P245, DOI 10.1046/j.1096-3642.2003.00047.x; Lester LA, 2007, THESIS; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Maddocks CE, 2015, J FISH DIS, V38, P653, DOI 10.1111/jfd.12306; Meirmans PG, 2014, MOL ECOL RESOUR, V14, P726, DOI 10.1111/1755-0998.12216; Moritz C, 1999, HEREDITAS, V130, P217, DOI 10.1111/j.1601-5223.1999.00217.x; Olson ZH, 2013, J WILDLIFE MANAGE, V77, P1553, DOI 10.1002/jwmg.624; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; Perez I, 2012, FRONT ECOL ENVIRON, V10, P494, DOI 10.1890/110175; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pongsiri MJ, 2009, BIOSCIENCE, V59, P945, DOI 10.1525/bio.2009.59.11.6; Pritchard JK, 2000, GENETICS, V155, P945; Puckett EE, 2014, MOL ECOL, V23, P2414, DOI 10.1111/mec.12748; Puechmaille SJ, 2016, MOL ECOL RESOUR, V16, P608, DOI 10.1111/1755-0998.12512; Roosenburg Willem M., 2008, Turtle and Tortoise Newsletter, V12, P27; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Seigel RA, 2002, CONSERV BIOL, V16, P552, DOI 10.1046/j.1523-1739.2002.01275.x; SHORT J, 1992, BIOL CONSERV, V62, P189, DOI 10.1016/0006-3207(92)91047-V; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Souty-Grosset C, 2008, BIODIVERSITY CONSERV; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Storfer A, 1999, BIOL CONSERV, V87, P173, DOI 10.1016/S0006-3207(98)00066-4; Templeton AR, 2001, P NATL ACAD SCI USA, V98, P5426, DOI 10.1073/pnas.091093098; Vamberger M, 2014, ZOOL SCR, V43, P313, DOI 10.1111/zsc.12055; Wagner S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127516; Webb S.D., 1990, P70; Westemeier RL, 1998, SCIENCE, V282, P1695, DOI 10.1126/science.282.5394.1695; Wilson GA, 2003, GENETICS, V163, P1177; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	66	5	5	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0181898	10.1371/journal.pone.0181898	http://dx.doi.org/10.1371/journal.pone.0181898			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28792964	Green Published, Green Submitted, gold			2022-12-26	WOS:000407196700025
J	Csuzdi, C; Chang, CH; Pavlicek, T; Szederjesi, T; Esopi, D; Szlavecz, K				Csuzdi, Csaba; Chang, Chih-Han; Pavlicek, Tomas; Szederjesi, Timea; Esopi, David; Szlavecz, Katalin			Molecular phylogeny and systematics of native North American lumbricid earthworms (Clitellata: Megadrili)	PLOS ONE			English	Article							OLIGOCHAETA ANNELIDA CLITELLATA; INCLUDING MEXICO; PUERTO-RICO; FAUNA; DIVERSIFICATION; EVOLUTION; BERINGIA; BIOLOGY; HAWAII; GREECE	The family Lumbricidae is arguably the most well-known and well-studied earthworm group due to its dominance in the European earthworm fauna and its invasion in temperate regions worldwide. However, its North American members, especially the genus Bimastos Moore, 1893, are poorly understood. We revised the systematics of the genus Bimastos and tested the hypothesis of the monophyly of North American lumbricids using morphological characters and eight molecular markers. Phylogenetic analyses based on our extensive sampling of Bimastos and inclusion of Dendrodrilus and Allolobophoridella indicated a well-supported clade containing Bimastos and Eisenoides Gates, 1969, and provided the first evidence supporting that North American lumbricids are monophyletic. Assuming the available divergence time estimations and dating of land bridges are correct, it would suggest that the ancestor of this clade arrived North America through Beringia or the De Geer route during Late Cretaceous, and since then the clade has diverged from its Eurasian sister group, Eisenia. The peregrine genera Dendrodrilus and Allolobophoridella are nested within the Bimastos clade; we propose to treat them as junior synonyms of the genus Bimastos, and, contradictory to the commonly held belief of being European, they are indeed part of the indigenous North American earthworm fauna. Morphological characters, such as red-violet pigmentation, proclinate U-shaped nephridial bladders and calciferous diverticula in segment 10 further support this placement. The East Mediterranean-Levantine Spermophorodrilus Bouche A, 1975 and Healyella Omodeo & Rota, 1989 are nested within the Dendrobaena sensu lato clade; therefore their close relationship with the North American Bimastos is refuted. Species fit the revised diagnosis of Bimastos are reviewed and keyed, and a new species, Bimastos schwerti sp. nov., is described.	[Csuzdi, Csaba] Eszterhazy Karoly Univ, Dept Zool, Eger, Hungary; [Chang, Chih-Han; Szlavecz, Katalin] Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA; [Pavlicek, Tomas] Univ Haifa, Inst Evolut, Haifa, Israel; [Szederjesi, Timea] Hungarian Acad Sci, Ctr Agr Res, Plant Protect Inst, Dept Zool & Anim Ecol, Budapest, Hungary; [Esopi, David] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA	Johns Hopkins University; University of Haifa; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Johns Hopkins University; Johns Hopkins Medicine	Chang, CH (corresponding author), Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA.	chihhanchang.jhu@gmail.com	Pavlicek, Tomas/C-4768-2008; Szlavecz, Katalin/A-5842-2008; Csuzdi, Csaba/A-8619-2010; Szederjesi, Tímea/A-7397-2018	Szlavecz, Katalin/0000-0003-2504-0298; Csuzdi, Csaba/0000-0002-0319-7836; Szederjesi, Tímea/0000-0001-7695-1468; Chang, Chih-Han/0000-0002-6289-9555	National Science Foundation [DEB 9714835, EAGER NEON 1550795, ACI 1244820]; Hungarian Scientific Research Fund [OTKA K100369]; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding to this study was partially provided by the National Science Foundation (DEB 9714835, EAGER NEON 1550795, ACI 1244820) to KS and by the Hungarian Scientific Research Fund (OTKA K100369) to CsC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman Daniil I., 1994, Megadrilogica, V5, P113; Blakemore RJ, 2008, AM EARTHWORMS N RIO; BLAKEMORE RJ, 2008, COSMOPOLITAN EARTHWO; BOUCHE M B, 1975, Zoologische Jahrbuecher Abteilung fuer Systematik Oekologie und Geographie der Tiere, V102, P1; Bouche M.B., 1972, LOMBRICIENS FRANCE E; Bretscher K., 1900, Revue Suisse de Zoologie, Vviii; Brikiatis L, 2014, J BIOGEOGR, V41, P1036, DOI 10.1111/jbi.12310; Burbrink FT, 2007, MOL PHYLOGENET EVOL, V43, P173, DOI 10.1016/j.ympev.2006.09.009; Cech Gabor, 2005, P85; Cernosvitov L., 1938, Zoologischer Anzeiger Leipzig, V123, P192; Chang CH, 2011, PEDOBIOLOGIA, V54, pS3, DOI 10.1016/j.pedobi.2011.07.015; Chang CH, 2016, ECOLOGY, V97, P160, DOI 10.1890/15-0551.1; Chang CH, 2008, MOL PHYLOGENET EVOL, V49, P958, DOI 10.1016/j.ympev.2008.08.025; Csuzdi C, 1999, ISR J ZOOL, V45, P467; Csuzdi C, 2003, EARTHWORM OF HUNGARY; Csuzdi C, 2004, ADV EARTHWORM TAXONO, P333; Csuzdi CS, 2006, ZOOTAXA, P1; Csuzdi Cs., 2012, Opuscula Zoologica (Budapest), V43, P97; Csuzdi Csaba, 2002, Zoology in the Middle East, V25, P105; Csuzdi C, 2011, ZOOL ANZ, V250, P2, DOI 10.1016/j.jcz.2010.10.001; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dominguez J, 2015, MOL PHYLOGENET EVOL, V83, P7, DOI 10.1016/j.ympev.2014.10.024; Easton EG, 1983, EARTHWORM ECOLOGY DA, P475; Eisen G., 1873, Ofversigt Ak Forhandlingar, VNo. 8, P43; Eisen G., 1874, OFVERSIGT KONGLIGA V, V31, P41; FENDER W M, 1985, Megadrilogica, V4, P93; Fernandez R, 2012, MOL PHYLOGENET EVOL, V64, P368, DOI 10.1016/j.ympev.2012.04.011; Gates G.E., 1976, Megadrilogica, V2, P1; GATES G E, 1982, Megadrilogica, V4, P12; GATES G E, 1975, Megadrilogica, V2, P1; GATES G. E., 1956, BULL MUS COMP ZOOL HARVARD UNIV, V115, P1; GATES G. E., 1942, AMER MIDLAND NAT, V27, P86, DOI 10.2307/2421027; GATES GE, 1972, T AM PHILOS SOC, V62, P5; GATES GE, 1969, J NAT HIST, V3, P305, DOI 10.1080/00222936900770261; Gerard BM, 1964, SYNOPSES BRIT FAUNA; James Samuel W., 1995, P29; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Krutsay M, 1980, HISTOLOGICAL TECHNIC; Lee K. E., 1985, Earthworms: their ecology and relationships with soils and land use.; Levinsen G.M.R., 1883, VIDENSKABELIGE MEDDE, V45, P92, DOI 10.5962/bhl.title.16117; Marshall Valin G., 2007, Megadrilogica, V11, P29; MCKEYFENDER D, 1994, CAN J ZOOL, V72, P1325, DOI 10.1139/z94-176; Mercadal de Barrio I.T., 1989, Physis Secciones A B y C (Buenos Aires), V46, P1; Michaelsen W., 1894, Zoologische Jahrbuecher (Systematik), P177; Michaelsen W., 1900, Das Tierreich, VLief. x, pUnpaginated; Michaelsen W., 1899, ABHANDLUNGEN VERHAND, V28, P421; Miller MA, 2011, P 2011 TERAGRID C EX, P41, DOI DOI 10.1145/2016741.2016785; MOORE HF, 1895, J MORPHOL, V10, P473; Moore HJ., 1893, ZOOL ANZ, V16, P333; Mrsic N., 1991, MONOGRAPHS EARTHWORM, VI-II; MRSIV N, 1990, Bioloski Vestnik, V38, P49; MULDAL S, 1952, P ZOOL SOC LOND, V122, P463; Novo M, 2015, J BIOGEOGR, V42, P751, DOI 10.1111/jbi.12447; Omodeo P, 2000, ITAL J ZOOL, V67, P179, DOI 10.1080/11250000009356313; OMODEO P., 1956, ARCH ZOOL ITAL, V41, P129; OMODEO P, 1989, B ZOOL, V56, P167; OMODEO P, 1991, B ZOOL, V58, P171, DOI 10.1080/11250009109355749; Pavlicek T, 2010, BIODIVERS CONSERV, V19, P1989, DOI 10.1007/s10531-010-9821-1; Perel T.S., 1979, RANGE REGULARITIES D; PEREL TS, 1976, REV ECOL BIOL SOL, V13, P635; PEREL TS, 1980, ZOOL ZH, V59, P507; Perez-Losada M, 2015, J PHYLOGENET EVOL BI, V3, P140, DOI DOI 10.4172/2329-9002-3-140; Perez-Losada M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028153; Pop AA, 2007, EUR J SOIL BIOL, V43, pS43, DOI 10.1016/j.ejsobi.2007.08.007; Pop V., 1941, Zoologische Jahrbuecher Jena Systematik, V74, P487; Pop V., 1938, Buletinul Societatii de Stiinte din Cluj, V9, P134; Qiu J.P., 1998, DOCUMENTS PEDOZOOLOG, V3, P119; Qiu J.P., 1998, DOCUMENTS PEDOZOOLOG, V4, P181; RAW F, 1959, NATURE, V184, P1661, DOI 10.1038/1841661a0; Reynolds J.W., 1974, Bulletin tall Timb Res Stn, VNo. 17,1974, P1; Reynolds J.W., 1974, Biologist Va, V56, P90; Reynolds John W., 1995, P1; Reynolds John Warren, 2012, Megadrilogica, V15, P191; Reynolds John Warren, 1994, Megadrilogica, V5, P13; Reynolds John Warren, 2008, Megadrilogica, V12, P157; Reynolds John Warren, 2004, Megadrilogica, V9, P71; Reynolds JW, 1977, EARTHWORMS LUMBRICI; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosa D., 1893, Memorie Accademia Torino, V(2), P399; Sanmartin I, 2001, BIOL J LINN SOC, V73, P345, DOI 10.1006/bijl.2001.0542; Savigny JC, 1826, ANAL TRAVAUX ACAD RO, V5, P176; Schwert D.P., 1990, P341; SCHWERT DP, 1979, CAN J ZOOL, V57, P1402, DOI 10.1139/z79-181; Smith F., 1928, Bull Div Nat Hist Surv Illinois, V18, P347; Smith F., 1917, Proceedings of the United States National Museum, V52; SMITH F, 1915, B ILLINOIS ST LAB NA, V10, P545; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stephenson J, 1932, P ZOOL SOC LOND; Stephenson J. L, 1930, OLIGOCHAETA; Szlavecz K, 2007, EUR J SOIL BIOL, V43, pS79, DOI 10.1016/j.ejsobi.2007.08.008; Ude H, 1895, ZOOL ANZ, V18, P339; Vila R, 2011, P ROY SOC B-BIOL SCI, V278, P2737, DOI 10.1098/rspb.2010.2213; Wu LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120764; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Zicsi A., 1968, Opuscula Zoologica (Budapest), V8, P99; ZICSI A, 1981, ACTA ZOOL ACAD SCI H, V27, P239; Zicsi A, 1999, REV SUISSE ZOOL, V106, P983, DOI 10.5962/bhl.part.80111; ZICSI A, 1982, ACTA ZOOL ACAD SCI H, V28, P421; Zicsi A., 1991, Opuscula Zoologica (Budapest), V24, P167; ZICSI A, 1993, ACTA ZOOL HUNG, V39, P301; ZICSI A, 1981, ACTA ZOOL ACAD SCI H, V27, P431; Zicsi A., 1959, Acta Zoologica Budapest, V5, P165	102	26	36	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0181504	10.1371/journal.pone.0181504	http://dx.doi.org/10.1371/journal.pone.0181504			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28792948	Green Published, gold, Green Accepted			2022-12-26	WOS:000407196700012
J	Fu, HJ; Qiu, WW; Ma, HY; Ma, QG				Fu, Huijian; Qiu, Wenwei; Ma, Haiying; Ma, Qingguo			Neurocognitive mechanisms underlying deceptive hazard evaluation: An event-related potentials investigation	PLOS ONE			English	Article							EXECUTIVE PROCESSES; NEURAL PROCESS; PHYSICAL RISK; LIE DETECTION; SIGNAL WORDS; PERCEPTION; RESPONSES; P300; ERP; TRUTHFUL	Deceptive behavior is common in human social interactions. Researchers have been trying to uncover the cognitive process and neural basis underlying deception due to its theoretical and practical significance. We used Event-related potentials (ERPs) to investigate the neural correlates of deception when the participants completed a hazard judgment task. Pictures conveying or not conveying hazard information were presented to the participants who were then requested to discriminate the hazard content (safe or hazardous) and make a response corresponding to the cues (truthful or deceptive). Behavioral and electrophysiological data were recorded during the entire experiment. Results showed that deceptive responses, compared to truthful responses, were associated with longer reaction time (RT), lower accuracy, increased N2 and reduced late positive potential (LPP), suggesting a cognitively more demanding process to respond deceptively. The decrement in LPP correlated negatively with the increment in RT for deceptive relative to truthful responses, regardless of hazard content. In addition, hazardous information evoked larger N1 and P300 than safe information, reflecting an early processing bias and a later evaluative categorization process based on motivational significance, respectively. Finally, the interaction between honesty (truthful/deceptive) and safety (safe/hazardous) on accuracy and LPP indicated that deceptive responses towards safe information required more effort than deceptive responses towards hazardous information. Overall, these results demonstrate the neurocognitive substrates underlying deception about hazard information.	[Fu, Huijian; Ma, Haiying] Guangdong Univ Technol, Sch Management, Guangzhou, Guangdong, Peoples R China; [Fu, Huijian; Ma, Haiying] Guangdong Univ Technol, Lab Managerial Psychol & Behav, Guangzhou, Guangdong, Peoples R China; [Qiu, Wenwei] Zhejiang Univ, Sch Management, Hangzhou, Zhejiang, Peoples R China; [Ma, Qingguo] Zhejiang Univ Technol, Inst Neural Management Sci, Hangzhou, Zhejiang, Peoples R China; [Ma, Qingguo] Zhejiang Univ, Neuromanagement Lab, Hangzhou, Zhejiang, Peoples R China	Guangdong University of Technology; Guangdong University of Technology; Zhejiang University; Zhejiang University of Technology; Zhejiang University	Ma, QG (corresponding author), Zhejiang Univ Technol, Inst Neural Management Sci, Hangzhou, Zhejiang, Peoples R China.; Ma, QG (corresponding author), Zhejiang Univ, Neuromanagement Lab, Hangzhou, Zhejiang, Peoples R China.	maqingguo3669@zju.edu.cn		Ma, Haiying/0000-0003-1949-8251	National Natural Science Foundation of China [71371167]; Natural Science Foundation of Guangdong Province [2017A030310466];  [AWS12J003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); 	This work was supported by grant No. 71371167 from the National Natural Science Foundation of China (http://www.nsfc.gov.cn), grant No. AWS12J003 from the National Project and grant No. 2017A030310466 from the Natural Science Foundation of Guangdong Province (http//www.gdstc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe N, 2014, BRAIN COGNITION, V90, P41, DOI 10.1016/j.bandc.2014.06.005; Abe N, 2009, CURR OPIN NEUROL, V22, P594, DOI 10.1097/WCO.0b013e328332c3cf; [Anonymous], 2012, GBT10011; [Anonymous], GB2894; Correll J, 2006, J EXP SOC PSYCHOL, V42, P120, DOI 10.1016/j.jesp.2005.02.006; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; Ding XP, 2013, NEUROPSYCHOLOGIA, V51, P704, DOI 10.1016/j.neuropsychologia.2012.12.018; Dong GH, 2010, NEUROSCI LETT, V479, P1, DOI 10.1016/j.neulet.2010.05.014; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Foti D, 2009, PSYCHOPHYSIOLOGY, V46, P521, DOI 10.1111/j.1469-8986.2009.00796.x; FUREDY JJ, 1988, PSYCHOPHYSIOLOGY, V25, P683, DOI 10.1111/j.1469-8986.1988.tb01908.x; Hacker FEK, 2015, SOC COGN AFFECT NEUR, V10, P612, DOI 10.1093/scan/nsu093; Hellier E, 2000, APPL COGNITIVE PSYCH, V14, P577; Herwig U, 2011, BRAIN RES, V1400, P78, DOI 10.1016/j.brainres.2011.05.023; Hu XQ, 2011, BRAIN RES, V1369, P149, DOI 10.1016/j.brainres.2010.10.106; Ito A, 2012, BRAIN RES, V1464, P43, DOI 10.1016/j.brainres.2012.05.004; Ito A, 2011, NEUROSCI RES, V69, P121, DOI 10.1016/j.neures.2010.11.001; Johnson R, 2005, COGNITIVE BRAIN RES, V24, P386, DOI 10.1016/j.cogbrainres.2005.02.011; Johnson R, 2004, NEUROPSYCHOLOGIA, V42, P878, DOI 10.1016/j.neuropsychologia.2003.12.005; Johnson R, 2008, NEUROIMAGE, V39, P469, DOI 10.1016/j.neuroimage.2007.08.032; Lee TMC, 2013, SCI REP-UK, V3, DOI 10.1038/srep01636; Lee TMC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012291; Lee TMC, 2002, HUM BRAIN MAPP, V15, P157, DOI 10.1002/hbm.10020; Leite J, 2012, INT J PSYCHOPHYSIOL, V83, P375, DOI 10.1016/j.ijpsycho.2011.12.005; Leue A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00570; Luck S, 2005, EVENTRELATED POTENTI, P17; Ma QG, 2014, NEUROREPORT, V25, P607, DOI 10.1097/WNR.0000000000000147; Ma QG, 2010, NEUROSCI LETT, V483, P206, DOI 10.1016/j.neulet.2010.08.009; Meijer EH, 2014, PSYCHOPHYSIOLOGY, V51, P879, DOI 10.1111/psyp.12239; Meixner JB, 2014, PSYCHOL SCI, V25, P1994, DOI 10.1177/0956797614547278; Munoz F, 2015, BRAIN RES, V1594, P154, DOI 10.1016/j.brainres.2014.10.061; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Pfister R, 2014, SOC NEUROSCI-UK, V9, P562, DOI 10.1080/17470919.2014.934392; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Proverbio AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059383; Qin JG, 2009, NEUROSCI LETT, V455, P110, DOI 10.1016/j.neulet.2009.03.008; Qin JG, 2009, HUM BRAIN MAPP, V30, P1338, DOI 10.1002/hbm.20604; Qin JG, 2009, NEUROPSYCHOLOGIA, V47, P397, DOI 10.1016/j.neuropsychologia.2008.09.010; Rosenfeld J.P., 2011, MEMORY DETECTION THE, P63, DOI [10.1017/CBO9780511975196.005, DOI 10.1017/CBO9780511975196.005]; Schupp HT, 2004, COGNITION EMOTION, V18, P593, DOI 10.1080/02699930341000239; Schupp HT, 2004, PSYCHOPHYSIOLOGY, V41, P441, DOI 10.1111/j.1469-8986.2004.00174.x; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Smith DP, 2005, J GERONTOL B-PSYCHOL, V60, pP49, DOI 10.1093/geronb/60.1.P49; Spence SA, 2001, NEUROREPORT, V12, P2849, DOI 10.1097/00001756-200109170-00019; Suchotzi K, 2015, INT J PSYCHOPHYSIOL, V95, P395, DOI 10.1016/j.ijpsycho.2015.01.010; Sun J, 2012, NEUROSCIENCE, V203, P91, DOI 10.1016/j.neuroscience.2011.12.038; Sun SY, 2011, SOC NEUROSCI-UK, V6, P348, DOI 10.1080/17470919.2010.544135; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; Vorhold V, 2007, NEUROPSYCHOLOGIA, V45, P3242, DOI 10.1016/j.neuropsychologia.2007.06.023; Vrij A, 2011, CURR DIR PSYCHOL SCI, V20, P28, DOI 10.1177/0963721410391245; Wu HY, 2009, NEUROSCI LETT, V467, P63, DOI 10.1016/j.neulet.2009.10.002; Yu RF, 2004, HUM FACTORS ERGONOM, V14, P69, DOI 10.1002/hfm.10048; Zheng Y, 2015, BIOL PSYCHOL, V107, P44, DOI 10.1016/j.biopsycho.2015.03.003	53	9	9	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182892	10.1371/journal.pone.0182892	http://dx.doi.org/10.1371/journal.pone.0182892			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC9YJ	28793344	Green Published, Green Submitted, gold			2022-12-26	WOS:000407196700078
J	Paullin, T; Powell, C; Menzie, C; Hill, R; Cheng, F; Martyniuk, CJ; Westerheide, SD				Paullin, Trillitye; Powell, Chase; Menzie, Christopher; Hill, Robert; Cheng, Feng; Martyniuk, Christopher J.; Westerheide, Sandy D.			Spheroid growth in ovarian cancer alters transcriptome responses for stress pathways and epigenetic responses	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; HISTONE MODIFICATIONS; BREAST-CANCER; TUMOR-CELL; TGF-BETA; EXPRESSION; PROTEIN; RESISTANCE; ADHESION; CULTURE	Ovarian cancer is the most lethal gynecological cancer, with over 200,000 women diagnosed each year and over half of those cases leading to death. These poor statistics are related to a lack of early symptoms and inadequate screening techniques. This results in the cancer going undetected until later stages when the tumor has metastasized through a process that requires the epithelial to mesenchymal transition (EMT). In lieu of traditional monolayer cell culture, EMT and cancer progression in general is best characterized through the use of 3D spheroid models. In this study, we examine gene expression changes through microarray analysis in spheroid versus monolayer ovarian cancer cells treated with TGF beta to induce EMT. Transcripts that included Coiled-Coil Domain Containing 80 (CCDC80), Solute Carrier Family 6 (Neutral Amino Acid Transporter), Member 15 (SLC6A15), Semaphorin 3E (SEMA3E) and PIF1 5'-To-3' DNA Helicase (PIF1) were downregulated more than 10-fold in the 3D cells while Inhibitor Of DNA Binding 2, HLH Protein (ID2), Regulator Of Cell Cycle (RGCC), Protease, Serine 35 (PRSS35), and Aldo-Keto Reductase Family 1, Member C1 (AKR1C1) were increased more than 50-fold. Interestingly, EMT factors, stress responses and epigenetic processes were significantly affected by 3D growth. The heat shock response and the oxidative stress response were also identified as transcriptome responses that showed significant changes upon 3D growth. Subnetwork enrichment analysis revealed that DNA integrity (e.g. DNA damage, genetic instability, nucleotide excision repair, and the DNA damage checkpoint pathway) were altered in the 3D spheroid model. In addition, two epigenetic processes, DNA methylation and histone acetylation, were increased with 3D growth. These findings support the hypothesis that three dimensional ovarian cell culturing is physiologically different from its monolayer counterpart.	[Paullin, Trillitye; Powell, Chase; Menzie, Christopher; Hill, Robert; Westerheide, Sandy D.] Univ S Florida, Coll Arts & Sci, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA; [Cheng, Feng] Univ S Florida, Dept Pharmaceut Sci, Coll Pharm, Tampa, FL USA; [Cheng, Feng] Univ S Florida, Coll Publ Hlth, Dept Epidemiol & Biostat, Tampa, FL USA; [Martyniuk, Christopher J.] Univ Florida, UF Genet Inst, Ctr Environm & Human Toxicol, Gainesville, FL 32611 USA; [Martyniuk, Christopher J.] Univ Florida, UF Genet Inst, Dept Physiol Sci, Gainesville, FL 32611 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Westerheide, SD (corresponding author), Univ S Florida, Coll Arts & Sci, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA.; Martyniuk, CJ (corresponding author), Univ Florida, UF Genet Inst, Ctr Environm & Human Toxicol, Gainesville, FL 32611 USA.; Martyniuk, CJ (corresponding author), Univ Florida, UF Genet Inst, Dept Physiol Sci, Gainesville, FL 32611 USA.	cmartyn@ufl.edu; swesterheide@usf.edu	Cheng, Feng/A-9760-2009	Cheng, Feng/0000-0003-3619-8090; Westerheide, Sandy/0000-0003-4683-9648; Martyniuk, Christopher J./0000-0003-0921-4796	University of South Florida	University of South Florida	This work was funded by a start-up grant from the University of South Florida to S.D.W.	Akhavan-Niaki H, 2013, CELL BIOCHEM BIOPHYS, V67, P501, DOI 10.1007/s12013-013-9555-2; Auersperg N, 2002, INT J GYNECOL CANCER, V12, P691, DOI 10.1046/j.1525-1438.2002.01152.x; Azad N, 2013, NAT REV CLIN ONCOL, V10, P256, DOI 10.1038/nrclinonc.2013.42; Barros GP, 2012, INT J GEOPHYS, V2012, DOI [10.1155/2012/459497, 10.5402/2012/137289]; Beckman KB, 1997, J BIOL CHEM, V272, P19633, DOI 10.1074/jbc.272.32.19633; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Casey RC, 2001, AM J PATHOL, V159, P2071, DOI 10.1016/S0002-9440(10)63058-1; CHANT ID, 1995, BRIT J HAEMATOL, V90, P163, DOI 10.1111/j.1365-2141.1995.tb03395.x; Chervona Y, 2012, AM J CANCER RES, V2, P589; Cheung A, 2016, ONCOTARGET, DOI 10.18632/oncotarget.9651; CIOCCA DR, 1993, J NATL CANCER I, V85, P570, DOI 10.1093/jnci/85.7.570; Cvetkovic Dusica, 2003, Reprod Biol Endocrinol, V1, P68; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Deng HB, 2002, J BIOL CHEM, V277, P15035, DOI 10.1074/jbc.M112028200; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; dos Santos CR, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-16; Ferraro A, 2013, J CLIN ENDOCR METAB, V98, P2834, DOI 10.1210/jc.2012-2926; Gagou ME, 2014, ONCOTARGET, V5, P11381, DOI 10.18632/oncotarget.2501; Ghajar CM, 2010, TISSUE ENG PT A, V16, P2153, DOI 10.1089/ten.TEA.2010.0135; Grassi ML, 2016, J PROTEOMICS; GREENBURG G, 1982, J CELL BIOL, V95, P333, DOI 10.1083/jcb.95.1.333; Guarino M, 2007, PATHOLOGY, V39, P305, DOI 10.1080/00313020701329914; Harjes U, 2016, CRIT REV ONCOL HEMAT, V97, P15, DOI 10.1016/j.critrevonc.2015.10.011; Hatfield MPD, 2012, PROTEIN PEPTIDE LETT, V19, P616; Hay ED, 1995, ACTA ANAT, V154, P8; JAMEEL A, 1992, INT J CANCER, V50, P409, DOI 10.1002/ijc.2910500315; Kelm JM, 2003, BIOTECHNOL BIOENG, V83, P173, DOI 10.1002/bit.10655; Khan Shafqat Ali, 2015, World J Biol Chem, V6, P333, DOI 10.4331/wjbc.v6.i4.333; Koensgen D, 2015, CYTOKINE, V71, P334, DOI 10.1016/j.cyto.2014.07.254; Korch C, 2012, GYNECOL ONCOL, V127, P241, DOI 10.1016/j.ygyno.2012.06.017; Kunz-Schughart LA, 1998, INT J EXP PATHOL, V79, P1, DOI 10.1046/j.1365-2613.1998.00051.x; Kurdistani SK, 2007, BRIT J CANCER, V97, P1, DOI 10.1038/sj.bjc.6603844; Langlois VS, 2013, MECH DEVELOP, V130, P304, DOI 10.1016/j.mod.2012.12.002; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Leone V, 2015, CANCER LETT, V357, P535, DOI 10.1016/j.canlet.2014.12.010; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Maehara Y, 2000, ONCOLOGY-BASEL, V58, P144, DOI 10.1159/000012091; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Milde-Langosch K, 2005, EUR J CANCER, V41, P2449, DOI 10.1016/j.ejca.2005.08.008; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Nanbu K, 1998, CANCER DETECT PREV, V22, P549, DOI 10.1046/j.1525-1500.1998.00069.x; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; OLIVE PL, 1994, CANCER METAST REV, V13, P121, DOI 10.1007/BF00689632; Padron JM, 2006, INVEST NEW DRUG, V24, P195, DOI 10.1007/s10637-005-3691-5; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Pavan S, 2014, INT J CANCER, V134, P1289, DOI 10.1002/ijc.28464; Penning TM, 2015, CHEM-BIOL INTERACT, V234, P236, DOI 10.1016/j.cbi.2014.09.024; Powell CD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168389; PROTTI MP, 1994, CANCER LETT, V85, P211, DOI 10.1016/0304-3835(94)90277-1; Proud CG, 2004, BIOCHEM BIOPH RES CO, V313, P429, DOI 10.1016/j.bbrc.2003.07.015; Santini MT, 2000, CRIT REV ONCOL HEMAT, V36, P75, DOI 10.1016/S1040-8428(00)00078-0; Shahzad MMK, 2010, J BIOL CHEM, V285, P35462, DOI 10.1074/jbc.M110.109579; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Shield K, 2009, GYNECOL ONCOL, V113, P143, DOI 10.1016/j.ygyno.2008.11.032; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Tania M, 2014, TUMOR BIOL, V35, P7335, DOI 10.1007/s13277-014-2163-y; Trieb K, 2000, BRIT J CANCER, V82, P85, DOI 10.1054/bjoc.1999.0881; Wahlberg P, 2008, ENDOCRINOLOGY, V149, P5070, DOI 10.1210/en.2007-1736; Wang K, 2016, ONCOTARGETS THER, V9, P377, DOI 10.2147/OTT.S96309; Wang Y, 2012, CYTOKINE, V59, P145, DOI 10.1016/j.cyto.2012.04.013; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wiemer EAC, 2011, NAT MED, V17, P1552, DOI 10.1038/nm.2593; Xu K, 2014, BBA-REV CANCER, V1846, P638, DOI 10.1016/j.bbcan.2014.10.007; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; ZIMMERMAN R, 1984, P NATL ACAD SCI-BIOL, V81, P2085, DOI 10.1073/pnas.81.7.2085	69	19	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182930	10.1371/journal.pone.0182930	http://dx.doi.org/10.1371/journal.pone.0182930			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28793334	gold, Green Published, Green Submitted			2022-12-26	WOS:000407196700080
J	Penley, MJ; Ha, GT; Morran, LT				Penley, McKenna J.; Ha, Giang T.; Morran, Levi T.			Evolution of Caenorhabditis elegans host defense under selection by the bacterial parasite Serratia marcescens	PLOS ONE			English	Article							INBREEDING DEPRESSION; SELF-FERTILIZATION; SEXUAL SELECTION; DELETERIOUS MUTATIONS; C-ELEGANS; RECOMBINATION; COEVOLUTION; PLANTS; POPULATIONS; ECOLOGY	Parasites can impose strong selection on hosts. In response, some host populations have adapted via the evolution of defenses that prevent or impede infection by parasites. However, host populations have also evolved life history shifts that maximize host fitness despite infection. Outcrossing and self-fertilization can have contrasting effects on evolutionary trajectories of host populations. While selfing and outcrossing are known to affect the rate at which host populations adapt in response to parasites, these mating systems may also influence the specific traits that underlie adaptation to parasites. Here, we determined the role of evolved host defense versus altered life history, in mixed mating (selfing and outcrossing) and obligately outcrossing C. elegans host populations after experimental evolution with the bacterial parasite, S. marcescens. Similar to previous studies, we found that both mixed mating and obligately outcrossing host populations adapted to S. marcescens exposure, and that the obligately outcrossing populations exhibited the greatest rates of adaptation. Regardless of the host population mating system, exposure to parasites did not significantly alter reproductive timing or total fecundity over the course of experimental evolution. However, both mixed mating and obligately outcrossing host populations exhibited significantly reduced mortality rates in the presence of the parasite after experimental evolution. Therefore, adaptation in both the mixed mating and obligately outcrossing populations was driven, at least in part, by the evolution of increased host defense and not changes in host life history. Thus, the host mating system altered the rate of adaptation, but not the nature of adaptive change in the host populations.	[Penley, McKenna J.; Ha, Giang T.; Morran, Levi T.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Emory University	Morran, LT (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	levi.morran@emory.edu			Emory University; NIH National Center for Research Resources (NCRR)	Emory University; NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funds provided by Emory University to LTM www.emory.edu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Sarah Hesse for logistical assistance. We also thank the members of the Morran lab, the GerMo HideR labs, and two anonymous reviewers for comments that improved this work. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR).	Agnew P, 2000, MICROBES INFECT, V2, P891, DOI 10.1016/S1286-4579(00)00389-0; BARTON NH, 1995, GENETICS, V140, P821; BRENNER S, 1974, GENETICS, V77, P71; Chadwick W, 2005, P ROY SOC B-BIOL SCI, V272, P505, DOI 10.1098/rspb.2004.2959; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; CHARLESWORTH D, 1993, GENET RES, V61, P39, DOI 10.1017/S0016672300031086; de Roode JC, 2013, SCIENCE, V340, P150, DOI 10.1126/science.1235824; Englemann I, 2010, INVERTEBRATE IMMUNIT; FELSENSTEIN J, 1974, GENETICS, V78, P737; Fisher RA, 1930, GENETICAL THEORY NAT; Gandon S, 2007, GENETICS, V175, P1835, DOI 10.1534/genetics.106.066399; Glater EE, 2014, G3-GENES GENOM GENET, V4, P265, DOI 10.1534/g3.113.008649; Goldberg EE, 2010, SCIENCE, V330, P493, DOI 10.1126/science.1194513; Goodwillie C, 2005, ANNU REV ECOL EVOL S, V36, P47, DOI 10.1146/annurev.ecolsys.36.091704.175539; Hartfield M, 2012, INTEGR ZOOL, V7, P192, DOI 10.1111/j.1749-4877.2012.00284.x; Heller J., 1979, GENET RES, V8, P269; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Hily JM, 2016, NEW PHYTOL, V209, P812, DOI 10.1111/nph.13631; Keightley PD, 2006, NATURE, V443, P89, DOI 10.1038/nature05049; LANDE R, 1985, EVOLUTION, V39, P24, DOI [10.2307/2408514, 10.1111/j.1558-5646.1985.tb04077.x]; Lively CM, 2014, J EVOLUTION BIOL, V27, P1292, DOI 10.1111/jeb.12354; Loewe L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-125; Long TAF, 2012, CURR BIOL, V22, P204, DOI 10.1016/j.cub.2011.12.020; Lynch M., 1995, EVOLUTION, V47, P1744; MacLellan K, 2009, BIOL LETTERS, V5, P795, DOI 10.1098/rsbl.2009.0475; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; MICHALAKIS Y, 1994, PARASITE, V1, P291, DOI 10.1051/parasite/1994014291; MILLER LM, 1988, CELL, V55, P167, DOI 10.1016/0092-8674(88)90019-0; Morran LT, 2014, AM NAT, V184, pS91, DOI 10.1086/676930; Morran LT, 2013, EVOLUTION, V67, P1860, DOI 10.1111/evo.12007; Morran LT, 2011, SCIENCE, V333, P216, DOI 10.1126/science.1206360; Morran LT, 2009, NATURE, V462, P350, DOI 10.1038/nature08496; Muller HJ, 1932, AM NAT, V66, P118, DOI 10.1086/280418; Parker BJ, 2011, TRENDS ECOL EVOL, V26, P242, DOI 10.1016/j.tree.2011.02.005; Parrish RC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154463; Polak M, 1998, P ROY SOC B-BIOL SCI, V265, P2197, DOI 10.1098/rspb.1998.0559; Roze D, 2006, GENETICS, V173, P1793, DOI 10.1534/genetics.106.058586; SCHEDL T, 1988, GENETICS, V119, P43; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Schmid-Hempel P, 2009, PHILOS T R SOC B, V364, P85, DOI 10.1098/rstb.2008.0157; Schulenburg H, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-49; STEBBINS GL, 1957, AM NAT, V91, P337, DOI 10.1086/281999; Teotonio H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035811; UYENOYAMA MK, 1991, THEOR POPUL BIOL, V40, P14, DOI 10.1016/0040-5809(91)90045-H; Whitlock MC, 2009, EVOLUTION, V63, P569, DOI 10.1111/j.1558-5646.2008.00558.x; Wong D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r194	46	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0181913	10.1371/journal.pone.0181913	http://dx.doi.org/10.1371/journal.pone.0181913			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28792961	gold, Green Submitted, Green Published			2022-12-26	WOS:000407196700026
J	Desai, P; Loke, SW; Desai, A				Desai, Prajakta; Loke, Seng W.; Desai, Aniruddha			Cooperative vehicles for robust traffic congestion reduction: An analysis based on algorithmic, environmental and agent behavioral factors	PLOS ONE			English	Article								Traffic congestion continues to be a persistent problem throughout the world. As vehicle-to-vehicle communication develops, there is an opportunity of using cooperation among close proximity vehicles to tackle the congestion problem. The intuition is that if vehicles could cooperate opportunistically when they come close enough to each other, they could, in effect, spread themselves out among alternative routes so that vehicles do not all jam up on the same roads. Our previous work proposed a decentralized multiagent based vehicular congestion management algorithm entitled Congestion Avoidance and Route Allocation using Virtual Agent Negotiation (CARAVAN), wherein the vehicles acting as intelligent agents perform cooperative route allocation using inter-vehicular communication. This paper focuses on evaluating the practical applicability of this approach by testing its robustness and performance (in terms of travel time reduction), across variations in: (a) environmental parameters such as road network topology and configuration; (b) algorithmic parameters such as vehicle agent preferences and route cost/preference multipliers; and (c) agent-related parameters such as equipped/non-equipped vehicles and compliant/non-compliant agents. Overall, the results demonstrate the adaptability and robustness of the decentralized cooperative vehicles approach to providing global travel time reduction using simple local coordination strategies.	[Desai, Prajakta; Desai, Aniruddha] La Trobe Univ, Dept Comp Sci & Informat Technol, Bundoora, Vic, Australia; [Loke, Seng W.] Deakin Univ, Sch Informat Technol, Geelong, Vic, Australia	La Trobe University; Deakin University	Loke, SW (corresponding author), Deakin Univ, Sch Informat Technol, Geelong, Vic, Australia.	seng.loke@deakin.edu.au	Loke, Seng/AAG-3182-2020	Loke, Seng/0000-0002-5339-9305				Adler JL, 2005, TRANSPORT RES B-METH, V39, P297, DOI 10.1016/j.trb.2004.03.005; Airiau S., 2010, P 9 INT C AUT AG MUL, P167; Allen-Williams M., 2009, THESIS; Bazzan A.L.C., 2013, SYNTHESIS LECT ARTIF, V7, P1, DOI DOI 10.2200/S00553ED1V01Y201312AIM025; Buscema D, 2009, IEEE TIC-STH 09: 2009 IEEE TORONTO INTERNATIONAL CONFERENCE: SCIENCE AND TECHNOLOGY FOR HUMANITY, P72, DOI 10.1109/TIC-STH.2009.5444404; Desai P, 2013, IEEE T INTELL TRANSP, V14, P1197, DOI 10.1109/TITS.2013.2256420; Desai P, 2011, IEEE INT VEH SYM, P1031, DOI 10.1109/IVS.2011.5940493; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Hill J.C., 2005, P 4 INT JOINT C AUTO, P1083, DOI [10.1145/1082473.1082637, DOI 10.1145/1082473.1082637]; Marler RT, 2004, STRUCT MULTIDISCIP O, V26, P369, DOI 10.1007/s00158-003-0368-6; Meneguette RI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159110; Miettinen K, 2001, LECT NOTES COMPUT SC, V1993, P1; Narzt W, 2010, IET INTELL TRANSP SY, V4, P93, DOI 10.1049/iet-its.2009.0022; Pournaras E, 2009, CISIS: 2009 INTERNATIONAL CONFERENCE ON COMPLEX, INTELLIGENT AND SOFTWARE INTENSIVE SYSTEMS, VOLS 1 AND 2, P185, DOI 10.1109/CISIS.2009.91; Rapoport A, 2009, GAME ECON BEHAV, V65, P538, DOI 10.1016/j.geb.2008.02.007; Rogers S., 1999, P AM ASS ART INT SPR; Roozemond DA, 2001, EUR J OPER RES, V131, P293, DOI 10.1016/S0377-2217(00)00129-6; Ruey-Shun C, 2015, IEICE T INFO SYST, V88, P119; Tumer K., 2009, MULTIAGENT ARCHITECT, P261; Xiang W, 2008, ENG APPL ARTIF INTEL, V21, P73, DOI 10.1016/j.engappai.2007.03.008	20	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2017	12	8							e0182621	10.1371/journal.pone.0182621	http://dx.doi.org/10.1371/journal.pone.0182621			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9EU	28792513	Green Published, gold, Green Submitted			2022-12-26	WOS:000407144700026
J	Fan, C; Wu, LH; Zhang, GF; Xu, FF; Zhang, S; Zhang, XL; Sun, L; Yu, Y; Zhang, Y; Ye, RD				Fan, Chao; Wu, Le-Hao; Zhang, Gu-Fang; Xu, Fangfang; Zhang, Shuo; Zhang, Xiuli; Sun, Lei; Yu, Yang; Zhang, Yan; Ye, Richard D.			4 '-Hydroxywogonin suppresses lipopolysaccharide-induced inflammatory responses in RAW 264.7 macrophages and acute lung injury mice	PLOS ONE			English	Article							NF-KAPPA-B; ANTIINFLAMMATORY ACTIVITY; PROTEIN-KINASES; GENE-EXPRESSION; P38 MAPK; WOGONIN; ACTIVATION; PATHWAYS; PHOSPHORYLATION; ALPHA	4'-Hydroxywogonin (4'-HW), a flavonoid, has been isolated from various plants and shown to inhibit NO production in macrophages. However, the molecular mechanisms and its in vivo activity have not been determined. Our study aimed to investigate the mechanisms underlying the anti-inflammatory effects of 4'-HW in vitro and in vivo. We showed that 4'-HW potently reduced the expression levels of COX-2 and iNOS as well as their products, prostaglandin E2 (PGE2) and nitric oxide (NO) respectively, in LPS-stimulated RAW 264.7 macrophages. 4'-HW also suppressed LPS-induced pro-inflammatory cytokines at mRNA and protein levels. Moreover, 4'-HW blocked the interaction of TAK1 and TAB1 in LPS-stimulated RAW 264.7 macrophages, resulting in an inhibition of the TAK1/IKK/NF-kappa B signaling pathway. Furthermore, 4'-HW also reduced the phosphorylation of MAPKs and PI3/Akt signaling pathways in LPS-stimulated RAW 264.7 macrophages. 4'-HW was also significantly decreased the intracellular reactive oxygen species (ROS) level. The effect of 4'-HW was confirmed in vivo. 4'-HW exhibited potent protective effect against LPS-induced ALI in mice. These findings indicate that 4'-HW suppresses the LPS-induced response in vitro and in vivo. It is likely that the inhibition of the TAK1/IKK/NF-kappa B, MAPKs and PI3/AKT signaling pathways contribute to the anti-inflammatory effects of 4'-HW. Our study suggests that 4'-HW may be an important functional constituent in the plants and has the potential value to be developed as a novel anti-inflammatory agent.	[Fan, Chao; Wu, Le-Hao; Zhang, Gu-Fang; Zhang, Shuo; Sun, Lei; Yu, Yang; Zhang, Yan; Ye, Richard D.] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai, Peoples R China; [Xu, Fangfang; Zhang, Xiuli] Chinese Acad Sci, Dalian Inst Chem Phys, Dalian, Peoples R China; [Ye, Richard D.] Univ Macau, Inst Chinese Med Sci, Macau, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; University of Macau	Zhang, Y; Ye, RD (corresponding author), Shanghai Jiao Tong Univ, Sch Pharm, Shanghai, Peoples R China.; Ye, RD (corresponding author), Univ Macau, Inst Chinese Med Sci, Macau, Peoples R China.	zhangyan_sjtu@sjtu.edu.cn; richardye@umac.mo	Ye, Richard/ABF-2413-2020	Ye, Richard/0000-0002-2164-5620; Wu, Lehao/0000-0003-0127-2609	National Science Foundation of China [81402806, 31470865]; Science and Technology Development Fund [FDCT 026/2016/A1]; University of Macau [CPG2015-00018-ICMS, SRG2015-00047-ICMS-QRCM]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Fund(Science and Technology Development Fund (STDF)); University of Macau	This work was supported by grants from the National Science Foundation of China (Grant 81402806 to Dr. Yan Zhang and Grant 31470865 to Dr. Richard D Ye). This work was also supported by the Science and Technology Development Fund (FDCT 026/2016/A1) and the funds from the University of Macau (CPG2015-00018-ICMS and SRG2015-00047-ICMS-QRCM) to Dr Richard D Ye.	Abarikwu SO, 2014, BBA-GEN SUBJECTS, V1840, P2373, DOI 10.1016/j.bbagen.2014.03.006; Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; Barton GM, 2008, J CLIN INVEST, V118, P413, DOI 10.1172/JCI34431; Beutler B, 2000, CURR OPIN IMMUNOL, V12, P20, DOI 10.1016/S0952-7915(99)00046-1; BRADLEY PP, 1982, J INVEST DERMATOL, V78, P206, DOI 10.1111/1523-1747.ep12506462; BRADLEY PP, 1982, BLOOD, V60, P618; Chen SB, 2015, CELL MOL NEUROBIOL, V35, P523, DOI 10.1007/s10571-014-0148-4; Cheon SY, 2015, J NAT PROD, V78, P1579, DOI 10.1021/acs.jnatprod.5b00145; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cuong TD, 2015, BIOORG MED CHEM LETT, V25, P1129, DOI 10.1016/j.bmcl.2014.12.055; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Goodman RB, 2003, CYTOKINE GROWTH F R, V14, P523, DOI 10.1016/S1359-6101(03)00059-5; Herlaar E, 1999, MOL MED TODAY, V5, P439, DOI 10.1016/S1357-4310(99)01544-0; Huang GC, 2007, INT IMMUNOPHARMACOL, V7, P1054, DOI 10.1016/j.intimp.2007.04.001; Imbert V, 1996, CELL, V86, P787, DOI 10.1016/S0092-8674(00)80153-1; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Li YS, 2003, CHEM PHARM BULL, V51, P872, DOI 10.1248/cpb.51.872; Lin YC, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003973; Liu J, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0493-y; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Lv HM, 2016, INT J BIOL SCI, V12, P72, DOI 10.7150/ijbs.13188; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Rosanna D, 2012, CURR PHARM DESIGN, V18, P3889, DOI 10.2174/138161212802083716; Scott T, 2008, MOL IMMUNOL, V45, P1001, DOI 10.1016/j.molimm.2007.07.035; Shin JS, 2012, BRIT J PHARMACOL, V165, P1926, DOI 10.1111/j.1476-5381.2011.01670.x; Sizemore N, 2002, J BIOL CHEM, V277, P3863, DOI 10.1074/jbc.M110572200; Song WH, 2010, TOXICOL LETT, V199, P389, DOI 10.1016/j.toxlet.2010.10.003; Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X; Tian QH, 2005, MOL PHARMACOL, V68, P1534, DOI 10.1124/mol.105.014720; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang WP, 2015, INFLAMM RES, V64, P423, DOI 10.1007/s00011-015-0822-0; Wang XX, 2014, NEUROPHARMACOLOGY, V79, P642, DOI 10.1016/j.neuropharm.2014.01.022; Wei CY, 2017, ENVIRON TOXICOL, V32, P397, DOI 10.1002/tox.22243; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Yao H, 2011, PLANTA MED, V77, P388, DOI 10.1055/s-0030-1250353; Yao J, 2014, IMMUNOLOGY, V143, P241, DOI 10.1111/imm.12305; Yeh YC, 2016, J PHARM PHARMACOL, V68, P257, DOI 10.1111/jphp.12500; Zhang J, 2016, OXID MED CELL LONGEV, V2016, DOI DOI 10.1155/2016/4350965; Zhao K, 2014, EUR J PHARMACOL, V737, P57, DOI 10.1016/j.ejphar.2014.05.011	43	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2017	12	8							e0181191	10.1371/journal.pone.0181191	http://dx.doi.org/10.1371/journal.pone.0181191			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9EU	28792498	Green Submitted, Green Published, gold			2022-12-26	WOS:000407144700004
J	Fonseca, BDFE; da Silva, MVP; de Araujo, KM; Sampaio, RB; Moraes, MO				Fonseca e Fonseca, Bruna de Paula; Pereira da Silva, Marcus Vinicius; de Araujo, Kizi Mendonca; Sampaio, Ricardo Barros; Moraes, Milton Ozorio			Network analysis for science and technology management: Evidence from tuberculosis research in Fiocruz, Brazil	PLOS ONE			English	Article							SCIENTIFIC COLLABORATION; BIOTECHNOLOGY; INNOVATION	Collaborative networks are of great value for science and technology (S&T) institutions as a way of sharing, generating and disseminating new knowledge that could ultimately lead to innovations. Driven by the need to assess the contribution and effectiveness of these networks in informing S&T management, we explored the evolution and dynamics of tuberculosis scientific networks involving the Oswaldo Cruz Foundation (Fiocruz), the major public health S&T Institution in Brazil. Social network analysis (SNA) was used to produce a 10-year (2005-2009, 2010-2014) retrospective longitudinal mapping of Brazilian tuberculosis research networks within the country and internationally, highlighting Fiocruz collaborations. Co-authorship analysis showed a significant expansion of collaboration in Brazil and the role of Fiocruz and other leading national institutions in maintaining connectivity, facilitating knowledge exchange and reducing network vulnerability. It also identified influential researchers that can act as information leaders and support strategic decisions. When we focused on networks inside the institution, the analysis showed a clear discontinuation between the clinical and the public health research areas, which needs specific internal policies to improve collaborations since outcomes in TB are expected to provide better diagnostic tools and more effective treatments. The approach provides evidence to support S&T management by pinpointing: key central institutions maintaining network connectivity; most influential researchers that can act as advisors/experts for investment and induction policies; key Fiocruz researchers that could improve information exchange, systems integration and innovation within the institution; opportunities for synergy between internal research groups working in complementary areas. In summary, we observed that SNA parameters proved to be a valuable tool that, along with other indicators, can strengthen knowledge platforms to support S&T management efforts.	[Fonseca e Fonseca, Bruna de Paula] Fiocruz MS, CDTS, Rio De Janeiro, Brazil; [Pereira da Silva, Marcus Vinicius] Fiocruz MS, COC, Rio De Janeiro, Brazil; [de Araujo, Kizi Mendonca] Fiocruz MS, Inst Informacao Cient & Tecnol Saude ICICT, Rio De Janeiro, Brazil; [Sampaio, Ricardo Barros] Fiocruz MS, Diretoria Reg Brasilia DIREB, Brasilia, DF, Brazil; [Moraes, Milton Ozorio] Fiocruz MS, Vice Presidencia Ensino Informacao & Comunicacao, Rio De Janeiro, Brazil; [Moraes, Milton Ozorio] Fiocruz MS, Inst Oswaldo Cruz, Lab Hanseniase, Rio De Janeiro, Brazil	Center for Technological Development in Health (CDTS); Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Fonseca, BDFE (corresponding author), Fiocruz MS, CDTS, Rio De Janeiro, Brazil.	bfonseca@cdts.fiocruz.br	Sampaio, Ricardo Barros/U-4977-2019; Moraes, Milton/AFF-1842-2022; Moraes, Milton Ozório/G-9753-2011; Pereira-Silva, Marcus Vinícius/AAD-8584-2020	Moraes, Milton Ozório/0000-0003-2653-0037; Pereira-Silva, Marcus Vinícius/0000-0002-4135-4011; Fonseca, Bruna de Paula/0000-0002-8795-2578	Fiocruz	Fiocruz	Fiocruz provided support in the form of salaries for authors BPFF and MOM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abbasi A, 2011, ARXIV11116804PHYS; Abramovsky L, 2011, J ECON GEOGR; Adams J, 2012, NATURE, V490, P335, DOI 10.1038/490335a; [Anonymous], 2015, GLOB ACT FRAM TB RES; [Anonymous], 2015, [No title captured]; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bastian M., 2009, GEPHI OPEN SOURCE SO; Bell GG, 2005, STRATEGIC MANAGE J, V26, P287, DOI 10.1002/smj.448; Bender ME, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004182; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Borgatti S.P., 2002, UCINET 6 WINDOWS SOF; Brasil, 2012, ESTR NAC CIENC TECN; Cassi L, 2008, ECON INNOV NEW TECH, V17, P663, DOI 10.1080/10438590701785603; Cross R, 2002, CALIF MANAGE REV, V44, P25, DOI 10.2307/41166121; D'Este P., 2012, J ECON GEOGR; Daar AS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-346; Disis ML, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000421; Fonseca BPF, 2016, SCI PUBLIC POLICY; Fonseca BDFE, 2016, HEALTH RES POLICY SY, V14, DOI 10.1186/s12961-016-0151-y; Fonseca BDFE, 2016, HEALTH RES POLICY SY, V14, DOI 10.1186/s12961-016-0104-5; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Glanzel W, 2004, HANDBOOK OF QUANTITATIVE SCIENCE AND TECHNOLOGY RESEARCH: THE USE OF PUBLICATION AND PATENT STATISTICS IN STUDIES OF S&T SYSTEMS, P257; Costa BMG, 2013, SCIENTOMETRICS, V95, P571, DOI 10.1007/s11192-012-0924-1; Hancean MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113271; Hara N, 2003, J AM SOC INF SCI TEC, V54, P952, DOI 10.1002/asi.10291; He J, 2009, TECHNOL FORECAST SOC, V76, P91, DOI 10.1016/j.techfore.2008.03.020; Kritski A, 2016, I HIG MED TROP, V15, pS35; Kritski A, 2016, REV SOC BRAS MED TRO, V49, P135, DOI 10.1590/0037-8682-0330-2015; Lee DH, 2012, SCIENTOMETRICS, V91, P925, DOI 10.1007/s11192-011-0602-8; Lienhardt C, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001965; Luzar B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094429; Mattsson P, 2015, Collaboration across Health Research and Medical Care: Healthy Collaboration, P13; Morel CM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000501; Morel CM, 2005, SCIENCE, V309, P401, DOI 10.1126/science.1115538; Phillips K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002568; Sizemore CF, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.21; Tsai WP, 2001, ACAD MANAGE J, V44, P996, DOI 10.2307/3069443; Valente TW, 2012, SCIENCE, V337, P49, DOI 10.1126/science.1217330; Valente TW, 2010, SOCIAL NETWORKS HLTH, DOI DOI 10.1093/ACPROF:OSO/9780195301014.001.0001/ACPROF-9780195301014; van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3; van Eck NJ, 2009, J AM SOC INF SCI TEC, V60, P1635, DOI 10.1002/asi.21075; Vanderelst D, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004266; Vasconcellos AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045569; Waltman L, 2010, J INFORMETR, V4, P629, DOI 10.1016/j.joi.2010.07.002; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478	45	8	8	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2017	12	8							e0181870	10.1371/journal.pone.0181870	http://dx.doi.org/10.1371/journal.pone.0181870			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC9EU	28792514	Green Published, gold, Green Submitted			2022-12-26	WOS:000407144700008
J	Hellwege, JN; Torstenson, ES; Russell, SB; Edwards, TL; Edwards, DRV				Hellwege, Jacklyn N.; Torstenson, Eric S.; Russell, Shirley B.; Edwards, Todd L.; Edwards, Digna R. Velez			Evidence of selection as a cause for racial disparities in fibroproliferative disease	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; SICKLE-CELL TRAIT; AFRICAN-AMERICANS; SYSTEMIC-SCLEROSIS; UTERINE FIBROIDS; ORGAN DAMAGE; KIDNEY-DISEASE; BLOOD-PRESSURE; RENAL-DISEASE; UNITED-STATES	Fibroproliferative diseases are common complex traits featuring scarring and overgrowth of connective tissue which vary widely in presentation because they affect many organ systems. Most fibroproliferative diseases are more prevalent in African-derived populations than in European populations, leading to pronounced health disparities. It is hypothesized that the increased prevalence of these diseases in African-derived populations is due to selection for pro-fibrotic alleles that are protective against helminth infections. We constructed a genetic risk score (GRS) of fibroproliferative disease risk-increasing alleles using 147 linkage disequilibrium-pruned variants identified through genome-wide association studies of seven fibroproliferative diseases with large African-European prevalence disparities. A comparison of the fibroproliferative disease GRS between 1000 Genomes Phase 3 populations detected a higher mean GRS in AFR (mean = 148 risk alleles) than EUR (mean = 136 risk alleles; T-test p-value = 1.75x10(-123)). To test whether differences in GRS burden are systematic and may be due to selection, we employed the quantitative trait loci (QTL) sign test. The QTL sign test result indicates that population differences in risk-increasing allele burdens at these fibroproliferative disease variants are systematic and support a model featuring selective pressure (p-value = 0.011). These observations were replicated in an independent sample and were more statistically significant (T-test p-value = 7.26x10(-237), sign test p-value = 0.015). This evidence supports the role of selective pressure acting to increase frequency of fibroproliferative alleles in populations of African relative to European ancestry populations.	[Hellwege, Jacklyn N.; Torstenson, Eric S.; Edwards, Todd L.] Vanderbilt Univ, Med Ctr, Dept Med, Div Epidemiol, Nashville, TN USA; [Hellwege, Jacklyn N.; Torstenson, Eric S.; Russell, Shirley B.; Edwards, Todd L.; Edwards, Digna R. Velez] Vanderbilt Univ, Med Ctr, Vanderbilt Genet Inst, Nashville, TN USA; [Edwards, Digna R. Velez] Vanderbilt Univ, Med Ctr, Dept Obstet & Gynecol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Edwards, TL (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Epidemiol, Nashville, TN USA.; Edwards, TL; Edwards, DRV (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Genet Inst, Nashville, TN USA.; Edwards, DRV (corresponding author), Vanderbilt Univ, Med Ctr, Dept Obstet & Gynecol, Nashville, TN 37232 USA.	todd.l.edwards@vanderbilt.edu; digna.r.velez.edwards@vanderbilt.edu		russell, shirley/0000-0002-9959-3672; Edwards, Todd/0000-0003-4318-6119	National Institutes of Health [R01HD074711, R03HD078567, R21AR067938, R21HL121429]; Vanderbilt Molecular and Genetic Epidemiology of Cancer (MAGEC) training program - US National Cancer Institute [R25 CA160056]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD078567, R01HD074711] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL121429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR067938] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD023680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Molecular and Genetic Epidemiology of Cancer (MAGEC) training program - US National Cancer Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was supported by National Institutes of Health grants R01HD074711 (DRVE), R03HD078567 (DRVE), R21AR067938 (DRVE), and R21HL121429 (TLE and DRVE), as well as the Vanderbilt Molecular and Genetic Epidemiology of Cancer (MAGEC) training program, which was funded by the US National Cancer Institute grant number R25 CA160056 (PI: X.-O. Shu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allanore Y, 2007, JOINT BONE SPINE, V74, P577, DOI 10.1016/j.jbspin.2007.04.005; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Arnett FC, 2001, ARTHRITIS RHEUM-US, V44, P1359, DOI 10.1002/1529-0131(200106)44:6<1359::AID-ART228>3.0.CO;2-S; August P, 2006, NEW ENGL J MED, V354, P2721, DOI 10.1056/NEJMcibr062143; August P, 2003, KIDNEY INT, V64, pS99, DOI 10.1046/j.1523-1755.64.s87.15.x; August P, 2000, Curr Hypertens Rep, V2, P184, DOI 10.1007/s11906-000-0080-5; Baird DD, 2003, AM J OBSTET GYNECOL, V188, P100, DOI 10.1067/mob.2003.99; Barrett J., 1973, BIRTH DEFECT COMPEND, P553; Berg JJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004412; Boynton-Jarrett R, 2005, AM J EPIDEMIOL, V161, P628, DOI 10.1093/aje/kwi072; Christopherson W M, 1981, Prog Clin Biol Res, V53, P185; Cree BAC, 2004, NEUROLOGY, V63, P2039, DOI 10.1212/01.WNL.0000145762.60562.5D; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Duan Q, 2013, BIOINFORMATICS, V29, P2744, DOI 10.1093/bioinformatics/btt477; DUSTAN HP, 1992, LANCET, V339, P1339, DOI 10.1016/0140-6736(92)91971-A; DUSTAN HP, 1995, HYPERTENSION, V26, P858, DOI 10.1161/01.HYP.26.6.858; Elgueroa E, 2015, P NATL ACAD SCI USA, V112, P7051, DOI 10.1073/pnas.1505665112; Feingold-Link L, 2002, J WOMENS HEALTH, V23, P1027; FERGUSON R, 1987, AM J PUBLIC HEALTH, V77, P864, DOI 10.2105/AJPH.77.7.864; Flake GP, 2003, ENVIRON HEALTH PERSP, V111, P1037, DOI 10.1289/ehp.5787; Freedman BI, 2005, NEPHROL DIAL TRANSPL, V20, P712, DOI 10.1093/ndt/gfh704; Gelber AC, 2013, MEDICINE, V92, P191, DOI 10.1097/MD.0b013e31829be125; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Glover M. J., 2005, Morbidity and Mortality Weekly Report, V54, P7; Haan YC, 2015, AM J HYPERTENS, V28, P487, DOI 10.1093/ajh/hpu183; Huang CY, 2014, WOUND REPAIR REGEN, V22, P462, DOI 10.1111/wrr.12197; Huang CY, 2012, CONNECT TISSUE RES, V53, P187, DOI 10.3109/03008207.2011.642035; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; Irigoyen MC, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-016-0642-9; Joshi PK, 2015, NATURE, V523, P459, DOI 10.1038/nature14618; KELLER AZ, 1971, AM J EPIDEMIOL, V94, P222, DOI 10.1093/oxfordjournals.aje.a121316; Kucera GP, 2003, CHEST, V123, P1527, DOI 10.1378/chest.123.5.1527; Lackland DT, 1996, SEMIN NEPHROL, V16, P63; Lan TH, 2013, CARDIOVASC PATHOL, V22, P401, DOI 10.1016/j.carpath.2013.01.003; Lohmueller KE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004379; Luoto R, 2000, MATURITAS, V37, P15, DOI 10.1016/S0378-5122(00)00160-2; Marneros AG, 2001, ARCH DERMATOL, V137, P1429; Marshall LM, 1997, OBSTET GYNECOL, V90, P967, DOI 10.1016/S0029-7844(97)00534-6; MASI AT, 1967, ANN INTERN MED, V66, P870, DOI 10.7326/0003-4819-66-5-870; Mayes MD, 2003, ARTHRITIS RHEUM, V48, P2246, DOI 10.1002/art.11073; Mayes MD, 2003, RHEUM DIS CLIN N AM, V29, P239, DOI 10.1016/S0889-857X(03)00022-X; McMaster WG, 2015, CIRC RES, V116, P1022, DOI 10.1161/CIRCRESAHA.116.303697; Meyrier A, 2015, NEPHRON, V129, P276, DOI 10.1159/000381195; Mirsaeidi M, 2015, CHEST, V147, P438, DOI 10.1378/chest.14-1120; Muller DN, 2011, CURR OPIN NEPHROL HY, V20, P113, DOI 10.1097/MNH.0b013e3283436f88; Okolo S, 2008, BEST PRACT RES CL OB, V22, P571, DOI 10.1016/j.bpobgyn.2008.04.002; Orr HA, 1998, GENETICS, V149, P2099; POLEDNAK AP, 1987, AM J PHYS ANTHROPOL, V74, P357, DOI 10.1002/ajpa.1330740308; Polednak AP, 1989, RACIAL ETHNIC DIFFER, P228; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Racette L, 2003, SURV OPHTHALMOL, V48, P295, DOI 10.1016/S0039-6257(03)00028-6; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Russell SB, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005568; Rybicki B A, 1998, Semin Respir Infect, V13, P166; Rybicki BA, 1997, AM J EPIDEMIOL, V145, P234, DOI 10.1093/oxfordjournals.aje.a009096; Rybicki BA, 1996, GENET EPIDEMIOL, V13, P23; Saboeiro AP, 2000, PLAST RECONSTR SURG, V106, P71, DOI 10.1097/00006534-200007000-00013; Sakakura K, 2013, HEART LUNG CIRC, V22, P399, DOI 10.1016/j.hlc.2013.03.001; SARTWELL PE, 1974, AM J EPIDEMIOL, V99, P250, DOI 10.1093/oxfordjournals.aje.a121609; Satko SG, 2007, SEMIN DIALYSIS, V20, P229, DOI 10.1111/j.1525-139X.2007.00282.x; Silver Marc A, 2005, J Clin Hypertens (Greenwich), V7, P664, DOI 10.1111/j.1524-6175.2005.04384.x; Suthanthiran M, 2000, P NATL ACAD SCI USA, V97, P3479, DOI 10.1073/pnas.050420897; Sverrild A, 2008, THORAX, V63, P894, DOI 10.1136/thx.2007.094060; Swigris JJ, 2012, RESP MED, V106, P588, DOI 10.1016/j.rmed.2012.01.002; TEIKARI JM, 1987, ACTA OPHTHALMOL, V65, P715; TERRIS M, 1966, AM REV RESPIR DIS, V94, P50; TIELSCH JM, 1991, JAMA-J AM MED ASSOC, V266, P369, DOI 10.1001/jama.266.3.369; Toto RB, 2003, KIDNEY INT, V64, P2331, DOI 10.1046/j.1523-1755.2003.00333.x; TRACY RE, 1991, MODERN PATHOL, V4, P602; Turchin MC, 2012, NAT GENET, V44, P1015, DOI 10.1038/ng.2368; Ud-Din S, 2013, BRIT J DERMATOL, V169, P71, DOI 10.1111/bjd.12588; URD S, 2003, USRDS 2003 ANN DAT R; URDS U, 1998, 1998 ANN DAT REP; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wenzke Kevin E, 2012, AMIA Jt Summits Transl Sci Proc, V2012, P106; Wernig G, 2017, P NATL ACAD SCI USA, V114, P4757, DOI 10.1073/pnas.1621375114; Williams TN, 2005, PLOS MED, V2, P441, DOI 10.1371/journal.pmed.0020128; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Zanchetti A, 1999, AM J CARDIOL, V84, p18K	80	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2017	12	8							e0182791	10.1371/journal.pone.0182791	http://dx.doi.org/10.1371/journal.pone.0182791			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC9EU	28792542	Green Published, gold, Green Submitted			2022-12-26	WOS:000407144700041
J	Stone, SA; Tata, MS				Stone, Scott A.; Tata, Matthew S.			Rendering visual events as sounds: Spatial attention capture by auditory augmented reality	PLOS ONE			English	Article							CEREBRAL-CORTEX; LOCALIZATION	Many salient visual events tend to coincide with auditory events, such as seeing and hearing a car pass by. Information from the visual and auditory senses can be used to create a stable percept of the stimulus. Having access to related coincident visual and auditory information can help for spatial tasks such as localization. However not all visual information has analogous auditory percepts, such as viewing a computer monitor. Here, we describe a system capable of detecting and augmenting visual salient events into localizable auditory events. The system uses a neuromorphic camera (DAVIS 240B) to detect logarithmic changes of brightness intensity in the scene, which can be interpreted as salient visual events. Participants were blindfolded and asked to use the device to detect new objects in the scene, as well as determine direction of motion for a moving visual object. Results suggest the system is robust enough to allow for the simple detection of new salient stimuli, as well accurately encoding direction of visual motion. Future successes are probable as neuromorphic devices are likely to become faster and smaller in the future, making this system much more feasible.	[Stone, Scott A.; Tata, Matthew S.] Univ Lethbridge, Canadian Ctr Behav Neurosci, Dept Neurosci, Lethbridge, AB, Canada	University of Lethbridge	Stone, SA (corresponding author), Univ Lethbridge, Canadian Ctr Behav Neurosci, Dept Neurosci, Lethbridge, AB, Canada.	scott.stone@uleth.ca		Stone, Scott/0000-0003-2525-5483	International Research Engagement Fund [14471]; Canadian National Science and Engineering Research Council [G2463]	International Research Engagement Fund; Canadian National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was funded by an International Research Engagement Fund #14471 and a Canadian National Science and Engineering Research Council Discovery Grant #G2463 to Matthew Tata. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brand A, 2002, NATURE, V417, P543, DOI 10.1038/417543a; Cao Y, 1992, SOL STAT CIRC C 1992; Delbruck T, 2014, 2014 IEEE INT S CIRC; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Franconeri SL, 2003, PERCEPT PSYCHOPHYS, V65, P999, DOI 10.3758/BF03194829; Jin C, 2004, J ACOUST SOC AM, V115, P3124, DOI 10.1121/1.1736649; Lewis JW, 2000, CEREB CORTEX, V10, P873, DOI 10.1093/cercor/10.9.873; Lichtsteiner P, 2008, IEEE J SOLID-ST CIRC, V43, P566, DOI 10.1109/JSSC.2007.914337; Liu SC, 2015, EVENT-BASED NEUROMORPHIC SYSTEMS, P1, DOI 10.1002/9781118927601; Martinez CS, 2015, P 33 ANN ACM C EXT A, P259; Maunsell JHR, 1999, VISUAL NEUROSCI, V16, P1, DOI 10.1017/S0952523899156177; Morillas C, 2008, REC COMP FPGAS 2008; Nielsen L, 1987, SEEHEAR; Rueckauer B, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00176; Tollin DJ, 2003, NEUROSCIENTIST, V9, P127, DOI 10.1177/1073858403252228; Vidal JR, 2006, J COGNITIVE NEUROSCI, V18, P1850, DOI 10.1162/jocn.2006.18.11.1850; WENZEL EM, 1993, J ACOUST SOC AM, V94, P111, DOI 10.1121/1.407089; Xu S, 2007, INT C VIRT REAL; Xu YD, 2007, P NATL ACAD SCI USA, V104, P18766, DOI 10.1073/pnas.0705618104; YANTIS S, 1984, J EXP PSYCHOL HUMAN, V10, P601, DOI 10.1037/0096-1523.10.5.601; Zotkin D, 2003, APPL SIGN PROC AUD A	22	1	1	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2017	12	8							e0182635	10.1371/journal.pone.0182635	http://dx.doi.org/10.1371/journal.pone.0182635			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9EU	28792518	gold, Green Published, Green Submitted			2022-12-26	WOS:000407144700027
J	Chen, WA; Zhang, JJ; Hall, KM; Martin, CB; Kisselev, S; Dasen, EJ; Vahanian, NN; Link, CJ; Martin, BK				Chen, Wenlan Alex; Zhang, Jinjin; Hall, Katie M.; Martin, Carol B.; Kisselev, Serguei; Dasen, Emily J.; Vahanian, Nicholas N.; Link, Charles J.; Martin, Brian K.			Addition of alpha Gal HyperAcute (TM) technology to recombinant avian influenza vaccines induces strong low-dose antibody responses	PLOS ONE			English	Article							LEUCINE-ZIPPER; H7N9 VACCINE; H5N1 VACCINE; VIRUS; IMMUNOGENICITY; HEMAGGLUTININ; ADJUVANTS; XENOTRANSPLANTATION; PROTECTION; CELLS	Highly pathogenic avian influenza represents a severe public health threat. Over the last decade, the demand for highly efficacious vaccines against avian influenza viruses has grown, especially after the 2013 H7N9 outbreak in China that resulted in over 600 human cases with over 200 deaths. Currently, there are several H5N1 and H7N9 influenza vaccines in clinical trials, all of which employ traditional oil-in-water adjuvants due to the poor immuno-genicity of avian influenza virus antigens. In this study, we developed potent recombinant avian influenza vaccine candidates using HyperAcute (TM) Technology, which takes advantage of naturally-acquired anti-alpha Gal immunity in humans. We successfully generated alpha Gal-positive recombinant protein and virus-like particle vaccine candidates of H5N1 and H7N9 influenza strains using either biological or our novel CarboLink chemical alpha Gal modification techniques. Strikingly, two doses of 100 ng alpha Gal-modified vaccine, with no traditional adjuvant, was able to induce a much stronger humoral response in alpha GT BALB/c knockout mice (the only experimental system readily available for testing alpha Gal in vivo) than unmodified vaccines even at 10-fold higher dose (1000 ng/dose). Our data strongly suggest that alpha Gal modification significantly enhances the humoral immunogenicity of the recombinant influenza vaccine candidates. Use of aGal HyperAcute (TM) technology allows significant dose-sparing while retaining desired immunogenicity. Our success in the development of highly potent H5N1 and H7N9 vaccine candidates demonstrated the potential of alpha Gal HyperAcute (TM) technology for the development of vaccines against other infectious diseases.	[Chen, Wenlan Alex; Zhang, Jinjin; Hall, Katie M.; Martin, Carol B.; Kisselev, Serguei; Dasen, Emily J.; Vahanian, Nicholas N.; Link, Charles J.; Martin, Brian K.] NewLink Genet Corp, Ames, IA 50010 USA		Chen, WA; Martin, BK (corresponding author), NewLink Genet Corp, Ames, IA 50010 USA.	achen@linkp.com; bmartin@linkp.com	zhang, jin/GXV-9154-2022; Chen, Wenlan/C-9907-2009	Martin, Brian/0000-0002-4873-5351; Chen, Wenlan/0000-0003-2705-436X	Defense Threat Reduction Agency Award [HDTRA1-09-C-0014]; Defense Threat Reduction Agency (DTRA)	Defense Threat Reduction Agency Award(United States Department of DefenseDefense Threat Reduction Agency); Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency)	This study was supported by Defense Threat Reduction Agency Award HDTRA1-09-C-0014 to BioProtection Systems Corporation, a wholly-owned subsidiary of NewLink Genetics Corporation." The Defense Threat Reduction Agency (DTRA) provided support in the form of salaries for authors [WAC, JZ, KMH, CBM, SK, EJD, BKM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. NewLink Genetics Corporation provided salary support for all authors of this manuscript, but the roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript were limited to the authors of this manuscript, and did not extend to others in the organization.	Abdel-Motal UM, 2007, J VIROL, V81, P9131, DOI 10.1128/JVI.00647-07; Adebamiro A, 2007, J GEN PHYSIOL, V130, P611, DOI 10.1085/jgp.200709781; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P561; Baldridge JR, 1999, METHODS, V19, P103, DOI 10.1006/meth.1999.0834; Black S, 2011, PEDIATR INFECT DIS J, V30, P1081, DOI 10.1097/INF.0b013e3182367662; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; Caproni E, 2012, J IMMUNOL, V188, P3088, DOI 10.4049/jimmunol.1101764; Chen JR, 2011, TRENDS BIOTECHNOL, V29, P426, DOI 10.1016/j.tibtech.2011.04.007; Chen WA, INVENTORSCARBOHYDRAT; Chen ZY, 2008, VACCINE, V26, P361, DOI 10.1016/j.vaccine.2007.11.013; Chia MY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120793; Clements CJ, 2002, VACCINE, V20, pS24, DOI 10.1016/S0264-410X(02)00168-8; Couch RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049704; Fries LF, 2013, NEW ENGL J MED, V369, P2564, DOI 10.1056/NEJMc1313186; Galili U, 2005, IMMUNOL CELL BIOL, V83, P674, DOI 10.1111/j.1440-1711.2005.01366.x; Galili U, 1996, VACCINE, V14, P321, DOI 10.1016/0264-410X(95)00189-8; GALILI U, 1984, J EXP MED, V160, P1519, DOI 10.1084/jem.160.5.1519; Galili U, 1991, Immunol Ser, V55, P355; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Henion TR, 1997, VACCINE, V15, P1174, DOI 10.1016/S0264-410X(96)00300-3; Heyman B, 2014, CURR TOP MICROBIOL, V382, P201, DOI 10.1007/978-3-319-07911-0_9; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Killian ML, 2014, METHODS MOL BIOL, V1161, P3, DOI 10.1007/978-1-4939-0758-8_1; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Koike C, 2007, P NATL ACAD SCI USA, V104, P559, DOI 10.1073/pnas.0610012104; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Lambert SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051618; Lin SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020052; Lindqvist M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020448; Mandell RB, 2009, ZOONOSES PUBLIC HLTH, V56, P391, DOI 10.1111/j.1863-2378.2008.01191.x; Mandell RB, 2010, J VIROL METHODS, V169, P259, DOI 10.1016/j.jviromet.2010.07.015; Mandell RB, 2010, VIROLOGY, V397, P187, DOI 10.1016/j.virol.2009.11.001; Mulligan MJ, 2014, JAMA-J AM MED ASSOC, V312, P1409, DOI 10.1001/jama.2014.12854; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; Pedersen JC, 2014, METHODS MOL BIOL, V1161, P11, DOI 10.1007/978-1-4939-0758-8_2; POTTER CW, 1979, BRIT MED BULL, V35, P69, DOI 10.1093/oxfordjournals.bmb.a071545; Prendergast GC, 2012, ONCOIMMUNOLOGY, V1, P924, DOI 10.4161/onci.21358; Pushko P, 2010, VACCINE, V28, P4771, DOI 10.1016/j.vaccine.2010.04.093; SANDRIN MS, 1994, IMMUNOL REV, V141, P169, DOI 10.1111/j.1600-065X.1994.tb00877.x; Seubert A, 2008, J IMMUNOL, V180, P5402, DOI 10.4049/jimmunol.180.8.5402; Tanemura M, 2000, J CLIN INVEST, V105, P301, DOI 10.1172/JCI7358; Tange M, 1996, TRANSPLANT P, V28, P620; Tearle RG, 1996, TRANSPLANTATION, V61, P13, DOI 10.1097/00007890-199601150-00004; Tosh PK, 2010, MAYO CLIN PROC, V85, P257, DOI 10.4065/mcp.2009.0615; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Varki A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005462; WATSON MEE, 1984, NUCLEIC ACIDS RES, V12, P5145, DOI 10.1093/nar/12.13.5145; Wei CJ, 2008, J VIROL, V82, P6200, DOI 10.1128/JVI.00187-08; Weldon WC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012466; Wong SS, 2015, J INFECT DIS, V212, P542, DOI 10.1093/infdis/jiv099; Yam KK, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00207	51	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182683	10.1371/journal.pone.0182683	http://dx.doi.org/10.1371/journal.pone.0182683			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28787006	Green Submitted, Green Published, gold			2022-12-26	WOS:000406998800058
J	Cilloniz, C; Ceccato, A; de la Calle, C; Gabarrus, A; Garcia-Vidal, C; Almela, M; Soriano, A; Martinez, JAA; Marco, F; Vila, J; Torres, A				Cilloniz, Catia; Ceccato, Adrian; de la Calle, Cristina; Gabarrus, Albert; Garcia-Vidal, Carolina; Almela, Manel; Soriano, Alex; Antonio Martinez, Jose; Marco, Francesc; Vila, Jordi; Torres, Antoni			Time to blood culture positivity as a predictor of clinical outcomes and severity in adults with bacteremic pneumococcal pneumonia	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; STREPTOCOCCUS-PNEUMONIAE; INFLAMMATORY RESPONSE; MORTALITY; DISEASE; CORTICOSTEROIDS; MANAGEMENT; SEROTYPES; CYTOKINES; CHILDREN	Objectives We aimed to investigate the association between the time to positivity of blood culture (TTP) with clinical outcome and severity of pneumococcal bacteremic pneumonia. Methods Prospective observational study carried out in 278 hospitalized adult CAP patients with positive blood culture for Streptococcus pneumonia (2003-2015). Results A total of 278 cases of bacteremic pneumococcal pneumonia were analyzed, median age 62 (46; 79) years. Fifty-one percent of the cases had PSI IV-V. Twenty-one (8%) died within 30-days after admission. The analysis of the TTP showed that the first quartile of the TTP (9.2h) was the best cut-off for differentiating 2 groups of patients at risk, early (TTP <9.2 h) and late (TTP >= 9.2 h) detection groups (AUC 0.66 [95% CI 0.53 to 0.79]). Early TTP was associated with a statistically significant risk of invasive mechanical ventilation (18% vs. 6%, p = 0.007), longer length of hospital stay (12 days vs. 8 days, p<0.001), higher in-hospital mortality (15% vs. 4%, p = 0.010), and 30-day mortality (15% vs. 5%, p = 0.018). After adjustment for potential confounders, regression analyses revealed early TTP as independently associated with high risk of invasive mechanical ventilation (OR 4.60, 95% CI 1.63 to 13.03), longer length of hospital stay (beta 5.20, 95% CI 1.81 to 8.52), higher in-hospital mortality (OR 5.35, 95% CI 1.55 to 18.53), and a trend to higher 30-day mortality (OR 2.47, 95% CI 0.85 to 7.21) to be a contributing factor. Conclusion Our results demonstrate that TTP is an easy to obtain surrogate marker of the severity of pneumococcal pneumonia and a good predictor of its outcome.	[Cilloniz, Catia; Gabarrus, Albert; Torres, Antoni] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Hosp Clin Barcelona,Dept Pneumol, Ciber Enfermedades Resp CIBERES,Inst Clin Torax, Barcelona, Spain; [Ceccato, Adrian] Natl Hosp Alejandro Posadas, Dept Pneumol, Palomar, Argentina; [de la Calle, Cristina; Garcia-Vidal, Carolina; Soriano, Alex; Antonio Martinez, Jose] Hosp Clin Barcelona, Dept Infect Dis, Barcelona, Spain; [Almela, Manel; Marco, Francesc; Vila, Jordi] Hosp Clin Barcelona, Dept Microbiol, Barcelona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona	Torres, A (corresponding author), Univ Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Hosp Clin Barcelona,Dept Pneumol, Ciber Enfermedades Resp CIBERES,Inst Clin Torax, Barcelona, Spain.	atorres@clinic.ub.es	Soriano, Alex/I-1210-2017; Ceccato, Adrian/O-8785-2018; Vila, Jordi/P-3613-2016; Marco, Francesc/K-2900-2017	Soriano, Alex/0000-0002-9374-0811; Gabarrus, Albert/0000-0003-3492-1310; Ceccato, Adrian/0000-0001-9454-062X; Vila, Jordi/0000-0002-8025-3926; Marco, Francesc/0000-0002-1863-6379; Garcia-Vidal, Carolina/0000-0002-8915-0683; cilloniz, catia/0000-0002-4646-9838	ERS Short Term Fellowship; Postdoctoral Junior Grants Ministerio de Economia y Competitividad, Spain; "Strategic Plan for Research and Innovation in Health, PERIS; ERS Long-term Fellowship; Ciber de Enfermedades Respiratorias [CibeResCB06/06/0028]	ERS Short Term Fellowship; Postdoctoral Junior Grants Ministerio de Economia y Competitividad, Spain; "Strategic Plan for Research and Innovation in Health, PERIS; ERS Long-term Fellowship; Ciber de Enfermedades Respiratorias	Dr. Cilloniz is a recipient of ERS Short Term Fellowship and Postdoctoral Junior Grants 2013 Ministerio de Economia y Competitividad, Spain and "Strategic Plan for Research and Innovation in Health, PERIS 2016-2020." Dr. Ceccato is a recipient of ERS Long-term Fellowship. This work was supported by Ciber de Enfermedades Respiratorias [CibeResCB06/06/0028], 2009 Support to Research Groups of Catalonia 911. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahl J, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-492; Amaro R, 2016, EUR RESP J; Armitage P., STAT METHODS MED RES; Blot F, 1998, J CLIN MICROBIOL, V36, P105, DOI 10.1128/JCM.36.1.105-109.1998; Bordon J, 2013, INT J INFECT DIS, V17, pE76, DOI 10.1016/j.ijid.2012.06.006; Brueggemann AB, 2004, J INFECT DIS, V190, P1203, DOI 10.1086/423820; Calbo E, 2008, ANTIMICROB AGENTS CH, V52, P2395, DOI 10.1128/AAC.00658-07; Carrol ED, 2007, PEDIATR INFECT DIS J, V26, P416, DOI 10.1097/01.inf.0000260253.22994.61; Cilloniz C, 2013, CHEST, V144, P999, DOI 10.1378/chest.13-0062; Cilloniz C, 2011, THORAX, V66, P340, DOI 10.1136/thx.2010.143982; Cole T.J, 1991, STAT MED, V10, P1162, DOI [10.1002/sim.4780100718, DOI 10.1002/SIM.4780100718]; Efron B, 1994, INTRO BOOTSTRAP; Feldman C, 2011, DRUGS, V71, P131, DOI 10.2165/11585310-000000000-00000; Fenoll A, 1998, J CLIN MICROBIOL, V36, P3447, DOI 10.1128/JCM.36.12.3447-3454.1998; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Fink D, 2015, EUR J CLIN MICROBIOL, V34, P1559, DOI 10.1007/s10096-015-2386-x; Jansen AGSC, 2009, CLIN INFECT DIS, V49, pE23, DOI 10.1086/600045; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Martin-Loeches I, 2010, INTENS CARE MED, V36, P612, DOI 10.1007/s00134-009-1730-y; Martinez JA, 2007, CLIN MICROBIOL INFEC, V13, P709, DOI 10.1111/j.1469-0691.2007.01736.x; Nau R, 2002, CLIN MICROBIOL REV, V15, P95, DOI 10.1128/CMR.15.1.95-110.2002; Neuman MI, 2001, CLIN INFECT DIS, V33, P1324, DOI 10.1086/322699; Pechous RD, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00160; Peralta G, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-79; Rello J, 2009, CHEST, V136, P832, DOI 10.1378/chest.09-0258; Rendon A, 2016, CURR INFECT DIS REP, V18, DOI 10.1007/s11908-016-0516-y; Sligl WI, 2014, CRIT CARE MED, V42, P420, DOI 10.1097/CCM.0b013e3182a66b9b; Torres A, 2015, JAMA-J AM MED ASSOC, V313, P677, DOI 10.1001/jama.2015.88; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Waterer G, 2011, CURR OPIN INFECT DIS, V24, P137, DOI 10.1097/QCO.0b013e328343b70d; Werno AM, 2012, J MED MICROBIOL, V61, P1129, DOI 10.1099/jmm.0.044107-0; Wunderink RG, 2015, JAMA-J AM MED ASSOC, V313, P673, DOI 10.1001/jama.2015.115; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	34	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182436	10.1371/journal.pone.0182436	http://dx.doi.org/10.1371/journal.pone.0182436			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28787020	Green Published, gold, Green Submitted			2022-12-26	WOS:000406998800037
J	Czyzewska, D; Ustymowicz, A; Kowalewski, R; Zurada, A; Krejza, J				Czyzewska, Dorota; Ustymowicz, Andrzej; Kowalewski, Radoslaw; Zurada, Anna; Krejza, Jaroslaw			Cross-sectional area of the femoral vein varies with leg position and distance from the inguinal ligament	PLOS ONE			English	Article							SAPHENOFEMORAL JUNCTION; VENOUS CATHETERIZATION; EXTERNAL ROTATION; COMPLICATIONS; CANNULATION; INCREASES; EXPOSURE; ACCESS; SIZE	Purpose The risk of complications associated with femoral venous catheterization could be potentially reduced if the procedure was performed at the location where the cross-sectional area (CSA) of the vessel is the largest. The diameter of the femoral vein depends on leg position as well as the distance from the inguinal ligament. We determined the CSA of the right femoral vein in three different leg positions at two distances from the inguinal ligament. Subjects and methods Informed consent was given by 205 healthy volunteers aged 19-39 years, mean: 23 +/- 3 years (108 women, 97 men). Ultrasonographic examinations were performed using a linear 14-MHz transducer with CSA measurements in three leg positions: abduction, abduction +external rotation, abduction+external rotation+90 degrees knee flexion/frog-leg position; at levels 20 mm caudally to the inguinal ligament, and 20 mm caudally to the inguinal crease. Results We found significant differences in mean values of CSA in three leg positions regardless of the measurement level. The largest mean CSA (114 mm(2)+/- 35 mm(2)) was found at the proximal level in the frog-leg position. There was a significant association of the CSA with sex and height. The CSA in males was greater than in females in all leg positions at the level of 20 mm caudally to the inguinal crease, while 20 mm caudally to the inguinal ligament the CSA was larger in females. The CSA of 25% of the femoral vein was smaller than 45.0 mm(2) at the proximal level, and 31.5 mm(2) at the distal level, which refers to diameters of 5.3 mm, and 4.5 mm, respectively. Conclusions The cross-sectional area of the femoral vein is the largest in the frog-leg position, and depends on gender.	[Czyzewska, Dorota] Maria Sklodowska Curie Mem Canc Ctr, Inst Oncol, Dept Radiol 1, Warsaw, Poland; [Ustymowicz, Andrzej] Med Univ Bialystok, Dept Radiol, Bialystok, Poland; [Kowalewski, Radoslaw] Med Univ Bialystok, Dept Vasc Surg & Transplantat, Bialystok, Poland; [Zurada, Anna] Univ Varmia & Mazury Olsztyn, Dept Anat, Fac Med, Olsztyn, Poland; [Krejza, Jaroslaw] Inst Innovat Med, Adv Biomed Image Lab, Bialystok, Poland	Maria Sklodowska-Curie National Research Institute of Oncology; Medical University of Bialystok; Medical University of Bialystok	Czyzewska, D (corresponding author), Maria Sklodowska Curie Mem Canc Ctr, Inst Oncol, Dept Radiol 1, Warsaw, Poland.	dorotaczyzewska@o2.pl	Zurada, Anna/AAX-2451-2021; Krejza, Jaroslaw/A-1355-2009; Zurada, Anna/G-6296-2011	Zurada, Anna/0000-0002-0574-7344; Krejza, Jaroslaw/0000-0003-3103-5268; Zurada, Anna/0000-0002-0574-7344				Albuquerque Junior F C, 1998, Curr Opin Clin Nutr Metab Care, V1, P297, DOI 10.1097/00075197-199805000-00011; Egan G, 2013, EMERG MED J, V30, P521, DOI 10.1136/emermed-2012-201652; Gordon AC, 1998, J VASC INTERV RADIOL, V9, P333, DOI 10.1016/S1051-0443(98)70277-5; Hamilton H, 2009, CENTRAL VENOUS ACCES, P92; Hopkins JW, 2009, ACAD EMERG MED, V16, P579, DOI 10.1111/j.1553-2712.2009.00430.x; Hoyt, 2007, TRAUMA EMERGENCY RES, V1; Lam King-Kwan, 2013, Biomed J, V36, P237, DOI 10.4103/2319-4170.113193; McGee DC, 2003, NEW ENGL J MED, V348, P1123, DOI 10.1056/NEJMra011883; Merrer J, 2001, JAMA-J AM MED ASSOC, V286, P700, DOI 10.1001/jama.286.6.700; Mirjalili SA, 2014, CLIN ANAT, V27, P915, DOI 10.1002/ca.22386; Muhlberger D, 2008, J VASC SURG, V48, P994, DOI 10.1016/j.jvs.2008.04.045; Oh DS, 2001, OPER TECH GEN SURG, V3, P232; Randall C, 2014, J EMERG MED, V47, P176, DOI 10.1016/j.jemermed.2014.02.001; Read H, 2012, EMERG MED AUSTRALAS, V24, P408, DOI 10.1111/j.1742-6723.2012.01568.x; Rippey JCR, 2008, ANN EMERG MED, V52, P446, DOI 10.1016/j.annemergmed.2008.04.022; Ryu JH, 2013, INT J CARDIOVAS IMAG, V29, P295, DOI 10.1007/s10554-012-0089-2; Suk EH, 2010, ANAESTHESIA, V65, P895, DOI 10.1111/j.1365-2044.2010.06378.x; SWEENEY MN, 2001, SEMIN ANESTH PERIO M, V20, P47; Troianos CA, 2011, J AM SOC ECHOCARDIOG, V24, P1291, DOI 10.1016/j.echo.2011.09.021; Werner SL, 2008, J EMERG MED, V35, P73, DOI 10.1016/j.jemermed.2007.03.023	20	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2017	12	8							e0182623	10.1371/journal.pone.0182623	http://dx.doi.org/10.1371/journal.pone.0182623			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD5CP	28806411	Green Published, gold, Green Submitted			2022-12-26	WOS:000407548800027
J	Lensen, KJDF; van Sijl, AM; Voskuyl, AE; van der Laken, CJ; Heymans, MW; Comans, EFI; Nurmohamed, MT; Smulders, YM; Boellaard, R				Lensen, Karel-Jan D. F.; van Sijl, Alper M.; Voskuyl, Alexandre E.; van der Laken, Conny J.; Heymans, Martijn W.; Comans, Emile F. I.; Nurmohamed, Mike T.; Smulders, Yvo M.; Boellaard, Ronald			Variability in quantitative analysis of atherosclerotic plaque inflammation using F-18-FDG PET/CT	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; VASCULAR INFLAMMATION; RISK; DISEASE; QUANTIFICATION; BIOMARKERS; THERAPY; IMPACT; IMAGE; TIME	Background: F-18-FDG-PET(/CT) is increasingly used in studies aiming at quantifying atherosclerotic plaque inflammation. Considerable methodological variability exists. The effect of data acquisition and image analysis parameters on quantitative uptake measures, such as standardized uptake value (SUV) and target-to-background ratio (TBR) has not been investigated extensively. Objective: The goal of this study was to explore the effect of several data acquisition and image analysis parameters on quantification of vascular wall F-18-FDG uptake measures, in order to increase awareness of potential variability. Methods: Three whole-body emission scans and a low-dose CT scan were acquired 38, 60 and 90 minutes after injection of F-18-FDG in six rheumatoid arthritis patients with high cardiovascular risk profiles.Data acquisition (1 and 2) and image analysis (3, 4 and 5) parameters comprised:1. F-18-FDG uptake time, 2. SUV normalisation, 3. drawing regions/volumes of interest (ROI's/VOI's) according to: a. hot-spot (HS), b. whole-segment (WS) and c. most-diseased segment (MDS), 4. Background activity, 5. Image matrix/voxel size.Intraclass correlation coefficients (ICC's) and Bland Altman plots were used to assess agreement between these techniques and between observers. A linear mixed model was used to determine the association between uptake time and continuous outcome variables. Results: 1. Significantly higher TBRmax values were found at 90 minutes (1,57 95%CI 1,35-1,80) compared to 38 minutes (1,30 95%CI 1,21-1,39) (P = 0,024) 2. Normalising SUV for BW, LBM and BSA significantly influences average SUVmax (2,25 (+/- 0,60) vs 1,67 (+/- 0,37) vs 0,058 (+/- 0,013)). 3. Intraclass correlation coefficients were high in all vascular segments when SUVmax HS was compared to SUVmax WS. SUVmax HS was consistently higher than SUVmax MDS in all vascular segments. 4. Blood pool activity significantly decreases in all (venous and arterial) segments over time, but does not differ between segments. 5. Image matrix/voxel size does not influence SUVmax. Conclusion: Quantitative measures of vascular wall F-18-FDG uptake are affected mainly by changes in data acquisition parameters. Standardization of methodology needs to be considered when studying atherosclerosis and/or vasculitis.	[Lensen, Karel-Jan D. F.; Smulders, Yvo M.] Vrije Univ Amsterdam, Med Ctr, Dept Internal Med, Amsterdam, Netherlands; [Lensen, Karel-Jan D. F.; Smulders, Yvo M.] Vrije Univ Amsterdam, Med Ctr, Inst Cardiovasc Res ICaR VU, Amsterdam, Netherlands; [van Sijl, Alper M.; Voskuyl, Alexandre E.; van der Laken, Conny J.; Nurmohamed, Mike T.] Vrije Univ Amsterdam, Med Ctr, Dept Rheumatol, Amsterdam Rheumatol & Immunol Ctr, Amsterdam, Netherlands; [Heymans, Martijn W.] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Heymans, Martijn W.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Comans, Emile F. I.; Boellaard, Ronald] Vrije Univ Amsterdam, Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Boellaard, R (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands.	r.boellaard@vumc.nl	Smulders, YM/AAG-7506-2021	Heymans, Martijn/0000-0002-3889-0921; Boellaard, Ronald/0000-0002-0313-5686; Voskuyl, Alexandre/0000-0002-9699-1827; Nurmohamed, Michael/0000-0002-6274-1934				Ben-Haim S, 2004, J NUCL MED, V45, P1816; Boellaard R, 2004, J NUCL MED, V45, P1519; Boellaard R, 2010, EUR J NUCL MED MOL I, V37, P181, DOI 10.1007/s00259-009-1297-4; Bucerius J, 2015, EUR J NUCL MED MOL I; Bucerius J, 2014, EUR J NUCL MED MOL I, V41, P369, DOI 10.1007/s00259-013-2569-6; Bucerius J, 2012, J AM COLL CARDIOL, V59, P2080, DOI 10.1016/j.jacc.2011.11.069; Burger IA, 2012, NUCL MED BIOL, V39, P666, DOI 10.1016/j.nucmedbio.2011.11.002; Choi HY, 2011, ARTERIOSCL THROM VAS, V31, P944, DOI 10.1161/ATVBAHA.110.220673; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Fayad ZA, 2011, LANCET, V378, P1547, DOI 10.1016/S0140-6736(11)61383-4; Figueroa AL, 2012, CIRC-CARDIOVASC IMAG, V5, P69, DOI 10.1161/CIRCIMAGING.110.959478; Huet P, 2015, J NUCL MED, V56, P552, DOI 10.2967/jnumed.114.142596; Kim TN, 2010, CIRC-CARDIOVASC IMAG, V3, P142, DOI 10.1161/CIRCIMAGING.109.888909; Kwee RM, 2011, AM J NEURORADIOL, V32, P950, DOI 10.3174/ajnr.A2381; Lee SJ, 2008, J NUCL MED, V49, P1277, DOI 10.2967/jnumed.108.052233; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; Maki-Petaja KM, 2012, CIRCULATION, V126, P2473, DOI 10.1161/CIRCULATIONAHA.112.120410; Menezes LJ, 2009, J NUCL MED, V50, P854, DOI 10.2967/jnumed.108.061432; Myers KS, 2012, JACC-CARDIOVASC IMAG, V5, P38, DOI 10.1016/j.jcmg.2011.08.019; Rudd JHF, 2008, J NUCL MED, V49, P871, DOI 10.2967/jnumed.107.050294; Rudd James H F, 2007, Top Magn Reson Imaging, V18, P379; Rudd JHF, 2009, CIRC-CARDIOVASC IMAG, V2, P107, DOI 10.1161/CIRCIMAGING.108.811752; Tahara N, 2007, J AM COLL CARDIOL, V49, P1533, DOI 10.1016/j.jacc.2006.11.046; Tahari AK, 2014, J NUCL MED, V55, P1481, DOI 10.2967/jnumed.113.136986; Tawakol A, 2006, J AM COLL CARDIOL, V48, P1818, DOI 10.1016/j.jacc.2006.05.076; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; Wasselius J, 2009, ANN NUCL MED, V23, P59, DOI 10.1007/s12149-008-0207-3; Wu YW, 2007, J NUCL MED, V48, P227; Yang SJ, 2012, ATHEROSCLEROSIS, V220, P402, DOI 10.1016/j.atherosclerosis.2011.11.008; Yoo HJ, 2011, J NUCL MED, V52, P10, DOI 10.2967/jnumed.110.080838	30	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0181847	10.1371/journal.pone.0181847	http://dx.doi.org/10.1371/journal.pone.0181847			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800625	Green Published, Green Submitted, gold			2022-12-26	WOS:000407431800007
J	Yanez, RJR; Lamprecht, R; Granadillo, M; Weber, B; Torrens, I; Rybicki, EP; Hitzeroth, II				Yanez, Romana J. R.; Lamprecht, Renate; Granadillo, Milaid; Weber, Brandon; Torrens, Isis; Rybicki, Edward P.; Hitzeroth, Inga I.			Expression optimization of a cell membrane-penetrating human papillomavirus type 16 therapeutic vaccine candidate in Nicotiana benthamiana	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; PHARMACEUTICAL PROTEINS; MONOCLONAL-ANTIBODIES; ANTICANCER ACTIVITY; YOUNG-WOMEN; PURIFICATION; PLANTS; IDENTIFICATION; LOCALIZATION; INFECTION	High-risk human papillomaviruses (hr-HPVs) cause cervical cancer, the fourth most common cancer in women worldwide. A HPV-16 candidate therapeutic vaccine, LALF(32-51)-E7, was developed by fusing a modified E7 protein to a bacterial cell-penetrating peptide (LALF): this elicited both tumour protection and regression in pre-clinical immunization studies. In the current study, we investigated the potential for producing LALF(32-51)-E7 in a plant expression system by evaluating the effect of subcellular localization and usage of different expression vectors and gene silencing suppressors. The highest expression levels of LALF(32-51)-E7 were obtained by using a self-replicating plant expression vector and chloroplast targeting, which increased its accumulation by 27-fold compared to cytoplasmic localization. The production and extraction of LALF(32-51)-E7 was scaled-up and purification optimized by affinity chromatography. If further developed, this platform could potentially allow for the production of a more affordable therapeutic vaccine for HPV-16. This would be extremely relevant in the context of developing countries, where cervical cancer and other HPV-related malignancies are most prevalent, and where the population have limited or no access to preventative vaccines due to their typical high costs.	[Yanez, Romana J. R.; Lamprecht, Renate; Rybicki, Edward P.; Hitzeroth, Inga I.] Univ Cape Town, Dept Mol & Cell Biol, Biopharming Res Unit, Cape Town, South Africa; [Granadillo, Milaid; Torrens, Isis] Cubanacan, Ctr Genet Engn & Biotechnol, Havana, Cuba; [Weber, Brandon] Univ Cape Town, Div Med Biochem, Dept Clin Lab Sci, Struct Biol Res Unit, Cape Town, South Africa; [Rybicki, Edward P.] Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa	University of Cape Town; Centro de Ingenieria Genetica y Biotecnologia; University of Cape Town; University of Cape Town	Hitzeroth, II (corresponding author), Univ Cape Town, Dept Mol & Cell Biol, Biopharming Res Unit, Cape Town, South Africa.	inga.hitzeroth@uct.ac.za	Hitzeroth, Inga I./I-6042-2019; Rybicki, Edward/D-6138-2014	Hitzeroth, Inga I./0000-0002-8515-9525; Rybicki, Edward/0000-0001-8024-9911; Granadillo Rodriguez, Milaid/0000-0001-5399-4836	Poliomyelitis Research Foundation, South Africa	Poliomyelitis Research Foundation, South Africa	Poliomyelitis Research Foundation, South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG DJ, 1993, BIOCHEM BIOPH RES CO, V192, P1380, DOI 10.1006/bbrc.1993.1569; Beiss V, 2015, BIOTECHNOL BIOENG, V112, P1297, DOI 10.1002/bit.25548; Benchabane M, 2008, PLANT BIOTECHNOL J, V6, P633, DOI 10.1111/j.1467-7652.2008.00344.x; BioTherapeutics P., 2010, PROTALIX BIOTHER; Buyel JF, 2012, J CHROMATOGR B, V880, P19, DOI 10.1016/j.jchromb.2011.11.010; Centers for disease control and prevention, 2012, INT CANC CONTR; Chen Q, 2011, HUM VACCINES, V7, P331, DOI 10.4161/hv.7.3.14262; de Villiers EM, 2013, VIROLOGY, V445, P2, DOI 10.1016/j.virol.2013.04.023; Demurtas OC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061473; Di Bonito P, 2009, INT J IMMUNOPATH PH, V22, P967, DOI 10.1177/039463200902200412; Dugdale B, 2013, PLANT CELL, V25, P2429, DOI 10.1105/tpc.113.113944; ELIAS BA, 1978, PLANTA, V142, P317, DOI 10.1007/BF00385083; Ferro M, 2002, P NATL ACAD SCI USA, V99, P11487, DOI 10.1073/pnas.172390399; Fischer R, 2004, CURR OPIN PLANT BIOL, V7, P152, DOI 10.1016/j.pbi.2004.01.007; Fischer R., 2013, PLANT DERIVED BIOPHA, V2013; Fischer R, 2012, BIOTECHNOL ADV, V30, P434, DOI 10.1016/j.biotechadv.2011.08.007; Franconi R, 2006, INT J IMMUNOPATH PH, V19, P187; Giorgi C, 2010, EXPERT REV VACCINES, V9, P913, DOI 10.1586/ERV.10.84; Granadillo M, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-12; Granadillo M, 2011, VACCINE, V29, P920, DOI 10.1016/j.vaccine.2010.11.083; Harper DM, 2004, LANCET, V364, P1757, DOI 10.1016/S0140-6736(04)17398-4; Hildesheim A, 2016, AM J OBSTET GYNECOL, P1; Hildesheim A, 2007, JAMA-J AM MED ASSOC, V298, P743, DOI 10.1001/jama.298.7.743; Hofbauer A, 2013, CURR PHARM DESIGN, V19, P5495, DOI 10.2174/1381612811319310005; Huang Z, 2010, BIOTECHNOL BIOENG, V106, P9, DOI 10.1002/bit.22652; Huang Z, 2009, BIOTECHNOL BIOENG, V103, P706, DOI 10.1002/bit.22299; Hung CF, 2008, EXPERT OPIN BIOL TH, V8, P421, DOI [10.1517/14712598.8.4.421, 10.1517/14712598.8.4.421 ]; Joura EA, 2015, NEW ENGL J MED, V372, P711, DOI 10.1056/NEJMoa1405044; Karg SR, 2009, BIOTECHNOL ADV, V27, P879, DOI 10.1016/j.biotechadv.2009.07.002; Kim KI, 2007, PLANT MOL BIOL, V64, P103, DOI 10.1007/s11103-007-9137-z; KIRNBAUER R, 1992, P NATL ACAD SCI USA, V89, P12180, DOI 10.1073/pnas.89.24.12180; Lin K, 2010, J FORMOS MED ASSOC, V109, P4, DOI 10.1016/S0929-6646(10)60017-4; Lomonossoff GP, 2016, SCIENCE, V353, P1237, DOI 10.1126/science.aaf6638; Maclean J, 2007, J GEN VIROL, V88, P1460, DOI 10.1099/vir.0.82718-0; Massa S, 2007, VACCINE, V25, P3018, DOI 10.1016/j.vaccine.2007.01.018; Merlin M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/136419; Meyers A, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-53; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Morrow MP, 2013, EXPERT REV VACCINES, V12, P271, DOI [10.1586/ERV.13.23, 10.1586/erv.13.23]; Munger K, 1997, HUMAN PAPILLOMAVIRUS, P17; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Regnard GL, 2010, PLANT BIOTECHNOL J, V8, P38, DOI 10.1111/j.1467-7652.2009.00462.x; Roman A, 2013, VIROLOGY, V445, P138, DOI 10.1016/j.virol.2013.04.013; Rybicki EP, 2010, PLANT BIOTECHNOL J, V8, P620, DOI 10.1111/j.1467-7652.2010.00507.x; Rybicki ER, 2009, DRUG DISCOV TODAY, V14, P16, DOI 10.1016/j.drudis.2008.10.002; Rybicki EP, 2011, VIRUS DERIVED SSDNA, V375, P19; Sabalza M, 2014, BIOTECHNOL LETT, V36, P2367, DOI 10.1007/s10529-014-1621-3; Sack M, 2015, CURR OPIN BIOTECH, V32, P163, DOI 10.1016/j.copbio.2014.12.008; Schottenfeld D, 2015, ANN EPIDEMIOL, V25, P183, DOI 10.1016/j.annepidem.2014.11.016; SHEN WJ, 1989, NUCLEIC ACIDS RES, V17, P8385, DOI 10.1093/nar/17.20.8385; Silhavy D, 2002, EMBO J, V21, P3070, DOI 10.1093/emboj/cdf312; Streatfield SJ, 2003, VACCINE, V21, P812, DOI 10.1016/S0264-410X(02)00605-9; Takeda A, 2002, FEBS LETT, V532, P75, DOI 10.1016/S0014-5793(02)03632-3; Vallespi MG, 2000, CLIN DIAGN LAB IMMUN, V7, P669, DOI 10.1128/CDLI.7.4.669-675.2000; Van Wezel R, 2002, MOL PLANT PATHOL, V3, P461, DOI 10.1046/j.1364-3703.2002.00141.x; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Whitehead M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-367; WHO, 2016, WHO HUM PAP HPV CERV; Yanez RJR, 2017, PLANT BIOTECHNOL J; Yusibov Vidadi, 2006, Drugs R D, V7, P203, DOI 10.2165/00126839-200607040-00001; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	62	11	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0183177	10.1371/journal.pone.0183177	http://dx.doi.org/10.1371/journal.pone.0183177			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800364	gold, Green Published			2022-12-26	WOS:000407431800061
J	Courbet, A; Bec, N; Constant, C; Larroque, C; Pugniere, M; El Messaoudi, S; Zghaib, Z; Khier, S; Deleuze-Masquefa, C; Gattacceca, F				Courbet, Alexis; Bec, Nicole; Constant, Caroline; Larroque, Christian; Pugniere, Martine; El Messaoudi, Safia; Zghaib, Zahraa; Khier, Sonia; Deleuze-Masquefa, Carine; Gattacceca, Florence			Imidazoquinoxaline anticancer derivatives and imiquimod interact with tubulin: Characterization of molecular microtubule inhibiting mechanisms in correlation with cytotoxicity	PLOS ONE			English	Article							RESPONSE MODIFIER IMIQUIMOD; IN-VITRO; CHEMOTHERAPEUTIC-AGENTS; SIGNAL-TRANSDUCTION; INTERFERON INDUCER; MALIGNANT-MELANOMA; TOPICAL IMIQUIMOD; DRUG-COMBINATION; APOPTOSIS; COLCHICINE	Displaying a strong antiproliferative activity on a wide variety of cancer cells, EAPB0203 and EAPB0503 belong to the imidazo[1,2-a]quinoxalines family of imiquimod structural analogues. EAPB0503 has been shown to inhibit tubulin polymerization. The aim of the present study is to characterize the interaction of EAPB0203 and EAPB0503 with tubulin. We combine experimental approaches at the cellular and the molecular level both in vitro and in silico in order to evaluate the interaction of EAPB0203 and EAPB0503 with tubulin. We examine the influence of EAPB0203 and EAPB0503 on the cell cycle and fate, explore the binding interaction with purified tubulin, and use a computational molecular docking model to determine the binding modes to the microtubule. We then use a drug combination study with other anti-microtubule agents to compare the binding site of EAPB0203 and EAPB0503 to known potent tubulin inhibitors. We demonstrate that EAPB0203 and EAPB0503 are capable of blocking human melanoma cells in G2 and M phases and inducing cell death and apoptosis. Second, we show that EAPB0203 and EAPB0503, but also unexpectedly imiquimod, bind directly to purified tubulin and inhibit tubulin polymerization. As suggested by molecular docking and binding competition studies, we identify the colchicine binding site on beta-tubulin as the interaction pocket. Furthermore, we find that EAPB0203, EAPB0503 and imiquimod display antagonistic cytotoxic effect when combined with colchicine, and disrupt tubulin network in human melanoma cells. We conclude that EAPB0203, EAPB0503, as well as imiquimod, interact with tubulin through the colchicine binding site, and that the cytotoxic activity of EAPB0203, EAPB0503 and imiquimod is correlated to their tubulin inhibiting effect. These compounds appear as interesting anticancer drug candidates as suggested by their activity and mechanism of action, and deserve further investigation for their use in the clinic.	[Courbet, Alexis; Bec, Nicole; Larroque, Christian; Pugniere, Martine; El Messaoudi, Safia; Khier, Sonia; Gattacceca, Florence] Univ Montpellier, Montpellier, France; [Courbet, Alexis] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Courbet, Alexis] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA; [Bec, Nicole; Larroque, Christian; Pugniere, Martine; El Messaoudi, Safia; Khier, Sonia; Gattacceca, Florence] Inst Rech Cancerol Montpellier, Montpellier, France; [Bec, Nicole; Constant, Caroline; Larroque, Christian; Pugniere, Martine; El Messaoudi, Safia; Khier, Sonia; Gattacceca, Florence] Inst Rech Cancerol Montpellier, INSERM, U1194, Montpellier, France; [Bec, Nicole; Larroque, Christian; Pugniere, Martine; El Messaoudi, Safia; Khier, Sonia; Gattacceca, Florence] Inst Reg Canc Montpellier, Montpellier, France; [Zghaib, Zahraa; Deleuze-Masquefa, Carine] Univ Montpellier, Inst Biomol Max Mousseron, UMR 5247, Montpellier, France	Universite de Montpellier; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier	Courbet, A; Gattacceca, F (corresponding author), Univ Montpellier, Montpellier, France.; Courbet, A (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.; Courbet, A (corresponding author), Univ Washington, Inst Prot Design, Seattle, WA 98195 USA.; Gattacceca, F (corresponding author), Inst Rech Cancerol Montpellier, Montpellier, France.; Gattacceca, F (corresponding author), Inst Rech Cancerol Montpellier, INSERM, U1194, Montpellier, France.; Gattacceca, F (corresponding author), Inst Reg Canc Montpellier, Montpellier, France.	acourbet@uw.edu; florence.gattacceca@umontpellier.fr	khier, sonia/A-7317-2012; Gattacceca, Florence/AAJ-1080-2020; PUGNIERE, Martine/AAD-4315-2020; Constant, Caroline/GZG-2724-2022; Pugniere, Martine/T-1355-2017	khier, sonia/0000-0001-6712-8461; PUGNIERE, Martine/0000-0002-2049-2909; Pugniere, Martine/0000-0002-2049-2909; masquefa, carine/0000-0002-4086-5178; Zghaib, Zahraa/0000-0002-7295-4503; Courbet, Alexis/0000-0003-0539-7011; bec, nicole/0000-0001-7608-2434	GEFLUC Montpellier (Groupements des Entreprises Francaises dans la Lutte contre le Cancer); WO (Societe Francaise de Pharmacie Oncologique); ANP (Academie Nationale de Pharmacie), Palmares	GEFLUC Montpellier (Groupements des Entreprises Francaises dans la Lutte contre le Cancer); WO (Societe Francaise de Pharmacie Oncologique); ANP (Academie Nationale de Pharmacie), Palmares	This work was supported by a grant from GEFLUC Montpellier (Groupements des Entreprises Francaises dans la Lutte contre le Cancer) and by the Elie Bzoura grant from WO (Societe Francaise de Pharmacie Oncologique) and ANP (Academie Nationale de Pharmacie), Palmares 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspord C, 2014, J INVEST DERMATOL, V134, P2551, DOI 10.1038/jid.2014.194; BHATTACH.B, 1974, P NATL ACAD SCI USA, V71, P2627, DOI 10.1073/pnas.71.7.2627; Bonfils C, 2007, J BIOL CHEM, V282, P5570, DOI 10.1074/jbc.M605641200; Burns EM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00135; Cantisani C, 2012, RECENT PATENTS INFLA, V6, P65, DOI 10.2174/187221312798889301; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; De Martino G, 2006, J MED CHEM, V49, P947, DOI 10.1021/jm050809s; DEBRABANDER M, 1976, JNCI-J NATL CANCER I, V56, P357, DOI 10.1093/jnci/56.2.357; Deleuze-Masquefa C, 2004, BIOORGAN MED CHEM, V12, P1129, DOI 10.1016/j.bmc.2003.11.034; Deleuze-Masquefa C., 2009, International Patent, Patent No. [PCT/EP2008/063290, 2008063290]; Deleuze-Masquefa C, 2009, EUR J MED CHEM, V44, P3406, DOI 10.1016/j.ejmech.2009.02.007; Denning DP, 2014, NAT CELL BIOL, V16, P741, DOI 10.1038/ncb3012; Fang XL, 2004, J CHEM INF COMP SCI, V44, P249, DOI 10.1021/ci034209i; Florin V, 2012, INVEST NEW DRUG, V30, P1641, DOI 10.1007/s10637-011-9717-2; Gajate C, 2000, CANCER RES, V60, P2651; Gaspari AA, 2009, J DRUGS DERMATOL, V8, P467; Giannakakou P, 2000, J NATL CANCER I, V92, P182, DOI 10.1093/jnci/92.3.182; Green DS, 2007, BRIT J DERMATOL, V156, P337, DOI 10.1111/j.1365-2133.2006.07664.x; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; Han JH, 2013, INT J ONCOL, V42, P2087, DOI 10.3892/ijo.2013.1898; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jordan M. A., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P1, DOI 10.2174/1568011023354290; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; JORDAN MA, 1992, J CELL SCI, V102, P401; Khier S, 2010, DRUG METAB DISPOS, V38, P1836, DOI 10.1124/dmd.110.034579; Khier S, 2009, J SEP SCI, V32, P1363, DOI 10.1002/jssc.200800668; Lebbe C, 2012, EUR J CANCER, V48, P3205, DOI 10.1016/j.ejca.2012.05.010; Lu Y, 2012, PHARM RES-DORDR, V29, P2943, DOI 10.1007/s11095-012-0828-z; Massarotti A, 2012, CHEMMEDCHEM, V7, P33, DOI 10.1002/cmdc.201100361; Moarbess G, 2008, BIOORGAN MED CHEM, V16, P6601, DOI 10.1016/j.bmc.2008.05.022; Moarbess G, 2008, BLOOD, V111, P3770, DOI 10.1182/blood-2007-11-121913; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; Moon SD, 2013, J DRUGS DERMATOL, V12, P107; Morjaria S, 2006, INT J IMMUNOPATH PH, V19, P525, DOI 10.1177/039463200601900308; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Narayan R, 2012, J INVEST DERMATOL, V132, P163, DOI 10.1038/jid.2011.247; Prota AE, 2014, J MOL BIOL, V426, P1848, DOI 10.1016/j.jmb.2014.02.005; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Saliba J, 2014, ANTI-CANCER DRUG, V7, P1; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Savage P, 1996, BRIT J CANCER, V74, P1482, DOI 10.1038/bjc.1996.569; Schon MP, 2007, BRIT J DERMATOL, V157, P8, DOI 10.1111/j.1365-2133.2007.08265.x; Schon M, 2003, J NATL CANCER I, V95, P1138, DOI 10.1093/jnci/djg016; Schon MP, 2004, J INVEST DERMATOL, V122, P1266, DOI 10.1111/j.0022-202X.2004.22528.x; SIDKY YA, 1992, CANCER RES, V52, P3528; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vacchelli E, 2013, ONCOIMMUNOLOGY, V2; Wang LG, 1999, CANCER CHEMOTH PHARM, V44, P355, DOI 10.1007/s002800050989; Weber A, 2009, TRANSL ONCOL, V2, P73, DOI 10.1593/tlo.08223; WILLIAMS RC, 1982, METHOD ENZYMOL, V85, P376; WITT PL, 1993, CANCER RES, V53, P5176; Zghaib Z, 2016, BIOORGAN MED CHEM, V24, P2433, DOI 10.1016/j.bmc.2016.04.004; Zhang C, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0004881, 10.1371/journal.pone.0005429]	55	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182022	10.1371/journal.pone.0182022	http://dx.doi.org/10.1371/journal.pone.0182022			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797090	gold, Green Published, Green Submitted			2022-12-26	WOS:000407396200026
J	Fujimura, Y; Yamauchi, Y; Murase, T; Nakamura, T; Fujita, S; Fujisaka, T; Ito, T; Sohmiya, K; Hoshiga, M; Ishizaka, N				Fujimura, Yuki; Yamauchi, Yohei; Murase, Takayo; Nakamura, Takashi; Fujita, Shu-ichi; Fujisaka, Tomohiro; Ito, Takahide; Sohmiya, Koichi; Hoshiga, Masaaki; Ishizaka, Nobukazu			Relationship between plasma xanthine oxidoreductase activity and left ventricular ejection fraction and hypertrophy among cardiac patients	PLOS ONE			English	Article							SERUM URIC-ACID; INDEPENDENT RISK-FACTOR; HIGHLY SENSITIVE ASSAY; CORONARY-HEART-DISEASE; CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR EVENTS; OXIDASE ACTIVITY; URATE LEVELS; WEIGHT-LOSS; HYPERURICEMIA	Background and purpose Xanthine oxidoreductase (XOR), which catalyzes purine catabolism, has two interconvertible forms, xanthine dehydrogenase and xanthine oxidase, the latter of which produces superoxide during uric acid (UA) synthesis. An association between plasma XOR activity and cardiovascular and renal outcomes has been previously suggested. We investigated the potential association between cardiac parameters and plasma XOR activity among cardiology patients. Methods and results Plasma XOR activity was measured by [C-13(2),N-15(2)]xanthine coupled with liquid chromatography/triplequadrupole mass spectrometry. Among 270 patients who were not taking UA-lowering drugs, XOR activity was associated with body mass index (BMI), alanine aminotransferase (ALT), HbA1c and renal function. Although XOR activity was not associated with serum UA overall, patients with chronic kidney disease (CKD), those with higher XOR activity had higher serum UA among patients without CKD. Compared with patients with the lowest XOR activity quartile, those with higher three XOR activity quartiles more frequently had left ventricular hypertrophy. In addition, plasma XOR activity showed a U-shaped association with low left ventricular ejection fraction (LVEF) and increased plasma B-type natriuretic peptide (BNP) levels, and these associations were independent of age, gender, BMI, ALT, HbA1C, serum UA, and CKD stages. Conclusions Among cardiac patients, left ventricular hypertrophy, low LVEF, and increased BNP were significantly associated with plasma XOR activity independent of various confounding factors. Whether pharmaceutical modification of plasma XOR activity might inhibit cardiac remodeling and improve cardiovascular outcome should be investigated in future studies.	[Fujimura, Yuki; Yamauchi, Yohei; Fujita, Shu-ichi; Fujisaka, Tomohiro; Ito, Takahide; Sohmiya, Koichi; Hoshiga, Masaaki; Ishizaka, Nobukazu] Osaka Med Coll, Dept Cardiol, Osaka, Japan; [Murase, Takayo; Nakamura, Takashi] Sanwa Kagaku Kenkyusho Co, Mie Res Labs, Inabe City, Mie, Japan	Osaka Medical College; Sanwa Kagaku Kenkyusho Co., Ltd.	Ishizaka, N (corresponding author), Osaka Med Coll, Dept Cardiol, Osaka, Japan.	ishizaka@osaka-med.ac.jp		nakamura, takashi/0000-0003-2324-3569	Sanwa Kagaku Kenkyusho Co., Ltd	Sanwa Kagaku Kenkyusho Co., Ltd	TM and TN belong to the Sanwa Kagaku Kenkyusho Co., Ltd., which company is selling uric acid lowering drugs. NI received research support from Sanwa Kagaku Kenkyusho Co., Ltd. The funder provided support in the form of salaries for TM and TN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The specific roles of these authors are articulated in the 'author contributions' section.	Abeles AM, 2015, CURR RHEUMATOL REP, V17, DOI 10.1007/s11926-015-0495-2; Battelli MG, 2016, CANCER MED-US, V5, P546, DOI 10.1002/cam4.601; Capuano V, 2017, J CARDIOVASC MED, V18, P159, DOI 10.2459/JCM.0000000000000347; Chan KM, 2014, HEMODIAL INT, V18, P555, DOI 10.1111/hdi.12137; Desco MC, 2002, DIABETES, V51, P1118, DOI 10.2337/diabetes.51.4.1118; DEVEREUX RB, 1977, CIRCULATION, V55, P613, DOI 10.1161/01.CIR.55.4.613; FREEDMAN DS, 1995, AM J EPIDEMIOL, V141, P637, DOI 10.1093/oxfordjournals.aje.a117479; FRIEDL HP, 1990, AM J PATHOL, V136, P491; FUKUSHIMA T, 1995, BIOL PHARM BULL, V18, P156; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gondouin B, 2015, NEPHRON, V131, P167, DOI 10.1159/000441091; Hakoda M, 2005, J RHEUMATOL, V32, P906; Houston M, 1999, J BIOL CHEM, V274, P4985, DOI 10.1074/jbc.274.8.4985; Ishizaka N, 2005, ARTERIOSCL THROM VAS, V25, P1038, DOI 10.1161/01.ATV.0000161274.87407.26; Keenan T, 2016, J AM COLL CARDIOL, V67, P407, DOI 10.1016/j.jacc.2015.10.086; Kim SY, 2010, ARTHRIT CARE RES, V62, P170, DOI 10.1002/acr.20065; Kleber ME, 2015, J AM SOC NEPHROL, V26, P2831, DOI 10.1681/ASN.2014070660; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Liu X, 2003, J CHROMATOGR B, V785, P101, DOI 10.1016/S1570-0232(02)00860-7; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Miric DJ, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/4370490; Murase T, 2016, J CHROMATOGR B, V1039, P51, DOI 10.1016/j.jchromb.2016.10.033; Murase T, 2016, J LABELLED COMPD RAD, V59, P214, DOI 10.1002/jlcr.3390; Nakamura T, 2016, EUR J PHARMACOL, V780, P224, DOI 10.1016/j.ejphar.2016.03.055; Narsale AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119888; Nossent J, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0421-1; Otaki Y, 2017, INT J CARDIOL, V228, P151, DOI 10.1016/j.ijcard.2016.11.077; Palmer TM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4262; Richette P, 2016, ARTHRIT CARE RES, V68, P1036, DOI 10.1002/acr.22798; Roman MJ, 1996, J AM COLL CARDIOL, V28, P751, DOI 10.1016/0735-1097(96)00225-2; ROOTWELT T, 1995, ACTA PAEDIATR, V84, P507, DOI 10.1111/j.1651-2227.1995.tb13683.x; Sica DA, 2012, NAT REV NEPHROL, V8, P100, DOI 10.1038/nrneph.2011.175; Spiekermann S, 2003, CIRCULATION, V107, P1383, DOI 10.1161/01.CIR.0000056762.69302.46; Tam HK, 2016, CHILD OBES, V12, P286, DOI 10.1089/chi.2015.0051; Tam HK, 2014, CHILD OBES, V10, P175, DOI 10.1089/chi.2013.0098; Tanaka S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156860; Vinik O, 2014, J RHEUMATOL, V41, P70, DOI 10.3899/jrheum.140465; Wang J, 2014, COMP BIOCHEM PHYS D, V11, P1, DOI 10.1016/j.cbd.2014.05.001; White J, 2016, LANCET DIABETES ENDO, V4, P327, DOI 10.1016/S2213-8587(15)00386-1; Yamagishi S, 2014, INT J CARDIOL, V176, P550, DOI 10.1016/j.ijcard.2014.07.023; YONETANI Y, 1987, JPN J PHARMACOL, V43, P399, DOI 10.1254/jjp.43.399; Zhang NJ, 2016, EUR J INTERN MED, V29, P32, DOI 10.1016/j.ejim.2016.01.019	42	24	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182699	10.1371/journal.pone.0182699	http://dx.doi.org/10.1371/journal.pone.0182699			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797123	Green Published, Green Submitted, gold			2022-12-26	WOS:000407396200084
J	Hernandez-Mora, G; Ruiz-Villalobos, N; Bonilla-Montoya, R; Romero-Zuniga, JJ; Jimenez-Arias, J; Gonzalez-Barrientos, R; Barquero-Calvo, E; Chacon-Diaz, C; Rojas, N; Chaves-Olarte, E; Guzman-Verri, C; Moreno, E				Hernandez-Mora, Gabriela; Ruiz-Villalobos, Nazareth; Bonilla-Montoya, Roberto; Romero-Zuniga, Juan-Jose; Jimenez-Arias, Julio; Gonzalez-Barrientos, Rocio; Barquero-Calvo, Elias; Chacon-Diaz, Carlos; Rojas, Norman; Chaves-Olarte, Esteban; Guzman-Verri, Caterina; Moreno, Edgardo			Epidemiology of bovine brucellosis in Costa Rica: Lessons learned from failures in the control of the disease	PLOS ONE			English	Article							SEROLOGICAL TESTS; DIAGNOSIS; INFECTION; AMERICA	Brucellosis, caused by Brucella abortus is a major disease of cattle and a zoonosis. In order to estimate the bovine brucellosis prevalence in Costa Rica (CR), a total 765 herds (13078 bovines) from six regions of CR were randomly sampled during 2012-2013. A non-random sample of 7907 herds (532199 bovines) of the six regions, arriving for diagnoses during 2014-2016 to the Costa Rican Animal Health Service was also studied. The prevalence estimated by Rose Bengal test (RBT) ranged from 10.5%-11.4%; alternatively, the prevalence estimated by testing the RBT positives in iELISA, ranged from 4.1%-6.0%, respectively. However, cattle in CR are not vaccinated with B. abortus S19 but with RB51 (vaccination coverage close to 11%), and under these conditions the RBT displays 99% specificity and 99% sensitivity. Therefore, the RBT herd depicted in the random analysis stands as a feasible assessment and then, the recommended value in case of planning an eradication program in CR. Studies of three decades reveled that bovine brucellosis prevalence has increased in CR. B. abortus was identified by biochemical and molecular studies as the etiological agent of bovine brucellosis. Multiple locus variable-number tandem repeat analysis-16 revealed four B. abortus clusters. Cluster one and three are intertwined with isolates from other countries, while clusters two and four have only representatives from CR. Cluster one is widely distributed in all regions of the country and may be the primary B. abortus source. The other clusters seem to be restricted to specific areas in CR. The implications of our findings, in relation to the control of the disease in CR, are critically discussed.	[Hernandez-Mora, Gabriela; Bonilla-Montoya, Roberto; Jimenez-Arias, Julio; Gonzalez-Barrientos, Rocio] Minist Agr & Ganaderia, Serv Nacl Salud Anim SENASA, Heredia, Costa Rica; [Ruiz-Villalobos, Nazareth; Guzman-Verri, Caterina; Moreno, Edgardo] Univ Nacl, Escuela Med Vet, PIET, Heredia, Costa Rica; [Romero-Zuniga, Juan-Jose] Univ Nacl, Escuela Med Vet, Programa Invest Med Poblac, Heredia, Costa Rica; [Chacon-Diaz, Carlos; Rojas, Norman; Chaves-Olarte, Esteban] Univ Costa Rica, Fac Microbiol, CIET, San Jose, Costa Rica; [Moreno, Edgardo] Univ CR, ICP, San Jose, Costa Rica	Universidad Nacional Costa Rica; Universidad Nacional Costa Rica; Universidad Costa Rica	Moreno, E (corresponding author), Univ Nacl, Escuela Med Vet, PIET, Heredia, Costa Rica.; Moreno, E (corresponding author), Univ CR, ICP, San Jose, Costa Rica.	edgardo.moreno.robles@una.cr	BARQUERO-CALVO, ELIAS/GLU-1867-2022; Guzman-Verri, Caterina/AAP-3074-2020; Hernandez-Mora, Gabriela/AAW-5911-2020	BARQUERO-CALVO, ELIAS/0000-0003-4428-3340; Guzman-Verri, Caterina/0000-0003-1036-920X; /0000-0002-7746-6920	Fondos del Sistema del Consejo Nacional de Rectores Costa Rica Reagents and materials [FEES-CONARE FSI001]; Ministerio de Ciencia, Tecnologia y Telecom unicaciones (MICITT-PINN) [PND-033-15-2]; University of Costa Rica scholarships [80364.5010]	Fondos del Sistema del Consejo Nacional de Rectores Costa Rica Reagents and materials; Ministerio de Ciencia, Tecnologia y Telecom unicaciones (MICITT-PINN); University of Costa Rica scholarships	This work was partially funded by Fondos del Sistema del Consejo Nacional de Rectores (FEES-CONARE FSI001) Costa Rica Reagents and materials. Fellowships are the following: GH-M was partially sponsored by scholarships project of Ministerio de Ciencia, Tecnologia y Telecom unicaciones (MICITT-PINN) PND-033-15-2 and NR-V by University of Costa Rica scholarships project 80364.5010,17-12-15. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrio MB, 2009, VACCINE, V27, P1741, DOI 10.1016/j.vaccine.2009.01.025; Borba MR, 2013, PREV VET MED, V110, P169, DOI 10.1016/j.prevetmed.2012.11.013; Bulgarelli OAguilar, 1974, CONSTITUCION 1949 AN, P188; Calderón-Rangel Alfonso, 2015, Orinoquia, V19, P203; Campos E, 1984, ACTA MED COST S, V47, P8; Cannon R.M., 1982, LIVESTOCK DIS SURVEY, P35; CNRS-Centre National de la Recherche Scientifique, 2017, MLVA NET BRUC; Crawford RP, 1977, BOV BRUC INT S; De Miguel MJ, 2011, J CLIN MICROBIOL, V49, P1458, DOI 10.1128/JCM.02301-10; Ducrotoy MJ, 2016, VET IMMUNOL IMMUNOP, V171, P81, DOI 10.1016/j.vetimm.2016.02.002; Gall D, 1998, CLIN DIAGN LAB IMMUN, V5, P654, DOI 10.1128/CDLI.5.5.654-661.1998; Hernandez-Mora G, 2017, PLOS ONE; Jimenez E., 2016, NACION; Le Fleche P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-9; Leon EA, 2007, EVALUACION SERVICIOS; MediVet-SENASA, 2016, VAC ANT DIR MED VET; Ministerio de Agricultura y Ganaderia, 2017, SIST INT REG EST AGR; Ministerio de Agricultura y Ganaderia, 1978, DIR SAL AN PROYECT S; Ministerio de Agricultura y Ganaderia, 1990, ARCH INF SEM AN; Ministerio de Agricultura y Ganaderia, 1979, EV PROGR SAL AN PROG; Ministerio de Economia y Hacienda, 1953, AN EST COST RIC; Ministerio de Economia y Hacienda, 1956, AN EST COST RIC; Moreno E, 2002, VET MICROBIOL, V90, P31, DOI 10.1016/S0378-1135(02)00242-0; Moreno E., 1998, INT ATOMIC ENERGY, P153; Moreno E, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00213; Moriyon I, 2004, VET RES, V35, P1, DOI 10.1051/vetres:2003037; Munoz PM, 2005, CLIN DIAGN LAB IMMUN, V12, P141, DOI 10.1128/CDLI.12.1.141-151.2005; Nicoletti P, 1979, Proc Annu Meet U S Anim Health Assoc, P75; Nielsen K, 2005, REV SCI TECH OIE, V24, P1027, DOI 10.20506/rst.24.3.1628; OIE-WAHIS interface. Selected disease, 2017, SEL DIS BRUC BRUC AB; Omer MK, 2001, PREV VET MED, V48, P215, DOI 10.1016/S0167-5877(00)00185-9; Palisade Corporation, 2017, RISK AN US MONT CARL; Perez-Roman C, 1984, ACTA MED COSTARRIC, V27, P41; Poulsen KP, 2014, AM J TROP MED HYG, V90, P712, DOI 10.4269/ajtmh.13-0362; Programa de Desarrollo Ganadero y Salud Animal -PROGASA, 1983, DIR SAL PROD PEC COS; Programa de informacion agropecuaria (PIAGRO), 1996, BRUC TUB TALL EV PER; Quiros D, 1915, GACETA MED COSTA RIC, V11, P241; Quiros-Quiros E, 2006, HIST GANADERIA BOVIN; Recio P., 2015, NACION; Saenz M, 2010, UNIVERSAL COVERAGE M; SEQUEIRA A, 1984, TURRIALBA, V34, P525; SZYFRES B, 1959, Bol Oficina Sanit Panam, V46, P48; Thrusfield M, 2001, VET REC, V148, P567, DOI 10.1136/vr.148.18.567; United Nation Development Program-UNDP. Human development report, HUM DEV REP REAL WEA; Vargas-Ulate T, 2004, GEOGRAFIA COSTA RICA, P124; Verger JM, 1988, TECHNIQUES BRUCELLOS; Vicente GS, 1983, CIEN VET, P123; Villalobos-Zúñiga Manuel Antonio, 2011, Acta méd. costarric, V53, P154; World Organisation for Animal Health (OIE), 2009, MANUAL DIAGNOSTIC TE; Zeledon-Alvarado J, 1940, REV MED, V72, P153	50	13	14	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182380	10.1371/journal.pone.0182380	http://dx.doi.org/10.1371/journal.pone.0182380			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797045	Green Published, Green Submitted, gold			2022-12-26	WOS:000407396200049
J	Manetti, M; Pratesi, S; Romano, E; Bellando-Randone, S; Rosa, I; Guiducci, S; Fioretto, BS; Ibba-Manneschi, L; Maggi, E; Matucci-Cerinic, M				Manetti, Mirko; Pratesi, Sara; Romano, Eloisa; Bellando-Randone, Silvia; Rosa, Irene; Guiducci, Serena; Fioretto, Bianca Saveria; Ibba-Manneschi, Lidia; Maggi, Enrico; Matucci-Cerinic, Marco			Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; VASCULOGENESIS; CLASSIFICATION; DYSFUNCTION; SCLERODERMA; BIOMARKERS; EXPRESSION; DISEASE; SKIN	The mechanisms underlying endothelial cell injury and defective vascular repair in systemic sclerosis (SSc) remain unclear. Since the recently discovered angiogenic T cells (Tang) may have an important role in the repair of damaged endothelium, this study aimed to analyze the Tang population in relation to disease-related peripheral vascular features in SSc patients. Tang (CD3(+) CD31(+) CXCR4(+)) were quantified by flow cytometry in peripheral blood samples from 39 SSc patients and 18 healthy controls (HC). Circulating levels of the CXCR4 ligand stromal cell-derived factor (SDF)-1 alpha and proangiogenic factors were assessed in paired serum samples by immunoassay. Serial skin sections from SSc patients and HC were subjected to CD3/CD31 and CD3/CXCR4 double immunofluorescence. Circulating Tang were significantly increased in SSc patients with digital ulcers (DU) compared either with SSc patients without DU or with HC. Tang levels were significantly higher in SSc patients with late nailfold videocapillaroscopy (NVC) pattern than in those with early/active NVC patterns and in HC. No difference in circulating Tang was found when comparing either SSc patients without DU or patients with early/active NVC patterns and HC. In SSc peripheral blood, Tang percentage was inversely correlated to levels of SDF-1 alpha and CD34(+) CD133(+) VEGFR-2(+) endothelial progenitor cells (EPC), and positively correlated to levels of vascular endothelial growth factor and matrix metalloproteinase-9. Tang were frequently detected in SSc dermal perivascular inflammatory infiltrates. In summary, our findings demonstrate for the first time that Tang cells are selectively expanded in the circulation of SSc patients displaying severe peripheral vascular complications like DU. In SSc, Tang may represent a potentially useful biomarker reflecting peripheral vascular damage severity. Tang expansion may be an ineffective attempt to compensate the need for increased angiogenesis and EPC function. Further studies are required to clarify the function of Tang cells and investigate the mechanisms responsible for their change in SSc.	[Manetti, Mirko; Rosa, Irene; Ibba-Manneschi, Lidia] Univ Florence, Sect Anat & Histol, Dept Expt & Clin Med, Florence, Italy; [Pratesi, Sara; Romano, Eloisa; Bellando-Randone, Silvia; Rosa, Irene; Guiducci, Serena; Fioretto, Bianca Saveria; Maggi, Enrico; Matucci-Cerinic, Marco] Univ Florence, AOUC, Sect Internal Med, Dept Expt & Clin Med, Florence, Italy	University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi	Manetti, M (corresponding author), Univ Florence, Sect Anat & Histol, Dept Expt & Clin Med, Florence, Italy.	mirko.manetti@unifi.it	Rosa, Irene/ABD-1854-2020; Romano, Eloisa/AEZ-7072-2022; Guiducci, Serena/AAB-9949-2019; CERINIC, marco MATUCCI/AAO-2769-2020; Maggi, Enrico/AAA-8045-2019; Manetti, Mirko/AEH-9944-2022	Rosa, Irene/0000-0001-6352-0175; Romano, Eloisa/0000-0003-2744-8625; Guiducci, Serena/0000-0003-2722-6475; Maggi, Enrico/0000-0002-1824-3583; Manetti, Mirko/0000-0003-3956-8480	University of Florence	University of Florence	The study was supported by grants from the University of Florence (Progetti di Ricerca di Ateneo to MM-C). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allanore Y, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.2; Altorok N, 2014, CURR OPIN RHEUMATOL, V26, P615, DOI 10.1097/BOR.0000000000000112; Andrigueti FV, 2015, MICROVASC RES, V98, P82, DOI 10.1016/j.mvr.2015.01.004; Avouac J, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4217; Bellando-Randone S, 2017, J SCLERODERMA RELAT, V2, P1; Borghini A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130166; Chora I, 2015, AUTOIMMUN REV, V14, P314, DOI 10.1016/j.autrev.2014.12.001; Cipriani P, 2006, ARTHRITIS RHEUM, V54, P3022, DOI 10.1002/art.22047; Del Papa N, 2010, J RHEUMATOL, V37, P2053, DOI 10.3899/jrheum.091346; Della Bella S, 2016, J LEUKOCYTE BIOL, V99, P399, DOI 10.1189/jlb.5CE0815-335RR; Hummers LK, 2009, J RHEUMATOL, V36, P576, DOI 10.3899/jrheum.080516; Hur J, 2007, CIRCULATION, V116, P1671, DOI 10.1161/CIRCULATIONAHA.107.694778; Ingegnoli F, 2013, EXPERT REV CLIN IMMU, V9, P1091, DOI 10.1586/1744666X.2013.849198; Kuwana M, 2004, LANCET, V364, P603, DOI 10.1016/S0140-6736(04)16853-0; Lambova SN, 2010, MICROVASC RES, V80, P534, DOI 10.1016/j.mvr.2010.07.005; LEROY EC, 1988, J RHEUMATOL, V15, P202; Lopez P, 2016, J LEUKOCYTE BIOL, V99, P405, DOI 10.1189/jlb.5HI0215-042R; Manetti M, 2017, ANN RHEUM DIS, V76, DOI 10.1136/annrheumdis-2016-210229; Manetti M, 2016, CURR OPIN RHEUMATOL, V28, P606, DOI 10.1097/BOR.0000000000000324; Manetti M, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0937-x; Manetti M, 2011, TRENDS CARDIOVAS MED, V21, P204, DOI 10.1016/j.tcm.2012.05.011; Manetti M, 2012, ANN RHEUM DIS, V71, P1064, DOI 10.1136/annrheumdis-2011-200837; Manetti M, 2010, J CELL MOL MED, V14, P1241, DOI 10.1111/j.1582-4934.2010.01027.x; Matucci-Cerinic M, 2013, ARTHRITIS RHEUM-US, V65, P1953, DOI 10.1002/art.37988; Miao JL, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/2842143; Rodriguez-Carrio J, 2015, ANN RHEUM DIS, V74, P921, DOI 10.1136/annrheumdis-2013-204250; Rouhl RPW, 2012, STROKE, V43, P256, DOI 10.1161/STROKEAHA.111.632208; Trojanowska M, 2010, NAT REV RHEUMATOL, V6, P453, DOI 10.1038/nrrheum.2010.102; van den Hoogen F, 2013, ANN RHEUM DIS, V72, P1747, DOI [10.1136/annrheumdis-2013-204424, 10.1002/art.38098]; Wilde B, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1044-8	30	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0183102	10.1371/journal.pone.0183102	http://dx.doi.org/10.1371/journal.pone.0183102			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797111	Green Published, Green Submitted, gold			2022-12-26	WOS:000407396200152
J	Qiu, WZ; Ke, LR; Xia, WX; Yang, J; Yu, YH; Liang, H; Huang, XJ; Liu, GY; Li, WZ; Xiang, YQ; Guo, X; Lv, X				Qiu, Wen-Ze; Ke, Liang-Ru; Xia, Wei-Xiong; Yang, Jing; Yu, Ya-Hui; Liang, Hu; Huang, Xin-Jun; Liu, Guo-Ying; Li, Wang-Zhong; Xiang, Yan-Qun; Guo, Xiang; Lv, Xing			A retrospective study of 606 cases of nasopharyngeal carcinoma with or without oropharyngeal candidiasis during radiotherapy	PLOS ONE			English	Article							INTENSITY-MODULATED RADIOTHERAPY; PATIENTS RECEIVING RADIATION; ORAL CANDIDIASIS; CANCER-PATIENTS; HEAD; NECK; EPIDEMIOLOGY; INFECTION; PATIENT; COLONIZATION	Background To evaluate the clinical characteristics, treatment-related toxicities and survival in patients with nasopharyngeal carcinoma (NPC) with or without oropharyngealcandidiasis (OPC) during radiotherapy. Methods The current study was conducted with NPC patients undergoing radiotherapy at Sun Yat-Sen University Cancer Center between June 2011 and May 2012. A clinical diagnosis of candidiasis was determined on the basis of a positive potassium hydroxide (KOH) test and the presence of pseudomembranous (white) form of candidal overgrowth. The Cox proportional hazard regression model was used to test the association of OPC and related survival rates. Results Compared with the non-OPC group, the OPC group had significantly increased occurrence rates of grade 3-4 mucositis (14.5% vs. 7.4%, P = 0.049), anaemia (11.3% vs. 4.4%, P = 0.020), hepatotoxicity (4.8% vs. 1.1%, P = 0.021) and critical weight loss (85.5% vs. 56.6%, P<0.001) during radiotherapy. The OPC group had a significantly lower disease-free survival (DFS) (70.9% vs. 82.6%, P = 0.012), mainly as a result of a reduction in locoregional relapse-free survival (LRFS) (87.0% vs. 94.9%, P = 0.025). After stratification by T stage, the 5-year DFS in T3-4 patients were 82.0% and 68.8% in non-OPC and OPC groups, respectively (P = 0.022). Multivariate analyses indicated that OPC was a prognostic factor for LRFS and DFS. Conclusions OPC during radiotherapy may worsen the nutritional status of NPC patients according to weight loss and anaemia, leading to a negative impact on 5-year locoregional relapse-free survival and disease-specific survival. Further investigations are needed to explore whether prevention and treatment of OPC during radiotherapy will be useful.	[Qiu, Wen-Ze; Ke, Liang-Ru; Xia, Wei-Xiong; Yu, Ya-Hui; Liang, Hu; Huang, Xin-Jun; Liu, Guo-Ying; Li, Wang-Zhong; Xiang, Yan-Qun; Guo, Xiang; Lv, Xing] Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Guangzhou, Guangdong, Peoples R China; [Qiu, Wen-Ze; Ke, Liang-Ru; Xia, Wei-Xiong; Yu, Ya-Hui; Liang, Hu; Huang, Xin-Jun; Liu, Guo-Ying; Li, Wang-Zhong; Xiang, Yan-Qun; Guo, Xiang; Lv, Xing] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [Yang, Jing] Shanghai Proton & Heavy Ion Ctr, Dept Radiat Oncol, Shanghai, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Guo, X; Lv, X (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Guangzhou, Guangdong, Peoples R China.; Guo, X; Lv, X (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China.	guoxiang@sysucc.org.cn; lvxing@sysucc.org.cn		Li, Wang-Zhong/0000-0002-2744-8775	Science and Technology Program of of Guangdong Province [201313021800141]; Science and Technology Program of Guangzhou [2014Y2-00179]; Science and Technology Plan Project of International Cooperation of Guangdong Province [2016A050502011]	Science and Technology Program of of Guangdong Province; Science and Technology Program of Guangzhou; Science and Technology Plan Project of International Cooperation of Guangdong Province	This study is supported by grants from the Science and Technology Program of of Guangdong Province [grant number 201313021800141] (http://pro.gdstc.gov.cn/egrantweb/proposal/prp-edit-list?year=& Science and Technology Program of Guangzhou [grant number 2014Y2-00179] (http://www.gzci.gov.cn/); and Science and Technology Plan Project of International Cooperation of Guangdong Province [grant number 2016A050502011] (http://www.gdstc.govcni). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagg J, 2003, PALLIATIVE MED, V17, P477, DOI 10.1191/0269216303pm793oa; Baujat B, 2006, INT J RADIAT ONCOL, V64, P47, DOI 10.1016/j.ijrobp.2005.06.037; Chandra RK, 2002, EUR J CLIN NUTR, V56, pS73, DOI 10.1038/sj.ejcn.1601492; Chua DTT, 2004, CANCER, V101, P307, DOI 10.1002/cncr.20366; Davies AN, 2006, ORAL ONCOL, V42, P698, DOI 10.1016/j.oraloncology.2005.11.010; Davies Michelle, 2005, Eur J Oncol Nurs, V9 Suppl 2, pS64, DOI 10.1016/j.ejon.2005.09.005; Deng ZY, 2010, OTOLARYNG HEAD NECK, V143, P242, DOI 10.1016/j.otohns.2010.02.003; EPSTEIN JB, 1993, ORAL SURG ORAL MED O, V76, P169, DOI 10.1016/0030-4220(93)90199-E; Geara FB, 1997, RADIOTHER ONCOL, V43, P53, DOI 10.1016/S0167-8140(97)01914-2; Gligorov J, 2011, INT J RADIAT ONCOL, V80, P532, DOI 10.1016/j.ijrobp.2010.02.006; Guo SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136033; Kumar P, 2000, ONCOLOGIST, V5, P13, DOI DOI 10.1634/THHEONCOLOGIST.5-SUPPL_2-13; Kwilas Anna R, 2012, Front Oncol, V2, P104, DOI 10.3389/fonc.2012.00104; Lai SZ, 2011, INT J RADIAT ONCOL, V80, P661, DOI 10.1016/j.ijrobp.2010.03.024; Langendijk JA, 2004, J CLIN ONCOL, V22, P4604, DOI 10.1200/JCO.2004.10.074; Langius JAE, 2013, BRIT J CANCER, V109, P1093, DOI 10.1038/bjc.2013.458; Lashof AMLO, 2004, EUR J CANCER, V40, P1314, DOI 10.1016/j.ejca.2004.03.003; Manas A, 2012, CLIN TRANSL ONCOL, V14, P740, DOI 10.1007/s12094-012-0861-8; MCCARTHY GM, 1992, ORAL SURG ORAL MED O, V73, P181, DOI 10.1016/0030-4220(92)90192-S; MCINTOSH EN, 1983, AM FAM PHYSICIAN, V27, P169; Nicolatou-Galitis O, 2001, J ORAL PATHOL MED, V30, P471, DOI 10.1034/j.1600-0714.2001.030008471.x; O'Sullivan B, 2007, INT J RADIAT ONCOL, V69, pS118, DOI 10.1016/j.ijrobp.2007.04.085; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Redding SW, 2004, ORAL SURG ORAL MED O, V97, P47, DOI 10.1016/j.tripleo.2003.09.008; Redding SW, 1999, J CLIN MICROBIOL, V37, P3896, DOI 10.1128/JCM.37.12.3896-3900.1999; Rohrig G, 2016, Z GERONTOL GERIATR; Schelenz S, 2011, J ORAL PATHOL MED, V40, P83, DOI 10.1111/j.1600-0714.2010.00937.x; Sharon V, 2010, DERMATOL THER, V23, P230, DOI 10.1111/j.1529-8019.2010.01320.x; Specht L, 2002, SUPPORT CARE CANCER, V10, P36, DOI 10.1007/s005200100283; Sun XM, 2014, RADIOTHER ONCOL, V110, P398, DOI 10.1016/j.radonc.2013.10.020; Tong CCL, 2012, IMMUNOL RES, V54, P266, DOI 10.1007/s12026-012-8306-6; Vaupel P, 2001, MED ONCOL, V18, P243, DOI 10.1385/MO:18:4:243; Vaupel P, 2005, TRANSFUS CLIN BIOL, V12, P5, DOI 10.1016/j.tracli.2004.11.005; von Meyenfeldt Maarten, 2005, Eur J Oncol Nurs, V9 Suppl 2, pS35, DOI 10.1016/j.ejon.2005.09.001; Vu HL, 2010, CANCER LETT, V288, P149, DOI 10.1016/j.canlet.2009.06.026; Wei KR, 2014, CHIN J CANCER, V33, P381, DOI 10.5732/cjc.014.10086; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; White JV, 2012, JPEN-PARENTER ENTER, V36, P275, DOI 10.1177/0148607112440285; Xue F, 2017, J CANCER, V8, P993, DOI 10.7150/jca.17858; Zeng L, 2014, BRIT J CANCER, V110, P49, DOI 10.1038/bjc.2013.720; Zhang MX, 2015, EUR J CANCER, V51, P2587, DOI 10.1016/j.ejca.2015.08.006; Zhao Chong, 2004, Ai Zheng, V23, P1532; Zomorodian K, 2016, J MYCOL MED, V26, P103, DOI 10.1016/j.mycmed.2015.12.008	43	4	4	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182963	10.1371/journal.pone.0182963	http://dx.doi.org/10.1371/journal.pone.0182963			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797119	Green Published, Green Submitted, gold			2022-12-26	WOS:000407396200133
J	Reed, S; Neuman, H; Glahn, RP; Koren, O; Tako, E				Reed, Spenser; Neuman, Hadar; Glahn, Raymond P.; Koren, Omry; Tako, Elad			Characterizing the gut (Gallus gallus) microbiota following the consumption of an iron biofortified Rwandan cream seeded carioca (Phaseolus Vulgaris L.) bean-based diet	PLOS ONE			English	Article							RED WINE POLYPHENOLS; METABOLIC-ACTIVITY; SUPPLEMENTATION; DEFICIENCY; ACID; BIOAVAILABILITY; FORTIFICATION; DIVERSITY; NUTRITION; CHILDREN	Biofortification is a plant breeding method that introduces increased concentrations of minerals in staple food crops (e.g., legumes, cereal grains), and has shown success in alleviating insufficient Fe intake in various human populations. Unlike other strategies utilized to alleviate Fe deficiency, studies of the gut microbiota in the context of Fe biofortification have not yet been reported, although the consumption of Fe biofortified staple food crops has increased significantly over time. Hence, in this study, we performed a 6-week feeding trial in Gallus gallus (n = 14), aimed to investigate the alterations in the gut microbiome following administration of an Fe biofortified bean-based diet (biofortified, BFe) versus a bean based diet with poorly-bioavailable Fe (standard, SFe). Cream seeded carioca bean based diets were designed in an identical fashion to those used in a recent human clinical trial of Fe biofortified beans in Rwanda. We hypothesized that the different dietary Fe contents in the beans based diets will alter the composition and function of the intestinal microbiome. The primary outcomes were changes in the gut microbiome composition and function analyzed by 16S rRNA gene sequencing. We observed no significant changes in phylogenetic diversity between groups. There were significant differences in the composition of the microbiota between groups, with the BFe group harboring fewer taxa participating in bacterial Fe uptake, increased abundance of bacteria involved in phenolic catabolism, and increased abundance of beneficial butyrate-producing bacteria. Additionally, depletion of key bacterial pathways responsible for bacterial viability and Fe uptake suggest that improvements in Fe bioavailability, in addition to increases in Fe-polyphenol and Fe-phytate complexes due to biofortification, led to decreased concentrations of cecal Fe available for bacterial utilization. Our findings demonstrate that Fe biofortification may improve Fe status without negatively altering the structure and function of the gut microbiota, as is observed with other nutritional methods of Fe supplementation. These results may be used to further improve the efficacy and safety of future biofortification efforts in eradicating global Fe deficiency.	[Reed, Spenser; Glahn, Raymond P.; Tako, Elad] Cornell Univ, USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA; [Reed, Spenser] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Neuman, Hadar; Koren, Omry] Bar Ilan Univ, Fac Med, Safed, Israel; [Reed, Spenser] Univ Arizona, Coll Med, Tucson, AZ USA	Cornell University; United States Department of Agriculture (USDA); Cornell University; Bar Ilan University; University of Arizona	Tako, E (corresponding author), Cornell Univ, USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA.	et79@cornell.edu	Koren, Omry/A-5222-2016	Koren, Omry/0000-0002-7738-1337				Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; BALMER SE, 1989, ARCH DIS CHILD, V64, P1685, DOI 10.1136/adc.64.12.1685; Bao YM, 2010, BRIT POULTRY SCI, V51, P109, DOI 10.1080/00071660903571904; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.3102/10769986025001060; Black R, 2003, B WORLD HEALTH ORGAN, V81, P79; Blair MW, 2013, J AGR FOOD CHEM, V61, P8287, DOI 10.1021/jf400774y; Bouis HE, 2014, IMPROVING DIETS AND NUTRITION: FOOD-BASED APPROACHES, P202, DOI 10.1079/9781780642994.0202; Cassat JE, 2013, CELL HOST MICROBE, V13, P510, DOI 10.1016/j.chom.2013.04.010; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; COOK JD, 1994, ADV EXP MED BIOL, V356, P219; COX CD, 1981, P NATL ACAD SCI-BIOL, V78, P4256, DOI 10.1073/pnas.78.7.4256; Crosa JH, 1997, MICROBIOL MOL BIOL R, V61, P319, DOI 10.1128/.61.3.319-336.1997; Cuervo A, 2015, NUTRIENTS, V7, P1301, DOI 10.3390/nu7021301; Danquah I, 2014, TROP MED INT HEALTH, V19, P117, DOI 10.1111/tmi.12216; Deschemin JC, 2016, FASEB J, V30, P252, DOI 10.1096/fj.15-276840; Dias DM, 2017, CRIT REV FOOD SCI NU, V17; Dostal A, 2014, BRIT J NUTR, V111, P2135, DOI 10.1017/S000711451400021X; Dostal A, 2012, J NUTR, V142, P271, DOI 10.3945/jn.111.148643; Dudonne Stephanie, 2015, PharmaNutrition, V3, P89, DOI 10.1016/j.phanu.2015.04.002; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fanzo J, 2011, COMBATING MICRONUTRIENT DEFICIENCIES: FOOD-BASED APPROACHES, P76, DOI 10.1079/9781845937140.0076; Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156; Haas JD, 2016, J NUTR, V146, P1586, DOI 10.3945/jn.115.224741; Hart JJ, 2015, J AGR FOOD CHEM, V63, P5950, DOI 10.1021/acs.jafc.5b00531; Queipo-Ortuno MI, 2012, AM J CLIN NUTR, V95, P1323, DOI 10.3945/ajcn.111.027847; Jaeggi T, 2015, GUT, V64, P731, DOI 10.1136/gutjnl-2014-307720; Khan MT, 2012, ISME J, V6, P1578, DOI 10.1038/ismej.2012.5; Kortman GAM, 2014, FEMS MICROBIOL REV, V38, P1202, DOI 10.1111/1574-6976.12086; Krebs NF, 2013, J PEDIATR-US, V163, P416, DOI 10.1016/j.jpeds.2013.01.024; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lee SH, 2008, BIOL TRACE ELEM RES, V126, pS57, DOI 10.1007/s12011-008-8209-5; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; LOZOFF B, 1991, NEW ENGL J MED, V325, P687, DOI 10.1056/NEJM199109053251004; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; Mead Geoffrey C., 1997, P216; Monk JM, 2016, J NUTR BIOCHEM, V28, P129, DOI 10.1016/j.jnutbio.2015.10.014; Moreno-Indias I, 2016, FOOD FUNCT, V7, P1775, DOI [10.1039/C5FO00886G, 10.1039/c5fo00886g]; Nairz M, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00152; Petry N, 2014, J NUTR, V144, P1681, DOI 10.3945/jn.114.192989; Power SE, 2014, BRIT J NUTR, V111, P387, DOI 10.1017/S0007114513002560; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Reed S, 2015, NUTRIENTS, V7, P9768, DOI 10.3390/nu7125497; Reed S, 2014, NUTRIENTS, V6, P1164, DOI 10.3390/nu6031164; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Seim GL, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060362; Selma MV, 2009, J AGR FOOD CHEM, V57, P6485, DOI 10.1021/jf902107d; Tako E, 2010, POULTRY SCI, V89, P514, DOI 10.3382/ps.2009-00326; TAKO E, 2015, NUTR J, V14; Tako E, 2016, NUTRIENTS, V8, DOI 10.3390/nu8110732; Tako E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138479; Tako E, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-113; Tako E, 2010, INT J VITAM NUTR RES, V80, P416, DOI 10.1024/0300-9831/a000028; Tompkins GR, 2001, CURR MICROBIOL, V43, P38, DOI 10.1007/s002840010257; Trijatmiko KR, 2016, SCI REP-UK, V6, DOI 10.1038/srep19792; Troxell B, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00059; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Wei S, 2013, POULTRY SCI, V92, P671, DOI 10.3382/ps.2012-02822; Weiss G, 2015, GUT, V64, P696, DOI 10.1136/gutjnl-2014-308147; Wright ADG, 2004, APPL ENVIRON MICROB, V70, P1263, DOI 10.1128/AEM.70.3.1263-1270.2004; Yegani M, 2008, POULTRY SCI, V87, P2052, DOI 10.3382/ps.2008-00091; Zhu XY, 2002, APPL ENVIRON MICROB, V68, P124, DOI 10.1128/AEM.68.1.124-137.2002; Zimmermann MB, 2010, AM J CLIN NUTR, V92, P1406, DOI 10.3945/ajcn.110.004564	64	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182431	10.1371/journal.pone.0182431	http://dx.doi.org/10.1371/journal.pone.0182431			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796793	Green Published, Green Submitted, gold			2022-12-26	WOS:000407396200051
J	Reins, RY; Courson, J; Lema, C; Redfern, RL				Reins, Rose Y.; Courson, Justin; Lema, Carolina; Redfern, Rachel L.			MyD88 contribution to ocular surface homeostasis	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; PSEUDOMONAS-AERUGINOSA KERATITIS; CORNEAL EPITHELIAL-CELLS; PATTERN-RECOGNITION RECEPTORS; MATRIX METALLOPROTEINASES; MICROBIAL KERATITIS; GROWTH-FACTOR; MICE; INFLAMMATION; ACTIVATION	The cornea must maintain homeostasis, enabling rapid response to injury and microbial insult, to protect the eye from insult and infection. Toll-like receptors (TLRs) are critical to this innate immune response through the recognition and response to pathogens. Myeloid differentiation primary response (MyD88) is a key signaling molecule necessary for Toll-like receptor (TLR) and interleukin-1 receptor (IL-1R)-mediated immune defense and has been shown to be necessary for corneal defense during infection. Here, we examined the intrinsic role of TLR signaling in ocular surface tissues by determining baseline levels of inflammatory mediators, the response to mechanical stimuli, and corneal infection in MyD88-deficient mice (MyD88(-/-)). In addition, cytokine, chemokine, and matrix metalloproteinase (MMP) expression was determined in ocular surface cells exposed to a panel of TLR agonists. Compared to wild-type (WT) animals, MyD88(-/-) mice expressed lower MMP-9 levels in the cornea and conjunctiva. Corneal IL-1 alpha, TNF alpha, and conjunctival IL-1 alpha, IL-2, IL-6, and IL-9 levels were also significantly reduced. Additionally, CXCL1 and RANTES expression was lower in both MyD88(-/-) tissues compared to WT and IL-1R(-/-) mice. Interestingly, MyD88(-/-) mice had lower corneal sensitivities (1.01 +/- 0.31 gm/mm(2)) than both WT (0.59 +/- 0.16 gm/mm(2)) and IL-1R(-/-) (0.52 +/- 0.08 gm/mm(2)). Following Pseudomonas aeruginosa challenge, MyD88(-/-) mice had better clinical scores (0.5 +/- 0.0) compared to IL-1R(-/-) (1.5 +/- 0.6) and WT (2.3 +/- 0.3) animals, but had significantly more corneal bacterial isolates. However, no signs of infection were detected in inoculated uninjured corneas from either MyD88 or IL-1R-deficient mice. This work furthers our understanding of the importance of TLR signaling in corneal defense and immune homeostasis, showing that a lack of MyD88 may compromise the baseline innate response to insult.	[Reins, Rose Y.; Courson, Justin; Lema, Carolina; Redfern, Rachel L.] Univ Houston, Coll Optometry, Ocular Surface Inst, Houston, TX 77004 USA	University of Houston System; University of Houston	Redfern, RL (corresponding author), Univ Houston, Coll Optometry, Ocular Surface Inst, Houston, TX 77004 USA.	rredfer2@Central.UH.EDU	Lema, Carolina/AFK-5176-2022; Courson, Justin/AAW-9273-2021; Courson, Justin/AAK-4802-2021; Lema, Carolina/AAG-3773-2022	Courson, Justin/0000-0002-1036-097X; 	National Eye Institute [RO1 EY023628, P30 EY07551]; NATIONAL EYE INSTITUTE [P30EY007551] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute RO1 EY023628 (RLR) and National Eye Institute P30 EY07551 (https://nei.nih.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092375; Bohan A, 2003, J BIOL CHEM, V278, P36688, DOI 10.1074/jbc.M304011200; Bonini S, 2005, OPHTHALMOLOGY, V112, P1528, DOI 10.1016/j.ophtha.2005.04.009; Bryant-Hudson KM, 2012, INVEST OPHTH VIS SCI, V53, P6785, DOI 10.1167/iovs.12-10400; Cortina MS, 2013, INVEST OPHTH VIS SCI, V54, P4109, DOI 10.1167/iovs.13-12075; Eslani M, 2014, INVEST OPHTH VIS SCI, V55, P6108, DOI 10.1167/iovs.14-14736; Evans DJ, 2013, AM J OPHTHALMOL, V155, P961, DOI 10.1016/j.ajo.2013.03.001; FINI ME, 1990, INVEST OPHTH VIS SCI, V31, P1779; Freria CM, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0579-6; Gao N, 2013, MUCOSAL IMMUNOL, V6, P993, DOI 10.1038/mi.2012.137; Hazlett LD, 2004, PROG RETIN EYE RES, V23, P1, DOI 10.1016/j.preteyeres.2003.10.002; Helin-Toiviainen M, 2015, ACTA OPHTHALMOL, V93, P165, DOI 10.1111/aos.12550; Huang LC, 2007, INVEST OPHTH VIS SCI, V48, P4498, DOI 10.1167/iovs.07-0274; Huang X, 2006, INVEST OPHTH VIS SCI, V47, P4910, DOI 10.1167/iovs.06-0537; Johnson AC, 2005, INVEST OPHTH VIS SCI, V46, P589, DOI 10.1167/iovs.04-1077; Kato J, 2016, EUR J PHARMACOL, V788, P261, DOI 10.1016/j.ejphar.2016.06.039; Kato J, 2015, PROG MOL BIOL TRANSL, V131, P251, DOI 10.1016/bs.pmbts.2014.11.014; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Kolar SSN, 2015, CELL MOL LIFE SCI, V72, P617, DOI 10.1007/s00018-014-1694-0; Krock E, 2016, J BIOL CHEM, V291, P3541, DOI 10.1074/jbc.M115.675900; Kubilus JK, 2010, INVEST OPHTH VIS SCI, V51, P782, DOI 10.1167/iovs.09-3942; Kumar A, 2008, INFECT IMMUN, V76, P89, DOI 10.1128/IAI.01232-07; Lai Yuping, 2008, Infectious Disorders - Drug Targets, V8, P144; Leal SM, 2012, CYTOKINE, V58, P107, DOI 10.1016/j.cyto.2011.12.022; Li DQ, 2001, EXP EYE RES, V73, P449, DOI 10.1006/exer.2001.1054; Li ZJ, 2006, INVEST OPHTH VIS SCI, V47, P1947, DOI 10.1167/iovs.05-1193; Li ZJ, 2011, FASEB J, V25, P2659, DOI 10.1096/fj.11-184804; MARFURT CF, 1993, J COMP NEUROL, V336, P517, DOI 10.1002/cne.903360405; Matsumoto K, 2005, CORNEA, V24, pS43, DOI 10.1097/01.ico.0000178737.35297.d4; McCusker RH, 2013, J EXP BIOL, V216, P84, DOI 10.1242/jeb.073411; McDermott AM, 2003, INVEST OPHTH VIS SCI, V44, P1859, DOI 10.1167/iovs.02-0787; Muller LJ, 2003, EXP EYE RES, V76, P521, DOI 10.1016/S0014-4835(03)00050-2; Omari KM, 2009, AM J PATHOL, V174, P164, DOI 10.2353/ajpath.2009.080350; Pearlman E, 2008, OCUL SURF, V6, P108, DOI 10.1016/S1542-0124(12)70279-3; Pearlman E, 2013, INT REV IMMUNOL, V32, P4, DOI 10.3109/08830185.2012.749400; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Redfern RL, 2013, INVEST OPHTH VIS SCI, V54, P1554, DOI 10.1167/iovs.12-10739; Redfern RL, 2011, EXP EYE RES, V92, P209, DOI 10.1016/j.exer.2010.12.005; Redfern RL, 2010, EXP EYE RES, V90, P679, DOI 10.1016/j.exer.2010.03.012; Reins RY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152889; Reins RY, 2015, INVEST OPHTH VIS SCI, V56, P7715, DOI 10.1167/iovs.15-17768; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; Rodet F, 2015, SCI REP-UK, V5, DOI 10.1038/srep09624; Roy S, 2014, J BIOL CHEM, V289, P1174, DOI 10.1074/jbc.M113.523167; Sarangi PP, 2007, J VIROL, V81, P11128, DOI 10.1128/JVI.01008-07; Shaykhiev R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001393; Spurr-Michaud Sandra J, 2013, Methods Mol Biol, V945, P31, DOI 10.1007/978-1-62703-125-7_3; Stokes JA, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-148; Sullivan AB, 2015, INFECT IMMUN, V83, P1629, DOI 10.1128/IAI.02329-14; Sun Y, 2006, INFECT IMMUN, V74, P5325, DOI 10.1128/IAI.00645-06; Sun Y, 2010, J IMMUNOL, V185, P4272, DOI 10.4049/jimmunol.1000874; Swamy M, 2010, NAT IMMUNOL, V11, P656, DOI 10.1038/ni.1905; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeda Kiyoshi, 2015, Curr Protoc Immunol, V109, DOI 10.1002/0471142735.im1412s109; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Tam C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024008; Taube MA, 2015, EYE, V29, P1399, DOI 10.1038/eye.2015.118; Van Lint P, 2007, J LEUKOCYTE BIOL, V82, P1375, DOI 10.1189/jlb.0607338; Wang J, 2002, CURR TOP MICROBIOL, V265, P23; Ward NS, 2000, AM J RESP CELL MOL, V22, P535, DOI 10.1165/ajrcmb.22.5.3808; Waxman AB, 2003, AM J RESP CELL MOL, V29, P513, DOI 10.1165/rcmb.2002-0044OC; Wells JM, 2011, P NATL ACAD SCI USA, V108, P4607, DOI 10.1073/pnas.1000092107; Wilson SE, 1999, PROG RETIN EYE RES, V18, P293, DOI 10.1016/S1350-9462(98)00017-2; Wilson SE, 2001, PROG RETIN EYE RES, V20, P625, DOI 10.1016/S1350-9462(01)00008-8; Xue ML, 2003, EXP EYE RES, V76, P221, DOI 10.1016/S0014-4835(02)00270-1; Yu CQ, 2008, INVEST OPHTH VIS SCI, V49, P3870, DOI 10.1167/iovs.07-1418; Yu FSX, 2010, BRAIN RES BULL, V81, P229, DOI 10.1016/j.brainresbull.2009.08.024; Zaidi TS, 2010, INVEST OPHTH VIS SCI, V51, P2085, DOI 10.1167/iovs.09-4139; Zhang J, 2003, INVEST OPHTH VIS SCI, V44, P4247, DOI 10.1167/iovs.03-0219	71	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182153	10.1371/journal.pone.0182153	http://dx.doi.org/10.1371/journal.pone.0182153			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796783	Green Published, Green Submitted, gold			2022-12-26	WOS:000407396200034
J	Sanneh, B; Joof, E; Sanyang, AM; Renneker, K; Camara, Y; Sey, AP; Jagne, S; Baldeh, I; Ceesay, SJ; Sambou, SM; Ogoussan, K				Sanneh, Bakary; Joof, Ebrima; Sanyang, Abdoulie M.; Renneker, Kristen; Camara, Yaya; Sey, Alhagie Papa; Jagne, Sheriffo; Baldeh, Ignatius; Ceesay, Serign Jawo; Sambou, Sana M.; Ogoussan, Kisito			Field evaluation of a schistosome circulating cathodic antigen rapid test kit at point-of-care for mapping of schistosomiasis endemic districts in The Gambia	PLOS ONE			English	Article							MANSONI INFECTION; DIAGNOSIS; HAEMATOBIUM; PREVALENCE; ACCURACY; AREAS	Background Studies in Sub Saharan Africa have shown that the Circulating Cathodic Antigen point-ofcare-test (POC-CCA) is more accurate in the detections of S. mansoni than the microscopic Kato-Katz technique but less is known about the accuracy of this rapid test in detecting S. haematobium infections. This study was intended to evaluate the field accuracy of POC-CCA as a rapid test kit for schistosomiasis mapping in The Gambia. Methods This prospective study was conducted in 4 regions in the country. Ten schools were randomly selected from each region, and a total of 2018 participants whose ages range from 7 to 14 years were enrolled in the study. Stool and urine samples were collected from each participant from May to June 2015, and tested for S. haematobium and S. mansoni infections in field and laboratory settings. The tests conducted included POC-CCA, double Kato-Katz slides, urine filtration and dipstick for hematuria. Results Of the 1954 participants that had complete data, the mean age of participants was 9.9 years. The prevalence of children infected with S. haematobium, using urine filtration technique was 10.1% (95% CI: 8.87-11.55). Central River Region had the highest level of urinary schistosomiasis with a prevalence of 28.0% (24.13-32.12). The lowest urinary schistosomiasis prevalence of 0.6% (0.12-1.86) was found in Lower River Region and North Bank Region had no cases of schistosomiasis detected. Only 5 participants were infected with S. mansoni. Using urine filtration as reference standard for the detection of S. haematobium, the sensitivity and specificity of POC-CCA was 47.7% and 75.8%. Whilst sensitivity and specificity of POC-CCA for detecting S. mansoni were 60.0% and 71.2% using double Kato-Katz as reference standard. Conclusion This study showed lower sensitivity of POC-CCA in detecting S. haematobium. Therefore POC-CCA is less useful for rapid diagnosis of urinary schistosomiasis.	[Sanneh, Bakary; Joof, Ebrima; Sanyang, Abdoulie M.; Sey, Alhagie Papa; Jagne, Sheriffo; Baldeh, Ignatius] Minist Hlth & Social Welf, Natl Publ Hlth Labs, Banjul, Gambia; [Renneker, Kristen; Ogoussan, Kisito] Neglected Trop Dis Support Ctr, Decatur, GA USA; [Camara, Yaya; Sambou, Sana M.] Minist Hlth & Social Welf, Epidemiol & Dis Control Dept, Banjul, Gambia; [Ceesay, Serign Jawo] MRC, Atlantic Blvd, Fajara, Gambia	University of London; London School of Hygiene & Tropical Medicine	Sanneh, B (corresponding author), Minist Hlth & Social Welf, Natl Publ Hlth Labs, Banjul, Gambia.	sheikbakary@yahoo.com	Sanyang, Abdoulie M./AAD-8871-2020; Renneker, Kristen/HGB-9323-2022	Joof, Ebrima/0000-0002-3367-0102; Sanneh, Bakary/0000-0002-6188-9283	Task Force for Global Health, INC [A992A78-CC70-4846-AF50BE65573CA71B]; Department for International Development (DFID) [300342] Funding Source: researchfish	Task Force for Global Health, INC; Department for International Development (DFID)	This work was supported by the Task Force for Global Health, INC (A992A78-CC70-4846-AF50BE65573CA71B) to BS	Colley DG, 2013, AM J TROP MED HYG, V88, P426, DOI 10.4269/ajtmh.12-0639; Coulibaly JT, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-29; Coulibaly JT, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001384; Danso-Appiah A, 2016, B WORLD HEALTH ORGAN, V94, P522, DOI 10.2471/BLT.15.158741; de Noya BA, 2007, ACTA TROP, V103, P41, DOI 10.1016/j.actatropica.2007.04.018; Doenhoff MJ, 2004, TRENDS PARASITOL, V20, P35, DOI 10.1016/j.pt.2003.10.019; Enk MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038947; Erko B, 2013, TROP MED INT HEALTH, V18, P1029, DOI 10.1111/tmi.12117; FELDMEIER H, 1993, ACTA TROP, V52, P205, DOI 10.1016/0001-706X(93)90009-Z; Gambia Ministry of Health and Social Welfare, 2014, NAT MAST PLAN NEGL T; Ibironke OA, 2011, AM J TROP MED HYG, V84, P998, DOI 10.4269/ajtmh.2011.10-0691; Jack A. D., 1989, THESIS; Nausch N, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-165; Ochodo EA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009579.pub2; Shane HL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000951; Sousa-Figueiredo JC, 2010, INT HEALTH, V2, P103, DOI 10.1016/j.inhe.2010.02.003; Stothard JR, 2009, ACTA TROP, V111, P64, DOI 10.1016/j.actatropica.2009.02.009; Tchuente LAT, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001758; The Gambia Ministry of Health and Social Welfare, 2014, NEGL TROP DIS SIT AN; WHA, 2012, 6521 WHA; WHO, 2010, WORKING TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: FIRST WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1; WHO, 2012, WKLY EPIDEMIOL REC, V87, P33; WHO, 2012, ACC WORK OV GLOB IMP, P13; WHO, 2011, WHO REP M REV RES ST; WILKINS HA, 1984, T ROY SOC TROP MED H, V78, P216, DOI 10.1016/0035-9203(84)90281-5	25	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182003	10.1371/journal.pone.0182003	http://dx.doi.org/10.1371/journal.pone.0182003			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797128	Green Published, Green Submitted, gold			2022-12-26	WOS:000407396200024
J	Shivani; Awasthi, P; Sharma, V; Kaur, N; Kaur, N; Pandey, P; Tiwari, S				Shivani; Awasthi, Praveen; Sharma, Vikrant; Kaur, Navjot; Kaur, Navneet; Pandey, Pankaj; Tiwari, Siddharth			Genome-wide analysis of transcription factors during somatic embryogenesis in banana (Musa spp.) cv. Grand Naine	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; SHOOT APICAL MERISTEM; BABY-BOOM; CELL SUSPENSIONS; COTYLEDON GENES; WUSCHEL GENE; MALE FLOWER; ARABIDOPSIS; EXPRESSION; EMBRYO	Transcription factors BABY BOOM (BBM), WUSCHEL (WUS), BSD, LEAFY COTYLEDON (LEC), LEAFY COTYLEDON LIKE (LIL), VIVIPAROUS1 (VP1), CUP SHAPED COTYLEDONS (CUC), BOLITA (BOL), and AGAMOUS LIKE (AGL) play a crucial role in somatic embryogenesis. In this study, we identified eighteen genes of these nine transcription factors families from the banana genome database. All genes were analyzed for their structural features, subcellular, and chromosomal localization. Protein sequence analysis indicated the presence of characteristic conserved domains in these transcription factors. Phylogenetic analysis revealed close evolutionary relationship among most transcription factors of various monocots. The expression patterns of eighteen genes in embryogenic callus containing somatic embryos (precisely isolated by Laser Capture Microdissection), nonembryogenic callus, and cell suspension cultures of banana cultivar Grand Naine were analyzed. The application of 2, 4-dichlorophenoxyacetic acid (2, 4-D) in the callus induction medium enhanced the expression of MaBBM1, MaBBM2, MaWUS2, and MaVP1 in the embryogenic callus. It suggested 2, 4-D acts as an inducer for the expression of these genes. The higher expression of MaBBM2 and MaWUS2 in embryogenic cell suspension (ECS) as compared to non-embryogenic cells suspension (NECS), suggested that these genes may play a crucial role in banana somatic embryogenesis. MaVP1 showed higher expression in both ECS and NECS, whereas MaLEC2 expression was significantly higher in NECS. It suggests that MaLEC2 has a role in the development of non-embryogenic cells. We postulate that MaBBM2 and MaWUS2 can be served as promising molecular markers for the embryogencity in banana.	[Shivani; Awasthi, Praveen; Sharma, Vikrant; Kaur, Navjot; Kaur, Navneet; Pandey, Pankaj; Tiwari, Siddharth] Natl Agri Food Biotechnol Inst NABI, Dept Biotechnol, Minist Sci & Technol Govt India, Mohali, Punjab, India; [Shivani; Kaur, Navneet] Panjab Univ, Dept Biotechnol, Chandigarh, India	Department of Biotechnology (DBT) India; National Agri Food Biotechnology Institute (NABI); Panjab University	Tiwari, S (corresponding author), Natl Agri Food Biotechnol Inst NABI, Dept Biotechnol, Minist Sci & Technol Govt India, Mohali, Punjab, India.	siddharthdna20@yahoo.com	Tiwari, Siddharth/V-3054-2017; Awasthi, Praveen/X-5765-2019; Tiwari, Siddharth/AAC-5135-2020	Tiwari, Siddharth/0000-0003-3958-8465; Awasthi, Praveen/0000-0003-3196-3427; Tiwari, Siddharth/0000-0003-3958-8465; Kaur, Navjot/0000-0001-8317-7132	National Agri-Food Biotechnology Institute (NABI), Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India; NABI CORE Research Grant; BIRAC for Banana Biofortification Project; Biotechnology Industry Research Assistance Council (BIRAC)	National Agri-Food Biotechnology Institute (NABI), Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India; NABI CORE Research Grant; BIRAC for Banana Biofortification Project; Biotechnology Industry Research Assistance Council (BIRAC)	The research was supported by National Agri-Food Biotechnology Institute (NABI), Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India for research facility. This study was funded by NABI CORE Research Grant and supported by BIRAC for Banana Biofortification Project to Dr Siddharth Tiwari. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The research was supported by National Agri-Food Biotechnology Institute (NABI), Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India for grant and research facility. Authors are thankful to Biotechnology Industry Research Assistance Council (BIRAC) for banana biofortification project grant to NABI. S and NK are thankful to Department of Biotechnology, Panjab University Chandigarh for Ph.D. registration.	Abdellatif KF., 2012, J GENET ENG BIOTECHN, V10, P47, DOI [10.1016/j.jgeb.2012.05.002, DOI 10.1016/J.JGEB.2012.05.002]; Alemanno L, 2008, PLANTA, V227, P853, DOI 10.1007/s00425-007-0662-4; Bairu MW, 2011, PLANT GROWTH REGUL, V63, P147, DOI 10.1007/s10725-010-9554-x; BJELLQVIST B, 1994, ELECTROPHORESIS, V15, P529, DOI 10.1002/elps.1150150171; Boutilier K, 2002, PLANT CELL, V14, P1737, DOI 10.1105/tpc.001941; Brady SM, 2003, PLANT J, V34, P67, DOI 10.1046/j.1365-313X.2003.01707.x; Braybrook SA, 2006, P NATL ACAD SCI USA, V103, P3468, DOI 10.1073/pnas.0511331103; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cote FX, 1996, PHYSIOL PLANTARUM, V97, P285, DOI 10.1034/j.1399-3054.1996.970211.x; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; Daimon Y, 2003, PLANT CELL PHYSIOL, V44, P113, DOI 10.1093/pcp/pcg038; Dey T, 2015, S AFR J BOT, V96, P112, DOI 10.1016/j.sajb.2014.10.010; Doerks T, 2002, TRENDS BIOCHEM SCI, V27, P168, DOI 10.1016/S0968-0004(01)02042-4; El Ouakfaoui S, 2010, PLANT MOL BIOL, V74, P313, DOI 10.1007/s11103-010-9674-8; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Florez SL, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0479-4; Footitt S, 2003, J EXP BOT, V54, P1711, DOI 10.1093/jxb/erg178; Gaj MD, 2005, PLANTA, V222, P977, DOI 10.1007/s00425-005-0041-y; Ganapathi TR, 1999, CURR SCI INDIA, V76, P1228; Ganapathi TR, 2001, PLANT CELL REP, V20, P157, DOI 10.1007/s002990000287; Gautam V, 2016, SCI REP-UK, V6, DOI 10.1038/srep21577; Ghosh A, 2009, PLANT CELL TISS ORG, V97, P131, DOI 10.1007/s11240-009-9507-0; Grapin A, 1996, IN VITRO CELL DEV-PL, V32, P66; Gruszczynska A, 2011, J APPL GENET, V52, P1, DOI 10.1007/s13353-010-0015-z; Heidmann I, 2011, PLANT CELL REP, V30, P1107, DOI 10.1007/s00299-011-1018-x; Hibara K, 2006, PLANT CELL, V18, P2946, DOI 10.1105/tpc.106.045716; Hussein Sobri, 2006, Iranian Journal of Biotechnology, V4, P156; Ikeda Y, 2006, PLANT CELL PHYSIOL, V47, P1443, DOI 10.1093/pcp/pcl023; Ikeda-Iwai M, 2002, J EXP BOT, V53, P1575, DOI 10.1093/jxb/erf006; Jaiswal P, 2011, METHODS MOL BIOL, V678, P247, DOI 10.1007/978-1-60761-682-5_18; Jones HD, 2000, PLANT J, V21, P133, DOI 10.1046/j.1365-313x.2000.00662.x; Kaur N, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00462; Khalil SM, 2004, ARAB J BIOTECHNOL, V7, P99; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumaravel M, 2017, PLANT CELL REP, V36, P163, DOI 10.1007/s00299-016-2067-y; Kwong RW, 2003, PLANT CELL, V15, P5, DOI 10.1105/tpc.006973; Larsson E, 2012, ANN BOT-LONDON, V110, P923, DOI 10.1093/aob/mcs151; Laux T, 1996, DEVELOPMENT, V122, P87; Lowe K, 2016, PLANT CELL, V28, P1998, DOI 10.1105/tpc.16.00124; Magnard JL, 2000, PLANT MOL BIOL, V44, P559, DOI 10.1023/A:1026521506952; Mahdavi-Darvari F, 2015, PLANT CELL TISS ORG, V120, P407, DOI 10.1007/s11240-014-0615-0; Maldonado-Borges JI, 2013, SCI WORLD J, V2013, P1; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Marsch-Martinez N, 2006, PLANT MOL BIOL, V62, P825, DOI 10.1007/s11103-006-9059-1; Motte H, 2011, J PLANT PHYSIOL, V168, P1598, DOI 10.1016/j.jplph.2011.02.014; Pandey A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00020; Park J, 2009, J PLANT BIOL, V52, P141, DOI 10.1007/s12374-009-9015-0; Passarinho P, 2008, PLANT MOL BIOL, V68, P225, DOI 10.1007/s11103-008-9364-y; Perry SE, 1999, PLANT PHYSIOL, V120, P121, DOI 10.1104/pp.120.1.121; Rohit Joshi, 2013, Agricultural Reviews, V34, P1; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shiu SH, 2005, PLANT PHYSIOL, V139, P18, DOI 10.1104/pp.105.065110; Singh HP, 2011, ASIA PACIFIC CONSORT, P92; Srinivasan C, 2007, PLANTA, V225, P341, DOI 10.1007/s00425-006-0358-1; Stone SL, 2001, P NATL ACAD SCI USA, V98, P11806, DOI 10.1073/pnas.201413498; Su YH, 2009, PLANT J, V59, P448, DOI 10.1111/j.1365-313X.2009.03880.x; Suzuki M, 2001, PLANT J, V28, P409, DOI 10.1046/j.1365-313X.2001.01165.x; Takada S, 2001, DEVELOPMENT, V128, P1127; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thakare D, 2008, PLANT PHYSIOL, V146, P1663, DOI 10.1104/pp.108.115832; Tripathi JN, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01025; van der Graaff E, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-248; Vroemen CW, 2003, PLANT CELL, V15, P1563, DOI 10.1105/tpc.012203; Wirakarnain S., 2008, American Journal of Biochemistry and Biotechnology, V4, P325, DOI 10.3844/ajbbsp.2008.325.328; Xu C.X., 2008, INT J PLANT DEV BIOL, V2, P52; Xu YY, 2005, PLANT MOL BIOL, V57, P773, DOI 10.1007/s11103-005-0952-9; Yadav RK, 2011, GENE DEV, V25, P2025, DOI 10.1101/gad.17258511; Yazawa K, 2004, PLANT PHYSIOL BIOCH, V42, P215, DOI 10.1016/j.plaphy.2003.12.003; Zeller R, 2001, CURR PROTOC MOL BIO, V17; Zhai L, 2016, SCI REP-UK, V6, DOI 10.1038/srep21652; Zheng QL, 2013, PLANT PHYSIOL, V161, P2113, DOI 10.1104/pp.113.216275; Zimmermann R, 2005, PLANT MOL BIOL, V58, P669, DOI 10.1007/s11103-005-7702-x; Zuo JR, 2002, PLANT J, V30, P349, DOI 10.1046/j.1365-313X.2002.01289.x	73	25	27	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182242	10.1371/journal.pone.0182242	http://dx.doi.org/10.1371/journal.pone.0182242			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797040	Green Published, gold, Green Submitted			2022-12-26	WOS:000407396200039
J	Tappa, K; Jammalamadaka, U; Ballard, DH; Bruno, T; Israel, MR; Vemula, H; Meacham, JM; Mills, DK; Woodard, PK; Weisman, JA				Tappa, Karthik; Jammalamadaka, Udayabhanu; Ballard, David H.; Bruno, Todd; Israel, Marissa R.; Vemula, Harika; Meacham, J. Mark; Mills, David K.; Woodard, Pamela K.; Weisman, Jeffery A.			Medication eluting devices for the field of OBGYN (MEDOBGYN): 3D printed biodegradable hormone eluting constructs, a proof of concept study	PLOS ONE			English	Article								3D printing has the potential to deliver personalized implants and devices for obstetric and gynecologic applications. The aim of this study is to engineer customizable and biodegradable 3D printed implant materials that can elute estrogen and/or progesterone. All 3D constructs were printed using polycaprolactone (PCL) biodegradable polymer laden with estrogen or progesterone and were subjected to hormone-release profile studies using ELISA kits. Material thermal properties were tested using thermogravimetric analysis and differential scanning calorimetry. The 3D printed constructs showed extended hormonal release over a one week period. Cytocompatibility and bioactivity were assessed using a luciferase assay. The hormone-laden 3D printed constructs demonstrated an increase in luciferase activity and without any deleterious effects. Thermal properties of the PCL and hormones showed degradation temperatures above that of the temperature used in the additive manufacturing process-suggesting that 3D printing can be achieved below the degradation temperatures of the hormones. Sample constructs in the shape of surgical meshes, subdermal rods, intrauterine devices and pessaries were designed and printed. 3D printing of estrogen and progesterone-eluting constructs was feasible in this proof of concept study. These custom designs have the potential to act as a form of personalized medicine for drug delivery and optimized fit based on patient-specific anatomy.	[Tappa, Karthik; Jammalamadaka, Udayabhanu; Ballard, David H.; Woodard, Pamela K.] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, St Louis, MO USA; [Bruno, Todd] Louisiana State Univ Hlth Shreveport, Dept Obstet & Gynecol, Shreveport, LA USA; [Israel, Marissa R.] St Louis Univ Hosp, Dept Pharm, St Louis, MO USA; [Vemula, Harika] Univ Missouri, Pharmaceut Sci & Chem, Kansas City, MO 64110 USA; [Meacham, J. Mark] Washington Univ, Dept Mech Engn & Mat Sci, St Louis, MO USA; [Mills, David K.] Louisiana Tech Univ, Dept Biomed Engn, Ruston, LA 71272 USA; [Weisman, Jeffery A.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA	Washington University (WUSTL); Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Saint Louis University; University of Missouri System; University of Missouri Kansas City; Washington University (WUSTL); University of Louisiana System; Louisiana Technical University; Washington University (WUSTL)	Weisman, JA (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.	jweisman@wustl.edu	Mills, David/GXF-1821-2022; Vemula, Harika/AAV-1762-2021; Mills, David/H-1414-2012; Tappa, Karthik/J-6354-2019; Ballard, David/P-5700-2018; Woodard, Pamela/AAC-3892-2020; Jammalamadaka, Udayabhanu/AAC-2463-2019	Mills, David/0000-0002-6489-4520; Tappa, Karthik/0000-0002-9857-8665; Ballard, David/0000-0001-7470-3364; Jammalamadaka, Udayabhanu/0000-0002-2913-0031; Meacham, John/0000-0002-3124-0707				Ballard DH, 2017, SURGERY, V161, P1479, DOI 10.1016/j.surg.2016.08.033; Banks J, 2013, IEEE PULSE, V4, P22, DOI 10.1109/MPUL.2013.2279617; Cui Xiaofeng, 2012, Recent Pat Drug Deliv Formul, V6, P149; Duan B, 2013, J BIOMED MATER RES A, V101, P1255, DOI 10.1002/jbm.a.34420; Edelman D, 1979, INTRAUTERINE DEVICES; Espey E, 2011, OBSTET GYNECOL, V117, P705, DOI 10.1097/AOG.0b013e31820ce2f0; Gross BC, 2014, ANAL CHEM, V86, P3240, DOI 10.1021/ac403397r; Hakim J, 2015, J PEDIATR ADOL GYNEC, V28, pe67; Jelovsek JE, 2007, LANCET, V369, P1027, DOI 10.1016/S0140-6736(07)60462-0; Kailasam Chandra, 2008, Patient Prefer Adherence, V2, P293; Laronda MM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15261; Mellis K., 2015, J APPL CLIN MED PHYS, V16, P5168, DOI [10.1120/jacmp.v16i1.5168, DOI 10.1120/JACMP.V16I1.5168]; Mertz L, 2013, IEEE PULSE, V4, P15, DOI 10.1109/MPUL.2013.2279616; Programme UND, 2017, CONTRACEPTION, V56, P341; Ricotti R, 2016, PHYS MEDICA, V32, P1698, DOI 10.1016/j.ejmp.2016.08.016; Roehl Barbara, 2006, Care Manag J, V7, P213, DOI 10.1891/cmj-v7i4a007; Sethi R, 2016, J CONTEMP BRACHYTHER, V8, P210, DOI 10.5114/jcb.2016.60679; Tudela F, 2016, OBSTET GYNECOL, V127, p154S, DOI 10.1097/01.AOG.0000483614.84976.50; Weisman JA, 2015, J VASC INTERV RADIOL, V26, pS12; Weisman Jeffery A, 2015, Int J Nanomedicine, V10, P357, DOI 10.2147/IJN.S74811	20	54	57	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							0182929	10.1371/journal.pone.0182929	http://dx.doi.org/10.1371/journal.pone.0182929			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797120	Green Submitted, Green Published, gold			2022-12-26	WOS:000407396200126
J	Iuchi, T; Kobayashi, M; Tsuchiya, S; Ohno, N; Dai, M; Matsumoto, M; Ogai, K; Sato, A; Sawazaki, T; Miyati, T; Tanaka, S; Sugama, J				Iuchi, Terumi; Kobayashi, Masato; Tsuchiya, Sayumi; Ohno, Naoki; Dai, Misako; Matsumoto, Masaru; Ogai, Kazuhiro; Sato, Aya; Sawazaki, Takuto; Miyati, Tosiaki; Tanaka, Shinobu; Sugama, Junko			Objective assessment of leg edema using ultrasonography with a gel pad	PLOS ONE			English	Article							LYMPHEDEMA; RELIABILITY	Ultrasonography (US) is useful for visual detection of edematous tissues to assess subcutaneous echogenicity. However, visualization of subcutaneous echogenicity is interpreted differently among operators because the evaluation is subjective and individual operators have unique knowledge. This study objectively assessed leg edema using US with a gel pad including fat for normalization of echogenicity in subcutaneous tissue. Five younger adults and four elderly people with leg edema were recruited. We compared assessments of US and limb circumference before and after the intervention of vibration to decrease edema in younger adults, and edema prior to going to sleep and reduced edema in the early morning in elderly people. These assessments were performed twice in elderly people by three operators and reliability, interrater differences, and bias were assessed. For US assessment, echogenicity in subcutaneous tissue was normalized to that of the gel pad by dividing the mean echogenicity of subcutaneous tissue by the mean echogenicity of the gel pad. In younger adults, the normalized subcutaneous echogenicity before the intervention was significantly higher than that after the intervention. In elderly people, echogenicity indicating edema was significantly higher than that after edema reduction. Edema was detected with accuracy rates of 76.9% in younger adults and 75.0% in elderly people. Meanwhile, limb circumference could be used to detect edema in 50.0% of healthy adults and 87.8% of elderly people. The intra-reliability was excellent (intraclass correlation coefficient > 0.9, p < 0.01), and the inter-reliability was good (intraclass correlation coefficient > 0.7, p < 0.01) for normalized subcutaneous echogenicity. Bland-Altman plots revealed that inter-rater differences and systematic bias were small. Normalized subcutaneous echogenicity with the pad can sensitively and objectively assess leg edema with high reliability. Therefore, this method has the potential to become a new gold standard for objective assessment of leg edema in clinical practice.	[Iuchi, Terumi; Ohno, Naoki; Dai, Misako; Matsumoto, Masaru; Miyati, Tosiaki] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Fac Hlth Sci, Kanazawa, Ishikawa, Japan; [Iuchi, Terumi; Kobayashi, Masato; Ohno, Naoki; Matsumoto, Masaru; Ogai, Kazuhiro; Miyati, Tosiaki; Sugama, Junko] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Wellness Promot Sci Ctr, Kanazawa, Ishikawa, Japan; [Tsuchiya, Sayumi; Sawazaki, Takuto] Kanazawa Univ, Grad Sch Med Sci, Div Hlth Sci, Kanazawa, Ishikawa, Japan; [Sato, Aya] Fukui Prefecture Univ, Fac Nursing & Social Welf Sci, Fukui, Japan; [Tanaka, Shinobu] Kanazawa Univ, Fac Mech Engn, Inst Sci & Engn, Kanazawa, Ishikawa, Japan; [Sugama, Junko] Kanazawa Univ, Inst Frontier Sci Initiat, Kanazawa, Ishikawa, Japan; [Matsumoto, Masaru] Univ Tokyo, Grad Sch Med, Visionary Innovat Nursing, Tokyo, Japan	Kanazawa University; Kanazawa University; Kanazawa University; Fukui Prefectural University; Kanazawa University; Kanazawa University; University of Tokyo	Kobayashi, M (corresponding author), Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Wellness Promot Sci Ctr, Kanazawa, Ishikawa, Japan.	kobayasi@mhs.mp.kanazawa-u.ac.jp	; Matsumoto, Masaru/C-3221-2015	Miyati, Tosiaki/0000-0001-6120-2990; Matsumoto, Masaru/0000-0003-0246-395X	Japan Society for the Promotion of Science [26293444, 26670919, 15K09949]; Suzuken Memorial Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Suzuken Memorial Foundation	This study was partly supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (Nos. 26293444, 26670919, and 15K09949) and the Suzuken Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge Ms. Akemi Yamashita for the collection of the data for this study. This study was partly supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (Nos. 26293444, 26670919, and 15K09949) and the Suzuken Memorial Foundation.	ABUOWN A, 1994, J VASC SURG, V20, P705, DOI 10.1016/S0741-5214(94)70157-1; Chen YW, 2008, AM J PHYS MED REHAB, V87, P33, DOI 10.1097/PHM.0b013e31815b6199; Dai M, 2013, J TSURUMA HLTH SCI S, V37, P13; Dix FP, 2003, EUR J VASC ENDOVASC, V25, P556, DOI 10.1053/ejvs.2002.1885; Fujiwara Y., 2011, MEDIX, V55, P40; Oremus M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-6; Perdomo M, 2014, REHABIL ONCOL, V32, P22, DOI 10.1097/01893697-201432010-00005; Sanada H, 2014, BIOENGINEERING NURSI, P173; Sato A., 2015, J TSURUMA HLTH SCI S, V39, P63; Stewart JM, 2005, AM J PHYSIOL-REG I, V288, pR623, DOI 10.1152/ajpregu.00513.2004; Suehiro K, 2017, J VASC SURG-VENOUS L, V5, P96, DOI 10.1016/j.jvsv.2016.07.006; Suehiro K, 2014, CIRC J, V78, P1733, DOI 10.1253/circj.CJ-13-1599; Tassenoy A, 2011, PHYSIOTHERAPY, V97, P234, DOI 10.1016/j.physio.2010.08.003; Taylor R, 2006, PHYS THER, V86, P205, DOI 10.1093/ptj/86.2.205; Ueda-Iuchi T, 2015, SAGE OPEN MED, V3, DOI 10.1177/2050312115613351; Warren AG, 2007, ANN PLAS SURG, V58, P541, DOI 10.1097/01.sap.0000244977.84130.cf	16	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182042	10.1371/journal.pone.0182042	http://dx.doi.org/10.1371/journal.pone.0182042			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28792959	gold, Green Submitted, Green Published			2022-12-26	WOS:000407196700030
J	Talbot, JJ; Houbraken, J; Frisvad, JC; Samson, RA; Kidd, SE; Pitt, J; Lindsay, S; Beatty, JA; Barrs, VR				Talbot, Jessica J.; Houbraken, Jos; Frisvad, Jens C.; Samson, Robert A.; Kidd, Sarah E.; Pitt, John; Lindsay, Sue; Beatty, Julia A.; Barrs, Vanessa R.			Discovery of Aspergillus frankstonensis sp nov during environmental sampling for animal and human fungal pathogens	PLOS ONE			English	Article							INVASIVE ASPERGILLOSIS; POLYPHASIC TAXONOMY; SECTION FUMIGATI; FELINE SINONASAL; AZOLE RESISTANCE; SOIL; NEOSARTORYA; IDENTIFICATION; VIRIDINUTANS; FISCHERI	Invasive fungal infections (IFI) due to species in Aspergillus section Fumigati (ASF), including the Aspergillus viridinutans species complex (AVSC), are increasingly reported in humans and cats. The risk of exposure to these medically important fungi in Australia is unknown. Air and soil was sampled from the domiciles of pet cats diagnosed with these IFI and from a nature reserve in Frankston, Victoria, where Aspergillus viridinutans sensu stricto was discovered in 1954. Of 104 ASF species isolated, 61% were A. fumigatus sensu stricto, 9% were AVSC (A. felis-clade and A. frankstonensis sp. nov.) and 30% were other species (30%). Seven pathogenic ASF species known to cause disease in humans and animals (A. felis-clade, A. fischeri, A. thermomutatus, A. lentulus, A. laciniosus A. fumisynne-matus, A. hiratsukae) comprised 25% of isolates overall. AVSC species were only isolated from Frankston soil where they were abundant, suggesting a particular ecological niche. Phylogenetic, morphological and metabolomic analyses of these isolates identified a new species, A. frankstonensis that is phylogenetically distinct from other AVSC species, hetero-thallic and produces a unique array of extrolites, including the UV spectrum characterized compounds DOLD, RAIMO and CALBO. Shared morphological and physiological characteristics with other AVSC species include slow sporulation, optimal growth at 37 degrees C, no growth at 50 degrees C, and viriditoxin production. Overall, the risk of environmental exposure to pathogenic species in ASF in Australia appears to be high, but there was no evidence of direct environmental exposure to AVSC species in areas where humans and cats cohabitate.	[Talbot, Jessica J.; Beatty, Julia A.; Barrs, Vanessa R.] Univ Sydney, Fac Sci, Sydney Sch Vet Sci, Camperdown, NSW, Australia; [Houbraken, Jos; Samson, Robert A.] Westerdijk Fungal Biodivers Inst, Utrecht, Netherlands; [Frisvad, Jens C.] Tech Univ Denmark, Dept Biotechnol & Biomed, Lyngby, Denmark; [Kidd, Sarah E.] SA Pathol, Natl Mycol Reference Ctr, Microbiol & Infect Dis, Adelaide, SA, Australia; [Pitt, John] CSIRO, CSIRO Food Sci, N Ryde, NSW, Australia; [Lindsay, Sue] Macquarie Univ, Fac Sci & Engn, N Ryde, NSW, Australia	University of Sydney; Technical University of Denmark; SA Pathology; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Macquarie University	Barrs, VR (corresponding author), Univ Sydney, Fac Sci, Sydney Sch Vet Sci, Camperdown, NSW, Australia.	vanessa.barrs@sydney.edu.au	Houbraken, Jos/AAE-7955-2019; Samson, Robert/ABE-6704-2020; Kidd, Sarah E./A-1731-2009; Frisvad, Jens C/K-2818-2017	Houbraken, Jos/0000-0003-4893-4438; Kidd, Sarah E./0000-0002-5957-4178; Frisvad, Jens C/0000-0002-0573-4340; Barrs, Vanessa/0000-0001-6761-8022; Samson, Robert A./0000-0002-2979-3097; Beatty, Julia/0000-0001-6520-7801	Australian Endeavour Research Fellowship; Thomson Fellowship; University of Sydney Compacts Grant	Australian Endeavour Research Fellowship(Australian GovernmentDepartment of Industry, Innovation and Science); Thomson Fellowship; University of Sydney Compacts Grant	This work was funded by an Australian Endeavour Research Fellowship (JT), a Thomson Fellowship (VB) and a University of Sydney Compacts Grant (VB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alastruey-Izquierdo A, 2013, ANTIMICROB AGENTS CH, V57, P3380, DOI 10.1128/AAC.00383-13; Alvarez-Perez S, 2014, J MED MICROBIOL, V63, P617, DOI 10.1099/jmm.0.068502-0; Balajee SA, 2009, J CLIN MICROBIOL, V47, P3138, DOI 10.1128/JCM.01070-09; Barrs VR, 2014, VET J, V201, P215, DOI 10.1016/j.tvjl.2014.02.020; Barrs VR, 2012, VET J, V191, P58, DOI 10.1016/j.tvjl.2011.02.009; Barrs VR, 2014, VET CLIN N AM-SMALL, V44, P51, DOI 10.1016/j.cvsm.2013.08.001; Barrs VR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064871; Coelho D, 2011, MED MYCOL, V49, P755, DOI 10.3109/13693786.2011.556672; ELDRIDGE DJ, 1994, AUST J SOIL RES, V32, P389, DOI 10.1071/SR9940389; Escribano P, 2013, ANTIMICROB AGENTS CH, V57, P2815, DOI 10.1128/AAC.02487-12; Frisvad JC, 2004, STUD MYCOL, P1; Frisvad JC, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01485; Furrow E, 2009, JAVMA-J AM VET MED A, V235, P1188, DOI 10.2460/javma.235.10.1188; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Gomes NM, 2014, MAR DRUGS, V12, P822, DOI 10.3390/md12020822; Goncalves VN, 2016, ENVIRON MICROBIOL, V18, P232, DOI 10.1111/1462-2920.13005; GREENE RSB, 1990, AUST J SOIL RES, V28, P755, DOI 10.1071/SR9900755; HOCKING AD, 2009, FUNGI FOOD SPOILAGE; Hong SB, 2008, ANTON LEEUW INT J G, V93, P87, DOI 10.1007/s10482-007-9183-1; Hong SB, 2005, MYCOLOGIA, V97, P1316, DOI 10.3852/mycologia.97.6.1316; Houbraken J, 2006, ADV EXP MED BIOL, V571, P107, DOI 10.1007/0-387-28391-9_5; Kano R, 2015, J VET MED SCI, V77, P1183, DOI 10.1292/jvms.14-0454; Kidd SE, 2009, INFECT CONT HOSP EP, V30, P1223, DOI 10.1086/648452; Matsuzawa T, 2015, MYCOSCIENCE, V56, P123, DOI 10.1016/j.myc.2014.04.006; McLENNAN ETHEL I., 1954, AUSTRALIAN JOUR BOT, V2, P355, DOI 10.1071/BT9540355; National Center for Biotechnology Information, 2016, BAS LOC AL SEARCH TO; Negri CE, 2014, J CLIN MICROBIOL, V52, P3633, DOI 10.1128/JCM.01582-14; Ni M, 2011, ANNU REV GENET, V45, P405, DOI 10.1146/annurev-genet-110410-132536; Nielsen ML, 2011, FEMS MICROBIOL LETT, V321, P157, DOI 10.1111/j.1574-6968.2011.02327.x; Novakova A, 2014, FUNGAL DIVERS, V64, P253, DOI 10.1007/s13225-013-0262-5; O'Gorman CM, 2009, NATURE, V457, P471, DOI 10.1038/nature07528; Panda A, 2015, J MICROBIOL METH, V109, P93, DOI 10.1016/j.mimet.2014.12.014; Pelaez T, 2013, J MED MICROBIOL, V62, P474, DOI 10.1099/jmm.0.044867-0; Pildain MB, 2008, INT J SYST EVOL MICR, V58, P725, DOI 10.1099/ijs.0.65123-0; Ronquist F., MRBAYES VERSION 3 2; Sabino R, 2014, MED MYCOL, V52, P517, DOI 10.1093/mmy/myu006; Samson RA, 2007, STUD MYCOL, P147, DOI 10.3114/sim.2007.59.14; Samson RA, 2010, FOOD INDOOR FUNGI; Smedsgaard J, 1997, J CHROMATOGR A, V760, P264, DOI 10.1016/S0021-9673(96)00803-5; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sugui JA, 2014, J CLIN MICROBIOL, V52, P3707, DOI 10.1128/JCM.01704-14; Sylvain ZA, 2011, AM J BOT, V98, P517, DOI 10.3732/ajb.1000305; Talbot JJ, 2015, COMP IMMUNOL MICROB, V42, P37, DOI 10.1016/j.cimid.2015.08.002; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vinh DC, 2009, CLIN INFECT DIS, V49, P102, DOI 10.1086/599345; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Whitney BL, 2005, J FELINE MED SURG, V7, P53, DOI 10.1016/j.jfms.2004.02.004; Whitney JL, 2016, J COMP PATHOL, V155, P130, DOI 10.1016/j.jcpa.2016.08.001	48	11	11	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0181660	10.1371/journal.pone.0181660	http://dx.doi.org/10.1371/journal.pone.0181660			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28792943	Green Published, gold, Green Submitted			2022-12-26	WOS:000407196700017
J	Xie, J; Hsieh, E; Sun, MQ; Wang, HL; Lv, W; Fan, HW; Li, TS				Xie, Jing; Hsieh, Evelyn; Sun, Meng-qing; Wang, Huan-ling; Lv, Wei; Fan, Hong-wei; Li, Tai-sheng			Delays in HIV diagnosis and associated factors among patients presenting with advanced disease at a tertiary care hospital in Beijing, China	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT; UNDIAGNOSED HIV; INFECTION; INITIATION; THERAPY; VIRUS	Delayed diagnosis of HIV infection is associated with advanced immunosuppression and increased risk of onward transmission. Little data exists regarding factors associated with diagnostic delays among patients presenting with advanced HIV disease in China. Medical records of patients with HIV/AIDS hospitalized at a 2000-bed tertiary hospital in Beijing, China between 1997 and 2012 were retrospectively reviewed. Demographic and clinical data of patients newly diagnosed with HIV at the hospital were abstracted. Patient characteristics, disease parameters, and the time interval between the first medical visit and the visit leading to HIV diagnosis were compared among three periods: 1997-2002, 2003-2008 and 2009-2012. Chi-square, Kruskal-Wallis and logistic regression analyses were used as appropriate. A quarter of patients (72/279) were newly diagnosed with HIV at the hospital, consisting of 11, 29 and 32 patients in 1997-2002, 2003-2008 and 2009-2012 respectively. The median time delay between the first medical visit and the visit leading to HIV diagnosis decreased over time from 91 days among patients diagnosed before 2002, to 75 days between 2003 to 2008, and 39 days after 2009 (p = 0.036). However, the median CD4(+)T cell count at diagnosis was 26 cells/mu L [interquartile range 3-132 cells/mu L] in 1997-2002, and remained unchanged across time intervals. Forty-one (57%) patients had AIDS-defining conditions and Pneumocystis jiroveci pneumonia was the most common opportunistic infection (31 cases). These results reveal persistent missed opportunities for timely HIV testing among patients with advanced disease. Strategies for promoting early HIV testing in healthcare settings are needed in China.	[Xie, Jing; Wang, Huan-ling; Lv, Wei; Fan, Hong-wei; Li, Tai-sheng] Beijing Union Med Coll Hosp, Peking Union Med Coll, Dept Infect Dis, Beijing, Peoples R China; [Xie, Jing; Wang, Huan-ling; Lv, Wei; Fan, Hong-wei; Li, Tai-sheng] Chinese Acad Med Sci, Beijing, Peoples R China; [Xie, Jing; Li, Tai-sheng] Chinese Acad Med Sci, Clin Immunol Ctr, Beijing, Peoples R China; [Hsieh, Evelyn] Yale Sch Med, Sect Rheumatol, New Haven, CT USA; [Sun, Meng-qing] Beijing Union Med Coll Hosp, Peking Union Med Coll, Dept Surg, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Yale University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital	Li, TS (corresponding author), Beijing Union Med Coll Hosp, Peking Union Med Coll, Dept Infect Dis, Beijing, Peoples R China.; Li, TS (corresponding author), Chinese Acad Med Sci, Beijing, Peoples R China.; Li, TS (corresponding author), Chinese Acad Med Sci, Clin Immunol Ctr, Beijing, Peoples R China.	litsh@263.net		Hsieh, Evelyn/0000-0001-5018-8409; , Jing/0000-0002-9115-8895	Chinese National Key Technologies R&D Program for the 12th Five-year Plan [2012ZX10001003-001, 2014ZX10001001-001-005, 2013ZX10001002-001-001]; PUMCH Research Foundation for Young Investigators [pumch-2016-2.3]; International Research Scientist Development Award of the National Institutes of Health/Fogarty International Center [1K01TW009995-01A1]; Chinese Ministry of Human Resources and Social Security; FOGARTY INTERNATIONAL CENTER [K01TW009995] Funding Source: NIH RePORTER	Chinese National Key Technologies R&D Program for the 12th Five-year Plan; PUMCH Research Foundation for Young Investigators; International Research Scientist Development Award of the National Institutes of Health/Fogarty International Center; Chinese Ministry of Human Resources and Social Security; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the Chinese National Key Technologies R&D Program for the 12th Five-year Plan (grant number 2012ZX10001003-001 to TL, 2014ZX10001001-001-005 to HW, 2013ZX10001002-001-001 to WL). JX is funded by the PUMCH Research Foundation for Young Investigators (pumch-2016-2.3). EH is supported by the International Research Scientist Development Award (1K01TW009995-01A1) of the National Institutes of Health/Fogarty International Center. HW was supported by the grant of Chinese Ministry of Human Resources and Social Security (2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Centers for Disease Control and Prevention, HIV SURVEILLANCE SUP, V21; Cheng W, 2008, BIOMED RES INT; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Fleishman JA, 2010, MED CARE, V48, P1071, DOI 10.1097/MLR.0b013e3181f81c4a; Grinsztejn B, 2014, LANCET INFECT DIS, V14, P281, DOI 10.1016/S1473-3099(13)70692-3; He X., 2012, INT J ANTENN PROPAG, V2012, P1, DOI DOI 10.1371/J0URNAL.P0NE.0047289; Kuo AM, 2005, AIDS PATIENT CARE ST, V19, P239, DOI 10.1089/apc.2005.19.239; Li YJ, 2014, AIDS, V28, P521, DOI 10.1097/QAD.0000000000000125; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Mayer KH, 2012, JAIDS-J ACQ IMM DEF, V59, P194, DOI 10.1097/QAI.0b013e31823bbecf; Mocroft A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001510; National Health and Family Planning Commission of the People's Republic of China, 2015 CHIN AIDA RESP; Ng OT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015738; O'Connell S, 2016, INT J STD AIDS; Senard O, 2016, AIDS RES HUM RETROVI; Tominski D, 2016, HIV MED; Tucker JD, 2012, AIDS CARE, V24, P1316, DOI 10.1080/09540121.2012.661835; Tucker JD, 2012, SEX TRANSM INFECT, V88, P116, DOI 10.1136/sextrans-2011-050135; Wang QQ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-955; Wang XW, 2010, INT J TUBERC LUNG D, V14, P921; World Health Organization, 2007, GUID PROV IN HIV TES; Zhang FJ, 2014, LANCET INFECT DIS, V14, P1065, DOI 10.1016/S1473-3099(14)70946-6; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4	23	7	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182335	10.1371/journal.pone.0182335	http://dx.doi.org/10.1371/journal.pone.0182335			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28793312	Green Published, Green Submitted, gold			2022-12-26	WOS:000407196700040
J	Cai, J; Wang, D; Bai, ZG; Yin, J; Zhang, J; Zhang, ZT				Cai, Jun; Wang, Dong; Bai, Zhi-Gang; Yin, Jie; Zhang, Jun; Zhang, Zhong-Tao			The long noncoding RNA XIAP-AS1 promotes XIAP transcription by XIAP-AS1 interacting with Sp1 in gastric cancer cells	PLOS ONE			English	Article							GENE; APOPTOSIS; LNCRNAS	Long noncoding RNAs (lncRNAs) play roles in the tumorigenesis, proliferation and metastasis of tumor cells. Previous studies indicate that the transcription factor Sp1 is responsible for transcription of the XIAP gene, but it is unknown whether lncRNAs are involved in XIAP transcription. Herein, we identified a novel lncRNA, denoted as XIAP-AS1, transcribed from the first intron of the complementary strand of the XIAP gene. Using RNA FISH, cell fraction-ation and qRT-PCR, XIAP-AS1 was determined to be located primarily in the nucleus. After various XIAP-AS1 deletion mutants were expressed, RIP assays showed that only the full-length XIAP-AS1 RNA interacted with Sp1 and thereby participated in XIAP transcription. ChIP assays showed that XIAP-AS1 knockdown decreased the binding of Sp1 to the promoter region of XIAP. XIAP-AS1 knockdown promoted tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in gastric tumor cells, as cleaved cas-pase-3 and caspase-9 was detected. Moreover, in an in vivo mouse xenograft model, tumor cell proliferation was inhibited by XIAP-AS1 knockdown in response to TRAIL administration. In conclusion, our results indicate that XIAP-AS1 is involved in XIAP transcription by interacting with Sp1. Additionally, XIAP-AS1 is a potential target for TRAIL-induced apoptosis in gastric cancer cells.	[Cai, Jun; Wang, Dong; Bai, Zhi-Gang; Yin, Jie; Zhang, Jun; Zhang, Zhong-Tao] Capital Med Univ, Beijing Friendship Hosp, Dept Gen Surg, Beijing, Peoples R China	Capital Medical University	Zhang, ZT (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Gen Surg, Beijing, Peoples R China.	zhangzht@medmail.com.cn	Bai, Zhigang/C-3872-2011	Bai, Zhigang/0000-0001-9234-9354	Basic-Clinical research cooperation fund of Beijing Friendship Hospital Affiliated to Capital Medical University [14JL33]	Basic-Clinical research cooperation fund of Beijing Friendship Hospital Affiliated to Capital Medical University	This research was supported by grants from Basic-Clinical research cooperation fund of Beijing Friendship Hospital Affiliated to Capital Medical University (14JL33).	BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; Carter BZ, 2008, BLOOD, V111, P3742, DOI 10.1182/blood-2007-05-091504; Chawla-Sarkar M, 2004, CELL DEATH DIFFER, V11, P915, DOI 10.1038/sj.cdd.4401416; Cummins JM, 2004, CANCER RES, V64, P3006, DOI 10.1158/0008-5472.CAN-04-0046; Dean EJ, 2007, EXPERT OPIN THER TAR, V11, P1459, DOI 10.1517/14728222.11.11.1459; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Huang GW, 2015, SCI REP-UK, V5, DOI 10.1038/srep07901; Kim KJ, 2006, CLIN CANCER RES, V12, P1292, DOI 10.1158/1078-0432.CCR-05-1793; Kim Y, 2002, J BIOL CHEM, V277, P22320, DOI 10.1074/jbc.M202458200; Lee TJ, 2006, MOL CANCER THER, V5, P2737, DOI 10.1158/1535-7163.MCT-06-0426; Li CQ, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.1; Li JG, 2014, GUT, V63, P1700, DOI 10.1136/gutjnl-2013-305806; Li Y, 2017, PLOS ONE, V5; Lima RT, 2004, CANCER GENE THER, V11, P309, DOI 10.1038/sj.cgt.7700706; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McHugh CA, 2015, NATURE, V521, P232, DOI 10.1038/nature14443; Ponzielli R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn735; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Suliman A, 2001, ONCOGENE, V20, P2122, DOI 10.1038/sj.onc.1204282; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Vogler M, 2009, CANCER RES, V69, P2425, DOI 10.1158/0008-5472.CAN-08-2436; Wilson TR, 2009, ONCOGENE, V28, P63, DOI 10.1038/onc.2008.366	23	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2017	12	8							e0182433	10.1371/journal.pone.0182433	http://dx.doi.org/10.1371/journal.pone.0182433			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9EU	28792527	Green Published, gold, Green Submitted			2022-12-26	WOS:000407144700019
J	Yang, CK; Wang, XK; Liao, XW; Han, CY; Yu, TD; Qin, W; Zhu, GZ; Su, H; Yu, L; Liu, XG; Lu, SC; Chen, ZW; Liu, Z; Huang, KT; Liu, ZT; Liang, Y; Huang, JL; Xiao, KY; Peng, MH; Winkle, CA; O'Brien, SJ; Peng, T				Yang, Cheng-kun; Wang, Xiang-kun; Liao, Xi-wen; Han, Chuang-ye; Yu, Ting-dong; Qin, Wei; Zhu, Guang-zhi; Su, Hao; Yu, Long; Liu, Xiao-guang; Lu, Si-cong; Chen, Zhi-wei; Liu, Zhen; Huang, Ke-tuan; Liu, Zheng-tao; Liang, Yu; Huang, Jian-lu; Xiao, Kai-yin; Peng, Min-hao; Winkle, Cheryl Ann; O'Brien, Stephen J.; Peng, Tao			Aldehyde dehydrogenase 1 (ALDH1) isoform expression and potential clinical implications in hepatocellular carcinoma	PLOS ONE			English	Article							CANCER STEM-CELLS; PROGENITOR CELLS; RESISTANCE; IDENTIFICATION; EPIDEMIOLOGY; ASSOCIATION; POPULATION; PROGNOSIS; GENES	Hepatocellular carcinoma (HCC) is one of the most prevalent and life-threatening malignancies worldwide. There are few diagnostic and prognostic biomarkers and druggable targets for HCC. Aldehyde dehydrogenase 1 (ALDH1) is a marker of stem cells in a variety of cancers, but the mRNA levels and prognostic value of ALDH1 isoforms in HCC patients remain unknown. In the present study, gene ontology annotation of the ALDH1 family was performed using the Database for Annotation, Visualization and Integrated Discovery (DAVID), and the gene pathway analsis was performed using GeneMANIA software. The initial prognostic value of ALDH1 expression in 360 HCC patients was assessed using the OncoLnc database. The expression levels of ALDH1 isoforms in normal liver tissues and clinical specimens of cancer vs. normal control datasets were determined using the GTEx and Oncomine databases, respectively. We then analyzed the prognostic value of ALDH1 expression in 212 hepatitis B virus (HBV)-related HCC patients using the GEO database. We found that the ALDH1 isoform showed high aldehyde dehydrogenase activity. The ALDH1A1, ALDH1B1, and ALDH1L1 genes encoded for the ALDH1 enzyme. High ALDH1B1 expression had protective qualities in HCC patients. Moreover, HBV-related HCC patients who showed high ALDH1L1 gene expression had a better clinical outcomes. In addition, high ALDH1A1 expression was associated with a 57-month recurrence-free survival in HBV-related HCC patients. High ALDH1B1 expression was protective for HCCs with multiple nodules and high serum alpha-fetoprotein (AFP) level. Furthermore, high serum AFP levels contributed to lower ALDH1L1. ALDH1A1, ALDH1B1, and ALDH1L1, all of which were considered promising diagnostic and prognostic markers as well as potential drug targets.	[Yang, Cheng-kun; Wang, Xiang-kun; Liao, Xi-wen; Han, Chuang-ye; Yu, Ting-dong; Qin, Wei; Zhu, Guang-zhi; Su, Hao; Lu, Si-cong; Chen, Zhi-wei; Liu, Zhen; Huang, Ke-tuan; Liu, Zheng-tao; Liang, Yu; Xiao, Kai-yin; Peng, Min-hao; Peng, Tao] Guangxi Med Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Nanning, Guangxi Provinc, Peoples R China; [Yu, Long] Zhengzhou Univ, Affiliated Hosp 1, Dept Hepatobiliary & Pancreat Surg, Zhengzhou, Henan, Peoples R China; [Liu, Xiao-guang] Guangdong Med Univ, Affiliated Hosp, Dept Hepatobiliary Surg, Zhanjiang, Guangdong, Peoples R China; [Huang, Jian-lu] Guangxi Med Univ, Affiliated Hosp 3, Dept Hepatobiliary Surg, Nanning, Guangxi Provinc, Peoples R China; [Winkle, Cheryl Ann; O'Brien, Stephen J.] NCI, Lab Genom Div, NIH, Frederick, MD 21701 USA	Guangxi Medical University; Zhengzhou University; Guangdong Medical University; Guangxi Medical University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Peng, T (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Nanning, Guangxi Provinc, Peoples R China.	pengtaocn@hotmail.com	OBRIEN, STEPHEN/ABD-1346-2020	OBRIEN, STEPHEN/0000-0001-7857-0757	National Nature Science Foundation of China [81560535, 81072321, 30760243, 30460143, 30560133]; Program for New Century Excellent Talents in University (NCET), Guangxi Nature Sciences Foundation [GuiKeGong 1104003A-7]; Guangxi Health Ministry Medicine Grant (Key-Scientific Research-Grant) [Z201018]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University (NCET), Guangxi Nature Sciences Foundation; Guangxi Health Ministry Medicine Grant (Key-Scientific Research-Grant)	This work was supported in part by the National Nature Science Foundation of China (No: 81560535, 81072321, 30760243, 30460143 and 30560133), 2009 Program for New Century Excellent Talents in University (NCET), Guangxi Nature Sciences Foundation (No: GuiKeGong 1104003A-7), and Guangxi Health Ministry Medicine Grant (Key-Scientific Research-Grant Z201018).	Anaya J, 2016, ONCOLNC LINKING TCGA, V2, pe67; Anthony TE, 2007, J COMP NEUROL, V500, P368, DOI 10.1002/cne.21179; Armstrong L, 2004, STEM CELLS, V22, P1142, DOI 10.1634/stemcells.2004-0170; Bagnardi V, 2001, ALCOHOL RES HEALTH, V25, P263; Balicki D, 2007, CELL STEM CELL, V1, P485, DOI 10.1016/j.stem.2007.10.015; BOND SL, 1990, ALCOHOL ALCOHOLISM, V25, P385; Bruix J, 2009, LANCET, V373, P614, DOI 10.1016/S0140-6736(09)60381-0; Chen XQ, 2012, MED ONCOL, V29, P1843, DOI 10.1007/s12032-011-0075-x; Chen Y, 2011, BIOCHEM BIOPH RES CO, V405, P173, DOI 10.1016/j.bbrc.2011.01.002; Corti S, 2006, STEM CELLS, V24, P975, DOI 10.1634/stemcells.2005-0217; Dolle L, 2012, HEPATOLOGY, V55, P540, DOI 10.1002/hep.24693; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Epperson LE, 2004, MOL CELL PROTEOMICS, V3, P920, DOI 10.1074/mcp.M400042-MCP200; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Hou WJ, 2014, EUR ARCH OTO-RHINO-L, V271, P171, DOI 10.1007/s00405-013-2517-x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hwang PH, 2012, MED HYPOTHESES, V78, P197, DOI 10.1016/j.mehy.2011.10.023; Krupenko SA, 2002, CELL GROWTH DIFFER, V13, P227; Li TK, 2007, HEPATOLOGY, V46, P2032; Lonsdale J, 2013, BIOPRESERV BIOBANK, V13, P307; Ma S, 2008, MOL CANCER RES, V6, P1146, DOI 10.1158/1541-7786.MCR-08-0035; Mas VR, 2009, MOL MED, V15, P85, DOI 10.2119/molmed.2008.00110; Moreb J, 1996, CANCER GENE THER, V3, P24; Moreb JS, 2007, CANCER CHEMOTH PHARM, V59, P127, DOI 10.1007/s00280-006-0233-6; Nishikawa S, 2013, INT J ONCOL, V42, P1437, DOI 10.3892/ijo.2013.1837; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Pearce DJ, 2005, STEM CELLS, V23, P752, DOI 10.1634/stemcells.2004-0292; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Rasheed ZA, 2010, JNCI-J NATL CANCER I, V102, P340, DOI 10.1093/jnci/djp535; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Shen JX, 2016, ONCOTARGET, V7, P25340, DOI 10.18632/oncotarget.8294; Shimozawa N, 2004, J AM COLL SURGEONS, V198, P356, DOI 10.1016/j.jamcollsurg.2003.10.017; Singh S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121648; Stagos D, 2010, DRUG METAB DISPOS, V38, P1679, DOI 10.1124/dmd.110.034678; Stewart MJ, 1996, J INVEST MED, V44, P42; Su Y, 2010, CANCER EPIDEM BIOMAR, V19, P327, DOI 10.1158/1055-9965.EPI-09-0865; Suzuki E, 2012, HEPATOL RES, V42, P1100, DOI 10.1111/j.1872-034X.2012.01028.x; Tackels-Horne D, 2001, CANCER-AM CANCER SOC, V92, P395, DOI 10.1002/1097-0142(20010715)92:2<395::AID-CNCR1335>3.0.CO;2-U; Tanei T, 2009, CLIN CANCER RES, V15, P4234, DOI 10.1158/1078-0432.CCR-08-1479; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Vasiliou V, 2000, PHARMACOLOGY, V61, P192, DOI 10.1159/000028400; Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05; Wang KF, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0574-z; Wu SK, 2015, TUMOR BIOL, V36, P2421, DOI 10.1007/s13277-014-2852-6; You QH, 2015, DRUG DES DEV THER, V9, P5087, DOI 10.2147/DDDT.S87197	45	22	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2017	12	8							e0182208	10.1371/journal.pone.0182208	http://dx.doi.org/10.1371/journal.pone.0182208			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9EU	28792511	Green Published, Green Submitted, gold			2022-12-26	WOS:000407144700014
J	Guevara-Flores, A; Herrera-Juarez, AM; Martinez-Gonzalez, JD; Mena, IPD; Flores-Herrera, O; Rendon, JL				Guevara-Flores, Alberto; Miguel Herrera-Juarez, Alvaro; de Jesus Martinez-Gonzalez, Jose; del Arenal Mena, Irene Patricia; Flores-Herrera, Oscar; Luis Rendon, Juan			Differential expression of disulfide reductase enzymes in a free-living platyhelminth (Dugesia dorotocephala)	PLOS ONE			English	Article							THIOREDOXIN-GLUTATHIONE-REDUCTASE; IN-VIVO MODEL; CRYSTAL-STRUCTURE; OXIDATIVE STRESS; GENE LOSS; PURIFICATION; IDENTIFICATION; MITOCHONDRIAL; ANTIOXIDANT; CELL	A search of the disulfide reductase activities expressed in the adult stage of the free-living platyhelminth Dugesia dorotocephala was carried out. Using GSSG or DTNB as substrates, it was possible to obtain a purified fraction containing both GSSG and DTNB reductase activities. Through the purification procedure, both disulfide reductase activities were obtained in the same chromatographic peak. By mass spectrometry analysis of peptide fragments obtained after tryptic digestion of the purified fraction, the presence of glutathione reductase (GR), thioredoxin-glutathione reductase (TGR), and a putative thioredoxin reductase (TrxR) was detected. Using the gold compound auranofin to selectively inhibit the GSSG reductase activity of TGR, it was found that barely 5% of the total GR activity in the D. dorotocephala extract can be assigned to GR. Such strategy did allow us to determine the kinetic parameters for both GR and TGR. Although It was not possible to discriminate DTNB reductase activity due to TrxR from that of TGR, a chromatofocusing experiment with a D. dorotocephala extract resulted in the obtention of a minor protein fraction enriched in TrxR, strongly suggesting its presence as a functional protein. Thus, unlike its parasitic counterparts, in the free-living platyhelminth lineage the three disulfide reductases are present as functional proteins, albeit TGR is still the major disulfide reductase involved in the reduction of both Trx and GSSG. This fact suggests the development of TGR in parasitic flatworms was not linked to a parasitic mode of life.	[Guevara-Flores, Alberto; Miguel Herrera-Juarez, Alvaro; de Jesus Martinez-Gonzalez, Jose; del Arenal Mena, Irene Patricia; Flores-Herrera, Oscar; Luis Rendon, Juan] Univ Nacl Autonoma Mexico, Dept Bioquim, Fac Med, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico	Rendon, JL (corresponding author), Univ Nacl Autonoma Mexico, Dept Bioquim, Fac Med, Mexico City, DF, Mexico.	jrendon@bq.unam.mx		del Arenal, Irene Patricia/0000-0001-8174-9985; Martinez-Gonzalez, Jose/0000-0002-4240-739X; Guevara-Flores, Alberto/0000-0003-4429-770X	Direccion General de Asuntos del Personal Academic (DGAPA) at Universidad Nacional Autonoma de Mexico (UNAM) [IN219414, IN218816]	Direccion General de Asuntos del Personal Academic (DGAPA) at Universidad Nacional Autonoma de Mexico (UNAM)	This work was supported by the research grants IN219414 and IN218816 from Direccion General de Asuntos del Personal Academic (DGAPA) at Universidad Nacional Autonoma de Mexico (UNAM).	Angelucci F, 2009, J BIOL CHEM, V284, P28977, DOI 10.1074/jbc.M109.020701; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Arner ESJ, 2009, BBA-GEN SUBJECTS, V1790, P495, DOI 10.1016/j.bbagen.2009.01.014; Bauer H, 2003, EUR J BIOCHEM, V270, P4272, DOI 10.1046/j.1432-1033.2003.03812.x; Bonilla M, 2008, J BIOL CHEM, V283, P17898, DOI 10.1074/jbc.M710609200; Breugelmans B, 2015, SCI REP-UK, V5, DOI 10.1038/srep09417; Brusca R. C., 2016, INVERTEBRATES; BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Can B, 2010, PROTEIN J, V29, P250, DOI 10.1007/s10930-010-9246-4; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; Dai SD, 1996, J MOL BIOL, V264, P1044, DOI 10.1006/jmbi.1996.0695; Davies KJA, 1995, BIOCHEM SOC SYMP, P1, DOI 10.1042/bss0610001; Dringen R, 2002, METHOD ENZYMOL, V348, P281, DOI 10.1016/S0076-6879(02)48646-6; Elias M, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0107-8; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Fu XH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/409626; Gandin V, 2010, BIOCHEM PHARMACOL, V79, P90, DOI 10.1016/j.bcp.2009.07.023; Gentile L, 2011, DIS MODEL MECH, V4, P12, DOI 10.1242/dmm.006692; Gilberger TW, 1997, J BIOL CHEM, V272, P29584, DOI 10.1074/jbc.272.47.29584; Gromer S, 1998, J BIOL CHEM, V273, P20096, DOI 10.1074/jbc.273.32.20096; Guevara-Flores Alberto, 2010, J Parasitol Res, V2010, DOI 10.1155/2010/719856; Guevara-Flores A, 2011, PARASITOL INT, V60, P156, DOI 10.1016/j.parint.2011.01.005; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; INGOLD KU, 1987, ARCH BIOCHEM BIOPHYS, V259, P224, DOI 10.1016/0003-9861(87)90489-9; Karami A, 2015, INT J STEM CELLS, V8, P128, DOI 10.15283/ijsc.2015.8.2.128; Kenk R., 1972, FRESHWATER PLANARIAN, V1, P208; Kuntz AN, 2007, PLOS MED, V4, P1071, DOI 10.1371/journal.pmed.0040206; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Maggioli G, 2004, J PARASITOL, V90, P205, DOI 10.1645/GE-3247; Markwell M A, 1981, Methods Enzymol, V72, P296; MCCALLUM MJ, 1995, INT J BIOCHEM CELL B, V27, P393, DOI 10.1016/1357-2725(95)00005-A; Otero L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-237; Plancarte A, 2015, EXP PARASITOL, V149, P65, DOI 10.1016/j.exppara.2014.12.009; Rendon JL, 2004, MOL BIOCHEM PARASIT, V133, P61, DOI 10.1016/j.molbiopara.2003.09.003; Rendon JL, 2008, ADV PROTEIN PHYS CHE, P317; Riddiford N, 2011, DEV GENES EVOL, V221, P187, DOI 10.1007/s00427-011-0370-8; Salinas G, 2004, TRENDS PARASITOL, V20, P340, DOI 10.1016/j.pt.2004.05.002; Savvides SN, 2002, J BIOL CHEM, V277, P2779, DOI 10.1074/jbc.M108190200; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Song LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069501; Su D, 2005, J BIOL CHEM, V280, P26491, DOI 10.1074/jbc.M503638200; Sun QA, 2001, P NATL ACAD SCI USA, V98, P3673, DOI 10.1073/pnas.051454398; Tsai IJ, 2013, NATURE, V496, P57, DOI 10.1038/nature12031; WAKSMAN G, 1994, J MOL BIOL, V236, P800, DOI 10.1006/jmbi.1994.1190; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Xolalpa W, 2007, PROTEOMICS, V7, P3332, DOI 10.1002/pmic.200600876; Yadav SS, 2013, PARASITOL INT, V62, P193, DOI 10.1016/j.parint.2012.12.008	50	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182499	10.1371/journal.pone.0182499	http://dx.doi.org/10.1371/journal.pone.0182499			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28787021	Green Submitted, gold, Green Published			2022-12-26	WOS:000406998800042
J	Matone, A; Derlindati, E; Marchetti, L; Spigoni, V; Dei Cas, A; Montanini, B; Ardigo, D; Zavaroni, I; Priami, C; Bonadonna, RC				Matone, Alice; Derlindati, Eleonora; Marchetti, Luca; Spigoni, Valentina; Dei Cas, Alessandra; Montanini, Barbara; Ardigo, Diego; Zavaroni, Ivana; Priami, Corrado; Bonadonna, Riccardo C.			Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; GENE-EXPRESSION PROFILES; GLUCOSE CLAMP TECHNIQUE; RISK-FACTORS; HEART; SENSITIVITY; POPULATION; CALCIUM; YOUNG; HYPERINSULINEMIA	Insulin resistance is considered to be a pathogenetic mechanism in several and diverse diseases (e.g. type 2 diabetes, atherosclerosis) often antedating them in apparently healthy subjects. The aim of this study is to investigate with a microarray based approach whether IR per se is characterized by a specific pattern of gene expression. For this purpose we analyzed the transcriptomic profile of peripheral blood mononuclear cells in two groups (10 subjects each) of healthy individuals, with extreme insulin resistance or sensitivity, matched for BMI, age and gender, selected within the MultiKnowledge Study cohort (n = 148). Data were analyzed with an ad-hoc rank-based classification method. 321 genes composed the gene set distinguishing the insulin resistant and sensitive groups, within which the "Adrenergic signaling in cardiomyocytes" KEGG pathway was significantly represented, suggesting a pattern of increased intracellular cAMP and Ca2+, and apoptosis in the IR group. The same pathway allowed to discriminate between insulin resistance and insulin sensitive subjects with BMI > 25, supporting his role as a biomarker of IR. Moreover, ASCM pathway harbored biomarkers able to distinguish healthy and diseased subjects (from publicly available data sets) in IR-related diseases involving excitable cells: type 2 diabetes, chronic heart failure, and Alzheimer's disease. The altered gene expression profile of the ASCM pathway is an early molecular signature of IR and could provide a common molecular pathogenetic platform for IR-related disorders, possibly representing an important aid in the efforts aiming at preventing, early detecting and optimally treating IR-related diseases.	[Matone, Alice; Marchetti, Luca; Priami, Corrado] Univ Trento, Microsoft Res, Ctr Computat & Syst Biol COSBI, Rovereto, Italy; [Derlindati, Eleonora; Spigoni, Valentina; Dei Cas, Alessandra; Ardigo, Diego; Zavaroni, Ivana; Bonadonna, Riccardo C.] Univ Parma, Dept Med & Surg, Parma, Italy; [Dei Cas, Alessandra; Zavaroni, Ivana; Bonadonna, Riccardo C.] Azienda Osped Univ Parma, Div Endocrinol & Metab Dis, Parma, Italy; [Montanini, Barbara] Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Parma, Italy; [Priami, Corrado] Univ Trento, Dept Math, Trento, Italy	University of Trento; University of Parma; University of Parma; University Hospital of Parma; University of Parma; University of Trento	Bonadonna, RC (corresponding author), Univ Parma, Dept Med & Surg, Parma, Italy.; Bonadonna, RC (corresponding author), Azienda Osped Univ Parma, Div Endocrinol & Metab Dis, Parma, Italy.	riccardo.bonadonna@unipr.it	ARDIGO, DIEGO/AAD-5928-2022	Marchetti, Luca/0000-0001-9043-7705; Matone, Alice/0000-0003-4530-908X; Montanini, Barbara/0000-0002-5419-7975; Spigoni, Valentina/0000-0001-5716-1671; Dei Cas, Alessandra/0000-0002-8666-4849	EU commission [FP6-IST-2004-027106]; University of Parma	EU commission(European CommissionEuropean Commission Joint Research Centre); University of Parma	This study was supported by the EU commission as part of the "Multi-Knowledge project" (reference: FP6-IST-2004-027106) to IZ and by grants of University of Parma to IZ, ADC and RCB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Belke DD, 2004, DIABETES, V53, P3201, DOI 10.2337/diabetes.53.12.3201; Beretta Martina, 2015, Advances in Biological Regulation, V58, P1, DOI 10.1016/j.jbior.2014.11.004; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Biessels GJ, 2015, NAT REV NEUROSCI, V16, P660, DOI 10.1038/nrn4019; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Birkenfeld AL, 2014, HEPATOLOGY, V59, P713, DOI 10.1002/hep.26672; Blalock EM, 2011, J CHEM NEUROANAT, V42, P118, DOI 10.1016/j.jchemneu.2011.06.007; Bolstad B, 2005, BIOINFORMATICS COMPU; BONADONNA RC, 1990, METABOLISM, V39, P452, DOI 10.1016/0026-0495(90)90002-T; Bonadonna RC, 2003, DIABETES, V52, P470, DOI 10.2337/diabetes.52.2.470; BONADONNA RC, 1994, AM J PHYSIOL, V266, pE501; Bonadonna RC, 2004, INT TXB DIABETES MEL, V2, P1379; Bonora E, 2004, DIABETES, V53, P1782, DOI 10.2337/diabetes.53.7.1782; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Bouchard-Mercier A, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-24; Caberlotto L, 2016, SCI REP-UK, V6, DOI 10.1038/srep32583; Cappuzzello C, 2009, PHYSIOL GENOMICS, V38, P233, DOI 10.1152/physiolgenomics.90364.2008; Carvajal K, 2014, CELL CALCIUM, V56, P408, DOI 10.1016/j.ceca.2014.08.003; Cas AD, 2013, NUTR METAB CARDIOVAS, V23, P272, DOI 10.1016/j.numecd.2011.04.005; Castaner O, 2013, AM J CLIN NUTR, V98, P845, DOI 10.3945/ajcn.113.060582; Cersosimo E, 2000, ENDOTEXT; Clausen JO, 1996, J CLIN INVEST, V98, P1195, DOI 10.1172/JCI118903; Craft S, 2000, ANN NY ACAD SCI, V903, P222, DOI 10.1111/j.1749-6632.2000.tb06371.x; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Dei Cas A, 2011, NUTR METAB CARDIOVAS, V21, P512, DOI 10.1016/j.numecd.2009.11.011; Derlindati E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119751; Dixit SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058655; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Erickson JR, 2013, NATURE, V502, P372, DOI 10.1038/nature12537; FERRANNINI E, 1987, NEW ENGL J MED, V317, P350, DOI 10.1056/NEJM198708063170605; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Haeusler RA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6190; Hardy OT, 2011, SURG OBES RELAT DIS, V7, P60, DOI 10.1016/j.soard.2010.05.013; Irving BA, 2011, J CLIN ENDOCR METAB, V96, pE713, DOI 10.1210/jc.2010-2170; Kahn R, 2005, DIABETOLOGIA, V48, P1684, DOI 10.1007/s00125-005-1876-2; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; Kemppainen J, 2003, J PHYSIOL-LONDON, V550, P305, DOI 10.1113/jphysiol.2003.042648; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; Korsheninnikova E, 2002, DIABETES-METAB RES, V18, P209, DOI 10.1002/dmrr.272; Lacroix S, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0508-9; Lauria M, 2015, NUCLEIC ACIDS RES, V43, pW188, DOI 10.1093/nar/gkv449; Lauria M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/192646; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Marselli L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011499; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; MUECKLER M, 1994, J BIOL CHEM, V269, P17765; Myhrstad MCW, 2014, J INTERN MED, V276, P498, DOI 10.1111/joim.12217; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; NUUTILA P, 1995, DIABETES, V44, P31, DOI 10.2337/diabetes.44.1.31; Parsonage W, 2002, AM J CARDIOL, V89, P696, DOI 10.1016/S0002-9149(01)02342-6; Pereira L, 2014, CELL CALCIUM, V56, P372, DOI 10.1016/j.ceca.2014.08.004; Pihlajamaki J, 2009, J CLIN ENDOCR METAB, V94, P3521, DOI 10.1210/jc.2009-0212; R Core Team, 2018, R LANG ENV STAT COMP; Rebhan M, 1998, BIOINFORMATICS, V14, P656, DOI 10.1093/bioinformatics/14.8.656; Rhrissorrakrai K, 2013, SYSTEMS BIOMEDICINE, V1, P196; Rorsman P, 2012, CELL CALCIUM, V51, P300, DOI 10.1016/j.ceca.2011.11.006; Rudkowska I, 2011, J NUTRIGENET NUTRIGE, V4, P192, DOI 10.1159/000330226; Scherbakov N, 2015, EUR J HEART FAIL, V17, P1015, DOI 10.1002/ejhf.317; Sesti G, 2001, FASEB J, V15, P2099, DOI 10.1096/fj.01-0009rev; Smedley D, 2015, NUCLEIC ACIDS RES, V43, pW589, DOI 10.1093/nar/gkv350; Smih F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020414; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stutzmann GE, 2006, J NEUROSCI, V26, P5180, DOI 10.1523/JNEUROSCI.0739-06.2006; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Tsuchida A, 2004, J BIOL CHEM, V279, P30817, DOI 10.1074/jbc.M402367200; Yamaoka M, 2013, BIOCHEM BIOPH RES CO, V433, P450, DOI 10.1016/j.bbrc.2013.02.096; ZAVARONI I, 1989, NEW ENGL J MED, V320, P702, DOI 10.1056/NEJM198903163201105; Zavaroni I, 1999, METABOLISM, V48, P989, DOI 10.1016/S0026-0495(99)90195-6	75	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0182559	10.1371/journal.pone.0182559	http://dx.doi.org/10.1371/journal.pone.0182559			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28777829	Green Submitted, Green Published, gold			2022-12-26	WOS:000406944300041
J	Schechter, MC; Buac, K; Adekambi, T; Cagle, S; Celli, J; Ray, SM; Mehta, CC; Rada, B; Rengarajan, J				Schechter, Marcos C.; Buac, Kristina; Adekambi, Toidi; Cagle, Stephanie; Celli, Justine; Ray, Susan M.; Mehta, Christina C.; Rada, Balazs; Rengarajan, Jyothi			Neutrophil extracellular trap (NET) levels in human plasma are associated with active TB	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; ELASTASE	Neutrophils are increasingly associated with tuberculosis (TB) disease. Neutrophil extracellular traps (NETs), which are released by neutrophils as a host antimicrobial defense mechanism, are also associated with tissue damage. However, a link between NET levels and TB disease has not been studied. Here we investigate plasma NETs levels in patients with active pulmonary tuberculosis using an ELISA assay that is suitable for high-throughput processing. We show that plasma NETs levels at baseline correlated with disease severity and decreased with antibiotic therapy. Our study demonstrates the biologic plausibility of measuring NETs in plasma samples from patients with TB.	[Schechter, Marcos C.; Cagle, Stephanie; Ray, Susan M.; Rengarajan, Jyothi] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA; [Buac, Kristina; Rada, Balazs] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA; [Adekambi, Toidi; Rengarajan, Jyothi] Emory Univ, Sch Med, Emory Vaccine Ctr, Dept Med, Atlanta, GA 30322 USA; [Celli, Justine] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA USA; [Mehta, Christina C.] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA USA	Emory University; University System of Georgia; University of Georgia; Emory University; Emory University; Rollins School Public Health; Emory University; Rollins School Public Health	Rengarajan, J (corresponding author), Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA.; Rada, B (corresponding author), Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA.; Rengarajan, J (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Dept Med, Atlanta, GA 30322 USA.	radab@uga.edu; jrengar@emory.edu		Ray, Susan/0000-0002-6327-088X; Rengarajan, Jyothi/0000-0003-1241-4705	Center for AIDS Research (CFAR) [P30A1050409]; Emory-CFAR [R03]; Office of Vice President for Research at the University of Georgia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409] Funding Source: NIH RePORTER	Center for AIDS Research (CFAR); Emory-CFAR; Office of Vice President for Research at the University of Georgia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Center for AIDS Research (CFAR) immunology core grant (grant P30A1050409 to Emory University), an Emory-CFAR R03 developmental grant (to S. M. R. and J. R.) and funds provided by the Office of Vice President for Research at the University of Georgia (to B.R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the patients who volunteered for this study and Fulton County Health Department TB Clinic staff for facilitating access to medical records.	Adekambi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036046; Arcos J, 2015, J INFECT DIS, V212, P948, DOI 10.1093/infdis/jiv146; Bardoel BW, 2014, CELL HOST MICROBE, V15, P526, DOI 10.1016/j.chom.2014.04.011; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Braian C, 2013, J INNATE IMMUN, V5, P591, DOI 10.1159/000348676; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Cai S, 2016, MUCOSAL IMMUNOL, V9, P718, DOI 10.1038/mi.2015.95; Dallenga T, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw012; Eum SY, 2010, CHEST, V137, P122, DOI 10.1378/chest.09-0903; Gopal R, 2013, AM J RESP CRIT CARE, V188, P1137, DOI 10.1164/rccm.201304-0803OC; Li PX, 2010, J EXP MED, V207, P1853, DOI 10.1084/jem.20100239; Nahid P, 2016, CLIN INFECT DIS; Ong CWM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004917; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Ramos-Kichik V, 2009, TUBERCULOSIS, V89, P29, DOI 10.1016/j.tube.2008.09.009; Sil P, 2016, JOVE-J VIS EXP, DOI 10.3791/52779; Sorensen OE, 2016, J CLIN INVEST, V126, P1612, DOI 10.1172/JCI84538; Tenland E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164431; Wang YM, 2009, J CELL BIOL, V184, P205, DOI 10.1083/jcb.200806072; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; Yoo DG, 2014, IMMUNOL LETT, V160, P186, DOI 10.1016/j.imlet.2014.03.003	21	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0182587	10.1371/journal.pone.0182587	http://dx.doi.org/10.1371/journal.pone.0182587			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28777804	Green Published, gold, Green Submitted			2022-12-26	WOS:000406944300044
J	Tserga, A; Binder, AM; Michels, KB				Tserga, Aggeliki; Binder, Alexandra M.; Michels, Karin B.			Impact of folic acid intake during pregnancy on genomic imprinting of IGF2/H19 and 1-carbon metabolism	FASEB JOURNAL			English	Article						folate; epigenetics; DNA methylation; MTHFR; placenta	NEURAL-TUBE DEFECTS; S-ADENOSYLHOMOCYSTEINE; DNA HYPOMETHYLATION; METHYLENETETRAHYDROFOLATE-REDUCTASE; COLORECTAL-CANCER; HOMOCYSTEINE LEVELS; METHYLATED REGIONS; BIRTH-WEIGHT; FOLATE; GENE	Folic acid is an essential component of 1-carbon metabolism, which generates methyl groups for DNA methylation. Disruption of genomic imprinting leads to biallelic expressionwhichmay affect disease susceptibility possibly reflected in high levels of S-adenosyl-homocysteine (SAH) and low levels of S-adenosyl-methionine (SAM). We investigated the association between folic acid supplementation during pregnancy and loss of imprinting (LOI) of IGF2 and H19 genes in placentas and cord blood of 90mother-child dyads in associationwith the methylenetetrahydrofolate reductase (MTHFR) genotype. Pyrosequencing was used to evaluate deviation from monoallelic expression among 47 placentas heterozygous for H19 and 37 placentas and cord blood tissues heterozygous for IGF2 and H19methylation levels of 48 placentas. We detected relaxation of imprinting (ROI) and LOI of H19 inplacentasnot associatedwithdifferences inmethylationlevels of theH19ICR. Placentas retainedmonoallelic allele-specific gene expression of IGF2, but 32.4% of cord blood samples displayed LOI of IGF2 and 10.8% showed ROI. High SAH levels were significantly associated with low H19 methylation. An interesting positive association between SAM/SAHratio and high H19methylation levelswasdetected among infantswith lowB(12) levels. Our data suggest profound differences in regulation of imprinting in placenta and cord blood; a lack of correlation of the methylome, transcriptome, and proteome; and a complex regulatory feedback network between free methyl groups and genomic imprinting at birth.-Tserga, A., Binder, A. M., Michels, K. B. Impact of folic acid intake during pregnancy on genomic imprinting of IGF2/H19 and 1-carbon metabolism.	[Tserga, Aggeliki; Michels, Karin B.] Univ Freiburg, Fac Med, Inst Prevent & Canc Epidemiol, Freiburg, Germany; [Tserga, Aggeliki; Michels, Karin B.] Univ Freiburg, Med Ctr, Freiburg, Germany; [Binder, Alexandra M.; Michels, Karin B.] Harvard Med Sch, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Obstet & Gynecol Epidemiol Ctr, Boston, MA USA; [Binder, Alexandra M.; Michels, Karin B.] Harvard Sch Publ Hlth, Dept Epidemiol, 677 Longwood Ave, Boston, MA 02115 USA	University of Freiburg; University of Freiburg; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Michels, KB (corresponding author), Harvard Sch Publ Hlth, Dept Epidemiol, 677 Longwood Ave, Boston, MA 02115 USA.	kmichels@hsph.harvard.edu		Tserga, Aggeliki/0000-0002-5531-2111	U.S. National Institutes of Health (NIH), National Cancer Institute Research [R21CA128382]; NIH National Institute of Child Health and Human Development Training Grant [T32HD060454]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060454] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R21CA128382] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Cancer Institute Research; NIH National Institute of Child Health and Human Development Training Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Harvard Epigenetic Birth Cohort was funded by U.S. National Institutes of Health (NIH), National Cancer Institute Research Grant R21CA128382 (to K.B.M.). A.M.B. was supported by NIH National Institute of Child Health and Human Development Training Grant T32HD060454 in Reproductive, Perinatal and Pediatric Epidemiology. The authors declare no conflicts of interest.	Allis C.D., 2008, EPIGENETICS; Azzi S, 2014, CURR OPIN ENDOCRINOL, V21, P30, DOI 10.1097/MED.0000000000000037; Badcock C, 2006, J EVOLUTION BIOL, V19, P1007, DOI 10.1111/j.1420-9101.2006.01091.x; Bailey LB, 1999, J NUTR, V129, P919, DOI 10.1093/jn/129.5.919; Bailey LB, 2015, J NUTR, V145, P1636, DOI 10.3945/jn.114.206599; Blom HJ, 2006, NAT REV NEUROSCI, V7, P724, DOI 10.1038/nrn1986; Cassidy SB, 2012, GENET MED, V14, P10, DOI 10.1038/gim.0b013e31822bead0; Caudill MA, 2001, J NUTR, V131, P2811, DOI 10.1093/jn/131.11.2811; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Crider KS, 2012, ADV NUTR, V3, P21, DOI 10.3945/an.111.000992; Cui HM, 1998, NAT MED, V4, P1276, DOI 10.1038/3260; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; DEKKER GA, 1995, AM J OBSTET GYNECOL, V173, P1042, DOI 10.1016/0002-9378(95)91324-6; Dominguez-Salas P, 2012, P NUTR SOC, V71, P154, DOI 10.1017/S0029665111003338; Eichholzer M, 2006, LANCET, V367, P1352, DOI 10.1016/S0140-6736(06)68582-6; Ferguson-Smith A. C, 2009, EPIGENOMICS; Food and Drug Administration, 1996, FED REGISTER, V61, P8781; Forman HJ, 2009, MOL ASPECTS MED, V30, P1, DOI 10.1016/j.mam.2008.08.006; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; Frost JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013556; Gao RF, 2012, BIOL RES, V45, P351, DOI 10.4067/S0716-97602012000400004; Guo L, 2008, DEV BIOL, V320, P79, DOI 10.1016/j.ydbio.2008.04.025; Haberg SE, 2009, ARCH DIS CHILD, V94, P180, DOI 10.1136/adc.2008.142448; Haggarty P, 2013, AM J CLIN NUTR, V97, P94, DOI 10.3945/ajcn.112.042572; HIBBARD B M, 1969, Journal of Obstetrics and Gynaecology of the British Commonwealth, V76, P1003; HOFFMAN DR, 1980, J BIOL CHEM, V255, P822; Hoyo C, 2011, EPIGENETICS-US, V6, P928, DOI 10.4161/epi.6.7.16263; Ito Y, 2008, HUM MOL GENET, V17, P2633, DOI 10.1093/hmg/ddn163; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; James SJ, 2002, J NUTR, V132, p2361S, DOI 10.1093/jn/132.8.2361S; James SJ, 2004, AM J CLIN NUTR, V80, P1611, DOI 10.1093/ajcn/80.6.1611; Kalish JM, 2014, INT J DEV BIOL, V58, P291, DOI 10.1387/ijdb.140077mb; Krumsiek J, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-21; Laanpere M, 2010, NUTR REV, V68, P99, DOI 10.1111/j.1753-4887.2009.00266.x; Lindblad B, 2005, ACTA OBSTET GYN SCAN, V84, P1055, DOI 10.1111/j.0001-6349.2005.00876.x; Mabb AM, 2011, TRENDS NEUROSCI, V34, P293, DOI 10.1016/j.tins.2011.04.001; Martinez-Frias ML, 2006, AM J MED GENET A, V140A, P987, DOI 10.1002/ajmg.a.31203; Mason JB, 2012, FOOD NUTR BULL, V33, pS104, DOI 10.1177/15648265120332S107; Michels KB, 2006, INT J CANCER, V119, P2007, DOI 10.1002/ijc.22004; Michels KB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025254; Monk D, 2006, P NATL ACAD SCI USA, V103, P6623, DOI 10.1073/pnas.0511031103; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Olsen IE, 2010, PEDIATRICS, V125, pE214, DOI 10.1542/peds.2009-0913; Parle-McDermott A, 2011, ADV NUTR, V2, P463, DOI 10.3945/an.111.001008; Pfeiffer CM, 2005, AM J CLIN NUTR, V82, P442, DOI 10.1093/ajcn/82.2.442; Rancourt RC, 2013, FASEB J, V27, P3335, DOI 10.1096/fj.12-225284; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Rondo PHC, 2000, ANN TROP PAEDIATR, V20, P253, DOI 10.1080/02724936.2000.11748144; Shaw GM, 2004, PUBLIC HEALTH REP, V119, P170, DOI 10.1177/003335490411900210; Stern LL, 2000, CANCER EPIDEM BIOMAR, V9, P849; Sullivan MJ, 1999, ONCOGENE, V18, P7527, DOI 10.1038/sj.onc.1203096; Vanhees K, 2014, CELL MOL LIFE SCI, V71, P271, DOI 10.1007/s00018-013-1427-9; Wang WH, 1996, J BIOL CHEM, V271, P27863, DOI 10.1074/jbc.271.44.27863; Whitrow MJ, 2009, AM J EPIDEMIOL, V170, P1486, DOI 10.1093/aje/kwp315; WOUTERS MGAJ, 1993, FERTIL STERIL, V60, P820; Yamada K, 2001, P NATL ACAD SCI USA, V98, P14853, DOI 10.1073/pnas.261469998; Yi P, 2000, J BIOL CHEM, V275, P29318, DOI 10.1074/jbc.M002725200	58	14	16	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5149	5158		10.1096/fj.201601214RR	http://dx.doi.org/10.1096/fj.201601214RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28778973	Green Published			2022-12-26	WOS:000416588300003
J	Ahmad, R; Kumar, B; Chen, Z; Chen, X; Muller, D; Lele, SM; Washington, MK; Batra, SK; Dhawan, P; Singh, AB				Ahmad, R.; Kumar, B.; Chen, Z.; Chen, X.; Mueller, D.; Lele, S. M.; Washington, M. K.; Batra, S. K.; Dhawan, P.; Singh, A. B.			Loss of claudin-3 expression induces IL6/gp130/Stat3 signaling to promote colon cancer malignancy by hyperactivating Wnt/beta-catenin signaling	ONCOGENE			English	Article							BETA-CATENIN; EPITHELIAL-CELLS; TIGHT JUNCTION; GROWTH; TRANSDUCER; PATHWAY; CLDN3; GENE; ACTIVATION; RESISTANCE	The hyperactivated Wnt/beta-catenin signaling acts as a switch to induce epithelial to mesenchymal transition and promote colorectal cancer. However, due to its essential role in gut homeostasis, therapeutic targeting of this pathway has proven challenging. Additionally, IL-6/Stat-3 signaling, activated by microbial translocation through the dysregulated mucosal barrier in colon adenomas, facilitates the adenoma to adenocarcinomas transition. However, inter-dependence between these signaling pathways and key mucosal barrier components in regulating colon tumorigenesis and cancer progression remains unclear. In current study, we have discovered, using a comprehensive investigative regimen, a novel and tissue-specific role of claudin-3, a tight junction integral protein, in inhibiting colon cancer progression by serving as the common rheostat of Stat-3 and Wnt-signaling activation. Loss of claudin-3 also predicted poor patient survival. These findings however contrasted an upregulated claudin-3 expression in other cancer types and implicated role of the epigenetic regulation. Claudin-3 -/- mice revealed dedifferentiated and leaky colonic epithelium, and developed invasive adenocarcinoma when subjected to colon cancer. Wnt-signaling hyperactivation, albeit in GSK-3 beta independent manner, differentiated colon cancer in claudin-3 -/- mice versus WT-mice. Claudin-3 loss also upregulated the gp130/IL6/Stat3 signaling in colonic epithelium potentially assisted by infiltrating immune components. Genetic and pharmacological studies confirmed that claudin-3 loss induces Wnt/beta-catenin activation, which is further exacerbated by Stat-3-activation and help promote colon cancer. Overall, these novel findings identify claudin-3 as a therapeutic target for inhibiting overactivation of Wnt-signaling to prevent CRC malignancy.	[Ahmad, R.; Kumar, B.; Batra, S. K.; Dhawan, P.; Singh, A. B.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Chen, Z.] Zhengzhou Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Zhengzhou, Henan, Peoples R China; [Chen, X.] Univ Miami, Miller Sch Med, Div Biostat, Miami, FL 33136 USA; [Mueller, D.] Charite, Dept Pediat Nephrol, Berlin, Germany; [Mueller, D.] Berlin Inst Hlth, Berlin, Germany; [Lele, S. M.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA; [Washington, M. K.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA; [Dhawan, P.; Singh, A. B.] VA Nebraska Western Iowa Hlth Care Syst, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; Zhengzhou University; University of Miami; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; University of Nebraska System; University of Nebraska Medical Center; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System	Singh, AB (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.	amar.singh@unmc.edu	kumar, Balawant/ABB-2847-2021; Kumar, Balawant/AAW-9616-2021	kumar, Balawant/0000-0002-8187-3078; 	 [BX002086];  [DK088902];  [BX002761]; NATIONAL CANCER INSTITUTE [P50CA095103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088902] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002761, I01BX002086] Funding Source: NIH RePORTER	; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by BX002086 (PD), DK088902 and BX002761 (ABS).	Ahmad R, 2014, MUCOSAL IMMUNOL, V7, P1340, DOI 10.1038/mi.2014.21; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Bartholow TL, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-12; Bhat AA, 2015, ONCOGENE, V34, P4570, DOI 10.1038/onc.2014.385; Cereijido M, 2008, BBA-BIOMEMBRANES, V1778, P770, DOI 10.1016/j.bbamem.2007.09.001; Clark JA, 2006, AM J PHYSIOL-GASTR L, V291, pG938, DOI 10.1152/ajpgi.00090.2006; de Araujo WM, 2010, J CANCER RES CLIN, V136, P1773, DOI 10.1007/s00432-010-0836-5; de Souza WF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074994; Deschenes C, 2001, GASTROENTEROLOGY, V120, P423, DOI 10.1053/gast.2001.21199; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; Dhawan P, 2011, ONCOGENE, V30, P3234, DOI 10.1038/onc.2011.43; Dube PE, 2012, J CLIN INVEST, V122, P2780, DOI 10.1172/JCI62888; Dzierzewicz Z, 2002, ACTA BIOCHIM POL, V49, P211; Gavert N, 2007, J CELL BIOCHEM, V102, P820, DOI 10.1002/jcb.21505; Gibson DL, 2008, CELL MICROBIOL, V10, P388, DOI 10.1111/j.1462-5822.2007.01052.x; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Hbibi AT, 2009, FEBS J, V276, P2505, DOI 10.1111/j.1742-4658.2009.06975.x; Heinzelmann-Schwarz VA, 2004, CLIN CANCER RES, V10, P4427, DOI 10.1158/1078-0432.CCR-04-0073; HENTTINEN T, 1995, J IMMUNOL, V155, P4582; Hinoi T, 2000, J BIOL CHEM, V275, P34399, DOI 10.1074/jbc.M003997200; Holmes JL, 2006, GENE EXPR PATTERNS, V6, P581, DOI 10.1016/j.modgep.2005.12.001; Honda H, 2007, CANCER BIOL THER, V6, P1733, DOI 10.4161/cbt.6.11.4832; Jiang L, 2014, ONCOTARGET, V5, P7663, DOI 10.18632/oncotarget.2288; KEDINGER M, 1990, DIFFERENTIATION, V43, P87, DOI 10.1111/j.1432-0436.1990.tb00434.x; Kooij G, 2014, ACTA NEUROPATHOL, V128, P267, DOI 10.1007/s00401-013-1227-1; Krishnan M, 2010, ONCOGENE, V29, P305, DOI 10.1038/onc.2009.324; Kwon MJ, 2010, CARCINOGENESIS, V31, P974, DOI 10.1093/carcin/bgp336; Lee J, 2012, J BIOL CHEM, V287, P18182, DOI 10.1074/jbc.M111.328831; Long HY, 2001, CANCER RES, V61, P7878; MATSUMOTO H, 1990, GASTROENTEROLOGY, V98, P1199, DOI 10.1016/0016-5085(90)90334-W; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; MOSER AR, 1995, EUR J CANCER, V31A, P1061, DOI 10.1016/0959-8049(95)00181-H; Mullin J M, 2004, Sci STKE, V2004, ppe2, DOI 10.1126/stke.2162004pe2; MULLIN JM, 1988, J CELL PHYSIOL, V134, P357, DOI 10.1002/jcp.1041340306; MULLIN JM, 1988, CANCER RES, V48, P4886; Nagaraja GM, 2006, ONCOGENE, V25, P2328, DOI 10.1038/sj.onc.1209265; Ngan CY, 2007, BRIT J CANCER, V96, P986, DOI 10.1038/sj.bjc.6603651; Patel RM, 2012, AM J PATHOL, V180, P626, DOI 10.1016/j.ajpath.2011.10.025; Pramanik KC, 2015, ONCOTARGET, V6, P11561, DOI 10.18632/oncotarget.3427; Rajput A, 2008, J SURG RES, V147, P276, DOI 10.1016/j.jss.2007.04.021; Ramalingam A, 2010, AM J PHYSIOL-CELL PH, V299, pC1028, DOI 10.1152/ajpcell.00482.2009; Ray S, 2013, J INVEST DERMATOL, V133, P1212, DOI 10.1038/jid.2012.499; Royer C, 2011, CELL DEATH DIFFER, V18, P1470, DOI 10.1038/cdd.2011.60; Singh AB, 2015, SEMIN CELL DEV BIOL, V42, P58, DOI 10.1016/j.semcdb.2015.05.001; Soler AP, 1999, CARCINOGENESIS, V20, P1425, DOI 10.1093/carcin/20.8.1425; Tenbaum SP, 2012, NAT MED, V18, P892, DOI 10.1038/nm.2772; Thaker AI, 2012, JOVE-J VIS EXP, DOI 10.3791/4100; Turgeon N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073785; Vucic EA, 2008, PHARMACOGENOMICS, V9, P215, DOI 10.2217/14622416.9.2.215; Wu JQ, 2016, CELL REP, V14, P1979, DOI 10.1016/j.celrep.2016.01.074; Yaqinuddin A, 2009, J UROLOGY, V182, P756, DOI 10.1016/j.juro.2009.03.082; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	54	69	75	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 23	2017	36	47					6592	6604		10.1038/onc.2017.259	http://dx.doi.org/10.1038/onc.2017.259			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FN5LN	28783170	Green Accepted			2022-12-26	WOS:000416049200008
J	Filippova, N; Yang, XH; Ananthan, S; Sorochinsky, A; Hackney, JR; Gentry, Z; Bae, S; King, P; Nabors, LB				Filippova, Natalia; Yang, Xiuhua; Ananthan, Subramaniam; Sorochinsky, Anastasia; Hackney, James R.; Gentry, Zachery; Bae, Sejong; King, Peter; Nabors, L. Burt			Hu antigen R (HuR) multimerization contributes to glioma disease progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioluminescence resonance energy transfer (BRET); cancer biology; cell proliferation; ELAV-like protein 1 (HuR (human antigen R)); RNA; glioma	BINDING PROTEIN HUR; MESSENGER-RNA STABILITY; CENTROSOME FUNCTION; GLIOBLASTOMA CELLS; RECOGNITION MOTIF; IDH1 MUTATIONS; CANCER; RICH; ELAV; TRANSLATION	Among primary brain cancers, gliomas are the most deadly and most refractory to current treatment modalities. Previous reports overwhelmingly support the role of the RNA-binding protein Hu antigen R (HuR) as a positive regulator of glioma disease progression. HuR expression is consistently elevated in tumor tissues, and a cytoplasmic localization appears essential for HuR-dependent oncogenic transformation. Here, we report HuR aggregation (multimerization) in glioma and the analysis of this tumor-specific HuR protein multimerization in clinical brain tumor samples. Using a split luciferase assay, a bioluminescence resonance energy transfer technique, and site-directed mutagenesis, we examined the domains involved in HuR multimerization. Results obtained with the combination of the split HuR luciferase assay with the bioluminescence resonance energy transfer technique suggested that multiple (at least three) HuR molecules come together during HuR multimerization in glioma cells. Using these data, we developed a model of HuR multimerization in glioma cells. We also demonstrate that exposing glioma cells to the HuR inhibitor tanshinone group compound 15,16-dihydrotanshinone-I or to the newly identified compound 5 disrupts HuR multimerization modules and reduces tumor cell survival and proliferation. In summary, our findings provide new insights into HuR multimerization in glioma and highlight possible pharmacological approaches for targeting HuR domains involved in cancer cell-specific multimerization.	[Filippova, Natalia; Yang, Xiuhua; Sorochinsky, Anastasia; Gentry, Zachery; King, Peter; Nabors, L. Burt] Univ Alabama Birmingham, Sch Med, Dept Neurol, Birmingham, AL 35294 USA; [Hackney, James R.] Univ Alabama Birmingham, Sch Med, Dept Pathol, Birmingham, AL 35294 USA; [Bae, Sejong] Univ Alabama Birmingham, Sch Med, Dept Med, Birmingham, AL 35294 USA; [Ananthan, Subramaniam] Southern Res, Drug Discovery Div, Birmingham, AL 35294 USA; [King, Peter] Birmingham Vet Affairs Med Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Nabors, LB (corresponding author), Dept Neurol, Div Neurooncol, 510 20th St South,FOT 1020, Birmingham, AL 35294 USA.	bnabors@uab.edu	Nabors, Louis/ABB-8223-2021	Nabors, Louis/0000-0001-5926-2230; King, Peter/0000-0001-9391-7464; Filippova, Natalia/0000-0003-2128-5511; bae, sejong/0000-0001-9982-3223	National Institutes of Health [R01 CA200624]; University of Alabama Comprehensive Cancer Center Neuro-oncology Research Acceleration Fund; NATIONAL CANCER INSTITUTE [R01CA200624] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001706] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Alabama Comprehensive Cancer Center Neuro-oncology Research Acceleration Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grant R01 CA200624 (to L. B. N.) and the University of Alabama Comprehensive Cancer Center Neuro-oncology Research Acceleration Fund. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Benoit RM, 2011, RNA BIOL, V8, P18, DOI 10.4161/rna.8.1.13555; Benoit RM, 2010, J MOL BIOL, V397, P1231, DOI 10.1016/j.jmb.2010.02.043; Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; Bronicki LM, 2013, RNA, V19, P1019, DOI 10.1261/rna.039164.113; Burkhart RA, 2013, RNA BIOL, V10, P1312, DOI 10.4161/rna.25274; CAMPOS AR, 1985, J NEUROGENET, V2, P197, DOI 10.3109/01677068509100150; Chou SD, 2015, ONCOGENE, V34, P2178, DOI 10.1038/onc.2014.177; Chu PC, 2012, J BIOL CHEM, V287, P43639, DOI 10.1074/jbc.M112.393678; Cobbs CS, 2013, CURR OPIN ONCOL, V25, P682, DOI 10.1097/CCO.0000000000000005; D'Agostino VG, 2015, SCI REP-UK, V5, DOI 10.1038/srep16478; David PS, 2007, RNA, V13, P1453, DOI 10.1261/rna.501707; de Silanes IL, 2003, ONCOGENE, V22, P7146, DOI 10.1038/sj.onc.1206862; Diaz-Quintana A, 2015, FEBS LETT, V589, P1059, DOI 10.1016/j.febslet.2015.03.013; Dickson AM, 2012, J BIOL CHEM, V287, P36229, DOI 10.1074/jbc.M112.371203; Doller A, 2008, MOL CELL BIOL, V28, P2608, DOI 10.1128/MCB.01530-07; Durie D, 2011, ONCOGENE, V30, P1460, DOI 10.1038/onc.2010.527; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Fialcowitz-White EJ, 2007, J BIOL CHEM, V282, P20948, DOI 10.1074/jbc.M701751200; Filippova N, 2015, BIOMOLECULES, V5, P263, DOI 10.3390/biom5010263; Filippova N, 2012, J BIOL CHEM, V287, P32277, DOI 10.1074/jbc.M112.353912; Filippova N, 2011, MOL CANCER RES, V9, P648, DOI 10.1158/1541-7786.MCR-10-0325; Galban S, 2008, MOL CELL BIOL, V28, P93, DOI 10.1128/MCB.00973-07; Gorospe M, 2003, CELL CYCLE, V2, P412, DOI 10.4161/cc.2.5.491; Gurgis FMS, 2015, ONCOGENE, V34, P2934, DOI 10.1038/onc.2014.225; Heinonen M, 2007, CLIN CANCER RES, V13, P6959, DOI 10.1158/1078-0432.CCR-07-1432; Hinman MN, 2013, NUCLEIC ACIDS RES, V41, P5049, DOI 10.1093/nar/gkt166; Ichimura K, 2009, NEURO-ONCOLOGY, V11, P341, DOI 10.1215/15228517-2009-025; Kasashima K, 2002, NUCLEIC ACIDS RES, V30, P4519, DOI 10.1093/nar/gkf567; Katsetos CD, 2013, SEMIN PEDIATR NEUROL, V20, P216, DOI 10.1016/j.spen.2013.09.003; Kim HH, 2008, GENE DEV, V22, P1804, DOI 10.1101/gad.1645808; Kodiha M., 2012, J SIGNAL TRANSDUCT, V2012, DOI DOI 10.1155/2012/208650; Lucchesi C, 2016, ONCOGENE, V35, P2565, DOI 10.1038/onc.2015.339; Matlaf LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068176; Meisner NC, 2007, NAT CHEM BIOL, V3, P508, DOI 10.1038/nchembio.2007.14; Nabors LB, 2001, CANCER RES, V61, P2154; Poria DK, 2016, ONCOGENE, V35, P1703, DOI 10.1038/onc.2015.235; Rebane A, 2004, RNA, V10, P590, DOI 10.1261/rna.5224304; ROBINOW S, 1988, SCIENCE, V242, P1570, DOI 10.1126/science.3144044; Scheiba RM, 2014, RNA BIOL, V11, P1250, DOI 10.1080/15476286.2014.996069; Sharma S, 2013, RNA BIOL, V10, P1283, DOI 10.4161/rna.25482; Sokoloski KJ, 2010, CELL HOST MICROBE, V8, P196, DOI 10.1016/j.chom.2010.07.003; Thota B, 2012, AM J CLIN PATHOL, V138, P177, DOI 10.1309/AJCPZOIY3WY4KIKE; Toba G, 2008, NUCLEIC ACIDS RES, V36, P1390, DOI 10.1093/nar/gkm1168; Vo DT, 2012, MOL CANCER RES, V10, P143, DOI 10.1158/1541-7786.MCR-11-0208; Wang H, 2013, ACTA CRYSTALLOGR D, V69, P373, DOI 10.1107/S0907444912047828; Wang J, 2013, INT J MOL SCI, V14, P10015, DOI 10.3390/ijms140510015; Wang J, 2011, MED ONCOL, V28, pS577, DOI 10.1007/s12032-010-9734-6; Wang WG, 2000, EMBO J, V19, P2340, DOI 10.1093/emboj/19.10.2340; Wang ZH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138780; Wu XQ, 2015, ACS CHEM BIOL, V10, P1476, DOI 10.1021/cb500851u; Yoon JH, 2014, NUCLEIC ACIDS RES, V42, P1196, DOI 10.1093/nar/gkt903; Zhang LF, 2015, EMBO J, V34, P2671, DOI 10.15252/embj.201591803	52	30	31	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					16999	17010		10.1074/jbc.M117.797878	http://dx.doi.org/10.1074/jbc.M117.797878			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28790173	hybrid, Green Published			2022-12-26	WOS:000413140600020
J	Langini, C; Caflisch, A; Vitalis, A				Langini, Cassiano; Caflisch, Amedeo; Vitalis, Andreas			The ATAD2 bromodomain binds different acetylation marks on the histone H4 in similar fuzzy complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSIC DISORDER; SELECTIVE RECOGNITION; MOLECULAR RECOGNITION; INTERACTION NETWORKS; PROTEIN DISORDER; LYSINE BINDING; CHROMATIN; DYNAMICS; ASSOCIATION; DISCOVERY	Bromodomains are protein modules adopting conserved helix bundle folds. Some bromodomain-containing proteins, such as ATPase family AAA domain-containing protein 2 (ATAD2), isoform A, have attracted much interest because they are overexpressed in many types of cancer. Bromodomains bind to acetylated lysine residues on histone tails and thereby facilitate the reading of the histone code. Epigenetic regulators in general have been implicated as indicators, mediators, or causes of a large number of diseases and disorders. To interfere with or modulate these processes, it is therefore of fundamental interest to understand the molecular mechanisms by which epigenetic regulation occurs. Here, we present results from molecular dynamics simulations of a doubly acetylated histone H4 peptide bound to the bromodomain of ATAD2 (hereafter referred to as ATAD2A). These simulations revealed how the flexibility of ATAD2A's major loop, the so-called ZA loop, creates an adaptable interface that preserves the disorder of both peptide and loop in the bound state. We further demonstrate that the binding involves an almost identical average pattern of interactions irrespective of which acetyl mark is inserted into the pocket. In conjunction with a likely mechanism of electrostatically driven recruitment, our simulation results highlight how the bromodomain is built toward promiscuous binding with low specificity. In conclusion, the simulations indicate that disorder and electrostatic steering function jointly to recruit ATAD2A to the histone core and that these fuzzy interactions may promote cooperativity between nearby epigenetic marks.	[Langini, Cassiano; Caflisch, Amedeo; Vitalis, Andreas] Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland	University of Zurich	Vitalis, A (corresponding author), Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	caflisch@bioc.uzh.ch; vitalis@bioc.uzh.ch		Caflisch, Amedeo/0000-0002-2317-6792	Swiss National Science Foundation [149897]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Grant 149897 from the Swiss National Science Foundation (to A. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Bamborough P, 2015, J MED CHEM, V58, P6151, DOI 10.1021/acs.jmedchem.5b00773; Barth TK, 2010, TRENDS BIOCHEM SCI, V35, P618, DOI 10.1016/j.tibs.2010.05.006; Bjorneras J, 2014, FEBS J, V281, P814, DOI 10.1111/febs.12626; Blochliger N, 2015, BIOPHYS J, V108, P2362, DOI 10.1016/j.bpj.2015.03.038; Blochliger N, 2014, SCI REP-UK, V4, DOI 10.1038/srep06264; Blochliger N, 2013, COMPUT PHYS COMMUN, V184, P2446, DOI 10.1016/j.cpc.2013.06.009; Caron C, 2010, ONCOGENE, V29, P5171, DOI 10.1038/onc.2010.259; Chaikuad A, 2014, MEDCHEMCOMM, V5, P1843, DOI 10.1039/c4md00237g; Ciro M, 2009, CANCER RES, V69, P8491, DOI 10.1158/0008-5472.CAN-09-2131; Convertino M, 2011, J BIOL CHEM, V286, P41578, DOI 10.1074/jbc.M111.285957; Demont EH, 2015, J MED CHEM, V58, P5649, DOI 10.1021/acs.jmedchem.5b00772; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Duan ZJ, 2013, PROSTATE, V73, P455, DOI 10.1002/pros.22587; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Filippakopoulos P, 2012, FEBS LETT, V586, P2692, DOI 10.1016/j.febslet.2012.04.045; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Fuxreiter M, 2012, MOL BIOSYST, V8, P168, DOI 10.1039/c1mb05234a; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; Hansen JC, 2006, J BIOL CHEM, V281, P1853, DOI 10.1074/jbc.R500022200; Harner MJ, 2014, J MED CHEM, V57, P9687, DOI 10.1021/jm501035j; Hassan AH, 2007, BIOCHEM J, V402, P125, DOI 10.1042/BJ20060907; Jain AK, 2017, J MOL BIOL, V429, P2003, DOI 10.1016/j.jmb.2016.11.020; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kanno T, 2004, MOL CELL, V13, P33, DOI 10.1016/S1097-2765(03)00482-9; Kiel C, 2004, P NATL ACAD SCI USA, V101, P9223, DOI 10.1073/pnas.0401160101; Koo SJ, 2016, ONCOTARGET, V7, P70323, DOI 10.18632/oncotarget.11855; Magno A, 2013, J CHEM THEORY COMPUT, V9, P4225, DOI 10.1021/ct400361k; Marchand JR, 2016, J MED CHEM, V59, P9919, DOI 10.1021/acs.jmedchem.6b01258; Marchand JR, 2015, CHEMMEDCHEM, V10, P1327, DOI 10.1002/cmdc.201500141; Mazza D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks701; McAdams HH, 1999, TRENDS GENET, V15, P65, DOI 10.1016/S0168-9525(98)01659-X; Minezaki Y, 2006, J MOL BIOL, V359, P1137, DOI 10.1016/j.jmb.2006.04.016; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Morozumi Y, 2016, J MOL CELL BIOL, V8, P349, DOI 10.1093/jmcb/mjv060; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Peng ZL, 2012, MOL BIOSYST, V8, P1886, DOI 10.1039/c2mb25102g; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; Philpott M, 2011, MOL BIOSYST, V7, P2899, DOI 10.1039/c1mb05099k; Poncet-Montange G, 2015, BIOCHEM J, V466, P337, DOI 10.1042/BJ20140933; Potoyan DA, 2012, P NATL ACAD SCI USA, V109, P17857, DOI 10.1073/pnas.1201805109; Rando OJ, 2012, CURR OPIN GENET DEV, V22, P148, DOI 10.1016/j.gde.2012.02.013; Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750; Revenko AS, 2010, MOL CELL BIOL, V30, P5260, DOI 10.1128/MCB.00484-10; Sanchez R, 2014, BBA-GENE REGUL MECH, V1839, P676, DOI 10.1016/j.bbagrm.2014.03.011; Schreiber G, 1996, NAT STRUCT BIOL, V3, P427, DOI 10.1038/nsb0596-427; Schreiber G, 2009, CHEM REV, V109, P839, DOI 10.1021/cr800373w; Shi JW, 2014, MOL CELL, V54, P728, DOI 10.1016/j.molcel.2014.05.016; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; SOBEL RE, 1995, P NATL ACAD SCI USA, V92, P1237, DOI 10.1073/pnas.92.4.1237; Steffen PA, 2012, BIOESSAYS, V34, P901, DOI 10.1002/bies.201200076; Steiner S, 2013, FEBS LETT, V587, P2158, DOI 10.1016/j.febslet.2013.05.032; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; Tompa P, 2015, CURR OPIN STRUC BIOL, V35, P49, DOI 10.1016/j.sbi.2015.08.009; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Unzue A, 2016, J MED CHEM, V59, P3087, DOI 10.1021/acs.jmedchem.5b01757; Vitalis A, 2012, J CHEM THEORY COMPUT, V8, P1108, DOI 10.1021/ct200801b; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Xu Y, 2017, NUCLEIC ACIDS RES, V45, pD264, DOI 10.1093/nar/gkw1011; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9; Zheng YP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3203; Zhu J, 2016, J MED CHEM, V59, P5555, DOI 10.1021/acs.jmedchem.6b00215	65	19	19	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16734	16745		10.1074/jbc.M117.786350	http://dx.doi.org/10.1074/jbc.M117.786350			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28798233	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000412414800032
J	Kamizaki, K; Doi, R; Hayashi, M; Saji, T; Kanagawa, M; Toda, T; Fukada, S; Ho, HYH; Greenberg, ME; Endo, M; Minami, Y				Kamizaki, Koki; Doi, Ryosuke; Hayashi, Makoto; Saji, Takeshi; Kanagawa, Motoi; Toda, Tatsushi; Fukada, So-ichiro; Ho, Hsin-Yi Henry; Greenberg, Michael Eldon; Endo, Mitsuharu; Minami, Yasuhiro			The Ror1 receptor tyrosine kinase plays a critical role in regulating satellite cell proliferation during regeneration of injured muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE; POLARITY PATHWAY; BINDING-SITES; EXPRESSION; GENE; MORPHOGENESIS; ACTIVATION; PROMOTES; PAX7; MICE	The Ror family receptor tyrosine kinases, Ror1 and Ror2, play important roles in regulating developmental morphogenesis and tissue-and organogenesis, but their roles in tissue regeneration in adult animals remain largely unknown. In this study, we examined the expression and function of Ror1 and Ror2 during skeletal muscle regeneration. Using an in vivo skeletal muscle injury model, we show that expression of Ror1 and Ror2 in skeletal muscles is induced transiently by the inflammatory cytokines, TNF-alpha and IL-1 beta, after injury and that inhibition of TNF-alpha and IL-1 beta by neutralizing antibodies suppresses expression of Ror1 and Ror2 in injured muscles. Importantly, expression of Ror1, but not Ror2, was induced primarily in Pax7-positive satellite cells (SCs) after muscle injury, and administration of neutralizing antibodies decreased the proportion of Pax7positive proliferative SCs after muscle injury. We also found that stimulation of a mouse myogenic cell line, C2C12 cells, with TNF-alpha or IL-1 beta induced expression of Ror1 via NF-kappa B activation and that suppressed expression of Ror1 inhibited their proliferative responses in SCs. Intriguingly, SC-specific depletion of Ror1 decreased the number of Pax7-positive SCs after muscle injury. Collectively, these findings indicate for the first time that Ror1 has a critical role in regulating SC proliferation during skeletal muscle regeneration. Weconclude that Ror1 might be a suitable target in the development of diagnostic and therapeutic approaches to manage muscular disorders.	[Kamizaki, Koki; Doi, Ryosuke; Hayashi, Makoto; Saji, Takeshi; Endo, Mitsuharu; Minami, Yasuhiro] Kobe Univ, Grad Sch Med, Div Cell Physiol, Dept Physiol & Cell Biol, Kobe, Hyogo 6500017, Japan; [Kanagawa, Motoi; Toda, Tatsushi] Kobe Univ, Grad Sch Med, Div Neurol Mol Brain Sci, Kobe, Hyogo 6500017, Japan; [Fukada, So-ichiro] Osaka Univ, Lab Mol & Cellular Physiol, Grad Sch Pharmaceut Sci, Osaka 5650871, Japan; [Ho, Hsin-Yi Henry; Greenberg, Michael Eldon] Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA; [Ho, Hsin-Yi Henry] Univ Calif Davis, Sch Med, Dept Cell Biol & Human Anat, Davis, CA 95616 USA	Kobe University; Kobe University; Osaka University; Harvard University; Harvard Medical School; University of California System; University of California Davis	Minami, Y (corresponding author), Kobe Univ, Grad Sch Med, Div Cell Physiol, Dept Physiol & Cell Biol, Kobe, Hyogo 6500017, Japan.	minami@kobe-u.ac.jp	Fukada, So-ichiro/AAI-9151-2020	Fukada, So-ichiro/0000-0003-4051-5108; Kanagawa, Motoi/0000-0003-0984-6398; DOI, RYOSUKE/0000-0002-1725-2082	Scientific Research on Innovative Areas [23112007]; Ministry of Education, Culture, Sports, Science and Technology, Japan [26670157];  [15K18968];  [17K15596];  [16H05152]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM119574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045500] Funding Source: NIH RePORTER	Scientific Research on Innovative Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Grants-in-aid for Young Scientists (B) 15K18968 and 17K15596 (to M.H.), for Scientific Research (B) 16H05152 (to Y.M.), for Scientific Research on Innovative Areas 23112007 (to Y.M.), and for Challenging Exploratory Research 26670157 (to Y.M.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Bentzinger CF, 2014, J CELL BIOL, V205, P97, DOI 10.1083/jcb.201310035; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen SE, 2007, AM J PHYSIOL-CELL PH, V292, pC1660, DOI 10.1152/ajpcell.00486.2006; DEMARTIN R, 1993, EMBO J, V12, P2773, DOI 10.1002/j.1460-2075.1993.tb05938.x; Diaz-Horta O, 2016, P NATL ACAD SCI USA, V113, P5993, DOI 10.1073/pnas.1522512113; Doi R, 2014, GENES CELLS, V19, P287, DOI 10.1111/gtc.12132; Endo M., 2015, RECEPTOR TYROSINE KI, P593; Endo M, 2017, GLIA, V65, P182, DOI 10.1002/glia.23086; Endo M, 2012, J CELL SCI, V125, P2017, DOI 10.1242/jcs.097782; Enomoto M, 2009, ONCOGENE, V28, P3197, DOI 10.1038/onc.2009.175; Fukada S, 2004, EXP CELL RES, V296, P245, DOI 10.1016/j.yexcr.2004.02.018; Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105; Fukuyo S, 2014, RHEUMATOLOGY, V53, P1282, DOI 10.1093/rheumatology/ket496; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; Gentile A, 2011, CANCER RES, V71, P3132, DOI 10.1158/0008-5472.CAN-10-2662; Green JL, 2008, TRENDS CELL BIOL, V18, P536, DOI 10.1016/j.tcb.2008.08.006; He FL, 2008, DEVELOPMENT, V135, P3871, DOI 10.1242/dev.025767; Ho HYH, 2012, P NATL ACAD SCI USA, V109, P4044, DOI 10.1073/pnas.1200421109; Laird DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002428; Langen RCJ, 2001, FASEB J, V15, P1169, DOI 10.1096/fj.00-0463; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; LENARDO M, 1987, SCIENCE, V236, P1573, DOI 10.1126/science.3109035; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Li X, 2013, GENES CELLS, V18, P608, DOI 10.1111/gtc.12064; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; MCGEACHIE JK, 1987, CELL TISSUE RES, V248, P125, DOI 10.1007/BF01239972; Minami Y, 2010, DEV DYNAM, V239, P1, DOI 10.1002/dvdy.21991; Miyoshi H, 2012, SCIENCE, V338, P108, DOI 10.1126/science.1223821; Nishita M, 2014, MOL CELL BIOL, V34, P3096, DOI 10.1128/MCB.00491-14; Nishita M, 2010, TRENDS CELL BIOL, V20, P346, DOI 10.1016/j.tcb.2010.03.001; Nomi M, 2001, MOL CELL BIOL, V21, P8329, DOI 10.1128/MCB.21.24.8329-8335.2001; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Otis JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092363; Otto A, 2008, J CELL SCI, V121, P2939, DOI 10.1242/jcs.026534; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Parisi A, 2015, J CELL BIOL, V210, P717, DOI 10.1083/jcb.201501053; Sato A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10536; Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016; SCHINDLER U, 1994, MOL CELL BIOL, V14, P5820, DOI 10.1128/MCB.14.9.5820; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Segawa M, 2008, EXP CELL RES, V314, P3232, DOI 10.1016/j.yexcr.2008.08.008; Tanaka Shingo, 2011, J Mol Signal, V6, P12, DOI 10.1186/1750-2187-6-12; Tidball JG, 2011, COMPR PHYSIOL, V1, P2029, DOI 10.1002/cphy.c100092; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; von Maltzahn J, 2012, TRENDS CELL BIOL, V22, P602, DOI 10.1016/j.tcb.2012.07.008; von Maltzahn J, 2012, NAT CELL BIOL, V14, P186, DOI 10.1038/ncb2404; Wright TM, 2009, ONCOGENE, V28, P2513, DOI 10.1038/onc.2009.116; Yamaguchi T, 2012, CANCER CELL, V21, P348, DOI 10.1016/j.ccr.2012.02.008; Yamamoto H, 2010, ONCOGENE, V29, P2036, DOI 10.1038/onc.2009.496; Yamamoto S, 2008, DEV CELL, V15, P23, DOI 10.1016/j.devcel.2008.05.007	50	18	18	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15939	15951		10.1074/jbc.M117.785709	http://dx.doi.org/10.1074/jbc.M117.785709			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28790171	Green Published, hybrid			2022-12-26	WOS:000411512200030
J	Nicholas, SE; Rowsey, TG; Priyadarsini, S; Mandal, NA; Karamichos, D				Nicholas, Sarah E.; Rowsey, Tyler G.; Priyadarsini, Shrestha; Mandal, Nawajes A.; Karamichos, Dimitrios			Unravelling the interplay of sphingolipids and TGF-beta signaling in the human corneal stroma	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; IN-VITRO MODEL; 1-PHOSPHATE STIMULATES PROLIFERATION; HUMAN HEPATIC MYOFIBROBLASTS; RECEPTOR EXPRESSION PROFILE; ENDOTHELIAL-CELL MIGRATION; MULLER GLIAL-CELLS; SPHINGOSINE 1-PHOSPHATE; CANCER CELLS; EXTRACELLULAR-MATRIX	Purpose To delineate the role of Sphingolipids (SPLs) in the human cornea and their cross-talks with transforming growth factor beta (TGF-beta) in order to develop novel, non-invasive therapies. Methods Human corneal fibroblasts (HCFs) were harvested from healthy donors, stimulated with Vitamin C to promote extracellular matrix assembly, treated with exogenous sphingosine-1-phosphate (S1P) or sphingosine kinase inhibitor 2 (SPHK I-2) and isolated after 4 weeks for further analysis. Results Data showed that S1P led to a significant decrease in cellular migration where SPHK I-2 just delayed it for 24h. Significant modulation of the sphingolipid pathway was also noted. Sphingosine kinase-1 (SphK1) was significantly downregulated upon exogenous stimulation with S1P at a concentration of 5 mu M and Sphingosine kinase-2 (SphK2) was also significantly downregulated at concentrations of 0.01 mu M, 0.1 mu M, and 5 mu M; whereas no effects were observed upon stimulation with SPHK I-2. S1PR3 was significantly downregulated by 0.1 mu M and 5 mu M S1P and upregulated by 5 mu M and 10 mu M SPHK I-2. Furthermore, both S1P and SPHK I-2 regulated corneal fibrosis markers such as alpha-smooth muscle actin, collagen I, III, and V. We also investigated the interplay between two TGF-beta isoforms and S1P/SPHK I-2 treatments and found that TGF-beta 1 and TGF-beta 3 were both significantly upregulated with the 0.1 mu M S1P but were significantly downregulated with the 5 mu M S1P concentration. When TGF-beta 1 was compared directly to TGF-beta 3 expression, we observed that TGF-beta 3 was significantly downregulated compared to TGF-beta 1 in the 5 mu M concentration of S1P. No changes were observed upon SPHK I-2 treatment. Conclusion Our study delineates the role of sphingolipids in the human cornea and highlights their different activities based on the cell/tissue type.	[Nicholas, Sarah E.; Rowsey, Tyler G.; Priyadarsini, Shrestha; Karamichos, Dimitrios] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Dean McGee Eye Inst, Oklahoma City, OK 73104 USA; [Rowsey, Tyler G.] Univ Oklahoma, Coll Med, Oklahoma City, OK 73190 USA; [Mandal, Nawajes A.] Univ Tennessee, Dept Ophthalmol, Hlth Sci Ctr, Memphis, TN USA; [Mandal, Nawajes A.] Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Memphis, TN USA; [Karamichos, Dimitrios] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Karamichos, D (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Dean McGee Eye Inst, Oklahoma City, OK 73104 USA.; Karamichos, D (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA.	dimitrios-karamichos@ouhsc.edu		karamichos, dimitrios/0000-0002-8761-3824	National Eye Institute [EY025256]; NEI, NIH; DMEI; NATIONAL EYE INSTITUTE [R01EY022071] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); DMEI; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Eye Institute: EY025256 (DK; NAM), Website:https://nei.nih.gov/.; The authors would like to thank NEI, NIH, and DMEI for their support, Rabab Sharif, M.D. for proofreading of the manuscript, and Tina B. McKay, Ph.D. for useful discussions and advice.	Alewijnse AE, 2004, BRIT J PHARMACOL, V143, P666, DOI 10.1038/sj.bjp.0705934; Anliker B, 2004, SEMIN CELL DEV BIOL, V15, P457, DOI 10.1016/j.semcdb.2004.05.005; Arikawa K, 2003, J BIOL CHEM, V278, P32841, DOI 10.1074/jbc.M305024200; Balthasar S, 2006, BIOCHEM J, V398, P547, DOI 10.1042/BJ20060299; Baradaran-Rafii A KF, 2007, IRANIAN J OPHTHALMIC, V2, P7; Beales MP, 1999, INVEST OPHTH VIS SCI, V40, P1658; Becciolini L, 2006, BBA-MOL CELL BIOL L, V1761, P43, DOI 10.1016/j.bbalip.2006.01.006; Brocklyn James R Van, 2010, World J Biol Chem, V1, P307, DOI 10.4331/wjbc.v1.i10.307; Brush RS, 2010, INVEST OPHTH VIS SCI, V51, P4422, DOI 10.1167/iovs.09-5134; Bu S, 2008, J BIOL CHEM, V283, P19593, DOI 10.1074/jbc.M802417200; Buccoliero R, 2003, PHARMACOL RES, V47, P409, DOI 10.1016/S1043-6618(03)00049-5; Caballero S, 2009, EXP EYE RES, V88, P367, DOI 10.1016/j.exer.2008.07.012; Calise S, 2012, BBA-MOL CELL RES, V1823, P439, DOI 10.1016/j.bbamcr.2011.11.016; Chae SS, 2004, J CLIN INVEST, V114, P1082, DOI 10.1172/JCI200422716; Chirila TV, 2001, BIOMATERIALS, V22, P3311, DOI 10.1016/S0142-9612(01)00168-5; Coster DJ, 2009, EYE, V23, P1894, DOI 10.1038/eye.2009.17; Davaille J, 2000, J BIOL CHEM, V275, P34628, DOI 10.1074/jbc.M006393200; Davaille J, 2002, J BIOL CHEM, V277, P37323, DOI 10.1074/jbc.M202798200; Esche M, 2010, NEUROSCI LETT, V480, P101, DOI 10.1016/j.neulet.2010.06.014; Fini ME, 1999, PROG RETIN EYE RES, V18, P529, DOI 10.1016/S1350-9462(98)00033-0; French KJ, 2003, CANCER RES, V63, P5962; Funderburgh JL, 2003, J BIOL CHEM, V278, P45629, DOI 10.1074/jbc.M303292200; Gallego-Munoz P, 2016, J TISSUE ENG REGEN M; Gellings Lowe N, 2009, CARDIOVASC RES, V82, P303, DOI 10.1093/cvr/cvp056; Guo XQ, 2007, INVEST OPHTH VIS SCI, V48, P4050, DOI 10.1167/iovs.06-1216; Hait NC, 2005, J BIOL CHEM, V280, P29462, DOI 10.1074/jbc.M502922200; Hisano N, 1999, BLOOD, V93, P4293, DOI 10.1182/blood.V93.12.4293.412k26_4293_4299; Hyder CL, 2015, J CELL SCI, V128, P2057, DOI 10.1242/jcs.160341; Ikeda H, 2009, J LIPID RES, V50, P556, DOI 10.1194/jlr.M800496-JLR200; Karamichos D, 2014, EXP EYE RES, V124, P31, DOI 10.1016/j.exer.2014.04.020; Karamichos D, 2011, J TISSUE ENG REGEN M, V5, pE228, DOI 10.1002/term.429; Karamichos D, 2012, J FUNCT BIOMATER, V3, P760, DOI 10.3390/jfb3040760; Karamichos D, 2010, INVEST OPHTH VIS SCI, V51, P1382, DOI 10.1167/iovs.09-3860; Karamichos D, 2009, CELL MOTIL CYTOSKEL, V66, P1, DOI 10.1002/cm.20326; Kawa S, 1997, FEBS LETT, V420, P196, DOI 10.1016/S0014-5793(97)01516-0; Kim DS, 2004, CELL SIGNAL, V16, P89, DOI 10.1016/S0898-6568(03)00114-1; Kimura T, 2000, BIOCHEM J, V348, P71, DOI 10.1042/0264-6021:3480071; Kon J, 1999, J BIOL CHEM, V274, P23940, DOI 10.1074/jbc.274.34.23940; Langlois S, 2004, BLOOD, V103, P3020, DOI 10.1182/blood-2003-08-2968; Lee OH, 1999, BIOCHEM BIOPH RES CO, V264, P743, DOI 10.1006/bbrc.1999.1586; Levade T, 2002, NEUROCHEM RES, V27, P601, DOI 10.1023/A:1020215815013; Li CY, 2011, J HEPATOL, V54, P1205, DOI 10.1016/j.jhep.2010.08.028; Li CY, 2009, AM J PATHOL, V175, P1464, DOI 10.2353/ajpath.2009.090037; Li MH, 2008, MOL CANCER RES, V6, P1649, DOI 10.1158/1541-7786.MCR-07-2048; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Litvak DA, 2003, J GASTROINTEST SURG, V7, P140, DOI 10.1016/S1091-255X(02)00126-9; Liu XH, 2011, J CELL PHYSIOL, V226, P2370, DOI 10.1002/jcp.22572; Maceyka M, 2008, MOL CELL BIOL, V28, P5687, DOI 10.1128/MCB.00465-08; McVerry BJ, 2004, J CELL BIOCHEM, V92, P1075, DOI 10.1002/jcb.20088; Means CK, 2009, CARDIOVASC RES, V82, P193, DOI 10.1093/cvr/cvp086; Niederkorn JY, 2003, J LEUKOCYTE BIOL, V74, P167, DOI 10.1189/jlb.1102543; Osada M, 2002, BIOCHEM BIOPH RES CO, V299, P483, DOI 10.1016/S0006-291X(02)02671-2; Osborne N, 2003, ANNU REV PHYSIOL, V65, P23, DOI 10.1146/annurev.physiol.65.092101.142235; Paik JH, 2001, J BIOL CHEM, V276, P11830, DOI 10.1074/jbc.M009422200; Payne SG, 2002, FEBS LETT, V531, P54, DOI 10.1016/S0014-5793(02)03480-4; Priyadarsini S, 2016, EXP EYE RES, V153, P90, DOI 10.1016/j.exer.2016.10.010; Qi H, 2017, J LIPID RES; Radeke HH, 2005, J IMMUNOL, V174, P2778, DOI 10.4049/jimmunol.174.5.2778; Rao PV, 2014, J OCUL PHARMACOL TH, V30, P181, DOI 10.1089/jop.2013.0194; Riboni L, 2002, GLIA, V39, P105, DOI 10.1002/glia.10087; Riboni L, 2002, NEUROCHEM RES, V27, P711, DOI 10.1023/A:1020236419556; Sabbadini RA, 2011, BRIT J PHARMACOL, V162, P1225, DOI 10.1111/j.1476-5381.2010.01118.x; Sauer B, 2004, J BIOL CHEM, V279, P38471, DOI 10.1074/jbc.M313557200; Serriere-Lanneau V, 2007, FASEB J, V21, P2005, DOI 10.1096/fj.06-6889com; Shea Barry S, 2012, Open Rheumatol J, V6, P123, DOI 10.2174/1874312901206010123; Shea BS, 2010, AM J RESP CELL MOL, V43, P662, DOI 10.1165/rcmb.2009-0345OC; Simon MV, 2015, INVEST OPHTH VIS SCI, V56, P5808, DOI 10.1167/iovs.14-16195; Spiegel S, 2000, FEBS LETT, V476, P55, DOI 10.1016/S0014-5793(00)01670-7; Swaney JS, 2008, EXP EYE RES, V87, P367, DOI 10.1016/j.exer.2008.07.005; Takuwa N, 2010, CARDIOVASC RES, V85, P484, DOI 10.1093/cvr/cvp312; Takuwa Y, 2013, BBA-MOL CELL BIOL L, V1831, P185, DOI 10.1016/j.bbalip.2012.06.008; Takuwa Y, 2012, BIOFACTORS, V38, P329, DOI 10.1002/biof.1030; Wang F, 1999, J BIOL CHEM, V274, P35343, DOI 10.1074/jbc.274.50.35343; Watsky MA, 2010, INT REV CEL MOL BIO, V282, P165, DOI 10.1016/S1937-6448(10)82004-0; Watterson K, 2003, PROG LIPID RES, V42, P344, DOI 10.1016/S0163-7827(03)00015-8; Watterson KR, 2007, WOUND REPAIR REGEN, V15, P607, DOI 10.1111/j.1524-475X.2007.00292.x; Wendler CC, 2006, DEV BIOL, V291, P264, DOI 10.1016/j.ydbio.2005.12.013; Wilson SE, 2012, EXP EYE RES, V99, P78, DOI 10.1016/j.exer.2012.03.018; Xin CY, 2004, J BIOL CHEM, V279, P35255, DOI 10.1074/jbc.M312091200; Yamanaka M, 2004, J BIOL CHEM, V279, P53994, DOI 10.1074/jbc.M410144200; Yamashita H, 2006, J SURG RES, V130, P80, DOI 10.1016/j.jss.2005.08.004; ZHANG H, 1991, J CELL BIOL, V114, P155, DOI 10.1083/jcb.114.1.155; Zieske JD, 2001, CURR OPIN OPHTHALMOL, V12, P237, DOI 10.1097/00055735-200108000-00001	83	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2017	12	8							e0182390	10.1371/journal.pone.0182390	http://dx.doi.org/10.1371/journal.pone.0182390			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD5CP	28806736	Green Submitted, Green Published, gold			2022-12-26	WOS:000407548800019
J	Vasquez, AL; Errea, RA; Hoces, D; Echevarria, J; Gonzalez-Lagos, E; Gotuzzo, E				Vasquez, Ana L.; Errea, Renato A.; Hoces, Daniel; Echevarria, Juan; Gonzalez-Lagos, Elsa; Gotuzzo, Eduardo			Missed opportunities for HIV control: Gaps in HIV testing for partners of people living with HIV in Lima, Peru	PLOS ONE			English	Article							UNITED-STATES; CARE; INFECTION; PREVENTION; LINKAGE; SEX; MEN; DISCLOSURE; ADVANTAGES; RETENTION	Introduction Based on the hypothesis that HIV programs struggle to deliver health services that harmonize necessities of treatment and prevention, we described the outcomes of routinely provided HIV testing to partners of people living with HIV (PLWH) through a secondary analysis of routine data collected at a public hospital in Lima, Peru. Methods Among PLWH enrolled in the study center's HIV program between 2005 and 2014, we identified index cases (IC): PLWH who reported a unique partner not previously enrolled. We grouped partners according to their HIV status as reported by IC and collected data on HIV testing, clinical characteristics and admissions. The main outcome was the frequency of HIV testing among partners with reported unknown/seronegative HIV status. Results Out of 1586 PLWH who reported a unique partner at enrollment, 171 had a previously enrolled partner, leaving 1415 (89%) IC. HIV status of the partner was reported as unknown in 571 (40%), seronegative in 325 (23%) and seropositive in 519 (37%). Out of 896 partners in the unknown/seronegative group, 72 (8%) had HIV testing, 42/72 (58%) tested within three months of IC enrollment. Among the 49/72 (68%) who tested positive for HIV, 33 (67%) were enrolled in the HIV program. The proportion in WHO clinical stage IV was lower in enrolled partners compared to IC (37% vs 9%, p = 0.04). Non-tested partners (824) were likely reachable by the hospital, as 297/824 (36%) of their IC were admitted in the study center at least once, 51/243 (21%) female IC had received pregnancy care at the study center, and 401/692 (64%) of IC on antiretroviral therapy had achieved viral suppression, implying frequent visits to the hospital for pill pick-up. Conclusion In this setting, HIV testing of partners of PLWH was suboptimal, illustrating missed opportunities for HIV control. Integration of HIV strategies in primarily clinical-oriented services is a challenging need.	[Vasquez, Ana L.; Errea, Renato A.; Hoces, Daniel; Echevarria, Juan; Gonzalez-Lagos, Elsa; Gotuzzo, Eduardo] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Vasquez, Ana L.; Errea, Renato A.; Echevarria, Juan; Gonzalez-Lagos, Elsa; Gotuzzo, Eduardo] Univ Peruana Cayetano Heredia, Fac Med, Lima, Peru; [Echevarria, Juan; Gotuzzo, Eduardo] Hosp Cayetano Heredia, Dept Enfermedades Infecciosas Trop & Dermatol, Lima, Peru	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia	Vasquez, AL (corresponding author), Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru.; Vasquez, AL (corresponding author), Univ Peruana Cayetano Heredia, Fac Med, Lima, Peru.	ana.vasquez.c@upch.pe	Hoces, Daniel/GLN-3941-2022	Hoces, Daniel/0000-0002-1451-5166; Vasquez Choy, Ana Lucia/0000-0001-9634-151X	John E.Fogarty International Center of the National Institutes of Health of the United States (NIH) [D43TW00976301]; FOGARTY INTERNATIONAL CENTER [D43TW009763] Funding Source: NIH RePORTER	John E.Fogarty International Center of the National Institutes of Health of the United States (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by Training Grant D43TW00976301 of John E.Fogarty International Center of the National Institutes of Health of the United States (NIH).	Ahmed S, 2016, TROP MED INT HEALTH, V21, P479, DOI 10.1111/tmi.12671; Aluisio A, 2011, JAIDS-J ACQ IMM DEF, V56, P76, DOI 10.1097/QAI.0b013e3181fdb4c4; Andrade L, 2008, REVISION ADHERENCIA; Aral S, 2004, CLIN INFECT DIS, V38, P104, DOI 10.1086/380131; Bavinton BR, 2016, AIDS BEHAV, V20, P1777, DOI 10.1007/s10461-016-1354-5; Bott S, 2013, SAHARA J-J SOC ASP H, V10, pS5, DOI 10.1080/02664763.2012.755319; Centers for Disease Control, 2008, MMWR RECOMM REP, V57, pCE1, DOI DOI 10.2307/42001003; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Crabtree-Ramirez B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020272; Czaicki NL, 2014, JAIDS-J ACQ IMM DEF, V66, pE1, DOI 10.1097/QAI.0000000000000076; Desgrees-Du-Lou A, 2009, AIDS BEHAV, V13, P348, DOI 10.1007/s10461-007-9316-6; El-Bassel N, 2010, JAIDS-J ACQ IMM DEF, V55, pS98, DOI 10.1097/QAI.0b013e3181fbf407; Farquhar C, 2004, JAIDS-J ACQ IMM DEF, V37, P1620, DOI 10.1097/00126334-200412150-00016; Gullon A, 2016, AIDS CARE, V28, P1296, DOI 10.1080/09540121.2016.1178700; Hightow-Weidman LB, 2011, AIDS PATIENT CARE ST, V25, pS31, DOI 10.1089/apc.2011.9878; Hoces D., 2015, OPEN FORUM INFECT DI, V2, DOI [10.1093/ofid/ofv133.282, DOI 10.1093/OFID/OFV133.282]; International Antiviral Society-USA, 2015, TOP ANTIVIR MED, V22, P702; Jiwatram-Negron T, 2014, AIDS BEHAV, V18, P1864, DOI 10.1007/s10461-014-0827-7; Joore IK, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009194; Bustamante MJ, 2017, INT J STD AIDS, V28, P133, DOI 10.1177/0956462416630674; Kairania RM, 2010, AIDS CARE, V22, P1041, DOI 10.1080/09540121003602226; Ketels B, 2012, MED LAW REV, V20, P399, DOI 10.1093/medlaw/fws010; Knapp H, 2015, VALUE HEALTH, V18, P735, DOI 10.1016/j.jval.2015.02.019; Konda KA, 2017, AIDS BEHAV, V21, P152, DOI 10.1007/s10461-016-1444-4; May M, 2007, AIDS, V21, P1185, DOI 10.1097/QAD.0b013e328133f285; MINSA, 2006, GUIA NAC AT INT PERS; MINSA, 2006, GUIA NAC CONS ITS HI; MINSA, 2012, NORM TECN SAULD AT I; MINSA, 2004, NORM TECN TRAT ANT G; MINSA, 2014, INF NAC PROGR REAL P; Mugavero MJ, 2013, CLIN INFECT DIS, V57, P1164, DOI 10.1093/cid/cit420; Nakao JH, 2014, INT J STD AIDS, V25, P887, DOI 10.1177/0956462414523944; Onotai L O, 2004, Niger J Med, V13, P282; Pineirua A, 2015, LANCET INFECT DIS, V15, P833, DOI 10.1016/S1473-3099(15)00108-5; Pollock L, 2016, GLOB PUBLIC HEALTH, V11, P981, DOI 10.1080/17441692.2016.1167932; Pulerwitz J, 2010, PUBLIC HEALTH REP, V125, P272, DOI 10.1177/003335491012500218; Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283; Rosenberg NE, 2013, JAIDS-J ACQ IMM DEF, V62, P226, DOI 10.1097/QAI.0b013e31827971ca; Rothman RE, 2012, ACAD EMERG MED, V19, P497, DOI 10.1111/j.1553-2712.2012.01351.x; Rynn L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Simbayi LC, 2017, AIDS BEHAV, V21, P82, DOI 10.1007/s10461-015-1278-5; Stephenson R, 2015, AIDS BEHAV, V19, P553, DOI 10.1007/s10461-014-0862-4; UNAIDS, 2010, STRAT GUID EV HIV PR; UNAIDS, 2014, THE GAP REP; Valenzuela C, 2015, AIDS BEHAV, V19, P235, DOI 10.1007/s10461-014-0908-7; Ward Helen, 2014, Medicine (Abingdon), V42, P314; World Health Organization, 2012, GUID OR PREEXP PROPH	47	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2017	12	8							e0181412	10.1371/journal.pone.0181412	http://dx.doi.org/10.1371/journal.pone.0181412			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD5CP	28806412	gold, Green Published, Green Submitted			2022-12-26	WOS:000407548800006
J	Hall, CE; Koparde, VN; Jameson-Lee, M; Elnasseh, AG; Scalora, AF; Kobulnicky, DJ; Serrano, MG; Roberts, CH; Buck, GA; Neale, MC; Nixon, DE; Toor, AA				Hall, Charles E.; Koparde, Vishal N.; Jameson-Lee, Maximilian; Elnasseh, Abdelrhman G.; Scalora, Allison F.; Kobulnicky, David J.; Serrano, Myrna G.; Roberts, Catherine H.; Buck, Gregory A.; Neale, Michael C.; Nixon, Daniel E.; Toor, Amir A.			Sequence homology between HLA-bound cytomegalovirus and human peptides: A potential trigger for alloreactivity	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; ACUTE MYELOID-LEUKEMIA; VERSUS-HOST-DISEASE; CROSS-REACTIVITY; T-CELLS; IMMUNE RECONSTITUTION; MASS-SPECTROMETRY; CMV REACTIVATION; ANTIGEN; RISK	Human cytomegalovirus (hCMV) reactivation may often coincide with the development of graft-versus-host-disease (GVHD) in stem cell transplantation (SCT). Seventy seven SCT donor-recipient pairs (DRP) (HLA matched unrelated donor (MUD), n = 50; matched related donor (MRD), n = 27) underwent whole exome sequencing to identify single nucleotide polymorphisms (SNPs) generating alloreactive peptide libraries for each DRP (9-mer peptide-HLA complexes); Human CMV CROSS (Cross-Reactive Open Source Sequence) database was compiled from NCBI; HLA class I binding affinity for each DRPs HLA was calculated by NetMHCpan 2.8 and hCMV- derived 9-mers algorithmically compared to the alloreactive peptide-HLA complex libraries. Short consecutive (>= 6) amino acid (AA) sequence homology matching hCMV to recipient peptides was considered for HLA-bound-peptide (IC50<500nM) cross reactivity. Of the 70,686 hCMV 9-mers contained within the hCMV CROSS database, an average of 29,658 matched the MRD DRP alloreactive peptides and 52,910 matched MUD DRP peptides (p<0.001). In silico analysis revealed multiple high affinity, immunogenic CMV-Human peptide matches (IC50<500 nM) expressed in GVHD-affected tissue-specific manner. hCMV+GVHD was found in 18 patients, 13 developing hCMV viremia before GVHD onset. Analysis of patients with GVHD identified potential cross reactive peptide expression within affected organs. We propose that hCMV peptide sequence homology with human alloreactive peptides may contribute to the pathophysiology of GVHD.	[Hall, Charles E.; Jameson-Lee, Maximilian; Elnasseh, Abdelrhman G.; Scalora, Allison F.; Kobulnicky, David J.; Buck, Gregory A.; Toor, Amir A.] Virginia Commonwealth Univ, Bone Marrow Transplant Program, Massey Canc Ctr, Richmond, VA 23284 USA; [Scalora, Allison F.; Buck, Gregory A.; Nixon, Daniel E.; Toor, Amir A.] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA; [Elnasseh, Abdelrhman G.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Toor, AA (corresponding author), Virginia Commonwealth Univ, Bone Marrow Transplant Program, Massey Canc Ctr, Richmond, VA 23284 USA.	amir.toor@vcuhealth.org	Neale, Michael/AAD-5056-2020; Toor, Amir Ahmed/GNM-9504-2022	Toor, Amir Ahmed/0000-0001-5317-8433; Koparde, Vishal/0000-0001-8978-8495	NIH-NCI Cancer Center Support Grant [P30-CA016059]; Virginia's Commonwealth Health Research Board Grant [236-11-13]	NIH-NCI Cancer Center Support Grant; Virginia's Commonwealth Health Research Board Grant	This study conducted at Virginia Commonwealth University's Massey Cancer Center was supported, in part, by research funding from the NIH-NCI Cancer Center Support Grant (P30-CA016059, Director, Gordon Ginder) to Amir Toor in the form of a Massey Pilot Project (https://projectreporter.nih.gov/reporter_SearchResults.cfm?icde=31442271) and by research funding from Virginia's Commonwealth Health Research Board Grant #236-11-13 to Michael Neale (http://www.chrb.org/linked_documents/2014%20CHRB%20Grant%20Awards%20and%20Recipients.pdf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study conducted at Virginia Commonwealth University's Massey Cancer Center was supported, in part, by research funding from the NIH-NCI Cancer Center Support Grant (P30-CA016059) to Amir Toor and by research funding from Virginia's Commonwealth Health Research Board Grant #236-11-13 to Michael Neale. Sequencing and Bioinformatics Analysis was performed in the Genomics Core of the Nucleic Acids Research Facilities at VCU. We appreciate the critical review of our work provided by Jeremy Meier, VCU student MD-PhD program, and all others who supported this work in some way.	Abelin JG, 2017, IMMUNITY, V46, P315, DOI 10.1016/j.immuni.2017.02.007; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amir AL, 2011, BLOOD, V118, P6733, DOI 10.1182/blood-2011-05-354787; Armistead PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023217; Bao XB, 2016, AM J TRANSL RES, V8, P653; Barrett AJ, 2011, BLOOD, V118, P1193, DOI 10.1182/blood-2011-06-354340; Bassani-Sternberg M, 2015, MOL CELL PROTEOMICS, V14, P658, DOI 10.1074/mcp.M114.042812; Birnbaum ME, 2014, CELL, V157, P1073, DOI 10.1016/j.cell.2014.03.047; Borbulevych OY, 2007, J MOL BIOL, V372, P1123, DOI 10.1016/j.jmb.2007.07.025; Cantoni N, 2010, BIOL BLOOD MARROW TR, V16, P1309, DOI 10.1016/j.bbmt.2010.03.020; Center for Biological Sequence Analysis Technical University of Denmark, 2016, CBS SOFTW DOWNL AM A; Crough T, 2012, IMMUNOL CELL BIOL, V90, P872, DOI 10.1038/icb.2012.19; Delogu LG, 2011, J INFECT DEV COUNTR, V5, P679, DOI 10.3855/jidc.2061; Derre L, 2008, P NATL ACAD SCI USA, V105, P15010, DOI 10.1073/pnas.0807954105; Elkington R, 2003, J VIROL, V77, P5226, DOI 10.1128/JVI.77.9.5226-5240.2003; Elmaagacli AH, 2011, BLOOD, V118, P1402, DOI 10.1182/blood-2010-08-304121; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; George B, 2012, TRANSPL INFECT DIS, V14, P141, DOI 10.1111/j.1399-3062.2011.00706.x; Gimenez E, 2016, TRANSPL INT, V29, P126, DOI 10.1111/tri.12689; Gotoh M, 2014, TRANSPL INFECT DIS, V16, P440, DOI 10.1111/tid.12229; GTEx Consortium, 2016, GENE EXPRESSION; Halenius A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/472978; Hemmer B, 1998, J IMMUNOL, V160, P3631; Hiemstra HS, 1998, J IMMUNOL, V161, P4078; Hiemstra HS, 2001, P NATL ACAD SCI USA, V98, P3988, DOI 10.1073/pnas.071050898; Hiemstra HS, 1999, EUR J IMMUNOL, V29, P2385, DOI 10.1002/(SICI)1521-4141(199908)29:08<2385::AID-IMMU2385>3.0.CO;2-B; IEDB Analysis Resource, 2016, MHC I BIND PRED DOWN; Jackson SE, 2011, VIRUS RES, V157, P151, DOI 10.1016/j.virusres.2010.10.031; Jameson-Lee M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00529; Jaskula E, 2010, TRANSPL P, V42, P3273, DOI 10.1016/j.transproceed.2010.07.027; Jaskula E, 2012, BONE MARROW RES, DOI 10.1155/2012/375075; Krenger W, 2011, BLOOD, V117, P6768, DOI 10.1182/blood-2011-02-334623; Ljungman P, 1998, BONE MARROW TRANSPL, V21, pS72; Ljungman P, 2006, HAEMATOLOGICA, V91, P78; Ljungman P, 2011, HEMATOL ONCOL CLIN N, V25, P151, DOI 10.1016/j.hoc.2010.11.011; Manjappa S, 2014, BIOL BLOOD MARROW TR, V20, P46, DOI 10.1016/j.bbmt.2013.10.003; Mason D, 1998, IMMUNOL TODAY, V19, P395, DOI 10.1016/S0167-5699(98)01299-7; MILLER W, 1986, BLOOD, V67, P1162; Motozono C, 2014, MICROBES INFECT, V16, P320, DOI 10.1016/j.micinf.2013.12.005; Motozono C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066152; Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215; National Center for Biotechnology Information, HUM CYT; Nguyen THO, 2014, J IMMUNOL, V192, P5039, DOI 10.4049/jimmunol.1303147; Paine A, 2010, J IMMUNOTHER, V33, P60, DOI 10.1097/CJI.0b013e3181b56dcc; Peters HL, 2017, CANC IMMUNOL RES; Razzaq BA, 2016, BIOL BLOOD MARROW TR, V22, P850, DOI 10.1016/j.bbmt.2015.11.1103; Regner M, 2001, IMMUNOL CELL BIOL, V79, P91, DOI 10.1046/j.1440-1711.2001.00994.x; Sampson JK, 2014, BRIT J HAEMATOL, V166, P566, DOI 10.1111/bjh.12898; Scheper W, 2013, LEUKEMIA, V27, P1328, DOI 10.1038/leu.2012.374; Schuessler A, 2014, CANCER RES, V74, P3466, DOI 10.1158/0008-5472.CAN-14-0296; Scrivano L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001256; Sewell AK, 2012, NAT REV IMMUNOL, V12, P668, DOI 10.1038/nri3279; Sijmons S, 2014, VIRUSES-BASEL, V6, P1049, DOI 10.3390/v6031049; Snyder LD, 2010, AM J RESP CRIT CARE, V181, P1391, DOI 10.1164/rccm.200911-1786OC; Suessmuth Y, 2015, BLOOD, V125, P3835, DOI 10.1182/blood-2015-03-631853; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Takenaka K, 2015, BIOL BLOOD MARROW TR, V21, P2008, DOI 10.1016/j.bbmt.2015.07.019; Teira P, 2016, BLOOD, V127, P2427, DOI 10.1182/blood-2015-11-679639; Tong CY, 2002, TRANSPLANTATION, P74; Toor AA, 2015, BIOL BLOOD MARROW TR, V21, P1237, DOI 10.1016/j.bbmt.2015.03.011; U. S. National Library of Medicine, 2016, CYT INF; Vanheusden M, 2015, TRENDS MOL MED, V21, P16, DOI 10.1016/j.molmed.2014.11.002; Varani Stefania, 2011, Herpesviridae, V2, P6, DOI 10.1186/2042-4280-2-6; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang LR, 2008, BONE MARROW TRANSPL, V42, P673, DOI 10.1038/bmt.2008.238	65	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0178763	10.1371/journal.pone.0178763	http://dx.doi.org/10.1371/journal.pone.0178763			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800601	gold, Green Published, Green Submitted			2022-12-26	WOS:000407431800001
J	Vatanparast, M; Kim, Y				Vatanparast, Mohammad; Kim, Yonggyun			Optimization of recombinant bacteria expressing dsRNA to enhance insecticidal activity against a lepidopteran insect, Spodoptera exigua	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; GENETIC INTERFERENCE; BEET ARMYWORM; IDENTIFICATION; CHYMOTRYPSIN; RESISTANCE; TOLERANCE; POTENT; PLANT	Double-stranded RNA (dsRNA) has been applied to control insect pests due to its induction of RNA interference (RNAi) of a specific target gene expression. However, developing dsRNA-based insecticidal agent has been a great challenge especially against lepidopteran insect pests due to variations in RNAi efficiency. The objective of this study was to screen genes of chymotrypsins (SeCHYs) essential for the survival of the beet armyworm, Spodoptera exigua, to construct insecticidal dsRNA. In addition, an optimal oral delivery method was developed using recombinant bacteria. At least 7 SeCHY genes were predicted from S. exigua transcriptomes. Subsequent analyses indicated that SeCHY2 was widely expressed in different developmental stages and larval tissues by RT-PCR and its expression knockdown by RNAi caused high mortality along with immunosuppression. However, a large amount of dsRNA was required to efficiently kill late instars of S. exigua because of high RNase activity in their midgut lumen. To minimize dsRNA degradation, bacterial expression and formulation of dsRNA were performed in HT115 Escherichia coli using L4440 expression vector. dsRNA (300 bp) specific to SeCHY2 overexpressed in E. coli was toxic to S. exigua larvae after oral administration. To enhance dsRNA release from E. coli, bacterial cells were sonicated before oral administration. RNAi efficiency of sonicated bacteria was significantly increased, causing higher larval mortality at oral administration. Moreover, targeting young larvae possessing weak RNase activity in the midgut lumen significantly enhanced RNAi efficiency and subsequent insecticidal activity against S. exigua.	[Vatanparast, Mohammad] Univ Bu Ali Sina, Coll Agr, Dept Plant Protect, Hamadan, Iran; [Kim, Yonggyun] Andong Natl Univ, Dept Plant Med, Andong, South Korea	Bu Ali Sina University; Andong National University	Kim, Y (corresponding author), Andong Natl Univ, Dept Plant Med, Andong, South Korea.	hosanna@anu.ac.kr	Vatanparast, Mohammad/ABC-3861-2021	Vatanparast, Mohammad/0000-0002-3785-286X; Kim, Yonggyun/0000-0002-6840-2167	National Research Foundation of Korea (NRF) - Korea government (MSIP) [2017R1A2133009815]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (no. 2017R1A2133009815).	Allen ML, J INSECT PHYSL, V58, P391; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Broehan G, 2010, INSECT BIOCHEM MOLEC, V40, P274, DOI 10.1016/j.ibmb.2009.10.009; Chen X, 2008, B ENTOMOL RES, V98, P613, DOI 10.1017/S0007485308005932; Chikate YR, 2016, PESTIC BIOCHEM PHYS, V133, P44, DOI 10.1016/j.pestbp.2016.03.006; Christiaens O, 2014, PEPTIDES, V53, P307, DOI 10.1016/j.peptides.2013.12.014; DELMAR EG, 1979, BIOCHEM BIOPH RES CO, V88, P346, DOI 10.1016/0006-291X(79)92054-0; DELORME R, 1988, PESTIC BIOCHEM PHYS, V32, P240, DOI 10.1016/0048-3575(88)90107-1; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gatehouse JA, 2011, CURR PROTEIN PEPT SC, V12, P409; GOH H G, 1990, Korean Journal of Applied Entomology, V29, P180; Guan RB, 2017, J PEST SCI, V90, P745, DOI 10.1007/s10340-016-0797-9; Herrero S, 2005, INSECT BIOCHEM MOLEC, V35, P1073, DOI 10.1016/j.ibmb.2005.05.006; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Kanost Michael R, 2004, Immunol Rev, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; Kim E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132631; Kim J, 2012, ARCH INSECT BIOCHEM, V81, P214, DOI 10.1002/arch.21051; KIM Y, 1999, KOR J APPL ENTOMOL, V38, P56; Kim Y, 2017, KOREAN J APPL ENTOMO, V56; Lee JB, 2017, CHEM PHYSIOL, V94; Lim ZX, 2016, J INSECT PHYSIOL, V85, P86, DOI 10.1016/j.jinsphys.2015.11.005; Lin HL, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2243-4; Liu JH, 2012, J INSECT PHYSIOL, V58, P1166, DOI 10.1016/j.jinsphys.2012.05.016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; MOAR WJ, 1995, APPL ENVIRON MICROB, V61, P2086, DOI 10.1128/AEM.61.6.2086-2092.1995; Park Y, 2017, J INVERTEBR PATHOL, V144, P74, DOI 10.1016/j.jip.2017.02.002; Park Y, 2013, J INVERTEBR PATHOL, V114, P285, DOI 10.1016/j.jip.2013.09.006; PETERSON AM, 1995, INSECT BIOCHEM MOLEC, V25, P765, DOI 10.1016/0965-1748(94)00092-V; Srinivasan A, 2006, CELL MOL BIOL LETT, V11, P132, DOI 10.2478/s11658-006-0012-8; Steppuhn A, 2007, ECOL LETT, V10, P499, DOI 10.1111/j.1461-0248.2007.01045.x; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Tian HG, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006225, 10.1371/journal.pone.0005157]; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Vinokurov KS, 2005, ANAL BIOCHEM, V337, P164, DOI 10.1016/j.ab.2004.10.043; Wynant N, 2014, INSECT BIOCHEM MOLEC, V46, P1, DOI 10.1016/j.ibmb.2013.12.008; Yang J, 2014, AUSTRAL ENTOMOL, V53, P83, DOI 10.1111/aen.12052; Yang J, 2014, J INTEGR AGR, V13, P115, DOI 10.1016/S2095-3119(13)60511-0; Yu R, 2014, INT J BIOL SCI, V10, P1171, DOI 10.7150/ijbs.9598; Zhan QL, 2011, ARCH INSECT BIOCHEM, V76, P130, DOI 10.1002/arch.20353; Zhang C, 2010, J INSECT PHYSIOL, V56, P788, DOI 10.1016/j.jinsphys.2010.02.001; Zhang DW, 2012, ARCH INSECT BIOCHEM, V79, P220, DOI 10.1002/arch.21018; Zhang L, 2015, INSECT MOL BIOL, V24, P155, DOI 10.1111/imb.12129	44	31	32	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0183054	10.1371/journal.pone.0183054	http://dx.doi.org/10.1371/journal.pone.0183054			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800614	gold, Green Published, Green Submitted			2022-12-26	WOS:000407431800048
J	Gussow, AB; Copeland, BR; Dhindsa, RS; Wang, QL; Petrovski, SA; Majoros, WH; Allen, AS; Goldstein, DB				Gussow, Ayal B.; Copeland, Brett R.; Dhindsa, Ryan S.; Wang, Quanli; Petrovski, Slave A.; Majoros, William H.; Allen, Andrew S.; Goldstein, David B.			Orion: Detecting regions of the human non-coding genome that are intolerant to variation using population genetics	PLOS ONE			English	Article							MENDELIAN DISORDERS; VARIANTS; RETRIEVAL; MUTATIONS; SEQUENCES; FEATURES; DISEASE	There is broad agreement that genetic mutations occurring outside of the protein-coding regions play a key role in human disease. Despite this consensus, we are not yet capable of discerning which portions of non-coding sequence are important in the context of human disease. Here, we present Orion, an approach that detects regions of the non-coding genome that are depleted of variation, suggesting that the regions are intolerant of mutations and subject to purifying selection in the human lineage. We show that Orion is highly correlated with known intolerant regions as well as regions that harbor putatively pathogenic variation. This approach provides a mechanism to identify pathogenic variation in the human non-coding genome and will have immediate utility in the diagnostic interpretation of patient genomes and in large case control studies using whole-genome sequences.	[Gussow, Ayal B.; Majoros, William H.] Duke Univ, Program Computat Biol & Bioinformat, Durham, NC 27708 USA; [Gussow, Ayal B.; Copeland, Brett R.; Dhindsa, Ryan S.; Wang, Quanli; Petrovski, Slave A.; Goldstein, David B.] Columbia Univ, Inst Genom Med, New York, NY 10027 USA; [Petrovski, Slave A.] Univ Melbourne, Austin Hlth, Dept Med, Melbourne, Vic, Australia; [Petrovski, Slave A.] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Majoros, William H.] Duke Univ, Ctr Genom & Computat Biol, Durham, NC USA; [Allen, Andrew S.] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA	Duke University; Columbia University; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Royal Melbourne Hospital; Duke University; Duke University	Gussow, AB (corresponding author), Duke Univ, Program Computat Biol & Bioinformat, Durham, NC 27708 USA.; Gussow, AB (corresponding author), Columbia Univ, Inst Genom Med, New York, NY 10027 USA.	ayal.gussow@gmail.com; dg2875@cumc.columbia.edu	Dhindsa, Ryan/W-9678-2019; Goldstein, David/AAY-8125-2020	Dhindsa, Ryan/0000-0002-8965-0813; Allen, Andrew/0000-0002-7232-2143; Copeland, Brett/0000-0003-2933-6061; Petrovski, Slave/0000-0002-1527-961X	National Institute of Mental Health of the National Institutes of Health [1U01 MH105670]; National Human Genome Research Institute of the National Institutes of Health under the Centers for Common Disease Genomics [1UM1HG00901]; National Institute of Neurological Disorders and Stroke of the National Institutes of Health [F31NS092362]; Biogen, Inc.; Bryan ADRC NIA [P30AG028377]; B57 SAIC-Fredrick Inc [M11074]; National Institute of Neurological Disorders and Stroke [RC2NS070344, U01NS077303, U01NS053998]; National Institute of Mental Health [RC2MH089915, K01MH098126, R01MH097971]; National Human Genome Research Institute [U01HG007672]; Center for HIV/AIDS Vaccine Immunology (CHAVI) [U19-AI067854]; National Institute of Allergy and Infectious Diseases Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery [UM1-AI100645]; Bill and Melinda Gates Foundation; Ellison Medical Foundation [AG-NS-0441-08]; Murdock Study Community Registry and Biorepository; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH105670] Funding Source: NIH RePORTER	National Institute of Mental Health of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Human Genome Research Institute of the National Institutes of Health under the Centers for Common Disease Genomics; National Institute of Neurological Disorders and Stroke of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Biogen, Inc.(Biogen); Bryan ADRC NIA; B57 SAIC-Fredrick Inc; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Center for HIV/AIDS Vaccine Immunology (CHAVI); National Institute of Allergy and Infectious Diseases Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Ellison Medical Foundation(Lawrence Ellison Foundation); Murdock Study Community Registry and Biorepository; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health of the National Institutes of Health under Award Number 1U01 MH105670 and by the National Human Genome Research Institute of the National Institutes of Health under the Centers for Common Disease Genomics Award Number 1UM1HG00901. ABG was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award Number F31NS092362. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The collection of samples and data was funded in part by: Biogen, Inc.; Bryan ADRC NIA P30AG028377; B57 SAIC-Fredrick Inc M11074; National Institute of Neurological Disorders and Stroke (RC2NS070344; U01NS077303; U01NS053998); National Institute of Mental Health (RC2MH089915, K01MH098126, R01MH097971); National Human Genome Research Institute (U01HG007672); Center for HIV/AIDS Vaccine Immunology (CHAVI) (U19-AI067854); National Institute of Allergy and Infectious Diseases Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (UM1-AI100645); Bill and Melinda Gates Foundation; the Ellison Medical Foundation New Scholar award AG-NS-0441-08; and the Murdock Study Community Registry and Biorepository.	Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Appenzeller S, 2014, AM J HUM GENET, V95, P360, DOI 10.1016/j.ajhg.2014.08.013; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Dimitrieva S, 2013, NUCLEIC ACIDS RES, V41, pD101, DOI 10.1093/nar/gks1092; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Gussow AB, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0869-4; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kryukov GV, 2009, P NATL ACAD SCI USA, V106, P3871, DOI 10.1073/pnas.0812824106; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604; Li H, 2011, BIOINFORMATICS, V27, P718, DOI 10.1093/bioinformatics/btq671; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Makrythanasis P, 2013, CLIN GENET, V84, P422, DOI 10.1111/cge.12272; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Miller NA, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0221-8; Munz M, 2016, WASH U PART 240 MILL; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Peng B, 2005, BIOINFORMATICS, V21, P3686, DOI 10.1093/bioinformatics/bti584; Peng B, 2010, HUM HERED, V70, P287, DOI 10.1159/000323316; Petrovski S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005492; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Turner TN, 2016, AM J HUM GENET, V98, P58, DOI 10.1016/j.ajhg.2015.11.023; Wakeley J., 2009, COALESCENT THEORY; Wang QL, 2012, J ELECTRON IMAGING, V21, DOI 10.1117/1.JEI.21.2.023020; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; Ward LD, 2012, SCIENCE, V337, P1675, DOI 10.1126/science.1225057; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Zhu XL, 2015, GENET MED, V17, P774, DOI 10.1038/gim.2014.191	35	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0181604	10.1371/journal.pone.0181604	http://dx.doi.org/10.1371/journal.pone.0181604			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797091	Green Published, Green Submitted, gold			2022-12-26	WOS:000407396200017
J	Huang, YJS; Lyons, AC; Hsu, WW; Park, SL; Higgs, S; Vanlandingham, DL				Huang, Yan-Jang S.; Lyons, Amy C.; Hsu, Wei-Wen; Park, So Lee; Higgs, Stephen; Vanlandingham, Dana L.			Differential outcomes of Zika virus infection in Aedes aegypti orally challenged with infectious blood meals and infectious protein meals	PLOS ONE			English	Article							JUVENILE-HORMONE; YELLOW-FEVER; MOSQUITO; TRANSMISSION; DIPTERA	Background Infection of mosquitoes is an essential step for the transmission of mosquito-borne arboviruses in nature. Engorgement of infectious blood meals from viremic infected vertebrate hosts allows the entry of viruses and initiates infection of midgut epithelial cells. Historically, the infection process of arboviruses in mosquitoes has been studied through the engorgement of mosquitoes from viremic laboratory animals or from artificial feeders containing blood mixed with viruses harvested from cell cultures. The latter approach using so-called artificial blood meals is more frequently used since it is readily optimized to maximize viral titer, negates the use of animals and can be used with viruses for which there are no small animal models. Use of artificial blood meals has enabled numerous studies on mosquito infections with a wide variety of viruses; however, as described here, with suitable modification it can also be used to study the interplay between infection, specific blood components, and physiological consequences associated with blood engorgement. For hematophagous female mosquitoes, blood is the primary nutritional source supporting all physiological process including egg development, and also influences neurological processes and behaviors such as host-seeking. Interactions between these blood-driven vector biological processes and arbovirus infection that is mediated via blood engorgement have not yet been specifically studied. This is in part because presentation of virus in whole blood inevitably induces enzymatic digestion processes, hormone driven oogenesis, and other biological changes. In this study, the infection process of Zika virus (ZIKV) in Aedes aegypti was characterized by oral exposure via viral suspension meals within minimally bovine serum albumin complemented medium or within whole blood. The use of bovine serum albumin in infectious meals provides an opportunity to evaluate the role of serum albumin during the process of flavivirus infection in mosquitoes. Methods Infectious whole blood meals and infectious bovine serum albumin meals containing ZIKV were orally presented to two different groups of Ae. aegypti through membrane feeding. At 7 and 14 days post infection, infectious viruses were detected and viral dissemination from gut to other mosquito tissues was analyzed in orally challenged mosquitoes with 50% tissue culture infectious dose method on Vero76 cells. Results/Conclusions Zika virus infection was significantly impaired among mosquitoes orally challenged with infectious protein meals as compared to infectious whole blood meals. These results indicate the importance of the blood meal in the infection process of arboviruses in mosquitoes. It provides the basis for future studies to identify critical components in the blood of vertebrate hosts that facilitate arbovirus infection in mosquitoes.	[Huang, Yan-Jang S.; Lyons, Amy C.; Park, So Lee; Higgs, Stephen; Vanlandingham, Dana L.] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA; [Huang, Yan-Jang S.; Lyons, Amy C.; Park, So Lee; Higgs, Stephen; Vanlandingham, Dana L.] Kansas State Univ, Biosecur Res Inst, Manhattan, KS 66506 USA; [Hsu, Wei-Wen] Kansas State Univ, Dept Stat, Coll Arts & Sci, Manhattan, KS 66506 USA	Kansas State University; Kansas State University; Kansas State University	Vanlandingham, DL (corresponding author), Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA.; Vanlandingham, DL (corresponding author), Kansas State Univ, Biosecur Res Inst, Manhattan, KS 66506 USA.	dlvanlan@vet.k-state.edu						BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3; BOROVSKY D, 1992, J MED ENTOMOL, V29, P619, DOI 10.1093/jmedent/29.4.619; Bottino-Rojas V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135985; Cosgrove JB, 1996, MED VET ENTOMOL, V10, P260, DOI 10.1111/j.1365-2915.1996.tb00740.x; Davis NC, 1933, J EXP MED, V58, P211, DOI 10.1084/jem.58.2.211; Dong SZ, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3775-6; Feitosa FM, 2006, J INSECT SCI, V6; FELIX CR, 1991, INSECT BIOCHEM, V21, P197, DOI 10.1016/0020-1790(91)90050-O; Gonzales KK, 2015, PEERJ, V3, DOI 10.7717/peerj.938; Grimaldi David, 2005, pi; Hernandez-Martinez S, 2015, J INSECT PHYSIOL, V72, P22, DOI 10.1016/j.jinsphys.2014.11.003; Higgs S, 2005, P NATL ACAD SCI USA, V102, P8871, DOI 10.1073/pnas.0503835102; Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058; Huang YJS, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-60; Hussain M, 2013, INSECT BIOCHEM MOLEC, V43, P146, DOI 10.1016/j.ibmb.2012.11.005; KOGAN PH, 1990, J MED ENTOMOL, V27, P709, DOI 10.1093/jmedent/27.4.709; Lequime S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005548; Majorek KA, 2012, MOL IMMUNOL, V52, P174, DOI 10.1016/j.molimm.2012.05.011; Merrill MH, 1935, J EXP MED, V62, P687, DOI 10.1084/jem.62.5.687; Nuckols JT, 2015, J MED ENTOMOL, V52, P447, DOI 10.1093/jme/tjv017; Pitts RJ, 2014, J INSECT PHYSIOL, V64, P1, DOI 10.1016/j.jinsphys.2014.02.012; SHAPIRO AB, 1986, J INSECT PHYSIOL, V32, P867, DOI 10.1016/0022-1910(86)90102-2; WATTS DM, 1973, SCIENCE, V182, P1140, DOI 10.1126/science.182.4117.1140; Whitman L, 1937, J EXP MED, V66, P133, DOI 10.1084/jem.66.2.133; Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P1109, DOI 10.1016/S1473-3099(17)30494-2	25	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182386	10.1371/journal.pone.0182386	http://dx.doi.org/10.1371/journal.pone.0182386			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796799	Green Submitted, Green Published, gold			2022-12-26	WOS:000407396200050
J	Mouzouvi, CRA; Umerska, A; Bigot, AAK; Saulnier, P				Mouzouvi, Celia R. A.; Umerska, Anita; Bigot, Andre A. K.; Saulnier, Patrick			Surface active properties of lipid nanocapsules	PLOS ONE			English	Article							AIR-WATER-INTERFACE; DROP TENSIOMETER; KINETICS; REORGANIZATION; ADSORPTION; NANOCARRIERS; TRANSITION; STABILITY; LIPOSOMES; DESIGN	Lipid nanocapsules (LNCs) are biomimetic nanocarriers used for the encapsulation of a broad variety of active ingredients. Similar to surface active compounds, LNCs contain both hydrophilic and hydrophobic parts in their structure. Moreover, the components of LNCs, macrogol 15 hydroxystearate (MHS) and lecithin, are known for their surface active properties. Therefore, the aim of this paper was to investigate the capability of the LNCs to decrease surface tension using two techniques: drop tensiometry and the Wilhelmy plate method. LNCs with diameters ranging from 30 to 100 nm were successfully obtained using a phase inversion technique. The LNCs' properties, such as size and zeta potential, depend on the composition. LNCs exhibit a lower limiting surface tension compared to MHS (34.8-35.0 mN/m and 37.7-38.8 mN/m, respectively), as confirmed by both drop tensiometry and the Wilhelmy plate method. LNCs have exhibited a saturated interfacial concentration (SIC) that was 10-fold higher than the critical micellar concentration (CMC) of MHS or the SIC of binary and ternary mixtures of LNC ingredients. The SIC of the LNC formulations depended on the mass mixing ratio of the MHS/triglycerides but not on the presence of lecithin. The CMC/SIC values measured by the Wilhelmy plate method were higher than those obtained using drop tensiometry because of the longer duration of the tensiometry measurement. In conclusion, the surfactantlike properties of the LNCs offer new possibilities for medical and pharmaceutical applications.	[Mouzouvi, Celia R. A.; Umerska, Anita; Saulnier, Patrick] Univ Bretagne Loire, CNRS 6021, Univ Angers, Micro & Nanomed Biomimet MINT,INSERM U1066, Angers, France; [Mouzouvi, Celia R. A.] Univ Abomey Calavi, Lab Pharm Galen & Technol Pharmaceut, UFR Pharm, FSS, Cotonou, Benin; [Bigot, Andre A. K.] Univ Abomey Calavi, Unite Immunol, Fac Sci Sante, Cotonou, Benin	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; University of Abomey Calavi; University of Abomey Calavi	Umerska, A (corresponding author), Univ Bretagne Loire, CNRS 6021, Univ Angers, Micro & Nanomed Biomimet MINT,INSERM U1066, Angers, France.	anitaumerska@yahoo.fr		Saulnier, Patrick/0000-0002-6408-3533; Umerska, Anita/0000-0002-4981-8247	'Service de Cooperation et d'Action Culturelle' of the French Embassy in Benin; Z-cube (Italy); Ministere de l'Enseignement Superieur et de la Recherche Scientifique du Benin	'Service de Cooperation et d'Action Culturelle' of the French Embassy in Benin; Z-cube (Italy); Ministere de l'Enseignement Superieur et de la Recherche Scientifique du Benin	This study was funded by 'Service de Cooperation et d'Action Culturelle' of the French Embassy in Benin, by Z-cube (Italy) and by Ministere de l'Enseignement Superieur et de la Recherche Scientifique du Benin.r This study was funded by 'Service de Cooperation et d'Action Culturelle' of the French Embassy in Benin, by Z-cube (Italy) and by Ministere de l'Enseignement Superieur et de la Recherche Scientifique du Benin.	Adamson A. W., 1967, PHYS CHEM SURFACES; Berry JD, 2015, J COLLOID INTERF SCI, V454, P226, DOI 10.1016/j.jcis.2015.05.012; Binks BP, 2002, CURR OPIN COLLOID IN, V7, P21, DOI 10.1016/S1359-0294(02)00008-0; Biresaw G., 2014, SURFACTANT SCI TECHN, P299; Blute I, 2009, COLLOID SURFACE A, V337, P127, DOI 10.1016/j.colsurfa.2008.12.009; Czajka A, 2015, LANGMUIR, V31, P8205, DOI 10.1021/acs.langmuir.5b00336; Du K, 2010, LANGMUIR, V26, P12518, DOI 10.1021/la100497h; Dulieu C, 2005, PHARM RES-DORDR, V22, P285, DOI 10.1007/s11095-004-1196-0; Fan H, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.051610; Fathi-Azarbayjani A, 2009, J PHARM PHARM SCI, V12, P218, DOI 10.18433/J32P40; Florence A. T., 2006, PHYSICOCHEMICAL PRIN; Gugliotti M, 1998, BIOCHEM EDUC, V26, P233, DOI 10.1016/S0307-4412(98)00091-0; Heurtault B, 2003, COLLOID SURFACE B, V30, P225, DOI 10.1016/S0927-7765(03)00096-1; Heurtault B, 2002, PHARMACEUT RES, V19, P875, DOI 10.1023/A:1016121319668; Hirsjavi S, 2012, INT J PHARMACEUT, V434, P460, DOI 10.1016/j.ijpharm.2012.06.019; Hsu CT, 1997, LANGMUIR, V13, P6204, DOI 10.1021/la970613y; Hureaux J, 2009, INT J PHARMACEUT, V379, P266, DOI 10.1016/j.ijpharm.2009.05.033; Hureaux J, 2009, EUR J PHARM BIOPHARM, V73, P239, DOI 10.1016/j.ejpb.2009.06.013; Huynh NT, 2009, INT J PHARMACEUT, V379, P201, DOI 10.1016/j.ijpharm.2009.04.026; Ivanova T, 2014, COLLOID POLYM SCI, V292, P1307, DOI 10.1007/s00396-014-3180-5; Kutuzov S, 2007, PHYS CHEM CHEM PHYS, V9, P6351, DOI 10.1039/b710060b; LABOURDENNE S, 1994, CHEM PHYS LIPIDS, V71, P163, DOI 10.1016/0009-3084(94)90068-X; Lamprecht A, 2004, INT J PHARM, V278, P407, DOI 10.1016/j.ijpharm.2004.03.018; Lemkadem B., 1999, COLLOID SURFACE B, V17, P1; Luo M, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/37/375109; Matougui N, 2016, INT J PHARMACEUT, V502, P80, DOI 10.1016/j.ijpharm.2016.02.019; Miles GD, 1944, J PHYS CHEM-US, V48, P57, DOI 10.1021/j150433a007; Minkov I, 2005, COLLOID SURFACE B, V45, P24, DOI 10.1016/j.colsurfb.2005.07.002; Minkov I, 2005, COLLOID SURFACE B, V45, P14, DOI 10.1016/j.colsurfb.2005.03.009; Minkov I, 2005, COLLOID SURFACE B, V44, P197, DOI 10.1016/j.colsurfb.2005.07.001; OKUBO T, 1995, J COLLOID INTERF SCI, V171, P55, DOI 10.1006/jcis.1995.1150; Paillard A, 2010, BIOMATERIALS, V31, P7542, DOI 10.1016/j.biomaterials.2010.06.024; PANAIOTOV I, 1995, COLLOID SURFACE A, V102, P159, DOI 10.1016/0927-7757(95)03253-A; Petelska AD, 2002, BBA-BIOMEMBRANES, V1567, P79, DOI 10.1016/S0005-2736(02)00582-5; RANEVA V, 1995, COLLOID POLYM SCI, V273, P150, DOI 10.1007/BF00654012; Schreier S, 2000, BBA-BIOMEMBRANES, V1508, P210, DOI 10.1016/S0304-4157(00)00012-5; SHINODA K, 1964, J PHYS CHEM-US, V68, P3485, DOI 10.1021/j100794a007; SHINODA K, 1962, J PHYS CHEM-US, V66, P577, DOI 10.1021/j100810a001; Umerska A, 2016, EUR J PHARM BIOPHARM, V108, P100, DOI 10.1016/j.ejpb.2016.09.001; Umerska A, 2017, CARBOHYD POLYM, V156, P276, DOI 10.1016/j.carbpol.2016.09.035; Umerska A, 2016, INT J PHARMACEUT, V506, P191, DOI 10.1016/j.ijpharm.2016.04.028; Umerska A, 2015, INT J PHARMACEUT, V493, P224, DOI 10.1016/j.ijpharm.2015.07.008; Umerska A, 2014, J BIOMED NANOTECHNOL, V10, P3658, DOI 10.1166/jbn.2014.1878; Vafaei S, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/18/185702; Valcourt C, 2016, INT J PHARMACEUT, V498, P23, DOI 10.1016/j.ijpharm.2015.11.042; Vonarbourg A, 2005, ELECTROPHORESIS, V26, P2066, DOI 10.1002/elps.200410145	46	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0179211	10.1371/journal.pone.0179211	http://dx.doi.org/10.1371/journal.pone.0179211			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796777	Green Published, Green Submitted, gold			2022-12-26	WOS:000407396200001
J	Qiao, SL; Wu, W; Chen, MJ; Tang, QQ; Xia, YK; Jia, W; Wang, XR				Qiao, Shanlei; Wu, Wei; Chen, Minjian; Tang, Qiuqin; Xia, Yankai; Jia, Wei; Wang, Xinru			Seminal plasma metabolomics approach for the diagnosis of unexplained male infertility	PLOS ONE			English	Article							ANTIOXIDANT; PROTEOMICS; BIOMARKERS; DISEASE; MEN	We used a gas chromatography-mass spectrometry (GC-MS) based metabolomics approach to obtain the metabolic profiling of unexplained male infertility (UMI), and identified seminal plasma biomarkers associated with UMI by a two-stage population study. A robust OPLS-DA model based on these identified metabolites was able to distinguish 82% of the UMI patients from health controls with a specificity of 92%. In this model, 44 metabolites were found differentially expressed in UMI subjects compared with health controls. By pathway enrichment analysis, we identified several major changed metabolic pathways related to UMI. Our findings provide new perspective for the diagnosis of UMI.	[Qiao, Shanlei; Wu, Wei; Chen, Minjian; Xia, Yankai; Wang, Xinru] Nanjing Med Univ, Inst Appl Toxicol, Sch Publ Hlth, State Key Lab Reprod Med, Nanjing, Peoples R China; [Qiao, Shanlei; Wu, Wei; Chen, Minjian; Xia, Yankai; Wang, Xinru] Nanjing Med Univ, Sch Publ Hlth, Key Lab Modern Toxicol, Minist Educ, Nanjing, Peoples R China; [Tang, Qiuqin] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing Matern & Child Hlth Hosp, Obstet & Gynecol Hosp,Dept Obstet, Nanjing, Jiangsu, Peoples R China; [Jia, Wei] Univ Hawaii, Canc Ctr, Honolulu, HI 96822 USA	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Cancer Research Center of Hawaii; University of Hawaii System	Jia, W (corresponding author), Univ Hawaii, Canc Ctr, Honolulu, HI 96822 USA.	wjia@cc.hawaii.edu; xrwang@njmu.edu.cn	Jia, Wei/AAN-5102-2020; Wang, Xin/GYU-1129-2022; Wu, Wei/C-4409-2012; Wang, Xin/AAN-8435-2021; Tang, Qiuqin/X-4817-2019	Jia, Wei/0000-0002-3739-8994; Wu, Wei/0000-0002-0267-1284; Wang, Xin/0000-0002-4457-7376; Tang, Qiuqin/0000-0001-9110-9973	National Natural Science Foundation of China; Priority Academic Program for the Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program for the Development of Jiangsu Higher Education Institutions	This work was supported by the National Natural Science Foundation of China and Priority Academic Program for the Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2014, REPROD BIOMED ONLINE, V29, P32, DOI 10.1016/j.rbmo.2014.02.013; AITKEN RJ, 1989, BIOL REPROD, V41, P183, DOI 10.1095/biolreprod41.1.183; Amaral A, 2014, J PROTEOME RES, V13, P5670, DOI 10.1021/pr500652y; Amaral A, 2014, HUM REPROD UPDATE, V20, P40, DOI 10.1093/humupd/dmt046; Com E, 2014, J PROTEOMICS, V107, P128, DOI 10.1016/j.jprot.2014.04.013; Courant F, 2013, J PROTEOME RES, V12, P2914, DOI 10.1021/pr400204q; De Iuliis GN, 2006, J CLIN ENDOCR METAB, V91, P1968, DOI 10.1210/jc.2005-2711; Gnoth C, 2005, HUM REPROD, V20, P1144, DOI 10.1093/humrep/deh870; Hamada A, 2012, INT BRAZ J UROL, V38, P576, DOI 10.1590/S1677-55382012000500002; Hotaling JM, 2014, UROL CLIN N AM, V41, P1, DOI 10.1016/j.ucl.2013.08.009; Jafarzadeh N, 2015, MOL REPROD DEV, V82, P150, DOI 10.1002/mrd.22457; Kovac JR, 2014, FERTIL STERIL, V101, pE31, DOI 10.1016/j.fertnstert.2014.02.029; Leridon H, 2008, HUM REPROD, V23, P1312, DOI 10.1093/humrep/den106; Qiu YP, 2009, J PROTEOME RES, V8, P4844, DOI 10.1021/pr9004162; Rhemrev JPT, 2000, J ANDROL, V21, P913; Scoditti E, 2014, ATHEROSCLEROSIS, V232, P17, DOI 10.1016/j.atherosclerosis.2013.10.017; Servili M., 2009, Inflammopharmacology, V17, P76, DOI 10.1007/s10787-008-8014-y; Song R, 2014, NATURE, V510, P115, DOI 10.1038/nature13413; Sroka Z, 2003, FOOD CHEM TOXICOL, V41, P753, DOI 10.1016/S0278-6915(02)00329-0; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Zhang J, 2014, FERTIL STERIL, V102, P44, DOI 10.1016/j.fertnstert.2014.03.033; Zhang YJ, 2011, NAT MED, V17, P79, DOI 10.1038/nm.2280	25	25	26	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0181115	10.1371/journal.pone.0181115	http://dx.doi.org/10.1371/journal.pone.0181115			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797078	Green Published, gold, Green Submitted			2022-12-26	WOS:000407396200013
J	Choi, IY; Karpus, ON; Turner, JD; Hardie, D; Marshall, JL; de Hair, MJH; Maijer, KI; Tak, PP; Raza, K; Hamann, J; Buckley, CD; Gerlag, DM; Filer, A				Choi, Ivy Y.; Karpus, Olga N.; Turner, Jason D.; Hardie, Debbie; Marshall, Jennifer L.; de Hair, Maria J. H.; Maijer, Karen I.; Tak, Paul P.; Raza, Karim; Hamann, Jorg; Buckley, Christopher D.; Gerlag, Danielle M.; Filer, Andrew			Stromal cell markers are differentially expressed in the synovial tissue of patients with early arthritis	PLOS ONE			English	Article							FIBROBLAST ACTIVATION PROTEIN; EARLY RHEUMATOID-ARTHRITIS; CLASSIFICATION CRITERIA; RHEUMATOLOGY/EUROPEAN LEAGUE; THERAPEUTIC TARGET; CLINICAL REMISSION; AMERICAN-COLLEGE; T-CELL; SYNOVIOCYTES; IDENTIFICATION	Introduction Previous studies have shown increased expression of stromal markers in synovial tissue (ST) of patients with established rheumatoid arthritis (RA). Here, ST expression of stromal markers in early arthritis in relationship to diagnosis and prognostic outcome was studied. Methods ST from 56 patients included in two different early arthritis cohorts and 7 non-inflammatory controls was analysed using immunofluorescence to detect stromal markers CD55, CD248, fibroblast activation protein (FAP) and podoplanin. Diagnostic classification (gout, psoriatic arthritis, unclassified arthritis (UA), parvovirus associated arthritis, reactive arthritis and RA), disease outcome (resolving vs persistent) and clinical variables were determined at baseline and after follow-up, and related to the expression of stromal markers. Results We observed expression of all stromal markers in ST of early arthritis patients, independent of diagnosis or prognostic outcome. Synovial expression of FAP was significantly higher in patients developing early RA compared to other diagnostic groups and non-inflammatory controls. In RA FAP protein was expressed in both lining and sublining layers. Podoplanin expression was higher in all early inflammatory arthritis patients than controls, but did not differentiate diagnostic outcomes. Stromal marker expression was not associated with prognostic outcomes of disease persistence or resolution. There was no association with clinical or sonographic variables. Conclusions Stromal cell markers CD55, CD248, FAP and podoplanin are expressed in ST in the earliest stage of arthritis. Baseline expression of FAP is higher in early synovitis patients who fulfil classification criteria for RA over time. These results suggest that significant fibroblast activation occurs in RA in the early window of disease.	[Choi, Ivy Y.; de Hair, Maria J. H.; Maijer, Karen I.; Tak, Paul P.; Gerlag, Danielle M.] Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, Amsterdam, Netherlands; [Karpus, Olga N.; Hamann, Jorg] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Amsterdam, Netherlands; [Turner, Jason D.; Hardie, Debbie; Marshall, Jennifer L.; Raza, Karim; Buckley, Christopher D.; Filer, Andrew] Univ Birmingham, Rheumatol Res Grp, Inst Inflammat & Ageing, Birmingham, W Midlands, England; [Raza, Karim] Sandwell & West Birmingham Hosp NHS Trust, Birmingham, W Midlands, England; [Filer, Andrew] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England; [Tak, Paul P.] Univ Cambridge, Cambridge, England; [Tak, Paul P.] Univ Ghent, Ghent, Belgium; [Tak, Paul P.] GlaxoSmithKline, Stevenage, Herts, England; [Gerlag, Danielle M.] GlaxoSmithKline, Cambridge, England	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Birmingham; University of Birmingham; University of Cambridge; Ghent University; GlaxoSmithKline; GlaxoSmithKline	Filer, A (corresponding author), Univ Birmingham, Rheumatol Res Grp, Inst Inflammat & Ageing, Birmingham, W Midlands, England.; Filer, A (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England.; Gerlag, DM (corresponding author), GlaxoSmithKline, Cambridge, England.	danielle.x.gerlag@gsk.com; a.filer@bham.ac.uk	Buckley, Christopher/AAN-6378-2021; Raza, Karim/AAN-3089-2021; Filer, Andrew/AAP-9179-2021	Buckley, Christopher/0000-0001-6924-6402; Raza, Karim/0000-0003-1570-1232; Filer, Andrew/0000-0001-8164-6249; Marshall, Jennifer/0000-0002-1727-8290; Choi, Ivy/0000-0002-3542-4909; Hamann, Jorg/0000-0002-9448-1727; Turner, Jason/0000-0002-5423-5302	National Institute for Health Research/Wellcome Trust Clinical Research Facility at University Hospitals Birmingham NHS Foundation Trust; Innovative Medicines Initiative [115142-1]; European Community's Collaborative project (EuroTEAM) [FP7-HEALTH-F2-2012-305549]; Arthritis Research UK [18547]; Arthritis Research UK (RACE Rheumatoid Arthritis Pathogenesis Centre of Excellence) [20298]; Dutch Arthritis Foundation [NR 07-010404]; Medical Research Council [1407712] Funding Source: researchfish	National Institute for Health Research/Wellcome Trust Clinical Research Facility at University Hospitals Birmingham NHS Foundation Trust; Innovative Medicines Initiative; European Community's Collaborative project (EuroTEAM); Arthritis Research UK(Versus Arthritis); Arthritis Research UK (RACE Rheumatoid Arthritis Pathogenesis Centre of Excellence); Dutch Arthritis Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This report is independent research supported by the National Institute for Health Research/Wellcome Trust Clinical Research Facility at University Hospitals Birmingham NHS Foundation Trust. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health. The study was supported by Innovative Medicines Initiative project BTCure (grant agreement number 115142-1 for DMG). The research leading to these results received funding from the European Community's Collaborative project FP7-HEALTH-F2-2012-305549 (EuroTEAM) for DMG. Funding was also provided by Arthritis Research UK (Fellowship 18547 and the RACE Rheumatoid Arthritis Pathogenesis Centre of Excellence grant 20298 for AF) and the Dutch Arthritis Foundation (NR 07-010404) for DMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton SE, 2012, IMMUNITY, V37, P276, DOI 10.1016/j.immuni.2012.05.022; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Ao Z, 2015, CANCER RES, V75, P4681, DOI 10.1158/0008-5472.CAN-15-1633; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Bauer S, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2080; Brown AK, 2008, ARTHRITIS RHEUM-US, V58, P2958, DOI 10.1002/art.23945; Brown AK, 2006, ARTHRITIS RHEUM, V54, P3761, DOI 10.1002/art.22190; Cader MZ, 2011, ANN RHEUM DIS, V70, P949, DOI 10.1136/ard.2010.143560; Chung KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088772; Croft AP, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1156-1; de Hair MJH, 2011, J RHEUMATOL, V38, P2068, DOI 10.3899/jrheum.110426; Drossaers-Bakker KW, 2002, ARTHRIT RHEUM-ARTHR, V47, P383, DOI 10.1002/art.10513; Ekwall AKH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3274; Filer A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120917; Filer A, 2013, CURR OPIN PHARMACOL, V13, P413, DOI 10.1016/j.coph.2013.02.006; Filer A, 2011, ANN RHEUM DIS, V70, P500, DOI 10.1136/ard.2010.131573; Frank-Bertoncelj M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14852; Hamann J, 1999, ARTHRITIS RHEUM-US, V42, P650, DOI 10.1002/1529-0131(199904)42:4<650::AID-ANR7>3.0.CO;2-S; Hardie DL, 2011, IMMUNOLOGY, V133, P288, DOI 10.1111/j.1365-2567.2011.03437.x; Harrison BJ, 1996, BRIT J RHEUMATOL, V35, P1096; Henry LR, 2007, CLIN CANCER RES, V13, P1736, DOI 10.1158/1078-0432.CCR-06-1746; Hitchon Carol A, 2011, Open Rheumatol J, V5, P107, DOI 10.2174/1874312901105010107; Karpus ON, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0518-4; Karpus ON, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035606; Kasperkovitz PV, 2005, ARTHRITIS RHEUM-US, V52, P430, DOI 10.1002/art.20811; Kelly S, 2015, ANN RHEUM DIS, V74, P611, DOI 10.1136/annrheumdis-2013-204603; Kiener HP, 2010, ARTHRITIS RHEUM-US, V62, P742, DOI 10.1002/art.27285; Kirwan JR, 1997, BRIT J RHEUMATOL, V36, P225; Kop EN, 2005, ARTHRITIS RHEUM-US, V52, P442, DOI 10.1002/art.20788; Kraan MC, 2004, ANN RHEUM DIS, V63, P1056, DOI 10.1136/ard.2003.014738; Laverman P, 2015, J NUCL MED, V56, P778, DOI 10.2967/jnumed.114.152959; Lefevre S, 2009, NAT MED, V15, P1414, DOI 10.1038/nm.2050; MacFadyen JR, 2005, FEBS LETT, V579, P2569, DOI 10.1016/j.febslet.2005.03.071; Maia M, 2010, ARTHRITIS RHEUM-US, V62, P3595, DOI 10.1002/art.27701; Mottonen T, 2002, ARTHRITIS RHEUM, V46, P894, DOI 10.1002/art.10135; Noss EH, 2008, IMMUNOL REV, V223, P252, DOI 10.1111/j.1600-065X.2008.00648.x; Ospelt C, 2010, ARTHRITIS RHEUM-US, V62, P1224, DOI 10.1002/art.27395; Park JE, 1999, J BIOL CHEM, V274, P36505, DOI 10.1074/jbc.274.51.36505; Raza K, 2005, ARTHRITIS RES THER, V7, pR784, DOI 10.1186/ar1733; Raza K, 2012, ANN RHEUM DIS, V71, P1921, DOI 10.1136/annrheumdis-2012-201893; Scott DL, 2002, ARTHRITIS RHEUM, V46, P286, DOI 10.1002/art.10134.abs; Smeets TJM, 1998, CLIN IMMUNOL IMMUNOP, V88, P84, DOI 10.1006/clin.1998.4525; Steenvoorden MMC, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2073; Tak PP, 2000, ARTHRITIS RHEUM-US, V43, P2619, DOI 10.1002/1529-0131(200012)43:12<2619::AID-ANR1>3.0.CO;2-V; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; Turner JD, 2015, CURR OPIN RHEUMATOL, V27, P175, DOI 10.1097/BOR.0000000000000148; van de Sande MGH, 2011, ANN RHEUM DIS, V70, P772, DOI 10.1136/ard.2010.139527; van de Sande MGH, 2011, ANN RHEUM DIS, V70, P423, DOI 10.1136/ard.2010.139550; van der Linden MPM, 2010, ARTHRITIS RHEUM-US, V62, P3537, DOI 10.1002/art.27692; Visser H, 2002, ARTHRITIS RHEUM, V46, P357, DOI 10.1002/art.10117; Waldele S, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0524-6; Wakefield RJ, 2005, J RHEUMATOL, V32, P2485; Wang H, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.122; Yeo L, 2016, ANN RHEUM DIS, V75, P763, DOI 10.1136/annrheumdis-2014-206921	55	27	28	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182751	10.1371/journal.pone.0182751	http://dx.doi.org/10.1371/journal.pone.0182751			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28793332	Green Submitted, Green Published, gold			2022-12-26	WOS:000407196700064
J	Rajalingham, R; Musallam, S				Rajalingham, Rishi; Musallam, Sam			Characterization of neurons in the primate medial intraparietal area reveals a joint representation of intended reach direction and amplitude	PLOS ONE			English	Article							FREE ARM MOVEMENTS; 3-DIMENSIONAL SPACE; PRIMARY MOTOR; CORTICAL CONNECTIONS; PREMOTOR CORTEX; PARIETAL CORTEX; VISUAL TARGETS; MACAQUE MONKEY; CELL DISCHARGE; EYE POSITION	To support accurate memory-guided reaching, the brain must represent both the direction and amplitude of reaches in a movement plan. Several cortical areas have been shown to represent the direction of a planned reaching movement, but the neuronal representation of reach amplitude is still unclear, especially in sensory-motor integration areas. To investigate this, we recorded from neurons in the medial intraparietal area (MIP) of monkeys performing a variable amplitude memory reach task. In one monkey, we additionally recorded from the dorsal premotor cortex (PMd) for direct cross-area comparisons. In both areas, we found modest but significant proportions of neurons with movement-planning activity sensitive to reach amplitude. However, reach amplitude was under-represented relative to direction in the neuronal population, with approximately one third as many selective neurons. We observed an interaction between neuronal selectivity for amplitude and direction; neurons in both areas exhibited significant modulation of neuronal activity by reach amplitude in some but not all directions. Consistent with an encoding of reach goals as a position in visual space, the response patterns of MIP/PMd neurons were best predicted by 2D Gaussian position encoding model, in contrast to a number of alternative direction and amplitude tuning models. Taken together, these results suggest that amplitude and direction jointly modulate activity in MIP, as in PMd, to form representations of intended reach position.	[Rajalingham, Rishi] MIT, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Musallam, Sam] McGill Univ, Dept Elect & Comp Engn, Montreal, PQ, Canada	Massachusetts Institute of Technology (MIT); McGill University	Musallam, S (corresponding author), McGill Univ, Dept Elect & Comp Engn, Montreal, PQ, Canada.	sam.musallam@mcgill.ca		/0000-0001-6499-1681	Canadian Institute of Health Research (CIHR); Natural Science and Engineering Research Council (NSERC); Canadian Foundation for Innovation (CFI); Canada Research Chair Program (CFC); Fonds de recherche du Quebec - Nature et technologies (FQRNT)	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Canada Research Chair Program (CFC); Fonds de recherche du Quebec - Nature et technologies (FQRNT)	This work was supported by the Canadian Institute of Health Research (CIHR), the Natural Science and Engineering Research Council (NSERC), the Canadian Foundation for Innovation (CFI), the Canada Research Chair Program (CFC), and the Fonds de recherche du Quebec - Nature et technologies (FQRNT) to SM.	ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; [Anonymous], 2001, SPRINGE SER STAT N; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Ben Hamed S, 2001, EXP BRAIN RES, V140, P127, DOI 10.1007/s002210100785; Bhattacharyya R, 2009, J NEUROPHYSIOL, V102, P805, DOI 10.1152/jn.90359.2008; BLATT GJ, 1990, J COMP NEUROL, V299, P421, DOI 10.1002/cne.902990404; Bremner LR, 2012, NEURON, V75, P342, DOI 10.1016/j.neuron.2012.03.041; Breveglieri R, 2012, J NEUROSCI, V32, P159, DOI 10.1523/JNEUROSCI.4028-11.2012; Brouwer AM, 2007, J VISION, V7, DOI 10.1167/7.5.6; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; Caminiti R, 1999, EUR J NEUROSCI, V11, P3339, DOI 10.1046/j.1460-9568.1999.00801.x; CAMINITI R, 1991, J NEUROSCI, V11, P1182; Christopoulos VN, 2015, J NEUROSCI, V35, P11719, DOI 10.1523/JNEUROSCI.1068-15.2015; Cisek P, 2002, J NEUROPHYSIOL, V87, P1149, DOI 10.1152/jn.00443.2001; Cui H, 2007, NEURON, V56, P552, DOI 10.1016/j.neuron.2007.09.031; Fabbri S, 2012, J NEUROPHYSIOL, V107, P1845, DOI 10.1152/jn.00435.2011; Fattori P, 2005, EUR J NEUROSCI, V22, P956, DOI 10.1111/j.1460-9568.2005.04288.x; Ferraina S, 2009, J NEUROSCI, V29, P11461, DOI 10.1523/JNEUROSCI.1305-09.2009; FU QG, 1995, J NEUROPHYSIOL, V73, P836, DOI 10.1152/jn.1995.73.2.836; FU QG, 1993, J NEUROPHYSIOL, V70, P2097, DOI 10.1152/jn.1993.70.5.2097; Gail A, 2006, J NEUROSCI, V26, P9376, DOI 10.1523/JNEUROSCI.1570-06.2006; GEORGOPOULOS AP, 1988, J NEUROSCI, V8, P2928; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Hadjidimitrakis K, 2014, CEREB CORTEX, V24, P1645, DOI 10.1093/cercor/bht021; Hadjidimitrakis K, 2015, J NEUROPHYSIOL, V114, P2340, DOI 10.1152/jn.00486.2015; Heath M, 2010, MEMORY GUIDED REACHI, P79; Heider B, 2010, J NEUROPHYSIOL, V104, P3494, DOI 10.1152/jn.01050.2009; Kakei S, 2001, NAT NEUROSCI, V4, P1020, DOI 10.1038/nn726; KALASKA JF, 1983, EXP BRAIN RES, V51, P247; Krigolson A, 2004, HUM MOVEMENT SCI, V23, P861, DOI 10.1016/j.humov.2004.10.011; KURATA K, 1993, J NEUROPHYSIOL, V69, P187, DOI 10.1152/jn.1993.69.1.187; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Lewis JW, 2000, J COMP NEUROL, V428, P79, DOI 10.1002/1096-9861(20001204)428:1<79::AID-CNE7>3.0.CO;2-Q; Messier J, 2000, J NEUROPHYSIOL, V84, P152, DOI 10.1152/jn.2000.84.1.152; Messier J, 1997, EXP BRAIN RES, V115, P469, DOI 10.1007/PL00005716; Messier J, 1999, EXP BRAIN RES, V125, P139, DOI 10.1007/s002210050669; Piserchia V, 2017, CEREB CORTEX, V27, P1976, DOI 10.1093/cercor/bhw039; Rajalingham R, 2014, J NEUROPHYSIOL, V112, P1775, DOI 10.1152/jn.00533.2012; RIEHLE A, 1989, J NEUROPHYSIOL, V61, P534, DOI 10.1152/jn.1989.61.3.534; Sarlegna FR, 2007, EXP BRAIN RES, V176, P267, DOI 10.1007/s00221-006-0613-5; SCHWARTZ AB, 1988, J NEUROSCI, V8, P2913; Seelke AM, 2011, CEREB CORTEX; SELTZER B, 1986, EXP BRAIN RES, V62, P459; Shen LM, 1997, J NEUROPHYSIOL, V77, P1195, DOI 10.1152/jn.1997.77.3.1195; Shipp S, 1998, EUR J NEUROSCI, V10, P3171, DOI 10.1046/j.1460-9568.1998.00327.x; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Westwood DA, 2003, J MOTOR BEHAV, V35, P127, DOI 10.1080/00222890309602128	47	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182519	10.1371/journal.pone.0182519	http://dx.doi.org/10.1371/journal.pone.0182519			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28793351	Green Published, Green Submitted, gold			2022-12-26	WOS:000407196700050
J	Zeng, WH; Wang, RY; Zhang, TY; Gong, CY; Zuo, WD; Liu, RP; Ou, Y; Xu, HF				Zeng, Wenhui; Wang, Riyuan; Zhang, Tianyang; Gong, Chunying; Zuo, Weidong; Liu, Rongpeng; Ou, Yao; Xu, Hanfu			Cloning and expression analysis of BmYki gene in silkworm, Bombyx mori	PLOS ONE			English	Article							WING IMAGINAL DISCS; ORGAN SIZE CONTROL; CELL-PROLIFERATION; SIGNALING PATHWAY; TUMOR-SUPPRESSOR; PROMOTES APOPTOSIS; PROTEIN-KINASE; HIPPO PATHWAY; DROSOPHILA; GROWTH	The transcriptional coactivator Yorkie(Yki), is a critical downstream effector of the Hippo (Hpo) signaling pathway that controls organ size through the regulation of cell proliferation and apoptosis. During the past ten years the biological function of Yki has been studied extensively in Drosophila and a few other insects, however, little is known about it in the silkworm, Bombyx mori, a major research model of lepidopteran insect. Here, we describe the isolation, characterization and expression of the B. mori Yki ortholog, BmYki. The coding sequence of the BmYki was 1314 bp in length, encoding a protein of 437 amino acids containing two conserved WW domains. BmYki transcripts were ubiquitous but not abundant in all detected tissues and developmental stages. Comparatively, it was expressed at pretty high level in silk glands and at the stage of fifth-instar day-3 larvae. Overexpression of BmYki in cultured B. mori embryonic cells significantly promoted transcription of genes associated with cell proliferation and apoptosis, indicating that BmYki functions in the regulation of organ growth-related biological processes. Interestingly, transcription of silk protein-coding genes and transcription factors regulating the synthesis of silk proteins was downregulated remarkably, suggesting that BmYki was involved in the regulation of silk protein synthesis. This study provides new insights into the role of BmYki in Hpo pathway regulation in silkworm.	[Zeng, Wenhui; Wang, Riyuan; Zhang, Tianyang; Gong, Chunying; Xu, Hanfu] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Zuo, Weidong; Liu, Rongpeng; Ou, Yao; Xu, Hanfu] Southwest Univ, Coll Biotechnol, Chongqing, Peoples R China; [Xu, Hanfu] Southwest Univ, Inst Sericulture & Syst Biol, Chongqing, Peoples R China	Southwest University - China; Southwest University - China; Southwest University - China	Xu, HF (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.; Xu, HF (corresponding author), Southwest Univ, Coll Biotechnol, Chongqing, Peoples R China.; Xu, HF (corresponding author), Southwest Univ, Inst Sericulture & Syst Biol, Chongqing, Peoples R China.	xuhf@swu.edu.cn			Chongqing Research Program of Basic Research and Frontier Technology [cstc2017jcyjBX0041]; Southwest University [20163107001]	Chongqing Research Program of Basic Research and Frontier Technology; Southwest University(Southwest University - China)	This work was supported by the Chongqing Research Program of Basic Research and Frontier Technology Award Number: cstc2017jcyjBX0041 to Hanfu Xu and the Science & Technology Innovation Fund of Southwest University Award Number: 20163107001 to Hanfu Xu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bando T, 2009, DEVELOPMENT, V136, P2235, DOI 10.1242/dev.035204; Bosch M, 2005, DEV BIOL, V280, P73, DOI 10.1016/j.ydbio.2005.01.002; Dong DJ, 2015, J BIOL CHEM, V290, P24738, DOI 10.1074/jbc.M115.643783; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Elshaer N, 2015, BIOL CELL, V107, P273, DOI 10.1111/boc.201500003; Forsthoefel DJ, 2009, CURR OPIN GENET DEV, V19, P412, DOI 10.1016/j.gde.2009.05.003; Gotoh H, 2015, DEV DYNAM, V244, P1039, DOI [10.1002/DVDY.24296, 10.1002/dvdy.24296]; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Grusche FA, 2011, DEV BIOL, V350, P255, DOI 10.1016/j.ydbio.2010.11.020; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Hong AW, 2016, NAT REV GASTRO HEPAT, V13, P324, DOI 10.1038/nrgastro.2016.59; Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Liu B, 2016, CELL, V164, P406, DOI 10.1016/j.cell.2015.12.029; Micchelli CA, 1999, NATURE, V401, P473, DOI 10.1038/46779; Oh H, 2011, DEV CELL, V20, P109, DOI 10.1016/j.devcel.2010.12.002; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Rink JC, 2009, SCIENCE, V326, P1406, DOI 10.1126/science.1178712; Smith-Bolton RK, 2009, DEV CELL, V16, P797, DOI 10.1016/j.devcel.2009.04.015; Staley BK, 2012, DEV DYNAM, V241, P3, DOI 10.1002/dvdy.22723; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tumaneng K, 2012, CURR BIOL, V22, pR368, DOI 10.1016/j.cub.2012.03.003; Wang D, 2016, J BIOL CHEM, V291, P21761, DOI 10.1074/jbc.M116.719856; Wang GH, 2008, INSECT SCI, V15, P405, DOI 10.1111/j.1744-7917.2008.00227.x; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; XU TA, 1995, DEVELOPMENT, V121, P1053; Yazawa S, 2009, P NATL ACAD SCI USA, V106, P22329, DOI 10.1073/pnas.0907464106; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000	32	5	5	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182690	10.1371/journal.pone.0182690	http://dx.doi.org/10.1371/journal.pone.0182690			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28793345	gold, Green Published, Green Submitted			2022-12-26	WOS:000407196700059
J	Bure, L; Boucher, LM; Blumenkrantz, M; Schob, S; de Micheaux, PL; Reinhold, C; Gallix, B				Bure, Lionel; Boucher, Louis-Martin; Blumenkrantz, Miriam; Schob, Stefan; de Micheaux, Pierre Lafaye; Reinhold, Caroline; Gallix, Benoit			Can magnetic resonance spectroscopy differentiate malignant and benign causes of lymphadenopathy? An in-vitro approach	PLOS ONE			English	Article							LYMPH-NODE METASTASES; MR SPECTROSCOPY; BREAST-CANCER; NECK-CANCER; ECHO TIMES; 3.8 PPM; VIVO; BRAIN; RESOLUTION; HEAD	Lymphadenopathy continues to be a common problem to radiologists and treating physicians because of the difficulty in confidently categorizing a node as being benign or malignant using standard diagnostic techniques. The goal of our research was to assess whether magnetic resonance (MR) spectroscopy contains the necessary information to allow differentiation of benign from malignant lymph nodes in an in-vitro approach using a modern pattern recognition method. Tissue samples from a tissue bank were analyzed on a nuclear magnetic resonance (NMR) spectrometer. A total of 69 samples were studied. The samples included a wide variety of malignant and benign etiologies. Using 45 samples, we initially created a model which was able to predict if a certain spectrum originates from benign or malignant lymph nodes using a pattern-recognition technique which takes into account the entire magnetic spectrum rather than single peaks alone. The remaining 24 samples were blindly loaded in the model to assess its performance. We obtained an excellent accuracy in differentiating benign and malignant lymphadenopathy using the model. It correctly differentiated as malignant or benign, in a blinded fashion, all of the malignant samples (13 of 13) and 10 out of the 11 benign samples. We thus showed that magnetic spectroscopy is able to differentiate benign from malignant causes of lymphadenopathy. Additional experiments were performed to verify that the differentiating abilities of our model were not due to differential tissue decay in between benign and malignant tissues. If future experiments demonstrate that a similar approach could be executed with standard MR imaging, this technique could be useful as a problem-solving tool when assessing lymphadenopathy in general. Alternatively, our in-vitro technique could also be useful to pathologists faced with indeterminate pathologies of the lymph nodes after validating our results with a larger sample size.	[Bure, Lionel; Boucher, Louis-Martin; Reinhold, Caroline; Gallix, Benoit] McGill Univ, Hlth Ctr, Montreal Gen Hosp, Dept Radiol, Montreal, PQ, Canada; [Blumenkrantz, Miriam] McGill Univ, Hlth Ctr, Royal Victoria Hosp, Dept Adult & Pediat Pathol, Montreal, PQ, Canada; [Schob, Stefan] Leipzig Univ Hosp, Dept Neuroradiol, Leipzig, Germany; [de Micheaux, Pierre Lafaye] Univ New South Wales, Sch Math & Stat, Sydney, NSW, Australia	McGill University; McGill University; Royal Victoria Hospital; Leipzig University; University of New South Wales Sydney	Gallix, B (corresponding author), McGill Univ, Hlth Ctr, Montreal Gen Hosp, Dept Radiol, Montreal, PQ, Canada.	benoit.gallix@mcgill.ca		Lafaye de Micheaux, Pierre/0000-0002-0247-5136; bure, lionel/0000-0002-1292-9875				Beckonert O, 2010, NAT PROTOC, V5, P1019, DOI 10.1038/nprot.2010.45; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Curtin HD, 1998, RADIOLOGY, V207, P123, DOI 10.1148/radiology.207.1.9530307; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Dragoni F, 1999, CANCER, V85, P2485, DOI 10.1002/(SICI)1097-0142(19990601)85:11<2485::AID-CNCR26>3.0.CO;2-Y; Emir UE, 2016, CANCER RES, V76, P43, DOI 10.1158/0008-5472.CAN-15-0934; Hattingen E, 2007, J MAGN RESON IMAGING, V26, P427, DOI 10.1002/jmri.20985; Hocke M, 2008, J CANCER RES CLIN, V134, P473, DOI 10.1007/s00432-007-0309-7; Jansen JFA, 2012, ORAL ONCOL, V48, P717, DOI 10.1016/j.oraloncology.2012.02.001; Johansen J, 2008, HEAD NECK-J SCI SPEC, V30, P471, DOI 10.1002/hed.20734; King AD, 2005, CLIN RADIOL, V60, P592, DOI 10.1016/j.crad.2004.11.012; Kousi E, 2012, MOL MED REP, V5, P1011, DOI 10.3892/mmr.2012.773; Kumar A, 2011, ANN THORAC MED, V6, P11, DOI 10.4103/1817-1737.74270; Li M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025563; Mekle R, 2009, MAGN RESON MED, V61, P1279, DOI 10.1002/mrm.21961; Mlynarik V, 2008, MAGN RESON MED, V59, P52, DOI 10.1002/mrm.21447; Morales H, 2015, NEURORADIOL J, V28, P294, DOI 10.1177/1971400915592077; Petrakis EA, 2015, FOOD CHEM, V173, P890, DOI 10.1016/j.foodchem.2014.10.107; Povazan M, 2015, NEUROIMAGE, V121, P126, DOI 10.1016/j.neuroimage.2015.07.042; Razek AAKA, 2013, EUR J RADIOL, V82, P982, DOI 10.1016/j.ejrad.2013.01.025; Seber T, 2015, CLIN IMAG, V39, P856, DOI 10.1016/j.clinimag.2015.05.006; Seenu V, 2005, MAGN RESON IMAGING, V23, P1005, DOI 10.1016/j.mri.2005.10.004; Star-Lack JM, 2000, AM J NEURORADIOL, V21, P183; Thomas MA, 2014, NMR BIOMED, V27, P53, DOI 10.1002/nbm.2991; Tugnoli V, 2006, INT J MOL MED, V18, P859; Veselkov KA, 2009, ANAL CHEM, V81, P56, DOI 10.1021/ac8011544; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Yamazaki Y, 2008, ANN NUCL MED, V22, P177, DOI 10.1007/s12149-007-0097-9; Yeung DKW, 2002, RADIOLOGY, V225, P190, DOI 10.1148/radiol.2243011519	29	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2017	12	8							e0182169	10.1371/journal.pone.0182169	http://dx.doi.org/10.1371/journal.pone.0182169			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9EU	28792506	Green Published, Green Submitted, gold			2022-12-26	WOS:000407144700013
J	Patel, P; Bharti, PK; Bansal, D; Raman, RK; Mohapatra, PK; Sehgal, R; Mahanta, J; Sultan, AA; Singh, N				Patel, Priyanka; Bharti, Praveen K.; Bansal, Devendra; Raman, Rajive K.; Mohapatra, Pradyumna K.; Sehgal, Rakesh; Mahanta, Jagadish; Sultan, Ali A.; Singh, Neeru			Genetic diversity and antibody responses against Plasmodium falciparum vaccine candidate genes from Chhattisgarh, Central India: Implication for vaccine development	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-2; PAPUA-NEW-GUINEA; BAY COHORT PROJECT; MALARIA VACCINE; CIRCUMSPOROZOITE PROTEIN; NUCLEOTIDE SUBSTITUTIONS; NATURAL-SELECTION; MIXED INFECTIONS; ENDEMIC AREA; POLYMORPHISM	The genetic diversity in Plasmodium falciparum antigens is a major hurdle in developing an effective malaria vaccine. Protective efficacy of the vaccine is dependent on the polymorphic alleles of the vaccine candidate antigens. Therefore, we investigated the genetic diversity of the potential vaccine candidate antigens i.e. msp-1, msp-2, glurp, csp and pfs25 from field isolates of P. falciparum and determined the natural immune response against the synthetic peptide of these antigens. Genotyping was performed using Sanger method and size of alleles, multiplicity of infection, heterogeneity and recombination rate were analyzed. Asexual stage antigens were highly polymorphic with 55 and 50 unique alleles in msp-1 and msp2 genes, respectively. The MOI for msp-1 and msp-2 were 1.67 and 1.28 respectively. A total 59 genotype was found in glurp gene with 8 types of amino acid repeats in the conserved part of RII repeat region. The number of NANP repeats from 40 to 44 was found among 55% samples in csp gene while pfs25 was found almost conserved with only two amino acid substitution site. The level of genetic diversity in the present study population was very similar to that from Asian countries. A higher IgG response was found in the B-cell epitopes of msp-1 and csp antigens and higher level of antibodies against csp B-cell epitope and glurp antigen were recorded with increasing age groups. Significantly, higher positive responses were observed in the csp antigen among the samples with >= 42 NANP repeats. The present finding showed extensive diversity in the asexual stage antigens.	[Patel, Priyanka; Bharti, Praveen K.; Singh, Neeru] Indian Council Med Res, Natl Inst Res Tribal Hlth, Jabalpur, Madhya Pradesh, India; [Bansal, Devendra; Sultan, Ali A.] Cornell Univ, Qatar Fdn Educ City, Weill Cornell Med Qatar, Dept Microbiol & Immunol, Doha, Qatar; [Raman, Rajive K.] Community Hlth Ctr Janakpur, Chhattisgarh, India; [Mohapatra, Pradyumna K.; Mahanta, Jagadish] Indian Council Med Res, Reg Med Res Ctr NE, Dibrugarh, Assam, India; [Sehgal, Rakesh] Postgrad Inst Med Educ & Res, Dept Parasitol, Chandigarh, Punjab, India; [Patel, Priyanka] Symbiosis Int Univ, Symbiosis Sch Biomed Sci, Lavale, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tribal Health (NIRTH); Qatar Foundation (QF); Weill Cornell Medical College Qatar; Indian Council of Medical Research (ICMR); Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Symbiosis International University	Singh, N (corresponding author), Indian Council Med Res, Natl Inst Res Tribal Hlth, Jabalpur, Madhya Pradesh, India.	neeru.singh@gmail.com	International, Symbiosis School of Biological Sciences Symbiosis/AAD-7708-2019	Bansal, Devendra/0000-0002-1387-4335	Qatar National Research Fund [NPRP 5 - 098 - 3 021, NPRP 5-098-3-021]	Qatar National Research Fund(Qatar National Research Fund (QNRF))	This work was supported by Qatar National Research Fund, NPRP 5 - 098 - 3 021.; This publication was made possible by NPRP grant [NPRP 5-098-3-021] from the Qatar National Research Fund (a member of Qatar Foundation). Disclaimer: The statements made herein are solely the responsibility of the author [s]. We thank all the study participants and their relatives for providing the informed consent.	ALYAMAN F, 1994, AM J TROP MED HYG, V51, P593, DOI 10.4269/ajtmh.1994.51.593; [Anonymous], 2013, DIGN TREATM MAL; Aubouy A, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-12; Babiker HA, 2000, PARASITOLOGY, V120, P105, DOI 10.1017/S0031182099005387; Baruah S, 2009, INFECT GENET EVOL, V9, P853, DOI 10.1016/j.meegid.2009.05.006; Bharti PK, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-78; BORRE MB, 1991, MOL BIOCHEM PARASIT, V49, P119, DOI 10.1016/0166-6851(91)90135-S; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Cavanagh DR, 2004, INFECT IMMUN, V72, P6492, DOI 10.1128/IAI.72.11.6492-6502.2004; Chenet SM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0887-9; Conway DJ, 1997, PARASITOL TODAY, V13, P26, DOI 10.1016/S0169-4758(96)10077-6; Crompton PD, 2010, J CLIN INVEST, V120, P4168, DOI 10.1172/JCI44423; DUBOIS P, 1987, ANN INST PASTEUR IMM, V138, P383, DOI 10.1016/S0769-2625(87)80050-8; Eisen DP, 2002, AM J TROP MED HYG, V67, P8, DOI 10.4269/ajtmh.2002.67.8; Escalante AA, 1998, GENETICS, V149, P189; Escalante AA, 2002, MOL BIOCHEM PARASIT, V125, P83, DOI 10.1016/S0166-6851(02)00216-5; FELGER I, 1994, EXP PARASITOL, V79, P106, DOI 10.1006/expr.1994.1070; Fluck C, 2007, INFECT GENET EVOL, V7, P44, DOI 10.1016/j.meegid.2006.03.006; Franks S, 2003, INFECT IMMUN, V71, P3485, DOI 10.1128/IAI.71.6.3485-3495.2003; Genton B, 2002, J INFECT DIS, V185, P820, DOI 10.1086/339342; Genton B, 2003, VACCINE, V22, P30, DOI 10.1016/S0264-410X(03)00536-X; Griffing SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023486; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jain V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115266; Jiang GF, 2000, ACTA TROP, V74, P51, DOI 10.1016/S0001-706X(99)00045-5; Joshi H, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-60; Jukes TH, 1969, EVOLUTION PROTEIN MO; Krishna S, 2015, EMERG INFECT DIS, V21, P1853, DOI 10.3201/eid2110.150678; Kumar D, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-450; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Mahajan R C, 2005, Indian J Pathol Microbiol, V48, P429; Mamillapalli A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-95; MARSH K, 1988, T ROY SOC TROP MED H, V82, P532, DOI 10.1016/0035-9203(88)90495-6; MCCUTCHAN TF, 1988, PROG ALLERGY, V41, P173; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nei M., 1987, MOL EVOLUTIONARY GEN; Okoyeh JN, 1999, INFECT IMMUN, V67, P5784, DOI 10.1128/IAI.67.11.5784-5791.1999; Peyerl-Hoffmann G, 2001, TROP MED INT HEALTH, V6, P607, DOI 10.1046/j.1365-3156.2001.00761.x; Plowe CV, 2009, J INFECT DIS, V200, P1646, DOI 10.1086/646613; Ranjit MR, 2005, T ROY SOC TROP MED H, V99, P389, DOI 10.1016/j.trstmh.2004.09.010; Rout R, 2009, TROP BIOMED, V26, P165; Sallenave-Sales S, 2007, MEM I OSWALDO CRUZ, V102, P421, DOI 10.1590/S0074-02762007005000048; SCHOFIELD L, 1990, B WORLD HEALTH ORGAN, V68, P66; Sharma RK, 2015, INDIAN J MED RES, V141, P537; Singh J., 1944, Indian Medical Gazette, V79, P102; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; TAYLOR RR, 1995, INFECT IMMUN, V63, P4382, DOI 10.1128/IAI.63.11.4382-4388.1995; Theisen M, 2001, INFECT IMMUN, V69, P5223, DOI 10.1128/IAI.69.9.5223-5229.2001; Waitumbi JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007849; White N. J., 1996, Manson's tropical diseases., P1087; WHO, 2015, WORLD MAL REP 2015; Zeeshan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043430; Zhou Z, 2002, AM J TROP MED HYG, V66, P7, DOI 10.4269/ajtmh.2002.66.7	55	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182674	10.1371/journal.pone.0182674	http://dx.doi.org/10.1371/journal.pone.0182674			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28787005	gold, Green Published, Green Submitted			2022-12-26	WOS:000406998800057
J	Im, K; Song, J; Hang, YT; Lee, S; Kang, S; Hwang, KW; Min, H; Min, KH				Im, Kyungtaek; Song, Jiho; Hang, Young Taek; Lee, Seul; Kang, Soowon; Hwang, Kwang Woo; Min, Hyeyoung; Min, Kyung Hoon			Identification of aminosulfonylarylisoxazole as microRNA-31 regulators	PLOS ONE			English	Article							RNA-INTERFERENCE PATHWAY; SMALL-MOLECULE; TUMOR-SUPPRESSOR; COLORECTAL-CANCER; MIR-31; CELLS; EXPRESSION; CARCINOGENESIS; ACTIVATION; INHIBITORS	The discovery of small-molecule regulators of microRNAs remains challenging, but a few have been reported. Herein, we describe small-molecule inhibitors of miR-31, a tumor-associated microRNA (miRNA), identified by high-throughput screening using a cell-based reporter assay. Aminosulfonylarylisoxazole compounds exhibited higher specificity for miR-31 than for six other miRNAs, i.e., miR-15a, miR-16, miR-21, miR-92a-1, miR-146a, and miR-155, and increased the expression of miR-31 target genes. The down-regulation of mature miR-31 was observed, while its precursor form increased following treatment with the compounds. Thus, the compounds may target the processing of pre-miR-31 into mature miR-31 and thereby inhibit the production of mature miR-31.	[Im, Kyungtaek; Song, Jiho; Lee, Seul; Kang, Soowon; Hwang, Kwang Woo; Min, Hyeyoung; Min, Kyung Hoon] Chung Ang Univ, Coll Pharm, Seoul, South Korea; [Hang, Young Taek] Dankook Univ, Coll Pharm, Chungnam, South Korea	Chung Ang University; Dankook University	Min, H; Min, KH (corresponding author), Chung Ang Univ, Coll Pharm, Seoul, South Korea.	hymin@cau.ac.kr; khmin@cau.ac.kr		Han, Young Taek/0000-0002-3617-1181; Kang, Soowon/0000-0003-3451-9882; Song, Jiho/0000-0002-0528-8096	Public welfare Welfare & Safety research program [20100020842]; Bio & Medical Technology Development Program [NRF-2012M3A9C7050137]; National Research Foundation of Korea - Korean government [2015R1A5A1008958]	Public welfare Welfare & Safety research program; Bio & Medical Technology Development Program; National Research Foundation of Korea - Korean government(National Research Foundation of KoreaKorean Government)	This work was supported by the Public welfare Welfare & Safety research program (20100020842), the Bio & Medical Technology Development Program (NRF-2012M3A9C7050137) and Advanced Research Center Program (2015R1A5A1008958) through the National Research Foundation of Korea funded by the Korean government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amr KS, 2016, RHEUMATOL INT, V36, P1617, DOI 10.1007/s00296-016-3550-z; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BERGER J, 1988, GENE, V66, P1, DOI 10.1016/0378-1119(88)90219-3; Chan YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058169; Chen XJ, 2012, CHEM COMMUN, V48, P6432, DOI 10.1039/c2cc32157b; Chiu YL, 2005, CHEM BIOL, V12, P643, DOI 10.1016/j.chembiol.2005.04.016; Connor CJO, 2011, CHEM SOC REV, V40, P4332, DOI 10.1039/c1cs15053g; Dai RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014302; Deiters A, 2010, AAPS J, V12, P51, DOI 10.1208/s12248-009-9159-3; Farooqi AA, 2014, ONCOTARGETS THER, V7, P2035, DOI 10.2147/OTT.S49652; Finlay-Schultz J, 2015, ONCOGENE, V34, P3676, DOI 10.1038/onc.2014.298; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Gumireddy K, 2008, ANGEW CHEM INT EDIT, V47, P7482, DOI 10.1002/anie.200801555; Hua DS, 2012, ONCOL REP, V27, P700, DOI 10.3892/or.2011.1555; Hung PS, 2014, CARCINOGENESIS, V35, DOI 10.1093/carcin/bgu024; Jan A, 2015, NEUROSCI LETT, V598, P66, DOI 10.1016/j.neulet.2015.05.007; Jeon C, 2011, J GINSENG RES, V35, P462, DOI 10.5142/jgr.2011.35.4.462; Kim HS, 2015, ONCOTARGET, V6, P8089, DOI 10.18632/oncotarget.3512; Korner C, 2013, J BIOL CHEM, V288, P8750, DOI 10.1074/jbc.M112.414128; Li T, 2015, BIOTECHNOL LETT, V37, P523, DOI 10.1007/s10529-014-1715-y; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Maiti M, 2012, BIOORG MED CHEM LETT, V22, P1709, DOI 10.1016/j.bmcl.2011.12.103; Merhautova J, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00329; Mohammadnia-Afrouzi M, 2016, IMMUNOL INVEST, V45, P63, DOI 10.3109/08820139.2015.1103749; Nosho K, 2014, CARCINOGENESIS, V35, P776, DOI 10.1093/carcin/bgt374; Okudela K, 2014, ONCOL REP, V32, P1374, DOI 10.3892/or.2014.3339; Olaru AV, 2011, INFLAMM BOWEL DIS, V17, P221, DOI 10.1002/ibd.21359; Rajbhandari R, 2015, ONCOTARGET, V6, P17805, DOI 10.18632/oncotarget.4596; Ren Y, 2015, CANCER LETT, V362, P174, DOI 10.1016/j.canlet.2015.03.038; Rouas R, 2009, EUR J IMMUNOL, V39, P1608, DOI 10.1002/eji.200838509; Ruoming W, 2015, CANCER GENE THER, V22, P564, DOI 10.1038/cgt.2015.41; Saki Najmaldin, 2015, Int J Hematol Oncol Stem Cell Res, V9, P33; Schwarzenbach H, 2015, CLIN CHEM, V61, P1333, DOI 10.1373/clinchem.2015.239459; Shan G, 2008, NAT BIOTECHNOL, V26, P933, DOI 10.1038/nbt.1481; Shibata Chikako, 2013, Mol Cell Ther, V1, P5, DOI 10.1186/2052-8426-1-5; Sun DF, 2013, J BIOL CHEM, V288, P9508, DOI 10.1074/jbc.M112.367763; Taccioli C, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv220; Tan GS, 2012, ACS CHEM BIOL, V7, P402, DOI 10.1021/cb200253h; Thorsen SB, 2012, CANCER J, V18, P275, DOI 10.1097/PPO.0b013e318258b5d6; Velagapudi SP, 2016, P NATL ACAD SCI USA, V113, P5898, DOI 10.1073/pnas.1523975113; Wang HD, 2016, ONCOTARGET, V7, P36577, DOI 10.18632/oncotarget.9288; Watashi K, 2010, J BIOL CHEM, V285, P24707, DOI 10.1074/jbc.M109.062976; Xu H, 2016, CLIN LAB, V62, P711, DOI 10.7754/Clin.Lab.2015.150903; Xu N, 2013, J IMMUNOL, V190, P678, DOI 10.4049/jimmunol.1202695; Xu TY, 2016, ONCOTARGET, V7, P27445, DOI 10.18632/oncotarget.8479; Xue F, 2013, GENES IMMUN, V14, P127, DOI 10.1038/gene.2012.58; Young DD, 2010, J AM CHEM SOC, V132, P7976, DOI 10.1021/ja910275u; Yu MC, 2016, ONCOTARGET, V7, P13742, DOI 10.18632/oncotarget.7328; Zhang LY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8639; Zhang TF, 2011, CLIN SCI, V121, P437, DOI 10.1042/CS20110207	50	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0182331	10.1371/journal.pone.0182331	http://dx.doi.org/10.1371/journal.pone.0182331			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28783765	Green Published, gold, Green Submitted			2022-12-26	WOS:000406944300029
J	Li, TT; Lu, M; Song, J; Wu, P; Cheng, XQ; Zhang, ZQ				Li, Tingting; Lu, Man; Song, Jun; Wu, Ping; Cheng, Xueqing; Zhang, Zhenqi			Improvement to ultrasonographical differential diagnosis of gastric lesions: The value of contrast enhanced sonography with gastric distention	PLOS ONE			English	Article							ENDOSCOPIC ULTRASONOGRAPHY; ULTRASOUND; TUMORS	Objective The purpose of this retrospective study is to evaluate the diagnostic value of contrast enhanced sonography plus gastric distention sonography, the Double Contrast-enhanced Ultrasound (DCUS) in gastric lesions. Methods 107 cases with pathology confirmed gastric lesions were retrospectively reviewed, DCUS and oral contrast agent ultrasound (US) were performed in all cases prior to operation. Perfusion parameters including arrival time (AT), peak intensity (PI), time to peak (TTP), and area under the curve (AUC) of the lesion and surrounding normal tissue were analyzed. A reader blinded to pathology results were asked to rate and compare each case with surgical or resection biopsy pathology results. Results From the 107 gastric lesions, 75 were malignant gastric lesions (33 gastric cancers, 42 gastrointestinal stromal tumors (GISTs)) and 32 were benign gastric lesions (11 inflammatory masses and 21 polypoid adenomas). Compared with US, DCUS achieved higher value in sensitivity (90.6% vs. 70.6%), specificity (75% vs. 62.5%), positive predictive value (89.5% vs. 81.5%), negative predictive value (77.4% vs. 47.6%), and overall accuracy (85.9% vs. 68.2%). When US was tested against DCUS, the increase in correct diagnoses value was significant (P=.01). Furthermore, gastric cancer had faster AT, higher PI and AUC than normal tissue (P<0.05); GIST and Inflammatory mass had higher PI than normal tissue (P<0.05); gastric cancer and GIST had faster AT than polypoid adenoma (P<0.05), Inflammatory mass showed higher PI than other 3 lesions and gastric cancer had higher PI than polypoid adenoma and GIST (P<0.05); gastric cancer and inflammatory mass had larger AUC than polypoid adenoma and GIST (P<0.05). Conclusion DCUS improved diagnostic performance compared with US. The combination of different CEUS enhancement characteristics with quantitative perfusion parameters may provide a promising tool to help differentiate gastric cancer and GIST from benign lesions.	[Li, Tingting; Lu, Man; Cheng, Xueqing; Zhang, Zhenqi] Univ Elect Sci & Technol China, Sch Med, Sichuan Canc Ctr, Sichuan Canc Hosp Inst,Dept Ultrasound, Chengdu, Sichuan, Peoples R China; [Song, Jun; Wu, Ping] Univ Elect Sci & Technol China, Sichuan Acad Med Sci, Dept Ultrasound, Chengdu, Sichuan, Peoples R China; [Song, Jun; Wu, Ping] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Sch Med, Chengdu, Sichuan, Peoples R China	University of Electronic Science & Technology of China; Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China	Lu, M (corresponding author), Univ Elect Sci & Technol China, Sch Med, Sichuan Canc Ctr, Sichuan Canc Hosp Inst,Dept Ultrasound, Chengdu, Sichuan, Peoples R China.	graceof@163.com	zhang, zhenqi/GSN-1651-2022	Lu, Man/0000-0002-3455-834X				Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Davies A. R., 2008, WORLD J SURG ONCOL, V6, P1; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Huang PT, 2011, ARCH MED SCI, V7, P287, DOI 10.5114/aoms.2011.22080; Hwang JH, 2005, GASTROINTEST ENDOSC, V62, P202, DOI 10.1016/S0016-5107(05)01567-1; Janson ET, 2014, ACTA ONCOL, V53, P1284, DOI 10.3109/0284186X.2014.941999; Jenssen C, 2008, Z GASTROENTEROL, V46, P1177, DOI 10.1055/s-2008-1027334; Johnson PT, 2010, AM J ROENTGENOL, V195, pW415, DOI 10.2214/AJR.10.4575; [李婷婷 Li Tingting], 2015, [中国超声医学杂志, Chinese Journal of Ultrasonic in Medicine], V31, P1096; Liu ZJ, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1943-0; Lu M, 2014, J ULTRAS MED, V33, P575, DOI 10.7863/ultra.33.4.575; Pickhardt PJ, 2003, RADIOGRAPHICS, V23, P645, DOI 10.1148/rg.233025134; Rosch T, 2002, SCAND J GASTROENTERO, V37, P856, DOI 10.1080/713786521; Shi H, 2012, WORLD J GASTROENTERO, V18, P4136, DOI 10.3748/wjg.v18.i31.4136; Wilson SR, 2009, AM J ROENTGENOL, V193, P55, DOI 10.2214/AJR.09.2553; Xue NY, 2011, ARCH MED SCI, V7, P457, DOI 10.5114/aoms.2011.23412; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; Zheng ZQ, 2011, AM J SURG, V202, P605, DOI 10.1016/j.amjsurg.2010.09.033	18	9	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0182332	10.1371/journal.pone.0182332	http://dx.doi.org/10.1371/journal.pone.0182332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28783738	Green Submitted, gold, Green Published			2022-12-26	WOS:000406944300030
J	Chen, J; Xue, J; Ruan, JS; Zhao, J; Tang, BS; Duan, RH				Chen, Jia; Xue, Jin; Ruan, Jingsong; Zhao, Juan; Tang, Beisha; Duan, Ranhui			Drosophila CHIP protects against mitochondrial dysfunction by acting downstream of Pink1 in parallel with Parkin	FASEB JOURNAL			English	Article						Parkinson disease; E3 ubiquitin ligase; CRISPR	E3 UBIQUITIN LIGASE; AUTOPHAGIC CLEARANCE; OXIDATIVE STRESS; ALPHA-SYNUCLEIN; IN-VITRO; DISEASE; MITOPHAGY; DEGRADATION; DEGENERATION; PROTEASOME	Mitochondrial kinase PTEN-induced putative kinase 1 (PINK1) and E3 ubiquitin ligase Parkin function in a common pathway to regulate mitochondrial homeostasis contributing to the pathogenesis of Parkinson disease. The carboxyl terminus of Hsc70-interacting protein (CHIP) acts as a heat shock protein 70/heat shock protein 90 cochaperone to mediate protein folding or as an E3 ubiquitin ligase to target proteins for degradation. In this study, overexpression of Drosophila CHIP suppressed a range of Pink1 mutant phenotypes in flies, including abnormal wing posture, thoracic indentation, locomotion defects, muscle degeneration, and loss of dopaminergic neurons. Mitochondrial defects of Pink1 mutant, such as excessive fusion, reduced ATP content, and crista disorganization, were rescued by CHIP but not its ligase-dead mutants. Similar phenotypes and mitochondrial impairment were ameliorated in Parkin mutant flies by wild-type CHIP. Inactivation of CHIP with null fly mutants resulted in mitochondrial defects, such as reduced thoracic ATP content at 3 d old, decreased thoracic mitochondrial DNA content, and defective mitochondrial morphology at 60 d old. CHIP mutants did not exacerbate the phenotypes of Pink1 mutant flies but markedly shortened the life span of Parkin mutant flies. These results indicate that CHIP is involved in mitochondrial integrity and may act downstream of Pink1 in parallel with Parkin.-Chen, J., Xue, J., Ruan, J., Zhao, J., Tang, B., Duan, R. Drosophila CHIP protects against mitochondrial dysfunction by acting downstream of Pink1 in parallel with Parkin.	[Chen, Jia; Xue, Jin; Ruan, Jingsong; Zhao, Juan; Tang, Beisha; Duan, Ranhui] Cent S Univ, Xiangya Hosp, Sch Life Sci, State Key Lab Med Genet, Changsha, Hunan, Peoples R China; [Tang, Beisha] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha 410008, Hunan, Peoples R China	Central South University; Central South University	Tang, BS (corresponding author), Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha 410008, Hunan, Peoples R China.; Duan, RH (corresponding author), State Key Lab Med Genet, 110 Xiangya Rd, Changsha 410008, Hunan, Peoples R China.	bstang7398@163.com; duanranhui@sklmg.edu.cn			National Natural Science Foundation of China [81571253, 81172513, 81071028]; Doctoral Student Autonomous Exploration Project of Central South University [2015zzts091]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Student Autonomous Exploration Project of Central South University	The authors thank Z. Zhang, K. Xia, C. Tang, T. Zhang, and R. Wang (State Key Laboratory of Medical Genetics) for technical support and valuable comments. The authors thank the Drosophila Stock Center (Indiana University, Bloomington, IN, USA) and the Tsinghua Fly Center (Tsinghua University, Beijing Shi, China) for fly stocks. This work was supported by National Natural Science Foundation of China (Grants 81571253, 81172513, and 81071028) and the Doctoral Student Autonomous Exploration Project of Central South University (Grant 2015zzts091). The authors declare no conflicts of interest.	Arun S, 2016, CURR NEUROPHARMACOL, V14, P143, DOI 10.2174/1570159X13666150703154541; Bras J, 2015, CELL, V160, P570, DOI 10.1016/j.cell.2015.01.019; Cha GH, 2005, P NATL ACAD SCI USA, V102, P10345, DOI 10.1073/pnas.0500346102; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cunningham CN, 2015, NAT CELL BIOL, V17, P160, DOI 10.1038/ncb3097; de Castro IP, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001456; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Duan RH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149039; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Hauser DN, 2013, NEUROBIOL DIS, V51, P35, DOI 10.1016/j.nbd.2012.10.011; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Ko HS, 2009, P NATL ACAD SCI USA, V106, P2897, DOI 10.1073/pnas.0810123106; Kumar P, 2007, HUM MOL GENET, V16, P848, DOI 10.1093/hmg/ddm030; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Li HM, 2005, FREE RADICAL RES, V39, P1091, DOI 10.1080/10715760500260348; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Miller VM, 2005, J NEUROSCI, V25, P9152, DOI 10.1523/JNEUROSCI.3001-05.2005; Morishima Y, 2008, HUM MOL GENET, V17, P3942, DOI 10.1093/hmg/ddn296; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Narendra D, 2009, AUTOPHAGY, V5, P706, DOI 10.4161/auto.5.5.8505; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Palubinsky AM, 2015, ANTIOXID REDOX SIGN, V23, P535, DOI 10.1089/ars.2014.6102; Park J, 2009, BIOCHEM BIOPH RES CO, V378, P518, DOI 10.1016/j.bbrc.2008.11.086; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Paul I, 2015, INT J BIOCHEM CELL B, V58, P37, DOI 10.1016/j.biocel.2014.10.027; Paul I, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/918183; Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Ren XJ, 2013, P NATL ACAD SCI USA, V110, P19012, DOI 10.1073/pnas.1318481110; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Singleton A, 2016, NEURON, V90, P1154, DOI 10.1016/j.neuron.2016.05.040; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; Takahashi R, 2003, J NEUROL, V250, P25, DOI 10.1007/s00415-003-1305-8; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Tetzlaff JE, 2008, J BIOL CHEM, V283, P17962, DOI 10.1074/jbc.M802283200; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Urushitani M, 2004, J NEUROCHEM, V90, P231, DOI 10.1111/j.1471-4159.2004.02486.x; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Whitworth AJ, 2011, ADV GENET, V73, P1, DOI 10.1016/B978-0-12-380860-8.00001-X; Wu K, 2014, FASEB J, V28, P5111, DOI 10.1096/fj.14-255802; Xu Z, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-26; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Yung C, 2016, MOL NEUROBIOL, V53, P6270, DOI 10.1007/s12035-015-9537-z; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zhang TM, 2016, J BIOL CHEM, V291, P21616, DOI 10.1074/jbc.M116.733410; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	64	13	13	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5234	5245		10.1096/fj.201700011R	http://dx.doi.org/10.1096/fj.201700011R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28778978				2022-12-26	WOS:000416588300010
J	Czajkowski, R; Smolarska, A; Ozymko, Z				Czajkowski, Robert; Smolarska, Anna; Ozymko, Zofia			The viability of lytic bacteriophage phi D5 in potato-associated environments and its effect on Dickeya solani in potato (Solanum tuberosum L.) plants	PLOS ONE			English	Article							PHAGE; HOST; MANAGEMENT; SOILBORNE; OUTBREAKS; CLADE	Dickeya solani is one of the most important pectinolytic phytopathogens responsible for high losses in potato, especially in seed potato production in Europe. Lytic bacteriophages can affect the structure of the host population and may influence spread, survival and virulence of the pathogen and in consequence, infection of the plant. In this study, we aimed to acquire information on the viability of the broad host lytic bacteriophage phi D5 on potato, as well as to apprehend the specific effect of this bacteriophage on its host D. solani type-strain in different settings, as a preliminary step to target co-adaptation of phages and host bacteria in plant environment. Viability of the phi D5 phage in tuber extract, on tuber surface, in potting compost, in rainwater and on the leaf surface, as well as the effect of copper sulfate, were examined under laboratory conditions. Also, the interaction of phi D5 with the target host D. solani in vitro and in compost-grown potato plants was evaluated. phi D5 remained infectious in potato tuber extract and rain water for up to 72 h but was inactivated in solutions containing 50 mM of copper. The phage population was stable for up to 28 days on potato tuber surface and in potting compost. In both, tissue culture and compost-grown potato plants, phi D5 reduced infection by D. solani by more than 50%. The implications of these findings are discussed.	[Czajkowski, Robert] Univ Gdansk, Dept Biotechnol, Intercollegiate Fac Biotechnol, Gdansk, Poland; Med Univ Gdansk, Gdansk, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk	Czajkowski, R (corresponding author), Univ Gdansk, Dept Biotechnol, Intercollegiate Fac Biotechnol, Gdansk, Poland.	robert.czajkowski@biotech.ug.edu.pl	Czajkowski, Robert/M-4612-2014; Czajkowski, Robert/B-2925-2012	Czajkowski, Robert/0000-0001-9641-5603; Czajkowski, Robert/0000-0001-9641-5603; Smolarska, Anna/0000-0001-6995-6316	National Science Center, Poland [FUGA1 (DEC-2012/04/S/NZ9/00018]; National Center for Research and Development via LIDER VI [LIDER/450/L-6/14/NCBR/2015]	National Science Center, Poland(National Science Centre, Poland); National Center for Research and Development via LIDER VI	This work was supported by the National Science Center, Poland via a postdoctoral research grant FUGA1 (DEC-2012/04/S/NZ9/00018 to Robert Czajkowski and the National Center for Research and Development via a LIDER VI research grant no. LIDER/450/L-6/14/NCBR/2015 to Robert Czajkowski. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens EM, 2012, ARCH VIROL, V157, P2035, DOI 10.1007/s00705-012-1360-5; Adriaenssens EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033227; Ashelford KE, 2000, APPL ENVIRON MICROB, V66, P4193, DOI 10.1128/AEM.66.10.4193-4199.2000; Bishop C, 2012, POTATOES CROP POSTHA, P334; Chibani-Chennoufi S, 2004, J BACTERIOL, V186, P3677, DOI 10.1128/JB.186.12.3677-3686.2004; Clokie Martha Rj, 2011, Bacteriophage, V1, P31, DOI 10.4161/bact.1.1.14942; COOK RJ, 1993, ANNU REV PHYTOPATHOL, V31, P53, DOI 10.1146/annurev.py.31.090193.000413; Czajkowski R, 2014, PLANT PATHOL, V63, P758, DOI 10.1111/ppa.12157; Czajkowski R, 2013, EUR J PLANT PATHOL, V136, P419, DOI 10.1007/s10658-013-0177-8; Czajkowski R, 2011, PLANT PATHOL, V60, P999, DOI 10.1111/j.1365-3059.2011.02470.x; Czajkowski R, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnv230; Czajkowski R, 2015, EUR J PLANT PATHOL, V141, P545, DOI 10.1007/s10658-014-0561-z; Czajkowski R, 2014, ARCH VIROL, V159, P3153, DOI 10.1007/s00705-014-2170-8; Czajkowski R, 2010, PHYTOPATHOLOGY, V100, P134, DOI 10.1094/PHYTO-100-2-0134; Czajkowski R, 2009, EUR J PLANT PATHOL, V125, P263, DOI 10.1007/s10658-009-9480-9; DAVIDSON T. M. W., 1958, American Potato Journal, V35, P451, DOI 10.1007/BF02851270; Degefu Y, 2013, ANN APPL BIOL, V162, P231, DOI 10.1111/aab.12020; ELPHINSTONE JG, 1987, ANN APPL BIOL, V110, P535, DOI 10.1111/j.1744-7348.1987.tb04171.x; ERSKINE JM, 1973, CAN J MICROBIOL, V19, P837, DOI 10.1139/m73-134; Frampton R. A., 2012, INT J MICROBIOL, V2012, DOI [10.1155/2012/326452, DOI 10.1155/2012/326452]; GILL JJ, 2003, BACTERIOPHAGE ECOLOG; Greer GG, 2005, J FOOD PROTECT, V68, P1102, DOI 10.4315/0362-028X-68.5.1102; Guenther S, 2009, APPL ENVIRON MICROB, V75, P93, DOI 10.1128/AEM.01711-08; Iriarte FB, 2007, APPL ENVIRON MICROB, V73, P1704, DOI 10.1128/AEM.02118-06; Johnson KB, 2000, BIOL CONTROL FIRE BL, P319; Jonczyk E, 2011, FOLIA MICROBIOL, V56, P191, DOI 10.1007/s12223-011-0039-8; Jones Jeffrey B, 2012, Bacteriophage, V2, P208, DOI 10.4161/bact.23857; Koskella B, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0297; Lang JM, 2007, PLANT DIS, V91, P871, DOI 10.1094/PDIS-91-7-0871; Li JY, 2011, APPL ENVIRON MICROB, V77, P6878, DOI 10.1128/AEM.05661-11; Lindow SE, 2002, CURR OPIN BIOTECH, V13, P238, DOI 10.1016/S0958-1669(02)00313-0; McKenna F, 2001, PLANT PATHOL, V50, P666, DOI 10.1046/j.1365-3059.2001.00648.x; Obradovic A, 2004, PLANT DIS, V88, P736, DOI 10.1094/PDIS.2004.88.7.736; OKABE NORIO, 1963, ANN REV PHYTOPATHOL, V1, P397, DOI 10.1146/annurev.py.01.090163.002145; Slawiak M, 2009, EUR J PLANT PATHOL, V125, P245, DOI 10.1007/s10658-009-9479-2; Summers WC, 2001, ANNU REV MICROBIOL, V55, P437, DOI 10.1146/annurev.micro.55.1.437; Thiel K, 2004, NAT BIOTECHNOL, V22, P31, DOI 10.1038/nbt0104-31; Toth IK, 2011, PLANT PATHOL, V60, P385, DOI 10.1111/j.1365-3059.2011.02427.x; Tsror L, 2009, EUR J PLANT PATHOL, V123, P311, DOI 10.1007/s10658-008-9368-0; van der Wolf JM, 2014, INT J SYST EVOL MICR, V64, P768, DOI 10.1099/ijs.0.052944-0	40	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0183200	10.1371/journal.pone.0183200	http://dx.doi.org/10.1371/journal.pone.0183200			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800363	gold, Green Published, Green Submitted			2022-12-26	WOS:000407431800064
J	Joachim, SC; Renner, M; Reinhard, J; Theiss, C; May, C; Lohmann, S; Reinehr, S; Stute, G; Faissner, A; Marcus, K; Dick, HB				Joachim, Stephanie C.; Renner, Marina; Reinhard, Jacqueline; Theiss, Carsten; May, Caroline; Lohmann, Stephanie; Reinehr, Sabrina; Stute, Gesa; Faissner, Andreas; Marcus, Katrin; Dick, H. Burkhard			Protective effects on the retina after ranibizumab treatment in an ischemia model	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PROLIFERATIVE DIABETIC-RETINOPATHY; AUTOIMMUNE GLAUCOMA MODEL; PRESSURE-INDUCED ISCHEMIA; REPERFUSION INJURY; RAT RETINA; MACULAR DEGENERATION; GANGLION-CELLS; OPTIC-NERVE; GLIAL-CELLS	Retinal ischemia is common in eye disorders, like diabetic retinopathy or retinal vascular occlusion. The goal of this study was to evaluate the potential protective effects of an intravitreally injected vascular endothelial growth factor (VEGF) inhibitor (ranibizumab) on retinal cells in an ischemia animal model via immunohistochemistry (IF) and quantitative real-time PCR (PCR). A positive binding of ranibizumab to rat VEGF-A was confirmed via dot blot. One eye underwent ischemia and a subgroup received ranibizumab. A significant VEGF increase was detected in aqueous humor of ischemic eyes (p = 0.032), whereas VEGF levels were low in ranibizumab eyes (p = 0.99). Ischemic retinas showed a significantly lower retinal ganglion cell number (RGC; IF Brn-3a: p < 0.001, IF RBPMS: p < 0.001; PCR: p = 0.002). The ranibizumab group displayed fewer RGCs (IF Brn-3a: 0.3, IF RBPMS: p < 0.001; PCR: p = 0.007), but more than the ischemia group (IF Brn-3a: p = 0.04, IF RBPMS: p = 0.03). Photoreceptor area was decreased after ischemia (IF: p = 0.049; PCR: p = 0.511), while the ranibizumab group (IF: p = 0.947; PCR: p = 0.122) was comparable to controls. In the ischemia (p < 0.001) and ranibizumab group (p < 0.001) a decrease of ChAT(+) amacrine cells was found, which was less prominent in the ranibizumab group. VEGF-receptor 2 (VEGF-R2; IF: p < 0.001; PCR: p = 0.021) and macroglia (GFAP; IF: p < 0.001; PCR: p < 0.001) activation was present in ischemic retinas. The activation was weaker in ranibizumab retinas (VEGF-R2: IF: p = 0.1; PCR: p = 0.03; GFAP: IF: p = 0.1; PCR: p = 0.015). An increase in the number of total (IF: p = 0.003; PCR: p = 0.023) and activated microglia (IF: p < 0.001; PCR: p = 0.009) was detected after ischemia. These levels were higher in the ranibizumab group (Iba1: IF: p < 0.001; PCR: p = 0.018; CD68: IF: p < 0.001; PCR: p = 0.004). Our findings demonstrate that photoreceptors and RGCs are protected by ranibizumab treatment. Only amacrine cells cannot be rescued. They seem to be particularly sensitive to ischemic damage and need maybe an earlier intervention.	[Joachim, Stephanie C.; Renner, Marina; Lohmann, Stephanie; Reinehr, Sabrina; Stute, Gesa; Dick, H. Burkhard] Ruhr Univ Bochum, Univ Eye Hosp, Expt Eye Res, Schornau 23-25, Bochum, Germany; [Reinhard, Jacqueline; Faissner, Andreas] Ruhr Univ Bochum, Fac Biol & Biotechnol, Dept Cell Morphol & Mol Neurobiol, Univ Str 150, Bochum, Germany; [Theiss, Carsten] Ruhr Univ Bochum, Fac Med, Dept Cytol, Univ Str 150, Bochum, Germany; [May, Caroline; Marcus, Katrin] Ruhr Univ Bochum, Med Proteom Ctr, Univ Str 150, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum	Joachim, SC (corresponding author), Ruhr Univ Bochum, Univ Eye Hosp, Expt Eye Res, Schornau 23-25, Bochum, Germany.	stephanie.joachim@rub.de	Joachim, Stephanie/AAV-5980-2021; Dick, Burkhard/AAI-7504-2020; Faissner, Andreas/A-5314-2008; Reinhard, Jacqueline/AEO-3422-2022	Faissner, Andreas/0000-0002-2211-8259; Lohmann, Stephanie/0000-0003-1540-6372; Reinhard, Jacqueline/0000-0002-4227-0493	Novartis Pharma GmbH; PURE, a project of North Rhine-Westphalia, a federal German state, Germany; Novartis	Novartis Pharma GmbH; PURE, a project of North Rhine-Westphalia, a federal German state, Germany; Novartis(Novartis)	The study was in part supported by Novartis Pharma GmbH and the spotting unit was funded by PURE, a project of North Rhine-Westphalia, a federal German state, Germany. No additional external funding was received for this study. The funders had no role in the study design; collection, analysis, and interpretation of data; writing of the paper; and/or decision to submit for publication.; SCJ received funding from Novartis Pharma GmbH, and Novartis produces Ranibizumab. This does not alter our adherence to PLOS ONE policies on sharing data and materials. There are no further patents, products in development, or marketed products to declare.	Abcouwer SF, 2010, INVEST OPHTH VIS SCI, V51, P5920, DOI 10.1167/iovs.10-5264; Adachi M, 1996, GRAEF ARCH CLIN EXP, V234, P445, DOI 10.1007/BF02539411; ADAMIS AP, 1994, AM J OPHTHALMOL, V118, P445, DOI 10.1016/S0002-9394(14)75794-0; Akkoyun I, 2012, ACTA OPHTHALMOL, V90, P564, DOI 10.1111/j.1755-3768.2010.01963.x; Bao Philip, 2009, J Surg Res, V153, P347, DOI 10.1016/j.jss.2008.04.023; Beazley-Long N, 2013, AM J PATHOL, V183, P918, DOI 10.1016/j.ajpath.2013.05.031; Behl T, 2015, PHARMACOL RES, V99, P137, DOI 10.1016/j.phrs.2015.05.013; Brar VS, 2010, MOL VIS, V16, P1848; Brown DM, 2015, OPHTHALMOLOGY; Campochiaro PA, 2015, PROG RETIN EYE RES, V49, P67, DOI 10.1016/j.preteyeres.2015.06.002; Carmeliet P, 2013, CELL MOL LIFE SCI, V70, P1763, DOI 10.1007/s00018-013-1283-7; Casola C, 2015, J MOL NEUROSCI, V56, P228, DOI 10.1007/s12031-014-0485-2; Cervia D, 2012, J NEUROCHEM, V120, P818, DOI 10.1111/j.1471-4159.2011.07622.x; Chernykh VV, 2015, INDIAN J OPHTHALMOL, V63, P33, DOI 10.4103/0301-4738.151464; de Groot H, 2007, TRANSPL P, V39, P481, DOI 10.1016/j.transproceed.2006.12.012; Dijk F, 2004, BRAIN RES, V1026, P205, DOI 10.1016/j.brainres.2004.08.014; Dvoriantchikova G, 2011, INVEST OPHTH VIS SCI, V52, P7187, DOI 10.1167/iovs.11-7793; Famiglietti EV, 2003, BRAIN RES, V969, P195, DOI 10.1016/S0006-8993(02)03766-6; Gaddini L, 2016, EXP EYE RES, V145, P158, DOI 10.1016/j.exer.2015.11.010; Henkel S, 2016, METHODS MOL BIOL, V1368, P209, DOI 10.1007/978-1-4939-3136-1_15; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Horstmann L, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-120; Huang TL, 2015, INVEST OPHTH VIS SCI, V56, P2290, DOI 10.1167/iovs.14-15999; HUGHES WF, 1991, EXP EYE RES, V53, P573, DOI 10.1016/0014-4835(91)90215-Z; Iwona BS, 2016, CURR NEUROPHARMACOL, V14, P792, DOI 10.2174/1570159X14666160813182009; Kambhampati SP, 2015, INVEST OPHTH VIS SCI, V56, P4413, DOI 10.1167/iovs.14-16250; Kim BJ, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-21; Kovacs K, 2015, INVEST OPHTH VIS SCI, V56, P6523, DOI 10.1167/iovs.15-16793; Krzystolik MG, 2002, ARCH OPHTHALMOL-CHIC, V120, P338; Kuo Hsi-Kung, 2006, Chang Gung Med J, V29, P555; Kwong JMK, 2011, INVEST OPHTH VIS SCI, V52, P9694, DOI 10.1167/iovs.11-7869; Lee I, 2007, BIOSCI BIOTECH BIOCH, V71, P1203, DOI 10.1271/bbb.60657; Martinez-de-la-Casa JM, 2012, INVEST OPHTH VIS SCI, V53, P6214, DOI 10.1167/iovs.12-9875; May C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089596; Miller NR, 2015, INVEST OPHTH VIS SCI, V56, P7679, DOI 10.1167/iovs.15-18015; Mizener JB, 1997, OPHTHALMOLOGY, V104, P859, DOI 10.1016/S0161-6420(97)30221-8; Molina M, 2015, J NEURAL TRANSM, V122, P993, DOI 10.1007/s00702-015-1414-4; Noristani R, 2016, J MOL NEUROSCI, V58, P470, DOI 10.1007/s12031-015-0707-2; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Osborne NN, 1996, NEUROCHEM INT, V29, P263, DOI 10.1016/0197-0186(96)00005-8; Pannicke T, 2005, GLIA, V50, P1, DOI 10.1002/glia.20151; Park HYL, 2014, AM J PATHOL, V184, P1752, DOI 10.1016/j.ajpath.2014.02.016; Presta LG, 1997, CANCER RES, V57, P4593; Proescholdt MA, 2002, J NEUROPATH EXP NEUR, V61, P914, DOI 10.1093/jnen/61.10.914; Romano MR, 2012, BRAIN RES, V1478, P55, DOI 10.1016/j.brainres.2012.08.014; Rosenbaum DM, 2001, J NEURO-OPHTHALMOL, V21, P62, DOI 10.1097/00041327-200103000-00015; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Rovere G, 2016, INVEST OPHTH VIS SCI, V57, P6098, DOI 10.1167/iovs.16-20425; Safa R, 2000, BRAIN RES, V862, P36, DOI 10.1016/S0006-8993(00)02090-4; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Schmid H, 2014, INVEST OPHTH VIS SCI, V55, P2777, DOI 10.1167/iovs.13-13372; Schnichels S, 2013, BR J OPHTHALMOL; SellesNavarro I, 1996, INVEST OPHTH VIS SCI, V37, P2002; Sharma TP, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.22; Shima DT, 1996, INVEST OPHTH VIS SCI, V37, P1334; Sim DA, 2013, INVEST OPHTH VIS SCI, V54, P2353, DOI 10.1167/iovs.12-11103; Terelak-Borys B, 2012, MED SCI MONITOR, V18, pRA138, DOI 10.12659/MSM.883260; Thaler S, 2010, ACTA OPHTHALMOL, V88, pE170, DOI 10.1111/j.1755-3768.2010.01927.x; Tolentino MJ, 1996, OPHTHALMOLOGY, V103, P1820, DOI 10.1016/S0161-6420(96)30420-X; Ueda H, 2016, NEUROSCIENCE, V318, P206, DOI 10.1016/j.neuroscience.2016.01.007; Ueda H, 2016, NEUROSCIENCE; van Asten F, 2015, ACTA OPHTHALMOL, V93, P126, DOI 10.1111/aos.12610; Yang JH, 2014, MOL PHARMACEUT, V11, P3421, DOI 10.1021/mp500160v; Yoo MH, 2007, INVEST OPHTH VIS SCI, V48, P5671, DOI 10.1167/iovs.07-0395; Zayit-Soudry S, 2010, RETINA-J RET VIT DIS, V30, P671, DOI 10.1097/IAE.0b013e3181c0858c; Zhang C, 2005, EXP EYE RES, V81, P700, DOI 10.1016/j.exer.2005.04.008; Zhang XY, 2013, INVEST OPHTH VIS SCI, V54, P3912, DOI 10.1167/iovs.13-11614; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhu WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063342	69	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0182407	10.1371/journal.pone.0182407	http://dx.doi.org/10.1371/journal.pone.0182407			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800629	Green Submitted, Green Published, gold			2022-12-26	WOS:000407431800015
J	Kouwenhoven, WM; von Oerthel, L; Smidt, MP				Kouwenhoven, Willemieke M.; von Oerthel, Lars; Smidt, Marten P.			Pitx3 and En1 determine the size and molecular programming of the dopaminergic neuronal pool	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; SUBSTANTIA-NIGRA; PARKINSONS-DISEASE; RETINOIC ACID; DEVELOPMENTAL DEFECTS; MOUSE DEVELOPMENT; GENE-EXPRESSION; MIDBRAIN; VULNERABILITY; MICE	Mesodiencephalic dopaminergic (mdDA) neurons are located in the ventral midbrain. These neurons form the substantia nigra (SNc) and the ventral tegmental area (VTA). Two transcription factors that play important roles in the process of terminal differentiation and subset- specification of mdDA neurons, are paired-like homeodomain transcription factor 3 (Pitx3), and homeobox transcription factor Engrailed 1 (En1). We previously investigated the single Pitx3KO and En1KO and observed important changes in the survival of mdDA neurons of the SNc and VTA as well as altered expression of pivotal rostral- and caudal-markers, Ahd2 and Cck, respectively. To refine our understanding of the regional-specific relationships between En1 and Pitx3 and their (combined) role in the programming mdDA neurons on the rostral- to-caudal axis, we created double En1(tm1Alj/tm1Alj); Pitx3(gfp/gfp) (En1KO; Pitx3GFP/GFP) animals. Here we report, that in absence of En1 and Pitx3, only a limited number of mdDA neurons are present at E14.5. These mdDA neurons have a rudimentary dopaminergic cell fate, as they express Nurr1, Pbx3 and Otx2 but have lost their rostral or caudal subset identity. Furthermore, we report that the expression of Cck depends on En1 expression, while (in contrast) both Pitx3 and En1 are involved in the initiation of Ahd2 expression. Thus we reveal in this manuscript that regulated levels of Pitx3 and En1 control the size and rostral/caudal-identity of the mdDA neuronal population.	[Kouwenhoven, Willemieke M.; von Oerthel, Lars; Smidt, Marten P.] Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Kouwenhoven, Willemieke M.] Univ Montreal, Fac Med, Cent Nervous Syst Res Grp GRSNC, Dept Neurosci, Montreal, PQ, Canada; [Kouwenhoven, Willemieke M.] Univ Montreal, Fac Med, Cent Nervous Syst Res Grp GRSNC, Dept Pharmacol & Physiol, Montreal, PQ, Canada	University of Amsterdam; Universite de Montreal; Universite de Montreal	Smidt, MP (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands.	m.p.smidt@uva.nl		Smidt, Marten/0000-0002-8815-747X	Nederlandse Organisatie voor Wetenschappelijk Onderzoek [865.09.002]	Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission)	This work was supported by the Nederlandse Organisatie voor Wetenschappelijk Onderzoek grant no 865.09.002 to MPS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilovocky NA, 2003, J NEUROSCI, V23, P5105; Brichta L, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00152; Burke WJ, 2003, BRAIN RES, V989, P205, DOI 10.1016/S0006-8993(03)03354-7; Chakrabarty K, 2012, BIOL OPEN, V1, P693, DOI 10.1242/bio.20121230; Chung CY, 2005, HUM MOL GENET, V14, P1709, DOI 10.1093/hmg/ddi178; Clagett-Dame M, 2011, NUTRIENTS, V3, P385, DOI 10.3390/nu3040385; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; DAVIS CA, 1988, GENE DEV, V2, P1736, DOI 10.1101/gad.2.12b.1736; Di Giovannantonio LG, 2013, DEV BIOL, V373, P176, DOI 10.1016/j.ydbio.2012.10.022; Di Salvio M, 2010, NAT NEUROSCI, V13, P1481, DOI 10.1038/nn.2661; Duester G, 2003, CHEM-BIOL INTERACT, V143, P201, DOI 10.1016/S0009-2797(02)00204-1; Ferretti E, 2011, DEV CELL, V21, P627, DOI 10.1016/j.devcel.2011.08.005; Greene JG, 2005, NEUROBIOL DIS, V18, P19, DOI 10.1016/j.nbd.2004.10.003; Grimm J, 2004, P NATL ACAD SCI USA, V101, P13891, DOI 10.1073/pnas.0405340101; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Hoekstra EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074049; Hoekstra EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052118; Hwang DY, 2003, MOL BRAIN RES, V114, P123, DOI 10.1016/S0169-328X(03)00162-1; Jacobs FMJ, 2007, DEVELOPMENT, V134, P2673, DOI 10.1242/dev.02865; Jacobs FMJ, 2011, DEVELOPMENT, V138, P5213, DOI 10.1242/dev.071704; Jacobs FMJ, 2009, DEVELOPMENT, V136, P531, DOI 10.1242/dev.029769; Kouwenhoven WM, 2016, BIOL OPEN; La Manno G, 2016, CELL, V167, P566, DOI 10.1016/j.cell.2016.09.027; Liu GX, 2014, J CLIN INVEST, V124, P3032, DOI 10.1172/JCI72176; Maxwell SL, 2005, DEV BIOL, V282, P467, DOI 10.1016/j.ydbio.2005.03.028; Nunes I, 2003, P NATL ACAD SCI USA, V100, P4245, DOI 10.1073/pnas.0230529100; Peng CG, 2011, J NEUROSCI, V31, P12802, DOI 10.1523/JNEUROSCI.0898-11.2011; Poulin JF, 2014, CELL REP, V9, P930, DOI 10.1016/j.celrep.2014.10.008; Puelles E, 2004, DEVELOPMENT, V131, P2037, DOI 10.1242/dev.01107; Reisi Parham, 2015, Adv Biomed Res, V4, P227, DOI 10.4103/2277-9175.166650; Rotzinger S, 2003, J PSYCHIATR NEUROSCI, V28, P171; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Selleri L, 2004, MOL CELL BIOL, V24, P5324, DOI 10.1128/MCB.24.12.5324-5331.2004; Sgado P, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-24; Smidt MP, 2004, DEVELOPMENT, V131, P1145, DOI 10.1242/dev.01022; Smidt MP, 1997, P NATL ACAD SCI USA, V94, P13305, DOI 10.1073/pnas.94.24.13305; Smits SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076037; Smits SM, 2003, EUR J NEUROSCI, V18, P1731, DOI 10.1046/j.1460-9568.2003.02885.x; SUGAYA K, 1992, JPN J PHARMACOL, V59, P125, DOI 10.1254/jjp.59.125; van den Munckhof P, 2003, DEVELOPMENT, V130, P2535, DOI 10.1242/dev.00464; Veenvliet JV, 2014, CELL MOL LIFE SCI; Veenvliet JV, 2013, SPECIFICATION DOPAMI; Villaescusa JC, 2016, EMBO J, V35, P1963, DOI 10.15252/embj.201593725; WURST W, 1994, DEVELOPMENT, V120, P2065; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	45	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0182421	10.1371/journal.pone.0182421	http://dx.doi.org/10.1371/journal.pone.0182421			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800615	Green Submitted, Green Published, gold			2022-12-26	WOS:000407431800017
J	Maureaud, A; Gascuel, D; Colleter, M; Palomares, MLD; Du Pontavice, H; Pauly, D; Cheung, WWL				Maureaud, Aurore; Gascuel, Didier; Colleter, Mathieu; Palomares, Maria L. D.; Du Pontavice, Hubert; Pauly, Daniel; Cheung, William W. L.			Global change in the trophic functioning of marine food webs	PLOS ONE			English	Article							CLIMATE-CHANGE; R-PACKAGE; FISH; FISHERIES; IMPACTS; OCEAN; EFFICIENCIES; ECOSYSTEMS; INDICATORS; CASCADES	The development of fisheries in the oceans, and other human drivers such as climate warming, have led to changes in species abundance, assemblages, trophic interactions, and ultimately in the functioning of marine food webs. Here, using a trophodynamic approach and global databases of catches and life history traits of marine species, we tested the hypothesis that anthropogenic ecological impacts may have led to changes in the global parameters defining the transfers of biomass within the food web. First, we developed two indicators to assess such changes: the Time Cumulated Indicator (TCI) measuring the residence time of biomass within the food web, and the Efficiency Cumulated Indicator (ECI) quantifying the fraction of secondary production reaching the top of the trophic chain. Then, we assessed, at the large marine ecosystem scale, the worldwide change of these two indicators over the 1950-2010 time-periods. Global trends were identified and cluster analyses were used to characterize the variability of trends between ecosystems. Results showed that the most common pattern over the study period is a global decrease in TCI, while the ECI indicator tends to increase. Thus, changes in species assemblages would induce faster and apparently more efficient biomass transfers in marine food webs. Results also suggested that the main driver of change over that period had been the large increase in fishing pressure. The largest changes occurred in ecosystems where 'fishing down the marine food web' are most intensive.	[Maureaud, Aurore; Gascuel, Didier; Du Pontavice, Hubert] Univ Bretagne Loire Agrocampus Ouest, UMR 985 Ecol & Ecosyst Hlth, Rennes, France; [Colleter, Mathieu; Du Pontavice, Hubert; Cheung, William W. L.] Univ British Columbia, Inst Oceans & Fisheries, Nippon Fdn Nereus Program, Vancouver, BC, Canada; [Colleter, Mathieu; Palomares, Maria L. D.; Pauly, Daniel] Univ British Columbia, Inst Oceans & Fisheries, Sea Around Us, Vancouver, BC, Canada	Institut Agro; Agrocampus Ouest; University of British Columbia; University of British Columbia	Maureaud, A (corresponding author), Univ Bretagne Loire Agrocampus Ouest, UMR 985 Ecol & Ecosyst Hlth, Rennes, France.	auma@aqua.dtu.dk	Pauly, Daniel Marc/AAY-2316-2021; Maureaud, Aurore A./AAN-9197-2020; Gascuel, Didier/C-1439-2011; martel, celine/O-6651-2016; Palomares, Maria Lourdes D./K-1641-2019	Maureaud, Aurore A./0000-0003-4778-9443; Gascuel, Didier/0000-0001-5447-6977; martel, celine/0000-0002-1800-4558; Pauly, Daniel/0000-0003-3756-4793; Du Pontavice, Hubert/0000-0001-9571-0651; Palomares, Maria Lourdes/0000-0001-5905-1556	Nippon Foundation-UBC; Sea Around Us - Paul G. Allen Family Foundation; Oak Foundation; Agrocampus Ouest [UMR 985]; Agrocampus Ouest, Rennes; University of British Columbia, Vancouver	Nippon Foundation-UBC; Sea Around Us - Paul G. Allen Family Foundation; Oak Foundation; Agrocampus Ouest; Agrocampus Ouest, Rennes; University of British Columbia, Vancouver	For AM, the present work was conducted while a master thesis at UMR 985 Ecology and ecosystem health, funded by Agrocampus Ouest (http//www.agrocampus-ouest.fr/). The work has been done in collaboration with the Institute for the Oceans and Fisheries at the University of British Columbia. This collaboration was funded by the Nippon Foundation-UBC Nereus Program (http.//www.nippon-foundation.or.jp/; http://www.nereusprogram.org/). MC, HDP and WWLC acknowledge funding support from the Nippon Foundation-UBC Nereus Program. DP, MLDP and MC acknowledge funding support from the Sea Around Us (http://www.seaaronndns.org/), funded by the Paul G. Allen Family Foundation (ham;// www.pgafamilyfoundation.orgi) and the Oak Foundation (http://oakfnd.org/). The funders had no role to play in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank the Nippon Foundation-UBC Nereus program and Yoshitaka Ota for supporting the collaboration between Agrocampus Ouest, Rennes, and the University of British Columbia, Vancouver. Mathieu Colleter, Hubert Du Pontavice and William W.L. Cheung acknowledge funding supporting from the Nippon Foundation-UBC Nereus Program. Daniel Pauly, Maria L.D Palomares and Mathieu Colleter acknowledge support from the Sea Around Us, funded by the Paul G. Allen Family Foundation, and the Oak Foundation. We acknowledge assistance from the FishBase and EcoBase consortia, from Gabriel Reygondeau, Francois Gouffier and Maxime Olmos for sharing data and ideas.	Ainsworth CH, 2011, ICES J MAR SCI, V68, P1217, DOI 10.1093/icesjms/fsr043; Andersen KH, 2009, P ROY SOC B-BIOL SCI, V276, P109, DOI 10.1098/rspb.2008.0951; Anderson SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024368; [Anonymous], 1993, [No title captured]; Barange M, 2014, NAT CLIM CHANGE, V4, P211, DOI [10.1038/NCLIMATE2119, 10.1038/nclimate2119]; Belkin IM, 2009, PROG OCEANOGR, V81, P207, DOI 10.1016/j.pocean.2009.04.011; Blanchard JL, 2012, PHILOS T R SOC B, V367, P2979, DOI 10.1098/rstb.2012.0231; Branch TA, 2010, NATURE, V468, P431, DOI 10.1038/nature09528; Britten GL, 2016, P NATL ACAD SCI USA, V113, P134, DOI 10.1073/pnas.1504709112; Chassot E, 2010, ECOL LETT, V13, P495, DOI 10.1111/j.1461-0248.2010.01443.x; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Cheung WWL, 2007, MAR ECOL PROG SER, V333, P1, DOI 10.3354/meps333001; Cheung WWL, 2013, NAT CLIM CHANGE, V3, P254, DOI 10.1038/NCLIMATE1691; Cheung WWL, 2013, NATURE, V497, P365, DOI 10.1038/nature12156; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; Christensen V, 2000, MAR FRESHWATER RES, V51, P447, DOI 10.1071/MF99085; Christensen V, 2008, IOC TECHNICAL SERIES, V80; Christensen V, 2014, MAR ECOL PROG SER, V512, P155, DOI 10.3354/meps10946; Coll M, 2009, ECOL MODEL, V220, P2088, DOI 10.1016/j.ecolmodel.2009.04.049; Coll M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003881; Colleter M, 2013, FISH CTR RES REP, V21, P60; Colleter M, 2015, ECOL MODEL, V302, P42, DOI 10.1016/j.ecolmodel.2015.01.025; Colleter M, 2013, R J, V5, P98; Daskalov GM, 2007, P NATL ACAD SCI USA, V104, P10518, DOI 10.1073/pnas.0701100104; Dickman EM, 2008, P NATL ACAD SCI USA, V105, P18408, DOI 10.1073/pnas.0805566105; Doubleday ZA, 2016, CURR BIOL, V26, pR406, DOI 10.1016/j.cub.2016.04.002; Essington TE, 2006, P NATL ACAD SCI USA, V103, P3171, DOI 10.1073/pnas.0510964103; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Friedland KD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028945; Garcia SM, 2005, ICES J MAR SCI, V62, P311, DOI 10.1016/j.icesjms.2004.12.003; Gascuel D, 2005, ICES J MAR SCI, V62, P443, DOI 10.1016/j.icesjms.2004.12.013; Gascuel D, 2008, ECOL MODEL, V217, P33, DOI 10.1016/j.ecolmodel.2008.05.012; Gascuel D, 2011, ICES J MAR SCI, V68, P1403, DOI 10.1093/icesjms/fsr062; Gascuel D, 2009, ECOL MODEL, V220, P2885, DOI 10.1016/j.ecolmodel.2009.07.031; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Heymans JJ, 2003, BACK FUTURE; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Jennings S, 2002, MAR ECOL PROG SER, V240, P11, DOI 10.3354/meps240011; Jennings S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133794; Kaiser MJ, 2002, FISH FISH, V3, P114, DOI 10.1046/j.1467-2979.2002.00079.x; Kirby RR, 2009, ECOSYSTEMS, V12, P548, DOI 10.1007/s10021-009-9241-9; Kleisner K, 2013, FISH FISH, V14, P293, DOI 10.1111/j.1467-2979.2012.00469.x; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Libralato S, 2004, J MARINE SYST, V51, P331, DOI 10.1016/j.jmarsys.2004.05.020; Libralato S, 2005, ICES CM 2005M23; Libralato S, 2008, MAR ECOL PROG SER, V355, P107, DOI 10.3354/meps07224; Lindeman RL, 1942, ECOLOGY, V23, P399, DOI 10.2307/1930126; Mackinson S, 2007, SCI SERIES TECHNICAL, V142, P196; Mcowen CJ, 2015, FISH FISH, V16, P623, DOI 10.1111/faf.12082; Morato T, 2006, FISH FISH, V7, P24, DOI 10.1111/j.1467-2979.2006.00205.x; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Myers RA, 2005, PHILOS T R SOC B, V360, P13, DOI 10.1098/rstb.2004.1573; ODUM EP, 1985, BIOSCIENCE, V35, P419, DOI 10.2307/1310021; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; Olsen EM, 2004, NATURE, V428, P932, DOI 10.1038/nature02430; Palomares MLD, 1998, MAR FRESHWATER RES, V49, P447, DOI 10.1071/MF98015; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; PAULY D, 1995, NATURE, V374, P255, DOI 10.1038/374255a0; Pauly D, 2000, ICES J MAR SCI, V57, P697, DOI 10.1006/jmsc.2000.0726; Pauly D, 2016, GLOBAL ATLAS MARINE, P448; Pauly D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10244; Pauly D, 2013, NATURE, V494, P303, DOI 10.1038/494303a; Perry RI, 2010, J MARINE SYST, V79, P427, DOI 10.1016/j.jmarsys.2008.12.017; Anh PV, 2015, ESTUAR COAST SHELF S, V165, P226, DOI 10.1016/j.ecss.2015.05.019; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Robinson KL, 2014, OCEANOGRAPHY, V27, P104, DOI 10.5670/oceanog.2014.90; Schramski JR, 2015, P NATL ACAD SCI USA, V112, P2617, DOI 10.1073/pnas.1423502112; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shannon L, 2014, MAR ECOL PROG SER, V512, P115, DOI 10.3354/meps10821; SHERMAN K, 1991, ECOL APPL, V1, P349, DOI 10.2307/1941896; Sherman K, 2015, ICES J MAR SCI, V72, P2521, DOI 10.1093/icesjms/fsv136; Stergiou KI, 2011, MAR ECOL PROG SER, V441, P295, DOI 10.3354/meps09377; Swartz W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015143; Tremblay-Boyer L, 2011, MAR ECOL PROG SER, V442, P169, DOI 10.3354/meps09375; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Watson R, 2001, NATURE, V414, P534, DOI 10.1038/35107050; Watson RA, 2013, FISH FISH, V14, P493, DOI 10.1111/j.1467-2979.2012.00483.x; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Zeidberg LD, 2007, P NATL ACAD SCI USA, V104, P12946, DOI 10.1073/pnas.0702043104	79	29	29	4	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0182826	10.1371/journal.pone.0182826	http://dx.doi.org/10.1371/journal.pone.0182826			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800358	gold, Green Published, Green Submitted			2022-12-26	WOS:000407431800030
J	Mustafa, AS; Habibi, N; Osman, A; Shaheed, F; Khan, MW				Mustafa, Abu S.; Habibi, Nazima; Osman, Amr; Shaheed, Faraz; Khan, Mohd W.			Species identification and molecular typing of human Brucella isolates from Kuwait	PLOS ONE			English	Article							GENE SEQUENCE-ANALYSIS; MULTIPLEX PCR ASSAY; MELITENSIS; MLVA; ABORTUS; STRAINS; DISCRIMINATION; DIAGNOSTICS; VACCINE; SYSTEM	Brucellosis is a zoonotic disease of major concern in Kuwait and the Middle East. Human brucellosis can be caused by several Brucella species with varying degree of pathogenesis, and relapses are common after apparently successful therapy. The classical biochemical methods for identification of Brucella are time-consuming, cumbersome, and provide information limited to the species level only. In contrast, molecular methods are rapid and provide differentiation at intra-species level. In this study, four molecular methods [16S rRNA gene sequencing, real-time PCR, enterobacterial repetitive intergenic consensus (ERIC)-PCR and multilocus variable-number tandem-repeat analysis (MLVA)-8, MLVA-11 and MLVA-16 were evaluated for the identification and typing of 75 strains of Brucella isolated in Kuwait. 16S rRNA gene sequencing of all isolates showed 9099% sequence identity with B. melitensis and real-time PCR with genus- and species- specific primers identified all isolates as B. melitensis. The results of ERIC-PCR suggested the existence of 75 ERIC genotypes of B. melitensis with a discriminatory index of 0.997. Cluster classification of these genotypes divided them into two clusters, A and B, diverging at similar to 25%. The maximum number of genotypes (n = 51) were found in cluster B5. MLVA-8 analysis identified all isolates as B. melitensis, and MLVA-8, MLVA-11 and MLVA-16 typing divided the isolates into 10, 32 and 71 MLVA types, respectively. Furthermore, the combined minimum spanning tree analysis demonstrated that, compared to MLVA types discovered all over the world, the Kuwaiti isolates were a distinct group of MLVA-11 and MLVA-16 types in the East Mediterranean Region.	[Mustafa, Abu S.; Habibi, Nazima; Osman, Amr; Shaheed, Faraz; Khan, Mohd W.] Kuwait Univ, Heath Sci Ctr, Heath Sci Ctr, Jabriya, Kuwait	Kuwait University	Mustafa, AS (corresponding author), Kuwait Univ, Heath Sci Ctr, Heath Sci Ctr, Jabriya, Kuwait.	abusalim@hsc.edu.kw	Habibi, Nazima/AAH-6425-2021	Habibi, Nazima/0000-0003-0752-4774; Mustafa, AbuSalim/0000-0002-6074-1041; , Amr/0000-0002-5851-0252	Kuwait University Research Sector's [MI04/15, SRUL02/13]	Kuwait University Research Sector's	The study was funded by Kuwait University Research Sector's grants MI04/15 and SRUL02/13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dahouk S, 2007, J MICROBIOL METH, V69, P137, DOI 10.1016/j.mimet.2006.12.015; Al Nakkas AF, 2002, ANN TROP MED PARASIT, V96, P397, DOI 10.1179/000349802125001203; Alavi SM, 2013, CASP J INTERN MED, V4, P636; [Anonymous], 2016, BRUCELLA 2013 MLVA D; Bricker BJ, 2002, VET MICROBIOL, V90, P435, DOI 10.1016/S0378-1135(02)00228-6; Ciammaruconi A, 2011, BMC MICROBIOL, V11, P60; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Corbel M.J., 2006, BRUCELLOSIS HUMANS A; Dash N, 2012, J INFECT DEV COUNTR, V6, P283; De Massis F, 2015, TRANSBOUND EMERG DIS, V62, P463, DOI 10.1111/tbed.12397; De Santis R, 2013, MOL BIOTECHNOL, V55, P101, DOI 10.1007/s12033-013-9659-3; DEAN AS, 2012, PLOS NEGLECT TROP D, V0006; Deshmukh A, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0458-9; Diaz AE., 2013, REV SCI TECH OIE, V32, P53; Diaz R, 2006, CLIN VACCINE IMMUNOL, V13, P1190, DOI 10.1128/CVI.00086-06; Dimitrov T, 2004, MED PRIN PRACT, V13, P215, DOI 10.1159/000078319; Doganay Gizem D, 2013, Recent Pat Antiinfect Drug Discov, V8, P27; Dorneles EMS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098758; Galinska EM, 2013, ANN AGR ENV MED, V20, P233; Garcia-Yoldi D, 2006, CLIN CHEM, V52, P779, DOI 10.1373/clinchem.2005.062596; Gee JE, 2004, J CLIN MICROBIOL, V42, P3649, DOI 10.1128/jcm.42.8.3649-3654.2004; Grissa I, 2008, BIOCHIMIE, V90, P660, DOI 10.1016/j.biochi.2007.07.014; Gyuranecz M, 2016, VET MICROBIOL, V186, P8, DOI 10.1016/j.vetmic.2016.02.009; Hathaway LJ, 2007, J CLIN MICROBIOL, V45, P803, DOI 10.1128/JCM.02169-06; Hollender D, 2013, REV ARGENT MICROBIOL, V45, P229, DOI 10.1016/S0325-7541(13)70029-4; Jiang H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-256; Kattar MM, 2008, J CLIN MICROBIOL, V46, P3935, DOI 10.1128/JCM.00464-08; Kilic S, 2011, J CLIN MICROBIOL, V49, P3276, DOI 10.1128/JCM.02538-10; Kreizinger Z, 2014, VET MICROBIOL, V172, P492, DOI 10.1016/j.vetmic.2014.05.031; Kursun E, 2013, INTERNAL MED, V52, P745, DOI 10.2169/internalmedicine.52.9048; Lau SKP, 2006, J CLIN PATHOL, V59, P219, DOI 10.1136/jcp.2004.025247; Le Fleche P, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-9; Lopez-Goni I, 2011, VET MICROBIOL, V154, P152, DOI 10.1016/j.vetmic.2011.06.035; Lounes N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115319; Ma JY, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0123-z; Maquart M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-145; Mercier E, 1996, J CLIN MICROBIOL, V34, P1299, DOI 10.1128/JCM.34.5.1299-1302.1996; Ogredici O, 2010, EMERG INFECT DIS, V16, P2021, DOI 10.3201/eid1612.100678; Pappas G, 2006, CELL MOL LIFE SCI, V63, P2229, DOI 10.1007/s00018-006-6311-4; Perkins SD, 2010, FEMS MICROBIOL REV, V34, P379, DOI 10.1111/j.1574-6976.2010.00211.x; Perry B.D., 2002, ANIMAL DIS IMPACT PO, P67; Redkar R, 2001, MOL CELL PROBE, V15, P43, DOI 10.1006/mcpr.2000.0338; Roth F, 2003, B WORLD HEALTH ORGAN, V81, P867; Rubach MP, 2013, CURR OPIN INFECT DIS, V26, P404, DOI 10.1097/QCO.0b013e3283638104; Ruppitsch W, 2007, J APPL MICROBIOL, V102, P852, DOI 10.1111/j.1365-2672.2006.03107.x; Scholz HC, 2013, REV SCI TECH OIE, V32, P149; Schwarz NG, 2017, ACTA TROP, V165, P40, DOI 10.1016/j.actatropica.2015.09.003; Singh A, 2013, SCI WORLD J, DOI 10.1155/2013/160376; Sofian M, 2014, SCAND J INFECT DIS, V46, P573, DOI 10.3109/00365548.2014.918275; Soler-Garcia AA, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00417; Srinivasan R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117617; Tcherneva E, 1996, VET MICROBIOL, V51, P169, DOI 10.1016/0378-1135(96)00036-3; Winchell JM, 2010, J CLIN MICROBIOL, V48, P697, DOI 10.1128/JCM.02021-09; Woo PCY, 2003, J CLIN MICROBIOL, V41, P1996, DOI 10.1128/JCM.41.5.1996-2001.2003; Xiao P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115932; Yu WL, 2010, CROAT MED J, V51, P306, DOI 10.3325/cmj.2010.51.306; Zahidi JM, 2015, DIAGN MICR INFEC DIS, V81, P227, DOI 10.1016/j.diagmicrobio.2014.12.012	58	15	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0182111	10.1371/journal.pone.0182111	http://dx.doi.org/10.1371/journal.pone.0182111			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800594	gold, Green Published, Green Submitted			2022-12-26	WOS:000407431800010
J	Martinez-Ghersa, MA; Menendez, AI; Gundel, PE; Folcia, AM; Romero, AM; Landesmann, JB; Ventura, L; Ghersa, CM				Alejandra Martinez-Ghersa, M.; Menendez, Analia I.; Gundel, Pedro E.; Folcia, Ana M.; Romero, Ana M.; Landesmann, Jennifer B.; Ventura, Laura; Ghersa, Claudio M.			Legacy of historic ozone exposure on plant community and food web structure	PLOS ONE			English	Article							TROPOSPHERIC OZONE; ECOSYSTEM GENETICS; VOLATILE EMISSIONS; AIR-POLLUTION; RESPONSES; ECOLOGY; SYSTEMS; STRESS; CROP; HERITABILITY	Information on whole community responses is needed to predict direction and magnitude of changes in plant and animal abundance under global changes. This study quantifies the effect of past ozone exposure on a weed community structure and arthropod colonization. We used the soil seed bank resulting from a long-term ozone exposure to reestablish the plant community under a new low-pollution environment. Two separate experiments using the same original soil seed bank were conducted. Plant and arthropod richness and species abundance was assessed during two years. We predicted that exposure to episodic high concentrations of ozone during a series of growing cycles would result in plant assemblies with lower diversity (lower species richness and higher dominance), due to an increase in dominance of the stress tolerant species and the elimination of the ozone-sensitive species. As a consequence, arthropod-plant interactions would also be changed. Species richness of the recruited plant communities from different exposure histories was similar (approximate to 15). However, the relative abundance of the dominant species varied according to history of exposure, with two annual species dominating ozone enriched plots (90 ppb: Spergula arvensis, and 120 ppb: Calandrinia ciliata). Being consistent both years, the proportion of carnivore species was significantly higher in plots with history of higher ozone concentration (approximate to 3.4 and approximate to 7.7 fold higher in 90 ppb and 120 ppb plots, respectively). Our study provides evidence that, past history of pollution might be as relevant as management practices in structuring agroecosystems, since we show that an increase in tropospheric ozone may influence biotic communities even years after the exposure.	[Alejandra Martinez-Ghersa, M.; Menendez, Analia I.; Gundel, Pedro E.; Landesmann, Jennifer B.; Ventura, Laura; Ghersa, Claudio M.] Univ Buenos Aires, CONICET, Fac Agron, IFEVA, Buenos Aires, DF, Argentina; [Folcia, Ana M.; Romero, Ana M.] Univ Buenos Aires, Dept Prod Vegetal, Fac Agron, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires	Martinez-Ghersa, MA (corresponding author), Univ Buenos Aires, CONICET, Fac Agron, IFEVA, Buenos Aires, DF, Argentina.	martinez@agro.uba.ar	Gundel, Pedro/A-5314-2013	Gundel, Pedro/0000-0003-3246-0282	Universidad de Buenos Aires, UBACyT [20020130100030BA]; Agencia Nacional de Investigaciones Gientificas y Tecnicas [PICT 2355]	Universidad de Buenos Aires, UBACyT(University of Buenos Aires); Agencia Nacional de Investigaciones Gientificas y Tecnicas	This study was funded by the Universidad de Buenos Aires, UBACyT 2014-2017 (grant No. 20020130100030BA) to MAMG and the Agencia Nacional de Investigaciones Gientificas y Tecnicas, PICT 2355 to MAMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Tom Pfleeger from the US Environmental Protection Agency's National Health and Environmental Effects Laboratory, Western Ecology Division in Corvallis for his generosity in providing soil material to carry out his study. This study was funded by the Universidad de Buenos Aires, UBACyT 2014-2017 (grant No. 20020130100030BA) to MAMG and the Agencia Nacional de Investigaciones Cientificas y Tecnicas, PICT 2355 to MAMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2012, ANNU REV PLANT BIOL, V63, P637, DOI 10.1146/annurev-arplant-042110-103829; Alard D, 2005, BASIC APPL ECOL, V6, P161, DOI 10.1016/j.baae.2005.01.010; Alexandratos N, 2012, ATMOS ENVIRON; Andersen CP, 2003, NEW PHYTOL, V157, P213, DOI 10.1046/j.1469-8137.2003.00674.x; Bailey JK, 2006, ECOL LETT, V9, P78, DOI 10.1111/j.1461-0248.2005.00844.x; Barbo DN, 1998, NEW PHYTOL, V138, P653, DOI 10.1046/j.1469-8137.1998.00138.x; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Blande JD, 2007, GLOBAL CHANGE BIOL, V13, P2538, DOI 10.1111/j.1365-2486.2007.01453.x; Blande JD, 2014, PLANT CELL ENVIRON, V37, P1892, DOI 10.1111/pce.12352; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Cui H, 2014, SCI REP, V4, P1; Dar TA, 2015, ENVIRON EXP BOT, V115, P49, DOI 10.1016/j.envexpbot.2015.02.010; de la Fuente EB, 1999, AGRON J, V91, P234, DOI 10.2134/agronj1999.00021962009100020010x; Fenner M., 2005, ECOLOGY SEEDS; Fiscus EL, 2005, PLANT CELL ENVIRON, V28, P997, DOI 10.1111/j.1365-3040.2005.01349.x; Foyer CH, 2016, J EXP BOT, V67, P2025, DOI 10.1093/jxb/erw079; Freckleton RP, 2002, J APPL ECOL, V39, P699, DOI 10.1046/j.1365-2664.2002.00748.x; Gate IM, 1995, WATER AIR SOIL POLL, V85, P1425, DOI 10.1007/BF00477181; Ghersa CM, 2000, FIELD CROP RES, V67, P141, DOI 10.1016/S0378-4290(00)00089-7; Gouinguene SP, 2002, PLANT PHYSIOL, V129, P1296, DOI 10.1104/pp.001941; Gundel PE, 2008, EUR J AGRON, V28, P606, DOI 10.1016/j.eja.2008.01.004; Gundel PE, 2015, ENVIRON EXP BOT, V113, P40, DOI 10.1016/j.envexpbot.2015.01.001; Harper J. L., 1974, Annual Review of Ecology and Systematics, V5, P419, DOI 10.1146/annurev.es.05.110174.002223; Hayes F, 2007, ENVIRON POLLUT, V146, P754, DOI 10.1016/j.envpol.2006.06.011; HEATH RL, 1994, PHOTOSYNTH RES, V39, P439, DOI 10.1007/BF00014597; Hillstrom ML, 2008, INSECT CONSERV DIVER, V1, P233, DOI 10.1111/j.1752-4598.2008.00031.x; Himanen SJ, 2010, NEW PHYTOL, V186, P722, DOI 10.1111/j.1469-8137.2010.03220.x; Holopainen Jarmo K, 2011, Tree Physiol, V31, P1356, DOI 10.1093/treephys/tpr111; Johnson MTJ, 2005, ECOLOGY, V86, P874, DOI 10.1890/04-1068; KANGASJARVI J, 1994, PLANT CELL ENVIRON, V17, P783, DOI 10.1111/j.1365-3040.1994.tb00173.x; Karnosky DF, 2007, ENVIRON POLLUT, V147, P489, DOI 10.1016/j.envpol.2006.08.043; Kawase H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046402; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kouba Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139031; Landesmann JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075820; Lucas-Barbosa D, 2011, PHYTOCHEMISTRY, V72, P1647, DOI 10.1016/j.phytochem.2011.03.013; Lunt ID, 2005, J BIOGEOGR, V32, P1859, DOI 10.1111/j.1365-2699.2005.01296.x; Martinez-Ghersa MA, 2000, FIELD CROP RES, V67, P181, DOI 10.1016/S0378-4290(00)00092-7; Martinez-Ghersa MA, 2008, P WEED SCI SOC AM AN; Mondor EB, 2004, GLOBAL CHANGE BIOL, V10, P1820, DOI 10.1111/j.1365-2486.2004.00838.x; Monks PS, 2015, ATMOS CHEM PHYS, V15, P8889, DOI 10.5194/acp-15-8889-2015; NEBEL B, 1994, ANGEW BOT, V68, P116; Ninkovic V, 2003, J EXP BOT, V54, P1931, DOI 10.1093/jxb/erg192; Norris RF, 2005, ANNU REV ENTOMOL, V50, P479, DOI 10.1146/annurev.ento.49.061802.123218; Payne RJ, 2011, ENVIRON POLLUT, V159, P2602, DOI 10.1016/j.envpol.2011.06.009; Pfleeger TG, 2010, AGR ECOSYST ENVIRON, V138, P116, DOI 10.1016/j.agee.2010.04.009; PIELOU E C, 1969, P286; Pinto DM, 2007, J CHEM ECOL, V33, P2218, DOI 10.1007/s10886-007-9376-0; Pinto DM, 2007, J CHEM ECOL, V33, P683, DOI 10.1007/s10886-007-9255-8; Pleijel H, 1997, NEW PHYTOL, V135, P361, DOI 10.1046/j.1469-8137.1997.00648.x; Price PW, 2002, ECOL RES, V17, P241, DOI 10.1046/j.1440-1703.2002.00483.x; Raupp MJ, 2010, ANNU REV ENTOMOL, V55, P19, DOI 10.1146/annurev-ento-112408-085351; Scursoni J, 1999, AGRON J, V91, P478, DOI 10.2134/agronj1999.00021962009100030020x; Simpson R.L., 1989, ECOLOGY SOIL SEED BA; Tang YJ, 2016, SCI REP-UK, V6, P1, DOI 10.1038/srep34607; Vandewalle M, 2014, J VEG SCI, V25, P750, DOI 10.1111/jvs.12126; WARWICK KR, 1995, GLOB CHANGE BIOL, V1, P143, DOI 10.1111/j.1365-2486.1995.tb00014.x; Whitfield CP, 1997, NEW PHYTOL, V137, P645, DOI 10.1046/j.1469-8137.1997.00860.x; Whitham TG, 2003, ECOLOGY, V84, P559, DOI 10.1890/0012-9658(2003)084[0559:CAEGAC]2.0.CO;2; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Williams AL, 2007, NEW PHYTOL, V176, P365, DOI 10.1111/j.1469-8137.2007.02170.x; WINNER WE, 1991, ECOLOGICAL GENETICS AND AIR POLLUTION, P177; Young PJ, 2013, ATMOS CHEM PHYS, V13, P2063, DOI 10.5194/acp-13-2063-2013; Zhao Y, 2013, ATMOS CHEM PHYS, V13, P487, DOI 10.5194/acp-13-487-2013; Zhou W, 2014, ATMOS CHEM PHYS, V14, P2777, DOI 10.5194/acp-14-2777-2014	65	3	3	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182796	10.1371/journal.pone.0182796	http://dx.doi.org/10.1371/journal.pone.0182796			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796821	gold, Green Published, Green Submitted			2022-12-26	WOS:000407396200098
J	Go, YY; Kim, SE; Cho, GJ; Chae, SW; Song, JJ				Go, Yoon Young; Kim, Sung Eun; Cho, Geum Joon; Chae, Sung-Won; Song, Jae-Jun			Differential effects of amnion and chorion membrane extracts on osteoblast-like cells due to the different growth factor composition of the extracts	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; OSTEOGENIC DIFFERENTIATION; PROLIFERATION; FIBROBLAST; TGF-BETA-1; BINDING	Human amniotic membrane extracts contain numerous growth factors and bioactive substances. However, osteogenic effects of amnion and chorion membrane extracts (AME and CME, respectively) on osteoblasts are unclear. In this study, we explored the ability of AME and CME to promote the osteogenic differentiation of osteoblast-like MG-63 cells. MG-63 cells were cultured in osteogenic induction medium (OIM) with or without exogenous AME and CME. CME enhanced the osteogenic differentiation of MG-63 cells compared with AME, as indicated by increased mineralization; alkaline phosphatase activity; and mRNA expression of osteogenic marker genes encoding integrin-binding sialoprotein (IBSP), RUNX2, OSTERIX, and osteocalcin (OCN). Interestingly, AME and CME contained different combinations of osteogenesis-related growth factors, including basic fibroblast growth factor (bFGF), transforming growth factor beta-1 (TGF beta-1), and epidermal growth factor (EGF), which differentially regulated the osteogenic differentiation of MG-63 cells. bFGF and TGF beta-1 present in CME positively regulated the osteogenic differentiation of MG-63 cells, whereas EGF present in AME negatively regulated the differentiation of MG-63 cells. Moreover, exogenous treatment of EGF antagonized CME-induced mineralization of extracellular matrix on MG-63 cells. We compared the osteogenic efficacy of CME with that of BMP2, bFGF, and TGF beta-1 alone or their combinations. We observed that CME greatly enhanced osteogenesis by providing a conductive environment for the differentiation of MG63 cells. Together, our results indicated that human AME and CME exerted differential effects on osteogenesis because of the presence of different compositions of growth factors. In addition, our results highlighted a new possible strategy of using CME as a biocompatible therapeutic material for bone regeneration.	[Go, Yoon Young; Chae, Sung-Won; Song, Jae-Jun] Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Kim, Sung Eun] Korea Univ, Coll Med, Dept Orthoped Surg, Seoul, South Korea; [Kim, Sung Eun] Korea Univ, Coll Med, Rare Dis Inst, Seoul, South Korea; [Cho, Geum Joon] Korea Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Song, JJ (corresponding author), Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea.	jjsong23@gmail.com		Go, Yoon/0000-0002-3164-7726	Korean Health Technology Research and Development Project, Ministry of Health and Welfare, Republic of Korea [H115C2835]	Korean Health Technology Research and Development Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by Korean Health Technology Research and Development Project, Ministry of Health and Welfare (H115C2835), Republic of Korea.	Blair HC, 2008, BIOL REV, V83, P401, DOI 10.1111/j.1469-185X.2008.00048.x; Blair HC, 2007, ANN NY ACAD SCI, V1116, P165, DOI 10.1196/annals.1402.029; Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; Carreira AC, 2014, J DENT RES, V93, P335, DOI 10.1177/0022034513518561; Choi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140502; COFFEY RJ, 1987, J CELL PHYSIOL, V132, P143, DOI 10.1002/jcp.1041320120; Compton J, 2015, JBJS REV, V3, DOI 10.2106/JBJS.RVW.N.00107; Dombrowski C, 2009, STEM CELLS DEV, V18, P661, DOI 10.1089/scd.2008.0157; Dua HS, 2010, BRIT J OPHTHALMOL, V94, P963, DOI 10.1136/bjo.2009.157941; Ducy P, 2000, SCIENCE, V289, P1501, DOI 10.1126/science.289.5484.1501; Garrison KR, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006950.pub2; Gholipourmalekabadi M, 2015, BURNS, V41, P1488, DOI 10.1016/j.burns.2015.04.015; Go YY, 2016, J APPL BIOMATER FUNC, V14, pE171, DOI 10.5301/jabfm.5000264; Gurkan UA, 2010, TISSUE ENG PT A, V16, P2295, DOI [10.1089/ten.tea.2009.0565, 10.1089/ten.TEA.2009.0565]; Hao YX, 2000, CORNEA, V19, P348, DOI 10.1097/00003226-200005000-00018; Huang Z, 2010, CYTOKINE, V51, P305, DOI 10.1016/j.cyto.2010.06.002; Kang M, 2013, ARCH PHARM RES, V36, P472, DOI 10.1007/s12272-013-0079-5; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Khan SN, 2004, EXPERT OPIN BIOL TH, V4, P741; Kim JM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2313; KLOEN P, 1994, EUR J CANCER, V30A, P678, DOI 10.1016/0959-8049(94)90544-4; Koizumi N, 2000, CURR EYE RES, V20, P173, DOI 10.1076/0271-3683(200003)20:3;1-9;FT173; Lad SP, 2013, NEUROSURGERY, V73, P440, DOI 10.1227/NEU.0000000000000018; Lee JH, 2015, J TISSUE ENG REGEN M, V9, P447, DOI 10.1002/term.1900; Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223; Li RD, 2012, BMB REP, V45, P509, DOI 10.5483/BMBRep.2012.45.9.053; Li XL, 2015, GENET MOL RES, V14, P7605, DOI 10.4238/2015.July.13.4; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Lu JT, 2015, MOL MED REP, V11, P1661, DOI 10.3892/mmr.2014.2998; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; Miraoui H, 2009, J BIOL CHEM, V284, P4897, DOI 10.1074/jbc.M805432200; Mitchell AC, ENG GROWTH FACTORS R; Ozkan K, 2007, GROWTH FACTORS, V25, P101, DOI 10.1080/08977190701352594; Peng HR, 2005, J BONE MINER RES, V20, P2017, DOI 10.1359/JBMR.050708; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rennie K, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/721538; Sakou T, 1998, BONE, V22, P591, DOI 10.1016/S8756-3282(98)00053-2; Salem O, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4614; Sangwan VS, 2011, BRIT J OPHTHALMOL, V95, P1, DOI 10.1136/bjo.2010.184259; Song SH, 2000, P NATL ACAD SCI USA, V97, P8658, DOI 10.1073/pnas.140210697; SORSBY A, 1947, BRIT J OPHTHALMOL, V31, P409, DOI 10.1136/bjo.31.7.409; Suzuki E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112566; TAKUWA Y, 1991, BIOCHEM BIOPH RES CO, V174, P96, DOI 10.1016/0006-291X(91)90490-X; Tamama K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/795385; Wu L-A, 2015, J COORD CHEM, P1; YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681; Yun YP, 2013, TISSUE ENG REGEN MED, V10, P183, DOI 10.1007/s13770-013-0389-1	47	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182716	10.1371/journal.pone.0182716	http://dx.doi.org/10.1371/journal.pone.0182716			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797129	Green Published, gold, Green Submitted			2022-12-26	WOS:000407396200088
J	Li, QH; Wang, YL; Lai, YX; Xu, P; Yang, ZW				Li, Qinghua; Wang, Yanlan; Lai, Yuexing; Xu, Ping; Yang, Zhiwen			HspB5 correlates with poor prognosis in colorectal cancer and prompts epithelial-mesenchymal transition through ERK signaling	PLOS ONE			English	Article							ALPHA-B-CRYSTALLIN; RENAL-CELL CARCINOMA; HEPATOCELLULAR-CARCINOMA; BREAST-CANCER; PROMOTES; DEMYELINATION; PROGRESSION; METASTASIS; RESISTANCE; PROFILES	Alpha B-crystallin (HspB5) is abnormally expressed in tumor tissues and portends a poor prognosis in cancer patients. However, the role of HspB5 in colorectal cancer (CRC) is still unclear. Seventy CRC patients and 40 healthy volunteers were sampled from August 2012 to March 2015 in order to determine the clinical significance of HspB5. In vitro cellular studies were used to validate its molecular mechanisms in CRC. Our clinical data indicated that HspB5 was up-regulated, and had a positive association with TNM stage CRC patients. The expression level of HspB5 in CRC patients was closely correlated with MMP7 and E-cadherin, two core epithelial-mesenchymal transition (EMT) gene products. The in vitro studies revealed that high HspB5 expression could prompt tumor cell proliferation and invasion, as well as EMT. Gene-microarray analysis suggested three significant signaling pathways (PI3K, p38 and ERK) were involved in HspB5-induced EMT. Signal transduction pathway inhibitors and HspB5 gene knockdown models suggested that HspB5 promotes CRC tumorigenesis and EMT progression through ERK signaling pathways. In summary, HspB5 maybe trigger the EMT in CRC by activating the ERK signaling pathway. It is a potential tumor biomarker for CRC diagnosis and prognosis.	[Li, Qinghua; Wang, Yanlan; Lai, Yuexing; Xu, Ping; Yang, Zhiwen] Shanghai Jiao Tong Univ, Songjiang Hosp, Affiliated Shanghai Peoples Hosp 1, Shanghai, Peoples R China; [Xu, Ping; Yang, Zhiwen] Nanjing Med Univ, Shanghai Songjiang Hosp, Nanjing, Jiangsu, Peoples R China	Shanghai Jiao Tong University; Nanjing Medical University	Xu, P; Yang, ZW (corresponding author), Shanghai Jiao Tong Univ, Songjiang Hosp, Affiliated Shanghai Peoples Hosp 1, Shanghai, Peoples R China.; Xu, P; Yang, ZW (corresponding author), Nanjing Med Univ, Shanghai Songjiang Hosp, Nanjing, Jiangsu, Peoples R China.	yfyxuping@126.com; yangzhiwen2009@sina.com			National Natural Science Foundation of China [81370569]; Science & Technology Commission of Shanghai Songjiang [QK1102]; Songjiang District Commission of Health and Family Planning [2012-III-03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science & Technology Commission of Shanghai Songjiang; Songjiang District Commission of Health and Family Planning	This work was supported by the National Natural Science Foundation of China (No 81370569), Science & Technology Commission of Shanghai Songjiang (No QK1102) and Songjiang District Commission of Health and Family Planning (No 2012-III-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to the National Natural Science Foundation of China (No 81370569), Science & Technology Commission of Shanghai Songjiang (No QK1102) and Songjiang District Commission of Health and Family Planning (No 2012-III-03).	Bains SJ, 2016, J CLIN ONCOL, V34, P2501, DOI 10.1200/JCO.2015.65.3519; Bian ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep23892; Bsibsi M, 2014, ACTA NEUROPATHOL, V128, P215, DOI 10.1007/s00401-014-1317-8; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Cherneva R, 2010, INTERACT CARDIOV TH, V10, P14, DOI 10.1510/icvts.2009.213546; Davis FM, 2014, TRENDS PHARMACOL SCI, V35, P479, DOI 10.1016/j.tips.2014.06.006; Ding CB, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-015-0280-0; Giordano G, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0225-7; Gu Y, 2016, J PATHOL, V239, P60, DOI 10.1002/path.4697; Guo YH, 2016, ONCOTARGET, V7, P42513, DOI 10.18632/oncotarget.9893; Ho PY, 2013, UROL ONCOL-SEMIN ORI, V31, P1367, DOI 10.1016/j.urolonc.2012.01.015; Holcakova J, 2008, INT J BIOL MARKER, V23, P48, DOI 10.1177/172460080802300108; Huang XY, 2013, HEPATOLOGY, V57, P2235, DOI 10.1002/hep.26255; Ke AW, 2011, GASTROENTEROLOGY, V140, P1629, DOI 10.1053/j.gastro.2011.02.008; Li JC, 2010, GASTROENTEROLOGY, V139, P2146, DOI 10.1053/j.gastro.2010.08.004; Lynch CC, 2007, CANCER RES, V67, P6760, DOI 10.1158/0008-5472.CAN-07-0026; Mao Y, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-101; Moyano JV, 2006, J CLIN INVEST, V116, P261, DOI 10.1172/JCI25888; Naumov I, 2012, EXP CELL RES, V318, P160, DOI 10.1016/j.yexcr.2011.09.015; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Rajasekaran NS, 2007, CELL, V130, P427, DOI 10.1016/j.cell.2007.06.044; Ruan Q, 2011, MOL CANCER RES, V9, P1632, DOI 10.1158/1541-7786.MCR-11-0327; Salazar R, 2011, J CLIN ONCOL, V29, P17, DOI 10.1200/JCO.2010.30.1077; Scott EC, 2016, GENOME RES, V26, P745, DOI 10.1101/gr.201814.115; Shi CB, 2017, BIOCHEM BIOPH RES CO, V489, P369, DOI 10.1016/j.bbrc.2017.05.070; Shin JH, 2009, NEUROSCI RES, V64, P355, DOI 10.1016/j.neures.2009.04.006; Tan Q, 2009, HUM PATHOL, V40, P300, DOI 10.1016/j.humpath.2008.09.002; Whiston EA, 2008, INFECT IMMUN, V76, P1781, DOI 10.1128/IAI.01285-07; Worthley Daniel L, 2010, Clin Biochem Rev, V31, P31; Wu Y, 2016, ONCOTARGET, V7, P51150, DOI 10.18632/oncotarget.9457; Zabet NR, 2015, NUCLEIC ACIDS RES, V43, P84, DOI 10.1093/nar/gku1269; Zhang L, 2016, ONCOTARGET, V7, P30990, DOI 10.18632/oncotarget.8824; Zhu K, 2011, CLIN CANCER RES, V17, P7294, DOI 10.1158/1078-0432.CCR-11-1327	33	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182588	10.1371/journal.pone.0182588	http://dx.doi.org/10.1371/journal.pone.0182588			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796798	Green Submitted, Green Published, gold			2022-12-26	WOS:000407396200066
J	Modica, CM; Schweser, F; Sudyn, ML; Bertolino, N; Preda, M; Polak, P; Siebert, DM; Krawiecki, JC; Sveinsson, M; Hagemeier, J; Dwyer, MG; Pol, S; Zivadinov, R				Modica, Claire M.; Schweser, Ferdinand; Sudyn, Michelle L.; Bertolino, Nicola; Preda, Marilena; Polak, Paul; Siebert, Danielle M.; Krawiecki, Jacqueline C.; Sveinsson, Michele; Hagemeier, Jesper; Dwyer, Michael G.; Pol, Suyog; Zivadinov, Robert			Effect of teriflunomide on cortex-basal ganglia-thalamus (CxBGTh) circuit glutamatergic dysregulation in the Theiler's Murine Encephalomyelitis Virus mouse model of multiple sclerosis	PLOS ONE			English	Article							CORTICAL DEMYELINATION; ORAL TERIFLUNOMIDE; ATROPHY; BRAIN; DISEASE; IMAGE; DISABILITY; CELLS; MICE; REMYELINATION	Background Pathology of gray matter is associated with development of physical and cognitive disability in patients with multiple sclerosis. In particular, glutamatergic dysregulation in the cortexbasal ganglia-thalamus (CxBGTh) circuit could be associated with decline in these behaviors. Objectives To investigate the effect of an immunomodulatory therapy (teriflunomide, Aubagio (R)) on changes of the CxBGTh loop in the Theiler's Murine Encephalomyelitis Virus, (TMEV) mouse model of MS. Methods Forty-eight (48) mice were infected with TMEV, treated with teriflunomide (24) or control vehicle (24) and followed for 39 weeks. Mice were examined with MRS and volumetric MRI scans (0, 8, 26, and 39 weeks) in the cortex, basal ganglia and thalamus, using a 9.4T scanner, and with behavioral tests (0, 4, 8, 12, 17, 26, and 39 weeks). Within conditions, MRI measures were compared between two time points by paired samples t-test and across multiple time points by repeated measures ANOVA (rmANOVA), and between conditions by independent samples t-test and rmANOVA, respectively. Data were considered as significant at the p<0.01 level and as a trend at p<0.05 level. Results In the thalamus, the teriflunomide arm exhibited trends toward decreased glutamate levels at 8 and 26 weeks compared to the control arm (p = 0.039 and p = 0.026), while the control arm exhibited a trend toward increased glutamate between 0 to 8 weeks (p = 0.045). In the basal ganglia, the teriflunomide arm exhibited a trend toward decreased glutamate earlier than the control arm, from 0 to 8 weeks (p = 0.011), resulting in decreased glutamate compared to the control arm at 8 weeks (p = 0.016). Conclusions Teriflunomide may reduce possible excitotoxicity in the thalamus and basal ganglia by lowering glutamate levels.	[Modica, Claire M.; Sudyn, Michelle L.] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Neurosci Program, Buffalo, NY USA; [Modica, Claire M.; Schweser, Ferdinand; Sudyn, Michelle L.; Bertolino, Nicola; Preda, Marilena; Polak, Paul; Siebert, Danielle M.; Krawiecki, Jacqueline C.; Sveinsson, Michele; Hagemeier, Jesper; Dwyer, Michael G.; Pol, Suyog; Zivadinov, Robert] Univ Buffalo, Buffalo Neuroimaging Anal Ctr, Dept Neurol, Jacobs Sch Med & Biomed Sci, Buffalo, NY 14260 USA; [Schweser, Ferdinand; Preda, Marilena; Zivadinov, Robert] Univ Buffalo, Translat Imaging Ctr, Clin & Translat Sci Inst, Buffalo, NY 14260 USA; [Siebert, Danielle M.] Univ Buffalo, Sch Publ Hlth & Hlth Profess, Exercise Sci, Buffalo, NY USA; [Krawiecki, Jacqueline C.] Univ Buffalo, Dept Geol, Buffalo, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Zivadinov, R (corresponding author), Univ Buffalo, Buffalo Neuroimaging Anal Ctr, Dept Neurol, Jacobs Sch Med & Biomed Sci, Buffalo, NY 14260 USA.; Zivadinov, R (corresponding author), Univ Buffalo, Translat Imaging Ctr, Clin & Translat Sci Inst, Buffalo, NY 14260 USA.	rzivadinov@bnac.net	Schweser, Ferdinand/Q-6932-2019; Zivadinov, Robert/Q-2054-2019; Pol, Suyog/AAO-8804-2020	Schweser, Ferdinand/0000-0003-0399-9211; Zivadinov, Robert/0000-0002-7799-1485; Hagemeier, Jesper/0000-0002-3286-5207; Modica, Claire/0000-0002-7033-7632; Polak, Paul/0000-0002-7719-7572; Bertolino, Nicola/0000-0002-5924-0995	Genzyme; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR001412]; NCI [P30CA16056]; RPCI Core Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001412] Funding Source: NIH RePORTER	Genzyme(Sanofi-AventisGenzyme Corporation); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); RPCI Core Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by Genzyme, which is a wholly owned subsidiary of Sanofi. Research reported in this publication was also supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award Number UL1TR001412. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful for the assistance of Doug Weston, Trina Rudra, and John Barbieri in helping to take care of the mice involved in this study. We thank Bill Macy, Gary Olsen, and Simon Peng at the University at Buffalo Engineering Machine Shop, who helped construct the T - maze. We also thank Dr. Irwin Gelman and Renae Holtz, who produced the virus at the Genomics/shRNA Shared Resource at Roswell Park Cancer Institute, which is funded by NCI P30CA16056 and RPCI Core Grant.	Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Azevedo CJ, 2014, ANN NEUROL, V76, P269, DOI 10.1002/ana.24202; Bar-Or A, 2014, DRUGS, V74, P659, DOI 10.1007/s40265-014-0212-x; Batista S, 2012, J NEUROL, V259, P139, DOI 10.1007/s00415-011-6147-1; Benedict RHB, 2004, ARCH NEUROL-CHICAGO, V61, P226, DOI 10.1001/archneur.61.2.226; Bertolino N, 2016, P INT SOC MAG RESON, V24, P2383; Bobholz JA, 2003, CURR OPIN NEUROL, V16, P283, DOI 10.1097/00019052-200306000-00006; Calabrese M, 2010, MULT SCLER J, V16, P1220, DOI 10.1177/1352458510376405; Cawley N, 2015, BRAIN, V138, P2584, DOI 10.1093/brain/awv209; CLATCH RJ, 1985, J IMMUNOL, V135, P1408; Confavreux C, 2000, NEW ENGL J MED, V343, P1430, DOI 10.1056/NEJM200011163432001; Conn PJ, 2005, NAT REV NEUROSCI, V6, P787, DOI 10.1038/nrn1763; Cotton PL, 2007, J NEUROPHYSIOL, V98, P1600, DOI 10.1152/jn.00419.2007; DALCANTO MC, 1977, AM J PATHOL, V88, P497; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Fisher E, 2008, ANN NEUROL, V64, P255, DOI 10.1002/ana.21436; Gerlai R, 1998, BEHAV BRAIN RES, V95, P91, DOI 10.1016/S0166-4328(97)00214-3; Gujar SK, 2005, J NEURO-OPHTHALMOL, V25, P217, DOI 10.1097/01.wno.0000177307.21081.81; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; Hevner RF, 2000, J NEUROPATH EXP NEUR, V59, P385, DOI 10.1093/jnen/59.5.385; Jelachich ML, 1996, J VIROL, V70, P6856, DOI 10.1128/JVI.70.10.6856-6861.1996; Johnson GA, 2010, NEUROIMAGE, V53, P365, DOI 10.1016/j.neuroimage.2010.06.067; Keirstead HS, 1997, J NEUROPATH EXP NEUR, V56, P1191, DOI 10.1097/00005072-199711000-00003; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Lipton HL, 2005, J IMMUNOL METHODS, V299, P107, DOI 10.1016/j.jim.2005.01.017; LIPTON HL, 1984, J IMMUNOL, V132, P1821; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; McGavern DB, 1999, J NEUROSCI RES, V58, P492, DOI 10.1002/(SICI)1097-4547(19991115)58:4<492::AID-JNR3>3.0.CO;2-P; Merrill JE, 2009, J NEUROL, V256, P89, DOI 10.1007/s00415-009-0075-3; Miller AE, 2015, CLIN THER, V37, P2366, DOI 10.1016/j.clinthera.2015.08.003; Miller AE, 2014, LANCET NEUROL, V13, P977, DOI 10.1016/S1474-4422(14)70191-7; Minagar A, 2013, NEUROLOGY, V80, P210, DOI 10.1212/WNL.0b013e31827b910b; Modica CM, 2016, APPL BIOSAFETY, V21, P142; O'Connor P, 2011, NEW ENGL J MED, V365, P1293, DOI 10.1056/NEJMoa1014656; Oleszak EL, 2004, CLIN MICROBIOL REV, V17, P174, DOI 10.1128/CMR.17.1.174-207.2004; Pachner AR, 2011, J NEUROIMMUNOL, V232, P35, DOI 10.1016/j.jneuroim.2010.09.026; PETERSON JD, 1992, IMMUNOLOGY, V75, P652; Peterson JW, 2001, ANN NEUROL, V50, P389, DOI 10.1002/ana.1123; Pirko I, 2011, NEUROIMAGE, V54, P802, DOI 10.1016/j.neuroimage.2010.08.055; Pirko I, 2009, J NEUROL SCI, V282, P34, DOI 10.1016/j.jns.2008.12.013; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Radue E, 2015, ECTRIMS 2015; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schoonheim MM, 2012, NEUROLOGY, V79, P1754, DOI 10.1212/WNL.0b013e3182703f46; Soldan P, 2015, J NEUROIMAGING; Srinivasan R, 2005, BRAIN, V128, P1016, DOI 10.1093/brain/awh467; Strijbis EMM, 2013, MULT SCLER J, V19, P281, DOI 10.1177/1352458512454345; Tkac I, 2004, MAGN RESON MED, V52, P478, DOI 10.1002/mrm.20184; Trottier M, 2002, J VIROL METHODS, V103, P89, DOI 10.1016/S0166-0934(02)00021-6; Vercellino M, 2007, J NEUROPATH EXP NEUR, V66, P732, DOI 10.1097/nen.0b013e31812571b0; Wang HZ, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00027; Werner P, 2001, ANN NEUROL, V50, P169, DOI 10.1002/ana.1077; Zivadinov R, 2008, NEUROLOGY, V71, P136, DOI 10.1212/01.wnl.0000316810.01120.05; Zivadinov R, 2017, AAN, P334; Zivadinov R, 2016, EXPERT REV NEUROTHER, V16, P777, DOI 10.1080/14737175.2016.1181543; Zivadinov R, 2013, RADIOLOGY, V268, P831, DOI 10.1148/radiol.13122424	57	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182729	10.1371/journal.pone.0182729	http://dx.doi.org/10.1371/journal.pone.0182729			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796815	Green Published, Green Submitted, gold			2022-12-26	WOS:000407396200091
J	Thaler, C; Schneider, T; Sedlacik, J; Kutzner, D; Stellmann, JP; Heesen, C; Fiehler, J; Siemonsen, S				Thaler, Christian; Schneider, Tanja; Sedlacik, Jan; Kutzner, Daniel; Stellmann, Jan-Patrick; Heesen, Christoph; Fiehler, Jens; Siemonsen, Susanne			T1w dark blood imaging improves detection of contrast enhancing lesions in multiple sclerosis	PLOS ONE			English	Article							GRADIENT-ECHO; SPIN-ECHO; BLACK-BLOOD; CONSENSUS GUIDELINES; MP-RAGE; 3 T; BRAIN; SEQUENCES; DIAGNOSIS; MRI	Purpose In multiple sclerosis (MS) the sensitivity for detection of contrast enhancing lesions (CEL) in T1-weighted scans is essential for diagnostics and therapy decisions. The purpose of our study was to evaluate the sensitivity of T1w MPRAGE scans in comparison to T1w dark blood technique (T1-DB) for CEL in MS. Materials and methods 3T MR imaging was performed in 37 MS patients, including T2-weighted imaging, T1w MPRAGE before and after gadolinium injection (unenhanced-T1 and T1-CE) and T1-DB imaging. After gadolinium application, the T1-DB scan was performed prior to T1-CE. From unenhanced-T1 and T1-CE scans, subtraction images (T1-SUB) were calculated. The number of CEL was determined separately on T1-CE and T1-DB by two raters independently. Lesions only detected on T1-DB scans then were verified on T1-SUB. Only lesions detected by both raters were included in further analysis. Results In 16 patients, at least one CEL was detected by both rater, either on T1-CE or T1-DB. All lesions that were detected on T1-CE were also detected on T1-DB images. The total number of contrast enhancing lesions detected on T1-DB images (n = 54) by both raters was significantly higher than the corresponding number of lesions identified on T1-CE (n = 27) (p = 0.01); all of these lesions could be verified on SUB images. In 21 patients, no CEL was detected in any of the sequences. Conclusions The application of T1-DB technique increases the sensitivity for CEL in MS, especially for those lesions that show only subtle increase in intensity after Gadolinium application but remain hypo- or iso-intense to surrounding tissue.	[Thaler, Christian; Schneider, Tanja; Sedlacik, Jan; Kutzner, Daniel; Fiehler, Jens; Siemonsen, Susanne] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany; [Stellmann, Jan-Patrick; Heesen, Christoph] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Stellmann, Jan-Patrick; Heesen, Christoph] Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & Clin MS Res, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Thaler, C (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Neuroradiol, Hamburg, Germany.	c.thaler@uke.de	Stellmann, Jan-Patrick/ABA-7132-2020	Stellmann, Jan-Patrick/0000-0003-2565-2833				Algin O, 2010, DIAGN INTERV RADIOL, V16, P106, DOI 10.4261/1305-3825.DIR.2879-09.1; Aymerich FX, 2017, EUR RADIOL, V27, P1361, DOI 10.1007/s00330-016-4503-3; Battaglini M, 2014, J MAGN RESON IMAGING, V39, P1543, DOI 10.1002/jmri.24293; BRANTZAWADZKI M, 1992, RADIOLOGY, V182, P769, DOI 10.1148/radiology.182.3.1535892; CHAPPELL PM, 1994, AM J NEURORADIOL, V15, P37; Crombe A, 2015, AM J NEURORADIOL, V36, P501, DOI 10.3174/ajnr.A4152; Cuvinciuc V, 2013, NEURORADIOLOGY, V55, P595, DOI 10.1007/s00234-013-1141-1; Downs RK, 2013, QUANT IMAGING MED SU, V3, P141, DOI 10.3978/j.issn.2223-4292.2013.05.02; Edjlali M, 2013, AM J NEURORADIOL, V34, pE103, DOI 10.3174/ajnr.A3261; Filippi M, 2016, LANCET NEUROL, V15, P292, DOI 10.1016/S1474-4422(15)00393-2; Fischbach F, 2005, J COMPUT ASSIST TOMO, V29, P499, DOI 10.1097/01.rct.0000166636.85918.3d; Hodel J, 2014, AM J NEURORADIOL, V35, P519, DOI 10.3174/ajnr.A3795; Horsfield MA, 2016, J NEUROIMAGING, V26, P395, DOI 10.1111/jon.12344; Im S, 2015, EUR RADIOL, V25, P3175, DOI 10.1007/s00330-015-3757-5; Kammer NN, 2016, EUR RADIOL, V26, P1818, DOI 10.1007/s00330-015-3975-x; Kanda T, 2015, RADIOLOGY, DOI DOI 10.1148/RADIOL.14140364; Kwak HS, 2015, CLIN IMAG, V39, P571, DOI 10.1016/j.clinimag.2015.02.010; Losseff NA, 2001, MULT SCLER J, V7, P23, DOI 10.1177/135245850100700105; Niu PP, 2016, J NEUROL SCI, V367, P46, DOI 10.1016/j.jns.2016.05.052; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Radbruch A, 2015, RADIOLOGY, V275, P783, DOI 10.1148/radiol.2015150337; Robert P, 2015, INVEST RADIOL, V50, P473, DOI 10.1097/RLI.0000000000000181; Rovaris M, 2003, AM J NEURORADIOL, V24, P75; Simon JH, 2006, AM J NEURORADIOL, V27, P455; Traboulsee A, 2016, AM J NEURORADIOL, V37, P394, DOI 10.3174/ajnr.A4539; Uysal E, 2007, AM J ROENTGENOL, V188, P697, DOI 10.2214/AJR.05.2212; WENZ F, 1994, MAGN RESON IMAGING, V12, P553, DOI 10.1016/0730-725X(94)92449-X; Yang Q, 2016, STROKE, V47, P404, DOI 10.1161/STROKEAHA.115.011369	28	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0183099	10.1371/journal.pone.0183099	http://dx.doi.org/10.1371/journal.pone.0183099			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797082	gold, Green Published, Green Submitted			2022-12-26	WOS:000407396200150
J	Zarai, Y; Margaliot, M; Kolomeisky, AB				Zarai, Yoram; Margaliot, Michael; Kolomeisky, Anatoly B.			A deterministic model for one-dimensional excluded flow with local interactions	PLOS ONE			English	Article							ASYMMETRIC EXCLUSION PROCESS; PROTEIN-SYNTHESIS; KINESIN MOTORS; CONTRACTION; TRANSLATION; SYSTEMS; MATRIX	Natural phenomena frequently involve a very large number of interacting molecules moving in confined regions of space. Cellular transport by motor proteins is an example of such collective behavior. We derive a deterministic compartmental model for the unidirectional flow of particles along a one-dimensional lattice of sites with nearest-neighbor interactions between the particles. The flow between consecutive sites is governed by a "soft" simple exclusion principle and by attracting or repelling forces between neighboring particles. Using tools from contraction theory, we prove that the model admits a unique steady-state and that every trajectory converges to this steady-state. Analysis and simulations of the effect of the attracting and repelling forces on this steady-state highlight the crucial role that these forces may play in increasing the steady-state flow, and reveal that this increase stems from the alleviation of traffic jams along the lattice. Our theoretical analysis clarifies microscopic aspects of complex multi-particle dynamic processes.	[Zarai, Yoram] Tel Aviv Univ, Sch Elect Engn, IL-69978 Tel Aviv, Israel; [Margaliot, Michael] Tel Aviv Univ, Sch Elect Engn, IL-69978 Tel Aviv, Israel; [Margaliot, Michael] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Kolomeisky, Anatoly B.] Rice Univ, Dept Chem, Houston, TX 77005 USA	Tel Aviv University; Tel Aviv University; Tel Aviv University; Rice University	Margaliot, M (corresponding author), Tel Aviv Univ, Sch Elect Engn, IL-69978 Tel Aviv, Israel.; Margaliot, M (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel.	michaelm@post.tau.ac.il	Kolomeisky, Anatoly B/A-9372-2011	Kolomeisky, Anatoly B/0000-0001-5677-6690	Edmond J. Safra Center for Bioinformatics at Tel Aviv University; Israeli Ministry of Science, Technology Space; US-Israel Binational Science Foundation; Israeli Science Foundation	Edmond J. Safra Center for Bioinformatics at Tel Aviv University; Israeli Ministry of Science, Technology Space; US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israeli Science Foundation(Israel Science Foundation)	The research of YZ is partially supported by the Edmond J. Safra Center for Bioinformatics at Tel Aviv University. The research of MM is partially supported by research grants from the Israeli Ministry of Science, Technology & Space, the US-Israel Binational Science Foundation, and the Israeli Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the anonymous referees and the Associate Editor for their helpful comments.; The research of YZ is partially supported by the Edmond J. Safra Center for Bioinformatics at Tel Aviv University. The research of MM is partially supported by research grants from the Israeli Ministry of Science, Technology & Space, the US-Israel Binational Science Foundation, and the Israeli Science Foundation.	Alberts B., 2010, MOL BIOL CELL; Aminzare Z, 2014, IEEE DECIS CONTR P, P3835, DOI 10.1109/CDC.2014.7039986; Antal T, 2000, PHYS REV E, V62, P83, DOI 10.1103/PhysRevE.62.83; Bauer WR, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.010703; Blythe RA, 2007, J PHYS A-MATH THEOR, V40, pR333, DOI 10.1088/1751-8113/40/46/R01; Celis-Garza D, 2015, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2015/04/P04013; Chowdhury D, 2005, PHYS LIFE REV, V2, P318, DOI 10.1016/j.plrev.2005.09.001; Ciandrini L, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002866; DESOER CA, 1972, IEEE T CIRCUITS SYST, VCT19, P480, DOI 10.1109/TCT.1972.1083507; Hager JS, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.056110; Kolomeisky A, 2015, MOTOR PROTEINS MOL M; Kolomeisky AB, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/46/463101; Kriecherbauer T, 2010, J PHYS A-MATH THEOR, V43, DOI 10.1088/1751-8113/43/40/403001; Lakatos G, 2003, J PHYS A-MATH GEN, V36, P2027, DOI 10.1088/0305-4470/36/8/302; Leduc C, 2012, P NATL ACAD SCI USA, V109, P6100, DOI 10.1073/pnas.1107281109; Lohmiller W, 1998, AUTOMATICA, V34, P683, DOI 10.1016/S0005-1098(98)00019-3; Mallik R, 2013, TRENDS CELL BIOL, V23, P575, DOI 10.1016/j.tcb.2013.06.003; Mandelkow E, 2002, TRENDS CELL BIOL, V12, P585, DOI 10.1016/S0962-8924(02)02400-5; Margaliot M, 2016, AUTOMATICA, V67, P178, DOI 10.1016/j.automatica.2016.01.018; Margaliot M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096039; Margaliot M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0267; Margaliot M, 2012, IEEE ACM T COMPUT BI, V9, P1724, DOI 10.1109/TCBB.2012.120; Margaliot M, 2012, IEEE ACM T COMPUT BI, V9, P1545, DOI 10.1109/TCBB.2012.88; NADLER W, 1986, J CHEM PHYS, V84, P4015, DOI 10.1063/1.450061; Pinkoviezky I, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.052703; Pinkoviezky I, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/2/025009; Poker G, 2015, SCI REP-UK, V5, DOI 10.1038/srep12795; Poker G, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0713; Raveh A, 2015, IEEE ACM T COMPUT BI, V12, P1429, DOI 10.1109/TCBB.2015.2418782; Reuveni S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002127; Romano MC, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.198104; Russo G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000739; Schadschneider A, 2011, STOCHASTIC TRANSPORT IN COMPLEX SYSTEMS: FROM MOLECULES TO VEHICLES, P1; Shaw LB, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.021910; Shaw LB, 2004, J PHYS A-MATH GEN, V37, P2105, DOI 10.1088/0305-4470/37/6/010; Smith H. L., 1995, MATH SURVEYS MONOGRA, V41; Srinivasa S, 2012, IEEE T MOBILE COMPUT, V11, P618, DOI 10.1109/TMC.2011.96; Teimouri H, 2015, J PHYS A-MATH THEOR, V48, DOI 10.1088/1751-8113/48/6/065001; Turci F, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012705; Zarai Y, 2016, IEEE ACM T IN PRESS; Zarai Y, 2016, PLOS ONE IN PRESS; Zarai Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep41243; Zarai Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166481; Zarai Y, 2013, IEEE ACM T COMPUT BI, V10, P1322, DOI 10.1109/TCBB.2013.120; Zia RKP, 2011, J STAT PHYS, V144, P405, DOI 10.1007/s10955-011-0183-1	45	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182074	10.1371/journal.pone.0182074	http://dx.doi.org/10.1371/journal.pone.0182074			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796838	Green Submitted, Green Published, gold			2022-12-26	WOS:000407396200027
J	Guilini, K; Weber, M; de Beer, D; Schneider, M; Molari, M; Lott, C; Bodnar, W; Mascart, T; De Troch, M; Vanreusel, A				Guilini, Katja; Weber, Miriam; de Beer, Dirk; Schneider, Matthias; Molari, Massimiliano; Lott, Christian; Bodnar, Wanda; Mascart, Thibaud; De Troch, Marleen; Vanreusel, Ann			Response of Posidonia oceanica seagrass and its epibiont communities to ocean acidification	PLOS ONE			English	Article							EELGRASS ZOSTERA-MARINA; SITU CO2 ENRICHMENT; DISSOCIATION-CONSTANTS; HARPACTICOID COPEPODS; BICARBONATE USE; CLIMATE-CHANGE; SEA-WATER; PHOTOSYNTHESIS; MEIOFAUNA; SEAWATER	The unprecedented rate of CO2 increase in our atmosphere and subsequent ocean acidification (OA) threatens coastal ecosystems. To forecast the functioning of coastal seagrass ecosystems in acidified oceans, more knowledge on the long-term adaptive capacities of seagrass species and their epibionts is needed. Therefore we studied morphological characteristics of Posidonia oceanica and the structure of its epibiont communities at a Mediterranean volcanic CO2 vent off Panarea Island (Italy) and performed a laboratory experiment to test the effect of OA on P. oceanica photosynthesis and its potential buffering capacity. At the study site east of Basiluzzo Islet, venting of CO2 gas was controlled by tides, resulting in an average pH difference of 0.1 between the vent and reference site. P. oceanica shoot and leaf density was unaffected by these levels of OA, although shorter leaves at the vent site suggest increased susceptibility to erosion, potentially by herbivores. The community of sessile epibionts differed in composition and was characterized by a higher species richness at the vent site, though net epiphytic calcium carbonate concentration was similar. These findings suggest a higher ecosystem complexity at the vent site, which may have facilitated the higher diversity of copepods in the otherwise unaffected motile epibiont community. In the laboratory experiment, P. oceanica photosynthesis increased with decreasing pH(T) (7.6, 6.6, 5.5), which induced an elevated pH at the leaf surfaces of up to 0.5 units compared to the ambient seawater pH(T) of 6.6. This suggests a temporary pH buffering in the diffusive boundary layer of leaves, which could be favorable for epibiont organisms. The results of this multispecies study contribute to understanding community-level responses and underlying processes in long-term acidified conditions. Increased replication and monitoring of physico-chemical parameters on an annual scale are, however, recommended to assure that the biological responses observed during a short period reflect long-term dynamics of these parameters.	[Guilini, Katja; Bodnar, Wanda; Mascart, Thibaud; De Troch, Marleen; Vanreusel, Ann] Univ Ghent, Dept Biol, Marine Biol Res Grp, Ghent, Belgium; [Weber, Miriam; Molari, Massimiliano] Max Planck Inst Marine Microbiol, Joint Res Grp Deep Sea Ecol & Technol, HGF MPG, Bremen, Germany; [Lott, Christian] HYDRA Inst Marine Sci, Elba Field Stn, Italy; [Molari, Massimiliano] Max Planck Inst Marine Microbiol, Microsensor Grp, Bremen, Germany	Ghent University; Max Planck Society; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR); Max Planck Society	Guilini, K (corresponding author), Univ Ghent, Dept Biol, Marine Biol Res Grp, Ghent, Belgium.	katja.guilini@ugent.be	de Beer, Dirk/L-4840-2013; De Troch, Marleen/AAB-9809-2019	de Beer, Dirk/0000-0001-5274-1781; De Troch, Marleen/0000-0002-6800-0299; Bodnar, Wanda/0000-0001-6772-0609; Mascart, Thibaud/0000-0003-4409-7978; Molari, Massimiliano/0000-0003-4995-7818; Guilini, Katja/0000-0003-1832-8875	European Commission's Framework Seven Programme Topic OCEAN.2010.3 [265847.T]; Flemish fund for Scientific Research [1242114N]	European Commission's Framework Seven Programme Topic OCEAN.2010.3; Flemish fund for Scientific Research(FWO)	Financial support for this study was provided under the European Commission's Framework Seven Programme Topic OCEAN.2010.3, project number 265847.T, "ECO2 - Sub-seabed CO2 Storage: Impact on Marine Ecosystems". Katja Guilini additionally acknowledges the Flemish fund for Scientific Research (grant number: 1242114N) for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alexandre A, 2012, ECOL EVOL, V2, P2620, DOI 10.1002/ece3.333; Anderson MJ, 2008, PERMANOVA PRIMER GUI; Apostolaki ET, 2014, MAR ENVIRON RES, V99, P9, DOI 10.1016/j.marenvres.2014.05.008; Arnold T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035107; Balestri E, 2003, MAR ECOL PROG SER, V250, P51, DOI 10.3354/meps250051; Brodersen KE, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00058; Burnell OW, 2014, OECOLOGIA, V176, P871, DOI 10.1007/s00442-014-3054-z; Campbell JE, 2013, LIMNOL OCEANOGR, V58, P839, DOI 10.4319/lo.2013.58.3.0839; Caramanna G, 2011, ENRGY PROCED, V4, P3262, DOI 10.1016/j.egypro.2011.02.245; Cigliano M, 2010, MAR BIOL, V157, P2489, DOI 10.1007/s00227-010-1513-6; Cox TE, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3136-7; Cox TE, 2016, BIOGEOSCIENCES, V13, P2179, DOI 10.5194/bg-13-2179-2016; Cox TE, 2015, J ECOL; Danovaro R, 1996, MAR BIOL, V127, P1, DOI 10.1007/BF00993638; De Beer D., 2000, IN SITU MONITORING A, P161; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; DICKSON AG, 1979, MAR CHEM, V7, P89, DOI 10.1016/0304-4203(79)90001-X; Dickson AG, 1994, ORNLCDIAC74; Donnarumma L, 2014, MEDITERR MAR SCI, V15, P498, DOI 10.12681/mms.677; Duarte CM, 2013, ESTUAR COAST, V36, P221, DOI 10.1007/s12237-013-9594-3; Duarte CM, 2001, ENCY BIODIVERSITY, P254, DOI DOI 10.1016/B0-12-226865-2/00241-8; Edenhofer O., 2014, CONTRIBUTION WORKING; EDMOND JM, 1970, DEEP-SEA RES, V17, P737, DOI 10.1016/0011-7471(70)90038-0; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Garrard SL, 2014, J EXP MAR BIOL ECOL, V461, P31, DOI 10.1016/j.jembe.2014.07.011; Grasshoff K., 1983, METHODS SEAWATER ANA, V2nd, DOI DOI 10.15359/REVMAR.3.2; Guidetti P, 2000, MAR POLLUT BULL, V40, P449, DOI 10.1016/S0025-326X(99)00229-5; HALL PO, 1992, LIMNOL OCEANOGR, V37, P1113, DOI 10.4319/lo.1992.37.5.1113; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Hassenruck C, 2015, ENV MICROBIOL REP, V7, P516, DOI 10.1111/1758-2229.12282; Heip Carlo H. R., 1998, Oceanis, V24, P61; Hendriks IE, 2014, BIOGEOSCIENCES, V11, P333, DOI 10.5194/bg-11-333-2014; Hendriks IE, AQUAT BOT IN PRESS; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Invers O, 1997, AQUAT BOT, V59, P185, DOI 10.1016/S0304-3770(97)00072-7; Invers O, 2001, J EXP MAR BIOL ECOL, V265, P203, DOI 10.1016/S0022-0981(01)00332-X; Jiang ZJ, 2010, J INTEGR PLANT BIOL, V52, P904, DOI 10.1111/j.1744-7909.2010.00991.x; Johnson VR, 2013, MAR BIOL, V160, P1813, DOI 10.1007/s00227-011-1840-2; Jorda G, 2012, NAT CLIM CHANGE, V2, P821, DOI [10.1038/NCLIMATE1533, 10.1038/nclimate1533]; Kerrison P, 2011, ESTUAR COAST SHELF S, V94, P129, DOI 10.1016/j.ecss.2011.05.025; Koch M, 2013, GLOBAL CHANGE BIOL, V19, P103, DOI 10.1111/j.1365-2486.2012.02791.x; Kroeker KJ, 2011, P NATL ACAD SCI USA, V108, P14515, DOI 10.1073/pnas.1107789108; Lewis ER, 1998, ESS-DIVE, DOI 10.15485/1464255; Marba N, 1997, LIMNOL OCEANOGR, V42, P800, DOI 10.4319/lo.1997.42.5.0800; Marba N, 2010, GLOBAL CHANGE BIOL, V16, P2366, DOI 10.1111/j.1365-2486.2009.02130.x; Martin S, 2008, BIOL LETTERS, V4, P689, DOI 10.1098/rsbl.2008.0412; Martinez-Crego B, 2014, BIOGEOSCIENCES, V11, P7237, DOI 10.5194/bg-11-7237-2014; Mascart T, 2015, J SEA RES, V95, P149, DOI 10.1016/j.seares.2014.07.009; Mascart T, 2013, J MAR BIOL ASSOC UK, V93, P1557, DOI 10.1017/S0025315413000222; Mayot N, 2005, CR BIOL, V328, P291, DOI 10.1016/j.crvi.2005.01.005; Meyer S, 2012, ECO23 M PLANCK I MAR; Milliman J. D., 1974, MARINE CARBONATES; Nagelkerken I, 2015, P NATL ACAD SCI USA, V112, P13272, DOI 10.1073/pnas.1510856112; NOVAK R, 1982, NETH J SEA RES, V16, P380, DOI 10.1016/0077-7579(82)90044-8; Ow YX, 2015, MAR BIOL, V162, P1005, DOI 10.1007/s00227-015-2644-6; Palacios SL, 2007, MAR ECOL PROG SER, V344, P1, DOI 10.3354/meps07084; Peirano A, 2001, SCI MAR, V65, P367, DOI 10.3989/scimar.2001.65n4367; Porzio L, 2011, J EXP MAR BIOL ECOL, V400, P278, DOI 10.1016/j.jembe.2011.02.011; R Core Team, 2021, R LANGUAGE ENV STAT; REVSBECH NP, 1989, LIMNOL OCEANOGR, V34, P474, DOI 10.4319/lo.1989.34.2.0474; ROY RN, 1993, MAR CHEM, V44, P249, DOI 10.1016/0304-4203(93)90207-5; Russell BD, 2013, MAR POLLUT BULL, V73, P463, DOI 10.1016/j.marpolbul.2013.01.031; SCHMALZ RF, 1969, J SEDIMENT PETROL, V39, P255; Semesi IS, 2009, MAR ECOL PROG SER, V382, P41, DOI 10.3354/meps07973; Takahashi T., 1982, GEOSECS PACIFIC EXPE, V3, P77; Thom RM, 1996, WATER AIR SOIL POLL, V88, P383, DOI 10.1007/BF00294113; Verges A, 2011, OECOLOGIA, V166, P381, DOI 10.1007/s00442-010-1830-y; WATSON DJ, 1947, ANN BOT-LONDON, V11, P41, DOI 10.1093/oxfordjournals.aob.a083148; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Welker C, 2002, ESTUAR COAST SHELF S, V55, P259, DOI 10.1006/ecss.2001.0901; WIESER W., 1953, ARKIV ZOOL, V4, P439; Zeebe R.E., 2001, ELSEV OCEANOGR SERIE; Zimmerman RC, 1997, PLANT PHYSIOL, V115, P599, DOI 10.1104/pp.115.2.599	74	25	25	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0181531	10.1371/journal.pone.0181531	http://dx.doi.org/10.1371/journal.pone.0181531			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28792960	Green Published, gold			2022-12-26	WOS:000407196700013
J	Lemaire, K; Granvik, M; Schraenen, A; Goyvaerts, L; Van Lommel, L; Gomez-Ruiz, A; t'Veld, PI; Gilon, P; Schuit, F				Lemaire, Katleen; Granvik, Mikaela; Schraenen, Anica; Goyvaerts, Lotte; Van Lommel, Leentje; Gomez-Ruiz, Ana; t'Veld, Peter in; Gilon, Patrick; Schuit, Frans			How stable is repression of disallowed genes in pancreatic islets in response to metabolic stress?	PLOS ONE			English	Article							INSULIN-PRODUCING CELLS; BETA-CELLS; MONOCARBOXYLATE TRANSPORTER-1; ZNT8 EXPRESSION; DIABETIC MICE; DELTA CELLS; B-CELLS; SECRETION; PREGNANCY; MOUSE	The specific phenotype of mature differentiated beta cells not only depends on the specific presence of genes that allow beta cell function but also on the selective absence of housekeeping genes ("disallowed genes") that would interfere with this function. Recent studies have shown that both histone modifications and DNA methylation via the de novo methyltransferase DNMT3A are involved in repression of disallowed genes in neonatal beta cells when these cells acquire their mature phenotype. It is unknown, however, if the environmental influence of advanced age, pregnancy and the metabolic stress of high fat diet or diabetes could alter the repression of disallowed genes in beta cells. In the present study, we show that islet disallowed genes-which are also deeply repressed in FACS-purified beta cells-remain deeply repressed in animals of advanced age and in pregnant females. Moreover, the stability of this repression was correlated with strong and stable histone repression marks that persisted in islets isolated from 2 year old mice and with overall high expression of Dnmt3a in islets. Furthermore, repression of disallowed genes was unaffected by the metabolic stress of high fat diet. However, repression of about half of the disallowed genes was weakened in 16 week-old diabetic db/db mice. In conclusion, we show that the disallowed status of islet genes is stable under physiological challenging conditions (advanced age, pregnancy, high fat diet) but partially lost in islets from diabetic animals.	[Lemaire, Katleen; Granvik, Mikaela; Schraenen, Anica; Goyvaerts, Lotte; Van Lommel, Leentje; Gomez-Ruiz, Ana; t'Veld, Peter in; Gilon, Patrick; Schuit, Frans] Katholieke Univ Leuven, Dept Cellular & Mol Med, Gene Express Unit, Leuven, Belgium	KU Leuven	Schuit, F (corresponding author), Katholieke Univ Leuven, Dept Cellular & Mol Med, Gene Express Unit, Leuven, Belgium.	frans.schuit@kuleuven.be	Goyvaerts, Lotte/AAP-9125-2020; In't Veld, Peter/E-3624-2013	In't Veld, Peter/0000-0001-5596-7129	Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO grants) [G.0672.12N, G12C2912N]; KU Leuven [GOA/12/016]; Actions de Recherche Concertees from the French Community of Belgium [ARC 13/18-051]	Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO grants)(FWO); KU Leuven(KU Leuven); Actions de Recherche Concertees from the French Community of Belgium	This research was supported by research grants from the Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO grants G.0672.12N and G12C2912N) and from the KU Leuven (GOA/12/016) and the Actions de Recherche Concertees (ARC 13/18-051) from the French Community of Belgium. PG is Research Director of the Fonds National de la Recherche Scientifique, Brussels.	Adriaenssens AE, 2016, DIABETOLOGIA, V59, P2156, DOI 10.1007/s00125-016-4033-1; Aguayo-Mazzucato C, 2011, DIABETOLOGIA, V54, P583, DOI 10.1007/s00125-010-2026-z; Almaca J, 2014, P NATL ACAD SCI USA, V111, P17612, DOI 10.1073/pnas.1414053111; Avrahami D, 2015, CELL METAB, V22, P619, DOI 10.1016/j.cmet.2015.07.025; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chen HA, 2009, GENE DEV, V23, P975, DOI 10.1101/gad.1742509; Dhawan S, 2015, J CLIN INVEST, V125, P2851, DOI 10.1172/JCI79956; DiGruccio MR, 2016, MOL METAB, V5, P449, DOI 10.1016/j.molmet.2016.04.007; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; GAPP DA, 1983, DIABETOLOGIA, V25, P439, DOI 10.1007/BF00282525; Gunasekaran U, 2011, AGING-US, V3, P565, DOI 10.18632/aging.100350; Gurgul E, 2004, DIABETES, V53, P2271, DOI 10.2337/diabetes.53.9.2271; Helman A, 2016, NAT MED, V22, P412, DOI 10.1038/nm.4054; Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Kushner JA, 2013, J CLIN INVEST, V123, P990, DOI 10.1172/JCI64095; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Lemaire K, 2009, P NATL ACAD SCI USA, V106, P14872, DOI 10.1073/pnas.0906587106; Lemaire K, 2016, ANNU REV NUTR, V36, P45, DOI 10.1146/annurev-nutr-071715-050808; Mosser RE, 2015, AM J PHYSIOL-ENDOC M, V308, pE573, DOI 10.1152/ajpendo.00460.2014; Nishimura W, 2015, DIABETOLOGIA, V58, P566, DOI 10.1007/s00125-014-3464-9; Otonkoski T, 2003, DIABETES, V52, P199, DOI 10.2337/diabetes.52.1.199; Otonkoski T, 2007, AM J HUM GENET, V81, P467, DOI 10.1086/520960; PARSONS JA, 1992, ENDOCRINOLOGY, V130, P1459, DOI 10.1210/en.130.3.1459; Piccand J, 2014, CELL REP, V9, P2219, DOI 10.1016/j.celrep.2014.11.033; PIPELEERS DG, 1985, ENDOCRINOLOGY, V117, P806, DOI 10.1210/endo-117-3-806; Pullen TJ, 2012, DIABETES, V61, P1719, DOI 10.2337/db11-1531; Pullen TJ, 2010, ISLETS, V2, P89, DOI 10.4161/isl.2.2.11025; Quintens R, 2008, BIOCHEM SOC T, V36, P300, DOI 10.1042/BST0360300; Quoix N, 2007, FEBS LETT, V581, P4235, DOI 10.1016/j.febslet.2007.07.068; Rieck S, 2010, TRENDS ENDOCRIN MET, V21, P151, DOI 10.1016/j.tem.2009.11.001; Rorsman P, 2013, ANNU REV PHYSIOL, V75, P155, DOI 10.1146/annurev-physiol-030212-183754; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SALOMON D, 1986, EXP CELL RES, V162, P507, DOI 10.1016/0014-4827(86)90354-X; Schraenen A, 2010, DIABETOLOGIA, V53, P2579, DOI 10.1007/s00125-010-1912-8; Schraenen A, 2010, DIABETOLOGIA, V53, P2589, DOI 10.1007/s00125-010-1913-7; Schuit F, 1999, J BIOL CHEM, V274, P32803, DOI 10.1074/jbc.274.46.32803; SCHUIT FC, 1988, P NATL ACAD SCI USA, V85, P3865, DOI 10.1073/pnas.85.11.3865; Schuit FC, 1996, HORM RES, V46, P99, DOI 10.1159/000185004; Schuit F, 2012, DIABETES, V61, P969, DOI 10.2337/db11-1564; Seiler Nikolaus, 2000, Current Drug Targets, V1, P119, DOI 10.2174/1389450003349254; SEKINE N, 1994, J BIOL CHEM, V269, P4895; Smismans A, 2000, CYTOKINE, V12, P49, DOI 10.1006/cyto.1999.0524; Smith SB, 2010, NATURE, V463, P775, DOI 10.1038/nature08748; Sone H, 2005, DIABETOLOGIA, V48, P58, DOI 10.1007/s00125-004-1605-2; Ta M, 2010, DIABETES, V59; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Tamaki M, 2009, ISLETS, V1, P124, DOI 10.4161/isl.1.2.9433; THORENS B, 1992, J CLIN INVEST, V90, P77, DOI 10.1172/JCI115858; Thorrez L, 2011, GENOME RES, V21, P95, DOI 10.1101/gr.109173.110; van Arensbergen J, 2013, GENE DEV, V27, P52, DOI 10.1101/gad.206094.112; van Arensbergen J, 2010, GENOME RES, V20, P722, DOI 10.1101/gr.101709.109; VANASSCHE FA, 1980, DIABETOLOGIA, V18, P487, DOI 10.1007/BF00261705; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	55	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0181651	10.1371/journal.pone.0181651	http://dx.doi.org/10.1371/journal.pone.0181651			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28792951	Green Published, Green Submitted, gold			2022-12-26	WOS:000407196700015
J	Theodosiou, A; Jones, AN; Marsden, BJ				Theodosiou, Alex; Jones, Abbie N.; Marsden, Barry J.			Thermal oxidation of nuclear graphite: A large scale waste treatment option	PLOS ONE			English	Article							AIR INGRESS; CARBON; GASIFICATION; OXYGEN; TEMPERATURE; KINETICS; MODEL; COMPLEX; RATIO	This study has investigated the laboratory scale thermal oxidation of nuclear graphite, as a proof-of-concept for the treatment and decommissioning of reactor cores on a larger industrial scale. If showed to be effective, this technology could have promising international significance with a considerable impact on the nuclear waste management problem currently facing many countries worldwide. The use of thermal treatment of such graphite waste is seen as advantageous since it will decouple the need for an operational Geological Disposal Facility (GDF). Particulate samples of Magnox Reactor Pile Grade-A (PGA) graphite, were oxidised in both air and 60% O-2, over the temperature range 400-1200 degrees C. Oxidation rates were found to increase with temperature, with a particular rise between 700-800 degrees C, suggesting a change in oxidation mechanism. A second increase in oxidation rate was observed between 1000-1200 degrees C and was found to correspond to a large increase in the CO/CO2 ratio, as confirmed through gas analysis. Increasing the oxidant flow rate gave a linear increase in oxidation rate, up to a certain point, and maximum rates of 23.3 and 69.6 mg/min for air and 60% O-2 respectively were achieved at a flow of 250 ml/min and temperature of 1000 degrees C. These promising results show that large-scale thermal treatment could be a potential option for the decommissioning of graphite cores, although the design of the plant would need careful consideration in order to achieve optimum efficiency and throughput.	[Theodosiou, Alex; Jones, Abbie N.; Marsden, Barry J.] Univ Manchester, Sch Mech Aeronaut & Civil Engn, NGRG, Manchester, Lancs, England	University of Manchester	Theodosiou, A (corresponding author), Univ Manchester, Sch Mech Aeronaut & Civil Engn, NGRG, Manchester, Lancs, England.	alex.theodosiou@manchester.ac.uk	; Jones, Abbie/A-2763-2012	Theodosiou, Alex/0000-0001-6504-6737; Jones, Abbie/0000-0002-1350-4617	Innovate UK [320302]; EPSRC [EP/P025021/1, EP/R00577X/1] Funding Source: UKRI	Innovate UK(UK Research & Innovation (UKRI)Innovate UK); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Innovate UK under grant application number 320302: Thermal Treatment of Irradiated Graphite. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank, in particular, Hiden Analytical (R) for advice, support and discussion with regards to gas analysis. A special thanks also to Mr Jason Petterson for help with the artwork. This study was supported by Innovate UK under grant application number 320302: Thermal Treatment of Irradiated Graphite.	AHMED S, 1985, CARBON, V23, P513, DOI 10.1016/0008-6223(85)90087-9; Blanchard A, 2003, TECDOC1154 IAEA, P207; Campbell PA, 2008, COMBUST FLAME, V154, P47, DOI 10.1016/j.combustflame.2007.11.002; CHEN SG, 1993, IND ENG CHEM RES, V32, P2835, DOI 10.1021/ie00023a054; Chi SH, 2008, J NUCL MATER, V381, P9, DOI 10.1016/j.jnucmat.2008.07.027; Choi WK, 2011, NUCL ENG DES, V241, P82, DOI 10.1016/j.nucengdes.2010.10.007; Clark T., 1962, NUCL GRAPHITE, P387; Contescu CI, 2008, J NUCL MATER, V381, P15, DOI 10.1016/j.jnucmat.2008.07.020; DU ZY, 1991, ENERG FUEL, V5, P214, DOI 10.1021/ef00025a035; El-Genk MS, 2013, PROG NUCL ENERG, V62, P26, DOI 10.1016/j.pnucene.2012.06.007; El-Genk MS, 2012, NUCL ENG DES, V250, P142, DOI 10.1016/j.nucengdes.2012.05.016; El-Genk MS, 2012, J NUCL MATER, V420, P141, DOI 10.1016/j.jnucmat.2011.09.027; El-Genk MS, 2011, J NUCL MATER, V411, P193, DOI 10.1016/j.jnucmat.2011.01.129; Essenhigh RH, 1981, CHEM COAL UTILIZATIO, P1152; Freeman HM, 2016, CARBON, V103, P45, DOI 10.1016/j.carbon.2016.03.011; Fuller L, 1997, J NUCL MATER, V240, P241, DOI 10.1016/S0022-3115(96)00462-X; Gao ZY, 1993, TECHN COMM M RESP FU; Geier M, 2013, P COMBUST INST, V34, P2411, DOI 10.1016/j.proci.2012.07.009; Gulbransen EA, 1963, J ELECTROCHEM SOC, P110; HAAG G, 1990, J NUCL MATER, V171, P41, DOI 10.1016/0022-3115(90)90345-N; Hinssen HK, 2008, NUCL ENG DES, V238, P3018, DOI 10.1016/j.nucengdes.2008.02.013; Hurt RH, 2005, P COMBUST INST, V30, P2161, DOI 10.1016/j.proci.2004.08.131; IAEA, 2006, TECDOC1521 IAEA; Klotz IM., 2000, CHEM THERMODYN, V4th; Konno, 2014, ADV MAT SCI ENG CARB, P387; Lewis J., 1970, MODERN ASPECTS GRAPH; Li C, 2001, CARBON, V39, P725, DOI 10.1016/S0008-6223(00)00189-5; Liu J, 2015, NUCL INSTRUM METH B, V352, P160, DOI 10.1016/j.nimb.2014.12.071; Luo XW, 2006, NUCL ENG DES, V236, P938, DOI 10.1016/j.nucengdes.2005.09.011; Luo XW, 2004, NUCL ENG DES, V227, P273, DOI 10.1016/j.nucengdes.2003.11.004; Marsden BJ, 2012, COMPREHENSIVE NUCLEAR MATERIALS, VOL 4: RADIATION EFFECTS IN STRUCTURAL AND FUNCTIONAL MATERIALS FOR FISSION AND FUSION REACTORS, P325; MARSH H, 1973, CARBON, V11, P421, DOI 10.1016/0008-6223(73)90085-7; MOORMANN R, 1984, J NUCL SCI TECHNOL, V21, P824, DOI 10.1080/18811248.1984.9731121; Mostafavi M, 2012, MAT SCI ENG A-STRUCT, V558, P265, DOI 10.1016/j.msea.2012.08.001; MOULIJN JA, 1995, CARBON, V33, P1155, DOI 10.1016/0008-6223(95)00070-T; Nagle J., 1962, P 5 CARB C, V1; Nightingale R. E., 1962, NUCL GRAPHITE, P1; Nuclear Decommissioning Authority, 2014, HIGH ACT WAST STRAT; Nuclear Decommissioning Authority, 2014, NDASTSTY140010; Nuclear Decommissioning Authority, 2012, 16495644 NDA; Nuclear Decommissioning Authority, 2016, NDA HIGH ACT WAST ST; OBrien M.H., 1988, EGGFSP8255; Payne L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143041; Pick ME, 2010, TECDOC1647 PICKME IA, P1; Shaddix CR, 2013, COMBUST FLAME, V160, P1827, DOI 10.1016/j.combustflame.2013.03.019; TAKAHASHI M, 1994, J NUCL SCI TECHNOL, V31, P1275, DOI 10.3327/jnst.31.1275; Takeda T, 2004, NUCL ENG DES, V233, P197, DOI 10.1016/j.nucengdes.2004.08.009; Tognotti L., 1990, P COMBUST INST, P1207; VASTOLA FJ, 1964, CARBON, V2, P65, DOI 10.1016/0008-6223(64)90029-6; Walker Jr PJ, 1959, ADV CATALYSIS, V11; WHEELER A, 1951, ADV CATAL, V3, P249, DOI 10.1016/S0360-0564(08)60109-1; Xiaowei Luo, 2008, Frontiers of Energy and Power Engineering in China, V2, P471, DOI 10.1007/s11708-008-0074-6; Yu XL, 2008, NUCL ENG DES, V238, P2230, DOI 10.1016/j.nucengdes.2008.02.022; Zeng TF, 1996, COMBUST FLAME, V107, P197, DOI 10.1016/S0010-2180(96)00071-5	54	12	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182860	10.1371/journal.pone.0182860	http://dx.doi.org/10.1371/journal.pone.0182860			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28793326	Green Submitted, Green Published, gold			2022-12-26	WOS:000407196700074
J	Moroso, A; Ruet, A; Lamargue-Hamel, D; Munsch, F; Deloire, M; Coupe, P; Charre-Morin, J; Saubusse, A; Ouallet, JC; Planche, V; Tourdias, T; Dousset, V; Brochet, B				Moroso, Amandine; Ruet, Aurelie; Lamargue-Hamel, Delphine; Munsch, Fanny; Deloire, Mathilde; Coupe, Pierrick; Charre-Morin, Julie; Saubusse, Aurore; Ouallet, Jean-Christophe; Planche, Vincent; Tourdias, Thomas; Dousset, Vincent; Brochet, Bruno			Microstructural analyses of the posterior cerebellar lobules in relapsing-onset multiple sclerosis and their implication in cognitive impairment	PLOS ONE			English	Article							INFORMATION-PROCESSING SPEED; APPEARING WHITE-MATTER; GRAY-MATTER; CLINICAL DISABILITY; IMAGE REGISTRATION; DIFFUSION CHANGES; WORKING-MEMORY; REMITTING MS; DYSFUNCTION; BRAIN	Background The posterior cerebellar lobules seem to be the anatomical substrate of cognitive cerebellar processes, but their microstructural alterations in multiple sclerosis (MS) remain unclear. Objectives To correlate diffusion metrics in lobules VI to VIIIb in persons with clinically isolated syndrome (PwCIS) and in cognitively impaired persons with MS (CIPwMS) with their cognitive performances. Methods Sixty-nine patients (37 PwCIS, 32 CIPwMS) and 36 matched healthy subjects (HS) underwent 3T magnetic resonance imaging, including 3D T1-weighted and diffusion tensor imaging (DTI). Fractional anisotropy (FA) and mean diffusivity (MD) were calculated within each lobule and in the cerebellar peduncles. We investigated the correlations between cognitive outcomes and the diffusion parameters of cerebellar sub-structures and performed multiple linear regression analysis to predict cognitive disability. Results FA was generally lower and MD was higher in the cerebellum and specifically in the vermis Crus II, lobules VIIb and VIIIb in CIPwMS compared with PwCIS and HS. In hierarchical regression analyses, 31% of the working memory z score variance was explained by FA in the left lobule VI and in the left superior peduncle. Working memory was also associated with MD in the vermis Crus II. FA in the left lobule VI and right VIIIa predicted part of the information processing speed (IPS) z scores. Conclusion DTI indicators of cerebellar microstructural damage were associated with cognitive deficits in MS. Our results suggested that cerebellar lobular alterations have an impact on attention, working memory and IPS.	[Moroso, Amandine; Ruet, Aurelie; Lamargue-Hamel, Delphine; Munsch, Fanny; Coupe, Pierrick; Planche, Vincent; Tourdias, Thomas; Dousset, Vincent; Brochet, Bruno] Univ Bordeaux, Bordeaux, France; [Moroso, Amandine; Ruet, Aurelie; Deloire, Mathilde; Charre-Morin, Julie; Saubusse, Aurore; Ouallet, Jean-Christophe; Tourdias, Thomas; Dousset, Vincent; Brochet, Bruno] CHU Bordeaux, INSERM CHU CICP 0005 & Serv Neurol & Neuroradiol, Bordeaux, France; [Moroso, Amandine; Ruet, Aurelie; Lamargue-Hamel, Delphine; Munsch, Fanny; Planche, Vincent; Tourdias, Thomas; Dousset, Vincent; Brochet, Bruno] INSERM, Neuroctr Magendie, U1215, Bordeaux, France; [Coupe, Pierrick] PICTURA, LaBRI, UMR 5800, Talence, France	UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Brochet, B (corresponding author), Univ Bordeaux, Bordeaux, France.; Brochet, B (corresponding author), CHU Bordeaux, INSERM CHU CICP 0005 & Serv Neurol & Neuroradiol, Bordeaux, France.; Brochet, B (corresponding author), INSERM, Neuroctr Magendie, U1215, Bordeaux, France.	bruno.brochet@chu-bordeaux.fr	Tourdias, Thomas/K-1209-2019	Tourdias, Thomas/0000-0002-7151-6325; Planche, Vincent/0000-0003-3713-227X; Coupe, Pierrick/0000-0003-2709-3350; Lamargue, Delphine/0000-0001-8415-889X	French Agence Nationale de la Recherche [ANR-10-LABX-57]; MERCK SANTE FRANCE; TEVA FRANCE; Fondation pour la Recherche Medicale [DEA20140630564]	French Agence Nationale de la Recherche(French National Research Agency (ANR)); MERCK SANTE FRANCE(Merck & Company); TEVA FRANCE(Teva Pharmaceutical Industries); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	REACTIV and SCICOG programs are supported by public grants from the French Agence Nationale de la Recherche within the context of the Investments for the Future program referenced ANR-10-LABX-57 named TRAIL (project IBIO-NI). REACTIV was also supported by a grant from MERCK SANTE FRANCE, and SCICOG by a grant from TEVA FRANCE. A. Moroso received a research grant from the Fondation pour la Recherche Medicale (DEA20140630564). The funders has no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G, 1997, SCIENCE, V275, P1940, DOI 10.1126/science.275.5308.1940; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Audoin B, 2007, NEUROIMAGE, V36, P1324, DOI 10.1016/j.neuroimage.2007.04.038; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Bonnet MC, 2010, NEUROLOGY, V75, P1241, DOI 10.1212/WNL.0b013e3181f612e3; Bozzali M, 2013, MULT SCLER J, V19, P1161, DOI 10.1177/1352458512474088; Cappellani R, 2014, J NEUROL SCI, V338, P128, DOI 10.1016/j.jns.2013.12.031; Caramia F, 2002, MAGN RESON IMAGING, V20, P383, DOI 10.1016/S0730-725X(02)00519-2; Cavallari M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101199; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Ciccarelli O, 2001, NEUROLOGY, V56, P926, DOI 10.1212/WNL.56.7.926; Clausi S, 2009, NEUROSCIENCE, V162, P827, DOI 10.1016/j.neuroscience.2009.02.001; Deloire MSA, 2005, J NEUROL NEUROSUR PS, V76, P519, DOI 10.1136/jnnp.2004.045872; Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045; Diedrichsen J, 2006, NEUROIMAGE, V33, P127, DOI 10.1016/j.neuroimage.2006.05.056; Dineen RA, 2009, BRAIN, V132, P239, DOI 10.1093/brain/awn275; Gallo A, 2005, ARCH NEUROL-CHICAGO, V62, P803, DOI 10.1001/archneur.62.5.803; Hannoun S, 2012, AM J NEURORADIOL, V33, P1363, DOI 10.3174/ajnr.A2983; Hayter AL, 2007, NEUROIMAGE, V36, P943, DOI 10.1016/j.neuroimage.2007.03.011; Hulst HE, 2013, NEUROLOGY, V80, P1025, DOI 10.1212/WNL.0b013e31828726cc; Jonkman LE, 2016, MULT SCLER; Keren-Happuch E, 2014, HUM BRAIN MAPP, V35, P593, DOI 10.1002/hbm.22194; Kolbe SC, 2014, HUM BRAIN MAPP, V35, P2310, DOI 10.1002/hbm.22329; Kutzelnigg A, 2007, BRAIN PATHOL, V17, P38, DOI 10.1111/j.1750-3639.2006.00041.x; Lamargue-Hamel D, 2015, J NEUROL SCI, V359, P94, DOI 10.1016/j.jns.2015.10.039; Li W, 2010, AM J NEURORADIOL, V31, P1861, DOI 10.3174/ajnr.A2195; Manjon JV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073021; Manjon JV, 2010, J MAGN RESON IMAGING, V31, P192, DOI 10.1002/jmri.22003; Mesaros S, 2012, NEUROLOGY, V78, P969, DOI 10.1212/WNL.0b013e31824d5859; Middleton FA, 2001, J NEUROSCI, V21, P700, DOI 10.1523/JNEUROSCI.21-02-00700.2001; Morgen K, 2006, NEUROIMAGE, V30, P891, DOI 10.1016/j.neuroimage.2005.10.032; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Moroso A, 2017, J NEUROL NEUROSUR PS, V88, P146, DOI 10.1136/jnnp-2016-313867; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Preziosa P, 2014, RADIOLOGY, V271, P822, DOI 10.1148/radiol.13132142; Roca M, 2008, MULT SCLER, V14, P364, DOI 10.1177/1352458507084270; Rocca MA, 2015, LANCET NEUROL, V14, P302, DOI 10.1016/S1474-4422(14)70250-9; Rovaris M, 2005, NEUROLOGY, V65, P1526, DOI 10.1212/01.wnl.0000184471.83948.e0; Ruet A, 2014, J NEUROL SCI, V347, P246, DOI 10.1016/j.jns.2014.10.008; Ruet A, 2013, NEUROLOGY, V80, P1501, DOI 10.1212/WNL.0b013e31828cf82f; Sbardella E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063250; Schmahmann JD, 2006, BRAIN, V129, P290, DOI 10.1093/brain/awh729; Schmahmann JD, 1998, TRENDS COGN SCI, V2, P362, DOI 10.1016/S1364-6613(98)01218-2; Schmahmann JD, 1997, J NEUROSCI, V17, P438, DOI 10.1523/JNEUROSCI.17-01-00438.1997; Schmahmann JD, 1996, HUM BRAIN MAPP, V4, P174, DOI 10.1002/(SICI)1097-0193(1996)4:3<174::AID-HBM3>3.0.CO;2-0; Schmierer K, 2007, NEUROIMAGE, V35, P467, DOI 10.1016/j.neuroimage.2006.12.010; Steckova T, 2014, J NEUROL SCI, V342, P62; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; Tovar-Moll F, 2009, AM J NEURORADIOL, V30, P1380, DOI 10.3174/ajnr.A1564; Valentino P, 2009, MULT SCLER J, V15, P854, DOI 10.1177/1352458509104589; van de Pavert SHP, 2016, J NEUROL NEUROSUR PS, V87, P461, DOI 10.1136/jnnp-2014-310142; Weier K, 2016, MULT SCLER J, V22, P599, DOI 10.1177/1352458515595132; Weier K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086916; Yu HJ, 2012, NEUROIMAGE, V59, P3713, DOI 10.1016/j.neuroimage.2011.10.053	55	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2017	12	8							e0182479	10.1371/journal.pone.0182479	http://dx.doi.org/10.1371/journal.pone.0182479			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9EU	28792528	Green Published, Green Submitted, gold			2022-12-26	WOS:000407144700021
J	Rao, VTS; Khan, D; Cui, QL; Fuh, SC; Hossain, S; Almazan, G; Multhaup, G; Healy, LM; Kennedy, TE; Antel, JP				Rao, Vijayaraghava T. S.; Khan, Damla; Cui, Qiao-Ling; Fuh, Shih-Chieh; Hossain, Shireen; Almazan, Guillermina; Multhaup, Gerhard; Healy, Luke M.; Kennedy, Timothy E.; Antel, Jack P.			Distinct age and differentiation-state dependent metabolic profiles of oligodendrocytes under optimal and stress conditions	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; WHITE-MATTER; HUMAN-BRAIN; RAT-BRAIN; PRECURSOR; INJURY; MATURATION; PATHWAYS; CULTURES; LESIONS	Within the microenvironment of multiple sclerosis lesions, oligodendrocytes are subject to metabolic stress reflecting effects of focal ischemia and inflammation. Previous studies have shown that under optimal conditions in vitro, the respiratory activity of human adult brain-derived oligodendrocytes is lower and more predominantly glycolytic compared to oligodendrocytes differentiated in vitro from post natal rat brain oligodendrocyte progenitor cells. In response to sub-lethal metabolic stress, adult human oligodendrocytes reduce overall energy production rate impacting the capacity to maintain myelination. Here, we directly compare the metabolic profiles of oligodendrocytes derived from adult rat brain with oligodendrocytes newly differentiated in vitro from oligodendrocyte progenitor cells obtained from the post natal rat brain, under both optimal culture and metabolic stress (low/no glucose) conditions. Oxygen consumption and extracellular acidification rates were measured using a Seahorse extracellular flux analyzer. Our findings indicate that under optimal conditions, adult rat oligodendrocytes preferentially use glycolysis whereas newly differentiated post natal rat oligodendrocytes, and the oligodendrocyte progenitor cells from which they are derived, mainly utilize oxidative phosphorylation to produce ATP. Metabolic stress increases the rate of ATP production via oxidative phosphorylation and significantly reduces glycolysis in adult oligodendrocytes. The rate of ATP production was relatively unchanged in newly differentiated post natal oligodendrocytes under these stress conditions, while it was significantly reduced in oligodendrocyte progenitor cells. Our study indicates that both age and maturation influence the metabolic profile under optimal and stressed conditions, emphasizing the need to consider these variables for in vitro studies that aim to model adult human disease.	[Rao, Vijayaraghava T. S.; Khan, Damla; Cui, Qiao-Ling; Fuh, Shih-Chieh; Healy, Luke M.; Kennedy, Timothy E.; Antel, Jack P.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Hossain, Shireen; Almazan, Guillermina; Multhaup, Gerhard] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada	McGill University; McGill University	Rao, VTS (corresponding author), McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ, Canada.	vijayaraghava.rao@mail.mcgill.ca	Healy, Luke/Y-5604-2019	Healy, Luke/0000-0001-9496-2216; antel, jack/0000-0002-5148-0636	Multiple Sclerosis Society of Canada	Multiple Sclerosis Society of Canada	This work was supported by the Multiple Sclerosis Society of Canada. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMAZAN G, 1993, J NEUROSCI RES, V36, P163, DOI 10.1002/jnr.490360206; Amaral AI, 2016, GLIA, V64, P21, DOI 10.1002/glia.22900; Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; Cui QL, 2013, AM J PATHOL, V183, P516, DOI 10.1016/j.ajpath.2013.04.016; Cui QL, 2017, ANN NEUROLOGY; Divakaruni Ajit S, 2014, Curr Protoc Toxicol, V60, DOI 10.1002/0471140856.tx2502s60; Franklin RJM, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020594; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Giedd JN, 1999, PROG NEURO-PSYCHOPH, V23, P571; Harris JJ, 2012, J NEUROSCI, V32, P356, DOI 10.1523/JNEUROSCI.3430-11.2012; HOVDA DA, 1992, J CEREBR BLOOD F MET, V12, P1039, DOI 10.1038/jcbfm.1992.141; Jacobs B, 2001, CEREB CORTEX, V11, P558, DOI 10.1093/cercor/11.6.558; Keuper M, 2014, FASEB J, V28, P761, DOI 10.1096/fj.13-238725; Khorchid A, 2002, NEUROPHARMACOLOGY, V42, P685, DOI 10.1016/S0028-3908(02)00013-8; Lassmann H, 2003, J NEUROL SCI, V206, P187, DOI 10.1016/S0022-510X(02)00421-5; Morland C, 2007, NEUROCHEM INT, V50, P703, DOI 10.1016/j.neuint.2007.01.003; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Rao VTS, 2016, SCI REP-UK, V6, DOI 10.1038/srep30020; RODRIGUEZ M, 1994, ULTRASTRUCT PATHOL, V18, P3, DOI 10.3109/01913129409016267; RODRIGUEZ M, 1993, MAYO CLIN PROC, V68, P627, DOI 10.1016/S0025-6196(12)60597-7; Rone MB, 2016, J NEUROSCI, V36, P4698, DOI 10.1523/JNEUROSCI.4077-15.2016; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; Salazar-Roa M, 2017, TRENDS CELL BIOL, V27, P69, DOI 10.1016/j.tcb.2016.08.009; Sanchez-Abarca LI, 2001, GLIA, V36, P321, DOI 10.1002/glia.1119; Shyh-Chang N, 2013, DEVELOPMENT, V140, P2535, DOI 10.1242/dev.091777; Veiga S, 2011, NEUROSCI LETT, V503, P10, DOI 10.1016/j.neulet.2011.07.053; Yeung MSY, 2014, CELL, V159, P766, DOI 10.1016/j.cell.2014.10.011; Zhang J, 2012, CELL STEM CELL, V11, P589, DOI 10.1016/j.stem.2012.10.005	30	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2017	12	8							e0182372	10.1371/journal.pone.0182372	http://dx.doi.org/10.1371/journal.pone.0182372			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9EU	28792512	gold, Green Published, Green Submitted			2022-12-26	WOS:000407144700016
J	Giacopuzzi, E; Gennarelli, M; Minelli, A; Gardella, R; Valsecchi, P; Traversa, M; Bonvicini, C; Vita, A; Sacchetti, E; Magri, C				Giacopuzzi, Edoardo; Gennarelli, Massimo; Minelli, Alessandra; Gardella, Rita; Valsecchi, Paolo; Traversa, Michele; Bonvicini, Cristian; Vita, Antonio; Sacchetti, Emilio; Magri, Chiara			Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways	PLOS ONE			English	Article							CHLORIDE CHANNEL; GENE; ASSOCIATION; POPULATIONS; NEURONS; PROTEIN; RUNS	Inbreeding is a known risk factor for recessive Mendelian diseases and previous studies have suggested that it could also play a role in complex disorders, such as psychiatric diseases. Recent inbreeding results in the presence of long runs of homozygosity (ROHs) along the genome, which are also defined as autozygosity regions. Genetic variants in these regions have two alleles that are identical by descent, thus increasing the odds of bearing rare recessive deleterious mutations due to a homozygous state. A recent study showed a suggestive enrichment of long ROHs in schizophrenic patients, suggesting that recent inbreeding could play a role in the disease. To better understand the impact of autozygosity on schizophrenia risk, we selected, from a cohort of 180 Italian patients, seven subjects with extremely high numbers of large ROHs that were likely due to recent inbreeding and characterized the mutational landscape within their ROHs using Whole Exome Sequencing and, gene set enrichment analysis. We identified a significant overlap (17%; empirical p-value = 0.0171) between genes inside ROHs affected by low frequency functional homozygous variants (107 genes) and the group of most promising candidate genes mutated in schizophrenia. Moreover, in four patients, we identified novel and extremely rare damaging mutations in the genes involved in neurodevelopment (MEGF8) and in GABA/glutamatergic synaptic transmission (GAD1, FMN1, ANO2). These results provide insights into the contribution of rare recessive mutations and inbreeding as risk factors for schizophrenia. ROHs that are likely due to recent inbreeding harbor a combination of predisposing low-frequency variants and extremely rare variants that have a high impact on pivotal biological pathways implicated in the disease. In addition, this study confirms that focusing on patients with high levels of homozygosity could be a useful prioritization strategy for discovering new high-impact mutations in genetically complex disorders.	[Giacopuzzi, Edoardo; Gennarelli, Massimo; Minelli, Alessandra; Gardella, Rita; Traversa, Michele; Magri, Chiara] Univ Brescia, Dept Mol & Translat Med, Brescia, Italy; [Gennarelli, Massimo; Bonvicini, Cristian] IRCCS, Ctr S Giovanni Dio Fatebenefratelli, Genet Unit, Brescia, Italy; [Valsecchi, Paolo; Vita, Antonio; Sacchetti, Emilio] Univ Brescia, Neurosci Sect, Dept Clin & Expt Sci, Brescia, Italy; [Valsecchi, Paolo; Vita, Antonio; Sacchetti, Emilio] Spedali Civili Hosp, Dept Mental Hlth, Brescia, Italy	University of Brescia; IRCCS Fatebenefratelli; University of Brescia; Hospital Spedali Civili Brescia	Magri, C (corresponding author), Univ Brescia, Dept Mol & Translat Med, Brescia, Italy.	chiara.magri@unibs.it	Vita, Antonio/K-4345-2018; Minelli, Alessandra/ABI-2890-2020; Gennarelli, Massimo/AAL-3542-2020; Bonvicini, Cristian/G-4427-2011; MAGRI, Chiara/I-4691-2017	Minelli, Alessandra/0000-0002-9463-7808; Bonvicini, Cristian/0000-0003-1577-2823; Vita, Antonio/0000-0002-3621-6394; MAGRI, Chiara/0000-0001-9933-8666; Giacopuzzi, Edoardo/0000-0002-5692-366X; GENNARELLI, Massimo/0000-0003-4192-945X	Brain and Behavior Research Foundation NARSAD [20751]; Health Authority of the regional administration of Lombardy [153]; Fondazione Cariplo and Regione Lombardia [20142256]	Brain and Behavior Research Foundation NARSAD(NARSAD); Health Authority of the regional administration of Lombardy; Fondazione Cariplo and Regione Lombardia(Regione Lombardia)	This study was supported by the Brain and Behavior Research Foundation NARSAD grant 20751 to Dr. Chiara Magri, by the Health Authority of the regional administration of Lombardy (Project 153) to Prof. Emilio Sacchetti, English editing costs were covered by Grant "New Opportunities and Ways towards ERC" (NOW ERC, Project: 20142256) from Fondazione Cariplo and Regione Lombardia.	Bersani G, 2003, ACTA NEUROPSYCHIATR, V15, P304, DOI 10.1034/j.1601-5215.2003.00046.x; Bittles AH, 2001, HLTH AND ETHNICITY; Cappi C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110198; Chahrour MH, 2012, PLOS GENET, V8, P236, DOI 10.1371/journal.pgen.1002635; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Cox DM, 2015, CLIN DYSMORPHOL, V24, P89, DOI 10.1097/MCD.0000000000000077; Du J, 2008, J NEURAL TRANSM, V115, P513, DOI 10.1007/s00702-007-0844-z; Engelhard C, 2013, ELIFE, V2, DOI 10.7554/eLife.01160; Fujihara K, 2015, NEUROPSYCHOPHARMACOL, V40, P2475, DOI 10.1038/npp.2015.117; Gandin I, 2014, GENET MED; Gao R, 2015, CURR MOL MED, V15, P146, DOI 10.2174/1566524015666150303003028; Gilissen C, 2012, EUR J HUM GENET, V20, P490, DOI 10.1038/ejhg.2011.258; Huang HS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000809; Huang WC, 2012, NEURON, V74, P179, DOI 10.1016/j.neuron.2012.01.033; Johnson EC, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006343; Lee PH, 2012, BIOINFORMATICS, V28, P1797, DOI 10.1093/bioinformatics/bts191; Magri C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013422; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Mitchell AC, 2014, SCHIZOPHR RES; Pemberton TJ, 2012, AM J HUM GENET, V91, P275, DOI 10.1016/j.ajhg.2012.06.014; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Rees E, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.99; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ruderfer DM, 2014, EUR J HUM GENET; Simon-Areces J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021825; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; Straub RE, 2007, MOL PSYCHIATR, V12, P854, DOI 10.1038/sj.mp.4001988; Szpiech ZA, 2013, AM J HUM GENET, V93, P90, DOI 10.1016/j.ajhg.2013.05.003; Twigg SRF, 2012, AM J HUM GENET, V91, P897, DOI 10.1016/j.ajhg.2012.08.027; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Zhao X, 2007, SCHIZOPHR RES, V93, P374, DOI 10.1016/j.schres.2007.02.023	33	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182778	10.1371/journal.pone.0182778	http://dx.doi.org/10.1371/journal.pone.0182778			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28787007	Green Submitted, Green Published, gold			2022-12-26	WOS:000406998800064
J	Pan, JQ; Chen, HM; Guo, BL; Liu, C				Pan, Junqian; Chen, Haimei; Guo, Baolin; Liu, Chang			Understanding the molecular mechanisms underlying the effects of light intensity on flavonoid production by RNA-seq analysis in Epimedium pseudowushanense BLGuo	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; GENE-EXPRESSION; LIGUSTRUM-VULGARE; BIOSYNTHESIS; ACCUMULATION; ARABIDOPSIS; ANTHOCYANIN; TEMPERATURE; IDENTIFICATION; PHYTOCHROME	Epimedium pseudowushanense B.L.Guo, a light-demanding shade herb, is used in traditional medicine to increase libido and strengthen muscles and bones. The recognition of the health benefits of Epimedium has increased its market demand. However, its resource recycling rate is low and environmentally dependent. Furthermore, its natural sources are endangered, further increasing prices. Commercial culture can address resource constraints of it. Understanding the effects of environmental factors on the production of its active components would improve the technology for cultivation and germplasm conservation. Here, we studied the effects of light intensities on the flavonoid production and revealed the molecular mechanism using RNA-seq analysis. Plants were exposed to five levels of light intensity through the periods of germination to flowering, the flavonoid contents were measured using HPLC. Quantification of epimedin A, epimedin B, epimedin C, and icariin showed that the flavonoid contents varied with different light intensity levels. And the largest amount of epimedin C was produced at light intensity level 4 (I4). Next, the leaves under the treatment of three light intensity levels ("L", "M" and "H") with the largest differences in the flavonoid content, were subjected to RNA-seq analysis. Transcriptome reconstruction identified 43,657 unigenes. All unigene sequences were annotated by searching against the Nr, Gene Ontology, and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases. In total, 4008, 5260, and 3591 significant differentially expressed genes (DEGs) were identified between the groups L vs. M, M vs. H and L vs. H. Particularly, twenty-one full-length genes involved in flavonoid biosynthesis were identified. The expression levels of the flavonol synthase, chalcone synthase genes were strongly associated with light-induced flavonoid abundance with the highest expression levels found in the H group. Furthermore, 65 transcription factors, including 31 FAR1, 17 MYB-related, 12 bHLH, and 5 WRKY, were differentially expressed after light induction. Finally, a model was proposed to explain the light-induced flavonoid production. This study provided valuable information to improve cultivation practices and produced the first comprehensive resource for E. pseudowushanense transcriptomes.	[Pan, Junqian; Guo, Baolin] Minist Educ, Key Lab Bioact Subst & Resources Utilizat Chinese, Beijing, Peoples R China; [Pan, Junqian; Chen, Haimei; Guo, Baolin; Liu, Chang] Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plant Dev, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Peking Union Medical College	Guo, BL (corresponding author), Minist Educ, Key Lab Bioact Subst & Resources Utilizat Chinese, Beijing, Peoples R China.; Guo, BL; Liu, C (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plant Dev, Beijing, Peoples R China.	blguo@implad.ac.cn; cliu6688@yahoo.com	Liu, Chang/A-1148-2014		National Natural Science Foundation of China [81473302]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (Grant No. 81473302 to BLG). TongJiTang (GuiZhou) Pharmaceutical Co. LTD provided material support in the form of plant materials for this study. TongJiTang (GuiZhou) Pharmaceutical Co. LTD had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agati G, 2013, PLANT PHYSIOL BIOCH, V72, P35, DOI 10.1016/j.plaphy.2013.03.014; Agati G, 2011, J PLANT PHYSIOL, V168, P204, DOI 10.1016/j.jplph.2010.07.016; Agati G, 2009, ANN BOT-LONDON, V104, P853, DOI 10.1093/aob/mcp177; Azuma A, 2012, PLANTA, V236, P1067, DOI 10.1007/s00425-012-1650-x; Bellin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-555; Czemmel S, 2009, PLANT PHYSIOL, V151, P1513, DOI 10.1104/pp.109.142059; Deng B, 2012, J AGR FOOD CHEM, V60, P6286, DOI 10.1021/jf301525s; Downey MO, 2004, AUST J GRAPE WINE R, V10, P55, DOI 10.1111/j.1755-0238.2004.tb00008.x; Feldbrugge M, 1997, PLANT J, V11, P1079, DOI 10.1046/j.1365-313X.1997.11051079.x; Ferreres F, 2011, J EXP BOT, V62, P2841, DOI 10.1093/jxb/erq458; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hardtke CS, 2000, EMBO J, V19, P4997, DOI 10.1093/emboj/19.18.4997; Hartmann U, 2005, PLANT MOL BIOL, V57, P155, DOI 10.1007/s11103-004-6910-0; Huang WJ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00689; Huang WJ, 2013, INT J MOL SCI, V14, P594, DOI 10.3390/ijms14010594; Hudson ME, 2003, PLANT J, V34, P453, DOI 10.1046/j.1365-313X.2003.01741.x; Kalra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083336; Kang SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028706; Kim B, 2014, BIOCHEMISTRY-US, V53, P7562, DOI 10.1021/bi5011927; Lau OS, 2012, TRENDS PLANT SCI, V17, P584, DOI 10.1016/j.tplants.2012.05.004; Lee J, 2007, PLANT CELL, V19, P731, DOI 10.1105/tpc.106.047688; LEYVA A, 1995, PLANT PHYSIOL, V108, P39, DOI 10.1104/pp.108.1.39; Li JG, 2010, PLANT CELL, V22, P3634, DOI 10.1105/tpc.110.075788; Lin CC, 2004, CLIN EXP PHARMACOL P, V31, P65, DOI 10.1111/j.1440-1681.2004.03951.x; Lin RC, 2007, SCIENCE, V318, P1302, DOI 10.1126/science.1146281; Liu LL, 2015, PLANT CELL ENVIRON, V38, P905, DOI 10.1111/pce.12349; Maier A, 2013, PLANT J, V74, P638, DOI 10.1111/tpj.12153; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Mehrtens F, 2005, PLANT PHYSIOL, V138, P1083, DOI 10.1104/pp.104.058032; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Neugart S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00326; Pacheco F. V., 2014, Australian Journal of Crop Science, V8, P1510; Pan JQ, 2016, MOLECULES, V21, DOI 10.3390/molecules21111475; Qiu DY, 2007, MOL PLANT MICROBE IN, V20, P492, DOI 10.1094/MPMI-20-5-0492; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shin DH, 2013, FEBS LETT, V587, P1543, DOI 10.1016/j.febslet.2013.03.037; Stearn WT, 2002, GENUS EPIMEDIUM OTHE; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Stracke R, 2010, PLANT CELL ENVIRON, V33, P88, DOI 10.1111/j.1365-3040.2009.02061.x; Tattini M, 2004, NEW PHYTOL, V163, P547, DOI 10.1111/j.1469-8137.2004.01126.x; Matus JT, 2009, J EXP BOT, V60, P853, DOI 10.1093/jxb/ern336; Wang H, 2015, TRENDS PLANT SCI, V20, P453, DOI 10.1016/j.tplants.2015.04.003; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yang CQ, 2012, J INTEGR PLANT BIOL, V54, P703, DOI 10.1111/j.1744-7909.2012.01161.x; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zeng SH, 2013, PLANT CELL TISS ORG, V115, P355, DOI 10.1007/s11240-013-0367-2; Zeng SH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-94; Zoratti L, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00534	51	11	12	17	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182348	10.1371/journal.pone.0182348	http://dx.doi.org/10.1371/journal.pone.0182348			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28786984	gold, Green Published, Green Submitted			2022-12-26	WOS:000406998800029
J	Zhu, J; Liang, RZ; Sun, C; Xie, LZ; Wang, J; Leng, DY; Wu, DM; Liu, WH				Zhu, Jie; Liang, Ruizhen; Sun, Chao; Xie, Lizhe; Wang, Juan; Leng, Diya; Wu, Daming; Liu, Weihong			Effects of nanosilver and nanozinc incorporated mesoporous calcium-silicate nanoparticles on the mechanical properties of dentin	PLOS ONE			English	Article							HUMAN ROOT DENTIN; BIOACTIVE GLASSES; IN-VITRO; ANTIBACTERIAL PROPERTIES; ENTEROCOCCUS-FAECALIS; HYDROXIDE APPLICATION; SODIUM-HYPOCHLORITE; DISINFECTION; MEDICATION; STRENGTH	Mesoporous calcium-silicate nanoparticles (MCSNs) are advanced biomaterials for drug delivery and mineralization induction. They can load silver and exhibit significantly antibacterial effects. However, the effects of MCSNs and silver-loaded MCSNs on dentin are unknown. The silver (Ag) and/or zinc (Zn) incorporated MCSNs (Ag-Zn-MCSNs) were prepared by a template method, and their characterizations were tested. Then the nanoparticles were filled into root canals and their effects on the dentin were investigated. Ag-Zn-MCSNs showed characteristics of mesoporous materials and sustained release of ions over time. Ag-Zn-MCSNs adhered well to the root canal walls and infiltrated into the dentinal tubules after ultrasound activation. Ag-Zn-MCSNs showed no significantly negative effects on either the flexural strength or the modulus of elasticity of dentin, while CH decreased the flexural strength of dentin significantly (P<0.05). These findings suggested that Ag and Zn can be incorporated into MCSNs using a template method, and the Ag-Zn-MCSNs may be developed into a new disinfectant for the root canal and dentinal tubules.	[Zhu, Jie; Liang, Ruizhen; Sun, Chao; Xie, Lizhe; Wang, Juan; Leng, Diya; Wu, Daming; Liu, Weihong] Nanjing Med Univ, Jiangsu Key Lab Oral Dis, Nanjing, Jiangsu, Peoples R China; [Zhu, Jie; Liang, Ruizhen; Wang, Juan; Leng, Diya; Wu, Daming; Liu, Weihong] Nanjing Med Univ, Affiliated Hosp Stomatol, Dept Endodont, Nanjing, Jiangsu, Peoples R China; [Sun, Chao; Wu, Daming] Nanjing Med Univ, Affiliated Hosp Stomatol, Dept Radiol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Wu, DM; Liu, WH (corresponding author), Nanjing Med Univ, Jiangsu Key Lab Oral Dis, Nanjing, Jiangsu, Peoples R China.; Wu, DM; Liu, WH (corresponding author), Nanjing Med Univ, Affiliated Hosp Stomatol, Dept Endodont, Nanjing, Jiangsu, Peoples R China.; Wu, DM (corresponding author), Nanjing Med Univ, Affiliated Hosp Stomatol, Dept Radiol, Nanjing, Jiangsu, Peoples R China.	wdaming@njmu.edu.cn; liuweihong@aliyun.com			Natural Science Foundation of Jiangsu Province [BK20151560]	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	Funding for this study was provided by the Natural Science Foundation of Jiangsu Province (grant BK20151560).	Banerjee J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119531; Batur YB, 2013, DENT TRAUMATOL, V29, P461, DOI 10.1111/edt.12037; Cerovic A, 2007, BIOL TRACE ELEM RES, V116, P61, DOI 10.1007/BF02685919; Dwivedi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111289; Fan W, 2015, DENT MATER J, V34, P54, DOI 10.4012/dmj.2014-104; Fan W, 2014, INT J NANOMED, V9, P5217, DOI 10.2147/IJN.S73144; Grigoratos D, 2001, INT ENDOD J, V34, P113, DOI 10.1046/j.1365-2591.2001.00356.x; Guven Y, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2863817; HAAPASALO M, 1987, J DENT RES, V66, P1375, DOI 10.1177/00220345870660081801; Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004; Jia HS, 2008, DENT MATER, V24, P244, DOI 10.1016/j.dental.2007.04.015; Kandaswamy D, 2010, INT ENDOD J, V43, P419, DOI 10.1111/j.1365-2591.2010.01696.x; Kim SK, 2002, INT ENDOD J, V35, P623, DOI 10.1046/j.1365-2591.2002.00539.x; Kishen A., 2010, ENDODONTIC TOPICS, V22, P99, DOI [10.1111/j.1601-1546.2012.00284.x, DOI 10.1111/J.1601-1546.2012.00284.X]; Kishen A, 2008, J ENDODONT, V34, P1515, DOI 10.1016/j.joen.2008.08.035; Lepparanta O, 2008, J MATER SCI-MATER M, V19, P547, DOI 10.1007/s10856-007-3018-5; Liu N, 2013, MATER LETT, V112, P105, DOI 10.1016/j.matlet.2013.08.099; Love RM, 2001, INT ENDOD J, V34, P399, DOI 10.1046/j.1365-2591.2001.00437.x; Manzoor U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154704; Marending M, 2009, DENT TRAUMATOL, V25, P126, DOI 10.1111/j.1600-9657.2008.00735.x; Mohammadi Z, 2011, INT ENDOD J, V44, P697, DOI 10.1111/j.1365-2591.2011.01886.x; Portenier I, 2001, INT ENDOD J, V34, P184, DOI 10.1046/j.1365-2591.2001.00366.x; Sahebi Safoora, 2012, Iran Endod J, V7, P68; Sahebi S, 2010, DENT TRAUMATOL, V26, P43, DOI 10.1111/j.1600-9657.2009.00834.x; Santos AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028088; Siqueira JF, 1999, INT ENDOD J, V32, P361, DOI 10.1046/j.1365-2591.1999.00275.x; Slutzky-Goldberg I, 2013, J ENDODONT, V39, P980, DOI 10.1016/j.joen.2013.04.040; TORABINEJAD M, 1995, J ENDODONT, V21, P349, DOI 10.1016/S0099-2399(06)80967-2; White JD, 2002, J ENDODONT, V28, P828, DOI 10.1097/00004770-200212000-00008; Wu CT, 2008, J BIOMED MATER RES B, V87B, P346, DOI 10.1002/jbm.b.31109; Wu CT, 2012, J MATER CHEM, V22, P16801, DOI 10.1039/c2jm33387b; Wu CT, 2012, INTERFACE FOCUS, V2, P292, DOI 10.1098/rsfs.2011.0121; Zarei M, 2013, DENT TRAUMATOL, V29, P156, DOI 10.1111/j.1600-9657.2012.01158.x; Zehnder M, 2004, J ENDODONT, V30, P220, DOI 10.1097/00004770-200404000-00009	34	15	16	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182583	10.1371/journal.pone.0182583	http://dx.doi.org/10.1371/journal.pone.0182583			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28787004	Green Published, gold, Green Submitted			2022-12-26	WOS:000406998800046
J	Kazumata, K; Tha, KK; Uchino, H; Ito, M; Nakayama, N; Abumiya, T				Kazumata, Ken; Tha, Khin Khin; Uchino, Haruto; Ito, Masaki; Nakayama, Naoki; Abumiya, Takeo			Mapping altered brain connectivity and its clinical associations in adult moyamoya disease: A resting-state functional MRI study	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; NETWORK; FMRI; IMPAIRMENT; STROKE; PERFORMANCE; MODE; BOLD; TIME; FLOW	Detection of subtle ischemic injuries in moyamoya disease may enable optimization of timing of revascularization surgery, and could potentially improve functional outcomes. Resting-state functional magnetic resonance imaging (rs-fMRI) is widely used to study functional organization of the brain, but it remains unclear whether rs-fMRI could elucidate distinct characteristics in moyamoya disease. Here, we aimed to determine changes in a conventional rs-fMRI measure and analyze any associations with clinical symptoms and cerebral hemodynamics. Thirty-one adults with moyamoya disease and 25 adult controls underwent rs-fMRI, in which we measured brain connectivity via temporal correlations of low-frequency BOLD signals. We identified the extent of between-group differences with multivoxel pattern analysis. Seed-based analysis was performed to determine associations with vascular lesions, symptoms, and regional cerebral blood flow (rCBF). There was significantly altered connectivity in the precentral gyrus, operculo-insular region, precuneus, cingulate cortex, and middle frontal gyrus in moyamoya disease. There was reduced connectivity in the left insula, left precuneus, right precentral, and right middle frontal regions, which form part of the salience, default mode, motor, and central executive networks, respectively. Patients with ischemic motor-related symptoms showed significantly decreased connectivity in precentral homotopic regions compared with those without, while there were no differences in vascular lesions or rCBF. Connectivity between the right occipital and left hippocampus was significantly associated with cognitive performance and posterior cerebral artery involvement. Our results demonstrate distinct alterations in the temporal correlations of low-frequency BOLD signals, predominantly in resting-state networks in moyamoya disease. Additionally, rs-fMRI measures were associated with ischemic motor-related symptoms and cognitive performance in the patients. Thus, rs-fMRI may offer a useful non-invasive method of acquiring additional information beyond cerebral perfusion as part of clinical investigations in patients with moyamoya disease.	[Kazumata, Ken; Uchino, Haruto; Ito, Masaki; Nakayama, Naoki; Abumiya, Takeo] Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Kita Ku, Sapporo, Hokkaido, Japan; [Tha, Khin Khin] Hokkaido Univ, Grad Sch Med, Dept Radiat Med, Kita Ku, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Kazumata, K (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Kita Ku, Sapporo, Hokkaido, Japan.	kazumata@med.hokudai.ac.jp	Tha, Khin/AAN-7345-2020; NAKAYAMA, NAOKI/A-4249-2012; Tha, Khin Khin/A-4762-2012; Uchino, Haruto/L-6627-2019	NAKAYAMA, NAOKI/0000-0003-2696-2462; Tha, Khin Khin/0000-0002-9072-4509; Uchino, Haruto/0000-0001-6567-8136; Kazumata, Ken/0000-0001-7409-9515	Research Committee on moyamoya disease - Ministry of Health, Labor, and Welfare of Japan; Global Institution for Collaborative Research and Education, Hokkaido University	Research Committee on moyamoya disease - Ministry of Health, Labor, and Welfare of Japan; Global Institution for Collaborative Research and Education, Hokkaido University	This work was supported by the Research Committee on moyamoya disease, sponsored by the Ministry of Health, Labor, and Welfare of Japan (http://www.nanbyou.or.jp and the Global Institution for Collaborative Research and Education, Hokkaido University (https://www.global.hokudai.ac.jp/research-and-education/discover-our-research-institutes-and-centers/global-institution-for-collaborative-research-and-education-gi-core/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a grant from the Research Committee on moyamoya disease, sponsored by the Ministry of Health, Labor, and Welfare of Japan. This work was also supported by the Global Institution for Collaborative Research and Education, Hokkaido University.	Amemiya S, 2014, RADIOLOGY, V270, P548, DOI 10.1148/radiol.13130982; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Beaty RE BM, 2015, DEFAULT EXECUTIVE NE; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Biswal BB, 2012, NEUROIMAGE, V62, P938, DOI 10.1016/j.neuroimage.2012.01.090; Calhoun VD, 2001, HUM BRAIN MAPP, V13, P43, DOI 10.1002/hbm.1024; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; Christen T, 2015, J MAGN RESON IMAGING, V41, P424, DOI 10.1002/jmri.24558; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Diciotti S, 2017, J NEUROL SCI, V373, P1, DOI 10.1016/j.jns.2016.12.003; Donahue M. J., 2015, J CEREB BLOOD FLOW M; Fang LL, 2016, J NEUROSURG, V125, P299, DOI 10.3171/2015.7.JNS142666; Festa JR, 2010, J NEUROL, V257, P806, DOI 10.1007/s00415-009-5424-8; Fox SA MD, 2005, P NATL ACAD SCI USA, V5, P9673; Funaki T, 2013, J NEUROSURG-PEDIATR, V12, P626, DOI 10.3171/2013.9.PEDS13111; Fushimi Y, 2006, RADIOLOGY, V239, P232, DOI 10.1148/radiol.2383042020; Fushimi Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148925; Garcia-Garcia I, 2013, HUM BRAIN MAPP, V34, P2786, DOI 10.1002/hbm.22104; Glascher J, 2009, NEURON, V61, P681, DOI 10.1016/j.neuron.2009.01.026; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Karzmark P, 2012, NEUROSURGERY, V70, P634, DOI 10.1227/NEU.0b013e3182320d1a; Kazumata K, 2016, J NEUROSURG, P1; Kazumata K, 2015, STROKE, V46, P354, DOI 10.1161/STROKEAHA.114.007407; Kuroda S, 2008, LANCET NEUROL, V7, P1056, DOI 10.1016/S1474-4422(08)70240-0; Lei Y, 2016, J NEUROSURG, DOI 10.1111/jdi.12603; Lei Y, 2014, BRAIN RES, V1546, P27, DOI 10.1016/j.brainres.2013.12.022; Liang X, 2013, P NATL ACAD SCI USA, V110, P1929, DOI 10.1073/pnas.1214900110; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Mohammadi B, 2012, HUM BRAIN MAPP, V33, P840, DOI 10.1002/hbm.21250; Rosenberg MD, 2016, NAT NEUROSCI, V19, P165, DOI 10.1038/nn.4179; Siegel JS, 2016, P NATL ACAD SCI USA, V113, pE4367, DOI 10.1073/pnas.1521083113; Smith SM, 2015, NAT NEUROSCI, V18, P1565, DOI 10.1038/nn.4125; Tavor I, 2016, SCIENCE, V352, P216, DOI 10.1126/science.aad8127; Thiel A, 2015, STROKE, V46, P296, DOI 10.1161/STROKEAHA.114.006307; Tong Y., 2016, J CEREB BLOOD FLOW M; Tong YJ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00313; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Yun TJ, 2013, INVEST RADIOL, V48, P795, DOI 10.1097/RLI.0b013e3182981137; Zhao ZY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166210	44	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0182759	10.1371/journal.pone.0182759	http://dx.doi.org/10.1371/journal.pone.0182759			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28783763	Green Submitted, Green Published, gold			2022-12-26	WOS:000406944300052
J	Dyari, HRE; Rawling, T; Chen, YJ; Sudarmana, W; Bourget, K; Dwyer, JM; Allison, SE; Murray, M				Dyari, Herryawan Ryadi Eziwar; Rawling, Tristan; Chen, Yongjuan; Sudarmana, William; Bourget, Kirsi; Dwyer, Julie M.; Allison, Sarah E.; Murray, Michael			A novel synthetic analogue of omega-3 17,18-epoxyeicosatetraenoic acid activates TNF receptor-1/ASK1/JNK signaling to promote apoptosis in human breast cancer cells	FASEB JOURNAL			English	Article						epoxyfatty acids; apoptotic signaling; death receptor	POLYUNSATURATED FATTY-ACIDS; PROTEIN-KINASE; EPOXYEICOSATRIENOIC ACIDS; LIPID RAFTS; INHIBITION; NECROSIS; ANGIOGENESIS; N-3; PROLIFERATION; RECRUITMENT	A saturated analog of the cytochrome P450-mediated omega-3-17,18-epoxide of omega-3-eicosapentaenoic acid (C20E) activated apoptosis in human triple-negative MDA-MB-231 breast cancer cells. This study evaluated the apoptotic mechanism of C20E. Increased cytosolic cytochrome c expression and altered expression of pro- and antiapoptotic B-cell lymphoma-2 proteins indicated activation of the mitochondrial pathway. Caspase-3 activation by C20E was prevented by pharmacological inhibition and silencing of the JNK and p38 MAP kinases (MAPK), upstream MAPK kinases MKK4 and MKK7, and the upstream MAPK kinase kinase apoptosis signal-regulating kinase 1 (ASK1). Silencing of the death receptorTNF receptor 1 (TNFR1), but not Fas, DR4, orDR5, and the adapters TRADD and TNF receptor-associated factor 2, but not Fas-associated death domain, prevented C20E-mediated apoptosis. B-cell lymphoma-2 homology 3-interacting domain death agonist (Bid) cleavage by JNK/p38 MAPK linked the extrinsic and mitochondrial pathways of apoptosis. In further studies, an antibody against the extracellular domain of TNFR1 prevented apoptosis by TNF-alpha but not C20E. These findings suggest that C20E acts intracellularly at TNFR1 to activate ASK1-MKK4/7-JNK/p38 MAPK signaling and to promote Bid-dependent mitochondrial disruption and apoptosis. In in vivo studies, tumors isolated from C20E-treated nu/nu mice carrying MDA-MB-231 xenografts showed increased TUNEL staining and decreased Ki67 staining, reflecting increased apoptosis and decreased proliferation, respectively. omega-3-Epoxy fatty acids like C20E could be incorporated into treatments for triple-negative breast cancers.	[Dyari, Herryawan Ryadi Eziwar; Chen, Yongjuan; Sudarmana, William; Bourget, Kirsi; Dwyer, Julie M.; Allison, Sarah E.; Murray, Michael] Univ Sydney, Sydney Med Sch, Sch Med Sci, Discipline Pharmacol, Sydney, NSW 2006, Australia; [Dyari, Herryawan Ryadi Eziwar] Univ Kebangsaan Malaysia, Sch Biosci & Biotechnol, Fac Sci & Technol, Bangi, Malaysia; [Rawling, Tristan] Univ Technol Sydney, Sch Math & Phys Sci, Fac Sci, Ultimo, NSW, Australia	University of Sydney; Universiti Kebangsaan Malaysia; University of Technology Sydney	Murray, M (corresponding author), Univ Sydney, Sydney Med Sch, Sch Med Sci, Discipline Pharmacol, Sydney, NSW 2006, Australia.	michael.murray@sydney.edu.au	Dyari, Herryawan Ryadi Eziwar/M-6776-2015	Rawling, Tristan/0000-0002-6624-6586; Eziwar Dyari, Herryawan Ryadi/0000-0002-4327-1180	Australian National Health and Medical Research Council [570933, 1031686]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the Australian National Health and Medical Research Council (570933 and 1031686). Supply of the dominant-negative mutant plasmids of p38 MAPK, JNK, MKK3, MKK6, and MKK7 by Dr. R. J. Davis (Howard Hughes Medical Institute, University of Massachusetts Medical School, Worcester, MA, USA) through Addgene (Cambridge, MA, USA) is gratefully acknowledged. The authors declare no conflicts of interest.	Altenburg JD, 2009, MOL CANCER RES, V7, P1013, DOI 10.1158/1541-7786.MCR-08-0385; Brenner D, 2009, CURR OPIN CELL BIOL, V21, P871, DOI 10.1016/j.ceb.2009.09.004; Chajes V, 2012, CANCER EPIDEM BIOMAR, V21, P319, DOI 10.1158/1055-9965.EPI-11-0896; Chang SH, 2004, P NATL ACAD SCI USA, V101, P591, DOI 10.1073/pnas.2535911100; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chen JK, 2001, MOL CELL BIOL, V21, P6322, DOI 10.1128/MCB.21.18.6322-6331.2001; Chen JK, 1998, J BIOL CHEM, V273, P29254, DOI 10.1074/jbc.273.44.29254; Cui PH, 2011, BRIT J PHARMACOL, V162, P1143, DOI 10.1111/j.1476-5381.2010.01113.x; Dulin NO, 1998, P NATL ACAD SCI USA, V95, P8098, DOI 10.1073/pnas.95.14.8098; Dyari HRE, 2014, J MED CHEM, V57, P7459, DOI 10.1021/jm501083y; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Greene ER, 2011, PROSTAG OTH LIPID M, V96, P27, DOI 10.1016/j.prostaglandins.2011.08.004; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Harper N, 2003, J BIOL CHEM, V278, P25534, DOI 10.1074/jbc.M303399200; Jiang JG, 2005, CANCER RES, V65, P4707, DOI 10.1158/0008-5472.CAN-04-4173; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Legler DF, 2003, IMMUNITY, V18, P655, DOI 10.1016/S1074-7613(03)00092-X; Liu YM, 2013, MOL PHARMACOL, V84, P925, DOI 10.1124/mol.113.088302; Los M, 2002, MOL BIOL CELL, V13, P978, DOI 10.1091/mbc.01-05-0272; MADHUN ZT, 1991, J CLIN INVEST, V88, P456, DOI 10.1172/JCI115325; Maillard V, 2002, INT J CANCER, V98, P78, DOI 10.1002/ijc.10130; McIlwain DR, 2015, CSH PERSPECT BIOL, V7; MURRAY M, 1991, ARCH BIOCHEM BIOPHYS, V286, P618, DOI 10.1016/0003-9861(91)90089-2; Nebot N, 2010, BRIT J PHARMACOL, V161, P1059, DOI 10.1111/j.1476-5381.2010.00946.x; Nishitoh H, 1998, MOL CELL, V2, P389, DOI 10.1016/S1097-2765(00)80283-X; Noguchi T, 2005, J BIOL CHEM, V280, P37033, DOI 10.1074/jbc.M506771200; Potente M, 2002, J BIOL CHEM, V277, P15671, DOI 10.1074/jbc.M110806200; Quilley J, 1997, BIOCHEM PHARMACOL, V54, P1059, DOI 10.1016/S0006-2952(97)00039-7; RIBEIRO CMP, 1994, AM J PHYSIOL, V266, pF497, DOI 10.1152/ajprenal.1994.266.3.F497; Rompe F, 2010, HYPERTENSION, V55, P924, DOI 10.1161/HYPERTENSIONAHA.109.147843; Rose DP, 2000, NUTR CANCER, V37, P119, DOI 10.1207/S15327914NC372_1; Schley PD, 2007, J NUTR, V137, P548, DOI 10.1093/jn/137.3.548; Shaikh SR, 2012, J NUTR BIOCHEM, V23, P101, DOI 10.1016/j.jnutbio.2011.07.001; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Spector AA, 2009, J LIPID RES, V50, pS52, DOI 10.1194/jlr.R800038-JLR200; Szymczak M, 2008, BLOOD, V111, P3514, DOI 10.1182/blood-2007-08-109934; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Whitmarsh AJ, 2007, ONCOGENE, V26, P3172, DOI 10.1038/sj.onc.1210410; Yang SL, 2007, AM J PHYSIOL-HEART C, V293, pH142, DOI 10.1152/ajpheart.00783.2006; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang GD, 2013, P NATL ACAD SCI USA, V110, P6530, DOI 10.1073/pnas.1304321110	42	23	23	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5246	+		10.1096/fj.201700033R	http://dx.doi.org/10.1096/fj.201700033R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28798154				2022-12-26	WOS:000416588300011
J	Miotti, S; Gulino, A; Ferri, R; Parenza, M; Chronowska, A; Lecis, D; Sangaletti, S; Tagliabue, E; Tripodo, C; Colombo, MP				Miotti, Silvia; Gulino, Alessandro; Ferri, Renata; Parenza, Mariella; Chronowska, Agnieszka; Lecis, Daniele; Sangaletti, Sabina; Tagliabue, Elda; Tripodo, Claudio; Colombo, Mario P.			Antibody-mediated blockade of JMJD6 interaction with collagen I exerts antifibrotic and antimetastatic activities	FASEB JOURNAL			English	Article						JmjC family; extracellular matrix; monoclonal antibody; in vivo treatment; peptide library	CONTAINING PROTEIN 6; PHOSPHATIDYLSERINE RECEPTOR; APOPTOTIC CELLS; BINDING-SITE; METASTASIS; FIBROSIS; SPARC; HYDROXYLATION; LOCALIZATION; FIBRONECTIN	JMJD6 is known to localize in the nucleus, exerting histone arginine demethylase and lysyl hydroxylase activities. A novel localization of JMJD6 in the extracellular matrix, resulting from its secretion as a soluble protein, was unveiled by a new anti-JMJD6 mAb called P4E11, which was developed to identify new targets in the stroma. Recombinant JMJD6 binds with collagen type I (Coll-I), and distinct JMJD6 peptides interfere with collagen fibrillogenesis, collagen-fibronectin interaction, and adhesion of human tumor cells to the collagen substrate. P4E11 and collagen binding to JMJD6 are mutually exclusive because the amino acid sequences of JMJD6 necessary for the interaction with Coll-I are part of the conformational epitope recognized by P4E11. In mice injected with mouse 4T1 breast carcinoma cells, treatment with P4E11 reduced fibrosis at the primary tumor and prevented lung metastases. Reduction of fibrosis has also been documented in human breast and ovarian tumors (MDA-MB-231 and IGROV1, respectively) xenotransplanted into immunodeficient mice treated with P4E11. In summary, this study uncovers a new localization and function for JMJD6 that is most likely independent from its canonical enzymatic activities, and demonstrates that JMJD6 can functionally interact with Coll-I. P4E11 mAb, inhibiting JMJD6/Coll-I interaction, represents a new opportunity to target fibrotic and tumor diseases.	[Miotti, Silvia; Ferri, Renata; Parenza, Mariella; Chronowska, Agnieszka; Lecis, Daniele; Sangaletti, Sabina; Colombo, Mario P.] Ist Nazl Tumori, Fdn Ist Ricovero & Cura Carattere Sci IRCCS, Dept Expt Oncol & Mol Med, Mol Immunol Unit, Milan, Italy; [Tagliabue, Elda] Ist Nazl Tumori, Fdn Ist Ricovero & Cura Carattere Sci IRCCS, Dept Expt Oncol & Mol Med, Mol Targeting Unit, Milan, Italy; [Gulino, Alessandro; Tripodo, Claudio] Univ Palermo, Dept Hlth Sci, Tumor Immunol Unit, Palermo, Italy; [Chronowska, Agnieszka] Univ Calif San Diego, La Jolla, CA 92093 USA	Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Palermo; University of California System; University of California San Diego	Colombo, MP (corresponding author), Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Mol Immunol Unit, Via Amadeo 42 St, I-20133 Milan, Italy.	mariopaolo.colombo@istitutotumori.mi.it	Sangaletti, Sabina/AAB-5873-2019; Lecis, Daniele/C-2113-2017; Tripodo, Claudio/AAB-6004-2022; Tagliabue, Elda/B-9377-2017; Colombo, Mario P./V-7166-2017	Sangaletti, Sabina/0000-0001-7047-287X; Lecis, Daniele/0000-0002-0564-0563; Tripodo, Claudio/0000-0002-0821-6231; Tagliabue, Elda/0000-0001-9877-2903; Colombo, Mario P./0000-0003-0042-7955	Associazione Italiana per la Ricerca sul Cancro [IG 10137]	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	The authors thank C. Melani (Fondazione IRCCS Istituto Nazionale dei Tumori) for initial characterization of P4E11 mAb; A. Andolfo and D. Drago (Protein Microsequencing Facility, San Raffaele Scientific Institute) for P4E11 epitope mapping; and I. Facetti (Fondazione IRCCS Istituto Nazionale dei Tumori) for technical support. The authors also thank the Associazione Italiana per la Ricerca sul Cancro for financial support (Grant IG 10137 to M.P.C.). The authors declare no conflicts of interest.	Bergamaschi A, 2008, J PATHOL, V214, P357, DOI 10.1002/path.2278; Bottger A, 2015, BIOCHEM J, V468, P191, DOI 10.1042/BJ20150278; Bose Jens, 2004, J Biol, V3, P15, DOI 10.1186/jbiol10; Bradshaw AD, 2009, J CELL COMMUN SIGNAL, V3, P239, DOI 10.1007/s12079-009-0062-6; Cellot S, 2013, BLOOD, V122, P1545, DOI 10.1182/blood-2013-04-496281; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Cikala M, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-26; Cox TR, 2014, CLIN CANCER RES, V20, P3637, DOI 10.1158/1078-0432.CCR-13-1059; Cox TR, 2013, CANCER RES, V73, P1721, DOI 10.1158/0008-5472.CAN-12-2233; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; Cui P, 2004, EXP CELL RES, V293, P154, DOI 10.1016/j.yexcr.2003.09.023; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Gao WW, 2015, P NATL ACAD SCI USA, V112, pE3327, DOI 10.1073/pnas.1509658112; Giridharan SSP, 2013, MOL BIOL CELL, V24, P1776, DOI 10.1091/mbc.E13-01-0026; Hankins HM, 2015, MOL BIOL CELL, V26, P4674, DOI 10.1091/mbc.E15-07-0487; Hehnly H, 2012, CURR BIOL, V22, P1944, DOI 10.1016/j.cub.2012.08.022; Heim A, 2014, NUCLEIC ACIDS RES, V42, P7833, DOI 10.1093/nar/gku488; Hong X, 2010, P NATL ACAD SCI USA, V107, P14568, DOI 10.1073/pnas.1008832107; Hu YJ, 2015, NUCLEIC ACIDS RES, V43, P7790, DOI 10.1093/nar/gkv645; Hullin-Matsuda F, 2014, SEMIN CELL DEV BIOL, V31, P48, DOI 10.1016/j.semcdb.2014.04.010; Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008; KLEINMAN HK, 1978, J BIOL CHEM, V253, P5642; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kottakis F, 2014, CANCER RES, V74, P3935, DOI 10.1158/0008-5472.CAN-13-2733; Lee YF, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3200; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Loenarz C, 2011, TRENDS BIOCHEM SCI, V36, P7, DOI 10.1016/j.tibs.2010.07.002; Mantri M, 2011, CHEMBIOCHEM, V12, P531, DOI 10.1002/cbic.201000641; Markolovic S, 2015, J BIOL CHEM, V290, P20712, DOI 10.1074/jbc.R115.662627; Miotti S, 2005, AM J PATHOL, V167, P1411, DOI 10.1016/S0002-9440(10)61228-X; Mouw JK, 2014, NAT REV MOL CELL BIO, V15, P771, DOI 10.1038/nrm3902; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Poulard C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126181; Poulard C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087982; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Rogasevskaia TP, 2015, J BIOL CHEM, V290, P28683, DOI 10.1074/jbc.M115.681429; RUOSLAHTI E, 1979, J BIOL CHEM, V254, P6054; Sangaletti S, 2003, J EXP MED, V198, P1475, DOI 10.1084/jem.20030202; Sangaletti S, 2008, CANCER RES, V68, P9050, DOI 10.1158/0008-5472.CAN-08-1327; Sangaletti S, 2014, CANCER RES, V74, P4706, DOI 10.1158/0008-5472.CAN-13-3334; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Unoki M, 2013, J BIOL CHEM, V288, P6053, DOI 10.1074/jbc.M112.433284; Wang F, 2014, CHIN J POPUL RESOUR, V12, P6, DOI 10.1080/10042857.2014.886802; Webby CJ, 2009, SCIENCE, V325, P90, DOI 10.1126/science.1175865; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yang HW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6717; Zemskov EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019414; Zhang J, 2013, TUMOR BIOL, V34, P2397, DOI 10.1007/s13277-013-0789-9	50	7	7	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5356	5370		10.1096/fj.201700377R	http://dx.doi.org/10.1096/fj.201700377R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28790175				2022-12-26	WOS:000416588300020
J	Xie, N; Khabbazi, S; Nassar, ZD; Gregory, K; Vithanage, T; Anand-Apte, B; Cabot, PJ; Sturgess, D; Shaw, PN; Parat, MO				Xie, Nan; Khabbazi, Samira; Nassar, Zeyad D.; Gregory, Kye; Vithanage, Tharindu; Anand-Apte, Bela; Cabot, Peter J.; Sturgess, David; Shaw, Paul N.; Parat, Marie-Odile			Morphine alters the circulating proteolytic profile in mice: functional consequences on cellular migration and invasion	FASEB JOURNAL			English	Article						MMP-9; TIMPs; endothelial cells; 4T1 cell line; opioids	LYMPHATIC ENDOTHELIAL-CELLS; NITRIC-OXIDE; OPIOID RECEPTOR; NODE METASTASIS; TUMOR-GROWTH; P38 MAPK; KAPPA-B; MATRIX-METALLOPROTEINASE-9; CANCER; MACROPHAGES	Opioids modulate the tumor microenvironment with potential functional consequences for tumor growth and metastasis. We evaluated the effects of morphine administration on the circulating proteolytic profile of tumor-freemice. Serum from morphine-treated (1 or 10mg/kg, i.p. every 12 h) or saline-treated mice was collected at different time points and tested ex vivo in endothelial, lymphatic endothelial, and breast cancer cell migration assays. Serum from mice that were treated with 10mg/kg morphine for 3 d displayed reduced chemotactic potential for endothelial and breast cancer cells, and elicited reduced cancer cell invasion through reconstituted basement membrane compared with serum from saline controls. This was associated with decreased circulating matrix metalloproteinase 9 (MMP-9) and increased circulating tissue inhibitor of metalloproteinase 1 (TIMP-1) and TIMP3/4 as assessed by zymography and reverse zymography. By using quantitative RT-PCR, we confirmed morphine induced alterations in MMP-9 and TIMP expression and identified organs, including the liver and spleen, in which these changes originated. Pharmacologic inhibition of MMP-9 abrogated the difference in chemotactic attraction between serum from saline-treated and morphine-treated mice, which indicated that reduced proteolytic ability mediated the decreased migration toward serum from morphine-treated mice. This novel mechanism may enable morphine administration to promote an environment that is less conducive to tumor growth, invasion, and metastasis.-Xie, N., Khabbazi, S., Nassar, Z. D., Gregory, K., Vithanage, T., Anand-Apte, B., Cabot, P. J., Sturgess, D., Shaw, P. N., Parat, M.-O. Morphine alters the circulating proteolytic profile inmice: functional consequences on cellular migration and invasion.	[Xie, Nan; Khabbazi, Samira; Nassar, Zeyad D.; Cabot, Peter J.; Shaw, Paul N.; Parat, Marie-Odile] Univ Queensland, Sch Pharm, St Lucia, Qld, Australia; [Gregory, Kye; Vithanage, Tharindu; Sturgess, David] Univ Queensland, Mater Res Inst MRI UQ, St Lucia, Qld, Australia; [Anand-Apte, Bela] Case Western Reserve Univ, Cleveland Clin, Dept Ophthalmol, Cole Eye Inst,Lerner Coll Med, Cleveland, OH 44106 USA; [Parat, Marie-Odile] Outcome Res Consortium, Cleveland, OH USA; [Nassar, Zeyad D.] Univ Adelaide, South Australian Hlth & Med Res Inst, North Terrace, Adelaide, SA 5000, Australia	University of Queensland; Mater Research; University of Queensland; Case Western Reserve University; Cleveland Clinic Foundation; South Australian Health & Medical Research Institute (SAHMRI); University of Adelaide	Parat, MO (corresponding author), Univ Queensland, 20 Cornwall St, Brisbane, Qld 4072, Australia.	m.parat@uq.edu.au	Sturgess, David/G-2965-2011; Parat, Marie-Odile/G-4410-2010; Shaw, Paul/Q-8454-2019; Shaw, Paul N/G-4418-2010; Cabot, Peter John/B-2424-2013; Nassar, Zeyad/B-1621-2012	Sturgess, David/0000-0002-4364-0038; Parat, Marie-Odile/0000-0003-4895-7381; Shaw, Paul/0000-0001-7154-592X; Shaw, Paul N/0000-0001-7154-592X; Cabot, Peter John/0000-0003-1778-3753; Nassar, Zeyad/0000-0002-7779-2697; Khabbazi, Samira/0000-0002-5410-795X	Pfizer - Anaesthesia and Pain Medicine Foundation, Australian and New Zealand College of Anaesthetists [14/020]; U.S. National Institutes of Health, National Eye Institute [EY027083, EY026181, P30EY025585]; Research to Prevent Blindness Challenge Grant; Foundation Fighting Blindness Center Grant; NATIONAL EYE INSTITUTE [P30EY025585, R01EY027083, R01EY026181] Funding Source: NIH RePORTER	Pfizer - Anaesthesia and Pain Medicine Foundation, Australian and New Zealand College of Anaesthetists; U.S. National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness Challenge Grant(Research to Prevent Blindness (RPB)); Foundation Fighting Blindness Center Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported, in part, by Pfizer funds granted by the Anaesthesia and Pain Medicine Foundation, Australian and New Zealand College of Anaesthetists (Project Grant 14/020). The sponsor had no involvement in study design, in collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. B.A.-A. is supported by U.S. National Institutes of Health, National Eye Institute Grants EY027083, EY026181, P30EY025585; a Research to Prevent Blindness Challenge Grant; and a Foundation Fighting Blindness Center Grant. The authors declare no conflicts of interest.	Afsharimani B, 2015, BRIT J PHARMACOL, V172, P251, DOI 10.1111/bph.12589; Afsharimani B, 2014, CLIN EXP METASTAS, V31, P149, DOI 10.1007/s10585-013-9616-3; Afsharimani B, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00046; Borner C, 2012, MOL PHARMACOL, V81, P587, DOI 10.1124/mol.111.076620; Cao MH, 2013, BEHAV BRAIN RES, V237, P249, DOI 10.1016/j.bbr.2012.09.040; Duraffourd C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110230; Eberhardt W, 2000, KIDNEY INT, V57, P59, DOI 10.1046/j.1523-1755.2000.00808.x; Gach K, 2011, MOL BIOL REP, V38, P1231, DOI 10.1007/s11033-010-0222-z; Harimaya Y, 2002, CANCER LETT, V187, P121, DOI 10.1016/S0304-3835(02)00360-9; Hosaka K, 2016, P NATL ACAD SCI USA, V113, pE5618, DOI 10.1073/pnas.1608384113; Khabbazi S., 2016, MRS 2016 16 WORLD U; Khabbazi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep31572; Khabbazi S, 2015, SCI REP-UK, V5, DOI 10.1038/srep11389; LEZA JC, 1995, EUR J PHARMACOL, V285, P95, DOI 10.1016/0014-2999(95)00474-Y; Liu C., 2017, ZEBRAFISH MODEL DISC, DOI [10.1158/1078-0432.CCR-17-0101, DOI 10.1158/1078-0432.CCR-17-0101]; Liu WT, 2010, J NEUROSCI, V30, P7613, DOI 10.1523/JNEUROSCI.1358-10.2010; Liu YC, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-19; Liu Y, 2017, ONCOTARGET, V8, P16988, DOI 10.18632/oncotarget.15217; Meschiari CA, 2013, MOL CELL BIOCHEM, V378, P127, DOI 10.1007/s11010-013-1602-1; Nakamoto K, 2012, EUR J PHARMACOL, V683, P86, DOI 10.1016/j.ejphar.2012.03.006; Nakamura ES, 2004, CANCER SCI, V95, P25, DOI 10.1111/j.1349-7006.2004.tb03166.x; Ninkovic J, 2012, AM J PATHOL, V180, P1068, DOI 10.1016/j.ajpath.2011.11.034; Plein LM, 2018, BRIT J PHARMACOL, V175, P2717, DOI 10.1111/bph.13750; Qiu SW, 2015, J IMMUNOL, V194, P1021, DOI 10.4049/jimmunol.1400106; Rebhun RB, 2006, NEOPLASIA, V8, P747, DOI 10.1593/neo.06322; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sinha I, 2006, ANN VASC SURG, V20, P92, DOI 10.1007/s10016-005-9429-1; Takeba Y, 2001, J RHEUMATOL, V28, P2176; Toda N, 2009, ANESTHESIOLOGY, V110, P166, DOI 10.1097/ALN.0b013e31819146a9; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; Wang JH, 2003, J BIOL CHEM, V278, P37622, DOI 10.1074/jbc.M301224200; Welters ID, 2007, EUR J ANAESTH, V24, P958, DOI 10.1017/S026502150700083X; Xie N, 2017, BRAIN BEHAV IMMUN, V61, P244, DOI 10.1016/j.bbi.2016.12.002; Yang YL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11385	34	13	13	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5208	+		10.1096/fj.201700546R	http://dx.doi.org/10.1096/fj.201700546R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28784632	Green Published			2022-12-26	WOS:000416588300008
J	Ambrosio, S; Sacca, CD; Amente, S; Paladino, S; Lania, L; Majello, B				Ambrosio, S.; Sacca, C. D.; Amente, S.; Paladino, S.; Lania, L.; Majello, B.			Lysine-specific demethylase LSD1 regulates autophagy in neuroblastoma through SESN2-dependent pathway	ONCOGENE			English	Article							EPIGENETIC REGULATION; MTOR; CANCER; TARGET; P53; INHIBITOR; SESTRIN2; EXPRESSION; STRESS; GENES	Autophagy is a physiological process, important for recycling of macromolecules and maintenance of cellular homeostasis. Defective autophagy is associated with tumorigenesis and has a causative role in chemotherapy resistance in leukemia and in solid cancers. Here, we report that autophagy is regulated by the lysine-specific demethylase LSD1/KDM1A, an epigenetic marker whose overexpression is a feature of malignant neoplasia with an instrumental role in cancer development. In the present study, we determine that two different LSD1 inhibitors (TCP and SP2509) as well as selective ablation of LSD1 expression promote autophagy in neuroblastoma cells. At a mechanistic level, we show that LSD1 binds to the promoter region of Sestrin2 (SESN2), a critical regulator of mTORC1 activity. Pharmacological inhibition of LSD1 triggers SESN2 expression that hampers mTORC1 activity, leading to enhanced autophagy. SESN2 overexpression suffices to promote autophagy in neuroblastoma cells, while loss of SESN2 expression reduces autophagy induced by LSD1 inhibition. Our findings elucidate a mechanism whereby LSD1 controls autophagy in neuroblastoma cells through SESN2 transcription regulation, and we suggest that pharmacological targeting of LSD1 may have effective therapeutic relevance in the control of autophagy in neuroblastoma.	[Ambrosio, S.; Sacca, C. D.; Majello, B.] Univ Naples Federico II, Div Genet, Dept Biol, Via Cinthia,Edificio 7, I-80126 Naples, Italy; [Amente, S.; Paladino, S.; Lania, L.] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Paladino, S.] Ceinge Biotecnol Avanzate Scarl, Naples, Italy	University of Naples Federico II; University of Naples Federico II; CEINGE Biotecnologie Avanzate	Majello, B (corresponding author), Univ Naples Federico II, Div Genet, Dept Biol, Via Cinthia,Edificio 7, I-80126 Naples, Italy.	majello@unina.it	Paladino, Simona/ABH-7826-2020; Amente, Stefano/AAU-7605-2020; Paladino, Simona/J-5383-2018	Amente, Stefano/0000-0003-0612-6096; Paladino, Simona/0000-0001-5332-6774; Sacca, Carmen Daniela/0000-0002-9861-9332; Majello, Barbara/0000-0003-2789-3585	AIRC [IG13173]; Epigenomics Flagship Project-EPIGEN; CNR; MOVIE of Rete delle Biotecnologie, Campania	AIRC(Fondazione AIRC per la ricerca sul cancro); Epigenomics Flagship Project-EPIGEN; CNR(Consiglio Nazionale delle Ricerche (CNR)); MOVIE of Rete delle Biotecnologie, Campania	We thank A Feliciello for helpful discussions, constructive criticisms, Dr M Capasso for help with the R2 package and Dr P Chumakov for providing us the SESN2-Flag expression vector. This work was supported by following grants: AIRC (IG13173 to BM), Epigenomics Flagship Project-EPIGEN, CNR and from Grant MOVIE of the Rete delle Biotecnologie, Campania.	Ambrosio S, 2017, ONCOTARGET, V8, P3854, DOI 10.18632/oncotarget.12924; Amente S, 2015, ONCOTARGET, V6, P14572, DOI 10.18632/oncotarget.3990; Amente S, 2013, BBA-GENE REGUL MECH, V1829, P981, DOI 10.1016/j.bbagrm.2013.05.002; Belounis A, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2906-9; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Cam M, 2014, J BIOL CHEM, V289, P4083, DOI 10.1074/jbc.M113.530303; Cimmino F, 2015, SCI REP-UK, V5, DOI 10.1038/srep11158; de Narvajas AAM, 2013, MOL CELL BIOL, V33, P3983, DOI 10.1128/MCB.00813-13; Eisenberg T, 2014, CELL METAB, V19, P431, DOI 10.1016/j.cmet.2014.02.010; Eisenberg-Lerner A, 2009, APOPTOSIS, V14, P376, DOI 10.1007/s10495-008-0307-5; Etani T, 2015, ONCOTARGET, V6, P2865, DOI 10.18632/oncotarget.3067; Feng SJ, 2016, MED SCI MONITOR, V22, P4742, DOI 10.12659/MSM.898825; Fiskus W, 2014, LEUKEMIA, V28, P2155, DOI 10.1038/leu.2014.119; Fullgrabe J, 2014, NAT REV MOL CELL BIO, V15, P65, DOI 10.1038/nrm3716; Gallagher LE, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5020024; Galluzzi L, 2015, EMBO J, V34, P856, DOI 10.15252/embj.201490784; Goldschneider D, 2006, NUCLEIC ACIDS RES, V34, P5603, DOI 10.1093/nar/gkl619; Han X, 2014, MOL CELL, V55, P482, DOI 10.1016/j.molcel.2014.06.006; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Jiang PD, 2014, CELL RES, V24, P69, DOI 10.1038/cr.2013.161; Kim H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10025; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Kontaki H, 2010, MOL CELL, V39, P152, DOI 10.1016/j.molcel.2010.06.006; Lan F, 2008, CURR OPIN CELL BIOL, V20, P316, DOI 10.1016/j.ceb.2008.03.004; Lapierre LR, 2015, AUTOPHAGY, V11, P867, DOI 10.1080/15548627.2015.1034410; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Maiese K, 2016, BRIT J CLIN PHARMACO, V82, P1245, DOI 10.1111/bcp.12804; Maiuri MC, 2009, CELL DEATH DIFFER, V16, P87, DOI 10.1038/cdd.2008.131; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maiuri MC, 2009, CELL CYCLE, V8, P1571, DOI 10.4161/cc.8.10.8498; Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Oberthuer A, 2006, J CLIN ONCOL, V24, P5070, DOI 10.1200/JCO.2006.06.1879; Parmigiani A, 2014, CELL REP, V9, P1281, DOI 10.1016/j.celrep.2014.10.019; Periz G, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002114; Rebecca VW, 2016, ONCOGENE, V35, P1, DOI 10.1038/onc.2015.99; Schulte JH, 2009, CANCER RES, V69, P2065, DOI 10.1158/0008-5472.CAN-08-1735; Sehgal AR, 2015, LEUKEMIA, V29, P517, DOI 10.1038/leu.2014.349; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Wang JX, 2015, NAT NEUROSCI, V18, P1256, DOI 10.1038/nn.4069; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Wei FZ, 2015, AUTOPHAGY, V11, P2309, DOI 10.1080/15548627.2015.1117734; White E, 2015, J CLIN INVEST, V125, P42, DOI 10.1172/JCI73941; Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674; Zapata PAM, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2388-9; Zhang F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6775; Zhang JB, 2015, AUTOPHAGY, V11, P629, DOI 10.1080/15548627.2015.1023981	51	47	49	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 30	2017	36	48					6701	6711		10.1038/onc.2017.267	http://dx.doi.org/10.1038/onc.2017.267			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FO4AJ	28783174	hybrid, Green Published			2022-12-26	WOS:000416780800005
J	Pence, N; Tokmina-Lukaszewska, M; Yang, ZY; Ledbetter, RN; Seefeldt, LC; Bothner, B; Peters, JW				Pence, Natasha; Tokmina-Lukaszewska, Monika; Yang, Zhi-Yong; Ledbetter, Rhesa N.; Seefeldt, Lance C.; Bothner, Brian; Peters, John W.			Unraveling the interactions of the physiological reductant flavodoxin with the different conformations of the Fe protein in the nitrogenase cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLYBDENUM-IRON PROTEIN; RATE-LIMITING STEP; AZOTOBACTER-VINELANDII; ELECTRON-TRANSFER; MOFE-PROTEIN; KLEBSIELLA-PNEUMONIAE; CATALYTIC CYCLE; 4FE-4S CLUSTER; MGATP; MECHANISM	Nitrogenase reduces dinitrogen (N-2) to ammonia in biological nitrogen fixation. The nitrogenase Fe protein cycle involves a transient association between the reduced, MgATP-bound Fe protein and the MoFe protein and includes electron transfer, ATP hydrolysis, release of Pi, and dissociation of the oxidized, MgADP-bound Fe protein from the MoFe protein. The cycle is completed by reduction of oxidized Fe protein and nucleotide exchange. Recently, a kinetic study of the nitrogenase Fe protein cycle involving the physiological reductant flavodoxin reported a major revision of the rate-limiting step from MoFe protein and Fe protein dissociation to release of Pi. Because the Fe protein cannot interact with flavodoxin and the MoFe protein simultaneously, knowledge of the interactions between flavodoxin and the different nucleotide states of the Fe protein is critically important for understanding the Fe protein cycle. Here we used time-resolved limited proteolysis and chemical cross-linking to examine nucleotide-induced structural changes in the Fe protein and their effects on interactions with flavodoxin. Differences in proteolytic cleavage patterns and chemical cross-linking patterns were consistent with known nucleotide-induced structural differences in the Fe protein and indicated that MgATP-bound Fe protein resembles the structure of the Fe protein in the stabilized nitrogenase complex structures. Docking models and cross-linking patterns between the Fe protein and flavodoxin revealed that the MgADP-bound state of the Fe protein has the most complementary docking interface with flavodoxin compared with the MgATP-bound state. Together, these findings provide new insights into the control mechanisms in protein-protein interactions during the Fe protein cycle.	[Pence, Natasha; Peters, John W.] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Pence, Natasha; Tokmina-Lukaszewska, Monika; Bothner, Brian; Peters, John W.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Yang, Zhi-Yong; Ledbetter, Rhesa N.; Seefeldt, Lance C.] Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA	Washington State University; Montana State University System; Montana State University Bozeman; Utah System of Higher Education; Utah State University	Peters, JW (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.; Peters, JW (corresponding author), Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA.	jw.peters@wsu.edu	Yang, Zhiyong/E-7834-2013	Yang, Zhiyong/0000-0001-8186-9450; Pence, Natasha/0000-0002-6096-4894	Biological Electron Transfer and Catalysis Energy Frontier Research Center - Department of Energy, Office of Science, Basic Energy Sciences under Award [SC0012518]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103474] Funding Source: NIH RePORTER	Biological Electron Transfer and Catalysis Energy Frontier Research Center - Department of Energy, Office of Science, Basic Energy Sciences under Award(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported as part of the Biological Electron Transfer and Catalysis Energy Frontier Research Center funded by the Department of Energy, Office of Science, Basic Energy Sciences under Award DE-SC0012518. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bothner B, 1998, J BIOL CHEM, V273, P673, DOI 10.1074/jbc.273.2.673; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; Bursey EH, 1998, J BIOL CHEM, V273, P16927, DOI 10.1074/jbc.273.27.16927; CHAN MK, 1993, SCIENCE, V260, P792, DOI 10.1126/science.8484118; Chiu HJ, 2001, BIOCHEMISTRY-US, V40, P641, DOI 10.1021/bi001645e; Christiansen J, 1998, BIOCHEMISTRY-US, V37, P12611, DOI 10.1021/bi981165b; Danyal K, 2011, BIOCHEMISTRY-US, V50, P9255, DOI 10.1021/bi201003a; Danyal K, 2010, J AM CHEM SOC, V132, P6894, DOI 10.1021/ja101737f; Duval S, 2013, P NATL ACAD SCI USA, V110, P16414, DOI 10.1073/pnas.1311218110; Duyvis MG, 1998, BIOCHEMISTRY-US, V37, P17345, DOI 10.1021/bi981509y; Einsle O, 2002, SCIENCE, V297, P1696, DOI 10.1126/science.1073877; HAGEMAN RV, 1978, P NATL ACAD SCI USA, V75, P2699, DOI 10.1073/pnas.75.6.2699; HAGEMAN RV, 1980, BIOCHEMISTRY-US, V19, P2333, DOI 10.1021/bi00552a009; Hilmer JK, 2008, J MOL BIOL, V375, P581, DOI 10.1016/j.jmb.2007.10.044; Hoffman BM, 2014, CHEM REV, V114, P4041, DOI 10.1021/cr400641x; Jang SB, 2000, BIOCHEMISTRY-US, V39, P14745, DOI 10.1021/bi001705g; KIM JS, 1992, SCIENCE, V257, P1677, DOI 10.1126/science.1529354; Lancaster KM, 2011, SCIENCE, V334, P974, DOI 10.1126/science.1206445; LANZILOTTA WN, 1995, BIOCHEMISTRY-US, V34, P15646, DOI 10.1021/bi00048a007; Lanzilotta WN, 1999, BBA-PROTEIN STRUCT M, V1429, P411, DOI 10.1016/S0167-4838(98)00251-9; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Ryle MJ, 1996, J BIOL CHEM, V271, P1551, DOI 10.1074/jbc.271.3.1551; RYLE MJ, 1995, J BIOL CHEM, V270, P13112, DOI 10.1074/jbc.270.22.13112; Ryle MJ, 1996, BIOCHEMISTRY-US, V35, P9424, DOI 10.1021/bi9608572; Schindelin N, 1997, NATURE, V387, P370, DOI 10.1038/387370a0; Schlessman JL, 1998, J MOL BIOL, V280, P669, DOI 10.1006/jmbi.1998.1898; Seefeldt LC, 2012, CURR OPIN CHEM BIOL, V16, P19, DOI 10.1016/j.cbpa.2012.02.012; Seefeldt LC, 2009, ANNU REV BIOCHEM, V78, P701, DOI 10.1146/annurev.biochem.78.070907.103812; SEEFELDT LC, 1994, PROTEIN SCI, V3, P2073, DOI 10.1002/pro.5560031120; SEEFELDT LC, 1992, J BIOL CHEM, V267, P6680; SEEFELDT LC, 1993, PROTEIN SCI, V2, P93; Sen S, 2004, BIOCHEMISTRY-US, V43, P1787, DOI 10.1021/bi0358465; Sen S, 2006, J INORG BIOCHEM, V100, P1041, DOI 10.1016/j.jinorgbio.2006.02.016; Spatzal T, 2011, SCIENCE, V334, P940, DOI 10.1126/science.1214025; Tezcan FA, 2005, SCIENCE, V309, P1377, DOI 10.1126/science.1115653; Thorneley R. N. F., 1985, MOLYBDENUM ENZYMES, P221; THORNELEY RNF, 1988, BIOCHEM J, V253, P587, DOI 10.1042/bj2530587; THORNELEY RNF, 1983, BIOCHEM J, V215, P393, DOI 10.1042/bj2150393; Thorneley RNF, 1979, BIOCHEM SOC T, V7, P633, DOI 10.1042/bst0070633; Wilson PE, 2001, BIOPHYS CHEM, V91, P281, DOI 10.1016/S0301-4622(01)00182-X; WOLLE D, 1992, J BIOL CHEM, V267, P3667; Yang ZY, 2016, BIOCHEMISTRY-US, V55, P3625, DOI 10.1021/acs.biochem.6b00421	42	13	13	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15661	15669		10.1074/jbc.M117.801548	http://dx.doi.org/10.1074/jbc.M117.801548			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28784660	Green Published, hybrid			2022-12-26	WOS:000411512200007
J	Cho, J; You, M; Yoon, Y				Cho, Jungwoo; You, Myoungsoon; Yoon, Yoonjin			Characterizing the influence of transportation infrastructure on Emergency Medical Services (EMS) in urban area - A case study of Seoul, South Korea	PLOS ONE			English	Article							AMBULANCE RESPONSE-TIMES; HOSPITAL CARDIAC-ARREST; SYSTEM; ACCESS; MODEL	In highly urbanized area where traffic condition fluctuates constantly, transportation infrastructure is one of the major contributing factors to Emergency Medical Service (EMS) availability and patient outcome. In this paper, we assess the impact of traffic fluctuation to the EMS first response availability in urban area, by evaluating the k-minute coverage under 21 traffic scenarios. The set of traffic scenarios represents the time-of-day and day-of-week effects, and is generated by combining road link speed information from multiple historical speed databases. In addition to the k-minute area coverage calculation, the k-minute population coverage is also evaluated for every 100m by 100m grid that partitions the case study area of Seoul, South Korea. In the baseline case of traveling at the speed limit, both the area and population coverage reached nearly 100% when compared to the five-minute travel time national target. Employing the proposed LoST (Loss of Serviceability due to Traffic) index, which measures coverage reduction in percentage compared to the baseline case, we find that the citywide average LoST for area and population coverage are similar at 34.2% and 33.8%. However, district-wise analysis reveals that such reduction varies significantly by district, and the magnitude of area and population coverage reduction is not always proportional. We conclude that the effect of traffic variation is significant to successful urban EMS first response performance, and regional variation is evident among local districts. Complexity in the urban environment requires a more adaptive approach in public health resource management and EMS performance target determination.	[Cho, Jungwoo; Yoon, Yoonjin] Korea Adv Inst Sci & Technol, Dept Civil & Environm Engn, Daejeon, South Korea; [You, Myoungsoon] Seoul Natl Univ, Grad Sch Publ Hlth, Dept Publ Hlth Sci, Seoul, South Korea; [You, Myoungsoon] Seoul Natl Univ, Inst Hlth & Environm, Seoul, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU); Seoul National University (SNU)	Yoon, Y (corresponding author), Korea Adv Inst Sci & Technol, Dept Civil & Environm Engn, Daejeon, South Korea.	yoonjin@kaist.ac.kr	You, Myoungsoon/AAQ-5431-2020; Yoon, Yoonjin/C-1845-2011	Yoon, Yoonjin/0000-0002-3550-4431	Brain Korea 21 Plus Project [NRF-21A20132000003]; National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning [NRF-2014R1A1A1003686]	Brain Korea 21 Plus Project; National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning	This work was supported by the Brain Korea 21 Plus Project (NRF-21A20132000003) and Young Career Awards (NRF-2014R1A1A1003686) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning. (http://www.nrf.re.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KO, 2010, PREHOSP EMERG CARE, V14, P469, DOI 10.3109/10903127.2010.497895; Amram O, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-40; Bauer SR, 2015, J URBAN HEALTH, V92, P853, DOI 10.1007/s11524-015-9971-2; Blackwell TH, 2002, ACAD EMERG MED, V9, P288, DOI 10.1197/aemj.9.4.288; Brabyn Lars, 2002, Int J Health Geogr, V1, P3, DOI 10.1186/1476-072X-1-3; Demiryurek U, 2009, TRANSDEC DATA DRIVEN; EISENBERG MS, 1980, LANCET, V1, P812; Ertugay K, 2015, UNDERSTANDING ACCESS, P223; FEERO S, 1995, AM J EMERG MED, V13, P133, DOI 10.1016/0735-6757(95)90078-0; Fleischman RJ, 2013, PREHOSP EMERG CARE, V17, P458, DOI 10.3109/10903127.2013.811562; Griffin R, 2013, J EMERG MED, V44, P398, DOI 10.1016/j.jemermed.2012.01.066; Jezek B, 2011, J SYSTEM MANAGEMENT, V1; Lam SSW, 2015, AM J EMERG MED, V33, P159, DOI 10.1016/j.ajem.2014.10.044; Liu HH, 2015, J COMPUT CIVIL ENG, V29, DOI 10.1061/(ASCE)CP.1943-5487.0000395; Ministry of Security and Public Administration, 2014, 2014 MOSAP YEARL REP, V1, P21; Patel AB, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-42; Peleg K, 2004, AM J EMERG MED, V22, P164, DOI 10.1016/j.ajem.2004.02.003; Pell JP, 2001, BRIT MED J, V322, P1385, DOI 10.1136/bmj.322.7299.1385; Schmid V, 2010, EUR J OPER RES, V207, P1293, DOI 10.1016/j.ejor.2010.06.033; Tansley G, 2016, PREHOSP EMERG CARE, V20, P768, DOI 10.3109/10903127.2016.1164775; Tansley G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141113; Vanderschuren M, 2015, INT J HEALTH GEOGR, V14, DOI 10.1186/1476-072X-14-5; Wang C, 2016, APPL SOFT COMPUT, V38, P1099, DOI 10.1016/j.asoc.2015.06.006; Zhang ZH, 2016, TRANSPORT RES C-EMER, V65, P97, DOI 10.1016/j.trc.2016.01.015	24	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2017	12	8							e0183241	10.1371/journal.pone.0183241	http://dx.doi.org/10.1371/journal.pone.0183241			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD5CP	28806405	Green Published, gold, Green Submitted			2022-12-26	WOS:000407548800066
J	Nowicka-Krawczyk, P; Zelazna-Wieczorek, J; Kozlecki, T				Nowicka-Krawczyk, Paulina; Zelazna-Wieczorek, Joanna; Kozlecki, Tomasz			Silver nanoparticles as a control agent against facades coated by aerial algae - A model study of Apatococcus lobatus (green algae)	PLOS ONE			English	Article							AUSCHWITZ II; HISTORIC BUILDINGS; STONE; CYANOBACTERIA; TOXICITY; BIOFILMS; BIODETERIORATION; COLONIZATION; DIVERSITY; MONUMENTS	Aerial algae are an important biological factor causing the biodegradation of building materials and facades. Conservation procedures aimed at the protection of historic and utility materials must be properly designed to avoid an increase of the degradation rate. The aim of the present study was to investigate the effect of silver nanoparticles (AgNP) synthetized with features contributing to the accessibility and toxicity (spherical shape, small size) on the most frequently occurring species of green algae in aerial biofilms and thus, the most common biodegradation factor - Apatococcus lobatus. Changes in the chloroplasts structure and the photosynthetic activity of the cells under AgNP exposure were made using confocal laser microscopy and digital image analysis and the estimation of growth inhibition rate was made using a biomass assay. In the majority of cases, treatment with AgNP caused a time and dose dependant degradation of chloroplasts and decrease in the photosynthetic activity of cells leading to the inhibition of aerial algae growth. However, some cases revealed an adaptive response of the cells. The response was induced by either a too low, or - after a short time - too high concentration of AgNP. Taken together, the data suggest that AgNP may be used as a biocide against aerial algal coatings; however, with a proper caution related to the concentration of the nanoparticles.	[Nowicka-Krawczyk, Paulina; Zelazna-Wieczorek, Joanna] Univ Lodz, Fac Biol & Environm Protect, Lab Algol & Mycol, Lodz, Poland; [Kozlecki, Tomasz] Wroclaw Univ Technol, Fac Chem, Dept Chem Engn, Wroclaw, Poland	University of Lodz; Wroclaw University of Science & Technology	Nowicka-Krawczyk, P (corresponding author), Univ Lodz, Fac Biol & Environm Protect, Lab Algol & Mycol, Lodz, Poland.	paulina.nowicka@biol.uni.lodz.pl	zelazna-wieczorek, joanna/AAH-3961-2019	zelazna-wieczorek, joanna/0000-0003-1044-8151; Nowicka-Krawczyk, Paulina/0000-0002-7722-9132	National Centre for Research and Development in Poland, project AgNASIL [PBS3/B1/10/2015]; Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW); University of Lodz task grant [B1611000001139.02 (2016), B1711000001489.02 (2017)]	National Centre for Research and Development in Poland, project AgNASIL; Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW); University of Lodz task grant	This work was supported by National Centre for Research and Development in Poland, project AgNASIL (PBS3/B1/10/2015) is gratefully acknowledged. Publication is financially supported by Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW) for years 2014-2018, and by the University of Lodz task grant for young researchers no. B1611000001139.02 (2016) and no B1711000001489.02 (2017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are gratefully acknowledged for the support of the National Centre for Research and Development in Poland, project AgNASIL (PBS3/B1/10/2015) and the University of Lodz (Poland) Task Grant for a Young Researchers no B1711000001489.02 (2017).	Aflori M, 2013, MATER SCI ENG B-ADV, V178, P1339, DOI 10.1016/j.mseb.2013.04.004; Andersen, 2005, ALGAL CULTURING TECH, P83, DOI DOI 10.1016/B978-012088426-1/50007-X; [Anonymous], 2007, 14821 DIN EN, P1; Barberousse H, 2007, BUILD ENVIRON, V42, P2555, DOI 10.1016/j.buildenv.2006.07.031; Berg J.M., 2007, BIOCHEMISTRY-US, V6th ed.; Biswas P, 2005, J AIR WASTE MANAGE, V55, P708, DOI 10.1080/10473289.2005.10464656; Brehm U, 2005, PALAEOGEOGR PALAEOCL, V219, P117, DOI 10.1016/j.palaeo.2004.10.017; Bruins MR, 1999, ECOTOX ENVIRON SAFE, V45, P1421; Burchardt AD, 2012, ENVIRON SCI TECHNOL, V46, P11336, DOI 10.1021/es300989e; Caneva G., 1992, P 7 INT C DET CONS S, P521; Codita Irina, 2010, Roum Arch Microbiol Immunol, V69, P204; Crispim CA, 2004, INT BIODETER BIODEGR, V54, P121, DOI 10.1016/j.ibiod.2004.03.001; Eyssautier-Chuine S, 2016, OPEN C P J, V7, P55; Fabrega J, 2011, ENVIRON INT, V37, P517, DOI 10.1016/j.envint.2010.10.012; GARTNER G, 1989, PLANT SYST EVOL, V164, P133, DOI 10.1007/BF00940434; Gartner G., 2003, BER NAT MED VEREIN I, V90, P73; Gaylarde C, 2002, ENVIRON MICROBIOL, V1, P516; Gaylarde CC, 1999, BIOFOULING, V14, P59, DOI 10.1080/08927019909378397; Gaylarde P, 2006, INT BIODETER BIODEGR, V58, P119, DOI 10.1016/j.ibiod.2006.05.005; Gaylarde PM, 2000, INT BIODETER BIODEGR, V46, P93, DOI 10.1016/S0964-8305(00)00074-3; Genitsaris Savvas, 2011, Front Biosci (Elite Ed), V3, P772, DOI 10.2741/e285; Goffredo GB, 2017, BUILD ENVIRON, V112, P209, DOI 10.1016/j.buildenv.2016.11.034; Gottredo GB, 2017, J CULT HERI IN PRESS, P1; Graham JE, 2008, ALGAE; Grbic ML, 2010, ARCH BIOL SCI, V62, P625, DOI 10.2298/ABS1003625L; GRIFFIN PS, 1991, INT BIODETERIOR, V28, P187, DOI 10.1016/0265-3036(91)90042-P; Gustavs L, 2016, J PHYCOL, V52, P311, DOI 10.1111/jpy.12381; Haase A, 2012, TOXICOL SCI, V126, P457, DOI 10.1093/toxsci/kfs003; Hamal DB, 2010, LANGMUIR, V26, P2805, DOI 10.1021/la902844r; Hund-Rinke K, 2006, ENVIRON SCI POLLUT R, V13, P225, DOI 10.1065/espr2006.06.311; JOHNSON A, 1974, Reinwardtia, V8, P495; Kartal SN, 2009, INT BIODETER BIODEGR, V63, P490, DOI 10.1016/j.ibiod.2009.01.007; Kawecka B, 1994, ZARYS EKOLOGII GLONE; Kowalska E, 2015, CATAL TODAY, V252, P136, DOI 10.1016/j.cattod.2014.10.038; Kozirog A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081364; Kozirog A, 2014, INT BIODETER BIODEGR, V86, P171, DOI 10.1016/j.ibiod.2013.08.004; Lee HY, 2007, CHEM COMMUN, P2959, DOI 10.1039/b703034g; Li MH, 2011, ENVIRON SCI TECHNOL, V45, P8989, DOI 10.1021/es201675m; Matorin DN, 2013, MICROBIOLOGY+, V82, P809, DOI 10.1134/S002626171401010X; McShan D, 2014, J FOOD DRUG ANAL, V22, P116, DOI 10.1016/j.jfda.2014.01.010; Navarro E, 2008, ECOTOXICOLOGY, V17, P372, DOI 10.1007/s10646-008-0214-0; Nowack B, 2011, ENVIRON SCI TECHNOL, V45, P1177, DOI 10.1021/es103316q; Nowicka-Krawczyk P, 2014, SCI TOTAL ENVIRON, V493, P116, DOI 10.1016/j.scitotenv.2014.05.113; NUSCH E. A., 1980, ARCH HYDROBIOL BEIH, V14, P14; Oukarroum A, 2012, ENVIRON SCI POLLUT R, V19, P1755, DOI 10.1007/s11356-011-0689-8; PARSON W W, 2015, MODERN OPTICAL SPECT; Pietrzak K, 2015, ACTA BIOCHIM POL, V62, P851, DOI 10.18388/abp.2015_1146; Pietrzak K, 2016, TEXT RES J, V86, P812, DOI 10.1177/0040517515596933; Pillai S, 2014, P NATL ACAD SCI USA, V111, P3490, DOI 10.1073/pnas.1319388111; Piotrowska M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109402; Rajkowska K, 2015, ACTA BIOCHIM POL, V62, P1; Rajkowska K, 2014, ANN MICROBIOL, V64, P799, DOI 10.1007/s13213-013-0716-8; Rindi F, 2004, PHYCOLOGIA, V43, P225, DOI 10.2216/i0031-8884-43-3-225.1; Rindi Fabio, 2007, V11; Ruffolo SA, 2017, PROG ORG COAT, V104, P64, DOI 10.1016/j.porgcoat.2016.12.004; Ruparelia JP, 2008, ACTA BIOMATER, V4, P707, DOI 10.1016/j.actbio.2007.11.006; Ryparova P, 2015, NANOCON, P1; Sahu N, 2015, AEROBIOLOGIA, V31, P89, DOI 10.1007/s10453-014-9349-z; Samad Lakshmi Kumari, 2008, Algae, V23, P91; Schagerl M, 2007, BIOLOGIA, V62, P270, DOI 10.2478/s11756-007-0048-x; Shirakawa MA, 2013, INT BIODETER BIODEGR, V85, P57, DOI 10.1016/j.ibiod.2013.04.018; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Vass Istvan Zoltan, 2015, Acta Biologica Szegediensis, V59, P225; Warscheid T, 2000, INT BIODETER BIODEGR, V46, P343, DOI 10.1016/S0964-8305(00)00109-8; Zhu YF, 2002, ATMOS ENVIRON, V36, P4323, DOI 10.1016/S1352-2310(02)00354-0	65	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2017	12	8							e0183276	10.1371/journal.pone.0183276	http://dx.doi.org/10.1371/journal.pone.0183276			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD5CP	28806422	gold, Green Published, Green Submitted			2022-12-26	WOS:000407548800068
J	Suzuki, D; Saito-Hakoda, A; Ito, R; Shimizu, K; Parvin, R; Shimada, H; Noro, E; Suzuki, S; Fujiwara, I; Kagechika, H; Rainey, WE; Kure, S; Ito, S; Yokoyama, A; Sugawara, A				Suzuki, Dai; Saito-Hakoda, Akiko; Ito, Ryo; Shimizu, Kyoko; Parvin, Rehana; Shimada, Hiroki; Noro, Erika; Suzuki, Susumu; Fujiwara, Ikuma; Kagechika, Hiroyuki; Rainey, William E.; Kure, Shigeo; Ito, Sadayoshi; Yokoyama, Atsushi; Sugawara, Akira			Suppressive effects of RXR agonist PA024 on adrenal CYP11B2 expression, aldosterone secretion and blood pressure	PLOS ONE			English	Article							ACUTE REGULATORY PROTEIN; ADRENOCORTICAL H295R CELLS; ACTIVATED RECEPTOR-GAMMA; ANGIOTENSIN-II; 3-BETA-HYDROXYSTEROID DEHYDROGENASE; DIFFERENTIAL REGULATION; ZONA GLOMERULOSA; HYPERTENSION; SYNTHASE; CANCER	The effects of retinoids on adrenal aldosterone synthase gene (CYP11B2) expression and aldosterone secretion are still unknown. We therefore examined the effects of nuclear retinoid X receptor (RXR) pan-agonist PA024 on CYP11B2 expression, aldosterone secretion and blood pressure, to elucidate its potential as a novel anti-hypertensive drug. We demonstrated that PA024 significantly suppressed angiotensin II (Ang II)-induced CYP11B2 mRNA expression, promoter activity and aldosterone secretion in human adrenocortical H295R cells. Human CYP11B2 promoter functional analyses using its deletion and point mutants indicated that the suppression of CYP11B2 promoter activity by PA024 was in the region from -1521 (full length) to -106 including the NBRE-1 and the Ad5 elements, and the Ad5 element may be mainly involved in the PA024-mediated suppression. PA024 also significantly suppressed the Ang II-induced mRNA expression of transcription factors NURR1 and NGFIB that bind to and activate the Ad5 element. NURR1 overexpression demonstrated that the decrease of NURR1 expression may contribute to the PA024-mediated suppression of CYP11B2 transcription. PA024 also suppressed the Ang II-induced mRNA expression of StAR, HSD3 beta 2 and CYP21A2, a steroidogenic enzyme group involved in aldosterone biosynthesis. Additionally, the PA024-mediated CYP11B2 transcription suppression was shown to be exerted via RXR alpha. Moreover, the combination of PPAR. agonist pioglitazone and PA024 caused synergistic suppressive effects on CYP11B2 mRNA expression. Finally, PA024 treatment significantly lowered both the systolic and diastolic blood pressure in Tsukuba hypertensive mice (hRN8-12 x hAG2-5). Thus, RXR pan-agonist PA024 may be a candidate anti-hypertensive drugs that acts via the suppression of aldosterone synthesis and secretion.	[Suzuki, Dai; Fujiwara, Ikuma; Kure, Shigeo] Tohoku Univ, Dept Pediat, Grad Sch Med, Sendai, Miyagi, Japan; [Suzuki, Dai; Saito-Hakoda, Akiko; Ito, Ryo; Shimizu, Kyoko; Parvin, Rehana; Shimada, Hiroki; Noro, Erika; Suzuki, Susumu; Yokoyama, Atsushi; Sugawara, Akira] Tohoku Univ, Dept Mol Endocrinol, Grad Sch Med, Sendai, Miyagi, Japan; [Kagechika, Hiroyuki] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo, Japan; [Rainey, William E.] Univ Michigan, Med Sch, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Ito, Sadayoshi] Tohoku Univ, Grad Sch Med, Div Nephrol Endocrinol & Vasc Med, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tokyo Medical & Dental University (TMDU); University of Michigan System; University of Michigan; Tohoku University	Sugawara, A (corresponding author), Tohoku Univ, Dept Mol Endocrinol, Grad Sch Med, Sendai, Miyagi, Japan.	akiras2i@med.tohoku.ac.jp	Yokoyama, Atsushi/W-3519-2019	Ito, Sadayoshi/0000-0002-5092-3626; Yokoyama, Atsushi/0000-0003-2842-4334; Sugawara, Akira/0000-0003-4511-8101	Japan Society for the Promotion of Science (JSPS) KAKENHI [16H03252, 15K09420]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 16H03252 (https://kaken.nii.ac.jp/en/search/?kw=16H03252) (for AS) and 15K09420 (https://kaken.nii.ac.jp/en/search/?kw=15K09420) (for ASH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to express our thanks to the members of Department of Molecular Endocrinology, Tohoku University Graduate School of Medicine for their helpful suggestions and technical supports. We also acknowledge the Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from Japan Agency for Medical Research and development (AMED) for helpful supports.	Altucci L, 2007, NAT REV DRUG DISCOV, V6, P793, DOI 10.1038/nrd2397; Bassett MH, 2004, MOL CELL ENDOCRINOL, V217, P67, DOI 10.1016/j.mce.2003.10.011; Bassett MH, 2004, MOL ENDOCRINOL, V18, P279, DOI 10.1210/me.2003-0005; Bassett MH, 2002, J MOL ENDOCRINOL, V28, P125, DOI 10.1677/jme.0.0280125; Betancourt-Calle S, 2001, MOL CELL ENDOCRINOL, V173, P87, DOI 10.1016/S0303-7207(00)00411-1; Bird IM, 1996, J CLIN ENDOCR METAB, V81, P2171, DOI 10.1210/jc.81.6.2171; Bird IM, 1998, J CLIN ENDOCR METAB, V83, P1592, DOI 10.1210/jc.83.5.1592; Bushue N, 2010, ADV DRUG DELIVER REV, V62, P1285, DOI 10.1016/j.addr.2010.07.003; Calhoun DA, 2008, HYPERTENSION, V51, P1403, DOI 10.1161/HYPERTENSIONAHA.108.189141; Cherradi N, 1997, J BIOL CHEM, V272, P7899, DOI 10.1074/jbc.272.12.7899; Clark BJ, 1995, MOL CELL ENDOCRINOL, V115, P215, DOI 10.1016/0303-7207(95)03683-0; Condon JC, 2002, ENDOCRINOLOGY, V143, P3651, DOI 10.1210/en.2001-211359; Denner K, 1996, MOL CELL ENDOCRINOL, V121, P87, DOI 10.1016/0303-7207(96)03853-1; Doi M, 2014, J CLIN ENDOCR METAB, V99, pE257, DOI 10.1210/jc.2013-3279; Doi M, 2010, NAT MED, V16, P67, DOI 10.1038/nm.2061; DYSON E, 1995, P NATL ACAD SCI USA, V92, P7386, DOI 10.1073/pnas.92.16.7386; FUKAMIZU A, 1993, J BIOL CHEM, V268, P11617; Gniadecki R, 2007, BRIT J DERMATOL, V157, P433, DOI 10.1111/j.1365-2133.2007.07975.x; Haraguchi G, 2006, J MOL CELL CARDIOL, V41, P885, DOI 10.1016/j.yjmcc.2006.07.022; Hattangady NG, 2012, MOL CELL ENDOCRINOL, V350, P151, DOI 10.1016/j.mce.2011.07.034; Howe LR, 2007, CLIN CANCER RES, V13, P5983, DOI 10.1158/1078-0432.CCR-07-1065; Kagechika H, 2005, J MED CHEM, V48, P5875, DOI 10.1021/jm0581821; Lackland DT, 2015, CAN J CARDIOL, V31, P569, DOI 10.1016/j.cjca.2015.01.009; Lefebvre P, 2010, TRENDS ENDOCRIN MET, V21, P676, DOI 10.1016/j.tem.2010.06.009; Lehoux JG, 1999, ENDOCRINOLOGY, V140, P5154, DOI 10.1210/en.140.11.5154; Liby KT, 2007, NAT REV CANCER, V7, P357, DOI 10.1038/nrc2129; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; MORNET E, 1989, J BIOL CHEM, V264, P20961; Nogueira EF, 2009, J MOL ENDOCRINOL, V42, P319, DOI 10.1677/JME-08-0112; Ota T, 2014, MOL CELL BIOL, V34, P3880, DOI 10.1128/MCB.00852-14; Pan ZQ, 2014, MOL CELL ENDOCRINOL, V394, P119, DOI 10.1016/j.mce.2014.07.007; Peters B, 1998, J HISTOCHEM CYTOCHEM, V46, P1215, DOI 10.1177/002215549804601101; Qu LY, 2010, CANCER CHEMOTH PHARM, V65, P201, DOI 10.1007/s00280-009-1140-4; RAINEY WE, 1991, ENDOCR RES, V17, P281, DOI 10.1080/07435809109027202; Romero DG, 2006, ENDOCRINOLOGY, V147, P6046, DOI 10.1210/en.2006-0794; Saito-Hakoda A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141960; SUCOV HM, 1994, GENE DEV, V8, P1007, DOI 10.1101/gad.8.9.1007; Sugawara A, 2002, J BIOL CHEM, V277, P9676, DOI 10.1074/jbc.M104560200; Takahashi B, 2002, J MED CHEM, V45, P3327, DOI 10.1021/jm0255320; Uruno A, 2011, J MOL ENDOCRINOL, V46, P37, DOI 10.1677/JME-10-0088; Zhu J, 2014, AM J HYPERTENS, V27, P1112, DOI 10.1093/ajh/hpu017	41	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0181055	10.1371/journal.pone.0181055	http://dx.doi.org/10.1371/journal.pone.0181055			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800627	Green Published, Green Submitted, gold			2022-12-26	WOS:000407431800004
J	Zhao, LP; Zhao, L; Zhang, BC; Robotham, JM; Roux, KH; Tang, HL				Zhao, Lipei; Zhao, Liang; Zhang, Buchang; Robotham, Jason M.; Roux, Kenneth H.; Tang, Hengli			Identification of a common Ara h 3 epitope recognized by both the capture and the detection monoclonal antibodies in an ELISA detection kit	PLOS ONE			English	Article							MAJOR PEANUT ALLERGEN; IGE-BINDING EPITOPES; CRYSTAL-STRUCTURE; FOOD ALLERGY; MUTATIONAL ANALYSIS; ATOPIC-DERMATITIS; SANDWICH ELISA; 11S GLOBULIN; EXPRESSION; PREVALENCE	Allergy to peanuts has become a common and severe problem, especially in westernized countries. In this study, we evaluated the target and epitope specificity of the capture and detection mouse monoclonal antibodies (mAbs) used in a commercial peanut allergen detection platform. We first identified the target of these antibodies as Ara h 3 and then used an overlapping peptide array of Ara h 3 to determine the antibody-binding epitopes. Further amino acids critical for the binding via alanine substitutions at individual amino acid residues within the epitope were mapped. Finally, inhibition ELISA and inhibition immunoblotting using a recombinant Ara h 3 protein were performed to confirm these results. Surprisingly, the capture and detection mAbs showed identical binding characteristics and were presumed to represent two isolates of the same clone, a notion supported by both isoelectric focusing electrophoresis and Liquid chromatography-mass spectrometry experiments. The simultaneous binding of a pair of identical mAbs to an individual allergen such as Ara h3 is attributed to the multivalency of the analyte and has implications for developing diagnostic assays for additional multimeric allergens.	[Zhao, Lipei; Zhao, Liang; Zhang, Buchang; Tang, Hengli] Anhui Univ, Inst Hlth Sci, Hefei, Anhui, Peoples R China; [Robotham, Jason M.; Roux, Kenneth H.; Tang, Hengli] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA	Anhui University; State University System of Florida; Florida State University	Tang, HL (corresponding author), Anhui Univ, Inst Hlth Sci, Hefei, Anhui, Peoples R China.; Tang, HL (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	tang@bio.fsu.edu			Anhui University; Anhui Provincial Hundred-Talent Program	Anhui University(Anhui University); Anhui Provincial Hundred-Talent Program	The research is supported by Anhui University (http://www.ahu.edu.cn/) to the Institute of Health Sciences (HT, BZ) and Anhui Provincial Hundred-Talent Program for Foreign Experts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2003, P NATL ACAD SCI USA, V100, P7395, DOI 10.1073/pnas.0832158100; Beyer K, 2016, BUNDESGESUNDHEITSBLA, V59, P732, DOI 10.1007/s00103-016-2353-4; Burks AW, 2008, LANCET, V371, P1538, DOI 10.1016/S0140-6736(08)60659-5; BURKS AW, 1992, J ALLERGY CLIN IMMUN, V90, P962, DOI 10.1016/0091-6749(92)90469-I; BURKS AW, 1991, J ALLERGY CLIN IMMUN, V88, P172, DOI 10.1016/0091-6749(91)90325-I; Burks AW, 1997, EUR J BIOCHEM, V245, P334, DOI 10.1111/j.1432-1033.1997.t01-1-00334.x; BURKS AW, 1995, J CLIN INVEST, V96, P1715, DOI 10.1172/JCI118216; Deng XF, 2012, FOOD AGR IMMUNOL, V23, P265, DOI 10.1080/09540105.2011.617358; Glenting J, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-28; Grundy J, 2002, J ALLERGY CLIN IMMUN, V110, P784, DOI 10.1067/mai.2002.128802; Jin T, 2009, MOL IMMUNOL, V46, P1796, DOI 10.1016/j.molimm.2009.01.023; Kagan RS, 2003, J ALLERGY CLIN IMMUN, V112, P1223, DOI 10.1016/j.jaci.2003.09.026; King N, 2005, MOL NUTR FOOD RES, V49, P963, DOI 10.1002/mnfr.200500073; Kleber-Janke T, 1999, INT ARCH ALLERGY IMM, V119, P265, DOI 10.1159/000024203; Krause S, 2009, J ALLERGY CLIN IMMUN, V124, P771, DOI 10.1016/j.jaci.2009.06.008; Lee LA, 2009, FRONT BIOSCI-LANDMRK, V14, P3361, DOI 10.2741/3458; Lehmann K, 2003, PROTEIN EXPRES PURIF, V31, P250, DOI 10.1016/S1046-5928(03)00190-6; Mittag D, 2004, J ALLERGY CLIN IMMUN, V114, P1410, DOI 10.1016/j.jaci.2004.09.014; Mueller GA, 2011, ALLERGY, V66, P878, DOI 10.1111/j.1398-9995.2010.02532.x; Nicolaou N, 2010, J ALLERGY CLIN IMMUN, V125, P191, DOI 10.1016/j.jaci.2009.10.008; Otsu K, 2011, DISCOV MED, V12, P319; Patel BY, 2015, MAYO CLIN PROC, V90, P1411, DOI 10.1016/j.mayocp.2015.07.012; Peng J, 2015, FOOD ANAL METHOD, V8, P2605, DOI 10.1007/s12161-015-0163-1; Peng J, 2013, INT J ENV RES PUB HE, V10, P2897, DOI 10.3390/ijerph10072897; Pons L, 1998, J CHROMATOGR B, V706, P131, DOI 10.1016/S0378-4347(97)00530-6; Pons L, 2002, ALLERGY, V57, P88, DOI 10.1034/j.1398-9995.57.s72.16.x; Rabjohn P, 1999, J CLIN INVEST, V103, P535, DOI 10.1172/JCI5349; Ramos ML, 2009, PLANT MOL BIOL, V69, P325, DOI 10.1007/s11103-008-9428-z; Robotham JM, 2009, MOL IMMUNOL, V46, P2975, DOI 10.1016/j.molimm.2009.06.020; Stanley JS, 1997, ARCH BIOCHEM BIOPHYS, V342, P244, DOI 10.1006/abbi.1997.9998; van Boxtel EL, 2008, J AGR FOOD CHEM, V56, P2223, DOI 10.1021/jf072907n; Willison LN, 2011, INT ARCH ALLERGY IMM, V156, P267, DOI 10.1159/000323887; Wu ZH, 2015, PREP BIOCHEM BIOTECH, V45, P438, DOI 10.1080/10826068.2014.940972; Zhuang YH, 2013, IMMUNOL RES, V55, P125, DOI 10.1007/s12026-012-8355-x	34	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0182935	10.1371/journal.pone.0182935	http://dx.doi.org/10.1371/journal.pone.0182935			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800361	Green Published, Green Submitted, gold			2022-12-26	WOS:000407431800036
J	Cooper, LV; Boukary, RM; Aseffa, A; Mihret, W; Collard, JM; Daugla, D; Hodgson, A; Sokhna, C; Omotara, B; Sow, S; Quaye, SL; Diallo, K; Manigart, O; Maiden, MCJ; Findlow, H; Borrow, R; Stuart, JM; Greenwood, BM; Trotter, CL				Cooper, Laura V.; Boukary, Rahamatou Moustapha; Aseffa, Abraham; Mihret, Wude; Collard, Jean-Marc; Daugla, Doumagoum; Hodgson, Abraham; Sokhna, Cheikh; Omotara, Babatunji; Sow, Samba; Quaye, Stephen Laryea; Diallo, Kanny; Manigart, Olivier; Maiden, Martin C. J.; Findlow, Helen; Borrow, Ray; Stuart, James M.; Greenwood, Brian M.; Trotter, Caroline L.			Investigation of correlates of protection against pharyngeal carriage of Neisseria meningitidis genogroups W and Y in the African meningitis belt	PLOS ONE			English	Article							MENINGOCOCCAL CONJUGATE VACCINE; HERD-IMMUNITY; PNEUMOCOCCAL COLONIZATION; BURKINA-FASO; SEROGROUP; ENGLAND; IMMUNOGENICITY; SEROPREVALENCE; SURVEILLANCE; VALIDATION	Background Serum bactericidal antibody titres that correlate with protection against invasive meningococcal disease have been characterised. However, titres that are associated with protection against acquisition of pharyngeal carriage of Neisseria meningitidis are not known. Methods Sera were obtained from the members of a household in seven countries of the African meningitis belt in which a pharyngeal carrier of N. meningitidis had been identified during a cross-sectional survey. Serum bactericidal antibody titres at baseline were compared between individuals in the household of the carrier who became a carrier of a meningococcus of the same genogroup during six months of subsequent follow-up and household members who did not become a carrier of a meningococcus of this genogroup during this period. Results Serum bacterial antibody titres were significantly higher in carriers of a serogroup W or Y meningococcus at the time of recruitment than in those who were not a carrier of N. meningitidis of the same genogroup. Serum bactericidal antibody titres to a strain of N. meningitis of the same genogroup as the index cases were no different in individuals who acquired carriage with a meningococcus of the same genogroup as the index case than in those who did not become a carrier during six months of follow-up. Conclusion Serum bacterial antibody titres to N. meningitidis of genogroup W or Y in the range of those acquired by natural exposure to meningococci of these genogroups, or with cross-reactive bacteria, are not associated with protection against acquisition of carriage with meningococci of either of these genogroups.	[Cooper, Laura V.; Trotter, Caroline L.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Boukary, Rahamatou Moustapha; Collard, Jean-Marc] Ctr Rech Med & Sanit CERMES, Niamey, Niger; [Aseffa, Abraham; Mihret, Wude] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Daugla, Doumagoum] CSSI, Ndjamena, Chad; [Hodgson, Abraham; Quaye, Stephen Laryea] Navrongo Hlth Res Ctr, Navrongo, Ghana; [Sokhna, Cheikh] Inst Rech Dev, Dakar, Senegal; [Omotara, Babatunji] Univ Maiduguri, Dept Community Med, Maiduguri, Nigeria; [Sow, Samba; Diallo, Kanny] Ctr Vaccins Dev, Bamako, Mali; [Manigart, Olivier; Stuart, James M.; Greenwood, Brian M.] London Sch Hyg & Trop Med, Fac Infect Dis, London, England; [Maiden, Martin C. J.] Univ Oxford, Dept Zool, Oxford, England; [Findlow, Helen; Borrow, Ray] Publ Hlth England, Vaccine Evaluat Unit, Manchester, Lancs, England	University of Cambridge; Navrongo Health Research Center; Institut de Recherche pour le Developpement (IRD); University of London; London School of Hygiene & Tropical Medicine; University of Oxford; Public Health England	Cooper, LV (corresponding author), Univ Cambridge, Dept Vet Med, Cambridge, England.	lvc32@cam.ac.uk	Trotter, Caroline L/H-5077-2013; Collard, Jean-Marc/Q-2342-2019; Maiden, Martin/N-6805-2019; Aseffa, Abraham/J-3248-2016; Maiden, Martin C J/C-5055-2014; Woldemedhin, Wude Mihret/AAD-5840-2021	Collard, Jean-Marc/0000-0002-1490-3978; Maiden, Martin/0000-0001-6321-5138; Aseffa, Abraham/0000-0002-8028-1150; Maiden, Martin C J/0000-0001-6321-5138; Cooper, Laura/0000-0002-2942-3627; Diallo, Kanny/0000-0002-0905-3980	Wellcome Trust [086546]; Bill & Melinda Gates Foundation [OPP51251]	Wellcome Trust(Wellcome TrustEuropean Commission); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	The MenAfriCar Consortium was supported by grants from the Wellcome Trust (086546) and the Bill & Melinda Gates Foundation (OPP51251). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali O, 2016, LANCET GLOB HEALTH, V4, pE989, DOI 10.1016/S2214-109X(16)30244-3; Ali O, 2015, J INFECT DIS, V212, P1298, DOI 10.1093/infdis/jiv211; Ali O, 2013, TROP MED INT HEALTH, V18, P968, DOI 10.1111/tmi.12125; AlMazrou Y, 2005, INFECT IMMUN, V73, P2932, DOI 10.1128/IAI.73.5.2932-2939.2005; Andrews N, 2003, CLIN DIAGN LAB IMMUN, V10, P780, DOI 10.1128/CDLI.10.5.780-786.2003; Anonymous, 2011, Morbidity and Mortality Weekly Report, V60, P1018; Bennett JS, 2014, J CLIN MICROBIOL, V52, P1375, DOI 10.1128/JCM.03529-13; Bernal N, 2011, HUM VACCINES, P239; Borrow R, 2005, VACCINE, V23, P2222, DOI 10.1016/j.vaccine.2005.01.051; Borrow R, 2001, INFECT IMMUN, V69, P1568, DOI 10.1128/IAI.69.3.1568-1573.2001; Claus H, 2002, MICROBIOL-SGM, V148, P1813, DOI 10.1099/00221287-148-6-1813; Dagan R, 2005, J INFECT DIS, V192, P367, DOI 10.1086/431679; Daugla DM, 2014, LANCET, V383, P40, DOI 10.1016/S0140-6736(13)61612-8; Diallo K, 2016, J INFECTION, V72, P667, DOI 10.1016/j.jinf.2016.03.010; Fernandez J, 2000, J INFECT DIS, V182, P1553, DOI 10.1086/315870; Goldblatt D, 2005, J INFECT DIS, V192, P387, DOI 10.1086/431524; Jones GR, 1998, J INFECT DIS, V178, P451, DOI 10.1086/515622; Jordens JZ, 2004, INFECT IMMUN, V72, P6503, DOI 10.1128/IAI.72.11.6503-6510.2004; Kristiansen PA, 2013, CLIN INFECT DIS, V56, P354, DOI 10.1093/cid/cis892; Kriz P, 1999, EPIDEMIOL INFECT, V123, P193, DOI 10.1017/S095026889900285X; Lingani C, 2015, CLIN INFECT DIS, V61, pS410, DOI 10.1093/cid/civ597; Maiden MCJ, 2008, J INFECT DIS, V197, P737, DOI 10.1086/527401; Maiden MCJ, 2002, LANCET, V359, P1829, DOI 10.1016/S0140-6736(02)08679-8; MAKELA PH, 1975, LANCET, V2, P883; Malley R, 2005, P NATL ACAD SCI USA, V102, P4848, DOI 10.1073/pnas.0501254102; Maslanka SE, 1997, CLIN DIAGN LAB IMMUN, V4, P156, DOI 10.1128/CDLI.4.2.156-167.1997; Millar EV, 2007, CLIN INFECT DIS, V44, P1173, DOI 10.1086/513199; Mueller JE, 2007, EMERG INFECT DIS, V13, P847, DOI 10.3201/eid1306.061395; Ostergaard L, 2009, VACCINE, V27, P161, DOI 10.1016/j.vaccine.2008.08.075; Phair JJ, 1944, AM J PUBLIC HEALTH N, V34, P148, DOI 10.2105/AJPH.34.2.148; Raghunathan PL, 2006, J INFECT DIS, V193, P607, DOI 10.1086/499822; Sow SO, 2011, NEW ENGL J MED, V364, P2293, DOI 10.1056/NEJMoa1003812; Trotter C, 2007, CLIN VACCINE IMMUNOL, V14, P863, DOI 10.1128/CVI.00102-07; Trotter CL, 2012, CLIN VACCINE IMMUNOL, V19, P219, DOI 10.1128/CVI.05515-11; Wang X, 2012, J CLIN MICROBIOL, V50, P702, DOI 10.1128/JCM.06087-11	35	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182575	10.1371/journal.pone.0182575	http://dx.doi.org/10.1371/journal.pone.0182575			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796795	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000407396200063
J	Lipska-Zietkiewicz, BS; Gellermann, J; Boyer, O; Gribouval, O; Zietkiewicz, S; Kari, JA; Shalaby, MA; Ozaltin, F; Dusek, J; Melk, A; Bayazit, AK; Massella, L; Hyla-Klekot, L; Habbig, S; Godron, A; Szczepanska, M; Bienias, B; Drozdz, D; Odeh, R; Jarmuzek, W; Zachwieja, K; Trautmann, A; Antignac, C; Schaefer, F				Lipska-Zietkiewicz, Beata S.; Gellermann, Jutta; Boyer, Olivia; Gribouval, Olivier; Zietkiewicz, Szymon; Kari, Jameela A.; Shalaby, Mohamed A.; Ozaltin, Fatih; Dusek, Jiri; Melk, Anette; Bayazit, Aysun K.; Massella, Laura; Hyla-Klekot, Lidia; Habbig, Sandra; Godron, Astrid; Szczepanska, Maria; Bienias, Beata; Drozdz, Dorota; Odeh, Rasha; Jarmuzek, Wioletta; Zachwieja, Katarzyna; Trautmann, Agnes; Antignac, Corinne; Schaefer, Franz		PodoNet Consortium	Low renal but high extrarenal phenotype variability in Schimke immuno-osseous dysplasia	PLOS ONE			English	Article							NEPHROTIC SYNDROME; STEROID-RESISTANT; EXPRESSION	Schimke immuno-osseous dysplasia (SIOD) is a rare multisystem disorder with early mortality and steroid-resistant nephrotic syndrome (SRNS) progressing to end-stage kidney disease. We hypothesized that next-generation gene panel sequencing may unsurface oli-gosymptomatic cases of SIOD with potentially milder disease courses. We analyzed the renal and extrarenal phenotypic spectrum and genotype-phenotype associations in 34 patients from 28 families, the largest SMARCAL1-associated nephropathy cohort to date. In 11 patients the diagnosis was made unsuspectedly through SRNS gene panel testing. Renal disease first manifested at median age 4.5 yrs, with focal segmental glmerulosclerosis or minimal change nephropathy on biopsy and rapid progression to end-stage kidney disease (ESKD) at median age 8.7 yrs. Whereas patients diagnosed by phenotype more frequently developed severe extrarenal complications (cerebral ischemic events, septicemia) and were more likely to die before age 10 years than patients identified by SRNS-gene panel screening (88 vs. 40%), the subgroups did not differ with respect to age at proteinuria onset and progression to ESKD. Also, 10 of 11 children diagnosed unsuspectedly by Next Generation Sequencing were small at diagnosis and all showed progressive growth failure. Severe phenotypes were usually associated with biallelic truncating mutations and milder phenotypes with biallelic missense mutations. However, no genotype-phenotype correlation was observed for the renal disease course. In conclusion, while short stature is a reliable clue to SIOD in children with SRNS, other systemic features are highly variable. Our findings support routine SMARCAL1 testing also in non-syndromic SRNS.	[Lipska-Zietkiewicz, Beata S.] Med Univ Gdansk, Dept Biol & Med Genet, Clin Genet Unit, Gdansk, Poland; [Gellermann, Jutta] Charite, Charite Childrens Hosp, Dept Pediat Nephrol, Berlin, Germany; [Boyer, Olivia; Gribouval, Olivier; Antignac, Corinne] Paris Descartes Univ, Imagine Inst, Inserm U1163, Paris, France; [Boyer, Olivia] Hop Necker Enfants Malad, AP HP, Pediat Nephrol, Paris, France; [Zietkiewicz, Szymon] Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Mol & Cellular Biol, Gdansk, Poland; [Kari, Jameela A.; Shalaby, Mohamed A.] King Abdulaziz Univ, Fac Med, Pediat Dept, Pediat Nephrol Ctr Excellence, Jeddah, Saudi Arabia; [Ozaltin, Fatih] Hacettepe Univ, Fac Med, Nephrogenet Lab, Dept Pediat Nephrol, Ankara, Turkey; [Ozaltin, Fatih] Hacettepe Univ, Fac Med, Dept Pediat Nephrol, Ankara, Turkey; [Ozaltin, Fatih] Hacettepe Univ, Ctr Biobanking & Genom, Ankara, Turkey; [Dusek, Jiri] Univ Hosp Motol, Dept Pediat, Prague, Czech Republic; [Melk, Anette] MHH Childrens Hosp, Liver & Metab Dis, Pediat Kidney, Hannover, Germany; [Bayazit, Aysun K.] Cukurova Univ, Dept Pediat Nephrol, Adana, Turkey; [Massella, Laura] IRCCS, Bambino Gesu Childrens Hosp, Pediat Subspecialties Dept, Nephrol & Dialysis Unit, Rome, Italy; [Hyla-Klekot, Lidia] Pediat & Oncol Ctr, Dept Pediat Nephrol, Chorzow, Poland; [Habbig, Sandra] Univ Childrens Hosp Cologne, Dept Pediat Nephrol, Cologne, Germany; [Godron, Astrid] Bordeaux Univ Hosp, Dept Pediat, Pediat Nephrol Unit, Bordeaux, France; [Szczepanska, Maria] Med Univ Silesia, SMDZ Zabrze, Chair & Dept Pediat, Zabrze, Poland; [Bienias, Beata] Lublin Med Univ, Dept Pediat Nephrol, Lublin, Poland; [Drozdz, Dorota; Zachwieja, Katarzyna] Jagiellonian Univ, Med Coll, Dept Pediat Nephrol & Hypertens, Dialysis Unit, Krakow, Poland; [Odeh, Rasha] Univ Jordan, Sch Med, Dept Pediat, Amman, Jordan; [Jarmuzek, Wioletta] Childrens Mem Hlth Inst, Dept Nephrol, Kidney Transplantat & Hypertens, Warsaw, Poland; [Trautmann, Agnes; Schaefer, Franz] Heidelberg Univ, Div Pediat Nephrol, Ctr Pediat & Adolescent Med, Heidelberg, Germany; [Antignac, Corinne] Hop Necker Enfants Malad, AP HP, Dept Genet, Paris, France	Fahrenheit Universities; Medical University Gdansk; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Fahrenheit Universities; University of Gdansk; King Abdulaziz University; Hacettepe University; Hacettepe University; Hacettepe University; Motol University Hospital; Hannover Medical School; Cukurova University; IRCCS Bambino Gesu; University of Cologne; CHU Bordeaux; Medical University Silesia; Medical University of Lublin; Jagiellonian University; Collegium Medicum Jagiellonian University; University of Jordan; Children's Memorial Health Institute; Ruprecht Karls University Heidelberg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Lipska-Zietkiewicz, BS (corresponding author), Med Univ Gdansk, Dept Biol & Med Genet, Clin Genet Unit, Gdansk, Poland.	b.lipska@gumed.edu.pl	Serna-Higuita, Lina Maria/J-8516-2017; Gribouval, Olivier/A-7689-2015; Massella, Laura/AAA-6165-2020; BAYAZIT, AYSUN K/E-8696-2018; Boyer, Olivia Gillion/H-9469-2017; Ziętkiewicz, Szymon/L-5259-2014; Lipska-Ziętkiewicz, Beata S./H-7047-2019; odeh, rasha/AAR-4519-2020; Odeh, Rasha/S-3867-2019; ANTIGNAC, Corinne/H-8945-2017; Habbig, Sandra/AHC-1168-2022	Serna-Higuita, Lina Maria/0000-0001-5182-8295; Gribouval, Olivier/0000-0003-0238-8224; BAYAZIT, AYSUN K/0000-0002-2644-5628; Boyer, Olivia Gillion/0000-0002-3957-1359; Lipska-Ziętkiewicz, Beata S./0000-0002-4169-9685; Odeh, Rasha/0000-0002-8419-0547; ANTIGNAC, Corinne/0000-0002-9934-4940; Hyla-Klekot, Lidia/0000-0002-2497-4737; Bienias, Beata/0000-0002-0176-9845; Zietkiewicz, Szymon/0000-0002-3435-4603; Szczepanska, Maria/0000-0002-6772-1983; Jarmuzek, Wioletta/0000-0002-9929-7486	European Community's Seventh Framework Programme [2012-305608]; Bundesministerium fur Bildung and Forschung (BMBF) through the e-Rare initiative (PodoNet)	European Community's Seventh Framework Programme(European Commission); Bundesministerium fur Bildung and Forschung (BMBF) through the e-Rare initiative (PodoNet)(Federal Ministry of Education & Research (BMBF))	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 2012-305608 (EURenOmics; http://cordis.europa.eu/project/rcn/105363_en.html) and from Bundesministerium fur Bildung and Forschung (BMBF; https://www.bmbf.de) through the e-Rare initiative (PodoNet). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardinger, 1993, GENEREVIEWS; Baradaran-Heravi A, 2012, HUM MOL GENET, V21, P2572, DOI 10.1093/hmg/dds083; Bhat KP, 2015, J BIOL CHEM, V290, P4110, DOI 10.1074/jbc.M114.627083; Boerkoel CF, 2002, NAT GENET, V30, P215, DOI 10.1038/ng821; Clewing JM, 2007, HUM MUTAT, V28, P273, DOI 10.1002/humu.20432; Elizondo LI, 2009, J MED GENET, V46, P49, DOI 10.1136/jmg.2008.060095; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lou S, 2002, J MED GENET, V39, P922, DOI 10.1136/jmg.39.12.922; Morimoto M, 2012, J DENT RES, V91, pS29, DOI 10.1177/0022034512450299; Sadowski CE, 2015, J AM SOC NEPHROL, V26, P1279, DOI 10.1681/ASN.2014050489; Safder O, 2014, PEDIATR NEPHROL, V29, P837, DOI [10.1007/s00467-014-2752-4, 10.1007/s00467-014-2754-2]; Sarin S, 2015, J HISTOCHEM CYTOCHEM, V63, P32, DOI 10.1369/0022155414558335; Trautmann A, 2015, CLIN J AM SOC NEPHRO, V10, P592, DOI 10.2215/CJN.06260614; Zachwieja K, 2012, NEFROL DIAL POL, V16, P37; Zieg J, 2011, PEDIATR RHEUMATOL, V9, DOI 10.1186/1546-0096-9-27	16	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0180926	10.1371/journal.pone.0180926	http://dx.doi.org/10.1371/journal.pone.0180926			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796785	Green Published, gold, Green Submitted			2022-12-26	WOS:000407396200010
J	Ofner, P; Schwarz, A; Pereira, J; Muller-Putz, GR				Ofner, Patrick; Schwarz, Andreas; Pereira, Joana; Mueller-Putz, Gernot R.			Upper limb movements can be decoded from the time-domain of low-frequency EEG	PLOS ONE			English	Article							POSTERIOR PARIETAL CORTEX; SPINAL-CORD-INJURY; SINGLE-TRIAL EEG; NEUROPROSTHESIS CONTROL; IMAGINED MOVEMENTS; UPPER EXTREMITY; MOTOR IMAGERY; CLASSIFICATION; TRAJECTORIES; INDIVIDUALS	How neural correlates of movements are represented in the human brain is of ongoing interest and has been researched with invasive and non-invasive methods. In this study, we analyzed the encoding of single upper limb movements in the time-domain of low-frequency electroencephalography (EEG) signals. Fifteen healthy subjects executed and imagined six different sustained upper limb movements. We classified these six movements and a rest class and obtained significant average classification accuracies of 55% (movement vs movement) and 87% (movement vs rest) for executed movements, and 27% and 73%, respectively, for imagined movements. Furthermore, we analyzed the classifier patterns in the source space and located the brain areas conveying discriminative movement information. The classifier patterns indicate that mainly premotor areas, primary motor cortex, somatosensory cortex and posterior parietal cortex convey discriminative movement information. The decoding of single upper limb movements is specially interesting in the context of a more natural non-invasive control of e.g., a motor neuroprosthesis or a robotic arm in highly motor disabled persons.	[Ofner, Patrick; Schwarz, Andreas; Pereira, Joana; Mueller-Putz, Gernot R.] Graz Univ Technol, Inst Neural Engn, BCI Lab, Graz, Austria	Graz University of Technology	Muller-Putz, GR (corresponding author), Graz Univ Technol, Inst Neural Engn, BCI Lab, Graz, Austria.	gernot.mueller@tugraz.at	Ofner, Patrick/AAA-8032-2020; Schwarz, Andreas/AAW-4973-2021; Pereira, Joana/AAG-7630-2021	Ofner, Patrick/0000-0001-7169-4300; Schwarz, Andreas/0000-0002-3883-4989; Pereira, Joana/0000-0002-2032-8981	European ICT Programme [H2020-643955]; ERC [ERC-681231]	European ICT Programme; ERC(European Research Council (ERC)European Commission)	This work is supported by the European ICT Programme Project H2020-643955 "MoreGrasp" and the ERC Consolidator Grant ERC-681231 "Feel Your Reach". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 2010, J NEURAL ENG, V7, DOI [10.1088/1741-2560/7/4/046002, 10.2202/1553-3840.1324]; Aflalo T, 2015, SCIENCE, V348, P906, DOI 10.1126/science.aaa5417; Agashe HA, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00121; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; [Anonymous], [No title captured], DOI DOI 10.1007/978-3-642-29746-5_17; Ball T, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016006; Blankertz B, 2011, NEUROIMAGE, V56, P814, DOI 10.1016/j.neuroimage.2010.06.048; Blokland Y, 2012, IEEE ENG MED BIO, P3967, DOI 10.1109/EMBC.2012.6346835; Bradberry TJ, 2010, J NEUROSCI, V30, P3432, DOI 10.1523/JNEUROSCI.6107-09.2010; Brunner Clemens, 2008, INT J BIOELEKTROMAGN, V10, P52, DOI DOI 10.1.1.330.3349; Bundy DT, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/2/026021; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; do Nascimento OF, 2006, EXP BRAIN RES, V171, P78, DOI 10.1007/s00221-005-0247-z; DUM RP, 1991, J NEUROSCI, V11, P667; Edelman BJ, 2016, IEEE T BIO-MED ENG, V63, P4, DOI 10.1109/TBME.2015.2467312; FARRAR DE, 1967, REV ECON STAT, V49, P92, DOI 10.2307/1937887; Gu Y, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.20.003.2009; Gu Y, 2009, CLIN NEUROPHYSIOL, V120, P1596, DOI 10.1016/j.clinph.2009.05.006; Hammer J, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00200; Haufe S, 2014, NEUROIMAGE, V87, P96, DOI 10.1016/j.neuroimage.2013.10.067; HJORTH B, 1975, ELECTROEN CLIN NEURO, V39, P526, DOI 10.1016/0013-4694(75)90056-5; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Hotson G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115236; Ibanez J, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/5/056009; Jochumsen M, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/5/056013; Kandel E. R., 2013, PRINCIPLES NEURAL SC; Kreilinger A, 2013, IEEE INTELL SYST, V28, P40; Lacourse MG, 1999, BEHAV BRAIN RES, V104, P73, DOI 10.1016/S0166-4328(99)00052-2; Liao X, 2007, IEEE T BIO-MED ENG, V54, P821, DOI 10.1109/TBME.2006.889206; Lopez-Larraz E, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-153; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Muller-Putz GR, 2005, NEUROSCI LETT, V382, P169, DOI 10.1016/j.neulet.2005.03.021; Neuper C, 2005, COGNITIVE BRAIN RES, V25, P668, DOI 10.1016/j.cogbrainres.2005.08.014; Niazi IK, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066009; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Ofner P, 2015, IEEE ENG MED BIO, P1468, DOI 10.1109/EMBC.2015.7318647; Ofner P, 2015, IEEE T BIO-MED ENG, V62, P972, DOI 10.1109/TBME.2014.2377023; Ofner P, 2012, IEEE ENG MED BIO, P6406, DOI 10.1109/EMBC.2012.6347460; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; PECK R, 1982, IEEE T PATTERN ANAL, V4, P530, DOI 10.1109/TPAMI.1982.4767298; Pfurtscheller G, 2000, NEUROSCI LETT, V292, P211, DOI 10.1016/S0304-3940(00)01471-3; Pfurtscheller G, 2003, NEUROSCI LETT, V351, P33, DOI 10.1016/S0304-3940(03)00947-9; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pistohl T, 2008, J NEUROSCI METH, V167, P105, DOI 10.1016/j.jneumeth.2007.10.001; Rohm M, 2013, ARTIF INTELL MED, V59, P133, DOI 10.1016/j.artmed.2013.07.004; Rupp R, 2007, ACTA NEUROCHIR SUPPL, V97, P419; Rupp R, 2015, P IEEE, V103, P954, DOI 10.1109/JPROC.2015.2395253; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Schalk G, 2007, J NEURAL ENG, V4, P264, DOI 10.1088/1741-2560/4/3/012; Seeber M, J NEUROSCI IN PRESS; Shibasaki H, 2006, CLIN NEUROPHYSIOL, V117, P2341, DOI 10.1016/j.clinph.2006.04.025; Shin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047992; Sugata H, 2016, SCI REP-UK, V6, DOI 10.1038/srep24663; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Vuckovic A, 2008, MED BIOL ENG COMPUT, V46, P529, DOI 10.1007/s11517-008-0345-8; Vuckovic A, 2012, MED ENG PHYS, V34, P964, DOI 10.1016/j.medengphy.2011.11.001; Wagner J, 2016, J NEUROSCI, V36, P2212, DOI 10.1523/JNEUROSCI.3543-15.2016; Waldert S, 2008, J NEUROSCI, V28, P1000, DOI 10.1523/JNEUROSCI.5171-07.2008; Wang W, 2010, J NEUROPHYSIOL, V104, P2451, DOI 10.1152/jn.00239.2010; Wodlinger B, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/1/016011; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Yong XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121896; Yuan H, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026001	66	107	110	12	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182578	10.1371/journal.pone.0182578	http://dx.doi.org/10.1371/journal.pone.0182578			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797109	Green Published, gold, Green Submitted			2022-12-26	WOS:000407396200064
J	Bangma, DF; Fuermaier, ABM; Tucha, L; Tucha, O; Koerts, J				Bangma, Dorien F.; Fuermaier, Anselm B. M.; Tucha, Lara; Tucha, Oliver; Koerts, Janneke			The effects of normal aging on multiple aspects of financial decision-making	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; PARKINSONS-DISEASE PATIENTS; IOWA GAMBLING TASK; TRAUMATIC BRAIN-INJURY; ADULT AGE-DIFFERENCES; OLDER-ADULTS; LIFE-SPAN; INDIVIDUAL-DIFFERENCES; EXTERNAL VALIDATION; ALZHEIMERS-DISEASE	Objectives Financial decision-making (FDM) is crucial for independent living. Due to cognitive decline that accompanies normal aging, older adults might have difficulties in some aspects of FDM. However, an improved knowledge, personal experience and affective decision-making, which are also related to normal aging, may lead to a stable or even improved age-related performance in some other aspects of FDM. Therefore, the present explorative study examines the effects of normal aging on multiple aspects of FDM. Methods One-hundred and eighty participants (range 18-87 years) were assessed with eight FDM tests and several standard neuropsychological tests. Age effects were evaluated using hierarchical multiple regression analyses. The validity of the prediction models was examined by internal validation (i.e. bootstrap resampling procedure) as well as external validation on another, independent, sample of participants (n = 124). Multiple regression and correlation analyses were applied to investigate the mediation effect of standard measures of cognition on the observed effects of age on FDM. Results On a relatively basic level of FDM (e.g., paying bills or using FDM styles) no significant effects of aging were found. However more complex FDM, such as making decisions in accordance with specific rules, becomes more difficult with advancing age. Furthermore, an older age was found to be related to a decreased sensitivity for impulsive buying. These results were confirmed by the internal and external validation analyses. Mediation effects of numeracy and planning were found to explain parts of the association between one aspect of FDM (i.e. Competence in decision rules) and age; however, these cognitive domains were not able to completely explain the relation between age and FDM. Conclusion Normal aging has a negative influence on a complex aspect of FDM, however, other aspects appear to be unaffected by normal aging or improve.	[Bangma, Dorien F.; Fuermaier, Anselm B. M.; Tucha, Lara; Tucha, Oliver; Koerts, Janneke] Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands	University of Groningen	Koerts, J (corresponding author), Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands.	janneke.koerts@rug.nl	Tucha, Oliver/AAD-1403-2019	Bangma, Dorien/0000-0003-4187-3679; Fuermaier, Anselm/0000-0002-2331-0840				APPELBAUM PS, 1988, NEW ENGL J MED, V319, P1635, DOI 10.1056/NEJM198812223192504; Barkley R. A., 2008, ADHD ADULTS WHAT SCI; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Beatty SE, 1998, J RETAILING, V74, P169, DOI 10.1016/S0022-4359(99)80092-X; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Beitz KM, 2014, J EXP PSYCHOL GEN, V143, P1677, DOI 10.1037/a0035823; Bleeker SE, 2003, J CLIN EPIDEMIOL, V56, P826, DOI 10.1016/S0895-4356(03)00207-5; Bouma A., 2012, HDB NEUROPSYCHOLOGIS, P717; Brand M, 2006, NEURAL NETWORKS, V19, P1266, DOI 10.1016/j.neunet.2006.03.001; Brickenkamp R, 2007, D2 AANDACHTS CONCENT; Brickenkamp R., 1998, D2 TEST ATTENTION, V1st; Buelow MT, 2009, NEUROPSYCHOL REV, V19, P102, DOI 10.1007/s11065-009-9083-4; Chen YW, 2014, EDUC GERONTOL, V40, P825, DOI 10.1080/03601277.2014.900263; Cohen J., 2003, APPL MULTIPLE REGRES; Coley A., 2003, J FASH MARK MANAG, V7, P282, DOI [10.1108/13612020310484834, DOI 10.1108/13612020310484834]; Davis C, 2008, J INT NEUROPSYCH SOC, V14, P1063, DOI 10.1017/S1355617708081204; de Bruin WB, 2015, MED DECIS MAKING, V35, P22, DOI 10.1177/0272989X14542485; De Bruin WB, 2012, J BEHAV DECIS MAKING, V25, P352, DOI 10.1002/bdm.712; de Bruin WB, 2007, J PERS SOC PSYCHOL, V92, P938, DOI 10.1037/0022-3514.92.5.938; Del Missier F, 2013, J EXP PSYCHOL LEARN, V39, P1344, DOI 10.1037/a0032379; Del Missier F, 2010, THINK REASONING, V16, P69, DOI 10.1080/13546781003630117; Denburg N.L., 2015, AGING DECISION MAKIN, P79, DOI 10.1016/B978-0-12-417148-0.00005-4; Denburg NL, 2005, NEUROPSYCHOLOGIA, V43, P1099, DOI 10.1016/j.neuropsychologia.2004.09.012; Dennis N. A., 2008, HDB AGING COGNITION, P1, DOI DOI 10.4324/9780203837665.CH1; Dijksterhuis A, 2006, SCIENCE, V311, P1005, DOI 10.1126/science.1121629; Dijksterhuis A, 2004, J PERS SOC PSYCHOL, V87, P586, DOI 10.1037/0022-3514.87.5.586; Dreer LE, 2012, REHABIL PSYCHOL, V57, P5, DOI 10.1037/a0025818; Earnst KS, 2001, AGING NEUROPSYCHOL C, V8, P109, DOI 10.1076/anec.8.2.109.839; Evans JSBT, 2008, ANNU REV PSYCHOL, V59, P255, DOI 10.1146/annurev.psych.59.103006.093629; Fein G, 2007, J INT NEUROPSYCH SOC, V13, P480, DOI 10.1017/S135561770707052X; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fry J, 2009, S AFR J PSYCHOL, V39, P122, DOI 10.1177/008124630903900111; Glimcher P.W., 2014, NEUROECONOMICS DECIS, P63; Grasman R. P. P. P., 2005, DHTML IMPLEMENTATION; GREEN L, 1994, PSYCHOL SCI, V5, P33, DOI 10.1111/j.1467-9280.1994.tb00610.x; Green L, 1996, PSYCHOL AGING, V11, P79, DOI 10.1037/0882-7974.11.1.79; GRISSO T, 1995, LAW HUMAN BEHAV, V19, P149, DOI 10.1007/BF01499323; HARREN VA, 1979, J VOCAT BEHAV, V14, P119, DOI 10.1016/0001-8791(79)90065-4; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Hess T.M., 2015, AGING DECISION MAKIN, P189, DOI [DOI 10.1016/B978-0-12-417148-0.00010-8, 10.1016/C2013-0-05180-8, DOI 10.1016/C2013-0-05180-8]; Hindmarch T, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-54; Karlawish J, 2013, NEUROLOGY, V81, P801, DOI 10.1212/WNL.0b013e3182a05ba5; Kennerley SW, 2011, BEHAV NEUROSCI, V125, P297, DOI 10.1037/a0023575; Kershaw M. M., 2004, PSYCHIAT PSYCHOL LAW, V11, P338, DOI [10.1375/pplt.2004.11.2.338, DOI 10.1375/PPLT.2004.11.2.338]; Kershaw MM, 2008, PSYCHIAT PSYCHOL LAW, V15, P40, DOI 10.1080/13218710701873965; Kim SYH, 2001, AM J PSYCHIAT, V158, P712, DOI 10.1176/appi.ajp.158.5.712; Krawczyk DC, 2002, NEUROSCI BIOBEHAV R, V26, P631, DOI 10.1016/S0149-7634(02)00021-0; Li SC, 2004, PSYCHOL SCI, V15, P155, DOI 10.1111/j.0956-7976.2004.01503003.x; Lockenhoff CE, 2011, PSYCHOL AGING, V26, P274, DOI 10.1037/a0023280; LOEWENSTEIN DA, 1989, J GERONTOL, V44, pP114, DOI 10.1093/geronj/44.4.P114; Loewenstein G., 2015, DECISION, P55, DOI [DOI 10.1037/DEC0000029, 10.1037/dec0000029]; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Loo R, 2000, PERS INDIV DIFFER, V29, P895, DOI 10.1016/S0191-8869(99)00241-X; Lui VWC, 2013, J GERIATR PSYCH NEUR, V26, P69, DOI 10.1177/0891988713481268; Luteijn F., 2004, GIT 2 GRONINGER INTE; Maillet D, 2013, AGEING RES REV, V12, P479, DOI 10.1016/j.arr.2012.11.001; Marson DC, 2000, ARCH NEUROL-CHICAGO, V57, P877, DOI 10.1001/archneur.57.6.877; Martin RC, 2008, MOVEMENT DISORD, V23, P1867, DOI 10.1002/mds.22170; Martin RC, 2013, PARKINSONISM RELAT D, V19, P986, DOI 10.1016/j.parkreldis.2013.06.017; Mather M, 2005, PSYCHOL AGING, V20, P554, DOI 10.1037/0882-7974.20.4.554; Mather M., 2006, REV DECISION MAKING, P145; MEYER BJF, 1995, PSYCHOL AGING, V10, P84, DOI 10.1037/0882-7974.10.1.84; Mikels JA, 2013, EMOTION, V13, P189, DOI 10.1037/a0030441; Mikels JA, 2011, EMOTION, V11, P743, DOI 10.1037/a0023986; Nieuwenstein MR, 2015, JUDGM DECIS MAK, V10, P1; Orgeta V, 2009, AGING MENT HEALTH, V13, P818, DOI 10.1080/13607860902989661; Parker AM, 2005, J BEHAV DECIS MAKING, V18, P1, DOI 10.1002/bdm.481; Pereira FS, 2010, J INT NEUROPSYCH SOC, V16, P297, DOI 10.1017/S1355617709991330; Peters E, 2007, PERSPECT PSYCHOL SCI, V2, P1, DOI 10.1111/j.1745-6916.2007.00025.x; Pirogovsky E, 2014, NEUROPSYCHOLOGY, V28, P229, DOI 10.1037/neu0000045; Read D, 2004, ORGAN BEHAV HUM DEC, V94, P22, DOI 10.1016/j.obhdp.2004.01.002; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Roelofs J, 2013, J PSYCHOPATHOL BEHAV, V35, P93, DOI 10.1007/s10862-012-9309-2; ROOK DW, 1987, J CONSUM RES, V14, P189, DOI 10.1086/209105; SALTHOUSE TA, 1995, J GERONTOL B-PSYCHOL, V50, pP297, DOI 10.1093/geronb/50B.6.P297; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Schmand B, 2008, Tijdschr Gerontol Geriatr, V39, P64; SCOTT SG, 1995, EDUC PSYCHOL MEAS, V55, P818, DOI 10.1177/0013164495055005017; Sherod MG, 2009, J INT NEUROPSYCH SOC, V15, P258, DOI 10.1017/S1355617709090365; Spicer D., 2005, J MANAGERIAL PSYCHOL, V20, P137, DOI [10.1108/02683940510579777, DOI 10.1108/02683940510579777]; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 2003, J CLIN EPIDEMIOL, V56, P441, DOI 10.1016/S0895-4356(03)00047-7; Suto WMI, 2005, J INTELL DISABIL RES, V49, P199, DOI 10.1111/j.1365-2788.2005.00635.x; Triebel KL, 2009, NEUROLOGY, V73, P928, DOI 10.1212/WNL.0b013e3181b87971; Van der Elst W, 2006, ASSESSMENT, V13, P62, DOI 10.1177/1073191105283427; Van der Elst W, 2005, J INT NEUROPSYCH SOC, V11, P290, DOI 10.1017/S1355617705050344; Van der Elst W, 2006, PSYCHOL ASSESSMENT, V18, P424, DOI 10.1037/1040-3590.18.4.424; van der Elst W, 2006, J CLIN EXP NEUROPSYC, V28, P998, DOI 10.1080/13803390591004428; Vellinga A, 2005, AGING MENT HEALTH, V9, P40, DOI 10.1080/13607860512331334059; Verplanken B, 2001, EUR J PERSONALITY, V15, pS71, DOI 10.1002/per.423; Webber LS., 2002, PSYCHIAT PSYCHOL LAW, V9, P248, DOI [10.1375/pplt.2002.9.2.248, DOI 10.1375/PPLT.2002.9.2.248]; Wechsler D., 2012, WAIS 4 KASIKIRJA; Wechsler D. WAIS-IV-NL, 2012, WAIS 4 NL WECHLER AD; West R., 2008, HDB AGING COGNITION, P311; Whelan R, 2009, PSYCHOL REC, V59, P247, DOI 10.1007/BF03395661; Wood RL, 2013, J INT NEUROPSYCH SOC, V19, P181, DOI 10.1017/S135561771200118X	98	19	19	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182620	10.1371/journal.pone.0182620	http://dx.doi.org/10.1371/journal.pone.0182620			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC9YJ	28792973	Green Published, gold, Green Submitted			2022-12-26	WOS:000407196700055
J	Gianino, MM; Politano, G; Scarmozzino, A; Charrier, L; Testa, M; Giacomelli, S; Benso, A; Zotti, CM				Gianino, Maria Michela; Politano, Gianfranco; Scarmozzino, Antonio; Charrier, Lorena; Testa, Marco; Giacomelli, Sebastian; Benso, Alfredo; Zotti, Carla Maria			Estimation of sickness absenteeism among Italian healthcare workers during seasonal influenza epidemics	PLOS ONE			English	Article							HOSPITAL STAFF; WORKING ADULTS; VACCINATION; ILLNESS; EMPLOYEES; ABSENCE; COSTS	Objectives To analyze absenteeism among healthcare workers (HCWs) at a large Italian hospital and to estimate the increase in absenteeism that occurred during seasonal flu periods. Design Retrospective observational study. Methods The absenteeism data were divided into three "epidemic periods," starting at week 42 of one year and terminating at week 17 of the following year (2010-2011, 2011-2012, 2012-2013), and three "non-epidemic periods" defined as week 18 to week 41 and used as baseline data. The excess of the absenteeism occurring among HCWs during periods of epidemic influenza in comparison with baseline was estimated. All data, obtained from Hospital's databases, were collected for each of the following six job categories: medical doctors, technical executives (i.e., pharmacists), nurses and allied health professionals (i.e., radiographers), other executives (i.e., engineers), nonmedical support staff, and administrative staff. The HCWs were classified by: in and no-contact; vaccinated and unvaccinated. Results 5,544, 5,369, and 5,291 workers in three years were studied. The average duration of absenteeism during the epidemic periods increased among all employees by +2.07 days/person (from 2.99 to 5.06), and the relative increase ranged from 64-94% among the different job categories. Workers not in contact with patients experienced a slightly greater increase in absenteeism (+2.28 days/person, from 2.73 to 5.01) than did employees in contact with patients (+2.04, from 3.04 to 5.08). The vaccination rate among HCWs was below 3%, however the higher excess of absenteeism rate among unvaccinated in comparison with vaccinated workers was observed during the epidemic periods (2.09 vs 1.45 days/person). Conclusion The influenza-related absenteeism during epidemic periods was quantified as totaling more than 11,000 days/year at the Italian hospital studied. This result confirms the economic impact of sick leave on healthcare systems and stresses on the necessity of encouraging HCWs to be immunized against influenza.	[Gianino, Maria Michela; Charrier, Lorena; Testa, Marco; Giacomelli, Sebastian; Zotti, Carla Maria] Univ Torino, Dept Publ Hlth Sci & Pediat, Turin, Italy; [Politano, Gianfranco; Benso, Alfredo] Politecn Torino, Dept Control & Comp Engn, Turin, Italy; [Scarmozzino, Antonio] AOU Citta Salute & Sci, Turin, Italy	University of Turin; Polytechnic University of Turin; A.O.U. Citta della Salute e della Scienza di Torino	Gianino, MM (corresponding author), Univ Torino, Dept Publ Hlth Sci & Pediat, Turin, Italy.	mariola.gianino@unito.it	Benso, Alfredo/ABC-5311-2020; Benso, Alfredo/GRO-2198-2022	Benso, Alfredo/0000-0003-3433-7739; Testa, Marco/0000-0001-5725-8131; Gianino, Maria Michela/0000-0003-4239-7475; Zotti, Carla Maria/0000-0003-3898-1206; Charrier, Lorena/0000-0002-1300-4508				Ahmed F, 2014, CLIN INFECT DIS, V58, P50, DOI 10.1093/cid/cit580; Akazawa M, 2003, VALUE HEALTH, V6, P107, DOI 10.1046/j.1524-4733.2003.00209.x; [Anonymous], 2021, LANG ENV STAT COMP; Blank PR, 2009, J INFECTION, V58, P446, DOI 10.1016/j.jinf.2009.04.001; Bridges CB, 2003, CLIN INFECT DIS, V37, P1094, DOI 10.1086/378292; Chan ALF, 2008, PHARM WORLD SCI, V30, P39, DOI 10.1007/s11096-007-9137-8; Del Manso M, 2016, GRUPPO LAVORO INFLUN; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; HAMMOND GW, 1984, CAN MED ASSOC J, V131, P449; Heuer C, 2016, EPIR TOOLS ANAL EPID; Huang XD, 2017, J INFECT DIS, V215, P1695, DOI 10.1093/infdis/jix181; Ip DKM, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1316-y; Keech M, 1998, OCCUP MED-OXFORD, V48, P85, DOI 10.1093/occmed/48.2.85; Ming RX, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0269-3; Ming RX, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0199-5; Mota NVYVP, 2011, EMERG INFECT DIS, V17, P1421, DOI 10.3201/eid1708.101546; Nguyen-Van-Tam J, 1999, INFECT CONT HOSP EP, V20, P691, DOI 10.1086/501568; NICHOL KL, 1995, NEW ENGL J MED, V333, P889, DOI 10.1056/NEJM199510053331401; O'Reilly FW, 2002, OCCUP MED-OXFORD, V52, P265, DOI 10.1093/occmed/52.5.265; Olsen GW, 1998, J OCCUP ENVIRON MED, V40, P311, DOI 10.1097/00043764-199804000-00004; Postma MJ, 2005, VACCINE, V23, P5365, DOI 10.1016/j.vaccine.2005.06.007; Schanzer DL, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-90; Schwarzer G., 2022, PACKAGE META VERSION; Tuccillo E, 2003, G Ital Med Lav Ergon, V25 Suppl, P155; Van Buynder PG, 2015, VACCINE, V33, P1625, DOI 10.1016/j.vaccine.2015.01.048; WEINGARTEN S, 1988, J GEN INTERN MED, V3, P32, DOI 10.1007/BF02595754; Yassi A, 1991, Can J Infect Dis, V2, P101	27	29	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182510	10.1371/journal.pone.0182510	http://dx.doi.org/10.1371/journal.pone.0182510			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28793335	Green Published, gold, Green Submitted			2022-12-26	WOS:000407196700049
J	Kochan, NA; Bunce, D; Pont, S; Crawford, JD; Brodaty, H; Sachdev, PS				Kochan, Nicole A.; Bunce, David; Pont, Sarah; Crawford, John D.; Brodaty, Henry; Sachdev, Perminder S.			Is intraindividual reaction time variability an independent cognitive predictor of mortality in old age? Findings from the Sydney Memory and Ageing Study	PLOS ONE			English	Article							MINI-MENTAL-STATE; ALL-CAUSE; DEMENTIA; IMPAIRMENT; COMMUNITY; ADULTS; ASSOCIATION; PERFORMANCE; INCONSISTENCY; FRAMINGHAM	Intraindividual variability of reaction time (IIVRT), a proposed cognitive marker of neurobiological disturbance, increases in old age, and has been associated with dementia and mortality. The extent to which IIVRT is an independent predictor of mortality, however, is unclear. This study investigated the association of IIVRT and all-cause mortality while accounting for cognitive level, incident dementia and biomedical risk factors in 861 participants aged 70-90 from the Sydney Memory and Ageing Study. Participants completed two computerised reaction time (RT) tasks (76 trials in total) at baseline, and comprehensive medical and neuropsychological assessments every 2 years. Composite RT measures were derived from the two tasks-the mean RT and the IIVRT measure computed from the intraindividual standard deviation of the RTs (with age and time-on-task effects partialled out). Consensus dementia diagnoses were made by an expert panel of clinicians using clinical criteria, and mortality data were obtained from a state registry. Cox proportional hazards models estimated the association of IIVRT and mean RT with survival time over 8 years during which 191 (22.2%) participants died. Greater IIVRT but not mean RT significantly predicted survival time after adjusting for age, sex, global cognition score, cardiovascular risk index and apolipoprotein epsilon 4 status. After excluding incident dementia cases, the association of IIVRT with mortality changed very little. Our findings suggest that greater IIVRT uniquely predicts shorter time to death and that lower global cognition and prodromal dementia in older individuals do not explain this relationship.	[Kochan, Nicole A.; Bunce, David; Pont, Sarah; Crawford, John D.; Brodaty, Henry; Sachdev, Perminder S.] UNSW, Sch Psychiat, Ctr Hlth Brain Ageing CHeBA, Sydney, NSW, Australia; [Kochan, Nicole A.; Sachdev, Perminder S.] Prince Wales Hosp, Neuropsychiat Inst, Randwick, NSW, Australia; [Bunce, David] Univ Leeds, Fac Med & Hlth, Sch Psychol, Leeds, W Yorkshire, England; [Brodaty, Henry] UNSW Australia, Sch Psychiat, DCRC ABC, Sydney, NSW, Australia	University of New South Wales Sydney; University of Leeds; University of New South Wales Sydney	Kochan, NA (corresponding author), UNSW, Sch Psychiat, Ctr Hlth Brain Ageing CHeBA, Sydney, NSW, Australia.	n.kochan@unsw.edu.au	Sachdev, Perminder/ABC-1137-2020	Sachdev, Perminder/0000-0002-9595-3220; Bunce, David/0000-0003-3265-2700	National Health and Medical Research Council of Australia Program Grant [350833]; National Health and Medical Research Council of Australia Early Career Fellowship [123148]; Dementia Collaborative Research Centre; Sydney Memory and Ageing Study; MAS research team	National Health and Medical Research Council of Australia Program Grant(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Dementia Collaborative Research Centre; Sydney Memory and Ageing Study; MAS research team	Funded by National Health and Medical Research Council of Australia Program Grant (grant number 350833) (HB PS), National Health and Medical Research Council of Australia Early Career Fellowship (grant number 123148) (NK), and Dementia Collaborative Research Centre (NK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank all participants and their supporters in the Sydney Memory and Ageing Study (MAS), and the MAS research team.	Anderson TM, 2007, AM J GERIAT PSYCHIAT, V15, P467, DOI 10.1097/JGP.0b013e3180547053; APA, 2000, DIAGN STAT MAN MENT; Batterham PJ, 2014, AGE AGEING, V43, P84, DOI 10.1093/ageing/aft116; Benton AL, 1996, BENTON TEST; Bielak AAM, 2014, DEV PSYCHOL, V50, P143, DOI 10.1037/a0032650; Bielak AAM, 2010, NEUROPSYCHOLOGY, V24, P731, DOI 10.1037/a0019802; Bielak AAM, 2010, PSYCHOL AGING, V25, P575, DOI 10.1037/a0019503; Brodaty H, 2012, INT PSYCHOGERIATR, V24, P1034, DOI 10.1017/S1041610211002924; Bunce D, 2004, BRAIN COGNITION, V56, P320, DOI 10.1016/j.bandc.2004.08.006; Bunce D, 2007, NEUROPSYCHOLOGIA, V45, P2009, DOI 10.1016/j.neuropsychologia.2007.02.006; Christensen H, 2001, PSYCHOL AGING, V16, P588, DOI 10.1037//0882-7974.16.4.588; Connors MH, 2016, J ALZHEIMERS DIS, V52, P967, DOI 10.3233/JAD-150946; Connors MH, 2015, AGE AGEING, V44, P1049, DOI 10.1093/ageing/afv139; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; de Frias CM, 2007, NEUROPSYCHOLOGIA, V45, P2499, DOI 10.1016/j.neuropsychologia.2007.03.022; Deary IJ, 2006, NEUROLOGY, V66, P505, DOI 10.1212/01.wnl.0000199954.81900.e2; Deary IJ, 2005, PSYCHOL SCI, V16, P64, DOI 10.1111/j.0956-7976.2005.00781.x; Dewey ME, 2001, INT J GERIATR PSYCH, V16, P751, DOI 10.1002/gps.397.abs; Drag L. L., 2009, J GERIATR PSYCHIAT, V23, P75, DOI DOI 10.1177/0891988709358590; Ewbank DC, 2007, J GERONTOL A-BIOL, V62, P899, DOI 10.1093/gerona/62.8.899; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fratiglioni L, 2000, NEUROLOGY, V54, pS10; Goh LGH, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-118; Graveson J, 2016, J GERONTOL B-PSYCHOL, V71, P857, DOI 10.1093/geronb/gbv027; Hultsch DF, 2000, NEUROPSYCHOLOGY, V14, P588, DOI 10.1037/0894-4105.14.4.588; Hultsch DF, 2002, J GERONTOL B-PSYCHOL, V57, pP101, DOI 10.1093/geronb/57.2.P101; Hultsch DF., 2008, HDB AGING COGNITION, P491, DOI DOI 10.4324/9780203837665.CH10; Jacova C, 2006, NEUROLOGY, V67, pS17, DOI 10.1212/WNL.67.9_suppl_3.S17; Kaplan E, 2001, BOSTON NAMING TEST; Knopman DS, 2014, AM J EPIDEMIOL, V180, P414, DOI 10.1093/aje/kwu103; Kochan NA, 2016, AM J GERIAT PSYCHIAT, V24, P221, DOI 10.1016/j.jagp.2015.12.005; Kochan NA, 2010, AM J GERIAT PSYCHIAT, V18, P711, DOI 10.1097/JGP.0b013e3181d6b6a9; Li SC, 2001, TRENDS COGN SCI, V5, P479, DOI 10.1016/S1364-6613(00)01769-1; Lipnicki DM, 2017, J AM MED DIR ASSOC, V18, P388, DOI 10.1016/j.jamda.2016.10.014; Low LF, 2012, AM J GERIAT PSYCHIAT, V20, P866, DOI 10.1097/JGP.0b013e31823e31e2; MacDonald SWS, 2008, PSYCHOL AGING, V23, P595, DOI 10.1037/0882-7974.23.3.595; MacDonald SWS, 2009, NEUROPSYCHOLOGIA, V47, P2299, DOI 10.1016/j.neuropsychologia.2009.01.016; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Mitchell AJ, 2009, J PSYCHIATR RES, V43, P411, DOI 10.1016/j.jpsychires.2008.04.014; Nelson H., 1991, NATL ADULT READING T; Perna L, 2015, AGE AGEING, V44, P445, DOI 10.1093/ageing/afu188; Sachdev PS, 2010, INT PSYCHOGERIATR, V22, P1248, DOI 10.1017/S1041610210001067; Schmiedek F, 2007, J EXP PSYCHOL GEN, V136, P414, DOI 10.1037/0096-3445.136.3.414; Shipley BA, 2007, PSYCHOSOM MED, V69, P640, DOI 10.1097/PSY.0b013e31814c3e7c; Song F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034078; Strauss E, 2006, COMPENDIUM NEUROPSYC; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wechsler D., 1997, WECHSLER ADULT INTEL; West R, 2002, BRAIN COGNITION, V49, P402, DOI 10.1006/brcg.2001.1507	50	14	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0181719	10.1371/journal.pone.0181719	http://dx.doi.org/10.1371/journal.pone.0181719			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC9YJ	28792946	Green Published, Green Submitted, gold			2022-12-26	WOS:000407196700019
J	Haserick, JR; Klein, JA; Costello, CE; Samuelson, J				Haserick, John R.; Klein, Joshua A.; Costello, Catherine E.; Samuelson, John			Cryptosporidium parvum vaccine candidates are incompletely modified with O-linked-N-acetylgalactosamine or contain N-terminal N-myristate and S-palmitate	PLOS ONE			English	Article							MUCIN-LIKE GLYCOPROTEINS; DEVELOPING-COUNTRIES; ANTIBODY-RESPONSES; IMMUNE-RESPONSES; BIRTH COHORT; CHILDREN; GLYCANS; ANTIGEN; SURFACE; PALMITOYLATION	Cryptosporidium parvum (studied here) and Cryptosporidium hominis are important causes of diarrhea in infants and immunosuppressed persons. C. parvum vaccine candidates, which are on the surface of sporozoites, include glycoproteins with Ser-and Thr-rich domains (Gp15, Gp40, and Gp900) and a low complexity, acidic protein (Cp23). Here we used mass spectrometry to determine that O-linked GalNAc is present in dense arrays on a glycopeptide with consecutive Ser derived from Gp40 and on glycopeptides with consecutive Thr derived from Gp20, a novel C. parvum glycoprotein with a formula weight of similar to 20 kDa. In contrast, the occupied Ser or Thr residues in glycopeptides from Gp15 and Gp900 are isolated from one another. Gly at the N-terminus of Cp23 is N-myristoylated, while Cys, the second amino acid, is S-palmitoylated. In summary, C. parvum O-GalNAc transferases, which are homologs of host enzymes, densely modify arrays of Ser or Thr, as well as isolated Ser and Thr residues on C. parvum vaccine candidates. The N-terminus of an immunodominant antigen has lipid modifications similar to those of host cells and other apicomplexan parasites. Mass spectrometric demonstration here of glycopeptides with O-glycans complements previous identification C. parvum O-GalNAc transferases, lectin binding to vaccine candidates, and human and mouse antibodies binding to glycopeptides. The significance of these post-translational modifications is discussed with regards to the function of these proteins and the design of serological tests and vaccines.	[Haserick, John R.; Samuelson, John] Boston Univ, Dept Mol & Cell Biol, Goldman Sch Dent Med, Boston, MA 02215 USA; [Haserick, John R.; Costello, Catherine E.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Klein, Joshua A.] Boston Univ, Program Bioinformat, Boston, MA 02215 USA	Boston University; Boston University; Boston University	Samuelson, J (corresponding author), Boston Univ, Dept Mol & Cell Biol, Goldman Sch Dent Med, Boston, MA 02215 USA.	jsamuels@bu.edu		Costello, Catherine/0000-0003-1594-5122; Klein, Joshua/0000-0003-1279-6838	NIH [R01 AI110638, R01 GM031318, UL1TR001430, P41 GM104603, S10 RR025082, S10 OD010724]; NIH-NHLBI [HHSN268201000031C]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support for this study came from NIH grants R01 AI110638, R01 GM031318, and UL1TR001430 (J.S.) and P41 GM104603, S10 RR025082, and S10 OD010724 (C.E.C.) and from NIH-NHLBI contract HHSN268201000031C (C.E.C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ajjampur SSR, 2011, CLIN VACCINE IMMUNOL, V18, P633, DOI 10.1128/CVI.00464-10; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARROWOOD MJ, 1989, INFECT IMMUN, V57, P2283, DOI 10.1128/IAI.57.8.2283-2288.1989; Aurrecoechea C, 2017, NUCLEIC ACIDS RES, V45, pD581, DOI 10.1093/nar/gkw1105; Baldursson S, 2011, WATER RES, V45, P6603, DOI 10.1016/j.watres.2011.10.013; Barnes DA, 1998, MOL BIOCHEM PARASIT, V96, P93, DOI 10.1016/S0166-6851(98)00119-4; Beck JR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003162; Bedi B, 2012, PARASITE IMMUNOL, V34, P473, DOI 10.1111/j.1365-3024.2012.01382.x; Benitez AJ, 2009, CLIN VACCINE IMMUNOL, V16, P1272, DOI 10.1128/CVI.00089-09; Bhat N, 2007, J BIOL CHEM, V282, P34877, DOI 10.1074/jbc.M706950200; Bhat N, 2013, MOL BIOCHEM PARASIT, V191, P24, DOI 10.1016/j.molbiopara.2013.08.002; Borad AJ, 2012, AM J TROP MED HYG, V86, P214, DOI 10.4269/ajtmh.2012.11-0273; Bushkin GG, 2013, MBIO, V4, DOI 10.1128/mBio.00387-13; Bushkin GG, 2010, EUKARYOT CELL, V9, P228, DOI 10.1128/EC.00197-09; Cabada MM, 2010, CURR OPIN INFECT DIS, V23, P494, DOI 10.1097/QCO.0b013e32833de052; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Cevallos AM, 2000, INFECT IMMUN, V68, P4108, DOI 10.1128/IAI.68.7.4108-4116.2000; Cevallos AM, 2000, INFECT IMMUN, V68, P5167, DOI 10.1128/IAI.68.9.5167-5175.2000; Chatterjee A, 2010, EUKARYOT CELL, V9, P84, DOI 10.1128/EC.00288-09; Checkley W, 2015, LANCET INFECT DIS, V15, P85, DOI 10.1016/S1473-3099(14)70772-8; Child MA, 2013, NAT CHEM BIOL, V9, P651, DOI 10.1038/nchembio.1315; Ciucanu I, 2003, J AM CHEM SOC, V125, P16213, DOI 10.1021/ja035660t; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Du XL, 2009, DIAGN MICR INFEC DIS, V65, P271, DOI 10.1016/j.diagmicrobio.2009.07.020; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Ehigiator HN, 2007, PARASITOL RES, V101, P943, DOI 10.1007/s00436-007-0565-0; Eisenhaber B, 1998, PROTEIN ENG, V11, P1155, DOI 10.1093/protein/11.12.1155; Esch KJ, 2013, CLIN MICROBIOL REV, V26, P58, DOI 10.1128/CMR.00067-12; Fayer Ronald, 2007, P1, DOI 10.1201/9781420052275.ch1; Foe IT, 2015, CELL HOST MICROBE, V18, P501, DOI 10.1016/j.chom.2015.09.006; Frenal K, 2014, INT J PARASITOL, V44, P121, DOI 10.1016/j.ijpara.2013.09.004; GARCIA LS, 1983, J CLIN MICROBIOL, V18, P185, DOI 10.1128/JCM.18.1.185-190.1983; Gill DJ, 2011, TRENDS CELL BIOL, V21, P149, DOI 10.1016/j.tcb.2010.11.004; Hanisch FA, 2001, BIOL CHEM, V382, P143, DOI 10.1515/BC.2001.022; Haserick JR, 2017, MOL CELL PROTEOMICS, V16, pS42, DOI [10.1074/mcp.M116.066035, 10.1074/mcp.m116.066035]; Heiges M, 2006, NUCLEIC ACIDS RES, V34, pD419, DOI 10.1093/nar/gkj078; Heimburg-Molinaro J, 2013, INT J PARASITOL, V43, P901, DOI 10.1016/j.ijpara.2013.05.012; Hira KG, 2011, J CLIN MICROBIOL, V49, P2307, DOI 10.1128/JCM.00164-11; Hurtado-Guerrero R, 2016, BIOCHEM SOC T, V44, P61, DOI 10.1042/BST20150178; Ji YH, 2016, J AM SOC MASS SPECTR, V27, P677, DOI 10.1007/s13361-015-1319-3; Ji YH, 2013, ANAL CHEM, V85, P11952, DOI 10.1021/ac402850s; Jones AR, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014381; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; Ju TZ, 2011, ANGEW CHEM INT EDIT, V50, P1770, DOI 10.1002/anie.201002313; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Lazarus RP, 2015, AM J TROP MED HYG, V93, P931, DOI 10.4269/ajtmh.15-0044; Liu K, 2010, PARASITE IMMUNOL, V32, P335, DOI 10.1111/j.1365-3024.2009.01191.x; Ludington Jacob G, 2015, Curr Trop Med Rep, V2, P171; MACKENZIE WR, 1995, CLIN INFECT DIS, V21, P57, DOI 10.1093/clinids/21.1.57; Madrid-Aliste CJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-38; McDonald AC, 2001, J INFECT DIS, V183, P1373, DOI 10.1086/319862; Mead JR, 2014, HUM VACC IMMUNOTHER, V10, P1505, DOI 10.4161/hv.28485; O'Connor RM, 2003, INFECT IMMUN, V71, P6027, DOI 10.1128/IAI.71.10.6027-6034.2003; O'Connor RM, 2007, MOL BIOCHEM PARASIT, V156, P80, DOI 10.1016/j.molbiopara.2007.07.010; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Paul P, 2015, J MOL MODEL, V21, DOI 10.1007/s00894-015-2586-4; Perryman LE, 1996, MOL BIOCHEM PARASIT, V80, P137, DOI 10.1016/0166-6851(96)02681-3; PETERSEN C, 1992, INFECT IMMUN, V60, P5132, DOI 10.1128/IAI.60.12.5132-5138.1992; Platts-Mills JA, 2015, LANCET GLOB HEALTH, V3, pE564, DOI 10.1016/S2214-109X(15)00151-5; Priest JW, 2006, MOL BIOCHEM PARASIT, V149, P108, DOI 10.1016/j.molbiopara.2006.04.006; Priest JW, 2000, MOL BIOCHEM PARASIT, V106, P261, DOI 10.1016/S0166-6851(99)00223-6; Resh MD, 2016, PROG LIPID RES, V63, P120, DOI 10.1016/j.plipres.2016.05.002; Risk BA, 2013, J PROTEOME RES, V12, P4240, DOI 10.1021/pr400286p; Roche JK, 2013, VACCINE, V31, P912, DOI 10.1016/j.vaccine.2012.12.007; Samuelson J, 2005, P NATL ACAD SCI USA, V102, P1548, DOI 10.1073/pnas.0409460102; Sanderson SJ, 2008, PROTEOMICS, V8, P1398, DOI 10.1002/pmic.200700804; Sarkar R, 2014, AM J TROP MED HYG, V91, P1128, DOI 10.4269/ajtmh.14-0304; Sarkar R, 2012, CLIN VACCINE IMMUNOL, V19, P849, DOI 10.1128/CVI.00051-12; Schiller B, 2012, BIOL CHEM, V393, P661, DOI 10.1515/hsz-2012-0150; Shayan P, 2008, PARASITOL RES, V103, P1207, DOI 10.1007/s00436-008-1117-y; Singh P, 2015, WORLD J MICROB BIOT, V31, P1923, DOI 10.1007/s11274-015-1936-9; Smith LM, 2001, J PARASITOL, V87, P704, DOI 10.1645/0022-3395(2001)087[0704:HTABCI]2.0.CO;2; Snelling WJ, 2007, MOL CELL PROTEOMICS, V6, P346, DOI 10.1074/mcp.M600372-MCP200; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Strong WB, 2000, INFECT IMMUN, V68, P4117, DOI 10.1128/IAI.68.7.4117-4134.2000; STROUS GJ, 1992, CRIT REV BIOCHEM MOL, V27, P57, DOI 10.3109/10409239209082559; TILLEY M, 1991, INFECT IMMUN, V59, P1002, DOI 10.1128/IAI.59.3.1002-1007.1991; Tzipori S, 2008, TRENDS PARASITOL, V24, P184, DOI 10.1016/j.pt.2008.01.002; Vinayak S, 2015, NATURE, V523, P477, DOI 10.1038/nature14651; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wang YC, 2010, P NATL ACAD SCI USA, V107, P9228, DOI 10.1073/pnas.0914004107; Wanyiri JW, 2007, INFECT IMMUN, V75, P184, DOI 10.1128/IAI.00944-06; Wanyiri JW, 2014, AM J TROP MED HYG, V91, P319, DOI 10.4269/ajtmh.13-0254; Wetzel J, 2015, J BIOL CHEM, V290, P1712, DOI 10.1074/jbc.M114.598094; Winter Gerhard, 2000, Functional and Integrative Genomics, V1, P207, DOI 10.1007/s101420000028; Wright MH, 2014, NAT CHEM, V6, P112, DOI [10.1038/NCHEM.1830, 10.1038/nchem.1830]; Yang Z, 2014, MOL CELL PROTEOMICS, V13, P3224, DOI 10.1074/mcp.M114.041541	88	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2017	12	8							e0182395	10.1371/journal.pone.0182395	http://dx.doi.org/10.1371/journal.pone.0182395			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9EU	28792526	Green Published, gold, Green Submitted			2022-12-26	WOS:000407144700017
J	Scheiber, IBR; de Jong, ME; Komdeur, J; Pschernig, E; Loonen, MJJE; Millesi, E; Weiss, BM				Scheiber, Isabella B. R.; de Jong, Margje E.; Komdeur, Jan; Pschernig, Elisabeth; Loonen, Maarten J. J. E.; Millesi, Eva; Weiss, Brigitte M.			Diel pattern of corticosterone metabolites in Arctic barnacle goslings (Branta leucopsis) under continuous natural light	PLOS ONE			English	Article							FECAL GLUCOCORTICOID METABOLITES; LONGSPURS CALCARIUS-LAPPONICUS; STRESS-INDUCED CORTICOSTERONE; BASE-LINE; ENZYME-IMMUNOASSAY; CIRCADIAN-RHYTHMS; PLASMA MELATONIN; PHYSIOLOGICAL VALIDATION; NONINVASIVE MEASUREMENT; HORMONE METABOLITES	Here we describe the excretion pattern of corticosterone metabolites collected from droppings in barnacle goslings (Branta leucopsis) raised under 24 hours of continuous natural light in the Arctic. In lower latitudes, circulating corticosterone peaks around waking and shows a nadir between midnight and 4:00, whereas the peak and nadir are time-delayed slightly when measuring corticosterone metabolites from droppings. Photoperiod, along with other environmental factors, helps to entrain an animal's endogenous rhythm to that of the natural world. North of the Arctic Circle, photoperiod may not be a reliable cue as light is continuously absent during the winter and continuously present during the summer. Here, for the first time, we used droppings to describe a 24-hour excretion pattern of corticosterone metabolites (CORTm). By applying circular statistics for dependent data, we found a diel rhythmic pattern even under continuous natural light. We discuss potential alternative 'Zeitgeber' that may function even in the polar regions, focusing on melatonin. We propose a line of research to measure melatonin non-invasively from droppings. We also provide a validation of the adopted enzyme immunoassay (EIA) that was originally developed for greylag geese.	[Scheiber, Isabella B. R.; Komdeur, Jan; Weiss, Brigitte M.] Univ Groningen, Groningen Inst Evolut Life Sci, Behav & Physiol Ecol, Groningen, Netherlands; [de Jong, Margje E.; Loonen, Maarten J. J. E.] Univ Groningen, Arctic Ctr, Groningen, Netherlands; [Pschernig, Elisabeth; Millesi, Eva] Univ Vienna, Dept Behav Biol, Vienna, Austria; [Weiss, Brigitte M.] Univ Leipzig, Behav Ecol Res Grp, Leipzig, Germany; [Weiss, Brigitte M.] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany	University of Groningen; University of Groningen; University of Vienna; Leipzig University; Max Planck Society	Scheiber, IBR (corresponding author), Univ Groningen, Groningen Inst Evolut Life Sci, Behav & Physiol Ecol, Groningen, Netherlands.	isabella_scheiber@t-online.de	de Jong, Margje E./S-3091-2019; Scheiber, Isabella B. R./E-4109-2015; Komdeur, Jan/X-1261-2019	de Jong, Margje E./0000-0002-4941-8323; Scheiber, Isabella B. R./0000-0003-3438-1836; Komdeur, Jan/0000-0002-9241-0124; Millesi, Eva/0000-0003-0740-0413; Loonen, Maarten J.J.E./0000-0002-3426-4595; Weiss, Brigitte/0000-0001-6316-5636	Netherlands Organisation for Scientific Research (NWO, Den Haag, The Netherlands) [866.12.406]; University of Groningen [132335]; Nikolaas Mulerius Stichting of the University of Groningen	Netherlands Organisation for Scientific Research (NWO, Den Haag, The Netherlands); University of Groningen; Nikolaas Mulerius Stichting of the University of Groningen	The study was funded by a grant (Dossier Nos. 866.12.406) from the Netherlands Organisation for Scientific Research (NWO, Den Haag, The Netherlands) to J. Komdeur, as well as a grant (No 132335) contributed by the University of Groningen to J. Komdeur, and a grant by the Nikolaas Mulerius Stichting of the University of Groningen to I. B. R. Scheiber. No funding body had any role in designing the study, collection, analysis or interpretation of the results nor did any funding body participate in writing any portion of this manuscript.; The Governor of Svalbard and the Norwegian Animal Research Authority gave permission for hand-raising goslings. We are grateful to Ben Frederiks, Peter Jordan, Marieke Krikke, Janwillem and Willemijn Loonen, and Ariadna Szczybelski Ciordia (The Netherlands Arctic Station), who were indispensable during the 24 -hour data dropping collection in Ny-Alesund, and the staff of the animal care facility (University of Groningen) for help with maintenance of the captive geese. We are grateful to Oceanwide Expeditions for their continued logistic support for transporting samples. Philipp Stoger-Haselbock (Department of Behavioural Biology, The University of Vienna, Austria) prepared dropping samples for EIAs. We thank Rupert Palme (Unit of Physiology, Pathophysiology and Experimental Endocrinology, University of Veterinary Medicine, Vienna, Austria) for helpful discussions and Jesse Krause, the editor Nicolas Cermakian, and several anonymous reviewers for helpful suggestions, also on a previous version of the paper. We very much appreciate all the help by Roelof Hut (University of Groningen, the Neurobiology group subfield Chronobiology, GELIFES) with analysing the circadian patterns, Max Ringler (Dept. of Ecology and Evolutionary Biology, UCLA, USA) for helpful discussion on non-parametric circular statistics, Michela Bursana (University of Groningen, Behavioural and Physiological Ecology, GELIFES) for help with writing the script for Fig 2 in R (Version 3.2.3; The R Foundation for Statistical Computing (2015), Ifflp://www.Rprojectorg) and Kenneth P. Able for his input and proofreading. The study was funded by a grant (Dossier Nos. 866.12.406) from the Netherlands Organisation for Scientific Research (NWO, Den Haag, The Netherlands) to J. Komdeur, as well as a grant (No 132335) contributed by the University of Groningen to J. Komdeur, and a grant by the Nikolaas Mulerius Stichting of the University of Groningen to I. B. R. Scheiber. No funding body had any role in designing the study, collection, analysis or interpretation of the results nor did any funding body participate in writing any portion of this manuscript.	ADER R, 1969, SCIENCE, V163, P1225, DOI 10.1126/science.163.3872.1225; Angelier F, 2013, GEN COMP ENDOCR, V182, P7, DOI 10.1016/j.ygcen.2012.10.008; Ashley NT, 2014, J BIOL RHYTHM, V29, P456, DOI 10.1177/0748730414552323; Ashley NT, 2013, J EXP ZOOL PART A, V319A, P10, DOI 10.1002/jez.1768; ASTHEIMER LB, 1992, ORNIS SCAND, V23, P355, DOI 10.2307/3676661; Aubin S, 2017, BEHAV BRAIN RES, V317, P515, DOI 10.1016/j.bbr.2016.09.060; Benhaiem S, 2012, GEN COMP ENDOCR, V178, P265, DOI 10.1016/j.ygcen.2012.05.006; Bloch G, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0019; Breuner CW, 1999, J EXP ZOOL, V284, P334, DOI 10.1002/(SICI)1097-010X(19990801)284:3<334::AID-JEZ11>3.3.CO;2-R; Cavigellil SA, 2005, J ENDOCRINOL, V184, P153, DOI 10.1677/joe.1.05935; Challet E, 2015, DIABETES OBES METAB, V17, P76, DOI 10.1111/dom.12516; Chung S, 2011, BBA-MOL BASIS DIS, V1812, P581, DOI 10.1016/j.bbadis.2011.02.003; COCKREM JF, 1991, J PINEAL RES, V11, P63, DOI 10.1111/j.1600-079X.1991.tb00457.x; Cyr NE, 2007, GEN COMP ENDOCR, V154, P59, DOI 10.1016/j.ygcen.2007.06.016; de Almeida EA, 2011, CHILD NERV SYST, V27, P879, DOI 10.1007/s00381-010-1278-8; Deviche P, 2014, GEN COMP ENDOCR, V203, P120, DOI 10.1016/j.ygcen.2014.01.010; Dolnik OV, 2011, PARASITOLOGY, V138, P1077, DOI 10.1017/S0031182011000795; Dufty AM, 1997, PHYSIOL ZOOL, V70, P143, DOI 10.1086/639564; Ebbinge B., 1975, Wildfowl, V26, P5; Ellis T, 2007, AQUACULTURE, V272, P698, DOI 10.1016/j.aquaculture.2007.07.219; Fowler Murray E., 2013, P131; FOX A D, 1985, Wildfowl, V36, P21; Frigerio D, 2004, GEN COMP ENDOCR, V137, P29, DOI 10.1016/j.ygcen.2004.02.013; Good T, 2003, PHYSIOL BEHAV, V80, P405, DOI 10.1016/j.physbeh.2003.09.006; Goymann W, 2005, ANN NY ACAD SCI, V1046, P35, DOI 10.1196/annals.1343.005; Goymann W, 2011, J BIOL RHYTHM, V26, P44, DOI 10.1177/0748730410388394; Harris A, 2011, INT J CIRCUMPOL HEAL, V70, P542, DOI 10.3402/ijch.v70i5.17857; Hau M, 2002, GEN COMP ENDOCR, V126, P101, DOI 10.1006/gcen.2002.7776; Hemetsberger J, 2010, INTERACT STUD, V11, P380, DOI 10.1075/is.11.3.03hem; Herring G, 2009, J WILDLIFE MANAGE, V73, P1010, DOI 10.2193/2008-398; Hirschenhauser K, 2012, J ORNITHOL, V153, P1179, DOI 10.1007/s10336-012-0848-9; JOSEPH MM, 1973, GEN COMP ENDOCR, V20, P326, DOI 10.1016/0016-6480(73)90184-6; Kalsbeek A, 2012, MOL CELL ENDOCRINOL, V349, P20, DOI 10.1016/j.mce.2011.06.042; Kidawa D, 2014, POLAR BIOL, V37, P641, DOI 10.1007/s00300-014-1464-3; Klasing KC, 2005, ANN NY ACAD SCI, V1046, P5, DOI 10.1196/annals.1343.003; Koch M, 2009, POLAR BIOL, V32, P281, DOI 10.1007/s00300-008-0529-6; Krause JS, 2015, PHYSIOL BIOCHEM ZOOL, V88, P589, DOI 10.1086/683321; Landys MM, 2006, GEN COMP ENDOCR, V148, P132, DOI 10.1016/j.ygcen.2006.02.013; Legagneux P, 2011, GEN COMP ENDOCR, V172, P440, DOI 10.1016/j.ygcen.2011.04.009; Loonen MJJE, 1999, J ANIM ECOL, V68, P753, DOI 10.1046/j.1365-2656.1999.00325.x; Meddle SL, 2003, P ROY SOC B-BIOL SCI, V270, P1849, DOI 10.1098/rspb.2003.2455; MICHE F, 1991, GEN COMP ENDOCR, V84, P249, DOI 10.1016/0016-6480(91)90048-B; Mostl E, 2005, ANN NY ACAD SCI, V1046, P17, DOI 10.1196/annals.1343.004; Mostl E, 2002, DOMEST ANIM ENDOCRIN, V23, P67, DOI 10.1016/S0739-7240(02)00146-7; Nakagawa S, 2003, POLAR BIOL, V26, P491, DOI 10.1007/s00300-003-0506-z; Nelson R. J., 2000, INTRO BEHAV ENDOCRIN; OWEN M, 1992, ORNIS SCAND, V23, P451, DOI 10.2307/3676676; Palme R, 2005, ANN NY ACAD SCI, V1046, P75, DOI 10.1196/annals.1343.007; Palme R, 2013, WIEN TIERARZTL MONAT, V100, P238; Palme R, 2012, ANIM WELFARE, V21, P331, DOI 10.7120/09627286.21.3.331; Palme R, 2009, BIOCH DOBS; PERISSIN L, 1993, J PINEAL RES, V15, P138, DOI 10.1111/j.1600-079X.1993.tb00520.x; Quillfeldt P, 2007, NATURWISSENSCHAFTEN, V94, P919, DOI 10.1007/s00114-007-0275-6; Reierth E, 1999, J BIOL RHYTHM, V14, P314, DOI 10.1177/074873099129000731; Rimbach R, 2013, GEN COMP ENDOCR, V191, P13, DOI 10.1016/j.ygcen.2013.05.010; Romero LM, 2000, GEN COMP ENDOCR, V119, P52, DOI 10.1006/gcen.2000.7491; Romero LM, 2005, COMP BIOCHEM PHYS A, V140, P73, DOI 10.1016/j.cbpb.2004.11.004; Scheiber IBR, 2015, J ANIM SCI, V93, P2124, DOI 10.2527/jas.2014-8523; Scheiber IBR, 2005, ANN NY ACAD SCI, V1046, P154, DOI 10.1196/annals.1343.012; Scheiber IBR, 2009, HORM BEHAV, V55, P133, DOI 10.1016/j.yhbeh.2008.09.006; SCHUTZ K, 1997, ADV ETHOL, V32, P66; Sheriff MJ, 2011, OECOLOGIA, V166, P869, DOI 10.1007/s00442-011-1943-y; Silverin B, 2009, HORM BEHAV, V56, P163, DOI 10.1016/j.yhbeh.2009.04.002; Stahl J, 2001, ANIM BEHAV, V61, P257, DOI 10.1006/anbe.2000.1564; Steenweg RJ, 2015, GEN COMP ENDOCR, V216, P39, DOI 10.1016/j.ygcen.2015.04.012; Steiger SS, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1016; Stowe M, 2010, HORM BEHAV, V58, P864, DOI 10.1016/j.yhbeh.2010.08.011; STOKKAN KA, 1986, AM J PHYSIOL, V251, pR264, DOI 10.1152/ajpregu.1986.251.2.R264; Thiel D, 2005, ANN NY ACAD SCI, V1046, P96, DOI 10.1196/annals.1343.009; Tombre IM, 1997, NORSK POLAR SKRIFT, V200, P57; Touma C, 2005, ANN NY ACAD SCI, V1046, P54, DOI 10.1196/annals.1343.006; Turriani Maura, 2016, Veterinary Medicine International, P3086353, DOI 10.1155/2016/3086353; van Oort B. E. H., 2000, Rangifer, V20, P99; van Oort BEH, 2007, NATURWISSENSCHAFTEN, V94, P183, DOI 10.1007/s00114-006-0174-2; Vleck CM, 2002, CONDOR, V104, P667, DOI 10.1650/0010-5422(2002)104[0667:AODROP]2.0.CO;2; Wada H, 2007, GEN COMP ENDOCR, V150, P405, DOI 10.1016/j.ygcen.2006.10.002; Walton JC, 2011, FRONT NEUROENDOCRIN, V32, P303, DOI 10.1016/j.yfrne.2010.12.003; WEBB ML, 1985, POULTRY SCI, V64, P744, DOI 10.3382/ps.0640744; Williams CT, 2015, PHYSIOLOGY, V30, P86, DOI 10.1152/physiol.00045.2014; WINGFIELD JC, 1994, J EXP ZOOL, V270, P372, DOI 10.1002/jez.1402700406	80	7	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182861	10.1371/journal.pone.0182861	http://dx.doi.org/10.1371/journal.pone.0182861			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28787012	Green Submitted, Green Published, gold			2022-12-26	WOS:000406998800065
J	Tong, ML; Zhao, Q; Liu, LL; Zhu, XZ; Gao, K; Zhang, HL; Lin, LR; Niu, JJ; Ji, ZL; Yang, TC				Tong, Man-Li; Zhao, Qiang; Liu, Li-Li; Zhu, Xiao-Zhen; Gao, Kun; Zhang, Hui-Lin; Lin, Li-Rong; Niu, Jian-Jun; Ji, Zhi-Liang; Yang, Tian-Ci			Whole genome sequence of the Treponema pallidum subsp pallidum strain Amoy: An Asian isolate highly similar to SS14	PLOS ONE			English	Article							MACROLIDE RESISTANCE; SYPHILIS; ALGORITHM; NICHOLS; CELL	Treponema pallidum ssp. pallidum (T. pallidum), the causative agent of the sexually transmitted disease syphilis, is an uncultivatable human pathogen. The geographical differences in T. pallidum genomes leading to differences in pathogenicity are not yet understood. Presently, twelve T. pallidum genomes are available to the public, all of which are American in origin and often co-infect patients with human immunodeficiency virus (HIV). In this study, we examined the T. pallidum subsp. pallidum strain Amoy, a syphilis pathogen found in Xiamen, China. We sequenced its genome using Illumina next-generation sequencing technology and obtained a nearly (98.83%) complete genome of approximately 1.12 Mbps. The new genome shows good synteny with its five T. pallidum sibling strains (Nichols, SS14, Mexico A, DAL-1, and Chicago), among which SS14 is the strain closest to the Amoy strain. Compared with strain SS14, the Amoy strain possesses four uncharacterized strain-specific genes and is likely missing six genes, including a gene encoding the TPR domain protein, which may partially account for the comparatively low virulence and toxicity of the Amoy strain in animal infection. Notably, we did not detect the 23S rRNA A2058G/A2059G mutation in the Amoy strain, which likely explains the sensitivity of Amoy strain to macrolides. The results of this study will lead to a better understanding of the pathogenesis of syphilis and the geographical distribution of T. pallidum genotypes.	[Tong, Man-Li; Liu, Li-Li; Zhu, Xiao-Zhen; Gao, Kun; Zhang, Hui-Lin; Lin, Li-Rong; Niu, Jian-Jun; Yang, Tian-Ci] Xiamen Univ, Med Coll, Zhongshan Hosp, Xiamen, Peoples R China; [Tong, Man-Li; Yang, Tian-Ci] Xiamen Univ, Med Coll, Inst Infect Dis, Xiamen, Peoples R China; [Zhao, Qiang; Ji, Zhi-Liang] Xiamen Univ, Sch Life Sci, State Key Lab Stress Cell Biol, Xiamen, Fujian, Peoples R China	Xiamen University; Xiamen University; Xiamen University	Niu, JJ; Yang, TC (corresponding author), Xiamen Univ, Med Coll, Zhongshan Hosp, Xiamen, Peoples R China.; Yang, TC (corresponding author), Xiamen Univ, Med Coll, Inst Infect Dis, Xiamen, Peoples R China.; Ji, ZL (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Stress Cell Biol, Xiamen, Fujian, Peoples R China.	niujianjun211@xmu.edu.cn; appo@xmu.edu.cn; yangtianci@xmu.edu.cn		Yang, Tian-Ci/0000-0002-4303-6252	National Natural Science Foundation [81271335, 81471967, 81471231, 81401749, 81672094]; Key Projects in Fujian Province Science and Technology Program [2013D025]; Projects of Xiamen Science and Technology Program [3502Z20139001]; Key Project of Cultivating Young Talent in Fujian Province's Health System [2013-ZQN-ZD-35, 2014-ZQN-ZD-34]; National Science Foundation for Distinguished Young Scholars of Fujian [2014D001]; Youth Foundation Project of Fujian Provincial Health Department [2014-2-68]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Key Projects in Fujian Province Science and Technology Program; Projects of Xiamen Science and Technology Program; Key Project of Cultivating Young Talent in Fujian Province's Health System; National Science Foundation for Distinguished Young Scholars of Fujian(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Youth Foundation Project of Fujian Provincial Health Department	This work was supported by the National Natural Science Foundation [grant nubmers 81271335, 81471967, 81471231, 81401749 and 81672094]; the Key Projects in Fujian Province Science and Technology Program [grant numbers 2013D025]; the Projects of Xiamen Science and Technology Program [grant numbers 3502Z20139001]; the Key Project of Cultivating Young Talent in Fujian Province's Health System [grants numbers 2013-ZQN-ZD-35, 2014-ZQN-ZD-34]; the National Science Foundation for Distinguished Young Scholars of Fujian [grant numbers 2014D001]; and the Youth Foundation Project of Fujian Provincial Health Department [grant numbers 2014-2-68]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assefa S, 2009, BIOINFORMATICS, V25, P1968, DOI 10.1093/bioinformatics/btp347; BASEMAN JB, 1974, INFECT IMMUN, V10, P1062, DOI 10.1128/IAI.10.5.1062-1067.1974; Boetzer M., 2011, GENOME BIOL, V13, P1; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Cejkova D, 2013, J MED MICROBIOL, V62, P196, DOI 10.1099/jmm.0.050658-0; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Flasarova M, 2012, ACTA DERM-VENEREOL, V92, P669, DOI 10.2340/00015555-1335; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Giacani L, 2014, GENOME ANNOUNCEMENTS, V2; Giacani L, 2007, INFECT IMMUN, V75, P104, DOI 10.1128/IAI.01124-06; Giacani L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001698; Giacani L, 2010, J BACTERIOL, V192, P2645, DOI 10.1128/JB.00159-10; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kristensen DM, 2010, BIOINFORMATICS, V26, P1481, DOI 10.1093/bioinformatics/btq229; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Marra CM, 2010, J INFECT DIS, V202, P1380, DOI 10.1086/656533; Martin IE, 2009, CLIN INFECT DIS, V49, P515, DOI 10.1086/600878; Matejkova P, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-76; Muller EE, 2012, SEX TRANSM INFECT, V88, P470, DOI 10.1136/sextrans-2011-050322; Nechvatal L, 2014, INT J MED MICROBIOL, V304, P645, DOI 10.1016/j.ijmm.2014.04.007; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Peng RR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001273; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Petrosova H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074319; Petrosova H, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001832; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Seth-Smith HMB, 2013, CURR OPIN INFECT DIS, V26, P90, DOI 10.1097/QCO.0b013e32835c2159; Smajs D, 2011, SYPHILIS RECOGNITION; Strouhal M, 2007, INFECT IMMUN, V75, P5859, DOI 10.1128/IAI.00709-07; TURNER TB, 1969, BRIT J VENER DIS, V45, P183; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Wu BR, 2014, CLIN MICROBIOL INFEC, V20, P802, DOI 10.1111/1469-0691.12529; Xiao YJ, 2016, SEX TRANSM DIS, V43, P310, DOI 10.1097/OLQ.0000000000000445; Zobanikova M, 2012, STANDARDS GENOMIC SC, V7	35	31	33	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182768	10.1371/journal.pone.0182768	http://dx.doi.org/10.1371/journal.pone.0182768			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28787460	Green Submitted, gold, Green Published			2022-12-26	WOS:000406998800062
J	Lustig, LC; Dingar, D; Tu, WB; Lourenco, C; Kalkat, M; Inamoto, I; Ponzielli, R; Chan, WCW; Shin, JA; Penn, LZ				Lustig, L. C.; Dingar, D.; Tu, W. B.; Lourenco, C.; Kalkat, M.; Inamoto, I.; Ponzielli, R.; Chan, W. C. W.; Shin, J. A.; Penn, L. Z.			Inhibiting MYC binding to the E-box DNA motif by ME47 decreases tumour xenograft growth	ONCOGENE			English	Article							C-MYC; TRANSCRIPTIONAL REGULATION; PROTEIN-INTERACTION; INDUCED APOPTOSIS; BET BROMODOMAINS; IN-VIVO; CANCER; MAX; RESISTANCE; OMOMYC	Developing therapeutics to effectively inhibit the MYC oncoprotein would mark a key advance towards cancer patient care as MYC is deregulated in over 50% of human cancers. MYC deregulation is correlated with aggressive disease and poor patient outcome. Despite strong evidence in mouse models that inhibiting MYC would significantly impact tumour cell growth and patient survival, traditional approaches have not yet yielded the urgently needed therapeutic agents that directly target MYC. MYC functions through its interaction with MAX to regulate gene transcription by binding to E-box DNA response elements of MYC target genes. Here we used a structure-based strategy to design ME47, a small minimalist hybrid protein (MHP) able to disrupt the MAX: E-box interaction/binding and block transcriptional MYC activity. We show that inducing ME47 expression in established tumour xenografts inhibits tumour growth and decreases cellular proliferation. Mechanistically, we show by chromatin immunoprecipitation that ME47 binds to E-box binding sites of MYC target genes. Moreover, ME47 occupancy decreases MYC: DNA interaction at its cognate E-box binding sites. Taken together, ME47 is a prototypic MHP inhibitor that antagonizes tumour cell growth in vitro and in vivo and inhibits the interaction of MYC with DNA E-box elements. These results support ME47's role as a MYC inhibitor and suggest that MHPs provide an alternative therapeutic targeting system that can be used to target transcription factors important in human diseases, including cancer.	[Lustig, L. C.; Dingar, D.; Tu, W. B.; Lourenco, C.; Kalkat, M.; Ponzielli, R.; Penn, L. Z.] Univ Hlth Network, Princess Margaret Canc Ctr, Princess Margaret Canc Res Tower 13-706, Toronto, ON M5G 1L7, Canada; [Tu, W. B.; Lourenco, C.; Kalkat, M.; Penn, L. Z.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Inamoto, I.; Shin, J. A.] Univ Toronto, Dept Chem, Toronto, ON, Canada; [Chan, W. C. W.] Univ Toronto, Inst Biomat & Biomed Engn, Donnelly Ctr Cellular & Biomol Res, Dept Mat Sci & Engn,Dept Chem Engn, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University of Toronto	Penn, LZ (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Princess Margaret Canc Res Tower 13-706, Toronto, ON M5G 1L7, Canada.	lpenn@uhnres.utoronto.ca		Penn, Linda/0000-0001-8133-5459; Tu, William/0000-0002-2365-1995; Kalkat, Manpreet/0000-0002-4843-9755	Collaborative Health Research Program; Canadian Research Chairs Program; Natural Sciences and Engineering Research Council; Canadian Breast Cancer Foundation Ontario Region Doctoral Fellowship	Collaborative Health Research Program; Canadian Research Chairs Program(Canada Research Chairs); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Breast Cancer Foundation Ontario Region Doctoral Fellowship	We would like to thank the Penn, Shin, and Chen labs for their helpful reviews and contributions to this manuscript. Special thanks to Dr Peter Mullen, Dr Sam Sathiamoorthy and Peter Tang. Funding was provided by way of Operating grant support from the Collaborative Health Research Program (JS, WC, LZP). Salary and stipend support from the Canadian Research Chairs Program (LZP), Natural Sciences and Engineering Research Council (LCL), Canadian Breast Cancer Foundation Ontario Region Doctoral Fellowship (WBT and MK).	Ahmadpour F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032136; Beaulieu ME, 2012, J MOL RECOGNIT, V25, P414, DOI 10.1002/jmr.2203; Berg T, 2011, CURR TOP MICROBIOL, V348, P139, DOI 10.1007/82_2010_90; Bhagwat AS, 2015, TRENDS CANCER, V1, P53, DOI 10.1016/j.trecan.2015.07.001; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Callus BA, 2008, CELL DEATH DIFFER, V15, P213, DOI 10.1038/sj.cdd.4402245; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Felsher Dean W, 2010, Genes Cancer, V1, P597, DOI 10.1177/1947601910377798; Follis AV, 2009, BIOORG MED CHEM LETT, V19, P807, DOI 10.1016/j.bmcl.2008.12.025; Fong CY, 2015, NATURE, V525, P538, DOI 10.1038/nature14888; Fu LL, 2015, ONCOTARGET, V6, P5501, DOI 10.18632/oncotarget.3551; Jain M, 2002, SCIENCE, V297, P102, DOI 10.1126/science.1071489; Jung KY, 2015, J MED CHEM, V58, P3002, DOI 10.1021/jm501440q; Kalkat M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115337; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Mongiardi MP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15494; Montagne M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032172; Oster SK, 2003, ONCOGENE, V22, P1998, DOI 10.1038/sj.onc.1206228; Picaud S, 2013, CANCER RES, V73, P3336, DOI 10.1158/0008-5472.CAN-12-3292; Ponzielli R, 2005, EUR J CANCER, V41, P2485, DOI 10.1016/j.ejca.2005.08.017; Ponzielli R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn735; Posternak V., 2016, F1000RESEARCH, V5, DOI [DOI 10.12688/F1000RESEARCH.7879.1, 10.12688/f1000research.7879.1]; Rathert P, 2015, NATURE, V525, P543, DOI 10.1038/nature14898; Sabo A, 2014, NATURE, V511, P488, DOI 10.1038/nature13537; Savino M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022284; Shi XR, 2016, P NATL ACAD SCI USA, V113, pE4558, DOI 10.1073/pnas.1608319113; Soodgupta D, 2015, MOL CANCER THER, V14, P1286, DOI 10.1158/1535-7163.MCT-14-0774-T; Soucek L, 2004, CELL DEATH DIFFER, V11, P1038, DOI 10.1038/sj.cdd.4401443; Soucek L, 2002, CANCER RES, V62, P3507; Soucek L, 1998, ONCOGENE, V17, P2463, DOI 10.1038/sj.onc.1202199; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Soucek L, 2013, GENE DEV, V27, P504, DOI 10.1101/gad.205542.112; Stojanova A, 2016, CELL CYCLE, V15, P1693, DOI 10.1080/15384101.2016.1146836; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wasylishen AR, 2014, ONCOGENE, V33, P1066, DOI 10.1038/onc.2013.36; Wasylishen AR, 2011, ONCOGENE, V30, P3727, DOI 10.1038/onc.2011.88; Wasylishen AR, 2013, CANCER RES, V73, P6504, DOI 10.1158/0008-5472.CAN-12-4063; Wilson CH, 2014, ONCOGENE, V33, P4877, DOI 10.1038/onc.2014.78; Xu J, 2009, J AM CHEM SOC, V131, P7839, DOI 10.1021/ja901306q; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641	43	16	16	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 7	2017	36	49					6830	6837		10.1038/onc.2017.275	http://dx.doi.org/10.1038/onc.2017.275			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FP0IK	28806396				2022-12-26	WOS:000417282500009
J	Zhao, Q; Zhou, D; You, HJ; Lou, BW; Zhang, Y; Tian, YL; Guo, N; Chen, XL; Liu, Y; Wu, Y; Yuan, ZY; Zhou, J				Zhao, Qiang; Zhou, Dong; You, Hongjun; Lou, Bowen; Zhang, Yan; Tian, Yuling; Guo, Ning; Chen, Xiaoli; Liu, Yan; Wu, Yue; Yuan, Zuyi; Zhou, Juan			IFN-gamma aggravates neointimal hyperplasia by inducing endoplasmic reticulum stress and apoptosis in macrophages by promoting ubiquitin-dependent liver X receptor-alpha degradation	FASEB JOURNAL			English	Article						inflammation; ER stress; restenosis	MUSCLE-CELL PROLIFERATION; INTERFERON-GAMMA; LXR-ALPHA; RESTENOSIS; INJURY; INFLAMMATION; ARTERY; PREDICTORS; MECHANISMS	Neointimal hyperplasia is the main cause of restenosis after percutaneous coronary interventions (PCIs). Both IFN-gamma and macrophages play nonredundant roles in the pathogenesis of vascular intimal hyperplasia; however, the underlying mechanisms remain elusive and must be further investigated. In mouse peritoneal macrophages, IFN-gamma significantly accelerated degradation and up-regulated polyubiquitination of liver X receptor (LXR)-alpha. Signal transducer and activator of transcription 1 (STAT1) inhibitor, fludarabine, and PIAS1 knockdown reduced ubiquitination and increased the expression of LXR-alpha in IFN-gamma-treated macrophages. IFN-gamma also increased the expression of endoplasmic reticulum (ER) stress-related proteins, including p-PERK, p-eIIF2 alpha, and CCAAT-enhancer-binding protein homologous protein (CHOP), as well as apoptosis of macrophages. Treatment with ER stress inhibitor, 4-phenylbutyric acid (4-PBA), and LXR agonist, T0901317 (T0), alleviated IFN-gamma-induced apoptosis in macrophages. Neointimal hyperplasia was significant after carotid ligation for 4 wk in ApoE(-/-) mice. IFN-gamma mAb, T0, and 4-PBA treatment not only significantly attenuated neointimal hyperplasia but also decreased CD68(+)TUNEL(+) double-positive macrophages in the hyperplastic neointima. Moreover, after 4-PBA or T0 administration, the number of CD68(+)p-eIIF2 alpha(+) and CD68(+)CHOP(+) double-positive cells in neointimal was also apparently decreased. Taken together, these results defined an unexpected role of IFN-gamma and LXR-alpha in the development of neointimal hyperplasia. The PIAS1/STAT1-dependent LXR-alpha degradation induced by IFN-gamma promoted ER stress and apoptosis in macrophages, which leads to aggravated neointimal hyperplasia. LXR agonist efficiently improved neointimal hyperplasia, which may be a promising new strategy to ameliorate restenosis and vascular remodeling after PCI.	[Zhao, Qiang; Zhou, Dong; You, Hongjun; Lou, Bowen; Zhang, Yan; Tian, Yuling; Guo, Ning; Chen, Xiaoli; Liu, Yan; Wu, Yue; Yuan, Zuyi; Zhou, Juan] Xi An Jiao Tong Univ, Minist Educ, Dept Cardiovasc Med, Med Sch,Affiliated Hosp 1, Xian, Shaanxi, Peoples R China; [Yuan, Zuyi] Xi An Jiao Tong Univ, Minist Educ, Key Lab Environm & Genes Related Dis, Xian, Shaanxi, Peoples R China; [Zhou, Juan] Key Lab Mol Cardiol Shanxi Prov, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Yuan, ZY; Zhou, J (corresponding author), Xi An Jiao Tong Univ, Dept Cardiovasc Med, Affiliated Hosp 1, 277 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China.	zuyiyuan@mail.xjtu.edu.cn; 1306899042@qq.com	Zhao, Qiang/AAS-9878-2020	Zhao, Qiang/0000-0003-0080-7210; Yuan, Zuyi/0000-0002-4141-0298	National Natural Science Foundation of China [91639301, 91339116, 81300226]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The author expresses heartfelt gratitude to her husband for valuable encouragement and spiritual support during the study. This work was supported by the National Natural Science Foundation of China (Grants 91639301, 91339116, and 81300226). The authors declare no conflicts of interest.	Alfonso F, 2014, J AM COLL CARDIOL, V63, P2659, DOI 10.1016/j.jacc.2014.02.545; Bayes-Genis A, 2002, ATHEROSCLEROSIS, V163, P89, DOI 10.1016/S0021-9150(01)00771-7; Blaschke F, 2004, CIRC RES, V95, pE110, DOI 10.1161/01.RES.0000150368.56660.4f; Cassese S, 2014, HEART, V100, P153, DOI 10.1136/heartjnl-2013-304933; Costa MA, 2005, CIRCULATION, V111, P2257, DOI 10.1161/01.CIR.0000163587.36485.A7; Dai XY, 2016, CIRC RES, V119, P1089, DOI 10.1161/CIRCRESAHA.116.309463; Danenberg HD, 2002, CIRCULATION, V106, P599, DOI 10.1161/01.CIR.0000023532.98469.48; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Guzeloglu M, 2012, J CARDIOTHORAC SURG, V7, DOI 10.1186/1749-8090-7-57; Hong C, 2014, NAT REV DRUG DISCOV, V13, P433, DOI 10.1038/nrd4280; Hui DY, 2008, CURR DRUG TARGETS, V9, P251, DOI 10.2174/138945008783755601; Ishimura S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06943; Kim KH, 2009, MOL ENDOCRINOL, V23, P466, DOI 10.1210/me.2008-0295; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; Lee JH, 2009, MOL CELL, V35, P806, DOI 10.1016/j.molcel.2009.07.021; Lee JY, 2011, J AM COLL CARDIOL, V57, P1349, DOI 10.1016/j.jacc.2010.10.041; Noda T, 2015, ARTERIOSCL THROM VAS, V35, P1246, DOI 10.1161/ATVBAHA.114.304923; Park SJ, 2012, J AM COLL CARDIOL, V59, P2051, DOI 10.1016/j.jacc.2011.10.909; Rong X, 2013, CELL METAB, V18, P685, DOI 10.1016/j.cmet.2013.10.002; Rose ML, 2007, CIRC RES, V101, P542, DOI 10.1161/CIRCRESAHA.107.160911; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shah PK, 2003, CIRCULATION, V107, P2175, DOI 10.1161/01.CIR.0000069943.41206.BD; Sun XW, 2016, J BIOL CHEM, V291, P1115, DOI 10.1074/jbc.M115.668269; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tavakoli NN, 2012, INT J MOL MED, V30, P545, DOI 10.3892/ijmm.2012.1034; Tellides G, 2007, CIRC RES, V100, P622, DOI 10.1161/01.RES.0000258861.72279.29; Toutouzas K, 2004, EUR HEART J, V25, P1679, DOI 10.1016/j.ehj.2004.06.011; Wang QX, 2014, CIRC RES, V114, P480, DOI 10.1161/CIRCRESAHA.114.302113; Wang YN, 2007, CIRC RES, V101, P560, DOI 10.1161/CIRCRESAHA.107.151068; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	31	10	11	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5321	+		10.1096/fj.201700327R	http://dx.doi.org/10.1096/fj.201700327R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28798155				2022-12-26	WOS:000416588300017
J	Chakraborty, D; Benham, V; Bullard, B; Kearney, T; Hsia, HC; Gibbon, D; Demireva, EY; Lunt, SY; Bernard, JJ				Chakraborty, D.; Benham, V.; Bullard, B.; Kearney, T.; Hsia, H. C.; Gibbon, D.; Demireva, E. Y.; Lunt, S. Y.; Bernard, J. J.			Fibroblast growth factor receptor is a mechanistic link between visceral adiposity and cancer	ONCOGENE			English	Article							BODY-MASS INDEX; SQUAMOUS-CELL CARCINOMA; DIET-INDUCED OBESITY; BREAST-CANCER; WAIST CIRCUMFERENCE; NEOPLASTIC TRANSFORMATION; GENE-EXPRESSION; TUMOR-GROWTH; FACTOR FGF-2; SKIN-CANCER	Epidemiological evidence implicates excess adipose tissue in increasing cancer risk. Despite a steeply rising global prevalence of obesity, how adiposity contributes to transformation (stage a non-tumorigenic cell undergoes to become malignant) is unknown. To determine the factors in adipose tissue that stimulate transformation, we used a novel ex vivo system of visceral adipose tissue (VAT)-condition medium-stimulated epithelial cell growth in soft agar. To extend this system in vivo, we used a murine lipectomy model of ultraviolet light B-induced, VAT-promoted skin tumor formation. We found that VAT from mice and obese human donors stimulated growth in soft agar of non-tumorigenic epithelial cells. The difference in VAT activity was associated with fibroblast growth factor-2 (FGF2) levels. Moreover, human and mouse VAT failed to stimulate growth in soft of agar in cells deficient in FGFR-1 (FGF2 receptor). We also demonstrated that circulating levels of FGF2 were associated with non-melanoma tumor formation in vivo. These data implicate FGF2 as a major factor VAT releases to transform epithelial cells-a novel, potential pathway of VAT-enhanced tumorigenesis. Strategies designed to deplete VAT stores of FGF2 or inhibit FGFR-1 in abdominally obese individuals may be important cancer prevention strategies as well as adjuvant therapies for improving outcomes.	[Chakraborty, D.; Benham, V.; Bullard, B.; Bernard, J. J.] Michigan State Univ, Dept Pharmacol & Toxicol, 1355 Bogue St,Life Sci B420, E Lansing, MI 48824 USA; [Kearney, T.] Rutgers Robert Wood Johnson Med Sch, Div Surg Oncol, New Brunswick, NJ USA; [Hsia, H. C.] Yale Sch Med, Sect Plast Surg, Dept Surg, New Haven, CT USA; [Gibbon, D.] Summit Medical4 Grp, Livingston, NJ USA; [Demireva, E. Y.] Michigan State Univ, Off Vice President Res & Grad Studies, E Lansing, MI 48824 USA; [Lunt, S. Y.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Yale University; Michigan State University; Michigan State University	Bernard, JJ (corresponding author), Michigan State Univ, Dept Pharmacol & Toxicol, 1355 Bogue St,Life Sci B420, E Lansing, MI 48824 USA.	jbernard@msu.edu	Hsia, Henry/W-6140-2019	Hsia, Henry/0000-0001-8674-9140; Lunt, Sophia/0000-0003-4522-6065; Bernard, Jamie/0000-0002-3800-2576	National Institutes of Health [R00 CA177868]; Michigan State University; Office of the Assistant Secretary of Defense for Health Affairs [W81XWH-15-1-0453]; AACR-Incyte Corporation NextGen Grant [16-20-46-LUNT]; NATIONAL CANCER INSTITUTE [R00CA177868, K99CA177868] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan State University; Office of the Assistant Secretary of Defense for Health Affairs; AACR-Incyte Corporation NextGen Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We acknowledge the MSU Investigative HistoPathology Laboratory, Amy S Porter, HT (ASCP) QIHC and Kathleen A Joseph, HT (ASCP) QIHC. We also thank Dr Karen Liby (MSU) for her consultation and providing antibodies, Dr Richard Neubig (MSU) and Dr Matthew Bernard (MSU) for their consultation and assistance with experimental design and Dr Dalen Agnew (MSU) for his consultation on tumor pathology. JJB is funded by National Institutes of Health Grant R00 CA177868, Michigan State University start-up funds. SYL is funded by the Office of the Assistant Secretary of Defense for Health Affairs, through the Breast Cancer Research Program, under Award No. W81XWH-15-1-0453 and the 2016 AACR-Incyte Corporation NextGen Grant for Transformative Cancer Research, Grant Number 16-20-46-LUNT.	Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Aggarwal BB, 2006, BIOCHEM PHARMACOL, V72, P1605, DOI 10.1016/j.bcp.2006.06.029; Ahmad I, 2012, BBA-MOL CELL RES, V1823, P850, DOI 10.1016/j.bbamcr.2012.01.004; Amstad PA, 1997, MOL CARCINOGEN, V20, P231, DOI 10.1002/(SICI)1098-2744(199710)20:2<231::AID-MC10>3.0.CO;2-B; Arnold M, 2015, LANCET ONCOL, V16, P36, DOI 10.1016/S1470-2045(14)71123-4; Ayala-Lopez N, 2015, AM J PHYSIOL-HEART C, V309, pH1904, DOI 10.1152/ajpheart.00308.2015; Baselga J, 2011, ONCOLOGIST, V16, P12, DOI 10.1634/theoncologist.2011-S1-12; BENARI ET, 1992, MOL CARCINOGEN, V5, P62, DOI 10.1002/mc.2940050111; Berg KK, 2009, SCAND J IMMUNOL, V69, P36, DOI 10.1111/j.1365-3083.2008.02187.x; Bernard Jamie J, 2014, J Carcinog Mutagen, V5, P2157; Binai NA, 2010, INT J CANCER, V127, P55, DOI 10.1002/ijc.25010; Bowden GT, 2004, NAT REV CANCER, V4, P23, DOI 10.1038/nrc1253; Chockalingam R, 2015, J CLIN MED, V4, P1229, DOI 10.3390/jcm4061229; COLBURN NH, 1981, P NATL ACAD SCI-BIOL, V78, P6912, DOI 10.1073/pnas.78.11.6912; Connolly BS, 2002, NUTR CANCER, V44, P127, DOI 10.1207/S15327914NC4402_02; Courneya KS, 2008, CANCER-AM CANCER SOC, V112, P2475, DOI 10.1002/cncr.23455; Cronauer MV, 1997, PROSTATE, V31, P223; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; DONG ZG, 1995, CARCINOGENESIS, V16, P749, DOI 10.1093/carcin/16.4.749; DONG ZG, 1994, P NATL ACAD SCI USA, V91, P609, DOI 10.1073/pnas.91.2.609; Dutta Deep, 2012, Indian J Endocrinol Metab, V16, pS596, DOI 10.4103/2230-8210.105577; Elsheikh SE, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1665; Font-Burgada J, 2016, CELL METAB, V23, P48, DOI 10.1016/j.cmet.2015.12.015; Freier K, 2007, ORAL ONCOL, V43, P60, DOI 10.1016/j.oraloncology.2006.01.005; Fried SK, 1998, J CLIN ENDOCR METAB, V83, P847, DOI 10.1210/jc.83.3.847; Gabrielsson BG, 2002, OBES RES, V10, P608, DOI 10.1038/oby.2002.83; Garratt M, 2016, AGING CELL, V15, P737, DOI 10.1111/acel.12489; Gaudet MM, 2014, CANCER CAUSE CONTROL, V25, P737, DOI 10.1007/s10552-014-0376-4; Goodwin PJ, 2002, J CLIN ONCOL, V20, P42, DOI 10.1200/JCO.20.1.42; Grazul-Bilska AT, 2002, EXP CLIN ENDOCR DIAB, V110, P176, DOI 10.1055/s-2002-32149; Hajian-Tilaki KO, 2011, MED ONCOL, V28, P1296, DOI 10.1007/s12032-010-9629-6; Hao RH, 2016, SCI REP-UK, V6, DOI 10.1038/srep19868; He ZQ, 2003, J BIOL CHEM, V278, P26435, DOI 10.1074/jbc.M303859200; Hill AL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000968; Hu MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147374; Huang Z, 1999, AM J EPIDEMIOL, V150, P1316, DOI 10.1093/oxfordjournals.aje.a009963; Huffman DM, 2013, CANCER PREV RES, V6, P177, DOI 10.1158/1940-6207.CAPR-12-0414; Hursting SD, 2003, ANNU REV MED, V54, P131, DOI 10.1146/annurev.med.54.101601.152156; Ibiebele TI, 2007, AM J CLIN NUTR, V85, P1401, DOI 10.1093/ajcn/85.5.1401; Ibiebele TI, 2009, INT J CANCER, V125, P1678, DOI 10.1002/ijc.24481; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Itoh N, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00247; Iyengar NM, 2016, CLIN CANCER RES, V22, P2283, DOI 10.1158/1078-0432.CCR-15-2239; JAIN AK, 1989, INDIAN J CHEM A, V28, P992; Jang MH, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3239; Kakudo N, 2007, BIOCHEM BIOPH RES CO, V359, P239, DOI 10.1016/j.bbrc.2007.05.070; Kawaguchi N, 1998, P NATL ACAD SCI USA, V95, P1062, DOI 10.1073/pnas.95.3.1062; Kim S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120073; Kornmann M, 1998, PANCREAS, V17, P169, DOI 10.1097/00006676-199808000-00010; Kuhn MC, 2012, MOL CELL ENDOCRINOL, V349, P180, DOI 10.1016/j.mce.2011.10.018; Larsson A., 2002, Angiogenesis, V5, P107, DOI 10.1023/A:1021588227705; Lau MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059083; Lepique AP, 2004, J MOL ENDOCRINOL, V33, P623, DOI 10.1677/jme.1.01485; Li HJ, 2013, ONCOL REP, V30, P2153, DOI 10.3892/or.2013.2678; Ligibel JA, 2014, J CLIN ONCOL, V32, P3568, DOI 10.1200/JCO.2014.58.4680; Liu YH, 2001, CARCINOGENESIS, V22, P607, DOI 10.1093/carcin/22.4.607; Logie A, 2005, HUM MOL GENET, V14, P1153, DOI 10.1093/hmg/ddi127; Lu FJ, 2006, CHEM-BIOL INTERACT, V162, P249, DOI 10.1016/j.cbi.2006.07.007; Lu YP, 2012, P NATL ACAD SCI USA, V109, P9065, DOI 10.1073/pnas.1205810109; Malley CO, 2016, BBA CLIN, V5, P29, DOI 10.1016/j.bbacli.2015.11.003; Marshall Fray F, 2002, J Urol, V168, P877; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Matsui R, 1999, CELL SIGNAL, V11, P221, DOI 10.1016/S0898-6568(98)00070-9; Miyoshi Y, 2003, CLIN CANCER RES, V9, P5699; Moore LL, 2004, INT J OBESITY, V28, P559, DOI 10.1038/sj.ijo.0802606; Murphy RA, 2014, APPL PHYSIOL NUTR ME, V39, P687, DOI 10.1139/apnm-2013-0360; Mydlo JH, 1998, J UROLOGY, V159, P2159, DOI 10.1016/S0022-5347(01)63298-1; NAKAMOTO T, 1992, CANCER RES, V52, P571; NAKAMURA KD, 1989, MECH AGEING DEV, V48, P199, DOI 10.1016/0047-6374(89)90051-1; NAKAMURA Y, 1988, CARCINOGENESIS, V9, P203, DOI 10.1093/carcin/9.2.203; Nan H, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-172; Neubauer M, 2004, FEBS LETT, V577, P277, DOI 10.1016/j.febslet.2004.10.020; Nunez NP, 2008, NUTR CANCER, V60, P534, DOI 10.1080/01635580801966195; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; Ortega S, 1998, P NATL ACAD SCI USA, V95, P5672, DOI 10.1073/pnas.95.10.5672; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pan RL, 2015, HEPATOLOGY, V61, P1708, DOI 10.1002/hep.27649; Pothiawala S, 2012, CANCER CAUSE CONTROL, V23, P717, DOI 10.1007/s10552-012-9941-x; QUARTO N, 1989, ONCOGENE RES, V5, P101; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Regad T, 2015, CANCERS, V7, P1758, DOI 10.3390/cancers7030860; Renehan AG, 2015, NAT REV CANCER, V15, P484, DOI 10.1038/nrc3967; SAHL WJ, 1995, INT J DERMATOL, V34, P398, DOI 10.1111/j.1365-4362.1995.tb04440.x; Samaras K, 2010, OBESITY, V18, P884, DOI 10.1038/oby.2009.443; Sarveswaran S, 2015, J BIOL CHEM, V290, P4994, DOI 10.1074/jbc.M114.599035; Sato T, 2009, ONCOL REP, V21, P211, DOI 10.3892/or_00000210; SCHAPIRA DV, 1994, CANCER, V74, P632, DOI 10.1002/1097-0142(19940715)74:2<632::AID-CNCR2820740215>3.0.CO;2-T; SMITH BM, 1986, CANCER RES, V46, P701; SMITH JS, 1992, CARCINOGENESIS, V13, P189, DOI 10.1093/carcin/13.2.189; SRINIVAS L, 1984, CARCINOGENESIS, V5, P515, DOI 10.1093/carcin/5.4.515; Steringer JP, 2015, J MOL BIOL, V427, P1202, DOI 10.1016/j.jmb.2014.07.012; Tsimafeyeu I, 2011, SCAND J UROL NEPHROL, V45, P190, DOI 10.3109/00365599.2011.552436; Turner N, 2010, CANCER RES, V70, P2085, DOI 10.1158/0008-5472.CAN-09-3746; VAGUE J, 1956, AM J CLIN NUTR, V4, P20, DOI 10.1093/ajcn/4.1.20; Vucenik I, 2012, ANN NY ACAD SCI, V1271, P37, DOI 10.1111/j.1749-6632.2012.06750.x; Weber TJ, 2010, J INVEST DERMATOL, V130, P1444, DOI 10.1038/jid.2009.383; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Xiao LP, 2010, BONE, V47, P360, DOI 10.1016/j.bone.2010.05.021; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yakar S, 2006, ENDOCRINOLOGY, V147, P5826, DOI 10.1210/en.2006-0311; Zhang DY, 2009, TOXICOL APPL PHARM, V235, P18, DOI 10.1016/j.taap.2008.11.002; Zhang XL, 2012, P NATL ACAD SCI USA, V109, P2790, DOI 10.1073/pnas.1100764108	103	24	25	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 30	2017	36	48					6668	6679		10.1038/onc.2017.278	http://dx.doi.org/10.1038/onc.2017.278			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FO4AJ	28783178	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000416780800002
J	Wada, M; Canals, D; Adada, M; Coant, N; Salama, MF; Helke, KL; Arthur, JS; Shroyer, KR; Kitatani, K; Obeid, LM; Hannun, YA				Wada, M.; Canals, D.; Adada, M.; Coant, N.; Salama, M. F.; Helke, K. L.; Arthur, J. S.; Shroyer, K. R.; Kitatani, K.; Obeid, L. M.; Hannun, Y. A.			P38 delta MAPK promotes breast cancer progression and lung metastasis by enhancing cell proliferation and cell detachment	ONCOGENE			English	Article							ACTIVATED PROTEIN-KINASE; EPITHELIAL-SPECIFIC DISRUPTION; TRANSGENIC MOUSE MODEL; GROWTH; P38-DELTA; INVASION; EXPRESSION; P38-GAMMA; TUMORIGENESIS; LOCALIZATION	The protein p38 mitogen-activated protein kinase (MAPK) delta isoform (p38 delta) is a poorly studied member of the MAPK family. Data analysis from The Cancer Genome Atlas database revealed that p38 delta is highly expressed in all types of human breast cancers. Using a human breast cancer tissue array, we confirmed elevation in cancer tissue. The breast cancer mouse model, MMTV-PyMT (PyMT), developed breast tumors with lung metastasis; however, mice deleted in p38 delta (PyMT/p38 delta(-/-)) exhibited delayed primary tumor formation and highly reduced lung metastatic burden. At the cellular level, we demonstrate that targeting of p38 delta in breast cancer cells, MCF-7 and MDA-MB-231 resulted in a reduced rate of cell proliferation. In addition, cells lacking p38 delta also displayed an increased cell-matrix adhesion and reduced cell detachment. This effect on cell adhesion was molecularly supported by the regulation of the focal adhesion kinase by p38 delta in the human breast cell lines. These studies define a previously unappreciated role for p38 delta in breast cancer development and evolution by regulating tumor growth and altering metastatic properties. This study proposes MAPK p38 delta protein as a key factor in breast cancer. Lack of p38 delta resulted in reduced primary tumor size and blocked the metastatic potential to the lungs.	[Wada, M.; Canals, D.; Adada, M.; Coant, N.; Salama, M. F.; Obeid, L. M.; Hannun, Y. A.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Canals, D.; Adada, M.; Obeid, L. M.; Hannun, Y. A.] SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA; [Salama, M. F.] Mansoura Univ, Dept Biochem, Fac Vet Med, Mansoura, Egypt; [Helke, K. L.] Med Univ South Carolina, Dept Comparat Med, Charleston, SC USA; [Arthur, J. S.] Univ Dundee, Sch Life Sci, MRC Prot Phosphorylat Unit, Dundee, Scotland; [Shroyer, K. R.] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Kitatani, K.] Tohoku Univ, Grad Sch Med, Tohoku Med Megabank Org, Sendai, Miyagi, Japan; [Kitatani, K.] Tohoku Univ, Grad Sch Med, Dept Obstet & Gynecol, Sendai, Miyagi, Japan; [Obeid, L. M.] Northport VA Med Ctr, Northport, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Egyptian Knowledge Bank (EKB); Mansoura University; Medical University of South Carolina; University of Dundee; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Tohoku University; Tohoku University	Hannun, YA (corresponding author), SUNY Stony Brook, Stony Brook Canc Ctr, Hlth Sci Ctr, L-4,182, Stony Brook, NY 11794 USA.	yusuf.hannun@sbumed.org	Canals, Daniel/AAW-1998-2021; Salama, Mohamed F/C-9010-2017; Canals, Daniel/AAJ-8176-2021; Kitatani, Kazuyuki/H-7100-2019; Salama, Mohamed/S-3493-2019	Canals, Daniel/0000-0002-9293-5123; Salama, Mohamed F/0000-0002-0002-9108; Kitatani, Kazuyuki/0000-0002-8516-6135; Salama, Mohamed/0000-0002-0002-9108; Adada, Mohamad/0000-0002-2988-2081; Helke, Kris/0000-0001-9746-0764; COANT, Nicolas/0000-0001-9237-2132; Arthur, Simon/0000-0002-8135-1958	National Cancer Institute [R01-CA87584]; NIH [CA087584]; NATIONAL CANCER INSTITUTE [R01CA087584, P01CA097132] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Eiji Suzuki (Fukushima Medical University), Dr Tatiana Efimova (Washington University), Dr Patricia Watson, Dr Dennis K. Watson and George Washington (Medical University of South Carolina), Dr Hideki Furuya, Dr Toshihiko Kawamori (University of Hawaii), Dr Vincent Yang and members of his laboratory, Mallory Korman, Dr Luisa Escobar-Hoyos, Dr Kai Wang, Dr Chiara Luberto, Dr Achraf Shamsedine, Dr Monica Garcia-Barros, Dr Jean-Philip Truman, Maria Hernandez, Dr Ashley Snider and Dr Magali Trayssac (Stony Brook University) for helpful technical advice and/or assistance. This work is supported by the National Cancer Institute (R01-CA87584). These studies were supported by NIH Grant CA087584.	Adada MM, 2015, FASEB J, V29, P4654, DOI 10.1096/fj.15-274340; Arold ST, 2011, CURR OPIN STRUC BIOL, V21, P808, DOI 10.1016/j.sbi.2011.09.008; Aust S, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-67; Chen L, 2009, CANCER RES, V69, P8853, DOI 10.1158/0008-5472.CAN-09-1636; Choi YK, 2013, CANCER GENOM PROTEOM, V10, P265; Cuadrado A, 2010, BIOCHEM J, V429, P403, DOI 10.1042/BJ20100323; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; del Reino P, 2014, CANCER RES, V74, P6150, DOI 10.1158/0008-5472.CAN-14-0870; Dethlefsen C, 2013, BREAST CANCER RES TR, V138, P657, DOI 10.1007/s10549-013-2488-z; Fluck MM, 2009, MICROBIOL MOL BIOL R, V73, P542, DOI 10.1128/MMBR.00009-09; Gandy KAO, 2013, FASEB J, V27, P3155, DOI 10.1096/fj.13-228460; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Ittner A, 2012, J EXP MED, V209, P2229, DOI 10.1084/jem.20120677; Jones LM, 2016, CANCER RES, V76, P1416, DOI 10.1158/0008-5472.CAN-15-2770; Junttila MR, 2007, ONCOGENE, V26, P5267, DOI 10.1038/sj.onc.1210332; Kesson EM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2718; Kitatani K, 2009, J BIOL CHEM, V284, P12979, DOI 10.1074/jbc.M809500200; Kohler BA, 2015, JNCI-J NATL CANCER I, V107, P1975, DOI DOI 10.1093/JNCI/DJV048; Lahlou H, 2007, P NATL ACAD SCI USA, V104, P20302, DOI 10.1073/pnas.0710091104; Liu Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep03098; Luo M, 2010, CANCER LETT, V289, P127, DOI 10.1016/j.canlet.2009.07.005; Luo M, 2009, CANCER RES, V69, P466, DOI 10.1158/0008-5472.CAN-08-3078; McAllister SS, 2014, NAT CELL BIOL, V16, P717, DOI 10.1038/ncb3015; O'Callaghan Carol, 2014, Int J Cell Biol, V2014, P272689, DOI 10.1155/2014/272689; O'Callaghan C, 2013, INT J ONCOL, V43, P405, DOI 10.3892/ijo.2013.1968; OWENS LV, 1995, CANCER RES, V55, P2752; Place AE, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2912; Provenzano PP, 2008, AM J PATHOL, V173, P1551, DOI 10.2353/ajpath.2008.080308; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; Risco A, 2012, P NATL ACAD SCI USA, V109, P11200, DOI 10.1073/pnas.1207290109; Sabio G, 2005, EMBO J, V24, P1134, DOI 10.1038/sj.emboj.7600578; Schindler EM, 2009, CANCER RES, V69, P4648, DOI 10.1158/0008-5472.CAN-08-4455; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; Tan FLS, 2010, INT J CANCER, V126, P2353, DOI 10.1002/ijc.24944; Zhong J, 2011, LUNG CANCER, V73, P166, DOI 10.1016/j.lungcan.2010.12.003	36	48	48	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 23	2017	36	47					6649	6657		10.1038/onc.2017.274	http://dx.doi.org/10.1038/onc.2017.274			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FN5LN	28783172	Green Accepted			2022-12-26	WOS:000416049200013
J	Neill, T; Sharpe, C; Owens, RT; Iozzo, RV				Neill, Thomas; Sharpe, Catherine; Owens, Rick T.; Iozzo, Renato V.			Decorin-evoked paternally expressed gene 3 (PEG3) is an upstream regulator of the transcription factor EB (TFEB) in endothelial cell autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPRINTED GENE; MATRIX METALLOPROTEINASES; LYSOSOMAL BIOGENESIS; SIGNALING PATHWAYS; LIPID-METABOLISM; VII COLLAGEN; IN-VIVO; GROWTH; ENDOREPELLIN; CANCER	Macroautophagy is a fundamental and evolutionarily conserved catabolic process that eradicates damaged and aging macromolecules and organelles in eukaryotic cells. Decorin, an archetypical small leucine-rich proteoglycan, initiates a protracted autophagic program downstream of VEGF receptor 2 (VEGFR2) signaling that requires paternally expressed gene 3 (PEG3). We have discovered that PEG3 is an upstream transcriptional regulator of transcription factor EB (TFEB), a master transcription factor of lysosomal biogenesis, for decorin-evoked endothelial cell autophagy. We found a functional requirement of PEG3 for TFEB transcriptional induction and nuclear translocation in human umbilical vein endothelial and PAER2 cells. Mechanistically, inhibiting VEGFR2 or AMP-activated protein kinase (AMPK), a major decorin-activated energy sensor kinase, prevented decorin-evoked TFEB induction and nuclear localization. In conclusion, our findings indicate a non-canonical (nutrient-and energy-independent) mechanism underlying the pro-autophagic bioactivity of decorin via PEG3 and TFEB.	[Neill, Thomas; Sharpe, Catherine; Iozzo, Renato V.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 1020 Locust St,Ste 336,Jefferson Alumni Hall, Philadelphia, PA 19107 USA; [Neill, Thomas; Sharpe, Catherine; Iozzo, Renato V.] Thomas Jefferson Univ, Canc Cell Biol & Signaling Program, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA; [Owens, Rick T.] LifeCell Corp, Branchburg, NJ 08876 USA	Jefferson University; Jefferson University	Iozzo, RV (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 1020 Locust St,Ste 336,Jefferson Alumni Hall, Philadelphia, PA 19107 USA.	renato.iozzo@jefferson.edu	Iozzo, Renato/AAS-1980-2020	sharpe, catherine/0000-0003-0704-3380	National Institutes of Health [RO1 CA39481, RO1 CA47282, RO1 CA164462, 5T32 AR060715-05]; Biotechnology and Biological Sciences Research Council [1618838] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA164462, R01CA047282, R01CA039481] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The original research was supported in part by National Institutes of Health Grants RO1 CA39481, RO1 CA47282, and RO1 CA164462 (to R. V. I.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by National Institutes of Health Training Grant 5T32 AR060715-05.	Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Buraschi S, 2013, P NATL ACAD SCI USA, V110, pE2582, DOI 10.1073/pnas.1305732110; Buraschi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045559; Buraschi Simone, 2010, J Biol Chem, V285, P42075, DOI 10.1074/jbc.M110.172841; Douglass S, 2015, CONNECT TISSUE RES, V56, P381, DOI 10.3109/03008207.2015.1045297; Dowdy SC, 2005, GYNECOL ONCOL, V99, P126, DOI 10.1016/j.ygyno.2005.05.036; Duarte S, 2015, MATRIX BIOL, V44-46, P147, DOI 10.1016/j.matbio.2015.01.004; Edelstein LC, 2005, GENE, V359, P1, DOI 10.1016/j.gene.2005.06.022; Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190; Feng WW, 2008, CANCER-AM CANCER SOC, V112, P1489, DOI 10.1002/cncr.23323; Frey H, 2013, FEBS J, V280, P2165, DOI 10.1111/febs.12145; Fullgrabe J, 2014, NAT REV MOL CELL BIO, V15, P65, DOI 10.1038/nrm3716; Fullgrabe J, 2013, NATURE, V500, P468, DOI 10.1038/nature12313; Gaffney J, 2015, MATRIX BIOL, V44-46, P191, DOI 10.1016/j.matbio.2015.01.012; Goldoni S, 2004, J BIOL CHEM, V279, P6606, DOI 10.1074/jbc.M310342200; Goyal A, 2016, J BIOL CHEM, V291, P19245, DOI 10.1074/jbc.M116.740266; Goyal A, 2014, MATRIX BIOL, V34, P46, DOI 10.1016/j.matbio.2013.12.011; Goyal A, 2012, J BIOL CHEM, V287, P43543, DOI 10.1074/jbc.M112.401786; Goyal A, 2011, J BIOL CHEM, V286, P25947, DOI 10.1074/jbc.M111.243626; Gubbiotti MA, 2016, MATRIX BIOL, V55, P7, DOI 10.1016/j.matbio.2016.09.009; Gubbiotti MA, 2015, MATRIX BIOL, V48, P6, DOI 10.1016/j.matbio.2015.10.002; Gubbiotti MA, 2015, MATRIX BIOL, V48, P14, DOI 10.1016/j.matbio.2015.09.001; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Iozzo RV, 2015, MATRIX BIOL, V42, P11, DOI 10.1016/j.matbio.2015.02.003; Jarvelainen H, 2006, WOUND REPAIR REGEN, V14, P443, DOI 10.1111/j.1743-6109.2006.00150.x; Jarvelainen H, 2015, MATRIX BIOL, V43, P15, DOI 10.1016/j.matbio.2015.01.023; Jiang XL, 2010, J BIOL CHEM, V285, P8472, DOI 10.1074/jbc.M109.069450; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim J, 1997, GENOME RES, V7, P532, DOI 10.1101/gr.7.5.532; Kim J, 2013, AUTOPHAGY, V9, P1110, DOI 10.4161/auto.24877; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kohda T, 2001, GENES CELLS, V6, P237, DOI 10.1046/j.1365-2443.2001.00412.x; Kuhajda FP, 2008, INT J OBESITY, V32, pS36, DOI 10.1038/ijo.2008.121; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Lee JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015394; Maegawa S, 2001, MOL CARCINOGEN, V31, P1, DOI 10.1002/mc.1034; Martina JA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004754; Merline R, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001868; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Moskot M, 2014, J BIOL CHEM, V289, P17054, DOI 10.1074/jbc.M114.555300; Naba A, 2016, MATRIX BIOL, V49, P10, DOI 10.1016/j.matbio.2015.06.003; Neill T, 2016, J CELL BIOL, V215, P687, DOI 10.1083/jcb.201603079; Neill T, 2016, ADV DRUG DELIVER REV, V97, P174, DOI 10.1016/j.addr.2015.10.016; Neill T, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723556.2014.975645; Neill T, 2015, BIOCHEMISTRY-US, V54, P4583, DOI 10.1021/acs.biochem.5b00653; Neill T, 2014, J BIOL CHEM, V289, P4952, DOI 10.1074/jbc.M113.512566; Neill T, 2013, AUTOPHAGY, V9, P1626, DOI 10.4161/auto.25881; Neill T, 2012, J BIOL CHEM, V287, P5492, DOI 10.1074/jbc.M111.283499; Nye MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056325; Palmieri M, 2011, HUM MOL GENET, V20, P3852, DOI 10.1093/hmg/ddr306; Poluzzi C, 2014, J BIOL CHEM, V289, P16114, DOI 10.1074/jbc.M114.556530; Rimsa V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069538; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Rohani MG, 2015, MATRIX BIOL, V44-46, P113, DOI 10.1016/j.matbio.2015.03.002; Rosenbluth JM, 2009, AUTOPHAGY, V5, P114, DOI 10.4161/auto.5.1.7294; RUDNICKA L, 1994, J CLIN INVEST, V93, P1709, DOI 10.1172/JCI117154; RYYNANEN M, 1992, J CLIN INVEST, V89, P974, DOI 10.1172/JCI115680; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Seok S, 2014, NATURE, V516, P108, DOI 10.1038/nature13949; Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Settembre C, 2011, AUTOPHAGY, V7, P1379, DOI 10.4161/auto.7.11.17166; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shin HJR, 2016, NATURE, V534, P553, DOI 10.1038/nature18014; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Theocharis AD, 2015, BBA-REV CANCER, V1855, P276, DOI 10.1016/j.bbcan.2015.03.006; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Torres A, 2017, J BIOL CHEM, V292, P5055, DOI 10.1074/jbc.M116.753632; Wells A, 2016, MATRIX BIOL, V49, P25, DOI 10.1016/j.matbio.2015.08.001; Xu W, 2015, GENE THER, V22, P247, DOI 10.1038/gt.2014.110; Yang YF, 2015, HUM GENE THER, V26, P813, DOI 10.1089/hum.2015.098; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076	76	37	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16211	16220		10.1074/jbc.M116.769950	http://dx.doi.org/10.1074/jbc.M116.769950			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28798237	hybrid, Green Published			2022-12-26	WOS:000412109400020
J	Wu, Q; Sun, M; Bernard, LP; Zhang, HY				Wu, Qian; Sun, Miao; Bernard, Laura P.; Zhang, Huaye			Postsynaptic density 95 (PSD-95) serine 561 phosphorylation regulates a conformational switch and bidirectional dendritic spine structural plasticity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM DEPRESSION; GUANYLATE KINASE DOMAINS; INTRAMOLECULAR INTERACTION; AMPA RECEPTORS; SYNAPTIC PLASTICITY; HIPPOCAMPAL-NEURONS; PROTEIN; MAGUK; POLARITY; IDENTIFICATION	Postsynaptic density 95 (PSD-95) is a major synaptic scaffolding protein that plays a key role in bidirectional synaptic plasticity, which is a process important for learning and memory. It is known that PSD-95 shows increased dynamics upon induction of plasticity. However, the underlying structural and functional changes in PSD-95 that mediate its role in plasticity remain unclear. Here we show that phosphorylation of PSD-95 at Ser-561 in its guanylate kinase (GK) domain, which is mediated by the partitioning-defective 1 (Par1) kinases, regulates a conformational switch and is important for bidirectional plasticity. Using a fluorescence resonance energy transfer (FRET) biosensor, we show that a phosphomimetic mutation of Ser-561 promotes an intramolecular interaction between GK and the nearby Src homology 3 (SH3) domain, leading to a closed conformation, whereas a non-phosphorylatable S561A mutation or inhibition of Par1 kinase activity decreases SH3-GK interaction, causing PSD-95 to adopt an open conformation. In addition, S561A mutation facilitates the interaction between PSD-95 and its binding partners. Fluorescence recovery after photobleaching imaging reveals that the S561A mutant shows increased stability, whereas the phosphomimetic S561D mutation increases PSD-95 dynamics at the synapse. Moreover, molecular replacement of endogenous PSD-95 with the S561A mutant blocks dendritic spine structural plasticity during chemical long-term potentiation and long-term depression. Endogenous Ser-561 phosphorylation is induced by synaptic NMDA receptor activation, and the SH3-GK domains exhibit a Ser-561 phosphorylation-dependent switch to a closed conformation during synaptic plasticity. Our results provide novel mechanistic insight into the regulation of PSD-95 in dendritic spine structural plasticity through phosphorylation-mediated regulation of protein dynamics and conformation.	[Wu, Qian; Sun, Miao; Bernard, Laura P.; Zhang, Huaye] Rutgers State Univ, Dept Neurosci & Cell Biol, Robert Wood Johnson Med Sch, Piscataway, NJ 08854 USA; [Wu, Qian] NewYork Univ, Sch Med, Dept Neurosci & Physiol, 550 First Ave, New York, NY 10016 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Zhang, HY (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, 675 Hoes Lane West, Piscataway, NJ 08854 USA.	huaye.zhang@rutgers.edu			National Institutes of Health [NS065183, NS089578]; Rutgers Robert Wood Johnson Medical School; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089578, K99NS065183, R00NS065183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rutgers Robert Wood Johnson Medical School; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants NS065183 and NS089578 and startup funds from the Rutgers Robert Wood Johnson Medical School (to H. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anggono V, 2012, CURR OPIN NEUROBIOL, V22, P461, DOI 10.1016/j.conb.2011.12.006; Ballif BA, 2008, J PROTEOME RES, V7, P311, DOI 10.1021/pr0701254; Bernard LP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124816; Bhattacharyya S, 2009, NAT NEUROSCI, V12, P172, DOI 10.1038/nn.2249; Bosch M, 2012, CURR OPIN NEUROBIOL, V22, P383, DOI 10.1016/j.conb.2011.09.002; Colgan LA, 2014, ANNU REV PHYSIOL, V76, P365, DOI 10.1146/annurev-physiol-021113-170400; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; Fortin DA, 2010, J NEUROSCI, V30, P11565, DOI 10.1523/JNEUROSCI.1746-10.2010; Fu M, 2012, NATURE, V483, P92, DOI 10.1038/nature10844; Hao Y, 2008, J CELL BIOL, V182, P827, DOI 10.1083/jcb.200803110; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hoey SE, 2009, J NEUROSCI, V29, P4442, DOI 10.1523/JNEUROSCI.6017-08.2009; Hou HL, 2013, J CELL BIOL, V203, P521, DOI 10.1083/jcb.201303035; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kim MJ, 2007, NEURON, V56, P488, DOI 10.1016/j.neuron.2007.09.007; Lai CSW, 2012, NATURE, V483, P87, DOI 10.1038/nature10792; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Marcette J, 2009, BIOCHEMISTRY-US, V48, P10014, DOI 10.1021/bi901160f; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; McGee AW, 1999, J BIOL CHEM, V274, P17431, DOI 10.1074/jbc.274.25.17431; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nelson CD, 2013, J NEUROSCI, V33, P12122, DOI 10.1523/JNEUROSCI.0131-13.2013; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Pontrello CG, 2012, P NATL ACAD SCI USA, V109, pE442, DOI 10.1073/pnas.1118803109; Reese ML, 2007, NAT STRUCT MOL BIOL, V14, P155, DOI 10.1038/nsmb1195; Sans N, 2005, NAT CELL BIOL, V7, P1179, DOI 10.1038/ncb1325; Shin HW, 2000, J NEUROSCI, V20, P3580, DOI 10.1523/JNEUROSCI.20-10-03580.2000; Stein V, 2003, J NEUROSCI, V23, P5503; Steiner P, 2008, NEURON, V60, P788, DOI 10.1016/j.neuron.2008.10.014; Sun M, 2013, JOVE-J VIS EXP, DOI 10.3791/50808; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; Wu Q, 2012, J BIOL CHEM, V287, P30781, DOI 10.1074/jbc.M112.351452; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Xu W, 2008, NEURON, V57, P248, DOI 10.1016/j.neuron.2007.11.027; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yu XZ, 2011, CURR OPIN NEUROBIOL, V21, P169, DOI 10.1016/j.conb.2010.07.010; Zhang HY, 2008, DEV CELL, V14, P216, DOI 10.1016/j.devcel.2007.11.020; Zhang HY, 2006, NAT CELL BIOL, V8, P227, DOI 10.1038/ncb1368; Zhang J, 2013, STRUCTURE, V21, P402, DOI 10.1016/j.str.2012.12.014; Zhang J, 2011, J BIOL CHEM, V286, P41776, DOI 10.1074/jbc.M111.272583; Zhang YL, 2007, NEURON, V53, P201, DOI 10.1016/j.neuron.2006.12.016; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zhu JW, 2011, EMBO J, V30, P4986, DOI 10.1038/emboj.2011.428	48	22	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16150	16160		10.1074/jbc.M117.782490	http://dx.doi.org/10.1074/jbc.M117.782490			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28790172	hybrid, Green Published			2022-12-26	WOS:000412109400015
J	Gurusamy, PD; Schafer, H; Ramamoorthy, S; Wink, M				Gurusamy, Poornima Devi; Schaefer, Holger; Ramamoorthy, Siva; Wink, Michael			Biologically active recombinant human erythropoietin expressed in hairy root cultures and regenerated plantlets of Nicotiana tabacum L.	PLOS ONE			English	Article							HIGH-LEVEL EXPRESSION; AGROBACTERIUM-RHIZOGENES; TISSUE CULTURES; T-DNA; TRANSGENIC PLANTS; TOBACCO CELLS; PROTEINS; GROWTH; GENE; OVEREXPRESSION	Hairy root culture is a potential alternative to conventional mammalian cell culture to produce recombinant proteins due to its ease in protein recovery, low costs and absence of potentially human pathogenic contaminants. The current study focussed to develop a new platform of a hairy root culture system from Nicotiana tabacum for the production of recombinant human EPO (rhEPO), which is regularly produced in mammalian cells. The human EPO construct was amplified with C-terminal hexahistidine tag from a cDNA of Caco-2 cells. Two versions of rhEPO clones, with or without the N-terminal calreticulin (cal) fusion sequence, were produced by cloning the amplified construct into gateway binary vector pK(7)WG2D. Following Agrobacterium rhizogenes mediated transformation of tobacco explants; integration and expression of constructs in hairy roots were confirmed by several tests at DNA, RNA and protein levels. The amount of intracellular rhEPO from hairy root cultures with cal signal peptide was measured up to 66.75 ng g(-1) of total soluble protein. The presence of the ER signal peptide (cal) was essential for the secretion of rhEPO into the spent medium; no protein was detected from hairy root cultures without ER signal peptide. The addition of polyvinylpyrrolidone enhanced the stabilization of secreted rhEPO leading to a 5.6 fold increase to a maximum concentration of 185.48 pg rhEPO(HR) g(-1) FW hairy root cultures. The rhizo-secreted rhEPO was separated by HPLC and its biological activity was confirmed by testing distinct parameters for proliferation and survival in retinal pigment epithelial cells (ARPE). In addition, the rhEPO was detected to an amount 14.8 ng g(-1) of total soluble leaf protein in transgenic T-0 generation plantlets regenerated from hairy root cultures with cal signal peptide.	[Gurusamy, Poornima Devi; Schaefer, Holger; Wink, Michael] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Dept Biol, Heidelberg, Germany; [Ramamoorthy, Siva] VIT Univ, Sch Bio Sci & Technol, Vellore, Tamil Nadu, India	Ruprecht Karls University Heidelberg; Vellore Institute of Technology	Wink, M (corresponding author), Heidelberg Univ, Inst Pharm & Mol Biotechnol, Dept Biol, Heidelberg, Germany.	wink@uni-hd.de	Ramamoorthy FLS, FRSB, FRSC, Prof. Siva/D-7133-2019; Wink, Michael/E-3803-2012	Ramamoorthy FLS, FRSB, FRSC, Prof. Siva/0000-0001-7509-8602; Wink, Michael/0000-0002-7875-4510; Gurusamy, Poornima Devi/0000-0002-1627-5063	Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg; DAAD-Stipenden-und Betreuungsprogramm (STIBET)-Grant from Graduate academy, University of Heidelberg, Germany; Rotary Club Schwetzingen-Walldorf, Germany; Gesellschaft der Freunde Universitat Heidelberg e.V., Stiftung Universitat Heidelberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg; DAAD-Stipenden-und Betreuungsprogramm (STIBET)-Grant from Graduate academy, University of Heidelberg, Germany; Rotary Club Schwetzingen-Walldorf, Germany; Gesellschaft der Freunde Universitat Heidelberg e.V., Stiftung Universitat Heidelberg	We acknowledge the financial support of the Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing. DAAD-Stipenden-und Betreuungsprogramm (STIBET)-Grant for the completion of a doctoral degree from the Graduate academy, University of Heidelberg, Germany, Rotary Club Schwetzingen-Walldorf, Germany and Gesellschaft der Freunde Universitat Heidelberg e.V., Stiftung Universitat Heidelberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcasoy MO, 2010, HAEMATOL-HEMATOL J, V95, P1803, DOI 10.3324/haematol.2010.030213; Becerra SP, 2002, NEW ENGL J MED, V347, P1968, DOI 10.1056/NEJMcibr022629; BENFEY PN, 1990, SCIENCE, V250, P959, DOI 10.1126/science.250.4983.959; BILL RM, 1995, BBA-GENE STRUCT EXPR, V1261, P35, DOI 10.1016/0167-4781(94)00213-M; Borisjuk NV, 1999, NAT BIOTECHNOL, V17, P466, DOI 10.1038/8643; Brzezianska E, 2014, BIOL SPORT, V31, P251, DOI [10.5604/20831862.1120931, 10.5604/200831862.1120931]; Castilho A, 2011, GLYCOBIOLOGY, V21, P813, DOI 10.1093/glycob/cwr009; Celik E, 2007, J APPL MICROBIOL, V103, P2084, DOI 10.1111/j.1365-2672.2007.03448.x; Cheon BY, 2004, TRANSGENIC RES, V13, P541, DOI 10.1007/s11248-004-2737-3; Choi PS, 2004, PLANT CELL REP, V22, P828, DOI 10.1007/s00299-004-0765-3; Conley AJ, 2011, PLANT BIOTECHNOL J, V9, P434, DOI 10.1111/j.1467-7652.2010.00563.x; Conley AJ, 2010, TRANSGENIC RES, V19, P291, DOI 10.1007/s11248-009-9306-8; Conley AJ, 2009, PLANT BIOTECHNOL J, V7, P183, DOI 10.1111/j.1467-7652.2008.00389.x; DAVID C, 1984, BIO-TECHNOL, V2, P73, DOI 10.1038/nbt0184-73; Doran PM, 2006, TRENDS BIOTECHNOL, V24, P426, DOI 10.1016/j.tibtech.2006.06.012; Doran PM, 2006, J BIOTECHNOL, V122, P39, DOI 10.1016/j.jbiotec.2005.08.029; ESCHBACH JW, 1987, NEW ENGL J MED, V316, P73, DOI 10.1056/NEJM198701083160203; Fan J, 2011, PLANT CELL TISS ORG, V107, P225, DOI 10.1007/s11240-011-9973-z; Gleba D, 1999, P NATL ACAD SCI USA, V96, P5973, DOI 10.1073/pnas.96.11.5973; Gunjan S. K., 2013, American Journal of Plant Sciences, V4, P1675, DOI 10.4236/ajps.2013.48203; HARTLEY JL, 2000, GENOME RES, V10, P1788, DOI DOI 10.1101/GR.143000; Hayat Amir, 2008, Patient Prefer Adherence, V2, P195; Hellwig S, 2004, NAT BIOTECHNOL, V22, P1415, DOI 10.1038/nbt1027; HIATT A, 1989, NATURE, V342, P76, DOI 10.1038/342076a0; Jelkmann W, 2005, CURR PHARM BIOTECHNO, V6, P65; Kittur FS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076468; Lappin TR, 2002, STEM CELLS, V20, P485, DOI 10.1634/stemcells.20-6-485; Lee KT, 2007, APPL MICROBIOL BIOT, V73, P1047, DOI 10.1007/s00253-006-0576-2; Lloyd GB, 1980, COMB P INT PLANT PRO, V30, P421; Ma JKC, 2003, NAT REV GENET, V4, P794, DOI 10.1038/nrg1177; Martinez C, 2005, ELECTRON J BIOTECHN, V8, P170, DOI 10.2225/vol8-issue2-fulltext-10; MATSUMOTO S, 1995, PLANT MOL BIOL, V27, P1163, DOI 10.1007/BF00020889; MATSUMOTO S, 1993, BIOSCI BIOTECH BIOCH, V57, P1249, DOI 10.1271/bbb.57.1249; Mishra BN, 2008, BIOTECHNOL APPL BIOC, V49, P1, DOI 10.1042/BA20070103; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Musa TA, 2009, PLANT BIOTECHNOL REP, V3, P157, DOI 10.1007/s11816-009-0086-7; Mussmann V, 2011, PLANT CELL TISS ORG, V107, P483, DOI 10.1007/s11240-011-9998-3; Pham NB, 2012, BIOTECHNOL J, V7, P537, DOI 10.1002/biot.201100430; Petersen LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024531; Pires AS, 2012, PLANT CELL TISS ORG, V110, P171, DOI 10.1007/s11240-012-0141-x; POWELL JS, 1986, P NATL ACAD SCI USA, V83, P6465, DOI 10.1073/pnas.83.17.6465; Rahman M. A., 2010, Bangladesh Journal of Agricultural Research, V35, P125; Sala F, 2003, VACCINE, V21, P803, DOI 10.1016/S0264-410X(02)00603-5; Sevon N, 2002, PLANTA MED, V68, P859, DOI 10.1055/s-2002-34924; TAYLOR BH, 1985, MOL GEN GENET, V201, P546, DOI 10.1007/BF00331354; TEPFER D, 1984, CELL, V37, P959, DOI 10.1016/0092-8674(84)90430-6; Twyman RM, 2003, TRENDS BIOTECHNOL, V21, P570, DOI 10.1016/j.tibtech.2003.10.002; van der Meer P, 2004, EUR HEART J, V25, P285, DOI 10.1016/j.ehj.2003.11.017; Vincent J., 1970, INT BIOL PROGRAMME H, V15; Weise A, 2007, PLANT BIOTECHNOL J, V5, P389, DOI 10.1111/j.1467-7652.2007.00248.x; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Wink Michael, 2005, Plant Genetic Resources Characterization and Utilization, V3, P90, DOI 10.1079/PGR200575	52	13	14	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0182367	10.1371/journal.pone.0182367	http://dx.doi.org/10.1371/journal.pone.0182367			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800637	gold, Green Published, Green Submitted			2022-12-26	WOS:000407431800014
J	Jiang, PC; Xing, FL; Guo, B; Yang, JY; Li, ZM; Wei, W; Hu, F; Lee, IS; Zhang, XZ; Pan, LT; Xu, JJ				Jiang, Pengchong; Xing, Fulin; Guo, Bu; Yang, Jianyu; Li, Zheming; Wei, Wei; Hu, Fen; Lee, Imshik; Zhang, Xinzheng; Pan, Leiting; Xu, Jingjun			Nucleotide transmitters ATP and ADP mediate intercellular calcium wave communication via P2Y(12/13) receptors among BV-2 microglia	PLOS ONE			English	Article							PURINERGIC RECEPTORS; EXTRACELLULAR ATP; P2Y(1) RECEPTOR; CELLS; PROPAGATION; ANTAGONISTS; CHEMOTAXIS; ACTIVATION; MECHANISMS; RELEASE	W Nerve injury is accompanied by a liberation of diverse nucleotides, some of which act as 'find/eat-me' signals in mediating neuron-glial interplay. Intercellular Ca2+ wave (ICW) communication is the main approach by which glial cells interact and coordinate with each other to execute immune defense. However, the detailed mechanisms on how these nucleotides participate in ICW communication remain largely unclear. In the present work, we employed a mechanical stimulus to an individual BV-2 microglia to simulate localized injury. Remarkable ICW propagation was observed no matter whether calcium was in the environment or not. Apyrase (ATP/ADP-hydrolyzing enzyme), suramin (broad-spectrum P2 receptor antagonist), 2-APB (IP3 receptor blocker) and thapsigargin (endoplasmic reticulum calcium pump inhibitor) potently inhibited these ICWs, respectively, indicating the dependence of nucleotide signals and P2Y receptors. Then, we detected the involvement of five naturally occurring nucleotides (ATP, ADP, UTP, UDP and UDP-glucose) by desensitizing receptors. Results showed that desensitization with ATP and ADP could block ICW propagation in a dose-dependent manner, whereas other nucleotides had little effect. Meanwhile, the expression of P2Y receptors in BV-2 microglia was identified and their contributions were analyzed, from which we suggested P2Y(12/13) receptors activation mostly contributed to ICWs. Besides, we estimated that extracellular ATP and ADP concentration sensed by BV-2 microglia was about 0.3 mu M during ICWs by analyzing calcium dynamic characteristics. Taken together, these results demonstrated that the nucleotides ATP and ADP were predominant signal transmitters in mechanical stimulation-induced ICW communication through acting on P2Y(12/13) receptors in BV-2 microglia.	[Jiang, Pengchong; Xing, Fulin; Guo, Bu; Yang, Jianyu; Li, Zheming; Wei, Wei; Hu, Fen; Lee, Imshik; Zhang, Xinzheng; Pan, Leiting; Xu, Jingjun] Nankai Univ, TEDA Inst Appl Phys, Minist Educ, Key Lab Weak Light Nonlinear Photon, Tianjin, Peoples R China; [Jiang, Pengchong; Xing, Fulin; Guo, Bu; Yang, Jianyu; Li, Zheming; Wei, Wei; Hu, Fen; Lee, Imshik; Zhang, Xinzheng; Pan, Leiting; Xu, Jingjun] Nankai Univ, Sch Phys, Tianjin, Peoples R China; [Zhang, Xinzheng; Xu, Jingjun] Shanxi Univ, Collaborat Innovat Ctr Extreme Opt, Taiyuan, Shanxi, Peoples R China; [Pan, Leiting] Nankai Univ, Project Collaborat Innovat Ctr Biol Therapy 2011, Tianjin, Peoples R China	Nankai University; Nankai University; Shanxi University; Nankai University	Pan, LT (corresponding author), Nankai Univ, TEDA Inst Appl Phys, Minist Educ, Key Lab Weak Light Nonlinear Photon, Tianjin, Peoples R China.; Pan, LT (corresponding author), Nankai Univ, Sch Phys, Tianjin, Peoples R China.; Pan, LT (corresponding author), Nankai Univ, Project Collaborat Innovat Ctr Biol Therapy 2011, Tianjin, Peoples R China.	plt@nankai.edu.cn	Lee, Imshik/G-6129-2010; yang, jian/HIK-0188-2022; Jingjun, Xu/A-1282-2010; xu, jing/GRR-8698-2022	Lee, Imshik/0000-0002-0098-392X; 	National Natural Science Foundation of China [11574165]; PCSIRT (Program for Changjiang Scholars and Innovative Research Team in University) [IRT_13R29]; 111 Project [B07013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); PCSIRT (Program for Changjiang Scholars and Innovative Research Team in University)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); 111 Project(Ministry of Education, China - 111 Project)	This work was supported by the National Natural Science Foundation of China (no. 11574165), the PCSIRT (Program for Changjiang Scholars and Innovative Research Team in University) (no. IRT_13R29), the 111 Project (no. B07013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burnstock G, 2016, NEUROPHARMACOLOGY, V104, P4, DOI 10.1016/j.neuropharm.2015.05.031; Cao Q, 2008, GLIA, V56, P1224, DOI 10.1002/glia.20692; Cavaliere F, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00211; Cekic C, 2016, NAT REV IMMUNOL, V16, P177, DOI 10.1038/nri.2016.4; Certal M, 2015, CELL CALCIUM, V58, P518, DOI 10.1016/j.ceca.2015.08.004; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Cotrina ML, 2000, J NEUROSCI, V20, P2835; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; De Simone R, 2010, J NEUROCHEM, V115, P450, DOI 10.1111/j.1471-4159.2010.06937.x; Eichhoff G, 2011, BBA-MOL CELL RES, V1813, P1014, DOI 10.1016/j.bbamcr.2010.10.018; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Ferrari D, 2016, TRENDS IMMUNOL, V37, P399, DOI 10.1016/j.it.2016.04.004; Fredholm B, 2010, ACTA PHYSIOL, V199, P91, DOI 10.1111/j.1748-1716.2010.02113.x; Gordon R, 2016, NEUROBIOL DIS, V93, P96, DOI 10.1016/j.nbd.2016.04.008; Hausmann R, 2015, CURR MED CHEM, V22, P799, DOI 10.2174/0929867322666141128163215; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Hechler B, 1998, MOL PHARMACOL, V53, P727, DOI 10.1124/mol.53.4.727; Hechler B, 2015, ARTERIOSCL THROM VAS, V35, P2307, DOI 10.1161/ATVBAHA.115.303395; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Horvath RJ, 2008, J NEUROCHEM, V107, P557, DOI 10.1111/j.1471-4159.2008.05633.x; Irino Y, 2008, J NEUROSCI RES, V86, P1511, DOI 10.1002/jnr.21610; Jacobson KA, 2009, PURINERG SIGNAL, V5, P75, DOI 10.1007/s11302-008-9106-2; James G, 2002, EUR J PHARMACOL, V447, P247, DOI 10.1016/S0014-2999(02)01756-9; Kauffenstein G, 2004, J THROMB HAEMOST, V2, P1980, DOI 10.1111/j.1538-7836.2004.00926.x; Khakh BS, 2009, SCI AM, V301, P84, DOI 10.1038/scientificamerican1209-84; Lazarowski ER, 2012, PURINERG SIGNAL, V8, P359, DOI 10.1007/s11302-012-9304-9; Lazarowski ER, 2011, ADV PHARMACOL, V61, P221, DOI 10.1016/B978-0-12-385526-8.00008-4; Leon C, 1997, FEBS LETT, V403, P26, DOI 10.1016/S0014-5793(97)00022-7; Li WZ, 2016, J NEUROIMMUNE PHARM, V11, P484, DOI 10.1007/s11481-016-9686-5; Light AR, 2006, NEURON GLIA BIOL, V2, P125, DOI 10.1017/S1740925X05000323; Lohman AW, 2012, CARDIOVASC RES, V95, P269, DOI 10.1093/cvr/cvs187; Ma L, 2007, J CELL SCI, V120, P213, DOI 10.1242/jcs.03338; Monif M, 2009, J NEUROSCI, V29, P3781, DOI 10.1523/JNEUROSCI.5512-08.2009; Obal F, 2001, REV NEUROL-FRANCE, V157, pS12; Ohsawa K, 2007, GLIA, V55, P604, DOI 10.1002/glia.20489; Piazza V, 2007, CELL CALCIUM, V41, P77, DOI 10.1016/j.ceca.2006.05.005; Pires M, 2014, J THEOR BIOL, V356, P201, DOI 10.1016/j.jtbi.2014.04.024; Raboisson P, 2002, J ORG CHEM, V67, P8063, DOI 10.1021/jo026268l; Rodrigues RJ, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00148; Samuels SE, 2010, J GEN PHYSIOL, V136, P425, DOI 10.1085/jgp.201010476; Sandal M, 2013, CURR PROTEIN PEPT SC, V14, P650, DOI 10.2174/13892037113146660085; Schipke CG, 2001, FASEB J, V15, P255, DOI 10.1096/fj.01-0514fje; Sieger D, 2012, DEV CELL, V22, P1138, DOI 10.1016/j.devcel.2012.04.012; Verderio C, 2001, J IMMUNOL, V166, P6383, DOI 10.4049/jimmunol.166.10.6383; Visentin S, 2006, Purinergic Signal, V2, P605, DOI 10.1007/s11302-006-9023-1; von Kugelgen I, 2006, PHARMACOL THERAPEUT, V110, P415, DOI 10.1016/j.pharmthera.2005.08.014; Weissman TA, 2004, NEURON, V43, P647, DOI 10.1016/j.neuron.2004.08.015; Wilson HL, 2004, J IMMUNOL, V173, P1202, DOI 10.4049/jimmunol.173.2.1202; Wu X, 2013, BIOCHEM BIOPH RES CO, V431, P664, DOI 10.1016/j.bbrc.2013.01.064; Zeng JW, 2014, NEUROCHEM RES, V39, P2240, DOI 10.1007/s11064-014-1426-8; Zeng Y, 2008, BRAIN RES, V1239, P12, DOI 10.1016/j.brainres.2008.08.085	51	18	18	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0183114	10.1371/journal.pone.0183114	http://dx.doi.org/10.1371/journal.pone.0183114			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800362	gold, Green Submitted, Green Published			2022-12-26	WOS:000407431800055
J	Hou, WY; Gupta, S; Beauchamp, MC; Yuan, LB; Jerome-Majewska, LA				Hou, Wenyang; Gupta, Swati; Beauchamp, Marie-Claude; Yuan, Libin; Jerome-Majewska, Loydie A.			Non-alcoholic fatty liver disease in mice with heterozygous mutation in TMED2	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; P24 FAMILY; TRAFFICKING; EXPRESSION; STEATOSIS; LOCALIZATION; TRANSPORT; GENES	The (t) under bar rans (m) under bar embrane (e) under bar mp24 (d) under bar omain/p24 (TMED) family are essential components of the vesicular transport machinery. Members of the TMED family serve as cargo receptors implicated in selection and packaging of endoplasmic reticulum (ER) luminal proteins into coatomer (COP) II coated vesicles for anterograde transport to the Golgi. Deletion or mutations of Tmed genes in yeast and Drosophila results in ER-stress and activation of the unfolded protein response (UPR). The UPR leads to expression of genes and proteins important for expanding the folding capacity of the ER, degrading misfolded proteins, and reducing the load of new proteins entering the ER. The UPR is activated in (n) under bar on-(a) under bar lcoholic (f) under bar atty (l) under bar iver (d) under bar isease (NAFLD) in human and mouse and may contribute to the development and the progression of NAFLD. Tmed2, the sole member of the vertebrate Tmed beta subfamily, exhibits tissue and temporal specific patterns of expression in embryos and developing placenta but is ubiquitously expressed in all adult organs. We previously identified a single point mutation, the 99J mutation, in the signal sequence of Tmed2 in an N-ethyl-N-nitrosourea (ENU) mutagenesis screen. Histological and molecular analysis of livers from heterozygous mice carrying the 99J mutation, Tmed(299J/+), revealed a requirement for TMED2 in liver health. We show that Tmed(299J/+) mice had decreased levels of TMED2 and TMED10, dilated endoplasmic reticulum membrane, and increased phosphorylation of eIF2 alpha, indicating ER-stress and activation of the UPR. Increased expression of Srebp1a and 2 at the newborn stage and increased incidence of NAFLD were also found in Tmed(299J/+) mice. Our data establishes Tmed(299J/+) mice as a novel mouse model for NAFLD and supports a role for TMED2 in liver health.	[Hou, Wenyang; Gupta, Swati; Beauchamp, Marie-Claude; Yuan, Libin; Jerome-Majewska, Loydie A.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Jerome-Majewska, Loydie A.] McGill Univ, Ctr Hlth, Dept Pediat, Glen Site, Montreal, PQ, Canada; [Jerome-Majewska, Loydie A.] McGill Univ, Dept Anat & Cell Biol, Strathcona Anat & Dent Bldg, Montreal, PQ, Canada; [Gupta, Swati] Yale Sch Med, Dept Pathol, New Haven, CT USA	McGill University; McGill University; McGill University; Yale University	Jerome-Majewska, LA (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.; Jerome-Majewska, LA (corresponding author), McGill Univ, Ctr Hlth, Dept Pediat, Glen Site, Montreal, PQ, Canada.; Jerome-Majewska, LA (corresponding author), McGill Univ, Dept Anat & Cell Biol, Strathcona Anat & Dent Bldg, Montreal, PQ, Canada.	loydie.majewska@mcgill.ca		Jerome-Majewska, Loydie/0000-0002-5047-4058	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2015-06699]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC), http://www.nserc-crsng.gc.ca/ index_eng.asp, RGPIN-2015-06699.	Abd El-Kader SM, 2015, WORLD J HEPATOL, V7, P846, DOI 10.4254/wjh.v7.i6.846; Au CE, 2015, MOL BIOL CELL, V26, P4015, DOI 10.1091/mbc.E14-12-1632; Belden WJ, 2001, MOL BIOL CELL, V12, P957, DOI 10.1091/mbc.12.4.957; Blum R, 1999, J CELL SCI, V112, P537; Boltz KA, 2007, DEV DYNAM, V236, P544, DOI 10.1002/dvdy.21032; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cusi K, 2016, ANN INTERN MED, V165, P305, DOI 10.7326/M15-1774; Denzel A, 2000, CURR BIOL, V10, P55, DOI 10.1016/S0960-9822(99)00266-3; Duquet A, 2014, EMBO MOL MED, V6, P882, DOI 10.15252/emmm.201303799; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Emery G, 2000, J CELL SCI, V113, P2507; Ferre P, 2010, DIABETES OBES METAB, V12, P83, DOI 10.1111/j.1463-1326.2010.01275.x; Fullekrug J, 1999, MOL BIOL CELL, V10, P1939, DOI 10.1091/mbc.10.6.1939; GARIBOLDI M, 1993, CANCER RES, V53, P209; Gupta S, 2016, COLD SPRING HARB MOL, V2, DOI DOI 10.1101/MCS.A00073727148587; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Henkel A, 2013, SEMIN LIVER DIS, V33, P321, DOI 10.1055/s-0033-1358522; Horton JD, 2002, COLD SPRING HARB SYM, V67, P491, DOI 10.1101/sqb.2002.67.491; Hou WY, 2016, PLACENTA, V47, P12, DOI 10.1016/j.placenta.2016.08.091; Hunt R, 2014, J CLIN GASTROENTEROL, V48, P567, DOI 10.1097/MCG.0000000000000141; Jenne N, 2002, J BIOL CHEM, V277, P46504, DOI 10.1074/jbc.M206989200; Jerome-Majewska LA, 2010, DEV BIOL, V341, P154, DOI 10.1016/j.ydbio.2010.02.019; Kim D, 2017, CLIN GASTROENTEROL H, V15, P474, DOI 10.1016/j.cgh.2016.08.028; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lavoie C, 1999, J CELL BIOL, V146, P285, DOI 10.1083/jcb.146.2.285; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Marques M, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0454-9; Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4; Pastor-Cantizano N, 2016, PROTOPLASMA, V253, P967, DOI 10.1007/s00709-015-0858-6; Provencher DM, 2014, JAAPA-J AM ACAD PHYS, V27, P18, DOI 10.1097/01.JAA.0000450801.19545.93; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Romero-Gomez M, 2017, J HEPATOL, V67, P829, DOI 10.1016/j.jhep.2017.05.016; Satpute-Krishnan P, 2014, CELL, V158, P522, DOI 10.1016/j.cell.2014.06.026; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Strating JRPM, 2009, BIOL CELL, V101, P495, DOI 10.1042/BC20080233; Strating JRPM, 2009, BIOL CELL, V101, P207, DOI 10.1042/BC20080075; Tandra S, 2011, J HEPATOL, V55, P654, DOI 10.1016/j.jhep.2010.11.021; Vainio Paula, 2012, PLoS One, V7, pe39801, DOI 10.1371/journal.pone.0039801; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Williams Tracy, 2015, FP Essent, V435, P24; Yamamoto K, 2010, MOL BIOL CELL, V21, P2975, DOI 10.1091/mbc.E09-02-0133; YARNAMOTO K, 2007, DEV CELL, V13, P365, DOI DOI 10.1016/J.DEVCEL.2007.07.018; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zakariyah A, 2012, PLACENTA, V33, P214, DOI 10.1016/j.placenta.2011.12.009; Zheng H, 2016, SCI REP-UK, V6, DOI 10.1038/srep37070	46	18	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182995	10.1371/journal.pone.0182995	http://dx.doi.org/10.1371/journal.pone.0182995			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797121	Green Published, Green Submitted, gold			2022-12-26	WOS:000407396200137
J	Huang, CM; Chang, KC; Hung, CH; Chiu, KW; Lu, SN; Wang, JH; Chen, CH; Kee, KM; Kuo, YH; Tsai, MC; Tseng, PL; Lin, MT; Wu, CK; Hu, TH; Cho, CL; Yen, YH				Huang, Chao-Min; Chang, Kuo-Chin; Hung, Chao-Hung; Chiu, King-Wah; Lu, Sheng-Nan; Wang, Jing-Houng; Chen, Chien-Hung; Kee, Kwong-Ming; Kuo, Yuan-Hung; Tsai, Ming-Chao; Tseng, Po-Lin; Lin, Ming-Tsung; Wu, Cheng-Kun; Hu, Tsung-Hui; Cho, Chung-Lung; Yen, Yi-Hao			Impact of PNPLA3 and IFNL3 polymorphisms on hepatic steatosis in Asian patients with chronic hepatitis C	PLOS ONE			English	Article							LIVER FIBROSIS; JAPANESE PATIENTS; IL28B GENOTYPE; HEPATOCELLULAR-CARCINOMA; GENETIC-POLYMORPHISM; ANTIVIRAL THERAPY; VIRUS-INFECTION; FATTY LIVER; DISEASE; INFLAMMATION	Background and aims A recent meta-analysis revealed that the genotype PNPLA3 rs738409 GG is associated with a higher risk of hepatic steatosis (HS) in Caucasian patients with chronic hepatitis C (CHC). However, controversial results were found regarding Asian populations. Furthermore, previous studies have shown a negative association between interferon lambda 3 (IFNL3) rs12979860 CC and HS in Caucasian CHC patients, but there have been no reports indicating any such association in Asian populations. In this study, then, we investigated the association of PNPLA3 and IFNL3 polymorphisms with HS in Asian CHC patients. Methods We enrolled consecutive CHC patients who underwent liver biopsy prior to antiviral therapy. We excluded those patients with decompensated liver disease, any co-existing chronic liver disease, or HIV or HBV co-infection. Results 1080 CHC patients were enrolled, and HS was found in 453 (41.9%) patients. The frequency distribution of the G allele was significantly associated with HS (P<0.001), and this conferred a higher risk to G allele homozygotes (OR: 2.06, 95% CI: 1.46-2.88, P <0.001) than to G allele carriers (OR: 1.98, 95% CI: 1.52-2.58, P<0.001). There was a borderline significant difference in the prevalence of HS in rs12979860 CC versus non-CC (40.8% versus 49.3%, P = 0.059). After adjustment for age, sex, body mass index, diabetes, and excessive alcohol intake, the rs738409 G allele homozygote carriers still carried a higher risk for HS (OR: 1.93, 95% CI: 1.35-2.77, P = 0.003). Conclusion The PNPLA3 rs738409 GG genotype is positively associated with HS, while the IFNL3 rs 12979860 CC genotype may be negatively associated with HS, in Asian CHC patients.	[Huang, Chao-Min; Cho, Chung-Lung] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung, Taiwan; [Chang, Kuo-Chin; Hung, Chao-Hung; Chiu, King-Wah; Lu, Sheng-Nan; Wang, Jing-Houng; Chen, Chien-Hung; Kee, Kwong-Ming; Kuo, Yuan-Hung; Tsai, Ming-Chao; Tseng, Po-Lin; Lin, Ming-Tsung; Wu, Cheng-Kun; Hu, Tsung-Hui; Yen, Yi-Hao] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan; [Chang, Kuo-Chin; Hung, Chao-Hung; Chiu, King-Wah; Lu, Sheng-Nan; Wang, Jing-Houng; Chen, Chien-Hung; Kee, Kwong-Ming; Kuo, Yuan-Hung; Tsai, Ming-Chao; Tseng, Po-Lin; Lin, Ming-Tsung; Wu, Cheng-Kun; Hu, Tsung-Hui; Yen, Yi-Hao] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan	National Sun Yat Sen University; Chang Gung Memorial Hospital; Chang Gung University	Yen, YH (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan.; Yen, YH (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung, Taiwan.	cassellyen@yahoo.com.tw	Tsai, Ming Chao/ABA-9806-2020	, Ming-Chao/0000-0002-3613-2051; Chiu, King-Wah/0000-0003-2108-6539	Chang Gung Memorial Hospital-Kaohsiung Medical Center; Taiwan [CMRPG8E1301]	Chang Gung Memorial Hospital-Kaohsiung Medical Center; Taiwan	This work was supported by Grant CMRPG8E1301 from Chang Gung Memorial Hospital-Kaohsiung Medical Center; Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agundez JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037998; Akuta N, 2001, J MED VIROL, V64, P109, DOI 10.1002/jmv.1025; ALTER HJ, 1989, NEW ENGL J MED, V321, P1494, DOI 10.1056/NEJM198911303212202; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Bochud PY, 2012, HEPATOLOGY, V55, P384, DOI 10.1002/hep.24678; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Cai T, 2011, J HEPATOL, V55, P529, DOI 10.1016/j.jhep.2010.12.020; Chang KC, 2015, CLIN GASTROENTEROL H, V13, P1017, DOI 10.1016/j.cgh.2014.10.035; Cooper S, 1999, IMMUNITY, V10, P439, DOI 10.1016/S1074-7613(00)80044-8; Crabb David W., 1999, Keio Journal of Medicine, V48, P184; Czaja AJ, 1998, J HEPATOL, V29, P198, DOI 10.1016/S0168-8278(98)80004-4; D'Ambrosio R, 2014, INT J MOL SCI, V15, P7213, DOI 10.3390/ijms15057213; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Dusheiko GM, 1998, J VIRAL HEPATITIS, V5, P9, DOI 10.1046/j.1365-2893.1998.0050s1009.x; Eslam M, 2017, NAT GENET, V49, P795, DOI 10.1038/ng.3836; Eslam M, 2016, J HEPATOL, V64, P390, DOI 10.1016/j.jhep.2015.11.008; Eslam M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7422; Fan JH, 2016, GUT LIVER, V10, P456, DOI 10.5009/gnl15261; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Huang CF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11901; Hui JM, 2002, J GASTROEN HEPATOL, V17, P873, DOI 10.1046/j.1440-1746.2002.02813.x; Ikeda K, 1998, J HEPATOL, V28, P930, DOI 10.1016/S0168-8278(98)80339-5; Kenny-Walsh E, 1999, NEW ENGL J MED, V340, P1228, DOI 10.1056/NEJM199904223401602; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Kurosaki M, 2010, HEPATOL RES, V40, P251, DOI 10.1111/j.1872-034X.2009.00607.x; Leandro G, 2006, GASTROENTEROLOGY, V130, P1636, DOI 10.1053/j.gastro.2006.03.014; Lee SH, 2005, J IMMUNOL, V175, P8226, DOI 10.4049/jimmunol.175.12.8226; Marabita F, 2011, HEPATOLOGY, V54, P1127, DOI 10.1002/hep.24503; Miyashita M, 2012, J VIRAL HEPATITIS, V19, P608, DOI 10.1111/j.1365-2893.2011.01580.x; Monto A, 2002, HEPATOLOGY, V36, P729, DOI 10.1053/jhep.2002.35064; Moqueet N, 2016, J INFECT DIS, V214, P80, DOI 10.1093/infdis/jiw088; Moritou Y, 2014, ACTA MED OKAYAMA, V68, P17; Nakamura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081312; Negro F, 2006, WORLD J GASTROENTERO, V12, P6756, DOI 10.3748/wjg.v12.i42.6756; Niederau C, 1998, HEPATOLOGY, V28, P1687, DOI 10.1002/hep.510280632; Noureddin M, 2013, HEPATOLOGY, V58, P1548, DOI 10.1002/hep.26506; Okanoue T, 2009, J GASTROENTEROL, V44, P952, DOI 10.1007/s00535-009-0087-x; Poynard T, 2003, HEPATOLOGY, V38, P481, DOI 10.1053/jhep.2003.50319; Rubbia-Brandt L, 2000, J HEPATOL, V33, P106, DOI 10.1016/S0168-8278(00)80166-X; Salameh H, 2015, AM J GASTROENTEROL, V110, P846, DOI 10.1038/ajg.2015.137; Shen J, 2014, ALIMENT PHARM THER, V39, P532, DOI 10.1111/apt.12609; Stattermayer AF, 2012, J HEPATOL, V57, P492, DOI 10.1016/j.jhep.2012.04.036; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Tillmann HL, 2011, J HEPATOL, V55, P1195, DOI 10.1016/j.jhep.2011.03.015; Trepo E, 2011, HEPATOLOGY, V54, P60, DOI 10.1002/hep.24350; Valenti L, 2012, J HEPATOL, V56, P1209, DOI 10.1016/j.jhep.2011.10.024; Valenti L, 2011, HEPATOLOGY, V53, P791, DOI 10.1002/hep.24123; Wu CK, 2016, J ANTIMICROB CHEMOTH, V71, P1943, DOI 10.1093/jac/dkw097; Wu CK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0142378; Yasui K, 2015, J GASTROENTEROL, V50, P887, DOI 10.1007/s00535-014-1018-z; Yasui K, 2010, J GASTROENTEROL, V45, P95, DOI 10.1007/s00535-009-0133-8; Zhang L, 2015, J GASTROEN HEPATOL, V30, P821, DOI 10.1111/jgh.12889	53	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182204	10.1371/journal.pone.0182204	http://dx.doi.org/10.1371/journal.pone.0182204			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797039	gold, Green Published, Green Submitted			2022-12-26	WOS:000407396200037
J	Rosales-Reyes, R; Gayosso-Vazquez, C; Fernandez-Vazquez, JL; Jarillo-Quijada, MD; Rivera-Benitez, C; Santos-Preciado, JI; Alcantar-Curiel, MD				Rosales-Reyes, Roberto; Gayosso-Vazquez, Catalina; Luis Fernandez-Vazquez, Jose; Dolores Jarillo-Quijada, Ma; Rivera-Benitez, Cesar; Ignacio Santos-Preciado, Jose; Dolores Alcantar-Curiel, Maria			Virulence profiles and innate immune responses against highly lethal, multidrug-resistant nosocomial isolates of Acinetobacter baumannii from a tertiary care hospital in Mexico	PLOS ONE			English	Article							BLOOD-STREAM INFECTION; ANTIMICROBIAL RESISTANCE; BIOFILM FORMATION; PSEUDOMONAS-AERUGINOSA; ABIOTIC SURFACES; DRUG-RESISTANCE; OUTBREAK; EPIDEMIOLOGY; MECHANISMS; SURVIVAL	Virulence profiles and innate immune responses were studied in Acinetobacter baumannii from nosocomial infections collected over one year in a tertiary care hospital in Mexico. A. baumannii were identified by VITEK 2 System followed by susceptibility tests. Carbapenemase genes, active efflux mechanism to imipenem and meropenem and outer membrane proteins profile were analyzed to evaluate their role on the activity of carbapenem resistance. All isolates were genotyped by pulsed field gel electrophoresis. The ability to form biofilm was determined on a polystyrene surface. The resistance to complement was determined with a pooled human normal serum and TNF alpha release by infected macrophages was determined by ELISA. The 112 isolates from this study were associated with a 52% of mortality. All were resistance to beta-lactams, fluoroquinolones, and trimethroprim-sulfamethoxal, 96 and 90% were resistant to meropenem and imipenem, respectively, but with high susceptibility to polymyxin B, colistin and tigecyclin. Isolates were classified in 11 different clones. Most isolates, 88% (99/112), were metallo-beta-lactamases and carbapenemases producers, associated in 95% with the presence of bla(OXA-72) gene. Only 4/99 and 1/99 of the carbapenem-resistant isolates were related to efflux mechanism to meropenem or imipenem resistance, respectively. The loss of expression of 22, 29, and/or 33-36-kDa proteins was detected in 8/11 of the clinical isolates with resistance to carbapenem. More than 96% (108/112) of the isolates were high producers of biofilms on biotic surfaces. Finally, all isolates showed variable resistance to normal human serum activity and were high inductors of TNFa release by macrophages. In summary, these results suggest that multidrug-resistant A. baumannii can persist in the hospital environment through its ability to form biofilms. The high mortality observed was due to their ability to survive normal human serum activity and capability to induce potent inflammatory immune response making this nosocomial pathogen a serious threat to hospitalized patients.	[Rosales-Reyes, Roberto; Gayosso-Vazquez, Catalina; Luis Fernandez-Vazquez, Jose; Dolores Jarillo-Quijada, Ma; Ignacio Santos-Preciado, Jose; Dolores Alcantar-Curiel, Maria] Univ Nacl Autonoma Mexico, Fac Med, Unidad Invest Med Expt, Mexico City, DF, Mexico; [Rivera-Benitez, Cesar] Hosp Gen Mexico City, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Hospital General de Mexico	Rosales-Reyes, R; Alcantar-Curiel, MD (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Unidad Invest Med Expt, Mexico City, DF, Mexico.	rrosalesr@ciencias.unam.mx; alcantar@unam.mx	Rosales-Reyes, Roberto/CAG-2458-2022	Jarillo-Quijada, Ma Dolores/0000-0003-4510-9707; Rosales-Reyes, Roberto/0000-0001-9519-8766	Consejo Nacional de Ciencia y Tecnologia, Mexico; PDCPN [247489]; Programa UNAM-DGAPA-PAPIIT [IN220613]; Consejo Nacional de Ciencia y Tecnologia, Mexico [CB-2013-01/222110]	Consejo Nacional de Ciencia y Tecnologia, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PDCPN; Programa UNAM-DGAPA-PAPIIT; Consejo Nacional de Ciencia y Tecnologia, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	MDAC received support from Consejo Nacional de Ciencia y Tecnologia, Mexico, PDCPN 247489 and Programa UNAM-DGAPA-PAPIIT IN220613. RRR received support from Consejo Nacional de Ciencia y Tecnologia, Mexico, CB-2013-01/222110.	Al Atrouni A, 2016, INT J INFECT DIS, V52, P29, DOI 10.1016/j.ijid.2016.09.017; AMES GFL, 1974, J BIOL CHEM, V249, P634; Antonio CS, 2011, ANTIMICROB AGENTS CH, V55, P1322, DOI 10.1128/AAC.01102-10; BECKSAGUE CM, 1990, AM J EPIDEMIOL, V132, P723, DOI 10.1093/oxfordjournals.aje.a115714; BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148, DOI 10.1128/CMR.9.2.148; Bernards AT, 2004, INFECT CONT HOSP EP, V25, P1002, DOI 10.1086/502335; Catalano M, 1999, J HOSP INFECT, V42, P27, DOI 10.1053/jhin.1998.0535; Costa Gislaine Franco de Moura, 2006, Braz J Infect Dis, V10, P346, DOI 10.1590/S1413-86702006000500009; Dalla-Costa LM, 2003, J CLIN MICROBIOL, V41, P3403, DOI 10.1128/JCM.41.7.3403-3406.2003; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Alcantar-Curiel MD, 2014, ARCH MED RES, V45, P553, DOI 10.1016/j.arcmed.2014.10.006; Eijkelkamp BA, 2011, FEMS MICROBIOL LETT, V323, P44, DOI 10.1111/j.1574-6968.2011.02362.x; Erridge C, 2007, J MED MICROBIOL, V56, P165, DOI 10.1099/jmm.0.46823-0; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; Garcia A, 2000, J MED MICROBIOL, V49, P1047, DOI 10.1099/0022-1317-49-11-1047; GERNERSMIDT P, 1991, J CLIN MICROBIOL, V29, P277, DOI 10.1128/JCM.29.2.277-282.1991; Gonzalez CR, 1995, ARCH MED RES, V26, pS99; Greene C, 2016, LETT APPL MICROBIOL, V63, P233, DOI 10.1111/lam.12627; Hanna H, 2004, INFECT CONT HOSP EP, V25, P646, DOI 10.1086/502455; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Huang L, 2008, DIAGN MICR INFEC DIS, V62, P326, DOI 10.1016/j.diagmicrobio.2008.06.008; Jacobs AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085729; Jamulitrat Silom, 2009, Journal of the Medical Association of Thailand, V92, P413; Jawad A, 1998, J CLIN MICROBIOL, V36, P1938, DOI 10.1128/JCM.36.7.1938-1941.1998; Jeong SH, 2006, J MICROBIOL, V44, P423; Jiang MJ, 2014, POL J MICROBIOL, V63, P275; Kim SW, 2009, FEMS MICROBIOL LETT, V301, P224, DOI 10.1111/j.1574-6968.2009.01820.x; King LB, 2009, FEMS IMMUNOL MED MIC, V55, P414, DOI 10.1111/j.1574-695X.2009.00538.x; Korneev KV, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00595; Landman D, 2007, J ANTIMICROB CHEMOTH, V60, P78, DOI 10.1093/jac/dkm129; LARSON EL, 1981, AM J INFECT CONTROL, V9, P112, DOI 10.1016/S0196-6553(81)80091-0; Lee HW, 2008, CLIN MICROBIOL INFEC, V14, P49, DOI 10.1111/j.1469-0691.2007.01842.x; Lee HY, 2015, J MICROBIOL IMMUNOL, V48, P588, DOI 10.1016/j.jmii.2015.03.003; Lee K, 2001, CLIN MICROBIOL INFEC, V7, P88, DOI 10.1046/j.1469-0691.2001.00204.x; Maragakis LL, 2008, CLIN INFECT DIS, V46, P1254, DOI 10.1086/529198; Maraki S, 2016, INFECT CHEMOTHER, V48, P190, DOI 10.3947/ic.2016.48.3.190; Moffatt JH, 2013, INFECT IMMUN, V81, P684, DOI 10.1128/IAI.01362-12; Morfin-Otero R, 2013, CHEMOTHERAPY, V59, P57, DOI 10.1159/000351098; Niu C, 2008, J BACTERIOL, V190, P3386, DOI 10.1128/JB.01929-07; Patel J.B., 2015, PERFORMANCE STANDARD; PATTERSON JE, 1991, AM J MED, V91, P479, DOI 10.1016/0002-9343(91)90183-X; Perez-Lopez A, 2013, J IMMUNOL, V190, P1201, DOI 10.4049/jimmunol.1200415; Potron A, 2015, INT J ANTIMICROB AG, V45, P568, DOI 10.1016/j.ijantimicag.2015.03.001; Rao RS, 2008, INDIAN J MED MICROBI, V26, P333; Rodriguez-Bano J, 2008, CLIN MICROBIOL INFEC, V14, P276, DOI 10.1111/j.1469-0691.2007.01916.x; Rosales-Reyes R, 2015, CHEMOTHERAPY, V61, P8, DOI 10.1159/000440605; Segal H, 2005, FEMS MICROBIOL LETT, V243, P425, DOI 10.1016/j.femsle.2005.01.005; Senda K, 1996, J CLIN MICROBIOL, V34, P2909, DOI 10.1128/JCM.34.12.2909-2913.1996; Shaw MJ, 2005, CURR OPIN PULM MED, V11, P236, DOI 10.1097/01.mcp.0000159834.05401.78; Smani Y, 2011, MICROB PATHOGENESIS, V50, P224, DOI 10.1016/j.micpath.2011.01.008; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Turton JF, 2006, J CLIN MICROBIOL, V44, P2630, DOI 10.1128/JCM.00547-06; Weber BS, 2016, J BACTERIOL, V198, P880, DOI 10.1128/JB.00906-15; Xiao SZ, 2016, MOL MED REP, V14, P2483, DOI 10.3892/mmr.2016.5538	54	17	17	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182899	10.1371/journal.pone.0182899	http://dx.doi.org/10.1371/journal.pone.0182899			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797068	gold, Green Submitted, Green Published			2022-12-26	WOS:000407396200115
J	Yan, L; Wang, H; Zhang, X; Li, MY; He, J				Yan, Long; Wang, Hong; Zhang, Xuan; Li, Ming-Yue; He, Juan			Impact of meteorological factors on the incidence of bacillary dysentery in Beijing, China: A time series analysis (1970-2012)	PLOS ONE			English	Article							TEMPERATURE; RAINFALL; DISEASE; TRANSMISSION; ASSOCIATION; THRESHOLD; DIARRHEA; NORTHERN; BURDEN; FEVER	Objectives Influence of meteorological variables on the transmission of bacillary dysentery (BD) is under investigated topic and effective forecasting models as public health tool are lacking. This paper aimed to quantify the relationship between meteorological variables and BD cases in Beijing and to establish an effective forecasting model. Methods A time series analysis was conducted in the Beijing area based upon monthly data on weather variables (i.e. temperature, rainfall, relative humidity, vapor pressure, and wind speed) and on the number of BD cases during the period 1970-2012. Autoregressive integrated moving average models with explanatory variables (ARIMAX) were built based on the data from 1970 to 2004. Prediction of monthly BD cases from 2005 to 2012 was made using the established models. The prediction accuracy was evaluated by the mean square error (MSE). Results Firstly, temperature with 2-month and 7-month lags and rainfall with 12-month lag were found positively correlated with the number of BD cases in Beijing. Secondly, ARIMAX model with covariates of temperature with 7-month lag (beta = 0.021, 95% confidence interval (CI): 0.004-0.038) and rainfall with 12-month lag (beta = 0.023, 95% CI: 0.009-0.037) displayed the highest prediction accuracy. Conclusions The ARIMAX model developed in this study showed an accurate goodness of fit and precise prediction accuracy in the short term, which would be beneficial for government departments to take early public health measures to prevent and control possible BD popularity.	[Yan, Long; Wang, Hong; He, Juan] Beijing Univ Chinese Med, Sch Preclin Med, Beijing, Peoples R China; [Zhang, Xuan] Hong Kong Baptist Univ, Hong Kong Chinese Med Clin Study Ctr, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Li, Ming-Yue] Peking Univ, Hlth Sci Ctr, Dept Appl Language, Beijing, Peoples R China	Beijing University of Chinese Medicine; Hong Kong Baptist University; Peking University	He, J (corresponding author), Beijing Univ Chinese Med, Sch Preclin Med, Beijing, Peoples R China.	hejuan6428@sina.com	Zhang, Xuan/GQH-6977-2022	Zhang, Xuan/0000-0002-9230-9210	National Natural Science Foundation of China [81574098]; National Natural Science Fundation of China [81574098]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Fundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No.81574098). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by grant from the National Natural Science Fundation of China (NO. 81574098), to whom went the authors' heartfelt thankfulness. The authors would like to record our gratitude to Beijing Center for Disease Control and Prevention for providing the indispensable data on BD cases as well as to Beijing Meteorological Bureau for sharing the necessary meteorological data. The authors also wish to acknowledge our indebtedness to Prof Abhaya Indrayan, PhD (Ohio State), FAMS, FRSS, FSMS, FASc and the other unknown reviewers and editors for their invaluable suggestions on our draft revision. Our thanks also go to Yu-Liang Huang from Peking University Health Science Centre for his help in proofreading.	Bandyopadhyay S, 2012, APPL GEOGR, V33, P63, DOI 10.1016/j.apgeog.2011.07.017; Chadsuthi S, 2012, ASIAN PAC J TROP MED, V5, P539, DOI 10.1016/S1995-7645(12)60095-9; Chou WC, 2010, SCI TOTAL ENVIRON, V409, P43, DOI 10.1016/j.scitotenv.2010.09.001; Cryer JD, 2008, SPRINGER TEXTS STAT, P1; Duan Y, 2017, SCI TOTAL ENVIRON, V581, P19, DOI 10.1016/j.scitotenv.2017.01.010; Duan Y, 2016, INT J BIOMETEOROL, V60, P1543, DOI 10.1007/s00484-016-1145-8; Gao L, 2014, AM J TROP MED HYG, V90, P697, DOI 10.4269/ajtmh.13-0198; Guan P, 2008, JPN J INFECT DIS, V61, P356; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Lama JR, 2004, J HEALTH POPUL NUTR, V22, P399; Li GZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124478; Li ZJ, 2015, EPIDEMIOL INFECT, V143, P3510, DOI 10.1017/S0950268815001156; Li ZJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep03239; Lin HL, 2014, INT J BIOMETEOROL, V58, P1031, DOI 10.1007/s00484-013-0688-1; Lin HL, 2012, INT J PUBLIC HEALTH, V57, P289, DOI 10.1007/s00038-011-0236-x; Ma WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062122; Niyogi SK, 2005, J MICROBIOL, V43, P133; Nourani V, 2011, J HYDROL, V402, P41, DOI 10.1016/j.jhydrol.2011.03.002; Singh RBK, 2001, ENVIRON HEALTH PERSP, V109, P155, DOI 10.2307/3434769; Wang XY, 2006, B WORLD HEALTH ORGAN, V84, P561, DOI 10.2471/BLT.05.023853; Wu HX, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24664; [张姝丽 ZHANG Shuli], 2009, [气候与环境研究, Climatic and Environmental Research], V14, P673; Zhang Y, 2008, PUBLIC HEALTH REP, V123, P61, DOI 10.1177/003335490812300109; Zhang Y, 2007, J INFECTION, V55, P194, DOI 10.1016/j.jinf.2006.12.002; Zhang Z, 2016, SCI TOTAL ENVIRON, V539, P576, DOI 10.1016/j.scitotenv.2015.09.027; Zhou YanLi, 2009, Disease Surveillance, V24, P697	26	20	23	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182937	10.1371/journal.pone.0182937	http://dx.doi.org/10.1371/journal.pone.0182937			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796834	Green Submitted, gold, Green Published			2022-12-26	WOS:000407396200128
J	Chen, YC; Lin, WC				Chen, Ying-Chou; Lin, Wei-Che			Risk of long-term infection-related death in clinical osteoporotic vertebral fractures: A hospital-based analysis	PLOS ONE			English	Article							MORTALITY; WOMEN; POPULATION; FIBRONECTIN; MEN; BISPHOSPHONATES	Background Osteoporotic vertebral fractures adversely impact quality of life and also increase the risk of infection and mortality. Alendronate treatment increases bone mass and reduces the risk of fractures in patients with osteoporosis by suppressing bone resorption. We investigated the relationship between alendronate treatment and infection-related death in patients with osteoporotic vertebral fractures. Methods We retrospectively reviewed patients with osteoporosis and vertebral fractures from January 2001 to December 2007. The use of alendronate, glucocorticoid and medical factors including smoking, alcohol consumption, diabetes, hypertension, stroke, liver disease, heart disease, and pulmonary disease were analyzed. Cox regression was used to analyze the factors associated with life-threatening infections. Results A total of 210 patients (161 females and 49 males) were included with a mean age of 74.06 +/- 7.43 years. Among them, 87 had life-threatening infections and 123 did not. In Cox regression analysis, the patients who used alendronate had a significantly lower risk of life-threatening infections (p = 0.006, HR = 0.845, 95% CI 0.750-0.954), while glucocorticoid users had higher risk of death (p = 0.010, HR = 2.037, 95% CI 1.187-3.498). Conclusions Osteoporosis was associated with a high rate of life-threatening infections, and the use of alendronate had a lower rate of infection-related death. Therefore, we suggest that alendronate be used after vertebral fractures in these patients.	[Chen, Ying-Chou] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Rheumatol, Kaohsiung, Taiwan; [Lin, Wei-Che] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Radiol, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Chen, YC (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Rheumatol, Kaohsiung, Taiwan.	r820713@ms13.hinet.net						Bolland MJ, 2010, J CLIN ENDOCR METAB, V95, P1174, DOI 10.1210/jc.2009-0852; Center JR, 2011, J CLIN ENDOCR METAB, V96, P1006, DOI 10.1210/jc.2010-2730; Cho HJ, 2015, J ORTHOP SCI, V20, P559, DOI 10.1007/s00776-013-0519-6; Colon-Emeric CS, 2010, J BONE MINER RES, V25, P91, DOI 10.1359/jbmr.090704; COOPER C, 1993, AM J EPIDEMIOL, V137, P1001, DOI 10.1093/oxfordjournals.aje.a116756; Corrado A, 2007, JOINT BONE SPINE, V74, P32, DOI 10.1016/j.jbspin.2006.06.005; Drake MT, 2008, MAYO CLIN PROC, V83, P1032, DOI 10.4065/83.9.1032; Geusens PP, 2008, NAT CLIN PRACT RHEUM, V4, P240, DOI 10.1038/ncprheum0773; Goto T, 2001, J Orthop Sci, V6, P608, DOI 10.1007/s007760100021; Goto Takahiro, 2002, J Orthop Sci, V7, P267, DOI 10.1007/s007760200045; Goto Takahiro, 2002, J Orthop Sci, V7, P274; Grey A, 2013, OSTEOPOROSIS INT, V24, P1, DOI 10.1007/s00198-012-2176-6; Hasserius R, 2005, CALCIFIED TISSUE INT, V76, P235, DOI 10.1007/s00223-004-2222-2; Hasserius R, 2003, OSTEOPOROSIS INT, V14, P61, DOI 10.1007/s00198-002-1316-9; HOFFSTEIN ST, 1981, J CELL SCI, V50, P315; HORMANN H, 1983, H-S Z PHYSIOL CHEM, V364, P1011, DOI 10.1515/bchm2.1983.364.2.1011; Ismail AA, 1998, OSTEOPOROSIS INT, V8, P291, DOI 10.1007/s001980050067; Lau E, 2008, J BONE JOINT SURG AM, V90A, P1479, DOI 10.2106/JBJS.G.00675; Lin WC, 2010, EUR SPINE J, V19, P1899, DOI 10.1007/s00586-010-1434-6; LUSTEFFES M, 1982, ANN CLIN LAB SCI, V12, P178; MALAVIYA AN, 1975, CLIN EXP IMMUNOL, V22, P399; NAUL LG, 1989, RADIOLOGY, V172, P219, DOI 10.1148/radiology.172.1.2740507; Naves M, 2003, OSTEOPOROSIS INT, V14, P520, DOI 10.1007/s00198-003-1405-4; Nguyen ND, 2007, J BONE MINER RES, V22, P781, DOI 10.1359/JBMR.070315; Puisto V, 2011, EUR SPINE J, V20, P2181, DOI 10.1007/s00586-011-1852-0; Shiraki M, 2011, INTERNAL MED, V50, P397, DOI 10.2169/internalmedicine.50.4437; Visvanathan S, 2007, J RHEUMATOL, V34, P1465	27	8	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182614	10.1371/journal.pone.0182614	http://dx.doi.org/10.1371/journal.pone.0182614			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28793342	Green Submitted, gold, Green Published			2022-12-26	WOS:000407196700054
J	Putman, BJ; Drury, JP; Blumstein, DT; Pauly, GB				Putman, Breanna J.; Drury, Jonathan P.; Blumstein, Daniel T.; Pauly, Gregory B.			Fear no colors? Observer clothing color influences lizard escape behavior	PLOS ONE			English	Article							NATURE-BASED TOURISM; PREDATION RISK; BODY CONDITION; RESPONSES; PREFERENCES; SIGNALS; DIRECTION; FORM	Animals often view humans as predators, leading to alterations in their behavior. Even nuanced aspects of human activity like clothing color affect animal behavior, but we lack an understanding of when and where such effects will occur. The species confidence hypothesis posits that birds are attracted to colors found on their bodies and repelled by non-body colors. Here, we extend this hypothesis taxonomically and conceptually to test whether this pattern is applicable in a non-avian reptile and to suggest that species should respond less fearfully to their sexually-selected signaling color. Responses to clothing color could also be impacted by habituation to humans, so we examine whether behavior varied between areas with low and high human activity. We quantified the effects of four T-shirt colors on flight initiation distances (FID) and on the ease of capture in western fence lizards (Sceloporus occidentalis), and we accounted for detectability against the background environment. We found no differences in lizard behavior between sites. However, lizards tolerated the closest approaches and were most likely to be captured when approached with the T-shirt that resembled their sexually-selected signaling color. Because changes in individual behavior affect fitness, choice of clothing color by people, including tourists, hikers, and researchers, could impact wildlife populations and research outcomes.	[Putman, Breanna J.; Drury, Jonathan P.; Blumstein, Daniel T.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Putman, Breanna J.; Pauly, Gregory B.] Nat Hist Museum Angeles Cty, Sect Herpetol, Los Angeles, CA 90007 USA; [Putman, Breanna J.; Pauly, Gregory B.] Nat Hist Museum Angeles Cty, Urban Nat Res Ctr, Los Angeles, CA 90007 USA	University of California System; University of California Los Angeles	Putman, BJ (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA.; Putman, BJ (corresponding author), Nat Hist Museum Angeles Cty, Sect Herpetol, Los Angeles, CA 90007 USA.; Putman, BJ (corresponding author), Nat Hist Museum Angeles Cty, Urban Nat Res Ctr, Los Angeles, CA 90007 USA.	putman.bree@gmail.com		Pauly, Gregory/0000-0002-2381-2576; Blumstein, Daniel/0000-0001-5793-9244	National Science Foundation [DBI-1611562]	National Science Foundation(National Science Foundation (NSF))	Support was provided by a Postdoctoral Research Fellowship in Biology from the National Science Foundation (DBI-1611562 to BJP; https://www.nsf.gov/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amo L, 2006, BIOL CONSERV, V131, P402, DOI 10.1016/j.biocon.2006.02.015; Anthony LL, 2000, BIOL CONSERV, V95, P303, DOI 10.1016/S0006-3207(00)00037-9; Batabyal A, 2017, BEHAV ECOL SOCIOBIOL, V71, DOI 10.1007/s00265-017-2307-3; Bateman PW, 2014, J ZOOL, V294, P93, DOI 10.1111/jzo.12156; Battle KE, 2016, WILSON J ORNITHOL, V128, P510; Blumstein DT, 2016, ANIM BEHAV, V120, P255, DOI 10.1016/j.anbehav.2016.05.012; Blumstein DT, 2010, BEHAV ECOL, V21, P440, DOI 10.1093/beheco/arq030; Blumstein DT, 2006, ANIM BEHAV, V71, P389, DOI 10.1016/j.anbehav.2005.05.010; BURLEY N, 1982, ANIM BEHAV, V30, P444, DOI 10.1016/S0003-3472(82)80055-9; BURLEY N, 1986, ANIM BEHAV, V34, P1732, DOI 10.1016/S0003-3472(86)80260-3; Cooper WE, 2015, ADV STUD BEHAV, V47, P147, DOI 10.1016/bs.asb.2015.02.002; Cooper WE, 2011, ACTA HERPETOL, V6, P247; Davidson GL, 2015, ANIM BEHAV, V108, P17, DOI 10.1016/j.anbehav.2015.07.010; Del Re, 2013, COMPUTEES COMPUTE EF; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Frid A, 2002, CONSERV ECOL, V6; Garrido M, 2015, EUR J WILDLIFE RES, V61, P617, DOI 10.1007/s10344-015-0915-7; Geffroy B, 2015, TRENDS ECOL EVOL, V30, P755, DOI 10.1016/j.tree.2015.09.010; Gould ML, 2004, EMU, V104, P267, DOI 10.1071/MU03033; GUTZWILLER KJ, 1993, WILSON BULL, V105, P628; Gutzwiller KJ, 1997, J WILDLIFE MANAGE, V61, P935, DOI 10.2307/3802203; Hews DK., 2013, REPTILES RES, P111; Huang B, 2011, CURR ZOOL, V57, P77, DOI 10.1093/czoolo/57.1.77; Leblond M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073695; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Macedonia JM, 2013, BEHAV ECOL, V24, P846, DOI 10.1093/beheco/art027; Macedonia JM, 2009, BIOL J LINN SOC, V97, P749, DOI 10.1111/j.1095-8312.2009.01217.x; Madden JR, 2003, ANIM BEHAV, V65, P1077, DOI 10.1006/anbe.2003.2126; Maia R, 2013, METHODS ECOL EVOL, V4, P906, DOI 10.1111/2041-210X.12069; Marzluff JM, 2012, P NATL ACAD SCI USA, V109, P15912, DOI 10.1073/pnas.1206109109; Nava SS, 2009, THESIS; Osorio D, 2004, AM NAT, V164, P696, DOI 10.1086/425332; Ossip-Drahos AG, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160728; Papworth S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062000; Raveh S, 2012, EUR J WILDLIFE RES, V58, P811, DOI 10.1007/s10344-012-0629-z; Riffell SK, 2002, J FIELD ORNITHOL, V73, P351, DOI 10.1648/0273-8570-73.4.351; Rodriguez-Prieto I, 2010, BEHAV ECOL SOCIOBIOL, V64, P1937, DOI 10.1007/s00265-010-1004-2; Samia DSM, 2016, BIOL REV, V91, P349, DOI 10.1111/brv.12173; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Siddiqi A, 2004, J EXP BIOL, V207, P2471, DOI 10.1242/jeb.01047; Sih A, 2013, ANIM BEHAV, V85, P1077, DOI 10.1016/j.anbehav.2013.02.017; Sih A, 2011, EVOL APPL, V4, P367, DOI 10.1111/j.1752-4571.2010.00166.x; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Swierk L, 2012, BEHAV ECOL SOCIOBIOL, V66, P1033, DOI 10.1007/s00265-012-1351-2; Troscianko J, 2015, METHODS ECOL EVOL, V6, P1320, DOI 10.1111/2041-210X.12439; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; Worrell T., 2016, ANIM CONSERV	48	11	11	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182146	10.1371/journal.pone.0182146	http://dx.doi.org/10.1371/journal.pone.0182146			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28792983	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000407196700033
J	Ma, MCJ; Pettus, JM; Jakoubek, JA; Traxler, MG; Clark, KC; Mennie, AK; Kwitek, AE				Ma, Man Chun John; Pettus, Janette M.; Jakoubek, Jessica A.; Traxler, Matthew G.; Clark, Karen C.; Mennie, Amanda K.; Kwitek, Anne E.			Contribution of independent and pleiotropic genetic effects in the metabolic syndrome in a hypertensive rat	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BLOOD-PRESSURE; LOCI; SUSCEPTIBILITY; IDENTIFICATION; PHENOTYPES; SELECTION; DISEASE; RISK; DETERMINANTS	Hypertension is a major risk factor for cardiovascular disease, Type 2 diabetes, and end organ failure, and is often found concomitant with disorders characteristic of the Metabolic Syndrome (MetS), including obesity, dyslipidemia, and insulin resistance. While the associated features often occur together, the pathway(s) or mechanism(s) linking hypertension in MetS are not well understood. Previous work determined that genetic variation on rat chromosome 17 (RNO17) contributes to several MetS-defining traits (including hypertension, obesity, and dyslipidemia) in the Lyon Hypertensive (LH) rat, a genetically determined MetS model. We hypothesized that at least some of the traits on RNO17 are controlled by a single gene with pleiotropic effects. To address this hypothesis, consomic and congenic strains were developed, whereby a defined fragment of RNO17 from the LH rat was substituted with the control Lyon Normotensive (LN) rat, and MetS phenotypes were measured in the resultant progeny. Compared to LH rats, LH-17(LN) consomic rats have significantly reduced body weight, blood pressure, and lipid profiles. A congenic strain (LH-17(LN)c), with a substituted fragment at the distal end of RNO17 (17q12.3; 74-97 Mb; rn4 assembly), showed differences from the LH rat in blood pressure and serum total cholesterol and triglycerides. Interestingly, there was no difference in body weight between the LH-17(LN)c and the parental LH rat. These data indicate that blood pressure and serum lipids are regulated by a gene(s) in the distal congenic interval, and could be due to pleiotropy. The data also indicate that body weight is not determined by the same gene(s) at this locus. Interestingly, only two small haplotypes spanning a total of approximately 0.5 Mb differ between the LH and LN genomes in the congenic interval. Genes in these haplotypes are strong candidate genes for causing dyslipidemia in the LH rat. Overall, MetS, even in a simplified genetic model such as the LH-17(LN) rat, is likely due to both independent and pleiotropic gene effects.	[Ma, Man Chun John; Pettus, Janette M.; Jakoubek, Jessica A.; Traxler, Matthew G.; Clark, Karen C.; Mennie, Amanda K.; Kwitek, Anne E.] Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA; [Kwitek, Anne E.] Univ Iowa, Iowa Inst Human Genet, Iowa City, IA USA	University of Iowa; University of Iowa	Kwitek, AE (corresponding author), Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA.; Kwitek, AE (corresponding author), Univ Iowa, Iowa Inst Human Genet, Iowa City, IA USA.	anne-kwitek@uiowa.edu		Kwitek, Anne/0000-0003-1024-4116; Ma, John/0000-0002-2000-8144	National Institutes of Health [R01 HL089895-04, DK089417-02, T32GM008629]; American Heart Association [14GRNT20410043]; Fraternal Order of Eagles Diabetes Research Center; Center for Hypertension Research at the University of Iowa; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL007485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008629] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD011062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Fraternal Order of Eagles Diabetes Research Center; Center for Hypertension Research at the University of Iowa; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The research was supported in part by National Institutes of Health R01 HL089895-04, DK089417-02 (AEK), and T32GM008629 (KCC); the American Heart Association 14GRNT20410043 (AEK); the Fraternal Order of Eagles Diabetes Research Center and the Center for Hypertension Research at the University of Iowa (AEK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gamboa-Melendez MA, 2012, DIABETES, V61, P3314, DOI 10.2337/db11-0550; Atanur SS, 2013, CELL, V154, P691, DOI 10.1016/j.cell.2013.06.040; Bilusic M, 2004, HYPERTENSION, V44, P695, DOI 10.1161/01.HYP.0000144542.57306.5e; Chauvet C, 2013, HUM MOL GENET, V22, P4451, DOI 10.1093/hmg/ddt294; Cheng G, 2014, ELIFE, V3, DOI 10.7554/eLife.05401; DUBAY C, 1993, NAT GENET, V3, P354, DOI 10.1038/ng0493-354; DUPONT J, 1973, BIOMEDICINE, V19, P36; Florin M, 2001, KIDNEY INT, V59, P1865, DOI 10.1046/j.1523-1755.2001.0590051865.x; Frau F, 2014, PHARMACOGENOMICS, V15, P1643, DOI [10.2217/PGS.14.119, 10.2217/pgs.14.119]; Gilibert S, 2008, PHYSIOL GENOMICS, V33, P212, DOI 10.1152/physiolgenomics.00262.2007; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Grondin M, 2005, PHYSIOL GENOMICS, V21, P112, DOI 10.1152/physiolgenomics.00275.2004; Haney S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064946; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Huang YC, 2011, OPHTHALMOLOGY, V118, P642, DOI 10.1016/j.ophtha.2010.07.020; Imamura M, 2011, DIABETOLOGIA, V54, P3071, DOI 10.1007/s00125-011-2293-3; Kovacs P, 2000, BIOCHEM BIOPH RES CO, V269, P660, DOI 10.1006/bbrc.2000.2352; Kraja AT, 2014, MOL GENET METAB, V112, P317, DOI 10.1016/j.ymgme.2014.04.007; LANDE R, 1990, GENETICS, V124, P743; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Ma MCJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-197; Moreno C, 2003, PHYSIOL GENOMICS, V15, P243, DOI 10.1152/physiolgenomics.00105.2003; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; Nanda A, 2004, CANCER RES, V64, P8507, DOI 10.1158/0008-5472.CAN-04-2716; Padmanabhan S, 2015, CIRC RES, V116, P937, DOI 10.1161/CIRCRESAHA.116.303647; Rankinen T, 2015, CIRC RES, V116, P909, DOI 10.1161/CIRCRESAHA.116.302888; Saar K, 2008, NAT GENET, V40, P560, DOI 10.1038/ng.124; SASSOLAS A, 1981, J CARDIOVASC PHARM, V3, P1008, DOI 10.1097/00005344-198109000-00011; Seda O, 2005, PHYSIOL GENOMICS, V21, P243, DOI 10.1152/physiolgenomics.00230.2004; Stancakova A, 2014, REV ENDOCR METAB DIS, V15, P243, DOI 10.1007/s11154-014-9293-9; Teran-Garcia M, 2007, APPL PHYSIOL NUTR ME, V32, P89, DOI [10.1139/H06-102, 10.1139/h06-102]; Verploegen S, 2000, BLOOD, V96, P3215; Verploegen S, 2005, BLOOD, V106, P1076, DOI 10.1182/blood-2004-09-3755; Vincent M, 1996, J HYPERTENS, V14, P469; VINCENT M, 1993, J HYPERTENS, V11, P1179; Vincent M, 1984, LYON STRAINS HYPERTE, P286; Wang JK, 2015, CIRC-CARDIOVASC GENE, V8, P316, DOI 10.1161/CIRCGENETICS.114.000520; WILLIAMS RR, 1990, CLIN EXP HYPERTENS A, V12, P865, DOI 10.3109/10641969009073505; Woods LCS, 2009, MAMM GENOME, V20, P486, DOI 10.1007/s00335-009-9211-8; Yagil C, 1998, HYPERTENSION, V31, P119, DOI 10.1161/01.HYP.31.1.119; Yao C, 2014, CIRCULATION; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	42	7	7	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2017	12	8							e0182650	10.1371/journal.pone.0182650	http://dx.doi.org/10.1371/journal.pone.0182650			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9EU	28792545	Green Published, gold			2022-12-26	WOS:000407144700030
J	Takayasu, L; Suda, W; Watanabe, E; Fukuda, S; Takanashi, K; Ohno, H; Takayasu, M; Takayasu, H; Hattori, M				Takayasu, Lena; Suda, Wataru; Watanabe, Eiichiro; Fukuda, Shinji; Takanashi, Kageyasu; Ohno, Hiroshi; Takayasu, Misako; Takayasu, Hideki; Hattori, Masahira			A 3-dimensional mathematical model of microbial proliferation that generates the characteristic cumulative relative abundance distributions in gut microbiomes	PLOS ONE			English	Article							ENTEROTYPES; METAGENOME; DIVERSITY; DYNAMICS; PATTERNS; TRANSIT; IMPACT	The gut microbiome is highly variable among individuals, largely due to differences in host lifestyle and physiology. However, little is known about the underlying processes or rules that shape the complex microbial community. In this paper, we show that the cumulative relative abundance distribution (CRAD) of microbial species can be approximated by a power law function, and found that the power exponent of CRADs generated from 16S rRNA gene and metagenomic data for normal gut microbiomes of humans and mice was similar consistently with similar to 0.9. A similarly robust power exponent was observed in CRADs of gut microbiomes during dietary interventions and several diseases. However, the power exponent was found to be similar to 0.6 in CRADs from gut microbiomes characterized by lower species richness, such as those of human infants and the small intestine of mice. In addition, the CRAD of gut microbiomes of mice treated with antibiotics differed slightly from those of infants and the small intestines of mice. Based on these observations, in addition to data on the spatial distribution of microbes in the digestive tract, we developed a 3-dimensional mathematical model of microbial proliferation that reproduced the experimentally observed CRAD patterns. Our model indicated that the CRAD may be determined by the ratio of emerging to pre-existing species during non-uniform spatially competitive proliferation, independent of species composition.	[Takayasu, Lena; Suda, Wataru; Takanashi, Kageyasu; Hattori, Masahira] Univ Tokyo, Grad Sch Frontier Sci, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778561, Japan; [Suda, Wataru] Keio Univ, Sch Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan; [Watanabe, Eiichiro; Fukuda, Shinji; Ohno, Hiroshi] RIKEN, Ctr Integrat Med Sci, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan; [Fukuda, Shinji] Keio Univ, Inst Adv Biosci, 246-2 Mizukami, Tsuruoka, Yamagata 9970052, Japan; [Takayasu, Misako] Tokyo Inst Technol, Inst Innovat Res, Midori Ku, G3-52,4259 Nagatsutacho, Yokohama, Kanagawa 2268502, Japan; [Takayasu, Hideki] Sony Comp Sci Labs Inc, Shinagawa Ku, 3-14-13 Higashigotanda, Tokyo 1410022, Japan; [Hattori, Masahira] Waseda Univ, Grad Sch Adv Sci & Engn, Shinjuku Ku, 3-4-1 Okubo, Tokyo 1698555, Japan	University of Tokyo; Keio University; RIKEN; Keio University; Tokyo Institute of Technology; Sony Corporation; Waseda University	Hattori, M (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, 5-1-5 Kashiwanoha, Kashiwa, Chiba 2778561, Japan.; Hattori, M (corresponding author), Waseda Univ, Grad Sch Adv Sci & Engn, Shinjuku Ku, 3-4-1 Okubo, Tokyo 1698555, Japan.	hattori@aoni.waseda.jp	Hattori, Masahira/AAD-3785-2019; Suda, Wataru/AAF-4469-2019	Fukuda, Shinji/0000-0001-5161-9880	 [26-7826]		The work was supported by a Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) Fellows to L. T. (Grant Number: 26-7826, HP: https://www.jsps.go.jp/english/). Sony Computer Science Laboratories, Inc. provided support in the form of salary for author H.T., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Bashan A, 2016, NATURE, V534, P259, DOI 10.1038/nature18301; Blekhman R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0759-1; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; CUMMINGS JH, 1976, GUT, V17, P210, DOI 10.1136/gut.17.3.210; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Dollive S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071806; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; EDWARDS CA, 1987, GUT, V28, P13, DOI 10.1136/gut.28.1.13; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Hoffmann KH, 2007, FEMS MICROBIOL LETT, V273, P224, DOI 10.1111/j.1574-6968.2007.00790.x; Hubbell Stephen P., 2001, V32, pi; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Inceoglu O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023321; Johansson MEV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041009; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kim SW, 2013, DNA RES, V20, P241, DOI 10.1093/dnares/dst006; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Koren O, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002863; Lahti L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5344; Li LW, 2016, SCI REP-UK, V6, DOI 10.1038/srep31448; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Miyake S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137429; Nishijima S, 2016, DNA RES, V23, P125, DOI 10.1093/dnares/dsw002; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Sala C, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-015-0858-8; Tailford LE, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00081; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Venkataraman A, 2015, MBIO, V6, DOI 10.1128/mBio.02284-14; Volkov I, 2007, NATURE, V450, P45, DOI 10.1038/nature06197; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	38	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2017	12	8							e0180863	10.1371/journal.pone.0180863	http://dx.doi.org/10.1371/journal.pone.0180863			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9EU	28792501	Green Published, gold, Green Submitted			2022-12-26	WOS:000407144700003
J	Wan, XH; Saito, JA; Newhouse, JS; Hou, SB; Alam, M				Wan, Xuehua; Saito, Jennifer A.; Newhouse, James S.; Hou, Shaobin; Alam, Maqsudul			The importance of conserved amino acids in heme-based globin-coupled diguanylate cyclases	PLOS ONE			English	Article							CYCLIC-DI-GMP; ESCHERICHIA-COLI; DOMAIN PROTEINS; OXYGEN SENSOR; SALMONELLA-TYPHIMURIUM; FE(II)-O-2 COMPLEX; ALLOSTERIC CONTROL; STRUCTURAL BASIS; BINDING-PROTEIN; PILZ DOMAIN	Globin-coupled diguanylate cyclases contain globin, middle, and diguanylate cyclase domains that sense O-2 to synthesize c-di-GMP and regulate bacterial motility, biofilm formation, and virulence. However, relatively few studies have extensively examined the roles of individual residues and domains of globin-coupled diguanylate cyclases, which can shed light on their signaling mechanisms and provide drug targets. Here, we report the critical residues of two globin-coupled diguanylate cyclases, EcGReg from Escherichia coli and BpeGReg from Bordetella pertussis, and show that their diguanylate cyclase activity requires an intact globin domain. In the distal heme pocket of the globin domain, residues Phe42, Tyr43, Ala68 (EcGReg)/Ser68 (BpeGReg), and Met69 are required to maintain full diguanylate cyclase activity. The highly conserved amino acids His223/His225 and Lys224/Lys226 in the middle domain of EcGReg/BpeGReg are essential to diguanylate cyclase activity. We also identified sixteen important residues (Leu300, Arg306, Asp333, Phe337, Lys338, Asn341, Asp342, Asp350, Leu353, Asp368, Arg372, Gly374, Gly375, Asp376, Glu377, and Phe378) in the active site and inhibitory site of the diguanylate cyclase domain of EcGReg. Moreover, BpeGReg266 (residues 1-266) and BpeGReg296 (residues 1-296), which only contain the globin and middle domains, can inhibit bacterial motility. Our findings suggest that the distal residues of the globin domain affect diguanylate cyclase activity and that BpeGReg may interact with other c-di-GMP-metabolizing proteins to form mixed signaling teams.	[Wan, Xuehua; Saito, Jennifer A.; Hou, Shaobin; Alam, Maqsudul] Univ Hawaii, Dept Microbiol, Honolulu, HI 96822 USA; [Wan, Xuehua; Saito, Jennifer A.; Newhouse, James S.; Hou, Shaobin; Alam, Maqsudul] Univ Hawaii, Adv Studies Genom Prote & Bioinformat, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii System	Wan, XH (corresponding author), Univ Hawaii, Dept Microbiol, Honolulu, HI 96822 USA.; Wan, XH (corresponding author), Univ Hawaii, Adv Studies Genom Prote & Bioinformat, Honolulu, HI 96822 USA.	xuehua@hawaii.edu	Wan, Xuehua/AAE-4237-2022	Wan, Xuehua/0000-0002-6367-848X	National Science Foundation [MCB0446431]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (grant no. MCB0446431) (MA). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739; Brown NP, 1998, BIOINFORMATICS, V14, P380, DOI 10.1093/bioinformatics/14.4.380; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Burns JL, 2016, BIOCHEMISTRY-US, V55, P6642, DOI 10.1021/acs.biochem.6b00526; Burns JL, 2014, MOL BIOSYST, V10, P2823, DOI 10.1039/c4mb00366g; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200; Cooley RB, 2010, J MOL BIOL, V404, P232, DOI 10.1016/j.jmb.2010.09.034; Dahlstrom KM, 2016, J BACTERIOL, V198, P1595, DOI 10.1128/JB.00090-16; Dahlstrom KM, 2015, MBIO, V6, DOI 10.1128/mBio.01978-15; Fang X, 2014, MOL MICROBIOL, V93, P439, DOI 10.1111/mmi.12672; Freitas TAK, 2003, FEBS LETT, V552, P99, DOI 10.1016/S0014-5793(03)00923-2; Freitas TAK, 2008, SMALLEST BIOMOLECULES: DIATOMICS AND THEIR INTERACTIONS WITH HEME PROTEINS, P175, DOI 10.1016/B978-044452839-1.50008-5; Hou SB, 2001, P NATL ACAD SCI USA, V98, P9353, DOI 10.1073/pnas.161185598; Hou SB, 2000, NATURE, V403, P540, DOI 10.1038/35000570; Hunter JL, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-22; Kader A, 2006, MOL MICROBIOL, V60, P602, DOI 10.1111/j.1365-2958.2006.05123.x; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kirillina O, 2004, MOL MICROBIOL, V54, P75, DOI 10.1111/j.1365-2958.2004.04253.x; Kitanishi K, 2011, J BIOL CHEM, V286, P35522, DOI 10.1074/jbc.M111.274811; Kitanishi K, 2010, BIOCHEMISTRY-US, V49, P10381, DOI 10.1021/bi100733q; Lahiri T, 2014, BIOCHEMISTRY-US, V53, P2126, DOI 10.1021/bi401597m; Li WH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9330; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Liu N, 2012, BIOCHEMISTRY-US, V51, P2087, DOI 10.1021/bi201753f; Lori C, 2015, NATURE, V523, P236, DOI 10.1038/nature14473; Malone JG, 2007, MICROBIOL-SGM, V153, P980, DOI 10.1099/mic.0.2006/002824-0; Mendez-Ortiz MM, 2006, J BIOL CHEM, V281, P8090, DOI 10.1074/jbc.M510701200; Nakajima K, 2012, J INORG BIOCHEM, V108, P163, DOI 10.1016/j.jinorgbio.2011.09.019; Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460; Paul R, 2007, J BIOL CHEM, V282, P29170, DOI 10.1074/jbc.M704702200; Perez-Mendoza D, 2011, MOL MICROBIOL, V82, P719, DOI 10.1111/j.1365-2958.2011.07849.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piatibratov M, 2000, BBA-GEN SUBJECTS, V1524, P149, DOI 10.1016/S0304-4165(00)00151-3; Pultz IS, 2012, MOL MICROBIOL, V86, P1424, DOI 10.1111/mmi.12066; Romling U, 1998, J BACTERIOL, V180, P722; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Ryan RP, 2012, TRENDS MICROBIOL, V20, P235, DOI 10.1016/j.tim.2012.02.008; Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005; Sawai H, 2010, BBA-PROTEINS PROTEOM, V1804, P166, DOI 10.1016/j.bbapap.2009.09.028; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Sommerfeldt N, 2009, MICROBIOL-SGM, V155, P1318, DOI 10.1099/mic.0.024257-0; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Tarnawski M, 2015, ACTA CRYSTALLOGR D, V71, P2158, DOI 10.1107/S139900471501545X; Thijs L, 2007, J BIOL CHEM, V282, P37325, DOI 10.1074/jbc.M705541200; Tuckerman JR, 2011, J MOL BIOL, V407, P633, DOI 10.1016/j.jmb.2011.02.019; Tuckerman JR, 2009, BIOCHEMISTRY-US, V48, P9764, DOI 10.1021/bi901409g; Wan XH, 2009, J MOL BIOL, V388, P262, DOI 10.1016/j.jmb.2009.03.015; Wu C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01945; Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x	50	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2017	12	8							e0182782	10.1371/journal.pone.0182782	http://dx.doi.org/10.1371/journal.pone.0182782			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9EU	28792538	Green Published, Green Submitted, gold			2022-12-26	WOS:000407144700040
J	Barnard, M; George, P; Perryman, ML; Wolff, LA				Barnard, Marie; George, Phillis; Perryman, Mandy L.; Wolff, Lori A.			Human papillomavirus (HPV) vaccine knowledge, attitudes, and uptake in college students: Implications from the Precaution Adoption Process Model	PLOS ONE			English	Article							LOW-INCOME; ADOLESCENTS; WOMEN; RISK; BARRIERS	The purpose of this study was to examine human papillomavirus (HPV) and HPV vaccine knowledge, attitudes, and uptake in college students and to identify factors associated with vaccination status utilizing the Precaution Adoption Process Model (PAPM). The sample included 383 undergraduates from a public university who participated in February and March 2015. Students were emailed an anonymous online survey assessing knowledge, attitudes, and perceptions related to HPV and HPV vaccination, as well as their stage in the PAPM regarding vaccination completion. Significantly more females (47.3%) than males (15.8%) were vaccinated. While most students had basic knowledge of HPV, they had low perceptions of their susceptibility to contract HPV. Most unvaccinated students were in the early stages of decision-making related to vaccination. Campus health centers have an opportunity to increase HPV vaccination rates. This study indicates that students need prompts from providers, as well as education regarding susceptibility to HPV.	[Barnard, Marie] Univ Mississippi, Dept Pharm Adm, University, MS 38677 USA; [George, Phillis; Perryman, Mandy L.] Univ Mississippi, Dept Leadership & Counselor Educ, University, MS 38677 USA; [Wolff, Lori A.] Fordham Univ, Grad Sch Educ, New York, NY 10023 USA	University of Mississippi; University of Mississippi; Fordham University	Barnard, M (corresponding author), Univ Mississippi, Dept Pharm Adm, University, MS 38677 USA.	mbarnard@olemiss.edu	Barnard, Marie/I-3567-2019	Barnard, Marie/0000-0003-0781-7438				Bastani R, 2011, CANCER EPIDEM BIOMAR, V20, P1463, DOI 10.1158/1055-9965.EPI-11-0267; Berenson AB, 2012, J PEDIATR ADOL GYNEC, V25, P218, DOI 10.1016/j.jpag.2012.01.003; Centers For Disease Control and Prevention, 2015, SEX TRANSM DIS SURV; Edwards Sharon M, 2010, Adolesc Med State Art Rev, V21, P173; Farrell RM, 2007, PEDIATRICS, V120, P434, DOI 10.1542/peds.2006-1692; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Hershey JH, 2009, J PUBLIC HEALTH MAN, V15, P384, DOI 10.1097/PHH.0b013e3181a23de6; Holman DM, 2014, JAMA PEDIATR, V168, P76, DOI 10.1001/jamapediatrics.2013.2752; Katz ML, 2011, J MENS HEALTH, V8, P175, DOI 10.1016/j.jomh.2011.04.002; Kester LM, 2013, MATERN CHILD HLTH J, V17, P879, DOI 10.1007/s10995-012-1066-z; Licht AS, 2010, SEX TRANSM INFECT, V86, P74, DOI 10.1136/sti.2009.037705; Marchand E, 2012, J COMMUN HEALTH, V37, P1136, DOI 10.1007/s10900-012-9572-x; Markowitz LE, 2014, MMWR RECOMM REP, V63, P1; Navalpakam A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155955; Nuno VL, 2016, J LOW GENIT TRACT DI, V20, P131, DOI 10.1097/LGT.0000000000000174; Perkins RB, 2012, J WOMENS HEALTH, V21, P813, DOI 10.1089/jwh.2011.3364; Rand CM, 2007, PEDIATRICS, V120, P461, DOI 10.1542/peds.2007-0012; Reiter PL, 2010, VACCINE, V28, P6292, DOI 10.1016/j.vaccine.2010.06.114; Satterwhite CL, 2013, SEX TRANSM DIS, V40, P187, DOI 10.1097/OLQ.0b013e318286bb53; Stokley S, 2014, MMWR-MORBID MORTAL W, V63, P620; Von Ah D, 2004, J ADV NURS, V48, P463, DOI 10.1111/j.1365-2648.2004.03229.x; WEINSTEIN ND, 1988, HEALTH PSYCHOL, V7, P355, DOI 10.1037/0278-6133.7.4.355; Wilson AR, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-016-0323-5	23	74	74	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182266	10.1371/journal.pone.0182266	http://dx.doi.org/10.1371/journal.pone.0182266			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC7CP	28786994	Green Published, gold, Green Submitted			2022-12-26	WOS:000406998800022
J	Yang, Y; Jia, J; Sun, ZW; Du, F; Yu, J; Liu, CL; Xiao, YJ; Zhang, XD				Yang, Ying; Jia, Jun; Sun, Zhiwei; Du, Feng; Yu, Jing; Liu, Chuanling; Xiao, Yanjie; Zhang, Xiaodong			Prognosis impact of clinical characteristics in patients with inoperable esophageal squamous cell carcinoma	PLOS ONE			English	Article							P-POSSUM; CANCER; SCORE; SURVIVAL; CHEMOTHERAPY; RADIOTHERAPY; PREDICTOR; MORTALITY; SURGERY	Background Patients with inoperable esophageal squamous cell carcinoma (ESCC) were not homogeneous and their outcomes were widely divergent. There was a lack of identified clinical factors related to prognosis; and there were no previous studies constructing prognosis score to predict survival and guide treatment. Methods In this retrospective cohort study, twelve clinical characteristics of one hundred and twenty inoperable ESCC patients were collected at diagnosis and analyzed by Cox regression model. Various methods including univariate analysis, confounding adjusted multivariate analysis and model selection were applied to determine factors associated with poor prognosis; and prognosis score was built on established factors. Results Four characters were identified as poor prognosis factors, including mid-and low-thoracic tumor (aHR = 2.20, 95% CI = 1.03, 4.72), abdominal and retroperitoneal lymph node metastasis (aHR = 1.62, 95% CI = 1.00, 2.64), albumin no more than 39g/L (aHR = 2.81, 95% CI = 1.24, 6.41) and hematogenous metastasis (aHR = 1.61, 95% CI = 0.97, 2.69). Patients were stratified into three groups by prognosis score, that was, good survival with none of four identified factors (score zero), poor survival with three to four factors (score three to four) and median with one to two factors (score one to two), survival of three groups were statistically different (p(trend) = 0.020). Conclusion Prognosis score based on selected clinical characteristics could predict survival among inoperable ESCC patients, which was critical for individualized treatment and central of precise medicine.	[Yang, Ying; Jia, Jun; Sun, Zhiwei; Du, Feng; Yu, Jing; Liu, Chuanling; Xiao, Yanjie; Zhang, Xiaodong] Peking Univ, Canc Hosp & Inst, VIP II Gastrointestinal Canc Div,Minist Educ Beij, Key Lab Carcinogenesis & Translat Res,Dept Med, Beijing, Peoples R China	Peking University	Zhang, XD (corresponding author), Peking Univ, Canc Hosp & Inst, VIP II Gastrointestinal Canc Div,Minist Educ Beij, Key Lab Carcinogenesis & Translat Res,Dept Med, Beijing, Peoples R China.	zhangxd0829@163.com			National Natural Science Foundation of China [81602924]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was funded by the National Natural Science Foundation of China (81602924). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlSarraf M, 1997, J CLIN ONCOL, V15, P277, DOI 10.1200/JCO.1997.15.1.277; Ataseven B, 2015, GYNECOL ONCOL, V138, P560, DOI 10.1016/j.ygyno.2015.07.005; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; COPELAND GP, 1991, BRIT J SURG, V78, P356; Dubecz A, 2010, J AM COLL SURGEONS, V211, P754, DOI 10.1016/j.jamcollsurg.2010.07.029; Dutta S, 2012, AM J SURG, V204, P294, DOI 10.1016/j.amjsurg.2011.10.015; Forrest LM, 2004, BRIT J CANCER, V90, P1704, DOI 10.1038/sj.bjc.6601789; Han LH, 2016, TUMOR BIOL, V37, P3081, DOI 10.1007/s13277-015-4152-1; Kim DE, 2013, CANCER RES TREAT, V45, P276, DOI 10.4143/crt.2013.45.4.276; La Torre M, 2012, ANN SURG ONCOL, V19, P2917, DOI 10.1245/s10434-012-2348-9; Leitch EF, 2007, BRIT J CANCER, V97, P1266, DOI 10.1038/sj.bjc.6604027; Lin CS, 2009, ANN THORAC SURG, V87, P1056, DOI 10.1016/j.athoracsur.2008.11.051; Lu CL, 2010, CANCER CAUSE CONTROL, V21, P269, DOI 10.1007/s10552-009-9458-0; Nagabhushan JS, 2007, POSTGRAD MED J, V83, P355, DOI 10.1136/pgmj.2006.053223; Nakatsu T, 2012, SURG TODAY, V42, P652, DOI 10.1007/s00595-012-0147-3; Oezcelik A, 2012, J SURG ONCOL, V105, P284, DOI 10.1002/jso.22096; Paulson EC, 2008, ARCH SURG-CHICAGO, V143, P1198, DOI 10.1001/archsurg.143.12.1198; Stahl M, 1996, J CLIN ONCOL, V14, P829, DOI 10.1200/JCO.1996.14.3.829; Tekkis PP, 2004, BRIT J SURG, V91, P288, DOI 10.1002/bjs.4414; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tran GD, 2005, INT J CANCER, V113, P456, DOI 10.1002/ijc.20616; Vashist YK, 2011, ANN SURG ONCOL, V18, P1130, DOI 10.1245/s10434-010-1383-7; Vizcaino AP, 2002, INT J CANCER, V99, P860, DOI 10.1002/ijc.10427; Worni M, 2012, J AM COLL SURGEONS, V215, P643, DOI 10.1016/j.jamcollsurg.2012.07.006; Yan J, 2011, J INT MED RES, V39, P1464, DOI 10.1177/147323001103900435; Zhang HX, 2010, DIS ESOPHAGUS, V23, P392, DOI 10.1111/j.1442-2050.2009.01020.x; Zhou MG, 2010, ZHONGHUA YU FANG YI, V44, P303	27	5	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182660	10.1371/journal.pone.0182660	http://dx.doi.org/10.1371/journal.pone.0182660			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28783764	Green Submitted, Green Published, gold			2022-12-26	WOS:000406998800056
J	Fidelix, T; Czapkowski, A; Azjen, S; Andriolo, A; Trevisani, VFM				Fidelix, Tania; Czapkowski, Adriano; Azjen, Sergio; Andriolo, Adagmar; Trevisani, Virginia F. M.			Salivary gland ultrasonography as a predictor of clinical activity in Sjogren's syndrome	PLOS ONE			English	Article							DISEASE-ACTIVITY INDEX; CLASSIFICATION CRITERIA; DIAGNOSTIC-VALUE; SIALOGRAPHY; ESSDAI; TOOL; MICROGLOBULIN	Purpose Primary Sjogren's syndrome is a multisystem autoimmune disease characterized by hypofunction of salivary and lacrimal glands and possible multi-organ system manifestations. Over the past 15 years, three sets of diagnostic criteria have been proposed, but none has included salivary gland ultrasonography. However, recent studies support its role in the diagnosis and prognostic evaluation of patients with Sjogren's syndrome. This study aimed to determine the value of salivary gland ultrasonography in the diagnosis and prognosis of Sjogren's syndrome by relating ultrasonography severity scores to clinical and laboratory data. Methods Seventy patients who fulfilled the 2002 American-European Consensus Group diagnostic criteria for primary Sjogren's syndrome were selected from 84 patients receiving care in specialized outpatient clinics at our institution from November 2013 to May 2016. Their serology, European League Against Rheumatism Sjogren's syndrome disease activity index (ESSDAI), salivary flow rate, immunoglobulin G, and salivary and serum beta-2 microglobulin levels were measured. Salivary gland ultrasonography was performed by an experienced radiologist, using scores of 1-4 to classify salivary gland impairment. Results Salivary gland ultrasonography scores of 1 or 2 were associated with an ESSDAI <5. Ultrasonography scores of 3 or 4 were associated with an ESSDAI >= 5 (p = 0.064), a positive antinuclear antibody test (p = 0.006), positive anti-Ro/SSA antibodies (p = 0.003), positive anti-La/SSB antibodies (p = 0.077), positive rheumatoid factor (p = 0.034), and immunoglobulin G levels >1600 mg/dL (p = 0.077). Salivary flow rate was lower in patients with scores 3 or 4 (p = 0.001). Conclusion This study provides further evidence that salivary gland ultrasonography can be used not only for diagnosis but also for prognostic evaluation of primary Sjogren's syndrome. These findings confirm what has been reported in the literature. However, further analyses involving larger matched samples are required to support this finding and include salivary gland ultrasonography as part of the diagnostic criteria for Sjogren's syndrome.	[Fidelix, Tania; Trevisani, Virginia F. M.] Univ Fed Sao Paulo UNIFESP, Dept Evidence Based Med, Sao Paulo, SP, Brazil; [Czapkowski, Adriano; Azjen, Sergio] Univ Fed Sao Paulo, Dept Radiol, Sao Paulo, SP, Brazil; [Andriolo, Adagmar] Univ Fed Sao Paulo, Dept Lab Med, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Fidelix, T (corresponding author), Univ Fed Sao Paulo UNIFESP, Dept Evidence Based Med, Sao Paulo, SP, Brazil.	fidelixtania@gmail.com	trevisani, Virginia Fernandes Moça/I-1137-2013; Andriolo, Adagmar/A-8265-2017; Trevisani, Virginia/AAI-5225-2020	trevisani, Virginia Fernandes Moça/0000-0002-7180-6285; Andriolo, Adagmar/0000-0002-7355-8684; Trevisani, Virginia/0000-0002-7180-6285				Asashima H, 2013, CLIN EXP RHEUMATOL, V31, P699; Baldini C, 2016, ISR MED ASSOC J, V18, P193; Baldini C, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3523; Bookman AAM, 2011, ARTHRITIS RHEUM-US, V63, P2014, DOI 10.1002/art.30295; Bournia VK, 2012, J AUTOIMMUN, V39, P15, DOI 10.1016/j.jaut.2012.03.001; Brito-Zeron P, 2012, J AUTOIMMUN, V39, P43, DOI 10.1016/j.jaut.2012.01.010; Cornec D, 2013, ARTHRITIS RHEUM-US, V65, P216, DOI [10.1002/art.37698, 10.1002/art.37944]; De Vita S, 2015, RHEUMATOLOGY, V54, P2249, DOI 10.1093/rheumatology/kev257; DEVITA S, 1992, CLIN EXP RHEUMATOL, V10, P351; Gotoh S, 2005, ORAL SURG ORAL MED O, V99, P299, DOI 10.1016/j.tripleo.2004.09.016; Hammenfors DS, 2015, CLIN EXP RHEUMATOL, V33, P56; Hocevar A, 2005, RHEUMATOLOGY, V44, P768, DOI 10.1093/rheumatology/keh588; Jonsson R, 2013, JAMA-J AM MED ASSOC, V310, P1854, DOI 10.1001/jama.2013.278448; Kedor C, 2016, CLIN RHEUMATOL, V35, P2203, DOI 10.1007/s10067-016-3360-4; Luciano N, 2015, CLIN EXP RHEUMATOL, V33, P259; MICHALSKI JP, 1975, NEW ENGL J MED, V293, P1228, DOI 10.1056/NEJM197512112932404; Milic V, 2012, RHEUMATOLOGY, V51, P1081, DOI 10.1093/rheumatology/ker431; Milic VD, 2009, J RHEUMATOL, V36, P1495, DOI 10.3899/jrheum.081267; NAVAZESH M, 1993, ANN NY ACAD SCI, V694, P72, DOI 10.1111/j.1749-6632.1993.tb18343.x; Ng W-F, 2011, ANN RHEUM DIS, V70, P510; Niemela RK, 2004, RHEUMATOLOGY, V43, P875, DOI 10.1093/rheumatology/keh187; Pertovaara M, 2011, ANN RHEUM DIS, V70, P2236, DOI 10.1136/ard.2011.153098; Qin BD, 2015, ANN RHEUM DIS, V74, P1983, DOI 10.1136/annrheumdis-2014-205375; Risselada AP, 2012, ANN RHEUM DIS, V71, P631, DOI 10.1136/annrheumdis-2011-200766; Salaffi F, 2008, RHEUMATOLOGY, V47, P1244, DOI 10.1093/rheumatology/ken222; Salaffi F, 2000, J RHEUMATOL, V27, P1229; Secco A, 2011, ANN RHEUM DIS     S3, V70, P299; Seror R., 2011, ANN RHEUM DIS, V70, P505; Seror R, 2016, ANN RHEUM DIS, V75, P382, DOI 10.1136/annrheumdis-2014-206008; Seror R, 2010, ANN RHEUM DIS, V69, P1103, DOI 10.1136/ard.2009.110619; Serrano EV, 2013, REV BRAS REUMATOL, V53, P483, DOI [10.1016/j.rbre.2013.04.003, 10.1016/j.rbr.2013.04.003]; Shiboski CH, 2017, ANN RHEUM DIS, V76, P9, DOI [10.1136/annrheumdis-2016-210571, 10.1002/art.39859]; Shiboski SC, 2012, ARTHRIT CARE RES, V64, P475, DOI 10.1002/acr.21591; Takagi Y, 2010, ANN RHEUM DIS, V69, P1321, DOI 10.1136/ard.2009.123836; TALAL N, 1975, SCIENCE, V187, P1196, DOI 10.1126/science.46621; Theander E, 2014, ARTHRIT CARE RES, V66, P1102, DOI 10.1002/acr.22264; Tishler M, 1997, SEMIN ARTHRITIS RHEU, V27, P173, DOI 10.1016/S0049-0172(97)80017-0; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554	38	26	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0182287	10.1371/journal.pone.0182287	http://dx.doi.org/10.1371/journal.pone.0182287			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28783737	Green Published, Green Submitted, gold			2022-12-26	WOS:000406944300026
J	Khalafalla, MG; Woods, LT; Camden, JM; Khan, AA; Limesand, KH; Petris, MJ; Erb, L; Weisman, GA				Khalafalla, Mahmoud G.; Woods, Lucas T.; Camden, Jean M.; Khan, Aslam A.; Limesand, Kirsten H.; Petris, Michael J.; Erb, Laurie; Weisman, Gary A.			P2X7 receptor antagonism prevents IL-1 beta release from salivary epithelial cells and reduces inflammation in a mouse model of autoimmune exocrinopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SJOGRENS-SYNDROME; P2X(7) RECEPTOR; NLRP3 INFLAMMASOME; SUBMANDIBULAR-GLAND; UP-REGULATION; NALP3 INFLAMMASOME; LUNG INFLAMMATION; EXTRACELLULAR ATP; IMMUNE-RESPONSES; ACTIVATION	Salivary gland inflammation is a hallmark of Sjogren's syndrome (SS), a common autoimmune disease characterized by lymphocytic infiltration of the salivary gland and loss of saliva secretion, predominantly in women. The P2X7 receptor (P2X7R) is an ATP-gated nonselective cation channel that induces inflammatory responses in cells and tissues, including salivary gland epithelium. In immune cells, P2X7R activation induces the production of proinflammatory cytokines, including IL-1 beta and IL-18, by inducing the oligomerization of the multiprotein complex NLRP3-type inflammasome. Here, our results show that in primary mouse submandibular gland (SMG) epithelial cells, P2X7R activation also induces the assembly of the NLRP3 inflammasome and the maturation and release of IL-1 beta, a response that is absent in SMG cells isolated from mice deficient in P2X7Rs (P2X7R(-/-)). P2X7R-mediated IL-1 beta release in SMG epithelial cells is dependent on transmembrane Na+ and/or K+ flux and the activation of heat shock protein 90 (HSP90), a protein required for the activation and stabilization of the NLRP3 inflammasome. Also, using the reactive oxygen species (ROS) scavengers N-acetyl cysteine and Mito-TEMPO, we determined that mitochondrial reactive oxygen species are required for P2X7R-mediated IL-1 beta release. Lastly, in vivo administration of the P2X7R antagonist A438079 in the CD28(-/-), IFN gamma(-/-), NOD.H-2(h4) mouse model of salivary gland exocrinopathy ameliorated salivary gland inflammation and enhanced carbachol-induced saliva secretion. These findings demonstrate that P2X7R antagonism in vivo represents a promising therapeutic strategy to limit salivary gland inflammation and improve secretory function.	[Khalafalla, Mahmoud G.; Woods, Lucas T.; Camden, Jean M.; Khan, Aslam A.; Petris, Michael J.; Erb, Laurie; Weisman, Gary A.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Khalafalla, Mahmoud G.; Woods, Lucas T.; Camden, Jean M.; Khan, Aslam A.; Petris, Michael J.; Erb, Laurie; Weisman, Gary A.] Univ Missouri, Christopher S Bond Life Sci Ctr, Columbia, MO 65211 USA; [Petris, Michael J.] Univ Missouri, Dept Nutr & Exercise Physiol, Columbia, MO 65211 USA; [Limesand, Kirsten H.] Univ Arizona, Dept Nutr Sci, Tucson, AZ 85721 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Arizona	Weisman, GA (corresponding author), Univ Missouri, 540E Life Sci Ctr,1201 Rollins Rd, Columbia, MO 65211 USA.	weismang@missouri.edu		Khalafalla, Mahmoud/0000-0002-7171-8162	National Institute of Dental and Craniofacial Research, National Institutes of Health [DE023342]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023342] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institute of Dental and Craniofacial Research, National Institutes of Health Grant DE023342. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abais JM, 2015, ANTIOXID REDOX SIGN, V22, P1111, DOI 10.1089/ars.2014.5994; Ahn JS, 2000, AM J PHYSIOL-CELL PH, V279, pC286, DOI 10.1152/ajpcell.2000.279.2.C286; Akundi RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016038; Alves LA, 2013, MOLECULES, V18, P10953, DOI 10.3390/molecules180910953; Arulkumaran N, 2011, EXPERT OPIN INV DRUG, V20, P897, DOI 10.1517/13543784.2011.578068; Atkinson Jane C, 2005, Dent Clin North Am, V49, P309, DOI 10.1016/j.cden.2004.10.002; Ayata CK, 2012, GASTROENTEROLOGY, V143, P1620, DOI 10.1053/j.gastro.2012.08.049; Baker OJ, 2008, MOL IMMUNOL, V45, P65, DOI 10.1016/j.molimm.2007.05.009; Baldini C, 2013, J INTERN MED, V274, P480, DOI 10.1111/joim.12115; Barrera MJ, 2013, J AUTOIMMUN, V42, P7, DOI 10.1016/j.jaut.2013.02.001; Bartlett R, 2014, PHARMACOL REV, V66, P638, DOI 10.1124/pr.113.008003; Blasche R, 2012, INT J BIOCHEM CELL B, V44, P514, DOI 10.1016/j.biocel.2011.12.003; Bolwell GP, 1999, CURR OPIN PLANT BIOL, V2, P287, DOI 10.1016/S1369-5266(99)80051-X; Cesaro A, 2010, AM J PHYSIOL-GASTR L, V299, pG32, DOI 10.1152/ajpgi.00282.2009; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Cloonan SM, 2012, CURR OPIN IMMUNOL, V24, P32, DOI 10.1016/j.coi.2011.11.001; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Coskun M, 2014, FRONT MED, V1, DOI 10.3389/fmed.2014.00024; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; d'Avila JC, 2008, CRIT CARE MED, V36, P1925, DOI 10.1097/CCM.0b013e3181760c4b; Deaglio S, 2011, ADV PHARMACOL, V61, P301, DOI 10.1016/B978-0-12-385526-8.00010-2; Degagne E, 2009, J IMMUNOL, V183, P4521, DOI 10.4049/jimmunol.0803977; Delaleu N, 2005, EUR J ORAL SCI, V113, P101, DOI 10.1111/j.1600-0722.2004.00183.x; Delaleu N, 2016, RHEUMATOLOGY, V55, P1127, DOI 10.1093/rheumatology/kew013; Deplano S, 2013, J LEUKOCYTE BIOL, V93, P127, DOI 10.1189/jlb.0612284; Di Virgilio F, 1998, BIOFACTORS, V8, P301; Di Virgilio F, 2015, CURR MED CHEM, V22, P866; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; El-Sayed FG, 2014, AM J PHYSIOL-CELL PH, V307, pC83, DOI 10.1152/ajpcell.00380.2013; Feng L, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0409-2; Fox PC, 2004, CARIES RES, V38, P241, DOI 10.1159/000077761; Friedle Scott A, 2010, Recent Pat CNS Drug Discov, V5, P35; Gombault A, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00414; Heid ME, 2013, J IMMUNOL, V191, P5230, DOI 10.4049/jimmunol.1301490; Hwang SM, 2009, KOREAN J PHYSIOL PHA, V13, P175, DOI 10.4196/kjpp.2009.13.3.175; Jonsson MV, 2006, ARTHRITIS RHEUM, V54, P2300, DOI 10.1002/art.21945; Juliana C, 2010, J BIOL CHEM, V285, P9792, DOI 10.1074/jbc.M109.082305; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Karmakar M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10555; Kayes TD, 2016, J IMMUNOL, V197, P2119, DOI 10.4049/jimmunol.1600133; Keystone EC, 2012, ANN RHEUM DIS, V71, P1630, DOI 10.1136/annrheumdis-2011-143578; Kim SR, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.460; Lee YA, 2012, EXP MOL MED, V44, P440, DOI 10.3858/emm.2012.44.7.049; Lister Martin F, 2007, J Inflamm (Lond), V4, P5, DOI 10.1186/1476-9255-4-5; Lopez-Castejon G, 2010, J IMMUNOL, V185, P2611, DOI 10.4049/jimmunol.1000436; Lucattelli M, 2011, AM J RESP CELL MOL, V44, P423, DOI 10.1165/rcmb.2010-0038OC; Manoussakis MN, 2007, CLIN REV ALLERG IMMU, V32, P225, DOI 10.1007/s12016-007-8007-4; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; McGaraughty S, 2007, NEUROSCIENCE, V146, P1817, DOI 10.1016/j.neuroscience.2007.03.035; Monif M, 2009, J NEUROSCI, V29, P3781, DOI 10.1523/JNEUROSCI.5512-08.2009; MOUTSOPOULOS HM, 1994, CLIN IMMUNOL IMMUNOP, V72, P162, DOI 10.1006/clin.1994.1123; Muller T, 2011, AM J RESP CELL MOL, V44, P456, DOI 10.1165/rcmb.2010-0129OC; Muller FL, 2003, BIOCHEMISTRY-US, V42, P6493, DOI 10.1021/bi0342160; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Nakamoto T, 2009, J BIOL CHEM, V284, P4815, DOI 10.1074/jbc.M808597200; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Perregaux DG, 1998, AM J PHYSIOL-CELL PH, V275, pC1538, DOI 10.1152/ajpcell.1998.275.6.C1538; Peterson TS, 2013, J NEUROCHEM, V125, P885, DOI 10.1111/jnc.12252; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Rathinam VAK, 2016, CELL, V165, P792, DOI 10.1016/j.cell.2016.03.046; Riteau N, 2010, AM J RESP CRIT CARE, V182, P774, DOI 10.1164/rccm.201003-0359OC; Roescher N, 2010, ANN RHEUM DIS, V69, P945, DOI 10.1136/ard.2009.115378; Schrader AM, 2005, ARCH ORAL BIOL, V50, P533, DOI 10.1016/j.archoralbio.2004.11.005; Scroggins BT, 2007, EXPERT OPIN DRUG DIS, V2, P1403, DOI 10.1517/17460441.2.10.1403; Sharma J. N., 2007, Inflammopharmacology, V15, P252, DOI 10.1007/s10787-007-0013-x; Shimoda S, 2008, HEPATOLOGY, V47, P958, DOI 10.1002/hep.22102; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Taylor SRJ, 2009, J AM SOC NEPHROL, V20, P1275, DOI 10.1681/ASN.2008060559; Thiel M, 2010, IMMUNOLOGY, V129, P28, DOI 10.1111/j.1365-2567.2009.03155.x; Tincani A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-93; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; Tsuda M, 2010, BRAIN RES REV, V63, P222, DOI 10.1016/j.brainresrev.2009.11.003; Tsunawaki S, 2002, J RHEUMATOL, V29, P1884; Turner JT, 1997, AM J PHYSIOL-CELL PH, V273, pC1100, DOI 10.1152/ajpcell.1997.273.3.C1100; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; WEISMAN GA, 1984, J CELL PHYSIOL, V119, P211, DOI 10.1002/jcp.1041190211; Wilson HL, 2002, J BIOL CHEM, V277, P34017, DOI 10.1074/jbc.M205120200; Witte E, 2016, J MOL MED, V94, P391, DOI 10.1007/s00109-015-1367-y; Woods LT, 2012, AM J PHYSIOL-CELL PH, V303, pC790, DOI 10.1152/ajpcell.00072.2012; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	85	51	54	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16626	16637		10.1074/jbc.M117.790741	http://dx.doi.org/10.1074/jbc.M117.790741			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28798231	Green Published, hybrid			2022-12-26	WOS:000412414800023
J	Orlov, M; Dmyterko, V; Wurfel, MM; Mikacenic, C				Orlov, Marika; Dmyterko, Victoria; Wurfel, Mark M.; Mikacenic, Carmen			Th17 cells are associated with protection from ventilator associated pneumonia	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; AIRWAY NEUTROPHILIA; IL-17; DEFENSE; INFECTION; DISEASE; IL-23	Background CD4(+) T-helper 17 (Th17) cells and Interleukin (IL)-17A play an important role in clearing pathogens in mouse models of pneumonia. We hypothesized that numbers of Th17 cells and levels of IL-17A are associated with risk for nosocomial pneumonia in humans. Methods We collected bronchoalveolar lavage (BAL) fluid from mechanically ventilated (n = 25) patients undergoing quantitative bacterial culture to evaluate for ventilator associated pneumonia (VAP). We identified Th17 cells by positive selection of CD4+ cells, stimulation with ionomycin and PMA, then staining for CD4, CD45, CCR6, IL-17A, and IFN-gamma followed by flow cytometric analysis (n = 21). We measured inflammatory cytokine levels, including IL-17A, in BAL fluid by immunoassay. Results VAP was detected in 13 of the 25 subjects. We identified a decreased percentage of IL-17A producing Th17 cells in BAL fluid from patients with VAP compared to those without (p = 0.02). However, we found no significant difference in levels of IL-17A in patients with VAP compared to those without (p = 0.07). Interestingly, IL-17A levels did not correlate with Th17 cell numbers. IL-17A levels did show strong positive correlations with alveolar neutrophil numbers and total protein levels. Conclusions Th17 cells are found at lower percentages in BAL fluid from mechanically ventilated patients with VAP and IL-17A levels correlated with Th17 cell percentages in non-VAP subjects, but not those with VAP. These findings suggest that Th17 cells may be protective against development of nosocomial pneumonia in patients receiving mechanical ventilation and that alveolar IL-17A in VAP may be derived from sources other than alveolar Th17 cells.	[Orlov, Marika] Univ Washington, Dept Med, Seattle, WA USA; [Dmyterko, Victoria; Wurfel, Mark M.; Mikacenic, Carmen] Univ Washington, Dept Med, Div Pulm & Crit Care Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Mikacenic, C (corresponding author), Univ Washington, Dept Med, Div Pulm & Crit Care Med, Seattle, WA 98195 USA.	cmikacen@uw.edu		Orlov, Marika/0000-0003-1961-0813; Mikacenic, Carmen/0000-0001-8966-5161	Parker B Francis Fellowship, NHLBI [K23HL120896]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL120896] Funding Source: NIH RePORTER	Parker B Francis Fellowship, NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Parker B Francis Fellowship, NHLBI K23HL120896. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arens C, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1233-5; Cai S, 2016, MUCOSAL IMMUNOL, V9, P718, DOI 10.1038/mi.2015.95; Chesne J, 2014, AM J RESP CRIT CARE, V190, P1094, DOI 10.1164/rccm.201405-0859PP; Choudhuri Anirban H, 2013, Int J Crit Illn Inj Sci, V3, P169, DOI 10.4103/2229-5151.119195; Dellit TH, 2008, INFECT CONT HOSP EP, V29, P525, DOI 10.1086/588160; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432; Li JT, 2015, J IMMUNOL, V195, P87, DOI 10.4049/jimmunol.1500054; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; McAleer JP, 2014, IMMUNOL REV, V260, P129, DOI 10.1111/imr.12183; Merlino James I, 2004, Surg Infect (Larchmt), V5, P21, DOI 10.1089/sur.2004.5.21; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; Mikacenic C, 2016, CRIT CARE MED, V44, P496, DOI 10.1097/CCM.0000000000001409; Milner JD, 2010, CURR OPIN HIV AIDS, V5, P179, DOI 10.1097/COH.0b013e328335ed3e; Morris AC, 2010, THORAX, V65, P201, DOI 10.1136/thx.2009.122291; Muenzer JT, 2010, INFECT IMMUN, V78, P1582, DOI 10.1128/IAI.01213-09; Paats MS, 2013, THORAX, V68, P468, DOI 10.1136/thoraxjnl-2012-202168; Punt S, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.984547; Roos AB, 2015, AM J RESP CRIT CARE, V191, P1232, DOI 10.1164/rccm.201410-1861OC; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Tan HL, 2011, AM J RESP CRIT CARE, V184, P252, DOI 10.1164/rccm.201102-0236OC; Tsai HC, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/267971; Wu Q, 2007, MICROBES INFECT, V9, P78, DOI 10.1016/j.micinf.2006.10.012; Ye P, 2001, AM J RESP CELL MOL, V25, P335, DOI 10.1165/ajrcmb.25.3.4424	25	7	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2017	12	8							e0182966	10.1371/journal.pone.0182966	http://dx.doi.org/10.1371/journal.pone.0182966			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD5CP	28806403	Green Published, Green Submitted, gold			2022-12-26	WOS:000407548800042
J	Voets, O; Tielen, F; Elstak, E; Benschop, J; Grimbergen, M; Stallen, J; Janssen, R; van Marle, A; Essrich, C				Voets, Olaf; Tielen, Frans; Elstak, Edo; Benschop, Julian; Grimbergen, Max; Stallen, Jan; Janssen, Richard; van Marle, Andre; Essrich, Christian			Highly efficient gene inactivation by adenoviral CRISPR/Cas9 in human primary cells	PLOS ONE			English	Article							AIRWAY EPITHELIAL-CELLS; CRISPR-CAS9 SYSTEM; TGF-BETA; GENOME; EXPRESSION; MICE; ENDONUCLEASE; REVEALS; CAS9; RNAI	Phenotypic assays using human primary cells are highly valuable tools for target discovery and validation in drug discovery. Expression knockdown (KD) of such targets in these assays allows the investigation of their role in models of disease processes. Therefore, efficient and fast modes of protein KD in phenotypic assays are required. The CRISPR/Cas9 system has been shown to be a versatile and efficient means of gene inactivation in immortalized cell lines. Here we describe the use of adenoviral (AdV) CRISPR/Cas9 vectors for efficient gene inactivation in two human primary cell types, normal human lung fibroblasts and human bronchial epithelial cells. The effects of gene inactivation were studied in the TGF-beta-induced fibroblast to myofibroblast transition assay (FMT) and the epithelial to mesenchymal transition assay (EMT), which are SMAD3 dependent and reflect pathogenic mechanisms observed in fibrosis. Co-transduction (co-TD) of AdV Cas9 with SMAD3-targeting guide RNAs (gRNAs) resulted in fast and efficient genome editing judged by insertion/deletion (indel) formation, as well as significant reduction of SMAD3 protein expression and nuclear translocation. This led to phenotypic changes downstream of SMAD3 inhibition, including substantially decreased alpha smooth muscle actin and fibronectin 1 expression, which are markers for FMT and EMT, respectively. A direct comparison between co-TD of separate Cas9 and gRNA AdV, versus TD with a single "all-in-one" Cas9/gRNA AdV, revealed that both methods achieve similar levels of indel formation. These data demonstrate that AdV CRISPR/Cas9 is a useful and efficient tool for protein KD in human primary cell phenotypic assays. The use of AdV CRISPR/Cas9 may offer significant advantages over the current existing tools and should enhance target discovery and validation opportunities.	[Voets, Olaf; Tielen, Frans; Elstak, Edo; Benschop, Julian; Grimbergen, Max; Stallen, Jan; Janssen, Richard; van Marle, Andre; Essrich, Christian] Galapagos BV, Cl Leiden, Netherlands	Galapagos NV	van Marle, A (corresponding author), Galapagos BV, Cl Leiden, Netherlands.	richard.janssen@glpg.com						Abrahimi P, 2015, CIRC RES, V117, P121, DOI 10.1161/CIRCRESAHA.117.306290; Arts GJ, 2003, GENOME RES, V13, P2325, DOI 10.1101/gr.1332603; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Bellec J, 2015, CURR GENE THER, V15, P447; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Chu HW, 2015, GENE THER, V22, P822, DOI 10.1038/gt.2015.53; Claussnitzer M, 2015, NEW ENGL J MED, V373; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Ghosh AK, 2000, ONCOGENE, V19, P3546, DOI 10.1038/sj.onc.1203693; Holkers M, 2014, NAT METHODS, V11, P1051, DOI [10.1038/NMETH.3075, 10.1038/nmeth.3075]; Hu B, 2003, AM J RESP CELL MOL, V29, P397, DOI 10.1165/rcmb.2003-0063OC; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kabadi AM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku749; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Li C, 2015, J GEN VIROL, V96, P2381, DOI 10.1099/vir.0.000139; Maggio I, 2014, SCI REP-UK, V4, DOI 10.1038/srep05105; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Michiels F, 2002, NAT BIOTECHNOL, V20, P1154, DOI 10.1038/nbt746; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Ohneda K, 2014, MOL CELL BIOL, V34, P1812, DOI 10.1128/MCB.01524-13; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Popp MW, 2016, CELL, V165, P1319, DOI 10.1016/j.cell.2016.05.053; Ratz M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09592; Rippmann JF, 2009, J LIPID RES, V50, P22, DOI 10.1194/jlr.M700571-JLR200; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Tan WF, 2013, P NATL ACAD SCI USA, V110, P16526, DOI 10.1073/pnas.1310478110; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; van Es HHG, 2005, DRUG DISCOV TODAY, V10, P1385, DOI 10.1016/S1359-6446(05)03590-7; Van Wetering S, 2000, AM J PHYSIOL-LUNG C, V278, pL51, DOI 10.1152/ajplung.2000.278.1.L51; Veres A, 2014, CELL STEM CELL, V15, P27, DOI 10.1016/j.stem.2014.04.020; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889	44	30	31	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0182974	10.1371/journal.pone.0182974	http://dx.doi.org/10.1371/journal.pone.0182974			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800587	Green Published, gold, Green Submitted			2022-12-26	WOS:000407431800040
J	Akmal, MA; Rasool, N; Khan, YD				Akmal, Muhammad Aizaz; Rasool, Nouman; Khan, Yaser Daanial			Prediction of N-linked glycosylation sites using position relative features and statistical moments	PLOS ONE			English	Article							ACTIVE FRACTION; PROTEIN; IDENTIFICATION; GLYCOPROTEINS	Glycosylation is one of the most complex post translation modification in eukaryotic cells. Almost 50% of the human proteome is glycosylated as glycosylation plays a vital role in various biological functions such as antigen's recognition, cell-cell communication, expression of genes and protein folding. It is a significant challenge to identify glycosylation sites in protein sequences as experimental methods are time taking and expensive. A reliable computational method is desirable for the identification of glycosylation sites. In this study, a comprehensive technique for the identification of N-linked glycosylation sites has been proposed using machine learning. The proposed predictor was trained using an up-to-date dataset through back propagation algorithm for multilayer neural network. The results of ten-fold cross-validation and other performance measures such as accuracy, sensitivity, specificity and Mathew's correlation coefficient inferred that the accuracy of proposed tool is far better than the existing systems such as Glyomine, GlycoEP, Ensemble SVM and GPP.	[Akmal, Muhammad Aizaz; Khan, Yaser Daanial] Univ Management & Technol, Sch Syst & Technol, Dept Comp Sci, Lahore, Pakistan; [Rasool, Nouman] Univ Management & Technol, Sch Sci, Dept Life Sci, Lahore, Pakistan	University of Management & Technology (UMT); University of Management & Technology (UMT)	Khan, YD (corresponding author), Univ Management & Technol, Sch Syst & Technol, Dept Comp Sci, Lahore, Pakistan.	yaser.khan@umt.edu.pk	Khan, Yaser Daanial/ABB-7928-2020	Khan, Yaser/0000-0002-2482-275X; Rasool, Nouman/0000-0003-0210-5845				Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; Akbar S, 2014, IJCSI, V11, P1694; [Anonymous], 2014, SCI WORLD J; Brown DP, 2007, PLOS COMPUT BIOL, V3, P1526, DOI 10.1371/journal.pcbi.0030160; Butt AH, 2017, J MEMBRANE BIOL, V250, P55, DOI 10.1007/s00232-016-9937-7; Butt AH, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8370132; Caragea C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-438; Chauhan JS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067008, 10.1371/journal.pone.0080000]; Chen C, 2013, CHEM BIOL DRUG DES, V81, P688, DOI 10.1111/cbdd.12114; Chen C, 2011, J PHARMACEUT BIOMED, V56, P443, DOI 10.1016/j.jpba.2011.05.010; Chen J, 2016, BRIEF BIOINFORM; Chen W, 2017, SCI REP-UK, V7, DOI 10.1038/srep40242; Chen YZ, 2008, BMC BIOINFORMATICS, P9; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Davis J., 2006, P 23 INT C MACH LEAR, P233, DOI [10.1145/1143844.1143874, DOI 10.1145/1143844.1143874]; Hamby SE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-500; Hansen JE, 1998, GLYCOCONJUGATE J, V15, P115, DOI 10.1023/A:1006960004440; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Jiang L, 2016, BIOMED RES INT; Jurman G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041882; Khan Y. D., 2012, WORLD APPL SCI J, V16, P678; Krishna K, 1999, IEEE T SYST MAN CY B, V29, P433, DOI 10.1109/3477.764879; Li FY, 2015, BIOINFORMATICS, V31, P1411, DOI 10.1093/bioinformatics/btu852; Lin C, 2014, NEUROCOMPUTING, V123, P424, DOI 10.1016/j.neucom.2013.08.004; Liu B, 2017, ONCOTARGET, V8, P13338, DOI 10.18632/oncotarget.14524; Liu B, 2016, IEEE T NANOBIOSCI, V15, P328, DOI 10.1109/TNB.2016.2555951; Liu B, 2017, BIOINFORMATICS, V33, P35, DOI [10.1093/bioinformatics/btv604, 10.1093/bioinformatics/btw539]; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121501; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106691; Liu J, 2015, J BIOMOL STRUCT DYN, V33, P7, DOI [10.1080/07391102.2015.1032552, 10.1080/07391102.2015.1014422]; LO CH, 1989, IEEE T PATTERN ANAL, V11, P1053, DOI 10.1109/34.42836; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; PAPADEMETRIOU RC, 1992, 11TH IAPR INTERNATIONAL CONFERENCE ON PATTERN RECOGNITION, PROCEEDINGS, VOL III, P476, DOI 10.1109/ICPR.1992.202028; Petersen B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015079; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Shi XH, 2005, J VIROL, V79, P13725, DOI 10.1128/JVI.79.21.13725-13734.2005; Sykes A. O., INTRO REGRESSION ANA; Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151; Van Durme J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000475; Xu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055844; Zhang H, 2003, NAT BIOTECHNOL, V21, P660, DOI 10.1038/nbt827; Zhu HQ, 2007, PATTERN RECOGN LETT, V28, P1688, DOI 10.1016/j.patrec.2007.04.013	43	56	57	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0181966	10.1371/journal.pone.0181966	http://dx.doi.org/10.1371/journal.pone.0181966			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797096	Green Published, gold, Green Submitted			2022-12-26	WOS:000407396200023
J	Liu, LM; Koo, Y; Collins, B; Xu, ZG; Sankar, J; Yun, Y				Liu, Lumei; Koo, Youngmi; Collins, Boyce; Xu, Zhigang; Sankar, Jagannathan; Yun, Yeoheung			Biodegradability and platelets adhesion assessment of magnesium-based alloys using a microfluidic system	PLOS ONE			English	Article							WALL SHEAR-STRESS; CORROSION BEHAVIOR; IN-VITRO; LOCALIZED CORROSION; PURE MAGNESIUM; MG ALLOYS; SURFACE; FLOW; MICROSTRUCTURE; STENTS	Magnesium (Mg)-based stents are extensively explored to alleviate atherosclerosis due to their biodegradability and relative hemocompatibility. To ensure the quality, safety and cost-efficacy of bioresorbable scaffolds and full utilization of the material tunability afforded by alloying, it is critical to access degradability and thrombosis potential of Mg-based alloys using improved in vitro models that mimic as closely as possible the in vivo microenvironment. In this study, we investigated biodegradation and initial thrombogenic behavior of Mg-based alloys at the interface between Mg alloys' surface and simulated physiological environment using a microfluidic system. The degradation properties of Mg-based alloys WE43, AZ31, ZWEK-L, and ZWEK-C were evaluated in complete culture medium and their thrombosis potentials in platelet rich plasma, respectively. The results show that 1) physiological shear stress increased the corrosion rate and decreased platelets adhesion rate as compared to static immersion; 2) secondary phases and impurities in material composition induced galvanic corrosion, resulting in higher corrosion resistance and platelet adhesion rate; 3) Mg-based alloys with higher corrosion rate showed higher platelets adhesion rate. We conclude that a microfluidic-based in vitro system allows evaluation of biodegradation behaviors and platelets responses of Mg-based alloys under specific shear stress, and degradability is related to platelets adhesion.	[Liu, Lumei; Koo, Youngmi; Collins, Boyce; Xu, Zhigang; Sankar, Jagannathan; Yun, Yeoheung] North Carolina Agr & Tech State Univ, Natl Sci Fdn, Engn Res Ctr Revolutionizing Metall Biomat, Greensboro, NC 27401 USA; [Liu, Lumei; Koo, Youngmi; Yun, Yeoheung] North Carolina Agr & Tech State Univ, Dept Chem Biol & Bioengn, FIT BEST Lab, Greensboro, NC 27401 USA	National Science Foundation (NSF); University of North Carolina; North Carolina A&T State University; University of North Carolina; North Carolina A&T State University	Yun, Y (corresponding author), North Carolina Agr & Tech State Univ, Natl Sci Fdn, Engn Res Ctr Revolutionizing Metall Biomat, Greensboro, NC 27401 USA.; Yun, Y (corresponding author), North Carolina Agr & Tech State Univ, Dept Chem Biol & Bioengn, FIT BEST Lab, Greensboro, NC 27401 USA.	yyun@ncat.edu	Xu, Zhigang/AAC-7839-2019	XU, ZHIGANG/0000-0003-4477-7391	NIH NIGMS [ISC3GM113728-01]; National Science Foundation (NSF) Engineering Research Center (ERC) [NSF 0812348]; National Science Foundation (NSF) Engineering Research Center (ERC) for Revolutionizing Metallic Biomaterials (RMB)at North Carolina A & T State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM113728] Funding Source: NIH RePORTER	NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation (NSF) Engineering Research Center (ERC)(European Research Council (ERC)National Science Foundation (NSF)); National Science Foundation (NSF) Engineering Research Center (ERC) for Revolutionizing Metallic Biomaterials (RMB)at North Carolina A & T State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH NIGMS grant (ISC3GM113728-01, https.//www.nigms.nih. gov/Research/Pages/default.aspx; YY is the recipient) and National Science Foundation (NSF) Engineering Research Center (ERC) for Revolutionizing Metallic Biomaterials (NSF 0812348, http://erc.ncat.edu/; JS is the recipient) at North Carolina A & T State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the support from all colleagues of National Science Foundation (NSF) Engineering Research Center (ERC) for Revolutionizing Metallic Biomaterials (RMB)at North Carolina A & T State University.	Atrens A, 2015, ADV ENG MATER, V17, P400, DOI 10.1002/adem.201400434; Atrens A, 2011, MATER SCI ENG B-ADV, V176, P1609, DOI 10.1016/j.mseb.2010.12.017; Ben-Hamu G, 2007, J ALLOY COMPD, V431, P269, DOI 10.1016/j.jallcom.2006.05.075; Birbilis N, 2006, CORROS SCI, V48, P4202, DOI 10.1016/j.corsci.2006.02.007; Bowen PK, 2014, ACTA BIOMATER, V10, P1475, DOI 10.1016/j.actbio.2013.11.021; CHAIMOFF C, 1978, AM J SURG, V136, P257, DOI 10.1016/0002-9610(78)90241-6; Chang JW, 2007, T NONFERR METAL SOC, V17, P1152, DOI 10.1016/S1003-6326(07)60241-6; Chang JW, 2008, CORROS SCI, V50, P166, DOI 10.1016/j.corsci.2007.06.003; Chen JL, 2009, APPL SURF SCI, V255, P6894, DOI 10.1016/j.apsusc.2009.03.011; Chen YJ, 2014, ACTA BIOMATER, V10, P4561, DOI 10.1016/j.actbio.2014.07.005; DAVIE EW, 1975, ANNU REV BIOCHEM, V44, P729, DOI 10.1146/annurev.bi.44.070175.004055; Di Mario Carlo, 2004, J Interv Cardiol, V17, P391, DOI 10.1111/j.1540-8183.2004.04081.x; Doriot PA, 2000, CORONARY ARTERY DIS, V11, P495, DOI 10.1097/00019501-200009000-00008; Emley EF, 1966, PRINCIPLES MAGNESIUM; Erbel R, 2007, LANCET, V369, P1869, DOI 10.1016/S0140-6736(07)60853-8; Erne P, 2006, CARDIOVASC INTER RAD, V29, P11, DOI 10.1007/s00270-004-0341-9; Fontana M.G., 2005, CORROSION ENG; Ghali E, 2004, J MATER ENG PERFORM, V13, P7, DOI 10.1361/10599490417533; Gu XZ, 2016, COLLOID SURFACE B, V144, P170, DOI 10.1016/j.colsurfb.2016.03.086; Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021; Hansi C, 2009, CATHETER CARDIO INTE, V73, P488, DOI 10.1002/ccd.21834; Hara N, 2007, CORROS SCI, V49, P166, DOI 10.1016/j.corsci.2006.05.033; Haude M, 2013, LANCET, V381, P836, DOI 10.1016/S0140-6736(12)61765-6; Helsen J.A., 1998, METALS BIOMATERIALS; Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651; Huang Y, 2001, NDT NET, V6; Inkson BJ, 2001, SCRIPTA MATER, V45, P753, DOI 10.1016/S1359-6462(01)01090-9; Jia HM, 2015, J MAGNES ALLOY, V3, P247, DOI 10.1016/j.jma.2015.08.006; Kendig KL, 2002, ACTA MATER, V50, P4165, DOI 10.1016/S1359-6454(02)00258-6; Kim H, 2016, SCI TECHNOLOGY ADV M; Kornet L, 1999, ARTERIOSCL THROM VAS, V19, P2933, DOI 10.1161/01.ATV.19.12.2933; Kuwahara H, 2001, MATER TRANS, V42, P1317, DOI 10.2320/matertrans.42.1317; Lafront AM, 2005, ELECTROCHIM ACTA, V51, P489, DOI 10.1016/j.electacta.2005.05.013; Levesque J, 2008, ACTA BIOMATER, V4, P284, DOI 10.1016/j.actbio.2007.09.012; Liu M, 2009, CORROS SCI, V51, P602, DOI 10.1016/j.corsci.2008.12.015; Lu P, 2011, COLLOID SURFACE B, V83, P23, DOI 10.1016/j.colsurfb.2010.10.038; MAKAR GL, 1993, INT MATER REV, V38, P138, DOI 10.1179/095066093790326320; McKeown KP, 1998, AM J PHYSIOL-HEART C, V275, pH322, DOI 10.1152/ajpheart.1998.275.1.H322; Mitra AK, 2006, J CLIN PATHOL, V59, P232, DOI 10.1136/jcp.2005.025742; Mondet M, 2016, ACTA MATER, V119, P55, DOI 10.1016/j.actamat.2016.08.006; Moravej M, 2011, INT J MOL SCI, V12, P4250, DOI 10.3390/ijms12074250; Mueller WD, 2010, ACTA BIOMATER, V6, P1749, DOI 10.1016/j.actbio.2009.12.048; Narasipura SD, 2008, AM J HEMATOL, V83, P627, DOI 10.1002/ajh.21204; Neil WC, 2009, CORROS SCI, V51, P387, DOI 10.1016/j.corsci.2008.11.005; Pourbaix M., 1966, ATLAS ELECTROCHEMICA; Qi GC, 2008, APPL SURF SCI, V255, P304, DOI 10.1016/j.apsusc.2008.06.106; Rad HRB, 2012, MATER DESIGN, V33, P88, DOI 10.1016/j.matdes.2011.06.057; Rollett A., 2004, RECRYSTALLIZATION RE; Rukshin V, 2002, CIRCULATION, V105, P1970, DOI 10.1161/01.CIR.0000014612.88433.62; Sanchez AHM, 2015, ACTA BIOMATER, V13, P16, DOI 10.1016/j.actbio.2014.11.048; Schlaepfer D. D., 1994, INTEGRIN MEDIATED SI; Schmutz P, 2003, J ELECTROCHEM SOC, V150, pB99, DOI 10.1149/1.1554721; Seitz JM, 2014, J BIOMED MATER RES A, V102, P3744, DOI 10.1002/jbm.a.35023; Shakibaei M, 2001, J BIOL CHEM, V276, P13289, DOI 10.1074/jbc.M010859200; Smith CE, 2013, EMERG MATER RES, V2, P283, DOI 10.1680/emr.13.00026; Song G, 2007, ADV ENG MATER, V9, P177, DOI 10.1002/adem.200600221; Song GL, 1999, ADV ENG MATER, V1, P11, DOI 10.1002/(SICI)1527-2648(199909)1:1<11::AID-ADEM11>3.0.CO;2-N; Song GL, 2003, ADV ENG MATER, V5, P837, DOI 10.1002/adem.200310405; Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003; Taylor CA, 2002, ANN BIOMED ENG, V30, P402, DOI 10.1114/1.1476016; Testing ASf Materials, G3172 ASTM; Thomas S, 2015, CURR OPIN SOLID ST M, V19, P85, DOI 10.1016/j.cossms.2014.09.005; van der Meer AD, 2012, INTEGR BIOL-UK, V4, P461, DOI 10.1039/c2ib00176d; Vorchheimer DA, 2006, MAYO CLIN P; Waksman R, 2006, CATHETER CARDIO INTE, V68, P607, DOI 10.1002/ccd.20727; Wallin R.F., 1998, MED DEVICE DIAGN IND, V20, P96; Wang J, 2016, ACTA BIOMATERIALIA; Wang J, 2016, CORROS SCI, V104, P277, DOI 10.1016/j.corsci.2015.12.020; Wang J, 2014, ACTA BIOMATER, V10, P5213, DOI 10.1016/j.actbio.2014.08.034; Wang J, 2013, ACTA BIOMATER, V9, P8678, DOI 10.1016/j.actbio.2013.02.041; Wang Y, 2008, MATER LETT, V62, P2181, DOI 10.1016/j.matlet.2007.11.045; WARD CA, 1977, AM J PHYSIOL, V233, pH100, DOI 10.1152/ajpheart.1977.233.1.H100; Willumeit R, 2011, ACTA BIOMATER, V7, P2704, DOI 10.1016/j.actbio.2011.03.004; Wittchow E, 2013, EUROINTERVENTION, V8, P1441, DOI 10.4244/EIJV8I12A218; Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037; Yang CW, 2013, TENSILE MECH PROPERT; Yang L, 2013, ACTA BIOMATER, V9, P8475, DOI 10.1016/j.actbio.2012.10.001; Yun YH, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/46/465505; Zeng RC, 2008, ADV ENG MATER, V10, pB3, DOI 10.1002/adem.200800035; Zhang EL, 2009, MAT SCI ENG C-BIO S, V29, P987, DOI 10.1016/j.msec.2008.08.024; Zheng YF, 2014, MAT SCI ENG R, V77, P1, DOI 10.1016/j.mser.2014.01.001; ZINGG W, 1982, CAN J SURG, V25, P16	82	15	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182914	10.1371/journal.pone.0182914	http://dx.doi.org/10.1371/journal.pone.0182914			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797069	Green Submitted, Green Published, gold			2022-12-26	WOS:000407396200121
J	Schafer, AGM; Joos, LJ; Roggemann, K; Waldvogel-Roker, K; Pfingsten, M; Petzke, F				Schaefer, Axel Georg Meender; Joos, Leonie Johanna; Roggemann, Katharina; Waldvogel-Roeker, Kerstin; Pfingsten, Michael; Petzke, Frank			Pain experiences of patients with musculoskeletal pain plus central sensitization: A comparative Group Delphi Study	PLOS ONE			English	Article							BACK-PAIN; GERMAN VERSION; FIBROMYALGIA; CLASSIFICATION; QUESTIONNAIRE; VALIDATION; SCALE; RELIABILITY; DISORDERS; DIAGNOSIS	Objectives Central sensitization (CS) is regarded as an important contributing factor for chronification of musculoskeletal pain (MSP). It is crucial to identify CS, as targeted multimodal treatment may be indicated. The primary objective of this study was therefore to explore pain experience of individuals with MSP+CS in order to gain a better understanding of symptoms in relation to CS from a patient perspective. The secondary objective was to investigate whether pain experiences of patients with MSP+CS differ from those of individuals with neuropathic pain (NP). Methods We conducted a comparative Group Delphi Study including patients with MSP+CS and neuropathic pain (NP). 13 guiding questions were used to gather information about sensory discriminatory, affective and associated bodily, mental and emotional phenomena related to the pain experience of patients. Descriptions were categorized using qualitative content analysis. Additionally, patients completed several pain related questionnaires. Results Nine participants with MSP+CS and nine participants with NP participated. The Delphi procedure revealed three main themes: psycho-emotional factors, bodily factors and environmental factors. Descriptions of patients with MSP+CS showed a complex picture, psycho-emotional factors seem to have a considerable impact on pain provocation, aggravation and relief. Impairments associated with mental ability and psyche affected many aspects of daily life. In contrast, descriptions of patients with NP revealed a rather mechanistic and bodily oriented pain experience. Discussion Patients with MSP+CS reported distinct features in relation to their pain that were not captured with current questionnaires. Insight in patient's pain experience may help to choose and develop appropriate diagnostic instruments.	[Schaefer, Axel Georg Meender] Univ Appl Sci Bremen, Fac Social Sci, Degree Programme Appl Sci Speech & Language Thera, Bremen, Germany; [Joos, Leonie Johanna; Roggemann, Katharina; Waldvogel-Roeker, Kerstin] Univ Appl Sci Hildesheim, Fac Social Work & Hlth, Degree Programme Occupat Therapy Speech & Languag, Hildesheim, Germany; [Pfingsten, Michael; Petzke, Frank] Univ Med Gottingen, Dept Anaesthesiol, Pain Clin, Gottingen, Germany	Bremen University of Applied Sciences; HAWK University of Applied Sciences & Arts Hildesheim Holzminden Gottingen; University of Gottingen	Petzke, F (corresponding author), Univ Med Gottingen, Dept Anaesthesiol, Pain Clin, Gottingen, Germany.	frank.petzke@med.uni-goettingen.de		Schafer, Axel Georg Meender/0000-0003-4222-1605				Amris K, 2010, PAIN, V151, P664, DOI 10.1016/j.pain.2010.08.023; Bortz J, 2003, KURZGEFASSTE STAT KL; Breivik H, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1229; Brummett CM, 2015, ARTHRITIS RHEUMATOL, V67, P1386, DOI 10.1002/art.39051; Coppieters I, 2015, PAIN PHYSICIAN, V18, pE389; Ellert U, 2004, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V47, P1027, DOI 10.1007/s00103-004-0933-1; Flor H, 2011, GEN PRINCIPLES TREAT, P321; Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488; Geissner E, 1996, SCHMERZEMPFINDUNASSK; Gerhardt A, 2014, PAIN MED, V15, P1200, DOI 10.1111/pme.12286; Graven-Nielsen Thomas, 2002, Curr Rheumatol Rep, V4, P313, DOI 10.1007/s11926-002-0040-y; Hader M, 2009, DELPHIBEFRAGUNGEN AR; Hauser W, 2010, SCHMERZ, V24, P226, DOI 10.1007/s00482-010-0931-1; Jensen MP, 2013, PAIN, V154, P2722, DOI 10.1016/j.pain.2013.08.003; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Lin CP, 2011, EUR J PAIN, V15, P628, DOI 10.1016/j.ejpain.2010.11.006; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Lovibond SH, 1995, MANUAL DEPRESSION AN, V2nd; Mayer TG, 2012, PAIN PRACT, V12, P276, DOI 10.1111/j.1533-2500.2011.00493.x; Mayring P, 1994, QUALITATIVE CONTENT; Meyer K, 2008, J PSYCHOSOM RES, V64, P469, DOI 10.1016/j.jpsychores.2007.12.004; Nijs J, 2014, PAIN PHYSICIAN, V17, P447; Nijs J, 2010, MANUAL THER, V15, P135, DOI 10.1016/j.math.2009.12.001; Rehm SE, 2010, RHEUMATOLOGY, V49, P1146, DOI 10.1093/rheumatology/keq066; Roelofs J, 2011, PAIN, V152, P1090, DOI 10.1016/j.pain.2011.01.028; Ruscheweyh R, 2012, PAIN, V153, P1210, DOI 10.1016/j.pain.2012.02.025; Ruscheweyh R, 2009, PAIN, V146, P65, DOI 10.1016/j.pain.2009.06.020; Schafer A, 2009, MANUAL THER, V14, P222, DOI 10.1016/j.math.2007.10.003; Scholz J, 2002, NAT NEUROSCI, V5, P1062, DOI 10.1038/nn942; Schulz M, 2009, DAS GRUPPENDELPHI; Shaygan M, 2013, EUR J PAIN, V17, P1529, DOI 10.1002/j.1532-2149.2013.00322.x; Smart KM, 2011, CLIN J PAIN, V27, P655, DOI 10.1097/AJP.0b013e318215f16a; Smart KM, 2010, J MAN MANIP THER, V18, P102, DOI 10.1179/106698110X12640740712897; Smart KM, 2010, MANUAL THER, V15, P80, DOI 10.1016/j.math.2009.07.005; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Turk DC, 2008, PAIN, V137, P276, DOI 10.1016/j.pain.2007.09.002; Woolf CJ, 1998, PAIN, V77, P227, DOI 10.1016/S0304-3959(98)00099-2; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030	38	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182207	10.1371/journal.pone.0182207	http://dx.doi.org/10.1371/journal.pone.0182207			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD2WT	28796805	gold, Green Published, Green Submitted			2022-12-26	WOS:000407396200038
J	Polanczyk, A; Piechota-Polanczyk, A; Stefanczyk, L				Polanczyk, Andrzej; Piechota-Polanczyk, Aleksandra; Stefanczyk, Ludomir			A new approach for the pre-clinical optimization of a spatial configuration of bifurcated endovascular prosthesis placed in abdominal aortic aneurysms	PLOS ONE			English	Article							COMPUTATIONAL FLUID-DYNAMICS; STENT-GRAFTS; THROMBUS FORMATION; PREDICTIVE FACTORS; LIMB OCCLUSIONS; FOLLOW-UP; MODEL; REPAIR; ENDOGRAFTS; ENDOLEAKS	Complexity of the spatial configuration of an aortic implant with bifurcation in the distal part is related to changes in blood hemodynamic in the area of bifurcation which may disturb blood flow and lead to thrombus formation. This study was designed to characterize parameters which define spatial configuration of an aortic implant for which the risk of thrombus formation is the smallest. We used AngioCT data from 74 patients, aged 55 +/- 10 years, after endovascular procedure to prepare 3D geometries of stent-grafts. Computational Fluid Dynamics (CFD) simulations were used to reconstruct blood hemodynamic and simulate thrombus formation. Next, geometric parameters of stent-grafts included the ratio of volume of upper part to the bifurcations, the relation of inlet and outlet diameters of a stent-graft and deformations in the iliac part of the stent-graft were analyzed. We also analyzed tortuosities (spiral twisting of the flow around the flow direction) and bends (the largest angulation in distal part of a stent-graft). The CFD results were confronted with AngioCT data to verify if computer generated thrombus appeared in particular patient. Additionally, geometric parameters of analyzed stent-grafts were used to propose a mathematical tool for prediction of thrombus appearance. The results showed that tortuosities and bends of a stent-graft had the highest impact on thrombus formation. Formation of thrombi was observed in 22% to 31% of cases (at blood hematocrit Hct = 40%) even for small values of tortuosities and bends indicating that these parameters are dominant in determining blood clotting. Our calculated results overlapped with clinical data in 80% to 91%. Therefore, we conclude that tortuosities and bends have high impact on thrombus formation and should be under special attention during stent-graft recommendation and patients' follow-ups.	[Polanczyk, Andrzej] Lodz Univ Technol, Fac Proc & Environm Engn, Dept Heat & Mass Transfer, Lodz, Poland; [Piechota-Polanczyk, Aleksandra] Jagiellonian Univ, Dept Med Biotechnol, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Stefanczyk, Ludomir] Med Univ Lodz, Dept Radiol & Diagnost Imaging, Lodz, Poland	Lodz University of Technology; Jagiellonian University; Medical University Lodz	Polanczyk, A (corresponding author), Lodz Univ Technol, Fac Proc & Environm Engn, Dept Heat & Mass Transfer, Lodz, Poland.	andrzej.polanczyk@gmail.com	Polanczyk, Andrzej/K-9853-2019; Polanczyk, Andrzej/X-7303-2018; Polanczyk, Andrzej/P-5705-2019; Piechota-Polanczyk, Aleksandra/P-5698-2019; Piechota-Polanczyk, Aleksandra/O-7329-2017	Polanczyk, Andrzej/0000-0001-8894-752X; Polanczyk, Andrzej/0000-0001-8894-752X; Piechota-Polanczyk, Aleksandra/0000-0001-8062-4435; Piechota-Polanczyk, Aleksandra/0000-0001-8062-4435	Polish National Centre for Research and Development [501/10-34-19-605]; Ministry of Science and Higher Education	Polish National Centre for Research and Development; Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by the Polish National Centre for Research and Development (501/10-34-19-605 to AP).; This work was supported by the Polish National Centre for Research and Development (501/10-34-19-605 to AP). Faculty of Biochemistry, Biophysics and Biotechnology of Jagiellonian University is a partner of the Leading National Research Center (KNOW) supported by the Ministry of Science and Higher Education.	Amblard A, 2009, MED ENG PHYS, V31, P27, DOI 10.1016/j.medengphy.2008.03.005; Behrendt CA, 2017, ANN VASCULAR SURG; Buth J, 2000, J VASC SURG, V31, P134, DOI 10.1016/S0741-5214(00)70075-9; Cao P, 2009, J CARDIOVASC SURG, V50, P483; Carroccio A, 2002, J VASC SURG, V36, P679, DOI 10.1067/mva.2002.128309; Chong CK, 2005, J ENDOVASC THER, V12, P435, DOI 10.1583/04-1465.1; Cieri E, 2013, EUR J VASC ENDOVASC, V46, P192, DOI 10.1016/j.ejvs.2013.05.012; Cochennec F, 2007, EUR J VASC ENDOVASC, V34, P59, DOI 10.1016/j.ejvs.2007.01.009; Demanget N, 2012, J MECH BEHAV BIOMED, V5, P272, DOI 10.1016/j.jmbbm.2011.09.006; Faure EM, 2015, J VASC SURG, V61, P1138, DOI 10.1016/j.jvs.2014.11.084; Go MR, 2008, J VASC SURG, V47, P1181, DOI 10.1016/j.jvs.2008.01.056; Hara H, 2006, ADV DRUG DELIVER REV, V58, P377, DOI 10.1016/j.addr.2006.01.022; Howell BA, 2007, J ENDOVASC THER, V14, P138, DOI 10.1583/1545-1550(2007)14[138:CFDWBA]2.0.CO;2; Ito H, 2013, ANN VASC DIS, V6, P189, DOI [10.3400/avd.oa.12-00101, DOI 10.3400/AVD.OA.12-00101]; Katritsis DG, 2007, EUROPACE, V9, P167, DOI 10.1093/europace/eul184; Katritsis DG, 2012, CIRC-CARDIOVASC INTE, V5, P530, DOI 10.1161/CIRCINTERVENTIONS.112.968347; Kleinstreuer C, 2008, J BIOMECH, V41, P2370, DOI 10.1016/j.jbiomech.2008.05.032; Kwon ST, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003134; Liang DF, 2007, J ALGEBRA, V307, P695, DOI 10.1016/j.jalgebra.2006.10.010; Maleux G, 2008, J VASC INTERV RADIOL, V19, P1558, DOI 10.1016/j.jvir.2008.08.007; Martens T, 2010, ACTA CHIR BELG, V110, P361, DOI 10.1080/00015458.2010.11680635; Morris L, 2004, J BIOMECH, V37, P1087, DOI 10.1016/j.jbiomech.2003.11.014; Petrini L, 2005, J BIOMECH ENG-T ASME, V127, P716, DOI 10.1115/1.1934203; Polanczyk A., 2010, INZYNIERIA APARATURA, V2, P103; Polanczyk A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153332; Polanczyk A, 2015, J BIOMECH, V48, P425, DOI 10.1016/j.jbiomech.2014.12.033; Polanczyk A, 2012, CHEM PROCESS ENG-INZ, V33, P53, DOI 10.2478/v10176-012-0005-2; Reilly MP, 2013, ARTERIOSCL THROM VAS, V33, P1458, DOI 10.1161/ATVBAHA.113.301632; Roy D, 2012, COMP MATH MATH PHYS, V2012; Solonynko Bohdan, 2012, Pol Przegl Chir, V84, P551, DOI 10.2478/v10035-012-0092-2; Vad S, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4002798; Wegener M, 2001, J ENDOVASC THER, V8, P372, DOI 10.1583/1545-1550(2001)008<0372:TFIAE>2.0.CO;2; Wu IH, 2009, EUR J VASC ENDOVASC, V38, P741, DOI 10.1016/j.ejvs.2009.09.004; Xenos M, 2010, ANN BIOMED ENG, V38, P3323, DOI 10.1007/s10439-010-0094-3	34	20	20	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182717	10.1371/journal.pone.0182717	http://dx.doi.org/10.1371/journal.pone.0182717			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28793343	Green Published, gold, Green Submitted			2022-12-26	WOS:000407196700061
J	Hummos, A; Nair, SS				Hummos, Ali; Nair, Satish S.			An integrative model of the intrinsic hippocampal theta rhythm	PLOS ONE			English	Article							GLUTAMATERGIC SYNAPTIC-TRANSMISSION; DUAL INTRACELLULAR-RECORDINGS; SPIKE FREQUENCY ADAPTATION; CA3 PYRAMIDAL CELLS; ENTORHINAL CORTEX; CHOLINERGIC MODULATION; H-CURRENT; SUBTHRESHOLD OSCILLATIONS; POPULATION OSCILLATIONS; POSTSYNAPTIC TARGETS	Hippocampal theta oscillations (4-12 Hz) are consistently recorded during memory tasks and spatial navigation. Despite several known circuits and structures that generate hippocampal theta locally in vitro, none of them were found to be critical in vivo, and the hippocampal theta rhythm is severely attenuated by disruption of external input from medial septum or entorhinal cortex. We investigated these discrepancies that question the sufficiency and robustness of hippocampal theta generation using a biophysical spiking network model of the CA3 region of the hippocampus that included an interconnected network of pyramidal cells, inhibitory basket cells (BC) and oriens-lacunosum moleculare (OLM) cells. The model was developed by matching biological data characterizing neuronal firing patterns, synaptic dynamics, short-term synaptic plasticity, neuromodulatory inputs, and the three-dimensional organization of the hippocampus. The model generated theta power robustly through five cooperating generators: spiking oscillations of pyramidal cells, recurrent connections between them, slow-firing interneurons and pyramidal cells subnetwork, the fast-spiking interneurons and pyramidal cells subnetwork, and non-rhythmic structured external input from entorhinal cortex to CA3. We used the modeling framework to quantify the relative contributions of each of these generators to theta power, across different cholinergic states. The largest contribution to theta power was that of the divergent input from the entorhinal cortex to CA3, despite being constrained to random Poisson activity. We found that the low cholinergic states engaged the recurrent connections in generating theta activity, whereas high cholinergic states utilized the OLM-pyramidal subnetwork. These findings revealed that theta might be generated differently across cholinergic states, and demonstrated a direct link between specific theta generators and neuromodulatory states.	[Hummos, Ali] Univ Missouri, Dept Hlth Informat, Columbia, MO USA; [Hummos, Ali] Univ Missouri, Dept Psychiat, Columbia, MO 65201 USA; [Nair, Satish S.] Univ Missouri, Dept Elect & Comp Engn, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Nair, SS (corresponding author), Univ Missouri, Dept Elect & Comp Engn, Columbia, MO 65211 USA.	NairS@Missouri.edu		Nair, Satish S./0000-0002-1489-7029; Hummos, Ali/0000-0003-4831-305X	National institute of mental health [MH087755]	National institute of mental health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	National institute of mental health. http://www.nimh.nih.gov/index.shtml grant MH087755 to S.S.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker CD, 2003, J COMPUT NEUROSCI, V15, P71, DOI 10.1023/A:1024474819512; Acsady L, 1998, J NEUROSCI, V18, P3386; Ali AB, 1998, J PHYSIOL-LONDON, V507, P201, DOI 10.1111/j.1469-7793.1998.201bu.x; Ali AB, 1998, J PHYSIOL-LONDON, V507, P185, DOI 10.1111/j.1469-7793.1998.185bu.x; ALONSO A, 1987, EXP BRAIN RES, V67, P502, DOI 10.1007/BF00247283; Asghar AUR, 2005, J PHYSIOL-LONDON, V562, P183, DOI 10.1113/jphysiol.2004.076398; Augustin M, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00009; BARRY C, 2012, FRONT NEURAL CIRCUIT, V6; Bartos M, 2010, SPR SER COMPUT NEURO, V5, P129, DOI 10.1007/978-1-4419-0996-1_5; Baude A, 2007, CEREB CORTEX, V17, P2094, DOI 10.1093/cercor/bhl117; Berger T, 2006, NEUROSCIENCE, V140, P1401, DOI 10.1016/j.neuroscience.2006.03.003; Bezaire MJ, 2013, HIPPOCAMPUS, V23, P751, DOI 10.1002/hipo.22141; BIANCHI R, 1994, J NEUROPHYSIOL, V72, P131, DOI 10.1152/jn.1994.72.1.131; Bower MR, 2008, J NEUROPHYSIOL, V99, P2431, DOI 10.1152/jn.01369.2007; Boyce R, 2016, SCIENCE, V352, P812, DOI 10.1126/science.aad5252; BRAZHNIK ES, 1986, BRAIN RES, V380, P94, DOI 10.1016/0006-8993(86)91433-2; Brown JT, 2009, J PHYSIOL-LONDON, V587, P1265, DOI 10.1113/jphysiol.2008.167007; Brunel N, 2003, J NEUROPHYSIOL, V90, P415, DOI 10.1152/jn.01095.2002; Buhl E, 2007, HIPPOCAMPUS BOOK, P297; Buhl EH, 1996, HIPPOCAMPUS, V6, P294; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Carnevale N.T., 2009, NEURON BOOK, V1st; Cea-del Rio CA, 2010, J NEUROSCI, V30, P6011, DOI 10.1523/JNEUROSCI.5040-09.2010; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Cobb S, 2010, SPR SER COMPUT NEURO, V5, P187, DOI 10.1007/978-1-4419-0996-1_7; Colgin LL, 2013, ANNU REV NEUROSCI, V36, P295, DOI 10.1146/annurev-neuro-062012-170330; Crook SM, 1998, NEURAL COMPUT, V10, P837, DOI 10.1162/089976698300017511; Denham MJ, 2000, HIPPOCAMPUS, V10, P698, DOI 10.1002/1098-1063(2000)10:6<698::AID-HIPO1008>3.0.CO;2-Z; Deshmukh SS, 2010, J NEUROPHYSIOL, V104, P994, DOI 10.1152/jn.01141.2009; Destexhe A, 1998, HIPPOCAMPAL MICROCIR, V2, P1; Dickson CT, 2000, J NEUROPHYSIOL, V83, P2562, DOI 10.1152/jn.2000.83.5.2562; Do VH, 2002, J NEUROPHYSIOL, V87, P669, DOI 10.1152/jn.00938.2000; Economo MN, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002354; EISEN JS, 1984, J NEUROPHYSIOL, V51, P1375, DOI 10.1152/jn.1984.51.6.1375; FREEMAN WALTER J., 1968, MATH BIOSCI, V2, P181, DOI 10.1016/0025-5564(68)90017-5; Fuhrmann G, 2002, J NEUROPHYSIOL, V88, P761, DOI 10.1152/jn.2002.88.2.761; Galan RF, 2006, J NEUROSCI, V26, P3646, DOI 10.1523/JNEUROSCI.4605-05.2006; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; Gerstner W, 2014, NEURONAL DYNAMICS: FROM SINGLE NEURONS TO NETWORKS AND MODELS OF COGNITION, P1, DOI 10.1017/CBO9781107447615; GETTING PA, 1989, ANNU REV NEUROSCI, V12, P185, DOI 10.1146/annurev.neuro.12.1.185; Gigante G, 2007, MATH BIOSCI, V207, P336, DOI 10.1016/j.mbs.2006.11.010; Gillies MJ, 2002, J PHYSIOL-LONDON, V543, P779, DOI 10.1113/jphysiol.2002.024588; Giocomo LM, 2011, CELL, V147, P1159, DOI 10.1016/j.cell.2011.08.051; Gloveli T, 2005, P NATL ACAD SCI USA, V102, P13295, DOI 10.1073/pnas.0506259102; Goutagny R, 2009, NAT NEUROSCI, V12, P1491, DOI 10.1038/nn.2440; GULYAS AI, 1993, NATURE, V366, P683, DOI 10.1038/366683a0; HANSEL D, 1995, NEURAL COMPUT, V7, P307, DOI 10.1162/neco.1995.7.2.307; HASSELMO ME, 1995, J NEUROSCI, V15, P5249; Hasselmo ME, 2001, J NEUROPHYSIOL, V86, P1792, DOI 10.1152/jn.2001.86.4.1792; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; Hoseini MS, 2016, J NEUROPHYSIOL, V115, P457, DOI 10.1152/jn.00578.2015; Hoskison MM, 2004, NEUROSCI LETT, V365, P48, DOI 10.1016/j.neulet.2004.04.050; Hosseini-Sharifabad M, 2007, J NEUROSCI METH, V162, P206, DOI 10.1016/j.jneumeth.2007.01.009; Hu H, 2002, J PHYSIOL-LONDON, V545, P783, DOI 10.1113/jphysiol.2002.029249; Hummos A, 2014, HIPPOCAMPUS, V24, P1430, DOI 10.1002/hipo.22324; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; Izhikevich E. M., 2010, DYNAMICAL SYSTEMS NE; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Katona I, 1999, NEUROSCIENCE, V88, P37, DOI 10.1016/S0306-4522(98)00302-9; Kim D, 2013, J NEUROSCI, V33, P14354, DOI 10.1523/JNEUROSCI.2430-13.2013; Kim D, 2013, LEARN MEMORY, V20, P421, DOI 10.1101/lm.030262.113; Kispersky TJ, 2012, J NEUROSCI, V32, P3637, DOI 10.1523/JNEUROSCI.1361-11.2012; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; KLINK R, 1993, J NEUROPHYSIOL, V70, P144, DOI 10.1152/jn.1993.70.1.144; Kocsis B, 1999, J NEUROSCI, V19, P6200, DOI 10.1523/JNEUROSCI.19-14-06200.1999; Kopell N, 2010, SPR SER COMPUT NEURO, V5, P423, DOI 10.1007/978-1-4419-0996-1_15; KOSAKA T, 1987, BRAIN RES, V419, P119, DOI 10.1016/0006-8993(87)90575-0; Kremin T, 2007, NEUROSCIENCE, V149, P760, DOI 10.1016/j.neuroscience.2007.07.007; Lawrence JJ, 2006, J PHYSIOL-LONDON, V570, P595, DOI 10.1113/jphysiol.2005.100875; Lee SG, 1998, PHYS REV E, V57, P3292, DOI 10.1103/PhysRevE.57.3292; Leung LS, 2004, HIPPOCAMPUS, V14, P510, DOI 10.1002/hipo.10199; Li GS, 2011, LEARN MEMORY, V18, P226, DOI 10.1101/lm.1938011; LILJENSTROM H, 1995, J NEUROPHYSIOL, V74, P288, DOI 10.1152/jn.1995.74.1.288; Maccaferri G, 2005, J PHYSIOL-LONDON, V562, P73, DOI 10.1113/jphysiol.2004.077081; MADISON DV, 1984, J PHYSIOL-LONDON, V354, P319, DOI 10.1113/jphysiol.1984.sp015378; Mainen T.J., 1998, METHODS NEURONAL MOD, V2, P1; Marder E, 2012, NEURON, V76, P1, DOI 10.1016/j.neuron.2012.09.010; McQuiston AR, 1999, J NEUROSCI, V19, P5693, DOI 10.1523/JNEUROSCI.19-14-05693.1999; McQuiston AR, 1999, J NEUROSCI, V19, P2887; MILES R, 1990, J PHYSIOL-LONDON, V428, P61, DOI 10.1113/jphysiol.1990.sp018200; MILES R, 1986, J PHYSIOL-LONDON, V373, P397, DOI 10.1113/jphysiol.1986.sp016055; MISGELD U, 1989, J PHYSIOL-LONDON, V409, P191, DOI 10.1113/jphysiol.1989.sp017492; Mizuseki K, 2013, CELL REP, V4, P1010, DOI 10.1016/j.celrep.2013.07.039; Mizuseki K, 2012, HIPPOCAMPUS, V22, P1659, DOI 10.1002/hipo.22002; Mizuseki Kenji, 2012, HIPPOCAMPUS, V22, P1659, DOI [10.1002/hipo.22002, DOI 10.1002/HIPO.22002]; Morin F, 1996, J NEUROPHYSIOL, V76, P1; Naber PA, 1997, NEUROREPORT, V8, P2617, DOI 10.1097/00001756-199707280-00039; Nakao H, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026220; Netoff TI, 2005, J COMPUT NEUROSCI, V18, P287, DOI 10.1007/s10827-005-0336-9; Neymotin SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076285; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; Orban G, 2006, J NEUROPHYSIOL, V96, P2889, DOI 10.1152/jn.01233.2005; Pendyam S, 2013, J NEUROPHYSIOL, V110, P844, DOI 10.1152/jn.00961.2012; PETSCHE H, 1962, ELECTROEN CLIN NEURO, V14, P202, DOI 10.1016/0013-4694(62)90030-5; Pikovsky AS, 1997, PHYS REV LETT, V78, P775, DOI 10.1103/PhysRevLett.78.775; Podlogar M, 2006, BRAIN RES, V1085, P95, DOI 10.1016/j.brainres.2006.02.050; Rotstein HG, 2005, J NEUROPHYSIOL, V94, P1509, DOI 10.1152/jn.00957.2004; Rotstein HG, 2006, J COMPUT NEUROSCI, V21, P271, DOI 10.1007/s10827-006-8096-8; Rotstein HG, 2015, J COMPUT NEUROSCI, V38, P325, DOI 10.1007/s10827-014-0544-2; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; SAMARTH P, 2016, BRAIN STRUCT FUNCT; SERESS L, 1981, J ANAT, V133, P181; SIK A, 1995, J NEUROSCI, V15, P6651; Springer M, 2006, NATURE, V439, P27, DOI 10.1038/439027a; STALEY KJ, 1992, J NEUROPHYSIOL, V67, P1346, DOI 10.1152/jn.1992.67.5.1346; Stark E, 2013, NEURON, V80, P1263, DOI 10.1016/j.neuron.2013.09.033; STEWART M, 1990, TRENDS NEUROSCI, V13, P163, DOI 10.1016/0166-2236(90)90040-H; Szabo GG, 2010, EUR J NEUROSCI, V31, P2234, DOI 10.1111/j.1460-9568.2010.07292.x; Teramae J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.204103; Toth K, 2000, J NEUROSCI, V20, P8279, DOI 10.1523/JNEUROSCI.20-22-08279.2000; TRAUB RD, 1989, SCIENCE, V243, P1319, DOI 10.1126/science.2646715; TRAUB RD, 1992, J PHYSIOL-LONDON, V451, P653, DOI 10.1113/jphysiol.1992.sp019184; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Varela JA, 1997, J NEUROSCI, V17, P7926; Vida I, 2010, SPR SER COMPUT NEURO, V5, P27, DOI 10.1007/978-1-4419-0996-1_2; VINOGRADOVA OS, 1995, PROG NEUROBIOL, V45, P523, DOI 10.1016/0301-0082(94)00051-I; Vogt KE, 2001, J NEUROSCI, V21, P75, DOI 10.1523/JNEUROSCI.21-01-00075.2001; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Wang XJ, 1996, J NEUROSCI, V16, P6402; WHITE JA, 1995, BIOPHYS J, V69, P1203, DOI 10.1016/S0006-3495(95)79995-7; Witter MP, 2010, SPR SER COMPUT NEURO, V5, P5, DOI 10.1007/978-1-4419-0996-1_1; Wittner L, 2007, BRAIN STRUCT FUNCT, V212, P75, DOI 10.1007/s00429-007-0148-y; Wittner L, 2006, EUR J NEUROSCI, V24, P1286, DOI 10.1111/j.1460-9568.2006.04992.x; WOOLF NJ, 1991, PROG NEUROBIOL, V37, P475, DOI 10.1016/0301-0082(91)90006-M; YECKEL MF, 1990, P NATL ACAD SCI USA, V87, P5832, DOI 10.1073/pnas.87.15.5832; Zemankovics R, 2010, J PHYSIOL-LONDON, V588, P2109, DOI 10.1113/jphysiol.2009.185975	129	9	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182648	10.1371/journal.pone.0182648	http://dx.doi.org/10.1371/journal.pone.0182648			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28787026	Green Published, gold, Green Submitted			2022-12-26	WOS:000406998800055
J	Skulstad, SM; Igland, J; Johannessen, A; Bertelsen, RJ; Lonnebotn, M; Omenaas, ER; Svanes, C; Real, FG				Skulstad, Svein Magne; Igland, Jannicke; Johannessen, Ane; Bertelsen, Randi Jacobsen; Lonnebotn, Marianne; Omenaas, Ernst Reidar; Svanes, Cecilie; Real, Francisco Gomez			Validation of maternal reported pregnancy and birth characteristics against the Medical Birth Registry of Norway	PLOS ONE			English	Article							CHILDHOOD; VALIDITY; WEIGHT; RECALL; AGREEMENT; RECORDS; DISEASE; WOMEN; PREECLAMPSIA; DIAGNOSIS	Studies using mothers' self-reported information on birth and pregnancy characteristics are common, but the validity of such data is uncertain. We evaluated questionnaire data from the RHINE III study on reproductive health provided by 715 mothers from Bergen, Norway, about their 1629 births between 1967 and 2010, using the Medical Birth Registry of Norway (MBRN) as gold standard. Validity of dichotomous variables (gender, preterm birth [<37 weeks' gestation], postterm birth [>42 weeks' gestation], induction of labour, forceps delivery, vacuum delivery, caesarean section, were assessed by sensitivity, specificity, positive and negative predictive values (PPV and NPV) and Cohen's kappa. Paired t-test, Pearson's correlation coefficient and Bland-Altman plots were used to validate birthweight, stratified by mother's level of education, parity, birth year and child's asthma status. Child's gender and caesarean section showed high degree of validity (kappa = 0.99, sensitivity and specificity 100%). Instrumental delivery and extremely preterm birth showed good agreement with sensitivity 75-92%. Preterm birth and induction of labour showed moderate agreement. Post term delivery was poorly reported. The validity appeared to be independent of recall time over 45 years, and of the child's asthma status. Maternally reported birth and pregnancy information is feasible and cheap, showed high validity for important birth and pregnancy parameters, and showed similar risk-associations compared to registry data.	[Skulstad, Svein Magne; Bertelsen, Randi Jacobsen; Real, Francisco Gomez] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Skulstad, Svein Magne] Haukeland Hosp, Dept Immunol & Transfus Med, Bergen, Norway; [Igland, Jannicke; Lonnebotn, Marianne] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Johannessen, Ane; Bertelsen, Randi Jacobsen; Svanes, Cecilie] Univ Bergen, Ctr Int Hlth, Bergen, Norway; [Lonnebotn, Marianne; Svanes, Cecilie] Haukeland Hosp, Dept Occupat Med, Bergen, Norway; [Omenaas, Ernst Reidar] Haukeland Hosp, Ctr Clin Res, Bergen, Norway; [Real, Francisco Gomez] Haukeland Hosp, Dept Obstet & Gynecol, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	Skulstad, SM (corresponding author), Univ Bergen, Dept Clin Sci, Bergen, Norway.; Skulstad, SM (corresponding author), Haukeland Hosp, Dept Immunol & Transfus Med, Bergen, Norway.	svein.skulstad@k2.uib.no	Svanes, Cecilie/N-7556-2017; Bertelsen, Randi J/N-6917-2017	Svanes, Cecilie/0000-0001-8512-5192; Bertelsen, Randi J/0000-0001-5319-525X; Johannessen, Ane/0000-0003-3269-8354; Skulstad, Svein Magne/0000-0003-4841-4328; Gomez Real, Francisco/0000-0001-5407-3270	Research Council of Norway [214123, 230827, 228174]; Bergen Medical Research Foundation; Western Norway Regional Health Authority; Norwegian Labour Inspection; Norwegian Asthma and Allergy Association; European Union [633212];  [912011];  [911892];  [911631]	Research Council of Norway(Research Council of Norway); Bergen Medical Research Foundation; Western Norway Regional Health Authority; Norwegian Labour Inspection; Norwegian Asthma and Allergy Association; European Union(European Commission); ; ; 	This work was funded by The Research Council of Norway (Grants No. 214123, 230827 and 228174) to CS, URL: http://www.forskringsracet.no/en/Home_page/1177315753906; The Bergen Medical Research Foundation, URL: http://htstiflelse.no; Western Norway Regional Health Authority. (Grants No. 912011, 911892 and 911631) to CS, URL: wwv.nsd.uib.no/polsys/data/en/forvaltning/enhet/7678; The Norwegian Labour Inspection, URL: http://www.arbeidstilsynet.no/working-Conditions-romayttml?tid=240097; The Norwegian Asthma and Allergy Association to CS, URL: www.naaf.no/english/; The European Union's Horizon 2020 research and innovation programme under grant agreement No 633212 to CS, URL: https://emegropmeu/programmes/horizon2020/enitags/horizon-2020-research-and-innovation-programme.	Adegboye ARA, 2008, BJOG-INT J OBSTET GY, V115, P886, DOI 10.1111/j.1471-0528.2008.01717.x; Baghestan E, 2007, ACTA OBSTET GYN SCAN, V86, P205, DOI 10.1080/00016340601111364; BARKER DJP, 1991, BRIT MED J, V303, P671, DOI 10.1136/bmj.303.6804.671; Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; Engeland A, 2009, ACTA OBSTET GYN SCAN, V88, P1083, DOI 10.1080/00016340903128454; FORSDAHL A, 1977, BRIT J PREV SOC MED, V31, P91; Gresham E, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0597-x; Johannessen A, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-63; Klungsoyr K, 2014, PAEDIATR PERINAT EP, V28, P362, DOI 10.1111/ppe.12138; Kristensen P, 2000, ACTA OBSTET GYN SCAN, V79, P471, DOI 10.1034/j.1600-0412.2000.079006471.x; O'Sullivan JJ, 2000, ARCH DIS CHILD, V82, P202, DOI 10.1136/adc.82.3.202; Olson JE, 1997, AM J EPIDEMIOL, V145, P58; Overbeek A, 2013, HUM REPROD, V28, P819, DOI 10.1093/humrep/des405; Quigley MA, 2007, BJOG-INT J OBSTET GY, V114, P195, DOI 10.1111/j.1471-0528.2006.01203.x; Rice F, 2007, EARLY HUM DEV, V83, P497, DOI 10.1016/j.earlhumdev.2006.09.015; Svanes C, 2008, INDOOR AIR, V18, P84, DOI 10.1111/j.1600-0668.2008.00523.x; Tehranifar P, 2009, AM J EPIDEMIOL, V170, P910, DOI 10.1093/aje/kwp205; Thomsen LCV, 2013, ACTA OBSTET GYN SCAN, V92, P943, DOI 10.1111/aogs.12159; Troude P, 2008, EUR J EPIDEMIOL, V23, P557, DOI 10.1007/s10654-008-9268-9; Vikanes A, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-115; World Health Organization, 1992, INT STAT CLASS DIS R	21	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0181794	10.1371/journal.pone.0181794	http://dx.doi.org/10.1371/journal.pone.0181794			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28783742	Green Published, Green Submitted, gold			2022-12-26	WOS:000406944300014
J	Tokuda, S; Hirai, T; Furuse, M				Tokuda, Shinsaku; Hirai, Toyohiro; Furuse, Mikio			Claudin-4 knockout by TALEN-mediated gene targeting in MDCK cells: Claudin-4 is dispensable for the permeability properties of tight junctions in wild-type MDCK cells	PLOS ONE			English	Article							ZONULAE-OCCLUDENTES; EPITHELIAL-CELLS; EXPRESSION; OCCLUDIN; CATION; CONDUCTANCE; SELECTIVITY; TRANSPORT; MEMBRANE; PROTEIN	Epithelia act as a barrier between the internal and external environments, and the movement of substances via the paracellular pathway is regulated by tight junctions (TJs). Claudins are major determinants of TJ permeability. Claudin-4 was the first claudin whose involvement in the TJ permeability in cultured cells was directly demonstrated, but the permeability properties of individual claudins including claudin-4 are still incompletely clarified. In this study, we established claudin-4 knockout cells using transcription activator-like effector nucleases (TALENs), a recently developed method for genome editing, and investigated the permeability property of claudin-4 in MDCK II cells. We found that claudin-4 knockout has no apparent effect on the localization of other claudins and electrophysiological properties in MDCK II cells. Therefore we further established claudin-2 and claudin-4 double knockout clones and investigated the effects on TJs. Claudin-4 knockout in addition to claudin-2 knockout slightly increased the localization of other claudins at TJs but showed no obvious effects on the electrophysiological properties in MDCK II cells. These results indicate that claudin-4 is dispensable for the barrier property of TJs in wild-type as well as claudin-2 knockout MDCK II cells. Our results suggest the need for further knockout analysis to reveal the permeability properties of individual claudins.	[Tokuda, Shinsaku; Hirai, Toyohiro] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan; [Furuse, Mikio] Natl Inst Physiol Sci, Div Cell Struct, Okazaki, Aichi, Japan; [Furuse, Mikio] SOKENDAI, Dept Physiol Sci, Okazaki, Aichi, Japan	Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan	Tokuda, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan.	tokku@kuhp.kyotosu.ac.ju		Furuse, Mikio/0000-0003-2847-8156	Japan Society for the Promotion of Science [16K21101, 26291043]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science, 16K21101, http://www.jsps.go.jp/, ST; and the Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science, 26291043, http://www.jsps.go.jp/, MF.	Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; CLAUDE P, 1973, J CELL BIOL, V58, P390, DOI 10.1083/jcb.58.2.390; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Furuse M, 1999, J CELL BIOL, V147, P891, DOI 10.1083/jcb.147.4.891; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Grau J, 2013, BIOINFORMATICS, V29, P2931, DOI 10.1093/bioinformatics/btt501; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Hou JH, 2006, J BIOL CHEM, V281, P36117, DOI 10.1074/jbc.M608853200; ITOH M, 1991, J CELL BIOL, V115, P1449, DOI 10.1083/jcb.115.5.1449; KIMIZUKA H, 1964, J THEOR BIOL, V6, P290, DOI 10.1016/0022-5193(64)90035-9; Larre I, 2010, P NATL ACAD SCI USA, V107, P11387, DOI 10.1073/pnas.1000500107; McCarthy KM, 2000, J CELL SCI, V113, P3387; Milatz S, 2010, BBA-BIOMEMBRANES, V1798, P2048, DOI 10.1016/j.bbamem.2010.07.014; Mineta K, 2011, FEBS LETT, V585, P606, DOI 10.1016/j.febslet.2011.01.028; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; POWELL DW, 1981, AM J PHYSIOL, V241, pG275, DOI 10.1152/ajpgi.1981.241.4.G275; Reuss L., 2001, TIGHT JUNCTIONS, V2, P61; Saitou M, 1997, EUR J CELL BIOL, V73, P222; STAEHELIN LA, 1973, J CELL SCI, V13, P763; Tokuda S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166904; Tokuda S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145522; Tokuda S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119869; Tokuda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104994; Tokuda S, 2010, BIOCHEM BIOPH RES CO, V393, P390, DOI 10.1016/j.bbrc.2010.02.002; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Van Itallie C, 2001, J CLIN INVEST, V107, P1319, DOI 10.1172/JCI12464; Van Itallie CM, 2003, AM J PHYSIOL-RENAL, V285, pF1078, DOI 10.1152/ajprenal.00116.2003; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Wu CJ, 2013, J BIOL CHEM, V288, P12253, DOI 10.1074/jbc.M113.457499; Yu ASL, 2010, J BIOL CHEM, V285, P37060, DOI 10.1074/jbc.M110.146621; Yu ASL, 2009, J GEN PHYSIOL, V133, P111, DOI 10.1085/jgp.200810154	36	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0182521	10.1371/journal.pone.0182521	http://dx.doi.org/10.1371/journal.pone.0182521			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28777806	Green Published, gold, Green Submitted			2022-12-26	WOS:000406944300038
J	Bos, RA; Plettenburg, DH				Bos, Ronald A.; Plettenburg, Dick H.			Design of a cosmetic glove stiffness compensation mechanism for toddler-sized hand prostheses	PLOS ONE			English	Article							VOLUNTARY CLOSING HAND; LIMB PROSTHESES; EFFICIENCY	The addition of a cosmetic glove to an upper limb prosthesis has a distinct effect on the cosmetic value, but its viscoelastic behaviour adds a substantial amount of stiffness and hysteresis to the system. As a result, the overall usability of the prosthesis is degraded. A novel negative stiffness element is designed to compensate for the cosmetic glove's stiffness. A combination of linear helical springs and the concept of rolling link mechanisms has resulted in a Rolling Stiffness Compensation Mechanism (RSCM). Results show that the RSCM is capable of exerting a progressive negative stiffness characteristic and can be built small enough to fit inside a 33 mm diameter wrist. Using the RSCM, an otherwise voluntary opening toddler-sized prosthesis is converted into a voluntary closing device, reducing maximum operation forces down to 40 N with a combined efficiency of 52%. Further adjustments to the design are possible to further improve the efficiency of the mechanism. Moreover, changes in geometric relations of the mechanism offers possibilities for a wide range of prostheses and other applications.	[Bos, Ronald A.; Plettenburg, Dick H.] Delft Univ Technol, Dept Biomech Engn, Delft, Netherlands	Delft University of Technology	Bos, RA; Plettenburg, DH (corresponding author), Delft Univ Technol, Dept Biomech Engn, Delft, Netherlands.	r.a.bos@tudelft.nl; d.h.plettenburg@tudelft.nl		Plettenburg, Dick/0000-0003-1022-5855				Biddiss EA, 2007, PROSTHET ORTHOT INT, V31, P236, DOI 10.1080/03093640600994581; Bilotto S, 1986, CLIN PROSTHETICS ORT, V10, P87; Cool JC, 2006, WERKTUIGKUNDIGE SYST; Corin J, 1987, CLIN PROSTHET ORTHOT, V11, P235; Darnall BD, 2005, ARCH PHYS MED REHAB, V86, P650, DOI 10.1016/j.apmr.2004.10.028; Datta D, 2004, CLIN REHABIL, V18, P172, DOI 10.1191/0269215504cr716oa; Davies E W, 1977, Prosthet Orthot Int, V1, P89; de Visser H, 2000, J REHABIL RES DEV, V37, P261; Dembo T, 1955, ARTIF LIMBS, P47; Desmond DM, 2007, J PSYCHOSOM RES, V62, P15, DOI 10.1016/j.jpsychores.2006.07.027; FILLAUER C, 1979, ORTHOTICS PROSTHET, V33, P30; Herder JL, 1998, J REHABIL RES DEV, V35, P201; Krouskop T A, 1974, Bull Prosthet Res, P411; Kuntz J.P, 1995, ROLLING LINK MECH; LeBlanc M., 1992, J ASS CHILD PROSTHET, V27, P70; Plettenburg D., 2006, UPPER EXTREMITY PROS; Plettenburg D. H., 2002, THESIS; Plettenburg D. H., 2003, TECHNOLOGY DISABILIT, V15, P85; Plettenburg DH, 2011, P MEC 11 C FRED NB C; Plettenburg DH, 2009, J PROSTHETICS ORTHOT, V21; Plettenburg DH, 2017, WILMER FRICTION WRIS; Shaperman J, 1995, PROSTHET ORTHOT INT, V19, P165; Smit G, 2013, J REHABIL RES DEV, V50, P723, DOI 10.1682/JRRD.2011.12.0238; Smit G, 2012, J REHABIL RES DEV, V49, P523, DOI 10.1682/JRRD.2011.07.0125; Smit G, 2010, PROSTHET ORTHOT INT, V34, P411, DOI 10.3109/03093646.2010.486390; Stevens P., 2011, THE O P EDGE; Tevema Technical Springs, 2017, PROD MOD; Tolou N, 2012, J MED DEVICES, V6, DOI 10.1115/1.4005781; Wijsman F, 2010, THESIS; Wilson PD., 1954, HUMAN LIMBS THEIR SU	30	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0183233	10.1371/journal.pone.0183233	http://dx.doi.org/10.1371/journal.pone.0183233			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD3KL	28800635	gold, Green Published, Green Submitted			2022-12-26	WOS:000407431800065
J	Sadh, K; Rai, P; Mallik, R				Sadh, Kritika; Rai, Priyanka; Mallik, Roop			Feeding-fasting dependent recruitment of membrane microdomain proteins to lipid droplets purified from the liver	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; CHOLESTEROL; FLOTILLINS; DOMAIN; RAFTS; ER; FUSION; ACCUMULATION; MITOCHONDRIA; TRAFFICKING	Lipid droplets (LDs) are cellular stores of neutral fat that facilitate lipid and protein trafficking in response to metabolic cues. Unlike other vesicles, the phospholipid membrane on the LD is a monolayer. Interestingly, this monolayer membrane has free cholesterol, and may therefore contain lipid microdomains that serve as a platform for assembling proteins involved in signal transduction, cell polarity, pathogen entry etc. In support of this, cell culture studies have detected microdomain-associated "raftophilic" proteins on LDs. However, the physiological significance of this observation has been unclear. Here we show that two proteins (Flotillin-1 and SNAP23) that bind to membrane microdomains associate differently with LDs purified from rat liver depending on the feeding/fasting state of the animal. Flotillin-1 increases on LDs in the fed state, possibly because LDs interact with the endoplasmic reticulum (ER), facilitating supply of flotillin-1 from ER to LDs. Interestingly, this increase in flotillin-1 is correlated with an increase in free cholesterol on the LDs in fed state. In opposite behaviour to flotillin-1, SNAP23 increases on LDs in the fasted state and this appears to mediate LD-mitochondria interactions. Such LD-mitochondria interactions may provide fatty acids to mitochondria for promoting beta-oxidation in hepatocytes in response to fasting. Our work brings out physiologically relevant aspects of lipid droplet biology that are different from, and may not be entirely possible to replicate and study in cell culture.	[Sadh, Kritika; Rai, Priyanka; Mallik, Roop] Tata Inst Fundamental Res, Dept Biol Sci, Bombay, Maharashtra, India	Tata Institute of Fundamental Research (TIFR)	Mallik, R (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Bombay, Maharashtra, India.	roop@tifr.res.in		mallik, roop/0000-0001-6820-6556	Tata Institute of Fundamental Research, Department of Atomic Energy; Wellcome Trust, Department of Biotechnology Alliance [IA/S/11/2500255, IA/E/11/1/500417]; Wellcome trust-Department of Biotechnology Alliance [IA/S/11/2500255, IA/E/11/1/500417]	Tata Institute of Fundamental Research, Department of Atomic Energy; Wellcome Trust, Department of Biotechnology Alliance; Wellcome trust-Department of Biotechnology Alliance	Funding provided by the Tata Institute of Fundamental Research, Department of Atomic Energy, and Wellcome Trust, Department of Biotechnology Alliance (grants IA/S/11/2500255 and IA/E/11/1/500417).; RM and PR acknowledge funding from the Wellcome trust-Department of Biotechnology Alliance (grants IA/S/11/2500255 and IA/E/11/1/500417). We thank Mukesh Kumar and Jagjeet Singh for help with experiments. The authors confirm that they have no conflict of interest. We thankfully acknowledge the services of the animal house facility at Tata Institute of Fundamental Research.	Andersson L, 2006, J CELL SCI, V119, P2246, DOI 10.1242/jcs.02941; Ando J, 2015, P NATL ACAD SCI USA, V112, P4558, DOI 10.1073/pnas.1418088112; Barak P, 2014, METHOD ENZYMOL, V540, P231, DOI 10.1016/B978-0-12-397924-7.00013-3; Barak P, 2013, NAT METHODS, V10, P68, DOI [10.1038/NMETH.2287, 10.1038/nmeth.2287]; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blouin CM, 2010, J LIPID RES, V51, P945, DOI 10.1194/jlr.M001016; Bodin S, 2014, J CELL SCI, V127, P5139, DOI 10.1242/jcs.159764; Bostrom P, 2005, ARTERIOSCL THROM VAS, V25, P1945, DOI 10.1161/01.ATV.0000179676.41064.d4; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Bradbury MW, 2006, AM J PHYSIOL-GASTR L, V290, pG194, DOI 10.1152/ajpgi.00413.2005; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Chitraju C, 2012, J LIPID RES, V53, P2141, DOI 10.1194/jlr.M028902; Cohen AW, 2004, DIABETES, V53, P1261, DOI 10.2337/diabetes.53.5.1261; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Dermine JF, 2001, J BIOL CHEM, V276, P18507, DOI 10.1074/jbc.M101113200; Enrich C, 2015, J CELL SCI, V128, P1071, DOI 10.1242/jcs.164459; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Fujimoto T, 2001, J CELL BIOL, V152, P1079, DOI 10.1083/jcb.152.5.1079; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; Ge LA, 2011, P NATL ACAD SCI USA, V108, P551, DOI 10.1073/pnas.1014434108; Herms A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8176; Hodges BDM, 2010, J LIPID RES, V51, P262, DOI 10.1194/jlr.R003582; Jagerstrom S, 2009, CELL BIOL INT, V33, P934, DOI 10.1016/j.cellbi.2009.06.011; Krahmer N, 2013, EMBO MOL MED, V5, P973, DOI 10.1002/emmm.201100671; Laude AJ, 2004, MOL MEMBR BIOL, V21, P193, DOI 10.1080/09687680410001700517; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Liu Y.X., 2014, BIOMED RES INT, V2014; Makino A, 2016, MOL BIOL CELL, V27, P3293, DOI 10.1091/mbc.E15-10-0730; Meister M, 2014, MEMBRANES-BASEL, V4, P356, DOI 10.3390/membranes4030356; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Murray JW, 2002, ANAL BIOCHEM, V305, P55, DOI 10.1006/abio.2002.5655; Rai A, 2016, CELL, V164, P722, DOI 10.1016/j.cell.2015.12.054; Rajendran L, 2005, J CELL SCI, V118, P1099, DOI 10.1242/jcs.01681; Rajendran L, 2007, BIOL CHEM, V388, P307, DOI 10.1515/BC.2007.034; Rambold AS, 2015, DEV CELL, V32, P678, DOI 10.1016/j.devcel.2015.01.029; Reuter A, 2004, CELL MOL LIFE SCI, V61, P2092, DOI 10.1007/s00018-004-4193-x; Robenek MJ, 2004, FASEB J, V18, P866, DOI 10.1096/fj.03-0782fje; ROGERS KS, 1980, J NUTR, V110, P248; Salaun C, 2005, J BIOL CHEM, V280, P1236, DOI 10.1074/jbc.M410674200; Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200; Sollner TH, 2007, NAT CELL BIOL, V9, P1219, DOI 10.1038/ncb1107-1219; Suzuki M, 2015, MOL BIOL CELL, V26, P2333, DOI 10.1091/mbc.E14-11-1504; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; Tacer KF, 2011, J LIPIDS, V2011, DOI 10.1155/2011/783976; Takahashi K, 2010, J LIPID RES, V51, P2571, DOI 10.1194/jlr.M004648; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; TOUSTER O, 1970, J CELL BIOL, V47, P604, DOI 10.1083/jcb.47.3.604; Umlauf E, 2004, J BIOL CHEM, V279, P23699, DOI 10.1074/jbc.M310546200; Vock R, 1996, J EXP BIOL, V199, P1689; Wang H, 2007, J BIOL CHEM, V282, P33218, DOI 10.1074/jbc.M706841200; Wang MY, 2016, BBA-MOL CELL BIOL L, V1861, P410, DOI 10.1016/j.bbalip.2016.02.018; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Wustner D, 2009, CELLULAR LIPID METABOLISM, P157, DOI 10.1007/978-3-642-00300-4_6; Ye J, 2009, CELL METAB, V9, P177, DOI 10.1016/j.cmet.2008.12.013	55	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0183022	10.1371/journal.pone.0183022	http://dx.doi.org/10.1371/journal.pone.0183022			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800633	Green Submitted, gold, Green Published			2022-12-26	WOS:000407431800045
J	Du, JH; Tu, R; Zeng, Y; Pan, L; Zhang, RC				Du, Jian-Hua; Tu, Ran; Zeng, Yi; Pan, Leng; Zhang, Ren-Cheng			An experimental study on the thermal characteristics and heating effect of arc-fault from Cu core in residential electrical wiring fires	PLOS ONE			English	Article								The characteristics of a series direct current (DC) arc-fault including both electrical and thermal parameters were investigated based on an arc-fault simulator to provide references for multi-parameter electrical fire detection method. Tests on arc fault behavior with three different initial circuit voltages, resistances and arc gaps were conducted, respectively. The influences of circuit conditions on arc dynamic image, voltage, current or power were interpreted. Also, the temperature rises of electrode surface and ambient air were studied. The results showed that, first, significant variations of arc structure and light emitting were observed under different conditions. A thin outer burning layer of vapor generated from electrodes with orange light was found due to the extremely high arc temperature. Second, with the increasing electrode gap in discharging, the arc power was shown to have a non monotonic relationship with arc length for constant initial circuit voltage and resistance. Finally, the temperature rises of electrode surface caused by heat transfer from arc were found to be not sensitive with increasing arc length due to special heat transfer mechanism. In addition, temperature of ambient air showed a large gradient in radial direction of arc.	[Du, Jian-Hua; Tu, Ran; Pan, Leng; Zhang, Ren-Cheng] Huaqiao Univ, Coll Mech Engn & Automat, Xiamen, Fujian, Peoples R China; [Zeng, Yi] Huaqiao Univ, Coll Tourism, Quanzhou, Fujian, Peoples R China	Huaqiao University; Huaqiao University	Tu, R (corresponding author), Huaqiao Univ, Coll Mech Engn & Automat, Xiamen, Fujian, Peoples R China.	turan@hqu.edu.cn			National Natural Science Foundation of China [51506059]; Fujian Science and Technology Plan Leading Project [2017Y0064]; Quanzhou SSP Project [2016E13]; Science and Technology Research of Huaqiao University [ZQN-PY403]; Huaqiao University Scientific Research Foundation [14BS305, 16BS801]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fujian Science and Technology Plan Leading Project; Quanzhou SSP Project; Science and Technology Research of Huaqiao University; Huaqiao University Scientific Research Foundation	This work was supported by the National Natural Science Foundation of China (No. 51506059), Fujian Science and Technology Plan Leading Project (No. 2017Y0064), Quanzhou SSP Project (No. 2016E13), Promotion Program for Young and Middle-aged Teacher in Science and Technology Research of Huaqiao University (No. ZQN-PY403) and Huaqiao University Scientific Research Foundation (No. 14BS305 & No. 16BS801). The authors thankfully acknowledge all these supports.	Babrauskas V, 2001, P FIRE MAT, P39; Celik T, 2009, FIRE SAFETY J, V44, P147, DOI 10.1016/j.firesaf.2008.05.005; Courty L, 2017, J HAZARD MATER, V321, P528, DOI 10.1016/j.jhazmat.2016.09.042; Gregory GD, 2004, IEEE T IND APPL, V40, P1006, DOI 10.1109/TIA.2004.831287; Gregory GD, 1998, IEEE T IND APPL, V34, P928, DOI 10.1109/28.720431; Hall JR, 1996, US FIRE PROBLEM OVER; He H, 2016, J HAZARD MATER, V320, P628, DOI 10.1016/j.jhazmat.2016.07.070; Hu LH, 2015, P COMBUST INST, V35, P2607, DOI 10.1016/j.proci.2014.05.059; Johnson J., 2011, 2011 37th IEEE Photovoltaic Specialists Conference (PVSC 2011), P003614, DOI 10.1109/PVSC.2011.6185930; Lezama J, 2015, ELECTR POW SYST RES, V129, P227, DOI 10.1016/j.epsr.2015.08.005; Naidu M, 2006, IEEE T POWER ELECTR, V21, P633, DOI 10.1109/TPEL.2006.872385; Restrepo CE, 2007, Proceedings of the 53rd IEEE Holm Conference on Electrical Contacts, P115, DOI 10.1109/HOLM.2007.4318203; Shea JJ, 2011, FIRE MATER, V35, P19, DOI 10.1002/fam.1033; United States Fire Administration, 2006, SAF CIRC FACTSH HOM; Wang S.-C., 2012, INT J CIRCUITS SYST, V6, P324; Xie QY, 2010, J HAZARD MATER, V179, P373, DOI 10.1016/j.jhazmat.2010.03.015; Yan CG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133851; Yereance RA, 1995, ELECT FIRE ANAL	18	5	6	7	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182811	10.1371/journal.pone.0182811	http://dx.doi.org/10.1371/journal.pone.0182811			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797055	gold, Green Published, Green Submitted			2022-12-26	WOS:000407396200100
J	Shinkai, H; Yamamoto, M; Tatebe, M; Iwatsuki, K; Kurimoto, S; Hirata, H				Shinkai, Hiroki; Yamamoto, Michiro; Tatebe, Masahiro; Iwatsuki, Katsuyuki; Kurimoto, Shigeru; Hirata, Hitoshi			Non-invasive volumetric analysis of asymptomatic hands using a 3-D scanner	PLOS ONE			English	Article							UPPER-EXTREMITY VOLUME; WATER DISPLACEMENT; LASER SCANNER; LIMB VOLUME; ARM VOLUME; EDEMA; RELIABILITY; LYMPHEDEMA; ACCURACY; WOMEN	Hand swelling is one of the symptoms often seen in practice, but none of the available morphometric methods can quickly and efficiently quantify hand volume in an objective manner, and the current gold-standard volume measurement requires immersion in water, which can be difficult to use. Therefore, we aimed to analyze the accuracy of using 3-dimensional (3-D) scanning to measure hand volume. First, we compared the hand volume calculated using the 3-D scanner to that calculated from the conventional method among 109 volunteers to determine the reliability of 3-D measurements. We defined the beginning of the hand as the distal wrist crease, and 3-D forms of the hands were captured by the 3-D scanning system. Second, 238 volunteers (87 men, 151 women) with no disease or history of hand surgery underwent 3-D scanning. Data collected included age, height, weight, and shoe size. The wrist circumference (WC) and the distance between distal wrist crease and tip of middle finger (DDT) were measured. Statistical analyses were performed using linear regression to investigate the relationship between the hand volume and these parameters. In the first study, a significantly strong positive correlation was observed [R = 0.98] between the hand volume calculated via 3-D scanning and that calculated via the conventional method. In the second study, no significant differences between the volumes, WC or DDT of right and left hands were found. The correlations of hand volume with weight, WC, and DDT were strong. We created a formula to predict the hand volume using these parameters; these variables explained approximately 80% of the predicted volume. We confirmed that the new 3-D scanning method, which is performed without touching the hand and can record the form of the hand, yields an accurate volumetric analysis of an asymptomatic hand.	[Shinkai, Hiroki; Yamamoto, Michiro; Tatebe, Masahiro; Iwatsuki, Katsuyuki; Kurimoto, Shigeru; Hirata, Hitoshi] Nagoya Univ, Grad Sch Med, Dept Hand Surg, Nagoya, Aichi, Japan	Nagoya University	Shinkai, H (corresponding author), Nagoya Univ, Grad Sch Med, Dept Hand Surg, Nagoya, Aichi, Japan.	shinnkai.3@gmail.com						[Anonymous], GO SCAN 3D; Armer JM, 2013, CURR BREAST CANCER R, V5, P134, DOI 10.1007/s12609-013-0105-0; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brodovicz KG, 2009, CLIN MED RES, V7, P21, DOI 10.3121/cmr.2009.819; Buffa R, 2015, SENSORS-BASEL, V15, P12342, DOI 10.3390/s150612342; Cau N, 2016, J VASC SURG-VENOUS L, V4, P64, DOI 10.1016/j.jvsv.2015.05.005; De Mits S, 2012, ARTHRIT CARE RES, V64, P1641, DOI 10.1002/acr.21794; Deltombe T, 2007, LYMPHOLOGY, V40, P26; DENNING DW, 1990, POSTGRAD MED J, V66, P363, DOI 10.1136/pgmj.66.775.363; Edgar D, 2008, J BURN CARE RES, V29, P994, DOI 10.1097/BCR.0b013e31818b9e97; ENGLER H S, 1962, Am Surg, V28, P465; Fan YF, 2014, MED PHYS, V41, DOI 10.1118/1.4895847; Hameeteman M, 2016, J PLAST RECONSTR AES, V69, P241, DOI 10.1016/j.bjps.2015.10.011; Harden RN, 2013, PAIN MED, V14, P180, DOI 10.1111/pme.12033; Karges JR, 2003, PHYS THER, V83, P134, DOI 10.1093/ptj/83.2.134; Kovacs L, 2006, IEEE T MED IMAGING, V25, P742, DOI 10.1109/TMI.2006.873624; Kovacs L, 2007, BREAST, V16, P137, DOI 10.1016/j.breast.2006.08.001; McKinnon JG, 2007, J SURG ONCOL, V96, P381, DOI 10.1002/jso.20790; Megens AM, 2001, ARCH PHYS MED REHAB, V82, P1639, DOI 10.1053/apmr.2001.26822; Menz HB, 2014, J FOOT ANKLE RES, V7, DOI 10.1186/1757-1146-7-3; RAJA C, 1978, HUM BIOL, V50, P103; Rosin M, 2002, J CLIN PERIODONTOL, V29, P240, DOI 10.1034/j.1600-051x.2002.290310.x; Sagen A, 2005, ARCH PHYS MED REHAB, V86, P86, DOI 10.1016/j.apmr.2003.12.042; Toon CD, 2015, COCHRANE DB SYST REV, V7, P1; Villeco JP, 2012, J HAND THER, V25, P153, DOI 10.1016/j.jht.2011.09.008	25	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182675	10.1371/journal.pone.0182675	http://dx.doi.org/10.1371/journal.pone.0182675			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796816	Green Published, Green Submitted, gold			2022-12-26	WOS:000407396200077
J	Trukhanova, IS; Grachev, AI; Somov, AG; Burkanov, VN; Laidre, KL; Boveng, PL				Trukhanova, Irina S.; Grachev, Aleksey I.; Somov, Aleksandr G.; Burkanov, Vladimir N.; Laidre, Kristin L.; Boveng, Peter L.			The commercial harvest of ice-associated seals in the Sea of Okhotsk, 1972-1994	PLOS ONE			English	Article							PHOCA-HISPIDA	Sealing log books from 75 out of 79 commercial harvest cruises carried out between 1972 and 1994 in the Sea of Okhotsk, Russia, were analyzed to describe spatial and temporal allocation of ice-associated seal harvest effort, species composition of catches, total harvest rates, and related parameters for species including ringed (Pusa hispida), ribbon (Histriophoca fasciata), bearded (Erignathus barbatus) and spotted (Phoca largha) seal. Variations in catch per unit effort were explored in relation to year, sea ice conditions, day of the year, and geographic location. In most years, the harvest was predominantly represented by ringed seals (mean = 0.43, range 0.25-0.67), followed by ribbon (mean = 0.31, range 0.15-0.43), spotted (mean = 0.19, range 0.11-0.35) and bearded seals (mean = 0.07, range 0.03-0.14). The struck-and-lost percentages were as high as 30-35% for ringed, bearded and spotted seals and 15-20% for ribbon seals. Catch per unit effort (number of seals/skiff*day) for ringed, ribbon, and spotted seals had a similar seasonal pattern with a distinct spike in catches for spotted seals in the first week of May, for ribbon seals in the last week of May, and for ringed seals in the second week of June. Catches of bearded seals showed a less pronounced temporal structure with a gradual increase toward the end of the harvest season in the majority of years. Spatial distribution of harvest effort followed closely with seal distribution obtained from aerial surveys. These data could be used as a source of information on seal herd location throughout the breeding and molting seasons and for more complex demographic or life-table models. We did not find any evidence of the decline of catch per unit effort over the study period. Timely introduction of state regulations and efficient harvest management apparently prevented severe depletion of ice-associated seal populations in the Sea of Okhotsk during the periods of their intense exploitation.	[Trukhanova, Irina S.; Laidre, Kristin L.] Univ Washington, Appl Phys Lab, Polar Sci Ctr, Seattle, WA 98105 USA; [Trukhanova, Irina S.; Burkanov, Vladimir N.; Boveng, Peter L.] NOAA, Marine Mammal Lab, Alaska Fisheries Sci Ctr, Seattle, WA 98115 USA; [Grachev, Aleksey I.] Magadan Res Inst Fisheries & Oceanog MagadanNIRO, Lab Coastal Resources, Magadan, Russia; [Somov, Aleksandr G.] Russian Fed Res Inst Fisheries & Oceanog VNIRO, Lab Marine Mammals, Moscow, Russia; [Burkanov, Vladimir N.] Russian Acad Sci, Kamchatka Branch, Pacific Geog Inst Far East Branch, Petropavlovsk Kamchatski, Russia	University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA; Research lnstitute of Fisheries & Oceanography; Research lnstitute of Fisheries & Oceanography; Pacific Geographical Institute of the Far Eastern Branch of the Russian Academy of Sciences; Russian Academy of Sciences	Trukhanova, IS (corresponding author), Univ Washington, Appl Phys Lab, Polar Sci Ctr, Seattle, WA 98105 USA.; Trukhanova, IS (corresponding author), NOAA, Marine Mammal Lab, Alaska Fisheries Sci Ctr, Seattle, WA 98115 USA.	irinatr@uw.edu	; Burkanov, Vladimir/C-3116-2012	Trukhanova, Irina/0000-0001-9058-4481; Burkanov, Vladimir/0000-0002-0129-7884	National Oceanic and Atmospheric Administration (NOAA) [NA150AR4320063]; University of Washington (UW); Future of Ice Initiative [624832]; Marine Mammal Council, Russia through grant from U.S. Marine Mammal Commission	National Oceanic and Atmospheric Administration (NOAA)(National Oceanic Atmospheric Admin (NOAA) - USA); University of Washington (UW)(University of Washington); Future of Ice Initiative; Marine Mammal Council, Russia through grant from U.S. Marine Mammal Commission	The funding, as salary for IT, was provided by the National Oceanic and Atmospheric Administration (NOAA) through cooperative agreement NA150AR4320063 with the University of Washington (UW), and by the Future of Ice Initiative (budget number 624832). PB's salary was paid by NOM. No other authors received funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Mikhail Zasypkin, Irina Zasypkina and Yevgeny Dubinin from the Russian Academy of Sciences, Institute of Biological Problems of the North for converting hard copies of the sealing log books into digital format with financial support provided by Marine Mammal Council, Russia through grant from U.S. Marine Mammal Commission. We thank Yuriy Bukhtiyarov for providing photographs for the supporting information. We thank two anonymous reviewers for providing constructive feedback which helped to improve the manuscript. In-kind contribution to this work was provided by North Pacific Wildlife Consulting, LLC. The findings and conclusions in the paper are those of the authors and do not necessarily represent the views of the National Marine Fisheries Service. Reference to trade names does not imply endorsement by the National Marine Fisheries Service, NOAA.	[Anonymous], 2021, LANG ENV STAT COMP; Antropova VV, 1971, CULTURE EVERYDAY LIF; Augustin NH, 2012, COMPUT STAT DATA AN, V56, P2404, DOI 10.1016/j.csda.2012.01.026; Boveng P. L., 2009, NMFSAFSC200 NOAA US; Boveng P.L., 2008, NMFSAFSC191 NOAA US; Cameron MF, 2010, NMFSAFSC211 NOAA US; Fedoseev G.A., 1997, Izvestiya Tikhookeanskogo Nauchno-Issledovatel'skogo Rybokhozyaistvennogo Tsentra, V122, P95; Fedoseev G.A., 1984, P130; Fedoseev G.A., 1973, Izvestiya tikhookean nauchno-issled Inst ryb Khoz Okeanogr, V86, P148; Fedoseev G. A., 2000, POPULATION BIOL ICE; Fedoseev GA, 1966, THESIS; Fedoseev GA, 1968, PINNIPEDS N PACIFIC, V68, P180; Fedoseev GA, 1991, 010113 TINRO; Fedoseev GA, 1981, 0605 TINRO; Fedoseev GA, 1986, 142403074010103H2 TI; Fedoseev GA, 1966, IZV TINRO, P129; Fedoseev GA, 1979, 519 TINRO; Fedoseev GA, 2005, MONOGRAPH MAGADANNIR; Fedoseev GA, 1969, P 4 ALL UN C STUD MA, P119; Fedoseev GA, 1983, 142403074010103H2 TI; Fedoseev GA, 1965, IZV TINRO, V65, P212; Fedoseev GA, 1989, RESULTS AERIAL SURVE; Fedoseev GA, 1979, POPULATION STRUCTURE; Grachev AI, 2006, 4 INT C MAR MAMM HOL, P155; Harkonen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043130; Kelly BP, 2010, STATUS REV RINGED SE; Kosygin GM, 1971, ISSLEDOVANIYA MORSKI, P238; Kovacs KM, 1996, J MAMMAL, V77, P1085, DOI 10.2307/1382789; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; LYDERSEN C, 1989, POLAR BIOL, V9, P489, DOI 10.1007/BF00261031; Mineev VN, 1975, 5 REUN C INT EXPL ME, V169, P550; Pikharev GA, 1941, IZV TINRO, V20, P62; QGIS Development Team, 2015, QGIS GEOGR INF SYST; Sipila T, 2002, PRESENT STATUS RECOM, P15; SMITH TG, 1975, CAN J ZOOL, V53, P1297, DOI 10.1139/z75-155; TIKHOMIROV E. A., 1966, IZV TIKHOOKEAN NAUCH ISSLED INST RYB OKEANOGR, V58, P105; Trukhin Alexey M., 2009, PICES Scientific Report, V36, P82; Trukhin AM, 2005, VLADIVOSTOK; Walsh J.E., 2015, GRIDDED MONTHLY SEA, DOI 10.7265/N5833PZ5; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	41	1	1	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182725	10.1371/journal.pone.0182725	http://dx.doi.org/10.1371/journal.pone.0182725			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796843	Green Submitted, Green Published, gold			2022-12-26	WOS:000407396200089
J	Jiang, JZ; Zhao, W; Liu, GF; Wang, JY				Jiang, Jing-Zhe; Zhao, Wang; Liu, Guang-Feng; Wang, Jiang-Yong			Relationships between and formation dynamics of the microbiota of consumers, producers, and the environment in an abalone aquatic system	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; BACTERIAL COMMUNITIES; GUT MICROBIOME; SUCCESSION; BIOFILMS; CHINA; MILK	An ecosystem is a community comprising living and nonliving components of the environment. Microbes are ubiquitous elements in each of these components. The dynamics of microbiota formation in an ecosystem is important to elucidate, because how the different components of a system exchange microbes, and how the microbes control ecological processes remain unresolved. In this study, an abalone, Haliotis diversicolor, seed-nursing pond was used as a model system. We first examined changes in bacterial communities during the seedling cultivation of this herbivorous juvenile aquatic invertebrate animal. Denaturing gradient gel electrophoresis (DGGE) and pyrosequencing were used to analyze bacterial community dynamics and spatio-temporal interactions of different system components: consumers (abalone), producers (algae or a substrate), and the environment (water). DGGE fingerprints revealed that the developmental stages of abalone influences bacterial communities of both the abalone and substrate. Although the communities in water fluctuated daily, they could be divided into two clusters that coincided with abalone stages, reflecting the transition from larva to juvenile at around day 21. Pyrosequencing showed that the microbiota in the abalone and substrate had more operational taxonomic units in common than that of either with water. The Bray-Curtis similarity index was used to quantify the formation dynamics of microbiota among the various components of the system. The bacterial communities in producers and consumers showed similar changes. These communities were unstable at the beginning and then slowly stabilized over time. The environmental bacterial community was more stable than the bacterial communities in consumers and producers, and may have been the basis for stability in the system. Our research provides insights into the dynamics of microbiota formation in various biotic elements of a system that will contribute to predictive systems modeling.	[Jiang, Jing-Zhe; Liu, Guang-Feng; Wang, Jiang-Yong] Chinese Acad Fishery Sci, South China Sea Fisheries Res Inst, Key Lab Aquat Prod Proc, Minist Agr, Guangzhou, Guangdong, Peoples R China; [Zhao, Wang] Chinese Acad Fishery Sci, South China Sea Fisheries Res Inst, Trop Fisheries Res & Dev Ctr, Sanya, Peoples R China	Chinese Academy of Fishery Sciences; South China Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Fishery Sciences	Jiang, JZ; Wang, JY (corresponding author), Chinese Acad Fishery Sci, South China Sea Fisheries Res Inst, Key Lab Aquat Prod Proc, Minist Agr, Guangzhou, Guangdong, Peoples R China.	jingzhejiang@scsfri.ac.cn; wjy104@163.com	Jiang, Jing-Zhe/CAI-9184-2022	Jiang, Jing-Zhe/0000-0001-5260-7822	Central Public-interest Scientific Institution Basal Research Fund, CAFS [2016RC-LX05]; Earmarked Fund for Modern Agro-industry Technology Research System [CARS-48]; Pearl River S&T Nova Program of Guangzhou [2014J2200018]; Guangdong Special Support Program [00-201620641]	Central Public-interest Scientific Institution Basal Research Fund, CAFS; Earmarked Fund for Modern Agro-industry Technology Research System; Pearl River S&T Nova Program of Guangzhou; Guangdong Special Support Program	This work was supported by the Central Public-interest Scientific Institution Basal Research Fund, CAFS (2016RC-LX05), the Earmarked Fund for Modern Agro-industry Technology Research System (CARS-48), the Pearl River S&T Nova Program of Guangzhou (2014J2200018), and the Guangdong Special Support Program (00-201620641).	Amin SA, 2012, MICROBIOL MOL BIOL R, V76, P667, DOI 10.1128/MMBR.00007-12; BELL W, 1972, BIOL BULL, V143, P265, DOI 10.2307/1540052; BLOOM SA, 1981, MAR ECOL PROG SER, V5, P125, DOI 10.3354/meps005125; Bowler C, 2009, NATURE, V459, P180, DOI 10.1038/nature08056; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; BuchholzCleven BEE, 1997, SYST APPL MICROBIOL, V20, P301, DOI 10.1016/S0723-2020(97)80077-X; Campbell AH, 2011, BIOFOULING, V27, P255, DOI 10.1080/08927014.2011.560384; Chapin III F.S., 2012, PRINCIPLES TERRESTRI, V2nd; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Favier CF, 2002, APPL ENVIRON MICROB, V68, P219, DOI 10.1128/AEM.68.1.219-226.2002; Ingerslev HC, 2014, AQUACULTURE, V12; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Krebs C., 1978, ECOLOGY EXPT ANAL DI; Lee MJ, 2016, INT J FOOD MICROBIOL, V234, P45, DOI 10.1016/j.ijfoodmicro.2016.06.032; Li YF, 2014, INT BIODETER BIODEGR, V96, P41, DOI 10.1016/j.ibiod.2014.08.012; Liu JJ, 2014, SOIL BIOL BIOCHEM, V70, P113, DOI 10.1016/j.soilbio.2013.12.014; Lokmer A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01367; Lokmer A, 2016, ENVIRON MICROBIOL, V18, P970, DOI 10.1111/1462-2920.13163; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Martin R, 2009, APPL ENVIRON MICROB, V75, P965, DOI 10.1128/AEM.02063-08; Martin V, 2012, J HUM LACT, V28, P36, DOI 10.1177/0890334411424729; Matamoros S, 2013, TRENDS MICROBIOL, V21, P167, DOI 10.1016/j.tim.2012.12.001; McFrederick QS, 2017, MICROB ECOL, V1, P13; Morelli L, 2008, J NUTR; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Thomas JC, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00149; Fernandez NT, 2014, FEMS MICROBIOL ECOL, V88, P69, DOI 10.1111/1574-6941.12270; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; WEST PA, 1979, J APPL BACTERIOL, V46, P269, DOI 10.1111/j.1365-2672.1979.tb00820.x; You WW, 2010, AQUAC RES, V41, P921, DOI 10.1111/j.1365-2109.2009.02376.x; Zhang GF, 2004, J SHELLFISH RES, V23, P947; [赵旺 Zhao Wang], 2013, [中国水产科学, Journal of Fishery Sciences of China], V20, P1225	36	6	6	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182590	10.1371/journal.pone.0182590	http://dx.doi.org/10.1371/journal.pone.0182590			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28787009	Green Published, Green Submitted, gold			2022-12-26	WOS:000406998800048
J	Lu, JH; Liu, SL				Lu, Jianhua; Liu, Shuli			Influence of acclimation to sublethal temperature on heat tolerance of Tribolium castaneum (Herbst) (Coleoptera: Tenebrionidae) exposed to 50 degrees C	PLOS ONE			English	Article							RED FLOUR BEETLE; THERMAL DEATH KINETICS; STORED-PRODUCT INSECTS; RHYZOPERTHA-DOMINICA F; SITOPHILUS-ORYZAE; LIFE STAGES; CURCULIONIDAE; MORTALITY; DISINFESTATION; BOSTRYCHIDAE	Tribolium castaneum (Herbst) (Coleoptera: Tenebrionidae) is a serious pest of stored agricultural products and one of the most common insects found in grain storage and food processing facilities. Heat treatment has been revisited to control stored-product insects as a potential alternative to methyl bromide for disinfesting mills and food-processing facilities. The influence of acclimation of T. castaneum adults, pupae, larvae, and eggs to sublethal temperatures of 36, and 42 degrees C on their subsequent susceptibility to lethal temperature of 50 degrees C was respectively investigated. The acclimation of T. castaneum eggs, larvae, pupae, and adults to 36, and 42 degrees C significantly decreased their subsequent susceptibility to lethal high temperature of 50 degrees C. The influence of acclimation to 42 degrees C was significantly greater than that of acclimation to 36 degrees C. The most influential acclimation times at 45 degrees C for mortality of T. castaneum eggs, larvae, pupae, and adults were 15, 5, 5, and 5 h, respectively, and their corresponding mortality were 41.24, 5.59, 20.19, and 4.48%, compared to 100% mortality of T. castaneum eggs, larvae, pupae, and adults without acclimation when exposed to 50 degrees C for 35 min, respectively. The present results have important implications for developing successful heat treatment protocols to control T. castaneum, improving disinfestation effectiveness of heat treatment and understanding insect response to high temperatures.	[Lu, Jianhua; Liu, Shuli] Henan Univ Technol, Sch Food Sci & Technol, Prov Key Lab Transformat & Utilizat Cereal Resour, Zhengzhou, Henan, Peoples R China	Henan University of Technology	Lu, JH (corresponding author), Henan Univ Technol, Sch Food Sci & Technol, Prov Key Lab Transformat & Utilizat Cereal Resour, Zhengzhou, Henan, Peoples R China.	jianhlv@163.com			National Natural Science Foundation of China [U1604115]; National Program on Key R D Project [2016YFD0401005]; Key Technologies R & D Program of the Education Department of Henan Province [16A210017]; Collaborative Innovation Center of Grain Storage and Security in Henan Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program on Key R D Project; Key Technologies R & D Program of the Education Department of Henan Province; Collaborative Innovation Center of Grain Storage and Security in Henan Province	This research was supported by National Natural Science Foundation of China (No. U1604115), National Program on Key R & D Project (No. 2016YFD0401005), Key Technologies R & D Program of the Education Department of Henan Province (No. 16A210017) and the Collaborative Innovation Center of Grain Storage and Security in Henan Province to JL.	Addo-Bediako A, 2002, FUNCT ECOL, V16, P332, DOI 10.1046/j.1365-2435.2002.00634.x; Angilletta MJ, 2010, PHYSIOL BIOCHEM ZOOL, V83, P197, DOI 10.1086/648567; [Anonymous], 1925, J ECON ENTOMOL; Arthur FH, 2006, J STORED PROD RES, V42, P1, DOI 10.1016/j.jspr.2004.10.003; Beckett SJ, 2007, HEAT TREATMENTS FOR POSTHARVEST PEST CONTROL: THEORY AND PRACTICE, P182, DOI 10.1079/9781845932527.0182; Beckett SJ, 1998, J STORED PROD RES, V34, P363, DOI 10.1016/S0022-474X(98)00022-8; Bennett AF, 1997, EVOLUTION, V51, P36, DOI 10.1111/j.1558-5646.1997.tb02386.x; CHOWN SL, 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1016/J.JSPR.2004.10.003; Dowdy AK, 1999, J STORED PROD RES, V35, P175, DOI 10.1016/S0022-474X(98)00043-5; Emekci M, 2002, J STORED PROD RES, V38, P413, DOI 10.1016/S0022-474X(01)00045-5; EVANS DE, 1981, J STORED PROD RES, V17, P65, DOI 10.1016/0022-474X(81)90018-7; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Fields PG, 2002, ANNU REV ENTOMOL, V47, P331, DOI 10.1146/annurev.ento.47.091201.145217; FIELDS PG, 1992, J STORED PROD RES, V28, P89, DOI 10.1016/0022-474X(92)90018-L; Frederick JL, 2016, THESIS; GONEN M, 1977, ENTOMOL EXP APPL, V21, P243, DOI 10.1007/BF00291786; Hazell SP, 2008, PHYSIOL ENTOMOL, V33, P389, DOI 10.1111/j.1365-3032.2008.00637.x; Huey Raymond B., 2010, P223, DOI 10.1017/CBO9780511675997.010; JEMBERE B, 1995, B ENTOMOL RES, V85, P361, DOI 10.1017/S0007485300036099; Jin Z., 2011, SCI TECHNOL CEREALS, V19, P1; Johnson JA, 2004, J ECON ENTOMOL, V97, P1868, DOI 10.1603/0022-0493-97.6.1868; Jovanovic Z, 2007, IND CROP PROD, V26, P100, DOI 10.1016/j.indcrop.2007.01.010; Ju RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054372; Kim HG, 2015, J INSECT PHYSIOL, V76, P47, DOI 10.1016/j.jinsphys.2015.03.008; Lachenicht MW, 2010, J INSECT PHYSIOL, V56, P822, DOI 10.1016/j.jinsphys.2010.02.010; Li W, 2015, J STORED PROD RES, V62, P52, DOI 10.1016/j.jspr.2015.04.001; Liu ZL, 1999, J STORED PROD RES, V35, P317, DOI 10.1016/S0022-474X(99)00015-6; Lu JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159400; Ma G, 2012, J INSECT PHYSIOL, V58, P303, DOI 10.1016/j.jinsphys.2011.09.003; Mahroof R, 2005, J ECON ENTOMOL, V98, P626, DOI 10.1603/0022-0493-98.2.626; Mahroof R, 2003, J ECON ENTOMOL, V96, P1345, DOI 10.1603/0022-0493-96.4.1345; Mahroof R, 2003, J STORED PROD RES, V39, P555, DOI 10.1016/S0022-474X(02)00062-0; MAHROOF R, 2004, THESIS; Neven LG, 2000, POSTHARVEST BIOL TEC, V21, P103, DOI 10.1016/S0925-5214(00)00169-1; Opit GP, 2011, J ECON ENTOMOL, V104, P1415, DOI 10.1603/EC11104; Piyaphongkul J, 2014, AGR FOREST ENTOMOL, V16, P174, DOI 10.1111/afe.12047; RAJENDRAN S, 1994, INT J PEST MANAGE, V40, P207, DOI 10.1080/09670879409371883; Roesli R, 2003, J STORED PROD RES, V39, P521, DOI 10.1016/S0022-474X(02)00058-9; SHELLIE KC, 1994, HORTSCIENCE, V29, P1524, DOI 10.21273/HORTSCI.29.12.1524; Tilley DR, 2007, J STORED PROD RES, V43, P221, DOI 10.1016/j.jspr.2006.04.005; Tungjitwitayakul J, 2015, J ECON ENTOMOL, V108, P1313, DOI 10.1093/jee/tov051; Wang S, 2005, J STORED PROD RES, V41, P469, DOI 10.1016/j.jspr.2004.07.003; Wijayaratne LKW, 2010, J STORED PROD RES, V46, P166, DOI 10.1016/j.jspr.2010.04.001; Yan RJ, 2014, J STORED PROD RES, V59, P231, DOI 10.1016/j.jspr.2014.03.006	44	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182269	10.1371/journal.pone.0182269	http://dx.doi.org/10.1371/journal.pone.0182269			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28786992	gold, Green Published, Green Submitted			2022-12-26	WOS:000406998800023
J	Tang, YJ; Wang, XQ; Zhang, SB; Duan, SC; Qing, WX; Chen, G; Ye, F; Le, Y; Ouyang, W				Tang, Yujie; Wang, Xueqin; Zhang, Shuibing; Duan, Shangchun; Qing, Wenxiang; Chen, Gong; Ye, Feng; Le, Yuan; Ouyang, Wen			Pre-existing weakness is critical for the occurrence of postoperative cognitive dysfunction in mice of the same age	PLOS ONE			English	Article							SYSTEMIC INFLAMMATION; SYNAPTIC PLASTICITY; ELDERLY-PATIENTS; SURGERY; DECLINE; MICROGLIA; DYSREGULATION; VULNERABILITY; IMPAIRMENT; ACTIVATION	Occurrence of postoperative cognitive dysfunction (POCD) is age-dependent and heterogenous. Factors deciding the occurrence of POCD in patients of the same age undergone same surgeries remain unclear. Here we investigated the effects of pre-existing weakness on the occurrence of POCD in mice of the same age. Pre-existing weakness of mice was induced by intraperitoneal injection of lipopolysaccharide (8mg/kg) and was evaluated by physical frailty index (by open field test), neuroinflammation level (by Iba1 immunostaining and inflammatory factors TNF-alpha and IL-1 beta), and neuronal activity (by p-CREB immunostaining). POCD was induced by partial hepatolobectomy and was evaluated by puzzle box test and Morris water maze test. The brains were collected to detect the levels of neuroinflammation, synaptophysin and NMDA receptor subunits NR2A, NR2B and NR1 (by western blot), and oxidative stress (by Dihydroethidium). Compared to the normal adult mice of the same age, LPS pretreated mice had increased physical frailty index, higher levels of neuroinflammation, and lower neuronal activity. Partial hepatolobectomy induced obvious impairments in executive function, learning and memory in LPS pretreated mice after surgery, but not in normal mice of the same age. Partial hepatolobectomy also induced heightened neuroinflammation, obvious loss of NMDA receptor subunits, strong oxidative stress in LPS pretreated mice on the 1(st) and 3(rd) postoperative day. However, the POCD-associated pathological changes didn't occur in normal mice of the same age after surgery. These results suggest that preexisting weakness is critical for the occurrence of POCD in mice of the same age.	[Tang, Yujie; Zhang, Shuibing; Duan, Shangchun; Qing, Wenxiang; Chen, Gong; Le, Yuan; Ouyang, Wen] Cent S Univ, Xiangya Hosp 3, Dept Anesthesiol, Changsha, Hunan, Peoples R China; [Wang, Xueqin] Cent S Univ, Xiangya Hosp 3, Ctr Med Expt, Changsha, Hunan, Peoples R China; [Ye, Feng] Chongqing Med Univ, Affiliated Hosp 2, Key Lab Mol Biol Infect Dis, Minist Educ China, Chongqing, Peoples R China	Central South University; Central South University; Chongqing Medical University; Ministry of Education, China	Le, Y; Ouyang, W (corresponding author), Cent S Univ, Xiangya Hosp 3, Dept Anesthesiol, Changsha, Hunan, Peoples R China.	leyuanxy@126.com; ouyangwen133@vip.sina.com			National Natural Science Foundation of China [81400896, 81371216, 31270028]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (YL No. 81400896, WOY No. 81371216, FY No. 31270028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benito E, 2010, TRENDS NEUROSCI, V33, P230, DOI 10.1016/j.tins.2010.02.001; Brummel N.E., 2016, AM J RESP CRIT CARE; Cerbai F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045250; Chen MH, 2013, J ANESTH, V27, P487, DOI 10.1007/s00540-012-1548-6; Cibelli M, 2010, ANN NEUROL, V68, P360, DOI 10.1002/ana.22082; Fidalgo AR, 2011, NEUROSCI LETT, V498, P63, DOI 10.1016/j.neulet.2011.04.063; Goddard SL, 2016, JAMA-J AM MED ASSOC, V315, P2671, DOI 10.1001/jama.2016.7211; Hansen RT, 2013, BRAIN RES, V1516, P93, DOI 10.1016/j.brainres.2013.04.033; He HJ, 2012, CNS NEUROSCI THER, V18, P994, DOI 10.1111/cns.12018; Jones C, 2013, MINERVA ANESTESIOL, V79, P1306; Julio-Amilpas A, 2015, J CEREBR BLOOD F MET, V35, P851, DOI 10.1038/jcbfm.2015.1; Kochlamazashvili G, 2010, J NEUROSCI, V30, P4171, DOI 10.1523/JNEUROSCI.5806-09.2010; Laalou FZ, 2008, J CHIR-PARIS, V145, P323, DOI 10.1016/S0021-7697(08)74310-2; Le Y, 2014, NEUROINFLAMMATION ME, V9; Le Y, 2014, AGING DIFFERENTIALLY, V9; Li YP, 2015, ARCH IMMUNOL THER EX, V63, P305, DOI 10.1007/s00005-015-0333-2; Liang XY, 2013, BRAIN RES, V1494, P109, DOI 10.1016/j.brainres.2012.11.046; Liao YR, 2015, LIFE SCI, V137, P89, DOI 10.1016/j.lfs.2015.07.015; Lin GX, 2014, ACTA ANAESTH SCAND, V58, P668, DOI 10.1111/aas.12320; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Messerotti Benvenuti S, 2012, PSYCHOSOM MED, V74, P73, DOI 10.1097/PSY.0b013e3182383a94; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; Monk TG, 2008, ANESTHESIOLOGY, V108, P18, DOI 10.1097/01.anes.0000296071.19434.1e; Monk TG, 2011, CURR OPIN CRIT CARE, V17, P376, DOI 10.1097/MCC.0b013e328348bece; Norden DM, 2013, NEUROPATH APPL NEURO, V39, P19, DOI 10.1111/j.1365-2990.2012.01306.x; Patterson SL, 2015, NEUROPHARMACOLOGY, V96, P11, DOI 10.1016/j.neuropharm.2014.12.020; Qiu LL, 2016, BRAIN BEHAV IMMUN, V51, P109, DOI 10.1016/j.bbi.2015.08.002; Ramaiah Ramesh, 2009, Anesthesiol Clin, V27, P485, DOI 10.1016/j.anclin.2009.07.011; Rasmussen LS, 2001, ACTA ANAESTH SCAND, V45, P275, DOI 10.1034/j.1399-6576.2001.045003275.x; Schmidt K, 2016, JAMA-J AM MED ASSOC, V315, P2703, DOI 10.1001/jama.2016.7207; Silbert B, 2015, ANESTHESIOLOGY, V122, P1224, DOI 10.1097/ALN.0000000000000671; Terrando N, 2011, MAYO CLIN PROC, V86, P885, DOI 10.4065/mcp.2011.0332; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; Tian A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141596; Vacas S, 2013, BRIT MED BULL, V106, P161, DOI 10.1093/bmb/ldt006; Waite A, 2010, BRIT J ANAESTH, V104, P768, DOI 10.1093/bja/aeq093; Whitehead JC, 2014, J GERONTOL A-BIOL, V69, P621, DOI 10.1093/gerona/glt136; Xu ZP, 2014, SCI REP-UK, V4, DOI 10.1038/srep03766; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; Yin S, 2015, PLOS ONE, V10; Zhang X, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0592-9; Zhang XQ, 2013, J NEUROSCI, V33, P17737, DOI 10.1523/JNEUROSCI.2049-13.2013; Zheng YB, 2016, CLIN CHIM ACTA, V455, P149, DOI 10.1016/j.cca.2016.02.007; Zurek AA, 2016, ANN CLIN TRANSL NEUR, V3, P392, DOI 10.1002/acn3.303	44	9	12	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182471	10.1371/journal.pone.0182471	http://dx.doi.org/10.1371/journal.pone.0182471			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28787017	Green Submitted, gold, Green Published			2022-12-26	WOS:000406998800041
J	Kostyak, JC; Liverani, E; Kunapuli, SP				Kostyak, John C.; Liverani, Elisabetta; Kunapuli, Satya P.			PKC-epsilon deficiency alters progenitor cell populations in favor of megakaryopoiesis	PLOS ONE			English	Article							KINASE-C-EPSILON; SIGNAL-TRANSDUCTION; MEGAKARYOCYTE PLOIDY; IN-VIVO; THROMBOPOIETIN; ACTIVATION; DIFFERENTIATION; INTERLEUKIN-11; PROLIFERATION; EXPRESSION	Background It has long been postulated that Protein Kinase C (PKC) is an important regulator of megakaryopoiesis. Recent contributions to the literature have outlined the functions of several individual PKC isoforms with regard to megakaryocyte differentiation and platelet production. However, the exact role of PKCe remains elusive. Objective To delineate the role of PKCe in megakaryopoiesis. Approach and results We used a PKCe knockout mouse model to examine the effect of PKCe deficiency on platelet mass, megakaryocyte mass, and bone marrow progenitor cell distribution. We also investigated platelet recovery in PKCe null mice and TPO-mediated signaling in PKCe null megakaryocytes. PKCe null mice have higher platelet counts due to increased platelet production compared to WT littermate controls (p<0.05, n = 8). Furthermore, PKCe null mice have more bone marrow megakaryocyte progenitor cells than WT littermate control mice. Additionally, thrombopoietin-mediated signaling is perturbed in PKCe null mice as Akt and ERK1/2 phosphorylation are enhanced in PKCe null megakaryocytes stimulated with thrombopoietin. Finally, in response to immune-induced thrombocytopenia, PKCe null mice recovered faster and had higher rebound thrombocytosis than WT littermate control mice. Conclusions Enhanced platelet recovery could be due to an increase in megakaryocyte progenitor cells found in PKCe null mice as well as enhanced thrombopoietin-mediated signaling observed in PKCe deficient megakaryocytes. These data suggest that PKCe is a negative regulator of megakaryopoiesis.	[Kostyak, John C.; Kunapuli, Satya P.] Temple Univ, Lewis Katz Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19122 USA; [Liverani, Elisabetta] Temple Univ, Lewis Katz Sch Med, Ctr Inflammat Translat & Clin Lung Res, Philadelphia, PA 19122 USA; [Kunapuli, Satya P.] Temple Univ, Lewis Katz Sch Med, Dept Pharmacol, Philadelphia, PA 19122 USA; [Kunapuli, Satya P.] Temple Univ, Lewis Katz Sch Med, Dept Physiol, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Kunapuli, SP (corresponding author), Temple Univ, Lewis Katz Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19122 USA.; Kunapuli, SP (corresponding author), Temple Univ, Lewis Katz Sch Med, Dept Pharmacol, Philadelphia, PA 19122 USA.; Kunapuli, SP (corresponding author), Temple Univ, Lewis Katz Sch Med, Dept Physiol, Philadelphia, PA 19122 USA.	spk@temple.edu	Liverani, Elisabetta/AAR-4132-2021	Liverani, Elisabetta/0000-0001-5540-0456	National Institutes of Health, National Heart, Lung, and Blood Institute [HL93231, HL118593]; American Heart Association [17SDG33370020, 16SDG26980003]	National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association)	This work was supported by the National Institutes of Health, National Heart, Lung, and Blood Institute (https://www.nhlbi.nih.gov) grant HL93231 and HL118593 to SPK and the American Heart Association (www.heart.org) grant 17SDG33370020) to JCK and 16SDG26980003 to EL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balduini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021015; BROUDY VC, 1995, BLOOD, V85, P1719, DOI 10.1182/blood.V85.7.1719.bloodjournal8571719; Bynagari-Settipalli YS, 2012, ARTERIOSCL THROM VAS, V32, P1211, DOI 10.1161/ATVBAHA.111.242388; Carubbi C, 2016, HAEMATOLOGICA; Chari R, 2009, BLOOD, V114, P3056, DOI 10.1182/blood-2008-11-188516; Chari R, 2009, ARTERIOSCL THROM VAS, V29, P699, DOI 10.1161/ATVBAHA.109.184010; Di Marcantonio D, 2015, EXP CELL RES, V339, P10, DOI 10.1016/j.yexcr.2015.09.017; Drachman JG, 1999, J BIOL CHEM, V274, P13480, DOI 10.1074/jbc.274.19.13480; Filippi MD, 2002, BLOOD, V99, P1174, DOI 10.1182/blood.V99.4.1174; Gobbi G, 2007, STEM CELLS, V25, P2322, DOI 10.1634/stemcells.2006-0839; Gobbi G, 2013, BLOOD, V122, P1305, DOI 10.1182/blood-2013-04-490599; Hitchcock IS, 2008, BLOOD, V111, P596, DOI 10.1182/blood-2007-05-089680; ISHIBASHI T, 1989, P NATL ACAD SCI USA, V86, P5953, DOI 10.1073/pnas.86.15.5953; Kinehara M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054122; Kosoff RE, 2015, BLOOD, V125, P2995, DOI 10.1182/blood-2014-10-604504; Kostyak JC, 2014, PLATELETS, P1; Kostyak JC, 2014, ARTERIOSCL THROM VAS, V34, P2579, DOI 10.1161/ATVBAHA.114.304492; Kostyak JC, 2012, BLOOD, V119, P838, DOI 10.1182/blood-2011-04-346098; Lannutti BJ, 2006, ONCOGENE, V25, P3316, DOI 10.1038/sj.onc.1209351; Liu RY, 1999, BLOOD, V93, P2369, DOI 10.1182/blood.V93.7.2369.407k18_2369_2379; Machlus KR, 2016, BLOOD, V127, P1468, DOI [10.1182/blood-2015-08663146, 10.1182/blood-2015-08-663146]; Majka M, 2002, EXP HEMATOL, V30, P751, DOI 10.1016/S0301-472X(02)00810-X; Moore SF, 2012, J BIOL CHEM; Nagy B, 2009, BLOOD, V113, P2557, DOI 10.1182/blood-2008-07-169268; Nakao T, 2008, CELL CYCLE, V7, P257, DOI 10.4161/cc.7.2.5148; Oshevski S, 1999, BIOCHEM BIOPH RES CO, V263, P603, DOI 10.1006/bbrc.1999.1425; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Sangkhae V, 2014, EXP HEMATOL, V42, P477, DOI 10.1016/j.exphem.2014.02.007; Shiroshita N, 2001, J PHARMACOL EXP THER, V297, P868; Singh A, 2013, J SKIN CANCER, V2013, DOI 10.1155/2013/452425; TERAMURA M, 1992, BLOOD, V79, P327; Travlos GS, 2006, TOXICOL PATHOL, V34, P548, DOI 10.1080/01926230600939856; Williams CM, 2011, J THROMB HAEMOST, V9, P2457, DOI 10.1111/j.1538-7836.2011.04520.x; Williams CM, 2013, PLATELETS	34	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0182867	10.1371/journal.pone.0182867	http://dx.doi.org/10.1371/journal.pone.0182867			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28783756	Green Published, gold, Green Submitted			2022-12-26	WOS:000406944300061
J	Rahman, SS; Moffitt, AEJ; Trease, AJ; Foster, KW; Storck, MD; Band, H; Boesen, EI				Rahman, Shamma S.; Moffitt, Alexandra E. J.; Trease, Andrew J.; Foster, Kirk W.; Storck, Matthew D.; Band, Hamid; Boesen, Erika I.			EHD4 is a novel regulator of urinary water homeostasis	FASEB JOURNAL			English	Article						endocytic recycling; arginine vasopressin; aquaporin-2; aquaporin-4	KIDNEY COLLECTING DUCT; SHORT-TERM STIMULATION; THICK ASCENDING LIMB; AQP2 TRAFFICKING; SUBCELLULAR-LOCALIZATION; AQUAPORIN-2 TRAFFICKING; DIFFERENTIAL REGULATION; MEMBRANE TRANSLOCATION; CL-COTRANSPORTER; PLASMA-MEMBRANE	The Eps15-homology domain-containing (EHD) protein family comprises 4 members that regulate endocytic recycling. Although the kidney expresses all 4 EHD proteins, their physiologic roles are largely unknown. This study focused on EHD4, which we found to be expressed differentially across nephron segments with the highest expression in the innermedullary collecting duct. Under baseline conditions, Ehd42/2 [EHD4-knockout (KO)] mice on a C57Bl/6 background excreted a higher volume of more dilute urine than control C57Bl/6 wild-type (WT) mice while maintaining a similar plasma osmolality. Urine excretion after an acute intraperitoneal water load was significantly increased in EHD4-KO mice compared to WT mice, and although EHD4-KO mice concentrated their urine during 24-h water restriction, urinary osmolality remained significantly lower than in WT mice, suggesting that EHD4 plays a role in renal water handling. Total aquaporin 2 (AQP2) and phospho-S256-AQP2 (pAQP2) protein expression in the inner medulla was similar in the two groups in baseline conditions. However, localization of both AQP2 and pAQP2 in the renal innermedullary principal cells appeared more dispersed, and the intensity of apical membrane staining for AQP2 was reduced significantly (by similar to 20%) in EHD4-KO mice compared to WT mice in baseline conditions, suggesting an important role of EHD4 in trafficking of AQP2. Together, these data indicate that EHD4 play important roles in the regulation of water homeostasis.-Rahman, S. S., Moffitt, A. E. J., Trease, A. J., Foster, K. W., Storck, M. D., Band, H., Boesen, E. I. EHD4 is a novel regulator of urinary water homeostasis.	[Rahman, Shamma S.; Boesen, Erika I.] Univ Nebraska Med Ctr, Dept Cellular & Integrat Physiol, 985850 Nebraska Med Ctr,Room DRC1-5005, Omaha, NE 68198 USA; [Moffitt, Alexandra E. J.; Storck, Matthew D.; Band, Hamid] Univ Nebraska Med Ctr, Eppley Inst Res Canc, Omaha, NE 68198 USA; [Trease, Andrew J.; Band, Hamid] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Foster, Kirk W.; Band, Hamid] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA; [Band, Hamid] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA; [Band, Hamid] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA; [Band, Hamid] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Boesen, EI (corresponding author), Univ Nebraska Med Ctr, Dept Cellular & Integrat Physiol, 985850 Nebraska Med Ctr,Room DRC1-5005, Omaha, NE 68198 USA.; Band, H (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, 985950 Nebraska Med Ctr, Omaha, NE 68198 USA.	hband@unmc.edu; erika.boesen@unmc.edu	Rahman, Shamma/L-6142-2018; Band, Hamid/AAF-4701-2020	Rahman, Shamma/0000-0003-2588-4466; Storck, Matthew/0000-0002-4029-8943; Boesen, Erika/0000-0002-5672-9197; Trease, Andrew/0000-0003-4912-6926	American Heart Association [15PRE25580003]; U.S. National Institutes of Health (NIH) Institutional Development Award (IDeA); NIH National Institute of General Medical Sciences [P30 GM106397]; NIH National Cancer Institute (NCI) [CA105489]; NCI Core Support Grant; NATIONAL CANCER INSTITUTE [R01CA105489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106397] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); U.S. National Institutes of Health (NIH) Institutional Development Award (IDeA); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI Core Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the following people of the University of Nebraska Medical Center for technical assistance: Eileen Marks for collection of IMCD and cortical proximal and distal tubular cells; Bangchen Wang for collection of mTAL; Timothy Bielecki for transfection of mpkCCD cells with shRNA; and Kaushik Patel and Xuefei Liu for collection of hypothalamic tissue. This work was supported by Predoctoral Fellowship 15PRE25580003 from the American Heart Association (to S.S.R.); a U.S. National Institutes of Health (NIH) Institutional Development Award (IDeA); NIH National Institute of General Medical Sciences Grant P30 GM106397 (to E.B. and H.B.); NIH National Cancer Institute (NCI) Grant CA105489 (to H.B.); and an NCI Core Support Grant to the Fred and Pamela Buffett Cancer Center. The authors declare no conflicts of interest.	Adrogue HJ, 2000, NEW ENGL J MED, V342, P1493, DOI 10.1056/NEJM200005183422006; Arnspang EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073977; Bouley R, 2006, BIOL CELL, V98, P215, DOI 10.1042/BC20040054; Braun A, 2005, MOL BIOL CELL, V16, P3642, DOI 10.1091/mbc.E05-01-0076; Brown D, 2003, AM J PHYSIOL-RENAL, V284, pF893, DOI 10.1152/ajprenal.00387.2002; Bugaj V, 2009, AM J PHYSIOL-RENAL, V297, pF1411, DOI 10.1152/ajprenal.00371.2009; Butterworth MB, 2009, AM J PHYSIOL-RENAL, V296, pF10, DOI 10.1152/ajprenal.90248.2008; Chou CL, 1998, AM J PHYSIOL-CELL PH, V274, pC549, DOI 10.1152/ajpcell.1998.274.2.C549; Chukkapalli S, 2014, CARCINOGENESIS, V35, P877, DOI 10.1093/carcin/bgt399; Curran J, 2014, CIRC RES, V115, P68, DOI 10.1161/CIRCRESAHA.115.304149; Gao Y, 2016, AM J PHYSIOL-RENAL, V311, pF1074, DOI 10.1152/ajprenal.00494.2016; George M, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-3; George M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017838; George M, 2010, GENESIS, V48, P328, DOI 10.1002/dvg.20620; Gimenez I, 2003, J BIOL CHEM, V278, P26946, DOI 10.1074/jbc.M303435200; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Grant BD, 2008, TRAFFIC, V9, P2043, DOI 10.1111/j.1600-0854.2008.00834.x; Gudmundsson H, 2012, J MOL CELL CARDIOL, V52, P1183, DOI 10.1016/j.yjmcc.2012.02.008; Gudmundsson H, 2010, CIRC RES, V107, P84, DOI 10.1161/CIRCRESAHA.110.216713; Gunaratne R, 2010, P NATL ACAD SCI USA, V107, P15653, DOI 10.1073/pnas.1007424107; Hasler U, 2002, J BIOL CHEM, V277, P10379, DOI 10.1074/jbc.M111880200; Hendriks G, 2004, J BIOL CHEM, V279, P2975, DOI 10.1074/jbc.M310767200; Ho HTB, 2000, MOL CELL BIOL, V20, P5840, DOI 10.1128/MCB.20.16.5840-5846.2000; Knepper MA, 2015, NEW ENGL J MED, V372, P1349, DOI 10.1056/NEJMra1404726; KOHAN DE, 1993, AM J PHYSIOL, V265, pF670, DOI 10.1152/ajprenal.1993.265.5.F670; Lee JW, 2015, J AM SOC NEPHROL, V26, P2669, DOI 10.1681/ASN.2014111067; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mutig K, 2010, AM J PHYSIOL-RENAL, V298, pF502, DOI 10.1152/ajprenal.00476.2009; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Naslavsky N, 2011, TRENDS CELL BIOL, V21, P122, DOI 10.1016/j.tcb.2010.10.003; Nedvetsky PI, 2007, TRAFFIC, V8, P110, DOI 10.1111/j.1600-0854.2006.00508.x; Nejsum LN, 2005, AM J PHYSIOL-RENAL, V288, pF930, DOI 10.1152/ajprenal.00291.2004; Nielsen S, 1996, P NATL ACAD SCI USA, V93, P5495, DOI 10.1073/pnas.93.11.5495; NIELSEN S, 1995, P NATL ACAD SCI USA, V92, P1013, DOI 10.1073/pnas.92.4.1013; Noda Y, 2006, BBA-BIOMEMBRANES, V1758, P1117, DOI 10.1016/j.bbamem.2006.03.004; Norregaard R, 2011, AM J PHYSIOL-RENAL, V301, pF1303, DOI 10.1152/ajprenal.00665.2010; Park EJ, 2013, AM J PHYSIOL-RENAL, V304, pF958, DOI 10.1152/ajprenal.00469.2012; Rapaport D, 2006, TRAFFIC, V7, P52, DOI 10.1111/j.1600-0854.2005.00359.x; Rieg T, 2013, AM J PATHOL, V182, P96, DOI 10.1016/j.ajpath.2012.09.014; Russo LM, 2006, AM J PHYSIOL-RENAL, V291, pF246, DOI 10.1152/ajprenal.00437.2005; Sauter D, 2006, KIDNEY INT, V69, P1024, DOI 10.1038/sj.ki.5000211; Simone LC, 2014, HISTOL HISTOPATHOL, V29, P285, DOI 10.14670/HH-29.285; Tajika Y, 2005, HISTOCHEM CELL BIOL, V124, P1, DOI 10.1007/s00418-005-0010-3; Tamma G, 2005, J CELL SCI, V118, P3623, DOI 10.1242/jcs.02495; U.S. National Institutes of Health National Heart Lung and Blood Institute, KIDN SYST BIOL PROJ; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; Vesey David A., 2009, V466, P19, DOI 10.1007/978-1-59745-352-3_2; VINAY P, 1981, AM J PHYSIOL, V241, pF403, DOI 10.1152/ajprenal.1981.241.4.F403; Welling PA, 2010, PHYSIOLOGY, V25, P280, DOI 10.1152/physiol.00022.2010; Yang J, 2009, AM J PHYSIOL-RENAL, V297, pF1220, DOI 10.1152/ajprenal.00314.2009	50	2	2	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5217	5233		10.1096/fj.201601182RR	http://dx.doi.org/10.1096/fj.201601182RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28778975	Green Published			2022-12-26	WOS:000416588300009
J	Ruegsegger, GN; Grigsby, KB; Kelty, TJ; Zidon, TM; Childs, TE; Vieira-Potter, VJ; Klinkebiel, DL; Matheny, M; Scarpace, PJ; Booth, FW				Ruegsegger, Gregory N.; Grigsby, Kolter B.; Kelty, Taylor J.; Zidon, Terese M.; Childs, Thomas E.; Vieira-Potter, Victoria J.; Klinkebiel, David L.; Matheny, Michael; Scarpace, Phillip J.; Booth, Frank W.			Maternal Western diet age-specifically alters female offspring voluntary physical activity and dopamine- and leptin-related gene expression	FASEB JOURNAL			English	Article						obesity; nucleus accumbens; VTA; in utero reprogramming	HIGH-FAT DIET; MU-OPIOID RECEPTOR; ENERGY-EXPENDITURE; OBESITY; INACTIVITY; EXERCISE; SENSITIVITY; MODULATION; PREGNANCY; TERM	Prenatal overnutrition affects development into adulthood and influences risk of obesity. We assessed the transgenerational effect of maternal Western diet (WD) consumption on offspring physical activity. Voluntary wheel running was increased in juvenile (4-7 wk of age), but decreased in adult (16-19 wk of age), F-1 female WD offspring. In contrast, no wheel-running differences in F-1 male offspring were observed. Increased wheel running in juvenile female WD offspring was associated with up-regulated dopamine receptor (DRD)-1 and -2 in the nucleus accumbens (NAc) and with down-regulated Lepr in the ventral tegmental area (VTA). Conversely, decreased wheel running by adult female WD offspring was associated with down-regulated DRD1 in the NAc and with up-regulated Lepr in the VTA. Body fat, leptin, and insulin were increased in male, but not in female, F-1 WD offspring. Recombinant virus (rAAV) leptin antagonism in the VTA decreased wheel running in standard diet but not in WD F1 female offspring. Analysis of F-2 offspring found no differences in wheel running or adiposity in male or female offspring, suggesting that changes in the F1 generation were related to in uterosomatic reprogramming. Our findings indicate prenatal WD exposure leads to age-specific changes in voluntary physical activity in female offspring that are differentially influenced by VTA leptin antagonism.	[Ruegsegger, Gregory N.; Grigsby, Kolter B.; Kelty, Taylor J.; Childs, Thomas E.; Booth, Frank W.] Univ Missouri, Dept Biomed Sci, E102 Vet Med Bldg,1600 E Rollins St, Columbia, MO 65211 USA; [Zidon, Terese M.; Vieira-Potter, Victoria J.; Booth, Frank W.] Univ Missouri, Dept Nutr & Exercise Physiol, Columbia, MO 65211 USA; [Booth, Frank W.] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO 65211 USA; [Booth, Frank W.] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA; [Klinkebiel, David L.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA; [Matheny, Michael; Scarpace, Phillip J.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Nebraska System; University of Nebraska Medical Center; State University System of Florida; University of Florida	Booth, FW (corresponding author), Univ Missouri, Dept Biomed Sci, E102 Vet Med Bldg,1600 E Rollins St, Columbia, MO 65211 USA.	boothf@missouri.edu		Ruegsegger, Gregory/0000-0002-8018-0456	College of Veterinary Medicine at the University of Missouri; American Heart Association [AHA 16PRE2715005]; University of Missouri Life Sciences Program	College of Veterinary Medicine at the University of Missouri; American Heart Association(American Heart Association); University of Missouri Life Sciences Program	This work was supported by grants from the College of Veterinary Medicine at the University of Missouri (to G.N.R. and F.W.B), American Heart Association Grant AHA 16PRE2715005 (to G.N.R.), and funding from the University of Missouri Life Sciences Program (to G.N.R.). The authors declare no conflicts of interest.	Baker MS, 2015, INT J OBESITY, V39, P98, DOI 10.1038/ijo.2013.146; Beeler JA, 2016, BIOL PSYCHIAT, V79, P887, DOI 10.1016/j.biopsych.2015.07.009; Booth FW, 2012, COMPR PHYSIOL, V2, P1143, DOI 10.1002/cphy.c110025; Catalano PM, 2006, BJOG-INT J OBSTET GY, V113, P1126, DOI 10.1111/j.1471-0528.2006.00989.x; Cunha FD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118586; Dearden L, 2014, ENDOCRINOLOGY, V155, P2144, DOI 10.1210/en.2014-1131; Desai M, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.025; Domingos AI, 2011, NAT NEUROSCI, V14, P1562, DOI 10.1038/nn.2977; Dunn GA, 2011, ENDOCRINOLOGY, V152, P2228, DOI 10.1210/en.2010-1461; Dunn GA, 2011, HORM BEHAV, V59, P290, DOI 10.1016/j.yhbeh.2010.05.004; Eclarinal JD, 2016, FASEB J, V30, P2541, DOI 10.1096/fj.201500018R; Ferezou-Viala J, 2007, AM J PHYSIOL-REG I, V293, pR1056, DOI 10.1152/ajpregu.00117.2007; Fernandes MFA, 2015, CELL METAB, V22, P741, DOI 10.1016/j.cmet.2015.08.003; Friend DM, 2017, CELL METAB, V25, P312, DOI 10.1016/j.cmet.2016.12.001; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Garland T, 2011, J EXP BIOL, V214, P206, DOI 10.1242/jeb.048397; Giraudo SQ, 2010, PHARMACOL BIOCHEM BE, V97, P121, DOI 10.1016/j.pbb.2010.04.017; Heerwagen MJR, 2010, AM J PHYSIOL-REG I, V299, pR711, DOI 10.1152/ajpregu.00310.2010; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Howie GJ, 2009, J PHYSIOL-LONDON, V587, P905, DOI 10.1113/jphysiol.2008.163477; Johnson SA, 2017, J DEV ORIG HLTH DIS, V8, P75, DOI 10.1017/S2040174416000490; Khan LY, 2003, HYPERTENSION, V41, P168, DOI 10.1161/01.HYP.0000047511.97879.FC; Knab AM, 2010, INT J BIOL SCI, V6, P133; Kohl HW, 2012, LANCET, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Lawlor DA, 2011, CIRCULATION, V123, P258, DOI 10.1161/CIRCULATIONAHA.110.980169; Lecoutre S, 2016, J ENDOCRINOL, V230, P39, DOI 10.1530/JOE-16-0037; Li G, 2013, DIABETES, V62, P2773, DOI 10.2337/db12-1306; Matheny M, 2009, AM J PHYSIOL-REG I, V297, pR1254, DOI 10.1152/ajpregu.90449.2008; Meek TH, 2012, PHYSIOL BEHAV, V106, P252, DOI 10.1016/j.physbeh.2012.02.012; Mehta SH, 2012, J MATERN-FETAL NEO M, V25, P41, DOI 10.3109/14767058.2012.626927; Ong ZY, 2011, FASEB J, V25, P2167, DOI 10.1096/fj.10-178392; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Rhodes JS, 2005, INTEGR COMP BIOL, V45, P438, DOI 10.1093/icb/45.3.438; Rhodes JS, 2003, PSYCHOPHARMACOLOGY, V167, P242, DOI 10.1007/s00213-003-1399-9; Roberts MD, 2014, J PHYSIOL-LONDON, V592, P2119, DOI 10.1113/jphysiol.2013.268805; Roberts MD, 2013, AM J PHYSIOL-REG I, V304, pR1024, DOI 10.1152/ajpregu.00581.2012; Roberts MD, 2012, PHYSIOL BEHAV, V105, P661, DOI 10.1016/j.physbeh.2011.09.024; Rowland TW, 1998, MED SCI SPORT EXER, V30, P392, DOI 10.1097/00005768-199803000-00009; Ruegsegger GN, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00109; Ruegsegger GN, 2015, PHYSIOL BEHAV, V152, P47, DOI 10.1016/j.physbeh.2015.09.004; Ruegsegger GN, 2015, NEUROPHARMACOLOGY, V97, P171, DOI 10.1016/j.neuropharm.2015.05.022; Vickers MH, 2003, AM J PHYSIOL-REG I, V285, pR271, DOI 10.1152/ajpregu.00051.2003; Vucetic Z, 2012, J NEUROCHEM, V120, P891, DOI 10.1111/j.1471-4159.2012.07649.x; Vucetic Z, 2011, NEUROPSYCHOPHARMACOL, V36, P1199, DOI 10.1038/npp.2011.4; Vucetic Z, 2010, ENDOCRINOLOGY, V151, P4756, DOI 10.1210/en.2010-0505; White CL, 2009, AM J PHYSIOL-REG I, V296, pR1464, DOI 10.1152/ajpregu.91015.2008; Yogev Y, 2009, OBSTET GYN CLIN N AM, V36, pviii; Yogev Y, 2009, OBSTET GYN CLIN N AM, V36, P285, DOI 10.1016/j.ogc.2009.03.003	48	12	12	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5371	5383		10.1096/fj.201700389R	http://dx.doi.org/10.1096/fj.201700389R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28794174				2022-12-26	WOS:000416588300021
J	Makhtar, WRW; Browne, G; Karountzos, A; Stevens, C; Alghamdi, Y; Bottrill, AR; Mistry, S; Smith, E; Bushel, M; Pringle, JH; Sayan, AE; Tulchinsky, E				Makhtar, W. R. Wan; Browne, G.; Karountzos, A.; Stevens, C.; Alghamdi, Y.; Bottrill, A. R.; Mistry, S.; Smith, E.; Bushel, M.; Pringle, J. H.; Sayan, A. E.; Tulchinsky, E.			Short stretches of rare codons regulate translation of the transcription factor ZEB2 in cancer cells	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GENE-EXPRESSION; RNA GENES; POL II; PROTEIN; BINDING; SIP1; EMT; PROGRESSION; METASTASIS	Two proteins comprising the ZEB family of zinc finger transcription factors, ZEB1 and ZEB2, execute EMT programs in embryonic development and cancer. By studying regulation of their expression, we describe a novel mechanism that limits ZEB2 protein synthesis. A protein motif located at the border of the SMAD-binding domain of ZEB2 protein induces ribosomal pausing and compromises protein synthesis. The function of this protein motif is dependent on stretches of rare codons, Leu(UUA)-Gly(GGU)-Val (GUA). Incorporation of these triplets in the homologous region of ZEB1 does not affect protein translation. Our data suggest that rare codons have a regulatory role only if they are present within appropriate protein structures. We speculate that pools of transfer RNA available for protein translation impact on the configuration of epithelial mesenchymal transition pathways in tumor cells.	[Makhtar, W. R. Wan; Browne, G.; Karountzos, A.; Stevens, C.; Alghamdi, Y.; Pringle, J. H.; Tulchinsky, E.] Univ Leicester, Dept Canc Studies, Leicester, Leics, England; [Makhtar, W. R. Wan; Smith, E.; Bushel, M.] MRC Toxicol Unit, Leicester, Leics, England; [Bottrill, A. R.; Mistry, S.] Univ Leicester, Prot & Nucle Acid Chem Lab PNACL, Leicester, Leics, England; [Sayan, A. E.] Univ Southampton, Canc Sci Div, Tremona Rd, Southampton SO16 6YD, Hants, England; [Makhtar, W. R. Wan; Browne, G.; Karountzos, A.; Stevens, C.; Alghamdi, Y.; Pringle, J. H.; Tulchinsky, E.] Univ Sains Malaysia, Sch Med Sci, George Town, Malaysia	University of Leicester; University of Leicester; University of Southampton; Universiti Sains Malaysia	Sayan, AE (corresponding author), Univ Southampton, Canc Sci Div, Tremona Rd, Southampton SO16 6YD, Hants, England.; Tulchinsky, E (corresponding author), Univ Leicester, Dept Canc Studies, RKCSB, LRI, Leicester LE2 7LX, Leics, England.; Tulchinsky, E (corresponding author), Univ Sains Malaysia, Sch Med Sci, George Town, Malaysia.	A.E.Sayan@soton.ac.uk; et32@le.ac.uk	SAYAN, A. EMRE/H-7330-2012; Tulchinsky, Eugene/ABD-7070-2021; Bottrill, Andrew/ABD-1459-2021; Alghamdi, Yousef G/N-2061-2016	SAYAN, A. EMRE/0000-0002-5291-1485; Bottrill, Andrew/0000-0002-5182-3643; Alghamdi, Yousef G/0000-0003-2671-6771; WAN MAKHTAR, WAN RATMAAZILA/0000-0003-1630-2137; Smith, Ewan/0000-0002-3992-3748	Cancer Research UK [C8851/A10844]; Wellcome Trust ISSF Grant [RM60G0406]	Cancer Research UK(Cancer Research UK); Wellcome Trust ISSF Grant(Wellcome Trust)	This research was supported by a Cancer Research UK project grant C8851/A10844 (ET), and Wellcome Trust ISSF Grant RM60G0406 (ET).	Barski A, 2010, NAT STRUCT MOL BIOL, V17, P629, DOI 10.1038/nsmb.1806; BENNETZEN JL, 1982, J BIOL CHEM, V257, P3026; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Bushell M, 2006, MOL CELL, V23, P401, DOI 10.1016/j.molcel.2006.06.012; Canella D, 2012, GENOME RES, V22, P666, DOI 10.1101/gr.130286.111; Caramel J, 2013, CANCER CELL, V24, P466, DOI 10.1016/j.ccr.2013.08.018; Chaffer CL, 2016, CANCER METAST REV, V35, P645, DOI 10.1007/s10555-016-9648-7; David A, 2011, J BIOL CHEM, V286, P20688, DOI 10.1074/jbc.M110.209452; Denecker G, 2014, CELL DEATH DIFFER, V21, P1250, DOI 10.1038/cdd.2014.44; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Duret L, 2000, TRENDS GENET, V16, P287, DOI 10.1016/S0168-9525(00)02041-2; Gingold H, 2014, CELL, V158, P1281, DOI 10.1016/j.cell.2014.08.011; Gingold H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.14; Goodarzi H, 2016, CELL, V165, P1416, DOI 10.1016/j.cell.2016.05.046; GOUY M, 1982, NUCLEIC ACIDS RES, V10, P7055, DOI 10.1093/nar/10.22.7055; Harper KL, 2016, NATURE, V540, P588, DOI 10.1038/nature20609; Hill L, 2013, INT J CANCER, V132, P745, DOI 10.1002/ijc.27708; Kaminska M, 2009, J BIOL CHEM, V284, P13746, DOI 10.1074/jbc.M900480200; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Komar AA, 2009, TRENDS BIOCHEM SCI, V34, P16, DOI 10.1016/j.tibs.2008.10.002; Krebs AM, 2017, NAT CELL BIOL, V19, P518, DOI 10.1038/ncb3513; Kutter C, 2011, NAT GENET, V43, P948, DOI 10.1038/ng.906; Lampson BL, 2013, CURR BIOL, V23, P70, DOI 10.1016/j.cub.2012.11.031; Lander R, 2011, J CELL BIOL, V194, P17, DOI 10.1083/jcb.201012085; Liu YQ, 2008, DEVELOPMENT, V135, P579, DOI 10.1242/dev.007047; Long JY, 2005, J BIOL CHEM, V280, P35477, DOI 10.1074/jbc.M504477200; Mejlvang J, 2007, MOL BIOL CELL, V18, P4615, DOI 10.1091/mbc.E07-05-0406; Miyoshi T, 2006, DEV DYNAM, V235, P1941, DOI 10.1002/dvdy.20799; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Oler AJ, 2010, NAT STRUCT MOL BIOL, V17, P620, DOI 10.1038/nsmb.1801; Ozturk N, 2006, P NATL ACAD SCI USA, V103, P2178, DOI 10.1073/pnas.0510877103; Pavon-Eternod M, 2009, NUCLEIC ACIDS RES, V37, P7268, DOI 10.1093/nar/gkp787; Pershing NLK, 2015, J CLIN INVEST, V125, P222, DOI 10.1172/JCI77627; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Sayan AE, 2009, P NATL ACAD SCI USA, V106, P14884, DOI 10.1073/pnas.0902042106; Sha Z, 2009, MOL CELL, V36, P141, DOI 10.1016/j.molcel.2009.09.026; Tsimokha AS, 2017, J CELL PHYSIOL, V232, P842, DOI 10.1002/jcp.25492; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Vandewalle C, 2009, CELL MOL LIFE SCI, V66, P773, DOI 10.1007/s00018-008-8465-8; Wang F, 2015, BIOCHIMIE, V114, P127, DOI 10.1016/j.biochi.2015.02.006; Xu M, 2015, ONCOTARGET, V6, P979, DOI 10.18632/oncotarget.2825	41	19	20	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 23	2017	36	47					6640	6648		10.1038/onc.2017.273	http://dx.doi.org/10.1038/onc.2017.273			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FN5LN	28783176	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000416049200012
J	Zhong, ZJ; Tian, YN; Song, Y; Deng, L; Li, JX; Ren, ZH; Ma, XP; Gu, XB; He, CL; Geng, Y; Peng, GN				Zhong, Zhijun; Tian, Yinan; Song, Yuan; Deng, Lei; Li, Junxian; Ren, Zhihua; Ma, Xiaoping; Gu, Xiaobin; He, Changliang; Geng, Yi; Peng, Guangneng			Molecular characterization and multi-locus genotypes of Enterocytozoon bieneusi from captive red kangaroos (Macropus Rfus) in Jiangsu province, China	PLOS ONE			English	Article							GIARDIA-DUODENALIS; CRYPTOSPORIDIUM SPP.; SEQUENCE; PREVALENCE; HORSES; TOOL	Enterocytozoon bieneusi is the most common pathogen of microsporidian species infecting humans worldwide. Although E. bieneusi has been found in a variety of animal hosts, information on the presence of E. bieneusi in captive kangaroos in China is limited. The present study was aimed at determining the occurrence and genetic diversity of E. bieneusi in captive kangaroos. A total of 61 fecal specimens (38 from red kangaroos and 23 from grey kangaroos) were collected from Nanjing Hongshan Forest Zoo and Hongshan Kangaroo Breeding Research Base, Jiangsu province, China. Using the nested PCR amplification ITS gene of rRNA of E. bieneusi, totally 23.0% (14/61) of tested samples were PCR-positive with three genotypes (i.e. one known genotype, CHK1, and two novel genotypes, CSK1 and CSK2). Multi-locus sequence typing using three microsatellites (MS1, MS3, and MS7) and one minisatellite (MS4) revealed one, five, two, and one types at these four loci, respectively. In phylogenetic analysis, the two genotypes, CHK1 and CSK1, were clustered into a new group of unknown zoonotic potential, and the novel genotype CSK2 was clustered into a separate clade with PtEb and PtEbIX. To date, this is the first report on the presence of E. bieneusi in captive red kangaroos in Jiangsu province, China. Furthermore, a high degree of genetic diversity was observed in the E. bieneusi genotype and seven MLGs (MLG1-7) were found in red kangaroos. Our findings suggest that infected kangaroo may act as potential reservoirs of E. bieneusi and be source to transmit infections to other animal.	[Zhong, Zhijun; Tian, Yinan; Song, Yuan; Deng, Lei; Ren, Zhihua; Ma, Xiaoping; Gu, Xiaobin; He, Changliang; Geng, Yi; Peng, Guangneng] Sichuan Agr Univ, Coll Vet Med, Key Lab Anim Dis & Human Hlth Sichuan Prov, Chengdu, Sichuan, Peoples R China; [Li, Junxian] Nanjing Hongshan Forest Zoo, Nanjing, Jiangsu, Peoples R China	Key Laboratory of Animal Disease & Human Health of Sichuan Province; Sichuan Agricultural University	Peng, GN (corresponding author), Sichuan Agr Univ, Coll Vet Med, Key Lab Anim Dis & Human Hlth Sichuan Prov, Chengdu, Sichuan, Peoples R China.	pgn.sicau@163.com	Deng, Lei/AAB-5622-2020	Deng, Lei/0000-0003-0391-6180	National Natural Science Foundation of China [31272620]; National Key Research and Development Program of China [2016YFD0501009]; Chengdu Giant Panda Breeding Research Foundation [CPF2015-4]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Chengdu Giant Panda Breeding Research Foundation	Funding provided by National Natural Science Foundation of China-31272620, Prof. Guangneng Peng; National Key Research and Development Program of China-2016YFD0501009, Prof. Guangneng Peng; and the Chengdu Giant Panda Breeding Research Foundation-CPF2015-4, Zhijun Zhong.	Deng L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171772; Deng L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168631; Deng L, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1844-3; Deplazes P, 1996, J EUKARYOT MICROBIOL, V43, pS93, DOI 10.1111/j.1550-7408.1996.tb05018.x; DESPORTES I, 1985, J PROTOZOOL, V32, P250; Feng YY, 2011, APPL ENVIRON MICROB, V77, P4822, DOI 10.1128/AEM.02803-10; Feng YY, 2011, J CLIN MICROBIOL, V49, P34, DOI 10.1128/JCM.01329-10; Guo YQ, 2014, APPL ENVIRON MICROB, V80, P218, DOI 10.1128/AEM.02997-13; Li JQ, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1425-5; Li JQ, 2015, J EUKARYOT MICROBIOL, V62, P833, DOI 10.1111/jeu.12269; Li W, 2015, VET PARASITOL, V208, P125, DOI 10.1016/j.vetpar.2015.01.014; Matos Olga, 2012, J Parasitol Res, V2012, P981424, DOI 10.1155/2012/981424; Qi M, 2016, J EUKARYOT MICROBIOL, V63, P591, DOI 10.1111/jeu.12308; Qi M, 2015, PARASITOL INT, V64, P339, DOI 10.1016/j.parint.2015.05.007; Santin M, 2009, J EUKARYOT MICROBIOL, V56, P34, DOI 10.1111/j.1550-7408.2008.00380.x; Sulaiman IM, 2003, APPL ENVIRON MICROB, V69, P4495, DOI 10.1128/AEM.69.8.4495-4501.2003; Tian GR, 2015, INFECT GENET EVOL, V34, P32, DOI 10.1016/j.meegid.2015.06.015; Wang XT, 2016, PARASITOL RES, V115, P1355, DOI 10.1007/s00436-016-4908-6; Wei JF, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1795-8; Zhang XX, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1356-1; Zhang ZJ, 2015, EXP PARASITOL, V155, P46, DOI 10.1016/j.exppara.2015.05.008; Zhao W, 2016, INFECT GENET EVOL, V40, P151, DOI 10.1016/j.meegid.2016.02.037; Zhao W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142611; Zhao W, 2015, INFECT GENET EVOL, V32, P265, DOI 10.1016/j.meegid.2015.03.026	24	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2017	12	8							e0183249	10.1371/journal.pone.0183249	http://dx.doi.org/10.1371/journal.pone.0183249			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD5CP	28806735	Green Submitted, gold, Green Published			2022-12-26	WOS:000407548800067
J	Siesing, C; Sorbye, H; Dragomir, A; Pfeiffer, P; Qvortrup, C; Ponten, F; Jirstrom, K; Glimelius, B; Eberhard, J				Siesing, Christina; Sorbye, Halfdan; Dragomir, Anca; Pfeiffer, Per; Qvortrup, Camilla; Ponten, Fredrik; Jirstrom, Karin; Glimelius, Bengt; Eberhard, Jakob			High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer	PLOS ONE			English	Article							FOLFIRI PLUS BEVACIZUMAB; BINDING MOTIF PROTEIN-3; 1ST-LINE TREATMENT; OPEN-LABEL; CHEMOTHERAPY; FLUOROURACIL; TRIAL; CIRP	Background High expression of the RNA-binding motif protein 3 (RBM3) has been shown to correlate, with prolonged survival in several malignant diseases and with the benefit of platinumbased chemotherapy in ovarian cancer. The aim of this study was to evaluate RBM3 in metastatic colorectal cancer (mCRC) as a prognostic factor for overall survival and in relation to benefit of first-line chemotherapy. Methods Immunohistochemical staining was conducted and evaluated in tumours from 455 mCRC patients. Kaplan- Meier analysis and Cox regression proportional hazards models were used to access the impact of RBM3 expression on overall survival (OS) and progressionfree survival (PFS). Results High RBM3 expression, both nuclear and cytoplasmic, was an independent prognostic factor for prolonged OS (hazard ratio [HR] 0.67, 95% confidence interval [CI] 0.50-0.90 and HR 0.66, 95% CI 0.48-0.91, respectively). PFS was significantly longer in patients with high RBM3 expression who had received first-line oxaliplatin based treatment, compared to those who had received irinotecan based treatment, both regarding nuclear and cytoplasmic expression (p-value 0.020 and 0.022 respectively). Conclusion High RBM3 expression is an independent predictor of prolonged survival in mCRC patients, in particular in patients treated with first-line oxaliplatin based chemotherapy.	[Siesing, Christina; Jirstrom, Karin; Eberhard, Jakob] Lund Univ, Skane Univ Hosp, Div Oncol & Pathol, Dept Clin Sci, Lund, Sweden; [Sorbye, Halfdan] Univ Bergen, Haukeland Univ Hosp, Dept Oncol, Bergen, Norway; [Sorbye, Halfdan] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Dragomir, Anca; Ponten, Fredrik] Uppsala Univ, Uppsala Univ Hosp, Sect Pathol, Uppsala, Sweden; [Dragomir, Anca; Ponten, Fredrik] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Pfeiffer, Per; Qvortrup, Camilla] Odense Univ Hosp, Dept Oncol, Odense, Denmark; [Glimelius, Bengt] Uppsala Univ, Dept Immunol Genet & Pathol, Sect Expt & Clin Oncol, Uppsala, Sweden	Lund University; Skane University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; Uppsala University; Uppsala University Hospital; Uppsala University; University of Southern Denmark; Odense University Hospital; Uppsala University	Siesing, C (corresponding author), Lund Univ, Skane Univ Hosp, Div Oncol & Pathol, Dept Clin Sci, Lund, Sweden.	christina.siesing@med.lu.se	Qvortrup, Camilla/AAD-3366-2019	Pfeiffer, Per/0000-0002-2925-0586; Qvortrup, Camilla/0000-0001-9338-9841; Dragomir, Anca/0000-0003-2777-8114	Swedish Research Council; Swedish and Norwegian Cancer Society; Swedish Government Grant for Clinical Research; Kamprad Family Foundation; Knut and Alice Wallenberg Foundation; Gunnar Nilsson Cancer Foundation; Lund University Faculty of Medicine; Lund University Hospital Research Grants	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish and Norwegian Cancer Society; Swedish Government Grant for Clinical Research; Kamprad Family Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Gunnar Nilsson Cancer Foundation; Lund University Faculty of Medicine; Lund University Hospital Research Grants	This study was supported by grants from the Swedish Research Council, (KJ, JE), the Swedish and Norwegian Cancer Society, (BG, HS), the Swedish Government Grant for Clinical Research, (KJ), the Kamprad Family Foundation, (JE), Knut and Alice Wallenberg Foundation, (FP), the Gunnar Nilsson Cancer Foundation, (KJ), Lund University Faculty of Medicine, (KJ), and the Lund University Hospital Research Grants (KJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by grants from the Swedish Research Council, KJ, JE, the Swedish and Norwegian Cancer Society, BG, HS, the Swedish Government Grant for Clinical Research, KJ, the Kamprad Family Foundation, JE, Knut and Alice Wallenberg Foundation, FP, the Gunnar Nilsson Cancer Foundation, KJ, Lund University Faculty of Medicine, KJ, and the Lund University Hospital Research Grants KJ.	Boman K, 2013, BMC UROL, V13, DOI 10.1186/1471-2490-13-17; Cremolini C, 2015, LANCET ONCOL, V16, P1306, DOI 10.1016/S1470-2045(15)00122-9; Danno S, 1997, BIOCHEM BIOPH RES CO, V236, P804, DOI 10.1006/bbrc.1997.7059; de Gramont A, 2000, J CLIN ONCOL, V18, P2938, DOI 10.1200/JCO.2000.18.16.2938; Douillard JY, 2000, LANCET, V355, P1041, DOI 10.1016/S0140-6736(00)02034-1; Ehlen A, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-78; Heinemann V, 2014, LANCET ONCOL, V15, P1065, DOI 10.1016/S1470-2045(14)70330-4; Hjelm B, 2011, PROTEOM CLIN APPL, V5, P624, DOI 10.1002/prca.201100020; Jang HH, 2017, ANTICANCER RES, V37, P1779, DOI 10.21873/anticanres.11511; Jogi A, 2009, MODERN PATHOL, V22, P1564, DOI 10.1038/modpathol.2009.124; Jonsson L, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-11; Jonsson L, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-114; Kampf C, 2012, JOVE-J VIS EXP, DOI 10.3791/3620; LLeonart ME, 2010, BBA-REV CANCER, V1805, P43, DOI 10.1016/j.bbcan.2009.11.001; Melling N, 2016, HISTOPATHOLOGY, V68, P191, DOI 10.1111/his.12726; Neubauer H, 2008, ANTICANCER RES, V28, P1797; Olofsson SE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121300; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Piper GL, 2004, AM SURGEON, V70, P1103; Raymond E, 2002, MOL CANCER THER, V1, P227; Raymond E, 1998, SEMIN ONCOL, V25, P4; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sorbye H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131046; Sorbye H, 2009, CANCER, V115, P4679, DOI 10.1002/cncr.24527; Torhorst J, 2001, AM J PATHOL, V159, P2249, DOI 10.1016/S0002-9440(10)63075-1; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Venook AP, 2005, CLIN COLORECTAL CANC, V5, P292, DOI 10.3816/CCC.2005.n.043; Wellmann S, 2004, J CELL SCI, V117, P1785, DOI 10.1242/jcs.01026; Wellmann S, 2010, PEDIATR RES, V67, P35, DOI 10.1203/PDR.0b013e3181c13326; Yokota T, 2011, BRIT J CANCER, V104, P856, DOI 10.1038/bjc.2011.19	31	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0182512	10.1371/journal.pone.0182512	http://dx.doi.org/10.1371/journal.pone.0182512			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800641	Green Published, Green Submitted, gold			2022-12-26	WOS:000407431800019
J	Strobl, F; Ross, JA; Stelzer, EHK				Strobl, Frederic; Ross, J. Alexander; Stelzer, Ernst H. K.			Non-lethal genotyping of Tribolium castaneum adults using genomic DNA extracted from wing tissue	PLOS ONE			English	Article							CRYPTIC FEMALE CHOICE; FLOUR BEETLE; COPULATORY COURTSHIP; APIS-MELLIFERA; EYE-COLOR; HONEY-BEE; RNAI; BEHAVIOR; GENES; TRANSFORMATION	The red flour beetle Tribolium castaneum has become the second most important insect model organism and is frequently used in developmental biology, genetics and pest-associated research. Consequently, the methodological arsenal increases continuously, but many routinely applied techniques for Drosophila melanogaster and other insect species are still unavailable. For example, a protocol for non-lethal genotyping has not yet been adapted but is particularly useful when individuals with known genotypes are required for downstream experiments. In this study, we present a workflow for non-lethal genotyping of T. castaneum adults based on extracting genomic DNA from wing tissue. In detail, we describe a convenient procedure for wing dissection and a custom method for wing digestion that allows PCR-based genotyping of up to fifty adults in less than an afternoon with a success rate of about 86%. The amount of template is sufficient for up to ten reactions while viability and fertility of the beetles are preserved. We prove the applicability of our protocol by genotyping the white / scarlet gene pair alleles from the black-eyed San Bernadino wild-type and whiteeyed Pearl recessive mutant strains spanning four generations. Non-lethal genotyping has the potential to improve and accelerate many workflows: Firstly, during the establishment process of homozygous cultures or during stock keeping of cultures that carry recessively lethal alleles, laborious test crossing is replaced by non-lethal genotyping. Secondly, in genome engineering assays, non-lethal genotyping allows the identification of appropriate founders before they are crossed against wild-types, narrowing the efforts down to only the relevant individuals. Thirdly, non-lethal genotyping simplifies experimental strategies, in which genotype and behavior should be correlated, since the genetic configuration of potential individuals can be determined before the actual behavior assays is performed.	[Strobl, Frederic; Ross, J. Alexander; Stelzer, Ernst H. K.] Goethe Univ Frankfurt Main, Buchmann Inst Mol Life Sci BMLS, Cluster Excellence Frankfurt Macromol Comp CEF MC, Phys Biol Phys Biol IZN FB 15, Campus Riedberg,Max von Laue Str 15, Frankfurt, Germany	Goethe University Frankfurt	Stelzer, EHK (corresponding author), Goethe Univ Frankfurt Main, Buchmann Inst Mol Life Sci BMLS, Cluster Excellence Frankfurt Macromol Comp CEF MC, Phys Biol Phys Biol IZN FB 15, Campus Riedberg,Max von Laue Str 15, Frankfurt, Germany.	ernst.stelzer@physikalischebiologie.de	Stelzer, Ernst H K/A-7648-2011	Stelzer, Ernst H K/0000-0003-1545-0736; Ross, Jean Alexander/0000-0001-9286-2748; Strobl, Frederic/0000-0002-5350-0194	Cluster of Excellence Frankfurt am Main for Macromolecular Complexes (CEF-MC) [EXC 115]	Cluster of Excellence Frankfurt am Main for Macromolecular Complexes (CEF-MC)	The research was funded by the Cluster of Excellence Frankfurt am Main for Macromolecular Complexes (CEF-MC, EXC 115) granted in part to EHKS at the Buchmann Institute for Molecular Life Sciences (BM LS) at the Goethe Universitat Frankfurt am Main by the Deutsche Forschungsgemeinschaft (DFG), www.dfg.de.	Altincicek B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052004; Angelini DR, 2012, G3-GENES GENOM GENET, V2, P235, DOI 10.1534/g3.111.001537; Audsley N, 2015, INSECT BIOCHEM MOLEC, V67, P27, DOI 10.1016/j.ibmb.2015.07.014; Bellen HJ, 2010, NAT REV NEUROSCI, V11, P514, DOI 10.1038/nrn2839; Berghammer A, 1999, DEV GENES EVOL, V209, P382, DOI 10.1007/s004270050268; Berghammer Andreas J, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5259; Broehan G, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-6; Brown S. J., 2009, COLD SPRING HARB PRO; Brown SJ, 2003, GENET RES, V82, P155, DOI 10.1017/S0016672303006451; Brown SJ, 1999, EVOL DEV, V1, P11, DOI 10.1046/j.1525-142x.1999.99013.x; Bucher G, 2004, DEVELOPMENT, V131, P1729, DOI 10.1242/dev.01073; Bucher G, 2002, CURR BIOL, V12, pR85, DOI 10.1016/S0960-9822(02)00666-8; Carvalho GB, 2009, BIOTECHNIQUES, V46, P312, DOI 10.2144/000113088; Chaline N, 2004, APIDOLOGIE, V35, P311, DOI 10.1051/apido:2004015; DAWSON PS, 1984, CAN J GENET CYTOL, V26, P762, DOI 10.1139/g84-120; Donitz J, 2015, NUCLEIC ACIDS RES, V43, pD720, DOI 10.1093/nar/gku1054; Edvardsson M, 2005, J INSECT BEHAV, V18, P313, DOI 10.1007/s10905-005-3692-4; Edvardsson M, 2000, P ROY SOC B-BIOL SCI, V267, P559, DOI 10.1098/rspb.2000.1037; Gilles AF, 2015, DEVELOPMENT, V142, P2832, DOI 10.1242/dev.125054; Gregory PG, 2004, ENTOMOL EXP APPL, V111, P173, DOI 10.1111/j.0013-8703.2004.00164.x; Grossmann D, 2009, DEV GENES EVOL, V219, P469, DOI 10.1007/s00427-009-0310-z; Grubbs N, 2015, GENETICS, V199, P749, DOI 10.1534/genetics.114.173971; Hilbrant M, 2016, ELIFE, V5, DOI 10.7554/eLife.13834; Inglis J, 2009, EMERGING MODEL ORGAN, V1; Inglis J, 2010, EMERGING MODEL ORGAN, V2; Klingler M, 2004, CURR BIOL, V14, pR639, DOI 10.1016/j.cub.2004.08.004; Lorenzen MD, 2003, INSECT MOL BIOL, V12, P433, DOI 10.1046/j.1365-2583.2003.00427.x; Lorenzen MD, 2002, GENETICS, V160, P225; Martin CM, 2015, J INSECT BEHAV, V28, P268, DOI 10.1007/s10905-015-9498-0; Mocelin G, 1996, J HERED, V87, P27, DOI 10.1093/oxfordjournals.jhered.a022949; Park T, 1934, Q REV BIOL, V9, P36, DOI 10.1086/394454; Pavlopoulos A, 2004, GENETICS, V167, P737, DOI 10.1534/genetics.103.023085; Posnien Nico, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5256; Qazi MCB, 2003, J EVOLUTION BIOL, V16, P170, DOI 10.1046/j.1420-9101.2003.00501.x; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Romero SA, 2010, ENVIRON ENTOMOL, V39, P919, DOI 10.1603/EN09324; Roth S, 2008, DEV GENES EVOL, V218, P115, DOI 10.1007/s00427-008-0215-2; Schinko J, 2009, COLD SPRING HARB PRO, V8; Schmitt-Engel C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8822; Schroder R, 2008, DEV GENES EVOL, V218, P119, DOI 10.1007/s00427-008-0214-3; SERRANO JM, 1991, BEHAV GENET, V21, P547, DOI 10.1007/BF01066681; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Sharma R, 2013, GENE EXPR PATTERNS, V13, P362, DOI 10.1016/j.gep.2013.07.002; Shippy TD, 2009, COLD SPRING HARBOR P, V2009; Siebert KS, 2008, INSECT BIOCHEM MOLEC, V38, P749, DOI 10.1016/j.ibmb.2008.04.007; Starks PT, 2002, INSECT SOC, V49, P20, DOI 10.1007/s00040-002-8272-4; Strobl F, 2017, JOVE-J VIS EXP, DOI 10.3791/55629; Strobl F, 2017, NAT PROTOC, V12, P1103, DOI 10.1038/nprot.2017.028; Strobl F, 2016, CURR OPIN INSECT SCI, V18, P17, DOI 10.1016/j.cois.2016.08.002; Strobl F, 2015, NAT PROTOC, V10, P1486, DOI 10.1038/nprot.2015.093; Strobl F, 2014, DEVELOPMENT, V141, P2331, DOI 10.1242/dev.108795; Tomoyasu Y, 2004, DEV GENES EVOL, V214, P575, DOI 10.1007/s00427-004-0434-0; Trauner J, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-73	53	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0182564	10.1371/journal.pone.0182564	http://dx.doi.org/10.1371/journal.pone.0182564			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800588	Green Published, gold, Green Submitted			2022-12-26	WOS:000407431800022
J	Kjaer, JB				Kjaer, Joergen B.			Divergent selection on home pen locomotor activity in a chicken model: Selection program, genetic parameters and direct response on activity and body weight	PLOS ONE			English	Article							LAYING HENS; ARTIFICIAL SELECTION; FEATHER-PECKING; LEG DISORDERS; BEHAVIOR; MEAT; BROILERS; EXERCISE; STRAIN; GROWTH	General locomotor activity (GLA) in poultry has attracted attention, as it negatively influences production costs (energy expenditure and feed consumption) and welfare parameters (bone strength, litter quality, feather pecking and cannibalism). Laying hen lines diverging in the average level of spontaneous locomotor activity in the home pen were developed by genetic selection using the founder New Hampshire line. Activity was recorded using RFID technology at around five weeks of age during four to five days in the home pen. After initial phenotyping, the least active birds were selected for the low activity line and the most active for the high activity line, with no gene transfer between lines. In each of six generations, approximately ten sires were mated to twenty dams producing 158 to 334 offspring per line per generation. The response to selection was rapid and of a considerable magnitude. In sixth generation, the level of GLA was approximately halved in the low and doubled in the high line compared to the control (7.2, 14.9 and 28.7 recordings/h). Estimated heritability of locomotor activity in the low and high line was 0.38 and 0.33, respectively. Males, in general, were more active than females. High line birds were significantly heavier than low line birds. In fourth, fifth, and sixth generation, low as well as high line birds were lighter than control line birds. This selection experiment demonstrates variation in heritability for GLA and, as a result, genetically diverged lines have been developed. These lines can be used as models for further studies of underlying physiological, neural and molecular genetic mechanisms of spontaneous locomotor activity.	[Kjaer, Joergen B.] Friedrich Loeffler Inst, Inst Anim Welf & Anim Husb, Celle, Germany	Friedrich Loeffler Institute	Kjaer, JB (corresponding author), Friedrich Loeffler Inst, Inst Anim Welf & Anim Husb, Celle, Germany.	joergen.kjaer@fli.de		Kjaer, Joergen/0000-0002-2192-9383				BESSEI W, 1983, ARCH GEFLUGELKD, V47, P134; Bizeray D, 2000, APPL ANIM BEHAV SCI, V68, P231, DOI 10.1016/S0168-1591(00)00105-2; BLOKHUIS HJ, 1984, APPL ANIM BEHAV SCI, V12, P145, DOI 10.1016/0168-1591(84)90104-7; Bokkers EAM, 2004, BEHAV PROCESS, V67, P121, DOI 10.1016/j.beproc.2004.03.015; Boyer JP, 1970, P 14 WORLDS POULTR C, P21; Burt DW, 2007, POULTRY SCI, V86, P1460, DOI 10.1093/ps/86.7.1460; Santos DMDE, 2012, BEHAV GENET, V42, P559, DOI 10.1007/s10519-012-9534-1; FAURE JM, 1981, BEHAV GENET, V11, P135, DOI 10.1007/BF01065624; GALLUP GG, 1980, ANIM BEHAV, V28, P368, DOI 10.1016/S0003-3472(80)80045-5; Gerken M., 1991, ANTAGONISTISCHE BEZI; GONYOU HW, 1983, BRIT POULTRY SCI, V24, P311, DOI 10.1080/00071668308416745; GOODMAN BL, 1956, POULTRY SCI, V35, P50, DOI 10.3382/ps.0350050; Horsted K, 2006, ACTA AGR SCAND A-AN, V56, P42, DOI 10.1080/09064700600866072; Horsted K, 2012, J SCI FOOD AGR, V92, P258, DOI 10.1002/jsfa.4569; JEZIERSKI T, 1978, ARCH GEFLUGELKD, V42, P159; KNOWLES TG, 1990, VET REC, V126, P354; Madsen P., 2013, PACKAGE ANAL MULTIVA; Mahboub HDH, 2004, BRIT POULTRY SCI, V45, P738, DOI 10.1080/00071660400014267; Maijala P K., 1979, ACTA AGR SCAND, V29, P273; Majdak P, 2014, BEHAV GENET, V44, P516, DOI 10.1007/s10519-014-9667-5; Mignon-Grasteau S, 2017, BEHAV GENET, V47, P114, DOI 10.1007/s10519-016-9807-1; Muir WM, 1998, POULTRY SCI, V77, P1781, DOI 10.1093/ps/77.12.1781; MURPHY LB, 1988, BRIT POULTRY SCI, V29, P571, DOI 10.1080/00071668808417083; Nicol CJ, 2013, WORLD POULTRY SCI J, V69, P775, DOI 10.1017/S0043933913000809; Ponte PIP, 2008, POULTRY SCI, V87, P71, DOI 10.3382/ps.2007-00147; Reiter K, 1998, ARCH GEFLUGELKD, V62, P247; Reiter K, 2004, ARCH GEFLUGELKD, V68, P98; Rhodes JS, 2009, EXPERIMENTAL EVOLUTION: CONCEPTS, METHODS, AND APPLICATIONS OF SELECTION EXPERIMENTS, P263; Saleh K, 1980, GENETISCHE PHANOTYPI, P75; SAVORY CJ, 1975, BRIT POULTRY SCI, V16, P315, DOI 10.1080/00071667508416192; Swallow JG, 1998, BEHAV GENET, V28, P227, DOI 10.1023/A:1021479331779; Szwaczkowski T., 2003, Poultry genetics, breeding and biotechnology, P165, DOI 10.1079/9780851996608.0165; Szydlowski M, 2001, POULTRY SCI, V80, P125, DOI 10.1093/ps/80.2.125; THORP BH, 1988, RES VET SCI, V45, P72, DOI 10.1016/S0034-5288(18)30897-X; van der Waaij EH, 2004, J ANIM SCI, V82, P973; WOODGUSH DG, 1972, ANIM BEHAV, V20, P72, DOI 10.1016/S0003-3472(72)80175-1	36	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182103	10.1371/journal.pone.0182103	http://dx.doi.org/10.1371/journal.pone.0182103			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796792	gold, Green Submitted, Green Published			2022-12-26	WOS:000407396200031
J	Reischies, FMJ; Krause, R; Holzer, J; Tiefenbacher, F; Winter, R; Eylert, G; Meikl, T; Tuca, A; Kofer, MJ; Kamolz, LP; Lumenta, DB				Reischies, Frederike M. J.; Krause, Robert; Holzer, Judith; Tiefenbacher, Fabian; Winter, Raimund; Eylert, Gertraud; Meikl, Tobias; Tuca, Alexandru; Koefer, Martin J.; Kamolz, Lars P.; Lumenta, David B.			What can we learn from sonication results of breast implants?	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; OF-THE-LITERATURE; CAPSULAR CONTRACTURE; ANTIBIOTIC-PROPHYLAXIS; AUGMENTATION MAMMAPLASTY; SUBCLINICAL INFECTION; RECONSTRUCTION; VANCOMYCIN; CONTAMINATION; ASSOCIATION	Background Different research groups have identified microorganisms on breast implants by sonication with significant correlation to the rate of capsular contracture. This substantiated the hypothesis of an infectious etiology of capsular contracture. However, no clinical consequence has been drawn from these results yet. Aim of this study was to review sonication results from breast implants and to evaluate the current preoperative antibiotic regime for breast-implant surgery. Methods We compared breast implant sonication culture results from published reports and our own database. Current preoperative antibiotic recommendations were compared with the susceptibility profile of the found organisms. Results We found Coagulase-negative staphylococci and Propionibacteria to be the main group of microorganism found by sonication on explanted breast implants. Most guidelines recommend cephalosporins for preoperative antibiotical prophylaxis for breast-implant surgery. Conclusion There is a discrepancy between antibiotic activity of commonly used antibiotics for preoperative prophylaxis of surgical site infections, and microorganisms found by sonication on breast implants, suspected to trigger the formation of capsular contracture. A targeted antibiotic prophylaxis for breast implant surgery with glycopeptides (e.g. Vancomycin) should be considered for the prevention of capsular contracture.	[Reischies, Frederike M. J.; Holzer, Judith; Tiefenbacher, Fabian; Winter, Raimund; Eylert, Gertraud; Tuca, Alexandru; Kamolz, Lars P.; Lumenta, David B.] Med Univ Graz, Dept Surg, Div Plast Aesthet & Reconstruct Surg, Graz, Austria; [Krause, Robert] Med Univ Graz, Dept Internal Med, Sect Infect Dis & Trop Med, Graz, Austria; [Meikl, Tobias] Landeskrankenhaus Feldbach Furstenfeld, Dept Surg, Feldbach, Austria; [Koefer, Martin J.] Med Univ Graz, Inst Hosp Hyg & Microbiol, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz	Reischies, FMJ (corresponding author), Med Univ Graz, Dept Surg, Div Plast Aesthet & Reconstruct Surg, Graz, Austria.	frederike.reischies@medunigraz.at	Lumenta, David Benjamin/AAD-5935-2019	Lumenta, David Benjamin/0000-0003-0903-252X; Holzer-Geissler, Judith Christine Julie/0000-0002-2244-2817; Kamolz, Lars-Peter/0000-0002-5975-876X				Ahmad SS, 2016, KNEE SURG SPORT TR A, V24, P3064, DOI 10.1007/s00167-016-4230-y; [Anonymous], [No title captured]; Araco A, 2007, AESTHET PLAST SURG, V31, P532, DOI 10.1007/s00266-007-0162-8; Ariyan S, 2015, PLAST RECONSTR SURG, V135, P1723, DOI 10.1097/PRS.0000000000001265; Becker K, 2014, CLIN MICROBIOL REV, V27, P870, DOI 10.1128/CMR.00109-13; Bratzler DW, 2013, AM J HEALTH-SYST PH, P195; Bull AL, 2012, ANN SURG, V256, P1089, DOI 10.1097/SLA.0b013e31825fa398; Cattoir V, 2013, J ANTIMICROB CHEMOTH, V68, P731, DOI 10.1093/jac/dks469; Courtney PM, 2015, CLIN ORTHOP RELAT R, V473, P2197, DOI 10.1007/s11999-014-4062-3; Del Pozo JL, 2009, J CLIN MICROBIOL, V47, P1333, DOI 10.1128/JCM.00096-09; Gowda AU, 2017, ANN PLAS SURG, V78, P153, DOI 10.1097/SAP.0000000000000822; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; GYLBERT L, 1990, PLAST RECONSTR SURG, V86, P260, DOI 10.1097/00006534-199008000-00009; Hardwicke JT, 2013, PLAST RECONSTR SURG, V131, P1395, DOI 10.1097/PRS.0b013e31828bd752; Henriksen TF, 2005, ANN PLAS SURG, V54, P343, DOI 10.1097/01.sap.0000151459.07978.fa; Huang NS, 2015, INT J SURG, V15, P31, DOI 10.1016/j.ijsu.2015.01.020; Jianu DM, 2016, AESTHET SURG J, V36, P51, DOI 10.1093/asj/sjv106; John Joseph F, 2007, Ther Clin Risk Manag, V3, P1143; May L, 2014, ANTIMICROB AGENTS CH, V58, P1404, DOI 10.1128/AAC.01908-13; Mirzabeigi M, AESTHET SURG J, P61; Mirzabeigi MN, 2011, PLAST RECONSTR SURG, V128, p34E, DOI 10.1097/PRS.0b013e3182173fe5; MLADICK RA, 1993, AESTHET PLAST SURG, V17, P183, DOI 10.1007/BF00636260; Namnoum JD, 2013, J PLAST RECONSTR AES, V66, P1165, DOI 10.1016/j.bjps.2013.04.046; Pajkos A, 2003, PLAST RECONSTR SURG, V111, P1605, DOI 10.1097/01.PRS.0000054768.14922.44; Phillips BT, 2016, PLAST RECONSTR SURG, V138, P751, DOI 10.1097/PRS.0000000000002530; Rahkonen M, 2012, EUR J CLIN MICROBIOL, V31, P2639, DOI 10.1007/s10096-012-1607-9; Rieger UM, 2013, BRIT J SURG, V100, P768, DOI 10.1002/bjs.9084; Rieger UM, 2009, AESTHET PLAST SURG, V33, P404, DOI 10.1007/s00266-009-9333-0; Rieger Ulrich Michael, 2014, J Long Term Eff Med Implants, V24, P131; Schaub TA, 2010, PLAST RECONSTR SURG, V126, P2140, DOI 10.1097/PRS.0b013e3181f2b5a2; Scottish Intercollegiate Guidelines Network, 2014, ANT PROPH SURG; SHAH Z, 1981, PLAST RECONSTR SURG, V68, P34, DOI 10.1097/00006534-198107000-00007; Sivagnanam S, 2003, CRIT CARE, V7, P119, DOI 10.1186/cc1871; SPEAR SL, 1995, PLAST RECONSTR SURG, V96, P1119, DOI 10.1097/00006534-199510000-00018; Tamboto H, 2010, PLAST RECONSTR SURG, V126, P835, DOI 10.1097/PRS.0b013e3181e3b456; Trampuz A, 2007, NEW ENGL J MED, V357, P654, DOI 10.1056/NEJMoa061588; Wan D, 2016, PLAST RECONSTR SURG, V137, P826, DOI 10.1097/01.prs.0000480095.23356.ae; Weigelt JA, 2010, AM J INFECT CONTROL, V38, P112, DOI 10.1016/j.ajic.2009.06.010; Wiener TC, 2008, AESTHET PLAST SURG, V32, P303, DOI 10.1007/s00266-007-9061-2; Wixtrom RN, 2012, AESTHET SURG J, V32, P956, DOI 10.1177/1090820X12456841; Xue M Xiao, 2011, J MED MICROBIOL, P1661	41	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182267	10.1371/journal.pone.0182267	http://dx.doi.org/10.1371/journal.pone.0182267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797044	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000407396200040
J	Nguyen, LT; Nakaishi, K; Motojima, K; Ohkawara, A; Minato, E; Maruyama, J; Hiono, T; Matsuno, K; Okamatsu, M; Kimura, T; Takada, A; Kida, H; Sakoda, Y				Lam Thanh Nguyen; Nakaishi, Kazunari; Motojima, Keiko; Ohkawara, Ayako; Minato, Erina; Maruyama, Junki; Hiono, Takahiro; Matsuno, Keita; Okamatsu, Masatoshi; Kimura, Takashi; Takada, Ayato; Kida, Hiroshi; Sakoda, Yoshihiro			Rapid and broad detection of H5 hemagglutinin by an immunochromatographic kit using novel monoclonal antibody against highly pathogenic avian influenza virus belonging to the genetic clade 2.3.4.4	PLOS ONE			English	Article							DETECTION SENSITIVITY; DRIFT VARIANTS; HONG-KONG; DIAGNOSIS; AMPLIFICATION; INFECTION; OUTBREAKS; SEASON; BIRDS; ASSAY	Highly pathogenic avian influenza viruses (HPAIVs) of H5 subtype have persistently caused outbreaks in domestic poultry and wild birds worldwide and sporadically infected humans. Rapid and accurate diagnosis is one of the key strategies for the control of H5 HPAIVs. However, the sensitivity of the diagnosis of H5 HPAIVs has gradually reduced due to extensive antigenic variation during their evolution. Particularly, the previously developed immunochromatographic diagnosis kit for H5 viruses, Linjudge Flu A/H5, exhibits reduced detection of H5 HPAIVs isolated in recent years. In the present study, we established a new advanced H5 rapid immunochromatographic detection kit (New Linjudge Flu A/H5) by a combination of two anti-H5 hemagglutinin monoclonal antibodies, A64/1 previously applied in the Linjudge Flu A/H5 and A32/2, a novel monoclonal antibody generated from a clade 2.3.4.4 H5 HPAIV. The new kit broadly detected all classical and recent H5 influenza viruses and showed a higher specificity and sensitivity than the original Linjudge Flu A/H5 with recently circulating H5 HPAIVs. Furthermore, the applicability of the New Linjudge Flu A/H5 was demonstrated by detecting antigens from the swabs and tissue homogenates of naturally infected birds and experimentally infected chickens with H5N6 HPAIVs belonging to the genetic clade 2.3.4.4. Our study, therefore, can provide an effective point-of-care rapid antigen detection kit for the surveillance of H5 avian influenza viruses and as a prompt countermeasure against the current widespread of the clade 2.3.4.4 H5 HPAIVs in domestic and wild birds.	[Lam Thanh Nguyen; Ohkawara, Ayako; Hiono, Takahiro; Matsuno, Keita; Okamatsu, Masatoshi; Sakoda, Yoshihiro] Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Lab Microbiol, Sapporo, Hokkaido, Japan; [Nakaishi, Kazunari; Motojima, Keiko] TAUNS Labs Inc, Shizuoka, Japan; [Minato, Erina; Kimura, Takashi] Hokkaido Univ, Grad Sch Vet Med, Dept Vet Clin Sci, Lab Comparat Pathol, Sapporo, Hokkaido, Japan; [Maruyama, Junki; Takada, Ayato; Kida, Hiroshi] Hokkaido Univ, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Matsuno, Keita; Kida, Hiroshi; Sakoda, Yoshihiro] Hokkaido Univ, Global Inst Collaborat Res & Educ GI CoRE, Global Stn Zoonosis Control, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University	Sakoda, Y (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Lab Microbiol, Sapporo, Hokkaido, Japan.; Sakoda, Y (corresponding author), Hokkaido Univ, Global Inst Collaborat Res & Educ GI CoRE, Global Stn Zoonosis Control, Sapporo, Hokkaido, Japan.	sakoda@vetmed.hokudai.ac.jp	Kida, Hiroshi/F-7244-2012; Hiono, Takahiro/L-9455-2018; Lam, Nguyen Thanh/X-8273-2019; Maruyama, Junki/H-7993-2013; Maruyama, Junki/M-4735-2019	Hiono, Takahiro/0000-0001-8897-3592; Maruyama, Junki/0000-0003-0088-4793; Maruyama, Junki/0000-0003-0088-4793; Nguyen, Lam Thanh/0000-0002-3413-8281; Matsuno, Keita/0000-0002-4205-6526	TAUNS Laboratories, Inc.	TAUNS Laboratories, Inc.	The author(s) received no specific funding for this work. The TAUNS Laboratories, Inc. provided support in the form of salaries for KN and KeikoM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2016, Weekly Epidemiological Record, V91, P485; [Anonymous], 2005, WHO REC US RAP TEST; Baas C, 2013, EUROSURVEILLANCE, V18, P19; Cattoli G, 2007, J WILDLIFE DIS, V43, pS35; Chan PKS, 2002, CLIN INFECT DIS, V34, pS58, DOI 10.1086/338820; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Dhingra MS, 2016, ELIFE, V5, DOI 10.7554/eLife.19571; European Centre for Disease Prevention and Control, 2015, RAP RISK ASS SIT OV; Huzly D, 2016, ARCH VIROL, V161, P2417, DOI 10.1007/s00705-016-2930-8; Kida Hiroshi, 2008, Global Environmental Research, V12, P9; Lycett SJ, 2016, SCIENCE, V354, P213, DOI 10.1126/science.aaf8852; Manzoor R, 2008, J VET MED SCI, V70, P557, DOI 10.1292/jvms.70.557; Mizuike R, 2011, CLIN VACCINE IMMUNOL, V18, P494, DOI 10.1128/CVI.00269-10; Ohkawara A, 2017, MICROBIOL IMMUNOL, V61, P149, DOI 10.1111/1348-0421.12478; Okamatsu M, 2017, EMERG INFECT DIS, V23, P691, DOI 10.3201/eid2304.161957; Okamatsu M, 2016, VET J, V215, P82, DOI 10.1016/j.tvjl.2016.05.007; Overmeire Y, 2016, DIAGN MICR INFEC DIS, V85, P42, DOI 10.1016/j.diagmicrobio.2016.02.004; Rose K, 2006, WILD BIRDS HIGHLY PA; Sakai-Tagawa Y, 2014, MICROBIOL IMMUNOL, V58, P600, DOI 10.1111/1348-0421.12185; Sakurai A, 2015, FLUORESCENT IMMUNOCH, V10; Sakurai A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076753; Si Y. J., 2017, EURO SURVEILL, V22; Slomka MJ, 2012, INFLUENZA OTHER RESP, V6, P318, DOI 10.1111/j.1750-2659.2011.00317.x; Smith GJD, 2015, INFLUENZA OTHER RESP, V9, P271, DOI 10.1111/irv.12324; Soda K, 2008, ARCH VIROL, V153, P2041, DOI 10.1007/s00705-008-0226-3; Swayne DE, 2012, AVIAN DIS, V56, P818, DOI 10.1637/10183-041012-Review.1; Tsuda Y, 2007, MICROBIOL IMMUNOL, V51, P903, DOI 10.1111/j.1348-0421.2007.tb03973.x; Wada A, 2011, J VIROL METHODS, V178, P82, DOI 10.1016/j.jviromet.2011.08.017; WHO, 2021, CUMULATIVE NUMBER CO; World Bank, 2015, MON EV CONS RED MEAT, P1; World Organisation for Animal Health (OIE), 2016, UPD HIGHL PATH AV IN; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; YEWDELL JW, 1985, P NATL ACAD SCI USA, V82, P1785, DOI 10.1073/pnas.82.6.1785	33	12	13	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182228	10.1371/journal.pone.0182228	http://dx.doi.org/10.1371/journal.pone.0182228			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28787440	Green Published, Green Submitted, gold			2022-12-26	WOS:000406998800020
J	Tijani, MK; Babalola, OA; Odaibo, AB; Anumudu, CI; Asinobi, AO; Morenikeji, OA; Asuzu, MC; Langer, C; Reiling, L; Beeson, JG; Wahlgren, M; Nwuba, RI; Persson, KEM				Tijani, Muyideen K.; Babalola, Oluwatoyin A.; Odaibo, Alex B.; Anumudu, Chiaka I.; Asinobi, Adanze O.; Morenikeji, Olajumoke A.; Asuzu, Michael C.; Langer, Christine; Reiling, Linda; Beeson, James G.; Wahlgren, Mats; Nwuba, Roseangela I.; Persson, Kristina E. M.			Acquisition, maintenance and adaptation of invasion inhibitory antibodies against Plasmodium falciparum invasion ligands involved in immune evasion	PLOS ONE			English	Article							ERYTHROCYTE-BINDING ANTIGEN; MEROZOITE SURFACE-PROTEINS; ACQUIRED-IMMUNITY; REGION-II; MALARIA; RECEPTOR; PROTECTION; RESPONSES; CHILDREN; PARASITEMIA	Erythrocyte-binding antigens (EBAs) and P. falciparum reticulocyte-binding homologue proteins (PfRhs) are two important protein families that can vary in expression and utilization by P. falciparum to evade inhibitory antibodies. We evaluated antibodies at repeated time-points among individuals living in an endemic region in Nigeria over almost one year against these vaccine candidates. Antibody levels against EBA140, EBA175, EBA181, PfRh2, PfRh4, and MSP2, were measured by ELISA. We also used parasites with disrupted EBA140, EBA175 and EBA181 genes to show that all these were targets of invasion inhibitory antibodies. However, antigenic targets of inhibitory antibodies were not stable and changed substantially over time in most individuals, independent of age. Antibodies levels measured by ELISA also varied within and between individuals over time and the antibodies against EBA181, PfRh2 and MSP2 declined more rapidly in younger individuals (<= 15 years) compared with older (> 15). The breadth of high antibody responses over time was more influenced by age than by the frequency of infection. High antibody levels were associated with a more stable invasion inhibitory response, which could indicate that during the long process of formation of immunity, many changes not only in levels but also in functional responses are needed. This is an important finding in understanding natural immunity against malaria, which is essential for making an efficacious vaccine.	[Tijani, Muyideen K.; Babalola, Oluwatoyin A.; Odaibo, Alex B.; Anumudu, Chiaka I.; Morenikeji, Olajumoke A.; Nwuba, Roseangela I.] Univ Ibadan, Dept Zool, Cellular Parasitol Programme, Cell Biol & Genet Unit, Ibadan, Nigeria; [Tijani, Muyideen K.; Wahlgren, Mats; Persson, Kristina E. M.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden; [Asinobi, Adanze O.] Univ Ibadan, Univ Coll Hosp, Dept Paediat, Ibadan, Nigeria; [Asuzu, Michael C.] Univ Ibadan, Coll Med, Dept Prevent Med & Primary Care, Ibadan, Nigeria; [Langer, Christine; Reiling, Linda; Beeson, James G.] Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic, Australia; [Persson, Kristina E. M.] Lund Univ, Univ Hosp, Dept Lab Med, Lund, Sweden	University of Ibadan; Karolinska Institutet; University of Ibadan; University College Hospital, Ibadan; University of Ibadan; Burnet Institute; Lund University; Skane University Hospital	Persson, KEM (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden.; Persson, KEM (corresponding author), Lund Univ, Univ Hosp, Dept Lab Med, Lund, Sweden.	kristina.persson@med.lu.se	Babalola, Oluwatoyin Aduke/AHC-9204-2022	Anumudu, Chiaka/0000-0002-9444-685X; Persson, Kristina E M/0000-0003-2661-3115; Nwuba, Roseangela/0000-0001-6570-9553	Multilateral Initiative on Malaria (MIM) project through UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Disease (TDR) [A60143]; National Health and Medical Research Council of Australia; University of Ibadan Senate Research Grant; Myndigheten for Samhallsskydd och Beredskap; Svenska Lakaresallskapet; Sida; Vetenskapsradet; Victorian State Government Operational Infrastructure Scheme; NHMRC Independent Research Institutes Infrastructure Support scheme	Multilateral Initiative on Malaria (MIM) project through UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Disease (TDR); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Ibadan Senate Research Grant; Myndigheten for Samhallsskydd och Beredskap; Svenska Lakaresallskapet; Sida; Vetenskapsradet(Swedish Research Council); Victorian State Government Operational Infrastructure Scheme; NHMRC Independent Research Institutes Infrastructure Support scheme(National Health and Medical Research Council (NHMRC) of Australia)	Multilateral Initiative on Malaria (MIM) project A60143 through UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Disease (TDR), and the National Health and Medical Research Council of Australia, University of Ibadan Senate Research Grant, Myndigheten for Samhallsskydd och Beredskap, Svenska Lakaresallskapet, Sida and Vetenskapsradet. J. Beeson was supported by a Senior Research Fellowship and Program Grant from the National Health and Medical Research Council of Australia, and the Burnet Institute is supported by the Victorian State Government Operational Infrastructure Scheme, and the NHMRC Independent Research Institutes Infrastructure Support scheme.	Achidi EA, 1996, AM J TROP MED HYG, V55, P138, DOI 10.4269/ajtmh.1996.55.138; Adams JH, 2001, TRENDS PARASITOL, V17, P297, DOI 10.1016/S1471-4922(01)01948-1; Akpogheneta OJ, 2008, INFECT IMMUN, V76, P1748, DOI 10.1128/IAI.01333-07; [Anonymous], 2009, MAL MICR QUAL ASS MA; Beeson JG, 2016, FEMS MICROBIOL REV, V40, P343, DOI 10.1093/femsre/fuw001; Bowyer PW, 2015, INFECT IMMUN, V83, P2575, DOI 10.1128/IAI.03009-14; Boyle MJ, 2015, IMMUNITY, V42, P580, DOI 10.1016/j.immuni.2015.02.012; Boyle MJ, 2014, INFECT IMMUN, V82, P924, DOI 10.1128/IAI.00866-13; CAMUS D, 1985, SCIENCE, V230, P553, DOI 10.1126/science.3901257; Chitnis CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117820; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Daou M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0567-9; DAVENPORT FM, 1953, J EXP MED, V98, P641, DOI 10.1084/jem.98.6.641; EDOZIEN JC, 1962, LANCET, V2, P951; El Sahly HM, 2010, CLIN VACCINE IMMUNOL, V17, P1552, DOI 10.1128/CVI.00082-10; Fairhurst RM, 2012, MICROBES INFECT, V14, P851, DOI 10.1016/j.micinf.2012.05.006; Fowkes FJI, 2012, J INFECT DIS, V206, P1612, DOI 10.1093/infdis/jis566; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; Gilberger TW, 2003, J BIOL CHEM, V278, P14480, DOI 10.1074/jbc.M211446200; GOOD MF, 1993, PARASITE IMMUNOL, V15, P187, DOI 10.1111/j.1365-3024.1993.tb00599.x; Healer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072504; Irani V, 2015, CLIN INFECT DIS, V61, P1244, DOI 10.1093/cid/civ525; Kim JH, 2012, P NATL ACAD SCI USA, V109, P13751, DOI 10.1073/pnas.0912458109; Kusi KA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-40; Lanzillotti R, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-100; Lobo CA, 2003, BLOOD, V101, P4628, DOI 10.1182/blood-2002-10-3076; Lopaticki S, 2011, INFECT IMMUN, V79, P1107, DOI 10.1128/IAI.01021-10; Mara SE, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-419; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; Mayer DCG, 2009, P NATL ACAD SCI USA, V106, P5348, DOI 10.1073/pnas.0900878106; McCallum FJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003571; Mensah-Brown HE, 2015, J INFECT DIS, V212, P1288, DOI 10.1093/infdis/jiv207; Noutcha MAE, 2009, J VECTOR DIS, V46, P43; Ohas EA, 2004, INFECT IMMUN, V72, P735, DOI 10.1128/IAI.72.2.735-741.2004; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Okenu DMN, 2000, INFECT IMMUN, V68, P5559, DOI 10.1128/IAI.68.10.5559-5566.2000; Omosun YO, 2005, ACTA TROP, V95, P233, DOI 10.1016/j.actatropica.2005.06.019; ORLANDI PA, 1992, J CELL BIOL, V116, P901, DOI 10.1083/jcb.116.4.901; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Osier FHA, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-108; PASVOL G, 1978, NATURE, V274, P701, DOI 10.1038/274701a0; Persson KEM, 2008, J CLIN INVEST, V118, P342, DOI 10.1172/JCI32138; Persson KEM, 2006, J CLIN MICROBIOL, V44, P1665, DOI 10.1128/JCM.44.5.1665-1673.2006; Persson KEM, 2013, J IMMUNOL, V191, P785, DOI 10.4049/jimmunol.1300444; Peterson DS, 2000, MOL BIOCHEM PARASIT, V105, P105, DOI 10.1016/S0166-6851(99)00173-5; Portugal S, 2013, J IMMUNOL, V190, P3039, DOI 10.4049/jimmunol.1203067; Reiling L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045253; Reiling L, 2010, J IMMUNOL, V185, P6157, DOI 10.4049/jimmunol.1001555; Richards JS, 2013, J IMMUNOL, V191, P795, DOI 10.4049/jimmunol.1300778; Richards JS, 2010, CLIN INFECT DIS, V51, pE50, DOI 10.1086/656413; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; RTS S Clinical Trials Partnership, 2015, LANCET, V6736, P1; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Stubbs J, 2005, SCIENCE, V309, P1384, DOI 10.1126/science.1115257; Taylor HM, 2002, INFECT IMMUN, V70, P5779, DOI 10.1128/IAI.70.10.5779-5789.2002; Taylor RR, 1996, INT IMMUNOL, V8, P905, DOI 10.1093/intimm/8.6.905; Tham WH, 2012, TRENDS PARASITOL, V28, P23, DOI 10.1016/j.pt.2011.10.002; Tham WH, 2010, P NATL ACAD SCI USA, V107, P17327, DOI 10.1073/pnas.1008151107; White MT, 2014, J INFECT DIS, V210, P1115, DOI 10.1093/infdis/jiu219; WHO, 2016, WORLD MAL REP 2016; Yasukochi Y, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0820-2; Zheng H, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/362605	63	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182187	10.1371/journal.pone.0182187	http://dx.doi.org/10.1371/journal.pone.0182187			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28787025	Green Published, gold			2022-12-26	WOS:000406998800018
J	Brunner, D; Abramovitch, A; Etherton, J				Brunner, Devon; Abramovitch, Amitai; Etherton, Joseph			A yoga program for cognitive enhancement	PLOS ONE			English	Article							ATTENTION AWARENESS SCALE; WORKING-MEMORY CAPACITY; EXECUTIVE FUNCTION; FLUID INTELLIGENCE; OLDER-ADULTS; MINDFULNESS; POPULATION; STRESS; SPAN; MAAS	Background Recent studies suggest that yoga practice may improve cognitive functioning. Although preliminary data indicate that yoga improves working memory (WM), high-resolution information about the type of WM subconstructs, namely maintenance and manipulation, is not available. Furthermore, the association between cognitive enhancement and improved mindfulness as a result of yoga practice requires empirical examination. The aim of the present study is to assess the impact of a brief yoga program on WM maintenance, WM manipulation and attentive mindfulness. Methods Measures of WM(Digit Span Forward, Backward, and Sequencing, and Letter-Number Sequencing) were administered prior to and following 6 sessions of yoga (N = 43). Additionally, the Mindfulness Attention Awareness Scale was administered to examine the potential impact of yoga practice on mindfulness, as well as the relationships among changes in WM and mindfulness. Results Analyses revealed significant improvement from pre- to post- training assessment on both maintenance WM (Digit Span Forward) and manipulation WM(Digit Span Backward and Letter-Number Sequencing). No change was found on Digit Span Sequencing. Improvement was also found on mindfulness scores. However, no correlation was observed between mindfulness and WM measures. Conclusions A 6-session yoga program was associated with improvement on manipulation and maintenance WM measures as well as enhanced mindfulness scores. Additional research is needed to understand the extent of yoga-related cognitive enhancement and mechanisms by which yoga may enhance cognition, ideally by utilizing randomized controlled trials and more comprehensive neuropsychological batteries.	[Brunner, Devon; Abramovitch, Amitai; Etherton, Joseph] Texas State Univ, Dept Psychol, San Marcos, TX 78666 USA	Texas State University System; Texas State University San Marcos	Brunner, D (corresponding author), Texas State Univ, Dept Psychol, San Marcos, TX 78666 USA.	brunner.devon@gmail.com	Abramovitch, Amitai/AAJ-9762-2021	Abramovitch, Amitai/0000-0001-9640-0970; Brunner, Devon/0000-0002-9690-7103	Texas State University	Texas State University	This study was supported by a grant that was an internal grant for under graduate students from Texas State University (DB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J, 2000, LEARNING MEMORY; [Anonymous], [No title captured]; Bhatia T, 2016, ACTA NEUROPSYCH 0812, P1; Bishop SR, 2004, CLIN PSYCHOL-SCI PR, V11, P230, DOI 10.1093/clipsy/bph077; Black DS, 2012, ASSESSMENT, V19, P42, DOI 10.1177/1073191111415365; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Brown RP, 2005, J ALTERN COMPLEM MED, V11, P711, DOI 10.1089/acm.2005.11.711; Carlson LE, 2005, J PSYCHOSOM RES, V58, P29, DOI 10.1016/j.jpsychores.2004.04.366; Carmody J, 2008, J BEHAV MED, V31, P23, DOI 10.1007/s10865-007-9130-7; Chandra S, 2016, BRAIN INFORM; Conway ARA, 2002, INTELLIGENCE, V30, P163, DOI 10.1016/S0160-2896(01)00096-4; Desai R, 2015, COMPLEMENT THER CLIN, V21, P112, DOI 10.1016/j.ctcp.2015.02.002; Hernandez SE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150757; Estevis E, 2012, CLIN NEUROPSYCHOL, V26, P239, DOI 10.1080/13854046.2012.659219; Evans JST, 2003, TRENDS COGN SCI, V7, P454, DOI 10.1016/j.tics.2003.08.012; Frazier TW, 2004, NEUROPSYCHOLOGY, V18, P543, DOI 10.1037/0894-4105.18.3.543; Gard T, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00137; Geyer Jason, 2015, Alzheimers Dement (Amst), V1, P260, DOI 10.1016/j.dadm.2015.04.002; Gothe NP, 2016, BIOL PSYCHOL, V121, P109, DOI 10.1016/j.biopsycho.2016.10.010; Gothe NP, 2015, PSYCHOSOM MED, V77, P784, DOI 10.1097/PSY.0000000000000218; Gothe NP, 2014, J GERONTOL A-BIOL, V69, P1109, DOI 10.1093/gerona/glu095; Hale JB, 2002, J PSYCHOEDUC ASSESS, V20, P128, DOI 10.1177/073428290202000202; Hardy JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134467; Hariprasad VR, 2013, INDIAN J PSYCHIAT, V55, pS357, DOI 10.4103/0019-5545.116308; IMPETT E. A., 2006, SEX RES SOC POL, V3, P39, DOI [DOI 10.1525/SRSP.2006.3.4.39, 10.1525/srsp.2006.3.4.39]; Iyengar BK, 1996, LIGHT YOGA BIBLE MOD; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Jerath R, 2006, MED HYPOTHESES, V67, P566, DOI 10.1016/j.mehy.2006.02.042; Jermann F, 2009, PSYCHOL ASSESSMENT, V21, P506, DOI 10.1037/a0017032; Jha AP, 2010, EMOTION, V10, P54, DOI 10.1037/a0018438; Kane MJ, 2004, J EXP PSYCHOL GEN, V133, P189, DOI 10.1037/0096-3445.133.2.189; Khalsa S.B.S., 2007, PRINCIPLES PRACTICE, P449; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; Leh SE, 2010, NEUROPSYCHOPHARMACOL, V35, P70, DOI 10.1038/npp.2009.88; Lutz A, 2008, TRENDS COGN SCI, V12, P163, DOI 10.1016/j.tics.2008.01.005; MacKillop J, 2007, J PSYCHOPATHOL BEHAV, V29, P289, DOI 10.1007/s10862-007-9045-1; McCall Marcy C, 2014, Int J Yoga, V7, P4, DOI 10.4103/0973-6131.123470; Mehling WE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048230; Melby-Lervag M, 2016, PERSPECT PSYCHOL SCI, V11, P512, DOI 10.1177/1745691616635612; Melby-Lervag M, 2013, DEV PSYCHOL, V49, P270, DOI 10.1037/a0028228; Nangia D., 2012, J INDIAN ACAD APPL P, V38, P262; Parker MG, 2007, GERONTOLOGIST, V47, P150, DOI 10.1093/geront/47.2.150; Rocha KKF, 2012, CONSCIOUS COGN, V21, P843, DOI 10.1016/j.concog.2012.01.014; Rodgers WL, 2003, J GERONTOL B-PSYCHOL, V58, pS338, DOI 10.1093/geronb/58.6.S338; Salmon P, 2009, COGN BEHAV PRACT, V16, P59, DOI 10.1016/j.cbpra.2008.07.002; Saoji A, 2016, J RELIG HLTH; Saper HB, 2004, ALTERNATIVE THERAPIE, V10; Shepherd GMG, 2013, NAT REV NEUROSCI, V14, P278, DOI 10.1038/nrn3469; Snyder HR, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00328; Subramanya P, 2009, BIOPSYCHOSOC MED, V3, DOI 10.1186/1751-0759-3-8; Theiling J, 2016, J ATTEN DISORD, V20, P913, DOI 10.1177/1087054713518241; Tran M D, 2001, Prev Cardiol, V4, P165, DOI 10.1111/j.1520-037X.2001.00542.x; Waters AJ, 2009, SUBST ABUS, V30, P328, DOI 10.1080/08897070903252080; Wechsler D, 2008, WAIS 4 WECHSLER ADUL; Wiley J, 2011, J EXP PSYCHOL LEARN, V37, P256, DOI 10.1037/a0021613; Woodyard Catherine, 2011, Int J Yoga, V4, P49, DOI 10.4103/0973-6131.85485; Young JC, 2012, CLIN NEUROPSYCHOL, V26, P147, DOI 10.1080/13854046.2011.647083	57	22	23	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0182366	10.1371/journal.pone.0182366	http://dx.doi.org/10.1371/journal.pone.0182366			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC6IS	28783749	gold, Green Published, Green Submitted			2022-12-26	WOS:000406944300034
J	Ferreira, AA; Souza, ZA; Goncalves, MJF; Santos, J; Pierin, AMG				Ferreira, Alaidistania Aparecida; Souza-Filho, Zilmar Augusto; Goncalves, Maria Jacirema F.; Santos, Juliano; Pierin, Angela Maria G.			Relationship between alcohol drinking and arterial hypertension in indigenous people of the Mura ethnics, Brazil	PLOS ONE			English	Article							BLOOD-PRESSURE; NECK CIRCUMFERENCE; YANOMAMO INDIANS; RISK-FACTORS; CONSUMPTION; OVERWEIGHT; OBESITY; STATE; LIFE	Objective To identify the consumption of alcoholic beverage and the relation with hypertension, their prevalence and associated factors, in indigenous Mura, Brazil. Methods A cross-sectional population-based study was conducted with 455 adult indigenous aged 18 years or more of Mura ethnics in Amazonia, Brazil. Interview was conducted and the alcohol intake was assessed by the Alcohol Use Disorders Identification Test. Blood pressure was measured in three measurements and the mean of the last two measurements was used. Physical examination included the following data: weight, height, waist and neck circumference, bioimpedance, and capillary measurement of glucose, triglycerides and cholesterol. Through multivariate Logistic regression in stepwise, the odds ratios for alcohol consumption and associated factors were identified. Results The prevalence of alcoholic beverage was 40.2%, with no significant difference for hypertension in those who drink (23.0%) and those who did not drink (29.0%). Referred hypertension in indigenous was associated to less use of alcoholic beverages (14.2% vs 24.3%, P = 0.009). After an adjusted analysis (Odds Ratio, 95% CI), there was a positive association between alcoholic drink intake and male sex (10.27, CI: 5.76-18.30), smoking (4.72, CI: 2.35-9.46) and live in rural areas (9.77, CI: 5.08-18.79). On the other hand, age (0.95, IC: 0.94-0.97), and absence of dyslipidemia (0.41, CI: 0.19-0.89) were associated to lower alcohol consumption. Conclusion The prevalence of alcoholic beverage was high and associated with referred hypertension, but this association was not maintained after adjusted analysis. Changes to habits and inappropriate lifestyles in indigenous populations and living in urban areas may contribute to increase risk for cardiovascular diseases. Therefore, health policies should be implemented to meet the uniqueness of indigenous people.	[Ferreira, Alaidistania Aparecida; Souza-Filho, Zilmar Augusto; Goncalves, Maria Jacirema F.] Univ Fed Amazonas, Escola Enfermagem Manaus, Manaus, Amazonas, Brazil; [Goncalves, Maria Jacirema F.] Fundacao Oswaldo Cruz, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil; [Santos, Juliano; Pierin, Angela Maria G.] Univ Sao Paulo, Escola Enfermagem, Sao Paulo, Brazil	Universidade Federal de Amazonas; Fundacao Oswaldo Cruz; Universidade de Sao Paulo	Ferreira, AA (corresponding author), Univ Fed Amazonas, Escola Enfermagem Manaus, Manaus, Amazonas, Brazil.	laiufam@gmail.com	dos Santos, Juliano/G-4523-2012; Goncalves, Maria Jacirema/Q-7455-2019	dos Santos, Juliano/0000-0001-9961-3576; Goncalves, Maria Jacirema/0000-0002-8460-8501	'Pro-Reitoria de Pesquisa e Pos-Graduacao' of the 'Universidade Federal do Amazonas'	'Pro-Reitoria de Pesquisa e Pos-Graduacao' of the 'Universidade Federal do Amazonas'	The publication fee of this article was supported by the 'Pro-Reitoria de Pesquisa e Pos-Graduacao' of the 'Universidade Federal do Amazonas.'	ABIA, 2013, SCEN SOD CONS BRAZ S; Aguiar JI, 1997, ALCOHOLISM TERENA IN; Albuquerque J, 1997, AN 1 OF MACR ESTR PR; Almeida T.S.O., 2016, REV SAUDE CIENCIA ON, V5, P76; Martins MSAS, 2010, ARQ BRAS CARDIOL, V94, P639, DOI 10.1590/S0066-782X2010005000028; [Anonymous], 2014, INSTRUCTION MANUAL B; [Anonymous], 2014, NAT SURV ALC DRUGS L; [Anonymous], 2000, WHO TECHN REP SER; Ben-Noun L, 2001, OBES RES, V9, P470, DOI 10.1038/oby.2001.61; Brasil. Ministerio da Saude, 2015, VIGITEL BRASIL 2014; Cardoso A, 2010, NATL SURVEY HLTH NUT; Chan DC, 2003, QJM-INT J MED, V96, P441, DOI 10.1093/qjmed/hcg069; Cibeira GH, 2013, CIENC SAUDE COLETIVA, V18, P3577, DOI 10.1590/S1413-81232013001200014; Coimbra CEAJ., 2000, CIENC SAUDE COLETIVA, V5, P125, DOI [10.1590/S1413-81232000000100011, DOI 10.1590/S1413-81232000000100011]; de Souza ZA, 2015, REV ESC ENFERM USP, V49, P1012, DOI 10.1590/S0080-623420150000600019; Favaro TR, 2015, CAD SAUDE PUBLICA, V31, P1685, DOI 10.1590/0102-311X00086014; Ghiggi A, 2014, CAD SAUDE PUBLICA, V30, P1250, DOI 10.1590/0102-311X00108613; Gruber S, 2015, STAT METHODS MED RES, V24, P1003, DOI 10.1177/0962280212437451; Guimarães Liliana A. M., 2007, Psicol. Soc., V19, P45, DOI 10.1590/S0102-71822007000100007; Higashiyama A, 2013, HYPERTENS RES, V36, P58, DOI 10.1038/hr.2012.133; IBGE. Brazilian Institute of Geography and Statistics, 2010, CENS 2010 IND GEN CH; IBGE. Brazilian Institute of Geography and Statistics, 2016, IND BRAZ SOC DOM CHA; IPAQ. Research Committee, 2017, INT PHYS ACT QUEST; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kavishe B, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0357-9; MALACHIAS MVB, 2016, ARQ BRAS CARDIOL S3, V107; Mancilha-Carvalho J J, 1992, Arq Bras Cardiol, V59, P275; Mancilha-Carvalho J J, 1991, Arq Bras Cardiol, V56, P477; Mancilha-Carvalho Jairo de Jesus, 2003, Arq. Bras. Cardiol., V80, P295, DOI 10.1590/S0066-782X2003000300005; MANCILHACARVALHO JJ, 1989, J HUM HYPERTENS, V3, P309; Melo Juliana Rízia Félix de, 2011, Physis, V21, P319, DOI 10.1590/S0103-73312011000100019; Oliveira GF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086278; OLIVER WJ, 1975, CIRCULATION, V52, P146, DOI 10.1161/01.CIR.52.1.146; Pitanga FJG, 2004, BRASIL REV BRAS EPID, V7, P259, DOI DOI 10.1590/S1415-790X2004000300004; de Souza MLP, 2008, CAD SAUDE PUBLICA, V24, pS91, DOI 10.1590/S0102-311X2008001300014; de Souza MLP, 2010, CIENC SAUDE COLETIVA, V15, P709, DOI 10.1590/S1413-81232010000300013; Lourenco AE, 2008, AM J HUM BIOL, V20, P564, DOI 10.1002/ajhb.20781; Sociedade Brasileira de Diabetes, 2015, GUID BRAZ DIAB SOC 2; Tibana RA, 2012, EINSTEIN-SAO PAULO, V10, P329, DOI 10.1590/S1679-45082012000300013; Jardim PCBV, 2007, ARQ BRAS CARDIOL, V88, P452, DOI 10.1590/S0066-782X2007000400015; Vera-Cala LM, 2011, ARQ BRAS CARDIOL, V96, P393, DOI 10.1590/S0066-782X2011005000038; Viertler RB, 2002, REV TELLUS INTERNET, V2, P9, DOI 10.20435/tellus.v0i2.8; World Health Organization, 1980, TECHNICAL REPORT SER, V650; Xavier HT, 2013, ARQ BRAS CARDIOL, V101, P1, DOI 10.5935/abc.2013S010	44	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0182352	10.1371/journal.pone.0182352	http://dx.doi.org/10.1371/journal.pone.0182352			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28777805	Green Published, Green Submitted, gold			2022-12-26	WOS:000406944300032
J	Vasseur, MV; Lacroix, MZ; Toutain, PL; Bousquet-Melou, A; Ferran, AA				Vasseur, Maleck V.; Lacroix, Marlene Z.; Toutain, Pierre-Louis; Bousquet-Melou, Alain; Ferran, Aude A.			Infection-stage adjusted dose of beta-lactams for parsimonious and efficient antibiotic treatments: A Pasteurella multocida experimental pneumonia in mice	PLOS ONE			English	Article							BOVINE RESPIRATORY-DISEASE; INOCULUM SIZE; KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; RESISTANCE; MODEL; EMERGENCE; SELECTION; EFFICACY; THERAPY	In this study, the impact of infection stage on clinically and microbiologically efficacious doses and on antibiotic consumption was assessed during a naturally evolving infectious disease, using an original mouse model of pulmonary infection produced by air-borne contamination. When Pasteurella multocida was administered as pathogenic agent to immunocompetent mice, 60% of the animals exhibited clinical symptoms of pneumonia 2 to 4 days after bacterial contamination of the lungs. Two beta-lactam antibiotics were evaluated: amoxicillin and cefquinome, a fourth generation cephalosporin developed for food animals. First, a pharmacokinetic study was performed in infected mice to determine the exposure to amoxicillin or cefquinome required to treat clinically affected animals, based on the targeted values of PK/PD indices for beta-lactams. We then confirmed that these doses resulted in a 100% clinical cure rate in animals exhibiting clinical signs of infection and harboring a high pathogenic inoculum. More interestingly, we also showed that the same 100% clinical cure could be obtained in our model with 10-fold lower doses in animals at pre-patent stages of infection i.e. when harboring a low pathogenic inoculum. At the group level, antimicrobial drug consumption was reduced by treating animals at an early stage of the infection course with a pre-patent tailored dose. These results suggest that early treatment with a dose suitably adjusted to the stage of infection might help to reduce both overall antibiotic consumption and resistance selection pressure in the animals and in the environment.	[Vasseur, Maleck V.; Lacroix, Marlene Z.; Toutain, Pierre-Louis; Bousquet-Melou, Alain; Ferran, Aude A.] Univ Toulouse, INRA, UPS, Toxalim Res Ctr Food Toxicol,ENVT,INP Purpan, Toulouse, France	INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Toulouse III - Paul Sabatier	Ferran, AA (corresponding author), Univ Toulouse, INRA, UPS, Toxalim Res Ctr Food Toxicol,ENVT,INP Purpan, Toulouse, France.	a.ferran@envt.fr	BOUSQUET-MELOU, Alain/O-5357-2017; Toutain, Pierre Louis/G-4540-2011; BOUSQUET-MELOU, Alain/AAS-5425-2020; Ferran, Aude/J-6344-2013	Toutain, Pierre Louis/0000-0002-8846-8892; BOUSQUET-MELOU, Alain/0000-0002-7661-4311; Ferran, Aude/0000-0002-6629-1088; Lacroix, Marlene/0000-0002-6981-8340				Ackermann MR, 2000, MICROBES INFECT, V2, P1079, DOI 10.1016/S1286-4579(00)01262-4; Andremont A, 2003, ASM NEWS, V69, P601; Canton R, 2011, FEMS MICROBIOL REV, V35, P977, DOI 10.1111/j.1574-6976.2011.00295.x; Cockerill F., 2015, METHODS DILUTION ANT, V10th; Craig WA, 1998, CLIN INFECT DIS, V26, P1, DOI 10.1086/516284; Craig WA, 2003, INFECT DIS CLIN N AM, V17, P479, DOI 10.1016/S0891-5520(03)00065-5; Dagleish MP, 2010, J COMP PATHOL, V142, P157, DOI 10.1016/j.jcpa.2009.10.015; Dudley M. N., 2001, ANTIMICROBIAL PHARMA, P67; EAGLE H, 1949, J EXP MED, V90, P595, DOI 10.1084/jem.90.6.595; Ferran A, 2007, ANTIMICROB AGENTS CH, V51, P4163, DOI 10.1128/AAC.00156-07; Ferran AA, 2011, VET MICROBIOL, V148, P292, DOI 10.1016/j.vetmic.2010.09.005; Ferran AA, 2009, ANTIMICROB AGENTS CH, V53, P3384, DOI 10.1128/AAC.01347-08; Forbes AB, 2011, ANTIMICROB AGENTS CH, V55, P831, DOI 10.1128/AAC.00552-10; Jumbe N, 2003, J CLIN INVEST, V112, P275, DOI 10.1172/JCI200316814; Kesteman AS, 2010, ANTIMICROB AGENTS CH, V54, P2960, DOI 10.1128/AAC.01612-09; Kesteman AS, 2009, ANTIMICROB AGENTS CH, V53, P4740, DOI 10.1128/AAC.00608-09; Martinez MN, 2012, ANTIMICROB AGENTS CH, V56, P2795, DOI 10.1128/AAC.05360-11; Mizunaga S, 2005, J ANTIMICROB CHEMOTH, V56, P91, DOI 10.1093/jac/dki163; Morrissey I, 1999, J ANTIMICROB CHEMOTH, V43, P423; Nickell JS, 2010, VET CLIN N AM-FOOD A, V26, P285, DOI 10.1016/j.cvfa.2010.04.006; Sanderson MW, 2008, CAN VET J, V49, P373; Timsit E, 2011, VET J, V190, P136, DOI 10.1016/j.tvjl.2010.09.012; Toutain PL, 2002, RES VET SCI, V73, P105, DOI 10.1016/S0034-5288(02)00039-5; Udekwu KI, 2009, J ANTIMICROB CHEMOTH, V63, P745, DOI 10.1093/jac/dkn554; United State Department of Agriculture, 2013, TYP COSTS RESP DIS T; Vasseur MV, 2014, ANTIMICROB AGENTS CH, V58, P1744, DOI 10.1128/AAC.02135-13	26	6	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0182863	10.1371/journal.pone.0182863	http://dx.doi.org/10.1371/journal.pone.0182863			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28777819	Green Submitted, Green Published, gold			2022-12-26	WOS:000406944300059
J	Gullmets, J; Torvaldson, E; Lindqvist, J; Imanishi, SY; Taimen, P; Meinander, A; Eriksson, JE				Gullmets, Josef; Torvaldson, Elin; Lindqvist, Julia; Imanishi, Susumu Y.; Taimen, Pekka; Meinander, Annika; Eriksson, John E.			Internal epithelia in Drosophila display rudimentary competence to form cytoplasmic networks of transgenic human vimentin	FASEB JOURNAL			English	Article						intermediate filaments; lamin; tropomyosin; arthropod; evolution	INTERMEDIATE-FILAMENT PROTEINS; EPIDERMOLYSIS-BULLOSA SIMPLEX; MICE LACKING VIMENTIN; NUCLEAR LAMINS; EVOLUTION; DIFFERENTIATION; INVERTEBRATES; MELANOGASTER; ORGANIZATION; ARCHITECTURE	Cytoplasmic intermediate filaments (cIFs) are found in all eumetazoans, except arthropods. To investigate the compatibility of cIFs in arthropods, we expressed human vimentin(h Vim), a cIF with filament-forming capacity in vertebrate cells and tissues, transgenically in Drosophila. Transgenic hVim could be recovered from whole-fly lysates by using a standard procedure for intermediate filament (IF) extraction. When this procedure was used to test for the possible presence of IF-like proteins in flies, only lamins and tropomyosin were observed in IF-enriched extracts, thereby providing biochemical reinforcement to the paradigm that arthropods lack cIFs. In Drosophila, transgenic hVim was unable to form filament networks in S2 cells and mesenchymal tissues; however, cage-like vimentin structures could be observed around the nuclei in internal epithelia, which suggests that Drosophila retains selective competence for filament formation. Taken together, our results imply that although the filament network formation competence is partially lost in Drosophila, a rudimentary filament network formation ability remains in epithelial cells. As a result of the observed selective competence for cIF assembly in Drosophila, we hypothesize that internal epithelial cIFs were the last cIFs to disappear from arthropods.	[Gullmets, Josef; Torvaldson, Elin; Lindqvist, Julia; Meinander, Annika; Eriksson, John E.] Abo Akad Univ, Cell Biol, Fac Sci & Engn, Turku, Finland; [Gullmets, Josef; Torvaldson, Elin; Lindqvist, Julia; Imanishi, Susumu Y.; Eriksson, John E.] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Gullmets, Josef; Torvaldson, Elin; Lindqvist, Julia; Imanishi, Susumu Y.; Eriksson, John E.] Abo Akad Univ, Turku, Finland; [Gullmets, Josef; Taimen, Pekka] Univ Turku, Dept Pathol, Turku, Finland; [Gullmets, Josef; Taimen, Pekka] Turku Univ Hosp, Turku, Finland; [Gullmets, Josef; Taimen, Pekka] MediCity Res Lab, Turku, Finland	Abo Akademi University; University of Turku; Abo Akademi University; University of Turku; University of Turku; University of Turku	Eriksson, JE (corresponding author), Abo Akad Univ, Fac Sci & Engn, Tykistokatu 6,2nd Floor, FIN-20520 Turku, Finland.; Eriksson, JE (corresponding author), Univ Turku, Tykistokatu 6,2nd Floor, FIN-20520 Turku, Finland.	john.eriksson@abo.fi	Imanishi, Susumu/B-8697-2014; Meinander, Annika/E-9260-2017	Imanishi, Susumu/0000-0002-3641-4390; Meinander, Annika/0000-0002-3878-2293; Torvaldson, Elin/0000-0002-7175-6396; Gullmets, Josef/0000-0003-2466-7574	Academy of Finland; Sigrid Juselius Foundation; Magnus Ehrnrooth Foundation; Svenska Kulturfonden; Svensk-Osterbottniska Samfundet; Waldemar von Frenckell's Foundation; K. Albin Johansson's Foundation; Medicinska Understodsforening Liv och Halsa r.f.; Finsk-Norska Medicinska Stiftelsen; Finnish Medical Foundation; Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse; Maud Kuistila Memorial Foundation; Turku Doctoral Network in Molecular Biosciences; Turku Graduate School for Biomedical Sciences	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Magnus Ehrnrooth Foundation; Svenska Kulturfonden; Svensk-Osterbottniska Samfundet; Waldemar von Frenckell's Foundation; K. Albin Johansson's Foundation; Medicinska Understodsforening Liv och Halsa r.f.; Finsk-Norska Medicinska Stiftelsen; Finnish Medical Foundation; Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse; Maud Kuistila Memorial Foundation; Turku Doctoral Network in Molecular Biosciences; Turku Graduate School for Biomedical Sciences	This work was supported by the Academy of Finland, the Sigrid Juselius Foundation, the Magnus Ehrnrooth Foundation, Svenska Kulturfonden, Svensk-Osterbottniska Samfundet, Waldemar von Frenckell's Foundation, K. Albin Johansson's Foundation, Medicinska Understodsforening Liv och Halsa r.f., Finsk-Norska Medicinska Stiftelsen, The Finnish Medical Foundation, Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse, and the Maud Kuistila Memorial Foundation. The authors thank Dr. Gregory Edgecombe (The Natural History Museum, London, United Kingdom) for valuable comments on the manuscript. The authors also thank Prof. Konrad Basler (University of Zurich, Zurich, Switzerland) for the pUAS-attB plasmid. The authors thank Karolina Ost and Fanny Orn for technical assistance, and Markku Saari and Jouko Sandholm (Imaging Core at Turku Center for Biotechnology) for assistance with imaging. Biocenter Finland and the Turku Proteomics Facility are acknowledged for assistance with mass spectrometry. Sinikka Collanus and the histology personnel at Pathology/Tyks are acknowledged for assistance in histological applications. Turku Doctoral Network in Molecular Biosciences and Turku Graduate School for Biomedical Sciences are acknowledged for their support. J. E. E. was the principal, and A. M. the coprincipal investigator in this project. The authors declare no conflicts of interest.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; BARTNIK E, 1989, EUR J CELL BIOL, V50, P17; Bischof J, 2014, NAT PROTOC, V9, P1607, DOI 10.1038/nprot.2014.105; BLUMENBERG M, 1989, MOL BIOL EVOL, V6, P53; Bohnekamp J, 2015, J INVEST DERMATOL, V135, P2031, DOI 10.1038/jid.2015.129; Boraas LC, 2016, SCI REP-UK, V6, DOI 10.1038/srep30814; Broers JLV, 1997, HISTOCHEM CELL BIOL, V107, P505, DOI 10.1007/s004180050138; Carberry K, 2009, CELL MOTIL CYTOSKEL, V66, P852, DOI 10.1002/cm.20372; Cheng F, 2016, P NATL ACAD SCI USA, V113, pE4320, DOI 10.1073/pnas.1519197113; Cho A, 2016, CELL REP, V16, P928, DOI 10.1016/j.celrep.2016.06.054; COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Dunn CW, 2014, ANNU REV ECOL EVOL S, V45, P371, DOI 10.1146/annurev-ecolsys-120213-091627; Eckes B, 2000, J CELL SCI, V113, P2455; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; Fedorchak GR, 2014, PROG BIOPHYS MOL BIO, V115, P76, DOI 10.1016/j.pbiomolbio.2014.06.009; Ganot P, 2015, MOL BIOL EVOL, V32, P44, DOI 10.1093/molbev/msu265; Gregory SL, 1998, J CELL BIOL, V143, P1271, DOI 10.1083/jcb.143.5.1271; Hering L, 2016, ELIFE, V5, DOI [10.7554/eLife.11117, 10.7554/eLife.1117]; Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214; Hwang JS, 2008, MOL BIOL EVOL, V25, P2009, DOI 10.1093/molbev/msn154; Imanishi SY, 2007, PROTEOMICS, V7, P174, DOI 10.1002/pmic.200600571; Li ZL, 1996, DEV BIOL, V175, P362, DOI 10.1006/dbio.1996.0122; LLOYD C, 1995, J CELL BIOL, V129, P1329, DOI 10.1083/jcb.129.5.1329; MARCHUK D, 1984, CELL, V39, P491, DOI 10.1016/0092-8674(84)90456-2; Matsuyama M, 2013, J BIOL CHEM, V288, P35626, DOI 10.1074/jbc.M113.514737; Mencarelli C, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-17; Milner DJ, 1996, J CELL BIOL, V134, P1255, DOI 10.1083/jcb.134.5.1255; Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762; Omary MB, 2009, J CLIN INVEST, V119, P1756, DOI 10.1172/JCI39894; Peter A, 2015, CURR OPIN CELL BIOL, V32, P48, DOI 10.1016/j.ceb.2014.12.009; Peter A, 2012, NUCLEUS-PHILA, V3, P44, DOI 10.4161/nucl.18927; Peters B, 2001, MOL BIOL CELL, V12, P1775, DOI 10.1091/mbc.12.6.1775; Sahlgren CM, 2003, MOL CELL BIOL, V23, P5090, DOI 10.1128/MCB.23.14.5090-5106.2003; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Virtakoivu R, 2015, CANCER RES, V75, P2349, DOI 10.1158/0008-5472.CAN-14-2842; WEBER K, 1989, EMBO J, V8, P3221, DOI 10.1002/j.1460-2075.1989.tb08481.x; ZACKROFF RV, 1980, SCIENCE, V208, P1152, DOI 10.1126/science.7189605; Zhang HY, 2013, AGING CELL, V12, P2, DOI 10.1111/acel.12021	39	1	1	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5332	+		10.1096/fj.201700332R	http://dx.doi.org/10.1096/fj.201700332R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28778974				2022-12-26	WOS:000416588300018
J	Somasagara, RR; Spencer, SM; Tripathi, K; Clark, DW; Mani, C; da Silva, LM; Scalici, J; Kothayer, H; Westwell, AD; Rocconi, RP; Palle, K				Somasagara, R. R.; Spencer, S. M.; Tripathi, K.; Clark, D. W.; Mani, C.; da Silva, L. Madeira; Scalici, J.; Kothayer, H.; Westwell, A. D.; Rocconi, R. P.; Palle, K.			RAD6 promotes DNA repair and stem cell signaling in ovarian cancer and is a promising therapeutic target to prevent and treat acquired chemoresistance	ONCOGENE			English	Article							UBIQUITIN-CONJUGATING ENZYME; HISTONE H2B MONOUBIQUITINATION; VITRO ANTICANCER EVALUATION; DAMAGE-INDUCED RESPONSE; S-PHASE CHECKPOINT; BETA-CATENIN; POTENTIAL MECHANISM; POLYMERASE SWITCH; COMPLEX-FORMATION; H3K4 METHYLATION	Ovarian cancer (OC) is the most deadly gynecological cancer and unlike most other neoplasms, survival rates for OC have not significantly improved in recent decades. We show that RAD6, an ubiquitin-conjugating enzyme, is significantly overexpressed in ovarian tumors and its expression increases in response to carboplatin chemotherapy. RAD6 expression correlated strongly with acquired chemoresistance and malignant behavior of OC cells, expression of stem cell genes and poor prognosis of OC patients, suggesting an important role for RAD6 in ovarian tumor progression. Upregulated RAD6 enhances DNA damage tolerance and repair efficiency of OC cells and promotes their survival. Increased RAD6 levels cause histone 2B ubiquitination-mediated epigenetic changes that stimulate transcription of stem cell genes, including ALDH1A1 and SOX2, leading to a cancer stem cell phenotype, which is implicated in disease recurrence and metastasis. Downregulation of RAD6 or its inhibition using a small molecule inhibitor attenuated DNA repair signaling and expression of cancer stem cells markers and sensitized chemoresistant OC cells to carboplatin. Together, these results suggest that RAD6 could be a therapeutic target to prevent and treat acquired chemoresistance and disease recurrence in OC and enhance the efficacy of standard chemotherapy.	[Somasagara, R. R.; Spencer, S. M.; Tripathi, K.; Clark, D. W.; Mani, C.; da Silva, L. Madeira; Scalici, J.; Rocconi, R. P.; Palle, K.] Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, Mobile, AL 36604 USA; [Kothayer, H.] Zagazig Univ, Dept Med Chem, Zagazig, Egypt; [Westwell, A. D.] Cardiff Univ, Sch Pharm & Pharmaceut Sci, Cardiff, Wales	University of South Alabama; Egyptian Knowledge Bank (EKB); Zagazig University; Cardiff University	Palle, K (corresponding author), Univ S Alabama, Mitchell Canc Inst, 1660 Springhill Ave, Mobile, AL 36604 USA.	kpalle@health.southalabama.edu	Kothayer, Hend/GRJ-5827-2022; Westwell, Andrew David/M-8126-2014	Kothayer, Hend/0000-0002-2954-0751; Westwell, Andrew David/0000-0002-5166-9236	Abraham Mitchell Cancer Research Scholar Endowment grant; National Institutes of Health [R01GM098956]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098956] Funding Source: NIH RePORTER	Abraham Mitchell Cancer Research Scholar Endowment grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Abraham Mitchell Cancer Research Scholar Endowment grant, and by National Institutes of Health grant [R01GM098956] to KP. We would like to thank Joel Andrews, PhD and Steve McClellan for assistance with microscopy and flow cytometry, respectively.	Abdullah LN, 2013, CLIN TRANSL MED, V2, DOI 10.1186/2001-1326-2-3; de la Rocha AMA, 2014, AM J CANCER RES, V4, P312; Nguyen AT, 2011, GENE DEV, V25, P1345, DOI 10.1101/gad.2057811; BAILLY V, 1994, GENE DEV, V8, P811, DOI 10.1101/gad.8.7.811; Bi XH, 2006, MOL CELL BIOL, V26, P3527, DOI 10.1128/MCB.26.9.3527-3540.2006; Braun S, 2012, EMBO REP, V13, P619, DOI 10.1038/embor.2012.78; Cadigan Ken M., 2002, Trends in Genetics, V18, P340, DOI 10.1016/S0168-9525(02)02707-5; Chandrasekharan MB, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12314; Chen S, 2012, CELL RES, V22, P1402, DOI 10.1038/cr.2012.114; Chirnomas D, 2006, MOL CANCER THER, V5, P952, DOI 10.1158/1535-7163.MCT-05-0493; Clark DW, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.11.82; Clark DW, 2015, ONCOTARGET, V6, P28816, DOI 10.18632/oncotarget.5006; Condello S, 2015, ONCOGENE, V34, P2297, DOI 10.1038/onc.2014.178; Davis A, 2014, GYNECOL ONCOL, V133, P624, DOI 10.1016/j.ygyno.2014.02.038; Djordjevic B, 2012, J BUON, V17, P627; Ferrer Miriam, 2005, Clin Lung Cancer, V6, P250, DOI 10.3816/CLC.2005.n.005; Foley OW, 2013, ONCOLOGY-NY, V27, P288; Geng LY, 2010, J CELL BIOL, V191, P249, DOI 10.1083/jcb.201005101; Gerard B, 2012, BBA-MOL CELL RES, V1823, P1686, DOI 10.1016/j.bbamcr.2012.05.032; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Haynes B, 2016, NANOMED-NANOTECHNOL, V12, P745, DOI 10.1016/j.nano.2015.10.010; Helchowski CM, 2013, CELL CYCLE, V12, P3749, DOI 10.4161/cc.26640; Houghtaling S, 2003, GENE DEV, V17, P2021, DOI 10.1101/gad.1103403; Hung SH, 2017, P NATL ACAD SCI USA, V114, pE2205, DOI 10.1073/pnas.1612633114; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; Ishiguro T, 2016, CANCER RES, V76, P150, DOI 10.1158/0008-5472.CAN-15-0361; Jazaeri AA, 2011, NEOPLASIA, V13, P899, DOI 10.1593/neo.11138; Kandalaft LE, 2011, J CLIN ONCOL, V29, P925, DOI 10.1200/JCO.2009.27.2369; Kannouche PL, 2004, CELL CYCLE, V3, P1011; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kao CF, 2004, GENE DEV, V18, P184, DOI 10.1101/gad.1149604; Khan IN, 2015, DRUG DISCOV TODAY, V20, P1205, DOI 10.1016/j.drudis.2015.06.013; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Kobayashi S, 2015, ONCOGENE, V34, P4403, DOI 10.1038/onc.2014.371; KOKEN MHM, 1991, P NATL ACAD SCI USA, V88, P8865, DOI 10.1073/pnas.88.20.8865; Kothayer H, 2016, BIOORG MED CHEM LETT, V26, P2030, DOI 10.1016/j.bmcl.2016.02.085; Kothayer H, 2014, TETRAHEDRON LETT, V55, P7015, DOI 10.1016/j.tetlet.2014.10.122; Kothayer H, 2013, BIOORG MED CHEM LETT, V23, P6886, DOI 10.1016/j.bmcl.2013.09.087; Kuhl SJ, 2013, BBA-GEN SUBJECTS, V1830, P2297, DOI 10.1016/j.bbagen.2012.08.010; LAWRENCE C, 1994, BIOESSAYS, V16, P253, DOI 10.1002/bies.950160408; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Lyakhovich A, 2004, ONCOGENE, V23, P3097, DOI 10.1038/sj.onc.1207449; Lyakhovich A, 2003, MOL CELL BIOL, V23, P2463, DOI 10.1128/MCB.23.7.2463-2475.2003; Meng E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107142; Miki T, 2011, STEM CELL REV REP, V7, P836, DOI 10.1007/s12015-011-9275-1; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Palle K, 2011, CELL CYCLE, V10, P1625, DOI 10.4161/cc.10.10.15617; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Ring A, 2014, STEM CELL REV REP, V10, P512, DOI 10.1007/s12015-014-9515-2; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Rosner K, 2014, J SKIN CANCER, V2014, DOI 10.1155/2014/439205; Rosner K, 2014, TRANSL ONCOL, V7, P384, DOI 10.1016/j.tranon.2014.04.009; Sanders MA, 2013, MOL CANCER THER, V12, P373, DOI 10.1158/1535-7163.MCT-12-0793; Shekhar MPV, 2008, CANCER RES, V68, P1741, DOI 10.1158/0008-5472.CAN-07-2111; Shekhar MPV, 2006, MOL CANCER RES, V4, P729, DOI 10.1158/1541-7786.MCR-06-0136; Shekhar MPV, 2002, CANCER RES, V62, P2115; Soares LM, 2013, MOL CELL, V49, P1019, DOI 10.1016/j.molcel.2013.03.012; Somasagara RR, 2016, BIOCHEM BIOPH RES CO, V469, P449, DOI 10.1016/j.bbrc.2015.11.134; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Tripathi K, 2014, J BIOL CHEM, V289, P31513, DOI 10.1074/jbc.M114.606483; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Yochum GS, 2008, MOL CELL BIOL, V28, P7368, DOI 10.1128/MCB.00744-08; Zhang F, 2011, MOL CELL, V41, P384, DOI 10.1016/j.molcel.2011.01.024; Zhang Z, 2013, GENE DEV, V27, P1581, DOI 10.1101/gad.211037.112	66	38	38	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 30	2017	36	48					6680	6690		10.1038/onc.2017.279	http://dx.doi.org/10.1038/onc.2017.279			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FO4AJ	28806395	Green Accepted			2022-12-26	WOS:000416780800003
J	Govaere, O; Petz, M; Wouters, J; Vandewynckel, YP; Scott, EJ; Topal, B; Nevens, F; Verslype, C; Anstee, QM; Van Vlierberghe, H; Mikulits, W; Roskams, T				Govaere, O.; Petz, M.; Wouters, J.; Vandewynckel, Y-P; Scott, E. J.; Topal, B.; Nevens, F.; Verslype, C.; Anstee, Q. M.; Van Vlierberghe, H.; Mikulits, W.; Roskams, T.			The PDGFR alpha-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma	ONCOGENE			English	Article							IRES-MEDIATED TRANSLATION; POOR-PROGNOSIS; EXPRESSION; CYTOKERATIN-19; ANGIOGENESIS; DIAGNOSIS; MARKER; B1; LA	Human hepatocellular carcinomas (HCCs) expressing the biliary/hepatic progenitor cell marker keratin 19 (K19) have been linked with a poor prognosis and exhibit an increase in platelet-derived growth factor receptor a (PDGFR alpha) and laminin beta 1 (LAMB1) expression. PDGFR alpha has been reported to induce de novo synthesis of LAMB1 protein in a Sjogren syndrome antigen B (La/SSB)-dependent manner in a murine metastasis model. However, the role of this cascade in human HCC remains unclear. This study focused on the functional role of the PDGFR alpha-La/SSB-LAMB1 pathway and its molecular link to K19 expression in human HCC. In surgical HCC specimens from a cohort of 136 patients, PDGFR alpha expression correlated with K19 expression, microvascular invasion and metastatic spread. In addition, PDGFR alpha expression in pre-operative needle biopsy specimens predicted poor overall survival during a 5-year follow-up period. Consecutive histological staining demonstrated that the signaling components of the PDGFR alpha-La/SSB-LAMB1 pathway were strongly expressed at the invasive front. K19-positive HCC cells displayed high levels of alpha 2 beta 1 integrin (ITG) receptor, both in vitro and in vivo. In vitro activation of PDGFR alpha signaling triggered the translocation of nuclear La/SSB into the cytoplasm, enhanced the protein synthesis of LAMB1 by activating its internal ribosome entry site, which in turn led to increased secretion of laminin-111. This effect was abrogated by the PDGFR alpha-specific inhibitor crenolanib. Importantly LAMB1 stimulated ITG-dependent focal adhesion kinase/Src proto-oncogene non-receptor tyrosine kinase signaling. It also promoted the ITG-specific downstream target Rho-associated coiled-coil containing protein kinase 2, induced K19 expression in an autocrine manner, invadopodia formation and cell invasion. Finally, we showed that the knockdown of LAMB1 or K19 in subcutaneous xenograft mouse models resulted in significant loss of cells invading the surrounding stromal tissue and reduced HepG2 colonization into lung and liver after tail vein injection. The PDGFR alpha-LAMB1 pathway supports tumor progression at the invasive front of human HCC through K19 expression.	[Govaere, O.; Wouters, J.; Roskams, T.] Katholieke Univ Leuven, Dept Imaging & Pathol, Leuven, Belgium; [Govaere, O.; Wouters, J.; Topal, B.; Nevens, F.; Verslype, C.; Roskams, T.] Univ Hosp Leuven, Leuven, Belgium; [Govaere, O.; Scott, E. J.; Anstee, Q. M.] Newcastle Univ, Med Sch, Liver Res Grp, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Petz, M.; Mikulits, W.] Med Univ Vienna, Comprehens Canc Ctr, Inst Canc Res, Dept Med 1, Borschke Gasse 8A, A-1090 Vienna, Austria; [Vandewynckel, Y-P; Van Vlierberghe, H.] Univ Ghent, Dept Hepatol & Gastroenterol, Ghent, Belgium; [Topal, B.] Katholieke Univ Leuven, Dept Abdominal Surg, Leuven, Belgium; [Nevens, F.; Verslype, C.] Katholieke Univ Leuven, Dept Hematol, Leuven, Belgium	KU Leuven; KU Leuven; University Hospital Leuven; Newcastle University - UK; Medical University of Vienna; Ghent University; KU Leuven; KU Leuven	Mikulits, W (corresponding author), Med Univ Vienna, Comprehens Canc Ctr, Inst Canc Res, Dept Med 1, Borschke Gasse 8A, A-1090 Vienna, Austria.; Govaere, O (corresponding author), Med Sch, Inst Cellular Med, Liver Res Grp, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	olivier.govaere@ncl.ac.uk; wolfgang.mikulits@meduniwien.ac.at	Govaere, Olivier/R-9372-2019; Anstee, Quentin M./L-2981-2013; Topal, Baki/AAH-9019-2021; Mikulits, Wolfgang/AAH-4043-2021; Scott, Emma/AAG-1311-2019; Wouters, Jasper/AAK-8597-2020	Govaere, Olivier/0000-0002-4426-6930; Anstee, Quentin M./0000-0002-9518-0088; Topal, Baki/0000-0002-2687-7535; Scott, Emma/0000-0002-5358-5132; Wouters, Jasper/0000-0002-7129-2990; Van Vlierberghe, Hans/0000-0003-0647-9238; Roskams, Tania/0000-0002-2816-1530; Mikulits, Wolfgang/0000-0003-4612-7106; Verslype, Chris/0000-0003-3857-466X	Belgian Federal Science Policy Office, Interuniversity Attraction Poles program [P7/83-HEPRO]; Austrian Science Fund, FWF [T597-B13, P25356]; Belgian Kom op tegen Kanker; Medical Research Council [1681148] Funding Source: researchfish	Belgian Federal Science Policy Office, Interuniversity Attraction Poles program; Austrian Science Fund, FWF(Austrian Science Fund (FWF)); Belgian Kom op tegen Kanker; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Belgian Federal Science Policy Office, Interuniversity Attraction Poles program-P7/83-HEPRO (to OG), Austrian Science Fund, FWF, T597-B13 (to MP) and P25356 (to WM) and the Belgian Kom op tegen Kanker (to JW). We thank Kathleen Van den Eynde and the Fibrosis Lab, Newcastle University, UK for their indispensible technical support.	Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Coulon S, 2011, LIVER INT, V31, P146, DOI 10.1111/j.1478-3231.2010.02369.x; Desmet VJ, 2011, VIRCHOWS ARCH, V458, P251, DOI 10.1007/s00428-011-1048-3; Dhanasekaran R, 2016, J HEPATOL, V64, P736, DOI 10.1016/j.jhep.2015.09.008; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Fernandez M, 2009, J HEPATOL, V50, P604, DOI 10.1016/j.jhep.2008.12.011; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Giannelli G, 2014, GUT, V63, P1668, DOI 10.1136/gutjnl-2014-307323; Govaere O, 2016, J HEPATOL, V64, P609, DOI 10.1016/j.jhep.2015.11.011; Govaere O, 2014, GUT, V63, P674, DOI 10.1136/gutjnl-2012-304351; Guldiken N, 2016, J HEPATOL, V65, P552, DOI 10.1016/j.jhep.2016.04.024; Heinrich MC, 2012, CLIN CANCER RES, V18, P4375, DOI 10.1158/1078-0432.CCR-12-0625; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kikuchi A, 2015, GENE EXPRESSION, V16, P109, DOI 10.3727/105221615X14181438356210; Kim H, 2011, HEPATOLOGY, V54, P1707, DOI 10.1002/hep.24559; Kojiro M, 2009, HEPATOLOGY, V49, P658, DOI 10.1002/hep.22709; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Llovet JM, 2006, GASTROENTEROLOGY, V131, P1758, DOI 10.1053/j.gastro.2006.09.014; Martin K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12502; Mu X, 2015, J CLIN INVEST, V125, P3891, DOI 10.1172/JCI77995; Patarroyo M, 2002, SEMIN CANCER BIOL, V12, P197, DOI 10.1016/S1044-579X(02)00023-8; Petz M, 2012, NUCLEIC ACIDS RES, V40, P9738, DOI 10.1093/nar/gks760; Petz M, 2012, NUCLEIC ACIDS RES, V40, P290, DOI 10.1093/nar/gkr717; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; Tsuchiya K, 2011, ONCOLOGY-BASEL, V80, P278, DOI 10.1159/000328448; Uenishi T, 2003, CANCER SCI, V94, P851, DOI 10.1111/j.1349-7006.2003.tb01366.x; van Zijl F, 2009, ONCOGENE, V28, P4022, DOI 10.1038/onc.2009.253; Villanueva A, 2010, ANNU REV MED, V61, P317, DOI 10.1146/annurev.med.080608.100623; Wei T, 2014, ONCOTARGET, V5, P10307, DOI 10.18632/oncotarget.2537; Wong CCL, 2009, HEPATOLOGY, V49, P1583, DOI 10.1002/hep.22836; Yang XR, 2008, CLIN CANCER RES, V14, P3850, DOI 10.1158/1078-0432.CCR-07-4338; Yimlamai D, 2014, CELL, V157, P1324, DOI 10.1016/j.cell.2014.03.060; Zhuang PY, 2008, CANCER-AM CANCER SOC, V112, P2740, DOI 10.1002/cncr.23488	38	37	38	4	12	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 23	2017	36	47					6605	6616		10.1038/onc.2017.260	http://dx.doi.org/10.1038/onc.2017.260			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FN5LN	28783171	Green Published, hybrid			2022-12-26	WOS:000416049200009
J	Utsumi, Y; Utsumi, C; Tanaka, M; Ha, VT; Matsui, A; Takahashi, S; Seki, M				Utsumi, Yoshinori; Utsumi, Chikako; Tanaka, Maho; Vu The Ha; Matsui, Akihiro; Takahashi, Satoshi; Seki, Motoaki			Formation of friable embryogenic callus in cassava is enhanced under conditions of reduced nitrate, potassium and phosphate	PLOS ONE			English	Article							MANIHOT-ESCULENTA CRANTZ; AGROBACTERIUM-MEDIATED TRANSFORMATION; POSTHARVEST PHYSIOLOGICAL DETERIORATION; TRANSGENIC CASSAVA; SUSPENSION-CULTURES; SOMATIC EMBRYOGENESIS; PARTICLE BOMBARDMENT; EFFICIENT PRODUCTION; PLANTS; REGENERATION	Agrobacterium-mediated transformation is an important research tool for the genetic improvement of cassava. The induction of friable embryogenic callus (FEC) is considered as a key step in cassava transformation. In the present study, the media composition was optimized for enhancing the FEC induction, and the effect of the optimized medium on gene expression was evaluated. In relative comparison to MS medium, results demonstrated that using a medium with reducing nutrition (a 10-fold less concentration of nitrogen, potassium, and phosphate), the increased amount of vitamin B1 (10 mg/L) and the use of picrolam led to reprogram non-FEC to FEC. Gene expression analyses revealed that FEC on modified media increased the expression of genes related to the regulation of polysaccharide biosynthesis and breakdown of cell wall components in comparison to FEC on normal CIM media, whereas the gene expression associated with energy flux was not dramatically altered. It is hypothesized that we reprogram non-FEC to FEC under low nitrogen, potassium and phosphate and high vitamin B1. These findings were more effective in inducing FEC formation than the previous protocol. It might contribute to development of an efficient transformation strategy in cassava.	[Utsumi, Yoshinori; Utsumi, Chikako; Tanaka, Maho; Vu The Ha; Matsui, Akihiro; Takahashi, Satoshi; Seki, Motoaki] RIKEN Ctr Sustainable Resource Sci, Plant Genom Network Res Team, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa, Japan; [Utsumi, Chikako; Seki, Motoaki] JST, CREST, 4-1-8 Honcho, Kawaguchi, Saitama, Japan; [Seki, Motoaki] Yokohama City Univ, Kihara Inst Biol Res, Totsuka Ku, 641-12 Maioka Cho, Yokohama, Kanagawa, Japan	RIKEN; Japan Science & Technology Agency (JST); Yokohama City University	Seki, M (corresponding author), RIKEN Ctr Sustainable Resource Sci, Plant Genom Network Res Team, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa, Japan.; Seki, M (corresponding author), JST, CREST, 4-1-8 Honcho, Kawaguchi, Saitama, Japan.; Seki, M (corresponding author), Yokohama City Univ, Kihara Inst Biol Res, Totsuka Ku, 641-12 Maioka Cho, Yokohama, Kanagawa, Japan.	motoaki.seki@riken.jp	Utsumi, Yoshinori/AAR-1844-2020; Seki, Motoaki/I-2854-2012	Utsumi, Yoshinori/0000-0002-9196-7123; Seki, Motoaki/0000-0001-8288-0467	East Asia Science and Innovation Area Joint Research Program (e-ASIA JRP); Strategic Funds for the Promotion of Science and Technology; Core Research for Evolutionary Science and Technology (CREST) [JPMJCR13B4]; EIG CONCERT-Japan under Japan Science and Technology Agency (JST); KAKENHI of Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [16K14832]; Science and Technology Research Partnership for Sustainable Development (SATREPS) of JST/Japan International Cooperation Agency (JICA); Japan Society for the Promotion of Science (JSPS); RIKEN Center for Sustainable Resource Science (CSRS)	East Asia Science and Innovation Area Joint Research Program (e-ASIA JRP); Strategic Funds for the Promotion of Science and Technology; Core Research for Evolutionary Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); EIG CONCERT-Japan under Japan Science and Technology Agency (JST); KAKENHI of Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Science and Technology Research Partnership for Sustainable Development (SATREPS) of JST/Japan International Cooperation Agency (JICA); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); RIKEN Center for Sustainable Resource Science (CSRS)	This work was supported by the following funding: 1) East Asia Science and Innovation Area Joint Research Program (e-ASIA JRP; to M.S.), Strategic Funds for the Promotion of Science and Technology (to M.S.), Core Research for Evolutionary Science and Technology (CREST Grant No.: JPMJCR13B4; to M.S.), and EIG CONCERT-Japan 4th Call under the Strategic international Research cooperative Program (to M.S.) of the Japan Science and Technology Agency (JST); 2) KAKENHI Grant Number 16K14832 (to M.S.) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; 3) Science and Technology Research Partnership for Sustainable Development (SATREPS; to M.S.) of JST/Japan International Cooperation Agency (JICA); 4) Japan Society for the Promotion of Science (JSPS) Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers (to M.S.); 5) RIKEN Center for Sustainable Resource Science (CSRS) (to M.S.).r This work was supported by the following funding: 1) East Asia Science and Innovation Area Joint Research Program (e-ASIA JRP; to M.S.), Strategic Funds for the Promotion of Science and Technology (to M.S.), Core Research for Evolutionary Science and Technology (CREST Grant No.: JPMJCR13B4; to M.S.), and EIG CONCERT-Japan 4th Call under the Strategic international Research cooperative Program (to M.S.) of the Japan Science and Technology Agency (JST); 2) KAKENHI Grant Number 16K14832 (to M.S.) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; 3) Science and Technology Research Partnership for Sustainable Development (SATREPS; to M.S.) of JST/Japan International Cooperation Agency (JICA); 4) Japan Society for the Promotion of Science (JSPS) Program for Advancing Strategic International Networks to Accelerate the Circulation of Talented Researchers (to M.S.); 5) RIKEN Center for Sustainable Resource Science (CSRS) (to M.S.).	Apio H. B., 2015, African Journal of Biotechnology, V14, P1854; Balat M, 2009, APPL ENERG, V86, P2273, DOI 10.1016/j.apenergy.2009.03.015; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOHRER R, 1967, J ROY STAT SOC B, V29, P110; Bonner J, 1938, BOT GAZ, V100, P226, DOI 10.1086/334775; Bull SE, 2009, NAT PROTOC, V4, P1845, DOI 10.1038/nprot.2009.208; Ceballos H, 2004, PLANT MOL BIOL, V56, P503, DOI 10.1007/s11103-004-5010-5; Chauhan RD, 2015, PLANT CELL TISS ORG, V121, P591, DOI 10.1007/s11240-015-0729-z; Chavarriaga-Aguirre P, 2016, IN VITRO CELL DEV-PL, V52, P461, DOI 10.1007/s11627-016-9776-3; Chetty CC, 2012, N BIOTECHNOL, V25, P136; CHU CC, 1975, SCI SINICA, V18, P659; Dhillon RS, 2011, BIOMASS BIOENERG, V35, P1502, DOI 10.1016/j.biombioe.2010.12.017; Driver J, 1981, HORTSCIENCE, V19, P507; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Ferraro V, 2015, CRITICAL REVIEWS FOO, V56, P2714; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; Gonzalez AE, 1998, PLANT CELL REP, V17, P827, DOI 10.1007/s002990050492; GRESSHOFF PM, 1972, PLANTA, V107, P161, DOI 10.1007/BF00387721; Hartwell J, 1999, PLANT J, V20, P333, DOI 10.1046/j.1365-313X.1999.t01-1-00609.x; HOOD EE, 1986, J BACTERIOL, V168, P1283, DOI 10.1128/jb.168.3.1283-1290.1986; Ihemere U, 2006, PLANT BIOTECHNOL J, V4, P453, DOI 10.1111/j.1467-7652.2006.00195.x; Ihemere UE, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00171; Ikeuchi M, 2013, PLANT CELL, V25, P3159, DOI 10.1105/tpc.113.116053; Jansson C, 2009, APPL ENERG, V86, pS95, DOI 10.1016/j.apenergy.2009.05.011; Jorgensen K, 2005, PLANT PHYSIOL, V139, P363, DOI 10.1104/pp.105.065904; Koehorst-van Putten HJJ, 2012, TRANSGENIC RES, V21, P39, DOI 10.1007/s11248-011-9507-9; Li HQ, 1996, NAT BIOTECHNOL, V14, P736, DOI 10.1038/nbt0696-736; Li KT, 2015, NAT BIOTECHNOL, V33, P1029, DOI 10.1038/nbt.3318; Li RM, 2009, BIOSCI BIOTECH BIOCH, V73, P2513, DOI 10.1271/bbb.90321; Liu J, 2011, J INTEGR PLANT BIOL, V53, P552, DOI 10.1111/j.1744-7909.2011.01048.x; Lloyd G., 1980, Combined Proceedings, International Plant Propagators' Society, V30, P421; Ma QX, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00824; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Ntui VO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120551; Nyaboga E, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00526; Nyaboga EN, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00411; Owiti J, 2011, PLANT J, V67, P145, DOI 10.1111/j.1365-313X.2011.04582.x; Raemakers CJJM, 1996, MOL BREEDING, V2, P339, DOI 10.1007/BF00437912; Raemakers K, 2001, EUPHYTICA, V120, P15, DOI 10.1023/A:1017574713880; SAELIM L, 2006, GLOBAL J BIOTECHNOL, V1, P7; Saelim L, 2009, PLANT CELL REP, V28, P445, DOI 10.1007/s00299-008-0658-y; Sayre R, 2011, ANNU REV PLANT BIOL, V62, P251, DOI 10.1146/annurev-arplant-042110-103751; SCHENK RU, 1972, CAN J BOTANY, V50, P199, DOI 10.1139/b72-026; Schopke C, 1996, NAT BIOTECHNOL, V14, P731, DOI 10.1038/nbt0696-731; Schreuder MM, 2001, EUPHYTICA, V120, P35, DOI 10.1023/A:1017530932536; STAMP JA, 1982, Z PFLANZENPHYSIOL, V105, P183, DOI 10.1016/S0044-328X(82)80011-1; Taylor N, 2012, TROP PLANT BIOL, V5, P127, DOI 10.1007/s12042-012-9099-4; Taylor NJ, 1996, NAT BIOTECHNOL, V14, P726, DOI 10.1038/nbt0696-726; Taylor NJ, 2001, EUPHYTICA, V120, P25, DOI 10.1023/A:1017526814789; Utsumi Y, 2016, J PLANT RES, V129, P711, DOI 10.1007/s10265-016-0828-x; Vanderschuren H, 2007, PLANT MOL BIOL, V64, P549, DOI 10.1007/s11103-007-9175-6; Welsch R, 2010, PLANT CELL, V22, P3348, DOI 10.1105/tpc.110.077560; Xu J, 2013, PLANT PHYSIOL, V161, P1517, DOI 10.1104/pp.112.212803; Yadav JS, 2011, MOL PLANT PATHOL, V12, P677, DOI 10.1111/J.1364-3703.2010.00700.X; Zainuddin IM, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-24; Zhang P, 2000, PLANT CELL REP, V19, P939, DOI 10.1007/s002990000224; Zhang P, 2000, TRANSGENIC RES, V9, P405, DOI 10.1023/A:1026509017142; Zhang P, 2005, PLANT BIOTECHNOL J, V3, P385, DOI 10.1111/j.1467-7652.2005.00132.x; Zhang P, 2004, TRANSGENIC CROPS OF THE WORLD: ESSENTIAL PROTOCOLS, P301; Zhang P, 2010, J INTEGR PLANT BIOL, V52, P653, DOI 10.1111/j.1744-7909.2010.00956.x; Zhao SS, 2011, BIOTECHNOL BIOENG, V108, P1925, DOI 10.1002/bit.23120; Zidenga T, 2012, PLANT PHYSIOL, V159, P1396, DOI 10.1104/pp.112.200345	62	14	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2017	12	8							e0180736	10.1371/journal.pone.0180736	http://dx.doi.org/10.1371/journal.pone.0180736			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD5CP	28806727	Green Published, gold, Green Submitted			2022-12-26	WOS:000407548800004
J	Sellami, M; Dhahbi, W; Hayes, LD; Padulo, J; Rhibi, F; Djemail, H; Chaouachi, A				Sellami, Maha; Dhahbi, Wissem; Hayes, Lawrence D.; Padulo, Johnny; Rhibi, Fatma; Djemail, Hanen; Chaouachi, Anis			Combined sprint and resistance training abrogates age differences in somatotropic hormones	PLOS ONE			English	Article							GROWTH-FACTOR-I; FACTOR-BINDING-PROTEIN; HUMAN SKELETAL-MUSCLE; CATECHOLAMINE RESPONSES; SUPRAMAXIMAL EXERCISE; GLUCOREGULATORY HORMONES; PLASMA-GLUCOSE; AGING MEN; 30 S; INTERVAL	The aim of this investigation was to compare serum growth hormone (GH), insulin-like growth factor-1 (IGF-1) and insulin-like growth factor-binding protein-3 (IGFBP-3) in response to a combined sprint and resistance training (CSRT) program in young and middle-aged men. Thirty-eight healthy, moderately trained men participated in this study. Young and middle-aged men were randomly assigned to, a young training group (YT = 10, 21.4 +/- 1.2yrs) ora young control group (YC = 9, 21.6 +/- 1.8 yrs), a middle-aged training group (MAT = 10, 40.4 +/- 2.1 yrs) or a middle-aged control group (MAC = 9, 40.5 +/- 1.8 yrs). Participants performed the Wingate Anaerobic Test (WAnT) before and after a 13-week CSRT program (three sessions per week). Blood samples were collected at rest, after warm-up, immediately post-WAnT, and 10 min post-WAnT. CSRT induced increases in GH at rest and in response to the WAnT in YT and MAT (P<0.05). CSRT-induced increases were observed for IGF-1 and IGFBP-3 at rest in MAT only (P<0.05). Pre-training, GH, IGF-1 and IGFBP-3 were significantly higher at rest and in response to the WAnT in young participants as compared to their middle-aged counterparts (P<0.05). Post-training, YT and MAT had comparable basal GH (P>0.05). In response to the WAnT, amelioration of the age-effect was observed between YT and MAT for IGF-1 and IGF-1/IGFBP-3 ratio following CSRT (P>0.05). These data suggest that CSRT increases the activity of the GH/IGF-1 axis at rest and in response to the WAnT in young and middle-aged men. In addition, CSRT reduces the normal age-related decline of somatotropic hormones in middle-age men.	[Sellami, Maha; Dhahbi, Wissem; Padulo, Johnny; Chaouachi, Anis] Natl Ctr Med & Sci Sports, Tunisian Res Lab Sport Performance Optimizat, Tunis, Tunisia; [Hayes, Lawrence D.] Univ Cumbria, Dept Med & Sport Sci, Act Ageing Res Grp, Bowerham Rd, Lancaster, England; [Padulo, Johnny] Univ eCampus, Novedrate, Italy; [Padulo, Johnny] Univ Split, Fac Kinesiol, Split, Croatia; [Rhibi, Fatma] Univ Rennes 2, Movement Sport Hlth & Sci Lab M2S, Rennes, France; [Djemail, Hanen] Mil Hosp Instruct Tunis, Dept Endocrinol, Tunis, Tunisia	Centre National de la Medecine Sciences des Sports; University of Cumbria; Universita Ecampus; University of Split; Universite Rennes 2	Padulo, J (corresponding author), Natl Ctr Med & Sci Sports, Tunisian Res Lab Sport Performance Optimizat, Tunis, Tunisia.; Padulo, J (corresponding author), Univ eCampus, Novedrate, Italy.; Padulo, J (corresponding author), Univ Split, Fac Kinesiol, Split, Croatia.	sportcinetic@gmail.com	Hayes, Lawrence/AAI-1315-2020; Hayes, Lawrence D/I-9694-2019; Padulo, Johnny/AAK-2207-2020; Dhahbi, Wissem/A-1445-2019; RHIBI, Fatma/H-1353-2019	Hayes, Lawrence D/0000-0002-6654-0072; Padulo, Johnny/0000-0002-4254-3105; Dhahbi, Wissem/0000-0001-6221-546X; Rhibi, Fatma/0000-0003-4017-7663; Sellami, Maha/0000-0003-1832-409X				Adams K., 1992, J STRENGTH COND RES, V6, P36, DOI DOI 10.1519/00124278-199202000-00006; Allen DB, 1996, ENDOCRIN METAB CLIN, V25, P699, DOI 10.1016/S0889-8529(05)70348-0; Arnarson A, 2015, J NUTR HEALTH AGING, V19, P856, DOI 10.1007/s12603-015-0547-3; ASTRAND PO, 1954, J APPL PHYSIOL, V7, P218, DOI 10.1152/jappl.1954.7.2.218; Ayalon A, 1974, BIOMECHANICS, P572; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; BAXTER RC, 1986, J CLIN INVEST, V78, P1504, DOI 10.1172/JCI112742; Birzniece V, 2011, TRENDS ENDOCRIN MET, V22, P171, DOI 10.1016/j.tem.2011.02.005; Blackman MB, 2002, JAMA-J AM MED ASSOC, V288, P2282, DOI 10.1001/jama.288.18.2282; Borst SE, 2001, MED SCI SPORT EXER, V33, P648; Botcazou M, 2007, PEDIATR EXERC SCI, V19, P132, DOI 10.1123/pes.19.2.132; Brandt T., 2003, NEUROLOGICAL DISORDE; Burgomaster KA, 2005, J APPL PHYSIOL, V98, P1985, DOI 10.1152/japplphysiol.01095.2004; Burgomaster KA, 2006, J APPL PHYSIOL, V100, P2041, DOI 10.1152/japplphysiol.01220.2005; CAPPON J, 1994, J APPL PHYSIOL, V76, P2490, DOI 10.1152/jappl.1994.76.6.2490; Chikani V, 2016, CLIN ENDOCRINOLOGY; Codner E, 1999, REV MED CHILE, V127, P807; Cooper CS, 1998, EUR J ENDOCRINOL, V138, P517, DOI 10.1530/eje.0.1380517; CORPAS E, 1993, ENDOCR REV, V14, P20, DOI 10.1210/er.14.1.20; CUNEO RC, 1991, J APPL PHYSIOL, V70, P695, DOI 10.1152/jappl.1991.70.2.695; De Palo EF, 2008, CLIN CHIM ACTA, V387, P71, DOI 10.1016/j.cca.2007.09.005; de Salles BF, 2009, SPORTS MED, V39, P765, DOI 10.2165/11315230-000000000-00000; Derbre F, 2010, INT J SPORTS MED, V31, P291, DOI 10.1055/s-0030-1248243; DOTAN R, 1983, EUR J APPL PHYSIOL O, V51, P409, DOI 10.1007/BF00429077; DOTAN R, 1980, EUR J APPL PHYSIOL, V44, P237, DOI 10.1007/BF00421623; Driss T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/589361; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Eliakim A, 1996, J CLIN ENDOCR METAB, V81, P3986, DOI 10.1210/jc.81.11.3986; Eliakim A, 2005, ENCYCL SPORTS MED, P165; Fekedulegn DB, 2007, PSYCHOSOM MED, V69, P651, DOI 10.1097/PSY.0b013e31814c405c; FLEG JL, 1988, J APPL PHYSIOL, V65, P1147, DOI 10.1152/jappl.1988.65.3.1147; FRONTERA WR, 1991, J APPL PHYSIOL, V71, P644, DOI 10.1152/jappl.1991.71.2.644; Frystyk J, 2010, MED SCI SPORT EXER, V42, P58, DOI 10.1249/MSS.0b013e3181b07d2d; Gent DN, 2013, J SPORT SCI, V31, P97, DOI 10.1080/02640414.2012.721561; Gibala MJ, 2006, J PHYSIOL-LONDON, V575, P901, DOI 10.1113/jphysiol.2006.112094; Giovannini S, 2010, J NUTR HEALTH AGING, V14, P457; Godfrey RJ, 2003, SPORTS MED, V33, P599, DOI 10.2165/00007256-200333080-00005; Gonzalez A, 2015, LECT NOTES COMPUT SC, V9117, P3, DOI 10.1007/978-3-319-19390-8_1; Harvey S., 1994, GROWTH HORMONE; Hayes LD, 2015, AGING MALE, V18, P195, DOI 10.3109/13685538.2015.1046123; HELLENIUS MLB, 1995, J INTERN MED, V238, P121, DOI 10.1111/j.1365-2796.1995.tb00909.x; Hermann M, 2001, EXP GERONTOL, V36, P1075, DOI 10.1016/S0531-5565(01)00113-9; HO KKY, 1993, HORM RES, V40, P80, DOI 10.1159/000183771; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; INBAR O, 1986, MED SCI SPORT EXER, V18, P264, DOI 10.1249/00005768-198606000-00002; Jaafar H, 2016, INT J SPORT PHYSIOL, V11, P48, DOI 10.1123/ijspp.2015-0063; Jacob C, 2004, EUR J APPL PHYSIOL, V91, P35, DOI 10.1007/s00421-003-1002-4; Jurimae J, 2015, CLIN PHYSL FUNCTIONA; Kim T, 2015, INT J SOFTW INNOV, V3, P1, DOI 10.4018/ijsi.2015010101; Knowles AM, 2015, AGE, V37, DOI 10.1007/s11357-015-9763-3; Korhonen MT, 2003, MED SCI SPORT EXER, V35, P1419, DOI 10.1249/01.MSS.0000079080.15333.CA; Kotzamanidis C, 2005, J STRENGTH COND RES, V19, P369; Kucera R, 2015, CLIN CHIM ACTA, V444, P271, DOI 10.1016/j.cca.2015.02.036; Maharam LG, 1999, SPORTS MED, V28, P273, DOI 10.2165/00007256-199928040-00005; Manetta J, 2002, AM J PHYSIOL-ENDOC M, V283, pE929, DOI 10.1152/ajpendo.00539.2001; Mazziotti G, 2013, NAT REV ENDOCRINOL, V9, P265, DOI 10.1038/nrendo.2013.5; McCall GE, 1999, CAN J APPL PHYSIOL, V24, P96, DOI 10.1139/h99-009; Meinhardt UJ, 2006, CLIN ENDOCRINOL, V65, P413, DOI 10.1111/j.1365-2265.2006.02676.x; Moussa E, 2003, J SPORT MED PHYS FIT, V43, P546; Naspi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098641; Nevill ME, 1996, EUR J APPL PHYSIOL, V72, P460, DOI 10.1007/BF00242276; Olivecrona H, 1999, J CLIN ENDOCR METAB, V84, P553, DOI 10.1210/jc.84.2.553; Ozaki H, 2013, EUR REV AGING PHYS A, V10, P107, DOI 10.1007/s11556-013-0120-1; Padulo J, 2015, J SPORT MED PHYS FIT, V55, P604; Padulo J, 2012, INT J SPORTS MED, V33, P376, DOI 10.1055/s-0031-1299702; Padulo J, 2013, J HUM KINET, V37, P5, DOI 10.2478/hukin-2013-0019; PATTON JF, 1985, INT J SPORTS MED, V6, P82, DOI 10.1055/s-2008-1025818; POEHLMAN ET, 1994, METABOLISM, V43, P1401, DOI 10.1016/0026-0495(94)90035-3; Reaburn P, 1997, J STRENGTH COND RES, V11, P256; RUTANEN EM, 1988, J CLIN ENDOCR METAB, V66, P173, DOI 10.1210/jcem-66-1-173; Salvadori A, 2010, CLIN ENDOCRINOL, V73, P491, DOI 10.1111/j.1365-2265.2010.03837.x; Sculthorpe N, 2015, J AM GERIATR SOC, V63, P2412, DOI 10.1111/jgs.13863; Sellami M, 2019, ETHNIC HEALTH, V24, P182, DOI 10.1080/13557858.2017.1315375; Sellami M, 2017, EXP BIOL MED, V242, P113, DOI 10.1177/1535370216662711; Sellami M, 2014, EUR J APPL PHYSIOL, V114, P969, DOI 10.1007/s00421-014-2828-7; Sipila S, 2013, BIOGERONTOLOGY, V14, P231, DOI 10.1007/s10522-013-9425-8; Sloth M, 2013, SCAND J MED SCI SPOR, V23, pE341, DOI 10.1111/sms.12092; Stokes KA, 2004, EUR J APPL PHYSIOL, V92, P26, DOI 10.1007/s00421-003-1038-5; Stokes KA, 2002, J SPORT SCI, V20, P487, DOI 10.1080/02640410252925152; SWAIN DP, 1994, MED SCI SPORT EXER, V26, P112; Tsai C-L, 2015, FRONTIERS BEHAV NEUR, V9; VANDEWALLE H, 1985, EUR J APPL PHYSIOL, V54, P222, DOI 10.1007/BF02335934; Velloso CP, 2008, BRIT J PHARMACOL, V154, P557, DOI 10.1038/bjp.2008.153; Vitiello MV, 1997, J GERONTOL A-BIOL, V52, pM149, DOI 10.1093/gerona/52A.3.M149; Wideman L, 2002, SPORTS MED, V32, P987, DOI 10.2165/00007256-200232150-00003; Wieczorek-Baranowska A, 2011, J SPORT MED PHYS FIT, V51, P525; Winter E.M., 2006, SPORT EXERCISE PHYSL, VI; Zouhal H, 1998, SCI SPORT, V13, P112, DOI 10.1016/S0765-1597(98)80046-4; Zouhal H, 1999, INT J SPORTS MED, V20, P343, DOI 10.1055/s-2007-971142; Zouhal H, 2001, J SPORT MED PHYS FIT, V41, P330; Zouhal H, 2008, SPORTS MED, V38, P401, DOI 10.2165/00007256-200838050-00004; Zouhal H, 2009, J SCI MED SPORT, V12, P652, DOI 10.1016/j.jsams.2008.03.003	92	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0183184	10.1371/journal.pone.0183184	http://dx.doi.org/10.1371/journal.pone.0183184			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800636	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000407431800062
J	Noor, RA; Abioye, AI; Ulenga, N; Msham, S; Kaishozi, G; Gunaratna, NS; Mwiru, R; Smith, E; Dhillon, CN; Spiegelman, D; Fawzi, W				Noor, Ramadhani A.; Abioye, Ajibola I.; Ulenga, Nzovu; Msham, Salum; Kaishozi, George; Gunaratna, Nilupa S.; Mwiru, Ramadhani; Smith, Erin; Dhillon, Christina Nyhus; Spiegelman, Donna; Fawzi, Wafaie			Large - scale wheat flour folic acid fortification program increases plasma folate levels among women of reproductive age in urban Tanzania	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; SHORT INTERPREGNANCY INTERVALS; ANEMIA PREVALENCE; SUPPLEMENTATION; PREVENTION; CONSUMPTION; NUTRITION; IMPACT; TRIAL	There is widespread vitamin and mineral deficiency problem in Tanzania with known deficiencies of at least vitamin A, iron, folate and zinc, resulting in lasting negative consequences especially on maternal health, cognitive development and thus the nation's economic potential. Folate deficiency is associated with significant adverse health effects among women of reproductive age, including a higher risk of neural tube defects. Several countries, including Tanzania, have implemented mandatory fortification of wheat and maize flour but evidence on the effectiveness of these programs in developing countries remains limited. We evaluated the effectiveness of Tanzania's food fortification program by examining folate levels for women of reproductive age, 18-49 years. A prospective cohort study with 600 non-pregnant women enrolled concurrent with the initiation of food fortification and followed up for 1 year thereafter. Blood samples, dietary intake and fortified foods consumption data were collected at baseline, and at 6 and 12 months. Plasma folate levels were determined using a competitive assay with folate binding protein. Using univariate and multivariate linear regression, we compared the change in plasma folate levels at six and twelve months of the program from baseline. We also assessed the relative risk of folate deficiency during follow-up using log-binomial regression. The mean (+/- SE) pre-fortification plasma folate level for the women was 5.44-ng/ml (+/- 2.30) at baseline. These levels improved significantly at six months [difference: 4.57ng/ml (+/- 2.89)] and 12 months [difference: 4.27ng/ml (+/- 4.18)]. Based on plasma folate cut-off level of 4 ng/ml, the prevalence of folate deficiency was 26.9% at baseline, and 5% at twelve months. One ng/ml increase in plasma folate from baseline was associated with a 25% decreased risk of folate deficiency at 12 months [(RR = 0.75; 95% CI = 0.67-0.85, P<0.001]. In a setting where folate deficiency is high, food fortification program with folic acid resulted in significant improvements in folate status among women of reproductive age.	[Noor, Ramadhani A.; Ulenga, Nzovu; Msham, Salum; Mwiru, Ramadhani] Africa Acad Publ Hlth AAPH, Dar Es Salaam, Tanzania; [Noor, Ramadhani A.; Abioye, Ajibola I.; Gunaratna, Nilupa S.; Fawzi, Wafaie] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Noor, Ramadhani A.; Gunaratna, Nilupa S.; Spiegelman, Donna; Fawzi, Wafaie] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Ulenga, Nzovu] Management Dev Hlth MDH, Dar Es Salaam, Tanzania; [Kaishozi, George; Smith, Erin; Dhillon, Christina Nyhus] Helen Keller Int, Dar Es Salaam, Tanzania; [Spiegelman, Donna; Fawzi, Wafaie] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Spiegelman, Donna] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Noor, RA (corresponding author), Africa Acad Publ Hlth AAPH, Dar Es Salaam, Tanzania.; Noor, RA (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA.; Noor, RA (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.	anoor@hsph.harvard.edu	Abioye, Ajibola Ibraheem/H-3302-2019	Abioye, Ajibola Ibraheem/0000-0002-6632-613X; Gunaratna, Nilupa/0000-0003-2504-4694	Helen Keller International (HKI), Tanzania [6225-2012-12-00]	Helen Keller International (HKI), Tanzania	The Helen Keller International (HKI), Tanzania, commissioned this evaluation, HKI SUBCONTRACT NUMBER: 6225-2012-12-00. Design and progress of this evaluation has received oversight by the Tanzania National Food Fortification Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, MIN HLTH SOC WELF TA; [Anonymous], 1985, THEORETICAL EPIDEMIO; [Anonymous], 2016, TANZ FACT SURV REP; [Anonymous], 2012, MON EV PLAN TANZ NAT; Atta CAM, 2016, AM J PUBLIC HEALTH, V106, pE24, DOI 10.2105/AJPH.2015.302902; Barkley JS, 2015, BRIT J NUTR, V114, P265, DOI 10.1017/S0007114515001646; Behrman JR, 2004, GLOB CRIS GLOB SOLUT; Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; BERRY RJ, 2010, FOOD NUTR B, V31; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Blencowe H, 2010, INT J EPIDEMIOL, V39, P110, DOI 10.1093/ije/dyq028; Chakraborty H, 2014, INT J VITAM NUTR RES, V84, P286, DOI 10.1024/0300-9831/a000215; Choumenkovitch SF, 2001, J NUTR, V131, P3277, DOI 10.1093/jn/131.12.3277; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; Czeizel AE, 2013, NUTRIENTS, V5, P4760, DOI 10.3390/nu5114760; Das JK, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-67; Fajardo V, 2012, INT J VITAM NUTR RES, V82, P177, DOI 10.1024/0300-9831/a000109; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Food Fortification Initiative, 2015, GLOB PROGR FOOD FORT; Gibson R, 2015, FOOD NUTR RES, V59, P1; Haddad L, 2015, J NUTR, V145, P663, DOI 10.3945/jn.114.206078; Hertrampf E, 2003, J NUTR, V133, P3166, DOI 10.1093/jn/133.10.3166; Institute of Medicine Food and Nutrition Board, 1998, DIET REF INT THIM RI; Ionescu-Ittu R, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1673; Kinasha ADA, 2002, EUR J PEDIATR SURG, V12, pS38; KISHIMBA RS, 2015, J GLOB HLTH, V5; Koren G, 2007, J OBSTET GYNAECOL CA, V29, P992, DOI 10.1016/S1701-2163(16)32690-1; Kristman V, 2004, EUR J EPIDEMIOL, V19, P751, DOI 10.1023/B:EJEP.0000036568.02655.f8; Kupka R, 2015, MATERN CHILD NUTR, V11, P1, DOI 10.1111/mcn.12102; Lindzon Gillian, 2007, Nutr Res Pract, V1, P163, DOI 10.4162/nrp.2007.1.3.163; Lukmanji Z., 2008, TANZANIA FOOD COMPOS, P259; Lukmanji Z, 2013, ECOL FOOD NUTR, V52, P34, DOI 10.1080/03670244.2012.705768; Martorell R, 2015, AM J CLIN NUTR, V101, P210, DOI 10.3945/ajcn.114.097709; Mason NM, 2012, MSU INT DEV WORKING; Matsui EC, 2009, J ALLERGY CLIN IMMUN, V123, P1253, DOI 10.1016/j.jaci.2009.03.007; Mazengo MC, 1997, ACTA TROP, V68, P313, DOI 10.1016/S0001-706X(97)00113-7; McLean E, 2008, FOOD NUTR BULL, V29, pS38, DOI 10.1177/15648265080292S107; McNulty B, 2013, AM J CLIN NUTR, V98, P92, DOI 10.3945/ajcn.112.057489; McNulty H, 2012, INT J VITAM NUTR RES, V82, P348, DOI 10.1024/0300-9831/a000130; Ogundipe O, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-481; Pachon H, 2015, NUTR REV; Pfeiffer CM, 2005, AM J CLIN NUTR, V82, P442, DOI 10.1093/ajcn/82.2.442; SANGHVI TG, 2010, FOOD NUTR B, V31; Morris MS, 2007, AM J CLIN NUTR, V85, P193, DOI 10.1093/ajcn/85.1.193; Schonfeldt HC, 2009, J FOOD COMPOS ANAL, V22, pS68, DOI 10.1016/j.jfca.2009.01.005; Smits LJM, 2001, LANCET, V358, P2074, DOI 10.1016/S0140-6736(01)07105-7; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Stampfer M, 2015, JAMA-J AM MED ASSOC, V313, P1321, DOI 10.1001/jama.2015.1961; Tanzania Bureau of Statistics and Macro International, 2010, TANZ DEM HLTH SURV 2, P1, DOI [10.1007/SpringerReference_187125, DOI 10.1007/SPRINGERREFERENCE_187125]; van Eijsden M, 2008, AM J CLIN NUTR, V88, P147, DOI 10.1093/ajcn/88.1.147; WALD N, 1991, LANCET, V338, P131; Wehby GL, 2013, INT J ENV RES PUB HE, V10, P590, DOI 10.3390/ijerph10020590; Welfare S, 2015, MIN HLTH SOC WELF NA; WHO, 2003, WHO TECH REP SER, V916, P1; WHO, 2008, REC WHEAT MAIZ FLOUR, P9; World Bank, 2012, ACT PLAN PROV VIT MI; World Health Organization, 2015, GUID OPT SER RED BLO, P38; Zaganjor I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151586	58	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182099	10.1371/journal.pone.0182099	http://dx.doi.org/10.1371/journal.pone.0182099			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD2WT	28797054	Green Published, gold, Green Submitted			2022-12-26	WOS:000407396200029
J	Kawamoto, H; Hirata, A; Kawano, S				Kawamoto, Hiroki; Hirata, Aiko; Kawano, Shigeyuki			Three-dimensional ultrastructural study of the anther of Silene latifolia infected with Microbotryum lychnidis-dioicae	PLOS ONE			English	Article							USTILAGO-VIOLACEA; SMUT INFECTION; FLOWERS	When Microbotryum lychnidis-dioicae infects a male Silene latifolia, M. lychnidis-dioicae smut spores develop in the pollen sac instead of pollen. In contrast, when M. lychnidis-dioicae infects a female S. latifolia, the female flowers become male-like, promoting stamen formation. However, it is unclear when and how M. lychnidis-dioicae invades the anther. It is important to investigate not only whether hyphae exist when the apical meristem tissue differentiates into flowers and anthers, but also whether hyphae exist when stamen filaments form. We used Grocott's methenamine silver stain and lectin stain, which stain chitin in the fungal cell wall, to search for M. lychnidis-dioicae in flower tissues. A few M. lychnidis-dioicae hyphae were observed intercellularly in the center of the connective of vascular bundles at the early anther developmental stage. Subsequently, large numbers of deeply stained M. lychnidis-dioicae hyphae were observed intercellularly in the cells surrounding the pollen sac, as well as in the center of the pollen sac. Hyphae stained with lectin were observed intercellularly in all of the stamen filaments at flower development stages. Hyphae were observed in the peduncle connecting the flower and stem. It is thought that M. lychnidis-dioicae invaded the anther via the stamen filament over a long period. Additionally, in total, 163 sections of connective were obtained, and the cell structure of each anther was colored and subjected to three-dimensional reconstruction. The M. lychnidis-dioicae hyphae observed in the connective were mainly old hyphae with large vacuoles or dead hyphae (S1 Fig). These hyphae branched out, towards the pollen sac, while growing between the cells. We also observed that the host cells that collapsed near the hyphae had thick cell walls and teliospores. Cell wall collapse and cell degeneration were observed only around hyphae with thick cell walls.	[Kawamoto, Hiroki; Kawano, Shigeyuki] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan; [Hirata, Aiko] Univ Tokyo, Grad Sch Frontier Sci, Bioimaging Ctr, Kashiwa, Chiba, Japan	University of Tokyo; University of Tokyo	Kawano, S (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan.	kawano@k.u-tokyo.ac.jp		Kawamoto, Hiroki/0000-0002-3182-2766	Japan Society for the Promotion of Science (JSPS), KAKENHI [24657046]	Japan Society for the Promotion of Science (JSPS), KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (JSPS), KAKENHI, Grant Number 24657046 to SK (https://.www.jsps.go.jp/english/).	ALEXANDER HM, 1990, OECOLOGIA, V84, P249, DOI 10.1007/BF00318280; ALEXANDER HM, 1988, J ECOL, V76, P91, DOI 10.2307/2260456; BAKER HG, 1947, ANN BOT-LONDON, V11, P333, DOI 10.1093/oxfordjournals.aob.a083161; Denchev C. M., 2009, Mycologia Balcanica, V6, P79; Garber ED, 2002, ADV APPL MICROBIOL, V51, P107, DOI 10.1016/S0065-2164(02)51003-0; Giraldo MC, 2013, NAT REV MICROBIOL, V11, P800, DOI 10.1038/nrmicro3119; Granberg A, 2008, INT J PLANT SCI, V169, P293, DOI 10.1086/523964; Kawamoto H, 2017, PLANT CELL PHYSIOL, V58, P320, DOI 10.1093/pcp/pcw193; Kemler M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-35; Matsuo Y, 2013, PLANT CELL REP, V32, P1743, DOI 10.1007/s00299-013-1487-1; MEYBERG M, 1988, HISTOCHEMISTRY, V88, P197, DOI 10.1007/BF00493305; Piepenbring M, 1998, PROTOPLASMA, V204, P155, DOI 10.1007/BF01280322; PINTOZZI RL, 1978, J CLIN PATHOL, V31, P803, DOI 10.1136/jcp.31.8.803; Schafer AM, 2010, BOTANY, V88, P875, DOI 10.1139/B10-061; Uchida W, 2005, PROTOPLASMA, V226, P207, DOI 10.1007/s00709-005-0113-7; Uchida W, 2003, PLANTA, V218, P240, DOI 10.1007/s00425-003-1110-8	16	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182686	10.1371/journal.pone.0182686	http://dx.doi.org/10.1371/journal.pone.0182686			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28792972	Green Published, gold, Green Submitted			2022-12-26	WOS:000407196700058
J	Rozenblum, E; Sotelo-Silveira, JR; Kim, GY; Zhu, JY; Lau, CC; McNeil, N; Korolevich, S; Liao, HL; Cherry, JM; Munroe, DJ; Ried, T; Meltzer, PS; Kuehl, WM; Roschke, AV				Rozenblum, Ester; Sotelo-Silveira, Jose R.; Kim, Gina Y.; Zhu, Jack Y.; Lau, Christopher C.; McNeil, Nicole; Korolevich, Susana; Liao, Hongling; Cherry, James M.; Munroe, David J.; Ried, Thomas; Meltzer, Paul S.; Kuehl, Walter M.; Roschke, Anna V.			Novel near-diploid ovarian cancer cell line derived from a highly aneuploid metastatic ovarian tumor	PLOS ONE			English	Article							CIRCULAR BINARY SEGMENTATION; CHROMOSOME-ABNORMALITIES; CARCINOMAS; EVOLUTION; HETEROGENEITY; PATTERN	A new ovarian near-diploid cell line, OVDM1, was derived from a highly aneuploid serous ovarian metastatic adenocarcinoma. A metastatic tumor was obtained from a 47-year-old Ashkenazi Jewish patient three years after the first surgery removed the primary tumor, both ovaries, and the remaining reproductive organs. OVDM1 was characterized by cell morphology, genotyping, tumorigenic assay, mycoplasma testing, spectral karyotyping (SKY), and molecular profiling of the whole genome by aCGH and gene expression microarray. Targeted sequencing of a panel of cancer-related genes was also performed. Hierarchical clustering of gene expression data clearly confirmed the ovarian origin of the cell line. OVDM1 has a near-diploid karyotype with a low-level aneuploidy, but samples of the original metastatic tumor were grossly aneuploid. A number of single nucleotide variations (SNVs)/mutations were detected in OVDM1 and the metastatic tumor samples. Some of them were cancer-related according to COSMIC and HGMD databases (no founder mutations in BRCA1 and BRCA2 have been found). A large number of focal copy number alterations (FCNAs) were detected, including homozygous deletions (HDs) targeting WWOX and GATA4. Progression of OVDM1 from early to late passages was accompanied by preservation of the near-diploid status, acquisition of only few additional large chromosomal rearrangements and more than 100 new small FCNAs. Most of newly acquired FCNAs seem to be related to localized but massive DNA fragmentation (chromothripsis-like rearrangements). Newly developed near-diploid OVDM1 cell line offers an opportunity to evaluate tumorigenesis pathways/events in a minor clone of metastatic ovarian adenocarcinoma as well as mechanisms of chromothripsis.	[Rozenblum, Ester; Kim, Gina Y.; Zhu, Jack Y.; Lau, Christopher C.; McNeil, Nicole; Liao, Hongling; Ried, Thomas; Meltzer, Paul S.; Kuehl, Walter M.; Roschke, Anna V.] NCI, Genet Branch, CCR, NIH, Bethesda, MD 20892 USA; [Sotelo-Silveira, Jose R.; Korolevich, Susana; Liao, Hongling; Cherry, James M.; Munroe, David J.] SAIC Frederick Inc, NCI Frederick, Adv Technol Program, Lab Mol Technol, Frederick, MD USA; [Munroe, David J.] SAIC Frederick Inc, NCI Frederick, Adv Technol Program, Frederick, MD USA; [Rozenblum, Ester] GeneDx, Gaithersburg, MD USA; [Sotelo-Silveira, Jose R.] Inst Invest Biol Clemente Estable, Dept Genom, Montevideo, Uruguay	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Instituto de Investigaciones Biologicas Clemente Estable Uruguay	Roschke, AV (corresponding author), NCI, Genet Branch, CCR, NIH, Bethesda, MD 20892 USA.	roschkea@mail.nih.gov		McNeil, Nicole/0000-0003-1440-6880; Sotelo-Silveira, Jose Roberto/0000-0002-4758-8556	National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC011091] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by the National Cancer Institute.	Almendro V, 2013, ANNU REV PATHOL-MECH, V8, P277, DOI 10.1146/annurev-pathol-020712-163923; Blagden SP, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00149; Bowtell DD, 2015, NAT REV CANCER, V15, P668, DOI 10.1038/nrc4019; Gorunova L, 1998, GENE CHROMOSOME CANC, V23, P81, DOI 10.1002/(SICI)1098-2264(199810)23:2<81::AID-GCC1>3.0.CO;2-0; HEIM S, 1988, CANCER GENET CYTOGEN, V36, P149, DOI 10.1016/0165-4608(88)90137-9; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ince TA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8419; Jacob F, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-60; JIN YS, 1993, CANCER RES, V53, P2140; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Leibowitz ML, 2015, ANNU REV GENET, V49, P183, DOI 10.1146/annurev-genet-120213-092228; MAINESBANDIERA SL, 1992, AM J OBSTET GYNECOL, V167, P729, DOI 10.1016/S0002-9378(11)91579-8; McShane LM, 2002, BIOINFORMATICS, V18, P1462, DOI 10.1093/bioinformatics/18.11.1462; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; PANDIS N, 1995, GENE CHROMOSOME CANC, V12, P173, DOI 10.1002/gcc.2870120304; SIMON R, 2003, DESIGN ANAL DNA MICR; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646	18	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182610	10.1371/journal.pone.0182610	http://dx.doi.org/10.1371/journal.pone.0182610			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28787462	Green Published, Green Submitted, gold			2022-12-26	WOS:000406998800051
J	Tudor, RA; D'Silva, A; Tremblay, A; MacEachern, P; Morris, D; Brenner, D; Kopciuk, K; Bebb, DG				Tudor, Roxana Aline; D'Silva, Adrijana; Tremblay, Alain; MacEachern, Paul; Morris, Don; Brenner, Darren; Kopciuk, Karen; Bebb, Dafydd Gwyn			Beyond disease-progression: Clinical outcomes after EGFR-TKIs in a cohort of EGFR mutated NSCLC patients	PLOS ONE			English	Article							CELL LUNG-CANCER; TYROSINE KINASE INHIBITORS; OPEN-LABEL; CHEMOTHERAPY; GEFITINIB; RESISTANCE; ERLOTINIB; METAANALYSIS; MULTICENTER; MUTATIONS	Purpose Treatment and clinical-outcomes were described in a sub-cohort of non-small-cell lung cancer (NSCLC) patients with disease-progression (PD) after epidermal growth factor tyrosine kinase inhibitors (EGFR-TKIs) treatment. Patients and methods We retrospectively analyzed a single-institutional EGFR mutation positive (EGFRm ut+) NSCLC cohort for post-TKI-PD management, and assessed overall survival (OS) and post progression survival (PPS). All de-novo (first lung-cancer occurrence) stage IIIA-IV patients, as well as de-novo stage IV subset was analyzed. Multi-state modeling (MSM) and a Cox PH regression model with propensity score weights adjusted for clinicopathological variables between: diagnosis and PD and PD to death. Results 123 stage IIIA-IV patients were identified with 104 meeting RECIST-1.1-PD criteria. This RECIST-1.1-PD criteria subset included females (64.6%), Asians (39.4%), never/nonsmokers (55.8%), and exon 19 deletion carriers (44.2%). Commonest treatment beyond initial -PD was continuing TKI alone (46/104), with another 21 patients continuing TKI plus additional systemic therapy. The median OS for patients who continued TKI treatment at initial -PD was 21.1 months versus 15.6 months for patients who discontinued TKI, p = 0.006. Via MSM analysis, continuing TKI at initial-PD followed by other systemic therapy was associated with an 83% reduced death risk, adjusted HR: 0.17 (95% CI: 0.07, 0.39). In the Cox PH model, ever-smokers with an exon 19 deletion had increased risk of death after PD (adjusted HR: 3.19, 95% CI: 1.54, 6.58), as did exon 21 mutation carriers, (adjusted HR: 2.10, 95% CI: 1.10, 4.00) and females (adjusted HR: 3.19, 95% CI: 1.54, 6.58). Conclusion Subsequent systemic therapy after continuing TKI at initial-PD reduced the risk of death. Additionally, our data suggest that positive smoking history increases death risk for some EGFR mutation types and females.	[Tudor, Roxana Aline; D'Silva, Adrijana; Morris, Don; Bebb, Dafydd Gwyn] Univ Calgary, Cumming Sch Med, Dept Med Oncol, Calgary, AB, Canada; [Tremblay, Alain; MacEachern, Paul] Univ Calgary, Cumming Sch Med, Div Resp Med, Calgary, AB, Canada; [Tremblay, Alain; MacEachern, Paul; Morris, Don; Kopciuk, Karen; Bebb, Dafydd Gwyn] Univ Calgary, Arnie Charbonneau Canc Inst, Calgary, AB, Canada; [Brenner, Darren; Kopciuk, Karen] Alberta Hlth Serv, Canc Control Alberta, Canc Epidemiol & Prevent Res, Calgary, AB, Canada; [Kopciuk, Karen] Univ Calgary, Dept Math & Stat, Fac Sci, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; Alberta Health Services (AHS); University of Calgary; University of Calgary	Tudor, RA (corresponding author), Univ Calgary, Cumming Sch Med, Dept Med Oncol, Calgary, AB, Canada.	roxana.tudor@ucalgary.ca; asevo@ucalgary.ca	D'Silva, Adrijana/ABE-1288-2021; Tremblay, Alain/F-3163-2011	Tremblay, Alain/0000-0002-0025-7426	AstraZeneca Canada Inc	AstraZeneca Canada Inc(AstraZeneca)	This study was funded by an educational grant from AstraZeneca Canada Inc, a commercial company. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan BA, 2015, TRANSL LUNG CANCER R, V4, P36, DOI 10.3978/j.issn.2218-6751.2014.05.01; D'Addario G, 2010, ANN ONCOL, V21, pv116, DOI 10.1093/annonc/mdq189; De Greve J, 2016, PLOS ONE, V11, P1; Douillard JY, 2014, BRIT J CANCER, V110, P55, DOI 10.1038/bjc.2013.721; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Goldberg SB, 2013, ONCOLOGIST, V18, P1214, DOI 10.1634/theoncologist.2013-0168; Gridelli C, 2015, CLIN LUNG CANCER, V16, P325, DOI 10.1016/j.cllc.2015.02.006; Hansen HH, 2008, LUNG CANC THERAPY AN, P1; Huang LH, 2015, ACTA PHARM SIN B, V5, P390, DOI 10.1016/j.apsb.2015.07.001; Keedy VL, 2011, J CLIN ONCOL, V29, P2121, DOI 10.1200/JCO.2010.31.8923; Kogure Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135393; Lee CK, 2015, J CLIN ONCOL, V33, P1958, DOI 10.1200/JCO.2014.58.1736; Lo PC, 2015, CANCER-AM CANCER SOC, V121, P2570, DOI 10.1002/cncr.29397; Lopes GL, 2015, J BRAS PNEUMOL, V41, P365, DOI 10.1590/S1806-37132015000004531; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Maruyama R, 2009, ANTICANCER RES, V29, P4217; Masters GA, 2015, J CLIN ONCOL, V33, P3488, DOI 10.1200/JCO.2015.62.1342; Mirsadraee S, 2012, WORLD J RADIOL, V4, P128, DOI 10.4329/wjr.v4.i4.128; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Mok TS, N ENGL J MED; Morgillo F, 2016, BMJ-BRIT MED J, V1, P1; National Comprehensive Cancer Network (NCCN), NONS CELL LUNG CANC; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Qiao XJ, 2015, THORAC CANCER, V6, P678, DOI 10.1111/1759-7714.12236; Ridgeway G, 2010, TOOLKIT WEIGHTING AN, P1; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Song ZB, 2016, ARCH MED SCI, V12, P107, DOI 10.5114/aoms.2016.57586; Soria JC, 2015, LANCET ONCOL, V16, P990, DOI 10.1016/S1470-2045(15)00121-7; Stravodimou A, 2013, J ONCOPATHOLOGY, V1, P63; Vavala T, 2016, LUNG CANCER, V95, P73, DOI 10.1016/j.lungcan.2016.02.011; Wang SH, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0268-z; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Zhang YX, 2015, CLIN LUNG CANCER, V16, P144, DOI 10.1016/j.cllc.2014.09.008; Zhou W, CHIN J CANC, V30, P287	35	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0181867	10.1371/journal.pone.0181867	http://dx.doi.org/10.1371/journal.pone.0181867			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28777825	Green Published, gold, Green Submitted			2022-12-26	WOS:000406944300017
J	Wurth, S; Kuenz, B; Bsteh, G; Ehling, R; Di Pauli, F; Hegen, H; Auer, M; Gredler, V; Deisenhammer, F; Reindl, M; Berger, T				Wurth, Sebastian; Kuenz, Bettina; Bsteh, Gabriel; Ehling, Rainer; Di Pauli, Franziska; Hegen, Harald; Auer, Michael; Gredler, Viktoria; Deisenhammer, Florian; Reindl, Markus; Berger, Thomas			Cerebrospinal fluid B cells and disease progression in multiple sclerosis - A longitudinal prospective study	PLOS ONE			English	Article							CLINICALLY ISOLATED SYNDROME; CENTRAL-NERVOUS-SYSTEM; OLIGOCLONAL BANDS; DIAGNOSTIC-CRITERIA; PATHOGENESIS; OCRELIZUMAB; PATHOLOGY; RISK	Background There is evidence that B cells play an important role in disease pathology of multiple sclerosis (MS). The aim of this prospective observational study was to determine the predictive value of cerebrospinal fluid (CSF) B cell subtypes in disease evolution of patients with MS. Materials and methods 128 patients were included between 2004 and 2012. Median follow up time was 7.9 years (range 3.3-10.8 years). 10 patients were lost to follow-up. 32 clinically isolated syndrome-(CIS), 25 relapsing remitting MS-(RRMS), 2 secondary progressive MS-(SPMS) and 9 primary progressive MS-(PPMS) patients were included. The control group consisted of 40 patients with other neurological diseases (OND). CSF samples were analyzed for routine diagnostic parameters. B cell phenotypes were characterized by flow cytometry using CD19 and CD138 specific antibodies. Standardized baseline brain MRI was conducted at the time of diagnostic lumbar puncture. Main outcome variables were likelihood of progressive disease course, EDSS progression, conversion to clinical definite MS (CDMS) and relapse rate. Results CSF mature B cells (CD19+CD138-) were increased in bout-onset MS compared to PPMS (p<0.05) and OND (p<0.001), whereas plasma blasts (CD19+CD138+) were increased in bout-onset MS (p<0.001) and PPMS (p<0.05) compared to OND. CSF B cells did not predict a progressive disease course, EDSS progression, an increased relapse rate or the conversion to CDMS. Likelihood of progressive disease course (p<0.05) and EDSS (p<0.01) was predicted by higher age at baseline, whereas conversion to CDMS was predicted by a lower age at onset (p<0.01) and the presence of >= 9 MRI T2 lesions (p<0.05). Conclusion We detected significant differences in the CSF B cell subsets between different clinical MS subtypes and OND patients. CSF B cells were neither predictive for disease and EDSS progression nor conversion to CDMS after a CIS.	[Wurth, Sebastian; Kuenz, Bettina; Bsteh, Gabriel; Di Pauli, Franziska; Hegen, Harald; Auer, Michael; Gredler, Viktoria; Deisenhammer, Florian; Reindl, Markus; Berger, Thomas] Med Univ Innsbruck, Clin Dept Neurol, Innsbruck, Tirol, Austria; [Ehling, Rainer] Clin Rehabil Munster, Dept Neurol, Munster, Tirol, Austria	Medical University of Innsbruck	Wurth, S (corresponding author), Med Univ Innsbruck, Clin Dept Neurol, Innsbruck, Tirol, Austria.	Sebastian.Wurth@i-med.ac.at	Reindl, Markus/ABE-5880-2020	Berger, Thomas/0000-0001-5626-1144; Reindl, Markus/0000-0003-2817-1402	Austrian Federal Ministry of Science, Research and Economy (BIG WIG MS); Austrian Multiple Sclerosis Research Society	Austrian Federal Ministry of Science, Research and Economy (BIG WIG MS); Austrian Multiple Sclerosis Research Society	This study was supported by research grants of the Austrian Federal Ministry of Science, Research and Economy (grant BIG WIG MS) and the Austrian Multiple Sclerosis Research Society.	Alroughani R, 2012, ISRN NEUROL, V2012, P1; Bar-Or A, 2014, NEUROLOGY S10, V82; Brettschneider J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011986; Cepok S, 2001, BRAIN, V124, P2169, DOI 10.1093/brain/124.11.2169; Cepok S, 2005, BRAIN, V128, P1667, DOI 10.1093/brain/awh486; Corcione A, 2004, P NATL ACAD SCI USA, V101, P11064, DOI 10.1073/pnas.0402455101; Disanto G, 2012, NEUROLOGY, V78, P823, DOI 10.1212/WNL.0b013e318249f6f0; Dobson R, 2012, MULT SCLER J, V18, P600, DOI 10.1177/1352458511426740; Fisniku LK, 2008, BRAIN, P131; Freedman MS, 2005, ARCH NEUROL AM MED A, V62, P121; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Giovannoni G, 2016, NEDA EPOCH ANAL PATI; Hauser SL, 2017, NEW ENGL J MED, V376, P221, DOI 10.1056/NEJMoa1601277; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; KABAT EA, 1948, AM J MED, V4, P653, DOI 10.1016/S0002-9343(48)90389-1; Koch M, 2009, NEUROLOGY, V73, P1996, DOI 10.1212/WNL.0b013e3181c5b47f; Krumbholz M, 2012, NAT REV NEUROL, V8, P613, DOI 10.1038/nrneurol.2012.203; Kuenz B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002559; Kuhle J, 2015, MULT SCLER J, V21, P1013, DOI 10.1177/1352458514568827; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; Lassmann H, 2012, NAT REV NEUROL, V8, P647, DOI 10.1038/nrneurol.2012.168; Mahad DH, 2015, LANCET NEUROL, V14, P183, DOI 10.1016/S1474-4422(14)70256-X; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Meinl E, 2006, ANN NEUROL, V59, P880, DOI 10.1002/ana.20890; Michel L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00636; Miller DH, 2012, LANCET NEUROL, V11, P157, DOI 10.1016/S1474-4422(11)70274-5; Montalban X, 2017, NEW ENGL J MED, V376, P209, DOI 10.1056/NEJMoa1606468; Mowry EM, 2009, J NEUROL, V256, P1061, DOI 10.1007/s00415-009-5063-0; Nemecek A, 2016, MULT SCLER J, V22, P483, DOI 10.1177/1352458515593821; Obermeier B, 2011, J NEUROIMMUNOLOGY; Obermeier B, 2008, NAT MED, V14, P688, DOI 10.1038/nm1714; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Rojas JI, 2012, NEUROL RES, V34, P889, DOI 10.1179/1743132812Y.0000000088; Skov AG, 2011, MULT SCLER J, V17, P404, DOI 10.1177/1352458510391340; Sorensen P, 2014, FOLLOW UP DATA MIRRO; Sorensen PS, 2014, NEUROLOGY, V82, P573, DOI 10.1212/WNL.0000000000000125; Sospedra M, 2016, SEMIN NEUROL, V36, P115, DOI 10.1055/s-0036-1579739; Stangel M, 2013, NAT REV NEUROL, V9, P267, DOI 10.1038/nrneurol.2013.41; Tintore M, 2008, NEUROLOGY, V70, P1079, DOI 10.1212/01.wnl.0000280576.73609.c6; Villar LM, 2008, MULT SCLER J, V14, P183, DOI 10.1177/1352458507082046; Villar LM, 2003, ANN NEUROL, V53, P222, DOI 10.1002/ana.10441; Wing AC, 2016, CLIN NEUROL NEUROSUR, V146, P40, DOI 10.1016/j.clineuro.2016.04.022	44	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0182462	10.1371/journal.pone.0182462	http://dx.doi.org/10.1371/journal.pone.0182462			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28777826	Green Published, gold, Green Submitted			2022-12-26	WOS:000406944300036
J	Gonyo, P; Bergom, C; Brandt, AC; Tsaih, SW; Sun, Y; Bigley, TM; Lorimer, EL; Terhune, SS; Rui, H; Flister, MJ; Long, RM; Williams, CL				Gonyo, P.; Bergom, C.; Brandt, A. C.; Tsaih, S-W; Sun, Y.; Bigley, T. M.; Lorimer, E. L.; Terhune, S. S.; Rui, H.; Flister, M. J.; Long, R. M.; Williams, C. L.			SmgGDS is a transient nucleolar protein that protects cells from nucleolar stress and promotes the cell cycle by regulating DREAM complex gene expression	ONCOGENE			English	Article							RNA-POLYMERASE-I; C-MYC; RIBOSOME BIOGENESIS; EMERGING TARGET; BRAIN CYTOSOL; TRANSCRIPTION; BINDING; UBF; GROWTH; LUNG	The chaperone protein and guanine nucleotide exchange factor SmgGDS (RAP1GDS1) is a key promoter of cancer cell proliferation and tumorigenesis. SmgGDS undergoes nucleocytoplasmic shuttling, suggesting that it has both cytoplasmic and nuclear functions that promote cancer. Previous studies indicate that SmgGDS binds cytoplasmic small GTPases and promotes their trafficking to the plasma membrane. In contrast, little is known about the functions of SmgGDS in the nucleus, or how these nuclear functions might benefit cancer cells. Here we show unique nuclear localization and regulation of gene transcription pathways by SmgGDS. Strikingly, SmgGDS depletion significantly reduces expression of over 600 gene products that are targets of the DREAM complex, which is a transcription factor complex that regulates expression of proteins controlling the cell cycle. The cell cycle regulators E2F1, MYC, MYBL2 (B-Myb) and FOXM1 are among the DREAM targets that are diminished by SmgGDS depletion. E2F1 is well known to promote G1 cell cycle progression, and the loss of E2F1 in SmgGDS-depleted cells provides an explanation for previous reports that SmgGDS depletion characteristically causes a G1 cell cycle arrest. We show that SmgGDS localizes in nucleoli, and that RNAimediated depletion of SmgGDS in cancer cells disrupts nucleolar morphology, signifying nucleolar stress. We show that nucleolar SmgGDS interacts with the RNA polymerase I transcription factor upstream binding factor (UBF). The RNAi-mediated depletion of UBF diminishes nucleolar localization of SmgGDS and promotes proteasome-mediated degradation of SmgGDS, indicating that nucleolar sequestration of SmgGDS by UBF stabilizes SmgGDS protein. The ability of SmgGDS to interact with UBF and localize in the nucleolus is diminished by expressing DiRas1 or DiRas2, which are small GTPases that bind SmgGDS and act as tumor suppressors. Taken together, our results support a novel nuclear role for SmgGDS in protecting malignant cells from nucleolar stress, thus promoting cell cycle progression and tumorigenesis.	[Gonyo, P.; Brandt, A. C.; Lorimer, E. L.; Williams, C. L.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Gonyo, P.; Bergom, C.; Brandt, A. C.; Lorimer, E. L.; Rui, H.; Flister, M. J.; Williams, C. L.] Med Coll Wisconsin, Canc Ctr, Milwaukee, WI 53226 USA; [Bergom, C.] Med Coll Wisconsin, Dept Radiat Oncol, Milwaukee, WI 53226 USA; [Tsaih, S-W; Flister, M. J.] Med Coll Wisconsin, Dept Physiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Sun, Y.; Rui, H.] Med Coll Wisconsin, Dept Pathol, Milwaukee, WI 53226 USA; [Bigley, T. M.; Terhune, S. S.; Long, R. M.] Med Coll Wisconsin, Dept Microbiol & Immunol, Milwaukee, WI 53226 USA; [Bigley, T. M.] Washington Univ, Dept Pediat, St Louis, MO 63130 USA; [Terhune, S. S.] Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA; [Flister, M. J.] Med Coll Wisconsin, Human & Mol Genet Ctr, Milwaukee, WI 53226 USA; [Flister, M. J.; Williams, C. L.] Med Coll Wisconsin, Cardiovasc Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Long, R. M.] Med Coll Wisconsin, Cent Wisconsin Campus, Wausau, WI USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Washington University (WUSTL); Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Williams, CL (corresponding author), Med Coll Wisconsin, Cardiovasc Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.; Williams, CL (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, Canc Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	williams@mcw.edu		Rui, Hallgeir/0000-0002-8778-261X; Bigley, Tarin/0000-0001-7443-9436; Sun, Yunguang/0000-0003-4004-9514; Bergom, Carmen/0000-0002-0886-5055	NCI [R01 CA188871, R01 CA193343, R01 CA188575]; NIAID [R01 AI083281]; American Cancer Society [86-004-26]; Kathleen M Duffey Fogarty Eminent Scholar in Breast Cancer Research Award; Mary Kay Foundation [024.16]; Nancy Laning Sobczak, PhD, Breast Cancer Research Award; National Center for Research Resources; National Center for Advancing Translational Sciences; Office of the Director of the National Institutes of Health [8KL2TR000056]; NATIONAL CANCER INSTITUTE [R01CA188871, R01CA193343, R01CA188575] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083281] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Cancer Society(American Cancer Society); Kathleen M Duffey Fogarty Eminent Scholar in Breast Cancer Research Award; Mary Kay Foundation; Nancy Laning Sobczak, PhD, Breast Cancer Research Award; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Office of the Director of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr Aniko Szabo (Medical College of Wisconsin) for assistance with statistical analysis. This work was supported by NCI R01 CA188871 (CLW), NCI R01 CA193343 (MJF), NIAID R01 AI083281 (SST), NCI R01 CA188575 (HR) and Institutional Research Grant 86-004-26 from the American Cancer Society (CB). Additional support was provided by the Kathleen M Duffey Fogarty Eminent Scholar in Breast Cancer Research Award (CLW), the Mary Kay Foundation Award Grant No. 024.16 (MJF), the Nancy Laning Sobczak, PhD, Breast Cancer Research Award (CB and CLW), and by the National Center for Research Resources, the National Center for Advancing Translational Sciences and the Office of the Director of the National Institutes of Health through Grant 8KL2TR000056 (CB).	Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Arabi A, 2003, J CELL SCI, V116, P1707, DOI 10.1242/jcs.00370; Berg TJ, 2010, J BIOL CHEM, V285, P35255, DOI 10.1074/jbc.M110.129916; Bergom C, 2016, J BIOL CHEM, V291, P10948, DOI 10.1074/jbc.A115.696831; Bertoli C, 2013, NAT REV MOL CELL BIO, V14, P518, DOI 10.1038/nrm3629; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; Chen DY, 2004, P NATL ACAD SCI USA, V101, P15106, DOI 10.1073/pnas.0404767101; Deisenroth C, 2010, ONCOGENE, V29, P4253, DOI 10.1038/onc.2010.189; Derenzini M, 2004, J CLIN PATHOL, V57, P755, DOI 10.1136/jcp.2003.015917; Derenzini M, 2009, HISTOPATHOLOGY, V54, P753, DOI 10.1111/j.1365-2559.2008.03168.x; Donati G, 2012, CANCER RES, V72, P1602, DOI 10.1158/0008-5472.CAN-11-3992; Donati G, 2011, J CELL SCI, V124, P3017, DOI 10.1242/jcs.086074; Drygin D, 2011, CANCER RES, V71, P1418, DOI 10.1158/0008-5472.CAN-10-1728; Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844; Ellis CA, 2002, P NATL ACAD SCI USA, V99, P9876, DOI 10.1073/pnas.142193799; Fields AP, 2010, ADV ENZYME REGUL, V50, P190, DOI 10.1016/j.advenzreg.2009.10.010; Fillmore CM, 2015, NATURE, V520, P239, DOI 10.1038/nature14122; Fischer M, 2016, NUCLEIC ACIDS RES, V44, P6070, DOI 10.1093/nar/gkw523; Fischer M, 2016, NUCLEIC ACIDS RES, V44, P164, DOI 10.1093/nar/gkv927; Goldenson B, 2015, ONCOGENE, V34, P537, DOI 10.1038/onc.2014.14; Grummt I, 2013, CHROMOSOMA, V122, P487, DOI 10.1007/s00412-013-0430-0; Hamdane N, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004505; Hauser AD, 2014, MOL CANCER RES, V12, P130, DOI 10.1158/1541-7786.MCR-13-0362; Hein N, 2013, TRENDS MOL MED, V19, P643, DOI 10.1016/j.molmed.2013.07.005; Holmberg Olausson Karl, 2012, Cells, V1, P774, DOI 10.3390/cells1040774; James A, 2014, NUCLEUS-PHILA, V5, P402, DOI 10.4161/nucl.32235; Justilien V, 2017, CANCER CELL, V31, P256, DOI 10.1016/j.ccell.2016.12.010; Kontani K, 2002, J BIOL CHEM, V277, P41070, DOI 10.1074/jbc.M202150200; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lanning CC, 2004, J BIOL CHEM, V279, P44197, DOI 10.1074/jbc.M404977200; Lanning CC, 2003, J BIOL CHEM, V278, P12495, DOI 10.1074/jbc.M211286200; Nguyen LXT, 2013, P NATL ACAD SCI USA, V110, P20681, DOI 10.1073/pnas.1313097110; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mais C, 2005, GENE DEV, V19, P50, DOI 10.1101/gad.310705; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; McStay B, 2016, GENE DEV, V30, P1598, DOI 10.1101/gad.283838.116; MIZUNO T, 1991, P NATL ACAD SCI USA, V88, P6442, DOI 10.1073/pnas.88.15.6442; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; Muller GA, 2017, ONCOTARGET, V8, P97736, DOI 10.18632/oncotarget.10888; Natoli G, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.11pe1; Ntantie E, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003374; O'Sullivan AC, 2002, MOL CELL BIOL, V22, P657, DOI 10.1128/MCB.22.2.657-668.2002; Ogita Y, 2015, J BIOL CHEM, V290, P20245, DOI 10.1074/jbc.M115.637769; Panov KI, 2006, EMBO J, V25, P3310, DOI 10.1038/sj.emboj.7601221; Pich A, 2000, MICRON, V31, P133, DOI 10.1016/S0968-4328(99)00070-0; Portella G, 2011, CURR MED CHEM, V18, P482, DOI 10.2174/092986711794480203; Quaas M, 2012, CELL CYCLE, V11, P4661, DOI 10.4161/cc.22917; Quin JE, 2014, BBA-MOL BASIS DIS, V1842, P802, DOI 10.1016/j.bbadis.2013.12.009; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Sadasivam S, 2013, NAT REV CANCER, V13, P585, DOI 10.1038/nrc3556; Sadasivam S, 2012, GENE DEV, V26, P474, DOI 10.1101/gad.181933.111; Sanij E, 2009, EPIGENETICS-US, V4, P274, DOI 10.4161/epi.4.6.9449; Sanij E, 2008, J CELL BIOL, V183, P1259, DOI 10.1083/jcb.200805146; Schuld NJ, 2014, CELL CYCLE, V13, P941, DOI 10.4161/cc.27804; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; Stefanovsky V, 2006, MOL CELL, V21, P629, DOI 10.1016/j.molcel.2006.01.023; Stefanovsky VY, 2001, MOL CELL, V8, P1063, DOI 10.1016/S1097-2765(01)00384-7; Sun XX, 2015, P NATL ACAD SCI USA, V112, P3734, DOI 10.1073/pnas.1411713112; Tew GW, 2008, J BIOL CHEM, V283, P963, DOI 10.1074/jbc.M707526200; Thoms HC, 2010, CANCER RES, V70, P139, DOI 10.1158/0008-5472.CAN-09-1397; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Woods SJ, 2015, BBA-GENE REGUL MECH, V1849, P821, DOI 10.1016/j.bbagrm.2014.10.007; YAMAMOTO T, 1990, J BIOL CHEM, V265, P16626; Zhang YD, 2011, MOL CELL BIOL, V31, P4676, DOI 10.1128/MCB.05832-11; Zhi H, 2009, J PATHOL, V217, P389, DOI 10.1002/path.2456; Zhu YH, 2013, CANCER RES, V73, P2298, DOI 10.1158/0008-5472.CAN-12-2663	70	9	9	0	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 14	2017	36	50					6873	6883		10.1038/onc.2017.280	http://dx.doi.org/10.1038/onc.2017.280			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FQ0JM	28806394	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000418041800004
J	Yan, Y; Xu, TH; Harikumar, KG; Miller, LJ; Melcher, K; Xu, HE				Yan, Yan; Xu, Ting-Hai; Harikumar, Kaleeckal G.; Miller, Laurence J.; Melcher, Karsten; Xu, H. Eric			Dimerization of the transmembrane domain of amyloid precursor protein is determined by residues around the gamma - secretase cleavage sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; ALZHEIMERS-DISEASE; APP DIMERIZATION; COUPLED SECRETIN; GXXXG MOTIFS; HOMODIMERIZATION; DIMER; BETA; OLIGOMERIZATION; DUPLICATION	One of the hallmarks of Alzheimer's disease is the formation of extracellular amyloid plaques that consist mainly of abnormally aggregated forms of amyloid beta (A beta) peptides. These peptides are generated by gamma-secretase-catalyzed cleavage of a dimeric membrane-bound C-terminal fragment (C99) of the amyloid precursor protein. Although C99 homodimerization has been linked to A beta production and changes in the aggregation-determining A beta 42/40 ratio, the motif through which C99 dimerizes has remained controversial. Here, we have used two independent assays to gain insight in to C99homodimerization in the context of the membrane of live cells: bioluminescence resonance energy transfer and Tango membrane proteinprotein interaction assays, which were further confirmed by traditional pull-down assays. Our results indicate a four-amino acid region within the C99 transmembrane helix (43TVIV46) as well as its local secondary structure as critical determinants for homodimerization. These four amino acids are also a hot spot of familial Alzheimer's disease-linked mutations that both decrease C99 homodimerization and gamma-secretase cleavage and alter the initial cleavage site to increase the A beta 42/40 ratio.	[Yan, Yan; Xu, Ting-Hai; Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, VARI SIMM Ctr, Key Lab Receptor Res, Shanghai 201203, Peoples R China; [Yan, Yan; Xu, Ting-Hai] Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China; [Yan, Yan; Xu, Ting-Hai; Melcher, Karsten; Xu, H. Eric] Van Andel Res Inst, Innovat & Integrat Program, Ctr Canc & Cell Biol, Grand Rapids, MI 49503 USA; [Harikumar, Kaleeckal G.; Miller, Laurence J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Van Andel Institute; Mayo Clinic; Mayo Clinic Phoenix	Xu, HE (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, VARI SIMM Ctr, Key Lab Receptor Res, Shanghai 201203, Peoples R China.; Melcher, K; Xu, HE (corresponding author), Van Andel Res Inst, Innovat & Integrat Program, Ctr Canc & Cell Biol, Grand Rapids, MI 49503 USA.	Karsten.melcher@vai.org; eric.xu@vai.org	Melcher, Karsten/AAZ-3861-2020; Xu, H. Eric/ABD-7487-2021	Melcher, Karsten/0000-0002-9125-4027; Xu, H. Eric/0000-0002-6829-8144; Xu, Tinghai/0000-0003-2239-1420	NIDDK NIH HHS [R01 DK071662] Funding Source: Medline; NIGMS NIH HHS [R01 GM102545, R01 GM104212] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102545, R01GM104212] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Beel AJ, 2008, BIOCHEMISTRY-US, V47, P9428, DOI 10.1021/bi800993c; Ben Khalifa N, 2012, FASEB J, V26, P855, DOI 10.1096/fj.11-190207; Chow VW, 2010, NEUROMOL MED, V12, P1, DOI 10.1007/s12017-009-8104-z; De-Paula Vanessa J, 2012, Subcell Biochem, V65, P329, DOI 10.1007/978-94-007-5416-4_14; Decock M, 2015, FEBS OPEN BIO, V5, P763, DOI 10.1016/j.fob.2015.09.002; Dimitrov M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3246; Dominguez L, 2016, P NATL ACAD SCI USA, V113, pE5281, DOI 10.1073/pnas.1606482113; Dominguez L, 2014, J AM CHEM SOC, V136, P9619, DOI 10.1021/ja503150x; Eggert S, 2009, J BIOL CHEM, V284, P28943, DOI 10.1074/jbc.M109.038646; Gorman PM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-17; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Harikumar KG, 2007, J BIOL CHEM, V282, P30363, DOI 10.1074/jbc.M702325200; Harikumar KG, 2016, J BIOL CHEM, V291, P17332, DOI 10.1074/jbc.M116.730754; Higashide H, 2017, J NEUROCHEM, V140, P955, DOI 10.1111/jnc.13942; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kelly DF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010532; Kienlen-Campard P, 2008, J BIOL CHEM, V283, P7733, DOI 10.1074/jbc.M707142200; Kinoshita June, 2007, Methods Mol Biol, V401, P365, DOI 10.1007/978-1-59745-520-6_19; Kummer MP, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt258; Liu HD, 2010, GENE DEV, V24, P2395, DOI 10.1101/gad.1975210; Mendrola JM, 2002, J BIOL CHEM, V277, P4704, DOI 10.1074/jbc.M108681200; Miyashita N, 2009, J AM CHEM SOC, V131, P3438, DOI 10.1021/ja809227c; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Nadezhdin KD, 2012, FEBS LETT, V586, P1687, DOI 10.1016/j.febslet.2012.04.062; Nunan J, 2000, FEBS LETT, V483, P6, DOI 10.1016/S0014-5793(00)02076-7; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Sato T, 2009, P NATL ACAD SCI USA, V106, P1421, DOI 10.1073/pnas.0812261106; Scheuermann S, 2001, J BIOL CHEM, V276, P33923, DOI 10.1074/jbc.M105410200; Sleegers K, 2006, BRAIN, V129, P2977, DOI 10.1093/brain/awl203; So Pauline Pl, 2013, Am J Neurodegener Dis, V2, P15; So Pauline Pl, 2012, Am J Neurodegener Dis, V1, P75; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; Song YL, 2013, BIOCHEMISTRY-US, V52, P5051, DOI 10.1021/bi400735x; Tang TC, 2014, STRUCTURE, V22, P387, DOI 10.1016/j.str.2013.12.012; van der Kant R, 2015, DEV CELL, V32, P502, DOI 10.1016/j.devcel.2015.01.022; Vooijs M, 2004, J BIOL CHEM, V279, P50864, DOI 10.1074/jbc.M409430200; Wang H, 2011, J MOL BIOL, V408, P879, DOI 10.1016/j.jmb.2011.03.028; Waring SC, 2008, ARCH NEUROL-CHICAGO, V65, P329, DOI 10.1001/archneur.65.3.329; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; Winkler E, 2015, BIOCHEMISTRY-US, V54, P6149, DOI 10.1021/acs.biochem.5b00986; Xu TH, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.26; Yan Y, 2017, ACTA PHARMACOL SIN, V38, P1412, DOI 10.1038/aps.2017.35; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3	46	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15826	15837		10.1074/jbc.M117.789669	http://dx.doi.org/10.1074/jbc.M117.789669			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28790170	Green Published, hybrid			2022-12-26	WOS:000411512200020
J	Konowalik, K; Prockow, M; Prockow, J				Konowalik, Kamil; Prockow, Malgorzata; Prockow, Jaroslaw			Climatic niche of Selinum alatum (Apiaceae, Selineae), a new invasive plant species in Central Europe and its alterations according to the climate change scenarios: Are the European mountains threatened by invasion?	PLOS ONE			English	Article							SAMPLE-SIZE; POPULATIONS; PERFORMANCE; MODELS; AREA	In recent years, a few established populations of Selinum alatum have been found in the Eastern Carpathians outside its native range that is the Caucasus and the Armenian Highlands. The species is spreading predominantly in Poland where it can outcompete native plants in certain cases. This study addresses a potential climatic niche of the plant with the special aims to illuminate future spreading and indicate areas suitable for invasion. Our results show that the extent of the favourable habitat of the species is broader than currently known. This suggests that the plant has the ability to become a potential new element in some semi-natural or disturbed ecosystems associated with mountainous areas, especially in Central and Southern Europe. Future (2070) models mostly rendered similar suitability maps, but showed slight differences over particular areas and a contraction of suitable habitats, mainly in the northern part of the non-native range.	[Konowalik, Kamil; Prockow, Jaroslaw] Wroclaw Univ Environm & Life Sci, Inst Biol, Dept Plant Biol, Wroclaw, Poland; [Prockow, Malgorzata] Univ Wroclaw, Museum Nat Hist, Wroclaw, Poland	Wroclaw University of Environmental & Life Sciences; University of Wroclaw	Konowalik, K (corresponding author), Wroclaw Univ Environm & Life Sci, Inst Biol, Dept Plant Biol, Wroclaw, Poland.	kamil.konowalik@upwr.edu.pl	Proćków, Jarosław/B-4832-2017; Konowalik, Kamil/C-5265-2011	Proćków, Jarosław/0000-0003-4100-3438; Konowalik, Kamil/0000-0003-4821-0608; Prockow, Malgorzata/0000-0003-2240-7306	Leading National Research Centre (KNOW) programme of the Wroclaw Center of Biotechnology	Leading National Research Centre (KNOW) programme of the Wroclaw Center of Biotechnology	The project is supported by the Leading National Research Centre (KNOW) programme of the Wroclaw Center of Biotechnology for years 2014-2018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The project is supported by the Leading National Research Centre (KNOW) programme of the Wroclaw Center of Biotechnology for years 2014-2018.	Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Baumel A, 2001, MOL ECOL, V10, P1689, DOI 10.1046/j.1365-294X.2001.01299.x; Davis M, 2011, NATURE, V474, P153, DOI 10.1038/474153a; Davis PH, 1972, FLORA TURKEY E AEGEA, V4; Dlugosch KM, 2015, MOL ECOL, V24, P2095, DOI 10.1111/mec.13183; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; Hengl T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105992; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 1999, GENET RESOUR CROP EV, V46, P291, DOI 10.1023/A:1008628005016; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Jahodova S, 2007, DIVERS DISTRIB, V13, P99, DOI 10.1111/j.1366-9516.2006.00305.x; Jueterbock A., 2015, MAXENTVARIABLESELECT; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kolanowska M, 2014, BIOTROPICA, V46, P157, DOI 10.1111/btp.12089; Moron D, 2009, BIOL CONSERV, V142, P1322, DOI 10.1016/j.biocon.2008.12.036; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nobis M, 2009, ACTA SOC BOT POL, V78, P131, DOI 10.5586/asbp.2009.017; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Prockow J, 2014, ARCH BIOL SCI, V66, P1135, DOI 10.2298/ABS1403135P; Pysek P., 1994, Ecology and management of invasive riverside plants., P19; Pysek Petr, 2009, V3, P43; Rai PK., 2013, PLANT INVASION ECOLO; Rai PK., 2015, ENV SKEP CRIT, V4, P36, DOI DOI 10.0000/ISSN-2224-4263-ENVIR0NSC-2015-V4-0003; Randall JM, 1996, WEED TECHNOL, V10, P370, DOI 10.1017/S0890037X00040124; Richardson DM, 2006, PROG PHYS GEOG, V30, P409, DOI 10.1191/0309133306pp490pr; Rodda GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014670; Skorka P, 2010, BIOL CONSERV, V143, P856, DOI 10.1016/j.biocon.2009.12.030; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stapley J, 2015, MOL ECOL, V24, P2241, DOI 10.1111/mec.13089; Thompson K., 2014, DO CAMELS BELONG STO; Tobergte D.R., 2013, J CHEM INF MODEL, V53, P1689, DOI DOI 10.1017/CBO9781107415324.004; Tokarska-Guzik B, 2012, ZENIA POLSCE SZCZEGO; Totland O, 2005, FOREST ECOL MANAG, V215, P329, DOI 10.1016/j.foreco.2005.05.023; Warren DL, 2014, DIVERS DISTRIB, V20, P334, DOI 10.1111/ddi.12160; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x	40	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2017	12	8							e0182793	10.1371/journal.pone.0182793	http://dx.doi.org/10.1371/journal.pone.0182793			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD5CP	28806731	Green Submitted, gold, Green Published			2022-12-26	WOS:000407548800032
J	Arras, L; Horn, F; Montavon, G; Muller, KR; Samek, W				Arras, Leila; Horn, Franziska; Montavon, Gregoire; Mueller, Klaus-Robert; Samek, Wojciech			"What is relevant in a text document?": An interpretable machine learning approach	PLOS ONE			English	Article							NETWORKS	Text documents can be described by a number of abstract concepts such as semantic category, writing style, or sentiment. Machine learning (ML) models have been trained to automatically map documents to these abstract concepts, allowing to annotate very large text collections, more than could be processed by a human in a lifetime. Besides predicting the text's category very accurately, it is also highly desirable to understand how and why the categorization process takes place. In this paper, we demonstrate that such understanding can be achieved by tracing the classification decision back to individual words using layer-wise relevance propagation (LRP), a recently developed technique for explaining predictions of complex non-linear classifiers. We train two word-based ML models, a convolutional neural network (CNN) and a bag-of-words SVM classifier, on a topic categorization task and adapt the LRP method to decompose the predictions of these models onto words. Resulting scores indicate how much individual words contribute to the overall classification decision. This enables one to distill relevant information from text documents without an explicit semantic information extraction step. We further use the word-wise relevance scores for generating novel vector-based document representations which capture semantic information. Based on these document vectors, we introduce a measure of model explanatory power and show that, although the SVM and CNN models perform similarly in terms of classification accuracy, the latter exhibits a higher level of explainability which makes it more comprehensible for humans and potentially more useful for other applications.	[Arras, Leila; Samek, Wojciech] Fraunhofer Heinrich Hertz Inst, Machine Learning Grp, Berlin, Germany; [Horn, Franziska; Montavon, Gregoire; Mueller, Klaus-Robert] Tech Univ Berlin, Machine Learning Grp, Berlin, Germany; [Mueller, Klaus-Robert] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea; [Mueller, Klaus-Robert] Max Planck Inst Informat, Saarbrucken, Germany	Fraunhofer Gesellschaft; Technical University of Berlin; Korea University; Max Planck Society	Samek, W (corresponding author), Fraunhofer Heinrich Hertz Inst, Machine Learning Grp, Berlin, Germany.; Muller, KR (corresponding author), Tech Univ Berlin, Machine Learning Grp, Berlin, Germany.; Muller, KR (corresponding author), Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea.; Muller, KR (corresponding author), Max Planck Inst Informat, Saarbrucken, Germany.	klaus-robert.mueller@tu-berlin.de; wojciech.samek@hhi.fraunhofer.de	Samek, Wojciech/AAZ-2165-2021; Mueller, Klaus-Robert/Y-3547-2019; Samek, Wojciech/AAZ-2156-2021	Samek, Wojciech/0000-0002-6283-3265; Mueller, Klaus-Robert/0000-0002-3861-7685; Samek, Wojciech/0000-0002-6283-3265; Arras, Leila/0000-0002-3404-0583	German Ministry for Education and Research as Berlin Big Data Center BBDC [01IS14013A]; Institute for Information & Communications Technology Promotion (IITP) grant - Korea government [2017-000451]; DFG; National Research Foundation of Korea - Ministry of Education, Science, and Technology in the BK21 program	German Ministry for Education and Research as Berlin Big Data Center BBDC; Institute for Information & Communications Technology Promotion (IITP) grant - Korea government(Institute for Information & Communication Technology Planning & Evaluation (IITP), Republic of Korea); DFG(German Research Foundation (DFG)); National Research Foundation of Korea - Ministry of Education, Science, and Technology in the BK21 program(National Research Foundation of Korea)	This work was supported by the German Ministry for Education and Research as Berlin Big Data Center BBDC, funding mark 01IS14013A, by the Institute for Information & Communications Technology Promotion (IITP) grant funded by the Korea government (No. 2017-0-00451) and by DFG. KRM thanks for partial funding by the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology in the BK21 program.	Aggarwal C.C., 2012, MINING TEXT DATA, P77, DOI [DOI 10.1007/978-1-4614-3223-44, 10.1007/978-1-4614-3223-4, 10.1007/978-1-4614-3223-4_4, DOI 10.1007/978-1-4614-3223-4_4]; Arbabzadah F, 2016, LECT NOTES COMPUT SC, V9796, P344, DOI 10.1007/978-3-319-45886-1_28; Arras L, ARXIV2017170607206; Arras Leila, 2016, P 1 WORKSH REPR LEAR, P1, DOI DOI 10.18653/V1/W16-1601; Bach S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130140; Baehrens D, 2010, J MACH LEARN RES, V11, P1803; Bengio Y, 2001, ADV NEUR IN, V13, P932; Bottou L., 2007, LARGE SCALE KERNEL M, V3, P301; Collobert R, 2011, J MACH LEARN RES, V12, P2493; Denil M, ARXIV201414126815; DIMOPOULOS Y, 1995, NEURAL PROCESS LETT, V2, P1, DOI 10.1007/BF02309007; Ding Y., 2017, P 55 ANN M ASS COMP; Gevrey M, 2003, ECOL MODEL, V160, P249, DOI 10.1016/S0304-3800(02)00257-0; Hasan Kazi Saidul, 2010, P 23 INT C COMP LING, P365; Kim Yoon, 2014, P 2014 C EMPIRICAL M, P1746, DOI [DOI 10.3115/V1/D14-1181, 10.3115/v1/D14-1181]; Landecker W, 2013, 2013 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE AND DATA MINING (CIDM), P32, DOI 10.1109/CIDM.2013.6597214; LAPUSCHKIN S, 2016, PROC CVPR IEEE, P2912, DOI DOI 10.1109/CVPR.2016.318; Lapuschkin S, 2016, J MACH LEARN RES, V17; Li Jiwei, 2016, P 2016 C N AM CHAPTE, P681, DOI DOI 10.18653/V1/N16-1082; Mikolov T., 2013, COMPUTING RES REPOSI, V1301, P3781; Mikolov Tomas, 2013, P ADV NEUR INF PROC, P3111, DOI DOI 10.1162/JMLR.2003.3.4-5.951; Mnih A., 2007, INT C MACHINE LEARNI, P641, DOI DOI 10.1145/1273496.1273577; Mnih Andriy, 2012, ARXIV12066426, P419; Montavon G, ARXIV2017170607979; Montavon G, 2017, PATTERN RECOGN, V65, P211, DOI 10.1016/j.patcog.2016.11.008; Nadeau C, 2003, MACH LEARN, V52, P239, DOI 10.1023/A:1024068626366; Poulin B., 2006, PROC NATL CONF ARTIF, V21, P1822; Ribeiro MT, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1135, DOI 10.1145/2939672.2939778; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; SALTON G, 1975, COMMUN ACM, V18, P613, DOI 10.1145/361219.361220; Samek W, 2017, IEEE T NEURAL NETWOR, V99, P1; Schutt KT, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13890; Simonyan K., 2013, 13126034 ARXIV, DOI DOI 10.1038/S41591-018-0335-9; Socher Richard, 2013, P 2013 C EMPIRICALME, P1631, DOI DOI 10.1371/JOURNAL.PONE.0073791; SPARCKJONES K, 1972, J DOC, V28, P11, DOI 10.1108/eb026526; Strumbelj E, 2010, J MACH LEARN RES, V11, P1; Sturm I, 2016, J NEUROSCI METH, V274, P141, DOI 10.1016/j.jneumeth.2016.10.008; Turner R, ARXIV2016160609517; Zeiler MD, 2014, LECT NOTES COMPUT SC, V8689, P818, DOI 10.1007/978-3-319-10590-1_53; Zhang X., 2015, P 28 INT C NEURAL IN	40	101	105	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0181142	10.1371/journal.pone.0181142	http://dx.doi.org/10.1371/journal.pone.0181142			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800619	Green Submitted, Green Published, gold			2022-12-26	WOS:000407431800005
J	Kruglikov, IL; Scherer, PE				Kruglikov, Ilja L.; Scherer, Philipp E.			General theory of skin reinforcement	PLOS ONE			English	Article							ADIPOSE-TISSUE; MECHANICAL-PROPERTIES; ELASTIC PROPERTIES; DERMAL ADIPOCYTES; MYOFIBROBLASTS; MODEL; BEHAVIOR; CRACKING; ANATOMY; STRESS	Macroscopic mechanical properties of human skin in vivo cannot be considered independent of adjacent subcutaneous white adipose tissue (sWAT). The layered system skin/sWAT appears as the hierarchical structural composite in which single layers behave as fiber-reinforced structures. Effective macroscopic mechanical properties of such composites are mainly determined either by the properties of the skin or by those of the sWAT, dependent on the conditions of mechanical loading. Mechanical interactions between the skin and the adjacent sWAT associated with a mismatch in the mechanical moduli of these two layers can lead to production of the skin wrinkles. Reinforcement of the composite skin/sWAT can take place in different ways. It can be provided through reorientation of collagen fibers under applied loading, through production of new bonds between existing collagen fibers and through induction of additional collagen structures. Effectiveness of this type of reinforcement is strongly dependent on the type of mechanical loading. Different physical interventions induce the reinforcement of at least one of these two layers, thus increasing the effective macroscopic stiffness of the total composite. At the same time, the standalone reinforcement of the skin appears to be less effective to achieve a delay or a reduction of the apparent signs of skin aging relative to the reinforcement of the sWAT.	[Kruglikov, Ilja L.] Wellcomet GmbH, Dept Sci, Karlsruhe, Germany; [Scherer, Philipp E.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Touchstone Diabet Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Scherer, PE (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Touchstone Diabet Ctr, Dallas, TX 75390 USA.	philipp.scherer@utsouthwestern.edu	Kruglikov, Ilja L./K-3077-2019; Scherer, Philipp E/K-7819-2012	Scherer, Philipp E/0000-0003-0680-3392	Wellcomet GmbH; US National Institutes of Health (NIH) [P01-DK088761, R01-DK55758, R01-DK099110, P01 AG051459]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099110, P01DK088761, R01DK055758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG051459] Funding Source: NIH RePORTER	Wellcomet GmbH; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	ILK is the managing partner of Wellcomet GmbH. No methods or devices of Wellcomet were used in this publication. ILK received no financial support from Wellcomet GmbH. Wellcomet GmbH provided support in the form of salaries for ILK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of ILK is articulated in the author contributions section. PES was supported by US National Institutes of Health (NIH) grants P01-DK088761, R01-DK55758, R01-DK099110 and P01 AG051459.	Adcock D, 1998, Aesthet Surg J, V18, P414, DOI 10.1016/S1090-820X(98)70069-X; Alkhouli N, 2013, AM J PHYSIOL-ENDOC M, V305, pE1427, DOI 10.1152/ajpendo.00111.2013; Bertossi D, 2015, AESTH MED, V1, P103; BEUTH JL, 1992, INT J SOLIDS STRUCT, V29, P1657, DOI 10.1016/0020-7683(92)90015-L; Bickel B, 2012, ACM T GRAPHIC, V31, DOI 10.1145/2185520.2185614; Cappellano Giuseppe, 2017, Stem Cell Investig, V4, P23, DOI 10.21037/sci.2017.03.03; Caves JM, 2011, BIOMATERIALS, V32, P5371, DOI 10.1016/j.biomaterials.2011.04.009; Comley K, 2010, INT J SOLIDS STRUCT, V47, P2982, DOI 10.1016/j.ijsolstr.2010.07.001; Comley K, 2010, J BIOMECH, V43, P1823, DOI 10.1016/j.jbiomech.2010.02.029; Flynn C, 2013, J MECH BEHAV BIOMED, V28, P484, DOI 10.1016/j.jmbbm.2013.03.004; Gerard JM, 2005, MED ENG PHYS, V27, P884, DOI 10.1016/j.medengphy.2005.08.001; Ghassemi A, 2003, AESTHET PLAST SURG, V27, P258, DOI 10.1007/s00266-003-3065-3; HASHIN Z, 1963, J MECH PHYS SOLIDS, V11, P127, DOI 10.1016/0022-5096(63)90060-7; Hendriks FM, 2003, SKIN RES TECHNOL, V9, P274, DOI 10.1034/j.1600-0846.2003.00019.x; Hendriks FM, 2006, MED ENG PHYS, V28, P259, DOI 10.1016/j.medengphy.2005.07.001; Hull D., 1996, INTRO COMPOSITE MAT, V2nd; HUTCHINSON JW, 1992, ADV APPL MECH, V29, P63, DOI 10.1016/s0065-2156(08)70164-9; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Kot BCW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044348; Krenchel H., 1964, FIBRE REINFORCEMENT; Kruglikov I, 2016, FACIAL PLAST SURG, V32, P671, DOI 10.1055/s-0036-1596046; Kruglikov IL, 2017, EXP DERMATOL, V26, P522, DOI 10.1111/exd.13379; Kruglikov IL, 2017, PSORIASIS-TARGETS TH, V7, P17, DOI 10.2147/PTT.S122959; Kruglikov IL, 2017, CURR RHEUMATOL REP, V19, DOI 10.1007/s11926-017-0627-y; Kruglikov IL, 2016, EXP DERMATOL, V25, P812, DOI 10.1111/exd.12996; Kruglikov IL, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/1953203; Kruglikov IL, 2016, AGING-US, V8, P1457, DOI 10.18632/aging.100999; Kruglikov IL, 2016, TRENDS ENDOCRIN MET, V27, P1, DOI 10.1016/j.tem.2015.11.002; Kruglikov IL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117072; Kuwazuru O, 2008, MED ENG PHYS, V30, P516, DOI 10.1016/j.medengphy.2007.06.001; Lackey DE, 2014, AM J PHYSIOL-ENDOC M, V306, pE233, DOI 10.1152/ajpendo.00476.2013; Lapeer RJ, 2011, IEEE T BIO-MED ENG, V58, P1013, DOI 10.1109/TBME.2009.2038364; Li CH, 2012, J R SOC INTERFACE, V9, P831, DOI 10.1098/rsif.2011.0583; Liang X, 2010, IEEE T BIO-MED ENG, V57, P953, DOI 10.1109/TBME.2009.2033464; Licup AJ, 2015, P NATL ACAD SCI USA, V112, P9573, DOI 10.1073/pnas.1504258112; Liu B, 2009, COMPOS SCI TECHNOL, V69, P2198, DOI 10.1016/j.compscitech.2009.06.004; Maganaris CN, 1999, J PHYSIOL-LONDON, V521, P307, DOI 10.1111/j.1469-7793.1999.00307.x; Magnenat-Thalmann N, 2002, IEEE T INF TECHNOL B, V6, P317, DOI 10.1109/TITB.2002.806097; Marangoni RG, 2015, ARTHRITIS RHEUMATOL, V67, P1062, DOI 10.1002/art.38990; MEYER W, 1982, J ANAT, V134, P139; Nesbitt S, 2015, MATERIALS, V8, P1841, DOI 10.3390/ma8041841; Pailler-Mattei C, 2008, MED ENG PHYS, V30, P599, DOI 10.1016/j.medengphy.2007.06.011; Pawlaczyk M, 2013, POSTEP DERM ALERGOL, V30, P302, DOI 10.5114/pdia.2013.38359; Plikus MV, 2017, SCIENCE, V355, P748, DOI 10.1126/science.aai8792; Rivera-Gonzalez GC, 2016, CELL STEM CELL, V19, P738, DOI 10.1016/j.stem.2016.09.002; Sbarbati A, 2010, EUR J HISTOCHEM, V54, P226, DOI 10.4081/ejh.2010.e48; Seery GE, 2002, DERMATOL SURG, V28, P581, DOI 10.1046/j.1524-4725.2002.12015.x; Sommer G, 2013, ACTA BIOMATER, V9, P9036, DOI 10.1016/j.actbio.2013.06.011; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Tsukahara K, 2011, ARCH DERMATOL, V147, P822, DOI 10.1001/archdermatol.2011.158; Van Houten EEW, 2003, J MAGN RESON IMAGING, V17, P72, DOI 10.1002/jmri.10232; van Oosten ASG, 2016, SCI REP-UK, V6, DOI 10.1038/srep19270; Vos BE, 161208601 ARXIV; Yin H, 2008, INT J FRACTURE, V153, P39, DOI 10.1007/s10704-008-9286-3	54	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182865	10.1371/journal.pone.0182865	http://dx.doi.org/10.1371/journal.pone.0182865			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797059	gold, Green Published, Green Submitted			2022-12-26	WOS:000407396200109
J	McNarry, MA; Wilson, RP; Holton, MD; Griffiths, IW; Mackintosh, KA				McNarry, M. A.; Wilson, R. P.; Holton, M. D.; Griffiths, I. W.; Mackintosh, K. A.			Investigating the relationship between energy expenditure, walking speed and angle of turning in humans	PLOS ONE			English	Article							INTERMITTENT EXERCISE; PHYSICAL-ACTIVITY; WALKWAY LENGTH; DIRECTION; DISTANCE; COST; ACCELEROMETRY	Recent studies have suggested that changing direction is associated with significant additional energy expenditure. A failure to account for this additional energy expenditure of turning has significant implications in the design and interpretation of health interventions. The purpose of this study was therefore to investigate the influence of walking speed and angle, and their interaction, on energy expenditure in 20 healthy adults (7 female; 28 +/- 7 yrs). On two separate days, participants completed a turning protocol at one of 16 speed-(2.5, 3.5, 4.5, 5.5 km.h(-1)) and angle (0, 45, 90, 180 degrees) combinations, involving three minute bouts of walking, interspersed by three minutes seated rest. Each condition involved 5 m of straight walking before turning through the pre-determined angle with the speed dictated by a digital, auditory metronome. Tri-axial accelerometry and magnetometry were measured at 60 Hz, in addition to gas exchange on a breath-by-breath basis. Mixed models revealed a significant main effect for speed (F = 121.609, P< 0.001) and angle (F = 19.186, P< 0.001) on oxygen uptake ((V) over dotO(2)) and a significant interaction between these parameters (F = 4.433, P < 0.001). Specifically, as speed increased, (V) over dotO(2) increased but significant increases in (V) over dotO(2) relative to straight line walking were only observed for 90 degrees and 180 degrees turns at the two highest speeds (4.5 and 5.5 km.hr(-1)). These findings therefore highlight the importance of accounting for the quantity and magnitude of turns completed when estimating energy expenditure and have significant implications within both sport and health contexts.	[McNarry, M. A.; Griffiths, I. W.; Mackintosh, K. A.] Swansea Univ, Coll Engn, Appl Sports Technol Exercise & Med Res Ctr, Swansea, W Glam, Wales; [Wilson, R. P.] Swansea Univ, Coll Sci, Swansea Lab Anim Movement, Biosci, Swansea, W Glam, Wales; [Holton, M. D.] Swansea Univ, Coll Sci, Visual Comp, Comp Sci, Swansea, W Glam, Wales	Swansea University; Swansea University; Swansea University	McNarry, MA (corresponding author), Swansea Univ, Coll Engn, Appl Sports Technol Exercise & Med Res Ctr, Swansea, W Glam, Wales.	m.mcnarry@swansea.ac.uk	McNarry, Melitta/AAC-6899-2020	McNarry, Melitta/0000-0003-0813-7477				[Anonymous], LANCET, V377, P1085; BAILEY RC, 1995, MED SCI SPORT EXER, V27, P1033, DOI 10.1249/00005768-199507000-00012; Baquet G, 2007, PREV MED, V44, P143, DOI 10.1016/j.ypmed.2006.10.004; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Beekman E, 2013, J PHYSIOTHER, V59, P169, DOI 10.1016/S1836-9553(13)70181-4; Bekraoui N, 2012, APPL PHYSIOL NUTR ME, V37, P982, DOI [10.1139/h2012-082, 10.1139/H2012-082]; Bloomfield J, 2007, J SPORT SCI MED, V6, P63; Browning RC, 2005, OBES RES, V13, P891, DOI 10.1038/oby.2005.103; Buchheit M, 2011, INT J SPORT PHYSIOL, V6, P380, DOI 10.1123/ijspp.6.3.380; Chetta A, 2006, RESP MED, V100, P1573, DOI 10.1016/j.rmed.2006.01.001; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Dellal A, 2010, J STRENGTH COND RES, V24, P3219, DOI 10.1519/JSC.0b013e3181b94a63; di Prampero PE, 2005, J EXP BIOL, V208, P2809, DOI 10.1242/jeb.01700; Effects) TGBoMRFfCDCBM, LANCET, V383, P970; Gleiss AC, 2011, METHODS ECOL EVOL, V2, P23, DOI 10.1111/j.2041-210X.2010.00057.x; HAGAN RD, 1986, MED SCI SPORT EXER, V18, P87; Hatamoto Y, 2013, OPEN ACCESS J SPORTS, V4, P117, DOI 10.2147/OAJSM.S39206; Hatamoto Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081850; Hendelman D, 2000, MED SCI SPORT EXER, V32, pS442, DOI 10.1097/00005768-200009001-00002; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; Hunter JP, 2005, J APPL BIOMECH, V21, P31, DOI 10.1123/jab.21.1.31; Jakicic JM, 2005, AM J CLIN NUTR, V82, p226S, DOI 10.1093/ajcn/82.1.226S; Jakicic JM, 1999, JAMA-J AM MED ASSOC, V282, P1554, DOI 10.1001/jama.282.16.1554; Jones AM, 1996, J SPORT SCI, V14, P321, DOI 10.1080/02640419608727717; Kontis V, 2014, LANCET, V384, P427, DOI 10.1016/S0140-6736(14)60616-4; LIPKIN DP, 1986, BRIT MED J, V292, P653, DOI 10.1136/bmj.292.6521.653; Ludlow LW, 2015, JAPH; Ng SS, 2013, PHYSIOTHERAPY, V99, P63, DOI 10.1016/j.physio.2011.11.005; Ng SS, 2011, ARCH PHYS MED REHAB, V92, P806, DOI 10.1016/j.apmr.2010.10.033; Qasem L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031187; SCHOT P, 1995, J ORTHOP SPORT PHYS, V22, P254, DOI 10.2519/jospt.1995.22.6.254; Shepard Emily L. C., 2008, Endangered Species Research, V4, P157, DOI 10.3354/esr00052; Sheppard JM, 2006, J SPORT SCI, V24, P919, DOI 10.1080/02640410500457109; Singh GP, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064893, 10.1371/journal.pone.0065174]; Studies C.Prospective, LANCET, V373, P1083; Swank AM, 2012, CIRC-HEART FAIL, V5, P579, DOI 10.1161/CIRCHEARTFAILURE.111.965186; Swartz AM, 2000, MED SCI SPORT EXER, V32, pS450, DOI 10.1097/00005768-200009001-00003; Troosters T, 1999, EUR RESPIR J, V14, P270, DOI 10.1034/j.1399-3003.1999.14b06.x; WHO, CHILD HLTH 2010; Wilson RP, 2013, ECOL LETT, V16, P1145, DOI 10.1111/ele.12149; World Health Organization, 2013, GLOB ACT PLAN PREV C; Zadro I, 2011, J STRENGTH COND RES, V25, P1767, DOI 10.1519/JSC.0b013e3181da85d1; Zagatto AM, 2017, J STRENGTH COND RES; Zamparo P, 2014, INT J SPORT PHYSIOL, V9, P1033, DOI 10.1123/ijspp.2013-0258; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679	46	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182333	10.1371/journal.pone.0182333	http://dx.doi.org/10.1371/journal.pone.0182333			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796796	Green Published, Green Submitted, gold			2022-12-26	WOS:000407396200045
J	Kantojarvi, K; Liuhanen, J; Saarenpaa-Heikkila, O; Satomaa, AL; Kylliainen, A; Polkki, P; Jaatela, J; Toivola, A; Milani, L; Himanen, SL; Porkka-Heiskanen, T; Paavonen, J; Paunio, T				Kantojarvi, Katri; Liuhanen, Johanna; Saarenpaa-Heikkila, Outi; Satomaa, Anna-Liisa; Kylliainen, Anneli; Polkki, Pirjo; Jaatela, Julia; Toivola, Auli; Milani, Lili; Himanen, Sari-Leena; Porkka-Heiskanen, Tarja; Paavonen, Juulia; Paunio, Tiina			Variants in calcium voltage-gated channel subunit Alpha1 C-gene (CACNA1C) are associated with sleep latency in infants	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; AMYGDALA STRUCTURE; DURATION; LOCI; SCHIZOPHRENIA; CONSORTIUM; DISORDER; CHILDREN; CA(V)1.2; VOLUME	Genetic variants in CACNA1C (calcium voltage-gated channel subunit alpha1 C) are associated with bipolar disorder and schizophrenia where sleep disturbances are common. In an experimental model, Cacna1c has been found to modulate the electrophysiological architecture of sleep. There are strong genetic influences for consolidation of sleep in infancy, but only a few studies have thus far researched the genetic factors underlying the process. We hypothesized that genetic variants in CACNA1C affect the regulation of sleep in early development. Seven variants that were earlier associated (genome-wide significantly) with psychiatric disorders at CACNA1C were selected for analyses. The study sample consists of 1086 infants (520 girls and 566 boys) from the Finnish CHILD-SLEEP birth cohort (geno-typed by Illumina Infinium PsychArray BeadChip). Sleep length, latency, and nightly awakenings were reported by the parents of the infants with a home-delivered questionnaire at 8 months of age. The genetic influence of CACNA1C variants on sleep in infants was examined by using PLINK software. Three of the examined CACNA1C variants, rs4765913, rs4765914, and rs2239063, were associated with sleep latency (permuted P<0.05). There was no significant association between studied variants and night awakenings or sleep duration. CACNA1C variants for psychiatric disorders were found to be associated with long sleep latency among 8-month-old infants. It remains to be clarified whether the findings refer to defective regulation of sleep, or to distractibility of sleep under external influences.	[Kantojarvi, Katri; Liuhanen, Johanna; Jaatela, Julia; Toivola, Auli; Paunio, Tiina] Natl Inst Hlth & Welf, Genom & Biomarkers Unit, Helsinki, Finland; [Kantojarvi, Katri; Liuhanen, Johanna; Jaatela, Julia; Toivola, Auli; Paunio, Tiina] Univ Helsinki, Dept Psychiat, Helsinki, Finland; [Kantojarvi, Katri; Liuhanen, Johanna; Jaatela, Julia; Toivola, Auli; Paunio, Tiina] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Saarenpaa-Heikkila, Outi] Univ Tampere, Human Informat Proc Lab, Tampere, Finland; [Satomaa, Anna-Liisa; Himanen, Sari-Leena] Tampere Univ Hosp, Pirkanmaa Hosp Dist, Dept Clin Neurophysiol, Med Imaging Ctr & Hosp Pharm, Tampere, Finland; [Kylliainen, Anneli] Univ Tampere, Sch Social Sci & Humanities Psychol, Tampere, Finland; [Polkki, Pirjo] Univ Eastern Finland, Dept Social Sci, Kuopio, Finland; [Milani, Lili] Univ Tartu, Estonian Genome Ctr, Tartu, Estonia; [Himanen, Sari-Leena] Univ Tampere, Fac Med & Life Sci, Tampere, Finland; [Porkka-Heiskanen, Tarja] Univ Helsinki, Inst Biomed Physiol, Helsinki, Finland; [Paavonen, Juulia] Natl Inst Hlth & Welf, Child & Adolescent Mental Hlth, Helsinki, Finland	Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Tampere University; Pirkanmaa Hospital District; Tampere University; Tampere University Hospital; Tampere University; University of Eastern Finland; University of Tartu; Tampere University; University of Helsinki; Finland National Institute for Health & Welfare	Paunio, T (corresponding author), Natl Inst Hlth & Welf, Genom & Biomarkers Unit, Helsinki, Finland.; Paunio, T (corresponding author), Univ Helsinki, Dept Psychiat, Helsinki, Finland.; Paunio, T (corresponding author), Univ Helsinki, Cent Hosp, Helsinki, Finland.	tiina.paunio@thl.fi	Paavonen, E. Juulia/AAD-3528-2019; Milani, Lili/N-1097-2019	Paavonen, E. Juulia/0000-0002-1421-9877; Milani, Lili/0000-0002-5323-3102; Liuhanen, Johanna/0000-0002-1153-1013; Kylliainen, Anneli/0000-0002-8839-3720; Kantojarvi, Katri/0000-0002-1294-0310; Stenberg, Tarja/0000-0003-1843-7625; Jaatela, Julia/0000-0003-0368-8608	Academy of Finland [134880, 253346]; Gyllenberg foundation; Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital [9P013, 9R007, 9S007]	Academy of Finland(Academy of Finland); Gyllenberg foundation; Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital	This study was funded by the Academy of Finland (grants 134880; www.aka.fi/skidi-kids, 253346 to TP) and Gyllenberg foundation (to TP). The polysomnography study was financially supported by Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital (Grants 9P013, 9R007, 9S007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the Academy of Finland (grants 134880; http://www.aka.fi/skidi-kids, 253346 to TP) and Gyllenberg foundation (to TP). The polysomnography study was financially supported by Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital (Grants 9P013, 9R007, 9S007). We acknowledge Antti-Pekka Sarin and Samuli Ripatti for reference panels and advices in imputation. Marja-Riitta Rautiainen and Antti-Jussi Ammala are acknowledged for help in genotype data quality control. The authors wish to acknowledge CSC-IT Center for Science, Finland, for computational resources.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amin N, 2016, EUR J HUM GENET, V24, P1488, DOI 10.1038/ejhg.2016.31; Bathory E, 2017, CURR PROB PEDIATR AD, V47, P29, DOI 10.1016/j.cppeds.2016.12.001; Berger S, 2014, CELL TISSUE RES, V357, P463, DOI 10.1007/s00441-014-1936-3; Bigos KL, 2010, ARCH GEN PSYCHIAT, V67, P939, DOI 10.1001/archgenpsychiatry.2010.96; Byrne EM, 2013, AM J MED GENET B, V162B, P439, DOI 10.1002/ajmg.b.32168; Cade BE, 2016, HUM MOL GENET, V25, P167, DOI 10.1093/hmg/ddv434; Dao DT, 2010, BIOL PSYCHIAT, V68, P801, DOI 10.1016/j.biopsych.2010.06.019; Doty TJ, 2008, PSYCHIAT RES-NEUROIM, V163, P84, DOI 10.1016/j.pscychresns.2007.08.003; Gottlieb DJ, 2015, MOL PSYCHIATR, V20, P1232, DOI 10.1038/mp.2014.133; Gruber R, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0500-x; Hamshere ML, 2013, MOL PSYCHIATR, V18, P708, DOI 10.1038/mp.2012.67; Heilbronner U, 2015, EUR NEUROPSYCHOPHARM, V25, P2262, DOI 10.1016/j.euroneuro.2015.09.012; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang L, 2016, AM J MED GENET B, V171, P396, DOI 10.1002/ajmg.b.32418; Hysing M, 2016, INFANT BEHAV DEV, V42, P111, DOI 10.1016/j.infbeh.2015.12.005; Iber C., 2007, AASM MANUAL SCORING; Ivanenko A, 2008, SEMIN PEDIATR NEUROL, V15, P70, DOI 10.1016/j.spen.2008.03.008; Kalmar JH, 2009, J AM ACAD CHILD PSY, V48, P636, DOI 10.1097/CHI.0b013e31819f6fbc; Klingaman EA, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0616-7; Kumar D, 2015, SLEEP, V38, P1371, DOI 10.5665/sleep.4972; Lewandowski AS, 2011, J PEDIATR PSYCHOL, V36, P780, DOI 10.1093/jpepsy/jsq119; Lim ET, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004494; Marinelli M, 2016, SLEEP, V39, P1859, DOI 10.5665/sleep.6170; Morrell JMB, 1999, CHILD PSYCHOL PSYCHI, V4, P20, DOI DOI 10.1111/1475-3588.00246; Ng TH, 2015, SLEEP MED REV, V20, P46, DOI 10.1016/j.smrv.2014.06.006; Nie FY, 2015, AM J MED GENET B, V168, P637, DOI 10.1002/ajmg.b.32348; Ollila HM, 2014, J SLEEP RES, V23, P609, DOI 10.1111/jsr.12175; Paavonen EJ, 2016, SLEEP MED; Parsons MJ, 2013, AM J MED GENET B, V162B, P431, DOI 10.1002/ajmg.b.32106; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Ruderfer DM, 2014, MOL PSYCHIATR, V19, P1017, DOI 10.1038/mp.2013.138; Sadeh A, 2004, PEDIATRICS, V113, pE570, DOI 10.1542/peds.113.6.e570; San Woon P, 2014, J CLIN PSYCHIAT, V75, P478; Sarkar SN, 2008, P NATL ACAD SCI USA, V105, P15148, DOI 10.1073/pnas.0802379105; Satomaa AL, 2016, CLIN NEUROPHYSIOL, V127, P1410, DOI 10.1016/j.clinph.2015.08.013; Shimada M, 2010, HUM GENET, V128, P433, DOI 10.1007/s00439-010-0862-z; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Skrzypinska D, 2013, ARCH PSYCHIATR PSYCH, V15, P29, DOI 10.12740/APP/18443; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Sorondo BM, 2015, INFANT BEHAV DEV, V39, P131, DOI 10.1016/j.infbeh.2015.02.010; Sribnick EA, 2009, BRAIN RES, V1276, P159, DOI 10.1016/j.brainres.2009.04.022; Sumner JA, 2015, J CHILD ADOL PSYCHOP, V25, P701, DOI 10.1089/cap.2015.0047; Takahashi S, 2015, SCHIZOPHR RES, V168, P429, DOI 10.1016/j.schres.2015.07.033; Touchette E, 2013, PEDIATRICS, V131, pE1874, DOI 10.1542/peds.2012-2284; Yoshimizu T, 2015, MOL PSYCHIATR, V20, P162, DOI 10.1038/mp.2014.143; Zhang QM, 2012, NEUROPSYCHOPHARMACOL, V37, P677, DOI 10.1038/npp.2011.242	50	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0180652	10.1371/journal.pone.0180652	http://dx.doi.org/10.1371/journal.pone.0180652			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28792954	Green Published, Green Submitted, gold			2022-12-26	WOS:000407196700003
J	Lee, YJ; Oh, SA; Kim, SH; Oh, SJ				Lee, Young Ju; Oh, Shin Ah; Kim, Sung Han; Oh, Seung-June			Patient satisfaction after holmium laser enucleation of the prostate (HoLEP): A prospective cohort study	PLOS ONE			English	Article							TRANSURETHRAL RESECTION; RANDOMIZED-TRIAL; FOLLOW-UP; PHOTOSELECTIVE VAPORIZATION; TRANSVESICAL PROSTATECTOMY; LEARNING-CURVE; HYPERPLASIA; MORCELLATION; SYMPTOMS; OUTCOMES	Objective To investigate patient satisfaction after holmium laser enucleation of the prostate (HoLEP) in a prospective study. Subjects and methods From May 2012 to December 2014, 397 patients underwent HoLEP by a single surgeon and enrolled in our prospective registry. Baseline data included age, PSA, transrectal ultrasonography, the international prostate symptom score (IPSS), and overactive bladder symptom score (OABSS). Subjective assessment of surgical outcomes was performed at 6 months postoperatively using self-administered questionnaires consisting of 'satisfaction with treatment question' (STQ), 'overall response assessment' (ORA), and 'willingness to undergo surgery question' (WSQ). Results A total of 331 patients (mean age 69.6 +/- 7.0 years) were included in the analysis. Mean total prostate volume was 69.5 (+/- 42.2) ml. Mean preoperative IPSS score was 18.5 (+/- 7.8). The STQ showed that most patients (91.8%) were satisfied after the surgery. Only 11 (3.3%) patients responded with 'dissatisfied', and no patients replied with ` very dissatisfied'. The WSQ showed that 311 (94.0%) patients were willing to undergo the surgery again if they had to reconsider the surgical decision. The ORA showed that all patients (99.4%) experienced an improvement. When compared with satisfied patients, neutral/dissatisfied patients had lower IPSS quality of life scores (2.7 vs. 0.9, p<0.001), higher IPSS voiding symptom scores (7.0 vs. 1.4, p<0.001), and more frequent episodes of urgency urinary incontinence in OABSS (1.0 vs. 0.3, p = 0.017) at 6 months postoperatively. Conclusions The overall level of satisfaction after HoLEP was high. The most common reason for dissatisfaction was the occurrence of urgency urinary incontinence after the surgery.	[Lee, Young Ju; Oh, Shin Ah; Oh, Seung-June] Seoul Natl Univ Hosp, Dept Urol, Seoul, South Korea; [Kim, Sung Han] Res Inst & Natl Canc Ctr, Prostate Canc Ctr, Dept Urol, Goyang, South Korea	Seoul National University (SNU); Seoul National University Hospital; National Cancer Center - Korea (NCC)	Oh, SJ (corresponding author), Seoul Natl Univ Hosp, Dept Urol, Seoul, South Korea.	sjo@snu.ac.kr		KIM, Sung Han/0000-0002-1689-5203	Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health & Welfare, Republic of Korea [HI15C1532]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI15C1532).; Timothy Lee provided English grammar support. This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI15C1532).	Abdel-Hakim AM, 2010, UROLOGY, V76, P448, DOI 10.1016/j.urology.2009.12.035; ALAOPAS MY, 1993, SCAND J UROL NEPHROL, V27, P235, DOI 10.3109/00365599309181256; Bae J, 2010, KOREAN J UROL, V51, P688, DOI 10.4111/kju.2010.51.10.688; BARRY MJ, 1993, J UROLOGY, V150, P351, DOI 10.1016/S0022-5347(17)35482-4; Brubaker L, 2006, UROLOGY, V68, P3, DOI 10.1016/j.urology.2006.05.045; Chen Q, 2012, J ENDOUROL, V26, P1625, DOI 10.1089/end.2012.0265; Cho MC, 2015, WORLD J UROL, V33, P1173, DOI 10.1007/s00345-014-1424-0; Cornu JN, 2015, EUR UROL, V67, P1066, DOI 10.1016/j.eururo.2014.06.017; Elmansy HM, 2011, J UROLOGY, V186, P1972, DOI 10.1016/j.juro.2011.06.065; Elzayat EA, 2007, EUR UROL, V52, P1465, DOI 10.1016/j.eururo.2007.04.074; Fagien S, 2008, PLAST RECONSTR SURG, V122, P1915, DOI 10.1097/PRS.0b013e31818dbfe3; Fraundorfer MR, 1998, EUR UROL, V33, P69, DOI 10.1159/000019535; Gilling PJ, 2008, EUR UROL, V53, P744, DOI 10.1016/j.eururo.2007.04.052; Gilling PJ, 2012, BJU INT, V109, P408, DOI 10.1111/j.1464-410X.2011.10359.x; Gratzke C, 2015, EUR UROL, V67, P1099, DOI 10.1016/j.eururo.2014.12.038; Hueber PA, 2013, CUAJ-CAN UROL ASSOC, V7, pE582, DOI 10.5489/cuaj.203; Ku JH, 2010, ASIAN J ANDROL, V12, P728, DOI 10.1038/aja.2010.23; Lee HN, 2010, INT UROGYNECOL J, V21, P1479, DOI 10.1007/s00192-010-1224-z; Malek RS, 2000, J UROLOGY, V163, P1730, DOI 10.1016/S0022-5347(05)67530-1; Masumori N, 2011, INT J UROL, V18, P166, DOI 10.1111/j.1442-2042.2010.02687.x; McVary KT, 2011, J UROLOGY, V185, P1793, DOI 10.1016/j.juro.2011.01.074; MEYHOFF HH, 1986, SCAND J UROL NEPHROL, V20, P27, DOI 10.3109/00365598609024476; MEYHOFF HH, 1984, SCAND J UROL NEPHROL, V18, P201, DOI 10.3109/00365598409180184; Mishriki SF, 2008, UROLOGY, V72, P322, DOI 10.1016/j.urology.2008.01.081; Montorsi F, 2008, J UROLOGY, V179, pS87, DOI 10.1016/j.juro.2008.03.143; Nam JK, 2015, WORLD J MENS HEALTH, V33, P88, DOI 10.5534/wjmh.2015.33.2.88; Piao S, 2015, INT NEUROUROL J, V19, P90, DOI 10.5213/inj.2015.19.2.90; Pleil AM, 2005, VALUE HEALTH, V8, pS25, DOI 10.1111/j.1524-4733.2005.00069.x; Rigatti L, 2006, UROLOGY, V67, P1193, DOI 10.1016/j.urology.2005.12.036; Shigemura K, 2016, INT NEUROUROL J, V20, P59, DOI 10.5213/inj.1630396.198; van Rij S, 2012, CURR UROL REP, V13, P427, DOI 10.1007/s11934-012-0279-4; Wilson LC, 2006, EUR UROL, V50, P569, DOI 10.1016/j.eururo.2006.04.002; Yin L, 2013, J ENDOUROL, V27, P604, DOI 10.1089/end.2012.0505	33	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182230	10.1371/journal.pone.0182230	http://dx.doi.org/10.1371/journal.pone.0182230			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28793314	gold, Green Published, Green Submitted			2022-12-26	WOS:000407196700036
J	Perez, M; Lee, KJ; Cardona, HJ; Taylor, JM; Robbins, ME; Waypa, GB; Berkelhamer, SK; Farrow, KN				Perez, Marta; Lee, Keng Jin; Cardona, Herminio J.; Taylor, Joann M.; Robbins, Mary E.; Waypa, Gregory B.; Berkelhamer, Sara K.; Farrow, Kathryn N.			Aberrant cGMP signaling persists during recovery in mice with oxygen-induced pulmonary hypertension	PLOS ONE			English	Article							BRONCHOPULMONARY DYSPLASIA; SILDENAFIL CITRATE; ARTERIAL-HYPERTENSION; PREMATURE-INFANTS; LUNG DEVELOPMENT; ANIMAL-MODELS; HYPEROXIA; MOUSE; EXPOSURE; GROWTH	Bronchopulmonary dysplasia (BPD), a common complication of preterm birth, is associated with pulmonary hypertension (PH) in 25% of infants with moderate to severe BPD. Neonatal mice exposed to hyperoxia for 14d develop lung disease similar to BPD, with evidence of associated PH. The cyclic guanosine monophosphate (cGMP) signaling pathway has not been well studied in BPD-associated PH. In addition, there is little data about the natural history of hyperoxia-induced PH in mice or the utility of phosphodiesterase-5 (PDE5) inhibition in established disease. C57BL/6 mice were placed in room air or 75% O-2 within 24h of birth for 14d, followed by recovery in room air for an additional 7 days (21d). Additional pups were treated with either vehicle or sildenafil for 7d during room air recovery. Mean alveolar area, pulmonary artery (PA) medial wall thickness (MWT), RVH, and vessel density were evaluated at 21d. PA protein from 21d animals was analyzed for soluble guanylate cyclase (sGC) activity, PDE5 activity, and cGMP levels. Neonatal hyperoxia exposure results in persistent alveolar simplification, RVH, decreased vessel density, increased MWT, and disrupted cGMP signaling despite a period of room air recovery. Delayed treatment with sildenafil during room air recovery is associated with improved RVH and decreased PA PDE5 activity, but does not have significant effects on alveolar simplification, PA remodeling, or vessel density. These data are consistent with clinical studies suggesting inconsistent effects of sildenafil treatment in infants with BPD-associated PH.	[Perez, Marta; Lee, Keng Jin; Cardona, Herminio J.; Taylor, Joann M.; Robbins, Mary E.; Waypa, Gregory B.; Farrow, Kathryn N.] Northwestern Univ, Dept Pediat, Chicago, IL 60611 USA; [Berkelhamer, Sara K.] Univ Buffalo, Dept Pediat, Buffalo, NY USA	Northwestern University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Perez, M (corresponding author), Northwestern Univ, Dept Pediat, Chicago, IL 60611 USA.	mtperez@luriechildrens.org	Perez, Marta/AGU-9924-2022	Perez, Marta/0000-0003-0017-4281; Robbins, Mary/0000-0002-7794-0493	Department of Pediatrics Physician Scientist Research Scholar Award, NIH [HL124295-01A1]; NIH [HL109478];  [NCI CCSG P30 CA060553]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL124295, R01HL109478] Funding Source: NIH RePORTER	Department of Pediatrics Physician Scientist Research Scholar Award, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by a Department of Pediatrics Physician Scientist Research Scholar Award (MP), NIH Grant HL124295-01A1 (MP), and an NIH Grant HL109478 (KF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Gina A. Kim for her technical assistance with mouse surgeries and colony maintenance. Histology services were provided by the Northwestern University Mouse Histology and Phenotyping Laboratory, which is supported by NCI CCSG P30 CA060553 awarded to the Robert H. Lurie Comprehensive Cancer Center.	Abman SH, 2001, AM J RESP CRIT CARE, V164, P1755, DOI 10.1164/ajrccm.164.10.2109111c; Barst RJ, 2012, CIRCULATION, V125, P324, DOI 10.1161/CIRCULATIONAHA.110.016667; Berger J, 2014, AM J PHYSIOL-LUNG C, V307, pL936, DOI 10.1152/ajplung.00159.2014; Bhat R, 2012, PEDIATRICS, V129, pE682, DOI 10.1542/peds.2011-1827; Check J, 2013, J PERINATOL, V33, P553, DOI 10.1038/jp.2012.164; Chen X, 2016, ACTA PHYSIOL, V216, P358, DOI 10.1111/apha.12622; Datta A, 2015, AM J PHYSIOL-LUNG C, V309, pL369, DOI 10.1152/ajplung.00176.2014; de Visser YP, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-30; Fanaroff Avroy A, 2007, Am J Obstet Gynecol, V196, DOI 10.1016/j.ajog.2006.09.014; Farrow KN, 2008, CIRC RES, V102, P226, DOI 10.1161/CIRCRESAHA.107.161463; Farrow KN, 2012, ANTIOXID REDOX SIGN, V17, P460, DOI 10.1089/ars.2011.4184; Farrow KN, 2010, AM J PHYSIOL-LUNG C, V299, pL109, DOI 10.1152/ajplung.00309.2009; Hansmann Georg, 2012, Pulm Circ, V2, P170, DOI 10.4103/2045-8932.97603; Heilman RP, 2015, AM J PHYSIOL-HEART C, V308, pH1575, DOI 10.1152/ajpheart.00569.2014; Hemnes AR, 2008, AM J PHYSIOL-LUNG C, V294, pL24, DOI 10.1152/ajplung.00245.2007; Jobe AJ, 1999, PEDIATR RES, V46, P641, DOI 10.1203/00006450-199912000-00007; Khemani E, 2007, PEDIATRICS, V120, P1260, DOI 10.1542/peds.2007-0971; Kirsch M, 2008, FASEB J, V22, P30, DOI 10.1096/fj.06-7526com; Ladha F, 2005, AM J RESP CRIT CARE, V172, P750, DOI 10.1164/rccm.200503-510OC; Lee KJ, 2014, AM J RESP CELL MOL, V50, P369, DOI 10.1165/rcmb.2013-0118OC; Leibovitch L, 2007, DRUGS, V67, P57, DOI 10.2165/00003495-200767010-00005; Liu Hao, 2007, Interact Cardiovasc Thorac Surg, V6, P608, DOI 10.1510/icvts.2006.147033; Mankouski A, 2016, AM J PHYSIOL-LUNG C; Martin CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098773; Mourani PM, 2009, J PEDIATR-US, V154, P379, DOI 10.1016/j.jpeds.2008.09.021; Murthy K, 2014, J PERINATOL, V34, P543, DOI 10.1038/jp.2014.35; Nardiello C, 2017, DIS MODEL MECH, V10, P185, DOI 10.1242/dmm.027086; Nyp M, 2012, J PERINATOL, V32, P64, DOI 10.1038/jp.2011.131; O'Reilly M, 2014, AM J PHYSIOL-LUNG C, V307, pL948, DOI 10.1152/ajplung.00160.2014; Park HS, 2013, AM J RESP CELL MOL, V48, P105, DOI 10.1165/rcmb.2012-0043OC; Ramani M, 2015, AM J RESP CELL MOL, V52, P594, DOI 10.1165/rcmb.2013-0491OC; RANDELL SH, 1989, AM J ANAT, V186, P55, DOI 10.1002/aja.1001860105; RANDELL SH, 1990, AM J PATHOL, V136, P1259; Rieger-Fackeldey E, 2014, AM J PATHOL, V184, P1010, DOI 10.1016/j.ajpath.2013.12.021; Rosenkranz S, 2015, HEART, V101, P1792, DOI 10.1136/heartjnl-2015-307832; Schermuly RT, 2004, AM J RESP CRIT CARE, V169, P39, DOI 10.1164/rccm.200302-282OC; Schneider JP, 2014, AM J PHYSIOL-LUNG C, V306, pL341, DOI 10.1152/ajplung.00329.2013; Simon DM, 2006, FASEB J, V20, P1507, DOI 10.1096/fj.05-5410fje; Tan K, 2015, EUR J PEDIATR, V174, P1109, DOI 10.1007/s00431-015-2515-7; Trottier-Boucher MN, 2015, PEDIATR CARDIOL, V36, P1255, DOI 10.1007/s00246-015-1154-0; Velten M, 2012, AM J PHYSIOL-REG I, V303, pR279, DOI 10.1152/ajpregu.00029.2012; Velten M, 2010, J APPL PHYSIOL, V108, P1347, DOI 10.1152/japplphysiol.01392.2009; Walker DK, 1999, XENOBIOTICA, V29, P297, DOI 10.1080/004982599238687; Warner BB, 1998, AM J PHYSIOL-LUNG C, V275, pL110, DOI 10.1152/ajplung.1998.275.1.L110; Xia XD, 2012, CELL BIOCHEM FUNCT, V30, P279, DOI 10.1002/cbf.2796; Yee M, 2011, AM J PATHOL, V178, P2601, DOI 10.1016/j.ajpath.2011.02.010; Yee M, 2009, AM J PHYSIOL-LUNG C, V297, pL641, DOI 10.1152/ajplung.00023.2009	47	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0180957	10.1371/journal.pone.0180957	http://dx.doi.org/10.1371/journal.pone.0180957			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28792962	Green Published, gold, Green Submitted			2022-12-26	WOS:000407196700005
J	Li, L; Wang, YS; An, LF; Kong, XY; Huang, T				Li, Lin; Wang, YanShu; An, Lifeng; Kong, XiangYin; Huang, Tao			A network-based method using a random walk with restart algorithm and screening tests to identify novel genes associated with Meniere's disease	PLOS ONE			English	Article							SENSORINEURAL HEARING-LOSS; INTRATYMPANIC GENTAMICIN TREATMENT; PROTEIN-PROTEIN INTERACTIONS; INNER-EAR; OXIDATIVE STRESS; CHEMOKINE CXCL9; T-CELLS; LIPID-PEROXIDATION; IMMUNE-RESPONSES; EXPRESSION	As a chronic illness derived from hair cells of the inner ear, Meniere's disease (MD) negatively influences the quality of life of individuals and leads to a number of symptoms, such as dizziness, temporary hearing loss, and tinnitus. The complete identification of novel genes related to MD would help elucidate its underlying pathological mechanisms and improve its diagnosis and treatment. In this study, a network-based method was developed to identify novel MD-related genes based on known MD-related genes. A human protein-protein interaction (PPI) network was constructed using the PPI information reported in the STRING database. A classic ranking algorithm, the random walk with restart (RWR) algorithm, was employed to search for novel genes using known genes as seed nodes. To make the identified genes more reliable, a series of screening tests, including a permutation test, an interaction test and an enrichment test, were designed to select essential genes from those obtained by the RWR algorithm. As a result, several inferred genes, such as CD4, NOTCH2 and IL6, were discovered. Finally, a detailed biological analysis was performed on fifteen of the important inferred genes, which indicated their strong associations with MD.	[Li, Lin; An, Lifeng] Jilin Univ, China Japan Union Hosp, Dept Otorhinolaryngol & Head & Neck, Changchun, Jilin, Peoples R China; [Wang, YanShu] Jilin Univ, Dept Anesthesia, Hosp 1, Changchun, Jilin, Peoples R China; [Kong, XiangYin; Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China	Jilin University; Jilin University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	An, LF (corresponding author), Jilin Univ, China Japan Union Hosp, Dept Otorhinolaryngol & Head & Neck, Changchun, Jilin, Peoples R China.	anlf@jlu.edu.cn		An, lifeng/0000-0002-5076-8910	National Natural Science Foundation of China [81100702]; Health and Family Planning Foundation of Jilin Province [20152046]; Science and technology Development plan Foundation of Jilin Province [20160101070JC, 20150204084SF]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Health and Family Planning Foundation of Jilin Province; Science and technology Development plan Foundation of Jilin Province	This work was supported by the National Natural Science Foundation of China (81100702), Health and Family Planning Foundation of Jilin Province (20152046), and Science and technology Development plan Foundation of Jilin Province (20160101070JC), Science and technology Development plan Foundation of Jilin Province (20150204084SF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This study was supported by the National Natural Science Foundation of China (81100702), Health and Family Planning Foundation of Jilin Province (20152046), and Science and technology Development plan Foundation of Jilin Province (20160101070JC), Science and technology Development plan Foundation of Jilin Province (20150204084SF).	Agrup C, 2007, J NEUROL NEUROSUR PS, V78, P114, DOI 10.1136/jnnp.2006.092064; Asher BF, 2016, ALTERN THER HEALTH M, V22, P44; Al Attrache NA, 2016, J INT ADV OTOL, V12, P92, DOI 10.5152/iao.2016.2177; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; BARNA BP, 1988, CLIN LAB MED, V8, P385, DOI 10.1016/S0272-2712(18)30690-5; Basura GJ, 2014, JAMA OTOLARYNGOL, V140, P754, DOI 10.1001/jamaoto.2014.1249; Benakanakere M, 2015, J DENT RES, V94, P183, DOI 10.1177/0022034514557545; Cabrera S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112171; Cai YD, 2017, J PROTEOME RES, V16, P1027, DOI 10.1021/acs.jproteome.6b00950; Calabrese V, 2010, NEUROCHEM RES, V35, P2208, DOI 10.1007/s11064-010-0304-2; Calzada AP, 2012, CELL TISSUE RES, V350, P373, DOI 10.1007/s00441-012-1481-x; Chen L, 2016, MOL GENET GENOMICS, V291, P2065, DOI 10.1007/s00438-016-1240-x; Chen L, 2017, ARTIF INTELL MED, V76, P27, DOI 10.1016/j.artmed.2017.02.001; Chen L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175185; Chen L, 2016, PROTEIN PEPTIDE LETT, V23, P1081, DOI 10.2174/0929866523666161021165506; Chen L, 2016, SCI REP-UK, V6, DOI 10.1038/srep29849; Chen L, 2016, MOL GENET GENOMICS, V291, P913, DOI 10.1007/s00438-015-1157-9; Chen L, 2016, CURR BIOINFORM, V11, P51, DOI 10.2174/1574893611666151119220024; Chen L, 2016, J BIOMOL STRUCT DYN, V34, P664, DOI 10.1080/07391102.2015.1042915; Ciuman RR, 2013, MED SCI MONITOR, V19, P1195, DOI 10.12659/MSM.889815; Derebery MJ, 2011, OTOLARYNG CLIN N AM, V44, P655, DOI 10.1016/j.otc.2011.03.004; Derebery MJ, 2010, OTOLARYNG CLIN N AM, V43, P1047, DOI 10.1016/j.otc.2010.05.004; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Dong Y, 2014, ACTA OTO-LARYNGOL, V134, P601, DOI 10.3109/00016489.2014.880795; Doobe G, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/457318; Duarte GV, 2015, CYTOKINE, V74, P287, DOI 10.1016/j.cyto.2015.04.015; Eckhard A, 2012, MOL ASPECTS MED, V33, P612, DOI 10.1016/j.mam.2012.06.004; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Franke L, 2006, AM J HUM GENET, V78, P1011, DOI 10.1086/504300; Friedland DR, 2016, JAMA OTOLARYNGOL, V142, P351, DOI 10.1001/jamaoto.2015.3663; Frykholm C, 2006, OTOL NEUROTOL, V27, P681, DOI 10.1097/01.mao.0000226315.27811.c8; Furuta T, 2011, INT J IMMUNOGENET, V38, P249, DOI 10.1111/j.1744-313X.2011.01004.x; Fuse T, 2003, ACTA OTO-LARYNGOL, V123, P26, DOI 10.1080/0036554021000028074; Gao P, 2012, PROTEIN PEPTIDE LETT, V19, P910, DOI 10.2174/092986612802084528; Gao YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045944; Gazquez I, 2013, EUR ARCH OTO-RHINO-L, V270, P1521, DOI 10.1007/s00405-012-2268-0; Gene Ontology Consortium, 2015, Nucleic Acids Res, V43, pD1049, DOI 10.1093/nar/gku1179; Gharagozloo P, 2016, HUM REPROD, V31, P252, DOI 10.1093/humrep/dev302; Giuca MR, 2010, J BIOL REG HOMEOS AG, V24, P359; Gurkov R, 2016, J NEUROL, V263, pS71, DOI 10.1007/s00415-015-7930-1; Gui TT, 2015, J COMPUT BIOL, V22, P63, DOI 10.1089/cmb.2014.0122; Gutsche M, 2009, J BIOL CHEM, V284, P31532, DOI 10.1074/jbc.M109.059246; Henrick BM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00426; Hoa M, 2015, LARYNGOSCOPE, V125, pS1, DOI 10.1002/lary.25579; Hornibrook J, 2016, OTOL NEUROTOL, V37, P1677, DOI 10.1097/MAO.0000000000001206; Hsia CCW, 1998, NEW ENGL J MED, V338, P239, DOI 10.1056/NEJM199801223380407; Hu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017668; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Huang GH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166580; Jablonka-Strom A, 2013, EUR ARCH OTO-RHINO-L, V270, P1751, DOI 10.1007/s00405-012-2246-6; Jegaskanda S, 2014, J VIROL, V88, P10412, DOI 10.1128/JVI.00111-14; Jiang R, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S2-S2; Ju Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep33870; Kadariya Y, 2016, CANCER PREV RES, V9, P406, DOI 10.1158/1940-6207.CAPR-15-0347; Keles E, 2004, J LARYNGOL OTOL, V118, P688; Kiernan AE, 2005, DEVELOPMENT, V132, P4353, DOI 10.1242/dev.02002; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Krauthammer M, 2004, P NATL ACAD SCI USA, V101, P15148, DOI 10.1073/pnas.0404315101; Labbe D, 2005, HEARING RES, V202, P21, DOI 10.1016/j.heares.2004.10.002; Lamounier P, 2017, BRAZ J OTORHINOLAR, V83, P394, DOI 10.1016/j.bjorl.2016.04.021; Le CH, 2013, CURR OPIN OTOLARYNGO, V21, P492, DOI 10.1097/MOO.0b013e328364869b; Lee JM, 2015, LARYNGOSCOPE, V125, P2175, DOI 10.1002/lary.25207; Li ZD, 2016, SCI REP-UK, V6, DOI 10.1038/srep25515; Liddell JR, 2006, J NEUROSCI RES, V84, P578, DOI 10.1002/jnr.20957; Lin FY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102450; Liu Y, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.42; Lu HL, 2015, J CANCER RES CLIN, V141, P983, DOI 10.1007/s00432-014-1869-y; Luzzi R, 2014, MINERVA MED, V105, P245; Ma C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121371; Mahmoudi M, 2011, EUR CYTOKINE NETW, V22, P175, DOI 10.1684/ecn.2011.0293; Mamikoglu B, 2002, ACTA OTO-LARYNGOL, V122, P857, DOI 10.1080/0036554021000028069; Matsushita M, 2015, J EXP MED, V212, P555, DOI 10.1084/jem.20140857; Mattia G, 2008, EXP HEMATOL, V36, P244, DOI 10.1016/j.exphem.2007.09.006; McNeill C, 2009, INT J AUDIOL, V48, P594, DOI 10.1080/14992020802716778; MICHEL O, 1992, Auris Nasus Larynx, V19, P7; Mick P, 2014, OTOL NEUROTOL, V35, P1172, DOI 10.1097/MAO.0000000000000202; Moller MN, 2016, EUR ARCH OTO-RHINO-L, V273, P1705, DOI 10.1007/s00405-015-3731-5; Moller MN, 2017, J ANAT, V230, P297, DOI 10.1111/joa.12559; Moller MN, 2015, LARYNGOSCOPE, V125, pE269, DOI 10.1002/lary.25242; Moreira LO, 2008, CELL MICROBIOL, V10, P2067, DOI 10.1111/j.1462-5822.2008.01189.x; MOSMANN TR, 1991, INT ARCH ALLER A IMM, V94, P110, DOI 10.1159/000235340; Nelson BR, 2013, J NEUROSCI, V33, P9122, DOI 10.1523/JNEUROSCI.0791-13.2013; Ng KL, 2010, COMPUT BIOL MED, V40, P300, DOI 10.1016/j.compbiomed.2010.01.001; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Padovan E, 2002, J LEUKOCYTE BIOL, V71, P669; Pan XC, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020242; Pathak S, 2013, J CLIN IMMUNOL, V33, P1204, DOI 10.1007/s10875-013-9926-x; Perez N, 2005, J VESTIBUL RES-EQUIL, V15, P49; Petrovic-Djergovic D, 2015, CLIN EXP IMMUNOL, V180, P305, DOI 10.1111/cei.12579; RASKANDERSEN H, 1991, ANN OTO RHINOL LARYN, V100, P148, DOI 10.1177/000348949110000211; Requena T, 2013, IMMUNOGENETICS, V65, P345, DOI 10.1007/s00251-013-0683-z; Rouault H, 2012, BIOPHYS J, V102, P417, DOI 10.1016/j.bpj.2011.11.4022; Sahin H, 2012, HEPATOLOGY, V55, P1610, DOI 10.1002/hep.25545; Sakthivel P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100970; Santulli P, 2014, J CLIN ENDOCR METAB, V99, P881, DOI 10.1210/jc.2013-2950; Seo YJ, 2016, AURIS NASUS LARYNX, V43, P620, DOI 10.1016/j.anl.2016.01.006; Shen JQ, 2013, CYTOKINE, V64, P382, DOI 10.1016/j.cyto.2013.05.012; Silverstein H, 2010, OTOLARYNG HEAD NECK, V142, P570, DOI 10.1016/j.otohns.2009.12.009; Song C, 2016, J CELL MOL MED, V20, P2064, DOI 10.1111/jcmm.12898; Stamatakis K, 2015, ONCOTARGET, V6, P39941, DOI 10.18632/oncotarget.5402; Talreja D, 2015, INVEST OPHTH VIS SCI, V56, P1719, DOI 10.1167/iovs.14-16087; Tassinari M, 2015, AUDIOL NEURO-OTOL, V20, P153, DOI 10.1159/000375393; Taura A, 2014, ACTA OTO-LARYNGOL, V134, P1140, DOI 10.3109/00016489.2014.936624; Taylor A, 2013, HUM REPROD, V28, P2332, DOI 10.1093/humrep/det237; Teranishi M, 2012, DNA CELL BIOL, V31, P1555, DOI 10.1089/dna.2012.1631; THOMSEN J, 1979, J OTOLARYNGOL, V8, P145; Trine M B, 1995, J Am Acad Audiol, V6, P264; Tyrrell JS, 2014, EAR HEARING, V35, pE162, DOI 10.1097/AUD.0000000000000041; van Esch BF, 2016, OTOL NEUROTOL, V37, P1620, DOI 10.1097/MAO.0000000000001215; Waalen J, 2011, EUR J HAEMATOL, V87, P107, DOI 10.1111/j.1600-0609.2011.01631.x; Wang BM, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/715639; Wang SP, 2016, BBA-GEN SUBJECTS, V1860, P2716, DOI 10.1016/j.bbagen.2016.04.010; Wong CP, 2015, MOL NUTR FOOD RES, V59, P991, DOI 10.1002/mnfr.201400761; Yamane H, 2012, ACTA OTO-LARYNGOL, V132, P1054, DOI 10.3109/00016489.2012.680980; Yang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107202; Yokota Y, 2016, AURIS NASUS LARYNX, V43, P287, DOI 10.1016/j.anl.2015.10.007; Yuan F, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/623121; Zeng XX, 2017, IEEE ACM T COMPUT BI, V14, P687, DOI 10.1109/TCBB.2016.2520947; Zhang J, 2016, NEUROCOMPUTING, V217, P63, DOI 10.1016/j.neucom.2015.09.136; Zhang Jian, 2014, Biomed Res Int, V2014, P450386, DOI 10.1155/2014/450386; Zhang JP, 2010, PEDIATR RES, V68, P479, DOI 10.1203/PDR.0b013e3181f90810; Zhang L, 2015, YONSEI MED J, V56, P1134, DOI 10.3349/ymj.2015.56.4.1134; ZHANG Q, 2016, BIOMED RES INT, DOI DOI 10.1155/2016/4895476; Zhao YX, 2015, EUR J IMMUNOL, V45, P2494, DOI 10.1002/eji.201445378; Zhou B, 2012, GENE THER, V19, P228, DOI 10.1038/gt.2011.88; Zhu LC, 2016, BBA-GEN SUBJECTS, V1860, P2756, DOI 10.1016/j.bbagen.2016.05.018; Zhu LC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159519; Zou Q, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0353-5; Zou Q, 2016, BRIEF FUNCT GENOMICS, V15, P55, DOI 10.1093/bfgp/elv024; Zou Q, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/416323	131	30	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182592	10.1371/journal.pone.0182592	http://dx.doi.org/10.1371/journal.pone.0182592			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28787010	Green Published, Green Submitted, gold			2022-12-26	WOS:000406998800049
J	Weiss, A; Martindale, RC				Weiss, Anna; Martindale, Rowan C.			Crustose coralline algae increased framework and diversity on ancient coral reefs	PLOS ONE			English	Article							CALCAREOUS RED ALGAE; OCEAN ACIDIFICATION; CLIMATE-CHANGE; FOSSIL RECORD; GLOBAL CHANGE; PALEOCENE; CARBONATE; PERSPECTIVE; ECOSYSTEMS; RHODOPHYTA	Crustose coralline algae (CCA) are key producers of carbonate sediment on reefs today. Despite their importance in modern reef ecosystems, the long-term relationship of CCA with reef development has not been quantitatively assessed in the fossil record. This study includes data from 128 Cenozoic coral reefs collected from the Paleobiology Database, the Paleoreefs Database, as well as the original literature and assesses the correlation of CCA abundance with taxonomic diversity (both corals and reef dwellers) and framework of fossil coral reefs. Chi-squared tests show reef type is significantly correlated with CCA abundance and post-hoc tests indicate higher involvement of CCA is associated with stronger reef structure. Additionally, general linear models show coral reefs with higher amounts of CCA had a higher diversity of reef-dwelling organisms. These data have important implications for paleoecology as they demonstrate that CCA increased building capacity, structural integrity, and diversity of ancient coral reefs. The analyses presented here demonstrate that the function of CCA on modern coral reefs is similar to their function on Cenozoic reefs; thus, studies of ancient coral reef collapse are even more meaningful as modern analogues.	[Weiss, Anna; Martindale, Rowan C.] Univ Texas Austin, Dept Geol Sci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Weiss, A (corresponding author), Univ Texas Austin, Dept Geol Sci, Austin, TX 78712 USA.	anna.weiss@utexas.edu	Martindale, Rowan/N-2602-2019; Martindale, Rowan/HDO-1408-2022; Martindale, Rowan C/N-9853-2015	Martindale, Rowan/0000-0003-2681-083X; Martindale, Rowan C/0000-0003-2681-083X; Weiss, Anna/0000-0003-0835-4906				Adey W.H., 1977, AMERICAN ASSOCIATION OF PETROLEUM GEOLOGISTS STUDIES IN GEOLOGY, P67; ADEY WH, 1978, PHYCOLOGIA, V17, P361, DOI 10.2216/i0031-8884-17-4-361.1; Adey WH, 1998, J PHYCOL, V34, P393, DOI 10.1046/j.1529-8817.1998.340393.x; Aguirre J., 2005, Revista Espanola de Micropaleontologia, V37, P57; Aguirre J, 2007, PALAEOGEOGR PALAEOCL, V249, P393, DOI 10.1016/j.palaeo.2007.02.009; Aguirre J, 2010, PALEOBIOLOGY, V36, P519, DOI 10.1666/09041.1; Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; Bak R.P.M., 1976, Netherlands J Sea Res, V10, P285, DOI 10.1016/0077-7579(76)90009-0; Basso D, 2012, GEODIVERSITAS, V34, P13, DOI 10.5252/g2012n1a2; Belliveau S.A., 2012, MARINE ECOLOGY PROGR, V232, P105; Comeau S, 2016, GLOBAL CHANGE BIOL, V22, P1225, DOI 10.1111/gcb.13023; DUNHAM RJ, 1970, AM ASSOC PETR GEOL B, V54, P1931; Fabricius K, 2001, CORAL REEFS, V19, P303, DOI 10.1007/s003380000120; Froyd CA, 2008, QUATERNARY SCI REV, V27, P1723, DOI 10.1016/j.quascirev.2008.06.006; Ghasemi A, 2012, INT J ENDOCRINOL MET, V10, P486, DOI 10.5812/ijem.3505; Gomez-Lemos LA, 2017, CORAL REEFS, V36, P453, DOI 10.1007/s00338-017-1549-x; Graham NAJ, 2014, CURR OPIN ENV SUST, V7, P9, DOI 10.1016/j.cosust.2013.11.023; Greenstein BJ, 2008, GLOBAL CHANGE BIOL, V14, P513, DOI 10.1111/j.1365-2486.2007.01506.x; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; HUBBARD DK, 1990, J SEDIMENT PETROL, V60, P335; Insalaco E, 1998, SEDIMENT GEOL, V118, P159, DOI 10.1016/S0037-0738(98)00011-6; Johnson J.H., 1965, J PALEONTOL, V35, P802; Jokiel PL, 2008, CORAL REEFS, V27, P473, DOI 10.1007/s00338-008-0380-9; Jouffray JB, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0268; Kiessling W, 1999, AAPG BULL, V83, P1552; KIESSLING W, 2002, SEPM SPEC PUBL, V72, P77; Kiessling W., 2002, SEPM SPECIAL PUBLICA, V72, P625; Kiessling W, 2012, P NATL ACAD SCI USA, V109, P21378, DOI 10.1073/pnas.1214037110; Kiessling W, 2009, ANNU REV ECOL EVOL S, V40, P173, DOI 10.1146/annurev.ecolsys.110308.120251; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Littler Mark M., 2013, Smithsonian Contributions to the Marine Sciences, P199; Littler MM, 1984, PROGR PHYCOLOGICAL R, V3, P323; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; McCoy SJ, 2015, J PHYCOL, V51, P6, DOI 10.1111/jpy.12262; McHugh ML, 2013, BIOCHEM MEDICA, V23, P143, DOI 10.11613/BM.2013.018; Misra PK, 1988, PALAEBOT, V37, P36; Nemenyi P. B., 1963, THESIS; Pandolfi JM, 2014, CURR OPIN ENV SUST, V7, P52, DOI 10.1016/j.cosust.2013.11.020; Patzkowsky ME, 2012, STRATIGRAPHIC PALEOB; Penman DE, 2014, PALEOCEANOGRAPHY, V29, P357, DOI 10.1002/2014PA002621; Perry CT, 2012, CORAL REEFS, V31, P853, DOI 10.1007/s00338-012-0901-4; Perry CT, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2409; Ritson-Williams R, 2016, MAR ECOL PROG SER, V548, P127, DOI 10.3354/meps11688; Scholz H., 1984, JB GEOLOGISCHEN BUND, V127, P471; Seddon AWR, 2014, J ECOL, V102, P256, DOI 10.1111/1365-2745.12195; STENECK RS, 1986, ANNU REV ECOL SYST, V17, P273, DOI 10.1146/annurev.es.17.110186.001421; Veron John E.N., 2011, Diversity, V3, P262; Warton DI, 2016, METHODS ECOL EVOL, V7, P882, DOI 10.1111/2041-210X.12552; WOODROFFE CD, 1991, QUATERNARY RES, V35, P246, DOI 10.1016/0033-5894(91)90071-C; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zachos JC, 2010, EARTH PLANET SC LETT, V299, P242, DOI 10.1016/j.epsl.2010.09.004; Zamagni J, 2012, PALAEOGEOGR PALAEOCL, V317, P48, DOI 10.1016/j.palaeo.2011.12.010	53	14	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0181637	10.1371/journal.pone.0181637	http://dx.doi.org/10.1371/journal.pone.0181637			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28783733	Green Published, Green Submitted, gold			2022-12-26	WOS:000406944300008
J	Bal, NC; Singh, S; Reis, FCG; Maurya, SK; Pani, S; Rowland, LA; Periasamy, M				Bal, Naresh C.; Singh, Sushant; Reis, Felipe C. G.; Maurya, Santosh K.; Pani, Sunil; Rowland, Leslie A.; Periasamy, Muthu			Both brown adipose tissue and skeletal muscle thermogenesis processes are activated during mild to severe cold adaptation in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADAPTIVE NONSHIVERING THERMOGENESIS; MITOCHONDRIAL UNCOUPLING PROTEIN; DIET-INDUCED THERMOGENESIS; DORSOMEDIAL HYPOTHALAMUS; ENERGY-EXPENDITURE; ADULT HUMANS; CROSS-TALK; SARCOLIPIN; UCP1; RATS	Thermogenesis is an important homeostatic mechanism essential for survival and normal physiological functions in mammals. Both brown adipose tissue (BAT) (i.e. uncoupling protein 1 (UCP1)-based) and skeletal muscle (i.e. sarcolipin (SLN)-based) thermogenesis processes play important roles in temperature homeostasis, but their relative contributions differ from small to large mammals. In this study, we investigated the functional interplay between skeletal muscle-and BAT-based thermogenesis under mild versus severe cold adaptation by employing UCP1(-/-) and SLN-/- mice. Interestingly, adaptation of SLN-/- mice to mild cold conditions (16 degrees C) significantly increased UCP1 expression, suggesting increased reliance on BAT-based thermogenesis. This was also evident from structural alterations in BAT morphology, including mitochondrial architecture, increased expression of electron transport chain proteins, and depletion of fat droplets. Similarly, UCP1(-/-) mice adapted to mild cold up-regulated muscle-based thermogenesis, indicated by increases in muscle succinate dehydrogenase activity, SLN expression, mitochondrial content, and neovascularization, compared with WT mice. These results further confirm that SLN-based thermogenesis is a key player in muscle non-shivering thermogenesis (NST) and can compensate for loss of BAT activity. We also present evidence that the increased reliance on BAT-based NST depends on increased autonomic input, as indicated by abundant levels of tyrosine hydroxylase and neuropeptide Y. Our findings demonstrate that both BAT and muscle-based NST are equally recruited during mild and severe cold adaptation and that loss of heat production from one thermogenic pathway leads to increased recruitment of the other, indicating a functional interplay between these two thermogenic processes.	[Bal, Naresh C.; Pani, Sunil] KIIT Univ, Sch Biotechnol, Bhubaneswar 751024, Orissa, India; [Bal, Naresh C.; Singh, Sushant; Maurya, Santosh K.; Rowland, Leslie A.; Periasamy, Muthu] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Bal, Naresh C.; Singh, Sushant; Reis, Felipe C. G.; Maurya, Santosh K.; Periasamy, Muthu] Sanford Burnham Prebys Med Discovery Inst Lake No, Orlando, FL 32827 USA	Kalinga Institute of Industrial Technology (KIIT); University System of Ohio; Ohio State University; Sanford Burnham Prebys Medical Discovery Institute	Bal, NC (corresponding author), KIIT Univ, Sch Biotechnol, Bhubaneswar 751024, Orissa, India.; Bal, NC; Periasamy, M (corresponding author), Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA.; Bal, NC; Periasamy, M (corresponding author), Sanford Burnham Prebys Med Discovery Inst Lake No, Orlando, FL 32827 USA.	naresh.bal@kiitbiotech.ac.in; mperiasamy@sbpdiscovery.org	Singh, Sushant/AAP-3860-2020; Maurya, Santosh/O-9066-2017; Singh, Sushant/AAQ-7930-2021; dos Reis, Felipe C Gomes/J-9867-2012	Maurya, Santosh/0000-0002-7610-2463; Singh, Sushant/0000-0002-0858-4405; dos Reis, Felipe C Gomes/0000-0001-8357-5261	National Institutes of Health [R01-HL-088555, R01 DK098240-01]; American Diabetes Association Basic Science Research Award [7-13-BS-131]; NIDDK, National Institutes of Health [DK102772]; Ramalingaswamy re-entry fellowship from the Department of Biotechnology, India; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK102772, R01DK098240] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Basic Science Research Award; NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Ramalingaswamy re-entry fellowship from the Department of Biotechnology, India; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants R01-HL-088555 and R01 DK098240-01 and American Diabetes Association Basic Science Research Award (7-13-BS-131) (to M. P.). The research reported in this work was supported in part by NIDDK, National Institutes of Health under Award DK102772 and a Ramalingaswamy re-entry fellowship from the Department of Biotechnology, India (to N. C. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anunciado-Koza RP, 2011, J BIOL CHEM, V286, P11659, DOI 10.1074/jbc.M110.203000; Aydin J, 2008, FASEB J, V22, P3919, DOI 10.1096/fj.08-113712; Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Bal NC, 2016, J BIOL CHEM, V291, P17247, DOI 10.1074/jbc.M116.728188; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; BLOCK BA, 1994, ANNU REV PHYSIOL, V56, P535; Blondin DP, 2017, J PHYSIOL-LONDON, V595, P2099, DOI 10.1113/JP273395; Bombardier E, 2013, FASEB J, V27, P3871, DOI 10.1096/fj.13-230631; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chen PL, 2004, J NEUROSCI, V24, P5091, DOI 10.1523/JNEUROSCI.0588-04.2004; DAVIS TRA, 1967, AM J PHYSIOL, V213, P1423, DOI 10.1152/ajplegacy.1967.213.6.1423; DAWKINS MJR, 1965, NATURE, V206, P201, DOI 10.1038/206201b0; De Matteis R, 1998, J NEUROCYTOL, V27, P877, DOI 10.1023/A:1006996922657; Dong J, 2016, INT J OBESITY, V40, P434, DOI 10.1038/ijo.2015.200; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Fredriksson JM, 2005, FEBS LETT, V579, P5680, DOI 10.1016/j.febslet.2005.09.044; Gamu D, 2014, EXERC SPORT SCI REV, V42, P136, DOI 10.1249/JES.0000000000000016; Giorgino F, 2009, AM J PHYSIOL-ENDOC M, V297, pE975, DOI 10.1152/ajpendo.00488.2009; Golozoubova V, 2001, FASEB J, V15, P2048, DOI 10.1096/fj.00-0536fje; GREENWAY DC, 1978, AM J PHYSIOL, V234, pC7, DOI 10.1152/ajpcell.1978.234.1.C7; Huang-Doran I, 2017, TRENDS ENDOCRIN MET, V28, P3, DOI 10.1016/j.tem.2016.10.003; Indrakusuma I, 2015, CURR OBES REP, V4, P411, DOI 10.1007/s13679-015-0174-7; Jastroch M, 2005, PHYSIOL GENOMICS, V22, P150, DOI 10.1152/physiolgenomics.00070.2005; Kanatous SB, 2008, J EXP BIOL, V211, P2559, DOI 10.1242/jeb.018119; Klingenspor M, 2003, EXP PHYSIOL, V88, P141, DOI 10.1113/eph8802508; Klingenspor M, 2008, BBA-BIOENERGETICS, V1777, P637, DOI 10.1016/j.bbabio.2008.03.006; Labbe SM, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00150; LEAN MEJ, 1986, CLIN SCI, V71, P291, DOI 10.1042/cs0710291; Li FN, 2017, CYTOKINE GROWTH F R, V33, P73, DOI 10.1016/j.cytogfr.2016.10.003; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Loiselle DS, 2016, AM J PHYSIOL-HEART C, V310, pH311, DOI 10.1152/ajpheart.00569.2015; Maurya SK, 2015, J BIOL CHEM, V290, P10840, DOI 10.1074/jbc.M115.636878; MCCARTHY HD, 1993, NEUROSCIENCE, V54, P127, DOI 10.1016/0306-4522(93)90388-V; McKay WP, 2013, APPL PHYSIOL NUTR ME, V38, P227, DOI 10.1139/apnm-2011-0358; Nedergaard J, 2001, BBA-BIOENERGETICS, V1504, P82, DOI 10.1016/S0005-2728(00)00247-4; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nishimura T, 2015, J PHYSIOL ANTHROPOL, V34, DOI 10.1186/s40101-015-0051-9; Oelkrug R, 2015, J COMP PHYSIOL B, V185, P587, DOI 10.1007/s00360-015-0907-7; Oelkrug R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3140; Pant M, 2016, TRENDS ENDOCRIN MET, V27, P881, DOI 10.1016/j.tem.2016.08.006; Pant M, 2015, J EXP BIOL, V218, P2321, DOI 10.1242/jeb.119164; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Reis M, 2002, MOL MEMBR BIOL, V19, P301, DOI 10.1080/09687680210166217; Ricquier D, 2017, BIOCHIMIE, V134, P3, DOI 10.1016/j.biochi.2016.10.018; Rodriguez A, 2017, ACTA PHYSIOL, V219, P362, DOI 10.1111/apha.12686; Rowland LA, 2015, BIOL REV, V90, P1279, DOI 10.1111/brv.12157; Rowland LA, 2015, J BIOL CHEM, V290, P12282, DOI 10.1074/jbc.M115.637603; Sahoo SK, 2015, J BIOL CHEM, V290, P14057, DOI 10.1074/jbc.M115.636738; Sahoo SK, 2013, J BIOL CHEM, V288, P6881, DOI 10.1074/jbc.M112.436915; Saito S, 2008, GENE, V408, P37, DOI 10.1016/j.gene.2007.10.018; Shi YC, 2013, CELL METAB, V17, P236, DOI 10.1016/j.cmet.2013.01.006; Silva J Enrique, 2011, Front Biosci (Schol Ed), V3, P352, DOI 10.2741/s156; Trayhurn Paul, 2011, Archives of Physiology and Biochemistry, V117, P47, DOI 10.3109/13813455.2010.535835; Tupone D, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00014; Wakabayashi H, 2017, INT J BIOMETEOROL, V61, P1261, DOI 10.1007/s00484-016-1303-z; Xue Y, 2009, CELL METAB, V9, P99, DOI 10.1016/j.cmet.2008.11.009; Zaretskaia MV, 2002, BRAIN RES, V928, P113, DOI 10.1016/S0006-8993(01)03369-8	59	66	67	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16616	16625		10.1074/jbc.M117.790451	http://dx.doi.org/10.1074/jbc.M117.790451			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28794154	hybrid, Green Published			2022-12-26	WOS:000412414800022
J	Balayssac, D; Pereira, B; Virot, J; Collin, A; Alapini, D; Cuny, D; Gagnaire, JM; Authier, N; Vennat, B				Balayssac, David; Pereira, Bruno; Virot, Julie; Collin, Aurore; Alapini, David; Cuny, Damien; Gagnaire, Jean-Marc; Authier, Nicolas; Vennat, Brigitte			Burnout, associated comorbidities and coping strategies in French community pharmacies-BOP study: A nationwide cross-sectional study	PLOS ONE			English	Article							STRESS; QUALITY; HEALTH; CARE; SATISFACTION; PHYSICIANS; SLEEP; LIFE	Background Work-related stress and burnout syndromes are unfortunately common comorbidities found in health professionals. However, burnout syndrome has only been partly and episodically assessed for community pharmacists whereas these professionals are exposed to patients' demands and difficulties every day. Prevalence of burnout, associated comorbidities and coping strategies were assessed in pharmacy teams (pharmacists and pharmacy technicians) in French community pharmacies. Methods This online survey was performed by emails sent to all French community pharmacies over 3 months. The survey assessed the prevalence of burnout (Maslach Burnout Inventory-MBI-questionnaire), anxiety, depression and strategies for coping with work-related stress. Results Of the 1,339 questionnaires received, 1,322 were completed and useable for the analysis. Burnout syndrome was detected in 56.2% of respondents and 10.5% of them presented severe burnout syndrome. Severe burnout syndrome was significantly associated with men, large urban areas and the number of hours worked. Depression and anxiety were found in 15.7% and 42.4% of respondents, respectively. These co-morbidities were significantly associated with severe burnout syndrome. Higher MBI scores were significantly associated with medical consultations and medicinal drug use. Conversely, respondents suffering from burnout syndrome declared they resorted less to non-medical strategies to manage their work-related stress (leisure, psychotherapy, holidays and time off). Conclusion This study demonstrated that community pharmacists and pharmacy technicians presented high prevalence of burnout syndrome, such as many healthcare professionals. Unfortunately, burnout syndrome was associated with several comorbidities (anxiety, depression and alcohol abuse) and the consumption of health resources. The psychological suffering of these healthcare professionals underlines the necessity to deploy a strategy to detect and manage burnout in community pharmacy.	[Balayssac, David] Univ Clermont Auvergne, Inserm U1107, NEURO DOL, UFR Pharm,CHU Clermont Ferrand, Clermont Ferrand, France; [Pereira, Bruno] CHU Clermont Ferrand, Clermont Ferrand, France; [Virot, Julie] Univ Clermont Auvergne, UFR Pharm, Clermont Ferrand, France; [Collin, Aurore] Univ Clermont Auvergne, Inserm U1107, NEURO DOL, UFR Pharm, Clermont Ferrand, France; [Alapini, David] Ordre Pharmaciens Conseil Reg Nord Pas de Calais, Lille, France; [Cuny, Damien] Univ Lille, CHU Lille, IMPECS IMPact Environm Chim Sante Humaine, Inst Pasteur Lille,EA 4483, Lille, France; [Gagnaire, Jean-Marc] Ordre Pharmaciens Conseil Reg Auvergne, Clermont Ferrand, France; [Authier, Nicolas] Univ Clermont Auvergne, CHU Clermont Ferrand, UFR Med, Inserm U1107,NEURO DOL, Clermont Ferrand, France; [Vennat, Brigitte] Univ Clermont Auvergne, UFR Pharm, Unite ACCePPT, Clermont Ferrand, France	CHU Clermont Ferrand; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; CHU Clermont Ferrand; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); Universite Clermont Auvergne (UCA)	Balayssac, D (corresponding author), Univ Clermont Auvergne, Inserm U1107, NEURO DOL, UFR Pharm,CHU Clermont Ferrand, Clermont Ferrand, France.	dbalayssac@chu-clermontferrand.fr	Balayssac, David/AAZ-3007-2020; Collin, Aurore/K-2251-2015; Balayssac, David/K-2265-2015	Balayssac, David/0000-0002-6126-6588; Collin, Aurore/0000-0002-1568-2775; Vennat, Brigitte/0000-0003-3479-3291				Ahola K, 2006, ADDICTION, V101, P1438, DOI 10.1111/j.1360-0443.2006.01539.x; Alexandrova-Karamanova A, 2016, INT ARCH OCCUP ENV H; American Psychological Association, COP STRESS WORK; [Anonymous], 2014, LIBERATION; Baldisseri MR, 2007, CRIT CARE MED, V35, pS106, DOI 10.1097/01.CCM.0000252918.87746.96; Bianchi R, 2015, CLIN PSYCHOL REV, V36, P28, DOI 10.1016/j.cpr.2015.01.004; Boyle TA, 2016, RES SOC ADMIN PHARM, V12, P772, DOI 10.1016/j.sapharm.2015.10.003; Calgan Z, 2011, INT J CLIN PHARM-NET, V33, P92, DOI 10.1007/s11096-010-9461-2; CATON DJ, 1988, AM J MENT RETARD, V93, P300; de Bloom J, 2009, J OCCUP HEALTH, V51, P13, DOI 10.1539/joh.K8004; de Vente W, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/431725; Dimou FM, 2016, J AM COLL SURG; Ding YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107130; Dyrbye LN, 2011, ARCH SURG-CHICAGO, V146, P211, DOI 10.1001/archsurg.2010.310; Ekstedt M, 2006, SCAND J WORK ENV HEA, V32, P121, DOI 10.5271/sjweh.987; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Grensman A, 2016, INT ARCH OCC ENV HEA, V89, P319, DOI 10.1007/s00420-015-1075-5; Hall LH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159015; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Harvey SB, 2017, OCCUP ENV MED; Hope CT-KC, TELEGRAPH, V19; Jacobs S, 2014, J HEALTH SERV RES PO, V19, P27, DOI 10.1177/1355819613500043; Lamers F, 2011, J CLIN PSYCHIAT, V72, P341, DOI 10.4088/JCP.10m06176blu; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Maslach C, 1996, MASLACH BURNOUT INVE; Maslach C, 2016, WORLD PSYCHIATRY, V15, P103, DOI 10.1002/wps.20311; May RW, 2014, STRESS, V17, P79, DOI 10.3109/10253890.2013.872618; McAbee JH, 2015, J NEUROSURG, V123, P161, DOI 10.3171/2014.12.JNS141348; McCann Laura, 2009, Int J Pharm Pract, V17, P261; O'Kelly F, 2015, BJU INT; Ordre National des Pharmaciens, DEM PHARM PHARM ORDR; Oreskovich MR, 2012, ARCH SURG-CHICAGO, V147, P168, DOI 10.1001/archsurg.2011.1481; Parker PA, 1995, J BEHAV MED, V18, P581, DOI 10.1007/BF01857897; Poghosyan L, 2009, INT J NURS STUD, V46, P894, DOI 10.1016/j.ijnurstu.2009.03.004; Rivera-Torres P, 2013, INT J ENV RES PUB HE, V10, P375, DOI 10.3390/ijerph10010375; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Shanafelt T, 2012, J CLIN ONCOL, V30, P1235, DOI 10.1200/JCO.2011.39.7380; Shanafelt TD, 2015, MAYO CLIN PROC, V90, P1600, DOI 10.1016/j.mayocp.2015.08.023; Shanafelt TD, 2011, ARCH SURG-CHICAGO, V146, P54, DOI 10.1001/archsurg.2010.292; Soler JK, 2008, FAM PRACT, V25, P245, DOI 10.1093/fampra/cmn038; Stults-Kolehmainen MA, 2014, SPORTS MED, V44, P81, DOI 10.1007/s40279-013-0090-5; van Dam A, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00090; Vela-Bueno A, 2008, J PSYCHOSOM RES, V64, P435, DOI 10.1016/j.jpsychores.2007.10.014; von Elm E, 2007, EPIDEMIOLOGY, V18, P800, DOI 10.1097/EDE.0b013e3181577654; Wurm W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149913; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	47	23	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0182956	10.1371/journal.pone.0182956	http://dx.doi.org/10.1371/journal.pone.0182956			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD3KL	28800612	Green Published, gold, Green Submitted			2022-12-26	WOS:000407431800037
J	Salem, JE; Germain, M; Hulot, JS; Voiriot, P; Lebourgeois, B; Waldura, J; Tregouet, DA; Charbit, B; Funck-Brentano, C				Salem, Joe-Elie; Germain, Marine; Hulot, Jean-Sebastien; Voiriot, Pascal; Lebourgeois, Bruno; Waldura, Jean; Tregouet, David-Alexandre; Charbit, Beny; Funck-Brentano, Christian			GENomE wide analysis of sotalol-induced IKr inhibition during ventricular REPOLarization, "GENEREPOL study": Lack of common variants with large effect sizes	PLOS ONE			English	Article							LONG-QT-SYNDROME; TRANSMURAL DISPERSION; STEROID-HORMONES; INTERVAL; PROLONGATION; ABNORMALITIES; GENE; PATTERNS; RESERVE; KCNE1	Many drugs used for non-cardiovascular and cardiovascular purposes, such as sotalol, have the side effect of prolonging cardiac repolarization, which can trigger life-threatening cardiac arrhythmias by inhibiting the potassium-channel IKr (KCNH2). On the electrocardiogram (ECG), IKr inhibition induces an increase in QTc and Tpeak-Tend (TpTe) interval and a decrease of T wave maximal amplitude (TAmp). These changes vary markedly between subjects, suggesting the existence of predisposing genetic factors. 990 healthy individuals, prospectively challenged with an oral 80mg sotalol dose, were monitored for changes in ventricular repolarization on ECG between baseline and 3 hours post dosing. QTc and TpTe increased by 5.5 +/- 3.5% and 15 +/- 19.6%, respectively, and TAmp decreased by 13.2 +/- 15.5%. A principal-component analysis derived from the latter ECG changes was performed. A random subsample of 489 individuals were subjected to a genome-wide-association analysis where 8,306,856 imputed single nucleotide polymorphisms (SNPs) were tested for association with QTc, TpTe and TAmp modulations, as well their derived principal-components, to search for common genetic variants associated with sotalol-induced IKr inhibition. None of the studied SNPs reached the statistical threshold for genome-wide significance. This study supports the lack of common variants with larger effect sizes than one would expect based on previous ECG genome-wide-association studies.	[Salem, Joe-Elie; Germain, Marine; Hulot, Jean-Sebastien; Lebourgeois, Bruno; Tregouet, David-Alexandre; Funck-Brentano, Christian] UPMC Univ Paris 06, Sorbonne Univ, INSERM, UMRS 1166,Inst Cardio Metab & Nutr ICAN, Paris, France; [Salem, Joe-Elie; Germain, Marine; Hulot, Jean-Sebastien; Lebourgeois, Bruno; Tregouet, David-Alexandre; Charbit, Beny; Funck-Brentano, Christian] UPMC Univ Paris 06, Sorbonne Univ, INSERM, UMRS 1166,Inst Cardio Metab & Nutr ICAN, Paris, France; [Voiriot, Pascal; Waldura, Jean] Cardiabase Banook Grp, Nancy, France; [Charbit, Beny] CHU Reims, Hop Robert Debre, Dept Anesthesiol & Intens Care, Reims, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHU de Reims	Germain, M (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, INSERM, UMRS 1166,Inst Cardio Metab & Nutr ICAN, Paris, France.; Germain, M (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, INSERM, UMRS 1166,Inst Cardio Metab & Nutr ICAN, Paris, France.	jean-sebastien.hulot@aphp.fr	Tregouet, David-Alexandre/E-3961-2016; Hulot, Jean-Sébastien/A-2278-2016; Trégouët, David-Alexandre/P-9210-2019; Funck-Brentano, Christian/C-2126-2009; Funck-Brentano, Christian/V-4753-2019	Hulot, Jean-Sébastien/0000-0001-5463-6117; Trégouët, David-Alexandre/0000-0001-9084-7800; Funck-Brentano, Christian/0000-0003-0406-5189; Funck-Brentano, Christian/0000-0003-0406-5189; Germain, Marine/0000-0002-8489-8916; Salem, Joe-Elie/0000-0002-0331-3307	INSERM/DHOS (Clinical and Translational Research award) [RCT07002]; French Ministry of Health [PHRC2008-A0R08004]	INSERM/DHOS (Clinical and Translational Research award); French Ministry of Health	The clinical study was supported by a grant from INSERM/DHOS (Clinical and Translational Research award 2007, RCT07002) and by the French Ministry of Health (PHRC2008-A0R08004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abehsira G, 2016, J CLIN ENDOCR METAB, V101, P2776, DOI 10.1210/jc.2016-1877; Arking DE, 2014, NAT GENET, V46, P826, DOI 10.1038/ng.3014; Aschard H, 2014, AM J HUM GENET, V94, P662, DOI 10.1016/j.ajhg.2014.03.016; Behr ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078511; Behr ER, 2013, EUR HEART J, V34, P89, DOI 10.1093/eurheartj/ehs351; Couderc JP, 2011, HEART RHYTHM, V8, P1036, DOI 10.1016/j.hrthm.2011.02.005; Food and Drug Administration, GUID IND E14 CLIN EV; FUNCKBRENTANO C, 1993, EUR HEART J, V14, P30, DOI 10.1093/eurheartj/14.suppl_H.30; Ghouse J, 2015, EUR HEART J, V36, P2523, DOI 10.1093/eurheartj/ehv297; Graff C, 2009, DRUG SAFETY, V32, P599, DOI 10.2165/00002018-200932070-00006; Isbister GK, 2013, BRIT J CLIN PHARMACO, V76, P48, DOI 10.1111/bcp.12040; Itoh H, 2015, EUR HEART J; Jamshidi Y, 2012, J AM COLL CARDIOL, V60, P841, DOI 10.1016/j.jacc.2012.03.031; Kaab S, 2012, CIRC-CARDIOVASC GENE, V5, P91, DOI 10.1161/CIRCGENETICS.111.960930; Kannankeril PJ, 2005, HEART RHYTHM, V2, P134, DOI 10.1016/j.hrthm.2004.10.039; Kannankeril P, 2010, PHARMACOL REV, V62, P760, DOI 10.1124/pr.110.003723; Kanters JK, 2004, HEART RHYTHM, V1, P285, DOI 10.1016/j.hrthm.2004.05.002; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lubinski A, 1998, PACE, V21, P172, DOI 10.1111/j.1540-8159.1998.tb01083.x; Lupoglazoff JM, 2001, CIRCULATION, V103, P1095, DOI 10.1161/01.CIR.103.8.1095; MALFATTO G, 1994, J AM COLL CARDIOL, V23, P296, DOI 10.1016/0735-1097(94)90410-3; MERRI M, 1989, CIRCULATION, V80, P1301, DOI 10.1161/01.CIR.80.5.1301; Minchole A, 2011, IEEE T BIO-MED ENG, V58, P1172, DOI 10.1109/TBME.2010.2097597; Paulussen ADC, 2004, J MOL MED, V82, P182, DOI 10.1007/s00109-003-0522-z; Peng Bo, 2007, BMC Proc, V1 Suppl 1, pS156; Pfeufer A, 2005, CIRC RES, V96, P693, DOI 10.1161/01.RES.0000161077.53751.e6; Postema PG, 2008, HEART RHYTHM, V5, P1015, DOI 10.1016/j.hrthm.2008.03.037; Priori SG, 2013, HEART RHYTHM, V10, P1932, DOI 10.1016/j.hrthm.2013.05.014; Roden DM, 2008, BRIT J PHARMACOL, V154, P1502, DOI 10.1038/bjp.2008.238; Roden DM, 2008, CIRCULATION, V118, P981, DOI 10.1161/CIRCULATIONAHA.108.798918; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; Roden DM, 2006, J INTERN MED, V259, P59, DOI 10.1111/j.1365-2796.2005.01589.x; Rodriguez I, 2001, JAMA-J AM MED ASSOC, V285, P1322, DOI 10.1001/jama.285.10.1322; Salem JE, 2016, PHARMACOL THERAPEUT, V167, P38, DOI 10.1016/j.pharmthera.2016.07.005; Sarganas G, 2014, EUROPACE, V16, P101, DOI 10.1093/europace/eut214; Splawski I, 2002, SCIENCE, V297, P1333, DOI 10.1126/science.1073569; Verweij N, 2016, HUM MOL GENET, V25, P2093, DOI 10.1093/hmg/ddw058; Viitasalo M, 2002, CIRCULATION, V106, P2473, DOI 10.1161/01.CIR.0000036369.16112.7D; Weeke P, 2014, J AM COLL CARDIOL, V63, P1430, DOI 10.1016/j.jacc.2014.01.031; Weeke P, 2013, EUROPACE, V15, P1791, DOI 10.1093/europace/eut153; Yang P, 2002, CIRCULATION, V105, P1943, DOI 10.1161/01.CIR.0000014448.19052.4C; Yap YG, 2003, HEART, V89, P1363, DOI 10.1136/heart.89.11.1363; Zhang L, 2000, CIRCULATION, V102, P2849; Zhang T, 2010, HUM MUTAT, V31, pE1801, DOI 10.1002/humu.21341	44	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0181875	10.1371/journal.pone.0181875	http://dx.doi.org/10.1371/journal.pone.0181875			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800628	Green Submitted, Green Published, gold			2022-12-26	WOS:000407431800008
J	Ivars, K; Nelson, N; Theodorsson, A; Theodorsson, E; Strom, JO; Morelius, E				Ivars, Katrin; Nelson, Nina; Theodorsson, Annette; Theodorsson, Elvar; Strom, Jakob O.; Morelius, Evalotte			Development of salivary cortisol circadian rhythm in preterm infants	PLOS ONE			English	Article							PLASMA-CORTISOL; LONGITUDINAL EVALUATION; PSYCHIATRIC-SYMPTOMS; PREMATURE; BIRTH; AGE; SECRETION; EMERGENCE; CHILDREN; STRESS	Objectives To investigate at what age preterm infants develop a salivary cortisol circadian rhythm and identify whether it is dependent on gestational age and/or postnatal age. To evaluate whether salivary cortisol circadian rhythm development is related to behavioral regularity. To elucidate salivary cortisol levels in preterm infants during the first year of life. Methods This prospective, longitudinal study included 51 preterm infants. 130 healthy full-term infants served as controls. Monthly salivary cortisol levels were obtained in the morning (07:30-09:30), at noon (10:00-12:00), and in the evening (19:30-21:30), beginning at gestational age week 28-32 and continuing until twelve months corrected age. Behavioral regularity was studied using the Baby Behavior Questionnaire. Results A salivary cortisol circadian rhythm was established by one month corrected age and persisted throughout the first year. The preterm infants showed a cortisol pattern increasingly more alike the full-term infants as the first year progressed. The preterm infants increase in behavioral regularity with age but no correlation was found between the development of salivary cortisol circadian rhythm and the development of behavior regularity. The time to establish salivary cortisol circadian rhythm differed between preterm and full-term infants according to postnatal age (p = 0.001) and was dependent on gestational age. Monthly salivary cortisol levels for preterm infants from birth until twelve months are presented. Additional findings were that topical corticosteroid medication was associated with higher concentrations of salivary cortisol (p = 0.02) and establishment of salivary cortisol circadian rhythm occurred later in infants treated with topical corticosteroid medication (p = 0.02). Conclusions Salivary cortisol circadian rhythm is established by one month corrected age in preterm infants. Establishment of salivary cortisol circadian rhythm is related to gestational age rather than to postnatal age. Salivary cortisol circadian rhythm development is not related to behavioral regularity.	[Ivars, Katrin; Nelson, Nina] Linkoping Univ, Dept Pediat, Linkoping, Sweden; [Ivars, Katrin; Nelson, Nina; Theodorsson, Annette; Theodorsson, Elvar; Strom, Jakob O.] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Nelson, Nina] Karolinska Univ Hosp, Dept Qual & Patient Safety, Stockholm, Sweden; [Theodorsson, Annette] Linkoping Univ, Dept Neurosurg, Linkoping, Sweden; [Theodorsson, Elvar; Strom, Jakob O.] Linkoping Univ, Dept Clin Chem, Linkoping, Sweden; [Strom, Jakob O.] Univ Orebro, Dept Neurol, Fac Med & Hlth, Orebro, Sweden; [Morelius, Evalotte] Linkoping Univ, Dept Social & Welf Studies, Div Nursing Sci, Norrkoping, Sweden	Linkoping University; Linkoping University; Karolinska Institutet; Karolinska University Hospital; Linkoping University; Linkoping University; Orebro University; Linkoping University	Morelius, E (corresponding author), Linkoping Univ, Dept Social & Welf Studies, Div Nursing Sci, Norrkoping, Sweden.	Evalotte.morelius@liu.se	Mörelius, Evalotte/AAH-8407-2021; Theodorsson, Elvar/H-2096-2011	Mörelius, Evalotte/0000-0002-3256-5407; Theodorsson, Elvar/0000-0003-0756-7723; Strom, Jakob/0000-0002-6681-0546	Medical Research Council of Southeast Sweden, FORSS [FORSS-8396, FORSS-12268, FORSS-37391, FORSS-78011]; County Council of Ostergotland, Sweden	Medical Research Council of Southeast Sweden, FORSS; County Council of Ostergotland, Sweden	This study was supported by the County Council of Ostergotland, Sweden and Medical Research Council of Southeast Sweden, FORSS (FORSS-8396, FORSS-12268, FORSS-37391, FORSS-78011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonini SRR, 2000, CLIN ENDOCRINOL, V52, P423, DOI 10.1111/j.1365-2265.2000.tb00561.x; Bettendorf M, 1998, HORM RES, V50, P303, DOI 10.1159/000023295; Blackmon LR, 2004, PEDIATRICS, V114, P1362, DOI 10.1542/peds.2004-1915; Bolt RJ, 2002, PEDIATR RES, V52, P405, DOI 10.1203/01.PDR.0000022343.57970.CF; Brummelte S, 2015, PSYCHONEUROENDOCRINO, V51, P151, DOI 10.1016/j.psyneuen.2014.09.018; Buske-Kirschbaum A, 2007, J CLIN ENDOCR METAB, V92, P3429, DOI 10.1210/jc.2006-2223; Clements AD, 1998, PSYCHONEUROENDOCRINO, V23, P613; COCKBURN F, 1993, LANCET, V342, P193; Custodio RJ, 2007, CLIN ENDOCRINOL, V66, P192, DOI 10.1111/j.1365-2265.2006.02706.x; DOERR HG, 1988, PEDIATR RES, V23, P525, DOI 10.1203/00006450-198805000-00018; Dorn F, 2014, CHRONOBIOL INT, V31, P1062, DOI 10.3109/07420528.2014.948183; ECONOMOU G, 1993, HORM RES, V40, P217, DOI 10.1159/000183798; GIANNAKOULOPOULOS X, 1994, LANCET, V344, P77, DOI 10.1016/S0140-6736(94)91279-3; Greenwald R, 1999, RES SOCIAL WORK PRAC, V9, P61, DOI 10.1177/104973159900900105; Grunau RE, 2007, J PEDIATR-US, V150, P151, DOI 10.1016/j.jpeds.2006.10.053; Gustafsson PE, 2010, NORD J PSYCHIAT, V64, P27, DOI 10.3109/08039480903265314; Gustafsson PE, 2009, AM J ORTHOPSYCHIAT, V79, P387, DOI 10.1037/a0016559; HAGEKULL B, 1985, SCAND J PSYCHOL, V26, P110, DOI 10.1111/j.1467-9450.1985.tb01148.x; HELBOCK HJ, 1993, PEDIATRICS, V92, P715; Hellhammer DH, 2009, PSYCHONEUROENDOCRINO, V34, P163, DOI 10.1016/j.psyneuen.2008.10.026; Holditch-Davis D, 2004, EARLY HUM DEV, V80, P43, DOI 10.1016/j.earlhumdev.2004.05.006; Ivars K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151888; Ivars K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129502; Jett PL, 1997, J CLIN ENDOCR METAB, V82, P2921, DOI 10.1210/jc.82.9.2921; Kidd S, 2005, HORM RES, V64, P20, DOI 10.1159/000087324; KIRSCHBAUM C, 1989, NEUROPSYCHOBIOLOGY, V22, P150, DOI 10.1159/000118611; Kristenson M., 2011, ROLE SALIVA CORTISOL; METZGER DL, 1993, J CLIN ENDOCR METAB, V77, P458, DOI 10.1210/jc.77.2.458; Morelius E, 2004, SCAND J CLIN LAB INV, V64, P113, DOI 10.1080/00365510410004452; Morelius E, 2006, EARLY HUM DEV, V82, P669, DOI 10.1016/j.earlhumdev.2005.12.013; Morelius E, 2015, EARLY HUM DEV, V91, P63, DOI 10.1016/j.earlhumdev.2014.12.005; Morelius E, 2012, EARLY HUM DEV, V88, P575, DOI 10.1016/j.earlhumdev.2011.12.033; PRICE DA, 1983, ARCH DIS CHILD, V58, P454, DOI 10.1136/adc.58.6.454; Reid S, 2015, J PAEDIATR CHILD H, V51, P524, DOI 10.1111/jpc.12742; Santiago LB, 1996, CLIN ENDOCRINOL, V44, P157, DOI 10.1046/j.1365-2265.1996.645466.x; SCOTT SM, 1995, PEDIATR RES, V37, P112, DOI 10.1203/00006450-199501000-00021; STAHL F, 1979, ENDOKRINOLOGIE, V74, P243; Tarnow-Mordi W, 1999, BRIT MED J, V319, P1385, DOI 10.1136/bmj.319.7222.1385; Tollenaar MS, 2010, EARLY HUM DEV, V86, P13, DOI 10.1016/j.earlhumdev.2009.12.003; VERMES I, 1980, HORM RES, V12, P237, DOI 10.1159/000179126; WATTERBERG KL, 1995, PEDIATRICS, V95, P120; Yehuda R, 1998, PSYCHIAT CLIN N AM, V21, P359, DOI 10.1016/S0193-953X(05)70010-1	42	18	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182685	10.1371/journal.pone.0182685	http://dx.doi.org/10.1371/journal.pone.0182685			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD2WT	28797126	Green Published, gold			2022-12-26	WOS:000407396200081
J	Langlet, B; Fagerberg, P; Glossner, A; Ioakimidis, I				Langlet, Billy; Fagerberg, Petter; Glossner, Andrew; Ioakimidis, Ioannis			Objective quantification of the food proximity effect on grapes, chocolate and cracker consumption in a Swedish high school. A temporal analysis	PLOS ONE			English	Article							PORTION SIZE; EATING RATE; OBESITY; MEAL; SATIETY; SNACKING; WEIGHT; IMPACT	Close food proximity leads to increased short-term energy intake, potentially contributing to the long-term development of obesity. However, its precise effects on eating behaviour are still unclear, especially with food available for extended periods of time. This study involved two similar high school student groups (15-17 years old), which had ad libitum access to grapes, chocolates and crackers during an hour-long experimental session. In the distal condition the foods were placed 6 meters away from the students (n = 24), in contrast to the proximal condition (n = 17) were the food was placed near the students. The identification of the type and the quantification of the amount of each food selected, for each individual serving, was facilitated through use of food scales and video recording. In the proximal condition individuals served themselves grapes and crackers more often and consumed more chocolate than in the distal condition. In total, participants in the proximal condition ingested significantly more energy (726 kcal vs. 504 kcal; p = 0.029), without reporting higher fullness. Food proximity also affected the temporal distribution of servings, with the first five minutes of the sessions corresponding to 53.1% and 45.6% of the total energy intake for the distal and proximal conditions, respectively. After the first five minutes, the servings in the distal condition were strongly clustered in time, with many students getting food together. In the proximal condition however, students displayed an unstructured pattern of servings over time. In conclusion, this study strengthens past evidence regarding the important role of food proximity on individual energy intake and, for the first time, it associates continuous food proximity to the emergence of unstructured eating over time. These conclusions, expanded upon by future studies, could support the creation of meaningful intervention strategies based on spatially and temporally controlled food availability.	[Langlet, Billy; Fagerberg, Petter; Ioakimidis, Ioannis] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Appl Neuroendocrinol, Stockholm, Sweden; [Glossner, Andrew] Int Engelska Skolan, Int Engelska Gymansiet Sodermalm, Stockholm, Sweden	Karolinska Institutet	Langlet, B (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Appl Neuroendocrinol, Stockholm, Sweden.	billy.langlet@ki.se	Ioakeimidis, Ioannis/AAN-2128-2021; Langlet, Billy/HHT-0845-2022	Ioakeimidis, Ioannis/0000-0002-7208-1722; Langlet, Billy/0000-0003-2806-6186	European Community's Information and Communication Technology Programme [610746, 01/10/2013-30/09/2016]	European Community's Information and Communication Technology Programme	Internationella Engelska Gymnasiet Sodermalm (Internationella Engelska Skolan) and Division of Applied Neuroendocrinology (Department of Neurobiology, Care Sciences and Society, Karolinska Institutet) received funding from the European Community's Information and Communication Technology Programme under Grant Agreement No. 610746, 01/10/2013-30/09/2016 (http://cordis.europa.eu/fp7/ict/home_en.html). The funder provided support in the form of salaries to Langlet B., loakimidis I., Fagerberg P. and Glossner A., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AITKEN RCB, 1969, P ROY SOC MED, V62, P989, DOI 10.1177/003591576906201005; Bellisle F, 2014, PHYSIOL BEHAV, V134, P38, DOI 10.1016/j.physbeh.2014.03.010; Berg C, 2015, CURR OBES REP, V4, P11, DOI 10.1007/s13679-015-0138-y; Bergh C, 2013, BEHAV NEUROSCI, V127, P878, DOI 10.1037/a0034921; Bray GA, 2017, OBES REV OFF J INT A; CLENDENEN VI, 1994, APPETITE, V23, P1, DOI 10.1006/appe.1994.1030; Cohen Deborah, 2008, Prev Chronic Dis, V5, pA23; Cruwys T, 2015, APPETITE, V86, P3, DOI 10.1016/j.appet.2014.08.035; de Graaf C, 2010, NAT REV ENDOCRINOL, V6, P290, DOI 10.1038/nrendo.2010.41; Dehais J, 2016, MADIMA'16: PROCEEDINGS OF THE 2ND INTERNATIONAL WORKSHOP ON MULTIMEDIA ASSISTED DIETARY MANAGEMENT, P23, DOI 10.1145/2986035.2986047; Duffey KJ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001050; European Commission, CORDIS PROJ RES SERV; Fay SH, 2015, EAT BEHAV, V18, P156, DOI 10.1016/j.eatbeh.2015.05.014; Ferriday D, 2015, PHYSIOL BEHAV, V152, P389, DOI 10.1016/j.physbeh.2015.06.038; Fisher JO, 2013, INT J OBESITY, V37, P954, DOI 10.1038/ijo.2012.216; Ford AL, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5388; Garaulet M, 2014, PHYSIOL BEHAV, V134, P44, DOI 10.1016/j.physbeh.2014.01.001; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Hunter JA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3184-9; Hutchison AT, 2016, BIOCHIMIE, V124, P187, DOI 10.1016/j.biochi.2015.07.025; Ioakimidis I, 2011, PHYSIOL BEHAV, V103, P290, DOI 10.1016/j.physbeh.2011.01.025; Ioakimidis I, 2012, NEUROCOMPUTING, V84, P31, DOI 10.1016/j.neucom.2011.12.017; Ioakimidis I, 2011, PHYSIOL BEHAV, V104, P761, DOI 10.1016/j.physbeh.2011.07.021; Ioakimidis I, 2009, BEHAV RES METHODS, V41, P755, DOI 10.3758/BRM.41.3.755; Just DR, 2015, OBES SCI PRACT, V1, P126, DOI 10.1002/osp4.14; Kissileff HR, 2001, APPETITE, V36, P70, DOI 10.1006/appe.2000.0369; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Langlet B, 2017, BEHAV INF TECHNOL, P1; Leech RM, 2015, NUTR RES REV, V28, P1, DOI 10.1017/S0954422414000262; LICHTMAN SW, 1992, NEW ENGL J MED, V327, P1893, DOI 10.1056/NEJM199212313272701; Likert R., 1932, ARCH PSYCHOL, V22, P55, DOI DOI 10.1037/H0053694; Maramis C., 2016, Appetite, V101, P234, DOI 10.1016/j.appet.2016.02.124; Moulos I, 2015, LECT NOTES COMPUT SC, V9281, P409, DOI 10.1007/978-3-319-23222-5_50; Musher-Eizenman DR, 2010, HEALTH EDUC BEHAV, V37, P186, DOI 10.1177/1090198109335656; Papapanagiotou V, 2015, IEEE ENG MED BIO, P7853, DOI 10.1109/EMBC.2015.7320212; Peneau S, 2009, BRIT J NUTR, V102, P1854, DOI 10.1017/S0007114509991280; Popkin BM, 2010, AM J CLIN NUTR, V91, P1342, DOI 10.3945/ajcn.2009.28962; Privitera GJ, 2014, APPETITE, V76, P175, DOI 10.1016/j.appet.2014.02.004; R Core Team, 2012, R LANG ENV STAT COMP; Roe LS, 2016, APPETITE, V99, P1, DOI 10.1016/j.appet.2016.01.001; Rolls BJ, 2004, APPETITE, V42, P63, DOI 10.1016/S0195-6663(03)00117-X; Rolls BJ, 2002, PHYSIOL BEHAV, V76, P623, DOI 10.1016/S0031-9384(02)00801-6; Sanz-Valero J, 2016, CRIT REV FOOD SCI, V56, P973, DOI 10.1080/10408398.2012.742865; Sturm R, 2002, HEALTH AFFAIR, V21, P245, DOI 10.1377/hlthaff.21.2.245; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Van Hook J, 2012, SOCIOL EDUC, V85, P23, DOI 10.1177/0038040711417011; Wansink B, 2006, INT J OBESITY, V30, P871, DOI 10.1038/sj.ijo.0803217; Wansink B, 2005, OBES RES, V13, P93, DOI 10.1038/oby.2005.12; Wansink B, 2005, J NUTR EDUC BEHAV, V37, P242, DOI 10.1016/S1499-4046(06)60278-9; Wansink B, 2016, HEALTH EDUC BEHAV, V43, P552, DOI 10.1177/1090198115610571; Wansink B, 2013, J EXP PSYCHOL-APPL, V19, P320, DOI 10.1037/a0035053; Wansink B, 2010, PHYSIOL BEHAV, V100, P454, DOI 10.1016/j.physbeh.2010.05.003; Watowicz RP, 2015, CHILD OBES, V11, P475, DOI 10.1089/chi.2015.0022; World Health Organization, OB OV; Zandian M, 2009, PHYSIOL BEHAV, V96, P270, DOI 10.1016/j.physbeh.2008.10.011	55	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182172	10.1371/journal.pone.0182172	http://dx.doi.org/10.1371/journal.pone.0182172			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD2WT	28797048	Green Published, Green Submitted, gold			2022-12-26	WOS:000407396200036
J	Mtangadura, TJ; Mtambanengwe, F; Nezomba, H; Rurinda, J; Mapfumo, P				Mtangadura, Tongai J.; Mtambanengwe, Florence; Nezomba, Hatirarami; Rurinda, Jairos; Mapfumo, Paul			Why organic resources and current fertilizer formulations in Southern Africa cannot sustain maize productivity: Evidence from a long-term experiment in Zimbabwe	PLOS ONE			English	Article							SOIL FERTILITY; SMALLHOLDER FARMS; SANDY SOILS; CROP PRODUCTIVITY; MANAGEMENT; QUALITY; RESTORATION; VARIABILITY; FRACTIONS; ADDITIONS	Sustainability of maize-based cropping systems is a major challenge for southern Africa, yet the demand for maize as staple food and animal feed in the region continues to increase. A study was conducted on a sandy clay loam (220 g clay kg(-1) soil) at Domboshawa in Zimbabwe to investigate the long-term effects of organic resource quality and application rate, and nitrogen (N) fertilization on soil chemical properties and maize (Zea mays L.) productivity. Crotalaria juncea (high quality), Calliandra calothyrsus (medium quality), cattle manure (variable quality), maize stover and Pinus patula sawdust (both low quality) were incorporated into soil at 4.0 t C ha(-1) (high rate) and 1.2 t C ha(-1) (low rate) at the start of each cropping season for nine consecutive years. At both high and low application rates, each of the five organic resources was applied in combination with or without mineral nitrogen (N) fertilizer at 120 kg N ha(-1). The nine-year period saw maize grain yields declining by 22% to 84% across treatments despite increases in soil organic carbon, total N and available P from 6% to 80%. Crotalaria, Calliandra and manure led to a less steep yield decline. Exchangeable calcium (Ca), magnesium (Mg) and potassium (K), and soil pH explained much of the variation in yield patterns observed under the different organic resource applications. Maize grain yield was positively correlated with exchangeable Ca (r = 0.51), Mg (r = 0.62) and K (r = 0.53), and soil pH (r = 0.49), but negatively correlated with other soil properties over the 9-year period. We concluded that declining soil exchangeable basic cations were the underlying causes of decreasing maize productivity, and was aggravated by use of low rates of organic resource inputs, particularly with N fertilization. Current nutrient management and fertilizer recommendations that emphasize inorganic N, P and K significantly undervalue the role played by organic resources in sustainability of maize cropping systems in southern Africa.	[Mtangadura, Tongai J.; Mtambanengwe, Florence; Nezomba, Hatirarami; Mapfumo, Paul] Univ Zimbabwe, Dept Soil Sci & Agr Engn, Soil Fertil Consortium Southern Africa SOFECSA, Harare, Zimbabwe; [Rurinda, Jairos] ICIPE Compound, IFDC East & Southern Africa Div, IPNI, Nairobi, Kenya	University of Zimbabwe; International Centre of Insect Physiology & Ecology (ICIPE)	Mapfumo, P (corresponding author), Univ Zimbabwe, Dept Soil Sci & Agr Engn, Soil Fertil Consortium Southern Africa SOFECSA, Harare, Zimbabwe.	paulmapfumo@gmail.com	Mtambanengwe, Florence/AAX-4571-2021	Mtambanengwe, Florence/0000-0002-8250-9075; Mapfumo, Paul/0000-0001-5580-4135				Abbasi MK, 2015, SOLID EARTH, V6, P197, DOI 10.5194/se-6-197-2015; Anderson J. M., 1993, TROPICAL SOIL BIOL F; Bationo A, 2007, AGR SYST, V94, P13, DOI 10.1016/j.agsy.2005.08.011; Bengtson P, 2004, THESIS; Bhogal A, 2009, EUR J SOIL SCI, V60, P276, DOI 10.1111/j.1365-2389.2008.01105.x; Buresh R.J., 1997, SSSA SPECIAL PUBLICA, P111, DOI DOI 10.2136/SSSASPECPUB51.C6; Buresh RJ, 1997, SSSA SPECIAL PUBLICA, V51, P193, DOI DOI 10.2136/SSSASPECPUB51.C8; Chivenge P, 2011, SOIL BIOL BIOCHEM, V43, P657, DOI 10.1016/j.soilbio.2010.12.002; Chivenge P, 2009, AGRON J, V101, P1266, DOI 10.2134/agronj2008.0188x; Coe R, 2014, CURR OPIN ENV SUST, V6, P73, DOI 10.1016/j.cosust.2013.10.013; FAO, 2009, SCAL CONS AGR AFR ST; FAO (Food and Agriculture Organization), 2010, CLIM SMART AGR POL P; Fosu-Mensah B.Y., 2016, ENV SYST RES, V5, P1, DOI [DOI 10.1186/S40068-016-0063-4, 10.1186/s40068-016-0063-4]; Gachimbi LN, 2005, LAND USE POLICY, V22, P13, DOI 10.1016/j.landusepol.2003.07.002; Gentile R, 2010, NUTR CYCL AGROECOSYS, V88, P121, DOI 10.1007/s10705-008-9216-9; Grant PM, 1981, ZIMBABWE AGR J, V78, P169; Haynes RJ, 2001, NUTR CYCL AGROECOSYS, V59, P47, DOI 10.1023/A:1009823600950; Huang P. M., 2012, HDB SOIL SCI PROPERT; Hue N. V., 1986, SOIL SCI SOC AM J, V25, P3291; IIRR ACT, 2005, CONS AGR MAN FARM EX; Lal R, 2006, LAND DEGRAD DEV, V17, P197, DOI 10.1002/ldr.696; Mafongoya PL, 2006, NUTR CYCL AGROECOSYS, V76, P137, DOI 10.1007/s10705-006-9049-3; MAHLER RL, 1984, SOIL SCI, V137, P52, DOI 10.1097/00010694-198401000-00008; Manzeke GM, 2014, FIELD CROP RES, V166, P128, DOI 10.1016/j.fcr.2014.05.019; Mapfumo P., 2009, ENHANCING INTEGRATED; Mapfumo P., 2001, SOIL FERTILITY MANAG; Mapfumo P, 2004, MANAGING NUTR CYCLES, P225; Mapfumo P., 2011, FIGHTING POVERTY SUB, P175, DOI DOI 10.1007/978-94-007-1536-3; Mapfumo P, 2007, PLANT SOIL, V296, P137, DOI 10.1007/s11104-007-9304-7; Mary B, 1996, PLANT SOIL, V181, P71, DOI 10.1007/BF00011294; Mtambanengwe F, 2008, NUTR CYCL AGROECOSYS, V81, P1, DOI 10.1007/s10705-007-9136-0; Mtambanengwe F, 2006, PLANT SOIL, V281, P173, DOI 10.1007/s11104-005-4182-3; Mtambanengwe F, 2005, NUTR CYCL AGROECOSYS, V73, P227, DOI 10.1007/s10705-005-2652-x; Mtambanengwe F, 2006, NUTR CYCL AGROECOSYS, V76, P271, DOI 10.1007/s10705-005-4988-7; Murwira HK, 1993, LIVESTOCK SUSTAINABL; Narambuye FX, 2006, AUST J SOIL RES, V15, P18; Nezomba H, 2009, SYMBIOSIS, V48, P78, DOI 10.1007/BF03179987; Nezomba H, 2015, GEODERMA, V239, P143, DOI 10.1016/j.geoderma.2014.10.006; Nyamangara J., 2003, African Crop Science Journal, V11, P289; Nyamapfene K., 1991, SOILS ZIMBABWE; Ohno T, 1996, J ENVIRON QUAL, V25, P1137, DOI 10.2134/jeq1996.00472425002500050029x; Palm CA, 2001, AGR ECOSYST ENVIRON, V83, P27, DOI 10.1016/S0167-8809(00)00267-X; Rabbi S. M. F., 2010, Proceedings of the 19th World Congress of Soil Science: Soil solutions for a changing world, Brisbane, Australia, 1-6 August 2010. Congress Symposium 4: Greenhouse gases from soils, P109; Ribeiro BT, 2013, SCI AGR, V70, P435, DOI 10.1590/S0103-90162013000600009; Rowe EC, 1998, AGROFOREST SYST, V43, P81, DOI 10.1023/A:1022123020738; Rurinda J, 2013, FIELD CROP RES, V154, P211, DOI 10.1016/j.fcr.2013.08.012; Sainju UM, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1122-4; Sanchez P.A., 1997, REPLENISHING SOIL FE, P1, DOI DOI 10.2136/SSSASPECPUB51.C1; Smaling E.M.A., 1993, THESIS; Tittonell P, 2005, AGR ECOSYST ENVIRON, V110, P166, DOI 10.1016/j.agee.2005.04.003; Tittonell P, 2012, FIELD CROP RES, V132, P168, DOI 10.1016/j.fcr.2011.12.011; Tittonell P, 2013, FIELD CROP RES, V143, P76, DOI 10.1016/j.fcr.2012.10.007; Vanlauwe B, 2010, OUTLOOK AGR, V39, P17, DOI 10.5367/000000010791169998; WRB (World Reference Base for Soil Resources), 2006, WORLD SOIL RESOURCES, P128; Xing YueHua, 2009, Better Crops with Plant Food, V93, P4; Yadav R.S., 2012, FARMING FOOD WATER S, P177, DOI [10.1007/978-94-007-4500-1_8, DOI 10.1007/978-94-007-4500-1_8]; Zingore S, 2008, NUTR CYCL AGROECOSYS, V80, P267, DOI 10.1007/s10705-007-9142-2	57	21	21	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182840	10.1371/journal.pone.0182840	http://dx.doi.org/10.1371/journal.pone.0182840			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797062	gold, Green Submitted, Green Published			2022-12-26	WOS:000407396200106
J	Pisani, C; Rascol, E; Dorandeu, C; Gaillard, JC; Charnay, C; Guari, Y; Chopineau, J; Armengaud, J; Devoisselle, JM; Prat, O				Pisani, Cedric; Rascol, Estelle; Dorandeu, Christophe; Gaillard, Jean-Charles; Charnay, Clarence; Guari, Yannick; Chopineau, Joel; Armengaud, Jean; Devoisselle, Jean-Marie; Prat, Odette			The species origin of the serum in the culture medium influences the in vitro toxicity of silica nanoparticles to HepG2 cells	PLOS ONE			English	Article							PROTEIN CORONA; DRUG-DELIVERY; BIOCOMPATIBILITY; BIODISTRIBUTION; NANOMATERIALS; CYTOTOXICITY; TOXICOLOGY; IMPACT	The formation of a protein corona around nanoparticles can influence their toxicity, triggering cellular responses that may be totally different from those elicited by pristine nanoparticles. The main objective of this study was to investigate whether the species origin of the serum proteins forming the corona influences the in vitro toxicity assessment of silica nanoparticles. Coronas were preformed around nanoparticles before cell exposures by incubation in fetal bovine (FBS) or human (HS) serum. The compositions of these protein coronas were assessed by nano-LC MS/MS. The effects of these protein-coated nanoparticles on HepG2 cells were monitored using real-time cell impedance technology. The nanoparticle coronas formed in human or fetal bovine serum comprised many homologous proteins. Using human compared with fetal bovine serum, nanoparticle toxicity in HepG2 cells decreased by 4-fold and 1.5-fold, when used at 50 and 10 mu g/mL, respectively. It is likely that "markers of self" are present in the serum and are recognized by human cell receptors. Preforming a corona with human serum seems to be more appropriate for in vitro toxicity testing of potential nanocarriers using human cells. In vitro cytotoxicity assays must reflect in vivo conditions as closely as possible to provide solid and useful results.	[Pisani, Cedric; Rascol, Estelle; Dorandeu, Christophe; Chopineau, Joel; Devoisselle, Jean-Marie] UM, ENSCM, CNRS, UMR 5253,Inst Charles Gerhardt Montpellier,MACS, Pl Eugene Bataillon, Montpellier, France; [Pisani, Cedric; Prat, Odette] CEA, Direct Rech Fondamentale BIAM, Site Marcoule, Bagnols Sur Ceze, France; [Gaillard, Jean-Charles; Armengaud, Jean] CEA, Direct Rech Fondamentale IBITECS, Site Marcoule, Bagnols Sur Ceze, France; [Charnay, Clarence; Guari, Yannick] UM, ENSCM, CNRS, UMR 5253,Inst Charles Gerhardt Montpellier,IMNO, 1701 Pl Eugene Bataillon, Montpellier, France; [Chopineau, Joel] Univ Nimes, Rue Georges Salan, Nimes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; CEA; Universite de Montpellier; CEA; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; Universite de Nimes	Prat, O (corresponding author), CEA, Direct Rech Fondamentale BIAM, Site Marcoule, Bagnols Sur Ceze, France.	odette.prat@cea.fr	Charnay, Clarence/Q-6514-2018; chopineau, joel/J-6674-2015; Dorandeu, Christophe/AAJ-5503-2021; guari, yannick/C-5015-2018; Devoisselle, Jean-Marie/I-7919-2017	Charnay, Clarence/0000-0002-8796-3701; chopineau, joel/0000-0001-8307-0167; guari, yannick/0000-0001-5205-3225; ARMENGAUD, Jean/0000-0003-1589-445X; Rascol, Estelle/0000-0002-2301-6107; Devoisselle, Jean-Marie/0000-0003-4534-9807	French National Research Agency (ANR) [ANR-13-NANO-0007-03]	French National Research Agency (ANR)(French National Research Agency (ANR))	This work was supported by the French National Research Agency (ANR), Grant ANR-13-NANO-0007-03, to JMD.	Aitken RA, 2011, SPECIFIC ADVICE EXPO; Anders CB, 2015, NANOSCALE RES LETT, V10, DOI 10.1186/s11671-015-1158-y; Anselmo AC, 2014, J CONTROL RELEASE, V190, P531, DOI 10.1016/j.jconrel.2014.03.050; Atienzar FA, 2013, BIOSENSORS-BASEL, V3, P132, DOI 10.3390/bios3010132; Brunner D, 2010, ALTEX-ALTERN ANIM EX, V27, P53; Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; Clair G, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013102; Corbo C, 2016, NANOMEDICINE-UK, V11, P81, DOI 10.2217/nnm.15.188; Docter D, 2015, NANOMEDICINE-UK, V10, P503, DOI 10.2217/nnm.14.184; Gunawan C, 2014, J MATER CHEM B, V2, P2060, DOI 10.1039/c3tb21526a; Hartung T, 2010, ALTEX-ALTERN ANIM EX, V27, P87; Hartung T, 2009, NATURE, V460, P208, DOI 10.1038/460208a; He QJ, 2011, SMALL, V7, P271, DOI 10.1002/smll.201001459; Izak-Nau E, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-56; Jensen KA., 2013, METHOD DETECTING POT; Kibria G, 2016, SCI REP-UK, V6, DOI 10.1038/srep36502; Kim JA, 2014, NANOSCALE, V6, P14180, DOI 10.1039/c4nr04970e; Klein G, 2016, LANGMUIR, V32, P195, DOI 10.1021/acs.langmuir.5b03890; Krewski D, 2010, J TOXICOL ENV HEAL B, V13, P51, DOI 10.1080/10937404.2010.483176; Kroll A, 2009, EUR J PHARM BIOPHARM, V72, P370, DOI 10.1016/j.ejpb.2008.08.009; Lee J, 2009, SMALL, V5, P1213, DOI 10.1002/smll.200801788; Li ZX, 2012, CHEM SOC REV, V41, P2590, DOI 10.1039/c1cs15246g; Barran-Berdon AL, 2013, LANGMUIR, V29, P6485, DOI 10.1021/la401192x; Lordan S, 2012, CELL BIOL INT, V36, P57, DOI 10.1042/CBI20100587; Lu J, 2010, SMALL, V6, P1794, DOI 10.1002/smll.201000538; McKim JM, 2015, J APPL VITRO TOXICOL; Mirshafiee V, 2016, BIOMATERIALS, V75, P295, DOI 10.1016/j.biomaterials.2015.10.019; Monopoli MP, 2012, NAT NANOTECHNOL, V7, P779, DOI [10.1038/NNANO.2012.207, 10.1038/nnano.2012.207]; Monopoli MP, 2011, J AM CHEM SOC, V133, P2525, DOI 10.1021/ja107583h; Mortensen NP, 2013, NANOSCALE, V5, P6372, DOI 10.1039/c3nr33280b; Nyalosaso JL, 2016, RSC ADV, V6, pS7275, DOI 10.1039/c6ra09017f; Nystrom AM, 2012, J CONTROL RELEASE, V161, P403, DOI 10.1016/j.jconrel.2012.01.027; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Pearson RM, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00108; Peng HH, 2011, NANOMEDICINE-UK, V6, P643, DOI [10.2217/NNM.11.24, 10.2217/nnm.11.24]; Pisani C, 2017, NANOSCALE, V9, P1840, DOI 10.1039/c6nr04765c; Pisani C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1521-5; Sergent JA, 2012, ANN OCCUP HYG, V56, P622, DOI 10.1093/annhyg/mes005; Shannahan JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074001; Stern S, 2010, GTA1 NCL, V1, P1; Strojan K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169552; Subramanian S, 2006, BLOOD, V107, P2548, DOI 10.1182/blood-2005-04-1463; Tarn D, 2013, ACCOUNTS CHEM RES, V46, P792, DOI 10.1021/ar3000986; Tenzer S, 2013, NAT NANOTECHNOL, V8, P772, DOI 10.1038/nnano.2013.181; Tenzer S, 2011, ACS NANO, V5, P7155, DOI 10.1021/nn201950e; Vivero-Escoto JL, 2010, SMALL, V6, P1952, DOI 10.1002/smll.200901789; Walkey CD, 2012, CHEM SOC REV, V41, P2780, DOI 10.1039/c1cs15233e; Wu SH, 2008, CHEMBIOCHEM, V9, P53, DOI 10.1002/cbic.200700509; Yallapu MM, 2015, BIOMATERIALS, V46, P1, DOI 10.1016/j.biomaterials.2014.12.045	49	23	24	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182906	10.1371/journal.pone.0182906	http://dx.doi.org/10.1371/journal.pone.0182906			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796831	Green Published, Green Submitted, gold			2022-12-26	WOS:000407396200118
J	Savol, AJ; Wang, PI; Jeon, Y; Colognori, D; Yildirim, E; Pinter, SF; Payer, B; Lee, JT; Sadreyev, RI				Savol, Andrej J.; Wang, Peggy I.; Jeon, Yesu; Colognori, David; Yildirim, Eda; Pinter, Stefan F.; Payer, Bernhard; Lee, Jeannie T.; Sadreyev, Ruslan I.			Genome-wide identification of autosomal genes with allelic imbalance of chromatin state	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; X-CHROMOSOME INACTIVATION; MONOALLELIC EXPRESSION; HISTONE MODIFICATIONS; MODIFIED NUCLEOSOMES; SINGLE-CELL; MOUSE; TRANSCRIPTION; SEQ; DISEASE	In mammals, monoallelic gene expression can result from X-chromosome inactivation, genomic imprinting, and random monoallelic expression (RMAE). Epigenetic regulation of RMAE is not fully understood. Here we analyze allelic imbalance in chromatin state of autosomal genes using ChIP-seq in a clonal cell line. We identify approximately 3.7% of autosomal genes that show significant differences between chromatin states of two alleles. Allelic regulation is represented among several functional gene categories including histones, chromatin modifiers, and multiple early developmental regulators. Most cases of allelic skew are produced by quantitative differences between two allelic chromatic states that belong to the same gross type (active, silent, or bivalent). Combinations of allelic states of different types are possible but less frequent. When different chromatin marks are skewed on the same gene, their skew is coordinated as a result of quantitative relationships between these marks on each individual allele. Finally, combination of allele-specific densities of chromatin marks is a quantitative predictor of allelic skew in gene expression.	[Savol, Andrej J.; Wang, Peggy I.; Jeon, Yesu; Colognori, David; Yildirim, Eda; Pinter, Stefan F.; Payer, Bernhard; Lee, Jeannie T.; Sadreyev, Ruslan I.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Savol, Andrej J.; Wang, Peggy I.; Jeon, Yesu; Colognori, David; Yildirim, Eda; Pinter, Stefan F.; Payer, Bernhard; Lee, Jeannie T.] Harvard Med Sch, Dept Genet, Boston, MA USA; [Jeon, Yesu; Colognori, David; Yildirim, Eda; Pinter, Stefan F.; Payer, Bernhard; Lee, Jeannie T.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Sadreyev, Ruslan I.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Sadreyev, Ruslan I.] Harvard Med Sch, Boston, MA 02115 USA; [Yildirim, Eda] Duke Univ, Sch Med, Dept Cell Biol, Durham, NC USA; [Pinter, Stefan F.] Univ Connecticut, UConn Hlth, Dept Genet & Genome Sci, Farmington, CT USA; [Payer, Bernhard] Barcelona Inst Sci & Technol, Ctr Genom Regulat, Barcelona, Spain; [Payer, Bernhard] Univ Pompeu Fabra, Barcelona, Spain	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Duke University; University of Connecticut; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University	Sadreyev, RI (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.; Sadreyev, RI (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.; Sadreyev, RI (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	sadreyev@molbio.mgh.harvard.edu	Payer, Bernhard/F-7353-2010; Pinter, Stefan/O-9228-2019	Payer, Bernhard/0000-0002-4694-2082; Pinter, Stefan/0000-0003-4750-1403; Colognori, David/0000-0001-6995-7079; Yildirim, Eda/0000-0002-4796-3854	German Research Foundation; MGH ECOR Fund; Human Frontiers Science Program; Charles King Foundation; National Institutes of Health [RO1-GM090278, P30 DK040561]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090278] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); MGH ECOR Fund; Human Frontiers Science Program(Human Frontier Science Program); Charles King Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the German Research Foundation (S.F.P.), the MGH ECOR Fund (E.Y.), the Human Frontiers Science Program and Charles King Foundation (B.P.), and the National Institutes of Health (RO1-GM090278, J.T.L., and P30 DK040561, R.I.S.). J.T.L. is an Investigator of the Howard Hughes Medical Institute.; We thank members of Sadreyev group and Lee laboratory for many valuable discussions. This work was supported by the German Research Foundation (S.F.P.), the MGH ECOR Fund (E.Y.), the Human Frontiers Science Program and Charles King Foundation (B.P.), and the National Institutes of Health (RO1-GM090278, J.T.L., and P30 DK040561, R.I.S.). J.T.L. is an Investigator of the Howard Hughes Medical Institute.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Borel C, 2015, AM J HUM GENET, V96, P70, DOI 10.1016/j.ajhg.2014.12.001; Cheng C, 2012, NUCLEIC ACIDS RES, V40, P553, DOI 10.1093/nar/gkr752; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eckersley-Maslin MA, 2014, DEV CELL, V28, P351, DOI 10.1016/j.devcel.2014.01.017; Engstrom PG, 2013, NAT METHODS, V10, P1185, DOI [10.1038/NMETH.2722, 10.1038/nmeth.2722]; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Gendre AV, 2014, DEV CELL, V28, P366, DOI 10.1016/j.devcel.2014.01.016; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Glaab WE, 1999, MUTAT RES-FUND MOL M, V430, P1, DOI 10.1016/S0027-5107(99)00147-5; Goncalves A, 2012, GENOME RES, V22, P2376, DOI 10.1101/gr.142281.112; Hart T, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145216; Hirayama T, 2006, CURR OPIN NEUROBIOL, V16, P336, DOI 10.1016/j.conb.2006.05.003; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jeffries AR, 2012, STEM CELLS, V30, P1938, DOI 10.1002/stem.1155; Jeon Y, 2012, CURR OPIN GENET DEV, V22, P62, DOI 10.1016/j.gde.2012.02.007; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kim J, 2015, NAT COMMUN, V6, P6781; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lee JT, 2013, CELL, V152, P1308, DOI 10.1016/j.cell.2013.02.016; Li BH, 2004, GENOMICS, V83, P311, DOI 10.1016/j.ygeno.2003.08.005; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marinov GK, 2014, GENOME RES, V24, P496, DOI 10.1101/gr.161034.113; Marks H, 2009, GENOME RES, V19, P1361, DOI 10.1101/gr.092643.109; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Nag A, 2013, ELIFE, V2, DOI 10.7554/eLife.01256; Ouyang ZQ, 2009, P NATL ACAD SCI USA, V106, P21521, DOI 10.1073/pnas.0904863106; Perez JD, 2016, ANN REV 4139 EL CAMI, V39; Peters J, 2014, NAT REV GENET, V15, P517, DOI 10.1038/nrg3766; Pinter SF, 2015, GENETICS, V200, P537, DOI 10.1534/genetics.115.176263; Pinter SF, 2012, GENOME RES, V22, P1864, DOI 10.1101/gr.133751.111; Plasschaert RN, 2014, DEVELOPMENT, V141, P1805, DOI 10.1242/dev.101428; Rando OJ, 2012, CURR OPIN GENET DEV, V22, P148, DOI 10.1016/j.gde.2012.02.013; Reinius B, 2015, NAT REV GENET, V16, P653, DOI 10.1038/nrg3888; Sadreyev RI, 2013, P NATL ACAD SCI USA, V110, P6949, DOI 10.1073/pnas.1216449110; Savova V, 2016, NAT GENET, V48, P231, DOI 10.1038/ng.3493; Shema E, 2016, SCIENCE, V352, P717, DOI 10.1126/science.aad7701; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tee WW, 2014, DEVELOPMENT, V141, P2376, DOI 10.1242/dev.096982; Tippmann SC, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.23; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Voigt P, 2012, CELL, V151, P181, DOI 10.1016/j.cell.2012.09.002; Yekta S, 2008, NAT REV GENET, V9, P789, DOI 10.1038/nrg2400; Yildirim E, 2012, NAT STRUCT MOL BIOL, V19, P56, DOI 10.1038/nsmb.2195; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Zwemer LM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r10	52	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182568	10.1371/journal.pone.0182568	http://dx.doi.org/10.1371/journal.pone.0182568			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796844	Green Submitted, Green Published, gold			2022-12-26	WOS:000407396200061
J	Vonaesch, P; Tondeur, L; Breurec, S; Bata, P; Binh, L; Nguyen, L; Frank, T; Farra, A; Rafai, C; Giles-Vernick, T; Gody, JC; Gouandjika-Vasilache, I; Sansonetti, P; Vray, M				Vonaesch, Pascale; Tondeur, Laura; Breurec, Sebastien; Bata, Petula; Binh, Liem; Nguyen, Luong; Frank, Thierry; Farra, Alain; Rafai, Clotaire; Giles-Vernick, Tamara; Gody, Jean Chrysostome; Gouandjika-Vasilache, Ionela; Sansonetti, Philippe; Vray, Muriel			Factors associated with stunting in healthy children aged 5 years and less living in Bangui (RCA)	PLOS ONE			English	Article							SAO-PAULO; YOUNG-CHILDREN; DOUBLE BURDEN; PERSISTENT DIARRHEA; IMPAIRS GROWTH; RISK-FACTORS; OVERWEIGHT; MALNUTRITION; UNDERNUTRITION; PREVALENCE	Stunting remains a major public health concern worldwide. Although its global prevalence is slowly decreasing, the actual number of affected children is still rising in Sub-Saharan Africa. In the Central African Republic (CAR), about one third of all children below the age of five are stunted. Stunting is correlated with many long-term consequences, including poor cognitive development and a higher rate of morbidity and mortality, making stunting a major contributor to poverty. In CAR, little is known about the factors that contribute to stunting. This study aimed at analysing, in a cross-sectional study, the main factors associated with stunting in a group of 414 children recruited between December 2011 and November 2013, aged five years or less and living in Bangui. For all children, demographic, socio-economic and anthropometric data were recorded and asymptomatic enteropathogen carriage was assessed in stool samples using classical microbiological assays. The study group had a mean age of 14.2 +/- 10 months. Fifty-eight percent (292/414) were boys, and 36 percent (148/414) exhibited stunted growth. Of the stunted children, 51% (75/148) showed a moderate delay in linear growth for their age group [height-for-age z-score (HAZ) between -2 and -3 SD] while 49% (73/148) presented a severe delay (HAZ <-3). Factors significantly associated with stunting included gender (aOR: 1.67; 95% CI: 1.07; 2.62 for boys compared to girls) and age (aOR of 3.98 (95% CI: 2.45; 6.46) for toddlers and aOR 4.42 (95% CI: 2.36; 8.28) for children compared to infants). Most importantly, we identified being overweight [weight-for-height z-score (WHZ) > 2 SD; aOR: 3.21; 95% CI: 1.50; 6.90 of overweight compared to normal weight] as also being significantly associated with stunting. This is the first study showing that even in the poorest countries of the world there is an association of stunting with being overweight.	[Vonaesch, Pascale; Sansonetti, Philippe] Inst Pasteur, Unite Pathogenie Microbienne Mol, Paris, France; [Vonaesch, Pascale; Tondeur, Laura; Giles-Vernick, Tamara; Vray, Muriel] Inst Pasteur, Unite Epidemiol & Expertise Malad Emergentes, Paris, France; [Breurec, Sebastien] Ctr Hosp Univ, Lab Microbiol Clin & Environm, Pointe a Pitre, Guadeloupe, France; [Breurec, Sebastien; Binh, Liem; Frank, Thierry; Farra, Alain; Rafai, Clotaire] Inst Pasteur, Lab Bacteriol Med, Bangui, Cent Afr Republ; [Breurec, Sebastien] Univ Antilles, Fac Med, Pointe Aa Pitre, Guadeloupe, France; [Bata, Petula; Gody, Jean Chrysostome] Complexe Pediat Bangui, Bangui, Cent Afr Republ; [Gouandjika-Vasilache, Ionela] Inst Pasteur, Lab Virus Enter Rougeole, Bangui, Cent Afr Republ; [Vray, Muriel] Inst Pasteur, Unite Epidemiol Malad Infect, Dakar, Senegal	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CHU Guadeloupe; Universite des Antilles; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar	Vray, M (corresponding author), Inst Pasteur, Unite Epidemiol & Expertise Malad Emergentes, Paris, France.; Vray, M (corresponding author), Inst Pasteur, Unite Epidemiol Malad Infect, Dakar, Senegal.	muriel.vray@pasteur.fr	Gouandjika, Ionela/AGR-0778-2022; Vray, Muriel/M-7947-2018	Gouandjika, Ionela/0000-0002-2498-8725; Vonaesch, Pascale/0000-0002-1064-6505	Total Foundation; SNF Early	Total Foundation(Total SA); SNF Early	The original study was funded by the Total Foundation. Pascale Vonaesch is the recipient of a SNF Early. Postdoc Mobility Fellowship as well as a Roux Cantarini Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adair Linda S, 2014, Nestle Nutr Inst Workshop Ser, V78, P111, DOI 10.1159/000354949; Adair LS, 2010, NESTLE NUTR WORKS SE, V65, P71, DOI 10.1159/000281146; Anuar Tengku Shahrul, 2014, Sci Rep, V4, P4101, DOI 10.1038/srep04101; Bartelt LA, 2013, J CLIN INVEST, V123, P2672, DOI 10.1172/JCI67294; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bolick DT, 2013, J MED MICROBIOL, V62, P896, DOI 10.1099/jmm.0.046300-0; Bove I, 2012, EARLY HUM DEV, V88, P747, DOI 10.1016/j.earlhumdev.2012.04.002; Breurec S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004283; Brown EM, DIET SPECIFIC MICROB; Caulfield LE, 2004, AM J TROP MED HYG, V71, P55, DOI 10.4269/ajtmh.2004.71.55; Checkley W, 1998, AM J EPIDEMIOL, V148, P497, DOI 10.1093/oxfordjournals.aje.a009675; Costa LB, 2011, J PARASITOL, V97, P1113, DOI 10.1645/GE-2848.1; De Boo HA, 2006, AUST NZ J OBSTET GYN, V46, P4, DOI 10.1111/j.1479-828X.2006.00506.x; de Onis M, 2016, MATERN CHILD NUTR, V12, P12, DOI 10.1111/mcn.12231; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Dewey KG, 2008, MATERN CHILD NUTR, V4, P24, DOI 10.1111/j.1740-8709.2007.00124.x; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; Fernald LC, 2007, EUR J CLIN NUTR, V61, P623, DOI 10.1038/sj.ejcn.1602558; Florencio TMDT, 2001, BRIT J NUTR, V86, P277, DOI 10.1079/BJN2001396; Freire WB, 2014, AM J CLIN NUTR, V100, p1636S, DOI 10.3945/ajcn.114.083766; Group WMGRS, 2007, STAT HEAD CIRC AGE A; Guerrant RL, 2008, NUTR REV, V66, P487, DOI 10.1111/j.1753-4887.2008.00082.x; GUERRANT RL, 1983, J INFECT DIS, V148, P986, DOI 10.1093/infdis/148.6.986; Hoffman DJ, 2007, NUTRITION, V23, P640, DOI 10.1016/j.nut.2007.06.006; Hoffman DJ, 2000, AM J CLIN NUTR, V72, P1025; Hoffman DJ, 2006, PEDIATRICS, V117, pE725, DOI 10.1542/peds.2005-0779; Hoffman DJ, 2000, J NUTR, V130, P2265, DOI 10.1093/jn/130.9.2265; Hoffman DJ, 2000, AM J CLIN NUTR, V72, P702; Ilechukwu GC, 2014, ANN MED HEALTH SCI R, V4, P119, DOI 10.4103/2141-9248.138027; Joseph KS, 1996, EPIDEMIOL REV, V18, P158, DOI 10.1093/oxfordjournals.epirev.a017923; Keino S, 2014, FOOD NUTR BULL, V35, P167, DOI 10.1177/156482651403500203; Kennedy G, 2006, PUBLIC HEALTH NUTR, V9, P187, DOI 10.1079/PHN2005835; Kosek MN, 2017, EBIOMEDICINE, V18, P109, DOI 10.1016/j.ebiom.2017.02.024; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; LaBeaud AD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003721; Langley-Evans S, 2014, J HUM NUTR DIET, V27, P105, DOI 10.1111/jhn.12204; Lee G, 2014, PEDIATR INFECT DIS J, V33, P1004, DOI 10.1097/INF.0000000000000351; Lima AAM, 2000, J INFECT DIS, V181, P1643, DOI 10.1086/315423; LIMA AAM, 1992, ACTA PAEDIATR, V81, P39, DOI 10.1111/j.1651-2227.1992.tb12370.x; Mamabolo RL, 2005, PUBLIC HEALTH NUTR, V8, P501, DOI 10.1079/PHN2005786; Martins PA, 2004, BRIT J NUTR, V92, P819, DOI 10.1079/BJN20041274; MATA LJ, 1977, AM J CLIN NUTR, V30, P1215, DOI 10.1093/ajcn/30.8.1215; McDonald CM, 2013, AM J CLIN NUTR, V97, P896, DOI 10.3945/ajcn.112.047639; Moore SR, 2010, GASTROENTEROLOGY, V139, P1156, DOI 10.1053/j.gastro.2010.05.076; Moore SR, 2001, INT J EPIDEMIOL, V30, P1457, DOI 10.1093/ije/30.6.1457; Ngui R, 2015, AM J TROP MED HYG, V93, P361, DOI 10.4269/ajtmh.13-0677; Oliveira D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137327; Onis M., 2006, WHO CHILD GROWTH STA; Ozanne SE, 2001, BRIT MED BULL, V60, P143, DOI 10.1093/bmb/60.1.143; Papier K, 2014, CLIN INFECT DIS, V59, P234, DOI 10.1093/cid/ciu211; Petri WA, 2008, J CLIN INVEST, V118, P1277, DOI 10.1172/JCI34005; Piernas C, 2015, EUR J CLIN NUTR, V69, P1323, DOI 10.1038/ejcn.2015.106; Popkin BM, 1996, J NUTR, V126, P3009, DOI 10.1093/jn/126.12.3009; Prendergast AJ, 2014, PAEDIATR INT CHILD H, V34, P250, DOI 10.1179/2046905514Y.0000000158; Rachmi CN, 2016, PUBLIC HEALTH NUTR, V19, P2698, DOI 10.1017/S1368980016000926; Ramirez-Zea M, 2014, AM J CLIN NUTR, V100, p1644S, DOI 10.3945/ajcn.114.083857; Randremanana RV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158862; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; Roche JK, 2010, J INFECT DIS, V202, P506, DOI 10.1086/654894; Said-Mohamed R, 2009, ANN HUM BIOL, V36, P146, DOI 10.1080/03014460802660526; Sawaya AL, 1998, J NUTR, V128, p415S, DOI 10.1093/jn/128.2.415S; Sire JM, 2013, PAEDIATR INT CHILD H, V33, P139, DOI 10.1179/2046905512Y.0000000046; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; Wamani H., 2007, BMC Pediatrics, V7	64	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182363	10.1371/journal.pone.0182363	http://dx.doi.org/10.1371/journal.pone.0182363			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796794	Green Published, gold, Green Submitted			2022-12-26	WOS:000407396200047
J	Choi, S; Jang, K; Park, K; Kim, H				Choi, Sungwon; Jang, Kwangmyung; Park, Kyunghoon; Kim, Hyunwook			Real-time measurement of fibers using an HY-differential mobility analyzer with an optical particle counter (KOFAM)	PLOS ONE			English	Article							ASBESTOS; NANOPARTICLES; SEPARATION	This study investigated the applicability of an HY-differential mobility analyzer with an optical particle counter (HY-DMA/OPC), named as KOFAM, for counting fibrous matters in real time. Fibers separated from particles by the HY-DMA were counted with an OPC. To assess the KOFAM performance, the proposed method and the conventional gold standard phase contrast microscopy (PCM) method were compared in terms of variables such as recovery, relative difference, coefficient of determination, and conformity. The optimal sheath-to-aerosol (outlet) flow ratio of the internal flow in the HY-DMA was determined to be 1.6:1. In terms of recovery of the HY-DMA, the highest recovery was obtained at a voltage of 500 V regardless of which type of asbestos was tested. The recovery rate for serpentine was 45.5% and that for amphibole was 34.9%. The coefficients of determination of serpentine (R-2 = 0.89) and amphibole (R-2 = 0.87) were highly correlated. With respect to the coefficient of variation (CV), the KOFAM demonstrated superior performance over the M7400AD and F-1 methods and showed almost no difference from the PCM method (KOFAM: 22.5%, M7400AD: 32.4%, F-1: 88.8%, and PCM: 21.9%). There was no statistically significant difference between concentration measurements of the KOFAM and PCM analyses. Accordingly, it was concluded that the KOFAM can be used as a superior alternative to conventional fiber measurement methods. The preliminary results support the use of the KOFAM for constant measurement of airborne asbestos concentrations in real time.	[Choi, Sungwon] Korea Workers Compensat & Welf Serv, Occupat Lung Dis Inst, Incheon, South Korea; [Jang, Kwangmyung; Park, Kyunghoon; Kim, Hyunwook] Catholic Univ Korea, Coll Med, Dept Prevent Med, Seoul, South Korea	Catholic University of Korea	Kim, H (corresponding author), Catholic Univ Korea, Coll Med, Dept Prevent Med, Seoul, South Korea.	hwkim@catholic.ac.kr		Kim, Hyunwook/0000-0002-1861-2529	Korean Ministry of Environment (ME)	Korean Ministry of Environment (ME)	This study was funded by the Korean Ministry of Environment (ME) as "the Environment Health Action Program", and the authors are grateful to Prof. Kang Ho Ahn, for providing the appropriate technique to be used with the HY-DMA.; This study was funded by the Korean Ministry of Environment (ME) as "the Environmental Health Action Program", and the authors are grateful to Prof. Kang Ho Ahn, for providing the appropriate technique to be used with the HY-DMA.	Afshari A, 2005, INDOOR AIR, V15, P141, DOI 10.1111/j.1600-0668.2005.00332.x; Ahn KH, 2012, AHN KH, Patent No. 10-1179039-0000; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; GRIFFITHS WD, 1985, J AEROSOL SCI, V16, P229, DOI 10.1016/0021-8502(85)90029-1; HAN RJ, 1994, AEROSOL SCI TECH, V21, P241, DOI 10.1080/02786829408959713; Hiromoto N, 1997, APPL OPTICS, V36, P9475, DOI 10.1364/AO.36.009475; IARC Solar and Ultraviolet Radiation, 2012, IARC MONOGRAPHS EVAL, V100D, P35; Intra P., 2008, SONGKLANAKARIN J SCI, V30, P243; Januch J, 2013, ANAL METHODS-UK, V5, P1658, DOI 10.1039/c3ay26254e; Jiang JK, 2011, AEROSOL SCI TECH, V45, P480, DOI 10.1080/02786826.2010.546819; Kauffer E, 2003, ANN OCCUP HYG, V47, P413, DOI 10.1093/annhyg/meg055; Kauffer E, 2000, CAH NOTES DOC HYG SE, V178, P55; Kim CS, 2009, CARBON, V47, P2511, DOI 10.1016/j.carbon.2009.05.005; Korea Asbestos Management Association, 2014, ASB MAN; Ku BK, 2007, J ELECTROSTAT, V65, P542, DOI 10.1016/j.elstat.2006.10.012; Ku BK, 2011, J ELECTROSTAT, V69, P641, DOI 10.1016/j.elstat.2011.08.006; Phanprasit W, 1988, APPL IND HYG, V3, P28; REINEKING A, 1986, AEROSOL SCI TECH, V5, P483, DOI 10.1080/02786828608959112; RICKARDS AL, 1978, ANN OCCUP HYG, V21, P315, DOI 10.1093/annhyg/21.3.315; RosellLlompart J, 1996, J AEROSOL SCI, V27, P695, DOI 10.1016/0021-8502(96)00016-X; Sachweh B, 1999, J AEROSOL SCI, V30, P1257, DOI 10.1016/S0021-8502(99)00045-2; Schneider T, 1998, ANALYST, V123, P1393, DOI 10.1039/a800292d; Seok-hwan Kim, 2014, PARTICLE AND AEROSOL RESEARCH, V10, P33, DOI 10.11629/jpaar.2014.10.1.033; The National Institute for Occupational Safety and Health (NIOSH), ASB OTH FIB PCM; Unrau CJ, 2008, MOL BUILDING BLOCKS, P212; Wang J, 2003, AEROSOL SCI TECH, V37, P46, DOI 10.1080/02786820300891; Wang J, 2011, J NANOPART RES, V13, P4565, DOI 10.1007/s11051-011-0415-y; YU PY, 1987, J AEROSOL SCI, V18, P73, DOI 10.1016/0021-8502(87)90012-7	28	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182119	10.1371/journal.pone.0182119	http://dx.doi.org/10.1371/journal.pone.0182119			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28793318	Green Published, gold, Green Submitted			2022-12-26	WOS:000407196700031
J	Herzing, DL; Augliere, BN; Elliser, CR; Green, ML; Pack, AA				Herzing, Denise L.; Augliere, Bethany N.; Elliser, Cindy R.; Green, Michelle L.; Pack, Adam A.			Exodus! Large-scale displacement and social adjustments of resident Atlantic spotted dolphins (Stenella frontalis) in the Bahamas	PLOS ONE			English	Article							BOTTLE-NOSED DOLPHINS; TURSIOPS-TRUNCATUS; ASSOCIATION PATTERNS; CLIMATE-CHANGE; KILLER WHALES; SOUTHERN GULF; COMMUNITY; BEHAVIOR; FEMALE; SIZE	Over the last 20 years, significant habitat shifts have been documented in some populations of cetaceans. On Little Bahama Bank (LBB) there are sympatric communities of resident Atlantic spotted dolphins (Stenella frontalis) and bottlenose dolphins (Tursiops truncatus), monitored since 1985. The size and social structure (three clusters: Northern, Central, Southern) have been stable among the spotted dolphin community with little immigration/emigration, even after large demographic losses (36%) following two major hurricanes in 2004. In 2013 an unprecedented exodus of over 50% (52 individuals) of the spotted dolphin community was documented. The entire Central cluster and a few Northern and Southern individuals relocated 161 km south to Great Bahama Bank (GBB), also home to two sympatric resident communities of spotted dolphins and bottlenose dolphins. During the late summer of 2013 and the summers of 2014 and 2015 both sites were regularly monitored but no former LBB dolphins returned to LBB. Uncharacteristic matriline splits were observed. Social analyses revealed random associations for those spotted dolphins and very little integration between spotted dolphins that moved to GBB (MGBB) and those dolphin resident to GBB (RGBB). Male alliances among spotted dolphins were present, with some altered patterns. On LBB, the operational sex ratio (OSR) was reduced (.40 to.25). OSR for MGBB and RGBB dolphins were similar (.45 and.43). A significant steady decrease in sea surface temperature and chlorophyll a (a proxy for plankton production) occurred on LBB leading up to this exodus. Similar trends were not present over the same period on GBB. The sudden large-scale shift of spotted dolphins from LBB to GBB in association with the gradual decline in certain environmental factors suggests that a possible "tipping point" was reached in prey availability. This study provides a unique view into social and genetic implications of large-scale displacement of stable dolphin communities.	[Herzing, Denise L.; Augliere, Bethany N.; Elliser, Cindy R.; Green, Michelle L.] Wild Dolphin Project, Jupiter, FL 33458 USA; [Herzing, Denise L.] Florida Atlantic Univ, Dept Biol Sci, Boca Raton, FL 33431 USA; [Elliser, Cindy R.] Pacific Mammal Res, Washington, DC USA; [Green, Michelle L.] Univ Illinois, Dept Anim Sci, Urbana, IL USA; [Green, Michelle L.] Univ Illinois, Illinois Nat Hist Survey, Urbana, IL USA; [Pack, Adam A.] Univ Hawaii, Dept Psychol, Hilo, HI 96720 USA; [Pack, Adam A.] Univ Hawaii, Dept Biol, Hilo, HI 96720 USA; [Pack, Adam A.] Dolphin Inst, Hilo, HI USA	State University System of Florida; Florida Atlantic University; University of Illinois System; University of Illinois Urbana-Champaign; Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign; University of Hawaii System; University Hawaii Hilo; University of Hawaii System; University Hawaii Hilo	Herzing, DL (corresponding author), Wild Dolphin Project, Jupiter, FL 33458 USA.; Herzing, DL (corresponding author), Florida Atlantic Univ, Dept Biol Sci, Boca Raton, FL 33431 USA.	dlherzing@wilddolphinproject.org			Marisla Foundation; Coypu Foundation; W. Bradford Ingalls Foundation	Marisla Foundation; Coypu Foundation; W. Bradford Ingalls Foundation	All the funding received during this specific study include: The Marisla Foundation, The Coypu Foundation, and The W. Bradford Ingalls Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No authors received a salary from any of these funders	AMOS B, 1991, HEREDITY, V67, P49, DOI 10.1038/hdy.1991.64; Augliere B., 2012, THESIS FLORIDA ATLAN; Baker AJ, 1996, AM J PRIMATOL, V38, P47, DOI 10.1002/(SICI)1098-2345(1996)38:1<47::AID-AJP5>3.0.CO;2-T; Barton AD, 2015, LIMNOL OCEANOGR, V60, P181, DOI 10.1002/lno.10011; Behrenfeld MJ, 2015, NATURE CLIMATE CHANG; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Brandt C.A., 1992, P96; Brockelman WY, 1998, BEHAV ECOL SOCIOBIOL, V42, P329, DOI 10.1007/s002650050445; Caballero S, 2010, ZOO BIOL, V29, P647, DOI 10.1002/zoo.20299; CAIRNS SJ, 1987, ANIM BEHAV, V35, P1454, DOI 10.1016/S0003-3472(87)80018-0; Cantor M, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160615; CONNOR RC, 1992, P NATL ACAD SCI USA, V89, P987, DOI 10.1073/pnas.89.3.987; Connor RC, 2007, PHILOS T R SOC B, V362, P587, DOI 10.1098/rstb.2006.1997; Connor RC, 2010, PHILOS T R SOC B, V365, P2687, DOI 10.1098/rstb.2010.0150; DOHL TP, 1974, J MAMMAL, V55, P217, DOI 10.2307/1379276; Elliser CR, 2016, MAR MAMMAL SCI, V32, P602, DOI 10.1111/mms.12289; Elliser CR, 2016, MAR MAMMAL SCI, V32, P38, DOI 10.1111/mms.12242; Elliser CR, 2014, MAR MAMMAL SCI, V30, P308, DOI 10.1111/mms.12039; Elliser CR, 2014, MAR MAMMAL SCI, V30, P329, DOI 10.1111/mms.12038; Elliser CR, 2012, MAR MAMMAL SCI, V28, pE486, DOI 10.1111/j.1748-7692.2012.00576.x; Elliser CR, 2011, MAR MAMMAL SCI, V27, P39, DOI 10.1111/j.1748-7692.2010.00403.x; Gero S, 2005, CAN J ZOOL, V83, P1566, DOI 10.1139/Z05-155; Gero S, 2015, ANIM BEHAV, V102, P15, DOI 10.1016/j.anbehav.2015.01.008; Green Michael, 2008, THESIS; Green ML, 2007, MOL ECOL NOTES, V7, P1287, DOI 10.1111/j.1471-8286.2007.01858.x; Green ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118227; Green ML, 2011, CAN J ZOOL, V89, P239, DOI 10.1139/Z10-111; Gubbins C. M., 2002, J MAMMAL, V83, P25; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Herzing D. L., 1997, Aquatic Mammals, V23, P85; Herzing Denise L., 1996, Aquatic Mammals, V22, P61; Herzing DL, 2014, MAR MAMMAL SCI, V30, P367, DOI 10.1111/mms.12016; Herzing Denise L., 2003, Aquatic Mammals, V29, P335, DOI 10.1578/01675420360736505; Herzing DL, 2000, SPR HDB AUD, V12, P225; Herzing DL, 1997, MAR MAMMAL SCI, V13, P576, DOI 10.1111/j.1748-7692.1997.tb00085.x; Herzing DL., 2013, INT J COMP PSYCHOL, V26, P124, DOI [10.46867/ijcp.2013.26.02.04, DOI 10.5811/WESTJEM.2011.5.6700]; Herzing DL., 2004, ECHOLOCATION BATS DO, P404; Hoelzel AR, 2007, MOL BIOL EVOL, V24, P1407, DOI 10.1093/molbev/msm063; Kahlenberg SM, 2008, ANIM BEHAV, V76, P1497, DOI 10.1016/j.anbehav.2008.05.029; Kahru M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006500; Karczmarski L, 2005, BEHAV ECOL, V16, P675, DOI 10.1093/beheco/ari028; Lammers MO, 2003, J ACOUST SOC AM, V114, P1629, DOI 10.1121/1.1596173; Lazaro-Perea C, 2000, BEHAV ECOL SOCIOBIOL, V48, P137, DOI 10.1007/s002650000215; Learmonth JA, 2006, OCEANOGR MAR BIOL, V44, P431; Lehmann J, 2004, BEHAV ECOL SOCIOBIOL, V56, P207, DOI 10.1007/s00265-004-0781-x; Lusseau D, 2004, ECOL LETT, V7, P1068, DOI 10.1111/j.1461-0248.2004.00669.x; Lusseau D, 2003, BEHAV ECOL SOCIOBIOL, V54, P396, DOI 10.1007/s00265-003-0651-y; Lusseau D, 2004, P ROY SOC B-BIOL SCI, V271, pS477, DOI 10.1098/rsbl.2004.0225; MacLeod CD, 2005, BIOL CONSERV, V124, P477, DOI 10.1016/j.biocon.2005.02.004; Malinowski CR, 2015, MAR MAMMAL SCI, V31, P1471, DOI 10.1111/mms.12238; Matkin CO, 2008, MAR ECOL PROG SER, V356, P269, DOI 10.3354/meps07273; McHugh KA, 2011, MAR MAMMAL SCI, V27, P622, DOI 10.1111/j.1748-7692.2010.00428.x; Moller LM, 2008, RES LETT ECOL; Morales JM, 2010, PHILOS T R SOC B, V365, P2289, DOI 10.1098/rstb.2010.0082; Nishiwaki M., 1982, SCI REP WHALES RES, V34, P109; O'Brien TD., 2016, IOC TECHNICAL SERIES, V129, P304; OBrien T., 2013, ICES COOP RES REP, P6; OBrien T. D, 2014, COPEPOD GLOBAL PLANK; Park JY, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007056; PAYNE PM, 1990, FISH B-NOAA, V88, P687; PERRIN WF, 1969, ZOOLOGICA-N Y, V54, P135; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Reale D, 2003, P ROY SOC B-BIOL SCI, V270, P591, DOI 10.1098/rspb.2002.2224; Rogers CA, 2004, MAR MAMMAL SCI, V20, P688, DOI 10.1111/j.1748-7692.2004.tb01188.x; Rossbach KA, 1999, CAN J ZOOL, V77, P581, DOI 10.1139/cjz-77-4-581; Sapolsky RM, 2004, PLOS BIOL, V2, P534, DOI 10.1371/journal.pbio.0020106; Schaffner CM, 1997, ANIM BEHAV, V54, P171, DOI 10.1006/anbe.1996.0413; Shane S.H., 1990, P245; SUGG DW, 1994, GENETICS, V137, P1147; Weinrich M, 1997, FISH B-NOAA, V95, P826; Wells R.S., 1990, P421; Wells R.S., 1987, Current Mammalogy, V1, P247; Wells RS., 1980, CETACEAN BEHAV MECH, P263; Whitehead H, 2005, ANIM BEHAV, V69, P117, DOI 10.1016/j.anbehav.2004.02.021; Whitehead H, 2008, ANAL ANIMAL SOC QUAN, DOI 10.7208/chicago/9780226895246.001.0001; Whitehead H, 2008, ANIM BEHAV, V75, P1093, DOI 10.1016/j.anbehav.2007.08.022; Whitehead H, 2012, INT J PRIMATOL, V33, P1142, DOI 10.1007/s10764-012-9598-z; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y; Zornetzer HR, 2003, CAN J ZOOL, V81, P1755, DOI 10.1139/Z03-150	79	9	9	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0180304	10.1371/journal.pone.0180304	http://dx.doi.org/10.1371/journal.pone.0180304			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28792947	Green Published, gold, Green Submitted			2022-12-26	WOS:000407196700002
J	Du, Y; Wolf, IK; Knopf, H				Du, Yong; Wolf, Ingrid-Katharina; Knopf, Hildtraud			Association of psychotropic drug use with falls among older adults in Germany. Results of the German Health Interview and Examination Survey for Adults 2008-2011 (DEGS1)	PLOS ONE			English	Article							SEROTONIN REUPTAKE INHIBITORS; RISK-INCREASING DRUGS; PEOPLE; METAANALYSIS; MEDICATIONS; POLYPHARMACY; PREVALENCE; INJURY; CONSUMPTION; IMPAIRMENT	Purpose To investigate the association of psychotropic drug use with falls among older adults in Germany based on data from the National Health Interview and Examination Survey for Adults 2008-2011 (DEGS1). Methods DEGS1 collected data on drug use in the past 7 days and on falls occurred in the last 12 months. Study participants were older adults aged 65-79 years with complete data on drug use and falls (N = 1,833). Odds ratio (OR) and 95% confidence intervals (95% CI) were derived from logistic regression models adjusting for potential confounders including socio-demographic characteristics, health-related behaviors (alcohol drinking), body mass index and health conditions (frailty, vision impairment, disability, polypharmacy, blood pressure) as well as use of potential falls-risk-increasing drugs. SPSS complex sample methods were used for statistical analysis. Results Compared to people without falls, people with falls (n = 370) had a higher psychotropic drug use (33.1% vs. 20.7%, p < .001). After adjusting for potential confounders, use of psychotropic drugs overall was associated with a higher risk of falls (OR 1.64, 95% CI 1.14-2.37). This was particularly true for the use of synthetic psychotropic drugs (1.57, 1.08-2.28), antidepressants overall (2.88, 1.63-5.09) or synthetic antidepressants (2.66, 1.50-4.73), specifically, selective serotonin reuptake inhibitors (SSRIs) (6.22, 2.28-17.0). Similar results were found for recurrent falls. Conclusions Use of psychotropic drugs overall, especially synthetic antidepressants like SSRIs, is associated with higher risks of falls and recurrent falls among community dwelling older adults aged 65-79 years in Germany.	[Du, Yong; Wolf, Ingrid-Katharina; Knopf, Hildtraud] Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Berlin, Germany	Robert Koch Institute	Du, Y (corresponding author), Robert Koch Inst, Dept Epidemiol & Hlth Monitoring, Berlin, Germany.	duy@rki.de		Du, Yong/0000-0001-8309-9293	Federal Ministry of Health; Robert Koch Institute	Federal Ministry of Health; Robert Koch Institute	This work was supported by the Federal Ministry of Health (https://www.bundesgesundheitsministerium.de/) and the Robert Koch Institute (www.rki.de/). The German Health Interview and Examination Survey for Adults 2008-2011 was funded by the Federal Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose AF, 2013, MATURITAS, V75, P51, DOI 10.1016/j.maturitas.2013.02.009; Bergen G, 2016, MMWR-MORBID MORTAL W, V65, P993, DOI 10.15585/mmwr.mm6537a2; Bloch F, 2011, J AGING HEALTH, V23, P329, DOI 10.1177/0898264310381277; Burns ER, 2016, J SAFETY RES, V58, P99, DOI 10.1016/j.jsr.2016.05.001; Buttery AK, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0022-3; Crews JE, 2016, MMWR-MORBID MORTAL W, V65, P433, DOI 10.15585/mmwr.mm6517a2; Do MT, 2015, HEALTH PROMOT CHRON, V35, P99; Du Y, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012182; Findley L Rebekah, 2015, Consult Pharm, V30, P346, DOI 10.4140/TCP.n.2015.346; Gebara MA, 2015, AM J GERIAT PSYCHIAT, V23, P1016, DOI 10.1016/j.jagp.2014.11.004; Grenier S, 2014, INT PSYCHOGERIATR, V26, P1511, DOI 10.1017/S104161021400074X; Hammond T, 2013, NURS MIDWIFERY STUD, V2, P171; Hartikainen S, 2007, J GERONTOL A-BIOL, V62, P1172, DOI 10.1093/gerona/62.10.1172; Hill KD, 2012, DRUG AGING, V29, P15, DOI 10.2165/11598420-000000000-00000; Hong T, 2014, INVEST OPHTH VIS SCI, V55, P7589, DOI 10.1167/iovs.14-14262; Houry D, 2016, AM J LIFESTYLE MED, V10, P74, DOI 10.1177/1559827615600137; Huang AR, 2012, DRUG AGING, V29, P359, DOI 10.2165/11599460-000000000-00000; Johnell K, 2016, INT J GERIATR PSYCHI; Kamtsiuris P, 2013, BUNDESGESUNDHEITSBLA, V56, P620, DOI 10.1007/s00103-012-1650-9; Kerse N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002423; Klein D, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-50; Knopf H, 2013, BUNDESGESUNDHEITSBLA, V56, P868, DOI 10.1007/s00103-013-1667-8; Kuschel BM, 2015, EUR J PUBLIC HEALTH, V25, P527, DOI 10.1093/eurpub/cku120; Kvelde T, 2013, J AM GERIATR SOC, V61, P694, DOI 10.1111/jgs.12209; Lampert T, 2013, BUNDESGESUNDHEITSBLA, V56, P631, DOI 10.1007/s00103-012-1663-4; Leipzig RM, 1999, J AM GERIATR SOC, V47, P30, DOI 10.1111/j.1532-5415.1999.tb01898.x; Marcum ZA, 2016, ANN PHARMACOTHER, V50, P525, DOI 10.1177/1060028016644466; Masud T, 2013, AGE AGEING, V42, P121, DOI 10.1093/ageing/afs118; Matsuda PN, 2015, ARCH PHYS MED REHAB, V96, P464, DOI 10.1016/j.apmr.2014.09.034; Milos V, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-40; Naples JG, 2016, AM J GERIATRIC PSYCH; Neuhauser H, 2013, BUNDESGESUNDHEITSBLA, V56, P795, DOI 10.1007/s00103-013-1669-6; Park H, 2015, EUR J CLIN PHARMACOL, V71, P1429, DOI 10.1007/s00228-015-1955-3; Pierce J Rush Jr, 2013, Int J Risk Saf Med, V25, P229, DOI 10.3233/JRS-130603; Potzsch O, 2015, BEVOLKERUNG DEUTSCHL, P20; Rapp K, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-105; Salas M, 1999, AM J EPIDEMIOL, V149, P981; Scheffer AC, 2008, AGE AGEING, V37, P19, DOI 10.1093/ageing/afm169; Scheidt-Nave C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-730; Schultz M, 2015, DAN MED J, V62; Scott D, 2009, QJM-INT J MED, V102, P625, DOI 10.1093/qjmed/hcp093; Signorello Lisa B, 2002, Am J Ther, V9, P199, DOI 10.1097/00045391-200205000-00005; Stubbs B, 2016, INT PSYCHOGERIATR, V28, P23, DOI 10.1017/S104161021500126X; Stubbs B, 2015, AM J GERIAT PSYCHIAT, V23, P1098, DOI 10.1016/j.jagp.2015.02.004; Stubbs B, 2015, PHYS THER, V95, P1095, DOI 10.2522/ptj.20140461; Tinetti ME, 2014, JAMA INTERN MED, V174, P588, DOI 10.1001/jamainternmed.2013.14764; Turner S, 2015, FALLS OLDER ADULTS E; Vieira ER, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1419; Wolf IK, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1254-x; Woolcott JC, 2009, ARCH INTERN MED, V169, P1952, DOI 10.1001/archinternmed.2009.357; Zia A, 2017, GERIATR GERONTOL INT, V17, P463, DOI 10.1111/ggi.12741; Zia A, 2015, POSTGRAD MED, V127, P330, DOI 10.1080/00325481.2014.996112	52	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2017	12	8							e0182432	10.1371/journal.pone.0182432	http://dx.doi.org/10.1371/journal.pone.0182432			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC9EU	28792521	Green Published, Green Submitted, gold			2022-12-26	WOS:000407144700018
J	Hong, SS; Hong, L; Li, BS; Wu, DB; Liu, C; Min, J; Guo, WJ; Hu, M; Tang, JM; Li, Y				Hong, Shasha; Hong, Li; Li, Bingshu; Wu, Debin; Liu, Cheng; Min, Jie; Guo, Wenjun; Hu, Ming; Tang, Jianming; Li, Yang			The role of GPX1 in the pathogenesis of female pelvic organ prolapse	PLOS ONE			English	Article							LIGAMENT-DERIVED FIBROBLASTS; OXIDATIVE STRESS; UTERINE PROLAPSE; GLUTATHIONE-PEROXIDASE; BIOMECHANICAL PROPERTIES; CONNECTIVE-TISSUE; GENITAL PROLAPSE; VAGINAL TISSUE; GROWTH-FACTOR; RISK-FACTORS	Gestation and delivery can increase intra-abdominal pressure, which are well-known risk factors for Pelvic Organ Prolapse (POP). But the pathogenesis mechanism of POP remains unclear. Our previous research showed that the expression of glutathione peroxidase type 1 (GPX1) decreased in pelvic floor ligaments from POP patients, implying that oxidative stress (OS) may be related to POP. The aim of this study was to figure out the role of GPx1 regulation in the pathogenesis of POP. Women (>45 years) who received hysterectomy surgery were enrolled in this research, identified by screening. We applied mechanical strain of 0 mu, 5333 mu to GPX1-overexpressing human uterosacral ligament fibroblasts (hUSLFs) isolated from menopausal women without POP respectively for 4 hours, in order to investigate the changes of cell apoptosis, oxidative status and ECM metabolism when cytomechanics model loaded on GPX1-overexpressing hUSLFs. Comparing with the non-transfection and mock-vehicle groups, we found that GPX1 not only protects hUSLFs from cell apoptosis, oxidative damage, but also improves the remodeling of ECM induced by mechanical stimulation. These results suggested that mechanical strain caused abnormalities of ECM metabolism via OS pathway in hUSLFs, which was involved in the pathogenesis of POP, and that GPx1 played a significant role in regulating mechanical strain induced POP.	[Hong, Shasha; Hong, Li; Li, Bingshu; Wu, Debin; Liu, Cheng; Min, Jie; Guo, Wenjun; Hu, Ming; Tang, Jianming; Li, Yang] Wuhan Univ, Renmin Hosp, Dept Obstet & Gynaecol, Wuhan, Hubei, Peoples R China	Wuhan University	Hong, L (corresponding author), Wuhan Univ, Renmin Hosp, Dept Obstet & Gynaecol, Wuhan, Hubei, Peoples R China.	lihong_wuhan@163.com			National Natural Science Foundation of China [81270684]; Foundation of Collaborative and Innovation Projects of Wuhan University School of Medicine [523-266078]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Collaborative and Innovation Projects of Wuhan University School of Medicine	This work was supported by 1. National Natural Science Foundation of China (No. 81270684), http://www.nsfc.gov.cn/; 2. Foundation of Collaborative and Innovation Projects of Wuhan University School of Medicine (No. 523-266078), http://wsm70.whu.edu.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao R, 2011, J XINXIANG MED COLL, V28, P577; Berger MB, 2012, INT UROGYNECOL J, V23, P1095, DOI 10.1007/s00192-012-1747-6; Brigelius-Flohe R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020; Budatha M, 2011, J CLIN INVEST, V121, P2048, DOI 10.1172/JCI45636; Cheng WH, 1998, J NUTR, V128, P1070, DOI 10.1093/jn/128.7.1070; Chow D, 2013, CURR OPIN UROL, V23, P293, DOI 10.1097/MOU.0b013e3283619ed0; Choy KW, 2008, BJOG-INT J OBSTET GY, V115, P1179, DOI 10.1111/j.1471-0528.2008.01806.x; Dimanov D, 1988, P 6 INT C AN HYG SKA, V2, P798; Ding Wenjuan, 2014, Wuhan Daxue Xuebao (Yixue Ban), V35, P16; Esposito LA, 2000, FREE RADICAL BIO MED, V28, P754, DOI 10.1016/S0891-5849(00)00161-1; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Glazener C, 2010, NEUROUROL URODYNAM, V29, P819; Gutierrez C, 2001, CAN VET J, V42, P803; Gyhagen M, 2013, BJOG-INT J OBSTET GY, V120, P152, DOI 10.1111/1471-0528.12020; Higashi Y, 2013, BBA-MOL BASIS DIS, V1832, P391, DOI 10.1016/j.bbadis.2012.12.005; Hong SS, 2015, MOL MED REP, V12, P5342, DOI 10.3892/mmr.2015.4115; Hong SS, 2013, CHIN J CLIN ELECT ED, V7, P10775; Jackson SR, 1996, LANCET, V347, P1658, DOI 10.1016/S0140-6736(96)91489-0; Jean-Charles C, 2010, INT UROGYNECOL J, V21, P1535, DOI 10.1007/s00192-010-1208-z; Kerkhof MH, 2009, INT UROGYNECOL J, V20, P461, DOI 10.1007/s00192-008-0737-1; Kim EJ, 2013, J UROLOGY, V189, P588, DOI 10.1016/j.juro.2012.09.041; Li BS, 2013, CLIN EXP OBSTET GYN, V40, P586; Liang CC, 2010, EUR J OBSTET GYN R B, V153, P94, DOI 10.1016/j.ejogrb.2010.06.008; Liu C, 2016, MOL MED REP, V13, P2999, DOI 10.3892/mmr.2016.4919; Miedel A, 2009, OBSTET GYNECOL, V113, P1089, DOI 10.1097/AOG.0b013e3181a11a85; Moalli PA, 2005, OBSTET GYNECOL, V106, P953, DOI 10.1097/01.AOG.0000182584.15087.dd; Phillips CH, 2006, BJOG-INT J OBSTET GY, V113, P39, DOI 10.1111/j.1471-0528.2005.00773.x; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Samuelsson EC, 1999, AM J OBSTET GYNECOL, V180, P299, DOI 10.1016/S0002-9378(99)70203-6; Subak LL, 2001, OBSTET GYNECOL, V98, P646, DOI 10.1016/S0029-7844(01)01472-7; Tan J. S., 2010, THESIS; Visco AG, 2003, AM J OBSTET GYNECOL, V189, P102, DOI 10.1067/mob.2003.372; Woodman PJ, 2006, INT UROGYNECOL J, V17, P340, DOI 10.1007/s00192-005-0009-2; Zhang QF, 2017, MOL MED REP IN PRESS; Zhou L, 2012, J UROLOGY, V188, P875, DOI 10.1016/j.juro.2012.05.017	35	7	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0181896	10.1371/journal.pone.0181896	http://dx.doi.org/10.1371/journal.pone.0181896			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28783735	Green Submitted, Green Published, gold			2022-12-26	WOS:000406998800011
J	Sorrie, MB; Yesuf, ME; GebreMichael, TG				Sorrie, Muluken Bekele; Yesuf, Melkie Edris; GebreMichael, Tsgehana GebreGyorgis			Overweight/Obesity and associated factors among preschool children in Gondar City, Northwest Ethiopia: A cross-sectional study	PLOS ONE			English	Article							OBESITY; DETERMINANTS; PREVALENCE; TRENDS	Background Overweight and obesity among children has emerged as one of the most serious public health concerns in the 21st century, which is a predictor of adulthood obesity, morbidity and mortality. The objective of this study was to assess the prevalence of overweight/obesity and associated factors among preschool children. Methods A community based cross-sectional study was conducted in Gondar City from February 14 to March 4, 2016. Multi stage sampling technique was used to select a total of 504 pre-school children. Data were collected using structured interviewer administered questionnaire and anthropometric measurements. Data were entered using Epidata version 3.1 and analyzed using SPSS version 20 and WHO 2007 Anthro version 2.0.4 software. Both bivariate and multivariate logistic regression analysis were performed to identify associated factors. P values <0.05 with 95% confidence level were used to declare statistical significance. Results A total of 500 study participants were included with 99.2% response rate and 51.6% were girls while 48.4% were boys. The mean (+/- SD) age of participants was 47.68 +/- 7.19 months. The combined prevalence of overweight/obesity was 13.8% (95% CI; 10.6, 17.2) the specific being 9.6% for overweight and 4.2% for obesity. The multivariable analysis indicated that the age group between 36-47 months [AOR = 2.38 (95% CI; 1.27,4.46)], high dietary diversity[AOR = 3.73(95% CI; 1.15,12.54), consumption of sweet food[AOR = 2.69 (95% CI, 1.21, 5.98)], time spent in watching television>2hr/day [AOR = 4.01 (95% CI; 2.22, 7.26)] and mother's education at secondary level [AOR = 0.35 (95% CI; 0.12, 0.96)] were associated with overweight/obesity among preschool children. Conclusions Once considered a high income country problem, result of this study in urban city like Gondar reveals that overweight/obesity is on the rise in urban Ethiopia, which indicates the need for formulating preventive programs and policies during a child's early years.	[Sorrie, Muluken Bekele] Arbaminch Univ, Coll Med & Hlth Sci, Dept Midwifery, Arbaminch, Ethiopia; [Yesuf, Melkie Edris; GebreMichael, Tsgehana GebreGyorgis] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Gondar, Ethiopia	Arba Minch University; University of Gondar	Sorrie, MB (corresponding author), Arbaminch Univ, Coll Med & Hlth Sci, Dept Midwifery, Arbaminch, Ethiopia.	mulukenbekele51@gmail.com		Bekele, Muluken/0000-0002-3464-2584				De Onis M., 2015, ECOGS EBOOK CHILD AD; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; de Menezes RCE, 2011, J PEDIAT-BRAZIL, V87, P231, DOI [10.2223/JPED.2092, 10.1590/S0021-75572011000300009]; Gebremedhin S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009005; Gibson RS, 2005, PRINCIPLES NUTR ASSE, P275; Hajian-Tilaki K, 2013, IRAN J PUBLIC HEALTH, V42, P1283; Ilaine Schucha, 2013, J PEDIAT, V89, P179; Do LM, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.28615; Lyu Y, 2013, PUBLIC HEALTH, V127, P1082, DOI 10.1016/j.puhe.2013.09.001; Musa WA., 2010, MED J BASRAH UNIV, P28, DOI [10.33762/mjbu.2010.49368, DOI 10.33762/MJBU.2010.49368]; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Rossen LM, 2014, ANN EPIDEMIOL, V24, P705, DOI 10.1016/j.annepidem.2014.07.010; Sobngwi-Tambekou Joelle, 2015, PLOS ONE, V10; Tesedeke W, 2014, FOOD SCI QUALITY MAN, V29; Toselli S, 2015, ENDOCRINE, V49, P717, DOI 10.1007/s12020-014-0479-4; Velde SJT, 2012, OBES REV, V13, P56, DOI 10.1111/j.1467-789X.2011.00960.x; Wandia FB, 2014, AFRICAN J FOOD AGR N, V14; World Health Organization, 2020, GLOB STRAT DIET PHYS; Zhang JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064542; Ziyab AH, 2014, J EPIDEMIOL COMMUN H, V68, P934, DOI 10.1136/jech-2014-203808	20	24	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182511	10.1371/journal.pone.0182511	http://dx.doi.org/10.1371/journal.pone.0182511			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28787013	gold, Green Submitted, Green Published			2022-12-26	WOS:000406998800043
J	Sunil, M; Hariharan, N; Dixit, S; Choudhary, B; Srinivasan, S				Sunil, Meeta; Hariharan, Nivedita; Dixit, Shubham; Choudhary, Bibha; Srinivasan, Subhashini			Differential genomic arrangements in Caryophyllales through deep transcriptome sequencing of A-hypochondriacus	PLOS ONE			English	Article							GENE-CLUSTER; EVOLUTION; REARRANGEMENT; GENERATION; KNOWLEDGE; PLATFORM; PROTEIN	Genome duplication event in edible dicots under the orders Rosid and Asterid, common during the oligocene period, is missing for species under the order Caryophyllales. Despite this, grain amaranths not only survived this period but display many desirable traits missing in species under rosids and asterids. For example, grain amaranths display traits like C4 photosynthesis, high-lysine seeds, high-yield, drought resistance, tolerance to infection and resilience to stress. It is, therefore, of interest to look for minor genome rearrangements with potential functional implications that are unique to grain amaranths. Here, by deep sequencing and assembly of 16 transcriptomes (86.8 billion bases) we have interrogated differential genome rearrangement unique to Amaranthus hypochondriacus with potential links to these phenotypes. We have predicted 125,581 non-redundant transcripts including 44,529 protein coding transcripts identified based on homology to known proteins and 13,529 predicted as novel/amaranth specific coding transcripts. Of the protein coding de novo assembled transcripts, we have identified 1810 chimeric transcripts. More than 30% and 19% of the gene pairs within the chimeric transcripts are found within the same loci in the genomes of A. hypochondriacus and Beta vulgaris respectively and are considered real positives. Interestingly, one of the chimeric transcripts comprises two important genes, namely DHDPS1, a key enzyme implicated in the biosynthesis of lysine, and alpha-glucosidase, an enzyme involved in sucrose catabolism, in close proximity to each other separated by a distance of 612 bases in the genome of A. hypochondriacus in a convergent configuration. We have experimentally validated that transcripts of these two genes are also overlapping in the 3' UTR with their expression negatively correlated from bud to mature seed, suggesting a potential link between the high seed lysine trait and unique genome organization.	[Sunil, Meeta; Hariharan, Nivedita; Dixit, Shubham; Choudhary, Bibha; Srinivasan, Subhashini] Inst Bioinformat & Appl Biotechnol, Bangalore, Karnataka, India; [Sunil, Meeta] Manipal Univ, Manipal, Karnataka, India	Manipal Academy of Higher Education (MAHE)	Srinivasan, S (corresponding author), Inst Bioinformat & Appl Biotechnol, Bangalore, Karnataka, India.	ssubha@ibab.ac.in			Department of Biotechnology, Government of India [BT-BRB-TF3-2013]; Ministry of Electronics and Information Technology, Government of India; Centre of Excellence for Research and Training in Bioinformatics; Department of Science and Technology, Governament of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Ministry of Electronics and Information Technology, Government of India; Centre of Excellence for Research and Training in Bioinformatics; Department of Science and Technology, Governament of India	This work was funded by: 1. Department of Biotechnology, Government of India; BT-BRB-TF3-2013; http://www.dbtindia.nic.in/; SS; 2. Ministry of Electronics and Information Technology, Government of India; Centre of Excellence for Research and Training in Bioinformatics; http://meity.gov.in/; IBAB; 3. Department of Science and Technology, Governament of India; FIST; http://www.dst.gov.in/scientific-pregrammes/scientific-engineering-researchituna-Improvementst-Intrastructurer-higher-educational-institutions-41st; IBAB.	Achigan-Dako EG, 2014, EUPHYTICA, V197, P303, DOI 10.1007/s10681-014-1081-9; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrews S., 2010, FASTQC QUALITY CONTR; Arnone JT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-546; Bardou P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-293; Brockington SF, 2011, NEW PHYTOL, V190, P854, DOI 10.1111/j.1469-8137.2011.03687.x; Caselato-Sousa VM, 2012, J FOOD SCI, V77, pR93, DOI 10.1111/j.1750-3841.2012.02645.x; Dohm JC, 2014, NATURE, V505, P546, DOI 10.1038/nature12817; Field B, 2008, SCIENCE, V320, P543, DOI 10.1126/science.1154990; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Huvet M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-721; Johnson ZI, 2004, GENOME RES, V14, P2268, DOI 10.1101/gr.2433104; Kannan K, 2011, P NATL ACAD SCI USA, V108, P9172, DOI 10.1073/pnas.1100489108; Krom N, 2010, DNA RES, V17, P343, DOI 10.1093/dnares/dsq022; Kunova A, 2012, INT J PLANT GENOMICS, V2012; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Levin JZ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r115; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Masoudi-Nejad A, 2006, NUCLEIC ACIDS RES, V34, pW459, DOI 10.1093/nar/gkl066; MCCLURE BA, 1989, PLANT CELL, V1, P229, DOI 10.1105/tpc.1.2.229; Nacu S, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-11; Nomura T, 2003, PLANTA, V217, P776, DOI 10.1007/s00425-003-1040-5; Qi X, 2004, P NATL ACAD SCI USA, V101, P8233, DOI 10.1073/pnas.0401301101; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rio DC., 2010, COLD SPRING HARB PRO, DOI [10.1101/pdb.prot5439, DOI 10.1101/PDB.PROT5439]; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Sunil M, 2014, DNA RES, V21, P585, DOI 10.1093/dnares/dsu021; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Vanneste K, 2014, GENOME RES, V24, P1334, DOI 10.1101/gr.168997.113; Xie YL, 2014, BIOINFORMATICS, V30, P1660, DOI 10.1093/bioinformatics/btu077; Yang Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-328; Zubko E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016769	35	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0180528	10.1371/journal.pone.0180528	http://dx.doi.org/10.1371/journal.pone.0180528			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28786999	Green Published, Green Submitted, gold			2022-12-26	WOS:000406998800001
J	Dong, ZJ; Sun, TT; Liang, LK; Wang, L				Dong, Zhijun; Sun, Tingting; Liang, Likun; Wang, Lei			Effect of tea saponin on ephyrae and polyps of the moon jellyfish Aurelia sp 1	PLOS ONE			English	Article							COMMON JELLYFISH; AURITA; BLOOMS; MODEL	The moon jellyfish (Aurelia sp. 1) is thought to be a nuisance for the sea cucumber aqua-culture, which commonly occur in the sea cucumber (Apostichopus japonicus) culture ponds of the Yellow Sea, China. To develop an appropriate method to control Aurelia sp. 1 blooms, the toxic effects of tea saponin on Aurelia sp. 1 ephyrae and polyps were tested in laboratory experiments. Our results revealed that tea saponin caused significant morphological changes, behavioral abnormality and mortality in Aurelia sp. 1 ephyrae and polyps in 24 h and 48 h exposure experiments. The 24 h and 48 h median lethal concentrations (LC50) values of tea saponin for Aurelia sp. 1 ephyrae were 1.9 and 1.1 mg L-1 respectively, while the LC50 value for Aurelia sp. 1 polyps was 0.4 mg L-1 after 24h and 48 h of exposure to tea saponin. Comparison with literature results of tea saponin on A. japonicus indicates that the resistance of A. japonicus to tea saponin is 12-18 times greater than that of Aurelia sp. 1 ephyrae. Therefore, the appropriate tea saponin dosage for the control of Aurelia sp. 1 should be paid enough attention in order to minimize possible damage for sea cucumber. We suggest that the recommended level of tea saponin to eradicate Aurelia sp. 1 ephyrae and polyps in sea cucumber culture ponds be lower than 1.35 mg L-1.	[Dong, Zhijun; Sun, Tingting; Wang, Lei] Chinese Acad Sci, Yantai Inst Coastal Zone Res, Key Lab Coastal Zone Environm Proc & Ecol Remedia, Yantai, Shandong, Peoples R China; [Sun, Tingting; Liang, Likun] Yantai Univ, Coll Life Sci, Yantai, Shandong, Peoples R China	Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS; Yantai University	Dong, ZJ (corresponding author), Chinese Acad Sci, Yantai Inst Coastal Zone Res, Key Lab Coastal Zone Environm Proc & Ecol Remedia, Yantai, Shandong, Peoples R China.	zjdong@yic.ac.cn			National Natural Science Foundation of China [41576152]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors received funding for this work from National Natural Science Foundation of China (http://www.nsfc.gov.cn/) No. 41576152. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnstedt U, 1998, SARSIA, V83, P79; Baxter EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018529; Chen JC, 1996, AQUACULTURE, V144, P165, DOI 10.1016/S0044-8486(96)01301-4; Costa E, 2015, HYDROBIOLOGIA, V759, P75, DOI 10.1007/s10750-015-2284-3; Dawson MN, 2005, P NATL ACAD SCI USA, V102, P11968, DOI 10.1073/pnas.0503811102; Dong ZJ, 2015, BIOCHEM SYST ECOL, V60, P15, DOI 10.1016/j.bse.2015.02.018; Dong Zhijun, 2014, P207; Dong ZJ, 2010, MAR POLLUT BULL, V60, P954, DOI 10.1016/j.marpolbul.2010.04.022; Faimali M, 2014, MAR ENVIRON RES, V93, P93, DOI 10.1016/j.marenvres.2013.07.004; Finney D.J., 1971, PROBIT ANAL; Garaventa F, 2010, ECOTOXICOLOGY, V19, P512, DOI 10.1007/s10646-010-0461-8; Hao WN, 2010, POSTHARVEST BIOL TEC, V56, P39, DOI 10.1016/j.postharvbio.2009.10.003; Homechaudhuri Sumit, 1991, Asian Fisheries Science, V4, P263; Ki JS, 2008, ICES J MAR SCI, V65, P443, DOI 10.1093/icesjms/fsn018; LAMBA SS, 1970, ECON BOT, V24, P134, DOI 10.1007/BF02860591; Lucas CH, 2014, J EXP MAR BIOL ECOL, V461, P154, DOI 10.1016/j.jembe.2014.08.003; Lucas CH, 2001, HYDROBIOLOGIA, V451, P229, DOI 10.1023/A:1011836326717; Mitchell SO, 2011, VET REC, V169, P609, DOI 10.1136/vr.100045; Purcell JE, 2013, WOODHEAD PUBL FOOD S, P404, DOI 10.1533/9780857097460.2.404; Qian W, 2015, J AGR FOOD CHEM, V63, P2782, DOI 10.1021/jf505898d; Roy P.K., 1990, Journal of Freshwater Biology, V2, P135; Shao GuoEr, 2004, Journal of Shanghai Fisheries University, V13, P75; Sparg SG, 2004, J ETHNOPHARMACOL, V94, P219, DOI 10.1016/j.jep.2004.05.016; SPRAGUE JB, 1971, WATER RES, V5, P245, DOI 10.1016/0043-1354(71)90171-0; TANG YUN-AN, 1961, PROGR FISH CULTURIST, V23, P43, DOI 10.1577/1548-8659(1961)23[43:TUOSTC]2.0.CO;2; TERAZAKI M, 1980, AQUACULTURE, V19, P235, DOI 10.1016/0044-8486(80)90047-2; Uye S, 2011, HYDROBIOLOGIA, V666, P71, DOI 10.1007/s10750-010-0208-9; Zhang X, 2008, SHANDONG FISHERIES, V25, P46; Zhu QF, 1991, J TEA SCI, V1	29	3	3	7	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0182787	10.1371/journal.pone.0182787	http://dx.doi.org/10.1371/journal.pone.0182787			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28777817	Green Published, gold, Green Submitted			2022-12-26	WOS:000406944300056
J	Tiller, KE; Li, LJ; Kumar, S; Julian, MC; Garde, S; Tessier, PM				Tiller, Kathryn E.; Li, Lijuan; Kumar, Sandeep; Julian, Mark C.; Garde, Shekhar; Tessier, Peter M.			Arginine mutations in antibody complementarity-determining regions display context-dependent affinity/specificity trade-offs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MONOCLONAL-ANTIBODIES; HYDROPHOBIC INTERACTIONS; AFFINITY MATURATION; MOLECULAR-DYNAMICS; COMPUTATIONAL DESIGN; PEPTIDE INHIBITORS; MEMBRANE-PROTEINS; VARIABLE DOMAINS; FORCE-FIELD; AMINO-ACIDS	Antibodies commonly accumulate charged mutations in their complementarity-determining regions (CDRs) during affinity maturation to enhance electrostatic interactions. However, charged mutations can mediate non-specific interactions, and it is unclear to what extent CDRs can accumulate charged residues to increase antibody affinity without compromising specificity. This is especially concerning for positively charged CDR mutations that are linked to antibody polyspecificity. To better understand antibody affinity/specificity trade-offs, we have selected single-chain antibody fragments specific for the negatively charged and hydrophobic Alzheimer's amyloid beta peptide using weak and stringent selections for antibody specificity. Antibody variants isolated using weak selections for specificity were enriched in arginine CDR mutations and displayed low specificity. Alanine-scanning mutagenesis revealed that the affinities of these antibodies were strongly dependent on their arginine mutations. Antibody variants isolated using stringent selections for specificity were also enriched in arginine CDR mutations, but these antibodies possessed significant improvements in specificity. Importantly, the affinities of the most specific antibodies were much less dependent on their arginine mutations, suggesting that over-reliance on arginine for affinity leads to reduced specificity. Structural modeling and molecular simulations reveal unique hydrophobic environments near the arginine CDR mutations. The more specific antibodies contained arginine mutations in the most hydrophobic portions of the CDRs, whereas the less specific antibodies contained arginine mutations in more hydrophilic regions. These findings demonstrate that arginine mutations in antibody CDRs display context-dependent impacts on specificity and that affinity/specificity trade-offs are governed by the relative contribution of arginine CDR residues to the overall antibody affinity.	[Tiller, Kathryn E.; Li, Lijuan; Julian, Mark C.; Garde, Shekhar; Tessier, Peter M.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Isermann Dept Chem & Biol Engn, Troy, NY 12180 USA; [Kumar, Sandeep] Pfizer Inc, Pharmaceut Res & Dev, Biotherapeut Pharmaceut Sci, Chesterfield, MO 63017 USA	Rensselaer Polytechnic Institute; Pfizer	Tessier, PM (corresponding author), Univ Michigan, Dept Chem Engn & Pharmaceut Sci, Ann Arbor, MI 48109 USA.; Tessier, PM (corresponding author), Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA.	ptessier@umich.edu	Tessier, Peter/GPP-3396-2022; Li, Lijuan/L-6073-2018	Li, Lijuan/0000-0002-9490-6844	National Institutes of Health [R01GM104130]; National Science Foundation [CBET 1159943, 1605266]; Richard Baruch M.D. Chair; MedImmune; Eli Lilly; Bristol-Myers Squibb; Janssen; Merck; Genentech; Amgen; Pfizer; Adimab; Abbvie; Roche; Boehringer Ingelheim; Bayer; Abbott; DuPont; Schrodinger; Novo Nordisk; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104130] Funding Source: NIH RePORTER; Directorate For Engineering [1813963] Funding Source: National Science Foundation; Div Of Chem, Bioeng, Env, & Transp Sys [1605266] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Richard Baruch M.D. Chair; MedImmune(AstraZenecaMedimmune); Eli Lilly(Eli Lilly); Bristol-Myers Squibb(Bristol-Myers Squibb); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); Genentech(Roche HoldingGenentech); Amgen(Amgen); Pfizer(Pfizer); Adimab; Abbvie(AbbVie); Roche(Roche Holding); Boehringer Ingelheim(Boehringer Ingelheim); Bayer(Bayer AG); Abbott(Abbott Laboratories); DuPont; Schrodinger(Austrian Science Fund (FWF)); Novo Nordisk(Novo Nordisk); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by National Institutes of Health Grant R01GM104130 (to P. M. T.), National Science Foundation Grants CBET 1159943 and 1605266 (to P. M. T.), Graduate Research Fellowships (to K. E. T. and M. C. J.), and the Richard Baruch M.D. Chair (to P. M. T.). P. M. T. has received consulting fees and/or honorariums for presentations of this and/or related research findings at MedImmune, Eli Lilly, Bristol-Myers Squibb, Janssen, Merck, Genentech, Amgen, Pfizer, Adimab, Abbvie, Roche, Boehringer Ingelheim, Bayer, Abbott, DuPont, Schrodinger, and Novo Nordisk. S. K. is an employee of Pfizer, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ackerman M, 2009, BIOTECHNOL PROGR, V25, P774, DOI 10.1002/btpr.174; Allen M. P., 1989, COMPUTER SIMULATION, DOI DOI 10.1093/OSO/9780198803195.001.0001; [Anonymous], 2017, MOL OP ENV MOE 2013; BARBAS CF, 1993, P NATL ACAD SCI USA, V90, P10003, DOI 10.1073/pnas.90.21.10003; Barthelemy PA, 2008, J BIOL CHEM, V283, P3639, DOI 10.1074/jbc.M708536200; Birtalan S, 2008, J MOL BIOL, V377, P1518, DOI 10.1016/j.jmb.2008.01.093; Birtalan S, 2010, MOL BIOSYST, V6, P1186, DOI 10.1039/b927393j; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Bond CJ, 2003, J MOL BIOL, V332, P643, DOI 10.1016/S0022-2836(03)00967-7; Bradbury ARM, 2011, NAT BIOTECHNOL, V29, P245, DOI 10.1038/nbt.1791; Brockmann EC, 2005, J IMMUNOL METHODS, V296, P159, DOI 10.1016/j.jim.2004.11.008; BRUGGEMANN M, 1986, EMBO J, V5, P1561, DOI 10.1002/j.1460-2075.1986.tb04397.x; Burkovitz A, 2014, FEBS J, V281, P306, DOI 10.1111/febs.12597; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; CHANDLER D, 1983, SCIENCE, V220, P787, DOI 10.1126/science.220.4599.787; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Cho YK, 2010, PROTEIN ENG DES SEL, V23, P567, DOI 10.1093/protein/gzq029; Clark LA, 2006, PROTEIN SCI, V15, P949, DOI 10.1110/ps.052030506; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Das U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001176; DeKosky BJ, 2016, P NATL ACAD SCI USA, V113, pE2636, DOI 10.1073/pnas.1525510113; EIGENBROT C, 1993, J MOL BIOL, V229, P969, DOI 10.1006/jmbi.1993.1099; Famm K, 2008, J MOL BIOL, V376, P926, DOI 10.1016/j.jmb.2007.10.075; Foit L, 2009, MOL CELL, V36, P861, DOI 10.1016/j.molcel.2009.11.022; Garde S, 2015, NATURE, V517, P277, DOI 10.1038/517277a; Giles I, 2005, ARTHRITIS RES THER, V7, pR47, DOI 10.1186/ar1449; Godawat R, 2009, P NATL ACAD SCI USA, V106, P15119, DOI 10.1073/pnas.0902778106; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Hackel BJ, 2008, J MOL BIOL, V381, P1238, DOI 10.1016/j.jmb.2008.06.051; Haley J, 2004, MOL IMMUNOL, V40, P745, DOI 10.1016/j.molimm.2003.10.018; Haupt C, 2011, J MOL BIOL, V405, P341, DOI 10.1016/j.jmb.2010.10.059; Hennecke F, 1998, PROTEIN ENG, V11, P405, DOI 10.1093/protein/11.5.405; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Houlihan G, 2015, PROTEIN ENG DES SEL, V28, P269, DOI 10.1093/protein/gzv029; Huang DM, 2002, J PHYS CHEM B, V106, P2047, DOI 10.1021/jp013289v; Jespers L, 2004, NAT BIOTECHNOL, V22, P1161, DOI 10.1038/nbt1000; Jespers L, 2004, J MOL BIOL, V337, P893, DOI 10.1016/j.jmb.2004.02.013; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Julian MC, 2017, SCI REP-UK, V7, DOI 10.1038/srep45259; Julian MC, 2015, PROTEIN ENG DES SEL, V28, P339, DOI 10.1093/protein/gzv050; Jung S, 1999, J MOL BIOL, V294, P163, DOI 10.1006/jmbi.1999.3196; Karanicolas J, 2011, MOL CELL, V42, P250, DOI 10.1016/j.molcel.2011.03.010; Kawasaki T, 2012, BIOSCI BIOTECH BIOCH, V76, P762, DOI 10.1271/bbb.110879; Kawasaki T, 2011, BIOSCI BIOTECH BIOCH, V75, P1496, DOI 10.1271/bbb.110198; Kawasaki T, 2010, BIOSCI BIOTECH BIOCH, V74, P2214, DOI 10.1271/bbb.100388; Kim DY, 2014, MABS-AUSTIN, V6, P219, DOI 10.4161/mabs.26844; Kiyoshi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087099; Kuroda D, 2012, PROTEIN ENG DES SEL, V25, P507, DOI 10.1093/protein/gzs024; Lambrianides A, 2007, ARTHRITIS RHEUM-US, V56, P2392, DOI 10.1002/art.22743; Lee CC, 2016, J BIOL CHEM, V291, P2858, DOI 10.1074/jbc.M115.682336; Lipovsek D, 2007, CHEM BIOL, V14, P1176, DOI 10.1016/j.chembiol.2007.09.008; Lippow SM, 2007, NAT BIOTECHNOL, V25, P1171, DOI 10.1038/nbt1336; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Lum K, 1999, J PHYS CHEM B, V103, P4570, DOI 10.1021/jp984327m; Ma CD, 2015, NATURE, V517, P347, DOI 10.1038/nature14018; Marvin JS, 2003, BIOCHEMISTRY-US, V42, P7077, DOI 10.1021/bi026947q; Monnet C, 2002, J MOL BIOL, V315, P699, DOI 10.1006/jmbi.2001.5284; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Orr BA, 2003, BIOTECHNOL PROGR, V19, P631, DOI 10.1021/bp0200797; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Patel AJ, 2014, J PHYS CHEM B, V118, P1564, DOI 10.1021/jp4081977; Patel AJ, 2010, J PHYS CHEM B, V114, P1632, DOI 10.1021/jp909048f; Patel AG, 2011, P NATL ACAD SCI USA, V108, P3406, DOI 10.1073/pnas.1013715108; Perchiacca JM, 2012, P NATL ACAD SCI USA, V109, P84, DOI 10.1073/pnas.1111232108; Short MK, 2002, J BIOL CHEM, V277, P16365, DOI 10.1074/jbc.M110444200; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Sormanni P, 2015, J MOL BIOL, V427, P478, DOI 10.1016/j.jmb.2014.09.026; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sun SB, 2013, J AM CHEM SOC, V135, P9980, DOI 10.1021/ja402927u; Tharakaraman K, 2013, P NATL ACAD SCI USA, V110, pE1555, DOI 10.1073/pnas.1303645110; Tillotson BJ, 2013, METHODS, V60, P27, DOI 10.1016/j.ymeth.2012.03.010; Tillotson BJ, 2013, PROTEIN ENG DES SEL, V26, P101, DOI 10.1093/protein/gzs077; Varilly P, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3532939; VILLAR HO, 1994, FEBS LETT, V349, P125, DOI 10.1016/0014-5793(94)00648-2; Wang F, 2013, P NATL ACAD SCI USA, V110, P4261, DOI 10.1073/pnas.1301810110; Wang XL, 2009, MABS-AUSTIN, V1, P254, DOI 10.4161/mabs.1.3.8035; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Willard AP, 2010, J PHYS CHEM B, V114, P1954, DOI 10.1021/jp909219k; Xu YD, 2013, PROTEIN ENG DES SEL, V26, P663, DOI 10.1093/protein/gzt047; Zemlin M, 2003, J MOL BIOL, V334, P733, DOI 10.1016/j.jmb.2003.10.007	88	35	36	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16638	16652		10.1074/jbc.M117.783837	http://dx.doi.org/10.1074/jbc.M117.783837			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28778924	Green Published, hybrid			2022-12-26	WOS:000412414800024
J	Higashiyama, T; Iwasa, M; Ohji, M				Higashiyama, Tomoaki; Iwasa, Maki; Ohji, Masahito			Changes in the anterior segment after cycloplegia with a biometer using swept-source optical coherence tomography	PLOS ONE			English	Article							INTERFEROMETRY; CYCLOPENTOLATE; REPEATABILITY; ATROPINE; REFRACTION; AGREEMENT; CHILDREN	The aim of this study was to investigate changes in the anterior segment of the eye after cycloplegia. A biometer combined with swept-source optical coherence tomography (SSOCT) was used for measurements. Patients with strabismus or amblyopia who underwent cycloplegia were included. The axial length, central corneal thickness, anterior chamber depth, and lens thickness were measured with the biometer-SSOCT system before and after cycloplegia. Altogether, 10 eyes of 10 patients (mean age 7.20 +/- 3.08 years, range 4-14 years) were evaluated. The mean measurements before cycloplegia were 22.75 +/- 0.96 mm axial length, 516 +/- 33 mu m central corneal thickness, 3.40 +/- 0.21 mm anterior chamber depth, and 3.77 +/- 0.26 mm lens thickness. The corresponding values after cycloplegia were 22.75 +/- 0.95 mm, 519 +/- 34 mu m, 3.68 +/- 0.16 mm, and 3.42 +/- 0.20 mm, respectively. The mean lens thickness had significantly decreased (P < 0.001) after cycloplegia, and the mean anterior chamber depth had significantly increased (P < 0.001). The means of the axial length (P = 0.66) and central corneal thickness (P = 0.17) had not changed significantly. The change in lens thickness was significantly correlated with the change in anterior chamber depth (r = -0.73, P = 0.02). The new biometer-SSOCT combination proved useful for accurately detecting changes in the anterior segment of the eye after cycloplegia in pediatric patients. The biometer's measurements indicated increased anterior chamber depth and decreased lens thickness after cycloplegia. The anterior chamber depth increased relative to the decrease in lens thickness.	[Higashiyama, Tomoaki; Iwasa, Maki; Ohji, Masahito] Shiga Univ Med Sci, Dept Ophthalmol, Otsu, Shiga, Japan	Shiga University of Medical Science	Higashiyama, T (corresponding author), Shiga Univ Med Sci, Dept Ophthalmol, Otsu, Shiga, Japan.	higashi@belle.shiga-med.ac.jp						Celebi S, 1999, ACTA OPHTHALMOL SCAN, V77, P426, DOI 10.1034/j.1600-0420.1999.770414.x; Gao L, 2002, JPN J OPHTHALMOL, V46, P293, DOI 10.1016/S0021-5155(02)00479-3; Gao RR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02463-z; Goldstein JH, 1996, OPHTHALMIC SURG LAS, V27, P1030; He WW, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/8656301; Hoffer KJ, 2016, J CATARACT REFR SURG, V42, P1165, DOI 10.1016/j.jcrs.2016.07.013; Huang JH, 2017, BRIT J OPHTHALMOL, V101, P493, DOI 10.1136/bjophthalmol-2016-308352; Huang WB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121740; Kawamoto K, 1997, OPHTHALMOLOGICA, V211, P57, DOI 10.1159/000310758; Kunert KS, 2016, J CATARACT REFR SURG, V42, P76, DOI 10.1016/j.jcrs.2015.07.039; Kurian M, 2016, J CATARACT REFR SURG, V42, P577, DOI 10.1016/j.jcrs.2016.01.038; Lin Z, 2017, OPHTHALMIC PHYSL OPT; Mcalinden C, 2017, AM J OPHTHALMOL, V173, P64, DOI 10.1016/j.ajo.2016.09.019; ROSENBAUM AL, 1981, OPHTHALMOLOGY, V88, P1031; Shammas HJ, 2016, J CATARACT REFR SURG, V42, P50, DOI 10.1016/j.jcrs.2015.07.042; Shimizu Y, 2016, J AAPOS, V21, P57, DOI 10.1016/j.jaapos.2016.10.005; Srivannaboon S, 2015, J CATARACT REFR SURG, V41, P2224, DOI 10.1016/j.jcrs.2015.03.019; STOLOVITCH C, 1995, AM J OPHTHALMOL, V119, P637, DOI 10.1016/S0002-9394(14)70222-3; Telenkov SA, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2337290; Yang JY, 2017, J CATARACT REFR SURG, V43, P328, DOI 10.1016/j.jcrs.2016.12.023; Zhu D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167628	21	10	10	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2017	12	8							e0183378	10.1371/journal.pone.0183378	http://dx.doi.org/10.1371/journal.pone.0183378			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD5CP	28806400	Green Published, Green Submitted, gold			2022-12-26	WOS:000407548800070
J	Mao, B; Yin, H; Wang, Y; Zhao, TH; Tian, RR; Wang, W; Ye, JS				Mao, Bing; Yin, Hong; Wang, Yan; Zhao, Tian-Hong; Tian, Rong-Rong; Wang, Wei; Ye, Jia-Shu			Combined effects of O-3 and UV radiation on secondary metabolites and endogenous hormones of soybean leaves	PLOS ONE			English	Article							SUPPLEMENTAL ULTRAVIOLET-B; ABSCISIC-ACID; TROPOSPHERIC OZONE; SURFACE OZONE; ELEVATED CO2; SHOOT GROWTH; GENE-EXPRESSION; L. CULTIVARS; RURAL SITE; YIELD	Enhanced ultraviolet radiation (UV) and elevated tropospheric ozone (O-3) may individually cause reductions in the growth and productivity of important agricultural crops. However, research regarding their combined effects on important agricultural crops is still scarce, especially on changes in secondary metabolites and endogenous hormones, which are important protective substances and signal components that control plant responses to environment stresses. In this study, using an experimental setup of open top chambers, we monitored the responses of seed yield per plant, leaf secondary metabolites and leaf endogenous hormones under the stress of elevated O-3 and enhanced UV radiation individually, as well as their combined stress. The results indicated that elevated O-3 (110 +/- 10 nmol mol(-1) for 8 hours per day) and enhanced UV radiation (1.73 kJ h(-1) m(-2)) significantly decreased seed yield per plant. Concentrations of rutin, queretin and total flavonoids were significantly increased under the elevated O-3 treatment or the enhanced UV radiation treatment or the combination treatment at flowering and podding stages, and concentrations of rutin, queretin and total flavonoids showed significant correlations with seed yield per plant. Concentrations of ABA and IAA decreased under the three treatments. There was a significant positive correlation between the ABA concentration and seed yield and a negative correlation between the IAA concentration and seed yield. We concluded that the combined stress of elevated O-3 and UV radiation significantly decreased seed yield per plant. Yield reduction was associated with changes in the concentrations of flavonoids, ABA and IAA in soybean leaves. The effects of the combined O-3 and UV stress were always greater than those of the individual stresses alone.	[Mao, Bing] Shenyang Agr Univ, Coll Agron, Postdoctoral Res Stn Crop Sci, Shenyang, Liaoning, Peoples R China; [Mao, Bing; Yin, Hong; Wang, Yan; Zhao, Tian-Hong; Tian, Rong-Rong; Wang, Wei] Shenyang Agr Univ, Coll Agron, Shenyang, Liaoning, Peoples R China; [Ye, Jia-Shu] Chinese Acad Sci, Inst Appl Ecol, Natl Field Observat & Res Stn Shenyang Agroecosys, Shenyang, Liaoning, Peoples R China	Shenyang Agricultural University; Shenyang Agricultural University; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS	Zhao, TH (corresponding author), Shenyang Agr Univ, Coll Agron, Shenyang, Liaoning, Peoples R China.	zth1999@163.com			National Natural Science Foundation of China [30970448, 31570404]; China Postdoctoral Science Foundation [2016M601342]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by National Natural Science Foundation of China (30970448; 31570404) and China Postdoctoral Science Foundation (2016M601342).	Albacete A, 2008, J EXP BOT, V59, P4119, DOI 10.1093/jxb/ern251; Ambasht NK, 2003, BIOL PLANTARUM, V47, P625, DOI 10.1023/B:BIOP.0000041076.95209.c3; Andersen CP, 2003, NEW PHYTOL, V157, P213, DOI 10.1046/j.1469-8137.2003.00674.x; Ballare CL, 2011, PHOTOCH PHOTOBIO SCI, V10, P226, DOI 10.1039/c0pp90035d; Barnes PW, 2015, PLANT PHYSIOL BIOCH, V93, P94, DOI 10.1016/j.plaphy.2014.11.015; Bartel Bonnie, 1997, Annu Rev Plant Physiol Plant Mol Biol, V48, P51, DOI 10.1146/annurev.arplant.48.1.51; Bassman JH, 2004, PHOTOCHEM PHOTOBIOL, V79, P382, DOI 10.1562/SI-03-24.1; Bianco J, 1999, TREE PHYSIOL, V19, P787; Bilger W, 2001, J EXP BOT, V52, P2007, DOI 10.1093/jexbot/52.363.2007; Binder BYK, 2009, BIOTECHNOL PROGR, V25, P861, DOI 10.1002/btpr.97; Biswas DK, 2008, GLOBAL CHANGE BIOL, V14, P46, DOI 10.1111/j.1365-2486.2007.01477.x; Bornman JF, 2015, PHOTOCH PHOTOBIO SCI, V14, P88, DOI 10.1039/c4pp90034k; Calatayud A, 2003, PLANT PHYSIOL BIOCH, V41, P839, DOI 10.1016/S0981-9428(03)00123-2; CHANDLER PM, 1994, ANNU REV PLANT PHYS, V45, P113, DOI 10.1146/annurev.pp.45.060194.000553; CHEN ZY, 1994, J AM OIL CHEM SOC, V71, P629, DOI 10.1007/BF02540591; Cho K, 2011, REV ENVIRON CONTAM T, V212, P61, DOI 10.1007/978-1-4419-8453-1_3; El Morchid EM, 2014, BIOCHEM SYST ECOL, V53, P81, DOI 10.1016/j.bse.2013.12.032; FEDER WA, 1990, ENVIRON EXP BOT, V30, P451, DOI 10.1016/0098-8472(90)90024-X; Feng ZZ, 2009, ATMOS ENVIRON, V43, P1510, DOI 10.1016/j.atmosenv.2008.11.033; FLETCHER RA, 1972, CAN J BOTANY, V50, P2389, DOI 10.1139/b72-305; Geissman T. A., 1955, MOD METHOD PLANT, P450; Gimeno BS, 1999, NEW PHYTOL, V144, P245, DOI 10.1046/j.1469-8137.1999.00509.x; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Herman JR, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012219; Hong JH, 2013, PLANT CELL REP, V32, P971, DOI 10.1007/s00299-013-1439-9; HOUGH AM, 1990, NATURE, V344, P645, DOI 10.1038/344645a0; Huang X, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00063; Kakani VG, 2003, AGR FOREST METEOROL, V120, P191, DOI 10.1016/j.agrformet.2003.08.015; Kolb CA, 2001, PLANT PHYSIOL, V127, P863, DOI 10.1104/pp.010373; Kuhlmann F, 2011, PROG BOT, V72, P305, DOI 10.1007/978-3-642-13145-5_12; Lee SC, 2009, PLANTA, V229, P383, DOI 10.1007/s00425-008-0837-7; Li XM, 2007, PLANT GROWTH REGUL, V53, P25, DOI 10.1007/s10725-007-9200-4; Li XM, 2011, ACTA PHYSIOL PLANT, V33, P129, DOI 10.1007/s11738-010-0528-4; Liu B, 2013, FIELD CROP RES, V154, P158, DOI 10.1016/j.fcr.2013.08.006; Liu FL, 2003, FUNCT PLANT BIOL, V30, P271, DOI 10.1071/FP02185; Mazza CA, 2013, PHYSIOL PLANTARUM, V147, P307, DOI 10.1111/j.1399-3054.2012.01661.x; MEEHL G. A., CLIMATE CHANGE 2007; MILLER JE, 1994, J ENVIRON QUAL, V23, P83, DOI 10.2134/jeq1994.00472425002300010012x; MONTEDORO G, 1992, J AGR FOOD CHEM, V40, P1571, DOI 10.1021/jf00021a019; Morales LO, 2010, TREE PHYSIOL, V30, P923, DOI 10.1093/treephys/tpq051; ORMROD DP, 1995, PHYSIOL PLANTARUM, V93, P602, DOI 10.1111/j.1399-3054.1995.tb05106.x; Pasqualini S, 2002, PLANT PHYSIOL BIOCH, V40, P599, DOI 10.1016/S0981-9428(02)01426-2; Pellegrini E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135056; Piikki K, 2004, AGR ECOSYST ENVIRON, V104, P483, DOI 10.1016/j.agee.2004.01.019; Rai R, 2008, SCI TOTAL ENVIRON, V407, P679, DOI 10.1016/j.scitotenv.2008.09.010; Rao MV, 1996, PLANT PHYSIOL, V110, P125, DOI 10.1104/pp.110.1.125; Reifenrath K, 2007, PHYTOCHEMISTRY, V68, P875, DOI 10.1016/j.phytochem.2006.12.008; Rinnan R, 2013, ENVIRON EXP BOT, V90, P43, DOI 10.1016/j.envexpbot.2012.10.009; Sharp RE, 2002, PLANT CELL ENVIRON, V25, P211, DOI 10.1046/j.1365-3040.2002.00798.x; Siipola SM, 2015, PLANT CELL ENVIRON, V38, P941, DOI 10.1111/pce.12403; Singh E, 2010, AGR ECOSYST ENVIRON, V135, P168, DOI 10.1016/j.agee.2009.09.004; Teng NJ, 2006, NEW PHYTOL, V172, P92, DOI 10.1111/j.1469-8137.2006.01818.x; Treutter D, 2005, PLANT BIOLOGY, V7, P581, DOI 10.1055/s-2005-873009; Tripathi R, 2011, PLANT BIOLOGY, V13, P93, DOI 10.1111/j.1438-8677.2010.00323.x; Tripathi R, 2013, J SCI FOOD AGR, V93, P1016, DOI 10.1002/jsfa.5838; Tsurunaga Y, 2013, FOOD CHEM, V141, P552, DOI 10.1016/j.foodchem.2013.03.032; Van Dingenen R, 2009, ATMOS ENVIRON, V43, P604, DOI 10.1016/j.atmosenv.2008.10.033; Vingarzan R, 2004, ATMOS ENVIRON, V38, P3431, DOI 10.1016/j.atmosenv.2004.03.030; Wang L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147613; Wang XP, 2004, ATMOS ENVIRON, V38, P4383, DOI 10.1016/j.atmosenv.2004.03.067; Waterman PG, 1994, BLACKWELL SCI PUBLIC, V38, P1064, DOI DOI 10.1007/BF03028669; Wilson KE, 2001, PHOTOCHEM PHOTOBIOL, V73, P678, DOI 10.1562/0031-8655(2001)073&lt;0678:EOUAEO&gt;2.0.CO;2; Yang JC, 2001, PLANT PHYSIOL, V127, P315, DOI 10.1104/pp.127.1.315; Yannarelli GG, 2006, PLANTA, V224, P1154, DOI 10.1007/s00425-006-0297-x; Zavala JA, 2015, PLANT CELL ENVIRON, V38, P920, DOI 10.1111/pce.12368; Zhao JL, 2014, PHARMACOGN MAG, V10, P234, DOI 10.4103/0973-1296.137362; Zhao TH, 2010, B ENVIRON CONTAM TOX, V85, P59, DOI 10.1007/s00128-010-0039-4; Zou XL, 2007, PLANT SCI, V172, P997, DOI 10.1016/j.plantsci.2007.02.003	68	15	16	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2017	12	8							e0183147	10.1371/journal.pone.0183147	http://dx.doi.org/10.1371/journal.pone.0183147			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD5CP	28806739	Green Published, gold, Green Submitted			2022-12-26	WOS:000407548800056
J	Lopez, A; Ortiz, F; Doerrier, C; Venegas, C; Fernandez-Ortiz, M; Aranda-Martinez, P; Diaz-Casado, ME; Fernandez-Gil, B; Barriocanal-Casado, E; Escames, G; Lopez, LC; Acuna-Castroviejo, D				Lopez, Ana; Ortiz, Francisco; Doerrier, Carolina; Venegas, Carmen; Fernandez-Ortiz, Marisol; Aranda-Martinez, Paula; Diaz-Casado, Maria E.; Fernandez-Gil, Beatriz; Barriocanal-Casado, Eliana; Escames, Germaine; Lopez, Luis C.; Acuna-Castroviejo, Dario			Mitochondrial impairment and melatonin protection in parkinsonian mice do not depend of inducible or neuronal nitric oxide synthases	PLOS ONE			English	Article							REACTIVE OXYGEN; COMPLEX-I; OXIDATIVE STRESS; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE-INDUCED PARKINSONISM; METABOLIC PATHWAY; BRAIN METABOLITE; SKELETAL-MUSCLE; MPTP TOXICITY; INHIBITION; DAMAGE	MPTP-mouse model constitutes a well-known model of neuroinflammation and mitochondrial failure occurring in Parkinson's disease (PD). Although it has been extensively reported that nitric oxide (NO center dot) plays a key role in the pathogenesis of PD, the relative roles of nitric oxide synthase isoforms iNOS and nNOS in the nigrostriatal pathway remains, however, unclear. Here, the participation of iNOS/nNOS isoforms in the mitochondrial dysfunction was analyzed in iNOS and nNOS deficient mice. Our results showed that MPTP increased iNOS activity in substantia nigra and striatum, whereas it sharply reduced complex I activity and mitochondrial bioenergetics in all strains. In the presence of MPTP, mice lacking iNOS showed similar restricted mitochondrial function than wild type or mice lacking nNOS. These results suggest that iNOS-dependent elevated nitric oxide, a major pathological hallmark of neuroinflammation in PD, does not contribute to mitochondrial impairment. Therefore, neuroinflammation and mitochondrial dysregulation seem to act in parallel in the MPTP model of PD. Melatonin administration, with well-reported neuroprotective properties, counteracted these effects, preventing from the drastic changes in mitochondrial oxygen consumption, increased NOS activity and prevented reduced locomotor activity induced by MPTP. The protective effects of melatonin on mitochondria are also independent of its anti-inflammatory properties, but both effects are required for an effective anti-parkinsonian activity of the indoleamine as reported in this study.	[Lopez, Ana; Ortiz, Francisco; Venegas, Carmen; Fernandez-Ortiz, Marisol; Aranda-Martinez, Paula; Diaz-Casado, Maria E.; Fernandez-Gil, Beatriz; Barriocanal-Casado, Eliana; Escames, Germaine; Lopez, Luis C.; Acuna-Castroviejo, Dario] Parque Tecnol Ciencias Salud, Ctr Invest Biomed, Inst Biotecnol, Granada, Spain; [Lopez, Ana; Ortiz, Francisco; Venegas, Carmen; Fernandez-Ortiz, Marisol; Aranda-Martinez, Paula; Diaz-Casado, Maria E.; Fernandez-Gil, Beatriz; Barriocanal-Casado, Eliana; Escames, Germaine; Lopez, Luis C.; Acuna-Castroviejo, Dario] Univ Granada, Fac Med, Dept Fisiol, Granada, Spain; [Doerrier, Carolina; Escames, Germaine; Lopez, Luis C.; Acuna-Castroviejo, Dario] Complejo Hosp Granada, Ibs Granada, CIBERfes, Granada, Spain; [Acuna-Castroviejo, Dario] Complejo Hosp Granada, UGC Lab Clin, Granada, Spain; [Lopez, Ana] Univ Cambridge, Dept Med Genet, Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge, England; [Doerrier, Carolina] Med Univ Innsbruck, D Swarovski Res Lab, Dept Visceral Transplant & Thorac Surg, Innsbruck, Austria	University of Granada; CIBER - Centro de Investigacion Biomedica en Red; CIBERFES; Instituto de Investigacion Biosanitaria IBS Granada; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Medical University of Innsbruck	Acuna-Castroviejo, D (corresponding author), Parque Tecnol Ciencias Salud, Ctr Invest Biomed, Inst Biotecnol, Granada, Spain.; Acuna-Castroviejo, D (corresponding author), Univ Granada, Fac Med, Dept Fisiol, Granada, Spain.; Acuna-Castroviejo, D (corresponding author), Complejo Hosp Granada, Ibs Granada, CIBERfes, Granada, Spain.; Acuna-Castroviejo, D (corresponding author), Complejo Hosp Granada, UGC Lab Clin, Granada, Spain.	dacuna@ugr.es	Doerrier, Carolina/AAH-3969-2021; Lopez, Luis Carlos/L-5129-2014; Ortiz, Fernández/I-9365-2018; Lopez, Luis Carlos/AAP-9411-2020; Venegas, Carmen/HIK-2268-2022; Fernandez-Gil, Beatriz Irene/C-1723-2019; Ramirez, Ana Lopez/AAJ-4585-2021; Casado, Elena Díaz/AAF-8786-2020; Acuña-Castroviejo, Dario/N-7456-2016; Casado, Eliana Barriocanal/Y-4121-2019; Escames, Germaine/N-7501-2016	Doerrier, Carolina/0000-0002-7969-6762; Lopez, Luis Carlos/0000-0003-3355-0298; Ortiz, Fernández/0000-0002-5334-9009; Lopez, Luis Carlos/0000-0003-3355-0298; Venegas, Carmen/0000-0002-8902-4986; Fernandez-Gil, Beatriz Irene/0000-0003-2347-2687; Ramirez, Ana Lopez/0000-0001-8105-7479; Casado, Elena Díaz/0000-0003-1172-6475; Acuña-Castroviejo, Dario/0000-0002-9680-1560; Casado, Eliana Barriocanal/0000-0001-8828-1182; Escames, Germaine/0000-0003-1256-7656; Aranda Martinez, Paula/0000-0002-1171-010X	Institute de Salud Carlos III (Ministerio de Economia y Competitividad and Fondos Feder, Spain) [RD12/0043/0005, PI08-1664, PI13-00981, CB16-10-00238]; Consejeria de Economia y Conocimiento (Junta de Andalucia, Spain) [P07-CTS-03135, P10-CTS-5784, CTS-101]; Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia, Spain; Ministerio de Economia y Competitividad, Spain	Institute de Salud Carlos III (Ministerio de Economia y Competitividad and Fondos Feder, Spain); Consejeria de Economia y Conocimiento (Junta de Andalucia, Spain)(Junta de Andalucia); Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia, Spain(Junta de Andalucia); Ministerio de Economia y Competitividad, Spain	This study was partially supported from the Institute de Salud Carlos III (Ministerio de Economia y Competitividad and Fondos Feder, Spain, http.//www.isciii.es) grants no. RD12/0043/0005; PI08-1664; PI13-00981; CB16-10-00238, and from the Consejeria de Economia y Conocimiento (Junta de Andalucia, Spain, http:// www.juntadeandalucia.es/organismos/economiayconocimiento/areas/investigacion-desarrello.html) grants no. P07-CTS-03135, P10-CTS-5784, and CTS-101. MED-C is a PhD student supported by the Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia, Spain. LCL is supported by the "Ramon y Cajal" National Program (Ministerio de Economia y Competitividad, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This study was partially supported from the Instituto de Salud Carlos III (Ministerio de Economia y Competitividad and Fondos Feder, Spain) grants no. RD12/0043/0005; PI08-1664; PI13-00981; CB16-10-00238), and from the Consejeria de Economia y Conocimiento (Junta de Andalucia, Spain) grants no. P07-CTS-03135, P10-CTS-5784, and CTS-101. The authors thank to Iryna Rusanova for her technical support. MED-C is a PhD student supported by the Consejeria de Innovacion, Ciencia y Empresa, Junta de Andalucia, Spain, and LCL is supported by the "Ramon y Cajal" National Program (Ministerio de Economia y Competitividad, Spain).	Acuna-Castroviejo D, 2001, J PINEAL RES, V30, P65, DOI 10.1034/j.1600-079X.2001.300201.x; Acuna-Castroviejo D, 2011, BRAIN RES BULL, V85, P133, DOI 10.1016/j.brainresbull.2011.03.008; Antolin I, 1996, FASEB J, V10, P882, DOI 10.1096/fasebj.10.8.8666165; Aulak KS, 2001, P NATL ACAD SCI USA, V98, P12056, DOI 10.1073/pnas.221269198; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Barrientos Antoni, 2009, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1903s63; Bassani TB, 2015, ARQ NEURO-PSIQUIAT, V73, P616, DOI 10.1590/0004-282X20150057; Borah A, 2009, J PINEAL RES, V47, P293, DOI 10.1111/j.1600-079X.2009.00713.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREDT DS, 1989, P NATL ACAD SCI USA, V86, P9030, DOI 10.1073/pnas.86.22.9030; Brown GC, 2002, FREE RADICAL BIO MED, V33, P1440, DOI 10.1016/S0891-5849(02)01112-7; Brown TP, 2006, ENVIRON HEALTH PERSP, V114, P156, DOI 10.1289/ehp.8095; Bueler H, 2009, EXP NEUROL, V218, P235, DOI 10.1016/j.expneurol.2009.03.006; Buneeva O. A., 2011, Biomeditsinskaya Khimiya, V57, P246; BURNS RS, 1991, ACTA NEUROL SCAND, V84, P29, DOI 10.1111/j.1600-0404.1991.tb05017.x; Carretero M, 2009, J PINEAL RES, V47, P192, DOI 10.1111/j.1600-079X.2009.00700.x; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; CLEETER MWJ, 1992, J NEUROCHEM, V58, P786, DOI 10.1111/j.1471-4159.1992.tb09789.x; Crespo E, 1999, FASEB J, V13, P1537, DOI 10.1096/fasebj.13.12.1537; Dehmer T, 2000, J NEUROCHEM, V74, P2213, DOI 10.1046/j.1471-4159.2000.0742213.x; Diaz-Casado ME, 2016, J PINEAL RES, V61, P96, DOI 10.1111/jpi.12332; Dolle C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13548; Drechsel DA, 2008, FREE RADICAL BIO MED, V44, P1873, DOI 10.1016/j.freeradbiomed.2008.02.008; Ebadi M, 2003, ANTIOXID REDOX SIGN, V5, P319, DOI 10.1089/152308603322110896; Escames G, 2004, J NEUROENDOCRINOL, V16, P929, DOI 10.1111/j.1365-2826.2004.01250.x; Escames G, 2006, J PINEAL RES, V40, P71, DOI 10.1111/j.1600-079X.2005.00281.x; Escames G, 2003, FASEB J, V17, P932, DOI 10.1096/fj.02-0692fje; Gao HM, 2003, FASEB J, V17, P1957, DOI 10.1096/fj.03-0203fje; Garcia JA, 2015, FASEB J OFFICIAL PUB; Goralski KB, 2004, TOXICOL APPL PHARM, V196, P381, DOI 10.1016/j.taap.2003.12.022; Greenamyre JT, 2001, IUBMB LIFE, V52, P135, DOI 10.1080/15216540152845939; Halliwell B, 1998, LANCET, V351, P1510, DOI 10.1016/S0140-6736(05)78898-X; Hardeland R, 2008, CELL MOL LIFE SCI, V65, P2001, DOI 10.1007/s00018-008-8001-x; Hardeland R., 2012, Central Nervous System Agents in Medicinal Chemistry, V12, P189; Hibaoui Y, 2009, J PINEAL RES, V47, P238, DOI 10.1111/j.1600-079X.2009.00707.x; Jenner P, 1998, MOVEMENT DISORD, V13, P24; Khaldy H, 2003, NEUROBIOL AGING, V24, P491, DOI 10.1016/S0197-4580(02)00133-1; Khaldy H, 2000, J PINEAL RES, V29, P100, DOI 10.1034/j.1600-079X.2000.290206.x; Leon J, 2000, MOL PHARMACOL, V58, P967, DOI 10.1124/mol.58.5.967; Leon J, 2006, J NEUROCHEM, V98, P2023, DOI 10.1111/j.1471-4159.2006.04029.x; Liberatore GT, 1999, NAT MED, V5, P1403; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Lopez A, 2009, J PINEAL RES, V46, P188, DOI 10.1111/j.1600-079X.2008.00647.x; Lopez LC, 2006, INT J BIOCHEM CELL B, V38, P267, DOI 10.1016/j.biocel.2005.09.008; Lopez-Fabuel I, 2017, NEUROCHEMICAL RES; MARET G, 1990, DRUG METAB REV, V22, P291, DOI 10.3109/03602539009041087; Murray J, 2003, J BIOL CHEM, V278, P37223, DOI 10.1074/jbc.M305694200; Naskar A, 2015, J PINEAL RES, V58, P262, DOI 10.1111/jpi.12212; Niranjan R, 2010, FREE RADICAL RES, V44, P1304, DOI 10.3109/10715762.2010.501080; Noack H, 1999, GLIA, V28, P13, DOI 10.1002/(SICI)1098-1136(199910)28:1<13::AID-GLIA2>3.0.CO;2-L; Ortiz F, 2015, J PINEAL RES, V58, P34, DOI 10.1111/jpi.12191; Ortiz F, 2014, J PINEAL RES, V56, P71, DOI 10.1111/jpi.12099; Patki G, 2011, PHARMACOL BIOCHEM BE, V99, P704, DOI 10.1016/j.pbb.2011.06.026; Patki G, 2009, FRONT AGING NEUROSCI, V1, DOI 10.3389/neuro.24.003.2009; Przedborski S, 2005, ANTIOXID REDOX SIGN, V7, P685, DOI 10.1089/ars.2005.7.685; Przedborski S, 2004, J BIOENERG BIOMEMBR, V36, P375, DOI 10.1023/B:JOBB.0000041771.66775.d5; Pyle A, 2016, NEUROBIOL AGING, V38, DOI 10.1016/j.neurobiolaging.2015.10.033; Reiter RJ, 2001, CELL BIOCHEM BIOPHYS, V34, P237, DOI 10.1385/CBB:34:2:237; Reynolds A, 2007, INT REV NEUROBIOL, V82, P297, DOI 10.1016/S0074-7742(07)82016-2; Rice JC, 1997, RICKWOOD; Semak I, 2005, BIOCHEMISTRY-US, V44, P9300, DOI 10.1021/bi050202d; Shin CY, 2001, BRAIN RES, V922, P267; Shukla V, 2011, ADV PHARMACOL SCI, V2011, DOI 10.1155/2011/572634; Speciale SG, 2002, NEUROTOXICOL TERATOL, V24, P607, DOI 10.1016/S0892-0362(02)00222-2; Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765; Su LY, 2015, AUTOPHAGY, V11, P1745, DOI 10.1080/15548627.2015.1082020; Tan D.X., 2016, INT J MOL SCI, V17; Tan DX, 2000, FREE RADICAL BIO MED, V29, P1177, DOI 10.1016/S0891-5849(00)00435-4; Tapias V, 2009, J NEUROSCI RES, V87, P3002, DOI 10.1002/jnr.22123; Terzioglu M, 2008, FEBS J, V275, P1384, DOI 10.1111/j.1742-4658.2008.06302.x; Tieu K, 2003, IUBMB LIFE, V55, P329, DOI 10.1080/1521654032000114320; Torano JS, 2000, BIOMED CHROMATOGR, V14, P306, DOI 10.1002/1099-0801(200008)14:5<306::AID-BMC986>3.0.CO;2-7; Tretter L, 2004, NEUROCHEM RES, V29, P569, DOI 10.1023/B:NERE.0000014827.94562.4b; Tsang AHK, 2009, BBA-MOL BASIS DIS, V1792, P643, DOI 10.1016/j.bbadis.2008.12.006; Tzoulis C, 2013, BRAIN, V136, P2393, DOI 10.1093/brain/awt103; Venegas C, 2012, J PINEAL RES, V52, P217, DOI 10.1111/j.1600-079X.2011.00931.x; Watanabe Y, 2005, MED SCI MONITOR, V11, pRA17; Zhang L, 2006, PHARMACOL THERAPEUT, V109, P33, DOI 10.1016/j.pharmthera.2005.05.007; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	79	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0183090	10.1371/journal.pone.0183090	http://dx.doi.org/10.1371/journal.pone.0183090			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800639	Green Submitted, Green Published, gold			2022-12-26	WOS:000407431800051
J	Muller, I; Pappritz, K; Savvatis, K; Puhl, K; Dong, F; El-Shafeey, M; Hamdani, N; Hamann, I; Noutsias, M; Infante-Duarte, C; Linke, WA; Van Linthout, S; Tschope, C				Mueller, Irene; Pappritz, Kathleen; Savvatis, Konstantinos; Puhl, Kerstin; Dong, Fengquan; El-Shafeey, Muhammad; Hamdani, Nazha; Hamann, Isabell; Noutsias, Michel; Infante-Duarte, Carmen; Linke, Wolfgang A.; Van Linthout, Sophie; Tschoepe, Carsten			CX3CR1 knockout aggravates Coxsackievirus B3-induced myocarditis	PLOS ONE			English	Article							RECEPTOR CX(3)CR1; OXIDATIVE STRESS; FRACTALKINE; EXPRESSION; MONOCYTES; FIBROSIS; CELLS; CARDIOMYOPATHY; INHIBITION; CHEMOKINES	Studies on inflammatory disorders elucidated the pivotal role of the CX3CL1/CX3CR1 axis with respect to the pathophysiology and diseases progression. Coxsackievirus B3 (CVB3)-induced myocarditis is associated with severe cardiac inflammation, which may progress to heart failure. We therefore investigated the influence of CX3CR1 ablation in the model of acute myocarditis, which was induced by inoculation with 5x10(5) plaque forming units of CVB3 (Nancy strain) in either CX3CR1(-/-) or C57BL6/j (WT) mice. Seven days after infection, myocardial inflammation, remodeling, and titin expression and phosphorylation were examined by immunohistochemistry, real-time PCR and Pro-Q diamond stain. Cardiac function was assessed by tip catheter. Compared to WT CVB3 mice, CX3CR1(-/-) CVB3 mice exhibited enhanced left ventricular expression of inflammatory cytokines and chemokines, which was associated with an increase of immune cell infiltration/presence. This shift towards a pro-inflammatory immune response further resulted in increased cardiac fibrosis and cardiomyocyte apoptosis, which was reflected by an impaired cardiac function in CX3CR1(-/-) CVB3 compared to WT CVB3 mice. These findings demonstrate a cardioprotective role of CX3CR1 in CVB3-infected mice and indicate the relevance of the CX3CL1/CX3CR1 system in CVB3-induced myocarditis.	[Mueller, Irene; Pappritz, Kathleen; Savvatis, Konstantinos; Puhl, Kerstin; Dong, Fengquan; El-Shafeey, Muhammad; Hamann, Isabell; Infante-Duarte, Carmen; Van Linthout, Sophie; Tschoepe, Carsten] Charite Univ Med Berlin, Humboldt Univ Berlin, Freie Univ Berlin, Berlin, Germany; [Mueller, Irene; Pappritz, Kathleen; Puhl, Kerstin; Dong, Fengquan; El-Shafeey, Muhammad; Van Linthout, Sophie; Tschoepe, Carsten] Campus Virchow Klinikum, Berlin Inst Hlth, Dept Internal Med & Cardiol, Berlin, Germany; [Mueller, Irene; Pappritz, Kathleen; Van Linthout, Sophie; Tschoepe, Carsten] DZHK German Ctr Cardiovasc Res, Berlin, Germany; [Mueller, Irene; Pappritz, Kathleen; Puhl, Kerstin; Dong, Fengquan; El-Shafeey, Muhammad; Van Linthout, Sophie; Tschoepe, Carsten] Campus Virchow Klinikum, Berlin Inst Hlth, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany; [Savvatis, Konstantinos] Barts Hlth NHS Trust, Barts Heart Ctr, Inherited Cardiovasc Dis Unit, London, England; [Savvatis, Konstantinos] Queen Mary Univ London, William Harvey Res Inst, London, England; [Hamdani, Nazha; Linke, Wolfgang A.] Ruhr Univ Bochum, Dept Cardiovasc Physiol, Bochum, Germany; [Hamann, Isabell; Infante-Duarte, Carmen] Campus Virchow Klinikum, Berlin Inst Hlth, Inst Med Immunol, Berlin, Germany; [Noutsias, Michel] Univ Hosp Halle, Dept Internal Med 3, Div Cardiol Angiol & Intens Med Care, Halle, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Centre for Cardiovascular Research; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Barts Health NHS Trust; University of London; Queen Mary University London; Ruhr University Bochum; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Martin Luther University Halle Wittenberg	Tschope, C (corresponding author), Charite Univ Med Berlin, Humboldt Univ Berlin, Freie Univ Berlin, Berlin, Germany.; Tschope, C (corresponding author), Campus Virchow Klinikum, Berlin Inst Hlth, Dept Internal Med & Cardiol, Berlin, Germany.; Tschope, C (corresponding author), DZHK German Ctr Cardiovasc Res, Berlin, Germany.; Tschope, C (corresponding author), Campus Virchow Klinikum, Berlin Inst Hlth, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany.	carsten.tschoepe@charite.de	Noutsias, Michel/AAM-4006-2021; Savvatis, Konstantinos/AAJ-9012-2020	Tschope, Carsten/0000-0001-5243-8985; Infante Duarte, Carmen/0000-0003-3005-351X; El-Shafeey, Muhammad/0000-0002-8345-0052; Linke, Wolfgang/0000-0003-0801-3773; Noutsias, Michel/0000-0002-9066-5262	DZHK - German Center for Cardiovascular Research	DZHK - German Center for Cardiovascular Research	This work was supported by the DZHK - German Center for Cardiovascular Research.	Altin SE, 2011, CARDIOVASC RES, V92, P361, DOI 10.1093/cvr/cvr272; Aoyama T, 2010, HEPATOLOGY, V52, P1390, DOI 10.1002/hep.23795; Cockwell P, 2002, J PATHOL, V196, P85, DOI 10.1002/path.1010; Damas JK, 2000, CARDIOVASC RES, V47, P778, DOI 10.1016/S0008-6363(00)00142-5; Engel DR, 2015, J IMMUNOL, V194, P1628, DOI 10.4049/jimmunol.1402149; Escher F, 2011, HEART, V97, P733, DOI 10.1136/hrt.2010.205716; Feng X, 2015, ONCOTARGET, V6, P15077, DOI 10.18632/oncotarget.3730; Frangogiannis NG, 2004, CIRCULATION, V110, P1341, DOI 10.1161/01.CIR.0000141560.18364.63; Green SR, 2006, J IMMUNOL, V176, P7412, DOI 10.4049/jimmunol.176.12.7412; GROTENDORST GR, 1989, J CELL PHYSIOL, V140, P396, DOI 10.1002/jcp.1041400226; Gu XS, 2015, EXP PHYSIOL, V100, P805, DOI 10.1113/EP085104; Gui J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046515; Hamdani N, 2013, CIRC RES, V112, P664, DOI 10.1161/CIRCRESAHA.111.300105; Henninger DD, 1997, J IMMUNOL, V158, P1825; Hertwig L, 2016, EUR J IMMUNOL, V46, P1984, DOI 10.1002/eji.201546194; Heymans S, 2016, J AM COLL CARDIOL, V68, P2348, DOI 10.1016/j.jacc.2016.09.937; Heymes C, 2003, J AM COLL CARDIOL, V41, P2164, DOI 10.1016/S0735-1097(03)00471-6; Horwitz MS, 2000, NAT MED, V6, P693, DOI 10.1038/76277; Husberg C, 2008, J MOL CELL CARDIOL, V45, P261, DOI 10.1016/j.yjmcc.2008.05.009; Karlmark KR, 2010, HEPATOLOGY, V52, P1769, DOI 10.1002/hep.23894; Kimura A, 2016, J HUM GENET, V61, P41, DOI 10.1038/jhg.2015.83; Kishimoto C, 2000, J MOL CELL CARDIOL, V32, P631, DOI 10.1006/jmcc.2000.1102; Kojima A, 2015, J PHARMACOL SCI, V127, P370, DOI 10.1016/j.jphs.2015.02.007; Lee JongUn, 2016, Chonnam Med J, V52, P81, DOI 10.4068/cmj.2016.52.2.81; Leri A, 1998, CIRCULATION, V97, P194, DOI 10.1161/01.CIR.97.2.194; Leri A, 1998, J CLIN INVEST, V101, P1326, DOI 10.1172/JCI316; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Li YC, 2010, EUR J PHARMACOL, V640, P112, DOI 10.1016/j.ejphar.2010.04.037; Linke WA, 2014, CIRC RES, V114, P1052, DOI 10.1161/CIRCRESAHA.114.301286; Mason JW, 2003, CARDIOVASC RES, V60, P5, DOI 10.1016/S0008-6363(03)00437-1; Menasria R, 2016, J GEN VIROL; Miteva K, 2017, STEM CELL TRANSL MED, V6, P1249, DOI 10.1002/sctm.16-0353; Noutsias M, 2002, MED SCI MONITOR, V8, pMT59; Poupel L, 2013, ARTERIOSCL THROM VAS, V33, P2297, DOI 10.1161/ATVBAHA.112.300930; Radke MH, 2007, P NATL ACAD SCI USA, V104, P3444, DOI 10.1073/pnas.0608543104; Robinson LA, 2000, J IMMUNOL, V165, P6067, DOI 10.4049/jimmunol.165.11.6067; Savvatis K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041047; Shen Y, 2004, J VIROL, V78, P12548, DOI 10.1128/JVI.78.22.12548-12556.2004; Spillmann F, 2006, REGEN MED, V1, P235, DOI 10.2217/17460751.1.2.235; Tada Y, 2016, CURR PHARM DESIGN, V22, P450, DOI 10.2174/1381612822666151222160559; Umehara H, 2001, IMMUNOL CELL BIOL, V79, P298, DOI 10.1046/j.1440-1711.2001.01004.x; Umehara Hisanori, 2006, Mod Rheumatol, V16, P124, DOI 10.1007/s10165-006-0471-9; Van Linthout S, 2011, EUR HEART J, V32, P2168, DOI 10.1093/eurheartj/ehq467; Van Linthout S, 2008, CIRCULATION, V117, P1563, DOI 10.1161/CIRCULATIONAHA.107.710830; Van Linthout S, 2014, CIRC RES, V115, P540, DOI 10.1161/CIRCRESAHA.114.304951; Van Linthout S, 2014, CARDIOVASC RES, V102, P258, DOI 10.1093/cvr/cvu062; Vitale S, 2004, J IMMUNOL, V172, P585, DOI 10.4049/jimmunol.172.1.585; Westermann D, 2011, CIRC-HEART FAIL, V4, P44, DOI 10.1161/CIRCHEARTFAILURE.109.931451	48	20	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0182643	10.1371/journal.pone.0182643	http://dx.doi.org/10.1371/journal.pone.0182643			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800592	Green Published, Green Submitted, gold			2022-12-26	WOS:000407431800025
J	Foster, TE; Stolen, ED; Hall, CR; Schaub, R; Duncan, BW; Hunt, DK; Drese, JH				Foster, Tammy E.; Stolen, Eric D.; Hall, Carlton R.; Schaub, Ronald; Duncan, Brean W.; Hunt, Danny K.; Drese, John H.			Modeling vegetation community responses to sea-level rise on Barrier Island systems: A case study on the Cape Canaveral Barrier Island complex, Florida, USA	PLOS ONE			English	Article							GROUNDWATER; DYNAMICS; IMPACT	Society needs information about how vegetation communities in coastal regions will be impacted by hydrologic changes associated with climate change, particularly sea level rise. Due to anthropogenic influences which have significantly decreased natural coastal vegetation communities, it is important for us to understand how remaining natural communities will respond to sea level rise. The Cape Canaveral Barrier Island complex (CCBIC) on the east central coast of Florida is within one of the most biologically diverse estuarine systems in North America and has the largest number of threatened and endangered species on federal property in the contiguous United States. The high level of biodiversity is susceptible to sea level rise. Our objective was to model how vegetation communities along a gradient ranging from hydric to upland xeric on CCBIC will respond to three sea level rise scenarios (0.2 m, 0.4 m, and 1.2 m). We used a probabilistic model of the current relationship between elevation and vegetation community to determine the impact sea level rise would have on these communities. Our model correctly predicted the current proportions of vegetation communities on CCBIC based on elevation. Under all sea level rise scenarios the model predicted decreases in mesic and xeric communities, with the greatest losses occurring in the most xeric communities. Increases in total area of salt marsh were predicted with a 0.2 and 0.4 m rise in sea level. With a 1.2 m rise in sea level approximately half of CCBIC's land area was predicted to transition to open water. On the remaining land, the proportions of most of the vegetation communities were predicted to remain similar to that of current proportions, but there was a decrease in proportion of the most xeric community (oak scrub) and an increase in the most hydric community (salt marsh). Our approach provides a first approximation of the impacts of sea level rise on terrestrial vegetation communities, including important xeric upland communities, as a foundation for management decisions and future modeling.	[Foster, Tammy E.; Stolen, Eric D.; Hall, Carlton R.; Schaub, Ronald; Duncan, Brean W.; Hunt, Danny K.; Drese, John H.] Integrated Mission Support Serv, Ecol Program, Kennedy Space Ctr, FL 32899 USA		Foster, TE (corresponding author), Integrated Mission Support Serv, Ecol Program, Kennedy Space Ctr, FL 32899 USA.	tammy.foster-1@nasa.gov			NASA, Kennedy Space Center [NNK080Q01C, NNK160B01C]; NASA Headquarters Climate Adaptation Science Investigators (CASI) [IHA-SA-13-006]	NASA, Kennedy Space Center(National Aeronautics & Space Administration (NASA)); NASA Headquarters Climate Adaptation Science Investigators (CASI)	This research was funded by the NASA, Kennedy Space Center, Ecological Program under contract NNK080Q01C, NNK160B01C, and the NASA Headquarters Climate Adaptation Science Investigators (CASI) program (Award: IHA-SA-13-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizad K, 2016, ECOL MODEL, V327, P29, DOI 10.1016/j.ecolmodel.2016.01.013; [Anonymous], 2021, LANG ENV STAT COMP; Bilskie MV, 2014, GEOPHYS RES LETT, V41, P927, DOI 10.1002/2013GL058759; Boughton EA, 2006, J VEG SCI, V17, P361, DOI 10.1111/j.1654-1103.2006.tb02456.x; BOX EO, 1993, J BIOGEOGR, V20, P629, DOI 10.2307/2845519; Bracho R, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000469; Breininger DR, 1994, NASA TECHNICAL MEMOR; Brockmeyer RE, 2004, OPTIMIZING IRL WETLA; Cadol D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164875; CARTER RWG, 1991, LANDSCAPE ECOL, V6, P29, DOI 10.1007/BF00157742; Conner W.H., 1989, Wetlands Ecology and Management, V1, P45; Foster TE, 2014, THESIS; Gutierrez BT, 2011, J GEOPHYS RES-EARTH, V116, DOI [10.1029/20101F001891, 10.1029/2010JF001891]; Hall CR, 2001, 2001210261 NASA KENN; Hall CR, 2014, 2014216639 NASA KENN; Hazen and Sawyer Environmental Engineers & Scientists, 2008, 24706 JOHNS RIV WAT; Houghton J.T., 1990, CLIMATE CHANGE IPCC; Incorporated IE, 2011, IMPACTS SEA LEVEL RI; Johnson JM, 2015, EARTH SURF PROC LAND, V40, P569, DOI 10.1002/esp.3650; Ketabchi H, 2014, HYDROL PROCESS, V28, P5938, DOI 10.1002/hyp.10059; Kirwan ML, 2016, NAT CLIM CHANGE, V6, P253, DOI 10.1038/NCLIMATE2909; Kirwan ML, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045489; Lewandowsky S, 2016, B AM METEOROL SOC, V97, P723, DOI 10.1175/BAMS-D-14-00106.1; Masterson JP, 2007, GROUND WATER, V45, P209, DOI 10.1111/j.1745-6584.2006.00279.x; Masterson JP, 2014, ECOHYDROLOGY, V7, P1064, DOI 10.1002/eco.1442; Maune DF, 2009, FINAL REPORT SPECIFI; Mcleod E, 2010, OCEAN COAST MANAGE, V53, P507, DOI 10.1016/j.ocecoaman.2010.06.009; Montague C.L., 1990, P481; National Aeronautics and Space Administration, 2010, KENN SPAC CTR ENV RE; O'Neill CM, 2007, P5409 COUNTR VOL PUB; Parkinson RW, 2006, J COASTAL RES, V22, P1268, DOI 10.2112/06A-0009.1; PARKINSON RW, 1994, J COASTAL RES, V10, P1077; Passeri DL, 2015, EARTHS FUTURE, V3, P159, DOI 10.1002/2015EF000298; Peter V., 1997, J COAST CONSERV, V3, P103, DOI DOI 10.1007/BF02908185; Pinheiro J, R PACKAGE VERSION; PROVANCHA M J, 1986, Florida Scientist, V49, P199; Rosenzweig C, 2014, B AM METEOROL SOC, V95, P1351, DOI 10.1175/BAMS-D-12-00169.1; Saha AK, 2011, CLIMATIC CHANGE, V107, P81, DOI 10.1007/s10584-011-0082-0; Saha S, 2015, ECOHYDROLOGY, V8, P128, DOI 10.1002/eco.1494; SCHMALZER PA, 1995, B MAR SCI, V57, P37; Schmalzer Paul A., 1999, Florida Scientist, V62, P13; Schmalzer Paul A., 2001, Florida Scientist, V64, P161; Small C, 2003, J COASTAL RES, V19, P584; SMITH NP, 1993, ESTUARIES, V16, P739, DOI 10.2307/1352432; SMITH NP, 1983, ESTUARIES, V6, P180, DOI 10.2307/1351510; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Todd MJ, 2012, ECOHYDROLOGY, V5, P326, DOI 10.1002/eco.223; Wade D, 1980, SE17 US DEP AGR FOR; WONG P. P, 2007, CLIMATE CHANGE, P315, DOI DOI 10.1017/CB09781107415379; Woodroffe C.D., 1997, COASTAL EVOLUTION LA; Wu XD, 2008, KNOWL INF SYST, V14, P1, DOI 10.1007/s10115-007-0114-2; Xiao H, 2016, HYDROGEOLOGY J; Yeh G, 1994, FEMWATER 3 DIMENTION; Yi S, 2015, GEOPHYS RES LETT, V42, P3998, DOI 10.1002/2015GL063902; Zinnert JC, 2016, ECOSYSTEMS, V19, P685, DOI 10.1007/s10021-016-9961-6	55	14	14	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182605	10.1371/journal.pone.0182605	http://dx.doi.org/10.1371/journal.pone.0182605			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796807	Green Published, gold, Green Submitted			2022-12-26	WOS:000407396200069
J	Li, J; Ghazwani, M; Liu, K; Huang, YX; Chang, N; Fan, J; He, FT; Li, LY; Bu, SZ; Xie, W; Ma, XC; Li, S				Li, Jiang; Ghazwani, Mohammed; Liu, Ke; Huang, Yixian; Chang, Na; Fan, Jie; He, Fengtian; Li, Liying; Bu, Shizhong; Xie, Wen; Ma, Xiaochao; Li, Song			Regulation of hepatic stellate cell proliferation and activation by glutamine metabolism	PLOS ONE			English	Article							HUMAN-SKIN FIBROBLASTS; LIVER FIBROSIS; CANCER METABOLISM; C-MYC; GROWTH; RAS; DIFFERENTIATION; EXPRESSION; PATHWAY	Liver fibrosis is the excessive accumulation of extracellular matrix proteins, which is mainly caused by accumulation of activated hepatic stellate cells (HSCs). The mechanisms of activation and proliferation of HSCs, two key events after liver damage, have been studied for many years. Here we report a novel pathway to control HSCs by regulating glutamine metabolism. We demonstrated that the proliferation of HSCs is critically dependent on glutamine that is used to generate alpha-ketoglutarate (alpha-KG) and non-essential amino acid (NEAA). In addition, both culture- and in vivo-activated HSCs have increased glutamine utilization and increased expression of genes related to glutamine metabolism, including GLS (glutaminase), aspartate transaminase (GOT1) and glutamate dehydrogenase (GLUD1). Inhibition of these enzymes, as well as glutamine depletion, had a significant inhibitory effect on HSCs activation. In addition to providing energy expenditure, conversion of glutamine to proline is enhanced. The pool of free proline may also be increased via downregulation of PDX expression. Hedgehog signaling plays an important role in the regulation of glutamine metabolism, as well as TGF-beta 1, c-Myc, and Ras signalings, via transcriptional upregulation and repression of key metabolic enzymes in this pathway. Finally, changes in glutamine metabolism were also found in mouse liver tissue following CCI4-induced acute injury. Conclusion: Glutamine metabolism plays an important role in regulating the proliferation and activation of HSCs. Strategies that are targeted at glutamine metabolism may represent a novel therapeutic approach to the treatment of liver fibrosis.	[Li, Jiang; Ghazwani, Mohammed; Liu, Ke; Huang, Yixian; Xie, Wen; Ma, Xiaochao; Li, Song] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Ctr Pharmacogenet, Pittsburgh, PA 15261 USA; [Chang, Na; Li, Liying] Capital Med Univ, Dept Cell Biol, Municipal Lab Liver Protect & Regulat Regenerat, Beijing, Peoples R China; [Fan, Jie] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA USA; [He, Fengtian] Third Mil Med Univ, Dept Biochem & Mol Biol, Coll Basic Med Sci, Chongqing, Peoples R China; [Bu, Shizhong] Ningbo Univ, Sch Med, Diabet Res Ctr, Ningbo, Zhejiang, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Capital Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Army Medical University; Ningbo University	Li, J; Li, S (corresponding author), Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Ctr Pharmacogenet, Pittsburgh, PA 15261 USA.	jil35@pitt.edu; sol4@pitt.edu	Ghazwani, Mohammed/AAL-5572-2020; Xie, Wen/M-1768-2016; He, Feng/HHS-6457-2022	He, Feng/0000-0002-1996-0744	NIH grants [R01CA174305, R01GM102989, R21CA173887]; National Natural Science Foundation of China [81228005, 81273226, 81430013, 281370165]	NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by NIH grants R01CA174305, R01GM102989, R21CA173887 and National Natural Science Foundation of China (81228005, 81273226, 81430013 & 281370165).	Atzori L, 2009, INT J BIOCHEM CELL B, V41, P1639, DOI 10.1016/j.biocel.2009.03.001; Barbul A, 2008, J NUTR, V138, p2021S, DOI 10.1093/jn/138.10.2021S; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bataller R, 2001, SEMIN LIVER DIS, V21, P437, DOI 10.1055/s-2001-17558; Biolo G, 2005, INT J BIOCHEM CELL B, V37, P2169, DOI 10.1016/j.biocel.2005.05.001; Chen YP, 2012, GASTROENTEROLOGY, V143, P1319, DOI 10.1053/j.gastro.2012.07.115; Coe DJ, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00590; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; Dang CV, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014217; DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358; Friedman SL, 2003, J HEPATOL, V38, pS38, DOI 10.1016/S0168-8278(02)00429-4; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Gaglio D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.56; Ghazwani M, 2014, PHYTOMEDICINE, V21, P254, DOI 10.1016/j.phymed.2013.09.014; Gross MI, 2014, MOL CANCER THER, V13, P890, DOI 10.1158/1535-7163.MCT-13-0870; Guo JX, 2009, CANCER CHEMOTH PHARM, V63, P615, DOI 10.1007/s00280-008-0774-y; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Huang WJ, 2013, CELL RES, V23, P724, DOI 10.1038/cr.2013.15; Jia YF, 2015, ARCH TOXICOL, V89, P179, DOI 10.1007/s00204-014-1433-1; Karna E, 2001, COMP BIOCHEM PHYS B, V130, P23, DOI 10.1016/S1096-4959(01)00400-6; Kim Min Hyun, 2013, J Cancer Prev, V18, P221; Kisseleva Tatiana, 2008, Proc Am Thorac Soc, V5, P338, DOI 10.1513/pats.200711-168DR; Labow BI, 2000, WORLD J SURG, V24, P1503, DOI 10.1007/s002680010269; Li J, 2013, J HEPATOL, V58, P522, DOI 10.1016/j.jhep.2012.11.011; Liem Minh Phan, 2014, Cancer Biology Medicine, V11, P1, DOI 10.7497/j.issn.2095-3941.2014.01.001; Marra F, 1999, J HEPATOL, V31, P1120; Moreira RK, 2007, ARCH PATHOL LAB MED, V131, P1728; Nevzorova YA, 2013, BBA-MOL BASIS DIS, V1832, P1765, DOI 10.1016/j.bbadis.2013.06.001; Phang JM, 2012, FRONT BIOSCI-LANDMRK, V17, P1835, DOI 10.2741/4022; Pinzani M, 1998, LIVER, V18, P2; Potter JJ, 1999, LIVER, V19, P135, DOI 10.1111/j.1478-3231.1999.tb00023.x; REED WD, 1981, LIPIDS, V16, P677, DOI 10.1007/BF02535063; Reif S, 1999, J HEPATOL, V31, P1053, DOI 10.1016/S0168-8278(99)80318-3; Reimann T, 1997, FEBS LETT, V403, P57, DOI 10.1016/S0014-5793(97)00024-0; Rotblat B, 2008, METHOD ENZYMOL, V439, P467, DOI 10.1016/S0076-6879(07)00432-6; Safadi Rifaat, 2002, MedGenMed, V4, P27; Seyfried TN, 2014, CARCINOGENESIS, V35, P515, DOI 10.1093/carcin/bgt480; Shukla SK, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-18; SMITH RJ, 1990, JPEN-PARENTER ENTER, V14, pS40, DOI 10.1177/014860719001400402; Soga T, 2013, CANCER SCI, V104, P275, DOI 10.1111/cas.12085; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Stumvoll M, 1999, KIDNEY INT, V55, P778, DOI 10.1046/j.1523-1755.1999.055003778.x; Teicher BA, 2012, CLIN CANCER RES, V18, P5537, DOI 10.1158/1078-0432.CCR-12-2587; Wahlstrom T, 2014, BIOCHIMICA BIOPHYSIC; Watford M, 2008, J NUTR, V138, p2003S, DOI 10.1093/jn/138.10.2003S; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; WOLFROM C, 1989, EXP CELL RES, V183, P303, DOI 10.1016/0014-4827(89)90391-1; Zhang YF, 2014, BIOCHEM BIOPH RES CO, V446, P940, DOI 10.1016/j.bbrc.2014.03.037; Zhao CY, 2006, BIOCHEM BIOPH RES CO, V350, P385, DOI 10.1016/j.bbrc.2006.09.069; Zhao C, 2010, P NATL ACAD SCI USA, V107, P1876, DOI 10.1073/pnas.0908750107	50	30	30	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182679	10.1371/journal.pone.0182679	http://dx.doi.org/10.1371/journal.pone.0182679			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797105	Green Submitted, Green Published, gold			2022-12-26	WOS:000407396200080
J	Sisino, G; Zhou, AX; Dahr, N; Sabirsh, A; Soundarapandian, MM; Perera, R; Larsson-Lekholm, E; Magnone, MC; Althage, M; Tyrberg, B				Sisino, Giorgia; Zhou, Alex-Xianghua; Dahr, Niklas; Sabirsh, Alan; Soundarapandian, Mangala M.; Perera, Ranjan; Larsson-Lekholm, Erik; Magnone, Maria Chiara; Althage, Magnus; Tyrberg, Bjorn			Long noncoding RNAs are dynamically regulated during beta-cell mass expansion in mouse pregnancy and control beta-cell proliferation in vitro	PLOS ONE			English	Article							GENE-EXPRESSION; PROLACTIN RECEPTORS; INSULIN-SECRETION; PANCREATIC-ISLETS; GROWTH-HORMONE; TRANSCRIPTION; LANGERHANS; PROMOTERS; SEROTONIN; GLUCOSE	Pregnancy is associated with increased beta-cell proliferation driven by prolactin. Long noncoding RNAs (lncRNA) are the most abundant RNA species in the mammalian genome, yet, their functional importance is mainly elusive. Aims/hypothesis: This study tests the hypothesis that lncRNAs regulate beta-cell proliferation in response to prolactin in the context of beta-cell mass compensation in pregnancy. Methods: The expression profile of lncRNAs in mouse islets at day 14.5 of pregnancy was explored by a bioinformatics approach, further confirmed by quantitative PCR at different days of pregnancy, and islet specificity was evaluated by comparing expression in islets versus other tissues. In order to establish the role of the candidate lncRNAs we studied cell proliferation in mouse islets and the MIN6 beta-cell line by EdU incorporation and cell count. Results: We found that a group of lncRNAs is differentially regulated in mouse islets at 14.5 days of pregnancy. At different stages of pregnancy, these lncRNAs are dynamically expressed, and expression is prolactin dependent in mouse islets and MIN6 cells. One of those lncRNAs, Gm16308 (Lnc03), is dynamically regulated during pregnancy, prolactin-dependent and islet-enriched. Silencing Lnc03 in primary beta-cells and MIN6 cells inhibits, whereas over-expression stimulates, proliferation even in the absence of prolactin, demonstrating that Lnc03 regulates beta-cell growth. Conclusions/interpretation: During pregnancy mouse islet proliferation is correlated with dynamic changes of lncRNA expression. In particular, Lnc03 regulates mouse beta-cell proliferation and may be a crucial component of beta-cell proliferation in beta-cell mass adaptation in both health and disease.	[Sisino, Giorgia; Zhou, Alex-Xianghua; Sabirsh, Alan; Magnone, Maria Chiara; Althage, Magnus; Tyrberg, Bjorn] AstraZeneca, Innovat Med & Early Dev Biotech Unit, Cardiovasc & Metab Dis, Molndal, Sweden; [Dahr, Niklas; Larsson-Lekholm, Erik] Univ Gothenburg, Inst Biomed, Gothenburg, Sweden; [Soundarapandian, Mangala M.; Perera, Ranjan] Sanford Burnham Prebys Med Discovery Inst, Orlando, FL USA; [Soundarapandian, Mangala M.] Alnylam Pharmaceut, Cambridge, MA USA	AstraZeneca; University of Gothenburg; Sanford Burnham Prebys Medical Discovery Institute	Tyrberg, B (corresponding author), AstraZeneca, Innovat Med & Early Dev Biotech Unit, Cardiovasc & Metab Dis, Molndal, Sweden.	bjorn.tyrberg@astrazeneca.com		Sabirsh, Alan/0000-0001-5310-0281; Tyrberg, Bjorn/0000-0003-0976-1220	AstraZeneca; Swedish Foundation for Strategic Research; Swedish Research Council; Swedish Cancer Society; American Diabetes Association [7-09-BETA-06]; AstraZeneca post doc grants	AstraZeneca(AstraZeneca); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); American Diabetes Association(American Diabetes Association); AstraZeneca post doc grants(AstraZeneca)	This study was funded by AstraZeneca (G.S., A-X.Z., A.S. M.C.M., MA, and B.T.), Swedish Foundation for Strategic Research (E.L-L.), Swedish Research Council (E.L-L.), Swedish Cancer Society, and American Diabetes Association (7-09-BETA-06 to B.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Special thanks to E-M. Andersson, C. Wennberg-Huldt, I. Ahlstedt and A -C. Andreasson for expert technical support, and to B. Zarrouki for helpful discussions (all at AstraZeneca Gothenburg). G.S. and A.Z. were funded by AstraZeneca post doc grants.	Amaral MEC, 2004, J ENDOCRINOL, V183, P469, DOI 10.1677/joe.1.05547; ANDERSSON A, 1978, DIABETOLOGIA, V14, P397, DOI 10.1007/BF01228134; Arumugam R, 2014, ENDOCRINE, V46, P568, DOI 10.1007/s12020-013-0073-1; Bouwens L, 2005, PHYSIOL REV, V85, P1255, DOI 10.1152/physrev.00025.2004; BRELJE TC, 1994, DIABETES, V43, P263, DOI 10.2337/diabetes.43.2.263; Brelje TC, 2004, ENDOCRINOLOGY, V145, P4162, DOI 10.1210/en.2004-0201; Catalano PM, 2010, REPRODUCTION, V140, P365, DOI 10.1530/REP-10-0088; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chen J, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0880-9; Galsgaard ED, 1999, J BIOL CHEM, V274, P18686, DOI 10.1074/jbc.274.26.18686; Georgia S, 2010, NAT MED, V16, P756, DOI 10.1038/nm0710-756; Haerty W, 2014, ANNU REV GENOM HUM G, V15, P71, DOI 10.1146/annurev-genom-090413-025621; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Jacovetti C, 2012, J CLIN INVEST, V122, P3541, DOI 10.1172/JCI64151; Jia H, 2010, RNA, V16, P1478, DOI 10.1261/rna.1951310; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; PARSONS JA, 1992, ENDOCRINOLOGY, V130, P1459, DOI 10.1210/en.130.3.1459; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Rieck S, 2010, TRENDS ENDOCRIN MET, V21, P151, DOI 10.1016/j.tem.2009.11.001; Robitaille K, 2016, J BIOL CHEM, V291, P4614, DOI 10.1074/jbc.M115.683912; Seal RL, 2011, NUCLEIC ACIDS RES, V39, pD514, DOI 10.1093/nar/gkq892; Soares Michael J, 2004, Reprod Biol Endocrinol, V2, P51, DOI 10.1186/1477-7827-2-51; Stewart AF, 2015, DIABETES, V64, P1872, DOI 10.2337/db14-1843; Wapinski O, 2011, TRENDS CELL BIOL, V21, P354, DOI 10.1016/j.tcb.2011.04.001; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Xu YL, 2015, DIABETOLOGIA, V58, P2064, DOI 10.1007/s00125-015-3670-0; Yang L, 2014, TRENDS BIOCHEM SCI, V39, P35, DOI 10.1016/j.tibs.2013.10.002	32	12	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182371	10.1371/journal.pone.0182371	http://dx.doi.org/10.1371/journal.pone.0182371			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796801	gold, Green Published, Green Submitted			2022-12-26	WOS:000407396200048
J	Wexler, C; Cheng, AL; Gautney, B; Finocchario-Kessler, S; Goggin, K; Khamadi, S				Wexler, Catherine; Cheng, An-Lin; Gautney, Brad; Finocchario-Kessler, Sarah; Goggin, Kathy; Khamadi, Samoel		HITSyst Team	Evaluating turnaround times for early infant diagnosis samples in Kenya from 2011-2014: A retrospective analysis of HITSystem program data	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; HIV; HEALTH; SYSTEMS	Long turnaround times (TAT) for the processing and posting of results of infant HIV DNA PCR samples can hinder the success of early infant diagnosis (EID) programs. The HITSystem is an eHealth intervention that alerts staff when services are overdue or results are delayed. We conducted a retrospective analysis of 3669 HIV-exposed infants enrolled in 15 Kenya hospital EID programs and three laboratories using the HITSystem from 2011-2014. We assessed mean and median TAT from when a sample was: 1) obtained to when it was shipped to the laboratory, 2) shipped to when it was received at the laboratory, 3) received to when a result was posted, and 4) the total time from obtaining the sample (step 1) to posting the result (step 3). TAT were compared by laboratory, clinic, year, and month of sample collection. 3625 infant samples had results posted by end of 2014. Mean TAT from sample collection to shipping was 5.2 days, from shipping to laboratory receipt was 2.0 days, and from laboratory receipt to result posting was 17.4 days. Altogether, it took an average of 24.7 days from sample collection until result posting. There was significant variation between laboratories, particularly in laboratory processing times (step 3). TAT showed a decreasing trend from 2011-2014, although TAT in December remained higher. Compared with other Kenyan studies, TAT in these HITSystem enrolled settings were shorter. Significant variation between laboratories, however, indicates the need to strengthen protocols and infrastructure to ensure that all laboratories can provide rapid, high-quality services.	[Wexler, Catherine; Finocchario-Kessler, Sarah] Univ Kansas, Med Ctr, Dept Family Med, Kansas City, KS USA; [Cheng, An-Lin; Goggin, Kathy] Univ Missouri, Sch Med, Kansas City, MO 64108 USA; [Gautney, Brad] Global Hlth Innovat, Kansas City, MO USA; [Goggin, Kathy] Childrens Mercy Hosp & Clin, Hlth Serv & Outcomes Res, Kansas City, MO USA; [Goggin, Kathy] Univ Missouri, Sch Pharm, Kansas City, MO 64110 USA; [Khamadi, Samoel; HITSyst Team] Kenya Govt Med Res Ctr, Nairobi, Kenya	University of Kansas; University of Kansas Medical Center; University of Missouri System; University of Missouri Kansas City; Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; Kenya Medical Research Institute	Wexler, C (corresponding author), Univ Kansas, Med Ctr, Dept Family Med, Kansas City, KS USA.	cwexler@kumc.edu	Khamadi, Samoel Ashimosi/GXZ-6071-2022		Kenya Medical Research Institute; Walter Reed Project, Kericho Field Station; Global Health Innovations; National Institutes of Child Health and Development [R01HD076673]	Kenya Medical Research Institute; Walter Reed Project, Kericho Field Station; Global Health Innovations; National Institutes of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding for this study was provided by private donations to Global Health Innovations and the National Institutes of Child Health and Development, R01HD076673 (Finocchario-Kessler PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the mothers and infants who participated in the HITSystem intervention and the clinical staff who were integral to these efforts. We also acknowledge the contributions of Vincent Okoth. We acknowledge the support we have received from Kenya Medical Research Institute and the Walter Reed Project, Kericho Field Station in executing this work. We also acknowledge the critical role of our government partners at NASCOP; Nancy Bowen, Dr. Martin Sirengo, Dr. Irene Mukui, Dr. Ibrahim Mohamed and Dr. William Maina. We are also appreciative of the support of KEMRI Director, Dr. Yeri Kombe and Deputy Director of Research, Dr. Evans Amukoye, and research mentors Drs. Andrea Ruff and Michael Sweat. Without the generous pro-bono contributions of HITSystem software developers at On Target LLC, Terry Oehrke and Brian Hickey, these efforts would not have been possible.	Birx D, 2009, AM J CLIN PATHOL, V131, P849, DOI 10.1309/AJCPGH89QDSWFONS; Ciaranello AL, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-59; Deo S, 2015, JAIDS-J ACQ IMM DEF, V70, pE1, DOI 10.1097/QAI.0000000000000719; Finocchario-Kessler S, 2015, HEALTHCARE, V3, P190, DOI 10.1016/j.hjdsi.2015.07.004; Finocchario-Kessler S, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0284-3; Finocchario-Kessler S, 2014, AIDS, V28, pS313, DOI 10.1097/QAD.0000000000000332; Gautney B, 2013, IMPROVING TURNAROUND; Hassan AS, 2012, AIDS BEHAV, V16, P5, DOI 10.1007/s10461-010-9877-7; Jani IV, 2014, JAIDS-J ACQ IMM DEF, V67, pE1, DOI 10.1097/QAI.0000000000000250; Khamadi S, 2008, J TROP PEDIATRICS, V54, P370, DOI 10.1093/tropej/fmn036; Lofgren SM, 2009, AIDS, V23, P2459, DOI 10.1097/QAD.0b013e328331f702; Ministry of Health National AIDS and STI Control Program, 2014, GUID US ANT DRUGS TR; Murray J, 2012, MED TECHNOL SA, V26; National AIDS and STD Control Programme, 2006, GUID HIV TEST CLIN S; National AIDS and STD Control Programme Ministry of Health Government of Kenya, 2014, NAT EID SUMM 2014; National AIDS and STI Control Programme Ministry of Public Health and Sanitation., 2008, NAT GUID HIV TEST CO; Pathfinder International, 2007, EARL INF DIAGN HIV D; Sutcliffe CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087028; UNITAID World Health Organization, 2014, HIV AIDS DIAGN TECHN; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971	20	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0181005	10.1371/journal.pone.0181005	http://dx.doi.org/10.1371/journal.pone.0181005			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796791	Green Published, Green Submitted, gold			2022-12-26	WOS:000407396200011
J	Serrano, JCE; Martin-Gari, M; Cassanye, A; Granado-Serrano, AB; Portero-Otin, M				Serrano, Jose C. E.; Martin-Gari, Meritxell; Cassanye, Anna; Belen Granado-Serrano, Ana; Portero-Otin, Manuel			Characterization of the post-prandial insulinemic response and low glycaemic index of a soy beverage	PLOS ONE			English	Article							OXIDATIVE STRESS; POSTMENOPAUSAL WOMEN; METABOLIC SYNDROME; ACID; PROTEIN; INHIBITOR; SECRETION; GENISTEIN; ISOFLAVONES; MUSCLE	Soybean is recognized as rich source of bioactive compounds for the improvement of glucose homeostasis. However, the post-prandial mechanisms of action have not been extensively described. The aim of this study is to determine the changes in glucose homeostasis and related factors after acute intake of a soy beverage. Twenty-nine subjects (15 women and 14 men, with an average age of 19.5 +/- 1.2) ingested 500 mL of water, glucose (20.5 g/500 mL) and soy beverage (20 g of carbohydrate) in three separate sessions. Capillary blood glucose was monitored every 15 min until 120 min post-prandial, and blood samples were collected at baseline and after 60 min for insulin, incretin, free amino acids, antioxidant capacity and inflammation marker analysis. The increase in capillary glucose after soy-beverage intake was negligible. This is explained in part by an increase in 83% in insulin levels than induced with glucose alone, which is mainly mediated by a low insulin degradation ratio (determined by c-peptide ratio), incretins and likely also by the modulation of the antioxidant environment. No associations were observed between the insulin levels and soy amino acid uptake. It could be concluded that the acute low glycaemic response of a soy beverage may involves a relationship between incretin and insulin secretion and insulin degradation.	[Serrano, Jose C. E.; Martin-Gari, Meritxell; Cassanye, Anna; Belen Granado-Serrano, Ana; Portero-Otin, Manuel] Univ Lleida, Fac Med, Dept Expt Med, Lleida, Spain	Universitat de Lleida	Serrano, JCE (corresponding author), Univ Lleida, Fac Med, Dept Expt Med, Lleida, Spain.	jceserrano@mex.udl.cat	Serrano, Jose C. E./C-6557-2011; Martin-Gari, Meritxell/ABF-6863-2021; Granado, Ana/F-5484-2016; Portero-Otin, Manuel/B-7122-2009	Serrano, Jose C. E./0000-0001-6714-6061; Martin-Gari, Meritxell/0000-0003-0539-7775; Granado, Ana/0000-0002-5328-513X; Portero-Otin, Manuel/0000-0002-1823-0299; Casane, Anna/0000-0003-3157-7403	Spanish Ministry of Science and Innovation (CENIT MET-DEV-FUN); Language Institute of the University of Lleida; Institute Leche Pascual and Secretaria de Estado de Investigacion, Desarrollo e Innovacion	Spanish Ministry of Science and Innovation (CENIT MET-DEV-FUN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Language Institute of the University of Lleida; Institute Leche Pascual and Secretaria de Estado de Investigacion, Desarrollo e Innovacion	This study was supported by grants from the Spanish Ministry of Science and Innovation (CENIT MET-DEV-FUN) to M. Portero-Otin. This research article has received a grant for its linguistic revision from the Language Institute of the University of Lleida (2015 call). This study was also supported by Institute Leche Pascual and Secretaria de Estado de Investigacion, Desarrollo e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by grants from the Spanish Ministry of Science and Innovation (CENIT MET-DEV-FUN) to M. Portero-Otin. This research article has received a grant for its linguistic revision from the Language Institute of the University of Lleida (2015 call).	AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; Aubertin-Leheudre M, 2008, J WOMENS HEALTH, V17, P1363, DOI 10.1089/jwh.2008.0836; Azadbakht L, 2007, AM J CLIN NUTR, V85, P735, DOI 10.1093/ajcn/85.3.735; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Ceriello A, 1998, EUR J CLIN INVEST, V28, P329; Christopher R, 2008, CLIN THER, V30, P513, DOI 10.1016/j.clinthera.2008.03.005; Foster-Powell K, 2002, AM J CLIN NUTR, V76, P5, DOI 10.1093/ajcn/76.1.5; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gunnerud UJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044731; Henriksen EJ, 2013, METHOD ENZYMOL, V528, P269, DOI 10.1016/B978-0-12-405881-1.00016-1; JENKINS DJA, 1981, AM J CLIN NUTR, V34, P362, DOI 10.1093/ajcn/34.3.362; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Kebede MA, 2009, DIABETES OBES METAB, V11, P10, DOI 10.1111/j.1463-1326.2009.01114.x; Kwon DY, 2011, NUTRITION, V27, P244, DOI 10.1016/j.nut.2010.02.004; Lee DS, 2001, FEBS LETT, V501, P84, DOI 10.1016/S0014-5793(01)02631-X; Liu DM, 2006, DIABETES, V55, P1043, DOI 10.2337/diabetes.55.04.06.db05-1089; Maddux BA, 2001, DIABETES, V50, P404, DOI 10.2337/diabetes.50.2.404; Morgan D, 2009, ENDOCRINOLOGY, V150, P2197, DOI 10.1210/en.2008-1149; Newsholme P, 2005, CLIN SCI, V108, P185, DOI 10.1042/CS20040290; Newsholme P, 2009, DIABETOLOGIA, V52, P2489, DOI 10.1007/s00125-009-1536-z; Nilsson M, 2007, AM J CLIN NUTR, V85, P996, DOI 10.1093/ajcn/85.4.996; Noriega-Lopez L, 2007, J BIOL CHEM, V282, P20657, DOI 10.1074/jbc.M701045200; Oh YS, 2014, NUTR METAB INSIGHTS, V7, P51, DOI 10.4137/NMI.S13589; Rudich A, 1998, DIABETES, V47, P1562, DOI 10.2337/diabetes.47.10.1562; van Loon LJC, 2003, DIABETES CARE, V26, P625, DOI 10.2337/diacare.26.3.625; Vasu S, 2013, ISLETS, V5, P170, DOI 10.4161/isl.26184; Vedavanam K, 1999, PHYTOTHER RES, V13, P601, DOI 10.1002/(SICI)1099-1573(199911)13:7&lt;601::AID-PTR550&gt;3.0.CO;2-O; Yabe D, 2013, CURR OPIN PHARMACOL, V13, P946, DOI 10.1016/j.coph.2013.09.013; Zimmermann C, 2012, ENDOCRINOLOGY, V153, P5200, DOI 10.1210/en.2012-1490	29	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182762	10.1371/journal.pone.0182762	http://dx.doi.org/10.1371/journal.pone.0182762			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28793331	gold, Green Published, Green Submitted			2022-12-26	WOS:000407196700065
J	Luukkonen, J; Pascual, LM; Patlaka, C; Lang, P; Turunen, S; Halleen, J; Nousiainen, T; Valkealahti, M; Tuukkanen, J; Andersson, G; Lehenkari, P				Luukkonen, Jani; Pascual, Laia Mira; Patlaka, Christina; Lang, Pernilla; Turunen, Sanna; Halleen, Jussi; Nousiainen, Tomi; Valkealahti, Maarit; Tuukkanen, Juha; Andersson, Goeran; Lehenkari, Petri			Increased amount of phosphorylated proinflammatory osteopontin in rheumatoid arthritis synovia is associated to decreased tartrate-resistant acid phosphatase 5B/5A ratio	PLOS ONE			English	Article							THROMBIN-CLEAVED OSTEOPONTIN; CATHEPSIN-K; OSTEOARTHRITIS; EXPRESSION; CARTILAGE; BONE; AUTOIMMUNITY; INHIBITION; MARKER; TRACP	Background Osteopontin (OPN) is an immunoregulatory protein which production increases in both rheumatoid arthritis (RA) and osteoarthritis (OA). Phosphorylated osteopontin (Phospho-OPN) is known to increase macrophage and osteoclast activation, this process is controlled by extracellular tartrate-resistant acid phosphatase (TRAcP), also a biomarker for RA. Here, we evaluated the phosphorylation status of OPN in RA and OA synovia, as well as its correlation with TRAcP isoforms. Methods Synovial tissue and fluid were obtained from 24 RA (14 seropositive and 10 seronegative) and 24 OA patients. Western blotting was used to analyze the extent of OPN phosphorylation. TRAcP isoforms were measured in synovial fluid using ELISA; immunohistochemistry assessed the distribution of OPN and TRAcP expressing cells in the synovial tissue, especially distinguishing between the TRAcP isoforms. Results Full-length OPN was more phosphorylated in RA than in OA (p<0.05). The thrombin cleaved C-terminal end of OPN was also more phosphorylated in RA (p<0.05). RA patients had a lower concentration of TRAcP 5B and higher concentration of less active 5A in their synovial fluid compared to OA patients. The TRAcP 5B/5A ratio was decreased in RA and correlated negatively with the amount of phospho-OPN (p<0.05). TRAcP positive cells for both isoforms were found all along the synovial lining; OPN antibody staining was localized in the extracellular matrix. Conclusion Our data suggests that in RA the synovial fluid contains insufficient amounts of TRAcP 5B which increase levels of the proinflammatory phospho-OPN. This may lead to increased macrophage and osteoclast activation, resulting in the increased local inflammation and bone resorption present in RA joints.	[Luukkonen, Jani; Turunen, Sanna; Tuukkanen, Juha; Lehenkari, Petri] Univ Oulu, Med Res Ctr Oulu, Dept Anat, Oulu, Finland; [Pascual, Laia Mira; Patlaka, Christina; Lang, Pernilla; Andersson, Goeran] Karolinska Inst, Dept Lab Med, Div Pathol, Stockholm, Sweden; [Halleen, Jussi] Pharmatest Serv Ltd, Itainen Pitkakatu 4, Turku, Finland; [Nousiainen, Tomi; Valkealahti, Maarit; Lehenkari, Petri] Univ Oulu, Univ Oulu Hosp, Dept Surg, Oulu, Finland	University of Oulu; Karolinska Institutet; Pharmatest Services; University of Oulu	Luukkonen, J (corresponding author), Univ Oulu, Med Res Ctr Oulu, Dept Anat, Oulu, Finland.	jani.luukkonen@oulu.fi	Tuukkanen, Juha/R-3728-2018; Lång, Pernilla/AAA-6660-2019; Turunen, Sanna/AAJ-1622-2020; Mira Pascual, Laia Mira/N-9088-2019; Lehenkari, Petri/O-3009-2016	Tuukkanen, Juha/0000-0002-1723-6461; Lång, Pernilla/0000-0002-3605-4014; Turunen, Sanna/0000-0003-1526-5784; Mira Pascual, Laia Mira/0000-0002-8550-5598; Nousiainen, Tomi/0000-0002-1705-8220; Valkealahti, Maarit/0000-0003-2135-6922; Lehenkari, Petri/0000-0002-0055-5183	Pharmatest Services Ltd (Pharmatest)	Pharmatest Services Ltd (Pharmatest)(Pharmatest Services)	The authors received no specific funding for this work. Jussi Halleen is employed by Pharmatest Services Ltd (Pharmatest). Pharmatest Services Ltd (Pharmatest) provided support in the form of salary for author JH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the author contributions section.	Addison WN, 2010, J BONE MINER RES, V25, P695, DOI 10.1359/jbmr.090832; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Behrens TW, 2011, NAT GENET, V43, P90, DOI 10.1038/ng0211-90; Christensen B, 2005, BIOCHEM J, V390, P285, DOI 10.1042/BJ20050341; Christensen B, 2007, J BIOL CHEM, V282, P19463, DOI 10.1074/jbc.M703055200; Ek-Rylander B, 2010, EXP CELL RES, V316, P443, DOI 10.1016/j.yexcr.2009.10.019; EkRylander B, 1997, BIOCHEM J, V321, P305, DOI 10.1042/bj3210305; Fagerlund KM, 2006, ARCH BIOCHEM BIOPHYS, V449, P1, DOI 10.1016/j.abb.2006.03.010; Gao SG, 2010, OSTEOARTHR CARTILAGE, V18, P82, DOI 10.1016/j.joca.2009.07.009; Halleen JM, 2006, CLIN LAB, V52, P499; Hasegawa M, 2009, J RHEUMATOL, V36, P240, DOI 10.3899/jrheum.080753; Hou WS, 2002, ARTHRITIS RHEUM, V46, P663, DOI 10.1002/art.10114; Iwadate H, 2014, INT J RHEUM DIS, V17, P50, DOI 10.1111/1756-185X.12115; Janckila AJ, 2001, CLIN CHEM, V47, P74; Janckila AJ, 2008, J BONE MINER RES, V23, P1287, DOI 10.1359/JBMR.080329; Kazanecki CC, 2007, J CELL BIOCHEM, V102, P912, DOI 10.1002/jcb.21558; Lang P, 2005, CELL MOL LIFE SCI, V62, P905, DOI 10.1007/s00018-005-4550-4; Lausch E, 2011, NAT GENET, V43, P132, DOI 10.1038/ng.749; Ljusberg J, 2005, J BIOL CHEM, V280, P28370, DOI 10.1074/jbc.M502469200; Lund SA, 2009, J CELL COMMUN SIGNAL, V3, P311, DOI 10.1007/s12079-009-0068-0; Nystrom T, 2007, EXP CELL RES, V313, P1149, DOI 10.1016/j.yexcr.2006.12.026; Pietras A, 2014, CELL STEM CELL, V14, P357, DOI 10.1016/j.stem.2014.01.005; Pozgan U, 2010, BIOL CHEM, V391, P571, DOI 10.1515/BC.2010.035; Sainger R, 2012, BIOMARKERS, V17, P111, DOI 10.3109/1354750X.2011.642407; Seol JW, 2009, INT J MOL MED, V24, P57, DOI 10.3892/ijmm_00000206; Shio K, 2010, J RHEUMATOL, V37, P704, DOI 10.3899/jrheum.090582; Sulzbacher I, 2013, WIEN MED WOCHENSCHR, V163, P212, DOI 10.1007/s10354-012-0168-y; Tsuboi H, 2003, ANN RHEUM DIS, V62, P196, DOI 10.1136/ard.62.3.196; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; Wang LJ, 2008, J PHYS CHEM B, V112, P9151, DOI 10.1021/jp804282u; Weber GF, 2002, J LEUKOCYTE BIOL, V72, P752; Weissmann G, 2004, JCR-J CLIN RHEUMATOL, V10, pS26, DOI 10.1097/01.rhu.0000130687.75646.44; Westwood OMR, 2006, RHEUMATOLOGY, V45, P379, DOI 10.1093/rheumatology/kei228; Xu M, 2013, RHEUMATOL INT, V33, P1313, DOI 10.1007/s00296-012-2548-4; Yamaguchi R, 2014, RHEUMATOLOGY, V53, P2191, DOI 10.1093/rheumatology/keu253; Yamamoto N, 2003, J CLIN INVEST, V112, P181, DOI 10.1172/JCI200317778	36	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2017	12	8							e0182904	10.1371/journal.pone.0182904	http://dx.doi.org/10.1371/journal.pone.0182904			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9EU	28792533	Green Published, gold			2022-12-26	WOS:000407144700045
J	Kader, MA; Satake, T; Yoshida, M; Hayashi, I; Suzuki, A				Kader, Mohammad Abdul; Satake, Tomoko; Yoshida, Masatoshi; Hayashi, Ikuko; Suzuki, Atsushi			Molecular basis of the microtubule-regulating activity of microtubule crosslinking factor 1	PLOS ONE			English	Article							TAU-PROTEIN; ORGANIZATION; NUCLEATION; DOMAINS; TUBULIN; ZIPPER; ALPHA; MTCL1	The variety of microtubule arrays observed across different cell types should require a diverse group of proteins that control microtubule organization. Nevertheless, mainly because of the intrinsic propensity of microtubules to easily form bundles upon stabilization, only a small number of microtubule crosslinking proteins have been identified, especially in postmitotic cells. Among them is microtubule crosslinking factor 1 (MTCL1) that not only interconnects microtubules via its N-terminal microtubule-binding domain (N-MTBD), but also stabilizes microtubules via its C-terminal microtubule-binding domain (C-MTBD). Here, we comprehensively analyzed the assembly structure of MTCL1 to elucidate the molecular basis of this dual activity in microtubule regulation. Our results indicate that MTCL1 forms a parallel dimer not only through multiple homo-interactions of the central coiled-coil motifs, but also the most C-terminal non-coiled-coil region immediately downstream of the C-MTBD. Among these homo-interaction regions, the first coiled-coil motif adjacent to N-MTBD is sufficient for the MTCL1 function to crosslink microtubules without affecting the dynamic property, and disruption of this motif drastically transformed MTCL1-induced microtubule assembly from tight to network-like bundles. Notably, suppression of the homo-interaction of this motif inhibited the endogenous MTCL1 function to stabilize Golgi-associated microtubules that are essential for Golgi-ribbon formation. Because the microtubule-stabilizing activity of MTCL1 is completely attributed to C-MTBD, the present study suggests possible interplay between N-MTBD and C-MTBD, in which normal crosslinking and accumulation of microtubules by N-MTBD is essential for microtubule stabilization by C-MTBD.	[Kader, Mohammad Abdul; Satake, Tomoko; Yoshida, Masatoshi; Suzuki, Atsushi] Yokohama City Univ, Grad Sch Med Life Sci, Mol Cellular Biol Lab, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Hayashi, Ikuko] Yokohama City Univ, Grad Sch Med Life Sci, Mol Med Biosci Lab, Tsurumi Ku, Yokohama, Kanagawa, Japan	Yokohama City University; Yokohama City University	Suzuki, A (corresponding author), Yokohama City Univ, Grad Sch Med Life Sci, Mol Cellular Biol Lab, Tsurumi Ku, Yokohama, Kanagawa, Japan.	abell@tsurumi.yokohama-cu.ac.jp			KAKENHI of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [16H04765]; Yokohama City University, Japan [IR2504]	KAKENHI of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Yokohama City University, Japan	Funding provided by KAKENHI (Grant No. 16H04765) of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan, http://www.mext.go.jp/en/; and a grant for the 2013 Strategic Research Promotion (No. IR2504) of Yokohama City University, Japan, http://www.yokohama-cu.ac.jp/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; BHATTACHARYYA B, 1985, J BIOL CHEM, V260, P208; BRANDT R, 1993, J BIOL CHEM, V268, P3414; CHAPIN SJ, 1991, NATURE, V349, P24, DOI 10.1038/349024a0; Chung PJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12278; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; KANAI Y, 1992, EMBO J, V11, P3953, DOI 10.1002/j.1460-2075.1992.tb05489.x; LEE G, 1992, Trends in Cell Biology, V2, P286, DOI 10.1016/0962-8924(92)90106-W; LEWIS SA, 1990, NATURE, V345, P674, DOI 10.1038/345674a0; LEWIS SA, 1989, NATURE, V342, P498, DOI 10.1038/342498a0; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Masuda-Hirata M, 2009, GENES CELLS, V14, P835, DOI 10.1111/j.1365-2443.2009.01315.x; MELKI R, 1991, BIOCHEMISTRY-US, V30, P11536, DOI 10.1021/bi00113a008; Meng FG, 2001, BIOCHIMIE, V83, P953, DOI 10.1016/S0300-9084(01)01340-2; Nishita M, J BIOCHEM IN PRESS; Pollard TD, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018226; Rivero S, 2009, EMBO J, V28, P1016, DOI 10.1038/emboj.2009.47; Safinya CR, 2016, ADV COLLOID INTERFAC, V232, P9, DOI 10.1016/j.cis.2015.11.002; Sanders AAWM, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00431; Satake T, 2017, EMBO J; Sato Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6266; Sato Y, 2013, J CELL SCI, V126, P4671, DOI 10.1242/jcs.127845; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; SCOTT CW, 1992, J NEUROSCI RES, V33, P19, DOI 10.1002/jnr.490330104; Walczak CE, 2010, CELL, V142, P364, DOI 10.1016/j.cell.2010.07.023; WEBSTER DR, 1989, J CELL SCI, V92, P57; WEHLAND J, 1983, P NATL ACAD SCI-BIOL, V80, P1938, DOI 10.1073/pnas.80.7.1938; Yamashita K, 2010, BIOCHEM BIOPH RES CO, V391, P812, DOI 10.1016/j.bbrc.2009.11.144; Zhou FX, 2000, NAT STRUCT BIOL, V7, P154	31	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182641	10.1371/journal.pone.0182641	http://dx.doi.org/10.1371/journal.pone.0182641			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28787032	Green Submitted, Green Published, gold			2022-12-26	WOS:000406998800054
J	Obiero, CW; Seale, AC; Jones, K; Ngari, M; Bendon, CL; Morpeth, S; Mohammed, S; Mturi, N; Fegan, G; Berkley, JA				Obiero, Christina W.; Seale, Anna C.; Jones, Kelsey; Ngari, Moses; Bendon, Charlotte L.; Morpeth, Susan; Mohammed, Shebe; Mturi, Neema; Fegan, Greg; Berkley, James A.			Should first-line empiric treatment strategies cover coagulase-negative staphylococcal infections in severely malnourished or HIV-infected children in Kenya?	PLOS ONE			English	Article							COMMUNITY-ACQUIRED BACTEREMIA; BLOOD-STREAM; THERAPY; MALARIA	Background Bloodstream infection is a common cause of morbidity in children aged <5 years in developing countries. In studies reporting bacteremia in Africa, coagulase-negative Staphylococci (CoNS) are commonly isolated. However, it is currently unclear whether children who are highly susceptible to infection because of severe acute malnutrition (SAM) or HIV should be treated with antimicrobials specifically to cover CoNS. We aimed to determine the clinical significance of CoNS amongst children admitted to a rural hospital in Kenya in relation to nutritional and HIV status. Methods Systematically collected clinical and microbiological surveillance data from children aged 6-59 months admitted to Kilifi County Hospital (2007-2013) were analysed. Multivariable regression was used to test associations between CoNS isolation from blood cultures and SAM (MUAC <11.5cm or nutritional oedema (kwashiorkor)), and HIV serostatus; and among children with SAM or HIV, associations between CoNS isolation and mortality, duration of hospitalization and clinical features. Results CoNS were isolated from blood culture in 906/13,315 (6.8%) children, of whom 135/906 (14.9%) had SAM and 54/906 (6.0%) were HIV antibody positive. CoNS isolation was not associated with SAM (MUAC<11.5cm (aOR 1.11, 95% CI 0.88-1.40) or kwashiorkor (aOR 0.84, 95% CI 0.48-1.49)), or a positive HIV antibody test (aOR 1.25, 95% CI 0.92-1.71). Among children with SAM or a positive HIV antibody test, CoNS isolation was not associated with mortality or prolonged hospitalization. Conclusion In a large, systematic study, there was no evidence that antimicrobial therapy should specifically target CoNS amongst children with SAM or HIV-infection or exposure.	[Obiero, Christina W.; Seale, Anna C.; Jones, Kelsey; Ngari, Moses; Morpeth, Susan; Mohammed, Shebe; Mturi, Neema; Fegan, Greg; Berkley, James A.] KEMRI Wellcome Trust Res Programme, Clin Res Dept, Kilifi, Kenya; [Obiero, Christina W.; Seale, Anna C.; Fegan, Greg; Berkley, James A.] Univ Oxford, Nuffield Dept Med, Oxford, England; [Jones, Kelsey] Imperial Coll London, Dept Med, London, England; [Bendon, Charlotte L.] Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England; [Morpeth, Susan] London Sch Hyg & Trop Med, London, England; [Morpeth, Susan] Middlemore Hosp, Counties Manukau Dist Hlth Board, Microbiol Lab, Auckland, New Zealand; [Fegan, Greg] Swansea Univ, Sch Med, Swansea, W Glam, Wales	University of Oxford; Imperial College London; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; Swansea University	Obiero, CW; Berkley, JA (corresponding author), KEMRI Wellcome Trust Res Programme, Clin Res Dept, Kilifi, Kenya.; Obiero, CW; Berkley, JA (corresponding author), Univ Oxford, Nuffield Dept Med, Oxford, England.	cobiero@kemri-wellcome.org; jberkley@kemri-wellcome.org	Fegan, Greg W/O-8079-2018	Fegan, Greg W/0000-0002-2663-2765; Ngari, Moses/0000-0001-7149-5491; Seale, Anna/0000-0002-0129-3146; Obiero, Christina/0000-0002-9321-0183	Wellcome Trust, UK [093804, 092088, 083579, 077092]; MRC [MR/M007367/1] Funding Source: UKRI; Medical Research Council [MR/M007367/1] Funding Source: researchfish	Wellcome Trust, UK(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by The Wellcome Trust, UK, https://wellcome.ac.uk/ (Grant numbers 093804 to Anna C. Seale, 092088 to Kelsey Jones, 083579 to James A. Berkley, and 077092 core grant to KEMRI Wellcome Trust Research Programme). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrha A, 2011, ETHIOP J HEALTH SCI, V21, P175; Aiken AM, 2011, LANCET, V378, P2021, DOI 10.1016/S0140-6736(11)61622-X; Asaad AM, 2016, INFECT DIS-NOR, V48, P356, DOI 10.3109/23744235.2015.1122833; Babirekere-Iriso E, 2006, ANN TROP PAEDIATR, V26, P319, DOI 10.1179/146532806X152845; Bachou H, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-160; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; CHRISTIE CDC, 1992, PEDIATR INFECT DIS J, V11, P1030, DOI 10.1097/00006454-199211120-00008; Costa SF, 2004, LANCET INFECT DIS, V4, P278, DOI 10.1016/S1473-3099(04)01003-5; Dramowski A, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0354-3; Giormezis N, 2014, J MED MICROBIOL, V63, P1500, DOI 10.1099/jmm.0.075259-0; Huang Shi-Ying, 2003, Journal of Microbiology Immunology and Infection, V36, P51; Huebner J, 1999, ANNU REV MED, V50, P223, DOI 10.1146/annurev.med.50.1.223; Isendahl J, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0715-9; Jaspan HB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003260; Kibuuka A, 2015, AM J TROP MED HYG, V93, P276, DOI 10.4269/ajtmh.14-0494; Marchant EA, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/586076; Meyers TM, 2000, J TROP PEDIATRICS, V46, P224, DOI 10.1093/tropej/46.4.224; Ministry of Medical Services, 2009, NAT GUID INT MAN AC; MOLYNEUX ME, 1989, Q J MED, V71, P441; Musiime V, 2013, PEDIATR INFECT DIS J, V32, P856, DOI 10.1097/INF.0b013e31828c3991; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nathoo KJ, 1996, PEDIATR INFECT DIS J, V15, P1092, DOI 10.1097/00006454-199612000-00007; National AIDS and STD Control Programme, 2010, GUID HIV TEST COUNS; Nielsen MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044063; Noorani N, 2005, East Afr Med J, V82, P343; Okomo UA, 2011, INT J PEDIAT, V2011, DOI 10.1155/2011/825123; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Rabasa AI, 2002, J TROP PEDIATRICS, V48, P359, DOI 10.1093/tropej/48.6.359; Thame M, 2001, W INDIAN MED J, V50, P140; World Health Organization, 2013, POCK BOOK HOSP CAR C	30	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182354	10.1371/journal.pone.0182354	http://dx.doi.org/10.1371/journal.pone.0182354			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28787002	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000406998800030
J	Katz, D; Gowda, MS; Vasireddi, M; Patrusheva, I; Seoh, HK; Filfili, CN; Wildesl, MJ; Oh, J; Hilliard, JK				Katz, David; Gowda, Manjunath S.; Vasireddi, Mugdha; Patrusheva, Irina; Seoh, Hyuk-Kyu; Filfili, Chadi N.; Wildesl, Martin J.; Oh, Jay; Hilliard, Julia K.			Identification of unique B virus (Macacine Herpesvirus 1) epitopes of zoonotic and macaque isolates using monoclonal antibodies	PLOS ONE			English	Article							WAVELENGTH ULTRAVIOLET-LIGHT; HERPESVIRUS-SIMIAE; GLYCOPROTEIN-D; PHOTOCHEMICAL TREATMENT; NONSTRUCTURAL PROTEINS; CELL-FUSION; SIMPLEX; ENTRY; ELISA; AMOTOSALEN	Our overall aim is to develop epitope-based assays for accurate differential diagnosis of B virus zoonotic infections in humans. Antibodies to cross-reacting epitopes on human-simplexviruses continue to confound the interpretation of current assays where abundant antibodies exist from previous infections with HSV types 1 and 2. To find B virus-specific epitopes we cloned ten monoclonal antibodies (mAbs) from the hybridomas we produced. Our unique collection of rare human sera from symptomatic and asymptomatic patients infected with B virus was key to the evaluation and identification of the mAbs as reagents in competition ELISAs (mAb-CE). The analysis of the ten mAbs revealed that the target proteins for six mAbs was glycoprotein B of which two are reactive to simian simplexviruses and not to human simplexviruses. Two mAbs reacted specifically with B virus glycoprotein D, and two other mAbs were specific to VP13/14 and gE-gI complex respectively. The mAbs specific to VP13/14 and gE-gI are strain specific reacting with B virus isolates from rhesus and Japanese macaques and not with isolates from cynomolgus and pigtail macaques. The mAb-CE revealed that a high proportion of naturally B virus infected rhesus macaques and two symptomatic humans possess antibodies to epitopes of VP13/14 protein and on the gE-gI complex. The majority of sera from B virus infected macaques and simplexvirus-infected humans competed with the less specific mAbs. These experiments produced a novel panel of mAbs that enabled B virus strain identification and confirmation of B virus infected macaques by the mAb-CE. For human sera the mAb-CE could be used only for selected cases due to the selective B virus strain-specificity of the mAbs against VP13/14 and gE/gI. To fully accomplish our aim to provide reagents for unequivocal differential diagnosis of zoonotic B virus infections, additional mAbs with a broader range of specificities is critical.	[Katz, David; Gowda, Manjunath S.; Vasireddi, Mugdha; Patrusheva, Irina; Filfili, Chadi N.; Wildesl, Martin J.; Oh, Jay; Hilliard, Julia K.] Georgia State Univ, Dept Biol, Viral Immunol Ctr, Atlanta, GA 30302 USA; [Seoh, Hyuk-Kyu] Georgia State Univ, Dept Biol, GSU Biol Prote Core Facil, Atlanta, GA USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Katz, D (corresponding author), Georgia State Univ, Dept Biol, Viral Immunol Ctr, Atlanta, GA 30302 USA.	dkatz@gsu.edu			National Institute of Allergy and Infectious Diseases [NIH P40RR0050-62-20]; Elizabeth R. Griffin Research Foundation [BLA89]; National Institutes of Health (NIH) [NIH P40RR0050-62-20]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Elizabeth R. Griffin Research Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded by National Institute of Allergy and Infectious Diseases, NIH P40RR0050-62-20, Dr Julia K Hilliard. Elizabeth R. Griffin Research Foundation, BLA89, Dr. David Katz.; We thank the resource medical technologists and administration specialists from the National B Virus Resource Center-Nina Beato, Natasha Burnett, Tasha Brooks, Yuronita Priest and Nikiesha Brooks for their invaluable contributions and support to this work. Funding for this project was provided by Elizabeth R. Griffin Research Foundation (BLA89) and National Institutes of Health (NIH) (NIH P40RR0050-62-20).	BENSON PM, 1989, ARCH DERMATOL, V125, P1247, DOI 10.1001/archderm.125.9.1247; Blackwell JM, 2009, CLIN MICROBIOL REV, V22, P370, DOI 10.1128/CMR.00048-08; Blewett EL, 1996, J GEN VIROL, V77, P2787, DOI 10.1099/0022-1317-77-11-2787; Blewett EL, 1999, J VIROL METHODS, V77, P59, DOI 10.1016/S0166-0934(98)00134-7; Busch Michael P., 1997, American Journal of Medicine, V102, P117, DOI 10.1016/S0002-9343(97)00077-6; Calvo CM, 2011, INVEST OPHTH VIS SCI, V52, P2975; Carfi A, 2001, MOL CELL, V8, P169, DOI 10.1016/S1097-2765(01)00298-2; CHEINGSONGPOPOV R, 1990, AIDS RES HUM RETROV, V6, P1099, DOI 10.1089/aid.1990.6.1099; Chen XY, 2017, VIRAL IMMUNOL, V30, P106, DOI 10.1089/vim.2016.0110; CROPPER LM, 1992, ARCH VIROL, V123, P267, DOI 10.1007/BF01317263; Dean C, 1998, MOLECULAR BIOMETHODS HANDBOOK, P567, DOI 10.1007/978-1-59259-642-3_44; EBERLE R, 1995, INFECT AGENT DIS, V4, P55; Elmore D, 2008, COMPARATIVE MED, V58, P11; Fan Q, 2012, J VIROL, V86, P4468, DOI 10.1128/JVI.00041-12; FIERER J, 1973, ANN INTERN MED, V79, P225, DOI 10.7326/0003-4819-79-2-225; Jansen GAJ, 2004, TRANSFUSION, V44, P313, DOI 10.1111/j.1537-2995.2003.00588.x; JOHNSON DC, 1988, J VIROL, V62, P1347, DOI 10.1128/JVI.62.4.1347-1354.1988; KATZ D, 1986, J VIROL METHODS, V14, P99, DOI 10.1016/0166-0934(86)90040-6; Katz D, 2002, ARCH VIROL, V147, P929, DOI 10.1007/s00705-001-0784-0; Katz D, 2012, COMPARATIVE MED, V62, P516; Katz D, 2012, COMPARATIVE MED, V62, P527; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lin L, 2004, TRANSFUSION, V44, P1496, DOI 10.1111/j.1537-2995.2004.04125.x; Lin LL, 2005, TRANSFUSION, V45, P580, DOI 10.1111/j.0041-1132.2005.04316.x; Morris GE, 1998, MOLECULAR BIOMETHODS HANDBOOK, P619, DOI 10.1007/978-1-59259-642-3_47; Ndjamen B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003961; NORCOTT JP, 1993, J CLIN MICROBIOL, V31, P931, DOI 10.1128/JCM.31.4.931-935.1993; Patrusheva I, 2016, J VIROL, V90, P9420, DOI 10.1128/JVI.00799-16; Perelygina L, 2005, J CLIN MICROBIOL, V43, P620, DOI 10.1128/JCM.43.2.620-628.2005; Perelygina L, 2015, J VIROL, V89, P5515, DOI 10.1128/JVI.03568-14; Pryor HWCH, 1970, PRIMATES, V11, P297; Sabin AB, 1934, J EXP MED, V59, P115, DOI 10.1084/jem.59.2.115; Smith AL, 1998, J VIROL, V72, P9224, DOI 10.1128/JVI.72.11.9224-9232.1998; Spear PG, 2006, VIROLOGY, V344, P17, DOI 10.1016/j.virol.2005.09.016; Valdes K, 2000, CLIN DIAGN LAB IMMUN, V7, P856, DOI 10.1128/CDLI.7.5.856-857.2000; VANHOOSER G, 1961, TEX REP BIOL MED, V19, P376; Ward JA, 2002, CONTEMP TOP LAB ANIM, V41, P36; WEIGLER BJ, 1992, CLIN INFECT DIS, V14, P555, DOI 10.1093/clinids/14.2.555	38	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0182355	10.1371/journal.pone.0182355	http://dx.doi.org/10.1371/journal.pone.0182355			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28783746	gold, Green Published, Green Submitted			2022-12-26	WOS:000406944300033
J	Pellowe, KE; Leslie, HM				Pellowe, Kara E.; Leslie, Heather M.			Seasonal variability shapes resilience of small-scale fisheries in Baja California Sur, Mexico	PLOS ONE			English	Article							EARLY-WARNING SIGNALS; CLIMATE; DIVERSIFICATION; FRAMEWORK; LESSONS; SHIFTS; RISK	Small-scale fisheries are an important source of food and livelihoods to coastal communities around the world. Understanding the seasonality of fisheries catch and composition is crucial to fisheries management, particularly in the context of changing environmental and socioeconomic conditions. While seasonal variability directly impacts the lives of fishers, most fisheries studies focus on longer-term change. Here we examine seasonal variability in the small-scale fisheries of Baja California Sur, Mexico based on 13 years of government fisheries data. We investigate how four fisheries indicators with direct relevance to ecological resilience-magnitude and variance of landed fish biomass, taxon richness and the proportion of top-trophic-level taxa in total catch-vary within and among years and at multiple spatial scales. We find that these resilience indicators vary both seasonally and spatially. These results highlight the value of finer-scale monitoring and management, particularly for data-poor fisheries.	[Pellowe, Kara E.; Leslie, Heather M.] Univ Maine, Darling Marine Ctr, Walpole, ME 04573 USA; [Pellowe, Kara E.; Leslie, Heather M.] Univ Maine, Ecol & Environm Sci Program, Orono, ME 04469 USA; [Leslie, Heather M.] Univ Maine, Sch Marine Sci, Orono, ME USA	University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono	Pellowe, KE (corresponding author), Univ Maine, Darling Marine Ctr, Walpole, ME 04573 USA.; Pellowe, KE (corresponding author), Univ Maine, Ecol & Environm Sci Program, Orono, ME 04469 USA.	kara.pellowe@maine.edu		Leslie, Heather/0000-0003-4512-9417	US National Science Foundation [GE0-1114964, DEB-1632648]; Brown University; University of Maine	US National Science Foundation(National Science Foundation (NSF)); Brown University; University of Maine	This work was funded by the US National Science Foundation (GE0-1114964 and DEB-1632648 to HML) with additional support from Brown University and University of Maine (to HML and KEP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger WN, 2000, PROG HUM GEOG, V24, P347, DOI 10.1191/030913200701540465; Bene C., 2006, SMALLSCALE FISHERIES, V1008; Bernhardt JR, 2013, ANNU REV MAR SCI, V5, P371, DOI 10.1146/annurev-marine-121211-172411; Biggs R, 2012, ANNU REV ENV RESOUR, V37, P421, DOI 10.1146/annurev-environ-051211-123836; Cisneros-Mata Miguel A., 2010, P119; Cline TJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14042; CONAPESCA (Comision Nacional de Acuacultura y Pesca), 2001, GOB EST UN MEX; Defeo O, 2013, ECOL SOC, V18, DOI 10.5751/ES-05971-180430; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Erisman BE, 2011, ICES J MAR SCI, V68, P564, DOI 10.1093/icesjms/fsq179; Essington TE, 2006, P NATL ACAD SCI USA, V103, P3171, DOI 10.1073/pnas.0510964103; Finkbeiner EM, 2015, GLOBAL ENVIRON CHANG, V32, P139, DOI 10.1016/j.gloenvcha.2015.03.009; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Folke C, 2010, ECOL SOC, V15; Fujita R, 2013, MAR POLICY, V38, P538, DOI 10.1016/j.marpol.2012.05.025; Halpern BS, 2012, NATURE, V488, P615, DOI 10.1038/nature11397; Hilborn R, 2001, CAN J FISH AQUAT SCI, V58, P99, DOI 10.1139/cjfas-58-1-99; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Johnson AF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174064; Kasperski S, 2013, P NATL ACAD SCI USA, V110, P2076, DOI 10.1073/pnas.1212278110; Kerr LA, 2010, ECOL APPL, V20, P497, DOI 10.1890/08-1382.1; Leslie HM, 2015, P NATL ACAD SCI USA, V112, P5979, DOI 10.1073/pnas.1414640112; McCay BJ, 2014, MAR POLICY, V44, P49, DOI 10.1016/j.marpol.2013.08.001; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; OECD (Organization for Economic Cooperation and Development), 2006, REC ACH CONT REF AG; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Pinsky ML, 2012, CLIMATIC CHANGE, V115, P883, DOI 10.1007/s10584-012-0599-x; Ramirez-Rodriguez M., 2001, ICES J MARINE SCI; Saenz-Arroyo A, 2005, P ROY SOC B-BIOL SCI, V272, P1957, DOI 10.1098/rspb.2005.3175; Sala E, 2004, FISHERIES, V29, P19, DOI 10.1577/1548-8446(2004)29[19:FDCFWI]2.0.CO;2; Salas S, 2004, CAN J FISH AQUAT SCI, V61, P374, DOI 10.1139/F04-007; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Schluter M, 2012, NAT RESOUR MODEL, V25, P219, DOI 10.1111/j.1939-7445.2011.00108.x; Sherman K, 2008, UNEP LARGE MARINE EC, V182; Sievanen L, 2014, MARIT STUD, V13, DOI 10.1186/s40152-014-0009-2; Wilson JA, 2006, ECOL SOC, V11; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Wouters N, 2015, ESTUAR COAST SHELF S, V152, P65, DOI 10.1016/j.ecss.2014.10.017	40	22	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0182200	10.1371/journal.pone.0182200	http://dx.doi.org/10.1371/journal.pone.0182200			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC6IS	28783740	Green Published, Green Submitted, gold			2022-12-26	WOS:000406944300022
J	Simond, AM; Rao, T; Zuo, D; Zhao, JJ; Muller, WJ				Simond, A. M.; Rao, T.; Zuo, D.; Zhao, J. J.; Muller, W. J.			ErbB2-positive mammary tumors can escape PI3K-p110 alpha loss through downregulation of the Pten tumor suppressor	ONCOGENE			English	Article							PHOSPHOINOSITIDE 3-KINASE PATHWAY; BREAST-CANCER; PHOSPHATIDYLINOSITOL 3-KINASE; CATALYTIC SUBUNIT; HIGH-FREQUENCY; PIK3CA GENE; ISOFORM; PI3K; P110-BETA; P110-ALPHA	Breast cancer is the most common cancer among women and 30% of patients will be diagnosed with an ErbB2-positive tumor. Forty percent of ErbB2-positive breast tumors have an activating mutation in p110 alpha, a catalytic subunit of phosphoinositide 3-kinase. Clinical and experimental data show that breast tumors treated with a p110 alpha-specific inhibitor often circumvent inhibition and resume growth. To understand this mechanism of resistance, we crossed a p110 alpha conditional (p110 alpha(flx/flx)) mouse model with mice that overexpress the ErbB2/Neu-IRES-Cre transgene (NIC) specifically in the mammary epithelium. Although mammary-specific deletion of p110 alpha dramatically delays tumor onset, tumors eventually arise and are dependent on p110 beta. Through biochemical analyses we find that a proportion of p110 alpha-deficient tumors (23%) display downregulation of the Pten tumor suppressor. We further demonstrate that loss of one allele of PTEN is sufficient to shift isoform dependency from p110 alpha to p110 beta in vivo. These results provide insight into the molecular mechanism by which ErbB2-positive breast cancer escapes p110 alpha inhibition.	[Simond, A. M.; Rao, T.; Zuo, D.; Muller, W. J.] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Dept Biochem, Room 516,1160 Pine Ave West, Montreal, PQ H3A 1A3, Canada; [Zhao, J. J.] Harvard Med Sch, Dana Farber Canc Inst, Dept Canc Biol, Pathol, Boston, MA USA	McGill University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Muller, WJ (corresponding author), McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Dept Biochem, Room 516,1160 Pine Ave West, Montreal, PQ H3A 1A3, Canada.	william.muller@mcgill.ca			Canadian Institutes of Health Research (CIHR) [MOP-133706, FDN-148373]; Terry Fox team [RI X-242115]; CRC Chair in Molecular Oncology; Roland and Marcel Gosselin Fellowship; National Institutes of Health (NIH) [P50 CA168504, CA187918-02, R35 CA210057, CA172461]; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [P50CA168504, R01CA187918, R35CA210057, R01CA172461] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Terry Fox team; CRC Chair in Molecular Oncology; Roland and Marcel Gosselin Fellowship; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Cynthia Lavoie for assistance with the GDC-0941 drug trial and Vasilios Papavasiliou for mammary fat pad injections and transplants; Colin Ratcliffe for technical support with the Metamorph software; Chen Ling for editorial assistance and all the students in the Muller laboratory for their constant feedback and support. Our work is supported by the Canadian Institutes of Health Research (CIHR): MOP-133706 (WJM), FDN-148373 (WJM), Terry Fox team program grant: RI X-242115 (WJM). WJM is supported by CRC Chair in Molecular Oncology. National Institutes of Health (NIH): P50 CA168504 (JJZ), CA187918-02 (JJZ), R35 CA210057 (JJZ), CA172461 (JJZ) and Breast Cancer Research Foundation (JJZ), Roland and Marcel Gosselin Fellowship (AMS).	Andrulis IL, 1998, J CLIN ONCOL, V16, P1340, DOI 10.1200/JCO.1998.16.4.1340; Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Beeton CA, 2000, BIOCHEM J, V350, P353, DOI 10.1042/0264-6021:3500353; Bellacosa A, 2005, WOM ONCOL REV, V5, P223; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; CARPENTER CL, 1990, J BIOL CHEM, V265, P19704; Chantry D, 1997, J BIOL CHEM, V272, P19236, DOI 10.1074/jbc.272.31.19236; Cheng H, 2015, ONCOGENE, V74, P15; Costa C, 2015, CANCER CELL, V27, P97, DOI 10.1016/j.ccell.2014.11.007; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; Dbouk Hashem A, 2015, Postdoc J, V3, P71; Dbouk HA, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003264; Dbouk HA, 2010, ONCOTARGET, V1, P729; Dourdin N, 2008, CANCER RES, V68, P2122, DOI 10.1158/0008-5472.CAN-07-5727; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Geering B, 2007, P NATL ACAD SCI USA, V104, P7809, DOI 10.1073/pnas.0700373104; Hernandez-Aya LF, 2011, ONCOLOGIST, V16, P404, DOI 10.1634/theoncologist.2010-0402; HILES ID, 1992, CELL, V70, P419, DOI 10.1016/0092-8674(92)90166-A; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Juric D, 2015, NATURE, V518, P240, DOI 10.1038/nature13948; Karakas B, 2006, BRIT J CANCER, V94, P455, DOI 10.1038/sj.bjc.6602970; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Martin V, 2010, BLOOD, V115, P2008, DOI 10.1182/blood-2009-04-217224; Meier TI, 2004, PROTEIN EXPRES PURIF, V35, P218, DOI 10.1016/j.pep.2003.12.010; Mellor P, 2012, BIOCHEM J, V441, P23, DOI 10.1042/BJ20111164; Ni J, 2012, CANCER DISCOV, V2, P425, DOI 10.1158/2159-8290.CD-12-0003; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Schmit F, 2014, P NATL ACAD SCI USA, V111, P6395, DOI 10.1073/pnas.1323004111; Schoenwaelder SM, 2010, J BIOL CHEM, V285, P2886, DOI 10.1074/jbc.M109.029132; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Thorpe LM, 2015, NAT REV CANCER, V15, P7, DOI 10.1038/nrc3860; Torbett NE, 2008, BIOCHEM J, V415, P97, DOI 10.1042/BJ20080639; Ursini-Siegel J, 2008, EMBO J, V27, P910, DOI 10.1038/emboj.2008.22; Utermark T, 2012, GENE DEV, V26, P1573, DOI 10.1101/gad.191973.112; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Wang Q, 2016, ONCOGENE, V35, P3607, DOI 10.1038/onc.2015.406; Wee S, 2008, P NATL ACAD SCI USA, V105, P13057, DOI 10.1073/pnas.0802655105; Zhao JJ, 2006, P NATL ACAD SCI USA, V103, P16296, DOI 10.1073/pnas.0607899103	43	5	5	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 26	2017	36	43					6059	6066		10.1038/onc.2017.264	http://dx.doi.org/10.1038/onc.2017.264			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FK9OT	28783168	Green Submitted, Green Accepted			2022-12-26	WOS:000413841400014
J	Jones, A; Pitts, M; Al Dulayymi, JR; Gibbons, J; Ramsay, A; Goletti, D; Gwenin, CD; Baird, MS				Jones, Alison; Pitts, Mark; Al Dulayymi, Juma'a R.; Gibbons, James; Ramsay, Andrew; Goletti, Delia; Gwenin, Christopher D.; Baird, Mark S.			New synthetic lipid antigens for rapid serological diagnosis of tuberculosis	PLOS ONE			English	Article							FACTOR TREHALOSE 6,6'-DIMYCOLATE; ANTIBODY DETECTION TESTS; MYCOLIC ACID ANTIBODIES; MYCOBACTERIUM-TUBERCULOSIS; CORD FACTOR; PULMONARY TUBERCULOSIS; IGG ANTIBODY; CLINICAL-EVALUATION; IMMUNE-RESPONSES; ASSAY ELISA	Background During pulmonary tuberculosis (PTB) antibodies are generated to trehalose esters of mycolic acids which are cell wall lipids of Mycobacterium tuberculosis (Mtb). Attempts have been made to use these complex natural mixtures in serological tests for PTB diagnosis. Aim The aim of this work was to determine whether a serological test based on a panel of defined individual trehalose esters of characteristic synthetic mycolic acids has improved diagnostic accuracy in distinguishing patients with culture positive PTB from individuals who were Mtb culture negative. Method One hundred serum samples from well-characterized patients with presumptive tuberculosis, and diagnosed as having pulmonary smear and culture positive TB, or being culture and smear negative were evaluated by ELISA using different combinations of synthetic antigens and secondary antibodies. Using cut-off values determined from these samples, we validated this study blind in samples from a further 249 presumptive TB patients. Results With the first 100 samples, detailed responses depended both on the precise structure of the antigen and on the secondary antibody. Using a single antigen, a sensitivity/specificity combination for smear and culture positive PTB detection of 85 and 88% respectively was achieved; this increased to 96% and 95% respectively by a statistical combination of the results with seven antigens. In the blind study a sensitivity/specificity of 87% and 83% was reached with a single antigen. With some synthetic antigens, the responses from all 349 samples were significantly better than those with the natural mixture. Combining the results for seven antigens allowed a distinction between culture positive and negative with a ROC AUC of 0.95. Conclusion We have identified promising antigen candidates for serological assays that could be used to diagnose PTB and which could be the basis of a much-needed, simple, rapid diagnostic test that would bring care closer to communities.	[Jones, Alison; Pitts, Mark; Al Dulayymi, Juma'a R.; Gwenin, Christopher D.; Baird, Mark S.] Bangor Univ, Sch Chem, Bangor, Gwynedd, Wales; [Gibbons, James] Bangor Univ, Sch Environm Nat Resources & Geog, Bangor, Gwynedd, Wales; [Ramsay, Andrew] WHO, Special Programme Res & Training Trop Dis TDR, Geneva, Switzerland; [Ramsay, Andrew] Univ St Andrews, Med Sch, St Andrews, Fife, Scotland; [Goletti, Delia] L Spallanzani Natl Inst Infect Dis, Dept Epidemiol & Preclin Res, Translat Res Unit, Rome, Italy	Bangor University; Bangor University; World Health Organization; University of St Andrews; IRCCS Lazzaro Spallanzani	Baird, MS (corresponding author), Bangor Univ, Sch Chem, Bangor, Gwynedd, Wales.	chs028@bangor.ac.uk	goletti, delia/AAM-6577-2020; Gwenin, Chris/AAM-8106-2020; Baird, Mark/A-2470-2009	Baird, Mark/0000-0001-5340-8745; Gibbons, James/0000-0002-0083-9872; Goletti, Delia/0000-0001-8360-4376; Gwenin, Chris/0000-0003-0363-8168	Welsh Government A4B Programme; Welsh Government A4B Programme [HE06 POC1022]	Welsh Government A4B Programme; Welsh Government A4B Programme	Funding for this work was provided by the Welsh Government A4B Programme, grant HE06 POC1022 to MSB and CDG.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; AJ and MP wish to acknowledge the support of the Welsh Government A4B programme. We wish to thank UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases for providing serum samples from their TB Specimen Bank.	Al Dulayymi JR, 2014, TETRAHEDRON, V70, P9836, DOI 10.1016/j.tet.2014.10.072; Al Dulayymi JR, 2009, TETRAHEDRON LETT, V50, P3702, DOI 10.1016/j.tetlet.2009.03.213; Banoo S, 2008, NAT REV MICROBIOL, V6, pS16, DOI 10.1038/nrmicro1523y; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; Benadie Y, 2008, CHEM PHYS LIPIDS, V152, P95, DOI 10.1016/j.chemphyslip.2008.01.004; BENJAMIN RG, 1982, AM REV RESPIR DIS, V126, P1013; Beukes M, 2010, CHEM PHYS LIPIDS, V163, P800, DOI 10.1016/j.chemphyslip.2010.09.006; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Broger T, 2017, CLIN INFECT DIS, V64, P947, DOI 10.1093/cid/cix023; Cresswell J, 2015, B WORLD HEALTH ORGAN, V92, P459; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Denkinger CM, 2015, J INFECT DIS, V211, pS29, DOI 10.1093/infdis/jiu821; Dubnau E, 2000, MOL MICROBIOLOGY, V36; Dvir H, 2010, J IMMUNOL, V184, P2504, DOI 10.4049/jimmunol.0903509; Flores LL, 2011, CLIN VACCINE IMMUNOL, V18, P1616, DOI 10.1128/CVI.05205-11; Fujita Y, 2005, CLIN CHEM LAB MED, V43, P1253, DOI 10.1515/CCLM.2005.216; Fujita Y, 2005, MICROBIOL-SGM, V151, P2065, DOI 10.1099/mic.0.27790-0; Fujiwara N, 1999, FEMS IMMUNOL MED MIC, V24, P141, DOI 10.1016/S0928-8244(99)00016-4; Fujiwara N, 1999, MICROBIOL IMMUNOL, V43, P785, DOI 10.1111/j.1348-0421.1999.tb02471.x; Goletti D, 2016, INFECT DIS REP, V8, P24, DOI 10.4081/idr.2016.6568; GRANGE JM, 1980, TUBERCLE, V61, P145, DOI 10.1016/0041-3879(80)90003-3; HE H, 1991, FEMS MICROBIOL IMMUN, V76, P201; Hothorn T, 2008, J STAT SOFTW, V28, P1; Imaz MS, 2004, J CLIN MICROBIOL, V42, P884, DOI 10.1128/JCM.42.2.884-887.2004; Joosten SA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005687; Julian E, 2002, J CLIN MICROBIOL, V40, P3782, DOI 10.1128/JCM.40.10.3782-3788.2002; Kashima K, 1995, DIGEST DIS SCI, V40, P2630, DOI 10.1007/BF02220452; KATO M, 1972, INFECT IMMUN, V5, P203, DOI 10.1128/IAI.5.2.203-212.1972; Kawamura M, 1997, J CLIN LAB ANAL, V11, P140, DOI 10.1002/(SICI)1098-2825(1997)11:3<140::AID-JCLA4>3.0.CO;2-E; Khan IH, 2011, CLIN VACCINE IMMUNOL, V18, P2148, DOI 10.1128/CVI.05304-11; Kik SV, 2015, J INFECT DIS, V211, pS58, DOI 10.1093/infdis/jiu817; KIRAN U, 1985, EUR J RESPIR DIS, V66, P187; Kunnath-Velayudhan S, 2010, P NATL ACAD SCI USA, V107, P14703, DOI 10.1073/pnas.1009080107; Lagrange PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096367; Lemmer Y, 2009, METHOD ENZYMOL, V464, P79, DOI 10.1016/S0076-6879(09)64005-2; Lu LL, 2016, CELL, V167, P433, DOI 10.1016/j.cell.2016.08.072; Lyashchenko K, 1998, INFECT IMMUN, V66, P3936, DOI 10.1128/IAI.66.8.3936-3940.1998; MAEKURA R, 1993, AM REV RESPIR DIS, V148, P997, DOI 10.1164/ajrccm/148.4_Pt_1.997; Maekura R, 2001, J CLIN MICROBIOL, V39, P3603, DOI 10.1128/JCM.39.10.3603-3608.2001; Matsunaga I, 1996, J BIOCHEM-TOKYO, V120, P663; Nathanson CM, 2010, INT J TUBERC LUNG D, V14, P1461; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413; Pan JW, 1999, MICROBIOL IMMUNOL, V43, P863, DOI 10.1111/j.1348-0421.1999.tb01221.x; Perkins MD, 2000, INT J TUBERC LUNG D, V4, pS182; Pottumarthy S, 2000, J CLIN MICROBIOL, V38, P2227; R Core Team, 2013, R LANG ENV STAT COMP; Rao V, 2005, J EXP MED, V201, P535, DOI 10.1084/jem.20041668; Rao V, 2006, J CLIN INVEST, V116, P1660, DOI 10.1172/JCI27335; Ridgeway G., 2015, GEN BOOSTED REGRESSI; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Ryll R, 2001, MICROBIOL IMMUNOL, V45, P801, DOI 10.1111/j.1348-0421.2001.tb01319.x; Samanich K, 2001, INFECT IMMUN, V69, P4600, DOI 10.1128/IAI.69.7.4600-4609.2001; Samanich KM, 2000, CLIN DIAGN LAB IMMUN, V7, P662, DOI 10.1128/CDLI.7.4.662-668.2000; Schleicher GK, 2002, CLIN CHEM LAB MED, V40, P882, DOI 10.1515/CCLM.2002.156; Schumacher SG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151073; Simonney N, 1996, J IMMUNOL METHODS, V199, P101, DOI 10.1016/S0022-1759(96)00169-X; Simonney N, 2007, TUBERCULOSIS, V87, P109, DOI 10.1016/j.tube.2006.05.005; Sirhan MM, 2013, THESIS; Steingart KR, 2007, THORAX, V62, P911, DOI 10.1136/thx.2006.075754; Steingart KR, 2007, PLOS MED, V4, P1041, DOI 10.1371/journal.pmed.0040202; Steingart KR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001062; Steingart KR, 2009, CLIN VACCINE IMMUNOL, V16, P260, DOI 10.1128/CVI.00355-08; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Taher SG, 2015, CHEM PHYS LIPIDS, V189, P28, DOI 10.1016/j.chemphyslip.2015.05.004; Tanimura T, 2014, EUR RESPIR J, V43, P1763, DOI 10.1183/09031936.00193413; Thanyani ST, 2008, J IMMUNOL METHODS, V332, P61, DOI 10.1016/j.jim.2007.12.009; Ueda S, 2001, MICROB PATHOGENESIS, V30, P91, DOI 10.1006/mpat.2000.0413; Velayudhan S, 2013, FRONT IMMUNOL, V4; Verschoor J, 2010, TROP MED INT HEALTH, V15, pS26; Watanabe M, 2002, MICROBIOL-SGM, V148, P1881, DOI 10.1099/00221287-148-6-1881; Watanabe M, 2001, MICROBIOL-SGM, V147, P1825, DOI 10.1099/00221287-147-7-1825; WHO, 2011, WHO LIB CAT IN PUBL; WHO, 2014, HIGH PRIOR TARG PROD; World Health Organization, DEF REP FRAM TUB 201	74	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2017	12	8							e0181414	10.1371/journal.pone.0181414	http://dx.doi.org/10.1371/journal.pone.0181414			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD5CP	28806423	Green Submitted, Green Published, gold			2022-12-26	WOS:000407548800007
J	Wong, P; Strange, W				Wong, Puisan; Strange, Winifred			Phonetic complexity affects children's Mandarin tone production accuracy in disyllabic words: A perceptual study	PLOS ONE			English	Article							LEXICAL TONE; PROTRACTED DEVELOPMENT; SPEAKING CHILDREN; SPEECH; COARTICULATION; ACQUISITION; CHINESE; ADULTS; VARIABILITY; REALIZATION	This is the first study to examine the effect of phonetic contexts on children's lexical tone production. Mandarin tones in disyllabic words produced by forty-four 2- to 6-year-old children and twelve mothers were low-pass filtered to eliminate lexical information. Native Mandarin-speaking adults categorized the tones based on the pitch information in the filtered stimuli. All mothers' tones were categorized with ceiling accuracy. Counter to the findings in most previous studies on children's tone acquisition and the prevailing assumption in models of speech development that children acquire suprasegmental features much earlier than segmental features, this study found that children as old as six years of age have not mastered the production of Mandarin tones. Children's tones were judged with significantly lower accuracy than mothers' productions. Tone accuracy improved, while cross subject variability in tone accuracy decreased, with age. Children's tone accuracy was affected by the articulatory complexity of phonetic contexts. Children made more errors in tone combinations with more complex fundamental frequency (F0) contours than tone sequences with simpler F0 changes. When producing disyllabic tone sequences with complex F0 contours, children tended to shift the F0 contour of the first tone to reduce the F0 change, resulting in more tone errors in the first syllable than in the second syllable and showing substantially more anticipatory coarticulation than adults. The results provide further evidence that acquisition of lexical tones is a protracted process in children. Tones produced accurately by children in one phonetic context may not be produced correctly in another phonetic context. Children demonstrate more anticipatory coarticulation in their disyllabic productions than adults, which may be attributed to children's immature speech motor control in tone production, and is presumably a by-product of their inability to accomplish complex F0 changes within the syllable time-frame.	[Wong, Puisan] Univ Hong Kong, Div Speech & Hearing Sci, Fac Educ, Pokfulam, Hong Kong, Peoples R China; [Strange, Winifred] CUNY, Grad Sch, PhD Program Speech Language Hearing Sci, New York, NY USA; [Strange, Winifred] CUNY, Univ Ctr, New York, NY 10021 USA	University of Hong Kong; City University of New York (CUNY) System; City University of New York (CUNY) System	Wong, P (corresponding author), Univ Hong Kong, Div Speech & Hearing Sci, Fac Educ, Pokfulam, Hong Kong, Peoples R China.	pswResearch@gmail.com	Wong, Puisan/P-5362-2019	Wong, Puisan/0000-0001-9027-8054	National Institute of Health (NIH-NIDCD) [1F31DC008470-01A1]; East Asia and Pacific Summer Institute (EAPSI) of the National Science Foundation (NSF) [OISE-0611641]; National Science Foundation (NSF) [OISE-0611641]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC008470] Funding Source: NIH RePORTER	National Institute of Health (NIH-NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); East Asia and Pacific Summer Institute (EAPSI) of the National Science Foundation (NSF); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by funding from the National Institute of Health (NIH-NIDCD 1F31DC008470-01A1, https://researchtraining.nih.gov/programs/fellowships/F31) and the East Asia and Pacific Summer Institute (EAPSI) of the National Science Foundation (NSF) (OISE-0611641, https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5284) to the first author.; This research was supported by funding from the National Institute of Health (NIH-NIDCD 1F31DC008470-01A1, https://researchtraining.nih.gov/programs/fellowships/F31) and the National Science Foundation (NSF) (OISE-0611641, https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5284) to the first author.	Bowles AR, 2016, LANG LEARN, V66, P774, DOI 10.1111/lang.12159; Chang C.B., 2016, HERITAGE LANGUAGE J, V13, P134, DOI [10.13140/RG.2.2.28570.39363, DOI 10.13140/RG.2.2.28570.39363]; Chang CB, 2015, J ACOUST SOC AM, V138, P3703, DOI 10.1121/1.4937612; Chao YR, 1951, U CALIFORNIA PUBLICA, V1, P27; Clumeck H., 1980, CHILD PHONOLOGY, P257; COOPER RP, 1994, CHILD DEV, V65, P1663, DOI 10.2307/1131286; Crelin ES, 1987, HUMAN VOCAL TRACT AN; Duanmu S., 2007, PHONOLOGY STANDARD C, V2nd; Fu Q-J, 2000, ASIA PAC J SPEECH LA, V5, P45, DOI DOI 10.1179/136132800807547582; Goffman L, 1999, J EXP PSYCHOL HUMAN, V25, P649, DOI 10.1037/0096-1523.25.3.649; Goffman L, 2007, J SPEECH LANG HEAR R, V50, P444, DOI 10.1044/1092-4388(2007/031); Goffman L, 2008, J SPEECH LANG HEAR R, V51, P1424, DOI 10.1044/1092-4388(2008/07-0020); GOODELL EW, 1993, J SPEECH HEAR RES, V36, P707, DOI 10.1044/jshr.3604.707; Hirano M, 1981, STRUCTURE VOCAL FOLD; Hua Z, 2000, J CHILD LANG, V27, P3, DOI 10.1017/S030500099900402X; Hua Z., 2002, PHONOLOGICAL DEV SPE; Katz WF, 2001, CLIN LINGUIST PHONET, V15, P139, DOI 10.3109/02699200109167646; Kent R., 1992, PHONOLOGICAL DEV MOD, P65; Kent R. D., 1995, DEV CRANIOFACIAL ORA; KENT RD, 1976, J SPEECH HEAR RES, V19, P421, DOI 10.1044/jshr.1903.421; Kent RD, 1983, SEGMENTAL ORG SPEECH, P57; KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; LI CN, 1977, J CHILD LANG, V4, P185, DOI 10.1017/S0305000900001598; LIN B, 1994, LANGUAGE DISORDER SC; NITTROUER S, 1989, J SPEECH HEAR RES, V32, P120, DOI 10.1044/jshr.3201.120; Pena M, 2012, J NEUROSCI, V32, P11159, DOI 10.1523/JNEUROSCI.6516-11.2012; REPP BH, 1986, J ACOUST SOC AM, V79, P1616, DOI 10.1121/1.393298; SERENO JA, 1987, J PHONETICS, V15, P247, DOI 10.1016/S0095-4470(19)30569-8; Singh L, 2016, CHILD DEV, V87, P834, DOI 10.1111/cdev.12512; Smith A, 2006, J COMMUN DISORD, V39, P331, DOI 10.1016/j.jcomdis.2006.06.017; Snow D, 1998, J SPEECH LANG HEAR R, V41, P576, DOI 10.1044/jslhr.4103.576; Sussman HM, 1999, J SPEECH LANG HEAR R, V42, P1080, DOI 10.1044/jslhr.4205.1080; Walsh B, 2002, J SPEECH LANG HEAR R, V45, P1119, DOI 10.1044/1092-4388(2002/090); WERKER JF, 1984, INFANT BEHAV DEV, V7, P49, DOI 10.1016/S0163-6383(84)80022-3; Wohlert AB, 2002, J SPEECH LANG HEAR R, V45, P1077, DOI 10.1044/1092-4388(2002/086); Wong P, FRONTIERS P IN PRESS; Wong PS, 2005, J SPEECH LANG HEAR R, V48, P1065, DOI 10.1044/1092-4388(2005/074); Wong P, 2013, J ACOUST SOC AM, V133, P434, DOI 10.1121/1.4768883; Wong P, 2012, J SPEECH LANG HEAR R, V55, P1423, DOI 10.1044/1092-4388(2012/11-0273); Wong PS, 2012, J PHONETICS, V40, P141, DOI 10.1016/j.wocn.2011.10.005; Xin L, 2004, J ACOUST SOC AM, V116, P3659, DOI 10.1121/1.1783352; Xu Y, 2005, J PHONETICS, V33, P159, DOI 10.1016/j.wocn.2004.11.001; Xu Y, 2002, J ACOUST SOC AM, V111, P1399, DOI 10.1121/1.1445789; Xu Y, 1997, J PHONETICS, V25, P61, DOI 10.1006/jpho.1996.0034; XU Y, 1994, J ACOUST SOC AM, V95, P2240, DOI 10.1121/1.408684; Xu Y, 2001, SPEECH COMMUN, V33, P319, DOI 10.1016/S0167-6393(00)00063-7; Xu Y., 2001, J CHINESE LINGUISTIC, V17, P1; Xu Y, 2009, J PHONETICS, V37, P502, DOI 10.1016/j.wocn.2009.08.003; Zharkova N, 2011, MOTOR CONTROL, V15, P118, DOI 10.1123/mcj.15.1.118; Zimmerman I.L., 2002, PRESCHOOL LANGUAGE S	50	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2017	12	8							e0182337	10.1371/journal.pone.0182337	http://dx.doi.org/10.1371/journal.pone.0182337			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD5CP	28806417	gold, Green Submitted, Green Published			2022-12-26	WOS:000407548800017
J	Mason, ED; Firn, J; Hines, HB; Baker, AM				Mason, Eugene D.; Firn, Jennifer; Hines, Harry B.; Baker, Andrew M.			Plant diversity and structure describe the presence of a new, threatened Australian marsupial within its highly restricted, post-fire habitat	PLOS ONE			English	Article							FIRE-PRONE LANDSCAPES; ANTECHINUS-MINIMUS-MARITIMUS; SILVER-HEADED ANTECHINUS; MUMBULLA STATE FOREST; NEW-SOUTH-WALES; SMALL MAMMALS; SOUTHEASTERN AUSTRALIA; EUCALYPT FOREST; CLIMATE-CHANGE; KROOMBIT TOPS	Management of critical habitat for threatened species with small ranges requires location-specific, fine-scale survey data. The silver-headed antechinus (Antechinus argentus) is known from only two isolated, fire-prone locations. At least one of these populations, at Kroombit Tops National Park in central-eastern Queensland, Australia, possesses a very small range. Here, we present detailed vegetation species diversity and structure data from three sites comprising the known habitat of A. argentus at Kroombit Tops and relate it to capture data obtained over two years. We found differences in both vegetation and capture data between burnt and unburnt habitat. Leaf litter and grasstrees (Xanthorrhoea johnsonii) were the strongest vegetative predictors for A. argentus capture. The species declined considerably over the two years of the trapping study, and we raise concern for its survival at Kroombit Tops. We suggest that future work should focus on structural vegetative variables (specifically, the diameter and leaf density of grasstree crowns) and relate them to A. argentus occurrence. We also recommend a survey of invertebrate diversity in grasstrees and leaf litter with a comparison to A. argentus prey. The data presented here illustrates how critical detailed monitoring is for planning habitat management and fire regimes, and highlights the utility of a high-resolution approach to habitat mapping. While a traditional approach to fire management contends that pyrodiversity encourages biodiversity, the present study demonstrates that some species prefer long-unburnt habitat. Additionally, in predicting the distribution of rare species like A. argentus, data quality (i.e., spatial resolution) may prevail over data quantity (i.e., number of data).	[Mason, Eugene D.; Firn, Jennifer; Baker, Andrew M.] Queensland Univ Technol, Earth Environm & Biol Sci Sch, Brisbane, Qld, Australia; [Hines, Harry B.; Baker, Andrew M.] Queensland Museum, South Brisbane, Qld, Australia; [Hines, Harry B.] Dept Natl Pk Sport & Racing, Queensland Pk & Wildlife Serv, Level 19, Brisbane, Qld, Australia	Queensland University of Technology (QUT); Queensland Museum	Mason, ED (corresponding author), Queensland Univ Technol, Earth Environm & Biol Sci Sch, Brisbane, Qld, Australia.	Eugene.mason@connect.qut.edu.au		Baker, Andrew/0000-0001-8825-1522	Fitzroy Basin Association [RGD14]; Burnett Mary Regional Group [S150000]	Fitzroy Basin Association; Burnett Mary Regional Group	EDM and AMB were funded by the Fitzroy Basin Association with activity agreement RGD14 (https://www.fba.org.au/). EDM and AMB were also funded by the Burnett Mary Regional Group with activity agreement S150000 (http://www.bmrg.org.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberton JG, 1996, ANTECHINUS MINIMUS; Allison LM, 2006, WILDLIFE RES, V33, P67, DOI 10.1071/WR05038; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Andren H, 1994, EFFECTS HABITAT FRAG, P355; Andrew N, 2000, AUSTRAL ECOL, V25, P99, DOI 10.1046/j.1442-9993.2000.01015.x; Baker AM, 2013, ZOOTAXA, V3746, P201, DOI 10.11646/zootaxa.3746.2.1; Banks SC, 2005, BIOL CONSERV, V122, P581, DOI 10.1016/j.biocon.2004.09.013; BENNETT AF, 1993, WILDLIFE RES, V20, P267, DOI 10.1071/WR9930267; Berry LE, 2015, J APPL ECOL, V52, P486, DOI 10.1111/1365-2664.12387; Borsboom A., 2005, XANTHORRHOEA REV CUR; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; BURBIDGE AA, 1989, BIOL CONSERV, V50, P143, DOI 10.1016/0006-3207(89)90009-8; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Chia EK, 2016, FOREST ECOL MANAG, V363, P130, DOI 10.1016/j.foreco.2015.12.008; Clarke KR, 2015, PRIMER V7 USER MANUA; Dale VH, 2001, BIOSCIENCE, V51, P723, DOI 10.1641/0006-3568(2001)051[0723:CCAFD]2.0.CO;2; DAUBENMIRE R., 1959, NORTHWEST SCI, V33, P43; Dickman CR, 1996, WILDLIFE BIOL, V2, P185, DOI 10.2981/wlb.1996.018; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x; FOX BJ, 1982, ECOLOGY, V63, P1332, DOI 10.2307/1938861; FOX BJ, 1979, AUST J BOT, V27, P157, DOI 10.1071/BT9790157; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; FRIEND GR, 1985, AUST J ECOL, V10, P173, DOI 10.1111/j.1442-9993.1985.tb00879.x; Gill AM, 2013, ECOL APPL, V23, P438, DOI 10.1890/10-2213.1; Green K., 1989, WILDLIFE RES, V16, P581, DOI [10.1071/WR9890581, DOI 10.1071/WR9890581]; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hindmarsh R., 1977, FOOD REQUIREMENTS MA; Hines H. B., 2014, Queensland Naturalist, V52, P4; Hobbs RJ, 2005, WILDLIFE RES, V32, P389, DOI 10.1071/WR03037; Holland GJ, 2007, WILDLIFE RES, V34, P387, DOI 10.1071/WR07061; Hutto RL, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1255; Kelly LT, 2017, SCIENCE, V355, P1264, DOI 10.1126/science.aam7672; Kelly LT, 2016, CONSERV BIOL; Kelly LT, 2013, AUSTRAL ECOL, V38, P786, DOI 10.1111/aec.12018; Knight EH, 2000, AUST J ZOOL, V48, P577, DOI 10.1071/ZO00018; Leahy L, 2015, WILDLIFE RES, V42, P705, DOI 10.1071/WR15011; Legge S, 2011, AUSTRAL ECOL, V36, P791, DOI 10.1111/j.1442-9993.2010.02218.x; Letnic M, 2004, J ARID ENVIRON, V59, P85, DOI 10.1016/j.jaridenv.2004.01.014; Lucas C., 2007, Bushfire weather in Southeast Australia: recent trends and projected climate change impacts; LUNNEY D, 1987, AUST WILDLIFE RES, V14, P163; Lunney D, 2001, WILDLIFE RES, V28, P459, DOI 10.1071/WR00015; Martin RE, 1992, P C BIOD NW CAL EC C; Mason ED, 2016, MAMMAL RES, P1; Mason ED, 2015, AUST MAMMAL, V37, P164, DOI 10.1071/AM14036; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; MCDONALD WJF, 1986, QUEENSL NATURALIST, V27, P3; McGregor HW, 2016, WILDLIFE RES, V43, P623, DOI 10.1071/WR16058; McGregor HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109097; Monamy V, 2010, AUSTRAL ECOL, V35, P334, DOI 10.1111/j.1442-9993.2009.02042.x; Moritz MA, 2013, ANN NY ACAD SCI, V1286, P92, DOI 10.1111/nyas.12104; NEWELL GR, 1993, WILDLIFE RES, V20, P251, DOI 10.1071/WR9930251; Pearson DE, 2003, WILDLIFE SOC B, V31, P454; Peet RK, 1998, FLEXIBLE MULTIPURPOS, P262; Penn AM, 2003, WILDLIFE RES, V30, P477, DOI 10.1071/WR02080; Ponisio LC, 2016, PYRODIVERSITY BEGETS; PURDIE RW, 1976, AUST J ECOL, V1, P223, DOI 10.1111/j.1442-9993.1976.tb01111.x; Recher HF, 2009, WILDLIFE RES, V36, P143, DOI 10.1071/WR08086; Regional Ecosystem Description Database (REDD), 2016, QUEENSL DEP SCI INF; Ridgeway G, 2006, GBM GENERALIZED BOOS, V1, P55; Robinson NM, 2014, FOREST ECOL MANAG, V318, P110, DOI 10.1016/j.foreco.2014.01.008; Robinson NM, 2013, J APPL ECOL, V50, P1321, DOI 10.1111/1365-2664.12153; Russell-Smith J, 1998, J APPL ECOL, V35, P829, DOI 10.1111/j.1365-2664.1998.tb00002.x; Stawski C, 2017, J EXP BIOL, V220, P220, DOI 10.1242/jeb.146548; Stokes VL, 2004, BIOL CONSERV, V117, P331, DOI 10.1016/j.biocon.2003.12.012; Swinburn ML, 2007, WILDLIFE RES, V34, P640, DOI 10.1071/WR07035; Team RC, 2015, R LANG ENV STAT COMP; Tingley MW, 2016, P ROYAL SOC B; Van Loon A, 1970, FORESTRY COMMISSION; Wakefield NA, 1967, SOME REVISION ANTECH; Whelan R, 1994, P LINNEAN SOC NEW S; Wilson B, 1990, P ECOLOGICAL SOC AUS; WILSON BA, 1986, AUST WILDLIFE RES, V13, P397; Wilson BA, 2001, WILDLIFE RES, V28, P527, DOI 10.1071/WR00016; Woolley P, 1966, S ZOO LOGICAL SOC LO; York A, 1999, J INSECT CONSERV, V3, P191, DOI 10.1023/A:1009643627781	77	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182319	10.1371/journal.pone.0182319	http://dx.doi.org/10.1371/journal.pone.0182319			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797038	Green Submitted, Green Published, gold			2022-12-26	WOS:000407396200043
J	Perez-Losada, M; Graham, RJ; Coquillette, M; Jafarey, A; Castro-Nallar, E; Aira, M; Freishtat, RJ; Mansbach, JM				Perez-Losada, Marcos; Graham, Robert J.; Coquillette, Madeline; Jafarey, Amenah; Castro-Nallar, Eduardo; Aira, Manuel; Freishtat, Robert J.; Mansbach, Jonathan M.			The temporal dynamics of the tracheal microbiome in tracheostomised patients with and without lower respiratory infections	PLOS ONE			English	Article							PATHOGENIC BACTERIA; LUNG MICROBIOME; CHILDREN; HEALTH; RISK; PNEUMONIA; EVOLUTION	Background Airway microbiota dynamics during lower respiratory infection (LRI) are still poorly understood due, in part, to insufficient longitudinal studies and lack of uncontaminated lower airways samples. Furthermore, the similarity between upper and lower airway microbiomes is still under debate. Here we compare the diversity and temporal dynamics of microbiotas directly sampled from the trachea via tracheostomy in patients with (YLRI) and without (NLRI) lower respiratory infections. Methods We prospectively collected 127 tracheal aspirates across four consecutive meteorological seasons (quarters) from 40 patients, of whom 20 developed LRIs and 20 remained healthy. All aspirates were collected when patients had no LRI. We generated 16S rRNA-based microbial profiles (similar to 250 bp) in a MiSeq platform and analyzed them using Mothur and the SILVAv123 database. Differences in microbial diversity and taxon normalized (via negative binomial distribution) abundances were assessed using linear mixed effects models and multivariate analysis of variance. Results and discussion Alpha-diversity (ACE, Fisher and phylogenetic diversity) and beta-diversity (Bray-Curtis, Jaccard and Unifrac distances) indices varied significantly (P<0.05) between NLRI and YLRI microbiotas from tracheostomised patients. Additionally, Haemophilus was significantly (P = 0.009) more abundant in YLRI patients than in NLRI patients, while Acinetobacter, Corynebacterium and Pseudomonas (P<0.05) showed the inverse relationship. We did not detect significant differences in diversity and bacterial abundance among seasons. This result disagrees with previous evidence suggesting seasonal variation in airway microbiotas. Further study is needed to address the interaction between microbes and LRI during times of health and disease.	[Perez-Losada, Marcos] George Washington Univ, Milken Inst Sch Publ Hlth, Computat Biol Inst, Washington, DC 20052 USA; [Perez-Losada, Marcos; Jafarey, Amenah; Freishtat, Robert J.] Childrens Natl Med Ctr, Div Emergency Med, Washington, DC 20010 USA; [Perez-Losada, Marcos] Univ Porto, CIBIO InBIO, Campus Agr Vairao, Vairao, Portugal; [Graham, Robert J.] Harvard Med Sch, Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Div Crit Care Med, Boston, MA USA; [Coquillette, Madeline; Mansbach, Jonathan M.] Harvard Med Sch, Boston Childrens Hosp, Dept Med, Boston, MA USA; [Castro-Nallar, Eduardo] Univ Andres Bello, Fac Ciencias Biol, Ctr Bioinformat & Integrat Biol, Santiago, Chile; [Aira, Manuel] Univ Vigo, Dept Ecol & Biol Anim, Vigo, Spain	George Washington University; Children's National Health System; Universidade do Porto; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Universidad Andres Bello; Universidade de Vigo	Perez-Losada, M (corresponding author), George Washington Univ, Milken Inst Sch Publ Hlth, Computat Biol Inst, Washington, DC 20052 USA.; Perez-Losada, M (corresponding author), Childrens Natl Med Ctr, Div Emergency Med, Washington, DC 20010 USA.; Perez-Losada, M (corresponding author), Univ Porto, CIBIO InBIO, Campus Agr Vairao, Vairao, Portugal.	mlosada323@gmail.com	Castro-Nallar, Eduardo/I-5925-2019; Graham, Robert J/AAJ-9835-2021; Aira, Manuel/B-4506-2016; Perez-Losada, Marcos/I-4407-2013	Castro-Nallar, Eduardo/0000-0003-4384-8661; Graham, Robert J/0000-0002-8659-6313; Aira, Manuel/0000-0002-2513-4609; Perez-Losada, Marcos/0000-0002-2585-4657; Freishtat, Robert/0000-0002-7411-2342	Office of Faculty Development at Boston Children's Hospital; K12 Career Development Program [K12HL119994]; Margaret Q. Landenberger Research Foundation; NIH National Center for Advancing Translational Sciences [UL1TR001876, KL2TR001877]; CONICYT + PAI/CONCURSO NACIONAL APOYO AL RETORNO DE INVESTIGADORES/AS DESDE EL EXTRANJERO, CONVOCATORIA [FOLIO 82140008]	Office of Faculty Development at Boston Children's Hospital; K12 Career Development Program; Margaret Q. Landenberger Research Foundation; NIH National Center for Advancing Translational Sciences; CONICYT + PAI/CONCURSO NACIONAL APOYO AL RETORNO DE INVESTIGADORES/AS DESDE EL EXTRANJERO, CONVOCATORIA	This work was supported by a special recognition grant from the Office of Faculty Development at Boston Children's Hospital to JMM. MP-L was funded in part by a K12 Career Development Program K12HL119994. This research was funded in part by a Margaret Q. Landenberger Research Foundation award to MP L. MP-L was also partially supported by Award Numbers UL1TR001876 and KL2TR001877 from the NIH National Center for Advancing Translational Sciences. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the National Center for Advancing Translational Sciences or the National Institutes of Health. ECN was funded by "CONICYT + PAI/CONCURSO NACIONAL APOYO AL RETORNO DE INVESTIGADORES/AS DESDE EL EXTRANJERO, CONVOCATORIA 2014 + FOLIO 82140008".	Allen EK, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-22; Antunes LCS, 2014, PATHOG DIS, V71, P292, DOI 10.1111/2049-632X.12125; Bassis CM, 2015, MBIO, V6, DOI 10.1128/mBio.00037-15; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Berry JG, 2009, PEDIATRICS, V124, P563, DOI 10.1542/peds.2008-3491; Biesbroek G, 2014, AM J RESP CRIT CARE, V190, P1283, DOI 10.1164/rccm.201407-1240OC; Bogaert D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017035; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; Bureau MCH., 2008, PREVALENCE OF CSHCN; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carlsson CJ, 2015, J ALLERGY CLIN IMMUN, V136, P1208, DOI 10.1016/j.jaci.2015.05.003; Castro-Nallar E, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0121-1; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Cremers AJH, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-44; Dickson RP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004923; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Dosa NP, 2001, PEDIATRICS, V107, P499, DOI 10.1542/peds.107.3.499; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Folsgaard NV, 2013, AM J RESP CRIT CARE, V187, P589, DOI 10.1164/rccm.201207-1297OC; Graham Robert J, 2005, Pediatr Crit Care Med, V6, P327, DOI 10.1097/01.PCC.0000161286.14032.6D; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Huang YJ, 2013, AM J RESP CRIT CARE, V187, P1382, DOI 10.1164/rccm.201303-0488WS; Hurley JC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1921-4; Johnson CL, 2012, PEDIATRICS, V129, P950, DOI 10.1542/peds.2011-2736; Kloepfer KM, 2014, J ALLERGY CLIN IMMUN, V133, P1301, DOI 10.1016/j.jaci.2014.02.030; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Larsen JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031976; Larsen JM, 2014, IMMUNOLOGY; Laufer AS, 2011, MBIO, V2, DOI 10.1128/mBio.00245-10; Lemon KP, 2010, MBIO, V1, DOI 10.1128/mBio.00129-10; Liptak GS, 1998, ARCH PEDIAT ADOL MED, V152, P1003; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Mackenzie GA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-304; Marchesi JR, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0094-5; Marsh RL, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0182-1; McCaleb R, 2016, RESP CARE, V61, P447, DOI 10.4187/respcare.03518; McCarthy K, 2015, SEMIN RESP CRIT CARE, V36, P44, DOI 10.1055/s-0034-1396907; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; McPherson ML, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e94; Morris A, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0183-0; Oliver A, 2015, DRUG RESIST UPDATE, V21-22, P41, DOI 10.1016/j.drup.2015.08.002; Perez-Losada M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170543; Perez-Losada M, 2016, AIMS MICROBIOL, V2, P108, DOI 10.3934/microbiol.2016.2.108; Perez-Losada M, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0170-5; Perez-Losada M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131819; Pillai DK, 2011, J INVEST MED, V59, P938, DOI 10.2310/JIM.0b013e318220df41; Prevaes SM, 2015, AM J RESP CRIT CARE; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; RDevelopmentCoreTeam, 2008, R LANG ENV STAT COMP; RStudio, 2015, RSTUDIO INT DEV R; Rusakow LS, 1998, CHEST, V113, P1549, DOI 10.1378/chest.113.6.1549; Sakwinska O, 2014, J CLIN MICROBIOL, V52, P1590, DOI 10.1128/JCM.03280-13; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Teo SM, 2015, CELL HOST MICROBE, V17, P704, DOI 10.1016/j.chom.2015.03.008; Toma I, 2014, J CLIN MICROBIOL, V52, P3913, DOI 10.1128/JCM.01678-14; Tomosada Y, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-40; Vissers M, 2014, MUCOSAL IMMUNOL, V7, P227, DOI 10.1038/mi.2013.93; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07	60	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182520	10.1371/journal.pone.0182520	http://dx.doi.org/10.1371/journal.pone.0182520			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796800	Green Published, gold, Green Submitted			2022-12-26	WOS:000407396200057
J	Yu, J; Oh, PC; Kim, M; Moon, J; Park, YM; Lee, K; Suh, SY; Han, SH; Byun, K; Ahn, T; Kang, WC				Yu, Jongwook; Oh, Pyung Chun; Kim, Minsu; Moon, Jeonggeun; Park, Yae Min; Lee, Kyounghoon; Suh, Soon Yong; Han, Seung Hwan; Byun, Kyunghee; Ahn, Taehoon; Kang, Woong Chol			Improved early risk stratification of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention using a combination of serum soluble ST2 and NT-proBNP	PLOS ONE			English	Article							RECEPTOR FAMILY-MEMBER; ACUTE HEART-FAILURE; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; NATRIURETIC PEPTIDE; BARE-METAL; MARKERS; INFLAMMATION; BIOMARKERS; MORTALITY	Background Although soluble suppression of tumorigenicity 2 (sST2) in serum is known to be associated with ischemic heart disease and heart failure, data regarding its prognostic impact in ST-segment elevation myocardial infarction (STEMI) is limited. We evaluated the prognostic impacts of serum sST2 and other serum biomarkers in STEMI patients undergoing primary percutaneous coronary intervention (PCI). Methods Consecutive all 323 patients with STEMI that underwent primary PCI were enrolled. Blood tests and samples were obtained in an emergency room. The primary endpoint was 1-year major adverse cardiovascular and cerebrovascular events (MACCEs), defined as a composite of cardiovascular death, non-fatal MI, non-fatal stroke, and ischemia-driven revascularization. Results Mean age was 59.1 +/- 13.1 years (men 84%). MACCE (20 cardiovascular deaths, 7 non-fatal MI, 4 non-fatal stroke, 7 ischemia-driven revascularizations) occurred in 38 patients (12%). After adjusting for confounding factors, Cox regression analysis revealed that high serum sST2 (>75.8 ng/mL mean value, adjusted hazard ratio 2.098, 95% CI 1.008-4.367, p = 0.048) and high serum NT-proBNP level (>400 pg/mL, adjusted hazard ratio 2.606, 95% CI 1.086-6.257, p = 0.032) at the time of presentation independently predicted MACCE within a year of primary PCI. Furthermore, when high serum sST2 level was combined with high serum NT-proBNP level, the hazard ratio of MACCE was highest (adjusted hazard ratio 7.93, 95% CI 2.97-20.38, p<0.001). Conclusion Elevated serum levels of sST2 or NT-proBNP at the time of presentation were found to predict 1-year MACCE independently and elevated serum levels of sST2 plus NT-proBNP were associated with even poorer prognosis in patients with STEMI undergoing primary PCI.	[Yu, Jongwook; Oh, Pyung Chun; Kim, Minsu; Moon, Jeonggeun; Park, Yae Min; Lee, Kyounghoon; Suh, Soon Yong; Han, Seung Hwan; Ahn, Taehoon; Kang, Woong Chol] Gachon Univ, Gil Med Ctr, Cardiol, Incheon, South Korea; [Oh, Pyung Chun; Moon, Jeonggeun; Park, Yae Min; Lee, Kyounghoon; Suh, Soon Yong; Han, Seung Hwan; Ahn, Taehoon; Kang, Woong Chol] Gachon Univ, Gachon Cardiovasc Res Inst, Incheon, South Korea; [Byun, Kyunghee] Gachon Univ, Grad Sch Med, Dept Anat & Cell Biol, Incheon, South Korea; [Byun, Kyunghee] Gachon Univ, Lee Gil Ya Canc & Diabet Inst, Funct Cellular Networks Lab, Incheon, South Korea	Gachon University; Gachon University; Gachon University; Gachon University	Ahn, T; Kang, WC (corresponding author), Gachon Univ, Gil Med Ctr, Cardiol, Incheon, South Korea.; Ahn, T; Kang, WC (corresponding author), Gachon Univ, Gachon Cardiovasc Res Inst, Incheon, South Korea.	encore@gilhospital.com; kangwch@gilhospital.com	안, 태훈/GON-9067-2022	안, 태훈/0000-0003-1544-1784; YU, JONGWOOK/0000-0001-7489-2222	Dong-A Pharmaceutical Company, Republic of Korea	Dong-A Pharmaceutical Company, Republic of Korea	This work was supported by research grant from the Dong-A Pharmaceutical Company, Republic of Korea. But the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbarash O, 2016, ANN LAB MED, V36, P313, DOI 10.3343/alm.2016.36.4.313; Bayes-Genis A, 2015, AM J CARDIOL, V115, p64B, DOI 10.1016/j.amjcard.2015.01.043; Chan D, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-34; Daemen J, 2009, EUROINTERVENTION, V4, P464, DOI 10.4244/EIJV4I4A80; Dhillon OS, 2013, INT J CARDIOL, V167, P2182, DOI 10.1016/j.ijcard.2012.05.073; Dhillon OS, 2011, AM HEART J, V161, P1163, DOI 10.1016/j.ahj.2011.03.025; Diez J, 2008, J AM COLL CARDIOL, V52, P1466, DOI 10.1016/j.jacc.2008.07.045; Kohli P, 2012, CLIN CHEM, V58, P257, DOI 10.1373/clinchem.2011.173369; Lindahl B, 2000, NEW ENGL J MED, V343, P1139, DOI 10.1056/NEJM200010193431602; Moon J, 2014, INT J CARDIOL, V177, P442, DOI 10.1016/j.ijcard.2014.09.002; O'Donoghue ML, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002586; O'Malley RG, 2014, J AM COLL CARDIOL, V63, P1644, DOI 10.1016/j.jacc.2013.12.034; Palmerini T, 2013, J AM COLL CARDIOL, V62, P496, DOI 10.1016/j.jacc.2013.05.022; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Piper SE, 2015, INT J CARDIOL, V178, P284, DOI 10.1016/j.ijcard.2014.11.097; Raskovalova T, 2014, EUR HEART J-ACUTE CA, V3, P18, DOI 10.1177/2048872613514015; Rehman SU, 2008, J AM COLL CARDIOL, V52, P1458, DOI 10.1016/j.jacc.2008.07.042; Richards AM, 2015, AM J CARDIOL, V115, p48B, DOI 10.1016/j.amjcard.2015.01.041; Sabatine MS, 2008, CIRCULATION, V117, P1936, DOI 10.1161/CIRCULATIONAHA.107.728022; Scirica BM, 2010, EUR HEART J, V31, P1993, DOI 10.1093/eurheartj/ehq190; Shimpo M, 2004, CIRCULATION, V109, P2186, DOI 10.1161/01.CIR.0000127958.21003.5A; Vargas KG, 2016, INT J CARDIOL, V223, P797, DOI 10.1016/j.ijcard.2016.08.304; Vieira C, 2014, REV PORT CARDIOL, V33, P127, DOI 10.1016/j.repc.2013.09.013; Weinberg EO, 2002, CIRCULATION, V106, P2961, DOI 10.1161/01.CIR.0000038705.69871.D9; Wong GC, 2002, CIRCULATION, V106, P202, DOI 10.1161/01.CIR.0000021921.14653.28; Yousuf O, 2013, J AM COLL CARDIOL, V62, P397, DOI 10.1016/j.jacc.2013.05.016	26	21	26	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182829	10.1371/journal.pone.0182829	http://dx.doi.org/10.1371/journal.pone.0182829			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796845	Green Published, gold, Green Submitted			2022-12-26	WOS:000407396200104
J	Zhang, XJ; Li, EY; Leung, CKS; Musch, DC; Tang, X; Zheng, CR; He, MG; Chang, DF; Lam, DSC				Zhang, Xiujuan; Li, Emmy Y.; Leung, Christopher Kai-Shun; Musch, David C.; Tang, Xin; Zheng, Chongren; He, Mingguang; Chang, David F.; Lam, Dennis Shun-Chiu			Prevalence of visual impairment and outcomes of cataract surgery in Chaonan, South China	PLOS ONE			English	Article							QUALITY-OF-LIFE; AVOIDABLE BLINDNESS; RAPID ASSESSMENT; RURAL CHINA; BEIJING EYE; DOUMEN COUNTY; LIWAN-EYE; URBAN; VISION; POPULATION	Purpose To estimate the prevalence and causes of blindness and visual impairment (VI), and report the outcomes of cataract surgery in Chaonan Region, Guangdong Province, southern China Design Cross-sectional population-based survey Participants A total of 3484 participants including 1397 men (40.1%) and 2087 women (59.9%) aged >= 50 years were examined (94.2% response rate). Method A two-stage cluster sampling procedure was used to select 3700 participants aged >= 50 years from 74 clusters of Chaonan Region. Participants were examined according to the Rapid Assessment of Avoidable Blindness (RAAB) method. Blindness and visual impairment (VI) were defined by the World Health Organization criteria. Participants with visual acuity (VA) < 6/18 in either eye were examined by ophthalmologists. The primary causes of blindness and VI were reported with reference to the participant's better eye. Main outcome measures Prevalence and main causes of blindness, severe visual impairment (SVI), VI and the outcomes of cataract surgery Results The standardized prevalence rates of blindness, SVI, and VI were 2.4% (95% confidence interval [CI], 1.9-2.9%), 1.0% (95% CI, 0.7-1.4%), and 6.4% (95% CI, 5.6%-7.1%), respectively. The principal cause of blindness and SVI was cataract, accounting for 67.1% and 67.6% respectively, and the principal cause of VI was refractive error (46.9%). One hundred and fifty five out of 3484 (4.4%) people (211 eyes) had cataract surgery. Of the 211 eyes that had cataract surgery, 96.7% were pseudophakic. 67.2% of the 211 operated eyes had a presenting visual acuity (PVA) of 6/18 or better. Conclusions The prevalence of blindness, SVI, and VI was high among rural residents in Chaonan. Cataract remained the leading cause of avoidable blindness. Outcomes of cataract surgery performed in rural private clinics were suboptimal. Quality-control initiatives such as hands-on training program should be introduced to improve cataract surgery outcomes.	[Zhang, Xiujuan; Li, Emmy Y.; Leung, Christopher Kai-Shun; Lam, Dennis Shun-Chiu] Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong, Hong Kong, Peoples R China; [Zhang, Xiujuan; Tang, Xin] Tianjin Eye Hosp, Tianjin, Peoples R China; [Li, Emmy Y.; Zheng, Chongren; Lam, Dennis Shun-Chiu] Project Vis Charitable Fdn, Hong Kong, Hong Kong, Peoples R China; [Li, Emmy Y.] Hong Kong Eye Hosp, Kowloon, Hong Kong, Peoples R China; [Musch, David C.] Univ Michigan, Med Sch, Dept Ophthalmol & Visual Sci, Ann Arbor, MI USA; [He, Mingguang; Lam, Dennis Shun-Chiu] Sun Yat Sen Univ, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Chang, David F.] Univ Calif San Francisco, San Francisco, CA 94143 USA	Chinese University of Hong Kong; Tianjin Medical University; University of Michigan System; University of Michigan; Sun Yat Sen University; University of California System; University of California San Francisco	Lam, DSC (corresponding author), Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong, Hong Kong, Peoples R China.; Lam, DSC (corresponding author), Project Vis Charitable Fdn, Hong Kong, Hong Kong, Peoples R China.; Lam, DSC (corresponding author), Sun Yat Sen Univ, State Key Lab Ophthalmol, Guangzhou, Guangdong, Peoples R China.	dlam.sklo.sysu.cn@gmail.com	Leung, Chris/N-8015-2019; Lam, Dennis/AAL-1211-2020; He, Mingguang/AAY-5239-2020	Leung, Chris/0000-0003-4862-777X; He, Mingguang/0000-0002-6912-2810; Musch, David/0000-0002-4164-3841; Zhang, Xiu Juan/0000-0002-4197-1423	Project Vision Charity Foundation, Hong Kong	Project Vision Charity Foundation, Hong Kong	Financial support for this research project: The Project Vision Charity Foundation, Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, 31 SAS US GROUP INT; Bureau CS, 2010, CHAONAN REGION; Dineen B, 2007, BRIT J OPHTHALMOL, V91, P1005, DOI 10.1136/bjo.2006.108035; Dua HS, 2009, BRIT J OPHTHALMOL, V93, P1, DOI 10.1136/bjo.2008.143685; He MG, 1999, OPHTHALMOLOGY, V106, P1609, DOI 10.1016/S0161-6420(99)90460-8; Huang GF, 2012, OPHTHAL EPIDEMIOL, V19, P67, DOI 10.3109/09286586.2011.628777; Huang SS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1362, DOI 10.1001/archophthalmol.2009.138; Huang W, 2012, CLIN EXPT OPHTHALMOL; Huang WY, 2011, INVEST OPHTH VIS SCI, V52, P16, DOI 10.1167/iovs.10-5382; Kandeke L, 2012, OPHTHAL EPIDEMIOL, V19, P211, DOI 10.3109/09286586.2012.690493; Kuper H, 2008, PLOS MED, V5, P1716, DOI 10.1371/journal.pmed.0050244; Kuper Hannah, 2006, Community Eye Health, V19, P68; Lam DS, 2009, CLIN EXP OPHTHALMOL, V37, P427, DOI 10.1111/j.1442-9071.2009.02084.x; Lam DSC, 2007, ARCH OPHTHALMOL-CHIC, V125, P1539, DOI 10.1001/archopht.125.11.eeb70013; Lavanya R, 2009, BRIT J OPHTHALMOL, V93, P299, DOI 10.1136/bjo.2008.148650; Li E, OPHTHALMOLO IN PRESS; Li SZ, 1999, OPHTHALMOLOGY, V106, P1602, DOI 10.1016/S0161-6420(99)90459-1; Li ZJ, 2008, OPHTHAL EPIDEMIOL, V15, P334, DOI 10.1080/09286580802227386; Liang YB, 2008, OPHTHALMOLOGY, V115, P1965, DOI 10.1016/j.ophtha.2008.05.030; Lin Y, 2007, CHINESE MED J-PEKING, V120, P280; Liu B, 2009, OPHTHALMOLOGY, V116, P1322, DOI 10.1016/j.ophtha.2009.01.030; Liu Yingpeng, 2007, Ophthalmology, V114, pe47, DOI 10.1016/j.ophtha.2007.07.013; Mathenge W, 2012, OPHTHALMOLOGY, V119, P2033, DOI 10.1016/j.ophtha.2012.04.019; Ministry of health of the people's republic of China, 2009, CHINAS CSR REPORT 20; Morchen M, 2012, ASIA-PAC J OPHTHALMO, V1, P340, DOI 10.1097/APO.0b013e3182710eff; Morchen M, 2015, ASIA-PAC J OPHTHALMO, V4, P25, DOI 10.1097/APO.0000000000000061; Ngondi J, 2006, PLOS MED, V3, P2416, DOI 10.1371/journal.pmed.0030477; Polack S, 2012, OPHTHALMOLOGY, V119, P1033, DOI 10.1016/j.ophtha.2011.11.002; Rajavi Z, 2011, OPHTHALMOLOGY, V118, P1812, DOI 10.1016/j.ophtha.2011.01.049; Taylor HR, 2016, ASIA-PAC J OPHTHALMO, V5, P95, DOI 10.1097/APO.0000000000000188; Turner AG, 1996, INT J EPIDEMIOL, V25, P198, DOI 10.1093/ije/25.1.198; Wu M, 2008, OPHTHALMOLOGY, V115, P969, DOI 10.1016/j.ophtha.2007.08.002; Xiao BX, 2010, BRIT J OPHTHALMOL, V94, P1437, DOI 10.1136/bjo.2009.165308; Xu L, 2006, AM J OPHTHALMOL, V141, P591, DOI 10.1016/j.ajo.2005.10.018; Xu L, 2006, OPHTHALMOLOGY, V113, P1134, DOI 10.1016/j.ophtha.2006.01.035; Yan XX, 2012, ASIA-PAC J OPHTHALMO, V1, P69, DOI 10.1097/APO.0b013e31824a4383; Zhang XJ, 2013, OPHTHALMOLOGY, V120, P260, DOI 10.1016/j.ophtha.2012.07.087; Zhao JL, 2010, OPHTHALMOLOGY, V117, P2120, DOI 10.1016/j.ophtha.2010.03.005; Zhao JL, 2010, OPHTHALMOLOGY, V117, P409, DOI 10.1016/j.ophtha.2009.11.023; Zhao JL, 1998, AM J OPHTHALMOL, V126, P515, DOI 10.1016/S0002-9394(98)00274-8	40	15	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0180769	10.1371/journal.pone.0180769	http://dx.doi.org/10.1371/journal.pone.0180769			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797099	Green Published, gold, Green Submitted			2022-12-26	WOS:000407396200007
J	Giannini, TC; Costa, WF; Cordeiro, GD; Imperatriz-Fonseca, VL; Saraiva, AM; Biesmeijer, J; Garibaldi, LA				Giannini, Tereza Cristina; Costa, Wilian Franca; Cordeiro, Guaraci Duran; Imperatriz-Fonseca, Vera Lucia; Saraiva, Antonio Mauro; Biesmeijer, Jacobus; Alejandro Garibaldi, Lucas			Projected climate change threatens pollinators and crop production in Brazil	PLOS ONE			English	Article							GLOBAL CHANGE; CONSERVATION; YIELD; BIODIVERSITY	Animal pollination can impact food security since many crops depend on pollinators to produce fruits and seeds. However, the effects of projected climate change on crop pollinators and therefore on crop production are still unclear, especially for wild pollinators and aggregate community responses. Using species distributional modeling, we assessed the effects of climate change on the geographic distribution of 95 pollinator species of 13 Brazilian crops, and we estimated their relative impacts on crop production. We described these effects at the municipality level, and we assessed the crops that were grown, the gross production volume of these crops, the total crop production value, and the number of inhabitants. Overall, considering all crop species, we found that the projected climate change will reduce the probability of pollinator occurrence by almost 0.13 by 2050. Our models predict that almost 90% of the municipalities analyzed will face species loss. Decreases in the pollinator occurrence probability varied from 0.08 (persimmon) to 0.25 (tomato) and will potentially affect 9% (mandarin) to 100% (sunflower) of the municipalities that produce each crop. Municipalities in central and southern Brazil will potentially face relatively large impacts on crop production due to pollinator loss. In contrast, some municipalities in northern Brazil, particularly in the northwestern Amazon, could potentially benefit from climate change because pollinators of some crops may increase. The decline in the probability of pollinator occurrence is found in a large number of municipalities with the lowest GDP and will also likely affect some places where crop production is high (20% to 90% of the GDP) and where the number of inhabitants is also high (more than 6 million people). Our study highlights key municipalities where crops are economically important and where pollinators will potentially face the worst conditions due to climate change. However, pollinators may be able to find new suitable areas that have the potential to improve crop production. The results shown here could guide policy decisions for adapting to climate change and for preventing the loss of pollinator species and crop production.	[Giannini, Tereza Cristina; Costa, Wilian Franca; Imperatriz-Fonseca, Vera Lucia] Inst Tecnol Vale Desenvolvimento Sustentavel, Belem, Para, Brazil; [Giannini, Tereza Cristina; Costa, Wilian Franca; Saraiva, Antonio Mauro] Univ Sao Paulo, Escola Politecn, Sao Paulo, SP, Brazil; [Cordeiro, Guaraci Duran; Imperatriz-Fonseca, Vera Lucia] Univ Sao Paulo, Inst Biociencias, Sao Paulo, SP, Brazil; [Biesmeijer, Jacobus] Nat Biodivers Ctr, Leiden, Netherlands; [Alejandro Garibaldi, Lucas] UNRN, Inst Invest Recursos Nat Agroecol & Desarrollo Ru, Sede Andina, San Carlos De Bariloche, Rio Negro, Argentina; Consejo Nacl Invest Cient & Tecn CONICET, San Carlos De Bariloche, Rio Negro, Argentina	Instituto Tecnologico Vale Desenvolvimento Sustentavel; Universidade de Sao Paulo; Universidade de Sao Paulo; Naturalis Biodiversity Center; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Giannini, TC (corresponding author), Inst Tecnol Vale Desenvolvimento Sustentavel, Belem, Para, Brazil.; Giannini, TC (corresponding author), Univ Sao Paulo, Escola Politecn, Sao Paulo, SP, Brazil.	tereza.giannini@itv.org	Cordeiro, Guaraci/F-8396-2015; Costa, Wilian França/A-6011-2018; Imperatriz-Fonseca, Vera Lucia/AAU-7633-2021; Saraiva, Antonio M/B-6350-2011; Giannini, Tereza C/F-2676-2012; Garibaldi, Lucas A/D-7302-2013; Giannini, Tereza Cristina/AAA-2958-2019; Imperatriz-Fonseca, Vera Lucia/H-5582-2012	Costa, Wilian França/0000-0003-2557-7386; Imperatriz-Fonseca, Vera Lucia/0000-0002-1079-2158; Saraiva, Antonio M/0000-0003-2283-1123; Giannini, Tereza Cristina/0000-0001-9830-1204; Imperatriz-Fonseca, Vera Lucia/0000-0002-1079-2158; Cordeiro, Guaraci/0000-0002-5434-7937; Garibaldi, Lucas Alejandro/0000-0003-0725-4049				Aguirre-Gutierrez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063708; Aizen MA, 2008, CURR BIOL, V18, P1572, DOI 10.1016/j.cub.2008.08.066; Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Becher MA, 2013, J APPL ECOL, V50, P868, DOI 10.1111/1365-2664.12112; Bishop J, 2016, AGR ECOSYST ENVIRON, V220, P89, DOI 10.1016/j.agee.2015.12.007; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; Burkle LA, 2013, SCIENCE, V339, P1611, DOI 10.1126/science.1232728; Chaplin-Kramer R, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1799; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Costanza R, 2014, GLOBAL ENVIRON CHANG, V26, P152, DOI 10.1016/j.gloenvcha.2014.04.002; Elias MAS, 2017, AGR ECOSYST ENVIRON, V239, P257, DOI [10.1016/j.agee.2017.01.026, 10.1]; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fischer G., 2002, CLIMATE CHANGE AGR V; Franklin J, 2009, MAPPING SPECIES DIST; Funk CC, 2009, FOOD SECUR, V1, P271, DOI 10.1007/s12571-009-0026-y; Garibaldi LA, 2011, P NATL ACAD SCI USA, V108, P5909, DOI 10.1073/pnas.1012431108; Giannini TC, 2015, J ECON ENTOMOL, V108, P839; Gianquitto T, 2014, AMERICA'S DARWIN: DARWINIAN THEORY AND U.S. LITERARY CULTURE, P1, DOI 10.1007/s13592-014-0316-z; Gillson L, 2013, TRENDS ECOL EVOL, V28, P135, DOI 10.1016/j.tree.2012.10.008; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2012, RASTER GEOGRAPHIC AN; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Knox J, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034032; Melstrom RT, 2015, ENVIRON DEV ECON, V21, P350; Memmott J, 2007, ECOL LETT, V10, P710, DOI 10.1111/j.1461-0248.2007.01061.x; Okazaki RR, 2017, GLOBAL CHANGE BIOL, V23, P1023, DOI 10.1111/gcb.13481; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pinto HS, 2008, AQUECIMENTO GLOBAL A; Potts SG, 2016, NATURE, V540, P220, DOI 10.1038/nature20588; Ramankutty N, 1999, GLOBAL BIOGEOCHEM CY, V13, P997, DOI 10.1029/1999GB900046; Reside AE, 2017, BIOL CONSERV, V207, P9, DOI 10.1016/j.biocon.2017.01.004; ROSENZWEIG C, 1994, NATURE, V367, P133, DOI 10.1038/367133a0; Schweiger O, 2008, ECOLOGY, V89, P3472, DOI 10.1890/07-1748.1; Smith MR, 2015, LANCET, V386, P1964, DOI 10.1016/S0140-6736(15)61085-6; Tamis WLM, 2005, CLIMATIC CHANGE, V72, P37, DOI 10.1007/s10584-005-5287-7; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Valiente-Banuet A, 2015, FUNCT ECOL, V29, P299, DOI 10.1111/1365-2435.12356; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Watson JEM, 2014, CONSERV LETT, V7, P1, DOI 10.1111/conl.12083; Wheeler T, 2013, SCIENCE, V341, P508, DOI 10.1126/science.1239402; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Yu QY, 2012, AGR ECOSYST ENVIRON, V156, P57, DOI 10.1016/j.agee.2012.04.026	44	39	42	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182274	10.1371/journal.pone.0182274	http://dx.doi.org/10.1371/journal.pone.0182274			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28792956	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000407196700038
J	Ronning, SB; Andersen, PV; Pedersen, ME; Hollung, K				Ronning, Sissel Beate; Andersen, Petter Vejle; Pedersen, Mona Elisabeth; Hollung, Kristin			Primary bovine skeletal muscle cells enters apoptosis rapidly via the intrinsic pathway when available oxygen is removed	PLOS ONE			English	Article							INTRACELLULAR ATP; CASPASE-3; DEATH; PROTEOLYSIS; ACTIVATION; EXPRESSION; MYOGENESIS; STRESS	Muscle cells undergo changes post-mortem during the process of converting muscle into meat, and this complex process is far from revealed. Recent reports have suggested programmed cell death (apoptosis) to be important in the very early period of converting muscle into meat. The dynamic balance that occurs between anti-apoptotic members, such as Bcl-2, and pro-apoptotic members (Bid, Bim) helps determine whether the cell initiates apoptosis. In this study, we used primary bovine skeletal muscle cells, cultured in monolayers in vitro, to investigate if apoptosis is induced when oxygen is removed from the growth medium. Primary bovine muscle cells were differentiated to form myotubes, and anoxia was induced for 6h. The anoxic conditions significantly increased (P<0.05) the relative gene expression of antiand pro-apoptotic markers (Aif, Bcl-2, Bid and Bim), and the PARK7 (P<0.05) and Grp75 (Hsp70) protein expressions were transiently increased. The anoxic conditions also led to a loss of mitochondrial membrane potential, which is an early apoptotic event, as well as cytochrome c release from the mitochondria. Finally, reorganization and degradation of cytoskeletal filaments occurred. These results suggest that muscle cells enters apoptosis via the intrinsic pathway rapidly when available oxygen in the muscle diminishes post-mortem.	[Ronning, Sissel Beate; Andersen, Petter Vejle; Pedersen, Mona Elisabeth; Hollung, Kristin] Nofima AS, As, Norway	Nofima	Ronning, SB (corresponding author), Nofima AS, As, Norway.	sissel.ronning@nofima.no		Ronning, Sissel Beate/0000-0002-2255-0172	Fund for Research Lew on Agricultural Products in Norway; Norwegian Research Council [203697/099]	Fund for Research Lew on Agricultural Products in Norway; Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by grants from the Fund for Research Lew on Agricultural Products in Norway and the Norwegian Research Council (203697/099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arya R, 2007, J BIOSCIENCES, V32, P595, DOI 10.1007/s12038-007-0059-3; Aslam M, 2013, J PHYSIOL-LONDON, V591, P461, DOI 10.1113/jphysiol.2012.237834; Becila S, 2010, EUR FOOD RES TECHNOL, V231, P485, DOI 10.1007/s00217-010-1296-5; Bell RAV, 2017, CELL DEATH DIFFER; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Chaillou T, 2016, FASEB J, V30, P3929, DOI 10.1096/fj.201600757R; Chen F, 2003, J BIOL CHEM, V278, P6848, DOI 10.1074/jbc.M212021200; Chipuk JE, 2005, NAT REV MOL CELL BIO, V6, P268, DOI [10.1038/nrm1573, 10.1038/nrm2239]; Dupont-Versteegden EE, 2006, WORLD J GASTROENTERO, V12, P7463, DOI 10.3748/wjg.v12.i46.7463; Dupont-Versteegden EE, 2006, AM J PHYSIOL-REG I, V291, pR1730, DOI 10.1152/ajpregu.00176.2006; Eguchi Y, 1997, CANCER RES, V57, P1835; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fan J, 2008, J BIOL CHEM, V283, P4022, DOI 10.1074/jbc.M707176200; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Fulda Simone, 2010, Int J Cell Biol, V2010, P370835, DOI 10.1155/2010/370835; Hilder TL, 2005, MOL CELL BIOCHEM, V275, P233, DOI 10.1007/s11010-005-2411-y; Ho Kwei-Chi, 2003, Am J Clin Oncol, V26, pe86, DOI 10.1097/00000421-200308000-00029; Huang F, 2016, FOOD CHEM, V190, P110, DOI 10.1016/j.foodchem.2015.05.056; Kemp CM, 2012, MEAT SCI, V92, P252, DOI 10.1016/j.meatsci.2012.03.013; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Longo V, 2015, J PROTEOMICS, V125, P29, DOI 10.1016/j.jprot.2015.04.023; Mohanty TR, 2010, J MUSCLE FOODS, V21, P51, DOI 10.1111/j.1745-4573.2009.00167.x; Murray TVA, 2008, J CELL SCI, V121, P3786, DOI 10.1242/jcs.024547; Ouali A, 2013, MEAT SCI, V95, P854, DOI 10.1016/j.meatsci.2013.05.010; Panagopoulou P, 2008, J CELL BIOL, V181, P761, DOI 10.1083/jcb.200710049; Robin E, 2007, J BIOL CHEM, V282, P19133, DOI 10.1074/jbc.M701917200; Ronning SB, 2013, DIFFERENTIATION, V86, P13, DOI 10.1016/j.diff.2013.06.006; Salakou S, 2007, IN VIVO, V21, P123; Sandri M, 2001, J NEUROPATH EXP NEUR, V60, P302, DOI 10.1093/jnen/60.3.302; Siu PM, 2009, LIFE SCI, V84, P468, DOI 10.1016/j.lfs.2009.01.014; Tait SWG, 2008, ONCOGENE, V27, P6452, DOI 10.1038/onc.2008.311; Tatsumi T, 2003, CARDIOVASC RES, V59, P428, DOI 10.1016/S0008-6363(03)00391-2; Wang F, 2016, J CELL BIOCH; Xiao RJ, 2011, APOPTOSIS, V16, P221, DOI 10.1007/s10495-010-0566-9; Yun Z, 2005, MOL CELL BIOL, V25, P3040, DOI 10.1128/MCB.25.8.3040-3055.2005	35	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2017	12	8							e0182928	10.1371/journal.pone.0182928	http://dx.doi.org/10.1371/journal.pone.0182928			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9EU	28792534	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000407144700046
J	Hayashi, S; Uehara, DT; Tanimoto, K; Mizuno, S; Chinen, Y; Fukumura, S; Takanashi, J; Osaka, H; Okamoto, N; Inazawa, J				Hayashi, Shin; Uehara, Daniela Tiaki; Tanimoto, Kousuke; Mizuno, Seiji; Chinen, Yasutsugu; Fukumura, Shinobu; Takanashi, Jun-ichi; Osaka, Hitoshi; Okamoto, Nobuhiko; Inazawa, Johji			Comprehensive investigation of CASK mutations and other genetic etiologies in 41 patients with intellectual disability and microcephaly with pontine and cerebellar hypoplasia (MICPCH)	PLOS ONE			English	Article							CAUSE PONTOCEREBELLAR HYPOPLASIA; MENTAL-RETARDATION; CYTOPLASMIC DYNEIN; BRAIN-DEVELOPMENT; SYNAPTIC FUNCTION; ARRAY-CGH; PHENOTYPE; DELETION; NEURONS; REELIN	The CASK gene (Xp11.4) is highly expressed in the mammalian nervous system and plays several roles in neural development and synaptic function. Loss-of-function mutations of CASK are associated with intellectual disability and microcephaly with pontine and cerebellar hypoplasia (MICPCH), especially in females. Here, we present a comprehensive investigation of 41 MICPCH patients, analyzed by mutational search of CASK and screening of candidate genes using an SNP array, targeted resequencing and whole-exome sequencing (WES). In total, we identified causative or candidate genomic aberrations in 37 of the 41 cases (90.2%). CASK aberrations including a rare mosaic mutation in a male patient, were found in 32 cases, and a mutation in ITPR1, another known gene in which mutations are causative for MICPCH, was found in one case. We also found aberrations involving genes other than CASK, such as HDAC2, MARCKS, and possibly HS3ST5, which may be associated with MICPCH. Moreover, the targeted resequencing screening detected heterozygous variants in RELN in two cases, of uncertain pathogenicity, and WES analysis suggested that concurrent mutations of both DYNC1H1 and DCTN1 in one case could lead to MICPCH. Our results not only identified the etiology of MICPCH in nearly all the investigated patients but also suggest that MICPCH is a genetically heterogeneous condition, in which CASK inactivating mutations appear to account for the majority of cases.	[Hayashi, Shin; Uehara, Daniela Tiaki; Tanimoto, Kousuke; Inazawa, Johji] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Tokyo, Japan; [Hayashi, Shin; Uehara, Daniela Tiaki; Tanimoto, Kousuke; Inazawa, Johji] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Tokyo, Japan; [Hayashi, Shin] Tokyo Med & Dent Univ, Hard Tissue Genome Res Ctr, Tokyo, Japan; [Hayashi, Shin] Yale Univ, Dept Neurobiol, Sch Med, New Haven, CT 06520 USA; [Hayashi, Shin] Yale Univ, Kavli Inst Neurosci, Sch Med, New Haven, CT 06520 USA; [Tanimoto, Kousuke] Tokyo Med & Dent Univ, Genome Lab, Med Res Inst, Tokyo, Japan; [Mizuno, Seiji] Cent Hosp Kasugai, Aichi Human Serv Ctr, Dept Pediat, Kasugai, Aichi, Japan; [Chinen, Yasutsugu] Univ Ryukyus, Sch Med, Dept Pediat, Nishihara, Okinawa, Japan; [Fukumura, Shinobu] Sapporo Med Univ, Sch Med, Dept Pediat, Sapporo, Hokkaido, Japan; [Takanashi, Jun-ichi] Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Pediat, Yachiyo, Japan; [Osaka, Hitoshi] Jichi Med Sch, Dept Pediat, Shimotsuke, Tochigi, Japan; [Okamoto, Nobuhiko] Osaka Womens & Childrens Hosp, Dept Med Genet, Osaka, Japan; [Inazawa, Johji] Tokyo Med & Dent Univ, Bioresource Res Ctr, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Yale University; Yale University; Tokyo Medical & Dental University (TMDU); University of the Ryukyus; Sapporo Medical University; Tokyo Women's Medical University; Jichi Medical University; Tokyo Medical & Dental University (TMDU)	Hayashi, S; Inazawa, J (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cytogenet, Tokyo, Japan.; Hayashi, S; Inazawa, J (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Tokyo, Japan.; Hayashi, S (corresponding author), Tokyo Med & Dent Univ, Hard Tissue Genome Res Ctr, Tokyo, Japan.; Hayashi, S (corresponding author), Yale Univ, Dept Neurobiol, Sch Med, New Haven, CT 06520 USA.; Hayashi, S (corresponding author), Yale Univ, Kavli Inst Neurosci, Sch Med, New Haven, CT 06520 USA.; Inazawa, J (corresponding author), Tokyo Med & Dent Univ, Bioresource Res Ctr, Tokyo, Japan.	shin.hayashi@yale.edu; johinaz.cgen@mri.tmd.ac.jp		Hayashi, Shin/0000-0002-0644-5890; Uehara, Daniela Tiaki/0000-0003-0971-1848; Takanashi, Jun-ichi/0000-0002-1147-1938	Japan Society for the Promotion of Science (JSPS), MEXT KAKENHI [23791155, 221S0002]; Health Labour Sciences Research Grant from The Ministry of Health Labour and Welfare, Japan; Grants-in-Aid for Scientific Research [16K10329] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS), MEXT KAKENHI; Health Labour Sciences Research Grant from The Ministry of Health Labour and Welfare, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research on Priority Areas and Grant-in-Aid for Young Scientists (B) (#23791155) from Japan Society for the Promotion of Science (JSPS), MEXT KAKENHI (No. 221S0002), and a Health Labour Sciences Research Grant from The Ministry of Health Labour and Welfare, Japan.	Agamy O, 2010, AM J HUM GENET, V87, P538, DOI 10.1016/j.ajhg.2010.09.007; Atasoy D, 2007, P NATL ACAD SCI USA, V104, P2525, DOI 10.1073/pnas.0611003104; Boycott KM, 2005, AM J HUM GENET, V77, P477, DOI 10.1086/444400; Budde BS, 2008, NAT GENET, V40, P1113, DOI 10.1038/ng.204; Burglen L, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-18; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; Dazzo E, 2015, AM J HUM GENET, V96, P992, DOI 10.1016/j.ajhg.2015.04.020; Froyen G, 2007, HUM MUTAT, V28, P1034, DOI 10.1002/humu.20564; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hammesfahr B, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-95; Hayashi S, 2005, AM J MED GENET A, V139A, P32, DOI 10.1002/ajmg.a.30982; Hayashi S, 2008, AM J MED GENET A, V146A, P2145, DOI 10.1002/ajmg.a.32433; Hayashi S, 2012, HUM GENET, V131, P99, DOI 10.1007/s00439-011-1047-0; Holzbaur ELF, 1996, GENOMICS, V31, P398, DOI 10.1006/geno.1996.0068; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Hsueh YP, 2006, CURR MED CHEM, V13, P1915, DOI 10.2174/092986706777585040; Hsueh YP, 2000, NATURE, V404, P298, DOI 10.1038/35005118; Huang LJ, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-67; Ioannidis NM, 2016, AM J HUM GENET, V99, P877, DOI 10.1016/j.ajhg.2016.08.016; KARKI S, 1995, J BIOL CHEM, V270, P28806, DOI 10.1074/jbc.270.48.28806; LaConte LEW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088276; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; MIKAMI A, 1993, NEURON, V10, P787, DOI 10.1016/0896-6273(93)90195-W; Mochida GH, 2012, NAT GENET, V44, P1260, DOI 10.1038/ng.2425; Mochizuki H, 2003, J BIOL CHEM, V278, P26780, DOI 10.1074/jbc.M301861200; Montgomery RL, 2009, P NATL ACAD SCI USA, V106, P7876, DOI 10.1073/pnas.0902750106; Moog U, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0256-3; Moog U, 2011, J MED GENET, V48, P741, DOI 10.1136/jmedgenet-2011-100218; Mutch CA, 2016, AM J NEURORADIOL, V37, P528, DOI 10.3174/ajnr.A4552; Najm J, 2008, NAT GENET, V40, P1065, DOI 10.1038/ng.194; Piluso G, 2009, AM J HUM GENET, V84, P162, DOI 10.1016/j.ajhg.2008.12.018; Poirier K, 2013, NAT GENET, V45, P639, DOI 10.1038/ng.2613; Renbaum P, 2009, AM J HUM GENET, V85, P281, DOI 10.1016/j.ajhg.2009.07.006; Rosenfeld JA, 2012, NEUROGENETICS, V13, P31, DOI 10.1007/s10048-011-0306-5; Saito-Ohara F, 2002, AM J HUM GENET, V71, P637, DOI 10.1086/342208; Schaffer AA, 2013, J MED GENET, V50, P641, DOI 10.1136/jmedgenet-2013-101713; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stevenson D, 2000, MAMM GENOME, V11, P934, DOI 10.1007/s003350010170; STUMPO DJ, 1995, P NATL ACAD SCI USA, V92, P944, DOI 10.1073/pnas.92.4.944; Takanashi J, 2010, AM J NEURORADIOL, V31, P1619, DOI 10.3174/ajnr.A2173; Takanashi J, 2012, AM J MED GENET A, V158A, P3112, DOI 10.1002/ajmg.a.35640; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Tassano E, 2015, MOL CYTOGENET, V8, DOI 10.1186/s13039-015-0134-7; Wan JJ, 2012, NAT GENET, V44, P704, DOI 10.1038/ng.2254; Yip JW, 2000, P NATL ACAD SCI USA, V97, P8612, DOI 10.1073/pnas.150040497; Zaki M, 2007, AM J MED GENET A, V143A, P939, DOI 10.1002/ajmg.a.31667; Zhang Y, 1998, MOL CELL, V1, P1021, DOI 10.1016/S1097-2765(00)80102-1	47	33	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0181791	10.1371/journal.pone.0181791	http://dx.doi.org/10.1371/journal.pone.0181791			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28783747	Green Published, gold, Green Submitted			2022-12-26	WOS:000406998800008
J	Mekonnen, SA; Koop, G; Lam, TJGM; Hogeveen, H				Mekonnen, Sefinew Alemu; Koop, Gerrit; Lam, Theo J. G. M.; Hogeveen, Henk			The intention of North-Western Ethiopian dairy farmers to control mastitis	PLOS ONE			English	Article							SUBCLINICAL MASTITIS; PLANNED BEHAVIOR; RISK-MANAGEMENT; ECONOMIC-LOSSES; ATTITUDES; KNOWLEDGE; HEALTH; NETHERLANDS; PERCEPTIONS; BIOSECURITY	Understanding the intentions of dairy farmers towards mastitis control is important to design effective udder health control programs. We used the Theory of Planned Behavior (TPB) to explore the intentions of North-Western Ethiopian dairy farmers towards implementing non-specified mastitis control measures (nsMCMs) and towards implementing 4 specific MCMs. Face to face interviews were held with 134 dairy farmers to study associations between their intentions and any of three factors (attitude, subjective norm and perceived behavioral control) that, according to the TPB, determine intentions. The majority of the farmers (93%) had a positive intention to implement nsMCMs, whereas a smaller majority of farmers had the intention to implement the specific MCMs to improve udder cleaning (87%), to improve stall hygiene (78%), to improve feeding of cows (76%), and to perform foremilk stripping (74%). Farmers had a more positive attitude, but lower subjective norm and lower perceived behavioural control towards implementing nsMCMs compared with implementing most specific MCMs, although the subjective norms for stall hygiene and perceived behavioural control for improving feeding of cows were also low. Attitude was positively associated with intentions to implement nsMCMs, to improve cleaning of the udders, to improve stall hygiene and to implement foremilk stripping. Both the intention to improve udder cleaning and to implement foremilk stripping, were positively associated to subjective norms towards these MCMs. Our data can help tailor intervention programs aiming to increase the intention of Ethiopian dairy farmers to implement MCMs and thus to improve udder health in this country. We show that such programs should primarily focus on changing attitude and secondarily on improving the farmers' subjective norms.	[Mekonnen, Sefinew Alemu; Koop, Gerrit; Lam, Theo J. G. M.; Hogeveen, Henk] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands; [Mekonnen, Sefinew Alemu] Univ Gondar, Fac Vet Med, Gondar, Ethiopia; [Lam, Theo J. G. M.] GD Anim Hlth, Deventer, Netherlands; [Hogeveen, Henk] Wageningen Univ, Business Econ Grp, Wageningen, Netherlands	Utrecht University; University of Gondar; Wageningen University & Research	Mekonnen, SA (corresponding author), Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands.; Mekonnen, SA (corresponding author), Univ Gondar, Fac Vet Med, Gondar, Ethiopia.	sefiale@yahoo.com		Hogeveen, Henk/0000-0002-9443-1412	Netherlands organization for international cooperation in higher education (Nuffic); University of Gondar, Ethiopia	Netherlands organization for international cooperation in higher education (Nuffic); University of Gondar, Ethiopia	SAM received funding from Netherlands organization for international cooperation in higher education (Nuffic): https://www.epnuffic.nl/; University of Gondar, Ethiopia: www.uog.edu.et.en/. One of the corresponding authors, TJGML, is employed in GD animal health. The funder provided support in the form of salaries for author, SAM, and covered all expenses of data collection and laboratory analysis, but did not have any additional	Ahmed MAM, 2004, 123 EPTD INT FOOD PO; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ajzen I, 2005, EBOOK ATTITUDES PERS; Ajzen I, 2011, PSYCHOL HEALTH, V26, P1113, DOI 10.1080/08870446.2011.613995; Ayenew YA, 2009, TROP ANIM HEALTH PRO, V41, P1143, DOI 10.1007/s11250-008-9294-3; Belay Duguma, 2012, Global Veterinaria, V8, P62; Bruijnis M, 2013, LIVEST SCI, V155, P103, DOI 10.1016/j.livsci.2013.04.005; Casal J, 2007, PREV VET MED, V82, P138, DOI 10.1016/j.prevetmed.2007.05.012; Dego OK, 2003, TROP ANIM HEALTH PRO, V35, P197, DOI 10.1023/A:1023352811751; Fasil N, 2016, VET SCI TECHNOL, V7, P5; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Fishbein M., 2010, PREDICTING CHANGING, DOI 10.4324/9780203838020; Food and Agriculture Organization, 2014, IMP MAST SMALL SCAL, V13, P10; Francis IJ, 2004, CONSTRUCTING QUESTIO; Garforth CJ, 2011, UDDER HEALTH AND COMMUNICATION, P55; Garforth CJ, 2013, PREV VET MED, V110, P456, DOI 10.1016/j.prevetmed.2013.02.018; Gebre-Wold A, 1998, WORKSH ROL VILL DAIR, P73; Getahun K, 2008, TROP ANIM HEALTH PRO, V40, P261, DOI 10.1007/s11250-007-9090-5; Getaneh AM, 2017, PREV VET MED, V138, P94, DOI 10.1016/j.prevetmed.2017.01.014; Gunn GJ, 2008, PREV VET MED, V84, P310, DOI 10.1016/j.prevetmed.2007.12.003; Holloway G, 2000, AGR ECON, V23, P279, DOI 10.1111/j.1574-0862.2000.tb00279.x; Huijps K, 2008, J DAIRY RES, V75, P113, DOI 10.1017/S0022029907002932; Jansen J, 2010, J DAIRY SCI, V93, P5737, DOI 10.3168/jds.2010-3318; Jansen J, 2009, PREV VET MED, V92, P210, DOI 10.1016/j.prevetmed.2009.08.015; Jemberu WT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138363; Kairu-Wanyoike SW, 2014, PREV VET MED, V115, P143, DOI 10.1016/j.prevetmed.2014.03.029; Lema M, 2001, TROP ANIM HEALTH PRO, V33, P85, DOI 10.1023/A:1005203628744; Lind A.-K., 2012, ACTA VET SCAND, V54, P1; Mekonnen H, 2010, REV MED VET-TOULOUSE, V161, P574; Mekonnen HM, 2006, PREV VET MED, V74, P99, DOI 10.1016/j.prevetmed.2005.10.004; Mekonnen SA, 2017, PREV VET MED, V145, P23, DOI 10.1016/j.prevetmed.2017.06.009; Mungube EO, 2005, TROP ANIM HEALTH PRO, V37, P503, DOI 10.1007/s11250-005-7049-y; Ndambi OA, DAIRYING AFRICA STAT; Park J, 2003, RELIAB ENG SYST SAFE, V82, P115, DOI 10.1016/S0951-8320(03)00123-6; Seegers H, 2003, VET RES, V34, P475, DOI 10.1051/vetres:2003027; Tesfaye D, 2012, TROP ANIM HEALTH PRO, V44, P873, DOI 10.1007/s11250-011-9981-3; Tesfaye GY, 2010, TROP ANIM HEALTH PRO, V42, P925, DOI 10.1007/s11250-009-9509-2; Tolosa T, 2013, PREV VET MED, V112, P68, DOI 10.1016/j.prevetmed.2013.06.009; Valeeva NI, 2007, J DAIRY SCI, V90, P4466, DOI 10.3168/jds.2007-0095; Valeeva NI, 2011, PREV VET MED, V102, P284, DOI 10.1016/j.prevetmed.2011.08.005; van den Borne BHP, 2014, RES VET SCI, V97, P226, DOI 10.1016/j.rvsc.2014.06.017; Workineh S, 2002, TROP ANIM HEALTH PRO, V34, P19, DOI 10.1023/A:1013729626377; Yilma Z., 2011, REV ETHIOPIAN DAIRY; Zelalem A, 2017, J ENTOMOL ZOOL STU O, V5, P1121	44	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182727	10.1371/journal.pone.0182727	http://dx.doi.org/10.1371/journal.pone.0182727			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28787018	Green Published, gold, Green Submitted			2022-12-26	WOS:000406998800059
J	Giguere, T; Perreault, JP				Giguere, Tamara; Perreault, Jean-Pierre			Classification of the Pospiviroidae based on their structural hallmarks	PLOS ONE			English	Article							MOLECULAR-PROPERTIES; GRAPEVINE; SEQUENCE; STRANDS; REVEAL; TOMATO; MOTIFS; PLUS	The simplest known plant pathogens are the viroids. Because of their non-coding single-stranded circular RNA genome, they depend on both their sequence and their structure for both a successful infection and their replication. In the recent years, important progress in the elucidation of their structures was achieved using an adaptation of the selective 2'-hydroxyl acylation analyzed by primer extension (SHAPE) protocol in order to probe viroid structures in solution. Previously, SHAPE has been adapted to elucidate the structures of all of the members of the family Avsunviroidae, as well as those of a few members of the family Pospiviroidae. In this study, with the goal of providing an entire compendium of the secondary structures of the various viroid species, a total of thirteen new Pospiviroidae members were probed in solution using the SHAPE protocol. More specifically, the secondary structures of eleven species for which the genus was previously known were initially elucidated. At this point, considering all of the SHAPE elucidated secondary structures, a classification system for viroids in their respective genera was proposed. On the basis of the structural classification reported here, the probings of both the Grapevine latent viroid and the Dahlia latent viroid provide sound arguments for the determination of their respective genera, which appear to be Apscaviroid and Hostuviroid, respectively. More importantly, this study provides the complete repertoire of the secondary structures, mapped in solution, of all of the accepted viroid species reported thus far. In addition, a classification scheme based on structural hallmarks, an important tool for many biological studies, is proposed.	[Giguere, Tamara; Perreault, Jean-Pierre] Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, RNA Grp,Grp ARN, Pavillon Rech Appl Canc, Sherbrooke, PQ, Canada	University of Sherbrooke	Perreault, JP (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Biochim, RNA Grp,Grp ARN, Pavillon Rech Appl Canc, Sherbrooke, PQ, Canada.	jean-pierraperreault@usherbrooke.ca			Natural Sciences and Engineering Research Council of Canada [155219-12, 155219-17]; Universite de Sherbrooke; Fonds de recherche du Quebec Nature et Technologies (FRONT)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Universite de Sherbrooke; Fonds de recherche du Quebec Nature et Technologies (FRONT)	This work was supported by grants 155219-12 and 155219-17 from the Natural Sciences and Engineering Research Council of Canada http://www.nserc-crsng.gc.ca/index_eng.asp to JPP. The RNA group is supported by grants from the Universite de Sherbrooke. JPP holds the Research Chair in RNA Structure and Genomics of Universite de Sherbrooke. TG holds a scholarship from the Fonds de recherche du Quebec Nature et Technologies (FRONT) http://www.frqnt.gouv.qc.ca/accuel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkar-Purushothama CR, 2015, PLANT CELL, V27, P2178, DOI 10.1105/tpc.15.00523; Bility MT, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004032; Bussiere F, 2000, J VIROL, V74, P2647, DOI 10.1128/JVI.74.6.2647-2654.2000; Dalakouras A, 2016, PLANT J, V87, P202, DOI 10.1111/tpj.13193; Delan-Forino C, 2014, VIRUSES-BASEL, V6, P489, DOI 10.3390/v6020489; Di Serio F, 2014, ARCH VIROL, V159, P3467, DOI 10.1007/s00705-014-2200-6; DiSerio F, 1996, J GEN VIROL, V77, P2833, DOI 10.1099/0022-1317-77-11-2833; Dube A, 2011, MOL PLANT PATHOL, V12, P688, DOI 10.1111/J.1364-3703.2010.00703.X; Dube A, 2010, RNA, V16, P463, DOI 10.1261/rna.1826710; Giguere T, 2014, MOL PLANT PATHOL, V15, P767, DOI 10.1111/mpp.12130; Giguere T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098655; HASHIMOTO J, 1987, NUCLEIC ACIDS RES, V15, P7045, DOI 10.1093/nar/15.17.7045; Karabiber F, 2013, RNA, V19, P63, DOI 10.1261/rna.036327.112; KEESE P, 1988, VIROLOGY, V162, P508, DOI 10.1016/0042-6822(88)90497-7; KIEFER MC, 1983, P NATL ACAD SCI-BIOL, V80, P6234, DOI 10.1073/pnas.80.20.6234; KOLTUNOW AM, 1988, NUCLEIC ACIDS RES, V16, P849, DOI 10.1093/nar/16.3.849; KOLTUNOW AM, 1989, VIROLOGY, V170, P575, DOI 10.1016/0042-6822(89)90450-9; Kovalskaya N, 2014, PLANT SCI, V228, P48, DOI 10.1016/j.plantsci.2014.05.006; Lopez-Carrasco A, 2017, RNA BIOL, V14, P1046, DOI 10.1080/15476286.2016.1223005; Lopez-Carrasco A, 2016, RNA BIOL, V13, P83, DOI 10.1080/15476286.2015.1119365; MartinezSoriano JP, 1996, P NATL ACAD SCI USA, V93, P9397, DOI 10.1073/pnas.93.18.9397; McGinnis JL, 2012, J AM CHEM SOC, V134, P6617, DOI 10.1021/ja2104075; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Mortimer SA, 2008, J AM CHEM SOC, V130, P16178, DOI 10.1021/ja8061216; Patzak J, 2001, BIOL PLANTARUM, V44, P579, DOI 10.1023/A:1013798821676; PUCHTA H, 1988, NUCLEIC ACIDS RES, V16, P4197, DOI 10.1093/nar/16.10.4197; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; REZAIAN MA, 1990, NUCLEIC ACIDS RES, V18, P1813, DOI 10.1093/nar/18.7.1813; Salman TM, 2014, VIRUS RES, V189, P243, DOI 10.1016/j.virusres.2014.03.028; Serra P, 2008, VIROLOGY, V370, P102, DOI 10.1016/j.virol.2007.07.033; Spieker RL, 1996, J GEN VIROL, V77, P2631, DOI 10.1099/0022-1317-77-10-2631; Szychowski JA, 1998, VIROLOGY, V248, P432, DOI 10.1006/viro.1998.9292; Takeda R, 2009, VIRUSES-BASEL, V1, P210, DOI 10.3390/v1020210; Verhoeven JTJ, 2011, ARCH VIROL, V156, P1433, DOI 10.1007/s00705-011-0975-2; Verhoeven JTJ, 2009, VIRUS RES, V144, P209, DOI 10.1016/j.virusres.2009.05.002; Verhoeven JTJ, 2013, J GEN VIROL, V94, P711, DOI 10.1099/vir.0.048751-0; Verhoeven JTJ, 2004, EUR J PLANT PATHOL, V110, P823, DOI 10.1007/s10658-004-2493-5; Xu WX, 2012, MOL PLANT PATHOL, V13, P666, DOI 10.1111/j.1364-3703.2011.00776.x; Zhong XH, 2006, J VIROL, V80, P8566, DOI 10.1128/JVI.00837-06	39	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0182536	10.1371/journal.pone.0182536	http://dx.doi.org/10.1371/journal.pone.0182536			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28783761	Green Published, gold, Green Submitted			2022-12-26	WOS:000406944300039
J	Parveen, M; Asaeda, T; Rashid, MH				Parveen, Mahfuza; Asaeda, Takashi; Rashid, Md H.			Biochemical adaptations of four submerged macrophytes under combined exposure to hypoxia and hydrogen sulphide	PLOS ONE			English	Article							ELODEA-NUTTALLII PLANCH.; PHYSIOLOGICAL-RESPONSES; OXIDATIVE STRESS; LIPID-PEROXIDATION; ANOXIA TOLERANCE; ZOSTERA-MARINA; ST-JOHN; GROWTH; PLANTS; OXYGEN	A hydroponic experiment was performed to investigate the stress responses and biochemical adaptations of four submerged macrophytes, Potamogeton crispus, Myriophyllum spicatum, Egeria densa, and Potamogeton oxyphyllus, to the combined exposure of hypoxia and hydrogen sulfide (H2S, provided by NaHS). The investigated plants were subjected to a control, hypoxia, 0.1 mM NaHS, 0.5 mM NaHS, 0.1 mM NaHS+hypoxia and 0.5 mM NaHS+hypoxia conditions. All experimental plants grew optimally under control, hypoxic and NaHS conditions in comparison to that grown in the combined exposure of hypoxia and hydrogen sulfide. For P. crispus and M. spicatum, significant decreases of total chlorophyll and increases in oxidative stress (measured by hydrogen peroxide, H2O2, and malondialdehyde, MDA) were observed with exposure to both sulfide concentrations. However, the decrease in catalase (CAT) and ascorbate peroxidase (APX) from exposure to 0.5 mM NaHS suggests that the function of the protective enzymes reached their limit under these conditions. In contrast, for E. densa and P. oxyphyllus, the higher activities of the three antioxidative enzymes and their anaerobic respiration abilities (ADH activity) resulted in higher tolerance and susceptibility under high sulfide concentrations.	[Parveen, Mahfuza] Saitama Univ, Grad Sch Sci & Engn, Sakura Ku, 255 Shimo Okubo, Saitama, Japan; [Asaeda, Takashi; Rashid, Md H.] Saitama Univ, Dept Environm Sci & Technol, Sakura Ku, 255 Shimo Okubo, Saitama, Japan; [Asaeda, Takashi] Chuo Univ, Res Inst, Bunkyo Ku, Tokyo, Japan; [Rashid, Md H.] Bangladesh Agr Univ, Dept Agron, Mymensingh, Bangladesh	Saitama University; Saitama University; Chuo University; Bangladesh Agricultural University (BAU)	Asaeda, T (corresponding author), Saitama Univ, Dept Environm Sci & Technol, Sakura Ku, 255 Shimo Okubo, Saitama, Japan.; Asaeda, T (corresponding author), Chuo Univ, Res Inst, Bunkyo Ku, Tokyo, Japan.	asaeda@mail.saitama-u.ac.jp	Asaeda, Takashi/C-5278-2008; Rashid, M. Harun/J-6337-2019; Parveen, Mahfuza/AAF-4223-2020	Rashid, M. Harun/0000-0001-6087-3469; PARVEEN, MAHFUZA/0000-0002-1491-0481				Aebi H, 1984, METHOD ENZYMOL, V6, P105, DOI DOI 10.1016/S0076-6879(84)05016-3; Ali B, 2015, ENVIRON SCI POLLUT R, V22, P3068, DOI 10.1007/s11356-014-3551-y; Andrews J, 2002, J EXP BOT, V53, P2393, DOI 10.1093/jxb/erf109; Armstrong J, 2005, ANN BOT-LONDON, V96, P625, DOI 10.1093/aob/mci215; ASADA K, 1992, PHYSIOL PLANTARUM, V85, P235, DOI 10.1111/j.1399-3054.1992.tb04728.x; Atapaththu KSS, 2015, HYDROBIOLOGIA, V747, P217, DOI 10.1007/s10750-014-2141-9; BAGARINAO T, 1992, AQUAT TOXICOL, V24, P21, DOI 10.1016/0166-445X(92)90015-F; Blokhina OB, 2001, J EXP BOT, V52, P1179, DOI 10.1093/jexbot/52.359.1179; Cao T, 2007, MAR FRESHWATER RES, V58, P581, DOI 10.1071/MF06090; Chen J, 2011, J EXP BOT, V62, P4481, DOI 10.1093/jxb/err145; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; DeBusk TA, 2015, AQUAT BOT, V124, P78, DOI 10.1016/j.aquabot.2015.03.006; Ding BZ, 2007, ENVIRON POLLUT, V147, P800, DOI 10.1016/j.envpol.2006.10.016; Dooley FD, 2013, AQUAT BOT, V105, P7, DOI 10.1016/j.aquabot.2012.10.007; Ellawala C, 2011, AQUAT ECOL, V45, P417, DOI 10.1007/s10452-011-9364-x; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Foyer CH, 2011, PLANT PHYSIOL, V155, P93, DOI 10.1104/pp.110.166181; Garcia ME, 2002, LIMNETICA, V21, P93; Geurts JJM, 2009, ENVIRON POLLUT, V157, P2072, DOI 10.1016/j.envpol.2009.02.024; Goel A, 2003, J PLANT PHYSIOL, V160, P1093, DOI 10.1078/0176-1617-00881; GORDON SA, 1951, PLANT PHYSIOL, V26, P192, DOI 10.1104/pp.26.1.192; Harada T, 2005, ANN BOT-LONDON, V96, P683, DOI 10.1093/aob/mci220; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hoagland D.R., 1950, CIRCULAR CALIFORNIA, V347; Holmer M, 2001, AQUAT BOT, V70, P29, DOI 10.1016/S0304-3770(00)00142-X; Hou ZH, 2013, J INTEGR PLANT BIOL, V55, P277, DOI 10.1111/jipb.12004; Hu LY, 2012, J AGR FOOD CHEM, V60, P8684, DOI 10.1021/jf300728h; Jackson MB, 2005, ANN BOT-LONDON, V96, P501, DOI 10.1093/aob/mci205; JANA S, 1982, AQUAT BOT, V12, P345, DOI 10.1016/0304-3770(82)90026-2; John C, 1976, FUNCTIONAL PLANT BIO, V3, P325, DOI DOI 10.1071/PP9760325; KOCH MS, 1990, LIMNOL OCEANOGR, V35, P399, DOI 10.4319/lo.1990.35.2.0399; KOK L, 1985, PLANT CELL ENV, V8, P189; Lamers LP, 2013, SULFIDE SOIL PHYTOTO; Li H, 2007, FUND APPL LIMNOL, V170, P141, DOI 10.1127/1863-9135/2007/0170-0141; LIN MW, 1995, J AM SOC HORTIC SCI, V120, P119, DOI 10.21273/JASHS.120.1.119; Long LH, 2009, BIOCHEM BIOPH RES CO, V388, P700, DOI 10.1016/j.bbrc.2009.08.069; [楼良旺 Lou Liangwang], 2005, [分析试验室, Chinese Journal of Analysis Laboratory], V24, P11; Maricle BR, 2006, J EXP MAR BIOL ECOL, V337, P30, DOI 10.1016/j.jembe.2006.05.019; Martin NM, 2015, PLANT PHYSIOL BIOCH, V88, P36, DOI 10.1016/j.plaphy.2015.01.007; Dominguez DM, 2010, PHYSIOL PLANTARUM, V139, P289, DOI 10.1111/j.1399-3054.2010.01368.x; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Moller IM, 2007, ANNU REV PLANT BIOL, V58, P459, DOI 10.1146/annurev.arplant.58.032806.103946; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Napoli A. M., 2006, HOSP PHYS, V42, P47; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Parveen M, 2017, FLORA, V230, P1, DOI 10.1016/j.flora.2017.03.005; PEARSON J, 1988, J EXP BOT, V39, P431, DOI 10.1093/jxb/39.4.431; Pedersen MO, 2015, J EXP MAR BIOL ECOL, V468, P138, DOI 10.1016/j.jembe.2015.04.004; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Prasad MNV, 2001, PLANT SCI, V161, P881, DOI 10.1016/S0168-9452(01)00478-2; Rashid MH, 2010, WEED BIOL MANAG, V10, P48, DOI 10.1111/j.1445-6664.2010.00366.x; Sinha S, 2006, CHEMOSPHERE, V62, P1340, DOI 10.1016/j.chemosphere.2005.07.030; Summers JE, 2000, J EXP BOT, V51, P1413, DOI 10.1093/jexbot/51.349.1413; Wu JH, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/435656; Wu J, 2009, B ENVIRON CONTAM TOX, V83, P497, DOI 10.1007/s00128-009-9800-y; Wu J, 2009, HYDROBIOLOGIA, V628, P111, DOI 10.1007/s10750-009-9749-1; Xing W, 2010, PLANT PHYSIOL BIOCH, V48, P873, DOI 10.1016/j.plaphy.2010.08.006; Xing W, 2010, ENVIRON TOXICOL, V25, P103, DOI 10.1002/tox.20480; Zaman T, 2013, FLORA, V208, P211, DOI 10.1016/j.flora.2013.02.009; Zhang FQ, 2007, CHEMOSPHERE, V67, P44, DOI 10.1016/j.chemosphere.2006.10.007; Zhang H, 2010, ACTA PHYSIOL PLANT, V32, P849, DOI 10.1007/s11738-010-0469-y; Zhang M, 2010, ENVIRON EXP BOT, V68, P44, DOI 10.1016/j.envexpbot.2009.09.003	62	15	16	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0182691	10.1371/journal.pone.0182691	http://dx.doi.org/10.1371/journal.pone.0182691			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28777815	Green Published, Green Submitted, gold			2022-12-26	WOS:000406944300051
J	Nio, Y; Tanaka, M; Hirozane, Y; Muraki, Y; Okawara, M; Hazama, M; Matsuo, T				Nio, Yasunori; Tanaka, Masayuki; Hirozane, Yoshihiko; Muraki, Yo; Okawara, Mitsugi; Hazama, Masatoshi; Matsuo, Takanori			Phosphodiesterase 4 inhibitor and phosphodiesterase 5 inhibitor combination therapy has antifibrotic and anti-inflammatory effects in mdx mice with Duchenne muscular dystrophy	FASEB JOURNAL			English	Article						DMD; piclamilast; sildenafil; muscle fibrosis	OXIDE SYNTHASE TRANSGENE; MOUSE MODEL; NITRIC-OXIDE; TGF-BETA; MUSCLE; RESVERATROL; FIBROSIS; SILDENAFIL; EXPRESSION; CELLS	Duchenne muscular dystrophy (DMD) is the most common inherited muscular dystrophy. Patients experience DMD in their 20s from cardiac or respiratory failure related to progressive muscle wasting. Currently, the only treatments for the symptoms of DMD are available. Muscle fibrosis, a DMD feature, leads to reduced muscle function and muscle mass, and hampers pharmaceutical therapeutic efficacy. Although antifibrotic agents may be useful, none is currently approved. Phosphodiesterase 4 (PDE4) inhibitors have exhibited antifibrotic effects in human and animal models. In this study, we showed beneficial effects of the PDE4 inhibitor piclamilast in the DMD mdx mouse. Piclamilast reduced the mRNA level of profibrotic genes, including collagen 1A1, in the gastrocnemius and diaphragm, in the mdx mouse, and significantly reduced the Sirius red staining area. The PDE5 inhibitors sildenafil and tadalafil ameliorated functional muscle ischemia in boys with DMD, and sildenafil reversed cardiac dysfunction in the mdx mouse. Single-treatment piclamilast or sildenafil showed similar antifibrotic effects on the gastrocnemius; combination therapy showed a potent antifibrotic effect, and piclamilast and combination therapy increased peroxisome proliferator-activated receptor gamma coactivator-1 alpha mRNA in mouse gastrocnemius. In summary, we confirmed that piclamilast has significant antifibrotic effects in mdx mouse muscle and is a potential treatment for muscle fibrosis in DMD.	[Nio, Yasunori; Muraki, Yo; Okawara, Mitsugi; Hazama, Masatoshi; Matsuo, Takanori] Takeda Pharmaceut Co Ltd, Extra Value Generat & Gen Med Drug Discovery Unit, Fujisawa, Kanagawa, Japan; [Tanaka, Masayuki] Takeda Pharmaceut Co Ltd, Inflammat Drug Discovery Unit, Fujisawa, Kanagawa, Japan; [Hirozane, Yoshihiko] Takeda Pharmaceut Co Ltd, Biomol Res Labs, Pharmaceut Res Div, Fujisawa, Kanagawa, Japan	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd	Nio, Y (corresponding author), Takeda Pharmaceut Co Ltd, Pharmaceut Res Div, 26-1 Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan.	yasunori.nio@takeda.com	Nio, Yasunori/AFE-2456-2022	Muraki, Yo/0000-0001-6891-3074	Takeda Exploratory Challenge	Takeda Exploratory Challenge	This work was supported by Takeda Exploratory Challenge. The authors thank Nikam Sham and Atsushi Nakanishi (Takeda Pharmaceutical Co.) for their important advice and comments regarding this study. The authors declare no conflicts of interest.	Abdel-Hamid H, 2012, CURR OPIN NEUROL, V25, P604, DOI 10.1097/WCO.0b013e328357f44c; Adamo CM, 2010, P NATL ACAD SCI USA, V107, P19079, DOI 10.1073/pnas.1013077107; Asai A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000806; Ascah A, 2011, AM J PHYSIOL-HEART C, V300, pH144, DOI 10.1152/ajpheart.00522.2010; Bella AJ, 2007, EUR UROL, V52, P990, DOI 10.1016/j.eururo.2007.06.048; Biressi S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008411; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; CARNWATH JW, 1987, J NEUROL SCI, V80, P39, DOI 10.1016/0022-510X(87)90219-X; Chini CCS, 1997, J BIOL CHEM, V272, P9854; Coley WD, 2016, HUM MOL GENET, V25, P130, DOI 10.1093/hmg/ddv460; DANGAIN J, 1984, MUSCLE NERVE, V7, P700, DOI 10.1002/mus.880070903; Desguerre I, 2009, J NEUROPATH EXP NEUR, V68, P762, DOI 10.1097/NEN.0b013e3181aa31c2; DIMARIO JX, 1991, DEV BIOL, V148, P314, DOI 10.1016/0012-1606(91)90340-9; Fukada S, 2010, AM J PATHOL, V176, P2414, DOI 10.2353/ajpath.2010.090887; Gan ZJ, 2011, GENE DEV, V25, P2619, DOI 10.1101/gad.178434.111; Gong KZ, 2011, MOL ENDOCRINOL, V25, P1794, DOI 10.1210/me.2011-1009; Gordon BS, 2014, CAN J PHYSIOL PHARM, V92, P243, DOI 10.1139/cjpp-2013-0350; Gordon BS, 2013, CLIN NUTR, V32, P104, DOI 10.1016/j.clnu.2012.06.003; Guevel L, 2011, J PROTEOME RES, V10, P2465, DOI 10.1021/pr2001385; Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107; Hori YS, 2011, J PHARMACOL EXP THER, V338, P784, DOI 10.1124/jpet.111.183210; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Kawahara G, 2011, P NATL ACAD SCI USA, V108, P5331, DOI 10.1073/pnas.1102116108; Keravis T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028899; Kolosionek E, 2009, MOL BIOL CELL, V20, P4751, DOI 10.1091/mbc.E09-01-0019; Lai Y, 2009, J CLIN INVEST, V119, P624, DOI 10.1172/JCI36612; Lee EM, 2015, LIFE SCI, V143, P35, DOI 10.1016/j.lfs.2015.10.023; Ljubicic V, 2014, AM J PHYSIOL-CELL PH, V307, pC66, DOI 10.1152/ajpcell.00357.2013; Lynch GS, 2001, J PHYSIOL-LONDON, V535, P591, DOI 10.1111/j.1469-7793.2001.00591.x; Martin EA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004327; McDonald AA, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12391; Mezzano V, 2007, J CELL COMMUN SIGNAL, V1, P205, DOI 10.1007/s12079-008-0018-2; Michelakis E, 2002, CIRCULATION, V105, P2398, DOI 10.1161/01.CIR.0000016641.12984.DC; MUNTONI F, 1993, J NEUROL SCI, V120, P71, DOI 10.1016/0022-510X(93)90027-V; Nelson MD, 2014, NEUROLOGY, V82, P2085, DOI 10.1212/WNL.0000000000000498; Nio Y, 2012, DIABETOLOGIA, V55, P3350, DOI 10.1007/s00125-012-2710-2; Oeckl P, 2012, J NEUROSCI METH, V203, P338, DOI 10.1016/j.jneumeth.2011.09.032; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Percival JM, 2012, J PATHOL, V228, P77, DOI 10.1002/path.4054; Perk H, 2008, J CLIN PHARM THER, V33, P635, DOI 10.1111/j.1365-2710.2008.00962.x; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Schinner E, 2015, INT J MOL SCI, V16, P2320, DOI 10.3390/ijms16022320; Segnani C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144630; Selsby JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030063; Stapleton DI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091514; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Tennen RI, 2012, CELL, V148, P387, DOI 10.1016/j.cell.2012.01.032; Turgeman T, 2008, NEUROMUSCULAR DISORD, V18, P857, DOI 10.1016/j.nmd.2008.06.386; Wehling M, 2001, J CELL BIOL, V155, P123, DOI 10.1083/jcb.200105110; Wehling-Henricks M, 2005, HUM MOL GENET, V14, P1921, DOI 10.1093/hmg/ddi197; Whitehead NP, 2015, P NATL ACAD SCI USA, V112, P12864, DOI 10.1073/pnas.1509536112; Wu B, 2008, P NATL ACAD SCI USA, V105, P14814, DOI 10.1073/pnas.0805676105; Xu W, 2015, CLIN EXP PHARMACOL P, V42, P1075, DOI 10.1111/1440-1681.12459; Zhou L, 2010, J NEUROPATH EXP NEUR, V69, P771, DOI 10.1097/NEN.0b013e3181e9a34b	55	18	19	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5307	5320		10.1096/fj.201700249R	http://dx.doi.org/10.1096/fj.201700249R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28798156				2022-12-26	WOS:000416588300016
J	Wiedmann, NM; Stefanidis, A; Oldfield, BJ				Wiedmann, Nicole M.; Stefanidis, Aneta; Oldfield, Brian J.			Characterization of the central neural projections to brown, white, and beige adipose tissue	FASEB JOURNAL			English	Article						neurotropic viruses; command neurons; brite fat	SYMPATHETIC-NERVOUS-SYSTEM; NEUROCHEMICAL CHARACTERIZATION; COMMAND NEURONS; PPAR-GAMMA; FAT; ADIPOCYTES; THERMOGENESIS; MOUSE; OUTFLOW; NERVES	The functional recruitment of classic brown adipose tissue (BAT) and inducible brown-like or beige fat is, to a large extent, dependent on intact sympathetic neural input. Whereas the central neural circuits directed specifically to BAT or white adipose tissue (WAT) are well established, there is only a developing insight into the nature of neural inputs common to both fat types. Moreover, there is no clear view of the specific central and peripheral innervation of the browned component of WAT: beige fat. The objective of the present study is to examine the neural input to both BAT and WAT in the same animal and, by exposing different cohorts of rats to either thermoneutral or cold conditions, define changes in central neural organization that will ensure that beige fat is appropriately recruited and modulated after browning of inguinal WAT (iWAT). At thermoneutrality, injection of the neurotropic (pseudorabies) viruses into BAT and WAT demonstrates that there are dedicated axonal projections, as well as collateral axonal branches of command neurons projecting to both types of fat. After cold exposure, central neural circuits directed to iWAT showed evidence of reorganization with a greater representation of command neurons projecting to both brown and beiged WAT in hypothalamic (paraventricular nucleus and lateral hypothalamus) and brainstem (raphe pallidus and locus coeruleus) sites. This shift was driven by a greater number of supraspinal neurons projecting to iWAT under cold conditions. These data provide evidence for a reorganization of the nervous system at the level of neural connectivity following browning of WAT.	[Wiedmann, Nicole M.; Stefanidis, Aneta; Oldfield, Brian J.] Monash Univ, Dept Physiol, 26 Innovat Walk, Clayton, Vic 3800, Australia	Monash University	Oldfield, BJ (corresponding author), Monash Univ, Dept Physiol, 26 Innovat Walk, Clayton, Vic 3800, Australia.	brian.oldfield@monash.edu		Oldfield, Brian/0000-0002-8609-6589; Wiedmann, Nicole/0000-0001-9390-2457	Australia National Health and Medical Research Council (NHMRC) [APP1082599]; NHMRC [APP1022451]	Australia National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a grant from the Australia National Health and Medical Research Council (NHMRC) Grant APP1082599, and an NHMRC Fellowship (APP1022451) (both to B.J.O.). The authors declare no conflicts of interest.	Adler ES, 2012, J NEUROSCI, V32, P15913, DOI 10.1523/JNEUROSCI.2591-12.2012; Bamshad M, 1999, AM J PHYSIOL-REG I, V276, pR1569, DOI 10.1152/ajpregu.1999.276.6.R1569; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; BARON R, 1985, J COMP NEUROL, V238, P158, DOI 10.1002/cne.902380204; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Bartness TJ, 2005, CAN J DIABETES, V29, P420; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Brito NA, 2008, AM J PHYSIOL-REG I, V294, pR1445, DOI 10.1152/ajpregu.00068.2008; Brown LM, 2006, PHYSIOL BEHAV, V89, P687, DOI 10.1016/j.physbeh.2006.08.008; Buettner C, 2008, NAT MED, V14, P667, DOI 10.1038/nm1775; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao L, 2011, CELL METAB, V14, P324, DOI 10.1016/j.cmet.2011.06.020; Contreras GA, 2014, AM J PHYSIOL-ENDOC M, V307, pE793, DOI 10.1152/ajpendo.00033.2014; COUSIN B, 1992, J CELL SCI, V103, P931; Cypess AM, 2010, CURR OPIN ENDOCRINOL, V17, P143, DOI 10.1097/MED.0b013e328337a81f; Dodd GT, 2015, CELL, V160, P88, DOI 10.1016/j.cell.2014.12.022; Douris N, 2015, ENDOCRINOLOGY, V156, P2470, DOI 10.1210/en.2014-2001; Fischer K, 2017, NAT MED, V23, P623, DOI 10.1038/nm.4316; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Frontini A, 2010, CELL METAB, V11, P253, DOI 10.1016/j.cmet.2010.03.004; Gabella G., 2001, ELS; Giordano A, 1996, J NEUROCYTOL, V25, P125, DOI 10.1007/BF02284791; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hettigoda NS, 2015, BRAIN STRUCT FUNCT, V220, P2103, DOI 10.1007/s00429-014-0781-1; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; HIMMSHAGEN J, 1991, FRONT NEUROENDOCRIN, V12, P38; Ishibashi J, 2010, SCIENCE, V328, P1113, DOI 10.1126/science.1190816; JANSEN ASP, 1995, SCIENCE, V270, P644, DOI 10.1126/science.270.5236.644; Jespersen NZ, 2013, CELL METAB, V17, P798, DOI 10.1016/j.cmet.2013.04.011; Kupfermann I, 2001, CURR OPIN NEUROBIOL, V11, P673, DOI 10.1016/S0959-4388(01)00267-7; Langley J.N, 1921, AUTONOMIC NERVOUS SY; LAZZARINI SJ, 1991, AM J PHYSIOL, V260, pR47, DOI 10.1152/ajpregu.1991.260.1.R47; Lee YH, 2015, FASEB J, V29, P286, DOI 10.1096/fj.14-263038; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Liu C, 2014, CELL METAB, V19, P722, DOI 10.1016/j.cmet.2014.01.021; McGlashon JM, 2015, CELL METAB, V21, P692, DOI 10.1016/j.cmet.2015.04.008; Mercader J, 2006, ENDOCRINOLOGY, V147, P5325, DOI 10.1210/en.2006-0760; Morrison SF, 2014, CELL METAB, V19, P741, DOI 10.1016/j.cmet.2014.02.007; Morrison Shaun F, 2012, Front Endocrinol (Lausanne), V3; Mottillo EP, 2014, J LIPID RES, V55, P2276, DOI 10.1194/jlr.M050005; Murano I, 2009, J ANAT, V214, P171, DOI 10.1111/j.1469-7580.2008.01001.x; Nedergaard J, 2014, CELL METAB, V20, P396, DOI 10.1016/j.cmet.2014.07.005; Nguyen NLT, 2017, AM J PHYSIOL-REG I, V312, pR132, DOI 10.1152/ajpregu.00344.2016; Norheim F, 2014, FEBS J, V281, P739, DOI 10.1111/febs.12619; Oldfield BJ, 2007, EUR J NEUROSCI, V25, P2404, DOI 10.1111/j.1460-9568.2007.05429.x; Oldfield BJ, 2002, NEUROSCIENCE, V110, P515, DOI 10.1016/S0306-4522(01)00555-3; OLDFIELD BJ, 1981, J COMP NEUROL, V196, P329, DOI 10.1002/cne.901960211; OLDFIELD BJ, 1980, NEUROSCI LETT, V18, P11, DOI 10.1016/0304-3940(80)90206-2; Patsouris D, 2015, CELL REP, V13, P1538, DOI 10.1016/j.celrep.2015.10.028; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Porter C, 2015, SHOCK, V44, P258, DOI 10.1097/SHK.0000000000000410; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Rao RR, 2014, CELL, V157, P1279, DOI 10.1016/j.cell.2014.03.065; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Ruan HB, 2014, CELL, V159, P306, DOI 10.1016/j.cell.2014.09.010; Schulz TJ, 2013, NATURE, V495, P379, DOI 10.1038/nature11943; Sellayah D, 2011, CELL METAB, V14, P478, DOI 10.1016/j.cmet.2011.08.010; Sidossis LS, 2015, CELL METAB, V22, P219, DOI 10.1016/j.cmet.2015.06.022; Song CK, 2005, VIRUS RES, V111, P235, DOI 10.1016/j.virusres.2005.04.012; Stefanidis A, 2014, BEST PRACT RES CL EN, V28, P685, DOI 10.1016/j.beem.2014.08.001; Villarroya F, 2013, CELL METAB, V17, P638, DOI 10.1016/j.cmet.2013.02.020; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Weiner J, 2016, SCI REP-UK, V6, DOI 10.1038/srep38124; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; YOUNG P, 1984, FEBS LETT, V167, P10, DOI 10.1016/0014-5793(84)80822-4; Zhang Y, 2016, AM J PHYSIOL-ENDOC M, V311, pE530, DOI 10.1152/ajpendo.00094.2016	72	22	22	0	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					4879	4890		10.1096/fj.201700433R	http://dx.doi.org/10.1096/fj.201700433R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28798153				2022-12-26	WOS:000413398500019
J	Trabjerg, E; Kartberg, F; Christensen, S; Rand, KD				Trabjerg, Esben; Kartberg, Fredrik; Christensen, Soren; Rand, Kasper D.			Conformational characterization of nerve growth factor-beta reveals that its regulatory pro-part domain stabilizes three loop regions in its mature part	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE MASS-SPECTROMETRY; HYDROGEN/DEUTERIUM EXCHANGE; HYDROGEN-EXCHANGE; NEUROTROPHIN RECEPTOR; N-GLYCOSYLATION; O-GLYCOSYLATION; ELECTROCHEMICAL REDUCTION; CRYSTAL-STRUCTURE; PROTEINS; BINDING	Nerve growth factor-beta (NGF) is essential for the correct development of the nervous system. NGF exists in both a mature form and a pro-form (proNGF). The two forms have opposing effects on neurons: NGF induces proliferation, whereas proNGF induces apoptosis via binding to a receptor complex of the common neurotrophin receptor (p75NTR) and sortilin. The overexpression of both proNGF and sortilin has been associated with several neurodegenerative diseases. Insights into the conformational differences between proNGF and NGF are central to a better understanding of the opposing mechanisms of action of NGF and proNGF on neurons. However, whereas the structure of NGF has been determined by X-ray crystallography, the structural details for proNGF remain elusive. Here, using a sensitive MS-based analytical method to measure the hydrogen/deuterium exchange of proteins in solution, we analyzed the conformational properties of proNGF and NGF. We detected the presence of a localized higher-order structure motif in the pro-part of proNGF. Furthermore, by comparing the hydrogen/deuterium exchange in the mature part of NGF and proNGF, we found that the presence of the pro-part in proNGF causes a structural stabilization of three loop regions in the mature part, possibly through a direct molecular interaction. Moreover, using tandem MS analyses, we identified two N-linked and two O-linked glycosylations in the pro-part of proNGF. These results advance our knowledge of the conformational properties of proNGF and NGF and help provide a rationale for the diverse biological effects of NGF and proNGF at the molecular level.	[Trabjerg, Esben; Rand, Kasper D.] Univ Copenhagen, Dept Pharm, Univ Pk 2, DK-2100 Copenhagen E, Denmark; [Trabjerg, Esben; Kartberg, Fredrik; Christensen, Soren] H Lundbeck & Co AS, Dept Biol, Ottiliavej 9, DK-2500 Valby, Denmark	University of Copenhagen; Lundbeck Corporation	Rand, KD (corresponding author), Univ Copenhagen, Dept Pharm, Univ Pk 2, DK-2100 Copenhagen E, Denmark.	kasper.rand@sund.ku.dk	Rand, Kasper/ABG-7446-2021; Trabjerg, Esben/HCI-4358-2022	Trabjerg, Esben/0000-0002-9883-4956; Christensen, Soren/0000-0003-2500-0085; Rand, Kasper/0000-0002-6337-5489	Innovation Fund Denmark [1355-00165]; Marie Curie Actions Programme of the European Union [PCIG09-GA-2011-294214]; Steno Grant from the Danish Council for Independent Research, Natural Sciences [11-104058]	Innovation Fund Denmark; Marie Curie Actions Programme of the European Union; Steno Grant from the Danish Council for Independent Research, Natural Sciences	This work was supported by Grant 1355-00165 from the Innovation Fund Denmark, Grant PCIG09-GA-2011-294214 from the Marie Curie Actions Programme of the European Union, and Steno Grant 11-104058 from the Danish Council for Independent Research, Natural Sciences. The authors declare that they have no conflicts of interest with the contents of this article.	BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Brockhausen I., 2009, ESSENTIALS GLYCOBIOL; Bruno MA, 2006, P NATL ACAD SCI USA, V103, P6735, DOI 10.1073/pnas.0510645103; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Cao L, 2014, ANAL BIOCHEM, V452, P96, DOI 10.1016/j.ab.2014.01.003; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Christensen S, 2005, BIOTECHNOL APPL BIOC, V41, P225, DOI 10.1042/BA20040144; Clewes O, 2008, J NEUROCHEM, V107, P1124, DOI 10.1111/j.1471-4159.2008.05698.x; Croset A, 2012, J BIOTECHNOL, V161, P336, DOI 10.1016/j.jbiotec.2012.06.038; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; EDWARDS RH, 1988, MOL CELL BIOL, V8, P2456, DOI 10.1128/MCB.8.6.2456; Engen JR, 2015, ANNU REV ANAL CHEM, V8, P127, DOI 10.1146/annurev-anchem-062011-143113; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; Feng D, 2010, J MOL BIOL, V396, P967, DOI 10.1016/j.jmb.2009.12.030; Geoghegan KF, 2013, PROTEIN EXPRES PURIF, V87, P27, DOI 10.1016/j.pep.2012.09.013; Gill DJ, 2011, TRENDS CELL BIOL, V21, P149, DOI 10.1016/j.tcb.2010.11.004; Guttman M, 2011, ANAL CHEM, V83, P7492, DOI 10.1021/ac201729v; He XL, 2004, SCIENCE, V304, P870, DOI 10.1126/science.1095190; IBANEZ CF, 1991, EMBO J, V10, P2105, DOI 10.1002/j.1460-2075.1991.tb07743.x; Iwase H, 1993, Methods Mol Biol, V14, P151; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Jensen PF, 2015, MOL CELL PROTEOMICS, V14, P148, DOI 10.1074/mcp.M114.042044; Jensen PH, 2010, FEBS J, V277, P81, DOI 10.1111/j.1742-4658.2009.07429.x; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; KENDREW JC, 1960, NATURE, V185, P422, DOI 10.1038/185422a0; Keppel TR, 2011, BIOCHEMISTRY-US, V50, P8722, DOI 10.1021/bi200875p; Kim M, 2011, NAT STRUCT MOL BIOL, V18, P1235, DOI 10.1038/nsmb.2154; Kliemannel M, 2004, FEBS LETT, V566, P207, DOI 10.1016/j.febslet.2004.04.034; Kliemannel M, 2007, PROTEIN SCI, V16, P411, DOI 10.1110/ps.062376207; Kolmar H, 2008, FEBS J, V275, P2684, DOI 10.1111/j.1742-4658.2008.06440.x; Kraj A, 2013, ANAL BIOANAL CHEM, V405, P9311, DOI 10.1007/s00216-013-7374-3; Lopez-Llano J, 2006, PROTEINS, V64, P769, DOI 10.1002/prot.21041; Lowry KS, 2001, AMYOTROPH LATERAL SC, V2, P127, DOI 10.1080/146608201753275463; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Mayampurath AM, 2011, RAPID COMMUN MASS SP, V25, P2007, DOI 10.1002/rcm.5059; McAllister RG, 2015, BIOCHEMISTRY-US, V54, P2683, DOI 10.1021/acs.biochem.5b00215; MCDONALD NQ, 1991, NATURE, V354, P411, DOI 10.1038/354411a0; Mysling S, 2014, ANAL CHEM, V86, P340, DOI 10.1021/ac403269a; North SJ, 2010, J BIOL CHEM, V285, P5759, DOI 10.1074/jbc.M109.068353; Nykjaer A, 2005, CURR OPIN NEUROBIOL, V15, P49, DOI 10.1016/j.conb.2005.01.004; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Pagadala PC, 2006, P NATL ACAD SCI USA, V103, P17939, DOI 10.1073/pnas.0604139103; Paoletti F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022615; Paoletti F, 2009, PROTEINS, V75, P990, DOI 10.1002/prot.22311; PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205; Perdivara I, 2009, J PROTEOME RES, V8, P631, DOI 10.1021/pr800758g; Perez SE, 2015, BIOL PSYCHIAT, V77, P693, DOI 10.1016/j.biopsych.2013.12.016; Persson F, 2015, P NATL ACAD SCI USA, V112, P10383, DOI 10.1073/pnas.1506079112; Pompach P, 2012, J PROTEOME RES, V11, P1728, DOI 10.1021/pr201183w; Rand KD, 2011, J AM SOC MASS SPECTR, V22, P1784, DOI 10.1007/s13361-011-0196-7; Rattenholl A, 2001, EUR J BIOCHEM, V268, P3296, DOI 10.1046/j.1432-1327.2001.02232.x; Seidah NG, 1996, BIOCHEM J, V314, P951, DOI 10.1042/bj3140951; Sheff JG, 2013, J AM SOC MASS SPECTR, V24, P1006, DOI 10.1007/s13361-013-0639-4; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Skinner JJ, 2012, PROTEIN SCI, V21, P996, DOI 10.1002/pro.2081; Skinner JJ, 2012, PROTEIN SCI, V21, P987, DOI 10.1002/pro.2082; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101; Trabjerg E, 2015, ANAL CHEM, V87, P8880, DOI 10.1021/acs.analchem.5b01996; Trelle MB, 2014, ACS CHEM BIOL, V9, P174, DOI 10.1021/cb400619v; TSUDA E, 1990, EUR J BIOCHEM, V188, P405, DOI 10.1111/j.1432-1033.1990.tb15417.x; van Maarschalkerweerd A, 2015, Intrinsically Disord Proteins, V3, pe1071302, DOI 10.1080/21690707.2015.1071302; Varki A., 2009, ESSENTIALS GLYCOBIOL; Vestrheim AC, 2013, SCAND J IMMUNOL, V77, P419, DOI 10.1111/sji.12046; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Walters BT, 2012, J AM SOC MASS SPECTR, V23, P2132, DOI 10.1007/s13361-012-0476-x; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Wiesmann C, 1999, NATURE, V401, P184, DOI 10.1038/43705; Yang Z, 2014, MOL CELL PROTEOMICS, V13, P3224, DOI 10.1074/mcp.M114.041541; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522	72	14	16	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 6	2017	292	40					16665	16676		10.1074/jbc.M117.803320	http://dx.doi.org/10.1074/jbc.M117.803320			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ0QT	28798232	Green Published, hybrid			2022-12-26	WOS:000412414800026
J	Chirico, AAD; McClanahan, TR; Eklof, JS				Chirico, Angelica A. D.; McClanahan, Timothy R.; Eklof, Johan S.			Community- and government-managed marine protected areas increase fish size, biomass and potential value	PLOS ONE			English	Article							UNDERWATER VISUAL CENSUS; CORAL-REEF FISHES; RESERVES; RECOVERY; ASSEMBLAGES; HABITAT; SEAGRASSES; DISTANCE; IMPACTS; TRADE	Government-managed marine protected areas (MPAs) can restore small fish stocks, but have been heavily criticized for excluding resource users and creating conflicts. A promising but less studied alternative are community-managed MPAs, where resource users are more involved in MPA design, implementation and enforcement. Here we evaluated effects of government-and community-managed MPAs on the density, size and biomass of seagrass- and coral reef-associated fish, using field surveys in Kenyan coastal lagoons. We also assessed protection effects on the potential monetary value of fish; a variable that increases non-linearly with fish body mass and is particularly important from a fishery perspective. We found that two recently established community MPAs (< 1 km(2) in size, <= 5 years of protection) harbored larger fish and greater total fish biomass than two fished (open access) areas, in both seagrass beds and coral reefs. As expected, protection effects were considerably stronger in the older and larger government MPAs. Importantly, across management and habitat types, the protection effect on the potential monetary value of the fish was much stronger than the effects on fish biomass and size (6.7 vs. 2.6 and 1.3 times higher value in community MPAs than in fished areas, respectively). This strong effect on potential value was partly explained by presence of larger (and therefore more valuable) individual fish, and partly by higher densities of high-value taxa (e.g. rabbitfish). In summary, we show that i) small and recently established community-managed MPAs can, just like larger and older government-managed MPAs, play an important role for local conservation of high-value fish, and that ii) these effects are equally strong in coral reefs as in seagrass beds; an important habitat too rarely included in formal management. Consequently, community-managed MPAs could benefit both coral reef and seagrass ecosystems and provide spillover of valuable fish to nearby fisheries.	[Chirico, Angelica A. D.; Eklof, Johan S.] Stockholm Univ, Dept Ecol Environm & Plant Sci DEEP, Stockholm, Sweden; [McClanahan, Timothy R.] Wildlife Conservat Soc, Marine Programs, Bronx, NY USA	Stockholm University; Wildlife Conservation Society	Chirico, AAD (corresponding author), Stockholm Univ, Dept Ecol Environm & Plant Sci DEEP, Stockholm, Sweden.	angelica.chirico@su.se	Eklöf, Johan S/C-7722-2017	Eklöf, Johan S/0000-0001-6936-0926	Vetenskapsradet / Uforsk [SW-2009-018]; Wildlife Conservation Society/Marine Programs; Stockholm University	Vetenskapsradet / Uforsk; Wildlife Conservation Society/Marine Programs; Stockholm University	The study was funded through research grant SW-2009-018 from Vetenskapsradet / Uforsk (www.vr.se) to JSE. The work of AADC and JSE was supported by Stockholm University (www.su.se). The work of TRM was funded by the Wildlife Conservation Society/Marine Programs (www.wcs.org). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aburto-Oropeza O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023601; Agardy T, 2011, MAR POLICY, V35, P226, DOI 10.1016/j.marpol.2010.10.006; Alcoverro T, 2004, ECOGRAPHY, V27, P361, DOI 10.1111/j.0906-7590.2004.03736.x; Alonso Aller E, 2014, MAR BIOL, V161, P2395, DOI 10.1007/s00227-014-2514-7; Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], 2006, MARINE COASTAL ECOSY; Archer E., 2016, RFPERMUTE ESTIMATE P; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Beldade R, 2012, P ROY SOC B-BIOL SCI, V279, P2116, DOI 10.1098/rspb.2011.2433; BELL JD, 1984, MAR ECOL PROG SER, V15, P265, DOI 10.3354/meps015265; Berkstrom C, 2012, ESTUAR COAST SHELF S, V107, P1, DOI 10.1016/j.ecss.2012.03.020; Bohnsack JA, 1998, AUST J ECOL, V23, P298, DOI 10.1111/j.1442-9993.1998.tb00734.x; BORTONE S A, 1989, Northeast Gulf Science, V10, P85; Breheny P., 2013, VISUALIZING REGRESSI; Burke L., 2001, PILOT ANAL GLOBAL EC; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cinner J, 2005, ECOLOGY SOC, V11; Cinner JE, 2016, NATURE, V535, P416, DOI 10.1038/nature18607; Cinner JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074321; Cinner JE, 2013, CONSERV BIOL, V27, P453, DOI 10.1111/j.1523-1739.2012.01933.x; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Clements C, 2012, MAR ECOL PROG SER, V449, P233, DOI 10.3354/meps09554; Coker DJ, 2012, CORAL REEFS, V31, P919, DOI 10.1007/s00338-012-0920-1; Coulthard S, 2012, ECOL SOC, V17, DOI 10.5751/ES-04483-170104; Cullen-Unsworth LC, 2014, MAR POLLUT BULL, V83, P387, DOI 10.1016/j.marpolbul.2013.06.001; da Silva MI, 2015, PLOS ONE, V10; de la Torre-Castro M, 2004, OCEAN COAST MANAGE, V47, P361, DOI 10.1016/j.ocecoaman.2004.07.005; Dorenbosch M, 2006, HYDROBIOLOGIA, V563, P45, DOI 10.1007/s10750-005-1428-2; Dorenbosch M, 2005, MAR ECOL PROG SER, V299, P277, DOI 10.3354/meps299277; Duarte CM, 2008, ESTUAR COAST, V31, P233, DOI 10.1007/s12237-008-9038-7; Froese R, 2013, WORLD WIDE WEB ELECT; Gell RF, 2002, FISHERY EFFECTS MARI; Gillanders BM, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P503; Gonzalez L, 1998, ENVIRONMETRICS, V9, P53; Graham AJN, 2011, OCEANOGRAPHY MARINE, V49, P117; Gray G. J., 2001, Journal of Sustainable Forestry, V12, P1, DOI 10.1300/J091v12n03_01; Grober-Dunsmore R, 2008, LANDSCAPE ECOL, V23, P37, DOI 10.1007/s10980-007-9147-x; Halpern BS, 2003, ECOL APPL, V13, pS117; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; Heck KL, 2003, MAR ECOL PROG SER, V253, P123, DOI 10.3354/meps253123; Hicks CC, 2009, ECOL SOC, V14; Hori M, 2009, MAR BIOL, V156, P1447, DOI 10.1007/s00227-009-1184-3; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Humphries AT, 2014, MAR ECOL PROG SER, V504, P119, DOI 10.3354/meps10744; Kaunda-Arara B, 2004, CORAL REEFS, V23, P410, DOI 10.1007/s00338-004-0409-7; Lieske E, 2002, CORAL REEF FISHES IN; Lokrantz J, 2008, CORAL REEFS, V27, P967, DOI 10.1007/s00338-008-0394-3; Maina JM, 2015, REMOTE SENS-BASEL, V7, P16571, DOI 10.3390/rs71215849; Martinez ML, 2007, ECOL ECON, V63, P254, DOI 10.1016/j.ecolecon.2006.10.022; McClanahan T, 2016, COAST MANAGE, V44, P1, DOI 10.1080/08920753.2016.1116667; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; McClanahan TR, 2006, CURR BIOL, V16, P1408, DOI 10.1016/j.cub.2006.05.062; McClanahan TR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154585; McClanahan TR, 2010, CONSERV BIOL, V24, P1519, DOI 10.1111/j.1523-1739.2010.01530.x; McClanahan TR, 2005, OCEAN COAST MANAGE, V48, P901, DOI 10.1016/j.ocecoaman.2005.03.005; McClanahan TR, 2005, MAR ECOL PROG SER, V294, P241, DOI 10.3354/meps294241; McClanahan TR, 1996, CONSERV BIOL, V10, P1187, DOI 10.1046/j.1523-1739.1996.10041187.x; Mork E, 2009, ESTUAR COAST SHELF S, V84, P331, DOI 10.1016/j.ecss.2009.03.033; Nakamura Y, 2004, FISHERIES SCI, V70, P788, DOI 10.1111/j.1444-2906.2004.00872.x; Oksanen J, 2017, VEGAN COMMUNITY ECOL; Oliver TA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129075; Pollnac RB, 2001, OCEAN COAST MANAGE, V44, P683, DOI 10.1016/S0964-5691(01)00075-8; POLUNIN NVC, 1993, MAR ECOL PROG SER, V100, P167, DOI 10.3354/meps100167; Pomeroy R, 2008, MAR POLICY, V32, P816, DOI 10.1016/j.marpol.2008.03.017; Roberts C.M., 1991, Reviews in Fish Biology and Fisheries, V1, P65, DOI 10.1007/BF00042662; ROBERTS CM, 1987, MAR ECOL PROG SER, V41, P1, DOI 10.3354/meps041001; Roberts MC, 2000, FULLY PROTECTED MARI; Russ GR, 2004, OECOLOGIA, V138, P622, DOI 10.1007/s00442-003-1456-4; Samoilys MA, 2000, ENVIRON BIOL FISH, V57, P289, DOI 10.1023/A:1007679109359; Samoilys MA, 2007, BIOL CONSERV, V136, P584, DOI 10.1016/j.biocon.2007.01.003; Seytre C, 2014, MAR FRESHWATER RES, V65, P244, DOI 10.1071/MF13080; Thyresson M, 2013, MAR POLICY, V38, P246, DOI 10.1016/j.marpol.2012.05.041; Thyresson M, 2011, COAST MANAGE, V39, P396, DOI 10.1080/08920753.2011.589226; Unsworth RKF, 2007, J MAR BIOL ASSOC UK, V87, P1287, DOI 10.1017/S002531540705638X; Unsworth RKF, 2010, OCEAN COAST MANAGE, V53, P218, DOI 10.1016/j.ocecoaman.2010.04.002; Valentine JF, 2008, ECOL APPL, V18, P1501, DOI 10.1890/07-1720.1; Valle C, 2009, J APPL ICHTHYOL, V25, P537, DOI 10.1111/j.1439-0426.2009.01255.x; Watson RA, 1997, ECOL MODEL, V104, P103, DOI 10.1016/S0304-3800(97)00117-8; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wells S, 2007, OCEAN COAST MANAGE, V50, P67, DOI 10.1016/j.ocecoaman.2006.08.012	81	21	22	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2017	12	8							e0182342	10.1371/journal.pone.0182342	http://dx.doi.org/10.1371/journal.pone.0182342			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD5CP	28806740	Green Published, Green Submitted, gold			2022-12-26	WOS:000407548800018
J	Blanco, N; Foxman, B; Malani, AN; Zhang, M; Walk, S; Rickard, AH; Eisenberg, MC				Blanco, Natalia; Foxman, Betsy; Malani, Anurag N.; Zhang, Min; Walk, Seth; Rickard, Alexander H.; Eisenberg, Marisa C.			An in silico evaluation of treatment regimens for recurrent Clostridium difficile infection	PLOS ONE			English	Article							GUT MICROBIOTA; VANCOMYCIN; DISEASE; SPORULATION; RELAPSE; MODEL; EPIDEMIOLOGY; FIDAXOMICIN; GERMINATION; VALIDATION	Background Clostridium difficile infection (CDI) is a significant nosocomial infection worldwide, that recurs in as many as 35% of infections. Risk of CDI recurrence varies by ribotype, which also vary in sporulation and germination rates. Whether sporulation/germination mediate risk of recurrence and effectiveness of treatment of recurring CDI remains unclear. We aim to assess the role of sporulation/germination patterns on risk of recurrence, and the relative effectiveness of the recommended tapered/pulsing regimens using an in silico model. Methods We created a compartmental in-host mathematical model of CDI, composed of vegetative cells, toxins, and spores, to explore whether sporulation and germination have an impact on recurrence rates. We also simulated the effectiveness of three tapered/pulsed vancomycin regimens by ribotype. Results Simulations underscored the importance of sporulation/germination patterns in determining pathogenicity and transmission. All recommended regimens for recurring CDI tested were effective in reducing risk of an additional recurrence. Most modified regimens were still effective even after reducing the duration or dosage of vancomycin. However, the effectiveness of treatment varied by ribotype. Conclusion Current CDI vancomycin regimen for treating recurrent cases should be studied further to better balance associated risks and benefits.	[Blanco, Natalia; Foxman, Betsy; Rickard, Alexander H.; Eisenberg, Marisa C.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Malani, Anurag N.] St Joseph Mercy Hlth Syst, Dept Internal Med, Dept Infect Prevent & Control, Div Infect Dis, Ann Arbor, MI USA; [Zhang, Min] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Walk, Seth] Coll Letters & Sci, Dept Microbiol & Immunol, Bozeman, MT USA	University of Michigan System; University of Michigan; Saint Joseph Mercy Health System (SJMHS); University of Michigan System; University of Michigan	Eisenberg, MC (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.	marisae@umich.edu	Zhang, Min/ACY-2759-2022	Zhang, Min/0000-0003-3331-3583; Eisenberg, Marisa/0000-0003-4221-830X	Blue Cross Blue Shield Foundation Student Award [2103.SAP]; University of Michigan, School of Public Health, Department of Epidemiology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM110712] Funding Source: NIH RePORTER	Blue Cross Blue Shield Foundation Student Award; University of Michigan, School of Public Health, Department of Epidemiology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Blue Cross Blue Shield Foundation Student Award (Grant#: 2103.SAP) and Block Grant Research Award from the University of Michigan, School of Public Health, Department of Epidemiology were received by Natalia Blanco in order to fund this project.	Bagdasarian N, 2015, JAMA-J AM MED ASSOC, V313, P398, DOI 10.1001/jama.2014.17103; Baines SD, 2009, J ANTIMICROB CHEMOTH, V63, P520, DOI 10.1093/jac/dkn502; Bakken JS, 2013, ANAEROBE, V24, P20, DOI 10.1016/j.anaerobe.2013.08.007; Burns DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024894; Burns DA, 2010, ANAEROBE, V16, P618, DOI 10.1016/j.anaerobe.2010.10.001; Carlson PE, 2013, ANAEROBE, V24, P109, DOI 10.1016/j.anaerobe.2013.04.003; Carroll KC, 2011, ANNU REV MICROBIOL, V65, P501, DOI 10.1146/annurev-micro-090110-102824; Cheknis AK, 2009, ANAEROBE, V15, P230, DOI 10.1016/j.anaerobe.2009.09.001; Codella J, 2015, MED DECIS MAKING, V35, P211, DOI 10.1177/0272989X14545788; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Crowther GS, 2014, J ANTIMICROB CHEMOTH, V69, P2137, DOI 10.1093/jac/dku116; Dalla Man C, 2006, IEEE T BIO-MED ENG, V53, P2472, DOI 10.1109/TBME.2006.883792; Doan TN, 2014, INFECT CONT HOSP EP, V35, P1521, DOI 10.1086/678596; Donskey CJ, 2000, NEW ENGL J MED, V343, P1925, DOI 10.1056/NEJM200012283432604; Drekonja DM, 2011, ANN INTERN MED, V155, P839, DOI 10.7326/0003-4819-155-12-201112200-00007; Eisenberg M, 2008, THYROID, V18, P1071, DOI 10.1089/thy.2007.0388; Eisenberg MC, 2014, MATH BIOSCI, V256, P116, DOI 10.1016/j.mbs.2014.08.008; Figueroa I, 2012, CLIN INFECT DIS, V55, pS104, DOI 10.1093/cid/cis357; Freeman J, 2007, J ANTIMICROB CHEMOTH, V60, P83, DOI 10.1093/jac/dkm113; Garey KW, 2008, J HOSP INFECT, V70, P298, DOI 10.1016/j.jhin.2008.08.012; Gerding DN, 2008, CLIN INFECT DIS, V46, pS32, DOI 10.1086/521860; Ghose C, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.62; Gillespie DT, 2001, J CHEM PHYS, V115, P1716, DOI 10.1063/1.1378322; Gonzales M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-363; Heeg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032381; Jabbari S, 2014, J MATH BIOL; JACQUEZ JA, 1990, AM J PHYSIOL, V258, pE727, DOI 10.1152/ajpendo.1990.258.4.E727; Kachrimanidou M, 2011, CRIT REV MICROBIOL, V37, P178, DOI 10.3109/1040841X.2011.556598; Kwon JH, 2015, INFECT DIS CLIN N AM, V29, P123, DOI 10.1016/j.idc.2014.11.003; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; LANDAW EM, 1984, AM J PHYSIOL, V246, pR665, DOI 10.1152/ajpregu.1984.246.5.R665; Lanzas C, 2011, INFECT CONT HOSP EP, V32, P553, DOI 10.1086/660013; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Louie TJ, 2011, NEW ENGL J MED, V364, P422, DOI 10.1056/NEJMoa0910812; Louie TJ, 2009, ANTIMICROB AGENTS CH, V53, P261, DOI 10.1128/AAC.01443-07; Man CD, 2007, IEEE T BIO-MED ENG, V54, P1740, DOI 10.1109/TBME.2007.893506; Marsh JW, 2012, J CLIN MICROBIOL, V50, P4078, DOI 10.1128/JCM.02291-12; McDonald LC, 2007, INFECT CONT HOSP EP, V28, P140, DOI 10.1086/511798; McFarland LV, 2002, AM J GASTROENTEROL, V97, P1769, DOI 10.1111/j.1572-0241.2002.05839.x; Merrigan M., 2010, HYPERVIRULENT CLOSTR; Merrigan M, 2010, J BACTERIOL, V192, P4904, DOI 10.1128/JB.00445-10; Moore P, 2013, J MED MICROBIOL, V62, P1405, DOI 10.1099/jmm.0.056614-0; Oka K, 2012, J CLIN MICROBIOL, V50, P915, DOI 10.1128/JCM.05588-11; Paredes-Sabja D, 2014, TRENDS MICROBIOL, V22, P406, DOI 10.1016/j.tim.2014.04.003; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; Vedantam G, 2012, GUT MICROBES, V3, P121, DOI 10.4161/gmic.19399; Vohra P, 2011, MICROBIOL-SGM, V157, P1343, DOI 10.1099/mic.0.046243-0; Vrieze A, 2014, J HEPATOL, V60, P824, DOI 10.1016/j.jhep.2013.11.034; Weese JS, 2000, J VET DIAGN INVEST, V12, P332, DOI 10.1177/104063870001200406; Willing BP, 2011, NAT REV MICROBIOL, V9, P233, DOI 10.1038/nrmicro2536; Yakob L, 2015, SCI REP-UK, V5, DOI 10.1038/srep12666	52	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0182815	10.1371/journal.pone.0182815	http://dx.doi.org/10.1371/journal.pone.0182815			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800598	gold, Green Published, Green Submitted			2022-12-26	WOS:000407431800029
J	Paar, M; Rossmann, C; Nusshold, C; Wagner, T; Schlagenhauf, A; Leschnik, B; Oettl, K; Koestenberger, M; Cvirn, G; Hallstrom, S				Paar, Margret; Rossmann, Christine; Nusshold, Christoph; Wagner, Thomas; Schlagenhauf, Axel; Leschnik, Bettina; Oettl, Karl; Koestenberger, Martin; Cvirn, Gerhard; Hallstrom, Seth			Anticoagulant action of low, physiologic, and high albumin levels in whole blood	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; HUMAN-SERUM-ALBUMIN; ALPHA-1-ACID GLYCOPROTEIN; VENOUS THROMBOEMBOLISM; THROMBIN GENERATION; ADULT PLASMA; COAGULATION; BINDING; PROTEIN; HEMODILUTION	Albumin is the most abundant plasma protein. Critical illness is often associated with altered, predominately decreased, serum albumin levels. This hypoalbuminaemia is usually corrected by administration of exogenous albumin. This study aimed to track the concentration-dependent influence of albumin on blood coagulation in vitro. Whole blood (WB) samples from 25 volunteers were prepared to contain low (19.3 +/- 7.7 g/L), physiological (45.2 +/- 7.8 g/L), and high (67.5 +/- 18.1 g/L) levels of albumin. Haemostatic profiling was performed using a platelet function analyzer (PFA) 200, impedance aggregometry, a Cone and Platelet analyzer (CPA), calibrated automated thrombogram, and thrombelastometry (TEM). Platelet aggregation-associated ATP release was assessed via HPLC analysis. In the low albumin group, when compared to the physiological albumin group, we found: i) shortened PFA 200-derived closure times indicating increased primary haemostasis; ii) increased impedance aggregometry-derived amplitudes, slopes, ATP release, as well as CPA-derived average size indicating improved platelet aggregation; iii) increased TEM-derived maximum clot firmness and alpha angles indicating enhanced clot formation. TEM measurements indicated impaired clot formation in the high albumin group compared with the physiological albumin group. Thus, albumin exerted significant anticoagulant action. Therefore, low albumin levels, often present in cancer or critically ill patients, might contribute to the frequently occurring venous thromboembolism.	[Paar, Margret; Rossmann, Christine; Nusshold, Christoph; Oettl, Karl; Cvirn, Gerhard; Hallstrom, Seth] Med Univ Graz, Inst Physiol Chem, Graz, Austria; [Wagner, Thomas] Med Univ Graz, Dept Blood Grp Serol & Transfus Med, Graz, Austria; [Schlagenhauf, Axel; Leschnik, Bettina; Koestenberger, Martin] Med Univ Graz, Dept Pediat, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz	Cvirn, G (corresponding author), Med Univ Graz, Inst Physiol Chem, Graz, Austria.	gerhard.cvirn@medunigraz.at	Koestenberger, Martin/J-5008-2019; Schlagenhauf, Axel/AAK-9598-2021	Koestenberger, Martin/0000-0003-1766-7859; Schlagenhauf, Axel/0000-0003-3408-6415; Oettl, Karl/0000-0001-9792-5760; Paar, Margret/0000-0001-5494-8890; Rossmann, Christine/0000-0002-1791-1981	Franz Lanyar-Stiftung [393]; Osterreichische Forschungsforderungsgesellschaft (FFG) [857011]	Franz Lanyar-Stiftung; Osterreichische Forschungsforderungsgesellschaft (FFG)	This study was supported by a grant from the "Franz Lanyar-Stiftung" P#393 and by the "Osterreichische Forschungsforderungsgesellschaft (FFG)" grant #857011 to GC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dieri R, 2012, BLOOD REV, V26, P197, DOI 10.1016/j.blre.2012.06.001; ANDREW M, 1992, BLOOD, V80, P1998, DOI 10.1182/blood.V80.8.1998.1998; Becker BF, 2015, BRIT J CLIN PHARMACO, V80, P389, DOI 10.1111/bcp.12629; Chang Yao-Wen, 2009, Acta Anaesthesiol Taiwan, V47, P110; CLAY KL, 1990, BIOCHIM BIOPHYS ACTA, V1046, P309, DOI 10.1016/0005-2760(90)90246-T; Cvirn G, 2005, BRIT J PHARMACOL, V146, P1082, DOI 10.1038/sj.bjp.0706436; Cvirn G, 2003, J THROMB HAEMOST, V1, P1785, DOI 10.1046/j.1538-7836.2003.00320.x; Cvirn G, 2003, J THROMB HAEMOST, V1, P263, DOI 10.1046/j.1538-7836.2003.00081.x; Cvirn G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042221; Deak AT, 2014, J CELL SCI, V127, P2944, DOI 10.1242/jcs.149807; DEVERA N, 1988, LIFE SCI, V43, P1277, DOI 10.1016/0024-3205(88)90582-6; FAUCETTE KJ, 1992, BLOOD, V79, P2888; Finestone HM, 1996, ARCH PHYS MED REHAB, V77, P340, DOI 10.1016/S0003-9993(96)90081-7; Folsom AR, 2010, THROMB HAEMOSTASIS, V104, P100, DOI 10.1160/TH09-12-0856; GALANAKIS DK, 1992, SEMIN THROMB HEMOST, V18, P44, DOI 10.1055/s-2007-1002409; Gines A, 1996, GASTROENTEROLOGY, V111, P1002, DOI 10.1016/S0016-5085(96)70068-9; GOLUB R, 1994, CRIT CARE MED, V22, P613, DOI 10.1097/00003246-199404000-00017; GRIGORIADIS G, 1992, BRIT J PHARMACOL, V107, P73, DOI 10.1111/j.1476-5381.1992.tb14465.x; Jellinge ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105983; JORGENSEN KA, 1979, THROMB RES, V16, P569, DOI 10.1016/0049-3848(79)90105-1; JORGENSEN KA, 1980, THROMB RES, V17, P13, DOI 10.1016/0049-3848(80)90289-3; Konigsbrugge O, 2016, ONCOLOGIST, V21, P252, DOI 10.1634/theoncologist.2015-0284; KRAUER B, 1984, BRIT J OBSTET GYNAEC, V91, P875, DOI 10.1111/j.1471-0528.1984.tb03700.x; Kujovich JL, 2015, HEMATOL-AM SOC HEMAT, P243, DOI 10.1182/asheducation-2015.1.243; Lang T, 2004, J THROMB HAEMOST, V2, P147, DOI 10.1111/j.1538-7836.2004.00555.x; Liu LH, 1997, THROMB RES, V85, P399, DOI 10.1016/S0049-3848(97)00028-5; MACLOUF J, 1980, EUR J BIOCHEM, V109, P561, DOI 10.1111/j.1432-1033.1980.tb04828.x; Mann KG, 2009, HAMOSTASEOLOGIE, V29, P7; McCammon AT, 2002, ANESTH ANALG, V95, P844, DOI 10.1097/00000539-200210000-00010; Morel-Kopp MC, 2012, THROMB HAEMOSTASIS, V107, P575, DOI 10.1160/TH11-09-0631; Nicholson JP, 2000, BRIT J ANAESTH, V85, P599, DOI 10.1093/bja/85.4.599; Oettl K, 2007, BRIT J PHARMACOL, V151, P580, DOI 10.1038/sj.bjp.0707251; Pathirana S, 2015, ANAESTH INTENS CARE, V43, P187, DOI 10.1177/0310057X1504300207; Podesser BK, 2007, BRIT J PHARMACOL, V151, P930, DOI 10.1038/sj.bjp.0707272; Poteser M, 2004, BRIT J PHARMACOL, V143, P143, DOI 10.1038/sj.bjp.0705897; Rasmussen KC, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002720; Rehak T, 2004, THROMB HAEMOSTASIS, V92, P682, DOI 10.1160/TH04-05-0270; Skhirtladze K, 2014, BRIT J ANAESTH, V112, P255, DOI 10.1093/bja/aet348; Sorensen B, 2003, J THROMB HAEMOST, V1, P551, DOI 10.1046/j.1538-7836.2003.00075.x; Suarez JI, 2016, CRIT CARE MED; Tholking G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130402; TSAI AL, 1991, BIOCHIM BIOPHYS ACTA, V1115, P131, DOI 10.1016/0304-4165(91)90021-8; Varon D, 1997, THROMB RES, V85, P283, DOI 10.1016/S0049-3848(97)00014-5; von Papen M, 2013, TRANSFUS MED HEMOTH, V40, P109, DOI 10.1159/000350294; WEISS HJ, 1979, BLOOD, V53, P244; Winstedt D, 2013, SCAND J CLIN LAB INV, V73, P161, DOI 10.3109/00365513.2012.762114	46	54	55	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0182997	10.1371/journal.pone.0182997	http://dx.doi.org/10.1371/journal.pone.0182997			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800610	Green Submitted, gold, Green Published			2022-12-26	WOS:000407431800043
J	Riviere, J; Le Strat, Y; Hendrikx, P; Dufour, B				Riviere, Julie; Le Strat, Yann; Hendrikx, Pascal; Dufour, Barbara			Cost-effectiveness evaluation of bovine tuberculosis surveillance in wildlife in France (Sylvatub system) using scenario trees	PLOS ONE			English	Article							BENEFIT-ANALYSIS; ANIMAL POPULATIONS; CATTLE; ERADICATION; DISEASE; RISK; BOAR	Bovine tuberculosis (bTB) is a common disease in cattle and wildlife, with health, zoonotic and economic implications. Infected wild animals, and particularly reservoirs, could hinder eradication of bTB from cattle populations, which could have an important impact on international cattle trade. Therefore, surveillance of bTB in wildlife is of particular importance to better understand the epidemiological role of wild species and to adapt the control measures. In France, a bTB surveillance system for free-ranging wildlife, the Sylvatub system, has been implemented since 2011. It relies on three surveillance components (SSCs) (passive surveillance on hunted animals (EC-SSC), passive surveillance on dead or dying animals (SAGIR-SSC) and active surveillance (PSURV-SSC)). The effectiveness of the Sylvatub system was previously assessed, through the estimation of its sensitivity (i.e. the probability of detecting at least one case of bTB infection by each SSC, specie and risk-level area). However, to globally assess the performance of a surveillance system, the measure of its sensitivity is not sufficient, as other factors such as economic or socio-economic factors could influence the effectiveness. We report here an estimation of the costs of the surveillance activities of the Sylvatub system, and of the cost-effectiveness of each surveillance component, by specie and risk-level, based on scenario tree modelling with the same tree structure as used for the sensitivity evaluation. The cost-effectiveness of the Sylvatub surveillance is better in higher-risk departments, due in particular to the higher probability of detecting the infection (sensitivity). Moreover, EC-SSC, which has the highest unit cost, is more efficient than the surveillance enhanced by the SAGIR-SSC, due to its better sensitivity. The calculation of the cost-effectiveness ratio shows that PSURV-SSC remains the most cost-effective surveillance component of the Sylvatub system, despite its high cost in terms of coordination, sample collection and laboratory analysis.	[Riviere, Julie; Dufour, Barbara] Univ Paris Est, Ecole Vet Alfort, Alfort Natl Vet Sch, Res Unit EpiMAI USC Anses Epidemiol Anim Infect D, Maisons Alfort, France; [Le Strat, Yann] French Natl Publ Hlth Agcy, Sante Publ France, St Maurice, France; [Hendrikx, Pascal] Agence Natl Securite Alimentaire Natl, French Agcy Food Environm & Occupat Hlth & Safety, Unit Coordinat & Support Surveillance, Maisons Alfort, France	Ecole Nationale Veterinaire d'Alfort (ENVA); Institute of Public Health Surveillance; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA)	Riviere, J (corresponding author), Univ Paris Est, Ecole Vet Alfort, Alfort Natl Vet Sch, Res Unit EpiMAI USC Anses Epidemiol Anim Infect D, Maisons Alfort, France.	julie.riviere@vet-alfort.fr	; Le Strat, Yann/C-9848-2013	RIVIERE, Julie/0000-0002-5857-6665; Le Strat, Yann/0000-0002-6180-4200				Amanfu W, 2006, TUBERCULOSIS, V86, P330, DOI 10.1016/j.tube.2006.01.007; Calvo-Artavia FF, 2012, PREV VET MED; Caminiti A, 2016, VET REC, V179, P70, DOI 10.1136/vr.103616; Corner LAL, 2006, VET MICROBIOL, V112, P303, DOI 10.1016/j.vetmic.2005.11.015; Fitzgerald SD, 2013, VET PATHOL, V50, P488, DOI 10.1177/0300985812467472; Garcia-Jimenez WL, 2013, PREV VET MED, V110, P435, DOI 10.1016/j.prevetmed.2013.02.017; Gormley AM, 2016, PREV VET MED, V125, P10, DOI 10.1016/j.prevetmed.2016.01.007; Gortazar C, 2012, MAMMAL REV, V42, P193, DOI 10.1111/j.1365-2907.2011.00191.x; Hadorn DC, 2009, VET RES, V40, DOI 10.1051/vetres/2009040; Hadorn DC, 2008, VET RES, V39, DOI 10.1051/vetres:2008033; Hardstaff JL, 2014, RES VET SCI, V97, pS86, DOI 10.1016/j.rvsc.2013.12.002; Hasler B, 2011, BMC HEALTH SERV RES, P11; Howe KS, 2013, EPIDEMIOL INFECT, V141, P91, DOI 10.1017/S095026881200060X; Knight-Jones TJD, 2010, VET RES, V41, DOI 10.1051/vetres/2010023; Martin RAJ, 2007, PREV VET MED, V79, P71, DOI 10.1016/j.prevetmed.2006.09.008; Mentaberre G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088824; Muller B, 2013, EMERG INFECT DIS, V19, P899, DOI 10.3201/eid1906.120543; Mwacalimba KK, 2013, PREV VET MED, V110, P274, DOI 10.1016/j.prevetmed.2012.10.020; Naranjo V, 2008, VET MICROBIOL, V127, P1, DOI 10.1016/j.vetmic.2007.10.002; Reist M, 2012, PREV VET MED, V105, P176, DOI 10.1016/j.prevetmed.2011.12.014; Rich KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082019; Richomme C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077842; Riviere J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141884; Rushton J., 2016, IMPROVING USE ECONOM; Schoning JM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054253, 10.1371/journal.pone.0060336]; Smith GC, 2007, VET J, V173, P302, DOI 10.1016/j.tvjl.2005.11.017; Tait P, 2017, J ENVIRON MANAGE, V189, P142, DOI 10.1016/j.jenvman.2016.12.045; Wilkinson D, 2009, J WILDLIFE DIS, V45, P1062, DOI 10.7589/0090-3558-45.4.1062	28	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0183126	10.1371/journal.pone.0183126	http://dx.doi.org/10.1371/journal.pone.0183126			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800642	gold, Green Submitted, Green Published			2022-12-26	WOS:000407431800056
J	Bussolati, G; Annaratone, L; Berrino, E; Miglio, U; Panero, M; Cupo, M; Gugliotta, P; Venesio, T; Sapino, A; Marchio, C				Bussolati, Gianni; Annaratone, Laura; Berrino, Enrico; Miglio, Umberto; Panero, Mara; Cupo, Marco; Gugliotta, Patrizia; Venesio, Tiziana; Sapino, Anna; Marchio, Caterina			Acid-free glyoxal as a substitute of formalin for structural and molecular preservation in tissue samples	PLOS ONE			English	Article							FIXATION; PATHOLOGY; AMPLIFICATION; FORMALDEHYDE; ALDEHYDES; DNA	Tissue fixation in phosphate buffered formalin (PBF) remains the standard procedure in histopathology, since it results in an optimal structural, antigenic and molecular preservation that justifies the pivotal role presently played by diagnoses on PBF-fixed tissues in precision medicine. However, toxicity of formaldehyde causes an environmental concern and may demand substitution of this reagent. Having observed that the reported drawbacks of commercially available glyoxal substitutes of PBF (Prefer, Glyo-fix, Histo-Fix, Histo-CHOICE, and Safe-Fix II) are likely related to their acidity, we have devised a neutral fixative, obtained by removing acids from the dialdehyde glyoxal with an ion-exchange resin. The resulting glyoxal acid-free (GAF) fixative has been tested in a cohort of 30 specimens including colon (N = 25) and stomach (N = 5) cancers. Our results show that GAF fixation produces a tissue and cellular preservation similar to that produced by PBF. Comparable immuno-histochemical and molecular (DNA and RNA) analytical data were obtained. We observed a significant enrichment of longer DNA fragment size in GAF-fixed compared to PBF-fixed samples. Adoption of GAF as a non-toxic histological fixative of choice would require a process of validation, but the present data suggest that it represents a reliable candidate.	[Bussolati, Gianni; Annaratone, Laura; Cupo, Marco; Gugliotta, Patrizia; Sapino, Anna; Marchio, Caterina] Univ Turin, Dept Med Sci, Turin, Italy; [Berrino, Enrico; Miglio, Umberto; Panero, Mara; Venesio, Tiziana; Sapino, Anna] IRCCS, FPO, Candiolo Canc Inst, Candiolo, Italy; [Marchio, Caterina] Azienda Osped Univ Citta Salute & Sci Torino, Div Pathol, Turin, Italy	University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia; A.O.U. Citta della Salute e della Scienza di Torino	Marchio, C (corresponding author), Univ Turin, Dept Med Sci, Turin, Italy.; Marchio, C (corresponding author), Azienda Osped Univ Citta Salute & Sci Torino, Div Pathol, Turin, Italy.	caterina.marchio@unito.it	Annaratone, Laura/J-9261-2016; Panero, Mara/AAB-7592-2020; Venesio, Tiziana/AAB-7568-2020; Sapino, Anna/AGY-9901-2022; Marchio, Caterina/J-9152-2016	Annaratone, Laura/0000-0001-5750-1445; Panero, Mara/0000-0003-0414-8179; Venesio, Tiziana/0000-0002-9035-056X; Sapino, Anna/0000-0003-3542-9571; Marchio, Caterina/0000-0003-2024-6131; Miglio, Umberto/0000-0001-5477-6080; Berrino, Enrico/0000-0001-6728-5619	Italian Ministry of Education, University and Research (MIUR); AIRC, Associazione Italiana per la Ricerca sul Cancro [MFAG13310]; 5xMille Ministero Salute - FPRC onlus AIRC 5xMille Molecular Clinical Oncology Extension program [9970]; Italian Ministry of Education, University and Research (PRIN) [2015HAJH8E]	Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); AIRC, Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); 5xMille Ministero Salute - FPRC onlus AIRC 5xMille Molecular Clinical Oncology Extension program(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Education, University and Research (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work was supported by the Italian Ministry of Education, University and Research (MIUR ex-60%-2016-17 to CM and PRIN 2015HAJH8E), by AIRC, Associazione Italiana per la Ricerca sul Cancro (MFAG13310 to CM), and by 5xMille Ministero Salute 2011 - FPRC onlus AIRC 5xMille Molecular Clinical Oncology Extension program - Ref 9970 (to AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Italian Ministry of Education, University and Research (MIUR ex-60%-2016-17 to CM and PRIN 2015HAJH8E), by AIRC, Associazione Italiana per la Ricerca sul Cancro (MFAG13310 to CM), and by SxMille Ministero Salute 2011-FPRC onlus AIRC SxMille Molecular Clinical Oncology Extension program Ref-9970 (to AS). We would like to thank Mrs. Maria Stella Scalzo for support in IHC and FISH assays and dr. Gianluca Barbieri (Diatech Pharmacogenetics, Jesi, Italy) for support in NGS data processing.	BETTERTON EA, 1988, ENVIRON SCI TECHNOL, V22, P1415, DOI 10.1021/es00177a004; Blum F, 1983, Z WISS MIKROSK, V10, P314; BROOKS BR, 1968, EUR J BIOCHEM, V5, P178, DOI 10.1111/j.1432-1033.1968.tb00355.x; Buesa RJ, 2008, ANN DIAGN PATHOL, V12, P387, DOI 10.1016/j.anndiagpath.2008.07.004; Dapson RW, 2007, BIOTECH HISTOCHEM, V82, P161, DOI 10.1080/10520290701488113; Dapson RW, 2006, J HISTOTECHNOL, V29, P65, DOI 10.1080/01478885.2006.11800879; Do HD, 2015, CLIN CHEM, V61, P64, DOI 10.1373/clinchem.2014.223040; Do HD, 2013, CLIN CHEM, V59, P1376, DOI 10.1373/clinchem.2012.202390; FOSS RD, 1994, DIAGN MOL PATHOL, V3, P148, DOI 10.1097/00019606-199409000-00003; FOX CH, 1985, J HISTOCHEM CYTOCHEM, V33, P845, DOI 10.1177/33.8.3894502; Gillespie JW, 2002, AM J PATHOL, V160, P449, DOI 10.1016/S0002-9440(10)64864-X; HARKE H-P, 1984, Hygiene + Medizin, V9, P259; HOPWOOD D, 1969, HISTOCHEMISTRY, V20, P127, DOI 10.1007/BF00268706; HUTTON JR, 1973, BIOCHEMISTRY-US, V12, P558, DOI 10.1021/bi00727a032; Illumina, 2014, EXPR AN FFPE SAMPL; Kim SJ, 2017, STEM CELL RES, V19, P46, DOI 10.1016/j.scr.2016.12.027; Lassalle S, 2009, THYROID, V19, P1239, DOI 10.1089/thy.2009.0095; Marcon N, 2009, ANN PATHOL, V29, P460, DOI 10.1016/j.annpat.2009.09.011; Prento P, 1997, BIOTECH HISTOCHEM, V72, P273, DOI 10.3109/10520299709082252; SABATINI DD, 1963, J CELL BIOL, V17, P19, DOI 10.1083/jcb.17.1.19; Sapino A, 2014, ONCOLOGIST, V19, P1118, DOI 10.1634/theoncologist.2014-0195; Titford ME, 2005, ARCH PATHOL LAB MED, V129, P502; Tubbs RR, 2004, AM J SURG PATHOL, V28, P417, DOI 10.1097/00000478-200403000-00022; Umlas J, 2004, HUM PATHOL, V35, P1058, DOI 10.1016/j.humpath.2004.04.013; Wicks L. F., 1943, SCIENCE, V98, P204, DOI 10.1126/science.98.2539.204; Willmore-Payne C, 2007, APPL IMMUNOHISTO M M, V15, P84, DOI 10.1097/01.pai.0000209866.20581.8e; World Health Organization/International Programme on Chemical Safety, 2004, 57 CONC INT CHEM ASS; Zhang ZY, 2013, J CHROMATOGR SCI, V51, P893, DOI 10.1093/chromsci/bms186	28	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182965	10.1371/journal.pone.0182965	http://dx.doi.org/10.1371/journal.pone.0182965			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796828	Green Published, gold, Green Submitted			2022-12-26	WOS:000407396200134
J	Chee, CG; Kim, YH; Lee, KH; Lee, YJ; Park, JH; Lee, HS; Ahn, S; Kim, B				Chee, Choong Guen; Kim, Young Hoon; Lee, Kyoung Ho; Lee, Yoon Jin; Park, Ji Hoon; Lee, Hye Seung; Ahn, Soyeon; Kim, Bohyoung			CT texture analysis in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy: A potential imaging biomarker for treatment response and prognosis	PLOS ONE			English	Article							TUMOR HETEROGENEITY; RADIATION-THERAPY; PREOPERATIVE CHEMORADIOTHERAPY; PREDICTS SURVIVAL; UTERINE CERVIX; HYPOXIA; CARCINOMA; CHEMORADIATION; CHEMOTHERAPY; ASSOCIATION	Purpose To evaluate the association of computed tomography (CT) texture features of locally advanced rectal cancer with neoadjuvant chemoradiotherapy (CRT) response and disease-free survival (DFS). Methods and findings The institutional review board approved this retrospective study. 95 patients who received neoadjuvant CRT, followed by surgery, for locally advanced rectal cancer were included. Texture features (entropy, uniformity, kurtosis, skewness, and standard deviation) were assessed in pretreatment CT images and obtained without filtration and with Laplacian of Gaussian spatial filter of various filter values (1.0, 1.5, 2.0, and 2.5). Dworak pathologic grading was used for treatment response assessment. Independent t-test was used to compare each texture feature between the treatment responder and non-responder groups. DFS was assessed with Kaplan-Meier method, and differences were compared with log-rank test. Cox proportional hazards models were constructed to predict prognosis based on stage, age, and each texture feature. Treatment responders (n = 32) showed significantly lower entropy, higher uniformity, and lower standard deviation in no filtration, fine (1.0), and medium (1.5) filter values. Entropy, uniformity, and standard deviation without filtration showed significant difference in DFS in Kaplan-Meier analysis (P = 0.015, 0.025, and 0.038). Homogeneous texture features (<= 6.7 for entropy, > 0.0118 for uniformity, and <= 28.06 for standard deviation) were associated with higher DFS. Entropy, uniformity, and standard deviation were independent texture features in predicting DFS (P = 0.017, 0.03, and 0.036) Conclusions Homogeneous texture features are associated with better neoadjuvant CRT response and higher DFS in patients with locally advanced rectal cancer.	[Chee, Choong Guen; Kim, Young Hoon; Lee, Kyoung Ho; Lee, Yoon Jin; Park, Ji Hoon] Seoul Natl Univ, Bundang Hosp, Dept Radiol, Coll Med,Inst Radiat Med,Med Res Ctr, Seongnamsi, South Korea; [Lee, Hye Seung] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Pathol, Seongnam Si, South Korea; [Ahn, Soyeon] Seoul Natl Univ, Bundang Hosp, Med Res Collaborating Ctr, Seongnam Si, South Korea; [Kim, Bohyoung] Hankuk Univ Foreign Studies, Div Biomed Engn, Yongin, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Hankuk University Foreign Studies	Kim, YH (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Radiol, Coll Med,Inst Radiat Med,Med Res Ctr, Seongnamsi, South Korea.	yhkrad@gmail.com	Lee, Hye Seung/G-6419-2011	Lee, Hye Seung/0000-0002-1667-7986; Lee, Kyoung Ho/0000-0001-6045-765X	SNUBH Research fund [02-2016-031]	SNUBH Research fund	This work was supported by SNUBH Research fund (https://rnsri.snubh.org/index.do), Grant number: 02-2016-031.	Bezy-Wendling J, 2001, IEEE T BIO-MED ENG, V48, P120, DOI 10.1109/10.900272; Chan I, 2006, J CLIN ONCOL, V24, P668, DOI 10.1200/JCO.2005.04.4875; Davnall F, 2012, INSIGHTS IMAGING, V3, P573, DOI 10.1007/s13244-012-0196-6; DeVries AF, 2014, INT J RADIAT ONCOL, V90, P1161, DOI 10.1016/j.ijrobp.2014.07.042; Dworak O, 1997, INT J COLORECTAL DIS, V12, P19, DOI 10.1007/s003840050072; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Ganeshan B, 2012, CLIN RADIOL, V67, P157, DOI 10.1016/j.crad.2011.08.012; Ganeshan B, 2012, EUR RADIOL, V22, P796, DOI 10.1007/s00330-011-2319-8; Goh V, 2011, RADIOLOGY, V261, P165, DOI 10.1148/radiol.11110264; Habr-Gama A, 2004, ANN SURG, V240, P711, DOI 10.1097/01.sla.0000141194.27992.32; Harrison LB, 2002, ONCOLOGIST, V7, P492, DOI 10.1634/theoncologist.7-6-492; Hockel M, 1996, CANCER RES, V56, P4509; HOCKEL M, 1993, RADIOTHER ONCOL, V26, P45, DOI 10.1016/0167-8140(93)90025-4; Kim SH, 2009, RADIOLOGY, V253, P116, DOI 10.1148/radiol.2532090027; Lubner MG, 2015, ABDOM IMAGING, V40, P2331, DOI 10.1007/s00261-015-0438-4; Maas M, 2011, J CLIN ONCOL, V29, P4633, DOI 10.1200/JCO.2011.37.7176; Martin ST, 2012, BRIT J SURG, V99, P918, DOI 10.1002/bjs.8702; Miles KA, 2009, RADIOLOGY, V250, P444, DOI 10.1148/radiol.2502071879; Movsas B, 2000, CANCER, V89, P2018, DOI 10.1002/1097-0142(20001101)89:9<2018::AID-CNCR19>3.3.CO;2-P; National cancer information center, CANC FACTS FIG 2012; National Comprehensive Cancer Network, 2015, RECT CANC VERS 2 201; Ng F, 2013, EUR J RADIOL, V82, P342, DOI 10.1016/j.ejrad.2012.10.023; Ng F, 2013, RADIOLOGY, V266, P177, DOI 10.1148/radiol.12120254; Park IJ, 2012, J CLIN ONCOL, V30, P1770, DOI 10.1200/JCO.2011.39.7901; Pucciarelli S, 2013, DIS COLON RECTUM, V56, P1349, DOI 10.1097/DCR.0b013e3182a2303e; Rodel C, 2005, J CLIN ONCOL, V23, P8688, DOI 10.1200/JCO.2005.02.1329; Sauer R, 2012, J CLIN ONCOL, V30, P1926, DOI 10.1200/JCO.2011.40.1836; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Taylor FGM, 2011, ANN SURG, V253, P711, DOI 10.1097/SLA.0b013e31820b8d52; TEICHER BA, 1995, HEMATOL ONCOL CLIN N, V9, P475; Yang ZH, 2011, AM J SURG PATHOL, V35, P853, DOI 10.1097/PAS.0b013e31821a0696; Yip C, 2014, RADIOLOGY, V270, P141, DOI 10.1148/radiol.13122869; Zhang HW, 2013, RADIOLOGY, V269, P801, DOI 10.1148/radiol.13130110	33	53	58	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182883	10.1371/journal.pone.0182883	http://dx.doi.org/10.1371/journal.pone.0182883			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797063	Green Submitted, Green Published, gold			2022-12-26	WOS:000407396200112
J	Choi, YR; Kim, JH; Park, SJ; Hur, BY; Han, JK				Choi, Ye Ra; Kim, Jung Hoon; Park, Sang Joon; Hur, Bo Yun; Han, Joon Koo			Therapeutic response assessment using 3D ultrasound for hepatic metastasis from colorectal cancer: Application of a personalized, 3D-printed tumor model using CT images	PLOS ONE			English	Article							3-DIMENSIONAL ULTRASOUND; VOLUMETRIC MEASUREMENTS; LIVER-TRANSPLANTATION; VERSION 1.1; RELIABILITY; ULTRASONOGRAPHY; VALIDITY; RECIST; CRITERIA; NODULES	Background & aims To evaluate accuracy and reliability of three-dimensional ultrasound (3D US) for response evaluation of hepatic metastasis from colorectal cancer (CRC) using a personalized 3D-printed tumor model. Methods Twenty patients with liver metastasis from CRC who underwent baseline and after chemotherapy CT, were retrospectively included. Personalized 3D-printed tumor models using CT were fabricated. Two radiologists measured volume of each 3D printing model using 3D US. With CT as a reference, we compared difference between CT and US tumor volume. The response evaluation was based on Response Evaluation Criteria in Solid Tumors (RECIST) criteria. Results 3D US tumor volume showed no significant difference from CT volume (7.18 +/- 5.44 mL, 8.31 +/- 6.32 mL vs 7.42 +/- 5.76 mL in CT, p>0.05). 3D US provided a high correlation coefficient with CT (r = 0.953, r = 0.97) as well as a high inter-observer intraclass correlation (0.978; 0.958-0.988). Regarding response, 3D US was in agreement with CT in 17 and 18 out of 20 patients for observer 1 and 2 with excellent agreement (k = 0.961). Conclusions 3D US tumor volume using a personalized 3D-printed model is an accurate and reliable method for the response evaluation in comparison with CT tumor volume.	[Choi, Ye Ra] Boramae Med Ctr, Dept Radiol, Seoul, South Korea; [Kim, Jung Hoon; Han, Joon Koo] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Kim, Jung Hoon; Han, Joon Koo] Seoul Natl Univ, Coll Med, Inst Radiat Med, Seoul, South Korea; [Park, Sang Joon] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Hur, Bo Yun] Natl Canc Ctr, Dept Radiol, Gyeonggi Do, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); National Cancer Center - Korea (NCC)	Kim, JH (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea.; Kim, JH (corresponding author), Seoul Natl Univ, Coll Med, Inst Radiat Med, Seoul, South Korea.	jhkim2008@gmail.com			National Research Foundation of Korea (NRF) - Ministry of Education [2013 R1 A1 A2058033]	National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (No. 2013 R1 A1 A2058033).; This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (No. 2013 R1 A1 A2058033). We thank Bonnie Hami, M.A. (USA) for her editorial assistance in the preparation of this manuscript.	Baimakhanov Z, 2015, LIVER TRANSPLANT, V21, P266, DOI 10.1002/lt.24019; Benacerraf BR, 2006, J ULTRAS MED, V25, P165, DOI 10.7863/jum.2006.25.2.165; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boito SME, 2002, RADIOLOGY, V223, P661, DOI 10.1148/radiol.2233010656; Burfeindt MJ, 2012, IEEE ANTENN WIREL PR, V11, P1610, DOI 10.1109/LAWP.2012.2236293; Chang FM, 1997, ULTRASOUND MED BIOL, V23, P381, DOI 10.1016/S0301-5629(96)00218-9; Chung WS, 2012, AM J ROENTGENOL, V199, P809, DOI 10.2214/AJR.11.7910; Downey DB, 2000, RADIOGRAPHICS, V20, P559, DOI 10.1148/radiographics.20.2.g00mc19559; Ehler ED, 2014, PHYS MED BIOL, V59, P5763, DOI 10.1088/0031-9155/59/19/5763; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fang WJ, 2013, ASIAN PAC J CANCER P, V14, P4151, DOI 10.7314/APJCP.2013.14.7.4151; Farrell T, 2001, BRIT J OBSTET GYNAEC, V108, P573, DOI 10.1016/S0306-5456(00)00148-0; Frauenfelder T, 2011, EUR RESPIR J, V38, P162, DOI 10.1183/09031936.00146110; Galizia MS, 2011, ACAD RADIOL, V18, P1555, DOI 10.1016/j.acra.2011.08.011; Igami T, 2014, WORLD J SURG, V38, P3163, DOI 10.1007/s00268-014-2740-7; Kim HC, 2002, ACTA RADIOL, V43, P571, DOI 10.1034/j.1600-0455.2002.430606.x; Landry A, 2004, STROKE, V35, P864, DOI 10.1161/01.STR.0000121161.61324.ab; Lyshchik A, 2004, J ULTRAS MED, V23, P247, DOI 10.7863/jum.2004.23.2.247; Martins WP, 2007, ULTRASOUND OBST GYN, V29, P210, DOI 10.1002/uog.3916; Matsumoto JS, 2015, RADIOGRAPHICS, V35, P1990, DOI 10.1148/rg.2015140260; Mitsouras D, 2015, RADIOGRAPHICS, V35, P1966, DOI 10.1148/rg.2015140320; Pang BSF, 2006, ULTRASOUND MED BIOL, V32, P1193, DOI 10.1016/j.ultrasmedbio.2006.04.012; Park SH, 2004, ULTRASOUND MED BIOL, V30, P27, DOI 10.1016/j.ultrasmedbio.2003.09.010; Pauletzki J, 1996, J CLIN ULTRASOUND, V24, P277, DOI 10.1002/(SICI)1097-0096(199607/08)24:6<277::AID-JCU1>3.0.CO;2-F; Prasad SR, 2002, RADIOLOGY, V225, P416, DOI 10.1148/radiol.2252011604; Raine-Fenning NJ, 2003, ULTRASOUND OBST GYN, V21, P283, DOI 10.1002/uog.61; Sohaib SA, 2000, BRIT J RADIOL, V73, P1178, DOI 10.1259/bjr.73.875.11144795; Souzaki R, 2015, PEDIATR SURG INT, V31, P593, DOI 10.1007/s00383-015-3709-9; Tong SD, 1998, ULTRASOUND MED BIOL, V24, P673, DOI 10.1016/S0301-5629(98)00039-8; Tran LN, 2004, ACAD RADIOL, V11, P1355, DOI 10.1016/j.acra.2004.09.004; Vogl TJ, 2008, RADIOLOGY, V249, P865, DOI 10.1148/radiol.2491072079; Winer-Muram HT, 2003, RADIOLOGY, V229, P184, DOI 10.1148/radiol.2291020859; Xu HX, 2003, ULTRASOUND MED BIOL, V29, P839, DOI 10.1016/S0301-5629(02)00775-5; Yankelevitz DF, 2000, RADIOLOGY, V217, P251, DOI 10.1148/radiology.217.1.r00oc33251	34	9	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182596	10.1371/journal.pone.0182596	http://dx.doi.org/10.1371/journal.pone.0182596			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797089	Green Submitted, gold, Green Published			2022-12-26	WOS:000407396200067
J	Ribera, J; Gandia, M; Marcos, JF; Bas, MD; Fink, S; Schwarze, FWMR				Ribera, Javier; Gandia, Monica; Marcos, Jose F.; del Carmen Bas, Maria; Fink, Siegfried; Schwarze, Francis W. M. R.			Effect of Trichoderma-enriched organic charcoal in the integrated wood protection strategy	PLOS ONE			English	Article							BROWN-ROT FUNGI; OXALIC-ACID; DECAY FUNGI; COPPER; BIOCHARS; ADSORPTION; BIODEGRADATION; PRESERVATIVES; DEGRADATION; RESISTANCE	The gradual elimination of chromium from wood preservative formulations results in higher Cu leaching and increased susceptibility to wood decay fungi. Finding a sustainable strategy in wood protection has become of great interest among researchers. The objective of these in vitro studies was to demonstrate the effect of T-720-enriched organic charcoal (biochar) against five wood decay basidiomycetes isolated from strongly damaged poles. For this purpose, the antagonistic potential of Trichoderma harzianum (strain T-720) was confirmed among other four Trichoderma spp. against five brown-rot basidiomycetes in dual culture tests. T-720 was genetically transformed and tagged with the green fluorescent protein (GFP) in order to study its antagonistic mechanism against wood decay basidiomycetes. It was also demonstrated that T-720 inhibits the oxalic acid production by basidiomycetes, a well-known mechanism used by brown-rot fungi to detoxify Cu from impregnated wood. Additionally, this study evaluated the effect of biochar, alone or in combination with T-720, on Cu leaching by different preservatives, pH stabilization and prevention of wood decay caused by five basidiomycetes. Addition of biochar resulted in a significant Cu binding released from impregnated wood specimens. T-720-enriched biochar showed a significant reduction of wood decay caused by four basidiomycetes. The addition of T-720-enriched biochar to the soil into which utility poles are placed may improve the efficiency of Cr-free wood preservatives.	[Ribera, Javier; Schwarze, Francis W. M. R.] Empa, Dept Appl Wood Mat, St Gallen, Switzerland; [Ribera, Javier; Fink, Siegfried; Schwarze, Francis W. M. R.] Albert Ludwigs Univ Freiburg, Forstbot, Freiburg, Germany; [Gandia, Monica; Marcos, Jose F.] CSIC, Inst Agroquim & Tecnol Alimentos, Dept Food Biotechnol, Paterna, Spain; [del Carmen Bas, Maria] Univ Politecn Valencia, Dept Appl Stat & Operat Res & Qual, Valencia, Spain	Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); University of Freiburg; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); Universitat Politecnica de Valencia	Ribera, J (corresponding author), Empa, Dept Appl Wood Mat, St Gallen, Switzerland.; Ribera, J (corresponding author), Albert Ludwigs Univ Freiburg, Forstbot, Freiburg, Germany.	javier.ribera@empa.ch	Gandía, Mónica/ABE-5929-2021; Ribera, Javier/V-7140-2019; del Carmen Bas Cerdá, María/J-4354-2016; Marcos, Jose F./A-7121-2011; Gandía, Mónica/E-7808-2011; Schwarze, Francis/Y-2157-2018	Gandía, Mónica/0000-0002-8663-0403; del Carmen Bas Cerdá, María/0000-0002-1221-0641; Marcos, Jose F./0000-0003-3339-2584; Gandía, Mónica/0000-0002-8663-0403; Schwarze, Francis/0000-0003-3306-8303; Ribera, Dr. Javier/0000-0001-6677-3020	Commission for Technical Innovation (CTI) [19082.3 PFLS-LS]; Mycosolutions AG; Swisscom AG; CarbonGold	Commission for Technical Innovation (CTI); Mycosolutions AG; Swisscom AG; CarbonGold	We would like to thank the Commission for Technical Innovation (CTI) for funding the studies (Project No. 19082.3 PFLS-LS). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; A European patent has been submitted (Patent num. 16179168.6) for the application of Trichoderma harzianum (T-720) to functionalize biochar for inhibiting the growth of wood decay basidiomycetes in the soil. The plasmid pCAMBgfp was kindly provided to JFM by Dr. Ane Sesma (Center for Plant Biotechnology and Genomics, Universidad Politecnica de Madrid, Madrid, Spain). The authors wish to thank Mycosolutions AG, Swisscom AG and CarbonGold for their support. Elisabeth Michel from Empa is thanked for assistance in ICPOES measurements.	Ameloot N, 2013, EUR J SOIL SCI, V64, P379, DOI 10.1111/ejss.12064; Bahmani M, 2015, EUR J WOOD WOOD PROD, V73, P377, DOI 10.1007/s00107-015-0901-5; Baker D. E., 1990, HEAVY METALS SOILS, P151; Beesley L, 2011, ENVIRON POLLUT, V159, P3269, DOI 10.1016/j.envpol.2011.07.023; Bergholm J., 1990, IRGWP3571; Bollmus S., 2012, IRGWP1240584; British Standards Institution (BSI), 1994, 600 BSI EN; Brown HL, 1999, INT BIODETER BIODEGR, V44, P225, DOI 10.1016/S0964-8305(99)00083-9; BRUCE A, 1991, HOLZFORSCHUNG, V45, P307, DOI 10.1515/hfsg.1991.45.4.307; CERVANTES C, 1994, FEMS MICROBIOL REV, V14, P121, DOI 10.1016/0168-6445(94)90002-7; Chacon MR, 2007, INT MICROBIOL, V10, P19, DOI 10.2436/20.1501.01.4; Chen XC, 2011, BIORESOURCE TECHNOL, V102, P8877, DOI 10.1016/j.biortech.2011.06.078; CIVARDI C, 2015, PLOS ONE, V10; Civardi C, 2015, ENVIRON POLLUT, V200, P126, DOI 10.1016/j.envpol.2015.02.018; Dickman MB, 1998, SOIL BIOL BIOCHEM, V30, P1195, DOI 10.1016/S0038-0717(98)00018-2; European Committee for Standardization (CEN), 2001, 807 CEN ENV; Freeman MH, 2008, FOREST PROD J, V58, P6; Gandia M, 2014, FUNGAL GENET BIOL, V67, P58, DOI 10.1016/j.fgb.2014.04.002; Han YX, 2013, J ENVIRON MANAGE, V118, P196, DOI 10.1016/j.jenvman.2013.01.001; Harman GE, 2004, NAT REV MICROBIOL, V2, P43, DOI 10.1038/nrmicro797; Harries E, 2015, MOL PLANT PATHOL, V16, P748, DOI 10.1111/mpp.12232; Hastrup ACS, 2012, INT BIODETER BIODEGR, V75, P109, DOI 10.1016/j.ibiod.2012.05.030; HIGHLEY TL, 1988, MATER ORGANISMEN, V23, P157; Khang Chang Hyun, 2006, V344, P403, DOI 10.1385/1-59745-131-2:403; Lebow S., FPLGTR93; Lehmann J, 2011, SOIL BIOL BIOCHEM, V43, P1812, DOI 10.1016/j.soilbio.2011.04.022; McBride M. B., 1981, Copper in soils and plants., P25; MURPHY RJ, 1983, T BRIT MYCOL SOC, V81, P165, DOI 10.1016/S0007-1536(83)80223-X; Murphy RJ, 1990, IRGWP3579; Naar Z, 1998, MICROBIOL RES, V153, P119, DOI 10.1016/S0944-5013(98)80029-3; Olaniran AO, 2013, INT J MOL SCI, V14, P10197, DOI 10.3390/ijms140510197; Paramasivan M., 2013, Archives of Phytopathology and Plant Protection, V46, P357, DOI 10.1080/03235408.2012.740983; Parker AJ, 1981, COPPER SOILS PLANTS, P1; Pellera FM, 2012, J ENVIRON MANAGE, V96, P35, DOI 10.1016/j.jenvman.2011.10.010; Ribera J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174335; Ribera J, 2017, HOLZFORSCHUNG, V71, P241, DOI 10.1515/hf-2016-0134; RITSCHKOFF AC, 1995, J BIOTECHNOL, V40, P179, DOI 10.1016/0168-1656(95)00044-Q; Schmidt O, 1996, HOLZFORSCHUNG, V50, P105, DOI 10.1515/hfsg.1996.50.2.105; Schmidt O, 1995, PORENHAUSSCHWAMME 20, P171; Schubert M, 2008, BIOL CONTROL, V45, P111, DOI 10.1016/j.biocontrol.2008.01.001; Schubert Mark, 2008, Arboricultural Journal, V31, P227; Schwarze FWMR, 2012, BIOL CONTROL, V61, P160, DOI 10.1016/j.biocontrol.2012.01.016; Sesma A, 2004, NATURE, V431, P582, DOI 10.1038/nature02880; SIEBER TN, 1995, MYCOL RES, V99, P274, DOI 10.1016/S0953-7562(09)80897-6; Sutter HP, 1983, FR MAT ORG, V18, P241; Taylor JL, 2005, HOLZFORSCHUNG, V59, P467, DOI 10.1515/HF.2005.077; Tong XJ, 2011, CHEM ENG J, V172, P828, DOI 10.1016/j.cej.2011.06.069; Young GY, 1961, 2223 USDA FOR SERV F	48	7	7	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0183004	10.1371/journal.pone.0183004	http://dx.doi.org/10.1371/journal.pone.0183004			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797118	gold, Green Published, Green Submitted			2022-12-26	WOS:000407396200140
J	Sechler, AJ; Tancos, MA; Schneider, DJ; King, JG; Fennessey, CM; Schroeder, BK; Murray, TD; Luster, DG; Schneider, WL; Rogers, EE				Sechler, Aaron J.; Tancos, Matthew A.; Schneider, David J.; King, Jonas G.; Fennessey, Christine M.; Schroeder, Brenda K.; Murray, Timothy D.; Luster, Douglas G.; Schneider, William L.; Rogers, Elizabeth E.			Whole genome sequence of two Rathayibacter toxicus strains reveals a tunicamycin biosynthetic cluster similar to Streptomyces chartreusis	PLOS ONE			English	Article							ANNUAL RYEGRASS TOXICITY; MICHIGANENSIS SUBSP MICHIGANENSIS; CORYNEBACTERIUM-RATHAYI; CLAVIBACTER-TOXICUS; IDENTIFICATION; CORYNETOXINS; DIVERSITY; PROTEASES; ALIGNMENT; CUTICLE	Rathayibacter toxicus is a forage grass associated Gram-positive bacterium of major concern to food safety and agriculture. This species is listed by USDA-APHIS as a plant pathogen select agent because it produces a tunicamycin-like toxin that is lethal to livestock and may be vectored by nematode species native to the U.S. The complete genomes of two strains of R. toxicus, including the type strain FH-79, were sequenced and analyzed in comparison with all available, complete R. toxicus genomes. Genome sizes ranged from 2,343,780 to 2,394,755 nucleotides, with 2079 to 2137 predicted open reading frames; all four strains showed remarkable synteny over nearly the entire genome, with only a small transposed region. A cluster of genes with similarity to the tunicamycin biosynthetic cluster from Streptomyces chartreusis was identified. The tunicamycin gene cluster (TGC) in R. toxicus contained 14 genes in two transcriptional units, with all of the functional elements for tunicamycin biosynthesis present. The TGC had a significantly lower GC content (52%) than the rest of the genome (61.5%), suggesting that the TGC may have originated from a horizontal transfer event. Further analysis indicated numerous remnants of other potential horizontal transfer events are present in the genome. In addition to the TGC, genes potentially associated with carotenoid and exopolysaccharide production, bacteriocins and secondary metabolites were identified. A CRISPR array is evident. There were relatively few plant-associated cell-wall hydrolyzing enzymes, but there were numerous secreted serine proteases that share sequence homology to the pathogenicity-associated protein Pat-1 of Clavibacter michiganensis. Overall, the genome provides clear insight into the possible mechanisms for toxin production in R. toxicus, providing a basis for future genetic approaches.	[Sechler, Aaron J.; Tancos, Matthew A.; King, Jonas G.; Fennessey, Christine M.; Luster, Douglas G.; Schneider, William L.; Rogers, Elizabeth E.] ARS, Foreign Disease Weed Sci Res Unit, USDA, Frederick, MD 21702 USA; [Schneider, David J.] ARS, Emerging Pests & Pathogens Res Unit, USDA, Ithaca, NY USA; [Schroeder, Brenda K.] Univ Idaho, Dept Entomol Plant Pathol & Nematol, Moscow, ID 83843 USA; [Murray, Timothy D.] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA; [Schneider, David J.] Univ Saskatchewan, Global Inst Food Secur, Saskatoon, SK, Canada; [Schneider, David J.] Univ Saskatchewan, Sch Environm & Sustainabil, Saskatoon, SK, Canada; [King, Jonas G.] Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA; [Fennessey, Christine M.] Frederick Natl Lab Canc Res, AIDS & Canc Virus Program, Frederick, MD USA; [Fennessey, Christine M.] Leidos Biomed Res Inc, Frederick, MD USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Idaho; University of Idaho; Washington State University; University of Saskatchewan; University of Saskatchewan; Mississippi State University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Schneider, WL; Rogers, EE (corresponding author), ARS, Foreign Disease Weed Sci Res Unit, USDA, Frederick, MD 21702 USA.	william.schneider@ars.usda.gov; elizabeth.rogers@ars.usda.gov	Schneider, David J/H-2236-2012; Murray, Timothy D/A-9771-2016; Rogers, Elizabeth/AAB-3643-2021	Schneider, David J/0000-0002-2124-8385; Murray, Timothy D/0000-0002-6772-202X; Rogers, Elizabeth/0000-0002-0545-4744; King, Jonas/0000-0003-2270-4212; Schroeder, Brenda/0000-0003-1518-6269	United States Department of Agriculture Agricultural Research Service appropriated project [8044-22000-040-00D]; Farm Bill grants [13-8130-0247-CA, 148130 -0367-CA]; United States Department of Agriculture (USDA) Agricultural Research Service appropriated project [8044-22000-040-00D]	United States Department of Agriculture Agricultural Research Service appropriated project; Farm Bill grants; United States Department of Agriculture (USDA) Agricultural Research Service appropriated project	Funding for this work was from the United States Department of Agriculture Agricultural Research Service appropriated project 8044-22000-040-00D to DGL, WLS, and EER. No grant website available. Funding was also received from two 2008 Farm Bill grants, Section 10201 administered through the United States Department of Agriculture, Animal and Plant Health Inspection Service: 13-8130-0247-CA and 148130 -0367-CA to BKS, TDM, DGL, and WLS. Grant website is http://www.aphis.usda.gov/aphis/resources/farm-bill/lut/p/z1/04 iIUDg4tKPAFJABpSA0fpReYllmemJJZn5eYk5-hH6kVF m8T7-; The authors would like to thank Dr. Ian Riley (University of Adelaide) for providing Rathayibacter toxicus strains and for considerable assistance over the years with R. toxicus. Funding for this work was from the United States Department of Agriculture (USDA) Agricultural Research Service appropriated project 8044-22000-040-00D and from two 2008 Farm Bill grants, Section 10201 administered through the United States Department of Agriculture, Animal and Plant Health Inspection Service (13-8130-0247-CA and 14-8130-0367-CA). Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the U.S. Department of Agriculture. USDA is an equal opportunity provider and employer.	Agarkova IV, 2006, PHYTOPATHOLOGY, V96, P1270, DOI 10.1094/PHYTO-96-1270; Akerman B, 2002, ELECTROPHORESIS, V23, P2549, DOI 10.1002/1522-2683(200208)23:16<2549::AID-ELPS2549>3.0.CO;2-Q; Alva V, 2016, NUCLEIC ACIDS RES, V44, pW410, DOI 10.1093/nar/gkw348; Arif M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156182; BIRD AF, 1984, INT J PARASITOL, V14, P503, DOI 10.1016/0020-7519(84)90032-8; BIRD AF, 1985, INT J PARASITOL, V15, P301, DOI 10.1016/0020-7519(85)90067-0; Chatel D. L., 1979, Journal of Agriculture Western Australia, V20, P89; Chen WQ, 2010, PROTEIN CELL, V1, P1093, DOI 10.1007/s13238-010-0127-6; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; DEBOER SH, 1980, AM POTATO J, V57, P457, DOI 10.1007/BF02854462; EDGAR JA, 1982, J CHEM SOC CHEM COMM, P222, DOI 10.1039/c39820000222; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eichenlaub R, 2011, ANNU REV PHYTOPATHOL, V49, P445, DOI 10.1146/annurev-phyto-072910-095258; Finnie JW, 2006, AUST VET J, V84, P271, DOI 10.1111/j.1751-0813.2006.00019.x; Gao F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-79; Gartemann KH, 2008, J BACTERIOL, V190, P2138, DOI 10.1128/JB.01595-07; Gomez-Escribano JP, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1652-8; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Heider SAE, 2014, FEBS J, V281, P4906, DOI 10.1111/febs.13033; JAGO MV, 1983, CHEM-BIOL INTERACT, V45, P223, DOI 10.1016/0009-2797(83)90070-4; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kessell D., 2010, ANN RYEGRASS TOXICIT, P1; Kirby R, 2011, FEMS MICROBIOL LETT, V319, P1, DOI 10.1111/j.1574-6968.2011.02242.x; Kowalski MC, 2007, AUST J EXP AGR, V47, P177, DOI 10.1071/EA05162; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lian LH, 2007, LETT APPL MICROBIOL, V45, P262, DOI 10.1111/j.1472-765X.2007.02184.x; Liu YC, 2010, BIOINFORMATICS, V26, P1958, DOI 10.1093/bioinformatics/btq338; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; McTaggart LR, 2010, J CLIN MICROBIOL, V48, P4525, DOI 10.1128/JCM.00883-10; Meganathan R, 2009, EcoSal Plus, V3, DOI 10.1128/ecosalplus.3.6.3.3; Monteiro-Vitorello CB, 2004, MOL PLANT MICROBE IN, V17, P827, DOI 10.1094/MPMI.2004.17.8.827; Odom AR, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002323; OPHEL KM, 1993, PHYTOPATHOLOGY, V83, P676, DOI 10.1094/Phyto-83-676; Peeters K, 2011, FEMS MICROBIOL LETT, V321, P130, DOI 10.1111/j.1574-6968.2011.02326.x; Riadi G, 2012, INT J GENOMICS, V2012; Riley IT, 2008, AUSTRALAS PLANT PATH, V37, P289, DOI 10.1071/AP08022; RILEY IT, 1992, INT J SYST BACTERIOL, V42, P64, DOI 10.1099/00207713-42-1-64; Sasaki J, 1998, INT J SYST BACTERIOL, V48, P403, DOI 10.1099/00207713-48-2-403; Schaad NW, 2004, SYST APPL MICROBIOL, V27, P763, DOI 10.1078/0723202042369848; Schneider WL, 2017, GENOME ANNOUCE UNPUB; Shin SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068824; Stork I, 2008, MOL PLANT PATHOL, V9, P599, DOI [10.1111/j.1364-3703.2008.00484.x, 10.1111/J.1364-3703.2008.00484.X]; STYNES BA, 1983, AUST J AGR RES, V34, P653, DOI 10.1071/AR9830653; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tatusova T, 2016, NUCLEIC ACIDS RES, V44, P6614, DOI 10.1093/nar/gkw569; Tian BY, 2009, J INVERTEBR PATHOL, V101, P143, DOI 10.1016/j.jip.2009.05.001; Trutko S M, 2005, Mikrobiologiia, V74, P335; van Heel AJ, 2013, NUCLEIC ACIDS RES, V41, pW448, DOI 10.1093/nar/gkt391; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; Weber T, 2015, NUCLEIC ACIDS RES, V43, pW237, DOI 10.1093/nar/gkv437; Wyszynski FJ, 2010, CHEM SCI, V1, P581, DOI 10.1039/c0sc00325e	52	9	9	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0183005	10.1371/journal.pone.0183005	http://dx.doi.org/10.1371/journal.pone.0183005			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796837	Green Published, Green Submitted, gold			2022-12-26	WOS:000407396200141
J	Singh, G; Da Ines, O; Gallego, ME; White, CI				Singh, Gunjita; Da Ines, Olivier; Gallego, Maria Eugenia; White, Charles I.			Analysis of the impact of the absence of RAD51 strand exchange activity in Arabidopsis meiosis	PLOS ONE			English	Article							MEIOTIC RECOMBINATION; CHROMOSOME SYNAPSIS; HOMOLOGOUS RECOMBINATION; SACCHAROMYCES-CEREVISIAE; DMC1; PROTEIN; GENE; DNA; ROLES; CROSSOVER	The ploidy of eukaryote gametes must be halved to avoid doubling of numbers of chromosomes with each generation and this is carried out by meiosis, a specialized cell division in which a single chromosomal replication phase is followed by two successive nuclear divisions. With some exceptions, programmed recombination ensures the proper pairing and distribution of homologous pairs of chromosomes in meiosis and recombination defects thus lead to sterility. Two highly related recombinases are required to catalyse the key strand-invasion step of meiotic recombination and it is the meiosis-specific DMC1 which is generally believed to catalyse the essential non-sister chromatid crossing-over, with RAD51 catalysing sister-chromatid and non-cross-over events. Recent work in yeast and plants has however shown that in the absence of RAD51 strand-exchange activity, DMC1 is able to repair all meiotic DNA breaks and surprisingly, that this does not appear to affect numbers of meiotic cross-overs. In this work we confirm and extend this conclusion. Given that more than 95% of meiotic homologous recombination in Arabidopsis does not result in inter-homologue crossovers, Arabidopsis is a particularly sensitive model for testing the relative importance of the two proteins-even minor effects on the non-crossover event population should produce detectable effects on crossing-over. Although the presence of RAD51 protein provides essential support for the action of DMC1, our results show no significant effect of the absence of RAD51 strand-exchange activity on meiotic crossing-over rates or patterns in different chromosomal regions or across the whole genome of Arabidopsis, strongly supporting the argument that DMC1 catalyses repair of all meiotic DNA breaks, not only non-sister cross-overs.	[Singh, Gunjita; Da Ines, Olivier; Gallego, Maria Eugenia; White, Charles I.] Univ Cleront Auvergne, Genet Reprod & Dev, UMR CNRS 6293, INSERM U1103, Campus Univ Cezeaux, Aubiere, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA)	White, CI (corresponding author), Univ Cleront Auvergne, Genet Reprod & Dev, UMR CNRS 6293, INSERM U1103, Campus Univ Cezeaux, Aubiere, France.	charles.white@uca.fr	DA INES, Olivier/J-6901-2015; Gallego, Maria E/F-1044-2011; White, Charles I/F-1001-2011	DA INES, Olivier/0000-0002-1868-3781; Gallego, Maria E/0000-0001-5588-9116; White, Charles I/0000-0001-8152-5797	European Commission Marie-Sklodowska Actions [FP7-PEOPLE-2013-ITN. COMREC.606956]; Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale; Universite Clermont Auvergne	European Commission Marie-Sklodowska Actions; Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)Centre National de la Recherche Scientifique (CNRS)); Universite Clermont Auvergne	This work was funded by the European Commission Marie-Sklodowska Actions (FP7-PEOPLE-2013-ITN. COMREC.606956), the Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale, and the Universite Clermont Auvergne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; Armstrong SJ, 2002, J CELL SCI, V115, P3645, DOI 10.1242/jcs.00048; Armstrong Susan, 2013, Methods Mol Biol, V990, P119, DOI 10.1007/978-1-62703-333-6_12; Barton NH, 1998, SCIENCE, V281, P1986, DOI 10.1126/science.281.5385.1986; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Berchowitz LE, 2008, NAT PROTOC, V3, P41, DOI 10.1038/nprot.2007.491; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Brown MS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016659; Bugreev DV, 2011, NAT STRUCT MOL BIOL, V18, P56, DOI 10.1038/nsmb.1946; Callender TL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006226; Chelysheva L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002799; Cloud V, 2012, SCIENCE, V337, P1222, DOI 10.1126/science.1219379; Couteau F, 1999, PLANT CELL, V11, P1623, DOI 10.1105/tpc.11.9.1623; Da Ines O, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003787; Dai JQ, 2017, CELL REP, V18, P1383, DOI 10.1016/j.celrep.2017.01.024; Deng ZY, 2007, PLANT MOL BIOL, V65, P31, DOI 10.1007/s11103-007-9195-2; Ding ZJ, 2001, SEX PLANT REPROD, V13, P285, DOI 10.1007/s004970100065; Franklin AE, 1999, PLANT CELL, V11, P809, DOI 10.1105/tpc.11.5.809; Fransz P, 1998, PLANT J, V13, P867, DOI 10.1046/j.1365-313X.1998.00086.x; GAME JC, 1980, GENETICS, V94, P51; GAME JC, 1974, MUTAT RES, V24, P281, DOI 10.1016/0027-5107(74)90176-6; Godin SK, 2016, BIOCHEM CELL BIOL, V94, P407, DOI 10.1139/bcb-2016-0012; Higgins JD, 2005, GENE DEV, V19, P2488, DOI 10.1101/gad.354705; Higgins JD, 2004, GENE DEV, V18, P2557, DOI 10.1101/gad.317504; Hong ERL, 2001, J BIOL CHEM, V276, P41906, DOI 10.1074/jbc.M105563200; Hong S, 2013, MOL CELL, V51, P440, DOI 10.1016/j.molcel.2013.08.008; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Hunter N, 2007, MOL GENETICS RECOMBI, P381; Kagawa W, 2010, FEBS J, V277, P590, DOI 10.1111/j.1742-4658.2009.07503.x; Kathiresan A, 2002, SEX PLANT REPROD, V14, P257, DOI 10.1007/s00497-001-0113-5; Kobayashi W, 2014, GENES GENET SYST, V89, P169, DOI 10.1266/ggs.89.169; Kurzbauer MT, 2012, PLANT CELL, V24, P2058, DOI 10.1105/tpc.112.098459; Li J, 2007, GENETICS, V176, P1469, DOI 10.1534/genetics.106.062604; Li WX, 2004, P NATL ACAD SCI USA, V101, P10596, DOI 10.1073/pnas.0404110101; Li ZF, 1997, P NATL ACAD SCI USA, V94, P11221, DOI 10.1073/pnas.94.21.11221; Lim DS, 1996, MOL CELL BIOL, V16, P7133; Lin ZG, 2006, P NATL ACAD SCI USA, V103, P10328, DOI 10.1073/pnas.0604232103; Lydall D, 1996, NATURE, V383, P840, DOI 10.1038/383840a0; Masson JY, 2001, TRENDS BIOCHEM SCI, V26, P131, DOI 10.1016/S0968-0004(00)01742-4; Moran ES, 2001, CHROMOSOME RES, V9, P121, DOI 10.1023/A:1009278902994; Morozumi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075451; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Pradillo M, 2012, PLANT J, V69, P921, DOI 10.1111/j.1365-313X.2011.04845.x; Rajanikant C, 2008, PLANT MOL BIOL, V68, P479, DOI 10.1007/s11103-008-9385-6; Ramesh MA, 2005, CURR BIOL, V15, P185, DOI 10.1016/j.cub.2005.01.003; ROCKMILL B, 1995, GENE DEV, V9, P2684, DOI 10.1101/gad.9.21.2684; ROCKMILL B, 1994, GENETICS, V136, P65; Ross KJ, 1996, CHROMOSOME RES, V4, P507, DOI 10.1007/BF02261778; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; Serrentino ME, 2012, EXP CELL RES, V318, P1347, DOI 10.1016/j.yexcr.2012.03.025; Sheridan SD, 2008, NUCLEIC ACIDS RES, V36, P4057, DOI 10.1093/nar/gkn352; Shimazu J, 2001, THEOR APPL GENET, V102, P1159, DOI 10.1007/s001220100557; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Stassen NY, 1997, CURR GENET, V31, P144, DOI 10.1007/s002940050189; Stronghill PE, 2014, PLANT METHODS, V10, DOI 10.1186/1746-4811-10-33; Su H, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006827; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Suwaki N, 2011, SEMIN CELL DEV BIOL, V22, P898, DOI 10.1016/j.semcdb.2011.07.019; Taylor MRG, 2016, MOL CELL, V64, P926, DOI 10.1016/j.molcel.2016.10.020; Tsubouchi H, 2003, DEV CELL, V5, P915, DOI 10.1016/S1534-5807(03)00357-5; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; Uanschou C, 2013, PLANT CELL, V25, P4924, DOI 10.1105/tpc.113.118521; Wang HJ, 2016, PLANT PHYSIOL, V171, P230, DOI 10.1104/pp.16.00167; Yelina NE, 2013, NAT PROTOC, V8, P2119, DOI 10.1038/nprot.2013.131; Yelina NE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002844; Yoshida K, 1998, MOL CELL, V1, P707, DOI 10.1016/S1097-2765(00)80070-2; Zelensky A, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016451; Zickler D, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016626	68	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0183006	10.1371/journal.pone.0183006	http://dx.doi.org/10.1371/journal.pone.0183006			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797117	Green Published, Green Submitted, gold			2022-12-26	WOS:000407396200142
J	Belogortseva, N; Krezalek, M; Guyton, K; Labno, C; Poroyko, V; Zaborina, O; Alverdy, JC				Belogortseva, Natalia; Krezalek, Monika; Guyton, Kristina; Labno, Christine; Poroyko, Valeriy; Zaborina, Olga; Alverdy, John C.			Media from macrophages co-incubated with Enterococcus faecalis induces epithelial cell monolayer reassembly and altered cell morphology	PLOS ONE			English	Article							E-CADHERIN; STEM-CELLS; ADHESION; BARRIER	Signal exchange between intestinal epithelial cells, microbes and local immune cells is an important mechanism of intestinal homeostasis. Given that intestinal macrophages are in close proximity to both the intestinal epithelium and the microbiota, their pathologic interactions may result in epithelial damage. The present study demonstrates that co-incubation of murine macrophages with E. faecalis strains producing gelatinase (GelE) and serine protease (SprE) leads to resultant condition media (CM) capable of inducing reassembly of primary colonic epithelial cell monolayers. Following the conditioned media (CM) exposure, some epithelial cells are shed whereas adherent cells are observed to undergo dissolution of cell-cell junctions and morphologic transformation with actin cytoskeleton reorganization resulting in flattened and elongated shapes. These cells exhibit marked filamentous filopodia and lamellipodia formation. Cellular reorganization is not observed when epithelial monolayers are exposed to: CM from macrophages co-incubated with E. faecalis GelE/SprE-deficient mutants, CM from macrophages alone, or E. faecalis (GelE/SprE) alone. Flow cytometry analysis reveals increased expression of CD24 and CD44 in cells treated with macrophage/E. faecalis CM. This finding in combination with the appearance colony formation in matrigel demonstrate that the cells treated with macrophage/E. faecalis CM contain a higher proportion progenitor cells compared to untreated control. Taken together, these findings provide evidence for a triangulated molecular dialogue between E. faecalis, macrophages and colonic epithelial cells, which may have important implications for conditions in the gut that involve inflammation, injury or tumorigenesis.	[Belogortseva, Natalia; Krezalek, Monika; Guyton, Kristina; Zaborina, Olga; Alverdy, John C.] Univ Chicago, Dept Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Labno, Christine] Univ Chicago, Integrated Light Microscopy Core Facil, Chicago, IL 60637 USA; [Poroyko, Valeriy] Res City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut, Duarte, CA USA	University of Chicago; University of Chicago	Alverdy, JC (corresponding author), Univ Chicago, Dept Surg, 5841 S Maryland Ave, Chicago, IL 60637 USA.	jalverdy@surgery.bsd.uchicago.edu	Guyton, Kristina/AAC-4734-2021; Zaborina, Olga/AAQ-6977-2021	Guyton, Kristina/0000-0003-2008-5577; 	NIH [5R01GM062344]; NIH Digestive Diseases Research Core Centers [P30 DK42086]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062344] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Digestive Diseases Research Core Centers; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH grant 5R01GM062344 (JCA) and by pilot and feasibility grant from the NIH Digestive Diseases Research Core Centers P30 DK42086 (JCA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arjonen A, 2011, CELL ADHES MIGR, V5, P421, DOI 10.4161/cam.5.5.17723; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Gracz AD, 2013, STEM CELLS, V31, P2024, DOI 10.1002/stem.1391; Grieve AG, 2014, J CELL SCI, V127, P3331, DOI 10.1242/jcs.147926; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; HEUSSEN C, 1980, ANAL BIOCHEM, V102, P196, DOI 10.1016/0003-2697(80)90338-3; Johnson HE, 2015, J CELL BIOL, V208, P443, DOI 10.1083/jcb.201406102; LEVI G, 1991, DEVELOPMENT, V111, P159; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Nava P, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24783; O'Rourke KP, 2016, BIOPROTOCOL, V6; Ocvirk S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004911; Okabe H, 2014, BRIT J CANCER, V110, P958, DOI 10.1038/bjc.2013.759; Rieder F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004731; Roig AI, 2010, GASTROENTEROLOGY, V138, P1012, DOI 10.1053/j.gastro.2009.11.052; Shogan BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010658; Steck N, 2012, GUT, V61, P1610, DOI 10.1136/gutjnl-2011-300775; Steck N, 2011, GASTROENTEROLOGY, V141, P959, DOI 10.1053/j.gastro.2011.05.035; Suzuki T, 2013, CELL MOL LIFE SCI, V70, P631, DOI 10.1007/s00018-012-1070-x; Symowicz J, 2007, CANCER RES, V67, P2030, DOI 10.1158/0008-5472.CAN-06-2808; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Thomas VC, 2008, J BACTERIOL, V190, P5690, DOI 10.1128/JB.00314-08; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Umar S, 2014, ONCOTARGET, V5, P6573, DOI 10.18632/oncotarget.2384; Wang FC, 2013, GASTROENTEROLOGY, V145, P383, DOI 10.1053/j.gastro.2013.04.050; Whitehead RH, 2009, AM J PHYSIOL-GASTR L, V296, pG455, DOI 10.1152/ajpgi.90381.2008; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Yeung TM, 2010, P NATL ACAD SCI USA, V107, P3722, DOI 10.1073/pnas.0915135107; Zheng GP, 2009, AM J PATHOL, V175, P580, DOI 10.2353/ajpath.2009.080983	30	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182825	10.1371/journal.pone.0182825	http://dx.doi.org/10.1371/journal.pone.0182825			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28793333	gold, Green Published, Green Submitted			2022-12-26	WOS:000407196700069
J	Wisskirchen, K; Metzger, K; Schreiber, S; Asen, T; Weigand, L; Dargel, C; Witter, K; Kieback, E; Sprinzl, MF; Uckert, W; Schiemann, M; Busch, DH; Krackhardt, AM; Protzer, U				Wisskirchen, Karin; Metzger, Kai; Schreiber, Sophia; Asen, Theresa; Weigand, Luise; Dargel, Christina; Witter, Klaus; Kieback, Elisa; Sprinzl, Martin F.; Uckert, Wolfgang; Schiemann, Matthias; Busch, Dirk H.; Krackhardt, Angela M.; Protzer, Ulrike			Isolation and functional characterization of hepatitis B virus-specific T-cell receptors as new tools for experimental and clinical use	PLOS ONE			English	Article							CHIMERIC ANTIGEN RECEPTOR; ANTITUMOR-ACTIVITY; CANCER REGRESSION; CD8(+); TCR; BINDING; PATHOGENESIS; LYMPHOCYTES; AFFINITY; THERAPY	T-cell therapy of chronic hepatitis B is a novel approach to restore antiviral T-cell immunity and cure the infection. We aimed at identifying T-cell receptors (TCR) with high functional avidity that have the potential to be used for adoptive T-cell therapy. To this end, we cloned HLA-A*02-restricted, hepatitis B virus (HBV)-specific T cells from patients with acute or resolved HBV infection. We isolated 11 envelope-or core-specific TCRs and evaluated them in comprehensive functional analyses. T cells were genetically modified by retroviral transduction to express HBV-specific TCRs. CD8(+) as well as CD4(+) T cells became effector T cells recognizing even picomolar concentrations of cognate peptide. TCR-transduced T cells were polyfunctional, secreting the cytokines interferon gamma, tumor necrosis factor alpha and interleukin-2, and effectively killed hepatoma cells replicating HBV. Notably, our collection of HBV-specific TCRs recognized peptides derived from HBV genotypes A, B, C and D presented on different HLA-A* 02 subtypes common in areas with high HBV prevalence. When co-cultured with HBV-infected cells, TCR-transduced T cells rapidly reduced viral markers within two days. Our unique set of HBV-specific TCRs with different affinities represents an interesting tool for elucidating mechanisms of TCR-MHC interaction and dissecting specific anti-HBV mechanisms exerted by T cells. TCRs with high functional avidity might be suited to redirect T cells for adoptive T-cell therapy of chronic hepatitis B and HBV-induced hepatocellular carcinoma.	[Wisskirchen, Karin; Metzger, Kai; Schreiber, Sophia; Asen, Theresa; Dargel, Christina; Sprinzl, Martin F.; Protzer, Ulrike] Tech Univ Munich, Helmholtz Zentrum Munchen, Inst Virol, Munich, Germany; [Wisskirchen, Karin; Busch, Dirk H.; Protzer, Ulrike] German Ctr Infect Res DZIF, Munich Partner Site, Munich, Germany; [Weigand, Luise; Krackhardt, Angela M.] Tech Univ Munich, Klinikum Rechts Isar, Med Dept 3, Munich, Germany; [Witter, Klaus] Klinikum Univ Munchen, Lab Immunogenet & Mol Diagnost, Munich, Germany; [Kieback, Elisa; Uckert, Wolfgang] Humboldt Univ, Max Delbruck Ctr Mol Med, Helmholtz Assoc, Berlin, Germany; [Kieback, Elisa; Uckert, Wolfgang] Berlin Inst Hlth, Berlin, Germany; [Schiemann, Matthias; Busch, Dirk H.] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, Munich, Germany; [Wisskirchen, Karin; Busch, Dirk H.; Protzer, Ulrike] Tech Univ Munich, Inst Adv Study, Focus Grp Viral Hepatitis & Clin Cell Proc & Puri, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; German Center for Infection Research; Technical University of Munich; University of Munich; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Humboldt University of Berlin; Berlin Institute of Health; Technical University of Munich; Technical University of Munich	Wisskirchen, K; Protzer, U (corresponding author), Tech Univ Munich, Helmholtz Zentrum Munchen, Inst Virol, Munich, Germany.; Wisskirchen, K; Protzer, U (corresponding author), German Ctr Infect Res DZIF, Munich Partner Site, Munich, Germany.; Wisskirchen, K; Protzer, U (corresponding author), Tech Univ Munich, Inst Adv Study, Focus Grp Viral Hepatitis & Clin Cell Proc & Puri, Munich, Germany.	karin.wisskirchen@tum.de; protzer@tum.de	Protzer, Ulrike/D-5915-2015	Protzer, Ulrike/0000-0002-9421-1911; Wisskirchen, Karin/0000-0002-7447-4044	German research Foundation (DFG) [TRR36]; Helmholtz Alliance on I mmunotherapy of Cancer; German Center for Infection Research (DZIF) [TTU Hepatitis 05.806]	German research Foundation (DFG)(German Research Foundation (DFG)); Helmholtz Alliance on I mmunotherapy of Cancer; German Center for Infection Research (DZIF)	This work was supported by the German research Foundation (DFG, www.dfg.de) via TRR36 to U.P., D.B. and W.U., and the Helmholtz Alliance on I mmunotherapy of Cancer and the German Center for Infection Research (DZIF, TTU Hepatitis 05.806, www.dzif.de) to U.P. K.W. received a Maternity Leave and M.F.S. a Clinical Leave stipend from DZIF.	Bendle GM, 2010, NAT MED, V16, P565, DOI 10.1038/nm.2128; Bertoni R, 1997, J CLIN INVEST, V100, P503, DOI 10.1172/JCI119559; Block TM, 2013, ANTIVIR RES, V98, P27, DOI 10.1016/j.antiviral.2013.01.006; Bohne F, 2007, J VIRAL HEPATITIS, V14, P45, DOI 10.1111/j.1365-2893.2007.00913.x; Bohne F, 2008, GASTROENTEROLOGY, V134, P239, DOI 10.1053/j.gastro.2007.11.002; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; Cohen CJ, 2006, CANCER RES, V66, P8878, DOI 10.1158/0008-5472.CAN-06-1450; Corse E, 2011, J IMMUNOL, V186, P5039, DOI 10.4049/jimmunol.1003650; Derby MA, 2001, J IMMUNOL, V166, P1690, DOI 10.4049/jimmunol.166.3.1690; Desmond CP, 2008, ANTIVIR THER, V13, P161; Engels B, 2003, HUM GENE THER, V14, P1155, DOI 10.1089/104303403322167993; Engels B, 2013, CANCER CELL, V23, P516, DOI 10.1016/j.ccr.2013.03.018; Gehring AJ, 2011, J HEPATOL, V55, P103, DOI 10.1016/j.jhep.2010.10.025; Hoh A, 2015, J VIROL, V89, P7433, DOI 10.1128/JVI.00605-15; Hombrink P, 2013, EUR J IMMUNOL, V43, P3038, DOI 10.1002/eji.201343397; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Koh S, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.43; Krebs K, 2013, GASTROENTEROLOGY, V145, P456, DOI 10.1053/j.gastro.2013.04.047; Leisegang M, 2008, J MOL MED, V86, P573, DOI 10.1007/s00109-008-0317-3; Liu JX, 2011, EUR J IMMUNOL, V41, P2097, DOI 10.1002/eji.201041370; Loirat D, 2000, J IMMUNOL, V165, P4748, DOI 10.4049/jimmunol.165.8.4748; Lucifora J, 2014, SCIENCE, V343, P1221, DOI 10.1126/science.1243462; Maini MK, 1999, GASTROENTEROLOGY, V117, P1386, DOI 10.1016/S0016-5085(99)70289-1; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Muranski P, 2009, CURR OPIN IMMUNOL, V21, P200, DOI 10.1016/j.coi.2009.02.004; Nauerth M, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005958; Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882; Rehermann B, 2013, NAT MED, V19, P859, DOI 10.1038/nm.3251; Reuss S, 2014, EUR J IMMUNOL, V44, P265, DOI 10.1002/eji.201343591; Sommermeyer D, 2016, LEUKEMIA, V30, P492, DOI 10.1038/leu.2015.247; Sommermeyer D, 2013, INT J CANCER, V132, P1360, DOI 10.1002/ijc.27792; Sommermeyer D, 2010, J IMMUNOL, V184, P6223, DOI 10.4049/jimmunol.0902055; Stone JD, 2013, FRONT IMMUNOL FRONTI, P4; Stone JD, 2009, IMMUNOLOGY, V126, P165, DOI 10.1111/j.1365-2567.2008.03015.x; Tan AT, 2008, J VIROL, V82, P10986, DOI 10.1128/JVI.01124-08; Thimme R, 2003, J VIROL, V77, P68, DOI 10.1128/JVI.77.1.68-76.2003; Urbani S, 2002, J VIROL, V76, P12423, DOI 10.1128/JVI.76.24.12423-12434.2002; Venturi V, 2008, NAT REV IMMUNOL, V8, P231, DOI 10.1038/nri2260; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Walker LJ, 2010, CLIN EXP IMMUNOL, V159, P245, DOI 10.1111/j.1365-2249.2009.04047.x; Webster GJM, 2000, HEPATOLOGY, V32, P1117, DOI 10.1053/jhep.2000.19324; WHO, 2017, WHO PUBLISHES LIST B; Xia YC, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010018; Xia YC, 2016, GASTROENTEROLOGY, V150, P194, DOI 10.1053/j.gastro.2015.09.026; Yang JZ, 2014, CELL MOL IMMUNOL, V11, P332, DOI 10.1038/cmi.2014.22; Zhong S, 2013, P NATL ACAD SCI USA, V110, P6973, DOI 10.1073/pnas.1221609110	47	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2017	12	8							e0182936	10.1371/journal.pone.0182936	http://dx.doi.org/10.1371/journal.pone.0182936			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9EU	28792537	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000407144700047
J	Sun, RR; Zhu, BL; Xiong, K; Sun, Y; Shi, DD; Chen, L; Zhang, YY; Li, ZJ; Xue, LX				Sun, Rongrong; Zhu, Baoling; Xiong, Kai; Sun, Yan; Shi, Dandan; Chen, Li; Zhang, Youyi; Li, Zijian; Xue, Lixiang			Senescence as a novel mechanism involved in beta-adrenergic receptor mediated cardiac hypertrophy	PLOS ONE			English	Article							INCREASES LIFE-SPAN; P16(INK4A) EXPRESSION; OXIDATIVE STRESS; DNA-DAMAGE; AUTOPHAGY; CARDIOMYOCYTE; RESVERATROL; GATA4; ACTIVATION; RENEWAL	Pathological cardiac hypertrophy used to be elucidated by biomechanical, stretch-sensitive or neurohumoral mechanisms. However, a series of hints have indicated that hypertrophy process simulates senescence program. However, further evidence need to be pursued. To verify this hypothesis and examine whether cardiac senescence is a novel mechanism of hypertrophy induced by isoproterenol, 2-month-old male Sprague Dawley rats were subjected to isoproterenol infusion (0.25mg/kg/day) for 7 days by subcutaneous injection). Key characteristics of senescence (senescence-associated beta-galactosidase activity, lipofuscin, expression of cyclin-dependent kinase inhibitors) were examined in cardiac hypertrophy model. Senescence-like phenotype, such as increased senescence-associated beta-galactosidase activity, accumulation of lipofuscin and high levels of cyclin-dependent kinase inhibitors (e.g. p16, p19, p21 and p53) was found along the process of cardiac hypertrophy. Cardiac-specific transcription factor GATA4 increased in isoproterenol-treated cardiomyocytes as well. We further found that myocardial hypertrophy could be inhibited by resveratrol, an anti-aging compound, in a dose-dependent manner. Our results showed for the first time that cardiac senescence is involved in the process of pathological cardiac hypertrophy induced by isoproterenol.	[Sun, Rongrong; Xue, Lixiang] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing, Peoples R China; [Sun, Rongrong; Zhu, Baoling; Zhang, Youyi; Li, Zijian] Peking Univ, Hosp 3, Inst Vasc Med, Beijing, Peoples R China; [Xiong, Kai; Sun, Yan; Shi, Dandan; Chen, Li; Xue, Lixiang] Peking Univ, Hosp 3, Med Res Ctr, Beijing, Peoples R China; [Xue, Lixiang] Peking Univ, Hosp 3, Dept Radiat Oncol, Beijing, Peoples R China	Peking University; Peking University; Peking University; Peking University	Xue, LX (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing, Peoples R China.; Li, ZJ (corresponding author), Peking Univ, Hosp 3, Inst Vasc Med, Beijing, Peoples R China.; Xue, LX (corresponding author), Peking Univ, Hosp 3, Med Res Ctr, Beijing, Peoples R China.; Xue, LX (corresponding author), Peking Univ, Hosp 3, Dept Radiat Oncol, Beijing, Peoples R China.	lizijian@bjmu.edu.cn; lixiangxue@hsc.pku.edu.cn			National Basic Research Program of China [2014CBA02003]; National Natural Science Foundation of China [81672091, 81541142, 81471893, 81270157, 91539123, 81070078]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from the National Basic Research Program of China (grant number. 2014CBA02003) and the National Natural Science Foundation of China (grant numbers. 81672091, 81541142, 81471893, 81270157, 91539123, 81070078). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Wahab BA, 2016, BEHAV BRAIN RES, V305, P65, DOI 10.1016/j.bbr.2016.02.030; Anisimov VN, 2011, CELL CYCLE, V10, P4230, DOI 10.4161/cc.10.24.18486; Anisimov VN, 2011, AGING-US, V3, P148, DOI 10.18632/aging.100273; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bernhard D, 2008, GERONTOLOGY, V54, P24, DOI 10.1159/000113503; Bisping E, 2006, P NATL ACAD SCI USA, V103, P14471, DOI 10.1073/pnas.0602543103; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Chan AYM, 2004, J BIOL CHEM, V279, P32771, DOI 10.1074/jbc.M403528200; Chen X, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/868753; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dolinsky VW, 2015, J MOL MED, V93, P413, DOI 10.1007/s00109-014-1220-8; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Fu YN, 2011, ACTA PHARMACOL SIN, V32, P879, DOI 10.1038/aps.2010.229; Gu J, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00104; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Heineke J, 2010, NAT MED, V16, P872, DOI 10.1038/nm.2181; Hernandez JS, 2014, J CELL MOL MED, V18, P709, DOI 10.1111/jcmm.12220; Ido Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115341; Inuzuka Y, 2009, CIRCULATION, V120, P1695, DOI 10.1161/CIRCULATIONAHA.109.871137; Jurk D, 2012, AGING CELL, V11, P996, DOI 10.1111/j.1474-9726.2012.00870.x; Kajstura J, 2000, AM J PATHOL, V156, P813, DOI 10.1016/S0002-9440(10)64949-8; Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612; Kuzman JA, 2007, ENDOCRINOLOGY, V148, P3477, DOI 10.1210/en.2007-0099; Li B, 2016, EXP PHYSIOL, V101, P1050, DOI 10.1113/EP085586; Li N, 2011, FEBS LETT, V585, P3106, DOI 10.1016/j.febslet.2011.08.044; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Lin ZQ, 2009, P NATL ACAD SCI USA, V106, P12103, DOI 10.1073/pnas.0811371106; Linton PJ, 2015, J MOL CELL CARDIOL, V83, P44, DOI 10.1016/j.yjmcc.2014.12.017; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Maejima Y, 2008, AGING CELL, V7, P125, DOI 10.1111/j.1474-9726.2007.00358.x; McMullen JR, 2004, CIRCULATION, V109, P3050, DOI 10.1161/01.CIR.0000130641.08705.45; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Misaka T, 2013, BIOCHEM BIOPH RES CO, V439, P142, DOI 10.1016/j.bbrc.2013.08.002; Nishida K, 2016, J MOL CELL CARDIOL, V95, P11, DOI 10.1016/j.yjmcc.2015.12.003; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Shioi T, 2003, CIRCULATION, V107, P1664, DOI 10.1161/01.CIR.0000057979.36322.88; Sorrentino JA, 2014, TRENDS MOL MED, V20, P375, DOI 10.1016/j.molmed.2014.04.004; SWYNGHEDAUW B, 1995, AM J CARDIOL, V76, pD2, DOI 10.1016/S0002-9149(99)80484-6; Terman A, 2005, CARDIOVASC RES, V68, P355, DOI 10.1016/j.cardiores.2005.08.014; Watt AJ, 2004, P NATL ACAD SCI USA, V101, P12573, DOI 10.1073/pnas.0400752101; Wu JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000164; Wu Qi, 2010, Zhong Yao Cai, V33, P1112; Xing YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044899; Yan L, 2007, CELL, V130, P247, DOI 10.1016/j.cell.2007.05.038; Yao CX, 2013, RNA BIOL, V10, P465, DOI 10.4161/rna.24370; Yin Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152005; Zhang CX, 2011, CLIN EXP PHARMACOL P, V38, P55, DOI 10.1111/j.1440-1681.2010.05461.x; Zhang GX, 2007, J MOL CELL CARDIOL, V42, P804, DOI 10.1016/j.yjmcc.2007.01.012; Zhang GX, 2005, CARDIOVASC RES, V65, P230, DOI 10.1016/j.cardiores.2004.08.013; Zhao L, 2012, AGING CELL, V11, P1094, DOI 10.1111/acel.12011; Zheng WJ, 2004, J BIOL CHEM, V279, P31524, DOI 10.1074/jbc.M400365200	54	21	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0182668	10.1371/journal.pone.0182668	http://dx.doi.org/10.1371/journal.pone.0182668			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28783759	Green Published, Green Submitted, gold			2022-12-26	WOS:000406944300050
J	Seo, HD; Choi, Y; Kim, M; Kang, K; Urano, T; Lee, D				Seo, Hogyu David; Choi, Yoonjung; Kim, Minhoo; Kang, Keunsoo; Urano, Takeshi; Lee, Daeyoup			The 19S proteasome is directly involved in the regulation of heterochromatin spreading in fission yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin regulation; epigenetics; heterochromatin; proteasome; RNA interference (RNAi); 19S RP; Epe1; RNAi; heterochromatin spreading; non-proteolytic function	JMJC DOMAIN PROTEIN; 26S PROTEASOME; HISTONE TURNOVER; S-PHASE; TRANSCRIPTION; RNAI; CHROMATIN; PARTICLE; LOCALIZATION; SUBUNIT	Cumulative evidence suggests that non-proteolytic functions of the proteasome are involved in transcriptional regulation, mRNA export, and ubiquitin-dependent histone modification and thereby modulate the intracellular levels of regulatory proteins implicated in controlling key cellular functions. To date, the non-proteolytic roles of the proteasome have been mainly investigated in euchromatin; their effects on heterochromatin are largely unknown. Here, using fission yeast as a model, we randomly mutagenized the subunits of the 19S proteasome subcomplex and sought to uncover a direct role of the proteasome in heterochromatin regulation. We identified a mutant allele, rpt4-1, that disrupts a non-proteolytic function of the proteasome, also known as a non-proteolytic allele. Experiments performed using rpt4-1 cells revealed that the proteasome is involved in the regulation of heterochromatin spreading to prevent its uncontrolled invasion into neighboring euchromatin regions. Intriguingly, the phenotype of the non-proteolytic rpt4-1 mutant resembled that of epe1 cells, which lack the Epe1 protein that counteracts heterochromatin spreading. Both mutants exhibited variegated gene-silencing phenotypes across yeast colonies, spreading of heterochromatin, bypassing of the requirement for RNAi in heterochromatin formation at the outer repeat region (otr), and up-regulation of RNA polymerase II. Further analysis revealed Mst2, another factor that antagonizes heterochromatin spreading, may function redundantly with Rpt4. These observations suggest that the 19S proteasome may be involved in modulating the activities of Epe1 and Mst2. In conclusion, our findings indicate that the proteasome appears to have a heterochromatin-regulating function that is independent of its canonical function in proteolysis.	[Seo, Hogyu David; Choi, Yoonjung; Kim, Minhoo; Lee, Daeyoup] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon 34141, South Korea; [Kang, Keunsoo] Dankook Univ, Dept Microbiol, Cheonan 31116, Chungnam, South Korea; [Urano, Takeshi] Shimane Univ, Fac Med, Dept Biochem, Izumo, Shimane 6908504, Japan	Korea Advanced Institute of Science & Technology (KAIST); Dankook University; Shimane University	Lee, D (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon 34141, South Korea.	daeyoup@kaist.ac.kr	Seo, Hogyu David/AAC-7382-2021; Lee, Daeyoup/C-1653-2011	Lee, Daeyoup/0000-0003-2006-1823	National Research Foundation of Korea [2016R1A2B2006354]; KAIST Future Systems Healthcare Project - Ministry of Science, ICT, and Future Planning; Grants-in-Aid for Scientific Research [17K08983] Funding Source: KAKEN	National Research Foundation of Korea(National Research Foundation of Korea); KAIST Future Systems Healthcare Project - Ministry of Science, ICT, and Future Planning; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Mid-career Researcher Program through the National Research Foundation of Korea Grants 2016R1A2B2006354 and the KAIST Future Systems Healthcare Project funded by the Ministry of Science, ICT, and Future Planning. The authors declare that they have no conflicts of interest with the contents of this article.	Aygun O, 2013, NAT STRUCT MOL BIOL, V20, P547, DOI 10.1038/nsmb.2565; Ayoub N, 2003, MOL CELL BIOL, V23, P4356, DOI 10.1128/MCB.23.12.4356-4370.2003; Barrales RR, 2016, GENE DEV, V30, P133, DOI 10.1101/gad.271288.115; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Bayne EH, 2010, CELL, V140, P666, DOI 10.1016/j.cell.2010.01.038; Bhat KP, 2011, BBA-GENE REGUL MECH, V1809, P150, DOI 10.1016/j.bbagrm.2010.11.006; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; Braun S, 2011, CELL, V144, P41, DOI 10.1016/j.cell.2010.11.051; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Chang C, 2001, J BIOL CHEM, V276, P30956, DOI 10.1074/jbc.M102254200; Chaves S, 2010, MOL CELL BIOL, V30, P5284, DOI 10.1128/MCB.00952-10; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; CORREABORDES J, 1995, CELL, V83, P1001, DOI 10.1016/0092-8674(95)90215-5; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; EKWALL K, 1994, GENETICS, V136, P53; Ekwall K, 1999, GENETICS, V153, P1153; Ezhkova E, 2004, MOL CELL, V13, P435, DOI 10.1016/S1097-2765(04)00026-7; Ferdous A, 2002, BIOCHEMISTRY-US, V41, P12798, DOI 10.1021/bi020425t; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Ferdous A, 2007, GENE DEV, V21, P112, DOI 10.1101/gad.1493207; Ferrell K, 2000, TRENDS BIOCHEM SCI, V25, P83, DOI 10.1016/S0968-0004(99)01529-7; Flury V, 2017, MOL CELL, V67, P294, DOI 10.1016/j.molcel.2017.05.026; FUNABIKI H, 1993, J CELL BIOL, V121, P961, DOI 10.1083/jcb.121.5.961; Geng FQ, 2012, P NATL ACAD SCI USA, V109, P6060, DOI 10.1073/pnas.1200854109; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Huisinga KL, 2006, CHROMOSOMA, V115, P110, DOI 10.1007/s00412-006-0052-x; Javerzat JP, 1999, MOL CELL BIOL, V19, P5155; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Kim HM, 2011, BBA-GENE REGUL MECH, V1809, P67, DOI 10.1016/j.bbagrm.2010.08.008; Kitagawa T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4597; Kominami K, 1997, GENE DEV, V11, P1548, DOI 10.1101/gad.11.12.1548; Kowalik KM, 2015, NATURE, V520, P248, DOI 10.1038/nature14337; Kwak J, 2011, BBA-GENE REGUL MECH, V1809, P88, DOI 10.1016/j.bbagrm.2010.08.001; Lee DY, 2005, CELL, V123, P423, DOI 10.1016/j.cell.2005.08.015; Lee JE, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02403-5; Lim S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3641; Maganti N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091200; McCann TS, 2014, BIOMOLECULES, V4, P1026, DOI 10.3390/biom4041026; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Oh S, 2010, BIOCHEM BIOPH RES CO, V399, P512, DOI 10.1016/j.bbrc.2010.07.100; Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Reddy BD, 2011, GENE DEV, V25, P214, DOI 10.1101/gad.1993611; Sadeghi L, 2015, EMBO REP, V16, P1673, DOI 10.15252/embr.201541214; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Shim YS, 2012, EMBO J, V31, P4375, DOI 10.1038/emboj.2012.267; Tatebe H, 2000, CURR BIOL, V10, P1329, DOI 10.1016/S0960-9822(00)00773-9; THON G, 1994, GENETICS, V138, P29; Trewick SC, 2007, EMBO J, V26, P4670, DOI 10.1038/sj.emboj.7601892; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Verrier L, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150045; Wang J., 2015, ELIFE, V015, P4; Wang JY, 2013, GENE DEV, V27, P1886, DOI 10.1101/gad.221010.113; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wilkinson CRM, 1998, EMBO J, V17, P6465, DOI 10.1093/emboj/17.22.6465; Zofall M, 2006, MOL CELL, V22, P681, DOI 10.1016/j.molcel.2006.05.010	60	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 13	2017	292	41					17144	17155		10.1074/jbc.M117.790824	http://dx.doi.org/10.1074/jbc.M117.790824			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FJ9ZS	28784663	Green Published, hybrid			2022-12-26	WOS:000413140600033
J	Brasher, MI; Martynowicz, DM; Grafinger, OR; Hucik, A; Shanks-Skinner, E; Uniacke, J; Coppolino, MG				Brasher, Megan I.; Martynowicz, David M.; Grafinger, Olivia R.; Hucik, Andrea; Shanks-Skinner, Emma; Uniacke, James; Coppolino, Marc G.			Interaction of Munc18c and syntaxin4 facilitates invadopodium formation and extracellular matrix invasion of tumor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUT4 TRANSLOCATION; MEMBRANE-FUSION; PLASMA-MEMBRANE; SM PROTEIN; SNARE; TRAFFICKING; MIGRATION; VAMP3; METALLOPROTEINASE; INVOLVEMENT	Tumor cell invasion involves targeted localization of proteins required for interactions with the extracellular matrix and for proteolysis. The localization of many proteins during these cell-extracellular matrix interactions relies on membrane trafficking mediated in part by SNAREs. The SNARE protein syntaxin4 (Stx4) is involved in the formation of invasive structures called invadopodia; however, it is unclear how Stx4 function is regulated during tumor cell invasion. Munc18c is known to regulate Stx4 activity, and here we show that Munc18c is required for Stx4-mediated invadopodium formation and cell invasion. Biochemical and microscopic analyses revealed a physical association between Munc18c and Stx4, which was enhanced during invadopodium formation, and that a reduction in Munc18c expression decreases invadopodium formation. We also found that an N-terminal Stx4-derived peptide associates with Munc18c and inhibits endogenous interactions of Stx4 with synaptosome-associated protein 23 (SNAP23) and vesicle-associated membrane protein 2 (VAMP2). Furthermore, expression of the Stx4 N-terminal peptide decreased invadopodium formation and cell invasion in vitro. Of note, cells expressing the Stx4 N-terminal peptide exhibited impaired trafficking of membrane type 1 matrix metalloproteinase (MT1-MMP) and EGF receptor (EGFR) to the cell surface during invadopodium formation. Our findings implicate Munc18c as a regulator of Stx4-mediated trafficking of MT1-MMP and EGFR, advancing our understanding of the role of SNARE function in the localization of proteins that drive tumor cell invasion.	[Brasher, Megan I.; Martynowicz, David M.; Grafinger, Olivia R.; Hucik, Andrea; Shanks-Skinner, Emma; Uniacke, James; Coppolino, Marc G.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Coppolino, MG (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	mcoppoli@uoguelph.ca		Grafinger, Olivia/0000-0001-8082-1594	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Natural Sciences and Engineering Research Council of Canada. The authors declare that they have no conflicts of interest with the contents of this article.	Artym VV, 2015, J CELL BIOL, V208, P331, DOI 10.1083/jcb.201405099; Bravo-Cordero JJ, 2012, CURR OPIN CELL BIOL, V24, P277, DOI 10.1016/j.ceb.2011.12.004; Brochetta C, 2008, BBA-MOL CELL RES, V1783, P1781, DOI 10.1016/j.bbamcr.2008.05.023; Carr CM, 2010, CURR OPIN CELL BIOL, V22, P488, DOI 10.1016/j.ceb.2010.04.006; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Clark ES, 2009, ONCOGENE, V28, P431, DOI 10.1038/onc.2008.389; Crowley JL, 2009, MOL BIOL CELL, V20, P948, DOI 10.1091/mbc.E08-08-0867; Day P, 2011, INT J ONCOL, V39, P863, DOI 10.3892/ijo.2011.1101; Gurung P., 2016, BRIT J HAEMATOL, V21, P193; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoover H, 2005, METHOD ENZYMOL, V404, P134, DOI 10.1016/S0076-6879(05)04014-0; Jewell J., 2010, AM J PHYSIOL-REG I, V298, P517; Jewell JL, 2011, J CELL BIOL, V193, P185, DOI 10.1083/jcb.201007176; Kalwat MA, 2012, MOL ENDOCRINOL, V26, P128, DOI 10.1210/me.2011-1112; Kean MJ, 2009, J CELL SCI, V122, P4089, DOI 10.1242/jcs.052761; Kioumourtzoglou D, 2014, MOL CELL BIOL, V34, P1271, DOI 10.1128/MCB.01203-13; Latham CF, 2006, TRAFFIC, V7, P1408, DOI 10.1111/j.1600-0854.2006.00474.x; Lohmer LL, 2014, CELL ADHES MIGR, V8, P246, DOI 10.4161/cam.28406; Miyata T, 2004, BIOCHEM BIOPH RES CO, V323, P118, DOI 10.1016/j.bbrc.2004.08.064; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Oh E, 2005, DIABETES, V54, P638, DOI 10.2337/diabetes.54.3.638; Peng RW, 2004, EMBO J, V23, P3939, DOI 10.1038/sj.emboj.7600410; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Proux-Gillardeaux V, 2005, P NATL ACAD SCI USA, V102, P6362, DOI 10.1073/pnas.0409613102; Riggs KA, 2012, J CELL SCI, V125, P3827, DOI 10.1242/jcs.102566; Steffen A, 2008, CURR BIOL, V18, P926, DOI 10.1016/j.cub.2008.05.044; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Tamori Y, 1998, J BIOL CHEM, V273, P19740, DOI 10.1074/jbc.273.31.19740; Tayeb MA, 2005, EXP CELL RES, V305, P63, DOI 10.1016/j.yexcr.2004.12.004; TELLAM JT, 1995, J BIOL CHEM, V270, P5857, DOI 10.1074/jbc.270.11.5857; Thurmond DC, 2000, MOL CELL BIOL, V20, P379, DOI 10.1128/MCB.20.1.379-388.2000; Thurmond DC, 1998, J BIOL CHEM, V273, P33876, DOI 10.1074/jbc.273.50.33876; Tolde O, 2010, EUR J CELL BIOL, V89, P674, DOI 10.1016/j.ejcb.2010.04.003; Veale KJ, 2011, EXP CELL RES, V317, P1817, DOI 10.1016/j.yexcr.2011.04.016; Williams KC, 2014, MOL BIOL CELL, V25, P2061, DOI 10.1091/mbc.E13-10-0582; Williams KC, 2014, J CELL SCI, V127, P1712, DOI 10.1242/jcs.134734; Yu HJ, 2013, P NATL ACAD SCI USA, V110, pE3271, DOI 10.1073/pnas.1311232110; Zhu D, 2015, MOL METAB, V4, P418, DOI 10.1016/j.molmet.2015.02.004	38	14	15	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16199	16210		10.1074/jbc.M117.807438	http://dx.doi.org/10.1074/jbc.M117.807438			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28798239	hybrid, Green Published			2022-12-26	WOS:000412109400019
J	Esaki, S; Evich, MG; Erlitzki, N; Germann, MW; Poon, GMK				Esaki, Shingo; Evich, Marina G.; Erlitzki, Noa; Germann, Markus W.; Poon, Gregory M. K.			Multiple DNA-binding modes for the ETS family transcription factor PU.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC STEM-CELLS; COOPERATIVE INTERACTIONS; SITE RECOGNITION; DOMAIN; PROTEIN; AUTOINHIBITION; DIMERIZATION; GATA-1; DIFFERENTIATION; DISCRIMINATION	The eponymous DNA-binding domain of ETS (E26 transformation-specific) transcription factors binds a single sequence-specific site as a monomer over a single helical turn. Following our previous observation by titration calorimetry that the ETS member PU.1 dimerizes sequentially at a single sequence-specific DNA-binding site to form a 2:1 complex, we have carried out an extensive spectroscopic and biochemical characterization of site-specific PU.1 ETS complexes. Whereas 10 bp ofDNA was sufficient to support PU.1 binding as a monomer, additional flanking bases were required to invoke sequential dimerization of the bound protein. NMRspectroscopy revealed a marked loss of signal intensity in the 2:1 complex, and mutational analysis implicated the distal surface away from the bound DNA as the dimerization interface. Hydroxyl radical DNA footprinting indicated that the site-specifically bound PU.1 dimers occupied an extended DNA interface downstream from the 5'-GGAA-3' core consensus relative to its 1:1 counterpart, thus explaining the apparent site size requirement for sequential dimerization. The site-specifically bound PU.1 dimer resisted competition from nonspecific DNA and showed affinities similar to other functionally significant PU.1 interactions. As sequential dimerization did not occur with the ETS domain of Ets-1, a close structural homolog of PU.1, 2:1 complex formation may represent an alternative autoinhibitory mechanism in the ETS family at the protein-DNA level.	[Esaki, Shingo; Evich, Marina G.; Erlitzki, Noa; Germann, Markus W.; Poon, Gregory M. K.] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA; [Germann, Markus W.] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA; [Poon, Gregory M. K.] Georgia State Univ, Ctr Diagnost & Therapeut, Atlanta, GA 30303 USA; [Esaki, Shingo] Georgia State Univ, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Germann, MW; Poon, GMK (corresponding author), POB 3965, Atlanta, GA 30302 USA.	mwg@gsu.edu; gpoon@gsu.edu	Evich, Marina/AAB-5434-2020	Evich, Marina/0000-0002-2386-0682; Germann, Markus/0000-0002-1674-8166; Erlitzki, Noa/0000-0002-4126-522X	National Science Foundation [MCB 15451600]; National Institutes of Health [R21 HL129063]; Georgia State University Brains and Behavior Fellowship; Barry Goldwater Scholarship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL129063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM109442] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia State University Brains and Behavior Fellowship; Barry Goldwater Scholarship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grant MCB 15451600 and National Institutes of Health Grant R21 HL129063 (to G. M. K. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by a Georgia State University Brains and Behavior Fellowship.; Supported by a 2017 Barry Goldwater Scholarship.	ALTIERI AS, 1995, J AM CHEM SOC, V117, P7566, DOI 10.1021/ja00133a039; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; Baillat D, 2002, J BIOL CHEM, V277, P29386, DOI 10.1074/jbc.M200088200; BAINS G, 1991, ANAL BIOCHEM, V192, P203, DOI 10.1016/0003-2697(91)90207-A; Cann JR, 1996, ANAL BIOCHEM, V237, P1, DOI 10.1006/abio.1996.0193; Costantini S, 2006, BIOCHEM BIOPH RES CO, V342, P441, DOI 10.1016/j.bbrc.2006.01.159; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dozmorov MG, 2014, EPIGENETICS-US, V9, P276, DOI 10.4161/epi.27021; Fitzsimmons D, 2009, J MOL BIOL, V392, P452, DOI 10.1016/j.jmb.2009.07.028; Gjoneska E, 2015, NATURE, V518, P365, DOI 10.1038/nature14252; Goetz TL, 2000, MOL CELL BIOL, V20, P81, DOI 10.1128/MCB.20.1.81-90.2000; Gross P, 1998, BIOCHEMISTRY-US, V37, P9802, DOI 10.1021/bi9731448; Gross P, 1998, BIOCHEMISTRY-US, V37, P5129, DOI 10.1021/bi972591k; He GF, 2015, NUCLEIC ACIDS RES, V43, P4322, DOI 10.1093/nar/gkv267; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; Hou CX, 2015, BIOCHEMISTRY-US, V54, P7365, DOI 10.1021/acs.biochem.5b01121; Imoto A, 2010, J BIOL CHEM, V285, P10300, DOI 10.1074/jbc.M109.095810; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Jia X, 1999, J MOL BIOL, V292, P1083, DOI 10.1006/jmbi.1999.3123; JIN LH, 1993, BIOCHEMISTRY-US, V32, P7302, DOI 10.1021/bi00079a029; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Jundt F, 2002, BLOOD, V99, P3060, DOI 10.1182/blood.V99.8.3060; Kodandapani R, 1996, NATURE, V380, P456, DOI 10.1038/380456a0; Kueh HY, 2013, SCIENCE, V341, P670, DOI 10.1126/science.1240831; Lamber EP, 2008, EMBO J, V27, P2006, DOI 10.1038/emboj.2008.117; Liew CW, 2006, J BIOL CHEM, V281, P28296, DOI 10.1074/jbc.M602830200; Mak Ka Sin, 2011, Int J Cell Biol, V2011, P808524, DOI 10.1155/2011/808524; Matulis D, 1998, BIOPHYS J, V74, P422, DOI 10.1016/S0006-3495(98)77799-9; Mimeault M, 2000, CRIT REV ONCOGENESIS, V11, P227; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; PIO F, 1995, J BIOL CHEM, V270, P24258, DOI 10.1074/jbc.270.41.24258; Poon GMK, 2003, J MOL BIOL, V328, P805, DOI 10.1016/S0022-2836(03)00362-0; Poon GMK, 2017, TRANSCR-AUSTIN, V8, P193, DOI 10.1080/21541264.2017.1302901; Poon GMK, 2012, J BIOL CHEM, V287, P18297, DOI 10.1074/jbc.M112.342345; Poon GMK, 2012, BIOCHEMISTRY-US, V51, P4096, DOI 10.1021/bi300331v; Poon GMK, 2010, ANAL BIOCHEM, V400, P229, DOI 10.1016/j.ab.2010.01.025; Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614; Rippin TM, 2002, J MOL BIOL, V319, P351, DOI 10.1016/S0022-2836(02)00326-1; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Samorodnitsky D, 2015, J BIOL CHEM, V290, P22101, DOI 10.1074/jbc.M115.671339; Siggers T, 2014, NUCLEIC ACIDS RES, V42, P2099, DOI 10.1093/nar/gkt1112; Stephens DC, 2016, NUCLEIC ACIDS RES, V44, P4005, DOI 10.1093/nar/gkw229; Tatetsu H, 2007, CANCER RES, V67, P5328, DOI 10.1158/0008-5472.CAN-06-4265; Wang S, 2014, J BIOL CHEM, V289, P21605, DOI 10.1074/jbc.M114.575340; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Xhani S, 2017, J PHYS CHEM B, V121, P2748, DOI 10.1021/acs.jpcb.7b00325; Xu ZQ, 2014, SCI WORLD J, DOI [10.1155/2014/915740, 10.1155/2014/707294]	48	4	5	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 29	2017	292	39					16044	16054		10.1074/jbc.M117.798207	http://dx.doi.org/10.1074/jbc.M117.798207			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FI6MC	28790174	Green Published, hybrid			2022-12-26	WOS:000412109400006
J	Bemena, LD; Mukama, O; Neiman, AM; Li, ZJ; Gao, XD; Nakanishi, H				Bemena, Leo D.; Mukama, Omar; Neiman, Aaron M.; Li, Zijie; Gao, Xiao-Dong; Nakanishi, Hideki			In vitro reconstitution of the yeast spore wall dityrosine layer discloses the mechanism of its assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ASCOSPORE WALL; CHITIN; CHITOSAN; GENES; MEMBRANE; MATURATION; PRECURSOR; PROTEINS; PATHWAY	In response to nutrient starvation, diploid cells of the budding yeast Saccharomyces cerevisiae differentiate into a dormant form of haploid cell termed a spore. The dityrosine layer forms the outermost layer of the wall of S. cerevisiae spores and endows them with resistance to environmental stresses. LL-Bisformyl dityrosine is the main constituent of the dityrosine layer, but the mechanism of its assembly remains elusive. Here, we found that LL-bisformyl dityrosine, but not LL-dityrosine, stably associated in vitro with dit1 Delta spores, which lack the dityrosine layer. No other soluble cytosolic materials were required for this incorporation. In several aspects, the dityrosine incorporated in trans resembled the dityrosine layer. For example, dityrosine incorporation obscured access of the dye calcofluor white to the underlying chitosan layer, and LL-bisformyl dityrosine molecules bound to dit1 Delta spores were partly isomerized to the DL-form. Mutational analyses revealed several spore wall components required for this binding. One was the chitosan layer located immediately below the dityrosine layer in the spore wall. However, LL-bisformyl dityrosine did not stably bind to chitosan particles, indicating that chitosan is not sufficient for this association. Several lines of evidence demonstrated that spore-resident proteins are involved in the incorporation, including the Lds proteins, which are localized to lipid droplets attached to the developing spore wall. In conclusion, our results provide insight into the mechanism of dityrosine layer formation, and the in vitro assay described here may be used to investigate additional mechanisms in spore wall assembly.	[Bemena, Leo D.; Mukama, Omar; Li, Zijie; Gao, Xiao-Dong; Nakanishi, Hideki] Jiangnan Univ, Key Lab Carbohydrate Chem & Biotechnol, Minist Educ, Sch Biotechnol, 1800 Lihu Ave, Wuxi 214122, Peoples R China; [Neiman, Aaron M.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	Jiangnan University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Gao, XD; Nakanishi, H (corresponding author), Jiangnan Univ, Key Lab Carbohydrate Chem & Biotechnol, Minist Educ, Sch Biotechnol, 1800 Lihu Ave, Wuxi 214122, Peoples R China.	xdgao@jiangnan.edu.cn; hideki@jiangnan.edu.cn	MUKAMA, Omar/AAJ-2096-2021	Neiman, Aaron/0000-0002-6600-6996	National Natural Science Foundation of China [21576118]; Fundamental Research Funds for the Central Universities [JUSRP51629B, JUSRP51319B]; National Institutes of Health [R01 GM072540]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072540] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Natural Science Foundation of China Grant 21576118 and Fundamental Research Funds for the Central Universities Grant JUSRP51629B (to H.N.), Fundamental Research Funds for the Central Universities Grant JUSRP51319B (to X.-D.G.), and National Institutes of Health Grant R01 GM072540 (to A.M.N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AMADO R, 1984, METHOD ENZYMOL, V107, P377; Atyabi F, 2009, J NANOSCI NANOTECHNO, V9, P4593, DOI 10.1166/jnn.2009.1090; BALLOU CE, 1977, P NATL ACAD SCI USA, V74, P4351, DOI 10.1073/pnas.74.10.4351; Bonawitz ND, 2010, ANNU REV GENET, V44, P337, DOI 10.1146/annurev-genet-102209-163508; Briza P, 1996, EUR J BIOCHEM, V239, P124, DOI 10.1111/j.1432-1033.1996.0124u.x; BRIZA P, 1986, J BIOL CHEM, V261, P4288; BRIZA P, 1990, J BIOL CHEM, V265, P15118; BRIZA P, 1988, J BIOL CHEM, V263, P11569; BRIZA P, 1990, GENE DEV, V4, P1775, DOI 10.1101/gad.4.10.1775; BRIZA P, 1994, P NATL ACAD SCI USA, V91, P4524, DOI 10.1073/pnas.91.10.4524; Arroyo ECJ, 2013, NAT REV MICROBIOL, V11, P648, DOI 10.1038/nrmicro3090; Christodoulidou A, 1999, FEBS LETT, V460, P275, DOI 10.1016/S0014-5793(99)01334-4; Christodoulidou A, 1996, J BIOL CHEM, V271, P31420, DOI 10.1074/jbc.271.49.31420; Coluccio A, 2004, EUKARYOT CELL, V3, P1464, DOI 10.1128/EC.3.6.1464-1475.2004; Coluccio A, 2004, MICROBIOL-SGM, V150, P3189, DOI 10.1099/mic.0.27253-0; DEITS T, 1984, J BIOL CHEM, V259, P3525; Esposito R. E., 1981, MOL BIOL YEAST SACCH, V11, P211; Felder T, 2002, EUKARYOT CELL, V1, P799, DOI 10.1128/EC.1.5.799-810.2002; Fujii N, 1999, MECH AGEING DEV, V107, P347, DOI 10.1016/S0047-6374(98)00129-8; GROSS AJ, 1959, J BIOL CHEM, V234, P1611; Kong J, 2017, BIOENGINEERED, V8, P411, DOI 10.1080/21655979.2016.1241926; KREGERVANRIJ NJW, 1978, ARCH MICROBIOL, V117, P73, DOI 10.1007/BF00689354; Lin CPC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003700; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lynn R R, 1970, J Cell Biol, V44, P688, DOI 10.1083/jcb.44.3.688; Mishra C, 1997, YEAST, V13, P327, DOI 10.1002/(SICI)1097-0061(19970330)13:4<327::AID-YEA96>3.0.CO;2-T; MOENS PB, 1971, CAN J MICROBIOL, V17, P507, DOI 10.1139/m71-084; Neiman AM, 2000, GENETICS, V155, P1643; Neiman AM, 2005, MICROBIOL MOL BIOL R, V69, P565, DOI 10.1128/MMBR.69.4.565-584.2005; Neiman AM, 1998, J CELL BIOL, V140, P29, DOI 10.1083/jcb.140.1.29; PAMMER M, 1992, YEAST, V8, P1089, DOI 10.1002/yea.320081211; Radkov AD, 2014, APPL MICROBIOL BIOT, V98, P5363, DOI 10.1007/s00253-014-5726-3; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; Suda Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007184; Tan YP, 2015, NAT CHEM BIOL, V11, P488, DOI [10.1038/NCHEMBIO.1833, 10.1038/nchembio.1833]; Ueno K, 2016, BIOCHEM BIOPH RES CO, V475, P315, DOI 10.1016/j.bbrc.2016.05.099; Wagner M, 1999, GENETICS, V151, P1327; Zhang HN, 2014, APPL ENVIRON MICROB, V80, P5098, DOI 10.1128/AEM.00677-14	38	5	7	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15880	15891		10.1074/jbc.M117.786202	http://dx.doi.org/10.1074/jbc.M117.786202			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28794156	Green Published, hybrid			2022-12-26	WOS:000411512200025
J	Hayward, J; Sanchez, J; Perry, A; Huang, C; Valle, MR; Canals, M; Payne, RJ; Stone, MJ				Hayward, Jenni; Sanchez, Julie; Perry, Andrew; Huang, Cheng; Valle, Manuel Rodriguez; Canals, Meritxell; Payne, Richard J.; Stone, Martin J.			Ticks from diverse genera encode chemokine-inhibitory evasin proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOOPHILUS-MICROPLUS INFESTATION; BINDING-PROTEIN; TYROSINE SULFATION; LYME-DISEASE; RHIPICEPHALUS-SANGUINEUS; IXODES-SCAPULARIS; IMMUNE-RESPONSE; RNA-SEQ; VECTOR; FAMILY	To prolong residence on their hosts, ticks secrete many salivary factors that target host defense molecules. In particular, the tick Rhipicephalus sanguineus has been shown to produce three salivary glycoproteins named "evasins," which bind to host chemokines, thereby inhibiting the recruitment of leukocytes to the location of the tick bite. Using sequence similarity searches, we have identified 257 new putative evasin sequences encoded by the genomes or salivary or visceral transcriptomes of numerous hard ticks, spanning the genera Rhipicephalus, Amblyomma, and Ixodes of the Ixodidae family. Nine representative sequences were successfully expressed in Escherichia coli, and eight of the nine candidates exhibited high-affinity binding to human chemokines. Sequence alignments enabled classification of the evasins into two subfamilies: C-8 evasins share a conserved set of eight Cys residues (four disulfide bonds), whereas C-6 evasins have only three of these disulfide bonds. Most of the identified sequences contain predicted secretion leader sequences, N-linked glycosylation sites, and a putative site of tyrosine sulfation. We conclude that chemokine-binding evasin proteins are widely expressed among tick species of the Ixodidae family, are likely to play important roles in subverting host defenses, and constitute a valuable pool of anti-inflammatory proteins for potential future therapeutic applications.	[Hayward, Jenni; Sanchez, Julie; Huang, Cheng; Stone, Martin J.] Monash Univ, Monash Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia; [Hayward, Jenni; Sanchez, Julie; Huang, Cheng; Stone, Martin J.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Perry, Andrew] Monash Univ, Monash Bioinformat Platform, Clayton, Vic 3800, Australia; [Valle, Manuel Rodriguez] Univ Melbourne, Fac Vet & Agr Sci, Dept Vet Biosci, Parkville, Vic 3010, Australia; [Canals, Meritxell] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol, Parkville, Vic 3052, Australia; [Payne, Richard J.] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia	Monash University; Monash University; Monash University; University of Melbourne; Monash University; University of Sydney	Stone, MJ (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	martin.stone@monash.edu	Rodriguez-Valle, Manuel/AAA-3819-2021; Payne, Richard/AAH-3666-2021; Rodriguez-Valle, Manuel/A-5272-2010; Perry, Andrew/E-5607-2010; Stone, Martin/C-2492-2012	Rodriguez-Valle, Manuel/0000-0003-2304-8085; Sanchez, Julie/0000-0002-5765-4342; Perry, Andrew/0000-0001-9256-6068; Payne, Richard/0000-0002-3618-9226; Canals, Meritxell/0000-0002-7942-5006; Hayward, Jenni/0000-0001-8228-8797; Stone, Martin/0000-0002-6468-4427	Australian Research Council Discovery [DP120100194]; Monash Institute of Pharmaceutical Sciences Large Grant Support Scheme; ANZTrustees [12-3831]	Australian Research Council Discovery(Australian Research Council); Monash Institute of Pharmaceutical Sciences Large Grant Support Scheme; ANZTrustees	This work was supported in part by Australian Research Council Discovery Grant DP120100194 (to M. J. S. and R. J. P.), the Monash Institute of Pharmaceutical Sciences Large Grant Support Scheme (to M. C.), andANZTrustees Grant 12-3831 (to M. J. S. and M. C.). The authors declare that they have no conflicts of interest with the contents of this article.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anatriello E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-450; Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Baggiolini M, 2001, J INTERN MED, V250, P91, DOI 10.1046/j.1365-2796.2001.00867.x; Becker CAM, 2009, EMERG INFECT DIS, V15, P320, DOI 10.3201/eid1502.081247; Bonvin P, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00208; Bonvin P, 2014, J BIOL CHEM, V289, P31846, DOI 10.1074/jbc.M114.599233; Copin JC, 2013, J CEREBR BLOOD F MET, V33, P490, DOI 10.1038/jcbfm.2012.198; Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P437, DOI 10.1016/j.pt.2012.07.003; de Castro MH, 2016, TICKS TICK-BORNE DIS, V7, P536, DOI 10.1016/j.ttbdis.2016.01.014; De La Fuente J, 2006, ANN NY ACAD SCI, V1078, P416, DOI 10.1196/annals.1374.081; Deruaz M, 2008, J EXP MED, V205, P2019, DOI 10.1084/jem.20072689; Deruaz M, 2013, FEBS J, V280, P4876, DOI 10.1111/febs.12463; Dias JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008514; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finn RD, 2015, NUCLEIC ACIDS RES, V43, pW30, DOI 10.1093/nar/gkv397; Fivaz B., 1992, TICK VECTOR BIOL; Frauenschuh A, 2007, J BIOL CHEM, V282, P27250, DOI 10.1074/jbc.M704706200; Garcia GR, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-430; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Giraldo-Calderon GI, 2015, NUCLEIC ACIDS RES, V43, pD707, DOI 10.1093/nar/gku1117; Gulia-Nuss M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10507; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hovius JWR, 2009, J INVEST DERMATOL, V129, P2337, DOI 10.1038/jid.2009.202; HUFF S, 1994, J BIOL CHEM, V269, P15563; Jiang LI, 2007, J BIOL CHEM, V282, P10576, DOI 10.1074/jbc.M609695200; Jonsson NN, 2006, VET PARASITOL, V137, P1, DOI 10.1016/j.vetpar.2006.01.010; Jonsson NN, 2001, AUST VET J, V79, P826, DOI 10.1111/j.1751-0813.2001.tb10929.x; Karim S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131292; Karim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028525; Kazimirova M, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00043; Ludeman JP, 2015, ORG BIOMOL CHEM, V13, P2162, DOI 10.1039/c4ob02262a; Monigatti F, 2002, BIOINFORMATICS, V18, P769, DOI 10.1093/bioinformatics/18.5.769; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Ogden NH, 2006, INT J PARASITOL, V36, P63, DOI 10.1016/j.ijpara.2005.08.016; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Proudfoot AEI, 2000, IMMUNOL REV, V177, P246, DOI 10.1034/j.1600-065X.2000.17721.x; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Radulovic ZM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-518; Rodriguez-Valle M, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0605-4; Rodriguez-Valle M, 2013, INT J PARASITOL, V43, P739, DOI 10.1016/j.ijpara.2013.04.005; Russo RC, 2011, AM J RESP CELL MOL, V45, P72, DOI 10.1165/rcmb.2009-0406OC; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh K, 2017, SCI REP, P7; Stone MJ, 2015, ACCOUNTS CHEM RES, V48, P2251, DOI 10.1021/acs.accounts.5b00255; Tan AWL, 2015, J PROTEOMICS, V117, P120, DOI 10.1016/j.jprot.2014.12.014; Thompson GL, 2015, MOL PHARMACOL, V88, P335, DOI 10.1124/mol.115.098848; Thompson RE, 2017, NAT CHEM, V9, P909, DOI [10.1038/NCHEM.2744, 10.1038/nchem.2744]; Vancova I, 2010, PARASITE IMMUNOL, V32, P460, DOI 10.1111/j.1365-3024.2010.01203.x; Vieira AT, 2009, AM J PATHOL, V175, P2382, DOI 10.2353/ajpath.2009.090093; Wang XY, 2017, ANGEW CHEM INT EDIT, V56, P8490, DOI 10.1002/anie.201703059; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	53	38	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15670	15680		10.1074/jbc.M117.807255	http://dx.doi.org/10.1074/jbc.M117.807255			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28778927	Green Published, hybrid			2022-12-26	WOS:000411512200008
J	Li, JY; Cui, Y; Xu, J; Wang, QH; Yang, XQ; Li, Y; Zhang, XY; Qiu, MS; Zhang, Z; Zhang, Z				Li, Jianying; Cui, Ying; Xu, Jie; Wang, Qihui; Yang, Xueqin; Li, Yan; Zhang, Xiaoyun; Qiu, Mengsheng; Zhang, Ze; Zhang, Zunyi			Suppressor of Fused restraint of Hedgehog activity level iscritical for osteogenic proliferation and differentiation during calvarial bone development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRANIAL NEURAL CREST; INDIAN HEDGEHOG; OSTEOBLAST DIFFERENTIATION; MORPHOGENETIC PROTEIN; CELL-PROLIFERATION; PRIMARY CILIA; GLI PROTEINS; EXPRESSION; MOUSE; SHH	Hedgehog signaling plays crucial roles in the development of calvarial bone, relying on the activation of Gli transcription factors. However, the molecular mechanism of the role of regulated Gli protein level in osteogenic specification of mesenchyme still remains elusive. Here, we show by conditionally inactivating Suppressor of Fused (Sufu), a critical repressor of Hedgehog signaling, in Wnt1-Cre-mediated cranial neural crest (CNC) or Dermo1-Cre-mediated mesodermal lineages that Sufu restraint of Hedgehog activity level is critical for differentiation of preosteogenic mesenchyme. Ablation of Sufu results in failure of calvarial bone formation, including CNC-derived bones and mesoderm-derived bones, depending on the Cre line being used. Although mesenchymal cells populate to frontonasal destinations, where they are then condensed, Sufu deletion significantly inhibits the proliferation of osteoprogenitor cells, and these cells no longer differentiate into osteoblasts. Weshow that there is suppression of Runx2 and Osterix, the osteogenic regulators, in calvarial mesenchyme in the Sufu mutant. We show that down-regulation of several genes upstream to Runx2 and Osterix is manifested within the calvarial primordia, including Bmp2 and its downstream genes Msx1/ 2 and Dlx5. By contrast, we find that Gli1, the Hedgehog activity readout gene, is excessively activated in mesenchyme. Deletion of Sufu in CNC leads to a discernible decrease in the repressive Gli3 form and an increase in the full-length Gli2. Finally, we demonstrate that simultaneous deletion of Gli2 and Sufu in CNCcompletely restores calvarial bone formation, suggesting that a sustained level of Hedgehog activity is critical in specification of the osteogenic mesenchymal cells.	[Li, Jianying; Cui, Ying; Xu, Jie; Wang, Qihui; Yang, Xueqin; Li, Yan; Zhang, Xiaoyun; Qiu, Mengsheng; Zhang, Zunyi] Hangzhou Normal Univ, Coll Life & Environm Sci, Inst Life Sci, Zhejiang Key Lab Organogenesis & Regenerat Techno, Hangzhou 310036, Zhejiang, Peoples R China; [Zhang, Ze] Tulane Univ, Tulane Med Ctr, Dept Ophthamol, New Orleans, LA 70112 USA; [Wang, Qihui] Nanjing Univ, Model Anim Res Ctr, State Key Lab Pharmaceut Biotechnol, Nanjing 210061, Jiangsu, Peoples R China	Hangzhou Normal University; Tulane University; Nanjing University	Zhang, Z (corresponding author), Hangzhou Normal Univ, Coll Life & Environm Sci, Inst Life Sci, Zhejiang Key Lab Organogenesis & Regenerat Techno, Hangzhou 310036, Zhejiang, Peoples R China.	zunyi_zhang@idrbio.org		Li, Jianying/0000-0003-1488-8322				Abzhanov A, 2007, DEVELOPMENT, V134, P3133, DOI 10.1242/dev.002709; Amano K, 2014, J BIOL CHEM, V289, P24898, DOI 10.1074/jbc.M114.570507; Bai CB, 2002, DEVELOPMENT, V129, P4753; Barnfield PC, 2005, DIFFERENTIATION, V73, P397, DOI 10.1111/j.1432-0436.2005.00042.x; Brugmann SA, 2010, HUM MOL GENET, V19, P1577, DOI 10.1093/hmg/ddq030; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chung IH, 2010, GENESIS, V48, P645, DOI 10.1002/dvg.20671; Cooper AF, 2005, DEVELOPMENT, V132, P4407, DOI 10.1242/dev.02021; Corrales JD, 2006, DEVELOPMENT, V133, P1811, DOI 10.1242/dev.02351; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Dennis JF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002927; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Gross JB, 2008, DEV BIOL, V317, P389, DOI 10.1016/j.ydbio.2008.02.046; Han J, 2007, MECH DEVELOP, V124, P729, DOI 10.1016/j.mod.2007.06.006; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Hojo H, 2013, J BIOL CHEM, V288, P9924, DOI 10.1074/jbc.M112.409342; Hojo H, 2012, J BIOL CHEM, V287, P17860, DOI 10.1074/jbc.M112.347716; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Huycke TR, 2012, DEVELOPMENT, V139, P2371, DOI 10.1242/dev.079806; Iseki S, 1999, DEVELOPMENT, V126, P5611; Ishii M, 2003, DEVELOPMENT, V130, P6131, DOI 10.1242/dev.00793; Iwata J, 2010, J BIOL CHEM, V285, P4975, DOI 10.1074/jbc.M109.035105; Jacob S, 2007, ANN PLAS SURG, V58, P215, DOI 10.1097/01.sap.0000232833.41739.a5; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; Jia JP, 2009, DEV BIOL, V330, P452, DOI 10.1016/j.ydbio.2009.04.009; Jiang XB, 2002, DEV BIOL, V241, P106, DOI 10.1006/dbio.2001.0487; Kim HJ, 1998, DEVELOPMENT, V125, P1241; Kise Y, 2009, BIOCHEM BIOPH RES CO, V387, P569, DOI 10.1016/j.bbrc.2009.07.087; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Lenton K, 2011, GENESIS, V49, P784, DOI 10.1002/dvg.20768; Li J, 2015, CHEM GEOL, V406, P10, DOI 10.1016/j.chemgeo.2015.04.010; Lin CW, 2014, GENE DEV, V28, P2547, DOI 10.1101/gad.249425.114; Lin CW, 2014, DEV BIOL, V392, P324, DOI 10.1016/j.ydbio.2014.05.014; Long FX, 2004, DEVELOPMENT, V131, P1309, DOI 10.1242/dev.01006; Ma XX, 2017, NEUROREPORT, V28, P141, DOI 10.1097/WNR.0000000000000725; Maxson Robert, 2008, V12, P197, DOI 10.1159/000115042; McGlinn E, 2005, MECH DEVELOP, V122, P1218, DOI 10.1016/j.mod.2005.06.012; Murakami S, 1997, ENDOCRINOLOGY, V138, P1972, DOI 10.1210/en.138.5.1972; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Naruse I, 2010, CONGENIT ANOM, V50, P1, DOI 10.1111/j.1741-4520.2009.00266.x; Nott RL, 2002, PLAST RECONSTR SURG, V110, P523, DOI 10.1097/00006534-200208000-00024; Pan A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00061; Panman L, 2006, DEVELOPMENT, V133, P3419, DOI 10.1242/dev.02529; Park HL, 2000, DEVELOPMENT, V127, P1593; Plaisant M, 2009, STEM CELLS, V27, P703, DOI 10.1634/stemcells.2008-0888; Rice DPC, 2010, HUM MOL GENET, V19, P3457, DOI 10.1093/hmg/ddq258; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Roybal PG, 2010, DEV BIOL, V343, P28, DOI 10.1016/j.ydbio.2010.04.007; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Sasaki T, 2006, DEVELOPMENT, V133, P371, DOI 10.1242/dev.02200; Shimoyama A, 2007, MOL BIOL CELL, V18, P2411, DOI 10.1091/mbc.E06-08-0743; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sun JJ, 2013, DEVELOPMENT, V140, P1034, DOI 10.1242/dev.085225; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Takarada T, 2016, DEVELOPMENT, V143, P211, DOI 10.1242/dev.128793; Tanimoto Y, 2012, J BIOL CHEM, V287, P21429, DOI 10.1074/jbc.M112.362145; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; Veistinen L, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00121; Wang CB, 2010, DEVELOPMENT, V137, P2001, DOI 10.1242/dev.052126; Wen XH, 2010, MOL CELL BIOL, V30, P1910, DOI 10.1128/MCB.01089-09; Xie GH, 2013, HEPATOLOGY, V58, P1801, DOI 10.1002/hep.26511; Yoshida T, 2008, MECH DEVELOP, V125, P797, DOI 10.1016/j.mod.2008.06.007; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Zhang Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3608; Zhang ZY, 2002, DEVELOPMENT, V129, P4135; Zhu XJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004687; Zhu XJ, 2013, J BIOL CHEM, V288, P12080, DOI 10.1074/jbc.M113.462473; Zhulyn O, 2014, DEV CELL, V29, P241, DOI 10.1016/j.devcel.2014.03.002	69	16	17	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15814	15825		10.1074/jbc.M117.777532	http://dx.doi.org/10.1074/jbc.M117.777532			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28794157	hybrid, Green Published			2022-12-26	WOS:000411512200019
J	Noh, Y; Yoon, Y				Noh, Yuna; Yoon, Yoonjin			Elderly road collision injury outcomes associated with seat positions and seatbelt use in a rapidly aging society-A case study in South Korea	PLOS ONE			English	Article							OLDER DRIVERS; RESTRAINT USE; CRASH INVOLVEMENT; TRAFFIC CRASHES; VEHICLE; RISK; CHILDREN; DEATH; SEVERITY; AGE	Introduction Aging has long been regarded as one of the most critical factors affecting crash injury outcomes. In South Korea, where the elderly population is projected to reach 35.9% by 2050, the implications of an increasing number of elderly vehicle users on road safety are evident. In this research, the confounding effect of occupant age in a vehicle in terms of seat position and seatbelt use was investigated. In addition, elderly occupants were divided into a younger-old group aged between 65 and 74 years and an older-old group aged 75 years and older in an effort to assess whether the conventional elderly age standard of 65 years should be reconsidered. Methods A multinomial logit framework was adopted to predict two-level injury severity using collision data between 2008 and 2015. Predictor variables included gender, age group, seat position, seatbelt, road type, road slope, road surface, road line, and type of vehicle. Five models, a base model with no interactions and four interaction models which were combinations of age group, seatbelt use and seat position, were devised and evaluated. Results With no interacting term, age was the most prominent predictor. Elderly occupants were most likely to suffer from severe injury without a seatbelt in all seat positions, and the use of a seatbelt reduced this likelihood the most in the elderly group as well. Front passenger seats had the highest risk to elderly occupants, while the driver seat was statistically insignificant. When the elderly group was divided into the younger-old group and the older-old group, the older-olds were found to be much more vulnerable compared to the younger-olds. In particular, older drivers were five times more likely to suffer a severe injury without a seatbelt. Conclusions The degree of injury severity of elderly occupants was reduced the most with the use of a seatbelt, demonstrating the importance of using seat restraints. The sharp increase in the risk of injury of the older-old group suggests that the age standard of 65 years as the elderly group with regard to traffic safety may require reconsideration due to the growing number of elderly vehicle users on the road. Our results provide practical evidence with which to formulate new safety policies, including mandatory seatbelt use, driving age limits and insurance pricing.	[Noh, Yuna; Yoon, Yoonjin] Korea Adv Inst Sci & Technol, Dept Civil & Environm Engn, Daejeon, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Yoon, Y (corresponding author), Korea Adv Inst Sci & Technol, Dept Civil & Environm Engn, Daejeon, South Korea.	yoonjin@kaist.ac.kr	Yoon, Yoonjin/C-1845-2011	Yoon, Yoonjin/0000-0002-3550-4431	National Research Foundation of Korea (NRF) - Ministry of Science, ICT, & Future Planning [NRF-2014R1A1A1003686]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT, & Future Planning	This study was supported by grant NRF-2014R1A1A1003686 from the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, & Future Planning (http://www.nrf.re.kr). The funders had no role in study design.	Abdel-Aty M, 2003, J SAFETY RES, V34, P597, DOI 10.1016/j.jsr.2003.05.009; Berg MD, 2000, PEDIATRICS, V105, P831, DOI 10.1542/peds.105.4.831; Braver E R, 1998, Inj Prev, V4, P181; Braver ER, 2004, INJURY PREV, V10, P27, DOI 10.1136/ip.2003.002923; Camp BJ, 2013, J SAFETY RES, V47, P1, DOI 10.1016/j.jsr.2013.06.002; Chen YK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158559; Daigneault G, 2002, J CLIN EXP NEUROPSYC, V24, P221, DOI 10.1076/jcen.24.2.221.993; Donmez B, 2015, J SAFETY RES, V52, P23, DOI 10.1016/j.jsr.2014.12.001; Durbin DR, 2005, PEDIATRICS, V115, pE305, DOI 10.1542/peds.2004-1522; Durbin DR, 2003, JAMA-J AM MED ASSOC, V289, P2835, DOI 10.1001/jama.289.21.2835; Eluru N, 2010, TRANSPORT RES REC, P1, DOI 10.3141/2165-01; Eustace D., 2010, J TRANSPORTATION SAF, V2, P28, DOI [DOI 10.1080/19439961003590811, 10.1080/19439961003590811]; Farmer CM, 1997, ACCIDENT ANAL PREV, V29, P399, DOI 10.1016/S0001-4575(97)00006-7; Glass RJ, 2000, RISK ANAL, V20, P521, DOI 10.1111/0272-4332.204049; HAKAMIESBLOMQVIST LE, 1993, ACCIDENT ANAL PREV, V25, P19, DOI 10.1016/0001-4575(93)90093-C; Haleem K, 2013, J SAFETY RES, V46, P67, DOI 10.1016/j.jsr.2013.04.002; He W., 2016, AN AGING WORLD 2015; Henary B, 2007, INJURY PREV, V13, P398, DOI 10.1136/ip.2006.015115; Karlaftis MG, 2002, ACCIDENT ANAL PREV, V34, P357, DOI 10.1016/S0001-4575(01)00033-1; Keskinen E, 1998, ACCIDENT ANAL PREV, V30, P323, DOI 10.1016/S0001-4575(97)00113-9; Kim I K, 1996, Korea J Popul Dev, V25, P27; KIM K, 1995, ACCIDENT ANAL PREV, V27, P469, DOI 10.1016/0001-4575(95)00001-G; Korea Road Traffic Authority, 2015, TRAFF ACC STAT DAT; Langford J, 2006, TRANSPORT RES F-TRAF, V9, P309, DOI 10.1016/j.trf.2006.03.005; Lardelli-Claret P, 2006, ACCIDENT ANAL PREV, V38, P563, DOI 10.1016/j.aap.2005.11.014; Lennon A, 2008, ACCIDENT ANAL PREV, V40, P829, DOI 10.1016/j.aap.2007.09.024; Li GH, 2003, ACCIDENT ANAL PREV, V35, P227, DOI 10.1016/S0001-4575(01)00107-5; Liu C., 2007, CHARACTERISTICS CRAS; Lyman JM, 2001, ACCIDENT ANAL PREV, V33, P413, DOI 10.1016/S0001-4575(00)00055-5; Macinko J, 2015, J SAFETY RES, V52, P47, DOI 10.1016/j.jsr.2014.12.003; Margolis KL, 2002, J GERONTOL A-BIOL, V57, pM186, DOI 10.1093/gerona/57.3.M186; MORTIMER RG, 1989, ACCIDENT ANAL PREV, V21, P273, DOI 10.1016/0001-4575(89)90018-3; Neyens DM, 2008, ACCIDENT ANAL PREV, V40, P254, DOI 10.1016/j.aap.2007.06.005; NIH Senior Health, 2015, AG AFF DRIV; OECD, 2015, OECD STAT; Pickrell TM, 2013, ANAL PASSENGER VEHIC; Preusser DF, 1998, ACCIDENT ANAL PREV, V30, P151, DOI 10.1016/S0001-4575(97)00090-0; Rita CS, 2014, BRAZILIAN J PHYS THE, V46, P375; Savolainen P, 2007, ACCIDENT ANAL PREV, V39, P955, DOI 10.1016/j.aap.2006.12.016; Seoul Metropolitan Government, 2015, TRANSP INF REAL TIM; Smith KM, 2006, INJURY PREV, V12, P83, DOI 10.1136/ip.2005.010306; Tay R, 2008, ACCIDENT ANAL PREV, V40, P1330, DOI 10.1016/j.aap.2008.02.003; United Nations Population Division (UNPD), 2002, WORLD POP AG 1950 20; Washington S., 2020, STAT ECONOMETRIC MET, VThird; Yamamoto T, 2008, ACCIDENT ANAL PREV, V40, P1320, DOI 10.1016/j.aap.2007.10.016; Zhu MT, 2007, INJURY PREV, V13, P183, DOI 10.1136/ip.2006.012153	46	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0183043	10.1371/journal.pone.0183043	http://dx.doi.org/10.1371/journal.pone.0183043			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD3KL	28800595	gold, Green Published			2022-12-26	WOS:000407431800047
J	Onojima, T; Kitajo, K; Mizuhara, H				Onojima, Takayuki; Kitajo, Keiichi; Mizuhara, Hiroaki			Ongoing slow oscillatory phase modulates speech intelligibility in cooperation with motor cortical activity	PLOS ONE			English	Article							LOW-FREQUENCY OSCILLATIONS; NEURONAL OSCILLATIONS; PREMOTOR CORTEX; AUDITORY-CORTEX; HUMAN SCALP; PERCEPTION; ARTIFACT; ENTRAINMENT; SELECTION; DYNAMICS	Neural oscillation is attracting attention as an underlying mechanism for speech recognition. Speech intelligibility is enhanced by the synchronization of speech rhythms and slow neural oscillation, which is typically observed as human scalp electroencephalography (EEG). In addition to the effect of neural oscillation, it has been proposed that speech recognition is enhanced by the identification of a speaker's motor signals, which are used for speech production. To verify the relationship between the effect of neural oscillation and motor cortical activity, we measured scalp EEG, and simultaneous EEG and functional magnetic resonance imaging (fMRI) during a speech recognition task in which participants were required to recognize spoken words embedded in noise sound. We proposed an index to quantitatively evaluate the EEG phase effect on behavioral performance. The results showed that the delta and theta EEG phase before speech inputs modulated the participant's response time when conducting speech recognition tasks. The simultaneous EEG-fMRI experiment showed that slow EEG activity was correlated with motor cortical activity. These results suggested that the effect of the slow oscillatory phase was associated with the activity of the motor cortex during speech recognition.	[Onojima, Takayuki; Mizuhara, Hiroaki] Kyoto Univ, Grad Sch Informat, Sakyo Ku, Kyoto, Japan; [Kitajo, Keiichi] RIKEN, Brain Sci Inst, Ctr Collaborat, Rhythm Based Brain Informat Proc Unit,RIKEN BSI T, Wako, Saitama, Japan; [Kitajo, Keiichi] RIKEN, Brain Sci Inst, Lab Adv Brain Signal Proc, Wako, Saitama, Japan	Kyoto University; RIKEN; RIKEN	Onojima, T; Mizuhara, H (corresponding author), Kyoto Univ, Grad Sch Informat, Sakyo Ku, Kyoto, Japan.	onojima@acs.i.kyoto-u.ac.jp; hmizu@i.kyoto-u.ac.jp	Mizuhara, Hiroaki/N-3326-2019; Kitajo, Keiichi/AAU-5445-2020	Mizuhara, Hiroaki/0000-0002-8267-1507; Kitajo, Keiichi/0000-0002-1094-908X	Japan Society for the Promotion of Science KAKENHI [15J07444, 25240019]; Ministry of Education, Culture, Sports, Science and Technology KAKENHI [21120008, 16H01610]; Grants-in-Aid for Scientific Research [15H05877, 15H05871] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	TO was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 15J07444. HM and KK were supported by Japan Society for the Promotion of Science KAKENHI Grant Number 25240019. HM was supported by Ministry of Education, Culture, Sports, Science and Technology KAKENHI Grant Numbers 21120008, 16H01610. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alho J, 2012, NEUROIMAGE, V60, P1937, DOI 10.1016/j.neuroimage.2012.02.011; Allen PJ, 1998, NEUROIMAGE, V8, P229, DOI 10.1006/nimg.1998.0361; Allen PJ, 2000, NEUROIMAGE, V12, P230, DOI 10.1006/nimg.2000.0599; Amano S., 1999, NIHONGO NO GOI TOKUS; Besle J, 2011, J NEUROSCI, V31, P3176, DOI 10.1523/JNEUROSCI.4518-10.2011; Bourguignon M, 2013, HUM BRAIN MAPP, V34, P314, DOI 10.1002/hbm.21442; Busch NA, 2010, P NATL ACAD SCI USA, V107, P16048, DOI 10.1073/pnas.1004801107; Busch NA, 2009, J NEUROSCI, V29, P7869, DOI 10.1523/JNEUROSCI.0113-09.2009; Du Y, 2014, P NATL ACAD SCI USA, V111, P7126, DOI 10.1073/pnas.1318738111; Esterman M, 2010, NEUROIMAGE, V50, P572, DOI 10.1016/j.neuroimage.2009.10.092; GALAMBOS R, 1981, P NATL ACAD SCI-BIOL, V78, P2643, DOI 10.1073/pnas.78.4.2643; Galantucci B, 2006, PSYCHON B REV, V13, P361, DOI 10.3758/BF03193857; Giraud AL, 2007, NEURON, V56, P1127, DOI 10.1016/j.neuron.2007.09.038; Giraud AL, 2012, NAT NEUROSCI, V15, P511, DOI 10.1038/nn.3063; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Gross J, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001752; Jerbi K, 2007, P NATL ACAD SCI USA, V104, P7676, DOI 10.1073/pnas.0609632104; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Liberman AM, 2000, TRENDS COGN SCI, V4, P187, DOI 10.1016/S1364-6613(00)01471-6; LIBERMAN AM, 1985, COGNITION, V21, P1, DOI 10.1016/0010-0277(85)90021-6; Liberman AM, 1962, P SPEECH COMM SEM ST; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; MARQUARDT DW, 1975, AM STAT, V29, P3, DOI 10.2307/2683673; Meister IG, 2007, CURR BIOL, V17, P1692, DOI 10.1016/j.cub.2007.08.064; Mizuhara H, 2004, NEUROREPORT, V15, P1233, DOI 10.1097/01.wnr.0000126755.09715.b3; Mizuhara H, 2015, NEUROIMAGE, V111, P76, DOI 10.1016/j.neuroimage.2015.02.019; Mizuhara H, 2012, NEUROIMAGE, V62, P1884, DOI 10.1016/j.neuroimage.2012.05.072; Ng BSW, 2012, J NEUROSCI, V32, P12268, DOI 10.1523/JNEUROSCI.1877-12.2012; Osnes B, 2011, NEUROIMAGE, V54, P2437, DOI 10.1016/j.neuroimage.2010.09.078; Park H, 2015, CURR BIOL, V25, P1649, DOI 10.1016/j.cub.2015.04.049; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Schroeder CE, 2008, TRENDS COGN SCI, V12, P106, DOI 10.1016/j.tics.2008.01.002; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Schubotz RI, 2003, NEUROIMAGE, V20, pS120, DOI 10.1016/j.neuroimage.2003.09.014; Schyns PG, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001064; Stefanics G, 2010, J NEUROSCI, V30, P13578, DOI 10.1523/JNEUROSCI.0703-10.2010; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Watkins KE, 2003, NEUROPSYCHOLOGIA, V41, P989, DOI 10.1016/S0028-3932(02)00316-0	41	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0183146	10.1371/journal.pone.0183146	http://dx.doi.org/10.1371/journal.pone.0183146			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD3KL	28800613	Green Published, gold, Green Submitted			2022-12-26	WOS:000407431800059
J	Hirata, A; Nakamura, K; Nakao, K; Kominami, Y; Tanaka, N; Ohashi, H; Takano, KT; Takeuchi, W; Matsui, T				Hirata, Akiko; Nakamura, Katsunori; Nakao, Katsuhiro; Kominami, Yuji; Tanaka, Nobuyuki; Ohashi, Haruka; Takano, Kohei Takenaka; Takeuchi, Wataru; Matsui, Tetsuya			Potential distribution of pine wilt disease under future climate change scenarios	PLOS ONE			English	Article							BURSAPHELENCHUS-XYLOPHILUS; WOOD NEMATODE; 1ST REPORT; SPREAD; TREE; PORTUGAL; DYNAMICS; IMPACTS; FORESTS; GROWTH	Pine wilt disease (PWD) constitutes a serious threat to pine forests. Since development depends on temperature and drought, there is a concern that future climate change could lead to the spread of PWD infections. We evaluated the risk of PWD in 21 susceptible Pinus species on a global scale. The MB index, which represents the sum of the difference between the mean monthly temperature and 15 when the mean monthly temperatures exceeds 15 degrees C, was used to determine current and future regions vulnerable to PWD (MB >= 22). For future climate conditions, we compared the difference in PWD risks among four different representative concentration pathways (RCPs 2.6, 4.5, 6.0, and 8.5) and two time periods (2050s and 2070s). We also evaluated the impact of climate change on habitat suitability for each Pinus species using species distribution models. The findings were then integrated and the potential risk of PWD spread under climate change was discussed. Within the natural Pinus distribution area, southern parts of North America, Europe, and Asia were categorized as vulnerable regions (MB >= 22; 16% of the total Pinus distribution area). Representative provinces in which PWD has been reported at least once overlapped with the vulnerable regions. All RCP scenarios showed expansion of vulnerable regions in northern parts of Europe, Asia, and North America under future climate conditions. By the 2070s, under RCP 8.5, an estimated increase in the area of vulnerable regions to approximately 50% of the total Pinus distribution area was revealed. In addition, the habitat conditions of a large portion of the Pinus distribution areas in Europe and Asia were deemed unsuitable by the 2070s under RCP 8.5. Approximately 40% of these regions overlapped with regions deemed vulnerable to PWD, suggesting that Pinus forests in these areas are at risk of serious damage due to habitat shifts and spread of PWD.	[Hirata, Akiko; Ohashi, Haruka; Takano, Kohei Takenaka; Matsui, Tetsuya] Forestry & Forest Prod Res Inst, Ctr Int Partnerships & Res Climate Change, Tsukuba, Ibaraki, Japan; [Nakamura, Katsunori] Forestry & Forest Prod Res Inst, Tohoku Res Ctr, Morioka, Iwate, Japan; [Nakao, Katsuhiro; Kominami, Yuji] Forestry & Forest Prod Res Inst, Kansai Res Ctr, Fushimi Ku, Kyoto, Kyoto, Japan; [Tanaka, Nobuyuki] Tokyo Univ Agr, Fac Int Agr & Food Studies, Setagaya Ku, Tokyo, Japan; [Takeuchi, Wataru] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo, Japan; [Takano, Kohei Takenaka] Nagano Environm Conservat Res Inst, Nat Environm Div, Nagano, Japan	Forestry & Forest Products Research Institute - Japan; Forestry & Forest Products Research Institute - Japan; Forestry & Forest Products Research Institute - Japan; Tokyo University of Agriculture; University of Tokyo	Hirata, A; Matsui, T (corresponding author), Forestry & Forest Prod Res Inst, Ctr Int Partnerships & Res Climate Change, Tsukuba, Ibaraki, Japan.	hirataa@affrc.go.jp; tematsui@affrc.go.jp	Matsui, Tetsuya/ABC-4710-2020; Takano, Kohei T/D-8077-2013	Matsui, Tetsuya/0000-0002-8626-3199; Takano, Kohei T/0000-0001-8803-0252; Takeuchi, Wataru/0000-0002-9138-6601	Environmental Research and Technology Development Fund of the Ministry of the Environment, Japan [S-14]	Environmental Research and Technology Development Fund of the Ministry of the Environment, Japan	This research was supported by the Environmental Research and Technology Development Fund (S-14, http://www.env.go.jp/policy/kenkyu/suishin/english/index.html) of the Ministry of the Environment (http://www.env.go.jp/), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelleira A, 2011, PLANT DIS, V95, P776, DOI 10.1094/PDIS-12-10-0902; [Anonymous], 2015, CLIMATE CHANGE 2014; [Anonymous], 2003, J RES, DOI [DOI 10.1007/S10310-003-0034-2, 10.1007/s10310-003-0034-2]; [Anonymous], 2010, MAPPING SPECIES DIST; Bigler C, 2006, ECOSYSTEMS, V9, P330, DOI 10.1007/s10021-005-0126-2; Bohn TJ, 2013, AGR FOREST METEOROL, V176, P38, DOI 10.1016/j.agrformet.2013.03.003; Boyd IL, 2013, SCIENCE, V342, P823, DOI 10.1126/science.1235773; Burns RM, 1990, SILVICS N AM, V1, P877; Cang-sang P, 2011, J XIAMEN U, V50, P476; Critchfield WB, 1966, GEOGRAPHIC DISTRIBUT; Dwinell LD, 1997, ANNU REV PHYTOPATHOL, V35, P153, DOI 10.1146/annurev.phyto.35.1.153; Dwinell LD, 1989, SE55 USDA FOR SERV; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; EPPO/CABI, 2015, DISTR MAPS PLANT PES; EPPO Reporting Service, 2010, 2010051 EPPO REP SER, V3; Evans H. F., 1996, Bulletin OEPP, V26, P199, DOI 10.1111/j.1365-2338.1996.tb00594.x; Forestry Agency, 2015, CHANG ANN LOSS PIN T; Fu ChuenHsu, 2012, Taiwan Journal of Forest Science, V27, P143; Futai K., 1979, Bulletin, Kyoto University Forests, P23; Gruffudd HR, 2016, BIOL INVASIONS, V18, P2823, DOI 10.1007/s10530-016-1173-7; HALIK S, 1994, EUR J FOREST PATHOL, V24, P357; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Ishikawa Y, 1999, J VEG SCI, V10, P439, DOI 10.2307/3237178; Kishi Y, 1995, PINE WOOD NEMATODE J; Li X, 2011, J PLANT BIOL, V54, P33, DOI 10.1007/s12374-010-9140-9; Lindner M, 2010, FOREST ECOL MANAG, V259, P698, DOI 10.1016/j.foreco.2009.09.023; Liu CR, 2016, ECOL EVOL, V6, P337, DOI 10.1002/ece3.1878; Lo YH, 2011, ENVIRON MODELL SOFTW, V26, P644, DOI 10.1016/j.envsoft.2010.11.005; MALEK RB, 1984, PLANT DIS, V68, P180, DOI 10.1094/PD-69-180; MAMIYA Y, 1988, J NEMATOL, V20, P219; MAMIYA Y, 1983, ANNU REV PHYTOPATHOL, V21, P201, DOI 10.1146/annurev.py.21.090183.001221; Maracchi G, 2005, CLIMATIC CHANGE, V70, P117, DOI 10.1007/s10584-005-5939-7; Martinez-Vilalta J, 2008, GLOBAL CHANGE BIOL, V14, P2868, DOI 10.1111/j.1365-2486.2008.01685.x; Moreno-Amat E, 2015, ECOL MODEL, V312, P308, DOI 10.1016/j.ecolmodel.2015.05.035; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Mota MM, 1999, NEMATOLOGY, V1, P727, DOI 10.1163/156854199508757; Nakamura K, 2004, NEMATOL MONOGR PERSP, V1, P269; Nakamura K, 2006, JAPANESE FOREST SOC, V117, P530; Nakamura K, 2014, HDB TREE DOCTORS, P353; Nose M., 2008, PINE WILT DIS, P334, DOI DOI 10.1007/978-4-431-75655-2_34; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pukkala T, 2014, FOREST PATHOL, V44, P341, DOI 10.1111/efp.12105; Robinet C, 2011, BIOL INVASIONS, V13, P2981, DOI 10.1007/s10530-011-9983-0; Robinet C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004646; Roques A, 2015, CABI CLIM CHANGE SER, V7, P220, DOI 10.1079/9781780643786.0220; RUNNING SW, 1987, CAN J FOREST RES, V17, P472, DOI 10.1139/x87-081; RUTHERFORD TA, 1990, FOREST SCI, V36, P145; RUTHERFORD TA, 1987, CAN J FOREST RES, V17, P1050, DOI 10.1139/x87-161; Schulze ED, 1999, GLOBAL CHANGE BIOL, V5, P703, DOI 10.1046/j.1365-2486.1999.00266.x; Shin S-C., 2008, PINE WILT DIS, P26, DOI [10.1007/978-4-431-75655-2_5, DOI 10.1007/978-4-431-75655-2_5]; SMITH I M, 1985, FAO (Food and Agriculture Organization of the United Nations) Plant Protection Bulletin, V33, P159; Son YoWhan, 2007, Eurasian Journal of Forest Research, V10-1, P41; Sturrock RN, 2011, PLANT PATHOL, V60, P133, DOI 10.1111/j.1365-3059.2010.02406.x; Sykes MT, 1996, CLIMATIC CHANGE, V34, P161, DOI 10.1007/BF00224628; TAKETANI A, 1975, Journal of the Japanese Forestry Society, V57, P169; Tamura N, 2007, J JAPANESE FOREST SO, V98, P71; Taniuchi H, 2016, MOKUZAI HOZON, V42, P225; TARES S, 1994, PHYTOPATHOLOGY, V84, P294, DOI 10.1094/Phyto-84-294; Thornton PE, 1997, J HYDROL, V133, P89; Toda T., 2004, Bulletin of the Forest Tree Breeding Institute, P83; UNEP, 1992, WORLD ATLAS DESERTIF; Valadas V, 2012, NEMATOLOGY, V14, P899, DOI 10.1163/156854112X632673; Vicente C, 2012, EUR J PLANT PATHOL, V133, P89, DOI 10.1007/s10658-011-9924-x; Xie LQ, 2008, J PHYTOPATHOL, V156, P385, DOI 10.1111/j.1439-0434.2007.01357.x; Yano S, 1913, SANRIN KOUHOU, V4, P1; Zamora P, 2015, PLANT DIS, V99, P1449, DOI 10.1094/PDIS-03-15-0252-PDN; Zhang KY, 2008, J NEMATOL, V40, P127; Zhao B.G., 2008, PINE WILT DISEASE, P18; [No title captured]	71	45	46	6	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182837	10.1371/journal.pone.0182837	http://dx.doi.org/10.1371/journal.pone.0182837			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797067	Green Submitted, Green Published, gold			2022-12-26	WOS:000407396200105
J	Katani, R; Cote, R; Kudva, IT; DebRoy, C; Arthur, TM; Kapur, V				Katani, Robab; Cote, Rebecca; Kudva, Indira T.; DebRoy, Chitrita; Arthur, Terrance M.; Kapur, Vivek			Comparative genomics of two super-shedder isolates of Escherichia coli O157: H7	PLOS ONE			English	Article							CATTLE; SEQUENCE; STRAINS	Shiga toxin-producing Escherichia coli O157: H7 (O157) are zoonotic foodborne pathogens and of major public health concern that cause considerable intestinal and extra-intestinal illnesses in humans. O157 colonize the recto-anal junction (RAJ) of asymptomatic cattle who shed the bacterium into the environment through fecal matter. A small subset of cattle, termed super-shedders (SS), excrete O157 at a rate (>= 10(4) CFU/g of feces) that is several orders of magnitude greater than other colonized cattle and play a major role in the prevalence and transmission of O157. To better understand microbial factors contributing to super-shedding we have recently sequenced two SS isolates, SS17 (GenBank accession no. CP008805) and SS52 (GenBank accession no. CP010304) and shown that SS isolates display a distinctive strongly adherent phenotype on bovine rectal squamous epithelial cells. Here we present a detailed comparative genomics analysis of SS17 and SS52 with other previously characterized O157 strains (EC4115, EDL933, Sakai, TW14359). The results highlight specific polymorphisms and genomic features shared amongst SS strains, and reveal several SNPs that are shared amongst SS isolates, including in genes involved in motility, adherence, and metabolism. Finally, our analyses reveal distinctive patterns of distribution of phage-associated genes amongst the two SS and other isolates. Together, the results of our comparative genomics studies suggest that while SS17 and SS52 share genomic features with other lineage I/II isolates, they likely have distinct recent evolutionary histories. Future comparative and functional genomic studies are needed to decipher the precise molecular basis for super shedding in O157.	[Katani, Robab; Kapur, Vivek] Penn State Univ, Dept Anim Sci, University Pk, PA 16802 USA; [Katani, Robab; Cote, Rebecca; Kapur, Vivek] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Cote, Rebecca; DebRoy, Chitrita] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Kudva, Indira T.] ARS, Food Safety & Enter Pathogens Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA USA; [DebRoy, Chitrita] Penn State Univ, E Coli Reference Ctr, University Pk, PA 16802 USA; [Arthur, Terrance M.] ARS, Roman L Hruska US Meat Anim Res Ctr, USDA, Clay Ctr, NE USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of Agriculture (USDA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of Agriculture (USDA)	Kapur, V (corresponding author), Penn State Univ, Dept Anim Sci, University Pk, PA 16802 USA.; Kapur, V (corresponding author), Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA.	vkapur@psu.edu	Katani, Robab/AAS-1292-2020	Kapur, Vivek/0000-0002-9648-0138	ITK: USDA-ARS CRIS [5030-32000-100-00D]; TMA: USDA-ARS CRIS [3040-42000-180-00D]	ITK: USDA-ARS CRIS; TMA: USDA-ARS CRIS	RK, RC, VK, CD: The authors received no specific funding for this work. ITK: USDA-ARS CRIS project 5030-32000-100-00D. TMA: USDA-ARS CRIS project 3040-42000-180-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur TM, 2013, APPL ENVIRON MICROB, V79, P4294, DOI 10.1128/AEM.00846-13; Arthur TM, 2011, APPL ENVIRON MICROB, V77, P3002, DOI 10.1128/AEM.02238-10; Arthur TM, 2010, MEAT SCI, V86, P32, DOI 10.1016/j.meatsci.2010.04.019; Bertels F, 2014, MOL BIOL EVOL, V31, P1077, DOI 10.1093/molbev/msu088; Carlson BA, 2009, APPL ENVIRON MICROB, V75, P5927, DOI 10.1128/AEM.00972-09; Chase-Topping M, 2008, NAT REV MICROBIOL, V6, P904, DOI 10.1038/nrmicro2029; Chase-Topping ME, 2007, J CLIN MICROBIOL, V45, P1594, DOI 10.1128/JCM.01690-06; Cote R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116743; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Eppinger M, 2011, P NATL ACAD SCI USA, V108, P20142, DOI 10.1073/pnas.1107176108; Gyles CL, 2007, J ANIM SCI, V85, pE45, DOI 10.2527/jas.2006-508; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Katani R, 2015, GENOME ANNOUNCEMENTS, V3; Kulasekara BR, 2009, INFECT IMMUN, V77, P3713, DOI 10.1128/IAI.00198-09; Latreille P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-321; Matthews L, 2006, P NATL ACAD SCI USA, V103, P547, DOI 10.1073/pnas.0503776103; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Naylor SW, 2003, INFECT IMMUN, V71, P1505, DOI 10.1128/IAI.71.3.1505-1512.2003; Omisakin F, 2003, APPL ENVIRON MICROB, V69, P2444, DOI 10.1128/AEM.69.5.2444-2447.2003; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Yang Z, 2004, APPL ENVIRON MICROB, V70, P6846, DOI 10.1128/AEM.70.11.6846-6854.2004; Zhang YX, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-121; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	27	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182940	10.1371/journal.pone.0182940	http://dx.doi.org/10.1371/journal.pone.0182940			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797098	Green Published, gold			2022-12-26	WOS:000407396200129
J	Nagai, T; Mizuno, K				Nagai, Tomoaki; Mizuno, Kensaku			Jasplakinolide induces primary cilium formation through cell rounding and YAP inactivation	PLOS ONE			English	Article							HIPPO SIGNALING PATHWAY; F-ACTIN; TISSUE-GROWTH; ORGAN SIZE; LIM-KINASE; CILIOGENESIS; YAP/TAZ; PHOSPHORYLATION; DYNAMICS; BINDING	Primary cilia are non-motile cilia that serve as cellular antennae for sensing and transducing extracellular signals. In general, primary cilia are generated by cell quiescence signals. Recent studies have shown that manipulations to increase actin assembly suppress quiescence-induced ciliogenesis. To further examine the role of actin dynamics in ciliogenesis, we analyzed the effect of jasplakinolide (Jasp), a potent inducer of actin polymerization, on ciliogenesis. Unexpectedly, Jasp treatment induced ciliogenesis in serum-fed cells cultured at low density. In contrast, Jasp had no apparent effect on ciliogenesis in cells cultured at higher densities. Jasp-induced ciliogenesis was correlated with a change in cell morphology from a flat and adherent shape to a round and weakly adherent one. Jasp treatment also induced the phosphorylation and cytoplasmic localization of the YAP transcriptional co-activator and suppressed cell proliferation in low density-cultured cells. Overexpression of an active form of YAP suppressed Jasp-induced ciliogenesis. These results suggest that Jasp induces ciliogenesis through cell rounding and cytoplasmic localization and inactivation of YAP. Knockdown of LATS1/2 only faintly suppressed Jasp-induced YAP phosphorylation, indicating that LATS1/2 are not primarily responsible for Jasp-induced YAP phosphorylation. Furthermore, overexpression of active Src kinase suppressed Jasp-induced cytoplasmic localization of YAP and ciliogenesis, suggesting that down-regulation of Src activity is involved in Jasp-induced YAP inactivation and ciliogenesis. Our data suggest that actin polymerization does not suppress ciliogenesis per se but rather that cell rounding and reduced cell adhesion are more crucially involved in Jasp-induced ciliogenesis.	[Nagai, Tomoaki; Mizuno, Kensaku] Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi, Japan	Tohoku University	Mizuno, K (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi, Japan.	kmizuno@biology.tohoku.ac.jp	Nagai, Tomoaki/N-8924-2017	Nagai, Tomoaki/0000-0002-9577-9314	Grants for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan [15H04347, 15H01197, 16K20910]	Grants for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by Grants for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (#15H04347 and 15H01197 to K.M. and #16K20910 to Dr. Tomoaki Nagai; http://www.jsps.go.jp/j-grantsinaid/).; We thank S. Mukoyama, K. Irie and H. Okabe for technical assistance; H. Nakanishi and M. Matsuyama for providing hTERT-RPE1 cells; and K. Ohashi for valuable comments. This work was supported by Grants for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (#15H04347 and 15H01197 to K.M. and #16K20910 to T.N.).	Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Bershteyn M, 2010, DEV CELL, V19, P270, DOI 10.1016/j.devcel.2010.07.009; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Cajanek L, 2014, P NATL ACAD SCI USA, V111, pE2841, DOI 10.1073/pnas.1401777111; Cao JL, 2012, NAT CELL BIOL, V14, P697, DOI 10.1038/ncb2512; Chiba S, 2013, EMBO J, V32, P874, DOI 10.1038/emboj.2013.32; Das A, 2016, J BIOL CHEM, V291, P6096, DOI 10.1074/jbc.M115.708313; Dawe HR, 2009, J CELL SCI, V122, P2716, DOI 10.1242/jcs.043794; Dupont S, 2016, EXP CELL RES, V343, P42, DOI 10.1016/j.yexcr.2015.10.034; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Gaspar P, 2014, CURR OPIN CELL BIOL, V31, P74, DOI 10.1016/j.ceb.2014.09.003; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Goetz SC, 2012, CELL, V151, P847, DOI 10.1016/j.cell.2012.10.010; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Gupta GD, 2015, CELL, V163, P1484, DOI 10.1016/j.cell.2015.10.065; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Izawa Ichiro, 2015, Cilia, V4, P12, DOI 10.1186/s13630-015-0021-1; Kim J, 2015, NAT COMMUN, V6, P6781; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Kim M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6370; Kim NG, 2015, J CELL BIOL, V210, P503, DOI 10.1083/jcb.201501025; Kiuchi T, 2007, J CELL BIOL, V177, P465, DOI 10.1083/jcb.200610005; Kobayashi T, 2011, J CELL BIOL, V193, P435, DOI 10.1083/jcb.201101005; Lazaro-Dieguez F, 2008, J CELL SCI, V121, P1415, DOI 10.1242/jcs.017665; Li P, 2016, GENE DEV, V30, P798, DOI 10.1101/gad.274951.115; Low BC, 2014, FEBS LETT, V588, P2663, DOI 10.1016/j.febslet.2014.04.012; Malicki JJ, 2017, TRENDS CELL BIOL, V27, P126, DOI 10.1016/j.tcb.2016.08.002; Mana-Capelli S, 2014, MOL BIOL CELL, V25, P1676, DOI 10.1091/mbc.E13-11-0701; Mateus R, 2015, DEVELOPMENT, V142, P2752, DOI 10.1242/dev.119701; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Miyamoto T, 2015, CELL REP, V10, P664, DOI 10.1016/j.celrep.2015.01.003; Nagai T, 2014, J BIOCHEM, V155, P137, DOI 10.1093/jb/mvu001; Nagai T, 2013, J CELL SCI, V126, P4369, DOI 10.1242/jcs.127209; Oda T, 2014, GENES CELLS, V19, P927, DOI 10.1111/gtc.12191; Ohashi K, 2014, MOL BIOL CELL, V25, P828, DOI 10.1091/mbc.E13-09-0540; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Pitaval A, 2010, J CELL BIOL, V191, P303, DOI 10.1083/jcb.201004003; Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035; Qi Q, 2015, P NATL ACAD SCI USA, V112, P7255, DOI 10.1073/pnas.1505917112; de Diego AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4500; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Seeley ES, 2010, J CELL SCI, V123, P511, DOI 10.1242/jcs.061093; Sung CH, 2013, NAT CELL BIOL, V15, P1387, DOI 10.1038/ncb2888; Valente EM, 2010, NAT GENET, V42, P619, DOI 10.1038/ng.594; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Yan XM, 2013, EXP CELL RES, V319, P147, DOI 10.1016/j.yexcr.2012.08.009; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	56	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0183030	10.1371/journal.pone.0183030	http://dx.doi.org/10.1371/journal.pone.0183030			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797107	Green Published, Green Submitted, gold			2022-12-26	WOS:000407396200144
J	Pereira, P; Aho, V; Arola, J; Boyd, S; Jokelainen, K; Paulin, L; Auvinen, P; Farkkila, M				Pereira, Pedro; Aho, Velma; Arola, Johanna; Boyd, Sonja; Jokelainen, Kalle; Paulin, Lars; Auvinen, Petri; Farkkila, Martti			Bile microbiota in primary sclerosing cholangitis: Impact on disease progression and development of biliary dysplasia	PLOS ONE			English	Article							MUCOSA-ASSOCIATED MICROBIOTA; CYTOLOGY RISK-FACTORS; INTESTINAL MICROBIOTA; DYSBIOSIS	Objective The etiopathogenesis and risk for development of biliary neoplasia in primary sclerosing cholangitis (PSC) are largely unknown. Microbes or their metabolites have been suggested to play a role. To explore this potential microbial involvement, we evaluated the differences in biliary microbiota in PSC patients at an early disease stage without previous endoscopic retrograde cholangiography (ERC) examinations, advanced disease stage, and with biliary dysplasia or cholangiocarcinoma. Design Bile samples from the common bile duct were collected from 46 controls and 80 patients with PSC during ERC (37 with early disease, 32 with advanced disease, and 11 with biliary dysplasia). DNA isolation, amplification, and Illumina MiSeq sequencing were performed for the V1-V3 regions of the bacterial 16S rRNA gene. Results The most common phyla found were Bacteroidetes, Firmicutes, Proteobacteria, Fusobacteria, and Actinobacteria. The most common families were Prevotellaceae, Streptococcaceae, Veillonellaceae, Fusobacteriaceae, and Pasteurellaceae, and the most common genera were Prevotella, Streptococcus, Veillonella, Fusobacterium, and Haemophilus. The bacterial communities of non-PSC subjects and early stage PSC patients were similar. Alpha diversity was lower in patients with biliary dysplasia/cholangiocarcinoma than in other groups. An increase in Streptococcus abundance was positively correlated with the number of ERC examinations. Streptococcus abundance was also positively correlated with an increase in disease severity, even after controlling for the number of ERC examinations. Conclusions Our findings suggest that the aetiology of PSC is not associated with changes in bile microbial communities, but the genus Streptococcus may play a pathogenic role in the progression of the disease.	[Pereira, Pedro; Aho, Velma; Paulin, Lars; Auvinen, Petri] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Arola, Johanna; Boyd, Sonja] Univ Helsinki, Dept Pathol, Helsinki Univ Hosp, Helsinki, Finland; [Jokelainen, Kalle; Farkkila, Martti] Univ Helsinki, Helsinki, Finland; [Jokelainen, Kalle; Farkkila, Martti] Helsinki Univ Hosp, Gastroenterol Clin, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Pereira, P (corresponding author), Univ Helsinki, Inst Biotechnol, Helsinki, Finland.	pedro.pereira@helsinki.fi	Aho, Velma T. E./AAF-9053-2020; Pereira, Pedro A B/L-6546-2018; Auvinen, Petri/D-5044-2009; Auvinen, Petri/AAP-8117-2021; Färkkilä, Martti/AAG-6970-2021	Aho, Velma T. E./0000-0003-2916-7018; Pereira, Pedro A B/0000-0002-2967-2252; Auvinen, Petri/0000-0002-3947-4778; Färkkilä, Martti/0000-0002-0250-8559	Sigrid Juselius Foundation; University-level health research [TYH2014206]; Doctoral Programme in Biomedicine	Sigrid Juselius Foundation(Sigrid Juselius Foundation); University-level health research; Doctoral Programme in Biomedicine	This work was supported by Sigrid Juselius Foundation (http://sigridjuselius.fi/en/ main-page/), granted to MF; State funding for University-level health research. Grant number: TYH2014206 and the Doctoral Programme in Biomedicine (http://ww.heisinki.fi/dpbm/), granted to VTEA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho VTE, 2015, WORLD ALLERGY ORGAN, V8, DOI 10.1186/s40413-015-0074-z; Bergquist A, 2002, J HEPATOL, V36, P321, DOI 10.1016/S0168-8278(01)00288-4; Boyd S, 2017, SCAND J GASTROENTERO, V52, P242, DOI 10.1080/00365521.2016.1250281; Boyd S, 2016, ENDOSCOPY, V48, P432, DOI 10.1055/s-0041-110792; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Duboc H, 2013, GUT, V62, P531, DOI 10.1136/gutjnl-2012-302578; DuPont AW, 2011, NAT REV GASTRO HEPAT, V8, P523, DOI 10.1038/nrgastro.2011.133; Eksteen B, 2014, BRIT MED BULL, V110, P89, DOI 10.1093/bmb/ldu008; Folseraas T, 2012, J HEPATOL, V57, P366, DOI 10.1016/j.jhep.2012.03.031; Hiramatsu K, 2000, J HEPATOL, V33, P9, DOI 10.1016/S0168-8278(00)80153-1; Hirschfield GM, 2013, LANCET, V382, P1587, DOI 10.1016/S0140-6736(13)60096-3; Karlsen TH, 2013, J HEPATOL, V59, P571, DOI 10.1016/j.jhep.2013.03.015; Kevans D, 2016, J CROHNS COLITIS, V10, P330, DOI 10.1093/ecco-jcc/jjv204; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kummen M, 2016, GUT; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Mattner J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111864; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Olsson R, 1998, J HEPATOL, V28, P426, DOI 10.1016/S0168-8278(98)80316-4; R Core Team, 2013, R LANG ENV STAT COMP; Rossen NG, 2015, J CROHNS COLITIS, V9, P342, DOI 10.1093/ecco-jcc/jju023; Sabino J, 2016, GUT, V65, P1681, DOI 10.1136/gutjnl-2015-311004; Salava A, 2017, EXP DERMATOL; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, STANDARD OPERATING P; Shen HZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17450; Tabibian JH, 2014, SCAND J GASTROENTERO, V49, P901, DOI 10.3109/00365521.2014.913189; Tabibian JH, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/389537; Torres J, 2016, ALIMENT PHARM THER, V43, P790, DOI 10.1111/apt.13552; Verdier J, 2015, VISZERALMEDIZIN, V31, P156, DOI 10.1159/000431071; Whiteside SA, 2015, NAT REV UROL, V12, P81, DOI 10.1038/nrurol.2014.361; Ye FQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150519	34	31	35	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182924	10.1371/journal.pone.0182924	http://dx.doi.org/10.1371/journal.pone.0182924			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796833	Green Published, Green Submitted, gold			2022-12-26	WOS:000407396200124
J	Vochyanova, Z; Pokorna, M; Rotrekl, D; Smekal, V; Fictum, P; Suchy, P; Gajdziok, J; Smejkal, K; Hosek, J				Vochyanova, Zora; Pokorna, Marie; Rotrekl, Dominik; Smekal, Vaclav; Fictum, Petr; Suchy, Pavel; Gajdziok, Jan; Smejkal, Karel; Hosek, Jan			Prenylated flavonoid morusin protects against TNBS-induced colitis in rats	PLOS ONE			English	Article							DEXTRAN SULFATE SODIUM; ANTIINFLAMMATORY ACTIVITY; ULCERATIVE-COLITIS; SULFONIC-ACID; FIBROSIS; INFLAMMATION; SUPPRESSION; EXPRESSION; PATHWAYS; MODEL	Morusin is a prenylated flavonoid isolated from the root bark of Morus alba. Many studies have shown the ability of flavonoids to act as anti-inflammatory agents. The aim of this study was to evaluate the effect of morusin on experimentally colitis induced by 2,4,6-trinitroben-zensulfonic acid in Wistar rats and to compare it with sulfasalazine, a drug conventionally used in the treatment of inflammatory bowel disease. Morusin was administered by gavage at doses of 12.5, 25, or 50 mg/kg/day for five days. The colonic tissue was evaluated macroscopically, histologically, and by performing immunodetection and zymographic analysis to determine the levels of antioxidant enzymes [superoxide dismutase (SOD) and catalase (CAT)], interleukin (IL)-1 beta, and transforming growth factor (TGF)-beta 1 and the activities of matrix metalloproteinases (MMP) 2 and 9. The tissue damage scores were significantly reduced with increasing dose of morusin, however efficacy was not demonstrated at the highest dose. At the dose of 12.5 mg/kg, morusin exerted therapeutic effectivity similar to that of sulfasalazine (50 mg/kg). This was associated with significant reduction of TGF-beta 1 levels and MMP2 and MMP9 activities, and slight reduction of IL-1 beta. Our results suggest that morusin possesses therapeutic potential for the treatment of chronic inflammatory diseases.	[Vochyanova, Zora; Rotrekl, Dominik; Smekal, Vaclav; Hosek, Jan] Univ Vet & Pharmaceut Sci Brno, Fac Pharm, Dept Mol Biol & Pharmaceut Biotechnol, Brno, Czech Republic; [Pokorna, Marie; Smejkal, Karel] Univ Vet & Pharmaceut Sci Brno, Fac Pharm, Dept Nat Drugs, Brno, Czech Republic; [Fictum, Petr] Univ Vet & Pharmaceut Sci Brno, Fac Vet Med, Dept Pathol Morphol & Parasitol, Brno, Czech Republic; [Suchy, Pavel] Univ Vet & Pharmaceut Sci Brno, Fac Pharm, Dept Human Pharmacol & Toxicol, Brno, Czech Republic; [Gajdziok, Jan] Univ Vet & Pharmaceut Sci Brno, Fac Pharm, Dept Pharmaceut, Brno, Czech Republic	University of Veterinary Sciences Brno; University of Veterinary Sciences Brno; University of Veterinary Sciences Brno; University of Veterinary Sciences Brno; University of Veterinary Sciences Brno	Vochyanova, Z; Hosek, J (corresponding author), Univ Vet & Pharmaceut Sci Brno, Fac Pharm, Dept Mol Biol & Pharmaceut Biotechnol, Brno, Czech Republic.	zorka.voch@seznam.cz; hosekj@vfu.cz	Hosek, Jan/B-6274-2009; Gajdziok, Jan/ABC-9766-2020; Čulenová, Marie/AGW-9767-2022; Rotrekl, Dominik/AAD-4899-2020; Šmejkal, Karel/ABF-5925-2020	Hosek, Jan/0000-0003-0975-1671; Čulenová, Marie/0000-0002-1155-272X; Rotrekl, Dominik/0000-0002-2325-8595; Šmejkal, Karel/0000-0002-4336-7924; Suchy, Pavel/0000-0002-6277-2749; Cechova (Vochyanova), Zora/0000-0003-3618-4529; Gajdziok, Jan/0000-0001-5599-5648	Internal Grant Agency of University of Veterinary and Pharmaceutical Sciences Brno [310/2015/FaF, 313/2015/FaF]; Ministry of Health of the Czech Republic [16-27522A]	Internal Grant Agency of University of Veterinary and Pharmaceutical Sciences Brno; Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic)	This work was supported by the Internal Grant Agency of University of Veterinary and Pharmaceutical Sciences Brno, project no. 310/2015/FaF (to ZV), and no. 313/2015/FaF (to MP), and by the grant of the Ministry of Health of the Czech Republic (http://www.azvcr.cz) no. 16-27522A (to ZV and JH). All rights reserved.	Ahn BO, 2001, INT J COLORECTAL DIS, V16, P174, DOI 10.1007/s003840000282; An RB, 2006, BIOL PHARM BULL, V29, P838, DOI 10.1248/bpb.29.838; Benavente-Garcia O, 2008, J AGR FOOD CHEM, V56, P6185, DOI 10.1021/jf8006568; Bruckner M, 2012, J CROHNS COLITIS, V6, P226, DOI 10.1016/j.crohns.2011.08.012; Fukai T, 2003, FITOTERAPIA, V74, P720, DOI 10.1016/j.fitote.2003.07.004; Gupta G, 2016, CENTR NERV IN PRESS; Hosek J, 2013, J NAT PROD, V76, P1586, DOI 10.1021/np400242e; Hosek J, 2011, J NAT PROD, V74, P614, DOI 10.1021/np100638h; Kim HP, 2004, J PHARMACOL SCI, V96, P229, DOI 10.1254/jphs.CRJ04003X; Kisseleva Tatiana, 2008, Proc Am Thorac Soc, V5, P338, DOI 10.1513/pats.200711-168DR; Kollar P, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/350519; Latella G, 2008, EUR J CLIN INVEST, V38, P410, DOI 10.1111/j.1365-2362.2008.01955.x; Lee DS, 2014, MOLECULES, V19, P10818, DOI 10.3390/molecules190810818; Lee HJ, 2014, TUBERC RESPIR DIS, V77, P65, DOI 10.4046/trd.2014.77.2.65; Loeuillard E, 2014, WORLD J GASTROENTERO, V20, P18207, DOI 10.3748/wjg.v20.i48.18207; Mao JW, 2012, WORLD J GASTROENTERO, V18, P7063, DOI 10.3748/wjg.v18.i47.7063; Marshall DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127063; Medina C, 2011, J PATHOL, V224, P461, DOI 10.1002/path.2870; Minaiyan M, 2014, RES PHARM SCI, V9, P225; MORRIS GP, 1989, GASTROENTEROLOGY, V96, P795, DOI 10.1016/0016-5085(89)90904-9; Sakthivel KM, 2013, INT IMMUNOPHARMACOL, V17, P907, DOI 10.1016/j.intimp.2013.09.022; Smejkal K, 2016, COMP INFL DIS; Sun Q, 2016, BIOORG MED CHEM LETT, V26, P3968, DOI 10.1016/j.bmcl.2016.07.002; Tao FF, 2013, BIOCHEM PHARMACOL, V85, P798, DOI 10.1016/j.bcp.2012.12.002; Terao J, 2014, ARCH BIOCHEM BIOPHYS, V559, P12, DOI 10.1016/j.abb.2014.04.002; Vochyanova Z, 2015, FITOTERAPIA, V101, P201, DOI 10.1016/j.fitote.2015.01.012; von Lampe B, 2000, GUT, V47, P63, DOI 10.1136/gut.47.1.63; Witaicenis A, 2012, CHEM-BIOL INTERACT, V195, P76, DOI 10.1016/j.cbi.2011.11.004; Yamaguchi H, 2012, MED MOL MORPHOL, V45, P140, DOI 10.1007/s00795-011-0550-7; Zelova H, 2014, J NAT PROD, V77, P1297, DOI 10.1021/np401025f	30	26	28	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182464	10.1371/journal.pone.0182464	http://dx.doi.org/10.1371/journal.pone.0182464			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797051	Green Published, Green Submitted, gold			2022-12-26	WOS:000407396200052
J	Dodzo, MK; Mhloyi, M				Dodzo, Munyaradzi Kenneth; Mhloyi, Marvellous			Home is best: Why women in rural Zimbabwe deliver in the community	PLOS ONE			English	Article							MATERNAL MORTALITY; AFRICA	Maternal mortality in Zimbabwe has unprecedentedly risen over the last two and half decades although a decline has been noted recently. Many reasons have been advanced for the rising trend, including deliveries without skilled care, in places without appropriate or adequate facilities to handle complications. The recent decline has been attributed to health systems strengthening through a multi-donor pooled funding mechanism. On the other hand, the proportion of community deliveries has also been growing steadily over the years and in this study we investigate why. We used twelve (12) focus group discussions with child-bearing women and eight (8) key informant interviews (KIIs). Four (4) were traditional birth attendants and four (4) were spiritual birth attendants. A thematic approach was used to analyse the data in Ethnography software. The study shows that women prefer community deliveries due to perceived low economic, social and opportunity costs involved; pliant and flexible services offered; and diminishing quality and appeal of institutional maternity services. We conclude that rural women are very economic, logical and rational in making choices on place of delivery. Delivering in the community offers financial, social and opportunity advantages to disenfranchised women, particularly in remote rural areas. We recommend for increased awareness of the dangers of community deliveries; establishment of basic obstetric care facilities in the community and more efficient emergency referral systems. In the long-term, there should be a sustainable improvement of the public health delivery system to make it accessible, affordable and usable by the public.	[Dodzo, Munyaradzi Kenneth; Mhloyi, Marvellous] Univ Zimbabwe, Ctr Populat Studies, Harare, Zimbabwe	University of Zimbabwe	Dodzo, MK (corresponding author), Univ Zimbabwe, Ctr Populat Studies, Harare, Zimbabwe.	dodzomk@yahoo.co.uk						Adejumo AO., 2013, GLOBAL J HLTH SCI, V5; Anandlakshmy P N, 1997, Indian J Matern Child Health, V8, P60; Blum LS, 2006, REPROD HEALTH MATTER, V14, P51, DOI 10.1016/S0968-8080(06)27234-3; Bouvier-Colle MH, 2001, ACTA OBSTET GYN SCAN, V80, P113; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Central Statistical Office [Zimbabwe] and Macro International Inc, 2000, ZIMB DEM HLTH SURV 1; Central Statistical Office (Zimbabwe) and Macro International Inc, 1995, ZIMB DEM HLTH SURV 1; Central Statistical Office/Zimbabwe & Macro International, 2007, ZIMB DEM HLTH SURV 2; Chinkhumba J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1014; Choguya NZ., 2013, J ANTHR, V2014; Dodzo MK, 2017, THESIS; Lohela TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052110; Ministry of Health and Child Welfare, 2009, NAT MAT PER MORT SUR; Ministry of Health and Child Welfare, 2009, ACC HLTH SERV STUD; Mueller DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020741; Munangagwa C.L., 2009, GETTYSBURG EC REV, V3, P9; MUTAMBIRWA J, 1989, SOC SCI MED, V29, P927, DOI 10.1016/0277-9536(89)90046-4; Ronsmans C, 2010, B WORLD HEALTH ORGAN, V88, P289, DOI 10.2471/BLT.09.069385; UNICEF, 2011, HLTH TRANS FUND MULT; World Bank, 1993, WORLD DEV REP INV HL; Zimbabwe National Statistics Agency and ICF International, 2016, ZIMB DEM HLTH SURV 2; Zimbabwe National Statistics Agency (ZIMSTAT), 2012, ZIMB CENS 2012 NAT R; Zimbabwe National Statistics Agency (ZIMSTAT) and ICF International, 2012, ZIMB DEM HLTH SURV 2; Zimbabwe National Statistics (ZIMSTAT), 2014, MULT IND CLUST SURV	24	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e181771	10.1371/journal.pone.0181771	http://dx.doi.org/10.1371/journal.pone.0181771			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28793315	Green Published, Green Submitted, gold			2022-12-26	WOS:000407196700022
J	Fang, XC; Xie, HY; Duan, HY; Li, P; Yousaf, M; Xu, HY; Yang, YL; Wang, C				Fang, Xiaocui; Xie, Hanyi; Duan, Hongyang; Li, Ping; Yousaf, Maryam; Xu, Haiyan; Yang, Yanlian; Wang, Chen			Anti-tumor activity of nanomicelles encapsulating CXCR4 peptide antagonist E5	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; CHEMOKINE RECEPTOR CXCR4; CANCER METASTASIS; DRUG-DELIVERY; MICELLES; EXPRESSION; TUMORS; THERAPEUTICS; NETWORKS; CELLS	Cancer is the leading cause of death worldwide, and metastasis is the main attribute to cancer death. CXCR4 and its natural ligand CXCL12 have been known to play a critical role in tumorigenesis, angiogenesis and metastasis. Therefore, designing a new CXCR4 antagonist to prevent tumor metastasis will be of great significance. Herein, a novel chemically synthesized peptide (E5) that has an ability to target CXCR4/CXCL12 axis was loaded in micelle glycol-phosphatidylethanolamine (PEG-PE) block copolymer to form micelle-encapsulated E5 (M-E5). We demonstrated that M-E5 exhibited higher affinity for CXCR4-overexpressing MCF-7 and HepG2 tumor cells as compared to free E5, and efficiently inhibited the tumor cells migration. Mechanistic studies implied that PEG-PE micelle can encapsulate E5 and improve E5 targeting efficiency for CXCR4 by accumulating E5 on the tumor cell membrane. Furthermore, through encapsulation of chemotherapeutic drug doxorubicin (Dox) in PEG-PE micelle, we proved that PEG-PE micelle could serve as a co-carrier for both E5 and Dox (M-E5-Dox). M-E5 enhanced the efficiency of Dox by down-regulating the phosphorylation level of Akt, Erk and p38/MAPK proteins. In conclusion, PEG-PE micelle demonstrated a promising delivery system for E5, and M-E5 is expected to be a potential therapeutic agent that will help to improve the clinical benefits in current therapies used for solid tumors.	[Fang, Xiaocui; Duan, Hongyang; Yousaf, Maryam; Yang, Yanlian] Natl Ctr Nanosci & Technol Beijing, CAS Ctr Excellence Nanosci, CAS Key Lab Standardizat & Measurement Nanotechno, Beijing, Peoples R China; [Xie, Hanyi; Li, Ping; Wang, Chen] Natl Ctr Nanosci & Technol, CAS Ctr Excellence Nanosci, CAS Key Lab Biol Effects Nanomat & Nanosafety, Beijing, Peoples R China; [Xu, Haiyan] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing, Peoples R China; [Xu, Haiyan] Peking Union Med Coll, Beijing, Peoples R China	Chinese Academy of Sciences; National Center for Nanoscience & Technology - China; Chinese Academy of Sciences; National Center for Nanoscience & Technology - China; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yang, YL (corresponding author), Natl Ctr Nanosci & Technol Beijing, CAS Ctr Excellence Nanosci, CAS Key Lab Standardizat & Measurement Nanotechno, Beijing, Peoples R China.; Wang, C (corresponding author), Natl Ctr Nanosci & Technol, CAS Ctr Excellence Nanosci, CAS Key Lab Biol Effects Nanomat & Nanosafety, Beijing, Peoples R China.; Xu, HY (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Beijing, Peoples R China.; Xu, HY (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.	xuhy@pumc.edu.cn; yangyl@nanoctr.cn; wangch@nanoctr.cn	Yousaf, Maryam/AAH-2654-2020		Chinese Academy of Sciences [XDA09030306, XDA09040300]; Chinese Postdoctoral Science Foundation [Y6791Z11GJ]	Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was financially supported by the Strategic Priority Research Program of Chinese Academy of Sciences (Grant No. XDA09030306, recipient:Y.Y., and XDA09040300, recipient:C.W.) and the Chinese Postdoctoral Science Foundation (Y6791Z11GJ, recipient:X.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Aryal S, 2010, ACS NANO, V4, P251, DOI 10.1021/nn9014032; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Debnath B, 2013, THERANOSTICS, V3, P47, DOI 10.7150/thno.5376; Gao ZG, 2002, NANO LETT, V2, P979, DOI 10.1021/nl025604a; Guo F, 2016, ONCOGENE, V35, P816, DOI 10.1038/onc.2015.139; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Ishii G, 2016, ADV DRUG DELIVER REV, V99, P186, DOI 10.1016/j.addr.2015.07.007; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kaspar AA, 2013, DRUG DISCOV TODAY, V18, P807, DOI 10.1016/j.drudis.2013.05.011; Kryczek I, 2005, CANCER RES, V65, P465; Li XJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep16228; LI XM, 2014, SCI REP UK, V4; Lou CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050956; Markovic SN, 2007, MAYO CLIN PROC, V82, P364; Mendoza M, 2009, INT J BIOCHEM CELL B, V41, P1452, DOI 10.1016/j.biocel.2009.01.015; Monk BJ, 2014, LANCET ONCOL, V15, P799, DOI 10.1016/S1470-2045(14)70244-X; Nakajima S, 2004, CLIN CANCER RES, V10, P4125, DOI 10.1158/1078-0432.CCR-0578-03; Pienta KJ, 2013, CLIN CANCER RES, V19, P5849, DOI 10.1158/1078-0432.CCR-13-2158; Pu X, 2017, APOPTOSIS, V22, P357, DOI 10.1007/s10495-016-1323-5; Qin L, 2013, J CONTROL RELEASE, V171, P133, DOI 10.1016/j.jconrel.2013.07.005; Rosca EV, 2011, CURR PHARM BIOTECHNO, V12, P1101; Shim H, 2009, SEMIN CANCER BIOL, V19, P123, DOI 10.1016/j.semcancer.2008.11.004; Tang N, 2007, JNCI-J NATL CANCER I, V99, P1004, DOI 10.1093/jnci/djm027; Tavor S, 2010, SEMIN CANCER BIOL, V20, P178, DOI 10.1016/j.semcancer.2010.07.001; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Torchilin Vladimir P., 2005, Current Drug Delivery, V2, P319, DOI 10.2174/156720105774370221; Torchilin VP, 2003, P NATL ACAD SCI USA, V100, P6039, DOI 10.1073/pnas.0931428100; Vaquero J, 2017, J HEPATOL, V66, P424, DOI 10.1016/j.jhep.2016.09.010; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Wang J, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0309; Wang J, 2012, ACS NANO, V6, P5018, DOI 10.1021/nn300571c; Wang J, 2012, J CONTROL RELEASE, V160, P637, DOI 10.1016/j.jconrel.2012.02.021; Wang YG, 2010, PHARM RES-DORDR, V27, P361, DOI 10.1007/s11095-009-0029-6; Wang ZB, 2005, CELL BIOL INT, V29, P489, DOI 10.1016/j.cellbi.2005.04.001; Wei XL, 2012, PHARM RES-DORDR, V29, P1977, DOI 10.1007/s11095-012-0725-5; Yuan QA, 2010, BIOMACROMOLECULES, V11, P1940, DOI 10.1021/bm100589g; Zhu XL, 2016, INT J ONCOL, V48, P2321, DOI 10.3892/ijo.2016.3485	39	5	6	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182697	10.1371/journal.pone.0182697	http://dx.doi.org/10.1371/journal.pone.0182697			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28793338	Green Published, gold, Green Submitted			2022-12-26	WOS:000407196700060
J	Swift, LL; Love, JD; Harris, CM; Chang, BH; Jerome, WG				Swift, Larry L.; Love, Joseph D.; Harris, Carla M.; Chang, Benny H.; Jerome, W. Gray			Microsomal triglyceride transfer protein contributes to lipid droplet maturation in adipocytes	PLOS ONE			English	Article							ABETALIPOPROTEINEMIA GENE; APOLIPOPROTEIN-B; ADIPOSE-TISSUE; EXPRESSION; ACCUMULATION; LIPOPROTEINS; MOUSE; KNOCKOUT; GROWTH; CELLS	Previous studies in our laboratory have established the presence of MTP in both white and brown adipose tissue in mice as well as in 3T3-L1 cells. Additional studies demonstrated an increase in MTP levels as 3T3-L1 cells differentiate into adipocytes concurrent with the movement of MTP from the juxtanuclear region of the cell to the surface of lipid droplets. This suggested a role for MTP in lipid droplet biogenesis and/or maturation. To probe the role of MTP in adipocytes, we used a Cre-Lox approach with aP2-Cre and Adipoq-Cre recombinase transgenic mice to knock down MTP expression in brown and white fat of mice. MTP expression was reduced approximately 55% in white fat and 65-80% in brown fat. Reducing MTP expression in adipose tissue had no effect on weight gain or body composition, whether the mice were fed a regular rodent or high fat diet. In addition, serum lipids and unesterified fatty acid levels were not altered in the knockdown mice. Importantly, decreased MTP expression in adipose tissue was associated with smaller lipid droplets in brown fat and smaller adipocytes in white fat. These results combined with our previous studies showing MTP lipid transfer activity is not necessary for lipid droplet initiation or growth in the early stages of differentiation, suggest that a structural feature of the MTP protein is important in lipid droplet maturation. We conclude that MTP protein plays a critical role in lipid droplet maturation, but does not regulate total body fat accumulation.	[Swift, Larry L.; Love, Joseph D.; Harris, Carla M.; Jerome, W. Gray] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Swift, Larry L.] Tennessee Valley Hlth Care Syst, Res Serv, Vet Affairs, Nashville, TN 37212 USA; [Chang, Benny H.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Chang, Benny H.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Baylor College of Medicine; Baylor College of Medicine	Swift, LL (corresponding author), Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA.; Swift, LL (corresponding author), Tennessee Valley Hlth Care Syst, Res Serv, Vet Affairs, Nashville, TN 37212 USA.	Larry.Swift@vanderbilt.edu		Swift, Larry/0000-0003-1476-4741	Veterans Administration Merit Award from the Tennessee Valley Health Care System and Department of Veterans Affairs [IBX000735A]; American Heart Association [15GRNT25700113]; National Institute of Diabetes and Digestive and Kidney Diseases [DK84495, DK59637]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER	Veterans Administration Merit Award from the Tennessee Valley Health Care System and Department of Veterans Affairs; American Heart Association(American Heart Association); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by a Veterans Administration Merit Award (IBX000735A) from the Tennessee Valley Health Care System and Department of Veterans Affairs (LS) and by funds from the American Heart Association (15GRNT25700113) (WJ) and the National Institute of Diabetes and Digestive and Kidney Diseases (DK84495) (BC). Lipid analyses were carried out in the Analytical Core of the Vanderbilt Mouse Metabolic Phenotyping Center funded by the National Institute of Diabetes and Digestive and Kidney Diseases (DK59637). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakillah A, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0061-6; Berriot-Varoqueaux N, 2000, ANNU REV NUTR, V20, P663, DOI 10.1146/annurev.nutr.20.1.663; Boren J, 1998, J CLIN INVEST, V101, P1197, DOI 10.1172/JCI1785; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Chang BHJ, 1999, J BIOL CHEM, V274, P6051, DOI 10.1074/jbc.274.10.6051; Dougan SK, 2005, J EXP MED, V202, P529, DOI 10.1084/jem.20050183; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gong JY, 2011, J CELL BIOL, V195, P953, DOI 10.1083/jcb.201104142; GORDON DA, 1995, TRENDS CELL BIOL, V5, P317, DOI 10.1016/S0962-8924(00)89054-6; Harno E, 2013, CELL METAB, V18, P21, DOI 10.1016/j.cmet.2013.05.019; Jeffery E, ADIPOCYTE, V3, P206; Krzystanek M, 2010, J BIOL CHEM, V285, P10583, DOI 10.1074/jbc.M109.078006; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Lee KY, 2013, DIABETES, V62, P864, DOI 10.2337/db12-1089; Li CM, 2005, J LIPID RES, V46, P628, DOI 10.1194/jlr.M400428-JLR200; Love JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135598; Madsen EM, 2004, J BIOL CHEM, V279, P55271, DOI 10.1074/jbc.M411404200; Mohler PJ, 2007, J BIOL CHEM, V282, P26981, DOI 10.1074/jbc.M700500200; MORRISON WR, 1964, J LIPID RES, V5, P600; Nielsen LB, 1998, CIRCULATION, V98, P13, DOI 10.1161/01.CIR.98.1.13; Nielsen LB, 2002, ARTERIOSCL THROM VAS, V22, P1489, DOI 10.1161/01.ATV.0000030199.06252.26; Olofsson SO, 2008, CURR OPIN LIPIDOL, V19, P441, DOI 10.1097/MOL.0b013e32830dd09b; Raabe M, 1998, P NATL ACAD SCI USA, V95, P8686, DOI 10.1073/pnas.95.15.8686; Rader DJ, 1991, JAMA-J AM MED ASSOC, V270, P865; Read J, 2000, J BIOL CHEM, V275, P30372, DOI 10.1074/jbc.C000364200; Shelton JM, 2000, J LIPID RES, V41, P532; SHOULDERS CC, 1993, HUM MOL GENET, V2, P2109, DOI 10.1093/hmg/2.12.2109; Sun ZQ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2581; Suzuki T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147252; Swift LL, 2005, FEBS LETT, V579, P3183, DOI 10.1016/j.febslet.2005.05.009; Swift LL, 2003, J LIPID RES, V44, P1841, DOI 10.1194/jlr.M300276-JLR200; Swift LL, 2001, J BIOL CHEM, V276, P22965, DOI 10.1074/jbc.M100172200; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Xu NY, 2012, J CELL BIOL, V198, P895, DOI 10.1083/jcb.201201139	35	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0181046	10.1371/journal.pone.0181046	http://dx.doi.org/10.1371/journal.pone.0181046			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28793320	Green Submitted, Green Published, gold			2022-12-26	WOS:000407196700006
J	Wickramasinghe, N; Robin, VV; Ramakrishnan, U; Reddy, S; Seneviratne, SS				Wickramasinghe, Nelum; Robin, V. V.; Ramakrishnan, Uma; Reddy, Sushma; Seneviratne, Sampath S.			Non-sister Sri Lankan white-eyes (genus Zosterops) are a result of independent colonizations	PLOS ONE			English	Article							SYMPATRIC SPECIATION; DIVERSIFICATION; BIRDS; EVOLUTION; HYBRIDIZATION; DIVERGENCE; DIVERSITY; GENOME; BLOOD; AVES	Co-occurrence of closely related taxa on islands could be attributed to sympatric speciation or multiple colonization. Sympatric speciation is considered to be rare in small islands, however multiple colonizations are known to be common in both oceanic and continental islands. In this study we investigated the phylogenetic relatedness and means of origin of the two sympatrically co-occurring Zosterops white-eyes, the endemic Zosterops ceylonensis and its widespread regional congener Z. palpebrosus, in the island of Sri Lanka. Sri Lanka is a continental island in the Indian continental shelf of the Northern Indian Ocean. Our multivariate morphometric analyses confirmed the phenotypic distinctness of the two species. Maximum Likelihood and Bayesian phylogenetic analyses with similar to 2000bp from two mitochondrial (ND2 and ND3) and one nuclear (TGF) gene indicated that they are phylogenetically distinct, and not sister to each other. The two subspecies of the peninsula India; Z. p. egregius of Sri Lanka and India and Z. p. nilgiriensis of Western Ghats (India) clustered within the Z. palpebrosus clade having a common ancestor. In contrast, the divergence of the endemic Z. ceylonensis appears to be much deeper and is basal to the other Zosterops white-eyes. Therefore we conclude that the two Zosterops species originated in the island through independent colonizations from different ancestral lineages, and not through island speciation or multiple colonization from the same continental ancestral population. Despite high endemism, Sri Lankan biodiversity is long considered to be a subset of southern India. This study on a speciose group with high dispersal ability and rapid diversification rate provide evidence for the contribution of multiple colonizations in shaping Sri Lanka's biodiversity. It also highlights the complex biogeographic patterns of the South Asian region, reflected even in highly vagile groups such as birds.	[Wickramasinghe, Nelum; Seneviratne, Sampath S.] Univ Colombo, Dept Zool & Environm Sci, Avian Evolut Node, Fac Sci, Colombo, Sri Lanka; [Wickramasinghe, Nelum; Robin, V. V.; Ramakrishnan, Uma] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Reddy, Sushma] Loyola Univ, Biol Dept, Chicago, IL 60611 USA; [Robin, V. V.] Indian Inst Sci Educ & Res, Dept Biol, Tirupati, Andhra Pradesh, India	University of Colombo; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Loyola University Chicago; Indian Institute of Science Education & Research (IISER) - Tirupati	Seneviratne, SS (corresponding author), Univ Colombo, Dept Zool & Environm Sci, Avian Evolut Node, Fac Sci, Colombo, Sri Lanka.	sam@sci.cmb.ac.lk	Robin, V.V./H-7299-2019	Robin, V.V./0000-0003-3109-5498; Ramakrishnan, Uma/0000-0002-5370-5966; Reddy, Sushma/0000-0001-7263-0763	National Research Council of Sri Lanka [14-072]; Outstanding Scientist Award Department of Atomic Energy, India; Division Of Environmental Biology [1457624] Funding Source: National Science Foundation	National Research Council of Sri Lanka; Outstanding Scientist Award Department of Atomic Energy, India; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Major funding is provided by the National Research Council of Sri Lanka (Grant number: 14-072) to S.S.S. (NRC URL http //www.gov.lk/) and an Outstanding Scientist Award Department of Atomic Energy, India to U.R. (DAE URL-http://dae.nic.in/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Prof. Preethi Udagama and Saminda Fernando, Department of Zoology, University of Colombo for the assistance provided during all steps of the project implementation; C. K. Vishnudas for extensive field assistance in the Western Ghats; Sequencing facility at the National Center for Biological Sciences, Bangalore India for performing Sanger Sequencing; Avian Evolution Node lab members at the Department of Zoology, University of Colombo and Lab 3 members at the National Center for Biological Sciences for the help during laboratory work; S.P. Vijay Kumar and Naveen Namboothri for discussions; Krishnapriya Tamma for comments on the manuscript; The Department of Wildlife Conservation of Sri Lanka (Permit No: WL/3/2/19/13), Forest Department of Sri Lanka (Permit No: R&E/RES/NFSRC/14) and Forest Departments of Kerala (Permit No: W110-1647/2011) for providing permits to carry out the field components of this study. Major funding is provided by the National Research Council of Sri Lanka research grant (Grant number: 14-072) to SS. Three anonymous reviewers and Prof. Tzen-Yuh Chiang the academic editor of PLOS-one provided insightful comments on the earlier versions of this manuscript.	Anderton J. C, 2012, BIRDS S ASIA RIPLEY, VSecond; [Anonymous], 1980, J NATL SCI FOUND; Baldwin SP, 1931, MEASUREMENTS BIRDS; Barluenga M, 2006, NATURE, V439, P719, DOI 10.1038/nature04325; Berlocher SH, 1998, ENDLESS FORMS, P3; Black RA, 2010, THESIS; Bossuyt F, 2004, SCIENCE, V306, P479, DOI 10.1126/science.1100167; Chesser RT, 1999, CONDOR, V101, P439, DOI 10.2307/1370012; Clegg SM, 2002, P NATL ACAD SCI USA, V99, P8127, DOI 10.1073/pnas.102583399; Clegg SM, 2010, PHILOS T R SOC B, V365, P1077, DOI 10.1098/rstb.2009.0281; Cook OF, 1908, AM NAT, V42, P727, DOI 10.1086/279001; Cook OF, 1906, SCIENCE, V23, P506, DOI 10.1126/science.23.587.506; Cornetti L, 2015, GENOME BIOL EVOL, V7, P2680, DOI 10.1093/gbe/evv168; Cowie RH, 1995, EVOLUTION, V49, P1191, DOI 10.1111/j.1558-5646.1995.tb04446.x; Cox SC, 2014, MOL ECOL, V23, P4103, DOI 10.1111/mec.12840; Coyne J.A., 2004, SPECIATION; Coyne JA, 2000, EVOLUTION, V54, P2166; Darwin C., 1859, ORIGINS SPECIES MEAN; DIAMOND JM, 1976, P NATL ACAD SCI USA, V73, P2160, DOI 10.1073/pnas.73.6.2160; DIAMOND JM, 1977, SYST ZOOL, V26, P263, DOI 10.2307/2412673; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Emerson BC, 2008, BIOL J LINN SOC, V95, P47, DOI 10.1111/j.1095-8312.2008.01120.x; Fair J., GUIDELINES USE WILD; Friesen VL, 2007, P NATL ACAD SCI USA, V104, P18589, DOI 10.1073/pnas.0700446104; Grant PR, 1996, PHILOS T ROY SOC B, V351, P765, DOI 10.1098/rstb.1996.0071; GRANT PR, 1972, SYST ZOOL, V21, P289, DOI 10.2307/2412167; Henry GM, 1971, GUIDE BIRDS SRI LANK; Holdsworth EW., 1872, P ZOOL SOC; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Johnson KP, 1998, MOL PHYLOGENET EVOL, V10, P82, DOI 10.1006/mpev.1997.0481; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; LACK DAVID, 1944, IBIS, V86, P260, DOI 10.1111/j.1474-919X.1944.tb04092.x; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Legge WV, 1878, HIST BIRDS CEYLON; Losos JB, 2000, NATURE, V408, P847, DOI 10.1038/35048558; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; Mayr E., 1942, P1; Mayr E, 1940, AM NAT, V74, P249, DOI 10.1086/280892; Mees G. F., 1957, Zoologische Verhandelingen, VNo. 35, P1; Melo M, 2011, MOL ECOL, V20, P4953, DOI 10.1111/j.1365-294X.2011.05099.x; Mila B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-158; Monteiro LR, 1998, PHILOS T ROY SOC B, V353, P945, DOI 10.1098/rstb.1998.0259; Moyle RG, 2009, P NATL ACAD SCI USA, V106, P1863, DOI 10.1073/pnas.0809861105; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Oatley G, 2012, MOL PHYLOGENET EVOL, V64, P633, DOI 10.1016/j.ympev.2012.05.022; Poulton, 1903, T ENTOMOL SOC LOND, P77; Price T, 2008, SPECIATION BIRDS; Primmer CR, 2002, MOL ECOL, V11, P603, DOI 10.1046/j.0962-1083.2001.01452.x; Rambaut A., 2014, TRACER V1 6; RIPLEY SD, 1949, EVOLUTION, V3, P150, DOI 10.2307/2405549; Rohling EJ, 1998, NATURE, V394, P162, DOI 10.1038/28134; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ryan PG, 2007, SCIENCE, V315, P1420, DOI 10.1126/science.1138829; Sefc KM, 2005, MOL ECOL, V14, P1407, DOI 10.1111/j.1365-294X.2005.02492.x; Seneviratne SS, 2016, J AVIAN BIOL, V47, P887, DOI 10.1111/jav.00946; Seneviratne SS, 2012, J AVIAN BIOL, V43, P119, DOI 10.1111/j.1600-048X.2012.05516.x; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Sheldon LD, 2008, J AVIAN BIOL, V39, P369, DOI 10.1111/j.0908-8857.2008.04295.x; Sorenson MD, 1999, MOL PHYLOGENET EVOL, V12, P105, DOI 10.1006/mpev.1998.0602; Sorenson MD, 2003, NATURE, V424, P928, DOI 10.1038/nature01863; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; van Balen S., 2008, P402; Wallace A. R., 1880; Wallace AR, 2011, GEOGRAPHICAL DISTRIB; Warren BH, 2006, MOL ECOL, V15, P3769, DOI 10.1111/j.1365-294X.2006.03058.x; Whitlock M. C., 2009, ANAL BIOL DATA	67	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0181441	10.1371/journal.pone.0181441	http://dx.doi.org/10.1371/journal.pone.0181441			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28792950	Green Submitted, Green Published, gold			2022-12-26	WOS:000407196700011
J	Duan, J; Yang, J; Tang, CJ; Chen, LH; Liu, YJ; Wang, LY				Duan, Jian; Yang, Jie; Tang, Chongjun; Chen, Lihua; Liu, Yaojun; Wang, Lingyun			Effects of rainfall patterns and land cover on the subsurface flow generation of sloping Ferralsols in southern China	PLOS ONE			English	Article							RED SOIL REGION; STORM-RUNOFF GENERATION; SEDIMENT YIELD; EROSION RATES; SURFACE RUNOFF; ROOT SYSTEMS; WATER; HILLSLOPE; IMPACTS; REGIMES	Rainfall patterns and land cover are two important factors that affect the runoff generation process. To determine the surface and subsurface flows associated with different rainfall patterns on sloping Ferralsols under different land cover types, observational data related to surface and subsurface flows from 5 m x 15 m plots were collected from 2010 to 2012. The experiment was conducted to assess three land cover types (grass, litter cover and bare land) in the Jiangxi Provincial Soil and Water Conservation Ecological Park. During the study period, 114 natural rainfall events produced subsurface flow and were divided into four groups using k-means clustering according to rainfall duration, rainfall depth and maximum 30-min rainfall intensity. The results showed that the total runoff and surface flow values were highest for bare land under all four rainfall patterns and lowest for the covered plots. However, covered plots generated higher subsurface flow values than bare land. Moreover, the surface and subsurface flows associated with the three land cover types differed significantly under different rainfall patterns. Rainfall patterns with low intensities and long durations created more subsurface flow in the grass and litter cover types, whereas rainfall patterns with high intensities and short durations resulted in greater surface flow over bare land. Rainfall pattern I had the highest surface and subsurface flow values for the grass cover and litter cover types. The highest surface flow value and lowest subsurface flow value for bare land occurred under rainfall pattern IV. Rainfall pattern II generated the highest subsurface flow value for bare land. Therefore, grass or litter cover are able to convert more surface flow into subsurface flow under different rainfall patterns. The rainfall patterns studied had greater effects on subsurface flow than on total runoff and surface flow for covered surfaces, as well as a greater effect on surface flows associated with bare land.	[Duan, Jian; Chen, Lihua] Beijing Forestry Univ, Sch Soil & Water Conservat, Beijing, Peoples R China; [Yang, Jie; Tang, Chongjun; Liu, Yaojun; Wang, Lingyun] Jiangxi Inst Soil & Water Conservat, Nanchang, Jiangxi, Peoples R China	Beijing Forestry University	Chen, LH (corresponding author), Beijing Forestry Univ, Sch Soil & Water Conservat, Beijing, Peoples R China.	djlynn200@126.com			National Natural Science Foundation of China [41361060, 41501287]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (Grant Nos. 41361060 and 41501287).	Barton AP, 2004, AGR ECOSYST ENVIRON, V104, P343, DOI 10.1016/j.agee.2004.01.034; Bosch DD, 1999, T ASAE, V42, P337, DOI 10.13031/2013.13365; Bronstert A, 2007, RIVER RES APPL, V23, P1102, DOI 10.1002/rra.1036; Chang HJ, 2008, GEOGR COMPASS, V2, P1549, DOI 10.1111/j.1749-8198.2008.00136.x; Czarnes S, 2000, EUR J SOIL SCI, V51, P435, DOI 10.1046/j.1365-2389.2000.00327.x; Fang NF, 2012, CATENA, V99, P1, DOI 10.1016/j.catena.2012.07.004; Flury M, 2003, REV GEOPHYS, V41, DOI 10.1029/2001RG000109; Fu ZY, 2012, HYDROL PROCESS, V26, P2248, DOI 10.1002/hyp.8331; Fu ZY, 2011, GEODERMA, V167-68, P41, DOI 10.1016/j.geoderma.2011.08.013; Fullen MA, 2006, SOIL TILL RES, V89, P122, DOI 10.1016/j.still.2005.07.003; Ghestem M, 2011, BIOSCIENCE, V61, P869, DOI 10.1525/bio.2011.61.11.6; Grismer ME, 2005, LAND DEGRAD DEV, V16, P489, DOI 10.1002/ldr.679; Gyssels G, 2005, PROG PHYS GEOG, V29, P189, DOI 10.1191/0309133305pp443ra; Gyssels G, 2003, EARTH SURF PROC LAND, V28, P371, DOI 10.1002/esp.447; Karamesouti M, 2015, CATENA, V132, P45, DOI 10.1016/j.catena.2015.04.010; KIRKBY M, 1988, J HYDROL, V100, P315, DOI 10.1016/0022-1694(88)90190-4; Leh MD, 2008, HYDROL PROCESS, V22, P4190, DOI 10.1002/hyp.7021; Li XY, 2011, CATENA, V86, P98, DOI 10.1016/j.catena.2011.03.003; Li XH, 2011, PEDOSPHERE, V21, P238, DOI 10.1016/S1002-0160(11)60123-9; Li Z, 2016, EURASIP J WIREL COMM, DOI 10.1186/s13638-016-0554-z; Liang Y, 2010, J MT SCI-ENGL, V7, P92, DOI 10.1007/s11629-010-1052-0; Liu YJ, 2016, J HYDROL, V539, P457, DOI 10.1016/j.jhydrol.2016.05.058; Mueller EN, 2014, PATTERNS LAND DEGRAD, P1; Niehoff D, 2002, J HYDROL, V267, P80, DOI 10.1016/S0022-1694(02)00142-7; Nouwakpo SK, 2012, SOIL SCI SOC AM J, V76, P1197, DOI 10.2136/sssaj2012.0013; Peng T, 2012, CATENA, V90, P53, DOI 10.1016/j.catena.2011.11.001; Rahma AE, 2017, AGR FOREST METEOROL, V232, P141, DOI 10.1016/j.agrformet.2016.07.015; REGANOLD JP, 1987, NATURE, V330, P370, DOI 10.1038/330370a0; Shi ZH, 2013, SOIL SCI SOC AM J, V77, P257, DOI 10.2136/sssaj2012.0273; SKLASH MG, 1986, WATER RESOUR RES, V22, P1273, DOI 10.1029/WR022i008p01273; Smets T, 2008, EARTH-SCI REV, V89, P1, DOI 10.1016/j.earscirev.2008.04.001; Souchere V, 2003, ENVIRON SCI POLICY, V6, P7, DOI 10.1016/S1462-9011(02)00121-1; Sun L, 2016, BIOSYST ENG, V147, P238, DOI 10.1016/j.biosystemseng.2016.04.017; Tang JL, 2012, J MT SCI-ENGL, V9, P1, DOI 10.1007/s11629-012-2199-7; Valentin C, 2005, CATENA, V63, P132, DOI 10.1016/j.catena.2005.06.001; Wei W, 2007, J HYDROL, V335, P247, DOI 10.1016/j.jhydrol.2006.11.016; Wongsa S, 2004, HYDROL PROCESS, V18, P1837, DOI 10.1002/hyp.1450; [谢颂华 Xie Songhua], 2015, [水科学进展, Advances in Water Science], V26, P526; Yang DW, 2003, HYDROL PROCESS, V17, P2913, DOI 10.1002/hyp.1441; Yu Y, 2016, J HYDROL, V538, P667, DOI 10.1016/j.jhydrol.2016.04.060; Zhang GH, 2015, J MT SCI-ENGL, V12, P1281, DOI 10.1007/s11629-014-3152-8; Zheng FL, 2000, SOIL SCI SOC AM J, V64, P4, DOI 10.2136/sssaj2000.6414; Zheng FL, 2004, J ENVIRON QUAL, V33, P2174, DOI 10.2134/jeq2004.2174; Zheng H, 2008, J HYDROL, V356, P174, DOI 10.1016/j.jhydrol.2008.04.007	44	9	14	7	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2017	12	8							e0182706	10.1371/journal.pone.0182706	http://dx.doi.org/10.1371/journal.pone.0182706			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9EU	28792507	Green Published, gold, Green Submitted			2022-12-26	WOS:000407144700036
J	Lee, D; Yun, S; Jang, C; Park, HJ				Lee, Dongha; Yun, Sungjae; Jang, Changwon; Park, Hae-Jeong			Multivariate Bayesian decoding of single-trial event-related fMRI responses for memory retrieval of voluntary actions	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; FUNCTIONAL MAGNETIC-RESONANCE; REAL-TIME FMRI; HUMAN BRAIN; PATTERN-ANALYSIS; EPISODIC MEMORY; CLASSIFICATION; CORTEX; INFORMATION; ACTIVATION	This study proposes a method for classifying event-related fMRI responses in a specialized setting of many known but few unknown stimuli presented in a rapid event-related design. Compared to block design fMRI signals, classification of the response to a single or a few stimulus trial(s) is not a trivial problem due to contamination by preceding events as well as the low signal-to-noise ratio. To overcome such problems, we proposed a single trial-based classification method of rapid event-related fMRI signals utilizing sparse multivariate Bayesian decoding of spatio-temporal fMRI responses. We applied the proposed method to classification of memory retrieval processes for two different classes of episodic memories: a voluntarily conducted experience and a passive experience induced by watching a video of others' actions. A cross-validation showed higher classification performance of the proposed method compared to that of a support vector machine or of a classifier based on the general linear model. Evaluation of classification performances for one, two, and three stimuli from the same class and a correlation analysis between classification accuracy and target stimulus positions among trials suggest that presenting two target stimuli at longer inter-stimulus intervals is optimal in the design of classification experiments to identify the target stimuli. The proposed method for decoding subject-specific memory retrieval of voluntary behavior using fMRI would be useful in forensic applications in a natural environment, where many known trials can be extracted from a simulation of everyday tasks and few target stimuli from a crime scene.	[Lee, Dongha] Univ Coimbra, Fac Psychol & Educ Sci, Coimbra, Portugal; [Lee, Dongha; Park, Hae-Jeong] Yonsei Univ, Inst Human Complex & Syst Sci, Ctr Syst & Translat Brain Sci, Seoul, South Korea; [Yun, Sungjae; Jang, Changwon; Park, Hae-Jeong] Yonsei Univ, Coll Med, PLUS Project Med Sci BK21, Seoul, South Korea; [Park, Hae-Jeong] Yonsei Univ, Coll Med, Dept Nucl Med, Seoul, South Korea; [Park, Hae-Jeong] Yonsei Univ, Dept Cognit Sci, Seoul, South Korea	Universidade de Coimbra; Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University	Park, HJ (corresponding author), Yonsei Univ, Inst Human Complex & Syst Sci, Ctr Syst & Translat Brain Sci, Seoul, South Korea.; Park, HJ (corresponding author), Yonsei Univ, Coll Med, PLUS Project Med Sci BK21, Seoul, South Korea.; Park, HJ (corresponding author), Yonsei Univ, Coll Med, Dept Nucl Med, Seoul, South Korea.; Park, HJ (corresponding author), Yonsei Univ, Dept Cognit Sci, Seoul, South Korea.	parkhj@yonsei.ac.kr		Park, Hae-Jeong/0000-0002-4633-0756; LEE, DONGHA/0000-0001-8316-2141	National Research Foundation of Korea (NRF) - Korean government (MSIP) [2014R1A2A1A10052762]	National Research Foundation of Korea (NRF) - Korean government (MSIP)	This work was supported by a grant from the National Research Foundation of Korea (NRF), funded by the Korean government (MSIP) (No. 2014R1A2A1A10052762;https://www.nrf.re.kr).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson P, 2013, BRAIN TOPOGR, V26, P177, DOI 10.1007/s10548-012-0252-z; Bonnici HM, 2012, HIPPOCAMPUS, V22, P1143, DOI 10.1002/hipo.20960; Chadwick MJ, 2014, P NATL ACAD SCI USA, V111, P10720, DOI 10.1073/pnas.1319641111; Chadwick MJ, 2012, NEUROPSYCHOLOGIA, V50, P3107, DOI 10.1016/j.neuropsychologia.2012.07.007; Chadwick MJ, 2010, CURR BIOL, V20, P544, DOI 10.1016/j.cub.2010.01.053; Chen QJ, 2016, CEREB CORTEX, V26, P1609, DOI 10.1093/cercor/bhu328; Christ SE, 2009, CEREB CORTEX, V19, P1557, DOI 10.1093/cercor/bhn189; Connolly AC, 2012, J NEUROSCI, V32, P2608, DOI 10.1523/JNEUROSCI.5547-11.2012; Conway MA, 2009, NEUROPSYCHOLOGIA, V47, P2305, DOI 10.1016/j.neuropsychologia.2009.02.003; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; De Martino F, 2008, NEUROIMAGE, V43, P44, DOI 10.1016/j.neuroimage.2008.06.037; Diana RA, 2008, HIPPOCAMPUS, V18, P536, DOI 10.1002/hipo.20433; Etzel JA, 2011, NEUROIMAGE, V54, P1159, DOI 10.1016/j.neuroimage.2010.08.050; Etzel JA, 2009, BRAIN RES, V1282, P114, DOI 10.1016/j.brainres.2009.05.090; FitzGerald THB, 2012, J NEUROSCI, V32, P16417, DOI 10.1523/JNEUROSCI.3254-12.2012; Friston KJ, 2008, NEUROIMAGE, V39, P181, DOI 10.1016/j.neuroimage.2007.08.013; Friston KJ, 2006, HUM BRAIN MAPP, V27, P722, DOI 10.1002/hbm.20214; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Ganis G, 2011, NEUROIMAGE, V55, P312, DOI 10.1016/j.neuroimage.2010.11.025; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Hakun JG, 2009, SOC NEUROSCI-UK, V4, P518, DOI 10.1080/17470910802188370; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2007, CURR BIOL, V17, P323, DOI 10.1016/j.cub.2006.11.072; Janoos F, 2011, NEUROIMAGE, V57, P362, DOI 10.1016/j.neuroimage.2011.03.047; Jin B, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S9-S15; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kriegeskorte N, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.004.2008; LaConte SM, 2007, HUM BRAIN MAPP, V28, P1033, DOI 10.1002/hbm.20326; Langleben DD, 2002, NEUROIMAGE, V15, P727, DOI 10.1006/nimg.2001.1003; Morcom AM, 2012, NEUROIMAGE, V59, P1772, DOI 10.1016/j.neuroimage.2011.08.071; Mumford JA, 2014, NEUROIMAGE, V103, P130, DOI 10.1016/j.neuroimage.2014.09.026; Mumford JA, 2012, NEUROIMAGE, V59, P2636, DOI 10.1016/j.neuroimage.2011.08.076; Mur M, 2009, SOC COGN AFFECT NEUR, V4, P101, DOI 10.1093/scan/nsn044; Park CH, 2015, NEUROIMAGE, V113, P101, DOI 10.1016/j.neuroimage.2015.03.033; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Phillips C, 2002, NEUROIMAGE, V16, P678, DOI 10.1006/nimg.2002.1143; Reddy L, 2010, NEUROIMAGE, V50, P818, DOI 10.1016/j.neuroimage.2009.11.084; Schacter DL, 2007, PHILOS T R SOC B, V362, P773, DOI 10.1098/rstb.2007.2087; Sitaram R, 2010, NEUROIMAGE; TULVING E, 1973, PSYCHOL REV, V80, P352, DOI 10.1037/h0020071	41	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0182657	10.1371/journal.pone.0182657	http://dx.doi.org/10.1371/journal.pone.0182657			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28777830	Green Published, Green Submitted, gold			2022-12-26	WOS:000406944300048
J	Zhang, YQ; Deng, RY; Yang, X; Xu, W; Liu, Y; Li, FY; Zhang, J; Tang, HJ; Ji, XY; Bi, YF; Wang, X; Zhou, LB; Ning, G				Zhang, Yuqing; Deng, Ruyuan; Yang, Xue; Xu, Wan; Liu, Yun; Li, Fengying; Zhang, Juan; Tang, Hongju; Ji, Xueying; Bi, Yufang; Wang, Xiao; Zhou, Libin; Ning, Guang			Glucose potentiates beta-cell function by inducing Tph1 expression in rat islets	FASEB JOURNAL			English	Article						tryptophan hydroxylase 1; islet function; serotonin; diabetes	INSULIN-SECRETION; PANCREATIC-ISLETS; SEROTONIN; GROWTH; PREGNANCY; RELEASE; PROLIFERATION; DYSFUNCTION; GLUCOKINASE; HOMEOSTASIS	Impaired pancreatic beta-cell function is the primary defect in type 2 diabetes. Glucose is an important regulator of b-cell growth and function; however, the mechanisms that are involved in the chronic adaptation of beta cells to hyperglycemia remain largely unknown. In the present study, global gene expression patterns revealed that tryptophan hydroxylase 1 (Tph1) was the most profound of genes that are up-regulated in rat islets exposed to high glucose. Calcium and cAMP signals synergistically mediated glucose-stimulated Tph1 transcription in b cells by activating cAMP-responsive element-binding protein and promoting its binding with a Tph1 promoter. Similar to in vitro results, in vivo infusion of high glucose also strongly induced Tph1 expression and serotonin production in rat islets, along with enhanced islet function. Inhibition or knockdown of Tph1 markedly decreased glucose-potentiated insulin secretion. In contrast, overexpression of Tph1 augmented glucose-stimulated insulin secretion in rat islets by up-regulating the expression of genes that are related to islet function. In addition, the long-acting glucagon-like peptide 1 receptor agonist, exendin-4, stimulated Tph1 expression in a glucose-dependent manner. Knockdown of Tph1 inhibited exendin-4-potentiated insulin secretion in rat islets. These findings suggest that Tph1 mediates the compensation of islet function induced by glucose, and that promoting Tph1 expression in pancreatic b cells will provide a new strategy for the treatment of type 2 diabetes mellitus.	[Zhang, Yuqing; Deng, Ruyuan; Yang, Xue; Xu, Wan; Liu, Yun; Li, Fengying; Zhang, Juan; Tang, Hongju; Ji, Xueying; Bi, Yufang; Wang, Xiao; Zhou, Libin; Ning, Guang] Shanghai Jiao Tong Univ, Dept Endocrine & Metab Dis, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis,Sch Med,Ruiji, 197 Ruijin Rd 2, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University	Wang, X; Zhou, LB (corresponding author), Shanghai Jiao Tong Univ, Dept Endocrine & Metab Dis, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis,Sch Med,Ruiji, 197 Ruijin Rd 2, Shanghai 200025, Peoples R China.	wangxiao1976@hotmail.com; libinzhou99@hotmail.com		Yuqing, Zhang/0000-0002-3485-4202	National Natural Science Foundation of China [81570693, 81400768, 81370876, 81471030, 81270910, 81170720]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (81570693, 81400768, 81370876, 81471030, 81270910, and 81170720). The authors thank Dr. Guangwu Xu (Oregon Health and Science University, Portland, OR, USA) for technical assistance.	Adeghate Ernest, 1999, Neuro Endocrinol Lett, V20, P315; Ahren B, 2005, CURR MOL MED, V5, P275, DOI 10.2174/1566524053766004; Amireault P, 2013, ACS CHEM NEUROSCI, V4, P64, DOI 10.1021/cn300154j; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Berglund ED, 2013, J CLIN INVEST, V123, P5061, DOI 10.1172/JCI70338; Bonner-Weir S, 2000, ENDOCRINOLOGY, V141, P1926, DOI 10.1210/en.141.6.1926; BONNERWEIR S, 1994, TRENDS ENDOCRIN MET, V5, P60, DOI 10.1016/1043-2760(94)90003-5; Brouwers B, 2014, CELL METAB, V20, P979, DOI 10.1016/j.cmet.2014.11.004; Buteau J, 1999, DIABETOLOGIA, V42, P856, DOI 10.1007/s001250051238; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; CHARLES MA, 1973, SCIENCE, V179, P569, DOI 10.1126/science.179.4073.569; Cornu M, 2010, J BIOL CHEM, V285, P10538, DOI 10.1074/jbc.M109.091116; Crane JD, 2015, NAT MED, V21, P166, DOI 10.1038/nm.3766; Deeney JT, 2000, SEMIN CELL DEV BIOL, V11, P267, DOI 10.1006/scdb.2000.0175; Donelan MJ, 2002, J BIOL CHEM, V277, P24232, DOI 10.1074/jbc.M203345200; Drucker DJ, 2015, DIABETES, V64, P317, DOI 10.2337/db14-1514; Filler G, 2000, NEPHROL DIAL TRANSPL, V15, P867, DOI 10.1093/ndt/15.6.867; Franklin IK, 2004, J GEN PHYSIOL, V123, P185, DOI 10.1085/jgp.200409016; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Hinke SA, 2004, J PHYSIOL-LONDON, V558, P369, DOI 10.1113/jphysiol.2004.064881; Holst Jens Juul, 2004, Expert Opin Emerg Drugs, V9, P155, DOI 10.1517/14728214.9.1.155; Hoorens A, 1996, J CLIN INVEST, V98, P1568, DOI 10.1172/JCI118950; Hui HX, 2003, ENDOCRINOLOGY, V144, P1444, DOI 10.1210/en.2002-220897; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Johnson D, 2007, DIABETES, V56, P1694, DOI 10.2337/db07-0026; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; Lingohr MK, 2006, J BIOL CHEM, V281, P15884, DOI 10.1074/jbc.M600356200; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Nesher R, 2002, DIABETES, V51, pS53, DOI 10.2337/diabetes.51.2007.S53; Odagiri H, 1996, J BIOL CHEM, V271, P1909, DOI 10.1074/jbc.271.4.1909; Ohara-Imaizumi M, 2013, P NATL ACAD SCI USA, V110, P19420, DOI 10.1073/pnas.1310953110; Ohta Y, 2011, DIABETES, V60, P3208, DOI 10.2337/db10-1192; Park S, 2006, J BIOL CHEM, V281, P1159, DOI 10.1074/jbc.M508307200; Path G, 2004, DIABETES, V53, pS82, DOI 10.2337/diabetes.53.2007.S82; Paulmann N, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000229; Peschke E, 1997, J PINEAL RES, V23, P156, DOI 10.1111/j.1600-079X.1997.tb00349.x; Poitout V, 2006, J NUTR, V136, P873, DOI 10.1093/jn/136.4.873; Porat S, 2011, CELL METAB, V13, P440, DOI 10.1016/j.cmet.2011.02.012; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Schraenen A, 2010, DIABETOLOGIA, V53, P2589, DOI 10.1007/s00125-010-1913-7; Shi YC, 2015, ENDOCRINOLOGY, V156, P3122, DOI 10.1210/en.2015-1168; Tengholm A, 2012, UPSALA J MED SCI, V117, P355, DOI 10.3109/03009734.2012.724732; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Wang WD, 2009, P NATL ACAD SCI USA, V106, P1427, DOI 10.1073/pnas.0811848106; Wierup N, 2006, DIABETES, V55, P305, DOI 10.2337/diabetes.55.02.06.db04-1383; Wu L, 2012, BBA-MOL BASIS DIS, V1822, P1815, DOI 10.1016/j.bbadis.2012.08.009; Wuttke A, 2015, BASIC CLIN PHARMACOL, V116, P281, DOI 10.1111/bcpt.12369; Zawalich WS, 2001, J BIOL CHEM, V276, P37120, DOI 10.1074/jbc.M105008200; Zhang HL, 2012, ENDOCRINOLOGY, V153, P602, DOI 10.1210/en.2011-1460	53	11	13	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5342	5355		10.1096/fj.201700351R	http://dx.doi.org/10.1096/fj.201700351R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28794173				2022-12-26	WOS:000416588300019
J	Guerrero, PA; Tchaicha, JH; Chen, Z; Morales, JE; McCarty, N; Wang, Q; Sulman, EP; Fuller, G; Lang, FF; Rao, G; McCarty, JH				Guerrero, P. A.; Tchaicha, J. H.; Chen, Z.; Morales, J. E.; McCarty, N.; Wang, Q.; Sulman, E. P.; Fuller, G.; Lang, F. F.; Rao, G.; McCarty, J. H.			Glioblastoma stem cells exploit the alpha v beta 8 integrin-TGF beta 1 signaling axis to drive tumor initiation and progression	ONCOGENE			English	Article							GROWTH-FACTOR-BETA; ANTI-VEGF THERAPY; TGF-BETA; INTEGRIN ALPHA-V-BETA-8; ANTIANGIOGENIC THERAPY; CEREBRAL-HEMORRHAGE; SELF-RENEWAL; BRAIN; CANCER; EXPRESSION	Glioblastoma (GBM) is a primary brain cancer that contains populations of stem-like cancer cells (GSCs) that home to specialized perivascular niches. GSC interactions with their niche influence self-renewal, differentiation and drug resistance, although the pathways underlying these events remain largely unknown. Here, we report that the integrin alpha v beta 8 and its latent transforming growth factor beta 1 (TGF beta 1) protein ligand have central roles in promoting niche co-option and GBM initiation. alpha v beta 8 integrin is highly expressed in GSCs and is essential for self-renewal and lineage commitment in vitro. Fractionation of beta 8(high) cells from freshly resected human GBM samples also reveals a requirement for this integrin in tumorigenesis in vivo. Whole-transcriptome sequencing reveals that alpha v beta 8 integrin regulates tumor development, in part, by driving TGF beta 1-induced DNA replication and mitotic checkpoint progression. Collectively, these data identify the av beta 8 integrin-TGF beta 1 signaling axis as crucial for exploitation of the perivascular niche and identify potential therapeutic targets for inhibiting tumor growth and progression in patients with GBM.	[Guerrero, P. A.; Tchaicha, J. H.; Chen, Z.; Morales, J. E.; Lang, F. F.; Rao, G.; McCarty, J. H.] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, 1515 Holcombe Blvd,Unit 1004, Houston, TX 77030 USA; [McCarty, N.] Univ Texas Hlth Sci Ctr Houston, Brown Inst Mol Med, Houston, TX 77030 USA; [Wang, Q.; Sulman, E. P.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Wang, Q.; Sulman, E. P.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Sulman, E. P.] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Fuller, G.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	McCarty, JH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, 1515 Holcombe Blvd,Unit 1004, Houston, TX 77030 USA.	jhmccarty@mdanderson.org		Sulman, Erik/0000-0003-4933-9120	NIH/NINDS [R01NS0 7635, R01NS078402]; Cancer Prevention and Research Institute of Texas [RP140411]; NIH/NCI SPORE in Brain Cancer [P50CA127001]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA127001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078402, R01NS094615, R01NS087635] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Cancer Prevention and Research Institute of Texas; NIH/NCI SPORE in Brain Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank colleagues in the M.D. Anderson Neurosurgery department for providing freshly resected human samples. This work was supported by grants to JHM from NIH/NINDS (R01NS0 7635 and R01NS078402), the Cancer Prevention and Research Institute of Texas (RP140411), and in part by an NIH/NCI SPORE in Brain Cancer (P50CA127001).	Allinson KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039336; Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023; Arnold TD, 2014, DEVELOPMENT, V141, P4489, DOI 10.1242/dev.107193; Arnold TD, 2012, J NEUROSCI, V32, P1197, DOI 10.1523/JNEUROSCI.5648-11.2012; Arrillaga-Romany I, 2014, EXPERT OPIN INV DRUG, V23, P199, DOI 10.1517/13543784.2014.856880; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Batchelor TT, 2014, CLIN CANCER RES, V20, P5612, DOI 10.1158/1078-0432.CCR-14-0834; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Cambier S, 2005, AM J PATHOL, V166, P1883, DOI 10.1016/S0002-9440(10)62497-2; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Cheerathodi M, 2016, MOL CANCER RES, V14, P1277, DOI 10.1158/1541-7786.MCR-16-0251; Dardiotis E, 2017, NEUROMOL MED, V19, P69, DOI 10.1007/s12017-016-8429-3; Delamarre E, 2009, AM J PATHOL, V175, P844, DOI 10.2353/ajpath.2009.080920; Ding Y, 2013, CANCER DISCOV, V3, P198, DOI 10.1158/2159-8290.CD-12-0353; Ellis LM, 2009, NATURE, V458, P290, DOI 10.1038/458290a; Fang L, 2011, ONCOGENE, V30, P806, DOI 10.1038/onc.2010.465; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Frei K, 2015, ONCOTARGET, V6, P5963, DOI 10.18632/oncotarget.3467; Gilbert MR, 2012, J NEURO-ONCOL, V106, P147, DOI 10.1007/s11060-011-0650-1; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Hamidi H, 2016, BRIT J CANCER, V115, P1017, DOI 10.1038/bjc.2016.312; Hirota S, 2015, DEVELOPMENT, V142, P4363, DOI 10.1242/dev.113746; Hirota S, 2011, DEVELOPMENT, V138, P5157, DOI 10.1242/dev.069153; Huang JJ, 2016, BIOCHEM SOC T, V44, P1441, DOI 10.1042/BST20160065; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Jahangiri A, 2013, CLIN CANCER RES, V19, P1773, DOI 10.1158/1078-0432.CCR-12-1281; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Kanamori M, 2004, CANCER RES, V64, P2751, DOI 10.1158/0008-5472.CAN-03-3354; Lathia JD, 2015, GENE DEV, V29, P1203, DOI 10.1101/gad.261982.115; Lathia JD, 2010, CELL STEM CELL, V6, P421, DOI 10.1016/j.stem.2010.02.018; Lee HS, 2015, MOL CELL BIOL, V35, P1401, DOI 10.1128/MCB.00112-15; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Lu KV, 2012, CANCER CELL, V22, P21, DOI 10.1016/j.ccr.2012.05.037; Ma L, 2016, TRANSL STROKE RES, V7, P488, DOI 10.1007/s12975-016-0478-2; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; McCarty JH, 2002, MOL CELL BIOL, V22, P7667, DOI 10.1128/MCB.22.21.7667-7677.2002; McCarty JH, 2013, CLIN CANCER RES, V19, P1631, DOI 10.1158/1078-0432.CCR-13-0051; McCarty JH, 2009, CURR OPIN HEMATOL, V16, P209, DOI 10.1097/MOH.0b013e32832a07eb; Ming XY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13568; Mobley AK, 2011, GLIA, V59, P1579, DOI 10.1002/glia.21199; Mobley AK, 2009, J CELL SCI, V122, P1842, DOI 10.1242/jcs.043257; Nakajima H, 2008, J CELL BIOL, V181, P89, DOI 10.1083/jcb.200708176; Nguyen HL, 2011, LAB INVEST, V91, P1554, DOI 10.1038/labinvest.2011.124; NISHIMURA SL, 1994, J BIOL CHEM, V269, P28708; Nyati S, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005379; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Penuelas S, 2009, CANCER CELL, V15, P315, DOI 10.1016/j.ccr.2009.02.011; Piao Y, 2013, CLIN CANCER RES, V19, P4392, DOI 10.1158/1078-0432.CCR-12-1557; Proctor JM, 2005, J NEUROSCI, V25, P9940, DOI 10.1523/JNEUROSCI.3467-05.2005; Reyes SB, 2013, MOL BIOL CELL, V24, P474, DOI 10.1091/mbc.E12-07-0521; Robertson IB, 2016, COLD SPRING HARB PER, V8, P6; Rojas A, 2009, BBA-MOL CELL RES, V1793, P1165, DOI 10.1016/j.bbamcr.2009.02.001; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Sathyan P, 2015, J NEUROSCI, V35, P15097, DOI 10.1523/JNEUROSCI.1265-15.2015; Schittenhelm J, 2013, INT J CLIN EXP PATHO, V6, P2719; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Su H, 2010, AM J PATHOL, V176, P1018, DOI 10.2353/ajpath.2010.090453; Tchaicha JH, 2010, ONCOGENE, V29, P4460, DOI 10.1038/onc.2010.199; Tchaicha JH, 2011, CANCER RES, V71, P6371, DOI 10.1158/0008-5472.CAN-11-0991; Toledo CM, 2015, CELL REP, V13, P2425, DOI 10.1016/j.celrep.2015.11.021; Upadhyaya M, 2012, HUM MUTAT, V33, P763, DOI 10.1002/humu.22044; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; VENSTROM K, 1995, MOL BIOL CELL, V6, P419, DOI 10.1091/mbc.6.4.419; Wee B, 2016, SCI REP-UK, V6, DOI 10.1038/srep25956; Wei J, 2010, CLIN CANCER RES, V16, P461, DOI 10.1158/1078-0432.CCR-09-1983; Weis SM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006478; Worthington JJ, 2011, TRENDS BIOCHEM SCI, V36, P47, DOI 10.1016/j.tibs.2010.08.002; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	69	31	31	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 23	2017	36	47					6568	6580		10.1038/onc.2017.248	http://dx.doi.org/10.1038/onc.2017.248			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FN5LN	28783169	Green Accepted			2022-12-26	WOS:000416049200006
J	Lamothe, SM; Song, W; Guo, J; Li, WT; Yang, TH; Baranchuk, A; Graham, CH; Zhang, ST				Lamothe, Shawn M.; Song, WonJu; Guo, Jun; Li, Wentao; Yang, Tonghua; Baranchuk, Adrian; Graham, Charles H.; Zhang, Shetuan			Hypoxia reduces mature hERG channels through calpain up-regulation	FASEB JOURNAL			English	Article						heart; ion channel regulation; LQTS; proteases	CELL-SURFACE EXPRESSION; HIPPEL-LINDAU PROTEIN; INDUCIBLE FACTOR-I; POTASSIUM CHANNEL; K+ CHANNELS; CARDIAC-ARRHYTHMIA; DIRECT BINDING; SLEEP-APNEA; KR; ISCHEMIA	Human ether-a-go-go-related gene (hERG) encodes the pore-forming subunit of the rapidly activating delayed rectifier potassium current (IKr) potassium channel, which is important for cardiac repolarization. Impairment of hERG function is the primary cause of acquired long QT syndrome, which predisposes individuals to cardiac arrhythmias and sudden death. Patients with hypoxia due to conditions such as cardiac ischemia or obstructive sleep apnea display increased incidence of cardiac arrhythmias and sudden death. We sought to understand the mechanisms that underlie hypoxia-associated cardiac arrhythmias. Using cell biology and electrophysiologic techniques, we found that hypoxic culture of hERG-expressing human embryonic kidney (HEK) cells and neonatal rat cardiomyocytes reduced hERGcurrent/IKr andmature ERGchannel expressionwith a concomitant increase in calpain expression. Calpainwas actively released into the extracellularmilieu and degraded cell-surface hERG. In contrast to hERG, the ether-a-go-go (EAG) channel was not reduced by hypoxic culture. By making chimeric channels between hERG and EAG, we identified that hypoxia-induced calpain degraded hERG by targeting its extracellular S5-pore linker. The scorpion toxin BeKm-1, which is known to selectively bind to the S5-pore linker of hERG, prevented hypoxia-induced hERG reduction. Our data provide novel information about hypoxia-mediated hERG dysfunction and may have biological and clinical implications in hypoxia-associated diseases.-Lamothe, S. M., Song, W., Guo, J., Li, W., Yang, T., Baranchuk, A., Graham, C. H., Zhang, S. Hypoxia reduces mature hERG channels through calpain up-regulation.	[Lamothe, Shawn M.; Song, WonJu; Guo, Jun; Li, Wentao; Yang, Tonghua; Graham, Charles H.; Zhang, Shetuan] Queens Univ, Kingston Gen Hosp, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Baranchuk, Adrian] Queens Univ, Kingston Gen Hosp, Dept Med, Kingston, ON, Canada	Queens University - Canada; Queens University - Canada	Zhang, ST (corresponding author), Queens Univ, Dept Biomed & Mol Sci, 18 Stuart St, Kingston, ON K7L 3N6, Canada.	shetuan.zhang@queensu.ca		Zhang, Shetuan/0000-0002-2297-0193; Lamothe, Shawn/0000-0001-8722-2631	Canadian Institutes of Health Research [MOP 72911]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported, in part, by Canadian Institutes of Health Research Grant MOP 72911 (to S.Z.). The authors declare no conflicts of interest.	ALLSHIRE A, 1987, BIOCHEM J, V244, P381, DOI 10.1042/bj2440381; Ardyanto TD, 2006, INT J ONCOL, V29, P549; Baranchuk A, 2012, J ELECTROCARDIOL, V45, P508, DOI 10.1016/j.jelectrocard.2012.03.003; Ben-Yosef Y, 2002, CIRC RES, V90, P784, DOI 10.1161/01.RES.0000015588.70132.DC; Bradley TD, 2009, LANCET, V373, P82, DOI 10.1016/S0140-6736(08)61622-0; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Culver C, 2010, MOL CELL BIOL, V30, P4901, DOI 10.1128/MCB.00409-10; Fan JS, 1999, BIOPHYS J, V76, P3128, DOI 10.1016/S0006-3495(99)77464-3; Ficker E, 1998, CIRC RES, V82, P386, DOI 10.1161/01.RES.82.3.386; Fontana L, 2001, BIOCHEM BIOPH RES CO, V286, P857, DOI 10.1006/bbrc.2001.5464; Frangie C, 2006, J BIOL CHEM, V281, P26624, DOI 10.1074/jbc.M603007200; Gille T, 2014, AM J RESP CELL MOL, V50, P526, DOI 10.1165/rcmb.2012-0518OC; Gong QM, 2002, AM J PHYSIOL-HEART C, V283, pH77, DOI 10.1152/ajpheart.00008.2002; Guo J, 2007, J PHARMACOL EXP THER, V321, P911, DOI 10.1124/jpet.107.120931; Guo J, 2012, J BIOL CHEM, V287, P33132, DOI 10.1074/jbc.M112.389643; Hamanaka RB, 2009, CURR OPIN CELL BIOL, V21, P894, DOI 10.1016/j.ceb.2009.08.005; Hool LC, 2004, J PHYSIOL-LONDON, V554, P743, DOI 10.1113/jphysiol.2003.055442; JANSE MJ, 1989, PHYSIOL REV, V69, P1049, DOI 10.1152/physrev.1989.69.4.1049; Kenigsberg DN, 2007, J AM COLL CARDIOL, V49, P1299, DOI 10.1016/j.jacc.2006.11.035; Lamothe SM, 2016, J BIOL CHEM, V291, P20387, DOI 10.1074/jbc.M116.743138; Letavernier B, 2012, ARTERIOSCL THROM VAS, V32, P335, DOI 10.1161/ATVBAHA.111.240242; Maurer E, 2012, BIOL CHEM, V393, P535, DOI 10.1515/hsz-2011-0221; Mehra R, 2009, ARCH INTERN MED, V169, P1147, DOI 10.1001/archinternmed.2009.138; Mehta JL, 1999, CARDIOVASC RES, V43, P291, DOI 10.1016/S0008-6363(99)00132-7; Nanduri J, 2008, BIOCHEM BIOPH RES CO, V373, P309, DOI 10.1016/j.bbrc.2008.06.028; Nanduri J, 2009, BIOCHEM BIOPH RES CO, V388, P212, DOI 10.1016/j.bbrc.2009.07.149; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; Perez J, 2016, J IMMUNOL, V196, P168, DOI 10.4049/jimmunol.1500749; Radisky DC, 2009, NAT REV MOL CELL BIO, V10, P228, DOI 10.1038/nrm2633; Rajamani S, 2006, AM J PHYSIOL-HEART C, V290, pH1278, DOI 10.1152/ajpheart.00777.2005; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Shamsuzzaman AS, 2015, SLEEP, V38, P1113, DOI 10.5665/sleep.4824; Shimoda LA, 2011, AM J PHYSIOL-CELL PH, V300, pC951, DOI 10.1152/ajpcell.00512.2010; Svoboda LK, 2012, CIRC RES, V111, P842, DOI 10.1161/CIRCRESAHA.111.263525; Taglialatela M, 1997, P NATL ACAD SCI USA, V94, P11698, DOI 10.1073/pnas.94.21.11698; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Tseng GN, 2007, BIOPHYS J, V92, P3524, DOI 10.1529/biophysj.106.097360; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang N, 2016, AM J PHYSIOL-CELL PH, V310, pC329, DOI 10.1152/ajpcell.00231.2015; Xu LJ, 2004, J BIOL CHEM, V279, P53683, DOI 10.1074/jbc.M409889200; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200; Zeidan-Shwiri T, 2011, HEART RHYTHM, V8, P657, DOI 10.1016/j.hrthm.2010.12.030; Zhang HL, 2013, J MOL CELL CARDIOL, V65, P51, DOI 10.1016/j.yjmcc.2013.09.002; Zhang JL, 1998, AM J PHYSIOL-LUNG C, V275, pL461, DOI 10.1152/ajplung.1998.275.3.L461; Zhang ST, 2006, AM J PHYSIOL-HEART C, V290, pH1038, DOI 10.1152/ajpheart.00679.2005; Zhao Y, 2016, HEART RHYTHM, V13, P2004, DOI 10.1016/j.hrthm.2016.06.019; Zheng XW, 2014, P NATL ACAD SCI USA, V111, P2560, DOI 10.1073/pnas.1320815111; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3	51	12	13	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2017	31	11					5068	5077		10.1096/fj.201700255R	http://dx.doi.org/10.1096/fj.201700255R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FK3PP	28784631				2022-12-26	WOS:000413398500034
J	Booiman, T; Wit, FW; Girigorie, AF; Maurer, I; De Francesco, D; Sabin, CA; Harskamp, AM; Prins, M; Franceschi, C; Deeks, SG; Winston, A; Reiss, P; Kootstra, NA				Booiman, Thijs; Wit, Ferdinand W.; Girigorie, Arginell F.; Maurer, Irma; De Francesco, Davide; Sabin, Caroline A.; Harskamp, Agnes M.; Prins, Maria; Franceschi, Claudio; Deeks, Steven G.; Winston, Alan; Reiss, Peter; Kootstra, Neeltje A.		Behalf Co-MorBidity Relation	Terminal differentiation of T cells is strongly associated with CMV infection and increased in HIV-positive individuals on ART and lifestyle matched controls	PLOS ONE			English	Article							IMMUNOGLOBULIN-G ANTIBODY; ANTIRETROVIRAL THERAPY; IMMUNE ACTIVATION; REPLICATIVE SENESCENCE; CIGARETTE-SMOKING; CYTOMEGALOVIRUS; INFLAMMATION; CD4(+); DISEASE; AGE	HIV-1-positive individuals on successful antiretroviral therapy (ART) are reported to have higher rates of age-associated non-communicable comorbidities (AANCCs). HIV-associated immune dysfunction has been suggested to contribute to increased AANCC risk. Here we performed a cross-sectional immune phenotype analysis of T cells in ART-treated HIV-1-positive individuals with undetectable vireamia (HIV-positives) and HIV-1-negative individuals (HIV-negatives) over 45 years of age. In addition, two control groups were studied: HIV-negative adults selected based on lifestyle and demographic factors (Co-morBidity in Relation to AIDS, or COBRA) and unselected age-matched donors from a blood bank. Despite long-term ART (median of 12.2 years), HIV-infected adults had lower CD4(+) T-cell counts and higher CD8+ T-cell counts compared to well-matched HIV-negative COBRA participants. The proportion of CD38(+)HLA-DR+ and PD-1(+)CD4(+) T-cells was higher in HIV-positive cohort compared to the two HIV-negative cohorts. The proportion CD57(+) and CD27(-)CD28(-)cells of both CD4(+) and CD8(+) T-cells in HIV-positives was higher compared to unselected adults (blood bank) as reported before but this difference was not apparent in comparison with well-matched HIV-negative COBRA participants. Multiple regression analysis showed that the presence of an increased proportion of terminally differentiated T cells was strongly associated with CMV infection. Compared to appropriately selected HIV-negative controls, HIV-positive individuals on ART with long-term suppressed viraemia exhibited incomplete immune recovery and increased immune activation/exhaustion. CMV infection rather than treated HIV-infection appears to have more consistent effects on measures of terminal differentiation of T cells.	[Booiman, Thijs; Girigorie, Arginell F.; Maurer, Irma; Harskamp, Agnes M.; Kootstra, Neeltje A.] Univ Amsterdam, Acad Med Ctr, Amsterdam Infect & Immun Inst, Dept Expt Immunol, Amsterdam, Netherlands; [Booiman, Thijs; Wit, Ferdinand W.; Girigorie, Arginell F.; Reiss, Peter] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Wit, Ferdinand W.; Reiss, Peter] Univ Amsterdam, Dept Global Hlth, Amsterdam, Netherlands; [Wit, Ferdinand W.; Reiss, Peter] Univ Amsterdam, Div Infect Dis, Acad Med Ctr, Amsterdam, Netherlands; [Wit, Ferdinand W.; Reiss, Peter] HIV Monitoring Fdn, Amsterdam, Netherlands; [De Francesco, Davide; Sabin, Caroline A.] UCL, Dept Infect & Populat Hlth, London, England; [Prins, Maria] Publ Hlth Serv, Amsterdam, Netherlands; [Franceschi, Claudio] Alma Mater Studiorum Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy; [Deeks, Steven G.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Winston, Alan] Imperial Coll Sci Technol & Med, London, England	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of London; University College London; Public Health Service Amsterdam; University of Bologna; University of California System; University of California San Francisco; Imperial College London	Kootstra, NA (corresponding author), Univ Amsterdam, Acad Med Ctr, Amsterdam Infect & Immun Inst, Dept Expt Immunol, Amsterdam, Netherlands.	n.a.kootstra@amc.uva.nl	Winston, Alan/AGZ-3015-2022; Sabin, Caroline/C-2464-2008; Pasternak, Alexander/P-2067-2017; Wit, Ferdinand/AAC-3803-2019	Winston, Alan/0000-0002-5847-8416; Sabin, Caroline/0000-0001-5173-2760; Pasternak, Alexander/0000-0002-4097-4251; Deeks, Steven/0000-0001-6371-747X; Kootstra, Neeltje A./0000-0001-9429-7754; De Francesco, Davide/0000-0002-6185-0514	European Union's Seventh Framework Programme for research, technological development and demonstration [305522]	European Union's Seventh Framework Programme for research, technological development and demonstration	The COBRA project has received funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no 305522. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Appay V, 2011, AIDS, V25, P1813, DOI 10.1097/QAD.0b013e32834640e6; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Breton G, 2013, J IMMUNOL, V191, P2194, DOI 10.4049/jimmunol.1200646; Brunt SJ, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/947432; Chevalier MF, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003453; Cockerham LR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110731; de Heens GLT, 2009, CYTOKINE, V47, P157, DOI 10.1016/j.cyto.2009.05.006; Deeks SG, 2013, IMMUNITY, V39, P633, DOI 10.1016/j.immuni.2013.10.001; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Deeks Steven G, 2009, Top HIV Med, V17, P118; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Dock JN, 2011, AGING DIS, V2, P382; Effros RB, 2008, CLIN INFECT DIS, V47, P542, DOI 10.1086/590150; Franceschi C, 2000, VACCINE, V18, P1717, DOI 10.1016/S0264-410X(99)00513-7; Franceschi C, 1996, NEPHROL DIAL TRANSPL, V11, P18; Freeman ML, 2016, CLIN INFECT DIS, V62, P392, DOI 10.1093/cid/civ840; Gianella S, 2014, J VIROL, V88, P7818, DOI 10.1128/JVI.00831-14; Gkrania-Klotsas E, 2012, J INFECT DIS, V206, P1897, DOI 10.1093/infdis/jis620; Grady BPX, 2016, IMMUN AGEING, V13, DOI 10.1186/s12979-016-0065-0; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Hasse B, 2011, CLIN INFECT DIS, V53, P1130, DOI 10.1093/cid/cir626; HOLT PG, 1987, THORAX, V42, P241, DOI 10.1136/thx.42.4.241; Hunt PW, 2011, J INFECT DIS, V203, P1474, DOI 10.1093/infdis/jir060; Jimenez V Cobos, 2016, J INFECT DIS; Kalayjian RC, 2003, J INFECT DIS, V187, P1924, DOI 10.1086/375372; Karim R, 2014, JAIDS-J ACQ IMM DEF, V67, P349, DOI 10.1097/QAI.0000000000000311; Klenerman P, 2016, NAT REV IMMUNOL, V16, P367, DOI 10.1038/nri.2016.38; Kooij KW, 2016, J INFECT DIS, V214, P1817, DOI 10.1093/infdis/jiw459; Le Priol Y, 2006, J IMMUNOL, V177, P5145, DOI 10.4049/jimmunol.177.8.5145; Lee SA, 2014, J INFECT DIS, V210, P374, DOI 10.1093/infdis/jiu109; Lee SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089444; Lichtner M, 2015, J INFECT DIS, V211, P178, DOI 10.1093/infdis/jiu417; Lim A, 2007, AIDS, V21, P1525, DOI 10.1097/QAD.0b013e32825eab8b; McComsey GA, 2014, JAIDS-J ACQ IMM DEF, V65, P167, DOI 10.1097/01.qai.0000437171.00504.41; Naeger DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008886; Parrinello CM, 2012, J INFECT DIS, V205, P1788, DOI 10.1093/infdis/jis276; Pathai S, 2014, J GERONTOL A-BIOL, V69, P833, DOI 10.1093/gerona/glt168; Piconi S, 2010, AIDS, V24, P1991, DOI 10.1097/QAD.0b013e32833c93ce; Roberts ET, 2010, AM J EPIDEMIOL, V172, P363, DOI 10.1093/aje/kwq177; Said EA, 2010, NAT MED, V16, P452, DOI 10.1038/nm.2106; Schouten J, 2014, CLIN INFECT DIS, V59, P1787, DOI 10.1093/cid/ciu701; Skiest DJ, 1996, AM J MED, V101, P605, DOI 10.1016/S0002-9343(96)00329-4; Staempfli MR, 2009, NAT REV IMMUNOL, V9, P377, DOI 10.1038/nri2530; Tassiopoulos K, 2012, J INFECT DIS, V205, P1730, DOI 10.1093/infdis/jis260; Tenorio AR, 2014, J INFECT DIS, V210, P1248, DOI 10.1093/infdis/jiu254; Valiathan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097698; Wada N, 2013, AM J EPIDEMIOL, V177, P116, DOI 10.1093/aje/kws321; Weber R, 2013, HIV MED, V14, P195, DOI 10.1111/j.1468-1293.2012.01051.x; Weiss L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011659; Wittkop L, 2013, J INFECT DIS, V207, P622, DOI 10.1093/infdis/jis732; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179	52	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2017	12	8							e0183357	10.1371/journal.pone.0183357	http://dx.doi.org/10.1371/journal.pone.0183357			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD5CP	28806406	Green Published, gold, Green Submitted			2022-12-26	WOS:000407548800069
J	Teng, MS; Hsu, LA; Juan, SH; Lin, WC; Lee, MC; Su, CW; Wu, S; Ko, YL				Teng, Ming-Sheng; Hsu, Lung-An; Juan, Shu-Hui; Lin, Wen-Chi; Lee, Ming-Cheng; Su, Cheng-Wen; Wu, Semon; Ko, Yu-Lin			A GDF15 3' UTR variant, rs1054564, results in allele-specific translational repression of GDF15 by hsa-miR-1233-3p	PLOS ONE			English	Article							DIFFERENTIATION FACTOR 15; CORONARY-ARTERY-DISEASE; GENOME-WIDE ASSOCIATION; SQUAMOUS-CELL CARCINOMA; MACROPHAGE INHIBITORY CYTOKINE-1; MICRORNA MAPS MIRMAPS; TGF-BETA SUPERFAMILY; CHINESE POPULATION; FUNCTIONAL SNP; HEART-FAILURE	Growth differentiation factor 15 (GDF15) is a strong predictor of cardiovascular events and mortality in individuals with or without cardiovascular diseases. Single nucleotide polymorphisms (SNPs) in microRNA (miRNA) target sites, also known as miRSNPs, are known to enhance or weaken miRNA-mRNA interactions and have been linked to diseases such as cardiovascular disease and cancer. In this study, we aimed to elucidate the functional significance of the miRSNP rs1054564 in regulating GDF15 levels. Two rs1054564-containing binding sites for hsa-miR-873-5p and hsa-miR-1233-3p were identified in the 3' untranslated region (UTR) of the GDF15 transcript using bioinformatics tools. Their activities were further characterized by in vitro reporter assays. Bioinformatics prediction suggested that miRNA binding sites harboring the rs1054564-G allele had lower free energies than those with the C allele and therefore were better targets with higher affinities for both hsa-miR-873-5p and hsa-miR-1233-3p. Reporter assays showed that luciferase activity was significantly decreased by rs1054564-G-containing 3' UTRs for both miRNAs (P < 0.05) and was restored by miRNA inhibitors. Comparing the fold suppression of the two miRNAs, only that of hsa-miR-1233-3p showed significant changes between the rs1054564-G- and C-containing 3' UTRs (P = 0.034). In addition, western blots showed that transfection of both miRNA mimics significantly decreased endogenous GDF15 expression in a melanoma cell line (P < 0.05). Taken together, our findings demonstrate that GDF15 is a target of hsa-miR873-5p and hsa-miR-1233-3p and that the rs1054564-C allele partially abolishes hsa-miR1233-3p-mediated translational suppression of GDF15. These results suggest that rs1054564 confers allele-specific translational repression of GDF15 via hsa-miR-1233-3p. Our work thus provides biological insight into the previously reported clinical association between rs1054564 and plasma GDF15 levels.	[Teng, Ming-Sheng; Lee, Ming-Cheng; Su, Cheng-Wen; Wu, Semon; Ko, Yu-Lin] Taipei Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Res, New Taipei, Taiwan; [Hsu, Lung-An] Chang Gung Mem Hosp, Dept Internal Med, Cardiovasc Div 1, Taoyuan, Taiwan; [Hsu, Lung-An] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Juan, Shu-Hui] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Dept Physiol, Taipei, Taiwan; [Lin, Wen-Chi; Wu, Semon] Chinese Culture Univ, Dept Life Sci, Taipei, Taiwan; [Ko, Yu-Lin] Buddhist Tzu Chi Med Fdn, Cardiovasc Ctr, New Taipei, Taiwan; [Ko, Yu-Lin] Buddhist Tzu Chi Med Fdn, Div Cardiol, Dept Internal Med, New Taipei, Taiwan; [Ko, Yu-Lin] Taipei Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, New Taipei, Taiwan; [Ko, Yu-Lin] Tzu Chi Univ, Sch Med, Hualien, Taiwan	Buddhist Tzu Chi General Hospital; Taipei Tzu Chi Hospital; Chang Gung Memorial Hospital; Chang Gung University; Taipei Medical University; Chinese Culture University; Buddhist Tzu Chi General Hospital; Taipei Tzu Chi Hospital; Tzu Chi University	Wu, S; Ko, YL (corresponding author), Taipei Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Res, New Taipei, Taiwan.; Wu, S (corresponding author), Chinese Culture Univ, Dept Life Sci, Taipei, Taiwan.; Ko, YL (corresponding author), Buddhist Tzu Chi Med Fdn, Cardiovasc Ctr, New Taipei, Taiwan.; Ko, YL (corresponding author), Buddhist Tzu Chi Med Fdn, Div Cardiol, Dept Internal Med, New Taipei, Taiwan.; Ko, YL (corresponding author), Taipei Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, New Taipei, Taiwan.; Ko, YL (corresponding author), Tzu Chi Univ, Sch Med, Hualien, Taiwan.	semonwu@yahoo.com.tw; yulinkotw@yahoo.com.tw		Hsu, Lung-An/0000-0002-0012-2804	Taipei Tzu Chi Hospital; Buddhist Tzu Chi Medical Foundation [TCRD-TPE-103-RT-2, TCRD-I103-01-01, TCRD-TPE-MOST-103-01, TCRD-TPE-MOST-104-09, TCRD-TPE-106-C1-1, TCRD-TPE106-RT-3, TCRD-TPE-103-22, TCRD-TPE-104-18, TCRD-TPE-106-46, TCRD-TPE-MOST-105-03]; Tzu Chi University, Hualien, Taiwan [TCMMP104-06-03]; National Science Council [MOST 104-2314-B-303-013-MY3, NSC 101-2314-B-303-023 -MY3]	Taipei Tzu Chi Hospital; Buddhist Tzu Chi Medical Foundation; Tzu Chi University, Hualien, Taiwan; National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by grants from the Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation (TCRD-TPE-103-RT-2, TCRD-I103-01-01, TCRD-TPE-MOST-103-01, TCRD-TPE-MOST-104-09, TCRD-TPE-106-C1-1, TCRD-TPE106-RT-3), a grant from the Tzu Chi University, Hualien, Taiwan (TCMMP104-06-03), a grant from the National Science Council (MOST 104-2314-B-303-013-MY3) to Y. L. Ko, and grants from the Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation (TCRD-TPE-103-22, TCRD-TPE-104-18, TCRD-TPE-106-46) to M. S. Teng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by grants from the Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation (TCRD-TPE-103-RT-2, TCRD-I103-01-01, TCRD-TPE-MOST-103-01, TCRD-TPE-MOST-104-09, TCRD-TPE-106-C1-1, TCRD-TPE-106-RT-3, TCRD-TPE-MOST-105-03); a grant from the Tzu Chi University, Hualien, Taiwan (TCMMP104-06-03); a grant from the National Science Council (MOST 104-2314-B-303-013-MY3, NSC 101-2314-B-303-023 -MY3) to Y. L. Ko; and grants from the Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation (TCRD-TPE-103-22, TCRD-TPE-104-18, TCRD-TPE-106-46) to M. S. Teng. We greatly appreciate technical support from the Core Laboratory of the Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation. We appreciate Dr. Tzung-Chieh Tsai (Department of Microbiology, Immunology and Biopharmaceuticals, National Chiayi University, Chiayi, Taiwan) supply us the Human embryonic kidney HEK293T cell line.	Ago T, 2006, CIRC RES, V98, P294, DOI 10.1161/01.RES.0000207919.83894.9d; Bao L, 2007, NUCLEIC ACIDS RES, V35, pD51, DOI 10.1093/nar/gkl797; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bauskin AR, 2005, CANCER RES, V65, P2330, DOI 10.1158/0008-5472.CAN-04-3827; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Breit SN, 2011, GROWTH FACTORS, V29, P187, DOI 10.3109/08977194.2011.607137; Brown DA, 2009, CLIN CANCER RES, V15, P6658, DOI 10.1158/1078-0432.CCR-08-3126; Caussy C, 2014, AM J HUM GENET, V94, P129, DOI 10.1016/j.ajhg.2013.12.001; Chan K, 2013, J AM COLL CARDIOL, V61, P957, DOI 10.1016/j.jacc.2012.10.051; Chan MMY, 2016, EUR J HEART FAIL, V18, P81, DOI 10.1002/ejhf.431; Cui GL, 2014, J AM COLL CARDIOL, V64, P267, DOI 10.1016/j.jacc.2014.03.050; Daniels LB, 2011, CIRCULATION, V123, P2101, DOI 10.1161/CIRCULATIONAHA.110.979740; Dichgans M, 2014, STROKE, V45, P24, DOI 10.1161/STROKEAHA.113.002707; Dostalova I, 2009, EUR J ENDOCRINOL, V161, P397, DOI 10.1530/EJE-09-0417; Eggers KM, 2010, CIRC-CARDIOVASC GENE, V3, P88, DOI 10.1161/CIRCGENETICS.109.877456; Ek WE, 2016, HUM MOL GENET, V25, P817, DOI 10.1093/hmg/ddv511; Gao YS, 2015, AM J TRANSL RES, V7, P2519; Glinsky GV, 2008, CELL CYCLE, V7, P3564, DOI 10.4161/cc.7.22.7073; Glinsky GV, 2008, CELL CYCLE, V7, P3680, DOI 10.4161/cc.7.23.7153; Goda N, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0219-5; Haas U, 2012, RNA BIOL, V9, P924, DOI 10.4161/rna.20497; Hannou SA, 2015, TRENDS ENDOCRIN MET, V26, P176, DOI 10.1016/j.tem.2015.01.008; Hariharan M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-108; Hiard S, 2010, NUCLEIC ACIDS RES, V38, pD640, DOI 10.1093/nar/gkp926; Ho JE, 2012, CLIN CHEM, V58, P1582, DOI 10.1373/clinchem.2012.190322; Horikawa Y, 2008, CLIN CANCER RES, V14, P7956, DOI 10.1158/1078-0432.CCR-08-1199; Hsu LA, MEDIATORS INFLAMMATI, V2017; Ji H, 2015, MOL MED REP, V12, P3841, DOI 10.3892/mmr.2015.3867; Kempf T, 2007, J AM COLL CARDIOL, V50, P1054, DOI 10.1016/j.jacc.2007.04.091; Kessler T, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0886-9; Landi D, 2008, CARCINOGENESIS, V29, P579, DOI 10.1093/carcin/bgm304; Lee IT, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001538; Li C, 2016, ONCOTARGET, V7, P860, DOI 10.18632/oncotarget.6205; Lill CM, 2014, NEUROGENETICS, V15, P129, DOI 10.1007/s10048-014-0396-y; Minguzzi S, 2014, HUM MUTAT, V35, P96, DOI 10.1002/humu.22459; Mishra PJ, 2009, PHARMACOGENOMICS, V10, P399, DOI 10.2217/14622416.10.3.399; Munir MS, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-66; Murabito JM, 2012, CIRC-CARDIOVASC GENE, V5, P100, DOI 10.1161/CIRCGENETICS.111.961292; Qiao Y, 2011, FEBS LETT, V585, P3095, DOI 10.1016/j.febslet.2011.08.039; Ryan BM, 2015, CANCER RES, V75, P566, DOI 10.1158/0008-5472.CAN-14-2101; Saba R, 2014, HUM MUTAT, V35, P1233, DOI 10.1002/humu.22627; Schlittenhardt D, 2004, CELL TISSUE RES, V318, P325, DOI 10.1007/s00441-004-0986-3; Shi TY, 2013, CARCINOGENESIS, V34, P770, DOI 10.1093/carcin/bgt001; Takeuchi F, 2012, EUR J HUM GENET, V20, P333, DOI 10.1038/ejhg.2011.184; Tian LB, 2013, J INT MED RES, V41, P106, DOI 10.1177/0300060512474569; Tsui KH, 2015, SCI REP-UK, V5, DOI 10.1038/srep12870; Urakawa N, 2015, LAB INVEST, V95, P491, DOI 10.1038/labinvest.2015.36; van Setten J, 2013, ATHEROSCLEROSIS, V228, P400, DOI 10.1016/j.atherosclerosis.2013.02.039; Vila G, 2011, CLIN CHEM, V57, P309, DOI 10.1373/clinchem.2010.153726; Wang CJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep32921; Wang XB, 2014, CANCER SCI, V105, P176, DOI 10.1111/cas.12331; Wiklund FE, 2010, AGING CELL, V9, P1057, DOI 10.1111/j.1474-9726.2010.00629.x; Wong LL, 2015, EUR J HEART FAIL, V17, P393, DOI 10.1002/ejhf.223; Wu DD, 2016, TUMOR BIOL, V37, P10499, DOI 10.1007/s13277-016-4944-y; Wulfken LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025787; Xu XY, 2011, BIOMARKERS, V16, P466, DOI 10.3109/1354750X.2011.580006; Yang CZ, 2014, ANN ONCOL, V25, P1215, DOI 10.1093/annonc/mdu120; Yao YL, 2015, CELL PHYSIOL BIOCHEM, V36, P306, DOI 10.1159/000374073; Yuan M, 2013, ATHEROSCLEROSIS, V226, P447, DOI 10.1016/j.atherosclerosis.2012.11.026; Zanetti D, 2016, J EPIDEMIOL, V26, P264, DOI 10.2188/jea.JE20150034; Zhang LN, 2011, P NATL ACAD SCI USA, V108, P13653, DOI 10.1073/pnas.1103360108; Zhang Y, 2016, TUMOR BIOL, V37, P9423, DOI 10.1007/s13277-015-4699-x; Zhang ZZ, 2015, INT J CLIN EXP MED, V8, P3700; Zhong WY, 2015, INT J CLIN EXP MED, V8, P9121; Zhu Q, 2015, TRANSL PEDIATR, V4, P57, DOI 10.3978/j.issn.2224-4336.2015.01.02; Zimmers TA, 2005, SHOCK, V23, P543, DOI 10.1097/01.shk.0000163393.55350.70	66	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2017	12	8							e0183187	10.1371/journal.pone.0183187	http://dx.doi.org/10.1371/journal.pone.0183187			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD5CP	28806401	Green Published, Green Submitted, gold			2022-12-26	WOS:000407548800062
J	Uchihara, Y; Ueda, F; Tago, K; Nakazawa, Y; Ohe, T; Mashino, T; Yokota, S; Kasahara, T; Tamura, H; Funakoshi-Tago, M				Uchihara, Yuki; Ueda, Fumihito; Tago, Kenji; Nakazawa, Yosuke; Ohe, Tomoyuki; Mashino, Tadahiko; Yokota, Shigenobu; Kasahara, Tadashi; Tamura, Hiroomi; Funakoshi-Tago, Megumi			Alpha-tocopherol attenuates the anti-tumor activity of crizotinib against cells transformed by NPM-ALK	PLOS ONE			English	Article							ANAPLASTIC LYMPHOMA KINASE; RECEPTOR TYROSINE KINASE; HEPATOCYTE GROWTH-FACTOR; VITAMIN-E; C-MET; PROTEIN; APOPTOSIS; FUSION; CANCER; GENERATION	Anaplastic large cell lymphomas (ALCL) are mainly characterized by harboring the fusion protein nucleophosmin-anaplastic lymphoma kinase (NPM-ALK). The ALK inhibitor, crizotinib specifically induced apoptosis in Ba/F3 cells expressing NPM-ALK by inhibiting the activation of NPM-ALK and its downstream molecule, signal transducer and activator of transcription factor 3 (STAT3). We found that a-tocopherol, a major component of vitamin E, attenuated the effects of crizotinib independently of its anti-oxidant properties. Although alpha-tocopherol suppressed the inhibitory effects of crizotinib on the signaling axis including NPM-ALK and STAT3, it had no influence on the intake of crizotinib into cells. Crizotinib also directly inhibited the kinase activity of NPM-ALK; however, this inhibitory effect was not altered by the co-treatment with a-tocopherol. Whereas the nuclear localization of NPM-ALK was disappeared by the treatment with crizotinib, the co-treatment with a-tocopherol swept the effect of crizotinib and caused the localization of NPM-ALK in nucleus. The administration of a-tocopherol attenuated the anti-tumor activity of crizotinib against NPM-ALKprovoked tumorigenesis in vivo. Furthermore, the a-tocopherol-induced inhibition of crizotinib-caused apoptosis was also observed in NPM-ALK-positive cells derived from ALCL patients, namely, SUDHL-1 and Ki-JK. Collectively, these results not only revealed the novel mechanism underlying crizotinib-induced apoptosis in NPM-ALK-positive cells, but also suggest that the anti-tumor effects of crizotinib are attenuated when it is taken in combination with vitamin E.	[Uchihara, Yuki; Ueda, Fumihito; Nakazawa, Yosuke; Yokota, Shigenobu; Tamura, Hiroomi; Funakoshi-Tago, Megumi] Keio Univ, Div Hyg Chem, Fac Pharm, Minato Ku, Tokyo, Japan; [Tago, Kenji] Jichi Med Univ, Div Struct Biochem, Dept Biochem, Shimotsuke Shi, Tochigiken, Japan; [Ohe, Tomoyuki; Mashino, Tadahiko] Keio Univ, Div Med Chem & Bioorgan Chem, Fac Pharm, Minato Ku, Tokyo, Japan; [Kasahara, Tadashi] Int Univ Hlth & Welf, Grad Sch, Minato Ku, Tokyo, Japan	Keio University; Jichi Medical University; Keio University; International University of Health & Welfare	Funakoshi-Tago, M (corresponding author), Keio Univ, Div Hyg Chem, Fac Pharm, Minato Ku, Tokyo, Japan.	tago-mg@pha.keio.ac.jp		Uchihara, Yuki/0000-0002-0052-6315; Ueda, Fumihito/0000-0003-1241-1643	NOVARTIS foundation	NOVARTIS foundation(Novartis)	We had a monetary support from NOVARTIS foundation for our current project. For this support, we would like to describe that NOVARTIS foundation had no control to alter our adherence to PLOS ONE policies on sharing data and materials.	Abe M, 2009, INT IMMUNOPHARMACOL, V9, P870, DOI 10.1016/j.intimp.2009.03.011; Bischof D, 1997, MOL CELL BIOL, V17, P2312, DOI 10.1128/MCB.17.4.2312; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Ceccon M, 2016, ONCOGENE, V35, P3854, DOI 10.1038/onc.2015.456; Chiarle R, 2005, NAT MED, V11, P623, DOI 10.1038/nm1249; Christensen JG, 2007, MOL CANCER THER, V6, P3314, DOI 10.1158/1535-7163.MCT-07-0365; Desjobert C, 2011, BLOOD, V117, P6627, DOI 10.1182/blood-2010-09-301994; EPSTEIN AL, 1974, CANCER-AM CANCER SOC, V34, P1851, DOI 10.1002/1097-0142(197412)34:6<1851::AID-CNCR2820340602>3.0.CO;2-4; Ford ES, 2005, ANN INTERN MED, V143, P116, DOI 10.7326/0003-4819-143-2-200507190-00010; Freedman JE, 1996, CIRCULATION, V94, P2434, DOI 10.1161/01.CIR.94.10.2434; Fujita K, 2012, NAT MED, V18, P589, DOI 10.1038/nm.2659; Gainor JF, 2016, TRANSL LUNG CANCER R, V5, P343, DOI 10.21037/tlcr.2016.03.05; Gambacorti-Passerini C, 2011, NEW ENGL J MED, V364, P775, DOI 10.1056/NEJMc1013224; Hallberg B, 2013, NAT REV CANCER, V13, P685, DOI 10.1038/nrc3580; Heun M, 1997, SCIENCE, V278, P1312, DOI 10.1126/science.278.5341.1312; Hosomi A, 1997, FEBS LETT, V409, P105, DOI 10.1016/S0014-5793(97)00499-7; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Mano H, 2012, CANCER DISCOV, V2, P495, DOI 10.1158/2159-8290.CD-12-0009; Marzec M, 2007, ONCOGENE, V26, P813, DOI 10.1038/sj.onc.1209843; Mason DY, 1998, CANCER RES, V58, P1057; Medeiros LJ, 2007, AM J CLIN PATHOL, V127, P707, DOI 10.1309/R2Q9CCUVTLRYCF3H; Megiorni F, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0228-4; National Academy of Sciences (NAS), 2000, DIET REF INT VIT C V, P284; Nishizawa C, 2009, FREE RADICAL RES, V43, P1240, DOI [10.3109/10715760903273849, 10.3109/13814780903260764]; Palmer RH, 2009, BIOCHEM J, V420, P345, DOI 10.1042/BJ20090387; PARRISH DB, 1980, CRC CR REV FOOD SCI, V13, P161, DOI 10.1080/10408398009527288; Peeters Pieter, 1997, Blood, V90, P2535; Pons E, 1998, LEUKEMIA RES, V22, P797, DOI 10.1016/S0145-2126(98)00071-X; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Roskoski R, 2013, EXPERT OPIN DRUG DIS, V8, P1165, DOI 10.1517/17460441.2013.813015; Sahu Arvind, 2013, South Asian J Cancer, V2, P91, DOI 10.4103/2278-330X.110506; SHIMAKAGE M, 1993, INTERVIROLOGY, V36, P215, DOI 10.1159/000150340; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Song ZL, 2015, ACTA PHARM SIN B, V5, P34, DOI 10.1016/j.apsb.2014.12.007; Tartari CJ, 2008, J BIOL CHEM, V283, P3743, DOI 10.1074/jbc.M706067200; Tasinato A, 1995, P NATL ACAD SCI USA, V92, P12190, DOI 10.1073/pnas.92.26.12190; Usatyuk PV, 2014, J BIOL CHEM, V289, P13476, DOI 10.1074/jbc.M113.527556	37	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2017	12	8							e0183003	10.1371/journal.pone.0183003	http://dx.doi.org/10.1371/journal.pone.0183003			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD5CP	28806414	Green Submitted, Green Published, gold			2022-12-26	WOS:000407548800045
J	Hutajulu, SH; Fachiroh, J; Argy, G; Indrasari, SR; Indrawati, PL; Paramita, DK; Jati, TBR; Middeldorp, JM				Hutajulu, Susanna Hilda; Fachiroh, Jajah; Argy, Gabriella; Indrasari, Sagung Rai; Indrawati, Putu Lusy; Paramita, Dewi Kartikawati; Jati, Theodola Baning Rahayu; Middeldorp, Jaap M.			Seroprevalence of IgA anti Epstein-Barr virus is high among family members of nasopharyngeal cancer patients and individuals presenting with chronic complaints in head and neck area	PLOS ONE			English	Article							NONDIETARY RISK-FACTORS; IMMUNOGLOBULIN-G IGG; CARCINOMA FAMILIES; EBV; SEROREACTIVITY; INFECTION; MARKER; EPIDEMIOLOGY; REPLICATION; POPULATION	Epstein-Barr (EBV) infection and presence of a nasopharyngeal cancer (NPC) case in the family increases the risk of developing NPC. Aberrant anti-EBV immunoglobulin A (IgA) antibodies (EBV-IgA) may be present in the sera of non-cancer individuals and predict NPC. Limited studies report the presence of EBV-IgA antibodies within non-cancer individuals in Indonesia where the disease is prevalent. This study aimed at exploring whether EBV-IgA was found more frequently among first degree relatives of NPC patients and individuals presenting with chronic symptoms in the head and neck area compared to healthy controls. A total of 967 non-cancer subjects were recruited, including 509 family members of NPC cases, 196 individuals having chronic complaints in the head and neck region, and 262 healthy donors of the local blood bank. Sera were analyzed using a standardized peptide- based EBV-IgA ELISA. Overall, 61.6% of all individuals had anti-EBV IgA reactivity equal to or below cut off value (CoV). Seroreactivity above CoV was significantly higher in females (38.7%) compared to males (28.7%) (p = 0.001). Older individuals had more serore-activity above CoV (42.5%) than the younger ones (26.4%) (p< 0.001). Seroprevalence was significantly higher in family members of NPC patients (41.7%), compared to 32.7% of individuals with chronic head and neck problems (p = 0.028) and 16.4% healthy blood donors (p< 0.001). As conclusion, this study showed a significant higher seroprevalence in healthy family members of NPC cases and subjects presenting with chronic symptoms in the head and neck area compared to healthy individuals from the general community. This finding indicates that both groups have elevated risk of developing NPC and may serve as targets for a regional NPC screening program.	[Hutajulu, Susanna Hilda] Univ Gadjah Mada, Dr Sardjito Hosp, Dept Internal Med, Div Hematol & Med Oncol,Fac Med, Yogyakarta, Indonesia; [Fachiroh, Jajah; Paramita, Dewi Kartikawati] Univ Gadjah Mada, Fac Med, Dept Histol & Cell Biol, Yogyakarta, Indonesia; [Argy, Gabriella] Univ Gadjah Mada, Study Program Med, Fac Med, Yogyakarta, Indonesia; [Indrasari, Sagung Rai; Indrawati, Putu Lusy] Univ Gadjah Mada, Dr Sardjito Hosp, Fac Med, Dept Otorhinolaryngol Head & Neck Surg, Yogyakarta, Indonesia; [Jati, Theodola Baning Rahayu] Univ Gadjah Mada, Dept Publ Hlth, Field Epidemiol Training Program, Fac Med, Yogyakarta, Indonesia; [Middeldorp, Jaap M.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands	Central General Hospital Dr. Sardjito; Gadjah Mada University; Gadjah Mada University; Gadjah Mada University; Central General Hospital Dr. Sardjito; Gadjah Mada University; Gadjah Mada University; Vrije Universiteit Amsterdam	Hutajulu, SH (corresponding author), Univ Gadjah Mada, Dr Sardjito Hosp, Dept Internal Med, Div Hematol & Med Oncol,Fac Med, Yogyakarta, Indonesia.	jajahfachiroh@ugm.ac.id	Fachiroh, Jajah/GLV-2448-2022; Hutajulu, Susanna Hilda/GPP-6026-2022	fachiroh, jajah/0000-0002-2650-1941; Paramita, Dewi K/0000-0001-6759-8658; Middeldorp, Jaap Michiel/0000-0002-0765-4125	Nuffic/Netherland Fellowship Program [NFP-PhD08-36]; Dutch Cancer Society [KWFIN-2004-17]; Grants of Public Fund (Hibah Dana Masyarakat)	Nuffic/Netherland Fellowship Program; Dutch Cancer Society(KWF Kankerbestrijding); Grants of Public Fund (Hibah Dana Masyarakat)	This work was funded by Nuffic/Netherland Fellowship Program, URL: www.studyinholland.nl/scholarships/highlighteds cholarships/netherlands-fellowship-programmes/, contract no: NFP-PhD08-36, Role: funding for data and sample acquisition for familial and clinical subjects; Dutch Cancer Society, URL: www.kwf.nl, Contract No: KWFIN-2004-17, Role: chemicals for IgA-EBV laboratory analysis; Grants of Public Fund (Hibah Dana Masyarakat) 2013, Faculty of Medicine, Universitas Gadjah Mada,Yogyakarta, Indonesia;URL:http://research.fk.ugm.ac.id/index.php/data/penelitian/412-tawaran-penelitian-danp ublikasi-fk-ugm-2017, Role: data and sample acquisition for blood donor subjects.; We thank Bambang Hariwiyanto, MD, PhD and Camelia Herdini, MD and staffs at Department of Otorhinolaryngology Head and Neck Surgery, Dr Sardjito Hospital for clinical support; Indonesia Red-Cross (blood bank) City of Yogyakarta and Sleman District for the collaboration in normal blood sample collection. We also thank Rosidah and Fransisca Erna Damayanti for epidemiological assistance, and Sumartiningsih, Yuli Kristianto, Arina Prihestri Nugraheni, Christine Fatmawati, Rahma Yuantari, Sri Fatmawati and Dewi Sulistyawati for technical assistance. We gratefully acknowledge Nuffic/Netherland Fellowship Program (NFP-PhD 08-36), Dutch Cancer Society (KWF IN-2004-17) and Grants of Public Fund (Hibah Dana Masyarakat) 2013, Faculty of Medicine, Universitas Gadjah Mada, Yogyakarta, Indonesia for grant fundings. Finally, we thank Adrian Coen and staff of Klinik Bahasa, Office for Research and Publication, Faculty of Medicine, Universitas Gadjah Mada for proofreading the text.	Adham M, 2012, CHIN J CANCER, V31, P185, DOI 10.5732/cjc.011.10328; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chen HS, 1999, WORLD J SURG, V23, P1301; CHEN JY, 1985, J MED VIROL, V17, P47, DOI 10.1002/jmv.1890170107; CHEN JY, 1989, J MED VIROL, V27, P269, DOI 10.1002/jmv.1890270403; Chien YC, 2001, NEW ENGL J MED, V345, P1877, DOI 10.1056/NEJMoa011610; Coghill AE, 2016, CLIN CANCER RES, V22, P3451, DOI 10.1158/1078-0432.CCR-15-2299; Coghill AE, 2014, CANCER EPIDEM BIOMAR, V23, P1213, DOI 10.1158/1055-9965.EPI-13-1262; Du JL, 2016, CHIN J CANCER, V35, DOI 10.1186/s40880-016-0130-2; Ekburanawat W, 2010, ASIAN PAC J CANCER P, V11, P929; Fachiroh J, 2008, J CLIN MICROBIOL, V46, P1374, DOI 10.1128/JCM.01368-07; Fachiroh J, 2006, J CLIN MICROBIOL, V44, P1459, DOI 10.1128/JCM.44.4.1459-1467.2006; Fachiroh J, 2004, J INFECT DIS, V190, P53, DOI 10.1086/421245; Friborg J, 2005, CANCER RES, V65, P8567, DOI 10.1158/0008-5472.CAN-04-4208; HENLE G, 1976, INT J CANCER, V17, P1, DOI 10.1002/ijc.2910170102; HILDESHEIM A, 1993, EPIDEMIOL REV, V15, P466, DOI 10.1093/oxfordjournals.epirev.a036130; Hutajulu SH, 2012, J MED VIROL, V84, P768, DOI 10.1002/jmv.23263; IRELAND B, 1988, INT J EPIDEMIOL, V17, P509, DOI 10.1093/ije/17.3.509; Ji MF, 2007, BRIT J CANCER, V96, P623, DOI 10.1038/sj.bjc.6603609; Ji MF, 2014, CANCER-AM CANCER SOC, V120, P1353, DOI 10.1002/cncr.28564; Ji XM, 2011, INT J CANCER, V129, P724, DOI 10.1002/ijc.25696; Lee CH, 2008, CANCER GENET CYTOGEN, V185, P1, DOI 10.1016/j.cancergencyto.2008.03.014; Li S, 2010, CHINESE MED J-PEKING, V123, P1201, DOI 10.3760/cma.j.issn.0366-6999.2010.09.018; Lin JH, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1902-9; Loh KS, 2006, ARCH OTOLARYNGOL, V132, P82, DOI 10.1001/archotol.132.1.82; Mettenleiter TC, 2002, J VIROL, V76, P1537, DOI 10.1128/JVI.76.4.1537-1547.2002; Middeldorp JM, 2003, CRIT REV ONCOL HEMAT, V45, P1, DOI 10.1016/S1040-8428(02)00078-1; Ng WT, 2010, FAM CANCER, V9, P221, DOI 10.1007/s10689-009-9296-y; Ng WT, 2005, INT J CANCER, V113, P998, DOI 10.1002/ijc.20672; Paramita DK, 2009, CLIN VACCINE IMMUNOL, V16, P706, DOI 10.1128/CVI.00425-08; Pickard A, 2004, INT J CANCER, V111, P117, DOI 10.1002/ijc.20222; Qin HD, 2011, J MED VIROL, V83, P1792, DOI 10.1002/jmv.22121; RAABTRAUB N, 1992, INFECT AGENT DIS, V1, P173; SCHUURS AHWM, 1990, J STEROID BIOCHEM, V35, P157, DOI 10.1016/0022-4731(90)90270-3; Soeripto, 1998, BERITA KEDOKTERAN MA, V13, P207; WAGNER HJ, 1994, IMMUNOBIOLOGY, V190, P424, DOI 10.1016/S0171-2985(11)80613-3; Ward MH, 2000, INT J CANCER, V86, P603, DOI 10.1002/(SICI)1097-0215(20000601)86:5&lt;603::AID-IJC1&gt;3.0.CO;2-H; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Wildeman MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063706; Xu BQ, 2016, CHIN J CANCER, V35, P1, DOI 10.1186/s40880-016-0098-y; Yang EV, 2010, BRAIN BEHAV IMMUN, V24, P1089, DOI 10.1016/j.bbi.2010.04.013; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0; YU MC, 1990, INT J CANCER, V45, P1033, DOI 10.1002/ijc.2910450609; YU MC, 1989, BRIT J CANCER, V60, P198, DOI 10.1038/bjc.1989.250; Yuan JM, 2000, INT J CANCER, V85, P364, DOI 10.1002/(SICI)1097-0215(20000201)85:3&lt;364::AID-IJC12&gt;3.0.CO;2-C; ZENG J, 1983, INT J CANCER, V31, P599, DOI 10.1002/ijc.2910310511; Zou J, 2000, J Radiat Res, V41 Suppl, P53; ZURHAUSE.H, 1970, NATURE, V228, P1056, DOI 10.1038/2281056a0	48	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0180683	10.1371/journal.pone.0180683	http://dx.doi.org/10.1371/journal.pone.0180683			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800616	Green Published, Green Submitted, gold			2022-12-26	WOS:000407431800002
J	Chamorro-Florescano, IA; Favila, ME; Macias-Ordonez, R				Chamorro-Florescano, Ivette A.; Favila, Mario E.; Macias-Ordonez, Rogelio			Contests over reproductive resources in female roller beetles: Outcome predictors and sharing as an option	PLOS ONE			English	Article							SEXUAL SELECTION; DROSOPHILA-MELANOGASTER; INTRASEXUAL COMPETITION; OVIPOSITION SITES; MATING-BEHAVIOR; DUNG BEETLE; EVOLUTION; COLEOPTERA; SIZE; DEFENSE	Fights among females are frequent, although less attention has been placed on them than on male fights. They arise when females compete for food, oviposition, mates, brooding sites, or access to resources which increase offspring survival. It has been shown that the outcome of female fights may be less predictable by asymmetries in resource holding power, than in male fights. Male roller beetles fight over food resources, food balls, needed for mating and nesting, and it has been show in some species that asymmetries in reproductive experience and resource holding power in terms of size predict fight outcome, including ties in which contenders cut and split the food ball. In this study, we tested the influence of asymmetries in reproductive status (experience) and body size on female fight outcome in the carrion roller beetle Canthon cyanellus cyanellus. As predicted, and as previously found for males of the same species, female reproductive status of both contenders and relative size predict fight outcome. Larger and reproductively experienced contenders have a higher probability of winning. Furthermore, ties are more likely in fights involving opposing asymmetries (vgr. Large reproductively naive owner versus small reproductively experienced intruder). Also as predicted, food ball splitting is more likely to be started by the predicted loser. This mode of resource sharing may be the result of a fighting strategy in which the costs of continuing to fight are greater than the benefits of not splitting, if a fraction of the disputed resource is more than the minimum needed for the present reproductive needs, and reduces costs associated to a longer fight.	[Chamorro-Florescano, Ivette A.] Univ Veracruzana, Fac Ciencias Biol & Agr, Tuxpan, Veracruz, Mexico; [Favila, Mario E.] Inst Ecol AC, Red Ecoetol, Xalapa, Veracruz, Mexico; [Macias-Ordonez, Rogelio] Inst Ecol AC, Red Biol Evolut, Xalapa, Veracruz, Mexico	Universidad Veracruzana; Instituto de Ecologia - Mexico; Instituto de Ecologia - Mexico	Chamorro-Florescano, IA (corresponding author), Univ Veracruzana, Fac Ciencias Biol & Agr, Tuxpan, Veracruz, Mexico.	ivette.chamorro@gmail.com	Macías-Ordóñez, Rogelio/AAO-3447-2020; Favila, Mario E./Q-8877-2018; Macías-Ordóñez, Rogelio/E-8286-2010	Favila, Mario E./0000-0002-2737-9327; Macías-Ordóñez, Rogelio/0000-0003-1101-6289	Consejo Nacional de Ciencia y Tecnologia [124849, 49472-Q]; CONACYT-Mexico [124849, 49472-Q]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	IACF received graduate scholarship no. 124849 from the Consejo Nacional de Ciencia y Tecnologia (www.conacyt.gob.mx). MEF received a research grant no. 49472-Q from the Consejo Nacional de Ciencia y Tecnologia (www.conacyt.gob.mx).; We thank Roberto Munguia and Roger Guevara for statistical advice. This work was supported by CONACYT-Mexico (grants No. 49472-Q to MEF and 124849). We are grateful for very helpful comments from two anonymous reviewers.	[Anonymous], 1994, SEXUAL SELECTION; Bath E, 2015, ECOL EVOL, V5, P1826, DOI 10.1002/ece3.1467; Bonduriansky R, 2001, BIOL REV, V76, P305, DOI 10.1017/S1464793101005693; Cain KE, 2016, BEHAV ECOL SOCIOBIOL, V70, P1867, DOI 10.1007/s00265-016-2192-1; Chamorro-Florescano IA, 2016, ETHOLOGY, V122, P53, DOI 10.1111/eth.12443; Chamorro-Florescano IA, 2011, EVOL ECOL, V25, P277, DOI 10.1007/s10682-010-9428-8; Chamorro-Florescano IA, 2008, BEHAVIOUR, V145, P1811, DOI 10.1163/156853908786279637; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; Clutton-Brock TH, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0074; Clutton-Brock T, 2009, ANIM BEHAV, V77, P3, DOI 10.1016/j.anbehav.2008.08.026; Cordero C, 2000, BEHAV ECOL SOCIOBIOL, V48, P458, DOI 10.1007/s002650000261; Crawley MJ, 2013, R BOOK, P557; de Oca E Montes, 1991, OBSERVACIONES CAMPO; Draud M, 2004, BEHAV ECOL, V15, P102, DOI 10.1093/beheco/arg081; Dubois F, 2003, AM NAT, V162, P768, DOI 10.1086/379202; Dubois FD, 2005, ECOLOGY, V86, P3, DOI 10.1890/04-0566; Dubois F, 2007, BEHAV ECOL SOCIOBIOL, V62, P263, DOI 10.1007/s00265-007-0461-8; Dunn DW, 2015, BEHAV ECOL, V26, P262, DOI 10.1093/beheco/aru191; Eggert AK, 2008, P ROY SOC B-BIOL SCI, V275, P2521, DOI 10.1098/rspb.2008.0661; Elias DO, 2010, BEHAV ECOL, V21, P868, DOI 10.1093/beheco/arq073; ENQUIST M, 1987, J THEOR BIOL, V127, P187, DOI 10.1016/S0022-5193(87)80130-3; FAVILA M E, 1988, Folia Entomologica Mexicana, P55; Favila ME, 1996, COLEOPTS BULL, V50, P52; FAVILA ME, 1993, ETHOL ECOL EVOL, V5, P319, DOI 10.1080/08927014.1993.9523019; Favila ME, 2012, TEMAS SELECTOS ECOLO, P446; FOWLER K, 1989, NATURE, V338, P760, DOI 10.1038/338760a0; Fox John, 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i15, DOI 10.18637/JSS.V008.I15]; Gilg MR, 2003, AM MIDL NAT, V149, P306, DOI 10.1674/0003-0031(2003)149[0306:RDLSIT]2.0.CO;2; Goubault M, 2007, ETHOLOGY, V113, P334, DOI 10.1111/j.1439-0310.2006.01325.x; GRAFEN A, 1987, ANIM BEHAV, V35, P462, DOI 10.1016/S0003-3472(87)80271-3; Halffter G., 1984, Bulletin de la Societe Entomologique de France, V88, P585; Halffter G, 1982, PUBLIC, V10; HALFFTER GONZALO, 1966, FOLIA ENTOMOL MEX, V12/14, P1; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hardy ICW, 1998, ANIM BEHAV, V56, P787, DOI 10.1006/anbe.1998.0833; HEINRICH B, 1979, PHYSIOL ZOOL, V52, P484, DOI 10.1086/physzool.52.4.30155939; HOLDER JL, 1991, ETHOLOGY, V88, P297; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Humphries EL, 2006, ANIM BEHAV, V72, P891, DOI 10.1016/j.anbehav.2006.02.015; Kemp DJ, 2004, OIKOS, V105, P65, DOI 10.1111/j.0030-1299.2004.12874.x; Kraaijeveld K, 2007, ANIM BEHAV, V74, P657, DOI 10.1016/j.anbehav.2006.12.027; Lebas NR, 2006, TRENDS ECOL EVOL, V21, P170, DOI 10.1016/j.tree.2006.01.007; Lee VE, 2013, BEHAV ECOLOGY; MATTHEWS ERIC G., 1963, PSYCHE, V70, P75, DOI 10.1155/1963/23630; MAYNARDSMITH J, 1973, NATURE, V0246, P00015, DOI DOI 10.1038/246015A0; Mesterton-Gibbons M, 2012, EVOL ECOL, V26, P943, DOI 10.1007/s10682-011-9550-2; Mohamad R, 2010, ANIM BEHAV, V80, P629, DOI 10.1016/j.anbehav.2010.06.022; Oliver C, 2009, EVOL ECOL, V23, P417, DOI 10.1007/s10682-007-9239-8; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; R Development Core Team, 2014, R LANG ENV STAT COMP; Rosvall KA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0083; Rosvall KA, 2011, BEHAV ECOL, V22, P1131, DOI 10.1093/beheco/arr106; Rubenstein DR, 2012, PHILOS T R SOC B, V367, P2248, DOI 10.1098/rstb.2011.0278; SATO H, 1993, J NAT HIST, V27, P657, DOI 10.1080/00222939300770381; Sato H, 1998, J INSECT BEHAV, V11, P833, DOI 10.1023/A:1020860010165; SATO H, 1987, ECOL ENTOMOL, V12, P415, DOI 10.1111/j.1365-2311.1987.tb01023.x; Schenker N, 2001, AM STAT, V55, P182, DOI 10.1198/000313001317097960; Shelly TE, 1999, FLA ENTOMOL, V82, P339, DOI 10.2307/3496587; Stevens JR, 2004, ANIM BEHAV, V67, P603, DOI 10.1016/j.anbehav.2003.04.012; Stockley P, 2013, FEMALE COMPETITION B, VB 368; Suzuki S, 2005, J INSECT BEHAV, V18, P233, DOI 10.1007/s10905-005-0477-8; Tibbetts EA, 2008, P ROY SOC B-BIOL SCI, V275, P2201, DOI 10.1098/rspb.2008.0477; Tibbetts EA, 2009, BEHAV ECOL SOCIOBIOL, V63, P1377, DOI 10.1007/s00265-009-0764-z; Tobias JA, 2012, PHILOS T R SOC B, V367, P2274, DOI 10.1098/rstb.2011.0280; Ueda A, 2002, PHYSIOL ENTOMOL, V27, P21, DOI 10.1046/j.1365-3032.2002.00262.x; Venables W., 2002, MODERN APPL STAT USI; Watson NL, 2010, P ROY SOC B-BIOL SCI, V277, P2035, DOI 10.1098/rspb.2009.2335; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; Yanagi S, 2003, J INSECT PHYSIOL, V49, P823, DOI 10.1016/S0022-1910(03)00119-7	69	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182931	10.1371/journal.pone.0182931	http://dx.doi.org/10.1371/journal.pone.0182931			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796846	Green Submitted, Green Published, gold			2022-12-26	WOS:000407396200127
J	He, H; Weir, RL; Toutounchian, JJ; Pagadala, J; Steinle, JJ; Baudry, J; Miller, DD; Yates, CR				He, Hui; Weir, Rebecca L.; Toutounchian, Jordan J.; Pagadala, Jayaprakash; Steinle, Jena J.; Baudry, Jerome; Miller, Duane D.; Yates, Charles R.			The quinic acid derivative KZ-41 prevents glucose-induced caspase-3 activation in retinal endothelial cells through an IGF-1 receptor dependent mechanism	PLOS ONE			English	Article							GROWTH-FACTOR-I; DIABETIC-RAT RETINA; INDUCED APOPTOSIS; OXIDATIVE STRESS; INSULIN-RECEPTOR; KINASE; DEATH; TRANSACTIVATION; IDENTIFICATION; RETINOPATHY	Retinal microaneurysms, an early disease manifestation of diabetic retinopathy, are associated with retinal endothelial cell (REC) death and macular edema. We previously demonstrated that a quinic acid (QA) analog, KZ-41, promoted REC survival by blunting stress-induced p38 MAPK activation. Herein, we sought to expand our understanding of the prosurvival signal transduction pathways actuated by KZ-41. Using human RECs exposed to high glucose (25 mM, 72 hours), we demonstrated that KZ-41 blocks caspase-3 activation by triggering phosphorylation of the PI3K regulatory subunit (p85; Tyr458) and its downstream target Akt (Ser473). Akt signal transduction was accompanied by autophosphorylation of the receptor tyrosine kinase, insulin growth factor-1 receptor (IGF-1R). IGF-1R knockdown using either the tyrosine kinase inhibitor AG1024 or silencing RNA abolished KZ-41's pro-survival effect. Under high glucose stress, caspase-3 activation correlated with elevated ERK1/ 2 phosphorylation and decreased insulin receptor substrate-1 (IRS-1) levels. KZ-41 decreased ERK1/ 2 phosphorylation and reversed the glucose-dependent reduction in IRS-1. To gain insight into the mechanistic basis for IGF-1R activation by KZ-41, we used molecular modeling and docking simulations to explore a possible protein: ligand interaction between the IGF-1R kinase domain and KZ-41. Computational investigations suggest two possible KZ-41 binding sites within the kinase domain: a region with high homology to the insulin receptor contains one potential allosteric binding site, and another potential site on the other side of the kinase domain, near the hinge domain. These data, together with previous proof-of-concept efficacy studies demonstrating KZ-41 mitigates pathologic retinal neovascularization in the murine oxygen-induced retinopathy model, suggests that QA derivatives may offer therapeutic benefit in ischemic retinopathies.	[He, Hui; Toutounchian, Jordan J.; Pagadala, Jayaprakash; Miller, Duane D.; Yates, Charles R.] UTHSC Coll Pharm, Dept Pharmaceut Sci, Memphis, TN 38163 USA; [Weir, Rebecca L.; Baudry, Jerome] Univ Tennessee, Biochem & Cellular & Mol Biol, Knoxville, TN USA; [Steinle, Jena J.] Wayne State Univ, Dept Anat, Detroit, MI USA; [Baudry, Jerome] Oak Ridge Natl Lab, UT ORNL Ctr Mol Biophys, Oak Ridge, TN USA; [Yates, Charles R.] UTHSC Coll Med, Dept Ophthalmol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Knoxville; Wayne State University; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Health Science Center	Yates, CR (corresponding author), UTHSC Coll Pharm, Dept Pharmaceut Sci, Memphis, TN 38163 USA.; Yates, CR (corresponding author), UTHSC Coll Med, Dept Ophthalmol, Memphis, TN 38163 USA.	cyates4@uthsc.edu		Steinle, Jena/0000-0002-7539-2892; Yates, Ryan/0000-0002-3730-3844	Colleges of Pharmacy (Pharmaceutical Sciences) and Medicine (Ophthalmology); NHLBI [HL094366]; NIAID [R33 AI080534-01]; Dept. of Ophthalmology from Research to Prevent Blindness, NY, NY; NEI Vision Core Grant [PHS 3P30, EY013080]; St. Giles Foundation; BCMB Department, University of Tennessee, Knoxville; UT/ORNL Center for Molecular Biophysics; NATIONAL EYE INSTITUTE [R01EY022045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	Colleges of Pharmacy (Pharmaceutical Sciences) and Medicine (Ophthalmology); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Dept. of Ophthalmology from Research to Prevent Blindness, NY, NY; NEI Vision Core Grant; St. Giles Foundation; BCMB Department, University of Tennessee, Knoxville; UT/ORNL Center for Molecular Biophysics; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Colleges of Pharmacy (Pharmaceutical Sciences) and Medicine (Ophthalmology), NHLBI grant HL094366, and NIAID R33 AI080534-01 (D.D.M.). This work was supported by an unrestricted grant to the Dept. of Ophthalmology from Research to Prevent Blindness, NY, NY; an NEI Vision Core Grant: PHS 3P30, EY013080; an unrestricted grant from the St. Giles Foundation. In addition, J.B. and R.L.W. acknowledge support from the BCMB Department, University of Tennessee, Knoxville, and the UT/ORNL Center for Molecular Biophysics.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Allen DA, 2005, J NUTR BIOCHEM, V16, P705, DOI 10.1016/j.jnutbio.2005.06.007; Barber AJ, 2001, J BIOL CHEM, V276, P32814, DOI 10.1074/jbc.M104738200; Baserga R, 1997, BBA-REV CANCER, V1332, pF105, DOI 10.1016/S0304-419X(97)00007-3; Behl Y, 2009, DIABETES, V58, P917, DOI 10.2337/db08-0537; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Buckley DA, 2002, J CLIN PATHOL-MOL PA, V55, P46, DOI 10.1136/mp.55.1.46; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Cao YY, 2013, J MOL ENDOCRINOL, V51, P15, DOI 10.1530/JME-12-0171; Costa GN, 2012, MOL CELL NEUROSCI, V50, P113, DOI 10.1016/j.mcn.2012.04.003; Du J, 2001, CIRC RES, V88, P1044, DOI 10.1161/hh1001.090840; Evangelista W, 2016, BIOORGAN MED CHEM, V24, P4928, DOI 10.1016/j.bmc.2016.07.064; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Favelyukis S, 2001, NAT STRUCT BIOL, V8, P1058, DOI 10.1038/nsb721; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Girnita A, 2012, ONCOGENE, V31, P352, DOI 10.1038/onc.2011.239; Heinrich T, 2010, ACS MED CHEM LETT, V1, P199, DOI 10.1021/ml100044h; Holzman JL, 2007, AM J PHYSIOL-RENAL, V292, pF1219, DOI 10.1152/ajprenal.00214.2006; Jiang YD, 2012, CELL SIGNAL, V24, P1086, DOI 10.1016/j.cellsig.2012.01.003; Jiang ZY, 1999, J CLIN INVEST, V104, P447, DOI 10.1172/JCI5971; Li YJ, 2007, GRAEF ARCH CLIN EXP, V245, P1523, DOI 10.1007/s00417-007-0616-3; Lofqvist C, 2009, INVEST OPHTH VIS SCI, V50, P1831, DOI 10.1167/iovs.08-2903; Matheny RW, 2010, CELL DEATH DIFFER, V17, P677, DOI 10.1038/cdd.2009.150; Munshi S, 2002, J BIOL CHEM, V277, P38797, DOI 10.1074/jbc.M205580200; Parrizas M, 1997, ENDOCRINOLOGY, V138, P1427, DOI 10.1210/en.138.4.1427; Poulaki V, 2002, J CLIN INVEST, V109, P805, DOI 10.1172/JCI200213776; Sehat B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000340; Seigel GM, 2006, J DIABETES COMPLICAT, V20, P196, DOI 10.1016/j.jdiacomp.2005.06.007; Shonberg J, 2014, MED RES REV, V34, P1286, DOI 10.1002/med.21318; Slomiany MG, 2004, AM J PHYSIOL-CELL PH, V287, pC746, DOI 10.1152/ajpcell.00568.2003; Spoerri PE, 1998, GROWTH HORM IGF RES, V8, P125, DOI 10.1016/S1096-6374(98)80102-0; Spranger J, 2000, HORM METAB RES, V32, P196, DOI 10.1055/s-2007-978621; Toutounchian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100210; Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609; Wilson S H, 2001, Growth Horm IGF Res, V11 Suppl A, pS53, DOI 10.1016/S1096-6374(01)80009-5; Wu JH, 2008, EMBO J, V27, P1985, DOI 10.1038/emboj.2008.116; Zahradka P, 2004, ENDOCRINOLOGY, V145, P2978, DOI 10.1210/en.2004-0029; Zeng K, 2011, XENOBIOTICA, V41, P1006, DOI 10.3109/00498254.2011.603387; Zeng K, 2009, BIOORG MED CHEM LETT, V19, P5458, DOI 10.1016/j.bmcl.2009.07.096; Zhang QH, 2013, INVEST OPHTH VIS SCI, V54, P5937, DOI 10.1167/iovs.13-12326; Zhang QH, 2013, APOPTOSIS, V18, P361, DOI 10.1007/s10495-012-0793-3; Zhang XY, 2005, CURR EYE RES, V30, P395, DOI 10.1080/02713680590956306; Zhang YL, 1998, J BIOL CHEM, V273, P12281, DOI 10.1074/jbc.273.20.12281; Zheng HY, 2012, P NATL ACAD SCI USA, V109, P7055, DOI 10.1073/pnas.1118359109	44	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0180808	10.1371/journal.pone.0180808	http://dx.doi.org/10.1371/journal.pone.0180808			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796787	Green Submitted, Green Published, gold			2022-12-26	WOS:000407396200008
J	Liu, X; Chen, X; Wang, H; Yang, QQ; Rehman, KU; Li, W; Cai, MM; Li, Q; Mazza, L; Zhang, JB; Yu, ZN; Zheng, LY				Liu, Xiu; Chen, Xuan; Wang, Hui; Yang, Qinqin; Rehman, Kashif Ur; Li, Wu; Cai, Minmin; Li, Qing; Mazza, Lorenzo; Zhang, Jibin; Yu, Ziniu; Zheng, Longyu			Dynamic changes of nutrient composition throughout the entire life cycle of black soldier fly	PLOS ONE			English	Article							HERMETIA-ILLUCENS L.; BIODIESEL PRODUCTION; TENEBRIO-MOLITOR; RAINBOW-TROUT; FLIES DIPTERA; LARVAE MEAL; RICE STRAW; STRATIOMYIDAE; WASTE; LIVESTOCK	Black soldier fly (BSF) larvae, Hermetia illucens L., develops on organic wastes, reducing ecological pollution and converting waste biomass into protein and fat rich insect biomass. BSF can replace increasingly expensive protein sources used in poultry, aquaculture and livestock compound diet formulation, such as fish meal and soybean meal, which holds the potential to alleviate future food and feed insecurity. The fate of nutritional spectra in BSF during its life cycle phases is still poorly understood. This study assessed metabolic changes in nutrition composition of BSF from egg to adult. A rapid increase of crude fat content was observed since the development of 4-14 days of larvae with its maximum level reaching 28.4% in dry mass, whereas the crude protein displayed a continuous decreasing trend in the same development phases with minimum level of 38% at larval phase (12 days) and peak level of 46.2% at early pupa stage. A sharp drop in crude fat was noticed from early prepupae to late pupae (24.2%, 8.2% respectively). However crude protein shows its maximum value being 57.6% at postmortem adult stage with 21.6% fat level. In addition, fatty acids, amino acids, minerals and vitamins composition in different development stages of BSF were presented and compared. Findings from this study could provide podium to food and feed industry for framing a strategy for specific molecular nutritional component intake into the diets of humans, aquaculture and animals. It is also indicated that BSF is a possible insect which can be applied to combating the food scarcity of countries where micronutrient deficiency is prevalent. Moreover it contributes to advance exploring for developmental and metabolic biology of this edible insect.	[Liu, Xiu; Chen, Xuan; Wang, Hui; Yang, Qinqin; Rehman, Kashif Ur; Li, Wu; Cai, Minmin; Mazza, Lorenzo; Zhang, Jibin; Yu, Ziniu; Zheng, Longyu] Huazhong Agr Univ, Coll Life Sci & Technol, Natl Engn Res Ctr Microbial Pesticides, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China; [Rehman, Kashif Ur] Poultry Res Inst Rawalpindi, Livestock & Dairy Dev Dept, Punjab, Pakistan; [Li, Qing] Huazhong Agr Univ, Coll Sci, Wuhan, Hubei, Peoples R China; [Mazza, Lorenzo] Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Messina, Italy	Huazhong Agricultural University; Huazhong Agricultural University; University of Messina	Zheng, LY (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, Natl Engn Res Ctr Microbial Pesticides, State Key Lab Agr Microbiol, Wuhan, Hubei, Peoples R China.	ly.zheng@mail.hzau.edu.cn	Rehman, Kashif ur/O-5605-2018; Rehman, Kashif ur/AAZ-9704-2021	Rehman, Kashif ur/0000-0003-4954-3172; 	Natural Science Foundation of China [31301913]; Fundamental Research Funds for the Central Universities of China [2662015QD006]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This study was supported by the Natural Science Foundation of China (grant 31301913) and Fundamental Research Funds for the Central Universities of China (2662015QD006).; This study was supported by the Natural Science Foundation of China (grant 31301913) and Fundamental Research Funds for the Central Universities of China (2662015QD006).	Alves AV., 2016, PLOS ONE, V11, P1, DOI DOI 10.1371/J0URNAL.P0NE.0151275; Anand AN, 2008, J INSECT PHYSIOL, V54, P1404, DOI 10.1016/j.jinsphys.2008.08.001; [Anonymous], 2010, FAO Food Nutr Pap, V91, P1; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Banks I.J., 2014, THESIS; Banks IJ, 2014, TROP MED INT HEALTH, V19, P14, DOI 10.1111/tmi.12228; BARRY T, 2004, EVALUATION EC SOCIAL; Boland MJ, 2013, TRENDS FOOD SCI TECH, V29, P62, DOI 10.1016/j.tifs.2012.07.002; BOOTH DC, 1984, ENVIRON ENTOMOL, V13, P421, DOI 10.1093/ee/13.2.421; Bovera F, 2016, J ANIM SCI, V94, P639, DOI 10.2527/jas.2015-9201; Bovera F, 2015, BRIT POULTRY SCI, V56, P569, DOI 10.1080/00071668.2015.1080815; Brammer CA, 2007, MOL PHYLOGENET EVOL, V43, P660, DOI 10.1016/j.ympev.2006.09.006; Christensen DL, 2006, INT J FOOD SCI NUTR, V57, P198, DOI 10.1080/09637480600738252; Cummins VC, 2017, AQUACULTURE, V473, P337, DOI 10.1016/j.aquaculture.2017.02.022; Diener S, 2011, WASTE BIOMASS VALORI, V2, P357, DOI 10.1007/s12649-011-9079-1; Diener S, 2009, WASTE MANAGE RES, V27, P603, DOI 10.1177/0734242X09103838; FAO WHO, 2004, VIT MIN REQ HUM NUTR, P1; Finke MD, 2015, ZOO BIOL, V34, P554, DOI 10.1002/zoo.21246; Ghosh S, 2016, J ASIA-PAC ENTOMOL, V19, P487, DOI 10.1016/j.aspen.2016.03.008; Hwangbo J, 2009, J ENVIRON BIOL, V30, P609; Iaconisi V, 2017, AQUACULTURE, V476, P49, DOI 10.1016/j.aquaculture.2017.04.007; Jozefiak D, 2016, ANN ANIM SCI, V16, P297, DOI 10.1515/aoas-2016-0010; Leong SY, 2016, WASTE MANAGE, V47, P84, DOI 10.1016/j.wasman.2015.03.030; Li Q, 2011, WASTE MANAGE, V31, P1316, DOI 10.1016/j.wasman.2011.01.005; Li W, 2015, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00247; Li W, 2015, BIORESOURCE TECHNOL, V194, P276, DOI 10.1016/j.biortech.2015.06.112; Makkar HPS, 2014, ANIM FEED SCI TECH, V197, P1, DOI 10.1016/j.anifeedsci.2014.07.008; Manurung Robert, 2016, Journal of Entomology and Zoology Studies, V4, P1036; Marineli RD, 2012, FOOD RES INT, V49, P487, DOI 10.1016/j.foodres.2012.07.022; Martinez-Sanchez A, 2011, FORENSIC SCI INT, V206, pE76, DOI 10.1016/j.forsciint.2010.10.021; Millward DJ, 2010, P NUTR SOC, V69, P103, DOI 10.1017/S0029665109991868; Myers HM, 2008, ENVIRON ENTOMOL, V37, P11, DOI 10.1603/0046-225X(2008)37[11:DOBSFD]2.0.CO;2; NEWTON GL, 1977, J ANIM SCI, V44, P395, DOI 10.2527/jas1977.443395x; Newton L., 2005, J KOREAN ENTOMOL APP; Nguyen TTX, 2013, J MED ENTOMOL, V50, P898, DOI 10.1603/ME12260; Nowak V, 2016, FOOD CHEM, V193, P39, DOI 10.1016/j.foodchem.2014.10.114; Ogunji J.O., 2006, C INT AGR RES DEV; Oonincx DGAB, 2015, J INSECTS FOOD FEED, V1, P131, DOI 10.3920/JIFF2014.0023; Oonincx DGAB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144601; Paz ASP, 2015, WASTE BIOMASS VALORI, V6, P1059, DOI 10.1007/s12649-015-9418-8; Paulk A, 2006, J EXP BIOL, V209, P3913, DOI 10.1242/jeb.02438; Payne CLR, 2016, TRENDS FOOD SCI TECH, V47, P69, DOI 10.1016/j.tifs.2015.10.012; Ray DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066428; Rehman KU, 2017, J ENVIRON MANAGE, V196, P458, DOI 10.1016/j.jenvman.2017.03.047; Salomone R., 2016, J CLEAN PROD, Vxxx, P1; Schiavone A, 2017, ITAL J ANIM SCI, V16, P93, DOI 10.1080/1828051X.2016.1249968; Sealey WM, 2011, J WORLD AQUACULT SOC, V42, P34, DOI 10.1111/j.1749-7345.2010.00441.x; Sheppard DC, 2002, J MED ENTOMOL, V39, P695, DOI 10.1603/0022-2585-39.4.695; St-Hilaire S, 2007, J WORLD AQUACULT SOC, V38, P309, DOI 10.1111/j.1749-7345.2007.00101.x; St-Hilaire S, 2007, J WORLD AQUACULT SOC, V38, P59, DOI 10.1111/j.1749-7345.2006.00073.x; Stamer A, 2015, EMBO REP, V16, P676, DOI 10.15252/embr.201540528; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Tomberlin JK, 2015, J INSECTS FOOD FEED, V1, P307, DOI 10.3920/JIFF2015.0098; Tomberlin JK, 2002, J ENTOMOL SCI, V37, P345, DOI 10.18474/0749-8004-37.4.345; Tomberlin JK, 2002, ANN ENTOMOL SOC AM, V95, P379, DOI 10.1603/0013-8746(2002)095[0379:SLHTOB]2.0.CO;2; van der Fels-Klerx HJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166186; Van Huis A., 2013, EDIBLE INSECTS FUTUR; van Huis A, 2013, ANNU REV ENTOMOL, V58, P563, DOI 10.1146/annurev-ento-120811-153704; Veldkamp T., 2015, Animal Frontiers, V5, P45; Veldkamp T., 2012, 638 WAG UR LIV RES; Zheng LY, 2012, ENERGY, V47, P225, DOI 10.1016/j.energy.2012.09.006; Zheng LY, 2012, RENEW ENERG, V41, P75, DOI 10.1016/j.renene.2011.10.004; Zhou F, 2013, J MED ENTOMOL, V50, P1224, DOI 10.1603/ME13021	63	91	96	13	170	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182601	10.1371/journal.pone.0182601	http://dx.doi.org/10.1371/journal.pone.0182601			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796830	Green Published, gold, Green Submitted			2022-12-26	WOS:000407396200068
J	Matsushita, N; Hassanein, MT; Martinez-Clemente, M; Lazaro, R; French, SW; Xie, W; Lai, K; Karin, M; Tsukamoto, H				Matsushita, Noriko; Hassanein, Mohamed T.; Martinez-Clemente, Marcos; Lazaro, Raul; French, Samuel W.; Xie, Wen; Lai, Keane; Karin, Michael; Tsukamoto, Hidekazu			Gender difference in NASH susceptibility: Roles of hepatocyte Ikk beta and Sult1e1	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; ACTIVATED PROTEIN-KINASE; FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; ESTROGEN SULFOTRANSFERASE; LINKS INFLAMMATION; OXIDATIVE STRESS; KUPFFER CELLS; X-RECEPTOR; OBESITY	Myeloid cell and hepatocyte IKK beta may mediate the genesis of obesity and insulin resistance in mice fed high fat diet. However, their gender-specific roles in the pathogenesis of non-alcoholic steatohepatitis (NASH) are not known. Here we demonstrate myeloid IKK beta deficiency prevents Western diet-induced obesity and visceral adiposity in females but not in males, and attenuates hyperglycemia, global IR, and NASH in both genders. In contrast, all metabolic sequela including NASH are aggravated by hepatocyte IKK beta deficiency (Ikbkb Delta hep) in male but not female mice. Gene profiling identifies sulfotransferase family 1E (Sult1e1), which encodes a sulfotransferase E1 responsible for inactivation of estrogen, as a gene upregulated in NASH in both genders and most conspicuously in male Ikbkb Delta hep mice having worst NASH and lowest plasma estradiol levels. LXR alpha is enriched to LXRE on Sult1e1 promoter in male WT and Ikbkb Delta hep mice with NASH, and a Sult1e1 promoter activity is increased by LXR alpha and its ligand and augmented by expression of a S32A mutant of I kappa B alpha. These results demonstrate striking gender differences in regulation by IKK beta of high cholesterol saturated fat diet-induced metabolic changes including NASH and suggest hepatocyte IKK beta is protective in male due at least in part to its ability to repress LXR-induced Sult1e1. Our findings also raise a caution for systemic IKK inhibition for the treatment of NASH as it may exacerbate the disease in male patients.	[Matsushita, Noriko; Hassanein, Mohamed T.; Martinez-Clemente, Marcos; Lazaro, Raul; French, Samuel W.; Lai, Keane; Tsukamoto, Hidekazu] Univ Southern Calif, Southern Calif Res Ctr ALPD & Cirrhosis, Los Angeles, CA 90007 USA; [Matsushita, Noriko; Hassanein, Mohamed T.; Martinez-Clemente, Marcos; Lazaro, Raul; Lai, Keane; Tsukamoto, Hidekazu] Univ Southern Calif, Dept Pathol, Keck Sch Med, Los Angeles, CA 90089 USA; [French, Samuel W.] Harbor UCLA Med Ctr, Torrance, CA 90509 USA; [Xie, Wen] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Ctr Pharmacogenet, Pittsburgh, PA 15261 USA; [Karin, Michael] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Karin, Michael] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Tsukamoto, Hidekazu] Dept Vet Affairs Greater Los Angeles Healthcare S, Los Angeles, CA USA	University of Southern California; University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Diego; University of California System; University of California San Diego	Tsukamoto, H (corresponding author), Univ Southern Calif, Southern Calif Res Ctr ALPD & Cirrhosis, Los Angeles, CA 90007 USA.; Tsukamoto, H (corresponding author), Univ Southern Calif, Dept Pathol, Keck Sch Med, Los Angeles, CA 90089 USA.; Tsukamoto, H (corresponding author), Dept Vet Affairs Greater Los Angeles Healthcare S, Los Angeles, CA USA.	htsukamo@usc.edu	Xie, Wen/M-1768-2016		NIH [P50AA011999, K08AA025112]; Pfizer Inc. [1101BX001991]; Suntory Business Expert Ltd; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K08AA025112] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer Inc.(Pfizer); Suntory Business Expert Ltd; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by NIH grant P50AA011999 (Southern California Research Center for ALPD and Cirrhosis); NIH grant K08AA025112, which has supported Keane Lai's effort on this project; 1101BX001991 Medical Research Service of Department of Veterans Affairs, grants from Pfizer Inc., and Suntory Business Expert Ltd. Dr. Matsushita's current address is Support Center for Women Health Care Professionals and Researchers, Institute of Gastroenterology, Tokyo Women's Medical University, 8-1 Kawada-cho Shinjuku-ku, Tokyo, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Beraza N, 2008, GUT, V57, P655, DOI 10.1136/gut.2007.134288; Cortez-Pinto H, 2006, J HEPATOL, V44, P197, DOI 10.1016/j.jhep.2005.09.002; de Ledinghen V, 2006, J HEPATOL, V45, P592, DOI 10.1016/j.jhep.2006.05.008; Deng QG, 2005, HEPATOLOGY, V42, P905, DOI 10.1002/hep.20877; Espeland MA, 1998, DIABETES CARE, V21, P1589, DOI 10.2337/diacare.21.10.1589; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Gao H, 2006, MOL ENDOCRINOL, V20, P1287, DOI 10.1210/me.2006-0012; Gong HB, 2007, MOL ENDOCRINOL, V21, P1781, DOI 10.1210/me.2007-0187; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Haralanova-Ilieva B, 2005, J HEPATOL, V42, P565, DOI 10.1016/j.jhep.2004.12.021; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Khor VK, 2008, ENDOCRINOLOGY, V149, P5440, DOI 10.1210/en.2008-0271; LEITER EH, 1994, J CLIN INVEST, V93, P2007, DOI 10.1172/JCI117194; Louet Jean-Francois, 2004, Curr Atheroscler Rep, V6, P180, DOI 10.1007/s11883-004-0030-9; Maeda S, 2003, IMMUNITY, V19, P725, DOI 10.1016/S1074-7613(03)00301-7; Margolis KL, 2004, DIABETOLOGIA, V47, P1175, DOI 10.1007/s00125-004-1448-x; Matsuzawa N, 2007, HEPATOLOGY, V46, P1392, DOI 10.1002/hep.21874; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Onaga M, 2003, J HEPATOL, V39, P779, DOI 10.1016/S0168-8278(03)00361-1; Otogawa K, 2007, AM J PATHOL, V170, P967, DOI 10.2353/ajpath.2007.060441; Raes G, 2002, J LEUKOCYTE BIOL, V71, P597; Rich JN, 2003, J BIOL CHEM, V278, P15951, DOI 10.1074/jbc.M211498200; Saglam K, 2002, ENDOCRINE, V18, P211, DOI 10.1385/ENDO:18:3:211; Song WC, 2001, ANN NY ACAD SCI, V948, P43; Wang YW, 2005, J LIPID RES, V46, P2377, DOI 10.1194/jlr.M500134-JLR200; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu ZJ, 2009, DIGDISSCI; Yakar S, 2006, ENDOCRINOLOGY, V147, P5826, DOI 10.1210/en.2006-0311; Yatsuji S, 2007, HEPATOL RES, V37, P1034, DOI 10.1111/j.1872-034X.2007.00156.x; You M, 2004, GASTROENTEROLOGY, V127, P1798, DOI 10.1053/j.gastro.2004.09.049; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043	40	13	13	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0181052	10.1371/journal.pone.0181052	http://dx.doi.org/10.1371/journal.pone.0181052			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797077	Green Published, Green Submitted, gold			2022-12-26	WOS:000407396200012
J	Muller, NZ; Jha, A				Muller, Nicholas Z.; Jha, Akshaya			Does environmental policy affect scaling laws between population and pollution? Evidence from American metropolitan areas	PLOS ONE			English	Article							GROWTH; OZONE; LIFE	Modern cities are engines of production, innovation, and growth. However, urbanization also increases both local and global pollution from household consumption and firms' production. Do emissions change proportionately to city size or does pollution tend to outpace or lag urbanization? Do emissions scale differently with population versus economic growth or are emissions, population, and economic growth inextricably linked? How are the scaling relationships between emissions, population, and economic growth affected by environmental regulation? This paper examines the link between urbanization, economic growth and pollution using data from Metropolitan Statistical Areas (MSAs) in the United States between 1999 and 2011. We find that the emissions of local air pollution in these MSAs scale according to a power law with both population size and gross domestic product (GDP). However, the monetary damages from these local emissions scale linearly with both population and GDP. Counties that have previously been out of attainment with the local air quality standards set by the Clean Air Act show an entirely different relationship: local emissions scale according to the square root of population, while the monetary damages from local air pollution follow a 2/3 rds power law with population. Counties out of attainment are subject to more stringent emission controls; we argue based on this that enforcement of the Clean Air Act induces sublinear scaling between emissions, damages, and city size. In contrast, we find that metropolitan GDP scales super-linearly with population in all MSAs regardless of attainment status. Summarizing, our findings suggest that environmental policy limits the adverse effects of urbanization without interfering with the productivity benefits that manifest in cities.	[Muller, Nicholas Z.] Carnegie Mellon Univ, Dept Engn Publ Policy & Management, Pittsburgh, PA 15213 USA; [Muller, Nicholas Z.] Carnegie Mellon Univ, Tepper Sch Business, Pittsburgh, PA 15213 USA; [Jha, Akshaya] Carnegie Mellon Univ, Heinz Coll Informat Syst & Publ Policy, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University	Muller, NZ (corresponding author), Carnegie Mellon Univ, Dept Engn Publ Policy & Management, Pittsburgh, PA 15213 USA.; Muller, NZ (corresponding author), Carnegie Mellon Univ, Tepper Sch Business, Pittsburgh, PA 15213 USA.	nicholas.muller74@gmail.com		Muller, Nicholas/0000-0003-1712-6526	U.S. Environmental Protection Agency [RD83587301]	U.S. Environmental Protection Agency(United States Environmental Protection Agency)	This publication was developed under assistance agreement no. RD83587301 awarded by the U.S. Environmental Protection Agency. It has not been formally reviewed by EPA. The views expressed in this document are solely those of authors and do not necessarily reflect those of the Agency. EPA does not endorse any products or commercial services mentioned in this publication.	Arcaute E, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.0745; Bell ML, 2004, JAMA-J AM MED ASSOC, V292, P2372, DOI 10.1001/jama.292.19.2372; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2013, SCIENCE, V340, P1438, DOI 10.1126/science.1235823; Chen Y, 2010, DISCRETE DYN NAT SOC, V2010, P1; Ciccone A, 1996, AM ECON REV, V86, P54; DOCKERY DW, 1994, ANNU REV PUBL HEALTH, V15, P107, DOI 10.1146/annurev.pu.15.050194.000543; Fann N, 2009, AIR QUAL ATMOS HLTH, V2, P169, DOI 10.1007/s11869-009-0044-0; Fragkias M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064727; Glaeser EL, 2010, J URBAN ECON, V67, P404, DOI 10.1016/j.jue.2009.11.006; Glaeser EL, 1999, J URBAN ECON, V46, P254, DOI 10.1006/juec.1998.2121; Hermstadt E., 2016, AIR POLLUTION CAUSE; Jaramillo P, 2016, ENERG POLICY, V90, P202, DOI 10.1016/j.enpol.2015.12.035; Krewski D., 2009, RES REPORT; Lamsal LN, 2013, ENVIRON SCI TECHNOL, V47, P7855, DOI 10.1021/es400744g; Leitao JC, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150649; Louf R., 2014, ARXIV14018200; Louf R, 2014, ENVIRON PLANN B, V41, P767, DOI 10.1068/b4105c; Muller NZ, 2014, SCIENCE, V345, P873, DOI 10.1126/science.1253506; Muller NZ, 2014, ENVIRON DEV ECON, V19, P466, DOI 10.1017/S1355770X1300048X; Muller NZ, 2011, AM ECON REV, V101, P1649, DOI 10.1257/aer.101.5.1649; Muller NZ, 2009, AM ECON REV, V99, P1714, DOI 10.1257/aer.99.5.1714; Muller Nicholas Z., 2014, NBER BOOK SERIES INC, V72; National Academies of Science National Research Council (NAS NRC), 2009, HIDD COSTS EN UN PRI; Oliveira E. A., 2014, ARXIV14017720; Paulus F, 2016, KNOWLEDGE CREATING M, P157; Samaniego H., 2008, J TRANSP LAND USE, V1, P21, DOI [DOI 10.5198/JTLU.V1I1.29, 10.5198/jtlu.v1i1.29]; Smith VK, 2004, J ENVIRON ECON MANAG, V47, P559, DOI 10.1016/j.jeem.2003.10.006; United States Environmental Protection Agency, 2011, NAT EM INV NEI 2008; United States Environmental Protection Agency, 2002, NAT EM INV NEI 1999; United States Environmental Protection Agency, 2014, NAT EM INV NEI 2011; United States Environmental Protection Agency, 2008, NAT EM INV NEI 2005; United States Environmental Protection Agency, 2006, NAT EM INV NEI 2002; US EPA, 2011, BEN COSTS CLEAN AIR; Viscusi WK, 2003, J RISK UNCERTAINTY, V27, P5, DOI 10.1023/A:1025598106257	35	17	19	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0181407	10.1371/journal.pone.0181407	http://dx.doi.org/10.1371/journal.pone.0181407			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC9YJ	28792949	Green Published, Green Submitted, gold			2022-12-26	WOS:000407196700010
J	Sagar, V; Pilakka-Kanthikeel, S; Martinez, PC; Atluri, VSR; Nair, M				Sagar, Vidya; Pilakka-Kanthikeel, S.; Martinez, Paola C.; Atluri, V. S. R.; Nair, M.			Common gene-network signature of different neurological disorders and their potential implications to neuroAIDS	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GROWTH-FACTOR RECEPTOR; NF-KAPPA-B; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; HIV-1; EXPRESSION; CELLS; BRAIN	The neurological complications of AIDS (neuroAIDS) during the infection of human immunodeficiency virus (HIV) are symptomized by non-specific, multifaceted neurological conditions and therefore, defining a specific diagnosis/treatment mechanism(s) for this neuro-complexity at the molecular level remains elusive. Using an in silico based integrated gene network analysis we discovered that HIV infection shares convergent gene networks with each of twelve neurological disorders selected in this study. Importantly, a common gene network was identified among HIV infection, Alzheimer's disease, Parkinson's disease, multiple sclerosis, and age macular degeneration. An mRNA microarray analysis in HIV-infected monocytes showed significant changes in the expression of several genes of this in silico derived common pathway which suggests the possible physiological relevance of this gene-circuit in driving neuroAIDS condition. Further, this unique gene network was compared with another in silico derived novel, convergent gene network which is shared by seven major neurological disorders (Alzheimer's disease, Parkinson's disease, Multiple Sclerosis, Age Macular Degeneration, Amyotrophic Lateral Sclerosis, Vascular Dementia, and Restless Leg Syndrome). These networks differed in their gene circuits; however, in large, they involved innate immunity signaling pathways, which suggests commonalities in the immunological basis of different neuropathogenesis. The common gene circuits reported here can provide a prospective platform to understand how gene-circuits belonging to other neuro-disorders may be convoluted during real-time neuroAIDS condition and it may elucidate the underlying-and so far unknown-genetic overlap between HIV infection and neuroAIDS risk. Also, it may lead to a new paradigm in understanding disease progression, identifying biomarkers, and developing therapies.	[Sagar, Vidya; Pilakka-Kanthikeel, S.; Martinez, Paola C.; Atluri, V. S. R.; Nair, M.] Florida Int Univ, Herbert Wertheim Coll Med, Dept Immunol, Inst Neuroimmune Pharmacol,Ctr Personalized Nanom, Miami, FL 33199 USA	State University System of Florida; Florida International University	Nair, M (corresponding author), Florida Int Univ, Herbert Wertheim Coll Med, Dept Immunol, Inst Neuroimmune Pharmacol,Ctr Personalized Nanom, Miami, FL 33199 USA.	nairm@fiu.edu	Atluri, Venkata/G-3277-2014	Atluri, Venkata/0000-0002-8070-6745	National Institute of Health [R01DA040537, R01DA034547, 1R21MH101025, 1R03DA037782]; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA037782, R01DA034547, R01DA040537] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by grants R01DA040537, R01DA034547, 1R21MH101025 and 1R03DA037782 from the National Institute of Health.	Acharjee S, 2014, BRAIN BEHAV IMMUN, V40, P74, DOI 10.1016/j.bbi.2014.02.016; Adlakha YK, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-33; Agrawal L, 2010, BRAIN RES, V1306, P116, DOI 10.1016/j.brainres.2009.09.113; Alexaki A, 2008, CURR HIV RES, V6, P388, DOI 10.2174/157016208785861195; Anthony IC, 2008, INT REV PSYCHIATR, V20, P15, DOI 10.1080/09540260701862037; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Atluri V.S.R., 2013, PLOS ONE, V8; Atluri VSR, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00212; Atluri VSR, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-37; Avdoshina V, 2013, J INTERN MED, V273, P454, DOI 10.1111/joim.12050; Baker K, 2015, J CLIN INVEST, V125, P1670, DOI 10.1172/JCI79765; Baxter PA, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0160-4; Benveniste EN, 2004, BRAIN BEHAV IMMUN, V18, P7, DOI 10.1016/j.bbi.2003.09.001; Bissel SJ, 2004, BRAIN PATHOL, V14, P97, DOI 10.1111/j.1750-3639.2004.tb00503.x; Bomprezzi R, 2003, J MED GENET, V40, P553, DOI 10.1136/jmg.40.8.553; Boven LA, 2000, J NEUROVIROL, V6, P382, DOI 10.3109/13550280009018302; Burdo TH, 2013, IMMUNOL REV, V254, P102, DOI 10.1111/imr.12068; Chambers RA, 2013, GENES BRAIN BEHAV, V12, P564, DOI 10.1111/gbb.12051; Chan SF, 2015, GENOM DATA, V3, P24, DOI 10.1016/j.gdata.2014.10.022; Chun TW, 2000, NAT MED, V6, P757, DOI 10.1038/77481; Conant K, 1999, ANN NEUROL, V46, P391, DOI 10.1002/1531-8249(199909)46:3<391::AID-ANA15>3.0.CO;2-0; Cui JG, 2010, J BIOL CHEM, V285, P38951, DOI 10.1074/jbc.M110.178848; Almeida Sergio Monteiro de, 2006, Braz J Infect Dis, V10, P41, DOI 10.1590/S1413-86702006000100009; Deeks SG, 2012, NAT REV IMMUNOL, V12, P607, DOI 10.1038/nri3262; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Feng J., 2015, 21 ANN M ORG HUM BRA; Fields JA, 2015, CURR HIV RES, V13, P43, DOI 10.2174/1570162X13666150311164201; Galvez-Contreras AY, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00258; Gil-Perotin S, 2011, EUR J NEUROSCI, V34, P1040, DOI 10.1111/j.1460-9568.2011.07836.x; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Gray F, 1996, BRAIN PATHOL, V6, P1, DOI 10.1111/j.1750-3639.1996.tb00775.x; Holley JE, 2003, NEUROPATH APPL NEURO, V29, P434, DOI 10.1046/j.1365-2990.2003.00491.x; Irimia M, 2014, CELL, V159, P1511, DOI 10.1016/j.cell.2014.11.035; James T, 2016, J NEUROVIROL, V22, P403, DOI 10.1007/s13365-016-0436-5; Kauppinen A, 2016, CELL MOL LIFE SCI, V73, P1765, DOI 10.1007/s00018-016-2147-8; Kedmi M, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-66; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; King JE, 2006, MICROBES INFECT, V8, P1347, DOI 10.1016/j.micinf.2005.11.014; Kitagishi Y, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt265; Kitchen RR, 2014, NAT NEUROSCI, V17, P1491, DOI 10.1038/nn.3829; Kong LY, 1996, CELL IMMUNOL, V172, P77, DOI 10.1006/cimm.1996.0217; Kovalevich J, 2012, FUTURE VIROL, V7, P687, DOI 10.2217/FVL.12.57; Kramer-Hammerle S, 2005, VIRUS RES, V111, P194, DOI 10.1016/j.virusres.2005.04.009; Kurapati KRV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077624; Larocque D, 2005, NAT NEUROSCI, V8, P27, DOI 10.1038/nn1359; Letendre Scott L, 2009, Top HIV Med, V17, P46; Lin CH, 2013, BRIT J PHARMACOL, V168, P920, DOI 10.1111/j.1476-5381.2012.02227.x; Lin JJ, 2006, PARKINSONISM RELAT D, V12, P9, DOI 10.1016/j.parkreldis.2005.07.010; Lindl KA, 2010, J NEUROIMMUNE PHARM, V5, P294, DOI 10.1007/s11481-010-9205-z; Liu Y, 2014, J NEUROSCI, V34, P12982, DOI 10.1523/JNEUROSCI.1348-14.2014; Louboutin JP, 2012, SCI WORLD J, P1, DOI 10.1100/2012/482575; McArthur JC, 2005, LANCET NEUROL, V4, P543, DOI 10.1016/S1474-4422(05)70165-4; McCarro SA, 2014, NAT NEUROSCI, V17, P756, DOI 10.1038/nn.3716; Minagar A, 2008, MOL DIAGN THER, V12, P25, DOI 10.1007/BF03256266; Minic S, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-25; Mitsui J, 2014, BIOCHEM BIOPH RES CO, V452, P221, DOI 10.1016/j.bbrc.2014.07.098; Naegele M, 2014, HAND CLINIC, V122, P59, DOI 10.1016/B978-0-444-52001-2.00003-0; Nair M, 2016, SCI REP-UK, V6, DOI 10.1038/srep34862; Nair M, 2016, ADV DRUG DELIVER REV, V103, P202, DOI 10.1016/j.addr.2016.02.008; Obulesu M, 2014, NEUROCHEM RES, V39, P2301, DOI 10.1007/s11064-014-1454-4; Okamoto S, 2007, CELL STEM CELL, V1; Olivetta E, 2003, J IMMUNOL, V170, P1716, DOI 10.4049/jimmunol.170.4.1716; Pilakka-Kanthikeel S, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0285-9; Pusztai L, BR J CANC, V99, P385; Reed-Geaghan EG, 2010, J NEUROSCI, V30, P15369, DOI 10.1523/JNEUROSCI.2637-10.2010; Repunte-Canonigo V, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-26; Roy K, 2014, J ALZHEIMERS DIS, V38, P881, DOI 10.3233/JAD-130929; Ruan QS, 2006, BIOINFORMATICS, V22, P2532, DOI 10.1093/bioinformatics/btl417; Sagar V, 2014, REV MED VIROL, V24, P103, DOI 10.1002/rmv.1778; Samikkannu T, 2014, CURR HIV RES, V12, P397; Santiago JA, 2014, TRENDS MOL MED, V20, P694, DOI 10.1016/j.molmed.2014.10.002; Santiago JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083940; Singer EJ, 2010, NEUROL CLIN, V28, P253, DOI 10.1016/j.ncl.2009.09.018; Sospedra M, 2016, SEMIN NEUROL, V36, P115, DOI 10.1055/s-0036-1579739; Sporer B, 1998, J INFECT DIS, V178, P854, DOI 10.1086/515342; Tsuji S, 2010, HUM MOL GENET, V19, pR65, DOI 10.1093/hmg/ddq162; Van Lint C, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-67; Vesce S, 1997, FEBS LETT, V411, P107, DOI 10.1016/S0014-5793(97)00674-1; Wang L, 2012, P NATL ACAD SCI USA, V109, P16743, DOI 10.1073/pnas.1208011109; Wang QQ, 2015, TRANSL NEURODEGENER, V4, DOI 10.1186/s40035-015-0042-0; Xiromerisiou G, 2008, NEUROSCI LETT, V436, P232, DOI 10.1016/j.neulet.2008.03.026; Yang Q, 2011, J NEUROCHEM, V119, P644, DOI 10.1111/j.1471-4159.2011.07446.x; Zhang QP, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0264-0; Zhou BY, 2004, NEUROSCI LETT, V359, P155, DOI 10.1016/j.neulet.2004.02.012; Zhu XL, 2014, NAT NEUROSCI, V17, P773, DOI 10.1038/nn.3713	85	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2017	12	8							e0181642	10.1371/journal.pone.0181642	http://dx.doi.org/10.1371/journal.pone.0181642			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9EU	28792504	Green Submitted, Green Published, gold			2022-12-26	WOS:000407144700007
J	Thinesh, T; Meenatchi, R; Pasiyappazham, R; Jose, PA; Selvan, M; Kiran, GS; Selvin, J				Thinesh, Thangadurai; Meenatchi, Ramu; Pasiyappazham, Ramasamy; Jose, Polpass Arul; Selvan, Muthamizh; Kiran, George Seghal; Selvin, Joseph			Short-term in situ shading effectively mitigates linear progression of coral-killing sponge Terpios hoshinota	PLOS ONE			English	Article							PALK BAY; SOUTHEAST COAST; REEF; OUTBREAK; HEALTH; OCEAN; INDIA; LIGHT	The coral-killing sponge, Terpios hoshinota is a global invasive species that has conquered coral patches within a short span of time, which has led to a significant decline in living coral cover at various geographical locations. In this study, we surveyed the linear progression and impact of the Terpios invasion on live coral patches along Palk Bay, Indian Ocean, from August 2013 to August 2015. The field inventory revealed an extensive fatality rate of 76% as a result of Terpios outbreak. Experimental findings showed that symbiotic cyanobacteria act as a nutritional factory for the aggressive growth of Terpios. Shading hypothetically impairs the nutritional symbiont of the invasive species: the effect of sunlight on cyanobacterial biomass and its influence on Terpios progression over live coral patches was tested through in situ shading experiments. This study showed that artificial shading with cotton fabric could effectively mitigate sponge growth on live coral without affecting coral homeostasis.	[Thinesh, Thangadurai; Meenatchi, Ramu; Pasiyappazham, Ramasamy; Selvin, Joseph] Pondicherry Univ, Sch Life Sci, Dept Microbiol, Pondicherry, India; [Jose, Polpass Arul] Madurai Kamaraj Univ, Sch Biotechnol, Madurai, Tamil Nadu, India; [Selvan, Muthamizh] Pondicherry Univ, Sch Life Sci, Dept Ecol & Environm Sci, Pondicherry, India; [Kiran, George Seghal] Pondicherry Univ, Sch Life Sci, Dept Food Sci & Technol, Pondicherry, India; [Thinesh, Thangadurai] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Jose, Polpass Arul] CSIR, CSMCRI, Cent Salt & Marine Res Inst, Marine Biotechnol & Ecol Div, Bhavnagar, Gujarat, India	Pondicherry University; Madurai Kamaraj University; Pondicherry University; Pondicherry University; State University System of Florida; Florida International University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Salt & Marine Chemical Research Institute (CSMCRI)	Selvin, J (corresponding author), Pondicherry Univ, Sch Life Sci, Dept Microbiol, Pondicherry, India.	josephselvinss@gmail.com	Jose, Polpass Arul/H-9935-2013; Ramasamy, Pasiyappazham/AAR-7318-2021	Jose, Polpass Arul/0000-0003-4488-7048; Ramasamy, Pasiyappazham/0000-0003-0099-2102; Ramu, Meenatchi/0000-0001-6356-9067; Selvin, Joseph/0000-0001-9292-8145	UGC; USIEF; IDEA WILD	UGC(University Grants Commission, India); USIEF; IDEA WILD	The authors are thankful to Department of Biotechnology, Ministry of Science and Technology. TT is thankful to UGC for Kothari post-doctoral fellowship, USIEF for the current Fulbright fellowship, and IDEA WILD small grant for support.; We thank Microbial Genomics Lab, Department of Microbiology, Pondicherry University for facilities and Volunteers Manimaran and Saqib Hassan, who participated in this study. We also thank Forest department permission to carry out continuing part of this research at Palk Bay (Ref. No. WL(A)/16437/2014). TT thank USIEF for current Fulbright fellowship.	BRYAN P G, 1973, Micronesica, V9, P237; Carballo JL, 2013, ECOL EVOL, V3, P872, DOI 10.1002/ece3.452; Márquez Juan Carlos, 2006, Bol. Invest. Mar. Cost., V35, P259; Chen S-L, 2009, NATL PARK B, V19, P32; de Voogd NJ, 2013, CORAL REEFS, V32, P755, DOI 10.1007/s00338-013-1030-4; Edward JKP, 2015, INDIAN J GEO-MAR SCI, V44, P1449; Elliott J, 2016, CORAL REEFS, V35, P1083, DOI 10.1007/s00338-016-1434-z; Elliott J, 2016, MAR BIODIVERS, V46, P489, DOI 10.1007/s12526-015-0370-4; English S., 1997, SURVEY MANUAL MARINE, V2nd ed.; Fujii T, 2011, CORAL REEFS, V30, P483, DOI 10.1007/s00338-011-0734-6; Harrington L, 2004, ECOLOGY, V85, P3428, DOI 10.1890/04-0298; Liao MH, 2007, ZOOL STUD, V46, P520; Lin WJ, 2009, J NAT PARK, V19, P46; Manikandan B, 2016, REG STUD MAR SCI, V8, P151, DOI 10.1016/j.rsma.2016.07.005; Marimuthu N, 2016, AQUAT ECOSYST HEALTH, V19, P360, DOI 10.1080/14634988.2016.1258925; Mass T, 2010, J EXP BIOL, V213, P4084, DOI 10.1242/jeb.039891; Montano S, 2016, MAR FRESHWATER RES, V67, P1253, DOI 10.1071/MF14373; Montano S, 2015, B MAR SCI, V91, P97, DOI 10.5343/bms.2014.1054; NOAA-Coral-Reef-Watch, 2015, NOAA COR REEF WATCH; Park CH, 2004, J APPL POLYM SCI, V94, P248, DOI 10.1002/app.20879; Parsons T., 2013, MANUAL CHEM BIOL MET, DOI DOI 10.1016/B978-0-08-030287-4.50011-6; PLUCERROSARIO G, 1987, CORAL REEFS, V5, P197, DOI 10.1007/BF00300963; Rai A.N., 1990, CRC HDB SYMBIOTIC CY; Ramesh A.D., 1996, THESIS; Rau GH, 2012, NAT CLIM CHANGE, V2, P720, DOI 10.1038/NCLIMATE1555; Reimer JD, 2011, ZOOL STUD, V50, P394; Reimer JD, 2011, GALAXEA J CORAL REEF, V13, P35, DOI DOI 10.3755/GALAXEA.13.35; Rutzler K., 2002, Acta Geologica Hispanica, V37, P61; Rutzler Klaus, 1993, Scientia Marina, V57, P395; Schonberg CHL, 2008, MAR ECOL-EVOL PERSP, V29, P247, DOI 10.1111/j.1439-0485.2007.00216.x; Shi Q, 2012, AMBIO, V41, P446, DOI 10.1007/s13280-011-0245-2; Sukumaran S, 2011, INDIAN J FISH, V58, P73; Thinesh T, 2015, CURR SCI INDIA, V109, P1030; Wang JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131509; WILKINSON CR, 1983, SCIENCE, V219, P410, DOI 10.1126/science.219.4583.410; Wilson K, 1987, CURR PROTOC MOL BIOL, V2, P4, DOI DOI 10.1002/0471142727.MB0204S56; Yu CH, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/s40793-015-0011-3	37	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182365	10.1371/journal.pone.0182365	http://dx.doi.org/10.1371/journal.pone.0182365			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28787024	Green Published, Green Submitted, gold			2022-12-26	WOS:000406998800033
J	Kang, P; Wang, XY; Wu, HT; Zhu, HL; Hou, YQ; Wang, LM; Liu, YL				Kang, Ping; Wang, Xiuying; Wu, Huanting; Zhu, Huiling; Hou, Yongqing; Wang, Longmei; Liu, Yulan			Glutamate alleviates muscle protein loss by modulating TLR4, NODs, Akt/FOXO and mTOR signaling pathways in LPS-challenged piglets	PLOS ONE			English	Article							FOXO TRANSCRIPTION FACTORS; RODENT SKELETAL-MUSCLE; TOLL-LIKE RECEPTOR-4; WEANED PIGS; PROINFLAMMATORY CYTOKINES; INSULIN-RESISTANCE; UBIQUITIN LIGASES; LIPOPOLYSACCHARIDE; ATROPHY; RAT	The experiment was conducted to study the effect of the glutamate (Glu) on muscle protein loss through toll-like receptor 4 (TLR4), nucleotide-binding oligomerization domain proteins (NODs), Akt/Forkhead Box O (Akt/FOXO) and mammalian target of rapamycin (mTOR) signaling pathways in LPS-challenged piglets. Twenty-four weaned piglets were assigned into four treatments: (1) Control; (2) LPS+0% Glu; (3) LPS+1.0% Glu; (4) LPS+2.0% Glu. The experiment was lasted for 28 days. On d 28, the piglets in the LPS challenged groups were injected with LPS on 100 mu g/kg body weight (BW), and the piglets in the control group were injected with the same volume of 0.9% NaCl solution. After 4 h LPS or saline injection, the piglets were slaughtered and the muscle samples were collected. Glu supplementation increased the protein/DNA ratio in gastrocnemius muscle, and the protein content in longissimus dorsi (LD) muscle after LPS challenge (P < 0.05). In addition, Glu supplementation decreased TLR4, IL-1 receptor-associated kinase (IRAK) 1, receptor-interacting serine/threonine- protein kinase (RIPK) 2, and nuclear factor-kappa B (NF-kappa B) mRNA expression in gastrocnemius muscle (P < 0.05), MyD88 mRNA expression in LD muscle, and FOXO1 mRNA expression in LD muscle (P < 0.05). Moreover, Glu supplementation increased p-Akt/t-Akt ratio (P < 0.05) in gastrocnemius muscle, and p-4EBP1/t-4EBP1 ratio in both gastrocnemius and LD muscles (P < 0.05). Glu supplementation in the piglets' diets might be an effective strategy to alleviate LPS-induced muscle protein loss, which might be due to suppressing the mRNA expression of TLR4 and NODs signaling-related genes, and modulating Akt/ FOXO and mTOR signaling pathways.	[Kang, Ping; Wang, Xiuying; Wu, Huanting; Zhu, Huiling; Hou, Yongqing; Wang, Longmei; Liu, Yulan] Wuhan Polytech Univ, Hubei Collaborat Innovat Ctr Anim Nutr & Feed Saf, Hubei Key Lab Anim Nutr & Feed Sci, Wuhan, Hubei, Peoples R China	Wuhan Polytechnic University	Liu, YL (corresponding author), Wuhan Polytech Univ, Hubei Collaborat Innovat Ctr Anim Nutr & Feed Saf, Hubei Key Lab Anim Nutr & Feed Sci, Wuhan, Hubei, Peoples R China.	yulanflower@126.com		Wang, Xiuying/0000-0001-6693-3813	National Natural Science Foundation of China [31372318, 31422053]; Hubei Provincial Department of Education [T201508]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Provincial Department of Education	Funded by the National Natural Science Foundation of China (31372318 and 31422053), and the Project of the Hubei Provincial Department of Education (T201508), Yulan Liu.; This study was supported by the National Natural Science Foundation of China (31372318 and 31422053), and the Project of the Hubei Provincial Department of Education (T201508).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Almilaji A, 2012, BIOCHEM BIOPH RES CO, V421, P159, DOI 10.1016/j.bbrc.2012.03.109; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bruunsgaard H, 2001, CURR OPIN HEMATOL, V8, P131, DOI 10.1097/00062752-200105000-00001; CARLSON BM, 1973, AM J ANAT, V137, P119, DOI 10.1002/aja.1001370202; Correa RG, 2012, BIOSCIENCE REP, V32, P597, DOI 10.1042/BSR20120055; Crossland H, 2008, J PHYSIOL-LONDON, V586, P5589, DOI 10.1113/jphysiol.2008.160150; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; ENESCO M, 1962, J EMBRYOL EXP MORPH, V10, P530; Franch HA, 2005, CURR OPIN CLIN NUTR, V8, P271, DOI 10.1097/01.mco.0000165005.01331.45; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Frisard MI, 2015, METABOLISM, V64, P416, DOI 10.1016/j.metabol.2014.11.007; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; JEPSON MM, 1986, BIOCHEM J, V235, P329, DOI 10.1042/bj2350329; Jortay J, 2010, ENDOCRINOLOGY, V151, P4840, DOI 10.1210/en.2009-1462; Juhasz B, 2008, AM J PHYSIOL-HEART C, V294, pH1365, DOI 10.1152/ajpheart.01005.2007; Kandarian SC, 2006, MUSCLE NERVE, V33, P155, DOI 10.1002/mus.20442; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Kessel A, 2008, CLIN EXP IMMUNOL, V151, P341, DOI 10.1111/j.1365-2249.2007.03571.x; Kim J, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105080; Kimmel PL, 1998, KIDNEY INT, V54, P236, DOI 10.1046/j.1523-1755.1998.00981.x; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; Lang CH, 2002, AM J PHYSIOL-ENDOC M, V282, pE336, DOI 10.1152/ajpendo.00366.2001; Lang CH, 2007, AM J PHYSIOL-ENDOC M, V293, pE453, DOI 10.1152/ajpendo.00204.2007; Lang CH, 2010, AM J PHYSIOL-ENDOC M, V298, pE1283, DOI 10.1152/ajpendo.00676.2009; Li Q, 2012, INNATE IMMUN-LONDON, V18, P804, DOI 10.1177/1753425912441955; Liu Y., 2016, EVID-BASED COMPL ALT, V2016, P1, DOI DOI 10.1007/S10291-016-0529-X; Liu Y, 2008, BRIT J NUTR, V100, P552, DOI 10.1017/S0007114508911612; Liu YL, 2013, J NUTR, V143, P1331, DOI 10.3945/jn.113.176255; Liu YL, 2012, J NUTR, V142, P2017, DOI 10.3945/jn.112.164947; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Lopez-Colome AM, 2012, ASN NEURO, V4, P331, DOI 10.1042/AN20120022; McKinnell LW, 2004, CELL, V119, P907, DOI 10.1016/j.cell.2004.12.007; Moreira LO, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00328; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nagata C, 2015, J NUTR, V145, P720, DOI 10.3945/jn.114.201293; NRC, 1998, NUTR REQ SWIN, DOI [10.17226/6016, DOI 10.17226/6016]; PETERSSON B, 1995, CLIN SCI, V88, P479, DOI 10.1042/cs0880479; Philpott DJ, 2014, NAT REV IMMUNOL, V14, P9, DOI 10.1038/nri3565; Radin MS, 2008, DIABETOLOGIA, V51, P336, DOI 10.1007/s00125-007-0861-3; Rezaei R, 2013, AMINO ACIDS, V44, P911, DOI 10.1007/s00726-012-1420-x; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Stentz FB, 2004, DIABETES, V53, P2079, DOI 10.2337/diabetes.53.8.2079; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Storch D, 2003, J COMP PHYSIOL B, V173, P611, DOI 10.1007/s00360-003-0371-7; VelazFaircloth M, 1996, AM J PHYSIOL-CELL PH, V270, pC67, DOI 10.1152/ajpcell.1996.270.1.C67; Wang XN, 2006, ENDOCRINOLOGY, V147, P4160, DOI 10.1210/en.2006-0251; Wu GY, 2013, AMINO ACIDS, V44, P1107, DOI 10.1007/s00726-012-1444-2; Wu GY, 1998, J NUTR, V128, P1249, DOI 10.1093/jn/128.8.1249; Xiang PJ, 2015, INFLAMM RES, V64, P799, DOI 10.1007/s00011-015-0863-4; Zlotchenko E, 2001, NAT CELL BIOL, V3, P1014, DOI DOI 10.1038/NCB1101	57	11	14	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0182246	10.1371/journal.pone.0182246	http://dx.doi.org/10.1371/journal.pone.0182246			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28783736	gold, Green Published, Green Submitted			2022-12-26	WOS:000406944300024
J	Wang, N; Wang, RQ; Wang, RK; Tian, YS; Shao, CW; Jia, XD; Chen, SL				Wang, Na; Wang, Ruoqing; Wang, Renkai; Tian, Yongsheng; Shao, Changwei; Jia, Xiaodong; Chen, Songlin			The integrated analysis of RNA-seq and microRNA-seq depicts miRNA-mRNA networks involved in Japanese flounder (Paralichthys olivaceus) albinism	PLOS ONE			English	Article							NEURAL CREST; SKIN PIGMENTATION; EXPRESSION; SURVIVAL; MELANOMA; TRANSCRIPTION; MUTATIONS; GROWTH; LOCALIZATION; ENRICHMENT	Albinism, a phenomenon characterized by pigmentation deficiency on the ocular side of Japanese flounder (Paralichthys olivaceus), has caused significant damage. Limited mRNA and microRNA (miRNA) information is available on fish pigmentation deficiency. In this study, a high-throughput sequencing strategy was employed to identify the mRNA and miRNAs involved in P. olivaceus albinism. Based on P. olivaceus genome, RNA-seq identified 21,787 know genes and 711 new genes by transcripts assembly. Of those, 235 genes exhibited significantly different expression pattern (fold change >= 2 or <= 0.5 and q-value<0.05), including 194 down-regulated genes and 41 up-regulated genes in albino versus normally pigmented individuals. These genes were enriched to 81 GO terms and 9 KEGG pathways (p<0.05). Among those, the pigmentation related pathways-Melanogenesis and tyrosine metabolism were contained. High-throughput miRNA sequencing identified a total of 475 miRNAs, including 64 novel miRNAs. Furthermore, 33 differentially expressed miRNAs containing 13 up-regulated and 20 down-regulated miRNAs were identified in albino versus normally pigmented individuals (fold change >= 1.5 or <= 0.67 and p<0.05). The next target prediction discovered a variety of putative target genes, of which, 134 genes including Tyrosinase (TYR), Tyrosinase-related protein 1 (TYRP1), Microphthalmia-associated transcription factor (MITF) were overlapped with differentially expressed genes derived from RNA-seq. These target genes were significantly enriched to 254 GO terms and 103 KEGG pathways (p<0.001). Of those, tyrosine metabolism, lysosomes, phototransduction pathways, etc., attracted considerable attention due to their involvement in regulating skin pigmentation. Expression patterns of differentially expressed mRNA and miRNAs were validated in 10 mRNA and 10 miRNAs by qRT-PCR. With high-throughput mRNA and miRNA sequencing and analysis, a series of interested mRNA and miRNAs involved in fish pigmentation are identified. And the miRNA-mRNA regulatory network also provides a solid starting point for further elucidation of fish pigmentation deficiency.	[Wang, Na; Wang, Ruoqing; Wang, Renkai; Tian, Yongsheng; Shao, Changwei; Chen, Songlin] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Minist Agr, Key Lab Sustainable Dev Marine Fisheries, Qingdao, Peoples R China; [Wang, Na; Tian, Yongsheng; Shao, Changwei; Chen, Songlin] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China; [Wang, Ruoqing; Wang, Renkai] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai, Peoples R China; [Jia, Xiaodong] Chinese Acad Sci, Beijing Inst Genom, Joint Lab Translat Med Res, Liaocheng, Peoples R China; [Jia, Xiaodong] Liaocheng Peoples Hosp, Liaocheng, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Qingdao National Laboratory for Marine Science & Technology; Shanghai Ocean University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS	Wang, N; Chen, SL (corresponding author), Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Minist Agr, Key Lab Sustainable Dev Marine Fisheries, Qingdao, Peoples R China.; Wang, N; Chen, SL (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China.	wangna@ysfri.ac.cn; chensl@ysfri.ac.cn	Shao, Changwei/I-2054-2016	Shao, Changwei/0000-0002-6953-2203	National Natural Science Foundation of China [31472273, 31461163005]; Taishan Scholar Climb Project of Shandong Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholar Climb Project of Shandong Province	This work was supported by grants from the National Natural Science Foundation of China (NW, 31472273; SLC, 31461163005) (http://www.nsfc.gov.cn/), and the Taishan Scholar Climb Project of Shandong Province (SLC, http//vvNekvrcsiigoycrugongcriengishengiigongcheng/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Malek Z, 2000, PIGM CELL RES, V13, P156, DOI 10.1034/j.1600-0749.13.s8.28.x; Allison WT, 2006, VISUAL NEUROSCI, V23, P25, DOI 10.1017/S0952523806231031; Ando H, 2007, J INVEST DERMATOL, V127, P751, DOI 10.1038/sj.jid.5700683; Baek S, 2014, BRAIN RES, V1587, P23, DOI 10.1016/j.brainres.2014.08.059; Baker EP, 1998, J WORLD AQUACULT SOC, V29, P494, DOI 10.1111/j.1749-7345.1998.tb00675.x; Baxter LL, 2009, WIRES SYST BIOL MED, V1, P359, DOI 10.1002/wsbm.20; Bennett DC, 2003, PIGM CELL RES, V16, P333, DOI 10.1034/j.1600-0749.2003.00067.x; Bertolesi GE, 2016, PIGM CELL MELANOMA R, V29, P186, DOI 10.1111/pcmr.12442; Bertolesi GE, 2015, PIGM CELL MELANOMA R, V28, P559, DOI 10.1111/pcmr.12387; Bilandzija H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080823; Bizuayehu TT, 2014, GENOME BIOL EVOL, V6, P1911, DOI 10.1093/gbe/evu151; Braasch I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-74; Braasch I, 2009, PIGM CELL MELANOMA R, V22, P839, DOI 10.1111/j.1755-148X.2009.00614.x; Caramuta S, 2010, J INVEST DERMATOL, V130, P2062, DOI 10.1038/jid.2010.63; Chi A, 2006, J PROTEOME RES, V5, P3135, DOI 10.1021/pr060363j; Couts KL, 2013, ONCOGENE, V32, P1959, DOI 10.1038/onc.2012.209; Denson MR, 1997, J WORLD AQUACULT SOC, V28, P366, DOI 10.1111/j.1749-7345.1997.tb00283.x; Dong CS, 2012, RNA, V18, P1679, DOI 10.1261/rna.033977.112; Drogemuueller C, 2007, J HERED, V98, P468, DOI 10.1093/jhered/esm021; Eberhart JK, 2008, NAT GENET, V40, P290, DOI 10.1038/ng.82; Estevez A, 1999, AQUACULTURE, V180, P321, DOI 10.1016/S0044-8486(99)00209-4; Farabee WC, 1903, SCIENCE, V17, P75, DOI 10.1126/science.17.419.75; Fu YS, 2012, COMP BIOCHEM PHYS B, V161, P226, DOI 10.1016/j.cbpb.2011.11.009; Fu YS, 2013, COMP BIOCHEM PHYS B, V165, P106, DOI 10.1016/j.cbpb.2013.03.012; Fu YS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022957; Fujii R, 2000, PIGM CELL RES, V13, P300, DOI 10.1034/j.1600-0749.2000.130502.x; Fukamachi S, 2004, GENETICS, V168, P1519, DOI 10.1534/genetics.104.030494; Goding CR, 2000, GENE DEV, V14, P1712; Gu YF, 2014, GEN COMP ENDOCR, V204, P181, DOI 10.1016/j.ygcen.2014.05.019; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hoek KS, 2008, PIGM CELL MELANOMA R, V21, P665, DOI 10.1111/j.1755-148X.2008.00505.x; Hou L, 2006, P NATL ACAD SCI USA, V103, P9081, DOI 10.1073/pnas.0603114103; Ishida Y, 2006, GENOMICS, V88, P698, DOI 10.1016/j.ygeno.2006.06.006; Kanazawa Akio, 1993, Journal of the World Aquaculture Society, V24, P162, DOI 10.1111/j.1749-7345.1993.tb00005.x; Kang HY, 2004, BRIT J DERMATOL, V150, P462, DOI 10.1111/j.1365-2133.2004.05844.x; Kelsh RN, 1996, DEVELOPMENT, V123, P369; Kim KH, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12179; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Levati L, 2009, INT J ONCOL, V35, P393, DOI 10.3892/ijo_00000352; Lin CY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3829; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Maresca V, 2013, PIGM CELL MELANOMA R, V26, P113, DOI 10.1111/j.1755-148X.2012.01042.x; Mione M, 2015, PIGM CELL MELANOMA R, V28, DOI 10.1111/pcmr.12346; Moraes MN, 2015, PHOTOCHEM PHOTOBIOL, V91, P1133, DOI 10.1111/php.12484; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagatsu T, 1995, ESSAYS BIOCHEM, V30, P15; Nemlich Y, 2013, J CLIN INVEST, V123, P2703, DOI 10.1172/JCI62980; Oetting WS, 1999, HUM MUTAT, V13, P99, DOI 10.1002/(SICI)1098-1004(1999)13:2<99::AID-HUMU2>3.3.CO;2-3; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; SEIKAI T, 1985, B JPN SOC SCI FISH, V51, P1261; Sepulveda-Vazquez HE, 2014, INT OPHTHALMOL, V34, P1075, DOI 10.1007/s10792-014-9912-1; Shao CW, 2017, NAT GENET, V49, P119, DOI 10.1038/ng.3732; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; VIJAYASARADHI S, 1995, J CELL BIOL, V130, P807, DOI 10.1083/jcb.130.4.807; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xie CX, 2011, COMP FUNCT GENOM, DOI 10.1155/2011/256038; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yamaguchi Y, 2007, J BIOL CHEM, V282, P27557, DOI 10.1074/jbc.R700026200; Yamaguchi Y, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a017046; Yan B, 2013, J CELL SCI, V126, P3401, DOI 10.1242/jcs.125831; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zehir A, 2010, DEV BIOL, V340, P459, DOI 10.1016/j.ydbio.2010.01.039; Zhang BC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-878; Zhu Z, 2010, DOMEST ANIM ENDOCRIN, V38, P200, DOI 10.1016/j.domaniend.2009.10.004	68	11	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0181761	10.1371/journal.pone.0181761	http://dx.doi.org/10.1371/journal.pone.0181761			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28777813	Green Published, Green Submitted, gold			2022-12-26	WOS:000406944300011
J	Zhang, T; Li, J; Yin, F; Lin, B; Wang, Z; Xu, J; Wang, H; Zuo, D; Wang, G; Hua, Y; Cai, Z				Zhang, T.; Li, J.; Yin, F.; Lin, B.; Wang, Z.; Xu, J.; Wang, H.; Zuo, D.; Wang, G.; Hua, Y.; Cai, Z.			Toosendanin demonstrates promising antitumor efficacy in osteosarcoma by targeting STAT3	ONCOGENE			English	Article							HISTONE DEACETYLASE INHIBITOR; BREAST-CANCER; TUMOR-METASTASIS; MALIGNANT-CELLS; EXPRESSION; ANGIOGENESIS; ACTIVATION; PATHWAY; OVEREXPRESSION; SPECIFICITY	Signal transducer and activator of transcription 3(STAT3) is an emerging target for cancer therapy. In this study, we identify Toosendanin (TSN) is an effective inhibitor of STAT3, leading to the impediment of various oncogenic processes in osteosarcoma. TSN selectively inactivates phospho-STAT3 (Tyr-705); subsequent molecular docking and in vitro SPR analysis uncover TSN directly binds to the SH2 domain of STAT3. Consequently, TSN blocks STAT3 dimerization and impairs the complex formation of STAT3 and epidermal growth factor receptor (EGFR). In an animal tumor model study, TSN is well tolerated, inhibits osteosarcoma growth and metastasis. In another osteosarcoma patient-derived xenografts (PDX) model, we find TSN triggers strong inhibitory effects on patient-derived tumors. Further studies show that TSN also displays activity against other solid tumors. Our preclinical work therefore supports that TSN acts as a novel inhibitor of STAT3 that blocks tumorigenesis in ostoesarcoma.	[Zhang, T.; Yin, F.; Wang, Z.; Hua, Y.; Cai, Z.] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Orthoped, Shanghai, Peoples R China; [Zhang, T.; Yin, F.; Lin, B.; Wang, Z.; Wang, H.; Zuo, D.; Wang, G.; Hua, Y.; Cai, Z.] Shanghai Bone Tumor Inst, Shanghai, Peoples R China; [Li, J.] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Inst Translat Med, Shanghai, Peoples R China; [Xu, J.] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Pharmacol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhang, T; Hua, Y; Cai, Z (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Orthopaed, 100 Haining Rd, Shanghai 200080, Peoples R China.	zhangtaoabc@2008.sina.com; hua_yingqi@163.com; czd856@vip.163.com			NSFC [81502604]; Shanghai Science and Technology Commission [14140904000]; Doctoral Innovation Fund of Shanghai Jiaotong University School of Medicine [BXJ201732]; Research Grant from Shanghai Hospital Development Center [SHDC12013107]	NSFC(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM)); Doctoral Innovation Fund of Shanghai Jiaotong University School of Medicine; Research Grant from Shanghai Hospital Development Center	This work was supported by NSFC (81502604); Shanghai Science and Technology Commission (14140904000); Doctoral Innovation Fund of Shanghai Jiaotong University School of Medicine (No. BXJ201732) and Research Grant from Shanghai Hospital Development Center (SHDC12013107).	Bharadwaj U, 2015, ONCOGENE, V34, P1341, DOI 10.1038/onc.2014.72; Bharti AC, 2003, J IMMUNOL, V171, P3863, DOI 10.4049/jimmunol.171.7.3863; Butler MS, 2008, NAT PROD REP, V25, P475, DOI 10.1039/b514294f; Cao L, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111928; Chun J, 2015, CANCER LETT, V357, P393, DOI 10.1016/j.canlet.2014.11.049; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Devarajan E, 2009, CURR MOL MED, V9, P626, DOI 10.2174/156652409788488720; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Ferrara N, 2002, NAT REV CANCER, V2, P795, DOI 10.1038/nrc909; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Fossey SL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-81; Haan S, 1999, J BIOL CHEM, V274, P1342, DOI 10.1074/jbc.274.3.1342; Hao WS, 2008, BIOORG MED CHEM LETT, V18, P4988, DOI 10.1016/j.bmcl.2008.08.032; Hayakawa F, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.63; Hsieh FC, 2005, BIOCHEM BIOPH RES CO, V335, P292, DOI 10.1016/j.bbrc.2005.07.075; Isakoff MS, 2015, J CLIN ONCOL, V33, P3029, DOI 10.1200/JCO.2014.59.4895; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kotha A, 2006, MOL CANCER THER, V5, P621, DOI 10.1158/1535-7163.MCT-05-0268; Li JJ, 2015, BRIT J PHARMACOL, V172, P3817, DOI 10.1111/bph.13165; Lu XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep34225; Malaney P, 2014, CANCER LETT, V344, P1, DOI 10.1016/j.canlet.2013.10.010; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; Nair RR, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00030; Nakajima M, 1991, Semin Cancer Biol, V2, P115; NICOLSON GL, 1988, CANCER METAST REV, V7, P143, DOI 10.1007/BF00046483; Niu GL, 2002, ONCOGENE, V21, P2000, DOI 10.1038/sj.onc.1205260; Picci P, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-6; Real PJ, 2002, ONCOGENE, V21, P7611, DOI 10.1038/sj.onc.1206004; Ryu K, 2010, J ORTHOP RES, V28, P971, DOI 10.1002/jor.21088; Sakai I, 2002, BLOOD, V100, P2926, DOI 10.1182/blood-2002-01-0073; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Su YX, 2009, CLIN EXP METASTAS, V26, P599, DOI 10.1007/s10585-009-9259-6; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wang JQ, 2014, BREAST CANCER RES TR, V148, P279, DOI 10.1007/s10549-014-3165-6; Xiong H, 2012, J BIOL CHEM, V287, P5819, DOI 10.1074/jbc.M111.295964; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang HY, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3640; ZHANG T, 2016, CELL DEATH DIS, V7; Zhang T, 2014, NEOPLASIA, V16, P665, DOI 10.1016/j.neo.2014.07.009; Zhang T, 2012, BREAST CANCER RES TR, V135, P445, DOI 10.1007/s10549-012-2175-5; Zhang XL, 2013, CANCER RES, V73, P1922, DOI 10.1158/0008-5472.CAN-12-3175; Zhang XL, 2010, BIOCHEM PHARMACOL, V79, P1398, DOI 10.1016/j.bcp.2010.01.001	43	81	84	3	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 23	2017	36	47					6627	6639		10.1038/onc.2017.270	http://dx.doi.org/10.1038/onc.2017.270			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FN5LN	28783167	Green Published, hybrid			2022-12-26	WOS:000416049200011
J	Zotter, A; Bauerle, F; Dey, D; Kiss, V; Schreiber, G				Zotter, Agnes; Baeuerle, Felix; Dey, Debabrata; Kiss, Vladimir; Schreiber, Gideon			Quantifying enzyme activity in living cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; BETA-LACTAMASE; PROTEIN; VITRO; THERMODYNAMICS; ENVIRONMENTS; MECHANISM; CATALYSIS; KINETICS; PROGRESS	For over a century, enzymatic activity has been studied in vitro, assuming similar activity in the crowded cellular milieu. Here, we determined in real time the catalytic activity of TEM1-beta-lactamase inside living cells and compared the values to those obtained in vitro. We found the apparent in vivo catalytic efficiency, k(cat)/K-m, to be lower than in vitro, with significant cell-tocell variability. Surprisingly, the results show that inside the cell the apparent catalytic efficiency decreases, and Km increases with increasing enzyme concentration. To rationalize these findings, we measured enzyme and substrate diffusion rates in the cell and found the latter to be slower than expected. Simulations showed that for attenuated diffusion the substrate flux becomes rate-limiting, explaining why reaction rates in vivo can be independent on enzyme concentrations. The octanol/water partition of the substrate is 4.5, which is in the range of Food and Drug Administration-approved drugs. This suggests substrate-limited reaction rates to be common. These findings indicate that in vitro data cannot be simply extrapolated to the crowded in vivo environment.	[Zotter, Agnes; Baeuerle, Felix; Dey, Debabrata; Kiss, Vladimir; Schreiber, Gideon] Weizmann Inst Sci, Dept Biomol Sci, IL-76100 Rehovot, Israel; [Baeuerle, Felix] Max Planck Inst Dynam & Self Org, D-37077 Gottingen, Germany	Weizmann Institute of Science; Max Planck Society	Schreiber, G (corresponding author), Weizmann Inst Sci, Dept Biomol Sci, IL-76100 Rehovot, Israel.	gideon.schreiber@weizmann.ac.il	DEY, DEBABRATA/AAR-5740-2021	DEY, DEBABRATA/0000-0003-3794-6476	Israel Science Foundation [1549/14]	Israel Science Foundation(Israel Science Foundation)	This work was supported by Israel Science Foundation Grant 1549/14. The authors declare that they have no conflicts of interest with the contents of this article.	Bauerle F, 2017, PROTEIN ENG DES SEL, V30, P151, DOI 10.1093/protein/gzw053; Barbieri L, 2016, NAT PROTOC, V11, P1101, DOI 10.1038/nprot.2016.061; BERG OG, 1990, BIOPOLYMERS, V30, P1027, DOI 10.1002/bip.360301104; Briggs GE, 1925, BIOCHEM J, V19, P338, DOI 10.1042/bj0190338; Danielsson J, 2015, P NATL ACAD SCI USA, V112, P12402, DOI 10.1073/pnas.1511308112; Davidi D, 2016, P NATL ACAD SCI USA, V113, P3401, DOI 10.1073/pnas.1514240113; Deichmann U, 2014, FEBS J, V281, P435, DOI 10.1111/febs.12598; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Frederick KK, 2015, CELL, V163, P620, DOI 10.1016/j.cell.2015.09.024; Garcia-Contreras R, 2012, FEBS J, V279, P4145, DOI 10.1111/febs.12007; Hooff GP, 2012, J PROTEOME RES, V11, P79, DOI 10.1021/pr200858r; Kovarik ML, 2011, TRENDS BIOTECHNOL, V29, P222, DOI 10.1016/j.tibtech.2011.01.003; Kuznetsova IM, 2014, INT J MOL SCI, V15, P23090, DOI 10.3390/ijms151223090; LAMOTTEBRASSEUR J, 1991, BIOCHEM J, V279, P213, DOI 10.1042/bj2790213; LAVERY PE, 1992, J BIOL CHEM, V267, P9307; Levin D, 2011, MOL CELL BIOL, V31, P3252, DOI 10.1128/MCB.05251-11; Marr C, 2016, CURR OPIN BIOTECH, V39, P207, DOI 10.1016/j.copbio.2016.04.015; MATAGNE A, 1995, BBA-PROTEIN STRUCT M, V1246, P109, DOI 10.1016/0167-4838(94)00177-I; Michaelis L, 1913, BIOCHEM Z, V49, P333; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; MINTON AP, 1981, BIOCHEMISTRY-US, V20, P4821, DOI 10.1021/bi00520a003; Norris MGS, 2011, BIOCHEM BIOPH RES CO, V405, P388, DOI 10.1016/j.bbrc.2011.01.037; Page MI, 1999, CURR PHARM DESIGN, V5, P895; Parry BR, 2014, CELL, V156, P183, DOI 10.1016/j.cell.2013.11.028; Peleg Y, 2014, METHODS MOL BIOL, V1116, P73, DOI 10.1007/978-1-62703-764-8_6; Phillip Y, 2013, FEBS LETT, V587, P1046, DOI 10.1016/j.febslet.2013.01.007; Phillip Y, 2012, P NATL ACAD SCI USA, V109, P1461, DOI 10.1073/pnas.1112171109; Rohwer JM, 1998, P NATL ACAD SCI USA, V95, P10547, DOI 10.1073/pnas.95.18.10547; Schnell S, 2004, PROG BIOPHYS MOL BIO, V85, P235, DOI 10.1016/j.pbiomolbio.2004.01.012; Sharp KA, 2015, P NATL ACAD SCI USA, V112, P7990, DOI 10.1073/pnas.1505396112; Shoemaker GK, 2005, ANAL CHEM, V77, P3132, DOI 10.1021/ac0481304; Smith AE, 2016, P NATL ACAD SCI USA, V113, P1725, DOI 10.1073/pnas.1518620113; van Eunen K, 2010, FEBS J, V277, P749, DOI 10.1111/j.1742-4658.2009.07524.x; Yue SH, 2016, CURR OPIN CHEM BIOL, V33, P46, DOI 10.1016/j.cbpa.2016.05.016; Zlokarnik G, 1998, SCIENCE, V279, P84, DOI 10.1126/science.279.5347.84	35	40	41	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15838	15848		10.1074/jbc.M117.792119	http://dx.doi.org/10.1074/jbc.M117.792119			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28784664	hybrid, Green Published			2022-12-26	WOS:000411512200021
J	Cho, CY; Lo, YC; Hung, MC; Lai, CC; Chen, CJ; Wu, KG				Cho, Ching-Yi; Lo, Yu-Cheng; Hung, Miao-Chiu; Lai, Chou-Cheng; Chen, Chun-Jen; Wu, Keh-Gong			Risk of cancer in patients with genital warts: A nationwide, population-based cohort study in Taiwan	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS INFECTION; NECK-CANCER; CONDYLOMATA ACUMINATA; MALIGNANT-TRANSFORMATION; CERVICAL-CANCER; HEAD; EPIDEMIOLOGY; HPV; ASSOCIATION	Background Condyloma acuminata currently affects around 1% of sexually active adults, and its incidence is increasing. The coexistence of genital warts (GW) and certain cancers and an association between human papillomavirus (HPV) and various malignancies have been reported. Therefore, we conducted this large national study to analyze the risk of malignancies among men and women with GW in Taiwan. Methods and findings Between January 2000 and December 2013, approximately 3 million patients were reported to the National Health Insurance Research Database of Taiwan. Of these patients, 21,763 were diagnosed with GW. In the same time period, a total of 213,541 cancer cases were reported to the registry, of which 1002 were recorded among patients with GW. The age-specific incidence rates of GW and standardized incidence ratios (SIRs) of malignancies compared to the general population were calculated. Women acquired GW earlier than men, with a mean age at diagnosis of 32.63 +/- 12.78 years. The highest incidence rate for both genders peaked at 20-29 years. Of the 1002 patients with GW and malignancies, the SIR was 1.95 (95% CI 1.83-2.07). The most markedly increased risk was found for HPV-related cancers, with a SIR of 9.74 (95% CI 3.70-15.77). Significantly elevated risks were also noted for smoking-related cancers, anogenital cancers, cervix in situ, colon, rectum, lung, kidney, and prostate cancers. Most cancers developed within 10 years after the diagnosis of GW. Conclusions Patients with GW have an increased risk of HPV-related cancers, especially anogenital malignancies in Taiwan. The elevated risk of other cancers highlights differences in exposure and risk factors among patients with GW compared to the general population. Cancer screening and HPV vaccination programs should be emphasized for at-risk patients.	[Cho, Ching-Yi; Lo, Yu-Cheng; Hung, Miao-Chiu; Lai, Chou-Cheng; Chen, Chun-Jen; Wu, Keh-Gong] Taipei Vet Gen Hosp, Dept Pediat, Taipei, Taiwan; [Cho, Ching-Yi; Lo, Yu-Cheng; Hung, Miao-Chiu; Lai, Chou-Cheng; Chen, Chun-Jen; Wu, Keh-Gong] Natl Yang Ming Univ, Taipei, Taiwan; [Cho, Ching-Yi; Hung, Miao-Chiu; Lai, Chou-Cheng; Chen, Chun-Jen; Wu, Keh-Gong] Taipei Vet Gen Hosp, Dept Pediat, Div Infect Dis, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Wu, KG (corresponding author), Taipei Vet Gen Hosp, Dept Pediat, Taipei, Taiwan.; Wu, KG (corresponding author), Natl Yang Ming Univ, Taipei, Taiwan.; Wu, KG (corresponding author), Taipei Vet Gen Hosp, Dept Pediat, Div Infect Dis, Taipei, Taiwan.	kgwu@vghtpe.gov.tw						Blomberg M, 2012, J INFECT DIS, V205, P1544, DOI 10.1093/infdis/jis228; BRINTON LA, 1990, GYNECOL ONCOL, V38, P49, DOI 10.1016/0090-8258(90)90010-I; Brown DR, 1999, J CLIN MICROBIOL, V37, P3316, DOI 10.1128/JCM.37.10.3316-3322.1999; BROWN DR, 1993, J CLIN MICROBIOL, V31, P2667, DOI 10.1128/JCM.31.10.2667-2673.1993; Chaturvedi AK, 2010, J ADOLESCENT HEALTH, V46, pS20, DOI 10.1016/j.jadohealth.2010.01.016; Chen CA, 2006, INT J GYNECOL CANCER, V16, P1801, DOI 10.1111/j.1525-1438.2006.00655.x; Chiou HL, 2003, CANCER, V97, P1558, DOI 10.1002/cncr.11191; D'Souza G, 2011, PREV MED, V53, pS5, DOI 10.1016/j.ypmed.2011.08.001; Ferlay J. S. I., 2013, IARC CANC BASE; Forslund O, 2007, J INFECT DIS, V196, P876, DOI 10.1086/521031; Friis S, 1997, J INFECT DIS, V175, P743, DOI 10.1086/513966; Frisch M, 1997, NEW ENGL J MED, V337, P1350, DOI 10.1056/NEJM199711063371904; Gillison ML, 2007, HEAD NECK-J SCI SPEC, V29, P779, DOI 10.1002/hed.20573; GISSMANN L, 1980, INT J CANCER, V25, P605, DOI 10.1002/ijc.2910250509; Hansson BG, 2005, ACTA OTO-LARYNGOL, V125, P1337, DOI 10.1080/00016480510043945; HOLLY EA, 1989, JNCI-J NATL CANCER I, V81, P1726, DOI 10.1093/jnci/81.22.1726; Hsueh PR, 2009, J MICROBIOL IMMUNOL, V42, P101; Hwang TZ, 2015, INT J CANCER, V137, P395, DOI 10.1002/ijc.29330; KJAER SK, 1992, CANCER CAUSE CONTROL, V3, P339, DOI 10.1007/BF00146887; KOVI J, 1974, AM J CLIN PATHOL, V61, P702; Lee CC, 2012, J FORMOS MED ASSOC, V111, P682, DOI 10.1016/j.jfma.2012.10.004; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; MCCANCE DJ, 1988, NATURE, V335, P765, DOI 10.1038/335765a0; McKaig RG, 1998, HEAD NECK-J SCI SPEC, V20, P250, DOI 10.1002/(SICI)1097-0347(199805)20:3<250::AID-HED11>3.0.CO;2-O; National Health Insurance Administration Ministry of Health and Welfare Taiwan ROC, 2014, NATL HLTH INSURANCE; Nordenvall C, 2006, INT J CANCER, V119, P888, DOI 10.1002/ijc.21892; Odenbro A, 2005, BRIT J CANCER, V92, P1326, DOI 10.1038/sj.bjc.6602475; Oon SF, 2010, J MED SCREEN, V17, P44, DOI 10.1258/jms.2009.009058; Patel AS, 2000, J INVEST DERMATOL, V128, P2888; Paz IB, 1997, CANCER-AM CANCER SOC, V79, P595, DOI 10.1002/(SICI)1097-0142(19970201)79:3<595::AID-CNCR24>3.0.CO;2-Y; Robbins CS, 2004, AM J RESP CELL MOL, V30, P202, DOI 10.1165/rcmb.2003-0259OC; Ryerson AB, 2008, CANCER-AM CANCER SOC, V113, P2901, DOI 10.1002/cncr.23745; Saslow D, 2007, CA-CANCER J CLIN, V57, P7, DOI 10.3322/canjclin.57.1.7; Schwartz SM, 1998, JNCI-J NATL CANCER I, V90, P1626, DOI 10.1093/jnci/90.21.1626; Sherman K J, 1991, Epidemiology, V2, P257, DOI 10.1097/00001648-199107000-00004; SIEGEL A, 1962, AM J SURG, V103, P613, DOI 10.1016/0002-9610(62)90531-7; SIGURGEIRSSON B, 1991, BMJ-BRIT MED J, V303, P341, DOI 10.1136/bmj.303.6798.341; Syrjanen S, 2010, ANN ONCOL, V21, P243, DOI 10.1093/annonc/mdq454; Tay SK, 2008, VACCINE, V26, pM60, DOI 10.1016/j.vaccine.2008.05.042; Wait S, 2012, KAOHSIUNG J MED SCI, V28, P1, DOI 10.1016/j.kjms.2011.10.027; Wiley D, 2006, OBSTET GYNECOL SURV, V61, pS3, DOI 10.1097/01.ogx.0000221010.82943.8c	41	12	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2017	12	8							e0183183	10.1371/journal.pone.0183183	http://dx.doi.org/10.1371/journal.pone.0183183			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD5CP	28806741	Green Submitted, gold, Green Published			2022-12-26	WOS:000407548800061
J	Dominguez, A; Ciruela, P; Hernandez, S; Garcia-Garcia, JJ; Soldevila, N; Izquierdo, C; Moraga-Llop, F; Diaz, A; de Sevilla, MF; Gonzalez-Peris, S; Campins, M; Uriona, S; Martinez-Osorio, J; Sole-Ribalta, A; Codina, G; Esteva, C; Planes, AM; Munoz-Almagro, C; Salleras, L				Dominguez, Angela; Ciruela, Pilar; Hernandez, Sergi; Garcia-Garcia, Juan Jose; Soldevila, Nuria; Izquierdo, Conchita; Moraga-Llop, Fernando; Diaz, Alvaro; de Sevilla, Mariona F.; Gonzalez-Peris, Sebastia; Campins, Magda; Uriona, Sonia; Martinez-Osorio, Johanna; Sole-Ribalta, Anna; Codina, Gemma; Esteva, Cristina; Planes, Ana Maria; Munoz-Almagro, Carmen; Salleras, Luis			Effectiveness of the 13-valent pneumococcal conjugate vaccine in preventing invasive pneumococcal disease in children aged 7-59 months. A matched case-control study	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; IMMUNOGENICITY; SEROTYPES; ADULTS; IDENTIFICATION; POPULATION; SAFETY; USA	Background The 13-valent pneumococcal conjugate vaccine (PCV13) was licensed based on the results of immunogenicity studies and correlates of protection derived from randomized clinical trials of the 7-valent conjugate pneumococcal vaccine. We assessed the vaccination effectiveness (VE) of the PCV13 in preventing invasive pneumococcal disease (IPD) in children aged 7-59 months in a population with suboptimal vaccination coverage of 55%. Methods The study was carried out in children with IPD admitted to three hospitals in Barcelona (Spain) and controls matched by hospital, age, sex, date of hospitalization and underlying disease. Information on the vaccination status was obtained from written medical records. Conditional logistic regression was made to estimate the adjusted VE and 95% confidence intervals (CI). Results 169 cases and 645 controls were included. The overall VE of >= 1 doses of PCV13 in preventing IPD due to vaccine serotypes was 75.8% (95% CI, 54.1-87.2) and 90% (95% CI, 63.9-97.2) when >= 2 doses before 12 months, two doses on or after 12 months or one dose on or after 24 months, were administered. The VE of >= 1 doses was 89% (95% CI, 42.7-97.9) against serotype 1 and 86.0% (95% CI, 51.2-99.7) against serotype 19A. Serotype 3 showed a non- statistically significant effectiveness (25.9%; 95% CI, - 65.3 to 66.8). Conclusions The effectiveness of >= 1 doses of PCV13 in preventing IPD caused by all PCV13 serotypes in children aged 7-59 months was good and, except for serotype 3, the effectiveness of >= 1 doses against the most frequent PCV13 serotypes causing IPD was high when considered individually.	[Dominguez, Angela; Soldevila, Nuria; Salleras, Luis] Univ Barcelona, Dept Med, Barcelona, Spain; [Dominguez, Angela; Ciruela, Pilar; Garcia-Garcia, Juan Jose; Soldevila, Nuria; de Sevilla, Mariona F.; Esteva, Cristina; Munoz-Almagro, Carmen; Salleras, Luis] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Ciruela, Pilar; Hernandez, Sergi; Izquierdo, Conchita] Agencia Salut Publ Catalunya, Generalitat Catalunya, Barcelona, Spain; [Garcia-Garcia, Juan Jose; de Sevilla, Mariona F.; Esteva, Cristina; Munoz-Almagro, Carmen] Inst Recerca St Joan Deu, Malalties Prevenibles Amb Vacunes, Esplugas de Llobregat, Spain; [Garcia-Garcia, Juan Jose; de Sevilla, Mariona F.; Martinez-Osorio, Johanna; Sole-Ribalta, Anna; Esteva, Cristina; Munoz-Almagro, Carmen] Univ Barcelona, Hosp St Joan Deu Barcelona, Barcelona, Spain; [Moraga-Llop, Fernando; Gonzalez-Peris, Sebastia; Campins, Magda; Uriona, Sonia; Codina, Gemma; Planes, Ana Maria] Hosp Univ Vall dHebron, Barcelona, Spain; [Diaz, Alvaro] Hosp Nens, Barcelona, Spain; [Campins, Magda; Uriona, Sonia] Vall Hebron Inst Recerca, Grp Recerca Epidemiol & Salut Publ, Barcelona, Spain; [Munoz-Almagro, Carmen] Univ Int Catalunya, Dept Med, Barcelona, Spain	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Universitat Internacional de Catalunya (UIC)	Dominguez, A (corresponding author), Univ Barcelona, Dept Med, Barcelona, Spain.; Dominguez, A (corresponding author), CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain.	angela.dominguez@ub.edu	Garcia-Garcia, Juan José/J-5295-2014; Grau, Gemma Codina/Z-5107-2019; Muñoz-Almagro, Carmen/N-7248-2015	Garcia-Garcia, Juan José/0000-0002-3483-528X; Muñoz-Almagro, Carmen/0000-0001-5586-404X; Hernandez Baeza, Sergi/0000-0002-0461-6190; Esteva Afonso, Cristina/0000-0001-7133-4540; Dominguez, Angela/0000-0003-0219-1907	Plan Nacional I+D+I, ISCIII - Subdireccion General de Evaluacion y Fomento de la Investigacion Sanitaria [PI 11/02081, PI 11/2345]; AGAUR [2014 SGR 1403]	Plan Nacional I+D+I, ISCIII - Subdireccion General de Evaluacion y Fomento de la Investigacion Sanitaria; AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR))	This work was supported by the Plan Nacional I+D+I, ISCIII - Subdireccion General de Evaluacion y Fomento de la Investigacion Sanitaria (Projects PI 11/02081, PI 11/2345) and cofounded by Fondo Europeo de Desarrollo Regional (FEDER) and AGAUR (Grant 2014 SGR 1403).	Almagro C, 2015, 25 ECCMID; Andrews NJ, 2014, LANCET INFECT DIS, V14, P839, DOI 10.1016/S1473-3099(14)70822-9; Antachopoulos C, 2014, PEDIATR INFECT DIS J, V33, P81, DOI 10.1097/INF.0000000000000041; Bryant KA, 2010, PEDIATRICS, V125, P866, DOI 10.1542/peds.2009-1405; Ciruela P, 2016, EPIDEMIOLOGY INVASIV; Cohen C, 2017, LANCET GLOB HEALTH, V5, pE359, DOI 10.1016/S2214-109X(17)30043-8; Dagan R, 2013, CLIN INFECT DIS, V57, P952, DOI 10.1093/cid/cit428; Deceuninck G, 2015, VACCINE, V33, P2684, DOI 10.1016/j.vaccine.2015.04.005; del Amo E, 2015, EUR J CLIN MICROBIOL, V34, P705, DOI 10.1007/s10096-014-2280-y; Demczuk WHB, 2013, CAN J MICROBIOL, V59, P778, DOI 10.1139/cjm-2013-0614; Dominguez A, 2011, VACCINE, V29, P9020, DOI 10.1016/j.vaccine.2011.09.034; Feavers I, 2009, VACCINE, V27, P3681, DOI 10.1016/j.vaccine.2009.03.087; Fukusumi M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2113-y; Geno KA, 2015, CLIN MICROBIOL REV, V28, P871, DOI 10.1128/CMR.00024-15; Guevara M, 2016, EURO SURVEILL, V21; Horacio AN, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01616; Htar MTT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1147-x; Katz MH, 2011, MULTIVARIABLE ANAL P, V3, P88; Kimberlin DW, 2015, RED BOOK 2015 REPORT, P626; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Martinon-Torres F, 2017, PEDIATR INFECT DIS J, V36, P326, DOI 10.1097/INF.0000000000001428; Miller E, 2011, VACCINE, V29, P9127, DOI 10.1016/j.vaccine.2011.09.112; Moore MR, 2016, LANCET RESP MED, V4, P399, DOI 10.1016/S2213-2600(16)00052-7; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; Moraga-Llop F, 2016, PEDIATR INFECT DIS J, V35, P460, DOI 10.1097/INF.0000000000001041; Picazo J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172222; Salleras L, 2009, CLIN MICROBIOL INFEC, V15, P997, DOI 10.1111/j.1469-0691.2009.02938.x; Savulescu C, 2017, LANCET RESP MED, V5, P648, DOI [10.1016/S2213-2600(17)30110-8, 10.1016/s2213-2600(17)30110-8]; Schlesselman JJ, 1982, CASE CONTROL STUDIES, P144; Selva L, 2012, J CLIN MICROBIOL, V50, P3451, DOI 10.1128/JCM.01368-12; Slotved HC, 2016, HELIYON, V2, DOI 10.1016/j.heliyon.2016.e00198; Snape MD, 2010, PEDIATR INFECT DIS J, V29, pE80, DOI 10.1097/INF.0b013e3181faa6be; Su WJ, 2016, PEDIATR INFECT DIS J, V35, pE124, DOI 10.1097/INF.0000000000001054; Tarrago D, 2008, CLIN MICROBIOL INFEC, V14, P828, DOI 10.1111/j.1469-0691.2008.02028.x; van der Linden M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161257; van der Linden M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131494; Vanderkooi OG, 2012, PEDIATR INFECT DIS J, V31, P72, DOI 10.1097/INF.0b013e318233049d; Waight PA, 2015, LANCET INFECT DIS, V15, P535, DOI 10.1016/S1473-3099(15)70044-7; WHO Publication, 2012, VACCINE, V30, P4717, DOI 10.1016/j.vaccine.2012.04.093; Wijmenga-Monsuur AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144739	40	53	54	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2017	12	8							e0183191	10.1371/journal.pone.0183191	http://dx.doi.org/10.1371/journal.pone.0183191			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD5CP	28806737	Green Published, Green Submitted, gold			2022-12-26	WOS:000407548800063
J	Namba, S; Nakano, R; Kitanaka, T; Kitanaka, N; Nakayama, T; Sugiya, H				Namba, Shinichi; Nakano, Rei; Kitanaka, Taku; Kitanaka, Nanako; Nakayama, Tomohiro; Sugiya, Hiroshi			ERK2 and JNK1 contribute to TNF-alpha-induced IL8 expression in synovial fibroblasts	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; TUMOR-NECROSIS-FACTOR; N-TERMINAL KINASE; RHEUMATOID-ARTHRITIS; INFLAMMATORY ARTHRITIS; SIGNAL-TRANSDUCTION; P38 INHIBITION; STROMAL CELLS; MAP KINASES; IN-VITRO	Tumor necrosis factor alpha (TNF-alpha) induces the expression and secretion of interleukin 8 ( IL8), which contributes to synovitis in rheumatoid arthritis ( RA). To elucidate the mechanism of the onset of RA, we used synovial fibroblasts without autoimmune inflammatory diseases and investigated MAPK signaling pathways in TNF-alpha-induced IL-8 expression. Synovial fibroblasts isolated from healthy dogs were characterized by flow cytometry, which were positive for the fibroblast markers CD29, CD44, and CD90 but negative for the hematopoietic cell markers CD14, CD34, CD45, and HLA-DR. TNF-alpha stimulated the secretion and mRNA expression of IL-8 in a time-and dose-dependent manner. ERK and JNK inhibitors attenuated TNF-alpha-induced IL-8 expression and secretion. TNF-alpha-induced the phosphorylation of ERK1/2 and JNK1/2. TNF-alpha-induced IL-8 expression was attenuated both in ERK2-and JNK1-knockdown cells. TNF-alpha-induced ERK1/2 or JNK1/2 was observed in ERK2-or JNK1-knockdown cells, respectively, showing that there is no crosstalk between ERK2-and JNK1 pathways. These observations indicate that the individual activation of ERK2 and JNK1 pathways contributes to TNF-alpha-induced IL-8 expression in synovial fibroblasts, which appears to be involved in the progress in RA.	[Namba, Shinichi; Nakano, Rei; Kitanaka, Taku; Kitanaka, Nanako; Sugiya, Hiroshi] Nihon Univ, Coll Bioresource Sci, Dept Vet Med, Lab Vet Biochem, Fujisawa, Kanagawa, Japan; [Nakayama, Tomohiro] Nihon Univ, Coll Bioresource Sci, Dept Vet Med, Lab Vet Radiol, Fujisawa, Kanagawa, Japan	Nihon University; Nihon University	Sugiya, H (corresponding author), Nihon Univ, Coll Bioresource Sci, Dept Vet Med, Lab Vet Biochem, Fujisawa, Kanagawa, Japan.	sugiya.hiroshi@nihon-u.ac.jp	Nakayama, Tomohiro/GYU-0303-2022	Namba, Shinichi/0000-0002-9182-3656; Nakano, Rei/0000-0003-0255-6347	Ministry of Education, Science, Sports, and Culture of Japan [15K07728]	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Scientific Research (#15K07728) from the Ministry of Education, Science, Sports, and Culture of Japan (http://wwwjsps.go.jp/j-grantsinaid/) to HS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler V, 2005, BIOCHEMISTRY-US, V44, P10784, DOI 10.1021/bi050619j; Akutsu M, 2013, J ORAL PATHOL MED, V42, P491, DOI 10.1111/jop.12040; Bavaria MN, 2014, APOPTOSIS, V19, P467, DOI 10.1007/s10495-013-0944-1; Berckmans RJ, 2005, ARTHRITIS RES THER, V7, pR536, DOI 10.1186/ar1706; Bessard A, 2008, ONCOGENE, V27, P5315, DOI 10.1038/onc.2008.163; Bodolay E, 2002, J CELL MOL MED, V6, P357, DOI 10.1111/j.1582-4934.2002.tb00514.x; Bonito NA, 2014, ONCOGENE, V33, P2255, DOI 10.1038/onc.2013.159; BOULTON TG, 1991, CELL REGUL, V2, P357, DOI 10.1091/mbc.2.5.357; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Catrina AI, 2017, NAT REV RHEUMATOL, V13, P79, DOI 10.1038/nrrheum.2016.200; Chen DP, 2011, CELL MOL IMMUNOL, V8, P469, DOI 10.1038/cmi.2011.35; Choi HS, 2012, MOL MED REP, V5, P1023, DOI 10.3892/mmr.2012.767; Cobb MH, 2000, TRENDS BIOCHEM SCI, V25, P7, DOI 10.1016/S0968-0004(99)01508-X; Cotton JA, 2016, INT J INTERFERON CYT, V8, P13, DOI DOI 10.2147/IJICMR.S63682; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; de Launay D, 2012, ANN RHEUM DIS, V71, P415, DOI 10.1136/ard.2010.143529; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Doom M, 2008, VET IMMUNOL IMMUNOP, V125, P143, DOI 10.1016/j.vetimm.2008.05.023; Dulos J, 2013, CLIN EXP RHEUMATOL, V31, P515; Filer A, 2009, ARTHRITIS RHEUM, V60, P1604, DOI 10.1002/art.24574; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Fremin C, 2007, HEPATOLOGY, V45, P1035, DOI 10.1002/hep.21551; Garcia S, 2008, ANN RHEUM DIS, V67, P631, DOI 10.1136/ard.2007.077040; Godoy RF, 2014, RES VET SCI, V96, P454, DOI 10.1016/j.rvsc.2014.02.013; Guma M, 2010, P NATL ACAD SCI USA, V107, P22122, DOI 10.1073/pnas.1016401107; Han ZN, 2001, J CLIN INVEST, V108, P73, DOI 10.1172/JCI12466; Hegemann N, 2005, VET COMP ORTHOPAED, V18, P67, DOI 10.1055/s-0038-1632931; Huber LC, 2006, RHEUMATOLOGY, V45, P669, DOI 10.1093/rheumatology/kel065; Jo CH, 2007, CYTOTHERAPY, V9, P316, DOI 10.1080/14653240701291620; Juarranz MG, 2004, RHEUMATOLOGY, V43, P416, DOI 10.1093/rheumatology/keh061; Kitanaka T, 2017, SCI REP-UK, V7, DOI 10.1038/srep39914; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; KOCH AE, 1991, J IMMUNOL, V147, P2187; Kunisch E, 2007, ANN RHEUM DIS, V66, P1043, DOI 10.1136/ard.2006.062521; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Li FF, 2009, BIOCHEM BIOPH RES CO, V382, P259, DOI 10.1016/j.bbrc.2009.02.165; Li J, 2006, BIOCHEM BIOPH RES CO, V345, P1425, DOI 10.1016/j.bbrc.2006.05.051; LOETSCHER P, 1994, CYTOKINE, V6, P162, DOI 10.1016/1043-4666(94)90038-8; Luo XJ, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2399; Matsuda N, 2000, PHOTOCHEM PHOTOBIOL, V72, P334, DOI 10.1562/0031-8655(2000)072<0334:DAOEAJ>2.0.CO;2; MELOCHE S, 1995, J CELL PHYSIOL, V163, P577, DOI 10.1002/jcp.1041630319; Mun SH, 2009, ARTHRITIS RHEUM-US, V60, P678, DOI 10.1002/art.24299; Nakano R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141581; Nakano R, 2015, J VET MED SCI, V77, P27, DOI 10.1292/jvms.14-0284; Neff L, 2003, J BIOL CHEM, V278, P27721, DOI 10.1074/jbc.M212065200; Radtke S, 2013, J CELL SCI, V126, P2381, DOI 10.1242/jcs.115832; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; Rodenburg RJT, 1999, ANN RHEUM DIS, V58, P648, DOI 10.1136/ard.58.10.648; Ronai Z, 2004, MOL CELL, V15, P843, DOI 10.1016/j.molcel.2004.09.011; Saba-El-Leil MK, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00067; Sabapathy K, 2004, CELL CYCLE, V3, P1520, DOI 10.4161/cc.3.12.1315; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Schett G, 2000, ARTHRITIS RHEUM, V43, P2501, DOI 10.1002/1529-0131(200011)43:11<2501::AID-ANR18>3.0.CO;2-K; Sehgal Vasudha, 2013, Genes Cancer, V4, P409, DOI 10.1177/1947601913507577; SEITZ M, 1991, J CLIN INVEST, V87, P463, DOI 10.1172/JCI115018; Shen YH, 2003, J BIOL CHEM, V278, P26715, DOI 10.1074/jbc.M303264200; Shin J, 2013, CELL SIGNAL, V25, P2540, DOI 10.1016/j.cellsig.2013.08.014; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Smolen JS, 2003, NAT REV DRUG DISCOV, V2, P473, DOI 10.1038/nrd1109; Suzuki M, 2000, FEBS LETT, V465, P23, DOI 10.1016/S0014-5793(99)01717-2; Szekanecz Z, 1998, SPRINGER SEMIN IMMUN, V20, P115, DOI 10.1007/BF00832002; Szekanecz Z, 2003, SEMIN IMMUNOL, V15, P15, DOI 10.1016/S1044-5323(02)00124-0; Szekanecz Z, 2001, CURR OPIN RHEUMATOL, V13, P202, DOI 10.1097/00002281-200105000-00009; Szekanecz Zoltan, 2010, Front Biosci (Schol Ed), V2, P153; Thalhamer T, 2008, RHEUMATOLOGY, V47, P409, DOI 10.1093/rheumatology/kem297; Tsuchiya H, 2015, VET IMMUNOL IMMUNOP, V168, P223, DOI 10.1016/j.vetimm.2015.10.003; Westra J, 2004, ANN RHEUM DIS, V63, P1453, DOI 10.1136/ard.2003.013011; Yu CR, 2003, CANCER BIOL THER, V2, P544, DOI 10.4161/cbt.2.5.454; Zhu XJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4377	70	40	42	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2017	12	8							e0182923	10.1371/journal.pone.0182923	http://dx.doi.org/10.1371/journal.pone.0182923			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD5CP	28806729	Green Submitted, gold, Green Published			2022-12-26	WOS:000407548800036
J	Arpawong, TE; Pendleton, N; Mekli, K; McArdle, JJ; Gatz, M; Armoskus, C; Knowles, JA; Prescott, CA				Arpawong, Thalida E.; Pendleton, Neil; Mekli, Krisztina; McArdle, John J.; Gatz, Margaret; Armoskus, Chris; Knowles, James A.; Prescott, Carol A.			Genetic variants specific to aging-related verbal memory: Insights from GWASs in a population-based cohort	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MILD COGNITIVE IMPAIRMENT; ALZHEIMER-DISEASE; EPISODIC MEMORY; INDIVIDUAL-DIFFERENCES; QUANTITATIVE TRAITS; PROCESSING SPEED; AGE-DIFFERENCES; APOE; TOMM40	Verbal memory is typically studied using immediate recall (IR) and delayed recall (DR) scores, although DR is dependent on IR capability. Separating these components may be useful for deciphering the genetic variation in age-related memory abilities. This study was conducted to (a) construct individual trajectories in IR and independent aspects of delayed recall, or residualized- DR (rDR), across older adulthood; and (b) identify genetic markers that contribute to four estimated phenotypes: IR and rDR levels and changes after age 60. A cognitively intact sample (N = 20,650 with 125,164 observations) was drawn from the U.S. Health and Retirement Study, a nationally representative study of adults aged 50 and older. Mixed effects regression models were constructed using repeated measures from data collected every two years (1996-2012) to estimate level at age 60 and change in memory post-60 in IR and rDR. Genome-wide association scans (GWAS) were conducted in the genotypic subsample (N = 7,486) using similar to 1.2 million single nucleotide polymorphisms (SNPs). One SNP (rs2075650) in TOMM40 associated with rDR level at the genome-wide level (p = 5.0x10(-08)), an effect that replicated in an independent sample from the English Longitudinal Study on Ageing (N = 6,898 with 41,328 observations). Meta-analysis of rDR level confirmed the association (p = 5.0x10(-11)) and identified two others in TOMM40 (rs71352238 p = 1.0x(-10) - 10; rs157582 p = 7.0x10(-09)), and one in APOE (rs7694 49 p = 3.1 x10(-12)). Meta-analysis of IR change identified associations with three of the same SNPs in TOMM40 (rs157582 p = 8.3x10(-10); rs71352238 p = 1.9x10(-09)) and APOE (rs769449 p = 2.2x10(-08)). Conditional analyses indicate GWAS signals on rDR level were driven by APOE, whereas signals on IR change were driven by TOMM40. Additionally, we found that TOMM40 had effects independent of APOE e4 on both phenotypes. Findings from this first U.S. population-based GWAS study conducted on both age-related immediate and delayed verbal memory merit continued examination in other samples and additional measures of verbal memory.	[Arpawong, Thalida E.; McArdle, John J.; Prescott, Carol A.] Univ Southern Calif, Dornsife Coll Letters Arts & Sci, Dept Psychol, Los Angeles, CA 90007 USA; [Pendleton, Neil] Univ Manchester, Sch Biol Sci, Div Neurosci & Expt Psychol, Manchester, Lancs, England; [Mekli, Krisztina] Univ Manchester, Cathie Marsh Inst Social Res, Manchester, Lancs, England; [McArdle, John J.; Gatz, Margaret; Prescott, Carol A.] Univ Southern Calif, Davis Sch Gerontol, Los Angeles, CA USA; [Gatz, Margaret; Armoskus, Chris] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA USA; [Knowles, James A.] Univ Southern Calif, Keck Sch Med, Dept Psychiat & Behav Sci, Los Angeles, CA USA	University of Southern California; University of Manchester; University of Manchester; University of Southern California; University of Southern California; University of Southern California	Arpawong, TE (corresponding author), Univ Southern Calif, Dornsife Coll Letters Arts & Sci, Dept Psychol, Los Angeles, CA 90007 USA.	arpawong@usc.edu	Pendleton, Neil/F-2333-2015	Pendleton, Neil/0000-0003-0794-2386; Arpawong, Thalida/0000-0001-9671-9535; Gatz, Margaret/0000-0002-1071-9970	National Institute on Aging, of the National Institutes of Health [F32AG048681, P30AG017265]; National Institute on Aging [U01AG009740, RC2AG036495, RC4AG039029, 2R01AG7644-01A1, 2R01AG017644]; English Longitudinal Study of Ageing; National Institute of Aging grants; MRC [MR/N01104X/2, MR/N01104X/1] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [P30AG017265, U01AG009740] Funding Source: NIH RePORTER	National Institute on Aging, of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); English Longitudinal Study of Ageing; National Institute of Aging grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Institute on Aging, of the National Institutes of Health, under award numbers F32AG048681 (PI: TEA) and P30AG017265 (Subcontract: CAP). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The Health and Retirement Study [genetic] data is sponsored by the National Institute on Aging (grant numbers U01AG009740, [RC2AG036495, and RC4AG039029]) and was conducted by the University of Michigan. Funding for the English Longitudinal Study of Ageing is provided by the National Institute of Aging [grants 2R01AG7644-01A1 and 2R01AG017644] and a consortium of UK government departments coordinated by the Office for National Statistics. Funding for the English Longitudinal Study of Ageing genotyping data was provided by the Economic and Social Research Council (ESRC) and by the National Institute of Aging grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon M, 1998, BEHAV GENET, V28, P255, DOI 10.1023/A:1021667213066; Ando J, 2001, BEHAV GENET, V31, P615, DOI 10.1023/A:1013353613591; [Anonymous], 1998, J AM GERIATR SOC, V46, P1493; Bacanu SA, 2002, GENET EPIDEMIOL, V22, P78, DOI 10.1002/gepi.1045; BOUCHARD TJ, 1990, ACTA GENET MED GEMEL, V39, P193, DOI 10.1017/S0001566000005420; Cacabelos R, 2014, J PHARMACOGENOMICS P, V2014; Caselli RJ, 2012, ALZHEIMERS DEMENT, V8, P490, DOI 10.1016/j.jalz.2011.11.006; Chang C. C., 2014, ARXIV14104803; Chen KHM, 2010, BRAIN COGNITION, V72, P400, DOI 10.1016/j.bandc.2009.11.007; CIDR, 2012, CIDR HLTH RET STUD I; Cohen RM, 2001, NEUROLOGY, V57, P2223, DOI 10.1212/WNL.57.12.2223; Crimmins EM, 2011, J GERONTOL B-PSYCHOL, V66, P162, DOI 10.1093/geronb/gbr048; Davies G, 2014, MOL PSYCHIATR, V19, P76, DOI 10.1038/mp.2012.159; Deary IJ, 2009, HUM GENET, V126, P215, DOI 10.1007/s00439-009-0655-4; Elger CE, 1997, NEUROPSYCHOLOGIA, V35, P657, DOI 10.1016/S0028-3932(96)00110-8; Faul J, 2014, HLTH RETIREMENT STUD; Ferencz B, 2013, FRONT HUM NEUROSCI, P7; Ferencz B, 2015, NEUROPSYCHOL REV, V25, P113, DOI 10.1007/s11065-014-9276-3; Finkel D, 2005, BEHAV GENET, V35, P535, DOI 10.1007/s10519-005-3281-5; FINKEL D, 1995, PSYCHOL AGING, V10, P437, DOI 10.1037/0882-7974.10.3.437; GOLOMB J, 1994, LEARN MEMORY, V1, P45; Gomar JJ, 2011, ARCH GEN PSYCHIAT, V68, P961, DOI 10.1001/archgenpsychiatry.2011.96; Greenaway MC, 2006, COGN BEHAV NEUROL, V19, P79, DOI 10.1097/01.wnn.0000208290.57370.a3; Greenbaum L, 2014, EUR NEUROPSYCHOPHARM, V24, P1492, DOI 10.1016/j.euroneuro.2014.06.002; Hayden KM, 2012, ALZHEIMERS DEMENT, V8, P381, DOI 10.1016/j.jalz.2011.10.005; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Helmstaedter C, 1997, BRAIN COGNITION, V35, P110, DOI 10.1006/brcg.1997.0930; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; HORN JL, 1992, EXP AGING RES, V18, P117, DOI 10.1080/03610739208253916; HORN JL, 1967, ACTA PSYCHOL, V26, P107, DOI 10.1016/0001-6918(67)90011-X; HRS, 2012, QUAL CONTR REP GEN D; HRS, 2014, COGN BEH PHEN SNPS I; Johansson B, 1999, J GERONTOL B-PSYCHOL, V54, pP173, DOI 10.1093/geronb/54B.3.P173; Johnson SC, 2011, ALZHEIMERS DEMENT, V7, P456, DOI 10.1016/j.jalz.2010.11.012; Kao PF, 2012, J NEUROPATH EXP NEUR, V71, P654, DOI 10.1097/NEN.0b013e31825d06b7; Kremen WS, 2014, PSYCHOL AGING, V29, P404, DOI 10.1037/a0035962; Laczo J, 2015, NEUROBIOL AGING, V36, P2024, DOI 10.1016/j.neurobiolaging.2015.03.004; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Li QZ, 2008, GENET EPIDEMIOL, V32, P215, DOI 10.1002/gepi.20296; Lind J, 2006, BRAIN, V129, P1240, DOI 10.1093/brain/awl054; Lindenberger U, 2008, FRONT NEUROSCI, V2, P39; LOFTUS GR, 1985, J EXP PSYCHOL LEARN, V11, P397, DOI 10.1037/0278-7393.11.2.397; Luciano M, 2001, BEHAV GENET, V31, P581, DOI 10.1023/A:1013397428612; Lyall DM, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.01.006; Ma XY, 2013, NEUROMOL MED, V15, P279, DOI 10.1007/s12017-012-8217-7; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; Martin ER, 2000, AM J HUM GENET, V67, P383, DOI 10.1086/303003; McArdle JJ, 2002, DEV PSYCHOL, V38, P115, DOI 10.1037//0012-1649.38.1.115; McArdle JJ, 2007, PSYCHOL AGING, V22, P525, DOI 10.1037/0882-7974.22.3.525; McArdle JJ, 2011, ASTA-ADV STAT ANAL, V95, P453, DOI 10.1007/s10182-011-0168-z; McArdle JJ, 2009, BEHAV GENET, V39, P472, DOI 10.1007/s10519-009-9272-1; Nilsson LG, 2003, ACTA NEUROL SCAND, V107, P7, DOI 10.1034/j.1600-0404.107.s179.5.x; Nilsson LG, 2002, NEUROSCI BIOBEHAV R, V26, P841, DOI 10.1016/S0149-7634(02)00070-2; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; O'Hara R, 2006, NEUROSCI LETT, V409, P205, DOI 10.1016/j.neulet.2006.09.047; Ofstedal M, 2005, DOCUMENTATION COGNIT, DOI DOI 10.1371/journal.pone.0144722; Oldmeadow C, 2014, J ALZHEIMERS DIS, V42, P391, DOI 10.3233/JAD-140846; Panizzon MS, 2011, NEUROPSYCHOLOGY, V25, P488, DOI 10.1037/a0022569; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; Papassotiropoulos A, 2011, TRENDS COGN SCI, V15, P381, DOI 10.1016/j.tics.2011.07.005; Papenberg G, 2015, TRENDS COGN SCI, V19, P506, DOI 10.1016/j.tics.2015.06.008; Papenberg G, 2015, NEUROPSYCHOL REV, V25, P47, DOI 10.1007/s11065-015-9279-8; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Payton A, 2016, NEUROBIOL AGING, V39, DOI 10.1016/j.neurobiolaging.2015.11.017; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Radmanesh F, 2014, EUR J HUM GENET, V22, P1239, DOI 10.1038/ejhg.2013.308; Reynolds CA, 2005, DEV PSYCHOL, V41, P3, DOI 10.1037/0012-1649.41.1.3; Reynolds CA, 2002, EXP AGING RES, V28, P407, DOI 10.1080/03610730290103104; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Ronnlund M, 2005, PSYCHOL AGING, V20, P3, DOI 10.1037/0882-7974.20.1.3; Ronnlund M, 2000, INT J PSYCHOL, V35, P366; Rosen AC, 2003, BEHAV NEUROSCI, V117, P1150, DOI 10.1037/0735-7044.117.6.1150; Roses AD, 2010, PHARMACOGENOMICS J, V10, P375, DOI 10.1038/tpj.2009.69; Roses AD, 2013, ALZHEIMERS DEMENT, V9, P132, DOI 10.1016/j.jalz.2012.10.009; Salthouse TA, 2003, ALZ DIS ASSOC DIS, V17, P162, DOI 10.1097/00002093-200307000-00008; SAS, 2013, SAS I VERS 9 4; Schaie K. W., 1996, INTELLECTUAL DEV ADU; Seripa D, 2012, J ALZHEIMERS DIS, V31, P731, DOI 10.3233/JAD-2012-120403; Serre D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001382; Shega JW, 2014, J GERONTOL B-PSYCHOL, V69, pS166, DOI 10.1093/geronb/gbu106; SLAMECKA NJ, 1983, J EXP PSYCHOL LEARN, V9, P384, DOI 10.1037/0278-7393.9.3.384; Stephan Y, 2014, AM J GERIAT PSYCHIAT, V22, P1180, DOI 10.1016/j.jagp.2013.03.007; Steptoe A, 2013, INT J EPIDEMIOL, V42, P1640, DOI 10.1093/ije/dys168; Swan GE, 1999, ARCH NEUROL-CHICAGO, V56, P1127, DOI 10.1001/archneur.56.9.1127; Tian C, 2008, HUM MOL GENET, V17, pR143, DOI 10.1093/hmg/ddn268; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Volk HE, 2006, TWIN RES HUM GENET, V9, P623, DOI 10.1375/twin.9.5.623; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; WELSH K, 1991, ARCH NEUROL-CHICAGO, V48, P278, DOI 10.1001/archneur.1991.00530150046016; WELSH KA, 1993, NEUROPSY NEUROPSY BE, V6, P103; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wilson RS, 2002, PSYCHOL AGING, V17, P179, DOI 10.1037/0882-7974.17.2.179; Wolk DA, 2011, NEUROIMAGE, V54, P1530, DOI 10.1016/j.neuroimage.2010.09.005; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yu CE, 2007, GENOMICS, V89, P655, DOI 10.1016/j.ygeno.2007.02.002; Zhang SL, 2003, GENET EPIDEMIOL, V24, P44, DOI 10.1002/gepi.10196; Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.210	102	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0182448	10.1371/journal.pone.0182448	http://dx.doi.org/10.1371/journal.pone.0182448			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD3KL	28800603	Green Submitted, gold, Green Published			2022-12-26	WOS:000407431800018
J	Mai, U; Sayyari, E; Mirarab, S				Mai, Uyen; Sayyari, Erfan; Mirarab, Siavash			Minimum variance rooting of phylogenetic trees and implications for species tree reconstruction	PLOS ONE			English	Article							MULTISPECIES COALESCENT MODEL; GENERAL MARKOV MODEL; DISTANT OUTGROUPS; UNIVERSAL TREE; LIFE; PHYLOGENOMICS; EVOLUTION; INFERENCE; COMPUTATION; NUCLEOTIDE	Phylogenetic trees inferred using commonly-used models of sequence evolution are unrooted, but the root position matters both for interpretation and downstream applications. This issue has been long recognized; however, whether the potential for discordance between the species tree and gene trees impacts methods of rooting a phylogenetic tree has not been extensively studied. In this paper, we introduce a new method of rooting a tree based on its branch length distribution; our method, which minimizes the variance of root to tip distances, is inspired by the traditional midpoint rerooting and is justified when deviations from the strict molecular clock are random. Like midpoint rerooting, the method can be implemented in a linear time algorithm. In extensive simulations that consider discordance between gene trees and the species tree, we show that the new method is more accurate than midpoint rerooting, but its relative accuracy compared to using outgroups to root gene trees depends on the size of the dataset and levels of deviations from the strict clock. We show high levels of error for all methods of rooting estimated gene trees due to factors that include effects of gene tree discordance, deviations from the clock, and gene tree estimation error. Our simulations, however, did not reveal significant differences between two equivalent methods for species tree estimation that use rooted and unrooted input, namely, STAR and NJst. Nevertheless, our results point to limitations of existing scalable rooting methods.	[Mai, Uyen] Univ Calif San Diego, Dept Comp Sci & Engn, San Diego, CA 92103 USA; [Sayyari, Erfan; Mirarab, Siavash] Univ Calif San Diego, Dept Elect & Comp Engn, San Diego, CA 92103 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Mirarab, S (corresponding author), Univ Calif San Diego, Dept Elect & Comp Engn, San Diego, CA 92103 USA.	smirarab@ucsd.edu		Mirarab, Siavash/0000-0001-5410-1518	National Science Foundation [IIS-1565862, ACI-1053575]; NSF [IIS-1565862, ACI-1053575]; Direct For Computer & Info Scie & Enginr [1565862] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by the National Science Foundation grant IIS-1565862 (http://www.nsf.gov/awardsearch/showAward?AWD_ID=1565862) to SM, UM, and ES. Computations were performed on the San Diego Supercomputer Center (SDSC) through XSEDE allocations, which is supported by the National Science Foundation grant ACI-1053575 (http://www.nsf.gov/awardsearch/showAward?AWD_ID=1053575).; This work was supported by the NSF grant IIS-1565862 to SM, UM, and ES. Computations were performed on the San Diego Supercomputer Center (SDSC) through XSEDE allocations, which is supported by the NSF grant ACI-1053575.	Allman E, 2016, IEEE ACM T COMPUT BI, VPP, P1; Allman ES, 2011, J MATH BIOL, V62, P833, DOI 10.1007/s00285-010-0355-7; Allman ES, 2003, MATH BIOSCI, V186, P113, DOI 10.1016/j.mbs.2003.08.004; Arcila D, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0020; Barry D., 1987, STAT SCI, V2, P191, DOI DOI 10.1214/SS/1177013353; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Blanquart S, 2008, MOL BIOL EVOL, V25, P842, DOI 10.1093/molbev/msn018; Bogdanowicz D, 2012, IEEE ACM T COMPUT BI, V9, P150, DOI [10.1109/TCBB.2011.48, 10.1109/TCBB.2011.38]; Boussau B, 2006, SYSTEMATIC BIOL, V55, P756, DOI 10.1080/10635150600975218; Boussau B, 2013, GENOME RES, V23, P323, DOI 10.1101/gr.141978.112; Boykin LM, 2010, MOL PHYLOGENET EVOL, V54, P687, DOI 10.1016/j.ympev.2009.11.016; BROWN JR, 1995, P NATL ACAD SCI USA, V92, P2441, DOI 10.1073/pnas.92.7.2441; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Edwards SV, 2016, MOL PHYLOGENET EVOL, V94, P447, DOI 10.1016/j.ympev.2015.10.027; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fletcher W, 2009, MOL BIOL EVOL, V26, P1879, DOI 10.1093/molbev/msp098; Forterre P, 1999, BIOESSAYS, V21, P871, DOI 10.1002/(SICI)1521-1878(199910)21:10<871::AID-BIES10>3.0.CO;2-Q; Gatesy J, 2014, MOL PHYLOGENET EVOL, V80, P231, DOI 10.1016/j.ympev.2014.08.013; Gouy R, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0329; Graham SW, 2002, MOL BIOL EVOL, V19, P1769, DOI 10.1093/oxfordjournals.molbev.a003999; Hess PN, 2007, BIOL J LINN SOC, V92, P669, DOI 10.1111/j.1095-8312.2007.00864.x; Hillis DM, 2003, SYST BIOL, V52, P124, DOI 10.1080/10635150390132911; Hinchliff CE, 2015, P NATL ACAD SCI USA, V112, P12764, DOI 10.1073/pnas.1423041112; Holland BR, 2003, SYST BIOL, V52, P229, DOI 10.1080/10635150390192771; Huelsenbeck JP, 2002, SYST BIOL, V51, P32, DOI 10.1080/106351502753475862; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Jayaswal V, 2005, EVOL BIOINFORM, V1, P62; Katz LA, 2012, SYST BIOL, V61, P653, DOI 10.1093/sysbio/sys026; Li CH, 2012, MOL PHYLOGENET EVOL, V63, P365, DOI 10.1016/j.ympev.2012.01.013; Liu L, 2011, SYST BIOL, V60, P661, DOI 10.1093/sysbio/syr027; Liu LA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-302; Liu L, 2009, SYST BIOL, V58, P468, DOI 10.1093/sysbio/syp031; MADDISON WP, 1984, SYST ZOOL, V33, P83, DOI 10.2307/2413134; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Mallo D, 2016, SYSTEMATIC BIOL, V65; Mathews S, 1999, SCIENCE, V286, P947, DOI 10.1126/science.286.5441.947; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Meiklejohn KA, 2016, SYST BIOL, V65, P612, DOI 10.1093/sysbio/syw014; Mirarab S, 2014, BIOINFORMATICS, V30, pI541, DOI 10.1093/bioinformatics/btu462; Mirarab S, 2015, BIOINFORMATICS, V31, P44, DOI 10.1093/bioinformatics/btv234; Mirarab S, 2015, J COMPUT BIOL, V22, P377, DOI 10.1089/cmb.2014.0156; Mossel E, 2010, IEEE ACM T COMPUT BI, V7, P166, DOI 10.1109/TCBB.2008.66; Nguyen NP, 2014, BIOINFORMATICS, V30, P3548, DOI 10.1093/bioinformatics/btu721; PAMILO P, 1988, MOL BIOL EVOL, V5, P568; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pearson T, 2013, SYST BIOL, V62, P752, DOI 10.1093/sysbio/syt038; PENNY D, 1976, J MOL EVOL, V8, P95, DOI 10.1007/BF01739097; Philippe H, 1998, CURR OPIN GENET DEV, V8, P616, DOI 10.1016/S0959-437X(98)80028-2; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Prum RO, 2015, NATURE, V526, P569, DOI 10.1038/nature15697; Quast C, 2012, NUCL ACIDS RES; Raymann K, 2015, P NATL ACAD SCI USA, V112, P6670, DOI 10.1073/pnas.1420858112; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Rosenfeld JA, 2012, MOL PHYLOGENET EVOL, V64, P12, DOI 10.1016/j.ympev.2012.02.029; Sayyari E, 2016, MOL BIOL EVOL, V33, P1654, DOI 10.1093/molbev/msw079; Simmons MP, 2015, MOL PHYLOGENET EVOL, V91, P98, DOI 10.1016/j.ympev.2015.05.011; Springer MS, 2016, MOL PHYLOGENET EVOL, V94, P1, DOI 10.1016/j.ympev.2015.07.018; Stechmann A, 2002, SCIENCE, V297, P89, DOI 10.1126/science.1071196; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Tarrio R, 2000, MOL PHYLOGENET EVOL, V16, P344, DOI 10.1006/mpev.2000.0813; Tarver JE, 2016, GENOME BIOL EVOL, V8, P330, DOI 10.1093/gbe/evv261; Tavare A S, 1986, LECT MATH LIFE SCI, V17, P57; Vachaspati P, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S10-S3; Wickett NJ, 2014, P NATL ACAD SCI USA, V111, pE4859, DOI 10.1073/pnas.1323926111; Williams TA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0336; Wu YF, 2009, BIOINFORMATICS, V25, P190, DOI 10.1093/bioinformatics/btn606; Xi ZX, 2014, SYST BIOL, V63, P919, DOI 10.1093/sysbio/syu055; Yu Y, 2011, J COMPUT BIOL, V18, P1543, DOI 10.1089/cmb.2011.0174	71	24	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0182238	10.1371/journal.pone.0182238	http://dx.doi.org/10.1371/journal.pone.0182238			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800608	Green Published, Green Submitted, gold			2022-12-26	WOS:000407431800011
J	Saiz-Baggetto, S; Mendez, E; Quilis, I; Igual, JC; Bano, MC				Saiz-Baggetto, Sara; Mendez, Ester; Quilis, Inma; Carlos Igual, J.; Carmen Bano, M.			Chimeric proteins tagged with specific 3xHA cassettes may present instability and functional problems	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; AFFINITY TAGS; DNA-DAMAGE; CELL-CYCLE; CHECKPOINT; EXPRESSION; PATHWAY; COMPLEX; GENE	Epitope-tagging of proteins has become a widespread technique for the analysis of protein function, protein interactions and protein localization among others. Tagging of genes by chromosomal integration of PCR amplified cassettes is a widely used and fast method to label proteins in vivo. Different systems have been developed during years in the yeast Saccharomyces cerevisiae. In the present study, we analysed systematically a set of yeast proteins that were fused to different tags. Analysis of the tagged proteins revealed an unexpected general effect on protein level when some specific tagging module was used. This was due in all cases to a destabilization of the proteins and caused a reduced protein activity in the cell that was only apparent in particular conditions. Therefore, an extremely cautious approach is required when using this strategy.	[Carlos Igual, J.; Carmen Bano, M.] Univ Valencia, Dept Bioquim & Biol Mol, Burjassot, Valencia, Spain; Univ Valencia, Estructura Recerca Interdisciplinar Biotecnol & B, Burjassot, Valencia, Spain	University of Valencia; University of Valencia	Igual, JC; Bano, MC (corresponding author), Univ Valencia, Dept Bioquim & Biol Mol, Burjassot, Valencia, Spain.	jcigual@uv.es; bano@uv.es	Méndez Belinchón, Ester/HGC-4096-2022; Igual, J. Carlos/L-3329-2014; Quilis, Inma/AAH-4849-2020; Bano, Carmen/K-7767-2014	Igual, J. Carlos/0000-0001-6910-5845; Quilis, Inma/0000-0003-1091-2348; Bano, Carmen/0000-0002-2211-4418	Spanish Government; ERDF from the European Union [BFU2013-47503, BFU2014-58429-P]; Generalitat Valenciana [GVPROMETE02016-123]; Generalitat Valenciana	Spanish Government(Spanish GovernmentEuropean Commission); ERDF from the European Union; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	This work was supported by the Spanish Government and co-financed by ERDF from the European Union (Grants no BFU2013-47503 and BFU2014-58429-P) and by the Generalitat Valenciana (Grant no GVPROMETE02016-123). EM is a recipient of a predoctoral Fellowship from Generalitat Valenciana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; Andrews B, 1998, TRENDS GENET, V14, P66, DOI 10.1016/S0168-9525(97)01322-X; Bell MR, 2013, PROTEIN SCI, V22, P1466, DOI 10.1002/pro.2356; Booher Keith R., 2008, Biotechnology Journal, V3, P524, DOI 10.1002/biot.200800012; Branzei D, 2006, EXP CELL RES, V312, P2654, DOI 10.1016/j.yexcr.2006.06.012; Brizzard B, 2008, BIOTECHNIQUES, V44, P693, DOI 10.2144/000112841; Bucher MH, 2002, ACTA CRYSTALLOGR D, V58, P392, DOI 10.1107/S0907444901021187; Burchell L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034748; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; Gauss R, 2005, YEAST, V22, P1, DOI 10.1002/yea.1187; Georgieva MV, 2015, NAT METHODS, V12, P955, DOI [10.1038/NMETH.3556, 10.1038/nmeth.3556]; HARTLEY JL, 2000, GENOME RES, V10, P1788, DOI DOI 10.1101/GR.143000; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; Jarvik JW, 1996, BIOTECHNIQUES, V20, P896; Jarvik JW, 1998, ANNU REV GENET, V32, P601, DOI 10.1146/annurev.genet.32.1.601; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; Longhese MP, 1997, EMBO J, V16, P5216, DOI 10.1093/emboj/16.17.5216; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mendenhall MD, 1998, MICROBIOL MOL BIOL R, V62, P1191, DOI 10.1128/MMBR.62.4.1191-1243.1998; Mikalsen T, 2005, INT J BIOCHEM CELL B, V37, P2513, DOI 10.1016/j.biocel.2005.06.007; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; PRASHER DC, 1995, TRENDS GENET, V11, P320, DOI 10.1016/S0168-9525(00)89090-3; Queralt E, 2004, GENETICS, V168, P129, DOI 10.1534/genetics.104.029587; Schembri L, 2007, NAT METHODS, V4, P107, DOI 10.1038/nmeth0207-107; Soriano-Carot M, 2014, NUCLEIC ACIDS RES, V42, P7084, DOI 10.1093/nar/gku373; Vecchio LM, 2014, MOL CELL NEUROSCI, V61, P123, DOI 10.1016/j.mcn.2014.05.007; Waugh DS, 2005, TRENDS BIOTECHNOL, V23, P316, DOI 10.1016/j.tibtech.2005.03.012; Yahya G, 2014, MOL CELL, V53, P115, DOI 10.1016/j.molcel.2013.11.015	30	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0183067	10.1371/journal.pone.0183067	http://dx.doi.org/10.1371/journal.pone.0183067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800621	Green Submitted, Green Published, gold			2022-12-26	WOS:000407431800049
J	Zhang, YZ; Fang, S; Dai, JZ; Zhu, L; Fan, H; Tang, WY; Fan, YJ; Dai, HY; Zhang, PP; Wang, Y; Xing, X; Yang, C				Zhang, Yuanzheng; Fang, Shuo; Dai, Jiezhi; Zhu, Lei; Fan, Hao; Tang, Weiya; Fan, Yongjie; Dai, Haiying; Zhang, Peipei; Wang, Ying; Xing, Xin; Yang, Chao			Experimental study of ASCs combined with POC-PLA patch for the reconstruction of full-thickness chest wall defects	PLOS ONE			English	Article							CELL SHEET; BIODEGRADABLE ELASTOMERS; STEM-CELLS; EXPERIENCE; SCAFFOLD; TISSUES; MODEL; MESH	To explore the repairing effect of combination of adipose stem cells (ASCs) and composite scaffolds on CWR, the electrospun Poly 1, 8-octanediol-co-citric acid (POC)-poly-L-lactide acid (PLA) composite scaffolds were prepared, followed by in vitro and in vivo biocompatibility evaluation of the scaffolds. Afterwards, ASCs were seeded on POC-PLA to construct the POC-PLA-ASCs scaffolds, and the POC-PLA, POC-PLA-ASCs, and traditional materials expanded polytetrafluoroethylene (ePTFE) were adopt for CWR in New Zealand white (NZW) rabbit models. As results, the POC-PLA-ASCs patches possessed good biocompatibility as the high proliferation ability of cells surrounding the patches. Rabbits in POC-PLA-ASCs groups showed better pulmonary function, less pleural adhesion, higher degradation rate and more neovascularization when compared with that in other two groups. The results of western blot indicated that POC-PLA-ASCs patches accelerated the expression of VEGF and Collagen I in rabbit models. From the above, our present study demonstrated that POC-PLA material was applied for CWR successfully, and ASCs seeded on the sheets could improve the pleural adhesions and promote the reparation of chest wall defects.	[Zhang, Yuanzheng; Fang, Shuo; Fan, Hao; Tang, Weiya; Fan, Yongjie; Dai, Haiying; Xing, Xin; Yang, Chao] Second Mil Med Univ, Changhai Hosp, Dept Plast Surg, Shanghai, Peoples R China; [Dai, Jiezhi] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Orthoped Surg, Shanghai, Peoples R China; [Zhu, Lei] Donghua Univ, Coll Mat Sci & Engn, State Key Lab Modificat Chem Fibers & Polymer Mat, Shanghai, Peoples R China; [Zhang, Peipei; Wang, Ying] 455th Hosp Chinese Peoples Liberat Army, Dept Plast Surg, Shanghai, Peoples R China	Naval Medical University; Shanghai Jiao Tong University; Donghua University	Xing, X; Yang, C (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Plast Surg, Shanghai, Peoples R China.	xingxin57@163.com; 139160866222@163.com			National Natural Science Foundation of China (NSFC) [81301644]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (NSFC, Grants no: 81301644).	Arnold PG, 1996, PLAST RECONSTR SURG, V98, P804, DOI 10.1097/00006534-199610000-00008; Cerqueira MT, 2013, BIOMACROMOLECULES, V14, P3997, DOI 10.1021/bm4011062; Chang RR, 2004, ANN PLAS SURG, V52, P471, DOI 10.1097/01.sap.0000122653.09641.f8; Chung EJ, 2017, J TISSUE ENG REGEN M, V11, P704, DOI 10.1002/term.1966; Ferraro GA, 2013, J CELL BIOCHEM, V114, P1039, DOI 10.1002/jcb.24443; Francesco FD, 2009, PLOS ONE, V4, pe6537; Getman Vladyslav, 2006, Interact Cardiovasc Thorac Surg, V5, P243, DOI 10.1510/icvts.2005.121129; Hamaji M, 2015, INTERACT CARDIOV TH, V20, P322, DOI 10.1093/icvts/ivu416; Hameed A, 2008, J PLAST RECONSTR AES, V61, P628, DOI 10.1016/j.bjps.2007.04.011; Hidalgo-Bastida LA, 2007, ACTA BIOMATER, V3, P457, DOI 10.1016/j.actbio.2006.12.006; Karacam V, 2011, INT J MED SCI, V8, P380, DOI 10.7150/ijms.8.380; Lin YC, 2013, ACTA BIOMATER, V9, P5243, DOI 10.1016/j.actbio.2012.09.028; Liu J, 2014, J BIOMATER APPL, V28, P729, DOI 10.1177/0885328213477893; Mansour KA, 2002, ANN THORAC SURG, V73, P1720, DOI 10.1016/S0003-4975(02)03527-0; Prabhakaran MP, 2012, BIOPOLYMERS, V97, P529, DOI 10.1002/bip.22035; Rd HL, 2007, PLAST RECONSTR SURG, V119, P1238; Taha MF, 2010, TISSUE CELL, V42, P211, DOI 10.1016/j.tice.2010.04.003; Tang H, 2009, BIOMATERIALS, V30, P3224, DOI 10.1016/j.biomaterials.2009.02.007; Xu H, 2012, J CARDIOVASC TRANSL, V5, P519, DOI 10.1007/s12265-012-9381-8; Yang J, 2004, ADV MATER, V16, P511, DOI 10.1002/adma.200306264; Yang J, 2006, BIOMATERIALS, V27, P1889, DOI 10.1016/j.biomaterials.2005.05.106; Yang J, 2007, BIOMATERIALS, V28, P5033, DOI 10.1016/j.biomaterials.2007.07.052; Yuhgetsu H, 2006, EXP LUNG RES, V32, P413, DOI 10.1080/01902140601047633; Zhang LJ, 2011, EUR J CARDIO-THORAC, V40, P939, DOI 10.1016/j.ejcts.2010.12.058	24	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0182971	10.1371/journal.pone.0182971	http://dx.doi.org/10.1371/journal.pone.0182971			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800620	Green Published, gold, Green Submitted			2022-12-26	WOS:000407431800039
J	Hemmatian, H; Laurent, MR; Ghazanfari, S; Vanderschueren, D; Bakker, AD; Klein-Nulend, J; van Lenthe, GH				Hemmatian, Haniyeh; Laurent, Michael R.; Ghazanfari, Samaneh; Vanderschueren, Dirk; Bakker, Astrid D.; Klein-Nulend, Jenneke; van Lenthe, G. Harry			Accuracy and reproducibility of mouse cortical bone microporosity as quantified by desktop microcomputed tomography	PLOS ONE			English	Article							OSTEOCYTE LACUNAR DENSITY; MICRO-CT; MINERAL DENSITY; 3D ASSESSMENT; HUMAN FEMUR; IN-SITU; POROSITY; MORPHOLOGY; WOMEN; RESOLUTION	Bone's microporosity plays important roles in bone biology and bone mechanical quality. In this study, we explored the accuracy and reproducibility of nondestructive desktop mu CT for 3D visualization and subsequent morphometric analysis of mouse cortical bone microporosity including the vascular canal network and osteocyte lacunae. The accuracy of measurements was evaluated in five murine fibula using confocal laser scanning microscopy (CLSM) in conjunction with Fluorescein isothiocyanate (FITC) staining as the reference method. The reproducibility of mu CT-derived cortical bone microstructural indices was examined in 10 fibulae of C57Bl/6J male mice at a nominal resolution of 700 nanometer. Three repeated measurements were made on different days. An excellent correlation between mu CT and CLSM was observed for both mean lacuna volume (r = 0.98, p = 0.002) and for mean lacuna orientation (r = 0.93, p = 0.02). Whereas the two techniques showed no significant differences for these parameters, the mean lacuna sphericity acquired from mu CT was significantly higher than CLSM (p = 0.01). Reproducibility was high, with precision errors (PE) of 1.57-4.69% for lacuna parameters, and of 1.01-9.45% for vascular canal parameters. Intraclass correlation coefficient (ICC) showed a high reliability of the measurements, ranging from 0.998-1.000 for cortical parameters, 0.973-0.999 for vascular canal parameters and 0.755-0.991 for lacuna parameters. In conclusion, desktop mu CT is a valuable tool to quantify the 3D characteristics of bone vascular canals as well as lacunae which can be applied to intact murine bones with high accuracy and reproducibility. Thus, mu CT might be an important tool to improve our understanding of the physiological and biomechanical significance of these cannular and lacunar structure in cortical bone.	[Hemmatian, Haniyeh; van Lenthe, G. Harry] Katholieke Univ Leuven, Dept Mech Engn, Biomech Sect, Leuven, Belgium; [Hemmatian, Haniyeh; Bakker, Astrid D.; Klein-Nulend, Jenneke] Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Oral Cell Biol, Amsterdam, Netherlands; [Hemmatian, Haniyeh; Bakker, Astrid D.; Klein-Nulend, Jenneke] Vrije Univ Amsterdam, Amsterdam Movement Sci, Amsterdam, Netherlands; [Laurent, Michael R.] Katholieke Univ Leuven, Dept Cellular & Mol Med, Mol Endocrinol Lab, Leuven, Belgium; [Laurent, Michael R.] Katholieke Univ Leuven, Dept Clin & Expt Med, Gerontol & Geriatr, Leuven, Belgium; [Ghazanfari, Samaneh] Maastricht Univ, Dept Humanities & Sci, Aachen Maastricht Inst Biobased Mat, Geleen, Netherlands; [Vanderschueren, Dirk] Katholieke Univ Leuven, Dept Clin & Expt Med, Clin & Expt Endocrinol, Leuven, Belgium	KU Leuven; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; KU Leuven; KU Leuven; Maastricht University; KU Leuven	van Lenthe, GH (corresponding author), Katholieke Univ Leuven, Dept Mech Engn, Biomech Sect, Leuven, Belgium.	harry.vanlenthe@kuleuven.be	Bakker, Astrid Diana/AAD-1286-2019; van Lenthe, Harry (GH)/C-1030-2008; Laurent, Michaël R./D-5748-2011	van Lenthe, Harry (GH)/0000-0001-8303-4959; Laurent, Michaël R./0000-0001-9681-8330; vanderschueren, dirk/0000-0003-1395-0104; Ghazanfari, Samaneh/0000-0001-8177-7521; Hemmatian, Haniyeh/0000-0001-6314-1765				ALTMAN DG, 1983, J ROY STAT SOC D-STA, V32, P307, DOI 10.2307/2987937; Bach-Gansmo FL, 2015, J STRUCT BIOL, V191, P59, DOI 10.1016/j.jsb.2015.05.005; Basillais A, 2007, J ORTHOP SCI, V12, P141, DOI 10.1007/s00776-006-1104-z; Britz HM, 2010, J MICROSC-OXFORD, V240, P32, DOI 10.1111/j.1365-2818.2010.03381.x; Britz HM, 2012, BONE, V51, P913, DOI 10.1016/j.bone.2012.08.112; Carter Y, 2013, J STRUCT BIOL, V183, P519, DOI 10.1016/j.jsb.2013.07.004; Carter Y, 2013, BONE, V52, P126, DOI 10.1016/j.bone.2012.09.010; Ciani C, 2009, BONE, V44, P1015, DOI 10.1016/j.bone.2009.01.376; Cooper D. M. L., 2003, Anatomical Record, V274B, P169, DOI 10.1002/ar.b.10024; Cooper DML, 2007, BONE, V40, P957, DOI 10.1016/j.bone.2006.11.011; Cooper DML, 2004, CALCIFIED TISSUE INT, V74, P437, DOI 10.1007/s00223-003-0071-z; Currey JD, 2003, J BIOMECH, V36, P1487, DOI 10.1016/S0021-9290(03)00124-6; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Dierolf M, 2010, NATURE, V467, P436, DOI 10.1038/nature09419; Dong P, 2014, BONE, V60, P172, DOI 10.1016/j.bone.2013.12.008; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; GLUER CC, 1995, OSTEOPOROSIS INT, V5, P262, DOI 10.1007/BF01774016; Hannah KM, 2010, BONE, V47, P866, DOI 10.1016/j.bone.2010.07.025; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Jones CW, 2005, PROG HISTOCHEM CYTO, V40, P1, DOI 10.1016/j.proghi.2005.02.001; Jordan GR, 2000, BONE, V26, P305, DOI 10.1016/S8756-3282(99)00272-0; Kamioka H, 2009, MICROSC MICROANAL, V15, P377, DOI 10.1017/S1431927609990420; Kaya S, 2017, J BONE MINER RES, V32, P688, DOI 10.1002/jbmr.3044; Klein-Nulend J, 2015, J BIOMECH, V48, P855, DOI 10.1016/j.jbiomech.2014.12.007; Klein-Nulend J, 2013, BONE, V54, P182, DOI 10.1016/j.bone.2012.10.013; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Laurent MR, 2016, MOL CELL ENDOCRINOL, V432, P24, DOI 10.1016/j.mce.2015.10.017; MAROTTI G, 1980, ACTA ANAT, V106, P84; MCCALDEN RW, 1993, J BONE JOINT SURG AM, V75A, P1193, DOI 10.2106/00004623-199308000-00009; McCreadie BR, 2004, J BIOMECH, V37, P563, DOI 10.1016/S0021-9290(03)00287-2; Moustafa A, 2009, BONE, V44, P930, DOI 10.1016/j.bone.2008.12.026; Muller R, 2009, NAT REV RHEUMATOL, V5, P373, DOI 10.1038/nrrheum.2009.107; Palacio-Mancheno PE, 2014, J BONE MINER RES, V29, P142, DOI 10.1002/jbmr.2012; Particelli F, 2012, J MICROSC-OXFORD, V245, P302, DOI 10.1111/j.1365-2818.2011.03573.x; Schneider P, 2007, J BONE MINER RES, V22, P1557, DOI 10.1359/JBMR.070703; Schneider P, 2011, BONE, V49, P304, DOI 10.1016/j.bone.2011.04.005; Schneider P, 2010, BONE, V47, P848, DOI 10.1016/j.bone.2010.07.026; Seeman E, 2013, J GERONTOL A-BIOL, V68, P1218, DOI 10.1093/gerona/glt071; Sharma D, 2012, BONE, V51, P488, DOI 10.1016/j.bone.2012.05.014; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sinnesael M, 2015, ENDOCRINOLOGY, V156, P1343, DOI 10.1210/en.2014-1673; Sugawara Y, 2005, BONE, V36, P877, DOI 10.1016/j.bone.2004.10.008; Tommasini SM, 2012, BONE, V50, P596, DOI 10.1016/j.bone.2011.12.012; van Hove RP, 2009, BONE, V45, P321, DOI 10.1016/j.bone.2009.04.238; Vatsa A, 2008, BONE, V43, P452, DOI 10.1016/j.bone.2008.01.030; Wachter NJ, 2001, CALCIFIED TISSUE INT, V68, P38, DOI 10.1007/BF02685001; Wang LY, 2005, P NATL ACAD SCI USA, V102, P11911, DOI 10.1073/pnas.0505193102; Yeni YN, 1997, BONE, V21, P453, DOI 10.1016/S8756-3282(97)00173-7; Zebaze RMD, 2010, LANCET, V375, P1729, DOI 10.1016/S0140-6736(10)60320-0	49	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182996	10.1371/journal.pone.0182996	http://dx.doi.org/10.1371/journal.pone.0182996			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797125	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000407396200138
J	Gray, EL; Dennis, TE; Baker, AM				Gray, Emma L.; Dennis, Todd E.; Baker, Andrew M.			Can remote infrared cameras be used to differentiate small, sympatric mammal species? A case study of the black-tailed dusky antechinus, Antechinus arktos and co-occurring small mammals in southeast Queensland, Australia	PLOS ONE			English	Article							DAILY ACTIVITY PATTERNS; DIGITAL CAMERAS; TRAP ORIENTATIONS; SP NOV.; COMPETITION; POTOROOS; ECOLOGY; RANGE; BAIT; RARE	The black-tailed dusky antechinus (Antechinus arktos) is an endangered, small carnivorous marsupial endemic to Australia, which occurs at low population density along with abundant sympatric populations of other small mammals: Antechinus stuartii, Rattus fuscipes and Melomys cervinipes. Using A. arktos as a model species, we aimed to evaluate the effectiveness of infrared digital camera traps for detecting and differentiating small mammals and to comment on the broad applicability of this methodology. We also sought to understand how the detection probabilities of our target species varied over time and characterize their activity patterns. We installed 11 infrared cameras at one of only three known sites where A. arktos occurs for five consecutive deployments. Cameras were fixed to wooden stakes and oriented vertically, 35 cm above ground, directly facing bait containers. Using this method, we successfully recorded and identified individuals from all four species of small mammal known previously in the area from live trapping, including A. arktos. This validates the effectiveness of the infrared camera type and orientation for small mammal studies. Periods of activity for all species were highly coincident, showing a strong peak in activity during the same two-hour period immediately following sunset. A. arktos, A. stuartii and M. cervinipes also displayed a strong negative linear relationship between detection probability and days since deployment. This is an important finding for camera trapping generally, indicating that routine camera deployment lengths (of one-to-two weeks) between baiting events may be too long when targeting some small mammals.	[Gray, Emma L.; Baker, Andrew M.] Queensland Univ Technol, Sci & Engn Fac, Sch Earth Environm & Biol Sci, Brisbane, Qld, Australia; [Dennis, Todd E.] Univ Auckland, Sci Fac, Sch Biol Sci, Auckland, New Zealand	Queensland University of Technology (QUT); University of Auckland	Gray, EL (corresponding author), Queensland Univ Technol, Sci & Engn Fac, Sch Earth Environm & Biol Sci, Brisbane, Qld, Australia.	el.gray@connect.qut.edu.au		Baker, Andrew/0000-0001-8825-1522	Australian Postgraduate Award for doctoral research	Australian Postgraduate Award for doctoral research	Gold Coast City Council, the School of Earth, Environmental and Biological Sciences at the Queensland University of Technology provided access to vehicles and field equipment. ELG was financially supported by an Australian Postgraduate Award for doctoral research. Australian Geographic ($1,000) ELG. Gold Coast City Council ($2 000) AMB/ Holsworth Wildlife Research Endowment ($3 000) ELG AMB. HOLSW2015-1-F146. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong K.N., 2008, MAMMALS AUSTR, P470; Baker A. M., 2016, Memoirs of the Queensland Museum, V59, P75, DOI 10.17082/j.2204-1478.59.2015.2014-10; Baker AM, 2014, ZOOTAXA, V 3765, P101, DOI 10.11646/zootaxa.3765.2.1; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Carver BD, 2011, J MAMMAL, V92, P134, DOI 10.1644/10-MAMM-A-066.1; Claridge AW, 2016, AUST MAMMAL, V38, P12, DOI 10.1071/AM15015; Claridge AW, 2014, CAMERA TRAPPING: WILDLIFE MANAGEMENT AND RESEARCH, P205; Claridge Andrew W., 2010, Australian Mammalogy, V32, P165, DOI 10.1071/AM09039; Claridge AW, 2004, WILDLIFE RES, V31, P645, DOI 10.1071/WR03072; Crawley M. J., 2013, R BOOK; Cunningham RB, 2005, WILDLIFE RES, V32, P657, DOI 10.1071/WR04069; De Bondi N, 2010, WILDLIFE RES, V37, P456, DOI 10.1071/WR10046; Diaz-Ruiz F, 2016, J ZOOL, V298, P128, DOI 10.1111/jzo.12294; DICKMAN CR, 1983, OECOLOGIA, V60, P127, DOI 10.1007/BF00379332; DICKMAN CR, 1991, OECOLOGIA, V85, P464, DOI 10.1007/BF00323757; Diete RL, 2015, AUST J ZOOL, V63, P376, DOI 10.1071/ZO15050; Driessen MM, 2014, CAMERA TRAPPING: WILDLIFE MANAGEMENT AND RESEARCH, P253; Glen AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067940; Gray EL, 2017, MAMMAL RES, V62, P47, DOI 10.1007/s13364-016-0281-1; Gray EL, 2016, AUST J ZOOL, V64, P249, DOI 10.1071/ZO16044; HALL S, 1980, AUST WILDLIFE RES, V7, P365, DOI 10.1071/WR9800365; Hunter RJ, 2003, WORLD HERITAGE ASS N; Leung LKP, 1999, WILDLIFE RES, V26, P287, DOI 10.1071/WR96042; McAllan BM, 2006, BIOL J LINN SOC, V87, P365, DOI 10.1111/j.1095-8312.2006.00571.x; MCARDLE BH, 1990, OIKOS, V57, P276, DOI 10.2307/3565950; Mccallum J, 2013, MAMMAL REV, V43, P196, DOI 10.1111/j.1365-2907.2012.00216.x; McCallum ML, 2015, BIODIVERS CONSERV, V24, P2497, DOI 10.1007/s10531-015-0940-6; McDonald PJ, 2015, BIOL CONSERV, V191, P93, DOI 10.1016/j.biocon.2015.06.027; MCILROY JC, 1988, AUST WILDLIFE RES, V15, P473, DOI 10.1071/WR9880473; Meek P.D., 2013, Wildlife Biology in Practice, V9, P7; Meek P, 2016, ECOL EVOL, V6, P3216, DOI 10.1002/ece3.2111; Meek PD, 2016, AUST MAMMAL, V38, P44, DOI 10.1071/AM15016; Meek PD, 2015, AUST MAMMAL, V37, P13, DOI 10.1071/AM14023; Meek PD, 2015, AUST MAMMAL, V37, P1, DOI 10.1071/AM14021; Meek PD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110832; Meek PD, 2012, AUST MAMMAL, V34, P223, DOI 10.1071/AM11032; Meredith M., 2016, OVERVIEW OVERLAP PAC; Paull DJ, 2011, WILDLIFE RES, V38, P188, DOI 10.1071/WR10203; Queensland Herbarium, 2013, REG EC DESCR DAT RED; R Core Team, 2021, R LANGUAGE ENV STAT; Rendall AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086592; Ridout MS, 2009, J AGR BIOL ENVIR ST, V14, P322, DOI 10.1198/jabes.2009.08038; Rovero F, 2013, HYSTRIX, V24, P148, DOI 10.4404/hystrix-24.2-6316; Rowcliffe JM, 2014, METHODS ECOL EVOL, V5, P1170, DOI 10.1111/2041-210X.12278; Sale MG, 2009, J MAMMAL, V90, P347, DOI 10.1644/08-MAMM-A-118.1; Smith JK, 2012, AUST MAMMAL, V34, P196, DOI 10.1071/AM11034; Tasker Elizabeth M., 2002, Australian Mammalogy, V23, P77; Taylor BD, 2014, AUST MAMMAL, V36, P60, DOI 10.1071/AM13012; Tobler MW, 2009, J TROP ECOL, V25, P261, DOI 10.1017/S0266467409005896; Wang SW, 2009, BIOL CONSERV, V142, P606, DOI 10.1016/j.biocon.2008.11.023; Weerakoon MK, 2014, CAMERA TRAPPING: WILDLIFE MANAGEMENT AND RESEARCH, P307; Welbourne DJ, 2015, WILDLIFE RES, V42, P414, DOI 10.1071/WR15054; Williams CT, 2014, J MAMMAL, V95, P1230, DOI 10.1644/14-MAMM-A-062; WOOD D H, 1970, Australian Journal of Zoology, V18, P185, DOI 10.1071/ZO9700185; WOOD D H, 1971, Australian Journal of Zoology, V19, P371, DOI 10.1071/ZO9710371; Wrobel A, 2015, EUR J WILDLIFE RES, V61, P475, DOI 10.1007/s10344-014-0892-2; Zuur AF, 2007, STAT BIOL HEALTH, P163	58	12	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0181592	10.1371/journal.pone.0181592	http://dx.doi.org/10.1371/journal.pone.0181592			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28792958	Green Submitted, gold, Green Published			2022-12-26	WOS:000407196700014
J	Zakrzewska, KE; Samluk, A; Wencel, A; Dudek, K; Pijanowska, DG; Pluta, KD				Zakrzewska, Karolina Ewa; Samluk, Anna; Wencel, Agnieszka; Dudek, Krzysztof; Pijanowska, Dorota Genowefa; Pluta, Krzysztof Dariusz			Liver tissue fragments obtained from males are the most promising source of human hepatocytes for cell-based therapies - Flow cytometric analysis of albumin expression	PLOS ONE			English	Article								Cell-based therapies that could provide an alternative treatment for the end-stage liver disease require an adequate source of functional hepatocytes. There is little scientific evidence for the influence of patient's age, sex, and chemotherapy on the cell isolation efficiency and metabolic activity of the harvested hepatocytes. The purpose of this study was to investigate whether hepatocytes derived from different sources display differential viability and biosynthetic capacity. Liver cells were isolated from 41 different human tissue specimens. Hepatocytes were labeled using specific antibodies and analyzed using flow cytometry. Multiparametric analysis of the acquired data revealed statistically significant differences between some studied groups of patients. Generally, populations of cells isolated from the male specimens had greater percentage of biosynthetically active hepatocytes than those from the female ones regardless of age and previous chemotherapy of the patient. Based on the albumin staining (and partially on the alpha-1-antitrypsin labeling) after donor liver exclusion (6 out of 41 samples), our results indicated that: 1. samples obtained from males gave a greater percentage of active hepatocytes than those from females (p = 0.034), and 2. specimens from the males after chemotherapy greater than those from the treated females (p = 0.032).	[Zakrzewska, Karolina Ewa; Samluk, Anna; Wencel, Agnieszka; Pijanowska, Dorota Genowefa; Pluta, Krzysztof Dariusz] Polish Acad Sci, Dept Hybrid Microbiosyst Engn, Nalecz Inst Biocybernet & Biomed Engn, Warsaw, Poland; [Dudek, Krzysztof] Med Univ Warsaw, Chair & Dept Gen Transplant & Liver Surg, Warsaw, Poland	Polish Academy of Sciences; Nalecz Institute of Biocybernetics & Biomedical Engineering of the Polish Academy of Sciences; Medical University of Warsaw	Pluta, KD (corresponding author), Polish Acad Sci, Dept Hybrid Microbiosyst Engn, Nalecz Inst Biocybernet & Biomed Engn, Warsaw, Poland.	kpluta@ibib.waw.pl	Pijanowska, Dorota/AAJ-3586-2021; Pijanowska, Dorota G/W-3182-2018; Wencel, Agnieszka/AAM-2346-2021	Pijanowska, Dorota/0000-0001-8431-8910; Pijanowska, Dorota G/0000-0001-8431-8910; Pluta, Krzysztof/0000-0003-1706-2788; Zakrzewska, Karolina/0000-0002-1346-2445; Wencel, Agnieszka/0000-0003-4582-8250	Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences	Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences	Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences statutory funding.	Alexandre E., 2002, Cell and Tissue Banking, V3, P223; Auguie B, 2017, GRIDEXTRA MISCELLANE; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhogal RH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018222; Donato MT, 2008, CELL TRANSPLANT, V17, P1211, DOI 10.3727/096368908787236620; Hughes RD, 2006, LIVER TRANSPLANT, V12, P713, DOI 10.1002/lt.20732; Kadyk LC, 2015, STEM CELL TRANSL MED, V4, P207, DOI 10.5966/sctm.2014-0276; Kleine M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101386; Kochanek KD, 2014, NATL VITAL STAT REPO, V65, P1; Lee SML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107567; Lloyd T. D. R., 2004, Cell and Tissue Banking, V5, P81, DOI 10.1023/B:CATB.0000034079.10985.bd; Mennecozzi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122786; No DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050723; Parkinson A, 2004, TOXICOL APPL PHARM, V199, P193, DOI 10.1016/j.taap.2004.01.010; Richert L, 2004, LIVER INT, V24, P371, DOI 10.1111/j.1478-3231.2004.0930.x; Samluk A, 2013, ARTIF ORGANS, V37, pE123, DOI 10.1111/aor.12064; Schmucker Douglas L, 2011, Curr Gerontol Geriatr Res, V2011, P526379, DOI 10.1155/2011/526379; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913; Vondran FWR, 2008, ARTIF ORGANS, V32, P205, DOI 10.1111/j.1525-1594.2007.00524.x	20	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182846	10.1371/journal.pone.0182846	http://dx.doi.org/10.1371/journal.pone.0182846			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28793328	Green Submitted, Green Published, gold			2022-12-26	WOS:000407196700071
J	Kranick, JC; Chadalavada, DM; Sahu, D; Showalter, SA				Kranick, Joshua C.; Chadalavada, Durga M.; Sahu, Debashish; Showalter, Scott A.			Engineering double-stranded RNA binding activity into the Drosha double-stranded RNA binding domain results in a loss of microRNA processing function	PLOS ONE			English	Article							PROTEIN INTERACTIONS; CLEAVAGE SITE; MINOR-GROOVE; COMPLEX; MICROPROCESSOR; DSRNA; TRBP; RECOGNITION; DGCR8; DICER	Canonical processing of miRNA begins in the nucleus with the Microprocessor complex, which is minimally composed of the RNase III enzyme Drosha and two copies of its cofactor protein DGCR8. In structural analogy to most RNase III enzymes, Drosha possesses a modular domain with the double-stranded RNA binding domain (dsRBD) fold. Unlike the dsRBDs found in most members of the RNase III family, the Drosha-dsRBD does not display double-stranded RNA binding activity; perhaps related to this, the Drosha-dsRBD amino acid sequence does not conform well to the canonical patterns expected for a dsRBD. In this article, we investigate the impact on miRNA processing of engineering double-stranded RNA binding activity into Drosha's non-canonical dsRBD. Our findings corroborate previous studies that have demonstrated the Drosha-dsRBD is necessary for miRNA processing and suggest that the amino acid composition in the second alpha-helix of the domain is critical to support its evolved function.	[Kranick, Joshua C.; Chadalavada, Durga M.; Sahu, Debashish; Showalter, Scott A.] Penn State Univ, Dept Chem, Ctr RNA Mol Biol, University Pk, PA 16802 USA; [Showalter, Scott A.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Chadalavada, Durga M.] US Geol Survey, MD DE DC Water Sci Ctr, Baltimore, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of the Interior; United States Geological Survey	Showalter, SA (corresponding author), Penn State Univ, Dept Chem, Ctr RNA Mol Biol, University Pk, PA 16802 USA.; Showalter, SA (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	sas76@psu.edu	Showalter, Scott A/A-1655-2012; Sahu, Debashish/G-8325-2018	Showalter, Scott A/0000-0001-5179-032X; Sahu, Debashish/0000-0002-5890-813X; Ghosh, Durga/0000-0003-1367-8198	US National Institutes of Health, National Institute of General Medical Science [R01-GM-098451]; Huck Institutes for the Life Sciences Shared Fermentation Facility; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098451] Funding Source: NIH RePORTER	US National Institutes of Health, National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Huck Institutes for the Life Sciences Shared Fermentation Facility; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding of this work was provided to SAS by the US National Institutes of Health, National Institute of General Medical Science through award number R01-GM-098451.; We are grateful to the Huck Institutes for the Life Sciences Shared Fermentation Facility for support performing the cell culture experiments. J.C.K. would like to acknowledge fruitful discussions with Dr. Kaycee A. Quarles in the initial stages of this project.	Acevedo R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116749; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bevilacqua PC, 1996, BIOCHEMISTRY-US, V35, P9983, DOI 10.1021/bi9607259; BRUSCHWEILER R, 1995, SCIENCE, V268, P886, DOI 10.1126/science.7754375; Du Z, 2008, P NATL ACAD SCI USA, V105, P2391, DOI 10.1073/pnas.0711506105; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Gleghorn ML, 2014, TRENDS BIOCHEM SCI, V39, P328, DOI 10.1016/j.tibs.2014.05.003; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Huang Y, 2009, NATURE, V461, P823, DOI 10.1038/nature08433; Laraki G, 2008, RNA BIOL, V5, P92, DOI 10.4161/rna.5.2.6069; Lee LK, 1997, J BIOMOL NMR, V9, P287, DOI 10.1023/A:1018631009583; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Masliah G, 2013, CELL MOL LIFE SCI, V70, P1875, DOI 10.1007/s00018-012-1119-x; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Mueller Geoffrey A, 2010, Silence, V1, P2, DOI 10.1186/1758-907X-1-2; Parker GS, 2008, J MOL BIOL, V384, P967, DOI 10.1016/j.jmb.2008.10.002; Pratt AJ, 2009, J BIOL CHEM, V284, P17897, DOI 10.1074/jbc.R900012200; Quarles KA, 2015, PROTEINS, V83, P1165, DOI 10.1002/prot.24810; Quarles KA, 2013, BIOCHEMISTRY-US, V52, P795, DOI 10.1021/bi301452a; Roth BM, 2013, J BIOL CHEM, V288, P26785, DOI 10.1074/jbc.M112.446880; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Sassen S, 2008, VIRCHOWS ARCH, V452, P1, DOI 10.1007/s00428-007-0532-2; Sohn SY, 2007, NAT STRUCT MOL BIOL, V14, P847, DOI 10.1038/nsmb1294; Stefl R, 2010, CELL, V143, P225, DOI 10.1016/j.cell.2010.09.026; Stephens OM, 2004, CHEM BIOL, V11, P1239, DOI 10.1016/j.chembiol.2004.06.009; Tian B, 2004, NAT REV MOL CELL BIO, V5, P1013, DOI 10.1038/nrm1528; Nguyen TA, 2015, CELL, V161, P1374, DOI 10.1016/j.cell.2015.05.010; Ucci JW, 2007, BIOCHEMISTRY-US, V46, P55, DOI 10.1021/bi061531o; Wilson RC, 2015, MOL CELL, V57, P397, DOI 10.1016/j.molcel.2014.11.030; Wostenberg C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051829; Wostenberg C, 2010, BIOCHEMISTRY-US, V49, P10728, DOI 10.1021/bi1015716; Yang SW, 2010, STRUCTURE, V18, P594, DOI 10.1016/j.str.2010.02.006; Zeng Y, 2004, NUCLEIC ACIDS RES, V32, P4776, DOI 10.1093/nar/gkh824; Zhang CX, 2008, PHYSIOL GENOMICS, V33, P139, DOI 10.1152/physiolgenomics.00034.2008; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	40	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2017	12	8							e0182445	10.1371/journal.pone.0182445	http://dx.doi.org/10.1371/journal.pone.0182445			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9EU	28792523	Green Published, Green Submitted, gold			2022-12-26	WOS:000407144700020
J	Ricci, SW; Bohnenstiehl, DR; Eggleston, DB; Kellogg, ML; Lyon, RP				Ricci, Shannon W.; Bohnenstiehl, DelWayne R.; Eggleston, David B.; Kellogg, M. Lisa; Lyon, R. Patrick			Oyster toadfish (Opsanus tau) boatwhistle call detection and patterns within a large-scale oyster restoration site	PLOS ONE			English	Article							SOUND PRODUCTION; MATING CALL; CRABS	During May 2015, passive acoustic recorders were deployed at eight subtidal oyster reefs within Harris Creek Oyster Sanctuary in Chesapeake Bay, Maryland USA. These sites were selected to represent both restored and unrestored habitats having a range of oyster densities. Throughout the survey, the soundscape within Harris Creek was dominated by the boatwhistle calls of the oyster toadfish, Opsanus tau. A novel, multi-kernel spectral correlation approach was developed to automatically detect these boatwhistle calls using their two lowest harmonic bands. The results provided quantitative information on how call rate and call frequency varied in space and time. Toadfish boatwhistle fundamental frequency ranged from 140 Hz to 260 Hz and was well correlated (r = 0.94) with changes in water temperature, with the fundamental frequency increasing by similar to 11 Hz for every 1 degrees C increase in temperature. The boatwhistle call rate increased from just a few calls per minute at the start of monitoring on May 7 th to similar to 100 calls/min on May 10 th and remained elevated throughout the survey. As male toadfish are known to generate boatwhistles to attract mates, this rapid increase in call rate was interpreted to mark the onset of spring spawning behavior. Call rate was not modulated by water temperature, but showed a consistent diurnal pattern, with a sharp decrease in rate just before sunrise and a peak just after sunset. There was a significant difference in call rate between restored and unrestored reefs, with restored sites having nearly twice the call rate as unrestored sites. This work highlights the benefits of using automated detection techniques that provide quantitative information on species-specific call characteristics and patterns. This type of non-invasive acoustic monitoring provides longterm, semi-continuous information on animal behavior and abundance, and operates effectively in settings that are otherwise difficult to sample.	[Ricci, Shannon W.; Bohnenstiehl, DelWayne R.; Eggleston, David B.; Lyon, R. Patrick] North Carolina State Univ, Dept Marine Earth & Atmospher Sci, Raleigh, NC 27695 USA; [Eggleston, David B.] North Carolina State Univ, Ctr Marine Sci & Technol, Morehead City, NC USA; [Kellogg, M. Lisa] Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; William & Mary; Virginia Institute of Marine Science	Ricci, SW (corresponding author), North Carolina State Univ, Dept Marine Earth & Atmospher Sci, Raleigh, NC 27695 USA.	swbrown@ncsu.edu		Kellogg, Mary Lisa/0000-0001-6577-5091; Eggleston, David/0000-0001-7840-2665; Ricci, Shannon/0000-0003-0123-4071	National Science Foundation [OCE-1234688]; North Carolina Sea Grant [RMRD56/12-HCE-2]; NC State University, Center for Marine Sciences and Technology; National Oceanic Atmospheric Administration Chesapeake Bay Office [NA13NMF4570209, NA14NMF4570287]; Division Of Ocean Sciences [1234688] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); North Carolina Sea Grant; NC State University, Center for Marine Sciences and Technology; National Oceanic Atmospheric Administration Chesapeake Bay Office; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work received support from the National Science Foundation (OCE-1234688) to DBE and DRB https://www.nsf.gov/; North Carolina Sea Grant (RMRD56/12-HCE-2) to DBE https:// ncseagrant.ncsu.edu/; and NC State University, Center for Marine Sciences and Technology https://cmast.ncsu.edu/. Funding for field operations was provided as part of a larger research program supported by the National Oceanic Atmospheric Administration Chesapeake Bay Office (NA13NMF4570209 and NA14NMF4570287) to MLK, https://chesapeakebay.noaa.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBE GR, 1992, AQUACULTURE, V107, P21, DOI 10.1016/0044-8486(92)90047-O; Breitburg Denise L., 1999, P239; Coen LD, 2000, ECOL ENG, V15, P323, DOI 10.1016/S0925-8574(00)00084-7; Dos Santos Manuel E., 2000, Bioacoustics, V10, P309; Fine ML, 2015, PEERJ, V3, DOI 10.7717/peerj.1330; Fine ML, 2004, COPEIA, P235, DOI 10.1643/CP-03-073R1; FINE ML, 1978, OECOLOGIA, V36, P45, DOI 10.1007/BF00344570; FINE ML, 1983, COMP BIOCHEM PHYS A, V76, P225, DOI 10.1016/0300-9629(83)90319-5; FINE ML, 1977, FISH B-NOAA, V75, P871; Fish M. P., 1954, Bulletin of the Bingham Oceanographic Collection, V14, P1; Freeman LA, 2016, MAR ECOL PROG SER, V561, P69, DOI 10.3354/meps11938; GIBBONS MC, 1985, AQUACULTURE, V47, P101, DOI 10.1016/0044-8486(85)90056-0; Grabowski JH, 2004, ECOLOGY, V85, P995, DOI 10.1890/03-0067; GRAY GA, 1961, ECOLOGY, V42, P274, DOI 10.2307/1932079; Gudger E. W., 1910, Bulletin U S Bur Fish, V28; Harris S A, 2016, METHODS ECOLOGY EVOL; Hughes AR, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0715; Kellogg LM, 2016, INTEGRATED ASSESSMEN; Luczkovich JJ, 2016, ADV EXP MED BIOL, V875, P647, DOI 10.1007/978-1-4939-2981-8_78; Mellinger DK, 2000, J ACOUST SOC AM, V107, P3518, DOI 10.1121/1.429434; Montie EW, 2015, T AM FISH SOC, V144, P705, DOI 10.1080/00028487.2015.1037014; Ricci SW, 2016, MAR ECOL PROG SER, V550, P25, DOI 10.3354/meps11724; Rindone RR, 2011, J EXP MAR BIOL ECOL, V407, P216, DOI 10.1016/j.jembe.2011.06.018; SCHWARTZ F J, 1974, Chesapeake Science, V15, P155, DOI 10.2307/1351033; TAVOLGA WILLIAM N., 1958, BULL MARINE SCI GULF AND CARIBBEAN, V8, P278; Thorson RF, 2002, ENVIRON BIOL FISH, V63, P321, DOI 10.1023/A:1014334425821; Wall CC, 2013, MAR ECOL PROG SER, V484, P173, DOI 10.3354/meps10268; Winn H.E., 1972, P361	28	18	18	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2017	12	8							e0182757	10.1371/journal.pone.0182757	http://dx.doi.org/10.1371/journal.pone.0182757			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9EU	28792543	Green Published, gold, Green Submitted			2022-12-26	WOS:000407144700038
J	Boser, SR; Mauad, T; de Araujo-Paulino, BB; Mitchell, I; Shrestha, G; Chiu, A; Butt, J; Kelly, MM; Caldini, E; James, A; Green, FHY				Boser, Stacey R.; Mauad, Thais; de Araujo-Paulino, Bianca Bergamo; Mitchell, Ian; Shrestha, Grishma; Chiu, Andrea; Butt, John; Kelly, Margaret M.; Caldini, Elia; James, Alan; Green, Francis H. Y.			Myofibroblasts are increased in the lung parenchyma in asthma	PLOS ONE			English	Article							AIRWAY SMOOTH-MUSCLE; ELASTIC RECOIL; MAST-CELL; MECHANICS; TISSUE; INFLAMMATION; STIMULATION; DEATH	Background Increased airway smooth muscle is observed in large and small airways in asthma. Semi-quantitative estimates suggest that cells containing alpha smooth muscle actin (alpha-SMA) are also increased in the lung parenchyma. This study quantified and characterized alpha-SMA positive cells (alpha-SMA+) in the lung parenchyma of non-asthmatic and asthmatic individuals. Methods Post-mortem sections of peripheral lung from cases of fatal asthma (FA), persons with asthma dying of non-respiratory causes (NFA) and non-asthma control subjects (NAC) were stained for alpha-SMA, quantified using point-counting and normalised to alveolar basement membrane length and interstitial area. Results alpha-SMA+ fractional area was increased in alveolar parenchyma in both FA (14.7 +/- 2.8% of tissue area) and NFA (13.0 +/- 1.2%), compared with NAC (7.4 +/- 2.4%), p < 0.05 The difference was greater in upper lobes compared with lower lobes (p < 0.01) in both asthma groups. Similar changes were observed in alveolar ducts and alveolar walls. The electron microscopic features of the alpha-SMA+ cells were characteristic of myofibroblasts. Conclusions We conclude that in asthma there is a marked increase in alpha-SMA+ myofibroblasts in the lung parenchyma. The physiologic consequences of this increase are unknown.	[Boser, Stacey R.; Mitchell, Ian; Shrestha, Grishma; Chiu, Andrea; Kelly, Margaret M.; Green, Francis H. Y.] Univ Calgary, Fac Med, Snyder Inst Chron Dis, Airway Inflammat Grp, Calgary, AB, Canada; [Mauad, Thais; de Araujo-Paulino, Bianca Bergamo; Caldini, Elia] Univ Sao Paulo, Sch Med, Dept Pathol, Sao Paulo, Brazil; [Butt, John] Pathfinder Forum, Forens Pathol, Vancouver, BC, Canada; [James, Alan] Sir Charles Gairdner Hosp, Dept Pulm Physiol & Sleep Med, Perth, WA, Australia	University of Calgary; Universidade de Sao Paulo	Green, FHY (corresponding author), Univ Calgary, Fac Med, Snyder Inst Chron Dis, Airway Inflammat Grp, Calgary, AB, Canada.	fgreen@ucalgary.ca	Caldini, Elia Garcia/F-1105-2011; Kelly, Margaret M/G-4128-2012	Kelly, Margaret M/0000-0002-1629-3210; Caldini, Elia Garcia/0000-0001-5322-3812	Health Canada; Alberta Lung Association; Herron Foundation of Alberta; Alberta Innovates Health Solutions (AI HS); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); National Health and Medical Research Council, Australia [618700]; ALA; CNPq	Health Canada; Alberta Lung Association; Herron Foundation of Alberta; Alberta Innovates Health Solutions (AI HS); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); ALA; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Health Canada, Alberta Lung Association, Herron Foundation of Alberta, Alberta Innovates Health Solutions (AI HS), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and National Health and Medical Research Council, Australia, Project Grant ID 618700. The funders provided support in the form of salaries for authors GS and AC funded in part by ALA. EC and BBA were funded by CNPq, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. No funder played a direct role in this study.	Araujo BB, 2008, EUR RESPIR J, V32, P61, DOI 10.1183/09031936.00147807; Asthma G.I.F, 2017, GLOB STRAT ASTHM MAN; Berair R, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-145; Bradding P, 2006, J ALLERGY CLIN IMMUN, V117, P1277, DOI 10.1016/j.jaci.2006.02.039; Brown RH, 1997, J APPL PHYSIOL, V82, P491, DOI 10.1152/jappl.1997.82.2.491; Brown RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010332; BRUSASCO V, 1995, RESP MED, V89, P317, DOI 10.1016/0954-6111(95)90001-2; Cahill KN, 2017, NEW ENGL J MED, V376, P1911, DOI 10.1056/NEJMoa1613125; Carroll NG, 2000, AM J RESP CRIT CARE, V161, P244, DOI 10.1164/ajrccm.161.1.9805005; CASTAIRS JR, 1986, EUR J PHARMACOL, V127, P295, DOI 10.1016/0014-2999(86)90380-8; CHURG A, 1990, EXP LUNG RES, V16, P159, DOI 10.3109/01902149009108838; Cleary RA, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-105; COLEBATCH HJ, 1973, J APPL PHYSIOL, V34, P143, DOI 10.1152/jappl.1973.34.2.143; Dolhnikoff M, 1998, AM J RESP CRIT CARE, V158, P1607, DOI 10.1164/ajrccm.158.5.9801068; Dolhnikoff M, 2009, J ALLERGY CLIN IMMUN, V123, P1090, DOI 10.1016/j.jaci.2009.02.032; Elliot JG, 2015, RESPIROLOGY, V20, P66, DOI 10.1111/resp.12384; Eyden B, 2008, J CELL MOL MED, V12, P22, DOI 10.1111/j.1582-4934.2007.00213.x; FINUCANE KE, 1969, J APPL PHYSIOL, V26, P330, DOI 10.1152/jappl.1969.26.3.330; Gelb AF, 2002, CHEST, V121, P715, DOI 10.1378/chest.121.3.715; Green FHY, 2010, THORAX, V65, P32, DOI 10.1136/thx.2008.111435; Green FHY, 2006, CHEST, V130, P1025, DOI 10.1378/chest.130.4.1025; Hanon S, 2014, RESP MED, V108, P1601, DOI 10.1016/j.rmed.2014.07.019; Hessel PA, 1999, ANN ALLERG ASTHMA IM, V83, P362, DOI 10.1016/S1081-1206(10)62832-3; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; INGRAM RH, 1995, CHEST, V107, pS148, DOI 10.1378/chest.107.3_Supplement.148S; James AL, 2009, EUR RESPIR J, V34, P1040, DOI 10.1183/09031936.00181608; JAMES AL, 1989, AM REV RESPIR DIS, V139, P242, DOI 10.1164/ajrccm/139.1.242; James AL, 2012, AM J RESP CRIT CARE, V185, P1058, DOI 10.1164/rccm.201110-1849OC; Kaminsky DA, 1997, AM J RESP CRIT CARE, V155, P1260, DOI 10.1164/ajrccm.155.4.9105064; Kaminsky DA, 2000, AM J RESP CRIT CARE, V162, P179, DOI 10.1164/ajrccm.162.1.9806079; KAPANCI Y, 1974, J CELL BIOL, V60, P375, DOI 10.1083/jcb.60.2.375; Kelly MM, 2006, CHEST, V130, P741, DOI 10.1378/chest.130.3.741; Kraft M, 1999, AM J RESP CRIT CARE, V159, P228, DOI 10.1164/ajrccm.159.1.9804033; Arreola-Ramirez JL, 2013, GAC MED MEX, V149, P502; Mauad T, 2004, AM J RESP CRIT CARE, V170, P857, DOI 10.1164/rccm.200403-305OC; Noble PB, 2013, J APPL PHYSIOL, V114, P1460, DOI 10.1152/japplphysiol.01489.2012; Oldmixon EH, 2001, J APPL PHYSIOL, V91, P459, DOI 10.1152/jappl.2001.91.1.459; PARE PD, 1991, AM REV RESPIR DIS, V143, P1189, DOI 10.1164/ajrccm/143.5_Pt_1.1189; Perry SF, 2000, EXP LUNG RES, V26, P27, DOI 10.1080/019021400269943; Piera-Velazquez S, 2011, AM J PATHOL, V179, P1074, DOI 10.1016/j.ajpath.2011.06.001; Robinson DS, 2004, J ALLERGY CLIN IMMUN, V114, P58, DOI 10.1016/j.jaci.2004.03.034; Schild C, 2002, EXP CELL RES, V274, P83, DOI 10.1006/excr.2001.5458; Simoes SD, 2005, CLIN EXP ALLERGY, V35, P602, DOI 10.1111/j.1365-2222.2005.02235.x; Suki B, 2011, COMPR PHYSIOL, V1, P1317, DOI 10.1002/cphy.c100033; Tang DD, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0296-1; Thompson BR, 2013, J ALLERGY CLIN IMMUN, V131, P1322, DOI 10.1016/j.jaci.2013.01.054; Tough SC, 1996, J ASTHMA, V33, P179, DOI 10.3109/02770909609054550; Weitoft M, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-67	48	21	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182378	10.1371/journal.pone.0182378	http://dx.doi.org/10.1371/journal.pone.0182378			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28787016	Green Published, gold, Green Submitted			2022-12-26	WOS:000406998800034
J	Di Palo, F; Fornara, DA				Di Palo, Francesca; Fornara, Dario A.			Plant and soil nutrient stoichiometry along primary ecological successions: Is there any link?	PLOS ONE			English	Article							ACQUISITION STRATEGIES; PHOSPHORUS LIMITATION; GLACIER FORELANDS; TESTING PROCEDURE; WATER EXTRACTION; LEAF NITROGEN; DIVERSITY; CHRONOSEQUENCES; NITRATE; GROWTH	Ecological stoichiometry suggests that plant Nitrogen (N)-to-Phosphorus (P) ratios respond to changes in both soil N:P stoichiometry and soil N and P availability. Thus we would expect that soil and plant N:P ratios be significantly related along natural gradients of soil development such as those associated with primary ecological successions. Here we explicitly search for linkages between plant and soil N:P stoichiometry along four primary successions distributed across Europe. We measured N and P content in soils and plant compartments (leaf, stem and root) of 72 wild plant species distributed along two sand dune and two glacier successions where soil age ranges from few to thousand years old. Overall we found that soil N:P ratios strongly increased along successional stages, however, plant N:P ratios were neither related to soil N:P stoichiometry nor to changes in soil N and P availability. Instead changes in plant nutrient stoichiometry were "driven" by plant-functional-group identity. Not only N:P ratios differed between legumes, grasses and forbs but each of these plant functional groups maintained N:P ratios relatively constant across pioneer, middle and advanced successional stages. Our evidence is that soil nutrient stoichiometry may not be a good predictor of changes in plant N:P stoichiometry along natural primary ecological successions, which have not reached yet a retrogressive stage. This could be because wild-plants rely on mechanisms of internal nutrient regulation, which make them less dependent to changes in soil nutrient availability under unpredictable environmental conditions. Further studies need to clarify what underlying evolutionary and eco-physiological mechanisms determine changes in nutrient stoichiometry in plant species distributed across natural environmental gradients.	[Di Palo, Francesca] Univ Ulster, Sch Geog & Environm Sci, Coleraine, Londonderry, North Ireland; [Fornara, Dario A.] AFBI, Newforge Lane, Belfast, Antrim, North Ireland	Ulster University; Agri-Food & Biosciences Institute	Fornara, DA (corresponding author), AFBI, Newforge Lane, Belfast, Antrim, North Ireland.	dario.fornara@afbini.gov.uk		Fornara, Dario/0000-0002-5381-0803	University of Ulster, UK	University of Ulster, UK	This research was funded by a Vice-Chancellor Scholarship from University of Ulster, UK.; This research was funded by a Vice-Chancellor Scholarship from University of Ulster. We thank the Institute for Nature Conservation and Forests (Portugal) and the Ulster Wildlife Trust (Northern Ireland) for authorizing fieldwork in their protected areas. We are very grateful to Cathleen McFadden, John Bailey, Hugh McKeating, Valeria Cenini, Rachael Carolan and Delia Millan for technical support.	Adler PB, 2003, ECOL LETT, V6, P749, DOI 10.1046/j.1461-0248.2003.00497.x; Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Agren GI, 2012, NEW PHYTOL, V194, P953, DOI 10.1111/j.1469-8137.2012.04116.x; Bausenwein U, 2001, NEW PHYTOL, V152, P283, DOI 10.1046/j.0028-646X.2001.00262.x; Bazzaz F.A., 1996, PLANTS CHANGING ENV, P14; BAZZAZ FA, 1979, ANNU REV ECOL SYST, V10, P351, DOI 10.1146/annurev.es.10.110179.002031; BERENDSE F, 1992, ECOLOGY, V73, P46, DOI 10.2307/1938719; Caccianiga M, 2004, PHYTOCOENOLOGIA, V34, P55, DOI 10.1127/0340-269X/2004/0034-0055; Clarke ML, 2006, HOLOCENE, V16, P341, DOI 10.1191/0959683606hl932rp; de Graaf MCC, 1998, PLANT ECOL, V135, P185, DOI 10.1023/A:1009717613380; Di Palo F, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00451.1; Dias JMA, 2000, MAR GEOL, V170, P177, DOI 10.1016/S0025-3227(00)00073-6; Egli M, 2003, GEODERMA, V117, P81, DOI 10.1016/S0016-7061(03)00136-8; Elser JJ, 2010, NEW PHYTOL, V186, P593, DOI 10.1111/j.1469-8137.2010.03214.x; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Forde BG, 2002, J EXP BOT, V53, P39, DOI 10.1093/jexbot/53.366.39; Fornara DA, 2013, GLOBAL CHANGE BIOL, V19, P3848, DOI 10.1111/gcb.12323; Gallardo MB, 2012, REV CHIL HIST NAT, V85, P291, DOI 10.4067/S0716-078X2012000300004; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Gusewell S, 2005, NEW PHYTOL, V166, P537, DOI 10.1111/j.1469-8137.2005.01320.x; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Gusewell S, 2002, PERSPECT PLANT ECOL, V5, P37, DOI 10.1078/1433-8319-0000022; Harpole WS, 2011, ECOL LETT, V14, P852, DOI 10.1111/j.1461-0248.2011.01651.x; Hayes P, 2014, J ECOL, V102, P396, DOI 10.1111/1365-2745.12196; He L, 2008, CATENA, V72, P259, DOI 10.1016/j.catena.2007.05.010; Huggett RJ, 1998, CATENA, V32, P155, DOI 10.1016/S0341-8162(98)00053-8; IMSANDE J, 1994, PLANT PHYSIOL, V105, P3, DOI 10.1104/pp.105.1.3; JONASSON S, 1985, OECOLOGIA, V67, P511, DOI 10.1007/BF00790022; Koerselman W, 1996, J APPL ECOL, V33, P1441, DOI 10.2307/2404783; Kong DL, 2011, PLANT SOIL, V346, P133, DOI 10.1007/s11104-011-0803-1; Lambers H, 2008, TRENDS ECOL EVOL, V23, P95, DOI 10.1016/j.tree.2007.10.008; Li L, 2014, NEW PHYTOL, V203, P63, DOI 10.1111/nph.12778; LUSCOMBE PC, 1979, COMMUN SOIL SCI PLAN, V10, P1361, DOI 10.1080/00103627909366991; MARTIN W. E., 1950, CALIFORNIA AGRIC, V4, P12; Menge DNL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042045; Monterin U., 1919, BOLLETTINO COMITATO, V3; Morgan K. T., 2010, 19 WORLD C SOIL SCI; Niklas KJ, 2006, ANN BOT-LONDON, V97, P155, DOI 10.1093/aob/mcj021; Oelmann Y, 2007, J ENVIRON QUAL, V36, P396, DOI 10.2134/jeq2006.0217; Otani T, 1996, SOIL SCI PLANT NUTR, V42, P553, DOI 10.1080/00380768.1996.10416324; Perez CA, 2014, AUSTRAL ECOL, V39, P288, DOI 10.1111/aec.12078; Sacco F., 1938, UNIVERSO, V19, P217; SAS Institute, 2010, JMP 9 0 0; Smiraglia C., 1992, GUIDA GHIACCIAI GLAC; SORNSRIVICHAI P, 1988, FERT RES, V15, P225, DOI 10.1007/BF01051344; Soudzilovskaia NA, 2005, J VEG SCI, V16, P399, DOI 10.1111/j.1654-1103.2005.tb02379.x; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Temperton VM, 2007, OECOLOGIA, V151, P190, DOI 10.1007/s00442-006-0576-z; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; TILMAN D, 1988; Venterink HO, 2011, PLANT SOIL, V345, P1, DOI 10.1007/s11104-011-0796-9; Venterink HO, 2010, FUNCT ECOL, V24, P877, DOI 10.1111/j.1365-2435.2010.01692.x; Vitousek PM, 1997, BIOGEOCHEMISTRY, V37, P63, DOI 10.1023/A:1005757218475; Walker LR, 2010, J ECOL, V98, P725, DOI 10.1111/j.1365-2745.2010.01664.x; WALKER TW, 1976, GEODERMA, V15, P1, DOI 10.1016/0016-7061(76)90066-5; Wang M, 2014, ECOSYSTEMS, V17, P673, DOI 10.1007/s10021-014-9752-x; Wardle DA, 2008, OIKOS, V117, P93, DOI 10.1111/j.2007.0030-1299.16130.x; WHITTAKER RH, 1967, BIOL REV, V42, P207, DOI 10.1111/j.1469-185X.1967.tb01419.x; Wilson P, 2004, HOLOCENE, V14, P406, DOI 10.1191/0959683604hl716rp; Zemunik G, 2015, NAT PLANTS, V1, P1, DOI [10.1038/NPLANTS.2015.50, 10.1038/nplants.2015.50]; Zhao N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095196; Zheng SX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051750	63	24	24	13	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182569	10.1371/journal.pone.0182569	http://dx.doi.org/10.1371/journal.pone.0182569			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28787437	Green Submitted, Green Published, gold			2022-12-26	WOS:000406998800044
J	Holldobler, B; Kwapich, CL				Hoelldobler, Bert; Kwapich, Christina L.			Amphotis marginata (Coleoptera: Nitidulidae) a highwayman of the ant Lasius fuliginosus	PLOS ONE			English	Article							AETHINA-TUMIDA; HYMENOPTERA; BIOLOGY; BEETLE	The space occupied by evolutionarily advanced ant societies can be subdivided into functional sites, such as broodchambers; peripheral nest chambers; kitchen middens; and foraging routes. Many predators and social parasites are specially adapted to make their living inside specific niches created by ants. In particular, the foraging paths of certain ant species are frequented by predatory and kleptoparasitic arthropods, including one striking example, the nitidulid beetle, Amphotis marginata. Adults of this species obtain the majority of their nutrition by acting as a kind of "highwayman" on the foraging trails of the ant Lasius fuliginosus, where they solicit regurgitation from food laden ant-workers by mimicking the ant's food-begging signals. Employing food labeled with the radio isotope P-32, we assessed the quantities of food the beetles siphoned-off of food-laden ants, and we investigated the site preferences, behavioral mechanisms and possible morphological adaptations underlying the food kleptoparasitism of A. marginata.	[Hoelldobler, Bert; Kwapich, Christina L.] Arizona State Univ, Sch Life Sci, Social Insect Res Grp, Tempe, AZ 85287 USA; [Hoelldobler, Bert] Univ Wurzburg, Biozentrum, Zool 2, Bavaria, Germany	Arizona State University; Arizona State University-Tempe; University of Wurzburg	Holldobler, B (corresponding author), Arizona State Univ, Sch Life Sci, Social Insect Res Grp, Tempe, AZ 85287 USA.; Holldobler, B (corresponding author), Univ Wurzburg, Biozentrum, Zool 2, Bavaria, Germany.	bert.hoelldobler@asu.edu		Kwapich, Christina/0000-0001-5141-7605	Johann-Wolfgang-von-Goethe-Universitat, Frankfurt; Julius-Maximilians-Universitat, Wurzburg; Deutsche Forschungsgemeinschaft DFG [SFB 251]; Arizona State University, Tempe	Johann-Wolfgang-von-Goethe-Universitat, Frankfurt; Julius-Maximilians-Universitat, Wurzburg; Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Arizona State University, Tempe	This work was supported by funds from the Johann-Wolfgang-von-Goethe-Universitat, Frankfurt, the Julius-Maximilians-Universitat, Wurzburg, the Deutsche Forschungsgemeinschaft DFG SFB 251, and the Arizona State University, Tempe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BH and CLK received salaries from Arizona State University.	Dobrzanska J., 1966, Acta Biologiae Experimentalis, V26, P193; Elzen PJ, 1999, APIDOLOGIE, V30, P361, DOI 10.1051/apido:19990501; Gosswald K., 1960, Zoologische Beitraege (NF), V5, P519; Holldobler B., 1990, pi; HOLLDOBLER B, 1968, NATURWISSENSCHAFTEN, V55, P397; Holldobler B., 2014, ENCY CINEMATOGRAPHIC, P3; HOLLDOLBER B, 1981, Psyche (Cambridge), V88, P347, DOI 10.1155/1981/75317; Kern F, 1997, J CHEM ECOL, V23, P779, DOI 10.1023/B:JOEC.0000006410.35938.49; Lencina Jose Luis, 2011, Boletin de la SEA, V49, P149; MASCHWITZ U, 1970, Z VERGL PHYSIOL, V66, P176, DOI 10.1007/BF00297777; Neumann P, 2004, APIDOLOGIE, V35, P229, DOI 10.1051/apido:2004010; Orloff A, 2014, FORENSIC SCI INT, V239, P1; Parson CT., 1938, NOTES NORT AM NITIDU, P156; Parsons Carl T., 1943, BULL MUS COMP ZOOL HARVARD UNIV, V92, P121; QUINET Y, 1991, BELG J ZOOL, V121, P55; QUINET Y, 1995, INSECT SOC, V42, P31, DOI 10.1007/BF01245697; Stoeffler M, 2003, PSYCHE; Wasmann E., 1892, DTSCH ENTOMOLOGISCHE, V36, P347	18	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0180847	10.1371/journal.pone.0180847	http://dx.doi.org/10.1371/journal.pone.0180847			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28783744	Green Published, gold, Green Submitted			2022-12-26	WOS:000406998800003
J	Haselgrubler, R; Stubl, F; Essl, K; Iken, M; Schroder, K; Weghuber, J				Haselgruebler, Renate; Stuebl, Flora; Essl, Katja; Iken, Marcus; Schroeder, Klaus; Weghuber, Julian			Gluc-HET, a complementary chick embryo model for the characterization of antidiabetic compounds	PLOS ONE			English	Article							HENS EGG TEST; SERIES; MN	Insulin resistance and beta cell failure are the main causes of elevated blood glucose levels in Type 2 diabetes mellitus (T2DM), a complex and multifactorial metabolic disease. Several medications to treat or reduce the symptoms of T2DM are used, including the injection of insulin and the application of insulin sensitizing or glucose production reducing drugs. Furthermore, the use of phytochemicals has attracted increasing attention for the therapy and prevention of T2DM. In order to identify and characterize antidiabetic compounds, efficient test systems are required. Here we present a modified chick embryo model (hens egg test, HET), which has originally been developed to determine the potential irritancy of chemicals, as a versatile tool for the characterization of phytochemicals with antidiabetic properties. We termed this modified assay variation Gluc-HET. More precisely, we determined the influence of variations in the incubation time of the fertilized eggs and studied the effects of different buffer parameters, such as the temperature, composition and volume, used for drug application. In addition, we tested several putative antidiabetic plant extracts, which have been identified in an in-vitro primary screening procedure, for their effectiveness in reducing blood glucose levels in-ovo. Taken together, our Gluc-HET model has proven to be a reliable and manageable system for the characterization of antidiabetic compounds.	[Haselgruebler, Renate; Stuebl, Flora; Essl, Katja; Weghuber, Julian] Univ Appl Sci Upper Austria, Wels, Austria; [Iken, Marcus] PM Int AG, Schengen, Luxembourg; [Schroeder, Klaus] NP Life Sci Technol KG, Linz, Austria; [Weghuber, Julian] Austrian Competence Ctr Feed & Food Qual Safety &, Wels, Austria		Weghuber, J (corresponding author), Univ Appl Sci Upper Austria, Wels, Austria.	julian.weghuber@fh-wels.at		Weghuber, Julian/0000-0001-6312-4666	Austrian Research Promotion Agency (FFG) [850681]; University of Applied Sciences Upper Austria Basic Funding initiative	Austrian Research Promotion Agency (FFG); University of Applied Sciences Upper Austria Basic Funding initiative	This work was funded by the Austrian Research Promotion Agency (FFG; project number 850681) and University of Applied Sciences Upper Austria Basic Funding initiative (project GlucoSTAR). Klaus Schroder is employed by NP Life Science Technologies KG and Marcus Iken is employed by PM-International AG. The funders provided support in the form of salaries for some authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aleman-Gonzalez-Duhart D, 2016, PPAR RES, V2016, DOI 10.1155/2016/7614270; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Bailey Clifford J, 2005, Curr Diab Rep, V5, P353, DOI 10.1007/s11892-005-0093-1; Bailey CJ, 2013, DIABETES VASC DIS RE, V10, P397, DOI 10.1177/1479164113490765; Barrio DA, 2010, CURR MED CHEM, V17, P3632; Cazarolli LH, 2013, EUR J PHARMACOL, V712, P1, DOI 10.1016/j.ejphar.2013.02.029; Cohen FJ, 2003, DIABETES CARE, V26, P1847, DOI 10.2337/diacare.26.6.1847; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Desai NR, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2011.07.033; Forouhi N, 2015, IDF DIABETES ATLAS, V7th; Govers R, 2014, DIABETES METAB, V40, P400, DOI 10.1016/j.diabet.2014.01.005; Greywe D, 2012, MUTAT RES-GEN TOX EN, V747, P118, DOI 10.1016/j.mrgentox.2012.04.012; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Kim JW, 2011, CLIN THER, V33, P1819, DOI 10.1016/j.clinthera.2011.09.023; Lanzerstorfer P, 2014, BRIT J PHARMACOL, V171, P5237, DOI 10.1111/bph.12845; Manakova E, 2010, NEUROENDOCRINOL LETT, V31, P8; Martel J, 2016, NATURE REV ENDOCRINO; Maruthur NM, 2016, ANN INTERN MED, V164, P740, DOI 10.7326/M15-2650; Onur S, 2013, PLANT EXTRACT COLLEC, V2; Patel D. K., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P320, DOI 10.1016/S2221-1691(12)60032-X; Rao YK, 2011, EVID-BASED COMPL ALT, V2011; Ribatti D, 2008, INT REV CEL MOL BIO, V270, P181, DOI 10.1016/S1937-6448(08)01405-6; Speake BK, 1998, PROG LIPID RES, V37, P1, DOI 10.1016/S0163-7827(97)00012-X; Spielmann H, 1995, Methods Mol Biol, V43, P199; Stadlbauer V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148109; Vardatsikos G, 2013, J INORG BIOCHEM, V120, P8, DOI 10.1016/j.jinorgbio.2012.11.006; Vijayakumar MV, 2012, METHOD ENZYMOL, V505, P257, DOI 10.1016/B978-0-12-388448-0.00022-X; Wolf T, 2002, MUTAT RES-GEN TOX EN, V514, P59, DOI 10.1016/S1383-5718(01)00317-5; Wolf T, 2008, MUTAT RES-GEN TOX EN, V650, P150, DOI 10.1016/j.mrgentox.2007.11.009; Yoshiyama Y, 2005, BIOL PHARM BULL, V28, P1986, DOI 10.1248/bpb.28.1986	31	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0182788	10.1371/journal.pone.0182788	http://dx.doi.org/10.1371/journal.pone.0182788			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28777818	Green Submitted, gold, Green Published			2022-12-26	WOS:000406944300057
J	Huser, A; Eschment, M; Gullu, N; Collins, KAN; Bopple, K; Pankevych, L; Rolsing, E; Thum, AS				Huser, Annina; Eschment, Melanie; Guellue, Nazli; Collins, Katharine A. N.; Boepple, Kathrin; Pankevych, Lyubov; Rolsing, Emilia; Thum, Andreas S.			Anatomy and behavioral function of serotonin receptors in Drosophila melanogaster larvae	PLOS ONE			English	Article							ANTENNAL LOBE; NERVOUS-SYSTEM; 5-HT RECEPTORS; FRUIT-FLY; LEARNED BEHAVIOR; APIS-MELLIFERA; NEUROPEPTIDE F; TERM-MEMORY; NEURONS; GENE	The biogenic amine serotonin (5-HT) is an important neuroactive molecule in the central nervous system of the majority of animal phyla. 5-HT binds to specific G protein-coupled and ligand-gated ion receptors to regulate particular aspects of animal behavior. In Drosophila, as in many other insects this includes the regulation of locomotion and feeding. Due to its genetic amenability and neuronal simplicity the Drosophila larva has turned into a useful model for studying the anatomical and molecular basis of chemosensory behaviors. This is particularly true for the olfactory system, which is mostly described down to the synaptic level over the first three orders of neuronal information processing. Here we focus on the 5 HT receptor system of the Drosophila larva. In a bipartite approach consisting of anatomical and behavioral experiments we describe the distribution and the implications of individual 5 HT receptors on nave and acquired chemosensory behaviors. Our data suggest that 5-HT1A, 5-HT1B, and 5-HT(7)are dispensable for larval naive olfactory and gustatory choice behaviors as well as for appetitive and aversive associative olfactory learning and memory. In contrast, we show that 5-HT/5-HT2A signaling throughout development, but not as an acute neuronal function, affects associative olfactory learning and memory using high salt concentration as a negative unconditioned stimulus. These findings describe for the first time an involvement of 5-HT signaling in learning and memory in Drosophila larvae. In the longer run these results may uncover developmental, 5-HT dependent principles related to reinforcement processing possibly shared with adult Drosophila and other insects.	[Huser, Annina; Eschment, Melanie; Guellue, Nazli; Collins, Katharine A. N.; Boepple, Kathrin; Pankevych, Lyubov; Rolsing, Emilia; Thum, Andreas S.] Univ Konstanz, Dept Biol, Constance, Germany; [Thum, Andreas S.] Univ Konstanz, Zukunftskolleg, Constance, Germany; [Thum, Andreas S.] Univ Leipzig, Dept Genet, Leipzig, Germany	University of Konstanz; University of Konstanz; Leipzig University	Thum, AS (corresponding author), Univ Konstanz, Dept Biol, Constance, Germany.; Thum, AS (corresponding author), Univ Konstanz, Zukunftskolleg, Constance, Germany.; Thum, AS (corresponding author), Univ Leipzig, Dept Genet, Leipzig, Germany.	andreas.thum@uni-leipzig.de	Thum, Andreas S/B-1083-2013	Thum, Andreas/0000-0002-3830-6596	Deutsche Forschungsgemeinschaft [TH1584/ 1-1, TH1584/3-1]; Swiss National Science Foundation [31003A132812/1]; Baden Wurttemberg Stiftung; Bioimaging Center and Zukunftkolleg of the University of Konstanz; International Max Planck Research School for Organismal Biology	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Baden Wurttemberg Stiftung; Bioimaging Center and Zukunftkolleg of the University of Konstanz; International Max Planck Research School for Organismal Biology	This work was supported by the Deutsche Forschungsgemeinschaft (TH1584/ 1-1 and TH1584/3-1 to A.S.T), the Swiss National Science Foundation (31003A132812/1 to A.S.T.), the Baden Wurttemberg Stiftung (to A.S.T.), the Bioimaging Center and Zukunftkolleg of the University of Konstanz (to A.S.T.). A.H. is supported by the International Max Planck Research School for Organismal Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT MK, 1991, GENETICS, V129, P783; ACEVESPINA FO, 1979, SCIENCE, V206, P93, DOI 10.1126/science.206.4414.93; Alekseyenko OV, 2014, CURR BIOL, V24, P2700, DOI 10.1016/j.cub.2014.09.051; Alekseyenko OV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010806; Apostolopoulou AA, 2013, JOVE-J VIS EXP, DOI 10.3791/4334; Apostolopoulou AA, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00006; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Becnel J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020800; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Berck ME, 2016, ELIFE, V5, DOI 10.7554/eLife.14859; Berghammer AJ, 1999, NATURE, V402, P370, DOI 10.1038/46463; Berh D, 2016, IEEE T BIOMEDICAL EN; Blenau W, 2001, ARCH INSECT BIOCHEM, V48, P13, DOI 10.1002/arch.1055; Blenau W, 2005, ARCH INSECT BIOCHEM, V59, P99, DOI 10.1002/arch.20072; Blenau W, 2011, ARTHROPOD STRUCT DEV, V40, P381, DOI 10.1016/j.asd.2011.01.004; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUDNIK V, 1989, J NEUROSCI, V9, P2866; Burke CJ, 2012, NATURE, V492, P433, DOI 10.1038/nature11614; Buznikov GA, 2001, CELL TISSUE RES, V305, P177, DOI 10.1007/s004410100408; Chen J, 2008, DEV BIOL, V320, P30, DOI 10.1016/j.ydbio.2008.03.038; Chen Y, 2014, NEURON, V81, P280, DOI 10.1016/j.neuron.2013.12.021; COLAS JF, 1995, P NATL ACAD SCI USA, V92, P5441, DOI 10.1073/pnas.92.12.5441; Colas JF, 1999, MECH DEVELOP, V87, P77, DOI 10.1016/S0925-4773(99)00141-0; Colas JF, 1999, MECH DEVELOP, V87, P67, DOI 10.1016/S0925-4773(99)00140-9; Colomb J, 2007, J COMP NEUROL, V502, P834, DOI 10.1002/cne.21312; Dacks AM, 2009, J NEUROGENET, V23, P366, DOI 10.3109/01677060903085722; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Fishilevich E, 2005, CURR BIOL, V15, P2086, DOI 10.1016/j.cub.2005.11.016; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Gasque G, 2013, SCI REP-UK, V3, DOI 10.1038/srep02120; Gerber B, 2009, RESULTS PROBL CELL D, V47, P139, DOI 10.1007/400_2008_9; Gerber B, 2007, CHEM SENSES, V32, P65, DOI 10.1093/chemse/bjl030; Gerber B, 2006, P ROY SOC B-BIOL SCI, V273, P2965, DOI 10.1098/rspb.2006.3673; Gershow M, 2012, NAT METHODS, V9, P290, DOI [10.1038/NMETH.1853, 10.1038/nmeth.1853]; Glebov K, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-14; Gomez-Marin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041642; Hacker U, 2003, P NATL ACAD SCI USA, V100, P7720, DOI 10.1073/pnas.1230526100; Hauser F, 2006, PROG NEUROBIOL, V80, P1, DOI 10.1016/j.pneurobio.2006.07.005; Herlenius E, 2001, EARLY HUM DEV, V65, P21, DOI 10.1016/S0378-3782(01)00189-X; HOFBAUER A, 1990, ROUX ARCH DEV BIOL, V198, P264, DOI 10.1007/BF00377393; Honjo K, 2005, J NEUROSCI, V25, P7905, DOI 10.1523/JNEUROSCI.2135-05.2005; Honjo K, 2009, J NEUROSCI, V29, P852, DOI 10.1523/JNEUROSCI.1315-08.2009; Horn C, 2000, DEV GENES EVOL, V210, P623, DOI 10.1007/s004270000111; Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8; Huser A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047518; Johnson O, 2011, NEUROSCIENCE, V192, P372, DOI 10.1016/j.neuroscience.2011.06.058; Johnson O, 2009, NEUROSCIENCE, V158, P1292, DOI 10.1016/j.neuroscience.2008.10.055; Kahsai L, 2012, NEUROSCIENCE, V208, P11, DOI 10.1016/j.neuroscience.2012.02.007; KAMYSHEV NG, 1983, PHARMACOL BIOCHEM BE, V18, P677, DOI 10.1016/0091-3057(83)90005-9; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Kreher SA, 2005, NEURON, V46, P445, DOI 10.1016/j.neuron.2005.04.007; Kubala MH, 2010, PROTEIN SCI, V19, P2389, DOI 10.1002/pro.519; Lee PT, 2011, P NATL ACAD SCI USA, V108, P13794, DOI 10.1073/pnas.1019483108; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Liu YT, 2015, J COMP NEUROL, V523, P1840, DOI 10.1002/cne.23768; Luo J, 2012, INT J DISTRIB SENS N, DOI 10.1155/2012/398460; Majeed ZR, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/7291438; Majeed ZR, 2014, J COMP PHYSIOL B, V184, P205, DOI 10.1007/s00360-013-0795-7; Masuda-Nakagawa LM, 2010, GENE EXPR PATTERNS, V10, P328, DOI 10.1016/j.gep.2010.07.004; Masuda-Nakagawa LM, 2009, P NATL ACAD SCI USA, V106, P10314, DOI 10.1073/pnas.0900178106; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Monastirioti M, 1999, MICROSC RES TECHNIQ, V45, P106, DOI 10.1002/(SICI)1097-0029(19990415)45:2<106::AID-JEMT5>3.3.CO;2-V; Moncalvo VGR, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-66; Nall A, 2014, BEHAV NEUROSCI, V128, P264, DOI 10.1037/a0036209; Nassif C, 2003, J COMP NEUROL, V455, P417, DOI 10.1002/cne.10482; Neckameyer WS, 2007, GENES BRAIN BEHAV, V6, P756, DOI 10.1111/j.1601-183X.2007.00307.x; Neckameyer WS, 2010, DEV NEUROSCI-BASEL, V32, P217, DOI 10.1159/000304888; Nichols CD, 2007, DEV NEUROBIOL, V67, P752, DOI 10.1002/dneu.20370; Niewalda T, 2008, CHEM SENSES, V33, P685, DOI 10.1093/chemse/bjn037; Ohyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071706; Okusawa S, 2014, J NEUROSCI, V34, P2544, DOI 10.1523/JNEUROSCI.3500-13.2014; OLAND LA, 1995, J NEUROBIOL, V28, P248, DOI 10.1002/neu.480280210; Oppliger FY, 2000, J INSECT PHYSIOL, V46, P135, DOI 10.1016/S0022-1910(99)00109-2; Pauls D, 2010, J NEUROSCI, V30, P10655, DOI 10.1523/JNEUROSCI.1281-10.2010; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Pineyro G, 1999, PHARMACOL REV, V51, P533; Pooryasin A, 2015, J NEUROSCI, V35, P12792, DOI 10.1523/JNEUROSCI.1638-15.2015; Python F, 2002, J COMP NEUROL, V445, P374, DOI 10.1002/cne.10188; Ramaekers A, 2005, CURR BIOL, V15, P982, DOI 10.1016/j.cub.2005.04.032; Risse B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053963; Ro J, 2016, ELIFE, V5, DOI 10.7554/eLife.16843; Rohwedder A, 2016, CURR BIOL, V26, P661, DOI 10.1016/j.cub.2016.01.012; Rohwedder A, 2015, J COMP NEUROL, V523, P2637, DOI 10.1002/cne.23873; Rohwedder A, 2012, CHEM SENSES, V37, P711, DOI 10.1093/chemse/bjs055; Roy B, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-20; SAUDOU F, 1992, EMBO J, V11, P7, DOI 10.1002/j.1460-2075.1992.tb05021.x; Scherer S, 2003, LEARN MEMORY, V10, P217, DOI 10.1101/lm.57903; Schipanski A, 2008, CHEM SENSES, V33, P563, DOI 10.1093/chemse/bjn024; Schleyer M, 2011, LEARN MEMORY, V18, P639, DOI 10.1101/lm.2163411; Schoofs A, 2014, J INSECT PHYSIOL, V69, P118, DOI 10.1016/j.jinsphys.2014.05.022; Schoofs A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001893; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Selcho M, 2014, J COMP NEUROL, V522, P3485, DOI 10.1002/cne.23616; Selcho M, 2012, J COMP NEUROL, V520, P3764, DOI 10.1002/cne.23152; Selcho M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005897; Shimada-Niwa Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6778; Silva B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089641; SINGH RN, 1984, INT J INSECT MORPHOL, V13, P255, DOI 10.1016/0020-7322(84)90001-1; Sitaraman D, 2012, J NEUROGENET, V26, P238, DOI 10.3109/01677063.2012.666298; Sizemore TR, 2016, SCI REP-UK, V6, DOI 10.1038/srep37119; Sykes PA, 2005, DEV BIOL, V286, P207, DOI 10.1016/j.ydbio.2005.07.025; Thum AS, 2011, J COMP NEUROL, V519, P3415, DOI 10.1002/cne.22713; Tierney AJ, 2001, COMP BIOCHEM PHYS A, V128, P791, DOI 10.1016/S1095-6433(00)00320-2; Venken KJT, 2011, NEURON, V72, P202, DOI 10.1016/j.neuron.2011.09.021; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Webb CM, 2012, VET PATHOL, V49, P727, DOI 10.1177/0300985811414033; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; Widmann A, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006378; WITZ P, 1990, P NATL ACAD SCI USA, V87, P8940, DOI 10.1073/pnas.87.22.8940; Yuan Q, 2005, NEURON, V47, P115, DOI 10.1016/j.neuron.2005.05.027; Yuan Q, 2006, CURR BIOL, V16, P1051, DOI 10.1016/j.cub.2006.04.032; Zhang X, 2016, ELIFE, P5	112	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0181865	10.1371/journal.pone.0181865	http://dx.doi.org/10.1371/journal.pone.0181865			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28777821	Green Published, gold, Green Submitted			2022-12-26	WOS:000406944300016
J	Matot, I; Nachmansson, N; Duev, O; Schulz, S; Schroeder-Stein, K; Frede, S; Abramovitch, R				Matot, Idit; Nachmansson, Nathalie; Duev, Omri; Schulz, Susanne; Schroeder-Stein, Katrin; Frede, Stilla; Abramovitch, Rinat			Impaired liver regeneration after hepatectomy and bleeding is associated with a shift from hepatocyte proliferation to hypertrophy	FASEB JOURNAL			English	Article						hypoxia-inducible factor; liver failure; mTOR	HYPOXIA-INDUCIBLE FACTOR; HEPATIC RESECTION; HEMORRHAGIC-SHOCK; RADIOFREQUENCY ABLATION; SURGICAL RESECTION; RAT MODEL; TRANSPLANTATION; RESUSCITATION; HYDROXYLASES; REPLICATION	Extensive liver resections are common, and bleeding is frequent in these operations. Impaired regeneration after partial hepatectomy (PHx) may contribute to liver failure. We thus assessed the impact of acute bleeding on the liver regeneration progress after PHx and explored possible contributing molecular mechanisms. In rats, the regeneration progress was delayed and attenuated with PHx and bleeding and was not restored with colloid resuscitation. Livers restored their initial volume by postoperative day (POD) 2 after PHx through hepatocyte proliferation vs. POD 4 in the PHx and bleeding group, primarily by hepatocyte hypertrophy. With bleeding, hepatocyte proliferation was hindered in two mechanisms: by inhibiting cells from starting proliferation and by causing hindrance in G(1)/S progression. Liver hypoxia was prominent, with significant prolonged up-regulation of hypoxia-inducible factors (HIF) and HIF-targeted genes only in the PHx and bleeding group. Gene expression profiling revealed alterations in numerous genes that belong to critical pathways, including cell cycle, DNA replication, PI3K-Akt, purine, and pyrimidine metabolism. Because liver surgery is frequently performed in patients with a predamaged liver, an improper regenerative process after PHx and bleeding might lead to decompensation. The results hint at specific pathways to target in order to improve liver regeneration during PHx and bleeding.	[Matot, Idit] Tel Aviv Univ, Sackler Sch Med, Div Anesthesiol Intens Care & Pain, Tel Aviv Med Ctr, Tel Aviv, Israel; [Nachmansson, Nathalie; Duev, Omri; Abramovitch, Rinat] Hadassah Hebrew Univ, Goldyne Savad Inst Gene Therapy, Med Ctr, POB1200, IL-91120 Jerusalem, Israel; [Schulz, Susanne; Schroeder-Stein, Katrin; Frede, Stilla] Univ Hosp Bonn, Clin Anesthesiol & Intens Care Med, Bonn, Germany	Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Bonn	Abramovitch, R (corresponding author), Hadassah Hebrew Univ, Goldyne Savad Inst Gene Therapy, Med Ctr, POB1200, IL-91120 Jerusalem, Israel.	rinat@hadassah.org.il			Israel Science Foundation [1157/12]; European Society of Anesthesiology; Israeli Health Ministry [3-10999]; German Israel Foundation [I-1318-422.13/2015]	Israel Science Foundation(Israel Science Foundation); European Society of Anesthesiology; Israeli Health Ministry; German Israel Foundation(German-Israeli Foundation for Scientific Research and Development)	The authors thank T. Asraf (Hadassah Hebrew University Medical Center) for performing histologic evaluation for liver samples of rats treated with rapamycin. This research was supported by the Israel Science Foundation (Grant 1157/12; to I.M.), a grant from the European Society of Anesthesiology (to R.A.), the Israeli Health Ministry (Grant 3-10999; to R.A.), and the German Israel Foundation (Grant I-1318-422.13/2015; to R.A., S.F. and I.M.). The authors declare no conflicts of interest.	Barash H, 2007, RADIOLOGY, V243, P727, DOI 10.1148/radiol.2433060433; Barasli H, 2008, HEPATOLOGY, V48, P1232, DOI 10.1002/hep.22394; Benzing C, 2015, CLIN TRANSPLANT, V29, P1081, DOI 10.1111/ctr.12631; Cescon M, 2009, ANN SURG, V249, P995, DOI 10.1097/SLA.0b013e3181a63c74; Clavien P, 2007, NEW ENGL J MED, V356, P1545, DOI 10.1056/NEJMra065156; Cramer T, 2003, CELL CYCLE, V2, P192, DOI 10.4161/cc.2.3.402; Diril MK, 2012, P NATL ACAD SCI USA, V109, P3826, DOI 10.1073/pnas.1115201109; Silva OCE, 2007, DIGEST DIS SCI, V52, P2610, DOI 10.1007/s10620-006-9722-z; Elorza A, 2012, MOL CELL, V48, P681, DOI 10.1016/j.molcel.2012.09.017; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Feng K, 2012, J HEPATOL, V57, P794, DOI 10.1016/j.jhep.2012.05.007; Gielchinsky Y, 2010, GENE DEV, V24, P543, DOI 10.1101/gad.563110; Gilgenkrantz H, 2011, CLIN RES HEPATOL GAS, V35, P623, DOI 10.1016/j.clinre.2011.04.002; Glover TE, 2016, TRANSPLANTATION, V100, P621, DOI 10.1097/TP.0000000000001006; Goodnough LT, 2014, TRANSFUSION, V54, P2753, DOI 10.1111/trf.12723; Haga S, 2005, J HEPATOL, V43, P799, DOI 10.1016/j.jhep.2005.03.027; Hammond JS, 2011, BRIT J SURG, V98, P1188, DOI 10.1002/bjs.7630; Higgins GM, 1931, ARCH PATHOL, V12, P186; Huang JS, 2014, AM J PATHOL, V184, P309, DOI 10.1016/j.ajpath.2013.04.034; Huang JW, 2010, ANN SURG, V252, P903, DOI 10.1097/SLA.0b013e3181efc656; Jaeschke H, 2003, AM J PHYSIOL-GASTR L, V284, pG15, DOI 10.1152/ajpgi.00342.2002; Jamagin WR, 2002, ANN SURG, V236, P397, DOI 10.1097/01.SLA.0000029003.66466.B3; Karhausen J, 2005, CELL CYCLE, V4, P256; Karkampouna S, 2012, CURR PHARM DESIGN, V18, P4103, DOI 10.2174/138161212802430521; Khan Z, 2006, AM J PATHOL, V169, P1251, DOI 10.2353/ajpath.2006.060360; KOBELT F, 1994, SHOCK, V2, P281, DOI 10.1097/00024382-199410000-00009; Kopetz S, 2009, J CLIN ONCOL, V27, P3677, DOI 10.1200/JCO.2008.20.5278; Liu YL, 2014, TOXICOL LETT, V226, P117, DOI 10.1016/j.toxlet.2014.01.033; Lokmic Z, 2012, INT REV CEL MOL BIO, V296, P139, DOI 10.1016/B978-0-12-394307-1.00003-5; Lu H, 2016, HEPATOBIL SURG NUTR, V5, P141, DOI 10.3978/j.issn.2304-3881.2015.10.02; Maeno H, 2005, LIVER INT, V25, P1002, DOI 10.1111/j.1478-3231.2005.01144.x; Matot I, 2008, SHOCK, V29, P16, DOI 10.1097/shk.0b013e3180556964; Matot I, 2013, CRIT CARE MED, V41, P842, DOI 10.1097/CCM.0b013e3182711b38; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Miyaoka Y, 2013, CELL DIV, V8, DOI 10.1186/1747-1028-8-8; Mollenhauer M, 2012, LANGENBECK ARCH SURG, V397, P1313, DOI 10.1007/s00423-012-0998-5; Nath B, 2012, HEPATOLOGY, V55, P622, DOI 10.1002/hep.25497; Rankin EB, 2009, MOL CELL BIOL, V29, P4527, DOI 10.1128/MCB.00200-09; Schadde E, 2017, SURGERY, V161, P666, DOI 10.1016/j.surg.2016.05.018; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Takahashi K, 2016, TOHOKU J EXP MED, V239, P47, DOI 10.1620/tjem.239.47; van den Broek MAJ, 2008, LIVER INT, V28, P767, DOI 10.1111/j.1478-3231.2008.01777.x; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; WANG P, 1990, J SURG RES, V48, P464, DOI 10.1016/0022-4804(90)90014-S; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501	46	13	13	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5283	5295		10.1096/fj.201700153R	http://dx.doi.org/10.1096/fj.201700153R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28790176	Green Published			2022-12-26	WOS:000416588300014
J	Hata, AN; Rowley, S; Archibald, HL; Gomez-Caraballo, M; Siddiqui, FM; Ji, F; Jung, J; Light, M; Lee, JS; Debussche, L; Sidhu, S; Sadreyev, RI; Watters, J; Engelman, JA				Hata, A. N.; Rowley, S.; Archibald, H. L.; Gomez-Caraballo, M.; Siddiqui, F. M.; Ji, F.; Jung, J.; Light, M.; Lee, J. S.; Debussche, L.; Sidhu, S.; Sadreyev, R. I.; Watters, J.; Engelman, J. A.			Synergistic activity and heterogeneous acquired resistance of combined MDM2 and MEK inhibition in KRAS mutant cancers	ONCOGENE			English	Article							CELL LUNG-CANCER; BH3-ONLY PROTEINS PUMA; P53 PATHWAY; EXPRESSION ANALYSIS; ANTAGONIST RG7112; IMPROVED SURVIVAL; FEEDBACK LOOP; TUMOR-GROWTH; MUTATIONS; ACTIVATION	There are currently no effective targeted therapies for KRAS mutant cancers. Therapeutic strategies that combine MEK inhibitors with agents that target apoptotic pathways may be a promising therapeutic approach. We investigated combining MEK and MDM2 inhibitors as a potential treatment strategy for KRAS mutant non-small cell lung cancers (NSCLC) and colorectal carcinomas that harbor wild-type TP53. The combination of pimasertib (MEK inhibitor) and SAR405838 (MDM2 inhibitor) was synergistic and induced the expression of PUMA and BIM, led to apoptosis and growth inhibition in vitro, and tumor regression in vivo. Acquired resistance to the combination commonly resulted from the acquisition of TP53 mutations, conferring complete resistance to MDM2 inhibition. In contrast, resistant clones exhibited marked variability in sensitivity to MEK inhibition, which significantly impacted sensitivity to subsequent treatment with alternative MEK inhibitor-based combination therapies. These results highlight both the potential promise and limitations of combining MEK and MDM2 inhibitors for treatment of KRAS mutant NSCLC and colorectal cancers.	[Hata, A. N.; Archibald, H. L.; Gomez-Caraballo, M.; Siddiqui, F. M.; Engelman, J. A.] Massachusetts Gen Hosp, Canc Ctr, Bldg 149,13th St, Charlestown, MA 02129 USA; [Hata, A. N.; Engelman, J. A.] Harvard Med Sch, Dept Med, Boston, MA USA; [Rowley, S.; Jung, J.; Light, M.; Lee, J. S.; Watters, J.] Sanofi Oncol, Cambridge, MA USA; [Ji, F.; Sadreyev, R. I.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Debussche, L.; Sidhu, S.] Sanofi Oncol, 13 Quai Jules Guesde, Vitry Sur Seine, France; [Sadreyev, R. I.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Hata, AN (corresponding author), Massachusetts Gen Hosp, Canc Ctr, Bldg 149,13th St, Charlestown, MA 02129 USA.	ahata@mgh.harvard.edu		Sidhu, Sukhvinder/0000-0002-2999-4358	NIH [R01CA14059408]; Uniting Against Lung Cancer; Conquer Cancer Foundation of ASCO; NATIONAL CANCER INSTITUTE [R01CA166480, R01CA140594] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uniting Against Lung Cancer; Conquer Cancer Foundation of ASCO; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank all members of the Engelman Lab for helpful discussions and feedback. We thank MercK KGaA, Darmstadt, Germany for provision of pimasertib for our research and for scientific review of this manuscript. This study was funded by support from the NIH R01CA14059408 (JAE), Uniting Against Lung Cancer (ANH), Conquer Cancer Foundation of ASCO (ANH).	Aziz MH, 2011, ONCOGENE, V30, P4678, DOI 10.1038/onc.2011.185; Blumenschein GR, 2015, ANN ONCOL, V26, P894, DOI 10.1093/annonc/mdv072; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bond GL, 2005, CURR CANCER DRUG TAR, V5, P3, DOI 10.2174/1568009053332627; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Caunt CJ, 2015, NAT REV CANCER, V15, P577, DOI 10.1038/nrc4000; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Corcoran RB, 2013, CANCER CELL, V23, P121, DOI 10.1016/j.ccr.2012.11.007; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ebi H, 2011, J CLIN INVEST, V121, P4311, DOI 10.1172/JCI57909; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Hainaut P, 2000, ADV CANCER RES, V77, P81; Hata AN, 2014, CANCER RES, V74, P3146, DOI 10.1158/0008-5472.CAN-13-3728; Hoffman-Luca CG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128807; Ji ZY, 2013, CLIN CANCER RES, V19, P4383, DOI 10.1158/1078-0432.CCR-13-0074; Ji ZY, 2012, J INVEST DERMATOL, V132, P356, DOI 10.1038/jid.2011.313; Jung J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12609; Kitai H, 2016, CANCER DISCOV, V6, P754, DOI 10.1158/2159-8290.CD-15-1377; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Manchado E, 2016, NATURE, V534, P647, DOI 10.1038/nature18600; Michaelis M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.129; MIYASHITA T, 1995, CELL, V80, P293; Momand J, 2000, GENE, V242, P15, DOI 10.1016/S0378-1119(99)00487-4; Mose LE, 2014, BIOINFORMATICS, V30, P2813, DOI 10.1093/bioinformatics/btu376; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; R Core Team, 2013, R LANG ENV STAT COMP; Ramos AH, 2015, HUM MUTAT, V36, pE2423, DOI 10.1002/humu.22771; Ray-Coquard I, 2012, LANCET ONCOL, V13, P1133, DOI 10.1016/S1470-2045(12)70474-6; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saiki AY, 2014, ONCOTARGET, V5, P2030, DOI 10.18632/oncotarget.1918; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Streibig, 2014, SYNERGY, V1, P22, DOI [10.1016/j.synres.2014.07.010, DOI 10.1016/J.SYNRES.2014.07.010]; Sun C, 2014, CELL REP, V7, P86, DOI 10.1016/j.celrep.2014.02.045; Tovar C, 2013, CANCER RES, V73, P2587, DOI 10.1158/0008-5472.CAN-12-2807; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Turke AB, 2012, CANCER RES, V72, P3228, DOI 10.1158/0008-5472.CAN-11-3747; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Wang SM, 2014, CANCER RES, V74, P5855, DOI 10.1158/0008-5472.CAN-14-0799; Wilm A, 2012, NUCLEIC ACIDS RES, V40, P11189, DOI 10.1093/nar/gks918; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zhang WG, 2010, CANCER RES, V70, P2424, DOI 10.1158/0008-5472.CAN-09-0878	56	22	22	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 23	2017	36	47					6581	6591		10.1038/onc.2017.258	http://dx.doi.org/10.1038/onc.2017.258			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FN5LN	28783173	Green Submitted, Green Accepted			2022-12-26	WOS:000416049200007
J	Tang, CG; Wang, P; Li, XX; Zhao, BQ; Yang, HC; Yu, HF; Li, CW				Tang, Chuangang; Wang, Pei; Li, Xiaoxin; Zhao, Bingqing; Yang, Haochang; Yu, Haifeng; Li, Changwen			Lymph node status have a prognostic impact in breast cancer patients with distant metastasis	PLOS ONE			English	Article							STAGE IV; SURVIVAL; CARCINOMA; TRENDS; WOMEN	Background The objective of this retrospective study was to determine whether lymph node metastasis has a prognostic impact on patients with stage IV breast cancer. Patients and methods Seven thousand three hundred and seventy-nine patients with de novo stage IV breast cancer diagnosed from 2004 to 2013 were identified. Kaplan-Meier estimate method was fitted to measure overall survival and breast cancer-specific survival (BCSS). Cox proportional hazard analysis was used to evaluate the association between N stage and BCSS after controlling variables such as other patient/ tumor characteristics. Results The primary site of M1 tumors was mainly upper-outer quadrant and overlapping lesion of the breast. Patients with N1 disease had better overall survival and BCSS than did those without lymph node metastasis. The overall survival and BCSS of M1 patients with N3 disease were significantly lower than that of those with N0, N1 and N2 disease, whereas patients with N2 and N0/N1 involvement showed no significant difference with survival. Multivariate analysis showed that lymph node metastasis was an important prognostic factor for M1 patients (N1 versus N0, hazard ratio [HR] = 0.902, 95% confidence interval [CI]: 0.825-0.986, p = 0.023; N3 versus N0, HR = 1.161, 95% CI: 1.055-1.276, p = 0.002). For M1 patients, age, race, marital status, primary site, ER, PR and HER2 were the independent prognostic factors. Conclusions The cohort study provides an insight into de novo stage IV breast cancer with lymph node metastasis. Our results indicated that accurate lymph node evaluation for stage IV patients is still necessary to obtain important prognostic information.	[Tang, Chuangang; Wang, Pei; Li, Changwen] Southeast Univ, Affiliated Xuzhou Hosp, Med Coll, Xuzhou Cent Hosp,Dept Breast Surg, Xuzhou, Peoples R China; [Li, Xiaoxin] Southeast Univ, Affiliated Xuzhou Hosp, Med Coll, Dept Pathol,Xuzhou Cent Hosp, Xuzhou, Peoples R China; [Zhao, Bingqing] Tianjin Second Peoples Hosp, Dept Surg, Tianjin, Peoples R China; [Yang, Haochang] Binzhou Med Univ, Coll Clin Med, Yantai, Peoples R China; [Yu, Haifeng] Tianjin First Cent Hosp, Dept Gen Surg, Tianjin, Peoples R China	Southeast University - China; Southeast University - China; Binzhou Medical University; Tianjin Medical University	Li, CW (corresponding author), Southeast Univ, Affiliated Xuzhou Hosp, Med Coll, Xuzhou Cent Hosp,Dept Breast Surg, Xuzhou, Peoples R China.	lichw84@aliyun.com						Amin M, 2016, AJCC CANC STAGING MA; Andre F, 2004, J CLIN ONCOL, V22, P3302, DOI 10.1200/JCO.2004.08.095; Bernard-Marty C, 2004, ONCOLOGIST, V9, P617, DOI 10.1634/theoncologist.9-6-617; Cardoso F, 2002, ANN ONCOL, V13, P197, DOI 10.1093/annonc/mdf101; Cianfrocca M, 2004, ONCOLOGIST, V9, P606, DOI 10.1634/theoncologist.9-6-606; da Cunha A, 2016, IMMUNOL LETT, V177, P25, DOI 10.1016/j.imlet.2016.07.009; Dai CY, 2016, J THORAC ONCOL, V11, P1745, DOI 10.1016/j.jtho.2016.06.030; Dawood S, 2010, ANN ONCOL, V21, P2169, DOI 10.1093/annonc/mdq220; Dawood S, 2008, J CLIN ONCOL, V26, P4891, DOI 10.1200/JCO.2007.14.1168; Dent DM, 1996, ARCH SURG-CHICAGO, V131, P1125; Donegan WL, 2002, CANC BREAST; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fisher ER, 2004, CANCER-AM CANCER SOC, V100, P238, DOI 10.1002/cncr.11883; Hauser CA, 2006, SUPPORT CARE CANCER, V14, P999, DOI 10.1007/s00520-006-0079-9; Hortobagyi GN, 1998, NEW ENGL J MED, V339, P974, DOI 10.1056/NEJM199810013391407; Largillier R, 2008, ANN ONCOL, V19, P2012, DOI 10.1093/annonc/mdn424; NORTON L, 1991, NEW ENGL J MED, V325, P1370, DOI 10.1056/NEJM199111073251909; Ries LAG, SEER CANC STAT REV 1; Salama JK, 2005, CANCER, V103, P664, DOI 10.1002/cncr.20830; Soerjomataram I, 2008, BREAST CANCER RES TR, V107, P309, DOI 10.1007/s10549-007-9556-1	20	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2017	12	8							e0182953	10.1371/journal.pone.0182953	http://dx.doi.org/10.1371/journal.pone.0182953			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD5CP	28806399	Green Published, gold, Green Submitted			2022-12-26	WOS:000407548800039
J	Wu, XL; Yang, J; Na, T; Zhang, KH; Davidoff, AM; Yuan, BZ; Wang, YC				Wu, Xueling; Yang, Jun; Na, Tao; Zhang, Kehua; Davidoff, Andrew M.; Yuan, Bao-Zhu; Wang, Youchun			RIG-I and IL-6 are negative-feedback regulators of STING induced by double-stranded DNA	PLOS ONE			English	Article							INNATE IMMUNE SENSOR; CYCLIC GMP-AMP; CYTOSOLIC DNA; ADAPTER; RECOGNITION; PATHWAY	The stimulator of interferon genes (STING) protein has emerged as a critical signal transduction molecule in the innate immune response. Sustained activation of the STING signaling induced by cytosolic DNA has been considered to be the cause of a variety of autoimmune diseases characterized by uncontrolled inflammation. Therefore, it is important to understand the molecular basis of the regulation of STING signaling pathway. Here we demonstrate that the STING protein undergoes a proteasome-mediated degradation in human diploid cell (HDC) lines including MRC-5 following the transfection of double-stranded DNA (dsDNA). The degradation of STING is accompanied by the increased expression of both RIG-I and IL-6. Employing the RIG-I siRNA knockdown and an IL-6 neutralizing antibody greatly inhibits the degradation of STING induced by dsDNA. We further demonstrate that both IL-6 and RIG-I are downstream molecules of STING along the DNA sensor pathway. Therefore, STING degradation mediated by RIG-I and IL-6 may serve as a negative feedback mechanism to limit the uncontrolled innate immune response induced by dsDNA. We have further shown that RIG-I and IL-6 promote STING degradation by activating/dephosphorylating UNC-51-like kinase (ULK1). Interestingly, the STING protein is not significantly affected by dsDNA in non-HDC HEK293 cells. Our study thus has identified a novel signaling pathway for regulating STING in HDCs.	[Wu, Xueling; Wang, Youchun] Peking Union Med Coll, Grad Sch, Beijing, Peoples R China; [Wu, Xueling; Na, Tao; Zhang, Kehua; Yuan, Bao-Zhu] Natl Inst Food & Drug Control, Cell Collect & Res Ctr, Beijing, Peoples R China; [Yang, Jun; Davidoff, Andrew M.] St Jude Childrens Res Hosp, Dept Surg, 332 N Lauderdale St, Memphis, TN 38105 USA; [Wang, Youchun] Natl Inst Food & Drug Control, HIV & Sexual Transmitted Viral Vaccine, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Institute of Food & Drug Control - China; St Jude Children's Research Hospital; National Institute of Food & Drug Control - China	Wang, YC (corresponding author), Peking Union Med Coll, Grad Sch, Beijing, Peoples R China.; Yuan, BZ (corresponding author), Natl Inst Food & Drug Control, Cell Collect & Res Ctr, Beijing, Peoples R China.; Wang, YC (corresponding author), Natl Inst Food & Drug Control, HIV & Sexual Transmitted Viral Vaccine, Beijing, Peoples R China.	yuanbaozhu@nifdc.org.cn; wangyc@nifdc.org.cn	Yang, Jun/N-2309-2018	Yang, Jun/0000-0002-4233-3220; Wang, Youchun/0000-0001-9769-5141	National Natural Science Foundation of China [H1609-81172102]; 'Strategic Priority Research Program' of the Chinese Academy of Sciences [XDA01030508]; 'Nation's Key Strategic Research Program' of the 'Nation's 13-Five Plan in Science and Technology' [2016YFA0101501]; Science and Technology Project of Guangdong Province [20146020226002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 'Strategic Priority Research Program' of the Chinese Academy of Sciences(Chinese Academy of Sciences); 'Nation's Key Strategic Research Program' of the 'Nation's 13-Five Plan in Science and Technology'; Science and Technology Project of Guangdong Province	This work was supported by the National Natural Science Foundation of China (H1609-81172102), the 'Strategic Priority Research Program' of the Chinese Academy of Sciences (XDA01030508), the 'Nation's Key Strategic Research Program' of the 'Nation's 13-Five Plan in Science and Technology' (2016YFA0101501), and the Science and Technology Project of Guangdong Province (20146020226002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Cheng GF, 2007, P NATL ACAD SCI USA, V104, P9035, DOI 10.1073/pnas.0703285104; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Choi MK, 2009, P NATL ACAD SCI USA, V106, P17870, DOI 10.1073/pnas.0909545106; Devhare PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063793; Goulet ML, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003298; Hu MM, 2016, IMMUNITY, V45, P555, DOI 10.1016/j.immuni.2016.08.014; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Konno H, 2013, CELL, V155, P688, DOI 10.1016/j.cell.2013.09.049; Lin XF, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/329405; Liu QP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048295; Lu LL, 2006, HAEMATOLOGICA, V91, P1017; Nitta S, 2013, HEPATOLOGY, V57, P46, DOI 10.1002/hep.26017; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wang Q, 2009, J IMMUNOL, V183, P6989, DOI 10.4049/jimmunol.0901386; Wang YM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005012; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Zhang L, 2014, IMMUNITY, V40, P329, DOI 10.1016/j.immuni.2014.01.010; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008	32	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2017	12	8							e0182961	10.1371/journal.pone.0182961	http://dx.doi.org/10.1371/journal.pone.0182961			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD5CP	28806404	gold, Green Published, Green Submitted			2022-12-26	WOS:000407548800041
J	Hill, NE; Murphy, KG; Saeed, S; Phadke, R; Chambers, D; Wilson, DR; Brett, SJ; Singer, M				Hill, Neil E.; Murphy, Kevin G.; Saeed, Saima; Phadke, Rahul; Chambers, Darren; Wilson, Duncan R.; Brett, Stephen J.; Singer, Mervyn			Impact of ghrelin on body composition and muscle function in a long-term rodent model of critical illness	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; FOOD-INTAKE; THERMAL-INJURY; HEART-FAILURE; ILL ADULTS; RAT MODEL; CACHEXIA; NUTRITION; SEPSIS; METABOLISM	Background Patients with multiple injuries or sepsis requiring intensive care treatment invariably develop a catabolic state with resultant loss of lean body mass, for which there are currently no effective treatments. Recovery can take months and mortality is high. We hypothesise that treatment with the orexigenic and anti-inflammatory gastric hormone, ghrelin may attenuate the loss of body mass following critical illness and improve recovery. Methods Male Wistar rats received an intraperitoneal injection of the fungal cell wall derivative zymosan to induce a prolonged peritonitis and consequent critical illness. Commencing at 48h after zymosan, animals were randomised to receive a continuous infusion of ghrelin or vehicle control using a pre-implanted subcutaneous osmotic mini-pump, and continued for 10 days. Results Zymosan peritonitis induced significant weight loss and reduced food intake with a nadir at Day 2 and gradual recovery thereafter. Supra-physiologic plasma ghrelin levels were achieved in the treated animals. Ghrelin-treated rats ate more food and gained more body mass than controls. Ghrelin increased adiposity and promoted carbohydrate over fat metabolism, but did not alter total body protein, muscle strength nor muscle morphology. Muscle mass and strength remained significantly reduced in all zymosan-treated animals, even at ten days post-insult. Conclusions Continuous infusion of ghrelin increased body mass and food intake, but did not increase muscle mass nor improve muscle function, in a long-term critical illness recovery model. Further studies with pulsatile ghrelin delivery or additional anabolic stimuli may further clarify the utility of ghrelin in survivors of critical illness.	[Hill, Neil E.; Murphy, Kevin G.] Imperial Coll London, Sect Invest Med, London, England; [Hill, Neil E.; Saeed, Saima; Singer, Mervyn] UCL, Div Med, Bloomsbury Inst Intens Care Med, London, England; [Hill, Neil E.; Wilson, Duncan R.] Royal Ctr Def Med, Acad Dept Mil Med, Birmingham, W Midlands, England; [Phadke, Rahul] UCL Inst Neurol, Div Neuropathol, London, England; [Phadke, Rahul] Natl Hosp Neurol & Neurosurg, London, England; [Chambers, Darren] UCL, Dubowitz Neuromuscular Ctr, Inst Child Hlth, London, England; [Chambers, Darren] UCL, MRC Ctr Neuromuscular Disorders, Inst Child Hlth, London, England; [Chambers, Darren] Great Ormond St Hosp Sick Children, London, England; [Brett, Stephen J.] Imperial Coll Healthcare NHS Trust, Ctr Perioperat Med & Crit Care Res, London, England	Imperial College London; University of London; University College London; Royal Centre for Defence Medicine; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Imperial College London	Hill, NE (corresponding author), Imperial Coll London, Sect Invest Med, London, England.; Hill, NE (corresponding author), UCL, Div Med, Bloomsbury Inst Intens Care Med, London, England.	n.hill@imperial.ac.uk	Phadke, Rahul/U-6960-2019; Singer, Mervyn/Q-6142-2019; Chambers, Darren/AAZ-6637-2021	Singer, Mervyn/0000-0002-1042-6350; Murphy, Kevin/0000-0002-3417-0310; Hill, Neil/0000-0002-4359-2646; Chambers, Darren/0000-0002-0200-9274	UK Ministry of Defence; MRC; BBSRC; NIHR, an Integrative Mammalian Biology (IMB) Capacity Building [FP7-HEALTH-2009-241592]; NIHR Imperial Biomedical Research Centre Funding Scheme	UK Ministry of Defence; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIHR, an Integrative Mammalian Biology (IMB) Capacity Building; NIHR Imperial Biomedical Research Centre Funding Scheme	Funding was provided by the UK Ministry of Defence as part of Dr Hill's PhD. The Section of Investigative Medicine is funded by grants from the MRC, BBSRC, NIHR, an Integrative Mammalian Biology (IMB) Capacity Building Award, an FP7-HEALTH-2009-241592 EuroCHIP grant and is supported by the NIHR Imperial Biomedical Research Centre Funding Scheme.	Acker CG, 2000, KIDNEY INT, V57, P293, DOI 10.1046/j.1523-1755.2000.00827.x; Akamizu T, 2008, J AM GERIATR SOC, V56, P2363, DOI 10.1111/j.1532-5415.2008.02031.x; Akashi YJ, 2009, INT J CARDIOL, V137, P267, DOI 10.1016/j.ijcard.2008.06.094; ALEXANDER JW, 1989, ANN SURG, V209, P334, DOI 10.1097/00000658-198903000-00014; Ashby DR, 2009, KIDNEY INT, V76, P199, DOI 10.1038/ki.2009.114; Balasubramaniam A, 2006, PEPTIDES, V27, P1624, DOI 10.1016/j.peptides.2006.02.005; Balasubramaniam A, 2009, AM J PHYSIOL-REG I, V296, pR893, DOI 10.1152/ajpregu.00015.2008; Barazzoni R, 2010, KIDNEY INT, V77, P23, DOI 10.1038/ki.2009.411; Casaer MP, 2014, NEW ENGL J MED, V370, P1227, DOI 10.1056/NEJMra1304623; Casaer MP, 2011, NEW ENGL J MED, V365, P506, DOI 10.1056/NEJMoa1102662; Chang L, 2003, ACTA PHARMACOL SIN, V24, P45; Chorny A, 2008, J IMMUNOL, V180, P8369, DOI 10.4049/jimmunol.180.12.8369; DeBoer MD, 2007, ENDOCRINOLOGY, V148, P3004, DOI 10.1210/en.2007-0016; FRAYN KN, 1986, CLIN ENDOCRINOL, V24, P577, DOI 10.1111/j.1365-2265.1986.tb03288.x; Hataya YJ, 2003, ENDOCRINOLOGY, V144, P5365, DOI 10.1210/en.2003-0427; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Hill NE, 2015, CRIT CARE MED, V43, pE84, DOI 10.1097/CCM.0000000000000854; Kress JP, 2014, NEW ENGL J MED, V370, P1626, DOI 10.1056/NEJMra1209390; Maurissen JPJ, 2003, NEUROTOXICOL TERATOL, V25, P543, DOI 10.1016/S0892-0362(03)00073-4; Miki K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035708; Nagaya N, 2005, CHEST, V128, P1187, DOI 10.1378/chest.128.3.1187; Nagaya N, 2001, CIRCULATION, V104, P2034, DOI 10.1161/hc4201.097836; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Neary NM, 2004, J CLIN ENDOCR METAB, V89, P2832, DOI 10.1210/jc.2003-031768; Nematy M, 2006, CRIT CARE, V10, DOI 10.1186/cc3957; Przkora R, 2005, ANN SURG, V242, P384, DOI 10.1097/01.sla.0000180398.70103.24; Strassburg S, 2008, AM J PHYSIOL-ENDOC M, V295, pE78, DOI 10.1152/ajpendo.00040.2008; Takala J, 1999, NEW ENGL J MED, V341, P785, DOI 10.1056/NEJM199909093411102; Theander-Carrillo C, 2006, J CLIN INVEST, V116, P1983, DOI 10.1172/JCI25811; Thompson NM, 2004, ENDOCRINOLOGY, V145, P234, DOI 10.1210/en.2003-0899; Thompson NM, 2003, ENDOCRINOLOGY, V144, P4859, DOI 10.1210/en.2003-0423; Witard OC, 2014, AM J CLIN NUTR, V99, P86, DOI 10.3945/ajcn.112.055517; Wren AM, 2001, DIABETES, V50, P2540, DOI 10.2337/diabetes.50.11.2540; Wu R, 2007, AM J PHYSIOL-ENDOC M, V293, pE1697, DOI 10.1152/ajpendo.00098.2007; Wynne K, 2005, J AM SOC NEPHROL, V16, P2111, DOI 10.1681/ASN.2005010039	35	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182659	10.1371/journal.pone.0182659	http://dx.doi.org/10.1371/journal.pone.0182659			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796827	Green Submitted, Green Published, gold			2022-12-26	WOS:000407396200075
J	Horton, S; Gelband, H; Jamison, D; Levin, C; Nugent, R; Watkins, D				Horton, Susan; Gelband, Hellen; Jamison, Dean; Levin, Carol; Nugent, Rachel; Watkins, David			Ranking 93 health interventions for low- and middle-income countries by cost-effectiveness	PLOS ONE			English	Article								Background Cost-effectiveness rankings of health interventions are useful inputs for national healthcare planning and budgeting. Previous comprehensive rankings for low- and middle-income countries were undertaken in 2005 and 2006, accompanying the development of strategies for the Millennium Development Goals. We update the rankings using studies published since 2000, as strategies are being considered for the Sustainable Development Goals. Methods Expert systematic searches of the literature were undertaken for a broad range of health interventions. Cost-effectiveness results using Disability Adjusted Life-Years (DALYs) as the health outcome were standardized to 2012 US dollars. Results 149 individual studies of 93 interventions qualified for inclusion. Interventions for Reproductive, Maternal, Newborn and Child Health accounted for 37% of interventions, and major infectious diseases (AIDS, TB, malaria and neglected tropical diseases) for 24%, consistent with the priorities of the Millennium Development Goals. More than half of the interventions considered cost less than $200 per DALY and hence can be considered for inclusion in Universal Health Care packages even in low-income countries. Discussion Important changes have occurred in rankings since 2006. Priorities have changed as a result of new technologies, new methods for changing behavior, and significant price changes for some vaccines and drugs. Achieving the Sustainable Development Goals will require LMICs to study a broader range of health interventions, particularly in adult health. Some interventions are no longer studied, in some cases because they have become usual care, in other cases because they are no longer relevant. Updating cost-effectiveness rankings on a regular basis is potentially a valuable exercise.	[Horton, Susan] Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON, Canada; [Gelband, Hellen] Ctr Dis Dynam Econ & Policy, Washington, DC USA; [Jamison, Dean; Levin, Carol; Watkins, David] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Nugent, Rachel] RTI Int, Seattle, WA USA	University of Waterloo; University of Washington; University of Washington Seattle; Research Triangle Institute	Horton, S (corresponding author), Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON, Canada.	sehorton@uwaterloo.ca	Watkins, David/ABC-3783-2020	Watkins, David/0000-0001-6341-9595; Nugent, Rachel/0000-0001-6421-9077; Horton, Susan/0000-0002-9243-4767	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This study was conducted as part of the Disease Control Priorities project, funded by the Bill & Melinda Gates Foundation (Principal Investigator: DJ). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, LANCET; Claxton K, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19140; Debas HT, 2015, DIS CONTROL PRIORITI, V1; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Evans DB, 2005, BMJ-BRIT MED J, V331, P1457, DOI 10.1136/bmj.38658.675243.94; Gaziano TA, 2017, DIS CONTROL PRIORITI, V5; Gelband H., 2015, DIS CONTROL PRIORITI, V3; Greenberg D, 2010, JNCI-J NATL CANCER I, V102, P82, DOI 10.1093/jnci/djp472; Holmes K.K., 2017, DIS CONTROL PRIORITI, V6; Horton S, 2015, CANC DIS CONTROL PRI; Horton S., 2016, DIS CONTROL PRIORITI, VVol. 2, P319, DOI DOI 10.1596/978-1-4648-0348-2_CH17; Husereau D, 2013, VALUE HEALTH, V16, P231, DOI 10.1016/j.jval.2013.02.002; Laxminarayan R, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P35; Levin C., 2016, MENTAL NEUROLOGICAL, V3rd, P219, DOI [10.1017/CBO9781107415324.004, DOI 10.1596/978-1-4648-0426-7]; NICE International, 2016, GAT REF CAS WHAT IT; Ochalek J, 2015, 122 CTR HLTH EC; Patel V, 2016, DIS CONTROL PRIORITI, V4; Prabhakaran D., 2017, CARDIOVASCULAR RESP, V5; Salomon JA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e355; Shankar Prinja, 2015, Disease control priorities, third edition: Volume 1. Essential surgery, P317; Vos T, ASSESSING COST EFFEC; Walker N., 2016, REPROD MATERNAL NEWB, V2; World Health Organization, 2001, MACR HLTH INV HLTH E	23	52	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182951	10.1371/journal.pone.0182951	http://dx.doi.org/10.1371/journal.pone.0182951			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797115	gold, Green Published, Green Submitted			2022-12-26	WOS:000407396200132
J	Lozano-Diez, A; Zazo, R; Toledano, DT; Gonzalez-Rodriguez, J				Lozano-Diez, Alicia; Zazo, Ruben; Toledano, Doroteo T.; Gonzalez-Rodriguez, Joaquin			An analysis of the influence of deep neural network (DNN) topology in bottleneck feature based language recognition	PLOS ONE			English	Article							SPEAKER	Language recognition systems based on bottleneck features have recently become the state-of-the-art in this research field, showing its success in the last Language Recognition Evaluation (LRE 2015) organized by NIST (U.S. National Institute of Standards and Technology). This type of system is based on a deep neural network (DNN) trained to discriminate between phonetic units, i.e. trained for the task of automatic speech recognition (ASR). This DNN aims to compress information in one of its layers, known as bottleneck (BN) layer, which is used to obtain a new frame representation of the audio signal. This representation has been proven to be useful for the task of language identification (LID). Thus, bottleneck features are used as input to the language recognition system, instead of a classical parameterization of the signal based on cepstral feature vectors such as MFCCs (Mel Frequency Cepstral Coefficients). Despite the success of this approach in language recognition, there is a lack of studies analyzing in a systematic way how the topology of the DNN influences the performance of bottleneck feature-based language recognition systems. In this work, we try to fill-in this gap, analyzing language recognition results with different topologies for the DNN used to extract the bottleneck features, comparing them and against a reference system based on a more classical cepstral representation of the input signal with a total variability model. This way, we obtain useful knowledge about how the DNN configuration influences bottleneck feature-based language recognition systems performance.	[Lozano-Diez, Alicia; Zazo, Ruben; Toledano, Doroteo T.; Gonzalez-Rodriguez, Joaquin] Univ Autonoma Madrid, Audias UAM, Madrid, Spain	Autonomous University of Madrid	Lozano-Diez, A (corresponding author), Univ Autonoma Madrid, Audias UAM, Madrid, Spain.	alicia.lozano@uam.es	Lozano-Diez, Alicia/U-4476-2019; Toledano, Doroteo T/C-7750-2014	Toledano, Doroteo T/0000-0003-1159-6455; Lozano Diez, Alicia/0000-0002-5918-8568	CMC-V2: Caracterizacion, Modelado y Compensacion de Variabilidad en la Senal de Voz - Ministerio de Economia y Competitividad, Spain [TEC2012-37585-C02-01, BES-2013-064886]; DSSL: Redes Profundas y Modelos de Subespacios para Deteccion y Seguimiento de Locutor ldioma y Enfermedades Degenerativas a partir de la Voz - Ministerio de Economia y Competitividad, Spain [TEC2015-68172-C2-1-P]	CMC-V2: Caracterizacion, Modelado y Compensacion de Variabilidad en la Senal de Voz - Ministerio de Economia y Competitividad, Spain; DSSL: Redes Profundas y Modelos de Subespacios para Deteccion y Seguimiento de Locutor ldioma y Enfermedades Degenerativas a partir de la Voz - Ministerio de Economia y Competitividad, Spain	This work was supported by projects CMC-V2: Caracterizacion, Modelado y Compensacion de Variabilidad en la Senal de Voz (TEC2012-37585-C02-01), which supports Alicia Lozano-Diez scholarship (BES-2013-064886); and DSSL: Redes Profundas y Modelos de Subespacios para Deteccion y Seguimiento de Locutor ldioma y Enfermedades Degenerativas a partir de la Voz (TEC2015-68172-C2-1-P). Both projects are funded by Ministerio de Economia y Competitividad, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop Christopher M., 2006, PATTERN RECOGNITION; Dehak N., 2011, P INTERSPEECH, V2011, P857; Dehak N, 2011, IEEE T AUDIO SPEECH, V19, P788, DOI 10.1109/TASL.2010.2064307; Fer R, 2015, 16TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION (INTERSPEECH 2015), VOLS 1-5, P389; Ferrer Luciana, 2016, IEEE/ACM Transactions on Audio, Speech and Language Processing, V24, P105, DOI 10.1109/TASLP.2015.2496226; Garcia-Romero D, 2015, 16TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION (INTERSPEECH 2015), VOLS 1-5, P1141; Gonzalez-Dominguez J, 2014, FRAME FRAME LANGUAGE; Grezl F, 2007, INT CONF ACOUST SPEE, P757; Hinton G, 2012, IEEE SIGNAL PROC MAG, V29, P82, DOI 10.1109/MSP.2012.2205597; Karafiat M, 2014, INTERSPEECH 2014, P3002; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lozano-Diez A., 2016, ODYSSEY, P352; Martinez D, 2011, 12TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2011 (INTERSPEECH 2011), VOLS 1-5, P868; Matejka P, 2014, PROC ODYSSEY SPEAKER, P299; Matejka P, 2016, INT CONF ACOUST SPEE, P5100, DOI 10.1109/ICASSP.2016.7472649; Muthusamy YK, 1994, IEEE SIGNAL PROC MAG, V11, P33, DOI 10.1109/79.317925; NIST, 2013, NIST 2015 LANG REC V; NIST, 2013, 2013 2014 SPEAK REC; NIST, 2015, 2015 NIST LANG REC E; Povey Daniel, 2011, P ASRU BIG ISL HI US; Richardson F, 2015, IEEE SIGNAL PROC LET, V22, P1671, DOI 10.1109/LSP.2015.2420092; Torres-Carrasquillo P. A., 2002, P INT C SPOK LANG PR, P89; Variani Ehsan, 2014, 2014 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP), P4052, DOI 10.1109/ICASSP.2014.6854363; Zazo R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146917; ZISSMAN MA, 1994, INT CONF ACOUST SPEE, P305	25	28	28	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182580	10.1371/journal.pone.0182580	http://dx.doi.org/10.1371/journal.pone.0182580			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796806	Green Published, Green Submitted, gold			2022-12-26	WOS:000407396200065
J	Chen, BJ; Yang, L; Zhang, R; Gan, YC; Zhang, W; Liu, D; Chen, H; Tang, HR				Chen, Bojiang; Yang, Lan; Zhang, Rui; Gan, Yuncui; Zhang, Wen; Liu, Dan; Chen, Hong; Tang, Huairong			Hyperphosphorylation of RPS6KB1, rather than overexpression, predicts worse prognosis in non-small cell lung cancer patients	PLOS ONE			English	Article							SIGNALING PATHWAY; POOR SURVIVAL; S6 KINASE; EXPRESSION; MTOR; PHOSPHORYLATION; CLASSIFICATION	RPS6KB1 is the kinase of ribosomal protein S6 which is 70 kDa and is required for protein translation. Although the abnormal activation of RPS6KB1 has been found in types of diseases, its role and clinical significance in non-small cell lung cancer (NSCLC) has not been fully investigated. In this study, we identified that RPS6KB1 was over-phosphorylated (p-RPS6KB1) in NSCLC and it was an independent unfavorable prognostic marker for NSCLC patients. In spite of the frequent expression of total RPS6KB1 and p-RPS6KB1 in NSCLC specimens by immunohistochemical staining (IHC), only p-RPS6KB1 was associated with the clinicopathologic characteristics of NSCLC subjects. Kaplan-Meier survival analysis revealed that the increased expression of p-RPS6KB1 indicated a poorer 5-year overall survival (OS) for NSCLC patients, while the difference between the positive or negative RPS6KB1 group was not significant. Univariate and multivariate Cox regression analysis was then used to confirm the independent prognostic value of p-RPS6KB1. To illustrate the underlying mechanism of RPS6KB1 phosphorylation in NSCLC, LY2584702 was employed to inhibit the RPS6KB1 phosphorylation specifically both in lung adenocarcinoma cell line A549 and squamous cell carcinoma cell line SK-MES-1. As expected, RPS6KB1 dephosphorylation remarkably suppressed cells proliferation in CCK-8 test, and promoted more cells arresting in G0-G1 phase by cell cycle analysis. Moreover, apoptotic A549 cells with RPS6KB1 dephosphorylation increased dramatically, with an elevating trend in SK-MES-1, indicating a potential involvement of RPS6KB1 phosphorylation in inducing apoptosis. In conclusion, our data suggest that RPS6KB1 is over-activated as p-RPS6KB1 in NSCLC, rather than just the total protein overexpressing. The phosphorylation level of RPS6KB1 might be used as a novel prognostic marker for NSCLC patients.	[Chen, Bojiang; Yang, Lan; Zhang, Rui; Gan, Yuncui; Zhang, Wen; Liu, Dan] Sichuan Univ, West China Hosp, Dept Resp & Crit Care Med, Chengdu, Sichuan, Peoples R China; [Chen, Hong] Sichuan Acad Med Sci, Dept Gen Med, Chengdu, Sichuan, Peoples R China; [Chen, Hong] Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China; [Tang, Huairong] Sichuan Univ, West China Hosp, Hlth Management Ctr, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Sichuan University	Chen, H (corresponding author), Sichuan Acad Med Sci, Dept Gen Med, Chengdu, Sichuan, Peoples R China.; Chen, H (corresponding author), Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China.; Tang, HR (corresponding author), Sichuan Univ, West China Hosp, Hlth Management Ctr, Chengdu, Sichuan, Peoples R China.	yisabei@sina.com; 1651682099@qq.com			National Natural Science Foundation of China [81501968, 81241068]; Key Program from the Department of Science and Technology [2017SZ0052, 2016CZYD0001, 2014SZ0148]; Program from Health and Family Planning Commission of Sichuan province, China [150127]; Sichuan Province, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program from the Department of Science and Technology; Program from Health and Family Planning Commission of Sichuan province, China; Sichuan Province, China	This work was supported by grants from the National Natural Science Foundation of China (81501968 and 81241068); the Key Program from the Department of Science and Technology, Sichuan Province, China (2017SZ0052, 2016CZYD0001 and 2014SZ0148); and the Program from Health and Family Planning Commission of Sichuan province, China (150127).	Bahrami-b F, 2014, J CLIN PATHOL, P70; Bhandaru M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134678; Cao GD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168085; Carnevalli LS, 2010, DEV CELL, V18, P763, DOI 10.1016/j.devcel.2010.02.018; Catalan V, 2015, ACTA DIABETOL, V52, P257, DOI 10.1007/s00592-014-0632-9; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Dai GH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108468; Davidson B, 2016, HUM PATHOL, V54, P64, DOI 10.1016/j.humpath.2016.02.023; Di Conza G, 2017, CELL REP, V18, P1699, DOI 10.1016/j.celrep.2017.01.051; Ding LJ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101617; Dominguez D, 2016, ELIFE, V5, DOI 10.7554/eLife.10288; Dugger DT, 2015, AM J RESP CELL MOL, V53, P761, DOI 10.1165/rcmb.2014-0452RC; Fan WY, 2016, J CHROMATOGR A, V1443, P1, DOI 10.1016/j.chroma.2016.03.017; Fenton TR, 2011, INT J BIOCHEM CELL B, V43, P47, DOI 10.1016/j.biocel.2010.09.018; Goldstraw P, 2016, J THORAC ONCOL, V11, P39, DOI 10.1016/j.jtho.2015.09.009; Li PD, 2012, MED ONCOL, V29, P3070, DOI 10.1007/s12032-012-0268-y; Li SH, 2015, SURGERY, V157, P570, DOI 10.1016/j.surg.2014.10.014; Liontos M, 2016, WORLD J UROL, P1; Lu Z, 2016, J IMMUNOLOGY RES, V2016; M'Baye M, 2015, J REPROD DEVELOP, V61, P391, DOI 10.1262/jrd.2014-158; Malvezzi M, 2016, ANN ONCOL, V27, P725, DOI 10.1093/annonc/mdw022; Maruani DM, 2012, ONCOGENE, V31, P5073, DOI 10.1038/onc.2011.657; Padmanabhan J, 2015, J BIOL CHEM, V290, P5267, DOI 10.1074/jbc.M114.575225; Pathania AS, 2016, SCI REP-UK, V6, DOI 10.1038/srep33146; Poleri C, 2003, CHEST, V123, P1858, DOI 10.1378/chest.123.6.1858; Qian ZR, 2013, J CLIN ONCOL, V31, P3418, DOI 10.1200/JCO.2012.46.6946; Qiu ZX, 2012, CANCER SCI, V103, P1774, DOI 10.1111/j.1349-7006.2012.02375.x; Ren HY, 2015, ONCOTARGET, V6, P4080, DOI 10.18632/oncotarget.2977; Schemmerer M, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8100267; Shen CC, 2015, PATHOL ONCOL RES, V21, P267, DOI 10.1007/s12253-014-9817-3; Shin S, 2011, P NATL ACAD SCI USA, V108, pE1204, DOI 10.1073/pnas.1110195108; Sinha RA, 2017, AUTOPHAGY, V13, P169, DOI 10.1080/15548627.2016.1235123; Song JW, 2015, MOL CELL BIOL, V35, P1926, DOI 10.1128/MCB.01488-14; Tao T, 2014, TUMOR BIOL, V35, P8543, DOI 10.1007/s13277-014-2057-z; Tavares MR, 2015, LIFE SCI, V131, P1, DOI 10.1016/j.lfs.2015.03.001; Travis WD, 2014, PATHOLOGE, V35, P188, DOI 10.1007/s00292-014-1974-3; Van Dyke JM, 2014, MUSCLE NERVE, V49, P98, DOI 10.1002/mus.23880; Zadeh RA, 2017, POLYMORPHISMS RPS6KB; Zhou L, 2017, CANCER LETT, V395, P45, DOI 10.1016/j.canlet.2017.02.036	39	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182891	10.1371/journal.pone.0182891	http://dx.doi.org/10.1371/journal.pone.0182891			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28792981	Green Published, gold, Green Submitted			2022-12-26	WOS:000407196700077
J	Palomino-Schatzlein, M; Garcia, H; Gutierrez-Carcedo, P; Pineda-Lucena, A; Herance, JAR				Palomino-Schatzlein, Martina; Garcia, Hermenegildo; Gutierrez-Carcedo, Patricia; Pineda-Lucena, Antonio; Raul Herance, Jose			Assessment of gold nanoparticles on human peripheral blood cells by metabolic profiling with H-1-NMR spectroscopy, a novel translational approach on a patient-specific basis	PLOS ONE			English	Article							LYMPHOCYTE RATIO; DRUG DISCOVERY; NEUTROPHILS; CANCER; OXIDE; NANOMEDICINE; PROTEOMICS; TOXICITY; PLASMA; NANOMATERIALS	Human peripheral blood cells are relevant ex vivo models for characterizing diseases and evaluating the pharmacological effects of therapeutic interventions, as they provide a close reflection of an individual pathophysiological state. In this work, a new approach to evaluate the impact of nanoparticles on the three main fractions of human peripheral blood cells by nuclear magnetic resonance spectroscopy is shown. Thus, a comprehensive protocol has been set-up including the separation of blood cells, their in vitro treatment with nanoparticles and the extraction and characterization of metabolites by nuclear magnetic resonance. This method was applied to assess the effect of gold nanoparticles, either coated with chitosan or supported on ceria, on peripheral blood cells from healthy individuals. A clear antioxidant effect was observed for chitosan-coated gold nanoparticles by a significant increase in reduced glutathione, that was much less pronounced for gold-cerium nanoparticles. In addition, the analysis revealed significant alterations of several other pathways, which were stronger for gold-cerium nanoparticles. These results are in accordance with the toxicological data previously reported for these materials, confirming the value of the current methodology.	[Palomino-Schatzlein, Martina; Pineda-Lucena, Antonio] Ctr Invest Principe Felipe, Lab Bioquim Estruct, Valencia, Spain; [Garcia, Hermenegildo] CSIC, UPV, Inst Univ Tecnol Quim, Valencia, Spain; [Gutierrez-Carcedo, Patricia; Raul Herance, Jose] Univ Autonoma Barcelona, Grp Recerca Imatge Med Mol, Vall dHebron Res Inst, CIBBIM Nanomed,Dept Med, Barcelona, Spain; [Pineda-Lucena, Antonio] Hosp Univ & Politecn La Fe, Inst Invest Sanit La Fe, Unidad Descubrimiento Farmacos, Valencia, Spain	Prince Felipe Research Center; Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital Universitari i Politecnic La Fe	Palomino-Schatzlein, M (corresponding author), Ctr Invest Principe Felipe, Lab Bioquim Estruct, Valencia, Spain.; Herance, JAR (corresponding author), Univ Autonoma Barcelona, Grp Recerca Imatge Med Mol, Vall dHebron Res Inst, CIBBIM Nanomed,Dept Med, Barcelona, Spain.	mpalomino@cipf.es; raul.herance@vhir.org	Pineda-Lucena, Antonio/B-1320-2014; Camacho, José Raul Herance/Q-3416-2016; Palomino-Schätzlein, Martina/L-6260-2014; Garcia, Hermenegildo/E-3296-2010	Pineda-Lucena, Antonio/0000-0002-3532-8781; Camacho, José Raul Herance/0000-0001-7178-3290; Garcia, Hermenegildo/0000-0002-9664-493X; Palomino-Schatzlein, Martina/0000-0001-7303-0743	Carlos III Health Institute [CP13/00252, PI16/02064]; European Regional Development Fund (ERDF); Ministry of Economy, Industry and Competitiveness [SAF2014-53977-R]; Miguel Servet I contract from the Ministry of Health of the Carlos III Health Institute; Ministry of Health of the Carlos III Health Institute	Carlos III Health Institute(Instituto de Salud Carlos III); European Regional Development Fund (ERDF)(European Commission); Ministry of Economy, Industry and Competitiveness; Miguel Servet I contract from the Ministry of Health of the Carlos III Health Institute; Ministry of Health of the Carlos III Health Institute	The present work was supported by grants CP13/00252 and PI16/02064 from Carlos III Health Institute and by the European Regional Development Fund (ERDF) and the grant SAF2014-53977-R from the Ministry of Economy, Industry and Competitiveness. In addition, JRH is recipient of a Miguel Servet I contract from the Ministry of Health of the Carlos III Health Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript instead of The present work was supported by grants CP13/00252 and PI16/02064 from Carlos III Health Institute, and by the European Regional Development Fund (ERDF). In addition, JRH is recipient of a contract from the Ministry of Health of the Carlos III Health Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkilany AM, 2010, J NANOPART RES, V12, P2313, DOI 10.1007/s11051-010-9911-8; Ansari AA, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2953686; Aranibar N, 2011, J BIOMOL NMR, V49, P195, DOI 10.1007/s10858-011-9490-8; Attri S, 2006, PEDIATR RES, V59, P593, DOI 10.1203/01.pdr.0000203098.77573.39; Babu KS, 2014, INT J NANOMED, V9, P5515, DOI 10.2147/IJN.S70087; Bakhtiari N, 2012, J DIABETES METAB DIS, V11, DOI 10.1186/2251-6581-11-9; Barasa B, 2014, BBA-PROTEINS PROTEOM, V1844, P1003, DOI 10.1016/j.bbapap.2013.10.002; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bhat T, 2013, EXPERT REV CARDIOVAS, V11, P55, DOI [10.1586/erc.12.159, 10.1586/ERC.12.159]; Blow N, 2008, NATURE, V455, P697, DOI 10.1038/455697a; Boca SC, 2011, MAT SCI ENG C-MATER, V31, P184, DOI 10.1016/j.msec.2010.08.015; Boyles MSP, 2016, PART FIBRE TOXICOL, V13, DOI 10.1186/s12989-016-0160-6; Boyles MSP, 2015, J NANOBIOTECHNOL, V13, DOI 10.1186/s12951-015-0146-9; BRINDLE KM, 1982, BIOCHEM J, V208, P583, DOI 10.1042/bj2080583; Carrola J, 2016, NANOTOXICOLOGY, V10, P1105, DOI 10.1080/17435390.2016.1177744; Catalan U, 2013, MOL BIOSYST, V9, P1411, DOI 10.1039/c3mb25554a; Chang EH, 2015, BIOCHEM BIOPH RES CO, V468, P511, DOI 10.1016/j.bbrc.2015.10.136; Choi SY, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-1234-5; Carabineiro SAC, 2017, MOLECULES, V22, DOI 10.3390/molecules22050857; Couto D, 2015, TOXICOL LETT, V234, P67, DOI 10.1016/j.toxlet.2015.02.010; D'Alessandro A, 2015, TRANSFUSION, V55, P1155, DOI 10.1111/trf.12975; D'Alessandro A, 2013, BLOOD TRANSFUS-ITALY, V11, P75, DOI 10.2450/2012.0164-11; Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+; Darghouth D, 2010, TRANSFUS CLIN BIOL, V17, P148, DOI 10.1016/j.tracli.2010.06.011; Delves PJ, 2000, NEW ENGL J MED, V343, P108, DOI 10.1056/NEJM200007133430207; Deng XY, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0957-z; Dobrovolskaia MA, 2008, MOL PHARMACEUT, V5, P487, DOI 10.1021/mp800032f; Esumi K, 2003, COLLOID SURFACE B, V32, P117, DOI 10.1016/S0927-7765(03)00151-6; Etheridge ML, 2013, NANOMED-NANOTECHNOL, V9, P1, DOI 10.1016/j.nano.2012.05.013; Freikman I, 2008, BBA-BIOMEMBRANES, V1778, P2388, DOI 10.1016/j.bbamem.2008.06.008; Gioria S, 2016, NANOTOXICOLOGY, V10, P736, DOI 10.3109/17435390.2015.1121412; Gregory AD, 2011, CANCER RES, V71, P2411, DOI 10.1158/0008-5472.CAN-10-2583; Her S, 2017, ADV DRUG DELIVER REV, V109, P84, DOI 10.1016/j.addr.2015.12.012; Humpfer E, 1997, MAGNET RESON MED, V38, P334, DOI 10.1002/mrm.1910380224; Hussain S, 2012, WIRES NANOMED NANOBI, V4, P169, DOI 10.1002/wnan.166; Ilinskaya AN, 2013, NANOMEDICINE-UK, V8, P773, DOI [10.2217/NNM.13.48, 10.2217/nnm.13.48]; Jain S, 2012, BRIT J RADIOL, V85, P101, DOI 10.1259/bjr/59448833; Kaplan MJ, 2011, NAT REV RHEUMATOL, V7, P691, DOI 10.1038/nrrheum.2011.132; Kawamoto EM, 2005, NEUROBIOL AGING, V26, P857, DOI 10.1016/j.neurobiolaging.2004.08.011; Khan MS, 2013, ADV COLLOID INTERFAC, V199, P44, DOI 10.1016/j.cis.2013.06.003; Kosenko EA, 2016, CNS NEUROL DISORD-DR, V15, P113, DOI 10.2174/1871527314666150821103444; Kramer PA, 2014, REDOX BIOL, V2, P206, DOI 10.1016/j.redox.2013.12.026; Kumerova A, MAT MED POL, V30, P12; Kyttaris VC, 2011, CURR OPIN RHEUMATOL, V23, P449, DOI 10.1097/BOR.0b013e328349a242; Li J, 2014, MOL BIOSYST, V10, P2994, DOI 10.1039/c4mb00388h; Li MX, 2014, INT J CANCER, V134, P2403, DOI 10.1002/ijc.28536; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; MAZZANTI L, 1992, CLIN BIOCHEM, V25, P41, DOI 10.1016/0009-9120(92)80044-H; Mena JF, 2013, J BIOMATER TISS ENG, V3, P135, DOI 10.1166/jbt.2013.1072; Menchon C, 2012, SMALL, V8, P1895, DOI 10.1002/smll.201102255; Mulleder M, 2016, CELL, V167, P553, DOI 10.1016/j.cell.2016.09.007; Neunkirchner A, 2014, INT ARCH ALLERGY IMM, V163, P259, DOI 10.1159/000360163; NOBLE PB, 1968, BLOOD, V31, P66, DOI 10.1182/blood.V31.1.66.66; OTIKO G, 1983, J INORG BIOCHEM, V19, P227, DOI 10.1016/0162-0134(83)85027-2; Palomino-Schatzlein M, 2013, ANAL BIOANAL CHEM, V405, P8431, DOI 10.1007/s00216-013-7271-9; Planchon M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178437; Porcherie A, 2011, J EXP MED, V208, P2225, DOI 10.1084/jem.20110845; Regiel-Futyra A, 2015, ACS APPL MATER INTER, V7, P1087, DOI 10.1021/am508094e; Robertson DG, 2013, CLIN PHARMACOL THER, V94, P559, DOI 10.1038/clpt.2013.120; Rojas S, 2012, MOL PHARMACEUT, V9, P3543, DOI 10.1021/mp300382n; Rothen-Rutishauser BM, 2006, ENVIRON SCI TECHNOL, V40, P4353, DOI 10.1021/es0522635; Saha SK, 2017, CARBOHYD POLYM, V157, P1666, DOI 10.1016/j.carbpol.2016.11.047; Sana TR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060840; Shi JJ, 2017, NAT REV CANCER, V17, P20, DOI 10.1038/nrc.2016.108; Shilo M, 2015, NANOSCALE, V7, P20489, DOI 10.1039/c5nr04881h; Silindir Gunay M, 2016, CURR NEUROPHARMACOL, V14, P376, DOI 10.2174/1570159X14666151230124904; Sporri R, 2008, J IMMUNOL, V181, P7121, DOI 10.4049/jimmunol.181.10.7121; Strehl C, 2015, INT J NANOMED, V10, P3429, DOI 10.2147/IJN.S75936; Tang LG, 2017, BIOMATERIALS, V129, P28, DOI 10.1016/j.biomaterials.2017.03.009; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Van Raam BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002013; Versiani AF, 2016, FUTURE VIROL, V11, P293, DOI 10.2217/fvl-2015-0010; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wang XD, 2004, J PROTEOME RES, V3, P921, DOI 10.1021/pr0499601; Wayteck L, 2016, BIOMATERIALS, V77, P243, DOI 10.1016/j.biomaterials.2015.11.016; Weintraub K, 2013, NATURE, V495, pS14, DOI 10.1038/495S14a; Wigren M, 2012, CLIN CHIM ACTA, V413, P1562, DOI 10.1016/j.cca.2012.04.031; Wishart DS, 2016, NAT REV DRUG DISCOV, V15, P473, DOI 10.1038/nrd.2016.32; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wright LC, 2000, EUR J BIOCHEM, V267, P68, DOI 10.1046/j.1432-1327.2000.00955.x; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Yang X, 2015, CHEM REV, V115, P10410, DOI 10.1021/acs.chemrev.5b00193; Yang Z, 2012, J POSTGENOMICS DRUG, V2; Zheng P, 2016, J AFFECT DISORDERS, V195, P75, DOI 10.1016/j.jad.2016.02.008; Zhou JB, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-6; Zolnik BS, 2010, ENDOCRINOLOGY, V151, P458, DOI 10.1210/en.2009-1082	87	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182985	10.1371/journal.pone.0182985	http://dx.doi.org/10.1371/journal.pone.0182985			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28793337	Green Submitted, Green Published, gold			2022-12-26	WOS:000407196700081
J	Rapp, O; Yifrach, O				Rapp, Olga; Yifrach, Ofer			Using the MWC model to describe heterotropic interactions in hemoglobin	PLOS ONE			English	Article							OXYGEN DISSOCIATION CURVE; 2-STATE ALLOSTERIC MODEL; SINGLE-CRYSTALS; FOURIER SYNTHESIS; SILICA-GELS; BINDING; COOPERATIVITY; CHANGEUX; MONOD; WYMAN	Hemoglobin is a classical model allosteric protein. Research on hemoglobin parallels the development of key cooperativity and allostery concepts, such as the 'all-or-none' Hill formalism, the stepwise Adair binding formulation and the concerted Monod-Wymann-Changuex (MWC) allosteric model. While it is clear that the MWC model adequately describes the cooperative binding of oxygen to hemoglobin, rationalizing the effects of H+, CO2 or organophosphate ligands on hemoglobin-oxygen saturation using the same model remains controversial. According to the MWC model, allosteric ligands exert their effect on protein function by modulating the quaternary conformational transition of the protein. However, data fitting analysis of hemoglobin oxygen saturation curves in the presence or absence of inhibitory ligands persistently revealed effects on both relative oxygen affinity (c) and conformational changes (L), elementary MWC parameters. The recent realization that data fitting analysis using the traditional MWC model equation may not provide reliable estimates for L and c thus calls for a re-examination of previous data using alternative fitting strategies. In the current manuscript, we present two simple strategies for obtaining reliable estimates for MWC mechanistic parameters of hemoglobin steady-state saturation curves in cases of both evolutionary and physiological variations. Our results suggest that the simple MWC model provides a reasonable description that can also account for heterotropic interactions in hemoglobin. The results, moreover, offer a general roadmap for successful data fitting analysis using the MWC model.	[Yifrach, Ofer] Ben Gurion Univ Negev, Dept Life Sci, Beer Sheva, Israel; Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Yifrach, O (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, Beer Sheva, Israel.	ofery@bgu.ac.il	Rapp, Olga/ABI-8297-2020		Israel Science Foundation [294/16, 488/12]	Israel Science Foundation(Israel Science Foundation)	This research was supported by the Israel Science Foundation (grant 294/16 to O.Y.). and the Israel Science Foundation, grant # 488/12 to OY. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair GS, 1925, J BIOL CHEM, V63, P529; Baldwin J.M., 1975, Progress Biophys Molec Biol, V29, P225; BENESCH RE, 1971, NATURE-NEW BIOL, V234, P174, DOI 10.1038/newbio234174a0; Bettati S, 1996, PROTEINS, V25, P425, DOI 10.1002/(SICI)1097-0134(199608)25:4<425::AID-PROT3>3.3.CO;2-A; Bohr C, 1904, SKAND ARCH PHYSIOL, V16, P402, DOI 10.1111/j.1748-1716.1904.tb01382.x; BOLTON W, 1970, NATURE, V228, P551, DOI 10.1038/228551a0; Brunori M, 1999, TRENDS BIOCHEM SCI, V24, P158, DOI 10.1016/S0968-0004(99)01380-8; Brunori M, 2014, FEBS J, V281, P633, DOI 10.1111/febs.12586; Changeux JP, 2012, ANNU REV BIOPHYS, V41, P103, DOI 10.1146/annurev-biophys-050511-102222; DICERA E, 1988, J MOL BIOL, V200, P593, DOI 10.1016/0022-2836(88)90545-1; DOYLE ML, 1987, J MOL BIOL, V196, P927, DOI 10.1016/0022-2836(87)90414-1; Eaton WA, 1999, NAT STRUCT BIOL, V6, P351, DOI 10.1038/7586; Eaton WA, 2007, IUBMB LIFE, V59, P586, DOI 10.1080/15216540701272380; EDELSTEIN SJ, 1971, NATURE, V230, P224, DOI 10.1038/230224a0; EDELSTEIN SJ, 1975, ANNU REV BIOCHEM, V44, P209, DOI 10.1146/annurev.bi.44.070175.001233; GOODFORD PJ, 1978, J PHYSIOL-LONDON, V283, P397, DOI 10.1113/jphysiol.1978.sp012508; Henry ER, 2002, BIOPHYS CHEM, V98, P149, DOI 10.1016/S0301-4622(02)00091-1; Henry ER, 2015, BIOPHYS J, V109, P1264, DOI 10.1016/j.bpj.2015.04.037; Hill A.V, 1910, J PHYSL, V40, piv, DOI DOI 10.1113/JPHYSIOL.1910.SP001386; IMAI K, 1975, J BIOL CHEM, V250, P2227; IMAI K, 1983, J MOL BIOL, V167, P741, DOI 10.1016/S0022-2836(83)80107-7; IMAI K, 1973, BIOCHEMISTRY-US, V12, P798, DOI 10.1021/bi00729a003; Imai K., 1982, ALLOSTERIC EFFECTS H; KILMARTIN JV, 1978, BIOCHIM BIOPHYS ACTA, V534, P15, DOI 10.1016/0005-2795(78)90471-3; KISTER J, 1987, J BIOL CHEM, V262, P12085; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Levitzki A., 1978, QUANTITATIVE ASPECTS; MATSUKAWA S, 1981, J MOL BIOL, V150, P615, DOI 10.1016/0022-2836(81)90386-7; Milo R, 2007, P NATL ACAD SCI USA, V104, P16998, DOI 10.1073/pnas.0707673104; MINTON A P, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1418, DOI 10.1073/pnas.71.4.1418; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MOZZARELLI A, 1991, NATURE, V351, P416, DOI 10.1038/351416a0; MUIRHEAD H, 1967, J MOL BIOL, V28, P117, DOI 10.1016/S0022-2836(67)80082-2; Pauling L, 1935, P NATL ACAD SCI USA, V21, P186, DOI 10.1073/pnas.21.4.186; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; PERUTZ MF, 1983, MOL BIOL EVOL, V1, P1; PERUTZ MF, 1989, Q REV BIOPHYS, V22, P139, DOI 10.1017/S0033583500003826; RIVETTI C, 1993, BIOCHEMISTRY-US, V32, P2888, DOI 10.1021/bi00062a021; RUBIN MM, 1966, J MOL BIOL, V21, P265, DOI 10.1016/0022-2836(66)90097-0; SHIBAYAMA N, 1995, J MOL BIOL, V251, P203, DOI 10.1006/jmbi.1995.0427; Shulman RG, 2001, IUBMB LIFE, V51, P351, DOI 10.1080/152165401753366104; Storz JF, 2008, HIGH ALT MED BIOL, V9, P148, DOI 10.1089/ham.2007.1079; Tsuneshige A, 2002, BIOPHYS CHEM, V98, P49, DOI 10.1016/S0301-4622(02)00084-4; Viappiani C, 2014, P NATL ACAD SCI USA, V111, P12758, DOI 10.1073/pnas.1413566111; Weber RE, 2007, RESP PHYSIOL NEUROBI, V158, P132, DOI 10.1016/j.resp.2007.05.001; Yonetani T, 2002, J BIOL CHEM, V277, P34508, DOI 10.1074/jbc.M203135200	46	5	6	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182871	10.1371/journal.pone.0182871	http://dx.doi.org/10.1371/journal.pone.0182871			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28793329	Green Submitted, Green Published, gold			2022-12-26	WOS:000407196700076
J	Siljak-Yakovlev, S; Godelle, B; Zoldos, V; Valles, J; Garnatje, T; Hidalgo, O				Siljak-Yakovlev, Sonja; Godelle, Bernard; Zoldos, Vlatka; Valles, Joan; Garnatje, Teresa; Hidalgo, Oriane			Evolutionary implications of heterochromatin and rDNA in chromosome number and genome size changes during dysploidy: A case study in Reichardia genus	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; RIBOSOMAL-RNA GENES; NUCLEAR-DNA CONTENT; ARTEMISIA ASTERACEAE; POLYPLOIDY; MODEL; PHYLOGENETICS; SPECIATION; POLLEN; 35S	In this study we showed that constitutive heterochromatin, GC-rich DNA and rDNA are implicated in chromosomal rearrangements during the basic chromosome number changing (dysploidy) in Reichardia genus. This small Mediterranean genus comprises 8 - 10 species and presents three basic chromosome numbers (x = 9, 8 and 7). To assess genome evolution and differentiation processes, studies were conducted in a dysploid series of six species: R. dichotoma, R. macrophylla and R. albanica (2n = 18), R. tingitana and R. gaditana (2n = 16), and R. picroides (2n = 14). The molecular phylogeny reconstruction comprised three additional species (R. crystallina and R. ligulata, 2n = 16 and R. intermedia, 2n = 14). Our results indicate that the way of dysploidy is descending. During this process, a positive correlation was observed between chromosome number and genome size, rDNA loci number and pollen size, although only the correlation between chromosome number and genome size is still recovered significant once considering the phylogenetic effect. Fluorescent in situ hybridisation also evidenced changes in number, position and organisation of two rDNA families (35S and 5S), including the reduction of loci number and, consequently, reduction in the number of secondary constrictions and nuclear organising regions from three to one per diploid genome. The potential mechanisms of chromosomal and genome evolution, strongly implicating heterochromatin, are proposed and discussed, with particular consideration for Reichardia genus.	[Siljak-Yakovlev, Sonja] Univ Paris Saclay, Univ Paris Sud, AgroParisTech, Ecol Systemat Evolut,CNRS, Orsay, France; [Godelle, Bernard] Univ Montpellier II, Inst Sci Evolut, CNRS, UMR 5554, Pl Eugene Bataillon, Montpellier, France; [Zoldos, Vlatka] Univ Zagreb, Fac Sci, Dept Biol, Div Mol Biol, Zagreb, Croatia; [Valles, Joan] Univ Barcelona, Fac Farm & Ciencies Alimentacio, Lab Bot UB, CSIC,Unitat Associada, Barcelona, Catalonia, Spain; [Garnatje, Teresa] CSIC, ICUB, IBB, Barcelona, Catalonia, Spain; [Hidalgo, Oriane] Royal Bot Gardens, Comparat Plant & Fungal Biol, Richmond, Surrey, England	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Zagreb; Consejo Superior de Investigaciones Cientificas (CSIC); University of Barcelona; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Botanic de Barcelona (ICUB); Royal Botanic Gardens, Kew	Siljak-Yakovlev, S (corresponding author), Univ Paris Saclay, Univ Paris Sud, AgroParisTech, Ecol Systemat Evolut,CNRS, Orsay, France.; Valles, J (corresponding author), Univ Barcelona, Fac Farm & Ciencies Alimentacio, Lab Bot UB, CSIC,Unitat Associada, Barcelona, Catalonia, Spain.	sonia.yakovlev@u-psud.fr; joanvalles@ub.edu	Hidalgo, Oriane/F-5985-2013; Garnatje, Teresa/L-3028-2014; Siljak-Yakovlev, Sonja/E-8433-2017	Hidalgo, Oriane/0000-0002-1547-8627; Garnatje, Teresa/0000-0001-6295-6217; Siljak-Yakovlev, Sonja/0000-0002-6247-3351	CNRS France; Catalan government project [2014SGR514]; Spanish government project [CGL2013-49097-C2-2-P]	CNRS France(Centre National de la Recherche Scientifique (CNRS)); Catalan government project; Spanish government project(Spanish Government)	This work was supported by CNRS France; Catalan government project no 2014SGR514 and the Spanish government project no CGL2013-49097-C2-2-P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; BENNETT MD, 1971, PROC R SOC SER B-BIO, V178, P259, DOI 10.1098/rspb.1971.0065; Bennett MD, 2005, ANN BOT-LONDON, V95, P45, DOI 10.1093/aob/mci003; Blamey M, 2008, FLORES SILVESTRES ME; BROCHMANN C, 1992, NORD J BOT, V12, P657, DOI 10.1111/j.1756-1051.1992.tb01843.x; BRUTLAG DL, 1980, ANNU REV GENET, V14, P121, DOI 10.1146/annurev.ge.14.120180.001005; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; Conti F, 2015, PHYTOTAXA, V236, P121, DOI 10.11646/phytotaxa.236.2.2; Datson PM, 2006, CHROMOSOME RES, V14, P845, DOI 10.1007/s10577-006-1092-z; de Oliveira VM, 2004, GENET MOL BIOL, V27, P215, DOI 10.1590/S1415-47572004000200015; DELATORRE J, 1987, HEREDITY, V58, P345, DOI 10.1038/hdy.1987.61; Dimitri P, 1999, TRENDS GENET, V15, P123, DOI 10.1016/S0168-9525(99)01711-4; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Ellermeier C, 2010, P NATL ACAD SCI USA, V107, P8701, DOI 10.1073/pnas.0914160107; Erdtman G., 1952, POLLEN MORPHOLOGY PL; Euro+Med, 2006, EURO MED PLANTBASE I; Faulkner GJ, 2009, CELL CYCLE, V8, P2895, DOI 10.4161/cc.8.18.9536; GALBRAITH DW, 1983, SCIENCE, V220, P1049, DOI 10.1126/science.220.4601.1049; Gallego M. J, 1980, LAGASCALIA, V9, P149; Garcia S, 2007, PLANT SYST EVOL, V267, P79, DOI 10.1007/s00606-007-0558-6; Garcia S, 2013, PLANT BIOSYST, V147, P1219, DOI 10.1080/11263504.2013.863811; Garcia S, 2009, CHROMOSOMA, V118, P85, DOI 10.1007/s00412-008-0179-z; Garnatje T, 2012, GENOME, V55, P529, DOI [10.1139/G2012-041, 10.1139/g2012-041]; GEBER G, 1988, PLANT SYST EVOL, V158, P97, DOI 10.1007/BF00936336; GODELLE B, 1993, CYTOMETRY, V14, P618, DOI 10.1002/cyto.990140606; Greilhuber J, 2005, ANN BOT-LONDON, V95, P255, DOI 10.1093/aob/mci019; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Heslop-Harrison J. S., 1991, Technique, a Journal of Methods in Cell and Molecular Biology, V3, P109; Hidalgo O, 2008, TAXON, V57, P769, DOI 10.1002/tax.573009; John B, 1988, HETEROCHROMATIN MOL, P1; JONES RN, 1976, HEREDITY, V36, P91, DOI 10.1038/hdy.1976.10; Kim SC, 1996, SYST BOT, V21, P417, DOI 10.2307/2419668; Knight C.A, 2010, J BOT; LABANI RM, 1987, HEREDITY, V59, P119, DOI 10.1038/hdy.1987.103; LANDE R, 1985, HEREDITY, V54, P323, DOI 10.1038/hdy.1985.43; Maddison, 2018, MESQUITE MODULAR SYS; MARIE D, 1993, BIOL CELL, V78, P41, DOI 10.1016/0248-4900(93)90113-S; Marinho RC, 2014, PLANT BIOLOGY, V16, P508, DOI 10.1111/plb.12135; MARKS GE, 1975, J CELL SCI, V18, P19; de Xaxars GM, 2016, ALPINE BOT, V126, P35, DOI 10.1007/s00035-015-0159-x; MIKLOS GLG, 1976, CHROMOSOMA, V56, P143; Moraes AP, 2015, BOT J LINN SOC, V177, P27, DOI 10.1111/boj.12232; Muratovic E, 2010, TAXON, V59, P165, DOI 10.1002/tax.591016; NAVASCASTILLO J, 1987, HEREDITY, V58, P409, DOI 10.1038/hdy.1987.69; Nazarova AE, 1968, ASTERACEAE BIOL ARM, V21, P93; NICKRENT DL, 1994, AM J BOT, V81, P1149, DOI 10.2307/2445477; Nylander JAA., 2004, MRMODELTEST 2 2; Ovchinnikov PN, 1971, FLORA RASTITELNOST U; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peruzzi L, 2013, PLANT BIOSYST, V147, P1238, DOI 10.1080/11263504.2013.861533; Pinheiro J, R PACKAGE VERSION; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; PRICE HJ, 1976, BOT REV, V42, P27, DOI 10.1007/BF02860861; R Core Team, 2021, R LANGUAGE ENV STAT; Raina SN, 1999, PLANT SYST EVOL, V214, P251, DOI 10.1007/BF00985743; Raskina O, 2004, P NATL ACAD SCI USA, V101, P14818, DOI 10.1073/pnas.0405817101; REES H, 1981, PHILOS T R SOC B, V292, P569, DOI 10.1098/rstb.1981.0051; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Ritter-Studnicka H, 1957, GOD BIOL I SARAJEVO, V10, P129; RITTER-STUDNICKA HILDA, 1967, VEGEATIO, V15, P190, DOI 10.1007/BF01963748; SCHUBERT I, 1985, CHROMOSOMA, V92, P143, DOI 10.1007/BF00328466; SCHWEIZER D, 1976, CHROMOSOMA, V58, P307, DOI 10.1007/BF00292840; Schweizer D, 1989, CHROMOSOMES TODAY, V10, P33; Sell PD, 1976, FLORA EUROPAEA, V4, P325; Semple J.C., 2009, SYSTEMATICS EVOLUTIO, P61; Siljak S. I. O. P. B., 1977, TAXON, V26, P447; Siljak-Yakovlev S, 1998, CYTOGENET CELL GENET, V81, P114; Siljak-Yakovlev S, 2002, THEOR APPL GENET, V104, P505, DOI 10.1007/s001220100755; Siljak-Yakovlev S, 2010, ADV SCI LETT, V3, P190, DOI 10.1166/asl.2010.1115; Siljak-Yakovlev S, 1986, THESIS; Siljak-Yakovlev S., 1996, BOCCONEA, V5, P211; Siljak-Yakovlev S., 1982, TAXON, V31, P768; Siljak-Yakovlev S, 2014, TREE GENET GENOMES, V10, P231, DOI 10.1007/s11295-013-0654-4; Siljak-Yakovlev S, 2014, METHODS MOL BIOL, V1115, P309, DOI 10.1007/978-1-62703-767-9_15; SILJAKYAKOVLEV S, 1981, CARYOLOGIA, V34, P267, DOI 10.1080/00087114.1981.10796891; Solbrig O.T., 1977, BIOL CHEM COMPOSITAE, V1, P269; SOLBRIG OT, 1964, AM J BOT, V51, P513, DOI 10.2307/2440279; SOLTIS DE, 1991, AM J BOT, V78, P1091, DOI 10.2307/2444898; Stebbins GL., NEW CLASSIFICATION T; STUCKY J, 1975, AM J BOT, V62, P509, DOI 10.2307/2441959; Stupar RM, 2002, GENETICS, V162, P1435; Suda J, 2003, ANN BOT-LONDON, V92, P153, DOI 10.1093/aob/mcg104; SWIFT H, 1950, P NATL ACAD SCI USA, V36, P643, DOI 10.1073/pnas.36.11.643; Torrell M, 2003, PLANT SYST EVOL, V239, P141, DOI 10.1007/s00606-002-0259-0; Torrell M, 2001, BOCCONEA, V13, P623; Valles J, 2013, CARYOLOGIA, V66, P221, DOI 10.1080/00087114.2013.829690; Vanrobays E, 2013, ANNU PLANT REV, V46, P157, DOI 10.1002/9781118472507.ch6; Watanabe K., 2013, INDEX CHROMOSOME NUM; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; WICHMAN HA, 1991, J HERED, V82, P369, DOI 10.1093/oxfordjournals.jhered.a111106; YAMAMOTO M, 1978, CHROMOSOMA, V66, P71, DOI 10.1007/BF00285817; Zoldos V, 2007, CHROMOSOME RES, V15, P38	94	19	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182318	10.1371/journal.pone.0182318	http://dx.doi.org/10.1371/journal.pone.0182318			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28792980	Green Published, Green Submitted, gold			2022-12-26	WOS:000407196700039
J	Wang, H; Chu, YX; Fang, CR; Huang, F; Song, YL; Xue, XD				Wang, Hua; Chu, Yixuan; Fang, Chengran; Huang, Fang; Song, Yali; Xue, Xiangdong			Sorption of tetracycline on biochar derived from rice straw under different temperatures	PLOS ONE			English	Article							ACTIVATED CARBON; WASTE-WATER; AGRICULTURAL WASTE; AQUEOUS-SOLUTIONS; EFFECTIVE REMOVAL; POROUS CARBON; ADSORPTION; SOIL; ANTIBIOTICS; MANURE	Biochars produced from the pyrolysis of waste biomass under limited oxygen conditions could serve as adsorbents in environmental remediation processes. Biochar samples derived from rice straw that were pyrolyzed at 300 (R300), 500 (R500) and 700 degrees C (R700) were used as adsorbents to remove tetracycline from an aqueous solution. Both the Langmuir and Freundlich models fitted the adsorption data well (R-2 > 0.919). The adsorption capacity increased with pyrolysis temperature. The R500 and R700 samples exhibited relative high removal efficiencies across a range of initial tetracycline concentrations (0.5mg/L-32mg/L) with the maximum (92.8%-96.7%) found for adsorption on R700 at 35 degrees C. The relatively high surface area of the R700 sample and pi-pi electron-donor acceptor contributed to the high adsorption capacities. A thermodynamic analysis indicated that the tetracycline adsorption process was spontaneous and endothermic. The pH of solution was also found to influence the adsorption processes; the maximum adsorption capacity occurred at a pH of 5.5. These experimental results highlight that biochar derived from rice straw is a promising candidate for low-cost removal of tetracycline from water.	[Wang, Hua; Chu, Yixuan; Fang, Chengran; Song, Yali; Xue, Xiangdong] Zhejiang Univ Sci & Technol, Key Lab Recycling & Ecotreatment Waste Biomass Zh, Hangzhou, Zhejiang, Peoples R China; [Wang, Hua; Chu, Yixuan; Fang, Chengran; Song, Yali; Xue, Xiangdong] Zhejiang Univ Sci & Technol, Sch Civil Engn & Architecture, Hangzhou, Zhejiang, Peoples R China; [Huang, Fang] Agr Comprehens Inspect & Testing Ctr Jiaxing, Jiaxing, Zhejiang, Peoples R China	Zhejiang University of Science & Technology; Zhejiang University of Science & Technology	Fang, CR (corresponding author), Zhejiang Univ Sci & Technol, Key Lab Recycling & Ecotreatment Waste Biomass Zh, Hangzhou, Zhejiang, Peoples R China.; Fang, CR (corresponding author), Zhejiang Univ Sci & Technol, Sch Civil Engn & Architecture, Hangzhou, Zhejiang, Peoples R China.	fangchengr@163.com			Innovative Team Foundation of Zhejiang Province [2013TD12]; International Science and Technology Cooperation Program of China [2014DFE90040]; Significant Science and Technology Project of Zhejiang Province [2015C33006]	Innovative Team Foundation of Zhejiang Province; International Science and Technology Cooperation Program of China; Significant Science and Technology Project of Zhejiang Province	Funding provided by the Innovative Team Foundation of Zhejiang Province (no. 2013TD12), Chengran Fang; International Science and Technology Cooperation Program of China (no. 2014DFE90040), Chengran Fang; and Significant Science and Technology Project of Zhejiang Province (no. 2015C33006), Chengran Fang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2014, CHEMOSPHERE, V99, P19, DOI 10.1016/j.chemosphere.2013.10.071; Ahmed MB, 2015, SCI TOTAL ENVIRON, V532, P112, DOI 10.1016/j.scitotenv.2015.05.130; Cabello FC, 2006, ENVIRON MICROBIOL, V8, P1137, DOI 10.1111/j.1462-2920.2006.01054.x; Cao XD, 2011, ENVIRON SCI TECHNOL, V45, P4884, DOI 10.1021/es103752u; Chao Y., 2014, J APPL POLYM SCI, V131, P1, DOI DOI 10.1002/APP.40561; Chen YJ, 2016, J MOL LIQ, V222, P487, DOI 10.1016/j.molliq.2016.07.090; Chen YS, 2012, ENVIRON MONIT ASSESS, V184, P2205, DOI 10.1007/s10661-011-2110-y; Chun Y, 2004, ENVIRON SCI TECHNOL, V38, P4649, DOI 10.1021/es035034w; Dai Z, 2016, EUR J SOIL SCI, V67, P40, DOI 10.1111/ejss.12290; Dirany A, 2012, ENVIRON SCI TECHNOL, V46, P4074, DOI 10.1021/es204621q; Gai XP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0113888, 10.1371/journal.pone.0097730]; Ghadim EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079254; Hameed BH, 2009, J HAZARD MATER, V164, P870, DOI 10.1016/j.jhazmat.2008.08.084; Jeong J, 2010, CHEMOSPHERE, V78, P533, DOI 10.1016/j.chemosphere.2009.11.024; Ji LL, 2009, ENVIRON SCI TECHNOL, V43, P2322, DOI 10.1021/es803268b; Jia MY, 2013, BIORESOURCE TECHNOL, V136, P87, DOI 10.1016/j.biortech.2013.02.098; Knapp CW, 2010, ENVIRON SCI TECHNOL, V44, P580, DOI 10.1021/es901221x; Kumar K, 2005, J ENVIRON QUAL, V34, P2082, DOI 10.2134/jeq2005.0026; Lehmann J., 2015, BIOCHAR ENV MANAGEME, Vsecond, P1, DOI DOI 10.4324/9780203762264; Lei ZF, 2010, BIORESOURCE TECHNOL, V101, P4343, DOI 10.1016/j.biortech.2010.01.083; Lian F, 2014, CHEM ENG J, V248, P128, DOI 10.1016/j.cej.2014.03.021; Liao P, 2013, CHEM ENG J, V228, P496, DOI 10.1016/j.cej.2013.04.118; Liu P, 2012, BIORESOURCE TECHNOL, V121, P235, DOI 10.1016/j.biortech.2012.06.085; Mitchell SM, 2015, J ENVIRON CHEM ENG, V3, P162, DOI 10.1016/j.jece.2014.11.012; Oller I, 2011, SCI TOTAL ENVIRON, V409, P4141, DOI 10.1016/j.scitotenv.2010.08.061; Pils JRV, 2007, ENVIRON SCI TECHNOL, V41, P1928, DOI 10.1021/es062316y; Pouretedal HR, 2014, J WATER PROCESS ENG, V1, P64, DOI 10.1016/j.jwpe.2014.03.006; Qian LB, 2015, J SOIL SEDIMENT, V15, P1130, DOI 10.1007/s11368-015-1073-y; Qian LB, 2014, J AGR FOOD CHEM, V62, P373, DOI 10.1021/jf404624h; Rivera-Utrilla J, 2013, J ENVIRON MANAGE, V131, P16, DOI 10.1016/j.jenvman.2013.09.024; Sassman SA, 2005, ENVIRON SCI TECHNOL, V39, P7452, DOI 10.1021/es0480217; Saygili H, 2016, ECOTOX ENVIRON SAFE, V131, P22, DOI 10.1016/j.ecoenv.2016.05.001; Shimabuku KK, 2016, WATER RES, V96, P236, DOI 10.1016/j.watres.2016.03.049; Sun JK, 2014, ECOTOX ENVIRON SAFE, V106, P226, DOI 10.1016/j.ecoenv.2014.04.042; Tan XF, 2015, CHEMOSPHERE, V125, P70, DOI 10.1016/j.chemosphere.2014.12.058; Wang YJ, 2010, GEODERMA, V156, P237, DOI 10.1016/j.geoderma.2010.02.022; Xie MX, 2014, ENVIRON POLLUT, V186, P187, DOI 10.1016/j.envpol.2013.11.022; Yuan XZ, 2016, ENVIRON SCI POLLUT R, V23, P18657, DOI 10.1007/s11356-016-6892-x; Zhang HF, 2011, ENVIRON SCI TECHNOL, V45, P5477, DOI 10.1021/es1037904; Zhang L, 2011, CHEM ENG J, V178, P26, DOI 10.1016/j.cej.2011.09.127; Zhang QQ, 2015, ENVIRON SCI TECHNOL, V49, P6772, DOI 10.1021/acs.est.5b00729; Zhao L, 2010, SCI TOTAL ENVIRON, V408, P1069, DOI 10.1016/j.scitotenv.2009.11.014; Zhu XD, 2014, CARBON, V77, P627, DOI 10.1016/j.carbon.2014.05.067; Zhu XD, 2014, BIORESOURCE TECHNOL, V154, P209, DOI 10.1016/j.biortech.2013.12.019	44	29	35	13	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2017	12	8							e0182776	10.1371/journal.pone.0182776	http://dx.doi.org/10.1371/journal.pone.0182776			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9EU	28792530	Green Published, Green Submitted, gold			2022-12-26	WOS:000407144700039
J	Demsar, U; Coltekin, A				Demsar, Urska; Coltekin, Arzu			Quantifying gaze and mouse interactions on spatial visual interfaces with a new movement analytics methodology	PLOS ONE			English	Article							EYE-MOVEMENT; TIME GEOGRAPHY; TRACKING; COORDINATION; SOFTWARE; DYNAMICS; PATTERNS	Eye movements provide insights into what people pay attention to, and therefore are commonly included in a variety of human-computer interaction studies. Eye movement recording devices (eye trackers) produce gaze trajectories, that is, sequences of gaze location on the screen. Despite recent technological developments that enabled more affordable hardware, gaze data are still costly and time consuming to collect, therefore some propose using mouse movements instead. These are easy to collect automatically and on a large scale. If and how these two movement types are linked, however, is less clear and highly debated. We address this problem in two ways. First, we introduce a new movement analytics methodology to quantify the level of dynamic interaction between the gaze and the mouse pointer on the screen. Our method uses volumetric representation of movement, the space-time densities, which allows us to calculate interaction levels between two physically different types of movement. We describe the method and compare the results with existing dynamic interaction methods from movement ecology. The sensitivity to method parameters is evaluated on simulated trajectories where we can control interaction levels. Second, we perform an experiment with eye and mouse tracking to generate real data with real levels of interaction, to apply and test our new methodology on a real case. Further, as our experiment tasks mimics route-tracing when using a map, it is more than a data collection exercise and it simultaneously allows us to investigate the actual connection between the eye and the mouse. We find that there seem to be natural coupling when eyes are not under conscious control, but that this coupling breaks down when instructed to move them intentionally. Based on these observations, we tentatively suggest that for natural tracing tasks, mouse tracking could potentially provide similar information as eye-tracking and therefore be used as a proxy for attention. However, more research is needed to confirm this.	[Demsar, Urska] Univ St Andrews, Sch Geog & Sustainable Dev, St Andrews, Fife, Scotland; [Coltekin, Arzu] Univ Zurich, Dept Geog, Zurich, Switzerland	University of St Andrews; University of Zurich	Demsar, U (corresponding author), Univ St Andrews, Sch Geog & Sustainable Dev, St Andrews, Fife, Scotland.	urska.demsar@st-andrews.ac.uk	; Coltekin, Arzu/C-7705-2018	Demsar, Urska/0000-0001-7791-2807; Coltekin, Arzu/0000-0002-3178-3509	Royal Society through an International Exchange Programme grant [1E120643]	Royal Society through an International Exchange Programme grant	This research was supported by the Royal Society (https://royalsociety.org/) through an International Exchange Programme grant (1E120643) awarded to UD and A. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach B, 2014, EUR C VIS EUROVIS; BALLARD DH, 1992, PHILOS T R SOC B, V337, P331, DOI 10.1098/rstb.1992.0111; Benhamou S, 2004, J THEOR BIOL, V229, P209, DOI 10.1016/j.jtbi.2004.03.016; Bernhard M, 2014, ACM T APPL PERCEPT, V11; Bieg HJ, 2010, P 2010 S EY TRACK RE; Bjtsch RLC, 1932, J EDUC PSYCHOL, V23, P104; Blascheck T, 2014, STAR STAT ART EUR C; Buchin Kevin, 2013, Algorithms and Data Structures. 13th International Symposium, WADS 2013. Proceedings. LNCS 8037, P219, DOI 10.1007/978-3-642-40104-6_19; Buchin K, 2011, INT J COMPUT GEOM AP, V21, P253, DOI 10.1142/S0218195911003652; Coltekin A, 2010, INT J GEOGR INF SCI, V24, P1559, DOI 10.1080/13658816.2010.511718; Coltekin A., 2009, P PICT COD S; Coltekin A., 2006, THESIS; Coltekin A, 2014, P 2 INT WORKSH EY TR; Demsar U, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0032-y; Demsar U, 2015, GEOINFORMATICA, V19, P85, DOI 10.1007/s10707-014-0207-5; Demsar U, 2010, INT J GEOGR INF SCI, V24, P1527, DOI 10.1080/13658816.2010.511223; Dodge S, 2009, COMPUT ENVIRON URBAN, V33, P419, DOI 10.1016/j.compenvurbsys.2009.07.008; Duchowski A., 2007, EYE TRACKING METHODO; Farber S, 2013, ANN ASSOC AM GEOGR, V103, P483, DOI 10.1080/00045608.2012.689238; Findlay J. M., 2008, ACTIVE VISION PSYCHO; Fobes J.L., 1982, P219; Freeman JB, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00059; Freeman JB, 2010, BEHAV RES METHODS, V42, P226, DOI 10.3758/BRM.42.1.226; Goodale M, 2013, SIGHT UNSEEN EXPLORA; Hagerstraand T., 1970, PAPERS REGIONAL SCI, V24, P7, DOI [DOI 10.1111/J.1435-5597.1970.TB01464.X, 10.1007/BF01936872]; Hansen IJ, 2013, POLAR BIOL, V36, P1363, DOI 10.1007/s00300-013-1356-y; Holmqvist K., 2011, EYE TRACKING COMPREH; Huang J, P CHI 2012; Hughes J. F., 2013, COMPUTER GRAPHICS PR; Hussain M, 2013, ISPRS J PHOTOGRAMM, V80, P91, DOI 10.1016/j.isprsjprs.2013.03.006; Inhoff AW, 1997, CURR DIR PSYCHOL SCI, V6, P153, DOI 10.1111/1467-8721.ep10772929; Johansen SA, 2015, EYETRIBETHE WORLDS 1; KHURANA B, 1987, VISION RES, V27, P1603, DOI 10.1016/0042-6989(87)90168-4; Kurzhals K, 2013, IEEE T VIS COMPUT GR, V19, P2129, DOI 10.1109/TVCG.2013.194; Kwan MP, 2014, INT J GEOGR INF SCI, V28, P851, DOI 10.1080/13658816.2014.889300; Lebreton P, 2015, P 4 INT WORKSH CROWD, P3, DOI [10.1145/2810188.2810192, DOI 10.1145/2810188.2810192]; Li X, LNCS, V6292, P295; Long JA, 2014, J ANIM ECOL, V83, P1216, DOI 10.1111/1365-2656.12198; Long JA, 2014, INT J GEOGR INF SCI, V28, P855, DOI 10.1080/13658816.2013.818151; Long JA, 2012, J WILDLIFE MANAGE, V76, P407, DOI 10.1002/jwmg.259; Mac Aoidh E, 2012, GEOINFORMATICA, V16, P409, DOI 10.1007/s10707-011-0137-4; Magnuson JS, 2005, P NATL ACAD SCI USA, V102, P9995, DOI 10.1073/pnas.0504413102; Manson SM, 2012, CARTOGR GEOGR INF SC, V39, P48, DOI 10.1559/1523040639148; May M., 2009, SENSATION PERCEPTION; Mercier G, 2010, MULTIVARIATE IMAGE P, P95; Miller HJ, 2005, GEOGR ANAL, V37, P17, DOI 10.1111/j.1538-4632.2005.00575.x; Miller JA, 2012, T GIS, V16, P271, DOI 10.1111/j.1467-9671.2012.01323.x; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Nourian P, 2016, METHODSX, V3, P69, DOI 10.1016/j.mex.2016.01.001; Ouzts AD, 2012, P 2012 S EY TRACK RE; Papastamatiou Y, FUNC ECOL REV; Pettit B, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0529; Raizman EA, 2013, PREV VET MED, V111, P76, DOI 10.1016/j.prevetmed.2013.04.007; ROBINSON DA, 1965, J PHYSIOL-LONDON, V180, P569, DOI 10.1113/jphysiol.1965.sp007718; Rodden K, 2008, P CHI 2008; Schotter ER, 2014, VIS COGN; Sekuler AB, 2000, EXP AGING RES, V26, P103, DOI 10.1080/036107300243588; Shalom DE, 2013, J VISION, V13, DOI 10.1167/13.3.4; Snowden R., 2012, BASIC VISION INTRO V; Souto D, 2008, J VISION, V8, DOI 10.1167/8.14.3; Sundstedt V., 2013, GAME ANAL, P543; Tahir Ali, 2013, Web and Wireless Geographical Information Systems. 12th International Symposium, W2GIS 2013. Proceedings, P117, DOI 10.1007/978-3-642-37087-8_9; Tahir A, 2011, LECT NOTES COMPUT SC, V6637, P132; Tatler BW, 2010, I-PERCEPTION, V1, P7, DOI 10.1068/i0382; Vosskuhler A, 2008, BEHAV RES METHODS, V40, P1150, DOI [10.3758/BRM.40.4.1150, 10.3758/BRM.40.4.U50]; Ware C., 2013, INFORM VISUALIZATION, V3rd; Williams DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084368	67	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0181818	10.1371/journal.pone.0181818	http://dx.doi.org/10.1371/journal.pone.0181818			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC6IS	28777822	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000406944300015
J	Soto-Burgos, J; Bassham, DC				Soto-Burgos, Junmarie; Bassham, Diane C.			SnRK1 activates autophagy via the TOR signaling pathway in Arabidopsis thaliana	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; SNF1-RELATED PROTEIN-KINASES; ENERGY SENSOR; PLANT-GROWTH; SACCHAROMYCES-CEREVISIAE; REGULATE AUTOPHAGY; REDUCTASE KINASE; PHOSPHORYLATION; AMPK; TARGET	Autophagy is a degradation process in which cells break down and recycle their cytoplasmic contents when subjected to environmental stress or during cellular remodeling. The Arabidopsis thaliana SnRK1 complex is a protein kinase that senses changes in energy levels and triggers downstream responses to enable survival. Its mammalian ortholog, AMPK, and yeast ortholog, Snf-1, activate autophagy in response to low energy conditions. We therefore hypothesized that SnRK1 may play a role in the regulation of autophagy in response to nutrient or energy deficiency in Arabidopsis. To test this hypothesis, we determined the effect of overexpression or knockout of the SnRK1 catalytic subunit KIN10 on autophagy activation by abiotic stresses, including nutrient deficiency, salt, osmotic, oxidative, and ER stress. While wild-type plants had low basal autophagy activity in control conditions, KIN10 overexpression lines had increased autophagy under these conditions, indicating activation of autophagy by SnRK1. A kin10 mutant had a basal level of autophagy under control conditions similar to wild-type plants, but activation of autophagy by most abiotic stresses was blocked, indicating that SnRK1 is required for autophagy induction by a wide variety of stress conditions. In mammals, TOR is a negative regulator of autophagy, and AMPK acts to activate autophagy both upstream of TOR, by inhibiting its activity, and in a parallel pathway. Inhibition of Arabidopsis TOR leads to activation of autophagy; inhibition of SnRK1 did not block this activation. Furthermore, an increase in SnRK1 activity was unable to induce autophagy when TOR was also activated. These results demonstrate that SnRK1 acts upstream of TOR in the activation of autophagy in Arabidopsis.	[Soto-Burgos, Junmarie; Bassham, Diane C.] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Bassham, Diane C.] Iowa State Univ, Plant Sci Inst, Ames, IA 50011 USA	Iowa State University; Iowa State University	Bassham, DC (corresponding author), Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA.; Bassham, DC (corresponding author), Iowa State Univ, Plant Sci Inst, Ames, IA 50011 USA.	bassham@iastate.edu			United States Department of Energy to DCB [DE-SC0014038]; Iowa Ste University Walter E. and Helen Parke Loomis Fund	United States Department of Energy to DCB; Iowa Ste University Walter E. and Helen Parke Loomis Fund	This work was supported by Grant No. DE-SC0014038 from the United States Department of Energy to DCB and by the Iowa Stete University Walter E. and Helen Parke Loomis Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Fillip Roland for the KIN10 overexpression lines, Dr. Raju Datla for the TOR overexpression lines and Margaret Carter for assistance with confocal microscopy.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Anderson GH, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-12; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Broeckx T, 2016, J EXP BOT, V67, P6215, DOI 10.1093/jxb/erw416; Carroll B, 2017, BIOCHEM J, V474, P1453, DOI 10.1042/BCJ20160780; Chen L, 2015, AUTOPHAGY, V11, P2233, DOI 10.1080/15548627.2015.1112483; Chinnusamy V, 2004, J EXP BOT, V55, P225, DOI 10.1093/jxb/erh005; Contento AL, 2005, PLANT J, V42, P598, DOI 10.1111/j.1365-313X.2005.02396.x; Crozet P, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00190; DALE S, 1995, FEBS LETT, V361, P191, DOI 10.1016/0014-5793(95)00172-6; DALE S, 1995, EUR J BIOCHEM, V233, P506, DOI 10.1111/j.1432-1033.1995.506_2.x; Delatte TL, 2011, PLANT PHYSIOL, V157, P160, DOI 10.1104/pp.111.180422; Deprost D, 2005, BIOCHEM BIOPH RES CO, V326, P844, DOI 10.1016/j.bbrc.2004.11.117; Deprost D, 2007, EMBO REP, V8, P864, DOI 10.1038/sj.embor.7401043; Doelling JH, 2002, J BIOL CHEM, V277, P33105, DOI 10.1074/jbc.M204630200; Dong P, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00677; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Emanuelle S, 2015, PLANT J, V82, P183, DOI 10.1111/tpj.12813; Floyd BE, 2015, AUTOPHAGY, V11, P2199, DOI 10.1080/15548627.2015.1106664; Fragoso S, 2009, PLANT PHYSIOL, V149, P1906, DOI 10.1104/pp.108.133298; Ghillebert R, 2011, FEBS J, V278, P3978, DOI 10.1111/j.1742-4658.2011.08315.x; Gissot L, 2006, PLANT PHYSIOL, V142, P931, DOI 10.1104/pp.106.087718; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Halford NG, 2003, J EXP BOT, V54, P467, DOI 10.1093/jxb/erg038; Halford NG, 2009, BIOCHEM J, V419, P247, DOI 10.1042/BJ20082408; Hanaoka H, 2002, PLANT PHYSIOL, V129, P1181, DOI 10.1104/pp.011024; Hao LH, 2003, PLANT CELL, V15, P1034, DOI 10.1105/tpc.009530; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; HARDING TM, 1995, J CELL BIOL, V131, P591, DOI 10.1083/jcb.131.3.591; Harthill JE, 2006, PLANT J, V47, P211, DOI 10.1111/j.1365-313X.2006.02780.x; HAWLEY SA, 1995, J BIOL CHEM, V270, P27186, DOI 10.1074/jbc.270.45.27186; Jossier M, 2009, PLANT J, V59, P316, DOI 10.1111/j.1365-313X.2009.03871.x; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Lai ZB, 2011, PLANT J, V66, P953, DOI 10.1111/j.1365-313X.2011.04553.x; Laurie S, 2003, J EXP BOT, V54, P739, DOI 10.1093/jxb/erg085; Lee JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015394; Li XJ, 2017, P NATL ACAD SCI USA, V114, P2765, DOI 10.1073/pnas.1618782114; Liu Y, 2005, CELL, V121, P567, DOI 10.1016/j.cell.2005.03.007; Liu YM, 2012, PLANT CELL, V24, P4635, DOI 10.1105/tpc.112.101535; Liu YM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011883; Liu YM, 2009, AUTOPHAGY, V5, P954, DOI 10.4161/auto.5.7.9290; Lovas A, 2003, PLANT J, V33, P139, DOI 10.1046/j.1365-313X.2003.016015.x; Mair A, 2015, ELIFE, V4, DOI 10.7554/eLife.05828; Menand B, 2002, P NATL ACAD SCI USA, V99, P6422, DOI 10.1073/pnas.092141899; Moreau M, 2012, PLANT CELL, V24, P463, DOI 10.1105/tpc.111.091306; Nagele T, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00365; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Nukarinen E, 2016, SCI REP-UK, V6, DOI 10.1038/srep31697; Nunes C, 2013, PLANT PHYSIOL, V162, P1720, DOI 10.1104/pp.113.220657; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Paul AL, 2005, MOL BIOL CELL, V16, P1735, DOI 10.1091/mbc.E04-09-0839; Pu YT, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01204; Ramon M, 2013, PLANT J, V75, P11, DOI 10.1111/tpj.12192; Reggiori F, 2005, AUTOPHAGY, V1, P101, DOI 10.4161/auto.1.2.1840; Ren MZ, 2011, PLANT PHYSIOL, V155, P1367, DOI 10.1104/pp.110.169045; Rodrigues A, 2013, PLANT CELL, V25, P3871, DOI 10.1105/tpc.113.114066; Sheen J., 2002, TRANSIENT EXPRESSION; Sugden C, 1999, PLANT J, V19, P433, DOI 10.1046/j.1365-313X.1999.00532.x; Sugden C, 1999, PLANT PHYSIOL, V120, P257, DOI 10.1104/pp.120.1.257; Suttangkakul A, 2011, PLANT CELL, V23, P3761, DOI 10.1105/tpc.111.090993; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5; Tsai AYL, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00119; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Wang Z, 2001, MOL CELL BIOL, V21, P5742, DOI 10.1128/MCB.21.17.5742-5752.2001; Williams SP, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00324; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Xiong Y, 2007, PLANT PHYSIOL, V143, P291, DOI 10.1104/pp.106.092106; Xiong Y, 2015, CURR OPIN PLANT BIOL, V28, P83, DOI 10.1016/j.pbi.2015.09.006; Yang XC, 2016, PLANT J, V85, P83, DOI 10.1111/tpj.13091; Yang XC, 2015, INT REV CEL MOL BIO, V320, P1, DOI 10.1016/bs.ircmb.2015.07.005; Yin ZY, 2016, MICROB CELL, V3, P457, DOI 10.15698/mic2016.12.546; Zhang Y, 2011, PLANT J, V68, P1081, DOI 10.1111/j.1365-313X.2011.04761.x; Zhang YH, 2009, PLANT PHYSIOL, V149, P1860, DOI 10.1104/pp.108.133934	76	105	109	5	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0182591	10.1371/journal.pone.0182591	http://dx.doi.org/10.1371/journal.pone.0182591			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28783755	Green Published, Green Submitted, gold			2022-12-26	WOS:000406944300045
J	Thefenne, L; de Brier, G; Leclerc, T; Jourdan, C; Nicolas, C; Truffaut, S; Lapeyre, E; Genet, F				Thefenne, Laurent; de Brier, Gratiane; Leclerc, Thomas; Jourdan, Claire; Nicolas, Claire; Truffaut, Stephanie; Lapeyre, Eric; Genet, Francois			Two new risk factors for heterotopic ossification development after severe burns	PLOS ONE			English	Article							PHARMACOLOGICALLY INDUCED PARALYSIS; BONE-FORMATION; EXPERIENCE; INJURY; MODEL	Objectives Life after severe burns is conditioned by the remaining sequelae. The pathophysiology and risk factors of Heterotopic Ossification (HO) after burns are still poorly understood. The aim of this study was to determine: 1) the incidence of HO after burns and 2) the risk factors associated with HO development, in a large retrospective study. Methods A case-control study of patients admitted to the burns intensive care unit of Percy Hospital, Paris, from the 1st January 2009 to the 31st December 2013 and then admitted to one of three centres specialised in the rehabilitation of patients with burns. Multivariate analysis was carried out to analyse the relationship between HO development and demographic and clinical data. Results 805 patients were included. 32 patients (4.0%) developed a total of 74 heterotopic ossifications, that is a little higher incidence than the incidence found in the literature. The epidemiological characteristics of the population studied was similar to the literature. HOs were mainly localized around the elbows, followed by the hips, shoulders and knees. Each case-patient was paired with 3 control-patients. There were significant associations between HO development and the length of stay in the burns intensive care unit, the extent and depth of the burns, the occurrence of pulmonary or cutaneous infections, use of curare and use of an air-fluidized bed. Conclusion In addition to recognized risk factors (duration of stay in the intensive care burns unit, extent and depth of burns, pulmonary and cutaneous infections), the use of curare and the use of a fluidized bed (with the duration of use) were significantly associated with HO formation.	[Thefenne, Laurent; de Brier, Gratiane] Hop Instruct Armees Laveran, Serv Sante Armees, Serv Med Phys & Readaptat, Marseille, France; [Leclerc, Thomas] Hop Instruct Armees Percy, Serv Sante Armees, Ctr Traitement Brules, Clamart, France; [Jourdan, Claire] Ctr Hosp Lapeyronie, Dept Med Phys & Readaptat Therapeut, Montpellier, France; [Nicolas, Claire] Ctr Readaptat Coubert, Serv Med Phys & Readaptat, Coubert, France; [Truffaut, Stephanie; Lapeyre, Eric; Genet, Francois] Hop Instruct Armees Percy, Serv Sante Armees, Serv Med Phys & Readaptat, Clamart, France; [Genet, Francois] Hop Raymond Poincare, Serv Med Phys & Readaptat, Garches, France; [Genet, Francois] Univ Versailles St Quentin Yvelines End Icap, INSERM, UFR Sci Sante Simone Veil, U1179, Montigny Le Bretonneux, France	Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Genet, F (corresponding author), Hop Instruct Armees Percy, Serv Sante Armees, Serv Med Phys & Readaptat, Clamart, France.; Genet, F (corresponding author), Hop Raymond Poincare, Serv Med Phys & Readaptat, Garches, France.; Genet, F (corresponding author), Univ Versailles St Quentin Yvelines End Icap, INSERM, UFR Sci Sante Simone Veil, U1179, Montigny Le Bretonneux, France.	francois.genet@aphp.fr		Genet, Francois/0000-0001-9732-7410				ACKMAN JB, 1995, SKELETAL RADIOL, V24, P395; Almangour W, 2016, ANN PHYS REHABIL MED, V59, P263, DOI 10.1016/j.rehab.2016.03.009; Chen HC, 2009, BURNS, V35, P857, DOI 10.1016/j.burns.2008.03.002; Coons David, 2013, Burns, V39, pe34, DOI 10.1016/j.burns.2012.10.014; ELLEDGE ES, 1988, J TRAUMA, V28, P684, DOI 10.1097/00005373-198805000-00023; EVANS EB, 1966, J BONE JOINT SURG AM, VA 48, P643, DOI 10.2106/00004623-196648040-00002; EVANS EB, 1991, CLIN ORTHOP RELAT R, P94; Genet F, 2015, SPINAL CORD, V53, P340, DOI 10.1038/sc.2015.20; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023129; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016632; Holguin P. H., 1996, Journal of Burn Care and Rehabilitation, V17, P150, DOI 10.1097/00004630-199603000-00009; Hunt JL, 2006, J BURN CARE RES, V27, P535, DOI 10.1097/01.BCR.0000226023.58438.14; Klein MB, 2007, J BURN CARE RES, V28, P447, DOI 10.1097/BCR.0B013E318053D378; Levi B, 2015, J TRAUMA ACUTE CARE, V79, P870, DOI 10.1097/TA.0000000000000838; Medina A, 2014, J BURN CARE RES, V35, P251, DOI 10.1097/BCR.0b013e3182957768; Nauth A, 2012, J ORTHOP TRAUMA, V26, P684, DOI 10.1097/BOT.0b013e3182724624; Nelson ER, 2012, J BURN CARE RES, V33, P463, DOI 10.1097/BCR.0b013e31825af547; Orchard GR, 2015, J BURN CARE RES, V36, P465, DOI 10.1097/BCR.0000000000000123; Pasquereau A, 2014, HOSPITALISATIONS BRU; Peterson JR, 2014, ANN SURG, V259, P993, DOI 10.1097/SLA.0b013e318291da85; PETERSON SL, 1989, J TRAUMA, V29, P365, DOI 10.1097/00005373-198903000-00015; PROULX R, 1972, UNION MED CAN, V101, P282; RAY TD, 1995, SKELETAL RADIOL, V24, P609; Richards AM, 1997, BURNS, V23, P64, DOI 10.1016/S0305-4179(96)00074-5; Rigout A, 2009, FRANCE METROPOLITAIN, P1; RUBIN MM, 1986, J ORAL MAXIL SURG, V44, P897, DOI 10.1016/0278-2391(86)90228-4; Salga M, 2015, SKELETAL RADIOL, V44, P233, DOI 10.1007/s00256-014-2003-6; Schurch B, 1998, SPINAL CORD, V36, P78, DOI 10.1038/sj.sc.3100561; Shafer DM, 2008, BURNS, V34, P355, DOI 10.1016/j.burns.2007.04.006; Vaishya R, CUREUS, V8; VanLaeken N, 1989, J Burn Care Rehabil, V10, P331, DOI 10.1097/00004630-198907000-00008; Zynnurodlu M, 2008, EUR J PHYS REHAB MED, V44, P81	32	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0182303	10.1371/journal.pone.0182303	http://dx.doi.org/10.1371/journal.pone.0182303			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28777823	Green Submitted, Green Published, gold			2022-12-26	WOS:000406944300027
J	Carmichael, SL; Kan, PY; Padula, AM; Rehkopf, DH; Oehlert, JW; Mayo, JA; Weber, AM; Wise, PH; Shaw, GM; Stevenson, DK				Carmichael, Suzan L.; Kan, Peiyi; Padula, Amy M.; Rehkopf, David H.; Oehlert, John W.; Mayo, Jonathan A.; Weber, Ann M.; Wise, Paul H.; Shaw, Gary M.; Stevenson, David K.			Social disadvantage and the black-white disparity in spontaneous preterm delivery among California births	PLOS ONE			English	Article							HEALTH DISPARITIES; RACIAL DISPARITIES; SOCIOECONOMIC DISPARITIES; RESIDENTIAL SEGREGATION; INCOME INEQUALITY; INTERVENTIONS; OUTCOMES	We examined the contribution of social disadvantage to the black-white disparity in preterm birth. Analyses included linked vital and hospital discharge records from 127,358 black and 615,721 white singleton California births from 2007-11. Odds ratios (OR) were estimated by 4 logistic regression models for 2 outcomes: early (< 32 wks) and moderate (32-36 wks) spontaneous preterm birth (ePTB, mPTB), stratified by 2 race-ethnicity groups (blacks and whites). We then conducted a potential impact analysis. The OR for less than high school education (vs. college degree) was 1.8 (95% confidence interval 1.6, 2.1) for ePTB among whites but smaller for the other 3 outcome groups (ORs 1.3-1.4). For all 4 groups, higher census tract poverty was associated with increased odds (ORs 1.03-1.05 per 9% change in poverty). Associations were less noteworthy for the other variables (payer, and tract percent black and Gini index of income inequality). Setting 3 factors (education, poverty, payer) to 'favorable' values was associated with lower predicted probability of ePTB (25% lower among blacks, 31% among whites) but a 9% higher disparity, compared to probabilities based on observed values; for mPTB, respective percentages were 28% and 13% lower probability, and 17% lower disparity. Results suggest that social determinants contribute to preterm delivery and its disparities, and that future studies should focus on ePTB and more specific factors related to social circumstances.	[Carmichael, Suzan L.; Kan, Peiyi; Oehlert, John W.; Mayo, Jonathan A.; Weber, Ann M.; Wise, Paul H.; Shaw, Gary M.; Stevenson, David K.] Stanford Univ, Sch Med, Dept Pediat, Div Neonatal & Dev Med, Stanford, CA 94305 USA; [Padula, Amy M.] Univ Calif San Francisco, Sch Med, Div Maternal Fetal Med, San Francisco, CA USA; [Rehkopf, David H.] Stanford Univ, Sch Med, Dept Med, Div Gen Med Disciplines, Stanford, CA 94305 USA	Stanford University; University of California System; University of California San Francisco; Stanford University	Carmichael, SL (corresponding author), Stanford Univ, Sch Med, Dept Pediat, Div Neonatal & Dev Med, Stanford, CA 94305 USA.	scarmichael@stanford.edu		Rehkopf, David/0000-0002-7597-6513; Shaw, Gary/0000-0001-7438-4914	March of Dimes Prematurity Research Center at Stanford [MOD PR625253]; Stanford Child Health Research Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES021470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG047280] Funding Source: NIH RePORTER	March of Dimes Prematurity Research Center at Stanford(March of Dimes); Stanford Child Health Research Institute; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the March of Dimes Prematurity Research Center at Stanford (MOD PR625253) and the Stanford Child Health Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Garcia D, 2008, AM J EPIDEMIOL, V168, P1255, DOI 10.1093/aje/kwn290; Ahern J, 2016, AM J PUBLIC HEALTH, V106, P1938, DOI 10.2105/AJPH.2016.303425; Ahern J, 2009, AM J EPIDEMIOL, V169, P1140, DOI 10.1093/aje/kwp015; Blumenshine P, 2010, AM J PREV MED, V39, P263, DOI 10.1016/j.amepre.2010.05.012; Braveman P, 2006, ANNU REV PUBL HEALTH, V27, P167, DOI 10.1146/annurev.publhealth.27.021405.102103; Braveman PA, 2015, AM J PUBLIC HEALTH, V105, P694, DOI 10.2105/AJPH.2014.302008; Carmichael SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094153; Culhane JF, 2011, SEMIN PERINATOL, V35, P234, DOI 10.1053/j.semperi.2011.02.020; Galea S, 2011, AM J PUBLIC HEALTH, V101, P1456, DOI 10.2105/AJPH.2010.300086; Hebert PL, 2017, HEALTH SERV RES, V52, P826, DOI 10.1111/1475-6773.12514; Hernan MA, 2016, ANN EPIDEMIOL, V26, P674, DOI 10.1016/j.annepidem.2016.08.016; Kaufman JS, 1997, EPIDEMIOLOGY, V8, P621, DOI 10.1097/00001648-199710000-00002; Kramer MR, 2008, PUBLIC HEALTH REP, V123, P576, DOI 10.1177/003335490812300507; Kramer MR, 2010, SOC SCI MED, V71, P2108, DOI 10.1016/j.socscimed.2010.09.011; Kramer MR, 2009, EPIDEMIOL REV, V31, P178, DOI 10.1093/epirev/mxp001; Kramer MR, 2009, EPIDEMIOL REV, V31, P84, DOI 10.1093/ajerev/mxp003; Krieger N, 2003, AM J PUBLIC HEALTH, V93, P1655, DOI 10.2105/AJPH.93.10.1655; Krieger N, 2005, AM J PUBLIC HEALTH, V95, P312, DOI 10.2105/AJPH.2003.032482; Messer LC, 2006, J URBAN HEALTH, V83, P1041, DOI 10.1007/s11524-006-9094-x; Messer LC, 2010, AM J EPIDEMIOL, V171, P664, DOI 10.1093/aje/kwp435; Nkansah-Amankra S, 2010, MATERN CHILD HLTH J, V14, P774, DOI 10.1007/s10995-009-0508-8; Olson ME, 2010, PEDIATRICS, V126, P1165, DOI 10.1542/peds.2009-3378; Osterman MJK, 2015, PEDIATRICS, V135, P1115, DOI 10.1542/peds.2015-0434; Osypuk TL, 2008, AM J EPIDEMIOL, V167, P1295, DOI 10.1093/aje/kwn043; Pickett KE, 2005, SOC SCI MED, V60, P2229, DOI 10.1016/j.socscimed.2004.10.023; Rehkopf DH, 2006, AM J PUBLIC HEALTH, V96, P2135, DOI 10.2105/AJPH.2005.075408; VanderWeele TJ, 2014, EPIDEMIOLOGY, V25, P473, DOI 10.1097/EDE.0000000000000105; Wallace ME, 2016, MATERN CHILD HLTH J, V20, P164, DOI 10.1007/s10995-015-1816-9; Yasmeen S, 2006, AM J OBSTET GYNECOL, V194, P992, DOI 10.1016/j.ajog.2005.08.058	29	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0182862	10.1371/journal.pone.0182862	http://dx.doi.org/10.1371/journal.pone.0182862			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD3KL	28800643	Green Published, Green Submitted, gold			2022-12-26	WOS:000407431800032
J	Bektik, E; Dennis, A; Prasanna, P; Madabhushi, A; Fu, JD				Bektik, Emre; Dennis, Adrienne; Prasanna, Prateek; Madabhushi, Anant; Fu, Ji-Dong			Single cell qPCR reveals that additional HAND2 and microRNA-1 facilitate the early reprogramming progress of seven-factor-induced human myocytes	PLOS ONE			English	Article							CARDIOMYOCYTE-LIKE CELLS; CARDIAC FIBROBLASTS; DIRECT CONVERSION; GATA4; MEF2C; INDUCTION	The direct reprogramming of cardiac fibroblasts into induced cardiomyocyte (CM)-like cells (iCMs) holds great promise in restoring heart function. We previously found that human fibroblasts could be reprogrammed toward CM-like cells by 7 reprogramming factors; however, iCM reprogramming in human fibroblasts is both more difficult and more time-intensive than that in mouse cells. In this study, we investigated if additional reprogramming factors could quantitatively and/or qualitatively improve 7-factor-mediated human iCM reprogramming by single-cell quantitative PCR. We first validated 46 pairs of TaqMan (R) primers/probes that had sufficient efficiency and sensitivity to detect the significant difference of gene expression between individual H9 human embryonic stem cell (ESC)-differentiated CMs (H9CMs) and human fibroblasts. The expression profile of these 46 genes revealed an improved reprogramming in 12-week iCMs compared to 4-week iCMs reprogrammed by 7 factors, indicating a prolonged stochastic phase during human iCM reprogramming. Although none of additional one reprogramming factor yielded a greater number of iCMs, our single-cell qPCR revealed that additional HAND2 or microRNA-1 could facilitate the silencing of fibroblast genes and yield a better degree of reprogramming in more reprogrammed iCMs. Noticeably, the more HAND2 expressed, the higher-level were cardiac genes activated in 7Fs+HAND2-reprogrammed iCMs. In conclusion, HAND2 and microRNA-1 could help 7 factors to facilitate the early progress of iCM-reprogramming from human fibroblasts. Our study provides valuable information to further optimize a method of direct iCM-reprogramming in human cells.	[Bektik, Emre; Dennis, Adrienne; Fu, Ji-Dong] Case Western Reserve Univ, Dept Med, Heart & Vasc Res Ctr, MetroHlth Campus, Cleveland, OH 44106 USA; [Bektik, Emre] Univ Tsukuba, Sch Integrat & Global Majors, Tsukuba, Ibaraki, Japan; [Prasanna, Prateek; Madabhushi, Anant] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA	Case Western Reserve University; MetroHealth System; University of Tsukuba; Case Western Reserve University	Fu, JD (corresponding author), Case Western Reserve Univ, Dept Med, Heart & Vasc Res Ctr, MetroHlth Campus, Cleveland, OH 44106 USA.	jidong.fu@case.edu	Bektik, Emre/GVT-7741-2022; Bektik, Emre/AAF-4122-2021; Prasanna, Prateek/Y-5136-2019; Madabhushi, Anant/AAG-2908-2019	Madabhushi, Anant/0000-0002-5741-0399; Prasanna, Prateek/0000-0002-3068-3573; Fu, Jidong/0000-0003-2797-5193; Bektik, Emre/0000-0002-3558-2886	MetroHealth System; American Heart Association [13SDG14580035]; National Institutes of Health (NIH) [R01HL139006]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL139006] Funding Source: NIH RePORTER	MetroHealth System; American Heart Association(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Start-up Fund from The MetroHealth System (J.D.F.) and grants from the American Heart Association-13SDG14580035 (J.D.F.) and the National Institutes of Health (NIH)-R01HL139006 (J.D.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis RC, 2013, NAT MED, V19, P829, DOI 10.1038/nm.3225; Addis RC, 2013, J MOL CELL CARDIOL, V60, P97, DOI 10.1016/j.yjmcc.2013.04.004; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Chien KR, 2012, J MOL CELL CARDIOL, V53, P311, DOI 10.1016/j.yjmcc.2012.06.010; Christoforou N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063577; Ennen M, 2015, ONCOGENE, V34, P3251, DOI 10.1038/onc.2014.262; Fu JD, 2015, CIRC J, V79, P245, DOI 10.1253/circj.CJ-14-1372; Fu JD, 2013, STEM CELL REP, V1, P235, DOI 10.1016/j.stemcr.2013.07.005; Go AS, 2013, CIRCULATION, V127, P143, DOI 10.1161/CIR.0b013e318282ab8f; Hirai H, 2014, CARDIOVASC RES, V102, P188, DOI 10.1093/cvr/cvu023; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Ifkovits JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089678; Inagawa K, 2012, CIRC RES, V111, P1147, DOI 10.1161/CIRCRESAHA.112.271148; Jayawardena TM, 2012, CIRC RES, V110, P1465, DOI 10.1161/CIRCRESAHA.112.269035; Kikuchi K, 2012, ANNU REV CELL DEV BI, V28, P719, DOI 10.1146/annurev-cellbio-101011-155739; Kita-Matsuo H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005046; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Margariti A, 2012, P NATL ACAD SCI USA, V109, P13793, DOI 10.1073/pnas.1205526109; Mathison M, 2014, J THORAC CARDIOV SUR, V148, P1656, DOI 10.1016/j.jtcvs.2014.03.033; Mathison M, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.005652; Mohamed T. M., 2016, CIRCULATION; Nam YJ, 2013, P NATL ACAD SCI USA, V110, P5588, DOI 10.1073/pnas.1301019110; Protze S, 2012, J MOL CELL CARDIOL, V53, P323, DOI 10.1016/j.yjmcc.2012.04.010; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Ramalingam N, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00070; Snider P, 2009, CIRC RES, V105, P934, DOI 10.1161/CIRCRESAHA.109.201400; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Srivastava D, 2016, CELL, V166, P1386, DOI 10.1016/j.cell.2016.08.055; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Szulwach KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135007; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wada R, 2013, P NATL ACAD SCI USA, V110, P12667, DOI 10.1073/pnas.1304053110; Wang L, 2015, CIRC RES, V116, P237, DOI 10.1161/CIRCRESAHA.116.305547; Yamakawa H, 2015, STEM CELL REPORTS; Zhao YB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9243; Zhou Y, 2016, CELL STEM CELL, V18, P382, DOI 10.1016/j.stem.2016.02.003	38	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0183000	10.1371/journal.pone.0183000	http://dx.doi.org/10.1371/journal.pone.0183000			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796841	gold, Green Published, Green Submitted			2022-12-26	WOS:000407396200139
J	Kraft, P; Schuhmann, MK; Garz, C; Jandke, S; Urlaub, D; Mencl, S; Zernecke, A; Heinze, HJ; Carare, RO; Kleinschnitz, C; Schreiber, S				Kraft, Peter; Schuhmann, Michael K.; Garz, Cornelia; Jandke, Solveig; Urlaub, Daniela; Mencl, Stine; Zernecke, Alma; Heinze, Hans-Jochen; Carare, Roxana O.; Kleinschnitz, Christoph; Schreiber, Stefanie			Hypercholesterolemia induced cerebral small vessel disease	PLOS ONE			English	Article							RECEPTOR KNOCKOUT MICE; DENSITY-LIPOPROTEIN RECEPTOR; INTRACEREBRAL HEMORRHAGE; STATIN USE; RISK; STROKE; ATHEROSCLEROSIS; METAANALYSIS; MICROBLEEDS; CHOLESTEROL	Background While hypercholesterolemia plays a causative role for the development of ischemic stroke in large vessels, its significance for cerebral small vessel disease (CSVD) remains unclear. We thus aimed to understand the detailed relationship between hypercholesterolemia and CSVD using the well described Ldlr(-/-) mouse model. Methods We used Ldlr(-/-) mice (n = 16) and wild-type (WT) mice (n = 15) at the age of 6 and 12 months. Ldlr(-/-) mice develop high plasma cholesterol levels following a high fat diet. We analyzed cerebral capillaries and arterioles for intravascular erythrocyte accumulations, thrombotic vessel occlusions, blood-brain barrier (BBB) dysfunction and microbleeds. Results We found a significant increase in the number of erythrocyte stases in 6 months old Ldlr(-/-) mice compared to all other groups (P < 0.05). Ldlr(-/-) animals aged 12 months showed the highest number of thrombotic occlusions while in WT animals hardly any occlusions could be observed (P < 0.001). Compared to WT mice, Ldlr(-/-) mice did not display significant gray matter BBB breakdown. Microhemorrhages were observed in one Ldlr(-/-) mouse that was 6 months old. Results did not differ when considering subcortical and cortical regions. Conclusions In Ldlr(-/-) mice, hypercholesterolemia is related to a thrombotic CSVD phenotype, which is different from hypertension-related CSVD that associates with a hemorrhagic CSVD phenotype. Our data demonstrate a relationship between hypercholesterolemia and the development of CSVD. Ldlr(-/-) mice appear to be an adequate animal model for research into CSVD.	[Kraft, Peter; Schuhmann, Michael K.; Urlaub, Daniela; Kleinschnitz, Christoph] Univ Hosp Wurzburg, Dept Neurol, Wurzburg, Germany; [Kraft, Peter] Univ Wurzburg, Comprehens Heart Failure Ctr, Wurzburg, Germany; [Kraft, Peter] Klinikum Main Spessart, Lohr, Germany; [Garz, Cornelia; Jandke, Solveig; Heinze, Hans-Jochen; Schreiber, Stefanie] German Ctr Neurodegenerat Dis DZNE, Magdeburg, Germany; [Garz, Cornelia; Jandke, Solveig; Heinze, Hans-Jochen; Schreiber, Stefanie] Otto von Guericke Univ, Dept Neurol, Magdeburg, Germany; [Mencl, Stine; Kleinschnitz, Christoph] Univ Hosp Essen, Dept Neurol, Essen, Germany; [Zernecke, Alma] Univ Hosp Wurzburg, Inst Clin Biochem & Pathobiochem, Wurzburg, Germany; [Carare, Roxana O.] Univ Southampton, Fac Med, Southampton, Hants, England	University of Wurzburg; University of Wurzburg; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Otto von Guericke University; University of Duisburg Essen; University of Wurzburg; University of Southampton	Kraft, P (corresponding author), Univ Hosp Wurzburg, Dept Neurol, Wurzburg, Germany.; Kraft, P (corresponding author), Univ Wurzburg, Comprehens Heart Failure Ctr, Wurzburg, Germany.; Kraft, P (corresponding author), Klinikum Main Spessart, Lohr, Germany.	kraft_p1@ukw.de	Schreiber, Stefanie/S-3223-2019	Schreiber, Stefanie/0000-0003-4439-4374; Kleinschnitz, Christoph/0000-0002-1650-8875	Deutsche Forschungsgemeinschaft [SFB688, TPA22]; Interdisziplinares Zentrum fur Klinische Forschung der Universitat Wurzburg [E-179]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Interdisziplinares Zentrum fur Klinische Forschung der Universitat Wurzburg	This project was supported by the Deutsche Forschungsgemeinschaft (SFB688, TPA22) and the Interdisziplinares Zentrum fur Klinische Forschung der Universitat Wurzburg (project E-179 to Drs Kleinschnitz and Zernecke-Madsen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braunwald E, 1997, NEW ENGL J MED, V337, P1360, DOI 10.1056/NEJM199711063371906; Carare RO, 2008, NEUROPATH APPL NEURO, V34, P131, DOI 10.1111/j.1365-2990.2007.00926.x; de la Sierra A, 2015, ADV THER, V32, P944, DOI 10.1007/s12325-015-0252-y; Ferroni P, 2004, ANTIOXID REDOX SIGN, V6, P747, DOI 10.1089/1523086041361587; Getz GS, 2012, ARTERIOSCL THROM VAS, V32, P1104, DOI 10.1161/ATVBAHA.111.237693; Haussen DC, 2012, STROKE, V43, P2677, DOI 10.1161/STROKEAHA.112.657486; Huisa BN, 2015, STROKE, V46, P2413, DOI 10.1161/STROKEAHA.115.009589; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Ishikawa M, 2004, CIRC RES, V94, P239, DOI 10.1161/01.RES.0000111524.05779.60; Khan U, 2007, J NEUROL NEUROSUR PS, V78, P702, DOI 10.1136/jnnp.2006.103549; Kraft P, 2015, STROKE, V46, P3502, DOI 10.1161/STROKEAHA.115.011114; Kurasawa JH, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.468108; Langbein H, 2015, ATHEROSCLEROSIS SUPP, V18, P59, DOI 10.1016/j.atherosclerosissup.2015.02.010; Lei C, 2014, EUR J NEUROL, V21, P192, DOI 10.1111/ene.12273; Lindley RI, 2009, LANCET NEUROL, V8, P628, DOI 10.1016/S1474-4422(09)70131-0; Lopes FG, 2013, MICROVASC RES, V85, P99, DOI 10.1016/j.mvr.2012.10.009; McKinney JS, 2012, STROKE, V43, P2149, DOI 10.1161/STROKEAHA.112.655894; Michalski D, 2010, BRAIN RES, V1359, P186, DOI 10.1016/j.brainres.2010.08.045; Morotti A, 2016, STROKE, V47, P2141, DOI 10.1161/STROKEAHA.116.013722; Ohwaki K, 2013, CLIN NEUROL NEUROSUR, V115, P669, DOI 10.1016/j.clineuro.2012.07.025; Rabelo LA, 2003, BRIT J PHARMACOL, V138, P1215, DOI 10.1038/sj.bjp.0705164; Rodrigues SF, 2014, HYPERTENSION, V63, P747, DOI 10.1161/HYPERTENSIONAHA.113.02627; Rodriguez-Luna D, 2011, STROKE, V42, P2447, DOI 10.1161/STROKEAHA.110.609461; Romero JR, 2014, STROKE, V45, P1492, DOI 10.1161/STROKEAHA.114.004130; Schreiber S, 2012, J CEREBR BLOOD F MET, V32, P278, DOI 10.1038/jcbfm.2011.122; Song SH, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0808-3; Van Damme EJM, 2004, PLANT J, V37, P34, DOI 10.1046/j.1365-313X.2003.01929.x; Wardlaw JM, 2013, LANCET NEUROL, V12, P483, DOI 10.1016/S1474-4422(13)70060-7; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570; Zhang CE, 2017, NEUROLOGY, V88, P426, DOI 10.1212/WNL.0000000000003556; Zhang XY, 2014, ARTERIOSCL THROM VAS, V34, P587, DOI 10.1161/ATVBAHA.113.302868	31	26	28	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182822	10.1371/journal.pone.0182822	http://dx.doi.org/10.1371/journal.pone.0182822			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796818	Green Submitted, Green Published, gold			2022-12-26	WOS:000407396200102
J	Moiseeva, E; Rabinowitz, C; Paz, G; Rinkevich, B				Moiseeva, Elizabeth; Rabinowitz, Claudette; Paz, Guy; Rinkevich, Baruch			Histological study on maturation, fertilization and the state of gonadal region following spawning in the model sea anemone, Nematostella vectensis	PLOS ONE			English	Article							EXPRESSION PATTERNS; GENE-EXPRESSION; OOCYTE NUCLEI; STARLET; KARYOSPHERE; OOGENESIS; CNIDARIAN; REPRODUCTION; REGENERATION; STEPHENSON	The starlet sea-anemone Nematostella vectensis has emerged as a model organism in developmental biology. Still, our understanding of various biological features, including reproductive biology of this model species are in its infancy. Consequently, through histological sections, we study here key stages of the oogenesis (oocyte maturation/fertilization), as the state of the gonad region immediately after natural spawning. Germ cells develop in a secluded mesenterial gastrodermal zone, where the developing oocytes are surrounded by mucoid glandular cells and trophocytes (accessory cells). During vitellogenesis, the germinal vesicle in oocytes migrates towards the animal pole and the large polarized oocytes begin to mature, characterized by karyosphere formation. Then, the karyosphere breaks down, the chromosomes form the metaphase plate I and the eggs are extruded from the animal enclosed in a sticky, jelly-like mucoid mass, along with numerous nematosomes. Fertilization occurs externally at metaphase II via swimming sperm extruded by males during natural spawning. The polar bodies are ejected from the eggs and are situated within a narrow space between the egg's vitelline membrane and the adjacent edge of the jelly coat. The cortical reaction occurs only at the polar bodies' ejection site. Several spermatozoa can penetrate the same egg. Fertilization is accompanied by a strong ooplasmatic segregation. Immediately after spawning, the gonad region holds many previtellogenic and vitellogenic oocytes, though no oocytes with karyosphere. Above are the first histological descriptions for egg maturation, meiotic chromosome's status at fertilization, fertilization and the gonadal region's state following spawning, also documenting for the first time the ejection of the polar body.	[Moiseeva, Elizabeth; Rabinowitz, Claudette; Paz, Guy; Rinkevich, Baruch] Natl Inst Oceanog, Israel Oceanog & Limnol Res, Haifa, Israel	Israel Oceanographic & Limnological Research Institute	Rinkevich, B (corresponding author), Natl Inst Oceanog, Israel Oceanog & Limnol Res, Haifa, Israel.	buki@ocean.org.il			Ministry of National Infrastructures, Energy and Water Resources in Israel	Ministry of National Infrastructures, Energy and Water Resources in Israel	This work was supported by the Ministry of National Infrastructures, Energy and Water Resources in Israel.; We thank the laboratory members for animals maintenance. This study was supported by a grant from the Ministry of National Infrastructures, Energy and Water Resources in Israel.	Abbineni PS, 2013, BIOL BULL-US, V224, P200, DOI 10.1086/BBLv224n3p200; ABE H, 1992, ROUX ARCH DEV BIOL, V201, P179, DOI 10.1007/BF00188717; Amiel A., 2010, OOGENESIS UNIVERSAL, P81; Batalova FM, 2010, CELL BIOL INT, V34, P1163, DOI 10.1042/CBI20090434; Belousoff LV, 1998, DINAMICS ARCHITECTUR; Beloussov LV, 1988, LECT THEORETICAL BIO, P55; Bocharova E., 2016, CNIDARIA PRESENT FUT, P239; Bocharova ES, 2011, ZOOL ZH, V90, P1283; Bogolyubov D, 2000, CHROMOSOMA, V109, P415, DOI 10.1007/s004120000090; Bogolyubov D, 2001, TISSUE CELL, V33, P549, DOI 10.1054/tice.2001.0210; Burton PM, 2009, DEV GENES EVOL, V219, P79, DOI 10.1007/s00427-009-0271-2; Byrum C.A., 2004, P33; CARRE D, 1981, BIOL CELL, V40, P119; CHATLYNNE LG, 1969, BIOL BULL-US, V136, P167, DOI 10.2307/1539811; Cinelli LP, 2010, GLYCOBIOLOGY, V20, P702, DOI 10.1093/glycob/cwq017; CLARK WH, 1974, AM ZOOL, V14, P495; Darling JA, 2005, BIOESSAYS, V27, P211, DOI 10.1002/bies.20181; Eckelbarger KJ, 2008, INVERTEBR BIOL, V127, P381, DOI 10.1111/j.1744-7410.2008.00146.x; ECKELBARGER KJ, 1988, MAR BIOL, V100, P103, DOI 10.1007/BF00392960; Extavour CG, 2005, EVOL DEV, V7, P201, DOI 10.1111/j.1525-142X.2005.05023.x; Fautin DG, 2002, CAN J ZOOL, V80, P1735, DOI 10.1139/Z02-133; Finnerty JR, 2004, SCIENCE, V304, P1335, DOI 10.1126/science.1091946; Finnerty JR, 1999, EVOL DEV, V1, P16, DOI 10.1046/j.1525-142x.1999.99010.x; FRANK P, 1976, J NAT HIST, V10, P441, DOI 10.1080/00222937600770331; Fraune S, 2016, SCIENCE, V3, P148; FREEMAN G, 1982, DEV BIOL, V94, P142, DOI 10.1016/0012-1606(82)90077-X; FREEMAN G, 1981, ROUX ARCH DEV BIOL, V190, P168, DOI 10.1007/BF00867804; Fritzenwanker JH, 2007, DEV BIOL, V310, P264, DOI 10.1016/j.ydbio.2007.07.029; Fritzenwanker JH, 2002, DEV GENES EVOL, V212, P99, DOI 10.1007/s00427-002-0214-7; Frizenwanker GH, 2004, DEV BIOL, V275, P389; GALL JG, 1995, DEV GENET, V16, P25, DOI 10.1002/dvg.1020160107; Genikhovich G, 2009, COLD SPRING HARBOR P; Genikhovich G., 2009, COLD SPRING HARB PRO, V2009, P5282, DOI DOI 10.1101/PDB.PR0T5282; Gilbert S.F., 2000, DEV BIOL; Ginsburg A. S, 1968, FERTILIZATION FISHES; Ginsburg AS, 1985, EVOLUTION MORPHOGEN, P459; Goldstone JV, 2008, CELL BIOL TOXICOL, V24, P483, DOI 10.1007/s10565-008-9107-5; Gruzova M. N., 1988, OOCYTE GROWTH MATURA, P77; GRUZOVA MN, 1975, TSITOLOGIYA+, V17, P219; GRUZOVA MN, 1977, J CELL SCI, V28, P1; GRUZOVA MN, 1993, INT REV CYTOL, V144, P1, DOI 10.1016/S0074-7696(08)61512-0; HAND C, 1994, ESTUARIES, V17, P501, DOI 10.2307/1352679; HAND C, 1992, BIOL BULL, V182, P169, DOI 10.2307/1542110; Harter VL, 2005, B ENVIRON CONTAM TOX, V74, P830, DOI 10.1007/s00128-005-0656-5; JONDEUNG A, 1982, HISTOCHEMISTRY, V76, P123, DOI 10.1007/BF00493291; KUBRAKIEWICZ J, 1995, CHROMOSOMA, V103, P606; Kumburegama Shalika, 2008, V469, P55, DOI 10.1007/978-1-60327-469-2_6; Layden MJ, 2016, WIRES DEV BIOL, V5, P408, DOI 10.1002/wdev.222; Lee PN, 2007, DEV BIOL, V310, P169, DOI 10.1016/j.ydbio.2007.05.040; Levitan S, 2015, PROTEOMICS, V15, P4096, DOI 10.1002/pmic.201500255; Lillie R D, 1954, HISTOPATHOLOGICAL TE; Marlow HQ, 2009, DEV NEUROBIOL, V69, P235, DOI 10.1002/dneu.20698; Martindale MQ, 2004, DEVELOPMENT, V131, P2463, DOI 10.1242/dev.01119; Masui Y., 1985, P189; Matus DQ, 2008, DEV BIOL, V313, P501, DOI 10.1016/j.ydbio.2007.09.032; NODA K, 1981, DEV GROWTH DIFFER, V23, P401; PARFENOV V, 1989, GAMETE RES, V22, P219, DOI 10.1002/mrd.1120220209; Pearse A.G.E., 1960, HISTOCHEMISTRY THEOR; Pochukalina GN, 2014, ANN RES REV BIOL, V4, P79; Primus A, 2004, BIOESSAYS, V26, P474, DOI 10.1002/bies.20031; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Rabinowitz C, 2016, CELL TISSUE RES, V366, P693, DOI 10.1007/s00441-016-2495-6; Reitzel AM, 2007, INVERTEBR BIOL, V126, P99, DOI 10.1111/j.1744-7410.2007.00081.x; Saina M, 2009, P NATL ACAD SCI USA, V106, P18592, DOI 10.1073/pnas.0900151106; Scholz CB, 2003, DEV GENES EVOL, V212, P563, DOI 10.1007/s00427-002-0272-x; Stefanik DJ, 2013, NAT PROTOC, V8, P916, DOI 10.1038/nprot.2013.044; Sullivan JC, 2006, NUCLEIC ACIDS RES, V34, pD495, DOI 10.1093/nar/gkj020; Tucker RP, 2011, INVERTEBR BIOL, V130, P11, DOI 10.1111/j.1744-7410.2010.00219.x; Uhlinger KR., 1997, THESIS; Vilela-Silva ACES, 2002, J BIOL CHEM, V277, P379, DOI 10.1074/jbc.M108496200; Watanabe H, 2009, SEMIN CELL DEV BIOL, V20, P1114, DOI 10.1016/j.semcdb.2009.09.008; Wilcox JA, 2001, THESIS; WILLIAMS RB, 1975, J NAT HIST, V9, P51, DOI 10.1080/00222937500770051	73	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182677	10.1371/journal.pone.0182677	http://dx.doi.org/10.1371/journal.pone.0182677			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796817	Green Submitted, gold, Green Published			2022-12-26	WOS:000407396200078
J	Pasteuning-Vuhman, S; Putker, K; Tanganyika-de Winter, CL; Boertje-van der Meulen, JW; van Vliet, L; Overzier, M; Plomp, JJ; Aartsma-Rus, A; van Putten, M				Pasteuning-Vuhman, S.; Putker, K.; Tanganyika-de Winter, C. L.; Boertje-van der Meulen, J. W.; van Vliet, L.; Overzier, M.; Plomp, J. J.; Aartsma-Rus, A.; van Putten, M.			Natural disease history of mouse models for limb girdle muscular dystrophy types 2D and 2F	PLOS ONE			English	Article							SARCOGLYCAN-SARCOSPAN COMPLEX; GLYCOPROTEIN COMPLEX; ALPHA-SARCOGLYCAN; SMOOTH-MUSCLE; MDX MICE; HUNTINGTONS-DISEASE; EXPRESSION; INJURY; DEFICITS; THERAPY	Limb-girdle muscular dystrophy types 2D and 2F (LGMD 2D and 2F) are autosomal recessive disorders caused by mutations in the alpha-and delta sarcoglycan genes, respectively, leading to severe muscle weakness and degeneration. The cause of the disease has been well characterized and a number of animal models are available for pre-clinical studies to test potential therapeutic interventions. To facilitate transition from drug discovery to clinical trials, standardized procedures and natural disease history data were collected for these mouse models. Implementing the TREAD-NMD standardized operating procedures, we here subjected LGMD2D (SGCA-null), LGMD2F (SGCD-null) and wild type (C57BL/6J) mice to five functional tests from the age of 4 to 32 weeks. To assess whether the functional test regime interfered with disease pathology, sedentary groups were taken along. Muscle physiology testing of tibialis anterior muscle was performed at the age of 34 weeks. Muscle histopathology and gene expression was analysed in skeletal muscles and heart. Muscle histopathology and gene expression was analysed in skeletal muscles and heart. Mice successfully accomplished the functional tests, which did not interfere with disease pathology. Muscle function of SGCA-and SGCD-null mice was impaired and declined over time. Interestingly, female SGCD-null mice outperformed males in the two and four limb hanging tests, which proved the most suitable non-invasive tests to assess muscle function. Muscle physiology testing of tibialis anterior muscle revealed lower specific force and higher susceptibility to eccentric-induced damage in LGMD mice. Analyzing muscle histopathology and gene expression, we identified the diaphragm as the most affected muscle in LGMD strains. Cardiac fibrosis was found in SGCD-null mice, being more severe in males than in females. Our study offers a comprehensive natural history dataset which will be useful to design standardized tests and future pre-clinical studies in LGMD2D and 2F mice.	[Pasteuning-Vuhman, S.; Putker, K.; Tanganyika-de Winter, C. L.; Boertje-van der Meulen, J. W.; van Vliet, L.; Overzier, M.; Aartsma-Rus, A.; van Putten, M.] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Plomp, J. J.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Pasteuning-Vuhman, S (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands.	s.k.pasteuning@lumc.nl		Aartsma-Rus, Annemieke/0000-0003-1565-654X; Overzier, Maurice/0000-0002-8143-4884; van Putten, Maaike/0000-0002-0683-8897	ZonMw [113302001]; Neuromics (FP7) [2012305121]; AFM [20251]	ZonMw(Netherlands Organization for Health Research and Development); Neuromics (FP7); AFM(Association Francaise contre les Myopathies)	This work was supported by grants from ZonMw (Project 113302001) received by A. Aartsma-Rus, Neuromics (FP7, Agreement 2012305121) received by Prof. dr. A. Aartsma-Rus and AFM, 20251, dr. M. van Putten. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsma-Rus A, 2014, JOVE-J VIS EXP, DOI 10.3791/51303; Allen DL, 2011, MED SCI SPORT EXER, V43, P1828, DOI 10.1249/MSS.0b013e3182178bb4; Amthor H, 2007, P NATL ACAD SCI USA, V104, P1835, DOI 10.1073/pnas.0604893104; Angelini Corrado, 2014, Acta Myol, V33, P119; Barresi R, 2000, J BIOL CHEM, V275, P38554, DOI 10.1074/jbc.M007799200; Blain AM, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-13; Burks TN, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-19; Bushby Kate, 2009, Pract Neurol, V9, P314, DOI 10.1136/jnnp.2009.193938; Camerino GM, 2014, HUM MOL GENET, V23, P5720, DOI 10.1093/hmg/ddu287; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; Carter RJ, 1999, J NEUROSCI, V19, P3248; Ceco E, 2013, FEBS J, V280, P4198, DOI 10.1111/febs.12266; Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO;2-T; Consolino CM, 2004, J APPL PHYSIOL, V96, P633, DOI 10.1152/japplphysiol.00587.2003; Coral-Vazquez R, 1999, CELL, V98, P465, DOI 10.1016/S0092-8674(00)81975-3; Duclos F, 1998, J CELL BIOL, V142, P1461, DOI 10.1083/jcb.142.6.1461; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Fayssoil A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153095; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Hack AA, 2000, J CELL SCI, V113, P2535; Jakubiec-Puka A, 2005, ACTA BIOCHIM POL, V52, P453; Kemaladewi DU, 2012, FASEB J, V26, P1462, DOI 10.1096/fj.11-191189; Kirschner Janbernd, 2011, Handb Clin Neurol, V101, P41, DOI 10.1016/B978-0-08-045031-5.00003-7; Liu MJ, 2005, MOL THER, V11, P245, DOI 10.1016/j.ymthe.2004.09.013; Parsons SA, 2006, AM J PATHOL, V168, P1975, DOI 10.2353/ajpath.2006.051316; Pasteuning-Vuhman S, 2016, FASEB J OFFICIAL PUB; Pedemonte M, 1999, BIOCHEM BIOPH RES CO, V255, P466, DOI 10.1006/bbrc.1999.0213; Sejerson T, 2009, ADV EXP MED BIOL, V652, P13, DOI 10.1007/978-90-481-2813-6_2; Sharp PS, 2011, MOL THER, V19, P165, DOI 10.1038/mt.2010.213; Smith LR, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-21; Southwell AL, 2009, J NEUROSCI, V29, P13589, DOI 10.1523/JNEUROSCI.4286-09.2009; Spurney CF, 2009, MUSCLE NERVE, V39, P591, DOI 10.1002/mus.21211; Straub V, 1999, J BIOL CHEM, V274, P27989, DOI 10.1074/jbc.274.39.27989; Straub V, 1997, CURR OPIN NEUROL, V10, P168, DOI 10.1097/00019052-199704000-00016; Thompson R, 2016, NAT REV NEUROL, V12, P294, DOI 10.1038/nrneurol.2016.35; van der Pijl EM, 2016, EUR J NEUROSCI, V43, P1623, DOI 10.1111/ejn.13249; van Putten M, 2010, NEUROMUSCULAR DISORD, V20, P273, DOI 10.1016/j.nmd.2010.02.004; van Westrum SMS, 2014, MUSCLE NERVE, V50, P909, DOI 10.1002/mus.24233; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1; Whitmore C, 2014, INT J EXP PATHOL, V95, P365, DOI 10.1111/iep.12095	42	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182704	10.1371/journal.pone.0182704	http://dx.doi.org/10.1371/journal.pone.0182704			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797108	Green Published, gold			2022-12-26	WOS:000407396200085
J	Tao, JH; Cheng, M; Tang, JP; Dai, XJ; Zhang, Y; Li, XP; Liu, Q; Wang, YL				Tao, Jin-Hui; Cheng, Miao; Tang, Jiang-Ping; Dai, Xiao-Juan; Zhang, Yong; Li, Xiang-Pei; Liu, Qin; Wang, Ya-Ling			Single nucleotide polymorphisms associated with P2X7R function regulate the onset of gouty arthritis	PLOS ONE			English	Article							GAIN-OF-FUNCTION; P2X(7) RECEPTOR; ASYMPTOMATIC HYPERURICEMIA; URATE DEPOSITION; ATP; INTERLEUKIN-1-BETA; INFLAMMATION; MECHANISMS; CRYSTALS; TOPHUS	Background Gout is an inflammatory disease that is caused by the increased production of Interleukin-1 beta (IL-1 beta) stimulated by monosodium urate (MSU) crystals. However, some hyperuricemia patients, even gouty patients with tophi in the joints, never experience gout attack, which indicates that pathogenic pathways other than MSU participate in the secretion of IL-1 beta in the pathogenesis of acute gouty arthritis. The ATP-P2X7R-IL-1 beta axis may be one of these pathways. Objective This study examines the role of Adenosine triphosphate (ATP) in the pathogenesis of gout and the association of ATP receptor (P2X7R) function with single nucleotide polymorphisms and gout arthritis. Methods Non-synonymous single nucleotide polymorphisms (SNP) loci of P2X7R in Chinese people were screened to compare the frequencies of different alleles and genotype distribution of selective SNPs in 117 gouty patients and 95 hyperuricemia patients. Peripheral white blood cells were purified from the peripheral blood of 43 randomly selected gout patients and 36 hyperuricemia patients from the total group. Cells were cultured with MSU or MSU + ATP, and supernatants were collected for the detection of IL-1 beta concentrations using enzyme-linked immunosorbent assay (ELISA). Results 1. Eight SNP loci, including rs1653624, rs10160951, rs1718119, rs7958316, rs16950860, rs208294, rs17525809 and rs2230912, were screened and detected, and rs1653624, rs7958316 and rs17525809 were associated with gout arthritis. 2. IL-1 beta concentrations in supernatants after MSU + ATP stimulation were significantly higher in gouty patients than in the hyperuricemia group [(131.08 +/- 176.11) pg/ml vs. (50.84 +/- 86.10) pg/ml]; Patients (including gout and hyperuricemia) carrying the susceptibility genotype AA or AT of rs1653624 exhibited significantly higher concentrations of IL-1 beta than patients carrying the non-susceptibility genotype TT [(104.20 +/- 164.25) pg/ml vs. (21.90 +/- 12.14) pg/ml]; However, no differences were found with MSU stimulation alone. Conclusions ATP promotes the pathogenesis of gouty arthritis via increasing the secretion of IL-1 beta, and its receptor (P2X7R) function associated single nucleotide polymorphisms may be related to gouty arthritis, which indicates that ATP-P2X7R signaling pathway plays a significant regulatory role in the pathogenesis of gout.	[Tao, Jin-Hui; Cheng, Miao; Tang, Jiang-Ping; Dai, Xiao-Juan; Zhang, Yong; Li, Xiang-Pei; Liu, Qin; Wang, Ya-Ling] Anhui Med Univ, Dept Rheumatol & Immunol, Anhui Prov Hosp, Hefei, Anhui, Peoples R China	Anhui Medical University	Tao, JH (corresponding author), Anhui Med Univ, Dept Rheumatol & Immunol, Anhui Prov Hosp, Hefei, Anhui, Peoples R China.	tao2002055@126.com	tao, jinhui/AAA-8818-2020		Anhui Provincial Natural Science Foundation [1708085MH191]; National Natural Science Foundation of China [81671601]	Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was sponsored and funded by the Anhui Provincial Natural Science Foundation (1708085MH191) and grants from the National Natural Science Foundation of China (81671601).	Bhattacharya A, 2016, GLIA, V64, P1772, DOI 10.1002/glia.23001; Buell GN, 1998, RECEPTOR CHANNEL, V5, P347; Cabrini G, 2005, J IMMUNOL, V175, P82, DOI 10.4049/jimmunol.175.1.82; Campion E W, 1987, Am J Med, V82, P421, DOI 10.1016/0002-9343(87)90441-4; Chapman PT, 1997, ARTHRITIS RHEUM, V40, P955, DOI 10.1002/art.1780400525; Church LD, 2008, NAT CLIN PRACT RHEUM, V4, P34, DOI 10.1038/ncprheum0681; Dalbeth N, 2005, RHEUMATOLOGY, V44, P1090, DOI [10.1093/rheumatology/keh640, 10.1186/ar2952]; Dalbeth N, 2015, ANN RHEUM DIS, V74, P908, DOI 10.1136/annrheumdis-2014-206397; Dalbeth N, 2010, ARTHRITIS RHEUM-US, V62, P1549, DOI 10.1002/art.27356; De Miguel E, 2012, ANN RHEUM DIS, V71, P157, DOI 10.1136/ard.2011.154997; HALL AP, 1967, AM J MED, V42, P27, DOI 10.1016/0002-9343(67)90004-6; Hillman KA, 2005, NEPHRON EXP NEPHROL, V101, pE24, DOI 10.1159/000086036; Hirsch GA, 2012, J AM COLL CARDIOL, V59, P802, DOI 10.1016/j.jacc.2011.10.895; HOLLINGWORTH P, 1983, ARTHRITIS RHEUM, V26, P98, DOI 10.1002/art.1780260117; Howard RG, 2011, ARTHRIT CARE RES, V63, P1456, DOI 10.1002/acr.20527; Jiang LH, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00055; Jindrichova M, 2015, J NEUROCHEM, V133, P815, DOI 10.1111/jnc.13078; Marques-Da-Silva C, 2011, BRIT J PHARMACOL, V163, P912, DOI 10.1111/j.1476-5381.2011.01254.x; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2010, IMMUNOL REV, V233, P218, DOI 10.1111/j.0105-2896.2009.00860.x; Oyanguren-Desez O, 2011, CELL CALCIUM, V50, P468, DOI 10.1016/j.ceca.2011.08.002; PASCUAL E, 1995, BRIT J RHEUMATOL, V34, P724; Pineda C, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3223; Puig JG, 2008, NUCLEOS NUCLEOT NUCL, V27, P592, DOI 10.1080/15257770802136040; Qing YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064845; REDONDO MJL, 1993, DERMATOLOGY, V187, P140; Roger S, 2010, J PSYCHIATR RES, V44, P347, DOI 10.1016/j.jpsychires.2009.10.005; ROUAULT T, 1982, ARTHRITIS RHEUM, V25, P209, DOI 10.1002/art.1780250215; ROUBENOFF R, 1990, RHEUM DIS CLIN N AM, V16, P539; Ru LB, 2005, ARTHRITIS RHEUM-US, V52, P2936, DOI 10.1002/art.21238; Shemon AN, 2006, J BIOL CHEM, V281, P2079, DOI 10.1074/jbc.M507816200; SHMERLING RH, 1988, ARCH INTERN MED, V148, P1830, DOI 10.1001/archinte.148.8.1830; Sluyter R, 2004, J IMMUNOL, V172, P3399, DOI 10.4049/jimmunol.172.6.3399; Solini A, 2015, ONCOTARGET, V6, P28743, DOI 10.18632/oncotarget.4926; Sorge RE, 2012, NAT MED, V18, P595, DOI 10.1038/nm.2710; Stokes L, 2010, FASEB J, V24, P2916, DOI 10.1096/fj.09-150862; Sun Y, 2015, INT J RHEUM DIS, V18, P560, DOI 10.1111/1756-185X.12194; Tao JH, 2013, SEMIN ARTHRITIS RHEU, V43, P376, DOI 10.1016/j.semarthrit.2013.04.007; Ursu D, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-37; Wesselius A, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-64; Wiley JS, 2003, J BIOL CHEM, V278, P17108, DOI 10.1074/jbc.M212759200	41	21	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0181685	10.1371/journal.pone.0181685	http://dx.doi.org/10.1371/journal.pone.0181685			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797095	Green Published, gold, Green Submitted			2022-12-26	WOS:000407396200018
J	Tao, YQ; Fang, PF; Kim, S; Guo, M; Young, NL; Marshall, AG				Tao, Yeqing; Fang, Pengfei; Kim, Sunghoon; Guo, Min; Young, Nicolas L.; Marshall, Alan G.			Mapping the contact surfaces in the Lamin A: AIMP3 complex by hydrogen/deuterium exchange FT-ICR mass spectrometry	PLOS ONE			English	Article							ION-CYCLOTRON RESONANCE; TRANSFER-RNA SYNTHETASES; RESOLUTION; DIGESTION; PROTEINS; ZMPSTE24; CELL; METALLOPROTEINASE; ADVANTAGES; HOMOLOGY	Aminoacyl-tRNA synthetases-interacting multifunctional protein3 (AIMP3/p18) is involved in the macromolecular tRNA synthetase complex via its interaction with several aminoacyl-tRNA synthetases. Recent reports reveal a novel function of AIMP3 as a tumor suppressor by accelerating cellular senescence and causing defects in nuclear morphology. AIMP3 specifically mediates degradation of mature Lamin A (LmnA), a major component of the nuclear envelope matrix; however, the mechanism of how AIMP3 interacts with LmnA is unclear. Here we report solution-phase hydrogen/deuterium exchange (HDX) for AIMP3, LmnA, and AIMP3 in association with the LmnA C-terminus. Reversed-phase LC coupled with LTQ 14.5 T Fourier transform ion cyclotron resonance mass spectrometry (FT-ICR MS) results in high mass accuracy and resolving power for comparing the D-uptake profiles for AIMP3, LmnA, and their complex. The results show that the AIMP3-LmnA interaction involves one of the two putative binding sites and an adjacent novel interface on AIMP3. LmnA binds AIMP3 via its extreme C-terminus. Together these findings provide a structural insight for understanding the interaction between AIMP3 and LmnA in AIMP3 degradation.	[Tao, Yeqing; Marshall, Alan G.] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; [Fang, Pengfei; Guo, Min] Scripps Florida, Scripps Res Inst, Dept Canc Biol, Jupiter, FL USA; [Kim, Sunghoon] Seoul Natl Univ, Coll Pharm, Med Bioconvergence Res Ctr, Seoul, South Korea; [Young, Nicolas L.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Marshall, Alan G.] Florida State Univ, Ion Cyclotron Resonance Program, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; Scripps Research Institute; State University System of Florida; University of Florida; Seoul National University (SNU); Baylor College of Medicine; State University System of Florida; Florida State University	Marshall, AG (corresponding author), Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA.; Marshall, AG (corresponding author), Florida State Univ, Ion Cyclotron Resonance Program, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA.	marshall@magnet.fsu.edu	Kim, Sunghoon/AAE-8314-2020; Young, Nicolas/AAI-5242-2020; Fang, Pengfei/O-3696-2015	Young, Nicolas/0000-0002-3323-2815; Fang, Pengfei/0000-0002-3448-5494; kim, sunghoon/0000-0002-1570-3230	National Science Foundation Division of Materials Research [DMR-06-54118]; Global Frontiers Project [NRFM1AXA002-2011-0028417]; WCU of Ministry of Education, Science and Technology, Korea [R31-2008-000-10103-0]; State of Florida to Scripps Florida	National Science Foundation Division of Materials Research(National Science Foundation (NSF)); Global Frontiers Project; WCU of Ministry of Education, Science and Technology, Korea; State of Florida to Scripps Florida	This research was supported by National Science Foundation Division of Materials Research through DMR-06-54118 (AM) (URL: (https://www.nsf.gov/div/index.jsp?div=DMR)), the Global Frontiers Project [NRFM1AXA002-2011-0028417] (URL: http://www.globalfrontierspeoject.org/) globalfrontiersproject.org) and the WCU project [R31-2008-000-10103-0] of the Ministry of Education, Science and Technology, Korea (SK) (URL: https://sejong.korea.ac.kr/mbshome/mbs/eng/subview.do?id=eng_ 040204000000), and funding from The State of Florida to Scripps Florida (MG) (URL: http://www.flgov.com/scripps-florida/).	Agarwal AK, 2003, HUM MOL GENET, V12, P1995, DOI 10.1093/hmg/ddg213; Ahn J, 2012, ANAL CHEM, V84, P7256, DOI 10.1021/ac301749h; Askenasy I, 2015, J BIOL CHEM, V290, P19319, DOI 10.1074/jbc.M115.662379; Bartesaghi A, 2015, SCIENCE, V348, P1147, DOI 10.1126/science.aab1576; BEU SC, 1992, ANAL CHEM, V64, P177, DOI 10.1021/ac00026a016; Blakney GT, 2011, INT J MASS SPECTROM, V306, P246, DOI 10.1016/j.ijms.2011.03.009; Bou-Assaf GM, 2010, ANAL CHEM, V82, P3293, DOI 10.1021/ac100079z; Cho HY, 2015, J BIOL CHEM, V290, P29313, DOI 10.1074/jbc.M115.690867; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Depaux A, 2006, BIOCHEM BIOPH RES CO, V348, P857, DOI 10.1016/j.bbrc.2006.07.092; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P17381, DOI 10.1074/jbc.C200038200; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; FISHER DZ, 1986, P NATL ACAD SCI USA, V83, P6450, DOI 10.1073/pnas.83.17.6450; Guan XY, 2015, J MASS SPECTROM, V50, P812, DOI 10.1002/jms.3589; Kaiser NK, 2011, ANAL CHEM, V83, P6907, DOI 10.1021/ac201546d; Kang T, 2012, J MOL BIOL, V423, P475, DOI 10.1016/j.jmb.2012.07.020; Kazazic S, 2010, J AM SOC MASS SPECTR, V21, P550, DOI 10.1016/j.jasms.2009.12.016; Kim KJ, 2008, J BIOL CHEM, V283, P14032, DOI 10.1074/jbc.M800859200; Kim S, 2011, NAT REV CANCER, V11, P708, DOI 10.1038/nrc3124; LEDFORD EB, 1984, ANAL CHEM, V56, P2744, DOI 10.1021/ac00278a027; Marshall AG, 1996, RAPID COMMUN MASS SP, V10, P1819, DOI 10.1002/(SICI)1097-0231(199611)10:14<1819::AID-RCM686>3.0.CO;2-Z; MCKEON FD, 1986, NATURE, V319, P463, DOI 10.1038/319463a0; Navarro CL, 2004, HUM MOL GENET, V13, P2493, DOI 10.1093/hmg/ddh265; Noble AJ, 2013, NAT STRUCT MOL BIOL, V20, P167, DOI 10.1038/nsmb.2467; Oh YS, 2010, AGING CELL, V9, P810, DOI 10.1111/j.1474-9726.2010.00614.x; Park BJ, 2005, CELL, V120, P209, DOI 10.1016/j.cell.2004.11.054; Park BJ, 2006, CANCER RES, V66, P6913, DOI 10.1158/0008-5472.CAN-05-3740; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Pendas AM, 2002, NAT GENET, V31, P94, DOI 10.1038/ng871; Robotham JM, 2010, MOL IMMUNOL, V47, P1830, DOI 10.1016/j.molimm.2009.12.009; Schaub TM, 2008, ANAL CHEM, V80, P3985, DOI 10.1021/ac800386h; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schwartz JC, 2002, J AM SOC MASS SPECTR, V13, P659, DOI 10.1016/S1044-0305(02)00384-7; Senko MW, 1997, J AM SOC MASS SPECTR, V8, P970, DOI 10.1016/S1044-0305(97)00126-8; Shi SDH, 2000, INT J MASS SPECTROM, V195, P591, DOI 10.1016/S1387-3806(99)00226-2; Simader H, 2006, NUCLEIC ACIDS RES, V34, P3968, DOI 10.1093/nar/gkl560; Sinz A, 2006, MASS SPECTROM REV, V25, P663, DOI 10.1002/mas.20082; Wales TE, 2008, ANAL CHEM, V80, P6815, DOI 10.1021/ac8008862; Wilcox BE, 2002, J AM SOC MASS SPECTR, V13, P1304, DOI 10.1016/S1044-0305(02)00622-0; Winter M, 2008, NAT CELL BIOL, V10, P812, DOI 10.1038/ncb1743; WUTHRICH K, 1990, J BIOL CHEM, V265, P22059; Zhang H, 2011, J AM SOC MASS SPECTR, V20, P520; Zhang HM, 2010, ANAL CHEM, V82, P1450, DOI 10.1021/ac902550n; Zhang HM, 2008, ANAL CHEM, V80, P9034, DOI 10.1021/ac801417d; Zhang Q, 2010, FRONT END AUTOMATION; Zhang Q, 2013, J AM SOC MASS SPECTR, V24, P1016, DOI 10.1007/s13361-013-0644-7; Zhang Q, 2011, ANAL CHEM, V83, P7129, DOI 10.1021/ac201501z; Zhang ZQ, 1997, PROTEIN SCI, V6, P2203	49	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0181869	10.1371/journal.pone.0181869	http://dx.doi.org/10.1371/journal.pone.0181869			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797100	gold, Green Published, Green Submitted			2022-12-26	WOS:000407396200020
J	Zhang, YY; Shao, LL; Li, XD; Zhong, GM				Zhang, Yuyang; Shao, Lili; Li, Xiaodong; Zhong, Guangming			Uterotubal junction prevents chlamydial ascension via innate immunity	PLOS ONE			English	Article							UPPER GENITAL-TRACT; TUBAL FACTOR INFERTILITY; CD8(+) T-CELLS; MURIDARUM INFECTION; ANTIMICROBIAL PEPTIDES; PROTECTIVE IMMUNITY; EPITHELIAL-CELLS; MICE; PATHOLOGY; OVIDUCT	Ascension to the oviduct is necessary for Chlamydia to induce tubal infertility. Using the Chlamydia muridarum induction of hydrosalpinx mouse model, we have demonstrated a significant role of the uterotubal junction in preventing chlamydial ascending infection. First, delivery of C. muridarum to either side of the uterotubal junction resulted in significant reduction in live organisms from the tissues on the opposite sides. However, the recovery yields remained similar among different sections of the uterine horn. These observations suggest that the uterotubal junction may function as a barrier between the uterine horn and oviduct. Second, deficiency in innate immunity signaling pathways mediated by either MyD88 or STING significantly compromised the uterotubal junction barrier function, permitting C. muridarum to spread freely between uterine horn and oviduct. Finally, transcervical inoculation of C. muridarum led to significantly higher incidence of bilateral hydrosalpinges in the STING-deficient mice while the same inoculation mainly induced unilateral hydrosalpinx in the wild type mice, suggesting that the STING pathway-dependent uterotubal junction plays a significant role in preventing tubal pathology. Thus, we have demonstrated for the first time that the uterotubal junction is a functional barrier for preventing tubal infection by a sexually transmitted agent, providing the first in vivo evidence for detecting chlamydial infection by the STING pathway.	[Zhang, Yuyang] Wenzhou Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Wenzhou, Zhejiang, Peoples R China; [Zhang, Yuyang; Shao, Lili; Li, Xiaodong; Zhong, Guangming] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA	Wenzhou Medical University; University of Texas System; University of Texas Health San Antonio	Zhong, GM (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA.	Zhongg@UTHSCSA.EDU		Li, Xiao-Dong/0000-0002-4349-6996; Zhong, Guangming/0000-0001-7053-5009	US National Institutes of Health; Wenzhou Medical University in China	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wenzhou Medical University in China	This work was supported in part by grants (to G. Zhong) from the US National Institutes of Health. YZ is supported by Wenzhou Medical University in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker JR, 2013, MBIO, V4, DOI 10.1128/mBio.00018-13; Budrys NM, 2012, OBSTET GYNECOL, V119, P1009, DOI 10.1097/AOG.0b013e3182519326; Campbell J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101634; Chen CQ, 2015, INFECT IMMUN, V83, P1881, DOI 10.1128/IAI.03158-14; Chen JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095076; Chen LL, 2010, J IMMUNOL, V184, P2602, DOI 10.4049/jimmunol.0901593; Chen LL, 2009, INFECT IMMUN, V77, P3080, DOI 10.1128/IAI.00611-08; Cheng W, 2008, INFECT IMMUN, V76, P515, DOI 10.1128/IAI.01064-07; Chong-Cerrillo C, 2003, J PEPT RES, V61, P237, DOI 10.1034/j.1399-3011.2003.00053.x; CHOW AW, 1980, AM J OBSTET GYNECOL, V138, P1003, DOI 10.1016/0002-9378(80)91096-0; Conrad TA, 2016, INFECT IMMUN, V84, P467, DOI 10.1128/IAI.01171-15; Dai J, 2016, MICROBES INFECT, V18, P190, DOI 10.1016/j.micinf.2015.11.003; DELAMAZA LM, 1994, INFECT IMMUN, V62, P2094, DOI 10.1128/IAI.62.5.2094-2097.1994; Fan T, 1998, J EXP MED, V187, P487, DOI 10.1084/jem.187.4.487; Jin L, 2011, J IMMUNOL, V187, P2595, DOI 10.4049/jimmunol.1100088; Johnson RM, 2014, IMMUNOLOGY, V142, P248, DOI 10.1111/imm.12248; KRZANOWSKA H, 1974, J REPROD FERTIL, V38, P81, DOI 10.1530/jrf.0.0380081; Lei L, 2014, INFECT IMMUN, V82, P983, DOI 10.1128/IAI.01543-13; Liu Y, 2014, INFECT IMMUN, V82, P5327, DOI 10.1128/IAI.02576-14; Manam S, 2013, PATHOG DIS, V67, P221, DOI 10.1111/2049-632X.12032; Murthy AK, 2011, INFECT IMMUN, V79, P2928, DOI 10.1128/IAI.05022-11; Nakanishi T, 2004, BIOL REPROD, V71, P959, DOI 10.1095/biolreprod.104.028647; O'Connell CM, 2007, J IMMUNOL, V179, P4027, DOI 10.4049/jimmunol.179.6.4027; Ojcius DM, 1998, J IMMUNOL, V161, P4220; Rajaram K, 2015, INFECT IMMUN, V83, P3164, DOI 10.1128/IAI.00382-15; Rank RG, 2008, FEMS IMMUNOL MED MIC, V54, P104, DOI 10.1111/j.1574-695X.2008.00459.x; Rasmussen SJ, 1997, J CLIN INVEST, V99, P77, DOI 10.1172/JCI119136; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; Rodgers AK, 2011, FERTIL STERIL, V96, P715, DOI 10.1016/j.fertnstert.2011.06.021; Rodgers AK, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.005; Schauber J, 2009, J ALLERGY CLIN IMMUN, V124, pR13, DOI 10.1016/j.jaci.2009.07.014; Shah AA, 2005, SEX TRANSM DIS, V32, P49, DOI 10.1097/01.olq.0000148299.14513.11; Tang LL, 2014, VACCINE, V32, P1407, DOI 10.1016/j.vaccine.2013.10.018; Tang LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060345; Vlcek KR, 2016, IMMUNOL CELL BIOL, V94, P208, DOI 10.1038/icb.2015.74; Yang ZS, 2014, INFECT IMMUN, V82, P3154, DOI 10.1128/IAI.01833-14; Zhang Q, 2015, INFECT IMMUN, V83, P3568, DOI 10.1128/IAI.00673-15; Zhang XY, 2009, J IMMUNOL, V183, P1291, DOI 10.4049/jimmunol.0803075; Zhang YG, 2014, J IMMUNOL, V193, P2394, DOI 10.4049/jimmunol.1302718	39	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0183189	10.1371/journal.pone.0183189	http://dx.doi.org/10.1371/journal.pone.0183189			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797102	Green Published, Green Submitted, gold			2022-12-26	WOS:000407396200154
J	Kim, S; Yang, LH; Kim, S; Lee, RG; Graham, MJ; Berliner, JA; Lusis, AJ; Cai, L; Temel, RE; Rateri, DL; Lee, S				Kim, Seonwook; Yang, Lihua; Kim, Seongu; Lee, Richard G.; Graham, Mark J.; Berliner, Judith A.; Lusis, Aldons J.; Cai, Lei; Temel, Ryan E.; Rateri, Debra L.; Lee, Sangderk			Targeting hepatic heparin-binding EGF-like growth factor (HB-EGF) induces anti-hyperlipidemia leading to reduction of angiotensin II-induced aneurysm development	PLOS ONE			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; MUSCLE-CELL PROLIFERATION; FACTOR RECEPTOR; MONOCLONAL-ANTIBODY; SMOOTH-MUSCLE; AORTIC-ANEURYSM; ANTISENSE OLIGONUCLEOTIDES; ATHEROSCLEROTIC PLAQUES; LIVER FIBROSIS; CANCER-THERAPY	Objective The upregulated expression of heparin binding EGF-like growth factor (HB-EGF) in the vessel and circulation is associated with risk of cardiovascular disease. In this study, we tested the effects of HB-EGF targeting using HB-EGF-specific antisense oligonucleotide (ASO) on the development of aortic aneurysm in a mouse aneurysm model. Approach and results Low-density lipoprotein receptor (LDLR) deficient mice (male, 16 weeks of age) were injected with control and HB-EGF ASOs for 10 weeks. To induce aneurysm, the mice were fed a high fat diet (22% fat, 0.2% cholesterol; w/w) at 5 week point of ASO administration and infused with angiotensin II (AngII, 1,000ng/kg/min) for the last 4 weeks of ASO administration. We confirmed that the HB-EGF ASO administration significantly downregulated HB-EGF expression in multiple tissues including the liver. Importantly, the HB-EGF ASO administration significantly suppressed development of aortic aneurysms including thoracic and abdominal types. Interestingly, the HB-EGF ASO administration induced a remarkable anti-hyperlipidemic effect by suppressing very low density lipoprotein (VLDL) level in the blood. Mechanistically, the HB-EGF targeting suppressed hepatic VLDL secretion rate without changing heparin-releasable plasma triglyceride (TG) hydrolytic activity or fecal neutral cholesterol excretion rate. Conclusion This result suggested that the HB-EGF targeting induced protection against aneurysm development through anti-hyperlipidemic effects. Suppression of hepatic VLDL production process appears to be a key mechanism for the anti-hyperlipidemic effects by the HB-EGF targeting.	[Kim, Seonwook; Yang, Lihua; Kim, Seongu; Cai, Lei; Temel, Ryan E.; Rateri, Debra L.; Lee, Sangderk] Univ Kentucky, Coll Med, Saha Cardiovasc Res Ctr, Lexington, KY 40506 USA; [Lee, Richard G.; Graham, Mark J.] Ionis Pharmaceut Inc, Cardiovasc Antisense Drug Discovery Grp, Carlsbad, CA USA; [Berliner, Judith A.; Lusis, Aldons J.] Univ Calif Los Angeles, Sch Med, Dept Med Cardiol, Los Angeles, CA USA; [Temel, Ryan E.; Lee, Sangderk] Univ Kentucky, Coll Med, Dept Pharmacol & Nutr Sci, Lexington, KY 40506 USA	University of Kentucky; Ionis Pharmaceuticals, Inc.; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Kentucky	Lee, S (corresponding author), Univ Kentucky, Coll Med, Saha Cardiovasc Res Ctr, Lexington, KY 40506 USA.; Lee, S (corresponding author), Univ Kentucky, Coll Med, Dept Pharmacol & Nutr Sci, Lexington, KY 40506 USA.	sangderk.lee@uky.edu			National Heart, Lung, and Blood Institute (NHLBI, US) [R00HL105577, R01HL030568, R01HL064731]; National Institute of General Medical Sciences (NIGMS, US) [P20GM103527]; lonis Pharmaceuticals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064731, P01HL030568, R00HL105577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103527] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI, US); National Institute of General Medical Sciences (NIGMS, US); lonis Pharmaceuticals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding sources were research grants of National Heart, Lung, and Blood Institute (NHLBI, US) R00HL105577, R01HL030568, R01HL064731, and National Institute of General Medical Sciences (NIGMS, US) P20GM103527. The lonis Pharmaceuticals provided support in the form of salaries for authors [RGL & MJG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ailawadi G, 2004, ARTERIOSCL THROM VAS, V24, P2116, DOI 10.1161/01.ATV.0000143386.26399.84; Bollee G, 2011, NAT MED, V17, P1242, DOI 10.1038/nm.2491; Chansel D, 2006, FASEB J, V20, P1936, DOI 10.1096/fj.05-5328fje; Chapman MJ, 2011, EUR HEART J, V32, P1345, DOI 10.1093/eurheartj/ehr112; Choi SH, 2011, TRENDS ENDOCRIN MET, V22, P353, DOI 10.1016/j.tem.2011.04.007; Conlon DM, 2016, J CLIN INVEST, V126, P3852, DOI 10.1172/JCI86028; Daugherty A, 1999, ANN NY ACAD SCI, V892, P108, DOI 10.1111/j.1749-6632.1999.tb07789.x; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Daugherty Alan, 2003, Methods Mol Biol, V209, P293; Davis FM, 2014, HEART, V100, P1498, DOI 10.1136/heartjnl-2014-305648; Davis HR, 2011, ATHEROSCLEROSIS, V215, P266, DOI 10.1016/j.atherosclerosis.2011.02.010; Dreux AC, 2006, ATHEROSCLEROSIS, V186, P38, DOI 10.1016/j.atherosclerosis.2005.06.038; Gao P, 2013, CARDIOVASC RES, V97, P533, DOI 10.1093/cvr/cvs369; Geary RS, 2015, ADV DRUG DELIVER REV, V87, P46, DOI 10.1016/j.addr.2015.01.008; Ginsberg HN, 2009, J LIPID RES, V50, pS162, DOI 10.1194/jlr.R800090-JLR200; Ginsberg HN, 2002, CIRCULATION, V106, P2137, DOI 10.1161/01.CIR.0000035280.64322.31; Huang GC, 2012, LAB INVEST, V92, P703, DOI 10.1038/labinvest.2012.3; Hussain MM, 2011, CLIN LIPIDOL, V6, P293, DOI 10.2217/CLP.11.21; Ichise T, 2010, CELL STRUCT FUNCT, V35, P3, DOI 10.1247/csf.09025; Iwamoto R, 2003, P NATL ACAD SCI USA, V100, P3221, DOI 10.1073/pnas.0537588100; Jackson LF, 2003, EMBO J, V22, P2704, DOI 10.1093/emboj/cdg264; Kasai N, 2016, PHARM RES-DORDR, V33, P476, DOI 10.1007/s11095-015-1803-2; Kasai N, 2014, MABS-AUSTIN, V6, P1220, DOI 10.4161/mabs.29792; KIEFT KA, 1991, J LIPID RES, V32, P859; King VL, 2002, ARTERIOSCL THROM VAS, V22, P456, DOI 10.1161/hq0302.104905; Lee JH, 2014, J NANOMATER, V2014, DOI 10.1155/2014/567827; Lee RG, 2013, J LIPID RES, V54, P602, DOI 10.1194/jlr.M029215; Lee S, 2012, ARTERIOSCL THROM VAS, V32, P1246, DOI 10.1161/ATVBAHA.111.241257; Lehner R, 2012, ARTERIOSCL THROM VAS, V32, P1087, DOI 10.1161/ATVBAHA.111.241497; Lu H, 2012, CLIN SCI, V123, P531, DOI 10.1042/CS20120097; Macdonald-Obermann JL, 2014, J BIOL CHEM, V289, P26178, DOI 10.1074/jbc.M114.586826; Manning MW, 2002, VASC MED, V7, P45, DOI 10.1191/1358863x02vm413ra; Matsumoto S, 2002, BIOCHEM BIOPH RES CO, V292, P781, DOI 10.1006/bbrc.2002.6720; Mifune M, 2005, J BIOL CHEM, V280, P26592, DOI 10.1074/jbc.M502906200; MITAMURA T, 1995, J BIOL CHEM, V270, P1015, DOI 10.1074/jbc.270.3.1015; Miyamoto S, 2006, CANCER SCI, V97, P341, DOI 10.1111/j.1349-7006.2006.00188.x; Miyamoto S, 2007, ANTICANCER RES, V27, P3713; Miyamoto S, 2011, CLIN CANCER RES, V17, P6733, DOI 10.1158/1078-0432.CCR-11-1029; Mulder GM, 2010, J PATHOL, V221, P183, DOI 10.1002/path.2698; Nakashima Hidekatsu, 2006, Current Vascular Pharmacology, V4, P67, DOI 10.2174/157016106775203126; Nakata A, 1996, CIRCULATION, V94, P2778, DOI 10.1161/01.CIR.94.11.2778; Nanba D, 2006, BIOCHEM BIOPH RES CO, V350, P315, DOI 10.1016/j.bbrc.2006.09.060; Nishida M, 2000, ARTERIOSCL THROM VAS, V20, P1236, DOI 10.1161/01.ATV.20.5.1236; Nishikawa K, 2012, J CONTROL RELEASE, V160, P274, DOI 10.1016/j.jconrel.2011.10.010; Norman PE, 2007, CIRCULATION, V115, P2865, DOI 10.1161/CIRCULATIONAHA.106.671859; Ohtsu H, 2006, ARTERIOSCL THROM VAS, V26, pE133, DOI 10.1161/01.ATV.0000236203.90331.d0; Oyagi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007461; PEOPLES GE, 1995, P NATL ACAD SCI USA, V92, P6547, DOI 10.1073/pnas.92.14.6547; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Rateri DL, 2011, CIRC RES, V108, P574, DOI 10.1161/CIRCRESAHA.110.222844; Reape TJ, 1997, J MOL CELL CARDIOL, V29, P1639, DOI 10.1006/jmcc.1997.0399; Ronan T, 2016, J BIOL CHEM, V291, P5528, DOI 10.1074/jbc.M115.710087; Sanchez-Vizcaino E, 2010, GROWTH FACTORS, V28, P98, DOI 10.3109/08977190903443030; Sarantopoulos J, 2016, TARGET ONCOL, V11, P317, DOI 10.1007/s11523-015-0394-5; Sato S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054509; Sato S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051964; Schneider MR, 2009, J CELL PHYSIOL, V218, P460, DOI 10.1002/jcp.21635; Seth PP, 2010, J ORG CHEM, V75, P1569, DOI 10.1021/jo902560f; Shepard HM, 2008, J CLIN INVEST, V118, P3574, DOI 10.1172/JCI36049; Sundaram M, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-35; Takemura T, 2013, BIOCHEM BIOPH RES CO, V437, P185, DOI 10.1016/j.bbrc.2013.05.097; Takemura T, 2013, HEPATOL RES, V43, P384, DOI 10.1111/j.1872-034X.2012.01074.x; Taylor SR, 2014, SEMIN CELL DEV BIOL, V28, P22, DOI 10.1016/j.semcdb.2014.03.004; Temel RE, 2005, J LIPID RES, V46, P2423, DOI 10.1194/jlr.M500232-JLR200; Tiwari S, 2012, ARTERIOSCL THROM VAS, V32, P1079, DOI 10.1161/ATVBAHA.111.241471; Tsujioka H, 2011, ANTICANCER RES, V31, P2461; Tsujioka H, 2011, CURR OPIN OBSTET GYN, V23, P24, DOI 10.1097/GCO.0b013e3283409c91; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Willecke F, 2015, ARTERIOSCL THROM VAS, V35, P102, DOI 10.1161/ATVBAHA.114.304615; Yamazaki S, 2003, J CELL BIOL, V163, P469, DOI 10.1083/jcb.200307035; Yang XP, 2005, MOL CELLS, V20, P263; Yao ZM, 2013, CURR OPIN LIPIDOL, V24, P160, DOI 10.1097/MOL.0b013e32835aebe7; Yotsumoto F, 2013, MOL CANCER RES, V11, P506, DOI 10.1158/1541-7786.MCR-12-0428; Zeng FH, 2016, AM J PHYSIOL-RENAL, V311, pF695, DOI 10.1152/ajprenal.00377.2015	74	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182566	10.1371/journal.pone.0182566	http://dx.doi.org/10.1371/journal.pone.0182566			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28792970	Green Published, Green Submitted, gold			2022-12-26	WOS:000407196700053
J	Zhang, Q; Zeng, LP; Zhou, P; Irving, AT; Li, S; Shi, ZL; Wang, LF				Zhang, Qian; Zeng, Lei-Ping; Zhou, Peng; Irving, Aaron T.; Li, Shang; Shi, Zheng-Li; Wang, Lin-Fa			IFNAR2-dependent gene expression profile induced by IFN-alpha in Pteropus alecto bat cells and impact of IFNAR2 knockout on virus infection	PLOS ONE			English	Article							EMERGING VIRUSES; DNA-DAMAGE; AUTOIMMUNE-DISEASES; HUMAN MACROPHAGES; INTERFERON; RESPONSES; RECEPTOR; RESERVOIRS; PATHWAY; MUTANT	Bats are important reservoirs of many viruses, which are capable of infecting the host without inducing obvious clinical diseases. Interferon and the downstream interferon regulated genes (IRGs) are known to act as the first line of defense against viral infections. Little is known about the transcriptional profile of genes being induced by interferon in bats and their role in controlling virus infection. In this study, we constructed IFNAR2 knockout bat cell lines using CRISPR technology and further characterized gene expression profiles induced by the most abundant IFN-alpha (IFN-alpha 3). Firstly, we demonstrated that the CRISPR/Cas9 system is applicable for bat cells as this represents the first CRIPSR knockout cell line for bats. Our results showed the pleiotropic effect of IFN-a3 on the bat kidney cell line, PaKiT03. As expected, we confirmed that IFNAR2 is indispensable for IFN-a signaling pathway and plays an important role in antiviral immunity. Unexpectedly, we also identified novel IFNAR2-dependent IRGs which are enriched in pathways related to cancer. To our knowledge, this seems to be bat-specific as no such observation has been reported for other mammalian species. This study expands our knowledge about bat immunology and the cell line established can provide a powerful tool for future study into virus-bat interaction and cancer biology.	[Zhang, Qian; Zeng, Lei-Ping; Zhou, Peng; Shi, Zheng-Li] Chinese Acad Sci, Wuhan Inst Virol, Key Lab Special Pathogens, Wuhan, Hubei, Peoples R China; [Irving, Aaron T.; Wang, Lin-Fa] Duke Natl Univ Singapore Med Sch, Programme Emerging Infect Dis, Singapore, Singapore; [Li, Shang] Duke Natl Univ Singapore Med Sch, Programme Canc & Stem Cell Biol, Singapore, Singapore	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Shi, ZL (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Key Lab Special Pathogens, Wuhan, Hubei, Peoples R China.	zlshi@wh.iov.cn	wang, lin/GSE-3040-2022; Irving, Aaron/AAE-8874-2021; wang, lin/HHM-2225-2022; irving, aaron/I-6754-2013; wang, lili/HDL-7210-2022; Shi, Zheng-Li/A-1013-2013	Irving, Aaron/0000-0002-0196-1570; irving, aaron/0000-0002-0196-1570; Zeng, Leiping/0000-0002-6421-0950; Shi, Zheng-Li/0000-0001-8089-163X; Wang, Lin-Fa/0000-0003-2752-0535	National Natural Science Foundation of China [31621061]; National Research Foundation-Competitive Research Program (NRF-CRP) from National Research Foundation in Singapore [NRF2012NRF-CRP001-056)]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Research Foundation-Competitive Research Program (NRF-CRP) from National Research Foundation in Singapore	This study was supported in part by National Natural Science Foundation of China (31621061) (to Z-LS) and the National Research Foundation-Competitive Research Program (NRF-CRP) grant (NRF2012NRF-CRP001-056) from the National Research Foundation in Singapore (to L-FW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge and thank Muhammad Khairul RAMLEE and Jing WANG for technical help with CRISPR work. This study was supported in part by National Natural Science Foundation of China (31621061) (to Z-LS) and the NRF-CRP grant (NRF2012NRF-CRP001-056) from the National Research Foundation in Singapore (to L-FW).	Ahn M, 2016, SCI REP-UK, V6, DOI 10.1038/srep21722; Anderson AC, 2006, CURR OPIN IMMUNOL, V18, P665, DOI 10.1016/j.coi.2006.09.009; Brook CE, 2015, TRENDS MICROBIOL, V23, P172, DOI 10.1016/j.tim.2014.12.004; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Conlan LA, 2004, ONCOGENE, V23, P307, DOI 10.1038/sj.onc.1207119; Cowled C, 2012, DEV COMP IMMUNOL, V36, P657, DOI 10.1016/j.dci.2011.11.008; Crameri G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008266; Curtiss ML, 2012, EUR J IMMUNOL, V42, P651, DOI 10.1002/eji.201141581; Dai SY, 2014, CELL IMMUNOL, V290, P72, DOI 10.1016/j.cellimm.2014.05.006; de Weerd NA, 2013, NAT IMMUNOL, V14, P901, DOI 10.1038/ni.2667; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Indraccolo S, 2007, J IMMUNOL, V178, P1122, DOI 10.4049/jimmunol.178.2.1122; Jaitin DA, 2006, MOL CELL BIOL, V26, P1888, DOI 10.1128/MCB.26.5.1888-1897.2006; Koyama S, 2007, J IMMUNOL, V179, P4711, DOI 10.4049/jimmunol.179.7.4711; Krebs DL, 2000, J CELL SCI, V113, P2813; Lamken P, 2004, J MOL BIOL, V341, P303, DOI 10.1016/j.jmb.2004.05.059; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Levin D, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004998; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luheshi N, 2014, EUR J IMMUNOL, V44, P162, DOI 10.1002/eji.201343351; Minn AJ, 2015, TRENDS IMMUNOL, V36, P725, DOI 10.1016/j.it.2015.09.007; Ni W, 2014, PLOS ONE, V9; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Osterlund P, 2010, J VIROL, V84, P1414, DOI 10.1128/JVI.01619-09; Ramlee MK, 2015, SCI REP-UK, V5, DOI 10.1038/srep15587; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Romagnani S, 1997, IMMUNOL TODAY, V18, P263, DOI 10.1016/S0167-5699(97)80019-9; Sakai R, 2014, INT J MOL SCI, V15, P17256, DOI 10.3390/ijms151017256; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; Sanda C, 2006, J INTERF CYTOK RES, V26, P462, DOI 10.1089/jir.2006.26.462; Schoggins JW, 2014, CURR OPIN VIROL, V6, P40, DOI 10.1016/j.coviro.2014.03.006; Schreiber G, 2015, TRENDS IMMUNOL, V36, P139, DOI 10.1016/j.it.2015.01.002; Smith I, 2013, CURR OPIN VIROL, V3, P84, DOI 10.1016/j.coviro.2012.11.006; Vinay DS, 2011, CLIN EXP IMMUNOL, V164, P145, DOI 10.1111/j.1365-2249.2011.04375.x; Wang LF, 2011, CURR OPIN VIROL, V1, P649, DOI 10.1016/j.coviro.2011.10.013; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wang XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep20620; Welsby I, 2012, BIOCHEM PHARMACOL, V84, P11, DOI 10.1016/j.bcp.2012.02.016; Yang XO, 2009, NAT IMMUNOL, V10, P1260, DOI 10.1038/ni.1821; Zhang GJ, 2013, SCIENCE, V339, P456, DOI 10.1126/science.1230835; Zhou P, 2016, P NATL ACAD SCI USA, V113, P2696, DOI 10.1073/pnas.1518240113; Zhou P, 2013, DEV COMP IMMUNOL, V40, P240, DOI 10.1016/j.dci.2013.03.006	46	20	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182866	10.1371/journal.pone.0182866	http://dx.doi.org/10.1371/journal.pone.0182866			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28793350	Green Published, Green Submitted, gold			2022-12-26	WOS:000407196700075
J	Arratia, G; Vila, I; Lam, N; Guerrero, CJ; Quezada-Romegialli, C				Arratia, Gloria; Vila, Irma; Lam, Natalia; Jimena Guerrero, Claudia; Quezada-Romegialli, Claudio			Morphological and taxonomic descriptions of a new genus and species of killifishes (Teleostei: Cyprinodontiformes) from the high Andes of northern Chile	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; PHYLOGENETIC-RELATIONSHIPS; ALTIPLANO; CLIMATE; EVOLUTION; POSITION; PLATEAU; ANCIENT; FISHES; PUNA	A new genus and species, Pseudorestias lirimensis, is described from the southern part of the Chilean Altiplano. While sharing several characters that clearly align the new species with Orestias, this new fish is characterized by numerous autapomorphies: the Meckel cartilage is a continuous cartilage that broadly expands posteriorly (in large specimens, it keeps its anterior part and is resorbed posteriorly), the basibranchials are fused into one long element, the second pharyngobranchial is not displaced dorsally over pharyngobranchial tooth plate 3+4, but they are aligned, the anterior and posterior ceratohyals are closely articulated keeping a scarce amount of cartilage between both bones and ventral to them, ossified middle and distal dorsal radials are present in females as well as ossified middle and distal anal radials. Pseudorestias lirimensis presents strong sexual dimorphism associated to size. Females are almost twice as large and long than males, neuromast lines are absent in males, a mesethmoid is present in males, squamation on head is reduced in males, and ossified middle and distal radial of dorsal fin are cartilaginous in males. Pseudorestias and Orestias are suggested as the sole members of the tribe Orestiini. A list of characters diagnosing the tribe is provided. The presence of the new genus is interpreted as a possible result of the ecosystem isolation where the fish is living from surrounding basins-as early as possibly from the Miocene-Pliocene times-and its physical and chemical characteristics. Small populations, living conditions, small habitat, and reduced distribution make this species a strong candidate to be considered critically endangered, a situation already established for all other Chilean species living in the Altiplano. There is high probability it will become extinct due to water demands and climate change in the region.	[Arratia, Gloria] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [Vila, Irma; Quezada-Romegialli, Claudio] Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Santiago, Chile; [Lam, Natalia] Univ Chile, Fac Ciencias Agron, Dept Prod Anim, Santiago, Chile; [Jimena Guerrero, Claudia] Univ Iberoamer Ciencia & Tecnol, Escuela Med Vet, Santiago, Chile; [Quezada-Romegialli, Claudio] Univ Antofagasta, Inst Ciencias Nat Alexander von Humboldt, Antofagasta, Chile	University of Kansas; Universidad de Chile; Universidad de Chile; Universidad Iberoamericana de Ciencias y Tecnologia; Universidad de Antofagasta	Arratia, G (corresponding author), Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA.	garratia@ku.edu	Quezada-Romegialli, Claudio/J-2207-2018; Lam, Natalia/J-9544-2016	Quezada-Romegialli, Claudio/0000-0003-3380-389X; 	Comision Nacional de Informacion Cientifica y Tecnologica (Chile); Fondo Nacional de Desarrollo Cientifico y Tecnologico [1140543, 3160659]	Comision Nacional de Informacion Cientifica y Tecnologica (Chile); Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by Comision Nacional de Informacion Cientifica y Tecnologica (Chile), Fondo Nacional de Desarrollo Cientifico y Tecnologico grant numbers 1140543 (IV) and 3160659 (CQ-R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; Aceituno P., 1997, ALTIPLANO CIENCIA CO, P63; Allmendinger RW, 1997, ANNU REV EARTH PL SC, V25, P139, DOI 10.1146/annurev.earth.25.1.139; Arai R., 2011, FISH KARYOTYPES CHEC, DOI [10.1007/978-4-431-53877-6, DOI 10.1007/978-4-431-53877-6]; Arratia G., 1997, P179; ARRATIA G, 1983, STUD NEOTROP FAUNA E, V18, P65, DOI 10.1080/01650528309360621; ARRATIA G, 1992, J MORPHOL, V214, P187, DOI 10.1002/jmor.1052140209; Arratia G, 1995, BONN ZOOL MONOGR; Arratia G., 2008, MESOZOIC FISHES 4 HO, P40; Arratia G., 1982, AMBIENTE NATURAL POB, V1, P93; Arratia Gloria, 1999, P265; Arratia G, 2010, REV BIOL MAR OCEANOG, V45, P635, DOI 10.4067/S0718-19572010000400009; Berg L. S., 1940, Travaux de l'Institut de Zoologie Acad Sci Leningrad, V5, P87; Blanco Jose L., 2006, Zootaxa, V1158, P39; Bleeker P, 1859, ACTA SOC REGIAE SCI, V6; Costa WJEM, 2006, NEOTROP ICHTHYOL, V4, P1, DOI 10.1590/S1679-62252006000100001; Costa Wilson J.E.M., 1997, Journal of Comparative Biology, V2, P1; Costa WJEM, 2002, COPEIA, P916, DOI 10.1643/0045-8511(2002)002[0916:MAPROT]2.0.CO;2; Costa WJEM, 2003, CHECK LIST FRESHWATE, P549; Cruz-Jofre F, 2014, GAYANA, V78, P41, DOI 10.4067/S0717-65382014000100006; DeTolla Louis J., 1995, ILAR J, V37, P159; DINGERKUS G, 1977, STAIN TECHNOL, V52, P229, DOI 10.3109/10520297709116780; Eigenmann C. H., 1942, FISHES W S AM; EIGENMANN CH, 1927, MEM NAT ACAD SCI, V22, P1; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Garcia G, 2012, J BIOGEOGR, V39, P1707, DOI 10.1111/j.1365-2699.2012.02722.x; Garrigos YE, 2013, ZOOTAXA, V3640, P373, DOI 10.11646/zootaxa.3640.3.3; Gholami Z, 2013, ZOOTAXA, V3619, P467, DOI 10.11646/zootaxa.3619.4.5; Keller B, 1998, REV CHIL HIST NAT, V71, P147; LAUZANNE L, 1982, Revue d'Hydrobiologie Tropicale, V15, P39; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Mann G. F., 1954, VIDA PECES AGUAS CHI; Martinez G, 1999, NOT MENS MUS NAC HIS, V339, P6; Morales P, 2011, CONSERV GENET, V12, P1639, DOI 10.1007/s10592-011-0245-6; Moreno A, 2009, J QUATERNARY SCI, V24, P373, DOI 10.1002/jqs.1240; Muller J., 1845, BERICHT AKAD WISSENS, P416; Muller Reinhard, 1993, Zoologische Jahrbuecher Abteilung fuer Anatomie und Ontogenie der Tiere, V123, P31; Munoz N, 1996, J S AM EARTH SCI, V9, P171, DOI 10.1016/0895-9811(96)00004-1; Nelson J.S., 2016, FISHES WORLD, DOI 10.1002/9781119174844; Nester PL, 2007, P NATL ACAD SCI USA, V104, P19724, DOI 10.1073/pnas.0705373104; PARENTI LR, 1984, B AM MUS NAT HIST, V178, P110; Parenti LR, 1981, B AM MUS NAT HIST, V168, P335, DOI DOI 10.1080/00222930210135631; Parenti Lynne R., 2005, P13; PARKER A, 1995, COPEIA, P8; Piacentini RD, 2003, J ATMOS SOL-TERR PHY, V65, P727, DOI 10.1016/S1364-6826(03)00084-1; Placzek C, 2006, GEOL SOC AM BULL, V118, P515, DOI 10.1130/B25770.1; Pohl M, 2015, VERTEBR ZOOL, V65, P37; Polanco E, 2000, 9 C GEOL CHIL PUERT, P324; Quezada-Romegialli C, 2016, MITOCHONDRIAL DNA A, V27, P2798, DOI 10.3109/19401736.2015.1053072; Quezada-Romegialli C, 2016, MITOCHONDRIAL DNA A, V27, P2840, DOI 10.3109/19401736.2015.1053119; Risacher F, 2003, EARTH-SCI REV, V63, P249, DOI 10.1016/S0012-8252(03)00037-0; Sabaj Perez M. H., 2014, STANDARD SYMBOLIC CO; Salazar C., 1997, ALTIPLANO CIENCIA CO, P71; Schultze H.-P, 2013, MESOZOIC FISHES, P187; Scott S, 2015, GAYANA, V79, P45, DOI 10.4067/S0717-65382015000100006; Selles D, 2015, 14 C GEOL CHIL LA SE, P77; Squeo FA, 2006, REV CHIL HIST NAT, V79, P245; Teimori A, 2012, SCI MAR, V76, P637, DOI 10.3989/scimar.03635.26C; UICN, 2012, CAT CRIT LIST ROJ UI; Valdes-Pineda R, 2014, J HYDROL, V519, P2538, DOI 10.1016/j.jhydrol.2014.04.016; Valenciennes MA, 1839, L I, V7, P118; Valero-Garces BL, 1999, PALAEOGEOGR PALAEOCL, V151, P101, DOI 10.1016/S0031-0182(99)00018-8; Vila I, 2013, J FISH BIOL, V82, P927, DOI 10.1111/jfb.12031; VILA I, 1986, Revue d'Hydrobiologie Tropicale, V19, P233; Vila I, 2011, ICHTHYOL EXPLOR FRES, V22, P345; Vila Irma, 2010, P471; Villwock W, 2000, P INT S IS VERT COMM, P55; Wagner R, 1828, ISIS, V21, P1050; Wildekamp RH., 1993, WORLD KILLIES ATLAS, P384	69	7	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2017	12	8							e0181989	10.1371/journal.pone.0181989	http://dx.doi.org/10.1371/journal.pone.0181989			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9EU	28792510	Green Published, gold, Green Submitted			2022-12-26	WOS:000407144700010
J	Rodriguez, K; Srivaths, PR; Tal, L; Watson, MN; Riley, AA; Himes, RW; Desai, MS; Braun, MC; Arikan, AA				Rodriguez, Keila; Srivaths, Poyyapakkam R.; Tal, Leyat; Watson, Mary N.; Riley, Alyssa A.; Himes, Ryan W.; Desai, Moreshwar S.; Braun, Michael C.; Arikan, Ayse Akcan			Regional citrate anticoagulation for continuous renal replacement therapy in pediatric patients with liver failure	PLOS ONE			English	Article							CONTINUOUS VENOVENOUS HEMODIALYSIS; HEPARIN ANTICOAGULATION; CRRT; METAANALYSIS; SUPERIOR; SAFETY	Pediatric liver failure patients frequently develop multiple organ failure and require continuous renal replacement therapy (CRRT) as part of supportive therapy in the pediatric intensive care unit. While many centers employ no anticoagulation for fear of bleeding complications, balanced coagulation disturbance predisposes these patients to clotting as well as bleeding, making maintenance of longer circuit life to deliver adequate dialysis clearance challenging. Regional citrate anticoagulation (RCA) is an attractive option as it avoids systemic anticoagulation, but since citrate metabolism is impaired in liver failure, concerns about toxicity has limited its use. Pediatric data on RCA with liver failure is very scarce. We aimed to establish safety and efficacy of RCA in pediatric liver failure patients on CRRT. Retrospective review of pediatric patients with liver failure receiving CRRT over 30 months. Demographic data and CRRT related data were collected by chart review. Citrate accumulation (CA) was defined as total calcium (mg/dl) /ionized calcium (mmol/L) ratio >2.5 for >48 hours. Efficacy was assessed by filter life. Safety was assessed by frequency of adverse events ((AEs) defined as bleeding, hemodynamic instability, arrhythmias). Fifty-one patients (median age 3.5 (IQR 0.75-14.2) years) received 861 CRRT days; 70% experienced at least one episode of CA, only 37% were recorded as such in the medical record. AE rate was 93/1000 CRRT days and did not differ between CA days and others. Median filter life was 66 hours (IQR 29-74); 63% filters lasted longer than 48 hrs. Though common, CA was not associated with increased AEs on in pediatric liver failure patients on CRRT receiving RCA. Filter life was adequate. RCA appears an effective anticoagulation for CRRT in pediatric liver failure. Application of a structured definition would increase recognition of CA to allow timely intervention.	[Rodriguez, Keila] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Srivaths, Poyyapakkam R.; Tal, Leyat; Riley, Alyssa A.; Braun, Michael C.; Arikan, Ayse Akcan] Baylor Coll Med, Dept Pediat, Renal Sect, Houston, TX 77030 USA; [Watson, Mary N.] Texas Childrens Hosp, Houston, TX 77030 USA; [Himes, Ryan W.] Baylor Coll Med, Dept Pediat, Liver Sect, Houston, TX 77030 USA; [Desai, Moreshwar S.; Arikan, Ayse Akcan] Baylor Coll Med, Dept Pediat, Sect Crit Care Med, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Arikan, AA (corresponding author), Baylor Coll Med, Dept Pediat, Renal Sect, Houston, TX 77030 USA.; Arikan, AA (corresponding author), Baylor Coll Med, Dept Pediat, Sect Crit Care Med, Houston, TX 77030 USA.	aysea@bcm.edu		Himes, Ryan/0000-0002-0116-2613; Akcan Arikan, Ayse/0000-0002-5123-6713				Agarwal B, 2009, J HEPATOL, V51, P504, DOI 10.1016/j.jhep.2009.05.028; Ashbrook MJ, 2015, CLIN EXP IMMUNOL; Bagshaw SM, 2005, J CRIT CARE, V20, P155, DOI 10.1016/j.jcrc.2005.01.001; Bai M, 2015, INTENS CARE MED, V41, P2098, DOI 10.1007/s00134-015-4099-0; Betrosian AP, 2007, WORLD J GASTROENTERO, V13, P5552, DOI 10.3748/wjg.v13.i42.5552; Brophy PD, 2005, NEPHROL DIAL TRANSPL, V20, P1416, DOI 10.1093/ndt/gfh817; Chadha V, 2002, PEDIATR NEPHROL, V17, P819, DOI 10.1007/s00467-002-0963-6; Cubattoli L, 2007, INT J ARTIF ORGANS, V30, P244, DOI 10.1177/039139880703000310; De Vico P, 2015, THER APHER DIAL, V19, P272, DOI 10.1111/1744-9987.12280; Deep A, 2016, CRIT CARE MED, V44, P1910, DOI 10.1097/CCM.0000000000001826; Elhanan N, 2004, PEDIATR NEPHROL, V19, P208, DOI 10.1007/s00467-003-1328-5; Gonwa TA, 2012, BLOOD PURIFICAT, V33, P144, DOI 10.1159/000334149; Gutierrez-Bernays D, 2016, THER APHER DIAL, V20, P53, DOI 10.1111/1744-9987.12331; Jacobs R, 2015, BLOOD PURIFICAT, V40, P194, DOI 10.1159/000438820; Jalan R, 2012, J HEPATOL, V57, P1336, DOI 10.1016/j.jhep.2012.06.026; Khadzhynov D, 2014, J CRIT CARE, V29, P265, DOI 10.1016/j.jcrc.2013.10.015; Lexmond WS, 2015, LIVER TRANSPLANT, V21, P369, DOI 10.1002/lt.24037; Liet JM, 2014, PEDIATR NEPHROL, V29, P1647, DOI 10.1007/s00467-014-2881-9; Liet JM, 2014, PEDIATR NEPHROL, V29, P1625, DOI 10.1007/s00467-014-2770-2; MacLaren G, 2009, INTENS CARE MED, V35, P596, DOI 10.1007/s00134-009-1425-4; Mariano F, 2011, INT J NEPHROL, V2011, DOI 10.4061/2011/748320; Meier-Kriesche HU, 2001, CRIT CARE MED, V29, P748, DOI 10.1097/00003246-200104000-00010; Musielak A, 2016, THER APHER DIAL; Fernandez SN, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/786301; Oudemans-van Straaten HM, 2012, CRIT CARE, V16, DOI 10.1186/cc11645; Park Joon-Sung, 2011, Korean Journal of Internal Medicine, V26, P68, DOI 10.3904/kjim.2011.26.1.68; Rico MP, 2016, PEDIATR NEPHROL, P1; Schilder L, 2014, CRIT CARE, V18; Schultheiss C, 2012, CRIT CARE, V16, DOI 10.1186/cc11485; SLOWINSKI T, 2015, CRIT CARE, V19; Squires RH, 2008, SEMIN LIVER DIS, V28, P153, DOI 10.1055/s-2008-1073115; Symons JM, 2007, CLIN J AM SOC NEPHRO, V2, P732, DOI 10.2215/CJN.03200906; Wu MY, 2012, AM J KIDNEY DIS, V59, P810, DOI 10.1053/j.ajkd.2011.11.030	33	20	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2017	12	8							e0182134	10.1371/journal.pone.0182134	http://dx.doi.org/10.1371/journal.pone.0182134			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9EU	28792509	Green Published, Green Submitted, gold			2022-12-26	WOS:000407144700012
J	Murray, J; Muruko, T; Gill, CIR; Kearney, MP; Farren, D; Scott, MG; McMullan, G; Ternan, NG				Murray, Jason; Muruko, Tendai; Gill, Chris I. R.; Kearney, M. Patricia; Farren, David; Scott, Michael G.; McMullan, Geoff; Ternan, Nigel G.			Evaluation of bactericidal and anti-biofilm properties of a novel surface-active organosilane biocide against healthcare associated pathogens and Pseudomonas aeruginosa biolfilm	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; ENVIRONMENTAL CONTAMINATION; INFECTIONS; MRSA; DISINFECTION; STRATEGIES; DEATH	Healthcare acquired infections (HAI) pose a great threat in hospital settings and environmental contamination can be attributed to the spread of these. De-contamination and, significantly, prevention of re-contamination of the environment could help in preventing/reducing this threat. Goldshield (GS5) is a novel organosilane biocide marketed as a single application product with residual biocidal activity. We tested the hypothesis that GS5 could provide longer-term residual antimicrobial activity than existing disinfectants once applied to surfaces. Thus, the residual bactericidal properties of GS5, Actichlor and Distel against repeated challenge with Staphylococcus aureus ATCC43300 were tested, and showed that GS5 alone exhibited longer-term bactericidal activity for up to 6 days on 316I stainless steel surfaces. Having established efficacy against S. aureus, we tested GS5 against common healthcare acquired pathogens, and demonstrated that, on average, a 1 log 10 bactericidal effect was exhibited by GS5 treated surfaces, although biocidal activity varied depending upon the surface type and the species of bacteria. The ability of GS5 to prevent Pseudomonas aeruginosa biofilm formation was measured in standard microtitre plate assays, where it had no significant effect on either biofilm formation or development. Taken together the data suggests that GS5 treatment of surfaces may be a useful means to reducing bacterial contamination in the context of infection control practices.	[Murray, Jason; Muruko, Tendai; Gill, Chris I. R.; Ternan, Nigel G.] Univ Ulster, Sch Biomed Sci, Nutr Innovat Ctr Food & HEalth NICHE, Coleraine, Londonderry, North Ireland; [Kearney, M. Patricia; Farren, David; Scott, Michael G.] Antrim Area Hosp, Northern Hlth & Social Care Trust, Bush House, Antrim, Antrim, North Ireland; [McMullan, Geoff] Queens Univ Belfast, Med Biol Ctr, Sch Biol Sci, Inst Global Food Secur, Belfast, Antrim, North Ireland	Ulster University; Queens University Belfast	Ternan, NG (corresponding author), Univ Ulster, Sch Biomed Sci, Nutr Innovat Ctr Food & HEalth NICHE, Coleraine, Londonderry, North Ireland.	ng.ternan@ulster.ac.uk	Scott, Mike/AAF-8441-2021	Ternan, Nigel/0000-0002-1788-7571; Scott, Michael/0000-0003-4048-0937; Kearney, Patricia/0000-0001-9599-3540	Department of Employment and Learning (N Ireland); Public Health Agency [SPI/5309/16] Funding Source: researchfish	Department of Employment and Learning (N Ireland); Public Health Agency	JM was supported by a postgraduate research studentship from the Department of Employment and Learning (N Ireland).	Abdallah M, 2014, ARCH MICROBIOL, V196, P453, DOI 10.1007/s00203-014-0983-1; Abreu AC, 2013, J ANTIMICROB CHEMOTH, V68, P2718, DOI 10.1093/jac/dkt281; Aldeyab MA, 2009, INFECT CONT HOSP EP, V30, P304, DOI 10.1086/595964; Altaf M, 2010, TUBERCULOSIS, V90, P333, DOI 10.1016/j.tube.2010.09.002; [Anonymous], 2014, DIS ORG HEALTHC SETT; Bauer J, 2013, ANTIMICROB AGENTS CH, V57, P2726, DOI 10.1128/AAC.00181-13; Baxa D, 2011, AM J INFECT CONTROL, V39, P483, DOI 10.1016/j.ajic.2010.10.015; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; Beggs C, 2015, INDOOR AIR, V25, P462, DOI 10.1111/ina.12170; Devlin-Mullin A, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201700033; Djordjevic D, 2002, APPL ENVIRON MICROB, V68, P2950, DOI 10.1128/AEM.68.6.2950-2958.2002; French GL, 2004, J HOSP INFECT, V57, P31, DOI 10.1016/j.jhin.2004.03.006; Hardy KJ, 2006, INFECT CONT HOSP EP, V27, P127, DOI 10.1086/500622; Hota B, 2004, CLIN INFECT DIS, V39, P1182, DOI 10.1086/424667; Muller MP, 2016, J HOSP INFECT, V92, P7, DOI 10.1016/j.jhin.2015.09.008; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Otter JA, 2015, J HOSP INFECT, V89, P16, DOI 10.1016/j.jhin.2014.09.008; Otter JA, 2013, AM J INFECT CONTROL, V41, pS6, DOI 10.1016/j.ajic.2012.12.004; Percival SL, 2015, J MED MICROBIOL, V64, P323, DOI 10.1099/jmm.0.000032; Ramphal Lilly, 2014, Proc (Bayl Univ Med Cent), V27, P88; Shen Y, 2013, J ANTIMICROB CHEMOTH, V68, P1818, DOI 10.1093/jac/dkt104; Thomas E, 2016, J HOSP INFECT; van Kleef E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-294; Wagenvoort JHT, 2011, J HOSP INFECT, V77, P282, DOI 10.1016/j.jhin.2010.11.008; Wagenvoort JHT, 2000, J HOSP INFECT, V45, P231, DOI 10.1053/jhin.2000.0757; Walker JT, 2014, J HOSP INFECT, V86, P16, DOI 10.1016/j.jhin.2013.10.003; Webb JS, 2003, J BACTERIOL, V185, P4585, DOI 10.1128/JB.185.15.4585-4592.2003; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763; Zingg W, 2015, LANCET INFECT DIS, V15, P212, DOI 10.1016/S1473-3099(14)70854-0	30	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182624	10.1371/journal.pone.0182624	http://dx.doi.org/10.1371/journal.pone.0182624			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28787014	gold, Green Submitted, Green Published			2022-12-26	WOS:000406998800052
J	Nakano, T; Kanai, Y; Amano, Y; Yoshimoto, T; Matsubara, D; Shibano, T; Tamura, T; Oguni, S; Katashiba, S; Ito, T; Murakami, Y; Fukayama, M; Murakami, T; Endo, S; Niki, T				Nakano, Tomoyuki; Kanai, Yoshihiko; Amano, Yusuke; Yoshimoto, Taichiro; Matsubara, Daisuke; Shibano, Tomoki; Tamura, Tomoko; Oguni, Sachiko; Katashiba, Shizuka; Ito, Takeshi; Murakami, Yoshinori; Fukayama, Masashi; Murakami, Takashi; Endo, Shunsuke; Niki, Toshiro			Establishment of highly metastatic KRAS mutant lung cancer cell sublines in long-term three-dimensional low attachment cultures	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HISTOLOGIC SUBTYPE; E-CADHERIN; ADENOCARCINOMA; GENE; INHIBITION; RESISTANCE; IMPACT; ZEB1; EMT	Decreased cell-substratum adhesion is crucially involved in metastasis. Previous studies demonstrated that lung cancer with floating cell clusters in histology is more likely to develop metastasis. In the present study, we investigated whether cancer cells in long-term, three-dimensional low attachment cultures acquire high metastatic potential; these cells were then used to examine the mechanisms underlying metastasis. Two KRAS-mutated adeno-carcinoma cell lines (A549 and H441) were cultured and selected on ultra-low attachment culture dishes, and the resulting cells were defined as FL (for floating) sublines. Cancer cells were inoculated into NOD/SCID mice via an intracardiac injection, and metastasis was evaluated using luciferase-based imaging and histopathology. In vitro cell growth (in attachment or suspension cultures), migration, and invasion were assayed. A whole genomic analysis was performed to identify key molecular alterations in FL sublines. Upon detachment on low-binding dishes, parental cells initially formed rounded spheroids with limited growth activity. However, over time in cultures, cells gradually formed smaller spheroids that grew slowly, and, after 3-4 months, we obtained FL sublines that regained prominent growth potential in suspension cultures. On ordinary dishes, FL cells reattached and exhibited a more spindle-shaped morphology than parental cells. No marked differences were observed in cell growth with attachment, migration, or invasion between FL sublines and parental cell lines; however, FL cells exhibited markedly increased growth potential under suspended conditions in vitro and stronger metastatic abilities in vivo. A genomic analysis identified epithelial-mesenchymal transition (EMT) and c-Myc amplification in A549-FL and H441-FL cells, respectively, as candidate mechanisms for metastasis. The growth potential of FL cells was markedly inhibited by lentiviral ZEB1 knockdown in A549-FL cells and by the inhibition of c-Myc through lentiviral knockdown or the pharmacological inhibitor JQ1 in H441FL cells. Long-term three-dimensional low attachment cultures may become a useful method for investigating the mechanisms underlying metastasis mediated by decreased cell-substratum adhesion.	[Nakano, Tomoyuki; Kanai, Yoshihiko; Yoshimoto, Taichiro; Endo, Shunsuke] Jichi Med Univ, Div Gen Thorac Surg, Shimotsuke, Tochigi, Japan; [Nakano, Tomoyuki; Amano, Yusuke; Yoshimoto, Taichiro; Matsubara, Daisuke; Tamura, Tomoko; Oguni, Sachiko; Katashiba, Shizuka; Niki, Toshiro] Jichi Med Univ, Div Integrat Pathol, Shimotsuke, Tochigi, Japan; [Ito, Takeshi; Murakami, Yoshinori] Univ Tokyo, Inst Med Sci, Mol Pathol Lab, Tokyo, Japan; [Fukayama, Masashi] Univ Tokyo, Grad Sch Med, Dept Human Pathol, Tokyo, Japan; [Murakami, Takashi] Saitama Med Univ, Fac Med, Dept Microbiol, Moroyama, Saitama, Japan	Jichi Medical University; Jichi Medical University; University of Tokyo; University of Tokyo; Saitama Medical University	Niki, T (corresponding author), Jichi Med Univ, Div Integrat Pathol, Shimotsuke, Tochigi, Japan.	tniki@jichi.ac.jp	niki, toshiro/K-8917-2012		JSPS KAKENHI [20390103, 23659189, 25670178]; MEXT-supported Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [17K16615] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT-supported Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by JSPS KAKENHI Grant Numbers 20390103, 23659189, and 25670178 (recipient, TN); and Subsidies to private Universities and the MEXT-supported Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Takumi Teratani (Division of Development of Advanced Therapy, Center for Development of Advanced Medical Technology, Jichi Medical University) for his technical advice on animal experiments. We would like to thank Miyoko Noguchi (Division of Integrative Pathology, Jichi Medical University) for secretarial work. This study was supported in part by JSPS KAKENHI Grant Numbers 20390103, 23659189, and 25670178; and Subsidies to private Universities and the MEXT-supported Program for the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Cai XP, 2015, ONCOTARGET, V6, P22905, DOI 10.18632/oncotarget.4416; Cappellen D, 2007, EMBO REP, V8, P70, DOI 10.1038/sj.embor.7400849; Douillard JY, 2010, J CLIN ONCOL, V28, P744, DOI 10.1200/JCO.2009.24.3030; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Hua JP, 2014, CANCER INFORM, V13, P1, DOI 10.4137/CIN.S13305; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kamata T, 2016, HISTOPATHOLOGY, V68, P356, DOI 10.1111/his.12763; Kelsey CR, 2009, CANCER-AM CANCER SOC, V115, P5218, DOI 10.1002/cncr.24625; Lockwood WW, 2012, P NATL ACAD SCI USA, V109, P19408, DOI 10.1073/pnas.1216363109; Mascaux C, 2005, BRIT J CANCER, V92, P131, DOI 10.1038/sj.bjc.6602258; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; Nitadori J, 2013, JNCI-J NATL CANCER I, V105, P1212, DOI 10.1093/jnci/djt166; Ohira T, 2003, P NATL ACAD SCI USA, V100, P10429, DOI 10.1073/pnas.1734137100; Paoli P, 2013, BBA-MOL CELL RES, V1833, P3481, DOI 10.1016/j.bbamcr.2013.06.026; Riely Gregory J, 2009, Proc Am Thorac Soc, V6, P201, DOI 10.1513/pats.200809-107LC; Roussos ET, 2010, CANCER RES, V70, P7360, DOI 10.1158/0008-5472.CAN-10-1208; Sanchez-Beato M, 2003, BLOOD, V101, P1220, DOI 10.1182/blood-2002-07-2009; Sanchez-Mora N, 2008, HUM PATHOL, V39, P324, DOI 10.1016/j.humpath.2007.05.029; Schraml P, 1999, CLIN CANCER RES, V5, P1966; Shimamura T, 2013, CLIN CANCER RES, V19, P6183, DOI 10.1158/1078-0432.CCR-12-3904; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Smit MA, 2011, ONCOGENE, V30, P3735, DOI 10.1038/onc.2011.96; Solis LM, 2012, CANCER-AM CANCER SOC, V118, P2889, DOI 10.1002/cncr.26584; Steinestel K, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-17; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takeyama Y, 2010, CANCER LETT, V296, P216, DOI 10.1016/j.canlet.2010.04.008; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Travis WD., 2015, J THORAC ONCOL, V10, P1243, DOI [10.1097/JTO.0000000000000630, DOI 10.1097/JTO.0000000000000630]; Tsao AS, 2016, J THORAC ONCOL, V11, P613, DOI 10.1016/j.jtho.2016.03.012; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	33	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0181342	10.1371/journal.pone.0181342	http://dx.doi.org/10.1371/journal.pone.0181342			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28786996	Green Submitted, gold, Green Published			2022-12-26	WOS:000406998800007
J	Pilyugin, M; Descloux, P; Andre, PA; Laszlo, V; Dome, B; Hegedus, B; Sardy, S; Janes, S; Bianco, A; Laurent, GJ; Irminger-Finger, I				Pilyugin, Maxim; Descloux, Pascaline; Andre, Pierre-Alain; Laszlo, Viktoria; Dome, Balazs; Hegedus, Balazs; Sardy, Sylvain; Janes, Samuel; Bianco, Andrea; Laurent, Geoffrey J.; Irminger-Finger, Irmgard			BARD1 serum autoantibodies for the detection of lung cancer	PLOS ONE			English	Article							EXPRESSION; BIOMARKERS; ISOFORMS; SUSCEPTIBILITY; IDENTIFICATION; VALIDATION; SURVIVAL; BREAST; BRCA1	Purpose Currently the screening for lung cancer for risk groups is based on Computed Tomography (CT) or low dose CT (LDCT); however, the lung cancer death rate has not decreased significantly with people undergoing LDCT. We aimed to develop a simple reliable blood test for early detection of all types of lung cancer based on the immunogenicity of aberrant forms of BARD1 that are specifically upregulated in lung cancer. Methods ELISA assays were performed with a panel of BARD1 epitopes to detect serum levels of antibodies against BARD1 epitopes. We tested 194 blood samples from healthy donors and lung cancer patients with a panel of 40 BARD1 antigens. Using fitted Lasso logistic regression we determined the optimal combination of BARD1 antigens to be used in ELISA for discriminating lung cancer from healthy controls. Random selection of samples for training sets or validations sets was applied to validate the accuracy of our test. Results Fitted Lasso logistic regression models predict high accuracy of the BARD1 autoimmune antibody test with an AUC = 0.96. Validation in independent samples provided and AUC = 0.86 and identical AUCs were obtained for combined stages 1-3 and late stage 4 lung cancers. The BARD1 antibody test is highly specific for lung cancer and not breast or ovarian cancer. Conclusion The BARD1 lung cancer test shows higher sensitivity and specificity than previously published blood tests for lung cancer detection and/or diagnosis or CT scans, and it could detect all types and all stages of lung cancer. This BARD1 lung cancer test could therefore be further developed as i) screening test for early detection of lung cancers in high-risk groups, and ii) diagnostic aid in complementing CT scan.	[Pilyugin, Maxim; Andre, Pierre-Alain; Irminger-Finger, Irmgard] Geneva Univ Hosp, Med Genet & Labs, Dept Gynecol & Obstet, Mol Gynecol & Obstet Lab, Geneva, Switzerland; [Descloux, Pascaline; Sardy, Sylvain] Univ Geneva, Dept Math, Geneva, Switzerland; [Laszlo, Viktoria; Dome, Balazs; Hegedus, Balazs] Med Univ Vienna, Comprehens Canc Ctr Vienna, Dept Surg, Div Thorac Surg, Vienna, Austria; [Dome, Balazs] Natl Koranyi Inst Pulmonol, Budapest, Hungary; [Dome, Balazs] Semmelweis Univ, Natl Inst Oncol, Dept Thorac Surg, Budapest, Hungary; [Hegedus, Balazs] Semmelweis Univ, Hungarian Acad Sci, Mol Oncol Res Grp, Budapest, Hungary; [Janes, Samuel] UCL, Rayne Inst, UCL Resp, Lungs Living Res Ctr, London, England; [Bianco, Andrea] Univ Molise, Dipartimento Med & Sci Salute V Tiberio, Campobasso, Italy; [Laurent, Geoffrey J.; Irminger-Finger, Irmgard] Univ Western Australia, Inst Resp Hlth, Perth, WA, Australia; [Laurent, Geoffrey J.; Irminger-Finger, Irmgard] Harry Perkins Inst Med Res, Perth, WA, Australia	University of Geneva; University of Geneva; Medical University of Vienna; National Institute of Oncology Hungary; Semmelweis University; Hungarian Academy of Sciences; Semmelweis University; University of London; King's College London; University College London; University of Molise; University of Western Australia; Harry Perkins Institute of Medical Research	Pilyugin, M (corresponding author), Geneva Univ Hosp, Med Genet & Labs, Dept Gynecol & Obstet, Mol Gynecol & Obstet Lab, Geneva, Switzerland.	maxim.pilyugin@unige.ch; irmgard.irminger@unige.ch	Hegedus, Balazs/B-6076-2008; laszlo, viktoria/A-4667-2017	Hegedus, Balazs/0000-0002-4341-4153; laszlo, viktoria/0000-0002-6567-3965; Dome, Balazs/0000-0001-8799-8624; Janes, Sam/0000-0002-6634-5939	European Research Commission FP7 Capacities [262318]; BARD1AG SA Geneva, Switzerland; KTIA AIK [12-1-2013-0041]; Hungarian National Research, Development and Innovation Office; Semmelweis University Start-Up grant [40148-11658]; Vienna Fund for Innovative Interdisciplinary Cancer Research;  [K109626];  [K108465];  [SNN114490]	European Research Commission FP7 Capacities; BARD1AG SA Geneva, Switzerland; KTIA AIK; Hungarian National Research, Development and Innovation Office; Semmelweis University Start-Up grant; Vienna Fund for Innovative Interdisciplinary Cancer Research; ; ; 	This work was supported by a grant from the European Research Commission FP7 Capacities project no. 262318 and by contributions from BARD1AG SA Geneva, Switzerland. BD was supported by KTIA AIK 12-1-2013-0041, the Hungarian National Research, Development and Innovation Office (K109626, K108465 and SNN114490), the Semmelweis University Start-Up grant (40148-11658), and the Vienna Fund for Innovative Interdisciplinary Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from the European Research Commission FP7 Capacities project no. 262318 and by contributions from BARD1AG SA Geneva, Switzerland.; BD was supported by KTIA AIK 12-1-2013-0041, the Hungarian National Research, Development and Innovation Office (K109626, K108465 and SNN114490), the Semmelweis University Start-Up grant (40148-11658), and the Vienna Fund for Innovative Interdisciplinary Cancer Research.	Baer R, 2002, CURR OPIN GENET DEV, V12, P86, DOI 10.1016/S0959-437X(01)00269-6; Bartolucci R, 2009, CLIN LUNG CANCER, V10, P47, DOI 10.3816/CLC.2009.n.007; Bosse KR, 2012, CANCER RES, V72, P2068, DOI 10.1158/0008-5472.CAN-11-3703; Boyle P, 2011, ANN ONCOL, V22, P383, DOI 10.1093/annonc/mdq361; Broodman I, 2016, J PROTEOME RES; Brothers JF, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-168; Cancer Research UK, 2015, LUNG CANC INC STAT; Capasso M, 2009, NAT GENET, V41, P718, DOI 10.1038/ng.374; Chapman CJ, 2008, THORAX, V63, P228, DOI 10.1136/thx.2007.083592; Chapman CJ, 2012, TUMOR BIOL, V33, P1319, DOI 10.1007/s13277-012-0379-2; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; Feki A, 2005, ONCOGENE, V24, P3726, DOI 10.1038/sj.onc.1208491; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gautier F, 2000, CANCER RES, V60, P6895; Hassanein M, 2012, CANCER PREV RES, V5, P992, DOI 10.1158/1940-6207.CAPR-11-0441; Henschke CI, 2006, NEW ENGL J MED, V355, P1763, DOI 10.1056/NEJMoa060476; Irminger-Finger I, 2006, NAT REV CANCER, V6, P382, DOI 10.1038/nrc1878; Irminger-Finger I, 2001, MOL CELL, V8, P1255, DOI 10.1016/S1097-2765(01)00406-3; Irminger-Finger I, 1998, J CELL BIOL, V143, P1329, DOI 10.1083/jcb.143.5.1329; Irminger-Finger I, 2010, GYNECOL ONCOL, V117, P211, DOI 10.1016/j.ygyno.2009.10.079; Jefford CE, 2004, ONCOGENE, V23, P3509, DOI 10.1038/sj.onc.1207427; Kargul J, 2015, INT J BIOCHEM CELL B, V63, P1, DOI 10.1016/j.biocel.2015.03.012; Lam S, 2011, CANCER PREV RES, V4, P1126, DOI 10.1158/1940-6207.CAPR-10-0328; Li L, 2007, CANCER RES, V67, P11876, DOI 10.1158/0008-5472.CAN-07-2370; Lopez-Raton M, 2014, J STAT SOFTWARE, V61; Matsuzaki J, 2017, INT J CLIN ONCOL, V22, P413, DOI 10.1007/s10147-017-1104-3; McWilliams A, 2013, NEW ENGL J MED, V369, P910, DOI 10.1056/NEJMoa1214726; Murray A, 2010, ANN ONCOL, V21, P1687, DOI 10.1093/annonc/mdp606; Nakamura H, 2017, SURG TODAY; National Cancer Institute, 2016, CANC STAT REV 1975 2; Nesterova M, 2006, BBA-MOL BASIS DIS, V1762, P398, DOI 10.1016/j.bbadis.2005.12.010; Ozden O, 2016, SCI REP-UK, V6, DOI 10.1038/srep26273; Pilyugin M, 2016, ONCOTARGET, V5; Reguart N, 2008, CLIN LUNG CANCER, V9, P331, DOI 10.3816/CLC.2008.n.048; Ribbing J, 2007, J PHARMACOKINET PHAR, V34, P485, DOI 10.1007/s10928-007-9057-1; Robertson JFR, 2005, J CLIN ONCOL, V23, p16S; Rosell R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001129; Ryser S, 2009, CANCER RES, V69, P1125, DOI 10.1158/0008-5472.CAN-08-2134; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sone S, 2001, BRIT J CANCER, V84, P25, DOI 10.1054/bjoc.2000.1531; Sporn JC, 2011, CLIN CANCER RES, V17, P5451, DOI 10.1158/1078-0432.CCR-11-0263; Tan EM, 2001, J CLIN INVEST, V108, P1411, DOI 10.1172/JCI200114451; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; World Health Organization, 2013, GLOBOCAN 2012 EST CA; Wu JY, 2006, INT J CANCER, V118, P1215, DOI 10.1002/ijc.21428; Xie Y, 2012, LANCET, V379, P785, DOI 10.1016/S0140-6736(12)60154-8; Zaenker P, 2013, CANCER EPIDEM BIOMAR, V22, P2161, DOI 10.1158/1055-9965.EPI-13-0621; Zhang JY, 2003, CANCER EPIDEM BIOMAR, V12, P136; Zhang YQ, 2012, BRIT J CANCER, V107, P675, DOI 10.1038/bjc.2012.297; Zhang YQ, 2012, INT J CANCER, V131, P83, DOI 10.1002/ijc.26346; Zhong L, 2006, J THORAC ONCOL, V1, P513, DOI 10.1097/01243894-200607000-00003	52	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182356	10.1371/journal.pone.0182356	http://dx.doi.org/10.1371/journal.pone.0182356			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28786985	Green Submitted, Green Published, gold			2022-12-26	WOS:000406998800031
J	Cho, JH; Guilminault, C; Joo, YH; Jin, SK; Han, KD; Park, CS				Cho, Jung-Hae; Guilminault, Christian; Joo, Young-Hoon; Jin, Sang-Kyun; Han, Kyung-Do; Park, Chan-Soon			A possible association between dysphonia and sleep duration: A cross-sectional study based on the Korean National Health and nutrition examination surveys from 2010 to 2012	PLOS ONE			English	Article							QUALITY-OF-LIFE; GENERAL-POPULATION; VOICE DISORDERS; FUNCTIONAL DYSPHONIA; PREVALENCE; ADULTS; MORTALITY; COHORT; APNEA; METAANALYSIS	Background Sleep is important in terms of good general health and appropriate sleep duration has been linked to quality-of-life. Dysphonia may impair communication and social relationships, and is thus also closely related to quality-of-life. No large-scale, cross-sectional epidemiological study of a sample representative of the population of an entire country has yet assessed the possible existence of a relationship between sleep duration and dysphonia. Methods We investigated a possible association between subjective voice problems and self-reported sleep duration in South Korean subjects using 2010-2012 data from the Korean National Health and Nutrition Examination Survey (KNHANES). Cross-sectional data on 17,806 adults (7,578 males and 10,228 females) over the age of 19 years who completed the KNHANES were analyzed. All participants reported voice problems (if present) and their daily average sleep duration using a self-reporting questionnaire. Sleep duration was classified into five categories as follows: <= 5, 6, 7, 8, and >= 9 h/day. Results The overall prevalence of dysphonia was 6.8%; 5.7% in males and 7.7% in females. The prevalence for dysphonia by sleep duration exhibited a U-shape, with the lowest point being at sleep duration of 7-8h. After adjustment for covariates (age, sex, smoking status, alcohol consumption, regular exercise, low income, high-level education), a sleep duration of <= 5 h (OR = 1.454; 95% CI, 1.153-1.832) and a sleep duration of >= 9 h (OR = 1.365; 95% CI, 1.017-1.832) were significantly associated with dysphonia, compared to a sleep duration of 7 h. In terms of gender, males who slept for >= 9 h were at a 2-fold (OR = 2.028; 95% CI, 1.22-3.35) higher odds for dysphonia (p < 0.05) compared to those who slept for 7 h. A sleep duration <= 5 h was associated with a 1.6-fold (OR = 1.574; 95% CI, 1.203-2.247) higher odds of dysphonia >= 3 weeks in duration (long-term dysphonia). Conclusions This is the first study to show that both short and long sleep duration were significantly associated with the development of dysphonia. The association between sleep duration and dysphonia was more marked in males than females. A sleep duration <= 5 h had a significant impact on the prevalence of long-term dysphonia.	[Cho, Jung-Hae; Joo, Young-Hoon; Jin, Sang-Kyun; Park, Chan-Soon] Catholic Univ Korea, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea; [Guilminault, Christian] Stanford Univ, Dept Psychiat & Behav Sci, Ctr Sleep Med, Redwood City, CA USA; [Han, Kyung-Do] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea	Catholic University of Korea; Stanford University; Catholic University of Korea	Park, CS (corresponding author), Catholic Univ Korea, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea.	pcs012@catholic.ac.kr	Joo, Young Hoon/AAU-7285-2020	Joo, Young Hoon/0000-0002-4662-1916				Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Bagnall AD, 2011, J VOICE, V25, P447, DOI 10.1016/j.jvoice.2010.10.020; BAKER SR, 1980, ARCH OTOLARYNGOL, V106, P486; Bhattacharyya N, 2014, LARYNGOSCOPE, V124, P2359, DOI 10.1002/lary.24740; Byeon H, 2015, ANN OTO RHINOL LARYN, V124, P770, DOI 10.1177/0003489415583684; Byeon H, 2015, PEERJ, V3, DOI 10.7717/peerj.912; Byeon HK, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/820654; Chiu HFK, 2013, BEHAV SLEEP MED, V11, P360, DOI 10.1080/15402002.2013.764524; Cohen SM, 2010, LARYNGOSCOPE, V120, P2022, DOI 10.1002/lary.21058; Deary V, 2011, CURR OPIN OTOLARYNGO, V19, P150, DOI 10.1097/MOO.0b013e328346494d; Eskiizmir G, 2009, MED HYPOTHESES, V73, P706, DOI 10.1016/j.mehy.2009.04.042; Faubel R, 2009, SLEEP, V32, P1059; Ferrie JE, 2007, SLEEP, V30, P1659, DOI 10.1093/sleep/30.12.1659; Gallicchio L, 2009, J SLEEP RES, V18, P148, DOI 10.1111/j.1365-2869.2008.00732.x; Gilani S, 2015, OTOLARYNGOL HEAD NEC; Gottlieb DJ, 2006, SLEEP, V29, P1009, DOI 10.1093/sleep/29.8.1009; Hah JH, 2015, LARYNGOSCOPE, V125, P2536, DOI 10.1002/lary.25424; Ikehara S, 2009, SLEEP, V32, P295, DOI 10.1093/sleep/32.3.295; Jones SM, 2006, CLIN OTOLARYNGOL, V31, P411, DOI 10.1111/j.1749-4486.2006.01291.x; Kim KH, 2015, J VOICE; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Lo CMH, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-72; McGlinchey EL, 2011, SLEEP, V34, P1233, DOI 10.5665/SLEEP.1246; Merrill RM, 2011, LARYNGOSCOPE, V121, P2004, DOI 10.1002/lary.21895; Murry T, 2004, J VOICE, V18, P183, DOI 10.1016/j.jvoice.2003.11.003; Nieto FJ, 2012, AM J RESP CRIT CARE, V186, P190, DOI 10.1164/rccm.201201-0130OC; Novakovic D, 2015, CURR OPIN OTOLARYNGO, V23, P464, DOI 10.1097/MOO.0000000000000209; O'Hara J, 2011, OTOLARYNG HEAD NECK, V144, P921, DOI 10.1177/0194599811401236; Ohayon MM, 2013, ANN NEUROL, V73, P785, DOI 10.1002/ana.23818; Parish JM, 2009, CHEST, V135, P563, DOI 10.1378/chest.08-0934; Patel SR, 2006, SLEEP, V29, P881, DOI 10.1093/sleep/29.7.881; Rosen CA, 2000, OTOLARYNG CLIN N AM, V33, P1035, DOI 10.1016/S0030-6665(05)70262-0; Roy N, 2005, LARYNGOSCOPE, V115, P1988, DOI 10.1097/01.mlg.0000179174.32345.41; Schwartz SR, 2009, OTOLARYNG HEAD NECK, V141, pS1, DOI 10.1016/j.otohns.2009.06.744; Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062; Van Houtte E, 2010, LARYNGOSCOPE, V120, P306, DOI 10.1002/lary.20696; Ward PD, 2002, J VOICE, V16, P303, DOI 10.1016/S0892-1997(02)00101-7; Willinger U, 2005, PSYCHIAT RES, V134, P85, DOI 10.1016/j.psychres.2003.07.007; Yeo Yohwan, 2013, J Prev Med Public Health, V46, P271, DOI 10.3961/jpmph.2013.46.5.271; Zanation AM, 2005, SLEEP MED REV, V9, P453, DOI 10.1016/j.smrv.2005.05.003; Zhai L, 2015, DEPRESS ANXIETY, V32, P664, DOI 10.1002/da.22386	41	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0182286	10.1371/journal.pone.0182286	http://dx.doi.org/10.1371/journal.pone.0182286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28783741	gold, Green Published, Green Submitted			2022-12-26	WOS:000406944300025
J	Thurstan, RH; Game, E; Pandolfi, JM				Thurstan, Ruth H.; Game, Edward; Pandolfi, John M.			Popular media records reveal multi-decadal trends in recreational fishing catch rates	PLOS ONE			English	Article							HISTORICAL DECLINES; IMPACTS; DEGRADATION; MANAGEMENT; AUSTRALIA; FISHERY; FLORIDA	Despite threats to human wellbeing from ecological degradation, public engagement with this issue remains at low levels. However, studies have shown that crafting messages to resonate with people's personal experiences can enhance engagement. Recreational fishing is one of the principal ways in which people interact with aquatic environments, but long-term data from this perspective are considered rare. We uncovered 852 popular media records of recreational fishing for an Australian estuary across a 140-year period. Using information contained in these articles we analysed the species composition of recreational catches over time and constructed two distinct time series of catch and effort (n fish fisher(-1) trip(-1); kg fish fisher(-1) trip(-1)) for recreational fishing trips and fishing club competitions (mean n and kg fish caught across all competitors, and n and kg fish caught by the competition winner). Reported species composition remained similar over time. Catch rates reported from recreational fishing trips (1900-1998) displayed a significant decline, averaging 32.5 fish fisher(-1) trip(-1) prior to 1960, and 18.8 fish fisher(-1) trip(-1) post-1960. Mean n fish fisher(-1) competition(-1) (1913-1983) also significantly declined, but best n fish fisher(-1) competition(-1) (1925-1980) displayed no significant change, averaging 31.2 fish fisher(-1) competition(-1) over the time series. Mean and best kg fish fisher(-1) competition(-1) trends also displayed no significant change, averaging 4.2 and 9.9 kg fisher(-1) competition(-1), respectively. These variable trends suggest that while some fishers experienced diminishing returns in this region over the last few decades, the most skilled inshore fishers were able to maintain their catch rates, highlighting the difficulties inherent in crafting conservation messages that will resonate with all sections of a community. Despite these challenges, this research demonstrates that popular media sources can provide multiple long-term trends at spatial scales, in units and via a recreational experience that many people can relate to.	[Thurstan, Ruth H.] Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Warrnambool, Vic, Australia; [Thurstan, Ruth H.; Pandolfi, John M.] Univ Queensland, Australian Res Council Ctr Excellence Coral Reef, St Lucia, Qld, Australia; [Thurstan, Ruth H.; Pandolfi, John M.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Game, Edward] Nature Conservancy, Conservat Sci, South Brisbane, Qld, Australia; [Game, Edward] Univ Queensland, Biodivers & Conservat Sci Ctr, St Lucia, Qld, Australia	Deakin University; University of Queensland; University of Queensland; Nature Conservancy; University of Queensland	Thurstan, RH (corresponding author), Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Warrnambool, Vic, Australia.; Thurstan, RH (corresponding author), Univ Queensland, Australian Res Council Ctr Excellence Coral Reef, St Lucia, Qld, Australia.; Thurstan, RH (corresponding author), Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia.	r.thurstan@deakin.edu.au	Pandolfi, John M/A-3121-2009; Game, Edward/AAD-2289-2020; Thurstan, Ruth/K-5551-2014	Pandolfi, John M/0000-0003-3047-6694; Game, Edward/0000-0003-4707-9281; Thurstan, Ruth/0000-0002-8045-1631	Noosa Council; Thomas Foundation; Australian Research Council's Centre of Excellence; Nature Conservancy	Noosa Council; Thomas Foundation; Australian Research Council's Centre of Excellence(Australian Research Council); Nature Conservancy	RT received support from the Noosa Council, and from a Barbara Thomas Fellowship from the Thomas Foundation and the Nature Conservancy. JP is supported by the Australian Research Council's Centre of Excellence for Coral Reef Studies.	Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, LME4 LINEAR MIXED EF; Buckley SM, 2017, CONSERY BIO IN PRESS; Campbell RA, 2003, MAR FRESHWATER RES, V54, P447, DOI 10.1071/MF01275; Cato N, 1979, THE NOOSA STORY; Chess C, 2007, CREATING A CLIMATE FOR CHANGE: COMMUNICATING CLIMATE CHANGE AND FACILITATING SOCIAL CHANGE, P223, DOI 10.1017/CBO9780511535871.017; Choi S.S., 2010, J SYST CYBERN INFORM, V8, P43; Clarke K. R., 2001, CHANGES MARINE COMMU; Cooke SJ, 2004, BIOSCIENCE, V54, P857, DOI 10.1641/0006-3568(2004)054[0857:TRORFI]2.0.CO;2; Cooke SJ, 2016, FISH FISH, V17, P249, DOI 10.1111/faf.12076; Frawley J, 2015, J AUST STUD, V39, P307, DOI 10.1080/14443058.2015.1052834; Gartside DF, 1999, FISH RES, V41, P47, DOI 10.1016/S0165-7836(99)00007-7; Gaynor A, 2016, GEOFORUM, V77, P114, DOI 10.1016/j.geoforum.2016.10.018; Hewson I, 2001, LIMNOL OCEANOGR, V46, P1734, DOI 10.4319/lo.2001.46.7.1734; Ihde TF, 2011, FISH RES, V108, P268, DOI 10.1016/j.fishres.2010.12.016; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Lewin WC, 2006, REV FISH SCI, V14, P305, DOI 10.1080/10641260600886455; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; McClenachan L, 2013, ENVIRON HIST-US, V18, P76, DOI 10.1093/envhis/ems110; McClenachan Loren, 2009, Endangered Species Research, V7, P175, DOI 10.3354/esr00167; McPhee D. P., 2002, Pacific Conservation Biology, V8, P40; Monks C, 2000, NOOSA WAY IT WAS WAY; Neis B, 1999, CAN J FISH AQUAT SCI, V56, P1949, DOI 10.1139/cjfas-56-10-1949; Novacek MJ, 2008, P NATL ACAD SCI USA, V105, P11571, DOI 10.1073/pnas.0802599105; Oksanen J., **DATA OBJECT**; Parsons DM, 2009, NEW ZEAL J MAR FRESH, V43, P965, DOI 10.1080/00288330909510054; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Platten JR, 2004, HIST TRENDS RECREATI; POLLOCK BR, 1983, J FISH BIOL, V22, P125, DOI 10.1111/j.1095-8649.1983.tb04732.x; Pollock BR, 1983, P R SOC QUEENSL, V94, P85; R Core Team, 2021, R LANGUAGE ENV STAT; Scannell L, 2013, ENVIRON BEHAV, V45, P60, DOI 10.1177/0013916511421196; Schlacher TA, 2007, MAR POLLUT BULL, V54, P1762, DOI 10.1016/j.marpolbul.2007.07.014; Thurstan RH, 2015, HIST ECOLOGY NOOSA E; Thwaites A. J., 1994, Memoirs of the Queensland Museum, V35, P249; Young MAL, 2014, ENVIRON CONSERV, V41, P350, DOI 10.1017/S0376892914000046	36	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0182345	10.1371/journal.pone.0182345	http://dx.doi.org/10.1371/journal.pone.0182345			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC6IS	28777809	Green Published, Green Submitted, gold			2022-12-26	WOS:000406944300031
J	Cappellari, GG; Semolic, A; Ruozi, G; Vinci, P; Guarnieri, G; Bortolotti, F; Barbetta, D; Zanetti, M; Giacca, M; Barazzoni, R				Cappellari, Gianluca Gortan; Semolic, Annamaria; Ruozi, Giulia; Vinci, Pierandrea; Guarnieri, Gianfranco; Bortolotti, Francesca; Barbetta, Davide; Zanetti, Michela; Giacca, Mauro; Barazzoni, Rocco			Unacylated ghrelin normalizes skeletal muscle oxidative stress and prevents muscle catabolism by enhancing tissue mitophagy in experimental chronic kidney disease	FASEB JOURNAL			English	Article						autophagy; uremia; mitochondria	INSULIN-RESISTANCE; P38 MAPK; INFLAMMATION; METABOLISM; EXPRESSION; AUTOPHAGY; PATHWAY; LIVER; HYPERGLYCEMIA; TRANSDUCTION	Unacylated ghrelin (UnAG) may lower skeletal muscle oxidative stress, inflammation, and insulin resistance in lean and obese rodents. UnAG-induced autophagy activation may contribute to these effects, likely involving removal of dysfunctional mitochondria (mitophagy) and redox state maintenance. In chronic kidney disease (CKD) oxidative stress, inflammation and insulin resistance may negatively influence patient outcome by worsening nutritional state throughmusclemass loss. Herewe showin a 5/ 6 nephrectomy (Nx) CKDratmodel that 4ds. c. UnAG administration (200mg twice aday) normalizes CKD-induced loss of gastrocnemius muscle mass and a cluster of high tissue mitochondrial reactive oxygen species generation, high proinflammatory cytokines, and low insulin signaling activation. Consistent with these results, human uremic serum enhanced mitochondrial reactive oxygen species generation and lowered insulin signaling activation in C2C12 myotubes while concomitant UnAG incubation completely prevented these effects. Importantly, UnAG enhanced muscle mitophagy in vivo and silencing RNA-mediated autophagy protein 5 silencing blocked UnAG activities in myotubes. UnAG therefore normalizes CKD-induced skeletal muscle oxidative stress, inflammation, and low insulin signaling as well as muscle loss. UnAG effects are mediated by autophagy activation at the mitochondrial level. UnAG administration and mitophagy activation are novel potential therapeutic strategies for skeletal muscle metabolic abnormalities and their negative clinical impact in CKD.-Gortan Cappellari, G., Semolic, A., Ruozi, G., Vinci, P., Guarnieri, G., Bortolotti, F., Barbetta, D., Zanetti, M., Giacca, M., Barazzoni, R. Unacylated ghrelin normalizes skeletal muscle oxidative stress and prevents muscle catabolism by enhancing tissue mitophagy in experimental chronic kidney disease.	[Cappellari, Gianluca Gortan; Semolic, Annamaria; Vinci, Pierandrea; Guarnieri, Gianfranco; Zanetti, Michela; Barazzoni, Rocco] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Barbetta, Davide] Univ Trieste, Anim Facil, Trieste, Italy; [Ruozi, Giulia; Bortolotti, Francesca; Giacca, Mauro] Int Ctr Genet Engn & Biotechnol, Mol Med Lab, Trieste, Italy	University of Trieste; University of Trieste; International Center for Genetic Engineering & Biotechnology (ICGEB)	Barazzoni, R (corresponding author), Univ Trieste, Dept Med Surg & Hlth Sci, Osped Cattinara, Str Fiume 447, I-34149 Trieste, Italy.	barazzon@units.it	; GIACCA, MAURO/J-9287-2016	ZANETTI, MICHELA/0000-0002-2634-6363; GIACCA, MAURO/0000-0003-2927-7225; Gortan Cappellari, Gianluca/0000-0002-0438-5003	European Society for Clinical Nutrition and Metabolism (ESPEN)	European Society for Clinical Nutrition and Metabolism (ESPEN)	The authors thank M. Stebel and R. Munao (both from the University of Trieste), for excellent assistance in in vivo procedures; G. Spirito (University of Trieste) and A. Falcione (International Centre for Genetic Engineering and Biotechnology, Trieste, Italy) are acknowledged for their skillful technical assistance in ex vivo and in vitro experiments. This work was supported, in part, by the European Society for Clinical Nutrition and Metabolism (ESPEN) through a fellowship to G.G.C. Presented, in part, in abstract form at ESPEN congresses in 2015 and 2016. The authors declare no conflicts of interest.	Barazzoni R, 2005, AM J PHYSIOL-ENDOC M, V288, pE228, DOI 10.1152/ajpendo.00115.2004; Barazzoni R, 2004, CURR OPIN CLIN NUTR, V7, P97, DOI 10.1097/00075197-200401000-00015; Barazzoni R, 2012, DIABETOLOGIA, V55, P773, DOI 10.1007/s00125-011-2396-x; Barazzoni R, 2008, CLIN NUTR, V27, P142, DOI 10.1016/j.clnu.2007.06.013; Barazzoni R, 2007, OBESITY, V15, P2614, DOI 10.1038/oby.2007.313; Barazzoni R, 2006, AM J PHYSIOL-ENDOC M, V291, pE428, DOI 10.1152/ajpendo.00225.2006; Barazzoni R, 2012, J RENAL NUTR, V22, P171, DOI 10.1053/j.jrn.2011.10.017; Barazzoni R, 2010, KIDNEY INT, V77, P23, DOI 10.1038/ki.2009.411; Broglio F, 2001, J CLIN ENDOCR METAB, V86, P5083, DOI 10.1210/jc.86.10.5083; Byun JY, 2009, CARCINOGENESIS, V30, P1880, DOI 10.1093/carcin/bgp235; Cantarin MPM, 2014, NEPHROL DIAL TRANSPL, V29, P2268, DOI 10.1093/ndt/gfu249; Cappellari GG, 2016, DIABETES, V65, P874, DOI 10.2337/db15-1019; Chen CY, 2009, PHARMACOL REV, V61, P430, DOI 10.1124/pr.109.001958; Crowe AV, 2007, NEPHROL DIAL TRANSPL, V22, P1177, DOI 10.1093/ndt/gfl721; Enoki Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep32084; Filiopoulos V, 2009, INT J ARTIF ORGANS, V32, P872, DOI 10.1177/039139880903201206; FOLLI F, 1986, METABOLISM, V35, P989, DOI 10.1016/0026-0495(86)90034-X; FRIEDMAN JE, 1991, AM J PHYSIOL, V261, pE87, DOI 10.1152/ajpendo.1991.261.1.E87; Gao X, 2010, BRIT J NUTR, V103, P608, DOI 10.1017/S0007114509992108; Guarnieri G, 2009, J RENAL NUTR, V19, P20, DOI 10.1053/j.jrn.2008.11.014; Holecek M, 2012, INT J EXP PATHOL, V93, P157, DOI 10.1111/j.1365-2613.2012.00812.x; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Keren A, 2006, MOL CELL ENDOCRINOL, V252, P224, DOI 10.1016/j.mce.2006.03.017; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Koppe L, 2014, NEPHROL DIAL TRANSPL, V29, P1666, DOI 10.1093/ndt/gft435; Kovesdy CP, 2009, SEMIN NEPHROL, V29, P3, DOI 10.1016/j.semnephrol.2008.10.002; Li YP, 2005, FASEB J, V19, P362, DOI 10.1096/fj.04-2364com; Lovric J, 2012, MOL THER, V20, P2087, DOI 10.1038/mt.2012.144; Meyer TW, 2007, NEW ENGL J MED, V357, P1316, DOI 10.1056/NEJMra071313; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Muller TD, 2015, MOL METAB, V4, P437, DOI 10.1016/j.molmet.2015.03.005; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Nishikawa M, 2015, NEPHROL DIAL TRANSPL, V30, P934, DOI 10.1093/ndt/gfv103; Ruozi G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8388; Ryter SW, 2014, CURR OPIN CLIN NUTR, V17, P329, DOI 10.1097/MCO.0000000000000068; Sandri M, 2013, INT J BIOCHEM CELL B, V45, P2121, DOI 10.1016/j.biocel.2013.04.023; Sarparanta J, 2017, CURR DIABETES REV, V13, P352, DOI 10.2174/1573399812666160217122530; SATO E, 2016, SCI REP, V6; Stenvinkel P, 1999, KIDNEY INT, V55, P1899, DOI 10.1046/j.1523-1755.1999.00422.x; Tong XX, 2012, PEPTIDES, V38, P217, DOI 10.1016/j.peptides.2012.06.020; Verzola D, 2017, J CACHEXIA SARCOPENI, V8, P131, DOI 10.1002/jcsm.12129; Wang DT, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/684965; Wang XNH, 2014, NAT REV NEPHROL, V10, P504, DOI 10.1038/nrneph.2014.112; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Workeneh BT, 2006, J AM SOC NEPHROL, V17, P3233, DOI 10.1681/ASN.2006020131; Workeneh BT, 2010, AM J CLIN NUTR, V91, p1128S, DOI 10.3945/ajcn.2010.28608B; Yamamoto N, 2010, ANAL BIOCHEM, V404, P238, DOI 10.1016/j.ab.2010.05.012; Yao ZY, 2016, AUTOPHAGY, V12, P1971, DOI 10.1080/15548627.2016.1235127; Yu M, 2003, J PHYSIOL-LONDON, V546, P327, DOI 10.1113/jphysiol.2002.034223; Zanetti M, 2008, J RENAL NUTR, V18, P70, DOI 10.1053/j.jrn.2007.10.015; Zhang Q, 2015, NAT IMMUNOL, V16, P458, DOI 10.1038/ni.3130	51	20	20	2	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2017	31	12					5159	+		10.1096/fj.201700126R	http://dx.doi.org/10.1096/fj.201700126R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FO2EX	28778977	Green Submitted			2022-12-26	WOS:000416588300004
J	Gebre, ST; Cameron, SA; Li, L; Babu, YS; Schramm, VL				Gebre, Sara T.; Cameron, Scott A.; Li, Lei; Babu, Y. S.; Schramm, Vern L.			Intracellular rebinding of transition-state analogues provides extended in vivo inhibition lifetimes on human purine nucleoside phosphorylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESIDENCE TIME; IMMUCILLIN-H; CONFORMATIONAL DYNAMICS; BINDING	Purine nucleoside phosphorylase (PNP) is part of the human purine salvage pathway. Its deficiency triggers apoptosis of activated T-cells, making it a target for T-cell proliferative disorders. Transition-state analogues of PNP bind with picomolar (pM) dissociation constants. Tight-binding PNP inhibitors show exceptionally long lifetimes on the target enzyme. We solve the mechanism of the target residence time by comparing functional off-rates in vitro and in vivo. We report in vitro PNPinhibitor dissociation rates (t(1/2)) from 3 to 31 min for seven Immucillins with dissociation constants of 115 to 6 pM. Treatment of human erythrocytes with DADMe-Immucillin-H (DADMe-ImmH, 22 pM) causes complete inhibition of PNP. Loss of [C-14] DADMe-ImmH from erythrocytes during multiple washes is slow and biphasic, resulting from inhibitor release and rebinding toPNPcatalytic sites. The slow phase gave a t(1/2) of 84 h. Loss of [C-14] DADMe-ImmH from erythrocytes in the presence of excess unlabeled DADMe-ImmH increased to a t(1/2) of 1.6 h by preventing rebinding. Thus, in human erythrocytes, rebinding of DADMe-ImmH is 50-fold more likely than diffusional loss of the inhibitor from the erythrocyte. Humans treated with a single oral dose of DADMe-ImmH in phase 1 clinical trials exhibit regain of PNP activity with a t(1/2) of 59 days, corresponding to the erythropoiesis rate in humans. Thus, the PNP catalytic site recapture of DADMe-ImmH is highly favored in vivo. We conclude that transition-state analogues with picomolar dissociation constants exhibit long lifetimes on their targets in vivo because the probability of the target enzyme recapturing inhibitor molecules is greater than diffusional loss to the extracellular space.	[Gebre, Sara T.; Cameron, Scott A.; Li, Lei; Schramm, Vern L.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Babu, Y. S.] BioCryst Pharmaceut Inc, Birmingham, AL 35244 USA; [Cameron, Scott A.] Victoria Univ Wellington, Ferrier Res Inst, Lower Hutt 5010, New Zealand; [Li, Lei] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA	Yeshiva University; Albert Einstein College of Medicine; Victoria University Wellington; Harvard University; Brigham & Women's Hospital	Schramm, VL (corresponding author), Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA.	vern.schramm@einstein.yu.edu		Cameron, Scott/0000-0003-2669-8622	National Institutes of Health [R01 GM041916]; PREP (Postbaccalaureate Research Education Program) [R25 GM104547]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM104547, R01GM041916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PREP (Postbaccalaureate Research Education Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM041916 and PREP (Postbaccalaureate Research Education Program) Grant R25 GM104547. The Albert Einstein College of Medicine and Victoria University of Wellington own patents for the Immucillins as purine nucleoside phosphorylase inhibitors. BioCryst Pharmaceuticals is a licensee of these patents and distributes license fees and royalties to the licensors.	Bantia S, 2001, INT IMMUNOPHARMACOL, V1, P1199, DOI 10.1016/S1567-5769(01)00056-X; Cassera MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026916; Clinch K, 2009, J MED CHEM, V52, P1126, DOI 10.1021/jm801421q; Copeland RA, 2006, NAT REV DRUG DISCOV, V5, P730, DOI 10.1038/nrd2082; Cramer J, 2017, ACS CHEM BIOL, V12, P225, DOI 10.1021/acschembio.6b00979; Edwards AA, 2010, BIOCHEMISTRY-US, V49, P2058, DOI 10.1021/bi902041j; Edwards AA, 2009, BIOCHEMISTRY-US, V48, P5226, DOI 10.1021/bi9005896; Evans GB, 2003, J MED CHEM, V46, P5271, DOI 10.1021/jm030305z; Evans GB, 2003, ORG LETT, V5, P3639, DOI 10.1021/ol035293q; Evans GB, 2001, J ORG CHEM, V66, P5723, DOI 10.1021/jo0155613; Firestone RS, 2017, ACS CHEM BIOL, V12, P464, DOI 10.1021/acschembio.6b00885; Hirschi JS, 2010, J PHYS CHEM B, V114, P16263, DOI 10.1021/jp108056s; Ho MC, 2010, P NATL ACAD SCI USA, V107, P4805, DOI 10.1073/pnas.0913439107; Hothersall JD, 2016, DRUG DISCOV TODAY, V21, P90, DOI 10.1016/j.drudis.2015.07.015; Huang M, 2008, LEUKEMIA RES, V32, P1268, DOI 10.1016/j.leukres.2007.12.015; Kicska GA, 2001, P NATL ACAD SCI USA, V98, P4593, DOI 10.1073/pnas.071050798; Lewandowicz A, 2004, BIOCHEMISTRY-US, V43, P1458, DOI 10.1021/bi0359123; Lewandowicz A, 2003, J BIOL CHEM, V278, P31465, DOI 10.1074/jbc.C300259200; Loffler M, 2007, ARTERIOSCL THROM VAS, V27, P1004, DOI 10.1161/ATVBAHA.106.126714; Miles RW, 1998, BIOCHEMISTRY-US, V37, P8615, DOI 10.1021/bi980658d; Molina-Arcas M, 2009, CURR VASC PHARMACOL, V7, P426, DOI 10.2174/157016109789043892; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; MURKIN AS, 2010, DRUG DESIGN STRUCTUR, P215; Pugmire MJ, 2002, BIOCHEM J, V361, P1, DOI 10.1042/0264-6021:3610001; Sattui SE, 2016, THER ADV MUSCULOSKEL, V8, P145, DOI 10.1177/1759720X16646703; Schafer CT, 2016, P NATL ACAD SCI USA, V113, P11961, DOI 10.1073/pnas.1606347113; Spagnuolo LA, 2017, J AM CHEM SOC, V139, P3417, DOI 10.1021/jacs.6b11148; Taylor EA, 2007, J AM CHEM SOC, V129, P6984, DOI 10.1021/ja071087s; Vauquelin G, 2015, EXPERT OPIN DRUG DIS, V10, P1085, DOI 10.1517/17460441.2015.1067196	29	13	13	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15907	15915		10.1074/jbc.M117.801779	http://dx.doi.org/10.1074/jbc.M117.801779			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28794158	hybrid, Green Published			2022-12-26	WOS:000411512200027
J	Chen, YR; Zeng, SY; Hu, RK; Wang, XX; Huang, WL; Liu, JF; Wang, LY; Liu, GF; Cao, Y; Zhang, Y				Chen, Yunru; Zeng, Shiyang; Hu, Ruikun; Wang, Xiangxiu; Huang, Weilai; Liu, Jiangfang; Wang, Luying; Liu, Guifen; Cao, Ying; Zhang, Yong			Using local chromatin structure to improve CRISPR/Cas9 efficiency in zebrafish	PLOS ONE			English	Article							POSITIONS IN-VIVO; NUCLEOSOME ORGANIZATION; CAS9 ENDONUCLEASE; READ ALIGNMENT; GENOME; SYSTEM; BINDING; DESIGN; SGRNAS; CELLS	Although the CRISPR/Cas9 has been successfully applied in zebrafish, considerable variations in efficiency have been observed for different gRNAs. The workload and cost of zebrafish mutant screening is largely dependent on the mutation rate of injected embryos; therefore, selecting more effective gRNAs is especially important for zebrafish mutant construction. Besides the sequence features, local chromatin structures may have effects on CRISPR/Cas9 efficiency, which remain largely unexplored. In the only related study in zebrafish, nucleosome organization was not found to have an effect on CRISPR/Cas9 efficiency, which is inconsistent with recent studies in vitro and in mammalian cell lines. To understand the effects of local chromatin structure on CRISPR/Cas9 efficiency in zebrafish, we first determined that CRISPR/Cas9 introduced genome editing mainly before the dome stage. Based on this observation, we reanalyzed our published nucleosome organization profiles and generated chromatin accessibility profiles in the 256-cell and dome stages using ATAC-seq technology. Our study demonstrated that chromatin accessibility showed positive correlation with CRISPR/Cas9 efficiency, but we did not observe a clear correlation between nucleosome organization and CRISPR/Cas9 efficiency. We constructed an online database for zebrafish gRNA selection based on local chromatin structure features that could prove beneficial to zebrafish homozygous mutant construction via CRISPR/Cas9.	[Chen, Yunru; Zeng, Shiyang; Hu, Ruikun; Wang, Xiangxiu; Huang, Weilai; Liu, Jiangfang; Wang, Luying; Liu, Guifen; Cao, Ying; Zhang, Yong] Tongji Univ, Shanghai East Hosp, Sch Life Sci & Technol, Translat Med Ctr Stem Cell Therapy & Inst Regener, Shanghai, Peoples R China; [Chen, Yunru; Zeng, Shiyang; Wang, Xiangxiu; Wang, Luying; Liu, Guifen; Zhang, Yong] Tongji Univ, Shanghai Key Lab Signaling & Dis Res, Shanghai, Peoples R China	Tongji University; Tongji University	Cao, Y; Zhang, Y (corresponding author), Tongji Univ, Shanghai East Hosp, Sch Life Sci & Technol, Translat Med Ctr Stem Cell Therapy & Inst Regener, Shanghai, Peoples R China.; Zhang, Y (corresponding author), Tongji Univ, Shanghai Key Lab Signaling & Dis Res, Shanghai, Peoples R China.	yingcao@tongji.edu.cn; yzhang@tongji.edu.cn	Zhang, Yong/B-4838-2011	Zhang, Yong/0000-0001-6316-2734	National Natural Science Foundation of China [31322031, 31571365, 31371288, 31601161, 31571515]; National Key Research and Development Program of China [2017YFA0102602, 2016YFA0100400]; Specialized Research Fund for the Doctoral Program of Higher Education [20130072110032]; Program of Shanghai Academic Research Leader [17XD1403600]; Exploration Program of Shanghai Natural Science Foundation [17ZR1449500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Program of Shanghai Academic Research Leader; Exploration Program of Shanghai Natural Science Foundation	This work was supported by National Natural Science Foundation of China (31322031, 31571365, 31371288, 31601161, 31571515), National Key Research and Development Program of China (2017YFA0102602, 2016YFA0100400), Specialized Research Fund for the Doctoral Program of Higher Education (20130072110032), Program of Shanghai Academic Research Leader (17XD1403600) and Exploration Program of Shanghai Natural Science Foundation (17ZR1449500).	Albert I, 2008, BIOINFORMATICS, V24, P1305, DOI 10.1093/bioinformatics/btn119; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Chari R, 2015, NAT METHODS, V12, P823, DOI [10.1038/NMETH.3473, 10.1038/nmeth.3473]; Daer RM, 2017, ACS SYNTH BIOL, V6, P428, DOI 10.1021/acssynbio.5b00299; del Ama LF, 2016, ONCOTARGET, V7, P40348, DOI 10.18632/oncotarget.9613; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Dooley K, 2000, CURR OPIN GENET DEV, V10, P252, DOI 10.1016/S0959-437X(00)00074-5; DRIEVER W, 1994, TRENDS GENET, V10, P152, DOI 10.1016/0168-9525(94)90091-4; Hinz JM, 2015, BIOCHEMISTRY-US, V54, P7063, DOI 10.1021/acs.biochem.5b01108; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.19760; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Irion U, 2014, DEVELOPMENT, V141, P4827, DOI 10.1242/dev.115584; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907; Moreno-Mateos MA, 2015, NAT METHODS, V12, P982, DOI [10.1038/NMETH.3543, 10.1038/nmeth.3543]; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Shah AN, 2015, NAT METHODS, V12, P535, DOI 10.1038/nmeth.3360; Stein A, 2010, NUCLEIC ACIDS RES, V38, P709, DOI 10.1093/nar/gkp1043; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Wager K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157365; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, P1; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang Y, 2014, GENOME RES, V24, P260, DOI 10.1101/gr.157750.113; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636	33	17	18	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0182528	10.1371/journal.pone.0182528	http://dx.doi.org/10.1371/journal.pone.0182528			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800611	Green Submitted, Green Published, gold			2022-12-26	WOS:000407431800021
J	Collins, FL; Rios-Arce, ND; McCabe, LR; Parameswaran, N				Collins, Fraser L.; Rios-Arce, Naiomy Deliz; McCabe, Laura R.; Parameswaran, Narayanan			Cytokine and hormonal regulation of bone marrow immune cell Wnt10b expression	PLOS ONE			English	Article							ESTROGEN DEFICIENCY; ALPHA; MICE; OSTEOBLASTOGENESIS; DIFFERENTIATION; ADIPOGENESIS; FEMALE; MASS	Background & aims Wnt10b is a crucial regulator of bone density through its ability to promote osteoblastogenesis. Parathyroid hormone has been shown to regulate Wnt10b expression in CD8(+) T cells. However, the relative expression and other source(s) of Wnt10b in the bone marrow immune cells (BMICs) is unknown. Sex hormones and cytokines such as, estrogen and TNF alpha are critical regulators of bone physiology but whether they regulate BMIC Wnt10b expression is unclear. To determine the potential regulation of Wnt10b by estrogen and TNF alpha, we assessed Wnt10b expression by flow cytometry under estrogen- and TNF alpha-deficient conditions. Methods Effects of TNF alpha was determined in male and female C57BL/6 wildtype and TNF alpha knockout mice. Effect of estrogen was investigated 4, 6 and 8 weeks post-surgery in ovariectomized Balb/c mice. Intracellular Wnt10b was detected using goat anti-mouse Wnt10b and a conjugated secondary antibody and analyzed by flow cytometry. Results Wnt10b expression was sex- and lineage-specific. Females had 1.8-fold higher Wnt10b signal compared to males. Percent of Wnt10b(+) myeloid cells was higher in females than males (8.9% Vs 5.4%) but Wnt10b(+) lymphoid cells was higher in males than females (6.3% Vs 2.5%). TNF alpha ablation in males increased total BM Wnt10b expression 1.5-fold but significantly reduced the percentage of BM Wnt10b(+) CD4(+) T cells (65%), CD8+ T cells (59%), dendritic cells (59%), macrophages (56%) and granulocytes (52%). These effects of TNF? on Wnt10b were observed only in males. In contrast to TNF alpha, estrogen-deficiency had indirect effects on BMIC Wnt10b levels; reducing the average percentage of BM Wnt10b(+) CD8(+) T cells (25%) and granulocytes (26%) across an 8-week time course. Conclusion Our results demonstrate unique cell type- and sex-dependent effects on BMIC Wnt10b expression. Together, our results reveal myeloid cells in the bone marrow as an important source of Wnt10b under complex hormonal and cytokine regulation.	[Collins, Fraser L.; Rios-Arce, Naiomy Deliz; McCabe, Laura R.; Parameswaran, Narayanan] Michigan State Univ, Eau Claire, WI 65523 USA	Michigan State University	McCabe, LR; Parameswaran, N (corresponding author), Michigan State Univ, Eau Claire, WI 65523 USA.	mccabel@msu.edu; narap@msu.edu	Parameswaran, Narayanan/V-1969-2019; Collins, Fraser/AAT-7889-2020	Collins, Fraser/0000-0002-1156-6873; Parameswaran, Narayanan/0000-0002-8894-5564	National Center for Complementary and Integrative Health; U.S National Institutes of Health [1R01AT007695-01]; National Institute of Diabetes and Digestive and Kidney Diseases, U.S National Institutes of Health [R01DK101050]; National Center for Complementary & Integrative Health [R01AT007695] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101050, P30DK020572] Funding Source: NIH RePORTER	National Center for Complementary and Integrative Health; U.S National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases, U.S National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study is funded by National Center for Complementary and Integrative Health (https.//nccihmih.gov/), U.S National Institutes of Health (Grant Code: 1R01AT007695-01) awarded to LRM and NP and by National Institute of Diabetes and Digestive and Kidney Diseases (www.raddkaghgov/), U.S National Institutes of Health (Grant code: R01DK101050) awarded to LRM and NP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron R, 2007, ENDOCRINOLOGY, V148, P2635, DOI 10.1210/en.2007-0270; Bennett CN, 2007, J BONE MINER RES, V22, P1924, DOI 10.1359/JBMR.070810; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bouxsein ML, 2005, J BONE MINER RES, V20, P1085, DOI 10.1359/JBMR.050307; Briolay A, 2013, BIOCHEM BIOPH RES CO, V430, P1072, DOI 10.1016/j.bbrc.2012.12.036; Cawthorn WP, 2007, CELL DEATH DIFFER, V14, P1361, DOI 10.1038/sj.cdd.4402127; Cenci S, 2003, P NATL ACAD SCI USA, V100, P10405, DOI 10.1073/pnas.1533207100; Chen QS, 2013, MEDIAT INFLAMM, V2013, DOI [10.1155/2013/928315, 10.1155/2013/434010]; Clarke BL, 2010, RADIOL CLIN N AM, V48, P483, DOI 10.1016/j.rcl.2010.02.014; Coe LM, 2011, J CELL PHYSIOL, V226, P477, DOI 10.1002/jcp.22357; D'Amelio P, 2015, OSTEOPOROSIS INT, V26, P2785, DOI 10.1007/s00198-015-3189-8; Garcia-Perez MA, 2006, HUM REPROD, V21, P880, DOI 10.1093/humrep/dei413; Gilbert LC, 2013, BONE, V56, P174, DOI 10.1016/j.bone.2013.06.002; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Grassi F, 2007, P NATL ACAD SCI USA, V104, P15087, DOI 10.1073/pnas.0703610104; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Li JY, 2013, BLOOD, V122, P2346, DOI 10.1182/blood-2013-03-487801; MASUZAWA T, 1994, J CLIN INVEST, V94, P1090, DOI 10.1172/JCI117424; Nadiri A, 2004, J HISTOCHEM CYTOCHEM, V52, P103, DOI 10.1177/002215540405200110; Ota K, 2013, ENDOCRINOLOGY, V154, P3745, DOI 10.1210/en.2013-1272; Ouji Y, 2006, BIOCHEM BIOPH RES CO, V342, P1063, DOI 10.1016/j.bbrc.2006.02.028; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qadir AS, BIOCH BIOPHYS RES CO; Roser-Page S, 2014, ARTHRITIS RHEUMATOL, V66, P990, DOI 10.1002/art.38319; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Rozov F N, 2006, Dokl Biochem Biophys, V408, P138, DOI 10.1134/S1607672906030082; Safadi FF, 2000, ENDOCRINE, V12, P81, DOI 10.1385/ENDO:12:1:81; Schett G, 2003, ARTHRITIS RHEUM, V48, P2042, DOI 10.1002/art.11150; Stevens JR, 2010, J BONE MINER RES, V25, P2138, DOI 10.1002/jbmr.118; Tarte K, 2003, BLOOD, V102, P592, DOI 10.1182/blood-2002-10-3161; Terauchi M, 2009, CELL METAB, V10, P229, DOI 10.1016/j.cmet.2009.07.010; Zhan FH, 2003, BLOOD, V101, P1128, DOI 10.1182/blood-2002-06-1737; Zhang J, 2015, ENDOCRINOLOGY, V156, P3169, DOI 10.1210/EN.2015-1308	33	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0181979	10.1371/journal.pone.0181979	http://dx.doi.org/10.1371/journal.pone.0181979			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800644	Green Published, Green Submitted, gold			2022-12-26	WOS:000407431800009
J	Macedo-Silva, T; Araujo, RBD; Meissner, KA; Fotoran, WL; Medeiros, MM; de Azevedo, MF; Wunderlich, G				Macedo-Silva, Tatiane; Duque Araujo, Rosana Beatriz; Meissner, Kamila Anna; Fotoran, Wesley Luzetti; Medeiros, Marcia Melo; de Azevedo, Mauro Ferreira; Wunderlich, Gerhard			Knockdown of the Plasmodium falciparum SURFIN4.1 antigen leads to an increase of its cognate transcript	PLOS ONE			English	Article							MALARIA PARASITE; VAR GENES; INFECTED ERYTHROCYTES; VIRULENCE GENES; HOST ERYTHROCYTE; SURF(4.1) GENE; EXPRESSION; PROTEIN-1; CULTURE; REGION	The genome of the malaria parasite Plasmodium falciparum contains the surf gene family which encodes large transmembrane proteins of unknown function. While some surf alleles appear to be expressed in sexual stages, others occur in asexual blood stage forms and may be associated to virulence-associated processes and undergo transcriptional switching. We accessed the transcription of surf genes along multiple invasions by real time PCR. Based on the observation of persistent expression of gene surf4.1, we created a parasite line which expresses a conditionally destabilized SURFIN4.1 protein. Upon destabilization of the protein, no interference of parasite growth or morphological changes were detected. However, we observed a strong increase in the transcript quantities of surf4.1 and sometimes of other surf genes in knocked-down parasites. While this effect was reversible when SURFIN4.1 was stabilized again after a few days of destabilization, longer destabilization periods resulted in a transcriptional switch away from surf4.1. When we tested if a longer transcript half-life was responsible for increased transcript detection in SURFIN4.1 knocked-down parasites, no alteration was found compared to control parasite lines. This suggests a specific feedback of the expressed SURFIN protein to its transcript pointing to a novel type of regulation, inedited in Plasmodium.	[Macedo-Silva, Tatiane; Duque Araujo, Rosana Beatriz; Meissner, Kamila Anna; Fotoran, Wesley Luzetti; Medeiros, Marcia Melo; de Azevedo, Mauro Ferreira; Wunderlich, Gerhard] Univ Sao Paulo, Dept Parasitol, Inst Biomed Sci, Ave Prof Lineu Prestes 1374, Sao Paulo, Brazil; [Medeiros, Marcia Melo] Univ Lisbon, Inst Mol Med, Lisbon, Portugal	Universidade de Sao Paulo; Universidade de Lisboa	Wunderlich, G (corresponding author), Univ Sao Paulo, Dept Parasitol, Inst Biomed Sci, Ave Prof Lineu Prestes 1374, Sao Paulo, Brazil.	gwunder@usp.br	Fotoran, Wesley/N-2545-2016; Wunderlich, Gerhard/G-8245-2012; Azevedo, Mauro/H-6180-2012	Fotoran, Wesley/0000-0001-8203-8384; Wunderlich, Gerhard/0000-0003-1724-0337; Azevedo, Mauro/0000-0002-5233-2037; Melo Medeiros, Marcia/0000-0002-5364-9087	FAPESP [2012/23306-5, 2015/17174-7, 2013/12439-7, 2009/51026-4, 2015/19316-3]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by FAPESP grant 2012/23306-5 and 2015/17174-7 (GW), a FAPESP master fellowship to TMS (2013/12439-7) and grants to MFA (2009/51026-4, 2015/19316-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Arnal L, 2013, CURR OPIN CELL BIOL, V25, P170, DOI 10.1016/j.ceb.2013.01.003; Amulic B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000256; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Brancucci NMB, 2014, CELL HOST MICROBE, V16, P165, DOI 10.1016/j.chom.2014.07.004; Brancucci NMB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100183; Brancucci NMB, 2012, CELL MICROBIOL, V14, P1836, DOI 10.1111/cmi.12004; Cabral FJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029881; Cabral FJ, 2009, MOL BIOCHEM PARASIT, V168, P186, DOI 10.1016/j.molbiopara.2009.08.002; Calderwood MS, 2003, J BIOL CHEM, V278, P34125, DOI 10.1074/jbc.M213065200; Cazzonelli CI, 2010, TRENDS PLANT SCI, V15, P266, DOI 10.1016/j.tplants.2010.02.003; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; Coleman BI, 2014, CELL HOST MICROBE, V16, P177, DOI 10.1016/j.chom.2014.06.014; Dalton RP, 2013, CELL, V155, P321, DOI 10.1016/j.cell.2013.09.033; de Azevedo MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040981; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Deitsch KW, 2001, NATURE, V412, P875, DOI 10.1038/35091146; del Portillo HA, 2001, NATURE, V410, P839, DOI 10.1038/35071118; Douglas AD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1615; Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036; Gitaka JN, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1743-x; Golnitz U, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-14; Guizetti J, 2016, NUCL ACIDS RES; Gunasekera AM, 2007, EXP PARASITOL, V117, P87, DOI 10.1016/j.exppara.2007.03.001; Hasenkamp S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-210; Howitt CA, 2009, MOL MICROBIOL, V73, P1171, DOI 10.1111/j.1365-2958.2009.06846.x; Jiang LB, 2013, NATURE, V499, P223, DOI 10.1038/nature12361; Joergensen L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001083; Kaewthamasorn M, 2012, PARASITOL INT, V61, P317, DOI 10.1016/j.parint.2011.12.003; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lavazec C, 2007, MOL MICROBIOL, V64, P1621, DOI 10.1111/j.1365-2958.2007.05767.x; Lavstsen T, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-21; LEECH JH, 1984, J EXP MED, V159, P1567, DOI 10.1084/jem.159.6.1567; Lelievre J, 2005, EXP PARASITOL, V109, P195, DOI 10.1016/j.exppara.2004.11.012; Ljungstrom I, 2008, MANASSAS; Lopez-Rubio JJ, 2007, CURR OPIN MICROBIOL, V10, P560, DOI 10.1016/j.mib.2007.10.003; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Mphande FA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-116; Pasternak ND, 2009, INT J BIOCHEM CELL B, V41, P1463, DOI 10.1016/j.biocel.2008.12.012; Perez-Toledo K, 2009, NUCLEIC ACIDS RES, V37, P2596, DOI 10.1093/nar/gkp115; Peters J, 2002, P NATL ACAD SCI USA, V99, P10689, DOI 10.1073/pnas.162349899; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Rutledge GG, 2017, NATURE, V542, P101, DOI 10.1038/nature21038; Salcedo-Amaya AM, 2009, P NATL ACAD SCI USA, V106, P9655, DOI 10.1073/pnas.0902515106; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; Sherman IW, 2003, MICROBES INFECT, V5, P897, DOI 10.1016/S1286-4579(03)00162-X; Sierra-Miranda M, 2012, MOL BIOCHEM PARASIT, V185, P36, DOI 10.1016/j.molbiopara.2012.06.005; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Tonkin CJ, 2009, PLOS BIOL, V7, P771, DOI 10.1371/journal.pbio.1000084; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Ukaegbu UE, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003854; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; van der Heyde HC, 2006, TRENDS PARASITOL, V22, P503, DOI 10.1016/j.pt.2006.09.002; Voss TS, 2006, NATURE, V439, P1004, DOI 10.1038/nature04407; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700; Wang CW, 2009, INT J PARASITOL, V39, P655, DOI 10.1016/j.ijpara.2008.11.014; Winter G, 2005, J EXP MED, V201, P1853, DOI 10.1084/jem.20041392; Wunderlich Gerhard, 2005, Rev. Inst. Med. trop. S. Paulo, V47, P195, DOI 10.1590/S0036-46652005000400004; Xangsayarath Phonepadith, 2012, Tropical Medicine and Health, V40, P79, DOI 10.2149/tmh.2012-12; Zhang K, 2002, SCIENCE, V296, P545, DOI 10.1126/science.1068274; Zhang QF, 2014, NATURE, V513, P431, DOI 10.1038/nature13468; Zhu XT, 2013, PARASITOL INT, V62, P215, DOI 10.1016/j.parint.2012.12.006	65	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0183129	10.1371/journal.pone.0183129	http://dx.doi.org/10.1371/journal.pone.0183129			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800640	gold, Green Published, Green Submitted			2022-12-26	WOS:000407431800057
J	Doucet, M; El-Turabi, A; Zabel, F; Hunn, BHM; Bengoa-Vergniory, N; Cioroch, M; Ramm, M; Smith, AM; Gomes, AC; de Miranda, GC; Wade-Martins, R; Bachmann, MF				Doucet, Marika; El-Turabi, Aadil; Zabel, Franziska; Hunn, Benjamin H. M.; Bengoa-Vergniory, Nora; Cioroch, Milena; Ramm, Mauricio; Smith, Amy M.; Gomes, Ariane Cruz; de Miranda, Gustavo Cabral; Wade-Martins, Richard; Bachmann, Martin F.			Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles	PLOS ONE			English	Article							MULTIPLE SYSTEM ATROPHY; GLIAL CYTOPLASMIC INCLUSIONS; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; TRANSGENIC MICE; LEWY BODIES; BETA IMMUNIZATION; GAMMA-SYNUCLEIN; BRAIN PATHOLOGY; ELEVATED LEVELS	Parkinson's disease (PD) is a progressive and currently incurable neurological disorder characterised by the loss of midbrain dopaminergic neurons and the accumulation of aggregated alpha-synuclein (a-syn). Oligomeric a-syn is proposed to play a central role in spreading protein aggregation in the brain with associated cellular toxicity contributing to a progressive neurological decline. For this reason, a-syn oligomers have attracted interest as therapeutic targets for neurodegenerative conditions such as PD and other alpha-synucleinopathies. In addition to strategies using small molecules, neutralisation of the toxic oligomers by antibodies represents an attractive and highly specific strategy for reducing disease progression. Emerging active immunisation approaches using vaccines are already being trialled to induce such antibodies. Here we propose a novel vaccine based on the RNA bacteriophage (Qbeta) virus-like particle conjugated with short peptides of human a-syn. High titres of antibodies were successfully and safely generated in wild-type and human a-syn over-expressing (SNCA-OVX) transgenic mice following vaccination. Antibodies from vaccine candidates targeting the C-terminal regions of a-syn were able to recognise Lewy bodies, the hallmark aggregates in human PD brains. Furthermore, antibodies specifically targeted oligomeric and aggregated a-syn as they exhibited 100 times greater affinity for oligomeric species over monomer a-syn proteins in solution. In the SNCA-OVX transgenic mice used, vaccination was, however, unable to confer significant changes to oligomeric a-syn bioburden. Similarly, there was no discernible effect of vaccine treatment on behavioural phenotype as compared to control groups. Thus, antibodies specific for oligomeric a-syn induced by vaccination were unable to treat symptoms of PD in this particular mouse model.	[Doucet, Marika; Hunn, Benjamin H. M.; Bengoa-Vergniory, Nora; Cioroch, Milena; Ramm, Mauricio; Smith, Amy M.; Wade-Martins, Richard] Univ Oxford, Dept Physiol Anat & Genet, South Parks Rd, Oxford, England; [El-Turabi, Aadil; Gomes, Ariane Cruz; de Miranda, Gustavo Cabral; Bachmann, Martin F.] Univ Oxford, Nuffield Dept Med, Jenner Inst, Henry Wellcome Bldg Mol Physiol,Roosevelt Dr, Oxford, England; [Zabel, Franziska] Univ Hosp Zurich, Immunol, Zurich, Switzerland; [Bachmann, Martin F.] Univ Bern, Inselspital, Immunol Rheumatol Immunol & Allergy RIA, Bern, Switzerland	University of Oxford; University of Oxford; Jenner Institute; University of Zurich; University Zurich Hospital; University of Bern; University Hospital of Bern	Wade-Martins, R (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, South Parks Rd, Oxford, England.	richard.wade-martins@dpag.ox.ac.uk; martin.bachmann@ndm.ox.ac.uk	El-Turabi, Aadil/AAH-4786-2020; Bengoa-Vergniory, Nora/J-2998-2019	El-Turabi, Aadil/0000-0003-1092-8155; Bengoa-Vergniory, Nora/0000-0002-3700-0464; Ramm, Mauricio/0000-0001-8456-3246; Cruz Gomes, Ariane Karla/0000-0002-3974-4088; Wade-Martins, Richard/0000-0001-6691-580X	Michael J Fox Foundation; Synuclein Therapeutic Acceleration Program (SynTAP) [8344]; Swiss National Science Foundation [31003A_149925]; Rhodes Trust; Guarantors of Brain; University of Oxford; Michael J Fox Foundation [8344]; MRC [MR/P007058/1] Funding Source: UKRI; Medical Research Council [MR/P007058/1] Funding Source: researchfish; Parkinson&quot;s UK [G-1003, J-0901, H-1301, J-1403] Funding Source: researchfish	Michael J Fox Foundation; Synuclein Therapeutic Acceleration Program (SynTAP); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Rhodes Trust; Guarantors of Brain; University of Oxford; Michael J Fox Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK)	MD, AET, RWM and MFB were supported by the Michael J Fox Foundation (https://www.michaeljfox.org), Synuclein Therapeutic Acceleration Program (SynTAP 2013) grant 8344. MFB is a Jenner Investigator and supported by the Swiss National Science Foundation (Grant 31003A_149925). BHMH is supported by the Rhodes Trust, the Guarantors of Brain and a Goodger and Schorstein Scholarship (University of Oxford). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We would like to thank the Michael J Fox Foundation for funding this program (Synuclein Therapeutic Acceleration Program (SynTAP 2013), Grant 8344). MFB is a Jenner Investigator and supported by the Swiss National Science Foundation (Grant 31003A_149925). BHMH is supported by the Rhodes Trust, the Guarantors of Brain and a Goodger and Schorstein Scholarship (University of Oxford).	[Anonymous], 2014, FOX FDN PARKINSONS R; Bachmann MF, 2011, PHILOS T R SOC B, V366, P2815, DOI 10.1098/rstb.2011.0103; Bae EJ, 2012, J NEUROSCI, V32, P13454, DOI 10.1523/JNEUROSCI.1292-12.2012; Barbour R, 2008, NEURODEGENER DIS, V5, P55, DOI 10.1159/000112832; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Cesta MF, 2006, TOXICOL PATHOL, V34, P455, DOI 10.1080/01926230600867743; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Christiansen JR, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0532-8; Cielens I, 2000, FEBS LETT, V482, P261, DOI 10.1016/S0014-5793(00)02061-5; Contet C, 2001, BEHAV BRAIN RES, V124, P33, DOI 10.1016/S0166-4328(01)00231-5; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; DeLong MR, 2015, JAMA NEUROL, V72, P1354, DOI 10.1001/jamaneurol.2015.2397; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Ferrer I, 2004, BRAIN PATHOL, V14, P11, DOI 10.1111/j.1750-3639.2004.tb00493.x; Fettelschoss A, 2014, HUM VACC IMMUNOTHER, V10, P847, DOI 10.4161/hv.28183; Games D, 2014, J NEUROSCI, V34, P9441, DOI 10.1523/JNEUROSCI.5314-13.2014; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; Goedert M, 2013, NEUROLOGY, V9; Hall S, 2015, NEUROLOGY, V84, P57, DOI 10.1212/WNL.0000000000001098; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Janezic S, 2013, P NATL ACAD SCI USA, V110, pE4016, DOI 10.1073/pnas.1309143110; Jennings GT, 2009, ANNU REV PHARMACOL, V49, P303, DOI 10.1146/annurev-pharmtox-061008-103129; Kim C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2534; Kuhl M.McGuire, 2014, AUSTRIAN CO LAUNCHES; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lindblad EB, 2004, VACCINE, V22, P3658, DOI 10.1016/j.vaccine.2004.03.032; Lindstrom V, 2014, NEUROBIOL DIS, V69, P134, DOI 10.1016/j.nbd.2014.05.009; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Mandler M, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0008-9; Mandler M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115237; Mandler M, 2014, ACTA NEUROPATHOL, V127, P861, DOI 10.1007/s00401-014-1256-4; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Masliah E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019338; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Nasstrom T, 2011, FREE RADICAL BIO MED, V50, P428, DOI 10.1016/j.freeradbiomed.2010.11.027; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Paleologou KE, 2009, BRAIN, V132, P1093, DOI 10.1093/brain/awn349; Park JY, 2003, BIOCHEMISTRY-US, V42, P3696, DOI 10.1021/bi020604a; Postuma RB, 2012, MOVEMENT DISORD, V27, P617, DOI 10.1002/mds.24996; Recasens A, 2014, ANN NEUROL, V75, P351, DOI 10.1002/ana.24066; Roberts RF, 2015, BRAIN, V138, P1642, DOI 10.1093/brain/awv040; Sacino AN, 2014, P NATL ACAD SCI USA, V111, P10732, DOI 10.1073/pnas.1321785111; Schneeberger A, 2016, MOVEMENT DISORD, V31, P214, DOI 10.1002/mds.26377; Senior SL, 2008, EUR J NEUROSCI, V27, P947, DOI 10.1111/j.1460-9568.2008.06055.x; Shahaduzzaman M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116841; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Snyder H, 2005, J BIOL CHEM, V280, P7562, DOI 10.1074/jbc.M412887200; Spencer B, 2016, ANN CLIN TRANSL NEUR, V3, P588, DOI 10.1002/acn3.321; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Tokuda T, 2010, NEUROLOGY, V75, P1766, DOI 10.1212/WNL.0b013e3181fd613b; Tran HT, 2014, CELL REP, V7, P2054, DOI 10.1016/j.celrep.2014.05.033; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; Villar-Pique A, 2016, J NEUROCHEM, V139, P240, DOI 10.1111/jnc.13249; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Wakabayashi K, 1998, NEUROSCI LETT, V249, P180, DOI 10.1016/S0304-3940(98)00407-8; Watts JC, 2013, P NATL ACAD SCI USA, V110, P19555, DOI 10.1073/pnas.1318268110; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wiessner C, 2011, J NEUROSCI, V31, P9323, DOI 10.1523/JNEUROSCI.0293-11.2011	65	22	24	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0181844	10.1371/journal.pone.0181844	http://dx.doi.org/10.1371/journal.pone.0181844			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797124	gold, Green Published, Green Submitted			2022-12-26	WOS:000407396200019
J	Khanal, S; Sultana, H; Catravas, JD; Carlyon, JA; Neelakanta, G				Khanal, Supreet; Sultana, Hameeda; Catravas, John D.; Carlyon, Jason A.; Neelakanta, Girish			Anaplasma phagocytophilum infection modulates expression of megakaryocyte cell cycle genes through phosphatidylinositol-3-kinase signaling	PLOS ONE			English	Article							HUMAN GRANULOCYTIC EHRLICHIOSIS; NF-KAPPA-B; HUMAN NEUTROPHIL APOPTOSIS; IXODES-SCAPULARIS TICKS; INTRACELLULAR INFECTION; PLATELET FORMATION; HL-60 CELLS; AGENT; INDUCTION; CHAFFEENSIS	Anaplasma phagocytophilum, the agent of human granulocytic anaplasmosis infects neutrophils and other cells from hematopoietic origin. Using human megakaryocytic cell line, MEG-01, we show that expression of cell cycle genes in these cells are altered upon A. phagocytophilum infection. Expression of several cell cycle genes in MEG-01 cells was significantly up regulated at early and then down regulated at later stages of A. phagocytophilum infection. Lactate dehydrogenase (LDH) assays revealed reduced cellular cytotoxicity in MEG-01 cells upon A. phagocytophilum infection. The levels of both PI3KCA (p110 alpha, catalytic subunit) and PI3KR1 (p85, regulatory subunit) of Class I PI3 kinases and phosphorylated protein kinase B (Akt/PKB) and inhibitory kappa B (I kappa B) were elevated at both early and late stages of A. phagocytophilum infection. Inhibition of PI3 kinases with LY294002 treatment resulted in significant reduction in the expression of tested cell cycle genes, A. phagocytophilum burden and phosphorylated Akt levels in these MEG-01 cells. Collectively, these results suggest a role for PI3K-Akt-NF-kappa B signaling pathway in the modulation of megakaryocyte cell cycle genes upon A. phagocytophilum infection.	[Khanal, Supreet; Sultana, Hameeda; Neelakanta, Girish] Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA; [Sultana, Hameeda; Neelakanta, Girish] Old Dominion Univ, Coll Sci, Ctr Mol Med, Norfolk, VA 23529 USA; [Catravas, John D.] Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA USA; [Catravas, John D.] Old Dominion Univ, Coll Hlth Sci, Sch Med Diagnost & Translat Sci, Norfolk, VA USA; [Carlyon, Jason A.] Virginia Commonwealth Univ, Med Ctr, Sch Med, Dept Microbiol Immunol, Richmond, VA USA	Old Dominion University; Old Dominion University; Old Dominion University; Old Dominion University; Virginia Commonwealth University	Neelakanta, G (corresponding author), Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA.; Neelakanta, G (corresponding author), Old Dominion Univ, Coll Sci, Ctr Mol Med, Norfolk, VA 23529 USA.	gneelaka@odu.edu		Khanal, Supreet/0000-0002-8483-9940	Old Dominion University Start-up funds; NIH [R01 AI072683]	Old Dominion University Start-up funds; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by Old Dominion University Start-up funds to GN and HS and by NIH R01 AI072683 to JAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2000, BIOCHEM PHARMACOL, V60, P1033, DOI 10.1016/S0006-2952(00)00393-2; Aguero-Rosenfeld ME, 2002, J CLIN MICROBIOL, V40, P2612, DOI 10.1128/JCM.40.7.2612-2615.2002; Anderson JF, 2008, INFECT DIS CLIN N AM, V22, P195, DOI 10.1016/j.idc.2007.12.006; BAKER DC, 1987, VET PATHOL, V24, P449, DOI 10.1177/030098588702400513; Bakken JS, 2015, INFECT DIS CLIN N AM, V29, P341, DOI 10.1016/j.idc.2015.02.007; Bakken JS, 1998, CLIN INFECT DIS, V27, P1491, DOI 10.1086/515048; Bakken JS, 1996, JAMA-J AM MED ASSOC, V275, P199, DOI 10.1001/jama.275.3.199; Battinelli E, 2001, P NATL ACAD SCI USA, V98, P14458, DOI 10.1073/pnas.241427398; Borjesson D, 2009, CLIN MICROBIOL INFEC, V15, P66, DOI 10.1111/j.1469-0691.2008.02182.x; Borjesson DL, 2001, J INFECT DIS, V184, P1475, DOI 10.1086/324518; Carlyon JA, 2006, CURR OPIN HEMATOL, V13, P28, DOI 10.1097/01.moh.0000190109.00532.56; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Clarke MCH, 2003, J CELL BIOL, V160, P577, DOI 10.1083/jcb.200210111; de la Fuente J, 2005, CELL MICROBIOL, V7, P549, DOI 10.1111/j.1462-5822.2004.00485.x; Dumler JS, 2005, ANN NY ACAD SCI, V1063, P361, DOI 10.1196/annals.1355.069; Dumler JS, 2005, EMERG INFECT DIS, V11, P1828, DOI 10.3201/eid1112.050898; Eliades A, 2010, J BIOL CHEM, V285, P18909, DOI 10.1074/jbc.M110.102145; Garcia P, 1996, ONCOGENE, V13, P695; Garyu JWA, 2005, ANN NY ACAD SCI, V1063, P416, DOI 10.1196/annals.1355.075; Ge Y, 2005, CELL MICROBIOL, V7, P29, DOI 10.1111/j.1462-5822.2004.00427.x; Ge Y, 2006, CELL MICROBIOL, V8, P1406, DOI 10.1111/j.1462-5822.2006.00720.x; Granick JL, 2008, J MED MICROBIOL, V57, P416, DOI 10.1099/jmm.0.47551-0; Greene GE., 2012, INFECT DIS DOG CAT, P241; HARVEY JW, 1978, J INFECT DIS, V137, P182, DOI 10.1093/infdis/137.2.182; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; Hodzic E, 1998, J INFECT DIS, V177, P737, DOI 10.1086/514236; HOFFMAN R, 1990, YALE J BIOL MED, V63, P411; Ismail N, 2010, CLIN LAB MED, V30, P261, DOI 10.1016/j.cll.2009.10.004; Joyce D, 2001, CYTOKINE GROWTH F R, V12, P73, DOI 10.1016/S1359-6101(00)00018-6; Klein MB, 2000, J INFECT DIS, V182, P200, DOI 10.1086/315641; Lappin MR, 2009, SMALL ANIMAL INTERNA, P1324; Lee HC, 2008, GENOMICS, V92, P144, DOI 10.1016/j.ygeno.2008.05.005; Lee HC, 2006, GENOMICS, V88, P496, DOI 10.1016/j.ygeno.2006.06.002; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Machlus KR, 2014, BRIT J HAEMATOL, V165, P227, DOI 10.1111/bjh.12758; Mott J, 1999, INFECT IMMUN, V67, P1368, DOI 10.1128/IAI.67.3.1368-1378.1999; Munderloh UG, 2004, VET MICROBIOL, V101, P53, DOI 10.1016/j.vetmic.2004.02.011; Muntean AG, 2007, BLOOD, V109, P5199, DOI 10.1182/blood-2006-11-059378; OGURA M, 1985, BLOOD, V66, P1384; OGURA M, 1988, BLOOD, V72, P49; Ozes ON, 1999, NATURE, V401, P82; Rikihisa Y, 2011, CLIN MICROBIOL REV, V24, P469, DOI 10.1128/CMR.00064-10; Rikihisa Y, 2010, NAT REV MICROBIOL, V8, P328, DOI 10.1038/nrmicro2318; Sarkar A, 2012, INFECT IMMUN, V80, P1615, DOI 10.1128/IAI.05219-11; Severo MS, 2013, J INFECT DIS, V208, P1830, DOI 10.1093/infdis/jit380; Sultana H, 2010, J EXP MED, V207, P1727, DOI 10.1084/jem.20100276; Takeuchi K, 1998, BRIT J HAEMATOL, V100, P436, DOI 10.1046/j.1365-2141.1998.00576.x; Thomas V, 2007, CELL MICROBIOL, V9, P1730, DOI 10.1111/j.1462-5822.2007.00908.x; van Opstal A, 2006, CELL MOL LIFE SCI, V63, P220, DOI 10.1007/s00018-005-5412-9; Villar M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137237; Vora A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44593; Walker DH, 1997, ARCH PATHOL LAB MED, V121, P785; Webster P, 1998, J CLIN INVEST, V101, P1932, DOI 10.1172/JCI1544; Wuerzberger-Davis SM, 2005, MOL CANCER RES, V3, P345, DOI 10.1158/1541-7786.MCR-05-0028; Yoshiie K, 2000, INFECT IMMUN, V68, P1125, DOI 10.1128/IAI.68.3.1125-1133.2000; Zhang HZ, 2004, INFECT IMMUN, V72, P498, DOI 10.1128/IAI.72.1.498-507.2004; Zimmet J, 2000, EXP HEMATOL, V28, P3, DOI 10.1016/S0301-472X(99)00124-1; Zimmet JM, 1997, MOL CELL BIOL, V17, P7248, DOI 10.1128/MCB.17.12.7248	58	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182898	10.1371/journal.pone.0182898	http://dx.doi.org/10.1371/journal.pone.0182898			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797056	gold, Green Published, Green Submitted			2022-12-26	WOS:000407396200114
J	Ramanathan, B; Jindal, HM; Le, CF; Gudimella, R; Anwar, A; Razali, R; Poole-Johnson, J; Manikam, R; Sekaran, SD				Ramanathan, Babu; Jindal, Hassan Mahmood; Le, Cheng Foh; Gudimella, Ranganath; Anwar, Arif; Razali, Rozaimi; Poole-Johnson, Johan; Manikam, Rishya; Sekaran, Shamala Devi			Next generation sequencing reveals the antibiotic resistant variants in the genome of Pseudomonas aeruginosa	PLOS ONE			English	Article							EPIDEMIOLOGY; AMINOGLYCOSIDES; VIRULENCE; MEXXY; OPRM	Rapid progress in next generation sequencing and allied computational tools have aided in identification of single nucleotide variants in genomes of several organisms. In the present study, we have investigated single nucleotide polymorphism (SNP) in ten multi-antibiotic resistant Pseudomonas aeruginosa clinical isolates. All the draft genomes were submitted to Rapid Annotations using Subsystems Technology (RAST) web server and the predicted protein sequences were used for comparison. Non-synonymous single nucleotide polymorphism (nsSNP) found in the clinical isolates compared to the reference genome (PAO1), and the comparison of nsSNPs between antibiotic resistant and susceptible clinical isolates revealed insights into the genome variation. These nsSNPs identified in the multi-drug resistant clinical isolates were found to be altering a single amino acid in several antibiotic resistant genes. We found mutations in genes encoding efflux pump systems, cell wall, DNA replication and genes involved in repair mechanism. In addition, nucleotide deletions in the genome and mutations leading to generation of stop codons were also observed in the antibiotic resistant clinical isolates. Next generation sequencing is a powerful tool to compare the whole genomes and analyse the single base pair variations found within the antibiotic resistant genes. We identified specific mutations within antibiotic resistant genes compared to the susceptible strain of the same bacterial species and these findings may provide insights to understand the role of single nucleotide variants in antibiotic resistance.	[Ramanathan, Babu] Sunway Univ, Sch Sci & Technol, Dept Biol Sci, Kuala Lumpur, Malaysia; [Jindal, Hassan Mahmood; Sekaran, Shamala Devi] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Le, Cheng Foh] Univ Nottingham, Fac Sci, Sch Pharm, Malaysia Campus,Jalan Broga, Selangor, Malaysia; [Gudimella, Ranganath; Anwar, Arif; Razali, Rozaimi; Poole-Johnson, Johan] Univ Malaya, HIR, Sengen, Kuala Lumpur, Malaysia; [Manikam, Rishya] Univ Malaya, Med Ctr, Dept Trauma & Emergency, Kuala Lumpur, Malaysia	Sunway University; Universiti Malaya; University of Nottingham Malaysia; Universiti Malaya; Universiti Malaya	Ramanathan, B (corresponding author), Sunway Univ, Sch Sci & Technol, Dept Biol Sci, Kuala Lumpur, Malaysia.; Sekaran, SD (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	babur@sunway.edu.my; shamalamy@yahoo.com	Razali, Rozaimi/AAF-9115-2021; Manikam, Rishya/F-5908-2014; Devi, Shamala Devi/B-9735-2010; Ramanathan, Babu/M-5959-2015; Sekaran, Shamala Devi/B-8482-2008; RAZALI, ROZAIMI/O-8694-2017; Jindal, Hassan/AAD-3807-2022	Razali, Rozaimi/0000-0002-8996-3975; Devi, Shamala Devi/0000-0002-0478-0425; Ramanathan, Babu/0000-0002-8216-3916; Sekaran, Shamala Devi/0000-0002-0478-0425; RAZALI, ROZAIMI/0000-0002-8996-3975; Jindal, Hassan/0000-0002-0788-3753; Le, Cheng Foh/0000-0002-2295-6690	University of Malaya High Impact Research Grant [UM.C/HIR/MOHE/MED/40]; University of Malaya Research Grant (UMRG) [RP020C-14AFR, RP001C-13ICT]; internal research grant [INTS-2017-SST-RCBS-01]; Sunway University	University of Malaya High Impact Research Grant; University of Malaya Research Grant (UMRG); internal research grant; Sunway University	This study was supported by University of Malaya High Impact Research Grant (reference number: UM.C/HIR/MOHE/MED/40, account number: H-848 20001-E000079) and University of Malaya Research Grant (UMRG Project no. RP020C-14AFR and RP001C-13ICT). Support from internal research grant (INTS-2017-SST-RCBS-01) and a publication support grant from Sunway University is gratefully acknowledged.	Aguilar-Rodea P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172882; Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Aloush V, 2006, ANTIMICROB AGENTS CH, V50, P43, DOI 10.1128/AAC.50.1.43-48.2006; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bragonzi A, 2009, AM J RESP CRIT CARE, V180, P138, DOI 10.1164/rccm.200812-1943OC; Chen LH, 2012, NUCLEIC ACIDS RES, V40, pD641, DOI 10.1093/nar/gkr989; Fujitani S, 2011, CHEST, V139, P909, DOI 10.1378/chest.10-0166; Gooderham WJ, 2009, FEMS MICROBIOL REV, V33, P279, DOI 10.1111/j.1574-6976.2008.00135.x; Grisaru-Soen G, 2000, PEDIATR INFECT DIS J, V19, P959, DOI 10.1097/00006454-200010000-00003; Grosso-Becerra MV, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-318; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Hocquet D, 2003, ANTIMICROB AGENTS CH, V47, P1371, DOI 10.1128/AAC.47.4.1371-1375.2003; Jansen G, 2016, EVOL MED PUBLIC HLTH; Jelsbak L, 2007, INFECT IMMUN, V75, P2214, DOI 10.1128/IAI.01282-06; Lalitha MK, 1997, INDIAN J MED RES, V106, P500; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lewis T, 2010, J HOSP INFECT, V75, P37, DOI 10.1016/j.jhin.2010.01.012; Li XZ, 2003, ANTIMICROB AGENTS CH, V47, P27, DOI 10.1128/AAC.47.1.27-33.2003; Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09; Lye DC, 2012, CLIN MICROBIOL INFEC, V18, P502, DOI 10.1111/j.1469-0691.2011.03606.x; Martin K, 2013, J MED MICROBIOL, V62, P988, DOI 10.1099/jmm.0.054841-0; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Nathwani D, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-32; Octavia S, 2007, J CLIN MICROBIOL, V45, P3795, DOI 10.1128/JCM.00720-07; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Poole Keith, 2002, Current Pharmaceutical Biotechnology, V3, P77, DOI 10.2174/1389201023378454; Robinson ER, 2013, GENOME MED, V5, DOI 10.1186/gm440; Sabat AJ, 2013, EUROSURVEILLANCE, V18, P17; Sanchez D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107754; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Septimus EJ, 2009, CLIN PHARMACOL THER, V86, P336, DOI 10.1038/clpt.2009.122; Snyder LA, 2013, EUROSURVEILLANCE, V18, P17, DOI 10.2807/1560-7917.ES2013.18.42.20611; Turton JF, 2010, CLIN MICROBIOL INFEC, V16, P1111, DOI 10.1111/j.1469-0691.2009.03049.x; Vogne C, 2004, ANTIMICROB AGENTS CH, V48, P1676, DOI 10.1128/AAC.48.5.1676-1680.2004; Wei Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029276	39	21	21	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182524	10.1371/journal.pone.0182524	http://dx.doi.org/10.1371/journal.pone.0182524			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797043	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000407396200058
J	Banks, LM; Zuurmond, M; Ferrand, R; Kuper, H				Banks, Lena Morgon; Zuurmond, Maria; Ferrand, Rashida; Kuper, Hannah			Knowledge of HIV-related disabilities and challenges in accessing care: Qualitative research from Zimbabwe	PLOS ONE			English	Article							HEALTH-CARE; LIFE EXPECTANCY; PEOPLE; REHABILITATION	Introduction While the rapid expansion in antiretroviral therapy access in low and middle income countries has resulted in dramatic declines in mortality rates, many people living with HIV face new or worsening experiences of disability. As nearly 1 in 20 adults are living with HIV in sub-Saharan Africa-many of whom are likely to develop disabling sequelae from long-term infection, co-morbidities and side effects of their treatment-understanding the availability and accessibility of services to address HIV-related disabilities is of vital importance. The aim of this study thus is to explore knowledge of HIV-related disabilities amongst stakeholders working in the fields of HIV and disability and factors impacting uptake and provision of interventions for preventing, treating or managing HIV-related disabilities. Methods In-depth, semi-structured interviews were conducted with ten stakeholders based in Harare, Zimbabwe, who were working in the fields of either disability or HIV. Stakeholders were identified through a priori stakeholder analysis. Thematic Analysis, complemented by constant comparison as described in Grounded Theory, was used to analyse findings. Results All key informants reported some level of knowledge of HIV-related disability, mostly from observations made in their line of work. However, they reported no interventions or policies were in place specifically to address HIV-related disability. While referrals between HIV and rehabilitation providers were not uncommon, no formal mechanisms had been established for collaborating on prevention, identification and management. Additional barriers to accessing and providing services to address HIV-related disabilities included: the availability of resources, including trained professionals, supplies and equipment in both the HIV and rehabilitation sectors; lack of disability-inclusive adaptations, particularly in HIV services; heavy centralization of available services in urban areas, without accessible, affordable transportation links; and attitudes and understanding among service providers and people living with HIV-related disabilities. Conclusions As people living with HIV are surviving longer, HIV-related disabilities will become a major source of disability globally, particularly in sub-Saharan Africa where infection is endemic. Preventing, treating and managing HIV-related disabilities must become a key component of both HIV response efforts and rehabilitation strategies.	[Banks, Lena Morgon; Zuurmond, Maria; Kuper, Hannah] London Sch Hyg & Trop Med, Int Ctr Evidence Disabil, London, England; [Banks, Lena Morgon; Zuurmond, Maria; Ferrand, Rashida; Kuper, Hannah] London Sch Hyg & Trop Med, Clin Res Dept, London, England; [Ferrand, Rashida] Biomed Res & Training Inst, Harare, Zimbabwe	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Biomedical Research Training Institute	Banks, LM (corresponding author), London Sch Hyg & Trop Med, Int Ctr Evidence Disabil, London, England.; Banks, LM (corresponding author), London Sch Hyg & Trop Med, Clin Res Dept, London, England.	morgon.banks@lshtm.ac.uk	Nyirenda, Makandwe/R-4080-2018	Nyirenda, Makandwe/0000-0002-1839-877X; Banks, Lena Morgon/0000-0002-4585-1103	Wellcome Trust [095878/Z/11/Z]; London School of Hygiene and Tropical Medicine	Wellcome Trust(Wellcome TrustEuropean Commission); London School of Hygiene and Tropical Medicine	Funding was received from the Wellcome Trust (Dr. Rashida Ferrand, Grant Number: 095878/Z/11/Z), as well as the London School of Hygiene and Tropical Medicine (Lena Morgon Banks, Research Degree Travelling Scholarship) to conduct and disseminate this research.	[Anonymous], 2004, DIS REH STAT REV DIS; [Anonymous], 2017, UPHLS AB US 2017; [Anonymous], 2009, DIS HIV POL BRIEF; AVERT, HIV AIDS ZIMB 2017; Banks LM, 2015, TROP MED INT HEALTH, V20, P411, DOI 10.1111/tmi.12449; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Boyatzis R. E., 1998, TRANSFORMING QUALITA, DOI 10.1191/1478088706qp063oa; Canadian-International HIV & Rehabilitation Research Collaborative, AB CIHRRC 2013; Chetty V, 2016, AIDS CARE, V28, P132, DOI 10.1080/09540121.2016.1146204; Chetty V, 2015, AFR J DISABIL, V4, DOI 10.4102/ajod.v4i1.137; Disability HAT, DHAT AB US; Glaser B.G., 1968, DISCOV GROUNDED THEO; Government of the Republic of Zimbabwe, 2016, GLOB AIDS RESP PROGR; Government of Zimbabwe, 2015, ZIMB NAT HIV AIDS ST; Groce NE, 2013, SOC SCI MED, V77, P31, DOI 10.1016/j.socscimed.2012.10.024; Hanass-Hancock J, 2015, DISABIL REHABIL, V37, P2012, DOI 10.3109/09638288.2014.991455; Hanass-Hancock Jill, 2009, J Int AIDS Soc, V12, P28, DOI 10.1186/1758-2652-12-28; Health Canada, 2009, HIV AIDS DIS FIN REP; Kotze H., 2012, STATUS DISABILITY RI; National AIDS Council of Zimbabwe, HIV AIDS SIT SIT AN; Nixon S, 2011, S AFR J HIV MED, P12; Nixon SA, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18806; Nixon SA, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-41; O'Brien KK, 2009, J INT AIDS SOC, V12, DOI [10.1186/1758-2652-12-30, 10.1186/1758-2652-2-5]; O'Brien KK, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-76; PENCHANSKY R, 1981, MED CARE, V19, P127, DOI 10.1097/00005650-198102000-00001; Peters DH, 2008, ANN NY ACAD SCI, V1136, P161, DOI 10.1196/annals.1425.011; Teeraananchai S, 2017, HIV MED, V18, P256, DOI 10.1111/hiv.12421; UNAIDS, 2016, PREV GAP REP; UNAIDS, 2015, AIDS NUMB 2015; University of Toronto University of Zambia The Canadian Working Group on HIV and Rehabilitation The DSP Kenya Project Canada GC, 2015, REH CAN HELP PEOPL L; van Egeraat L, 2015, AJAR-AFR J AIDS RES, V14, P285, DOI 10.2989/16085906.2015.1084938; WHO, 2011, WORLD REPORT ON DISABILITY, P1; World Health Organization, 2011, PED ADV TOOLK IMPR P; World Health Organization, 2002, COMMON LANGUAGE FUNC; World Health Organization, 2016, ANT THER COV DAT EST; World Health Organization, GLOB HLTH OBS DAT	37	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0181144	10.1371/journal.pone.0181144	http://dx.doi.org/10.1371/journal.pone.0181144			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC9YJ	28793316	Green Accepted, gold, Green Published			2022-12-26	WOS:000407196700007
J	Goren, S; Lugassi, N; Stein, O; Yeselson, Y; Schaffer, AA; David-Schwartz, R; Granot, D				Goren, Shlomo; Lugassi, Nitsan; Stein, Ofer; Yeselson, Yelena; Schaffer, Arthur A.; David-Schwartz, Rakefet; Granot, David			Suppression of sucrose synthase affects auxin signaling and leaf morphology in tomato	PLOS ONE			English	Article							GENE-EXPRESSION; COTYLEDON DEVELOPMENT; TRANSCRIPTION FACTOR; ADP-GLUCOSE; STARCH; ARABIDOPSIS; FRUIT; INVERTASE; GROWTH; METABOLISM	Metabolic enzymes have been found to play roles in plant development. Sucrose synthase (SUS) is one of the two enzyme families involved in sucrose cleavage in plants. In tomato, six SUS genes have been found. We generated transgenic tomato plants with RNAi suppression of SlSUS1, SlSUS3 and SlSUS4 genes. Independent transgenic lines with RNAi suppression of more than one SUS gene exhibited morphological effects on their cotyledons and leaf structure, but there were no significant effects on their carbohydrate levels, demonstrating that SUS has a developmental function, in addition to its metabolic function. Shoot apices of the transgenic lines showed elevated expression of JAGGED (JAG) and the auxin transporter PIN1. In a PIN1-GFP fusion reporter/SUS-RNAi hybrid, PIN1-GFP patterns were altered in developing leaves (as compared to control plants), indicating that SlSUS suppression alters auxin signaling. These results suggest possible roles for SUS in the regulation of plant growth and leaf morphology, in association with the auxin-signaling pathway.	[Goren, Shlomo; Lugassi, Nitsan; Stein, Ofer; Yeselson, Yelena; Schaffer, Arthur A.; David-Schwartz, Rakefet; Granot, David] Agr Res Org, Volcani Ctr, Inst Plant Sci, Bet Dagan, Israel	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Granot, D (corresponding author), Agr Res Org, Volcani Ctr, Inst Plant Sci, Bet Dagan, Israel.	granot@agri.gov.il	David-Schwartz, Rakefet/O-7263-2016; David-Schwartz, Rakefet/ABI-3825-2020	David-Schwartz, Rakefet/0000-0001-5923-8636; Granot, David/0000-0002-4047-0272	United States Israel Binational Agricultural Research and Development Fund [IS-4541-12]	United States Israel Binational Agricultural Research and Development Fund(US-Israel Binational Science Foundation)	The project was funded by the United States Israel Binational Agricultural Research and Development Fund (IS-4541-12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baroja-Fernandez E, 2012, P NATL ACAD SCI USA, V109, pE777, DOI 10.1073/pnas.1201538109; Baroja-Fernandez E, 2012, P NATL ACAD SCI USA, V109, P321, DOI 10.1073/pnas.1117099109; Baroja-Fernandez E, 2009, PLANT CELL PHYSIOL, V50, P1651, DOI 10.1093/pcp/pcp108; Barratt DHP, 2009, P NATL ACAD SCI USA, V106, P13124, DOI 10.1073/pnas.0900689106; Bayer EM, 2009, GENE DEV, V23, P373, DOI 10.1101/gad.497009; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Bieniawska Z, 2007, PLANT J, V49, P810, DOI 10.1111/j.1365-313X.2006.03011.x; Cheng YF, 2008, P NATL ACAD SCI USA, V105, P21017, DOI 10.1073/pnas.0809761106; Chengappa S, 1999, PLANT MOL BIOL, V40, P213, DOI 10.1023/A:1006136524725; Coleman HD, 2006, PLANT BIOTECHNOL J, V4, P87, DOI 10.1111/j.1467-7652.2005.00160.x; Coleman HD, 2010, TRANSGENIC RES, V19, P269, DOI 10.1007/s11248-009-9309-5; D'Aoust MA, 1999, PLANT CELL, V11, P2407, DOI 10.1105/tpc.11.12.2407; Damari-Weissler H, 2009, PLANTA, V230, P795, DOI 10.1007/s00425-009-0985-4; David-Schwartz R, 2009, PLANT CELL, V21, P3093, DOI 10.1105/tpc.109.069948; Dhonukshe P, 2010, DEVELOPMENT, V137, P3245, DOI 10.1242/dev.052456; Eastmond PJ, 2003, J EXP BOT, V54, P533, DOI 10.1093/jxb/erg039; Feraru E, 2011, CURR BIOL, V21, P338, DOI 10.1016/j.cub.2011.01.036; Friml J, 2004, SCIENCE, V306, P862, DOI 10.1126/science.1100618; FU HY, 1995, PLANT CELL, V7, P1395, DOI 10.1105/tpc.7.9.1395; FU HY, 1995, PLANT CELL, V7, P1369, DOI 10.1105/tpc.7.9.1369; FU HY, 1995, PLANT CELL, V7, P1387, DOI 10.1105/tpc.7.9.1387; Fujii S, 2010, PLANT CELL PHYSIOL, V51, P294, DOI 10.1093/pcp/pcp190; Furutani M, 2004, DEVELOPMENT, V131, P5021, DOI 10.1242/dev.01388; Furutani M, 2007, DEVELOPMENT, V134, P3849, DOI 10.1242/dev.009654; Angeles-Nunez JG, 2010, PLANTA, V232, P701, DOI 10.1007/s00425-010-1207-9; German MA, 2003, PLANT J, V34, P837, DOI 10.1046/j.1365-313X.2003.01765.x; German MA, 2003, PLANT SCI, V164, P183, DOI 10.1016/S0168-9452(02)00381-3; Gibson SI, 2005, CURR OPIN PLANT BIOL, V8, P93, DOI 10.1016/j.pbi.2004.11.003; Godt DE, 1997, PLANT PHYSIOL, V115, P273, DOI 10.1104/pp.115.1.273; Goren S, 2011, PLANTA, V233, P1011, DOI 10.1007/s00425-011-1356-5; Granot D, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00044; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Ho SL, 2001, PLANT PHYSIOL, V125, P877, DOI 10.1104/pp.125.2.877; Jang JC, 1997, PLANT CELL, V9, P5, DOI 10.1105/tpc.9.1.5; Jiang Y, 2011, PLANT BIOTECHNOL J; KLANN E, 1992, PLANT PHYSIOL, V99, P351, DOI 10.1104/pp.99.1.351; Koenig D, 2013, P NATL ACAD SCI USA, V110, pE2655, DOI 10.1073/pnas.1309606110; Koenig D, 2009, DEVELOPMENT, V136, P2997, DOI 10.1242/dev.033811; Li J, 2013, PLANT CELL PHYSIOL, V54, P282, DOI 10.1093/pcp/pcs180; Mason MG, 2014, P NATL ACAD SCI USA, V111, P6092, DOI 10.1073/pnas.1322045111; McCormick S, 1991, PLANT TISSUE CULTURE, P1; McHale NA, 2004, PLANT CELL, V16, P1251, DOI 10.1105/tpc.019307; MIRON D, 1991, PLANT PHYSIOL, V95, P623, DOI 10.1104/pp.95.2.623; Mishra BS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004502; Moller B, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001545; Munoz FJ, 2005, PLANT CELL PHYSIOL, V46, P1366, DOI 10.1093/pcp/pci148; Naz AA, 2013, P NATL ACAD SCI USA, V110, P2401, DOI 10.1073/pnas.1214300110; Park SJ, 2012, P NATL ACAD SCI USA, V109, P639, DOI 10.1073/pnas.1114963109; Paul MJ, 2008, ANNU REV PLANT BIOL, V59, P417, DOI 10.1146/annurev.arplant.59.032607.092945; Qin GZ, 2016, PLANT PHYSIOL, V172, P1596, DOI 10.1104/pp.16.01269; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Ruan YL, 2003, PLANT CELL, V15, P952, DOI 10.1105/tpc.010108; Samac DA, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0649-4; Sheen J, 1999, CURR OPIN PLANT BIOL, V2, P410, DOI 10.1016/S1369-5266(99)00014-X; Shields R, 1998, PLANT PHYSIOL, V118, P1533; Tang GQ, 1999, PLANT MOL BIOL, V41, P465, DOI 10.1023/A:1006327606696; Treml BS, 2005, DEVELOPMENT, V132, P4063, DOI 10.1242/dev.01969; Wahl V, 2013, SCIENCE, V339, P704, DOI 10.1126/science.1230406; WANG F, 1993, PLANT PHYSIOL, V103, P1463, DOI 10.1104/pp.103.4.1463; Wang H, 2005, PLANT CELL, V17, P2676, DOI 10.1105/tpc.105.033415; Weise A, 2008, PLANT MOL BIOL, V68, P251, DOI 10.1007/s11103-008-9366-9; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Won C, 2011, P NATL ACAD SCI USA, V108, P18518, DOI 10.1073/pnas.1108436108; Xu SM, 2012, MOL PLANT, V5, P430, DOI 10.1093/mp/ssr090; Yang L, 2013, ELIFE, V2, DOI 10.7554/eLife.00260	67	22	25	8	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182334	10.1371/journal.pone.0182334	http://dx.doi.org/10.1371/journal.pone.0182334			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28787452	Green Submitted, Green Published, gold			2022-12-26	WOS:000406998800026
J	Kajla, S; Mukhopadhyay, A; Pradhan, AK				Kajla, Sachin; Mukhopadhyay, Arundhati; Pradhan, Akshay K.			Development of transgenic Brassica juncea lines for reduced seed sinapine content by perturbing phenylpropanoid pathway genes	PLOS ONE			English	Article							ARTIFICIAL MICRORNA; NAPUS; BIOSYNTHESIS; ARABIDOPSIS; ENZYME; PLANTS; TRANSCRIPTION; SUPPRESSION; EXPRESSION; REGULATOR	Sinapine is a major anti-nutritive compound that accumulates in the seeds of Brassica species. When ingested, sinapine imparts gritty flavuor in meat and milk of animals and fishy odor to eggs of brown egg layers, thereby compromising the potential use of the valuable protein rich seed meal. Sinapine content in Brassica juncea germplasm ranges from 6.7 to 15.1 mg/g of dry seed weight (DSW) which is significantly higher than the prescribed permissible level of 3.0 mg/g of DSW. Due to limited natural genetic variability, conventional plant breeding approach for reducing the sinapine content has largely been unsuccessful. Hence, transgenic approach for gene silencing was adopted by targeting two genes-SGT and SCT, encoding enzymes UDP-glucose: sinapate glucosyltransferase and sinapoylglucose: choline sinapoyltransferase, respectively, involved in the final two steps of sinapine biosynthetic pathway. These two genes were isolated from B. juncea and eight silencing constructs were developed using three different RNA silencing approaches viz. antisense RNA, RNAi and artificial microRNA. Transgenics in B. juncea were developed following Agrobacterium-mediated transformation. From a total of 1232 independent T-0 transgenic events obtained using eight silencing constructs, 25 homozygous lines showing single gene inheritance were identified in the T-2 generation. Reduction of seed sinapine content in these lines ranged from 15.8% to 67.2%; the line with maximum reduction had sinapine content of 3.79 mg/g of DSW. The study also revealed that RNAi method was more efficient than the other two methods used in this study.	[Kajla, Sachin; Pradhan, Akshay K.] Univ Delhi, Dept Genet, South Campus, New Delhi, India; [Mukhopadhyay, Arundhati; Pradhan, Akshay K.] Univ Delhi, Ctr Genet Manipulat Crop Plants, South Campus, New Delhi, India	University of Delhi; University of Delhi	Pradhan, AK (corresponding author), Univ Delhi, Ctr Genet Manipulat Crop Plants, South Campus, New Delhi, India.	pradhancgmcp@gmail.com			Department of Biotechnology, Government of India; Council of Scientific and Industrial Research (CSIR), India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	The study was funded by the Department of Biotechnology, Government of India. SK acknowledges the receipt of a research fellowship from the Council of Scientific and Industrial Research (CSIR), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was funded by the Department of Biotechnology, Government of India. SK is thankful to Vedvrat Verma for his help in silico analyses. SK acknowledges the receipt of research fellowship from the Council of Scientific and Industrial Research (CSIR), India.	Arumugam N, 2007, TRANSGENIC RES, V16, P703, DOI 10.1007/s11248-006-9058-7; Augustine R, 2013, J EXP BOT, V64, P4907, DOI 10.1093/jxb/ert280; Baulcombe DC, 1996, CURR OPIN BIOTECH, P173; Bhinu VS, 2009, TRANSGENIC RES, V18, P31, DOI 10.1007/s11248-008-9194-3; BOUCHEREAU A, 1991, PHYTOCHEMISTRY, V30, P1873, DOI 10.1016/0031-9422(91)85031-T; Butardo VM, 2011, J EXP BOT, V62, P4927, DOI 10.1093/jxb/err188; DELISLE AJ, 1989, PLANT PHYSIOL, V91, P617, DOI 10.1104/pp.91.2.617; Dhakate P, 2014, ACTA PHYSIOL PLANT, V36, P2125, DOI 10.1007/s11738-014-1589-6; Fang JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048006; Gigolashvili T, 2007, PLANT J, V51, P247, DOI 10.1111/j.1365-313X.2007.03133.x; GOH YK, 1979, CAN J ANIM SCI, V59, P313, DOI 10.4141/cjas79-037; Harloff HJ, 2012, THEOR APPL GENET, V124, P957, DOI 10.1007/s00122-011-1760-z; Huang J, 2008, PLANT PHYSIOL BIOCH, V46, P647, DOI 10.1016/j.plaphy.2008.04.014; Husken A, 2005, MOL BREEDING, V16, P127, DOI 10.1007/s11032-005-6825-8; ISMAIL F, 1981, J FOOD SCI, V46, P1241, DOI 10.1111/j.1365-2621.1981.tb03031.x; Jha GK., 2012, EDIBLE OILSEEDS SUPP; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Li LN, 2007, J MOL BIOL, V370, P951, DOI 10.1016/j.jmb.2007.05.036; Li Y, 2001, J BIOL CHEM, V276, P4338, DOI 10.1074/jbc.M007447200; Long D, 2007, NAT STRUCT MOL BIOL, V14, P287, DOI 10.1038/nsmb1226; Mansoor S, 2006, TRENDS PLANT SCI, V11, P559, DOI 10.1016/j.tplants.2006.09.010; Matthaus B, 2000, IND CROP PROD, V12, P9, DOI 10.1016/S0926-6690(99)00040-0; Mehra S, 2000, CURR SCI INDIA, V78, P1358; Melito S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-104; Milkowski C, 2004, PLANT J, V38, P80, DOI 10.1111/j.1365-313X.2004.02036.x; Milkowski C, 2010, PLANTA, V232, P19, DOI 10.1007/s00425-010-1168-z; Mittasch J, 2010, THEOR APPL GENET, V120, P1485, DOI 10.1007/s00122-010-1270-4; MUELLER MM, 1978, CAN J ANIM SCI, V58, P579, DOI 10.4141/cjas78-076; Niu DD, 2011, MOL PLANT MICROBE IN, V24, P533, DOI 10.1094/MPMI-09-10-0213; PEARSON AW, 1980, COMP BIOCHEM PHYS A, V67, P397, DOI 10.1016/S0300-9629(80)80015-6; Rajput R, 2013, EXTREMOPHILES, V17, P29, DOI 10.1007/s00792-012-0490-8; Rogers SO, 1994, PLANT MOL BIOL MANUA, P1; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Shirley AM, 2001, PLANT J, V28, P83, DOI 10.1046/j.1365-313X.2001.01123.x; Sivaraman I, 2004, MOL BREEDING, V13, P365, DOI 10.1023/B:MOLB.0000034092.47934.d6; Tiwari M, 2014, PLANT MOL BIOL, V86, P1, DOI 10.1007/s11103-014-0224-7; Toppino L, 2011, PLANT BIOTECHNOL J, V9, P684, DOI 10.1111/j.1467-7652.2010.00567.x; Warthmann N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001829; Weier D, 2008, PLANTA, V227, P375, DOI 10.1007/s00425-007-0624-x; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Yang JH, 2016, NAT GENET, V48, P1225, DOI 10.1038/ng.3657; Zhang XH, 2011, TRANSGENIC RES, V20, P569, DOI 10.1007/s11248-010-9440-3	43	5	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182747	10.1371/journal.pone.0182747	http://dx.doi.org/10.1371/journal.pone.0182747			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28787461	Green Submitted, gold, Green Published			2022-12-26	WOS:000406998800061
J	Li, XX; Zhao, Y; Jin, YA; Zhang, TJ; Chang, XY; Liao, S; Xu, HX; Liu, XY; Yang, JJ; Zhang, JJ; Zhang, YH				Li, Xiaoxia; Zhao, Yi; Jin, Yanan; Zhang, Tianjing; Chang, Xiaoyu; Liao, Sha; Xu, Hongxia; Liu, Xiuying; Yang, Jianjun; Zhang, Jianjun; Zhang, Yuhong			Associations between serum adipocytokines and glycemic tolerance biomarkers in a rural Chinese population	PLOS ONE			English	Article							REVERSES INSULIN-RESISTANCE; LEPTIN LEVELS; WEIGHT-LOSS; ADIPONECTIN; OBESITY; SENSITIVITY; RISK; LIPODYSTROPHY; METAANALYSIS; VALIDATION	Although experimental studies have shown that adiponectin and leptin modulate glucose tolerance and insulin resistance, it remains unclear whether these adipocytokines exert similar effects in general human populations. We evaluated the associations of serum adiponectin and leptin with beta-cell function and insulin resistance in a population with low obesity prevalence. A cross-sectional study of 783 rural residents, aged 25-74 years, recruited in Ningxia, China was conducted during 2008-2012. beta-cell function and insulin resistance were estimated using the Homeostasis Model Assessment. Serum adiponectin and leptin were measured with ELISA. Serum adiponectin concentrations (mean +/- SD) were highest in subjects with normal glucose tolerance (36.65 +/- 61.13 mu g/ml), intermediate in those with impaired fasting glucose (25.92 +/- 34.48 mu g/ml), and lowest in those with diabetes (15.08 +/- 12.14 mu g/ml) (p = 0.001). A similar pattern of differences was found for beta-cell function, whereas opposite results were observed for insulin resistance and blood glucose. After adjustment for confounders including metabolic syndrome components, serum adiponectin (mu g/ml) was inversely associated with beta-cell function (% beta) [beta (95% CI): -7.57 (-12.33, -2.81)] and insulin resistance (100/% S) [beta (95% CI): -0.21 (-0.33, -0.09)]. A significant inverse association also existed between serum leptin and beta-cell function, but serum leptin was not significantly associated with insulin resistance. The present study suggests that adiponectin and leptin play a role in the development of insulin resistance and diabetes independent of metabolic syndrome.	[Li, Xiaoxia; Zhao, Yi; Zhang, Tianjing; Chang, Xiaoyu; Xu, Hongxia; Liu, Xiuying; Yang, Jianjun; Zhang, Yuhong] Ningxia Med Univ, Sch Publ Hlth & Management, Dept Epidemiol, Yinchuan, Ningxia Hui Aut, Peoples R China; [Jin, Yanan] Ningxia Ctr Dis Control & Prevent, Yinchuan, Ningxia Hui Aut, Peoples R China; [Liao, Sha] Sichuan Prov Ctr Dis Control & Prevent, Chengdu, Sichuan, Peoples R China; [Zhang, Jianjun] Indiana Univ, Richard M Fairbanks Sch Publ Hlth, Dept Epidemiol, Indianapolis, IN 46204 USA	Ningxia Medical University; Indiana University System; Indiana University-Purdue University Indianapolis	Zhang, YH (corresponding author), Ningxia Med Univ, Sch Publ Hlth & Management, Dept Epidemiol, Yinchuan, Ningxia Hui Aut, Peoples R China.; Zhang, JJ (corresponding author), Indiana Univ, Richard M Fairbanks Sch Publ Hlth, Dept Epidemiol, Indianapolis, IN 46204 USA.	JZ21@iu.edu; zhabour@163.com	yang, jian/HIK-0188-2022; Zhang, Yuhong/I-5056-2012	Zhang, Yuhong/0000-0002-7110-8401; Zhang, Jianjun/0000-0003-2179-2388	Natural Science Foundation of China [81160358]; YHZ	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); YHZ	This study was supported by the Natural Science Foundation of China (No. 81160358) and the recipient was YHZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hamodi Z, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-99; BONADONNA RC, 1990, METABOLISM, V39, P452, DOI 10.1016/0026-0495(90)90002-T; Chen GC, 2014, OBES REV, V15, P134, DOI 10.1111/obr.12088; Cloostermans L, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0304-3; Cotton B, 2018, CALLS HALTELECTRONIC; Dosaev T, 2014, AM J HUM BIOL, V26, P760, DOI 10.1002/ajhb.22583; Duncan BB, 2004, DIABETES, V53, P2473, DOI 10.2337/diabetes.53.9.2473; Gokulakrishnan K, 2015, ENDOCR PRACT, V21, P1143, DOI 10.4158/EP15741.OR; Gutt M, 2000, DIABETES RES CLIN PR, V47, P177, DOI 10.1016/S0168-8227(99)00116-3; Jin M. J, 2013, PLOS ONE, V8, DOI DOI 10.1371/journal.pone.0079946; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Mason C, 2011, AM J PREV MED, V41, P366, DOI 10.1016/j.amepre.2011.06.042; Meek TH, 2016, DIABETOLOGIA, V59, P928, DOI 10.1007/s00125-016-3898-3; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Pantsulaia I, 2009, AM J HUM BIOL, V21, P84, DOI 10.1002/ajhb.20821; Petersen KF, 2002, J CLIN INVEST, V109, P1345, DOI [10.1172/JCI0215001, 10.1172/JCI200215001]; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Sjostrom CD, 2000, HYPERTENSION, V36, P20, DOI 10.1161/01.HYP.36.1.20; Tatti P, 2001, ENDOCRINE, V15, P305, DOI 10.1385/ENDO:15:3:305; Tozzo E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126642; Tremblay AJ, 2004, CLIN BIOCHEM, V37, P785, DOI 10.1016/j.clinbiochem.2004.03.008; Vinitha R, 2015, DIABETES RES CLIN PR, V109, P340, DOI 10.1016/j.diabres.2015.05.035; Wallace TM, 2004, DIABETIC MED, V21, P568, DOI 10.1111/j.1464-5491.2004.01218.x; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wasim H, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-10; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zhang JJ, 2001, EUR J EPIDEMIOL, V17, P469, DOI 10.1023/A:1013773517052; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8; Zimmet PZ, 1998, INT J OBESITY, V22, P171, DOI 10.1038/sj.ijo.0800559	34	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182273	10.1371/journal.pone.0182273	http://dx.doi.org/10.1371/journal.pone.0182273			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28786989	gold, Green Published, Green Submitted			2022-12-26	WOS:000406998800024
J	Jain, P; Fierst, TM; Han, HJ; Smith, TE; Vakil, A; Storm, PB; Resnick, AC; Waanders, AJ				Jain, P.; Fierst, T. M.; Han, H. J.; Smith, T. E.; Vakil, A.; Storm, P. B.; Resnick, A. C.; Waanders, A. J.			CRAF gene fusions in pediatric low-grade gliomas define a distinct drug response based on dimerization profiles	ONCOGENE			English	Article							RNA-BINDING PROTEIN; RAF INHIBITORS; MAPK PATHWAY; PARADOXICAL ACTIVATION; PROSTATE-CANCER; KINASE FUSIONS; NERVOUS-SYSTEM; GASTRIC-CANCER; SOLID TUMORS; BRAF	Pediatric low-grade gliomas (PLGGs) are commonly associated with BRAF gene fusions that aberrantly activate the mitogenactivated protein kinase (MAPK) signaling pathway. This has led to PLGG clinical trials utilizing RAF- and MAPK pathway-targeted therapeutics. Whole-genome profiling of PLGGs has also identified rare gene fusions involving another RAF isoform, CRAF/RAF1, in PLGGs and cancers occuring in adults. Whereas BRAF fusions primarily dysregulate MAPK signaling, the CRAF fusions QKI-RAF1 and SRGAP3-RAF1 aberrantly activate both the MAPK and phosphoinositide-3 kinase/mammalian target of rapamycin (PI3K/mTOR) signaling pathways. Although ATP-competitive, first-generation RAF inhibitors (vemurafenib/PLX4720, RAFi) cause paradoxical activation of the MAPK pathway in BRAF-fusion tumors, inhibition can be achieved with 'paradox breaker' RAFi, such as PLX8394. Here we report that, unlike BRAF fusions, CRAF fusions are unresponsive to both generations of RAFi, vemurafenib and PLX8394, highlighting a distinct responsiveness of CRAF fusions to clinically relevant RAFi. Whereas PLX8394 decreased BRAF-fusion dimerization, CRAF-fusion dimerization is unaffected primarily because of robust protein-protein interactions mediated by the N-terminal non-kinase fusion partner, such as QKI. The pan-RAF dimer inhibitor, LY3009120, could suppress CRAF-fusion oncogenicity by inhibiting dimer-mediated signaling. In addition, as CRAF fusions activate both the MAPK and PI3K/mTOR signaling pathways, we identify combinatorial inhibition of the MAPK/mTOR pathway as a potential therapeutic strategy for CRAF-fusiondriven tumors. Overall, we define a mechanistic distinction between PLGG-associated BRAF-and CRAF/RAF1 fusions in response to RAFi, highlighting the importance of molecularly classifying PLGG patients for targeted therapy. Furthermore, our study uncovers an important contribution of the non-kinase fusion partner to oncogenesis and potential therapeutic strategies against PLGG-associated CRAF fusions and possibly pan-cancer CRAF fusions.	[Jain, P.; Han, H. J.; Storm, P. B.; Resnick, A. C.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Jain, P.] Univ Penn, Perelman Sch Med, Cell & Mol Grad Grp, Philadelphia, PA 19104 USA; [Jain, P.; Fierst, T. M.; Han, H. J.; Smith, T. E.; Vakil, A.; Storm, P. B.; Resnick, A. C.] Childrens Hosp Philadelphia, Div Neurosurg, CTRB 4052,3501 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Fierst, T. M.] Temple Univ, Sch Med, Dept Neurosurg, Philadelphia, PA USA; [Storm, P. B.; Resnick, A. C.; Waanders, A. J.] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA; [Storm, P. B.; Resnick, A. C.; Waanders, A. J.] Childrens Hosp Philadelphia, Ctr Data Driven Discovery Biomed D3b, Philadelphia, PA 19104 USA; [Resnick, A. C.] Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA; [Waanders, A. J.] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA; [Waanders, A. J.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Resnick, AC (corresponding author), Childrens Hosp Philadelphia, Div Neurosurg, CTRB 4052,3501 Civ Ctr Blvd, Philadelphia, PA 19104 USA.; Waanders, AJ (corresponding author), Dept Pediat, CTRB 4030,3501 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	RESNICK@email.chop.edu; WAANDERSA@email.chop.edu		Jain, Payal/0000-0002-5914-9083	Kids' Brain Tumor Cure Foundation Pediatric Low-Grade Astrocytoma Foundation; Voices Against Brain Cancer; Children's Brain Tumor Foundation; Damon-Runyon Sohn Pediatric Fellowship Award; Hyundai Scholar Grant; Bear Necessities Pediatric Cancer Foundation; Rally Foundation for Childhood Cancer Research; Thea's Star of HopeNIH National Center for Advancing Translational Sciences Award [TL1TR000138]; National Institute of Health grant [R01NS085336]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085336] Funding Source: NIH RePORTER	Kids' Brain Tumor Cure Foundation Pediatric Low-Grade Astrocytoma Foundation; Voices Against Brain Cancer; Children's Brain Tumor Foundation; Damon-Runyon Sohn Pediatric Fellowship Award; Hyundai Scholar Grant; Bear Necessities Pediatric Cancer Foundation; Rally Foundation for Childhood Cancer Research; Thea's Star of HopeNIH National Center for Advancing Translational Sciences Award; National Institute of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Plexxikon Inc. for providing PLX4720 and PLX8394/PB-3 compounds and GlaxoSmithKline for providing trametinib. We greatly appreciate Jake Budlow, Tim Delaney, Namrata Choudhari and Katie Boucher for excellent technical assistance, and all members of the Resnick Lab for helpful discussion. We thank Dr Matthew Weitzman and Dr Mateusz P Koptyra for careful reading of the manuscript, and Dr Koptyra for helping with revision. This work was funded by the A Kids' Brain Tumor Cure Foundation Pediatric Low-Grade Astrocytoma Foundation (ACR), Voices Against Brain Cancer (ACR), the Children's Brain Tumor Foundation (ACR, AJW), the Damon-Runyon Sohn Pediatric Fellowship Award (AJW), a Hyundai Scholar Grant (AJW), the Bear Necessities Pediatric Cancer Foundation (AJW, ACR), the Rally Foundation for Childhood Cancer Research (AJW), Thea's Star of Hope (ACR, AJW), NIH National Center for Advancing Translational Sciences Award TL1TR000138 (HJH) and the National Institute of Health grant R01NS085336 (ACR).	Ali M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057345; Antony R, 2013, CANCER RES, V73, P4840, DOI 10.1158/0008-5472.CAN-12-4089; Bandopadhayay P, 2016, NAT GENET, V48, P273, DOI 10.1038/ng.3500; Bax DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005209; Beuck C, 2012, J MOL BIOL, V423, P766, DOI 10.1016/j.jmb.2012.08.027; Bian YQ, 2012, BIOCHEM BIOPH RES CO, V422, P187, DOI 10.1016/j.bbrc.2012.04.138; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Carlson BR, 2011, J NEUROSCI, V31, P2447, DOI 10.1523/JNEUROSCI.4433-10.2011; Chen AJ, 2012, GENE DEV, V26, P1459, DOI 10.1101/gad.189001.112; Chen SH, 2016, CANCER DISCOV, V6, P300, DOI 10.1158/2159-8290.CD-15-0896; Chen TP, 1998, MOL CELL BIOL, V18, P4863, DOI 10.1128/MCB.18.8.4863; Chmielecki J, 2014, CANCER DISCOV, V4, P1398, DOI 10.1158/2159-8290.CD-14-0617; Conn SJ, 2015, CELL, V160, P1125, DOI 10.1016/j.cell.2015.02.014; Danan-Gotthold M, 2015, NUCLEIC ACIDS RES, V43, P5130, DOI 10.1093/nar/gkv210; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Freeman Alyson K, 2013, Small GTPases, V4, P180, DOI 10.4161/sgtp.26117; Freeman AK, 2013, MOL CELL, V49, P751, DOI 10.1016/j.molcel.2012.12.018; FRIEDRIC.VL, 1974, BRAIN RES, V82, P168, DOI 10.1016/0006-8993(74)90902-0; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; HEIDECKER G, 1990, MOL CELL BIOL, V10, P2503, DOI 10.1128/MCB.10.6.2503; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Henry JR, 2015, J MED CHEM, V58, P4165, DOI 10.1021/acs.jmedchem.5b00067; Jones DTW, 2009, ONCOGENE, V28, P2119, DOI 10.1038/onc.2009.73; Jones DTW, 2006, J NEUROPATH EXP NEUR, V65, P1049, DOI 10.1097/01.jnen.0000240465.33628.87; Karajannis MA, 2014, NEURO-ONCOLOGY, V16, P1408, DOI 10.1093/neuonc/nou059; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Lahoz A, 2013, ONCOGENE, V32, P4854, DOI 10.1038/onc.2012.489; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Li ZZ, 2002, JPN J CANCER RES, V93, P167, DOI 10.1111/j.1349-7006.2002.tb01255.x; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Olow A, 2016, CLIN CANCER RES, V22, P5312, DOI 10.1158/1078-0432.CCR-15-1101; Palanisamy N, 2010, NAT MED, V16, P793, DOI 10.1038/nm.2166; Peng SB, 2015, CANCER CELL, V28, P384, DOI 10.1016/j.ccell.2015.08.002; Phillips JJ, 2016, ACTA NEUROPATHOL, V132, P757, DOI 10.1007/s00401-016-1616-3; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; RAPP UR, 1983, P NATL ACAD SCI-BIOL, V80, P4218, DOI 10.1073/pnas.80.14.4218; Rothrock CR, 2005, EMBO J, V24, P2792, DOI 10.1038/sj.emboj.7600745; Selt F, 2017, ONCOTARGET, V8, P11460, DOI 10.18632/oncotarget.14004; Shingu T, 2017, NAT GENET, V49, P75, DOI 10.1038/ng.3711; Sievert AJ, 2013, P NATL ACAD SCI USA, V110, P5957, DOI 10.1073/pnas.1219232110; Sievert AJ, 2009, BRAIN PATHOL, V19, P449, DOI 10.1111/j.1750-3639.2008.00225.x; STANTON VP, 1989, MOL CELL BIOL, V9, P639, DOI 10.1128/MCB.9.2.639; Stransky N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5846; Tolcher AW, 2015, ANN ONCOL, V26, P58, DOI 10.1093/annonc/mdu482; Varga A, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aai8482; Vernet C, 1997, TRENDS GENET, V13, P479, DOI 10.1016/S0168-9525(97)01269-9; Wu X, 2012, MOL CELL BIOL, V32, P3872, DOI 10.1128/MCB.00751-12; Yao Z, 2015, CANCER CELL, V28, P370, DOI 10.1016/j.ccell.2015.08.001; Yoshihara K, 2015, ONCOGENE, V34, P4845, DOI 10.1038/onc.2014.406; Zhang C, 2015, NATURE, V526, P583, DOI 10.1038/nature14982; Zhang JH, 2013, NAT GENET, V45, P602, DOI 10.1038/ng.2611; Zhao Y, 2014, CANCER BIOL THER, V15, P108, DOI 10.4161/cbt.26722; Zong FY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004289	55	38	38	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 9	2017	36	45					6348	6358		10.1038/onc.2017.276	http://dx.doi.org/10.1038/onc.2017.276			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FM1WY	28806393	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000414774800013
J	Ning, WS; Wang, TQ; Chen, HX; Yang, XZ; Jin, YF				Ning, Wensheng; Wang, Tianqi; Chen, Hongxian; Yang, Xiazhen; Jin, Yangfu			The effect of Fe2O3 crystal phases on CO2 hydrogenation	PLOS ONE			English	Article							FISCHER-TROPSCH SYNTHESIS; IRON-OXIDE; CARBON-DIOXIDE; CATALYSTS; HYDROCARBONS; ALPHA-FE2O3; GAMMA-FE2O3; CONVERSION; REDUCTION; FE	The effect of Fe2O3 crystal phases on their performance in CO2 hydrogenation was studied alpha-Fe2O3 crystal was prepared by precipitation method from Fe(NO3)(3)center dot 9H(2)O and (NH4)(2)CO3, and gamma-Fe2O3 was prepared by grinding Fe(NO3)(3)center dot 9H(2)O and L(+)-Tartaric acid in agate mortar completely. The crystal phases of Fe2O3 influence the distribution of promoter Zn, K and Cu on catalysts. The dispersity of K on gamma-Fe2O3 surface is higher than alpha-Fe2O3. On the contrary, Cu and Zn are more dispersive on alpha-Fe2O3 surface than gamma-Fe2O3. The catalyst in gamma-Fe2O3 phase is easily reduced relative to the catalyst in alpha-Fe2O3 phase. The former presents higher CO2 conversion and C2+ hydrocarbon selectivity than the latter in CO2 hydrogenation.	[Ning, Wensheng; Wang, Tianqi; Chen, Hongxian; Yang, Xiazhen] Zhejiang Univ Technol, Coll Chem Engn, Hangzhou, Zhejiang, Peoples R China; [Jin, Yangfu] Zhejiang Univ Technol, Coll Mat Sci & Technol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University of Technology; Zhejiang University of Technology	Ning, WS (corresponding author), Zhejiang Univ Technol, Coll Chem Engn, Hangzhou, Zhejiang, Peoples R China.	wenshning@sohu.com	Ning, Wensheng/G-8598-2012	Ning, Wensheng/0000-0002-6558-4831	Zhejiang Provincial Natural Science Foundation of China [LY14B030003]; National Ministry of Science and Technology of China [2014BAD02B05]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by the Zhejiang Provincial Natural Science Foundation of China (LY14B030003) and the National Ministry of Science and Technology of China (2014BAD02B05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Dossary M, 2015, APPL CATAL B-ENVIRON, V165, P651, DOI 10.1016/j.apcatb.2014.10.064; Albrecht M, 2017, APPL CATAL B-ENVIRON, V204, P119, DOI 10.1016/j.apcatb.2016.11.017; Ando H, 1998, CATAL TODAY, V45, P229, DOI 10.1016/S0920-5861(98)00220-X; Apte SK, 2007, J AM CERAM SOC, V90, P412, DOI 10.1111/j.1551-2916.2006.01424.x; [陈红贤 Chen Hongxian], 2015, [燃料化学学报, Journal of Fuel Chemistry and Technology], V43, P1387; DICTOR RA, 1986, J CATAL, V97, P121, DOI 10.1016/0021-9517(86)90043-6; Dorner RW, 2011, CATAL COMMUN, V15, P88, DOI 10.1016/j.catcom.2011.08.017; Dorner RW, 2010, APPL CATAL A-GEN, V373, P112, DOI 10.1016/j.apcata.2009.11.005; Drab DM, 2013, ENERG FUEL, V27, P6348, DOI 10.1021/ef4011115; DRY ME, 1969, J CATAL, V15, P190, DOI 10.1016/0021-9517(69)90023-2; Genuzio F, 2016, SURF SCI, V648, P177, DOI 10.1016/j.susc.2015.11.016; Hardy DR, 2008, U. S. Patent, Patent No. [7420004, B2, 7420004]; Jun KW, 2004, APPL CATAL A-GEN, V259, P221, DOI 10.1016/j.apcata.2003.09.034; Keyvanloo K, 2014, ACS CATAL, V4, P1071, DOI 10.1021/cs401242d; Lan BY, 2014, ACTA PHYS-CHIM SIN, V30, P2177, DOI 10.3866/PKU.WHXB201409303; LEE MD, 1989, B CHEM SOC JPN, V62, P2756, DOI 10.1246/bcsj.62.2756; Li SS, 2016, ANAL CHEM, V88, P906, DOI 10.1021/acs.analchem.5b03570; Liu CX, 2013, CATAL LETT, V143, P697, DOI 10.1007/s10562-013-1017-3; Ma HQ, 1995, CHINESE J CATAL+, V16, P365; Mattia D, 2015, CHEMSUSCHEM, V8, P4064, DOI 10.1002/cssc.201500739; Ning W., 2012, CURR CATAL, V1, P88, DOI [10.2174/2211544711201020088, DOI 10.2174/2211544711201020088]; Ning WS, 2007, CATAL COMMUN, V8, P275, DOI 10.1016/j.catcom.2006.05.047; Ning WS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124228; Ning WS, 2009, ENERG FUEL, V23, P4696, DOI 10.1021/ef900428t; NOZAKI F, 1987, J CATAL, V104, P339, DOI 10.1016/0021-9517(87)90366-6; Riedel T, 1999, APPL CATAL A-GEN, V186, P201, DOI 10.1016/S0926-860X(99)00173-8; Rohde MP, 2005, IND ENG CHEM RES, V44, P9653, DOI 10.1021/ie050289z; Saeidi S, 2014, J CO2 UTIL, V5, P66, DOI 10.1016/j.jcou.2013.12.005; Satthawong R, 2015, CATAL TODAY, V251, P34, DOI 10.1016/j.cattod.2015.01.011; SCHERER GW, 1990, J AM CERAM SOC, V73, P3, DOI 10.1111/j.1151-2916.1990.tb05082.x; SCHILD C, 1991, J PHYS CHEM-US, V95, P6341, DOI 10.1021/j100169a049; Song CS, 2006, CATAL TODAY, V115, P2, DOI 10.1016/j.cattod.2006.02.029; Wan HJ, 2007, ACTA PHYS-CHIM SIN, V23, P1151, DOI 10.1016/S1872-1508(07)60059-X; Wang W, 2011, CHEM SOC REV, V40, P3703, DOI 10.1039/c1cs15008a; Wei J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15174; Willauer HD, 2014, IND ENG CHEM RES, V53, P12192, DOI 10.1021/ie502128x; Willauer HD, 2012, IND ENG CHEM RES, V51, P11254, DOI 10.1021/ie301006y; Willauer HD, 2011, IND ENG CHEM RES, V50, P9876, DOI 10.1021/ie2008136; WILLIAMS KJ, 1991, CATAL LETT, V9, P415, DOI 10.1007/BF00764834; Yang Y, 2004, APPL CATAL A-GEN, V266, P181, DOI 10.1016/j.apcata.2004.02.018; Zhang YQ, 2002, CATAL TODAY, V71, P411, DOI 10.1016/S0920-5861(01)00468-0; Zhu WH, 2016, J PHYS CHEM C, V120, P14854, DOI 10.1021/acs.jpcc.6b02033	42	13	13	13	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2017	12	8							e0182955	10.1371/journal.pone.0182955	http://dx.doi.org/10.1371/journal.pone.0182955			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD5CP	28806421	Green Published, Green Submitted, gold			2022-12-26	WOS:000407548800040
J	Gonzales, J; Tymon, T; Kupper, FC; Edwards, MS; Carrano, CJ				Gonzales, Jennifer; Tymon, Teresa; Kupper, Frithjof C.; Edwards, Matthew S.; Carrano, Carl J.			The potential role of kelp forests on iodine speciation in coastal seawater	PLOS ONE			English	Article							BROMINE CHEMISTRY; IODATE REDUCTION; DISSOLVED IODATE; METHYL-IODIDE; GIANT-KELP; OZONE; PHYTOPLANKTON; MACROCYSTIS; EMISSIONS; ATLANTIC	Kelps have a major role in marine and atmospheric iodine cycling in the coastal zone of temperate regions, with potential wide-ranging impacts on ozone destruction in the coastal marine boundary layer. However, little is known about the impact of kelp forests on iodine speciation in coastal sea water. To address this, we examined iodide and iodate concentrations in seawater in and around a giant kelp forest near San Diego, CA, USA, and a nearby site that was not influenced by kelp biology. Our data shows that while both iodide and iodate concentrations remained unchanged during the year at the nearby site, these concentrations changed significantly in and around the kelp forest, and were strongly related to changes in kelp canopy biomass. In particular, iodide reached its highest concentration and iodate reached its lowest concentration during the summer when the kelp canopies were near their maximum, while the opposite pattern was observed during the winter and spring when the kelp canopies were near their minimum. Further, comparisons of these changes with corresponding changes in seawater temperature and wind speed indicated that these relationships were relatively small compared to those with changes in kelp biomass. Together, our data show a strong relationship between kelp biomass and iodine metabolism.	[Gonzales, Jennifer; Tymon, Teresa; Carrano, Carl J.] San Diego State Univ, Dept Chem & Biochem, San Diego, CA 92182 USA; [Kupper, Frithjof C.] Univ Aberdeen, Oceanlab, Newburgh, Scotland; [Edwards, Matthew S.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	California State University System; San Diego State University; University of Aberdeen; California State University System; San Diego State University	Carrano, CJ (corresponding author), San Diego State Univ, Dept Chem & Biochem, San Diego, CA 92182 USA.	ccarrano@mail.sdsu.edu		Kuepper, Frithjof/0000-0003-1273-7109	TOTAL Foundation (Paris); MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Funding Council [HR09011]; SDSU Research Foundation Summer Undergraduate Research Award	TOTAL Foundation (Paris); MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland); Scottish Funding Council; SDSU Research Foundation Summer Undergraduate Research Award	FCK would like to thank the TOTAL Foundation (Paris) and the MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland) for their support. MASTS is funded by the Scottish Funding Council (grant reference HR09011) and contributing institutions. JG acknowledges support from an SDSU Research Foundation Summer Undergraduate Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ar Gall E, 2004, BOT MAR, V47, P30; Bloss WJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022168; Bluhm K, 2010, AQUAT BIOL, V11, P1, DOI 10.3354/ab00284; BUTLER ECV, 1981, LIMNOL OCEANOGR, V26, P382, DOI 10.4319/lo.1981.26.2.0382; Campos MLAM, 1996, DEEP-SEA RES PT II, V43, P455, DOI 10.1016/0967-0645(95)00100-X; Campos MLAM, 1997, MAR CHEM, V57, P107, DOI 10.1016/S0304-4203(96)00093-X; Campos MLAM, 1999, MAR CHEM, V65, P167, DOI 10.1016/S0304-4203(98)00094-2; Carpenter LJ, 2000, GLOBAL BIOGEOCHEM CY, V14, P1191, DOI 10.1029/2000GB001257; Carpenter LJ, 2003, CHEM REV, V103, P4953, DOI 10.1021/cr0206465; Chance R, 2014, ENVIRON SCI-PROC IMP, V16, P1841, DOI 10.1039/c4em00139g; Chance R, 2009, ESTUAR COAST SHELF S, V82, P406, DOI 10.1016/j.ecss.2009.02.004; Chipperfield MP, 1998, J GEOPHYS RES-ATMOS, V103, P28389, DOI 10.1029/98JD01960; Davis D, 1996, J GEOPHYS RES-ATMOS, V101, P2135, DOI 10.1029/95JD02727; DAYTON PK, 1985, ANNU REV ECOL SYST, V16, P215, DOI 10.1146/annurev.es.16.110185.001243; Edwards MS, 2004, OECOLOGIA, V138, P436, DOI 10.1007/s00442-003-1452-8; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Farrenkopf AM, 1997, MAR CHEM, V57, P347, DOI 10.1016/S0304-4203(97)00039-X; Graham MH, 2001, OIKOS, V93, P505, DOI 10.1034/j.1600-0706.2001.930317.x; Hardisty DS, 2014, GEOLOGY, V42, P619, DOI 10.1130/G35439.1; Hossaini R, 2015, NAT GEOSCI, V8, P186, DOI 10.1038/NGEO2363; Hung CC, 2005, B MAR SCI, V76, P61; Kupper FC, 2008, P NATL ACAD SCI USA, V105, P6954, DOI 10.1073/pnas.0709959105; Kupper FC, 2011, ANGEW CHEM INT EDIT, V50, P11598, DOI 10.1002/anie.201100028; Kupper FC, 1998, PLANTA, V207, P163, DOI 10.1007/s004250050469; Leigh RJ, 2010, ATMOS CHEM PHYS, V10, P11823, DOI 10.5194/acp-10-11823-2010; LUTHER GW, 1988, ANAL CHEM, V60, P1721, DOI 10.1021/ac00168a017; MANLEY SL, 1992, LIMNOL OCEANOGR, V37, P1652, DOI 10.4319/lo.1992.37.8.1652; MANLEY SL, 1984, J PHYCOL, V20, P192, DOI 10.1111/j.0022-3646.1984.00192.x; MANLEY SL, 1987, LIMNOL OCEANOGR, V32, P709, DOI 10.4319/lo.1987.32.3.0709; MANLEY SL, 1988, MAR BIOL, V98, P477, DOI 10.1007/BF00391538; Manley SL, 2012, ENVIRON SCI TECHNOL, V46, P3731, DOI 10.1021/es203598r; McFiggans G, 2004, ATMOS CHEM PHYS, V4, P701, DOI 10.5194/acp-4-701-2004; McFiggans G, 2010, ATMOS CHEM PHYS, V10, P2975, DOI 10.5194/acp-10-2975-2010; NORTH WJ, 1986, AQUAT BOT, V26, P9, DOI 10.1016/0304-3770(86)90003-3; O'Dowd CD, 2002, NATURE, V417, P632, DOI 10.1038/nature00775; Palmer CJ, 2006, ENVIRON CHEM, V2, P282; Quack B, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020597; Read KA, 2008, NATURE, V453, P1232, DOI 10.1038/nature07035; Saiz-Lopez A, 2006, ATMOS CHEM PHYS, V6, P883, DOI 10.5194/acp-6-883-2006; Saiz-Lopez A, 2015, GEOPHYS RES LETT, V42, P6852, DOI 10.1002/2015GL064796; Saiz-Lopez A, 2014, ATMOS CHEM PHYS, V14, P13119, DOI 10.5194/acp-14-13119-2014; Saiz-Lopez A, 2012, ATMOS CHEM PHYS, V12, P3939, DOI 10.5194/acp-12-3939-2012; Saiz-Lopez A, 2012, CHEM REV, V112, P1773, DOI 10.1021/cr200029u; Salawitch RJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021504; Sander R, 1999, GEOPHYS RES LETT, V26, P2857, DOI 10.1029/1999GL900478; Schiel DR, 2015, BIOL ECOLOGY GIANT K; Sherwen T, 2016, ATMOS CHEM PHYS, V16, P1161, DOI 10.5194/acp-16-1161-2016; SOLOMON S, 1994, J GEOPHYS RES-ATMOS, V99, P20491, DOI 10.1029/94JD02028; Truesdale VW, 2008, ESTUAR COAST SHELF S, V78, P155, DOI 10.1016/j.ecss.2007.11.022; Truesdale VW, 2003, LIMNOL OCEANOGR, V48, P1569, DOI 10.4319/lo.2003.48.4.1569; Tymon TM, 2017, J PHYCOL IN PRESS; von Glasow R, 2004, ATMOS CHEM PHYS, V4, P2481, DOI 10.5194/acp-4-2481-2004; Waite TJ, 2003, MAR CHEM, V81, P137, DOI 10.1016/S0304-4203(03)00013-6; Wong GTF, 2002, MAR ECOL PROG SER, V237, P27, DOI 10.3354/meps237027; Yang X, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006244; Yarimizu K, 2014, METALLOMICS, V6, P1156, DOI 10.1039/c4mt00053f	56	13	13	5	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0180755	10.1371/journal.pone.0180755	http://dx.doi.org/10.1371/journal.pone.0180755			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800586	gold, Green Published, Green Submitted			2022-12-26	WOS:000407431800003
J	Harlow, CR; Wu, X; van Deemter, M; Gardiner, F; Poland, C; Green, R; Sarvi, S; Brown, P; Kadler, KE; Lu, YH; Mason, JI; Critchley, HOD; Hillier, SG				Harlow, Christopher R.; Wu, Xuan; van Deemter, Marielle; Gardiner, Fiona; Poland, Craig; Green, Rebecca; Sarvi, Sana; Brown, Pamela; Kadler, Karl E.; Lu, Yinhui; Mason, J. Ian; Critchley, Hilary O. D.; Hillier, Stephen G.			Targeting lysyl oxidase reduces peritoneal fibrosis	PLOS ONE			English	Article							SURFACE EPITHELIAL-CELLS; TO-MESENCHYMAL TRANSITION; ADHESION FORMATION; CARBON NANOTUBES; INJURED PERITONEUM; MESOTHELIAL CELLS; FOLLICULAR-FLUID; ABDOMINAL-CAVITY; MICE; PROGESTERONE	Background Abdominal surgery and disease cause persistent abdominal adhesions, pelvic pain, infertility and occasionally, bowel obstruction. Current treatments are ineffective and the aetiology is unclear, although excessive collagen deposition is a consistent feature. Lysyl oxidase (Lox) is a key enzyme required for crosslinking and deposition of insoluble collagen, so we investigated whether targeting Lox might be an approach to reduce abdominal adhesions. Methods Female C57Bl/6 mice were treated intraperitoneally with multiwalled carbon nanotubes (NT) to induce fibrosis, together with chemical (beta-aminoproprionitrile-BAPN) or miRNA Lox inhibitors, progesterone or dexamethasone. Fibrotic lesions on the diaphragm, and expression of fibrosis-related genes in abdominal wall peritoneal mesothelial cells (PMC) were measured. Effects of BAPN and dexamethasone on collagen fibre alignment were observed by TEM. Isolated PMC were cultured with interleukin-1 alpha (IL-1 alpha) and progesterone to determine effects on Lox mRNA in vitro. Results NT-induced fibrosis and collagen deposition on the diaphragm was ameliorated by BAPN, Lox miRNA, or steroids. BAPN and dexamethasone disrupted collagen fibres. NT increased PMC Lox, Col1a1, Col3a1 and Bmp1 mRNA, which was inhibited by steroids. Progesterone significantly inhibited IL-1 alpha induced Lox expression by PMC in vitro. Conclusion Our results provide proof-of-concept that targeting peritoneal Lox could be an effective approach in ameliorating fibrosis and adhesion development.	[Harlow, Christopher R.; Wu, Xuan; van Deemter, Marielle; Gardiner, Fiona; Green, Rebecca; Sarvi, Sana; Brown, Pamela; Mason, J. Ian; Critchley, Hilary O. D.; Hillier, Stephen G.] Univ Edinburgh, MRC, Ctr Reprod Hlth, Edinburgh Med Sch,Queens Med Res Inst, 47 Little France Crescent, Edinburgh, Midlothian, Scotland; [Poland, Craig] Univ Edinburgh, MRC, Ctr Inflammat Res, Edinburgh Med Sch,Queens Med Res Inst, 47 Little France Crescent, Edinburgh, Midlothian, Scotland; [Kadler, Karl E.; Lu, Yinhui] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Fac Life Sci, Michael Smith Bldg, Manchester, Lancs, England	University of Edinburgh; University of Edinburgh; University of Manchester	Harlow, CR (corresponding author), Univ Edinburgh, MRC, Ctr Reprod Hlth, Edinburgh Med Sch,Queens Med Res Inst, 47 Little France Crescent, Edinburgh, Midlothian, Scotland.	c.harlow@ed.ac.uk	CRITCHLEY, HILARY OD/C-7575-2013; KADLER, KARL/ABI-2403-2020; Poland, Craig/AAM-8237-2020	KADLER, KARL/0000-0003-4977-4683; Poland, Craig/0000-0002-5345-1249; CRITCHLEY, HILARY/0000-0003-1913-4044; hillier, stephen/0000-0001-7378-5855	Medical Research Council [G0900550]; Wellcome Trust [091840/Z/10/Z]; Medical Research Council [G0701127] Funding Source: researchfish; MRC [G0701127, G0900550] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was support by Medical Research Council Project Grant G0900550 (to SGH, JIM, HODC, CRH) and a Wellcome Trust Grant 091840/Z/10/Z (to KEK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Prof Ken Donaldson for access to his intra-peritoneal NT-induced fibrosis model, and for his advice throughout the study. We gratefully acknowledge Dr Pamela Brown for advising use of miRNA to knock-down gene expression, and her expertise in generation of the DNA constructs and subsequent lentivirus production (http://surf.ed.ac.uk/viral-vectors/). We also thank Prof John Iredale for his helpful comments and advice during the study. This study was support by Medical Research Council Project Grant G0900550 (to SGH, JIM, HODC & CRH) and a Wellcome Trust Grant 091840/Z/10/Z (to KEK).	ABUHIJLEH MF, 1995, J ANAT, V186, P453; Ahmad G, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001298.pub4; Atta HM, 2011, WORLD J GASTROENTERO, V17, P5049, DOI 10.3748/wjg.v17.i46.5049; Binda MM, 2007, SURG ENDOSC, V21, P1826, DOI 10.1007/s00464-007-9296-7; Braun N, 2011, PERITON DIALYSIS INT, V31, P291, DOI 10.3747/pdi.2010.00118; Burnett SH, 2004, J LEUKOCYTE BIOL, V75, P612, DOI 10.1189/jlb.0903442; Calabro ML, 2009, BLOOD, V113, P4525, DOI 10.1182/blood-2008-09-180307; Cicinelli E, 2009, FERTIL STERIL, V92, P306, DOI 10.1016/j.fertnstert.2008.05.044; Colwell AS, 2006, PLAST RECONSTR SURG, V118, P1125, DOI 10.1097/01.prs.0000221056.27536.db; Corona R, 2011, FERTIL STERIL, V95, P1224, DOI 10.1016/j.fertnstert.2011.01.004; diZeregal GS, 2001, HUM REPROD UPDATE, V7, P547, DOI 10.1093/humupd/7.6.547; Donaldson K, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-5; Evans J, 2009, FASEB J, V23, P2165, DOI 10.1096/fj.08-124495; FAYEZ JA, 1987, AM J OBSTET GYNECOL, V157, P1184, DOI 10.1016/S0002-9378(87)80291-0; Fegan KS, 2008, J ENDOCRINOL, V196, P369, DOI 10.1677/JOE-07-0419; FUJII T, 1983, J REPROD FERTIL, V69, P307, DOI 10.1530/jrf.0.0690307; Haney AF, 2000, FERTIL STERIL, V73, P988, DOI 10.1016/S0015-0282(00)00490-8; Harlow CR, 2003, ENDOCRINOLOGY, V144, P154, DOI 10.1210/en.2002-220652; Harlow CR, 1997, FERTIL STERIL, V68, P48, DOI 10.1016/S0015-0282(97)81474-4; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; HOCKEL M, 1987, ANN CHIR GYNAECOL FE, V76, P306; HOFFMAN DL, 1983, EXP MOL PATHOL, V39, P154, DOI 10.1016/0014-4800(83)90048-5; Hoshino A, 2007, J IMMUNOL, V178, P5296, DOI 10.4049/jimmunol.178.8.5296; Jansen R P, 1990, Prog Clin Biol Res, V358, P177; Kamel RM, 2010, EUR J OBSTET GYN R B, V150, P111, DOI 10.1016/j.ejogrb.2010.02.003; Kucukozkan T, 2004, ANZ J SURG, V74, P1111, DOI 10.1111/j.1445-1433.2004.03261.x; Li YC, 2013, P NATL ACAD SCI USA, V110, P2324, DOI 10.1073/pnas.1214136110; Maki JM, 2005, AM J PATHOL, V167, P927, DOI 10.1016/S0002-9440(10)61183-2; Margetts PJ, 2013, NEPHROL DIAL TRANSPL, V28, P2015, DOI 10.1093/ndt/gfs289; MAURER JH, 1983, FERTIL STERIL, V39, P485; McCloskey C, 2014, EMBO MOL MED, V6, P1161, DOI 10.15252/emmm.201403944; Murphy FA, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-8; Olaso E, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-5; OZASA H, 1981, ENDOCRINOLOGY, V109, P618, DOI 10.1210/endo-109-2-618; Pados G, 2010, REPROD BIOMED ONLINE, V21, P290, DOI 10.1016/j.rbmo.2010.04.021; Papacleovoulou G, 2011, J ENDOCRINOL, V211, P273, DOI 10.1530/JOE-11-0081; Perfumo F, 1996, NEPHROL DIAL TRANSPL, V11, P1803; Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111; Qu C, 2012, GENE, V493, P9, DOI 10.1016/j.gene.2011.11.046; Rae MT, 2004, J ENDOCRINOL, V183, P19, DOI 10.1677/joe.1.05754; Rae MT, 2004, J CLIN ENDOCR METAB, V89, P4538, DOI 10.1210/jc.2003-032225; Ruiz LA, 2015, REPROD SCI, V22, P1496, DOI 10.1177/1933719115585144; SIITERI PK, 1977, ANN NY ACAD SCI, V286, P384, DOI 10.1111/j.1749-6632.1977.tb29431.x; Smith-Mungo LI, 1998, MATRIX BIOL, V16, P387, DOI 10.1016/S0945-053X(98)90012-9; Starborg T, 2013, NAT PROTOC, V8, P1433, DOI 10.1038/nprot.2013.086; Strippoli R, 2008, DIS MODEL MECH, V1, P264, DOI 10.1242/dmm.001321; Sulaiman H, 2002, BIOCHEM SOC T, V30, P126, DOI 10.1042/BST0300126; Trackman PC, 2005, J CELL BIOCHEM, V96, P927, DOI 10.1002/jcb.20605; Vercellini P, 2014, NAT REV ENDOCRINOL, V10, P261, DOI 10.1038/nrendo.2013.255; Wang L, 2014, J BIOL CHEM, V289, P921, DOI 10.1074/jbc.M113.496364; Watson A, 2000, COCHRANE DB SYST REV; Yamaguchi A, 2012, J TOXICOL SCI, V37, P177, DOI 10.2131/jts.37.177; Yaron Y, 1999, J REPROD MED, V44, P253; Yokoi H, 2013, PERITON DIALYSIS INT, V33, P143, DOI 10.3747/pdi.2011.00033	54	26	26	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0183013	10.1371/journal.pone.0183013	http://dx.doi.org/10.1371/journal.pone.0183013			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800626	Green Submitted, Green Published, gold			2022-12-26	WOS:000407431800044
J	Diao, RG; Mu, XD; Wang, TT; Li, SQ				Diao, Ruigang; Mu, Xiaodong; Wang, Tingting; Li, Shuqing			Risk score based on ten lncRNA-mRNA expression predicts the survival of stage II-III colorectal carcinoma	PLOS ONE			English	Article							CANCER; PROLIFERATION; TRICELLULIN	The prognosis of colorectal carcinoma (CRC) is unstable in the stage II-III patients. Patients with early stage II CRC have a relative poor prognosis while other stage III CRC patients have a better prognosis. In our work, by utilizing the expression of lncRNAs and mRNAs measured by microarray (GSE39582), we constructed a risk score staging system with Cox multivariate regression model to predict the outcome of grade II-III CRC patients. Ten genes including two lncRNAs and eight mRNAs were used to estimate the survival of stage II-III CRC patients. The patients with high risk scores have poorer survival rate those with low risk scores, significantly. These results were further validated in another three independent datasets (GSE37892, GSE33113, and GSE17536). The relationship between clinical information and were evaluated, and the risk score is independent from the other clinical information and performs better in evaluating the survival of stage II-III CRC patients. Moreover, the correlation between chemotherapy was also evaluated, and we found that both patients with or without chemotherapy have a poor survival in high risk group. Gene Set Enrichment Analysis were used to find the difference between high-risk and low-risk groups, and pathways including cell adhesion and focal adhesion were significantly enriched, suggesting that the risk score reflects the status of cell-cell physical interaction. In summary, we constructed a risk staging model for grade II-III CRC, which is independent from and performs better than clinical information.	[Diao, Ruigang; Mu, Xiaodong; Wang, Tingting; Li, Shuqing] Yangtai Yuhuangding Hosp, Yantai, Shandong, Peoples R China		Li, SQ (corresponding author), Yangtai Yuhuangding Hosp, Yantai, Shandong, Peoples R China.	lishuqing2017@163.com	wang, tingting/AAK-2640-2020					Ballarino M, 2015, MOL CELL BIOL, V35, P728, DOI 10.1128/MCB.01394-14; Bock AJ, 2012, HUM PATHOL, V43, P669, DOI 10.1016/j.humpath.2011.06.003; Brown CO, 2013, LEUKEMIA RES, V37, P963, DOI 10.1016/j.leukres.2013.03.004; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li X, 2016, ONCOTARGET; Li Y, 2016, TUMOR BIOL, V37, P14205, DOI 10.1007/s13277-016-5254-0; Lian YF, 2016, TUMOR BIOL, V37, P7431, DOI 10.1007/s13277-015-4617-2; Liu T, 2016, ONCOTARGETS THER, V9, P1437, DOI 10.2147/OTT.S98268; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Saus E, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00054; Schneider MA, 2015, CLIN CANCER RES, V21, P3529, DOI 10.1158/1078-0432.CCR-14-2464; Shi YG, 2014, BIOCHEM BIOPH RES CO, V446, P448, DOI 10.1016/j.bbrc.2014.02.144; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Somoracz A, 2014, PATHOL ONCOL RES, V20, P755, DOI 10.1007/s12253-014-9758-x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takasawa A, 2013, CELL TISSUE RES, V351, P73, DOI 10.1007/s00441-012-1512-7; Yang L, 2016, ONCOL REP, V35, P318, DOI 10.3892/or.2015.4364; Yang P, 2016, ONCOTARGETS THER, V9, P2465, DOI 10.2147/OTT.S102348; Yu GY, 2006, AM J PATHOL, V168, P597, DOI 10.2353/ajpath.2006.050620; Zeng XM, 2007, MOL BIOL CELL, V18, P617, DOI 10.1091/mbc.E06-09-0801	21	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182908	10.1371/journal.pone.0182908	http://dx.doi.org/10.1371/journal.pone.0182908			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796819	gold, Green Published, Green Submitted			2022-12-26	WOS:000407396200119
J	Higgins, I; Stringer, S; Schnupp, J				Higgins, Irina; Stringer, Simon; Schnupp, Jan			Unsupervised learning of temporal features for word categorization in a spiking neural network model of the auditory brain	PLOS ONE			English	Article							COCHLEAR NUCLEUS; COMPLEX SOUNDS; ADAPTATION; CA3-CA1; CODES; PITCH; CELL	The nature of the code used in the auditory cortex to represent complex auditory stimuli, such as naturally spoken words, remains a matter of debate. Here we argue that such representations are encoded by stable spatio-temporal patterns of firing within cell assemblies known as polychronous groups, or PGs. We develop a physiologically grounded, unsupervised spiking neural network model of the auditory brain with local, biologically realistic, spike-time dependent plasticity (STDP) learning, and show that the plastic cortical layers of the network develop PGs which convey substantially more information about the speaker independent identity of two naturally spoken word stimuli than does rate encoding that ignores the precise spike timings. We furthermore demonstrate that such informative PGs can only develop if the input spatio-temporal spike patterns to the plastic cortical areas of the model are relatively stable.	[Higgins, Irina; Stringer, Simon] Univ Oxford, Dept Expt Psychol, Oxford, England; [Schnupp, Jan] Univ Oxford, DPAG, Oxford, England	University of Oxford; University of Oxford	Higgins, I (corresponding author), Univ Oxford, Dept Expt Psychol, Oxford, England.	irina.higgins@gmail.com		schnupp, jan w h/0000-0002-2604-0057	BBSRC CASE studentship [BB/H016287/1]; Oxford Foundation for Theoretical Neuroscience and Artificial Intelligence	BBSRC CASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Oxford Foundation for Theoretical Neuroscience and Artificial Intelligence	This research was funded by a BBSRC CASE studentship award (No. BB/H016287/1), and by the Oxford Foundation for Theoretical Neuroscience and Artificial Intelligence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This research was funded by a BBSRC CASE studentship award (No. BB/H016287/1), and by the Oxford Foundation for Theoretical Neuroscience and Artificial Intelligence.	Barlow HB, 1961, SENSORY COMMUNICATIO, V1; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bizley JK, 2010, J NEUROSCI, V30, P5078, DOI 10.1523/JNEUROSCI.5475-09.2010; Debanne D, 1999, J NEUROSCI, V19, P10664, DOI 10.1523/JNEUROSCI.19-24-10664.1999; Debanne D, 1996, P NATL ACAD SCI USA, V93, P11225, DOI 10.1073/pnas.93.20.11225; Deneve S, 2016, NAT NEUROSCI, V19, P375, DOI 10.1038/nn.4243; Eggermont JJ, 2001, HEARING RES, V157, P1, DOI 10.1016/S0378-5955(01)00259-3; Evans BD, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00046; EVANS EF, 1992, PHILOS T R SOC B, V336, P295, DOI 10.1098/rstb.1992.0062; Frisina RD, 2001, HEARING RES, V158, P1, DOI 10.1016/S0378-5955(01)00296-9; Goodman Dan, 2008, Front Neuroinform, V2, P5, DOI 10.3389/neuro.11.005.2008; Hawkins J, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00023; Higgins I, 2016, BIORXIV; Hopfield IJ, 2000, P NATL ACAD SCI USA, V97, P13919, DOI 10.1073/pnas.250483697; Hopfield J, 1995, NATURE; Hopfield JJ, 2001, P NATL ACAD SCI USA, V98, P1282, DOI 10.1073/pnas.031567098; Huetz C, 2011, HEARING RES, V271, P147, DOI 10.1016/j.heares.2010.01.010; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Izhikevich EM, 2006, NEURAL COMPUT, V18, P245, DOI 10.1162/089976606775093882; Kempter R, 1999, PHYS REV E, V59, P4498, DOI 10.1103/PhysRevE.59.4498; Klampfl S, 2013, J NEUROSCIENCE; Klatt D. H., 1980, PERCEPTION PRODUCTIO; Leonard R.G., 1993, TIDIGITS SPEECH CORP; Liao Q, 2013, LEARNING INVARIANT R; Masquelier T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001377; Meddis R, 2006, J ACOUST SOC AM, V120, P3861, DOI 10.1121/1.2372595; Miller R, 1996, PSYCHOBIOLOGICAL THE; Moller M., 1993, NEURAL NETW, V6; Nelken I, 2007, HEARING RES, V229, P94, DOI 10.1016/j.heares.2007.01.012; Oertel D, 2000, PNAS, V97; Paugam-Moisy H, 2008, NEUROCOMPUTING, V71, P1143, DOI 10.1016/j.neucom.2007.12.027; Perrinet L, 2001, NEUROCOMPUTING, V38, P817, DOI 10.1016/S0925-2312(01)00460-X; Recio A, 2000, HEARING RES, V146, P167, DOI 10.1016/S0378-5955(00)00111-8; Rhode WS, 2010, HEARING RES, V259, P1, DOI 10.1016/j.heares.2009.06.004; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Stringer SM, 2006, BIOL CYBERN, V94, P128, DOI 10.1007/s00422-005-0030-z; Tikidji-Hamburyan RA, 2015, J NEUROSCI, V35, P15682, DOI 10.1523/JNEUROSCI.2601-15.2015; Tromans JM, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00048; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; Wang XJ, 1996, J NEUROSCI, V16, P6402; Wever E, 1930, J EXPER PSYCHOL, V13; Winter IM, 2003, SPEECH COMMUN, V41, P135, DOI 10.1016/S0167-6393(02)00098-5; WINTER IM, 1990, HEARING RES, V44, P161, DOI 10.1016/0378-5955(90)90078-4; Zilany MSA, 2009, J ACOUST SOC AM, V126, P2390, DOI 10.1121/1.3238250	46	5	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0180174	10.1371/journal.pone.0180174	http://dx.doi.org/10.1371/journal.pone.0180174			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797034	Green Published, Green Submitted, gold			2022-12-26	WOS:000407396200003
J	Monchusi, B; Ntwasa, M				Monchusi, Bernice; Ntwasa, Monde			Methyl pyruvate protects a normal lung fibroblast cell line from irinotecan-induced cell death: Potential use as adjunctive to chemotherapy	PLOS ONE			English	Article							MODULATE EXPRESSION; AEROBIC GLYCOLYSIS; BINDING-PROTEIN; ETHYL PYRUVATE; P53; CANCER; REGULATOR; ARREST; GROWTH; DAMAGE	The Warburg Effect, characterized by increased rate of glycolysis even under normoxic conditions, is one of the hallmarks of cancer. Relatively lower oxidative phosphorylation (OXPHOS) is also a characteristic feature in cancer cells. We hypothesized that interference with this phenomenon, by introducing exogenous pyruvate, would upset this cancer phenotype and boost the energy requirements of normal cells. We find that methyl pyruvate protects irinotecan-treated normal lung fibroblast cell line (MRC-5) probably by turning off the p53/p21 axis of the apoptotic pathways. When the MRC-5 fibroblasts recover in drug-free medium, the intrinsic apoptotic pathway is also turned off and the cells survive with no discernible exponential growth during the observation period. In contrast, the mere introduction of exogenous pyruvate kills the lung cancer cell line (A549). Although, functional p53 is important in the drug-induced cancer cell death, it is probably not essential because cancer cell lines with mutated p53 also die albeit less efficiently. We conclude that methyl pyruvate may preferentially kill cancer cells and protect normal cells during chemotherapy.	[Monchusi, Bernice] Univ Witwatersrand, Sch Mol & Cell Biol, Gatehouse 514, Johannesburg, South Africa; [Ntwasa, Monde] Univ South Africa, Dept Life & Consumer Sci, 211 Calabash Bldg, Johannesburg, South Africa	University of Witwatersrand; University of South Africa	Ntwasa, M (corresponding author), Univ South Africa, Dept Life & Consumer Sci, 211 Calabash Bldg, Johannesburg, South Africa.	ntwasmm@unisa.ac.za	Ntwasa, Monde/C-1395-2018	Ntwasa, Monde/0000-0002-6400-8867	National Research Foundation	National Research Foundation	This study is funded by the National Research Foundation http://www.nrf.ac.za/GUN:99190. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer DE, 2004, FASEB J, V18, P1303, DOI 10.1096/fj.03-1001fje; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291; CHOMCZYNSKI P, 1995, BIOTECHNIQUES, V19, P942; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Di Giammartino DC, 2014, GENE DEV, V28, P2248, DOI 10.1101/gad.245787.114; Epperly M, 2007, RADIAT RES, V168, P552, DOI 10.1667/RR1009.1; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Golman K, 2006, P NATL ACAD SCI USA, V103, P11270, DOI 10.1073/pnas.0601319103; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hollenbach M, 2008, BIOCHEM PHARMACOL, V76, P631, DOI 10.1016/j.bcp.2008.06.006; Hull R, 2010, ANTI-CANCER DRUG, V21, P945, DOI 10.1097/CAD.0b013e32833e2f60; Jijakli H, 1996, ARCH BIOCHEM BIOPHYS, V335, P245, DOI 10.1006/abbi.1996.0505; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Knudsen ES, 1998, GENE DEV, V12, P2278, DOI 10.1101/gad.12.15.2278; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lansiaux A, 2001, ANTICANCER RES, V21, P471; Lembert N, 2001, BIOCHEM J, V354, P345, DOI 10.1042/0264-6021:3540345; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Li L, 2007, P NATL ACAD SCI USA, V104, P7951, DOI 10.1073/pnas.0701916104; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Luvero D, 2014, THER ADV MED ONCOL, V6, P229, DOI 10.1177/1758834014544121; Ma WZ, 2007, J BIOENERG BIOMEMBR, V39, P243, DOI 10.1007/s10863-007-9083-0; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mbita Z, 2012, MOL CELL BIOCHEM, V362, P249, DOI 10.1007/s11010-011-1150-5; MONTGOMERY CM, 1956, J BIOL CHEM, V221, P359; Moreno-Sanchez R, 2009, BIOFACTORS, V35, P209, DOI 10.1002/biof.31; Na YK, 2010, MOL CELLS, V30, P89, DOI 10.1007/s10059-010-0092-1; Ntwasa M, 2015, FRONTIERS ANTICANCER, P199; Ntwasa M, 2016, TRENDS CANCER, V2, P635, DOI 10.1016/j.trecan.2016.10.003; Ohtani N, 2001, NATURE, V409, P1067, DOI 10.1038/35059131; Simons A, 1997, ONCOGENE, V14, P145, DOI 10.1038/sj.onc.1200825; Takeuchi S, 1991, Gan To Kagaku Ryoho, V18, P579; Ueno M, 2002, EUR UROL, V42, P390, DOI 10.1016/S0302-2838(02)00321-4; Vairapandi M, 2002, J CELL PHYSIOL, V192, P327, DOI 10.1002/jcp.10140; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Wamelink M, 2008, J INHERIT METAB DIS, V31, P703, DOI 10.1007/s10545-008-1015-6; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Weinhouse S, Z KREBSFORSCHUNG KLI, V87, P115; WILLEMS JL, 1978, FEBS LETT, V86, P42, DOI 10.1016/0014-5793(78)80094-5	43	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182789	10.1371/journal.pone.0182789	http://dx.doi.org/10.1371/journal.pone.0182789			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797070	Green Published, gold, Green Submitted			2022-12-26	WOS:000407396200096
J	Tsilimingras, D; Ghosh, S; Duke, A; Zhang, LY; Carretta, H; Schnipper, J				Tsilimingras, Dennis; Ghosh, Samiran; Duke, Ashley; Zhang, Liying; Carretta, Henry; Schnipper, Jeffrey			The association of post-discharge adverse events with timely follow-up visits after hospital discharge	PLOS ONE			English	Article							PATIENTS AFTER-DISCHARGE; PHARMACIST INTERVENTION; CARE	Objective There has been little research to examine the association of post-discharge adverse events (AEs) with timely follow-up visits after hospital discharge. We aimed to examine whether having a timely follow-up outpatient visit would reduce the risk for post-discharge AEs. Methods This was a methods study of patients at risk for post-discharge AEs from December 2011 through October 2012. Five hundred and forty-five patients who were under the care of hospitalist physicians and were discharged home from a community hospital, spoke English, and could be contacted after discharge were evaluated. The aim of the study was to examine the association of post-discharge AEs with timely follow-up visits after hospital discharge based on structured telephone interviews, health record review, and adjudication by two blinded, trained physicians using a previously established methodology. Results We observed a higher incidence of AEs with patients that had their first follow-up visit within 7 days after hospital discharge (33.5% vs. 23.0%, p = 0.007). This effect was attenuated somewhat but remained significant when adjusted for several patient factors (adjusted OR 1.33, 95% confidence interval 1.16-2.71). Conclusion This observational study paradoxically showed an increase in post-discharge AEs with early follow-up, likely a result of confounding by indication and/or information bias that could not be completely adjusted for. This study illustrates the potential hazards with conducting observational studies to determine the efficacy of various transitional care interventions, such as early follow-up, where risk for confounding by indication is high.	[Tsilimingras, Dennis; Ghosh, Samiran; Zhang, Liying] Wayne State Univ, Sch Med, Dept Family Med & Publ Hlth Sci, Detroit, MI 48202 USA; [Duke, Ashley] Tallahassee Mem Hosp, Tallahassee, FL USA; [Carretta, Henry] Florida State Univ, Coll Med, Dept Behav Sci & Social Med, Tallahassee, FL 32306 USA; [Schnipper, Jeffrey] Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA; [Schnipper, Jeffrey] Harvard Med Sch, Boston, MA USA	Wayne State University; State University System of Florida; Florida State University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Tsilimingras, D (corresponding author), Wayne State Univ, Sch Med, Dept Family Med & Publ Hlth Sci, Detroit, MI 48202 USA.	dtsilimi@med.wayne.edu		Carretta, Henry/0000-0002-1876-352X	Agency for Healthcare Research and Quality [R01HS018694]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This work is supported by an R01 award from the Agency for Healthcare Research and Quality (grant R01HS018694 to Dr. Tsilimingras). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Field TS, 2015, J GEN INTERN MED, V30, P565, DOI 10.1007/s11606-014-3106-4; Forster AJ, 2004, CAN MED ASSOC J, V170, P345; Forster AJ, 2003, ANN INTERN MED, V138, P161, DOI 10.7326/0003-4819-138-3-200302040-00007; Jackson C, 2015, ANN FAM MED, V13, P115, DOI 10.1370/afm.1753; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Kashiwagi DT, 2012, AM J MED QUAL, V27, P11, DOI 10.1177/1062860611409197; Kripalani S, 2012, ANN INTERN MED, V157, P1, DOI 10.7326/0003-4819-157-1-201207030-00003; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; Misky GJ, 2010, J HOSP MED, V5, P392, DOI 10.1002/jhm.666; Parry C, 2008, MED CARE, V46, P317, DOI 10.1097/MLR.0b013e3181589bdc; Schnipper JL, 2010, CIRC-CARDIOVASC QUAL, V3, P212, DOI 10.1161/CIRCOUTCOMES.109.921833; Schnipper JL, 2006, ARCH INTERN MED, V166, P565, DOI 10.1001/archinte.166.5.565; Thomas EJ, 2000, MED CARE, V38, P261, DOI 10.1097/00005650-200003000-00003; Tsilimingras D, 2015, J GEN INTERN MED, V30, P1164, DOI 10.1007/s11606-015-3260-3; Tsilimingras D, 2008, JT COMM J QUAL PATIE, V34, P85, DOI 10.1016/S1553-7250(08)34011-2	15	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182669	10.1371/journal.pone.0182669	http://dx.doi.org/10.1371/journal.pone.0182669			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796810	Green Submitted, Green Published, gold			2022-12-26	WOS:000407396200076
J	Lee, S; Jiang, X				Lee, Sanghoon; Jiang, Xia			Modeling miRNA-mRNA interactions that cause phenotypic abnormality in breast cancer patients	PLOS ONE			English	Article							REGULATORY MODULES; MESENCHYMAL TRANSITION; TRANSLATION INITIATION; MICRORNA-21 TARGETS; PROTEIN-SYNTHESIS; EXPRESSION; MIR-21; INVASION; DEREGULATION; METASTASIS	Background The dysregulation of microRNAs (miRNAs) alters expression level of pro-oncogenic or tumor suppressive mRNAs in breast cancer, and in the long run, causes multiple biological abnormalities. Identification of such interactions of miRNA-mRNA requires integrative analysis of miRNA-mRNA expression profile data. However, current approaches have limitations to consider the regulatory relationship between miRNAs and mRNAs and to implicate the relationship with phenotypic abnormality and cancer pathogenesis. Methodology/Findings We modeled causal relationships between genomic expression and clinical data using a Bayesian Network (BN), with the goal of discovering miRNA-mRNA interactions that are associated with cancer pathogenesis. The Multiple Beam Search (MBS) algorithm learned interactions from data and discovered that hsa-miR-21, hsa-miR-10b, hsa-miR-448, and hsa-miR-96 interact with oncogenes, such as, CCND2, ESR1, MET, NOTCH1, TGFBR2 and TGFB1 that promote tumor metastasis, invasion, and cell proliferation. We also calculated Bayesian network posterior probability (BNPP) for the models discovered by the MBS algorithm to validate true models with high likelihood. Conclusion/Significance The MBS algorithm successfully learned miRNA and mRNA expression profile data using a BN, and identified miRNA-mRNA interactions that probabilistically affect breast cancer pathogenesis. The MBS algorithm is a potentially useful tool for identifying interacting gene pairs implicated by the deregulation of expression.	[Lee, Sanghoon; Jiang, Xia] Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Jiang, X (corresponding author), Univ Pittsburgh, Dept Biomed Informat, Pittsburgh, PA 15260 USA.	xij6@pitt.edu		/0000-0001-8564-2392	National Library of Medicine of the National Institutes of Health [R01LM011663]; CURE - Pennsylvania Department of Health [PA DOH 4100070287]; NATIONAL LIBRARY OF MEDICINE [R01LM011663] Funding Source: NIH RePORTER	National Library of Medicine of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); CURE - Pennsylvania Department of Health; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Research reported in this paper was supported by grant R01LM011663 awarded by the National Library of Medicine of the National Institutes of Health, and by a CURE grant awarded by the Pennsylvania Department of Health (PA DOH 4100070287). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Research reported in this paper was supported by grant R01LM011663 awarded by the National Library of Medicine of the National Institutes of Health, and by a CURE grant awarded by the Pennsylvania Department of Health (PA DOH 4100070287). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The National Institutes of Health had no role in study design, analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Andorfer CA, 2011, TRENDS MOL MED, V17, P313, DOI 10.1016/j.molmed.2011.01.006; [Anonymous], [No title captured]; [Anonymous], 2006, ATLAS GENETICS CYTOG; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Beilharz TH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006783; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cantini L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9878; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Cloonan N, 2015, BIOESSAYS, V37, P379, DOI 10.1002/bies.201400191; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Eulalio A, 2009, RNA, V15, P21, DOI 10.1261/rna.1399509; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fishelson M, 2004, J COMPUT BIOL, V11, P263, DOI 10.1089/1066527041410409; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Fu JH, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-68; Gevaert O, 2006, BIOINFORMATICS, V22, pE184, DOI 10.1093/bioinformatics/btl230; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; Huang JC, 2007, J COMPUT BIOL, V14, P550, DOI 10.1089/cmb.2007.R002; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Ikeda K, 2006, J IMMUNOL METHODS, V317, P38, DOI 10.1016/j.jim.2006.09.010; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jiang QH, 2009, NUCLEIC ACIDS RES, V37, pD98, DOI 10.1093/nar/gkn714; Jiang X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143247; Jiang X, 2015, GENET EPIDEMIOL, V39, P173, DOI 10.1002/gepi.21889; Jiang X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022075; Jiang Xia, 2010, AMIA Annu Symp Proc, V2010, P341; Karim SMM, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2300-z; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Li QQ, 2011, CELL DEATH DIFFER, V18, P16, DOI 10.1038/cdd.2010.103; Li Y., 2013, NUCLEIC ACIDS RES; Liang Y-J, 2012, CARCINOGENESIS; Lin HX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015797; Liu B., 2009, BMC BIOINFORMATICS, V10, P1; Liu B, 2010, BIOINFORMATICS, V26, P3105, DOI 10.1093/bioinformatics/btq576; Liu B, 2009, J BIOMED INFORM, V42, P685, DOI 10.1016/j.jbi.2009.01.005; Lu LG, 2009, EUR J CANCER, V45, P2212, DOI 10.1016/j.ejca.2009.05.003; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Luqmani YA, 2015, MICRORNA BREAST CANC; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Maru DM, 2009, AM J PATHOL, V174, P1940, DOI 10.2353/ajpath.2009.080718; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Neapolitan R.E., 2004, LEARNING BAYESIAN NE; Neapolitan R, 2014, CANCER INFORM, V13, P77, DOI 10.4137/CIN.S13578; Nease RF, 1997, MED DECIS MAKING, V17, P263, DOI 10.1177/0272989X9701700302; Nilsen TW, 2007, TRENDS GENET, V23, P243, DOI 10.1016/j.tig.2007.02.011; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; RCore Team, 2020, R LANG ENV STAT COMP; Schwarzenbacher D, 2013, INT J MOL SCI, V14, P14712, DOI 10.3390/ijms140714712; Segal E, 2005, J MACH LEARN RES, V6, P557; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Spizzo R, 2009, EXPT THERAPEUTICS CA; Stingo FC, 2010, ANN APPL STAT, V4, P2024, DOI 10.1214/10-AOAS360; Tchatchou S, 2009, CARCINOGENESIS, V30, P59, DOI 10.1093/carcin/bgn253; van Schooneveld E, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0526-y; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vetter G, 2010, ONCOGENE, V29, P4436, DOI 10.1038/onc.2010.181; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Walter BA, 2011, J CANCER, V2, P67, DOI 10.7150/jca.2.67; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Wu ZS, 2011, CANCER-AM CANCER SOC, V117, P2842, DOI 10.1002/cncr.25860; Xie B., 2013, BIOINFORMATICS; Xiong Y, 2014, LIFE SCI, V106, P19, DOI 10.1016/j.lfs.2014.04.017; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yoon SR, 2005, BIOINFORMATICS, V21, P93, DOI 10.1093/bioinformatics/bti1116; Yu ZR, 2010, AM J PATHOL, V176, P1058, DOI 10.2353/ajpath.2010.090664; Yuan XL, 2015, J CHEM-NY, V2015, DOI 10.1155/2015/853105; Zenz T, 2009, BLOOD, V113, P3801, DOI 10.1182/blood-2008-08-172254; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhang ZJ, 2012, ONCOL REP, V27, P903, DOI 10.3892/or.2011.1611; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200; Zou Q, 2014, COMPUT BIOL MED, V45, P157, DOI 10.1016/j.compbiomed.2013.12.007	85	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182666	10.1371/journal.pone.0182666	http://dx.doi.org/10.1371/journal.pone.0182666			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28793339	Green Published, Green Submitted, gold			2022-12-26	WOS:000407196700057
J	Macegoniuk, K; Grela, E; Biernat, M; Psurski, M; Gosciniak, G; Dzielak, A; Mucha, A; Wietrzyk, J; Berlicki, L; Grabowiecka, A				Macegoniuk, Katarzyna; Grela, Ewa; Biernat, Monika; Psurski, Mateusz; Gosciniak, Grazyna; Dzielak, Anna; Mucha, Artur; Wietrzyk, Joanna; Berlicki, Lukasz; Grabowiecka, Agnieszka			Aminophosphinates against Helicobacter pylori ureolysis-Biochemical and whole-cell inhibition characteristics	PLOS ONE			English	Article							UREASE INHIBITION; ACID RESISTANCE; IN-VIVO; PROTEIN; PURIFICATION; RABEPRAZOLE; EXPRESSION; CHEMISTRY; INFECTION	Urease is an important virulence factor from Helicobacter pylori that enables bacterial colonization of human gastric mucosa. Specific inhibition of urease activity can be regarded as a promising adjuvant strategy for eradication of this pathogen. A group of organophosphorus inhibitors of urease, namely, aminophosphinic acid and aminophosphonic acid derivatives, were evaluated in vitro against H. pylori urease. The kinetic characteristics of recombinant enzyme activity demonstrated a competitive reversible mode of inhibition with Ki values ranging from 0.294 to 878 mu M. N-n-Hexylaminomethyl-P-aminomethylphosphinic acid and N-methylaminomethyl-P-hydroxymethylphosphinic acid were the most effective inhibitors (Ki = 0.294 mu M and 1.032 ae M, respectively, compared to Ki = 23 mu M for the established urease inhibitor acetohydroxamic acid). The biological relevance of the inhibitors was verified in vitro against a ureolytically active Escherichia coli Rosetta host that expressed H. pylori urease and against a reference strain, H. pylori J99 (CagA(+)/VacA(+)). The majority of the studied compounds exhibited ureaseinhibiting activity in these whole-cell systems. Bis(N-methylaminomethyl) phosphinic acid was found to be the most effective inhibitor in the susceptibility profile studies of H. pylori J99. The cytotoxicity of nine structurally varied inhibitors was evaluated against four normal human cell lines and was found to be negligible.	[Macegoniuk, Katarzyna; Grela, Ewa; Dzielak, Anna; Mucha, Artur; Berlicki, Lukasz; Grabowiecka, Agnieszka] Wroclaw Univ Technol, Dept Bioorgan Chem, Fac Chem, Wroclaw, Poland; [Biernat, Monika; Gosciniak, Grazyna] Med Univ Wroclaw, Dept Microbiol, Wroclaw, Poland; [Psurski, Mateusz; Wietrzyk, Joanna] Polish Acad Sci, Inst Immunol & Expt Therapy, Wroclaw, Poland	Wroclaw University of Science & Technology; Wroclaw Medical University; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences	Grabowiecka, A (corresponding author), Wroclaw Univ Technol, Dept Bioorgan Chem, Fac Chem, Wroclaw, Poland.	agnieszka.grabowiecka@pwr.edu.pl	Wietrzyk, Joanna/O-4392-2018; Berlicki, Lukasz/AAB-2140-2019; Berlicki, Łukasz/AAB-2359-2019	Wietrzyk, Joanna/0000-0003-4980-6606; Berlicki, Lukasz/0000-0003-0318-4944; Mucha, Artur/0000-0002-6421-1371; Grela, Ewa/0000-0003-1721-6839; Biernat, Monika/0000-0003-3161-3398; Grabowiecka, Agnieszka/0000-0002-5825-0702; Psurski, Mateusz/0000-0001-8866-7149; Gosciniak, Grazyna/0000-0001-6597-9609	National Science Centre, Poland [2011/03/B/NZ6/04964, 2015/17/N/NZ1/00027]; Wroclaw Centre of Biotechnology Program, The Leading National Research Centre (KNOW)	National Science Centre, Poland(National Science Centre, Poland); Wroclaw Centre of Biotechnology Program, The Leading National Research Centre (KNOW)	The study was supported by the National Science Centre, Poland (www.ncn.gov.pl), grant no. 2011/03/B/NZ6/04964 to AG and 2015/17/N/NZ1/00027 to KM. English editing was funded by the Wroclaw Centre of Biotechnology Program, The Leading National Research Centre (KNOW) for the years 2014-2018 (know.wroc.pl).; The work was supported by the National Science Centre, Poland, grant no. 2011/03/B/NZ6/04964. K.M. is grateful for support from the National Science Centre, Poland (grant no. 2015/17/N/NZ1/00027). The gift of plasmid pGEM::ureOP from Prof. Stefano Ciurli (University of Bologna, Italy) is kindly acknowledged. The project was supported by the Wroclaw Centre of Biotechnology Program, The Leading National Research Centre (KNOW) for the years 2014-2018.	Abadi ATB, 2016, WORLD J GASTROENTERO, V22, P3150, DOI 10.3748/wjg.v22.i11.3150; Amtul Z, 2002, CURR MED CHEM, V9, P1323, DOI 10.2174/0929867023369853; Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125; Barth J, 2002, ALIMENT PHARM THER, V16, P31, DOI 10.1046/j.1365-2036.2002.0160s1031.x; Berlicki L, 2012, AMINO ACIDS, V42, P1937, DOI 10.1007/s00726-011-0920-4; BIZOUARNE N, 1993, BIOL CELL, V79, P209, DOI 10.1016/0248-4900(93)90139-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carlini CR, 2016, TOXICON, V110, P90, DOI 10.1016/j.toxicon.2015.11.020; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; EATON KA, 1994, INFECT IMMUN, V62, P3604, DOI 10.1128/IAI.62.9.3604-3607.1994; Follmer C, 2010, J CLIN PATHOL, V63, P424, DOI 10.1136/jcp.2009.072595; Grela E, 2016, J MED MICROBIOL, V65, P1123, DOI 10.1099/jmm.0.000342; HU LT, 1992, INFECT IMMUN, V60, P2657, DOI 10.1128/IAI.60.7.2657-2666.1992; HU LT, 1993, INFECT IMMUN, V61, P2563, DOI 10.1128/IAI.61.6.2563-2569.1993; Kao CY, 2016, BIOMED J, V39, P14, DOI 10.1016/j.bj.2015.06.002; Keilberg D, 2015, CELL HOST MICROBE, V18, P135, DOI 10.1016/j.chom.2015.07.013; Kosikowska P, 2011, EXPERT OPIN THER PAT, V21, P945, DOI 10.1517/13543776.2011.574615; Macegoniuk K, 2016, J MED CHEM, V59, P8125, DOI 10.1021/acs.jmedchem.6b00986; Macegoniuk K, 2015, ACS MED CHEM LETT, V6, P146, DOI 10.1021/ml500380f; McGee DJ, 1999, J BACTERIOL, V181, P2477, DOI 10.1128/JB.181.8.2477-2484.1999; Mobley HLT, 2001, HELICOBACTER PYLORI: MOLECULAR AND CELLULAR BIOLOGY, P155; Nevozhay D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106186; Pope AJ, 1998, DIGEST DIS SCI, V43, P109, DOI 10.1023/A:1018884322973; Rektorschek M, 2000, MOL MICROBIOL, V36, P141, DOI 10.1046/j.1365-2958.2000.01835.x; Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00172; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHAFER UK, 1994, ARCH MICROBIOL, V161, P393, DOI 10.1007/BF00288948; Scott DR, 1998, GASTROENTEROLOGY, V114, P58, DOI 10.1016/S0016-5085(98)70633-X; Shukla SK, 2011, BRAZ J INFECT DIS, V15, P583, DOI 10.1590/S1413-86702011000600014; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Stenstrom B, 2016, CLIN CASE REP, V4, P1026, DOI 10.1002/ccr3.687; Stingl K, 2008, MOL CELL PROTEOMICS, V7, P2429, DOI 10.1074/mcp.M800160-MCP200; Taylor J. R., 1997, ERROR ANAL STUDY UNC; TSUCHIYA M, 1995, BIOL PHARM BULL, V18, P1053; Vassiliou S, 2008, J MED CHEM, V51, P5736, DOI 10.1021/jm800570q; Vassiliou S, 2012, ARKIVOC, P33, DOI 10.3998/ark.5550190.0013.404; Vassiliou S, 2010, J MED CHEM, V53, P5597, DOI 10.1021/jm100340m; WEATHERBURN MW, 1967, ANAL CHEM, V39, P971, DOI 10.1021/ac60252a045; Williams CL, 1996, FEMS IMMUNOL MED MIC, V13, P87, DOI 10.1111/j.1574-695X.1996.tb00220.x; Zambelli B, 2014, J BIOL INORG CHEM, V19, P319, DOI 10.1007/s00775-013-1068-3; Zambelli B, 2011, ACCOUNTS CHEM RES, V44, P520, DOI 10.1021/ar200041k	41	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182437	10.1371/journal.pone.0182437	http://dx.doi.org/10.1371/journal.pone.0182437			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28792967	Green Published, Green Submitted, gold			2022-12-26	WOS:000407196700044
J	Bamford, AJ; Razafindrajao, F; Young, RP; Hilton, GM				Bamford, Andrew J.; Razafindrajao, Felix; Young, Richard P.; Hilton, Geoff M.			Profound and pervasive degradation of Madagascar's freshwater wetlands and links with biodiversity	PLOS ONE			English	Article							PROTECTED AREAS; CONSERVATION; FUTURE; MANAGEMENT; ECOLOGY; LONG	Reflecting a global trend, freshwater wetlands in Madagascar have received little conservation or research attention. Madagascar is a global conservation priority due to its high level of species endemism but most work has focused on protecting forests. For the first time, we investigated the state of wetlands across the country to determine the effects of human disturbance. We conducted a rapid survey of 37 wetlands, using waterbirds and benthic invertebrates as ecological indicators. We recorded nine variables relating to human disturbance, revealing widespread wetland destruction. Principal Components Analysis reduced the nine variables to a single Principal Component (PC) that explained 50% of the dataset variance, demonstrating that different forms of human disturbance are ubiquitous and inseparable. The disturbance PC provides an index of how pristine a lake is and in Generalized Linear Models (GLMs) was significantly inversely related to the number of waterbird species present and the density of Chironomidae. The disturbance PC was estimated for every wetland in a GIS-derived dataset of wetland locations in Madagascar, giving a country-wide frequency distribution of disturbance. To validate the estimated PC values, we used the GLMs to predict the number of endemic bird species at an independent sample of 22 lakes. The predicted values correlated with the observed number of species, demonstrating that our procedure can identify lakes with high biodiversity value. The disturbance PC provides a convenient method for ranking sites, and a country-wide ranking demonstrates that the only near-pristine lakes in Madagascar are small sites that have been preserved by remoteness from human activity and not conservation management. The strategy of conserving high biodiversity remnants is insufficient because existing remnants suffer some degree of degradation and only support small populations of threatened species. Large-scale restoration of degraded wetlands is required for the long-term conservation of Madagascar's freshwater biodiversity.	[Bamford, Andrew J.; Hilton, Geoff M.] Wildfowl & Wetlands Trust, Slimbridge, Glos, England; [Razafindrajao, Felix] Durrell Wildlife Conservat Trust, Antananarivo 101, Madagascar; [Young, Richard P.] Durrell Wildlife Conservat Trust, Trinity, Jersey, England; [Young, Richard P.] Imperial Coll London, Dept Life Sci, Silwood Pk Campus, Ascot, Berks, England	Imperial College London	Bamford, AJ (corresponding author), Wildfowl & Wetlands Trust, Slimbridge, Glos, England.	andrew.bamford@wwt.org.uk	Hilton, Geoff M/H-3086-2017	Hilton, Geoff M/0000-0001-9062-3030; Bamford, Andrew/0000-0003-4143-8087; Young, Richard/0000-0002-6515-6343	BBC Wildlife Fund [BBCWF83]	BBC Wildlife Fund	Fieldwork was funded by the BBC Wildlife Fund (grant ref: BBCWF83, http://www.bbc.co.uk/wild/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell R, 2007, BIOL CONSERV, V134, P48, DOI 10.1016/j.biocon.2006.08.017; Bamford AJ, 2015, BIRD CONSERV INT, V25, P97, DOI 10.1017/S0959270914000033; Benstead JP, 2003, BIOSCIENCE, V53, P1101, DOI 10.1641/0006-3568(2003)053[1101:CMFB]2.0.CO;2; Carroll M, 2009, GLOBAL RASTER WATER; Christie I. T., 2003, AFRICA REGION WORKIN, V63; CIESIN (Center for International Earth Science Information Netowrk) and CIAT (Centro Internacional de Agricultura Tropical), 2005, GRIDD POP WORLD V3 P; Colquhoun Ian C., 2015, Madagascar Conservation & Development, V10, P35; Darwall WRT, 2011, CONSERV LETT, V4, P474, DOI 10.1111/j.1755-263X.2011.00202.x; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; FAO, 2002, FAO RIC INF, V3; Freudenberger K., 2010, PARADISE LOST LESSON; Gardner CJ, 2013, J APPL ECOL, V50, P1289, DOI 10.1111/1365-2664.12164; Gardner Charlie J., 2009, Phelsuma, V17, P20; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Hines JE., 2006, PRESENCESOFTWARE EST; Hockley N. J., 2007, EC COMMUNITY FOREST; Hodkinson ID, 2005, ENVIRON MANAGE, V35, P649, DOI 10.1007/s00267-004-0211-x; Holland RA, 2012, BIOL CONSERV, V148, P167, DOI 10.1016/j.biocon.2012.01.016; Irvine K, 2016, AQUAT CONSERV, V26, P917, DOI 10.1002/aqc.2706; IUCN, 2016, RED LIST THREAT SPEC; Jarvis A., 2008, CGIAR CSI SRTM 90 M, DOI DOI 10.1111/ecog.00774; Junk WJ, 2002, ENVIRON CONSERV, V29, P414, DOI 10.1017/S0376892902000310; Junk WJ, 2013, AQUAT SCI, V75, P113, DOI 10.1007/s00027-012-0253-8; Kull C. A., 2012, Madagascar Conservation and Development, V7, P144; Lammers P. L., 2015, Madagascar Conservation and Development, V10, P116; Laurance WF, 2014, TRENDS ECOL EVOL, V29, P107, DOI 10.1016/j.tree.2013.12.001; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Maina J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2986; Moat J, 2007, MADAGASCAR VEGETATIO; Mutschler T., 2003, NATURAL HIST MADAGAS, P1530; Pollini J, 2014, EARTH CONSERV DEV, P172; R Core Team, 2013, R LANG ENV STAT COMP; Rabearivony Jeanneney, 2010, Madagascar Conservation & Development, V5, P35; Ranarijaona HLA, 2003, NATURAL HIST MADAGAS, P250; Rasolofoson RA, 2015, BIOL CONSERV, V184, P271, DOI 10.1016/j.biocon.2015.01.027; Richard A. F., 2013, Madagascar Conservation and Development, V8, P12; Smol JP, 2001, TRACKING ENV CHANGE, V4; Sparks J.S., 2003, P849; Strayer DL, 2010, J N AM BENTHOL SOC, V29, P344, DOI 10.1899/08-171.1; Venables WN., 2002, MODERN APPL STAT S 4; Waeber PO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161115; Weir SM, 2012, BIOL INVASIONS, V14, P385, DOI 10.1007/s10530-011-0084-x; World Bank, 2015, WORLD DEV INDICATORS; WWF, 2014, WWF LIV PLAN REP 201; Young H. Glyn, 2014, Wildfowl, V64, P35	45	13	13	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2017	12	8							e0182673	10.1371/journal.pone.0182673	http://dx.doi.org/10.1371/journal.pone.0182673			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9EU	28792516	Green Published, gold, Green Submitted			2022-12-26	WOS:000407144700033
J	Hu, SE; Chen, XL; Liao, J; Chen, YQ; Zhao, CC; Zhang, Y				Hu, Sheng'en; Chen, Xiaolan; Liao, Ji; Chen, Yiqing; Zhao, Chengchen; Zhang, Yong			CAM: A quality control pipeline for MNase-seq data	PLOS ONE			English	Article							NUCLEOSOME ORGANIZATION; GENOME; DETERMINANTS	Nucleosome organization affects the accessibility of cis-elements to trans-acting factors. Micrococcal nuclease digestion followed by high-throughput sequencing (MNase-seq) is the most popular technology used to profile nucleosome organization on a genome-wide scale. Evaluating the data quality of MNase-seq data remains challenging, especially in mammalian. There is a strong need for a convenient and comprehensive approach to obtain dedicated quality control (QC) for MNase-seq data analysis. Here we developed CAM, which is a comprehensive QC pipeline for MNase-seq data. The CAM pipeline provides multiple informative QC measurements and nucleosome organization profiles on different potentially functional regions for given MNase-seq data. CAM also includes 268 historical MNase-seq datasets from human and mouse as a reference atlas for unbiased assessment. CAM is freely available at: http://www.tongji.edu.cn/similar to zhanglab/CAM.	[Zhang, Yong] Tongji Univ, Translat Med Ctr Stem Cell Therapy, Shanghai, Peoples R China; Tongji Univ, Inst Regenerat Med, Shanghai Key Lab Signaling & Dis Res, Shanghai East Hosp,Sch Life Sci & Technol, Shanghai, Peoples R China	Tongji University; Tongji University	Zhang, Y (corresponding author), Tongji Univ, Translat Med Ctr Stem Cell Therapy, Shanghai, Peoples R China.	yzhang@tongji.edu.cn	Zhao, Chengchen/AAH-4166-2019; Zhang, Yong/B-4838-2011	Zhang, Yong/0000-0001-6316-2734; Zhao, Chengchen/0000-0002-8454-6347	National Natural Science Foundation of China [31571365, 31322031, 31371288]; National Key Research and Development Program of China [2017YFA0102602, 2016YFA0100400]; Specialized Research Fund for the Doctoral Program of Higher Education [20130072110032]; Program of Shanghai Academic Research Leader [17XD1403600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Program of Shanghai Academic Research Leader	This work was supported by National Natural Science Foundation of China (31571365, 31322031 and 31371288), National Key Research and Development Program of China (2017YFA0102602 and 2016YFA0100400), Specialized Research Fund for the Doctoral Program of Higher Education (20130072110032), and Program of Shanghai Academic Research Leader (17XD1403600).	Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Hughes AL, 2014, ANNU REV BIOPHYS, V43, P41, DOI 10.1146/annurev-biophys-051013-023114; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Struhl K, 2013, NAT STRUCT MOL BIOL, V20, P267, DOI 10.1038/nsmb.2506; Teif VB, 2016, BRIEF BIOINFORM, V17, P745, DOI 10.1093/bib/bbv086; Teves SS, 2014, TRENDS BIOCHEM SCI, V39, P577, DOI 10.1016/j.tibs.2014.10.004; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; Xi YX, 2011, GENOME RES, V21, P718, DOI 10.1101/gr.117101.110; Zang CZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11305; Zhang Y, 2014, GENOME RES, V24, P260, DOI 10.1101/gr.157750.113	12	2	2	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182771	10.1371/journal.pone.0182771	http://dx.doi.org/10.1371/journal.pone.0182771			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28787030	Green Submitted, Green Published, gold			2022-12-26	WOS:000406998800063
J	Mancio, RD; Hermes, TD; Macedo, AB; Mizobuti, DS; Rupcic, IF; Minatel, E				Mancio, Rafael Dias; Hermes, Tulio de Almeida; Macedo, Aline Barbosa; Mizobuti, Daniela Sayuri; Rupcic, Ian Feller; Minatel, Elaine			Dystrophic phenotype improvement in the diaphragm muscle of mdx mice by diacerhein	PLOS ONE			English	Article							OXIDATIVE STRESS; SKELETAL-MUSCLE; NITRIC-OXIDE; TNF-ALPHA; MUSCULAR-DYSTROPHY; DAMAGE; MOUSE; PATHOPHYSIOLOGY; OSTEOARTHRITIS; PROGRESSION	Chronic inflammation and oxidative stress are striking features of Duchenne muscular dystrophy disease. Diacerhein is an anthraquinone, which exhibits anti-inflammatory and antioxidant properties. Based on their actions, the present study evaluated the effects of diacerhein against myonecrosis, oxidative stress and inflammatory response in the diaphragm muscle of mdx mice and compared these results to current treatment widely used in DMD patients, with a main focus on the impact of prednisone. The results demonstrated that diacerhein treatment prevented muscle damage indicated by a decrease in the IgG uptake by muscle fibers, lower CK levels in serum, reduction of fibers with central nuclei with a concomitant increase in fibers with peripheral nuclei. It also had an effect on the inflammatory process, decreasing the inflammatory area, macrophage staining and TNF-alpha and IL-1 beta content. Regarding oxidative stress, diacerhein treatment was effective in reducing the ROS and lipid peroxidation in the diaphragm muscle from mdx mice. Compared to prednisone treatment, our findings demonstrated that diacerhein treatment improved the dystrophic phenotype in the diaphragm muscle of mdx mice similar to that of glucocorticoid therapy. In this respect, this work suggests that diacerhein has a potential use as an alternative drug in dystrophino-pathy treatment and recommends that its anti-inflammatory and antioxidants properties in the dystrophic muscle should be better understood.	[Mancio, Rafael Dias; Hermes, Tulio de Almeida; Macedo, Aline Barbosa; Mizobuti, Daniela Sayuri; Rupcic, Ian Feller; Minatel, Elaine] State Univ Campinas UNICAMP, Inst Biol, Dept Struct & Funct Biol, Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas	Minatel, E (corresponding author), State Univ Campinas UNICAMP, Inst Biol, Dept Struct & Funct Biol, Campinas, SP, Brazil.	minatel@unicamp.br	Minatel, Elaine/ABI-1583-2020; Hermes, Túlio/W-1288-2019; Mizobuti, Daniela Sayuri/GPF-5727-2022; Hermes, Tulio/AAK-3362-2021	Mizobuti, Daniela Sayuri/0000-0002-6114-4863; Hermes, Tulio/0000-0003-2937-3890; Minatel, Elaine/0000-0001-9863-0761; Dias Mancio, Rafael/0000-0002-6299-187X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [13/17732-4]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-PROEX); FAPESP fellowship [14/01970-6, 14/2510-1]; CNPq fellowship; CAPES fellowship	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-PROEX)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP fellowship(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq fellowship(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES fellowship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, grant 13/17732-4) and by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES-PROEX). RDM and IFR were recipients of FAPESP fellowship (#14/01970-6; (#14/2510-1). RDM, TAH and ABM were the recipients of a CNPq fellowship and DSM was the recipient of a CAPES fellowship.	BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; CULLEN MJ, 1988, ACTA NEUROPATHOL, V77, P69, DOI 10.1007/BF00688245; Disatnik MH, 1998, J NEUROL SCI, V161, P77, DOI 10.1016/S0022-510X(98)00258-5; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Engel AG, 1994, MYOLOGY BASIC CLIN, V2, P1133; Evans NP, 2010, CLIN NUTR, V29, P391, DOI 10.1016/j.clnu.2009.10.001; Haycock JW, 1996, NEUROREPORT, V8, P357, DOI 10.1097/00001756-199612200-00070; Hermes TD, 2016, CLIN EXP PHARMACOL P, V43, P259, DOI 10.1111/1440-1681.12521; Hodgetts S, 2006, NEUROMUSCULAR DISORD, V16, P591, DOI 10.1016/j.nmd.2006.06.011; Klimek MEB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155944; Lawler JM, 2011, J PHYSIOL-LONDON, V589, P2161, DOI 10.1113/jphysiol.2011.207456; Li ZF, 2015, INFLAMMATION, V38, P1563, DOI 10.1007/s10753-015-0131-3; Malaguti C, 2008, INT IMMUNOPHARMACOL, V8, P782, DOI 10.1016/j.intimp.2008.01.020; Maranhao JB, 2015, INT J EXP PATHOL, V96, P285, DOI 10.1111/iep.12142; Pasin JSM, 2010, INFLAMM RES, V59, P189, DOI 10.1007/s00011-009-0085-8; Mauricio AF, 2013, CLIN NUTR, V32, P636, DOI 10.1016/j.clnu.2012.11.013; Mendell JR, 2012, ANN NEUROL, V71, P304, DOI 10.1002/ana.23528; Messina S, 2006, EXP NEUROL, V198, P234, DOI 10.1016/j.expneurol.2005.11.021; MIAN M, 1987, J PHARM PHARMACOL, V39, P845, DOI 10.1111/j.2042-7158.1987.tb05131.x; Pinto RDM, 2013, CLIN NUTR, V32, P472, DOI 10.1016/j.clnu.2012.06.001; Moxley RT, 2005, NEUROLOGY, V64, P13, DOI 10.1212/01.WNL.0000148485.00049.B7; Nakae Y, 2012, HISTOCHEM CELL BIOL, V137, P811, DOI 10.1007/s00418-012-0926-3; Pelletier JP, 1998, J RHEUMATOL, V25, P2417; Pelletier JP, 1998, ARTHRITIS RHEUM-US, V41, P1275, DOI 10.1002/1529-0131(199807)41:7<1275::AID-ART19>3.0.CO;2-T; Pelletier JP, 2001, J RHEUMATOL, V28, P814; Pelosi L, 2015, EBIOMEDICINE, V2, P285, DOI 10.1016/j.ebiom.2015.02.014; Piers AT, 2011, NEUROMUSCULAR DISORD, V21, P132, DOI 10.1016/j.nmd.2010.09.013; POMARELLI P, 1980, FARMACO-ED SCI, V35, P836; Radley HG, 2008, NEUROMUSCULAR DISORD, V18, P227, DOI 10.1016/j.nmd.2007.11.002; Rando TA, 2002, AM J PHYS MED REHAB, V81, pS175, DOI 10.1097/00002060-200211001-00018; Moraes LHR, 2015, BIOL TRACE ELEM RES, V167, P115, DOI 10.1007/s12011-015-0290-y; Rawat R, 2010, AM J PATHOL, V176, P2891, DOI 10.2353/ajpath.2010.090058; Shin J, 2013, INT J BIOCHEM CELL B, V45, P2266, DOI 10.1016/j.biocel.2013.05.001; Spencer CM, 1997, DRUGS, V53, P98, DOI 10.2165/00003495-199753010-00007; Tamura T, 2001, EUR J PHARMACOL, V419, P269, DOI 10.1016/S0014-2999(01)00990-6; Terrill JR, 2016, REDOX BIOL, V9, P276, DOI 10.1016/j.redox.2016.08.016; Tidball JG, 2007, J APPL PHYSIOL, V102, P1677, DOI 10.1152/japplphysiol.01145.2006; Tonon E, 2012, NUTRITION, V28, P686, DOI 10.1016/j.nut.2011.09.013; Whitehead NP, 2008, J PHYSIOL-LONDON, V586, P2003, DOI 10.1113/jphysiol.2007.148338; Whitehead NP, 2006, CLIN EXP PHARMACOL P, V33, P657, DOI 10.1111/j.1440-1681.2006.04394.x	40	10	10	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182449	10.1371/journal.pone.0182449	http://dx.doi.org/10.1371/journal.pone.0182449			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28787441	Green Submitted, gold, Green Published			2022-12-26	WOS:000406998800038
J	Amireddy, N; Puttapaka, SN; Vinnakota, RL; Ravuri, HG; Thonda, S; Kalivendi, SV				Amireddy, Niharika; Puttapaka, Srinivas N.; Vinnakota, Ravali L.; Ravuri, Halley G.; Thonda, Swaroop; Kalivendi, Shasi V.			The unintended mitochondrial uncoupling effects of the FDA-approved anti-helminth drug nitazoxanide mitigates experimental parkinsonism in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGETED ANTIOXIDANT MITOQ; DISEASE; DYSFUNCTION; PINK1; 2,4-DINITROPHENOL; NEUROPROTECTION; DEGENERATION; INHIBITION; PROTEINS; THERAPY	Mitochondria play a primary role in the pathophysiology of Parkinson's disease (PD), and small molecules that counteract the initial stages of disease may offer therapeutic benefit. In this regard, we have examined whether the off- target effects of the Food and Drug Administration (FDA)-approved anti-helminth drug nitazoxanide (NTZ) on mitochondrial respiration could possess any therapeutic potential for PD. Results indicate that MPP+ - induced loss in oxygen consumption rate (OCR) and ATP production by mitochondria were ameliorated byNTZin real time by virtue of its mild uncoupling effect. Pretreatment of cells with NTZ mitigated MPP+ - induced loss in mitochondrial OCR and reactive oxygen species (ROS). Similarly, addition of NTZ to cells pretreated with MPP+ could reverse block in mitochondrialOCRand reactive oxygen species induced by MPP+ in real time. The observed effects of NTZ were found to be transient and reversible as removal of NTZ from incubation medium restored the mitochondrial respiration tothatofcontrols. Apoptosisinducedby MPP+ wasamelioratedby NTZ in a dose-dependent manner. In vivo results demonstrated that oral administration of NTZ (50 mg/kg) in an acute MPTP mouse model of PD conferred significant protection against the loss of tyrosine hydroxylase (TH)-positive neurons of substantia nigra. Based on the above observationswebelieve that repurposing of NTZ for PD may offer therapeutic benefit.	[Amireddy, Niharika; Puttapaka, Srinivas N.; Vinnakota, Ravali L.; Thonda, Swaroop; Kalivendi, Shasi V.] Indian Inst Chem Technol, Council Sci & Ind Res, Ctr Chem Biol, Uppal Rd, Hyderabad 500007, Telangana State, India; [Ravuri, Halley G.] Indian Inst Chem Technol, Council Sci & Ind Res, Ctr Pharmacol & Toxicol, Uppal Rd, Hyderabad 500007, Telangana State, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT)	Kalivendi, SV (corresponding author), Indian Inst Chem Technol, Council Sci & Ind Res, Ctr Chem Biol, Uppal Rd, Hyderabad 500007, Telangana State, India.	kalivendi@iict.res.in	Ravuri, Halley/AAD-2517-2021					Andrews ZB, 2005, NAT REV NEUROSCI, V6, P829, DOI 10.1038/nrn1767; Bose A, 2016, J NEUROCHEM, V139, P216, DOI 10.1111/jnc.13731; Burte F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228; Carvalho C, 2015, EXPERT REV NEUROTHER, V15, P867, DOI 10.1586/14737175.2015.1058160; Cole GM, 2003, NEURON, V37, P889, DOI 10.1016/S0896-6273(03)00160-0; De Felice FG, 2006, IUBMB LIFE, V58, P185, DOI 10.1080/15216540600702198; Di Santo N, 2014, MUTAT RES-FUND MOL M, V768, P16, DOI 10.1016/j.mrfmmm.2014.05.005; Gandhi S, 2005, HUM MOL GENET, V14, P2749, DOI 10.1093/hmg/ddi308; Gassen M, 1999, J NEURAL TRANSM-SUPP, P193; Ghosh A, 2010, FREE RADICAL BIO MED, V49, P1674, DOI 10.1016/j.freeradbiomed.2010.08.028; Kalia LV, 2015, MOVEMENT DISORD, V30, P1442, DOI 10.1002/mds.26354; Kalivendi SV, 2010, FREE RADICAL BIO MED, V48, P377, DOI 10.1016/j.freeradbiomed.2009.10.045; Kalivendi SV, 2003, BIOCHEM J, V371, P151, DOI 10.1042/BJ20021525; Kaur D, 2003, NEURON, V37, P899, DOI 10.1016/S0896-6273(03)00126-0; Kenwood BM, 2014, MOL METAB, V3, P114, DOI 10.1016/j.molmet.2013.11.005; Kieburtz K, 2006, NEUROLOGY, V66, pS50, DOI 10.1212/WNL.66.10_suppl_4.S50; Korde AS, 2005, J NEUROCHEM, V94, P1676, DOI 10.1111/j.1471-4159.2005.03328.x; Lam KKY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002691; Lindholm D, 2004, BIOCHEM BIOPH RES CO, V321, P753, DOI 10.1016/j.bbrc.2004.06.138; Liu D, 2015, J NEUROCHEM, V134, P677, DOI 10.1111/jnc.13176; Lou PH, 2007, BIOCHEM J, V407, P129, DOI 10.1042/BJ20070606; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; MIZUNO Y, 1987, BIOCHEM BIOPH RES CO, V143, P294, DOI 10.1016/0006-291X(87)90664-4; Morais VA, 2014, SCIENCE, V344, P203, DOI 10.1126/science.1249161; Norris EH, 2005, ANTIOXID REDOX SIGN, V7, P673; Orth M, 2001, AM J MED GENET, V106, P27, DOI 10.1002/ajmg.1425; Perry RJ, 2013, CELL METAB, V18, P740, DOI 10.1016/j.cmet.2013.10.004; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; RAMSAY RR, 1986, BIOCHEM BIOPH RES CO, V135, P269, DOI 10.1016/0006-291X(86)90972-1; Requejo-Aguilar R, 2016, FREE RADICAL BIO MED, V100, P123, DOI 10.1016/j.freeradbiomed.2016.04.012; Rossignol JF, 2014, ANTIVIR RES, V110, P94, DOI 10.1016/j.antiviral.2014.07.014; Ryan BJ, 2015, TRENDS BIOCHEM SCI, V40, P200, DOI 10.1016/j.tibs.2015.02.003; Sahdeo S, 2014, MITOCHONDRION, V17, P116, DOI 10.1016/j.mito.2014.07.002; Schapira A. H., 2011, PARKINSONS DIS, V2011, DOI DOI 10.4061/2011/159160; Senkowski W, 2015, MOL CANCER THER, V14, P1504, DOI 10.1158/1535-7163.MCT-14-0792; Sharma OP, 2009, FOOD CHEM, V113, P1202, DOI 10.1016/j.foodchem.2008.08.008; Smith RAJ, 2010, ANN NY ACAD SCI, V1201, P96, DOI 10.1111/j.1749-6632.2010.05627.x; Snow BJ, 2010, MOVEMENT DISORD, V25, P1670, DOI 10.1002/mds.23148; Tanik SA, 2013, J BIOL CHEM, V288, P15194, DOI 10.1074/jbc.M113.457408; Torok N, 2016, EXPERT OPIN INV DRUG, V25, P1281, DOI 10.1080/13543784.2016.1237501; TREVOR AJ, 1987, J NEURAL TRANSM, P73; White Clinton A Jr, 2004, Expert Rev Anti Infect Ther, V2, P43; Wu K, 2014, FASEB J, V28, P5111, DOI 10.1096/fj.14-255802	43	18	19	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15731	15743		10.1074/jbc.M117.791863	http://dx.doi.org/10.1074/jbc.M117.791863			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28798236	Green Published, hybrid			2022-12-26	WOS:000411512200013
J	Jin, HL; Xie, QP; Guo, XR; Xu, JH; Wang, A; Li, JX; Zhu, JL; Wu, XR; Huang, HS; Huang, CS				Jin, Honglei; Xie, Qipeng; Guo, Xirui; Xu, Jiheng; Wang, Annette; Li, Jingxia; Zhu, Junlan; Wu, Xue-Ru; Huang, Haishan; Huang, Chuanshu			p63 alpha protein up-regulates heat shock protein 70 expression via E2F1 transcription factor 1, promoting Wasf3/Wave3/MMP9 signaling and bladder cancer invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOWN-REGULATION CONTRIBUTES; LAMELLIPODIA FORMATION; TUMOR PROGRESSION; P63 EXPRESSION; CELL-MIGRATION; METASTASIS; WAVE3; SURVIVAL; GENE; ACTIVATION	Bladder cancer (BC) is the sixth most common cancer in the United States and is the number one cause of death among patients with urinary system malignancies. This makes the identification of invasive regulator(s)/effector(s) as the potential therapeutic targets for managing BC a high priority. p63 is a member of the p53 family of tumor suppressor genes/proteins, plays a role in the differentiation of epithelial tissues, and is believed to function as a tumor suppressor. However, it remains unclear whether and how p63 functions in BC cell invasion after tumorigenesis. Here, we show that p63 alpha protein levels were much higher in mouse high-invasive BC tissues than in normal tissues. Our results also revealed that p63 alpha is crucial for heat shock protein 70 (Hsp70) expression and subsequently increases the ability of BC invasion. Mechanistic experiments demonstrated that p63 alpha can transcriptionally up-regulate Hsp70 expression, thereby promoting BC cell invasion via the Hsp70/Wasf3/Wave3/MMP-9 axis. Wefurther show that E2F transcription factor 1 (E2F1) mediates p63 alpha overexpressioninduced Hsp70 transcription. We also found that p63 alpha overexpression activates E2F1 transcription, which appears to be stimulated by p63 alpha together with E2F1. Collectively, our results demonstrate that p63 alpha is a positive regulator of BC cell invasion after tumorigenesis, providing significant insights into the biological function of p63 alpha in BC and supporting the notion that p63 alpha might be a potential target for invasive BC therapy.	[Jin, Honglei; Guo, Xirui; Xu, Jiheng; Wang, Annette; Li, Jingxia; Zhu, Junlan; Huang, Chuanshu] NYU, Sch Med, Nelson Inst Environm Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA; [Jin, Honglei; Xie, Qipeng; Huang, Haishan] Wenzhou Med Univ, Sch Life Sci, Zhejiang Prov Key Lab Technol & Applicat Model Or, Wenzhou 325035, Zhejiang, Peoples R China; [Wu, Xue-Ru] NYU, Sch Med, Dept Urol, New York, NY 10016 USA; [Wu, Xue-Ru] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Wu, Xue-Ru] Vet Affairs New York Harbor Healthcare Syst Manha, New York, NY 10010 USA	New York University; Wenzhou Medical University; New York University; New York University	Huang, CS (corresponding author), NYU, Sch Med, Nelson Inst Environm Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.; Huang, HS (corresponding author), Wenzhou Med Univ, Sch Life Sci, Zhejiang Prov Key Lab Technol & Applicat Model Or, Wenzhou 325035, Zhejiang, Peoples R China.	haishan_333@163.com; chuanshu.huang@nyumc.org	Xu, Jiheng/AAV-5732-2020	Xu, Jiheng/0000-0002-3538-3174; Wu, Xue-Ru/0000-0001-6058-6291; Huang, Chuanshu/0000-0003-4133-5096	National Institutes of Health [CA112557, CA165980]; NCI [CA177665]; NIEHS [ES000260]; Natural Science Foundation of China [NSFC81773391, NSFC81702530, NSFC81372946, NSFC81601849]; Key Project of Science and Technology Innovation Team of Zhejiang Province [2013TD10]; NATIONAL CANCER INSTITUTE [P30CA016087, R01CA112557, R01CA177665, P01CA165980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Science and Technology Innovation Team of Zhejiang Province; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA112557, CA165980, and CA177665 (NCI) and ES000260 (NIEHS). This work was also supported by the Natural Science Foundation of China (NSFC81773391, NSFC81702530, NSFC81372946, and NSFC81601849) and the Key Project of Science and Technology Innovation Team of Zhejiang Province (2013TD10). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ADLER V, 1995, J BIOL CHEM, V270, P26071, DOI 10.1074/jbc.270.44.26071; [Anonymous], 2017, J BIOL CHEM, V292, P15952; Armstrong SR, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122041; Candi E, 2007, CELL CYCLE, V6, P274, DOI 10.4161/cc.6.3.3797; Candi E, 2014, HUM MUTAT, V35, P702, DOI 10.1002/humu.22523; Canoz Ozlem, 2002, Pathology & Oncology Research, V8, P262; Cowan NC, 2010, CURR OPIN UROL, V20, P409, DOI 10.1097/MOU.0b013e32833cbcb9; Crowe DL, 2001, NUCLEIC ACIDS RES, V29, P2789, DOI 10.1093/nar/29.13.2789; Crum CP, 2010, ANNU REV PATHOL-MECH, V5, P349, DOI 10.1146/annurev-pathol-121808-102117; Dimri GP, 2000, MOL CELL BIOL, V20, P273, DOI 10.1128/MCB.20.1.273-285.2000; Dohn M, 2001, ONCOGENE, V20, P3193, DOI 10.1038/sj.onc.1204427; Fang Y, 2013, MOL CANCER THER, V12, P1492, DOI 10.1158/1535-7163.MCT-12-0922; Flores ER, 2007, CELL CYCLE, V6, P300, DOI 10.4161/cc.6.3.3793; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Giacobbe A, 2013, CELL CYCLE, V12, P1395, DOI 10.4161/cc.24478; Gressner O, 2005, EMBO J, V24, P2458, DOI 10.1038/sj.emboj.7600708; HELIN K, 1993, MOL CELL BIOL, V13, P6501, DOI 10.1128/MCB.13.10.6501; Huang HS, 2015, CLIN CANCER RES, V21, P3783, DOI 10.1158/1078-0432.CCR-14-2829; Huang HY, 2007, HUM PATHOL, V38, P1703, DOI 10.1016/j.humpath.2007.04.003; Jin HL, 2016, ONCOTARGET, V7, P56540, DOI 10.18632/oncotarget.10645; Jin HL, 2015, ONCOTARGET, V6, P522, DOI 10.18632/oncotarget.2680; Juhasz K, 2014, CANCERS, V6, P42, DOI 10.3390/cancers6010042; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Kluger HM, 2005, CANCER RES, V65, P5578, DOI 10.1158/0008-5472.CAN-05-0108; Knowles MA, 2015, NAT REV CANCER, V15, P25, DOI 10.1038/nrc3817; Levine AJ, 2011, NAT REV MOL CELL BIO, V12, P259, DOI 10.1038/nrm3086; Liu JY, 2010, J BIOL CHEM, V285, P26058, DOI 10.1074/jbc.M110.100271; Matsumura I, 2003, CELL CYCLE, V2, P333, DOI 10.4161/cc.2.4.428; Melino G, 2011, CELL DEATH DIFFER, V18, P1487, DOI 10.1038/cdd.2011.81; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; MURPHY WM, 1984, CANCER, V53, P1555, DOI 10.1002/1097-0142(19840401)53:7<1555::AID-CNCR2820530723>3.0.CO;2-G; Park BJ, 2000, CANCER RES, V60, P3370; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Rowland BD, 2002, CANCER CELL, V2, P55, DOI 10.1016/S1535-6108(02)00085-5; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Silver JT, 2012, CELL STRESS CHAPERON, V17, P1, DOI 10.1007/s12192-011-0290-6; Sossey-Alaoui K, 2005, EXP CELL RES, V308, P135, DOI 10.1016/j.yexcr.2005.04.011; Sossey-Alaoui K, 2005, J BIOL CHEM, V280, P21748, DOI 10.1074/jbc.M500503200; Sossey-Alaoui K, 2002, ONCOGENE, V21, P5967, DOI 10.1038/sj.onc.1205734; Sossey-Alaoui K, 2007, J BIOL CHEM, V282, P26257, DOI 10.1074/jbc.M701484200; Sossey-Alaoui K, 2007, AM J PATHOL, V170, P2112, DOI 10.2353/ajpath.2007.060975; Sossey-Alaoui K, 2011, INT J CANCER, V129, P1331, DOI 10.1002/ijc.25793; Soti C, 2005, CURR OPIN CELL BIOL, V17, P210, DOI 10.1016/j.ceb.2005.02.012; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Teng Y, 2010, BRIT J CANCER, V103, P1066, DOI 10.1038/sj.bjc.6605850; Teng Y, 2012, J BIOL CHEM, V287, P10051, DOI 10.1074/jbc.M111.335000; Teng Y, 2011, INT J CANCER, V129, P2825, DOI 10.1002/ijc.25964; Trink B, 2007, CELL CYCLE, V6, P240, DOI 10.4161/cc.6.3.3803; Urist MJ, 2002, AM J PATHOL, V161, P1199, DOI 10.1016/S0002-9440(10)64396-9; von der Maase H, 2005, J CLIN ONCOL, V23, P4602, DOI 10.1200/JCO.2005.07.757; Wu GJ, 2003, CANCER RES, V63, P2351; Xie QP, 2016, ONCOTARGET, V7, P16636, DOI 10.18632/oncotarget.7674; Xu JW, 2016, ONCOTARGET, V7, P34112, DOI 10.18632/oncotarget.8746; Yang A, 2000, NAT REV MOL CELL BIO, V1, P199, DOI 10.1038/35043127; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yu Y, 2014, ONCOGENE, V33, P996, DOI 10.1038/onc.2013.8; Zhang DY, 2015, J BIOL CHEM, V290, P4784, DOI 10.1074/jbc.M114.598219; Zhang DY, 2012, J BIOL CHEM, V287, P34361, DOI 10.1074/jbc.M112.365882; Zhang DY, 2010, CANCER RES, V70, P813, DOI 10.1158/0008-5472.CAN-09-0448	61	19	19	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 22	2017	292	38					15952	15963		10.1074/jbc.M117.792010	http://dx.doi.org/10.1074/jbc.M117.792010			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FH9EL	28794159	Green Published, hybrid			2022-12-26	WOS:000411512200031
J	Wang, RL; Du, ZY; Bai, ZQ; Liang, ZS				Wang, Ruilin; Du, Zhiyou; Bai, Zhenqing; Liang, Zongsuo			The interaction between endogenous 30S ribosomal subunit protein S11 and Cucumber mosaic virus LS2b protein affects viral replication, infection and gene silencing suppressor activity	PLOS ONE			English	Article							2B; RESISTANCE; ACCUMULATION; TOBACCO; VECTOR	Cucumber mosaic virus (CMV) is a model virus for plant-virus protein interaction and mechanism research because of its wide distribution, high-level of replication and simple genome structure. The 2b protein is a multifunctional protein encoded by CMV that suppresses RNA silencing-based antiviral defense and contributes to CMV virulence in host plants. In this report, 12 host proteins were identified as CMV LS2b binding partners using the yeast two-hybrid screen system from the Arabidopsis thaliana cDNA library. Among the host proteins, 30S ribosomal subunit protein S11 (RPS11) was selected for further studies. The interaction between LS2b and full-length RPS11 was confirmed using the yeast two-hybrid system. Bimolecular fluorescence complementation (BIFC) assays observed by confocal laser microscopy and Glutathione S-transferase (GST) pull-down assays were used to verify the interaction between endogenous NbRPS11 and viral CMVLS2b both in vivo and in vitro. TRV-based gene silencing vector was used to knockdown NbRPS11 transcription, and immunoblot analysis revealed a decline in infectious viral RNA replication and a decrease in CMV infection in RPS11 down-regulated Nicotiana benthamiana plants. Thus, the knockdown of RPS11 likely inhibited CMV replication and accumulation. The gene silencing suppressor activity of CMV2b protein was reduced by the RPS11 knockdown. This study demonstrated that the function of viral LS2b protein was remarkably affected by the interaction with host RPS11 protein.	[Wang, Ruilin; Bai, Zhenqing; Liang, Zongsuo] Northwest Agr & Forestry Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Wang, Ruilin] Xian Mision Biotech, Xian, Shaanxi, Peoples R China; [Du, Zhiyou; Liang, Zongsuo] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China	Northwest A&F University - China; Zhejiang Sci-Tech University	Liang, ZS (corresponding author), Northwest Agr & Forestry Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.; Liang, ZS (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China.	wrl1110@163.com	DU, ZHIYOU/M-7675-2014		National Natural Science Foundation of China [31170141, 31470007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (grants 31170141 and 31470007)	Bonfim K, 2007, MOL PLANT MICROBE IN, V20, P717, DOI 10.1094/MPMI-20-6-0717; DING SW, 1995, EMBO J, V14, P5762, DOI 10.1002/j.1460-2075.1995.tb00265.x; Du ZY, 2008, VIROLOGY, V380, P363, DOI 10.1016/j.virol.2008.07.036; Goto K, 2007, PLANT CELL PHYSIOL, V48, P1050, DOI 10.1093/pcp/pcm074; Huh SU, 2011, NEW PHYTOL, V191, P746, DOI 10.1111/j.1469-8137.2011.03717.x; Inaba J, 2011, PLANT PHYSIOL, V156, P2026, DOI 10.1104/pp.111.180042; Joseph S, 2015, ENCY CELL BIOL, V1, P384; Kang WH, 2010, THEOR APPL GENET, V120, P1587, DOI 10.1007/s00122-010-1278-9; Kim MJ, 2006, J GEN VIROL, V87, P3425, DOI 10.1099/vir.0.82252-0; Lewsey M, 2009, MOL PLANT MICROBE IN, V22, P642, DOI 10.1094/MPMI-22-6-0642; Liao QS, 2015, SCI REP-UK, V5, DOI 10.1038/srep13178; Ng JCK, 2005, VIROLOGY, V332, P397, DOI 10.1016/j.virol.2004.11.021; PALUKAITIS P, 1992, ADV VIRUS RES, V41, P281, DOI 10.1016/B978-0-12-394314-9.00013-0; Sekine KT, 2004, MOL PLANT MICROBE IN, V17, P623, DOI 10.1094/MPMI.2004.17.6.623; Soards AJ, 2002, MOL PLANT MICROBE IN, V15, P647, DOI 10.1094/MPMI.2002.15.7.647; Su SZ, 2010, PLANT CELL, V22, P1373, DOI 10.1105/tpc.108.064212; Wang Y, 2004, ARCH VIROL, V149, P379, DOI 10.1007/s00705-003-0240-4; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506	18	5	6	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2017	12	8							e0182459	10.1371/journal.pone.0182459	http://dx.doi.org/10.1371/journal.pone.0182459			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD5CP	28806733	Green Published, Green Submitted, gold			2022-12-26	WOS:000407548800021
J	Abdelrahman, M; El-Sayed, M; Sato, S; Hirakawa, H; Ito, S; Tanaka, K; Mine, Y; Sugiyama, N; Suzuki, M; Yamauchi, N; Shigyo, M				Abdelrahman, Mostafa; El-Sayed, Magdi; Sato, Shusei; Hirakawa, Hideki; Ito, Shin-ichi; Tanaka, Keisuke; Mine, Yoko; Sugiyama, Nobuo; Suzuki, Minoru; Yamauchi, Naoki; Shigyo, Masayoshi			RNA-sequencing-based transcriptome and biochemical analyses of steroidal saponin pathway in a complete set of Allium fistulosum -A. cepa monosomic addition lines	PLOS ONE			English	Article							AGGREGATUM GROUP; TRITERPENOID BIOSYNTHESIS; MEDICAGO-TRUNCATULA; FUSARIUM-OXYSPORUM; ARABIDOPSIS; GENE; L.; SHALLOT; PLANTS; RESISTANCE	The genus Allium is a rich source of steroidal saponins, and its medicinal properties have been attributed to these bioactive compounds. The saponin compounds with diverse structures play a pivotal role in Allium's defense mechanism. Despite numerous studies on the occurrence and chemical structure of steroidal saponins, their biosynthetic pathway in Allium species is poorly understood. The monosomic addition lines (MALs) of the Japanese bunching onion (A. fistulosum, FF) with an extra chromosome from the shallot (A. cepa Aggregatum group, AA) are powerful genetic resources that enable us to understand many physiological traits of Allium. In the present study, we were able to isolate and identify Alliospiroside A saponin compound in A. fistulosum with extra chromosome 2A from shallot (FF2A) and its role in the defense mechanism against Fusarium pathogens. Furthermore, to gain molecular insight into the Allium saponin biosynthesis pathway, high-throughput RNA-Seq of the root, bulb, and leaf of AA, MALs, and FF was carried out using Illumina's HiSeq 2500 platform. An open access Allium Transcript Database (Allium TDB, http://alliumtdb.kazusa.or.jp) was generated based on RNA-Seq data. The resulting assembled transcripts were functionally annotated, revealing 50 unigenes involved in saponin biosynthesis. Differential gene expression (DGE) analyses of AA and MALs as compared with FF (as a control) revealed a strong up-regulation of the saponin downstream pathway, including cytochrome P450, glycosyltransferase, and beta-glucosidase in chromosome 2A. An understanding of the saponin compounds and biosynthesis-related genes would facilitate the development of plants with unique saponin content and, subsequently, improved disease resistance.	[Abdelrahman, Mostafa; El-Sayed, Magdi; Sato, Shusei; Hirakawa, Hideki; Ito, Shin-ichi; Tanaka, Keisuke; Mine, Yoko; Sugiyama, Nobuo; Suzuki, Minoru; Yamauchi, Naoki; Shigyo, Masayoshi] Grad Sch Sci & Technol Innovat, Coll Agr, Lab Vegetable Crop Sci, Tokyo, Japan		Shigyo, M (corresponding author), Grad Sch Sci & Technol Innovat, Coll Agr, Lab Vegetable Crop Sci, Tokyo, Japan.	shigyo@yamaguchi-u.ac.jp	El-Sayed, Magdi/G-4080-2019; Abdelrahman, Mostafa/I-4381-2019; Sato, Shusei/A-3616-2015; Shigyo, Masayoshi/AAX-9460-2021; Ito, Shin-ichi/AAJ-6442-2020	El-Sayed, Magdi/0000-0001-8914-4104; Abdelrahman, Mostafa/0000-0002-6733-8423; Sato, Shusei/0000-0002-0293-5366; Shigyo, Masayoshi/0000-0003-4014-6613; Ito, Shin-ichi/0000-0002-4520-0378	JSPS KAKENHI [16H06279]; Cooperative Research Grant of the Genome Research for BioResource; NODAI Genome Research Center; Tokyo University of Agriculture [FY2014, FY2015]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Cooperative Research Grant of the Genome Research for BioResource; NODAI Genome Research Center; Tokyo University of Agriculture	This research topic was fully supported by JSPS KAKENHI Grant Number 16H06279. The RNA-Sequencing experiments were supported by Cooperative Research Grant of the Genome Research for BioResource, NODAI Genome Research Center, Tokyo University of Agriculture in FY2014 and FY2015, respectively for leaf sheath and leaf blade. Another RNA-Sequencing experiment in FY2014 for root was supported by JSPS KAKENHI Grant Number 16H06279.	Abdelrahman M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02566-7; Abdelrahman M, 2016, PLANT SCI, V246, P128, DOI 10.1016/j.plantsci.2016.02.008; Abdelrahman M, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0378-2; Abdelrahman M, 2014, BIOSCI BIOTECH BIOCH, V78, P1112, DOI 10.1080/09168451.2014.915722; Achnine L, 2005, PLANT J, V41, P875, DOI 10.1111/j.1365-313X.2005.02344.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Carelli M, 2011, PLANT CELL, V23, P3070, DOI 10.1105/tpc.111.087312; Caruso G, 2014, SCI HORTIC-AMSTERDAM, V166, P111, DOI 10.1016/j.scienta.2013.12.019; COREY EJ, 1993, P NATL ACAD SCI USA, V90, P11628, DOI 10.1073/pnas.90.24.11628; Currah L., 2002, P379, DOI 10.1079/9780851995106.0379; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Faizal A, 2013, PHYTOCHEM REV, V12, P877, DOI 10.1007/s11101-013-9322-4; Fritsch RM, 2010, PHYTON-ANN REI BOT A, V49, P145; Fu WQ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-61; Fukushima EO, 2011, PLANT CELL PHYSIOL, V52, P2050, DOI 10.1093/pcp/pcr146; Geisler K, 2013, P NATL ACAD SCI USA, V110, pE3360, DOI 10.1073/pnas.1309157110; Ginglinger JF, 2013, PLANT CELL, V25, P4640, DOI 10.1105/tpc.113.117382; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haralampidis K, 2002, ADV BIOCHEM ENG BIOT, V75, P31; Heitz T, 2012, J BIOL CHEM, V287, P6296, DOI 10.1074/jbc.M111.316364; Herrera JBR, 1998, PHYTOCHEMISTRY, V49, P1905, DOI 10.1016/S0031-9422(98)00366-5; Inoue K, 1996, FEBS LETT, V378, P157, DOI 10.1016/0014-5793(95)01447-0; Kalra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083336; Kamenetsky R., 2006, Horticultural Reviews, V32, P329; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KOFOET A, 1990, PLANT BREEDING, V105, P144, DOI 10.1111/j.1439-0523.1990.tb00467.x; Kohara A, 2005, PLANT MOL BIOL, V57, P225, DOI 10.1007/s11103-004-7204-2; Kushiro T, 1998, EUR J BIOCHEM, V256, P238, DOI 10.1046/j.1432-1327.1998.2560238.x; Lanzotti V, 2012, PHYTOCHEM REV, V11, P179, DOI 10.1007/s11101-012-9247-3; Lanzotti V, 2014, PHYTOCHEM REV, V13, P769, DOI 10.1007/s11101-014-9366-0; Li HY, 2015, J PROTEOMICS, V127, P18, DOI 10.1016/j.jprot.2015.03.025; Luo HM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S5-S5; Masamura N, 2011, J JPN SOC HORTIC SCI, V80, P322, DOI 10.2503/jjshs1.80.322; Masuzaki S, 2006, GENES GENET SYST, V81, P255, DOI 10.1266/ggs.81.255; Matsuura H, 2001, J NUTR, V131, p1000S, DOI 10.1093/jn/131.3.1000S; Miettinen K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14153; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Moses T, 2014, CRIT REV BIOCHEM MOL, V49, P439, DOI 10.3109/10409238.2014.953628; Mostafa A, 2013, PHYTOCHEM LETT, V6, P274, DOI 10.1016/j.phytol.2013.03.001; Mylona P, 2008, PLANT CELL, V20, P201, DOI 10.1105/tpc.107.056531; Ohnishi T, 2006, PHYTOCHEMISTRY, V67, P1895, DOI 10.1016/j.phytochem.2006.05.042; Ohyama K, 2009, P NATL ACAD SCI USA, V106, P725, DOI 10.1073/pnas.0807675106; Osbourn AE, 2002, RECENT ADV PHYTOCHEM, V75, P31; Pang X, 2012, PLANTA MED, V78, P276, DOI 10.1055/s-0031-1280373; Pankaj C, 2012, MOL BIOL REP, V39, P9755; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Phillips DR, 2006, CURR OPIN PLANT BIOL, V9, P305, DOI 10.1016/j.pbi.2006.03.004; Rohdich F, 2001, CURR OPIN CHEM BIOL, V5, P535, DOI 10.1016/S1367-5931(00)00240-4; Saito K, 2013, PLANT PHYSIOL BIOCH, V72, P21, DOI 10.1016/j.plaphy.2013.02.001; Schuhr Christoph A., 2003, Phytochemistry Reviews, V2, P3, DOI 10.1023/B:PHYT.0000004180.25066.62; Shibuya M, 2010, FEBS LETT, V584, P2258, DOI 10.1016/j.febslet.2010.03.037; Shigyo M, 1996, GENES GENET SYST, V71, P363, DOI 10.1266/ggs.71.363; Shigyo M, 1997, GENES GENET SYST, V72, P149, DOI 10.1266/ggs.72.149; Simon C, 2014, PLANT CELL ENVIRON, V37, P1114, DOI 10.1111/pce.12221; Sobolewska D, 2016, PHYTOCHEM REV, V15, P1, DOI 10.1007/s11101-014-9381-1; SONAWANE PD, 2017, NAT PLANTS, V3; Teshima Y, 2013, J AGR FOOD CHEM, V61, P7440, DOI 10.1021/jf401720q; Upadhyay S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-746; Vincken JP, 2007, PHYTOCHEMISTRY, V68, P275, DOI 10.1016/j.phytochem.2006.10.008; Vu HQ, 2012, GENOME, V55, P797, DOI 10.1139/g2012-065; Yaguchi S, 2008, PLANT CELL PHYSIOL, V49, P730, DOI 10.1093/pcp/pcn048; Yang L, 2013, J PROTEOME RES, V12, P4931, DOI 10.1021/pr400177m	64	40	41	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0181784	10.1371/journal.pone.0181784	http://dx.doi.org/10.1371/journal.pone.0181784			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800607	Green Submitted, gold, Green Published			2022-12-26	WOS:000407431800006
J	Lilly, FR; Culpepper, J; Stuart, M; Steinwachs, D				Lilly, Flavius Robert; Culpepper, Joel; Stuart, Mary; Steinwachs, Donald			Stroke survivors with severe mental illness: Are they at-risk for increased non-psychiatric hospitalizations?	PLOS ONE			English	Article							HEALTH-CARE UTILIZATION; ADMINISTRATIVE DATA; MEDICAL-CARE; VETERANS; READMISSION; COMORBIDITY; PREVALENCE; PEOPLE; SCHIZOPHRENIA; MORTALITY	Background This study examined outcomes for two groups of stroke survivors treated in Veteran Health Administration (VHA) hospitals, those with a severe mental illness (SMI) and those without prior psychiatric diagnoses, to examine risk of non-psychiatric medical hospitalizations over five years after initial stroke. Methods This retrospective cohort study included 523 veterans who survived an initial stroke hospitalization in a VHA medical center during fiscal year 2003. The survivors were followed using administrative data documenting inpatient stroke treatment, patient demographics, disease comorbidities, and VHA hospital admissions. Multivariate Poisson regression was used to examine the relationship between patients with and without SMI diagnosis preceding the stroke and their experience with non-psychiatric medical hospitalizations after the stroke. Results The study included 100 patients with SMI and 423 without SMI. Unadjusted means for pre-stroke non-psychiatric hospitalizations were higher (p = 0.0004) among SMI patients (1.47 +/- 0.51) compared to those without SMI (1.00 +/- 1.33), a difference which persisted through the first year post-stroke (SMI: 2.33 +/- 2.46; No SMI: 1.74 +/- 1.86; p = 0.0004). Number of non-psychiatric hospitalizations were not significantly different between the two groups after adjustment for patient sociodemographic, comorbidity, length of stay and inpatient stroke treatment characteristics. Antithrombotic medications significantly lowered risk (OR = 0.61; 95% CI: 0.49-0.73) for stroke-related readmission within 30 days of discharge. Conclusions No significant differences in medical hospitalizations were present after adjusting for comorbid and sociodemographic characteristics between SMI and non-SMI stroke patients in the five-year follow-up. However, unadjusted results continue to draw attention to disparities, with SMI patients experiencing more non-psychiatric hospitalizations both prior to and up to one year after their initial stroke. Additionally, stroke survivors discharged on antithrombotic medications were at lower risk of re-admission within 30 days suggesting the VHA should continue to focus on effective stroke management irrespective of SMI.	[Lilly, Flavius Robert] Univ Maryland, Grad Sch, Baltimore, MD 21201 USA; [Culpepper, Joel] Vet Affairs Maryland Hlth Care Syst, Baltimore, MD USA; [Stuart, Mary] Univ Maryland Baltimore Cty, Dept Sociol Anthropol & Hlth Adm & Policy, Baltimore, MD 21228 USA; [Steinwachs, Donald] Johns Hopkins Univ, Dept Hlth Policy & Management, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore County; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Lilly, FR (corresponding author), Univ Maryland, Grad Sch, Baltimore, MD 21201 USA.	Flilly@umaryland.edu			VHA	VHA	The study is a subsidiary investigation of the VHA-funded study to translate exercise research into direct patient care delivery for stroke survivors. The parent study, "Translational Research for Task-Oriented Exercise in Chronic Stroke is designed to develop descriptive and comparable data to plan community based demonstration projects using Veterans Affairs administrative databases with the broad goal of improving stroke patient outcomes.	ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Billings J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003352; Blank MB, 2002, PSYCHIATR SERV, V53, P868, DOI 10.1176/appi.ps.53.7.868; Borckardt Jeffrey J, 2011, Qual Manag Health Care, V20, P98, DOI 10.1097/QMH.0b013e3182134af0; Camberg LC, 1997, MED CARE, V35, P756, DOI 10.1097/00005650-199708000-00002; Culpepper WJ, 2006, J REHABIL RES DEV, V43, P17, DOI 10.1682/JRRD.2004.09.0122; Curkendall SM, 2004, J CLIN PSYCHIAT, V65, P715; Daumit GL, 2010, PSYCHIAT RES, V176, P242, DOI 10.1016/j.psychres.2009.01.006; Daumit GL, 2003, J NERV MENT DIS, V191, P799, DOI 10.1097/01.nmd.0000100923.20188.2d; De Hert M, 2011, WORLD PSYCHIATRY, V10, P52, DOI 10.1002/j.2051-5545.2011.tb00014.x; Dossa A., 2011, BIOMED CENTRAL HLTH, V11, P1; Drake RE, 2001, COMPREHENSIVE CARE S, P243; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Epstein AM, 2011, NEW ENGL J MED, V365, P2287, DOI 10.1056/NEJMsa1101942; Fleishacker W.W., 2008, J CLIN PSYCHIAT 0318, pe1; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Halfon P, 2006, MED CARE, V44, P972, DOI 10.1097/01.mlr.0000228002.43688.c2; Hankin CS, 1999, AM J PSYCHIAT, V156, P1924; Hendrie HC, 2013, AM J GERIAT PSYCHIAT, V21, P1267, DOI 10.1016/j.jagp.2013.01.056; Himelhoch S, 2004, AM J PSYCHIAT, V161, P2317, DOI 10.1176/appi.ajp.161.12.2317; Jha A. K., 2009, NEW ENGL J MED, V348, P2218; Jia HG, 2007, STROKE, V38, P355, DOI 10.1161/01.STR.0000254457.38901.fb; Joint Commission, 2008, DIS SPEC CAR CERT PR; Kashner TM, 1998, MED CARE, V36, P1324, DOI 10.1097/00005650-199809000-00005; Kennedy BS, 2005, J NATL MED ASSOC, V97, P699; Kilbourne AM, 2009, PSYCHIAT SERV, V60, P589, DOI 10.1176/appi.ps.60.5.589; Koepsell TD, 2009, PREV MED, V48, P267, DOI 10.1016/j.ypmed.2009.01.008; Lester HE, 2005, BMJ-BRIT MED J, V330, P1122, DOI 10.1136/bmj.38440.418426.8F; Lichtman JH, 2010, STROKE, V41, P2525, DOI 10.1161/STROKEAHA.110.599159; Lichtman JH, 2009, STROKE, V40, P3574, DOI 10.1161/STROKEAHA.109.561472; Lin HC, 2008, SCHIZOPHR RES, V101, P234, DOI 10.1016/j.schres.2007.12.485; Lin HJ, 2011, NEUROLOGY, V76, P438, DOI 10.1212/WNL.0b013e31820a0cd8; Martin MY, 2006, J AGING PHYS ACTIV, V14, P392, DOI 10.1123/japa.14.4.392; Miller DR, 2004, DIABETES CARE, V27, pB10, DOI 10.2337/diacare.27.suppl_2.B10; Montgomery AE, 2013, AM J PUBLIC HEALTH, V103, pS210, DOI 10.2105/AJPH.2013.301398; O'Day B, 2005, PSYCHIATR REHABIL J, V28, P339, DOI 10.2975/28.2005.339.345; Parks J., 2006, MORBIDITY MORTALITY; Peabody JW, 2004, MED CARE, V42, P1066, DOI 10.1097/00005650-200411000-00005; Petersen LA, 2003, HEALTH SERV RES, V38, P41, DOI 10.1111/1475-6773.00104; Phelan M, 2001, BRIT MED J, V322, P443, DOI 10.1136/bmj.322.7284.443; Post EP, 2010, FAM SYST HEALTH, V28, P83, DOI 10.1037/a0020130; QUERI, QUAL ENH RES IN STRO; Saha S, 2007, ARCH GEN PSYCHIAT, V64, P1123, DOI 10.1001/archpsyc.64.10.1123; Saravay SM, 1996, AM J PSYCHIAT, V153, P397; SAS Institute Inc, 2011, BAS SAS 9 3 PROC GUI; Schneider KM, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-82; Stahl S., 2008, STAHLS ESSENTIAL PSY; Sun Y., 2009, VALUE HEALTH, P12; Tirschwell DL, 2002, STROKE, V33, P2465, DOI 10.1161/01.STR.0000032240.28636.BD; Trivedi AN, 2011, MED CARE, V49, P76, DOI 10.1097/MLR.0b013e3181f53575; Viron MJ, 2010, PSYCHOSOMATICS, V51, P458, DOI 10.1176/appi.psy.51.6.458; Zeiss AM, 2008, J CLIN PSYCHOL MED S, V15, P73, DOI 10.1007/s10880-008-9100-4	52	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0182330	10.1371/journal.pone.0182330	http://dx.doi.org/10.1371/journal.pone.0182330			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD3KL	28800605	gold, Green Published, Green Submitted			2022-12-26	WOS:000407431800013
J	Lin, YQ; Zhu, JJ; Wang, Y; Li, Q; Lin, S				Lin, Yaqiu; Zhu, Jiangjiang; Wang, Yong; Li, Qian; Lin, Sen			Identification of differentially expressed genes through RNA sequencing in goats (Capra hircus) at different postnatal stages	PLOS ONE			English	Article							INTRAMUSCULAR FAT; LIPID-METABOLISM; SKELETAL-MUSCLE; PATTERNS; PROTEIN; ALPHA; PDK4	Intramuscular fat (IMF) content and fatty acid composition of longissimus dorsi muscle (LM) change with growth, which partially determines the flavor and nutritional value of goat (Capra hircus) meat. However, unlike cattle, little information is available on the transcriptome- wide changes during different postnatal stages in small ruminants, especially goats. In this study, the sequencing reads of goat LM tissues collected from kid, youth, and adult period were mapped to the goat genome. Results showed that out of total 24 689 Unigenes, 20 435 Unigenes were annotated. Based on expected number of fragments per kilobase of transcript sequence per million base pairs sequenced (FPKM), 111 annotated differentially expressed genes (DEGs) were identified among different postnatal stages, which were subsequently assigned to 16 possible expression patterns by series-cluster analysis. Functional classification by Gene Ontology (GO) analysis was used for selecting the genes showing highest expression related to lipid metabolism. Finally, we identified the node genes for lipid metabolism regulation using co-expression analysis. In conclusion, these data may uncover candidate genes having functional roles in regulation of goat muscle development and lipid metabolism during the various growth stages in goats.	[Lin, Yaqiu; Zhu, Jiangjiang; Wang, Yong; Li, Qian; Lin, Sen] Key Lab Sichuan Prov Qinghai Tibetan Plateau Anim, Chengdu, Sichuan, Peoples R China		Wang, Y (corresponding author), Key Lab Sichuan Prov Qinghai Tibetan Plateau Anim, Chengdu, Sichuan, Peoples R China.	wangyong010101@hotmail.com			Science and Technology Support Program of Sichuan Province [2016NYZ0045]; National Natural Science Foundation of China [31672395, 31601921]; Basic Research Programs of Sichuan Province [2016JY0147]; Animal Science Discipline Program of Southwest University for Nationalities [2014XWD-S0905]	Science and Technology Support Program of Sichuan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Research Programs of Sichuan Province; Animal Science Discipline Program of Southwest University for Nationalities	This work was jointly supported by the 'Science and Technology Support Program of Sichuan Province (2016NYZ0045)', 'National Natural Science Foundation of China (31672395 and 31601921)', 'Basic Research Programs of Sichuan Province (2016JY0147)' and 'Animal Science Discipline Program of Southwest University for Nationalities' (2014XWD-S0905).	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bong JJ, 2012, MEAT SCI, V91, P284, DOI 10.1016/j.meatsci.2012.02.004; Canovas E, 2009, LIVEST SCI, V126, P298, DOI 10.1016/j.livsci.2009.06.005; Cheng HL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000369; De Jager N, 2013, J ANIM SCI, V91, P1112, DOI 10.2527/jas.2012-5409; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Filion C, 2009, J PATHOL, V217, P83, DOI 10.1002/path.2445; Gao WN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091462; Geng RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062704; Guo B, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-35; Guo QQ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-676; Huang Zhi-Guo, 2006, Acta Genetica Sinica, V33, P507, DOI 10.1016/S0379-4172(06)60079-6; Lee KT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016356; Li L, 2013, GENE, V528, P195, DOI 10.1016/j.gene.2013.07.013; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Ma L, 2012, J DAIRY SCI, V95, P3743, DOI 10.3168/jds.2011-5083; Park KG, 2008, HEPATOLOGY, V48, P1477, DOI 10.1002/hep.22496; Prieto C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003911; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Qiao Yong, 2008, Agricultural Sciences in China, V7, P104, DOI 10.1016/S1671-2927(08)60028-0; Ropelle ER, 2009, J PHYSIOL-LONDON, V587, P2069, DOI 10.1113/jphysiol.2008.164202; Sheng XH, 2014, MOL BIOL REP, V41, P1631, DOI 10.1007/s11033-013-3010-8; Shi HB, 2015, FUNCT INTEGR GENOMIC, V15, P309, DOI 10.1007/s10142-014-0420-1; Shi HB, 2013, PPAR RES, V2013, DOI 10.1155/2013/310948; Sugden MC, 2000, BIOCHEM J, V346, P651, DOI 10.1042/0264-6021:3460651; Sugden MC, 2003, OBES RES, V11, P167, DOI 10.1038/oby.2003.26; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040084, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0036663, 10.1371/journal.pone.0045380, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0045036]; Wang YH, 2009, J ANIM SCI, V87, P119, DOI 10.2527/jas.2008-1082; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Wenzl K, 2015, CURR DRUG TARGETS, V16, P38, DOI 10.2174/1389450115666141120112818; Xu WD, 2013, BIOINORG CHEM APPL, V2013, DOI 10.1155/2013/959764; Ye YQ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/724274; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Yu K, 2015, J CELL BIOCHEM, V116, P192, DOI 10.1002/jcb.24958; Zhang C, 2015, ANIMAL, V9, P1073, DOI 10.1017/S1751731115000324; Zhang L, 2015, SCI REP-UK, V5, DOI 10.1038/srep14244; Zhao SM, 2010, LIVEST SCI, V128, P101, DOI 10.1016/j.livsci.2009.11.005; Zhao SM, 2009, LIPIDS, V44, P1029, DOI 10.1007/s11745-009-3356-9; Zhu WZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121280	41	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0182602	10.1371/journal.pone.0182602	http://dx.doi.org/10.1371/journal.pone.0182602			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800357	Green Published, gold, Green Submitted			2022-12-26	WOS:000407431800024
J	Abdelhak, A; Hottenrott, T; Mayer, C; Hintereder, G; Zettl, UK; Stich, O; Tumani, H				Abdelhak, Ahmed; Hottenrott, Tilman; Mayer, Christoph; Hintereder, Gudrun; Zettl, Uwe K.; Stich, Oliver; Tumani, Hayrettin			CSF profile in primary progressive multiple sclerosis: Re-exploring the basics	PLOS ONE			English	Article							ANTIVIRAL IMMUNE-RESPONSE; CENTRAL NERVOUS-SYSTEM; CEREBROSPINAL-FLUID; DIAGNOSTIC-CRITERIA; INTRATHECAL SYNTHESIS; OLIGOCLONAL BANDS; IGG SYNTHESIS; DOUBLE-BLIND; MULTICENTER; MARKER	Objective The aim of this study was to report the basic cerebrospinal fluid (CSF) profile in patients with primary progressive multiple sclerosis (PPMS). Methods The results of CSF analysis from 254 patients with PPMS were collected at four university hospitals in Germany. Routine CSF parameters and different indices of intrathecal immunoglobulin synthesis were evaluated. We assessed possible correlations between the various CSF parameters and the expanded disability status scale (EDSS) both at the time of lumbar puncture and during the course of the disease. Results The median cell count and albumin concentration in the CSF did not deviate from normal values. The CSF-serum albumin-quotient (Q(ALB)) was elevated in 29.6% of the patients, while intrathecal immunoglobulin G (IgG) oligoclonal bands (OCBs) were detected in 91.1% of the patients. CSF-lactate levels as well as local IgM- and IgA-synthesis were correlated with the yearly disease progression rate, as assessed by EDSS. Conclusion We present the results of the hitherto largest and most detailed CSF biomarker profile in a cohort of 254 patients with PPMS. As reported previously, OCBs are the most sensitive marker for intrathecal IgG synthesis. CSF-lactate concentrations are positively correlated with the progression rate, which might suggest that mitochondrial dysfunction plays a relevant role in PPMS. The negative correlation between intrathecally produced IgM and IgA and disease progression may indicate their hitherto unexplored protective role.	[Abdelhak, Ahmed; Tumani, Hayrettin] Ulm Univ, Dept Neurol, Ulm, Germany; [Hottenrott, Tilman; Stich, Oliver] Univ Hosp Freiburg, Dept Neurol, Freiburg, Germany; [Mayer, Christoph; Hintereder, Gudrun] Univ Hosp Frankfurt, Dept Neurol, Frankfurt, Germany; [Zettl, Uwe K.] Univ Hosp Rostock, Dept Neurol, Neuroimmunol Sect, Rostock, Germany	Ulm University; University of Freiburg; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Rostock	Tumani, H (corresponding author), Ulm Univ, Dept Neurol, Ulm, Germany.	hayrettin.tumani@uni-ulm.de	Abdelhak, Ahmed/AAN-2957-2020; Abdelhak, Ahmed/ABA-2764-2020	Abdelhak, Ahmed/0000-0001-9731-4169; Abdelhak, Ahmed/0000-0001-9731-4169				Aasly J, 1997, ACTA NEUROL SCAND, V95, P9, DOI 10.1111/j.1600-0404.1997.tb00060.x; Albanese M, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0502-1; Arnorini AM, 2014, BBA-MOL BASIS DIS, V1842, P1137, DOI 10.1016/j.bbadis.2014.04.005; Brettschneider J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007638; Christensen JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057820; Cottrell DA, 1999, BRAIN, V122, P625, DOI 10.1093/brain/122.4.625; FORSBERG P, 1984, SCAND J CLIN LAB INV, V44, P7, DOI 10.3109/00365518409083780; Freedman MS, 2005, ARCH NEUROL-CHICAGO, V62, P865, DOI 10.1001/archneur.62.6.865; Hawker K, 2009, ANN NEUROL, V66, P460, DOI 10.1002/ana.21867; Helwick C., 2016, OCRELIZUMAB BENEFIT; Hottenrott T, 2017, FLUIDS BARRIERS CNS, V14, DOI 10.1186/s12987-016-0049-7; Hottenrott T, 2015, FLUIDS BARRIERS CNS, V12, DOI 10.1186/s12987-015-0024-8; Izquierdo G, 2002, ACTA NEUROL SCAND, V105, P158, DOI 10.1034/j.1600-0404.2002.1o009.x; Jarius S, 2008, J NEUROL NEUROSUR PS, V79, P1134, DOI 10.1136/jnnp.2007.133330; Jarius S, 2017, J NEUROL, V264, P453, DOI 10.1007/s00415-016-8360-4; Jarius S, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0718-0; Jarius S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-14; Jarius S, 2009, J NEUROL SCI, V280, P98, DOI 10.1016/j.jns.2008.08.002; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Leen WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042745; LINK H, 1977, SCAND J CLIN LAB INV, V37, P397, DOI 10.3109/00365517709091498; LOLLI F, 1989, ACTA NEUROL SCAND, V80, P238, DOI 10.1111/j.1600-0404.1989.tb03869.x; Lourenco P, 2013, MULT SCLER J, V19, P577, DOI 10.1177/1352458512459684; Lunding J, 2000, ACTA NEUROL SCAND, V102, P322, DOI 10.1034/j.1600-0404.2000.102005322.x; Lutz NW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000595; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; MCLEAN BN, 1990, BRAIN, V113, P1269, DOI 10.1093/brain/113.5.1269; Meinl E, 2008, J NEUROL SCI, V274, P42, DOI 10.1016/j.jns.2008.06.032; Meyer-Moock S, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-58; Miller DH, 2007, LANCET NEUROL, V6, P903, DOI 10.1016/S1474-4422(07)70243-0; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; REBOUL J, 1995, EUR J NEUROL, V2, P429, DOI 10.1111/j.1468-1331.1995.tb00152.x; Regenold WT, 2008, J NEUROL SCI, V275, P106, DOI 10.1016/j.jns.2008.07.032; REIBER H, 1994, J NEUROL SCI, V122, P189, DOI 10.1016/0022-510X(94)90298-4; Reiber H, 1998, MULT SCLER, V4, P111, DOI 10.1177/135245859800400304; Reiber H, 2001, CLIN CHEM LAB MED, V39, P324, DOI 10.1515/CCLM.2001.051; Reiber H, 2011, LIQUORDIAGNOSTIK, P143, DOI [10.1007/978-3-642-16920-5_6., DOI 10.1007/978-3-642-16920-5_6]; Simone IL, 1996, J NEUROL SCI, V144, P182, DOI 10.1016/S0022-510X(96)00224-9; Teunissen CE, 2009, NEUROLOGY, V73, P1914, DOI 10.1212/WNL.0b013e3181c47cc2; Thompson AJ, 1997, BRAIN, V120, P1085, DOI 10.1093/brain/120.6.1085; Thompson AJ, 2000, ANN NEUROL, V47, P831; Tourbah A, 2016, MULTIPLE SCLEROSIS; TOURTELLOTTE WW, 1978, NEUROLOGY, V28, P76, DOI 10.1212/WNL.28.9_Part_2.76; Trapp BD, 2009, LANCET NEUROL, V8, P280, DOI 10.1016/S1474-4422(09)70043-2; Ukkonen M, 2007, MULT SCLER, V13, P701, DOI 10.1177/1352458506075378; Villar LM, 2005, ARCH NEUROL-CHICAGO, V62, P574, DOI 10.1001/archneur.62.4.574; Warrington AE, 2010, J CLIN IMMUNOL, V30, pS50, DOI 10.1007/s10875-010-9406-5; Wolinsky JS, 2007, ANN NEUROL, V61, P14, DOI 10.1002/ana.21079; WOOTLA B, 2016, J NEUROINFLAMM, V13, DOI DOI 10.1186/S12974-; Zettl UK LR, 2003, KLINISCHE LIQUORDIAG	51	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182647	10.1371/journal.pone.0182647	http://dx.doi.org/10.1371/journal.pone.0182647			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797088	Green Published, gold, Green Submitted			2022-12-26	WOS:000407396200074
J	Ilie, M; Khambata-Ford, S; Copie-Bergman, C; Huang, LK; Juco, J; Hofman, V; Hofman, P				Ilie, Marius; Khambata-Ford, Shirin; Copie-Bergman, Christiane; Huang, Lingkang; Juco, Jonathan; Hofman, Veronique; Hofman, Paul			Use of the 22C3 anti-PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platforms	PLOS ONE			English	Article							CELL LUNG-CANCER; PEMBROLIZUMAB; HETEROGENEITY	Background For non-small cell lung cancer (NSCLC), treatment with pembrolizumab is limited to patients with tumours expressing PD-L1 assessed by immunohistochemistry (IHC) using the PD-L1 IHC 22C3 pharmDx (Dako, Inc.) companion diagnostic test, on the Dako Auto-stainer Link 48 (ASL48) platform. Optimised protocols are urgently needed for use of the 22C3 antibody concentrate to test PD-L1 expression on more widely available IHC autostainers. Methods We evaluated PD-L1 expression using the 22C3 antibody concentrate in the three main commercially available autostainers Dako ASL48, BenchMark ULTRA (Ventana Medical Systems, Inc.), and Bond-III (Leica Biosystems) and compared the staining results with the PD-L1 IHC 22C3 pharmDx kit on the Dako ASL48 platform. Several technical conditions for laboratory-developed tests (LDTs) were evaluated in tonsil specimens and a training set of three NSCLC samples. Optimised protocols were then validated in 120 NSCLC specimens. Results Optimised protocols were obtained on both the VENTANA BenchMark ULTRA and Dako ASL48 platforms. Significant expression of PD-L1 was obtained on tissue controls with the Leica Bond-III autostainer when high concentrations of the 22C3 antibody were used. It therefore was not tested on the 120 NSCLC specimens. An almost 100% concordance rate for dichotomized tumour proportion score (TPS) results was observed between TPS ratings using the 22C3 antibody concentrate on the Dako ASL48 and VENTANA BenchMark ULTRA platforms relative to the PD-L1 IHC 22C3 pharmDx kit on the Dako ASL48 platform. Interpathologist agreement was high on both LDTs and the PD-L1 IHC 22C3 pharmDx kit on the Dako ASL48 platform. Conclusion Availability of standardized protocols for determining PD-L1 expression using the 22C3 antibody concentrate on the widely available Dako ASL48 and VENTANA BenchMark ULTRA IHC platforms will expand the number of laboratories able to determine eligibility of patients with NSCLC for treatment with pembrolizumab in a reliable and concordant manner.	[Ilie, Marius; Hofman, Veronique; Hofman, Paul] Univ Cote Azur, Univ Hosp Federat OncoAge, Lab Clin & Expt Pathol, Hop Pasteur, Nice, France; [Ilie, Marius; Hofman, Veronique; Hofman, Paul] Univ Cote Azur, Univ Hosp Federat OncoAge, Hosp Related Biobank, Hop Pasteur, Nice, France; [Ilie, Marius; Hofman, Veronique; Hofman, Paul] Univ Cote Azur, Univ Hosp Federat OncoAge, Hop Pasteur, CNRS,INSERM,IRCAN, Nice, France; [Khambata-Ford, Shirin; Huang, Lingkang; Juco, Jonathan] Merck & Co Inc, Kenilworth, NJ USA; [Copie-Bergman, Christiane] Hop Henri Mondor, AP HP, Grp Henri Mondor Albert Chenevier, Dept Pathol, Creteil, France; [Copie-Bergman, Christiane] Univ Paris Est, Fac Med, Creteil, France; [Copie-Bergman, Christiane] Hop Henri Mondor, INSERM, Unite U955, Creteil, France	CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Merck & Company; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Hofman, P (corresponding author), Univ Cote Azur, Univ Hosp Federat OncoAge, Lab Clin & Expt Pathol, Hop Pasteur, Nice, France.; Hofman, P (corresponding author), Univ Cote Azur, Univ Hosp Federat OncoAge, Hosp Related Biobank, Hop Pasteur, Nice, France.; Hofman, P (corresponding author), Univ Cote Azur, Univ Hosp Federat OncoAge, Hop Pasteur, CNRS,INSERM,IRCAN, Nice, France.	hofman.p@chu-nice.fr	Ilié, Marius/M-7964-2019; Hofman, Paul/P-7654-2018	Ilié, Marius/0000-0002-2014-1236; Hofman, Paul/0000-0003-0431-9353; copie bergman, christiane/0000-0001-5408-894X; veronique, HOFMAN/0000-0003-0943-1627	Merck & Co., Inc., Kenilworth, NJ, USA; Merck & Co., Inc., Kenilworth, New Jersey, USA	Merck & Co., Inc., Kenilworth, NJ, USA; Merck & Co., Inc., Kenilworth, New Jersey, USA	This study was sponsored by Merck & Co., Inc., Kenilworth, NJ, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Robin Mogg and Jared Lunceford for their statistical expertise and Marame Hamila for her technical assistance. Editorial assistance was provided by Melanie Sweetlove, MSc, and Jennifer M. Kulak, PhD, of the ApotheCom oncology team (Yardley, Pennsylvania, USA) and was funded by Merck & Co., Inc., Kenilworth, New Jersey, USA.	[Anonymous], 2017, KEYTR PACK INS; [Anonymous], 2017, KEYTR SUMM PROD CHAR; Armand P, 2015, BLOOD, V125, P3393, DOI 10.1182/blood-2015-02-567453; Dako North American Inc, 2015, PD L1 IHC 22C3 PHARM; Dolled-Filhart M, 2016, ARCH PATHOL LAB MED, V140, P1243, DOI 10.5858/arpa.2015-0542-OA; FARGION S, 1986, CANCER RES, V46, P2633; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7; Ilie M, 2016, VIRCHOWS ARCH, V468, P511, DOI 10.1007/s00428-016-1910-4; McLaughlin J, 2016, JAMA ONCOL, V2, P46, DOI 10.1001/jamaoncol.2015.3638; Neuman T, 2016, J THORAC ONCOL, V11, P1863, DOI 10.1016/j.jtho.2016.08.146; Rehman JA, 2017, MODERN PATHOL, V30, P340, DOI 10.1038/modpathol.2016.186; Roach C, 2016, APPL IMMUNOHISTO M M, V24, P392, DOI 10.1097/PAI.0000000000000408; Roge R, 2017, APPL IMMUNOHISTO M M, V25, P381, DOI 10.1097/PAI.0000000000000534; Scarpace Sarah L, 2015, Drugs Context, V4, P212289, DOI 10.7573/dic.212289; Scheel AH, 2016, MODERN PATHOL, V29, P1165, DOI 10.1038/modpathol.2016.117	16	60	60	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0183023	10.1371/journal.pone.0183023	http://dx.doi.org/10.1371/journal.pone.0183023			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797130	Green Submitted, gold, Green Published			2022-12-26	WOS:000407396200143
J	Jiao, YS; Ding, LY; Chu, M; Wang, TS; Kang, JR; Zhao, XF; Li, HH; Chen, X; Gao, ZR; Gao, LK; Wang, YD				Jiao, Yunshen; Ding, Lingyu; Chu, Ming; Wang, Tieshan; Kang, Jiarui; Zhao, Xiaofan; Li, Huanhuan; Chen, Xi; Gao, Zirui; Gao, Likai; Wang, Yuedan			Effects of cancer-testis antigen, TFDP3, on cell cycle regulation and its mechanism in L-02 and HepG2 cell lines in vitro	PLOS ONE			English	Article							E2F1; APOPTOSIS; DP-1	TFDP3, also be known as HCA661, was one of the cancer-testis antigens, which only expressed in human tissues. The recent researches about TFDP3 mostly focused on its ability to control the drug resistance and apoptosis of tumor cells. However, the role of TFDP3 in the progress of the cell cycle is rarely involved. In this study, we examined the expression of TFDP3 in human liver tissues firstly. After that, we detect the expression of TFDP3 at the RNA level and protein level in L-02 cell line and HepG2 cell line, and the location of TFDP3 was defined by immunofluorescence technique. Furthermore, we synchronized the cells to G1 phase, S phase and G2 phase, and arrested cell mitosis. The localization of TFDP3 and co-localization with E2F1 molecules in different phases of hepatocyte lines. Finally, TFDP3 gene knockout was performed on L-02 and HepG2 cell lines, and detected the new cell cycles by flow cytometry. The result showed that the expression of TFDP3 molecule is negative in normal liver tissue, but positive in immortalized human hepatocyte cell line, and the expression level is lower than in hepatocellular carcinoma cell line. The expression level of TFDP3 was in the dynamic change of L-02 and HepG2 cell lines, and was related to the phase transition. TFDP3 can bind to E2F1 molecule to form E2F/TFDP3 complex; and the localizations of TFDP3 and E2F1 molecules and the co-localization were different in different phases of cell cycle in the nucleus and cytoplasm, which indicated that the E2F/TFDP3 complex involved in the process of regulating the cell cycle. By knocking down the TFDP3 expression level in L-02 and HepG2 cell lines, the cell cycle would be arrested in S phase, which confirmed that TFDP3 can be a potential target for tumor therapy.	[Jiao, Yunshen; Ding, Lingyu; Chu, Ming; Zhao, Xiaofan; Li, Huanhuan; Chen, Xi; Gao, Zirui; Gao, Likai; Wang, Yuedan] Peking Univ, Sch Basic Med Sci, Dept Immunol, Beijing, Peoples R China; [Jiao, Yunshen; Ding, Lingyu; Chu, Ming; Li, Huanhuan; Wang, Yuedan] Minist Hlth, Key Lab Med Immunol, Beijing, Peoples R China; [Wang, Tieshan] Beijing Univ Chinese Med, Beijing Res Inst Chinese Med, Beijing, Peoples R China; [Kang, Jiarui] Chinese Peoples Liberat Army, Affiliated Hosp 1, Gen Hosp, Dept Pathol, Beijing, Peoples R China	Peking University; Beijing University of Chinese Medicine; Chinese People's Liberation Army General Hospital	Chu, M; Wang, YD (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Immunol, Beijing, Peoples R China.; Chu, M; Wang, YD (corresponding author), Minist Hlth, Key Lab Med Immunol, Beijing, Peoples R China.	famous@bjmu.edu.cn; wangyuedan@bjmu.edu.cn			Natural Science Foundation of Beijing Municipality [7162099, 7174316]; Science and Technology Program of Shenzhen [JCYJ20150403110829615]; National Natural Science Foundation of China [81603119]; Leading Academic Discipline Project of Beijing Education Bureau [BMU20110254]; Fostering Talents in Basic Science of the National Natural Science Foundation of China [J1030831/J0108]	Natural Science Foundation of Beijing Municipality(Beijing Natural Science Foundation); Science and Technology Program of Shenzhen; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Leading Academic Discipline Project of Beijing Education Bureau; Fostering Talents in Basic Science of the National Natural Science Foundation of China	This work was supported by Natural Science Foundation of Beijing Municipality (7162099, 7174316) (http://www.bjnsf.org/), Science and Technology Program of Shenzhen (JCYJ20150403110829615) (http://www.szsti.gov.cn), National Natural Science Foundation of China (81603119) (http://www.nsfc.gov.cn/), Leading Academic Discipline Project of Beijing Education Bureau (BMU20110254) (http://www.bjedu.gov.cn/) and Fostering Talents in Basic Science of the National Natural Science Foundation of China (J1030831/J0108) (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; CHU M, 2016, MOLECULES, V21; Chu M, 2015, CELLULAR MOL IMMUNOL; Chu M, 2017, ONCOTARGET, V8, P1405, DOI 10.18632/oncotarget.13630; Chu M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/263630; Chu M, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-89; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Herlihy AE, 2017, GENES-BASEL, V8, DOI 10.3390/genes8030092; Ingram L, 2011, CELL DEATH DIFFER, V18, P122, DOI 10.1038/cdd.2010.70; Ishida H, 2005, J BIOL CHEM, V280, P24642, DOI 10.1074/jbc.M500189200; James KM, 2013, INTERACTION HUMAN AD; Julian LM, 2016, CELL DEATH DIFFER, V23, P565, DOI 10.1038/cdd.2015.36; Ma YY, 2014, GENE, V537, P253, DOI 10.1016/j.gene.2013.12.051; Munro S, 2014, ONCOGENE, V33, P3594, DOI 10.1038/onc.2013.316; Putzer BM, 2013, TRENDS MOL MED, V19, P89, DOI 10.1016/j.molmed.2012.10.009; Qiao H, 2007, J BIOL CHEM, V282, P454, DOI 10.1074/jbc.M606169200; Singh S, 2010, BBA-GENE REGUL MECH, V1799, P788, DOI 10.1016/j.bbagrm.2010.07.004; Sun HX, 2013, HEPATOLOGY, V57, P1088, DOI 10.1002/hep.26188; Tan HT, 2009, FEBS J, V276, P6880, DOI 10.1111/j.1742-4658.2009.07396.x; Tian C, 2007, BIOCHEM BIOPH RES CO, V361, P20, DOI 10.1016/j.bbrc.2007.06.128; Wadhwa R, 2016, HEALTHY AGEING LONG, V4, P145, DOI 10.1007/978-3-319-26239-0_9; Yamada R, 2013, TISSUE ANTIGENS, V81, P428, DOI 10.1111/tan.12113; Yin KL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170573; Zhan L, 2016, TUMOR BIOL, V37, P2823, DOI 10.1007/s13277-015-4770-7	25	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182781	10.1371/journal.pone.0182781	http://dx.doi.org/10.1371/journal.pone.0182781			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797103	gold, Green Submitted, Green Published			2022-12-26	WOS:000407396200095
J	Por, ED; Sandoval, ML; Thomas-Benson, C; Burke, TA; Brackley, AD; Jeske, NA; Cleland, JM; Lund, BJ				Por, Elaine D.; Sandoval, Melody L.; Thomas-Benson, Chiquita; Burke, Teresa A.; Brackley, Allison Doyle; Jeske, Nathaniel A.; Cleland, Jeffery M.; Lund, Brian J.			Repeat low-level blast exposure increases transient receptor potential vanilloid 1 (TRPV1) and endothelin-1 (ET-1) expression in the trigeminal ganglion	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; PRIMARY AFFERENT NEURONS; INDUCED OCULAR TRAUMA; GENE-RELATED PEPTIDE; PAIN-LIKE BEHAVIOR; THERMAL HYPERALGESIA; PROSTATE-CANCER; PROTEIN-KINASE; A-RECEPTOR; CA2+-DEPENDENT DESENSITIZATION	Blast-associated sensory and cognitive trauma sustained by military service members is an area of extensively studied research. Recent studies in our laboratory have revealed that low-level blast exposure increased expression of transient receptor potential vanilloid 1 (TRPV1) and endothelin-1 (ET-1), proteins well characterized for their role in mediating pain transmission, in the cornea. Determining the functional consequences of these alterations in protein expression is critical to understanding blast-related sensory trauma. Thus, the purpose of this study was to examine TRPV1 and ET-1 expression in ocular associated sensory tissues following primary and tertiary blast. A rodent model of blast injury was used in which anesthetized animals, unrestrained or restrained, received a single or repeat blast (73.8 +/- 5.5 kPa) from a compressed air shock tube once or daily for five consecutive days, respectively. Behavioral and functional analyses were conducted to assess blast effects on nocifensive behavior and TRPV1 activity. Immunohistochemistry and Western Blot were also performed with trigeminal ganglia (TG) to determine TRPV1, ET-1 and glial fibrillary associated protein (GFAP) expression following blast. Increased TRPV1, ET-1 and GFAP were detected in the TG of animals exposed to repeat blast. Increased nocifensive responses were also observed in animals exposed to repeat, tertiary blast as compared to single blast and control. Moreover, decreased TRPV1 desensitization was observed in TG neurons exposed to repeat blast. Repeat, tertiary blast resulted in increased TRPV1, ET-1 and GFAP expression in the TG, enhanced nociception and decreased TRPV1 desensitization.	[Por, Elaine D.; Sandoval, Melody L.; Thomas-Benson, Chiquita; Burke, Teresa A.; Cleland, Jeffery M.; Lund, Brian J.] US Army Inst Surg Res, Ocular Trauma, Houston, TX 78234 USA; [Brackley, Allison Doyle; Jeske, Nathaniel A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Jeske, Nathaniel A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Oral & Maxillofacial Surg, San Antonio, TX 78229 USA; [Jeske, Nathaniel A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA	United States Department of Defense; United States Army; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Por, ED (corresponding author), US Army Inst Surg Res, Ocular Trauma, Houston, TX 78234 USA.	elaine.d.por.mil@mail.mil		Por, Elaine/0000-0001-8025-5713; Brackley, Allison/0000-0002-9552-3159	U.S. Army Military Operational Medicine Research Program (MOMRP); Clinical Rehabilitative Medicine Research Program (CRMRP); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F31DE025551] Funding Source: NIH RePORTER	U.S. Army Military Operational Medicine Research Program (MOMRP); Clinical Rehabilitative Medicine Research Program (CRMRP); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by U.S. Army Military Operational Medicine Research Program (MOMRP) and Clinical Rehabilitative Medicine Research Program (CRMRP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the U.S. Army Military Operational Medicine Research Program (MOMRP) and the Clinical Rehabilitative Medicine Research Program (CRMRP). We would like to thank Josianne Babineaux and Shenouda Zarif for expert technical assistance and Andre Akers and Peter Edsall for assistance with illustrations, ocular imaging and operation of the USAISR shock tube.	Amaya F, 2004, EUR J NEUROSCI, V20, P2303, DOI 10.1111/j.1460-9568.2004.03701.x; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bates BD, 2010, PAIN, V149, P522, DOI 10.1016/j.pain.2010.03.024; Cady RJ, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-94; Capo-Aponte JE, 2015, J REHABIL RES DEV, V52, P273, DOI 10.1682/JRRD.2014.09.0204; Carr W, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00049; Chichorro JG, 2009, NEUROPEPTIDES, V43, P133, DOI 10.1016/j.npep.2008.12.001; Chichorro JG, 2010, BRAIN RES, V1345, P73, DOI 10.1016/j.brainres.2010.04.075; Choi JH, 2015, CLIN EXP OPHTHALMOL, V43, P239, DOI 10.1111/ceo.12407; Clark ME, 2009, PAIN MED, V10, P447, DOI 10.1111/j.1526-4637.2009.00590.x; Cornelison LE, 2016, NEUROSCIENCE, V339, P491, DOI 10.1016/j.neuroscience.2016.10.013; Czikora A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078184; DAHLOF B, 1990, J HYPERTENS, V8, P811, DOI 10.1097/00004872-199009000-00004; Davar G, 1998, NEUROREPORT, V9, P2279, DOI 10.1097/00001756-199807130-00025; Del Fiacco M, 2015, J NEUROL NEUROSUR PS, V86, P393, DOI 10.1136/jnnp-2014-308813; Digre KB, 2012, J NEURO-OPHTHALMOL, V32, P68, DOI 10.1097/WNO.0b013e3182474548; Farazifard R, 2005, BRAIN RES PROTOC, V16, P44, DOI 10.1016/j.brainresprot.2005.10.003; FERREIRA SH, 1989, J CARDIOVASC PHARM, V13, pS220, DOI 10.1097/00005344-198900135-00065; French LM, 2010, ANN NY ACAD SCI, V1208, P38, DOI 10.1111/j.1749-6632.2010.05696.x; Garami A, 2010, J NEUROSCI, V30, P1435, DOI 10.1523/JNEUROSCI.5150-09.2010; Gokin AP, 2001, J NEUROSCI, V21, P5358, DOI 10.1523/JNEUROSCI.21-14-05358.2001; Guo W, 2007, J NEUROSCI, V27, P6006, DOI 10.1523/JNEUROSCI.0176-07.2007; Jeske NA, 2008, PAIN, V138, P604, DOI 10.1016/j.pain.2008.02.022; Ji RR, 2001, NEUROBIOL DIS, V8, P1, DOI 10.1006/nbdi.2000.0360; Ji RR, 2013, PAIN, V154, pS10, DOI 10.1016/j.pain.2013.06.022; Karai L, 2004, J CLIN INVEST, V113, P1344, DOI 10.1172/JCI200420449; Kawamata T, 2008, NEUROSCIENCE, V154, P1067, DOI 10.1016/j.neuroscience.2008.04.010; Kawamata T, 2009, NEUROREPORT, V20, P233, DOI 10.1097/WNR.0b013e32831befa5; Knotkova H, 2008, CLIN J PAIN, V24, P142, DOI 10.1097/AJP.0b013e318158ed9e; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Kopetz ES, 2002, INVEST NEW DRUG, V20, P173, DOI 10.1023/A:1015630513908; Lassiter LK, 2003, SEMIN ONCOL, V30, P678, DOI 10.1016/S0093-7754(03)00353-1; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Magone MT, 2014, J REHABIL RES DEV, V51, P71, DOI 10.1682/JRRD.2013.01.0008; Marfurt CF, 2010, EXP EYE RES, V90, P478, DOI 10.1016/j.exer.2009.12.010; Mathews ZR, 2015, J EMERG MED, V49, P573, DOI 10.1016/j.jemermed.2015.03.013; Menendez L, 2003, N-S ARCH PHARMACOL, V367, P28, DOI 10.1007/s00210-002-0655-6; Mergler S, 2014, OPHTHALMIC RES, V52, P151, DOI 10.1159/000365334; Mohapatra DP, 2005, J BIOL CHEM, V280, P13424, DOI 10.1074/jbc.M410917200; Motta EM, 2009, NEUROSCI LETT, V457, P146, DOI 10.1016/j.neulet.2009.03.055; Nelson J, 2003, NAT REV CANCER, V3, P110, DOI 10.1038/nrc990; Nelson JB, 2003, J UROLOGY, V170, pS65, DOI 10.1097/01.ju.0000096372.07687.86; Okamoto K, 2009, NEUROSCIENCE, V160, P858, DOI 10.1016/j.neuroscience.2009.03.003; Patil VK, 2011, HEADACHE, V51, P1112, DOI 10.1111/j.1526-4610.2011.01946.x; Plant TD, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-35; Plant TD, 2006, EXP BIOL MED, V231, P1161; Por ED, 2016, CURR EYE RES, V41, P1294, DOI 10.3109/02713683.2015.1122812; Raffa RB, 1996, J PHARMACOL EXP THER, V278, P1; Rigoni M, 2003, BRIT J PHARMACOL, V138, P977, DOI 10.1038/sj.bjp.0705110; Romanovsky AA, 2009, PHARMACOL REV, V61, P228, DOI 10.1124/pr.109.001263; Sanz-Salvador L, 2012, J BIOL CHEM, V287, P19462, DOI 10.1074/jbc.M111.289751; Schicho R, 2005, BRAIN RES, V1039, P108, DOI 10.1016/j.brainres.2005.01.050; Schlereth T, 2016, NEUROPEPTIDES, V59, P57, DOI 10.1016/j.npep.2016.06.001; Schmidt BL, 2007, EUR J PAIN, V11, P406, DOI 10.1016/j.ejpain.2006.05.007; Schnizler K, 2008, J NEUROSCI, V28, P4904, DOI 10.1523/JNEUROSCI.0233-08.2008; Silberstein SD, 2015, J NEUROL NEUROSUR PS, V86, P361, DOI 10.1136/jnnp-2014-309295; St Onge Paul, 2011, US Army Med Dep J, P97; Stratton KJ, 2014, J REHABIL RES DEV, V51, P1189, DOI 10.1682/JRRD.2014.04.0111; Stratton KJ, 2014, J PAIN, V15, P1023, DOI 10.1016/j.jpain.2014.07.002; Takeda M, 2007, PAIN, V129, P155, DOI 10.1016/j.pain.2006.10.007; Tang HB, 2004, EUR J PHARMACOL, V498, P37, DOI 10.1016/j.ejphar.2004.07.076; Wang HCH, 2014, MIL MED, V179, P34, DOI 10.7205/MILMED-D-13-00504; Weichel ED, 2008, CURR OPIN OPHTHALMOL, V19, P519, DOI 10.1097/ICU.0b013e3283140e98; Yamamoto H, 2006, NEUROSCIENCE, V137, P949, DOI 10.1016/j.neuroscience.2005.09.036; Yamamoto T, 2013, J DENT RES, V92, P335, DOI 10.1177/0022034513478428; Yang YX, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.340.5470; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893; Zhang XM, 2008, NEURON, V59, P450, DOI 10.1016/j.neuron.2008.05.015	68	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182102	10.1371/journal.pone.0182102	http://dx.doi.org/10.1371/journal.pone.0182102			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797041	Green Published, Green Submitted, gold			2022-12-26	WOS:000407396200030
J	Adams, DJ; Nemkov, TG; Mayer, JP; Old, WM; Stowell, MHB				Adams, Daniel J.; Nemkov, Travis G.; Mayer, John P.; Old, William M.; Stowell, Michael H. B.			Identification of the primary peptide contaminant that inhibits fibrillation and toxicity in synthetic amyloid-beta 42	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; AMYLOID-BETA; OLIGOMERIZATION; NEUROTOXICITY; THERAPEUTICS; HYPOTHESIS; PROTEINS	Understanding the pathophysiology of Alzheimer disease has relied upon the use of amyloid peptides from a variety of sources, but most predominantly synthetic peptides produced using t-butyloxycarbonyl (Boc) or 9-fluorenylmethoxycarbonyl (Fmoc) chemistry. These synthetic methods can lead to minor impurities which can have profound effects on the biological activity of amyloid peptides. Here we used a combination of cytotoxicity assays, fibrillation assays and high resolution mass spectrometry (MS) to identify impurities in synthetic amyloid preparations that inhibit both cytotoxicity and aggregation. We identify the A beta 42 Delta 39 species as the major peptide contaminant responsible for limiting both cytotoxicity and fibrillation of the amyloid peptide. In addition, we demonstrate that the presence of this minor impurity inhibits the formation of a stable A beta 42 dimer observable by MS in very pure peptide samples. These results highlight the critical importance of purity and provenance of amyloid peptides in Alzheimer's research in particular, and biological research in general.	[Adams, Daniel J.; Nemkov, Travis G.; Old, William M.; Stowell, Michael H. B.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Nemkov, Travis G.] Univ Colorado, Dept Biochem & Mol Genet, Anschutz Med Campus, Denver, CO 80202 USA; [Mayer, John P.] Novo Nordisk Res Ctr, Indianapolis, IN USA; [Stowell, Michael H. B.] Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Novo Nordisk; University of Colorado System; University of Colorado Boulder	Old, WM; Stowell, MHB (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.; Stowell, MHB (corresponding author), Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA.	william.old@colorado.edu; stowellm@colorado.edu		STOWELL, MICHAEL/0000-0001-7250-1419	NIH EUREKA; HHMI CIA; Corden Pharma Fellowship; NIH [T32 GM065103]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065103] Funding Source: NIH RePORTER	NIH EUREKA; HHMI CIA(Howard Hughes Medical Institute); Corden Pharma Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH EUREKA award (M.H.B.S.), an HHMI CIA award (M.H.B.S.), a Corden Pharma Fellowship (D.J.A.) and a NIH (T32 GM065103)/CU Molecular Biophysics Predoctoral Traineeship (D.J.A.).	[Anonymous], 2011, NATURE NEUROSCIENCE, V14, P399; Finder VH, 2010, J MOL BIOL, V396, P9, DOI 10.1016/j.jmb.2009.12.016; Fonte V, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-61; Gessel MM, 2012, BIOCHEMISTRY-US, V51, P108, DOI 10.1021/bi201520b; Giuffrida ML, 2010, REV NEUROSCIENCE, V21, P83; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Harmeier A, 2009, J NEUROSCI, V29, P7582, DOI 10.1523/JNEUROSCI.1336-09.2009; Hung LW, 2008, J NEUROSCI, V28, P11950, DOI 10.1523/JNEUROSCI.3916-08.2008; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kim S, 2005, P NATL ACAD SCI USA, V102, P14278, DOI 10.1073/pnas.0501234102; Komatsu H, 2010, J BIOL CHEM, V285, P41843, DOI 10.1074/jbc.M110.165068; Li HY, 2011, J MED CHEM, V54, P8451, DOI 10.1021/jm200982p; Masters CL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006262; Reiber DC, 1998, ANAL CHEM, V70, P673, DOI 10.1021/ac971157l; Seeman P, 2011, SYNAPSE, V65, P1289, DOI 10.1002/syn.20957; Tickler AK, 2004, PROTEIN PEPTIDE LETT, V11, P377, DOI 10.2174/0929866043406986; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; YOUNG J D, 1990, Peptide Research, V3, P194	19	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182804	10.1371/journal.pone.0182804	http://dx.doi.org/10.1371/journal.pone.0182804			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28792968	Green Published, Green Submitted, gold			2022-12-26	WOS:000407196700067
J	Annunziata, L; Visciano, P; Stramenga, A; Colagrande, MN; Campana, G; Scortichini, G; Migliorati, G; Compagnone, D				Annunziata, Loredana; Visciano, Pierina; Stramenga, Arianna; Colagrande, Maria Novella; Campana, Guido; Scortichini, Giampiero; Migliorati, Giacomo; Compagnone, Dario			Determination of regulatory ionophore coccidiostat residues in feedstuffs at carry-over levels by liquid chromatography-mass spectrometry	PLOS ONE			English	Article							FEED	In this study samples of feedstuffs were collected from different feed mills and animal farms located in central Italy and analyzed for ionophore coccidiostat residues at carry-over levels by liquid chromatography-mass spectrometry. Since unavoidable cross-contamination of feedstuffs may occur during their production as well as distribution and storage, the collection of samples covered all these different stages. Residues of lasalocid, monensin, salinomycin and maduramicin were detected in 32.4% of samples, both at production and storage level. The maximum content for unavoidable carry-over set by Regulation (EU) No 574/2011 was exceeded in 11.3% of samples. The variability of the results highlighted the different approach of each investigated feed business operator to avoid any cross-contamination in non-target feed. The method developed in this study can be able to detect ionophore coccidiostats at low concentrations consequent to carry-over.	[Annunziata, Loredana; Colagrande, Maria Novella; Campana, Guido; Migliorati, Giacomo] Ist Zooprofilatt Sperimentale Abruzzo & Molise G, Teramo, Italy; [Visciano, Pierina; Compagnone, Dario] Univ Teramo, Fac Biosci & Technol Food Agr & Environm, Teramo, Italy; [Stramenga, Arianna; Scortichini, Giampiero] Ist Zooprofilatt Sperimentale Umbria & Marche, Perugia, Italy	IZS Dell'abruzzo E Del Molise Giuseppe Caporale; University of Teramo; IZS Umbria e Marche	Visciano, P (corresponding author), Univ Teramo, Fac Biosci & Technol Food Agr & Environm, Teramo, Italy.	pvisciano@unite.it	Scortichini, Giampiero/I-2539-2018; Colagrande, Maria Novella/E-7033-2016; Annunziata, Loredana/F-3804-2016	Scortichini, Giampiero/0000-0003-0591-8649; Colagrande, Maria Novella/0000-0001-8760-8729; Visciano, Pierina/0000-0002-3199-5931; Annunziata, Loredana/0000-0003-4813-1109				Caldeira C, 2001, AM J KIDNEY DIS, V38, P1108, DOI 10.1053/ajkd.2001.28618; Cronly M, 2011, ANAL CHIM ACTA, V700, P26, DOI 10.1016/j.aca.2010.11.001; Delahaut P, 2010, FOOD ADDIT CONTAM A, V27, P801, DOI 10.1080/19440040903552408; Dorne JLCM, 2013, TOXICOL APPL PHARM, V270, P196, DOI 10.1016/j.taap.2010.12.014; EURACHEM/CITAC, 2012, QUANTIFYING UNCERTAI; European Commission, 2003, OFF J EUR UNION L; Hansen M, 2009, TRAC-TREND ANAL CHEM, V28, P534, DOI 10.1016/j.trac.2009.02.015; Moretti S, 2013, J AOAC INT, V96, P1245, DOI 10.5740/jaoacint.12-440; Nebot C, 2012, FOOD CONTROL, V27, P29, DOI 10.1016/j.foodcont.2012.02.012; Olejnik M, 2014, FOOD CHEM, V149, P178, DOI 10.1016/j.foodchem.2013.10.091; Omar J, 2015, FOOD ADDIT CONTAM A, V32, P1464, DOI 10.1080/19440049.2015.1075177; Pietruk K, 2015, J PHARMACEUT BIOMED, V112, P50, DOI 10.1016/j.jpba.2015.03.019; Sun PZ, 2013, J CHROMATOGR A, V1312, P10, DOI 10.1016/j.chroma.2013.08.044; Verstraete F, 2013, TOXICOL APPL PHARM, V270, P230, DOI 10.1016/j.taap.2010.09.015; Vincent U, 2011, J PHARMACEUT BIOMED, V54, P526, DOI 10.1016/j.jpba.2010.09.038	15	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182831	10.1371/journal.pone.0182831	http://dx.doi.org/10.1371/journal.pone.0182831			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28792977	Green Published, gold, Green Submitted			2022-12-26	WOS:000407196700070
J	Li, Y; Zheng, J; Li, F; Jin, XT; Xu, C				Li, Yu; Zheng, Ji; Li, Fei; Jin, Xueting; Xu, Chen			Assessment of municipal infrastructure development and its critical influencing factors in urban China: A FA and STIRPAT approach	PLOS ONE			English	Article							SOLID-WASTE MANAGEMENT; GREEN INFRASTRUCTURE; WATER; SYSTEM; SANITATION; CHALLENGES; IMPACT; MODEL	Municipal infrastructure is a fundamental facility for the normal operation and development of an urban city and is of significance for the stable progress of sustainable urbanization around the world, especially in developing countries. Based on the municipal infrastructure data of the prefecture-level cities in China, municipal infrastructure development is assessed comprehensively using a FA (factor analysis) model, and then the stochastic model STIRPAT (stochastic impacts by regression on population, affluence and technology) is examined to investigate key factors that influence municipal infrastructure of cities in various stages of urbanization and economy. This study indicates that the municipal infrastructure development in urban China demonstrates typical characteristics of regional differentiation, in line with the economic development pattern. Municipal infrastructure development in cities is primarily influenced by income, industrialization and investment. For China and similar developing countries under transformation, national public investment remains the primary driving force of economy as well as the key influencing factor of municipal infrastructure. Contribution from urbanization and the relative consumption level, and the tertiary industry is still scanty, which is a crux issue for many developing countries under transformation. With economic growth and the transformation requirements, the influence of the conventional factors such as public investment and industrialization on municipal infrastructure development would be expected to decline, meanwhile, other factors like the consumption and tertiary industry driven model and the innovation society can become key contributors to municipal infrastructure sustainability.	[Li, Yu; Zheng, Ji; Li, Fei; Jin, Xueting; Xu, Chen] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Li, Yu; Zheng, Ji; Li, Fei; Jin, Xueting; Xu, Chen] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, F (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China.; Li, F (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	lifcas@gmail.com	LIU, Yansui/T-6954-2019		State Basic Science Key Project of China [2007FY110300]; National Natural Science Foundation of China [41271186, 41301642, 41271556]	State Basic Science Key Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the State Basic Science Key Project of China (No. 2007FY110300), and the National Natural Science Foundation of China (No. 41271186, 41301642, 41271556). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade C E S, 2016, SUSTAINABILITY, V8, P1; Avritzer A, 2015, ELECTRON NOTES THEOR, V310, P5, DOI 10.1016/j.entcs.2014.12.010; Ben Ammar S, 2015, ENERG ECON, V49, P257, DOI 10.1016/j.eneco.2015.01.021; Bensassi S, 2015, TRANSPORT RES A-POL, V72, P47, DOI 10.1016/j.tra.2014.11.007; Bouabid A, 2015, J ENVIRON MANAGE, V161, P335, DOI 10.1016/j.jenvman.2015.07.012; Brands E, 2014, ENVIRON REV, V22, P346, DOI 10.1139/er-2013-0082; Bray S, 2015, TRANSP RES PROC, V5, P186, DOI 10.1016/j.trpro.2015.01.005; Bulleri F, 2010, J APPL ECOL, V47, P26, DOI 10.1111/j.1365-2664.2009.01751.x; Carr RI, 2000, J CONSTR ENG M ASCE, V126, P105, DOI 10.1061/(ASCE)0733-9364(2000)126:2(105); Chen XP, 2014, SUSTAINABILITY-BASEL, V6, P9268, DOI 10.3390/su6129268; Clark S, 2005, TRANSPORT RES B-METH, V39, P119, DOI 10.1016/j.trb.2003.10.006; Dietz T., 1994, HUM ECOL REV, V1, P277, DOI [10.2307/24706840, DOI 10.2307/24706840]; Dunn S, 2002, INT J HYDROGEN ENERG, V27, P235, DOI 10.1016/S0360-3199(01)00131-8; EHRLICH PR, 1971, SCIENCE, V171, P1212, DOI 10.1126/science.171.3977.1212; ESCOFIER B, 1994, COMPUT STAT DATA AN, V18, P121, DOI 10.1016/0167-9473(94)90135-X; Escofier B., 1998, ANAL FACTORIELLES SI; Forman RTT, 2000, CONSERV BIOL, V14, P31, DOI 10.1046/j.1523-1739.2000.99299.x; Freni G, 2011, WATER RES, V45, P37, DOI 10.1016/j.watres.2010.08.004; Futcher JA, 2013, ENERG POLICY, V53, P218, DOI 10.1016/j.enpol.2012.10.080; Galvis A, 2014, J CLEAN PROD, V66, P599, DOI 10.1016/j.jclepro.2013.10.057; Ghosh S., 2004, International Journal of Project Management, V22, P633, DOI 10.1016/j.ijproman.2004.05.004; Hatt BE, 2004, ENVIRON MANAGE, V34, P112, DOI 10.1007/s00267-004-0221-8; Henriques JJ, 2011, J ENVIRON MANAGE, V92, P214, DOI 10.1016/j.jenvman.2010.09.016; Herva M, 2014, J CLEAN PROD, V70, P183, DOI 10.1016/j.jclepro.2014.02.007; J ohnson J. A., 2014, STAT PRINCIPLES METH; Joardar SD, 1998, HABITAT INT, V22, P327, DOI 10.1016/S0197-3975(98)00002-2; Lin SF, 2009, ENVIRON IMPACT ASSES, V29, P341, DOI 10.1016/j.eiar.2009.01.009; Liu QQ, 2017, HABITAT INT, V64, P59, DOI 10.1016/j.habitatint.2017.04.010; Lu D, 2009, REGIONAL DEV CHINA 2; Ma X, 2015, SUSTAINABILITY-BASEL, V7, P12071, DOI 10.3390/su70912071; Matthews JC, 2015, ENVIRON IMPACT ASSES, V50, P196, DOI 10.1016/j.eiar.2014.10.001; National Bureau of Statistics of China, 1999, CHIN STAT YB; National Bureau of Statistics of China, 2015, CHIN STAT YB; Northam RM., 1975, URBAN GEOGR; Paatero P, 1999, J COMPUT GRAPH STAT, V8, P854, DOI 10.2307/1390831; Pradhan RP, 2016, Q REV ECON FINANC, V59, P25, DOI 10.1016/j.qref.2015.06.008; Rigamonti L, 2016, ECOL INDIC, V60, P1, DOI 10.1016/j.ecolind.2015.06.022; Rostami R, 2015, SUSTAINABILITY-BASEL, V7, P13290, DOI 10.3390/su71013290; Schaffler A, 2013, ECOL ECON, V86, P246, DOI 10.1016/j.ecolecon.2012.05.008; Shao S, 2011, ENERG POLICY, V39, P6476, DOI 10.1016/j.enpol.2011.07.049; Topalovic P, 2012, SOC INDIC RES, V108, P329, DOI 10.1007/s11205-012-0069-x; Tzoulas K, 2007, LANDSCAPE URBAN PLAN, V81, P167, DOI 10.1016/j.landurbplan.2007.02.001; UNEP (United Nations Environment Programme), 2012, SUST RES EFF CIT MAK; Upadhyaya JK, 2014, CAN J CIVIL ENG, V41, P483, DOI 10.1139/cjce-2013-0430; van Riel W, 2015, LECT N MECH ENG, P615, DOI 10.1007/978-3-319-06966-1_55; Wendel HEW, 2011, ENVIRON SCI TECHNOL, V45, P6728, DOI 10.1021/es103949f; Wu X H, 2016, URBAN RURAL MUNICIPA; Yan S., 2012, URBAN STUD, V19, P28; Yang JK, 2013, KSCE J CIV ENG, V17, P1637, DOI 10.1007/s12205-013-0096-4; Yeo IA, 2013, APPL ENERG, V110, P304, DOI 10.1016/j.apenergy.2013.04.065; York R, 2003, ECOL ECON, V46, P351, DOI 10.1016/S0921-8009(03)00188-5; York R, 2002, SOC SCI QUART, V83, P18, DOI 10.1111/1540-6237.00068	52	6	6	8	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0181917	10.1371/journal.pone.0181917	http://dx.doi.org/10.1371/journal.pone.0181917			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC7CP	28787031	Green Published, Green Submitted, gold			2022-12-26	WOS:000406998800012
J	Johnsen, A; Pauliny, A; Lifjeldl, JT; Blomqvist, D				Johnsen, Arild; Pauliny, Angela; Lifjeldl, Jan T.; Blomqvist, Donald			Is telomere length associated with mate choice in a songbird with a high rate of extra-pair paternity?	PLOS ONE			English	Article							BLUETHROATS AVES; QUANTITATIVE PCR; WILD; DYNAMICS; AGE; GROWTH; SELECTION; SPERM; BLOOD; BIRDS	Telomere length is related to aging in many eukaryotes and the rate of telomere attrition has been suggested to reflect individual genetic quality. Telomere length could thus have implications for mate choice. We investigated telomere length variation in bluethroat Luscinia svecica families with mixed paternity, including social parents, extra-pair fathers and nestlings, testing whether telomere length is associated with social and/or extra-pair mate choice through assortative mating or selection of mates with relatively long telomeres. In adults, relative telomere length (rTL) did not differ between the sexes, nor between two age categories. In chicks, however, rTL decreased with body mass at sampling (an index of nestling age). We found a positive correlation between the rTL of social mates, suggesting assortative mating with respect to telomere length or a correlative thereof. However, extra-pair males did not differ from social mates in rTL, and accordingly there was also no difference between within-and extra-pair young (i.e. half-siblings) when controlling for the effect of mass. We found no relationships between telomere length, age and fitness-related traits in adults, but an intriguing year-difference in telomere length in both sexes. In conclusion, we found no support for the idea that females choose extra-pair males based on their telomere length, but social mate choice seems to be influenced by rTL, possibly through its co-variation with aspects reflecting individual quality, like early arrival at the breeding grounds.	[Johnsen, Arild; Lifjeldl, Jan T.] Univ Oslo, Nat Hist Museum, Oslo, Norway; [Pauliny, Angela; Blomqvist, Donald] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden	University of Oslo; University of Gothenburg	Johnsen, A (corresponding author), Univ Oslo, Nat Hist Museum, Oslo, Norway.	arild.johnsen@nhm.uio.no		Johnsen, Arild/0000-0003-4864-6284	Natural History Museum of Oslo; Norwegian Research Council [129213/410]; research council Formas [215-2009-463]	Natural History Museum of Oslo; Norwegian Research Council(Research Council of NorwayEuropean Commission); research council Formas(Swedish Research Council Formas)	This work was supported by the Natural History Museum of Oslo, a grant to AJ from the Norwegian Research Council (grant no 129213/410) and a grant to DB from the research council Formas (grant no 215-2009-463). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens B, 2016, PHYSIOL BEHAV, V165, P217, DOI 10.1016/j.physbeh.2016.07.005; Amundsen T, 1997, P ROY SOC B-BIOL SCI, V264, P1579, DOI 10.1098/rspb.1997.0220; Andersson Malte, 1994; Arct A, 2015, BEHAV ECOL, V26, P959, DOI 10.1093/beheco/arv004; Asghar M, 2015, SCIENCE, V347, P436, DOI 10.1126/science.1261121; Asghar M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2263; Aston KI, 2012, MOL HUM REPROD, V18, P517, DOI 10.1093/molehr/gas028; Atema E, 2015, J ORNITHOL, V156, P1113, DOI 10.1007/s10336-015-1212-7; Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Badas EP, 2015, J EVOLUTION BIOL, V28, P896, DOI 10.1111/jeb.12615; Barrett ELB, 2013, MOL ECOL, V22, P249, DOI 10.1111/mec.12110; Bauch C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2540; Beaulieu M, 2011, FUNCT ECOL, V25, P577, DOI 10.1111/j.1365-2435.2010.01825.x; Bebbington K, 2016, MOL ECOL, V25, P2949, DOI 10.1111/mec.13670; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cleasby IR, 2012, IBIS, V154, P318, DOI 10.1111/j.1474-919X.2011.01209.x; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; Criscuolo F, 2009, J AVIAN BIOL, V40, P342, DOI 10.1111/j.1600-048X.2008.04623.x; de Magalhaes JP, 2009, J EVOLUTION BIOL, V22, P1770, DOI 10.1111/j.1420-9101.2009.01783.x; Delany ME, 2000, CYTOGENET CELL GENET, V90, P139, DOI 10.1159/000015649; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Foote CG, 2011, J ZOOL, V283, P203, DOI 10.1111/j.1469-7998.2010.00774.x; Fossoy F, 2008, EVOLUTION, V62, P145, DOI 10.1111/j.1558-5646.2007.00284.x; Gomes NMV, 2010, FEBS LETT, V584, P3741, DOI 10.1016/j.febslet.2010.07.031; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Hall ME, 2004, P ROY SOC B-BIOL SCI, V271, P1571, DOI 10.1098/rspb.2004.2768; Haussmann MF, 2005, BIOL LETTERS, V1, P212, DOI 10.1098/rsbl.2005.0301; Haussmann MF, 2002, OECOLOGIA, V130, P325, DOI 10.1007/s00442-001-0827-y; Heidinger BJ, 2012, P NATL ACAD SCI USA, V109, P1743, DOI 10.1073/pnas.1113306109; Horn T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017199; JOHNSEN A, 1995, ETHOLOGY, V101, P200; Johnsen A, 2000, NATURE, V406, P296, DOI 10.1038/35018556; Johnsen A, 2003, OECOLOGIA, V136, P476, DOI 10.1007/s00442-003-1286-4; Johnsen A, 2001, BEHAVIOUR, V138, P1371, DOI 10.1163/156853901317367645; Johnsen A, 1998, BEHAV ECOL SOCIOBIOL, V43, P401, DOI 10.1007/s002650050507; Johnsen A, 1998, P ROY SOC B-BIOL SCI, V265, P1313, DOI 10.1098/rspb.1998.0435; Kamiya T, 2014, MOL ECOL, V23, P5151, DOI 10.1111/mec.12934; Kempenaers B, 2007, ADV STUD BEHAV, V37, P189, DOI 10.1016/S0065-3454(07)37005-8; Kimura M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040037; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Naslund J, 2015, OECOLOGIA, V177, P1221, DOI 10.1007/s00442-015-3263-0; Olsson M, 2011, MOL ECOL, V20, P2085, DOI 10.1111/j.1365-294X.2011.05085.x; Parolini M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142530; Pauliny A, 2006, MOL ECOL, V15, P1681, DOI 10.1111/j.1365-294X.2006.02862.x; Pauliny A, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0436-8; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prescott J, 2012, HUM REPROD, V27, P3622, DOI 10.1093/humrep/des314; Questiau S, 1999, MOL ECOL, V8, P1331, DOI 10.1046/j.1365-294X.1999.00703.x; Rangbru B, 1994, THESIS; Reichert S, 2015, HEREDITY, V114, P10, DOI 10.1038/hdy.2014.60; Ringsby TH, 2015, P ROY SOC LOND B BIO, P282; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Simons MJP, 2015, AGEING RES REV, V24, P191, DOI 10.1016/j.arr.2015.08.002; Soler JJ, 2015, J EVOLUTION BIOL, V28, P1610, DOI 10.1111/jeb.12680; Stier A, 2015, EXP GERONTOL, V71, P118, DOI 10.1016/j.exger.2015.09.001; Stier A, 2015, OECOLOGIA, V179, P999, DOI 10.1007/s00442-015-3429-9; Sudyka J, 2014, J EVOLUTION BIOL, V27, P2258, DOI 10.1111/jeb.12479; Svec David, 2015, Biomol Detect Quantif, V3, P9, DOI 10.1016/j.bdq.2015.01.005; Svensson L., 1992, IDENTIFICATION GUIDE	61	8	8	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0182446	10.1371/journal.pone.0182446	http://dx.doi.org/10.1371/journal.pone.0182446			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28783753	Green Published, Green Submitted, gold			2022-12-26	WOS:000406944300035
J	Molakarimi, M; Mohseni, A; Taghdir, M; Pashandi, Z; Gorman, MA; Parker, MW; Naderi-Manesh, H; Sajedi, RH				Molakarimi, Maryam; Mohseni, Ammar; Taghdir, Majid; Pashandi, Zaiddodine; Gorman, Michael A.; Parker, Michael W.; Naderi-Manesh, Hossein; Sajedi, Reza H.			QM/MM simulations provide insight into the mechanism of bioluminescence triggering in ctenophore photoproteins	PLOS ONE			English	Article							LIGHT-SENSITIVE PHOTOPROTEIN; COELENTERAZINE-BINDING; MOLECULAR-DYNAMICS; MNEMIOPSIS-LEIDYI; OBELIN BIOLUMINESCENCE; VIOLET BIOLUMINESCENCE; CRYSTAL-STRUCTURES; BEROE ABYSSICOLA; W92F OBELIN; PROTEIN	Photoproteins are responsible for light emission in a variety of marine ctenophores and coelenterates. The mechanism of light emission in both families occurs via the same reaction. However, the arrangement of amino acid residues surrounding the chromophore, and the catalytic mechanism of light emission is unknown for the ctenophore photoproteins. In this study, we used quantum mechanics/molecular mechanics (QM/MM) and site-directed mutagenesis studies to investigate the details of the catalytic mechanism in berovin, a member of the ctenophore family. In the absence of a crystal structure of the berovin-substrate complex, molecular docking was used to determine the binding mode of the protonated (2-hydroperoxy) and deprotonated (2-peroxy anion) forms of the substrate to berovin. A total of 13 mutants predicted to surround the binding site were targeted by site-directed mutagenesis which revealed their relative importance in substrate binding and catalysis. Molecular dynamics simulations and MM-PBSA (Molecular Mechanics Poisson-Boltzmann/surface area) calculations showed that electrostatic and polar solvation energy are +115.65 and -100.42 kcal/mol in the deprotonated form, respectively. QM/MM calculations and pKa analysis revealed the deprotonated form of substrate is unstable due to the generation of a dioxetane intermediate caused by nucleophilic attack of the substrate peroxy anion at its C-3 position. This work also revealed that a hydrogen bonding network formed by a D158-R41-Y204 triad could be responsible for shuttling the proton from the 2-hydroperoxy group of the substrate to bulk solvent.	[Molakarimi, Maryam; Mohseni, Ammar; Sajedi, Reza H.] Tarbiat Modares Univ, Fac Biol Sci, Dept Biochem, Tehran, Iran; [Taghdir, Majid; Pashandi, Zaiddodine; Naderi-Manesh, Hossein] Tarbiat Modares Univ, Fac Biol Sci, Dept Biophys, Tehran, Iran; [Gorman, Michael A.; Parker, Michael W.] St Vincents Inst Med Res, Australian Canc Res Fdn, Rational Drug Discovery Ctr, Fitzroy, Vic, Australia; [Parker, Michael W.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic, Australia	Tarbiat Modares University; Tarbiat Modares University; St. Vincent's Institute of Medical Research; University of Melbourne	Sajedi, RH (corresponding author), Tarbiat Modares Univ, Fac Biol Sci, Dept Biochem, Tehran, Iran.; Naderi-Manesh, H (corresponding author), Tarbiat Modares Univ, Fac Biol Sci, Dept Biophys, Tehran, Iran.	naderman@modares.ac.ir; sajedi_r@modares.ac.ir	Parker, Michael W/F-9069-2013; H. Sajedi, Reza/AAA-8355-2022	Parker, Michael W/0000-0002-3101-1138; Naderi-Manesh, Hossein/0000-0002-4227-171X; Taghdir, Majid/0000-0002-6060-9921				Aghamaali MR, 2011, PROTEIN J, V30, P566, DOI 10.1007/s10930-011-9363-8; Burakova L, 2014, LUMINESCENCE; Burakova LP, 2016, PHOTOCH PHOTOBIO SCI, V15, P691, DOI 10.1039/c6pp00050a; Case D.A., 2012, AMBER; Chen SF, 2014, J PHYS CHEM B, V118, P2896, DOI 10.1021/jp412198w; Deng L, 2005, PROTEIN SCI, V14, P663, DOI 10.1110/ps.041142905; Deng L, 2001, FEBS LETT, V506, P281, DOI 10.1016/S0014-5793(01)02937-4; Dikici E, 2009, PROTEIN ENG DESIGN S; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Eremeeva EV, 2013, J PHOTOCH PHOTOBIO B, V127, P133, DOI 10.1016/j.jphotobiol.2013.08.012; Eremeeva EV, 2013, PHOTOCH PHOTOBIO SCI, V12, P1016, DOI 10.1039/c3pp00002h; Eremeeva EV, 2013, CHEMBIOCHEM, V14, P739, DOI 10.1002/cbic.201300002; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; GILSON MK, 1988, J COMPUT CHEM, V9, P327, DOI 10.1002/jcc.540090407; Hakiminia F, 2016, J MOL STRUCT, V1117, P287, DOI 10.1016/j.molstruc.2016.03.082; Head JF, 2000, NATURE, V405, P372, DOI 10.1038/35012659; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Isobe H, 2009, J PHYS CHEM A, V113, P15171, DOI 10.1021/jp905401b; Jafarian V, 2011, BIOCHEM BIOPH RES CO, V413, P164, DOI 10.1016/j.bbrc.2011.08.022; Jao SC, 2006, BIOCHEMISTRY-US, V45, P1547, DOI 10.1021/bi051786m; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Liu ZJ, 2006, P NATL ACAD SCI USA, V103, P2570, DOI 10.1073/pnas.0511142103; Liu ZJ, 2003, BIOCHEM BIOPH RES CO, V311, P433, DOI 10.1016/j.bbrc.2003.09.231; Mahdavi A, 2015, PHOTOCH PHOTOBIO SCI, V14, P792, DOI 10.1039/c4pp00191e; Mahdavi A, 2013, PHOTOCH PHOTOBIO SCI, V12, P467, DOI 10.1039/c2pp25320h; Markova SV, 2012, FEBS J, V279, P856, DOI 10.1111/j.1742-4658.2012.08476.x; Mongan J, 2005, CURR OPIN STRUC BIOL, V15, P157, DOI 10.1016/j.sbi.2005.02.002; Mongan J, 2004, J COMPUT CHEM, V25, P2038, DOI 10.1002/jcc.20139; Natashin PV, 2014, FEBS J, V281, P1432, DOI 10.1111/febs.12715; Natashin PV, 2014, ACTA CRYSTALLOGR D, V70, P720, DOI 10.1107/S1399004713032434; OHMIYA Y, 1993, FEBS LETT, V320, P267, DOI 10.1016/0014-5793(93)80600-Y; Ohmiya Y, 1996, CHEM BIOL, V3, P337, DOI 10.1016/S1074-5521(96)90116-7; PASTOR RW, 1988, MOL PHYS, V65, P1409, DOI 10.1080/00268978800101881; Powers ML, 2013, BIOCHEM BIOPH RES CO, V431, P360, DOI 10.1016/j.bbrc.2012.12.026; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Shiganova TA, 2001, MAR BIOL, V139, P431; Shimomura O, 2006, BIOLUMINESCENCE: CHEMICAL PRINCIPLES AND METHODS, P1; SHIMOMURA O, 1972, BIOCHEMISTRY-US, V11, P1602, DOI 10.1021/bi00759a009; SINGH UC, 1986, J COMPUT CHEM, V7, P718, DOI 10.1002/jcc.540070604; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Srinivasan J, 1999, THEOR CHEM ACC, V101, P426, DOI 10.1007/s002140050460; Stepanyuk GA, 2005, FEBS LETT, V579, P1008, DOI 10.1016/j.febslet.2005.01.004; Stepanyuk GA, 2013, BBA-PROTEINS PROTEOM, V1834, P2139, DOI 10.1016/j.bbapap.2013.07.006; STEWART JJP, 1989, J COMPUT CHEM, V10, P221, DOI 10.1002/jcc.540100209; STEWART JJP, 1989, J COMPUT CHEM, V10, P209, DOI 10.1002/jcc.540100208; Titushin MS, 2008, PHOTOCH PHOTOBIO SCI, V7, P189, DOI 10.1039/b713109g; Titushin MS, 2010, J BIOL CHEM, V285, P40891, DOI 10.1074/jbc.M110.133843; Vysotski ES, 2004, ACCOUNTS CHEM RES, V37, P405, DOI 10.1021/ar0400037; Vysotski ES, 2003, BIOCHEMISTRY-US, V42, P6013, DOI 10.1021/bi027258h; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	55	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0182317	10.1371/journal.pone.0182317	http://dx.doi.org/10.1371/journal.pone.0182317			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28777808	gold, Green Published			2022-12-26	WOS:000406944300028
J	Gonzalez-Guerra, JL; Castilla-Cortazar, I; Aguirre, GA; Munoz, U; Martin-Estal, I; Avila-Gallego, E; Granado, M; Puche, JE; Garcia-Villalon, AL				Luis Gonzalez-Guerra, Jose; Castilla-Cortazar, Inma; Aguirre, Gabriel A.; Munoz, Ursula; Martin-Estal, Irene; Avila-Gallego, Elena; Granado, Miriam; Puche, Juan E.; Luis Garcia-Villalon, Angel			Partial IGF-1 deficiency is sufficient to reduce heart contractibility, angiotensin II sensibility, and alter gene expression of structural and functional cardiac proteins	PLOS ONE			English	Article							GROWTH-FACTOR-I; MYOCARDIAL-INFARCTION; G(BETA-GAMMA) SUBUNITS; CARDIOVASCULAR-DISEASE; DIASTOLIC DYSFUNCTION; ISCHEMIA-REPERFUSION; INSULIN SENSITIVITY; RECEPTOR; MICE; HSP47	Circulating levels of IGF-1 may decrease under several circumstances like ageing, metabolic syndrome, and advanced cirrhosis. This reduction is associated with insulin resistance, dyslipidemia, progression to type 2 diabetes, and increased risk for cardiovascular diseases. However, underlying mechanisms between IGF-1 deficiency and cardiovascular disease remain elusive. The specific aim of the present work was to study whether the partial IGF-1 deficiency influences heart and/or coronary circulation, comparing vasoactive factors before and after of ischemia-reperfusion (I/R). In addition, histology of the heart was performed together with cardiac gene expression for proteins involved in structure and function (extracellular matrix, contractile proteins, active peptides); carried out using microarrays, followed by RT-qPCR confirmation of the three experimental groups. IGF-1 partial deficiency is associated to a reduction in contractility and angiotensin II sensitivity, interstitial fibrosis as well as altered expression pattern of genes involved in extracellular matrix proteins, calcium dynamics, and cardiac structure and function. Although this work is descriptive, it provides a clear insight of the impact that partial IGF-1 deficiency on the heart and establishes this experimental model as suitable for studying cardiac disease mechanisms and exploring therapeutic options for patients under IGF-1 deficiency conditions.	[Luis Gonzalez-Guerra, Jose; Castilla-Cortazar, Inma; Aguirre, Gabriel A.; Martin-Estal, Irene] Tecnol Monterrey, Escuela Med, Monterrey, Mexico; [Castilla-Cortazar, Inma] HM Hosp, Fdn Invest Hosp Madrid, Madrid, Spain; [Munoz, Ursula; Avila-Gallego, Elena; Puche, Juan E.] Univ CEU San Pablo, Fac Med, Dept Med Physiol, Madrid, Spain; [Granado, Miriam; Luis Garcia-Villalon, Angel] Univ Autonoma Madrid, Fac Med, Dept Physiol, Madrid, Spain; [Puche, Juan E.] Hosp Univ Puerta Mar, Dept Cardiol, Cadiz, Spain	Tecnologico de Monterrey; San Pablo CEU University; Autonomous University of Madrid; Universidad de Cadiz; Hospital Universitario Puerta del Mar	Castilla-Cortazar, I (corresponding author), Tecnol Monterrey, Escuela Med, Monterrey, Mexico.; Castilla-Cortazar, I (corresponding author), HM Hosp, Fdn Invest Hosp Madrid, Madrid, Spain.	iccortazar@itesm.mx	Garcia-Villalon, Angel/AAA-3067-2019; Granado, Miriam/B-8978-2017; MUÑOZ MORON, URSULA/L-4561-2017; Aguirre, Gabriel A/K-7839-2017; Martin Del Estal, Irene/K-6158-2017	Granado, Miriam/0000-0001-9178-8822; MUÑOZ MORON, URSULA/0000-0001-6024-4697; Aguirre, Gabriel A/0000-0003-4125-2661; Martin Del Estal, Irene/0000-0002-8987-3240	Fundacion de Investigacion Hospitales de Madrid and Tecnologico de Monterrey	Fundacion de Investigacion Hospitales de Madrid and Tecnologico de Monterrey	This work was supported by Fundacion de Investigacion Hospitales de Madrid and Tecnologico de Monterrey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelnasir A, 2014, GENET MOL RES, V13, P10787, DOI 10.4238/2014.December.18.20; Aguirre GA, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-015-0762-z; Asahi M, 2002, J BIOL CHEM, V277, P26725, DOI 10.1074/jbc.C200269200; Bhupathy P, 2007, J MOL CELL CARDIOL, V42, P903, DOI 10.1016/j.yjmcc.2007.03.738; Castilla-Cortazar I, 2014, J PHYSIOL BIOCHEM, V70, P129, DOI 10.1007/s13105-013-0287-y; Castilla-Cortazar I, 2015, UROLOGY, V86, pe1, DOI DOI 10.1016/J.UR0L0GY.2015.09.012; Cheng YS, 2012, BIOCHEM PHARMACOL, V83, P97, DOI 10.1016/j.bcp.2011.10.006; Clemmons DR, 2004, J CLIN INVEST, V113, P25, DOI 10.1172/JCI200420660; Conti E, 2004, CIRCULATION, V110, P2260, DOI 10.1161/01.CIR.0000144309.87183.FB; Conti E, 2001, J AM COLL CARDIOL, V38, P26, DOI 10.1016/S0735-1097(01)01367-5; Dalle S, 2001, J BIOL CHEM, V276, P15688, DOI 10.1074/jbc.M010884200; Dang MQ, 2015, CELL PHYSIOL BIOCHEM, V35, P467, DOI 10.1159/000369712; Demetriou M, 1996, J BIOL CHEM, V271, P12755, DOI 10.1074/jbc.271.22.12755; Etique N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/152163; Fan D, 2014, CARDIOVASC RES, V103, P268, DOI 10.1093/cvr/cvu072; Franco Celina, 2006, Metabolic Syndrome and Related Disorders, V4, P51, DOI 10.1089/met.2006.4.51; Garcia-Fernandez M, 2008, ENDOCRINOLOGY, V149, P2433, DOI 10.1210/en.2007-1190; Garcia-Villalon AL, 2005, EUR J PHARMACOL, V509, P165, DOI 10.1016/j.ejphar.2004.11.065; Garcia-Villalon AL, 2009, CARDIOVASC RES, V81, P336, DOI 10.1093/cvr/cvn321; Goldstein David S, 2010, Cleve Clin J Med, V77 Suppl 3, pS34, DOI 10.3949/ccjm.77.s3.06; Granado M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065172; Granado M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054984; Guo DC, 2009, AM J HUM GENET, V84, P617, DOI 10.1016/j.ajhg.2009.04.007; Hagiwara S, 2011, THORAC CARDIOV SURG, V59, P386, DOI 10.1055/s-0030-1250658; Hallak H, 2000, J BIOL CHEM, V275, P2255, DOI 10.1074/jbc.275.4.2255; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Johnsen SP, 2005, J CLIN ENDOCR METAB, V90, P5937, DOI 10.1210/jc.2004-2088; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kawaguchi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014297; Keummerle JF, 2001, J BIOL CHEM, V276, P7187, DOI 10.1074/jbc.M011145200; Kim J, 2008, MOL ENDOCRINOL, V22, P2531, DOI 10.1210/me.2008-0265; Lara-Diaz V.J., 2017, J PHYSL BIOCH; Laughlin GA, 2004, J CLIN ENDOCR METAB, V89, P114, DOI 10.1210/jc.2003-030967; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUTTRELL LM, 1995, J BIOL CHEM, V270, P16495, DOI 10.1074/jbc.270.28.16495; Malik J, 2008, PHYSIOL RES, V57, P919, DOI 10.33549/physiolres.931281; Mallea-Gil Maria Susana, 2012, Acta Gastroenterol Latinoam, V42, P20; McMullen JR, 2004, J BIOL CHEM, V279, P4782, DOI 10.1074/jbc.M310405200; Merx MW, 2005, J AM SOC NEPHROL, V16, P3357, DOI 10.1681/ASN.2005040365; Milewicz DM, 2010, AM J MED GENET A, V152A, P2437, DOI 10.1002/ajmg.a.33657; Moses AC, 2005, ENDOCRIN DEV, V9, P121, DOI 10.1159/000085762; Periasamy M, 2001, J MOL CELL CARDIOL, V33, P1053, DOI 10.1006/jmcc.2001.1366; Puche JE, 2016, BIOFACTORS, V42, P60, DOI 10.1002/biof.1255; Regalado ES, 2015, CIRC-CARDIOVASC GENE, V8, P457, DOI 10.1161/CIRCGENETICS.114.000943; De Ita JR, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0684-9; ROSEN T, 1990, LANCET, V336, P285, DOI 10.1016/0140-6736(90)91812-O; Stoynev N, 2014, J CARDIOVASC MED, V15, P702, DOI 10.2459/JCM.0b013e32835dbcc8; Taguchi T, 2007, TRENDS MOL MED, V13, P45, DOI 10.1016/j.molmed.2006.12.001; Thun GA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003585; Tijero B, 2013, PARKINSONISM RELAT D, V19, P95, DOI 10.1016/j.parkreldis.2012.08.001; Ungvari Z, 2012, J GERONTOL A-BIOL, P599; Vasan RS, 2003, ANN INTERN MED, V139, P642, DOI 10.7326/0003-4819-139-8-200310210-00007; Vinciguerra M, 2010, AGING-US, V2, P43; Yakar S, 2004, J CLIN INVEST, V113, P96, DOI 10.1172/JCI200417763	55	14	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 14	2017	12	8							e0181760	10.1371/journal.pone.0181760	http://dx.doi.org/10.1371/journal.pone.0181760			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD5CP	28806738	Green Published, gold, Green Submitted			2022-12-26	WOS:000407548800009
J	Kim, YS; Yoon, D; Byun, J; Park, H; Lee, A; Kim, IH; Lee, S; Lim, HS; Park, RW				Kim, Yoon Seob; Yoon, Dukyong; Byun, JungHyun; Park, Hojun; Lee, Ahram; Kim, Il Hyun; Lee, Sukhoon; Lim, Hong-Seok; Park, Rae Woong			Extracting information from free-text electronic patient records to identify practice-based evidence of the performance of coronary stents	PLOS ONE			English	Article							BIOLIMUS-ELUTING STENTS; TERM CLINICAL-OUTCOMES; ARTERY-DISEASE; FOLLOW-UP; POOLED ANALYSIS; PROMUS ELEMENT; THROMBOSIS; SAFETY; RISK; ANGIOGRAPHY	Background and objective Percutaneous coronary intervention (PCI) using drug-eluting stents (DES) is an indispensable treatment for coronary artery disease. However, to evaluate the performance of various types of stents for PCI, numerous resources are required. We extracted clinical information from free-text records and, using practice-based evidence, compared the efficacy of various DES. Materials and methods We developed a text mining tool based on regular expression and applied it to PCI reports stored in the electronic health records (EHRs) of Ajou University Hospital from 2010-2014. The PCI data were extracted from EHRs with a sensitivity of 0.996, a specificity of 1.000, and an F-measure of 0.995 when compared with a sample of 200 reports. Using these data, we compared the performance of stents by Kaplan-Meier analysis and the Cox hazard proportional regression. Results In the self-validation analysis comparing the first-generation to the second-generation DES, the second-generation DES was superior to the first-generation DES (hazard ratio [HR]: 0.423, 95% confidence interval [CI]: 0.284-0.630) in terms of target vessel revascularization (TVR), showing similar findings to the established results of previous studies. Among the second-generation DES, the biodegradable-polymer DES tended to be superior, with a risk of TVR (HR: 0.568, 95% CI: 0.281-1.147) falling below than that for the durable-polymer DES approximately 1 year after the index procedure. The Endeavor stent had the highest TVR risk among the newer generation DES (HR: 2.576, 95% CI: 1.273-5.210). Conclusions In this study, we demonstrated how to construct a PCI data warehouse of PCI-related parameters obtained from free-text electronic records with high accuracy for use in the post surveillance of coronary stents in a time-and cost effective manner. Post surveillance of the practice based evidence in the PCI data warehouse indicated that the biodegradable-polymer DES might have a lower risk of TVR than the durable-polymer DES.	[Kim, Yoon Seob; Yoon, Dukyong; Byun, JungHyun; Park, Hojun; Lee, Ahram; Kim, Il Hyun; Park, Rae Woong] Ajou Univ, Sch Med, Dept Biomed Informat, Suwon, Gyeonggi Do, South Korea; [Yoon, Dukyong; Park, Rae Woong] Ajou Univ, Sch Med, Dept Biomed Sci, Suwon, Gyeonggi Do, South Korea; [Lee, Sukhoon] Kunsan Natl Univ, Dept Software Convergence Engn, Gunsan, Jeollabuk Do, South Korea; [Lim, Hong-Seok] Ajou Univ, Sch Med, Dept Cardiol, Suwon, Gyeonggi Do, South Korea	Ajou University; Ajou University; Kunsan National University; Ajou University	Park, RW (corresponding author), Ajou Univ, Sch Med, Dept Biomed Informat, Suwon, Gyeonggi Do, South Korea.; Park, RW (corresponding author), Ajou Univ, Sch Med, Dept Biomed Sci, Suwon, Gyeonggi Do, South Korea.; Lim, HS (corresponding author), Ajou Univ, Sch Med, Dept Cardiol, Suwon, Gyeonggi Do, South Korea.	camdhslim@ajou.ac.kr; veritas@ajou.ac.kr		Kim, Yoon Seob/0000-0002-6363-1999	Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI16C0992, HI16C0982]; Ajou University School of Medicine [M-2015-C0460-00109]	Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; Ajou University School of Medicine	This research was supported by grants of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI16C0992 to RWP & HI16C0982 to DY). This work was also supported by Ajou University School of Medicine (M-2015-C0460-00109 to HSL).	Bartorelli AL, 2010, CATHETER CARDIO INTE, V76, P60, DOI 10.1002/ccd.22452; Canan T, 2010, CATHETER CARDIO INTE, V75, P237, DOI 10.1002/ccd.22212; Chakravarty T, 2010, AM J CARDIOL, V106, P1075, DOI 10.1016/j.amjcard.2010.06.010; Colombo A, 2000, CIRCULATION, V102, P371; Friedman C, 1995, Proc Annu Symp Comput Appl Med Care, P347; Kaiser C, 2015, CIRCULATION, V131, P74, DOI 10.1161/CIRCULATIONAHA.114.013520; Kaul U, 2015, NEW ENGL J MED, V373, P1709, DOI 10.1056/NEJMoa1510188; Kaur G., 2014, INT J RES ENG TECHNO, V3, P168; Kedhi E, 2010, LANCET, V375, P201, DOI 10.1016/S0140-6736(09)62127-9; Kho AN, 2012, J AM MED INFORM ASSN, V19, P212, DOI 10.1136/amiajnl-2011-000439; Kobayashi N, 2015, J INTERV CARDIOL, V28, P551, DOI 10.1111/joic.12247; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Nabel EG, 2012, NEW ENGL J MED, V366, P54, DOI 10.1056/NEJMra1112570; Nakazawa G, 2008, CIRCULATION, V118, P1138, DOI 10.1161/CIRCULATIONAHA.107.762047; Sager N, 1986, MEDINFO, V2, P1101; Sarno G, 2013, INT J CARDIOL, V167, P146, DOI 10.1016/j.ijcard.2011.12.057; Sarno G, 2012, EUR HEART J, V33, P606, DOI 10.1093/eurheartj/ehr479; Sen H, 2015, JACC-CARDIOVASC INTE, V8, P889, DOI 10.1016/j.jcin.2015.01.033; Serruys PW, 2013, JACC-CARDIOVASC INTE, V6, P777, DOI 10.1016/j.jcin.2013.04.011; Serruys PW, 2001, NEW ENGL J MED, V344, P1117, DOI 10.1056/NEJM200104123441502; Shaikh F, 2008, CATHETER CARDIO INTE, V71, P614, DOI 10.1002/ccd.21371; SIGWART U, 1987, NEW ENGL J MED, V316, P701, DOI 10.1056/NEJM198703193161201; Spaulding C, 2006, NEW ENGL J MED, V355, P1093, DOI 10.1056/NEJMoa062006; Stefanini GG, 2013, NEW ENGL J MED, V368, P254, DOI 10.1056/NEJMra1210816; Stefanini GG, 2012, EUR HEART J, V33, P1214, DOI 10.1093/eurheartj/ehs086; Stefanini GG, 2011, LANCET, V378, P1940, DOI 10.1016/S0140-6736(11)61672-3; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Stone GW, 2010, NEW ENGL J MED, V362, P1663, DOI 10.1056/NEJMoa0910496; Vlachojannis GJ, 2015, EUROINTERVENTION, V11, P272, DOI 10.4244/EIJV11I3A53	30	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0182889	10.1371/journal.pone.0182889	http://dx.doi.org/10.1371/journal.pone.0182889			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD3KL	28800599	gold, Green Submitted, Green Published			2022-12-26	WOS:000407431800033
J	Chen, HR; Rairat, T; Loh, SH; Wu, YC; Vickroy, TW; Chou, CC				Chen, Hui-Ru; Rairat, Tirawat; Loh, Shih-Hurng; Wu, Yu-Chieh; Vickroy, Thomas W.; Chou, Chi-Chung			Assessment of veterinary drugs in plants using pharmacokinetic approaches: The absorption, distribution and elimination of tetracycline and sulfamethoxazole in ephemeral vegetables	PLOS ONE			English	Article							PEARL RIVER DELTA; ANTIBIOTIC-RESIDUES; SULFADIAZINE UPTAKE; WASTE STREAMS; MANURE; ENVIRONMENT; SOIL; OXYTETRACYCLINE; ACCUMULATION; SULFONAMIDES	The present study was carried out to demonstrate novel use of pharmacokinetic approaches to characterize drug behaviors/movements in the vegetables with implications to food safety. The absorption, distribution, metabolism and most importantly, the elimination of tetracycline (TC) and sulfamethoxazole (SMX) in edible plants Brassica rapa chinensis and Ipomoea aquatica grown hydroponically were demonstrated and studied using non-compartmental pharmacokinetic analysis. The results revealed drug-dependent and vegetable-dependent pharmacokinetic differences and indicated that ephemeral vegetables could have high capacity accumulating antibiotics (up to 160 mu g g(-1) for TC and 38 mu g g(-1) for SMX) within hours. TC concentration in the root (C-max) could reach 11 times higher than that in the cultivation fluid and 3-28 times higher than the petioles/stems. Based on the volume of distribution (Vss), SMX was 3-6 times more extensively distributed than TC. Both antibiotics showed evident, albeit slow elimination phase with elimination half-lives ranging from 22 to 88 hours. For the first time drug elimination through the roots of a plant was demonstrated, and by viewing the root as a central compartment and continuous infusion without a loading dose as drug administration mode, it is possible to pharmacokinetically monitor the movement of antibiotics and their fate in the vegetables with more detailed information not previously available. Phyto-pharmacokinetic could be a new area worth developing new models for the assessment of veterinary drugs in edible plants.	[Chen, Hui-Ru; Rairat, Tirawat; Wu, Yu-Chieh; Chou, Chi-Chung] Natl Chung Hsing Univ, Dept Vet Med, Coll Vet Med, Taichung, Taiwan; [Loh, Shih-Hurng] Natl Def Med Ctr, Dept & Grad Inst Pharmacol, Taipei, Taiwan; [Vickroy, Thomas W.] Univ Florida, Coll Vet Med, Dept Physiol Sci, Gainesville, FL 32610 USA	National Chung Hsing University; National Defense Medical Center; State University System of Florida; University of Florida	Chou, CC (corresponding author), Natl Chung Hsing Univ, Dept Vet Med, Coll Vet Med, Taichung, Taiwan.	ccchou@nchu.edu.tw	Chou, Chi-Chung/AAR-5086-2021; Rairat, Tirawat/AAX-8198-2021	Rairat, Tirawat/0000-0001-7966-3592; Chou, Chi-Chung/0000-0002-4622-2552; Loh, Shih-hurng/0000-0001-9269-5580	Ministry of Science and Technology, Taiwan [MOST 101-2621-M-005-002, 102-2621-M-005-002, 103-2621-M-005-001]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was funded by Ministry of Science and Technology, Taiwan, grant numbers: MOST 101-2621-M-005-002,102-2621-M-005-002, 103-2621-M-005-001 (URLs: https://www.most.gov.tw).	Agwuh KN, 2006, J ANTIMICROB CHEMOTH, V58, P256, DOI 10.1093/jac/dkl224; Ahmed MBM, 2015, J AGR FOOD CHEM, V63, P398, DOI 10.1021/jf5034637; Arikan OA, 2007, BIORESOURCE TECHNOL, V98, P169, DOI 10.1016/j.biortech.2005.10.041; Bartikova H, 2016, CHEMOSPHERE, V144, P2290, DOI 10.1016/j.chemosphere.2015.10.137; Boonsaner M, 2012, ECOTOX ENVIRON SAFE, V78, P142, DOI 10.1016/j.ecoenv.2011.11.023; Chee-Sanford JC, 2009, J ENVIRON QUAL, V38, P1086, DOI 10.2134/jeq2008.0128; Christian T, 2003, ACTA HYDROCH HYDROB, V31, P36, DOI 10.1002/aheh.200390014; Daghrir R, 2013, ENVIRON CHEM LETT, V11, P209, DOI 10.1007/s10311-013-0404-8; Du LF, 2012, AGRON SUSTAIN DEV, V32, P309, DOI 10.1007/s13593-011-0062-9; Farkas MH, 2009, ANALYST, V134, P1594, DOI 10.1039/b902147g; Gothwal R, 2015, CLEAN-SOIL AIR WATER, V43, P479, DOI 10.1002/clen.201300989; Grote M, 2007, LANDBAUFORSCH VOLK, V57, P25; Herklotz PA, 2010, CHEMOSPHERE, V78, P1416, DOI 10.1016/j.chemosphere.2009.12.048; Hirsch R, 1999, SCI TOTAL ENVIRON, V225, P109, DOI 10.1016/S0048-9697(98)00337-4; Hu XG, 2010, ENVIRON POLLUT, V158, P2992, DOI 10.1016/j.envpol.2010.05.023; Jjemba PK, 2002, AGR ECOSYST ENVIRON, V93, P267, DOI 10.1016/S0167-8809(01)00350-4; Kang DH, 2013, J AGR FOOD CHEM, V61, P9992, DOI 10.1021/jf404045m; Kemper N, 2008, ECOL INDIC, V8, P1, DOI 10.1016/j.ecolind.2007.06.002; Kim KR, 2011, WATER AIR SOIL POLL, V214, P163, DOI 10.1007/s11270-010-0412-2; Koesukwiwat U, 2007, J CHROMATOGR A, V1140, P147, DOI 10.1016/j.chroma.2006.11.099; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; Kong WD, 2007, ENVIRON POLLUT, V147, P187, DOI 10.1016/j.envpol.2006.08.016; Lacy CF, DRUG INFORM HDB 2008; Li LL, 2010, PEDOSPHERE, V20, P807, DOI 10.1016/S1002-0160(10)60071-9; Li WH, 2015, ENVIRON SCI-PROC IMP, V17, P1611, DOI 10.1039/c5em00216h; Li YW, 2011, J AGR FOOD CHEM, V59, P7268, DOI 10.1021/jf1047578; Li ZJ, 2011, PEDOSPHERE, V21, P244, DOI 10.1016/S1002-0160(11)60124-0; Lin AYC, 2009, SCI TOTAL ENVIRON, V407, P3793, DOI 10.1016/j.scitotenv.2009.03.009; Lin AYC, 2008, CHEMOSPHERE, V74, P131, DOI 10.1016/j.chemosphere.2008.08.027; Liu L, 2013, ECOL ENG, V53, P138, DOI 10.1016/j.ecoleng.2012.12.033; Mathews S, 2013, ENVIRON SCI POLLUT R, V20, P4327, DOI 10.1007/s11356-013-1693-y; Michael I, 2013, WATER RES, V47, P957, DOI 10.1016/j.watres.2012.11.027; Michelini L, 2013, PLANT PHYSIOL BIOCH, V67, P55, DOI 10.1016/j.plaphy.2013.02.027; Michelini L, 2012, WATER AIR SOIL POLL, V223, P5243, DOI 10.1007/s11270-012-1275-5; Michelini L, 2015, ENVIRON SCI POLLUT R, V22, P13362, DOI 10.1007/s11356-015-4560-1; MIGLIORE L, 1995, AGR ECOSYST ENVIRON, V52, P103, DOI 10.1016/0167-8809(94)00549-T; Migliore L, 1996, AGR ECOSYST ENVIRON, V60, P121, DOI 10.1016/S0167-8809(96)01090-0; Pan M, 2016, ECOTOX ENVIRON SAFE, V126, P228, DOI 10.1016/j.ecoenv.2015.12.027; Pan M, 2014, J AGR FOOD CHEM, V62, P11062, DOI 10.1021/jf503850v; Rang HP, 2012, RANG DALES PHARM, P99; Sarmah AK, 2006, CHEMOSPHERE, V65, P725, DOI 10.1016/j.chemosphere.2006.03.026; Seo Youngho, 2010, [Korean Journal of Soil Science & Fertilizer, 한국토양비료학회지(Korean Journal of Soil Science and Fertilizer)], V43, P466; Singh OV, 2003, APPL MICROBIOL BIOT, V63, P128, DOI 10.1007/s00253-003-1425-1; Thiele-Bruhn S, 2003, J PLANT NUTR SOIL SC, V166, P145, DOI 10.1002/jpln.200390023; Yoshida S., 1976, LAB MANUAL PHYSL STU, P61	45	25	26	6	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0183087	10.1371/journal.pone.0183087	http://dx.doi.org/10.1371/journal.pone.0183087			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797073	Green Submitted, gold, Green Published			2022-12-26	WOS:000407396200149
J	Egan, PF; Gonella, VC; Engensperger, M; Ferguson, SJ; Shea, K				Egan, Paul F.; Gonella, Veronica C.; Engensperger, Max; Ferguson, Stephen J.; Shea, Kristina			Computationally designed lattices with tuned properties for tissue engineering using 3D printing	PLOS ONE			English	Article							FUSION CAGE; BONE; PERMEABILITY; SCAFFOLDS; MICROSTRUCTURE; OPTIMIZATION; FOAMS; MODEL; REGENERATION; SIMULATION	Tissue scaffolds provide structural support while facilitating tissue growth, but are challenging to design due to diverse property trade-offs. Here, a computational approach was developed for modeling scaffolds with lattice structures of eight different topologies and assessing properties relevant to bone tissue engineering applications. Evaluated properties include porosity, pore size, surface-volume ratio, elastic modulus, shear modulus, and permeability. Lattice topologies were generated by patterning beam-based unit cells, with design parameters for beam diameter and unit cell length. Finite element simulations were conducted for each topology and quantified how elastic modulus and shear modulus scale with porosity, and how permeability scales with porosity cubed over surface-volume ratio squared. Lattices were compared with controlled properties related to porosity and pore size. Relative comparisons suggest that lattice topology leads to specializations in achievable properties. For instance, Cube topologies tend to have high elastic and low shear moduli while Octet topologies have high shear moduli and surface-volume ratios but low permeability. The developed method was utilized to analyze property trade-offs as beam diameter was altered for a given topology, and used to prototype a 3D printed lattice embedded in an interbody cage for spinal fusion treatments. Findings provide a basis for modeling and understanding relative differences among beam-based lattices designed to facilitate bone tissue growth.	[Egan, Paul F.; Ferguson, Stephen J.] Swiss Fed Inst Technol, Inst Biomech, Dept Hlth Sci & Technol, Zurich, Switzerland; [Gonella, Veronica C.] UMIT Hlth & Life Sci Univ, Biomed Comp Sci & Mechatron, Hall In Tirol, Austria; [Engensperger, Max; Shea, Kristina] Swiss Fed Inst Technol, Dept Mech & Proc Engn, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Egan, PF (corresponding author), Swiss Fed Inst Technol, Inst Biomech, Dept Hlth Sci & Technol, Zurich, Switzerland.	pegan@ethz.ch	Ferguson, Stephen J./A-4118-2012; Egan, Paul Francis/E-1599-2013	Ferguson, Stephen J./0000-0003-0650-5889; Egan, Paul Francis/0000-0003-1252-5819				Adachi T, 2006, BIOMATERIALS, V27, P3964, DOI 10.1016/j.biomaterials.2006.02.039; Almeida HA, 2013, PROCEDIA ENGINEER, V59, P298, DOI 10.1016/j.proeng.2013.05.125; Arabnejad S, 2016, ACTA BIOMATER, V30, P345, DOI 10.1016/j.actbio.2015.10.048; Ashby MF, 2006, PHILOS T R SOC A, V364, P15, DOI 10.1098/rsta.2005.1678; Aznar JMG, 2016, BIOMANUFACTURING REV, V1, P2, DOI DOI 10.1007/S40898-016-0002-1; Baroud G, 2004, J BIOMECH, V37, P189, DOI 10.1016/S0021-9290(03)00246-X; Boccaccio A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146935; Boccaccio A, 2016, INT J BIOL SCI, V12, P1, DOI 10.7150/ijbs.13158; Byrne DP, 2007, BIOMATERIALS, V28, P5544, DOI 10.1016/j.biomaterials.2007.09.003; Chang PS, 2013, INT J COMPUT INTEG M, V26, P907, DOI 10.1080/0951192X.2011.650880; Chantarapanich N, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/407805; Checa S, 2010, J BIOMECH, V43, P961, DOI 10.1016/j.jbiomech.2009.10.044; Chen YH, 2011, BIOMATERIALS, V32, P5003, DOI 10.1016/j.biomaterials.2011.03.064; de Wild M, 2016, 3D PRINT ADDIT MANUF, V3, P142, DOI 10.1089/3dp.2016.0004; Deshpande VS, 2001, J MECH PHYS SOLIDS, V49, P1747, DOI 10.1016/S0022-5096(01)00010-2; Dias MR, 2012, J BIOMECH, V45, P938, DOI 10.1016/j.jbiomech.2012.01.019; Dong L, 2015, INT J SOLIDS STRUCT, V60-61, P107, DOI 10.1016/j.ijsolstr.2015.02.020; Egan P, 2017, J MECH DESIGN, P139; Egan P, 2017, DESIGN FABRICATION 3; Egan P, 2016, J MECH DESIGN, V138, DOI 10.1115/1.4033751; Egan P, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004177; FYHRIE DP, 1993, J BIOMECH, V26, P955, DOI 10.1016/0021-9290(93)90057-L; Guest JK, 2007, COMPUT METHOD APPL M, V196, P1006, DOI 10.1016/j.cma.2006.08.006; Guyot Y, 2015, BIOTECHNOL BIOENG, V112, P2591, DOI 10.1002/bit.25672; Guyot Y, 2014, BIOMECH MODEL MECHAN, V13, P1361, DOI 10.1007/s10237-014-0577-5; Habib FN, 2016, 3D PRINT ADDIT MANUF, V3, P119, DOI 10.1089/3dp.2015.0014; Huang YP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166452; Jang WY, 2010, INT J SOLIDS STRUCT, V47, P2872, DOI 10.1016/j.ijsolstr.2010.06.014; Joly P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073545; Jones AC, 2009, BIOMATERIALS, V30, P1440, DOI 10.1016/j.biomaterials.2008.10.056; Kang H, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025102; Kang H, 2010, STRUCT MULTIDISCIP O, V42, P633, DOI 10.1007/s00158-010-0508-8; Lee YH, 2016, COMPUT BIOL MED, V71, P35, DOI 10.1016/j.compbiomed.2016.01.024; Li Y, 2014, BIOMATERIALS, V35, P5647, DOI 10.1016/j.biomaterials.2014.03.075; Lipowiecki M, 2014, J BIOMED MATER RES A, V102, P4127, DOI 10.1002/jbm.a.35084; MARTYS NS, 1994, PHYS REV E, V50, P403, DOI 10.1103/PhysRevE.50.403; Melchels FPW, 2011, BIOMATERIALS, V32, P2878, DOI 10.1016/j.biomaterials.2011.01.023; Melchels FPW, 2010, BIOMATERIALS, V31, P6909, DOI 10.1016/j.biomaterials.2010.05.068; Moongkhamklang P, 2010, ACTA MATER, V58, P2822, DOI 10.1016/j.actamat.2010.01.004; Ochoa I, 2009, J BIOMECH, V42, P257, DOI 10.1016/j.jbiomech.2008.10.030; Rahbari A, 2017, COMPUT METHOD BIOMEC, V20, P231, DOI 10.1080/10255842.2016.1215436; Roohani-Esfahani S-I, 2016, SCI REPORTS, V6; Sandino C, 2008, J BIOMECH, V41, P1005, DOI 10.1016/j.jbiomech.2007.12.011; Sanz-Herrera JA, 2008, BIOMECH MODEL MECHAN, V7, P355, DOI 10.1007/s10237-007-0089-7; Sanz-Herrera JA, 2009, ACTA BIOMATER, V5, P219, DOI 10.1016/j.actbio.2008.06.021; Sanz-Herrera JA, 2009, BIOMATERIALS, V30, P6674, DOI 10.1016/j.biomaterials.2009.08.053; Singh R, 2009, ACTA BIOMATER, V5, P477, DOI 10.1016/j.actbio.2008.06.014; Stankovic T, 2015, J MECH DESIGN, V137, DOI 10.1115/1.4030995; Sturm S, 2010, J BIOMECH, V43, P1738, DOI 10.1016/j.jbiomech.2010.02.020; Sun W, 2005, COMPUT AIDED DESIGN, V37, P1097, DOI 10.1016/j.cad.2005.02.002; Tai CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146294; Thompson MK, 2016, CIRP ANN-MANUF TECHN, V65, P737, DOI 10.1016/j.cirp.2016.05.004; Truscello S, 2012, ACTA BIOMATER, V8, P1648, DOI 10.1016/j.actbio.2011.12.021; Tsai PI, 2016, COMPUT BIOL MED, V76, P14, DOI 10.1016/j.compbiomed.2016.06.016; Van Bael S, 2012, ACTA BIOMATER, V8, P2824, DOI 10.1016/j.actbio.2012.04.001; Wang XJ, 2016, BIOMATERIALS, V83, P127, DOI 10.1016/j.biomaterials.2016.01.012; Widmer RP, 2013, COMPUT METHOD BIOMEC, V16, P908, DOI 10.1080/10255842.2011.643787; Wieding J, 2013, J APPL BIOMATERIALS, V11; Wieding J, 2014, J MECH BEHAV BIOMED, V37, P56, DOI 10.1016/j.jmbbm.2014.05.002; Wilke HJ, 1999, SPINE, V24, P755, DOI 10.1097/00007632-199904150-00005; Xu P, 2008, ADV WATER RESOUR, V31, P74, DOI 10.1016/j.advwatres.2007.06.003; Xu SQ, 2016, MATER DESIGN, V93, P443, DOI 10.1016/j.matdes.2016.01.007; Zhang H, 2014, MATH PROBL ENG, V2014, DOI [10.1155/2014/183580, 10.1007/978-3-319-07200-5_1]; Zhang M, 2016, INT ORTHOP, P1; Zhao LY, 2014, ACTA MATER, V81, P326, DOI 10.1016/j.actamat.2014.08.037; Zheng XY, 2014, SCIENCE, V344, P1373, DOI 10.1126/science.1252291	66	76	78	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182902	10.1371/journal.pone.0182902	http://dx.doi.org/10.1371/journal.pone.0182902			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797066	Green Submitted, Green Published, gold			2022-12-26	WOS:000407396200116
J	Klaka, P; Grudl, S; Banowski, B; Giesen, M; Sattler, A; Proksch, P; Welss, T; Forster, T				Klaka, Patricia; Gruedl, Sabine; Banowski, Bernhard; Giesen, Melanie; Saettler, Andrea; Proksch, Peter; Welss, Thomas; Foerster, Thomas			A novel organotypic 3D sweat gland model with physiological functionality	PLOS ONE			English	Article							STEM-CELL POPULATIONS; HUMAN SKIN; MYOEPITHELIAL CELLS; CHLORIDE TRANSPORT; EPITHELIAL-CELLS; POTASSIUM; CHANNEL; SODIUM; HYPERHIDROSIS; PHARMACOLOGY	Dysregulated human eccrine sweat glands can negatively impact the quality-of-life of people suffering from disorders like hyperhidrosis. Inability of sweating can even result in serious health effects in humans affected by anhidrosis. The underlying mechanisms must be elucidated and a reliable in vitro test system for drug screening must be developed. Here we describe a novel organotypic three-dimensional (3D) sweat gland model made of primary human eccrine sweat gland cells. Initial experiments revealed that eccrine sweat gland cells in a two-dimensional (2D) culture lose typical physiological markers. To resemble the in vivo situation as close as possible, we applied the hanging drop cultivation technology regaining most of the markers when cultured in its natural spherical environment. To compare the organotypic 3D sweat gland model versus human sweat glands in vivo, we compared markers relevant for the eccrine sweat gland using transcriptomic and proteomic analysis. Comparing the marker profile, a high in vitro-in vivo correlation was shown. Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5), muscarinic acetylcholine receptor M3 (CHRM3), Na+-K+-Cl- cotransporter 1 (NKCC1), calcium-activated chloride channel anoctamin-1 (ANO1/TMEM16A), and aquaporin-5 (AQP5) are found at significant expression levels in the 3D model. Moreover, cholinergic stimulation with acetylcholine or pilocarpine leads to calcium influx monitored in a calcium flux assay. Cholinergic stimulation cannot be achieved with the sweat gland cell line NCL-SG3 used as a sweat gland model system. Our results show clear benefits of the organotypic 3D sweat gland model versus 2D cultures in terms of the expression of essential eccrine sweat gland key regulators and in the physiological response to stimulation. Taken together, this novel organotypic 3D sweat gland model shows a good in vitro-in vivo correlation and is an appropriate alternative for screening of potential bioactives regulating the sweat mechanism.	[Klaka, Patricia; Gruedl, Sabine; Banowski, Bernhard; Giesen, Melanie; Saettler, Andrea; Welss, Thomas; Foerster, Thomas] Henkel AG & Co KGaA, Dusseldorf, Germany; [Proksch, Peter] Heinrich Heine Univ, Inst Pharmaceut Biol & Biotechnol, Dusseldorf, Germany	Henkel; Heinrich Heine University Dusseldorf	Klaka, P; Welss, T (corresponding author), Henkel AG & Co KGaA, Dusseldorf, Germany.	patricia.klaka@hhu.de; thomas.welss@henkel.com	Proksch, Peter/AAR-4593-2020		Henkel AG Co. KGaA; German Federal Ministry of Education and Research (Bundesminesterium fur Bildung and Forschung, BMBF); BMBF	Henkel AG Co. KGaA; German Federal Ministry of Education and Research (Bundesminesterium fur Bildung and Forschung, BMBF)(Federal Ministry of Education & Research (BMBF)); BMBF(Federal Ministry of Education & Research (BMBF))	This work was supported by Henkel AG & Co. KGaA. Since March 2016 further research is part of the Natural Life Excellence Network 2020 (NatLifE 2020) funded by the German Federal Ministry of Education and Research (Bundesminesterium fur Bildung and Forschung, BMBF). The funding organization Henkel AG & Co. KGaA supported authors (PK, SG, BB, MG, AS, TW, TF) as well as BMBF (PK, SG, BB, TW) in the form of salaries and in form of research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Ackermann K, 2010, SKIN PHARMACOL PHYS, V23, P105, DOI 10.1159/000265681; Bartosh TJ, 2010, P NATL ACAD SCI USA, V107, P13724, DOI 10.1073/pnas.1008117107; Bellas E, 2012, MACROMOL BIOSCI, V12, P1627, DOI 10.1002/mabi.201200262; Biedermann T, 2010, J INVEST DERMATOL, V130, P1996, DOI 10.1038/jid.2010.83; Bovell, 2015, J LOCAL GLOBAL HLTH, V2015, p[1, 5]; Bovell DL, 2008, EXP DERMATOL, V17, P505, DOI 10.1111/j.1600-0625.2007.00659.x; Bovell DL, 2013, EXP DERMATOL, V22, P141, DOI 10.1111/exd.12067; Cui CY, 2015, EXP DERMATOL, V24, P644, DOI 10.1111/exd.12773; Cui CY, 2012, P NATL ACAD SCI USA, V109, P1199, DOI 10.1073/pnas.1117213109; Diekmann J, 2016, EXP DERMATOL, V25, P56, DOI 10.1111/exd.12866; Du Q, 2016, DERMATOLOGY, V232, P150, DOI 10.1159/000444081; Ertongur-Fauth T, 2014, EXP DERMATOL, V23, P825, DOI 10.1111/exd.12543; HIBBS RG, 1958, AM J ANAT, V103, P201, DOI 10.1002/aja.1001030204; Zhijian HJ, 2016, CELL TISSUE BANK, V17, P317, DOI 10.1007/s10561-016-9548-7; Ishikawa Y, 1998, BIOCHEM BIOPH RES CO, V245, P835, DOI 10.1006/bbrc.1998.8395; Kreyden OP, 2004, CLIN DERMATOL, V22, P40, DOI 10.1016/j.clindermatol.2003.12.029; Kurata R, 2014, CELL STRUCT FUNCT, V39, P101, DOI 10.1247/csf.14009; Kurzen H, 2004, J INVEST DERMATOL, V123, P937, DOI 10.1111/j.0022-202X.2004.23425.x; LEE CM, 1989, J CELL SCI, V92, P241; Lei X, 2011, ANAT REC, V294, P1525, DOI 10.1002/ar.21459; Li H., 2015, WORLD J CONDENS MATT, V5, P10, DOI DOI 10.4236/JEP.2015.65044; Li HH, 2015, EXP CELL RES, V332, P67, DOI 10.1016/j.yexcr.2015.01.014; Li HH, 2014, ACTA HISTOCHEM, V116, P1237, DOI 10.1016/j.acthis.2014.07.005; Li HH, 2013, CELL TISSUE RES, V354, P897, DOI 10.1007/s00441-013-1718-3; Lindsay SL, 2008, BRIT J DERMATOL, V159, P653, DOI 10.1111/j.1365-2133.2008.08740.x; Lu CP, 2012, CELL, V150, P136, DOI 10.1016/j.cell.2012.04.045; Metze D, 1996, J INVEST DERMATOL, V106, P64, DOI 10.1111/1523-1747.ep12327258; Mork AC, 1996, ACTA PHYSIOL SCAND, V157, P21, DOI 10.1046/j.1365-201X.1996.450223000.x; Muchekehu RW, 2009, STEROIDS, V74, P212, DOI 10.1016/j.steroids.2008.10.013; Nagel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078365; Nejsum LN, 2002, P NATL ACAD SCI USA, V99, P511, DOI 10.1073/pnas.012588099; NOVAK I, 1992, PFLUG ARCH EUR J PHY, V422, P151, DOI 10.1007/BF00370414; Overeem AW, 2015, TRENDS CELL BIOL, V25, P476, DOI 10.1016/j.tcb.2015.04.002; Papadimitropoulos A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102359; Petschnik AE, 2010, BRIT J DERMATOL, V162, P380, DOI 10.1111/j.1365-2133.2009.09512.x; Pontiggia L, 2014, J INVEST DERMATOL, V134, P1735, DOI 10.1038/jid.2014.30; Reijnders CMA, 2015, TISSUE ENG PT A, V21, P2448, DOI [10.1089/ten.tea.2015.0139, 10.1089/ten.TEA.2015.0139]; RING A, 1995, CELL BIOL INT, V19, P265, DOI 10.1006/cbir.1995.1069; Ring A, 1997, BIOCHEM BIOPH RES CO, V234, P30, DOI 10.1006/bbrc.1997.9995; Saga K, 2002, PROG HISTOCHEM CYTO, V37, P323, DOI 10.1016/S0079-6336(02)80005-5; SARKANY I, 1965, J ANAT, V99, P359; SATO K, 1981, AM J PHYSIOL, V240, pR44, DOI 10.1152/ajpregu.1981.240.1.R44; SATO K, 1984, J CLIN INVEST, V73, P1763, DOI 10.1172/JCI111385; SATO K, 1989, J AM ACAD DERMATOL, V20, P537, DOI 10.1016/S0190-9622(89)70063-3; SATO K, 1977, REV PHYSIOL BIOCH P, V79, P51, DOI 10.1007/BFb0037089; Schittek B, 2001, NAT IMMUNOL, V2, P1133, DOI 10.1038/ni732; Schittek B, 2012, J INNATE IMMUN, V4, P349, DOI 10.1159/000336844; Schon M, 1999, J CELL SCI, V112, P1925; SCHULZ IJ, 1969, J CLIN INVEST, V48, P1470, DOI 10.1172/JCI106113; SCHWARTZ IL, 1956, J CLIN INVEST, V35, P114, DOI 10.1172/JCI103245; Servetnyk Z, 2007, EXP MOL PATHOL, V83, P47, DOI 10.1016/j.yexmp.2007.02.003; Tiede S, 2009, J INVEST DERMATOL, V129, P2711, DOI 10.1038/jid.2009.148; Tsukada T, 2013, ACTA HISTOCHEM CYTOC, V46, P121, DOI 10.1267/ahc.13015; Watabe A, 2013, J DERMATOL SCI, V72, P177, DOI 10.1016/j.jdermsci.2013.06.005; Wilke K., 2007, International Journal of Cosmetic Science, V29, P169, DOI 10.1111/j.1467-2494.2007.00387.x; Zanoni M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19103; Zhang MJ, 2014, ACTA HISTOCHEM, V116, P1374, DOI 10.1016/j.acthis.2014.08.010	57	20	25	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182752	10.1371/journal.pone.0182752	http://dx.doi.org/10.1371/journal.pone.0182752			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796813	Green Submitted, Green Published, gold			2022-12-26	WOS:000407396200093
J	Kutuk, O; Aytan, N; Karakas, B; Kurt, AG; Acikbas, U; Temel, SG; Basaga, H				Kutuk, Ozgur; Aytan, Nurgul; Karakas, Bahriye; Kurt, Asli Giray; Acikbas, Ufuk; Temel, Sehime Gulsun; Basaga, Huveyda			Biphasic ROS production, p53 and BIK dictate the mode of cell death in response to DNA damage in colon cancer cells	PLOS ONE			English	Article							LYSOSOMAL MEMBRANE PERMEABILIZATION; BH3-ONLY PROTEIN BIK; BCL-X-L; ENDOPLASMIC-RETICULUM; MEDIATED APOPTOSIS; OXIDATIVE STRESS; FAMILY PROTEINS; INDUCTION; MITOCHONDRIA; ACTIVATION	Necrosis, apoptosis and autophagic cell death are the main cell death pathways in multicellular organisms, all with distinct and overlapping cellular and biochemical features. DNA damage may trigger different types of cell death in cancer cells but the molecular events governing the mode of cell death remain elusive. Here we showed that increased BH3-only protein BIK levels promoted cisplatin-and UV-induced mitochondrial apoptosis and biphasic ROS production in HCT-116 wild-type cells. Nonetheless, early single peak of ROS formation along with lysosomal membrane permeabilization and cathepsin activation regulated cisplatin-and UV-induced necrosis in p53-null HCT-116 cells. Of note, necrotic cell death in p53-null HCT-116 cells did not depend on BIK, mitochondrial outer membrane permeabilization or caspase activation. These data demonstrate how cancer cells with different p53 background respond to DNA-damaging agents by integrating distinct cell signaling pathways dictating the mode of cell death.	[Kutuk, Ozgur; Kurt, Asli Giray; Acikbas, Ufuk] Baskent Univ, Adana Dr Turgut Noyan Med & Res Ctr, Dept Med Genet, Sch Med, Adana, Turkey; [Aytan, Nurgul] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Karakas, Bahriye; Basaga, Huveyda] Sabanci Univ, Genet & Bioengn Program, Mol Biol, Istanbul, Turkey; [Temel, Sehime Gulsun] Uludag Univ, Dept Histol & Embryol, Sch Med, Bursa, Turkey; [Temel, Sehime Gulsun] Near East Univ, Sch Med, Dept Histol & Embryol, Nicosia, Northern Cyprus, Turkey	Baskent University; Boston University; Sabanci University; Uludag University; Near East University	Kutuk, O (corresponding author), Baskent Univ, Adana Dr Turgut Noyan Med & Res Ctr, Dept Med Genet, Sch Med, Adana, Turkey.	ozgurkutuk@sabanciuniv.edu	KUTUK, OZGUR/AAH-1671-2019; karakas, bahriye/GOK-0965-2022; Karakas, Bahriye/GOP-0970-2022; Temel, Sehime/AAG-8385-2021	KUTUK, OZGUR/0000-0001-9854-7220; Temel, Sehime G/0000-0002-9802-0880	TUBITAK, Baskent University Research Fund [SBAG-113S481]; Science Academy	TUBITAK, Baskent University Research Fund; Science Academy	This work was supported by grants from TUBITAK (SBAG-113S481), Baskent University Research Fund and The Science Academy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from TUBITAK (SBAG-113S481), Baskent University Research Fund and The Science Academy.	Aits S, 2015, METHOD CELL BIOL, V126, P261, DOI 10.1016/bs.mcb.2014.10.032; Aits S, 2013, J CELL SCI, V126, P1905, DOI 10.1242/jcs.091181; Berndtsson M, 2007, INT J CANCER, V120, P175, DOI 10.1002/ijc.22132; Bhola PD, 2016, MOL CELL, V61, P695, DOI 10.1016/j.molcel.2016.02.019; Bodet L, 2010, BRIT J CANCER, V103, P1808, DOI 10.1038/sj.bjc.6605981; BOYD JM, 1995, ONCOGENE, V11, P1921; Bragado P, 2007, APOPTOSIS, V12, P1733, DOI 10.1007/s10495-007-0082-8; Brojatsch J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095032; Brunelle JK, 2009, J CELL BIOL, V187, P429, DOI 10.1083/jcb.200904049; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chinnadurai G, 2008, ONCOGENE, V27, pS20, DOI 10.1038/onc.2009.40; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Erdal H, 2005, P NATL ACAD SCI USA, V102, P192, DOI 10.1073/pnas.0408592102; Frame FM, 2016, CANCER MED-US, V5, P61, DOI 10.1002/cam4.553; Germain M, 2005, EMBO J, V24, P1546, DOI 10.1038/sj.emboj.7600592; Germain M, 2002, J BIOL CHEM, V277, P18053, DOI 10.1074/jbc.M201235200; Gurley KE, 2009, EMBO REP, V10, P87, DOI 10.1038/embor.2008.214; Hagenbuchner J, 2012, J CELL SCI, V125, P1191, DOI 10.1242/jcs.092098; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Happo L, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.42; Hur J, 2006, CANCER RES, V66, P10153, DOI 10.1158/0008-5472.CAN-05-3696; Jacobson LS, 2013, J BIOL CHEM, V288, P7481, DOI 10.1074/jbc.M112.400655; Kang MA, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.134; Kramer G, 2004, CANCER RES, V64, P1751, DOI 10.1158/0008-5472.CAN-03-2455; Kurz T, 2008, BBA-GEN SUBJECTS, V1780, P1291, DOI 10.1016/j.bbagen.2008.01.009; Le Pen J, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.400; Marullo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081162; Mathai JP, 2005, J BIOL CHEM, V280, P23829, DOI 10.1074/jbc.M500800200; Mathai JP, 2002, ONCOGENE, V21, P2534, DOI 10.1038/sj.onc.1205340; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; Montero J, 2013, CELL DEATH DIFFER, V20, P1465, DOI 10.1038/cdd.2013.52; Montero J, 2015, CELL, V160, P977, DOI 10.1016/j.cell.2015.01.042; Moore VD, 2013, CANCER LETT, V332, P202, DOI 10.1016/j.canlet.2011.12.021; Motani K, 2010, CANCER SCI, V101, P1822, DOI 10.1111/j.1349-7006.2010.01610.x; Oberle C, 2010, CELL DEATH DIFFER, V17, P1167, DOI 10.1038/cdd.2009.214; Oh SY, 2007, MOL CANCER THER, V6, P2178, DOI 10.1158/1535-7163.MCT-07-0111; Okamoto K, 2015, MOL CANCER RES, V13, P659, DOI 10.1158/1541-7786.MCR-14-0476; Oppermann M, 2005, ONCOGENE, V24, P7369, DOI 10.1038/sj.onc.1208890; Paquet C, 2005, LEUKEMIA, V19, P784, DOI 10.1038/sj.leu.2403717; Rashmi R, 2008, ONCOGENE, V27, P1366, DOI 10.1038/sj.onc.1210783; Real PJ, 2006, FEBS LETT, V580, P5905, DOI 10.1016/j.febslet.2006.08.088; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sarosiek KA, 2013, TRENDS CELL BIOL, V23, P612, DOI 10.1016/j.tcb.2013.08.003; Shimazu T, 2007, GENE DEV, V21, P929, DOI 10.1101/gad.1522007; Shin HJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep15798; Song EA, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081257; Spender LC, 2009, CELL DEATH DIFFER, V16, P593, DOI 10.1038/cdd.2008.183; Surova O, 2013, ONCOGENE, V32, P3789, DOI 10.1038/onc.2012.556; Troyano A, 2003, CELL DEATH DIFFER, V10, P889, DOI 10.1038/sj.cdd.4401249; Tu HC, 2009, P NATL ACAD SCI USA, V106, P1093, DOI 10.1073/pnas.0808173106; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P555, DOI 10.1038/sj.cdd.4402286; Xing FQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163935; Yamaguchi H, 2013, CLIN CANCER RES, V19, P845, DOI 10.1158/1078-0432.CCR-12-2621	54	13	15	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0182809	10.1371/journal.pone.0182809	http://dx.doi.org/10.1371/journal.pone.0182809			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28796811	Green Submitted, gold, Green Published			2022-12-26	WOS:000407396200099
J	Amato, P; Joly, M; Besaury, L; Oudart, A; Taib, N; Mone, AI; Deguillaume, L; Delort, AM; Debroas, D				Amato, Pierre; Joly, Muriel; Besaury, Ludovic; Oudart, Anne; Taib, Najwa; Mone, Anne I.; Deguillaume, Laurent; Delort, Anne-Marie; Debroas, Didier			Active microorganisms thrive among extremely diverse communities in cloud water	PLOS ONE			English	Article							AIRBORNE BACTERIAL COMMUNITIES; SP NOV.; METHYLOTROPHIC BACTERIA; ATMOSPHERIC PROCESSES; EMENDED DESCRIPTION; GLOBAL ATMOSPHERE; FUNGAL DIVERSITY; POTENTIAL IMPACT; ICE NUCLEI; DOME	Clouds are key components in Earth's functioning. In addition of acting as obstacles to light radiations and chemical reactors, they are possible atmospheric oases for airborne microorganisms, providing water, nutrients and paths to the ground. Microbial activity was previously detected in clouds, but the microbial community that is active in situ remains unknown. Here, microbial communities in cloud water collected at puy de Do A me Mountain's meteorological station (1465 m altitude, France) were fixed upon sampling and examined by high-throughput sequencing from DNA and RNA extracts, so as to identify active species among community members. Communities consisted of similar to 10(3)-10(4) bacteria and archaea mL(-1) and similar to 10(2)-10(3) eukaryote cells mL(-1). They appeared extremely rich, with more than 28 000 distinct species detected in bacteria and 2 600 in eukaryotes. Proteobacteria and Bacteroidetes largely dominated in bacteria, while eukaryotes were essentially distributed among Fungi, Stramenopiles and Alveolata. Within these complex communities, the active members of cloud microbiota were identified as Alpha-(Sphingomonadales, Rhodospirillales and Rhizobiales), Beta-(Burkholderiales) and Gamma-Proteobacteria (Pseudomonadales). These groups of bacteria usually classified as epiphytic are probably the best candidates for interfering with abiotic chemical processes in clouds, and the most prone to successful aerial dispersion.	[Amato, Pierre; Joly, Muriel; Besaury, Ludovic; Oudart, Anne; Delort, Anne-Marie] Univ Clermont Auvergne, CNRS, Inst Chim Clermont Ferrand, Clermont Ferrand, France; [Amato, Pierre; Oudart, Anne; Taib, Najwa; Mone, Anne I.; Debroas, Didier] Univ Clermont Auvergne, CNRS, Lab Microorganismes Genome & Environm, Clermont Ferrand, France; [Deguillaume, Laurent] Univ Clermont Auvergne, CNRS, Observ Phys Globe, Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA)	Amato, P (corresponding author), Univ Clermont Auvergne, CNRS, Inst Chim Clermont Ferrand, Clermont Ferrand, France.; Amato, P (corresponding author), Univ Clermont Auvergne, CNRS, Lab Microorganismes Genome & Environm, Clermont Ferrand, France.	pierre.amato@uca.fr	Amato, Pierre/E-8912-2018	Amato, Pierre/0000-0003-3486-0714; BESAURY, Ludovic/0000-0002-1463-1239; Amato, Pierre/0000-0003-3168-0398; Deguillaume, Laurent/0000-0002-3187-4793	CNRS MicrobiEN program, "FONCOMIC" project;  [ANR-15-CE01-0002];  [ANR-DFG-14-CE35-005-02]	CNRS MicrobiEN program, "FONCOMIC" project; ; 	Funding provided by CNRS MicrobiEN program (http://www.insu.cnrs.fr/ec2co), "FONCOMIC" project, attributed to PA. MJ and LB were hired on the projects ANR-15-CE01-0002 ("INHALE") and ANR-DFG-14-CE35-005-02 ("CHLOROFILTER"), respectively.	Ahern HE, 2007, BIOGEOSCIENCES, V4, P115, DOI 10.5194/bg-4-115-2007; Aller JY, 2005, J AEROSOL SCI, V36, P801, DOI 10.1016/j.jaerosci.2004.10.012; Amato P, 2007, ATMOS CHEM PHYS, V7, P4159, DOI 10.5194/acp-7-4159-2007; Amato P, 2005, ATMOS ENVIRON, V39, P4143, DOI 10.1016/j.atmosenv.2005.04.002; Amato P, 2015, ATMOS CHEM PHYS, V15, P6455, DOI 10.5194/acp-15-6455-2015; Amato P, 2007, ATMOS ENVIRON, V41, P8253, DOI 10.1016/j.atmosenv.2007.06.022; Amato P, 2007, FEMS MICROBIOL ECOL, V59, P242, DOI 10.1111/j.1574-6941.2006.00199.x; Baldrian P, 2012, ISME J, V6, P248, DOI 10.1038/ismej.2011.95; Barberan A, 2014, SCI TOTAL ENVIRON, V487, P187, DOI 10.1016/j.scitotenv.2014.04.030; Battista JR, 1997, ANNU REV MICROBIOL, V51, P203, DOI 10.1146/annurev.micro.51.1.203; Bigg EK, 2015, ATMOS CHEM PHYS, V15, P2313, DOI 10.5194/acp-15-2313-2015; BLANCHARD DC, 1982, APPL ENVIRON MICROB, V43, P1001, DOI 10.1128/AEM.43.5.1001-1005.1982; Bowers RM, 2013, ENVIRON SCI TECHNOL, V47, P12097, DOI 10.1021/es402970s; Bowers RM, 2011, ISME J, V5, P601, DOI 10.1038/ismej.2010.167; Bowers RM, 2009, APPL ENVIRON MICROB, V75, P5121, DOI 10.1128/AEM.00447-09; Bridge TAM, 2000, GEOMICROBIOL J, V17, P193; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; Burrows SM, 2009, ATMOS CHEM PHYS, V9, P9263, DOI 10.5194/acp-9-9263-2009; Burrows SM, 2009, ATMOS CHEM PHYS, V9, P9281, DOI 10.5194/acp-9-9281-2009; Busse HJ, 2003, INT J SYST EVOL MICR, V53, P1253, DOI 10.1099/ijs.0.02461-0; Camarinha-Silva A, 2014, ENVIRON MICROBIOL, V16, P2939, DOI 10.1111/1462-2920.12362; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Cho BC, 2014, ATMOS ENVIRON, V94, P409, DOI 10.1016/j.atmosenv.2014.05.048; CONSTANTINIDOU HA, 1990, PHYTOPATHOLOGY, V80, P934, DOI 10.1094/Phyto-80-934; Copeland JK, 2015, MOL PLANT MICROBE IN, V28, P274, DOI 10.1094/MPMI-10-14-0331-FI; CORPE WA, 1989, FEMS MICROBIOL ECOL, V62, P243, DOI 10.1111/j.1574-6968.1989.tb03698.x; Creamean JM, 2013, SCIENCE, V339, P1572, DOI 10.1126/science.1227279; Curtis TP, 2004, CURR OPIN MICROBIOL, V7, P221, DOI 10.1016/j.mib.2004.04.010; de Wit R, 2006, ENVIRON MICROBIOL, V8, P755, DOI 10.1111/j.1462-2920.2006.01017.x; Deguillaume L, 2014, ATMOS CHEM PHYS, V14, P1485, DOI 10.5194/acp-14-1485-2014; DeLeon-Rodriguez N, 2013, P NATL ACAD SCI USA, V110, P2575, DOI 10.1073/pnas.1212089110; Despres VR, 2012, TELLUS B, V64, DOI 10.3402/tellusb.v64i0.15598; Dueker ME, 2012, BIOGEOSCIENCES, V9, P803, DOI 10.5194/bg-9-803-2012; Emelyanov VV, 2001, FEBS LETT, V501, P11, DOI 10.1016/S0014-5793(01)02618-7; Fahlgren C, 2011, AEROBIOLOGIA, V27, P107, DOI 10.1007/s10453-010-9181-z; Fahlgren C, 2010, APPL ENVIRON MICROB, V76, P3015, DOI 10.1128/AEM.02092-09; Finster KW, 2009, INT J SYST EVOL MICR, V59, P839, DOI 10.1099/ijs.0.002725-0; Foght J, 2004, MICROB ECOL, V47, P329, DOI 10.1007/s00248-003-1036-5; Frohlich-Nowoisky J, 2012, BIOGEOSCIENCES, V9, P1125, DOI 10.5194/bg-9-1125-2012; Frohlich-Nowoisky J, 2009, P NATL ACAD SCI USA, V106, P12814, DOI 10.1073/pnas.0811003106; Fuzzi S, 1997, ATMOS ENVIRON, V31, P287, DOI 10.1016/1352-2310(96)00160-4; Gales A, 2015, ATMOS ENVIRON, V107, P225, DOI 10.1016/j.atmosenv.2015.02.035; Gast RK, 2004, AVIAN DIS, V48, P148, DOI 10.1637/7086; Gnanamanickam S.S., 2007, PLANT ASS BACTERIA; Griffin D.W., 2001, AEROBIOLOGIA BOLOGNA, V17, P203, DOI [10.1023/A:1011868218901, DOI 10.1023/A:1011868218901]; Griffin DW, 2007, CLIN MICROBIOL REV, V20, P459, DOI 10.1128/CMR.00039-06; HABER CL, 1983, SCIENCE, V221, P1147, DOI 10.1126/science.221.4616.1147; Haritash AK, 2009, J HAZARD MATER, V169, P1, DOI 10.1016/j.jhazmat.2009.03.137; Herrmann H, 2015, CHEM REV, V115, P4259, DOI 10.1021/cr500447k; Hill KA, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008002; Huffman J. A., 2013, ATMOS CHEM PHYS DISC, V13, P1767, DOI DOI 10.5194/ACPD-13-1767-2013; Hughes JB, 2001, APPL ENVIRON MICROB, V67, P4399, DOI 10.1128/AEM.67.10.4399-4406.2001; Joly M, 2014, ATMOS CHEM PHYS, V14, P8185, DOI 10.5194/acp-14-8185-2014; Joly M, 2015, ATMOS ENVIRON, V117, P92, DOI 10.1016/j.atmosenv.2015.07.009; Joung YS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14668; Kim M, 2011, J MICROBIOL METH, V84, P81, DOI 10.1016/j.mimet.2010.10.020; Kivlin SN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159131; Klein AM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00772; Kourtev PS, 2011, ATMOS ENVIRON, V45, P5399, DOI 10.1016/j.atmosenv.2011.06.041; Krumins V, 2014, ENVIRON SCI TECH LET, V1, P376, DOI 10.1021/ez500245y; Lee JJ, 2015, J MICROBIOL, V53, P429, DOI 10.1007/s12275-015-5008-5; LINDEMANN J, 1982, APPL ENVIRON MICROB, V44, P1059, DOI 10.1128/AEM.44.5.1059-1063.1982; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; Luo J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09448; Maki T, 2017, ATMOS CHEM PHYS DISC, V2017, P1, DOI DOI 10.5194/ACP-2016-1095; Mangot JF, 2013, ENVIRON MICROBIOL, V15, P1745, DOI 10.1111/1462-2920.12065; Marinoni A, 2004, ATMOS CHEM PHYS, V4, P715, DOI 10.5194/acp-4-715-2004; Maron PA, 2005, ATMOS ENVIRON, V39, P3687, DOI 10.1016/j.atmosenv.2005.03.002; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mohler O, 2007, BIOGEOSCIENCES, V4, P1059; Monteil CL, 2014, ISME J, V8, P2290, DOI 10.1038/ismej.2014.55; Morris CE, 2011, BIOGEOSCIENCES, V8, P17, DOI 10.5194/bg-8-17-2011; Morris CE, 2017, IMPACTS MICROBIAL AE; Morris CE, 2008, ISME J, V2, P321, DOI 10.1038/ismej.2007.113; Nadalig T, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00523; Neef A, 1999, J IND MICROBIOL BIOT, V23, P261, DOI 10.1038/sj.jim.2900768; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; O'Brien SL, 2016, ENVIRON MICROBIOL, V18, P2039, DOI 10.1111/1462-2920.13231; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Perlman SJ, 2006, P ROY SOC B-BIOL SCI, V273, P2097, DOI 10.1098/rspb.2006.3541; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Price PB, 2004, P NATL ACAD SCI USA, V101, P4631, DOI 10.1073/pnas.0400522101; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; R Core Team, 2011, R LANG ENV STAT COMP; Renard P, 2016, ATMOS CHEM PHYS, V16, P12347, DOI 10.5194/acp-16-12347-2016; Santl-Temkiv T, 2013, AEROBIOLOGIA, P1; Santl-Temkiv T., 2012, FEMS MICROBIOL ECOL, V81, P684; Sattler B, 2001, GEOPHYS RES LETT, V28, P239, DOI 10.1029/2000GL011684; Smith DJ, 2013, APPL ENVIRON MICROB, V79, P1134, DOI 10.1128/AEM.03029-12; Smith DJ, 2011, AEROBIOLOGIA, V27, P319, DOI 10.1007/s10453-011-9203-5; Stadler M, 2005, CHEMOTAXONOMY XYLARI; STALEY JT, 1987, INT J SYST BACTERIOL, V37, P289, DOI 10.1099/00207713-37-3-289; Stoddard SF, 2015, NUCLEIC ACIDS RES, V43, pD593, DOI 10.1093/nar/gku1201; Stopelli E, 2015, SCI REP-UK, V5, DOI 10.1038/srep16433; Taib N, 2012, EPANAM WEB SERVER DE; Taib N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058950; Vaitilingom M, 2013, P NATL ACAD SCI USA, V110, P559, DOI 10.1073/pnas.1205743110; Vaitilingom M, 2012, ATMOS ENVIRON, V56, P88, DOI 10.1016/j.atmosenv.2012.03.072; Vaitilingom M, 2010, APPL ENVIRON MICROB, V76, P23, DOI 10.1128/AEM.01127-09; Vaz-Moreira I, 2011, APPL ENVIRON MICROB, V77, P5697, DOI 10.1128/AEM.00579-11; Vinatier V, 2016, ENVIRON SCI TECHNOL, V50, P9315, DOI 10.1021/acs.est.6b02335; Wakao N, 1996, PLANT CELL PHYSIOL, V37, P889, DOI 10.1093/oxfordjournals.pcp.a029029; Wei M, 2016, ATMOS CHEM PHYS DISC, P1, DOI DOI 10.5194/ACP-2016-776; Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wittebolle L, 2009, NATURE, V458, P623, DOI 10.1038/nature07840; Wittmaack K, 2005, SCI TOTAL ENVIRON, V346, P244, DOI 10.1016/j.scitotenv.2004.11.009; Womack AM, 2015, BIOGEOSCIENCES, V12, P6337, DOI 10.5194/bg-12-6337-2015; Womack AM, 2010, PHILOS T R SOC B, V365, P3645, DOI 10.1098/rstb.2010.0283; Xu CH, 2017, SCI TOTAL ENVIRON, V580, P258, DOI 10.1016/j.scitotenv.2016.12.081; Youssef NH, 2008, J MICROBIOL METH, V75, P86, DOI 10.1016/j.mimet.2008.05.009; Zeileis A., 2014, INEQ MEASURING INEQU; Zhang Y, 2009, STUD MYCOL, P85, DOI 10.3114/sim.2009.64.04; Zhang Y, 2014, MOL ECOL, V23, P2260, DOI 10.1111/mec.12739; Zhao TL, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003363; Zweifel UL, 2012, AEROBIOLOGIA, V28, P481, DOI 10.1007/s10453-012-9250-6	117	70	70	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2017	12	8							e0182869	10.1371/journal.pone.0182869	http://dx.doi.org/10.1371/journal.pone.0182869			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9EU	28792539	Green Published, gold, Green Submitted			2022-12-26	WOS:000407144700043
J	Chiodelli, P; Rezzola, S; Urbinati, C; Signori, FF; Monti, E; Ronca, R; Presta, M; Rusnati, M				Chiodelli, P.; Rezzola, S.; Urbinati, C.; Signori, F. Federici; Monti, E.; Ronca, R.; Presta, M.; Rusnati, M.			Contribution of vascular endothelial growth factor receptor-2 sialylation to the process of angiogenesis	ONCOGENE			English	Article							CHORIOALLANTOIC MEMBRANE; ALPHA(V)BETA(3) INTEGRIN; LECTIN HISTOCHEMISTRY; CELL ADHESION; SIALIC ACIDS; EXPRESSION; SURFACE; GLYCOSYLATION; ACTIVATION; PROTEOGLYCAN	Vascular endothelial growth factor receptor-2 (VEGFR2) is the main pro-angiogenic receptor expressed by endothelial cells (ECs). Using surface plasmon resonance, immunoprecipitation, enzymatic digestion, immunofluorescence and cross-linking experiments with specific sugar-binding lectins, we demonstrated that VEGFR2 bears both alpha,1-fucose and alpha(2,6)-linked sialic acid (NeuAc). However, only the latter is required for VEGF binding to VEGFR2 and consequent VEGF-dependent VEGFR2 activation and motogenic response in ECs. Notably, downregulation of beta-galactoside alpha(2,6)-sialyltransferase expression by short hairpin RNA transduction inhibits VEGFR2 alpha(2,6) sialylation that is paralleled by an increase of beta-galactoside alpha(2,3)-sialyltransferase expression. This results in an ex-novo alpha(2,3)-NeuAc sialylation of the receptor that functionally replaces the lacking alpha(2,6)-NeuAc, thus allowing VEGF/VEGFR2 interaction. In keeping with the role of VEGFR2 sialylation in angiogenesis, the alpha(2,6)-NeuAc-binding lectin Sambucus nigra (SNA) prevents VEGF-dependent VEGFR2 autophosphorylation and EC motility, proliferation and motogenesis. In addition, SNA exerts a VEGF-antagonist activity in tridimensional angiogenesis models in vitro and in the chick-embryo chorioallantoic membrane neovascularization assay and mouse matrigel plug assay in vivo. In conclusion, VEGFR2-associated NeuAc plays an important role in modulating VEGF/VEGFR2 interaction, EC pro-angiogenic activation and neovessel formation. VEGFR2 sialylation may represent a target for the treatment of angiogenesis-dependent diseases.	[Chiodelli, P.; Rezzola, S.; Urbinati, C.; Signori, F. Federici; Ronca, R.; Presta, M.; Rusnati, M.] Univ Brescia, Unit Expt Oncol, Brescia, Italy; [Chiodelli, P.; Rezzola, S.; Urbinati, C.; Signori, F. Federici; Ronca, R.; Presta, M.; Rusnati, M.] Univ Brescia, Unit Immunol, Brescia, Italy; [Monti, E.] Univ Brescia, Unit Biotechnol, Dept Mol & Translat Med, Brescia, Italy	University of Brescia; University of Brescia; University of Brescia	Chiodelli, P; Rusnati, M (corresponding author), Dept Mol & Translat Med, Expt Oncol & Immunol, Viale Europa 11, I-25123 Brescia, Italy.	paola.chiodelli@unibs.it; marco.rusnati@unibs.it	Rezzola, Sara/AAE-8980-2020; Rezzola, Sara/AAA-2745-2019; Ronca, Roberto/AAC-6470-2022; Rusnati, Marco/F-1168-2010	Rezzola, Sara/0000-0003-1193-8929; Ronca, Roberto/0000-0001-8979-7068; Rusnati, Marco/0000-0001-9968-5908; PRESTA, Marco/0000-0002-4398-8376; Urbinati, Chiara Eva/0000-0002-0138-7871	Ministero dell'Istruzione, Universita e Ricerca (MIUR); Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG 18943, MFAG 18459]; AIRC	Ministero dell'Istruzione, Universita e Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); AIRC(Fondazione AIRC per la ricerca sul cancro)	This work was supported by grant from Ministero dell'Istruzione, Universita e Ricerca (MIUR) (ex 60%) to MR and by IG 18943 and MFAG 18459 grants from Associazione Italiana per la Ricerca sul Cancro (AIRC) to MP and RR, respectively. PC and SR were supported by AIRC Fellowships.	Abe Y, 1999, J IMMUNOL, V163, P2867; Antony P, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-901; BORN GVR, 1985, BRIT J EXP PATHOL, V66, P543; Brambilla A, 2015, INT J BIOCHEM CELL B, V69, P95, DOI 10.1016/j.biocel.2015.10.005; Brozzo MS, 2012, BLOOD, V119, P1781, DOI 10.1182/blood-2011-11-390922; Bugatti A, 2013, J BIOL CHEM, V288, P1150, DOI 10.1074/jbc.M112.400077; Cai J, 2012, EMBO MOL MED, V4, P980, DOI 10.1002/emmm.201101084; Chandler KB, 2017, J PROTEOME RES, V16, P677, DOI 10.1021/acs.jproteome.6b00738; Chen JY, 2011, CANCER RES, V71, P473, DOI 10.1158/0008-5472.CAN-10-1303; Chiodelli P, 2012, J BIOL CHEM, V287, P20456, DOI 10.1074/jbc.M111.337139; Chiodelli P, 2011, ARTERIOSCL THROM VAS, V31, pE116, DOI 10.1161/ATVBAHA.111.235184; Chuang IC, 2015, LIFE SCI, V139, P52, DOI 10.1016/j.lfs.2015.08.002; Cioffi DL, 2012, AM J PHYSIOL-LUNG C, V302, pL1067, DOI 10.1152/ajplung.00190.2011; Claesson-Welsh L, 2013, J INTERN MED, V273, P114, DOI 10.1111/joim.12019; Coltrini D, 2013, ANGIOGENESIS, V16, P469, DOI 10.1007/s10456-012-9324-7; Croci DO, 2014, GLYCOBIOLOGY, V24, P1283, DOI 10.1093/glycob/cwu083; Croci DO, 2014, CELL, V156, P744, DOI 10.1016/j.cell.2014.01.043; DENG X, 2017, SCI REP UK, V7; Doiron AL, 2004, TECH PAPERS ISA, V449, P331; Esko JD, 1991, CURR OPIN CELL BIOL, V3, P805, DOI 10.1016/0955-0674(91)90054-3; Fairbrother WJ, 1998, STRUCT FOLD DES, V6, P637, DOI 10.1016/S0969-2126(98)00065-3; FERRARA N, 1991, J CELL BIOCHEM, V47, P211, DOI 10.1002/jcb.240470305; Franklin MC, 2011, STRUCTURE, V19, P1097, DOI 10.1016/j.str.2011.01.019; Fuh G, 2000, J BIOL CHEM, V275, P26690; Garcia-Vallejo JJ, 2006, J CELL PHYSIOL, V206, P203, DOI 10.1002/jcp.20458; Cabral MG, 2010, IMMUNOL LETT, V131, P89, DOI 10.1016/j.imlet.2010.02.009; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Henry CBS, 1996, TISSUE CELL, V28, P449, DOI 10.1016/S0040-8166(96)80030-9; Hutchings H, 2003, FASEB J, V17, P1520, DOI 10.1096/fj.02-0691fje; Kitazume S, 2014, J BIOL CHEM, V289, P27604, DOI 10.1074/jbc.M114.563585; Koch S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006502; Lauder H, 1998, Angiogenesis, V2, P67, DOI 10.1023/A:1009006527462; Lee C, 2014, J BIOL CHEM, V289, P9121, DOI 10.1074/jbc.M114.555888; Lee JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056211; Leppanen VM, 2010, P NATL ACAD SCI USA, V107, P2425, DOI 10.1073/pnas.0914318107; Liu WS, 1998, CELL SIGNAL, V10, P529, DOI 10.1016/S0898-6568(98)00012-6; Manning JC, 2004, HISTOL HISTOPATHOL, V19, P1043, DOI 10.14670/HH-19.1043; Marino K, 2010, NAT CHEM BIOL, V6, P713, DOI [10.1038/nchembio.437, 10.1038/NCHEMBIO.437]; Markowska AI, 2011, J BIOL CHEM, V286, P29913, DOI 10.1074/jbc.M111.226423; Mitola S, 2008, BLOOD, V112, P1154, DOI 10.1182/blood-2007-09-111450; Miyagawa S, 2010, XENOTRANSPLANTATION, V17, P61, DOI 10.1111/j.1399-3089.2009.00565.x; Monaco L, 1996, CYTOTECHNOLOGY, V22, P197, DOI 10.1007/BF00353939; Nacev BA, 2011, J BIOL CHEM, V286, P44045, DOI 10.1074/jbc.M111.278754; PEVERALI FA, 1994, J CELL PHYSIOL, V161, P1, DOI 10.1002/jcp.1041610102; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Rahimi N, 2015, PROTEOMICS, V15, P300, DOI 10.1002/pmic.201400183; Ravelli C, 2013, ANGIOGENESIS, V16, P235, DOI 10.1007/s10456-012-9309-6; Rezzola S, 2013, EXP EYE RES, V112, P51, DOI 10.1016/j.exer.2013.04.014; Ribatti D, 2012, METHODS MOL BIOL, V843, P47, DOI 10.1007/978-1-61779-523-7_5; Roskoski R, 2008, BIOCHEM BIOPH RES CO, V375, P287, DOI 10.1016/j.bbrc.2008.07.121; Safina G, 2012, ANAL CHIM ACTA, V712, P9, DOI 10.1016/j.aca.2011.11.016; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; SHIBUYA N, 1987, J BIOL CHEM, V262, P1596; Stabile H, 2007, BLOOD, V109, P1834, DOI 10.1182/blood-2006-06-032276; TAATJES DJ, 1988, J BIOL CHEM, V263, P6302; Takahashi T, 1997, ONCOGENE, V14, P2079, DOI 10.1038/sj.onc.1201047; Tao Q, 2001, J BIOL CHEM, V276, P21916, DOI 10.1074/jbc.M100763200; Tatsuzuki A, 2009, ARCH HISTOL CYTOL, V72, P35, DOI 10.1679/aohc.72.35; Urbinati C, 2004, FEBS LETT, V568, P171, DOI 10.1016/j.febslet.2004.05.033; WANG WC, 1988, J BIOL CHEM, V263, P4576; Windwarder M, 2016, GLYCOCONJUGATE J, V33, P387, DOI 10.1007/s10719-015-9602-x	61	23	24	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 23	2017	36	47					6531	6541		10.1038/onc.2017.243	http://dx.doi.org/10.1038/onc.2017.243			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	FN5LN	28783175				2022-12-26	WOS:000416049200003
J	Albritton, HL; Kozlowski, PA; Lillis, RA; McGowin, CL; Siren, JD; Taylor, SN; Ibana, JA; Buckner, LR; Shen, L; Quayle, AJ				Albritton, Hannah L.; Kozlowski, Pamela A.; Lillis, Rebecca A.; McGowin, Chris L.; Siren, Julia D.; Taylor, Stephanie N.; Ibana, Joyce A.; Buckner, Lyndsey R.; Shen, Li; Quayle, Alison J.			A novel whole-bacterial enzyme linked-immunosorbant assay to quantify Chlamydia trachomatis specific antibodies reveals distinct differences between systemic and genital compartments	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; FAMILY-PLANNING CLINICS; MONOCLONAL-ANTIBODY; TRACT INFECTION; INTRACELLULAR NEUTRALIZATION; PROTECTIVE IMMUNITY; ACQUIRED-IMMUNITY; MEMBRANE-PROTEIN; HUMAN ENDOCERVIX; SECRETORY IGA	Chlamydia trachomatis (CT) is the leading sexually transmitted bacterial infection. The continued global burden of CT infection strongly predicates the need for a vaccine to supplement current chlamydial control programs. The correlates of protection against CT are currently unknown, but they must be carefully defined to guide vaccine design. The localized nature of chlamydial infection in columnar epithelial cells of the genital tract necessitates investigation of immunity at the site of infection. The purpose of this study was to develop a sensitive whole bacterial enzyme-linked immunosorbent assay (ELISA) to quantify and compare CT-specific IgG and IgA in sera and genital secretions from CT-infected women. To achieve this, elementary bodies (EBs) from two of the most common genital serovars (D and E) were attached to poly-L-lysine-coated microtiter plates with glutaraldehyde. EB attachment and integrity were verified by the presence of outer membrane antigens and the absence of bacterial cytoplasmic antigens. EB-specific IgG and IgA standards were developed by pooling sera with high titers of CT-specific antibodies from infected women. Serum, endocervical and vaginal secretions, and endocervical cytobrush specimens from CT-infected women were used to quantify CT-specific IgG and IgA which were then normalized to total IgG and IgA, respectively. Analyses of paired serum and genital samples revealed significantly higher proportions of EB-specific antibodies in genital secretions compared to sera. Cervical and vaginal secretions and cytobrush specimens had similar proportions of EB-specific antibodies, suggesting any one of these genital sampling techniques could be used to quantify CT-specific antibodies when appropriate normalization methodologies are implemented. Overall, these results illustrate the need to investigate genital tract CT antibody responses, and our assay provides a useful quantitative tool to assess natural immunity in defined clinical groups and CT vaccine trials.	[Albritton, Hannah L.; Kozlowski, Pamela A.; McGowin, Chris L.; Ibana, Joyce A.; Buckner, Lyndsey R.; Shen, Li; Quayle, Alison J.] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA 70803 USA; [Lillis, Rebecca A.; Siren, Julia D.; Taylor, Stephanie N.] Louisiana State Univ, Hlth Sci Ctr, Dept Med, Div Infect Dis, New Orleans, LA USA; [Ibana, Joyce A.] Univ Philippines Diliman, Inst Biol, Natl Capital Reg, Quezon City, Philippines	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of the Philippines System; University of the Philippines Diliman	Quayle, AJ (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA 70803 USA.	aquayl@lsuhsc.edu	TAYLOR, STEPHANIE/GYV-4768-2022		Louisiana Vaccine Center - Louisiana Board of Regents; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104940] Funding Source: NIH RePORTER	Louisiana Vaccine Center - Louisiana Board of Regents; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Louisiana Vaccine Center funded by the Louisiana Board of Regents. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDISS DG, 1993, SEX TRANSM DIS, V20, P28, DOI 10.1097/00007435-199301000-00006; Aiyar A, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00072; Armitage CW, 2014, IMMUNOLOGY, V143, P520, DOI 10.1111/imm.12317; Armitage CW, 2014, IMMUNOL CELL BIOL, V92, P417, DOI 10.1038/icb.2013.110; Bai Y, 2011, P NATL ACAD SCI USA, V108, P18406, DOI 10.1073/pnas.1115348108; BAKE AWLV, 1992, CELL IMMUNOL, V144, P417, DOI 10.1016/0008-8749(92)90256-O; Bakshi R, 2017, J INFECT DIS; BATTEIGER BE, 1989, J INFECT DIS, V160, P332, DOI 10.1093/infdis/160.2.332; Bidgood SR, 2014, P NATL ACAD SCI USA, V111, P13463, DOI 10.1073/pnas.1410980111; BIESBROCK AR, 1991, INFECT IMMUN, V59, P3492, DOI 10.1128/IAI.59.10.3492-3497.1991; Bode J, 2012, PLOS ONE, V7; Bomsel M, 1998, IMMUNITY, V9, P277, DOI 10.1016/S1074-7613(00)80610-X; BRADE L, 1990, INFECT IMMUN, V58, P205, DOI 10.1128/IAI.58.1.205-213.1990; BRIONES OC, 1974, J IMMUNOL, V113, P1262; Brunham RC, 1996, J INFECT DIS, V173, P950, DOI 10.1093/infdis/173.4.950; BRUNHAM RC, 1983, INFECT IMMUN, V39, P1491, DOI 10.1128/IAI.39.3.1491-1494.1983; Brunham RC, 2013, J INFECT DIS, V207, P1796, DOI 10.1093/infdis/jit095; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Castell S, 2014, BUNDESGESUNDHEITSBLA, V57, P1270, DOI 10.1007/s00103-014-2054-9; CAVACINI LA, 1993, J ACQ IMMUN DEF SYND, V6, P1093; Cotter TW, 1997, INFECT IMMUN, V65, P2145, DOI 10.1128/IAI.65.6.2145-2152.1997; Crane DD, 2006, P NATL ACAD SCI USA, V103, P1894, DOI 10.1073/pnas.0508983103; CROWLEYNOWICK PA, 1995, AM J REPROD IMMUNOL, V34, P241, DOI 10.1111/j.1600-0897.1995.tb00948.x; Darville T, 2010, J INFECT DIS, V201, pS114, DOI 10.1086/652397; Dehon PM, 2014, J CLIN MICROBIOL, V52, P2398, DOI 10.1128/JCM.00159-14; Fine D, 2008, SEX TRANSM DIS, V35, P47, DOI 10.1097/OLQ.0b013e31813e0c26; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Frohlich K, 2012, J MICROBIOL METH, V91, P222, DOI 10.1016/j.mimet.2012.08.012; Gallichan WS, 1996, J EXP MED, V184, P1879, DOI 10.1084/jem.184.5.1879; Geisler WM, 2008, SEX TRANSM DIS, V35, P119, DOI 10.1097/OLQ.0b013e318151497d; Geisler WM, 2006, SEX TRANSM DIS, V33, P621, DOI 10.1097/01.olq.0000216027.71144.74; Geisler WM, 2013, J INFECT DIS, V207, P1850, DOI 10.1093/infdis/jit094; Geisler WM, 2012, J INFECT DIS, V206, P1836, DOI 10.1093/infdis/jis621; Geisler WM, 2010, J INFECT DIS, V201, pS104, DOI 10.1086/652402; Ghys PD, 1997, AIDS, V11, pF85, DOI 10.1097/00002030-199712000-00001; Golden MR, 2000, SEX TRANSM DIS, V27, P329, DOI 10.1097/00007435-200007000-00006; GRAYSTON JT, 1985, REV INFECT DIS, V7, P717; HAJIMORAD MR, 1991, J VIROL METHODS, V33, P13, DOI 10.1016/0166-0934(91)90003-I; HANNA L, 1982, J CLIN MICROBIOL, V16, P895, DOI 10.1128/JCM.16.5.895-900.1982; HARE MJ, 1981, BRIT J OBSTET GYNAEC, V88, P174, DOI 10.1111/j.1471-0528.1981.tb00964.x; Hildesheim A, 1999, J IMMUNOL METHODS, V225, P131, DOI 10.1016/S0022-1759(99)00037-X; Hosenfeld CB, 2009, SEX TRANSM DIS, V36, P478, DOI 10.1097/OLQ.0b013e3181a2a933; Huang YT, 2005, J IMMUNOL, V174, P4828, DOI 10.4049/jimmunol.174.8.4828; Ibana JA, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-66; ISON CA, 1981, J CLIN PATHOL, V34, P1040, DOI 10.1136/jcp.34.9.1040; Johansson M, 2003, CURR OPIN INFECT DIS, V16, P43, DOI 10.1097/00001432-200302000-00008; KATZ BP, 1987, SEX TRANSM DIS, V14, P160, DOI 10.1097/00007435-198707000-00008; Kimani J, 1996, J INFECT DIS, V173, P1437, DOI 10.1093/infdis/173.6.1437; Klaes R, 1999, CANCER RES, V59, P6132; KOZLOWSKI PA, 1994, AIDS RES HUM RETROV, V10, P813, DOI 10.1089/aid.1994.10.813; Kozlowski PA, 2000, J ACQ IMMUN DEF SYND, V24, P297; Kozlowski PA, 2002, J IMMUNOL, V169, P566, DOI 10.4049/jimmunol.169.1.566; KRIEGER JN, 1988, JAMA-J AM MED ASSOC, V259, P1223, DOI 10.1001/jama.259.8.1223; Lamm ME, 1997, ANNU REV MICROBIOL, V51, P311, DOI 10.1146/annurev.micro.51.1.311; Levine MM, 2000, J PEDIATR GASTR NUTR, V31, P336, DOI 10.1097/00005176-200010000-00003; Lewis ME, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00071; Li LX, 2015, IMMUNOL LETT, V164, P88, DOI 10.1016/j.imlet.2015.02.004; Li ZL, 2011, P NATL ACAD SCI USA, V108, P4388, DOI 10.1073/pnas.1012861108; Mertz KJ, 2002, SEX TRANSM DIS, V29, P834, DOI 10.1097/00007435-200212000-00016; Mestecky J, 1999, J INFECT DIS, V179, pS470, DOI 10.1086/314806; Mestecky J, 2011, AIDS RES HUM RETROV, V27, P469, DOI 10.1089/aid.2010.0169; MOLDOVEANU Z, 1995, VACCINE, V13, P1006, DOI 10.1016/0264-410X(95)00016-T; MOORE JP, 1993, J VIROL, V67, P4785, DOI 10.1128/JVI.67.8.4785-4796.1993; Moore T, 2003, J INFECT DIS, V188, P617, DOI 10.1086/377134; Moore T, 2002, IMMUNOLOGY, V105, P213, DOI 10.1046/j.0019-2805.2001.01354.x; Morrison RP, 2002, INFECT IMMUN, V70, P2741, DOI 10.1128/IAI.70.6.2741-2751.2002; Morrison SG, 2005, J IMMUNOL, V175, P7536, DOI 10.4049/jimmunol.175.11.7536; Morrison SG, 2000, INFECT IMMUN, V68, P6979, DOI 10.1128/IAI.68.12.6979-6987.2000; MOULDER JW, 1991, MICROBIOL REV, V55, P143, DOI 10.1128/MMBR.55.1.143-190.1991; Nardelli-Haefliger D, 2003, JNCI-J NATL CANCER I, V95, P1128, DOI 10.1093/jnci/djg018; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; PAAVONEN J, 1982, OBSTET GYNECOL, V59, P712; Pantophlet R, 2007, VIROLOGY, V364, P441, DOI 10.1016/j.virol.2007.03.007; Peipert JF, 2003, NEW ENGL J MED, V349, P2424, DOI 10.1056/NEJMcp030542; Persson K, 2002, BEST PRACT RES CL OB, V16, P801, DOI 10.1053/beog.2002.0321; Phalipon A, 2002, IMMUNITY, V17, P107, DOI 10.1016/S1074-7613(02)00341-2; Pincus SH, 2003, J IMMUNOL, V170, P2236, DOI 10.4049/jimmunol.170.4.2236; Prakash M, 2001, J IMMUNOL METHODS, V258, P37, DOI 10.1016/S0022-1759(01)00464-1; Rakebrandt N, 2014, PATHOG DIS, V72, P131, DOI 10.1111/2049-632X.12192; RAMSEY KH, 1991, INFECT IMMUN, V59, P925, DOI 10.1128/IAI.59.3.925-931.1991; Ramsey KH, 1999, INFECT IMMUN, V67, P3019, DOI 10.1128/IAI.67.6.3019-3025.1999; RANK RG, 1985, INFECT IMMUN, V48, P847, DOI 10.1128/IAI.48.3.847-849.1985; RANK RG, 1983, INFECT IMMUN, V39, P463, DOI 10.1128/IAI.39.1.463-465.1983; Rao XC, 2009, GENE DEV, V23, P1818, DOI 10.1101/gad.1784009; Robinson JE, 2016, NAT COMMUN, V7; SLIFKA MK, 1995, J VIROL, V69, P1895, DOI 10.1128/JVI.69.3.1895-1902.1995; Su H, 1997, INFECT IMMUN, V65, P1993, DOI 10.1128/IAI.65.6.1993-1999.1997; TAKAHASHI K, 1992, J IMMUNOL METHODS, V153, P67, DOI 10.1016/0022-1759(92)90306-E; Waller J, 2006, J MED SCREEN, V13, P208, DOI 10.1177/096914130601300409; Wang SH, 1999, EUR J IMMUNOL, V29, P3782, DOI 10.1002/(SICI)1521-4141(199911)29:11<3782::AID-IMMU3782>3.0.CO;2-B; Wang YY, 2014, MUCOSAL IMMUNOL, V7, P1036, DOI 10.1038/mi.2013.120; Wyrick PB, 2010, J INFECT DIS, V201, pS88, DOI 10.1086/652394; Yu XC, 2013, J IMMUNOL, V190, P205, DOI 10.4049/jimmunol.1201469; YUAN Y, 1992, INFECT IMMUN, V60, P2288, DOI 10.1128/IAI.60.6.2288-2296.1992; Zhang L, 1998, INFECT IMMUN, V66, P1167, DOI 10.1128/IAI.66.3.1167-1173.1998; ZHANG YX, 1987, INFECT IMMUN, V55, P2570, DOI 10.1128/IAI.55.11.2570-2573.1987	100	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0183101	10.1371/journal.pone.0183101	http://dx.doi.org/10.1371/journal.pone.0183101			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797112	Green Submitted, gold, Green Published			2022-12-26	WOS:000407396200151
J	Grasso, F; Coppola, M; Carbone, F; Baldoni, L; Alagna, F; Perrotta, G; Perez-Pulido, AJ; Garonna, A; Facella, P; Daddiego, L; Lopez, L; Vitiello, A; Rao, R; Corrado, G				Grasso, Filomena; Coppola, Mariangela; Carbone, Fabrizio; Baldoni, Luciana; Alagna, Fiammetta; Perrotta, Gaetano; Perez-Pulido, Antonio J.; Garonna, Antonio; Facella, Paolo; Daddiego, Loretta; Lopez, Loredana; Vitiello, Alessia; Rao, Rosa; Corrado, Giandomenico			The transcriptional response to the olive fruit fly (Bactrocera oleae) reveals extended differences between tolerant and susceptible olive (Olea europaea L.) varieties	PLOS ONE			English	Article							SERINE-CARBOXYPEPTIDASE; DIPTERA TEPHRITIDAE; INDUCED RESISTANCE; DEFENSE; INFESTATION; CULTIVARS; PLANTS; METABOLISM; PARAMETERS; HERBIVORE	The olive fruit fly Bactrocera oleae (Diptera: Tephritidae) is the most devastating pest of cultivated olive (Olea europaea L.). Intraspecific variation in plant resistance to B. oleae has been described only at phenotypic level. In this work, we used a transcriptomic approach to study the molecular response to the olive fruit fly in two olive cultivars with contrasting level of susceptibility. Using next-generation pyrosequencing, we first generated a catalogue of more than 80,000 sequences expressed in drupes from approximately 700k reads. The assembled sequences were used to develop a microarray layout with over 60,000 olive-specific probes. The differential gene expression analysis between infested (i.e. with II or III instar larvae) and control drupes indicated a significant intraspecific variation between the more tolerant and susceptible cultivar. Around 2500 genes were differentially regulated in infested drupes of the tolerant variety. The GO annotation of the differentially expressed genes implies that the inducible resistance to the olive fruit fly involves a number of biological functions, cellular processes and metabolic pathways, including those with a known role in defence, oxidative stress responses, cellular structure, hormone signalling, and primary and secondary metabolism. The difference in the induced transcriptional changes between the cultivars suggests a strong genetic role in the olive inducible defence, which can ultimately lead to the discovery of factors associated with a higher level of tolerance to B. oleae.	[Grasso, Filomena; Coppola, Mariangela; Garonna, Antonio; Vitiello, Alessia; Rao, Rosa; Corrado, Giandomenico] Univ Napoli Federico II, Dipartimento Agr, Portici, NA, Italy; [Carbone, Fabrizio] Consiglio Ric Agr Analisi Econ Agr CREA, Ctr Ric Olivicoltura Ind Olearia, Arcavacata Di Rende, CS, Italy; [Baldoni, Luciana; Alagna, Fiammetta] CNR, Inst Biosci & Bioresources IBBR, Perugia, Italy; [Perrotta, Gaetano; Facella, Paolo; Daddiego, Loretta; Lopez, Loredana] Trisaia Res Ctr, Italian Natl Agcy New Technol Energy & Sustainabl, Rotondella, MT, Italy; [Perez-Pulido, Antonio J.] Univ Pablo Olavide, Dept Biol Mol & Ingn Bioquim, Seville, Spain	University of Naples Federico II; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); Italian National Agency New Technical Energy & Sustainable Economics Development; Universidad Pablo de Olavide	Rao, R; Corrado, G (corresponding author), Univ Napoli Federico II, Dipartimento Agr, Portici, NA, Italy.	rao@unina.it; giandomenico.corrado@unina.it	Carbone, Fabrizio/O-2443-2017; Perez-Pulido, Antonio J/K-3384-2012; Facella, Paolo/HHC-1895-2022; Baldoni, Luciana/A-4411-2016; Alagna, Fiammetta/AAF-3169-2020; Carbone, Fabrizio/AAE-1065-2019	Carbone, Fabrizio/0000-0002-0393-7099; Perez-Pulido, Antonio J/0000-0003-3343-2822; Facella, Paolo/0000-0001-9076-3754; Baldoni, Luciana/0000-0002-3221-333X; Carbone, Fabrizio/0000-0002-0393-7099; GARONNA, Antonio Pietro/0000-0002-8441-5208; Alagna, Fiammetta/0000-0003-1878-2023; Vitiello, Alessia/0000-0003-0124-5109; BALDONI, LUCIANA/0000-0002-6636-0055; Perrotta, Gaetano/0000-0003-2037-1063	"Progetto Olea - Genomica e miglioramento genetico dell'olivo", Ministero per le Politiche Agricole Alimentari e Forestall [DM.27011/7643/10]	"Progetto Olea - Genomica e miglioramento genetico dell'olivo", Ministero per le Politiche Agricole Alimentari e Forestall	This work was partially supported by the "Progetto Olea - Genomica e miglioramento genetico dell'olivo", Ministero per le Politiche Agricole Alimentari e Forestall (DM.27011/7643/10).	Alagna F, 2015, J INTEGRATIVE PLANT; Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; ANGEROSA F, 1992, GRASAS ACEITES, V43, P134, DOI 10.3989/gya.1992.v43.i3.1165; Armstead I, 2009, BRIEF BIOINFORM; Benitez Y, 2005, MOL PLANT PATHOL, V6, P425, DOI 10.1111/j.1364-3703.2005.00290.x; Broekgaarden C, 2008, PLANT CELL ENVIRON, V31, P1592, DOI 10.1111/j.1365-3040.2008.01871.x; Garcia-Lopez MC, 2014, TREE GENET GENOMES, V10, P585, DOI 10.1007/s11295-014-0706-4; Coppola V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-515; Corrado G, 2016, COMPEND PL GENOME, P75, DOI 10.1007/978-3-319-48887-5_6; Corrado G, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-86; Daane KM, 2015, BIOCONTROL, V60, P317, DOI 10.1007/s10526-015-9652-9; Daane KM, 2010, ANNU REV ENTOMOL, V55, P151, DOI 10.1146/annurev.ento.54.110807.090553; Di Vaio C., 2012, GERMOPLASMA OLIVO CA; FLETCHER BS, 1987, ANNU REV ENTOMOL, V32, P115, DOI 10.1146/annurev.en.32.010187.000555; Garantonakis N, 2016, APPL ENTOMOL ZOOL, V51, P257, DOI 10.1007/s13355-016-0397-4; Glas JJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0098-9; Gomez-Caravaca AM, 2008, J AGR FOOD CHEM, V56, P4577, DOI 10.1021/jf800118t; Gonzalez-Plaza JJ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00240; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grasso F, 2016, FOOD RES INT, V86, P121, DOI 10.1016/j.foodres.2016.06.005; Gucci R, 2012, HORTSCIENCE, V47, P301, DOI 10.21273/HORTSCI.47.2.301; Hoelmer KA, 2011, BIOCONTROL SCI TECHN, V21, P1005, DOI 10.1080/09583157.2011.594951; Iannotta N, 2012, OLIVE GERMPLASM - THE OLIVE CULTIVATION, TABLE OLIVE AND OLIVE OIL INDUSTRY IN ITALY, P81, DOI 10.5772/52036; Kafer C, 2004, FRONT BIOSCI-LANDMRK, V9, P1611; Kliebenstein DJ, 2002, GENETICS, V161, P1685; Kliebenstein DJ, 2001, PLANT PHYSIOL, V126, P811, DOI 10.1104/pp.126.2.811; Koudounas K, 2015, J EXP BOT, V66, P2093, DOI 10.1093/jxb/erv002; La Camera S, 2004, IMMUNOL REV, V198, P267, DOI 10.1111/j.0105-2896.2004.0129.x; Liu HZ, 2008, GENE, V420, P57, DOI 10.1016/j.gene.2008.05.006; Malheiro R, 2016, PHYTOCHEMISTRY, V121, P11, DOI 10.1016/j.phytochem.2015.10.005; Malheiro R, 2015, TRENDS FOOD SCI TECH, V44, P226, DOI 10.1016/j.tifs.2015.04.009; Martinelli F, 2013, SCI HORTIC-AMSTERDAM, V159, P52, DOI 10.1016/j.scienta.2013.04.039; Medjkouh L, 2016, FOOD FUNCT, V7, P2780, DOI [10.1039/C6FO00295A, 10.1039/c6fo00295a]; Moura DS, 2001, PLANTA, V212, P222, DOI 10.1007/s004250000380; Munoz-Merida A, 2014, DNA RES, V21, P341, DOI 10.1093/dnares/dsu001; Munoz-Merida A, 2013, DNA RES, V20, P93, DOI 10.1093/dnares/dss036; Musser RO, 2002, NATURE, V416, P599, DOI 10.1038/416599a; Myhre S, 2006, BIOINFORMATICS, V22, P2020, DOI 10.1093/bioinformatics/btl334; Nardi F, 2010, MOL PHYLOGENET EVOL, V57, P678, DOI 10.1016/j.ympev.2010.08.008; Ozgenturk N Ozdemir, 2010, COMP FUNCTIONAL GENO, V2010; Pieterse CMJ, 2007, TRENDS PLANT SCI, V12, P564, DOI 10.1016/j.tplants.2007.09.004; Pugliano G, 2000, RISORSA GENETICA OLI; R Developmental Team Core, 2009, R LANG ENV STAT COMP; Rizzo R, 2006, P OL 2006 2 INT SEM; Rizzo R, 2012, ENTOMOL EXP APPL, V145, P15, DOI 10.1111/j.1570-7458.2012.01311.x; Rossi L, 2016, J PLANT PHYSIOL, V204, P8, DOI 10.1016/j.jplph.2016.07.014; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sarmento RA, 2011, ECOL LETT, V14, P229, DOI 10.1111/j.1461-0248.2010.01575.x; Sauge MH, 2006, OIKOS, V113, P305, DOI 10.1111/j.2006.0030-1299.14250.x; Scarpati ML, 1996, J CHEM ECOL, V22, P1027, DOI 10.1007/BF02029952; Schuman MC, 2009, NEW PHYTOL, V183, P1134, DOI 10.1111/j.1469-8137.2009.02894.x; Selote D, 2010, PLANT SIGNAL BEHAV, V5, P1453, DOI [10.4161/psb.5.11.13462, 10.1104/pp.110.158147]; Tayeh C, 2015, PLANT PHYSIOL BIOCH, V96, P9, DOI 10.1016/j.plaphy.2015.07.015; Thudi M, 2012, BRIEF FUNCT GENOMICS, V11, P3, DOI 10.1093/bfgp/elr045; Tsolakis H, 2011, B INSECTOL, V64, P1; Uceda M., 1975, P 2 SEM OL INT CORD, P6; Voigt C., 2011, SYNTHETIC BIOL METHO; Vontas JG, 2002, INSECT MOL BIOL, V11, P329, DOI 10.1046/j.1365-2583.2002.00343.x; Walling LL, 2008, PLANT PHYSIOL, V146, P859, DOI 10.1104/pp.107.113142; Windsor AJ, 2005, PHYTOCHEMISTRY, V66, P1321, DOI 10.1016/j.phytochem.2005.04.016; Wu JQ, 2008, PLANT PHYSIOL, V146, P927, DOI 10.1104/pp.107.114785; Wu JQ, 2010, ANNU REV GENET, V44, P1, DOI 10.1146/annurev-genet-102209-163500; Zhou SQ, 2015, PLANT PHYSIOL, V169, P1488, DOI 10.1104/pp.15.01405; Zimmermann P, 2006, PLANT METHODS, V2, DOI 10.1186/1746-4811-2-1; Zygouridis NE, 2009, HEREDITY, V102, P402, DOI 10.1038/hdy.2008.125	66	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0183050	10.1371/journal.pone.0183050	http://dx.doi.org/10.1371/journal.pone.0183050			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797083	Green Published, gold, Green Submitted			2022-12-26	WOS:000407396200146
J	Kharkova, OA; Grjibovski, AM; Krettek, A; Nieboer, E; Odland, JO				Kharkova, Olga A.; Grjibovski, Andrej M.; Krettek, Alexandra; Nieboer, Evert; Odland, Jon O.			First-trimester smoking cessation in pregnancy did not increase the risk of preeclampsia/eclampsia: A Murmansk County Birth Registry study	PLOS ONE			English	Article							CIGARETTE-SMOKING; MATERNAL SMOKING; CARBON-MONOXIDE; WOMEN; HYPERTENSION; OUTCOMES; PATHOGENESIS; HABITS; WEIGHT; GROWTH	Background Although prior studies have shown that smoking reduces preeclampsia/eclampsia risk, the consequence of giving up this habit during pregnancy should be assessed. The aims of the current study were threefold: (i) describe maternal characteristics of women with preeclampsia/ eclampsia; (ii) examine a possible association between the number of cigarettes smoked daily during pregnancy and the development of this affliction; and (iii) determine if first-trimester discontinuation of smoking during pregnancy influences the risk. Methods A registry-based study was conducted using data from the Murmansk County Birth Registry (MCBR). It included women without pre-existing hypertension, who delivered a singleton infant during 2006-2011 and had attended the first antenatal visit before 12 week of gestation. We adjusted for potential confounders using logistic regression. Results The prevalence of preeclampsia/eclampsia was 8.3% (95% CI: 8.0-8.6). Preeclampsia/ eclampsia associated with maternal age, education, marital status, parity, excessive weight gain and body mass index at the first antenatal visit. There was a dose-response relationship between the number of smoked cigarettes per day during pregnancy and the risk of preeclampsia/ eclampsia (adjusted OR1-5 cig/day = 0.69 with 95% CI: 0.56-0.87; OR6-10 cig/day = 0.65 with 95% CI: 0.51-0.82; and OR (>= 11 cig/day) = 0.49 with 95% CI: 0.30-0.81). There was no difference in this risk among women who smoked before and during pregnancy and those who did so before but not during pregnancy (adjusted OR = 1.10 with 95% CI: 0.91-1.32). Conclusions Preeclampsia/eclampsia was associated with maternal age, education, marital status, parity, excessive weight gain, and body mass index at the first antenatal visit. There was a negative dose-response relationship between the number of smoked cigarettes per day during pregnancy and the odds of preeclampsia/eclampsia. However, women who gave up smoking during the first trimester of gestation had the same risk of preeclampsia/eclampsia as those who smoked while pregnant. Consequently, antenatal clinic specialists are advised to take these various observations into account when counselling women on smoking cessation during pregnancy.	[Kharkova, Olga A.; Krettek, Alexandra; Odland, Jon O.] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Community Med, Tromso, Norway; [Kharkova, Olga A.; Grjibovski, Andrej M.] Northern State Med Univ, Int Sch Publ Hlth, Arkhangelsk, Russia; [Grjibovski, Andrej M.] Norwegian Inst Publ Hlth, Dept Int Publ Hlth, Oslo, Norway; [Grjibovski, Andrej M.] Int Kazakh Turkish Univ, Dept Prevent Med, Turkestan, Kazakhstan; [Krettek, Alexandra] Univ Skovde, Sch Hlth & Educ, Dept Biomed & Publ Hlth, Skovde, Sweden; [Krettek, Alexandra] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Internal Med & Clin Nutr, Gothenburg, Sweden; [Nieboer, Evert] Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Odland, Jon O.] Univ Pretoria, Sch Hlth Syst & Publ Hlth, Fac Hlth Sci, Pretoria, South Africa	UiT The Arctic University of Tromso; Northern State Medical University; Norwegian Institute of Public Health (NIPH); Akhmet Yassawi International Kazakh-Turkish University; University of Skovde; University of Gothenburg; McMaster University; University of Pretoria	Kharkova, OA (corresponding author), UiT Arctic Univ Norway, Fac Hlth Sci, Dept Community Med, Tromso, Norway.; Kharkova, OA (corresponding author), Northern State Med Univ, Int Sch Publ Hlth, Arkhangelsk, Russia.	okh000@post.uit.no	Grjibovski, Andrej/B-9815-2016; Kharkova, Olga/AAO-8495-2020	Grjibovski, Andrej/0000-0002-5464-0498; Kharkova, Olga/0000-0002-3130-2920				Aagaard-Tillery KM, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.078; Abalos E, 2013, EUR J OBSTET GYN R B, V170, P1, DOI 10.1016/j.ejogrb.2013.05.005; Anda EE, 2008, INT J CIRCUMPOL HEAL, V67, P318, DOI 10.3402/ijch.v67i4.18339; [Anonymous], 2013, FEDERAL CLIN GUIDELI; [Anonymous], 2011, MAIN IND MOTH CHILD; Baba S, 2013, BJOG-INT J OBSTET GY, V120, P456, DOI 10.1111/1471-0528.12067; Bainbridge SA, 2005, MED HYPOTHESES, V64, P17, DOI 10.1016/j.mehy.2004.06.019; Bhide A, 2015, ACTA OBSTET GYN SCAN, V94, P542, DOI 10.1111/aogs.12624; Campos TD, 2014, INT J CARDIOL, V174, P808, DOI 10.1016/j.ijcard.2014.04.150; Chappell LC, 2008, HYPERTENSION, V51, P1002, DOI 10.1161/HYPERTENSIONAHA.107.107565; Cnattingius S, 1997, AM J OBSTET GYNECOL, V177, P156, DOI 10.1016/S0002-9378(97)70455-1; Conde-Agudelo A, 1999, AM J OBSTET GYNECOL, V181, P1026, DOI 10.1016/S0002-9378(99)70341-8; Engel SM, 2009, AM J EPIDEMIOL, V169, P33, DOI 10.1093/aje/kwn293; England LJ, 2002, AM J OBSTET GYNECOL, V186, P1035, DOI 10.1067/mob.2002.122404; Frolova OG, 2014, B PFUR, V2, P70; Jaddoe VWV, 2008, PAEDIATR PERINAT EP, V22, P162, DOI 10.1111/j.1365-3016.2007.00916.x; Janakiraman V, 2009, NICOTINE TOB RES, V11, P679, DOI 10.1093/ntr/ntp049; Karumanchi SA, 2010, HYPERTENSION, V55, P1100, DOI 10.1161/HYPERTENSIONAHA.109.148973; Kharkova OA, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0144-x; Lindqvist PG, 1999, ACTA OBSTET GYN SCAN, V78, P693, DOI 10.1034/j.1600-0412.1999.780806.x; Loboda A, 2015, VASC PHARMACOL, V74, P11, DOI 10.1016/j.vph.2015.09.004; Loboda A, 2015, THROMB HAEMOSTASIS, V114, P432, DOI 10.1160/TH15-01-0082; Luo ZC, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.09.041; Martin CL, 2000, BRIT J OBSTET GYNAEC, V107, P745, DOI 10.1111/j.1471-0528.2000.tb13335.x; Meyer KA, 2004, EPIDEMIOLOGY, V15, P671, DOI 10.1097/01.ede.0000142148.51230.60; Naljayan MV, 2013, ADV CHRONIC KIDNEY D, V20, P265, DOI 10.1053/j.ackd.2013.02.003; Oyelese Y, 2006, OBSTET GYNECOL, V107, P927, DOI 10.1097/01.AOG.0000207559.15715.98; Perni UC, 2012, AM J HYPERTENS, V25, P372, DOI 10.1038/ajh.2011.225; Pipkin FB, 2008, HYPERTENSION, V51, P1042, DOI 10.1161/HYPERTENSIONAHA.107.106559; Raisanen S, 2014, PREV MED, V67, P6, DOI 10.1016/j.ypmed.2014.06.026; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; SIBAI BM, 1995, AM J OBSTET GYNECOL, V172, P642, DOI 10.1016/0002-9378(95)90586-3; Stojanovic M, 2010, VOJNOSANIT PREGL, V67, P145, DOI 10.2298/VSP1002145S; Tikkanen M, 2006, ACTA OBSTET GYN SCAN, V85, P40, DOI 10.1080/00016340500324241; Tranquilli AL, 2014, PREGNANCY HYPERTENS, V4, P97, DOI [10.1016/j.preghy.2014.02.001, 10.1016/j.preghy.2014.04.007, 10.1016/j.preghy.2014.04.017]; US Department of Health and Human Services, 2010, TOB SMOK CAUS DIS BI; Venditti CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106502; Vest AR, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-013-0395-8; Villar K., 2003, ECLAMPSIA PREECLAMPS, P189; Wikstrom AK, 2010, HYPERTENSION, V55, P1254, DOI 10.1161/HYPERTENSIONAHA.109.147082; World Health Organization, 2011, WHO RECOMMENDATIONS; Xiong X, 2009, J OBSTET GYNAECOL CA, V31, P702, DOI 10.1016/S1701-2163(16)34273-6; Yang QY, 2006, INT J EPIDEMIOL, V35, P288, DOI 10.1093/ije/dyi247; Zhai DS, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.03.022	44	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0179354	10.1371/journal.pone.0179354	http://dx.doi.org/10.1371/journal.pone.0179354			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797036	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000407396200002
J	Kim, YA; Trinh, S; Thura, S; Kyi, KP; Lee, T; Sze, S; Richards, A; Aronsohn, A; Wong, GLH; Tanaka, Y; Dusheiko, G; Nguyen, MH				Kim, Yoona A.; Trinh, Sam; Thura, Si; Kyi, Khin Pyone; Lee, Thomas; Sze, Stan; Richards, Adam; Aronsohn, Andrew; Wong, Grace L. H.; Tanaka, Yasuhito; Dusheiko, Geoffrey; Nguyen, Mindie H.			Physician perspectives on the management of viral hepatitis and hepatocellular carcinoma in Myanmar	PLOS ONE			English	Article							CARE	Background In Myanmar, over five million people are infected with hepatitis B virus (HBV) and hepatitis C virus (HCV). Hepatitis has been a recent focus with the development of a National Strategic Plan on Hepatitis and plans to subsidize HCV treatment. Methods During a two-day national liver disease symposium covering HCV, HBV, hepatocellular (HCC), and end-stage liver disease (ESLD), physician surveys were administered using the automated response system (ARS) to assess physician knowledge, perceptions of barriers to screening and treatment, and proposed solutions. Multivariate logistic regression was used to estimate odds ratio (OR) relating demography and practice factors with higher provider knowledge and improvement. Results One hundred two physicians attending from various specialty areas (31.0% specializing in gastroenterology/hepatology and/or infectious disease) were of mixed gender (46.8% male), were younger than or equal to 40 years old (51.1% 20 to 40 years), had less experience (61.6% with <= 10 years of medical practice), were from the metropolitan area of Yangon (72.1%), and saw <10 liver disease patients per week (74.3%). The majority of physicians were not comfortable with treating or managing patients with liver disease. The post-test scores demonstrated an improvement in liver disease knowledge (9.0% +/- 27.0) compared to the baseline pre-test scores; no variables were associated with significant improvement in hepatitis knowledge. Physicians identified the cost of diagnostic blood tests and treatment as the most significant barrier to treatment. Top solutions proposed were universal screening policies (46%), removal of financial barriers for treatment (29%), patient education (14%) and provider education (11%). Conclusions Physician knowledge improved after this symposium, and many other needs were revealed by the physician input on barriers to care and their solutions. These survey results are important in guiding the next steps to improve liver disease management and future medical education efforts in Myanmar.	[Kim, Yoona A.; Trinh, Sam; Nguyen, Mindie H.] Stanford Univ, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA; [Thura, Si; Lee, Thomas; Nguyen, Mindie H.] Community Partners Int, Berkeley, CA USA; [Kyi, Khin Pyone] Myanmar Liver Fdn, Yangon, Myanmar; [Lee, Thomas] Univ Calif Los Angeles, Dept Emergency Med, Los Angeles, CA USA; [Sze, Stan] BK Kee Fdn, Yangon, Myanmar; [Richards, Adam] Univ Calif Los Angeles, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA USA; [Aronsohn, Andrew] Univ Chicago, Med Ctr, Div Gastroenterol & Hepatol, Chicago, IL 60637 USA; [Wong, Grace L. H.] Chinese Univ Hong Kong, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Wong, Grace L. H.] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Tanaka, Yasuhito] Nagoya City Univ, Grad Sch Med Sci, Nagoya, Aichi, Japan; [Dusheiko, Geoffrey] Kings Coll Hosp London, London, England; [Dusheiko, Geoffrey] UCL, Sch Med, London, England	Stanford University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Chicago; University of Chicago Medical Center; Chinese University of Hong Kong; Chinese University of Hong Kong; Nagoya City University; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; University College London; UCL Medical School	Nguyen, MH (corresponding author), Stanford Univ, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA.; Nguyen, MH (corresponding author), Community Partners Int, Berkeley, CA USA.	mindiehn@stanford.edu	Wong, Grace LH/L-8586-2014; richards, adam/ABF-8189-2021	Wong, Grace LH/0000-0002-2863-9389; richards, adam/0000-0002-7098-0513; Tanaka, Yasuhito/0000-0002-2473-6966	SPO [124904]; Bristol-Myers Squibb; Chugai Pharmaceutical Co., Ltd.; FujiRebio; TOYAMA CHEMICAL CO., LTD.; Abbvie; Gilead Sciences; Boehringer Ingelheim; Merck Sharp and Dohme; Janssen Pharmaceuticals; Bristol-Meyer Squibb	SPO(Prime Ministry Turkey); Bristol-Myers Squibb(Bristol-Myers Squibb); Chugai Pharmaceutical Co., Ltd.; FujiRebio; TOYAMA CHEMICAL CO., LTD.; Abbvie(AbbVie); Gilead Sciences(Gilead Sciences); Boehringer Ingelheim(Boehringer Ingelheim); Merck Sharp and Dohme(Merck & Company); Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Bristol-Meyer Squibb	This work was supported by SPO#124904. http://www.bkkeefoundation.org.r YAK: Stockholder: Gilead Sciences, Employee: Proteus Digital Health; S Trinh: nothing to disclose; S Thura: nothing to disclose; KPK: nothing to disclose; TL: nothing to disclose; SS: nothing to disclose; AR: nothing to disclose; M: nothing to disclose; GLHW: Advisory board: Gilead Sciences; Speakers: Abbott, Abbvie, Bristol-Myers Squibb, Echosens, Furui, Gilead Sciences, Janssen, and Roche; YT: Research support: Bristol-Myers Squibb, Chugai Pharmaceutical Co., Ltd., FujiRebio, TOYAMA CHEMICAL CO., LTD., Abbvie, Gilead Sciences, Boehringer Ingelheim, Merck Sharp and Dohme; Advisory board: Gilead Sciences, Janssen; Speakers: Gilead Sciences, Janssen, Bristol-Myers Squibb, Chugai Pharmaceutical Co., Ltd., GSK, FujiRebio, Sysmex, Merck Sharp and Dohme, Sumitomo Dainippon Pharma Co., Ltd.; GD: Advisory board: Gilead Sciences; Abbott, Abbvie, Bristol-Myers Squibb, Janssen, and Roche.; MHN: Research support: Janssen Pharmaceuticals, Bristol-Meyer Squibb, Gilead Sciences; Advisory board/consulting: Roche Laboratories, Gilead Sciences, Anylam Pharmaceuticals, Intercept Pharmaceuticals, Dynavax Laboratories, Janssen Pharmaceuticals, Bayer Pharmaceutical, Onyx Pharmaceuticals, Novartis Pharmaceuticals. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	[Anonymous], 2015, MINISTRY SUBSIDISE H; Arora S, 2011, NEW ENGL J MED, V364, P2199, DOI 10.1056/NEJMoa1009370; Asia Pacific Observatory on Health Systems and Policies, 2014, HLTH SYSTEMS TRANSIT, V4, P1; Asian Development Bank, POV MYANM 2017; Aung KS, 2016, NATL HEPATITIS PROGR; Blitz J, 2016, EDUC PRIM CARE, V27, P375, DOI 10.1080/14739879.2016.1220237; Gorsche R, 2006, CAN FAM PHYSICIAN, V52, P601; Hepatitis B Free, MYANMAR; Kim YA, 2016, BMJ OPEN GASTROENTER, V3, DOI 10.1136/bmjgast-2016-000119; Kyi A, 2011, MYANMAR TIMES   0711; Latt NN, 2016, NAGOYA J MED SCI, V78, P123; McGowan CE, 2013, HEPATOLOGY, V57, P1325, DOI 10.1002/hep.26246; Myo-Khin, 2010, ACTA MED OKAYAMA, V64, P317; Rajapakse BN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079491; SEIN M, 1958, Burma Med J, V6, P89; Shwe Yee Saw Myint, 2016, HEP SURV POINTS NEAR; Tin-Nu-Swe Myo-Khin, 2003, DMR B, V17, P1; World Health Organization, TRANSF SCAL HLTH PRO	18	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0181603	10.1371/journal.pone.0181603	http://dx.doi.org/10.1371/journal.pone.0181603			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797080	gold, Green Submitted, Green Published			2022-12-26	WOS:000407396200016
J	Xu, WL; Comhair, SAA; Janocha, AJ; Lara, A; Mavrakis, LA; Bennett, CD; Kalhan, SC; Erzurum, SC				Xu, Weiling; Comhair, Suzy A. A.; Janocha, Allison J.; Lara, Abigail; Mavrakis, Lori A.; Bennett, Carole D.; Kalhan, Satish C.; Erzurum, Serpil C.			Arginine metabolic endotypes related to asthma severity	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ARGINASE ACTIVITY; NO SYNTHESIS; INHIBITION; CELLS; DYSFUNCTION; THERAPY; AIRWAY	Aims Arginine metabolism via inducible nitric oxide synthase (iNOS) and arginase 2 (ARG2) is higher in asthmatics than in healthy individuals. We hypothesized that a sub-phenotype of asthma might be defined by the magnitude of arginine metabolism categorized on the basis of high and low fraction of exhaled nitric oxide (FENO). Methods To test this hypothesis, asthmatics (n = 52) were compared to healthy controls (n = 51) for levels of FENO, serum arginase activity, and airway epithelial expression of iNOS and ARG2 proteins, in relation to clinical parameters of asthma inflammation and airway reactivity. In parallel, bronchial epithelial cells were evaluated for metabolic effects of iNOS and ARG2 expression in vitro. Results Asthmatics with high FENO (>= 35 ppb; 44% of asthmatics) had higher expression of iNOS (P = 0.04) and ARG2 (P = 0.05) in the airway, indicating FENO is a marker of the high arginine metabolic endotype. High FENO asthmatics had the lowest FEV1%(P < 0.001), FEV1/FVC (P = 0.0002) and PC20 (P < 0.001) as compared to low FENO asthmatics or healthy controls. Low FENO asthmatics had near normal iNOS and ARG2 expression (both P > 0.05), and significantly higher PC20 (P < 0.001) as compared to high FENO asthmatics. In vitro studies to evaluate metabolic effects showed that iNOS overexpression and iNOS + ARG2 co-expression in a human bronchial epithelial cell line led to greater reliance on glycolysis with higher rate of pyruvate going to lactate. Conclusions The high FENO phenotype represents a large portion of the asthma population, and is typified by greater arginine metabolism and more severe and reactive asthma.	[Xu, Weiling; Comhair, Suzy A. A.; Janocha, Allison J.; Lara, Abigail; Mavrakis, Lori A.; Bennett, Carole D.; Kalhan, Satish C.; Erzurum, Serpil C.] Cleveland Clin, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44106 USA; [Erzurum, Serpil C.] Cleveland Clin, Resp Inst, Cleveland, OH 44106 USA; [Lara, Abigail] Univ Colorado, Div Pulm Sci & Crit Care Med, Aurora, CO USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Colorado System; University of Colorado Anschutz Medical Campus	Xu, WL (corresponding author), Cleveland Clin, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44106 USA.	xuw@ccf.org			Alfred Lerner Chair for Biomedical Research [HL081064, HL103453, HL109250]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL109250, P01HL081064, P01HL103453] Funding Source: NIH RePORTER	Alfred Lerner Chair for Biomedical Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by HL081064, HL103453, and HL109250; SCE was supported in part by the Alfred Lerner Chair for Biomedical Research.	Antunes F, 2004, P NATL ACAD SCI USA, V101, P16774, DOI 10.1073/pnas.0405368101; Bratt JM, 2011, J BIOMED RES, V25, P299, DOI 10.1016/S1674-8301(11)60041-9; Bratt JM, 2009, TOXICOL APPL PHARM, V234, P273, DOI 10.1016/j.taap.2008.10.007; Brown GC, 2004, BBA-BIOENERGETICS, V1658, P44, DOI 10.1016/j.bbabio.2004.03.016; Ckless K, 2008, J IMMUNOL, V181, P4255, DOI 10.4049/jimmunol.181.6.4255; Comhair SAA, 2015, J IMMUNOL, V195, P643, DOI 10.4049/jimmunol.1500736; Cowan DC, 2015, J ALLERGY CLIN IMMUN, V135, P877, DOI 10.1016/j.jaci.2014.10.026; Cowan DC, 2010, THORAX, V65, P384, DOI 10.1136/thx.2009.126722; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; Dweik RA, 2001, P NATL ACAD SCI USA, V98, P2622, DOI 10.1073/pnas.051629498; Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI 10.1164/rccm.9120-11ST; Dweik RA, 2010, AM J RESP CRIT CARE, V181, P1033, DOI 10.1164/rccm.200905-0695OC; Geiger R, 2016, CELL, V167, P829, DOI 10.1016/j.cell.2016.09.031; Guo FH, 2000, J IMMUNOL, V164, P5970, DOI 10.4049/jimmunol.164.11.5970; Iglesias DE, 2015, FREE RADICAL BIO MED, V89, P602, DOI 10.1016/j.freeradbiomed.2015.08.024; Lara A, 2008, AM J RESP CRIT CARE, V178, P673, DOI 10.1164/rccm.200710-1542OC; Maarsingh H, 2009, BRIT J PHARMACOL, V158, P652, DOI 10.1111/j.1476-5381.2009.00374.x; Mabalirajan U, 2009, J IMMUNOL, V183, P2059, DOI 10.4049/jimmunol.0900342; Morris CR, 2004, AM J RESP CRIT CARE, V170, P148, DOI 10.1164/rccm.200309-1304OC; Morris SM, 1998, AM J PHYSIOL-ENDOC M, V275, pE740, DOI 10.1152/ajpendo.1998.275.5.E740; National Heart Lung and Blood Institute/ National Asthma Education and Prevention Program, 2007, NIH PUBLICATION, V07-4051; Panda K, 2005, P NATL ACAD SCI USA, V102, P10117, DOI 10.1073/pnas.0408972102; Ramachandran A, 2002, FREE RADICAL BIO MED, V33, P1465, DOI 10.1016/S0891-5849(02)01142-5; Reinke SN, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01740-2016; Silkoff PE, 2001, CHEST, V119, P1322, DOI 10.1378/chest.119.5.1322; Smith AD, 2005, AM J RESP CRIT CARE, V172, P453, DOI 10.1164/rccm.200411-1498OC; Szefler SJ, 2002, J ALLERGY CLIN IMMUN, V109, P410, DOI 10.1067/mai.2002.122635; Trian T, 2007, J EXP MED, V204, P3173, DOI 10.1084/jem.20070956; Uetani K, 2001, AM J RESP CELL MOL, V24, P720, DOI 10.1165/ajrcmb.24.6.4297; Xu WL, 2016, J CLIN INVEST, V126, P2465, DOI 10.1172/JCI82925; Xu WL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132007; Xu WL, 2004, FASEB J, V18, P1746, DOI 10.1096/fj.04-2317fje; Xu WL, 2003, AM J PHYSIOL-LUNG C, V285, pL137, DOI 10.1152/ajplung.00441.2002; Zimmermann N, 2003, J CLIN INVEST, V111, P1863, DOI 10.1172/JCI200317912	35	33	35	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0183066	10.1371/journal.pone.0183066	http://dx.doi.org/10.1371/journal.pone.0183066			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797075	gold, Green Published, Green Submitted			2022-12-26	WOS:000407396200147
J	Allen, MR; McNerny, E; Aref, M; Organ, JM; Newman, CL; McGowan, B; Jang, T; Burr, DB; Brown, DM; Hammond, M; Territo, PR; Lin, C; Persohn, S; Jiang, L; Riley, AA; McCarthy, BP; Hutchins, GD; Wallace, JM				Allen, Matthew R.; McNerny, Erin; Aref, Mohammad; Organ, Jason M.; Newman, Christopher L.; McGowan, Brian; Jang, Tim; Burr, David B.; Brown, Drew M.; Hammond, Max; Territo, Paul R.; Lin, Chen; Persohn, Scott; Jiang, Lei; Riley, Amanda A.; McCarthy, Brian P.; Hutchins, Gary D.; Wallace, Joseph M.			Effects of combination treatment with alendronate and raloxifene on skeletal properties in a beagle dog model	PLOS ONE			English	Article							REFERENCE-POINT INDENTATION; MECHANICAL-PROPERTIES; MICRODAMAGE ACCUMULATION; BIOMECHANICAL PROPERTIES; BONE TOUGHNESS; POSTMENOPAUSAL WOMEN; ANIMAL-MODEL; UTE-MRI; WATER; TURNOVER	A growing number of studies have investigated combination treatment as an approach to treat bone disease. The goal of this study was to investigate the combination of alendronate and raloxifene with a particular focus on mechanical properties. To achieve this goal we utilized a large animal model, the beagle dog, used previously by our laboratory to study both alendronate and raloxifene monotherapies. Forty-eight skeletally mature female beagles (1-2 years old) received daily oral treatment: saline vehicle (VEH), alendronate (ALN), raloxifene (RAL) or both ALN and RAL. After 6 and 12 months of treatment, all animals underwent assessment of bone material properties using in vivo reference point indentation (RPI) and skeletal hydration using ultra-short echo magnetic resonance imaging (UTE-MRI). End point measures include imaging, histomorphometry, and mechanical properties. Bone formation rate was significantly lower in iliac crest trabecular bone of animals treated with ALN (-71%) and ALN+ RAL (-81%) compared to VEH. In vivo assessment of properties by RPI yielded minimal differences between groups while UTE-MRI showed a RAL and RAL+ ALN treatment regimens resulted in significantly higher bound water compared to VEH (+23 and +18%, respectively). There was no significant difference among groups for DXA-or CT-based measures lumbar vertebra, or femoral diaphysis. Ribs of RAL-treated animals were smaller and less dense compared to VEH and although mechanical properties were lower the material-level properties were equivalent to normal. In conclusion, we present a suite of data in a beagle dog model treated for one year with clinically-relevant doses of alendronate and raloxifene monotherapies or combination treatment with both agents. Despite the expected effects on bone remodeling, our study did not find the expected benefit of ALN to BMD or structural mechanical properties, and thus the viability of the combination therapy remains unclear.	[Allen, Matthew R.; McNerny, Erin; Aref, Mohammad; Organ, Jason M.; Newman, Christopher L.; McGowan, Brian; Jang, Tim; Burr, David B.; Brown, Drew M.; Hammond, Max] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Allen, Matthew R.; Burr, David B.; Wallace, Joseph M.] Indiana Univ Sch Med, Dept Orthoped, Indianapolis, IN 46202 USA; [Allen, Matthew R.; Organ, Jason M.; Burr, David B.; Hammond, Max; Wallace, Joseph M.] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA; [Territo, Paul R.; Lin, Chen; Persohn, Scott; Jiang, Lei; Riley, Amanda A.; McCarthy, Brian P.; Hutchins, Gary D.] Indiana Univ Sch Med, Dept Radiol & Imaging Sci, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington	Allen, MR (corresponding author), Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA.; Allen, MR (corresponding author), Indiana Univ Sch Med, Dept Orthoped, Indianapolis, IN 46202 USA.; Allen, MR (corresponding author), Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA.	matallen@iupui.edu	Wallace, Joseph Michael/G-7906-2012; Allen, Matthew/A-8799-2015	Wallace, Joseph Michael/0000-0001-6077-8058; Allen, Matthew/0000-0002-1174-9004; McNerny, Erin/0000-0002-1825-9657; Organ, Jason/0000-0001-8462-0271	NIH [AR62002]; BIRT [DK108554, DK100093, AR65971, AR067221]; NIH S10 grant [OD 016208]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K25AR067221, T32AR065971, R01AR062002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK108554, F30DK100093] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016208] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BIRT; NIH S10 grant; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants AR62002 and a BIRT supplement (MRA), DK108554 (F32 support for EM), DK100093 (F30 support for CLN), AR65971 (T32 support for MWA) and AR067221 (K25 support for JMW). The microCT utilized in this experiment was purchased through a NIH S10 grant (OD 016208). Active Life Scientific provided the OsteoProbe instrument and probes for this work. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest related to this work.; This work was supported by NIH grants AR62002 and a BIRT supplement (MRA), DK108554 (F32 support for EM), DK100093 (F30 support for CLN), AR65971 (T32 support for MWA) and AR067221 (K25 support for JMW). The microCT utilized in this experiment was purchased through a NIH S10 grant (OD 016208). Active Life Scientific provided the OsteoProbe instrument and probes for this work. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest related to this work.	Acevedo C, 2015, BONE, V81, P352, DOI 10.1016/j.bone.2015.08.002; Allen MR, 2008, OSTEOPOROSIS INT, V19, P329, DOI 10.1007/s00198-007-0533-7; Allen MR, 2008, OSTEOPOROSIS INT, V19, P95, DOI 10.1007/s00198-007-0451-8; Allen MR, 2006, CALCIFIED TISSUE INT, V79, P255, DOI 10.1007/s00223-006-0031-5; Allen MR, 2008, CALCIFIED TISSUE INT, V82, P354, DOI 10.1007/s00223-008-9131-8; Allen MR, 2007, J BONE MINER RES, V22, P1759, DOI 10.1359/JBMR.070720; Allen MR, 2007, ENDOCRINOLOGY, V148, P3908, DOI 10.1210/en.2007-0275; Allen MR, 2006, BONE, V39, P1130, DOI 10.1016/j.bone.2006.05.007; Allen MR, 2006, BONE, V39, P872, DOI 10.1016/j.bone.2006.04.028; Allen MR, 2015, J BONE MINER RES, V30, P1539, DOI 10.1002/jbmr.2603; Allen MR, 2015, J BONE MINER RES, V30, P1441, DOI 10.1002/jbmr.2470; Aref M, 2013, BONE, V56, P449, DOI 10.1016/j.bone.2013.07.009; Bae WC, 2012, J BONE MINER RES, V27, P848, DOI 10.1002/jbmr.1535; Bajaj D, 2014, BONE, V64, P57, DOI 10.1016/j.bone.2014.03.045; Berman AG, 2016, MATRIX BIOL, V52-54, P19, DOI 10.1016/j.matbio.2015.12.008; Biswas R, 2012, BONE, V50, P749, DOI 10.1016/j.bone.2011.11.029; Bivi N, 2016, BIOORGAN MED CHEM, V24, P759, DOI 10.1016/j.bmc.2015.12.045; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Burr DB, 2015, BONE, V71, P58, DOI 10.1016/j.bone.2014.10.010; Cosman Felicia, 2014, Bonekey Rep, V3, P518, DOI 10.1038/bonekey.2014.13; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Diab T, 2011, J BONE MINER RES, V26, P270, DOI 10.1002/jbmr.197; Diaz E, 2012, NMR BIOMED, V25, P161, DOI 10.1002/nbm.1728; Diez-Perez A, 2010, J BONE MINER RES, V25, P1877, DOI 10.1002/jbmr.73; Farr JN, 2014, J BONE MINER RES, V29, P787, DOI 10.1002/jbmr.2106; Gallant MA, 2014, BONE, V61, P191, DOI 10.1016/j.bone.2014.01.009; Gallant MA, 2013, BONE, V53, P301, DOI 10.1016/j.bone.2012.12.015; Johnell O, 2002, J CLIN ENDOCR METAB, V87, P985, DOI 10.1210/jc.87.3.985; Khosla S, 2007, J BONE MINER RES, V22, P1479, DOI 10.1359/JBMR.0707ONJ; Khosla S, 2016, J BONE MINER RES, V31, P1485, DOI 10.1002/jbmr.2888; Komatsubara S, 2003, J BONE MINER RES, V18, P512, DOI 10.1359/jbmr.2003.18.3.512; Krege JB, 2016, BONE, V87, P97, DOI 10.1016/j.bone.2016.04.002; Mashiba T, 2000, J BONE MINER RES, V15, P613, DOI 10.1359/jbmr.2000.15.4.613; McNerny Erin M B, 2016, Bone Rep, V5, P192; MILLER AJ, 1993, MAGN RESON IMAGING, V11, P1051, DOI 10.1016/0730-725X(93)90225-3; Newman CL, 2016, KIDNEY INT, V89, P95, DOI 10.1038/ki.2015.315; Randall C, 2013, J MED DEVICES, V7, DOI 10.1115/1.4024829; Reid IR, 2015, NAT REV ENDOCRINOL, V11, P418, DOI 10.1038/nrendo.2015.71; Sato M, 2004, J BONE MINER RES, V19, P623, DOI 10.1359/JBMR.040112; Shane E, 2014, J BONE MINER RES, V29, P1, DOI 10.1002/jbmr.1998; Techawiboonwong A, 2008, RADIOLOGY, V248, P824, DOI 10.1148/radiol.2482071995; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K	42	4	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0181750	10.1371/journal.pone.0181750	http://dx.doi.org/10.1371/journal.pone.0181750			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28793321	Green Published, Green Submitted, gold			2022-12-26	WOS:000407196700021
J	Capucci, S; Wee, EG; Schiffner, T; LaBranche, CC; Borthwick, N; Cupo, A; Dodd, J; Dean, H; Sattentau, Q; Montefiori, D; Klasse, PJ; Sanders, RW; Moore, JP; Hanke, T				Capucci, Silvia; Wee, Edmund G.; Schiffner, Torben; LaBranche, Celia C.; Borthwick, Nicola; Cupo, Albert; Dodd, Jonathan; Dean, Hansi; Sattentau, Quentin; Montefiori, David; Klasse, Per J.; Sanders, Rogier W.; Moore, John P.; Hanke, Tomas			HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers	PLOS ONE			English	Article							BROADLY NEUTRALIZING ANTIBODIES; SUBUNIT VACCINE IMMUNOGENICITY; T-CELL RESPONSES; HIV-1 ENV; POTENT NEUTRALIZATION; MONOCLONAL-ANTIBODIES; PASSIVE-IMMUNIZATION; STRUCTURAL INSIGHTS; DEPENDENT EPITOPE; VIRUS	Rabbits and monkeys immunized with HIV type 1 (HIV-1) native-like BG505 SOSIP. 664 (BG505s) glycoprotein trimers are known to induce antibodies that can neutralize the autologous tier-2 virus. Here, we assessed the induction of HIV-1 trimer binding and neutralizing antibody (nAb) titres when BG505s trimers were also delivered by non-replicating simian (chimpanzee) adenovirus and non-replicating poxvirus modified vaccinia virus Ankara (MVA) vaccine vectors. First, we showed that approximately two-thirds and one-third of the trimers secreted from the ChAdOx1. BG505s (C) and MVA. BG505s (M) vaccine-infected cells, respectively, were cleaved and in a native-like conformation. Rabbits were immunized intramuscularly with these vaccine vectors and in some cases boosted with ISCOMA-TRIX (TM) adjuvanted BG505s protein trimer (P), using CCC, MMM, PPP, CPP, MPP and CMP vaccine regimens. We found that the peak trimer-binding antibody and tier-1A and autologous tier-2 nAb responses induced by the CC, CM, PPP, CPP, MPP and CMP regimens were comparable, although only PPP induced autologous tier-2 nAbs in all the immunized animals. Three animals developed weak heterologous tier-2 nAbs. These results demonstrate that ChAdOx1 and MVA vectors are useful delivery modalities for not only T-cell, but also antibody vaccine development.	[Capucci, Silvia; Wee, Edmund G.; Borthwick, Nicola; Hanke, Tomas] Univ Oxford, Jenner Inst, Oxford, England; [Capucci, Silvia] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy; [Schiffner, Torben; Dodd, Jonathan; Sattentau, Quentin] Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England; [LaBranche, Celia C.; Montefiori, David] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Cupo, Albert; Klasse, Per J.; Sanders, Rogier W.; Moore, John P.] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY USA; [Dean, Hansi] Int AIDS Vaccine Initiat, New York, NY USA; [Sanders, Rogier W.] Univ Amsterdam, Dept Med Microbiol, Amsterdam, Netherlands; [Hanke, Tomas] Kumamoto Univ, Int Res Ctr Med Sci, Kumamoto, Japan; [Schiffner, Torben] Scripps Res Inst, Dept Immunol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Dean, Hansi] Takeda Pharmaceut, Cambridge, MA USA	University of Oxford; Jenner Institute; University of Bologna; University of Oxford; Duke University; Cornell University; International AIDS Vaccine Initiative; University of Amsterdam; Kumamoto University; Scripps Research Institute	Hanke, T (corresponding author), Univ Oxford, Jenner Inst, Oxford, England.; Hanke, T (corresponding author), Kumamoto Univ, Int Res Ctr Med Sci, Kumamoto, Japan.	tomas.hanke@ndm.ox.ac.uk	Klasse, P.J./AEX-0142-2022	Klasse, P.J./0000-0001-8222-278X	Medical Research Council (MRC) UK; UK Department for International Development (DFID) under MRC/DFID [G1001757, MR/N023668/1]; National Institutes of Health [P01 AI100657, UM1-AI100645, 210782, HHSN27201100016C]; European AIDS Vaccine Initiative (EAVI) [681137]; MRC [G0000635, MR/N023668/1, G1001757] Funding Source: UKRI; Medical Research Council [G0000635, MR/N023668/1, G1001757] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100645, P01AI110657] Funding Source: NIH RePORTER	Medical Research Council (MRC) UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under MRC/DFID; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European AIDS Vaccine Initiative (EAVI); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work is jointly funded by the Medical Research Council (MRC) UK and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreements (G1001757 and MR/N023668/1); National Institutes of Health grant P01 AI100657; National Institutes of Health grant UM1-AI100645 to the Duke Center for HIV/AIDS Vaccine Immunology lmmunogen Discovery (CHAVI-ID) - subcontract 210782; National Institutes of Health contract HHSN27201100016C; European AIDS Vaccine Initiative (EAVI) 2020 (681137); T.H. and Q.S. are the Jenner Institute Investigators, and Q.S. is a James Martin Senior fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Jawad S, 2016, MOL THER, V24, P375, DOI 10.1038/mt.2015.210; BARKJ, 2012, PLOS PATHOG, V0008; Biswas S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107903; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Borthwick N, 2014, MOL THER, V22, P464, DOI 10.1038/mt.2013.248; Burton DR, 2015, NAT IMMUNOL, V16, P571, DOI 10.1038/ni.3158; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Clutton G, 2014, AIDS, V28, P2495, DOI 10.1097/QAD.0000000000000468; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; de Taeye SW, 2016, TRENDS IMMUNOL, V37, P221, DOI 10.1016/j.it.2016.01.007; de Taeye SW, 2015, CELL, V163, P1702, DOI 10.1016/j.cell.2015.11.056; deCamp A, 2014, J VIROL, V88, P2489, DOI 10.1128/JVI.02853-13; Dicks MDJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040385; Dosenovic P, 2015, CELL, V161, P1505, DOI 10.1016/j.cell.2015.06.003; Douglas AD, 2010, VACCINE, V28, P7167, DOI 10.1016/j.vaccine.2010.08.068; Draper SJ, 2010, J IMMUNOL, V185, P7583, DOI 10.4049/jimmunol.1001760; Elias SC, 2014, IMMUNOLOGY, V141, P628, DOI 10.1111/imm.12226; Euler Z, 2010, J INFECT DIS, V201, P1045, DOI 10.1086/651144; Ewer K, 2016, NEW ENGL J MED, V374, P1635, DOI 10.1056/NEJMoa1411627; Ewer KJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3836; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Gauduin MC, 1997, NAT MED, V3, P1389, DOI 10.1038/nm1297-1389; Hanke T, 2014, EXPERT OPIN BIOL TH, V14, P601, DOI 10.1517/14712598.2014.885946; Haynes BF, 2016, CELL HOST MICROBE, V19, P292, DOI 10.1016/j.chom.2016.02.002; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Hofmann-Lehmann R, 2001, J VIROL, V75, P7470, DOI 10.1128/JVI.75.16.7470-7480.2001; Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Jardine JG, 2015, SCIENCE, V349, P156, DOI 10.1126/science.aac5894; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Julien JP, 2012, IMMUNOL REV, V250, P180, DOI 10.1111/imr.12005; Klasse PJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005864; Klein F., 2012, NATURE; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Liu X, 2016, CHEM COMMUN CAMB; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Mc Cann C. M., 2005, Current Drug Targets - Infectious Disorders, V5, P95, DOI 10.2174/1568005054201580; McGuire AT, 2014, SCIENCE, V346, P1380, DOI 10.1126/science.1259206; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Moore JP, 2012, NAT MED, V18, P346, DOI 10.1038/nm.2689; Mouquet H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024078; Mutua G, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.61; Ondondo B, 2016, MOL THER, V24, P832, DOI 10.1038/mt.2016.3; Piantadosi A, 2009, J VIROL, V83, P10269, DOI 10.1128/JVI.01149-09; Rampling T, 2016, J INFECT DIS, V214, P772, DOI 10.1093/infdis/jiw244; Ringe RP, 2013, P NATL ACAD SCI USA, V110, P18256, DOI 10.1073/pnas.1314351110; Sanders RW, 2015, SCIENCE, V349, DOI 10.1126/science.aac4223; Sanders RW, 2017, IMMUNOL REV, V275, P161, DOI 10.1111/imr.12481; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sarzotti-Kelsoe M, 2013, J IMMUNOL METHODS; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Sheehy SH, 2012, MOL THER, V20, P2355, DOI 10.1038/mt.2012.223; Shingai M, 2014, J EXP MED, V211, P2061, DOI 10.1084/jem.20132494; Sliepen K, 2015, VIROLOGY, V486, P116, DOI 10.1016/j.virol.2015.08.002; van Gils MJ, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.199; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Zhou TQ, 2013, IMMUNITY, V39, P245, DOI 10.1016/j.immuni.2013.04.012; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	65	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0181886	10.1371/journal.pone.0181886	http://dx.doi.org/10.1371/journal.pone.0181886			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28792942	Green Published, gold			2022-12-26	WOS:000407196700024
J	Enright, HA; Falso, MJS; Malfatti, MA; Lao, V; Kuhn, EA; Hum, N; Shi, YL; Sales, AP; Haack, KW; Kulp, KS; Buchholz, BA; Loots, GG; Bench, G; Turteltaub, KW				Enright, Heather A.; Falso, Miranda J. S.; Malfatti, Michael A.; Lao, Victoria; Kuhn, Edward A.; Hum, Nicholas; Shi, Yilan; Sales, Ana Paula; Haack, Kurt W.; Kulp, Kristen S.; Buchholz, Bruce A.; Loots, Gabriela G.; Bench, Graham; Turteltaub, Kenneth W.			Maternal exposure to an environmentally relevant dose of triclocarban results in perinatal exposure and potential alterations in offspring development in the mouse model	PLOS ONE			English	Article							ACCELERATOR MASS-SPECTROMETRY; POTAMOPYRGUS-ANTIPODARUM; TRICLOSAN; OBESITY; REPRODUCTION; ESTROGENS; BIOASSAY; RECEPTOR; AGENTS; RATS	Triclocarban (TCC) is among the top 10 most commonly detected wastewater contaminants in both concentration and frequency. Its presence in water, as well as its propensity to bioaccumulate, has raised numerous questions about potential endocrine and developmental effects. Here, we investigated whether exposure to an environmentally relevant concentration of TCC could result in transfer from mother to offspring in CD-1 mice during gestation and lactation using accelerator mass spectrometry (AMS). C-14-TCC (100 nM) was administered to dams through drinking water up to gestation day 18, or from birth to post-natal day 10. AMS was used to quantify C-14-concentrations in offspring and dams after exposure. We demonstrated that TCC does effectively transfer from mother to offspring, both trans-placentally and via lactation. TCC-related compounds were detected in the tissues of offspring with significantly higher concentrations in the brain, heart and fat. In addition to transfer from mother to offspring, exposed offspring were heavier in weight than unexposed controls demonstrating an 11% and 8.5% increase in body weight for females and males, respectively. Quantitative real-time polymerase chain reaction (qPCR) was used to examine changes in gene expression in liver and adipose tissue in exposed offspring. qPCR suggested alterations in genes involved in lipid metabolism in exposed female offspring, which was consistent with the observed increased fat pad weights and hepatic triglycerides. This study represents the first report to quantify the transfer of an environmentally relevant concentration of TCC from mother to offspring in the mouse model and evaluate bio-distribution after exposure using AMS. Our findings suggest that early-life exposure to TCC may interfere with lipid metabolism and could have implications for human health.	[Enright, Heather A.; Malfatti, Michael A.; Lao, Victoria; Kuhn, Edward A.; Hum, Nicholas; Kulp, Kristen S.; Loots, Gabriela G.; Turteltaub, Kenneth W.] Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, Livermore, CA 94550 USA; [Falso, Miranda J. S.; Shi, Yilan; Haack, Kurt W.; Buchholz, Bruce A.; Bench, Graham] Lawrence Livermore Natl Lab, Ctr Accelerator Mass Spectrometry, Livermore, CA USA; [Sales, Ana Paula] Lawrence Livermore Natl Lab, Data Analyt & Decis Sci, Livermore, CA USA; [Falso, Miranda J. S.] Slippery Rock Univ, Dept Biol, Slippery Rock, PA 16057 USA; [Shi, Yilan] Biorad, Hercules, CA USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Pennsylvania State System of Higher Education (PASSHE); Slippery Rock University - Pennsylvania	Enright, HA (corresponding author), Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, Livermore, CA 94550 USA.	enright3@llnl.gov	Buchholz, Bruce A/G-1356-2011; Loots, Gabriela G/AGA-4868-2022	Buchholz, Bruce A/0000-0002-9531-551X; Loots, Gabriela G/0000-0001-9546-5561; Kuhn, Edward/0000-0002-5521-3404; Bench, Graham/0000-0002-1969-6867; Enright, Heather/0000-0001-6422-0481; Hum, Nicholas/0000-0003-1605-3193	U.S. Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; LDRD [11-LW-018]; National Institutes of Health [NIGMS 8P41GM103483];  [LLNL-JRNL-666068]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103483] Funding Source: NIH RePORTER	U.S. Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); LDRD; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344. This work was supported by LDRD funding (11-LW-018, MF) and from the National Institutes of Health (NIGMS 8P41GM103483, KWT). LLNL-JRNL-666068.	Ahn KC, 2008, ENVIRON HEALTH PERSP, V116, P1203, DOI 10.1289/ehp.11200; Chen JG, 2008, ENDOCRINOLOGY, V149, P1173, DOI 10.1210/en.2007-1057; Christian MS, 1998, DRUG CHEM TOXICOL, V21, P51, DOI 10.3109/01480549809007404; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; Coogan MA, 2008, ENVIRON TOXICOL CHEM, V27, P1788, DOI 10.1897/07-374.1; Costa LG, 2004, ANNU REV PHARMACOL, V44, P87, DOI 10.1146/annurev.pharmtox.44.101802.121424; Duleba AJ, 2011, REPROD SCI, V18, P119, DOI 10.1177/1933719110382581; Geiss C, 2016, J ENVIRON SCI HEAL A, V51, P1173, DOI 10.1080/10934529.2016.1206388; Giudice BD, 2010, ENVIRON TOXICOL CHEM, V29, P966, DOI 10.1002/etc.105; Halden RU, 2014, ENVIRON SCI TECHNOL, V48, P3603, DOI 10.1021/es500495p; Halden RU, 2005, ENVIRON SCI TECHNOL, V39, P1420, DOI 10.1021/es049071e; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Huang HY, 2014, J APPL TOXICOL, V34, P1060, DOI 10.1002/jat.3012; Kennedy RCM, 2015, REPROD SCI, V22, P75, DOI 10.1177/1933719114532844; Lim CT, 2010, J MOL ENDOCRINOL, V44, P87, DOI 10.1677/JME-09-0063; Malfatti MA, 2012, NANO LETT, V12, P5532, DOI 10.1021/nl302412f; Newbold RR, 2007, MOL NUTR FOOD RES, V51, P912, DOI 10.1002/mnfr.200600259; Newbold RR, 2005, BIRTH DEFECTS RES A, V73, P478, DOI 10.1002/bdra.20147; Newbold RR, 2004, REPROD TOXICOL, V18, P399, DOI 10.1016/j.reprotox.2004.01.007; NOLEN GA, 1979, TOXICOL APPL PHARM, V51, P417, DOI 10.1016/0041-008X(79)90366-1; Ognibene TJ, 2003, ANAL CHEM, V75, P2192, DOI 10.1021/ac026334j; Padilla-Banks E, 2001, ENVIRON HEALTH PERSP, V109, P821, DOI 10.2307/3454825; Papaconstantinou AD, 2000, TOXICOL SCI, V56, P332, DOI 10.1093/toxsci/56.2.332; Pycke BFG, 2014, ENVIRON SCI TECHNOL, V48, P8831, DOI 10.1021/es501100w; RODIER PM, 1995, ENVIRON HEALTH PERSP, V103, P73, DOI 10.2307/3432351; Ross SM, 2003, J ENG TECHNOL, V20, P38; Schebb NH, 2012, DRUG METAB DISPOS, V40, P25, DOI 10.1124/dmd.111.042283; Snyder EH, 2011, CHEMOSPHERE, V82, P460, DOI 10.1016/j.chemosphere.2010.09.054; Somm E, 2009, ENVIRON HEALTH PERSP, V117, P1549, DOI 10.1289/ehp.11342; Vogel JS, 2005, METHOD ENZYMOL, V402, P402, DOI 10.1016/S0076-6879(05)02013-6; VOGEL JS, 1995, ANAL CHEM, V67, pA353, DOI 10.1021/ac00107a001; Yoon M, 2009, PHARMACOL RES, V60, P151, DOI 10.1016/j.phrs.2009.02.004	32	15	15	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0181996	10.1371/journal.pone.0181996	http://dx.doi.org/10.1371/journal.pone.0181996			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28792966	gold, Green Published, Green Submitted			2022-12-26	WOS:000407196700029
J	Lauterbach, A; Usbeck, JC; Behr, J; Vogel, RF				Lauterbach, Alexander; Usbeck, Julia C.; Behr, Juergen; Vogel, Rudi F.			MALDI-TOF MS typing enables the classification of brewing yeasts of the genus Saccharomyces to major beer styles	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; DESORPTION-IONIZATION-TIME; POLYMERASE-CHAIN-REACTION; SENSU-STRICTO; SPOILAGE MICROORGANISMS; LACTOBACILLUS-BREVIS; CEREVISIAE STRAINS; GENETIC DIVERSITY; INDUSTRIAL YEASTS; IDENTIFICATION	Brewing yeasts of the genus Saccharomyces are either available from yeast distributor centers or from breweries employing their own "in-house strains". During the last years, the classification and characterization of yeasts of the genus Saccharomyces was achieved by using biochemical and DNA-based methods. The current lack of fast, cost-effective and simple methods to classify brewing yeasts to a beer type, may be closed by Matrix Assisted Laser Desorption/Ionization-Time-Of-Flight Mass Spectrometry (MALDI-TOF MS) upon establishment of a database based on sub-proteome spectra from reference strains of brewing yeasts. In this study an extendable "brewing yeast" spectra database was established including 52 brewing yeast strains of the most important types of bottom-and top-fermenting strains as well as beer-spoiling S. cerevisiae var. diastaticus strains. 1560 single spectra, prepared with a standardized sample preparation method, were finally compared against the established database and investigated by bioinformatic analyses for similarities and distinctions. A 100% separation between bottom-, top-fermenting and S. cerevisiae var. diastaticus strains was achieved. Differentiation between Alt and Kolsch strains was not achieved because of the high similarity of their protein patterns. Whereas the Ale strains show a high degree of dissimilarity with regard to their sub-proteome. These results were supported by MDS and DAPC analysis of all recorded spectra. Within five clusters of beer types that were distinguished, and the wheat beer (WB) cluster has a clear separation from other groups. With the establishment of this MALDI-TOF MS spectra database proof of concept is provided of the discriminatory power of this technique to classify brewing yeasts into different major beer types in a rapid, easy way, and focus brewing trails accordingly. It can be extended to yeasts for specialty beer types and other applications including wine making or baking.	[Lauterbach, Alexander; Usbeck, Julia C.; Behr, Juergen; Vogel, Rudi F.] Tech Univ Munich, Lehrstuhl Tech Mikrobiol, Freising Weihenstephan, Germany; [Behr, Juergen] Bavarian Ctr Biomol Mass Spectrometry, Freising Weihenstephan, Germany	Technical University of Munich	Vogel, RF (corresponding author), Tech Univ Munich, Lehrstuhl Tech Mikrobiol, Freising Weihenstephan, Germany.	rudi.vogel@wzw.tum.de		Behr, Juergen/0000-0001-8782-4456	German Ministry of Economics and Technology; WiFo (Wirtschaftsforderung der Deutschen Brauwirtschaft e.V., Berlin Germany) [AiF 17698]	German Ministry of Economics and Technology(Federal Ministry for Economic Affairs and Energy (BMWi)); WiFo (Wirtschaftsforderung der Deutschen Brauwirtschaft e.V., Berlin Germany)	Money giving parties non impact on the conducted research or its design: German Ministry of Economics and Technology and the WiFo (Wirtschaftsforderung der Deutschen Brauwirtschaft e.V., Berlin Germany) in the project AiF 17698. Support with materials: We would like to thank Dr. Mathias Hutzler and Tim MeierDbrnberg of the yeast center of the Research Center Weihenstephan for Brewing and Food Quality for the supply of the brewing yeast strains and respective information on these. Center Weihenstephan for Brewing and Food Quality for the supply of the brewing yeast strains and respective information on these.; Part of this work was funded by the German Ministry of Economics and Technology and the WiFo (Wirtschaftsforderung der Deutschen Brauwirtschaft e.V., Berlin Germany) in the project AiF 17698. We would like to thank Dr. Mathias Hutzler, Tim Meier-Dornberg and Dominique Stretz of the yeast center of the Research Center Weihenstephan for Brewing and Food Quality for the supply of the brewing yeast strains and respective information on these.	Adams WJ, 2006, J ECON PERSPECT, V20, P189, DOI 10.1257/089533006776526120; Andrews BJ, 1952, J I BREWING, V58, P189; Annemuller G., 2008, HEFE BRAUEREI HEFEMA; Azumi M, 2001, YEAST, V18, P1145, DOI 10.1002/yea.767; Banfort CW., 2000, J CHEM EDUC, V5, P102, DOI [10.1007/s00897000378a, DOI 10.1007/S00897000378A]; Bayly JC, 2005, FEMS YEAST RES, V5, P1151, DOI 10.1016/j.femsyr.2005.05.004; Bing J, 2014, CURR BIOL, V24, pR380, DOI 10.1016/j.cub.2014.04.031; Blattel V, 2013, APPL MICROBIOL BIOT, V97, P4597, DOI 10.1007/s00253-013-4823-z; Coghe S, 2004, J AGR FOOD CHEM, V52, P602, DOI 10.1021/jf0346556; Couto MMB, 1996, APPL ENVIRON MICROB, V62, P41, DOI 10.1128/AEM.62.1.41-46.1996; Fester T, 2009, CUDA BASED MULTI COR; Firacative C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037566; Frank AM, 2008, J PROTEOME RES, V7, P113, DOI 10.1021/pr070361e; Gallone B, 2016, CELL, V166, P1397, DOI 10.1016/j.cell.2016.08.020; Gibson B, 2014, YEAST; Gibson BR, 2013, YEAST, V30, P255, DOI 10.1002/yea.2960; Goncalves M, 2016, CURR BIOL, V26, P2750, DOI 10.1016/j.cub.2016.08.040; Gronau I, 2007, INFORM PROCESS LETT, V104, P205, DOI 10.1016/j.ipl.2007.07.002; Hirst MB, 2016, AM J ENOL VITICULT, V67, P361, DOI 10.5344/ajev.2016.15098; Holl L, 2016, FOOD MICROBIOL, V60, P84, DOI 10.1016/j.fm.2016.07.003; Hutzler M, 2010, J I BREWING, V116, P464, DOI 10.1002/j.2050-0416.2010.tb00798.x; Jombart T., 2015, TUTORIAL DISCRIMINAN, DOI DOI 10.1007/s10750-017-3486-7; Kern CC, 2014, FOOD MICROBIOL, V40, P18, DOI 10.1016/j.fm.2013.11.015; Kopecka J, 2016, J APPL MICROBIOLOGY; Krogerus K, 2015, J IND MICROBIOL BIOT, V42, P769, DOI 10.1007/s10295-015-1597-6; Kunze W., 2011, TECHNOLOGIE BRAUER M; Laidlaw L, 1996, J AM SOC BREW CHEM, V54, P97; Legras JL, 2007, MOL ECOL, V16, P2091, DOI 10.1111/j.1365-294X.2007.03266.x; Libkind D, 2011, P NATL ACAD SCI USA, V108, P14539, DOI 10.1073/pnas.1105430108; Liu HH, 2007, APPL ENVIRON MICROB, V73, P1899, DOI 10.1128/AEM.02391-06; Lopes MD, 1999, INT J SYST BACTERIOL, V49, P915, DOI 10.1099/00207713-49-2-915; Mair P., 2012, APPL MULTIDIMENSIONA; Mantini D, 2010, J PROTEOMICS, V73, P562, DOI 10.1016/j.jprot.2009.11.004; Masneuf I, 1998, APPL ENVIRON MICROB, V64, P3887; Meussdoerffer F, 2014, BIER EINE GESCH HOPF; Meussdoerffer FG, 2009, HDB BREWING PROCESSE, P1, DOI DOI 10.1002/9783527623488; Moothoo-Padayachie A, 2013, EUR FOOD RES TECHNOL, V236, P351, DOI 10.1007/s00217-012-1898-1; Mukai N, 2014, J BIOSCI BIOENG, V118, P50, DOI 10.1016/j.jbiosc.2013.12.017; Mukai N, 2010, J BIOSCI BIOENG, V109, P564, DOI 10.1016/j.jbiosc.2009.11.011; Nacef M, 2016, INT J FOOD MICROBIOL; NARZISS L, 1984, J I BREWING, V90, P351, DOI 10.1002/j.2050-0416.1984.tb04288.x; Pavlovic M, 2014, J MICROBIOL METH, V106, P123, DOI 10.1016/j.mimet.2014.08.021; Peris D, 2014, MOL ECOL, V23, P2031, DOI 10.1111/mec.12702; Petcek M, 2007, STRUCTURE, V15, P1357; PRZYBYT M, 1988, STARCH-STARKE, V40, P108, DOI 10.1002/star.19880400307; Rainieri S, 2003, J BIOSCI BIOENG, V96, P1; Replansky T, 2008, TRENDS ECOL EVOL, V23, P494, DOI 10.1016/j.tree.2008.05.005; Richard P, 2015, AMB EXPRESS, V5, DOI 10.1186/s13568-015-0103-x; Schlee D., 1975, SYST ZOOL, V24, P263, DOI [10.2307/2412767, DOI 10.2307/2412767]; Schneiderbanger H, 2016, J I BREWING, V122, P403, DOI 10.1002/jib.337; Schott AS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165504; Schurr BC, 2015, FOOD MICROBIOL, V46, P501, DOI 10.1016/j.fm.2014.09.018; SHEEHAN CA, 1991, J I BREWING, V97, P163, DOI 10.1002/j.2050-0416.1991.tb01061.x; SPENCER JFT, 1983, ANNU REV MICROBIOL, V37, P121, DOI 10.1146/annurev.mi.37.100183.001005; Stevenson LG, 2010, J CLIN MICROBIOL, V48, P3482, DOI 10.1128/JCM.00687-09; Timmins EM, 1998, YEAST, V14, P885, DOI 10.1002/(SICI)1097-0061(199807)14:10<885::AID-YEA286>3.0.CO;2-G; Tokpohozin SE, 2016, EUROPEAN FOOD RES TE, P1; Turvey ME, 2016, APPL MICROBIOL BIOT, V100, P2761, DOI 10.1007/s00253-016-7344-8; Usbeck JC, 2014, APPL MICROBIOL BIOT, V98, P3737, DOI 10.1007/s00253-014-5586-x; Usbeck JC, 2013, FOOD MICROBIOL, V36, P379, DOI 10.1016/j.fm.2013.07.004; Vanbeneden N, 2008, FOOD CHEM, V107, P221, DOI 10.1016/j.foodchem.2007.08.008; Verstrepen KJ, 2003, APPL MICROBIOL BIOT, V61, P197, DOI 10.1007/s00253-002-1200-8; Wieme AD, 2014, INT J FOOD MICROBIOL, V185, P41, DOI 10.1016/j.ijfoodmicro.2014.05.003; YAMASHITA I, 1984, AGR BIOL CHEM TOKYO, V48, P1611, DOI 10.1080/00021369.1984.10866345; Yan YJ, 2011, J CLIN MICROBIOL, V49, P2528, DOI 10.1128/JCM.00339-11	65	16	16	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0181694	10.1371/journal.pone.0181694	http://dx.doi.org/10.1371/journal.pone.0181694			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28792944	Green Submitted, Green Published, gold			2022-12-26	WOS:000407196700018
J	Rachul, C; Rasko, JEJ; Caulfield, T				Rachul, Christen; Rasko, John E. J.; Caulfield, Timothy			Implicit hype? Representations of platelet rich plasma in the news media	PLOS ONE			English	Article							CHRONIC ACHILLES TENDINOPATHY; RANDOMIZED CONTROLLED-TRIAL; ROTATOR CUFF REPAIR; SPORTS-MEDICINE; FOLLOW-UP; INTERVENTIONS; INJECTIONS; THERAPIES; INJURIES	Platelet Rich Plasma (PRP) has gained popularity in recent years for treating sports-related injuries and the news media frequently reports on elite athletes' and celebrities' use of PRP. We conducted a content analysis of newspaper coverage of PRP in Australia, Canada, Ireland, New Zealand, United Kingdom, and the United States. Findings show that news media coverage of PRP appears most frequently in sports-related stories, and in relation to elite athletes use of PRP. PRP injections are largely portrayed as a routine treatment for sports-related injuries and newspaper articles rarely discuss the limitations or efficacy of PRP. We argue that while news media coverage of PRP exhibits very few common hallmarks of hype, its portrayal as a routine treatment used by elite athletes and celebrities creates an implicit hype. This implicit hype can contribute to public misunderstandings of the efficacy of PRP.	[Rachul, Christen] Univ Manitoba, Off Educ, Winnipeg, MB, Canada; [Rachul, Christen] Univ Manitoba, Fac Dev, Rady Fac Hlth Sci, Winnipeg, MB, Canada; [Rasko, John E. J.] Univ Sydney, Centenary Inst, Gene & Stem Cell Therapy Program, Camperdown, NSW, Australia; [Rasko, John E. J.] Univ Sydney, Sydney Med Sch, Camperdown, NSW, Australia; [Rasko, John E. J.] Royal Prince Alfred Hosp, Cell & Mol Therapies, Camperdown, NSW, Australia; [Caulfield, Timothy] Univ Alberta, Hlth Law Inst, Edmonton, AB, Canada; [Caulfield, Timothy] Univ Alberta, Fac Law, Edmonton, AB, Canada; [Caulfield, Timothy] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada	University of Manitoba; University of Manitoba; University of Sydney; Centenary Institute; University of Sydney; University of Sydney; University of Alberta; University of Alberta; University of Alberta	Caulfield, T (corresponding author), Univ Alberta, Hlth Law Inst, Edmonton, AB, Canada.; Caulfield, T (corresponding author), Univ Alberta, Fac Law, Edmonton, AB, Canada.; Caulfield, T (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.	caulfield@ualberta.ca		rasko, John/0000-0003-2975-807X; Rachul, Christen/0000-0002-3726-1891	Trudeau Foundation	Trudeau Foundation	The authors thank the Trudeau Foundation for funding support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beitzel K, 2015, J KNEE SURG, V28, P29, DOI 10.1055/s-0034-1390030; Berger I, 2016, CELL STEM CELL, V19, P158, DOI 10.1016/j.stem.2016.07.015; Best TM, 2017, CURR SPORT MED REP, V16, P202, DOI 10.1249/JSR.0000000000000357; Biancovilli P, 2015, J MEDIA COMMUN STUD, V7, P41, DOI DOI 10.5897/JMCS2014.0423; Castricini R, 2011, AM J SPORT MED, V39, P258, DOI 10.1177/0363546510390780; Caulfield T, 2012, PUBLIC HEALTH GENOM, V15, P209, DOI 10.1159/000336533; Caulfield T, 2016, SCIENCE, V352, P776, DOI 10.1126/science.aaf4620; Caulfield T, 2012, MOL THER, V20, P1656, DOI 10.1038/mt.2012.172; Chalmers S., 2014, TELEGRAPH; de Jonge S, 2011, AM J SPORT MED, V39, P1623, DOI 10.1177/0363546511404877; de Vos RJ, 2010, JAMA-J AM MED ASSOC, V303, P144, DOI 10.1001/jama.2009.1986; Engebretsen L, 2010, BRIT J SPORT MED, V44, P1072, DOI 10.1136/bjsm.2010.079822; Hoffman SJ, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/2049-3258-73-3; Hoffman SJ, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7151; ISSCR, GUID STEM CELL RES C; Kamenova K, 2014, GENET MED, V16, P522, DOI 10.1038/gim.2013.199; Kimmelman J, 2016, NATURE, V533, P311, DOI 10.1038/533311a; Laudy ABM, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-094036; Maddeaux S., 2016, NATL POST       0927; Matthews KRW, 2014, STEM CELLS DEV, V23, P60, DOI 10.1089/scd.2014.0358; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Moraes VY, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010071.pub3; Pas HIMFL, 2015, BRIT J SPORT MED, V49, P1197, DOI 10.1136/bjsports-2015-094879; Rachul C, 2016, J CYST FIBROS, V15, P624, DOI 10.1016/j.jcf.2016.03.006; Rachul C, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0320-z; Randelli P, 2011, J SHOULDER ELB SURG, V20, P518, DOI 10.1016/j.jse.2011.02.008; Reurink G, 2014, NEW ENGL J MED, V370, P2546, DOI 10.1056/NEJMc1402340; Schwarz A, 2009, NY TIMES, pA1; Silva A, 2009, KNEE SURG SPORT TR A, V17, P676, DOI 10.1007/s00167-009-0762-8; Sipp D, 2017, SCI TRANSL IN PRESS; Soroka SN, 2011, PUBLIC PERCEPTIONS M; Swami V, 2009, PERS INDIV DIFFER, V47, P869, DOI 10.1016/j.paid.2009.07.006; Turner L, 2016, CELL STEM CELL, V19, P154, DOI 10.1016/j.stem.2016.06.007; Vinkers CH, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6467; Woloshin S, 2006, PLOS MED, V3, P452, DOI 10.1371/journal.pmed.0030170	35	35	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0182496	10.1371/journal.pone.0182496	http://dx.doi.org/10.1371/journal.pone.0182496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28792974	Green Published, gold, Green Submitted			2022-12-26	WOS:000407196700048
J	Telfer, S; Obradovich, N				Telfer, Scott; Obradovich, Nick			Local weather is associated with rates of online searches for musculoskeletal pain symptoms	PLOS ONE			English	Article							CLIMATE-CHANGE; KNEE OSTEOARTHRITIS; PHYSICAL-ACTIVITY; UNITED-STATES; TEMPERATURE; PREVALENCE; ARTHRITIS; VARIABLES; PROJECT; HEALTH	Weather conditions are commonly believed to influence musculoskeletal pain, however the evidence for this is mixed. This study aimed to examine the relationship between local meteorological conditions and online search trends for terms related to knee pain, hip pain, and arthritis. Five years of relative online search volumes for these terms were obtained for the 50 most populous cities in the contiguous United States, along with corresponding local weather data for temperature, relative humidity, barometric pressure, and precipitation. Methods from the climate econometrics literature were used to assess the casual impact of these meteorological variables on the relative volumes of searches for pain. For temperatures between -5 degrees C and 30 degrees C, search volumes for hip pain increased by 12 index points, and knee pain increased by 18 index points. Precipitation had a negative effect on search volumes for these terms. At temperatures >30 degrees C, search volumes for arthritis related pain decreased by 7 index points. These patterns were not seen for pain searches unrelated to the musculoskeletal system. In summary, selected local weather conditions are significantly associated with online search volumes for specific musculoskeletal pain symptoms. We believe the predominate driver for this to be the relative changes in physical activity levels associated with meteorological conditions.	[Telfer, Scott] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA; [Obradovich, Nick] Harvard Univ, Belfer Ctr Sci & Int Affairs, Kennedy Sch Govt, Cambridge, MA 02138 USA; [Obradovich, Nick] MIT, Media Lab, Cambridge, MA 02139 USA	University of Washington; University of Washington Seattle; Harvard University; Massachusetts Institute of Technology (MIT)	Telfer, S (corresponding author), Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA.	telfers@uw.edu		Obradovich, Nick/0000-0003-1127-2231				Althouse BM, 2014, AM J PREV MED, V46, P166, DOI 10.1016/j.amepre.2013.10.008; ANDERSEN I, 1973, ARCH ENVIRON HEALTH, V26, P22, DOI 10.1080/00039896.1973.10666213; Auffhammer M, 2013, REV ENV ECON POLICY, V7, P181, DOI 10.1093/reep/ret016; Ayers JW, 2014, JAMA-J AM MED ASSOC, V311, P1399, DOI 10.1001/jama.2014.1505; Bragazzi NL, 2016, CLIN RHEUMATOL; Bratucu R, 2014, J Med Life, V7, P310; Brennan SA, 2012, INT ORTHOP, V36, P643, DOI 10.1007/s00264-011-1304-9; Carleton TA, 2016, SCIENCE, V80, P353; Carneiro HA, 2009, CLIN INFECT DIS, V49, P1557, DOI 10.1086/630200; Crowson MG, 2016, OTOL NEUROTOL, V37, P1049, DOI 10.1097/MAO.0000000000001115; Deschenes O, 2011, AM ECON J-APPL ECON, V3, P152, DOI 10.1257/app.3.4.152; Dillon CF, 2006, J RHEUMATOL, V33, P2271; Dorleijn DMJ, 2014, PAIN, V155, P808, DOI 10.1016/j.pain.2014.01.018; Fors EA, 2002, ANN RHEUM DIS, V61, P247, DOI 10.1136/ard.61.3.247; Gamma A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166566; GUEDJ D, 1990, ANN RHEUM DIS, V49, P158, DOI 10.1136/ard.49.3.158; Hausman J, 2001, J ECON PERSPECT, V15, P57, DOI 10.1257/jep.15.4.57; Hsiang S, 2016, ANNU REV RESOUR ECON, V8, P43, DOI 10.1146/annurev-resource-100815-095343; Hsiang SM, 2013, SCIENCE, V341, P1212, DOI 10.1126/science.1235367; Jordan JM, 2007, J RHEUMATOL, V34, P172; McAlindon T, 2007, AM J MED, V120, P429, DOI 10.1016/j.amjmed.2006.07.036; McLean S, 2017, BMJ SUPPORT PALLIAT; Nuti SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109583; O'Connell SE, 2014, ANN HUM BIOL, V41, P1, DOI 10.3109/03014460.2013.827737; Obradovich N, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-017-0097; Obradovich N, 2017, CLIMATIC CHANGE, V140, P135, DOI 10.1007/s10584-016-1833-8; Pew Research Center, 2014, PEW EWS CTR INT PROJ; Powell J, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1600; Quicke JG, 2015, OSTEOARTHR CARTILAGE, V23, P1445, DOI 10.1016/j.joca.2015.05.002; Rozin A, 2003, CLIN EXP RHEUMATOL, V21, P161; Santillana M, 2014, AM J PREV MED, V47, P341, DOI 10.1016/j.amepre.2014.05.020; Shulman BS, 2016, INJURY, V47, P1841, DOI 10.1016/j.injury.2016.05.043; SHUTTY MS, 1992, PAIN, V49, P199, DOI 10.1016/0304-3959(92)90143-Y; Stone B V, 2016, INT UROGYNECOL J; Strusberg I, 2002, J RHEUMATOL, V29, P335; Telfer S, 2015, J FOOT ANKLE RES, V8, DOI 10.1186/s13047-015-0074-9; Timmermans EJ, 2015, J RHEUMATOL, V42, P1885, DOI 10.3899/jrheum.141594; Timmermans EJ, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-66; Tucker P, 2007, PUBLIC HEALTH, V121, P909, DOI 10.1016/j.puhe.2007.04.009; van Tuyl LHD, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-28; Wiley KE, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3933-9; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1; Zivin JG, 2014, J LABOR ECON, V32, P1, DOI 10.1086/671766	43	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0181266	10.1371/journal.pone.0181266	http://dx.doi.org/10.1371/journal.pone.0181266			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9YJ	28792953	gold, Green Published, Green Submitted			2022-12-26	WOS:000407196700008
J	Williams, H; McOwan, PW				Williams, Howard; McOwan, Peter W.			The magic words: Using computers to uncover mental associations for use in magic trick design	PLOS ONE			English	Article								The use of computational systems to aid in the design of magic tricks has been previously explored. Here further steps are taken in this direction, introducing the use of computer technology as a natural language data sourcing and processing tool for magic trick design purposes. Crowd sourcing of psychological concepts is investigated; further, the role of human associative memory and its exploitation in magical effects is explored. A new trick is developed and evaluated: a physical card trick partially designed by a computational system configured to search for and explore conceptual spaces readily understood by spectators.	[Williams, Howard; McOwan, Peter W.] Queen Mary Univ London, Sch Elect Engn & Comp Sci, London, England	University of London; Queen Mary University London	Williams, H (corresponding author), Queen Mary Univ London, Sch Elect Engn & Comp Sci, London, England.	h.williams@eecs.qmul.ac.uk		Williams, Howard/0000-0002-6418-2785	EPSRC [EP/J50029X/1]; Engineering and Physical Sciences Research Council [1086704, EP/J019860/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by EPSRC grant number EP/J50029X/1.	Annemann T, 2008, PRACTICAL MENTAL MAG; Banachek, 1998, PSYCHOL SUBTLETIES; Boden MA, 1998, ARTIF INTELL, V103, P347, DOI 10.1016/S0004-3702(98)00055-1; Chen K., 2013, ADV NEURAL INF PROCE, V26, P3111, DOI DOI 10.5555/2999792.2999959; Corinda T, 1996, 13 STEPS MENTALISM; Diaconis  P., 2012, MAGICAL MATH; Earle L, 2003, MIND MENTALISM NEW D; Erdnase SW. Artifice, 1902, ARTIFICE RUSE SUBTER; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Hartley David, 1834, OBSERVATIONS MAN HIS; Hugard Jean, 1974, EXPERT CARD TECHNIQU; MacTier AF, 2000, CARD CONCEPTS ANTHOL; Mikolov T., 2013, P ICLR WORKSH POST S; Mill J., 1822, ANAL PHENOMENA HUMAN; MILLER GA, 1995, COMMUN ACM, V38, P39, DOI 10.1145/219717.219748; Resnik P., 1995, CMPLG9511007 ARXIV; ROBERTSON SE, 1990, J DOC, V46, P359, DOI 10.1108/eb026866; Russell S, 2009, ARTIFICIAL INTELLIGE; Shettleworth S.J., 2009, COGNITION EVOLUTION; Von Eckardt B., 1995, WHAT IS COGNITIVE SC; Williams H, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01283	21	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 9	2017	12	8							e0181877	10.1371/journal.pone.0181877	http://dx.doi.org/10.1371/journal.pone.0181877			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FC9YJ	28792941	Green Published, gold, Green Submitted			2022-12-26	WOS:000407196700023
J	Dengo-Baloi, LC; Sema-Baltazar, CA; Manhique, LV; Chitio, JE; Inguane, DL; Langa, JP				Candida Dengo-Baloi, Liliana; Amino Sema-Baltazar, Cynthia; Vania Manhique, Lena; Elias Chitio, Jucunu; Luisa Inguane, Dorteia; Paulo Langa, Jose			Antibiotics resistance in El Tor Vibrio cholerae 01 isolated during cholera outbreaks in Mozambique from 2012 to 2015	PLOS ONE			English	Article							VIBRIO-CHOLERAE; STRAINS; EPIDEMIOLOGY; VARIANT; INDIA	Rationale Mozambique has recorded cyclically epidemic outbreaks of cholera. Antibiotic therapy is recommended in specific situations for management and control of cholera outbreaks. However, an increase in resistance rates to antibiotics by Vibrio cholerae has been reported in several epidemic outbreaks worldwide. On the other hand, there are few recent records of continuous surveillance of antibiotics susceptibility pattern of V. cholerae in Mozambique. Goals The purpose of this study was to evaluate antibiotics resistance pattern of Vibrio cholerae O1 Ogawa isolated during Cholera outbreaks in Mozambique to commonly used antibiotics. Methodology We analyzed data from samples received in the context of surveillance and response to Cholera outbreaks in the National Reference Laboratory of Microbiology from the National Institute of Health of Mozambique, 159 samples suspected of cholera from cholera treatment centers of, Metangula (09), Memba (01), Tete City (08), Moatize (01), Morrumbala (01) districts, City of Quelimane (01), Lichinga (06) and Nampula (86) districts, from 2012 to 2015. Laboratory culture and standard biochemical tests were employed to isolate and identify Vibrio cholerae; serotypes were determined by antisera agglutination reaction in blade. Biotype and presence of important virulence factors analysis was done by PCR. Antibiotics susceptibility pattern was detected by disk diffusion method Kirby Bauer. Antibiotic susceptibility and results were interpreted by following as per recommendations of CLSI (Clinical and Laboratory Standards Institute) 2014. All samples were collected and tested in the context of Africhol Project, approved by the National Bioethics Committee for Health. Results Among isolates from of Vibrio cholerae O1 El Tor Ogawa resistance to Sulphamethoxazole-trimethropim was 100% (53/53) to Trimethoprim-, being 100% (54/54) for Ampicillin, 99% (72/74) for Nalidixic Acid, 97% (64/66) to Chloramphenicol, 95% (42/44) for Nitrofurantoin and (19/20) Cotrimoxazole, 83% (80/97) Tetracycline, 56% (5/13) Doxycycline, 56% (39/70) Azithromycin and 0% (0/101) for Ciprofloxacin. PCR analysis suggested strains of V. cholerae O1 being descendants of the current seventh pandemic V. cholerae O1 CIRS 101 hybrid variant. The V. cholerae O1 currently causing cholera epidemics in north and central Mozambique confirmed a CTXF genotype and a molecular arrangement similar to the V. cholerae O1 CIRS 101. Conclusion Although V. cholerae infections in Mozambique are generally not treated with antibiotics circulating strains of the bacteria showed high frequency of in vitro resistance to available antibiotics. Continuous monitoring of antibiotic resistance pattern of epidemic strains is therefore crucial since the appearance of antibiotic resistance can influence cholera control strategies.	[Candida Dengo-Baloi, Liliana; Amino Sema-Baltazar, Cynthia; Vania Manhique, Lena; Elias Chitio, Jucunu; Luisa Inguane, Dorteia; Paulo Langa, Jose] Inst Nacl Saude, Maputo, Mozambique		Dengo-Baloi, LC (corresponding author), Inst Nacl Saude, Maputo, Mozambique.	liliana.dengo.baloi@gmail.com		MANHIQUE-COUTINHO, LENA VANIA/0000-0002-6245-1160; Sema Baltazar, Cynthia/0000-0001-8901-2240	AFRICHOL PROJECT - Bill and Melinda Gates; Africhol project (Africa network for cholera surveillance)	AFRICHOL PROJECT - Bill and Melinda Gates; Africhol project (Africa network for cholera surveillance)	This work was supported by AFRICHOL PROJECT (Cholera surveillance in Africa consortium) funded by Bill and Melinda Gates.; Special thanks and gratitude to the Africhol project (Africa network for cholera surveillance) for the financial support; the Mozambican national reference laboratory of Microbiology team as well as Provincial field teams, Claudio Muianga and Dr. Sergio Chicumbe are acknowledged for their technical support to this study and on writing this manuscript.	Ansaruzzaman M, 2004, EMERG INFECT DIS, V10, P2057, DOI 10.3201/eid1011.040682; ARAGON M, 1994, REV SAUDE PUBL, V28, P332, DOI 10.1590/S0034-89101994000500004; Biemer J J, 1973, Ann Clin Lab Sci, V3, P135; Das S, 2011, J INFECT DEV COUNTR, V5, P294; Folgosa E, 2001, EPIDEMIOL INFECT, V127, P17, DOI 10.1017/S0950268801005623; Garg P, 2000, EPIDEMIOL INFECT, V124, P393, DOI 10.1017/S0950268899003957; GREENOUGH WB, 1964, LANCET, V1, P355; Gujral L, 2013, J INFECT DIS, V208, pS107, DOI 10.1093/infdis/jit212; Kitaoka M, 2011, J MED MICROBIOL, V60, P397, DOI 10.1099/jmm.0.023051-0; Klontz EH, 2014, CLIN INFECT DIS; Kuma GK, 2014, INT J INFECT CONTROL, V10; Mala E, 2013, INT J BASIC APPL SCI, V3; Mandal J, 2012, J HEALTH POPUL NUTR, V30, P12; Mandomando I, 2007, J ANTIMICROB CHEMOTH, V60, P662, DOI 10.1093/jac/dkm257; Marin MA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002049; Mengel MA, 2014, T ROY SOC TROP MED H, V108, P391, DOI 10.1093/trstmh/tru077; Miwanda B, 2015, EMERG INFECT DIS, V21, P847, DOI 10.3201/eid2105.141233; Mwansa JCL, 2007, EPIDEMIOL INFECT, V135, P847, DOI 10.1017/S0950268806007254; Naha A, 2012, J CLIN MICROBIOL, V50, P1733, DOI 10.1128/JCM.00387-12; Sack D.A., 2001, ANTIMICROBIAL RESIST; Salimi-Khorashad A, 2012, ZAHEDAN J RES MED SC, V14, P63; Sjolund-Karlsson M, 2011, EMERG INFECT DIS, V17; Waturangi DE, 2013, J MED MICROBIOL, V62, P352, DOI 10.1099/jmm.0.048769-0	23	36	36	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2017	12	8							e0181496	10.1371/journal.pone.0181496	http://dx.doi.org/10.1371/journal.pone.0181496			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9EU	28792540	gold, Green Published, Green Submitted			2022-12-26	WOS:000407144700006
J	Ji, ZH; Chen, J; Gao, W; Zhang, JY; Quan, FS; Hu, JP; Yuan, B; Ren, WZ				Ji, Zhong-Hao; Chen, Jian; Gao, Wei; Zhang, Jin-Yu; Quan, Fu-Shi; Hu, Jin-Ping; Yuan, Bao; Ren, Wen-Zhi			Cutaneous transcriptome analysis in NIH hairless mice	PLOS ONE			English	Article							FOLLICLE MORPHOGENESIS; MUTATION; MOUSE; CELLS; MODEL; VIRUS; SKIN; HR	Mice with spontaneous coat mutations are ideal animal models for studying skin development and tumorigenesis. In this study, skin hair growth cycle abnormalities were examined in NIH hairless mice 42 days after birth (P42) by using hematoxylin-eosin (H&E) staining. To examine the gene expression patterns in the skin of mutant mice, the dorsal skin of P42 female NIH mice and NIH hairless mice was sequenced by RNA-Seq, and 5,068 differentially expressed genes (DEGs) were identified (false discovery rate [FDR] >= 2, P < 0.05). A pathway analysis showed that basal cell carcinoma, the cell cycle and the Hippo, Hedgehog and Wnt signaling pathways were up-regulated in NIH hairless mice. Previous studies have shown that these pathways are closely associated with cell proliferation, cell cycle, organ size and cancer development. In contrast, signal transduction, bacterial and parasitic infection, and receptor-mediated pathways, including calcium signaling, were down-regulated in NIH hairless mice. A gene interaction network analysis was performed to identify genes related to hair follicle development. To verify the reliability of the RNA-Seq results, we used q-PCR to analyze 12 key genes identified from the gene interaction network analysis, including eight down-regulated and four up-regulated genes, and the results confirmed the reliability of the RNA-Seq results. Finally, we constructed the differential gene expression profiles of mutant mice by RNA-Seq. NIH hairless mice exhibited abnormalities in hair development and immune-related pathways. Pik3r1 and Pik3r3 were identified as key genes, laying the foundation for additional in-depth studies of hairless mice.	[Ji, Zhong-Hao; Chen, Jian; Gao, Wei; Zhang, Jin-Yu; Quan, Fu-Shi; Hu, Jin-Ping; Yuan, Bao; Ren, Wen-Zhi] Jilin Univ, Coll Anim Sci, Dept Lab Anim, Changchun, Jilin, Peoples R China	Jilin University	Yuan, B; Ren, WZ (corresponding author), Jilin Univ, Coll Anim Sci, Dept Lab Anim, Changchun, Jilin, Peoples R China.	yuan_bao@jlu.edu.cn; rwz1964@163.com	Quan, Fu-Shi/V-1826-2019		National Key Technology RD Program [2015BA107602]; National Natural Science Foundation of China [31501954]; Natural Science Foundation of Jilin Province [20170623034TC]	National Key Technology RD Program(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jilin Province	This study was supported by the National Key Technology R&D Program (2015BA107602), National Natural Science Foundation of China (31501954), and Natural Science Foundation of Jilin Province (20170623034TC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baek IC, 2009, MAMM GENOME, V20, P350, DOI 10.1007/s00335-009-9191-8; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bichsel KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069368; Cai ZW, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1283-0; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Chen J, 2016, INT J CLIN EXP MED, V9, P8925; Drokhlyansky E, 2017, P NATL ACAD SCI USA, V114, pE95, DOI 10.1073/pnas.1618157114; Dupuy D, 2007, NAT BIOTECHNOL, V25, P663, DOI 10.1038/nbt1305; Fang W, 2017, ONCOTARGET, V8, P13253, DOI 10.18632/oncotarget.14710; Hatesuer B, 2016, J INNATE IMMUN; He S, 2017, DRUG DELIV, V24, P471, DOI 10.1080/10717544.2016.1267821; Iglesias-Bartolome R, 2015, NAT CELL BIOL, V17, P793, DOI 10.1038/ncb3164; Jansen Ronald, 2002, Journal of Structural and Functional Genomics, V2, P71, DOI 10.1023/A:1020495201615; Jiang JP, 2017, J ETHNOPHARMACOL, V196, P253, DOI 10.1016/j.jep.2016.12.012; Kim BK, 2014, J DERMATOL SCI, V74, P81, DOI 10.1016/j.jdermsci.2013.12.007; Kim BK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-640; Kim SN, 2016, J IMMUNOTOXICOL, V13, P92, DOI 10.3109/1547691X.2015.1014581; KLIPPERAURBACH Y, 1995, MED HYPOTHESES, V45, P486, DOI 10.1016/0306-9877(95)90228-7; Kobayashi H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13336; Kwack MH, 2012, J INVEST DERMATOL, V132, P1554, DOI 10.1038/jid.2012.24; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Leshkowitz D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153782; Li XF, 2016, INFECT GENET EVOL, V39, P249, DOI 10.1016/j.meegid.2016.01.028; Liu YT, 2007, J INVEST DERMATOL, V127, P1605, DOI 10.1038/sj.jid.5700755; Ma QF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151994; Miao XY, 2015, MOL CELL ENDOCRINOL, V402, P32, DOI 10.1016/j.mce.2014.12.023; Morifuji M, 2015, J DERMATOL SCI, V78, P224, DOI 10.1016/j.jdermsci.2015.02.017; Nakamura M, 2013, J DERMATOL SCI, V69, P6, DOI 10.1016/j.jdermsci.2012.10.001; Nam Y, 2006, GENOMICS, V87, P520, DOI 10.1016/j.ygeno.2005.12.005; Ouyang YS, 2016, TUMOR BIOL, V37, P10827, DOI 10.1007/s13277-015-4379-x; Packer LM, 2017, MOL CANCER THER, V16, P637, DOI 10.1158/1535-7163.MCT-16-0415; Pazhamala LT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164959; Peng XZ, 2017, ONCOTARGET, V8, P679, DOI 10.18632/oncotarget.13510; Araujo VCP, 2015, EXP PARASITOL, V157, P138, DOI 10.1016/j.exppara.2015.07.010; Pratt CH, 2015, EXP MOL PATHOL, V98, P164, DOI 10.1016/j.yexmp.2015.01.015; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Schlitt T, 2003, GENOME RES, V13, P2568, DOI 10.1101/gr.1111403; Shao L, 2016, BIOCH BIOPHYSICAL RE; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2015, STEROIDS, V103, P72, DOI 10.1016/j.steroids.2015.04.006; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Spirin V. F., 2003, Meditsina Truda i Promyshlennaya Ekologiya, P1; Mendoza EMT, 2008, BIOTECHNOL ANN REV, V14, P423, DOI 10.1016/S1387-2656(08)00019-7; Troy NM, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0474-9; Tsai CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141761; Wang L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146791; Wei Zhi, 2007, BMC Proc, V1 Suppl 1, pS19; Yang K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020077; Yin H, 2017, CANCER GENE THER, V24, P180, DOI 10.1038/cgt.2017.3; Zhang ZK, 2014, MOL MED REP, V9, P1049, DOI 10.3892/mmr.2014.1908	51	3	3	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182463	10.1371/journal.pone.0182463	http://dx.doi.org/10.1371/journal.pone.0182463			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28787439	Green Submitted, Green Published, gold			2022-12-26	WOS:000406998800040
J	Stincardini, C; Massignan, T; Biggi, S; Elezgarai, SR; Sangiovanni, V; Vanni, I; Pancher, M; Adami, V; Moreno, J; Stravalaci, M; Maietta, G; Gobbi, M; Negro, A; Requena, JR; Castilla, J; Nonno, R; Biasini, E				Stincardini, Claudia; Massignan, Tania; Biggi, Silvia; Elezgarai, Saioa R.; Sangiovanni, Valeria; Vanni, Ilaria; Pancher, Michael; Adami, Valentina; Moreno, Jorge; Stravalaci, Matteo; Maietta, Giulia; Gobbi, Marco; Negro, Alessandro; Requena, Jesus R.; Castilla, Joaquin; Nonno, Romolo; Biasini, Emiliano			An antipsychotic drug exerts anti-prion effects by altering the localization of the cellular prion protein	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; CREUTZFELDT-JAKOB-DISEASE; PENTOSAN POLYSULFATE; CYCLIC AMPLIFICATION; SCRAPIE; QUINACRINE; PRP; INHIBITION; STRATEGIES; INFECTION	Prion diseases are neurodegenerative conditions characterized by the conformational conversion of the cellular prion protein (PrPC), an endogenous membrane glycoprotein of uncertain function, into PrPSc, a pathological isoform that replicates by imposing its abnormal folding onto PrPC molecules. A great deal of evidence supports the notion that PrPC plays at least two roles in prion diseases, by acting as a substrate for PrPSc replication, and as a mediator of its toxicity. This conclusion was recently supported by data suggesting that PrPC may transduce neurotoxic signals elicited by other disease-associated protein aggregates. Thus, PrPC may represent a convenient pharmacological target for prion diseases, and possibly other neurodegenerative conditions. Here, we sought to characterize the activity of chlorpromazine (CPZ), an antipsychotic previously shown to inhibit prion replication by directly binding to PrPC. By employing biochemical and biophysical techniques, we provide direct experimental evidence indicating that CPZ does not bind PrPC at biologically relevant concentrations. Instead, the compound exerts anti-prion effects by inducing the relocalization of PrPC from the plasma membrane. Consistent with these findings, CPZ also inhibits the cytotoxic effects delivered by a PrP mutant. Interestingly, we found that the different pharmacological effects of CPZ could be mimicked by two inhibitors of the GTPase activity of dynamins, a class of proteins involved in the scission of newly formed membrane vesicles, and recently reported as potential pharmacological targets of CPZ. Collectively, our results redefine the mechanism by which CPZ exerts anti-prion effects, and support a primary role for dynamins in the membrane recycling of PrPC, as well as in the propagation of infectious prions.	[Stincardini, Claudia; Massignan, Tania; Biggi, Silvia; Elezgarai, Saioa R.; Sangiovanni, Valeria; Maietta, Giulia; Biasini, Emiliano] Univ Trento, Ctr Integrat Biol CIBIO, Dulbecco Telethon Lab Prions & Amyloids, Trento, Italy; [Elezgarai, Saioa R.; Stravalaci, Matteo; Gobbi, Marco] IRCCS, Dept Mol Biochem & Pharmacol, Ist Ric Farmacol Mario Negri, Milan, Italy; [Vanni, Ilaria; Nonno, Romolo] Ist Super Sanita, Dept Food Safety & Vet Hlth, Rome, Italy; [Pancher, Michael; Adami, Valentina] Univ Trento, Ctr Integrat Biol CIBIO, HTS Core Facil, Trento, Italy; [Moreno, Jorge; Castilla, Joaquin] CIC BioGUNE, Parque Tecnol Bizkaia, Derio, Spain; [Negro, Alessandro] Univ Padua, Dept Biomed Sci, Padua, Italy; [Requena, Jesus R.] Univ Santiago de Compostela, CIMUS Biomed Res Inst, Santiago De Compostela, Spain; [Requena, Jesus R.] Univ Santiago de Compostela, Dept Med Sci, Santiago De Compostela, Spain; [Castilla, Joaquin] Basque Fdn Sci, Ikerbasque, Bizkaia, Bizkaia, Spain; [Biasini, Emiliano] IRCCS, Dept Neurosci, Ist Ric Farmacol Mario Negri, Milan, Italy	University of Trento; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto Superiore di Sanita (ISS); University of Trento; CIC bioGUNE; University of Padua; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Basque Foundation for Science; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Biasini, E (corresponding author), Univ Trento, Ctr Integrat Biol CIBIO, Dulbecco Telethon Lab Prions & Amyloids, Trento, Italy.; Biasini, E (corresponding author), IRCCS, Dept Neurosci, Ist Ric Farmacol Mario Negri, Milan, Italy.	biasinie@gmail.com	Gobbi, Marco/J-2638-2016; Vanni, Ilaria/J-3713-2016; Requena, Jesús/ABH-2344-2020; NONNO, ROMOLO/C-8323-2015; Stravalaci, Matteo/AAB-8963-2019; Castilla, Joaquín/J-8414-2019; Castilla, Joaquin/D-5261-2011; Biasini, Emiliano/A-3147-2011	Gobbi, Marco/0000-0003-1014-6225; Vanni, Ilaria/0000-0003-2617-4263; NONNO, ROMOLO/0000-0001-7556-1564; Stravalaci, Matteo/0000-0002-5636-4204; Castilla, Joaquín/0000-0002-2216-1361; Castilla, Joaquin/0000-0002-2216-1361; NEGRO, ALESSANDRO/0000-0003-3142-7632; Stincardini, Claudia/0000-0003-4432-1562; massignan, tania/0000-0002-6176-2696; Adami, Valentina/0000-0002-0617-9393; Biasini, Emiliano/0000-0002-3927-6341; Pancher, Michael/0000-0002-3783-6069; M. Charco, Jorge/0000-0003-3476-1855	Italian Ministry of Health [AGL2015-65046-C2-1-R]; CJD Foundation [GR-2010-2312769]; E-Rare Joint Transnational Call	Italian Ministry of Health(Ministry of Health, Italy); CJD Foundation; E-Rare Joint Transnational Call	The study was supported by a national grant from Spain to JC (AGL2015-65046-C2-1-R), a Young Investigator Award from the Italian Ministry of Health (http://www.salute.gov.it/portale/temi/p2_6.jsp?lingua=italiano&id=4357&area=Ricerca%20sanitaria&menu=finalizzata), and a grant from the CJD Foundation (https://cjdfoundation.org/grant-recipients) to EB (GR-2010-2312769). SRE was supported by a grant from the E-Rare Joint Transnational Call (Chaprion; http://www.erare.eu/financed-projects/chaprion). EB is an Assistant Telethon Scientist at the Dulbecco Telethon Institute (TCP14009, Fondazione Telethon, Italy; http://www.telethon.it/cosa-facciamo/il-metodo/gli-istituti/istituto-telethon-dulbecco). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmeppen Hermann C, 2012, Am J Neurodegener Dis, V1, P15; Baral PK, 2014, STRUCTURE, V22, P291, DOI 10.1016/j.str.2013.11.009; Barret A, 2003, J VIROL, V77, P8462, DOI 10.1128/JVI.77.15.8462-8469.2003; Benito-Leon J, 2004, CLIN NEUROPHARMACOL, V27, P201, DOI 10.1097/01.wnf.0000134853.36429.0e; Biasini E, 2013, J NEUROSCI, V33, P2408, DOI 10.1523/JNEUROSCI.3406-12.2013; Biasini E, 2012, FUTURE MED CHEM, V4, P1655, DOI [10.4155/FMC.12.114, 10.4155/fmc.12.114]; Biasini E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033472; Biasini E, 2010, BIOCHEM J, V430, P477, DOI 10.1042/BJ20100615; Biasini E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007816; Brandner S, 1996, P NATL ACAD SCI USA, V93, P13148, DOI 10.1073/pnas.93.23.13148; CAUGHEY B, 1994, J VIROL, V68, P2135, DOI 10.1128/JVI.68.4.2135-2141.1994; Christensen HM, 2010, AM J PATHOL, V176, P2695, DOI 10.2353/ajpath.2010.091007; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Daniel JA, 2015, TRAFFIC, V16, P635, DOI 10.1111/tra.12272; Dealler S, 2003, IDRUGS, V6, P470; Di Bari MA, 2008, J GEN VIROL, V89, P2975, DOI 10.1099/vir.0.2008/005520-0; Doh-Ura K, 2004, J VIROL, V78, P4999, DOI 10.1128/JVI.78.10.4999-5006.2004; Elezgarai SR, 2016, BIOL CHEM, V397, P1115, DOI 10.1515/hsz-2016-0190; Filesi I, 2007, J NEUROCHEM, V101, P1516, DOI 10.1111/j.1471-4159.2006.04439.x; Forloni G, 2002, P NATL ACAD SCI USA, V99, P10849, DOI 10.1073/pnas.162195499; Giles K, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a023747; Haik S, 2014, LANCET NEUROL, V13, P150, DOI 10.1016/S1474-4422(13)70307-7; Harris DA, 2003, BRIT MED BULL, V66, P71, DOI 10.1093/bmb/66.1.71; Hussain KM, 2011, J BIOL CHEM, V286, P309, DOI 10.1074/jbc.M110.168468; Iraci N, 2014, VIRUS RES; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Ivanova L, 2001, J BIOL CHEM, V276, P42409, DOI 10.1074/jbc.M106928200; Kang YS, 2009, J CELL SCI, V122, P4062, DOI 10.1242/jcs.046292; Kapur S, 2005, SCHIZOPHR RES, V79, P59, DOI 10.1016/j.schres.2005.01.003; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; LADOGANA A, 1992, J GEN VIROL, V73, P661, DOI 10.1099/0022-1317-73-3-661; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Massignan T, 2016, SCI REP-UK, V6, DOI 10.1038/srep23180; Massignan T, 2011, METHODS, V53, P214, DOI 10.1016/j.ymeth.2010.11.005; Massignan T, 2010, J BIOL CHEM, V285, P7752, DOI 10.1074/jbc.M109.064949; McNally KL, 2009, J VIROL, V83, P4469, DOI 10.1128/JVI.02412-08; Mettlen M, 2009, BIOCHEM SOC T, V37, P1022, DOI 10.1042/BST0371022; Nakajima M, 2004, DEMENT GERIATR COGN, V17, P158, DOI 10.1159/000076350; Polymenidou M, 2005, LANCET NEUROL, V4, P805, DOI 10.1016/S1474-4422(05)70225-8; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Prusiner SB, 2004, PRION BIOL DIS; ROIKHEL VM, 1984, ACTA VIROL, V28, P321; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Sarnataro D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005829; SHYNG SL, 1994, J CELL BIOL, V125, P1239, DOI 10.1083/jcb.125.6.1239; SHYNG SL, 1995, J BIOL CHEM, V270, P30221; Sim Valerie L., 2012, Infectious Disorders - Drug Targets, V12, P144; Sim Valerie L., 2009, Infectious Disorders - Drug Targets, V9, P81; Solomon IH, 2012, PRION, V6, P40, DOI 10.4161/pri.6.1.18627; Solomon IH, 2011, J BIOL CHEM, V286, P14724, DOI 10.1074/jbc.M110.214973; SUBTIL A, 1994, J CELL SCI, V107, P3461; Tapella L, 2013, BIOCHEM J, V454, P417, DOI 10.1042/BJ20130563; Teruya K, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a024430; Tsuboi Y, 2009, NEUROPATHOLOGY, V29, P632, DOI 10.1111/j.1440-1789.2009.01058.x; Umasankar PK, 2012, NAT CELL BIOL, V14, P488, DOI 10.1038/ncb2473; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; White MD, 2008, P NATL ACAD SCI USA, V105, P10238, DOI 10.1073/pnas.0802759105; Yamasaki T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106516	60	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182589	10.1371/journal.pone.0182589	http://dx.doi.org/10.1371/journal.pone.0182589			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28787011	Green Published, gold, Green Submitted			2022-12-26	WOS:000406998800047
J	Jacobson, PC; Hansen, GJA; Bethke, BJ; Cross, TK				Jacobson, Peter C.; Hansen, Gretchen J. A.; Bethke, Bethany J.; Cross, Timothy K.			Disentangling the effects of a century of eutrophication and climate warming on freshwater lake fish assemblages	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; MULTIPLE STRESSORS; POTENTIAL IMPACTS; MODELS; BIODIVERSITY; TOLERANCE; HABITAT; TRENDS; FUTURE; SHIFTS	Eutrophication and climate warming are profoundly affecting fish in many freshwater lakes. Understanding the specific effects of these stressors is critical for development of effective adaptation and remediation strategies for conserving fish populations in a changing environment. Ecological niche models that incorporated the individual effects of nutrient concentration and climate were developed for 25 species of fish sampled in standard gillnet surveys from 1,577 Minnesota lakes. Lake phosphorus concentrations and climates were hind-casted to a pre-disturbance period of 1896-1925 using existing land use models and historical temperature data. Then historical fish assemblages were reconstructed using the ecological niche models. Substantial changes were noted when reconstructed fish assemblages were compared to those from the contemporary period (1981-2010). Disentangling the sometimes opposing, sometimes compounding, effects of eutrophication and climate warming was critical for understanding changes in fish assemblages. Reconstructed abundances of eutrophication-tolerant, warmwater taxa increased in prairie lakes that experienced significant eutrophication and climate warming. Eutrophication-intolerant, warmwater taxa abundance increased in forest lakes where primarily climate warming was the stressor. Coolwater fish declined in abundance in both ecoregions. Large changes in modeled abundance occurred when the effects of both climate and eutrophication operated in the same direction for some species. Conversely, the effects of climate warming and eutrophication operated in opposing directions for other species and dampened net changes in abundance. Quantifying the specific effects of climate and eutrophication will allow water resource managers to better understand how lakes have changed and provide expectations for sustainable fish assemblages in the future.	[Jacobson, Peter C.] Minnesota Dept Nat Resources, Pk Rapids, MN 56470 USA; [Hansen, Gretchen J. A.] Minnesota Dept Nat Resources, St Paul, MN USA; [Bethke, Bethany J.] Minnesota Dept Nat Resources, Duluth, MN USA; [Cross, Timothy K.] Minnesota Dept Nat Resources, Hutchinson, MN USA		Jacobson, PC (corresponding author), Minnesota Dept Nat Resources, Pk Rapids, MN 56470 USA.	peter.jacobson@state.mn.us		Hansen, Gretchen/0000-0003-0241-7048	United States Federal Aid in Sport Fish Restoration program	United States Federal Aid in Sport Fish Restoration program	This research was supported by the United States Federal Aid in Sport Fish Restoration program.	Adrian R, 2009, LIMNOL OCEANOGR, V54, P2283, DOI 10.4319/lo.2009.54.6_part_2.2283; Alofs KM, 2014, DIVERS DISTRIB, V20, P123, DOI 10.1111/ddi.12130; Alvarado-Serrano DF, 2014, MOL ECOL RESOUR, V14, P233, DOI 10.1111/1755-0998.12184; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Bajer PG, 2010, BIOL INVASIONS, V12, P1101, DOI 10.1007/s10530-009-9528-y; Benson BJ, 2000, FRESHWATER BIOL, V43, P517, DOI 10.1046/j.1365-2427.2000.00572.x; Bethke BJ, 2015, T AM FISH SOC, V144, P68, DOI 10.1080/00028487.2014.965345; Chu C, 2005, DIVERS DISTRIB, V11, P299, DOI 10.1111/j.1366-9516.2005.00153.x; Cole KL, 1998, BRDBSR19980003 USGS; Comte L, 2013, FRESHWATER BIOL, V58, P625, DOI 10.1111/fwb.12081; Cross TK, 2013, LAKE RESERV MANAGE, V29, P1, DOI 10.1080/10402381.2012.754808; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Dominguez-Dominguez O, 2006, CONSERV BIOL, V20, P1730, DOI 10.1111/j.1523-1739.2006.00588.x; Dormann CF, 2007, BASIC APPL ECOL, V8, P387, DOI 10.1016/j.baae.2006.11.001; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; Egertson CJ, 2004, CAN J FISH AQUAT SCI, V61, P1784, DOI 10.1139/F04-109; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fang X, 2004, ECOL MODEL, V172, P13, DOI 10.1016/S0304-3800(03)00282-5; Farmer TM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8724; Ficke AD, 2007, REV FISH BIOL FISHER, V17, P581, DOI 10.1007/s11160-007-9059-5; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Guisan A, 2006, J APPL ECOL, V43, P386, DOI 10.1111/j.1365-2664.2006.01164.x; Hansen GJA, 2015, CAN J FISH AQUAT SCI, V72, P661, DOI 10.1139/cjfas-2014-0513; Heathcote AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053554; Hecky RE, 2010, FRESHWATER BIOL, V55, P19, DOI 10.1111/j.1365-2427.2009.02374.x; Heino J, 2009, BIOL REV, V84, P39, DOI 10.1111/j.1469-185X.2008.00060.x; Heiskary S, 2008, LAKE RESERV MANAGE, V24, P282, DOI 10.1080/07438140809354068; Homer C, 2007, PHOTOGRAMM ENG REM S, V73, P337; Jacobson PC, 2012, ADV LIMNOL, V63, P417; Jacobson PC, 2010, CAN J FISH AQUAT SCI, V67, P2002, DOI 10.1139/F10-115; Jeppesen E, 2000, FRESHWATER BIOL, V45, P201, DOI 10.1046/j.1365-2427.2000.00675.x; Jeppesen E, 2012, HYDROBIOLOGIA, V694, P1, DOI 10.1007/s10750-012-1182-1; Jeppesen E, 2010, HYDROBIOLOGIA, V646, P73, DOI 10.1007/s10750-010-0171-5; Labay BJ, 2015, ENVIRON MANAGE, V56, P835, DOI 10.1007/s00267-015-0567-0; Lassalle G, 2008, BIOL CONSERV, V141, P1105, DOI 10.1016/j.biocon.2008.02.010; Lynch AJ, 2016, FISHERIES, V41, P346, DOI 10.1080/03632415.2016.1186016; Mantyka-Pringle CS, 2014, J APPL ECOL, V51, P572, DOI 10.1111/1365-2664.12236; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Mehner T, 2005, FRESHWATER BIOL, V50, P70, DOI 10.1111/j.1365-2427.2004.01294.x; Mooij WM, 2005, AQUAT ECOL, V39, P381, DOI 10.1007/s10452-005-9008-0; Moss B, 2010, FRESHWATER BIOL, V55, P175, DOI 10.1111/j.1365-2427.2009.02381.x; Nelson KC, 2009, J APPL ECOL, V46, DOI 10.1111/j.1365-2664.2008.01599.x; Olden JD, 2010, DIVERS DISTRIB, V16, P496, DOI 10.1111/j.1472-4642.2010.00655.x; Omernik JM, 2014, ENVIRON MANAGE, V54, P1249, DOI 10.1007/s00267-014-0364-1; Ormerod SJ, 2010, FRESHWATER BIOL, V55, P1, DOI 10.1111/j.1365-2427.2009.02395.x; Piggott JJ, 2015, ECOL EVOL, V5, P1538, DOI 10.1002/ece3.1465; Pryor S. C., 2014, CLIMATE CHANGE IMPAC, P418, DOI DOI 10.7930/J0J1012N; Ramstack JM, 2004, CAN J FISH AQUAT SCI, V61, P561, DOI [10.1139/f04-015, 10.1139/F04-015]; Read JS, 2016, ECOGRAPHY, V39, P354, DOI 10.1111/ecog.01880; Read JS, 2013, LIMNOL OCEANOGR, V58, P921, DOI 10.4319/lo.2013.58.3.0921; Rose KC, 2016, LIMNOL OCEANOGR LETT, V1, P44, DOI 10.1002/lol2.10027; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Schindler DW, 2001, CAN J FISH AQUAT SCI, V58, P18, DOI 10.1139/cjfas-58-1-18; Segurado P, 2011, ECOL INDIC, V11, P1623, DOI 10.1016/j.ecolind.2011.04.006; Sharma S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022906; Sharma S, 2009, ECOGRAPHY, V32, P517, DOI 10.1111/j.1600-0587.2008.05544.x; Shimoda Y, 2011, J GREAT LAKES RES, V37, P173, DOI 10.1016/j.jglr.2010.10.004; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Stefan HG, 2001, T AM FISH SOC, V130, P459, DOI 10.1577/1548-8659(2001)130<0459:SFHCIN>2.0.CO;2; Wehrly KE, 2007, T AM FISH SOC, V136, P365, DOI 10.1577/T06-163.1; Wehrly KE, 2012, T AM FISH SOC, V141, P414, DOI 10.1080/00028487.2012.667046; Whittier Thomas R., 1998, North American Journal of Fisheries Management, V18, P236, DOI 10.1577/1548-8675(1998)018<0236:EOFSTT>2.0.CO;2; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; Winslow LA, 2015, GEOPHYS RES LETT, V42, P355, DOI 10.1002/2014GL062325; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Wyatt LH, 2010, AQUAT SCI, V72, P361, DOI 10.1007/s00027-010-0129-8; Yuan LL, 2004, FRESHWATER BIOL, V49, P662, DOI 10.1111/j.1365-2427.2004.01206.x; Zimmer KD, 2009, ECOSYSTEMS, V12, P843, DOI 10.1007/s10021-009-9262-4	69	24	27	6	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0182667	10.1371/journal.pone.0182667	http://dx.doi.org/10.1371/journal.pone.0182667			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28777816	Green Published, gold, Green Submitted			2022-12-26	WOS:000406944300049
J	Born, JPL; Matos, HD; de Araujo, MA; Castro, OW; Duzzioni, M; Peixoto-Santos, JE; Leite, JP; Garcia-Cairasco, N; Paco-Larson, ML; Gitai, DLG				Lopes Born, Joao Paulo; Matos, Heloisa de Carvalho; de Araujo, Mykaella Andrade; Castro, Olagide Wagner; Duzzioni, Marcelo; Peixoto-Santos, Jose Eduardo; Leite, Joao Pereira; Garcia-Cairasco, Norberto; Paco-Larson, Maria Luisa; Goes Gitai, Daniel Leite			Using Postmortem hippocampi tissue can interfere with differential gene expression analysis of the epileptogenic process	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; MESSENGER-RNA; HUMAN BRAIN; INFLAMMATORY CYTOKINES; STATUS EPILEPTICUS; PILOCARPINE MODEL; CHRONIC PHASE; TIME-COURSE; MOLECULES; RATS	Neuropathological studies often use autopsy brain tissue as controls to evaluate changes in protein or RNA levels in several diseases. In mesial temporal lobe epilepsy (MTLE), several genes are up or down regulated throughout the epileptogenic and chronic stages of the disease. Given that postmortem changes in several gene transcripts could impact the detection of changes in case-control studies, we evaluated the effect of using autopsy specimens with different postmortem intervals (PMI) on differential gene expression of the Pilocarpine (PILO) induced Status Epilepticus (SE) of MTLE. For this, we selected six genes (Gfap, Ppia, Gad65, Gad67, Npy, and Tnf-alpha) whose expression patterns in the hippocampus of PILO-injected rats are well known. Initially, we compared hippocampal expression of naive rats whose hippocampi were harvested immediately after death (0h-PMI) with those harvested at 6h postmortem interval (6h-PMI): Npy and Ppia transcripts increased and Tnf-alpha transcripts decreased in the 6h-PMI group (p<0.05). We then investigated if these PMI-related changes in gene expression have the potential to adulterate or mask RT-qPCR results obtained with PILO-injected rats euthanized at acute or chronic phases. In the acute group, Npy transcript was significantly higher when compared with 0h-PMI rats, whereas Ppia transcript was lower than 6h-PMI group. When we used epileptic rats (chronic group), the RT-qPCR results showed higher Tnf-alpha only when compared to 6h-PMI group. In conclusion, our study demonstrates that PMI influences gene transcription and can mask changes in gene transcription seen during epileptogenesis in the PILO-SE model. Thus, to avoid erroneous conclusions, we strongly recommend that researchers account for changes in postmortem gene expression in their experimental design.	[Lopes Born, Joao Paulo; Matos, Heloisa de Carvalho; de Araujo, Mykaella Andrade; Goes Gitai, Daniel Leite] Univ Fed Alagoas, Inst Biol Sci & Hlth, Dept Cellular & Mol Biol, Maceio, Alagoas, Brazil; [Castro, Olagide Wagner; Duzzioni, Marcelo] Univ Fed Alagoas, Inst Biol Sci & Hlth, Dept Physiol & Pharmacol, Maceio, Alagoas, Brazil; [Peixoto-Santos, Jose Eduardo; Leite, Joao Pereira] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Neurosci & Behav Sci, Div Neurol, Ribeirao Preto, SP, Brazil; [Garcia-Cairasco, Norberto] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Physiol, Ribeirao Preto, SP, Brazil; [Paco-Larson, Maria Luisa] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Cellular & Mol Biol, Ribeirao Preto, SP, Brazil	Universidade Federal de Alagoas; Universidade Federal de Alagoas; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Gitai, DLG (corresponding author), Univ Fed Alagoas, Inst Biol Sci & Hlth, Dept Cellular & Mol Biol, Maceio, Alagoas, Brazil.	danielgitai@gmail.com	Peixoto-Santos, Jose Eduardo/L-5123-2013; Castro, Olagide/C-6781-2015; Duzzioni, Marcelo/C-6797-2015; Leite, Joao/B-9070-2012; de Araújo, Mykaella Andrade/X-3778-2018; Gitai, Daniel LG/A-7982-2019; da Saúde, Programa Ciências/ABF-1705-2020	Peixoto-Santos, Jose Eduardo/0000-0001-7461-1902; Castro, Olagide/0000-0002-1874-509X; Leite, Joao/0000-0003-0558-3519; Gitai, Daniel LG/0000-0001-7056-2373; Araujo, Mykaella/0000-0002-6425-2595	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2016/17882-4, 2015/20840-9]; Conselho de Desenvolvimento Cientifico e Tecnologico [466995/2014-8, 312161/2015-8]; Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPAHCRP)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL)(Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPAHCRP)	Funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, grant numbers: 2016/17882-4 and 2015/20840-9, JPL, NG, MLP. Conselho de Desenvolvimento Cientifico e Tecnologico, grant numbers: 466995/2014-8 and 312161/2015-8, JPL, DLGG. Fundacao de Amparo a Pesquisa do Estado de Alagoas (FAPEAL); DLG, JPLB, HCM. Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); MAA, JPLB, HCM. Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (FAEPAHCRP). JPL, NG, MLP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasolo N, 2011, J PSYCHIATR RES, V45, P1411, DOI 10.1016/j.jpsychires.2011.06.001; Ali I., 2016, GEN COMP ENDOCRINOL; Ashhab MU, 2013, J MOL NEUROSCI, V51, P950, DOI 10.1007/s12031-013-0013-9; BARTON AJL, 1993, J NEUROCHEM, V61, P1, DOI 10.1111/j.1471-4159.1993.tb03532.x; Marques TEBS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071892; Birdsill AC, 2011, CELL TISSUE BANK, V12, P311, DOI 10.1007/s10561-010-9210-8; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Castensson A, 2000, GENOME RES, V10, P1219, DOI 10.1101/gr.10.8.1219; Catts VS, 2005, MOL BRAIN RES, V138, P164, DOI 10.1016/j.molbrainres.2005.04.017; Chen J, 2001, LAB INVEST, V81, P913, DOI 10.1038/labinvest.3780300; Corton JC, 2012, MUTAT RES-GEN TOX EN, V746, P104, DOI 10.1016/j.mrgentox.2011.12.017; Cummings TJ, 2001, MODERN PATHOL, V14, P1157, DOI 10.1038/modpathol.3880451; Curcio C, 2006, J CHEM NEUROANAT, V32, P191, DOI 10.1016/j.jchemneu.2006.09.003; Curia G, 2014, CURR MED CHEM, V21, P663, DOI 10.2174/0929867320666131119152201; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; Santos EAD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141121; de Araujo M, 2016, PLOS ONE, V11, P1; de Araujo MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100529; De Simoni MG, 2000, EUR J NEUROSCI, V12, P2623, DOI 10.1046/j.1460-9568.2000.00140.x; Du Xiao-ping, 2007, Zhonghua Yi Xue Za Zhi, V87, P2025; Dudek F. E., 2012, JASPERS BASIC MECH E, P595; Durrenberger PF, 2010, J NEUROPATH EXP NEUR, V69, P70, DOI 10.1097/NEN.0b013e3181c7e32f; Duszczyk M, 2009, NEUROPEPTIDES, V43, P31, DOI 10.1016/j.npep.2008.09.008; El-Kashef N, 2015, FORENSIC SCI MED PAT, V11, P517, DOI 10.1007/s12024-015-9717-1; Engel J, 1996, EPILEPSY RES, V26, P141, DOI 10.1016/S0920-1211(96)00043-5; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Freichel C, 2006, NEUROSCIENCE, V141, P2177, DOI 10.1016/j.neuroscience.2006.05.040; Garzillo CL, 2002, EPILEPSIA, V43, P107, DOI 10.1046/j.1528-1157.43.s.5.40.x; Gitai DLG, 2011, BRAIN RES, V1367, P114, DOI 10.1016/j.brainres.2010.10.069; Gitai DLG, 2010, HIPPOCAMPUS, V20, P125, DOI 10.1002/hipo.20590; Goto EM, 2010, NEUROPEPTIDES, V44, P169, DOI 10.1016/j.npep.2009.12.007; Gupta S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-26; Hammer J, 2008, GLIA, V56, P856, DOI 10.1002/glia.20659; Hansen KF, 2014, SCI REP-UK, V4, DOI 10.1038/srep06930; Holmberg KH, 2006, BRAIN RES, V1075, P26, DOI 10.1016/j.brainres.2005.12.103; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Huth A, 2013, INT J LEGAL MED, V127, P335, DOI 10.1007/s00414-012-0787-2; Ikematsu Kazuya, 2006, Legal Medicine, V8, P128, DOI 10.1016/j.legalmed.2005.08.012; Kafel J, 2006, BRAIN RES BULL, V70, P304, DOI 10.1016/j.brainresbull.2006.06.004; Kandratavicius L, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0266-z; Kuteykin-Teplyakov K, 2009, EPILEPSIA, V50, P887, DOI 10.1111/j.1528-1167.2008.01916.x; Lauren HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010733; Lehtimaki KA, 2003, MOL BRAIN RES, V110, P253, DOI 10.1016/S0169-328X(02)00654-X; Lindberg AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091215; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo WY, 2010, AM J CHINESE MED, V38, P745, DOI 10.1142/S0192415X10008214; Lue L, 2011, POSTMORTEM INTERVAL, V12, P311; Lukasiuk K, 2003, EUR J NEUROSCI, V17, P271, DOI 10.1046/j.1460-9568.2003.02461.x; Lv YH, 2014, J FORENSIC SCI, V59, P1286, DOI 10.1111/1556-4029.12447; Muciaccia B, 2015, INT J LEGAL MED, V129, P11, DOI 10.1007/s00414-014-1066-1; Okamoto OK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-230; Opitz L, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-36; Ozbas-Gerceker F, 2006, NEUROSCIENCE, V138, P457, DOI 10.1016/j.neuroscience.2005.11.043; Partemi S, 2010, FORENSIC SCI INT, V203, P99, DOI 10.1016/j.forsciint.2010.07.005; Peixoto-Santos JE, 2017, EPILEPSIA, V58, P149, DOI 10.1111/epi.13620; Peixoto-Santos JE, 2015, EPILEPSIA, V56, P1562, DOI 10.1111/epi.13082; Peixoto-Santos JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044709; Pernot F, 2011, EPILEPSIA, V52, P2315, DOI 10.1111/j.1528-1167.2011.03273.x; Pernot F, 2010, J NEUROSCI RES, V88, P1000, DOI 10.1002/jnr.22282; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pitkanen A, 2009, EPILEPSY BEHAV, V14, P16, DOI 10.1016/j.yebeh.2008.09.023; Poncet L, 1996, BRAIN RES, V733, P64, DOI 10.1016/S0006-8993(96)00539-2; Preece P, 2003, MOL BRAIN RES, V118, P60, DOI 10.1016/S0169-328X(03)00337-1; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Romcy-Pereira RN, 2008, REV ASSOC MED BRAS, V54, P461; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Silva AP, 2005, J NEUROCHEM, V93, P163, DOI 10.1111/j.1471-4159.2004.03005.x; Sobue S, 2016, EXP MOL PATHOL, V100, P482, DOI 10.1016/j.yexmp.2016.05.007; STEWARD O, 1990, J NEUROSCI, V10, P2373; Szabo G, 2000, NEUROSCIENCE, V100, P287, DOI 10.1016/S0306-4522(00)00275-X; Thom M, 2014, NEUROPATH APPL NEURO, V40, P520, DOI 10.1111/nan.12150; TORRE ER, 1993, BRAIN RES, V631, P256, DOI 10.1016/0006-8993(93)91543-2; van der Weerd L, 2005, EXP NEUROL, V195, P257, DOI 10.1016/j.expneurol.2005.05.002; Vennemann M, 2010, FORENSIC SCI INT, V203, P71, DOI 10.1016/j.forsciint.2010.07.006; Vennemann M, 2010, FORENSIC SCI INT, V203, P76, DOI 10.1016/j.forsciint.2010.07.007; Vezzani A, 2002, EPILEPSIA, V43, P30, DOI 10.1046/j.1528-1157.43.s.5.14.x; Walker DG, 2016, CELL TISSUE BANK, V17, P361, DOI 10.1007/s10561-016-9555-8; Wierschke S, 2010, BIOCHEM BIOPH RES CO, V403, P385, DOI 10.1016/j.bbrc.2010.10.138; Xu ZC, 2011, NEUROCHEM RES, V36, P2208, DOI 10.1007/s11064-011-0576-1; Zhao Dong, 2009, Leg Med (Tokyo), V11 Suppl 1, pS43, DOI 10.1016/j.legalmed.2009.01.066	80	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0182765	10.1371/journal.pone.0182765	http://dx.doi.org/10.1371/journal.pone.0182765			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28783762	gold, Green Submitted, Green Published			2022-12-26	WOS:000406944300053
J	Algamal, M; Ahmed, R; Jafari, N; Ahsan, B; Ortega, J; Melacini, G				Algamal, Moustafa; Ahmed, Rashik; Jafari, Naeimeh; Ahsan, Bilal; Ortega, Joaquin; Melacini, Giuseppe			Atomic-resolution map of the interactions between an amyloid inhibitor protein and amyloid beta(A beta) peptides in the monomer and protofibril states	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-SERUM-ALBUMIN; A-BETA-PEPTIDE; ALZHEIMERS-DISEASE; THERAPEUTIC ALBUMIN; NMR-SPECTROSCOPY; STRUCTURAL BASIS; PLASMA-EXCHANGE; OLIGOMERS; BINDING; A-BETA(1-40)	Self-association of amyloid beta (A beta) peptides is a hallmark of Alzheimer's disease and serves as a general prototype for amyloid formation. A key endogenous inhibitor of A beta self-association is human serum albumin (HSA), which binds similar to 90% of plasma A beta. However, the exact molecular mechanism by which HSA binds A beta monomers and protofibrils is not fully understood. Here, using dark-state exchange saturation transfer NMR and relaxation experiments complemented by morphological characterization, we mapped the HSA-A beta interactions at atomic resolution by examining the effects ofHSAonA beta monomers and soluble high-molecular weight oligomeric protofibrils. We found that HSA binds both monomeric and protofibrillar A beta, but the affinity of HSA for A beta monomers is lower than for A beta protofibrils (K-d values are submillimolar rather than micromolar) yet physiologically relevant because of the similar to 0.6-0.7 mM plasma HSA concentration. In both A beta-protofibrils and monomers, HSA targets key A beta self-recognition sites spanning the beta strands found in cross-beta protofibril structures, leading to a net switch from direct to tethered contacts between the monomeric A beta and the protofibril surface. These HSAA beta interactions are isoform-specific, because the HSA affinity of A beta monomers is lower for A beta (1-42) than for A beta (1-40). In addition, the HSA-induced perturbations of the monomer/protofibrils pseudo-equilibrium extend to the C-terminal residues in the A beta (1-42) isoform but not in A beta (1-40). These results provide an unprecedented view of how albumin interacts with A beta and illustrate the potential of dark-state exchange saturation transfer NMR in mapping the interactions between amyloid-inhibitory proteins and amyloidogenic peptides.	[Algamal, Moustafa; Jafari, Naeimeh; Melacini, Giuseppe] McMaster Univ, Dept Chem & Chem Biol, Hamilton, ON L8S 4M1, Canada; [Ahmed, Rashik; Ahsan, Bilal; Ortega, Joaquin; Melacini, Giuseppe] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4M1, Canada	McMaster University; McMaster University	Melacini, G (corresponding author), McMaster Univ, 1280 Main St W, Hamilton, ON L8S 4M1, Canada.	melacin@mcmaster.ca	Ahmed, Rashik/AAZ-2325-2020; Ortega, Joaquin/AAS-1322-2020	Ahmed, Rashik/0000-0003-2001-9684; Algamal, Moustafa/0000-0002-6215-0122	Natural Sciences and Engineering Research Council of Canada [RGPIN-2014-04514]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Grant RGPIN-2014-04514 from the Natural Sciences and Engineering Research Council of Canada (to G.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Algamal M, 2013, BIOPHYS J, V105, P1700, DOI 10.1016/j.bpj.2013.08.025; Anaya F, 2010, REV NEUROLOGIA, V50, pS5; Biere AL, 1996, J BIOL CHEM, V271, P32916, DOI 10.1074/jbc.271.51.32916; Boada M, 2016, NEUROLOGIA, V31, P473, DOI 10.1016/j.nrl.2014.02.003; Boada M, 2009, DRUG NEWS PERSPECT, V22, P325, DOI 10.1358/dnp.2009.22.6.1395256; Boada-Rovira M, 2010, REV NEUROLOGIA, V50, pS9; Bohrmann B, 1999, J BIOL CHEM, V274, P15990, DOI 10.1074/jbc.274.23.15990; Bouvignies G, 2012, J PHYS CHEM B, V116, P14311, DOI 10.1021/jp311109u; Cohen T, 2006, BIOCHEMISTRY-US, V45, P4727, DOI 10.1021/bi051525c; Costa M, 2012, J ALZHEIMERS DIS, V29, P159, DOI 10.3233/JAD-2012-111139; DeToma AS, 2012, CHEM SOC REV, V41, P608, DOI 10.1039/c1cs15112f; Ezra A, 2016, J ALZHEIMERS DIS, V50, P175, DOI 10.3233/JAD-150694; Fawzi NL, 2012, NAT PROTOC, V7, P1523, DOI 10.1038/nprot.2012.077; Fawzi NL, 2011, NATURE, V480, P268, DOI 10.1038/nature10577; Fawzi NL, 2010, J AM CHEM SOC, V132, P9948, DOI 10.1021/ja1048253; Fusco G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12563; Jang H, 2014, CHEM SOC REV, V43, P6750, DOI 10.1039/c3cs60459d; Jang H, 2013, J PHYS CHEM B, V117, P11518, DOI 10.1021/jp405389n; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kotler SA, 2014, CHEM SOC REV, V43, P6692, DOI 10.1039/c3cs60431d; Kotler SA, 2015, SCI REP-UK, V5, DOI 10.1038/srep11811; Kuo YM, 1999, BIOCHEM BIOPH RES CO, V257, P787, DOI 10.1006/bbrc.1999.0552; Llewellyn DJ, 2010, CURR ALZHEIMER RES, V7, P91, DOI 10.2174/156720510790274392; Long D, 2013, ANGEW CHEM INT EDIT, V52, P10771, DOI 10.1002/anie.201305434; Manzoni C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024909; Miller Y, 2009, BIOPHYS J, V97, P1168, DOI 10.1016/j.bpj.2009.05.042; Milojevic J., 2012, THESIS; Milojevic J, 2007, J AM CHEM SOC, V129, P4282, DOI 10.1021/ja067367+; Milojevic J, 2014, J ALZHEIMERS DIS, V38, P753, DOI 10.3233/JAD-131169; Milojevic J, 2011, BIOPHYS J, V100, P183, DOI 10.1016/j.bpj.2010.11.037; Milojevic J, 2009, BIOPHYS J, V97, P2585, DOI 10.1016/j.bpj.2009.08.028; Naldi M, 2012, ACS CHEM NEUROSCI, V3, P952, DOI 10.1021/cn3000982; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Raditsis AV, 2013, BIOPHYS J, V105, P473, DOI 10.1016/j.bpj.2013.03.065; Roche J, 2016, BIOCHEMISTRY-US, V55, P762, DOI 10.1021/acs.biochem.5b01259; Roche J, 2016, J BIOMOL NMR, V64, P1, DOI 10.1007/s10858-015-0004-y; Rozga M, 2007, BIOCHEM BIOPH RES CO, V364, P714, DOI 10.1016/j.bbrc.2007.10.080; Scherzer-Attali R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011101; Stanyon HF, 2012, J BIOL CHEM, V287, P28163, DOI 10.1074/jbc.C112.360800; Suzuki Y, 2013, BIOCHEMISTRY-US, V52, P1903, DOI 10.1021/bi400027y; Teplow DB, 1998, AMYLOID, V5, P121, DOI 10.3109/13506129808995290; Vallurupalli P, 2012, J AM CHEM SOC, V134, P8148, DOI 10.1021/ja3001419; Wang CG, 2016, RSC ADV, V6, P71165, DOI 10.1039/c6ra14590f; Xiao YL, 2015, NAT STRUCT MOL BIOL, V22, P499, DOI 10.1038/nsmb.2991; Yang MF, 2008, J MOL BIOL, V384, P450, DOI 10.1016/j.jmb.2008.09.039	47	41	41	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 20	2017	292	42					17158	17168		10.1074/jbc.M117.792853	http://dx.doi.org/10.1074/jbc.M117.792853			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FL1YC	28798235	Green Published, hybrid			2022-12-26	WOS:000414009300001
J	Smyrnakis, I; Andreadakis, V; Selimis, V; Kalaitzakis, M; Bachourou, T; Kaloutsakis, G; Kymionis, GD; Smirnakis, S; Aslanides, IM				Smyrnakis, Ioannis; Andreadakis, Vassilios; Selimis, Vassilios; Kalaitzakis, Michail; Bachourou, Theodora; Kaloutsakis, Georgios; Kymionis, George D.; Smirnakis, Stelios; Aslanides, Ioannis M.			RADAR: A novel fast-screening method for reading difficulties with special focus on dyslexia	PLOS ONE			English	Article							DEVELOPMENTAL SURFACE DYSLEXIA; EYE-MOVEMENTS; FIXATION DURATIONS; CHILDREN; DEFINITION; SENTENCES; TASKS	Dyslexia is a developmental learning disorder of single word reading accuracy and/or fluency, with compelling research directed towards understanding the contributions of the visual system. While dyslexia is not an oculomotor disease, readers with dyslexia have shown different eye movements than typically developing students during text reading. Readers with dyslexia exhibit longer and more frequent fixations, shorter saccade lengths, more backward refixations than typical readers. Furthermore, readers with dyslexia are known to have difficulty in reading long words, lower skipping rate of short words, and high gaze duration on many words. It is an open question whether it is possible to harness these distinctive oculomotor scanning patterns observed during reading in order to develop a screening tool that can reliably identify struggling readers, who may be candidates for dyslexia. Here, we introduce a novel, fast, objective, non-invasive method, named Rapid Assessment of Difficulties and Abnormalities in Reading (RADAR) that screens for features associated with the aberrant visual scanning of reading text seen in dyslexia. Eye tracking parameter measurements that are stable under retest and have high discriminative power, as indicated by their ROC (receiver operating characteristic) curves, were obtained during silent text reading. These parameters were combined to derive a total reading score (TRS) that can reliably separate readers with dyslexia from typical readers. We tested TRS in a group of school-age children ranging from 8.5 to 12.5 years of age. TRS achieved 94.2% correct classification of children tested. Specifically, 35 out of 37 control (specificity 94.6%) and 30 out of 32 readers with dyslexia (sensitivity 93.8%) were classified correctly using RADAR, under a circular validation condition (see section Results/Total Reading Score) where the individual evaluated was not included in the test construction group. In conclusion, RADAR is a novel, automated, fast and reliable way to identify children at high risk of dyslexia that is amenable to large-scale screening. Moreover, analysis of eye movement parameters obtained with RADAR during reading will likely be useful for implementing individualized treatment strategies and for monitoring objectively the success of chosen interventions. We envision that it will be possible to use RADAR as a sensitive, objective, and quantitative first pass screen to identify individuals with reading disorders that manifest with abnormal oculomotor reading strategies, like dyslexia.	[Smyrnakis, Ioannis] Technol Educ Inst Crete, Iraklion, Greece; [Andreadakis, Vassilios] Optotech Ltd, Iraklion, Greece; [Selimis, Vassilios; Bachourou, Theodora; Aslanides, Ioannis M.] Emmetropia Eye Inst, Iraklion, Greece; [Kalaitzakis, Michail; Kaloutsakis, Georgios] Medot Ltd, Basel, Switzerland; [Kymionis, George D.] Univ Athens, Athens Med Sch, Athens, Greece; [Kymionis, George D.] Univ Lausanne, Jules Gonin Eye Hosp, Fac Biol & Med, Lausanne, Switzerland; [Smirnakis, Stelios] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Boston, MA USA; [Smirnakis, Stelios] Harvard Med Sch, Jama Plain VA Hosp, Boston, MA USA	Hellenic Mediterranean University; National & Kapodistrian University of Athens; University of Lausanne; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Aslanides, IM (corresponding author), Emmetropia Eye Inst, Iraklion, Greece.	i.aslanides@emmetropia.gr	Selimis, Vasileios/AAH-4471-2021; Aslanides, Ioannis/L-2716-2019	Selimis, Vasileios/0000-0002-5553-5593; Kymionis, George/0000-0003-1618-8047; Kalaitzakis, Michail/0000-0003-4889-3330	Emmetropia Eye Institute S.A.; Medotics Ltd.	Emmetropia Eye Institute S.A.; Medotics Ltd.	The authors received funding from Emmetropia Eye Institute S.A. and from Medotics Ltd. Vassilios Selimis, Theodora Bachourou and loannis M. Aslanides are affiliated to Emmetropia Eye Institute S.A. Emmetropia Eye Institute S.A. provided support in the form of salaries for authors VS, TB and I MA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Michail Kalaitzakis and Georgios Kaloutsakis are affiliated to Medotics Ltd. Medotics Ltd. provided support in the form of salaries for authors MK and GK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Vassilios Andreadakis is affiliated to Optotech Ltd. Optotech Ltd provided support in the form of salary for author VA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Biscaldi M, 1998, NEUROPSYCHOLOGIA, V36, P1189, DOI 10.1016/S0028-3932(97)00170-X; Blythe H, 2011, CHILDRENS EYE MOVEME, P643; Bricout-Tomasi L, 2010, BEHAV NEUROLOGY, V23; De Luca M, 2002, BRAIN LANG, V80, P617, DOI 10.1006/brln.2001.2637; De Luca M, 1999, NEUROPSYCHOLOGIA, V37, P1407, DOI 10.1016/S0028-3932(99)00038-X; Dyslexia International, 2014, BETT TRAIN BETT TEAC; ELTERMAN RD, 1980, J LEARN DISABIL, V13, P11, DOI 10.1177/002221948001300104; Ferrer E, 2010, PSYCHOL SCI, V21, P93, DOI 10.1177/0956797609354084; FRAZIER L, 1982, COGNITIVE PSYCHOL, V14, P178, DOI 10.1016/0010-0285(82)90008-1; Gough P. B., 1986, REM SPEC EDUC, V7, P6, DOI [10.1177/074193258600700104, DOI 10.1177/074193258600700104]; Hall W., 2009, DYSLEXIA PRIMARY CLA; Hatzidaki A, 2011, DYSLEXIA, V17, P85, DOI 10.1002/dys.416; Hawelka S, 2010, COGNITION, V115, P367, DOI 10.1016/j.cognition.2009.11.004; Hayes HC, 2006, DYSLEXIA CHILDREN; Hutzler F, 2004, BRAIN LANG, V89, P235, DOI 10.1016/S0093-934X(03)00401-2; HYONA J, 1995, J EXP PSYCHOL LEARN, V21, P1430, DOI 10.1037/0278-7393.21.6.1430; Kirkby JA, 2008, PSYCHOL BULL, V134, P742, DOI 10.1037/a0012979; Legge GE, 2002, VISION RES, V42, P2219, DOI 10.1016/S0042-6989(02)00131-1; Lyon GR, 2003, ANN DYSLEXIA, V53, P1, DOI 10.1007/s11881-003-0001-9; MORRISON RE, 1981, PERCEPT PSYCHOPHYS, V30, P395, DOI 10.3758/BF03206156; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; RAYNER K, 1983, J VERB LEARN VERB BE, V22, P358, DOI 10.1016/S0022-5371(83)90236-0; RAYNER K, 1978, PSYCHOL BULL, V85, P618, DOI 10.1037/0033-2909.85.3.618; RAYNER K, 1983, ANN DYSLEXIA, V33, P163, DOI 10.1007/BF02648003; Rayner K, 1985, DEV NEUROPSYCHOL, V1, P3, DOI 10.1080/87565648509540294; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Salvucci D.D., 2000, P 2000 S EYE TRACK R, P71, DOI [10.1145/355017.355028, DOI 10.1145/355017.355028]; SCARBOROUGH HS, 1984, BRIT J PSYCHOL, V75, P329, DOI 10.1111/j.2044-8295.1984.tb01904.x; Schiffman HR, 2001, INTEGRATED APPROACH; Schneps MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071161; Snowling JM, 2013, SCI READING HDB; Speigel M, 2014, SCHAUMS OUTLINE STAT; Sprenger-Charolles L, 2011, SCI STUD READ, V15, P498, DOI 10.1080/10888438.2010.524463; Staub A, 2010, J EXP PSYCHOL HUMAN, V36, P1280, DOI 10.1037/a0016896; Temple E, 2003, P NATL ACAD SCI USA, V100, P2860, DOI 10.1073/pnas.0030098100; Vorstius C, 2014, VIS COGN, V22, P458, DOI 10.1080/13506285.2014.881445; White SJ, 2012, J EXP PSYCHOL HUMAN, V38, P603, DOI 10.1037/a0025338; WIMMER H, 1993, APPL PSYCHOLINGUIST, V14, P1, DOI 10.1017/S0142716400010122; Zoccolotti P, 1999, APPL PSYCHOLINGUIST, V20, P191, DOI 10.1017/S0142716499002027	39	8	9	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2017	12	8							e0182597	10.1371/journal.pone.0182597	http://dx.doi.org/10.1371/journal.pone.0182597			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FD3KL	28800632	gold, Green Submitted, Green Published			2022-12-26	WOS:000407431800023
J	Shelukhina, I; Spirova, E; Kudryavtsev, D; Ojomoko, L; Werner, M; Methfessel, C; Hollmann, M; Tsetlin, V				Shelukhina, Irina; Spirova, Ekaterina; Kudryavtsev, Denis; Ojomoko, Lucy; Werner, Markus; Methfessel, Christoph; Hollmann, Michael; Tsetlin, Victor			Calcium imaging with genetically encoded sensor Case12: Facile analysis of alpha 7/alpha 9 nAChR mutants	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; LIGAND-BINDING DOMAIN; POSITIVE ALLOSTERIC MODULATORS; PHARMACOLOGICAL-PROPERTIES; FUNCTIONAL EXPRESSION; PAIRWISE INTERACTIONS; CHOLINERGIC-RECEPTOR; ALZHEIMERS-DISEASE; TRANSMEMBRANE SITE; MAMMALIAN-CELLS	Elucidation of the structural basis of pharmacological differences for highly homologous alpha 7 and alpha 9 nicotinic acetylcholine receptors (nAChRs) may shed light on their involvement in different physiological functions and diseases. Combination of site-directed mutagenesis and electrophysiology is a powerful tool to pinpoint the key amino-acid residues in the receptor ligand-binding site, but for alpha 7 and alpha 9 nAChRs it is complicated by their poor expression and fast desensitization. Here, we probed the ligand-binding properties of alpha 7/alpha 9 nAChR mutants by a proposed simple and fast calcium imaging method. The method is based on transient co-expression of alpha 7/alpha 9 nAChR mutants in neuroblastoma cells together with Ric-3 or NACHO chaperones and Case12 fluorescent calcium ion sensor followed by analysis of their pharmacology using a fluorescence microscope or a fluorometric imaging plate reader (FLIPR) with a GFP filter set. The results obtained were confirmed by electrophysiology and by calcium imaging with the conventional calcium indicator Fluo-4. The affinities for acetylcholine and epibatidine were determined for human and rat alpha 7 nAChRs, and for their mutants with homologous residues of alpha 9 nAChR incorporated at positions 117-119, 184, 185, 187, and 189, which are anticipated to be involved in ligand binding. The strongest decrease in the affinity was observed for mutations at positions 187 and 119. The L119D mutation of alpha 7 nAChR, showing a larger effect for epibatidine than for acetylcholine, may implicate this position in pharmacological differences between alpha 7 and alpha 9 nAChRs.	[Shelukhina, Irina; Spirova, Ekaterina; Kudryavtsev, Denis; Ojomoko, Lucy; Tsetlin, Victor] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Dept Mol Basis Neurosignalling, Moscow, Russia; [Werner, Markus; Methfessel, Christoph; Hollmann, Michael] Ruhr Univ Bochum, Dept Biochem 1, Bochum, Germany	Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Ruhr University Bochum	Shelukhina, I (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Dept Mol Basis Neurosignalling, Moscow, Russia.	shelukhina.iv@yandex.ru	Shelukhina, Irina/AHE-5496-2022; Kudryavtsev, Denis S/O-4811-2015; Tsetlin, Victor/X-2491-2018; Ojomoko, Lucy/ABD-9910-2020	Shelukhina, Irina/0000-0003-3476-1441; Kudryavtsev, Denis S/0000-0002-0313-9193; Hollmann, Michael/0000-0001-8000-7787	ERA-Net EuroTransBio [12614r/9282]; Russian Federation [6216.2016.4]; RFBR [16-34-00627]; Russian Science Foundation [16-14-00215]	ERA-Net EuroTransBio; Russian Federation(Russian Federation); RFBR(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	The work of E. Spirova,. Methfessel, M. Werner, and Prof. M. Hollmann was supported by ERA-Net EuroTransBio 12614r/9282. The work of Shelukhina I. was supported by a grant of the President of the Russian Federation (project No. 6216.2016.4). The work of Kudryavtsev D. was supported by RFBR grant (project No. 16-34-00627). The work of Ojomoko L. and Prof. Tsetlin V. was supported by Russian Science Foundation grant 16-14-00215. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlSharari SD, 2013, BIOCHEM PHARMACOL, V86, P1201, DOI 10.1016/j.bcp.2013.06.018; Araud T, 2010, BIOCHEM PHARMACOL, V80, P160, DOI 10.1016/j.bcp.2010.03.017; Azam L, 2015, MOL PHARMACOL, V87, P855, DOI 10.1124/mol.114.096511; Azam L, 2009, ACTA PHARMACOL SIN, V30, P771, DOI 10.1038/aps.2009.47; Baker ER, 2004, MOL PHARMACOL, V65, P453, DOI 10.1124/mol.65.2.453; Barrantes Francisco J, 2014, Front Synaptic Neurosci, V6, P25, DOI 10.3389/fnsyn.2014.00025; Barron SC, 2009, MOL PHARMACOL, V76, P253, DOI 10.1124/mol.109.056226; Bencherif M, 2011, CELL MOL LIFE SCI, V68, P931, DOI 10.1007/s00018-010-0525-1; Collins T, 2011, NEUROPHARMACOLOGY, V61, P1306, DOI 10.1016/j.neuropharm.2011.07.035; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; Craig PJ, 2004, EUR J PHARMACOL, V502, P31, DOI 10.1016/j.ejphar.2004.08.042; Curtis MJ, 2015, BRIT J PHARMACOL, V172, P3461, DOI 10.1111/bph.12856; Dineley KT, 2015, TRENDS PHARMACOL SCI, V36, P96, DOI 10.1016/j.tips.2014.12.002; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X; Elgoyhen AB, 2001, P NATL ACAD SCI USA, V98, P3501, DOI 10.1073/pnas.051622798; Geerts H, 2012, EXPERT OPIN INV DRUG, V21, P59, DOI 10.1517/13543784.2012.633510; Gopalakrishnan SM, 2011, ASSAY DRUG DEV TECHN, V9, P635, DOI 10.1089/adt.2010.0319; Gronlien JH, 2007, MOL PHARMACOL, V72, P715, DOI 10.1124/mol.107.035410; Grutter T, 2005, P NATL ACAD SCI USA, V102, P18207, DOI 10.1073/pnas.0509024102; Gu SY, 2016, NEURON, V89, P948, DOI 10.1016/j.neuron.2016.01.018; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Kasheverov IE, 2009, CURR PHARM DESIGN, V15, P2430, DOI 10.2174/138161209788682316; Katz E, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00224; Kudryavtsev D, 2015, TOXINS, V7, P1683, DOI 10.3390/toxins7051683; Lansdell SJ, 2005, MOL PHARMACOL, V68, P1431, DOI 10.1124/mol.105.017459; Li SX, 2011, NAT NEUROSCI, V14, P1253, DOI 10.1038/nn.2908; Marchi M, 2010, PROG NEUROBIOL, V92, P105, DOI 10.1016/j.pneurobio.2010.06.004; Marotta CB, 2015, CHEM BIOL; McManus OB, 2014, CURR OPIN PHARMACOL, V15, P91, DOI 10.1016/j.coph.2014.01.004; Millar NS, 2009, BIOCHEM PHARMACOL, V78, P766, DOI 10.1016/j.bcp.2009.06.015; Mohammadi S, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-64; Molgo J, 2013, EXPERT OPIN DRUG DIS, V8, P1203, DOI 10.1517/17460441.2013.822365; Moretti M, 2014, MOL PHARMACOL, V86, P306, DOI 10.1124/mol.114.093377; Nizri E, 2013, AMINO ACIDS, V45, P73, DOI 10.1007/s00726-011-1192-8; Papke RL, 2000, EUR J PHARMACOL, V393, P179, DOI 10.1016/S0014-2999(00)00009-1; Papke RL, 2011, NEUROPHARMACOLOGY, V60, P159, DOI 10.1016/j.neuropharm.2010.07.014; Peng C, 2013, MOL PHARMACOL, V84, P459, DOI 10.1124/mol.113.086462; Pesti K, 2014, NEUROPHARMACOLOGY, V81, P101, DOI 10.1016/j.neuropharm.2014.01.034; Quiram PA, 1999, J BIOL CHEM, V274, P19517, DOI 10.1074/jbc.274.28.19517; Quiram PA, 2000, J BIOL CHEM, V275, P4889, DOI 10.1074/jbc.275.7.4889; Rothlin CV, 1999, MOL PHARMACOL, V55, P248, DOI 10.1124/mol.55.2.248; Rucktooa P, 2009, BIOCHEM PHARMACOL, V78, P777, DOI 10.1016/j.bcp.2009.06.098; Russo P, 2014, CURR PHARM DESIGN, V20, P6014, DOI 10.2174/1381612820666140316130720; Shelukhina IV, 2009, J NEUROCHEM, V109, P1087, DOI 10.1111/j.1471-4159.2009.06033.x; Shen JX, 2009, ACTA PHARMACOL SIN, V30, P673, DOI 10.1038/aps.2009.64; SINE SM, 1995, NEURON, V15, P229, DOI 10.1016/0896-6273(95)90080-2; Stokes C, 2015, TRENDS PHARMACOL SCI, V36, P514, DOI 10.1016/j.tips.2015.05.002; TOMASELLI GF, 1991, BIOPHYS J, V60, P721, DOI 10.1016/S0006-3495(91)82102-6; Tsunoyama K, 1998, MOL BIOL EVOL, V15, P518, DOI 10.1093/oxfordjournals.molbev.a025951; Umana IC, 2013, BIOCHEM PHARMACOL, V86, P1208, DOI 10.1016/j.bcp.2013.08.001; Valles AS, 2012, BBA-BIOMEMBRANES, V1818, P718, DOI 10.1016/j.bbamem.2011.10.012; Verbitsky M, 2000, NEUROPHARMACOLOGY, V39, P2515, DOI 10.1016/S0028-3908(00)00124-6; Williams DK, 2011, MOL PHARMACOL, V80, P1013, DOI 10.1124/mol.111.074302; Williams ME, 2005, J BIOL CHEM, V280, P1257, DOI 10.1074/jbc.M410039200; Yamauchi JG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016519; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zoli M, 2015, NEUROPHARMACOLOGY, V96, P302, DOI 10.1016/j.neuropharm.2014.11.003; Zondlo NJ, 2013, ACCOUNTS CHEM RES, V46, P1039, DOI 10.1021/ar300087y; Zouridakis M, 2014, NAT STRUCT MOL BIOL, V21, P976, DOI 10.1038/nsmb.2900	61	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 10	2017	12	8							e0181936	10.1371/journal.pone.0181936	http://dx.doi.org/10.1371/journal.pone.0181936			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FD2WT	28797116	Green Published, gold, Green Submitted			2022-12-26	WOS:000407396200021
J	Yimam, YT; Ochsner, TE; Fox, GA				Yimam, Yohannes Tadesse; Ochsner, Tyson E.; Fox, Garey A.			Hydrologic cost-effectiveness ratio favors switchgrass production on marginal croplands over existing grasslands	PLOS ONE			English	Article							BIOENERGY PRODUCTION; RIVER-BASIN; BIOFUEL PRODUCTION; ALAMO SWITCHGRASS; PANICUM-VIRGATUM; UNITED-STATES; ENERGY CROPS; SWAT MODEL; LAND-USE; WATER	Switchgrass (Panicum virgatum L.) has attracted attention as a promising second generation biofuel feedstock. Both existing grasslands and marginal croplands have been suggested as targets for conversion to switchgrass, but the resulting production potentials and hydrologic impacts are not clear. The objectives of this study were to model switchgrass production on existing grasslands (scenario-I) and on marginal croplands that have severe to very severe limitations for crop production (scenario-II) and to evaluate the effects on evapotranspiration (ET) and streamflow. The Soil and Water Assessment Tool (SWAT) was applied to the 1063 km 2 Skeleton Creek watershed in north-central Oklahoma, a watershed dominated by grasslands (35%) and winter wheat cropland (47%). The simulated average annual yield (2002-2011) for rainfed Alamo switchgrass for both scenarios was 12 Mg ha(-1). Yield varied spatially under scenario-I from 6.1 to 15.3 Mg ha(-1), while under scenario-II the range was from 8.2 to 13.8 Mg ha(-1). Comparison of average annual ET and streamflow between the baseline simulation (existing land use) and scenario-I showed that scenario-I had 5.6% (37 mm) higher average annual ET and 27.7% lower streamflow, representing a 40.7 million m(3) yr(-1) streamflow reduction. Compared to the baseline, scenario-II had only 0.5% higher ET and 3.2% lower streamflow, but some monthly impacts were larger. In this watershed, the water yield reduction per ton of biomass production (i.e. hydrologic cost-effectiveness ratio) was more than 5X greater under scenario-I than under scenario-II. These results suggest that, from a hydrologic perspective, it may be preferable to convert marginal cropland to switchgrass production rather than converting existing grasslands.	[Yimam, Yohannes Tadesse] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Ochsner, Tyson E.] Oklahoma State Univ, Dept Plant & Soil Sci, Stillwater, OK 74078 USA; [Fox, Garey A.] Oklahoma State Univ, Biosyst & Agr Engn, Stillwater, OK 74078 USA	Texas A&M University System; Texas A&M University College Station; Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater	Yimam, YT (corresponding author), Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA.	yohannes.yimam@tamu.edu		Fox, Garey/0000-0002-9965-7920; Ochsner, Tyson/0000-0003-0875-4491	USDA National Institute of Food and Agriculture [2009-10006-06070]; Division of Agricultural Sciences and Natural Resources at Oklahoma State University; Hatch Project	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Division of Agricultural Sciences and Natural Resources at Oklahoma State University; Hatch Project(United States Department of Agriculture (USDA))	Financial support for this research was provided by the USDA National Institute of Food and Agriculture, Grant No. 2009-10006-06070, Hatch Project and the Division of Agricultural Sciences and Natural Resources at Oklahoma State University. TEO received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the Oklahoma NRCS staff at Stillwater for their help in preparing the LCC map and Collin Craige for his assistance with SWAT wheat yield calibration. The authors also appreciate the helpful input from two anonymous reviewers. Funding for this work was provided by USDA National Institute of Food and Agriculture, Grant No. 2009-10006-06070, Hatch Project and the Division of Agricultural Sciences and Natural Resources at Oklahoma State University.	Acreman M, 2004, HYDROL EARTH SYST SC, V8, P861, DOI 10.5194/hess-8-861-2004; Baskaran L, 2010, T ASABE, V53, P1547; Berndes G, 2002, GLOBAL ENVIRON CHANG, V12, P253, DOI 10.1016/S0959-3780(02)00040-7; Blanco-Canqui H, 2016, SOIL SCI SOC AM J, V80, P845, DOI 10.2136/sssaj2016.03.0080; Bransby D, 1998, BIOENERGY 98, P4; Burba GG, 2005, AGR FOREST METEOROL, V135, P190, DOI 10.1016/j.agrformet.2005.11.017; Cai XM, 2011, ENVIRON SCI TECHNOL, V45, P334, DOI 10.1021/es103338e; Ceotto E, 2008, AGRON SUSTAIN DEV, V28, P47, DOI 10.1051/agro:2007034; Chen Y, 2016, BIOENERG RES, V9, P1126, DOI 10.1007/s12155-016-9758-7; Dale VH, 2011, ECOL APPL, V21, P1039, DOI 10.1890/09-0501.1; Fisher CF, 1959, SOIL SURVEY KINGFISH; Foster A., 2013, THESIS; Froschl L, 2008, ECOL ECON, V68, P96, DOI 10.1016/j.ecolecon.2008.02.005; Fry J, 2011, PHOTOGRAMM ENG REMOT, V77, P858; Fuentes R. G., 2002, Trends in new crops and new uses. Proceedings of the Fifth National Symposium, Atlanta, Georgia, USA, 10-13 November, 2001, P276; Galloway HM, 1948, SOIL SURVEY LOGAN CO; Gassman PW, 2007, T ASABE, V50, P1211, DOI 10.13031/2013.23637; Gelfand I, 2013, NATURE, V493, P514, DOI 10.1038/nature11811; Gesch D, 2002, PHOTOGRAMM ENG REM S, V68, P5; Goldstein JC, 2015, HYDROL PROCESS, V29, P724, DOI 10.1002/hyp.10159; Goldstein JC, 2014, HYDROL RES, V45, P99, DOI 10.2166/nh.2013.163; Gopalakrishnan G, 2009, ENVIRON SCI TECHNOL, V43, P6094, DOI 10.1021/es900801u; GRAHAM RL, 1994, BIOMASS BIOENERG, V6, P175, DOI 10.1016/0961-9534(94)90074-4; Gu YX, 2012, GCB BIOENERGY, V4, P96, DOI 10.1111/j.1757-1707.2011.01113.x; Hong CO, 2014, BIOENERG RES, V7, P777, DOI 10.1007/s12155-014-9484-y; Johnson J.M.F., 2007, AM J PLANT SCI BIOTE, V1, P1; Khanal S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109129; Kim H, 2012, T ASABE, V55, P2123; Kiniry JR, 2013, BIOENERG RES, V6, P276, DOI 10.1007/s12155-012-9254-7; Kiniry JR, 1996, AGRON J, V88, P602, DOI 10.2134/agronj1996.00021962008800040018x; Klingebiel AA, 1961, USDA AGR HDB, V210; McLaughlin SB, 2002, ENVIRON SCI TECHNOL, V36, P2122, DOI 10.1021/es010963d; McLaughlin SB, 2005, BIOMASS BIOENERG, V28, P515, DOI 10.1016/j.biombioe.2004.05.006; McPherson RA, 2007, J ATMOS OCEAN TECH, V24, P301, DOI 10.1175/JTECH1976.1; Moriasi DN, 2007, T ASABE, V50, P885, DOI 10.13031/2013.23153; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; Natural Resources Conservation Service, 2012, SOIL SURV GEOGR SSUR; Neitsch S.L., 2011, SOIL WATER ASSESSMEN, DOI [10.1016/j.scitotenv.2015.11.063, DOI 10.1016/J.SCITOTENV.2015.11.063]; Oklahoma Water Resouces Board (OWRB), 2012, OWRB STREAMS; Panagopoulos Y, 2011, J ENVIRON MANAGE, V92, P2823, DOI 10.1016/j.jenvman.2011.06.035; Patrignani A, 2014, AGRON J, V106, P1329, DOI 10.2134/agronj14.0011; SAMSON RA, 1994, PROCEEDINGS OF THE THIRTEENTH NORTH AMERICAN PRAIRIE CONFERENCE: SPIRIT OF THE LAND, OUR PRAIRIE LEGACY, P253; Scanlon B.R, 2007, WATER RESOUR RES, V43; Schilling KE, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006644; Shaviv A, 2004, J IRRIG DRAIN ENG, V130, P485, DOI 10.1061/(ASCE)0733-9437(2004)130:6(485); Shen H, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-71; Singh G, 2016, ENVIRON MODELL SOFTW, V81, P26, DOI 10.1016/j.envsoft.2015.12.001; Srinivasan R, 2010, T ASABE, V53, P1533; Swarfford BG, 1967, SOIL SURVEY GARFIELD; Thomas MA, J WATER RESOURCE PRO, V6, P1352; Van Griensven A., 2005, SENSITIVITY AUTOCALI; Wilcox BP, 2007, HYDROL PROCESS, V21, P2961, DOI 10.1002/hyp.6856; WILLIAMS JR, 1984, T ASAE, V27, P129; Wu YP, 2012, GCB BIOENERGY, V4, P875, DOI 10.1111/j.1757-1707.2012.01164.x; Wu YP, 2012, BIOMASS BIOENERG, V36, P182, DOI 10.1016/j.biombioe.2011.10.030; Yimam YT, 2014, SOIL SCI SOC AM J, V78, P1584, DOI 10.2136/sssaj2014.04.0165; Zhang X, 2010, GCB BIOENERGY, V2, P258, DOI 10.1111/j.1757-1707.2010.01046.x	57	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 8	2017	12	8							e0181924	10.1371/journal.pone.0181924	http://dx.doi.org/10.1371/journal.pone.0181924			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC9EU	28792541	Green Published, Green Submitted, gold			2022-12-26	WOS:000407144700009
J	Wang, RC; Chen, XM; Parissenti, AM; Joy, AA; Tuszynski, J; Brindley, DN; Wang, ZX				Wang, Richard C.; Chen, Xinmei; Parissenti, Amadeo M.; Joy, Anil A.; Tuszynski, Jack; Brindley, David N.; Wang, Zhixiang			Sensitivity of docetaxel-resistant MCF-7 breast cancer cells to microtubule-destabilizing agents including vinca alkaloids and colchicine-site binding agents	PLOS ONE			English	Article							BETA-TUBULIN ISOTYPES; IN-VITRO; DOXORUBICIN; MECHANISMS; EXPRESSION; PACLITAXEL; DYNAMICS; TAXANE; 2-METHOXYESTRADIOL; CYCLOPHOSPHAMIDE	Introduction One of the main reasons for disease recurrence in the curative breast cancer treatment setting is the development of drug resistance. Microtubule targeted agents (MTAs) are among the most commonly used drugs for the treatment of breaset cancer and therefore overcoming taxane resistance is of primary clinical importance. Our group has previously demonstrated that the microtubule dynamics of docetaxel-resistant MCF-7(TXT) cells are insensitivity to docetaxel due to the distinct expression profiles of beta-tubulin isotypes in addition to the high expression of p-glycoprotein (ABCB1). In the present investigation we examined whether taxane-resistant breast cancer cells are more sensitive to microtubule destabilizing agents including vinca alkaloids and colchicine-site binding agents (CSBAs) than the nonresistant cells. Methods Two isogenic MCF-7 breast cancer cell lines were selected for resistance to docetaxel (MCF-7(TXT)) and the wild type parental cell line (MCF-7(CC)) to examine if taxane-resistant breast cancer cells are sensitive to microtubule-destabilizing agents including vinca alkaloids and CSBAs. Cytotoxicity assays, immunoblotting, indirect immunofluorescence and live imaging were used to study drug resistance, apoptosis, mitotic arrest, microtubule formation, and microtubule dynamics. Results MCF-7(TXT) cells were demonstrated to be cross resistant to vinca alkaloids, but were more sensitive to treatment with colchicine compared to parental non-resistant MCF-7(CC) cells. Cytotoxicity assays indicated that the IC50 of MCF-7(TXT) cell to vinorelbine and vinblastine was more than 6 and 3 times higher, respectively, than that of MCF-7(CC) cells. By contrast, the IC50 of MCF-7(TXT) cell for colchincine was 4 times lower than that of MCF-7(CC) cells. Indirect immunofluorescence showed that all MTAs induced the disorganization of microtubules and the chromatin morphology and interestingly each with a unique pattern. In terms of microtubule and chromain morphology, MCF-7(TXT) cells were more resistant to vinorelbine and vinblastine, but more sensitive to colchicine compared to MCF-7(CC) cells. PARP cleavage assay further demonstrated that all of the MTAs induced apoptosis of the MCF-7 cells. However, again, MCF-7(TXT) cells were more resistant to vinorelbine and vinblastine, and more sensitive to colchicine compared to MCF-7(CC) cells. Live imaging demonstrated that the microtubule dynamics of MCF-7(TXT) cells were less sensitive to vinca alkaloids, and more sensitive to colchicine. MCF-7(TXT) cells were also noted to be more sensitive to other CSBAs including 2MeOE(2), ABT-751 and phosphorylated combretastatin A-4 (CA-4P). Conclusion Docetaxel-resistant MCF-7(TXT) cells have demonstrated cross-resistance to vinca alkaloids, but appear to be more sensitive to CSBAs (colchicine, 2MeOE(2), ABT-751 and CA-4P) compared to non-resistant MCF-7(CC) cells. Taken together these results suggest that CSBAs should be evaluated further in the treatment of taxane resistant breast cancer.	[Wang, Richard C.; Chen, Xinmei; Wang, Zhixiang] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada; [Wang, Richard C.; Chen, Xinmei; Brindley, David N.; Wang, Zhixiang] Univ Alberta, Signal Transduct Res Grp, Fac Med & Dent, Edmonton, AB, Canada; [Parissenti, Amadeo M.] Sudbury Reg Hosp, Reg Canc Program, Sudbury, ON, Canada; [Joy, Anil A.; Tuszynski, Jack] Univ Alberta, Fac Med & Dent, Dept Oncol, Edmonton, AB, Canada; [Brindley, David N.] Univ Alberta, Dept Biochem, Edmonton, AB, Canada; [Wang, Richard C.] Harvard Univ, Cambridge, MA 02138 USA	University of Alberta; University of Alberta; Health Sciences North; University of Alberta; University of Alberta; Harvard University	Wang, ZX (corresponding author), Univ Alberta, Dept Med Genet, Edmonton, AB, Canada.; Wang, ZX (corresponding author), Univ Alberta, Signal Transduct Res Grp, Fac Med & Dent, Edmonton, AB, Canada.	zhixiang.wang@ualberta.ca	Tuszynski, Jack/AAA-2073-2020	Tuszynski, Jack/0000-0001-9976-0429; North, scott/0000-0003-4427-5439; Wang, Richard/0000-0003-3442-0559	Canadian Breast Cancer Foundation (CBCF); Sanofi-aventis BioTalent Challenge (SABC)	Canadian Breast Cancer Foundation (CBCF); Sanofi-aventis BioTalent Challenge (SABC)	This research is supported in part by funding from Canadian Breast Cancer Foundation (CBCF) to DNB and ZW and Sanofi-aventis BioTalent Challenge (SABC) to RW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abal M, 2003, CURR CANCER DRUG TAR, V3, P193, DOI 10.2174/1568009033481967; ALVAREZ M, 1995, J CLIN INVEST, V95, P2205, DOI 10.1172/JCI117910; Banerjee A, 2002, BIOCHEM BIOPH RES CO, V293, P598, DOI 10.1016/S0006-291X(02)00269-3; Bayes M, 2008, Methods Find Exp Clin Pharmacol, V30, P67; BREUNINGER LM, 1995, CANCER RES, V55, P5342; BRUGGEMANN EP, 1992, J BIOL CHEM, V267, P21020; Burkhart CA, 2001, BBA-REV CANCER, V1471, pO1, DOI 10.1016/S0304-419X(00)00022-6; Chan KS, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.148; CHEN X, 2000, BIOCHEMBIOPHYSRESCOM; Derry WB, 1997, BIOCHEMISTRY-US, V36, P3554, DOI 10.1021/bi962724m; Diaz JF, 1998, J BIOL CHEM, V273, P33803, DOI 10.1074/jbc.273.50.33803; Downing KH, 1999, CELL STRUCT FUNCT, V24, P269; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Escuin D, 2009, CELL CYCLE, V8, P3914, DOI 10.4161/cc.8.23.10105; Gascoigne KE, 2009, J CELL SCI, V122, P2579, DOI 10.1242/jcs.039719; Hembruff SL, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-318; Iseri OD, 2010, UHOD-ULUSLAR HEMATOL, V20, P75; Jassem J, 2001, J CLIN ONCOL, V19, P1707, DOI 10.1200/JCO.2001.19.6.1707; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jordan M. A., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P1, DOI 10.2174/1568011023354290; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kamath K, 2005, J BIOL CHEM, V280, P12902, DOI 10.1074/jbc.M414477200; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Kufe DW, 2003, HOLLAND FREI CANC ME, V6th; Lal S, 2010, CURR DRUG METAB, V11, P115, DOI 10.2174/138920010791110890; Liu L, 2011, TRAFFIC, V12, P201, DOI 10.1111/j.1600-0854.2010.01141.x; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Lu Y, 2012, PHARM RES-DORDR, V29, P2943, DOI 10.1007/s11095-012-0828-z; McGrogan BT, 2008, BBA-REV CANCER, V1785, P96, DOI 10.1016/j.bbcan.2007.10.004; Meyer-Losic F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080305; Murray S, 2012, CANCER TREAT REV, V38, P890, DOI 10.1016/j.ctrv.2012.02.011; Nabholtz JM, 2003, J CLIN ONCOL, V21, P968, DOI 10.1200/JCO.2003.04.040; PANDA D, 1994, P NATL ACAD SCI USA, V91, P11358, DOI 10.1073/pnas.91.24.11358; Rivera E, 2010, BREAST J, V16, P252, DOI 10.1111/j.1524-4741.2009.00896.x; Schumacher G, 2007, J GASTROEN HEPATOL, V22, P1469, DOI 10.1111/j.1440-1746.2007.05033.x; Simoni D, 2005, J MED CHEM, V48, P723, DOI 10.1021/jm049622b; Stengel C, 2010, BRIT J CANCER, V102, P316, DOI 10.1038/sj.bjc.6605489; Tsukamoto, 1997, Breast Cancer, V4, P259, DOI 10.1007/BF02966518; WANG H, 2014, ABSTR APPL ANAL, V2014, P1, DOI DOI 10.1186/1471-2407-14-37.PMID:24447372;PUBMED; Wehbe H, 2005, ANTICANCER RES, V25, P3865; Wiesen KM, 2007, CANCER LETT, V257, P227, DOI 10.1016/j.canlet.2007.07.022; Yardley DA, 2013, INT J BREAST CANCER, V2013, DOI 10.1155/2013/137414; Zelnak A, 2010, BREAST J, V16, P309, DOI 10.1111/j.1524-4741.2010.00911.x	44	18	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 7	2017	12	8							e0182400	10.1371/journal.pone.0182400	http://dx.doi.org/10.1371/journal.pone.0182400			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC7CP	28787019	Green Published, Green Submitted, gold			2022-12-26	WOS:000406998800036
J	Zhou, QT; Flores, A; Glenn, NF; Walters, R; Hang, BS				Zhou, Qingtao; Flores, Alejandro; Glenn, Nancy F.; Walters, Reggie; Hang, Bangshuai			A machine learning approach to estimation of downward solar radiation from satellite-derived data products: An application over a semi-arid ecosystem in the US	PLOS ONE			English	Article							ADIRONDACK REGION; LAKE-WATERSHEDS; LAND; ALBEDO; MODIS; ALGORITHM; MODEL; VALIDATION; RETRIEVAL; BRDF	Shortwave solar radiation is an important component of the surface energy balance and provides the principal source of energy for terrestrial ecosystems. This paper presents a machine learning approach in the form of a random forest (RF) model for estimating daily downward solar radiation flux at the land surface over complex terrain using MODIS (MODerate Resolution Imaging Spectroradiometer) remote sensing data. The model-building technique makes use of a unique network of 16 solar flux measurements in the semi-arid Reynolds Creek Experimental Watershed and Critical Zone Observatory, in southwest Idaho, USA. Based on a composite RF model built on daily observations from all 16 sites in the watershed, the model simulation of downward solar radiation matches well with the observation data (r(2) = 0.96). To evaluate model performance, RF models were built from 12 of 16 sites selected at random and validated against the observations at the remaining four sites. Overall root mean square errors (RMSE), bias, and mean absolute error (MAE) are small (range: 37.17 W/m(2) -81.27 W/m(2), -48.31 W/m(2) -15.67 W/m(2), and 26.56 W/m(2) -63.77 W/m(2), respectively). When extrapolated to the entire watershed, spatiotemporal patterns of solar flux are largely consistent with expected trends in this watershed. We also explored significant predictors of downward solar flux in order to reveal important properties and processes controlling downward solar radiation. Based on the composite RF model built on all 16 sites, the three most important predictors to estimate downward solar radiation include the black sky albedo (BSA) near infrared band (0.858 mu m), BSA visible band (0.3-0.7 mu m), and clear day coverage. This study has important implications for improving the ability to derive downward solar radiation through a fusion of multiple remote sensing datasets and can potentially capture spatiotemporally varying trends in solar radiation that is useful for land surface hydrologic and terrestrial ecosystem modeling.	[Zhou, Qingtao; Flores, Alejandro; Glenn, Nancy F.; Walters, Reggie] Boise State Univ, Dept Geosci, Boise, ID 83725 USA; [Hang, Bangshuai] Dept Nat Resources & Environm Management, Muncie, IN USA	Idaho; Boise State University	Zhou, QT (corresponding author), Boise State Univ, Dept Geosci, Boise, ID 83725 USA.	qingtaozhou@gmail.com	Glenn, Nancy/B-4491-2014	Glenn, Nancy/0000-0003-2124-7654	NASA EPSCoR program [NNX14AN39A]; NASA [NNX14AN39A]; Division Of Earth Sciences [1331872] Funding Source: National Science Foundation	NASA EPSCoR program; NASA(National Aeronautics & Space Administration (NASA)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by the NASA EPSCoR program, Award #NNX14AN39A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the NASA Award #NNX14AN39A.	Aber JD, 2000, CLIMATE RES, V15, P33, DOI 10.3354/cr015033; Angstrom A., 1924, Q J ROY METEOR SOC, V50, P121, DOI [10.1002/qj.49705021008, DOI 10.1002/QJ.49705021008]; [Anonymous], 1940, T ROY SOC SOUTH AUST; BECKER F, 1990, INT J REMOTE SENS, V11, P369, DOI 10.1080/01431169008955028; Bisht G, 2005, REMOTE SENS ENVIRON, V97, P52, DOI 10.1016/j.rse.2005.03.014; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen M, 2014, REMOTE SENS-BASEL, V6, P7136, DOI 10.3390/rs6087136; Dozier J, 2008, ADV WATER RESOUR, V31, P1515, DOI 10.1016/j.advwatres.2008.08.011; Finzel JA, 2015, ECOHYDROLOGY; Gao F, 2001, REMOTE SENS ENVIRON, V76, P57, DOI 10.1016/S0034-4257(00)00192-9; Gbondo-Tugbawa SS, 2001, WATER RESOUR RES, V37, P1057, DOI 10.1029/2000WR900375; Hanson CL, 2001, WATER RESOUR RES, V37, P2839, DOI 10.1029/2001WR000417; HARGREAVES GH, 1982, J IRR DRAIN DIV-ASCE, V108, P225; Hasenauer H, 2012, FOREST ECOL MANAG, V276, P196, DOI 10.1016/j.foreco.2012.03.022; JANSSEN PHM, 1995, ECOL MODEL, V83, P55, DOI 10.1016/0304-3800(95)00084-9; Liang SL, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005493; Liang X, 1994, J GEOPHYS RES-ATMOS, V99, P14415, DOI 10.1029/94JD00483; Liepert BG, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014910; Lucht W, 2000, IEEE T GEOSCI REMOTE, V38, P977, DOI 10.1109/36.841980; Ma Y, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD018332; Martonchik JV, 1998, IEEE T GEOSCI REMOTE, V36, P1266, DOI 10.1109/36.701077; Nayak A, 2010, WATER RESOUR RES, V46, DOI 10.1029/2008WR007525; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Oleson K, 2013, NCARTTN503STR; Pan SF, 2014, ADV METEOROL, V2014, DOI 10.1155/2014/965936; Running SW, 2004, BIOSCIENCE, V54, P547, DOI 10.1641/0006-3568(2004)054[0547:ACSMOG]2.0.CO;2; Schaaf CB, 2002, REMOTE SENS ENVIRON, V83, P135, DOI 10.1016/S0034-4257(02)00091-3; Skamarock W, 2008, NCARTTN4751STR; Stanhill G, 2001, AGR FOREST METEOROL, V107, P255, DOI 10.1016/S0168-1923(00)00241-0; Tinkham WT, 2011, REMOTE SENS-BASEL, V3, P638, DOI 10.3390/rs3030638; Wan ZM, 2008, REMOTE SENS ENVIRON, V112, P59, DOI 10.1016/j.rse.2006.06.026; Wan ZM, 1996, IEEE T GEOSCI REMOTE, V34, P892, DOI 10.1109/36.508406; Waske B., 2012, SIGNAL IMAGE PROCESS, P365; Yang K, 2005, WATER RESOUR RES, V41, DOI 10.1029/2005WR003976; Zhang TJ, 2005, REV GEOPHYS, V43, DOI 10.1029/2004RG000157; Zhang XT, 2014, REMOTE SENS ENVIRON, V152, P318, DOI 10.1016/j.rse.2014.07.003; Zhou QT, 2015, BIOGEOCHEMISTRY, V124, P353, DOI 10.1007/s10533-015-0102-7; Zhou QT, 2015, SCI TOTAL ENVIRON, V511, P186, DOI 10.1016/j.scitotenv.2014.12.044	38	14	14	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 4	2017	12	8							e0180239	10.1371/journal.pone.0180239	http://dx.doi.org/10.1371/journal.pone.0180239			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FC6IS	28777811	Green Submitted, Green Published, gold			2022-12-26	WOS:000406944300004
